Original gene set ID	Original gene set description	Nominal P value	False discovery rate	Reconstituted gene set Z score gene 1	Reconstituted gene set Z score gene 2	Reconstituted gene set Z score gene 3	Reconstituted gene set Z score gene 4	Reconstituted gene set Z score gene 5	Reconstituted gene set Z score gene 6	Reconstituted gene set Z score gene 7	Reconstituted gene set Z score gene 8	Reconstituted gene set Z score gene 9	Reconstituted gene set Z score gene 10
MP:0000180	abnormal circulating cholesterol level	1.55e-07	<= 0.05	ABCG5 (7.0)	ABCG8 (7.0)	APOC1 (5.6)	APOA5 (5.2)	TM6SF2 (5.0)	NPC1L1 (5.0)	APOB (4.7)	APOC4 (4.5)	FADS1 (4.2)	FADS2 (4.1)
MP:0000609	abnormal liver physiology	8.27e-07	<= 0.05	APOA5 (6.3)	APOC4 (6.0)	PLG (5.1)	APOB (5.0)	ABCG5 (4.6)	HP (4.5)	ABCG8 (4.3)	APOC1 (4.2)	ANGPTL3 (4.2)	SLC22A1 (3.7)
MP:0000599	enlarged liver	1.82e-06	<= 0.05	ABCG8 (5.7)	APOA5 (4.8)	RHD (4.4)	APOC4 (4.0)	TM6SF2 (3.6)	LPA (3.6)	SLC22A1 (3.5)	CYP7A1 (3.4)	ABCG5 (3.3)	RHCE (3.2)
MP:0001552	increased circulating triglyceride level	4.50e-06	<= 0.05	ABCG8 (5.2)	APOA5 (5.1)	ABCG5 (5.1)	GPAM (5.1)	MOSC1 (4.9)	NPC1L1 (4.7)	APOB (4.6)	TM6SF2 (4.6)	HP (4.0)	APOC1 (3.9)
MP:0002118	abnormal lipid homeostasis	5.34e-06	<= 0.05	GPAM (5.5)	APOC1 (5.1)	APOA5 (5.1)	MOSC1 (4.9)	ABCG8 (4.9)	ABCG5 (4.8)	HP (4.7)	TM6SF2 (4.6)	APOB (4.2)	APOC4 (4.1)
MP:0005179	decreased circulating cholesterol level	5.41e-06	<= 0.05	ABCG5 (7.8)	APOB (7.3)	NPC1L1 (7.2)	TM6SF2 (6.9)	ABCG8 (6.8)	APOA5 (5.4)	PLG (4.9)	APOC1 (4.6)	APOC4 (3.8)	HP (3.5)
GO:0055088	lipid homeostasis	7.74e-06	<= 0.05	ABCG8 (5.5)	NPC1L1 (5.0)	ABCG5 (4.8)	TM6SF2 (4.2)	APOC1 (3.5)	HNF1A (3.5)	APOB (3.3)	APOA5 (3.2)	APOC4 (3.1)	CYP7A1 (3.1)
GO:0042803	protein homodimerization activity	9.17e-06	<= 0.05	APOC1 (2.8)	KANK2 (2.6)	ALDH2 (2.5)	ST3GAL4 (2.5)	NPC1L1 (2.3)	APOB (2.3)	FADS1 (2.2)	SH2B3 (2.2)	HP (2.2)	RHD (2.1)
MP:0000208	decreased hematocrit	9.20e-06	<= 0.05	RHCE (10.2)	RHD (9.7)	ITGB3 (3.4)	GMPR (3.3)	GRINA (2.7)	CETP (2.5)	C12orf51 (2.3)	BCL3 (2.3)	TIMD4 (2.2)	APOC1 (2.2)
ENSG00000108984	MAP2K6 PPI subnetwork	9.72e-06	<= 0.05	CETP (3.3)	OASL (2.7)	BRAP (2.3)	TRIB1 (2.1)	ACAD10 (2.1)	MYLIP (2.0)	TIMD4 (2.0)	ENSG00000254235 (1.9)	TSSK6 (1.9)	ALDH2 (1.7)
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	1.01e-05	<= 0.05	MOSC1 (3.5)	TM6SF2 (3.3)	ABCG8 (2.5)	CETP (2.2)	GRINA (2.1)	LPAR2 (2.0)	ABCG5 (2.0)	NPC1L1 (2.0)	PLEKHH2 (1.9)	FADS1 (1.8)
GO:0044264	cellular polysaccharide metabolic process	1.07e-05	<= 0.05	LPA (2.9)	ZNF180 (2.8)	NT5DC1 (2.7)	SORT1 (2.7)	ZNF101 (2.6)	AMIGO1 (2.5)	SYPL2 (2.4)	CYB561D1 (2.0)	ENSG00000254235 (2.0)	ZHX3 (1.8)
ENSG00000158796	DEDD PPI subnetwork	1.30e-05	<= 0.05	BLOC1S3 (3.0)	ABCG8 (2.7)	FRK (2.6)	ABCG5 (2.4)	ZNF180 (2.3)	TRAFD1 (2.2)	MAU2 (2.0)	TOP1 (2.0)	COL4A3BP (2.0)	PVRL2 (1.9)
MP:0001764	abnormal homeostasis	1.79e-05	<= 0.05	SLC22A1 (4.0)	ABCG5 (4.0)	LPA (3.4)	HP (3.4)	TM6SF2 (3.1)	TRIB1 (2.8)	NPC1L1 (2.7)	TRAPPC6A (2.7)	MOSC1 (2.3)	APOB (2.3)
GO:0055092	sterol homeostasis	1.97e-05	<= 0.05	ABCG8 (5.7)	NPC1L1 (5.3)	ABCG5 (4.9)	TM6SF2 (4.4)	APOB (3.5)	APOC1 (3.4)	APOC4 (3.2)	HNF1A (3.0)	APOA5 (3.0)	TIMD4 (2.7)
GO:0042632	cholesterol homeostasis	1.97e-05	<= 0.05	ABCG8 (5.7)	NPC1L1 (5.3)	ABCG5 (4.9)	TM6SF2 (4.4)	APOB (3.5)	APOC1 (3.4)	APOC4 (3.2)	HNF1A (3.0)	APOA5 (3.0)	TIMD4 (2.7)
ENSG00000186350	RXRA PPI subnetwork	2.01e-05	<= 0.05	BCL3 (3.2)	TRIB1 (3.1)	ATXN2 (2.9)	PPP1R37 (2.8)	RELB (2.5)	MARK4 (2.5)	ABCG5 (2.4)	CARM1 (2.2)	CLPTM1 (2.2)	MAFB (2.0)
ENSG00000125686	MED1 PPI subnetwork	2.06e-05	<= 0.05	GEMIN7 (3.1)	BUD13 (3.1)	ATXN2 (2.9)	C12orf51 (2.5)	DHX38 (2.2)	ATXN7L2 (2.1)	SMARCA4 (2.1)	LDLR (1.7)	ENSG00000226648 (1.6)	MAPKAPK5 (1.5)
MP:0003406	failure of zygotic cell division	2.08e-05	<= 0.05	PSRC1 (3.3)	ATXN2 (3.2)	MAPKAPK5 (3.0)	LPIN3 (2.9)	APOC1 (2.8)	APOB (2.7)	ATXN7L2 (2.6)	BRAP (2.5)	GRINA (2.5)	ERP29 (2.1)
GO:0052689	carboxylic ester hydrolase activity	2.10e-05	<= 0.05	APOC1 (3.7)	TM6SF2 (3.5)	CETP (3.4)	APOC4 (3.3)	SLC22A1 (3.2)	NKPD1 (3.0)	MOSC1 (3.0)	CYP7A1 (3.0)	APOA5 (2.8)	GPAM (2.8)
MP:0002599	increased mean platelet volume	2.19e-05	<= 0.05	ABCG8 (6.8)	ITGB3 (4.9)	ABCG5 (4.8)	CETP (4.2)	TM6SF2 (4.1)	RHCE (3.5)	NPC1L1 (3.5)	GMPR (2.9)	TIMD4 (2.9)	RHD (2.8)
MP:0000639	abnormal adrenal gland morphology	2.30e-05	<= 0.05	APOC1 (4.8)	FADS2 (4.2)	FADS1 (3.9)	GPAM (2.8)	C11orf9 (2.8)	PVRL2 (2.6)	HMGCR (2.6)	GCNT4 (2.2)	COL4A3BP (2.0)	GOT2P1 (1.8)
MP:0003982	increased cholesterol level	2.40e-05	<= 0.05	APOC4 (5.2)	APOA5 (4.7)	FADS2 (4.6)	FADS1 (4.3)	APOE (4.2)	CYP7A1 (4.1)	HMGCR (3.9)	ABCG5 (3.2)	APOC1 (3.0)	ABCG8 (3.0)
GO:0005976	polysaccharide metabolic process	2.51e-05	<= 0.05	LPA (2.9)	SORT1 (2.9)	ENSG00000228044 (2.8)	NT5DC1 (2.7)	ST3GAL4 (2.5)	ZNF180 (2.3)	CILP2 (2.2)	CYB561D1 (2.1)	AMIGO1 (2.1)	SYPL2 (2.0)
REACTOME_LIPOPROTEIN_METABOLISM	REACTOME_LIPOPROTEIN_METABOLISM	2.53e-05	<= 0.05	APOB (9.0)	APOC1 (7.8)	ABCG5 (6.9)	NPC1L1 (6.4)	APOA5 (5.9)	PLG (5.8)	TM6SF2 (5.4)	APOC4 (4.8)	APOE (4.4)	ANGPTL3 (4.4)
ENSG00000131910	NR0B2 PPI subnetwork	2.62e-05	<= 0.05	CYP7A1 (3.5)	ABCG8 (3.5)	ST3GAL4 (3.2)	APOC1 (2.6)	HNF1A (2.5)	MOSC1 (2.5)	APOA5 (2.3)	TM6SF2 (2.1)	GCNT4 (2.1)	ENSG00000254235 (2.0)
ENSG00000113889	KNG1 PPI subnetwork	2.70e-05	<= 0.05	ANGPTL3 (6.6)	APOC4 (5.1)	PLG (5.1)	HP (4.6)	LPA (4.0)	ITGB3 (3.6)	APOA5 (3.5)	CYP7A1 (3.0)	PCSK9 (2.9)	SLC22A1 (2.8)
GO:0032370	positive regulation of lipid transport	2.81e-05	<= 0.05	GEMIN7 (2.9)	TIMD4 (2.7)	APOC1 (2.6)	CBLC (2.5)	C12orf43 (2.4)	MYLIP (2.3)	CETP (2.3)	PMFBP1 (2.1)	ST3GAL4 (2.0)	MAFB (1.9)
MP:0002727	decreased circulating insulin level	3.02e-05	<= 0.05	KIAA1324 (2.5)	TRIB1 (2.5)	APOC1 (2.4)	PPP1R37 (2.3)	MAFB (2.1)	GPAM (2.1)	APOB (2.0)	ZHX3 (1.9)	CETP (1.8)	TOP1 (1.8)
ENSG00000197561	ELANE PPI subnetwork	3.16e-05	<= 0.05	HP (8.3)	PLG (3.9)	TIMD4 (3.5)	APOA5 (3.2)	ANGPTL3 (3.1)	APOC1 (3.1)	SLC22A1 (2.9)	CETP (2.6)	RHD (2.6)	APOB (2.4)
MP:0002702	decreased circulating free fatty acid level	3.25e-05	<= 0.05	MOSC1 (5.9)	APOB (4.4)	HP (4.3)	GPAM (3.9)	APOA5 (3.6)	APOC4 (3.5)	PLG (3.2)	APOC1 (3.2)	TM6SF2 (2.7)	TRIB1 (2.6)
MP:0000182	increased circulating LDL cholesterol level	3.25e-05	<= 0.05	APOC1 (5.5)	NPC1L1 (4.5)	TM6SF2 (4.0)	ABCG5 (3.6)	TIMD4 (3.5)	APOA5 (3.2)	APOE (3.0)	GPAM (2.9)	FADS1 (2.8)	ABCG8 (2.7)
MP:0002941	increased circulating alanine transaminase level	3.45e-05	<= 0.05	APOA5 (5.1)	SLC22A1 (4.8)	TM6SF2 (4.3)	ABCG5 (4.0)	APOC4 (3.9)	CYP7A1 (3.4)	LPIN3 (3.3)	PLG (3.3)	HP (3.2)	LPA (3.2)
MP:0004773	abnormal bile composition	3.68e-05	<= 0.05	ABCG5 (9.0)	ABCG8 (8.1)	APOA5 (6.0)	APOB (5.7)	NPC1L1 (5.6)	APOC4 (5.5)	TM6SF2 (5.2)	CYP7A1 (3.9)	PLG (3.8)	SLC22A1 (2.7)
MP:0000691	enlarged spleen	4.07e-05	<= 0.05	RHCE (4.7)	RHD (4.6)	BCL3 (3.4)	RELB (3.3)	GMIP (3.3)	PARP10 (3.1)	SH2B3 (2.1)	SLC44A2 (2.1)	MAFB (1.8)	TIMD4 (1.8)
MP:0005311	abnormal circulating amino acid level	4.45e-05	<= 0.05	PLG (5.4)	SLC22A1 (5.0)	APOA5 (4.9)	LPA (4.7)	ANGPTL3 (4.5)	APOC4 (4.5)	TM6SF2 (4.2)	CYP7A1 (4.0)	HP (3.7)	ABCG8 (3.6)
GO:0032376	positive regulation of cholesterol transport	4.45e-05	<= 0.05	APOC1 (3.6)	GEMIN7 (3.4)	MYLIP (3.1)	TIMD4 (2.9)	APOE (2.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.3)	CETP (2.1)	MOSC1 (2.1)	ALDH2 (2.0)
GO:0032373	positive regulation of sterol transport	4.45e-05	<= 0.05	APOC1 (3.6)	GEMIN7 (3.4)	MYLIP (3.1)	TIMD4 (2.9)	APOE (2.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.3)	CETP (2.1)	MOSC1 (2.1)	ALDH2 (2.0)
MP:0005559	increased circulating glucose level	4.63e-05	<= 0.05	NPC1L1 (3.6)	GPAM (2.7)	MOSC1 (2.2)	KIAA1324 (2.0)	HP (1.9)	ABCG8 (1.8)	PCSK9 (1.8)	LPIN3 (1.7)	BCL3 (1.7)	LDLR (1.7)
GO:0046527	glucosyltransferase activity	4.88e-05	<= 0.05	PVR (3.5)	ATP13A1 (3.3)	PVRL2 (2.9)	HP (2.6)	ANKRD31 (2.6)	CLPTM1 (2.4)	NAA25 (2.4)	SORT1 (2.4)	MOSC1 (2.2)	ENSG00000254235 (2.0)
GO:0006869	lipid transport	5.26e-05	<= 0.05	ABCG8 (3.9)	TM6SF2 (3.9)	ABCG5 (3.6)	NPC1L1 (3.4)	LPIN3 (2.5)	APOB (2.4)	APOA5 (2.4)	APOC1 (2.4)	GPAM (2.3)	MOSC1 (2.3)
GO:0042304	regulation of fatty acid biosynthetic process	5.27e-05	<= 0.05	FADS2 (2.7)	HNF1A (2.7)	PCSK9 (2.6)	FADS1 (2.4)	LPIN3 (2.2)	NPC1L1 (2.1)	ABCG5 (2.0)	TM6SF2 (1.9)	CYP7A1 (1.9)	CBLC (1.7)
REACTOME_METABOLISM_OF_CARBOHYDRATES	REACTOME_METABOLISM_OF_CARBOHYDRATES	5.70e-05	<= 0.05	TM6SF2 (4.4)	ABCG5 (3.6)	DOCK7 (3.4)	NPC1L1 (3.3)	SYPL2 (3.2)	MOSC1 (3.1)	DHODH (3.0)	SORT1 (2.9)	GPAM (2.7)	ABCG8 (2.6)
ENSG00000110330	BIRC2 PPI subnetwork	5.76e-05	<= 0.05	RELB (4.6)	TRAFD1 (2.7)	USP24 (2.7)	PARP10 (2.4)	LPAR2 (2.1)	TRAPPC6A (2.0)	SLC22A1 (1.9)	C1orf63 (1.9)	BCL3 (1.9)	COL4A3BP (1.8)
ENSG00000100288	CHKB PPI subnetwork	6.13e-05	<= 0.05	CYP7A1 (3.6)	APOA5 (3.6)	ANGPTL3 (3.5)	LPA (3.4)	PLG (3.4)	SLC22A1 (3.1)	NKPD1 (2.8)	APOC1 (2.7)	HAPLN4 (2.5)	C11orf9 (2.4)
MP:0001711	abnormal placenta morphology	6.23e-05	<= 0.05	CBLC (2.9)	MOSC1 (2.7)	APOB (2.7)	PTPN11 (2.5)	TRIB1 (2.4)	APOA5 (2.4)	LDLR (2.4)	DHODH (2.4)	HP (2.3)	ANGPTL3 (2.1)
GO:0005506	iron ion binding	6.40e-05	<= 0.05	SLC22A1 (5.5)	CYP7A1 (5.0)	HP (4.9)	LPA (4.7)	FADS1 (4.5)	PLG (4.0)	APOA5 (4.0)	ANGPTL3 (4.0)	RHCE (3.9)	ABCG5 (3.7)
MP:0005145	increased circulating VLDL cholesterol level	6.84e-05	<= 0.05	APOC1 (5.6)	MOSC1 (3.9)	GPAM (3.7)	ALDH2 (3.5)	APOC4 (3.2)	TIMD4 (3.0)	HP (2.7)	FADS2 (2.6)	FADS1 (2.4)	DNM2 (2.3)
GO:0003706	ligand-regulated transcription factor activity	6.93e-05	<= 0.05	PPP1R37 (4.9)	BCL3 (3.4)	ENSG00000254235 (2.0)	PLEC (2.0)	BLOC1S3 (2.0)	BCAM (2.0)	ATXN2 (1.9)	CLPTM1 (1.9)	KANK2 (1.9)	ST3GAL4 (1.8)
MP:0005668	decreased circulating leptin level	7.18e-05	<= 0.05	GPAM (4.6)	MOSC1 (3.4)	SORT1 (3.4)	HP (3.0)	APOC1 (2.9)	ST3GAL4 (2.8)	ALDH2 (2.6)	PPP1R37 (2.2)	HLX (2.2)	BCL3 (2.1)
MP:0001786	skin edema	7.25e-05	<= 0.05	ITGB3 (4.5)	NYNRIN (3.1)	GRINA (2.8)	CETP (2.6)	MAFB (2.3)	MYLIP (2.1)	BCL3 (2.1)	TM6SF2 (2.0)	SLC44A2 (1.9)	C12orf51 (1.7)
ENSG00000171564	FGB PPI subnetwork	7.49e-05	<= 0.05	PLG (7.2)	APOB (6.7)	ANGPTL3 (6.6)	APOA5 (6.1)	APOC4 (5.3)	APOC1 (4.6)	HP (4.4)	SLC22A1 (2.9)	CYP7A1 (2.7)	ABCG5 (2.7)
GO:0005625	soluble fraction	7.56e-05	<= 0.05	SARS (4.0)	MOSC1 (3.0)	GRINA (2.8)	GPAM (2.5)	TM6SF2 (2.2)	NPC1L1 (2.2)	ERP29 (2.2)	HP (2.2)	ALDH2 (2.1)	FADS2 (2.1)
MP:0009289	decreased epididymal fat pad weight	7.71e-05	<= 0.05	SORT1 (3.7)	APOC4 (3.5)	HP (3.5)	ZHX3 (3.4)	MOSC1 (3.3)	GPAM (2.7)	MAFB (2.4)	PLG (2.1)	SYPL2 (2.1)	APOC1 (2.1)
GO:0033692	cellular polysaccharide biosynthetic process	7.71e-05	<= 0.05	ZNF101 (2.5)	ENSG00000254235 (2.5)	CYB561D1 (2.4)	SORT1 (2.4)	AMIGO1 (2.3)	LPA (2.3)	NT5DC1 (2.3)	ZNF180 (2.3)	SYPL2 (2.0)	ENSG00000228044 (1.9)
MP:0002874	decreased hemoglobin content	8.28e-05	<= 0.05	RHD (10.0)	RHCE (9.6)	GMPR (3.7)	CETP (3.5)	TIMD4 (3.3)	ITGB3 (3.1)	MAFB (2.8)	PVR (2.4)	ENSG00000226645 (2.1)	C12orf51 (2.1)
MP:0005278	abnormal cholesterol homeostasis	8.55e-05	<= 0.05	NPC1L1 (8.1)	ABCG5 (7.6)	FADS1 (7.5)	HMGCR (7.4)	FADS2 (7.0)	APOB (6.8)	ABCG8 (5.9)	LDLR (5.9)	APOC1 (5.8)	PCSK9 (4.8)
GO:0015918	sterol transport	9.28e-05	<= 0.05	ABCG8 (4.6)	ABCG5 (4.1)	NPC1L1 (3.6)	TM6SF2 (3.3)	TIMD4 (3.3)	APOC1 (3.2)	APOB (2.9)	MOSC1 (2.8)	APOA5 (2.7)	APOE (2.6)
GO:0010876	lipid localization	9.31e-05	<= 0.05	ABCG8 (3.7)	TM6SF2 (3.6)	ABCG5 (3.3)	NPC1L1 (3.2)	MOSC1 (2.9)	GPAM (2.9)	APOC1 (2.6)	NKPD1 (2.5)	APOB (2.3)	APOA5 (2.3)
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	9.66e-05	<= 0.05	APOB (7.3)	NPC1L1 (7.1)	ABCG5 (7.1)	APOC1 (6.0)	TM6SF2 (5.8)	ABCG8 (5.7)	APOA5 (4.7)	PLG (4.1)	GPAM (3.9)	APOC4 (3.9)
GO:0032368	regulation of lipid transport	9.97e-05	<= 0.05	ABCG8 (4.0)	TIMD4 (3.8)	NPC1L1 (3.8)	ABCG5 (3.7)	TM6SF2 (3.2)	CBLC (2.8)	GEMIN7 (2.7)	APOC1 (2.6)	MOSC1 (2.6)	APOE (2.5)
ENSG00000164344	KLKB1 PPI subnetwork	1.06e-04	<= 0.05	ANGPTL3 (7.5)	LPA (6.8)	PLG (6.2)	APOA5 (6.2)	APOC4 (5.9)	SLC22A1 (4.9)	CYP7A1 (3.8)	HP (3.6)	APOE (3.5)	APOC1 (2.6)
GO:0030301	cholesterol transport	1.13e-04	<= 0.05	ABCG8 (4.5)	ABCG5 (4.1)	NPC1L1 (3.7)	TIMD4 (3.4)	TM6SF2 (3.3)	APOC1 (3.1)	APOB (2.9)	MOSC1 (2.7)	APOA5 (2.7)	APOE (2.5)
ENSG00000146674	IGFBP3 PPI subnetwork	1.18e-04	<= 0.05	LPA (3.9)	CYP7A1 (3.9)	APOA5 (3.8)	HP (3.8)	SLC22A1 (3.6)	APOC4 (3.4)	ANGPTL3 (3.1)	APOE (2.8)	APOB (2.6)	PLG (2.6)
GO:0070328	triglyceride homeostasis	1.29e-04	<= 0.05	ABCG8 (4.9)	TM6SF2 (3.9)	ABCG5 (3.8)	NPC1L1 (3.3)	TIMD4 (3.2)	CYP7A1 (3.0)	HNF1A (3.0)	APOC4 (2.7)	APOC1 (2.7)	LPIN3 (2.6)
ENSG00000168092	PAFAH1B2 PPI subnetwork	1.36e-04	<= 0.05	GEMIN7 (2.7)	TOMM40 (2.5)	CBLC (2.4)	RHD (2.2)	TMEM116 (2.1)	SMARCA4 (2.0)	PTPN11 (1.9)	ABO (1.9)	NYNRIN (1.8)	MARK4 (1.8)
MP:0005637	abnormal iron homeostasis	1.42e-04	<= 0.05	RHD (6.8)	RHCE (5.1)	HP (4.7)	TM6SF2 (2.7)	TIMD4 (2.4)	ALDH2 (2.3)	TMED4 (2.3)	APOC1 (2.2)	CYP7A1 (2.1)	GPAM (2.1)
ENSG00000144908	ALDH1L1 PPI subnetwork	1.50e-04	<= 0.05	PLG (3.8)	ANGPTL3 (3.4)	APOC4 (2.9)	APOA5 (2.5)	OGDH (2.4)	ILF3 (2.4)	DDX56 (2.3)	CYP7A1 (2.2)	TOMM40 (2.1)	APOB (2.0)
GO:0009395	phospholipid catabolic process	1.51e-04	<= 0.05	NKPD1 (6.4)	DNAH11 (3.0)	CETP (2.9)	TSSK6 (2.6)	APOE (2.3)	LPIN3 (1.8)	CYB561D1 (1.8)	APOC4 (1.6)	PLEKHH2 (1.5)	ENSG00000235545 (1.5)
ENSG00000175354	PTPN2 PPI subnetwork	1.52e-04	<= 0.05	PARP10 (3.1)	PLCG1 (2.8)	C1orf63 (2.3)	BCL3 (2.3)	TMEM50A (2.1)	CBLC (2.1)	PBX4 (1.8)	APOE (1.8)	C12orf47 (1.7)	ZHX3 (1.7)
ENSG00000175899	A2M PPI subnetwork	1.56e-04	<= 0.05	APOC4 (4.5)	HP (4.2)	ANGPTL3 (4.2)	APOB (4.1)	APOA5 (4.0)	APOC1 (3.8)	PLG (3.3)	SLC22A1 (3.3)	ABCG5 (2.9)	MOSC1 (2.6)
MP:0005659	decreased susceptibility to diet-induced obesity	1.59e-04	<= 0.05	MOSC1 (4.6)	TRIB1 (3.8)	TM6SF2 (3.8)	ABCG5 (3.6)	ABCG8 (3.1)	GCNT4 (2.5)	HP (2.5)	SORT1 (2.3)	APOA5 (2.3)	PLEC (2.2)
MP:0003983	decreased cholesterol level	1.61e-04	<= 0.05	HMGCR (7.0)	LDLR (7.0)	FADS1 (5.7)	FADS2 (5.6)	TM6SF2 (4.9)	ABCG8 (4.7)	ABCG5 (4.4)	NPC1L1 (4.3)	CYP7A1 (3.9)	PCSK9 (3.5)
GO:0004623	phospholipase A2 activity	1.61e-04	<= 0.05	NKPD1 (4.5)	CETP (3.8)	APOC1 (3.7)	TIMD4 (3.5)	APOE (3.1)	LPIN3 (2.7)	MOSC1 (2.5)	CEACAM19 (2.1)	TSSK6 (1.8)	TMEM116 (1.7)
MP:0010182	decreased susceptibility to weight gain	1.64e-04	<= 0.05	APOB (4.1)	APOA5 (4.0)	PCSK9 (3.9)	HMGCR (3.8)	HP (3.6)	LPA (3.0)	FADS2 (2.9)	SLC44A2 (2.8)	APOC1 (2.7)	DNAH11 (2.7)
GO:0046470	phosphatidylcholine metabolic process	1.69e-04	<= 0.05	NPC1L1 (3.0)	LPA (3.0)	HAVCR1 (2.9)	C17orf57 (2.8)	TIMD4 (2.7)	APOC4 (2.7)	APOA5 (2.7)	ENSG00000235545 (2.6)	CYP7A1 (2.5)	APOE (2.4)
ENSG00000124151	NCOA3 PPI subnetwork	1.75e-04	<= 0.05	TRIB1 (3.5)	MAU2 (2.4)	SH2B3 (2.4)	UBXN2B (2.1)	ATXN2 (2.0)	C12orf51 (2.0)	LPIN3 (2.0)	PLEC (1.8)	APOA5 (1.7)	CYP7A1 (1.7)
MP:0002647	decreased intestinal cholesterol absorption	1.77e-04	<= 0.05	ABCG5 (5.9)	APOA5 (4.1)	ABCG8 (4.0)	APOC4 (3.9)	TM6SF2 (3.8)	NPC1L1 (3.0)	PLG (2.9)	GPAM (2.9)	APOB (2.7)	HP (2.3)
ENSG00000106633	GCK PPI subnetwork	1.77e-04	<= 0.05	ENSG00000254235 (4.4)	C12orf43 (3.7)	ZNF259 (2.3)	APOA5 (2.3)	QTRT1 (2.3)	LPA (2.1)	ENSG00000238078 (1.9)	ANKRD31 (1.9)	MOSC1 (1.8)	HNF1A (1.8)
ENSG00000198734	F5 PPI subnetwork	1.82e-04	<= 0.05	HP (7.1)	PLG (4.7)	APOA5 (4.3)	APOB (4.1)	ITGB3 (4.0)	APOC4 (3.5)	ANGPTL3 (3.0)	APOC1 (2.8)	SLC22A1 (2.7)	TIMD4 (2.5)
MP:0002644	decreased circulating triglyceride level	1.83e-04	<= 0.05	NPC1L1 (5.2)	APOB (5.1)	MOSC1 (5.0)	APOC1 (4.8)	HP (4.5)	GPAM (4.2)	TM6SF2 (4.0)	ABCG5 (3.8)	APOA5 (3.2)	ABCG8 (3.2)
ENSG00000206266	ENSG00000206266 PPI subnetwork	1.86e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
ENSG00000204348	DOM3Z PPI subnetwork	1.86e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
ENSG00000206346	DOM3Z PPI subnetwork	1.86e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	1.86e-04	<= 0.05	PLG (6.0)	APOA5 (5.5)	ANGPTL3 (5.4)	APOC4 (5.4)	SLC22A1 (4.6)	APOB (4.3)	HP (3.9)	LPA (3.9)	ABO (3.1)	HNF1A (2.9)
MP:0002551	abnormal blood coagulation	1.90e-04	<= 0.05	ITGB3 (6.5)	PLG (5.9)	ANGPTL3 (5.6)	HP (5.4)	APOA5 (5.2)	APOC4 (4.7)	GMPR (4.5)	SLC22A1 (3.9)	APOB (3.9)	LPA (3.6)
MP:0002981	increased liver weight	1.95e-04	<= 0.05	ABCG8 (6.9)	TM6SF2 (5.2)	APOA5 (5.0)	APOC4 (5.0)	SLC22A1 (4.6)	FADS1 (4.5)	ABCG5 (4.5)	PLG (4.4)	CYP7A1 (4.0)	LPA (3.7)
GO:0034358	plasma lipoprotein particle	1.96e-04	<= 0.05	APOC1 (9.0)	APOA5 (7.8)	PLG (7.3)	APOB (7.1)	APOC4 (7.0)	APOE (5.7)	HP (5.2)	ANGPTL3 (4.8)	LPA (4.6)	ABCG5 (4.5)
GO:0032994	protein-lipid complex	1.96e-04	<= 0.05	APOC1 (9.0)	APOA5 (7.8)	PLG (7.3)	APOB (7.1)	APOC4 (7.0)	APOE (5.7)	HP (5.2)	ANGPTL3 (4.8)	LPA (4.6)	ABCG5 (4.5)
ENSG00000100448	CTSG PPI subnetwork	2.03e-04	<= 0.05	ITGB3 (6.7)	HP (6.4)	TIMD4 (5.1)	CETP (4.7)	APOC1 (3.8)	APOE (3.5)	ANGPTL3 (3.4)	PLG (3.4)	MAFB (3.2)	RHD (3.2)
GO:0034185	apolipoprotein binding	2.06e-04	<= 0.05	ANGPTL3 (4.6)	APOA5 (4.5)	APOC4 (4.1)	APOB (3.8)	LPA (3.4)	ABCG5 (3.1)	PCSK9 (2.9)	NPC1L1 (2.8)	APOE (2.7)	APOC1 (2.7)
GO:0030169	low-density lipoprotein particle binding	2.11e-04	<= 0.05	TIMD4 (4.4)	HMGCR (4.3)	CETP (4.3)	LPA (4.1)	APOA5 (3.9)	PCSK9 (3.7)	FADS2 (3.4)	APOC4 (3.4)	APOC1 (3.2)	PLG (3.2)
GO:0031099	regeneration	2.11e-04	<= 0.05	HAPLN4 (2.7)	GCNT4 (2.4)	ENSG00000228044 (2.1)	APOB (1.9)	GOT2P1 (1.8)	PSRC1 (1.8)	APOA5 (1.7)	APOC1 (1.7)	APOC4 (1.7)	CEACAM19 (1.7)
MP:0005319	abnormal enzyme/ coenzyme level	2.12e-04	<= 0.05	HP (4.0)	SLC22A1 (3.6)	LDLR (3.2)	LPA (3.2)	ST3GAL4 (3.1)	FADS1 (3.1)	NPC1L1 (3.0)	ABCG8 (2.9)	PLG (2.8)	FADS2 (2.6)
MP:0004774	abnormal bile salt level	2.17e-04	<= 0.05	APOC4 (6.0)	ABCG8 (5.6)	ABCG5 (5.1)	APOA5 (4.9)	TM6SF2 (4.6)	ANGPTL3 (4.4)	PLG (3.3)	CYP7A1 (2.6)	SLC22A1 (2.6)	APOB (2.5)
ENSG00000155660	PDIA4 PPI subnetwork	2.33e-04	<= 0.05	ABCG5 (3.8)	ERP29 (3.8)	PCSK9 (3.6)	NPC1L1 (3.3)	TM6SF2 (3.3)	HMGCR (3.0)	TMED4 (2.7)	BRAP (2.2)	C12orf43 (2.1)	HP (2.0)
REACTOME_HEXOSE_TRANSPORT	REACTOME_HEXOSE_TRANSPORT	2.37e-04	<= 0.05	DOCK7 (3.5)	NAA25 (2.7)	BUD13 (2.6)	DDX56 (2.5)	ABCG5 (2.5)	TM6SF2 (2.4)	USP1 (2.3)	DHODH (2.3)	POC5 (2.3)	LPA (2.2)
MP:0003179	decreased platelet cell number	2.42e-04	<= 0.05	ITGB3 (8.7)	CETP (4.5)	GMPR (3.6)	RHCE (3.1)	TIMD4 (2.8)	RHD (2.6)	MAFB (2.4)	SLC44A2 (2.4)	BCL3 (2.3)	PARP10 (2.2)
GO:0019217	regulation of fatty acid metabolic process	2.44e-04	<= 0.05	PCSK9 (2.6)	MOSC1 (2.5)	AMIGO1 (2.1)	ACAD10 (2.0)	GMPR (2.0)	FADS1 (1.9)	GPAM (1.9)	SYPL2 (1.8)	FADS2 (1.8)	TXNL4B (1.8)
MP:0001860	liver inflammation	2.49e-04	<= 0.05	RELB (4.8)	BCL3 (4.8)	APOA5 (3.3)	APOC4 (3.1)	LPA (2.9)	GMIP (2.9)	APOC1 (2.9)	PLG (2.7)	HAVCR1 (2.6)	SH2B3 (2.5)
ENSG00000197461	PDGFA PPI subnetwork	2.51e-04	<= 0.05	ITGB3 (4.5)	APOE (3.4)	ZHX3 (2.3)	ENSG00000226645 (2.2)	C17orf57 (2.0)	KANK2 (1.9)	GCNT4 (1.9)	CETP (1.7)	HNF1A (1.7)	CEACAM19 (1.6)
ENSG00000173281	PPP1R3B PPI subnetwork	2.55e-04	<= 0.05	ZNF180 (3.9)	DHODH (3.5)	LPA (3.4)	SYPL2 (3.1)	MOSC1 (2.6)	CLPTM1 (2.4)	MARK4 (2.1)	SORT1 (2.1)	TSSK6 (2.0)	SLC44A2 (1.9)
ENSG00000109680	TBC1D19 PPI subnetwork	2.61e-04	<= 0.05	APOB (6.7)	ANGPTL3 (5.4)	APOE (4.5)	APOC4 (4.3)	APOC1 (4.0)	APOA5 (4.0)	PLG (3.9)	HP (3.7)	PCSK9 (3.1)	ABCG5 (2.9)
ENSG00000019991	HGF PPI subnetwork	2.63e-04	<= 0.05	MYLIP (4.1)	LPA (3.8)	APOA5 (3.6)	CBLC (3.2)	ENSG00000254235 (3.1)	CYP7A1 (3.1)	HLX (3.1)	C1orf63 (3.0)	SLC22A1 (2.8)	ABCG5 (2.6)
ENSG00000185324	CDK10 PPI subnetwork	2.77e-04	<= 0.05	MYLIP (2.9)	NYNRIN (2.8)	ZNF180 (2.0)	TRIB1 (1.8)	TIMD4 (1.8)	ZNF101 (1.7)	DHODH (1.5)	ENSG00000254235 (1.5)	PVRL2 (1.5)	MAFB (1.5)
REACTOME_FACILITATIVE_NA:INDEPENDENT_GLUCOSE_TRANSPORTERS	REACTOME_FACILITATIVE_NA:INDEPENDENT_GLUCOSE_TRANSPORTERS	2.82e-04	<= 0.05	TMED4 (3.3)	TM6SF2 (2.8)	APOB (2.6)	GCNT4 (2.5)	ABCG5 (2.4)	ABCG8 (2.2)	NPC1L1 (1.9)	AMIGO1 (1.7)	TSSK6 (1.7)	MYLIP (1.6)
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	2.82e-04	<= 0.05	HMGCR (8.0)	LDLR (7.9)	FADS2 (7.7)	FADS1 (7.6)	PCSK9 (5.6)	GPAM (5.5)	ABCG5 (4.8)	APOC1 (4.6)	TM6SF2 (4.2)	ABCG8 (4.1)
REACTOME_HDL:MEDIATED_LIPID_TRANSPORT	REACTOME_HDL:MEDIATED_LIPID_TRANSPORT	2.83e-04	<= 0.05	APOC1 (8.8)	APOB (6.9)	APOE (6.6)	ABCG5 (4.6)	APOA5 (4.4)	TIMD4 (4.3)	NPC1L1 (4.3)	PLG (4.3)	MYLIP (4.0)	ANGPTL3 (3.8)
ENSG00000088926	F11 PPI subnetwork	2.86e-04	<= 0.05	PLG (8.3)	ANGPTL3 (7.3)	ITGB3 (6.6)	APOC4 (6.1)	APOA5 (5.9)	LPA (5.0)	HP (4.7)	SLC22A1 (4.4)	APOB (4.2)	CETP (3.9)
MP:0004772	abnormal bile secretion	2.86e-04	<= 0.05	ABCG8 (10.7)	APOA5 (6.6)	APOC4 (5.9)	TM6SF2 (5.1)	APOB (4.6)	NPC1L1 (4.4)	CYP7A1 (4.2)	ABCG5 (4.1)	PLG (4.1)	ANGPTL3 (3.6)
GO:0043691	reverse cholesterol transport	2.86e-04	<= 0.05	APOC1 (3.9)	HAVCR1 (3.5)	APOB (3.4)	TIMD4 (3.3)	APOA5 (3.0)	ABCG5 (2.9)	APOE (2.8)	APOC4 (2.7)	MYLIP (2.6)	HNF1A (2.5)
GO:0046982	protein heterodimerization activity	2.88e-04	<= 0.05	MARK4 (2.3)	APOB (2.2)	NPC1L1 (2.1)	GRINA (2.0)	CLPTM1 (2.0)	ITGB3 (1.9)	ABCG8 (1.9)	MAFB (1.9)	PPP1R37 (1.9)	HLX (1.9)
GO:0046890	regulation of lipid biosynthetic process	3.04e-04	<= 0.05	ST3GAL4 (3.6)	FADS2 (2.8)	GPAM (2.8)	HNF1A (2.8)	FADS1 (2.5)	LDLR (2.4)	NPC1L1 (2.4)	CYP7A1 (2.1)	ABCG8 (2.0)	ENSG00000226645 (2.0)
ENSG00000180210	F2 PPI subnetwork	3.10e-04	<= 0.05	PLG (7.4)	ANGPTL3 (7.4)	HP (6.1)	APOA5 (6.0)	APOC4 (5.7)	ITGB3 (5.4)	APOB (5.4)	APOC1 (4.8)	SLC22A1 (4.8)	LPA (4.6)
GO:0005319	lipid transporter activity	3.23e-04	<= 0.05	ABCG5 (7.2)	APOB (6.2)	ABCG8 (5.6)	TM6SF2 (5.5)	APOC1 (5.5)	APOA5 (5.3)	APOC4 (4.5)	NPC1L1 (4.4)	PLG (4.4)	ANGPTL3 (3.4)
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	3.23e-04	<= 0.05	TM6SF2 (3.5)	ABCG8 (3.5)	ABCG5 (3.1)	TRIB1 (2.9)	HNF1A (2.6)	CYP7A1 (2.4)	NPC1L1 (2.4)	APOA5 (2.2)	APOB (2.1)	GCNT4 (2.1)
GO:0004252	serine-type endopeptidase activity	3.29e-04	<= 0.05	HP (4.4)	SLC22A1 (4.2)	CBLC (3.8)	APOC4 (3.7)	PLG (3.6)	APOA5 (3.6)	ANGPTL3 (3.0)	CEACAM19 (3.0)	CYP7A1 (2.9)	LPA (2.6)
MP:0004952	increased spleen weight	3.29e-04	<= 0.05	RHCE (8.4)	RHD (8.2)	TIMD4 (5.3)	CETP (4.3)	MAFB (3.9)	GMIP (2.9)	GRINA (2.8)	TRIB1 (2.7)	BCL3 (2.2)	PARP10 (2.1)
MP:0002743	glomerulonephritis	3.31e-04	<= 0.05	MAFB (4.4)	BCL3 (3.1)	TRIB1 (2.8)	RELB (2.6)	TIMD4 (2.6)	TOP1 (2.5)	APOE (2.4)	GCNT4 (2.1)	GMIP (2.1)	LPIN3 (1.9)
ENSG00000143379	SETDB1 PPI subnetwork	3.33e-04	<= 0.05	BUD13 (3.7)	C19orf52 (2.6)	ZNF180 (2.5)	MARK4 (2.3)	ILF3 (2.0)	SMARCA4 (2.0)	GATAD2A (2.0)	MYLIP (1.9)	TMEM57 (1.8)	ATXN2 (1.6)
MP:0005292	improved glucose tolerance	3.35e-04	<= 0.05	MOSC1 (3.6)	GPAM (2.9)	SORT1 (2.6)	ZHX3 (2.3)	TRIB1 (2.2)	HLX (2.2)	APOA5 (2.1)	HP (2.1)	NPC1L1 (2.1)	ENSG00000254235 (2.1)
MP:0001577	anemia	3.41e-04	<= 0.05	RHCE (7.6)	RHD (7.6)	GMPR (3.7)	ITGB3 (3.2)	BCL3 (2.6)	RELB (2.5)	SH2B3 (2.5)	HLX (2.3)	TRIB1 (2.1)	C12orf51 (2.0)
MP:0002078	abnormal glucose homeostasis	3.54e-04	<= 0.05	GPAM (5.8)	MOSC1 (4.6)	TIMD4 (2.8)	CETP (2.6)	APOA5 (2.3)	SORT1 (2.1)	SYPL2 (2.1)	AMIGO1 (2.0)	HP (2.0)	COL4A3BP (1.9)
GO:0007568	aging	3.55e-04	<= 0.05	FADS2 (2.9)	ENSG00000235545 (2.7)	LDLR (2.1)	FADS1 (2.0)	GCNT4 (1.9)	KANK2 (1.9)	GRINA (1.8)	BLOC1S3 (1.7)	ACAD10 (1.6)	GOT2P1 (1.5)
REACTOME_INNATE_IMMUNE_SYSTEM	REACTOME_INNATE_IMMUNE_SYSTEM	3.57e-04	<= 0.05	OASL (6.9)	PARP10 (4.7)	RELB (4.0)	BCL3 (3.6)	TRAFD1 (3.4)	HP (3.2)	LPA (2.8)	TRIB1 (2.2)	GMIP (2.1)	ANGPTL3 (2.1)
ENSG00000211949	ENSG00000211949 PPI subnetwork	3.67e-04	<= 0.05	APOE (6.4)	APOC1 (4.9)	TIMD4 (4.1)	APOB (4.1)	HP (3.5)	BCAM (3.5)	PLG (3.3)	APOC4 (2.9)	ANGPTL3 (2.8)	APOA5 (2.7)
MP:0003887	increased hepatocyte apoptosis	3.70e-04	<= 0.05	APOB (3.8)	TRIB1 (3.1)	PCSK9 (3.0)	APOE (2.7)	HMGCR (2.4)	APOC1 (2.3)	PLG (2.3)	FADS1 (2.2)	GATAD2A (2.1)	BLOC1S3 (2.1)
GO:0005792	microsome	3.72e-04	<= 0.05	FADS2 (6.0)	HMGCR (5.7)	CYP7A1 (5.6)	FADS1 (5.5)	SLC22A1 (5.3)	LDLR (5.1)	LPA (4.7)	APOC4 (4.6)	ANGPTL3 (4.4)	PLG (4.4)
ENSG00000100522	GNPNAT1 PPI subnetwork	3.72e-04	<= 0.05	C19orf52 (3.7)	SYPL2 (2.8)	CYP7A1 (2.7)	AMIGO1 (2.3)	MAU2 (2.2)	NKPD1 (2.1)	CYB561D1 (2.0)	DHODH (2.0)	CBLC (1.9)	ENSG00000226645 (1.8)
GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	3.72e-04	<= 0.05	SLC22A1 (6.2)	LPA (6.0)	CYP7A1 (5.3)	FADS2 (4.6)	FADS1 (4.5)	ABCG5 (4.3)	PLG (4.3)	ANGPTL3 (4.3)	APOC4 (4.2)	HMGCR (4.1)
ENSG00000167711	SERPINF2 PPI subnetwork	3.73e-04	<= 0.05	HP (5.9)	ANGPTL3 (5.2)	PLG (4.4)	APOC4 (4.1)	CEACAM19 (4.0)	APOA5 (3.3)	LPA (2.6)	NKPD1 (2.6)	MOSC1 (2.1)	PCSK9 (2.1)
GO:0042598	vesicular fraction	3.73e-04	<= 0.05	FADS2 (5.9)	HMGCR (5.6)	CYP7A1 (5.6)	FADS1 (5.5)	SLC22A1 (5.3)	LDLR (5.0)	LPA (4.7)	APOC4 (4.6)	ANGPTL3 (4.5)	PLG (4.4)
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	3.76e-04	<= 0.05	C11orf9 (3.3)	HNF1A (3.2)	PCSK9 (3.0)	CYP7A1 (3.0)	ABO (2.8)	NPC1L1 (2.6)	KIAA1324 (2.4)	LPA (2.2)	TM6SF2 (2.2)	ABCG8 (2.2)
ENSG00000160282	FTCD PPI subnetwork	3.82e-04	<= 0.05	CLPTM1 (3.3)	SARS (3.3)	PLG (3.1)	GOT2P1 (2.9)	CARM1 (2.8)	ILF3 (2.6)	ANGPTL3 (2.6)	OGDH (2.5)	APOA5 (2.5)	TOMM40 (2.4)
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR:ACTIVATED_RECEPTOR_ALPHA_PPARALPHA	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR:ACTIVATED_RECEPTOR_ALPHA_PPARALPHA	3.90e-04	<= 0.05	LDLR (5.2)	FADS2 (5.2)	GPAM (3.8)	APOB (3.7)	HMGCR (3.6)	FADS1 (3.5)	HP (3.0)	APOC4 (3.0)	ANGPTL3 (2.8)	PCSK9 (2.8)
KEGG_INSULIN_SIGNALING_PATHWAY	KEGG_INSULIN_SIGNALING_PATHWAY	3.91e-04	<= 0.05	GPAM (4.0)	SORT1 (3.5)	DNM2 (3.3)	MOSC1 (3.1)	SLC44A2 (2.6)	PTPN11 (2.5)	SYPL2 (2.5)	USP24 (2.4)	GMIP (2.1)	MARK4 (2.1)
MP:0009763	increased sensitivity to induced morbidity/mortality	4.15e-04	<= 0.05	HP (5.0)	TIMD4 (3.6)	LPA (3.2)	MAFB (3.2)	SLC22A1 (2.9)	APOC4 (2.7)	ANGPTL3 (2.7)	CETP (2.5)	APOA5 (2.5)	GPAM (2.5)
MP:0002642	anisocytosis	4.17e-04	<= 0.05	RHD (12.8)	RHCE (12.6)	GMPR (4.0)	C12orf51 (2.9)	BLOC1S3 (2.4)	CETP (2.2)	NT5DC1 (1.9)	MAFB (1.8)	ACAD10 (1.7)	TIMD4 (1.6)
ENSG00000215756	ENSG00000215756 PPI subnetwork	4.30e-04	<= 0.05	APOC4 (6.0)	APOB (5.9)	APOA5 (5.8)	APOC1 (5.6)	PLG (5.4)	ABCG5 (4.8)	NPC1L1 (4.6)	ANGPTL3 (4.6)	HP (4.3)	APOE (4.2)
ENSG00000118137	APOA1 PPI subnetwork	4.30e-04	<= 0.05	APOC4 (6.0)	APOB (5.9)	APOA5 (5.8)	APOC1 (5.6)	PLG (5.4)	ABCG5 (4.8)	NPC1L1 (4.6)	ANGPTL3 (4.6)	HP (4.3)	APOE (4.2)
GO:0042439	ethanolamine-containing compound metabolic process	4.31e-04	<= 0.05	LPA (3.6)	ENSG00000235545 (3.1)	HAVCR1 (3.1)	TSSK6 (3.0)	APOC4 (2.5)	TM6SF2 (2.5)	CYP7A1 (2.4)	SLC22A1 (2.3)	TIMD4 (2.2)	NPC1L1 (2.2)
GO:0038024	cargo receptor activity	4.48e-04	<= 0.05	TIMD4 (6.1)	HP (3.8)	MAFB (2.9)	CETP (2.7)	APOB (2.6)	ABCG5 (2.5)	ABCG8 (2.4)	APOA5 (2.3)	CILP2 (2.2)	NPC1L1 (2.1)
GO:0004879	ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity	4.74e-04	<= 0.05	TRIB1 (3.0)	ABCG8 (2.9)	ABCG5 (2.5)	TM6SF2 (2.4)	ST3GAL4 (2.4)	CYP7A1 (2.3)	GCNT4 (2.2)	PPP1R37 (2.1)	HNF1A (2.1)	FRK (2.0)
ENSG00000141101	NOB1 PPI subnetwork	4.81e-04	<= 0.05	QTRT1 (4.6)	DDX56 (4.4)	NAA25 (4.2)	ZNF259 (3.8)	TOMM40 (3.5)	DHODH (3.2)	DHX38 (2.6)	ATP13A1 (2.5)	C12orf43 (2.4)	ILF3 (2.3)
MP:0005048	thrombosis	4.83e-04	<= 0.05	ITGB3 (5.1)	ANGPTL3 (4.9)	APOB (3.8)	RHD (3.8)	PLG (3.7)	RHCE (3.7)	APOA5 (3.6)	GMPR (3.2)	HP (3.1)	SLC22A1 (3.0)
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	4.87e-04	<= 0.05	APOC4 (9.2)	CYP7A1 (7.6)	APOA5 (7.5)	ANGPTL3 (7.3)	PLG (7.1)	LPA (6.5)	SLC22A1 (6.4)	ABCG5 (4.7)	HP (4.2)	ABCG8 (4.0)
GO:0034637	cellular carbohydrate biosynthetic process	4.98e-04	<= 0.05	LPA (3.1)	SORT1 (2.7)	ENSG00000254235 (2.6)	SYPL2 (2.6)	GPAM (2.4)	NT5DC1 (2.4)	ZNF180 (2.3)	DHODH (2.2)	MOSC1 (2.1)	SLC22A1 (1.8)
MP:0005334	abnormal fat pad morphology	5.02e-04	<= 0.05	GPAM (4.3)	PCSK9 (2.7)	MOSC1 (2.7)	FADS1 (2.6)	HAPLN4 (2.5)	COL4A3BP (2.5)	FADS2 (2.3)	SH2B3 (2.3)	SYPL2 (2.1)	HLX (2.1)
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	5.03e-04	<= 0.05	APOC4 (9.0)	APOA5 (7.7)	ANGPTL3 (7.7)	CYP7A1 (7.5)	PLG (7.3)	SLC22A1 (5.5)	ABCG5 (5.1)	ABCG8 (4.4)	LPA (4.1)	HP (3.4)
GO:0009746	response to hexose stimulus	5.07e-04	<= 0.05	HNF1A (2.7)	ENSG00000254235 (2.6)	PCSK9 (2.5)	ABCG5 (2.3)	KIAA1324 (2.0)	ABCG8 (1.9)	COL4A3BP (1.8)	TM6SF2 (1.6)	GPAM (1.6)	FRK (1.6)
ENSG00000171557	FGG PPI subnetwork	5.14e-04	<= 0.05	ANGPTL3 (6.5)	HP (6.3)	PLG (5.7)	APOB (5.5)	APOA5 (4.7)	APOC4 (4.5)	APOC1 (4.3)	ITGB3 (4.1)	APOE (2.7)	PCSK9 (2.7)
MP:0005343	increased circulating aspartate transaminase level	5.37e-04	<= 0.05	NPC1L1 (3.6)	TM6SF2 (3.4)	ABCG5 (3.4)	APOC1 (3.1)	APOA5 (3.0)	FADS1 (2.9)	ABCG8 (2.6)	APOB (2.5)	SLC22A1 (2.4)	CBLC (2.3)
MP:0000603	pale liver	5.42e-04	<= 0.05	RHD (3.3)	RHCE (2.7)	LPAR2 (2.7)	GRINA (2.6)	GPAM (2.4)	PARP10 (2.3)	MOSC1 (2.0)	SLC44A2 (1.9)	TIMD4 (1.9)	ACAD10 (1.8)
GO:0031406	carboxylic acid binding	5.43e-04	<= 0.05	MOSC1 (4.6)	PLG (4.3)	APOA5 (4.3)	ANGPTL3 (4.3)	APOC1 (3.6)	APOC4 (3.6)	APOB (3.6)	TM6SF2 (3.6)	ABCG8 (3.3)	ABCG5 (3.3)
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	5.52e-04	<= 0.05	FADS2 (5.3)	LDLR (5.2)	APOB (4.0)	GPAM (4.0)	HMGCR (3.7)	FADS1 (3.7)	HP (3.1)	APOC4 (3.0)	ANGPTL3 (3.0)	PCSK9 (2.8)
GO:0032371	regulation of sterol transport	5.58e-04	<= 0.05	ABCG8 (4.8)	ABCG5 (4.4)	TIMD4 (4.0)	NPC1L1 (3.8)	TM6SF2 (3.5)	APOC1 (3.3)	GEMIN7 (3.1)	MOSC1 (3.0)	APOB (2.9)	APOE (2.6)
GO:0032374	regulation of cholesterol transport	5.58e-04	<= 0.05	ABCG8 (4.8)	ABCG5 (4.4)	TIMD4 (4.0)	NPC1L1 (3.8)	TM6SF2 (3.5)	APOC1 (3.3)	GEMIN7 (3.1)	MOSC1 (3.0)	APOB (2.9)	APOE (2.6)
MP:0008478	increased spleen white pulp amount	5.79e-04	<= 0.05	HP (2.7)	SLC22A1 (2.3)	KANK2 (2.1)	PLG (2.0)	APOC4 (2.0)	ANGPTL3 (1.9)	LPA (1.8)	SLC44A2 (1.7)	ZNF101 (1.6)	ALDH2 (1.6)
GO:0097006	regulation of plasma lipoprotein particle levels	5.87e-04	<= 0.05	TIMD4 (3.9)	APOC1 (3.8)	APOE (3.6)	NPC1L1 (3.3)	MOSC1 (3.1)	ABCG5 (2.9)	APOB (2.8)	HAVCR1 (2.7)	CETP (2.4)	APOC4 (2.3)
ENSG00000151835	SACS PPI subnetwork	5.90e-04	<= 0.05	APOB (4.3)	PLG (3.7)	APOA5 (3.6)	ANGPTL3 (3.5)	APOC4 (3.1)	HP (3.1)	APOC1 (2.8)	LPA (2.6)	NPC1L1 (2.4)	ABCG5 (2.2)
ENSG00000068976	PYGM PPI subnetwork	5.91e-04	<= 0.05	CLPTM1 (3.1)	OGDH (3.0)	DNM2 (2.8)	PPP1R37 (2.4)	SLC44A2 (2.4)	SYPL2 (2.4)	GOT2P1 (2.2)	TRAPPC6A (2.0)	SUGP1 (2.0)	ST3GAL4 (2.0)
MP:0002640	reticulocytosis	6.00e-04	<= 0.05	RHCE (11.7)	RHD (11.1)	GMPR (4.1)	C12orf51 (3.8)	KANK2 (2.5)	TMEM57 (1.9)	ABCG8 (1.9)	CETP (1.8)	GRINA (1.7)	FADS2 (1.7)
GO:0005543	phospholipid binding	6.01e-04	<= 0.05	ABCG5 (4.9)	NPC1L1 (3.6)	APOB (3.6)	ABCG8 (3.4)	COL4A3BP (2.9)	HLX (2.6)	APOC1 (2.4)	MAFB (2.3)	MYLIP (2.2)	APOC4 (2.2)
MP:0003333	liver fibrosis	6.01e-04	<= 0.05	BCL3 (3.7)	ANGPTL3 (3.4)	SLC22A1 (3.2)	PCSK9 (3.1)	CEACAM19 (3.0)	APOA5 (2.7)	LPA (2.5)	PVR (2.5)	HP (2.3)	APOC4 (2.3)
GO:0016052	carbohydrate catabolic process	6.08e-04	<= 0.05	GOT2P1 (2.5)	ERP29 (2.4)	SORT1 (2.2)	SYPL2 (2.1)	TMED4 (2.1)	TRAPPC6A (2.0)	PMFBP1 (1.9)	ACAD10 (1.8)	OGDH (1.7)	CEACAM19 (1.7)
GO:0046906	tetrapyrrole binding	6.11e-04	<= 0.05	SLC22A1 (6.8)	LPA (5.8)	CYP7A1 (5.2)	APOA5 (4.7)	ANGPTL3 (4.5)	ABCG5 (4.4)	PLG (4.4)	APOC4 (4.2)	ABCG8 (4.1)	ALDH2 (3.7)
ENSG00000204319	ENSG00000204319 PPI subnetwork	6.14e-04	<= 0.05	HP (4.9)	APOC1 (4.5)	PLG (4.3)	ANGPTL3 (4.1)	APOC4 (4.0)	APOA5 (3.9)	APOB (3.3)	LPA (3.1)	CYP7A1 (2.7)	MOSC1 (2.6)
REACTOME_GLUCOSE_TRANSPORT	REACTOME_GLUCOSE_TRANSPORT	6.22e-04	<= 0.05	DOCK7 (3.7)	NAA25 (2.8)	DDX56 (2.6)	LPA (2.6)	BUD13 (2.6)	DHODH (2.4)	POC5 (2.4)	USP1 (2.3)	USP24 (2.2)	MOSC1 (2.0)
GO:0005355	glucose transmembrane transporter activity	6.24e-04	<= 0.05	TMED4 (3.5)	GOT2P1 (3.5)	NPC1L1 (3.2)	TM6SF2 (3.0)	APOB (2.7)	ABCG5 (2.6)	GCNT4 (2.4)	TSSK6 (2.2)	HNF1A (2.0)	PBX4 (1.8)
MP:0002628	hepatic steatosis	6.26e-04	<= 0.05	APOA5 (5.1)	APOC4 (4.6)	HP (3.9)	ABCG5 (3.9)	APOC1 (3.7)	APOB (3.6)	TM6SF2 (3.6)	GPAM (3.5)	PLG (3.3)	ANGPTL3 (2.9)
GO:0019200	carbohydrate kinase activity	6.34e-04	<= 0.05	DHODH (3.0)	GOT2P1 (2.9)	MOSC1 (2.6)	TRAPPC6A (2.6)	TM6SF2 (2.5)	ST3GAL4 (2.3)	CYP7A1 (2.2)	NPC1L1 (2.1)	PBX4 (2.0)	ACAD10 (2.0)
REACTOME_GAMMA:CARBOXYLATION_TRANSPORT_AND_AMINO:TERMINAL_CLEAVAGE_OF_PROTEINS	REACTOME_GAMMA:CARBOXYLATION_TRANSPORT_AND_AMINO:TERMINAL_CLEAVAGE_OF_PROTEINS	6.42e-04	<= 0.05	PLG (6.7)	APOA5 (6.0)	APOC4 (5.9)	ANGPTL3 (5.9)	LPA (5.1)	SLC22A1 (4.9)	HP (4.3)	APOB (4.3)	APOC1 (3.9)	ABO (3.4)
GO:0008289	lipid binding	6.42e-04	<= 0.05	ABCG5 (5.7)	APOB (4.9)	ABCG8 (4.3)	TM6SF2 (4.2)	APOC1 (3.6)	APOA5 (3.6)	NPC1L1 (3.4)	APOC4 (3.3)	MOSC1 (3.3)	PLG (2.8)
GO:0006644	phospholipid metabolic process	6.46e-04	<= 0.05	BLOC1S3 (3.5)	NKPD1 (3.5)	LPAR2 (3.2)	ATP13A1 (2.7)	TSSK6 (2.4)	HMGCR (2.3)	SLC44A2 (2.3)	GCNT4 (2.3)	UBXN2B (2.0)	SORT1 (2.0)
MP:0005621	abnormal cell physiology	6.47e-04	<= 0.05	OASL (3.9)	YIPF2 (2.8)	PARP10 (2.4)	DHX38 (2.4)	CLPTM1 (2.3)	BCL3 (2.2)	TMEM50A (2.2)	ATP13A1 (2.1)	SLC44A2 (2.0)	LDLR (2.0)
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	6.51e-04	<= 0.05	PLG (8.5)	ANGPTL3 (8.3)	APOC4 (7.9)	HP (7.7)	APOA5 (7.3)	APOC1 (6.1)	SLC22A1 (5.5)	LPA (5.4)	APOB (4.8)	APOE (4.4)
GO:0008203	cholesterol metabolic process	6.54e-04	<= 0.05	HMGCR (8.2)	LDLR (7.8)	FADS2 (7.6)	FADS1 (7.2)	PCSK9 (6.8)	CYP7A1 (3.6)	NPC1L1 (3.5)	LPA (3.3)	TMEM57 (2.8)	NKPD1 (2.7)
ENSG00000117601	SERPINC1 PPI subnetwork	6.67e-04	<= 0.05	APOC4 (8.3)	PLG (7.6)	APOA5 (6.9)	ANGPTL3 (6.8)	HP (5.3)	CYP7A1 (4.8)	SLC22A1 (4.7)	APOB (4.3)	LPA (4.2)	APOC1 (4.1)
GO:0034362	low-density lipoprotein particle	6.67e-04	<= 0.05	APOC1 (9.0)	PCSK9 (4.6)	PLG (4.4)	APOE (4.3)	HMGCR (4.0)	APOA5 (3.9)	LPA (3.7)	APOC4 (3.7)	LPAR2 (2.8)	ABCG5 (2.7)
ENSG00000180879	SSR4 PPI subnetwork	6.69e-04	<= 0.05	ATP13A1 (3.8)	TOMM40 (3.6)	QTRT1 (2.7)	POLK (2.7)	CETP (2.6)	NT5DC1 (2.1)	TIMD4 (1.9)	ERP29 (1.9)	YIPF2 (1.8)	LPA (1.8)
MP:0001783	decreased white adipose tissue amount	6.72e-04	<= 0.05	MOSC1 (3.9)	APOC1 (3.2)	GPAM (3.0)	HP (2.3)	PMFBP1 (2.2)	TOP1 (2.1)	SORT1 (2.1)	ST3GAL4 (1.8)	TRIB1 (1.5)	LDLR (1.5)
GO:0015248	sterol transporter activity	6.86e-04	<= 0.05	APOC1 (9.0)	ABCG5 (8.6)	ABCG8 (7.6)	APOB (7.5)	APOA5 (5.5)	NPC1L1 (5.4)	APOC4 (4.3)	TM6SF2 (4.3)	TIMD4 (4.2)	APOE (3.9)
REACTOME_GLUCOSE_METABOLISM	REACTOME_GLUCOSE_METABOLISM	6.91e-04	<= 0.05	SYPL2 (4.4)	GPAM (3.2)	GOT2P1 (2.8)	HP (2.8)	MOSC1 (2.8)	SORT1 (2.6)	DHODH (2.5)	LPA (2.4)	DOCK7 (2.3)	PLG (2.2)
GO:0005796	Golgi lumen	6.92e-04	<= 0.05	APOC4 (4.3)	SLC22A1 (4.2)	PLG (4.1)	ANGPTL3 (4.0)	LPA (4.0)	ABO (3.9)	APOA5 (3.8)	APOB (2.7)	HNF1A (2.7)	PCSK9 (2.6)
GO:0045723	positive regulation of fatty acid biosynthetic process	6.96e-04	<= 0.05	CEACAM19 (3.2)	HNF1A (3.0)	ENSG00000254235 (2.4)	C12orf47 (1.8)	PCSK9 (1.8)	CBLC (1.6)	TSSK6 (1.6)	TXNL4B (1.6)	HAPLN4 (1.6)	MOSC1 (1.6)
ENSG00000135100	HNF1A PPI subnetwork	6.97e-04	<= 0.05	PARP10 (2.8)	CBLC (2.7)	BCL3 (2.4)	GMIP (2.4)	USP24 (2.1)	PPP1R37 (2.1)	MAU2 (2.0)	PLEKHH2 (1.8)	PLCG1 (1.7)	PLEC (1.7)
GO:0002020	protease binding	7.10e-04	<= 0.05	HNF1A (3.3)	APOB (3.0)	HP (2.8)	APOA5 (2.8)	ADAM1 (2.7)	BCL3 (2.4)	GRINA (2.0)	RELB (2.0)	ZNF101 (1.9)	ST3GAL4 (1.8)
KEGG_PPAR_SIGNALING_PATHWAY	KEGG_PPAR_SIGNALING_PATHWAY	7.17e-04	<= 0.05	MOSC1 (5.7)	APOC1 (4.9)	GPAM (4.8)	APOA5 (4.7)	APOC4 (4.3)	TM6SF2 (4.2)	HP (4.2)	PLG (4.2)	APOB (4.1)	ABCG5 (3.9)
GO:0017171	serine hydrolase activity	7.31e-04	<= 0.05	HP (4.1)	SLC22A1 (4.0)	APOC4 (3.5)	APOA5 (3.5)	PLG (3.5)	CBLC (3.3)	ANGPTL3 (2.9)	CYP7A1 (2.9)	CEACAM19 (2.8)	NKPD1 (2.8)
MP:0004255	abnormal spongiotrophoblast layer morphology	7.32e-04	<= 0.05	DNM2 (3.1)	BCL3 (2.7)	LDLR (2.5)	PCSK9 (2.1)	PLEC (2.1)	NYNRIN (2.0)	ST3GAL4 (1.9)	ENSG00000254235 (1.8)	SLC22A1 (1.7)	GATAD2A (1.6)
GO:0031100	organ regeneration	7.34e-04	<= 0.05	DNAH11 (2.4)	ENSG00000254235 (2.3)	GCNT4 (2.2)	APOB (2.0)	CETP (2.0)	GOT2P1 (1.8)	HAVCR1 (1.7)	MOSC1 (1.7)	TRAPPC6A (1.7)	HP (1.7)
ENSG00000198646	NCOA6 PPI subnetwork	7.39e-04	<= 0.05	PLEC (3.5)	TRIB1 (3.2)	ATXN7L2 (2.8)	C12orf51 (2.4)	GRINA (2.4)	GMIP (2.3)	ZHX3 (2.1)	RELB (2.1)	GEMIN7 (2.1)	GOT2P1 (2.1)
GO:0045923	positive regulation of fatty acid metabolic process	7.59e-04	<= 0.05	ENSG00000254235 (2.5)	MOSC1 (2.5)	HNF1A (2.1)	ENSG00000235545 (1.6)	TIMD4 (1.6)	GPAM (1.6)	CBLC (1.5)	PCSK9 (1.5)	ABCG8 (1.5)	APOC4 (1.5)
GO:0008202	steroid metabolic process	7.65e-04	<= 0.05	FADS2 (5.9)	LDLR (5.5)	CYP7A1 (5.4)	HMGCR (5.3)	FADS1 (5.3)	PCSK9 (4.9)	LPA (3.9)	NPC1L1 (3.8)	SLC22A1 (3.7)	TM6SF2 (3.5)
GO:0034284	response to monosaccharide stimulus	7.71e-04	<= 0.05	HNF1A (2.8)	PCSK9 (2.4)	ENSG00000254235 (2.4)	KIAA1324 (2.2)	ABCG5 (2.2)	ABCG8 (1.9)	COL4A3BP (1.8)	GPAM (1.6)	TM6SF2 (1.6)	ANKRD31 (1.5)
MP:0005318	decreased triglyceride level	7.82e-04	<= 0.05	GPAM (5.0)	MOSC1 (3.9)	HP (3.4)	LPA (3.0)	ACAD10 (2.8)	SH2B3 (2.6)	TMEM57 (2.3)	SORT1 (2.0)	MAFB (2.0)	SYPL2 (1.9)
ENSG00000125730	C3 PPI subnetwork	7.91e-04	<= 0.05	HP (6.7)	APOC4 (5.6)	LPA (5.5)	ANGPTL3 (5.4)	APOA5 (4.6)	PLG (4.4)	SLC22A1 (4.0)	TIMD4 (3.6)	APOC1 (3.4)	CYP7A1 (3.3)
ENSG00000170927	PKHD1 PPI subnetwork	7.95e-04	<= 0.05	APOB (6.2)	ANGPTL3 (5.1)	APOE (4.5)	APOC4 (4.3)	PLG (3.9)	APOA5 (3.7)	APOC1 (3.6)	HP (3.4)	ABCG5 (2.9)	PCSK9 (2.5)
ENSG00000057593	F7 PPI subnetwork	7.98e-04	<= 0.05	PLG (4.9)	ANGPTL3 (4.4)	APOA5 (4.3)	APOC4 (4.2)	HP (3.7)	APOB (3.5)	LPA (3.4)	APOC1 (3.1)	CYP7A1 (2.9)	SLC22A1 (2.8)
GO:0005496	steroid binding	7.99e-04	<= 0.05	APOB (6.0)	APOC1 (4.9)	ABCG5 (4.6)	TM6SF2 (4.1)	ANGPTL3 (4.0)	APOA5 (4.0)	APOC4 (3.9)	PLG (3.8)	ABCG8 (3.2)	KIAA1324 (2.9)
GO:0020037	heme binding	7.99e-04	<= 0.05	SLC22A1 (7.2)	LPA (6.0)	CYP7A1 (5.4)	ABCG5 (4.8)	APOA5 (4.7)	APOC4 (4.4)	PLG (4.3)	ABCG8 (4.3)	ANGPTL3 (4.2)	HP (3.7)
ENSG00000109819	PPARGC1A PPI subnetwork	8.12e-04	<= 0.05	MAU2 (2.8)	PLEC (2.7)	USP24 (2.7)	ZHX3 (2.4)	DHX38 (2.1)	ATXN2 (2.0)	GOT2P1 (2.0)	GMIP (1.9)	TOP1 (1.8)	SMARCA4 (1.7)
GO:0016540	protein autoprocessing	8.13e-04	<= 0.05	HNF1A (2.7)	CBLC (2.6)	GEMIN7 (2.6)	AP1M2 (2.1)	NPC1L1 (1.9)	ZNF180 (1.8)	HAPLN4 (1.8)	ENSG00000238078 (1.7)	LPAR2 (1.6)	RHCE (1.6)
GO:0045834	positive regulation of lipid metabolic process	8.31e-04	<= 0.05	ENSG00000228044 (2.6)	GPAM (2.6)	APOC1 (2.2)	ST3GAL4 (2.1)	ALDH2 (2.1)	POLK (2.1)	MYLIP (2.0)	TMEM57 (2.0)	TIMD4 (1.9)	CETP (1.9)
MP:0008808	decreased spleen iron level	8.35e-04	<= 0.05	RHD (7.1)	RHCE (5.2)	HP (4.8)	APOA5 (3.3)	APOC1 (3.3)	SLC22A1 (3.2)	APOC4 (3.2)	TIMD4 (2.8)	PCSK9 (2.6)	LPA (2.5)
GO:0019842	vitamin binding	8.42e-04	<= 0.05	PLG (5.3)	ANGPTL3 (5.3)	APOA5 (5.2)	TM6SF2 (4.6)	APOC4 (4.4)	MOSC1 (3.9)	CYP7A1 (3.7)	SLC22A1 (3.6)	ABCG8 (3.3)	ABCG5 (3.3)
GO:0008610	lipid biosynthetic process	8.42e-04	<= 0.05	FADS2 (6.4)	FADS1 (6.0)	HMGCR (5.6)	LDLR (5.4)	PCSK9 (4.3)	CYP7A1 (3.9)	GPAM (3.1)	NKPD1 (3.1)	TRAPPC6A (2.6)	ST3GAL4 (2.2)
MP:0010180	increased susceptibility to weight loss	8.50e-04	<= 0.05	FADS1 (3.7)	ABCG5 (3.5)	CYP7A1 (3.4)	ABCG8 (3.1)	HMGCR (3.0)	LDLR (2.8)	SLC22A1 (2.8)	APOC4 (2.2)	ALDH2 (2.2)	GCNT4 (2.0)
MP:0009549	decreased platelet aggregation	8.72e-04	<= 0.05	ITGB3 (8.9)	GMPR (4.2)	TIMD4 (3.3)	FADS1 (2.9)	APOC1 (2.7)	APOE (2.7)	ABCG8 (2.7)	APOB (2.4)	APOC4 (2.4)	APOA5 (2.3)
GO:0016125	sterol metabolic process	8.83e-04	<= 0.05	HMGCR (8.1)	LDLR (7.9)	FADS2 (7.8)	FADS1 (7.3)	PCSK9 (6.7)	CYP7A1 (3.7)	NPC1L1 (3.4)	LPA (3.2)	NKPD1 (2.6)	TMEM57 (2.5)
KEGG_LINOLEIC_ACID_METABOLISM	KEGG_LINOLEIC_ACID_METABOLISM	8.83e-04	<= 0.05	ABCG5 (7.3)	SLC22A1 (6.7)	ABCG8 (5.6)	LPA (5.5)	APOC4 (4.7)	TM6SF2 (4.4)	NPC1L1 (4.0)	ANGPTL3 (3.5)	APOA5 (3.4)	HP (3.4)
GO:0032870	cellular response to hormone stimulus	8.84e-04	<= 0.05	TMEM57 (2.5)	ST3GAL4 (2.1)	COL4A3BP (2.0)	HNF1A (1.9)	PPP1R37 (1.8)	GCNT4 (1.8)	NPC1L1 (1.7)	ABCG8 (1.7)	ATXN7L2 (1.6)	ATXN2 (1.6)
REACTOME_CHYLOMICRON:MEDIATED_LIPID_TRANSPORT	REACTOME_CHYLOMICRON:MEDIATED_LIPID_TRANSPORT	8.86e-04	<= 0.05	APOB (10.9)	NPC1L1 (7.9)	ABCG5 (7.7)	APOC1 (6.6)	TM6SF2 (6.0)	PLG (5.2)	APOA5 (5.1)	ABCG8 (4.4)	APOC4 (4.3)	ANGPTL3 (3.7)
ENSG00000123240	OPTN PPI subnetwork	8.88e-04	<= 0.05	ATP13A1 (3.2)	MAU2 (2.7)	PARP10 (2.6)	MAPKAPK5 (2.2)	ACAD10 (2.2)	TMEM50A (2.1)	NT5DC1 (2.1)	TRAFD1 (2.1)	GMIP (2.1)	C12orf51 (2.0)
GO:0008236	serine-type peptidase activity	8.88e-04	<= 0.05	HP (4.2)	SLC22A1 (3.8)	APOA5 (3.5)	APOC4 (3.5)	PLG (3.4)	CBLC (3.3)	CYP7A1 (2.9)	ANGPTL3 (2.8)	CEACAM19 (2.7)	NKPD1 (2.6)
GO:0090181	regulation of cholesterol metabolic process	8.93e-04	<= 0.05	ENSG00000238078 (4.1)	ABCG8 (2.9)	TMEM57 (2.7)	CYP7A1 (2.5)	FADS2 (2.4)	APOC1 (2.3)	FRK (2.0)	TRAPPC6A (2.0)	NT5DC1 (1.9)	UBXN2B (1.7)
MP:0005178	increased circulating cholesterol level	8.98e-04	<= 0.05	MOSC1 (5.0)	APOB (4.8)	APOA5 (4.3)	APOC1 (4.3)	APOC4 (3.6)	GPAM (3.6)	HP (3.1)	ABCG5 (3.0)	TIMD4 (2.9)	APOE (2.8)
GO:0019216	regulation of lipid metabolic process	9.00e-04	<= 0.05	GPAM (3.8)	MOSC1 (2.8)	APOC1 (2.3)	ST3GAL4 (2.3)	BLOC1S3 (2.0)	ENSG00000228044 (1.9)	TMEM57 (1.9)	ALDH2 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)
GO:0016829	lyase activity	9.13e-04	<= 0.05	GPAM (4.0)	MOSC1 (4.0)	DHODH (3.6)	FADS2 (3.3)	APOA5 (3.3)	PLG (3.1)	FADS1 (3.0)	LPA (2.9)	ALDH2 (2.9)	RHD (2.8)
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	9.21e-04	<= 0.05	PLG (7.9)	ANGPTL3 (7.7)	APOC4 (6.7)	HP (6.6)	ITGB3 (5.9)	APOA5 (5.9)	APOB (4.7)	SLC22A1 (4.4)	APOC1 (3.9)	LPA (3.8)
ENSG00000182446	NPLOC4 PPI subnetwork	9.53e-04	<= 0.05	BRAP (3.3)	ATXN2 (3.0)	SUGP1 (2.9)	TMEM57 (2.6)	DHX38 (2.2)	ATP13A1 (2.1)	SARS (2.0)	YIPF2 (2.0)	LDLR (2.0)	LPAR2 (1.9)
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	9.57e-04	<= 0.05	RELB (4.6)	GPAM (4.3)	BCL3 (4.0)	MOSC1 (3.3)	SORT1 (2.5)	GRINA (2.3)	SYPL2 (2.2)	ABCG8 (2.2)	HP (2.1)	MAPKAPK5 (2.0)
GO:0052548	regulation of endopeptidase activity	9.62e-04	<= 0.05	POLK (2.9)	GOT2P1 (2.7)	HP (2.4)	PCSK9 (2.1)	SLC22A1 (2.1)	C17orf57 (2.1)	APOA5 (2.0)	PLG (1.8)	PSMA5 (1.7)	ANGPTL3 (1.7)
ENSG00000005339	CREBBP PPI subnetwork	9.62e-04	<= 0.05	TRIB1 (4.4)	ATXN2 (3.2)	PARP10 (3.1)	BCL3 (2.8)	HLX (2.7)	CARM1 (2.5)	SH2B3 (2.5)	GRINA (2.4)	BUD13 (2.4)	NYNRIN (2.2)
ENSG00000067048	DDX3Y PPI subnetwork	9.67e-04	<= 0.05	QTRT1 (5.5)	DDX56 (5.1)	NAA25 (4.2)	ATP13A1 (3.8)	ZNF259 (3.7)	DHX38 (3.1)	TOMM40 (3.1)	ILF3 (3.0)	DHODH (2.9)	TOP1 (2.8)
GO:0034364	high-density lipoprotein particle	9.72e-04	<= 0.05	APOA5 (8.8)	PLG (8.3)	APOC4 (8.0)	APOC1 (8.0)	APOB (7.9)	LPA (6.1)	ANGPTL3 (5.8)	SLC22A1 (5.2)	HP (4.9)	ABCG5 (4.7)
ENSG00000163736	PPBP PPI subnetwork	9.77e-04	<= 0.05	ANGPTL3 (3.2)	APOC4 (3.1)	PLG (3.1)	HP (3.0)	LPA (2.7)	APOA5 (2.7)	CYP7A1 (2.6)	MOSC1 (2.5)	ST3GAL4 (2.4)	PVRL2 (2.0)
MP:0000607	abnormal hepatocyte morphology	9.94e-04	<= 0.05	APOA5 (4.4)	APOC4 (3.6)	ANGPTL3 (3.1)	HP (3.1)	SLC22A1 (2.9)	PLG (2.7)	APOB (2.6)	APOC1 (2.5)	ABCG5 (2.4)	ABCG8 (2.4)
GO:0009743	response to carbohydrate stimulus	1.02e-03	<= 0.05	HNF1A (2.8)	PCSK9 (2.6)	ABCG5 (2.6)	ABCG8 (2.4)	ANKRD31 (2.3)	NPC1L1 (2.2)	KIAA1324 (2.1)	GPAM (2.0)	TM6SF2 (2.0)	COL4A3BP (1.8)
GO:0045178	basal part of cell	1.02e-03	<= 0.05	PLEC (3.3)	CYP7A1 (3.1)	POLK (2.6)	CBLC (2.5)	DOCK7 (2.5)	LDLR (2.3)	TSSK6 (2.1)	TMEM116 (2.1)	ABCG8 (2.0)	BCAM (2.0)
KEGG_PRION_DISEASES	KEGG_PRION_DISEASES	1.03e-03	<= 0.05	LPA (5.5)	TIMD4 (5.1)	SLC22A1 (4.5)	APOE (4.5)	APOC4 (4.3)	PLG (4.0)	HP (3.9)	APOC1 (3.8)	ANGPTL3 (3.5)	APOA5 (3.4)
ENSG00000131187	F12 PPI subnetwork	1.04e-03	<= 0.05	ANGPTL3 (7.3)	PLG (6.0)	APOC4 (6.0)	HP (5.5)	APOA5 (4.8)	SLC22A1 (4.4)	APOE (3.9)	APOC1 (3.7)	ITGB3 (3.6)	CYP7A1 (3.5)
ENSG00000211896	ENSG00000211896 PPI subnetwork	1.05e-03	<= 0.20	APOE (4.5)	APOC1 (3.9)	TIMD4 (3.7)	MAFB (2.9)	NKPD1 (2.2)	LPA (2.2)	SLC22A1 (1.9)	PCSK9 (1.8)	GPAM (1.8)	HP (1.8)
GO:0000271	polysaccharide biosynthetic process	1.05e-03	<= 0.20	ENSG00000254235 (2.5)	CYB561D1 (2.5)	ST3GAL4 (2.4)	NT5DC1 (2.2)	LPA (2.2)	ZNF180 (2.2)	ENSG00000228044 (2.1)	AMIGO1 (2.1)	SORT1 (2.1)	TMEM57 (2.1)
GO:0019637	organophosphate metabolic process	1.05e-03	<= 0.20	BLOC1S3 (3.4)	LPAR2 (3.2)	NKPD1 (2.9)	TSSK6 (2.7)	ATP13A1 (2.4)	GCNT4 (2.3)	MOSC1 (2.2)	HMGCR (2.1)	SORT1 (2.0)	SLC44A2 (2.0)
GO:0052547	regulation of peptidase activity	1.05e-03	<= 0.20	POLK (2.6)	GOT2P1 (2.5)	HP (2.4)	PCSK9 (2.2)	SLC22A1 (2.0)	APOA5 (1.9)	CEACAM19 (1.8)	ST3GAL4 (1.7)	C17orf57 (1.7)	PLG (1.7)
MP:0011109	partial lethality throughout fetal growth and development	1.06e-03	<= 0.20	PVRL2 (3.4)	ATXN2 (3.4)	KANK2 (3.2)	PLEC (2.6)	MYLIP (2.6)	NYNRIN (2.5)	BCAM (2.2)	MAFB (2.1)	C12orf51 (2.1)	ITGB3 (2.0)
GO:0017127	cholesterol transporter activity	1.08e-03	<= 0.20	APOC1 (8.8)	ABCG5 (8.7)	APOB (8.1)	ABCG8 (7.5)	NPC1L1 (6.2)	APOA5 (5.5)	TM6SF2 (4.6)	TIMD4 (4.6)	APOC4 (4.2)	MYLIP (3.8)
MP:0004777	abnormal phospholipid level	1.08e-03	<= 0.20	ABCG8 (6.5)	APOC1 (5.3)	APOC4 (3.8)	MYLIP (3.7)	GPAM (3.5)	HP (3.4)	COL4A3BP (3.2)	APOA5 (3.1)	FADS1 (3.0)	CYP7A1 (2.9)
GO:0032411	positive regulation of transporter activity	1.08e-03	<= 0.20	C17orf57 (2.9)	ENSG00000228044 (2.5)	AMIGO1 (2.2)	ENSG00000254235 (2.0)	DNAH11 (2.0)	CETP (1.8)	OGDH (1.7)	PLEKHH2 (1.6)	NKPD1 (1.6)	ANKRD31 (1.6)
MP:0002875	decreased erythrocyte cell number	1.10e-03	<= 0.20	RHCE (8.4)	RHD (8.0)	CETP (3.7)	GMPR (3.5)	ITGB3 (3.0)	TIMD4 (3.0)	C12orf51 (2.9)	ENSG00000238078 (1.8)	SLC44A2 (1.8)	ATXN2 (1.7)
MP:0001634	internal hemorrhage	1.11e-03	<= 0.20	ITGB3 (4.9)	NYNRIN (3.6)	ANGPTL3 (2.9)	ST3GAL4 (2.8)	HP (2.8)	HLX (2.5)	C12orf51 (2.2)	LPA (2.1)	PLG (2.0)	GMPR (2.0)
ENSG00000116353	MECR PPI subnetwork	1.11e-03	<= 0.20	ABCG8 (5.0)	TM6SF2 (4.1)	SLC22A1 (3.8)	GPAM (3.7)	ABCG5 (3.6)	CYP7A1 (3.6)	NPC1L1 (3.0)	APOB (2.9)	FRK (2.4)	APOA5 (2.3)
MP:0000490	abnormal crypts of Lieberkuhn morphology	1.12e-03	<= 0.20	GEMIN7 (2.6)	ABO (2.4)	HLX (2.4)	CEACAM19 (2.4)	GCNT4 (2.1)	TIMD4 (2.0)	UBXN2B (1.9)	KIAA1324 (1.7)	BCL3 (1.7)	LPAR2 (1.7)
MP:0005146	decreased circulating VLDL cholesterol level	1.12e-03	<= 0.20	NPC1L1 (9.1)	TM6SF2 (7.7)	ABCG5 (7.7)	APOB (7.7)	ABCG8 (5.5)	APOA5 (5.0)	APOC1 (4.7)	GPAM (3.7)	PLG (3.7)	HP (3.5)
GO:0048029	monosaccharide binding	1.13e-03	<= 0.20	LPA (4.7)	TRAPPC6A (3.0)	GPAM (2.7)	MOSC1 (2.7)	APOA5 (2.6)	DHODH (2.4)	ERP29 (2.4)	ENSG00000254235 (2.4)	ATP13A1 (2.2)	CYP7A1 (2.2)
GO:0044403	symbiosis, encompassing mutualism through parasitism	1.13e-03	<= 0.20	OASL (2.3)	TIMD4 (2.1)	CETP (2.1)	SLC22A1 (2.0)	GRINA (1.8)	TRAFD1 (1.8)	HP (1.8)	PARP10 (1.8)	GCNT4 (1.8)	LPA (1.7)
GO:0015149	hexose transmembrane transporter activity	1.13e-03	<= 0.20	TMED4 (3.6)	NPC1L1 (3.2)	GOT2P1 (3.1)	TM6SF2 (2.6)	APOB (2.6)	GCNT4 (2.4)	ABCG5 (2.3)	TSSK6 (2.1)	ITGB3 (1.8)	PBX4 (1.8)
GO:0071495	cellular response to endogenous stimulus	1.14e-03	<= 0.20	C11orf9 (2.3)	TMEM57 (2.2)	COL4A3BP (2.0)	PPP1R37 (2.0)	NPC1L1 (2.0)	HNF1A (1.9)	ATXN7L2 (1.8)	SH2B3 (1.7)	KANK2 (1.7)	GPAM (1.6)
ENSG00000186832	KRT16 PPI subnetwork	1.17e-03	<= 0.20	APOB (4.7)	APOE (4.4)	HP (4.0)	PLG (4.0)	ANGPTL3 (3.9)	APOC4 (3.9)	APOA5 (3.7)	APOC1 (3.5)	NPC1L1 (3.1)	PCSK9 (2.3)
GO:0034381	plasma lipoprotein particle clearance	1.18e-03	<= 0.20	APOC1 (3.2)	NPC1L1 (3.1)	HNF1A (3.0)	PCSK9 (2.9)	APOB (2.8)	APOE (2.7)	TIMD4 (2.5)	GCNT4 (2.5)	GPAM (2.4)	HAVCR1 (2.4)
MP:0003949	abnormal circulating lipid level	1.18e-03	<= 0.20	ABCG8 (7.6)	TM6SF2 (7.1)	ABCG5 (6.5)	NPC1L1 (4.9)	APOB (4.4)	APOA5 (4.3)	PLG (4.3)	APOC1 (3.5)	APOC4 (3.4)	ANGPTL3 (3.2)
GO:0004620	phospholipase activity	1.19e-03	<= 0.20	CETP (4.4)	NKPD1 (4.4)	APOE (3.7)	TIMD4 (3.3)	APOC1 (3.1)	MAFB (2.8)	LPIN3 (2.7)	MOSC1 (2.5)	SORT1 (2.4)	ABCG8 (1.9)
GO:0004175	endopeptidase activity	1.20e-03	<= 0.20	CBLC (3.4)	PVRL2 (2.9)	SLC22A1 (2.8)	HP (2.6)	CEACAM19 (2.4)	CYP7A1 (2.3)	APOC4 (2.3)	TM6SF2 (2.3)	NKPD1 (2.2)	APOA5 (2.0)
MP:0005023	abnormal wound healing	1.20e-03	<= 0.20	ANGPTL3 (5.2)	HP (5.0)	PLG (4.5)	APOA5 (4.1)	APOB (3.5)	APOC4 (3.3)	ABCG5 (3.3)	SLC22A1 (3.1)	APOC1 (2.7)	PCSK9 (2.5)
MP:0001570	abnormal circulating enzyme level	1.21e-03	<= 0.20	RHD (3.0)	APOA5 (2.9)	RHCE (2.7)	ENSG00000254235 (2.5)	ERP29 (2.3)	BCAM (2.3)	LPA (2.3)	ABCG5 (2.1)	ENSG00000238078 (2.1)	MYLIP (2.1)
GO:0003707	steroid hormone receptor activity	1.22e-03	<= 0.20	TM6SF2 (3.4)	ABCG8 (3.3)	ABCG5 (3.2)	HNF1A (2.8)	CYP7A1 (2.6)	TRIB1 (2.5)	GCNT4 (2.3)	NPC1L1 (2.1)	APOB (2.0)	PPP1R37 (2.0)
ENSG00000138750	NUP54 PPI subnetwork	1.26e-03	<= 0.20	NAA25 (3.4)	GATAD2A (2.9)	FEN1 (2.9)	USP1 (2.7)	ILF3 (2.7)	POC5 (2.6)	DDX56 (2.5)	ENSG00000226648 (2.1)	BUD13 (2.0)	CARM1 (1.9)
MP:0005309	increased circulating ammonia level	1.29e-03	<= 0.20	TM6SF2 (7.3)	ABCG5 (6.3)	ABCG8 (5.1)	NPC1L1 (5.0)	PLG (4.6)	APOA5 (4.3)	HP (4.2)	APOC4 (4.1)	APOB (4.1)	ANGPTL3 (2.9)
ENSG00000000971	CFH PPI subnetwork	1.29e-03	<= 0.20	HP (5.7)	ANGPTL3 (4.8)	PLG (4.6)	LPA (4.3)	APOC4 (4.1)	DHODH (3.6)	APOA5 (3.5)	ST3GAL4 (2.6)	APOC1 (2.5)	RHD (2.5)
KEGG_LYSINE_DEGRADATION	KEGG_LYSINE_DEGRADATION	1.31e-03	<= 0.20	PLG (3.5)	ANGPTL3 (3.5)	ACAD10 (3.4)	MOSC1 (3.1)	GPAM (2.9)	CYP7A1 (2.8)	LPA (2.6)	OGDH (2.5)	APOC4 (2.4)	ATXN2 (2.4)
ENSG00000164733	CTSB PPI subnetwork	1.31e-03	<= 0.20	MAFB (4.7)	APOC1 (4.3)	APOE (3.3)	HLX (2.9)	HP (2.8)	HAVCR1 (2.3)	ENSG00000238078 (2.1)	ANGPTL3 (2.0)	ALDH2 (1.9)	RHD (1.7)
MP:0009356	decreased liver triglyceride level	1.32e-03	<= 0.20	GPAM (4.2)	MOSC1 (3.7)	SORT1 (3.5)	LDLR (3.3)	HP (3.0)	ALDH2 (2.6)	FADS2 (2.5)	PPP1R37 (2.4)	FADS1 (2.4)	APOC1 (2.3)
MP:0011427	mesangial cell hyperplasia	1.33e-03	<= 0.20	C11orf9 (3.9)	BCAM (3.5)	PLEKHH2 (3.5)	PVR (2.5)	PVRL2 (2.3)	TRIB1 (2.1)	APOA5 (1.9)	ATXN7L2 (1.9)	BCL3 (1.7)	TMED4 (1.7)
GO:0045334	clathrin-coated endocytic vesicle	1.34e-03	<= 0.20	HMGCR (3.1)	CLPTM1 (2.8)	FADS1 (2.5)	PLCG1 (2.4)	PPP1R37 (2.4)	FADS2 (2.4)	OGDH (2.2)	CEACAM19 (2.0)	C11orf9 (1.9)	BRAP (1.8)
MP:0005642	decreased mean corpuscular hemoglobin concentration	1.34e-03	<= 0.20	RHD (8.6)	RHCE (7.3)	ENSG00000254235 (3.2)	GMPR (3.1)	TIMD4 (2.9)	FRK (2.6)	SYPL2 (1.9)	LPA (1.9)	MYLIP (1.9)	CYP7A1 (1.8)
GO:0071813	lipoprotein particle binding	1.35e-03	<= 0.20	APOC1 (6.7)	APOB (6.2)	APOA5 (4.7)	PLG (4.7)	TIMD4 (4.5)	CETP (4.5)	APOC4 (4.3)	ANGPTL3 (3.9)	HP (3.6)	PCSK9 (3.5)
GO:0071814	protein-lipid complex binding	1.35e-03	<= 0.20	APOC1 (6.7)	APOB (6.2)	APOA5 (4.7)	PLG (4.7)	TIMD4 (4.5)	CETP (4.5)	APOC4 (4.3)	ANGPTL3 (3.9)	HP (3.6)	PCSK9 (3.5)
MP:0006271	abnormal involution of the mammary gland	1.35e-03	<= 0.20	LPA (3.0)	BCL3 (2.3)	ENSG00000238078 (2.3)	SLC22A1 (2.3)	HP (2.2)	PVR (2.2)	ENSG00000254235 (2.1)	PLEKHH2 (1.9)	AP1M2 (1.8)	CEACAM19 (1.8)
MP:0008735	increased susceptibility to endotoxin shock	1.35e-03	<= 0.20	OASL (5.0)	PARP10 (4.2)	TRIB1 (4.1)	MAFB (3.4)	TIMD4 (2.9)	PLEKHH2 (2.4)	BCL3 (2.3)	HP (2.3)	ITGB3 (2.2)	CETP (2.1)
GO:0032934	sterol binding	1.35e-03	<= 0.20	APOC1 (6.7)	APOB (6.5)	APOE (4.4)	ABCG5 (4.2)	APOC4 (4.1)	APOA5 (4.1)	TIMD4 (3.7)	HP (3.3)	MOSC1 (3.3)	NPC1L1 (3.3)
GO:0051635	bacterial cell surface binding	1.36e-03	<= 0.20	HP (8.5)	LPA (4.6)	APOC4 (4.2)	APOA5 (4.2)	TIMD4 (3.8)	CETP (3.7)	PLG (3.6)	DHODH (3.2)	MOSC1 (3.2)	ABCG5 (2.9)
KEGG_ABC_TRANSPORTERS	KEGG_ABC_TRANSPORTERS	1.38e-03	<= 0.20	ABCG8 (6.3)	ABCG5 (4.3)	TM6SF2 (3.8)	CYP7A1 (3.5)	ATP13A1 (2.8)	PARP10 (2.7)	APOC4 (2.6)	SLC22A1 (2.5)	APOA5 (2.5)	APOB (2.4)
ENSG00000084674	APOB PPI subnetwork	1.39e-03	<= 0.20	APOB (5.9)	APOC1 (4.5)	PLG (3.4)	ERP29 (3.4)	PCSK9 (3.3)	ANGPTL3 (3.0)	HP (3.0)	NPC1L1 (2.9)	APOA5 (2.6)	APOC4 (2.5)
GO:0030669	clathrin-coated endocytic vesicle membrane	1.40e-03	<= 0.20	HMGCR (3.5)	FADS1 (3.1)	FADS2 (2.3)	CEACAM19 (2.2)	DOCK7 (2.1)	ZHX3 (2.0)	PVRL2 (2.0)	PPP1R37 (2.0)	C11orf9 (2.0)	GRINA (1.9)
GO:0034361	very-low-density lipoprotein particle	1.40e-03	<= 0.20	APOB (8.7)	APOC1 (8.2)	PLG (7.3)	APOA5 (6.4)	APOC4 (5.6)	HP (5.4)	APOE (5.1)	ANGPTL3 (4.7)	ABCG5 (4.5)	NPC1L1 (3.9)
GO:0034385	triglyceride-rich lipoprotein particle	1.40e-03	<= 0.20	APOB (8.7)	APOC1 (8.2)	PLG (7.3)	APOA5 (6.4)	APOC4 (5.6)	HP (5.4)	APOE (5.1)	ANGPTL3 (4.7)	ABCG5 (4.5)	NPC1L1 (3.9)
GO:0034375	high-density lipoprotein particle remodeling	1.43e-03	<= 0.20	APOC1 (4.2)	APOA5 (3.6)	APOB (3.6)	APOC4 (3.4)	APOE (3.3)	ABCG5 (3.0)	TIMD4 (3.0)	HNF1A (2.8)	PLG (2.7)	ANGPTL3 (2.5)
ENSG00000169598	DFFB PPI subnetwork	1.44e-03	<= 0.20	CBLC (2.9)	GEMIN7 (2.2)	ABO (2.2)	GCNT4 (2.0)	CETP (2.0)	CYB561D1 (1.9)	TMEM57 (1.8)	ABCG5 (1.7)	ABCG8 (1.7)	PSRC1 (1.7)
ENSG00000170486	KRT72 PPI subnetwork	1.45e-03	<= 0.20	APOB (8.4)	APOC1 (6.4)	PLG (5.5)	ANGPTL3 (4.8)	APOA5 (4.4)	APOE (4.1)	ABCG5 (4.0)	APOC4 (3.9)	HP (3.7)	NPC1L1 (3.3)
GO:0019825	oxygen binding	1.47e-03	<= 0.20	SLC22A1 (5.9)	ABCG5 (5.0)	ANGPTL3 (4.9)	PLG (4.9)	APOA5 (4.4)	LPA (4.3)	APOC4 (4.0)	TM6SF2 (3.8)	APOC1 (3.8)	RHCE (3.8)
MP:0011108	partial embryonic lethality during organogenesis	1.48e-03	<= 0.20	PVRL2 (4.3)	NYNRIN (2.9)	TRIB1 (2.6)	HNF1A (2.6)	BCAM (2.6)	APOB (2.5)	PVR (2.5)	ATXN2 (2.3)	KANK2 (2.1)	C11orf9 (2.1)
ENSG00000154582	TCEB1 PPI subnetwork	1.50e-03	<= 0.20	BUD13 (3.5)	PLG (2.7)	DHX38 (2.6)	ANGPTL3 (2.5)	ZNF259 (2.4)	BCL3 (2.3)	SUGP1 (2.3)	GEMIN7 (2.1)	APOB (2.1)	HP (2.0)
ENSG00000164438	TLX3 PPI subnetwork	1.50e-03	<= 0.20	TXNL4B (3.5)	OASL (3.0)	TIMD4 (2.9)	CETP (2.8)	SH2B3 (1.9)	BUD13 (1.8)	BLOC1S3 (1.8)	SUGP1 (1.7)	DHX38 (1.6)	MYLIP (1.5)
GO:0004867	serine-type endopeptidase inhibitor activity	1.51e-03	<= 0.20	PLG (5.2)	HP (5.2)	APOB (5.2)	APOA5 (5.1)	APOC4 (3.9)	APOC1 (3.8)	ANGPTL3 (3.8)	PCSK9 (3.2)	SLC22A1 (3.2)	ABCG5 (2.7)
GO:0016747	transferase activity, transferring acyl groups other than amino-acyl groups	1.56e-03	<= 0.20	HMGCR (4.2)	FADS1 (4.1)	FADS2 (3.8)	GPAM (3.6)	ABCG5 (3.5)	TM6SF2 (3.1)	ABCG8 (2.8)	MOSC1 (2.7)	COL4A3BP (2.7)	UBXN2B (2.6)
MP:0000465	gastrointestinal hemorrhage	1.57e-03	<= 0.20	ALDH2 (3.3)	NYNRIN (3.2)	ITGB3 (2.9)	HP (2.8)	CETP (2.5)	APOC4 (2.3)	MAFB (2.2)	APOA5 (2.0)	GMIP (2.0)	APOE (2.0)
ENSG00000198780	FAM169A PPI subnetwork	1.58e-03	<= 0.20	APOE (7.6)	APOB (6.1)	APOC1 (4.7)	TIMD4 (4.6)	NPC1L1 (3.9)	APOA5 (3.6)	HP (3.5)	MAFB (3.5)	APOC4 (3.4)	ANGPTL3 (3.3)
MP:0002089	abnormal postnatal growth/weight/body size	1.58e-03	<= 0.20	PPP1R37 (2.8)	NYNRIN (2.8)	NPC1L1 (2.7)	CLPTM1 (2.3)	PLCG1 (2.3)	CILP2 (2.3)	MARK4 (2.2)	GATAD2A (2.1)	CELSR2 (2.0)	HNF1A (1.6)
ENSG00000213923	CSNK1E PPI subnetwork	1.63e-03	<= 0.20	QTRT1 (4.0)	ZNF259 (3.8)	NAA25 (3.5)	DDX56 (3.1)	ILF3 (2.9)	ATP13A1 (2.8)	TOMM40 (2.8)	DHX38 (2.7)	CARM1 (2.7)	TOP1 (2.6)
MP:0009355	increased liver triglyceride level	1.63e-03	<= 0.20	FADS1 (5.5)	APOB (4.4)	GPAM (4.4)	MOSC1 (4.1)	TM6SF2 (3.6)	NPC1L1 (3.6)	ABCG5 (3.5)	HMGCR (3.4)	HP (3.0)	APOA5 (2.9)
ENSG00000181827	RFX7 PPI subnetwork	1.64e-03	<= 0.20	APOB (5.0)	BCAM (4.1)	APOE (3.9)	PLG (3.9)	HP (3.7)	APOC1 (3.6)	APOC4 (3.3)	APOA5 (3.2)	ANGPTL3 (3.1)	PCSK9 (2.5)
ENSG00000206340	C4A PPI subnetwork	1.64e-03	<= 0.20	APOB (6.7)	APOA5 (4.5)	PLG (4.3)	HP (4.1)	APOC1 (3.7)	ANGPTL3 (3.6)	APOC4 (3.5)	ABCG5 (3.5)	NPC1L1 (3.4)	TM6SF2 (2.9)
MP:0002310	decreased susceptibility to hepatic steatosis	1.65e-03	<= 0.20	TM6SF2 (4.0)	TRIB1 (3.4)	NPC1L1 (2.9)	MAU2 (2.7)	BRAP (2.6)	HP (2.5)	ABCG5 (2.5)	GPAM (2.5)	MAFB (2.4)	AMIGO1 (2.4)
ENSG00000162409	PRKAA2 PPI subnetwork	1.65e-03	<= 0.20	BRAP (3.0)	SARS (2.8)	CARM1 (2.7)	PTPN11 (2.4)	GPAM (2.4)	C12orf51 (2.4)	MOSC1 (2.4)	OGDH (2.2)	MAPKAPK5 (2.2)	TRIB1 (2.1)
MP:0000229	abnormal megakaryocyte differentiation	1.65e-03	<= 0.20	ABCG8 (7.8)	ITGB3 (6.0)	RHD (5.6)	RHCE (4.5)	CETP (4.5)	GMPR (3.7)	TIMD4 (2.6)	TM6SF2 (2.5)	FADS2 (1.8)	CYP7A1 (1.7)
ENSG00000197081	IGF2R PPI subnetwork	1.68e-03	<= 0.20	GRINA (3.2)	LPAR2 (2.4)	UBXN2B (1.9)	MAFB (1.8)	MYLIP (1.8)	CEACAM19 (1.7)	USP24 (1.7)	DNM2 (1.6)	C11orf9 (1.6)	APOC1 (1.5)
ENSG00000181031	RPH3AL PPI subnetwork	1.68e-03	<= 0.20	TIMD4 (3.4)	KIAA1324 (3.3)	OASL (3.3)	CETP (3.1)	TMEM57 (2.4)	SUGP1 (2.3)	LPAR2 (2.2)	YIPF2 (2.1)	C1orf63 (2.1)	C19orf52 (1.9)
GO:0009749	response to glucose stimulus	1.69e-03	<= 0.20	HNF1A (3.0)	PCSK9 (2.5)	ENSG00000254235 (2.4)	KIAA1324 (2.0)	ANKRD31 (2.0)	ABCG5 (1.6)	GPAM (1.6)	ABCG8 (1.5)	COL4A3BP (1.4)	MOSC1 (1.4)
MP:0000186	decreased circulating HDL cholesterol level	1.70e-03	<= 0.20	APOB (8.0)	NPC1L1 (7.7)	ABCG5 (6.8)	TM6SF2 (5.9)	APOC1 (5.1)	APOA5 (4.6)	GPAM (4.4)	ABCG8 (4.0)	PLG (3.8)	APOC4 (3.7)
ENSG00000154415	PPP1R3A PPI subnetwork	1.71e-03	<= 0.20	USP24 (3.4)	DNM2 (3.1)	GMIP (2.9)	SORT1 (2.8)	PLEC (2.5)	SYPL2 (2.4)	COL4A3BP (2.3)	ZNF180 (2.1)	SLC44A2 (2.1)	DNAH11 (2.1)
ENSG00000136250	AOAH PPI subnetwork	1.71e-03	<= 0.20	APOB (5.1)	BCAM (4.1)	PLG (4.0)	APOE (3.9)	HP (3.7)	APOC1 (3.5)	APOA5 (3.3)	APOC4 (3.2)	ANGPTL3 (3.1)	PCSK9 (2.9)
ENSG00000110245	APOC3 PPI subnetwork	1.71e-03	<= 0.20	APOB (5.7)	NPC1L1 (5.0)	APOC1 (4.9)	ABCG5 (4.2)	APOA5 (4.1)	APOC4 (3.4)	PLG (3.3)	HP (3.2)	APOE (3.1)	ANGPTL3 (3.0)
ENSG00000215755	ENSG00000215755 PPI subnetwork	1.71e-03	<= 0.20	APOB (5.7)	NPC1L1 (5.0)	APOC1 (4.9)	ABCG5 (4.2)	APOA5 (4.1)	APOC4 (3.4)	PLG (3.3)	HP (3.2)	APOE (3.1)	ANGPTL3 (3.0)
ENSG00000186395	KRT10 PPI subnetwork	1.72e-03	<= 0.20	KANK2 (2.7)	NYNRIN (2.5)	SLC22A1 (2.1)	OGDH (2.0)	PCSK9 (1.9)	PLEC (1.8)	ANGPTL3 (1.7)	GMPR (1.6)	APOC1 (1.5)	BCAM (1.5)
GO:0051119	sugar transmembrane transporter activity	1.72e-03	<= 0.20	TMED4 (3.5)	TM6SF2 (2.5)	GOT2P1 (2.3)	APOB (2.0)	CLPTM1 (1.9)	BLOC1S3 (1.9)	SLC44A2 (1.9)	ATP13A1 (1.8)	NPC1L1 (1.7)	LDLR (1.7)
ENSG00000118690	ARMC2 PPI subnetwork	1.73e-03	<= 0.20	APOB (5.0)	BCAM (4.2)	PLG (3.9)	APOE (3.7)	HP (3.7)	APOC1 (3.5)	APOC4 (3.3)	APOA5 (3.2)	PCSK9 (3.1)	ANGPTL3 (3.0)
GO:0016840	carbon-nitrogen lyase activity	1.73e-03	<= 0.20	LPA (6.7)	APOA5 (5.6)	APOC4 (4.9)	SLC22A1 (4.8)	PLG (4.8)	ANGPTL3 (4.1)	CEACAM19 (3.8)	APOC1 (3.1)	ABCG5 (3.0)	MOSC1 (2.9)
GO:0033344	cholesterol efflux	1.77e-03	<= 0.20	ABCG8 (4.4)	ABCG5 (4.2)	NPC1L1 (3.7)	TIMD4 (3.6)	APOC1 (3.6)	APOE (3.6)	APOB (3.3)	TM6SF2 (2.9)	APOA5 (2.4)	MYLIP (2.3)
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA:HYDROXYCHOLESTEROL	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA:HYDROXYCHOLESTEROL	1.77e-03	<= 0.20	APOC4 (10.3)	APOA5 (8.5)	CYP7A1 (8.0)	PLG (6.8)	ANGPTL3 (6.7)	SLC22A1 (5.9)	LPA (5.5)	ABCG8 (4.8)	ABCG5 (4.8)	APOC1 (4.2)
ENSG00000165140	FBP1 PPI subnetwork	1.78e-03	<= 0.20	GRINA (3.2)	CYP7A1 (3.2)	PLG (3.2)	APOC4 (2.7)	UBXN2B (2.6)	ANGPTL3 (2.4)	LPA (2.3)	HNF1A (2.2)	MOSC1 (2.1)	APOA5 (1.9)
ENSG00000119335	SET PPI subnetwork	1.79e-03	<= 0.20	CARM1 (2.4)	BUD13 (2.2)	PLEC (2.1)	PSRC1 (2.1)	ILF3 (1.9)	NCAN (1.9)	BRAP (1.9)	GATAD2A (1.7)	TXNL4B (1.7)	TOP1 (1.6)
MP:0010026	decreased liver cholesterol level	1.79e-03	<= 0.20	LDLR (8.5)	HMGCR (7.3)	FADS1 (6.4)	FADS2 (6.2)	PCSK9 (3.7)	SORT1 (2.9)	TIMD4 (2.8)	LPA (2.6)	NPC1L1 (2.5)	GRINA (2.3)
GO:0015485	cholesterol binding	1.80e-03	<= 0.20	APOC1 (7.2)	APOB (6.9)	APOE (4.7)	NPC1L1 (4.6)	TIMD4 (4.3)	APOA5 (4.2)	ABCG5 (4.1)	APOC4 (4.1)	PLG (3.4)	HP (3.3)
ENSG00000092439	TRPM7 PPI subnetwork	1.81e-03	<= 0.20	CETP (3.3)	TIMD4 (2.8)	OASL (2.7)	C1orf63 (2.4)	SORT1 (2.0)	DNAH11 (2.0)	MOSC1 (1.8)	HNF1A (1.7)	PLEKHH2 (1.6)	TMEM57 (1.6)
MP:0001585	hemolytic anemia	1.82e-03	<= 0.20	RHD (9.2)	RHCE (8.1)	C12orf51 (4.1)	ABCG8 (3.6)	GRINA (2.6)	CYP7A1 (2.4)	GMPR (2.2)	LPA (2.1)	APOC4 (2.0)	APOA5 (1.8)
ENSG00000086061	DNAJA1 PPI subnetwork	1.82e-03	<= 0.20	RELB (4.4)	BCL3 (3.5)	PLEC (2.8)	PLG (2.7)	ANGPTL3 (2.7)	PVR (2.4)	APOC4 (2.3)	OGDH (2.1)	HLX (2.0)	MYLIP (2.0)
ENSG00000103479	RBL2 PPI subnetwork	1.83e-03	<= 0.20	FEN1 (3.3)	USP1 (2.9)	MAPKAPK5 (2.7)	DHODH (2.4)	TOMM40 (2.1)	TMED4 (2.0)	DDX56 (2.0)	BUD13 (1.9)	ENSG00000226645 (1.8)	PSRC1 (1.8)
GO:0061008	hepaticobiliary system development	1.85e-03	<= 0.20	CYP7A1 (3.9)	PCSK9 (3.0)	HNF1A (2.9)	ABCG5 (2.6)	ABCG8 (2.4)	COL4A3BP (2.3)	ANGPTL3 (1.9)	TRAPPC6A (1.9)	APOA5 (1.9)	APOB (1.9)
REACTOME_INTRINSIC_PATHWAY	REACTOME_INTRINSIC_PATHWAY	1.85e-03	<= 0.20	PLG (7.0)	ITGB3 (6.4)	ANGPTL3 (6.4)	APOC4 (6.1)	APOA5 (5.1)	LPA (4.9)	SLC22A1 (4.5)	HP (4.4)	CETP (4.2)	GMPR (3.5)
MP:0006298	abnormal platelet activation	1.87e-03	<= 0.20	ITGB3 (8.1)	ABCG8 (5.5)	CETP (4.0)	TIMD4 (3.2)	GMPR (3.0)	GMIP (2.4)	LPA (2.3)	MAFB (2.2)	SLC44A2 (1.7)	NPC1L1 (1.6)
GO:0015145	monosaccharide transmembrane transporter activity	1.89e-03	<= 0.20	TMED4 (3.8)	NPC1L1 (3.3)	GOT2P1 (3.2)	TM6SF2 (2.8)	APOB (2.6)	ABCG5 (2.3)	GCNT4 (2.3)	TSSK6 (2.2)	PMFBP1 (1.8)	PBX4 (1.8)
ENSG00000115414	FN1 PPI subnetwork	1.89e-03	<= 0.20	CILP2 (3.5)	APOE (3.5)	APOC4 (2.7)	APOC1 (2.6)	ABCG5 (2.6)	APOB (2.4)	ST3GAL4 (2.4)	ITGB3 (2.4)	PLEC (2.3)	HP (2.2)
GO:0001889	liver development	1.91e-03	<= 0.20	CYP7A1 (4.0)	PCSK9 (3.1)	HNF1A (3.0)	ABCG5 (2.6)	ABCG8 (2.4)	C19orf52 (2.0)	GEMIN7 (2.0)	TRAPPC6A (1.9)	APOB (1.9)	ANGPTL3 (1.9)
ENSG00000103363	TCEB2 PPI subnetwork	1.92e-03	<= 0.20	BUD13 (3.4)	DHX38 (2.7)	SUGP1 (2.5)	PLG (2.5)	APOB (2.2)	ANGPTL3 (2.1)	HP (2.1)	BCL3 (2.1)	DOCK7 (2.0)	APOA5 (1.8)
GO:0016051	carbohydrate biosynthetic process	1.92e-03	<= 0.20	LPA (2.5)	SORT1 (2.5)	SYPL2 (2.4)	NT5DC1 (2.4)	ST3GAL4 (2.3)	DHODH (2.3)	GPAM (2.3)	ZNF180 (2.3)	ENSG00000254235 (2.2)	MOSC1 (1.9)
ENSG00000126218	F10 PPI subnetwork	1.93e-03	<= 0.20	APOA5 (6.2)	ANGPTL3 (6.1)	PLG (6.0)	HP (5.5)	APOB (5.0)	APOC4 (5.0)	SLC22A1 (4.8)	APOC1 (4.0)	PCSK9 (3.5)	ABCG5 (2.9)
ENSG00000160285	LSS PPI subnetwork	1.95e-03	<= 0.20	HMGCR (13.2)	LDLR (11.3)	FADS1 (9.4)	FADS2 (8.8)	PCSK9 (7.4)	SLC22A1 (3.6)	NPC1L1 (3.4)	CYP7A1 (3.0)	PLG (2.5)	TM6SF2 (2.2)
GO:0016763	transferase activity, transferring pentosyl groups	1.95e-03	<= 0.20	PARP10 (5.8)	OASL (5.3)	TRAFD1 (2.9)	DHODH (2.5)	UBXN2B (2.1)	TRIB1 (2.0)	POLK (1.3)	HNF1A (1.3)	CARM1 (1.3)	TOP1 (1.3)
ENSG00000136108	CKAP2 PPI subnetwork	1.97e-03	<= 0.20	APOB (6.9)	ANGPTL3 (6.4)	PLG (4.9)	APOC4 (4.7)	APOA5 (4.4)	APOE (4.2)	APOC1 (4.2)	HP (3.9)	PCSK9 (3.2)	ABCG5 (2.9)
MP:0000240	extramedullary hematopoiesis	1.98e-03	<= 0.20	RHD (5.9)	RHCE (5.1)	BCL3 (4.6)	RELB (4.0)	PARP10 (3.7)	GMIP (3.6)	SH2B3 (2.8)	GRINA (2.7)	DNM2 (2.2)	MAFB (2.0)
GO:0071827	plasma lipoprotein particle organization	1.98e-03	<= 0.20	APOC1 (4.1)	APOE (3.8)	ABCG5 (3.7)	NPC1L1 (3.5)	APOB (3.4)	HAVCR1 (3.3)	TIMD4 (3.2)	MOSC1 (2.8)	ABCG8 (2.7)	APOA5 (2.7)
GO:0071825	protein-lipid complex subunit organization	1.98e-03	<= 0.20	APOC1 (4.1)	APOE (3.8)	ABCG5 (3.7)	NPC1L1 (3.5)	APOB (3.4)	HAVCR1 (3.3)	TIMD4 (3.2)	MOSC1 (2.8)	ABCG8 (2.7)	APOA5 (2.7)
ENSG00000100181	ENSG00000100181 PPI subnetwork	1.99e-03	<= 0.20	QTRT1 (4.0)	ZNF259 (3.7)	DDX56 (3.4)	NAA25 (3.3)	CARM1 (2.9)	ATP13A1 (2.9)	DHX38 (2.9)	TOMM40 (2.8)	ILF3 (2.7)	TOP1 (2.6)
MP:0004151	decreased circulating iron level	1.99e-03	<= 0.20	TIMD4 (4.2)	MAFB (3.3)	CETP (3.1)	HNF1A (3.0)	HP (2.7)	RHD (2.7)	BCL3 (2.5)	APOE (2.2)	GCNT4 (2.1)	APOC1 (1.9)
GO:0017187	peptidyl-glutamic acid carboxylation	1.99e-03	<= 0.20	LPA (4.3)	ABO (4.1)	HNF1A (3.6)	ANGPTL3 (3.6)	SLC22A1 (3.4)	APOC4 (3.3)	APOA5 (3.2)	ENSG00000254235 (3.0)	PLG (3.0)	CEACAM19 (2.6)
GO:0018214	protein carboxylation	1.99e-03	<= 0.20	LPA (4.3)	ABO (4.1)	HNF1A (3.6)	ANGPTL3 (3.6)	SLC22A1 (3.4)	APOC4 (3.3)	APOA5 (3.2)	ENSG00000254235 (3.0)	PLG (3.0)	CEACAM19 (2.6)
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	1.99e-03	<= 0.20	FADS1 (4.7)	NKPD1 (3.8)	ABCG8 (2.7)	ABCG5 (2.2)	TMEM57 (2.2)	GCNT4 (2.2)	HMGCR (2.1)	BLOC1S3 (2.0)	LDLR (2.0)	TIMD4 (2.0)
REACTOME_ABC:FAMILY_PROTEINS_MEDIATED_TRANSPORT	REACTOME_ABC:FAMILY_PROTEINS_MEDIATED_TRANSPORT	2.00e-03	<= 0.20	ABCG8 (6.3)	ABCG5 (5.3)	TM6SF2 (4.0)	APOB (4.0)	NPC1L1 (3.8)	NT5DC1 (3.3)	CYP7A1 (2.8)	CLPTM1 (2.3)	C17orf57 (2.2)	APOA5 (2.2)
ENSG00000186951	PPARA PPI subnetwork	2.03e-03	<= 0.20	C12orf51 (3.4)	TOP1 (3.2)	ZHX3 (2.4)	SMARCA4 (2.2)	ATXN2 (2.0)	APOA5 (2.0)	MAFB (1.8)	TM6SF2 (1.8)	APOB (1.8)	ABCG8 (1.7)
GO:0009991	response to extracellular stimulus	2.06e-03	<= 0.20	TM6SF2 (3.0)	ABCG8 (2.8)	NPC1L1 (2.7)	ABCG5 (2.3)	FADS2 (2.2)	CYP7A1 (2.1)	ALDH2 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	ACAD10 (1.9)
ENSG00000122861	PLAU PPI subnetwork	2.06e-03	<= 0.20	ANGPTL3 (3.4)	APOE (3.3)	APOC1 (3.3)	HP (3.0)	PVRL2 (2.9)	APOA5 (2.7)	PLG (2.5)	APOB (2.3)	PVR (2.1)	CEACAM19 (1.8)
MP:0001547	abnormal lipid level	2.08e-03	<= 0.20	APOC1 (5.5)	GPAM (4.3)	MOSC1 (4.1)	APOE (3.6)	APOC4 (3.5)	FADS2 (3.2)	FADS1 (3.2)	SORT1 (3.1)	APOA5 (2.9)	LDLR (2.4)
ENSG00000047457	CP PPI subnetwork	2.10e-03	<= 0.20	RHD (3.5)	HP (3.4)	TIMD4 (3.2)	ALDH2 (2.9)	CYP7A1 (2.6)	APOE (2.6)	CETP (2.5)	APOC4 (2.4)	DOCK7 (2.2)	APOA5 (2.0)
MP:0000183	decreased circulating LDL cholesterol level	2.10e-03	<= 0.20	NPC1L1 (9.2)	APOB (7.1)	ABCG5 (6.4)	TM6SF2 (6.4)	APOC1 (5.9)	GPAM (4.7)	PCSK9 (4.1)	ABCG8 (4.0)	HP (3.8)	PLG (3.8)
ENSG00000105671	DDX49 PPI subnetwork	2.11e-03	<= 0.20	DDX56 (4.4)	NAA25 (4.4)	ZNF259 (4.0)	QTRT1 (3.6)	TOMM40 (3.3)	DHODH (2.6)	DHX38 (2.4)	C12orf43 (2.4)	HMGCR (2.1)	PSMA5 (2.1)
ENSG00000156453	PCDH1 PPI subnetwork	2.12e-03	<= 0.20	APOB (6.8)	APOA5 (4.5)	PLG (4.3)	ANGPTL3 (3.9)	HP (3.9)	APOC4 (3.5)	ABCG5 (3.5)	APOC1 (3.4)	NPC1L1 (3.2)	TM6SF2 (2.6)
MP:0005365	abnormal bile salt homeostasis	2.13e-03	<= 0.20	ABCG5 (3.8)	APOA5 (3.7)	APOC4 (3.4)	ABCG8 (2.9)	HNF1A (2.8)	APOC1 (2.7)	TM6SF2 (2.7)	CETP (2.3)	APOE (2.2)	PLG (2.1)
GO:0016853	isomerase activity	2.14e-03	<= 0.20	HMGCR (4.0)	FADS2 (3.8)	FADS1 (3.4)	TRAPPC6A (3.3)	NT5DC1 (3.3)	DHODH (3.2)	QTRT1 (3.1)	PCSK9 (3.1)	ERP29 (3.0)	TOMM40 (2.9)
ENSG00000188488	SERPINA5 PPI subnetwork	2.14e-03	<= 0.20	PLG (7.2)	ANGPTL3 (6.4)	APOC4 (5.6)	APOA5 (5.4)	APOB (5.3)	HP (4.3)	APOC1 (3.5)	PCSK9 (2.9)	HNF1A (2.8)	SLC22A1 (2.7)
ENSG00000136110	LECT1 PPI subnetwork	2.15e-03	<= 0.20	APOE (7.6)	APOB (6.6)	TIMD4 (5.5)	APOC1 (4.7)	APOA5 (4.0)	ANGPTL3 (3.6)	APOC4 (3.6)	NPC1L1 (3.5)	HP (3.4)	ABCG5 (3.4)
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	2.16e-03	<= 0.20	APOC4 (9.1)	CYP7A1 (7.0)	APOA5 (6.9)	LPA (6.4)	PLG (6.2)	ANGPTL3 (6.0)	SLC22A1 (5.8)	HP (4.2)	ABCG5 (3.7)	ABCG8 (3.4)
KEGG_ARGININE_AND_PROLINE_METABOLISM	KEGG_ARGININE_AND_PROLINE_METABOLISM	2.17e-03	<= 0.20	ABCG8 (4.9)	TM6SF2 (4.6)	PLG (4.5)	ABCG5 (4.2)	ANGPTL3 (3.7)	PCSK9 (3.0)	APOA5 (3.0)	HP (2.9)	APOC4 (2.8)	CYP7A1 (2.6)
ENSG00000148965	SAA4 PPI subnetwork	2.17e-03	<= 0.20	APOB (5.9)	APOE (4.9)	PLG (4.7)	HP (4.2)	APOA5 (3.9)	APOC4 (3.9)	APOC1 (3.9)	ANGPTL3 (3.5)	BCAM (3.2)	PCSK9 (3.0)
MP:0005416	abnormal circulating protein level	2.18e-03	<= 0.20	APOC1 (4.4)	PLG (4.3)	APOA5 (4.1)	SLC22A1 (4.1)	ANGPTL3 (3.9)	HP (3.9)	APOB (3.4)	APOC4 (3.2)	NPC1L1 (2.5)	TM6SF2 (2.5)
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	2.19e-03	<= 0.20	APOC4 (8.3)	LPA (7.5)	CYP7A1 (7.1)	APOA5 (6.6)	PLG (5.4)	SLC22A1 (5.4)	ANGPTL3 (5.2)	HP (4.1)	ABCG5 (3.9)	APOC1 (3.4)
GO:0090207	regulation of triglyceride metabolic process	2.20e-03	<= 0.20	TM6SF2 (3.3)	NPC1L1 (2.9)	GCNT4 (2.8)	ABCG5 (2.6)	ABCG8 (2.5)	APOC1 (2.3)	MOSC1 (2.3)	GPAM (2.1)	ANKRD31 (2.0)	ENSG00000226648 (1.8)
ENSG00000115548	KDM3A PPI subnetwork	2.23e-03	<= 0.20	SARS (4.3)	OGDH (3.1)	CLPTM1 (3.1)	PTPN11 (3.1)	C12orf43 (2.8)	BRAP (2.7)	GATAD2A (2.3)	CARM1 (2.1)	DNAH11 (1.9)	ILF3 (1.8)
ENSG00000125124	BBS2 PPI subnetwork	2.23e-03	<= 0.20	PLG (3.2)	BCAM (3.0)	DYNC2LI1 (2.7)	SLC22A1 (2.6)	ANGPTL3 (2.5)	DHODH (2.4)	BCL3 (2.3)	LPAR2 (2.1)	HP (2.0)	PLEC (1.9)
ENSG00000068971	PPP2R5B PPI subnetwork	2.23e-03	<= 0.20	SARS (3.6)	BRAP (3.0)	BLOC1S3 (2.4)	C17orf57 (2.2)	TRAPPC6A (2.0)	CLPTM1 (1.8)	GOT2P1 (1.7)	PCSK9 (1.7)	ILF3 (1.6)	NKPD1 (1.5)
REACTOME_HEMOSTASIS	REACTOME_HEMOSTASIS	2.25e-03	<= 0.20	ITGB3 (7.9)	HP (2.7)	CETP (2.6)	GMPR (2.6)	PLG (2.5)	SH2B3 (2.5)	ANGPTL3 (2.3)	APOB (2.2)	APOE (2.1)	APOC4 (2.1)
GO:0016746	transferase activity, transferring acyl groups	2.26e-03	<= 0.20	HMGCR (5.3)	FADS1 (4.6)	FADS2 (4.5)	GPAM (3.7)	TM6SF2 (3.1)	MOSC1 (2.9)	ABCG5 (2.9)	LDLR (2.8)	ABCG8 (2.6)	NKPD1 (2.5)
ENSG00000064692	SNCAIP PPI subnetwork	2.28e-03	<= 0.20	CYP7A1 (2.2)	ANGPTL3 (2.1)	APOA5 (2.1)	GCNT4 (2.0)	ENSG00000226645 (1.9)	RHD (1.8)	SLC22A1 (1.8)	FADS2 (1.8)	PCSK9 (1.8)	SLC44A2 (1.8)
ENSG00000183508	FAM46C PPI subnetwork	2.28e-03	<= 0.20	CBLC (4.3)	CLPTM1 (3.0)	BLOC1S3 (2.8)	QTRT1 (2.6)	AP1M2 (2.5)	PLCG1 (2.3)	C12orf43 (2.2)	HNF1A (2.1)	TXNL4B (2.1)	DNM2 (2.1)
ENSG00000141141	DDX52 PPI subnetwork	2.29e-03	<= 0.20	DDX56 (4.8)	NAA25 (4.5)	ZNF259 (4.5)	TOMM40 (3.8)	QTRT1 (3.6)	C12orf43 (3.0)	DHX38 (2.7)	DHODH (2.5)	TOP1 (2.4)	SUGP1 (2.0)
GO:0005996	monosaccharide metabolic process	2.32e-03	<= 0.20	SYPL2 (2.6)	ACAD10 (2.4)	NT5DC1 (2.2)	LPA (2.2)	ENSG00000254235 (2.1)	SORT1 (2.1)	DHODH (2.1)	SLC22A1 (2.1)	GOT2P1 (1.9)	TRAPPC6A (1.8)
MP:0010377	abnormal gut flora balance	2.33e-03	<= 0.20	ABCG5 (3.0)	HP (3.0)	CEACAM19 (2.8)	PARP10 (2.5)	TM6SF2 (2.3)	NPC1L1 (2.3)	ALDH2 (2.2)	ABCG8 (2.1)	CBLC (2.1)	GMIP (2.0)
ENSG00000154134	ROBO3 PPI subnetwork	2.35e-03	<= 0.20	APOE (7.8)	APOB (6.2)	TIMD4 (4.9)	APOC1 (4.8)	NPC1L1 (4.0)	APOA5 (3.6)	MAFB (3.6)	HP (3.5)	ABCG5 (3.5)	PLG (3.3)
ENSG00000033800	PIAS1 PPI subnetwork	2.38e-03	<= 0.20	TRAFD1 (3.2)	BCL3 (2.4)	CETP (2.0)	ABCG8 (1.8)	ALDH2 (1.7)	GOT2P1 (1.7)	OASL (1.7)	PARP10 (1.6)	ENSG00000228044 (1.6)	GATAD2A (1.6)
ENSG00000180530	NRIP1 PPI subnetwork	2.39e-03	<= 0.20	PPP1R37 (4.1)	KANK2 (2.2)	ATXN2 (2.0)	SH2B3 (2.0)	YIPF2 (1.9)	MYLIP (1.9)	NYNRIN (1.8)	APOC1 (1.5)	ST3GAL4 (1.5)	AMIGO1 (1.5)
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	2.39e-03	<= 0.20	ERP29 (4.8)	ATP13A1 (3.3)	TMED4 (2.9)	NKPD1 (2.7)	TMEM50A (2.3)	TRAPPC6A (2.3)	CETP (2.0)	GCNT4 (1.9)	PMFBP1 (1.8)	COL4A3BP (1.7)
ENSG00000182010	RTKN2 PPI subnetwork	2.40e-03	<= 0.20	APOB (5.1)	BCAM (4.1)	PLG (3.8)	APOE (3.8)	HP (3.7)	APOC1 (3.3)	APOA5 (3.2)	APOC4 (3.2)	ANGPTL3 (3.0)	PCSK9 (2.7)
MP:0009831	abnormal sperm midpiece morphology	2.41e-03	<= 0.20	TSSK6 (3.0)	PMFBP1 (3.0)	BRAP (2.5)	PVR (2.3)	GCNT4 (2.2)	ZNF180 (2.2)	ANKRD31 (2.1)	YIPF2 (1.9)	TIMD4 (1.7)	BCAM (1.6)
GO:0051183	vitamin transporter activity	2.42e-03	<= 0.20	TM6SF2 (4.5)	APOB (4.4)	ABCG8 (4.0)	ABCG5 (3.4)	ANGPTL3 (3.3)	APOC4 (3.3)	GPAM (3.2)	PLG (2.6)	APOA5 (2.6)	NPC1L1 (2.6)
GO:0006576	cellular biogenic amine metabolic process	2.43e-03	<= 0.20	LPA (3.1)	ENSG00000254235 (2.9)	TSSK6 (2.9)	CYP7A1 (2.7)	SLC22A1 (2.5)	TM6SF2 (2.3)	APOA5 (2.2)	APOC4 (2.2)	HNF1A (2.1)	ANGPTL3 (2.1)
ENSG00000142515	KLK3 PPI subnetwork	2.43e-03	<= 0.20	HP (3.7)	APOC1 (3.7)	APOA5 (3.6)	RHD (3.3)	PCSK9 (3.2)	LPA (2.8)	ANGPTL3 (2.5)	APOE (2.5)	TIMD4 (2.4)	APOC4 (2.2)
ENSG00000143569	UBAP2L PPI subnetwork	2.43e-03	<= 0.20	PPP1R37 (3.3)	C17orf57 (3.3)	GRINA (3.2)	CARM1 (2.6)	UBXN2B (2.2)	MARK4 (2.1)	BLOC1S3 (1.9)	PTPN11 (1.9)	CEACAM19 (1.7)	OGDH (1.7)
REACTOME_COMPLEMENT_CASCADE	REACTOME_COMPLEMENT_CASCADE	2.45e-03	<= 0.20	APOC4 (7.0)	LPA (6.5)	PLG (6.1)	ANGPTL3 (6.0)	HP (5.9)	TIMD4 (5.9)	SLC22A1 (5.8)	APOA5 (5.7)	APOC1 (5.5)	APOE (4.4)
GO:0016298	lipase activity	2.47e-03	<= 0.20	NKPD1 (4.2)	CETP (4.0)	APOE (3.2)	APOC1 (3.0)	MAFB (2.9)	MOSC1 (2.7)	TIMD4 (2.5)	SORT1 (2.3)	ABCG8 (2.3)	APOC4 (2.0)
ENSG00000158874	APOA2 PPI subnetwork	2.47e-03	<= 0.20	APOC1 (6.2)	APOB (6.1)	NPC1L1 (4.8)	ABCG5 (4.5)	APOA5 (4.2)	APOC4 (4.0)	APOE (4.0)	PLG (3.8)	HP (3.6)	ANGPTL3 (3.3)
ENSG00000084774	CAD PPI subnetwork	2.48e-03	<= 0.20	RELB (5.2)	BCL3 (4.3)	CARM1 (2.5)	CEACAM19 (2.4)	CLPTM1 (2.2)	ATP13A1 (2.2)	MAU2 (2.1)	DNM2 (2.0)	SH2B3 (2.0)	PLEC (1.9)
MP:0001556	increased circulating HDL cholesterol level	2.48e-03	<= 0.20	APOC1 (5.0)	FADS2 (4.7)	FADS1 (4.6)	GPAM (4.5)	MOSC1 (4.4)	HMGCR (3.9)	PCSK9 (2.9)	HP (2.3)	HNF1A (2.3)	NPC1L1 (2.2)
MP:0003657	abnormal erythrocyte osmotic lysis	2.50e-03	<= 0.20	RHD (12.0)	RHCE (11.4)	GMPR (3.8)	C12orf51 (3.5)	ABCG8 (3.0)	APOA5 (2.4)	CYP7A1 (2.2)	ADAM1 (1.9)	NPC1L1 (1.9)	GRINA (1.8)
ENSG00000141378	PTRH2 PPI subnetwork	2.51e-03	<= 0.20	DNM2 (3.8)	GATAD2A (3.2)	CARM1 (3.0)	QTRT1 (2.7)	MAU2 (2.6)	TOMM40 (2.4)	CLPTM1 (2.4)	PPP1R37 (2.3)	SUGP1 (2.2)	TMEM57 (2.0)
ENSG00000125998	FAM83C PPI subnetwork	2.54e-03	<= 0.20	APOE (7.6)	APOB (6.2)	TIMD4 (4.6)	APOC1 (4.6)	NPC1L1 (3.8)	APOA5 (3.6)	MAFB (3.5)	APOC4 (3.4)	HP (3.4)	ABCG5 (3.2)
ENSG00000167751	KLK2 PPI subnetwork	2.54e-03	<= 0.20	PLG (4.4)	APOA5 (4.3)	APOC1 (3.7)	SLC22A1 (3.4)	HP (3.2)	PVRL2 (3.2)	ANGPTL3 (2.9)	APOB (2.9)	APOC4 (2.8)	HNF1A (2.6)
GO:0032451	demethylase activity	2.55e-03	<= 0.20	SLC22A1 (4.1)	LPA (3.7)	ABCG8 (3.6)	CYP7A1 (3.0)	APOA5 (2.9)	NPC1L1 (2.9)	ABCG5 (2.7)	TRAFD1 (2.5)	C12orf47 (2.4)	TMEM57 (2.4)
ENSG00000091831	ESR1 PPI subnetwork	2.55e-03	<= 0.20	ATXN2 (3.3)	BCL3 (2.8)	PPP1R37 (2.8)	TRIB1 (2.7)	ZHX3 (2.5)	PLEC (2.4)	SMARCA4 (2.4)	DHX38 (2.3)	DNM2 (2.2)	MAU2 (2.2)
GO:0044419	interspecies interaction between organisms	2.58e-03	<= 0.20	PARP10 (3.3)	OASL (2.9)	TRAFD1 (2.7)	GRINA (2.4)	MAU2 (2.3)	NAA25 (2.3)	TOP1 (2.0)	ADAM1 (1.8)	BUD13 (1.8)	PTPN11 (1.7)
ENSG00000206289	RXRB PPI subnetwork	2.59e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000206218	ENSG00000206218 PPI subnetwork	2.59e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000204231	RXRB PPI subnetwork	2.59e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000211592	ENSG00000211592 PPI subnetwork	2.61e-03	<= 0.20	APOE (5.4)	TIMD4 (4.6)	MAFB (4.0)	APOC1 (2.8)	CETP (2.4)	ALDH2 (2.3)	DOCK7 (1.9)	GPAM (1.9)	GCNT4 (1.8)	RHD (1.6)
ENSG00000038002	AGA PPI subnetwork	2.61e-03	<= 0.20	APOB (7.4)	PLG (5.4)	APOA5 (5.3)	HP (4.5)	ANGPTL3 (4.3)	APOC4 (4.2)	APOC1 (3.7)	APOE (3.1)	ABCG5 (3.1)	NPC1L1 (3.1)
GO:0016053	organic acid biosynthetic process	2.62e-03	<= 0.20	CYP7A1 (4.7)	FADS2 (3.4)	PCSK9 (3.0)	FADS1 (2.9)	APOC4 (2.8)	TM6SF2 (2.8)	ANGPTL3 (2.8)	ALDH2 (2.7)	LPA (2.7)	ABCG8 (2.6)
GO:0046394	carboxylic acid biosynthetic process	2.62e-03	<= 0.20	CYP7A1 (4.7)	FADS2 (3.4)	PCSK9 (3.0)	FADS1 (2.9)	APOC4 (2.8)	TM6SF2 (2.8)	ANGPTL3 (2.8)	ALDH2 (2.7)	LPA (2.7)	ABCG8 (2.6)
MP:0000598	abnormal liver morphology	2.62e-03	<= 0.20	APOC4 (4.7)	APOA5 (4.6)	SLC22A1 (4.0)	LPA (3.9)	CYP7A1 (3.7)	COL4A3BP (3.6)	HP (3.5)	PCSK9 (3.5)	APOC1 (3.3)	ANGPTL3 (3.0)
ENSG00000137561	TTPA PPI subnetwork	2.64e-03	<= 0.20	APOB (6.2)	PLG (6.1)	ANGPTL3 (5.4)	APOA5 (5.0)	APOC4 (4.1)	APOC1 (3.3)	HP (3.1)	GOT2P1 (2.6)	PCSK9 (2.4)	SLC22A1 (2.3)
ENSG00000197766	CFD PPI subnetwork	2.64e-03	<= 0.20	APOB (7.7)	PLG (5.9)	APOA5 (5.8)	HP (4.7)	ANGPTL3 (4.7)	APOC4 (4.5)	APOC1 (4.0)	ABCG5 (3.2)	APOE (3.0)	NPC1L1 (3.0)
GO:0031983	vesicle lumen	2.66e-03	<= 0.20	ANGPTL3 (6.2)	HP (5.7)	PLG (5.3)	ITGB3 (5.3)	APOB (4.5)	APOA5 (4.2)	APOC4 (4.0)	APOE (3.9)	APOC1 (3.5)	LPA (2.3)
ENSG00000012963	UBR7 PPI subnetwork	2.70e-03	<= 0.20	ATXN7L2 (4.6)	DNM2 (3.5)	QTRT1 (2.8)	PSMA5 (2.5)	ABO (2.5)	C19orf52 (2.3)	SYPL2 (2.2)	MAFB (2.1)	C17orf57 (2.1)	ATP13A1 (2.0)
GO:0046486	glycerolipid metabolic process	2.73e-03	<= 0.20	MOSC1 (3.7)	GPAM (3.7)	NPC1L1 (3.4)	BLOC1S3 (3.4)	TM6SF2 (2.8)	FADS1 (2.8)	HMGCR (2.6)	FADS2 (2.4)	CYP7A1 (2.4)	PCSK9 (2.1)
MP:0002891	increased insulin sensitivity	2.73e-03	<= 0.20	PPP1R37 (3.1)	ATXN7L2 (2.8)	TRIB1 (2.7)	ZHX3 (2.3)	SORT1 (2.2)	SYPL2 (2.2)	AMIGO1 (2.1)	ZNF101 (2.0)	HAVCR1 (1.9)	BCL3 (1.8)
ENSG00000127948	POR PPI subnetwork	2.74e-03	<= 0.20	LPA (6.0)	SLC22A1 (5.6)	ABCG5 (4.7)	APOA5 (4.2)	APOC4 (3.9)	ABCG8 (3.6)	HP (3.2)	APOC1 (2.9)	TM6SF2 (2.9)	PLG (2.7)
ENSG00000166285	ENSG00000166285 PPI subnetwork	2.74e-03	<= 0.20	APOB (8.5)	APOA5 (5.7)	PLG (5.4)	HP (5.2)	ANGPTL3 (4.6)	APOC4 (4.4)	APOC1 (4.2)	ABCG5 (4.0)	NPC1L1 (3.8)	APOE (3.7)
ENSG00000204359	CFB PPI subnetwork	2.74e-03	<= 0.20	APOB (8.5)	APOA5 (5.7)	PLG (5.4)	HP (5.2)	ANGPTL3 (4.6)	APOC4 (4.4)	APOC1 (4.2)	ABCG5 (4.0)	NPC1L1 (3.8)	APOE (3.7)
ENSG00000067225	PKM2 PPI subnetwork	2.76e-03	<= 0.20	SARS (4.5)	PLEC (2.5)	SMARCA4 (2.1)	FADS2 (2.1)	NAA25 (2.0)	NT5DC1 (1.9)	OGDH (1.8)	FADS1 (1.8)	GRINA (1.8)	PSMA5 (1.8)
ENSG00000165630	PRPF18 PPI subnetwork	2.78e-03	<= 0.20	DHX38 (4.0)	SMARCA4 (2.5)	TOP1 (2.4)	ATP13A1 (2.3)	USP1 (2.3)	MAU2 (2.2)	ZNF180 (2.0)	SUGP1 (2.0)	POC5 (1.9)	DDX56 (1.9)
GO:0008757	S-adenosylmethionine-dependent methyltransferase activity	2.78e-03	<= 0.20	QTRT1 (3.7)	DHODH (3.1)	NAA25 (2.7)	C12orf43 (2.4)	C12orf51 (2.3)	ILF3 (2.2)	MAPKAPK5 (2.1)	C19orf52 (2.0)	ATP13A1 (1.9)	ATXN2 (1.9)
ENSG00000169896	ITGAM PPI subnetwork	2.80e-03	<= 0.20	HP (5.5)	CETP (5.3)	ITGB3 (4.0)	TIMD4 (4.0)	APOE (3.5)	RHD (3.3)	ENSG00000228044 (3.1)	APOC1 (2.9)	APOA5 (2.8)	RELB (2.4)
ENSG00000167971	CASKIN1 PPI subnetwork	2.82e-03	<= 0.20	AP1M2 (2.4)	ENSG00000228044 (2.4)	PSRC1 (2.4)	ILF3 (2.4)	C11orf9 (2.3)	MAU2 (2.2)	ATXN2 (2.1)	LDLR (2.0)	DNM2 (1.9)	CARM1 (1.7)
ENSG00000132394	EEFSEC PPI subnetwork	2.84e-03	<= 0.20	SARS (3.6)	PTPN11 (2.9)	BRAP (2.9)	ILF3 (2.4)	CLPTM1 (2.4)	BLOC1S3 (2.2)	C12orf43 (2.1)	OGDH (2.1)	CARM1 (2.0)	C12orf47 (1.9)
ENSG00000101361	NOP56 PPI subnetwork	2.85e-03	<= 0.20	NAA25 (4.8)	ZNF259 (4.8)	DDX56 (4.5)	QTRT1 (4.0)	TOMM40 (3.9)	ILF3 (3.0)	ATP13A1 (3.0)	DHX38 (2.8)	TOP1 (2.6)	DHODH (2.5)
ENSG00000120158	RCL1 PPI subnetwork	2.87e-03	<= 0.20	DDX56 (4.9)	QTRT1 (4.6)	ZNF259 (4.5)	NAA25 (4.1)	C12orf43 (3.1)	DHODH (3.1)	TOMM40 (3.1)	DHX38 (2.3)	ATP13A1 (2.2)	SUGP1 (2.1)
ENSG00000141076	CIRH1A PPI subnetwork	2.89e-03	<= 0.20	ZNF259 (4.7)	DDX56 (4.7)	NAA25 (4.4)	QTRT1 (3.9)	TOMM40 (3.5)	DHODH (2.8)	ATP13A1 (2.5)	DHX38 (2.5)	GATAD2A (2.2)	C12orf43 (2.1)
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	3.01e-03	<= 0.20	TIMD4 (5.7)	APOE (5.3)	APOC1 (4.9)	APOC4 (4.5)	HP (4.2)	LPA (4.2)	SLC22A1 (4.0)	APOA5 (3.5)	ANGPTL3 (3.4)	PLG (3.3)
ENSG00000173039	RELA PPI subnetwork	3.01e-03	<= 0.20	BCL3 (4.6)	TRIB1 (4.5)	RELB (4.1)	BUD13 (2.5)	TRAFD1 (2.4)	MYLIP (2.3)	PARP10 (2.1)	LDLR (2.0)	GRINA (1.9)	C12orf51 (1.9)
GO:0045725	positive regulation of glycogen biosynthetic process	3.01e-03	<= 0.20	LPA (2.0)	ENSG00000226645 (1.8)	ENSG00000228044 (1.7)	GPAM (1.7)	KANK2 (1.6)	MYLIP (1.6)	HNF1A (1.5)	TMEM116 (1.2)	ZNF180 (1.2)	PPP1R37 (1.2)
MP:0000187	abnormal triglyceride level	3.01e-03	<= 0.20	PCSK9 (5.7)	NPC1L1 (5.2)	FADS2 (5.1)	ABCG5 (5.0)	FADS1 (5.0)	HMGCR (4.9)	APOC1 (4.8)	GPAM (3.9)	LDLR (3.6)	TM6SF2 (3.3)
GO:0032369	negative regulation of lipid transport	3.02e-03	<= 0.20	ABCG8 (5.0)	C17orf57 (4.4)	ABCG5 (3.7)	NPC1L1 (3.4)	TM6SF2 (3.4)	APOB (2.7)	GEMIN7 (2.6)	APOE (2.5)	CYB561D1 (2.2)	LPIN3 (2.2)
GO:0044283	small molecule biosynthetic process	3.03e-03	<= 0.20	CYP7A1 (4.5)	FADS2 (3.3)	TM6SF2 (3.1)	LPA (2.9)	FADS1 (2.8)	ALDH2 (2.7)	SLC22A1 (2.7)	GPAM (2.6)	PCSK9 (2.5)	ABCG8 (2.5)
ENSG00000138757	G3BP2 PPI subnetwork	3.03e-03	<= 0.20	TIMD4 (3.5)	CETP (3.3)	C1orf63 (2.7)	OASL (2.5)	TOP1 (2.4)	SMARCA4 (2.4)	FADS2 (2.1)	ILF3 (2.0)	GATAD2A (1.9)	RELB (1.9)
ENSG00000100902	PSMA6 PPI subnetwork	3.04e-03	<= 0.20	PSMA5 (5.0)	NAA25 (3.5)	DDX56 (3.3)	TOMM40 (3.0)	ZNF259 (2.6)	SARS (2.3)	SUGP1 (2.3)	NT5DC1 (2.0)	TRAFD1 (1.9)	QTRT1 (1.8)
MP:0005339	increased susceptibility to atherosclerosis	3.05e-03	<= 0.20	NPC1L1 (8.2)	APOB (7.7)	APOC1 (6.5)	ABCG5 (5.9)	TM6SF2 (4.8)	FADS1 (4.3)	FADS2 (4.3)	APOA5 (4.0)	HMGCR (3.6)	ABCG8 (3.3)
GO:0044042	glucan metabolic process	3.07e-03	<= 0.20	SYPL2 (3.3)	LPA (3.3)	NT5DC1 (3.1)	SORT1 (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	ZNF180 (2.2)	MOSC1 (2.2)	GPAM (2.2)	ZNF101 (2.1)
GO:0006073	cellular glucan metabolic process	3.07e-03	<= 0.20	SYPL2 (3.3)	LPA (3.3)	NT5DC1 (3.1)	SORT1 (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	ZNF180 (2.2)	MOSC1 (2.2)	GPAM (2.2)	ZNF101 (2.1)
MP:0003303	peritoneal inflammation	3.07e-03	<= 0.20	SH2B3 (2.4)	RELB (2.4)	CETP (2.4)	ENSG00000228044 (2.1)	HLX (2.0)	BCL3 (2.0)	FRK (1.9)	CYP7A1 (1.8)	TRIB1 (1.8)	ITGB3 (1.8)
GO:0051259	protein oligomerization	3.07e-03	<= 0.20	NT5DC1 (2.6)	ACAD10 (2.2)	HAPLN4 (1.9)	C12orf43 (1.8)	SLC22A1 (1.7)	MOSC1 (1.7)	GMPR (1.7)	TRAPPC6A (1.6)	PARP10 (1.6)	C19orf52 (1.5)
ENSG00000034971	MYOC PPI subnetwork	3.08e-03	<= 0.20	APOE (4.1)	KANK2 (3.3)	APOC1 (3.1)	PCSK9 (2.2)	GPAM (2.2)	C1orf63 (1.9)	CYB561D1 (1.8)	UBXN2B (1.7)	TIMD4 (1.5)	PLEC (1.5)
MP:0003566	abnormal cell adhesion	3.10e-03	<= 0.20	ITGB3 (4.5)	CLPTM1 (3.4)	PLEC (2.7)	KANK2 (2.7)	PVRL2 (2.3)	OGDH (2.1)	GMPR (2.0)	PVR (2.0)	LDLR (1.8)	BCAM (1.8)
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	3.11e-03	<= 0.20	PLG (5.5)	ANGPTL3 (5.0)	SLC22A1 (4.9)	APOA5 (4.8)	LPA (4.1)	APOC4 (4.0)	CYP7A1 (4.0)	ABCG8 (3.3)	PSMA5 (3.2)	ALDH2 (3.2)
GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	3.13e-03	<= 0.20	APOA5 (3.3)	SLC22A1 (2.2)	BLOC1S3 (1.9)	TRAFD1 (1.9)	LPA (1.9)	PVR (1.8)	POC5 (1.8)	CYP7A1 (1.7)	ATXN7L2 (1.7)	HP (1.7)
GO:0031667	response to nutrient levels	3.17e-03	<= 0.20	TM6SF2 (3.0)	NPC1L1 (2.9)	ABCG8 (2.7)	FADS2 (2.4)	ABCG5 (2.1)	ACAD10 (2.0)	PCSK9 (2.0)	CYP7A1 (1.9)	TRAPPC6A (1.8)	KIAA1324 (1.7)
ENSG00000126934	MAP2K2 PPI subnetwork	3.21e-03	<= 0.20	CARM1 (2.9)	DNM2 (2.9)	APOB (2.8)	PLG (2.6)	HP (2.5)	ANGPTL3 (2.3)	PLEC (2.3)	UBXN2B (2.1)	SYPL2 (1.9)	PTPN11 (1.9)
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	3.22e-03	<= 0.20	TIMD4 (5.5)	APOE (5.1)	APOC4 (4.7)	SLC22A1 (4.6)	LPA (4.3)	APOC1 (4.2)	APOA5 (3.9)	PLG (3.8)	ANGPTL3 (3.7)	HP (2.9)
ENSG00000047849	MAP4 PPI subnetwork	3.22e-03	<= 0.20	PSRC1 (2.7)	DNAH11 (2.5)	GRINA (2.3)	POC5 (2.3)	ENSG00000235545 (2.2)	GMIP (2.0)	OGDH (2.0)	BRAP (1.9)	ZHX3 (1.9)	ENSG00000226648 (1.9)
GO:0046930	pore complex	3.23e-03	<= 0.20	ANGPTL3 (3.5)	LPA (3.2)	PLG (2.9)	DDX56 (2.9)	POC5 (2.8)	NAA25 (2.7)	CARM1 (2.4)	USP24 (2.4)	DHODH (2.3)	USP1 (2.3)
GO:0051213	dioxygenase activity	3.24e-03	<= 0.20	APOA5 (3.2)	SLC22A1 (2.2)	BLOC1S3 (2.1)	TRAFD1 (1.9)	PVR (1.9)	POC5 (1.8)	LPA (1.8)	CYP7A1 (1.7)	ATXN7L2 (1.7)	HAPLN4 (1.7)
GO:0031348	negative regulation of defense response	3.25e-03	<= 0.20	ANKRD31 (3.0)	ADAM1 (2.4)	PARP10 (2.3)	ALDH2 (2.3)	APOC1 (1.7)	SH2B3 (1.7)	GEMIN7 (1.7)	OASL (1.6)	HLX (1.5)	MYLIP (1.5)
ENSG00000107623	GDF10 PPI subnetwork	3.27e-03	<= 0.20	APOB (6.3)	ANGPTL3 (5.8)	APOE (4.4)	PLG (4.4)	APOC1 (4.2)	APOC4 (4.2)	APOA5 (4.1)	HP (3.8)	ABCG5 (2.8)	PCSK9 (2.6)
MP:0001914	hemorrhage	3.28e-03	<= 0.20	ITGB3 (3.7)	KANK2 (3.4)	NYNRIN (3.2)	PVRL2 (2.9)	HLX (2.8)	APOB (2.6)	SLC44A2 (2.5)	BCAM (2.0)	HP (1.9)	PVR (1.9)
ENSG00000084676	NCOA1 PPI subnetwork	3.29e-03	<= 0.20	TRIB1 (4.8)	UBXN2B (3.8)	BCL3 (2.9)	ATXN2 (2.8)	PLEC (2.8)	CYP7A1 (2.8)	C12orf51 (2.5)	ABCG5 (2.4)	ABCG8 (2.3)	MAU2 (2.2)
ENSG00000130164	LDLR PPI subnetwork	3.29e-03	<= 0.20	ERP29 (5.3)	HMGCR (4.2)	TMED4 (4.1)	NPC1L1 (3.1)	ITGB3 (3.0)	PCSK9 (2.9)	APOC1 (2.9)	FADS1 (2.5)	YIPF2 (2.4)	FADS2 (1.9)
ENSG00000110244	APOA4 PPI subnetwork	3.29e-03	<= 0.20	APOB (7.0)	NPC1L1 (4.8)	ABCG5 (4.6)	PLG (4.3)	APOA5 (4.2)	ANGPTL3 (3.7)	APOC1 (3.5)	APOC4 (3.5)	TM6SF2 (3.4)	HP (2.8)
ENSG00000163586	FABP1 PPI subnetwork	3.31e-03	<= 0.20	PLG (5.4)	ANGPTL3 (5.2)	APOA5 (5.2)	APOB (5.0)	APOC4 (4.8)	APOC1 (3.5)	HP (3.5)	CYP7A1 (3.4)	GOT2P1 (3.2)	SLC22A1 (2.3)
MP:0008705	increased interleukin-6 secretion	3.33e-03	<= 0.20	OASL (4.0)	GMIP (3.4)	ALDH2 (3.1)	MOSC1 (2.9)	TRIB1 (2.9)	BCL3 (2.7)	COL4A3BP (2.3)	RELB (2.2)	GRINA (2.2)	HP (2.2)
MP:0002404	increased intestinal adenoma incidence	3.33e-03	<= 0.20	ANKRD31 (2.8)	SLC44A2 (2.3)	FEN1 (2.1)	PARP10 (2.1)	DNM2 (2.0)	ATP13A1 (2.0)	FADS2 (1.9)	TM6SF2 (1.7)	ENSG00000226648 (1.7)	ENSG00000254235 (1.7)
ENSG00000150527	CTAGE5 PPI subnetwork	3.33e-03	<= 0.20	APOB (7.3)	PLG (5.3)	APOA5 (5.3)	ANGPTL3 (4.4)	HP (4.4)	APOC4 (4.3)	APOC1 (3.9)	ABCG5 (3.3)	APOE (3.0)	NPC1L1 (2.9)
REACTOME_GLYCOLYSIS	REACTOME_GLYCOLYSIS	3.38e-03	<= 0.20	NPC1L1 (2.9)	GOT2P1 (2.5)	PCSK9 (2.0)	SYPL2 (1.9)	FADS2 (1.9)	TM6SF2 (1.8)	CELSR2 (1.7)	CEACAM19 (1.6)	HP (1.5)	ABCG5 (1.5)
ENSG00000105926	MPP6 PPI subnetwork	3.38e-03	<= 0.20	QTRT1 (4.4)	SUGP1 (3.2)	DDX56 (2.9)	ATP13A1 (2.5)	C19orf52 (2.3)	ILF3 (2.2)	DHODH (2.2)	MAU2 (2.1)	APOE (2.1)	UBXN2B (2.0)
MP:0005560	decreased circulating glucose level	3.40e-03	<= 0.20	APOA5 (4.0)	APOC4 (3.7)	GPAM (3.2)	KIAA1324 (3.0)	HP (2.9)	MOSC1 (2.8)	APOC1 (2.4)	LPA (2.3)	TM6SF2 (2.2)	ANGPTL3 (2.1)
ENSG00000172602	RND1 PPI subnetwork	3.40e-03	<= 0.20	DOCK7 (2.3)	ZNF180 (2.0)	PPP1R37 (1.9)	HAPLN4 (1.9)	ABCG8 (1.8)	AP1M2 (1.8)	SLC44A2 (1.7)	ENSG00000254235 (1.7)	PVRL2 (1.7)	LPIN3 (1.5)
GO:0005542	folic acid binding	3.41e-03	<= 0.20	CYP7A1 (4.0)	MOSC1 (3.8)	SLC22A1 (3.7)	LPA (3.5)	APOA5 (3.0)	APOC4 (3.0)	ENSG00000226645 (2.8)	ANGPTL3 (2.7)	TIMD4 (2.6)	GCNT4 (2.5)
ENSG00000089199	CHGB PPI subnetwork	3.44e-03	<= 0.20	C17orf57 (3.0)	C12orf51 (2.8)	GPAM (2.8)	ATXN7L2 (2.7)	MARK4 (2.7)	SMARCA4 (2.4)	PLEC (2.4)	ACAD10 (2.4)	HAPLN4 (2.2)	MAPKAPK5 (2.1)
ENSG00000125810	CD93 PPI subnetwork	3.45e-03	<= 0.20	PLG (4.0)	APOC4 (3.5)	APOE (3.5)	SLC22A1 (3.2)	APOA5 (3.1)	APOC1 (3.0)	BCAM (2.7)	LPA (2.6)	CETP (2.4)	C17orf57 (2.3)
GO:0015718	monocarboxylic acid transport	3.46e-03	<= 0.20	TM6SF2 (3.6)	ABCG8 (3.1)	CYP7A1 (2.7)	APOA5 (2.3)	APOC4 (2.2)	DNAH11 (2.0)	ABCG5 (1.9)	GPAM (1.8)	CYB561D1 (1.8)	MOSC1 (1.7)
REACTOME_METABOLISM_OF_POLYAMINES	REACTOME_METABOLISM_OF_POLYAMINES	3.47e-03	<= 0.20	QTRT1 (3.8)	GMPR (2.5)	SLC44A2 (2.4)	APOE (2.4)	HNF1A (2.3)	TOMM40 (2.3)	TSSK6 (2.0)	DHODH (1.9)	CARM1 (1.7)	MAFB (1.6)
GO:0006639	acylglycerol metabolic process	3.48e-03	<= 0.20	GPAM (4.7)	MOSC1 (4.3)	NPC1L1 (4.0)	FADS1 (4.0)	PCSK9 (3.9)	FADS2 (3.6)	HMGCR (3.3)	TM6SF2 (3.3)	LDLR (3.0)	APOC1 (2.5)
ENSG00000164695	CHMP4C PPI subnetwork	3.48e-03	<= 0.20	MARK4 (2.6)	MAU2 (2.6)	ATP13A1 (2.4)	BLOC1S3 (2.2)	ENSG00000226648 (2.2)	SUGP1 (1.9)	DYNC2LI1 (1.9)	ABO (1.8)	APOB (1.8)	GCNT4 (1.6)
ENSG00000185479	KRT6B PPI subnetwork	3.50e-03	<= 0.20	APOB (7.5)	PLG (5.3)	APOA5 (5.2)	ANGPTL3 (4.4)	HP (4.4)	APOC4 (4.2)	APOC1 (3.7)	ABCG5 (3.3)	NPC1L1 (3.0)	APOE (2.8)
ENSG00000075643	MOCOS PPI subnetwork	3.50e-03	<= 0.20	APOE (7.7)	APOB (5.8)	TIMD4 (4.8)	APOC1 (4.5)	MAFB (3.6)	APOA5 (3.5)	NPC1L1 (3.5)	HP (3.4)	APOC4 (3.4)	PLG (3.3)
ENSG00000185010	F8 PPI subnetwork	3.52e-03	<= 0.20	PLG (4.7)	ANGPTL3 (4.5)	APOC4 (4.5)	APOA5 (4.5)	APOB (4.0)	HP (3.9)	SLC22A1 (3.9)	APOC1 (3.1)	ERP29 (2.8)	LPA (2.3)
REACTOME_COMMON_PATHWAY	REACTOME_COMMON_PATHWAY	3.52e-03	<= 0.20	PLG (7.8)	ANGPTL3 (7.8)	HP (7.7)	APOB (6.4)	APOC4 (6.3)	APOA5 (5.9)	APOC1 (4.1)	ITGB3 (3.8)	PCSK9 (3.6)	SLC22A1 (3.5)
MP:0002086	abnormal extraembryonic tissue morphology	3.54e-03	<= 0.20	PVRL2 (2.5)	DOCK7 (2.4)	C17orf57 (2.3)	GATAD2A (2.3)	ITGB3 (2.1)	LDLR (2.0)	ATXN2 (2.0)	DNM2 (2.0)	COL4A3BP (1.9)	KANK2 (1.9)
GO:0016701	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen	3.54e-03	<= 0.20	APOA5 (3.4)	SLC22A1 (2.1)	BLOC1S3 (2.1)	PVR (1.9)	TRAFD1 (1.9)	POC5 (1.8)	CYP7A1 (1.8)	LPA (1.8)	HP (1.7)	ATXN7L2 (1.6)
ENSG00000089154	GCN1L1 PPI subnetwork	3.55e-03	<= 0.20	DDX56 (4.2)	NAA25 (3.7)	SARS (3.2)	TOMM40 (3.2)	USP24 (3.1)	DHX38 (2.9)	SMARCA4 (2.6)	PSMA5 (2.6)	POC5 (2.5)	ZNF259 (2.3)
GO:0050997	quaternary ammonium group binding	3.55e-03	<= 0.20	PLG (7.8)	APOC4 (6.7)	ANGPTL3 (6.3)	APOB (5.6)	APOA5 (5.1)	LPA (4.5)	HP (4.4)	ABCG5 (3.9)	TIMD4 (3.7)	APOE (3.6)
ENSG00000106804	C5 PPI subnetwork	3.57e-03	<= 0.20	APOC4 (7.8)	LPA (7.7)	PLG (7.7)	HP (7.3)	ANGPTL3 (7.0)	APOA5 (6.6)	SLC22A1 (5.5)	APOC1 (5.4)	PCSK9 (4.0)	APOB (3.8)
ENSG00000106617	PRKAG2 PPI subnetwork	3.59e-03	<= 0.20	LDLR (3.9)	FADS1 (3.2)	GPAM (3.0)	FADS2 (2.8)	CYP7A1 (2.7)	PLG (2.6)	TM6SF2 (2.4)	SARS (2.3)	ACAD10 (2.3)	C12orf51 (2.2)
MP:0001852	conjunctivitis	3.60e-03	<= 0.20	HP (3.9)	LPA (2.7)	CYB561D1 (2.5)	HLX (2.4)	CETP (2.3)	ENSG00000238078 (2.1)	APOA5 (1.9)	ANGPTL3 (1.8)	KANK2 (1.8)	BCL3 (1.8)
GO:0006638	neutral lipid metabolic process	3.61e-03	<= 0.20	GPAM (4.7)	MOSC1 (4.4)	NPC1L1 (4.1)	FADS1 (4.0)	PCSK9 (3.9)	FADS2 (3.6)	HMGCR (3.3)	TM6SF2 (3.3)	LDLR (3.0)	APOC1 (2.5)
MP:0002447	abnormal erythrocyte morphology	3.64e-03	<= 0.20	RHCE (11.7)	RHD (11.6)	GMPR (4.5)	C12orf51 (4.0)	SLC44A2 (2.2)	MAU2 (2.2)	FADS2 (2.1)	KANK2 (2.0)	TMEM57 (1.9)	DNM2 (1.8)
ENSG00000105197	TIMM50 PPI subnetwork	3.67e-03	<= 0.20	RELB (8.0)	BCL3 (4.9)	HAVCR1 (2.8)	PVR (2.5)	CLPTM1 (2.5)	CEACAM19 (2.0)	GCNT4 (1.9)	GRINA (1.9)	LPAR2 (1.9)	CARM1 (1.8)
MP:0008809	increased spleen iron level	3.69e-03	<= 0.20	RHCE (10.8)	RHD (10.7)	TIMD4 (5.9)	CETP (5.0)	GMPR (2.2)	HP (2.2)	APOC1 (2.2)	SLC44A2 (1.6)	GEMIN7 (1.6)	APOE (1.6)
ENSG00000154262	ABCA6 PPI subnetwork	3.69e-03	<= 0.20	APOE (7.8)	APOB (6.2)	APOC1 (4.7)	TIMD4 (4.5)	NPC1L1 (3.9)	MAFB (3.6)	APOA5 (3.4)	HP (3.4)	APOC4 (3.0)	ABCG5 (3.0)
GO:0071383	cellular response to steroid hormone stimulus	3.72e-03	<= 0.20	HNF1A (3.7)	ABCG8 (3.3)	LPIN3 (2.7)	CYP7A1 (2.5)	ABO (2.3)	GCNT4 (2.1)	TM6SF2 (2.0)	FRK (2.0)	TMEM57 (1.7)	ABCG5 (1.7)
ENSG00000072778	ACADVL PPI subnetwork	3.72e-03	<= 0.20	BCAM (2.8)	ANGPTL3 (2.7)	APOC1 (2.0)	OGDH (2.0)	APOE (1.9)	PLEC (1.9)	ALDH2 (1.9)	RHD (1.8)	BRAP (1.8)	GMPR (1.8)
ENSG00000186153	WWOX PPI subnetwork	3.74e-03	<= 0.20	SMARCA4 (3.9)	DHX38 (3.0)	MAU2 (2.8)	GMIP (2.6)	ILF3 (2.6)	CARM1 (2.6)	GRINA (2.3)	CLPTM1 (2.3)	GATAD2A (2.3)	PPP1R37 (2.1)
ENSG00000215754	ENSG00000215754 PPI subnetwork	3.74e-03	<= 0.20	APOB (8.1)	APOC1 (5.8)	ABCG5 (5.1)	PLG (4.9)	NPC1L1 (4.9)	APOA5 (4.9)	ANGPTL3 (4.2)	APOC4 (3.9)	HP (3.4)	TM6SF2 (3.2)
ENSG00000163631	ALB PPI subnetwork	3.75e-03	<= 0.20	PLG (8.3)	ANGPTL3 (6.6)	APOB (5.9)	APOA5 (5.7)	APOC1 (5.4)	APOC4 (5.3)	HP (4.6)	SLC22A1 (3.1)	PCSK9 (2.8)	ABCG5 (2.3)
REACTOME_PLATELET_DEGRANULATION	REACTOME_PLATELET_DEGRANULATION	3.75e-03	<= 0.20	ITGB3 (7.9)	HP (5.3)	ANGPTL3 (5.1)	PLG (4.4)	APOB (4.0)	APOE (3.9)	APOC1 (3.2)	APOC4 (3.2)	APOA5 (3.2)	GMPR (2.8)
GO:0044106	cellular amine metabolic process	3.81e-03	<= 0.20	CYP7A1 (3.1)	DHODH (3.1)	NT5DC1 (2.9)	LPA (2.9)	ABCG8 (2.9)	ANGPTL3 (2.7)	SLC22A1 (2.7)	TM6SF2 (2.5)	SARS (2.5)	ALDH2 (2.2)
ENSG00000179409	GEMIN4 PPI subnetwork	3.82e-03	<= 0.20	QTRT1 (3.6)	TOMM40 (3.2)	RELB (2.4)	C12orf43 (2.4)	PSMA5 (2.3)	GEMIN7 (2.3)	CARM1 (2.0)	SARS (2.0)	ILF3 (1.9)	ATXN7L2 (1.9)
GO:0016042	lipid catabolic process	3.83e-03	<= 0.20	NKPD1 (4.9)	ACAD10 (3.7)	MOSC1 (3.1)	GCNT4 (2.7)	ABCG8 (2.6)	TM6SF2 (2.5)	GPAM (2.5)	LPA (2.3)	APOC4 (2.3)	SLC22A1 (2.2)
GO:0045540	regulation of cholesterol biosynthetic process	3.86e-03	<= 0.20	ENSG00000238078 (4.4)	ABCG8 (3.5)	FADS2 (2.9)	APOC1 (2.6)	CYP7A1 (2.5)	HMGCR (2.4)	ENSG00000235545 (2.2)	FADS1 (2.2)	ABCG5 (2.2)	TMEM57 (1.9)
MP:0000512	intestinal ulcer	3.90e-03	<= 0.20	SLC22A1 (5.5)	FADS1 (4.4)	APOC4 (3.2)	LPA (3.1)	APOA5 (3.0)	ANGPTL3 (2.7)	C17orf57 (2.7)	HP (2.6)	NYNRIN (2.6)	LDLR (2.5)
ENSG00000115718	PROC PPI subnetwork	3.90e-03	<= 0.20	HP (5.2)	APOA5 (4.0)	PLG (3.8)	ANGPTL3 (3.6)	TIMD4 (3.5)	SLC22A1 (3.5)	ITGB3 (3.4)	APOB (3.3)	PVR (2.7)	PVRL2 (2.6)
ENSG00000197530	MIB2 PPI subnetwork	3.93e-03	<= 0.20	TIMD4 (3.6)	OASL (3.5)	CETP (3.3)	HNF1A (2.3)	SYPL2 (2.0)	BRAP (1.9)	PLG (1.8)	LPA (1.7)	GOT2P1 (1.7)	HAPLN4 (1.6)
GO:0043176	amine binding	3.96e-03	<= 0.20	PLG (4.7)	ANGPTL3 (4.7)	APOC4 (4.4)	ABCG5 (4.0)	ABCG8 (3.6)	SLC22A1 (3.5)	APOA5 (3.3)	LPA (3.3)	HP (3.2)	APOC1 (2.8)
ENSG00000038358	EDC4 PPI subnetwork	3.98e-03	<= 0.20	MAU2 (4.2)	BRAP (3.1)	TRIB1 (2.8)	COL4A3BP (2.8)	TXNL4B (2.7)	DNM2 (2.5)	C12orf43 (2.4)	ACAD10 (2.4)	TRAFD1 (2.3)	ENSG00000254235 (2.3)
ENSG00000128708	HAT1 PPI subnetwork	3.98e-03	<= 0.20	PSMA5 (2.7)	NAA25 (2.7)	TOMM40 (2.6)	DHX38 (2.4)	ENSG00000254235 (2.2)	TXNL4B (2.1)	DDX56 (2.0)	QTRT1 (1.9)	SMARCA4 (1.8)	FEN1 (1.8)
GO:0004709	MAP kinase kinase kinase activity	4.00e-03	<= 0.20	NT5DC1 (3.3)	FRK (2.7)	NKPD1 (2.6)	TRIB1 (2.4)	BCL3 (2.4)	ZHX3 (2.3)	CYB561D1 (2.1)	POLK (1.9)	LPIN3 (1.8)	SH2B3 (1.8)
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	4.01e-03	<= 0.20	GPAM (3.9)	TM6SF2 (3.2)	NT5DC1 (3.1)	MOSC1 (3.0)	DHODH (3.0)	ABCG8 (2.7)	ALDH2 (2.2)	ACAD10 (2.2)	CYP7A1 (2.0)	ABCG5 (1.9)
REACTOME_METABOLISM_OF_WATER:SOLUBLE_VITAMINS_AND_COFACTORS	REACTOME_METABOLISM_OF_WATER:SOLUBLE_VITAMINS_AND_COFACTORS	4.01e-03	<= 0.20	GPAM (3.9)	TM6SF2 (3.2)	NT5DC1 (3.1)	MOSC1 (3.0)	DHODH (3.0)	ABCG8 (2.7)	ALDH2 (2.2)	ACAD10 (2.2)	CYP7A1 (2.0)	ABCG5 (1.9)
GO:0008395	steroid hydroxylase activity	4.02e-03	<= 0.20	APOC4 (5.0)	ABCG5 (5.0)	SLC22A1 (4.6)	LPA (4.0)	TM6SF2 (3.8)	ABCG8 (3.8)	APOA5 (3.6)	CYP7A1 (3.6)	ST3GAL4 (3.0)	APOC1 (3.0)
ENSG00000168454	TXNDC2 PPI subnetwork	4.02e-03	<= 0.20	APOE (7.4)	APOB (6.4)	TIMD4 (5.3)	APOC1 (4.5)	APOA5 (3.9)	NPC1L1 (3.8)	ABCG5 (3.6)	APOC4 (3.5)	MAFB (3.4)	PLG (3.4)
GO:0070988	demethylation	4.04e-03	<= 0.20	NPC1L1 (3.8)	LPA (3.6)	ABCG8 (3.5)	ABCG5 (3.2)	SLC22A1 (3.1)	TM6SF2 (2.6)	BLOC1S3 (2.2)	GCNT4 (2.1)	C17orf57 (2.0)	CYP7A1 (1.8)
MP:0005317	increased triglyceride level	4.04e-03	<= 0.20	APOC1 (5.8)	GPAM (4.4)	MOSC1 (3.7)	TIMD4 (3.0)	HP (2.8)	SORT1 (2.4)	ALDH2 (2.1)	MYLIP (2.0)	PPP1R37 (2.0)	CETP (1.9)
GO:0043434	response to peptide hormone stimulus	4.05e-03	<= 0.20	COL4A3BP (3.3)	SORT1 (2.7)	MOSC1 (2.5)	ENSG00000254235 (2.5)	GPAM (2.3)	KIAA1324 (2.1)	NPC1L1 (2.0)	HAPLN4 (2.0)	TM6SF2 (1.9)	CYP7A1 (1.9)
GO:0003714	transcription corepressor activity	4.05e-03	<= 0.20	ATXN2 (2.6)	TRIB1 (2.6)	GATAD2A (2.4)	PPP1R37 (2.3)	MARK4 (2.2)	ATXN7L2 (2.2)	BCL3 (2.1)	SARS (2.1)	NYNRIN (2.0)	ZNF101 (2.0)
GO:0060205	cytoplasmic membrane-bounded vesicle lumen	4.06e-03	<= 0.20	ANGPTL3 (6.3)	HP (5.6)	ITGB3 (5.4)	PLG (5.3)	APOB (4.4)	APOA5 (4.1)	APOC4 (4.1)	APOE (4.0)	APOC1 (3.5)	LPA (2.7)
MP:0005251	blepharitis	4.06e-03	<= 0.20	LPAR2 (3.0)	SLC44A2 (2.5)	BCL3 (2.5)	GMIP (2.3)	DNM2 (2.2)	QTRT1 (2.2)	KANK2 (2.0)	GCNT4 (1.9)	SH2B3 (1.9)	PPP1R37 (1.8)
ENSG00000100311	PDGFB PPI subnetwork	4.06e-03	<= 0.20	C1orf63 (4.0)	MYLIP (2.8)	PLEC (2.6)	HLX (2.5)	CBLC (2.5)	C17orf57 (2.3)	SLC44A2 (2.0)	HAVCR1 (2.0)	ADAM1 (2.0)	APOE (1.7)
GO:0008206	bile acid metabolic process	4.10e-03	<= 0.20	CYP7A1 (6.5)	APOC4 (4.3)	ANGPTL3 (4.1)	LPA (4.1)	SLC22A1 (3.8)	ABCG8 (3.7)	ABCG5 (3.3)	APOA5 (3.2)	TM6SF2 (2.7)	NKPD1 (2.7)
ENSG00000004455	AK2 PPI subnetwork	4.10e-03	<= 0.20	NYNRIN (3.4)	MARK4 (2.8)	ZNF180 (2.6)	RHCE (2.3)	PSMA5 (2.0)	ZNF101 (1.9)	GRINA (1.8)	MYLIP (1.8)	TM6SF2 (1.8)	CELSR2 (1.7)
GO:0004866	endopeptidase inhibitor activity	4.11e-03	<= 0.20	HP (5.7)	APOB (5.4)	PLG (5.2)	APOA5 (4.9)	APOC1 (4.5)	APOC4 (4.2)	ANGPTL3 (4.0)	SLC22A1 (3.3)	PCSK9 (3.2)	LPA (2.7)
MP:0000420	ruffled hair	4.12e-03	<= 0.20	BCL3 (2.9)	CBLC (2.7)	LDLR (2.7)	PLEC (2.0)	YIPF2 (1.9)	NPC1L1 (1.8)	AP1M2 (1.8)	SLC44A2 (1.8)	CYB561D1 (1.7)	SH2B3 (1.7)
GO:0005977	glycogen metabolic process	4.12e-03	<= 0.20	LPA (3.5)	SYPL2 (3.3)	NT5DC1 (3.1)	ENSG00000254235 (2.5)	SORT1 (2.5)	CYP7A1 (2.5)	ZNF180 (2.3)	GPAM (2.2)	ZHX3 (2.1)	ZNF101 (2.1)
ENSG00000049618	ARID1B PPI subnetwork	4.12e-03	<= 0.20	CARM1 (3.5)	GRINA (3.1)	TRAFD1 (2.9)	SMARCA4 (2.7)	CLPTM1 (2.7)	PPP1R37 (2.6)	ATXN2 (2.3)	PCSK9 (2.2)	NYNRIN (2.1)	MAU2 (2.1)
ENSG00000213512	GBP7 PPI subnetwork	4.15e-03	<= 0.20	TRAPPC6A (2.6)	GEMIN7 (2.5)	PVRL2 (2.2)	MYLIP (2.1)	GCNT4 (2.1)	FRK (2.1)	ZNF180 (1.8)	ENSG00000228044 (1.7)	ILF3 (1.6)	FADS2 (1.6)
ENSG00000130939	UBE4B PPI subnetwork	4.16e-03	<= 0.20	DHX38 (2.7)	HMGCR (2.3)	TMEM57 (2.1)	FADS2 (2.0)	CARM1 (2.0)	GOT2P1 (1.9)	ZNF101 (1.8)	TRAFD1 (1.7)	BUD13 (1.6)	QTRT1 (1.6)
MP:0002575	increased circulating ketone body level	4.20e-03	<= 0.20	ACAD10 (3.8)	MOSC1 (3.7)	GPAM (3.4)	APOA5 (2.8)	HNF1A (2.6)	NPC1L1 (2.4)	ZHX3 (2.3)	ABCG8 (1.8)	HP (1.7)	ABCG5 (1.7)
GO:0070279	vitamin B6 binding	4.22e-03	<= 0.20	APOA5 (5.2)	PLG (4.9)	ANGPTL3 (4.6)	SLC22A1 (4.2)	APOC4 (4.0)	MOSC1 (3.9)	LPA (3.8)	TM6SF2 (3.7)	ALDH2 (3.5)	ABCG5 (3.4)
GO:0030170	pyridoxal phosphate binding	4.22e-03	<= 0.20	APOA5 (5.2)	PLG (4.9)	ANGPTL3 (4.6)	SLC22A1 (4.2)	APOC4 (4.0)	MOSC1 (3.9)	LPA (3.8)	TM6SF2 (3.7)	ALDH2 (3.5)	ABCG5 (3.4)
ENSG00000166949	SMAD3 PPI subnetwork	4.24e-03	<= 0.20	GATAD2A (4.2)	TRIB1 (3.4)	BUD13 (3.0)	PLEC (2.8)	PLCG1 (2.5)	CARM1 (2.5)	NYNRIN (2.4)	ATXN7L2 (2.4)	ATXN2 (2.3)	KANK2 (2.3)
MP:0010027	increased liver cholesterol level	4.26e-03	<= 0.20	FADS1 (6.9)	FADS2 (6.6)	HMGCR (5.9)	PCSK9 (5.8)	APOC1 (4.2)	APOB (4.0)	NPC1L1 (3.7)	TM6SF2 (3.6)	LDLR (3.5)	GPAM (3.4)
MP:0003909	increased eating behavior	4.26e-03	<= 0.20	GPAM (5.2)	NPC1L1 (4.2)	MOSC1 (4.1)	HP (2.8)	TM6SF2 (2.7)	KIAA1324 (2.6)	APOC1 (2.6)	ALDH2 (2.3)	APOB (2.0)	PMFBP1 (2.0)
GO:0034774	secretory granule lumen	4.31e-03	<= 0.20	ANGPTL3 (6.5)	HP (5.7)	PLG (5.4)	ITGB3 (5.3)	APOE (4.2)	APOA5 (4.2)	APOB (4.1)	APOC4 (4.1)	APOC1 (3.7)	LPA (2.9)
GO:0006641	triglyceride metabolic process	4.32e-03	<= 0.20	GPAM (4.9)	MOSC1 (4.2)	NPC1L1 (4.2)	FADS1 (4.1)	PCSK9 (4.0)	FADS2 (3.8)	HMGCR (3.4)	TM6SF2 (3.3)	LDLR (3.2)	APOC1 (2.5)
GO:0006730	one-carbon metabolic process	4.35e-03	<= 0.20	QTRT1 (2.7)	DHODH (2.5)	ZNF180 (2.3)	LPA (2.2)	UBXN2B (2.1)	ILF3 (2.1)	ATXN7L2 (2.0)	C12orf51 (1.9)	ENSG00000238078 (1.9)	SLC22A1 (1.7)
MP:0005344	increased circulating bilirubin level	4.35e-03	<= 0.20	RHD (9.2)	RHCE (8.0)	GMPR (3.4)	C12orf51 (3.1)	CYP7A1 (2.9)	KANK2 (2.7)	APOA5 (2.5)	APOC4 (2.2)	ANGPTL3 (2.0)	SLC22A1 (2.0)
GO:0072593	reactive oxygen species metabolic process	4.38e-03	<= 0.20	ALDH2 (3.4)	GOT2P1 (2.6)	C17orf57 (2.3)	TRAPPC6A (2.1)	RHD (1.9)	AP1M2 (1.9)	RHCE (1.6)	ACAD10 (1.5)	PCSK9 (1.5)	CEACAM19 (1.5)
MP:0003103	liver degeneration	4.40e-03	<= 0.20	OASL (4.2)	PARP10 (3.9)	PLG (3.8)	APOC4 (3.4)	APOA5 (3.2)	RHD (3.2)	BCL3 (2.8)	ANGPTL3 (2.8)	LPA (2.6)	TIMD4 (2.5)
MP:0000221	decreased leukocyte cell number	4.40e-03	<= 0.20	BCL3 (3.5)	PARP10 (2.9)	CYP7A1 (2.9)	SLC22A1 (2.9)	LPA (2.8)	RELB (2.8)	OASL (2.5)	ZNF101 (2.4)	PVR (2.2)	ABCG8 (2.2)
GO:0001530	lipopolysaccharide binding	4.43e-03	<= 0.20	HP (3.7)	MAFB (3.7)	MYLIP (2.6)	LDLR (2.2)	NKPD1 (2.1)	FADS1 (2.1)	APOC1 (2.1)	ALDH2 (1.9)	APOE (1.9)	TRIB1 (1.8)
GO:0031091	platelet alpha granule	4.44e-03	<= 0.20	ITGB3 (7.5)	HP (5.7)	ANGPTL3 (5.5)	PLG (4.7)	APOC4 (3.7)	APOE (3.7)	APOA5 (3.6)	APOB (3.5)	APOC1 (3.4)	GMPR (3.1)
ENSG00000215320	ENSG00000215320 PPI subnetwork	4.45e-03	<= 0.20	PARP10 (3.1)	USP24 (2.6)	CBLC (2.4)	BCL3 (2.3)	GMIP (2.2)	MAU2 (2.1)	MAFB (1.8)	OASL (1.8)	PPP1R37 (1.8)	HNF1A (1.7)
GO:0033762	response to glucagon stimulus	4.47e-03	<= 0.20	CYP7A1 (2.6)	ITGB3 (2.5)	PCSK9 (2.3)	ENSG00000254235 (2.3)	ST3GAL4 (2.3)	TM6SF2 (2.1)	LPA (2.1)	PMFBP1 (2.0)	ABCG8 (2.0)	GCNT4 (1.8)
MP:0002356	abnormal spleen red pulp morphology	4.48e-03	<= 0.20	RHCE (3.3)	HLX (3.0)	MAFB (2.6)	PLEKHH2 (2.4)	RHD (2.4)	ATP13A1 (2.1)	ZNF101 (2.0)	YIPF2 (1.8)	GMPR (1.8)	MYLIP (1.8)
MP:0008553	increased circulating tumor necrosis factor level	4.49e-03	<= 0.20	BCL3 (4.8)	MAFB (4.5)	TRIB1 (4.4)	CETP (4.2)	TIMD4 (4.2)	RELB (3.7)	GMIP (3.4)	PARP10 (2.4)	PVR (2.3)	LPAR2 (2.2)
ENSG00000008083	JARID2 PPI subnetwork	4.52e-03	<= 0.20	OASL (3.2)	TIMD4 (2.9)	CETP (2.5)	C11orf9 (2.3)	NPC1L1 (2.3)	GMPR (2.2)	HNF1A (2.1)	LPAR2 (2.0)	ABCG8 (1.6)	PVRL2 (1.6)
ENSG00000002330	BAD PPI subnetwork	4.54e-03	<= 0.20	SH2B3 (2.5)	TRIB1 (2.2)	MARK4 (2.2)	LDLR (2.1)	GATAD2A (1.9)	DNM2 (1.8)	GRINA (1.7)	C11orf9 (1.7)	AP1M2 (1.6)	UBXN2B (1.6)
KEGG_TRYPTOPHAN_METABOLISM	KEGG_TRYPTOPHAN_METABOLISM	4.55e-03	<= 0.20	SLC22A1 (4.2)	APOA5 (4.1)	PLG (4.0)	CYP7A1 (3.7)	LPA (3.7)	MOSC1 (3.6)	TM6SF2 (3.6)	ANGPTL3 (3.4)	APOC4 (2.9)	ACAD10 (2.8)
ENSG00000140463	BBS4 PPI subnetwork	4.55e-03	<= 0.20	BCAM (3.4)	PLEC (2.5)	PLG (2.4)	DYNC2LI1 (2.3)	ANGPTL3 (2.2)	KANK2 (2.2)	SLC22A1 (2.2)	OGDH (2.1)	SUGP1 (2.0)	CEACAM19 (2.0)
ENSG00000007402	CACNA2D2 PPI subnetwork	4.55e-03	<= 0.20	APOB (6.4)	ANGPTL3 (6.0)	PLG (4.3)	APOE (4.2)	APOC4 (4.1)	APOA5 (3.9)	APOC1 (3.9)	HP (3.5)	PCSK9 (2.8)	ABCG5 (2.7)
ENSG00000136986	DERL1 PPI subnetwork	4.56e-03	<= 0.20	PLG (3.2)	APOC4 (3.1)	ANGPTL3 (3.1)	LPA (2.7)	HP (2.4)	APOC1 (2.3)	CYP7A1 (2.2)	APOA5 (1.8)	ITGB3 (1.8)	APOB (1.7)
REACTOME_PHASE_1_:_FUNCTIONALIZATION_OF_COMPOUNDS	REACTOME_PHASE_1_:_FUNCTIONALIZATION_OF_COMPOUNDS	4.57e-03	<= 0.20	LPA (6.8)	SLC22A1 (6.7)	CYP7A1 (5.9)	APOC4 (5.5)	ABCG5 (5.3)	TM6SF2 (4.9)	APOA5 (4.7)	ANGPTL3 (4.6)	ABCG8 (4.5)	ALDH2 (4.2)
ENSG00000175536	LIPT2 PPI subnetwork	4.58e-03	<= 0.20	USP24 (3.1)	QTRT1 (2.4)	NAA25 (2.2)	GMPR (2.1)	ENSG00000254235 (1.9)	SMARCA4 (1.7)	DHX38 (1.7)	CYP7A1 (1.7)	GEMIN7 (1.6)	ATP13A1 (1.6)
MP:0001935	decreased litter size	4.59e-03	<= 0.20	APOB (2.6)	PLEKHH2 (2.4)	TRIB1 (2.4)	KANK2 (2.3)	PCSK9 (2.3)	ALDH2 (1.9)	APOE (1.8)	CYP7A1 (1.8)	GMPR (1.7)	NYNRIN (1.7)
ENSG00000132703	APCS PPI subnetwork	4.59e-03	<= 0.20	HP (4.9)	APOC4 (4.4)	APOE (4.4)	PLG (4.2)	APOC1 (4.1)	ANGPTL3 (4.1)	SLC22A1 (3.9)	LPA (3.8)	APOA5 (3.6)	TIMD4 (3.1)
MP:0008875	abnormal xenobiotic pharmacokinetics	4.61e-03	<= 0.20	SLC22A1 (6.0)	APOA5 (5.6)	CYP7A1 (5.6)	ABCG8 (5.4)	APOC4 (5.1)	ABCG5 (4.9)	LPA (4.4)	ANGPTL3 (4.3)	TM6SF2 (4.2)	PLG (4.2)
GO:0061135	endopeptidase regulator activity	4.62e-03	<= 0.20	HP (5.7)	APOB (5.4)	PLG (5.1)	APOA5 (4.8)	APOC1 (4.5)	APOC4 (4.1)	ANGPTL3 (3.9)	PCSK9 (3.4)	SLC22A1 (3.4)	LPA (2.6)
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	4.63e-03	<= 0.20	ITGB3 (8.2)	APOB (3.8)	HP (3.4)	APOC1 (3.3)	CETP (3.3)	PLG (3.0)	APOC4 (2.9)	APOA5 (2.8)	ANGPTL3 (2.8)	APOE (2.7)
MP:0002419	abnormal innate immunity	4.65e-03	<= 0.20	TRIB1 (5.3)	HP (3.6)	MAFB (3.5)	BCL3 (3.4)	PVR (3.2)	HLX (2.6)	ALDH2 (2.6)	GMIP (2.5)	GRINA (2.3)	SLC22A1 (2.2)
ENSG00000113580	NR3C1 PPI subnetwork	4.65e-03	<= 0.20	ATXN2 (3.0)	SMARCA4 (2.7)	CARM1 (2.6)	TRAFD1 (2.6)	TRIB1 (2.5)	CYP7A1 (2.4)	APOB (2.4)	BCL3 (2.4)	PBX4 (2.3)	PLCG1 (2.2)
ENSG00000065154	OAT PPI subnetwork	4.66e-03	<= 0.20	C19orf52 (3.1)	CLPTM1 (2.9)	SUGP1 (2.5)	TOMM40 (2.3)	DDX56 (2.2)	PSMA5 (2.1)	HAPLN4 (2.0)	QTRT1 (2.0)	ENSG00000226645 (2.0)	ZNF101 (1.9)
ENSG00000204983	PRSS1 PPI subnetwork	4.74e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.0)	ANGPTL3 (5.0)	HP (4.4)	APOC4 (4.1)	APOC1 (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.3)
ENSG00000122194	PLG PPI subnetwork	4.74e-03	<= 0.20	ANGPTL3 (5.3)	PLG (4.8)	APOC4 (4.5)	APOA5 (4.4)	HP (4.1)	SLC22A1 (3.9)	APOB (3.7)	PVRL2 (3.0)	APOC1 (2.9)	APOE (2.8)
ENSG00000168907	PLA2G4F PPI subnetwork	4.74e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.8)	ABCG5 (3.6)	APOE (3.3)
MP:0003111	abnormal cell nucleus morphology	4.78e-03	<= 0.20	FEN1 (5.0)	USP1 (4.0)	PSRC1 (3.7)	NKPD1 (2.4)	ILF3 (1.9)	SUGP1 (1.8)	RHCE (1.8)	PVR (1.7)	ENSG00000228044 (1.7)	UBXN2B (1.5)
GO:0016209	antioxidant activity	4.79e-03	<= 0.20	ALDH2 (4.0)	MOSC1 (4.0)	RHD (3.4)	HP (2.9)	PSMA5 (2.3)	APOC1 (2.3)	HLX (2.1)	NYNRIN (2.0)	RHCE (1.9)	AP1M2 (1.8)
ENSG00000213044	ENSG00000213044 PPI subnetwork	4.82e-03	<= 0.20	APOB (8.4)	APOC1 (5.9)	PLG (5.8)	APOA5 (5.6)	ANGPTL3 (5.0)	HP (5.0)	APOC4 (4.4)	ABCG5 (4.2)	NPC1L1 (3.9)	APOE (3.5)
GO:0000272	polysaccharide catabolic process	4.82e-03	<= 0.20	SYPL2 (2.8)	SORT1 (2.7)	PMFBP1 (2.6)	CEACAM19 (2.5)	ENSG00000228044 (2.4)	ENSG00000235545 (2.1)	ST3GAL4 (1.9)	HP (1.8)	TMED4 (1.8)	AMIGO1 (1.8)
GO:0008374	O-acyltransferase activity	4.85e-03	<= 0.20	MOSC1 (4.8)	TM6SF2 (4.6)	NPC1L1 (4.0)	GPAM (3.9)	FADS1 (2.9)	ABCG5 (2.8)	FADS2 (2.6)	APOB (2.3)	LPAR2 (2.2)	GRINA (2.1)
ENSG00000110107	PRPF19 PPI subnetwork	4.86e-03	<= 0.20	SUGP1 (3.5)	DHX38 (3.3)	MAU2 (2.8)	DDX56 (2.7)	BUD13 (2.7)	BRAP (2.4)	ZNF259 (2.3)	ILF3 (2.2)	SMARCA4 (2.2)	TRAFD1 (2.1)
MP:0008470	abnormal spleen B cell follicle morphology	4.87e-03	<= 0.20	RELB (5.7)	GRINA (4.6)	CLPTM1 (3.5)	PVRL2 (3.3)	HAVCR1 (3.1)	TIMD4 (2.8)	GMIP (2.4)	CETP (2.2)	BCAM (2.0)	PLEC (1.8)
ENSG00000205813	ENSG00000205813 PPI subnetwork	4.94e-03	<= 0.20	APOB (7.8)	PLG (5.4)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.7)	ABCG5 (3.6)	APOE (3.2)
ENSG00000109272	PF4V1 PPI subnetwork	4.94e-03	<= 0.20	APOB (7.8)	PLG (5.4)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.7)	ABCG5 (3.6)	APOE (3.2)
ENSG00000156587	UBE2L6 PPI subnetwork	4.96e-03	<= 0.20	GRINA (2.8)	OGDH (2.5)	CARM1 (2.5)	GOT2P1 (2.4)	OASL (2.4)	TRAFD1 (2.3)	PPP1R37 (2.2)	COL4A3BP (2.1)	C19orf52 (2.0)	PARP10 (1.8)
GO:0006006	glucose metabolic process	4.97e-03	<= 0.20	SYPL2 (2.8)	GOT2P1 (2.8)	GPAM (2.6)	LPA (2.4)	ENSG00000254235 (2.4)	ACAD10 (2.4)	HAPLN4 (2.2)	OGDH (2.2)	MOSC1 (2.1)	SORT1 (2.1)
GO:0051248	negative regulation of protein metabolic process	4.98e-03	<= 0.20	PSMA5 (2.9)	TMEM57 (2.4)	TRAFD1 (1.9)	GRINA (1.8)	NAA25 (1.7)	ENSG00000238078 (1.6)	GCNT4 (1.6)	TRIB1 (1.4)	PARP10 (1.4)	DDX56 (1.4)
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	5.00e-03	<= 0.20	HNF1A (4.4)	C11orf9 (3.6)	PCSK9 (3.5)	ABO (3.4)	KIAA1324 (3.1)	CYP7A1 (3.1)	NPC1L1 (2.5)	HAPLN4 (2.4)	TM6SF2 (2.4)	ABCG8 (2.3)
GO:0031093	platelet alpha granule lumen	5.01e-03	<= 0.20	ANGPTL3 (6.5)	HP (5.7)	PLG (5.4)	ITGB3 (5.3)	APOE (4.2)	APOB (4.1)	APOA5 (4.1)	APOC4 (4.0)	APOC1 (3.7)	LPA (2.6)
GO:0046463	acylglycerol biosynthetic process	5.03e-03	<= 0.20	FADS1 (4.9)	FADS2 (4.8)	GPAM (4.6)	PCSK9 (4.4)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.4)	NPC1L1 (2.5)	TM6SF2 (2.4)	BLOC1S3 (2.2)
GO:0046460	neutral lipid biosynthetic process	5.03e-03	<= 0.20	FADS1 (4.9)	FADS2 (4.8)	GPAM (4.6)	PCSK9 (4.4)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.4)	NPC1L1 (2.5)	TM6SF2 (2.4)	BLOC1S3 (2.2)
ENSG00000160255	ITGB2 PPI subnetwork	5.03e-03	<= 0.20	SH2B3 (3.1)	HP (3.1)	GMIP (3.0)	APOB (2.8)	HLX (2.8)	ANGPTL3 (2.7)	PLG (2.6)	CETP (2.6)	SLC44A2 (2.4)	APOE (2.3)
ENSG00000131095	GFAP PPI subnetwork	5.04e-03	<= 0.20	ITGB3 (2.2)	MOSC1 (2.1)	C11orf9 (1.9)	PLEC (1.8)	LPA (1.6)	POLK (1.6)	ENSG00000238078 (1.5)	CELSR2 (1.5)	HAPLN4 (1.5)	SYPL2 (1.4)
MP:0011097	complete embryonic lethality before turning of embryo	5.07e-03	<= 0.20	DOCK7 (3.8)	LDLR (3.1)	FADS1 (2.7)	ALDH2 (2.5)	TMEM57 (2.2)	DNM2 (2.2)	GOT2P1 (2.1)	TOP1 (2.0)	USP24 (1.8)	ZNF259 (1.7)
MP:0005266	abnormal metabolism	5.10e-03	<= 0.20	ABCG8 (6.2)	HP (3.8)	NPC1L1 (3.6)	KIAA1324 (3.5)	TM6SF2 (3.2)	ABCG5 (3.2)	LPIN3 (3.1)	APOB (2.7)	APOC4 (2.7)	MOSC1 (2.6)
MP:0004185	abnormal adipocyte glucose uptake	5.13e-03	<= 0.20	GPAM (3.2)	SYPL2 (3.2)	PLCG1 (3.0)	ATXN7L2 (2.6)	PLEC (2.6)	ENSG00000254235 (2.3)	CETP (2.3)	GATAD2A (2.3)	DNM2 (2.2)	PTPN11 (2.1)
MP:0003038	decreased infarction size	5.14e-03	<= 0.20	MAFB (2.9)	APOC1 (2.4)	TSSK6 (2.4)	SLC22A1 (2.4)	ENSG00000226648 (2.2)	HP (2.1)	PMFBP1 (2.1)	HLX (2.0)	TMEM57 (2.0)	ITGB3 (1.9)
ENSG00000171401	KRT13 PPI subnetwork	5.19e-03	<= 0.20	APOB (8.1)	PLG (5.5)	APOA5 (5.2)	ANGPTL3 (4.9)	HP (4.5)	APOC1 (4.3)	APOC4 (4.2)	NPC1L1 (3.9)	ABCG5 (3.8)	APOE (3.2)
MP:0004111	abnormal coronary artery morphology	5.21e-03	<= 0.20	MAFB (3.0)	MYLIP (2.8)	FRK (2.3)	TMEM57 (2.3)	TRIB1 (2.3)	SYPL2 (1.8)	PVR (1.7)	BCL3 (1.7)	TOP1 (1.6)	TMED4 (1.6)
GO:0042157	lipoprotein metabolic process	5.22e-03	<= 0.20	NPC1L1 (3.0)	HNF1A (2.8)	ABCG5 (2.5)	ADAM1 (2.4)	CEACAM19 (2.4)	C17orf57 (2.3)	ERP29 (2.3)	TM6SF2 (2.2)	APOC1 (2.2)	TMED4 (2.1)
GO:0044275	cellular carbohydrate catabolic process	5.27e-03	<= 0.20	GOT2P1 (2.5)	SYPL2 (2.1)	OGDH (1.9)	ACAD10 (1.9)	HAPLN4 (1.9)	TM6SF2 (1.8)	PCSK9 (1.7)	ENSG00000254235 (1.7)	SORT1 (1.7)	DHODH (1.7)
ENSG00000124120	TTPAL PPI subnetwork	5.28e-03	<= 0.20	APOB (7.2)	NPC1L1 (4.1)	APOC1 (3.9)	APOE (3.5)	ABCG5 (3.4)	HP (3.1)	PCSK9 (2.9)	PLG (2.8)	APOA5 (2.7)	TM6SF2 (2.7)
ENSG00000188994	ZNF292 PPI subnetwork	5.28e-03	<= 0.20	APOB (7.7)	PLG (5.4)	APOA5 (5.0)	ANGPTL3 (4.7)	HP (4.3)	APOC4 (4.1)	APOC1 (4.1)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.2)
ENSG00000160220	ENSG00000160220 PPI subnetwork	5.31e-03	<= 0.20	ZNF259 (4.7)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (3.6)	TOMM40 (3.6)	DHODH (2.9)	DHX38 (2.5)	ATP13A1 (2.5)	BRAP (2.3)	C12orf43 (2.1)
GO:0065005	protein-lipid complex assembly	5.31e-03	<= 0.20	NPC1L1 (5.2)	APOB (4.0)	ABCG5 (3.9)	APOC1 (3.5)	HAVCR1 (3.3)	APOE (3.2)	TM6SF2 (3.0)	APOA5 (2.8)	ABCG8 (2.4)	APOC4 (2.1)
GO:0034377	plasma lipoprotein particle assembly	5.31e-03	<= 0.20	NPC1L1 (5.2)	APOB (4.0)	ABCG5 (3.9)	APOC1 (3.5)	HAVCR1 (3.3)	APOE (3.2)	TM6SF2 (3.0)	APOA5 (2.8)	ABCG8 (2.4)	APOC4 (2.1)
GO:0015144	carbohydrate transmembrane transporter activity	5.32e-03	<= 0.20	TMED4 (3.4)	TM6SF2 (2.7)	APOB (2.4)	ATP13A1 (2.3)	CLPTM1 (2.3)	TSSK6 (2.2)	TMEM50A (2.0)	SORT1 (2.0)	HAPLN4 (1.9)	NPC1L1 (1.8)
ENSG00000119938	PPP1R3C PPI subnetwork	5.34e-03	<= 0.20	SYPL2 (3.7)	LPA (3.0)	ZNF180 (3.0)	DHODH (2.8)	SORT1 (2.6)	CLPTM1 (2.4)	DOCK7 (2.2)	SLC44A2 (2.1)	NT5DC1 (2.1)	MOSC1 (2.0)
GO:0033293	monocarboxylic acid binding	5.34e-03	<= 0.20	MOSC1 (5.3)	GPAM (4.2)	APOB (4.0)	APOC1 (3.7)	APOE (3.5)	ACAD10 (3.4)	APOA5 (3.1)	ALDH2 (2.8)	TM6SF2 (2.8)	PCSK9 (2.7)
GO:0051184	cofactor transporter activity	5.35e-03	<= 0.20	TM6SF2 (4.7)	ABCG8 (4.1)	ABCG5 (3.1)	NPC1L1 (2.8)	GRINA (2.4)	APOB (2.4)	HAVCR1 (2.3)	DNAH11 (2.2)	TMEM116 (2.1)	NT5DC1 (2.0)
MP:0005325	abnormal renal glomerulus morphology	5.35e-03	<= 0.20	PVRL2 (4.3)	BCAM (4.0)	NYNRIN (2.5)	TRIB1 (2.5)	PVR (2.4)	TMED4 (2.2)	APOE (2.0)	MAFB (1.9)	BCL3 (1.7)	HLX (1.6)
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	5.39e-03	<= 0.20	SLC44A2 (4.2)	ITGB3 (3.7)	APOE (3.4)	BCAM (2.8)	APOC1 (2.7)	APOB (2.5)	C17orf57 (2.4)	CETP (2.2)	GMIP (2.2)	PLEC (2.1)
GO:0043498	cell surface binding	5.39e-03	<= 0.20	HP (8.8)	PLG (5.8)	ANGPTL3 (5.6)	APOC4 (5.1)	APOB (5.0)	APOA5 (4.9)	MOSC1 (3.4)	LPA (3.2)	PCSK9 (2.8)	TIMD4 (2.7)
ENSG00000132361	KIAA0664 PPI subnetwork	5.39e-03	<= 0.20	DDX56 (4.3)	NAA25 (3.7)	ZNF259 (3.5)	SARS (3.4)	TOMM40 (3.4)	QTRT1 (3.0)	DHX38 (2.6)	SUGP1 (2.6)	TOP1 (2.5)	PSMA5 (2.5)
ENSG00000124006	OBSL1 PPI subnetwork	5.40e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.2)	APOC1 (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.2)
ENSG00000157326	DHRS4 PPI subnetwork	5.44e-03	<= 0.20	SARS (3.8)	BRAP (3.0)	CLPTM1 (2.7)	PTPN11 (2.7)	ILF3 (2.3)	CARM1 (2.2)	OGDH (2.2)	C12orf43 (2.1)	GATAD2A (2.0)	BLOC1S3 (2.0)
MP:0001622	abnormal vasculogenesis	5.48e-03	<= 0.20	MAFB (2.4)	TOP1 (2.3)	HLX (2.3)	APOE (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	MYLIP (1.8)	SH2B3 (1.7)	ATXN2 (1.7)	BCAM (1.6)
ENSG00000170871	KIAA0232 PPI subnetwork	5.48e-03	<= 0.20	APOB (8.6)	PLG (5.9)	APOA5 (5.6)	ANGPTL3 (5.0)	HP (4.9)	APOC4 (4.5)	APOC1 (4.3)	NPC1L1 (3.9)	ABCG5 (3.8)	APOE (3.4)
ENSG00000184588	PDE4B PPI subnetwork	5.53e-03	<= 0.20	APOE (5.3)	TIMD4 (3.7)	APOC4 (3.5)	APOB (3.4)	APOA5 (3.4)	ANGPTL3 (2.9)	PLG (2.9)	APOC1 (2.8)	PCSK9 (2.7)	MAFB (2.7)
ENSG00000103742	IGDCC4 PPI subnetwork	5.56e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.4)	APOC4 (4.0)	APOC1 (3.9)	NPC1L1 (3.8)	ABCG5 (3.7)	APOE (3.1)
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	5.57e-03	<= 0.20	ITGB3 (7.8)	HP (5.1)	ANGPTL3 (5.0)	PLG (4.3)	APOE (3.9)	APOB (3.9)	APOC1 (3.3)	APOC4 (3.0)	APOA5 (3.0)	TIMD4 (3.0)
REACTOME_CYTOCHROME_P450_:_ARRANGED_BY_SUBSTRATE_TYPE	REACTOME_CYTOCHROME_P450_:_ARRANGED_BY_SUBSTRATE_TYPE	5.57e-03	<= 0.20	SLC22A1 (8.0)	LPA (7.3)	CYP7A1 (6.0)	APOC4 (5.6)	ABCG5 (5.3)	TM6SF2 (5.3)	APOA5 (5.1)	ABCG8 (4.6)	ANGPTL3 (4.5)	PLG (4.3)
ENSG00000133805	AMPD3 PPI subnetwork	5.61e-03	<= 0.20	APOB (7.8)	PLG (5.6)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.6)	ABCG5 (3.6)	APOE (3.1)
ENSG00000087191	PSMC5 PPI subnetwork	5.61e-03	<= 0.20	PSMA5 (6.0)	NT5DC1 (3.0)	NAA25 (2.9)	SARS (2.6)	DHX38 (2.5)	TRAFD1 (2.5)	BRAP (2.2)	SUGP1 (2.2)	DDX56 (2.2)	TOMM40 (2.1)
GO:0016863	intramolecular oxidoreductase activity, transposing C=C bonds	5.61e-03	<= 0.20	HMGCR (7.1)	FADS2 (6.1)	FADS1 (6.0)	LDLR (5.5)	MOSC1 (3.4)	TRAPPC6A (2.9)	PCSK9 (2.7)	CYP7A1 (2.7)	APOA5 (2.5)	APOC1 (2.1)
GO:0019318	hexose metabolic process	5.62e-03	<= 0.20	SYPL2 (2.7)	ENSG00000254235 (2.6)	ACAD10 (2.4)	GOT2P1 (2.4)	SORT1 (2.3)	GPAM (2.3)	NT5DC1 (2.2)	LPA (2.1)	DHODH (2.1)	TRAPPC6A (2.1)
ENSG00000169627	BOLA2B PPI subnetwork	5.65e-03	<= 0.20	LPIN3 (2.5)	GOT2P1 (2.5)	NT5DC1 (2.5)	DOCK7 (2.5)	FADS2 (1.7)	TOP1 (1.6)	TOMM40 (1.6)	ABO (1.6)	SH2B3 (1.5)	PBX4 (1.5)
ENSG00000183336	BOLA2 PPI subnetwork	5.65e-03	<= 0.20	LPIN3 (2.5)	GOT2P1 (2.5)	NT5DC1 (2.5)	DOCK7 (2.5)	FADS2 (1.7)	TOP1 (1.6)	TOMM40 (1.6)	ABO (1.6)	SH2B3 (1.5)	PBX4 (1.5)
MP:0010025	decreased total body fat amount	5.69e-03	<= 0.20	GPAM (3.5)	SYPL2 (3.2)	TM6SF2 (2.7)	HP (2.5)	HAPLN4 (2.4)	DNAH11 (2.3)	KANK2 (2.3)	BCL3 (2.3)	MOSC1 (2.2)	ZHX3 (2.0)
ENSG00000167768	KRT1 PPI subnetwork	5.70e-03	<= 0.20	APOC4 (3.5)	PLG (3.5)	ANGPTL3 (3.2)	HP (2.9)	APOA5 (2.8)	SLC22A1 (2.7)	LPA (2.5)	CEACAM19 (2.5)	CBLC (2.4)	APOC1 (2.3)
ENSG00000172594	SMPDL3A PPI subnetwork	5.71e-03	<= 0.20	APOE (6.7)	APOB (6.5)	TIMD4 (4.8)	APOC1 (4.4)	APOA5 (3.9)	ABCG5 (3.7)	APOC4 (3.7)	NPC1L1 (3.6)	PLG (3.5)	ANGPTL3 (3.3)
KEGG_ARACHIDONIC_ACID_METABOLISM	KEGG_ARACHIDONIC_ACID_METABOLISM	5.72e-03	<= 0.20	ABCG5 (4.3)	ALDH2 (4.2)	ABCG8 (3.7)	LPA (3.2)	TM6SF2 (2.8)	ANGPTL3 (2.4)	HP (2.3)	SLC22A1 (2.3)	APOC4 (2.3)	NKPD1 (2.2)
MP:0003229	abnormal vitelline vasculature morphology	5.73e-03	<= 0.20	PVR (2.6)	SH2B3 (2.6)	NYNRIN (2.4)	CLPTM1 (2.4)	DNM2 (2.3)	GATAD2A (2.2)	PVRL2 (2.2)	SLC44A2 (2.0)	ATXN2 (2.0)	CETP (2.0)
MP:0010875	increased bone volume	5.87e-03	<= 0.20	TRIB1 (2.4)	CETP (2.4)	PLEKHH2 (2.4)	ATXN7L2 (2.0)	LPA (1.9)	DNAH11 (1.8)	MAFB (1.7)	SH2B3 (1.7)	ABCG5 (1.6)	PARP10 (1.4)
ENSG00000070423	RNF126 PPI subnetwork	5.91e-03	<= 0.20	USP24 (3.4)	GMPR (2.9)	TMEM57 (2.3)	GRINA (2.3)	CLPTM1 (2.2)	ATP13A1 (1.9)	UBXN2B (1.9)	C12orf51 (1.8)	MAU2 (1.7)	SLC44A2 (1.7)
ENSG00000032742	IFT88 PPI subnetwork	5.92e-03	<= 0.20	PPP1R37 (4.1)	GOT2P1 (3.4)	CLPTM1 (3.1)	CILP2 (2.4)	UBXN2B (2.2)	GRINA (2.1)	NT5DC1 (2.0)	CELSR2 (2.0)	CEACAM19 (1.9)	PBX4 (1.8)
MP:0005342	abnormal intestinal lipid absorption	5.92e-03	<= 0.20	ABCG8 (6.6)	TM6SF2 (6.0)	ABCG5 (5.4)	NPC1L1 (5.3)	APOB (3.1)	HAPLN4 (2.1)	GCNT4 (2.1)	CBLC (2.0)	KIAA1324 (2.0)	C11orf9 (1.9)
MP:0005015	increased T cell number	5.93e-03	<= 0.20	RELB (3.5)	ZNF101 (2.9)	TIMD4 (2.8)	CETP (2.8)	BCL3 (2.7)	GMIP (2.5)	TRIB1 (2.5)	MAFB (2.4)	PBX4 (2.2)	TRAFD1 (1.8)
GO:0009925	basal plasma membrane	5.93e-03	<= 0.20	PLEC (3.2)	CYP7A1 (3.1)	DOCK7 (2.5)	CBLC (2.5)	BCAM (2.4)	ABCG8 (2.4)	C17orf57 (2.1)	TSSK6 (2.1)	TMEM116 (2.0)	ABCG5 (2.0)
ENSG00000197471	SPN PPI subnetwork	5.95e-03	<= 0.20	SH2B3 (3.0)	PBX4 (2.9)	ST3GAL4 (2.5)	OASL (2.4)	RELB (2.4)	TIMD4 (2.2)	PVR (2.2)	OGDH (2.1)	GATAD2A (1.9)	PLEC (1.9)
ENSG00000145692	BHMT PPI subnetwork	5.96e-03	<= 0.20	PLG (6.3)	ANGPTL3 (5.5)	APOB (5.5)	APOC4 (5.4)	APOA5 (5.0)	HP (3.6)	APOC1 (3.3)	CYP7A1 (3.2)	UBXN2B (2.9)	GOT2P1 (2.6)
MP:0001200	thick skin	5.96e-03	<= 0.20	HMGCR (3.8)	CBLC (3.5)	PPP1R37 (2.9)	NPC1L1 (2.8)	BCL3 (2.8)	GCNT4 (2.7)	C11orf9 (2.3)	YIPF2 (2.2)	TRIB1 (2.1)	FRK (2.1)
ENSG00000084754	HADHA PPI subnetwork	6.00e-03	<= 0.20	SYPL2 (3.3)	ACAD10 (3.0)	OGDH (2.5)	GMPR (2.4)	TMEM50A (2.3)	PLEC (2.0)	RHD (1.9)	RELB (1.8)	LPAR2 (1.7)	LPIN3 (1.7)
MP:0003717	pallor	6.02e-03	<= 0.20	RHD (5.6)	RHCE (5.1)	KANK2 (3.7)	USP24 (2.6)	C12orf51 (2.3)	GMPR (2.1)	ATXN2 (1.7)	DNM2 (1.7)	ITGB3 (1.7)	PTPN11 (1.6)
MP:0001846	increased inflammatory response	6.06e-03	<= 0.20	BCL3 (4.0)	TIMD4 (3.5)	RELB (3.4)	MAFB (3.0)	PLEC (2.9)	GMIP (2.9)	CETP (2.7)	SH2B3 (2.5)	LPAR2 (2.5)	TRIB1 (2.3)
GO:0005788	endoplasmic reticulum lumen	6.09e-03	<= 0.20	ERP29 (5.4)	TMED4 (4.5)	YIPF2 (3.6)	APOB (2.6)	ABCG5 (2.4)	NPC1L1 (2.3)	TM6SF2 (2.2)	CLPTM1 (2.2)	PVR (2.2)	PLG (2.1)
ENSG00000110169	HPX PPI subnetwork	6.13e-03	<= 0.20	APOB (7.8)	PLG (5.0)	APOA5 (4.8)	ANGPTL3 (4.3)	HP (3.9)	APOC1 (3.7)	APOC4 (3.6)	NPC1L1 (3.6)	ABCG5 (3.6)	APOE (3.1)
MP:0000418	focal hair loss	6.14e-03	<= 0.20	HMGCR (3.2)	FADS1 (3.0)	FADS2 (2.9)	LDLR (2.6)	SLC44A2 (2.2)	BLOC1S3 (2.1)	BCAM (2.0)	APOC4 (1.9)	PLCG1 (1.9)	ABCG5 (1.9)
MP:0008479	decreased spleen white pulp amount	6.21e-03	<= 0.20	HLX (2.3)	SH2B3 (2.3)	BCL3 (2.2)	ZNF101 (2.1)	GRINA (2.1)	ZNF259 (1.8)	RHCE (1.7)	ATP13A1 (1.7)	GMPR (1.6)	PARP10 (1.6)
GO:0007584	response to nutrient	6.21e-03	<= 0.20	FADS2 (3.0)	ATXN7L2 (2.8)	CYP7A1 (2.7)	TM6SF2 (2.6)	NPC1L1 (2.4)	ABCG8 (2.4)	PCSK9 (2.3)	ENSG00000235545 (2.3)	FADS1 (2.0)	LDLR (1.9)
GO:0001701	in utero embryonic development	6.24e-03	<= 0.20	PVRL2 (2.3)	ATXN2 (2.1)	ATXN7L2 (2.1)	KANK2 (1.9)	SLC44A2 (1.9)	CEACAM19 (1.8)	PPP1R37 (1.7)	NYNRIN (1.6)	CARM1 (1.6)	TRIB1 (1.4)
KEGG_STEROID_HORMONE_BIOSYNTHESIS	KEGG_STEROID_HORMONE_BIOSYNTHESIS	6.25e-03	<= 0.20	CYP7A1 (6.1)	ABCG5 (5.9)	SLC22A1 (5.5)	ABCG8 (5.2)	APOC4 (5.2)	LPA (4.7)	APOA5 (4.2)	ANGPTL3 (3.8)	TM6SF2 (3.5)	ST3GAL4 (3.1)
ENSG00000013364	MVP PPI subnetwork	6.25e-03	<= 0.20	PLG (6.1)	APOB (5.7)	ANGPTL3 (5.4)	APOC4 (4.9)	APOA5 (4.8)	HP (3.4)	CYP7A1 (3.1)	APOC1 (2.8)	UBXN2B (2.7)	GOT2P1 (2.6)
ENSG00000112651	MRPL2 PPI subnetwork	6.27e-03	<= 0.20	NAA25 (4.5)	DDX56 (4.3)	TOMM40 (3.8)	ZNF259 (3.8)	QTRT1 (3.7)	DHODH (3.0)	C12orf43 (2.5)	TOP1 (2.3)	BRAP (2.2)	DHX38 (2.2)
ENSG00000132693	CRP PPI subnetwork	6.27e-03	<= 0.20	LPA (5.5)	APOC4 (5.3)	ANGPTL3 (5.1)	TIMD4 (4.4)	PLG (4.4)	APOA5 (4.3)	HP (4.2)	APOC1 (4.1)	SLC22A1 (3.8)	APOE (3.6)
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	6.33e-03	<= 0.20	ABCG8 (6.9)	ABCG5 (6.8)	APOB (4.8)	NPC1L1 (4.6)	TM6SF2 (3.8)	NT5DC1 (2.8)	APOA5 (2.7)	CYP7A1 (2.3)	C17orf57 (2.2)	APOC1 (2.1)
ENSG00000107223	EDF1 PPI subnetwork	6.39e-03	<= 0.20	GCNT4 (2.5)	TIMD4 (2.5)	MOSC1 (2.4)	APOC1 (2.1)	HNF1A (2.0)	PMFBP1 (1.9)	HAVCR1 (1.8)	ST3GAL4 (1.7)	COL4A3BP (1.7)	ZNF180 (1.6)
ENSG00000017427	IGF1 PPI subnetwork	6.44e-03	<= 0.20	MYLIP (4.7)	LPA (3.8)	HLX (3.2)	APOE (3.2)	C1orf63 (3.2)	APOA5 (2.9)	ABCG5 (2.6)	ATXN7L2 (2.3)	SLC22A1 (2.3)	APOC4 (2.2)
ENSG00000101680	LAMA1 PPI subnetwork	6.48e-03	<= 0.20	BCAM (3.8)	KANK2 (3.4)	PVRL2 (2.5)	TMED4 (2.5)	C17orf57 (2.4)	SLC44A2 (2.4)	CBLC (2.2)	APOC4 (2.1)	ST3GAL4 (2.1)	PLEC (2.1)
ENSG00000055957	ITIH1 PPI subnetwork	6.51e-03	<= 0.20	APOB (7.7)	PLG (5.0)	APOA5 (4.7)	ANGPTL3 (4.3)	HP (3.9)	APOC1 (3.8)	NPC1L1 (3.8)	APOC4 (3.6)	ABCG5 (3.4)	APOE (3.2)
REACTOME_XENOBIOTICS	REACTOME_XENOBIOTICS	6.52e-03	<= 0.20	SLC22A1 (11.2)	LPA (7.8)	ABCG5 (7.8)	TM6SF2 (6.8)	ABCG8 (6.1)	APOA5 (5.8)	NPC1L1 (5.7)	APOC4 (5.5)	ANGPTL3 (4.9)	PLG (4.4)
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	6.55e-03	<= 0.20	FADS2 (6.5)	GPAM (6.0)	LDLR (5.8)	FADS1 (5.7)	HMGCR (5.1)	MOSC1 (4.0)	PCSK9 (3.6)	APOB (3.2)	HP (3.1)	ALDH2 (2.8)
GO:0016769	transferase activity, transferring nitrogenous groups	6.55e-03	<= 0.20	SLC22A1 (4.4)	APOA5 (4.1)	PLG (4.1)	ANGPTL3 (3.8)	LPA (3.6)	ALDH2 (3.5)	APOC4 (3.5)	TM6SF2 (3.3)	SARS (2.9)	CYP7A1 (2.8)
ENSG00000125775	SDCBP2 PPI subnetwork	6.55e-03	<= 0.20	UBXN2B (3.3)	PBX4 (2.7)	AP1M2 (2.6)	PLEKHH2 (2.5)	PVR (2.2)	APOE (2.2)	HAVCR1 (2.0)	YIPF2 (1.9)	GOT2P1 (1.9)	TMEM50A (1.9)
GO:0004497	monooxygenase activity	6.63e-03	<= 0.20	SLC22A1 (6.4)	LPA (6.1)	CYP7A1 (5.6)	ABCG5 (4.9)	APOC4 (4.9)	ANGPTL3 (4.7)	PLG (4.6)	TM6SF2 (4.2)	ABCG8 (4.0)	APOA5 (3.8)
KEGG_STARCH_AND_SUCROSE_METABOLISM	KEGG_STARCH_AND_SUCROSE_METABOLISM	6.65e-03	<= 0.20	ABCG5 (4.8)	ABCG8 (4.3)	TM6SF2 (4.3)	CYP7A1 (3.8)	MOSC1 (2.8)	SLC22A1 (2.6)	HP (2.5)	HAPLN4 (2.4)	SYPL2 (2.3)	LPA (2.3)
ENSG00000050820	BCAR1 PPI subnetwork	6.66e-03	<= 0.20	DNM2 (3.3)	GATAD2A (3.1)	PLEC (2.9)	SLC44A2 (2.9)	APOE (2.9)	LPAR2 (2.6)	CBLC (2.5)	PPP1R37 (2.4)	ENSG00000226645 (2.4)	KANK2 (2.3)
GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen	6.78e-03	<= 0.20	LPA (5.9)	SLC22A1 (5.9)	PLG (5.7)	APOC4 (5.6)	ABCG5 (5.4)	CYP7A1 (5.3)	ANGPTL3 (4.7)	APOA5 (4.6)	ABCG8 (4.0)	TM6SF2 (3.8)
ENSG00000067596	DHX8 PPI subnetwork	6.80e-03	<= 0.20	SUGP1 (3.8)	DHX38 (3.7)	MAU2 (3.4)	ZNF259 (2.7)	BUD13 (2.7)	BRAP (2.5)	SMARCA4 (2.4)	POC5 (2.3)	QTRT1 (2.1)	TOP1 (2.0)
ENSG00000003436	TFPI PPI subnetwork	6.81e-03	<= 0.20	HP (5.1)	DNAH11 (2.5)	PVRL2 (2.3)	ITGB3 (2.2)	NPC1L1 (2.1)	ENSG00000226645 (2.0)	MOSC1 (1.8)	SLC22A1 (1.7)	CYP7A1 (1.7)	PBX4 (1.6)
ENSG00000169371	SNUPN PPI subnetwork	6.85e-03	<= 0.20	ZNF180 (3.4)	BUD13 (3.2)	POC5 (2.3)	C12orf47 (2.1)	ENSG00000238078 (2.0)	DHODH (1.9)	ENSG00000228044 (1.8)	AMIGO1 (1.8)	USP1 (1.8)	C12orf43 (1.8)
MP:0002417	abnormal megakaryocyte morphology	6.87e-03	<= 0.20	ABCG8 (5.2)	MARK4 (3.1)	GMPR (2.8)	RHCE (2.8)	RHD (2.7)	ITGB3 (2.5)	C17orf57 (2.1)	NPC1L1 (2.1)	SH2B3 (1.9)	HLX (1.6)
GO:0034383	low-density lipoprotein particle clearance	6.87e-03	<= 0.20	NPC1L1 (3.8)	GCNT4 (3.2)	ABCG5 (2.3)	GPAM (2.2)	MOSC1 (2.2)	ABCG8 (2.1)	HMGCR (2.1)	TIMD4 (2.0)	TM6SF2 (2.0)	DNAH11 (1.9)
ENSG00000197451	HNRNPAB PPI subnetwork	6.88e-03	<= 0.20	SYPL2 (3.6)	BCAM (2.9)	CARM1 (2.5)	OGDH (2.2)	ACAD10 (1.8)	TMEM50A (1.5)	NT5DC1 (1.5)	C1orf63 (1.4)	LPA (1.3)	C17orf57 (1.2)
ENSG00000150990	DHX37 PPI subnetwork	6.92e-03	<= 0.20	ZNF259 (4.6)	DDX56 (4.4)	NAA25 (3.9)	DHODH (3.6)	QTRT1 (3.6)	TOMM40 (3.5)	DHX38 (2.3)	SUGP1 (2.1)	ATP13A1 (2.0)	TOP1 (1.9)
GO:0042974	retinoic acid receptor binding	6.98e-03	<= 0.20	APOC1 (3.1)	TM6SF2 (2.3)	DNM2 (2.3)	ABCG5 (2.0)	LPIN3 (2.0)	HNF1A (1.9)	TIMD4 (1.9)	ATXN2 (1.7)	PLEC (1.7)	MAPKAPK5 (1.7)
GO:0016846	carbon-sulfur lyase activity	6.99e-03	<= 0.20	TM6SF2 (4.5)	APOA5 (3.7)	ABCG5 (3.3)	NPC1L1 (3.1)	ALDH2 (3.1)	ENSG00000235545 (2.7)	SLC22A1 (2.6)	APOC4 (2.6)	PCSK9 (2.5)	ABCG8 (2.4)
ENSG00000211662	ENSG00000211662 PPI subnetwork	7.02e-03	<= 0.20	APOC1 (3.0)	HP (2.9)	SLC22A1 (2.9)	APOE (2.8)	APOB (2.5)	ENSG00000228044 (2.3)	USP24 (2.3)	PLG (2.3)	CYP7A1 (2.2)	APOC4 (2.0)
GO:0006112	energy reserve metabolic process	7.04e-03	<= 0.20	SORT1 (3.3)	HAPLN4 (3.1)	ENSG00000238078 (2.9)	GPAM (2.9)	CYP7A1 (2.8)	ENSG00000254235 (2.5)	MOSC1 (2.5)	KIAA1324 (2.4)	AMIGO1 (2.4)	LPA (2.1)
ENSG00000133937	GSC PPI subnetwork	7.08e-03	<= 0.20	KANK2 (2.8)	PCSK9 (2.4)	ABO (2.3)	ENSG00000226648 (2.3)	PLCG1 (1.9)	TRIB1 (1.8)	ATXN7L2 (1.7)	KIAA1324 (1.6)	CILP2 (1.6)	NKPD1 (1.6)
ENSG00000030582	GRN PPI subnetwork	7.10e-03	<= 0.20	HP (2.7)	RHD (2.6)	PVRL2 (2.4)	ERP29 (1.9)	NPC1L1 (1.8)	CEACAM19 (1.8)	NYNRIN (1.8)	ITGB3 (1.7)	PVR (1.6)	RHCE (1.6)
ENSG00000160310	PRMT2 PPI subnetwork	7.10e-03	<= 0.20	PPP1R37 (3.4)	ZHX3 (3.1)	ATXN2 (2.8)	CLPTM1 (2.6)	GRINA (2.5)	CELSR2 (2.4)	TOMM40 (2.2)	MARK4 (2.2)	C12orf51 (2.0)	ABO (1.9)
MP:0008770	decreased survivor rate	7.17e-03	<= 0.20	PCSK9 (4.5)	LDLR (3.3)	MYLIP (2.8)	USP24 (2.7)	HLX (2.6)	OASL (2.5)	FADS1 (2.5)	PLEC (2.3)	KANK2 (2.2)	GMPR (2.2)
GO:0019439	aromatic compound catabolic process	7.20e-03	<= 0.20	CYP7A1 (5.5)	SLC22A1 (4.2)	LPA (4.1)	APOA5 (3.4)	ANGPTL3 (3.2)	APOC4 (3.0)	ENSG00000254235 (2.8)	PLG (2.6)	ENSG00000228044 (2.5)	CEACAM19 (2.4)
ENSG00000102103	PQBP1 PPI subnetwork	7.21e-03	<= 0.20	GATAD2A (2.8)	BUD13 (2.7)	CARM1 (2.7)	GEMIN7 (2.6)	MAU2 (2.5)	GMIP (2.4)	MARK4 (2.2)	SMARCA4 (2.1)	ENSG00000254235 (2.0)	FADS2 (2.0)
ENSG00000197263	OR8D2 PPI subnetwork	7.26e-03	<= 0.20	APOB (5.0)	PLG (4.5)	ANGPTL3 (4.4)	APOC1 (4.2)	APOA5 (3.8)	APOC4 (3.7)	HP (3.7)	APOE (3.2)	PCSK9 (2.9)	C11orf9 (2.4)
MP:0002357	abnormal spleen white pulp morphology	7.28e-03	<= 0.20	GRINA (4.7)	FADS1 (3.7)	RELB (2.5)	BCL3 (2.5)	PARP10 (2.1)	MAFB (1.8)	TRIB1 (1.8)	UBXN2B (1.8)	SLC22A1 (1.7)	TOMM40 (1.7)
MP:0005264	glomerulosclerosis	7.28e-03	<= 0.20	BCAM (3.5)	PVRL2 (3.5)	MAFB (3.4)	PLEKHH2 (2.1)	CETP (2.0)	CEACAM19 (2.0)	C17orf57 (1.8)	HLX (1.6)	KANK2 (1.6)	NT5DC1 (1.5)
ENSG00000159352	PSMD4 PPI subnetwork	7.42e-03	<= 0.20	PSMA5 (5.2)	NAA25 (3.1)	TOMM40 (2.6)	SARS (2.6)	DDX56 (2.5)	OGDH (2.2)	NT5DC1 (2.1)	ZNF259 (2.0)	PTPN11 (1.9)	TRAFD1 (1.9)
MP:0004993	decreased bone resorption	7.44e-03	<= 0.20	GMIP (2.6)	FRK (2.4)	ENSG00000228044 (2.3)	DNM2 (2.2)	MYLIP (2.0)	MAU2 (1.9)	PARP10 (1.6)	ITGB3 (1.5)	CLPTM1 (1.5)	HLX (1.5)
MP:0003205	testicular atrophy	7.46e-03	<= 0.20	TMEM116 (3.0)	ITGB3 (2.6)	UBXN2B (2.5)	ZHX3 (2.4)	PCSK9 (2.0)	USP1 (2.0)	FEN1 (1.9)	CELSR2 (1.9)	BCAM (1.7)	PBX4 (1.7)
GO:0030414	peptidase inhibitor activity	7.48e-03	<= 0.20	HP (5.6)	APOB (5.5)	PLG (5.1)	APOA5 (4.7)	APOC1 (4.4)	APOC4 (4.0)	ANGPTL3 (3.7)	PCSK9 (3.1)	SLC22A1 (3.0)	GPAM (2.6)
MP:0004259	small placenta	7.51e-03	<= 0.20	LDLR (3.4)	PCSK9 (3.2)	APOB (3.1)	FADS2 (2.5)	HMGCR (2.4)	DNM2 (2.3)	APOA5 (2.3)	HP (2.1)	C11orf9 (2.1)	AP1M2 (2.1)
MP:0008537	increased susceptibility to induced colitis	7.51e-03	<= 0.20	KIAA1324 (3.3)	BCL3 (3.2)	OASL (2.6)	ABCG5 (2.3)	PARP10 (2.3)	ALDH2 (2.2)	HLX (2.2)	TM6SF2 (1.9)	PLEKHH2 (1.9)	ABCG8 (1.8)
MP:0001853	heart inflammation	7.53e-03	<= 0.20	APOE (2.8)	BCL3 (2.6)	PARP10 (2.5)	TRAFD1 (2.4)	CLPTM1 (2.0)	RELB (1.9)	ENSG00000226645 (1.8)	SYPL2 (1.7)	TIMD4 (1.5)	FRK (1.5)
GO:0016741	transferase activity, transferring one-carbon groups	7.54e-03	<= 0.20	DHODH (4.2)	QTRT1 (4.0)	C12orf43 (3.4)	TXNL4B (2.7)	DDX56 (2.7)	NAA25 (2.2)	ZNF259 (1.9)	UBXN2B (1.9)	ATP13A1 (1.8)	ACAD10 (1.7)
GO:0018904	organic ether metabolic process	7.58e-03	<= 0.20	GPAM (4.5)	MOSC1 (4.2)	PCSK9 (3.6)	FADS1 (3.6)	NPC1L1 (3.6)	FADS2 (3.5)	HMGCR (3.5)	TM6SF2 (3.2)	LDLR (3.0)	CYP7A1 (2.5)
ENSG00000116030	SUMO1 PPI subnetwork	7.60e-03	<= 0.20	SARS (4.0)	NAA25 (2.9)	HMGCR (2.8)	USP24 (2.5)	TOP1 (2.4)	GATAD2A (2.3)	ILF3 (2.2)	ENSG00000238078 (2.2)	LDLR (2.2)	USP1 (2.1)
GO:0008329	pattern recognition receptor activity	7.61e-03	<= 0.20	MAFB (5.4)	TIMD4 (4.1)	HP (3.7)	MYLIP (2.8)	HLX (2.7)	ABCG5 (2.1)	APOC1 (2.1)	CEACAM19 (1.9)	UBXN2B (1.9)	ALDH2 (1.7)
GO:0051260	protein homooligomerization	7.70e-03	<= 0.20	LPA (2.4)	TRAPPC6A (2.4)	ACAD10 (2.3)	ALDH2 (1.9)	CYP7A1 (1.9)	TMEM116 (1.9)	SLC22A1 (1.8)	TMEM57 (1.8)	CILP2 (1.8)	MOSC1 (1.7)
ENSG00000164338	UTP15 PPI subnetwork	7.71e-03	<= 0.20	ZNF259 (4.6)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (3.5)	TOMM40 (3.0)	DHODH (2.7)	DHX38 (2.3)	ATP13A1 (2.3)	BRAP (2.2)	SUGP1 (2.2)
GO:0006694	steroid biosynthetic process	7.71e-03	<= 0.20	FADS2 (7.3)	HMGCR (7.0)	LDLR (6.9)	FADS1 (6.6)	PCSK9 (5.7)	CYP7A1 (4.7)	ST3GAL4 (3.4)	TRAPPC6A (3.0)	SLC22A1 (2.1)	APOC4 (2.1)
MP:0005332	abnormal amino acid level	7.87e-03	<= 0.20	APOC4 (4.5)	APOA5 (4.1)	SLC22A1 (4.0)	ANGPTL3 (4.0)	LPA (4.0)	PLG (3.9)	TM6SF2 (3.8)	CYP7A1 (3.0)	ABCG8 (2.8)	NT5DC1 (2.6)
MP:0008873	increased physiological sensitivity to xenobiotic	7.88e-03	<= 0.20	CYP7A1 (4.0)	SLC22A1 (3.7)	ABCG8 (3.5)	TM6SF2 (3.4)	ABCG5 (2.9)	LPA (2.7)	ENSG00000254235 (2.5)	HP (2.4)	ALDH2 (2.3)	APOA5 (2.2)
MP:0001798	impaired macrophage phagocytosis	7.90e-03	<= 0.20	TIMD4 (5.5)	MAFB (5.1)	CETP (4.8)	APOE (3.2)	APOC1 (2.9)	HP (1.9)	PLEC (1.9)	UBXN2B (1.8)	TMEM116 (1.7)	ALDH2 (1.7)
GO:0051701	interaction with host	7.96e-03	<= 0.20	GCNT4 (3.0)	OASL (2.7)	PARP10 (2.1)	GRINA (2.0)	LPA (2.0)	PPP1R37 (1.9)	ENSG00000254235 (1.9)	HAVCR1 (1.9)	TRAFD1 (1.9)	SLC44A2 (1.8)
ENSG00000126768	TIMM17B PPI subnetwork	7.96e-03	<= 0.20	DHODH (3.7)	TRAPPC6A (3.3)	TOMM40 (3.2)	CYP7A1 (3.0)	SARS (2.8)	ANGPTL3 (2.6)	DNM2 (2.5)	ILF3 (2.4)	APOC4 (2.3)	GCNT4 (2.3)
GO:0045017	glycerolipid biosynthetic process	7.97e-03	<= 0.20	FADS1 (3.3)	GPAM (3.3)	FADS2 (3.2)	MOSC1 (3.1)	HMGCR (2.9)	BLOC1S3 (2.7)	NPC1L1 (2.3)	PCSK9 (2.3)	LDLR (2.1)	TM6SF2 (2.1)
REACTOME_CLASSICAL_ANTIBODY:MEDIATED_COMPLEMENT_ACTIVATION	REACTOME_CLASSICAL_ANTIBODY:MEDIATED_COMPLEMENT_ACTIVATION	7.98e-03	<= 0.20	TIMD4 (5.5)	APOE (5.5)	APOC1 (3.7)	MAFB (3.1)	SLC22A1 (2.8)	CETP (2.4)	ANGPTL3 (2.2)	HP (2.0)	PLG (2.0)	LPA (2.0)
ENSG00000198911	SREBF2 PPI subnetwork	7.98e-03	<= 0.20	LDLR (7.7)	HMGCR (7.2)	FADS2 (5.4)	FADS1 (4.9)	PCSK9 (4.1)	ABO (2.5)	CARM1 (2.4)	UBXN2B (2.3)	HNF1A (2.3)	SH2B3 (2.0)
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	7.98e-03	<= 0.20	ANGPTL3 (3.8)	PLG (3.0)	UBXN2B (2.7)	SLC22A1 (2.5)	ALDH2 (2.3)	CYB561D1 (2.3)	GEMIN7 (2.3)	TM6SF2 (2.1)	LPA (2.0)	CYP7A1 (1.9)
ENSG00000106462	EZH2 PPI subnetwork	7.99e-03	<= 0.20	TOP1 (2.8)	SMARCA4 (2.8)	ATXN2 (2.5)	MARK4 (2.4)	ATP13A1 (2.4)	ILF3 (2.4)	PSRC1 (2.3)	NYNRIN (2.3)	DNM2 (2.3)	TRAFD1 (2.2)
MP:0000218	increased leukocyte cell number	8.00e-03	<= 0.20	GMIP (3.9)	BCL3 (3.6)	RELB (3.4)	TIMD4 (3.1)	CETP (3.0)	RHD (2.7)	RHCE (2.4)	HLX (2.3)	ITGB3 (2.1)	SH2B3 (2.0)
GO:0019432	triglyceride biosynthetic process	8.01e-03	<= 0.20	FADS2 (5.0)	FADS1 (4.9)	GPAM (4.8)	PCSK9 (4.4)	HMGCR (4.2)	LDLR (3.7)	MOSC1 (3.7)	NPC1L1 (2.7)	TM6SF2 (2.5)	NKPD1 (2.2)
MP:0005459	decreased percent body fat	8.03e-03	<= 0.20	TRIB1 (3.4)	MOSC1 (2.5)	SORT1 (2.3)	GPAM (2.3)	ST3GAL4 (2.2)	HLX (2.1)	LPA (2.0)	GCNT4 (1.9)	ZHX3 (1.9)	NPC1L1 (1.9)
ENSG00000133104	SPG20 PPI subnetwork	8.07e-03	<= 0.20	DYNC2LI1 (3.5)	GATAD2A (2.4)	MARK4 (2.3)	CYP7A1 (2.3)	UBXN2B (2.2)	TMEM57 (2.0)	BLOC1S3 (1.8)	ENSG00000228044 (1.7)	DOCK7 (1.7)	USP1 (1.7)
ENSG00000120800	UTP20 PPI subnetwork	8.13e-03	<= 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (4.2)	TOMM40 (4.1)	DHODH (4.0)	DHX38 (2.4)	ATP13A1 (2.2)	SUGP1 (2.2)	MAPKAPK5 (2.0)
MP:0000488	abnormal intestinal epithelium morphology	8.13e-03	<= 0.20	TIMD4 (3.7)	BCL3 (2.4)	HLX (2.0)	PLEKHH2 (2.0)	TOP1 (1.9)	MOSC1 (1.7)	NYNRIN (1.7)	KANK2 (1.7)	PLEC (1.7)	PBX4 (1.6)
ENSG00000104823	ECH1 PPI subnetwork	8.14e-03	<= 0.20	TRAPPC6A (3.0)	ZNF180 (2.9)	GEMIN7 (2.5)	USP24 (2.3)	PVRL2 (2.3)	BLOC1S3 (2.2)	CETP (2.0)	MARK4 (1.9)	QTRT1 (1.8)	ENSG00000228044 (1.8)
MP:0009548	abnormal platelet aggregation	8.14e-03	<= 0.20	ITGB3 (6.7)	CETP (2.9)	ENSG00000238078 (2.3)	MOSC1 (2.0)	GMPR (2.0)	SLC22A1 (1.8)	PLG (1.7)	PLEKHH2 (1.7)	APOB (1.7)	ENSG00000228044 (1.6)
MP:0008657	increased interleukin-1 beta secretion	8.17e-03	<= 0.20	PVR (2.9)	BCL3 (2.8)	CEACAM19 (2.7)	DNAH11 (2.2)	TRIB1 (2.0)	DHX38 (1.8)	MAPKAPK5 (1.7)	C12orf47 (1.7)	TMEM50A (1.7)	GCNT4 (1.6)
GO:0016725	oxidoreductase activity, acting on CH or CH2 groups	8.20e-03	<= 0.20	SLC22A1 (7.2)	ABCG5 (6.6)	LPA (6.4)	CYP7A1 (5.8)	APOC4 (5.5)	APOA5 (5.1)	ABCG8 (5.1)	TM6SF2 (5.0)	HP (4.8)	NPC1L1 (4.4)
GO:0016811	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	8.24e-03	<= 0.20	ACAD10 (3.0)	SLC22A1 (2.9)	HNF1A (2.6)	NT5DC1 (2.5)	NPC1L1 (2.4)	TM6SF2 (2.4)	ATXN7L2 (2.2)	LPA (1.9)	C11orf9 (1.9)	ABCG5 (1.9)
ENSG00000117984	CTSD PPI subnetwork	8.30e-03	<= 0.20	APOE (4.8)	MAFB (3.5)	CETP (3.5)	APOC1 (2.6)	GRINA (2.6)	PLCG1 (2.5)	TRAPPC6A (2.4)	TIMD4 (2.4)	CEACAM19 (2.4)	BCAM (2.3)
MP:0001195	flaky skin	8.30e-03	<= 0.20	NKPD1 (4.1)	ENSG00000254235 (3.3)	HMGCR (2.9)	MAFB (2.9)	LDLR (2.4)	CELSR2 (2.2)	CEACAM19 (2.0)	APOC4 (2.0)	FADS1 (1.9)	TRIB1 (1.9)
ENSG00000183520	UTP11L PPI subnetwork	8.34e-03	<= 0.20	DDX56 (4.4)	ZNF259 (4.2)	QTRT1 (3.9)	NAA25 (3.9)	TOMM40 (3.6)	DHODH (3.0)	C12orf43 (2.4)	ATP13A1 (2.4)	DHX38 (2.1)	BRAP (2.1)
GO:0045087	innate immune response	8.34e-03	<= 0.20	OASL (6.1)	PARP10 (5.3)	TRAFD1 (3.9)	LPA (2.5)	CYB561D1 (2.4)	TIMD4 (2.3)	BCL3 (1.8)	ADAM1 (1.7)	GMIP (1.6)	HP (1.6)
MP:0008617	increased circulating interleukin-12 level	8.38e-03	<= 0.20	OASL (4.8)	PARP10 (4.0)	TRAFD1 (3.7)	TIMD4 (3.1)	CETP (2.4)	GMIP (2.1)	ATP13A1 (2.0)	NPC1L1 (1.9)	YIPF2 (1.7)	ENSG00000254235 (1.6)
MP:0001696	failure to gastrulate	8.39e-03	<= 0.20	ATXN7L2 (3.1)	C17orf57 (2.7)	ENSG00000254235 (2.3)	ATXN2 (2.2)	PVR (2.2)	DOCK7 (2.1)	C1orf63 (1.8)	MAPKAPK5 (1.7)	RHCE (1.7)	ZNF180 (1.6)
ENSG00000133935	C14orf1 PPI subnetwork	8.41e-03	<= 0.20	LDLR (9.1)	HMGCR (8.9)	FADS2 (7.9)	FADS1 (6.6)	PCSK9 (5.6)	GEMIN7 (2.9)	TRAPPC6A (2.9)	CYP7A1 (2.3)	BUD13 (2.1)	TOMM40 (1.7)
GO:0016597	amino acid binding	8.49e-03	<= 0.20	ANGPTL3 (5.0)	PLG (4.6)	ABCG8 (4.2)	SLC22A1 (4.1)	APOC4 (4.1)	ABCG5 (3.7)	CYP7A1 (3.7)	APOA5 (3.7)	LPA (3.3)	TM6SF2 (3.2)
ENSG00000185950	IRS2 PPI subnetwork	8.50e-03	<= 0.20	DNM2 (4.3)	MARK4 (3.1)	TOP1 (2.9)	CARM1 (2.8)	SMARCA4 (2.8)	GMIP (2.7)	ZHX3 (2.6)	C12orf51 (2.5)	COL4A3BP (2.3)	BCL3 (2.3)
ENSG00000169100	SLC25A6 PPI subnetwork	8.58e-03	<= 0.20	HAVCR1 (3.5)	GOT2P1 (3.1)	C19orf52 (2.3)	DHODH (1.9)	LPAR2 (1.7)	TOMM40 (1.7)	KIAA1324 (1.6)	PSMA5 (1.6)	NAA25 (1.6)	ZNF259 (1.5)
ENSG00000127445	PIN1 PPI subnetwork	8.61e-03	<= 0.20	PSRC1 (3.0)	GRINA (2.8)	RHD (2.8)	MARK4 (2.8)	C12orf51 (2.4)	BUD13 (2.4)	FEN1 (2.1)	ILF3 (2.0)	BCL3 (1.9)	RHCE (1.7)
GO:0000932	cytoplasmic mRNA processing body	8.63e-03	<= 0.20	PARP10 (3.7)	TXNL4B (3.1)	OASL (2.9)	USP24 (2.6)	GEMIN7 (2.4)	ATXN2 (2.4)	UBXN2B (2.2)	ENSG00000228044 (2.1)	DHX38 (2.1)	GATAD2A (1.9)
GO:0033993	response to lipid	8.66e-03	<= 0.20	PCSK9 (2.8)	FADS2 (2.5)	HMGCR (2.4)	FADS1 (2.3)	GPAM (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (2.0)	LDLR (2.0)	ATXN7L2 (2.0)	ABCG8 (1.9)
MP:0002723	abnormal immune serum protein physiology	8.66e-03	<= 0.20	APOC1 (4.1)	RELB (3.3)	HP (3.0)	BCL3 (2.7)	C17orf57 (2.6)	SH2B3 (2.4)	SLC44A2 (2.3)	ITGB3 (2.1)	GMIP (2.1)	SLC22A1 (2.1)
MP:0011091	complete prenatal lethality	8.68e-03	<= 0.20	PCSK9 (2.4)	CLPTM1 (2.2)	MAFB (2.0)	ALDH2 (2.0)	APOE (2.0)	C11orf9 (2.0)	HMGCR (1.8)	PVRL2 (1.8)	ATP13A1 (1.7)	ENSG00000226648 (1.7)
GO:0072376	protein activation cascade	8.71e-03	<= 0.20	LPA (7.0)	TIMD4 (4.9)	APOC4 (4.6)	SLC22A1 (4.5)	CETP (4.0)	ANGPTL3 (3.9)	APOA5 (3.6)	PLG (3.4)	HP (3.3)	APOE (2.8)
GO:0002443	leukocyte mediated immunity	8.75e-03	<= 0.20	LPA (2.6)	SLC22A1 (2.6)	TIMD4 (2.3)	GMIP (1.9)	APOE (1.8)	CYB561D1 (1.7)	APOC4 (1.7)	GEMIN7 (1.7)	HP (1.7)	PARP10 (1.6)
ENSG00000185245	GP1BA PPI subnetwork	8.82e-03	<= 0.20	ITGB3 (9.3)	HP (4.4)	PLG (4.2)	ANGPTL3 (3.7)	APOC4 (3.2)	CETP (3.0)	CYP7A1 (2.9)	RHD (2.6)	APOA5 (2.4)	TIMD4 (2.3)
ENSG00000182326	C1S PPI subnetwork	8.86e-03	<= 0.20	APOE (5.9)	TIMD4 (4.9)	APOC1 (3.6)	MAFB (3.6)	CETP (2.3)	HP (2.2)	SLC22A1 (1.7)	KANK2 (1.5)	C19orf52 (1.4)	ENSG00000235545 (1.4)
ENSG00000186847	KRT14 PPI subnetwork	8.94e-03	<= 0.20	TIMD4 (2.8)	GMPR (2.8)	ANGPTL3 (2.7)	CETP (2.6)	OASL (2.6)	PMFBP1 (2.4)	ENSG00000228044 (2.3)	PLG (2.2)	DNAH11 (2.1)	CEACAM19 (2.1)
MP:0005294	abnormal heart ventricle morphology	8.94e-03	<= 0.20	PVR (3.1)	BCAM (2.7)	PVRL2 (2.5)	HP (1.9)	ENSG00000226648 (1.9)	CEACAM19 (1.8)	NYNRIN (1.6)	KANK2 (1.4)	GPAM (1.4)	SLC22A1 (1.3)
ENSG00000178607	ERN1 PPI subnetwork	8.99e-03	<= 0.20	ERP29 (4.1)	BRAP (4.0)	ST3GAL4 (2.7)	C12orf47 (2.7)	YIPF2 (2.3)	ATXN2 (2.2)	MAPKAPK5 (2.2)	PPP1R37 (2.2)	DNM2 (2.1)	TRAFD1 (2.0)
ENSG00000102878	HSF4 PPI subnetwork	9.00e-03	<= 0.20	PARP10 (3.0)	MAU2 (2.9)	USP24 (2.7)	MARK4 (2.5)	ZNF180 (2.2)	GMIP (2.1)	BCL3 (2.1)	SMARCA4 (2.1)	DHX38 (2.1)	ATXN2 (1.9)
ENSG00000168310	IRF2 PPI subnetwork	9.12e-03	<= 0.20	PARP10 (4.7)	OASL (3.9)	RELB (3.8)	BCL3 (3.6)	SH2B3 (2.8)	TRAFD1 (2.7)	GRINA (2.6)	TOP1 (2.3)	ILF3 (2.2)	C1orf63 (1.9)
ENSG00000165704	HPRT1 PPI subnetwork	9.19e-03	<= 0.20	RHD (2.5)	ANGPTL3 (2.4)	UBXN2B (2.3)	TXNL4B (2.3)	GEMIN7 (2.3)	MAU2 (2.3)	PLG (2.2)	LPA (2.1)	HNF1A (1.8)	TMEM50A (1.7)
ENSG00000122484	RPAP2 PPI subnetwork	9.22e-03	<= 0.20	ZNF259 (4.4)	C12orf43 (3.7)	NAA25 (3.5)	DDX56 (3.2)	DHX38 (3.1)	QTRT1 (3.0)	ENSG00000226645 (2.8)	TOMM40 (2.8)	DHODH (2.7)	SUGP1 (2.1)
MP:0001201	translucent skin	9.26e-03	<= 0.20	CELSR2 (4.3)	SYPL2 (2.6)	ENSG00000238078 (2.2)	ZNF180 (2.1)	BCAM (1.8)	CEACAM19 (1.8)	ENSG00000254235 (1.7)	NYNRIN (1.6)	MARK4 (1.6)	PLEC (1.5)
MP:0001255	decreased body height	9.27e-03	<= 0.20	CBLC (2.3)	PLEKHH2 (2.2)	CILP2 (2.0)	MAFB (2.0)	APOE (2.0)	ST3GAL4 (2.0)	TIMD4 (2.0)	CLPTM1 (1.8)	NKPD1 (1.8)	TMEM57 (1.8)
MP:0005289	increased oxygen consumption	9.29e-03	<= 0.20	MOSC1 (5.8)	GPAM (4.2)	TM6SF2 (3.3)	APOA5 (2.8)	SORT1 (2.8)	ALDH2 (2.5)	HP (2.4)	ZNF101 (2.3)	NPC1L1 (2.3)	LPA (2.2)
ENSG00000146587	RBAK PPI subnetwork	9.32e-03	<= 0.20	C19orf52 (2.5)	GRINA (2.3)	ZNF180 (2.2)	OASL (2.2)	PARP10 (2.1)	OGDH (2.1)	BRAP (2.1)	QTRT1 (2.1)	YIPF2 (2.1)	SUGP1 (1.9)
ENSG00000167721	TSR1 PPI subnetwork	9.40e-03	<= 0.20	DDX56 (5.0)	ZNF259 (4.5)	NAA25 (4.5)	QTRT1 (3.6)	TOMM40 (3.1)	DHX38 (2.9)	DHODH (2.8)	ATP13A1 (2.7)	MAPKAPK5 (2.7)	C12orf43 (2.2)
ENSG00000083520	DIS3 PPI subnetwork	9.42e-03	<= 0.20	DDX56 (4.9)	NAA25 (4.0)	C12orf43 (3.9)	ZNF259 (3.8)	QTRT1 (3.6)	DHODH (3.5)	TOMM40 (3.1)	DHX38 (2.9)	USP24 (2.7)	BRAP (2.2)
GO:0071702	organic substance transport	9.45e-03	<= 0.20	ABCG8 (4.7)	TM6SF2 (4.2)	ABCG5 (3.5)	NPC1L1 (3.4)	GCNT4 (2.9)	MOSC1 (2.3)	HAPLN4 (1.8)	APOB (1.8)	SORT1 (1.8)	APOA5 (1.8)
ENSG00000101266	CSNK2A1 PPI subnetwork	9.57e-03	<= 0.20	TOP1 (4.2)	CARM1 (4.1)	SMARCA4 (4.1)	ILF3 (3.6)	TOMM40 (3.5)	TRIB1 (2.7)	DHX38 (2.5)	QTRT1 (2.5)	GATAD2A (2.4)	C12orf43 (2.4)
ENSG00000177425	PAWR PPI subnetwork	9.63e-03	<= 0.20	PVRL2 (3.5)	ANGPTL3 (3.2)	PLG (3.0)	NPC1L1 (2.9)	APOB (2.7)	ABCG5 (2.7)	PVR (2.3)	HP (2.2)	FRK (2.2)	TM6SF2 (2.1)
MP:0000601	small liver	9.64e-03	<= 0.20	RHD (3.0)	C12orf51 (2.9)	USP24 (2.8)	RHCE (2.7)	TRIB1 (2.7)	BCL3 (2.2)	TOP1 (1.9)	GCNT4 (1.8)	SMARCA4 (1.7)	ATXN2 (1.7)
GO:0045120	pronucleus	9.69e-03	<= 0.20	PSRC1 (3.4)	POC5 (2.7)	USP1 (2.7)	BUD13 (2.4)	CEACAM19 (2.4)	FEN1 (2.0)	GEMIN7 (1.8)	TMED4 (1.7)	RHD (1.6)	MAU2 (1.6)
GO:0046965	retinoid X receptor binding	9.70e-03	<= 0.20	APOC1 (3.3)	DNM2 (2.8)	TM6SF2 (2.6)	ABCG5 (2.3)	CETP (2.2)	TIMD4 (2.0)	MAPKAPK5 (1.9)	LPIN3 (1.9)	APOB (1.8)	PLEC (1.6)
MP:0010375	increased kidney iron level	9.71e-03	<= 0.20	RHD (11.7)	RHCE (11.0)	APOC4 (3.9)	PLG (3.9)	GMPR (3.8)	ANGPTL3 (3.4)	APOC1 (2.9)	APOA5 (2.9)	C12orf51 (2.6)	SLC22A1 (2.3)
ENSG00000171560	FGA PPI subnetwork	9.73e-03	<= 0.20	ANGPTL3 (5.7)	PLG (5.5)	APOA5 (4.5)	HP (4.3)	APOC4 (4.1)	APOB (4.1)	APOC1 (3.5)	PCSK9 (2.8)	GPAM (2.2)	ITGB3 (1.8)
ENSG00000136169	SETDB2 PPI subnetwork	9.74e-03	<= 0.20	PLG (3.2)	APOB (3.2)	BCAM (3.1)	HP (3.1)	APOC1 (2.7)	APOC4 (2.6)	TIMD4 (2.5)	SLC22A1 (2.4)	APOA5 (2.3)	APOE (2.3)
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	9.76e-03	<= 0.20	PLG (4.5)	ANGPTL3 (4.0)	ABCG5 (3.3)	SLC22A1 (3.3)	CYP7A1 (3.1)	APOC4 (3.1)	ABCG8 (3.0)	TM6SF2 (2.6)	APOA5 (2.6)	HP (2.4)
ENSG00000196365	LONP1 PPI subnetwork	9.77e-03	<= 0.20	C12orf47 (3.4)	DDX56 (2.6)	TOMM40 (2.4)	SARS (2.1)	CYP7A1 (2.1)	ATP13A1 (2.0)	DOCK7 (1.8)	AP1M2 (1.8)	PSMA5 (1.7)	BLOC1S3 (1.5)
GO:0072378	blood coagulation, fibrin clot formation	9.79e-03	<= 0.20	ITGB3 (4.8)	ANGPTL3 (3.1)	LPA (3.0)	APOC4 (2.9)	PLG (2.9)	ENSG00000226648 (2.6)	GMPR (2.6)	CETP (2.5)	APOA5 (2.5)	CYP7A1 (2.4)
MP:0005166	decreased susceptibility to injury	9.80e-03	<= 0.20	HP (3.1)	BCL3 (2.7)	C17orf57 (2.4)	PLEKHH2 (2.0)	NPC1L1 (1.8)	ENSG00000228044 (1.8)	CBLC (1.7)	SLC22A1 (1.7)	ABCG5 (1.6)	LPA (1.5)
MP:0003918	decreased kidney weight	9.81e-03	<= 0.20	AMIGO1 (2.5)	CBLC (2.4)	BCAM (2.2)	HNF1A (2.2)	ATXN7L2 (2.1)	TM6SF2 (2.0)	SLC44A2 (1.9)	NPC1L1 (1.8)	CYB561D1 (1.8)	CILP2 (1.8)
ENSG00000125755	SYMPK PPI subnetwork	9.85e-03	<= 0.20	GRINA (3.3)	ENSG00000228044 (2.4)	UBXN2B (2.3)	OGDH (2.2)	ENSG00000235545 (2.2)	DYNC2LI1 (1.9)	DHX38 (1.8)	CYP7A1 (1.8)	ATP13A1 (1.6)	HNF1A (1.5)
ENSG00000005961	ITGA2B PPI subnetwork	9.87e-03	<= 0.20	HP (6.2)	APOB (5.2)	ITGB3 (5.0)	PLG (4.3)	ANGPTL3 (4.2)	APOA5 (3.3)	APOC1 (3.3)	APOC4 (3.3)	CILP2 (2.6)	APOE (2.6)
ENSG00000128272	ATF4 PPI subnetwork	9.96e-03	<= 0.20	TRIB1 (5.4)	SARS (4.4)	MAFB (2.8)	BCL3 (2.7)	MAPKAPK5 (2.5)	PVR (2.3)	POC5 (2.3)	TXNL4B (2.2)	HLX (2.1)	APOB (1.8)
ENSG00000103319	EEF2K PPI subnetwork	0.01	<= 0.20	PTPN11 (2.5)	NAA25 (2.4)	BRAP (2.3)	GATAD2A (2.3)	C12orf43 (2.3)	NKPD1 (2.0)	APOB (2.0)	ADAM1 (2.0)	MAPKAPK5 (1.7)	AP1M2 (1.7)
ENSG00000197249	SERPINA1 PPI subnetwork	0.01	<= 0.20	HP (4.1)	MOSC1 (3.1)	RHD (3.0)	CEACAM19 (2.8)	FRK (2.0)	APOA5 (2.0)	HAPLN4 (1.9)	APOC4 (1.9)	DNAH11 (1.8)	RHCE (1.6)
MP:0000493	rectal prolapse	0.01	<= 0.20	PLEC (3.3)	BCL3 (2.5)	APOC4 (2.3)	ANGPTL3 (2.0)	CLPTM1 (2.0)	LDLR (2.0)	NYNRIN (2.0)	PPP1R37 (1.8)	SH2B3 (1.8)	PLEKHH2 (1.7)
GO:0051170	nuclear import	0.01	<= 0.20	ENSG00000254235 (2.8)	ENSG00000235545 (2.2)	USP24 (2.2)	GATAD2A (2.0)	MYLIP (1.8)	NAA25 (1.8)	BLOC1S3 (1.7)	OASL (1.7)	TRAFD1 (1.7)	PTPN11 (1.5)
MP:0004229	abnormal embryonic erythropoiesis	0.01	<= 0.20	RHD (5.7)	RHCE (4.6)	FADS2 (3.7)	BCL3 (3.1)	GMPR (3.0)	FADS1 (2.7)	ITGB3 (2.6)	LDLR (2.5)	TRAPPC6A (2.5)	HMGCR (2.3)
GO:0035264	multicellular organism growth	0.01	<= 0.20	AMIGO1 (3.1)	C12orf51 (2.5)	ZNF180 (2.3)	ENSG00000235545 (2.3)	USP24 (2.3)	ANKRD31 (1.9)	KIAA1324 (1.7)	ENSG00000228044 (1.6)	SLC44A2 (1.6)	GEMIN7 (1.4)
ENSG00000030110	BAK1 PPI subnetwork	0.01	<= 0.20	POLK (3.2)	CBLC (2.8)	TRAPPC6A (2.7)	GATAD2A (2.4)	MARK4 (2.4)	ERP29 (2.3)	TOP1 (2.1)	PLCG1 (2.1)	GEMIN7 (2.0)	C12orf43 (1.8)
MP:0000681	abnormal thyroid gland morphology	0.01	<= 0.20	HAVCR1 (3.6)	MYLIP (2.8)	HAPLN4 (2.2)	MAFB (1.9)	BCAM (1.8)	HLX (1.8)	GRINA (1.7)	ENSG00000254235 (1.6)	APOE (1.5)	ABCG5 (1.5)
MP:0002665	decreased circulating corticosterone level	0.01	<= 0.20	FADS2 (3.9)	FADS1 (3.9)	GPAM (2.9)	ABO (2.9)	CYP7A1 (2.5)	HMGCR (2.3)	ST3GAL4 (2.2)	LPIN3 (1.9)	TSSK6 (1.9)	APOC1 (1.9)
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.01	<= 0.20	TIMD4 (3.5)	APOC1 (2.8)	ANGPTL3 (2.7)	APOE (2.7)	C19orf52 (2.0)	APOC4 (1.9)	MYLIP (1.9)	HP (1.9)	MAFB (1.8)	PLG (1.6)
GO:0009607	response to biotic stimulus	0.01	<= 0.20	OASL (5.3)	PARP10 (4.0)	TRAFD1 (3.1)	ENSG00000235545 (2.4)	GRINA (2.2)	ADAM1 (2.0)	MAFB (2.0)	HP (1.7)	TXNL4B (1.5)	BCL3 (1.5)
ENSG00000112249	ASCC3 PPI subnetwork	0.01	<= 0.20	ATXN2 (2.9)	MAPKAPK5 (2.5)	BRAP (2.3)	ANKRD31 (2.0)	DHX38 (2.0)	PCSK9 (1.9)	SMARCA4 (1.8)	CLPTM1 (1.8)	TRAFD1 (1.8)	SLC44A2 (1.8)
ENSG00000104368	PLAT PPI subnetwork	0.01	<= 0.20	ANGPTL3 (4.4)	APOB (3.8)	APOC4 (3.6)	APOE (3.6)	HP (3.5)	PVRL2 (3.4)	APOA5 (3.3)	PLG (3.2)	APOC1 (3.2)	CYP7A1 (3.0)
MP:0008249	abnormal common lymphocyte progenitor cell morphology	0.01	<= 0.20	KANK2 (3.7)	CETP (3.5)	TIMD4 (3.3)	LPA (2.6)	C19orf52 (2.5)	CEACAM19 (2.2)	MAU2 (1.9)	NT5DC1 (1.9)	PLCG1 (1.8)	TMEM57 (1.8)
ENSG00000212645	ENSG00000212645 PPI subnetwork	0.01	<= 0.20	ERP29 (3.9)	BRAP (3.1)	ST3GAL4 (2.6)	YIPF2 (2.5)	PPP1R37 (2.4)	DNM2 (2.3)	C12orf47 (2.3)	LPAR2 (2.0)	CBLC (1.9)	CLPTM1 (1.7)
ENSG00000041357	PSMA4 PPI subnetwork	0.01	<= 0.20	PSMA5 (5.3)	NAA25 (3.4)	DDX56 (3.3)	TOMM40 (3.0)	ZNF259 (2.6)	SARS (2.3)	SUGP1 (1.8)	HMGCR (1.8)	QTRT1 (1.8)	TRAFD1 (1.6)
ENSG00000151576	QTRTD1 PPI subnetwork	0.01	<= 0.20	APOB (4.6)	ANGPTL3 (3.3)	PLG (3.2)	NPC1L1 (3.2)	APOA5 (2.8)	APOC1 (2.8)	APOC4 (2.7)	ABCG5 (2.7)	GMPR (2.4)	HP (2.3)
MP:0009766	increased sensitivity to xenobiotic induced morbidity/mortality	0.01	<= 0.20	LPA (3.9)	SLC22A1 (3.6)	CYP7A1 (3.3)	PBX4 (2.6)	ANGPTL3 (2.5)	MOSC1 (2.3)	APOC4 (2.3)	PLG (2.2)	PARP10 (2.2)	TRIB1 (2.0)
ENSG00000077348	EXOSC5 PPI subnetwork	0.01	<= 0.20	DDX56 (5.0)	ZNF259 (3.6)	C12orf43 (3.2)	NAA25 (3.2)	SUGP1 (3.0)	USP24 (2.7)	DHODH (2.6)	DHX38 (2.3)	QTRT1 (2.3)	TOMM40 (2.1)
ENSG00000112773	FAM46A PPI subnetwork	0.01	<= 0.20	YIPF2 (3.7)	AP1M2 (3.1)	CARM1 (2.9)	SMARCA4 (2.8)	C19orf52 (2.5)	LPIN3 (2.4)	PPP1R37 (2.3)	CLPTM1 (2.3)	SUGP1 (2.2)	DNM2 (2.1)
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	0.01	<= 0.20	ITGB3 (4.4)	APOB (4.0)	APOC1 (3.4)	HP (3.3)	ANGPTL3 (3.2)	APOA5 (3.0)	PLG (3.0)	APOC4 (2.8)	APOE (2.5)	SH2B3 (2.5)
ENSG00000079385	CEACAM1 PPI subnetwork	0.01	<= 0.20	CETP (4.4)	HP (3.7)	PLEC (3.0)	TIMD4 (2.6)	C12orf47 (2.5)	LPA (2.5)	ENSG00000226648 (2.4)	PVRL2 (2.1)	GMIP (2.1)	DOCK7 (2.0)
ENSG00000204898	ENSG00000204898 PPI subnetwork	0.01	<= 0.20	CETP (4.4)	HP (3.7)	PLEC (3.0)	TIMD4 (2.6)	C12orf47 (2.5)	LPA (2.5)	ENSG00000226648 (2.4)	PVRL2 (2.1)	GMIP (2.1)	DOCK7 (2.0)
ENSG00000181929	PRKAG1 PPI subnetwork	0.01	<= 0.20	GPAM (4.0)	PLG (3.1)	SARS (2.9)	BCAM (2.6)	CYP7A1 (2.4)	DOCK7 (2.3)	HAPLN4 (2.2)	SORT1 (2.0)	MOSC1 (2.0)	LDLR (2.0)
GO:0071496	cellular response to external stimulus	0.01	<= 0.20	TXNL4B (2.5)	BLOC1S3 (2.4)	POLK (2.2)	ABO (2.1)	CEACAM19 (1.9)	LPIN3 (1.9)	PCSK9 (1.7)	AP1M2 (1.7)	BRAP (1.6)	GCNT4 (1.5)
ENSG00000135047	CTSL1 PPI subnetwork	0.01	<= 0.20	MAFB (4.8)	GCNT4 (2.0)	ANGPTL3 (2.0)	APOE (1.9)	CYP7A1 (1.9)	GRINA (1.8)	ALDH2 (1.8)	TIMD4 (1.7)	MYLIP (1.7)	HLX (1.7)
GO:0032414	positive regulation of ion transmembrane transporter activity	0.01	<= 0.20	C17orf57 (3.0)	DNAH11 (2.4)	ENSG00000228044 (2.4)	NKPD1 (2.2)	OGDH (2.1)	AMIGO1 (1.9)	CYB561D1 (1.9)	ZNF180 (1.8)	ENSG00000226648 (1.8)	PLEKHH2 (1.7)
MP:0001915	intracranial hemorrhage	0.01	<= 0.20	PLEC (2.5)	NYNRIN (2.4)	SH2B3 (2.3)	LPA (2.3)	PLG (2.2)	APOA5 (2.2)	APOC4 (2.1)	BCAM (1.9)	KANK2 (1.9)	APOC1 (1.9)
MP:0001511	disheveled coat	0.01	<= 0.20	LDLR (3.6)	GRINA (3.1)	BCL3 (2.9)	HMGCR (2.9)	TRAPPC6A (2.8)	CETP (2.7)	CBLC (2.6)	PCSK9 (2.5)	PLEC (2.5)	FADS1 (2.1)
REACTOME_GLUCONEOGENESIS	REACTOME_GLUCONEOGENESIS	0.01	<= 0.20	SYPL2 (3.6)	PLG (3.1)	TM6SF2 (2.7)	FADS2 (2.7)	SARS (2.5)	FADS1 (2.5)	APOA5 (2.3)	ALDH2 (2.2)	SLC22A1 (2.1)	HAPLN4 (2.1)
GO:0051707	response to other organism	0.01	<= 0.20	OASL (5.3)	PARP10 (4.1)	TRAFD1 (3.2)	ENSG00000235545 (2.8)	GRINA (2.1)	MAFB (2.0)	ADAM1 (1.7)	HP (1.7)	BCL3 (1.5)	GMIP (1.5)
ENSG00000067177	PHKA1 PPI subnetwork	0.01	<= 0.20	SYPL2 (3.4)	TXNL4B (2.6)	ZHX3 (2.4)	ZNF180 (2.3)	GPAM (2.2)	GMPR (2.1)	OGDH (2.0)	SORT1 (2.0)	DHODH (1.7)	PBX4 (1.6)
ENSG00000064703	DDX20 PPI subnetwork	0.01	<= 0.20	TOMM40 (3.6)	PSMA5 (2.6)	C12orf43 (2.5)	DHX38 (2.5)	QTRT1 (2.2)	DDX56 (2.1)	ZNF259 (2.1)	ATXN2 (2.1)	ZNF180 (1.9)	NAA25 (1.8)
MP:0005282	decreased fatty acid level	0.01	<= 0.20	GPAM (4.7)	FADS1 (4.6)	MOSC1 (4.2)	FADS2 (4.1)	APOC1 (3.2)	HMGCR (2.8)	HP (2.8)	LDLR (2.7)	APOC4 (2.6)	NCAN (2.3)
GO:0002252	immune effector process	0.01	<= 0.20	PARP10 (3.2)	LPA (3.0)	OASL (3.0)	TIMD4 (2.8)	GMIP (2.6)	GEMIN7 (2.1)	CYB561D1 (2.0)	SLC22A1 (1.9)	CETP (1.9)	TRAFD1 (1.8)
ENSG00000145833	DDX46 PPI subnetwork	0.01	<= 0.20	CARM1 (4.4)	SMARCA4 (4.2)	SUGP1 (3.1)	BUD13 (2.9)	MARK4 (2.8)	GATAD2A (2.8)	BRAP (2.5)	DNM2 (2.4)	MAU2 (2.4)	ABO (2.2)
GO:0060416	response to growth hormone stimulus	0.01	<= 0.20	ABO (3.1)	CYP7A1 (2.8)	HNF1A (2.7)	ABCG8 (2.6)	PBX4 (2.4)	ENSG00000254235 (2.3)	LPA (2.1)	TRAFD1 (2.1)	ABCG5 (2.1)	TM6SF2 (1.9)
ENSG00000064835	POU1F1 PPI subnetwork	0.01	<= 0.20	ABCG8 (4.3)	CYP7A1 (3.9)	ABCG5 (3.8)	ENSG00000254235 (3.4)	MOSC1 (3.3)	SLC22A1 (3.3)	TM6SF2 (3.1)	APOA5 (3.0)	TRIB1 (2.9)	LPA (2.7)
GO:0006094	gluconeogenesis	0.01	<= 0.20	HAPLN4 (2.6)	TM6SF2 (2.5)	ENSG00000254235 (2.3)	MOSC1 (2.3)	TSSK6 (2.2)	LPA (2.2)	ACAD10 (2.2)	CEACAM19 (2.1)	GOT2P1 (2.1)	SYPL2 (2.0)
MP:0002591	decreased mean corpuscular volume	0.01	<= 0.20	RHCE (12.3)	RHD (11.2)	GMPR (4.4)	C12orf51 (2.9)	APOC1 (2.2)	PCSK9 (2.1)	HP (2.0)	GRINA (1.9)	TIMD4 (1.9)	FADS2 (1.7)
MP:0005439	decreased glycogen level	0.01	<= 0.20	GPAM (5.7)	MOSC1 (4.6)	APOA5 (3.3)	HP (3.2)	SYPL2 (3.1)	CYP7A1 (3.0)	NT5DC1 (2.7)	LPA (2.0)	APOC4 (1.9)	PPP1R37 (1.8)
ENSG00000180733	ENSG00000180733 PPI subnetwork	0.01	<= 0.20	SARS (4.3)	BCL3 (3.2)	MAFB (2.9)	HLX (2.6)	RELB (2.4)	TRAFD1 (2.3)	TXNL4B (2.0)	MAPKAPK5 (1.7)	GRINA (1.7)	PLEKHH2 (1.5)
ENSG00000140264	SERF2 PPI subnetwork	0.01	<= 0.20	ANGPTL3 (3.8)	NYNRIN (3.3)	FRK (2.6)	ATXN2 (2.0)	C11orf9 (1.9)	TOP1 (1.9)	PPP1R37 (1.8)	KANK2 (1.8)	APOB (1.8)	PLG (1.7)
ENSG00000126461	SCAF1 PPI subnetwork	0.01	<= 0.20	APOB (6.0)	APOC1 (4.5)	HP (4.2)	PLG (4.1)	APOE (4.0)	ANGPTL3 (3.5)	APOA5 (3.5)	PCSK9 (3.3)	APOC4 (2.9)	SLC22A1 (2.8)
ENSG00000174175	SELP PPI subnetwork	0.01	<= 0.20	ITGB3 (6.5)	TIMD4 (3.8)	ZNF101 (3.3)	CETP (3.3)	GMPR (2.3)	GMIP (2.3)	ATP13A1 (2.3)	BLOC1S3 (2.0)	DYNC2LI1 (1.9)	CLPTM1 (1.9)
ENSG00000140379	BCL2A1 PPI subnetwork	0.01	<= 0.20	RELB (3.0)	PPP1R37 (2.9)	TRAPPC6A (2.8)	CBLC (2.6)	GEMIN7 (2.5)	GATAD2A (2.3)	LPAR2 (1.8)	CLPTM1 (1.8)	C12orf43 (1.8)	BRAP (1.8)
ENSG00000206383	HSPA1L PPI subnetwork	0.01	<= 0.20	SARS (4.5)	OGDH (3.2)	CLPTM1 (3.1)	SYPL2 (2.8)	DNAH11 (2.3)	DNM2 (2.2)	C17orf57 (2.2)	GOT2P1 (2.0)	ZNF259 (2.0)	PLEC (2.0)
ENSG00000206274	ENSG00000206274 PPI subnetwork	0.01	<= 0.20	SARS (4.5)	OGDH (3.2)	CLPTM1 (3.1)	SYPL2 (2.8)	DNAH11 (2.3)	DNM2 (2.2)	C17orf57 (2.2)	GOT2P1 (2.0)	ZNF259 (2.0)	PLEC (2.0)
ENSG00000143575	HAX1 PPI subnetwork	0.01	<= 0.20	ABCG8 (2.7)	ABCG5 (2.3)	C1orf63 (2.1)	ALDH2 (2.0)	ERP29 (2.0)	PBX4 (2.0)	KANK2 (2.0)	TRAPPC6A (1.9)	APOC4 (1.9)	TM6SF2 (1.8)
ENSG00000148296	SURF6 PPI subnetwork	0.01	<= 0.20	TOMM40 (3.8)	ZNF259 (3.4)	QTRT1 (3.4)	NAA25 (2.7)	DDX56 (2.2)	ANKRD31 (2.1)	C12orf43 (2.0)	ILF3 (1.9)	DHODH (1.7)	ZNF180 (1.6)
GO:0016229	steroid dehydrogenase activity	0.01	<= 0.20	SLC22A1 (4.6)	APOC1 (3.9)	FADS2 (3.8)	LPA (3.5)	FADS1 (3.4)	HMGCR (3.4)	CYP7A1 (3.1)	APOC4 (3.0)	APOA5 (2.9)	PLG (2.4)
MP:0000414	alopecia	0.01	<= 0.20	PLEC (4.0)	CBLC (3.7)	HMGCR (3.4)	AP1M2 (2.9)	MAFB (2.9)	LDLR (2.8)	APOC1 (2.6)	CELSR2 (2.3)	TRIB1 (2.1)	YIPF2 (2.0)
ENSG00000115461	IGFBP5 PPI subnetwork	0.01	<= 0.20	APOA5 (3.1)	APOB (2.9)	LPA (2.9)	HP (2.9)	APOE (2.6)	SLC22A1 (2.6)	PVR (2.3)	APOC4 (2.3)	PLG (2.2)	CYP7A1 (2.0)
ENSG00000147140	NONO PPI subnetwork	0.01	<= 0.20	ILF3 (3.4)	TOP1 (3.3)	SMARCA4 (2.4)	USP1 (2.1)	DOCK7 (2.1)	DHX38 (2.0)	NAA25 (1.8)	QTRT1 (1.8)	PLEC (1.7)	NT5DC1 (1.6)
ENSG00000154162	CDH12 PPI subnetwork	0.01	<= 0.20	BCAM (3.6)	APOB (3.3)	PLG (3.2)	HP (3.0)	APOC4 (2.7)	APOA5 (2.5)	SLC22A1 (2.5)	APOC1 (2.4)	PCSK9 (2.2)	TIMD4 (2.1)
MP:0001780	decreased brown adipose tissue amount	0.01	<= 0.20	MOSC1 (5.0)	GPAM (4.2)	APOC1 (3.2)	SORT1 (3.0)	SYPL2 (2.4)	ST3GAL4 (2.3)	LDLR (2.3)	MAU2 (2.1)	PPP1R37 (1.9)	NT5DC1 (1.8)
GO:0005504	fatty acid binding	0.01	<= 0.20	MOSC1 (5.0)	APOB (4.2)	APOE (3.7)	APOC1 (3.6)	APOA5 (3.6)	ACAD10 (3.1)	ALDH2 (2.9)	PLG (2.9)	GPAM (2.9)	HNF1A (2.5)
GO:0005537	mannose binding	0.01	<= 0.20	LPA (6.0)	CETP (4.8)	TIMD4 (4.4)	APOA5 (4.1)	SLC22A1 (4.0)	APOC4 (3.2)	PLG (3.2)	ERP29 (3.0)	DHODH (2.5)	ATP13A1 (2.3)
ENSG00000112936	C7 PPI subnetwork	0.01	<= 0.20	LPA (8.2)	APOC4 (7.6)	ANGPTL3 (7.6)	HP (6.4)	APOA5 (6.3)	SLC22A1 (6.3)	PLG (6.2)	APOC1 (3.7)	ABCG5 (3.4)	APOB (3.1)
GO:0044242	cellular lipid catabolic process	0.01	<= 0.20	NKPD1 (4.9)	ACAD10 (3.9)	MOSC1 (3.4)	GPAM (3.0)	NT5DC1 (2.7)	ALDH2 (2.5)	TM6SF2 (2.2)	ABCG8 (2.2)	ENSG00000238078 (2.1)	APOC4 (1.9)
REACTOME_REGULATION_OF_IFNA_SIGNALING	REACTOME_REGULATION_OF_IFNA_SIGNALING	0.01	<= 0.20	OASL (6.9)	TRAFD1 (5.0)	PARP10 (4.6)	BCL3 (3.6)	ATP13A1 (2.2)	CYP7A1 (2.1)	TMEM50A (2.1)	GOT2P1 (2.0)	NAA25 (1.9)	ZNF101 (1.8)
GO:0008170	N-methyltransferase activity	0.01	<= 0.20	QTRT1 (3.4)	DHODH (3.1)	C12orf51 (2.9)	ATXN2 (2.8)	ATP13A1 (2.6)	NAA25 (2.4)	LPA (2.3)	C19orf52 (2.2)	MAU2 (2.1)	ILF3 (2.1)
ENSG00000173372	C1QA PPI subnetwork	0.01	<= 0.20	HP (3.8)	APOE (3.2)	PLG (3.1)	ANGPTL3 (3.0)	SLC22A1 (3.0)	APOC4 (2.6)	APOA5 (2.3)	TIMD4 (2.3)	APOC1 (1.9)	LPA (1.9)
ENSG00000163806	SPDYA PPI subnetwork	0.01	<= 0.20	GATAD2A (3.3)	PTPN11 (2.4)	KANK2 (2.3)	OGDH (2.0)	SYPL2 (1.9)	SORT1 (1.7)	LPA (1.6)	DNM2 (1.6)	PLEC (1.6)	SLC44A2 (1.5)
ENSG00000164220	F2RL2 PPI subnetwork	0.01	<= 0.20	ANGPTL3 (2.9)	KANK2 (2.6)	ZHX3 (2.3)	ENSG00000238078 (2.2)	MOSC1 (2.2)	APOA5 (2.1)	APOC4 (2.0)	POC5 (1.9)	ITGB3 (1.9)	LPIN3 (1.8)
GO:0051241	negative regulation of multicellular organismal process	0.01	<= 0.20	OASL (2.6)	ALDH2 (2.0)	TIMD4 (2.0)	SH2B3 (1.9)	ANGPTL3 (1.9)	HP (1.9)	APOC4 (1.7)	CETP (1.6)	SLC22A1 (1.6)	APOB (1.6)
ENSG00000054267	ARID4B PPI subnetwork	0.01	<= 0.20	RELB (3.6)	PVRL2 (2.6)	OASL (2.6)	BCL3 (2.4)	CEACAM19 (2.2)	TRAFD1 (2.2)	POLK (2.1)	PARP10 (2.1)	GRINA (2.1)	ST3GAL4 (2.1)
MP:0000245	abnormal erythropoiesis	0.01	<= 0.20	RHD (9.4)	RHCE (8.8)	GMPR (3.1)	C12orf51 (2.9)	TMEM57 (2.9)	BCL3 (2.5)	TOP1 (2.3)	SH2B3 (2.1)	GRINA (1.9)	DNM2 (1.7)
ENSG00000187741	FANCA PPI subnetwork	0.01	<= 0.20	OASL (4.6)	TRAFD1 (3.1)	ZNF101 (2.7)	USP1 (2.6)	FEN1 (2.2)	ATP13A1 (2.0)	TOP1 (1.9)	PARP10 (1.8)	POC5 (1.7)	MAFB (1.7)
ENSG00000086189	DIMT1 PPI subnetwork	0.01	<= 0.20	DDX56 (4.9)	ZNF259 (4.4)	NAA25 (4.1)	QTRT1 (3.6)	TOMM40 (3.4)	DHX38 (3.3)	ATP13A1 (3.3)	C12orf43 (2.6)	DHODH (2.4)	USP24 (2.3)
ENSG00000165271	NOL6 PPI subnetwork	0.01	<= 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.6)	QTRT1 (4.4)	DHODH (3.9)	TOMM40 (3.8)	ATP13A1 (2.6)	DHX38 (2.5)	C12orf43 (2.5)	BRAP (2.5)
ENSG00000185057	ENSG00000185057 PPI subnetwork	0.01	<= 0.20	DDX56 (4.9)	QTRT1 (4.5)	ZNF259 (4.4)	NAA25 (4.0)	TOMM40 (3.5)	DHODH (3.2)	C12orf43 (2.8)	SUGP1 (2.4)	ATP13A1 (2.2)	DHX38 (2.2)
ENSG00000132471	WBP2 PPI subnetwork	0.01	<= 0.20	PPP1R37 (3.4)	USP24 (2.9)	ZNF180 (2.4)	DYNC2LI1 (2.4)	BCAM (2.3)	GATAD2A (2.2)	CLPTM1 (2.1)	YIPF2 (1.8)	SUGP1 (1.8)	ATXN2 (1.7)
GO:0061134	peptidase regulator activity	0.01	<= 0.20	HP (5.4)	APOB (5.1)	PLG (4.7)	APOA5 (4.4)	APOC1 (4.2)	APOC4 (3.7)	ANGPTL3 (3.5)	PCSK9 (3.3)	SLC22A1 (3.1)	GPAM (2.4)
GO:0016712	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	0.01	<= 0.20	SLC22A1 (8.7)	LPA (6.2)	ABCG5 (6.1)	ABCG8 (5.5)	TM6SF2 (5.3)	CYP7A1 (5.0)	APOC4 (4.4)	APOA5 (4.1)	NPC1L1 (3.8)	ANGPTL3 (3.7)
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	0.01	<= 0.20	ANGPTL3 (2.6)	PLG (2.4)	MOSC1 (2.3)	ATP13A1 (2.2)	CLPTM1 (2.2)	SLC22A1 (2.2)	APOC4 (2.1)	SORT1 (2.0)	HP (2.0)	APOC1 (1.9)
ENSG00000188313	PLSCR1 PPI subnetwork	0.01	<= 0.20	ACAD10 (2.7)	ATXN2 (2.7)	PVRL2 (2.6)	ABO (2.5)	CEACAM19 (2.3)	BCAM (2.1)	TMED4 (2.1)	PPP1R37 (2.0)	GRINA (2.0)	C11orf9 (2.0)
ENSG00000206172	HBA1 PPI subnetwork	0.01	<= 0.20	APOB (5.2)	PLG (4.7)	ANGPTL3 (4.5)	APOA5 (4.2)	RHCE (3.9)	APOC4 (3.8)	APOC1 (3.7)	RHD (3.2)	HP (2.9)	PCSK9 (2.8)
ENSG00000188536	HBA2 PPI subnetwork	0.01	<= 0.20	APOB (5.2)	PLG (4.7)	ANGPTL3 (4.5)	APOA5 (4.2)	RHCE (3.9)	APOC4 (3.8)	APOC1 (3.7)	RHD (3.2)	HP (2.9)	PCSK9 (2.8)
ENSG00000103942	HOMER2 PPI subnetwork	0.01	> 0.20	PLG (6.2)	ANGPTL3 (5.7)	APOB (4.8)	APOA5 (4.4)	APOC4 (4.1)	HP (3.5)	APOC1 (3.3)	SLC22A1 (2.6)	C12orf47 (2.2)	GPAM (2.2)
GO:0034369	plasma lipoprotein particle remodeling	0.01	> 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
GO:0034367	macromolecular complex remodeling	0.01	> 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
GO:0034368	protein-lipid complex remodeling	0.01	> 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
ENSG00000143815	LBR PPI subnetwork	0.01	> 0.20	HMGCR (10.8)	LDLR (8.7)	FADS1 (8.5)	FADS2 (7.7)	PCSK9 (5.9)	GRINA (2.5)	TOP1 (2.3)	NPC1L1 (2.0)	ENSG00000226645 (1.8)	ADAM1 (1.8)
GO:0034504	protein localization to nucleus	0.01	> 0.20	ENSG00000254235 (3.1)	USP24 (2.4)	MYLIP (2.3)	GATAD2A (2.1)	ZNF101 (2.0)	POLK (1.7)	OASL (1.6)	TRAFD1 (1.6)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)
MP:0002712	increased circulating glucagon level	0.01	> 0.20	APOC4 (3.2)	APOB (3.1)	APOA5 (3.1)	ABCG5 (3.1)	NPC1L1 (3.0)	CYP7A1 (3.0)	ABCG8 (2.9)	GCNT4 (2.7)	ZHX3 (2.5)	HAVCR1 (2.5)
ENSG00000197616	MYH6 PPI subnetwork	0.01	> 0.20	SYPL2 (3.2)	GMPR (2.7)	OGDH (2.5)	BCAM (2.1)	C12orf47 (2.1)	C1orf63 (2.1)	TMEM50A (1.9)	ACAD10 (1.8)	LPIN3 (1.6)	NKPD1 (1.5)
ENSG00000124610	HIST1H1A PPI subnetwork	0.01	> 0.20	TSSK6 (2.5)	GCNT4 (2.4)	MYLIP (2.1)	PSRC1 (2.1)	NPC1L1 (1.7)	POLK (1.7)	PLG (1.6)	ANGPTL3 (1.5)	TXNL4B (1.4)	C11orf9 (1.4)
ENSG00000143514	TP53BP2 PPI subnetwork	0.01	> 0.20	LPAR2 (2.7)	MARK4 (2.7)	CARM1 (2.4)	C11orf9 (2.3)	CETP (2.3)	AP1M2 (2.2)	TIMD4 (2.2)	GATAD2A (2.1)	OASL (2.0)	GRINA (1.9)
GO:0005529	GO:0005529	0.01	> 0.20	LPA (3.8)	HP (3.5)	MOSC1 (2.8)	ERP29 (2.7)	APOA5 (2.7)	SORT1 (2.2)	DHODH (2.2)	TM6SF2 (2.1)	ABCG5 (2.0)	APOC4 (2.0)
ENSG00000137642	SORL1 PPI subnetwork	0.01	> 0.20	AP1M2 (3.3)	KIAA1324 (2.8)	HNF1A (2.7)	DNM2 (2.3)	CETP (1.8)	DHX38 (1.7)	FRK (1.7)	TMED4 (1.6)	C12orf47 (1.6)	CBLC (1.5)
GO:0071375	cellular response to peptide hormone stimulus	0.01	> 0.20	COL4A3BP (2.9)	PTPN11 (2.9)	SORT1 (2.4)	TMEM57 (2.0)	ENSG00000254235 (2.0)	USP24 (1.9)	MOSC1 (1.8)	GPAM (1.7)	BRAP (1.6)	GRINA (1.6)
ENSG00000161618	ALDH16A1 PPI subnetwork	0.01	> 0.20	PLG (6.2)	APOB (5.6)	APOA5 (5.4)	ANGPTL3 (5.3)	APOC4 (5.3)	HP (3.6)	APOC1 (3.1)	CYP7A1 (3.0)	UBXN2B (2.5)	ABCG5 (2.1)
ENSG00000148498	PARD3 PPI subnetwork	0.01	> 0.20	CBLC (4.0)	MARK4 (3.2)	AP1M2 (2.8)	PSRC1 (2.4)	LPAR2 (2.4)	KANK2 (1.9)	UBXN2B (1.8)	COL4A3BP (1.8)	CELSR2 (1.7)	DNM2 (1.7)
GO:0008831	dTDP-4-dehydrorhamnose reductase activity	0.01	> 0.20	HMGCR (4.6)	LDLR (3.6)	FADS2 (3.5)	FADS1 (3.1)	PCSK9 (2.9)	NT5DC1 (2.9)	TMEM50A (2.5)	TRAPPC6A (2.0)	BLOC1S3 (2.0)	YIPF2 (1.9)
MP:0002079	increased circulating insulin level	0.01	> 0.20	GPAM (6.2)	MOSC1 (4.4)	NPC1L1 (2.7)	KIAA1324 (2.7)	ENSG00000254235 (2.4)	APOA5 (2.3)	TM6SF2 (2.2)	ABCG5 (2.1)	GCNT4 (1.9)	TIMD4 (1.7)
ENSG00000133958	UNC79 PPI subnetwork	0.01	> 0.20	ANGPTL3 (3.6)	KANK2 (2.8)	DYNC2LI1 (2.7)	APOC4 (2.1)	APOB (2.0)	APOC1 (1.9)	ZNF180 (1.9)	APOA5 (1.8)	MARK4 (1.8)	SLC22A1 (1.7)
ENSG00000130208	APOC1 PPI subnetwork	0.01	> 0.20	APOB (5.0)	APOC4 (3.4)	PLG (3.3)	APOA5 (3.2)	NPC1L1 (3.1)	ANGPTL3 (3.0)	APOC1 (2.7)	APOE (2.6)	ABCG5 (2.4)	HP (2.4)
MP:0008813	decreased common myeloid progenitor cell number	0.01	> 0.20	RHD (2.8)	ITGB3 (2.8)	KANK2 (2.4)	CETP (2.3)	LPA (2.0)	C12orf51 (1.9)	RHCE (1.9)	TOP1 (1.8)	ATXN2 (1.7)	RELB (1.6)
ENSG00000169251	NMD3 PPI subnetwork	0.01	> 0.20	ZNF259 (4.9)	DHODH (3.6)	SUGP1 (3.5)	QTRT1 (3.4)	NAA25 (3.4)	DDX56 (3.4)	DHX38 (3.2)	TOMM40 (3.0)	ATP13A1 (3.0)	ENSG00000226645 (2.2)
MP:0003727	abnormal retinal layer morphology	0.01	> 0.20	MYLIP (4.4)	GEMIN7 (2.5)	SH2B3 (2.4)	MOSC1 (2.3)	APOC4 (2.2)	ABO (2.0)	PVRL2 (1.8)	CYP7A1 (1.6)	PPP1R37 (1.6)	BCAM (1.6)
ENSG00000163743	RCHY1 PPI subnetwork	0.01	> 0.20	PPP1R37 (2.6)	ITGB3 (2.4)	PBX4 (2.4)	MYLIP (2.2)	GMPR (2.0)	RHD (1.9)	DNAH11 (1.9)	FADS2 (1.8)	BCAM (1.6)	FRK (1.4)
ENSG00000162645	GBP2 PPI subnetwork	0.01	> 0.20	GEMIN7 (3.1)	TRAPPC6A (2.8)	APOE (2.1)	PVRL2 (2.1)	ZNF180 (2.0)	C11orf9 (1.7)	GCNT4 (1.6)	ENSG00000254235 (1.5)	DOCK7 (1.5)	FRK (1.4)
ENSG00000086619	ERO1LB PPI subnetwork	0.01	> 0.20	DDX56 (4.3)	NAA25 (4.1)	QTRT1 (3.9)	ZNF259 (3.9)	TOMM40 (3.6)	DHODH (3.1)	TOP1 (2.7)	ATP13A1 (2.5)	PSMA5 (2.1)	HMGCR (2.1)
ENSG00000141510	TP53 PPI subnetwork	0.01	> 0.20	TRIB1 (3.5)	FEN1 (2.8)	USP1 (2.7)	PSRC1 (2.6)	ILF3 (2.0)	BUD13 (1.7)	TOP1 (1.7)	BCL3 (1.5)	GRINA (1.5)	MYLIP (1.4)
ENSG00000196415	PRTN3 PPI subnetwork	0.01	> 0.20	HP (4.2)	ALDH2 (2.8)	BCL3 (2.8)	PVR (2.7)	RELB (2.3)	HLX (2.1)	ENSG00000228044 (2.1)	GMIP (1.9)	APOC1 (1.6)	MAFB (1.5)
GO:0043178	alcohol binding	0.01	> 0.20	APOC4 (4.5)	PLG (3.9)	TIMD4 (3.4)	LPA (3.3)	ANGPTL3 (3.2)	HP (2.9)	APOB (2.8)	MOSC1 (2.7)	SLC22A1 (2.6)	ABCG5 (2.5)
ENSG00000118785	SPP1 PPI subnetwork	0.01	> 0.20	APOE (3.1)	PTPN11 (2.4)	PVR (2.3)	ITGB3 (2.3)	CARM1 (2.0)	C17orf57 (1.9)	APOC1 (1.8)	GMPR (1.8)	APOC4 (1.7)	PLG (1.7)
GO:0000790	nuclear chromatin	0.01	> 0.20	CARM1 (2.7)	ATXN2 (2.7)	MAFB (2.5)	ATXN7L2 (2.5)	BUD13 (2.3)	TOP1 (2.2)	ILF3 (2.2)	MARK4 (2.2)	MAPKAPK5 (2.1)	NYNRIN (1.9)
MP:0005331	insulin resistance	0.01	> 0.20	GPAM (5.5)	MOSC1 (3.4)	NPC1L1 (3.2)	PCSK9 (2.6)	APOC1 (2.5)	USP24 (2.3)	PLEC (2.1)	SYPL2 (2.0)	GCNT4 (1.9)	TM6SF2 (1.8)
GO:0070875	positive regulation of glycogen metabolic process	0.01	> 0.20	LPA (2.4)	MYLIP (1.6)	ENSG00000226645 (1.6)	PPP1R37 (1.6)	ENSG00000228044 (1.5)	GPAM (1.5)	ZHX3 (1.4)	PBX4 (1.3)	ZNF180 (1.3)	TMEM116 (1.2)
ENSG00000145192	AHSG PPI subnetwork	0.01	> 0.20	ANGPTL3 (6.6)	PLG (6.4)	APOC4 (5.1)	APOA5 (4.7)	APOB (4.4)	APOC1 (3.6)	HP (3.4)	CYP7A1 (2.8)	SLC22A1 (2.3)	PCSK9 (2.3)
MP:0003436	decreased susceptibility to induced arthritis	0.01	> 0.20	GMIP (3.3)	MAFB (3.0)	HLX (2.7)	BCL3 (2.6)	CYP7A1 (2.4)	HP (2.3)	SH2B3 (2.2)	MYLIP (2.1)	RELB (2.0)	TRIB1 (1.8)
GO:0033365	protein localization to organelle	0.01	> 0.20	USP24 (2.2)	GOT2P1 (1.9)	ZNF101 (1.8)	BLOC1S3 (1.7)	AMIGO1 (1.7)	POLK (1.6)	MAU2 (1.5)	PTPN11 (1.5)	GATAD2A (1.5)	YIPF2 (1.4)
REACTOME_REGULATION_OF_BETA:CELL_DEVELOPMENT	REACTOME_REGULATION_OF_BETA:CELL_DEVELOPMENT	0.01	> 0.20	ABO (3.8)	KIAA1324 (3.5)	HNF1A (3.2)	CYP7A1 (2.9)	C11orf9 (2.8)	PCSK9 (2.6)	ABCG8 (2.5)	NPC1L1 (2.5)	TM6SF2 (2.3)	HAPLN4 (1.9)
MP:0008807	increased liver iron level	0.01	> 0.20	RHD (11.5)	RHCE (10.3)	HP (4.1)	GMPR (2.9)	TIMD4 (2.0)	C12orf51 (1.8)	CETP (1.8)	APOA5 (1.6)	APOC1 (1.6)	APOC4 (1.5)
GO:0014070	response to organic cyclic compound	0.01	> 0.20	ENSG00000235545 (3.0)	LDLR (2.0)	FADS2 (1.9)	ANKRD31 (1.9)	PCSK9 (1.8)	CYP7A1 (1.7)	TRIB1 (1.7)	MAFB (1.6)	POLK (1.5)	ALDH2 (1.4)
MP:0005584	abnormal enzyme/coenzyme activity	0.01	> 0.20	GPAM (3.5)	APOC1 (2.6)	HP (2.6)	TM6SF2 (2.4)	PVR (2.2)	GOT2P1 (2.1)	SLC22A1 (2.0)	ALDH2 (2.0)	USP24 (1.5)	ABCG8 (1.5)
GO:0006633	fatty acid biosynthetic process	0.01	> 0.20	FADS2 (4.7)	FADS1 (4.6)	NKPD1 (3.9)	PCSK9 (3.5)	HMGCR (3.3)	LDLR (3.0)	ALDH2 (2.4)	TRAPPC6A (2.4)	CYB561D1 (2.3)	GMPR (2.3)
KEGG_RETINOL_METABOLISM	KEGG_RETINOL_METABOLISM	0.01	> 0.20	LPA (7.1)	ABCG5 (7.1)	SLC22A1 (6.9)	CYP7A1 (6.2)	ABCG8 (5.9)	TM6SF2 (5.8)	APOC4 (5.5)	APOA5 (4.7)	ANGPTL3 (4.0)	NPC1L1 (3.5)
ENSG00000082781	ITGB5 PPI subnetwork	0.01	> 0.20	ITGB3 (3.5)	KANK2 (3.3)	PLEC (3.1)	PVR (2.6)	PVRL2 (2.6)	APOE (2.5)	SH2B3 (2.0)	FRK (1.7)	PPP1R37 (1.7)	MAFB (1.7)
GO:0042737	drug catabolic process	0.01	> 0.20	LPA (6.6)	SLC22A1 (6.5)	TM6SF2 (4.5)	ABCG8 (4.0)	ABCG5 (3.8)	NPC1L1 (3.5)	GCNT4 (3.4)	CYP7A1 (2.2)	APOA5 (2.0)	APOC4 (2.0)
GO:0042991	transcription factor import into nucleus	0.01	> 0.20	ENSG00000235545 (3.0)	LPAR2 (2.5)	MYLIP (2.4)	ABO (2.3)	OASL (2.3)	ZNF101 (2.1)	GCNT4 (1.9)	PARP10 (1.8)	ENSG00000226645 (1.8)	SH2B3 (1.6)
GO:0008198	ferrous iron binding	0.01	> 0.20	RHCE (6.2)	RHD (6.1)	GMPR (3.2)	APOC1 (2.9)	APOC4 (2.8)	APOE (2.2)	GEMIN7 (2.2)	ZNF180 (2.1)	C12orf51 (2.0)	ABCG5 (2.0)
GO:0006606	protein import into nucleus	0.01	> 0.20	ENSG00000254235 (2.8)	ENSG00000235545 (2.2)	USP24 (2.1)	GATAD2A (2.0)	MYLIP (1.7)	BLOC1S3 (1.7)	OASL (1.6)	NAA25 (1.6)	TRAFD1 (1.6)	PLCG1 (1.5)
GO:0004806	triglyceride lipase activity	0.01	> 0.20	MOSC1 (3.9)	GPAM (3.2)	PMFBP1 (2.1)	KIAA1324 (2.0)	NPC1L1 (2.0)	APOC1 (1.9)	TM6SF2 (1.8)	APOC4 (1.6)	CYP7A1 (1.4)	HP (1.4)
ENSG00000120693	SMAD9 PPI subnetwork	0.01	> 0.20	PLEC (2.7)	CLPTM1 (2.6)	ATP13A1 (2.3)	MAFB (2.2)	PPP1R37 (2.1)	MAU2 (2.1)	TRIB1 (2.1)	CYB561D1 (2.0)	YIPF2 (1.9)	DNM2 (1.8)
MP:0008596	increased circulating interleukin-6 level	0.01	> 0.20	TRIB1 (3.8)	PARP10 (3.7)	CETP (3.1)	OASL (3.0)	BCL3 (2.8)	HLX (2.4)	GMIP (2.4)	SH2B3 (2.3)	TRAFD1 (2.1)	FADS2 (2.0)
GO:0006631	fatty acid metabolic process	0.01	> 0.20	ACAD10 (4.2)	FADS2 (3.4)	FADS1 (3.2)	NKPD1 (3.0)	GPAM (3.0)	ALDH2 (2.7)	MOSC1 (2.7)	TRAPPC6A (2.6)	CYP7A1 (2.2)	HMGCR (2.2)
ENSG00000118922	KLF12 PPI subnetwork	0.01	> 0.20	PSRC1 (2.5)	ENSG00000228044 (2.1)	USP1 (2.1)	DOCK7 (2.0)	POC5 (2.0)	ILF3 (1.9)	ENSG00000226648 (1.9)	C12orf51 (1.9)	BRAP (1.8)	CYB561D1 (1.8)
ENSG00000007264	MATK PPI subnetwork	0.01	> 0.20	ITGB3 (3.5)	PLEC (2.7)	GMIP (2.4)	SLC44A2 (2.4)	ST3GAL4 (2.3)	OGDH (2.2)	MAFB (1.9)	LPAR2 (1.8)	BCAM (1.8)	C17orf57 (1.7)
MP:0001654	hepatic necrosis	0.01	> 0.20	LPA (5.4)	SLC22A1 (4.9)	APOA5 (4.1)	ANGPTL3 (3.9)	APOC4 (3.8)	CETP (3.5)	ITGB3 (3.2)	PLG (3.2)	CYP7A1 (3.1)	BCL3 (2.4)
GO:0006725	cellular aromatic compound metabolic process	0.01	> 0.20	LPA (3.7)	CYP7A1 (3.7)	SLC22A1 (3.4)	ENSG00000254235 (2.7)	ANKRD31 (2.5)	ABCG8 (2.5)	DHODH (2.4)	TM6SF2 (2.3)	TRAPPC6A (2.1)	ABCG5 (2.1)
GO:0045833	negative regulation of lipid metabolic process	0.01	> 0.20	TRAPPC6A (2.1)	ENSG00000228044 (2.0)	GPAM (1.9)	NPC1L1 (1.8)	PPP1R37 (1.6)	CETP (1.5)	APOC1 (1.5)	C12orf47 (1.5)	TXNL4B (1.4)	FADS1 (1.4)
ENSG00000115415	STAT1 PPI subnetwork	0.01	> 0.20	PARP10 (4.8)	BCL3 (4.2)	TRAFD1 (4.1)	RELB (3.6)	OASL (3.5)	HLX (3.0)	TRIB1 (2.5)	SH2B3 (2.4)	TMEM50A (2.4)	MAU2 (2.2)
ENSG00000156127	BATF PPI subnetwork	0.01	> 0.20	TRIB1 (6.4)	BCL3 (3.5)	SARS (3.4)	MAFB (3.2)	PARP10 (2.7)	HLX (2.5)	MAPKAPK5 (2.3)	POC5 (2.0)	TRAFD1 (1.9)	GRINA (1.7)
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	0.01	> 0.20	ITGB3 (5.6)	APOB (4.9)	ANGPTL3 (4.2)	APOC1 (4.1)	HAVCR1 (3.7)	HP (3.6)	PLG (3.6)	APOA5 (3.3)	APOC4 (3.0)	PCSK9 (2.5)
MP:0002810	microcytic anemia	0.01	> 0.20	RHD (9.5)	RHCE (7.7)	TIMD4 (3.6)	GMPR (3.1)	MAFB (2.9)	CETP (2.5)	BCL3 (1.9)	HP (1.9)	C12orf51 (1.8)	TMEM57 (1.6)
ENSG00000137801	THBS1 PPI subnetwork	0.01	> 0.20	ANGPTL3 (4.5)	APOC4 (4.2)	PLG (3.7)	HP (3.3)	ITGB3 (3.2)	APOE (3.1)	APOA5 (3.1)	CYP7A1 (2.7)	APOC1 (2.6)	KANK2 (2.3)
ENSG00000213764	ENSG00000213764 PPI subnetwork	0.01	> 0.20	TRAPPC6A (2.7)	TMEM50A (2.6)	QTRT1 (2.3)	LPA (2.3)	FADS2 (2.2)	LDLR (2.0)	GEMIN7 (1.9)	CYB561D1 (1.9)	CLPTM1 (1.9)	HAVCR1 (1.8)
ENSG00000196459	TRAPPC2 PPI subnetwork	0.01	> 0.20	TRAPPC6A (2.7)	TMEM50A (2.6)	QTRT1 (2.3)	LPA (2.3)	FADS2 (2.2)	LDLR (2.0)	GEMIN7 (1.9)	CYB561D1 (1.9)	CLPTM1 (1.9)	HAVCR1 (1.8)
GO:0010874	regulation of cholesterol efflux	0.01	> 0.20	TIMD4 (4.8)	GEMIN7 (3.5)	APOC1 (3.2)	ENSG00000238078 (3.2)	MYLIP (2.8)	APOE (2.2)	NKPD1 (2.1)	ST3GAL4 (1.8)	GPAM (1.8)	CETP (1.8)
ENSG00000136205	TNS3 PPI subnetwork	0.01	> 0.20	TIMD4 (3.4)	APOE (2.5)	MAFB (2.1)	FADS2 (2.1)	BCAM (2.0)	PSRC1 (1.9)	ALDH2 (1.8)	DOCK7 (1.8)	AMIGO1 (1.7)	CYP7A1 (1.7)
GO:0055102	lipase inhibitor activity	0.01	> 0.20	APOB (5.4)	HP (4.2)	PLG (4.0)	APOC4 (3.5)	APOE (3.2)	APOA5 (3.2)	ANGPTL3 (2.9)	APOC1 (2.5)	PVR (2.3)	CYP7A1 (2.3)
GO:0015908	fatty acid transport	0.01	> 0.20	NKPD1 (2.9)	TM6SF2 (2.7)	CYB561D1 (2.6)	ACAD10 (2.1)	AMIGO1 (2.0)	ABCG8 (2.0)	OGDH (1.9)	LPIN3 (1.8)	MOSC1 (1.6)	ABCG5 (1.5)
ENSG00000172216	CEBPB PPI subnetwork	0.01	> 0.20	BCL3 (3.7)	CARM1 (3.6)	TRIB1 (3.5)	RELB (3.5)	GRINA (3.2)	ATXN2 (3.2)	GMIP (2.4)	HLX (2.0)	SARS (2.0)	PLEC (1.9)
GO:0019903	protein phosphatase binding	0.01	> 0.20	DNM2 (3.2)	PPP1R37 (2.6)	COL4A3BP (2.2)	PVRL2 (2.1)	CLPTM1 (2.1)	SLC44A2 (2.1)	BRAP (2.0)	C11orf9 (1.8)	ENSG00000235545 (1.7)	BCAM (1.6)
ENSG00000205572	SERF1B PPI subnetwork	0.01	> 0.20	ILF3 (3.5)	DHX38 (2.9)	SUGP1 (2.9)	QTRT1 (2.7)	DDX56 (2.5)	PLCG1 (2.5)	SMARCA4 (2.4)	BUD13 (2.3)	MAU2 (2.2)	ADAM1 (2.2)
ENSG00000172058	SERF1A PPI subnetwork	0.01	> 0.20	ILF3 (3.5)	DHX38 (2.9)	SUGP1 (2.9)	QTRT1 (2.7)	DDX56 (2.5)	PLCG1 (2.5)	SMARCA4 (2.4)	BUD13 (2.3)	MAU2 (2.2)	ADAM1 (2.2)
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	0.01	> 0.20	POC5 (3.1)	DOCK7 (3.0)	DDX56 (3.0)	NAA25 (3.0)	USP1 (2.7)	BUD13 (2.6)	USP24 (2.6)	MAPKAPK5 (2.1)	ILF3 (2.0)	DHX38 (2.0)
GO:0070330	aromatase activity	0.01	> 0.20	SLC22A1 (8.3)	LPA (5.7)	ABCG8 (5.4)	ABCG5 (5.4)	TM6SF2 (4.9)	CYP7A1 (4.2)	NPC1L1 (3.6)	APOA5 (3.4)	ANGPTL3 (3.3)	APOC4 (3.2)
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.01	> 0.20	OASL (10.1)	PARP10 (5.7)	RELB (4.4)	TRAFD1 (4.3)	BCL3 (3.1)	CYP7A1 (2.2)	ZNF101 (2.2)	ZNF180 (2.2)	PVR (2.2)	CYB561D1 (2.0)
GO:0018200	peptidyl-glutamic acid modification	0.01	> 0.20	HNF1A (3.9)	ABO (3.9)	LPA (3.5)	ANGPTL3 (2.8)	SLC22A1 (2.8)	APOC4 (2.7)	ADAM1 (2.7)	DNAH11 (2.5)	PLG (2.5)	APOA5 (2.4)
MP:0004567	decreased myocardial fiber number	0.01	> 0.20	KANK2 (3.6)	BCAM (2.4)	MYLIP (1.9)	PLEC (1.8)	CYB561D1 (1.7)	ITGB3 (1.7)	AP1M2 (1.6)	SORT1 (1.6)	CBLC (1.5)	PVRL2 (1.5)
ENSG00000131018	SYNE1 PPI subnetwork	0.01	> 0.20	TIMD4 (3.9)	OASL (3.4)	CETP (3.4)	GMPR (2.6)	DNAH11 (2.5)	KANK2 (2.3)	BLOC1S3 (2.2)	NKPD1 (1.9)	GOT2P1 (1.8)	BCAM (1.7)
ENSG00000182636	NDN PPI subnetwork	0.01	> 0.20	YIPF2 (3.3)	LDLR (3.2)	FADS1 (2.9)	HMGCR (2.7)	ATP13A1 (2.5)	FADS2 (2.3)	CLPTM1 (2.3)	GOT2P1 (2.1)	ERP29 (2.0)	PVRL2 (2.0)
ENSG00000100105	PATZ1 PPI subnetwork	0.01	> 0.20	TIMD4 (3.7)	OASL (3.6)	CETP (3.4)	PLEKHH2 (2.1)	TMEM57 (2.1)	HNF1A (1.9)	C1orf63 (1.8)	ENSG00000226648 (1.5)	TMEM116 (1.4)	TXNL4B (1.4)
ENSG00000074800	ENO1 PPI subnetwork	0.01	> 0.20	UBXN2B (4.0)	ANGPTL3 (3.1)	APOC4 (3.0)	CYP7A1 (3.0)	MOSC1 (2.8)	C19orf52 (2.4)	PLEC (2.1)	ENSG00000238078 (2.1)	SLC22A1 (1.6)	PSMA5 (1.5)
ENSG00000112159	MDN1 PPI subnetwork	0.01	> 0.20	ZNF259 (4.8)	TOMM40 (4.8)	NAA25 (4.7)	DDX56 (4.5)	QTRT1 (3.4)	SUGP1 (3.1)	PSMA5 (3.1)	DHX38 (3.0)	DHODH (2.5)	ATP13A1 (2.3)
ENSG00000100714	MTHFD1 PPI subnetwork	0.01	> 0.20	SARS (4.6)	NAA25 (2.7)	ACAD10 (2.2)	FADS2 (1.9)	QTRT1 (1.8)	DDX56 (1.8)	ILF3 (1.8)	LDLR (1.8)	ATP13A1 (1.7)	HMGCR (1.6)
ENSG00000204435	CSNK2B PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
ENSG00000206406	CSNK2B PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
ENSG00000206300	ENSG00000206300 PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
MP:0001718	abnormal visceral yolk sac morphology	0.01	> 0.20	APOB (4.1)	C11orf9 (3.3)	HNF1A (3.2)	APOA5 (2.8)	NPC1L1 (2.5)	SH2B3 (2.2)	KANK2 (2.0)	HP (2.0)	ATXN2 (1.8)	PLG (1.7)
ENSG00000108821	COL1A1 PPI subnetwork	0.01	> 0.20	ITGB3 (5.7)	ST3GAL4 (2.9)	CETP (2.9)	APOE (2.9)	TIMD4 (2.0)	KANK2 (1.9)	MAFB (1.6)	C17orf57 (1.5)	CBLC (1.5)	GMPR (1.4)
ENSG00000187837	HIST1H1C PPI subnetwork	0.01	> 0.20	C1orf63 (2.8)	PSRC1 (2.7)	USP1 (2.5)	ILF3 (2.4)	TOP1 (2.3)	ERP29 (2.0)	ACAD10 (1.9)	TMEM50A (1.8)	USP24 (1.8)	SMARCA4 (1.7)
ENSG00000140848	CPNE2 PPI subnetwork	0.01	> 0.20	TOMM40 (3.7)	CLPTM1 (3.0)	GEMIN7 (2.8)	TMEM57 (2.6)	ZNF180 (2.4)	DNM2 (2.3)	GOT2P1 (2.2)	ADAM1 (2.2)	PSRC1 (2.1)	KANK2 (2.0)
GO:0006662	glycerol ether metabolic process	0.01	> 0.20	GPAM (4.4)	MOSC1 (4.3)	PCSK9 (3.6)	FADS1 (3.5)	NPC1L1 (3.4)	FADS2 (3.3)	HMGCR (3.2)	TM6SF2 (3.0)	LDLR (2.7)	HP (2.2)
ENSG00000132464	ENAM PPI subnetwork	0.01	> 0.20	PLG (3.3)	APOB (3.3)	CILP2 (3.2)	ERP29 (3.1)	ANGPTL3 (3.0)	TMEM50A (2.6)	HP (2.5)	APOC1 (2.4)	SLC22A1 (2.3)	CLPTM1 (2.3)
ENSG00000082701	GSK3B PPI subnetwork	0.01	> 0.20	TRIB1 (2.9)	PLEC (2.9)	DNM2 (2.9)	ILF3 (2.5)	LDLR (2.4)	DOCK7 (2.4)	GATAD2A (2.4)	MARK4 (2.2)	PTPN11 (2.1)	ZHX3 (1.9)
GO:0016064	immunoglobulin mediated immune response	0.01	> 0.20	LPA (3.6)	SLC22A1 (3.4)	TIMD4 (3.1)	APOC4 (2.6)	APOE (2.5)	DHODH (2.2)	ANGPTL3 (2.2)	CETP (2.0)	APOA5 (1.9)	DYNC2LI1 (1.8)
GO:0019724	B cell mediated immunity	0.01	> 0.20	LPA (3.5)	SLC22A1 (3.3)	TIMD4 (3.1)	APOC4 (2.5)	APOE (2.5)	ANGPTL3 (2.2)	DHODH (2.1)	CETP (2.0)	APOA5 (1.9)	HP (1.7)
ENSG00000073578	SDHA PPI subnetwork	0.01	> 0.20	GEMIN7 (2.3)	ATXN7L2 (2.2)	BRAP (1.9)	OGDH (1.8)	LPIN3 (1.7)	RELB (1.6)	RHCE (1.6)	ZNF259 (1.5)	BUD13 (1.5)	GOT2P1 (1.4)
ENSG00000002834	LASP1 PPI subnetwork	0.01	> 0.20	PLG (5.6)	APOB (5.2)	ANGPTL3 (4.9)	APOA5 (4.6)	APOC4 (4.4)	HP (3.1)	APOC1 (2.4)	GOT2P1 (2.3)	UBXN2B (2.2)	ABCG5 (2.2)
GO:0046718	viral entry into host cell	0.01	> 0.20	CETP (3.7)	ENSG00000228044 (3.0)	GCNT4 (2.8)	SLC44A2 (2.7)	PVR (2.4)	NKPD1 (2.3)	TIMD4 (2.2)	GEMIN7 (2.0)	CBLC (2.0)	LPA (1.9)
MP:0001152	Leydig cell hyperplasia	0.01	> 0.20	ST3GAL4 (3.9)	TSSK6 (2.3)	HNF1A (1.8)	LPIN3 (1.8)	C12orf47 (1.8)	ZNF180 (1.7)	NYNRIN (1.5)	ATXN7L2 (1.5)	ABO (1.4)	DHODH (1.4)
MP:0002413	abnormal megakaryocyte progenitor cell morphology	0.01	> 0.20	ABCG8 (4.1)	SH2B3 (3.2)	GMPR (3.0)	ITGB3 (2.8)	RHCE (2.4)	BCL3 (2.2)	NYNRIN (2.2)	FADS2 (2.1)	SLC44A2 (2.1)	HAPLN4 (1.6)
ENSG00000148843	PDCD11 PPI subnetwork	0.01	> 0.20	ZNF259 (5.1)	NAA25 (5.0)	DDX56 (4.5)	QTRT1 (4.1)	TOMM40 (3.7)	DHODH (3.1)	C12orf43 (2.7)	DHX38 (2.6)	TOP1 (2.3)	MAPKAPK5 (2.3)
ENSG00000164251	F2RL1 PPI subnetwork	0.01	> 0.20	HP (5.6)	MOSC1 (3.1)	ANGPTL3 (2.9)	RHD (2.9)	APOC4 (2.5)	APOA5 (2.4)	AP1M2 (2.3)	PBX4 (2.2)	CBLC (2.1)	CYP7A1 (2.0)
GO:0003712	transcription cofactor activity	0.01	> 0.20	ATXN2 (3.1)	BUD13 (2.7)	NYNRIN (2.6)	MAPKAPK5 (2.5)	TMEM57 (2.5)	TRIB1 (2.5)	SMARCA4 (2.4)	CARM1 (2.4)	ATXN7L2 (2.2)	MAU2 (2.2)
MP:0005293	impaired glucose tolerance	0.02	> 0.20	KIAA1324 (4.5)	GPAM (3.3)	MOSC1 (2.7)	AMIGO1 (2.1)	TRIB1 (2.0)	TMEM57 (1.9)	GCNT4 (1.9)	NPC1L1 (1.8)	LDLR (1.7)	PVR (1.7)
GO:0032787	monocarboxylic acid metabolic process	0.02	> 0.20	CYP7A1 (4.1)	ACAD10 (3.7)	FADS2 (3.2)	GPAM (3.1)	SLC22A1 (3.0)	ALDH2 (2.9)	FADS1 (2.9)	APOC4 (2.7)	LPA (2.7)	TRAPPC6A (2.6)
ENSG00000092208	GEMIN2 PPI subnetwork	0.02	> 0.20	PSMA5 (3.2)	QTRT1 (3.1)	TOMM40 (3.0)	ILF3 (2.6)	BUD13 (2.2)	ZNF180 (2.1)	DDX56 (2.1)	USP1 (1.9)	ATXN7L2 (1.8)	ATP13A1 (1.7)
MP:0009413	skeletal muscle fiber atrophy	0.02	> 0.20	SYPL2 (3.7)	APOC4 (2.5)	CYP7A1 (2.4)	UBXN2B (2.4)	KANK2 (2.2)	ANGPTL3 (1.9)	C11orf9 (1.8)	NCAN (1.7)	GOT2P1 (1.7)	GMPR (1.6)
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	0.02	> 0.20	PLG (6.0)	ANGPTL3 (5.8)	SLC22A1 (5.2)	APOA5 (5.1)	CYP7A1 (4.6)	APOC4 (4.1)	LPA (4.1)	MOSC1 (3.5)	TM6SF2 (3.4)	SARS (3.2)
MP:0001698	decreased embryo size	0.02	> 0.20	PVRL2 (2.9)	ATXN2 (2.8)	PTPN11 (2.5)	LDLR (2.4)	GATAD2A (2.2)	DOCK7 (2.2)	NYNRIN (2.1)	SMARCA4 (1.9)	USP24 (1.9)	TOP1 (1.8)
ENSG00000123416	TUBA1B PPI subnetwork	0.02	> 0.20	OGDH (3.1)	PLEC (2.9)	SARS (2.5)	GRINA (2.0)	CLPTM1 (1.8)	C17orf57 (1.8)	CARM1 (1.8)	C12orf51 (1.7)	NAA25 (1.7)	ATP13A1 (1.7)
ENSG00000081019	RSBN1 PPI subnetwork	0.02	> 0.20	C19orf52 (2.7)	SUGP1 (2.1)	QTRT1 (2.1)	PARP10 (2.1)	BRAP (1.9)	OASL (1.9)	GRINA (1.8)	CLPTM1 (1.8)	YIPF2 (1.8)	DHX38 (1.7)
MP:0005508	abnormal skeleton morphology	0.02	> 0.20	CILP2 (4.0)	TRIB1 (3.0)	MAFB (2.5)	PLEKHH2 (2.4)	LDLR (2.3)	NYNRIN (2.2)	TMEM57 (1.9)	APOE (1.9)	MYLIP (1.9)	KANK2 (1.8)
GO:0051059	NF-kappaB binding	0.02	> 0.20	RELB (4.5)	ENSG00000226645 (2.7)	BCL3 (2.3)	PARP10 (2.2)	ZNF259 (2.1)	GMIP (2.0)	GRINA (2.0)	GCNT4 (2.0)	BRAP (1.9)	BUD13 (1.7)
GO:0019915	lipid storage	0.02	> 0.20	APOE (3.1)	APOC1 (2.9)	MOSC1 (2.9)	ENSG00000238078 (2.7)	COL4A3BP (2.5)	GPAM (2.5)	ABCG8 (2.2)	CETP (2.0)	NKPD1 (1.9)	ABCG5 (1.9)
ENSG00000039537	C6 PPI subnetwork	0.02	> 0.20	PLG (8.3)	ANGPTL3 (7.5)	APOC4 (7.1)	APOA5 (6.5)	LPA (6.5)	HP (5.4)	SLC22A1 (5.4)	APOC1 (4.4)	APOB (3.8)	ABCG5 (3.4)
GO:2001056	positive regulation of cysteine-type endopeptidase activity	0.02	> 0.20	POLK (3.7)	TRAFD1 (2.5)	GOT2P1 (2.4)	BLOC1S3 (2.2)	C17orf57 (2.2)	OASL (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PARP10 (1.7)	TRAPPC6A (1.7)
GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	0.02	> 0.20	POLK (3.7)	TRAFD1 (2.5)	GOT2P1 (2.4)	BLOC1S3 (2.2)	C17orf57 (2.2)	OASL (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PARP10 (1.7)	TRAPPC6A (1.7)
ENSG00000125835	SNRPB PPI subnetwork	0.02	> 0.20	ILF3 (3.9)	C1orf63 (3.1)	TOP1 (3.0)	DHX38 (2.9)	BUD13 (2.8)	SMARCA4 (2.8)	USP1 (2.6)	PSMA5 (2.1)	PTPN11 (1.9)	FEN1 (1.9)
ENSG00000107796	ACTA2 PPI subnetwork	0.02	> 0.20	SYPL2 (4.8)	ITGB3 (3.9)	NPC1L1 (3.0)	UBXN2B (2.8)	ANGPTL3 (2.3)	C12orf51 (2.2)	TOP1 (1.9)	TM6SF2 (1.9)	USP24 (1.8)	APOB (1.7)
ENSG00000182367	ENSG00000182367 PPI subnetwork	0.02	> 0.20	DHX38 (3.6)	USP1 (2.3)	SMARCA4 (2.2)	TOP1 (2.2)	MAU2 (2.2)	PLCG1 (2.1)	ILF3 (2.1)	BUD13 (2.1)	ATP13A1 (2.1)	TRAFD1 (1.9)
ENSG00000149357	LAMTOR1 PPI subnetwork	0.02	> 0.20	ACAD10 (4.6)	NT5DC1 (3.3)	OGDH (2.6)	HNF1A (2.6)	TMED4 (2.4)	TRAPPC6A (2.3)	GMPR (2.0)	C1orf63 (1.8)	GCNT4 (1.7)	CETP (1.6)
ENSG00000137656	BUD13 PPI subnetwork	0.02	> 0.20	BUD13 (4.3)	BRAP (3.6)	SUGP1 (3.4)	BLOC1S3 (2.3)	ZNF259 (2.3)	POC5 (2.3)	C19orf52 (2.3)	DHX38 (2.3)	ZNF180 (2.3)	USP1 (2.2)
ENSG00000132825	PPP1R3D PPI subnetwork	0.02	> 0.20	CBLC (5.5)	AP1M2 (3.7)	PVRL2 (2.3)	CELSR2 (1.9)	ZNF180 (1.9)	MARK4 (1.8)	ST3GAL4 (1.7)	DHODH (1.7)	MOSC1 (1.6)	PTPN11 (1.6)
ENSG00000105220	GPI PPI subnetwork	0.02	> 0.20	OGDH (3.6)	CYP7A1 (2.2)	TOMM40 (2.2)	TMED4 (2.1)	ZNF180 (2.1)	SARS (1.9)	GRINA (1.7)	CLPTM1 (1.7)	ABCG8 (1.5)	GOT2P1 (1.5)
MP:0001881	abnormal mammary gland physiology	0.02	> 0.20	PLEKHH2 (3.1)	C11orf9 (2.3)	HNF1A (2.2)	PARP10 (2.0)	ENSG00000238078 (2.0)	GPAM (1.8)	ENSG00000228044 (1.7)	RHD (1.6)	CYP7A1 (1.6)	AMIGO1 (1.5)
ENSG00000104549	SQLE PPI subnetwork	0.02	> 0.20	HMGCR (10.9)	LDLR (9.9)	FADS2 (8.3)	FADS1 (8.1)	PCSK9 (7.3)	CYP7A1 (3.7)	SLC22A1 (3.7)	NPC1L1 (3.4)	PLG (3.1)	TM6SF2 (3.0)
GO:0006520	cellular amino acid metabolic process	0.02	> 0.20	DHODH (3.2)	NT5DC1 (3.2)	SARS (2.9)	CYP7A1 (2.8)	ABCG8 (2.8)	SLC22A1 (2.6)	ANGPTL3 (2.5)	LPA (2.5)	QTRT1 (2.3)	ALDH2 (2.2)
GO:0034339	regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor	0.02	> 0.20	GCNT4 (3.2)	HNF1A (2.8)	PPP1R37 (2.5)	ABCG8 (2.4)	LPIN3 (2.0)	TSSK6 (2.0)	TM6SF2 (1.9)	NPC1L1 (1.7)	ABO (1.7)	ST3GAL4 (1.7)
ENSG00000023734	STRAP PPI subnetwork	0.02	> 0.20	ZNF180 (3.4)	MAPKAPK5 (3.4)	GEMIN7 (2.9)	POC5 (2.9)	PLEC (2.1)	C19orf52 (2.1)	SH2B3 (2.0)	PVR (1.9)	NAA25 (1.8)	ATXN7L2 (1.7)
GO:0005978	glycogen biosynthetic process	0.02	> 0.20	ENSG00000254235 (3.4)	SYPL2 (3.3)	LPA (2.9)	NT5DC1 (2.7)	ZNF101 (2.2)	SORT1 (2.2)	GPAM (2.1)	CYP7A1 (1.9)	AMIGO1 (1.7)	MOSC1 (1.6)
GO:0009250	glucan biosynthetic process	0.02	> 0.20	ENSG00000254235 (3.4)	SYPL2 (3.3)	LPA (2.9)	NT5DC1 (2.7)	ZNF101 (2.2)	SORT1 (2.2)	GPAM (2.1)	CYP7A1 (1.9)	AMIGO1 (1.7)	MOSC1 (1.6)
GO:0044448	cell cortex part	0.02	> 0.20	RHD (3.3)	RHCE (2.8)	GMPR (2.5)	DNM2 (2.3)	ENSG00000238078 (2.3)	C12orf51 (2.1)	KANK2 (2.1)	OGDH (1.9)	LPIN3 (1.9)	PLCG1 (1.8)
MP:0009789	decreased susceptibility to bacterial infection induced morbidity/mortality	0.02	> 0.20	HP (5.0)	BCL3 (3.0)	RELB (2.9)	FRK (2.5)	MAFB (2.3)	CEACAM19 (2.2)	HLX (2.1)	PLG (1.9)	SLC22A1 (1.8)	ANGPTL3 (1.8)
ENSG00000164167	LSM6 PPI subnetwork	0.02	> 0.20	SUGP1 (4.2)	DHX38 (4.2)	MAU2 (3.5)	SMARCA4 (3.5)	DDX56 (3.3)	ATP13A1 (3.1)	QTRT1 (2.8)	CARM1 (2.5)	TOP1 (2.5)	BUD13 (2.5)
ENSG00000197343	ZNF655 PPI subnetwork	0.02	> 0.20	TIMD4 (3.7)	CETP (3.3)	OASL (3.3)	C1orf63 (1.9)	HNF1A (1.7)	TSSK6 (1.5)	ANKRD31 (1.5)	DNAH11 (1.3)	TMEM57 (1.3)	MOSC1 (1.3)
MP:0009767	decreased sensitivity to xenobiotic induced morbidity/mortality	0.02	> 0.20	ABCG5 (3.7)	ABCG8 (3.2)	CETP (2.9)	NPC1L1 (2.7)	SLC22A1 (2.4)	APOA5 (2.2)	TM6SF2 (2.1)	LPA (2.0)	APOC4 (1.9)	PARP10 (1.8)
MP:0003068	enlarged kidney	0.02	> 0.20	DYNC2LI1 (3.7)	C11orf9 (3.2)	BCAM (2.9)	FADS1 (2.8)	PLEKHH2 (2.7)	NYNRIN (2.3)	KANK2 (1.9)	SLC22A1 (1.9)	TRAPPC6A (1.8)	QTRT1 (1.8)
ENSG00000115594	IL1R1 PPI subnetwork	0.02	> 0.20	UBXN2B (2.8)	BCL3 (2.8)	ENSG00000254235 (2.7)	PARP10 (2.6)	ST3GAL4 (2.2)	OASL (2.2)	ENSG00000235545 (2.1)	BLOC1S3 (1.9)	GCNT4 (1.6)	ABCG5 (1.5)
ENSG00000103035	PSMD7 PPI subnetwork	0.02	> 0.20	PSMA5 (5.3)	TRAFD1 (3.1)	NAA25 (2.8)	NT5DC1 (2.5)	DDX56 (2.0)	TOMM40 (1.8)	BRAP (1.6)	SUGP1 (1.5)	CLPTM1 (1.3)	ABCG8 (1.3)
MP:0001722	pale yolk sac	0.02	> 0.20	KANK2 (3.4)	GATAD2A (3.3)	ATXN2 (3.3)	RHCE (2.8)	RHD (2.5)	C12orf51 (2.4)	SH2B3 (2.4)	MARK4 (2.2)	APOB (2.1)	BCAM (2.0)
MP:0001274	curly vibrissae	0.02	> 0.20	AP1M2 (3.0)	MARK4 (2.4)	NYNRIN (2.0)	CBLC (1.8)	DNM2 (1.6)	LPIN3 (1.6)	ENSG00000254235 (1.5)	ABO (1.5)	BCAM (1.4)	SLC22A1 (1.4)
MP:0004001	decreased hepatocyte proliferation	0.02	> 0.20	TRIB1 (3.0)	ABCG5 (2.8)	APOB (2.7)	GCNT4 (2.0)	POLK (2.0)	ANGPTL3 (1.8)	PMFBP1 (1.7)	ENSG00000254235 (1.6)	HP (1.6)	APOA5 (1.6)
GO:0006956	complement activation	0.02	> 0.20	LPA (7.1)	TIMD4 (5.1)	SLC22A1 (4.3)	APOC4 (4.2)	CETP (3.4)	ANGPTL3 (3.3)	APOA5 (3.1)	HP (3.0)	APOE (3.0)	DHODH (2.8)
ENSG00000115761	NOL10 PPI subnetwork	0.02	> 0.20	ZNF259 (4.6)	DDX56 (4.5)	QTRT1 (3.9)	NAA25 (3.9)	TOMM40 (3.3)	DHODH (3.1)	ATP13A1 (2.6)	DHX38 (2.5)	SUGP1 (2.3)	GATAD2A (2.3)
REACTOME_ASSOCIATION_OF_TRICCCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	REACTOME_ASSOCIATION_OF_TRICCCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	0.02	> 0.20	NT5DC1 (2.7)	LPIN3 (2.6)	ZHX3 (2.4)	QTRT1 (2.1)	DHX38 (2.1)	ENSG00000238078 (1.9)	ZNF259 (1.8)	DDX56 (1.7)	MAPKAPK5 (1.7)	PSMA5 (1.7)
MP:0000530	abnormal kidney blood vessel morphology	0.02	> 0.20	PLEKHH2 (3.5)	HLX (3.4)	NYNRIN (3.1)	BCAM (3.1)	C11orf9 (2.6)	NPC1L1 (2.2)	ABCG5 (2.2)	PVRL2 (2.2)	APOB (2.1)	TM6SF2 (1.9)
ENSG00000127993	RBM48 PPI subnetwork	0.02	> 0.20	TXNL4B (2.7)	ALDH2 (2.6)	C11orf9 (2.4)	PSMA5 (2.1)	POLK (1.9)	LPA (1.9)	MAFB (1.7)	GEMIN7 (1.7)	TRAFD1 (1.6)	FEN1 (1.6)
GO:0071396	cellular response to lipid	0.02	> 0.20	HMGCR (2.8)	ENSG00000254235 (2.7)	PCSK9 (2.6)	ABCG8 (2.4)	FADS2 (2.1)	APOC4 (2.0)	BLOC1S3 (2.0)	FADS1 (1.9)	ABCG5 (1.9)	HLX (1.9)
GO:0005044	scavenger receptor activity	0.02	> 0.20	TIMD4 (7.3)	CETP (3.9)	MAFB (3.6)	ABCG8 (2.8)	ABCG5 (2.8)	NPC1L1 (2.3)	HP (2.3)	CILP2 (2.3)	TM6SF2 (2.0)	MYLIP (2.0)
MP:0003888	liver hemorrhage	0.02	> 0.20	CETP (3.7)	HP (2.8)	HLX (2.3)	LPA (2.1)	LPIN3 (2.1)	UBXN2B (2.1)	PLG (2.0)	PVRL2 (1.8)	APOA5 (1.7)	C12orf51 (1.6)
ENSG00000102974	CTCF PPI subnetwork	0.02	> 0.20	USP1 (2.9)	PLEC (2.6)	GOT2P1 (2.2)	ENSG00000228044 (1.9)	MYLIP (1.9)	USP24 (1.8)	ATXN2 (1.8)	SH2B3 (1.7)	GATAD2A (1.7)	ILF3 (1.6)
REACTOME_APOPTOSIS	REACTOME_APOPTOSIS	0.02	> 0.20	TRAFD1 (4.5)	PSMA5 (4.2)	PARP10 (2.5)	RELB (2.0)	TMEM50A (1.8)	NT5DC1 (1.7)	DDX56 (1.6)	SUGP1 (1.6)	TOMM40 (1.5)	CBLC (1.5)
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	0.02	> 0.20	ITGB3 (9.5)	CETP (3.5)	APOE (3.0)	ANGPTL3 (2.9)	SH2B3 (2.8)	HP (2.7)	PLG (2.6)	APOB (2.3)	TIMD4 (2.3)	APOC1 (2.3)
GO:0030145	manganese ion binding	0.02	> 0.20	PMFBP1 (3.4)	ENSG00000228044 (2.4)	TXNL4B (2.2)	ANKRD31 (2.1)	HP (1.9)	GPAM (1.9)	MOSC1 (1.8)	USP24 (1.7)	ENSG00000226648 (1.7)	BCL3 (1.6)
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	0.02	> 0.20	APOA5 (4.3)	SLC22A1 (4.0)	APOC4 (3.8)	PLG (3.6)	LPA (3.2)	CYP7A1 (3.0)	ALDH2 (2.6)	DHODH (2.5)	GOT2P1 (2.5)	ANGPTL3 (2.2)
MP:0005076	abnormal cell differentiation	0.02	> 0.20	BCL3 (3.5)	TRIB1 (3.0)	MAFB (2.8)	MYLIP (2.5)	ANKRD31 (2.2)	PLEC (2.2)	TOP1 (2.2)	PPP1R37 (2.1)	ALDH2 (1.9)	C12orf51 (1.8)
ENSG00000169047	IRS1 PPI subnetwork	0.02	> 0.20	DNM2 (2.4)	SMARCA4 (2.2)	CBLC (2.2)	SLC44A2 (2.2)	ENSG00000226645 (2.1)	GMIP (2.1)	AP1M2 (2.1)	PTPN11 (2.0)	ATXN2 (1.9)	ST3GAL4 (1.9)
ENSG00000114767	RRP9 PPI subnetwork	0.02	> 0.20	ZNF259 (4.7)	DDX56 (4.3)	NAA25 (4.0)	QTRT1 (3.7)	TOMM40 (3.4)	DHODH (2.7)	TOP1 (2.3)	ATP13A1 (2.0)	DHX38 (1.8)	C12orf43 (1.8)
GO:0046504	glycerol ether biosynthetic process	0.02	> 0.20	GPAM (4.7)	FADS1 (4.6)	FADS2 (4.6)	PCSK9 (4.2)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.1)	NPC1L1 (2.1)	TM6SF2 (2.1)	SORT1 (2.0)
ENSG00000196517	SLC6A9 PPI subnetwork	0.02	> 0.20	BCAM (2.7)	TIMD4 (2.4)	PCSK9 (2.3)	KANK2 (2.1)	RPH3A (2.1)	CYP7A1 (2.1)	NYNRIN (1.9)	LPA (1.6)	HP (1.6)	DOCK7 (1.5)
MP:0002412	increased susceptibility to bacterial infection	0.02	> 0.20	HP (5.5)	MAFB (3.8)	TIMD4 (3.6)	BCL3 (3.0)	RELB (2.3)	GMIP (2.3)	OASL (2.2)	PARP10 (2.2)	CETP (2.2)	HLX (2.0)
MP:0005606	increased bleeding time	0.02	> 0.20	ITGB3 (9.6)	GMPR (4.4)	HP (2.9)	ABCG8 (2.9)	APOC4 (2.7)	FADS1 (2.7)	CYP7A1 (2.6)	ANGPTL3 (2.3)	APOA5 (2.2)	PLG (2.2)
ENSG00000078061	ARAF PPI subnetwork	0.02	> 0.20	AP1M2 (3.1)	CARM1 (3.1)	PLEC (3.0)	CBLC (2.8)	LPIN3 (2.5)	TOP1 (2.4)	PPP1R37 (2.2)	KANK2 (2.1)	SMARCA4 (2.1)	DNM2 (2.1)
ENSG00000107807	TLX1 PPI subnetwork	0.02	> 0.20	GCNT4 (2.4)	PTPN11 (2.2)	ZHX3 (2.2)	SH2B3 (1.8)	ENSG00000226648 (1.7)	BRAP (1.6)	KANK2 (1.6)	MAPKAPK5 (1.6)	NKPD1 (1.5)	DYNC2LI1 (1.5)
GO:0000989	transcription factor binding transcription factor activity	0.02	> 0.20	ATXN2 (3.0)	TRIB1 (2.6)	BUD13 (2.6)	NYNRIN (2.6)	CARM1 (2.5)	ATXN7L2 (2.5)	MAPKAPK5 (2.4)	TMEM57 (2.4)	SMARCA4 (2.3)	MAU2 (2.1)
MP:0000189	hypoglycemia	0.02	> 0.20	MOSC1 (3.8)	GPAM (3.5)	ACAD10 (2.8)	OGDH (2.3)	APOA5 (2.2)	APOC4 (2.0)	PLG (1.9)	ENSG00000226645 (1.8)	GOT2P1 (1.8)	SLC22A1 (1.8)
MP:0010383	increased adenoma incidence	0.02	> 0.20	PTPN11 (3.0)	ADAM1 (2.8)	C12orf51 (2.5)	DOCK7 (2.3)	KANK2 (2.3)	POC5 (2.2)	TMEM116 (2.1)	ENSG00000226648 (2.0)	C12orf43 (1.9)	ZNF180 (1.8)
ENSG00000198373	WWP2 PPI subnetwork	0.02	> 0.20	CETP (3.7)	GRINA (3.1)	AP1M2 (2.7)	TIMD4 (2.3)	SLC44A2 (2.2)	HNF1A (1.9)	BCAM (1.8)	OASL (1.8)	HAVCR1 (1.7)	SYPL2 (1.7)
GO:0016638	oxidoreductase activity, acting on the CH-NH2 group of donors	0.02	> 0.20	PLG (4.4)	ANGPTL3 (3.9)	SLC22A1 (3.1)	MOSC1 (3.0)	HP (2.6)	ATXN7L2 (2.5)	TM6SF2 (2.3)	APOC4 (2.2)	GPAM (2.1)	SYPL2 (1.8)
GO:0008144	drug binding	0.02	> 0.20	GMPR (2.4)	ALDH2 (2.4)	C12orf47 (2.3)	APOB (2.3)	HMGCR (2.0)	ST3GAL4 (2.0)	C1orf63 (1.9)	ABCG5 (1.9)	FADS2 (1.7)	KIAA1324 (1.6)
ENSG00000145819	ARHGAP26 PPI subnetwork	0.02	> 0.20	CETP (3.5)	TIMD4 (3.5)	OASL (3.4)	SLC44A2 (3.0)	LPAR2 (2.0)	CILP2 (1.8)	SYPL2 (1.7)	ATP13A1 (1.6)	MOSC1 (1.6)	HNF1A (1.5)
KEGG_FOLATE_BIOSYNTHESIS	KEGG_FOLATE_BIOSYNTHESIS	0.02	> 0.20	TM6SF2 (2.8)	ST3GAL4 (2.6)	ABO (2.5)	HNF1A (2.3)	MOSC1 (2.2)	CBLC (1.8)	ABCG8 (1.8)	NT5DC1 (1.7)	SLC22A1 (1.6)	ZNF259 (1.5)
ENSG00000139726	DENR PPI subnetwork	0.02	> 0.20	PSMA5 (2.5)	ADAM1 (2.3)	ANGPTL3 (2.2)	APOC1 (2.0)	BRAP (2.0)	ILF3 (2.0)	PLG (1.9)	C12orf43 (1.8)	PTPN11 (1.7)	SUGP1 (1.7)
GO:0016645	oxidoreductase activity, acting on the CH-NH group of donors	0.02	> 0.20	PLG (4.2)	ANGPTL3 (3.7)	CYP7A1 (3.2)	APOC4 (3.2)	SLC22A1 (2.9)	ALDH2 (2.7)	DHODH (2.7)	APOA5 (2.5)	SARS (2.3)	ACAD10 (2.1)
MP:0005666	abnormal adipose tissue physiology	0.02	> 0.20	MAFB (2.9)	GPAM (2.8)	SYPL2 (2.6)	TIMD4 (2.4)	TRIB1 (2.3)	BLOC1S3 (2.1)	ATXN7L2 (1.8)	ACAD10 (1.7)	AMIGO1 (1.7)	MOSC1 (1.7)
ENSG00000152582	SPEF2 PPI subnetwork	0.02	> 0.20	APOE (5.9)	APOB (4.7)	ANGPTL3 (3.4)	HAVCR1 (3.3)	TIMD4 (3.0)	APOC4 (3.0)	APOC1 (3.0)	MAFB (2.9)	APOA5 (2.9)	PLG (2.7)
REACTOME_BIOLOGICAL_OXIDATIONS	REACTOME_BIOLOGICAL_OXIDATIONS	0.02	> 0.20	SLC22A1 (6.5)	CYP7A1 (6.1)	LPA (5.9)	TM6SF2 (5.5)	ABCG5 (5.3)	APOC4 (5.2)	ANGPTL3 (4.7)	ABCG8 (4.7)	APOA5 (4.2)	ALDH2 (4.2)
ENSG00000064012	CASP8 PPI subnetwork	0.02	> 0.20	RELB (3.5)	BCL3 (2.9)	ST3GAL4 (2.6)	TRAFD1 (2.5)	CEACAM19 (2.5)	PVRL2 (2.4)	GRINA (2.3)	OASL (2.3)	PARP10 (2.0)	POLK (1.9)
GO:0004857	enzyme inhibitor activity	0.02	> 0.20	APOB (5.6)	HP (5.3)	PLG (4.7)	APOA5 (4.3)	APOC4 (4.1)	APOC1 (4.1)	ANGPTL3 (3.2)	PCSK9 (2.7)	APOE (2.7)	ABCG5 (2.6)
ENSG00000161955	TNFSF13 PPI subnetwork	0.02	> 0.20	COL4A3BP (2.2)	PVR (2.0)	CYB561D1 (1.9)	NT5DC1 (1.9)	ENSG00000226648 (1.8)	ZNF101 (1.8)	PLEKHH2 (1.7)	AMIGO1 (1.5)	PBX4 (1.5)	HAVCR1 (1.4)
MP:0009674	decreased birth weight	0.02	> 0.20	LDLR (3.0)	NYNRIN (2.8)	MARK4 (2.6)	LPAR2 (2.5)	TOP1 (2.4)	FADS1 (2.3)	FADS2 (2.2)	HMGCR (2.0)	TRIB1 (1.8)	CELSR2 (1.8)
ENSG00000132196	HSD17B7 PPI subnetwork	0.02	> 0.20	HMGCR (15.1)	LDLR (13.0)	FADS1 (10.7)	FADS2 (9.7)	PCSK9 (8.4)	CYP7A1 (3.8)	NPC1L1 (3.4)	SLC22A1 (3.3)	PLG (3.0)	GPAM (2.0)
GO:0008209	androgen metabolic process	0.02	> 0.20	CYP7A1 (3.5)	ST3GAL4 (3.3)	LPA (3.0)	NKPD1 (2.7)	FRK (2.6)	LPIN3 (2.4)	ENSG00000228044 (2.2)	ABCG8 (2.0)	PMFBP1 (2.0)	CYB561D1 (2.0)
GO:0050892	intestinal absorption	0.02	> 0.20	NPC1L1 (7.4)	ABCG8 (6.3)	TM6SF2 (5.6)	ABCG5 (5.2)	APOB (3.5)	GCNT4 (2.5)	CBLC (2.3)	FRK (2.2)	TMED4 (2.1)	HNF1A (1.8)
GO:0016860	intramolecular oxidoreductase activity	0.02	> 0.20	ERP29 (3.4)	HMGCR (3.4)	FADS2 (3.3)	FADS1 (3.2)	TRAPPC6A (2.7)	PCSK9 (2.7)	TMED4 (2.5)	LDLR (2.4)	DHODH (2.4)	PMFBP1 (2.1)
ENSG00000149131	SERPING1 PPI subnetwork	0.02	> 0.20	APOC4 (6.2)	ANGPTL3 (5.8)	SLC22A1 (5.8)	LPA (5.2)	APOA5 (5.2)	HP (5.0)	PLG (4.9)	CYP7A1 (4.6)	BCL3 (2.5)	MOSC1 (2.4)
ENSG00000168090	COPS6 PPI subnetwork	0.02	> 0.20	PPP1R37 (2.5)	SARS (2.2)	CLPTM1 (2.2)	MYLIP (2.0)	CEACAM19 (1.8)	ALDH2 (1.8)	GRINA (1.7)	YIPF2 (1.7)	USP1 (1.6)	NKPD1 (1.6)
ENSG00000171914	TLN2 PPI subnetwork	0.02	> 0.20	NPC1L1 (3.3)	APOB (2.6)	APOA5 (2.4)	FRK (2.3)	APOC1 (2.2)	LPIN3 (2.1)	ZNF101 (2.1)	LPAR2 (2.0)	HAPLN4 (2.0)	ABCG5 (2.0)
ENSG00000112578	BYSL PPI subnetwork	0.02	> 0.20	DDX56 (4.5)	ZNF259 (4.4)	NAA25 (4.3)	QTRT1 (3.7)	TOMM40 (3.5)	DHX38 (3.1)	ATP13A1 (2.5)	DHODH (2.4)	SUGP1 (2.2)	C12orf43 (1.9)
GO:0019902	phosphatase binding	0.02	> 0.20	DNM2 (3.4)	PPP1R37 (3.1)	PVRL2 (2.9)	C11orf9 (2.6)	BCAM (2.3)	SLC44A2 (2.1)	CLPTM1 (2.1)	MARK4 (1.9)	COL4A3BP (1.8)	KANK2 (1.8)
ENSG00000146729	GBAS PPI subnetwork	0.02	> 0.20	AP1M2 (3.3)	ILF3 (2.9)	LPAR2 (2.6)	BCAM (2.4)	PVRL2 (2.2)	KANK2 (2.0)	TOMM40 (1.9)	CARM1 (1.7)	TOP1 (1.6)	SMARCA4 (1.6)
GO:0016866	intramolecular transferase activity	0.02	> 0.20	ZNF259 (3.8)	DHODH (3.5)	TOMM40 (2.7)	C12orf43 (2.6)	GPAM (2.5)	QTRT1 (2.4)	DDX56 (2.3)	BUD13 (2.3)	NAA25 (2.3)	NT5DC1 (2.3)
MP:0005152	pancytopenia	0.02	> 0.20	ST3GAL4 (2.9)	DOCK7 (2.7)	UBXN2B (2.5)	DNAH11 (2.5)	CEACAM19 (2.4)	RHD (2.2)	RHCE (2.2)	SLC44A2 (2.1)	NYNRIN (2.1)	POC5 (2.1)
GO:0031907	microbody lumen	0.02	> 0.20	PLG (5.0)	SLC22A1 (4.7)	MOSC1 (4.3)	APOA5 (4.2)	ANGPTL3 (4.1)	APOC4 (3.9)	FADS2 (3.3)	TM6SF2 (3.2)	GPAM (3.1)	CYP7A1 (2.9)
GO:0005782	peroxisomal matrix	0.02	> 0.20	PLG (5.0)	SLC22A1 (4.7)	MOSC1 (4.3)	APOA5 (4.2)	ANGPTL3 (4.1)	APOC4 (3.9)	FADS2 (3.3)	TM6SF2 (3.2)	GPAM (3.1)	CYP7A1 (2.9)
ENSG00000007908	SELE PPI subnetwork	0.02	> 0.20	PLEC (4.3)	ITGB3 (3.5)	KANK2 (2.8)	ADAM1 (2.6)	DNM2 (2.6)	DHX38 (2.5)	ENSG00000226648 (2.4)	PVR (2.4)	SLC44A2 (2.2)	ZHX3 (2.2)
ENSG00000120210	INSL6 PPI subnetwork	0.02	> 0.20	PARP10 (3.0)	PLEKHH2 (2.9)	LPAR2 (2.7)	OASL (2.5)	BCL3 (2.5)	NT5DC1 (2.4)	GMIP (2.2)	TRIB1 (2.2)	COL4A3BP (2.2)	PLCG1 (2.1)
REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	0.02	> 0.20	RELB (4.4)	BCL3 (4.2)	TRIB1 (3.8)	OASL (3.4)	SH2B3 (3.2)	PVR (3.1)	GMIP (2.9)	MAFB (2.7)	HLX (2.5)	PARP10 (2.1)
ENSG00000167508	MVD PPI subnetwork	0.02	> 0.20	DDX56 (4.4)	NAA25 (4.4)	ZNF259 (4.1)	QTRT1 (3.9)	TOMM40 (3.9)	DHODH (3.1)	SARS (2.6)	SUGP1 (2.4)	TOP1 (2.3)	C12orf43 (2.3)
MP:0002643	poikilocytosis	0.02	> 0.20	RHD (11.5)	RHCE (11.1)	C12orf51 (2.8)	GMPR (2.7)	FADS1 (2.0)	ZNF180 (1.9)	APOC1 (1.9)	PPP1R37 (1.8)	ADAM1 (1.8)	FADS2 (1.8)
GO:0010884	positive regulation of lipid storage	0.02	> 0.20	ABCG8 (3.5)	GCNT4 (2.6)	MOSC1 (2.6)	BLOC1S3 (2.4)	ABCG5 (2.3)	C12orf43 (2.2)	APOC1 (2.2)	GPAM (2.1)	GEMIN7 (2.1)	CYB561D1 (2.0)
ENSG00000184083	FAM120C PPI subnetwork	0.02	> 0.20	C19orf52 (2.3)	SUGP1 (2.3)	DHX38 (2.2)	PARP10 (2.2)	QTRT1 (1.9)	BRAP (1.9)	OASL (1.9)	ZNF180 (1.9)	GRINA (1.8)	SORT1 (1.7)
MP:0010701	fusion of atlas and odontoid process	0.02	> 0.20	BCAM (3.5)	NYNRIN (2.7)	ENSG00000235545 (2.0)	C11orf9 (2.0)	ENSG00000254235 (1.8)	PVRL2 (1.7)	ST3GAL4 (1.6)	MARK4 (1.5)	PLEC (1.5)	SLC44A2 (1.5)
ENSG00000015171	ZMYND11 PPI subnetwork	0.02	> 0.20	ZNF180 (2.9)	GRINA (2.8)	PARP10 (2.0)	OASL (1.7)	C19orf52 (1.6)	QTRT1 (1.6)	ATXN2 (1.6)	AMIGO1 (1.5)	SORT1 (1.5)	BRAP (1.4)
ENSG00000023445	BIRC3 PPI subnetwork	0.02	> 0.20	RELB (4.9)	PARP10 (3.5)	ST3GAL4 (3.0)	LPAR2 (2.3)	TRAFD1 (2.3)	BCL3 (2.3)	NT5DC1 (2.1)	SLC22A1 (1.8)	ENSG00000238078 (1.8)	C19orf52 (1.7)
ENSG00000115234	SNX17 PPI subnetwork	0.02	> 0.20	HMGCR (4.7)	FADS1 (4.1)	FADS2 (3.8)	ITGB3 (3.2)	C17orf57 (2.4)	TMEM57 (2.3)	MAFB (2.2)	ZHX3 (2.0)	ZNF101 (1.9)	PCSK9 (1.9)
GO:0051050	positive regulation of transport	0.02	> 0.20	KIAA1324 (2.9)	ENSG00000235545 (2.2)	YIPF2 (2.2)	ENSG00000228044 (1.9)	AMIGO1 (1.9)	GPAM (1.8)	NPC1L1 (1.7)	AP1M2 (1.7)	PLEKHH2 (1.5)	ENSG00000238078 (1.4)
GO:0006699	bile acid biosynthetic process	0.02	> 0.20	CYP7A1 (5.8)	LPA (4.5)	APOC4 (4.2)	SLC22A1 (3.5)	ANGPTL3 (3.5)	APOA5 (3.0)	ABCG8 (2.8)	PLG (2.4)	UBXN2B (2.2)	ABCG5 (2.1)
ENSG00000177156	TALDO1 PPI subnetwork	0.02	> 0.20	ERP29 (3.0)	FRK (2.7)	OGDH (2.0)	ZNF101 (1.8)	GOT2P1 (1.7)	TM6SF2 (1.6)	SMARCA4 (1.6)	GRINA (1.5)	PARP10 (1.4)	COL4A3BP (1.4)
GO:0050728	negative regulation of inflammatory response	0.02	> 0.20	ANKRD31 (3.2)	ALDH2 (2.0)	DNAH11 (1.8)	SH2B3 (1.7)	APOC1 (1.5)	POLK (1.5)	TRIB1 (1.5)	HLX (1.5)	TIMD4 (1.4)	ADAM1 (1.3)
GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	0.02	> 0.20	POLK (3.4)	TRAFD1 (2.8)	BLOC1S3 (2.7)	GOT2P1 (2.7)	OASL (2.5)	ST3GAL4 (2.1)	PARP10 (1.8)	FRK (1.7)	C12orf43 (1.6)	TRAPPC6A (1.5)
GO:0071941	nitrogen cycle metabolic process	0.02	> 0.20	TM6SF2 (5.1)	ABCG8 (5.0)	NPC1L1 (4.8)	ABCG5 (4.8)	C17orf57 (3.8)	CYP7A1 (3.0)	ZHX3 (2.6)	APOC4 (2.6)	TMED4 (2.5)	SLC22A1 (2.4)
ENSG00000106355	LSM5 PPI subnetwork	0.02	> 0.20	DHX38 (4.2)	MAU2 (3.3)	ATP13A1 (3.2)	SMARCA4 (2.6)	ILF3 (2.5)	BUD13 (2.5)	DDX56 (2.4)	SUGP1 (2.3)	TOMM40 (2.2)	TXNL4B (2.2)
ENSG00000186979	ENSG00000186979 PPI subnetwork	0.02	> 0.20	DDX56 (2.3)	PLG (2.2)	USP24 (2.1)	ZHX3 (1.9)	ATP13A1 (1.9)	APOA5 (1.8)	NAA25 (1.7)	TMED4 (1.7)	QTRT1 (1.6)	ANGPTL3 (1.6)
KEGG_STEROID_BIOSYNTHESIS	KEGG_STEROID_BIOSYNTHESIS	0.02	> 0.20	HMGCR (16.5)	LDLR (14.5)	FADS1 (13.1)	FADS2 (11.9)	PCSK9 (8.7)	NPC1L1 (3.8)	TRAPPC6A (2.4)	CYP7A1 (2.4)	GPAM (2.2)	NKPD1 (1.8)
ENSG00000172780	RAB43 PPI subnetwork	0.02	> 0.20	DHX38 (3.6)	BUD13 (3.4)	BRAP (3.3)	SUGP1 (3.3)	ZNF259 (2.8)	SMARCA4 (2.5)	MAU2 (2.3)	ZNF180 (2.2)	POC5 (1.7)	SARS (1.7)
ENSG00000122779	TRIM24 PPI subnetwork	0.02	> 0.20	CELSR2 (3.1)	KIAA1324 (2.9)	CYP7A1 (2.9)	FRK (2.5)	ZNF180 (2.5)	PSRC1 (2.4)	POLK (2.1)	PLCG1 (2.0)	ABCG8 (2.0)	DYNC2LI1 (1.8)
KEGG_PEROXISOME	KEGG_PEROXISOME	0.02	> 0.20	MOSC1 (3.7)	GPAM (3.7)	ANGPTL3 (3.5)	PLG (3.4)	ACAD10 (3.3)	TRAPPC6A (3.3)	APOC4 (2.8)	NT5DC1 (2.7)	ALDH2 (2.7)	HP (2.7)
ENSG00000115641	FHL2 PPI subnetwork	0.02	> 0.20	SYPL2 (3.4)	UBXN2B (2.7)	BCAM (2.5)	ABO (2.3)	PLEC (2.1)	GOT2P1 (2.1)	SH2B3 (2.1)	BUD13 (2.0)	ENSG00000238078 (1.9)	ACAD10 (1.9)
GO:0030246	carbohydrate binding	0.02	> 0.20	HP (4.8)	CILP2 (4.2)	LPA (3.2)	MAFB (2.7)	MOSC1 (2.6)	PLG (2.4)	APOC4 (2.4)	TIMD4 (2.3)	SLC22A1 (2.3)	APOA5 (2.2)
ENSG00000196290	NIF3L1 PPI subnetwork	0.02	> 0.20	GEMIN7 (2.8)	ZNF180 (2.6)	GMPR (2.4)	HAVCR1 (2.4)	TXNL4B (2.1)	SLC22A1 (2.0)	MAU2 (1.9)	TRAFD1 (1.9)	KIAA1324 (1.7)	CARM1 (1.5)
MP:0002060	abnormal skin morphology	0.02	> 0.20	CBLC (4.2)	GCNT4 (2.8)	PLEC (2.5)	C17orf57 (2.3)	AP1M2 (2.0)	LDLR (1.9)	ABCG8 (1.9)	MAFB (1.7)	CYB561D1 (1.7)	DYNC2LI1 (1.6)
ENSG00000025800	KPNA6 PPI subnetwork	0.02	> 0.20	TOMM40 (4.2)	FEN1 (2.9)	GATAD2A (2.8)	QTRT1 (2.8)	TOP1 (2.8)	DHODH (2.7)	NAA25 (2.7)	CARM1 (2.5)	DHX38 (2.4)	DDX56 (2.3)
ENSG00000109606	DHX15 PPI subnetwork	0.02	> 0.20	DDX56 (4.7)	ZNF259 (4.6)	NAA25 (4.2)	TOMM40 (3.8)	QTRT1 (3.7)	DHX38 (3.0)	SMARCA4 (2.9)	SUGP1 (2.7)	C12orf43 (2.6)	ATP13A1 (2.6)
ENSG00000143373	ZNF687 PPI subnetwork	0.02	> 0.20	C19orf52 (2.6)	QTRT1 (2.2)	DHX38 (2.1)	ZNF180 (2.1)	OASL (2.0)	SUGP1 (2.0)	BRAP (2.0)	PARP10 (2.0)	SORT1 (1.6)	TRAFD1 (1.5)
GO:0009755	hormone-mediated signaling pathway	0.02	> 0.20	HNF1A (3.3)	GCNT4 (2.3)	ST3GAL4 (2.2)	ABCG8 (2.1)	CYP7A1 (2.0)	TM6SF2 (2.0)	NPC1L1 (2.0)	FRK (2.0)	PPP1R37 (1.9)	ATXN7L2 (1.8)
MP:0001713	decreased trophoblast giant cell number	0.02	> 0.20	GOT2P1 (2.1)	CARM1 (2.0)	APOA5 (1.9)	ABCG8 (1.7)	DNM2 (1.7)	ANGPTL3 (1.7)	LDLR (1.6)	RHCE (1.5)	AP1M2 (1.4)	HLX (1.4)
ENSG00000171791	BCL2 PPI subnetwork	0.02	> 0.20	GRINA (3.3)	RELB (3.0)	TRAPPC6A (2.7)	TMEM50A (2.4)	PVR (2.1)	CLPTM1 (2.1)	BRAP (2.1)	PVRL2 (1.9)	C1orf63 (1.8)	TRIB1 (1.8)
MP:0009788	increased susceptibility to bacterial infection induced morbidity/mortality	0.02	> 0.20	HP (4.4)	OASL (4.2)	PARP10 (3.2)	BCL3 (3.1)	RELB (2.7)	TRAFD1 (2.6)	CYP7A1 (2.3)	HLX (2.1)	ENSG00000228044 (1.9)	TIMD4 (1.7)
GO:0046889	positive regulation of lipid biosynthetic process	0.02	> 0.20	MYLIP (2.7)	COL4A3BP (2.6)	ENSG00000238078 (2.3)	HNF1A (2.2)	TMEM57 (2.1)	ST3GAL4 (2.0)	ENSG00000228044 (1.8)	POC5 (1.8)	POLK (1.7)	GPAM (1.6)
REACTOME_SIGNALING_BY_SCF:KIT	REACTOME_SIGNALING_BY_SCF:KIT	0.02	> 0.20	DNM2 (2.9)	ZHX3 (2.2)	PARP10 (2.2)	MARK4 (2.2)	COL4A3BP (2.0)	PTPN11 (2.0)	HLX (1.8)	MYLIP (1.8)	PLEC (1.8)	GMIP (1.5)
ENSG00000011260	UTP18 PPI subnetwork	0.02	> 0.20	ZNF259 (4.8)	DDX56 (4.4)	NAA25 (4.2)	QTRT1 (4.0)	TOMM40 (3.3)	C12orf43 (3.0)	DHODH (2.9)	SARS (2.3)	SUGP1 (2.2)	ATP13A1 (2.1)
GO:0042311	vasodilation	0.02	> 0.20	NPC1L1 (2.4)	LPIN3 (2.1)	C12orf47 (2.0)	ANKRD31 (1.9)	ERP29 (1.9)	ENSG00000235545 (1.7)	ST3GAL4 (1.6)	TXNL4B (1.6)	ENSG00000228044 (1.6)	FRK (1.5)
MP:0005419	hypoalbuminemia	0.02	> 0.20	TM6SF2 (3.1)	SH2B3 (2.9)	ACAD10 (2.8)	BCL3 (2.7)	NT5DC1 (2.6)	ABCG8 (2.5)	PVRL2 (2.3)	APOE (2.0)	CLPTM1 (1.9)	TRAPPC6A (1.9)
GO:0009064	glutamine family amino acid metabolic process	0.02	> 0.20	ABCG8 (3.4)	CYP7A1 (3.2)	LPA (2.8)	ANGPTL3 (2.6)	TM6SF2 (2.6)	DHODH (2.5)	ABCG5 (2.2)	SLC22A1 (2.2)	ACAD10 (2.1)	PLG (2.0)
ENSG00000072832	CRMP1 PPI subnetwork	0.02	> 0.20	APOE (2.5)	FADS2 (2.0)	C11orf9 (1.9)	KIAA1324 (1.8)	DYNC2LI1 (1.8)	APOC1 (1.7)	TRAPPC6A (1.7)	ZNF180 (1.7)	TOMM40 (1.5)	GCNT4 (1.5)
ENSG00000089737	DDX24 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	DDX56 (4.0)	NAA25 (4.0)	QTRT1 (4.0)	TOMM40 (3.9)	DHODH (3.0)	C12orf43 (2.9)	DHX38 (2.9)	ATP13A1 (2.8)	USP24 (2.3)
ENSG00000139197	PEX5 PPI subnetwork	0.02	> 0.20	NT5DC1 (2.6)	SLC22A1 (2.0)	ALDH2 (2.0)	MYLIP (2.0)	AMIGO1 (2.0)	LPA (1.9)	DYNC2LI1 (1.9)	GRINA (1.9)	APOC4 (1.7)	ACAD10 (1.5)
MP:0001770	abnormal iron level	0.02	> 0.20	RHD (4.6)	RHCE (4.4)	HP (3.0)	GMPR (2.8)	ABCG5 (2.2)	ABCG8 (2.0)	CYP7A1 (1.8)	PARP10 (1.5)	ENSG00000228044 (1.5)	BCL3 (1.4)
ENSG00000170458	CD14 PPI subnetwork	0.02	> 0.20	HP (5.2)	PARP10 (3.9)	OASL (3.0)	MYLIP (2.7)	LPIN3 (2.0)	APOA5 (1.8)	PLG (1.8)	GMIP (1.7)	SH2B3 (1.7)	FADS2 (1.6)
ENSG00000211660	ENSG00000211660 PPI subnetwork	0.02	> 0.20	APOE (6.6)	TIMD4 (5.2)	MAFB (4.5)	APOC1 (3.3)	CETP (2.5)	CARM1 (1.6)	GPAM (1.6)	LPA (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
ENSG00000211653	ENSG00000211653 PPI subnetwork	0.02	> 0.20	APOE (6.6)	TIMD4 (5.2)	MAFB (4.5)	APOC1 (3.3)	CETP (2.5)	CARM1 (1.6)	GPAM (1.6)	LPA (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
ENSG00000124383	MPHOSPH10 PPI subnetwork	0.02	> 0.20	ZNF259 (5.0)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (3.8)	TOMM40 (3.3)	DHODH (3.0)	DHX38 (2.6)	ATP13A1 (2.2)	SUGP1 (2.1)	BRAP (2.0)
GO:0042493	response to drug	0.02	> 0.20	ABCG8 (3.6)	TM6SF2 (2.9)	ABCG5 (2.8)	SLC22A1 (2.5)	TMED4 (2.4)	NPC1L1 (2.2)	FADS2 (2.2)	LPA (2.0)	PCSK9 (1.8)	LDLR (1.7)
ENSG00000081479	LRP2 PPI subnetwork	0.02	> 0.20	PLG (5.0)	APOC1 (4.9)	ANGPTL3 (4.8)	APOC4 (4.0)	HP (3.3)	APOA5 (3.1)	APOB (2.7)	APOE (2.5)	C11orf9 (2.3)	GPAM (2.1)
GO:0019218	regulation of steroid metabolic process	0.02	> 0.20	ST3GAL4 (3.8)	FADS2 (2.7)	FADS1 (2.3)	APOC1 (2.3)	GPAM (2.2)	LDLR (2.1)	TRAPPC6A (2.0)	TMEM50A (1.9)	BLOC1S3 (1.8)	ENSG00000226645 (1.8)
ENSG00000130985	UBA1 PPI subnetwork	0.02	> 0.20	SARS (4.7)	ATXN2 (2.5)	RHD (2.4)	NYNRIN (2.3)	FEN1 (1.9)	DDX56 (1.8)	GRINA (1.7)	GMPR (1.7)	RHCE (1.6)	MAPKAPK5 (1.5)
GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	0.02	> 0.20	ERP29 (3.2)	PVR (3.1)	POC5 (2.1)	DHODH (2.0)	BUD13 (2.0)	BLOC1S3 (1.9)	PVRL2 (1.7)	C12orf47 (1.6)	TRAPPC6A (1.6)	ADAM1 (1.5)
ENSG00000206284	WDR46 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (4.0)	TOMM40 (3.6)	DHODH (3.1)	DHX38 (2.6)	C12orf43 (2.5)	BRAP (2.4)	SUGP1 (2.3)
ENSG00000204221	WDR46 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (4.0)	TOMM40 (3.6)	DHODH (3.1)	DHX38 (2.6)	C12orf43 (2.5)	BRAP (2.4)	SUGP1 (2.3)
MP:0003725	increased autoantibody level	0.02	> 0.20	MAFB (2.8)	TRAFD1 (2.6)	RELB (2.4)	APOC1 (2.4)	PARP10 (2.1)	SLC22A1 (2.1)	TRIB1 (2.0)	GMIP (1.9)	ZNF101 (1.9)	HAVCR1 (1.7)
ENSG00000145907	G3BP1 PPI subnetwork	0.02	> 0.20	GATAD2A (4.0)	SMARCA4 (2.8)	ABO (2.8)	PBX4 (2.8)	PLEC (2.7)	BUD13 (2.7)	GMIP (2.4)	C19orf52 (2.1)	TOP1 (2.0)	SH2B3 (1.9)
ENSG00000104938	CLEC4M PPI subnetwork	0.02	> 0.20	HNF1A (3.7)	ERP29 (2.6)	CETP (2.3)	NT5DC1 (2.3)	ACAD10 (2.1)	TRAPPC6A (1.9)	CBLC (1.7)	PCSK9 (1.6)	BRAP (1.6)	PTPN11 (1.6)
ENSG00000126749	ENSG00000126749 PPI subnetwork	0.02	> 0.20	ZNF259 (4.3)	DDX56 (4.3)	NAA25 (4.2)	QTRT1 (3.3)	TOMM40 (3.1)	C12orf43 (2.8)	DHODH (2.8)	DHX38 (2.4)	SUGP1 (2.1)	ATXN7L2 (2.0)
MP:0004948	abnormal neuronal precursor proliferation	0.02	> 0.20	ENSG00000254235 (2.7)	PLCG1 (2.5)	PSRC1 (2.1)	APOA5 (2.0)	C12orf51 (1.8)	BRAP (1.8)	SLC22A1 (1.7)	PPP1R37 (1.5)	ABO (1.5)	APOC4 (1.4)
MP:0002451	abnormal macrophage physiology	0.02	> 0.20	BCL3 (4.0)	MAFB (4.0)	RELB (3.8)	PARP10 (3.0)	GMIP (2.9)	TRIB1 (2.2)	MYLIP (2.2)	HLX (2.1)	OASL (2.1)	PVR (2.0)
GO:0002449	lymphocyte mediated immunity	0.02	> 0.20	SLC22A1 (3.1)	LPA (2.5)	TIMD4 (2.4)	APOE (2.3)	APOC4 (2.0)	ANGPTL3 (1.7)	POLK (1.6)	APOA5 (1.6)	PARP10 (1.6)	GEMIN7 (1.5)
KEGG_PYRUVATE_METABOLISM	KEGG_PYRUVATE_METABOLISM	0.02	> 0.20	FADS2 (5.1)	FADS1 (4.8)	GPAM (4.7)	ALDH2 (3.6)	PCSK9 (3.5)	MOSC1 (3.5)	ACAD10 (3.3)	LDLR (3.0)	HMGCR (2.6)	OGDH (2.6)
GO:0032332	positive regulation of chondrocyte differentiation	0.02	> 0.20	LPIN3 (2.7)	GOT2P1 (2.1)	CEACAM19 (2.0)	PMFBP1 (1.9)	ZHX3 (1.6)	PLEKHH2 (1.4)	TMED4 (1.3)	ENSG00000228044 (1.3)	CILP2 (1.3)	ANKRD31 (1.2)
REACTOME_TRYPTOPHAN_CATABOLISM	REACTOME_TRYPTOPHAN_CATABOLISM	0.02	> 0.20	APOA5 (5.6)	SLC22A1 (5.5)	CYP7A1 (4.5)	ENSG00000254235 (4.1)	PLG (4.0)	LPA (4.0)	APOC4 (3.4)	ANGPTL3 (3.3)	ENSG00000228044 (2.0)	TM6SF2 (2.0)
ENSG00000168610	STAT3 PPI subnetwork	0.02	> 0.20	BCL3 (5.1)	TRIB1 (4.4)	PARP10 (3.2)	RELB (2.7)	HLX (2.5)	POLK (2.4)	TMEM50A (2.2)	COL4A3BP (2.2)	PLCG1 (2.2)	MYLIP (2.1)
ENSG00000163785	RYK PPI subnetwork	0.02	> 0.20	CBLC (2.6)	TRAPPC6A (2.4)	C1orf63 (2.2)	HNF1A (2.2)	ANKRD31 (2.1)	ERP29 (2.1)	AP1M2 (2.0)	ATXN2 (1.7)	SORT1 (1.6)	MYLIP (1.5)
GO:0016830	carbon-carbon lyase activity	0.02	> 0.20	FADS2 (3.9)	FADS1 (3.6)	GPAM (3.5)	PLG (3.3)	DHODH (3.3)	HMGCR (3.3)	TRAPPC6A (3.1)	SARS (2.7)	PCSK9 (2.5)	ANGPTL3 (2.3)
ENSG00000182752	PAPPA PPI subnetwork	0.02	> 0.20	HP (2.9)	NYNRIN (2.3)	GMPR (2.1)	RHD (2.1)	DNAH11 (2.1)	CYP7A1 (2.0)	LPA (1.9)	APOC4 (1.8)	APOC1 (1.8)	PCSK9 (1.7)
ENSG00000155380	SLC16A1 PPI subnetwork	0.02	> 0.20	ACAD10 (4.1)	TMED4 (3.2)	HNF1A (2.9)	NT5DC1 (2.6)	TMEM50A (2.2)	TRAPPC6A (2.1)	CETP (2.0)	GMPR (1.9)	PLEKHH2 (1.9)	KANK2 (1.8)
ENSG00000058729	RIOK2 PPI subnetwork	0.02	> 0.20	DDX56 (4.3)	NAA25 (4.3)	QTRT1 (4.3)	ZNF259 (4.2)	TOMM40 (3.0)	DHODH (2.8)	DHX38 (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	C12orf43 (2.3)
GO:0032259	methylation	0.02	> 0.20	QTRT1 (2.5)	ZNF180 (2.5)	ENSG00000238078 (2.3)	C19orf52 (2.3)	DHODH (2.1)	MAPKAPK5 (1.9)	ILF3 (1.9)	ATXN7L2 (1.7)	ENSG00000254235 (1.7)	BUD13 (1.6)
MP:0011099	complete lethality throughout fetal growth and development	0.02	> 0.20	NYNRIN (3.8)	HLX (3.6)	USP24 (2.5)	C12orf51 (2.5)	PLEC (2.3)	BCAM (2.3)	ATXN2 (2.2)	KANK2 (2.0)	PTPN11 (1.9)	TRIB1 (1.8)
GO:0003854	3-beta-hydroxy-delta5-steroid dehydrogenase activity	0.02	> 0.20	HMGCR (4.3)	FADS2 (3.6)	FADS1 (3.4)	LDLR (3.3)	PCSK9 (3.1)	ENSG00000254235 (2.3)	NT5DC1 (2.2)	TRAPPC6A (2.1)	BLOC1S3 (2.0)	GMPR (1.9)
ENSG00000107447	DNTT PPI subnetwork	0.02	> 0.20	TIMD4 (3.3)	ALDH2 (2.9)	APOE (2.8)	BCL3 (2.3)	MAFB (2.2)	ENSG00000226645 (2.0)	ZNF180 (1.9)	AMIGO1 (1.9)	CETP (1.8)	FADS1 (1.8)
GO:0008483	transaminase activity	0.02	> 0.20	SLC22A1 (4.8)	APOA5 (4.5)	PLG (4.3)	LPA (3.9)	ANGPTL3 (3.6)	ALDH2 (3.6)	APOC4 (3.5)	SARS (2.9)	CYP7A1 (2.6)	TM6SF2 (2.5)
ENSG00000177600	RPLP2 PPI subnetwork	0.02	> 0.20	DDX56 (3.1)	NAA25 (3.1)	ZNF259 (3.0)	TOMM40 (2.6)	PVR (2.3)	C12orf43 (2.1)	QTRT1 (2.1)	GATAD2A (2.0)	ILF3 (1.8)	TOP1 (1.8)
MP:0005438	abnormal glycogen homeostasis	0.02	> 0.20	GRINA (2.7)	SYPL2 (2.5)	PPP1R37 (2.1)	ATP13A1 (2.1)	DNM2 (2.1)	BCAM (2.0)	PARP10 (1.9)	PLEC (1.9)	BLOC1S3 (1.8)	ZNF180 (1.8)
ENSG00000131370	SH3BP5 PPI subnetwork	0.02	> 0.20	ANGPTL3 (3.4)	PLG (3.0)	APOA5 (2.8)	TMEM57 (2.6)	APOC1 (2.2)	ABO (2.1)	LPA (2.0)	APOC4 (2.0)	ST3GAL4 (2.0)	CYP7A1 (1.9)
ENSG00000152147	GEMIN6 PPI subnetwork	0.02	> 0.20	ZNF180 (3.8)	TOMM40 (2.8)	C12orf47 (2.7)	POC5 (2.2)	C12orf43 (2.0)	BLOC1S3 (2.0)	GEMIN7 (1.8)	BUD13 (1.7)	ABO (1.6)	TRAPPC6A (1.6)
ENSG00000164342	TLR3 PPI subnetwork	0.02	> 0.20	PARP10 (5.0)	OASL (4.8)	FRK (2.8)	TRAFD1 (2.6)	BCL3 (2.6)	GMIP (2.5)	LPAR2 (2.1)	RELB (2.0)	MAU2 (1.9)	PTPN11 (1.8)
ENSG00000066926	FECH PPI subnetwork	0.02	> 0.20	NT5DC1 (3.9)	ACAD10 (2.9)	NAA25 (2.6)	ERP29 (2.2)	TOMM40 (2.2)	MAPKAPK5 (1.9)	BRAP (1.9)	BUD13 (1.8)	TMED4 (1.7)	RHD (1.6)
ENSG00000160185	UBASH3A PPI subnetwork	0.02	> 0.20	PARP10 (3.2)	PLEKHH2 (3.1)	OASL (2.6)	LPAR2 (2.5)	BCL3 (2.4)	COL4A3BP (2.4)	TRIB1 (2.4)	PPP1R37 (2.2)	ABCG8 (2.0)	NT5DC1 (2.0)
ENSG00000196498	NCOR2 PPI subnetwork	0.02	> 0.20	TRIB1 (3.6)	MAU2 (2.7)	ZHX3 (2.6)	PARP10 (2.5)	BCL3 (2.3)	DHX38 (2.3)	PLEC (2.0)	GMIP (1.9)	ATXN2 (1.6)	RELB (1.6)
MP:0003135	increased erythroid progenitor cell number	0.02	> 0.20	RHCE (9.2)	RHD (8.6)	GMPR (3.4)	C12orf51 (2.8)	C19orf52 (2.3)	SLC44A2 (2.2)	DNM2 (2.2)	ADAM1 (1.8)	SH2B3 (1.7)	ILF3 (1.6)
MP:0003702	abnormal chromosome morphology	0.02	> 0.20	UBXN2B (4.3)	PSRC1 (3.9)	USP1 (3.4)	FEN1 (3.0)	ENSG00000226648 (2.3)	DOCK7 (1.9)	HNF1A (1.6)	ENSG00000254235 (1.5)	ERP29 (1.5)	POC5 (1.5)
MP:0002752	abnormal somatic nervous system morphology	0.02	> 0.20	PVR (2.5)	CELSR2 (2.3)	TMED4 (1.9)	TRIB1 (1.9)	TSSK6 (1.8)	ENSG00000254235 (1.7)	FADS1 (1.7)	TIMD4 (1.7)	ABCG5 (1.5)	HLX (1.5)
MP:0003667	hemangiosarcoma	0.02	> 0.20	POLK (2.7)	TMEM50A (2.2)	MOSC1 (1.8)	LPIN3 (1.8)	PTPN11 (1.7)	ENSG00000228044 (1.7)	C12orf51 (1.6)	HAVCR1 (1.6)	CYP7A1 (1.5)	GCNT4 (1.5)
GO:0032403	protein complex binding	0.02	> 0.20	PLEC (3.0)	APOE (2.9)	CYP7A1 (2.7)	APOC4 (2.3)	CLPTM1 (2.2)	CELSR2 (2.2)	MAFB (2.1)	MARK4 (2.0)	SLC44A2 (2.0)	SH2B3 (1.9)
ENSG00000101040	ZMYND8 PPI subnetwork	0.02	> 0.20	USP24 (3.3)	MARK4 (2.7)	GMIP (2.5)	DHX38 (2.5)	PARP10 (2.5)	PPP1R37 (2.2)	MAFB (2.2)	SMARCA4 (2.1)	BCL3 (2.0)	POLK (1.9)
ENSG00000156482	RPL30 PPI subnetwork	0.02	> 0.20	NAA25 (3.5)	ZNF259 (3.3)	DDX56 (3.2)	TOMM40 (3.1)	QTRT1 (2.8)	GATAD2A (2.6)	TOP1 (2.0)	SARS (2.0)	PVR (2.0)	ATP13A1 (2.0)
ENSG00000128709	HOXD9 PPI subnetwork	0.02	> 0.20	DHODH (2.3)	ITGB3 (1.8)	MAU2 (1.8)	GCNT4 (1.7)	ZHX3 (1.7)	DHX38 (1.7)	LPIN3 (1.6)	MAPKAPK5 (1.6)	LDLR (1.6)	PVRL2 (1.6)
GO:0010950	positive regulation of endopeptidase activity	0.02	> 0.20	POLK (3.4)	TRAFD1 (2.4)	OASL (2.2)	C17orf57 (2.2)	GOT2P1 (2.2)	PARP10 (2.0)	BLOC1S3 (2.0)	ST3GAL4 (1.8)	GEMIN7 (1.7)	TRAPPC6A (1.7)
ENSG00000164934	DCAF13 PPI subnetwork	0.02	> 0.20	ZNF259 (4.7)	DDX56 (4.5)	NAA25 (4.1)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.8)	SUGP1 (2.4)	DHX38 (2.2)	ATP13A1 (2.1)	TOP1 (2.1)
ENSG00000205246	RPSAP58 PPI subnetwork	0.02	> 0.20	NAA25 (5.1)	ZNF259 (3.6)	PSMA5 (3.4)	TOMM40 (3.4)	DDX56 (3.3)	QTRT1 (3.1)	SARS (2.9)	DHODH (2.5)	BRAP (2.1)	NT5DC1 (2.0)
MP:0004756	abnormal proximal convoluted tubule morphology	0.02	> 0.20	RHD (4.6)	RHCE (3.9)	GMPR (2.8)	HNF1A (2.7)	GPAM (2.2)	POLK (2.1)	PLG (2.0)	GRINA (2.0)	DHODH (2.0)	DOCK7 (1.9)
ENSG00000087269	NOP14 PPI subnetwork	0.02	> 0.20	DDX56 (4.8)	ZNF259 (4.8)	NAA25 (4.2)	QTRT1 (3.8)	TOMM40 (3.4)	DHODH (3.1)	DHX38 (2.2)	ATP13A1 (2.1)	TOP1 (2.1)	C12orf43 (2.0)
ENSG00000171105	INSR PPI subnetwork	0.02	> 0.20	TRIB1 (2.7)	HLX (2.4)	SLC44A2 (2.3)	USP24 (2.3)	COL4A3BP (2.1)	SH2B3 (2.1)	MARK4 (2.1)	PVRL2 (1.9)	SORT1 (1.7)	GMIP (1.7)
ENSG00000215301	DDX3X PPI subnetwork	0.02	> 0.20	SMARCA4 (3.5)	ILF3 (3.2)	DHX38 (3.0)	NAA25 (2.9)	TOP1 (2.9)	GATAD2A (2.4)	USP1 (2.4)	DDX56 (2.3)	ATP13A1 (2.3)	OASL (2.3)
ENSG00000211619	ENSG00000211619 PPI subnetwork	0.02	> 0.20	APOE (2.4)	NPC1L1 (2.3)	APOB (2.2)	MAFB (2.2)	GCNT4 (1.9)	APOC4 (1.9)	ABCG5 (1.8)	GPAM (1.7)	ZNF180 (1.7)	FRK (1.7)
ENSG00000169306	IL1RAPL1 PPI subnetwork	0.02	> 0.20	ST3GAL4 (2.8)	AP1M2 (2.7)	HNF1A (2.5)	DNM2 (2.3)	KIAA1324 (2.2)	NYNRIN (1.9)	ITGB3 (1.8)	CETP (1.8)	PLEC (1.7)	CBLC (1.7)
ENSG00000123329	ARHGAP9 PPI subnetwork	0.02	> 0.20	PLEKHH2 (3.8)	PARP10 (2.9)	OASL (2.6)	TRIB1 (2.5)	BCL3 (2.5)	TRAFD1 (2.3)	PPP1R37 (2.3)	LPAR2 (2.2)	COL4A3BP (2.2)	NT5DC1 (2.0)
GO:0051262	protein tetramerization	0.02	> 0.20	NT5DC1 (3.4)	NKPD1 (2.8)	LPA (2.4)	CYP7A1 (2.4)	TRAPPC6A (2.4)	ANKRD31 (2.3)	ACAD10 (2.3)	GOT2P1 (2.2)	DHODH (2.1)	SLC22A1 (2.1)
ENSG00000157456	CCNB2 PPI subnetwork	0.02	> 0.20	USP1 (3.9)	FEN1 (3.5)	PSRC1 (2.8)	POC5 (2.1)	TOMM40 (1.9)	SMARCA4 (1.8)	ILF3 (1.8)	DHX38 (1.8)	ENSG00000226648 (1.6)	PTPN11 (1.5)
ENSG00000103671	TRIP4 PPI subnetwork	0.02	> 0.20	ATXN2 (2.6)	C12orf51 (2.4)	BCL3 (2.2)	PLEC (2.2)	ANKRD31 (1.9)	RELB (1.8)	NT5DC1 (1.7)	TRIB1 (1.7)	GCNT4 (1.6)	UBXN2B (1.6)
MP:0001533	abnormal skeleton physiology	0.02	> 0.20	CILP2 (5.7)	MAFB (2.9)	ITGB3 (2.5)	TMEM57 (2.2)	CLPTM1 (2.2)	FRK (2.1)	PPP1R37 (1.9)	ST3GAL4 (1.7)	APOC1 (1.7)	MYLIP (1.7)
ENSG00000113460	BRIX1 PPI subnetwork	0.02	> 0.20	NAA25 (4.9)	ZNF259 (4.8)	TOMM40 (4.0)	DDX56 (3.8)	QTRT1 (3.8)	DHODH (2.9)	C12orf43 (2.6)	DHX38 (2.4)	ATP13A1 (2.1)	ILF3 (1.8)
ENSG00000052749	RRP12 PPI subnetwork	0.02	> 0.20	NAA25 (5.0)	ZNF259 (4.7)	DDX56 (4.7)	TOMM40 (3.6)	QTRT1 (3.6)	DHODH (2.5)	DHX38 (2.3)	C12orf43 (2.2)	ATP13A1 (2.1)	PVR (2.0)
MP:0004056	abnormal myocardium compact layer morphology	0.02	> 0.20	C11orf9 (3.6)	TMEM57 (3.3)	APOB (3.0)	COL4A3BP (2.6)	ABCG8 (2.5)	GPAM (2.3)	TMED4 (2.1)	ALDH2 (2.1)	C17orf57 (2.1)	PVRL2 (2.0)
ENSG00000185736	ADARB2 PPI subnetwork	0.02	> 0.20	C19orf52 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)	DHX38 (2.1)	PARP10 (2.0)	OASL (2.0)	BRAP (2.0)	ZNF180 (1.8)	YIPF2 (1.8)	GRINA (1.7)
MP:0003402	decreased liver weight	0.02	> 0.20	LDLR (3.9)	POLK (3.3)	PCSK9 (2.2)	HMGCR (2.2)	KIAA1324 (2.0)	SLC44A2 (1.9)	ZHX3 (1.8)	ATXN7L2 (1.6)	GCNT4 (1.6)	C11orf9 (1.6)
ENSG00000212981	ENSG00000212981 PPI subnetwork	0.02	> 0.20	NAA25 (4.6)	DDX56 (4.1)	ZNF259 (3.5)	QTRT1 (3.3)	TOMM40 (2.7)	DHX38 (2.5)	DHODH (2.5)	C12orf43 (2.5)	PTPN11 (2.1)	SUGP1 (2.1)
ENSG00000079246	XRCC5 PPI subnetwork	0.02	> 0.20	SMARCA4 (3.1)	FEN1 (2.9)	ILF3 (2.7)	TOP1 (2.4)	PLCG1 (2.3)	USP1 (2.2)	POLK (2.1)	DHX38 (2.0)	ACAD10 (2.0)	NAA25 (1.7)
GO:0030162	regulation of proteolysis	0.02	> 0.20	ENSG00000228044 (3.3)	GEMIN7 (2.5)	DYNC2LI1 (2.2)	CLPTM1 (1.8)	ENSG00000235545 (1.8)	BLOC1S3 (1.5)	APOC1 (1.4)	SLC22A1 (1.3)	APOA5 (1.3)	ZNF180 (1.2)
ENSG00000125538	IL1B PPI subnetwork	0.02	> 0.20	BCL3 (4.9)	RELB (4.3)	TRIB1 (4.3)	HLX (3.2)	HP (2.5)	ST3GAL4 (2.3)	ENSG00000235545 (1.8)	ENSG00000228044 (1.5)	RHD (1.4)	OASL (1.4)
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	0.02	> 0.20	GPAM (3.5)	MOSC1 (3.4)	GEMIN7 (2.6)	C12orf51 (2.4)	HP (2.4)	MAPKAPK5 (2.3)	SH2B3 (2.3)	TIMD4 (2.1)	ATXN2 (1.8)	GRINA (1.8)
ENSG00000130203	APOE PPI subnetwork	0.02	> 0.20	APOB (6.7)	APOC1 (5.0)	NPC1L1 (3.4)	APOA5 (3.3)	ABCG5 (3.1)	PLG (3.0)	ANGPTL3 (2.8)	HP (2.6)	APOE (2.5)	FADS1 (2.4)
ENSG00000117318	ID3 PPI subnetwork	0.02	> 0.20	LPIN3 (2.2)	MYLIP (2.2)	SYPL2 (2.0)	GCNT4 (2.0)	CLPTM1 (1.9)	BCL3 (1.9)	TRIB1 (1.8)	LDLR (1.6)	ATXN2 (1.6)	ATXN7L2 (1.6)
MP:0001882	abnormal lactation	0.02	> 0.20	KIAA1324 (3.1)	NPC1L1 (3.1)	LPA (2.7)	GPAM (2.3)	CYP7A1 (1.9)	CELSR2 (1.8)	APOC1 (1.8)	HLX (1.7)	PLEKHH2 (1.7)	MAFB (1.7)
GO:0042301	phosphate ion binding	0.02	> 0.20	TM6SF2 (3.8)	LPA (3.8)	ABCG5 (3.8)	NPC1L1 (3.6)	ABCG8 (2.6)	TMEM50A (2.5)	HAPLN4 (2.4)	PLG (2.3)	GCNT4 (2.2)	ALDH2 (2.2)
GO:0010575	positive regulation vascular endothelial growth factor production	0.02	> 0.20	ENSG00000228044 (2.4)	ST3GAL4 (2.4)	PMFBP1 (2.4)	TMEM116 (1.9)	ATXN7L2 (1.8)	DOCK7 (1.7)	ENSG00000226648 (1.6)	ENSG00000235545 (1.5)	TSSK6 (1.4)	POLK (1.4)
ENSG00000153879	CEBPG PPI subnetwork	0.02	> 0.20	SARS (4.2)	TRIB1 (4.1)	BCL3 (3.3)	MAFB (3.1)	PVR (3.0)	HLX (2.4)	ABCG8 (2.3)	ST3GAL4 (2.1)	PVRL2 (2.1)	POC5 (2.0)
REACTOME_TOLL_RECEPTOR_CASCADES	REACTOME_TOLL_RECEPTOR_CASCADES	0.02	> 0.20	OASL (4.2)	RELB (3.9)	BCL3 (3.7)	TRIB1 (3.6)	SH2B3 (3.5)	GMIP (2.9)	PARP10 (2.8)	MAFB (2.5)	PVR (2.4)	TRAFD1 (2.2)
MP:0002344	abnormal lymph node B cell domain morphology	0.02	> 0.20	RELB (6.7)	BCL3 (4.4)	UBXN2B (4.0)	GRINA (3.7)	CEACAM19 (3.2)	TRIB1 (2.7)	PARP10 (2.7)	ST3GAL4 (2.5)	MAFB (2.5)	GOT2P1 (2.2)
ENSG00000135372	NAT10 PPI subnetwork	0.02	> 0.20	ZNF259 (5.1)	NAA25 (4.5)	DDX56 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.2)	DHX38 (2.8)	SUGP1 (2.7)	ATP13A1 (2.6)	C12orf43 (2.6)
MP:0005533	increased body temperature	0.02	> 0.20	MOSC1 (3.5)	TM6SF2 (3.2)	APOC1 (3.1)	ALDH2 (2.8)	SYPL2 (2.7)	HP (2.6)	OASL (2.4)	PVR (2.2)	CETP (2.1)	TIMD4 (2.1)
KEGG_VEGF_SIGNALING_PATHWAY	KEGG_VEGF_SIGNALING_PATHWAY	0.02	> 0.20	GATAD2A (3.4)	DNM2 (3.0)	MARK4 (2.6)	MYLIP (2.3)	GMIP (2.1)	CYB561D1 (2.0)	SH2B3 (2.0)	PLEC (2.0)	TMEM57 (2.0)	TMEM116 (1.6)
MP:0011098	complete embryonic lethality during organogenesis	0.02	> 0.20	ATXN2 (2.8)	KANK2 (2.8)	HLX (2.5)	GATAD2A (2.4)	PVR (2.0)	SMARCA4 (2.0)	PVRL2 (2.0)	NYNRIN (2.0)	DNM2 (2.0)	USP24 (1.9)
ENSG00000001630	CYP51A1 PPI subnetwork	0.02	> 0.20	HMGCR (12.0)	LDLR (11.6)	FADS1 (8.9)	FADS2 (8.2)	PCSK9 (6.8)	TM6SF2 (2.4)	CYP7A1 (2.4)	NPC1L1 (2.3)	ATP13A1 (2.3)	TMED4 (2.1)
MP:0005479	decreased circulating triiodothyronine level	0.02	> 0.20	C17orf57 (3.6)	HAVCR1 (3.5)	MYLIP (3.1)	COL4A3BP (3.0)	POLK (2.4)	TRIB1 (2.4)	MAFB (2.3)	MOSC1 (1.9)	C11orf9 (1.8)	CYP7A1 (1.7)
ENSG00000010244	ZNF207 PPI subnetwork	0.02	> 0.20	ILF3 (3.4)	ATXN2 (3.3)	SUGP1 (3.2)	PPP1R37 (2.9)	BUD13 (2.4)	C1orf63 (2.3)	SMARCA4 (2.2)	ATXN7L2 (2.1)	MAU2 (2.0)	TOP1 (1.9)
MP:0002816	colitis	0.02	> 0.20	CYP7A1 (2.6)	HLX (2.3)	OASL (2.3)	LPA (2.2)	BCL3 (2.2)	GMIP (2.1)	PLEC (2.1)	SH2B3 (2.0)	PBX4 (1.9)	APOC4 (1.8)
GO:0007249	I-kappaB kinase/NF-kappaB cascade	0.02	> 0.20	PARP10 (3.4)	RELB (2.6)	SH2B3 (2.4)	ST3GAL4 (2.3)	TRAFD1 (2.3)	ZNF101 (2.2)	GRINA (2.1)	BCL3 (2.0)	CYB561D1 (2.0)	GEMIN7 (1.9)
ENSG00000143013	LMO4 PPI subnetwork	0.02	> 0.20	CARM1 (3.0)	NYNRIN (2.3)	KANK2 (2.1)	C12orf51 (2.0)	MAFB (1.9)	ENSG00000226648 (1.6)	TIMD4 (1.6)	ZHX3 (1.4)	ENSG00000254235 (1.4)	POC5 (1.4)
GO:0001678	cellular glucose homeostasis	0.02	> 0.20	ENSG00000254235 (4.8)	ST3GAL4 (2.7)	GEMIN7 (2.6)	PCSK9 (2.1)	ENSG00000238078 (1.6)	KIAA1324 (1.6)	UBXN2B (1.5)	ADAM1 (1.4)	PPP1R37 (1.4)	HNF1A (1.4)
ENSG00000107611	CUBN PPI subnetwork	0.02	> 0.20	APOB (7.1)	ANGPTL3 (6.1)	PLG (5.6)	APOC4 (3.6)	NPC1L1 (3.6)	APOA5 (3.6)	HP (3.3)	C11orf9 (3.3)	APOC1 (3.1)	ABCG5 (2.9)
ENSG00000214078	CPNE1 PPI subnetwork	0.02	> 0.20	GOT2P1 (2.6)	CEACAM19 (2.4)	NT5DC1 (2.3)	PLEC (2.2)	C12orf51 (2.1)	ZNF180 (2.1)	C17orf57 (2.1)	PVRL2 (2.1)	PVR (1.9)	PTPN11 (1.8)
ENSG00000120156	TEK PPI subnetwork	0.02	> 0.20	COL4A3BP (3.1)	DNM2 (2.1)	TMEM57 (1.9)	HLX (1.9)	ZHX3 (1.8)	TRAFD1 (1.8)	PARP10 (1.7)	ITGB3 (1.7)	USP24 (1.6)	DNAH11 (1.6)
GO:0001540	beta-amyloid binding	0.02	> 0.20	RPH3A (2.8)	APOB (2.5)	APOE (2.5)	ABCG5 (2.5)	APOC1 (2.5)	AMIGO1 (1.9)	TM6SF2 (1.9)	CELSR2 (1.8)	NPC1L1 (1.8)	CEACAM19 (1.8)
ENSG00000166598	HSP90B1 PPI subnetwork	0.02	> 0.20	ERP29 (3.7)	CELSR2 (2.2)	BCAM (2.2)	PCSK9 (1.9)	TMED4 (1.8)	YIPF2 (1.7)	HMGCR (1.7)	PLCG1 (1.6)	GRINA (1.6)	CARM1 (1.6)
MP:0000367	abnormal coat/ hair morphology	0.02	> 0.20	LDLR (4.5)	HMGCR (3.8)	PCSK9 (3.4)	FADS1 (2.2)	CYB561D1 (2.1)	BLOC1S3 (2.0)	AP1M2 (1.9)	FADS2 (1.8)	NYNRIN (1.8)	ENSG00000238078 (1.6)
ENSG00000164692	COL1A2 PPI subnetwork	0.02	> 0.20	ITGB3 (9.5)	CETP (3.8)	CILP2 (2.9)	APOE (2.7)	GMPR (2.4)	MAFB (2.1)	ALDH2 (2.0)	TIMD4 (2.0)	ST3GAL4 (1.7)	ABCG8 (1.7)
GO:0015721	bile acid and bile salt transport	0.02	> 0.20	CYP7A1 (6.7)	APOC4 (4.5)	ANGPTL3 (4.0)	APOA5 (3.5)	SLC22A1 (3.3)	ABCG8 (3.2)	LPA (2.9)	PLG (2.6)	GOT2P1 (2.5)	TM6SF2 (2.4)
ENSG00000125991	ERGIC3 PPI subnetwork	0.02	> 0.20	YIPF2 (2.5)	TMEM57 (2.4)	C12orf43 (2.4)	POC5 (2.3)	ERP29 (2.3)	KIAA1324 (2.3)	DHODH (2.2)	CLPTM1 (1.9)	ANKRD31 (1.8)	CYP7A1 (1.8)
ENSG00000092098	RNF31 PPI subnetwork	0.02	> 0.20	PARP10 (6.2)	OASL (4.1)	TRAFD1 (4.0)	BCL3 (2.9)	RHD (2.9)	GRINA (2.7)	RHCE (2.6)	CYB561D1 (2.5)	ABO (2.4)	RELB (2.3)
MP:0000628	abnormal mammary gland development	0.02	> 0.20	CELSR2 (3.3)	KIAA1324 (2.7)	CYP7A1 (2.2)	POLK (2.2)	SLC22A1 (1.8)	BCL3 (1.8)	PTPN11 (1.8)	ANKRD31 (1.8)	UBXN2B (1.8)	APOC4 (1.7)
MP:0004794	increased anti-nuclear antigen antibody level	0.02	> 0.20	RELB (4.7)	BCL3 (3.8)	MAFB (3.1)	TRIB1 (2.5)	COL4A3BP (2.5)	PARP10 (2.3)	GMIP (2.3)	TIMD4 (2.1)	CETP (2.1)	ENSG00000238078 (1.8)
GO:0017144	drug metabolic process	0.02	> 0.20	CYP7A1 (5.3)	SLC22A1 (5.2)	LPA (5.1)	ABCG8 (4.5)	TM6SF2 (4.5)	ABCG5 (3.9)	GCNT4 (3.1)	NPC1L1 (2.9)	APOC4 (2.6)	APOA5 (2.3)
ENSG00000146109	ABT1 PPI subnetwork	0.02	> 0.20	NAA25 (4.4)	DDX56 (4.0)	ZNF259 (3.9)	TOMM40 (3.7)	QTRT1 (3.5)	DHODH (3.2)	C12orf43 (2.6)	DHX38 (2.5)	TOP1 (2.4)	MAPKAPK5 (2.2)
ENSG00000129255	MPDU1 PPI subnetwork	0.02	> 0.20	ANKRD31 (2.9)	PMFBP1 (2.2)	LDLR (2.1)	PLEKHH2 (1.7)	DHODH (1.7)	FADS2 (1.6)	FADS1 (1.6)	TMEM116 (1.5)	HMGCR (1.4)	CILP2 (1.4)
GO:0042562	hormone binding	0.02	> 0.20	KIAA1324 (3.7)	GPAM (2.7)	LPA (2.6)	PLG (2.3)	C12orf47 (2.2)	MYLIP (2.2)	ALDH2 (2.2)	MOSC1 (2.2)	SLC22A1 (2.1)	ANGPTL3 (2.0)
GO:0006027	glycosaminoglycan catabolic process	0.02	> 0.20	CEACAM19 (4.4)	PMFBP1 (4.0)	ENSG00000228044 (3.8)	NKPD1 (3.8)	CETP (3.2)	TMED4 (2.9)	TIMD4 (2.2)	GCNT4 (2.2)	ERP29 (2.0)	PBX4 (2.0)
ENSG00000136628	EPRS PPI subnetwork	0.02	> 0.20	SARS (3.9)	NAA25 (3.5)	DDX56 (3.4)	HMGCR (3.4)	ZNF259 (3.2)	RELB (2.6)	PSMA5 (2.5)	ATP13A1 (2.3)	LDLR (2.1)	CLPTM1 (2.1)
ENSG00000124299	PEPD PPI subnetwork	0.02	> 0.20	USP24 (3.0)	QTRT1 (2.5)	DHX38 (2.2)	SMARCA4 (2.1)	NAA25 (2.0)	GMPR (1.9)	ILF3 (1.8)	CYP7A1 (1.8)	ENSG00000254235 (1.7)	CELSR2 (1.7)
MP:0001559	hyperglycemia	0.02	> 0.20	GPAM (4.9)	MOSC1 (3.5)	C11orf9 (2.4)	RHCE (2.1)	SORT1 (2.1)	CETP (1.8)	LPIN3 (1.7)	TMEM57 (1.7)	GCNT4 (1.7)	TIMD4 (1.7)
ENSG00000173369	C1QB PPI subnetwork	0.02	> 0.20	TIMD4 (3.7)	APOE (3.2)	MAFB (3.2)	SLC22A1 (2.9)	APOC1 (2.0)	APOC4 (1.8)	CILP2 (1.8)	ANGPTL3 (1.8)	CETP (1.8)	HP (1.7)
GO:0051055	negative regulation of lipid biosynthetic process	0.02	> 0.20	TRAPPC6A (2.4)	NPC1L1 (2.4)	BLOC1S3 (2.0)	HNF1A (1.8)	C12orf47 (1.7)	HMGCR (1.6)	FADS1 (1.5)	GCNT4 (1.5)	PPP1R37 (1.4)	TM6SF2 (1.4)
ENSG00000122180	MYOG PPI subnetwork	0.02	> 0.20	KANK2 (3.2)	NYNRIN (2.5)	CARM1 (2.3)	MAPKAPK5 (2.2)	HLX (1.9)	CYB561D1 (1.7)	ATXN7L2 (1.6)	SYPL2 (1.5)	UBXN2B (1.5)	ENSG00000254235 (1.5)
ENSG00000174177	CTU2 PPI subnetwork	0.02	> 0.20	HMGCR (6.9)	LDLR (4.7)	APOA5 (2.9)	FADS1 (2.5)	FADS2 (2.5)	ATXN7L2 (2.2)	CYP7A1 (2.1)	PLG (1.9)	LPA (1.8)	ABCG5 (1.8)
GO:0010565	regulation of cellular ketone metabolic process	0.02	> 0.20	ENSG00000254235 (2.6)	PSMA5 (2.5)	TXNL4B (2.3)	NT5DC1 (2.2)	GPAM (2.2)	PCSK9 (1.9)	OGDH (1.8)	TRAFD1 (1.7)	ZNF180 (1.7)	NAA25 (1.6)
ENSG00000197586	ENTPD6 PPI subnetwork	0.02	> 0.20	LDLR (4.7)	HMGCR (4.1)	C17orf57 (2.4)	CYB561D1 (2.3)	NPC1L1 (2.2)	FADS1 (2.2)	DNAH11 (2.1)	TXNL4B (1.9)	TMED4 (1.8)	FADS2 (1.8)
GO:0006953	acute-phase response	0.02	> 0.20	ENSG00000228044 (3.5)	HP (2.9)	SLC22A1 (2.8)	ENSG00000235545 (2.5)	APOA5 (2.5)	LPA (2.3)	ABCG5 (2.0)	APOC4 (1.9)	PLG (1.8)	TIMD4 (1.8)
ENSG00000177971	IMP3 PPI subnetwork	0.02	> 0.20	ZNF259 (4.8)	DDX56 (4.1)	NAA25 (3.9)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.7)	SUGP1 (2.3)	ATP13A1 (2.3)	DHX38 (2.3)	TOP1 (2.2)
GO:0032862	activation of Rho GTPase activity	0.02	> 0.20	CEACAM19 (3.3)	ENSG00000238078 (3.2)	AP1M2 (3.1)	LPIN3 (2.6)	HNF1A (2.4)	CETP (2.2)	ENSG00000228044 (2.1)	CBLC (1.7)	ENSG00000226645 (1.7)	C11orf9 (1.6)
ENSG00000170484	KRT74 PPI subnetwork	0.02	> 0.20	PLEKHH2 (3.3)	PARP10 (2.9)	LPAR2 (2.7)	OASL (2.6)	NT5DC1 (2.4)	BCL3 (2.3)	PLCG1 (2.2)	COL4A3BP (2.2)	GMIP (2.0)	TRIB1 (2.0)
ENSG00000181104	F2R PPI subnetwork	0.02	> 0.20	HP (4.4)	APOC4 (2.8)	ANGPTL3 (2.6)	KANK2 (2.3)	APOA5 (2.2)	RHD (2.2)	HLX (2.1)	ST3GAL4 (1.9)	PLG (1.8)	CEACAM19 (1.8)
GO:0048037	cofactor binding	0.02	> 0.20	ALDH2 (4.5)	ACAD10 (3.8)	MOSC1 (3.7)	PLG (3.6)	SLC22A1 (3.4)	FADS2 (3.3)	FADS1 (3.2)	GPAM (3.2)	ANGPTL3 (2.8)	LPA (2.4)
MP:0005562	decreased mean corpuscular hemoglobin	0.02	> 0.20	RHCE (10.0)	RHD (9.0)	GMPR (2.6)	TIMD4 (2.4)	DNAH11 (2.0)	CETP (1.9)	BLOC1S3 (1.9)	FADS2 (1.9)	ERP29 (1.8)	ATXN7L2 (1.7)
REACTOME_MYD88:INDEPENDENT_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88:INDEPENDENT_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.02	> 0.20	RELB (4.7)	BCL3 (3.6)	SH2B3 (3.5)	TRIB1 (3.4)	PVR (3.4)	OASL (3.2)	PARP10 (2.8)	HLX (2.6)	GMIP (2.4)	GRINA (1.9)
MP:0009399	increased skeletal muscle fiber size	0.02	> 0.20	SYPL2 (5.2)	KANK2 (3.3)	CLPTM1 (2.7)	COL4A3BP (2.6)	CEACAM19 (2.2)	GRINA (2.1)	LPIN3 (2.1)	PLEC (2.0)	ATP13A1 (1.9)	OGDH (1.8)
GO:0050817	coagulation	0.02	> 0.20	ITGB3 (7.1)	GMPR (3.2)	CETP (2.1)	ANGPTL3 (1.9)	PTPN11 (1.8)	TMEM50A (1.8)	C11orf9 (1.8)	TIMD4 (1.7)	PLG (1.5)	ZNF101 (1.5)
GO:0071371	cellular response to gonadotropin stimulus	0.02	> 0.20	DNAH11 (3.2)	C11orf9 (3.1)	ABO (2.6)	ST3GAL4 (2.5)	FADS2 (2.1)	HMGCR (2.0)	TMED4 (2.0)	ENSG00000238078 (1.9)	GOT2P1 (1.8)	LDLR (1.7)
GO:0051346	negative regulation of hydrolase activity	0.02	> 0.20	HP (2.7)	APOB (2.5)	APOA5 (2.4)	CEACAM19 (2.4)	APOC4 (2.3)	PLG (2.2)	ANGPTL3 (2.1)	ABCG5 (2.1)	SLC22A1 (1.9)	HNF1A (1.9)
ENSG00000118046	STK11 PPI subnetwork	0.02	> 0.20	DNM2 (3.8)	MAU2 (3.7)	LPAR2 (2.6)	CARM1 (2.4)	GMIP (2.1)	SLC44A2 (2.0)	C19orf52 (2.0)	ILF3 (2.0)	ATP13A1 (1.9)	CELSR2 (1.9)
MP:0004947	skin inflammation	0.02	> 0.20	BCL3 (4.5)	PARP10 (3.7)	GMIP (3.4)	GRINA (2.8)	DNM2 (2.7)	ST3GAL4 (2.7)	TRAFD1 (2.3)	PLEC (2.2)	GCNT4 (2.1)	CYB561D1 (1.8)
MP:0005108	abnormal ulna morphology	0.02	> 0.20	DNAH11 (2.4)	ANKRD31 (2.2)	PLEC (2.2)	PCSK9 (2.1)	NYNRIN (2.0)	ZHX3 (1.7)	NPC1L1 (1.5)	KANK2 (1.4)	PLEKHH2 (1.4)	PLCG1 (1.3)
ENSG00000137500	CCDC90B PPI subnetwork	0.02	> 0.20	HAVCR1 (2.4)	ALDH2 (2.3)	BLOC1S3 (2.2)	KANK2 (2.1)	GEMIN7 (2.0)	TMEM57 (1.9)	TRAPPC6A (1.9)	GMPR (1.7)	GCNT4 (1.7)	NCAN (1.7)
REACTOME_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE	0.02	> 0.20	RELB (4.6)	OASL (4.4)	PARP10 (3.8)	BCL3 (3.6)	SH2B3 (3.2)	TRIB1 (3.1)	PVR (3.0)	TRAFD1 (2.7)	GMIP (2.5)	HLX (2.3)
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	0.02	> 0.20	RELB (4.6)	OASL (4.4)	PARP10 (3.8)	BCL3 (3.6)	SH2B3 (3.2)	TRIB1 (3.1)	PVR (3.0)	TRAFD1 (2.7)	GMIP (2.5)	HLX (2.3)
ENSG00000173566	NUDT18 PPI subnetwork	0.02	> 0.20	NT5DC1 (2.8)	UBXN2B (2.4)	MAU2 (2.3)	CARM1 (2.1)	GMPR (1.9)	APOA5 (1.9)	TXNL4B (1.9)	LPA (1.8)	PMFBP1 (1.6)	KIAA1324 (1.5)
MP:0004796	increased anti-histone antibody level	0.02	> 0.20	ZNF101 (3.2)	TIMD4 (2.9)	MAFB (2.4)	CETP (2.3)	TRIB1 (2.3)	ENSG00000226648 (2.2)	POLK (2.1)	GRINA (2.1)	ENSG00000238078 (2.0)	KANK2 (2.0)
ENSG00000005844	ITGAL PPI subnetwork	0.02	> 0.20	APOE (3.4)	SH2B3 (3.0)	SLC44A2 (2.9)	RELB (2.5)	GMIP (2.3)	C19orf52 (1.9)	CYB561D1 (1.9)	TMEM116 (1.8)	CETP (1.7)	APOC1 (1.6)
MP:0008752	abnormal tumor necrosis factor level	0.02	> 0.20	PARP10 (5.0)	MAFB (4.0)	BCL3 (3.6)	RELB (3.3)	TRIB1 (3.1)	APOE (3.1)	PMFBP1 (2.5)	APOC1 (2.3)	SH2B3 (1.9)	OASL (1.9)
ENSG00000132780	NASP PPI subnetwork	0.02	> 0.20	DNAH11 (2.3)	GEMIN7 (2.2)	ZHX3 (2.1)	ABO (1.7)	TRIB1 (1.7)	C19orf52 (1.7)	MYLIP (1.7)	C11orf9 (1.6)	TMEM50A (1.6)	PMFBP1 (1.4)
MP:0002652	thin myocardium	0.02	> 0.20	C11orf9 (3.3)	KANK2 (3.2)	MAPKAPK5 (2.4)	USP24 (2.4)	PVRL2 (2.3)	UBXN2B (2.3)	DOCK7 (2.2)	ATXN2 (2.1)	TIMD4 (2.0)	C12orf51 (2.0)
ENSG00000162909	CAPN2 PPI subnetwork	0.03	> 0.20	ANGPTL3 (3.4)	SH2B3 (3.2)	PLG (2.9)	FRK (2.4)	PVR (2.1)	C17orf57 (2.1)	GRINA (2.0)	LPA (1.9)	ALDH2 (1.9)	SLC44A2 (1.7)
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	0.03	> 0.20	RHCE (10.2)	RHD (9.7)	NT5DC1 (2.4)	DHODH (2.4)	MAFB (2.3)	ADAM1 (2.2)	ANGPTL3 (2.2)	ALDH2 (2.1)	GMPR (2.0)	C12orf51 (1.9)
ENSG00000179588	ZFPM1 PPI subnetwork	0.03	> 0.20	C11orf9 (3.0)	NYNRIN (2.9)	GMPR (2.7)	ABO (2.2)	RHCE (2.1)	RHD (2.0)	MARK4 (1.9)	PVRL2 (1.9)	MAU2 (1.8)	YIPF2 (1.8)
GO:0042990	regulation of transcription factor import into nucleus	0.03	> 0.20	ENSG00000235545 (2.9)	LPAR2 (2.6)	OASL (2.4)	ABO (2.2)	ZNF101 (2.0)	MYLIP (2.0)	PARP10 (1.8)	SH2B3 (1.7)	GCNT4 (1.7)	RELB (1.6)
GO:0009617	response to bacterium	0.03	> 0.20	HP (2.4)	PMFBP1 (2.0)	HLX (2.0)	MAFB (2.0)	BCL3 (1.9)	ADAM1 (1.8)	PVR (1.8)	CEACAM19 (1.8)	ENSG00000228044 (1.7)	DNAH11 (1.7)
GO:0032354	response to follicle-stimulating hormone stimulus	0.03	> 0.20	ST3GAL4 (3.5)	DNAH11 (2.8)	HMGCR (2.7)	FADS2 (2.4)	LDLR (2.4)	ABCG8 (2.2)	FADS1 (2.2)	TMED4 (2.0)	GCNT4 (1.9)	CYP7A1 (1.6)
GO:0000988	protein binding transcription factor activity	0.03	> 0.20	ATXN2 (3.0)	TRIB1 (2.6)	BUD13 (2.6)	NYNRIN (2.5)	CARM1 (2.5)	ATXN7L2 (2.4)	TMEM57 (2.4)	MAPKAPK5 (2.4)	SMARCA4 (2.2)	MAU2 (2.0)
GO:0016363	nuclear matrix	0.03	> 0.20	TOP1 (4.0)	USP1 (3.1)	ZNF180 (2.8)	ILF3 (2.6)	DNM2 (2.6)	PSRC1 (2.2)	SUGP1 (2.1)	FEN1 (2.1)	BUD13 (2.0)	SMARCA4 (1.9)
ENSG00000101343	CRNKL1 PPI subnetwork	0.03	> 0.20	SUGP1 (4.1)	DHX38 (3.9)	BUD13 (3.6)	MAU2 (2.8)	BRAP (2.8)	C12orf43 (2.7)	SMARCA4 (2.7)	ZNF180 (2.6)	DDX56 (2.5)	TRAFD1 (2.2)
ENSG00000166888	STAT6 PPI subnetwork	0.03	> 0.20	RELB (5.5)	BCL3 (5.2)	PARP10 (4.0)	GMIP (3.5)	TRAFD1 (3.0)	DNM2 (2.7)	TMEM50A (2.5)	SH2B3 (2.3)	COL4A3BP (2.3)	BUD13 (2.2)
ENSG00000165556	CDX2 PPI subnetwork	0.03	> 0.20	PCSK9 (5.1)	HMGCR (4.9)	LDLR (4.4)	FADS1 (3.7)	FADS2 (3.3)	HAVCR1 (2.8)	ABO (2.7)	ENSG00000226645 (2.5)	HNF1A (2.5)	NPC1L1 (2.1)
GO:0010952	positive regulation of peptidase activity	0.03	> 0.20	POLK (3.1)	TRAFD1 (2.3)	ST3GAL4 (2.2)	OASL (2.1)	PARP10 (2.0)	C17orf57 (1.8)	MAPKAPK5 (1.8)	BLOC1S3 (1.7)	ENSG00000238078 (1.7)	FRK (1.7)
ENSG00000137975	CLCA2 PPI subnetwork	0.03	> 0.20	APOB (7.8)	APOC1 (4.0)	PLG (4.0)	APOA5 (3.8)	ABCG5 (3.7)	NPC1L1 (3.6)	GMPR (3.0)	HP (3.0)	GPAM (2.8)	APOC4 (2.8)
GO:0031434	mitogen-activated protein kinase kinase binding	0.03	> 0.20	PPP1R37 (3.0)	MAU2 (2.7)	DNM2 (2.5)	C11orf9 (2.3)	RPH3A (2.3)	SORT1 (2.0)	LPAR2 (1.9)	GEMIN7 (1.7)	HLX (1.7)	CLPTM1 (1.6)
ENSG00000167363	FN3K PPI subnetwork	0.03	> 0.20	PLEKHH2 (3.2)	PARP10 (3.0)	LPAR2 (2.7)	OASL (2.6)	BCL3 (2.3)	NT5DC1 (2.3)	PLCG1 (2.1)	COL4A3BP (2.1)	TRIB1 (2.1)	GMIP (2.0)
MP:0005440	increased glycogen level	0.03	> 0.20	APOA5 (4.4)	APOC4 (4.0)	PLG (4.0)	APOB (3.9)	LPA (3.3)	MOSC1 (3.2)	HP (3.1)	CYP7A1 (2.8)	ANGPTL3 (2.7)	SORT1 (2.7)
ENSG00000215612	HMX1 PPI subnetwork	0.03	> 0.20	ZNF180 (3.9)	GEMIN7 (2.6)	PPP1R37 (2.5)	PLCG1 (2.2)	HAPLN4 (2.0)	TRAPPC6A (2.0)	SARS (1.9)	ERP29 (1.8)	ALDH2 (1.8)	ZNF101 (1.7)
ENSG00000089157	RPLP0 PPI subnetwork	0.03	> 0.20	NAA25 (4.2)	DDX56 (3.3)	ILF3 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	TOMM40 (2.6)	TOP1 (2.5)	DHX38 (2.2)	PTPN11 (2.1)	CARM1 (2.0)
ENSG00000087088	BAX PPI subnetwork	0.03	> 0.20	PPP1R37 (3.0)	LPIN3 (2.8)	TRAPPC6A (2.3)	MARK4 (2.1)	POLK (1.9)	CBLC (1.9)	C12orf43 (1.7)	CLPTM1 (1.7)	GRINA (1.7)	TXNL4B (1.7)
ENSG00000106006	HOXA6 PPI subnetwork	0.03	> 0.20	ATXN2 (4.3)	ANKRD31 (2.6)	C12orf51 (2.5)	CARM1 (2.4)	ATXN7L2 (2.4)	MARK4 (2.3)	HNF1A (2.2)	MAU2 (2.2)	GOT2P1 (2.0)	GATAD2A (1.9)
ENSG00000131043	C20orf4 PPI subnetwork	0.03	> 0.20	DHX38 (4.3)	SUGP1 (3.2)	MAU2 (2.8)	SMARCA4 (2.7)	BRAP (2.5)	ATP13A1 (2.5)	QTRT1 (2.4)	DDX56 (2.1)	DNM2 (2.0)	BUD13 (2.0)
GO:0046164	alcohol catabolic process	0.03	> 0.20	GOT2P1 (2.6)	ENSG00000254235 (2.3)	FRK (1.9)	PCSK9 (1.9)	ACAD10 (1.9)	LPIN3 (1.8)	TSSK6 (1.7)	GPAM (1.7)	TRAPPC6A (1.7)	FADS2 (1.6)
MP:0008254	increased megakaryocyte cell number	0.03	> 0.20	ABCG8 (4.4)	GMPR (4.1)	ITGB3 (3.2)	RHCE (2.9)	RHD (2.9)	GRINA (2.4)	SH2B3 (2.0)	TM6SF2 (1.9)	TMEM57 (1.9)	USP24 (1.8)
ENSG00000123685	BATF3 PPI subnetwork	0.03	> 0.20	TRIB1 (6.0)	SARS (3.9)	BCL3 (3.5)	PVR (2.7)	MAFB (2.7)	ABCG8 (2.5)	KIAA1324 (2.1)	MAPKAPK5 (2.0)	ABCG5 (1.8)	LDLR (1.7)
GO:0032496	response to lipopolysaccharide	0.03	> 0.20	ENSG00000228044 (2.9)	PVR (2.7)	MAFB (2.3)	BCL3 (2.3)	DNAH11 (2.2)	GRINA (2.2)	TRIB1 (2.1)	HLX (2.0)	HP (1.9)	PARP10 (1.7)
ENSG00000116962	NID1 PPI subnetwork	0.03	> 0.20	BCAM (3.7)	PVR (2.6)	APOE (2.6)	HAVCR1 (2.3)	CBLC (2.2)	AP1M2 (2.1)	FRK (2.0)	ERP29 (2.0)	C17orf57 (1.9)	APOC1 (1.8)
GO:0015929	hexosaminidase activity	0.03	> 0.20	ERP29 (4.9)	NKPD1 (3.5)	TRAPPC6A (2.9)	TMED4 (2.6)	ATP13A1 (2.5)	GCNT4 (2.4)	ABCG8 (1.9)	ENSG00000238078 (1.8)	CEACAM19 (1.6)	SORT1 (1.6)
ENSG00000111707	SUDS3 PPI subnetwork	0.03	> 0.20	BUD13 (3.5)	BRAP (3.3)	MAU2 (2.7)	C19orf52 (2.2)	ILF3 (2.2)	SUGP1 (2.1)	MARK4 (2.1)	ATXN2 (2.0)	CARM1 (2.0)	C12orf51 (1.9)
GO:0061041	regulation of wound healing	0.03	> 0.20	ITGB3 (4.1)	ANGPTL3 (3.0)	PVR (2.8)	HNF1A (2.7)	CYP7A1 (2.5)	PCSK9 (2.4)	GMPR (2.3)	CEACAM19 (2.2)	APOC4 (2.1)	PLG (2.0)
ENSG00000151552	QDPR PPI subnetwork	0.03	> 0.20	TIMD4 (5.7)	APOE (5.4)	MAFB (3.7)	APOC1 (2.9)	CETP (2.7)	ALDH2 (2.1)	ANGPTL3 (2.1)	GPAM (2.0)	APOC4 (1.9)	PLG (1.9)
ENSG00000167004	PDIA3 PPI subnetwork	0.03	> 0.20	PCSK9 (3.0)	ERP29 (2.5)	CBLC (2.4)	BCAM (2.2)	ST3GAL4 (2.1)	PARP10 (2.0)	HMGCR (1.9)	ENSG00000228044 (1.9)	TRAFD1 (1.8)	PVR (1.8)
ENSG00000215292	ENSG00000215292 PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000204388	HSPA1B PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000204389	HSPA1A PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000212866	HSPA1B PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000212860	ENSG00000212860 PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
GO:0070325	lipoprotein particle receptor binding	0.03	> 0.20	APOB (7.7)	ABCG5 (5.9)	NPC1L1 (5.5)	APOC1 (5.1)	PLG (4.1)	APOC4 (3.3)	HP (3.3)	APOA5 (3.2)	ANGPTL3 (2.9)	ABCG8 (2.5)
ENSG00000142507	PSMB6 PPI subnetwork	0.03	> 0.20	PSMA5 (6.0)	TRAFD1 (3.0)	TOMM40 (2.6)	NAA25 (2.3)	NT5DC1 (2.2)	DDX56 (1.9)	SUGP1 (1.6)	SARS (1.6)	DHX38 (1.5)	CLPTM1 (1.4)
ENSG00000073009	IKBKG PPI subnetwork	0.03	> 0.20	RELB (4.5)	SARS (3.1)	USP24 (2.7)	BCL3 (2.5)	PARP10 (2.5)	NAA25 (2.2)	PLEC (2.2)	OGDH (2.2)	HAVCR1 (2.2)	PTPN11 (2.0)
ENSG00000109072	SEBOX PPI subnetwork	0.03	> 0.20	APOB (3.7)	PLG (3.4)	ANGPTL3 (3.1)	PVR (2.9)	APOA5 (2.9)	APOC1 (2.7)	PLEKHH2 (2.7)	HP (2.7)	SLC22A1 (2.4)	APOC4 (2.0)
GO:0002455	humoral immune response mediated by circulating immunoglobulin	0.03	> 0.20	LPA (5.1)	SLC22A1 (4.3)	TIMD4 (4.1)	APOC4 (3.5)	ANGPTL3 (3.2)	HP (2.9)	CETP (2.7)	PLG (2.6)	APOE (2.6)	APOA5 (2.5)
GO:0040029	regulation of gene expression, epigenetic	0.03	> 0.20	MAPKAPK5 (2.5)	USP24 (2.2)	MAU2 (2.0)	BUD13 (1.9)	DOCK7 (1.9)	ATXN2 (1.9)	NT5DC1 (1.7)	ZNF180 (1.7)	C17orf57 (1.6)	ILF3 (1.5)
ENSG00000072694	FCGR2B PPI subnetwork	0.03	> 0.20	PLG (2.7)	APOA5 (2.3)	LPA (2.3)	APOC4 (2.2)	HP (2.2)	ANGPTL3 (2.0)	GMIP (2.0)	SLC22A1 (2.0)	SLC44A2 (1.5)	MOSC1 (1.5)
MP:0001716	abnormal placenta labyrinth morphology	0.03	> 0.20	DNM2 (2.7)	AP1M2 (2.5)	PVRL2 (2.4)	APOB (2.4)	LDLR (2.3)	PLEC (2.1)	APOE (1.9)	APOC1 (1.9)	GPAM (1.9)	PCSK9 (1.9)
ENSG00000136045	PWP1 PPI subnetwork	0.03	> 0.20	ZNF259 (4.9)	TOMM40 (4.1)	QTRT1 (3.9)	NAA25 (3.8)	DDX56 (3.6)	ATP13A1 (2.6)	ILF3 (2.5)	CARM1 (2.1)	DHODH (2.1)	SMARCA4 (2.0)
ENSG00000125485	DDX31 PPI subnetwork	0.03	> 0.20	ZNF259 (4.9)	NAA25 (4.2)	TOMM40 (4.0)	DDX56 (3.7)	QTRT1 (3.4)	DHX38 (3.0)	DHODH (2.6)	MAPKAPK5 (2.4)	C12orf43 (2.3)	ATP13A1 (2.3)
ENSG00000165733	BMS1 PPI subnetwork	0.03	> 0.20	ZNF259 (5.4)	DDX56 (4.9)	NAA25 (4.6)	QTRT1 (4.1)	TOMM40 (3.6)	DHODH (3.4)	C12orf43 (2.5)	SUGP1 (2.4)	DHX38 (2.4)	ATP13A1 (2.3)
MP:0003674	oxidative stress	0.03	> 0.20	APOC1 (3.4)	RHCE (2.7)	ALDH2 (2.4)	TRAPPC6A (2.4)	NT5DC1 (2.2)	ANGPTL3 (2.2)	HP (2.2)	PLG (2.1)	RHD (2.0)	BLOC1S3 (2.0)
ENSG00000204427	ABHD16A PPI subnetwork	0.03	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
ENSG00000096467	ENSG00000096467 PPI subnetwork	0.03	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
ENSG00000206403	ABHD16A PPI subnetwork	0.03	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
MP:0003091	abnormal cell migration	0.03	> 0.20	PLEC (3.5)	RELB (3.5)	BCL3 (3.1)	CLPTM1 (3.1)	TRIB1 (2.7)	ITGB3 (2.3)	PVRL2 (2.3)	HLX (2.3)	CETP (2.0)	KANK2 (1.8)
GO:0034614	cellular response to reactive oxygen species	0.03	> 0.20	DNAH11 (3.6)	GOT2P1 (3.0)	ACAD10 (2.5)	ALDH2 (2.4)	PBX4 (2.4)	C17orf57 (2.4)	RHD (2.0)	MOSC1 (1.9)	RHCE (1.8)	C12orf51 (1.7)
ENSG00000148143	ZNF462 PPI subnetwork	0.03	> 0.20	C19orf52 (2.3)	PARP10 (2.2)	DHX38 (2.2)	BRAP (2.0)	QTRT1 (2.0)	SUGP1 (1.9)	OASL (1.9)	GRINA (1.8)	YIPF2 (1.8)	SORT1 (1.8)
GO:0046627	negative regulation of insulin receptor signaling pathway	0.03	> 0.20	ST3GAL4 (2.2)	ENSG00000226645 (2.0)	BCL3 (1.8)	TRIB1 (1.7)	GCNT4 (1.7)	TMED4 (1.6)	TOP1 (1.5)	AP1M2 (1.4)	TSSK6 (1.4)	PBX4 (1.4)
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	0.03	> 0.20	OASL (9.4)	TRAFD1 (4.3)	PARP10 (4.2)	RELB (3.7)	BCL3 (3.2)	PVR (3.1)	CYP7A1 (2.5)	GOT2P1 (2.1)	GEMIN7 (2.0)	C12orf43 (1.9)
ENSG00000179348	GATA2 PPI subnetwork	0.03	> 0.20	RHD (3.5)	SH2B3 (3.4)	RHCE (2.9)	GMPR (2.6)	MAFB (2.2)	MARK4 (2.1)	BCL3 (2.0)	TMEM57 (1.7)	USP24 (1.7)	TRIB1 (1.6)
ENSG00000111615	KRR1 PPI subnetwork	0.03	> 0.20	ZNF259 (4.8)	DDX56 (4.5)	QTRT1 (4.4)	NAA25 (4.4)	TOMM40 (3.7)	DHODH (3.3)	DHX38 (2.6)	TOP1 (2.5)	C12orf43 (2.4)	SUGP1 (2.4)
GO:0000062	fatty-acyl-CoA binding	0.03	> 0.20	ACAD10 (5.0)	MOSC1 (3.7)	TRAPPC6A (2.4)	C19orf52 (2.4)	ALDH2 (2.3)	GPAM (2.0)	APOA5 (1.9)	ABCG8 (1.9)	OGDH (1.9)	LPA (1.8)
GO:0030194	positive regulation of blood coagulation	0.03	> 0.20	ANGPTL3 (3.7)	PCSK9 (3.4)	APOC4 (3.2)	APOA5 (2.9)	PLG (2.7)	HP (2.6)	SLC22A1 (2.1)	LPA (2.1)	APOB (1.9)	ADAM1 (1.8)
GO:0043531	ADP binding	0.03	> 0.20	POLK (3.8)	ERP29 (3.1)	FADS1 (2.6)	ACAD10 (2.5)	GMPR (2.0)	PARP10 (2.0)	OGDH (1.9)	FADS2 (1.9)	ENSG00000238078 (1.9)	HAPLN4 (1.7)
GO:0007596	blood coagulation	0.03	> 0.20	ITGB3 (7.2)	GMPR (3.2)	CETP (2.1)	ANGPTL3 (1.9)	PTPN11 (1.8)	C11orf9 (1.7)	TMEM50A (1.7)	TIMD4 (1.6)	ZNF101 (1.6)	PLG (1.5)
MP:0003849	greasy coat	0.03	> 0.20	APOA5 (4.0)	LPA (4.0)	APOC4 (3.7)	ENSG00000254235 (3.5)	TRAPPC6A (2.1)	PLG (2.0)	SLC22A1 (2.0)	AMIGO1 (1.8)	BLOC1S3 (1.7)	HP (1.5)
MP:0001601	abnormal myelopoiesis	0.03	> 0.20	GMIP (3.2)	RHCE (3.1)	BCL3 (2.5)	HLX (2.4)	RHD (2.3)	HP (2.3)	TRIB1 (2.2)	PARP10 (1.9)	GOT2P1 (1.8)	TIMD4 (1.6)
GO:0006695	cholesterol biosynthetic process	0.03	> 0.20	HMGCR (10.2)	LDLR (9.4)	FADS2 (8.5)	PCSK9 (8.3)	FADS1 (8.1)	CYP7A1 (2.9)	NKPD1 (2.7)	NPC1L1 (2.5)	TRAPPC6A (2.5)	TMEM57 (2.2)
ENSG00000143799	PARP1 PPI subnetwork	0.03	> 0.20	FEN1 (3.7)	DHX38 (3.1)	RELB (2.7)	USP1 (2.5)	RHD (2.3)	ENSG00000226648 (2.1)	PLCG1 (2.0)	KANK2 (1.8)	SMARCA4 (1.7)	ILF3 (1.6)
ENSG00000131759	RARA PPI subnetwork	0.03	> 0.20	C12orf51 (3.1)	ATXN2 (2.7)	MAU2 (2.4)	TRIB1 (2.3)	ABO (2.2)	SMARCA4 (2.2)	PPP1R37 (2.1)	ZHX3 (2.0)	BCL3 (2.0)	MAPKAPK5 (1.9)
ENSG00000059378	PARP12 PPI subnetwork	0.03	> 0.20	ZNF180 (3.1)	GMIP (2.6)	USP24 (2.5)	MAU2 (2.3)	PLCG1 (2.0)	BCL3 (1.9)	DHX38 (1.9)	ZHX3 (1.9)	PSRC1 (1.9)	LPAR2 (1.7)
GO:0042993	positive regulation of transcription factor import into nucleus	0.03	> 0.20	ENSG00000235545 (2.8)	ENSG00000238078 (2.8)	OASL (2.8)	GCNT4 (2.5)	SH2B3 (2.2)	FRK (2.2)	MYLIP (2.1)	CYB561D1 (2.1)	PARP10 (2.0)	ENSG00000228044 (1.9)
ENSG00000104946	TBC1D17 PPI subnetwork	0.03	> 0.20	TMEM57 (3.6)	GMPR (2.9)	C12orf51 (2.4)	LPAR2 (2.4)	NYNRIN (2.3)	MARK4 (2.2)	PVRL2 (2.2)	BCAM (2.2)	DDX56 (2.1)	OGDH (2.1)
ENSG00000135900	MRPL44 PPI subnetwork	0.03	> 0.20	ACAD10 (4.7)	TMED4 (2.4)	NT5DC1 (2.4)	HNF1A (2.2)	OGDH (2.2)	ATXN7L2 (2.1)	TRAPPC6A (1.8)	TMEM50A (1.7)	PLEKHH2 (1.7)	ERP29 (1.6)
ENSG00000007816	ENSG00000007816 PPI subnetwork	0.03	> 0.20	ZNF259 (4.8)	DDX56 (4.8)	NAA25 (4.5)	QTRT1 (4.3)	TOMM40 (3.8)	DHODH (3.2)	DHX38 (2.5)	ATP13A1 (2.5)	BRAP (2.3)	GATAD2A (2.3)
ENSG00000136938	ANP32B PPI subnetwork	0.03	> 0.20	DOCK7 (3.1)	AP1M2 (2.9)	BCAM (2.7)	TOMM40 (2.7)	PVRL2 (2.3)	OGDH (2.3)	NAA25 (2.0)	ILF3 (1.9)	NT5DC1 (1.8)	CARM1 (1.8)
ENSG00000099194	SCD PPI subnetwork	0.03	> 0.20	FADS2 (5.7)	FADS1 (5.0)	LDLR (4.5)	HMGCR (3.9)	TM6SF2 (3.3)	NPC1L1 (3.1)	SLC22A1 (2.4)	PCSK9 (2.1)	C11orf9 (2.1)	GPAM (2.0)
GO:0051240	positive regulation of multicellular organismal process	0.03	> 0.20	HLX (2.3)	ENSG00000235545 (2.1)	GEMIN7 (1.9)	MAFB (1.6)	PVR (1.6)	ZNF101 (1.6)	OASL (1.6)	ALDH2 (1.5)	C17orf57 (1.5)	SLC44A2 (1.4)
REACTOME_SIGNALING_BY_TGF_BETA	REACTOME_SIGNALING_BY_TGF_BETA	0.03	> 0.20	SH2B3 (3.5)	TMEM57 (2.5)	KANK2 (2.2)	GATAD2A (2.1)	PLEC (1.8)	MAPKAPK5 (1.8)	MARK4 (1.8)	TMEM50A (1.7)	CYP7A1 (1.6)	SLC44A2 (1.6)
GO:0043401	steroid hormone mediated signaling pathway	0.03	> 0.20	HNF1A (3.7)	GCNT4 (3.0)	ABCG8 (2.7)	TM6SF2 (2.5)	PPP1R37 (2.3)	ENSG00000226648 (2.0)	CYP7A1 (2.0)	GOT2P1 (1.8)	AMIGO1 (1.8)	ABCG5 (1.7)
ENSG00000110799	VWF PPI subnetwork	0.03	> 0.20	ITGB3 (8.4)	CETP (4.4)	GMPR (3.1)	TIMD4 (2.8)	ERP29 (2.5)	YIPF2 (2.2)	MOSC1 (2.0)	RHD (1.8)	CYP7A1 (1.7)	TMED4 (1.6)
MP:0001190	reddish skin	0.03	> 0.20	CBLC (5.4)	BCL3 (5.1)	GRINA (3.0)	AP1M2 (2.8)	RELB (2.4)	CEACAM19 (2.3)	TRIB1 (2.2)	NPC1L1 (2.0)	GMIP (1.9)	PARP10 (1.8)
GO:0008158	hedgehog receptor activity	0.03	> 0.20	LDLR (6.6)	FADS2 (5.8)	FADS1 (5.4)	PCSK9 (3.9)	HMGCR (3.0)	ST3GAL4 (2.9)	CYP7A1 (2.6)	TM6SF2 (2.4)	ATP13A1 (2.3)	ABCG8 (2.3)
GO:0030193	regulation of blood coagulation	0.03	> 0.20	ITGB3 (4.2)	ANGPTL3 (3.4)	CYP7A1 (2.9)	GMPR (2.8)	APOC4 (2.7)	PCSK9 (2.6)	PLG (2.4)	PVR (2.3)	SLC22A1 (2.3)	PMFBP1 (2.3)
MP:0001926	female infertility	0.03	> 0.20	FADS1 (3.2)	LDLR (3.1)	FADS2 (2.3)	CYP7A1 (2.2)	PCSK9 (2.2)	NYNRIN (2.0)	MOSC1 (1.9)	PLCG1 (1.9)	KIAA1324 (1.8)	ABCG8 (1.8)
MP:0009346	decreased trabecular bone thickness	0.03	> 0.20	PVRL2 (2.9)	MAFB (2.7)	TRIB1 (2.6)	ENSG00000238078 (2.4)	BCL3 (2.1)	ADAM1 (2.0)	TMEM57 (1.9)	FRK (1.9)	ENSG00000228044 (1.9)	BCAM (1.8)
MP:0000928	incomplete cephalic closure	0.03	> 0.20	NYNRIN (3.0)	CARM1 (2.7)	ENSG00000226648 (2.4)	MAFB (2.3)	APOB (2.2)	SLC44A2 (2.2)	ABO (2.1)	MARK4 (2.1)	DYNC2LI1 (1.9)	GEMIN7 (1.9)
ENSG00000110987	BCL7A PPI subnetwork	0.03	> 0.20	RELB (5.8)	BCL3 (4.9)	CARM1 (4.5)	MAU2 (2.9)	GRINA (2.8)	CLPTM1 (2.7)	GMIP (2.5)	TRAFD1 (2.2)	C12orf43 (2.1)	MARK4 (2.0)
ENSG00000168884	TNIP2 PPI subnetwork	0.03	> 0.20	RELB (9.9)	BCL3 (5.5)	C12orf43 (2.6)	SH2B3 (2.1)	DHX38 (2.1)	GRINA (2.0)	PVR (2.0)	MAU2 (1.9)	ACAD10 (1.8)	ST3GAL4 (1.8)
ENSG00000211979	ENSG00000211979 PPI subnetwork	0.03	> 0.20	APOE (6.1)	TIMD4 (5.8)	MAFB (4.2)	APOC1 (3.0)	CETP (2.3)	MYLIP (1.8)	LPIN3 (1.7)	GPAM (1.6)	ADAM1 (1.3)	SLC22A1 (1.1)
ENSG00000211973	ENSG00000211973 PPI subnetwork	0.03	> 0.20	APOE (6.1)	TIMD4 (5.8)	MAFB (4.2)	APOC1 (3.0)	CETP (2.3)	MYLIP (1.8)	LPIN3 (1.7)	GPAM (1.6)	ADAM1 (1.3)	SLC22A1 (1.1)
GO:0034698	response to gonadotropin stimulus	0.03	> 0.20	DNAH11 (4.3)	ST3GAL4 (2.7)	C11orf9 (2.3)	SLC44A2 (2.1)	FADS2 (2.1)	ATXN7L2 (2.0)	ABO (2.0)	HMGCR (1.9)	PMFBP1 (1.8)	CEACAM19 (1.7)
ENSG00000163513	TGFBR2 PPI subnetwork	0.03	> 0.20	SH2B3 (3.5)	MYLIP (3.2)	KANK2 (3.2)	GATAD2A (3.0)	NYNRIN (2.8)	PVR (2.4)	CETP (2.0)	DNM2 (1.6)	PLEC (1.6)	PLCG1 (1.5)
ENSG00000074211	PPP2R2C PPI subnetwork	0.03	> 0.20	NAA25 (2.8)	CEACAM19 (2.2)	TOMM40 (2.2)	PSMA5 (2.2)	QTRT1 (2.0)	C12orf51 (1.8)	CLPTM1 (1.8)	NKPD1 (1.7)	ZNF259 (1.6)	ENSG00000254235 (1.6)
GO:0006575	cellular modified amino acid metabolic process	0.03	> 0.20	MOSC1 (2.7)	TM6SF2 (2.6)	ABCG8 (2.4)	AMIGO1 (2.3)	LPA (2.3)	SLC22A1 (2.1)	CYP7A1 (1.9)	NT5DC1 (1.9)	ABCG5 (1.9)	SYPL2 (1.8)
ENSG00000099860	GADD45B PPI subnetwork	0.03	> 0.20	TRIB1 (3.2)	PSRC1 (2.5)	MOSC1 (2.0)	HLX (2.0)	RHCE (1.9)	ZHX3 (1.6)	POLK (1.6)	MYLIP (1.6)	BCL3 (1.5)	PPP1R37 (1.5)
ENSG00000151276	MAGI1 PPI subnetwork	0.03	> 0.20	PVRL2 (3.3)	FRK (3.2)	BCAM (2.8)	AP1M2 (2.7)	SYPL2 (2.5)	CARM1 (2.1)	GCNT4 (1.8)	CELSR2 (1.8)	OGDH (1.7)	HAVCR1 (1.7)
GO:0010951	negative regulation of endopeptidase activity	0.03	> 0.20	CEACAM19 (3.0)	HP (2.7)	GOT2P1 (2.4)	APOA5 (2.2)	HNF1A (2.2)	PLG (2.1)	PCSK9 (2.1)	SLC22A1 (2.0)	APOB (1.9)	ANGPTL3 (1.9)
GO:0010466	negative regulation of peptidase activity	0.03	> 0.20	CEACAM19 (3.6)	GOT2P1 (2.6)	HP (2.6)	HNF1A (2.1)	APOA5 (2.1)	SLC22A1 (2.0)	PCSK9 (1.9)	PLG (1.9)	ANGPTL3 (1.7)	APOB (1.7)
ENSG00000124788	ATXN1 PPI subnetwork	0.03	> 0.20	TRAFD1 (2.8)	GRINA (2.7)	FADS2 (2.7)	LDLR (2.7)	FADS1 (2.5)	RPH3A (2.5)	C12orf51 (2.5)	BUD13 (2.5)	CLPTM1 (2.4)	ATXN7L2 (2.3)
ENSG00000136718	IMP4 PPI subnetwork	0.03	> 0.20	ZNF259 (4.6)	DDX56 (4.3)	NAA25 (4.0)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.7)	TOP1 (2.1)	SUGP1 (2.0)	DHX38 (2.0)	ATP13A1 (1.9)
GO:0033273	response to vitamin	0.03	> 0.20	ENSG00000235545 (2.5)	FADS2 (2.3)	ATXN7L2 (2.2)	ABO (1.9)	AP1M2 (1.8)	YIPF2 (1.8)	TSSK6 (1.7)	CYP7A1 (1.7)	TMED4 (1.7)	ALDH2 (1.7)
MP:0008577	increased circulating interferon-gamma level	0.03	> 0.20	PARP10 (6.3)	OASL (6.3)	TRAFD1 (4.7)	BCL3 (3.7)	TRIB1 (2.8)	RELB (2.7)	GRINA (2.2)	GMIP (2.2)	POLK (1.8)	CEACAM19 (1.7)
GO:0005938	cell cortex	0.03	> 0.20	KANK2 (2.5)	RHD (2.4)	DNM2 (2.4)	PLCG1 (2.0)	RHCE (2.0)	ITGB3 (1.9)	LPIN3 (1.8)	ENSG00000238078 (1.8)	OGDH (1.7)	HAVCR1 (1.7)
ENSG00000141551	CSNK1D PPI subnetwork	0.03	> 0.20	DDX56 (3.9)	ZNF259 (3.9)	QTRT1 (3.8)	NAA25 (3.5)	CARM1 (2.9)	ATP13A1 (2.9)	ILF3 (2.9)	TOMM40 (2.8)	DHX38 (2.4)	PTPN11 (2.3)
ENSG00000182953	ENSG00000182953 PPI subnetwork	0.03	> 0.20	QTRT1 (4.4)	DDX56 (3.8)	NAA25 (3.6)	ZNF259 (3.6)	TOMM40 (3.3)	DHX38 (3.2)	DHODH (3.2)	C12orf43 (2.6)	ILF3 (2.5)	ATP13A1 (2.2)
ENSG00000165029	ABCA1 PPI subnetwork	0.03	> 0.20	PLCG1 (3.2)	ZHX3 (3.0)	PPP1R37 (2.8)	COL4A3BP (2.5)	KANK2 (2.5)	MAPKAPK5 (2.5)	APOB (2.3)	ITGB3 (2.2)	GATAD2A (2.0)	APOE (1.9)
GO:0009103	lipopolysaccharide biosynthetic process	0.03	> 0.20	ENSG00000228044 (3.4)	ENSG00000226648 (2.8)	BRAP (2.3)	CYB561D1 (1.6)	ST3GAL4 (1.6)	PPP1R37 (1.5)	ABO (1.5)	CARM1 (1.5)	DNM2 (1.5)	SH2B3 (1.4)
ENSG00000164168	TMEM184C PPI subnetwork	0.03	> 0.20	C1orf63 (2.6)	ZHX3 (2.4)	CYP7A1 (2.3)	ATXN7L2 (2.2)	ST3GAL4 (1.7)	GRINA (1.6)	DNM2 (1.6)	C12orf43 (1.5)	ENSG00000254235 (1.4)	OGDH (1.4)
ENSG00000134987	WDR36 PPI subnetwork	0.03	> 0.20	DDX56 (4.8)	ZNF259 (4.7)	QTRT1 (4.1)	NAA25 (4.0)	TOMM40 (4.0)	DHODH (3.5)	DHX38 (2.9)	ATP13A1 (2.6)	GATAD2A (2.2)	C12orf43 (2.2)
ENSG00000105974	CAV1 PPI subnetwork	0.03	> 0.20	PLEC (3.8)	BCAM (3.7)	CLPTM1 (3.2)	SLC44A2 (3.2)	PVRL2 (2.6)	GRINA (2.5)	BCL3 (2.3)	DNM2 (2.0)	OGDH (1.9)	APOE (1.7)
GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.03	> 0.20	SLC22A1 (3.2)	TIMD4 (3.1)	LPA (2.6)	APOE (2.3)	CETP (2.2)	PARP10 (2.0)	APOC4 (1.9)	RELB (1.8)	GMIP (1.7)	BCL3 (1.6)
MP:0009264	failure of eyelid fusion	0.03	> 0.20	DOCK7 (3.3)	AMIGO1 (2.8)	TRIB1 (2.6)	ENSG00000235545 (2.2)	CBLC (2.2)	NYNRIN (1.9)	MARK4 (1.9)	CEACAM19 (1.9)	ENSG00000238078 (1.8)	LDLR (1.7)
GO:0017038	protein import	0.03	> 0.20	NAA25 (2.2)	MYLIP (1.9)	AMIGO1 (1.7)	ENSG00000226645 (1.7)	PTPN11 (1.6)	ENSG00000254235 (1.6)	USP24 (1.6)	BLOC1S3 (1.5)	ENSG00000238078 (1.5)	GATAD2A (1.5)
ENSG00000125482	TTF1 PPI subnetwork	0.03	> 0.20	MAPKAPK5 (3.4)	DHX38 (2.7)	ZNF259 (2.7)	TXNL4B (2.6)	C12orf43 (2.5)	DYNC2LI1 (2.5)	GEMIN7 (2.2)	DDX56 (2.1)	ATXN2 (2.0)	NAA25 (1.9)
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	0.03	> 0.20	ABCG5 (6.3)	SLC22A1 (5.7)	LPA (5.6)	ABCG8 (5.2)	APOC4 (5.0)	CYP7A1 (5.0)	TM6SF2 (4.7)	ANGPTL3 (4.4)	ALDH2 (4.2)	APOA5 (3.8)
MP:0006043	decreased apoptosis	0.03	> 0.20	PARP10 (3.6)	MAFB (2.2)	ADAM1 (2.2)	TRAFD1 (2.1)	POLK (2.1)	SH2B3 (2.0)	HLX (1.9)	FRK (1.8)	TRAPPC6A (1.7)	SARS (1.5)
MP:0001282	short vibrissae	0.03	> 0.20	MAFB (2.2)	NYNRIN (2.2)	NKPD1 (2.1)	ABO (2.0)	ERP29 (1.7)	ENSG00000254235 (1.7)	BCAM (1.7)	PLEC (1.6)	GEMIN7 (1.6)	SYPL2 (1.5)
ENSG00000198336	MYL4 PPI subnetwork	0.03	> 0.20	APOB (7.5)	APOC1 (4.1)	PLG (3.9)	NPC1L1 (3.7)	ABCG5 (3.7)	APOA5 (3.6)	GPAM (2.8)	APOC4 (2.8)	HP (2.7)	ANGPTL3 (2.6)
MP:0001859	kidney inflammation	0.03	> 0.20	TM6SF2 (3.5)	GCNT4 (3.1)	HNF1A (3.0)	FRK (2.9)	TRIB1 (2.9)	NPC1L1 (2.8)	TMEM116 (2.3)	ABCG5 (2.3)	MAFB (2.0)	ADAM1 (1.9)
GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	0.03	> 0.20	ERP29 (4.4)	TMED4 (3.7)	ATP13A1 (3.2)	SORT1 (3.1)	TRAPPC6A (2.9)	TM6SF2 (2.4)	NPC1L1 (2.4)	NKPD1 (2.1)	GCNT4 (2.1)	APOE (1.8)
ENSG00000176165	FOXG1 PPI subnetwork	0.03	> 0.20	ATXN2 (2.6)	PLCG1 (2.4)	MYLIP (2.1)	LPIN3 (2.0)	MAFB (1.9)	TRIB1 (1.9)	KANK2 (1.8)	ANKRD31 (1.6)	PVRL2 (1.5)	ENSG00000238078 (1.4)
ENSG00000187498	COL4A1 PPI subnetwork	0.03	> 0.20	APOE (3.1)	C17orf57 (3.1)	CETP (2.7)	KANK2 (2.3)	ITGB3 (1.7)	PLEC (1.5)	PCSK9 (1.5)	ATXN7L2 (1.5)	ANGPTL3 (1.4)	HP (1.3)
ENSG00000100284	TOM1 PPI subnetwork	0.03	> 0.20	BLOC1S3 (2.2)	DNM2 (1.9)	DOCK7 (1.9)	C11orf9 (1.9)	ADAM1 (1.8)	COL4A3BP (1.7)	GRINA (1.7)	FRK (1.6)	C17orf57 (1.5)	TRAFD1 (1.5)
ENSG00000115232	ITGA4 PPI subnetwork	0.03	> 0.20	SLC44A2 (3.4)	APOE (3.4)	ITGB3 (2.7)	TIMD4 (2.6)	GMIP (2.4)	SH2B3 (2.4)	APOC1 (2.1)	RHD (2.0)	ST3GAL4 (1.9)	MAFB (1.8)
ENSG00000150347	ARID5B PPI subnetwork	0.03	> 0.20	C19orf52 (2.6)	BRAP (2.3)	PARP10 (2.3)	SUGP1 (2.2)	DHX38 (2.2)	OASL (2.0)	QTRT1 (2.0)	ZNF180 (1.9)	GRINA (1.9)	YIPF2 (1.8)
ENSG00000108559	NUP88 PPI subnetwork	0.03	> 0.20	USP1 (3.2)	POC5 (2.9)	NAA25 (2.7)	BUD13 (2.6)	ZNF180 (2.5)	FEN1 (2.2)	CARM1 (2.1)	MAPKAPK5 (2.0)	DOCK7 (1.9)	DDX56 (1.9)
GO:0010885	regulation of cholesterol storage	0.03	> 0.20	ABCG8 (3.0)	TIMD4 (2.9)	APOC1 (2.9)	APOE (2.7)	MYLIP (2.5)	ATXN7L2 (2.5)	TMEM116 (2.5)	GEMIN7 (2.4)	LPIN3 (2.2)	GCNT4 (2.1)
ENSG00000160049	DFFA PPI subnetwork	0.03	> 0.20	CYB561D1 (2.5)	CBLC (2.4)	UBXN2B (2.1)	ST3GAL4 (1.9)	ABO (1.6)	TM6SF2 (1.5)	C1orf63 (1.5)	ENSG00000254235 (1.4)	DNM2 (1.3)	ABCG8 (1.3)
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.03	> 0.20	OASL (5.7)	RELB (3.9)	BCL3 (3.7)	TRAFD1 (3.3)	PARP10 (3.2)	GMIP (2.4)	MYLIP (1.9)	MAU2 (1.9)	PVR (1.8)	SH2B3 (1.8)
ENSG00000171735	CAMTA1 PPI subnetwork	0.03	> 0.20	APOB (7.7)	APOC1 (4.1)	PLG (3.8)	NPC1L1 (3.7)	ABCG5 (3.6)	APOA5 (3.6)	HP (2.8)	GMPR (2.7)	APOC4 (2.6)	ANGPTL3 (2.6)
ENSG00000178105	DDX10 PPI subnetwork	0.03	> 0.20	DDX56 (4.4)	NAA25 (4.0)	ZNF259 (4.0)	QTRT1 (3.7)	TOMM40 (3.4)	DHODH (2.9)	C12orf43 (2.9)	DHX38 (2.7)	SUGP1 (2.6)	TOP1 (2.3)
MP:0005220	abnormal exocrine pancreas morphology	0.03	> 0.20	LPA (3.1)	APOA5 (2.6)	ALDH2 (2.5)	PPP1R37 (2.2)	ENSG00000226648 (2.0)	KANK2 (1.9)	APOC4 (1.7)	TMEM57 (1.7)	NYNRIN (1.6)	ANGPTL3 (1.6)
REACTOME_PLATELET_SENSITIZATION_BY_LDL	REACTOME_PLATELET_SENSITIZATION_BY_LDL	0.03	> 0.20	ABCG5 (3.0)	HP (2.7)	ABCG8 (2.4)	MOSC1 (2.3)	GPAM (2.2)	PVR (1.9)	ENSG00000226645 (1.9)	CLPTM1 (1.8)	MAPKAPK5 (1.8)	NPC1L1 (1.7)
ENSG00000185591	SP1 PPI subnetwork	0.03	> 0.20	TRIB1 (4.2)	ATXN2 (3.4)	RELB (3.0)	SH2B3 (2.8)	PLEC (2.6)	BCL3 (2.6)	LDLR (2.4)	MAFB (2.2)	TOP1 (2.0)	MARK4 (2.0)
ENSG00000116717	GADD45A PPI subnetwork	0.03	> 0.20	PSRC1 (3.0)	TRIB1 (2.7)	TXNL4B (2.3)	MYLIP (2.1)	HLX (2.0)	POLK (1.9)	GCNT4 (1.9)	BUD13 (1.8)	PLEC (1.8)	ZHX3 (1.8)
GO:0008235	metalloexopeptidase activity	0.03	> 0.20	NPC1L1 (2.2)	PMFBP1 (2.2)	KIAA1324 (2.1)	ENSG00000226648 (2.0)	TM6SF2 (1.9)	APOB (1.9)	HAPLN4 (1.8)	PLG (1.7)	FRK (1.6)	ADAM1 (1.5)
ENSG00000042832	TG PPI subnetwork	0.03	> 0.20	ERP29 (4.3)	HP (2.9)	TMED4 (2.3)	PLG (2.1)	APOC4 (2.0)	ADAM1 (2.0)	APOA5 (1.9)	ANGPTL3 (1.9)	BCAM (1.8)	MAFB (1.8)
GO:0006958	complement activation, classical pathway	0.03	> 0.20	LPA (5.5)	SLC22A1 (4.4)	TIMD4 (4.2)	APOC4 (3.7)	ANGPTL3 (3.4)	HP (3.0)	APOE (2.9)	APOA5 (2.8)	PCSK9 (2.8)	PLG (2.7)
GO:0030228	lipoprotein particle receptor activity	0.03	> 0.20	FADS1 (4.9)	HMGCR (4.9)	FADS2 (4.7)	TIMD4 (3.1)	ADAM1 (2.8)	PCSK9 (2.7)	CEACAM19 (2.4)	CETP (2.1)	SORT1 (2.1)	ACAD10 (2.1)
GO:0071222	cellular response to lipopolysaccharide	0.03	> 0.20	PVR (3.6)	LPIN3 (2.5)	PARP10 (2.5)	OASL (2.3)	GRINA (2.2)	DNAH11 (1.8)	CEACAM19 (1.8)	ENSG00000226645 (1.6)	UBXN2B (1.6)	MAFB (1.6)
ENSG00000065183	WDR3 PPI subnetwork	0.03	> 0.20	ZNF259 (4.7)	DDX56 (4.4)	NAA25 (4.0)	QTRT1 (3.8)	TOMM40 (3.5)	DHODH (2.9)	ATP13A1 (2.2)	DHX38 (2.1)	C12orf43 (2.0)	TOP1 (1.9)
GO:0030863	cortical cytoskeleton	0.03	> 0.20	RHD (4.7)	RHCE (4.6)	GMPR (3.6)	C12orf51 (2.9)	ENSG00000238078 (2.5)	KANK2 (2.1)	ITGB3 (1.9)	PMFBP1 (1.9)	BCAM (1.8)	PLCG1 (1.8)
GO:0051289	protein homotetramerization	0.03	> 0.20	TRAPPC6A (3.7)	LPA (3.3)	CYP7A1 (2.6)	ACAD10 (2.6)	GOT2P1 (2.6)	DNAH11 (2.5)	UBXN2B (2.3)	DHODH (2.2)	NT5DC1 (2.1)	SLC22A1 (1.9)
GO:0007599	hemostasis	0.03	> 0.20	ITGB3 (7.1)	GMPR (3.1)	CETP (2.2)	ANGPTL3 (1.9)	PTPN11 (1.8)	TMEM50A (1.6)	C11orf9 (1.6)	ZNF101 (1.6)	TIMD4 (1.6)	PLG (1.5)
MP:0000596	abnormal liver development	0.03	> 0.20	TRIB1 (3.6)	C11orf9 (3.1)	DOCK7 (2.3)	KANK2 (2.3)	MAPKAPK5 (2.3)	PVR (2.1)	LDLR (2.0)	ENSG00000238078 (1.9)	HNF1A (1.9)	HLX (1.8)
GO:0006595	polyamine metabolic process	0.03	> 0.20	QTRT1 (3.9)	TSSK6 (2.9)	HNF1A (2.8)	C19orf52 (2.3)	SLC44A2 (2.2)	ZNF101 (2.1)	GMPR (1.9)	ATP13A1 (1.9)	UBXN2B (1.9)	DHODH (1.7)
ENSG00000134597	RBMX2 PPI subnetwork	0.03	> 0.20	BUD13 (4.3)	SUGP1 (3.9)	BRAP (3.1)	DHX38 (2.9)	ZNF259 (2.9)	POC5 (2.4)	MAU2 (1.9)	DDX56 (1.9)	C12orf43 (1.8)	ZNF180 (1.7)
MP:0000496	abnormal small intestine morphology	0.03	> 0.20	HLX (3.2)	NPC1L1 (2.8)	HNF1A (2.7)	ZNF101 (2.5)	MAFB (2.4)	PBX4 (2.3)	LPAR2 (2.3)	CBLC (2.0)	TM6SF2 (1.8)	GATAD2A (1.8)
MP:0001664	abnormal digestion	0.03	> 0.20	GRINA (2.4)	SYPL2 (2.2)	ATP13A1 (2.1)	NPC1L1 (2.1)	UBXN2B (2.1)	HLX (2.1)	MOSC1 (2.0)	TMEM57 (1.9)	AMIGO1 (1.8)	CYP7A1 (1.8)
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	0.03	> 0.20	SYPL2 (5.3)	MOSC1 (3.0)	SORT1 (2.9)	HP (2.9)	DOCK7 (2.7)	GPAM (2.6)	GMPR (2.6)	NT5DC1 (2.2)	LPAR2 (2.1)	DHODH (2.1)
ENSG00000164924	YWHAZ PPI subnetwork	0.03	> 0.20	PLEC (4.1)	SMARCA4 (3.9)	SARS (3.3)	OGDH (2.9)	PTPN11 (2.5)	ATXN2 (2.2)	ILF3 (2.1)	PSMA5 (2.0)	DNM2 (1.9)	HMGCR (1.7)
GO:0016126	sterol biosynthetic process	0.03	> 0.20	HMGCR (9.8)	LDLR (9.4)	FADS2 (8.4)	FADS1 (8.1)	PCSK9 (8.0)	CYP7A1 (2.9)	NPC1L1 (2.4)	TRAPPC6A (2.3)	NKPD1 (2.1)	TMEM57 (1.9)
ENSG00000148248	SURF4 PPI subnetwork	0.03	> 0.20	HMGCR (3.3)	TMEM50A (3.3)	TMED4 (3.2)	ATP13A1 (2.9)	LDLR (2.4)	TMEM57 (2.3)	YIPF2 (2.1)	ABCG8 (2.1)	FADS1 (2.1)	CYB561D1 (2.1)
ENSG00000111652	COPS7A PPI subnetwork	0.03	> 0.20	NT5DC1 (2.3)	ATXN7L2 (2.0)	ITGB3 (2.0)	DYNC2LI1 (2.0)	UBXN2B (1.9)	RHD (1.8)	ZNF259 (1.8)	QTRT1 (1.7)	NYNRIN (1.6)	PBX4 (1.6)
MP:0005464	abnormal platelet physiology	0.03	> 0.20	ITGB3 (9.1)	GMPR (4.9)	FADS1 (2.2)	PTPN11 (1.8)	ABCG5 (1.7)	ST3GAL4 (1.7)	POLK (1.6)	NYNRIN (1.5)	ENSG00000238078 (1.4)	GCNT4 (1.4)
REACTOME_ACTIVATED_TLR4_SIGNALLING	REACTOME_ACTIVATED_TLR4_SIGNALLING	0.03	> 0.20	RELB (4.6)	BCL3 (4.2)	TRIB1 (3.9)	OASL (3.4)	SH2B3 (3.1)	PVR (2.9)	HLX (2.8)	GMIP (2.5)	PARP10 (2.5)	MAFB (1.9)
GO:0010608	posttranscriptional regulation of gene expression	0.03	> 0.20	ADAM1 (2.6)	MYLIP (2.6)	BRAP (2.5)	ILF3 (2.3)	MAPKAPK5 (2.2)	PTPN11 (2.0)	USP24 (1.9)	ZNF259 (1.8)	C12orf43 (1.8)	DOCK7 (1.8)
ENSG00000123609	NMI PPI subnetwork	0.03	> 0.20	PARP10 (5.5)	TRAPPC6A (2.9)	TRAFD1 (2.6)	OASL (2.6)	BLOC1S3 (2.3)	GEMIN7 (2.2)	TMEM50A (2.2)	ENSG00000254235 (2.0)	APOE (1.8)	HAPLN4 (1.8)
ENSG00000099942	CRKL PPI subnetwork	0.03	> 0.20	SLC44A2 (3.5)	TIMD4 (2.7)	PLEKHH2 (2.6)	CETP (2.4)	SH2B3 (2.2)	USP24 (2.1)	GMIP (2.1)	DNM2 (2.0)	LPAR2 (2.0)	MAU2 (2.0)
GO:0008168	methyltransferase activity	0.03	> 0.20	DHODH (4.2)	QTRT1 (3.9)	C12orf43 (3.6)	TXNL4B (2.9)	DDX56 (2.6)	NAA25 (2.2)	ZNF259 (2.0)	UBXN2B (1.9)	ATP13A1 (1.7)	BUD13 (1.6)
ENSG00000179715	FAM113B PPI subnetwork	0.03	> 0.20	APOB (7.7)	APOC1 (3.9)	PLG (3.9)	NPC1L1 (3.7)	APOA5 (3.6)	ABCG5 (3.6)	HP (2.8)	GMPR (2.7)	GPAM (2.7)	APOC4 (2.6)
ENSG00000078401	EDN1 PPI subnetwork	0.03	> 0.20	RHCE (3.3)	CETP (3.1)	KANK2 (2.7)	RHD (2.7)	ATXN7L2 (2.4)	APOE (1.6)	ANKRD31 (1.6)	ENSG00000228044 (1.6)	SUGP1 (1.6)	ZNF259 (1.4)
ENSG00000115233	PSMD14 PPI subnetwork	0.03	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	NAA25 (2.6)	OGDH (2.4)	NT5DC1 (2.3)	TOMM40 (2.2)	DDX56 (1.9)	SARS (1.7)	SMARCA4 (1.7)	CLPTM1 (1.7)
GO:0016798	hydrolase activity, acting on glycosyl bonds	0.03	> 0.20	ERP29 (4.2)	TMED4 (3.5)	ATP13A1 (3.1)	TRAPPC6A (2.8)	SORT1 (2.7)	NKPD1 (2.5)	TM6SF2 (2.4)	NPC1L1 (2.2)	NT5DC1 (2.0)	HNF1A (2.0)
ENSG00000159251	ACTC1 PPI subnetwork	0.03	> 0.20	KANK2 (3.2)	C1orf63 (3.0)	OGDH (2.8)	PLEC (2.6)	PVR (2.1)	ITGB3 (2.1)	C17orf57 (2.0)	NPC1L1 (2.0)	PVRL2 (1.9)	ANGPTL3 (1.8)
ENSG00000111859	NEDD9 PPI subnetwork	0.03	> 0.20	SH2B3 (3.1)	SLC44A2 (2.8)	DNM2 (2.7)	ABO (2.6)	PLEC (2.4)	GMIP (2.2)	MAPKAPK5 (2.2)	PLCG1 (2.1)	GATAD2A (2.0)	KANK2 (2.0)
GO:0070201	regulation of establishment of protein localization	0.03	> 0.20	ZNF101 (2.2)	ST3GAL4 (1.7)	ENSG00000238078 (1.7)	PLEKHH2 (1.7)	GEMIN7 (1.7)	HLX (1.6)	AP1M2 (1.6)	SH2B3 (1.5)	PVRL2 (1.5)	OASL (1.4)
MP:0003331	hepatocellular carcinoma	0.03	> 0.20	APOA5 (3.0)	C17orf57 (2.8)	LPIN3 (2.8)	LPA (2.6)	ANGPTL3 (2.6)	TMEM57 (2.6)	SLC22A1 (2.4)	CYP7A1 (2.4)	APOC4 (2.3)	PLG (2.1)
GO:0019835	cytolysis	0.03	> 0.20	LPA (5.1)	SLC22A1 (3.3)	APOC4 (2.8)	ZNF101 (2.2)	ANGPTL3 (2.2)	APOA5 (2.2)	ABCG5 (2.1)	DHODH (2.0)	TMEM116 (2.0)	PLG (1.9)
ENSG00000167244	IGF2 PPI subnetwork	0.03	> 0.20	APOB (4.0)	BCAM (3.2)	APOC4 (2.9)	APOA5 (2.8)	TMED4 (2.4)	ANGPTL3 (2.2)	ABCG5 (2.2)	APOE (2.1)	SLC22A1 (2.0)	MYLIP (2.0)
MP:0004500	increased incidence of ionizing radiation-induced tumors	0.03	> 0.20	TRIB1 (2.8)	PVR (2.5)	POLK (2.5)	DYNC2LI1 (2.4)	MYLIP (2.4)	UBXN2B (2.1)	RHCE (2.0)	ATXN7L2 (1.9)	CYP7A1 (1.8)	USP1 (1.7)
MP:0002418	increased susceptibility to viral infection	0.03	> 0.20	OASL (9.3)	PARP10 (7.5)	TRAFD1 (5.2)	RELB (2.3)	GMIP (2.3)	BCL3 (2.1)	ATP13A1 (1.7)	POLK (1.4)	SH2B3 (1.3)	QTRT1 (1.1)
ENSG00000167088	SNRPD1 PPI subnetwork	0.03	> 0.20	ILF3 (3.7)	DHX38 (3.3)	BUD13 (3.1)	C1orf63 (3.0)	TOP1 (2.8)	USP1 (2.7)	SMARCA4 (2.7)	FEN1 (2.7)	SUGP1 (2.7)	QTRT1 (2.5)
GO:0008654	phospholipid biosynthetic process	0.03	> 0.20	ATP13A1 (2.6)	TSSK6 (2.4)	FADS2 (2.3)	TMED4 (2.2)	HMGCR (2.1)	CLPTM1 (2.1)	LPAR2 (2.0)	GCNT4 (1.9)	ERP29 (1.9)	YIPF2 (1.9)
KEGG_BUTANOATE_METABOLISM	KEGG_BUTANOATE_METABOLISM	0.03	> 0.20	ACAD10 (5.1)	MOSC1 (4.5)	FADS2 (4.4)	HMGCR (4.2)	FADS1 (4.0)	PCSK9 (3.4)	CYP7A1 (3.1)	PLG (3.0)	LDLR (3.0)	ALDH2 (2.9)
GO:0019319	hexose biosynthetic process	0.03	> 0.20	TM6SF2 (2.4)	LPA (2.2)	MOSC1 (2.2)	HAPLN4 (2.2)	HNF1A (2.1)	ABCG8 (2.0)	ENSG00000254235 (1.9)	ACAD10 (1.9)	APOA5 (1.9)	SYPL2 (1.9)
ENSG00000184481	FOXO4 PPI subnetwork	0.03	> 0.20	PPP1R37 (2.0)	UBXN2B (1.8)	PLEC (1.7)	GATAD2A (1.6)	PLCG1 (1.6)	SLC44A2 (1.5)	ABO (1.5)	ENSG00000254235 (1.4)	GCNT4 (1.4)	BCL3 (1.4)
ENSG00000175866	BAIAP2 PPI subnetwork	0.03	> 0.20	CBLC (3.2)	CARM1 (3.1)	ZHX3 (2.6)	PPP1R37 (2.5)	HNF1A (2.5)	AP1M2 (2.4)	MARK4 (2.4)	TSSK6 (2.3)	C11orf9 (2.3)	DNM2 (2.2)
MP:0001683	absent mesoderm	0.03	> 0.20	ENSG00000254235 (2.6)	PVR (2.4)	DOCK7 (2.3)	LDLR (2.2)	TMEM57 (2.1)	NYNRIN (1.7)	ATXN7L2 (1.7)	KIAA1324 (1.7)	HMGCR (1.6)	TMEM50A (1.5)
ENSG00000136869	TLR4 PPI subnetwork	0.03	> 0.20	RELB (4.4)	BCL3 (3.4)	PVR (3.2)	SH2B3 (2.7)	MAFB (2.6)	TRIB1 (2.0)	GMIP (1.9)	OASL (1.8)	DNM2 (1.6)	BRAP (1.6)
ENSG00000149177	PTPRJ PPI subnetwork	0.03	> 0.20	HAVCR1 (3.3)	ENSG00000226648 (3.1)	LPIN3 (2.9)	ZHX3 (2.5)	MAFB (2.3)	C11orf9 (2.0)	APOE (1.9)	DDX56 (1.9)	PLEC (1.8)	PLCG1 (1.8)
ENSG00000138363	ATIC PPI subnetwork	0.03	> 0.20	FADS1 (3.4)	FADS2 (3.1)	C19orf52 (2.4)	ST3GAL4 (2.3)	NT5DC1 (2.2)	FRK (2.2)	SARS (2.1)	ENSG00000238078 (2.1)	C12orf47 (2.0)	GMIP (1.9)
GO:0005777	peroxisome	0.03	> 0.20	MOSC1 (4.8)	GPAM (4.3)	FADS2 (4.1)	PLG (3.4)	ACAD10 (3.4)	TRAPPC6A (3.4)	HMGCR (3.2)	FADS1 (3.1)	NT5DC1 (3.0)	ANGPTL3 (3.0)
GO:0042579	microbody	0.03	> 0.20	MOSC1 (4.8)	GPAM (4.3)	FADS2 (4.1)	PLG (3.4)	ACAD10 (3.4)	TRAPPC6A (3.4)	HMGCR (3.2)	FADS1 (3.1)	NT5DC1 (3.0)	ANGPTL3 (3.0)
ENSG00000158711	ELK4 PPI subnetwork	0.03	> 0.20	TRIB1 (3.1)	NCAN (2.7)	HLX (2.6)	KANK2 (2.2)	ENSG00000226648 (2.1)	CEACAM19 (2.0)	BCL3 (2.0)	CYB561D1 (1.9)	PLEC (1.8)	PLCG1 (1.7)
ENSG00000163110	PDLIM5 PPI subnetwork	0.03	> 0.20	TIMD4 (3.3)	CETP (3.2)	PLEKHH2 (2.9)	SH2B3 (2.3)	GMPR (2.3)	RHD (2.0)	DNAH11 (1.8)	SYPL2 (1.7)	C11orf9 (1.7)	FADS1 (1.6)
ENSG00000145332	KLHL8 PPI subnetwork	0.03	> 0.20	ATXN7L2 (2.7)	QTRT1 (2.2)	ENSG00000226645 (2.0)	YIPF2 (1.9)	APOA5 (1.9)	TMEM50A (1.8)	ENSG00000238078 (1.7)	C19orf52 (1.7)	ERP29 (1.7)	SARS (1.6)
ENSG00000163714	U2SURP PPI subnetwork	0.03	> 0.20	NAA25 (2.6)	CYB561D1 (2.2)	ATXN2 (2.0)	DDX56 (1.9)	PSMA5 (1.7)	ATP13A1 (1.7)	C12orf43 (1.7)	NT5DC1 (1.7)	DHX38 (1.6)	ATXN7L2 (1.6)
GO:0006959	humoral immune response	0.03	> 0.20	LPA (5.7)	TIMD4 (4.4)	SLC22A1 (3.7)	CETP (3.4)	APOC4 (3.1)	HP (2.7)	DHODH (2.5)	ANGPTL3 (2.1)	APOE (2.1)	APOA5 (2.0)
ENSG00000129988	LBP PPI subnetwork	0.03	> 0.20	HP (6.7)	APOB (4.4)	APOC4 (3.2)	ABCG5 (3.1)	PLG (2.9)	APOC1 (2.9)	ADAM1 (2.7)	ANGPTL3 (2.7)	NPC1L1 (2.7)	MAFB (2.6)
ENSG00000074370	ATP2A3 PPI subnetwork	0.03	> 0.20	FRK (3.4)	AP1M2 (3.1)	CBLC (2.9)	HNF1A (2.7)	C12orf47 (2.0)	DHX38 (1.9)	ENSG00000238078 (1.8)	NT5DC1 (1.6)	MYLIP (1.6)	KIAA1324 (1.5)
ENSG00000008853	RHOBTB2 PPI subnetwork	0.03	> 0.20	CLPTM1 (2.4)	GMIP (2.3)	PPP1R37 (2.2)	ENSG00000235545 (2.1)	SLC44A2 (2.1)	OGDH (2.1)	DNM2 (2.0)	GRINA (1.9)	COL4A3BP (1.9)	CARM1 (1.8)
ENSG00000169957	ZNF768 PPI subnetwork	0.03	> 0.20	C19orf52 (2.5)	SUGP1 (2.3)	BRAP (2.0)	OASL (2.0)	PARP10 (2.0)	ENSG00000228044 (2.0)	DHX38 (1.8)	SORT1 (1.8)	QTRT1 (1.7)	GRINA (1.6)
ENSG00000177200	CHD9 PPI subnetwork	0.03	> 0.20	ZNF180 (2.5)	BRAP (2.3)	TOP1 (2.2)	GEMIN7 (2.2)	BUD13 (2.2)	C1orf63 (2.2)	TXNL4B (2.1)	C17orf57 (1.9)	TMEM57 (1.7)	DHX38 (1.7)
GO:0032101	regulation of response to external stimulus	0.03	> 0.20	ENSG00000228044 (3.4)	TIMD4 (2.2)	GCNT4 (2.2)	CETP (2.2)	HLX (2.1)	APOE (1.8)	PVR (1.7)	ITGB3 (1.6)	SLC22A1 (1.6)	SH2B3 (1.6)
GO:0015914	phospholipid transport	0.03	> 0.20	C17orf57 (4.3)	ABCG5 (3.9)	COL4A3BP (3.0)	MYLIP (2.8)	NPC1L1 (2.5)	APOB (2.3)	APOC1 (2.2)	TM6SF2 (2.1)	PMFBP1 (2.1)	TIMD4 (1.9)
MP:0000281	abnormal interventricular septum morphology	0.03	> 0.20	MYLIP (3.9)	MAFB (2.7)	BCAM (2.1)	TRIB1 (2.0)	ATXN7L2 (1.7)	MARK4 (1.7)	TIMD4 (1.7)	TMEM57 (1.6)	GRINA (1.5)	HLX (1.5)
ENSG00000101255	TRIB3 PPI subnetwork	0.03	> 0.20	PARP10 (3.2)	GMIP (3.0)	MAU2 (2.7)	DHX38 (2.2)	BCL3 (2.2)	PPP1R37 (2.2)	ZNF180 (2.0)	TRAFD1 (2.0)	OASL (1.9)	USP24 (1.9)
ENSG00000145912	NHP2 PPI subnetwork	0.03	> 0.20	QTRT1 (4.8)	ZNF259 (4.3)	DDX56 (4.1)	C12orf43 (3.7)	C19orf52 (3.4)	TOMM40 (3.2)	SUGP1 (3.0)	DHX38 (2.4)	ATP13A1 (2.4)	DHODH (2.3)
ENSG00000163528	CHCHD4 PPI subnetwork	0.03	> 0.20	MOSC1 (2.6)	ANGPTL3 (2.1)	GPAM (1.9)	GMIP (1.8)	ENSG00000238078 (1.8)	TOMM40 (1.8)	PBX4 (1.8)	CYP7A1 (1.7)	TRAPPC6A (1.6)	ENSG00000226648 (1.6)
ENSG00000140284	SLC27A2 PPI subnetwork	0.03	> 0.20	HMGCR (10.2)	LDLR (8.2)	FADS1 (7.1)	FADS2 (7.1)	PCSK9 (6.6)	GRINA (2.3)	GPAM (2.2)	NKPD1 (2.0)	MOSC1 (1.8)	TMEM50A (1.6)
GO:0005126	cytokine receptor binding	0.03	> 0.20	RELB (3.4)	BCL3 (3.3)	TIMD4 (3.1)	OASL (2.5)	CETP (2.3)	PVR (2.1)	CYP7A1 (1.8)	PVRL2 (1.8)	SH2B3 (1.8)	ZNF101 (1.6)
GO:0006778	porphyrin-containing compound metabolic process	0.03	> 0.20	RHCE (7.3)	RHD (7.0)	ADAM1 (3.1)	C12orf51 (2.6)	GMPR (2.5)	ACAD10 (2.2)	TRAPPC6A (2.0)	NT5DC1 (1.9)	BLOC1S3 (1.8)	BRAP (1.5)
GO:0033013	tetrapyrrole metabolic process	0.03	> 0.20	RHCE (7.3)	RHD (7.0)	ADAM1 (3.1)	C12orf51 (2.6)	GMPR (2.5)	ACAD10 (2.2)	TRAPPC6A (2.0)	NT5DC1 (1.9)	BLOC1S3 (1.8)	BRAP (1.5)
ENSG00000108651	UTP6 PPI subnetwork	0.03	> 0.20	MAU2 (4.0)	PARP10 (3.1)	USP24 (2.5)	MARK4 (2.4)	GMIP (2.3)	SMARCA4 (2.3)	BCL3 (2.1)	DHX38 (1.9)	ZNF180 (1.9)	MAFB (1.8)
ENSG00000100354	TNRC6B PPI subnetwork	0.03	> 0.20	TMED4 (3.3)	NPC1L1 (3.3)	FADS1 (3.2)	PCSK9 (3.2)	HMGCR (2.7)	FADS2 (2.6)	USP24 (2.2)	LDLR (2.2)	GATAD2A (2.0)	UBXN2B (2.0)
ENSG00000105202	FBL PPI subnetwork	0.03	> 0.20	NAA25 (4.8)	ZNF259 (4.6)	DDX56 (4.6)	TOMM40 (4.1)	QTRT1 (3.8)	DHODH (2.8)	DHX38 (2.6)	ATP13A1 (2.5)	SUGP1 (2.5)	TOP1 (2.4)
ENSG00000116560	SFPQ PPI subnetwork	0.03	> 0.20	SMARCA4 (3.3)	C1orf63 (3.2)	DHX38 (3.1)	RELB (3.0)	TOP1 (2.9)	ILF3 (2.9)	CLPTM1 (2.7)	BCL3 (2.7)	NT5DC1 (1.9)	DOCK7 (1.7)
MP:0001545	abnormal hematopoietic system physiology	0.03	> 0.20	RHD (3.8)	RHCE (3.7)	USP24 (2.2)	ENSG00000228044 (2.2)	APOC1 (2.2)	POLK (2.1)	C17orf57 (2.1)	GMIP (2.0)	C1orf63 (1.9)	LPA (1.8)
GO:0030128	clathrin coat of endocytic vesicle	0.03	> 0.20	ZHX3 (3.1)	CLPTM1 (2.6)	PPP1R37 (2.6)	GRINA (2.2)	USP24 (2.1)	TMEM50A (1.9)	POLK (1.8)	PVRL2 (1.8)	ZNF180 (1.8)	CBLC (1.7)
MP:0000604	amyloidosis	0.03	> 0.20	APOC1 (5.1)	APOE (5.1)	PLG (3.5)	APOB (3.4)	APOA5 (3.1)	ANGPTL3 (2.9)	HP (2.8)	APOC4 (2.7)	SLC22A1 (2.6)	MAFB (2.4)
GO:0016922	ligand-dependent nuclear receptor binding	0.03	> 0.20	C12orf51 (3.2)	UBXN2B (2.6)	ATXN2 (2.4)	ZHX3 (2.1)	HNF1A (2.1)	PLCG1 (1.9)	MAPKAPK5 (1.7)	MAU2 (1.7)	USP24 (1.7)	COL4A3BP (1.7)
GO:0032933	SREBP-mediated signaling pathway	0.03	> 0.20	LDLR (5.3)	FADS2 (5.1)	HMGCR (5.0)	FADS1 (4.5)	PCSK9 (4.1)	TMEM57 (3.1)	PPP1R37 (2.6)	ENSG00000226648 (2.2)	C17orf57 (2.2)	POLK (2.1)
ENSG00000071462	WBSCR22 PPI subnetwork	0.03	> 0.20	DDX56 (4.9)	QTRT1 (4.4)	NAA25 (4.2)	ZNF259 (4.2)	DHODH (3.2)	TOMM40 (3.2)	C12orf43 (2.8)	ATP13A1 (2.6)	ATXN7L2 (2.3)	PTPN11 (2.2)
GO:0044282	small molecule catabolic process	0.03	> 0.20	ACAD10 (4.2)	LPA (3.5)	MOSC1 (3.0)	SLC22A1 (3.0)	ALDH2 (2.9)	CYP7A1 (2.6)	TRAPPC6A (2.6)	ANGPTL3 (2.5)	NT5DC1 (2.5)	DHODH (2.3)
ENSG00000080824	HSP90AA1 PPI subnetwork	0.03	> 0.20	BCL3 (3.4)	RELB (3.2)	OGDH (2.8)	GOT2P1 (2.7)	SARS (2.6)	GRINA (2.5)	PLEC (2.4)	NAA25 (2.2)	TOMM40 (2.2)	DHX38 (2.0)
ENSG00000108592	FTSJ3 PPI subnetwork	0.03	> 0.20	ZNF259 (4.9)	NAA25 (4.6)	QTRT1 (3.9)	DDX56 (3.6)	TOMM40 (3.6)	DHX38 (2.8)	DHODH (2.7)	ATP13A1 (2.5)	MAPKAPK5 (2.2)	C12orf43 (2.2)
ENSG00000110958	PTGES3 PPI subnetwork	0.03	> 0.20	PARP10 (2.9)	TRIB1 (2.5)	CYP7A1 (2.2)	GOT2P1 (2.0)	AP1M2 (2.0)	ENSG00000254235 (2.0)	YIPF2 (1.9)	GRINA (1.9)	HAPLN4 (1.8)	ZNF101 (1.7)
ENSG00000086758	HUWE1 PPI subnetwork	0.03	> 0.20	ATP13A1 (3.4)	SMARCA4 (3.0)	TOMM40 (3.0)	CLPTM1 (2.9)	BRAP (2.9)	PSMA5 (2.9)	SARS (2.9)	DHX38 (2.6)	DDX56 (2.5)	NAA25 (2.4)
MP:0009643	abnormal urine homeostasis	0.03	> 0.20	PLG (4.6)	ANGPTL3 (3.7)	TM6SF2 (3.1)	AP1M2 (2.9)	TMEM116 (2.8)	SLC22A1 (2.6)	GRINA (2.0)	CEACAM19 (1.9)	SYPL2 (1.9)	ENSG00000228044 (1.8)
REACTOME_RIG:IMDA5_MEDIATED_INDUCTION_OF_IFN:ALPHABETA_PATHWAYS	REACTOME_RIG:IMDA5_MEDIATED_INDUCTION_OF_IFN:ALPHABETA_PATHWAYS	0.03	> 0.20	OASL (10.7)	PARP10 (7.4)	RELB (5.8)	TRAFD1 (4.9)	BCL3 (4.1)	ZNF101 (2.2)	CYP7A1 (2.0)	MAU2 (1.7)	GMIP (1.6)	CYB561D1 (1.6)
MP:0002429	abnormal blood cell morphology/development	0.03	> 0.20	BCL3 (4.2)	GMIP (2.8)	ENSG00000228044 (2.6)	PMFBP1 (2.3)	TRIB1 (2.0)	ILF3 (2.0)	MAFB (2.0)	C12orf51 (1.8)	HAVCR1 (1.8)	ENSG00000226648 (1.7)
ENSG00000103502	CDIPT PPI subnetwork	0.03	> 0.20	ABCG8 (3.7)	TMED4 (3.5)	YIPF2 (3.4)	TMEM50A (3.4)	SLC22A1 (3.0)	TM6SF2 (2.6)	ABCG5 (2.3)	CEACAM19 (1.9)	NKPD1 (1.8)	TMEM57 (1.8)
GO:0030299	intestinal cholesterol absorption	0.03	> 0.20	NPC1L1 (7.8)	ABCG8 (6.3)	ABCG5 (5.2)	TM6SF2 (4.7)	APOB (3.8)	APOA5 (2.2)	CBLC (2.0)	FRK (2.0)	GCNT4 (2.0)	MOSC1 (1.7)
KEGG_APOPTOSIS	KEGG_APOPTOSIS	0.03	> 0.20	RELB (5.3)	BCL3 (4.8)	ST3GAL4 (2.7)	GMIP (2.5)	TRAFD1 (2.2)	SH2B3 (2.2)	PARP10 (2.1)	POLK (2.0)	GRINA (1.7)	PTPN11 (1.7)
ENSG00000173702	MUC13 PPI subnetwork	0.03	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.9)	DNM2 (2.7)	SH2B3 (2.1)	KIAA1324 (2.0)	HNF1A (2.0)	NYNRIN (1.9)	ITGB3 (1.6)	PLEC (1.5)	FRK (1.5)
ENSG00000172531	PPP1CA PPI subnetwork	0.03	> 0.20	PSRC1 (3.0)	BLOC1S3 (2.8)	DNM2 (2.5)	MARK4 (2.5)	USP1 (2.2)	SORT1 (2.2)	ATXN2 (1.9)	PTPN11 (1.9)	KANK2 (1.8)	SYPL2 (1.7)
ENSG00000196540	ENSG00000196540 PPI subnetwork	0.03	> 0.20	APOB (7.6)	APOC1 (4.1)	PLG (3.8)	NPC1L1 (3.7)	APOA5 (3.6)	ABCG5 (3.6)	GMPR (2.8)	HP (2.8)	APOC4 (2.7)	GPAM (2.6)
MP:0003131	increased erythrocyte cell number	0.03	> 0.20	RHCE (4.0)	RHD (3.5)	BCL3 (3.5)	POLK (2.4)	HLX (2.3)	TOP1 (2.3)	HP (2.3)	C12orf47 (2.2)	TRIB1 (2.1)	SH2B3 (2.0)
REACTOME_BMAL1CLOCKNPAS2_ACTIVATES_GENE_EXPRESSION	REACTOME_BMAL1CLOCKNPAS2_ACTIVATES_GENE_EXPRESSION	0.03	> 0.20	ZHX3 (4.1)	TRIB1 (3.5)	C12orf51 (2.4)	GPAM (2.3)	LPIN3 (2.0)	LDLR (2.0)	CILP2 (1.7)	MAFB (1.6)	CYP7A1 (1.5)	USP24 (1.4)
GO:0001666	response to hypoxia	0.03	> 0.20	DNAH11 (2.6)	POLK (1.9)	PVR (1.8)	CETP (1.5)	FRK (1.4)	LPIN3 (1.4)	NT5DC1 (1.4)	ENSG00000238078 (1.3)	RHD (1.3)	RHCE (1.2)
MP:0008410	increased cellular sensitivity to ultraviolet irradiation	0.03	> 0.20	MAU2 (2.6)	SUGP1 (2.4)	POC5 (2.2)	MYLIP (1.9)	GCNT4 (1.9)	MAPKAPK5 (1.8)	UBXN2B (1.8)	TRAPPC6A (1.7)	POLK (1.7)	NYNRIN (1.7)
ENSG00000105972	ENSG00000105972 PPI subnetwork	0.03	> 0.20	GRINA (3.3)	YIPF2 (2.3)	TXNL4B (2.2)	PSRC1 (2.1)	QTRT1 (2.1)	CARM1 (2.1)	DNM2 (2.0)	SLC22A1 (2.0)	UBXN2B (1.9)	CLPTM1 (1.8)
MP:0004955	increased thymus weight	0.03	> 0.20	ZNF101 (4.2)	HLX (2.2)	PBX4 (2.0)	TRIB1 (1.9)	ENSG00000238078 (1.8)	ANKRD31 (1.5)	BCL3 (1.4)	GCNT4 (1.4)	FEN1 (1.4)	USP1 (1.4)
MP:0001712	abnormal placenta development	0.03	> 0.20	MYLIP (2.5)	AP1M2 (2.1)	HLX (1.9)	CBLC (1.9)	LPAR2 (1.8)	DHX38 (1.7)	ATXN7L2 (1.7)	LPIN3 (1.7)	DNM2 (1.7)	PVRL2 (1.5)
MP:0011101	partial prenatal lethality	0.03	> 0.20	LDLR (2.7)	OGDH (2.6)	PLEKHH2 (2.6)	BCAM (2.4)	CILP2 (2.4)	HMGCR (2.2)	NYNRIN (2.1)	PCSK9 (2.1)	KANK2 (1.9)	GATAD2A (1.7)
GO:0002250	adaptive immune response	0.03	> 0.20	TIMD4 (3.2)	SLC22A1 (3.1)	LPA (2.6)	CETP (2.3)	APOE (2.2)	PARP10 (2.0)	ZNF101 (2.0)	RELB (1.9)	APOC4 (1.8)	BCL3 (1.7)
ENSG00000116830	TTF2 PPI subnetwork	0.03	> 0.20	MAPKAPK5 (3.1)	PSRC1 (2.8)	FEN1 (2.5)	BUD13 (2.3)	ATXN2 (2.1)	CETP (2.0)	USP1 (1.9)	ADAM1 (1.9)	POC5 (1.9)	C1orf63 (1.6)
ENSG00000179801	ENSG00000179801 PPI subnetwork	0.03	> 0.20	DDX56 (2.3)	PLG (2.3)	TMED4 (2.2)	APOA5 (1.8)	GOT2P1 (1.6)	ZHX3 (1.6)	NAA25 (1.6)	PLEKHH2 (1.5)	USP24 (1.5)	APOB (1.4)
ENSG00000052802	MSMO1 PPI subnetwork	0.03	> 0.20	HMGCR (12.8)	LDLR (12.2)	FADS1 (9.9)	FADS2 (9.3)	PCSK9 (7.2)	CYP7A1 (2.7)	NPC1L1 (2.6)	GPAM (2.4)	CLPTM1 (2.3)	TMEM50A (2.1)
ENSG00000101182	PSMA7 PPI subnetwork	0.03	> 0.20	PSMA5 (5.2)	NAA25 (3.3)	DDX56 (3.0)	TOMM40 (2.5)	SARS (2.4)	TRAFD1 (2.3)	NT5DC1 (2.2)	HMGCR (2.1)	ZNF259 (2.1)	SUGP1 (1.9)
ENSG00000158691	ZSCAN12 PPI subnetwork	0.03	> 0.20	C19orf52 (2.4)	PARP10 (2.4)	QTRT1 (2.2)	OASL (2.2)	SUGP1 (2.1)	DHX38 (2.1)	GRINA (1.9)	YIPF2 (1.9)	BRAP (1.7)	SORT1 (1.6)
REACTOME_CHOLESTEROL_BIOSYNTHESIS	REACTOME_CHOLESTEROL_BIOSYNTHESIS	0.03	> 0.20	HMGCR (17.8)	LDLR (16.0)	FADS1 (13.3)	FADS2 (12.7)	PCSK9 (10.2)	TRAPPC6A (2.8)	CYP7A1 (2.5)	NPC1L1 (2.5)	NKPD1 (2.0)	GPAM (2.0)
ENSG00000130826	DKC1 PPI subnetwork	0.03	> 0.20	DDX56 (4.9)	NAA25 (4.3)	QTRT1 (4.3)	TOMM40 (4.2)	ZNF259 (4.0)	DHODH (3.2)	TOP1 (3.0)	SUGP1 (2.7)	DHX38 (2.7)	ATP13A1 (2.3)
ENSG00000124782	RREB1 PPI subnetwork	0.03	> 0.20	GRINA (2.4)	C19orf52 (2.3)	QTRT1 (2.2)	ZNF180 (2.2)	OASL (2.2)	PARP10 (2.2)	SUGP1 (2.0)	YIPF2 (1.9)	BRAP (1.9)	ATP13A1 (1.7)
ENSG00000100726	TELO2 PPI subnetwork	0.03	> 0.20	C19orf52 (2.5)	GPAM (2.4)	ENSG00000226645 (2.0)	SUGP1 (2.0)	TRAPPC6A (1.9)	DHX38 (1.9)	USP24 (1.8)	DHODH (1.7)	YIPF2 (1.6)	MAU2 (1.6)
GO:0016411	acylglycerol O-acyltransferase activity	0.03	> 0.20	GPAM (5.2)	TM6SF2 (5.0)	MOSC1 (4.6)	NPC1L1 (3.8)	ENSG00000254235 (3.7)	LPAR2 (2.9)	GRINA (2.9)	FADS1 (2.5)	FADS2 (2.3)	SORT1 (2.2)
GO:0050818	regulation of coagulation	0.03	> 0.20	ITGB3 (3.7)	ANGPTL3 (3.1)	GMPR (2.9)	PCSK9 (2.8)	CYP7A1 (2.6)	PVR (2.6)	APOC4 (2.5)	ENSG00000228044 (2.4)	SLC22A1 (2.3)	PLG (2.2)
GO:0050820	positive regulation of coagulation	0.03	> 0.20	ANGPTL3 (3.3)	PCSK9 (3.2)	APOC4 (3.1)	APOA5 (2.9)	PLG (2.5)	ADAM1 (2.4)	HP (2.3)	SLC22A1 (2.3)	LPA (2.1)	ABO (2.1)
GO:0006954	inflammatory response	0.03	> 0.20	TIMD4 (3.1)	MAFB (2.8)	ENSG00000228044 (2.8)	PMFBP1 (2.1)	BCL3 (2.0)	HP (1.9)	HLX (1.7)	C17orf57 (1.7)	SLC22A1 (1.7)	ST3GAL4 (1.6)
ENSG00000211677	ENSG00000211677 PPI subnetwork	0.03	> 0.20	APOE (5.2)	TIMD4 (4.3)	APOC1 (3.7)	MAFB (3.2)	CETP (2.6)	GPAM (2.1)	KANK2 (1.9)	PCSK9 (1.9)	DYNC2LI1 (1.9)	SLC22A1 (1.9)
ENSG00000211679	ENSG00000211679 PPI subnetwork	0.03	> 0.20	APOE (5.2)	TIMD4 (4.3)	APOC1 (3.7)	MAFB (3.2)	CETP (2.6)	GPAM (2.1)	KANK2 (1.9)	PCSK9 (1.9)	DYNC2LI1 (1.9)	SLC22A1 (1.9)
MP:0001192	scaly skin	0.04	> 0.20	HMGCR (3.0)	CBLC (2.8)	CEACAM19 (2.7)	MAFB (2.6)	NKPD1 (2.4)	GRINA (2.2)	TRIB1 (2.1)	CYB561D1 (2.0)	AP1M2 (2.0)	NPC1L1 (2.0)
GO:0042558	pteridine-containing compound metabolic process	0.04	> 0.20	CYP7A1 (3.1)	GOT2P1 (2.6)	HNF1A (2.6)	DHODH (2.4)	ABCG8 (2.4)	TXNL4B (2.2)	NT5DC1 (2.2)	ENSG00000254235 (2.1)	UBXN2B (2.1)	ENSG00000238078 (2.0)
ENSG00000173486	FKBP2 PPI subnetwork	0.04	> 0.20	APOE (3.2)	CARM1 (2.3)	TIMD4 (2.3)	CETP (2.3)	SLC44A2 (2.2)	USP24 (2.1)	GMIP (1.9)	C12orf51 (1.8)	C19orf52 (1.7)	KANK2 (1.6)
GO:0009055	electron carrier activity	0.04	> 0.20	SLC22A1 (6.2)	LPA (4.8)	ALDH2 (4.6)	ANGPTL3 (4.4)	APOC4 (4.3)	PLG (4.1)	ABCG5 (3.6)	APOA5 (3.5)	ABCG8 (3.4)	CYP7A1 (3.3)
ENSG00000113595	TRIM23 PPI subnetwork	0.04	> 0.20	MYLIP (2.9)	GCNT4 (2.5)	CBLC (2.4)	BLOC1S3 (2.3)	GEMIN7 (2.2)	TRAPPC6A (2.0)	C17orf57 (2.0)	ZNF180 (2.0)	TMEM57 (1.7)	NKPD1 (1.4)
MP:0004816	abnormal class switch recombination	0.04	> 0.20	RELB (6.0)	BCL3 (3.6)	GMIP (3.1)	GCNT4 (2.1)	GRINA (1.7)	SH2B3 (1.7)	TIMD4 (1.6)	NT5DC1 (1.5)	ZNF101 (1.5)	TRIB1 (1.5)
GO:0008643	carbohydrate transport	0.04	> 0.20	GCNT4 (2.8)	NPC1L1 (2.7)	ABCG8 (2.4)	TMED4 (2.4)	POC5 (2.3)	SORT1 (2.1)	TM6SF2 (2.1)	AMIGO1 (2.0)	KIAA1324 (1.9)	ABCG5 (1.8)
GO:0035770	ribonucleoprotein granule	0.04	> 0.20	TRAFD1 (3.0)	OASL (2.5)	PARP10 (2.1)	ANKRD31 (2.0)	COL4A3BP (2.0)	TXNL4B (1.9)	GATAD2A (1.8)	MAPKAPK5 (1.8)	ENSG00000238078 (1.8)	ENSG00000228044 (1.7)
ENSG00000100030	MAPK1 PPI subnetwork	0.04	> 0.20	TRIB1 (5.1)	PLEC (3.1)	LDLR (2.8)	SH2B3 (2.3)	DNM2 (2.2)	PLCG1 (1.9)	PVR (1.9)	BCL3 (1.8)	ATXN2 (1.8)	PPP1R37 (1.7)
GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	0.04	> 0.20	APOC1 (3.9)	SLC22A1 (3.7)	FADS2 (3.4)	FADS1 (3.4)	HMGCR (3.1)	CBLC (2.7)	APOC4 (2.2)	LDLR (2.1)	TRAPPC6A (2.1)	ALDH2 (2.0)
ENSG00000044574	HSPA5 PPI subnetwork	0.04	> 0.20	PSMA5 (3.8)	TRAFD1 (3.1)	SMARCA4 (2.6)	SARS (2.6)	NAA25 (2.3)	CLPTM1 (2.2)	OGDH (2.2)	TOP1 (2.1)	ERP29 (1.9)	TOMM40 (1.9)
ENSG00000182809	CRIP2 PPI subnetwork	0.04	> 0.20	SYPL2 (4.2)	GMPR (2.7)	OGDH (2.2)	ACAD10 (2.2)	C11orf9 (2.1)	TMEM50A (1.9)	BCAM (1.6)	PSMA5 (1.5)	PVRL2 (1.3)	FADS2 (1.3)
GO:0044439	peroxisomal part	0.04	> 0.20	MOSC1 (4.4)	GPAM (4.2)	FADS2 (3.5)	PLG (3.3)	ANGPTL3 (3.0)	APOA5 (2.7)	SLC22A1 (2.7)	APOC4 (2.7)	CYP7A1 (2.6)	ABCG8 (2.6)
GO:0044438	microbody part	0.04	> 0.20	MOSC1 (4.4)	GPAM (4.2)	FADS2 (3.5)	PLG (3.3)	ANGPTL3 (3.0)	APOA5 (2.7)	SLC22A1 (2.7)	APOC4 (2.7)	CYP7A1 (2.6)	ABCG8 (2.6)
GO:0042800	histone methyltransferase activity (H3-K4 specific)	0.04	> 0.20	C12orf51 (3.9)	BRAP (3.1)	BUD13 (2.7)	C19orf52 (2.6)	ATXN2 (2.5)	ATXN7L2 (2.0)	C12orf43 (1.9)	PLEC (1.9)	GOT2P1 (1.6)	QTRT1 (1.6)
ENSG00000112304	ACOT13 PPI subnetwork	0.04	> 0.20	SYPL2 (3.4)	ACAD10 (2.9)	GMPR (2.2)	TMEM50A (2.1)	OGDH (2.0)	PLCG1 (1.7)	DDX56 (1.5)	C1orf63 (1.4)	TMED4 (1.4)	LPIN3 (1.4)
GO:0071900	regulation of protein serine/threonine kinase activity	0.04	> 0.20	ENSG00000226645 (3.8)	TRIB1 (3.1)	HLX (2.5)	PVR (2.1)	MYLIP (1.8)	SLC44A2 (1.7)	GCNT4 (1.7)	ENSG00000226648 (1.7)	LPAR2 (1.6)	KANK2 (1.5)
GO:0000303	response to superoxide	0.04	> 0.20	GOT2P1 (2.9)	RHCE (2.7)	ENSG00000235545 (2.5)	RHD (2.5)	PBX4 (2.3)	C12orf51 (2.0)	TRAPPC6A (1.8)	TMEM116 (1.7)	PMFBP1 (1.6)	LPAR2 (1.6)
GO:0000305	response to oxygen radical	0.04	> 0.20	GOT2P1 (2.9)	RHCE (2.7)	ENSG00000235545 (2.5)	RHD (2.5)	PBX4 (2.3)	C12orf51 (2.0)	TRAPPC6A (1.8)	TMEM116 (1.7)	PMFBP1 (1.6)	LPAR2 (1.6)
GO:0015645	fatty acid ligase activity	0.04	> 0.20	APOC4 (3.8)	MOSC1 (3.3)	PLG (3.1)	HMGCR (3.1)	FADS1 (2.8)	CYP7A1 (2.8)	APOA5 (2.7)	APOC1 (2.5)	GPAM (2.3)	FADS2 (2.3)
ENSG00000173545	ZNF622 PPI subnetwork	0.04	> 0.20	ZNF259 (5.4)	NAA25 (4.5)	DDX56 (3.8)	QTRT1 (3.7)	TOMM40 (3.5)	DHODH (3.0)	MAPKAPK5 (2.8)	ENSG00000226645 (2.4)	SUGP1 (2.2)	C12orf43 (2.1)
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	0.04	> 0.20	ABCG5 (6.3)	SLC22A1 (5.7)	LPA (5.7)	CYP7A1 (5.5)	ABCG8 (5.2)	APOC4 (5.1)	TM6SF2 (4.7)	ANGPTL3 (4.5)	APOA5 (3.8)	ALDH2 (3.7)
GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	0.04	> 0.20	PPP1R37 (3.4)	YIPF2 (2.9)	SARS (2.6)	BLOC1S3 (2.6)	ERP29 (2.3)	LPAR2 (2.0)	DNAH11 (1.9)	ENSG00000226648 (1.7)	FRK (1.6)	CARM1 (1.6)
ENSG00000102007	PLP2 PPI subnetwork	0.04	> 0.20	ST3GAL4 (2.7)	TMEM116 (2.5)	PVR (2.3)	TMEM50A (2.2)	ADAM1 (2.1)	CYB561D1 (1.9)	DOCK7 (1.7)	PLEC (1.7)	BRAP (1.7)	MAU2 (1.6)
GO:0005720	nuclear heterochromatin	0.04	> 0.20	NYNRIN (3.9)	ENSG00000254235 (2.8)	HAVCR1 (2.2)	ZNF180 (2.1)	USP1 (2.0)	TOP1 (2.0)	PVRL2 (1.9)	CYP7A1 (1.8)	ILF3 (1.6)	NT5DC1 (1.6)
GO:0031063	regulation of histone deacetylation	0.04	> 0.20	TMEM57 (4.5)	FADS2 (3.0)	GCNT4 (2.4)	FADS1 (2.2)	PPP1R37 (2.1)	PCSK9 (2.0)	POLK (1.9)	GATAD2A (1.8)	PLCG1 (1.7)	BLOC1S3 (1.6)
ENSG00000118520	ARG1 PPI subnetwork	0.04	> 0.20	NAA25 (3.3)	HP (2.8)	PVRL2 (2.3)	PVR (2.2)	CEACAM19 (2.2)	SARS (2.0)	OGDH (1.9)	RHCE (1.9)	TMEM57 (1.6)	AMIGO1 (1.5)
ENSG00000138495	COX17 PPI subnetwork	0.04	> 0.20	GEMIN7 (2.5)	FADS2 (2.2)	FADS1 (2.1)	TRAPPC6A (2.1)	BLOC1S3 (2.0)	ZNF180 (2.0)	ITGB3 (1.9)	RHD (1.8)	GRINA (1.6)	HMGCR (1.6)
ENSG00000165156	ZHX1 PPI subnetwork	0.04	> 0.20	ILF3 (2.3)	TOP1 (2.3)	ITGB3 (2.2)	FADS2 (2.2)	GMPR (2.2)	BUD13 (2.1)	UBXN2B (1.9)	TXNL4B (1.9)	GRINA (1.8)	PSMA5 (1.8)
ENSG00000104980	TIMM44 PPI subnetwork	0.04	> 0.20	DNM2 (3.1)	SARS (2.7)	DHODH (2.7)	ANGPTL3 (2.5)	CYP7A1 (2.4)	ILF3 (2.3)	ACAD10 (2.3)	TOMM40 (2.2)	QTRT1 (2.1)	LPA (2.1)
ENSG00000174483	BBS1 PPI subnetwork	0.04	> 0.20	UBXN2B (3.3)	BCAM (2.6)	DYNC2LI1 (2.4)	PLEC (2.3)	KANK2 (2.3)	ABCG5 (2.3)	SUGP1 (2.2)	SLC22A1 (2.0)	OGDH (2.0)	TM6SF2 (1.8)
ENSG00000127526	SLC35E1 PPI subnetwork	0.04	> 0.20	CLPTM1 (3.5)	BLOC1S3 (3.0)	ERP29 (2.7)	ATP13A1 (2.5)	SARS (2.3)	TMEM57 (2.3)	CBLC (2.2)	NT5DC1 (2.2)	OGDH (2.2)	YIPF2 (2.1)
ENSG00000197283	SYNGAP1 PPI subnetwork	0.04	> 0.20	PPP1R37 (3.0)	PLCG1 (2.8)	CELSR2 (2.6)	RPH3A (2.3)	NCAN (2.0)	MAPKAPK5 (2.0)	AMIGO1 (2.0)	DNAH11 (1.9)	MARK4 (1.8)	CETP (1.8)
MP:0009832	abnormal sperm mitochondrial sheath morphology	0.04	> 0.20	C11orf9 (3.1)	TSSK6 (3.0)	NT5DC1 (2.8)	FRK (2.3)	HLX (1.9)	PVR (1.8)	NPC1L1 (1.7)	APOE (1.7)	FADS1 (1.6)	ENSG00000228044 (1.6)
ENSG00000088247	KHSRP PPI subnetwork	0.04	> 0.20	DHX38 (2.6)	TRAPPC6A (2.5)	C1orf63 (2.2)	BUD13 (2.1)	ENSG00000254235 (2.1)	ABCG8 (1.9)	C19orf52 (1.8)	ILF3 (1.8)	SUGP1 (1.8)	CYP7A1 (1.6)
ENSG00000173511	VEGFB PPI subnetwork	0.04	> 0.20	MYLIP (4.3)	C1orf63 (3.6)	HLX (3.0)	C17orf57 (2.4)	ENSG00000226648 (2.2)	ADAM1 (2.1)	ATXN7L2 (1.8)	DNAH11 (1.8)	SLC44A2 (1.6)	ENSG00000254235 (1.6)
ENSG00000160808	MYL3 PPI subnetwork	0.04	> 0.20	ADAM1 (3.6)	ANKRD31 (2.6)	BRAP (2.5)	ENSG00000238078 (2.4)	TRAFD1 (2.2)	FADS2 (2.1)	C12orf51 (2.1)	SYPL2 (2.0)	TOP1 (1.9)	KANK2 (1.8)
GO:0008653	lipopolysaccharide metabolic process	0.04	> 0.20	ENSG00000228044 (3.5)	ENSG00000226648 (2.7)	BRAP (2.3)	CYB561D1 (1.7)	PPP1R37 (1.6)	ST3GAL4 (1.5)	DNM2 (1.5)	CILP2 (1.5)	ABO (1.4)	CARM1 (1.4)
ENSG00000163879	DNALI1 PPI subnetwork	0.04	> 0.20	TXNL4B (3.2)	BLOC1S3 (3.0)	GEMIN7 (2.5)	TRAPPC6A (2.3)	TOP1 (2.3)	BRAP (2.2)	TRAFD1 (2.0)	ZNF180 (2.0)	FRK (1.9)	C19orf52 (1.8)
GO:0010878	cholesterol storage	0.04	> 0.20	APOC1 (3.0)	TMEM116 (2.9)	ATXN7L2 (2.7)	APOE (2.7)	TIMD4 (2.6)	ABCG8 (2.6)	MOSC1 (2.2)	MYLIP (2.1)	LPIN3 (2.0)	ENSG00000238078 (2.0)
ENSG00000137309	HMGA1 PPI subnetwork	0.04	> 0.20	MAPKAPK5 (3.1)	BUD13 (2.9)	POC5 (2.9)	USP1 (2.5)	NAA25 (2.5)	DOCK7 (2.5)	ILF3 (2.3)	RELB (2.2)	TOP1 (2.2)	PSRC1 (2.0)
ENSG00000180138	CSNK1A1L PPI subnetwork	0.04	> 0.20	NYNRIN (3.1)	ENSG00000226648 (2.4)	LPIN3 (1.8)	CARM1 (1.7)	PLCG1 (1.7)	TRIB1 (1.7)	NPC1L1 (1.6)	MARK4 (1.5)	ENSG00000235545 (1.5)	PBX4 (1.5)
MP:0000322	increased granulocyte number	0.04	> 0.20	RELB (4.5)	BCL3 (4.4)	GMIP (2.9)	PARP10 (2.8)	HLX (2.7)	TRAFD1 (2.3)	MAFB (2.1)	TRIB1 (2.1)	SH2B3 (1.9)	GRINA (1.6)
ENSG00000083093	PALB2 PPI subnetwork	0.04	> 0.20	APOB (8.2)	APOC1 (4.6)	PLG (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOA5 (3.6)	HP (3.0)	GPAM (2.7)	ANGPTL3 (2.7)	APOC4 (2.6)
MP:0009657	failure of chorioallantoic fusion	0.04	> 0.20	CLPTM1 (2.6)	HAVCR1 (2.5)	APOE (2.3)	PPP1R37 (2.3)	ATXN2 (2.0)	BCAM (2.0)	GATAD2A (1.9)	CETP (1.8)	DOCK7 (1.7)	APOC1 (1.7)
ENSG00000115816	CEBPZ PPI subnetwork	0.04	> 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.6)	QTRT1 (3.3)	DHODH (3.1)	DHX38 (3.1)	ATP13A1 (2.8)	C12orf43 (2.6)	SUGP1 (2.5)
ENSG00000113407	TARS PPI subnetwork	0.04	> 0.20	SARS (4.3)	SUGP1 (3.3)	BRAP (3.0)	PSMA5 (2.9)	DDX56 (2.7)	ZNF259 (2.4)	NAA25 (2.4)	TOMM40 (2.3)	CBLC (2.1)	NT5DC1 (2.0)
MP:0000600	liver hypoplasia	0.04	> 0.20	BCL3 (3.6)	C11orf9 (3.5)	RHD (2.1)	TRIB1 (1.9)	RELB (1.9)	KANK2 (1.8)	MAU2 (1.7)	UBXN2B (1.6)	ST3GAL4 (1.6)	RHCE (1.5)
GO:0009251	glucan catabolic process	0.04	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.8)	AMIGO1 (2.5)	SORT1 (2.5)	ST3GAL4 (2.3)	ABCG8 (2.0)	ABCG5 (2.0)	ZHX3 (1.9)	ZNF101 (1.9)	HAPLN4 (1.8)
GO:0044247	cellular polysaccharide catabolic process	0.04	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.8)	AMIGO1 (2.5)	SORT1 (2.5)	ST3GAL4 (2.3)	ABCG8 (2.0)	ABCG5 (2.0)	ZHX3 (1.9)	ZNF101 (1.9)	HAPLN4 (1.8)
GO:0008093	cytoskeletal adaptor activity	0.04	> 0.20	ST3GAL4 (2.9)	PLEC (2.7)	PBX4 (2.3)	HLX (2.1)	GMPR (2.0)	PPP1R37 (2.0)	UBXN2B (2.0)	PMFBP1 (1.9)	RHD (1.9)	C11orf9 (1.8)
GO:0016878	acid-thiol ligase activity	0.04	> 0.20	HMGCR (5.1)	FADS2 (4.7)	LDLR (4.2)	ACAD10 (4.1)	FADS1 (3.9)	PCSK9 (3.9)	GPAM (3.4)	MOSC1 (3.0)	TRAPPC6A (2.9)	CYP7A1 (2.7)
ENSG00000205560	CPT1B PPI subnetwork	0.04	> 0.20	CYP7A1 (3.0)	HAPLN4 (2.9)	LPA (2.5)	SLC22A1 (2.5)	C11orf9 (2.4)	RHD (2.3)	ALDH2 (2.0)	ITGB3 (1.9)	C12orf47 (1.8)	RHCE (1.8)
MP:0008428	abnormal spatial working memory	0.04	> 0.20	HMGCR (3.7)	FADS1 (3.2)	NCAN (2.9)	APOC1 (2.8)	ABCG5 (2.7)	ENSG00000238078 (2.4)	CELSR2 (2.3)	RPH3A (2.2)	ABCG8 (2.2)	FADS2 (2.0)
ENSG00000100079	LGALS2 PPI subnetwork	0.04	> 0.20	NPC1L1 (5.0)	C11orf9 (3.5)	PCSK9 (3.1)	KIAA1324 (2.5)	HNF1A (2.5)	PLEC (2.4)	NT5DC1 (2.3)	DNAH11 (1.9)	TMEM50A (1.9)	LDLR (1.9)
ENSG00000105976	MET PPI subnetwork	0.04	> 0.20	DNM2 (3.2)	TOP1 (3.1)	CETP (2.5)	GRINA (2.1)	DNAH11 (2.1)	DOCK7 (2.0)	ITGB3 (1.9)	KANK2 (1.9)	NCAN (1.9)	C12orf51 (1.9)
MP:0003304	large intestinal inflammation	0.04	> 0.20	BCL3 (6.0)	RELB (5.6)	GRINA (4.4)	PARP10 (3.0)	GMIP (2.6)	PLEC (2.4)	SH2B3 (2.1)	SLC44A2 (2.1)	POLK (2.0)	HP (1.9)
ENSG00000115541	HSPE1 PPI subnetwork	0.04	> 0.20	FADS2 (3.7)	TRAPPC6A (3.2)	NT5DC1 (3.1)	FADS1 (2.6)	LDLR (2.3)	FRK (1.9)	OASL (1.9)	PCSK9 (1.8)	PVRL2 (1.8)	KANK2 (1.8)
MP:0001873	stomach inflammation	0.04	> 0.20	KIAA1324 (4.0)	BCL3 (2.8)	CBLC (2.5)	SLC44A2 (2.5)	PLEC (2.4)	GRINA (2.3)	PLEKHH2 (2.0)	DNM2 (2.0)	C17orf57 (1.9)	GEMIN7 (1.8)
GO:0046365	monosaccharide catabolic process	0.04	> 0.20	GOT2P1 (2.5)	ENSG00000254235 (2.2)	PCSK9 (2.0)	ACAD10 (2.0)	LPIN3 (1.9)	FRK (1.9)	TRAPPC6A (1.8)	NT5DC1 (1.6)	TSSK6 (1.6)	ERP29 (1.6)
MP:0002972	abnormal cardiac muscle contractility	0.04	> 0.20	SYPL2 (3.0)	RELB (2.9)	BCAM (2.0)	ACAD10 (1.9)	BCL3 (1.9)	PVR (1.8)	PTPN11 (1.7)	GMPR (1.7)	CETP (1.6)	HP (1.5)
ENSG00000196700	ZNF512B PPI subnetwork	0.04	> 0.20	DHX38 (3.5)	ANKRD31 (2.3)	BCAM (2.2)	C12orf47 (2.1)	PLCG1 (2.1)	ATXN2 (2.1)	BRAP (2.0)	DOCK7 (1.9)	SMARCA4 (1.9)	PPP1R37 (1.8)
MP:0003606	kidney failure	0.04	> 0.20	BCAM (4.9)	PLEKHH2 (2.8)	POLK (2.5)	C11orf9 (2.3)	GRINA (2.1)	NYNRIN (2.1)	PVR (2.0)	CELSR2 (1.9)	ZHX3 (1.7)	TMED4 (1.7)
MP:0004808	abnormal hematopoietic stem cell morphology	0.04	> 0.20	KANK2 (3.1)	TIMD4 (2.8)	TRIB1 (2.7)	UBXN2B (2.7)	ATXN2 (2.6)	HNF1A (2.5)	PARP10 (2.0)	GRINA (2.0)	CETP (1.9)	C12orf51 (1.9)
ENSG00000185627	PSMD13 PPI subnetwork	0.04	> 0.20	PSMA5 (5.3)	NAA25 (2.8)	SARS (2.7)	NT5DC1 (2.6)	TOMM40 (2.6)	TRAFD1 (2.1)	ENSG00000254235 (1.8)	SMARCA4 (1.7)	DDX56 (1.6)	PTPN11 (1.4)
ENSG00000153046	CDYL PPI subnetwork	0.04	> 0.20	C19orf52 (2.7)	TMEM57 (2.6)	MYLIP (2.4)	CARM1 (2.2)	MARK4 (2.1)	GATAD2A (1.7)	BUD13 (1.7)	GRINA (1.6)	ST3GAL4 (1.5)	USP24 (1.5)
ENSG00000119285	HEATR1 PPI subnetwork	0.04	> 0.20	ZNF259 (5.2)	DDX56 (4.8)	NAA25 (4.5)	TOMM40 (4.1)	QTRT1 (3.9)	DHODH (3.5)	DHX38 (2.6)	ATP13A1 (2.6)	SUGP1 (2.3)	GATAD2A (2.0)
ENSG00000077150	NFKB2 PPI subnetwork	0.04	> 0.20	RELB (4.3)	BCL3 (3.7)	PLEC (2.3)	ILF3 (2.1)	SARS (2.0)	NAA25 (1.9)	PVR (1.7)	CLPTM1 (1.7)	USP24 (1.6)	GRINA (1.6)
REACTOME_ANDROGEN_BIOSYNTHESIS	REACTOME_ANDROGEN_BIOSYNTHESIS	0.04	> 0.20	ENSG00000254235 (3.7)	CYP7A1 (2.6)	LPA (2.6)	DNAH11 (2.3)	FADS2 (2.2)	ST3GAL4 (2.2)	FADS1 (2.0)	APOA5 (1.9)	FRK (1.8)	KIAA1324 (1.8)
GO:0031593	polyubiquitin binding	0.04	> 0.20	GRINA (3.6)	HAVCR1 (2.4)	NT5DC1 (2.3)	GMPR (2.3)	YIPF2 (2.2)	CARM1 (2.1)	MAU2 (2.0)	SLC22A1 (1.8)	SUGP1 (1.7)	LPAR2 (1.6)
GO:0016810	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	0.04	> 0.20	TM6SF2 (3.1)	NPC1L1 (3.0)	HP (2.9)	SLC22A1 (2.8)	ABCG5 (2.7)	ABCG8 (2.7)	HNF1A (2.5)	LPA (2.4)	LPIN3 (2.3)	ATXN7L2 (2.3)
MP:0000523	cortical renal glomerulopathies	0.04	> 0.20	POLK (2.8)	MOSC1 (2.7)	ALDH2 (2.3)	KANK2 (2.3)	GRINA (1.9)	GPAM (1.8)	GCNT4 (1.8)	PLEKHH2 (1.6)	BLOC1S3 (1.4)	TSSK6 (1.4)
ENSG00000104856	RELB PPI subnetwork	0.04	> 0.20	RELB (4.2)	CARM1 (3.1)	BCL3 (2.8)	ILF3 (2.5)	GRINA (2.5)	SMARCA4 (2.3)	CLPTM1 (2.2)	C12orf43 (2.1)	NT5DC1 (2.1)	USP24 (1.4)
ENSG00000108270	AATF PPI subnetwork	0.04	> 0.20	ZNF259 (4.6)	DDX56 (4.0)	NAA25 (3.9)	DHODH (3.7)	QTRT1 (3.6)	TOMM40 (3.4)	C12orf43 (2.7)	DHX38 (2.2)	TOP1 (2.0)	ATP13A1 (1.9)
ENSG00000119616	FCF1 PPI subnetwork	0.04	> 0.20	DDX56 (4.4)	ZNF259 (4.1)	NAA25 (3.9)	QTRT1 (3.8)	C12orf43 (3.5)	DHODH (3.0)	TOMM40 (2.7)	BRAP (2.0)	SARS (1.9)	PVR (1.8)
MP:0005564	increased hemoglobin content	0.04	> 0.20	RHCE (3.6)	RHD (3.3)	CETP (2.2)	SLC44A2 (2.1)	FRK (2.0)	ANGPTL3 (1.8)	ABO (1.8)	PCSK9 (1.6)	MAU2 (1.5)	ENSG00000226648 (1.4)
ENSG00000171552	BCL2L1 PPI subnetwork	0.04	> 0.20	RELB (3.6)	TRAPPC6A (3.4)	TMEM50A (2.8)	GRINA (2.6)	CLPTM1 (2.4)	C12orf47 (2.3)	TRAFD1 (2.0)	GMIP (2.0)	C12orf43 (1.9)	ENSG00000238078 (1.9)
ENSG00000172071	EIF2AK3 PPI subnetwork	0.04	> 0.20	PARP10 (3.1)	USP24 (2.7)	BCL3 (2.1)	ZNF180 (2.1)	MARK4 (1.9)	MAU2 (1.9)	POLK (1.9)	MAFB (1.8)	SMARCA4 (1.8)	MYLIP (1.8)
MP:0003311	aminoaciduria	0.04	> 0.20	HAVCR1 (5.5)	TM6SF2 (4.6)	ALDH2 (3.1)	TMEM116 (2.8)	NPC1L1 (2.5)	FRK (2.2)	ANGPTL3 (2.2)	SLC22A1 (2.1)	AP1M2 (2.1)	MOSC1 (1.9)
REACTOME_ENDOGENOUS_STEROLS	REACTOME_ENDOGENOUS_STEROLS	0.04	> 0.20	ST3GAL4 (4.8)	APOC4 (4.4)	CYP7A1 (3.9)	APOA5 (3.2)	APOC1 (2.9)	PLG (2.8)	LPA (2.8)	SLC22A1 (2.6)	HMGCR (2.3)	FADS2 (2.2)
ENSG00000182973	CNOT10 PPI subnetwork	0.04	> 0.20	BLOC1S3 (3.3)	TMEM116 (3.1)	BRAP (2.8)	TMEM50A (2.4)	ST3GAL4 (2.1)	TOMM40 (1.9)	GCNT4 (1.8)	ATP13A1 (1.8)	TRAPPC6A (1.8)	CLPTM1 (1.7)
MP:0003957	abnormal nitric oxide homeostasis	0.04	> 0.20	PARP10 (3.8)	TRIB1 (3.6)	TRAFD1 (3.3)	BCL3 (3.0)	RELB (2.8)	HP (2.6)	MAFB (2.6)	GRINA (2.5)	PVR (2.4)	SYPL2 (2.1)
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	0.04	> 0.20	FADS1 (7.8)	HMGCR (7.5)	FADS2 (7.1)	GPAM (6.8)	LDLR (6.5)	PCSK9 (4.3)	MOSC1 (4.1)	NPC1L1 (3.0)	SORT1 (2.7)	GRINA (2.4)
ENSG00000065243	PKN2 PPI subnetwork	0.04	> 0.20	CETP (3.7)	TIMD4 (3.2)	TMEM57 (2.8)	OASL (2.5)	TMEM50A (2.2)	C1orf63 (2.2)	HNF1A (1.9)	SLC44A2 (1.8)	ANKRD31 (1.7)	FADS2 (1.7)
GO:0050810	regulation of steroid biosynthetic process	0.04	> 0.20	ST3GAL4 (4.4)	ENSG00000226645 (3.1)	FADS2 (2.9)	LDLR (2.7)	HMGCR (2.6)	FADS1 (2.4)	BLOC1S3 (2.4)	ABCG8 (2.2)	COL4A3BP (1.9)	GPAM (1.9)
ENSG00000144158	ENSG00000144158 PPI subnetwork	0.04	> 0.20	SUGP1 (4.6)	DHX38 (4.4)	BUD13 (3.2)	MAU2 (3.0)	SMARCA4 (3.0)	DDX56 (2.5)	BRAP (2.4)	ZNF259 (2.4)	ILF3 (2.2)	QTRT1 (2.1)
ENSG00000130803	ZNF317 PPI subnetwork	0.04	> 0.20	DHX38 (2.1)	PARP10 (2.0)	SUGP1 (2.0)	OASL (2.0)	C19orf52 (1.9)	QTRT1 (1.9)	GRINA (1.9)	SORT1 (1.7)	AMIGO1 (1.7)	YIPF2 (1.6)
MP:0001879	abnormal lymphatic vessel morphology	0.04	> 0.20	CETP (5.1)	HLX (3.2)	BCAM (3.0)	ITGB3 (2.4)	SLC44A2 (1.9)	PVRL2 (1.8)	MAFB (1.5)	LPA (1.5)	DNAH11 (1.4)	CILP2 (1.4)
ENSG00000197122	SRC PPI subnetwork	0.04	> 0.20	PLEC (3.6)	SH2B3 (2.7)	SORT1 (2.4)	DNM2 (2.4)	GMIP (2.4)	SMARCA4 (2.2)	ITGB3 (2.2)	C11orf9 (2.0)	MARK4 (1.9)	MAFB (1.8)
MP:0006356	abnormal third branchial arch artery morphology	0.04	> 0.20	PVR (3.1)	TMEM116 (2.3)	PLCG1 (2.2)	TMEM57 (1.7)	TSSK6 (1.5)	KANK2 (1.5)	ENSG00000235545 (1.5)	HLX (1.5)	PVRL2 (1.5)	SH2B3 (1.4)
MP:0006058	decreased cerebral infarction size	0.04	> 0.20	TRIB1 (4.0)	PLEKHH2 (3.3)	APOC1 (3.3)	MAFB (3.0)	ENSG00000254235 (2.9)	PVR (2.7)	FRK (2.3)	CELSR2 (2.1)	NCAN (1.8)	HLX (1.8)
ENSG00000102900	NUP93 PPI subnetwork	0.04	> 0.20	POC5 (3.2)	DDX56 (2.9)	CARM1 (2.9)	NAA25 (2.8)	USP1 (2.8)	TOMM40 (2.7)	USP24 (2.3)	MAPKAPK5 (2.2)	FEN1 (1.9)	ENSG00000226648 (1.9)
GO:0002237	response to molecule of bacterial origin	0.04	> 0.20	PVR (2.7)	ENSG00000228044 (2.6)	MAFB (2.4)	TRIB1 (2.4)	BCL3 (2.3)	DNAH11 (2.2)	GRINA (2.1)	HLX (2.1)	PARP10 (1.8)	HP (1.8)
ENSG00000175197	DDIT3 PPI subnetwork	0.04	> 0.20	TRIB1 (6.8)	SARS (3.3)	PVR (3.0)	BCL3 (2.7)	ENSG00000226645 (2.3)	HLX (1.9)	MAFB (1.8)	TSSK6 (1.7)	YIPF2 (1.6)	LDLR (1.6)
GO:0071219	cellular response to molecule of bacterial origin	0.04	> 0.20	PVR (3.4)	PARP10 (2.3)	OASL (2.3)	DNAH11 (2.2)	LPIN3 (2.2)	GRINA (2.1)	CEACAM19 (1.9)	UBXN2B (1.8)	MAFB (1.7)	AMIGO1 (1.6)
ENSG00000122257	RBBP6 PPI subnetwork	0.04	> 0.20	TIMD4 (3.6)	CETP (3.2)	OASL (2.6)	NKPD1 (2.4)	GATAD2A (2.2)	YIPF2 (1.9)	NPC1L1 (1.9)	HNF1A (1.7)	TXNL4B (1.5)	PTPN11 (1.5)
GO:0051427	hormone receptor binding	0.04	> 0.20	DNM2 (2.6)	DHX38 (2.3)	MAPKAPK5 (2.3)	TRAFD1 (2.2)	ATXN2 (2.1)	BUD13 (1.8)	MAFB (1.7)	COL4A3BP (1.5)	USP24 (1.5)	SMARCA4 (1.4)
ENSG00000132382	MYBBP1A PPI subnetwork	0.04	> 0.20	NAA25 (3.6)	SMARCA4 (3.2)	TOMM40 (2.7)	ILF3 (2.7)	C12orf43 (2.5)	TRIB1 (2.4)	DHX38 (2.3)	ANKRD31 (2.3)	USP1 (2.3)	ADAM1 (2.2)
ENSG00000171150	SOCS5 PPI subnetwork	0.04	> 0.20	BCL3 (4.4)	PARP10 (2.8)	GMIP (2.8)	PLEKHH2 (2.8)	HLX (2.6)	RELB (2.6)	TRIB1 (2.2)	CETP (2.0)	ZNF101 (2.0)	PBX4 (1.9)
GO:0051604	protein maturation	0.04	> 0.20	TMED4 (3.0)	ENSG00000254235 (2.8)	KIAA1324 (2.8)	YIPF2 (2.4)	CEACAM19 (2.2)	DYNC2LI1 (2.1)	ENSG00000238078 (1.9)	CYB561D1 (1.8)	ERP29 (1.6)	ENSG00000228044 (1.4)
MP:0002962	increased urine protein level	0.04	> 0.20	BCAM (4.5)	PVR (3.2)	PVRL2 (2.7)	NT5DC1 (2.6)	C11orf9 (2.2)	PLEKHH2 (2.2)	POLK (2.0)	PLEC (2.0)	MAFB (1.6)	CEACAM19 (1.6)
MP:0004187	cardia bifida	0.04	> 0.20	PVRL2 (3.3)	MARK4 (2.9)	PVR (2.8)	LPAR2 (2.5)	C11orf9 (2.4)	HNF1A (2.1)	ADAM1 (1.8)	CLPTM1 (1.7)	GRINA (1.7)	ENSG00000226648 (1.6)
ENSG00000166582	CENPV PPI subnetwork	0.04	> 0.20	SUGP1 (2.3)	DHX38 (2.1)	C19orf52 (2.1)	BRAP (2.0)	YIPF2 (2.0)	QTRT1 (2.0)	PARP10 (1.9)	OASL (1.8)	AMIGO1 (1.8)	SORT1 (1.7)
GO:0022600	digestive system process	0.04	> 0.20	NPC1L1 (6.2)	TM6SF2 (4.4)	ABCG5 (3.8)	ABCG8 (3.7)	KIAA1324 (3.6)	C17orf57 (2.7)	APOB (2.7)	ABO (2.2)	CBLC (2.1)	TMED4 (1.9)
GO:0019841	retinol binding	0.04	> 0.20	ABCG5 (5.0)	TM6SF2 (4.3)	APOB (4.3)	APOA5 (3.2)	ABCG8 (3.0)	NYNRIN (2.8)	APOC4 (2.7)	NKPD1 (2.6)	NPC1L1 (2.5)	LPAR2 (2.4)
ENSG00000164305	CASP3 PPI subnetwork	0.04	> 0.20	PTPN11 (3.4)	GATAD2A (2.6)	POLK (2.5)	ST3GAL4 (2.2)	UBXN2B (1.9)	BCL3 (1.9)	DHX38 (1.7)	OGDH (1.5)	TRAFD1 (1.5)	ILF3 (1.5)
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU:RICH_ELEMENTS	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU:RICH_ELEMENTS	0.04	> 0.20	PSMA5 (5.2)	TRAFD1 (3.1)	NAA25 (2.9)	TOMM40 (2.8)	NT5DC1 (2.6)	DDX56 (2.2)	TMEM50A (2.1)	PARP10 (1.8)	SMARCA4 (1.8)	SUGP1 (1.7)
GO:0006306	DNA methylation	0.04	> 0.20	ENSG00000238078 (3.5)	ANKRD31 (3.3)	MAU2 (2.1)	LPAR2 (2.1)	YIPF2 (2.0)	C17orf57 (1.9)	COL4A3BP (1.8)	ACAD10 (1.8)	ATP13A1 (1.7)	SUGP1 (1.7)
GO:0006305	DNA alkylation	0.04	> 0.20	ENSG00000238078 (3.5)	ANKRD31 (3.3)	MAU2 (2.1)	LPAR2 (2.1)	YIPF2 (2.0)	C17orf57 (1.9)	COL4A3BP (1.8)	ACAD10 (1.8)	ATP13A1 (1.7)	SUGP1 (1.7)
ENSG00000143772	ITPKB PPI subnetwork	0.04	> 0.20	ATP13A1 (2.6)	MAPKAPK5 (2.5)	TOMM40 (2.5)	DHODH (2.4)	ANKRD31 (2.1)	ZNF180 (2.1)	CARM1 (2.0)	HNF1A (2.0)	PCSK9 (1.9)	SMARCA4 (1.8)
ENSG00000004799	PDK4 PPI subnetwork	0.04	> 0.20	ACAD10 (3.0)	OGDH (2.8)	USP24 (2.8)	CLPTM1 (2.4)	GPAM (2.3)	C12orf43 (2.2)	MOSC1 (1.9)	HAVCR1 (1.8)	ABCG8 (1.8)	NAA25 (1.7)
ENSG00000150337	FCGR1A PPI subnetwork	0.04	> 0.20	PLG (5.9)	ANGPTL3 (5.5)	APOC4 (5.2)	HP (4.5)	APOA5 (4.2)	LPA (3.4)	SLC22A1 (2.9)	ABCG5 (2.6)	MAFB (2.0)	DHODH (1.9)
ENSG00000164751	PEX2 PPI subnetwork	0.04	> 0.20	CYP7A1 (3.0)	FADS2 (2.9)	GPAM (2.9)	LDLR (2.9)	CEACAM19 (2.8)	HMGCR (2.5)	PCSK9 (2.4)	TSSK6 (2.3)	MOSC1 (2.3)	C19orf52 (2.2)
GO:0016485	protein processing	0.04	> 0.20	ENSG00000254235 (3.1)	KIAA1324 (3.0)	CEACAM19 (2.9)	TMED4 (2.5)	ENSG00000238078 (2.3)	YIPF2 (2.0)	DYNC2LI1 (1.8)	GCNT4 (1.7)	CYB561D1 (1.6)	ENSG00000228044 (1.4)
MP:0006042	increased apoptosis	0.04	> 0.20	ATP13A1 (3.1)	DHX38 (2.8)	GATAD2A (2.6)	SMARCA4 (2.4)	MAU2 (2.3)	TOP1 (2.3)	CARM1 (1.9)	USP1 (1.9)	FEN1 (1.8)	TMEM57 (1.8)
MP:0009243	hairpin sperm flagellum	0.04	> 0.20	TSSK6 (2.8)	ENSG00000228044 (2.5)	FRK (2.0)	CYP7A1 (2.0)	C12orf47 (1.9)	HLX (1.7)	ST3GAL4 (1.7)	PMFBP1 (1.7)	PCSK9 (1.7)	TMEM57 (1.5)
ENSG00000165409	TSHR PPI subnetwork	0.04	> 0.20	BLOC1S3 (2.5)	USP24 (1.9)	DNM2 (1.8)	BCL3 (1.7)	C17orf57 (1.6)	HAVCR1 (1.5)	PCSK9 (1.5)	PPP1R37 (1.5)	KIAA1324 (1.4)	YIPF2 (1.4)
ENSG00000196504	PRPF40A PPI subnetwork	0.04	> 0.20	DHX38 (4.1)	ATXN2 (3.9)	SMARCA4 (3.7)	ILF3 (3.3)	BRAP (3.1)	TOP1 (2.9)	NAA25 (2.5)	DNM2 (2.5)	ATP13A1 (2.4)	BUD13 (2.3)
ENSG00000163938	GNL3 PPI subnetwork	0.04	> 0.20	QTRT1 (4.5)	ZNF259 (4.3)	TOMM40 (4.2)	NAA25 (4.0)	DDX56 (3.7)	ATP13A1 (2.7)	C12orf43 (2.6)	DHODH (2.6)	DHX38 (2.3)	SUGP1 (2.2)
ENSG00000165916	PSMC3 PPI subnetwork	0.04	> 0.20	PSMA5 (5.4)	NAA25 (3.0)	TOMM40 (2.7)	DDX56 (2.6)	NT5DC1 (2.6)	SARS (2.5)	TRAFD1 (2.2)	ENSG00000254235 (2.0)	SMARCA4 (1.9)	ZNF259 (1.8)
MP:0000372	irregular coat pigmentation	0.04	> 0.20	GMPR (2.8)	MYLIP (2.7)	NKPD1 (2.3)	PLEKHH2 (1.9)	PCSK9 (1.8)	BLOC1S3 (1.6)	HMGCR (1.6)	FRK (1.6)	TMEM50A (1.5)	HAVCR1 (1.5)
ENSG00000166930	MS4A5 PPI subnetwork	0.04	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.8)	DNM2 (2.4)	KIAA1324 (2.3)	HNF1A (2.3)	PLEC (1.9)	ITGB3 (1.7)	SH2B3 (1.6)	C12orf47 (1.6)	CBLC (1.5)
ENSG00000101210	EEF1A2 PPI subnetwork	0.04	> 0.20	RELB (4.1)	BCL3 (3.4)	COL4A3BP (2.3)	BUD13 (2.3)	ENSG00000226645 (2.0)	SMARCA4 (1.8)	CARM1 (1.7)	DHX38 (1.7)	C1orf63 (1.6)	C19orf52 (1.6)
MP:0004090	abnormal sarcomere morphology	0.04	> 0.20	SYPL2 (6.0)	GMPR (2.9)	BCAM (2.0)	ENSG00000228044 (1.8)	TRAPPC6A (1.8)	HNF1A (1.6)	OGDH (1.6)	LPAR2 (1.6)	C17orf57 (1.5)	PVRL2 (1.4)
MP:0001874	acanthosis	0.04	> 0.20	CBLC (4.2)	BCL3 (3.2)	RELB (3.0)	AP1M2 (2.5)	MAFB (2.4)	GEMIN7 (2.1)	PARP10 (2.1)	PMFBP1 (2.0)	GMIP (1.8)	PLEC (1.7)
GO:0006706	steroid catabolic process	0.04	> 0.20	LPA (6.6)	SLC22A1 (4.7)	CYP7A1 (3.4)	ENSG00000228044 (3.0)	APOC4 (3.0)	ENSG00000254235 (2.9)	ABCG8 (2.8)	ABCG5 (2.5)	ANGPTL3 (2.4)	APOA5 (2.4)
MP:0008706	decreased interleukin-6 secretion	0.04	> 0.20	BCL3 (4.0)	PARP10 (3.9)	RELB (3.7)	OASL (3.5)	MAFB (3.0)	CETP (2.5)	TRIB1 (2.4)	GMIP (2.2)	TRAFD1 (2.0)	PVR (1.7)
ENSG00000092820	EZR PPI subnetwork	0.04	> 0.20	PVR (2.7)	TIMD4 (2.7)	PLEC (2.6)	RELB (2.5)	GATAD2A (2.3)	C11orf9 (2.1)	BCL3 (2.1)	SLC44A2 (2.1)	ZNF101 (1.7)	LDLR (1.6)
GO:0010745	negative regulation of macrophage derived foam cell differentiation	0.04	> 0.20	TIMD4 (4.4)	APOE (2.6)	ENSG00000238078 (2.6)	GEMIN7 (2.5)	C17orf57 (2.3)	MYLIP (2.3)	MOSC1 (2.2)	APOC1 (2.2)	PBX4 (2.2)	CETP (1.9)
KEGG_GALACTOSE_METABOLISM	KEGG_GALACTOSE_METABOLISM	0.04	> 0.20	DOCK7 (2.9)	TM6SF2 (2.7)	NPC1L1 (2.5)	TRAPPC6A (2.5)	CYP7A1 (2.1)	GOT2P1 (2.0)	ABCG5 (2.0)	NT5DC1 (1.8)	DHODH (1.6)	ABCG8 (1.6)
REACTOME_GRB2SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS	REACTOME_GRB2SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS	0.04	> 0.20	ITGB3 (5.5)	APOB (5.2)	APOC1 (4.3)	ANGPTL3 (4.0)	PLG (3.8)	HP (3.7)	HAVCR1 (3.7)	APOA5 (3.3)	APOC4 (2.8)	APOE (2.8)
MP:0010373	myeloid hyperplasia	0.04	> 0.20	BCL3 (3.4)	RELB (3.0)	SH2B3 (2.5)	UBXN2B (2.4)	C12orf51 (2.1)	ENSG00000254235 (2.1)	MAPKAPK5 (2.0)	BUD13 (2.0)	ST3GAL4 (1.9)	USP24 (1.7)
MP:0010279	increased gastrointestinal tumor incidence	0.04	> 0.20	ZNF180 (3.0)	BCAM (2.4)	CLPTM1 (2.3)	BLOC1S3 (2.2)	FEN1 (2.0)	PARP10 (1.8)	DYNC2LI1 (1.8)	FADS2 (1.8)	AP1M2 (1.8)	POC5 (1.8)
MP:0000219	increased neutrophil cell number	0.04	> 0.20	GMIP (4.3)	BCL3 (4.3)	RELB (3.0)	ITGB3 (2.6)	SLC44A2 (2.6)	DNM2 (2.0)	SH2B3 (2.0)	CETP (1.9)	PLEC (1.9)	ST3GAL4 (1.9)
ENSG00000171566	PLRG1 PPI subnetwork	0.04	> 0.20	DHX38 (4.5)	SUGP1 (4.0)	SMARCA4 (3.3)	BUD13 (3.3)	MAU2 (3.1)	DDX56 (2.7)	ZNF259 (2.5)	C19orf52 (2.4)	SARS (2.1)	ILF3 (2.1)
ENSG00000204310	AGPAT1 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
ENSG00000206255	ENSG00000206255 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
ENSG00000206324	AGPAT1 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
ENSG00000151224	MAT1A PPI subnetwork	0.04	> 0.20	TOMM40 (4.3)	NAA25 (4.2)	SARS (3.6)	ZNF259 (3.5)	DDX56 (3.4)	PSMA5 (3.4)	CLPTM1 (3.2)	DHX38 (2.5)	ATP13A1 (2.1)	QTRT1 (2.1)
MP:0008412	increased cellular sensitivity to oxidative stress	0.04	> 0.20	RHCE (6.9)	RHD (4.2)	TRAPPC6A (3.3)	TMEM57 (2.2)	C12orf51 (2.0)	ABCG5 (2.0)	PSMA5 (1.9)	ALDH2 (1.9)	ZHX3 (1.9)	DHODH (1.9)
ENSG00000175387	SMAD2 PPI subnetwork	0.04	> 0.20	KANK2 (3.1)	ATXN2 (3.0)	MARK4 (2.9)	DHX38 (2.7)	GATAD2A (2.5)	PTPN11 (2.5)	SH2B3 (2.4)	PLCG1 (2.4)	CLPTM1 (2.4)	SMARCA4 (2.3)
ENSG00000123838	C4BPA PPI subnetwork	0.04	> 0.20	APOC4 (3.1)	APOA5 (3.1)	ANGPTL3 (3.0)	ABCG5 (2.4)	ENSG00000254235 (2.4)	C11orf9 (2.2)	ABCG8 (2.2)	FRK (2.1)	NKPD1 (1.8)	ZNF259 (1.7)
MP:0000602	enlarged liver sinusoidal spaces	0.04	> 0.20	RHCE (3.6)	RHD (3.5)	LPA (3.2)	POLK (2.6)	SLC22A1 (2.5)	CETP (2.3)	C12orf51 (2.3)	APOC4 (2.1)	COL4A3BP (1.8)	TMEM57 (1.8)
GO:0009074	aromatic amino acid family catabolic process	0.04	> 0.20	CYP7A1 (3.9)	SLC22A1 (3.9)	ENSG00000254235 (3.9)	LPA (3.3)	APOA5 (3.3)	ANGPTL3 (3.2)	PLG (2.6)	APOC4 (2.6)	ENSG00000228044 (1.9)	CEACAM19 (1.8)
GO:0032677	regulation of interleukin-8 production	0.04	> 0.20	HP (2.2)	PVR (1.9)	HLX (1.8)	ENSG00000228044 (1.7)	ST3GAL4 (1.7)	ZNF180 (1.7)	TIMD4 (1.6)	SH2B3 (1.6)	DNAH11 (1.6)	FRK (1.5)
ENSG00000162407	PPAP2B PPI subnetwork	0.04	> 0.20	USP24 (2.9)	PARP10 (2.8)	MARK4 (2.7)	GMIP (2.7)	MAU2 (2.4)	DHX38 (2.3)	POLK (2.1)	ATXN2 (2.1)	BCL3 (2.0)	SMARCA4 (2.0)
GO:0004197	cysteine-type endopeptidase activity	0.04	> 0.20	APOE (4.0)	NKPD1 (2.6)	MAFB (2.5)	CEACAM19 (2.2)	ENSG00000254235 (2.0)	USP24 (2.0)	CBLC (1.9)	TMEM50A (1.8)	TMEM57 (1.8)	ERP29 (1.7)
ENSG00000134398	ERN2 PPI subnetwork	0.04	> 0.20	ATP13A1 (4.3)	LDLR (3.8)	YIPF2 (3.7)	ERP29 (3.6)	FADS1 (2.9)	TMEM57 (2.9)	TMEM50A (2.8)	TMED4 (2.6)	CLPTM1 (2.6)	QTRT1 (2.5)
MP:0000611	jaundice	0.04	> 0.20	RHCE (10.1)	RHD (10.0)	GMPR (3.6)	C12orf51 (3.3)	ACAD10 (2.2)	ABO (1.9)	CYP7A1 (1.8)	USP24 (1.6)	KANK2 (1.4)	ENSG00000228044 (1.4)
ENSG00000124571	XPO5 PPI subnetwork	0.04	> 0.20	NAA25 (3.6)	DDX56 (3.3)	TOMM40 (2.6)	ATP13A1 (2.4)	QTRT1 (2.1)	DHX38 (2.1)	ENSG00000226648 (2.0)	PSMA5 (1.9)	SMARCA4 (1.9)	POC5 (1.8)
GO:0006702	androgen biosynthetic process	0.04	> 0.20	ST3GAL4 (3.3)	DNAH11 (2.5)	CYP7A1 (2.3)	ABO (2.2)	ABCG8 (2.2)	FADS2 (2.1)	TSSK6 (2.1)	FRK (2.1)	FADS1 (1.8)	HNF1A (1.7)
MP:0005031	abnormal trophoblast layer morphology	0.04	> 0.20	CBLC (2.6)	PTPN11 (2.5)	OGDH (1.9)	PLEC (1.8)	LDLR (1.8)	DHX38 (1.7)	C12orf51 (1.7)	DNM2 (1.7)	ATXN7L2 (1.5)	ABO (1.5)
GO:0004521	endoribonuclease activity	0.04	> 0.20	ZNF180 (3.3)	DHODH (2.7)	CEACAM19 (2.1)	C12orf43 (2.0)	FEN1 (1.8)	LPA (1.7)	DDX56 (1.6)	BUD13 (1.6)	CARM1 (1.6)	ENSG00000235545 (1.5)
GO:0009310	amine catabolic process	0.04	> 0.20	LPA (3.2)	SLC22A1 (2.9)	ANGPTL3 (2.9)	CYP7A1 (2.9)	ACAD10 (2.6)	DHODH (2.5)	ENSG00000254235 (2.5)	MOSC1 (2.4)	QTRT1 (2.4)	PLG (2.3)
ENSG00000183751	TBL3 PPI subnetwork	0.04	> 0.20	ZNF259 (4.6)	DDX56 (4.3)	QTRT1 (4.0)	NAA25 (3.8)	TOMM40 (3.6)	DHODH (2.6)	C12orf43 (2.3)	DHX38 (2.2)	SUGP1 (2.2)	GATAD2A (2.0)
MP:0005032	abnormal ectoplacental cone morphology	0.04	> 0.20	PPP1R37 (3.7)	ZNF180 (3.1)	LPAR2 (2.3)	LPIN3 (2.1)	PVRL2 (2.1)	ENSG00000238078 (2.0)	PSRC1 (1.9)	PVR (1.9)	ST3GAL4 (1.8)	QTRT1 (1.7)
ENSG00000120885	CLU PPI subnetwork	0.04	> 0.20	TIMD4 (3.8)	HP (2.7)	APOC4 (2.6)	GPAM (2.6)	SLC22A1 (2.4)	ANGPTL3 (2.3)	LPA (2.2)	CETP (2.0)	ALDH2 (2.0)	PLG (2.0)
ENSG00000125733	TRIP10 PPI subnetwork	0.04	> 0.20	ATXN2 (2.7)	LPIN3 (2.6)	GOT2P1 (2.5)	C12orf51 (2.3)	ENSG00000238078 (2.2)	DOCK7 (2.1)	UBXN2B (2.0)	NT5DC1 (1.8)	SLC44A2 (1.8)	AP1M2 (1.6)
GO:0004467	long-chain fatty acid-CoA ligase activity	0.04	> 0.20	HMGCR (3.8)	FADS1 (3.7)	APOC4 (3.3)	PLG (3.1)	PCSK9 (3.0)	LDLR (2.8)	FADS2 (2.7)	HP (2.3)	APOA5 (2.3)	MOSC1 (2.2)
KEGG_GLYCEROLIPID_METABOLISM	KEGG_GLYCEROLIPID_METABOLISM	0.04	> 0.20	MOSC1 (4.4)	TM6SF2 (3.9)	GPAM (2.6)	ENSG00000226645 (1.9)	KIAA1324 (1.9)	GCNT4 (1.8)	NPC1L1 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)	APOA5 (1.6)
ENSG00000214528	ENSG00000214528 PPI subnetwork	0.04	> 0.20	DNAH11 (2.7)	SYPL2 (2.6)	ANKRD31 (2.5)	ATXN7L2 (2.5)	ENSG00000228044 (2.1)	ATXN2 (2.1)	HLX (2.0)	PMFBP1 (1.9)	KANK2 (1.9)	PCSK9 (1.7)
ENSG00000143546	S100A8 PPI subnetwork	0.04	> 0.20	BLOC1S3 (2.4)	AP1M2 (2.2)	GMIP (2.2)	GEMIN7 (2.2)	CLPTM1 (2.1)	HP (1.9)	TOMM40 (1.8)	TRAPPC6A (1.7)	PCSK9 (1.7)	PLEKHH2 (1.5)
ENSG00000090104	RGS1 PPI subnetwork	0.04	> 0.20	YIPF2 (3.3)	DNM2 (3.1)	C19orf52 (3.0)	ITGB3 (2.7)	ATP13A1 (2.5)	SUGP1 (2.3)	SMARCA4 (2.2)	MAU2 (2.1)	TSSK6 (2.0)	QTRT1 (2.0)
GO:0031528	microvillus membrane	0.04	> 0.20	APOB (3.2)	HNF1A (3.2)	TMED4 (3.0)	C11orf9 (2.4)	BCAM (1.9)	DNAH11 (1.8)	NPC1L1 (1.8)	LDLR (1.7)	OGDH (1.6)	TM6SF2 (1.6)
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	0.04	> 0.20	GPAM (5.1)	HMGCR (3.7)	C19orf52 (2.2)	LDLR (2.2)	DHODH (2.2)	USP24 (2.1)	PCSK9 (2.0)	FADS2 (2.0)	NT5DC1 (2.0)	MOSC1 (1.6)
GO:0045926	negative regulation of growth	0.04	> 0.20	TXNL4B (2.4)	AMIGO1 (2.2)	GCNT4 (2.1)	TMED4 (2.0)	CILP2 (1.9)	MYLIP (1.9)	POLK (1.9)	C19orf52 (1.8)	HLX (1.6)	PVR (1.5)
MP:0008525	decreased cranium height	0.04	> 0.20	NYNRIN (2.9)	CILP2 (2.0)	PLEKHH2 (2.0)	KANK2 (1.8)	MAPKAPK5 (1.8)	CLPTM1 (1.8)	ABO (1.8)	DOCK7 (1.6)	PLCG1 (1.5)	PPP1R37 (1.4)
ENSG00000107816	LZTS2 PPI subnetwork	0.04	> 0.20	RHD (3.3)	ITGB3 (2.2)	PPP1R37 (2.2)	FRK (1.9)	MARK4 (1.8)	GMPR (1.7)	ENSG00000226648 (1.7)	PVRL2 (1.6)	TRAPPC6A (1.6)	ENSG00000228044 (1.6)
ENSG00000143627	PKLR PPI subnetwork	0.04	> 0.20	SARS (4.0)	PSMA5 (2.7)	OGDH (2.2)	NT5DC1 (2.1)	TOMM40 (2.1)	ALDH2 (2.0)	GPAM (2.0)	FRK (1.9)	NAA25 (1.8)	SYPL2 (1.7)
GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	0.04	> 0.20	POLK (3.2)	ENSG00000238078 (2.7)	C17orf57 (2.6)	TRAPPC6A (2.3)	OASL (2.1)	ITGB3 (2.0)	TRAFD1 (1.9)	PARP10 (1.7)	GOT2P1 (1.7)	GEMIN7 (1.7)
ENSG00000128322	IGLL1 PPI subnetwork	0.04	> 0.20	BCAM (3.2)	ALDH2 (2.8)	CILP2 (2.6)	RPH3A (2.1)	TIMD4 (2.0)	NYNRIN (1.9)	RHD (1.9)	SLC22A1 (1.8)	CLPTM1 (1.8)	DOCK7 (1.7)
GO:0006897	endocytosis	0.04	> 0.20	TIMD4 (2.6)	DNM2 (2.5)	CETP (2.5)	GRINA (2.5)	MAFB (2.5)	CLPTM1 (2.2)	SH2B3 (2.1)	C12orf51 (2.1)	PPP1R37 (2.0)	ERP29 (1.8)
GO:0010324	membrane invagination	0.04	> 0.20	TIMD4 (2.6)	DNM2 (2.5)	CETP (2.5)	GRINA (2.5)	MAFB (2.5)	CLPTM1 (2.2)	SH2B3 (2.1)	C12orf51 (2.1)	PPP1R37 (2.0)	ERP29 (1.8)
GO:0033619	membrane protein proteolysis	0.04	> 0.20	ST3GAL4 (3.3)	CLPTM1 (2.5)	ENSG00000254235 (2.4)	TMEM50A (2.3)	GCNT4 (1.9)	SLC44A2 (1.9)	CYB561D1 (1.8)	ENSG00000228044 (1.7)	ZNF101 (1.7)	NYNRIN (1.7)
ENSG00000148719	DNAJB12 PPI subnetwork	0.04	> 0.20	ACAD10 (4.3)	NT5DC1 (2.9)	HNF1A (2.8)	TMED4 (2.7)	OGDH (2.1)	TRAPPC6A (2.0)	GMPR (2.0)	TIMD4 (1.9)	PLEKHH2 (1.9)	CETP (1.8)
ENSG00000160094	ZNF362 PPI subnetwork	0.04	> 0.20	DHX38 (2.5)	C19orf52 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)	PARP10 (2.1)	BRAP (1.9)	OASL (1.9)	YIPF2 (1.9)	AMIGO1 (1.8)	OGDH (1.7)
REACTOME_CIRCADIAN_CLOCK	REACTOME_CIRCADIAN_CLOCK	0.04	> 0.20	ZHX3 (3.9)	TRIB1 (3.4)	LPIN3 (2.1)	C12orf51 (2.0)	GPAM (1.9)	ATXN2 (1.8)	CILP2 (1.6)	TMEM57 (1.5)	MYLIP (1.5)	LDLR (1.5)
ENSG00000070061	IKBKAP PPI subnetwork	0.04	> 0.20	GEMIN7 (3.1)	ENSG00000226645 (2.0)	MAPKAPK5 (2.0)	MYLIP (1.9)	BRAP (1.8)	ENSG00000235545 (1.7)	RELB (1.6)	BUD13 (1.6)	ATXN7L2 (1.5)	TXNL4B (1.5)
MP:0004929	decreased epididymis weight	0.04	> 0.20	FRK (3.7)	FADS2 (2.2)	TRAPPC6A (2.1)	ANGPTL3 (2.0)	ST3GAL4 (2.0)	CETP (1.8)	LDLR (1.7)	LPIN3 (1.7)	MYLIP (1.6)	HMGCR (1.4)
GO:0032452	histone demethylase activity	0.04	> 0.20	LPA (2.6)	C12orf47 (2.5)	TMEM57 (2.5)	TOP1 (2.5)	C12orf51 (2.4)	ATXN7L2 (2.3)	BUD13 (2.3)	ERP29 (2.2)	TRAFD1 (2.2)	GCNT4 (2.1)
ENSG00000116001	TIA1 PPI subnetwork	0.04	> 0.20	SMARCA4 (4.8)	DHX38 (4.6)	ILF3 (4.4)	SUGP1 (3.9)	CARM1 (3.1)	TOP1 (2.8)	ATP13A1 (2.7)	QTRT1 (2.7)	TOMM40 (2.6)	NAA25 (2.4)
ENSG00000168542	COL3A1 PPI subnetwork	0.04	> 0.20	FRK (3.1)	ST3GAL4 (2.6)	PARP10 (2.4)	CILP2 (2.1)	CBLC (2.0)	PPP1R37 (2.0)	KANK2 (1.9)	ZNF180 (1.8)	ENSG00000238078 (1.8)	PTPN11 (1.8)
ENSG00000113387	SUB1 PPI subnetwork	0.04	> 0.20	BUD13 (3.0)	C12orf47 (2.5)	TMED4 (2.1)	TOP1 (1.9)	PLEC (1.7)	MARK4 (1.6)	ATXN7L2 (1.6)	OGDH (1.5)	POC5 (1.5)	TRIB1 (1.5)
GO:0001067	regulatory region nucleic acid binding	0.04	> 0.20	TRIB1 (4.1)	HLX (2.7)	BCL3 (2.4)	ATXN2 (2.1)	CARM1 (1.9)	MYLIP (1.8)	MAFB (1.8)	SH2B3 (1.7)	PARP10 (1.7)	KANK2 (1.7)
GO:0000975	regulatory region DNA binding	0.04	> 0.20	TRIB1 (4.1)	HLX (2.7)	BCL3 (2.4)	ATXN2 (2.1)	CARM1 (1.9)	MYLIP (1.8)	MAFB (1.8)	SH2B3 (1.7)	PARP10 (1.7)	KANK2 (1.7)
ENSG00000160208	RRP1B PPI subnetwork	0.04	> 0.20	ZNF259 (5.1)	NAA25 (4.2)	TOMM40 (4.0)	DDX56 (3.5)	QTRT1 (3.4)	DHODH (3.1)	DHX38 (3.1)	ATP13A1 (2.6)	C12orf43 (2.5)	MAPKAPK5 (2.3)
MP:0003542	abnormal vascular endothelial cell development	0.04	> 0.20	SH2B3 (4.3)	SLC44A2 (2.4)	ZHX3 (2.4)	NCAN (2.2)	HLX (2.1)	ENSG00000226648 (2.0)	OGDH (2.0)	TMEM57 (2.0)	ITGB3 (1.9)	MAFB (1.8)
GO:0071450	cellular response to oxygen radical	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
GO:0019430	removal of superoxide radicals	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
GO:0071451	cellular response to superoxide	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
ENSG00000143171	RXRG PPI subnetwork	0.04	> 0.20	TRIB1 (3.7)	PLEC (3.3)	ABCG5 (1.7)	AMIGO1 (1.7)	HNF1A (1.7)	ACAD10 (1.5)	LDLR (1.5)	NYNRIN (1.5)	TM6SF2 (1.4)	MARK4 (1.4)
ENSG00000185637	ENSG00000185637 PPI subnetwork	0.05	> 0.20	PSMA5 (3.6)	SMARCA4 (2.6)	SARS (2.3)	TOMM40 (2.0)	NAA25 (2.0)	SUGP1 (1.9)	C11orf9 (1.8)	ANGPTL3 (1.8)	FEN1 (1.6)	DDX56 (1.6)
MP:0000511	abnormal intestinal mucosa morphology	0.05	> 0.20	HLX (2.7)	NYNRIN (2.6)	GRINA (2.5)	C11orf9 (2.2)	HNF1A (2.0)	LPAR2 (1.9)	TM6SF2 (1.9)	MOSC1 (1.8)	UBXN2B (1.8)	ENSG00000238078 (1.7)
ENSG00000126562	WNK4 PPI subnetwork	0.05	> 0.20	CBLC (3.9)	USP24 (3.5)	AP1M2 (3.0)	PARP10 (2.9)	GMIP (2.3)	ATXN2 (2.2)	SMARCA4 (1.9)	BCL3 (1.9)	MAU2 (1.8)	PBX4 (1.8)
MP:0008561	decreased tumor necrosis factor secretion	0.05	> 0.20	MAFB (3.7)	CETP (3.2)	RELB (3.0)	BCL3 (3.0)	TIMD4 (2.6)	GMIP (2.3)	SH2B3 (2.2)	OASL (2.1)	APOE (1.9)	APOC1 (1.8)
ENSG00000184895	SRY PPI subnetwork	0.05	> 0.20	BCAM (2.8)	NKPD1 (2.6)	SYPL2 (2.2)	NYNRIN (2.1)	PPP1R37 (1.9)	PLEKHH2 (1.9)	GEMIN7 (1.8)	YIPF2 (1.8)	POLK (1.6)	PVRL2 (1.6)
ENSG00000152104	PTPN14 PPI subnetwork	0.05	> 0.20	CETP (3.7)	TIMD4 (3.4)	PVRL2 (2.8)	AP1M2 (2.7)	OASL (2.5)	ATP13A1 (2.3)	LPAR2 (2.1)	C11orf9 (2.0)	PLEKHH2 (1.9)	SORT1 (1.7)
GO:0035162	embryonic hemopoiesis	0.05	> 0.20	RHCE (4.2)	RHD (4.0)	CYB561D1 (2.0)	DNAH11 (2.0)	ENSG00000238078 (1.9)	ENSG00000254235 (1.9)	BRAP (1.8)	ITGB3 (1.8)	ZNF259 (1.7)	GMPR (1.7)
ENSG00000171403	KRT9 PPI subnetwork	0.05	> 0.20	POLK (3.1)	DYNC2LI1 (2.3)	CEACAM19 (2.2)	ANGPTL3 (2.0)	APOC1 (2.0)	ALDH2 (1.8)	APOC4 (1.8)	PBX4 (1.8)	PLG (1.7)	HMGCR (1.6)
GO:0044241	lipid digestion	0.05	> 0.20	NPC1L1 (7.2)	ABCG8 (5.3)	ABCG5 (4.2)	TM6SF2 (4.0)	APOB (2.9)	GCNT4 (2.0)	APOA5 (1.8)	FRK (1.7)	ADAM1 (1.6)	CBLC (1.5)
ENSG00000105401	CDC37 PPI subnetwork	0.05	> 0.20	GRINA (2.1)	UBXN2B (2.1)	PTPN11 (1.8)	TXNL4B (1.8)	ENSG00000238078 (1.7)	C1orf63 (1.7)	POLK (1.6)	PVR (1.6)	BRAP (1.5)	GEMIN7 (1.5)
GO:0005635	nuclear envelope	0.05	> 0.20	LDLR (3.3)	NAA25 (3.1)	USP24 (2.6)	DOCK7 (2.5)	USP1 (2.4)	DDX56 (2.3)	POC5 (2.1)	PLEC (2.1)	FEN1 (1.9)	FADS1 (1.8)
ENSG00000064547	LPAR2 PPI subnetwork	0.05	> 0.20	USP24 (2.9)	PARP10 (2.6)	POLK (2.2)	BCL3 (2.1)	MARK4 (2.1)	MAU2 (2.1)	SMARCA4 (2.0)	ZNF180 (1.9)	ATXN2 (1.9)	PPP1R37 (1.8)
ENSG00000142534	RPS11 PPI subnetwork	0.05	> 0.20	NAA25 (3.9)	DDX56 (3.5)	DHX38 (3.0)	C12orf43 (2.9)	SARS (2.8)	ZNF259 (2.7)	QTRT1 (2.7)	TOMM40 (2.6)	SUGP1 (2.4)	PTPN11 (2.1)
ENSG00000012048	BRCA1 PPI subnetwork	0.05	> 0.20	FEN1 (4.0)	USP1 (3.8)	SMARCA4 (2.4)	BUD13 (2.2)	USP24 (2.1)	TOP1 (2.0)	PTPN11 (2.0)	CARM1 (1.9)	ILF3 (1.9)	GEMIN7 (1.7)
REACTOME_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME	REACTOME_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME	0.05	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.6)	OASL (3.4)	BCL3 (3.1)	HLX (2.5)	PARP10 (2.3)	PVR (2.2)	CARM1 (2.0)	GMIP (1.9)
REACTOME_TOLL_LIKE_RECEPTOR_78_TLR78_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_78_TLR78_CASCADE	0.05	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.6)	OASL (3.4)	BCL3 (3.1)	HLX (2.5)	PARP10 (2.3)	PVR (2.2)	CARM1 (2.0)	GMIP (1.9)
GO:0033500	carbohydrate homeostasis	0.05	> 0.20	ST3GAL4 (2.6)	ENSG00000254235 (2.4)	GPAM (2.1)	PCSK9 (2.1)	MOSC1 (2.1)	HNF1A (2.1)	ADAM1 (2.0)	LPA (1.6)	KIAA1324 (1.5)	ACAD10 (1.5)
GO:0042593	glucose homeostasis	0.05	> 0.20	ST3GAL4 (2.6)	ENSG00000254235 (2.4)	GPAM (2.1)	PCSK9 (2.1)	MOSC1 (2.1)	HNF1A (2.1)	ADAM1 (2.0)	LPA (1.6)	KIAA1324 (1.5)	ACAD10 (1.5)
GO:0032637	interleukin-8 production	0.05	> 0.20	HP (2.1)	ST3GAL4 (1.8)	HLX (1.8)	BLOC1S3 (1.8)	PVR (1.7)	ENSG00000228044 (1.7)	TIMD4 (1.6)	DNAH11 (1.5)	FRK (1.4)	ZNF180 (1.4)
GO:0031347	regulation of defense response	0.05	> 0.20	PARP10 (3.3)	OASL (3.1)	ENSG00000228044 (2.9)	SH2B3 (2.6)	BCL3 (2.3)	TRAFD1 (2.2)	ZNF101 (2.1)	GMIP (2.0)	TIMD4 (2.0)	RELB (1.9)
ENSG00000099341	PSMD8 PPI subnetwork	0.05	> 0.20	PSMA5 (5.5)	TOMM40 (2.7)	NT5DC1 (2.6)	NAA25 (2.5)	SARS (2.3)	TRAFD1 (2.2)	ENSG00000254235 (1.8)	QTRT1 (1.7)	SMARCA4 (1.6)	CYP7A1 (1.5)
MP:0008734	decreased susceptibility to endotoxin shock	0.05	> 0.20	BCL3 (4.8)	RELB (4.3)	PVR (3.2)	MAFB (3.1)	HP (2.7)	TIMD4 (2.7)	CETP (2.5)	ST3GAL4 (2.3)	TRIB1 (2.2)	ENSG00000228044 (1.9)
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	KEGG_GLYCOLYSIS_GLUCONEOGENESIS	0.05	> 0.20	ALDH2 (3.2)	LPA (3.1)	PLG (3.1)	CYP7A1 (3.0)	MOSC1 (2.7)	SLC22A1 (2.5)	APOC4 (2.2)	ANGPTL3 (2.2)	HP (2.1)	GPAM (2.0)
ENSG00000211893	ENSG00000211893 PPI subnetwork	0.05	> 0.20	APOB (5.8)	APOE (4.7)	APOA5 (4.4)	PLG (3.9)	APOC4 (3.5)	PCSK9 (3.5)	HP (3.3)	APOC1 (3.3)	ANGPTL3 (3.0)	NPC1L1 (2.8)
ENSG00000066044	ELAVL1 PPI subnetwork	0.05	> 0.20	ILF3 (5.2)	QTRT1 (4.4)	SMARCA4 (4.2)	CARM1 (4.2)	ATP13A1 (2.9)	MAU2 (2.8)	GATAD2A (2.7)	DNM2 (2.6)	AP1M2 (2.4)	DDX56 (2.3)
ENSG00000197818	SLC9A8 PPI subnetwork	0.05	> 0.20	APOB (8.2)	APOC1 (4.5)	PLG (4.0)	ABCG5 (3.9)	NPC1L1 (3.8)	APOA5 (3.7)	HP (2.8)	APOC4 (2.7)	APOE (2.6)	ANGPTL3 (2.6)
GO:0071548	response to dexamethasone stimulus	0.05	> 0.20	RHCE (3.9)	RHD (3.2)	ABCG8 (2.7)	ABCG5 (2.5)	TXNL4B (2.0)	ENSG00000226645 (1.9)	DNAH11 (1.9)	TMEM57 (1.9)	C19orf52 (1.8)	CEACAM19 (1.7)
ENSG00000102309	PIN4 PPI subnetwork	0.05	> 0.20	CARM1 (3.3)	TMEM57 (2.2)	ILF3 (2.1)	C12orf51 (2.0)	SMARCA4 (1.8)	GMPR (1.8)	CYB561D1 (1.8)	NKPD1 (1.8)	ALDH2 (1.5)	BRAP (1.5)
ENSG00000005175	RPAP3 PPI subnetwork	0.05	> 0.20	CARM1 (3.5)	TRAPPC6A (3.0)	GATAD2A (2.7)	TOMM40 (2.7)	ILF3 (2.6)	DNM2 (2.6)	QTRT1 (2.5)	CLPTM1 (2.4)	MARK4 (2.2)	BLOC1S3 (2.1)
GO:0016877	ligase activity, forming carbon-sulfur bonds	0.05	> 0.20	HMGCR (5.8)	FADS1 (5.1)	FADS2 (5.0)	LDLR (4.7)	GPAM (4.4)	PCSK9 (4.3)	MOSC1 (3.5)	ACAD10 (3.0)	APOC1 (2.2)	PLG (2.1)
ENSG00000095015	MAP3K1 PPI subnetwork	0.05	> 0.20	TOMM40 (3.1)	SARS (2.7)	PARP10 (2.1)	NAA25 (2.1)	ILF3 (1.9)	PLEC (1.9)	SMARCA4 (1.9)	DOCK7 (1.9)	DDX56 (1.8)	ANKRD31 (1.6)
MP:0008560	increased tumor necrosis factor secretion	0.05	> 0.20	CETP (4.0)	GMIP (3.6)	MAFB (3.6)	TRIB1 (3.4)	OASL (3.2)	RELB (3.0)	BCL3 (2.8)	PARP10 (2.5)	TIMD4 (2.4)	GRINA (2.3)
GO:0051271	negative regulation of cellular component movement	0.05	> 0.20	PVRL2 (3.0)	CEACAM19 (2.8)	GCNT4 (2.5)	KANK2 (2.5)	ENSG00000254235 (2.4)	CILP2 (2.2)	HLX (2.0)	BCAM (1.8)	PLEKHH2 (1.7)	ENSG00000226645 (1.6)
ENSG00000075673	ATP12A PPI subnetwork	0.05	> 0.20	ACAD10 (4.0)	NT5DC1 (3.0)	HNF1A (2.4)	C1orf63 (2.0)	TRAPPC6A (1.8)	TMED4 (1.7)	GMPR (1.7)	PCSK9 (1.6)	CETP (1.5)	KIAA1324 (1.5)
ENSG00000107643	MAPK8 PPI subnetwork	0.05	> 0.20	TRIB1 (6.2)	POLK (3.7)	SH2B3 (3.6)	BCL3 (2.6)	PLEC (2.6)	PVR (2.5)	LDLR (2.0)	RELB (1.9)	PLCG1 (1.8)	GRINA (1.8)
ENSG00000133027	PEMT PPI subnetwork	0.05	> 0.20	TMEM50A (3.4)	TMED4 (3.1)	CLPTM1 (2.9)	TM6SF2 (2.9)	ERP29 (2.7)	SLC22A1 (2.5)	NPC1L1 (2.5)	TMEM57 (2.4)	YIPF2 (2.2)	LPA (2.2)
GO:0034399	nuclear periphery	0.05	> 0.20	TOP1 (3.9)	USP1 (3.3)	ZNF180 (2.9)	DNM2 (2.8)	ILF3 (2.7)	FEN1 (2.4)	PSRC1 (2.2)	SMARCA4 (2.1)	SUGP1 (2.0)	BUD13 (2.0)
ENSG00000100380	ST13 PPI subnetwork	0.05	> 0.20	ST3GAL4 (2.9)	HP (2.5)	PLG (2.4)	APOC4 (2.3)	APOC1 (2.3)	CELSR2 (2.1)	ANGPTL3 (2.0)	BRAP (2.0)	PARP10 (2.0)	OASL (1.7)
ENSG00000088205	DDX18 PPI subnetwork	0.05	> 0.20	ZNF259 (5.1)	NAA25 (4.7)	DDX56 (4.4)	TOMM40 (4.3)	DHODH (3.7)	QTRT1 (3.6)	DHX38 (2.9)	ATP13A1 (2.5)	SARS (2.3)	C12orf43 (2.1)
MP:0005244	hemopericardium	0.05	> 0.20	PVRL2 (4.4)	C11orf9 (4.1)	NYNRIN (2.5)	BCAM (2.4)	PVR (2.2)	C17orf57 (2.0)	PLEKHH2 (1.5)	ENSG00000226648 (1.5)	CBLC (1.4)	KANK2 (1.4)
GO:0005980	glycogen catabolic process	0.05	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.7)	SORT1 (2.4)	AMIGO1 (2.3)	ST3GAL4 (2.3)	ZHX3 (1.9)	C17orf57 (1.9)	ABCG8 (1.9)	ZNF101 (1.8)	GMPR (1.8)
ENSG00000174744	BRMS1 PPI subnetwork	0.05	> 0.20	OASL (6.2)	PARP10 (3.1)	TRAFD1 (2.7)	USP1 (2.2)	TMED4 (1.9)	CYP7A1 (1.9)	PCSK9 (1.8)	HNF1A (1.8)	KANK2 (1.7)	ENSG00000235545 (1.7)
MP:0002397	abnormal bone marrow morphology	0.05	> 0.20	RHD (5.6)	RHCE (4.9)	CILP2 (3.2)	GMIP (2.8)	GRINA (2.4)	C12orf47 (2.2)	C12orf51 (2.1)	RELB (2.1)	MAPKAPK5 (2.1)	PLEC (2.1)
GO:0008527	taste receptor activity	0.05	> 0.20	GCNT4 (2.9)	ABO (2.6)	ENSG00000228044 (2.5)	TSSK6 (1.9)	DNAH11 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.6)	ANKRD31 (1.5)	NPC1L1 (1.4)	C11orf9 (1.2)
ENSG00000142192	APP PPI subnetwork	0.05	> 0.20	APOE (3.5)	CELSR2 (2.6)	PLEKHH2 (2.3)	APOC1 (2.2)	CLPTM1 (2.1)	BCAM (2.0)	PVRL2 (2.0)	ABCG5 (1.9)	RPH3A (1.9)	GRINA (1.7)
ENSG00000090487	SPG21 PPI subnetwork	0.05	> 0.20	PVR (2.3)	TRAPPC6A (2.1)	APOE (2.1)	ENSG00000254235 (2.1)	BLOC1S3 (2.0)	C12orf47 (1.8)	CETP (1.8)	GEMIN7 (1.8)	ENSG00000228044 (1.8)	APOC1 (1.7)
ENSG00000138722	MMRN1 PPI subnetwork	0.05	> 0.20	ILF3 (2.9)	HMGCR (2.7)	TOMM40 (2.5)	SMARCA4 (2.4)	FADS1 (2.2)	TMEM57 (2.1)	OGDH (2.0)	LDLR (1.9)	TMEM50A (1.8)	FADS2 (1.7)
ENSG00000119812	FAM98A PPI subnetwork	0.05	> 0.20	MAPKAPK5 (3.2)	ATXN2 (3.0)	SMARCA4 (2.9)	BRAP (2.8)	C12orf51 (2.4)	C12orf43 (2.4)	TRAFD1 (2.3)	CLPTM1 (2.3)	NAA25 (2.2)	OGDH (2.0)
GO:0016323	basolateral plasma membrane	0.05	> 0.20	PLEC (3.8)	BCAM (3.5)	AP1M2 (2.8)	ANGPTL3 (2.6)	TMEM116 (2.6)	PLG (2.5)	SLC22A1 (2.2)	CBLC (1.8)	ENSG00000226648 (1.7)	DNM2 (1.7)
GO:0002039	p53 binding	0.05	> 0.20	ATXN2 (3.5)	DHX38 (3.3)	BRAP (2.5)	ILF3 (2.5)	SMARCA4 (2.3)	USP24 (2.1)	TMEM57 (2.1)	CARM1 (2.0)	ATP13A1 (1.7)	GATAD2A (1.7)
GO:0050662	coenzyme binding	0.05	> 0.20	ACAD10 (4.3)	ALDH2 (4.1)	FADS2 (3.5)	FADS1 (3.4)	MOSC1 (3.3)	SLC22A1 (2.9)	TRAPPC6A (2.8)	GPAM (2.8)	PLG (2.6)	NT5DC1 (2.6)
ENSG00000173406	DAB1 PPI subnetwork	0.05	> 0.20	HMGCR (3.1)	C11orf9 (2.8)	GATAD2A (2.6)	SORT1 (2.4)	SLC44A2 (2.4)	PLEC (2.2)	FADS2 (2.2)	FADS1 (2.2)	ENSG00000228044 (2.1)	PCSK9 (2.1)
MP:0003396	abnormal embryonic hematopoiesis	0.05	> 0.20	GMPR (4.1)	SH2B3 (3.4)	ITGB3 (2.7)	HLX (2.5)	ENSG00000226648 (2.5)	PLCG1 (2.4)	RHD (2.4)	FADS2 (2.3)	NYNRIN (2.0)	SLC44A2 (1.9)
ENSG00000105438	KDELR1 PPI subnetwork	0.05	> 0.20	HMGCR (5.0)	FADS1 (4.9)	LDLR (4.0)	PCSK9 (3.1)	TMED4 (2.9)	FADS2 (2.7)	YIPF2 (2.4)	BLOC1S3 (2.2)	DYNC2LI1 (2.1)	SORT1 (2.1)
ENSG00000141646	SMAD4 PPI subnetwork	0.05	> 0.20	KANK2 (3.3)	ATXN2 (3.2)	GATAD2A (2.8)	MAU2 (2.5)	CARM1 (2.3)	MYLIP (2.3)	BUD13 (2.1)	SMARCA4 (2.0)	DHX38 (1.9)	ATXN7L2 (1.8)
ENSG00000161204	ABCF3 PPI subnetwork	0.05	> 0.20	NAA25 (3.6)	BRAP (2.8)	GPAM (2.7)	NT5DC1 (2.2)	ILF3 (2.2)	OGDH (2.2)	TMEM116 (2.1)	SARS (2.1)	POC5 (2.1)	CYP7A1 (2.0)
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	0.05	> 0.20	ZHX3 (3.9)	PLEC (2.8)	MARK4 (2.5)	ITGB3 (2.5)	MYLIP (2.3)	SH2B3 (2.3)	DNM2 (2.2)	COL4A3BP (2.0)	CLPTM1 (2.0)	OGDH (2.0)
MP:0004953	decreased spleen weight	0.05	> 0.20	RHCE (2.4)	RELB (2.3)	POLK (1.9)	ATXN7L2 (1.8)	SLC44A2 (1.8)	RHD (1.7)	ANGPTL3 (1.6)	NPC1L1 (1.6)	APOB (1.5)	FRK (1.4)
ENSG00000143226	FCGR2A PPI subnetwork	0.05	> 0.20	ITGB3 (4.8)	LPA (3.4)	MAFB (2.7)	CETP (2.6)	TIMD4 (2.5)	ANGPTL3 (2.5)	PLG (2.5)	HP (2.5)	APOC4 (2.5)	ABCG5 (2.1)
MP:0008641	increased circulating interleukin-1 beta level	0.05	> 0.20	BCL3 (3.2)	HMGCR (3.2)	TRIB1 (3.1)	MAFB (2.9)	GMIP (2.5)	TIMD4 (2.4)	ENSG00000228044 (2.3)	SH2B3 (1.8)	TOP1 (1.7)	CETP (1.7)
GO:0030141	secretory granule	0.05	> 0.20	KIAA1324 (4.7)	HP (4.4)	ITGB3 (4.1)	TSSK6 (2.3)	MOSC1 (2.2)	APOB (2.0)	ERP29 (2.0)	APOA5 (1.8)	AP1M2 (1.7)	GMPR (1.7)
GO:0000323	lytic vacuole	0.05	> 0.20	ERP29 (5.1)	APOE (3.5)	TMEM50A (3.2)	COL4A3BP (2.8)	GRINA (2.8)	SORT1 (2.6)	TMED4 (2.5)	ATP13A1 (2.4)	MAFB (2.3)	CLPTM1 (2.1)
GO:0005764	lysosome	0.05	> 0.20	ERP29 (5.1)	APOE (3.5)	TMEM50A (3.2)	COL4A3BP (2.8)	GRINA (2.8)	SORT1 (2.6)	TMED4 (2.5)	ATP13A1 (2.4)	MAFB (2.3)	CLPTM1 (2.1)
GO:0007569	cell aging	0.05	> 0.20	POLK (2.8)	CARM1 (2.1)	GOT2P1 (1.9)	BLOC1S3 (1.9)	TRAPPC6A (1.6)	ENSG00000226648 (1.6)	CEACAM19 (1.5)	PLEC (1.5)	PARP10 (1.5)	KANK2 (1.4)
ENSG00000111145	ELK3 PPI subnetwork	0.05	> 0.20	TMEM57 (2.5)	PLCG1 (2.0)	GATAD2A (2.0)	ENSG00000254235 (2.0)	C19orf52 (1.8)	CARM1 (1.8)	POC5 (1.7)	PPP1R37 (1.7)	ATXN7L2 (1.6)	ZHX3 (1.6)
REACTOME_REGULATION_OF_INSULIN:LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN:LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	REACTOME_REGULATION_OF_INSULIN:LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN:LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	0.05	> 0.20	APOC4 (4.2)	APOA5 (4.0)	SLC22A1 (3.7)	HP (3.7)	APOB (3.0)	LPA (3.0)	PLG (2.8)	BCAM (2.7)	ANGPTL3 (2.6)	ABCG5 (2.5)
MP:0005558	decreased creatinine clearance	0.05	> 0.20	PLG (4.4)	ANGPTL3 (3.2)	ANKRD31 (2.9)	APOA5 (2.6)	ENSG00000228044 (2.3)	BCAM (2.3)	GRINA (2.3)	APOC4 (2.2)	ZHX3 (2.2)	TXNL4B (1.9)
MP:0005027	increased susceptibility to parasitic infection	0.05	> 0.20	RELB (3.2)	BCL3 (2.8)	CETP (2.3)	TIMD4 (2.2)	HLX (1.7)	SLC22A1 (1.5)	PVR (1.4)	PBX4 (1.4)	TRAFD1 (1.3)	PLCG1 (1.3)
GO:0009119	ribonucleoside metabolic process	0.05	> 0.20	TXNL4B (2.7)	DHODH (2.5)	LPA (2.3)	FADS2 (1.7)	TRAPPC6A (1.7)	PCSK9 (1.7)	GOT2P1 (1.6)	MOSC1 (1.6)	LDLR (1.5)	DDX56 (1.5)
ENSG00000078808	SDF4 PPI subnetwork	0.05	> 0.20	ACAD10 (3.9)	NT5DC1 (3.2)	TMED4 (2.6)	HNF1A (2.1)	GMPR (1.9)	TRAPPC6A (1.9)	PLEKHH2 (1.8)	TIMD4 (1.6)	PCSK9 (1.6)	GCNT4 (1.6)
GO:0016893	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	0.05	> 0.20	ZNF180 (3.0)	C12orf43 (2.4)	LPA (2.2)	CETP (1.8)	BUD13 (1.7)	DHODH (1.7)	GEMIN7 (1.6)	FEN1 (1.6)	DDX56 (1.6)	LPAR2 (1.6)
GO:0048545	response to steroid hormone stimulus	0.05	> 0.20	KIAA1324 (2.5)	TM6SF2 (2.3)	ABCG5 (2.3)	LPA (2.0)	TMED4 (1.7)	PVRL2 (1.7)	ABCG8 (1.6)	HAPLN4 (1.6)	ENSG00000226648 (1.6)	SLC22A1 (1.6)
REACTOME_AMYLOIDS	REACTOME_AMYLOIDS	0.05	> 0.20	NPC1L1 (4.1)	APOB (3.5)	ABCG5 (3.1)	HP (2.8)	GMPR (2.7)	APOA5 (2.6)	MYLIP (2.2)	PLG (2.2)	PCSK9 (2.0)	ABCG8 (1.9)
ENSG00000129965	INS-IGF2 PPI subnetwork	0.05	> 0.20	USP24 (3.1)	APOE (2.9)	HAVCR1 (2.7)	C11orf9 (2.5)	PLEKHH2 (2.0)	KANK2 (1.9)	PLCG1 (1.6)	CELSR2 (1.6)	MYLIP (1.6)	TMED4 (1.5)
GO:0031418	L-ascorbic acid binding	0.05	> 0.20	PVR (3.1)	ERP29 (2.7)	MYLIP (2.0)	DHODH (1.7)	CETP (1.7)	ZNF180 (1.6)	GOT2P1 (1.6)	ATP13A1 (1.5)	DYNC2LI1 (1.5)	TMED4 (1.5)
ENSG00000144852	NR1I2 PPI subnetwork	0.05	> 0.20	PPP1R37 (2.4)	KIAA1324 (2.3)	TM6SF2 (2.3)	MAFB (2.2)	MAU2 (2.1)	SLC22A1 (1.8)	GOT2P1 (1.8)	ABCG5 (1.8)	APOA5 (1.7)	PLEC (1.7)
ENSG00000145715	RASA1 PPI subnetwork	0.05	> 0.20	SH2B3 (2.9)	SLC44A2 (2.5)	CETP (2.4)	MARK4 (2.3)	DNM2 (2.1)	PLEC (2.0)	GMIP (2.0)	MAFB (1.9)	GATAD2A (1.9)	HAVCR1 (1.8)
ENSG00000132182	NUP210 PPI subnetwork	0.05	> 0.20	USP1 (3.6)	NAA25 (3.5)	POC5 (3.3)	DDX56 (2.7)	DOCK7 (2.6)	ILF3 (2.5)	FEN1 (2.4)	ENSG00000226648 (2.1)	PSRC1 (2.0)	BUD13 (1.9)
ENSG00000184047	DIABLO PPI subnetwork	0.05	> 0.20	RELB (5.7)	PBX4 (3.4)	BCL3 (2.8)	TRAFD1 (2.7)	ST3GAL4 (2.6)	PARP10 (2.5)	ZNF180 (2.2)	ZNF259 (1.9)	UBXN2B (1.8)	LPAR2 (1.7)
ENSG00000132432	SEC61G PPI subnetwork	0.05	> 0.20	HMGCR (5.3)	LDLR (4.9)	FADS1 (3.4)	FADS2 (3.3)	PCSK9 (3.2)	TMEM57 (2.9)	ATP13A1 (2.8)	TMEM50A (2.3)	SUGP1 (2.3)	POLK (2.1)
MP:0000714	increased thymocyte number	0.05	> 0.20	RELB (2.2)	CYB561D1 (2.2)	TRAPPC6A (2.0)	PLCG1 (2.0)	BCL3 (1.9)	MAU2 (1.7)	PBX4 (1.7)	TMEM50A (1.5)	GMIP (1.5)	ZNF101 (1.5)
GO:0000187	activation of MAPK activity	0.05	> 0.20	LPAR2 (2.9)	ABO (2.8)	ENSG00000226645 (2.2)	ENSG00000228044 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)	GCNT4 (1.7)	GMIP (1.7)	TSSK6 (1.5)	MAU2 (1.4)
MP:0009283	decreased gonadal fat pad weight	0.05	> 0.20	MOSC1 (4.3)	HAPLN4 (2.9)	GPAM (2.7)	ALDH2 (2.5)	HLX (2.4)	LPA (2.3)	TXNL4B (2.2)	SORT1 (2.1)	TM6SF2 (1.9)	CETP (1.9)
ENSG00000172340	SUCLG2 PPI subnetwork	0.05	> 0.20	TXNL4B (3.1)	GMPR (2.8)	C11orf9 (2.3)	DHX38 (2.2)	PMFBP1 (2.1)	PPP1R37 (2.0)	ENSG00000228044 (1.9)	UBXN2B (1.7)	ENSG00000238078 (1.6)	NKPD1 (1.5)
GO:0006957	complement activation, alternative pathway	0.05	> 0.20	LPA (6.8)	APOC4 (4.3)	SLC22A1 (4.1)	ANGPTL3 (3.9)	TIMD4 (3.7)	HP (3.5)	APOA5 (3.1)	PLG (3.0)	PBX4 (2.5)	DHODH (2.4)
ENSG00000039987	BEST2 PPI subnetwork	0.05	> 0.20	ATP13A1 (4.5)	HNF1A (2.9)	MAPKAPK5 (2.7)	DDX56 (2.6)	PTPN11 (2.3)	BRAP (2.2)	TOMM40 (2.2)	MAU2 (2.2)	GATAD2A (2.1)	DHODH (2.0)
GO:0019320	hexose catabolic process	0.05	> 0.20	GOT2P1 (2.6)	PCSK9 (2.2)	ENSG00000254235 (2.0)	ACAD10 (1.9)	TRAPPC6A (1.9)	LPIN3 (1.8)	FRK (1.8)	TSSK6 (1.6)	FADS2 (1.6)	ERP29 (1.6)
GO:0005041	low-density lipoprotein receptor activity	0.05	> 0.20	HMGCR (4.4)	TIMD4 (3.5)	FADS2 (3.4)	FADS1 (3.3)	PCSK9 (3.0)	CEACAM19 (2.6)	CETP (2.5)	PVRL2 (2.4)	SORT1 (2.3)	ENSG00000228044 (2.2)
ENSG00000005189	ENSG00000005189 PPI subnetwork	0.05	> 0.20	SYPL2 (5.1)	ZHX3 (2.7)	GMPR (2.3)	NKPD1 (2.1)	FADS1 (1.9)	CILP2 (1.9)	ENSG00000235545 (1.7)	ALDH2 (1.7)	C19orf52 (1.6)	MAU2 (1.5)
GO:0046128	purine ribonucleoside metabolic process	0.05	> 0.20	DHODH (3.1)	TXNL4B (2.7)	PCSK9 (2.5)	TRAPPC6A (2.3)	CYP7A1 (2.1)	LPA (2.1)	FADS2 (1.9)	C12orf47 (1.8)	LDLR (1.6)	ENSG00000254235 (1.5)
ENSG00000169429	IL8 PPI subnetwork	0.05	> 0.20	RELB (6.8)	BCL3 (4.4)	TRIB1 (3.8)	OASL (3.0)	ITGB3 (2.6)	MAFB (2.5)	GRINA (2.1)	PVR (2.0)	LPAR2 (1.7)	APOE (1.7)
ENSG00000055044	NOP58 PPI subnetwork	0.05	> 0.20	ZNF259 (5.0)	DDX56 (5.0)	NAA25 (4.7)	QTRT1 (3.8)	TOMM40 (3.8)	C12orf43 (3.1)	DHODH (3.1)	SUGP1 (2.4)	TOP1 (2.4)	DHX38 (2.3)
GO:0042107	cytokine metabolic process	0.05	> 0.20	ENSG00000228044 (3.0)	TIMD4 (1.9)	ENSG00000226645 (1.7)	CYB561D1 (1.7)	GMIP (1.6)	ENSG00000235545 (1.6)	DNAH11 (1.6)	ST3GAL4 (1.6)	PARP10 (1.6)	BCL3 (1.5)
ENSG00000173692	PSMD1 PPI subnetwork	0.05	> 0.20	PSMA5 (4.8)	NAA25 (2.8)	TRAFD1 (2.7)	SARS (2.6)	NT5DC1 (2.5)	TOMM40 (1.9)	DDX56 (1.8)	BRAP (1.7)	TOP1 (1.7)	SMARCA4 (1.6)
REACTOME_INTERLEUKIN:6_SIGNALING	REACTOME_INTERLEUKIN:6_SIGNALING	0.05	> 0.20	BCL3 (6.8)	TRAFD1 (3.2)	PARP10 (2.8)	RELB (2.6)	PVR (2.4)	TRIB1 (2.4)	USP24 (2.3)	ZNF101 (2.2)	ENSG00000228044 (1.8)	CYB561D1 (1.7)
MP:0003961	decreased lean body mass	0.05	> 0.20	HMGCR (4.2)	FADS2 (3.2)	TMEM57 (3.0)	GPAM (3.0)	NPC1L1 (2.8)	FADS1 (2.4)	LDLR (2.3)	PCSK9 (2.3)	LPIN3 (2.0)	USP24 (2.0)
ENSG00000137285	TUBB2B PPI subnetwork	0.05	> 0.20	RELB (3.7)	TXNL4B (2.8)	SARS (2.5)	HP (2.4)	PLG (2.3)	DNM2 (2.3)	ZNF259 (2.1)	LDLR (2.1)	SUGP1 (2.0)	BCL3 (2.0)
GO:0042036	negative regulation of cytokine biosynthetic process	0.05	> 0.20	ENSG00000238078 (2.7)	ENSG00000254235 (2.7)	ENSG00000228044 (2.6)	CEACAM19 (2.5)	C12orf47 (1.7)	ENSG00000226645 (1.5)	TMED4 (1.5)	ST3GAL4 (1.3)	ZNF101 (1.3)	ZNF180 (1.2)
GO:0022618	ribonucleoprotein complex assembly	0.05	> 0.20	C12orf43 (3.1)	BRAP (3.0)	QTRT1 (2.7)	ZNF259 (2.7)	SUGP1 (2.7)	DHX38 (2.2)	BUD13 (2.1)	NAA25 (2.0)	DDX56 (2.0)	GOT2P1 (1.8)
ENSG00000183735	TBK1 PPI subnetwork	0.05	> 0.20	PARP10 (5.3)	OASL (4.5)	RELB (4.2)	GRINA (3.6)	TRAFD1 (3.2)	BCL3 (2.6)	FRK (2.4)	ILF3 (1.9)	CLPTM1 (1.8)	NAA25 (1.8)
GO:0051341	regulation of oxidoreductase activity	0.05	> 0.20	ENSG00000235545 (4.1)	ENSG00000228044 (2.0)	GOT2P1 (2.0)	ATXN7L2 (1.9)	TXNL4B (1.8)	ZNF101 (1.8)	AMIGO1 (1.6)	FRK (1.5)	PVR (1.5)	HNF1A (1.4)
REACTOME_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
REACTOME_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
GO:0046777	protein autophosphorylation	0.05	> 0.20	SLC44A2 (2.6)	CEACAM19 (2.3)	PTPN11 (2.2)	C12orf51 (2.2)	C1orf63 (2.1)	ENSG00000228044 (2.0)	MARK4 (1.9)	LPIN3 (1.8)	BLOC1S3 (1.7)	ENSG00000238078 (1.6)
ENSG00000179562	GCC1 PPI subnetwork	0.05	> 0.20	PPP1R37 (2.8)	CELSR2 (2.7)	ENSG00000254235 (2.7)	ATXN2 (2.3)	MARK4 (2.3)	C12orf43 (2.2)	C17orf57 (2.1)	ATXN7L2 (1.9)	HAVCR1 (1.9)	GEMIN7 (1.7)
ENSG00000197621	ENSG00000197621 PPI subnetwork	0.05	> 0.20	HP (3.7)	APOB (3.1)	FRK (2.7)	NPC1L1 (2.5)	HAVCR1 (2.3)	GMPR (2.3)	APOE (2.1)	APOA5 (2.1)	CELSR2 (2.1)	BRAP (2.0)
GO:0010907	positive regulation of glucose metabolic process	0.05	> 0.20	GOT2P1 (2.1)	TSSK6 (2.0)	ZHX3 (1.9)	TMEM116 (1.9)	HNF1A (1.9)	CYP7A1 (1.8)	AMIGO1 (1.8)	FRK (1.7)	LPA (1.6)	GPAM (1.6)
ENSG00000120688	WBP4 PPI subnetwork	0.05	> 0.20	ILF3 (4.6)	SUGP1 (3.9)	SMARCA4 (3.6)	DHX38 (3.3)	C1orf63 (2.8)	MAU2 (2.7)	TOP1 (2.7)	ATP13A1 (2.5)	USP1 (2.5)	CLPTM1 (2.3)
GO:0051180	vitamin transport	0.05	> 0.20	LPAR2 (2.6)	TM6SF2 (2.6)	ABCG8 (2.5)	TMED4 (2.5)	TMEM116 (2.0)	GCNT4 (2.0)	POLK (2.0)	ANGPTL3 (1.8)	HAVCR1 (1.7)	HAPLN4 (1.5)
GO:0004386	helicase activity	0.05	> 0.20	DHX38 (4.3)	SUGP1 (4.0)	OASL (3.5)	MAPKAPK5 (3.0)	ATP13A1 (2.7)	ILF3 (2.7)	DHODH (2.6)	SMARCA4 (2.6)	NAA25 (2.6)	DDX56 (2.5)
REACTOME_ASSEMBLY_OF_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ASSEMBLY_OF_THE_PRE:REPLICATIVE_COMPLEX	0.05	> 0.20	PSMA5 (5.5)	FEN1 (3.2)	NT5DC1 (3.0)	TRAFD1 (2.7)	NAA25 (2.1)	SUGP1 (1.9)	TOMM40 (1.9)	PARP10 (1.6)	DDX56 (1.5)	USP1 (1.5)
MP:0002376	abnormal dendritic cell physiology	0.05	> 0.20	RELB (3.8)	SH2B3 (2.8)	BCL3 (2.7)	TRAFD1 (2.7)	PARP10 (2.6)	OASL (2.5)	HLX (2.3)	GMIP (2.1)	TRIB1 (1.5)	TIMD4 (1.5)
KEGG_THYROID_CANCER	KEGG_THYROID_CANCER	0.05	> 0.20	PLEC (3.0)	MAFB (2.0)	ENSG00000238078 (2.0)	AMIGO1 (1.9)	CARM1 (1.9)	CELSR2 (1.8)	DNM2 (1.8)	GRINA (1.8)	LPIN3 (1.7)	AP1M2 (1.7)
ENSG00000163347	CLDN1 PPI subnetwork	0.05	> 0.20	CBLC (4.5)	AP1M2 (4.3)	PVRL2 (3.4)	BCAM (3.0)	ATXN2 (2.7)	FRK (2.1)	ITGB3 (2.0)	KANK2 (2.0)	YIPF2 (1.9)	GPAM (1.8)
ENSG00000196943	C14orf21 PPI subnetwork	0.05	> 0.20	ZNF259 (4.6)	NAA25 (4.4)	DDX56 (4.2)	QTRT1 (3.7)	TOMM40 (3.5)	DHODH (3.2)	TOP1 (2.5)	C12orf43 (2.3)	PVR (2.2)	DHX38 (1.8)
GO:0090311	regulation of protein deacetylation	0.05	> 0.20	TMEM57 (4.6)	FADS2 (2.6)	GCNT4 (2.1)	FADS1 (2.0)	PPP1R37 (1.8)	PCSK9 (1.8)	GOT2P1 (1.6)	POLK (1.6)	DNM2 (1.5)	BRAP (1.5)
ENSG00000136156	ITM2B PPI subnetwork	0.05	> 0.20	DNM2 (3.1)	COL4A3BP (2.7)	GMIP (2.4)	USP24 (2.4)	PLEC (2.2)	POLK (2.1)	BCL3 (1.8)	ALDH2 (1.8)	DNAH11 (1.8)	SLC44A2 (1.8)
MP:0001231	abnormal epidermis stratum basale morphology	0.05	> 0.20	CBLC (4.6)	PLEC (3.4)	ABCG8 (2.5)	MAFB (2.4)	AP1M2 (2.3)	ENSG00000254235 (2.1)	CELSR2 (2.0)	BCAM (1.9)	RELB (1.9)	LDLR (1.7)
MP:0005657	abnormal neural plate morphology	0.05	> 0.20	CARM1 (3.4)	GRINA (2.6)	GATAD2A (2.4)	CLPTM1 (2.3)	ATXN7L2 (2.3)	UBXN2B (2.3)	NYNRIN (2.2)	ENSG00000235545 (2.2)	OASL (2.1)	PLCG1 (2.1)
GO:0007597	blood coagulation, intrinsic pathway	0.05	> 0.20	ITGB3 (5.2)	ANGPTL3 (3.5)	PLG (3.1)	APOC4 (2.9)	LPA (2.8)	GMPR (2.8)	CETP (2.7)	APOA5 (2.5)	SLC22A1 (2.5)	HP (2.1)
ENSG00000204390	HSPA1L PPI subnetwork	0.05	> 0.20	RELB (5.3)	BCL3 (4.6)	PLEC (3.0)	ILF3 (2.4)	PVR (2.4)	TOMM40 (2.2)	PARP10 (1.9)	ZNF259 (1.8)	GRINA (1.8)	ATP13A1 (1.7)
ENSG00000164077	MON1A PPI subnetwork	0.05	> 0.20	ITGB3 (4.2)	RHD (3.6)	ZNF259 (3.3)	CLPTM1 (2.6)	GEMIN7 (2.5)	SARS (2.3)	RHCE (2.3)	C12orf43 (2.3)	C12orf51 (2.2)	BRAP (2.0)
ENSG00000106344	RBM28 PPI subnetwork	0.05	> 0.20	ZNF259 (5.2)	NAA25 (4.9)	TOMM40 (4.0)	QTRT1 (4.0)	DDX56 (3.9)	C12orf43 (3.1)	DHODH (2.9)	DHX38 (2.7)	ATP13A1 (2.5)	MAPKAPK5 (2.3)
GO:0005158	insulin receptor binding	0.05	> 0.20	GPAM (2.5)	CELSR2 (2.3)	CYP7A1 (2.2)	C11orf9 (2.2)	APOC4 (1.9)	ANGPTL3 (1.8)	NAA25 (1.6)	SH2B3 (1.6)	KANK2 (1.5)	BRAP (1.4)
ENSG00000162772	ATF3 PPI subnetwork	0.05	> 0.20	TRIB1 (5.8)	BCL3 (4.7)	PVR (3.7)	RELB (3.6)	SARS (3.3)	TRAFD1 (2.4)	ATXN2 (2.3)	MAPKAPK5 (2.1)	POLK (1.9)	PLEC (1.8)
MP:0010209	abnormal circulating chemokine level	0.05	> 0.20	BCL3 (5.2)	RELB (2.9)	TIMD4 (2.8)	MAFB (2.5)	ENSG00000228044 (2.1)	CETP (2.0)	C11orf9 (1.9)	HP (1.8)	FRK (1.6)	ST3GAL4 (1.6)
MP:0008127	decreased dendritic cell number	0.05	> 0.20	RELB (4.9)	BCL3 (4.0)	TRAFD1 (3.1)	SH2B3 (2.5)	PARP10 (2.1)	HAVCR1 (2.1)	ATXN7L2 (2.1)	PVRL2 (2.1)	HLX (2.1)	GEMIN7 (2.0)
MP:0004130	abnormal muscle cell glucose uptake	0.05	> 0.20	SYPL2 (4.3)	GPAM (4.0)	SORT1 (3.5)	PLEKHH2 (2.9)	BLOC1S3 (2.6)	MOSC1 (2.5)	AMIGO1 (2.4)	DNM2 (2.2)	CYB561D1 (2.2)	PPP1R37 (2.1)
ENSG00000142867	BCL10 PPI subnetwork	0.05	> 0.20	BCL3 (3.1)	RELB (3.1)	MYLIP (2.4)	PLEC (2.2)	UBXN2B (2.2)	ZNF180 (2.1)	PARP10 (1.9)	ZNF101 (1.9)	ANKRD31 (1.9)	HLX (1.8)
ENSG00000131791	PRKAB2 PPI subnetwork	0.05	> 0.20	C12orf51 (2.6)	ILF3 (2.5)	OGDH (2.4)	CARM1 (1.8)	SARS (1.8)	ZNF180 (1.6)	DNM2 (1.5)	HAPLN4 (1.5)	CILP2 (1.4)	LDLR (1.4)
KEGG_ACUTE_MYELOID_LEUKEMIA	KEGG_ACUTE_MYELOID_LEUKEMIA	0.05	> 0.20	DNM2 (4.0)	GATAD2A (2.5)	GMIP (2.5)	GEMIN7 (2.4)	BCL3 (2.4)	RELB (2.3)	BLOC1S3 (2.2)	GRINA (2.1)	HLX (2.1)	SLC44A2 (2.0)
GO:0032868	response to insulin stimulus	0.05	> 0.20	COL4A3BP (3.3)	SORT1 (2.7)	MOSC1 (2.6)	TMEM57 (2.2)	GPAM (2.1)	ENSG00000238078 (2.0)	HAPLN4 (1.9)	ENSG00000254235 (1.9)	PTPN11 (1.7)	GRINA (1.6)
GO:0006720	isoprenoid metabolic process	0.05	> 0.20	PCSK9 (5.1)	FADS2 (4.6)	FADS1 (4.5)	LDLR (4.4)	HMGCR (4.4)	CYP7A1 (3.7)	LPA (3.2)	NPC1L1 (3.1)	TM6SF2 (2.6)	ABCG8 (2.5)
ENSG00000108924	HLF PPI subnetwork	0.05	> 0.20	SARS (3.2)	TRIB1 (3.2)	MAPKAPK5 (2.6)	POC5 (2.3)	GCNT4 (2.2)	BCL3 (2.0)	TRAFD1 (1.8)	MYLIP (1.6)	RELB (1.6)	MAFB (1.6)
GO:0046395	carboxylic acid catabolic process	0.05	> 0.20	ACAD10 (4.2)	LPA (3.8)	SLC22A1 (3.2)	ANGPTL3 (3.1)	MOSC1 (2.8)	CYP7A1 (2.7)	APOA5 (2.5)	ALDH2 (2.5)	PLG (2.5)	APOC4 (2.4)
GO:0016054	organic acid catabolic process	0.05	> 0.20	ACAD10 (4.2)	LPA (3.8)	SLC22A1 (3.2)	ANGPTL3 (3.1)	MOSC1 (2.8)	CYP7A1 (2.7)	APOA5 (2.5)	ALDH2 (2.5)	PLG (2.5)	APOC4 (2.4)
ENSG00000147383	NSDHL PPI subnetwork	0.05	> 0.20	HMGCR (16.7)	LDLR (14.7)	FADS1 (12.2)	FADS2 (10.7)	PCSK9 (9.2)	CYP7A1 (4.0)	GPAM (2.3)	TRAPPC6A (2.1)	NPC1L1 (2.0)	GCNT4 (1.5)
GO:0046503	glycerolipid catabolic process	0.05	> 0.20	MOSC1 (3.9)	NPC1L1 (3.8)	GPAM (3.7)	TM6SF2 (3.0)	ABCG5 (2.8)	APOB (2.4)	PMFBP1 (2.3)	APOC1 (2.3)	APOC4 (2.3)	HP (2.3)
ENSG00000117707	PROX1 PPI subnetwork	0.05	> 0.20	HAVCR1 (2.6)	ZHX3 (2.5)	UBXN2B (2.1)	GCNT4 (1.7)	PMFBP1 (1.6)	ABCG8 (1.5)	MOSC1 (1.4)	DNAH11 (1.4)	ABO (1.3)	ENSG00000226648 (1.2)
REACTOME_TRAF6_MEDIATED_NF:KB_ACTIVATION	REACTOME_TRAF6_MEDIATED_NF:KB_ACTIVATION	0.05	> 0.20	RELB (8.8)	OASL (7.0)	PARP10 (5.6)	BCL3 (4.9)	CYB561D1 (2.8)	TRAFD1 (2.5)	GRINA (2.0)	PVR (1.7)	MYLIP (1.7)	CLPTM1 (1.6)
ENSG00000109929	SC5DL PPI subnetwork	0.05	> 0.20	HMGCR (13.2)	LDLR (10.9)	FADS1 (9.4)	FADS2 (8.4)	PCSK9 (7.1)	NPC1L1 (3.8)	CYP7A1 (2.9)	TM6SF2 (2.1)	GPAM (2.1)	C12orf47 (1.9)
MP:0009429	decreased embryo weight	0.05	> 0.20	UBXN2B (3.7)	PPP1R37 (3.1)	ST3GAL4 (2.4)	ZNF180 (2.1)	TRIB1 (2.1)	PVRL2 (2.1)	CLPTM1 (1.8)	LPIN3 (1.8)	MAU2 (1.6)	NYNRIN (1.6)
MP:0002358	abnormal spleen periarteriolar lymphoid sheath morphology	0.05	> 0.20	RELB (4.2)	ZNF101 (3.5)	BCL3 (3.1)	GMIP (2.7)	CYB561D1 (2.0)	GRINA (1.8)	TIMD4 (1.8)	SLC44A2 (1.8)	ITGB3 (1.8)	PLCG1 (1.7)
ENSG00000131459	GFPT2 PPI subnetwork	0.05	> 0.20	NAA25 (3.6)	SARS (3.3)	GPAM (3.1)	OGDH (3.1)	SMARCA4 (2.8)	DDX56 (2.5)	PSMA5 (2.4)	DHODH (2.3)	SLC22A1 (2.3)	TOMM40 (2.2)
ENSG00000204103	MAFB PPI subnetwork	0.05	> 0.20	TRIB1 (5.9)	COL4A3BP (2.8)	MAFB (2.6)	AMIGO1 (1.8)	NPC1L1 (1.7)	C12orf43 (1.7)	ACAD10 (1.6)	MAU2 (1.6)	HNF1A (1.5)	PVR (1.5)
GO:0001816	cytokine production	0.05	> 0.20	OASL (3.1)	PARP10 (2.7)	SH2B3 (2.5)	POLK (2.1)	TIMD4 (2.1)	RELB (2.1)	GMIP (2.0)	ZNF101 (2.0)	CYB561D1 (1.8)	BCL3 (1.7)
GO:0071826	ribonucleoprotein complex subunit organization	0.05	> 0.20	C12orf43 (3.3)	BRAP (3.2)	SUGP1 (2.7)	QTRT1 (2.7)	ZNF259 (2.6)	DHX38 (2.2)	NAA25 (2.1)	PTPN11 (2.0)	GOT2P1 (1.9)	DDX56 (1.9)
MP:0008074	increased CD4-positive T cell number	0.05	> 0.20	BCL3 (3.7)	RELB (3.5)	CETP (3.3)	ZNF101 (2.8)	TIMD4 (2.8)	GMIP (2.4)	MAFB (2.4)	APOC1 (2.2)	SLC44A2 (2.2)	TRIB1 (1.9)
ENSG00000139515	PDX1 PPI subnetwork	0.05	> 0.20	PARP10 (3.0)	LPAR2 (2.7)	OASL (2.5)	ENSG00000228044 (2.4)	ABCG5 (2.4)	C12orf43 (2.2)	ABCG8 (2.2)	COL4A3BP (2.1)	TRAFD1 (2.0)	PLEKHH2 (1.9)
ENSG00000175467	SART1 PPI subnetwork	0.05	> 0.20	C19orf52 (3.6)	QTRT1 (3.5)	DHX38 (3.1)	SMARCA4 (3.1)	BRAP (3.1)	MAU2 (3.1)	CARM1 (3.1)	TOP1 (2.8)	BUD13 (2.6)	ILF3 (2.5)
GO:0050996	positive regulation of lipid catabolic process	0.05	> 0.20	APOC4 (2.7)	APOB (2.4)	ABCG8 (2.4)	PLG (2.3)	ABCG5 (2.1)	MOSC1 (2.0)	TM6SF2 (1.9)	ANGPTL3 (1.8)	C17orf57 (1.6)	APOA5 (1.6)
GO:0007595	lactation	0.05	> 0.20	DNAH11 (3.0)	GOT2P1 (2.7)	ATXN7L2 (2.7)	KIAA1324 (2.5)	ANKRD31 (2.4)	GEMIN7 (2.0)	DHODH (1.9)	BLOC1S3 (1.8)	PMFBP1 (1.7)	TRAPPC6A (1.5)
ENSG00000196781	TLE1 PPI subnetwork	0.05	> 0.20	ENSG00000238078 (2.3)	PPP1R37 (2.2)	PVRL2 (2.2)	KIAA1324 (2.0)	ALDH2 (1.9)	TOP1 (1.9)	GRINA (1.8)	TXNL4B (1.7)	KANK2 (1.7)	ILF3 (1.7)
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	0.05	> 0.20	OASL (9.3)	PARP10 (6.4)	TRAFD1 (5.0)	RELB (3.0)	BCL3 (2.6)	CYP7A1 (2.5)	GOT2P1 (2.3)	TMEM50A (2.0)	BLOC1S3 (2.0)	GEMIN7 (2.0)
ENSG00000074696	PTPLAD1 PPI subnetwork	0.05	> 0.20	GRINA (2.5)	POC5 (2.4)	HLX (1.8)	BCL3 (1.8)	MAPKAPK5 (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.7)	POLK (1.7)	BRAP (1.6)	RHD (1.5)
ENSG00000132153	DHX30 PPI subnetwork	0.05	> 0.20	OGDH (2.0)	DHX38 (2.0)	NT5DC1 (2.0)	QTRT1 (1.9)	PLCG1 (1.8)	ATXN7L2 (1.8)	ATP13A1 (1.8)	DNAH11 (1.7)	BUD13 (1.7)	ABO (1.7)
ENSG00000146007	ZMAT2 PPI subnetwork	0.05	> 0.20	SUGP1 (3.4)	DHX38 (3.1)	SMARCA4 (2.9)	BUD13 (2.9)	ILF3 (2.9)	CARM1 (2.8)	ATP13A1 (2.6)	MAU2 (2.3)	FEN1 (2.1)	TOMM40 (2.1)
ENSG00000131721	RHOXF2 PPI subnetwork	0.05	> 0.20	PPP1R37 (4.5)	NYNRIN (3.3)	YIPF2 (3.0)	CLPTM1 (2.6)	SARS (2.3)	AP1M2 (2.3)	SUGP1 (2.2)	ANKRD31 (2.1)	CARM1 (2.1)	ILF3 (1.9)
GO:0035257	nuclear hormone receptor binding	0.05	> 0.20	DNM2 (2.5)	ATXN2 (2.5)	TRAFD1 (2.0)	MAFB (2.0)	DHX38 (1.9)	MAPKAPK5 (1.9)	BUD13 (1.8)	C12orf51 (1.6)	TOP1 (1.6)	TIMD4 (1.4)
GO:0016407	acetyltransferase activity	0.05	> 0.20	C19orf52 (2.6)	FADS2 (2.6)	CARM1 (2.4)	HMGCR (2.4)	COL4A3BP (2.3)	FADS1 (2.2)	PCSK9 (2.1)	ENSG00000254235 (2.1)	LDLR (2.1)	UBXN2B (2.0)
ENSG00000105248	CCDC94 PPI subnetwork	0.05	> 0.20	DHX38 (3.4)	ZNF259 (3.4)	BUD13 (3.1)	SARS (2.5)	POC5 (2.5)	SUGP1 (2.4)	QTRT1 (2.4)	BRAP (2.4)	SMARCA4 (2.0)	USP24 (1.9)
ENSG00000102241	HTATSF1 PPI subnetwork	0.05	> 0.20	SUGP1 (3.5)	ILF3 (3.0)	DHX38 (2.8)	TOP1 (2.7)	MAU2 (2.6)	SMARCA4 (2.2)	BUD13 (2.2)	ENSG00000226645 (2.1)	PSMA5 (2.0)	ATP13A1 (1.9)
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	0.05	> 0.20	RELB (4.4)	SH2B3 (3.5)	TRIB1 (3.4)	PVR (3.3)	BCL3 (3.2)	HLX (2.8)	GMIP (1.9)	GRINA (1.5)	ENSG00000228044 (1.5)	MAFB (1.4)
ENSG00000143995	MEIS1 PPI subnetwork	0.05	> 0.20	SYPL2 (2.7)	DNAH11 (2.6)	ANKRD31 (2.5)	ATXN7L2 (2.3)	ENSG00000228044 (2.1)	PMFBP1 (2.0)	ATXN2 (2.0)	KANK2 (1.9)	HLX (1.8)	PCSK9 (1.8)
GO:0008009	chemokine activity	0.05	> 0.20	TIMD4 (4.7)	RELB (3.6)	MAFB (3.2)	OASL (2.9)	BCL3 (2.8)	CETP (2.8)	PVRL2 (2.5)	GRINA (1.8)	ENSG00000228044 (1.6)	PARP10 (1.4)
GO:0019203	carbohydrate phosphatase activity	0.05	> 0.20	NPC1L1 (3.6)	SORT1 (2.9)	TM6SF2 (2.4)	PLG (2.2)	ACAD10 (2.2)	LPA (2.0)	AP1M2 (1.9)	TRIB1 (1.9)	ENSG00000228044 (1.8)	MAFB (1.8)
GO:0050308	sugar-phosphatase activity	0.05	> 0.20	NPC1L1 (3.6)	SORT1 (2.9)	TM6SF2 (2.4)	PLG (2.2)	ACAD10 (2.2)	LPA (2.0)	AP1M2 (1.9)	TRIB1 (1.9)	ENSG00000228044 (1.8)	MAFB (1.8)
KEGG_TYROSINE_METABOLISM	KEGG_TYROSINE_METABOLISM	0.05	> 0.20	APOC4 (4.9)	APOA5 (4.4)	PLG (3.8)	ANGPTL3 (3.5)	SLC22A1 (3.4)	HP (3.4)	ABCG5 (3.4)	LPA (3.3)	ALDH2 (2.9)	MOSC1 (2.8)
GO:0019865	immunoglobulin binding	0.05	> 0.20	PLG (3.1)	ANGPTL3 (2.9)	HP (2.5)	MAFB (2.4)	APOC4 (2.4)	GMPR (2.2)	ALDH2 (1.9)	LPA (1.9)	SLC22A1 (1.9)	CYP7A1 (1.7)
GO:0006805	xenobiotic metabolic process	0.05	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.3)	ABCG8 (4.1)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
MP:0011423	kidney cortex atrophy	0.05	> 0.20	TMED4 (2.8)	HAVCR1 (2.6)	APOB (2.4)	C11orf9 (2.3)	HNF1A (2.3)	TRIB1 (1.9)	DNAH11 (1.8)	NYNRIN (1.8)	ABCG5 (1.8)	NPC1L1 (1.8)
ENSG00000143748	NVL PPI subnetwork	0.06	> 0.20	ZNF259 (5.1)	NAA25 (4.9)	DDX56 (4.2)	TOMM40 (3.7)	QTRT1 (3.2)	DHODH (3.1)	DHX38 (2.8)	MAPKAPK5 (2.5)	C12orf43 (2.4)	ENSG00000226645 (2.4)
MP:0002109	abnormal limb morphology	0.06	> 0.20	BCAM (3.8)	CILP2 (3.2)	MAFB (2.8)	LDLR (2.7)	PCSK9 (2.4)	ZHX3 (2.3)	PLEKHH2 (2.1)	PLEC (2.1)	SLC44A2 (2.1)	NYNRIN (2.0)
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	0.06	> 0.20	BCL3 (4.9)	TRAFD1 (4.0)	PARP10 (3.6)	HLX (3.0)	GRINA (2.2)	LDLR (2.1)	TRIB1 (2.1)	ALDH2 (1.8)	AMIGO1 (1.7)	ENSG00000228044 (1.6)
GO:0002064	epithelial cell development	0.06	> 0.20	DNAH11 (2.9)	ENSG00000238078 (2.5)	AP1M2 (2.5)	CILP2 (2.3)	CELSR2 (2.3)	PVRL2 (2.2)	GOT2P1 (2.2)	TSSK6 (2.0)	ENSG00000235545 (2.0)	BCAM (1.9)
GO:0042730	fibrinolysis	0.06	> 0.20	ANGPTL3 (4.1)	APOC4 (3.3)	PLG (3.1)	SLC22A1 (2.8)	CEACAM19 (2.8)	APOA5 (2.8)	ENSG00000228044 (2.7)	PCSK9 (2.6)	HP (2.6)	CYP7A1 (2.6)
ENSG00000106628	POLD2 PPI subnetwork	0.06	> 0.20	FEN1 (4.6)	USP1 (3.6)	SLC22A1 (2.2)	PLG (2.1)	APOC4 (2.1)	ANGPTL3 (2.1)	LPA (2.0)	ENSG00000235545 (2.0)	GOT2P1 (1.7)	TXNL4B (1.5)
GO:0071466	cellular response to xenobiotic stimulus	0.06	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.2)	ABCG8 (4.0)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
GO:0009410	response to xenobiotic stimulus	0.06	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.2)	ABCG8 (4.0)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
ENSG00000140795	MYLK3 PPI subnetwork	0.06	> 0.20	APOB (7.1)	APOC1 (3.9)	PLG (3.6)	NPC1L1 (3.4)	ABCG5 (3.4)	APOA5 (3.2)	HP (2.5)	ANGPTL3 (2.4)	APOC4 (2.4)	GPAM (2.3)
GO:0004622	lysophospholipase activity	0.06	> 0.20	TIMD4 (4.1)	NKPD1 (3.3)	CETP (3.1)	SORT1 (2.5)	MAFB (2.4)	PLEKHH2 (2.1)	MYLIP (2.1)	ABCG8 (2.0)	HLX (2.0)	UBXN2B (1.9)
GO:0008234	cysteine-type peptidase activity	0.06	> 0.20	USP24 (3.2)	ZNF180 (3.0)	APOE (2.6)	OASL (2.4)	TMEM57 (2.4)	BRAP (2.3)	ADAM1 (2.0)	MAU2 (2.0)	CEACAM19 (1.9)	NKPD1 (1.9)
MP:0006085	myocardial necrosis	0.06	> 0.20	RHD (4.2)	PLEC (2.9)	RHCE (2.8)	KANK2 (2.5)	MAFB (2.2)	TIMD4 (2.1)	SYPL2 (2.1)	BCAM (1.8)	GMPR (1.8)	ENSG00000235545 (1.7)
GO:0008063	Toll signaling pathway	0.06	> 0.20	SH2B3 (2.6)	TRIB1 (2.3)	ENSG00000228044 (2.2)	BLOC1S3 (2.2)	CYB561D1 (2.1)	LPAR2 (2.0)	GMIP (2.0)	BCL3 (2.0)	PVR (1.9)	RELB (1.9)
ENSG00000183785	TUBA8 PPI subnetwork	0.06	> 0.20	ENSG00000228044 (3.0)	GOT2P1 (2.6)	ADAM1 (2.5)	ZNF101 (2.0)	PMFBP1 (1.9)	GEMIN7 (1.7)	BRAP (1.6)	DYNC2LI1 (1.6)	C11orf9 (1.6)	CARM1 (1.6)
ENSG00000107566	ERLIN1 PPI subnetwork	0.06	> 0.20	RELB (8.8)	BCL3 (6.0)	SH2B3 (2.9)	CYB561D1 (2.2)	CLPTM1 (2.0)	BLOC1S3 (1.8)	PLEC (1.6)	PVR (1.6)	MYLIP (1.5)	MAU2 (1.5)
ENSG00000089351	GRAMD1A PPI subnetwork	0.06	> 0.20	CARM1 (3.3)	ILF3 (2.7)	DNM2 (2.7)	C12orf51 (2.6)	ATXN2 (2.3)	ATP13A1 (2.2)	ENSG00000228044 (2.1)	SMARCA4 (2.0)	QTRT1 (1.8)	ATXN7L2 (1.7)
ENSG00000186416	NKRF PPI subnetwork	0.06	> 0.20	RELB (4.0)	BCL3 (3.9)	PARP10 (3.3)	USP24 (2.9)	GMIP (2.9)	MAU2 (2.9)	DHX38 (2.5)	MARK4 (2.1)	SMARCA4 (2.1)	ATXN2 (2.0)
MP:0003057	abnormal epicardium morphology	0.06	> 0.20	KANK2 (3.5)	RHD (3.2)	TIMD4 (2.9)	CETP (2.6)	MAFB (2.4)	C12orf51 (2.2)	C11orf9 (2.0)	BCAM (1.9)	C1orf63 (1.8)	TMEM50A (1.8)
GO:0004181	metallocarboxypeptidase activity	0.06	> 0.20	KIAA1324 (2.3)	FRK (2.2)	CILP2 (1.8)	C11orf9 (1.7)	DYNC2LI1 (1.6)	ENSG00000226648 (1.6)	MYLIP (1.6)	APOB (1.5)	PMFBP1 (1.5)	UBXN2B (1.5)
ENSG00000134070	IRAK2 PPI subnetwork	0.06	> 0.20	ACAD10 (3.3)	HNF1A (2.4)	NT5DC1 (2.2)	CETP (2.0)	PLEKHH2 (2.0)	CBLC (1.9)	TMEM50A (1.7)	TRAPPC6A (1.7)	ATXN7L2 (1.7)	ERP29 (1.6)
ENSG00000182359	KBTBD3 PPI subnetwork	0.06	> 0.20	ACAD10 (3.8)	NT5DC1 (3.2)	HNF1A (2.4)	TRAPPC6A (1.7)	CETP (1.6)	C1orf63 (1.6)	PCSK9 (1.6)	GMPR (1.5)	TMED4 (1.5)	ATP13A1 (1.5)
MP:0001870	salivary gland inflammation	0.06	> 0.20	BCL3 (3.3)	CETP (2.5)	TIMD4 (2.3)	CARM1 (2.2)	GRINA (2.2)	MAFB (2.1)	PBX4 (2.1)	CLPTM1 (2.0)	GOT2P1 (2.0)	RELB (2.0)
GO:0060759	regulation of response to cytokine stimulus	0.06	> 0.20	ZNF101 (3.4)	GRINA (2.7)	CEACAM19 (2.7)	OASL (2.6)	PARP10 (2.6)	C17orf57 (2.5)	ENSG00000238078 (2.5)	TRAFD1 (2.0)	MAU2 (1.9)	NKPD1 (1.9)
GO:0071407	cellular response to organic cyclic compound	0.06	> 0.20	NKPD1 (2.8)	LPIN3 (2.6)	PBX4 (2.5)	ENSG00000254235 (2.4)	GEMIN7 (2.3)	TRAPPC6A (2.0)	LPA (1.6)	BLOC1S3 (1.6)	CYB561D1 (1.5)	SLC44A2 (1.5)
GO:0006656	phosphatidylcholine biosynthetic process	0.06	> 0.20	NPC1L1 (3.9)	ENSG00000235545 (3.5)	C17orf57 (2.7)	TM6SF2 (2.5)	APOA5 (2.3)	APOB (2.3)	ABCG5 (2.2)	HAVCR1 (2.0)	AP1M2 (2.0)	PMFBP1 (1.9)
GO:0042402	cellular biogenic amine catabolic process	0.06	> 0.20	ENSG00000254235 (4.6)	SLC22A1 (3.0)	LPA (2.7)	DNAH11 (2.5)	APOA5 (1.9)	CYP7A1 (1.8)	TM6SF2 (1.7)	HNF1A (1.5)	ATXN7L2 (1.4)	FRK (1.4)
GO:0042278	purine nucleoside metabolic process	0.06	> 0.20	DHODH (3.1)	TXNL4B (2.9)	TRAPPC6A (2.8)	PCSK9 (2.4)	CYP7A1 (2.2)	LPA (2.0)	C12orf47 (1.9)	FADS2 (1.8)	ENSG00000254235 (1.7)	NT5DC1 (1.6)
ENSG00000157106	SMG1 PPI subnetwork	0.06	> 0.20	USP24 (4.3)	DHODH (3.7)	CARM1 (3.1)	C12orf51 (2.7)	SMARCA4 (2.2)	SUGP1 (2.1)	PVRL2 (2.1)	MAU2 (1.9)	NYNRIN (1.8)	ILF3 (1.8)
GO:0042605	peptide antigen binding	0.06	> 0.20	PARP10 (3.8)	NPC1L1 (3.4)	TM6SF2 (3.3)	CETP (2.9)	TRAFD1 (2.3)	CELSR2 (2.2)	LPA (2.1)	FADS1 (2.0)	HMGCR (2.0)	HAPLN4 (1.9)
MP:0002928	abnormal bile duct morphology	0.06	> 0.20	DYNC2LI1 (4.0)	HAVCR1 (2.9)	BCL3 (2.3)	CYB561D1 (2.3)	PLEKHH2 (1.9)	ZHX3 (1.7)	HNF1A (1.6)	ENSG00000254235 (1.6)	FRK (1.6)	CEACAM19 (1.5)
ENSG00000081377	CDC14B PPI subnetwork	0.06	> 0.20	PSRC1 (3.4)	DNM2 (3.3)	MAU2 (3.2)	ILF3 (2.5)	LDLR (2.0)	C12orf51 (1.9)	RELB (1.8)	AP1M2 (1.8)	PLEC (1.8)	RHCE (1.8)
ENSG00000173542	MOB1B PPI subnetwork	0.06	> 0.20	PSRC1 (3.0)	BLOC1S3 (2.3)	POC5 (2.2)	RHCE (2.0)	GMPR (1.7)	DOCK7 (1.6)	ENSG00000254235 (1.5)	GEMIN7 (1.5)	USP1 (1.5)	ILF3 (1.2)
MP:0004950	abnormal brain vasculature morphology	0.06	> 0.20	GCNT4 (3.8)	ITGB3 (3.1)	PLEC (2.5)	POLK (2.4)	TIMD4 (2.1)	LPA (2.0)	GEMIN7 (1.9)	DNAH11 (1.8)	CETP (1.7)	LDLR (1.6)
ENSG00000082641	NFE2L1 PPI subnetwork	0.06	> 0.20	TRIB1 (9.5)	BCL3 (2.9)	TSSK6 (2.3)	LDLR (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (1.9)	GRINA (1.9)	MAFB (1.9)	PVR (1.6)	LPIN3 (1.6)
MP:0008843	absent subcutaneous adipose tissue	0.06	> 0.20	TRIB1 (2.7)	PLEC (2.4)	MOSC1 (2.3)	PCSK9 (2.3)	ACAD10 (2.2)	KANK2 (2.1)	CYB561D1 (2.1)	ENSG00000226648 (1.8)	CBLC (1.8)	SUGP1 (1.7)
GO:0010883	regulation of lipid storage	0.06	> 0.20	MOSC1 (3.0)	TIMD4 (2.7)	CETP (2.6)	APOC1 (2.5)	GPAM (2.4)	ABCG8 (2.4)	GCNT4 (2.3)	GEMIN7 (2.1)	ENSG00000238078 (2.0)	APOE (2.0)
ENSG00000101945	SUV39H1 PPI subnetwork	0.06	> 0.20	SMARCA4 (2.9)	C12orf51 (2.7)	MAU2 (2.6)	PLCG1 (2.2)	TOP1 (1.9)	ATP13A1 (1.8)	NT5DC1 (1.8)	ZHX3 (1.7)	MARK4 (1.6)	CEACAM19 (1.6)
GO:0051181	cofactor transport	0.06	> 0.20	DNAH11 (3.0)	ABCG8 (2.9)	TMED4 (2.7)	TM6SF2 (2.5)	HAVCR1 (2.1)	TMEM116 (2.0)	CEACAM19 (1.8)	LPAR2 (1.8)	ABCG5 (1.6)	NPC1L1 (1.6)
GO:0048569	post-embryonic organ development	0.06	> 0.20	DNAH11 (3.7)	GEMIN7 (3.0)	MAFB (2.8)	ENSG00000226648 (2.6)	POLK (2.5)	HNF1A (2.5)	LPAR2 (2.4)	PPP1R37 (2.3)	TRAPPC6A (2.3)	FRK (2.1)
REACTOME_METABOLISM_OF_RNA	REACTOME_METABOLISM_OF_RNA	0.06	> 0.20	PSMA5 (3.3)	NAA25 (3.1)	DHX38 (2.4)	DDX56 (2.4)	TOMM40 (2.4)	TRAFD1 (2.1)	BUD13 (2.0)	ILF3 (1.9)	POC5 (1.9)	ZNF259 (1.8)
MP:0002421	abnormal cell-mediated immunity	0.06	> 0.20	APOC1 (4.2)	HLX (3.9)	BCL3 (3.7)	CETP (3.0)	GRINA (2.8)	SH2B3 (2.6)	PARP10 (2.0)	BRAP (2.0)	ST3GAL4 (1.8)	ALDH2 (1.8)
MP:0010724	thick interventricular septum	0.06	> 0.20	NPC1L1 (2.6)	TM6SF2 (2.2)	MYLIP (2.2)	GMPR (2.2)	C11orf9 (2.0)	ATXN7L2 (1.9)	C12orf47 (1.9)	ABO (1.8)	ATXN2 (1.8)	BLOC1S3 (1.5)
MP:0008008	early cellular replicative senescence	0.06	> 0.20	DOCK7 (3.0)	MARK4 (2.8)	UBXN2B (2.7)	BRAP (2.4)	ATXN7L2 (2.0)	ANKRD31 (1.9)	USP24 (1.9)	DHX38 (1.9)	PBX4 (1.9)	TMEM116 (1.9)
GO:0050880	regulation of blood vessel size	0.06	> 0.20	C12orf47 (2.4)	LPIN3 (1.8)	TSSK6 (1.8)	CETP (1.7)	ENSG00000228044 (1.7)	FRK (1.6)	ABO (1.5)	GMPR (1.5)	HAPLN4 (1.4)	NPC1L1 (1.4)
GO:0030864	cortical actin cytoskeleton	0.06	> 0.20	RHD (4.0)	RHCE (3.0)	C12orf51 (2.6)	PLCG1 (2.3)	KANK2 (2.3)	ZNF101 (2.1)	PLEC (1.8)	CETP (1.7)	AP1M2 (1.7)	ENSG00000238078 (1.6)
ENSG00000105063	PPP6R1 PPI subnetwork	0.06	> 0.20	TOMM40 (3.2)	RELB (2.9)	NAA25 (2.3)	C19orf52 (2.2)	ATP13A1 (2.1)	PPP1R37 (2.1)	POC5 (2.1)	NT5DC1 (2.0)	USP24 (1.9)	PTPN11 (1.9)
ENSG00000115274	INO80B PPI subnetwork	0.06	> 0.20	DHX38 (2.6)	BUD13 (2.1)	PCSK9 (2.1)	BRAP (2.0)	USP24 (2.0)	PLCG1 (1.9)	ATXN7L2 (1.9)	C12orf43 (1.8)	ZNF180 (1.7)	KANK2 (1.7)
ENSG00000159189	C1QC PPI subnetwork	0.06	> 0.20	TIMD4 (4.9)	APOE (4.4)	MAFB (3.4)	CETP (2.6)	APOC1 (2.2)	CLPTM1 (1.6)	HP (1.6)	BCL3 (1.6)	ALDH2 (1.5)	GCNT4 (1.5)
ENSG00000135341	MAP3K7 PPI subnetwork	0.06	> 0.20	PARP10 (3.2)	TRAFD1 (3.1)	FRK (3.1)	TRIB1 (2.5)	PTPN11 (2.4)	C1orf63 (2.2)	BCL3 (2.1)	OASL (2.0)	HLX (2.0)	PVR (1.9)
MP:0005262	coloboma	0.06	> 0.20	DYNC2LI1 (3.9)	ZNF180 (2.1)	DNAH11 (2.1)	PLEKHH2 (2.1)	ENSG00000226648 (2.0)	TMEM116 (2.0)	ENSG00000228044 (2.0)	ABO (1.9)	ZHX3 (1.6)	FRK (1.5)
MP:0009114	decreased pancreatic beta cell mass	0.06	> 0.20	TRIB1 (2.5)	DNAH11 (2.4)	KIAA1324 (2.4)	PLEKHH2 (2.1)	ENSG00000226645 (1.8)	MYLIP (1.8)	OASL (1.6)	GCNT4 (1.6)	LPIN3 (1.5)	LDLR (1.5)
ENSG00000117154	IGSF21 PPI subnetwork	0.06	> 0.20	PVRL2 (3.6)	PVR (2.9)	C17orf57 (2.5)	NYNRIN (2.5)	TRAPPC6A (2.3)	ATXN7L2 (1.9)	MARK4 (1.8)	GEMIN7 (1.8)	RPH3A (1.7)	ENSG00000238078 (1.7)
ENSG00000100888	CHD8 PPI subnetwork	0.06	> 0.20	DHX38 (2.7)	C19orf52 (2.7)	QTRT1 (2.5)	BUD13 (2.4)	BLOC1S3 (2.0)	ANKRD31 (1.9)	PCSK9 (1.8)	ILF3 (1.8)	OGDH (1.8)	ZNF180 (1.6)
GO:0009063	cellular amino acid catabolic process	0.06	> 0.20	CYP7A1 (3.2)	ANGPTL3 (3.1)	LPA (3.0)	SLC22A1 (2.8)	ACAD10 (2.7)	MOSC1 (2.5)	DHODH (2.4)	PLG (2.4)	ENSG00000254235 (2.4)	UBXN2B (2.4)
ENSG00000163810	TGM4 PPI subnetwork	0.06	> 0.20	APOB (5.6)	ANGPTL3 (4.3)	PLG (4.2)	APOE (3.9)	APOC1 (3.4)	HP (3.2)	APOC4 (3.2)	APOA5 (3.1)	PCSK9 (2.6)	GPAM (2.1)
GO:0008305	integrin complex	0.06	> 0.20	ITGB3 (3.3)	SLC44A2 (2.7)	C17orf57 (2.4)	CEACAM19 (2.2)	MAFB (2.1)	GMIP (2.0)	ST3GAL4 (1.9)	ENSG00000238078 (1.8)	PLEC (1.8)	SH2B3 (1.8)
ENSG00000131236	CAP1 PPI subnetwork	0.06	> 0.20	USP24 (3.4)	NAA25 (2.5)	OGDH (2.5)	SMARCA4 (2.3)	CLPTM1 (2.2)	TOMM40 (2.0)	CARM1 (1.8)	TOP1 (1.6)	NT5DC1 (1.6)	DDX56 (1.6)
MP:0003921	abnormal heart left ventricle morphology	0.06	> 0.20	PVRL2 (2.8)	CBLC (2.4)	BCAM (1.9)	BCL3 (1.5)	APOB (1.4)	C17orf57 (1.4)	KANK2 (1.4)	ACAD10 (1.3)	C11orf9 (1.3)	NYNRIN (1.3)
ENSG00000078304	PPP2R5C PPI subnetwork	0.06	> 0.20	MYLIP (2.7)	CEACAM19 (2.6)	ENSG00000226645 (2.6)	MARK4 (2.3)	TRIB1 (2.1)	PSRC1 (2.1)	CBLC (1.9)	LPAR2 (1.8)	PVRL2 (1.7)	UBXN2B (1.7)
GO:0043574	peroxisomal transport	0.06	> 0.20	NT5DC1 (3.6)	C19orf52 (3.0)	AMIGO1 (2.5)	YIPF2 (2.4)	CYP7A1 (1.9)	ACAD10 (1.8)	TMEM116 (1.6)	TSSK6 (1.6)	ABO (1.5)	GOT2P1 (1.4)
GO:0044212	transcription regulatory region DNA binding	0.06	> 0.20	TRIB1 (4.0)	HLX (2.5)	ATXN2 (2.2)	BCL3 (2.0)	CARM1 (1.8)	MAFB (1.8)	PLEC (1.8)	KANK2 (1.7)	GATAD2A (1.7)	ATXN7L2 (1.7)
ENSG00000113658	SMAD5 PPI subnetwork	0.06	> 0.20	ZNF180 (2.7)	KANK2 (2.1)	MARK4 (2.0)	ALDH2 (1.9)	MAPKAPK5 (1.9)	PVRL2 (1.9)	ATXN2 (1.9)	PTPN11 (1.8)	CLPTM1 (1.8)	PLEC (1.8)
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	0.06	> 0.20	RELB (4.1)	SH2B3 (3.7)	TRIB1 (3.5)	OASL (3.2)	BCL3 (2.9)	HLX (2.4)	PARP10 (2.2)	MAPKAPK5 (2.2)	BUD13 (1.9)	CARM1 (1.9)
GO:0042379	chemokine receptor binding	0.06	> 0.20	TIMD4 (4.2)	RELB (3.8)	MAFB (3.3)	BCL3 (3.1)	OASL (3.0)	PVRL2 (2.8)	CETP (2.6)	GRINA (1.8)	ENSG00000228044 (1.7)	TRAFD1 (1.5)
ENSG00000122406	RPL5 PPI subnetwork	0.06	> 0.20	NAA25 (4.3)	ZNF259 (3.8)	DDX56 (3.6)	TOMM40 (2.8)	QTRT1 (2.8)	SARS (2.7)	DHX38 (2.3)	SUGP1 (2.3)	C12orf43 (2.2)	BRAP (2.1)
ENSG00000134376	CRB1 PPI subnetwork	0.06	> 0.20	NYNRIN (3.1)	UBXN2B (2.3)	BCAM (2.0)	PLCG1 (2.0)	SLC22A1 (2.0)	APOE (1.9)	PARP10 (1.6)	LPIN3 (1.6)	PTPN11 (1.5)	ZHX3 (1.5)
ENSG00000100393	EP300 PPI subnetwork	0.06	> 0.20	TRIB1 (4.5)	HLX (2.9)	MAFB (2.5)	ATXN2 (2.3)	PARP10 (2.1)	KANK2 (2.1)	BCL3 (2.0)	BUD13 (1.8)	DHX38 (1.8)	MAU2 (1.7)
ENSG00000100316	RPL3 PPI subnetwork	0.06	> 0.20	ZNF259 (3.9)	NAA25 (3.3)	C12orf43 (2.9)	DDX56 (2.8)	DHX38 (2.6)	SARS (2.5)	TOMM40 (2.3)	SUGP1 (2.2)	TOP1 (2.2)	ATP13A1 (2.1)
GO:0042054	histone methyltransferase activity	0.06	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	MAU2 (2.6)	C12orf43 (2.3)	SMARCA4 (2.3)	QTRT1 (2.2)	ATXN7L2 (2.1)	BUD13 (2.1)	ATP13A1 (2.0)	ILF3 (1.8)
MP:0000321	increased bone marrow cell number	0.06	> 0.20	RHD (4.0)	RHCE (3.7)	HLX (3.2)	BCL3 (3.2)	HP (3.0)	PARP10 (2.2)	GMIP (2.1)	TRIB1 (2.1)	RELB (1.7)	MAFB (1.5)
MP:0005026	decreased susceptibility to parasitic infection	0.06	> 0.20	RHD (5.0)	RHCE (4.7)	SLC22A1 (2.3)	PARP10 (2.2)	CYP7A1 (2.2)	MAFB (2.1)	TIMD4 (1.8)	APOC1 (1.7)	PLG (1.6)	RELB (1.6)
ENSG00000128602	SMO PPI subnetwork	0.06	> 0.20	PARP10 (2.7)	GMIP (2.6)	MAU2 (2.4)	PPP1R37 (2.3)	BCL3 (2.2)	USP24 (2.1)	ATXN2 (2.0)	MYLIP (2.0)	SMARCA4 (1.9)	MAFB (1.9)
ENSG00000183048	SLC25A10 PPI subnetwork	0.06	> 0.20	HAVCR1 (2.9)	TRAFD1 (2.8)	CEACAM19 (2.4)	ADAM1 (2.4)	ANKRD31 (1.9)	DYNC2LI1 (1.9)	ATXN2 (1.8)	ITGB3 (1.7)	PVR (1.5)	RHD (1.5)
ENSG00000172115	CYCS PPI subnetwork	0.06	> 0.20	TRAPPC6A (2.6)	BUD13 (2.5)	DNM2 (2.4)	BRAP (2.4)	ALDH2 (2.0)	PSMA5 (1.9)	SH2B3 (1.8)	RELB (1.7)	OGDH (1.7)	ENSG00000226645 (1.6)
ENSG00000140678	ITGAX PPI subnetwork	0.06	> 0.20	APOB (6.5)	HP (5.9)	ANGPTL3 (4.5)	APOA5 (4.4)	APOC1 (4.4)	PLG (4.4)	APOE (4.3)	APOC4 (3.4)	HAVCR1 (3.1)	ENSG00000235545 (2.2)
ENSG00000166025	AMOTL1 PPI subnetwork	0.06	> 0.20	USP24 (2.6)	MAU2 (2.2)	SMARCA4 (2.0)	ATXN2 (2.0)	ZNF180 (1.9)	DHX38 (1.9)	CARM1 (1.8)	MAPKAPK5 (1.8)	DOCK7 (1.6)	SUGP1 (1.6)
ENSG00000163814	CDCP1 PPI subnetwork	0.06	> 0.20	CBLC (3.1)	TMED4 (2.5)	ALDH2 (2.5)	BCAM (2.3)	NYNRIN (2.2)	ANGPTL3 (2.1)	APOC4 (2.1)	AP1M2 (2.1)	MARK4 (2.0)	ENSG00000238078 (2.0)
ENSG00000103342	GSPT1 PPI subnetwork	0.06	> 0.20	TXNL4B (3.3)	TOP1 (3.2)	BRAP (3.1)	GATAD2A (2.7)	PTPN11 (2.2)	C12orf43 (2.2)	ACAD10 (2.2)	RELB (2.1)	TRAFD1 (2.0)	NCAN (2.0)
ENSG00000196353	CPNE4 PPI subnetwork	0.06	> 0.20	ZNF180 (2.8)	GOT2P1 (2.6)	PLEC (2.3)	C12orf51 (2.2)	C17orf57 (2.1)	ENSG00000235545 (1.9)	NT5DC1 (1.9)	PBX4 (1.9)	DNM2 (1.9)	PTPN11 (1.9)
GO:0006304	DNA modification	0.06	> 0.20	ANKRD31 (2.9)	ENSG00000238078 (2.8)	C17orf57 (2.4)	MAPKAPK5 (2.0)	SUGP1 (2.0)	ACAD10 (2.0)	DHODH (1.7)	MAU2 (1.5)	YIPF2 (1.5)	FRK (1.4)
GO:0016279	protein-lysine N-methyltransferase activity	0.06	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	C12orf43 (2.4)	MAU2 (2.4)	GOT2P1 (2.0)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	BRAP (1.7)
GO:0016278	lysine N-methyltransferase activity	0.06	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	C12orf43 (2.4)	MAU2 (2.4)	GOT2P1 (2.0)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	BRAP (1.7)
MP:0004003	abnormal vascular endothelial cell physiology	0.06	> 0.20	SH2B3 (2.4)	BCAM (2.3)	ALDH2 (2.0)	ITGB3 (1.9)	CILP2 (1.7)	PVR (1.6)	CYP7A1 (1.5)	TRIB1 (1.5)	NCAN (1.4)	ENSG00000228044 (1.3)
ENSG00000117133	RPF1 PPI subnetwork	0.06	> 0.20	ZNF259 (4.8)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.8)	QTRT1 (3.7)	DHX38 (3.0)	DHODH (2.8)	C12orf43 (2.3)	ATP13A1 (2.3)	ENSG00000226645 (2.2)
ENSG00000104375	STK3 PPI subnetwork	0.06	> 0.20	CEACAM19 (2.8)	UBXN2B (2.7)	PARP10 (2.7)	NT5DC1 (2.6)	TRAFD1 (2.4)	LPIN3 (1.9)	C1orf63 (1.7)	DHX38 (1.6)	ANKRD31 (1.6)	NKPD1 (1.6)
ENSG00000076555	ACACB PPI subnetwork	0.06	> 0.20	SARS (3.3)	GPAM (3.1)	NAA25 (3.0)	ATP13A1 (2.7)	TOMM40 (2.6)	ILF3 (2.5)	USP24 (2.3)	DDX56 (2.2)	PSMA5 (2.1)	OGDH (2.0)
ENSG00000172915	NBEA PPI subnetwork	0.06	> 0.20	MYLIP (3.1)	NKPD1 (3.0)	SH2B3 (3.0)	MAFB (2.7)	LPIN3 (2.7)	TIMD4 (2.1)	NYNRIN (2.0)	BLOC1S3 (1.7)	GPAM (1.7)	ZNF180 (1.7)
ENSG00000169136	ATF5 PPI subnetwork	0.06	> 0.20	SARS (4.3)	HLX (3.8)	PVRL2 (2.4)	BCL3 (2.3)	PVR (2.3)	RPH3A (2.0)	MAFB (1.8)	YIPF2 (1.6)	POC5 (1.5)	ZNF259 (1.4)
ENSG00000213639	PPP1CB PPI subnetwork	0.06	> 0.20	GATAD2A (3.0)	KANK2 (2.4)	UBXN2B (2.4)	PLEC (2.4)	GCNT4 (2.3)	GOT2P1 (2.1)	DNM2 (2.1)	TMEM50A (1.9)	CARM1 (1.8)	DYNC2LI1 (1.6)
ENSG00000170962	PDGFD PPI subnetwork	0.06	> 0.20	MYLIP (4.6)	C1orf63 (4.1)	HLX (3.0)	C17orf57 (2.4)	ENSG00000238078 (2.0)	LPIN3 (2.0)	SLC44A2 (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	GMIP (1.7)
ENSG00000145431	PDGFC PPI subnetwork	0.06	> 0.20	MYLIP (4.6)	C1orf63 (4.1)	HLX (3.0)	C17orf57 (2.4)	ENSG00000238078 (2.0)	LPIN3 (2.0)	SLC44A2 (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	GMIP (1.7)
ENSG00000118271	TTR PPI subnetwork	0.06	> 0.20	APOB (3.0)	PLG (2.7)	APOC4 (2.6)	APOA5 (2.5)	ANGPTL3 (2.4)	APOC1 (2.3)	C11orf9 (2.2)	HP (2.2)	GPAM (2.0)	CYP7A1 (2.0)
ENSG00000174718	C12orf35 PPI subnetwork	0.06	> 0.20	APOB (5.8)	APOC1 (4.1)	NPC1L1 (2.8)	GPAM (2.8)	APOA5 (2.7)	PLG (2.6)	ITGB3 (2.5)	HP (2.4)	ABCG5 (2.4)	HAVCR1 (2.3)
ENSG00000115866	DARS PPI subnetwork	0.06	> 0.20	SARS (7.4)	NAA25 (3.1)	PSMA5 (2.9)	FADS2 (2.7)	SMARCA4 (2.7)	SUGP1 (2.6)	ZNF259 (2.6)	HMGCR (2.5)	QTRT1 (2.2)	FADS1 (2.1)
ENSG00000165527	ARF6 PPI subnetwork	0.06	> 0.20	SARS (4.4)	SMARCA4 (4.1)	ILF3 (3.4)	ATP13A1 (3.4)	DOCK7 (3.1)	CLPTM1 (2.8)	DNM2 (2.7)	OGDH (2.3)	ERP29 (2.3)	PSMA5 (2.2)
REACTOME_INTERFERON_ALPHABETA_SIGNALING	REACTOME_INTERFERON_ALPHABETA_SIGNALING	0.06	> 0.20	OASL (14.4)	PARP10 (9.0)	TRAFD1 (5.7)	GMPR (2.1)	BCL3 (1.8)	TMEM50A (1.7)	ATP13A1 (1.7)	RELB (1.3)	ENSG00000228044 (1.2)	TRIB1 (1.2)
GO:0070482	response to oxygen levels	0.06	> 0.20	LPIN3 (2.3)	DNAH11 (2.2)	PVR (2.2)	POLK (2.0)	FRK (1.4)	NT5DC1 (1.3)	BLOC1S3 (1.3)	CETP (1.3)	CEACAM19 (1.2)	TRIB1 (1.2)
GO:0016628	oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor	0.06	> 0.20	FADS2 (8.2)	FADS1 (7.5)	HMGCR (6.8)	LDLR (5.7)	PCSK9 (4.9)	TRAPPC6A (4.3)	APOC1 (3.3)	MOSC1 (2.5)	LPA (2.3)	CYP7A1 (2.3)
MP:0010090	increased circulating creatine kinase level	0.06	> 0.20	SYPL2 (3.6)	LPIN3 (3.1)	KANK2 (2.5)	GEMIN7 (2.3)	AMIGO1 (2.3)	CEACAM19 (2.3)	TMEM50A (2.2)	SLC44A2 (2.1)	MOSC1 (2.0)	GPAM (1.9)
GO:0052192	movement in environment of other organism involved in symbiotic interaction	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0051806	entry into cell of other organism involved in symbiotic interaction	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0030260	entry into host cell	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0044409	entry into host	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0051828	entry into other organism involved in symbiotic interaction	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0052126	movement in host environment	0.06	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0034142	toll-like receptor 4 signaling pathway	0.06	> 0.20	SH2B3 (2.6)	ENSG00000228044 (2.5)	TRIB1 (2.3)	RELB (2.2)	CYB561D1 (2.1)	ENSG00000226645 (2.0)	BLOC1S3 (2.0)	BCL3 (2.0)	GMIP (1.8)	OASL (1.8)
GO:0032269	negative regulation of cellular protein metabolic process	0.06	> 0.20	PSMA5 (3.0)	TMEM57 (2.7)	NAA25 (2.1)	TRAFD1 (2.1)	DDX56 (1.7)	GRINA (1.5)	TRIB1 (1.5)	C12orf43 (1.4)	GCNT4 (1.3)	ZNF259 (1.3)
ENSG00000164609	SLU7 PPI subnetwork	0.06	> 0.20	DHX38 (4.1)	SUGP1 (3.6)	BRAP (2.7)	BUD13 (2.5)	POC5 (2.4)	MAU2 (2.2)	ZNF259 (2.2)	TOP1 (2.1)	SMARCA4 (2.1)	ZNF180 (2.0)
ENSG00000125347	IRF1 PPI subnetwork	0.06	> 0.20	PARP10 (4.9)	RELB (3.9)	OASL (3.7)	BCL3 (3.4)	TRAFD1 (2.8)	SH2B3 (2.7)	GRINA (2.1)	C12orf51 (1.9)	CEACAM19 (1.9)	USP24 (1.5)
MP:0004883	abnormal vascular wound healing	0.06	> 0.20	APOB (2.6)	ABCG5 (2.6)	GPAM (2.6)	CELSR2 (2.6)	KIAA1324 (2.0)	TRIB1 (2.0)	BCAM (1.9)	LDLR (1.8)	APOA5 (1.7)	ABCG8 (1.7)
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	0.06	> 0.20	FADS1 (3.7)	LDLR (3.6)	FADS2 (3.4)	HMGCR (3.1)	ABCG8 (3.0)	ST3GAL4 (2.9)	APOC1 (2.7)	TM6SF2 (2.6)	GCNT4 (2.1)	PLG (2.1)
ENSG00000100109	TFIP11 PPI subnetwork	0.06	> 0.20	MAU2 (4.0)	SUGP1 (3.8)	DHX38 (3.8)	SMARCA4 (2.8)	ATP13A1 (2.8)	BUD13 (2.6)	QTRT1 (2.5)	ILF3 (2.5)	DDX56 (2.3)	TOP1 (2.3)
ENSG00000143942	CHAC2 PPI subnetwork	0.06	> 0.20	CLPTM1 (5.4)	BCAM (3.3)	OGDH (3.3)	DNM2 (2.9)	GRINA (2.3)	PLEC (2.2)	CELSR2 (2.1)	GATAD2A (2.0)	PPP1R37 (2.0)	UBXN2B (2.0)
ENSG00000125695	STRADA PPI subnetwork	0.06	> 0.20	ILF3 (3.8)	DNM2 (3.1)	C19orf52 (2.9)	CARM1 (2.7)	TOP1 (2.5)	BRAP (2.3)	ZHX3 (2.1)	MAU2 (2.1)	SLC44A2 (2.0)	GMPR (1.8)
ENSG00000170632	ARMC10 PPI subnetwork	0.06	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.1)	C1orf63 (1.9)	TRAPPC6A (1.8)	GMPR (1.7)	PCSK9 (1.6)	CETP (1.6)	SORT1 (1.5)	TIMD4 (1.4)
ENSG00000138756	BMP2K PPI subnetwork	0.06	> 0.20	CARM1 (3.6)	DNM2 (3.4)	NKPD1 (2.8)	SMARCA4 (2.7)	GCNT4 (2.7)	BRAP (2.4)	PTPN11 (2.3)	ZNF259 (1.8)	ATXN2 (1.7)	DHX38 (1.6)
ENSG00000166333	ILK PPI subnetwork	0.06	> 0.20	FADS2 (3.6)	ITGB3 (2.7)	FADS1 (2.7)	DNM2 (2.6)	DHX38 (2.5)	LDLR (2.4)	DDX56 (2.4)	GATAD2A (2.2)	DOCK7 (2.2)	HMGCR (2.2)
MP:0011402	renal cast	0.06	> 0.20	PLEKHH2 (3.2)	BCAM (2.9)	FRK (2.4)	GRINA (2.3)	MAFB (2.3)	ENSG00000228044 (1.7)	NT5DC1 (1.6)	BCL3 (1.6)	CEACAM19 (1.6)	ACAD10 (1.6)
ENSG00000198301	SDAD1 PPI subnetwork	0.06	> 0.20	ZNF259 (5.3)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.8)	QTRT1 (3.4)	DHODH (2.9)	MAPKAPK5 (2.8)	C12orf43 (2.7)	DHX38 (2.7)	ADAM1 (2.3)
MP:0011320	abnormal glomerular capillary morphology	0.06	> 0.20	BCAM (4.6)	PVRL2 (4.0)	C11orf9 (3.8)	PLEKHH2 (3.4)	PPP1R37 (2.3)	NYNRIN (2.1)	CELSR2 (2.0)	AP1M2 (1.6)	DYNC2LI1 (1.6)	CLPTM1 (1.5)
GO:0034435	cholesterol esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
GO:0034433	steroid esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
GO:0034434	sterol esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB cascade	0.06	> 0.20	PARP10 (3.1)	ST3GAL4 (3.0)	SH2B3 (2.4)	CYB561D1 (2.2)	TRAFD1 (2.1)	GRINA (2.1)	BLOC1S3 (1.9)	RELB (1.9)	C19orf52 (1.9)	ZNF101 (1.8)
MP:0008944	decreased sensitivity to induced cell death	0.06	> 0.20	TRIB1 (2.9)	PARP10 (2.4)	OASL (2.4)	C17orf57 (2.1)	C1orf63 (1.8)	NYNRIN (1.8)	SH2B3 (1.8)	PVR (1.7)	LPAR2 (1.5)	ENSG00000254235 (1.5)
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	0.06	> 0.20	TOMM40 (3.0)	DHODH (2.9)	PVR (2.6)	TXNL4B (2.6)	DDX56 (2.1)	POC5 (2.0)	GRINA (1.9)	COL4A3BP (1.9)	TRAPPC6A (1.8)	TMEM50A (1.7)
MP:0001146	abnormal testis morphology	0.06	> 0.20	FADS1 (3.1)	ABCG8 (3.0)	C11orf9 (2.9)	ST3GAL4 (2.9)	ABCG5 (2.7)	PVRL2 (2.5)	TSSK6 (2.4)	C12orf47 (2.0)	UBXN2B (1.9)	CYP7A1 (1.9)
ENSG00000136636	KCTD3 PPI subnetwork	0.06	> 0.20	GPAM (2.7)	LDLR (2.5)	ENSG00000228044 (2.3)	FADS2 (2.3)	HAVCR1 (1.9)	FADS1 (1.9)	PCSK9 (1.8)	CETP (1.8)	C12orf51 (1.7)	SLC22A1 (1.6)
MP:0001869	pancreas inflammation	0.06	> 0.20	LPA (3.5)	GEMIN7 (2.5)	C17orf57 (2.4)	PLEKHH2 (1.9)	SLC22A1 (1.9)	BCL3 (1.9)	RELB (1.8)	SH2B3 (1.8)	TIMD4 (1.8)	APOA5 (1.7)
ENSG00000009844	VTA1 PPI subnetwork	0.06	> 0.20	TRAPPC6A (3.9)	POC5 (2.7)	UBXN2B (2.7)	TOMM40 (2.5)	RHD (2.2)	BCAM (2.1)	GRINA (2.1)	RHCE (2.1)	ENSG00000238078 (2.0)	C12orf43 (2.0)
GO:0008633	activation of pro-apoptotic gene products	0.06	> 0.20	C12orf43 (2.6)	HAVCR1 (2.5)	TXNL4B (2.4)	BRAP (2.4)	LPIN3 (2.4)	CYB561D1 (2.2)	LPAR2 (2.1)	BLOC1S3 (2.0)	FRK (2.0)	PARP10 (1.9)
ENSG00000123908	EIF2C2 PPI subnetwork	0.06	> 0.20	ATXN2 (2.7)	C12orf43 (2.4)	TMED4 (2.4)	COL4A3BP (2.3)	MAPKAPK5 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.6)	USP24 (1.6)	AMIGO1 (1.6)	C12orf51 (1.6)
MP:0011405	tubulointerstitial nephritis	0.06	> 0.20	BCAM (4.6)	GRINA (3.3)	TMED4 (2.8)	NPC1L1 (2.6)	GMPR (2.6)	HNF1A (2.6)	ABCG5 (2.6)	PVR (2.3)	NT5DC1 (2.2)	NYNRIN (2.2)
ENSG00000120694	HSPH1 PPI subnetwork	0.06	> 0.20	PSMA5 (3.4)	SARS (3.2)	SMARCA4 (3.2)	OGDH (3.1)	NAA25 (2.4)	CARM1 (2.4)	SUGP1 (2.3)	GOT2P1 (2.0)	ATP13A1 (2.0)	PTPN11 (2.0)
MP:0003917	increased kidney weight	0.06	> 0.20	GPAM (3.7)	PLEKHH2 (2.9)	MOSC1 (2.8)	SLC22A1 (2.7)	APOC4 (2.5)	APOA5 (2.5)	PLG (2.5)	CEACAM19 (2.3)	ALDH2 (2.2)	APOB (2.2)
ENSG00000198824	CHAMP1 PPI subnetwork	0.06	> 0.20	SMARCA4 (4.2)	C1orf63 (3.0)	DOCK7 (2.6)	ILF3 (2.5)	GATAD2A (2.4)	PPP1R37 (2.2)	BUD13 (2.2)	TOP1 (2.1)	SUGP1 (2.0)	TMEM57 (2.0)
GO:0043603	cellular amide metabolic process	0.06	> 0.20	TM6SF2 (5.0)	ABCG5 (4.3)	ABCG8 (4.3)	NPC1L1 (3.7)	CYP7A1 (2.5)	PBX4 (2.5)	APOC4 (2.3)	SLC22A1 (2.3)	ANKRD31 (2.2)	ZHX3 (2.2)
GO:0050776	regulation of immune response	0.06	> 0.20	TIMD4 (3.4)	ZNF101 (3.1)	GMIP (2.8)	LPA (2.2)	CETP (2.1)	PARP10 (2.1)	CYB561D1 (2.1)	MAFB (2.0)	SH2B3 (2.0)	POLK (1.8)
ENSG00000114062	UBE3A PPI subnetwork	0.06	> 0.20	POLK (2.5)	ATXN2 (2.1)	CARM1 (1.9)	LPA (1.9)	GOT2P1 (1.8)	COL4A3BP (1.8)	KIAA1324 (1.7)	C19orf52 (1.6)	LPAR2 (1.6)	MARK4 (1.5)
MP:0000733	abnormal muscle development	0.06	> 0.20	SYPL2 (5.1)	POLK (3.0)	PVR (2.7)	TRIB1 (2.0)	PLEC (2.0)	CYP7A1 (1.8)	ATXN7L2 (1.7)	KANK2 (1.6)	LPIN3 (1.5)	COL4A3BP (1.3)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_PROINFLAMMATORY_CYTOKINES	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_PROINFLAMMATORY_CYTOKINES	0.06	> 0.20	RELB (4.4)	SH2B3 (3.3)	TRIB1 (3.1)	BCL3 (3.0)	PVR (2.7)	HLX (2.6)	GMIP (1.8)	ENSG00000228044 (1.7)	GRINA (1.6)	PARP10 (1.6)
ENSG00000158486	DNAH3 PPI subnetwork	0.06	> 0.20	GPAM (3.1)	LDLR (2.5)	CETP (2.5)	MOSC1 (2.0)	FADS2 (1.9)	PCSK9 (1.9)	AMIGO1 (1.9)	HAVCR1 (1.8)	PTPN11 (1.8)	ENSG00000228044 (1.7)
ENSG00000163737	PF4 PPI subnetwork	0.06	> 0.20	ITGB3 (4.5)	FADS1 (3.6)	HMGCR (3.6)	PCSK9 (3.3)	FADS2 (3.3)	PVR (3.2)	OASL (2.9)	SLC22A1 (2.6)	TRIB1 (1.9)	CYP7A1 (1.8)
ENSG00000108344	PSMD3 PPI subnetwork	0.06	> 0.20	PSMA5 (5.7)	NAA25 (2.8)	NT5DC1 (2.8)	DDX56 (2.5)	TRAFD1 (2.2)	TOMM40 (2.0)	ENSG00000254235 (1.7)	SARS (1.6)	ZNF259 (1.5)	SMARCA4 (1.4)
MP:0002971	abnormal brown adipose tissue morphology	0.06	> 0.20	SORT1 (3.1)	MOSC1 (2.6)	SYPL2 (2.4)	APOC1 (2.3)	GPAM (2.2)	MAFB (2.2)	ST3GAL4 (2.0)	GCNT4 (1.9)	ACAD10 (1.8)	FADS1 (1.7)
ENSG00000127884	ECHS1 PPI subnetwork	0.06	> 0.20	TMEM50A (2.5)	MYLIP (2.0)	GRINA (1.8)	C1orf63 (1.7)	POC5 (1.7)	GMIP (1.6)	RHD (1.5)	RELB (1.4)	USP1 (1.4)	C12orf47 (1.4)
MP:0004502	decreased incidence of chemically-induced tumors	0.06	> 0.20	PVRL2 (3.9)	BCL3 (3.2)	HLX (2.5)	PVR (2.1)	HP (2.0)	SLC22A1 (1.9)	RELB (1.8)	TRAPPC6A (1.7)	PLEKHH2 (1.7)	C11orf9 (1.6)
REACTOME_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE	0.06	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_MYD88MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.06	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_TOLL_LIKE_RECEPTOR_TLR1TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_TLR1TLR2_CASCADE	0.06	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_TOLL_LIKE_RECEPTOR_TLR6TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_TLR6TLR2_CASCADE	0.06	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
ENSG00000214265	SNURF PPI subnetwork	0.06	> 0.20	PSMA5 (3.5)	TOMM40 (3.1)	ZNF180 (2.8)	BLOC1S3 (2.7)	BUD13 (2.3)	USP1 (1.7)	C12orf47 (1.7)	GEMIN7 (1.6)	PARP10 (1.5)	OASL (1.4)
ENSG00000147649	MTDH PPI subnetwork	0.06	> 0.20	ACAD10 (4.2)	NT5DC1 (2.7)	HNF1A (2.5)	TMED4 (2.2)	GCNT4 (1.9)	GMPR (1.8)	C1orf63 (1.8)	CETP (1.8)	TIMD4 (1.7)	OGDH (1.6)
MP:0003070	increased vascular permeability	0.06	> 0.20	PLEC (3.0)	ST3GAL4 (2.7)	APOE (2.4)	LPIN3 (2.3)	CETP (2.2)	KANK2 (2.2)	GATAD2A (1.8)	C11orf9 (1.8)	PVRL2 (1.8)	NCAN (1.7)
MP:0009431	decreased fetal weight	0.06	> 0.20	LPAR2 (3.0)	FRK (2.5)	MYLIP (2.4)	LDLR (1.9)	MAU2 (1.8)	AMIGO1 (1.8)	GPAM (1.7)	YIPF2 (1.6)	PLEKHH2 (1.6)	COL4A3BP (1.6)
ENSG00000103343	ZNF174 PPI subnetwork	0.06	> 0.20	C19orf52 (2.3)	GRINA (2.1)	OASL (2.1)	QTRT1 (2.1)	SUGP1 (2.0)	ZNF180 (1.9)	YIPF2 (1.9)	PARP10 (1.9)	BRAP (1.8)	AMIGO1 (1.7)
ENSG00000168918	INPP5D PPI subnetwork	0.06	> 0.20	ACAD10 (3.2)	C17orf57 (2.6)	HNF1A (2.5)	ITGB3 (2.1)	ERP29 (2.0)	PLEKHH2 (1.9)	ENSG00000226648 (1.9)	OGDH (1.9)	TIMD4 (1.8)	MAFB (1.7)
ENSG00000103994	ZFP106 PPI subnetwork	0.06	> 0.20	C19orf52 (2.3)	ATP13A1 (2.1)	SUGP1 (2.1)	DHX38 (1.9)	TRAFD1 (1.8)	BRAP (1.8)	OGDH (1.7)	QTRT1 (1.7)	ATXN2 (1.6)	YIPF2 (1.5)
ENSG00000168546	GFRA2 PPI subnetwork	0.06	> 0.20	OASL (2.8)	TMEM57 (2.0)	HNF1A (1.9)	PLEKHH2 (1.9)	TIMD4 (1.6)	CETP (1.5)	POLK (1.5)	C1orf63 (1.5)	ENSG00000228044 (1.5)	DNAH11 (1.5)
MP:0001289	persistence of hyaloid vascular system	0.06	> 0.20	BCAM (3.8)	NYNRIN (2.6)	PVRL2 (2.5)	PVR (2.3)	NCAN (2.0)	HLX (1.9)	CYP7A1 (1.7)	C11orf9 (1.7)	POLK (1.7)	PLCG1 (1.4)
GO:0016859	cis-trans isomerase activity	0.06	> 0.20	YIPF2 (3.7)	ERP29 (3.2)	TOMM40 (2.6)	QTRT1 (2.5)	TMED4 (2.1)	TXNL4B (2.0)	CLPTM1 (1.8)	OGDH (1.8)	ST3GAL4 (1.7)	DYNC2LI1 (1.7)
ENSG00000196497	IPO4 PPI subnetwork	0.06	> 0.20	NAA25 (3.6)	PSMA5 (3.4)	DDX56 (3.3)	TOMM40 (2.9)	SARS (2.8)	NT5DC1 (2.5)	SUGP1 (2.1)	SMARCA4 (2.1)	ZNF259 (2.1)	OGDH (1.9)
ENSG00000105373	GLTSCR2 PPI subnetwork	0.06	> 0.20	NAA25 (3.4)	USP24 (2.9)	DHODH (2.8)	ZNF259 (2.6)	DHX38 (2.2)	DDX56 (2.0)	GCNT4 (2.0)	ABCG5 (2.0)	POC5 (1.9)	NPC1L1 (1.7)
ENSG00000179776	CDH5 PPI subnetwork	0.06	> 0.20	NYNRIN (2.3)	KANK2 (2.2)	PVRL2 (2.2)	C11orf9 (2.1)	SH2B3 (1.9)	PLEC (1.9)	DHX38 (1.8)	PLG (1.8)	APOB (1.8)	PVR (1.7)
ENSG00000126226	PCID2 PPI subnetwork	0.06	> 0.20	DHX38 (4.6)	SUGP1 (3.2)	SMARCA4 (3.0)	BUD13 (2.8)	TOP1 (2.8)	ILF3 (2.5)	DDX56 (2.5)	MAU2 (2.4)	TOMM40 (2.0)	FEN1 (1.8)
MP:0002189	abnormal myocardial trabeculae morphology	0.06	> 0.20	C17orf57 (3.0)	MAFB (2.7)	ATXN2 (2.4)	ACAD10 (2.3)	MOSC1 (2.3)	KANK2 (2.1)	COL4A3BP (1.8)	DOCK7 (1.7)	C11orf9 (1.6)	GPAM (1.6)
ENSG00000163510	CWC22 PPI subnetwork	0.07	> 0.20	SUGP1 (4.0)	DHX38 (4.0)	BUD13 (3.4)	MAU2 (2.9)	SMARCA4 (2.5)	ZNF259 (2.4)	BRAP (2.4)	DDX56 (2.4)	TOP1 (2.1)	ILF3 (2.1)
MP:0011348	abnormal renal glomerulus basement membrane morphology	0.07	> 0.20	BCAM (4.3)	PLEKHH2 (3.1)	NT5DC1 (2.9)	KANK2 (2.8)	CELSR2 (2.7)	ABO (1.8)	TMED4 (1.7)	POLK (1.6)	PVRL2 (1.6)	CYP7A1 (1.5)
MP:0008565	decreased interferon-beta secretion	0.07	> 0.20	OASL (12.0)	PARP10 (8.1)	TRAFD1 (5.8)	BCL3 (3.0)	RELB (2.7)	ATP13A1 (2.5)	FRK (1.8)	GRINA (1.5)	C1orf63 (1.5)	CYB561D1 (1.5)
MP:0004889	increased energy expenditure	0.07	> 0.20	ST3GAL4 (3.3)	MYLIP (3.0)	MOSC1 (2.6)	GPAM (2.6)	HP (2.6)	SORT1 (2.4)	ZHX3 (2.0)	LPIN3 (1.8)	MAU2 (1.8)	AMIGO1 (1.7)
ENSG00000106245	BUD31 PPI subnetwork	0.07	> 0.20	SUGP1 (4.2)	DHX38 (4.0)	BUD13 (3.2)	MAU2 (2.6)	DDX56 (2.6)	BRAP (2.4)	SMARCA4 (2.4)	C19orf52 (2.3)	ILF3 (2.2)	ZNF259 (2.1)
GO:0030195	negative regulation of blood coagulation	0.07	> 0.20	ANGPTL3 (4.3)	ITGB3 (3.4)	PLG (3.2)	APOC4 (3.1)	ENSG00000228044 (3.1)	PCSK9 (3.0)	CEACAM19 (2.9)	SLC22A1 (2.9)	CYP7A1 (2.6)	GMPR (2.5)
ENSG00000184863	RBM33 PPI subnetwork	0.07	> 0.20	ATXN2 (3.1)	MAPKAPK5 (2.9)	SMARCA4 (2.9)	BRAP (2.7)	NAA25 (2.5)	TRAFD1 (2.4)	C12orf43 (2.3)	CLPTM1 (2.2)	ANKRD31 (2.1)	C12orf51 (2.1)
GO:0005507	copper ion binding	0.07	> 0.20	APOB (3.1)	CILP2 (2.5)	HP (2.3)	BCAM (2.0)	PBX4 (1.8)	TRAPPC6A (1.7)	RHCE (1.7)	APOA5 (1.7)	ENSG00000254235 (1.5)	PLG (1.5)
ENSG00000072201	LNX1 PPI subnetwork	0.07	> 0.20	LPAR2 (2.4)	MAU2 (2.3)	TRAPPC6A (2.1)	MYLIP (2.0)	TRAFD1 (1.9)	C1orf63 (1.9)	TXNL4B (1.9)	POC5 (1.8)	PPP1R37 (1.8)	TOMM40 (1.7)
MP:0010300	increased skin tumor incidence	0.07	> 0.20	PBX4 (2.6)	MARK4 (2.2)	SLC44A2 (2.0)	ZNF101 (1.9)	ALDH2 (1.7)	LPIN3 (1.7)	TMEM116 (1.7)	SORT1 (1.7)	FADS2 (1.6)	POLK (1.6)
ENSG00000120949	TNFRSF8 PPI subnetwork	0.07	> 0.20	PARP10 (3.0)	USP24 (2.8)	MAU2 (2.8)	GMIP (2.8)	ZNF180 (2.6)	BCL3 (2.6)	RELB (2.0)	ATXN2 (2.0)	PSRC1 (1.8)	SMARCA4 (1.8)
ENSG00000196136	SERPINA3 PPI subnetwork	0.07	> 0.20	ENSG00000228044 (4.1)	HP (2.8)	CEACAM19 (2.4)	MOSC1 (1.7)	RHD (1.6)	SLC22A1 (1.5)	ACAD10 (1.5)	ANKRD31 (1.3)	APOC4 (1.2)	ENSG00000226648 (1.2)
ENSG00000111641	NOP2 PPI subnetwork	0.07	> 0.20	ZNF259 (5.1)	NAA25 (4.5)	TOMM40 (4.2)	DDX56 (4.0)	QTRT1 (3.6)	DHX38 (3.2)	C12orf43 (2.9)	ATP13A1 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)
ENSG00000145425	RPS3A PPI subnetwork	0.07	> 0.20	DDX56 (3.9)	NAA25 (3.3)	TOMM40 (3.1)	ILF3 (2.8)	ZNF259 (2.7)	QTRT1 (2.7)	SARS (2.7)	SMARCA4 (2.6)	DHX38 (2.4)	SUGP1 (2.4)
ENSG00000184343	SRPK3 PPI subnetwork	0.07	> 0.20	C1orf63 (3.7)	POC5 (2.7)	SARS (2.5)	PSMA5 (2.1)	LPIN3 (1.9)	PLEKHH2 (1.9)	GEMIN7 (1.8)	MYLIP (1.7)	USP1 (1.7)	CEACAM19 (1.6)
ENSG00000102882	MAPK3 PPI subnetwork	0.07	> 0.20	TRIB1 (3.8)	LDLR (2.8)	GRINA (2.8)	RPH3A (2.6)	PLEC (2.5)	SH2B3 (2.4)	BCL3 (2.2)	PVR (2.0)	RELB (1.8)	DNM2 (1.7)
ENSG00000164107	HAND2 PPI subnetwork	0.07	> 0.20	MARK4 (2.6)	GRINA (2.6)	DNM2 (2.4)	OGDH (2.3)	C11orf9 (2.3)	CARM1 (2.3)	KANK2 (2.1)	ATXN7L2 (1.8)	ENSG00000238078 (1.8)	HLX (1.5)
ENSG00000069399	BCL3 PPI subnetwork	0.07	> 0.20	RELB (5.0)	BCL3 (4.3)	TRIB1 (3.4)	BUD13 (2.6)	PSMA5 (2.5)	PLEC (2.3)	GRINA (2.2)	ATXN2 (1.8)	LDLR (1.8)	C12orf51 (1.7)
MP:0002773	decreased circulating luteinizing hormone level	0.07	> 0.20	KIAA1324 (3.8)	MYLIP (2.9)	MOSC1 (2.8)	PMFBP1 (2.1)	TM6SF2 (2.0)	PBX4 (1.8)	C12orf51 (1.8)	GCNT4 (1.7)	GPAM (1.7)	KANK2 (1.7)
MP:0001785	edema	0.07	> 0.20	BCAM (4.0)	NYNRIN (3.7)	PVRL2 (3.3)	HLX (2.8)	SLC44A2 (2.1)	SH2B3 (2.0)	KANK2 (1.9)	ATXN7L2 (1.8)	C11orf9 (1.7)	CETP (1.7)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR78_OR_9_ACTIVATION	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR78_OR_9_ACTIVATION	0.07	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.4)	BCL3 (3.1)	HLX (2.5)	PVR (2.3)	CARM1 (2.1)	GMIP (1.8)	OASL (1.7)	BUD13 (1.7)
MP:0005097	polychromatophilia	0.07	> 0.20	RHCE (11.3)	RHD (11.1)	GMPR (4.6)	KANK2 (2.8)	FRK (2.0)	PBX4 (1.8)	TMEM50A (1.7)	C12orf51 (1.6)	DHODH (1.5)	ENSG00000226645 (1.5)
GO:0016127	sterol catabolic process	0.07	> 0.20	ENSG00000254235 (7.4)	LPA (5.5)	NKPD1 (2.5)	ADAM1 (2.1)	SLC22A1 (2.0)	APOC4 (1.9)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)
GO:0006707	cholesterol catabolic process	0.07	> 0.20	ENSG00000254235 (7.4)	LPA (5.5)	NKPD1 (2.5)	ADAM1 (2.1)	SLC22A1 (2.0)	APOC4 (1.9)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)
GO:0043499	eukaryotic cell surface binding	0.07	> 0.20	APOB (5.9)	HP (5.9)	ANGPTL3 (4.6)	PLG (4.4)	APOA5 (4.0)	APOC4 (3.5)	APOC1 (2.8)	MOSC1 (2.6)	ITGB3 (2.5)	PVR (2.5)
MP:0008024	absent lymph nodes	0.07	> 0.20	BCL3 (4.9)	CILP2 (3.9)	GMIP (3.4)	CETP (3.3)	NT5DC1 (2.9)	SH2B3 (2.1)	RELB (1.9)	GEMIN7 (1.9)	CLPTM1 (1.9)	CYB561D1 (1.8)
GO:0030532	small nuclear ribonucleoprotein complex	0.07	> 0.20	DHX38 (3.7)	C12orf47 (2.4)	SUGP1 (2.3)	DDX56 (2.2)	TOMM40 (2.2)	ATP13A1 (2.1)	POC5 (2.1)	FEN1 (1.9)	BUD13 (1.9)	USP1 (1.9)
ENSG00000175166	PSMD2 PPI subnetwork	0.07	> 0.20	PSMA5 (5.2)	NAA25 (2.8)	TOMM40 (2.6)	SARS (2.6)	DDX56 (2.4)	NT5DC1 (2.4)	ZNF259 (1.9)	TRAFD1 (1.9)	SMARCA4 (1.8)	BRAP (1.7)
ENSG00000166716	ZNF592 PPI subnetwork	0.07	> 0.20	C19orf52 (2.3)	QTRT1 (2.2)	PARP10 (2.1)	BRAP (2.0)	DHX38 (2.0)	AMIGO1 (1.9)	SUGP1 (1.9)	OASL (1.9)	YIPF2 (1.9)	GRINA (1.8)
MP:0002781	increased circulating testosterone level	0.07	> 0.20	BCAM (2.9)	KIAA1324 (2.6)	GPAM (2.2)	PVRL2 (2.1)	ST3GAL4 (1.9)	FADS2 (1.6)	GOT2P1 (1.6)	LPIN3 (1.5)	TXNL4B (1.5)	ABCG5 (1.4)
ENSG00000108256	NUFIP2 PPI subnetwork	0.07	> 0.20	BRAP (3.1)	ATXN2 (3.0)	MAPKAPK5 (3.0)	SMARCA4 (2.9)	TRAFD1 (2.8)	C12orf51 (2.6)	C12orf43 (2.4)	ANKRD31 (2.2)	SUGP1 (2.1)	CLPTM1 (2.1)
MP:0011090	partial perinatal lethality	0.07	> 0.20	HAVCR1 (2.9)	BCAM (2.8)	TRIB1 (2.5)	PVR (2.3)	PVRL2 (2.3)	MYLIP (2.1)	HLX (1.9)	ENSG00000238078 (1.9)	KANK2 (1.9)	USP24 (1.8)
MP:0004933	abnormal epididymis epithelium morphology	0.07	> 0.20	ST3GAL4 (3.0)	YIPF2 (2.4)	FRK (2.1)	ITGB3 (2.1)	TMED4 (2.0)	ABO (2.0)	HMGCR (2.0)	CYP7A1 (1.9)	FADS1 (1.6)	APOC1 (1.5)
ENSG00000114354	TFG PPI subnetwork	0.07	> 0.20	PARP10 (2.5)	BLOC1S3 (2.4)	OASL (2.3)	LDLR (2.1)	KANK2 (2.1)	LPAR2 (1.9)	FADS1 (1.9)	FADS2 (1.9)	TSSK6 (1.9)	GEMIN7 (1.8)
ENSG00000138468	SENP7 PPI subnetwork	0.07	> 0.20	PSRC1 (3.2)	PARP10 (2.8)	USP24 (2.8)	MAU2 (2.7)	DHX38 (2.4)	GMIP (2.4)	BCL3 (2.2)	MARK4 (2.1)	ZNF180 (1.9)	SMARCA4 (1.9)
MP:0009764	decreased sensitivity to induced morbidity/mortality	0.07	> 0.20	OASL (3.0)	SH2B3 (2.9)	PVR (2.2)	ST3GAL4 (2.2)	PARP10 (2.1)	APOE (1.9)	HLX (1.9)	ITGB3 (1.9)	ALDH2 (1.8)	BCL3 (1.8)
ENSG00000173575	CHD2 PPI subnetwork	0.07	> 0.20	C19orf52 (2.8)	BRAP (2.4)	SUGP1 (2.2)	DHX38 (2.1)	SMARCA4 (2.1)	ILF3 (2.1)	BUD13 (1.9)	ZNF180 (1.9)	PARP10 (1.8)	ATP13A1 (1.7)
GO:0019840	isoprenoid binding	0.07	> 0.20	TM6SF2 (3.9)	ABCG5 (3.8)	APOB (3.6)	C11orf9 (2.8)	APOC4 (2.7)	NYNRIN (2.6)	APOA5 (2.5)	ABCG8 (2.3)	CYP7A1 (2.3)	LPAR2 (2.2)
GO:0001085	RNA polymerase II transcription factor binding	0.07	> 0.20	RHD (5.3)	RHCE (3.9)	FADS2 (3.3)	ITGB3 (3.2)	GMPR (3.0)	TMEM57 (2.5)	FADS1 (2.0)	C1orf63 (1.9)	UBXN2B (1.8)	SH2B3 (1.8)
ENSG00000124228	DDX27 PPI subnetwork	0.07	> 0.20	NAA25 (4.8)	ZNF259 (4.6)	TOMM40 (4.2)	DDX56 (4.0)	QTRT1 (4.0)	DHODH (3.3)	DHX38 (3.0)	ATP13A1 (2.7)	C12orf43 (2.7)	USP24 (2.1)
MP:0002135	abnormal kidney morphology	0.07	> 0.20	BCAM (3.1)	PLEKHH2 (3.1)	NYNRIN (3.1)	TMEM116 (2.8)	KANK2 (2.4)	PVRL2 (2.4)	ENSG00000228044 (1.9)	AP1M2 (1.8)	PVR (1.6)	HLX (1.5)
MP:0001919	abnormal reproductive system physiology	0.07	> 0.20	TRIB1 (2.7)	FRK (2.5)	ZNF101 (2.2)	LDLR (2.1)	FADS1 (2.0)	ENSG00000228044 (2.0)	CELSR2 (2.0)	ANKRD31 (1.9)	HMGCR (1.9)	PLEKHH2 (1.7)
ENSG00000135213	POM121C PPI subnetwork	0.07	> 0.20	POC5 (3.8)	NAA25 (2.7)	USP1 (2.6)	POLK (2.4)	BUD13 (2.3)	FEN1 (2.2)	DOCK7 (2.2)	KIAA1324 (2.0)	ILF3 (1.9)	DDX56 (1.8)
GO:0031625	ubiquitin protein ligase binding	0.07	> 0.20	MYLIP (3.7)	BRAP (3.6)	GRINA (2.9)	TMEM57 (2.6)	ALDH2 (2.2)	GATAD2A (1.9)	MAFB (1.8)	TRIB1 (1.8)	SH2B3 (1.7)	POC5 (1.5)
ENSG00000049323	LTBP1 PPI subnetwork	0.07	> 0.20	GRINA (2.7)	ITGB3 (2.7)	CEACAM19 (2.1)	APOE (2.1)	SH2B3 (1.9)	APOB (1.9)	CARM1 (1.8)	KANK2 (1.7)	LPA (1.7)	MAFB (1.6)
MP:0006396	decreased long bone epiphyseal plate size	0.07	> 0.20	HNF1A (2.8)	CILP2 (2.0)	PLEKHH2 (1.8)	KIAA1324 (1.7)	PVRL2 (1.7)	CELSR2 (1.7)	APOE (1.6)	MYLIP (1.6)	SLC22A1 (1.5)	MAFB (1.5)
ENSG00000198478	SH3BGRL2 PPI subnetwork	0.07	> 0.20	ST3GAL4 (3.3)	DNM2 (2.7)	AP1M2 (2.5)	KIAA1324 (2.5)	HNF1A (2.4)	SH2B3 (1.9)	CBLC (1.8)	NYNRIN (1.7)	PLEC (1.6)	DOCK7 (1.6)
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	0.07	> 0.20	SARS (6.6)	ALDH2 (3.0)	HAPLN4 (2.9)	GPAM (2.5)	TM6SF2 (2.1)	ABCG5 (1.9)	C19orf52 (1.8)	ABCG8 (1.8)	ENSG00000254235 (1.6)	APOA5 (1.5)
ENSG00000121966	CXCR4 PPI subnetwork	0.07	> 0.20	BCL3 (4.5)	PARP10 (3.5)	TRAFD1 (3.4)	GMIP (3.1)	HLX (2.6)	CETP (2.3)	HP (2.2)	GRINA (2.0)	OASL (1.8)	RELB (1.8)
GO:0042089	cytokine biosynthetic process	0.07	> 0.20	ENSG00000228044 (2.5)	ENSG00000226645 (2.2)	TIMD4 (1.9)	ENSG00000235545 (1.8)	GMIP (1.7)	CYB561D1 (1.6)	PARP10 (1.6)	BCL3 (1.6)	HLX (1.6)	OASL (1.5)
ENSG00000198835	GJC2 PPI subnetwork	0.07	> 0.20	APOB (5.9)	APOE (4.5)	PLG (4.3)	APOA5 (4.1)	ANGPTL3 (4.0)	APOC1 (3.8)	APOC4 (3.5)	PCSK9 (3.4)	HP (3.2)	NPC1L1 (2.5)
ENSG00000113360	DROSHA PPI subnetwork	0.07	> 0.20	PARP10 (3.1)	MAU2 (3.0)	GMIP (2.7)	USP24 (2.6)	ZNF180 (2.3)	MARK4 (2.1)	POLK (2.0)	ATXN2 (2.0)	BCL3 (2.0)	SMARCA4 (1.9)
ENSG00000198104	OR2T6 PPI subnetwork	0.07	> 0.20	APOB (5.8)	APOE (4.4)	PLG (4.3)	APOA5 (4.1)	ANGPTL3 (3.9)	APOC1 (3.7)	APOC4 (3.5)	PCSK9 (3.4)	HP (3.1)	NPC1L1 (2.6)
GO:0006909	phagocytosis	0.07	> 0.20	HP (3.0)	MAFB (2.9)	TIMD4 (2.6)	ALDH2 (2.4)	CILP2 (2.2)	DHODH (2.2)	LPA (2.1)	HAVCR1 (2.0)	ANKRD31 (1.8)	C17orf57 (1.6)
ENSG00000111605	CPSF6 PPI subnetwork	0.07	> 0.20	BUD13 (3.3)	PCSK9 (2.7)	TRAPPC6A (2.4)	ACAD10 (2.2)	HNF1A (2.1)	OGDH (2.1)	ILF3 (2.1)	NT5DC1 (1.9)	ABO (1.8)	CARM1 (1.7)
REACTOME_INTERLEUKIN:7_SIGNALING	REACTOME_INTERLEUKIN:7_SIGNALING	0.07	> 0.20	BCL3 (2.6)	DNAH11 (2.3)	DNM2 (2.3)	USP24 (2.2)	GRINA (2.0)	CETP (2.0)	PARP10 (1.9)	C12orf47 (1.8)	COL4A3BP (1.7)	HAVCR1 (1.6)
GO:0004708	MAP kinase kinase activity	0.07	> 0.20	MOSC1 (2.5)	CARM1 (2.5)	CYB561D1 (2.4)	GEMIN7 (2.4)	SH2B3 (2.3)	CEACAM19 (2.3)	HAPLN4 (2.0)	ERP29 (1.9)	C19orf52 (1.9)	ZNF180 (1.8)
ENSG00000079459	FDFT1 PPI subnetwork	0.07	> 0.20	HMGCR (11.3)	LDLR (10.2)	FADS1 (7.8)	FADS2 (5.8)	PCSK9 (5.5)	GEMIN7 (2.7)	TMEM50A (2.4)	BLOC1S3 (2.4)	CILP2 (2.3)	GPAM (2.0)
ENSG00000040199	PHLPP2 PPI subnetwork	0.07	> 0.20	QTRT1 (3.5)	TRIB1 (3.2)	ATP13A1 (2.6)	TOMM40 (2.6)	SARS (2.4)	DHX38 (2.2)	UBXN2B (2.0)	ZNF259 (1.7)	LPIN3 (1.7)	DDX56 (1.7)
ENSG00000198788	MUC2 PPI subnetwork	0.07	> 0.20	AP1M2 (3.0)	HNF1A (2.6)	KIAA1324 (2.4)	DNM2 (2.4)	ST3GAL4 (2.1)	CBLC (1.8)	FRK (1.8)	ENSG00000235545 (1.6)	CETP (1.6)	ITGB3 (1.4)
ENSG00000164587	RPS14 PPI subnetwork	0.07	> 0.20	DDX56 (2.8)	NAA25 (2.6)	ZNF259 (2.5)	QTRT1 (2.5)	SUGP1 (2.3)	ILF3 (2.3)	DHX38 (2.1)	C12orf43 (2.0)	PTPN11 (1.9)	SARS (1.8)
ENSG00000161638	ITGA5 PPI subnetwork	0.07	> 0.20	ITGB3 (4.7)	APOE (4.4)	BCAM (3.2)	SLC22A1 (2.6)	PLEC (2.4)	PLG (2.3)	APOC1 (2.3)	CLPTM1 (2.3)	HP (2.3)	APOC4 (2.0)
ENSG00000004948	CALCR PPI subnetwork	0.07	> 0.20	RPH3A (2.4)	PLEC (2.1)	LPA (2.1)	APOC4 (2.0)	ABCG5 (2.0)	PVRL2 (1.9)	AMIGO1 (1.9)	ZNF180 (1.8)	PSRC1 (1.8)	KANK2 (1.6)
GO:0015923	mannosidase activity	0.07	> 0.20	ERP29 (3.4)	TRAPPC6A (2.8)	ATP13A1 (2.7)	TMEM50A (2.1)	YIPF2 (2.1)	TMED4 (1.9)	TMEM57 (1.8)	ENSG00000235545 (1.5)	C17orf57 (1.5)	TRIB1 (1.5)
GO:0072662	protein localization to peroxisome	0.07	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
GO:0072663	establishment of protein localization to peroxisome	0.07	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
GO:0006625	protein targeting to peroxisome	0.07	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
MP:0002020	increased tumor incidence	0.07	> 0.20	FEN1 (3.3)	TMEM57 (2.2)	USP1 (2.0)	C17orf57 (2.0)	DNM2 (1.9)	C12orf51 (1.8)	RELB (1.8)	BCL3 (1.8)	KANK2 (1.8)	PSRC1 (1.7)
MP:0008255	decreased megakaryocyte cell number	0.07	> 0.20	BCL3 (3.8)	ITGB3 (2.8)	CETP (2.4)	SLC44A2 (2.0)	ABCG8 (1.8)	CEACAM19 (1.8)	MARK4 (1.8)	ABCG5 (1.6)	CYB561D1 (1.5)	PCSK9 (1.4)
GO:0010742	macrophage derived foam cell differentiation	0.07	> 0.20	TIMD4 (4.2)	MOSC1 (2.7)	APOE (2.6)	ENSG00000228044 (2.5)	APOC1 (2.3)	GEMIN7 (2.0)	GOT2P1 (2.0)	ST3GAL4 (1.8)	GPAM (1.7)	ITGB3 (1.7)
GO:0090077	foam cell differentiation	0.07	> 0.20	TIMD4 (4.2)	MOSC1 (2.7)	APOE (2.6)	ENSG00000228044 (2.5)	APOC1 (2.3)	GEMIN7 (2.0)	GOT2P1 (2.0)	ST3GAL4 (1.8)	GPAM (1.7)	ITGB3 (1.7)
ENSG00000196954	CASP4 PPI subnetwork	0.07	> 0.20	TRAFD1 (2.5)	DOCK7 (2.5)	FRK (2.4)	ENSG00000228044 (2.1)	C17orf57 (1.8)	TMEM50A (1.7)	HMGCR (1.7)	ATP13A1 (1.6)	BLOC1S3 (1.6)	POLK (1.5)
ENSG00000128829	EIF2AK4 PPI subnetwork	0.07	> 0.20	DDX56 (4.4)	QTRT1 (4.1)	NAA25 (3.8)	ZNF259 (3.6)	C12orf43 (3.0)	ILF3 (2.9)	PLCG1 (2.7)	DHX38 (2.6)	TOP1 (2.3)	TOMM40 (2.2)
ENSG00000089234	BRAP PPI subnetwork	0.07	> 0.20	ZNF259 (3.7)	TOMM40 (3.1)	TOP1 (2.9)	NAA25 (2.8)	DDX56 (2.3)	DHX38 (2.2)	USP24 (2.2)	SMARCA4 (2.1)	C12orf51 (2.0)	RHCE (1.9)
ENSG00000163530	DPPA2 PPI subnetwork	0.07	> 0.20	GRINA (2.7)	ATXN7L2 (2.3)	ENSG00000254235 (2.3)	ZNF180 (2.2)	CLPTM1 (2.0)	TMED4 (2.0)	LDLR (1.9)	ABO (1.9)	C12orf43 (1.8)	HAPLN4 (1.7)
MP:0005201	abnormal retinal pigment epithelium morphology	0.07	> 0.20	DOCK7 (2.9)	ST3GAL4 (2.6)	PMFBP1 (2.3)	MAFB (2.2)	FADS1 (1.9)	GMPR (1.7)	GPAM (1.6)	HMGCR (1.5)	DYNC2LI1 (1.5)	APOE (1.3)
ENSG00000105640	RPL18A PPI subnetwork	0.07	> 0.20	ZNF259 (3.8)	DDX56 (3.6)	NAA25 (3.3)	QTRT1 (3.0)	TOMM40 (2.7)	DHX38 (2.5)	C12orf43 (2.5)	SUGP1 (2.5)	DHODH (2.4)	ATP13A1 (2.1)
MP:0004779	abnormal production of surfactant	0.07	> 0.20	TMEM116 (3.3)	ERP29 (3.0)	APOA5 (2.6)	BCAM (2.4)	HLX (2.2)	APOC1 (1.9)	KIAA1324 (1.9)	SLC22A1 (1.8)	SORT1 (1.8)	DNAH11 (1.6)
ENSG00000163811	WDR43 PPI subnetwork	0.07	> 0.20	ZNF259 (4.3)	QTRT1 (4.2)	DDX56 (4.0)	TOMM40 (3.8)	NAA25 (3.3)	DHODH (3.3)	C12orf43 (3.1)	PVR (2.2)	DHX38 (2.1)	SARS (2.0)
ENSG00000149923	PPP4C PPI subnetwork	0.07	> 0.20	RELB (3.0)	CLPTM1 (2.2)	SARS (2.1)	PSMA5 (2.0)	SMARCA4 (1.9)	DHX38 (1.8)	ILF3 (1.7)	USP24 (1.7)	NAA25 (1.7)	NT5DC1 (1.5)
GO:0060338	regulation of type I interferon-mediated signaling pathway	0.07	> 0.20	OASL (3.1)	GOT2P1 (2.9)	TRAFD1 (2.8)	ZNF101 (2.7)	PARP10 (2.6)	ENSG00000235545 (2.2)	ATP13A1 (2.1)	MAU2 (1.9)	C19orf52 (1.9)	CYP7A1 (1.6)
ENSG00000171094	ALK PPI subnetwork	0.07	> 0.20	PLEKHH2 (3.8)	PARP10 (2.9)	COL4A3BP (2.8)	OASL (2.8)	LPAR2 (2.6)	TRIB1 (2.3)	ABCG5 (2.2)	C12orf43 (2.1)	BCL3 (2.1)	PSRC1 (2.1)
ENSG00000114270	COL7A1 PPI subnetwork	0.07	> 0.20	CBLC (4.3)	BCAM (4.3)	AP1M2 (3.0)	CELSR2 (2.3)	PLEC (2.3)	C17orf57 (2.2)	HAVCR1 (2.2)	PLEKHH2 (2.0)	FRK (1.9)	ITGB3 (1.9)
GO:0004519	endonuclease activity	0.07	> 0.20	ZNF180 (2.6)	DHODH (2.6)	FEN1 (2.1)	C12orf43 (2.0)	POC5 (1.8)	BUD13 (1.6)	NT5DC1 (1.6)	CEACAM19 (1.5)	DDX56 (1.5)	ZHX3 (1.5)
ENSG00000163029	SMC6 PPI subnetwork	0.07	> 0.20	PARP10 (3.7)	PLEKHH2 (2.9)	OASL (2.6)	LPAR2 (2.4)	ABCG8 (2.3)	DNM2 (2.0)	TRAFD1 (1.8)	POLK (1.8)	TMEM116 (1.8)	ZNF101 (1.8)
GO:0043414	macromolecule methylation	0.07	> 0.20	C19orf52 (2.8)	ENSG00000238078 (2.7)	QTRT1 (2.5)	ZNF180 (2.4)	MAPKAPK5 (2.3)	C12orf51 (2.1)	DNAH11 (2.0)	ILF3 (2.0)	DHODH (1.8)	BUD13 (1.8)
ENSG00000080608	KIAA0020 PPI subnetwork	0.07	> 0.20	NAA25 (4.8)	ZNF259 (4.3)	DDX56 (4.0)	TOMM40 (3.8)	QTRT1 (3.1)	ATP13A1 (2.8)	DHODH (2.5)	USP24 (2.4)	DHX38 (2.4)	SUGP1 (2.2)
ENSG00000198062	POTEH PPI subnetwork	0.07	> 0.20	ACAD10 (4.0)	NT5DC1 (3.0)	HNF1A (2.4)	TRAPPC6A (1.7)	C1orf63 (1.7)	PCSK9 (1.7)	CETP (1.6)	GMPR (1.5)	SORT1 (1.5)	TIMD4 (1.5)
ENSG00000160469	BRSK1 PPI subnetwork	0.07	> 0.20	DDX56 (4.6)	QTRT1 (4.0)	NAA25 (3.9)	ZNF259 (3.7)	DHODH (3.6)	C12orf43 (3.1)	TOMM40 (2.6)	HMGCR (2.4)	DHX38 (2.4)	SUGP1 (2.3)
GO:0016779	nucleotidyltransferase activity	0.07	> 0.20	OASL (3.7)	DDX56 (3.4)	ZNF259 (3.1)	PARP10 (2.8)	DHODH (2.7)	GEMIN7 (2.4)	MAPKAPK5 (2.2)	C12orf43 (2.1)	USP1 (2.1)	FEN1 (2.1)
ENSG00000138685	FGF2 PPI subnetwork	0.07	> 0.20	HAVCR1 (3.0)	PLEKHH2 (2.8)	APOE (2.2)	CETP (2.1)	PPP1R37 (1.9)	ENSG00000238078 (1.9)	MAFB (1.8)	TIMD4 (1.8)	C17orf57 (1.8)	BCAM (1.7)
ENSG00000198327	HIST1H4F PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000158406	HIST1H4H PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000183941	HIST2H4A PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000196176	HIST1H4A PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197061	HIST1H4C PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000124529	HIST1H4B PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197238	HIST1H4J PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197837	HIST4H4 PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198558	HIST1H4L PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000188987	HIST1H4D PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197914	HIST1H4K PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000182217	HIST2H4B PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198518	HIST1H4E PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198339	HIST1H4I PPI subnetwork	0.07	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
MP:0011102	partial embryonic lethality	0.07	> 0.20	FADS2 (3.4)	FADS1 (3.3)	LDLR (3.2)	ENSG00000226648 (2.9)	PCSK9 (2.9)	HMGCR (2.8)	NYNRIN (2.5)	PLCG1 (2.3)	COL4A3BP (2.1)	GMPR (1.9)
ENSG00000068438	FTSJ1 PPI subnetwork	0.07	> 0.20	PSMA5 (3.9)	TOMM40 (3.4)	QTRT1 (2.4)	DDX56 (2.2)	SARS (2.0)	ZNF259 (1.8)	ERP29 (1.7)	GEMIN7 (1.7)	DHODH (1.6)	TMEM50A (1.6)
GO:0071260	cellular response to mechanical stimulus	0.07	> 0.20	GCNT4 (2.6)	ANKRD31 (2.6)	TXNL4B (2.2)	ST3GAL4 (2.0)	UBXN2B (2.0)	TRAFD1 (2.0)	C12orf43 (1.8)	SH2B3 (1.8)	FRK (1.7)	PARP10 (1.7)
ENSG00000089048	ESF1 PPI subnetwork	0.07	> 0.20	DDX56 (4.2)	ZNF259 (4.1)	NAA25 (3.8)	TOMM40 (3.7)	QTRT1 (3.3)	DHODH (2.5)	SUGP1 (2.4)	DHX38 (2.0)	TOP1 (2.0)	GATAD2A (1.9)
GO:0042612	MHC class I protein complex	0.07	> 0.20	PARP10 (3.2)	PVR (2.7)	POLK (2.0)	TMEM50A (1.9)	APOA5 (1.9)	PVRL2 (1.8)	SLC22A1 (1.7)	APOE (1.7)	SH2B3 (1.5)	ANKRD31 (1.4)
MP:0003355	decreased ovulation rate	0.07	> 0.20	MAFB (2.7)	TRIB1 (2.7)	BCL3 (2.6)	MOSC1 (2.1)	CELSR2 (1.8)	HP (1.8)	HLX (1.8)	C11orf9 (1.8)	BCAM (1.7)	C17orf57 (1.6)
ENSG00000129354	AP1M2 PPI subnetwork	0.07	> 0.20	CLPTM1 (3.6)	SH2B3 (3.0)	GATAD2A (2.6)	FADS2 (2.5)	MAU2 (2.3)	FADS1 (2.2)	SMARCA4 (2.2)	GRINA (2.0)	DNM2 (1.9)	ZNF101 (1.9)
ENSG00000003402	CFLAR PPI subnetwork	0.07	> 0.20	RELB (5.4)	PVR (3.3)	PARP10 (3.0)	TRAFD1 (2.7)	BLOC1S3 (2.6)	BCL3 (2.5)	ST3GAL4 (2.3)	ZNF180 (2.3)	FRK (2.3)	BUD13 (2.2)
ENSG00000100926	TM9SF1 PPI subnetwork	0.07	> 0.20	ACAD10 (3.9)	NT5DC1 (3.2)	HNF1A (2.3)	GMPR (1.8)	TRAPPC6A (1.7)	C1orf63 (1.7)	PCSK9 (1.6)	CETP (1.6)	TMED4 (1.5)	SORT1 (1.5)
ENSG00000100201	DDX17 PPI subnetwork	0.07	> 0.20	PPP1R37 (2.7)	C1orf63 (2.6)	UBXN2B (2.5)	NYNRIN (2.4)	ILF3 (2.4)	MAU2 (2.1)	SMARCA4 (1.8)	NCAN (1.8)	TOP1 (1.8)	CLPTM1 (1.7)
ENSG00000105329	TGFB1 PPI subnetwork	0.07	> 0.20	CILP2 (5.1)	KANK2 (2.5)	ITGB3 (2.3)	BCAM (1.8)	MAFB (1.8)	SLC22A1 (1.8)	LPA (1.7)	SLC44A2 (1.7)	PVR (1.7)	ALDH2 (1.5)
GO:0004091	carboxylesterase activity	0.07	> 0.20	TM6SF2 (4.6)	SLC22A1 (4.3)	CYP7A1 (3.7)	ABCG8 (3.5)	ABCG5 (3.5)	ANGPTL3 (3.0)	APOC4 (2.1)	APOA5 (2.1)	AMIGO1 (2.1)	PMFBP1 (2.0)
ENSG00000065618	COL17A1 PPI subnetwork	0.07	> 0.20	PLEC (4.3)	CBLC (4.3)	BCAM (4.2)	PVRL2 (3.1)	AP1M2 (2.9)	ST3GAL4 (1.9)	CELSR2 (1.9)	DOCK7 (1.7)	ALDH2 (1.4)	PVR (1.4)
MP:0008057	abnormal DNA replication	0.07	> 0.20	POLK (2.4)	MYLIP (2.4)	USP1 (2.3)	PPP1R37 (2.1)	BCL3 (2.0)	NT5DC1 (1.9)	AMIGO1 (1.7)	PMFBP1 (1.7)	KANK2 (1.5)	SH2B3 (1.4)
ENSG00000175826	CTDNEP1 PPI subnetwork	0.07	> 0.20	BUD13 (2.6)	GEMIN7 (2.6)	USP24 (2.6)	CARM1 (2.5)	MAU2 (2.2)	NAA25 (2.1)	MAPKAPK5 (2.1)	C12orf43 (2.0)	TRAFD1 (1.9)	ZNF259 (1.9)
KEGG_OTHER_GLYCAN_DEGRADATION	KEGG_OTHER_GLYCAN_DEGRADATION	0.07	> 0.20	ERP29 (4.7)	TRAPPC6A (2.9)	NT5DC1 (2.8)	ATP13A1 (2.8)	TMED4 (2.4)	SORT1 (1.9)	HNF1A (1.7)	COL4A3BP (1.7)	PCSK9 (1.7)	CEACAM19 (1.7)
GO:0051186	cofactor metabolic process	0.07	> 0.20	ACAD10 (4.2)	NT5DC1 (3.4)	TRAPPC6A (3.3)	DHODH (2.8)	OGDH (2.6)	GPAM (2.6)	PCSK9 (2.5)	FADS1 (2.5)	FADS2 (2.5)	MOSC1 (2.4)
ENSG00000214485	ENSG00000214485 PPI subnetwork	0.07	> 0.20	DDX56 (4.7)	NAA25 (4.7)	ZNF259 (4.6)	TOMM40 (3.6)	QTRT1 (3.5)	DHODH (3.2)	DHX38 (2.8)	ATP13A1 (2.6)	ILF3 (2.6)	SUGP1 (2.5)
ENSG00000196914	ARHGEF12 PPI subnetwork	0.07	> 0.20	CELSR2 (3.7)	KANK2 (3.4)	ENSG00000238078 (3.4)	LPIN3 (3.3)	DOCK7 (2.6)	PTPN11 (2.4)	PLEC (2.4)	ENSG00000235545 (2.1)	HLX (2.0)	AP1M2 (1.9)
GO:0070001	aspartic-type peptidase activity	0.07	> 0.20	CLPTM1 (4.1)	GRINA (2.8)	MAU2 (2.8)	TMED4 (2.8)	TMEM50A (2.6)	TMEM57 (2.3)	C17orf57 (2.0)	GCNT4 (2.0)	PVRL2 (1.9)	ATP13A1 (1.9)
GO:0004190	aspartic-type endopeptidase activity	0.07	> 0.20	CLPTM1 (4.1)	GRINA (2.8)	MAU2 (2.8)	TMED4 (2.8)	TMEM50A (2.6)	TMEM57 (2.3)	C17orf57 (2.0)	GCNT4 (2.0)	PVRL2 (1.9)	ATP13A1 (1.9)
GO:0006536	glutamate metabolic process	0.07	> 0.20	ANGPTL3 (3.2)	ABCG8 (3.1)	TM6SF2 (3.0)	SLC22A1 (3.0)	LPA (3.0)	DNAH11 (2.8)	ABO (2.6)	PMFBP1 (2.4)	APOC4 (2.4)	PLG (2.2)
ENSG00000213585	VDAC1 PPI subnetwork	0.07	> 0.20	OGDH (3.5)	GMPR (3.0)	ENSG00000226648 (2.4)	ENSG00000238078 (2.1)	NT5DC1 (2.1)	C11orf9 (2.1)	FADS2 (2.1)	SYPL2 (2.1)	PLCG1 (2.0)	C1orf63 (2.0)
MP:0008563	decreased interferon-alpha secretion	0.07	> 0.20	OASL (12.6)	PARP10 (8.5)	TRAFD1 (5.0)	BCL3 (3.0)	RELB (2.0)	SH2B3 (1.5)	ATP13A1 (1.4)	CYB561D1 (1.4)	RHCE (1.3)	C1orf63 (1.2)
MP:0006270	abnormal mammary gland growth during lactation	0.07	> 0.20	LPA (2.8)	SLC22A1 (2.4)	ALDH2 (1.7)	APOC4 (1.7)	APOA5 (1.6)	GRINA (1.5)	NPC1L1 (1.5)	ENSG00000226648 (1.4)	CEACAM19 (1.3)	RELB (1.2)
GO:0003018	vascular process in circulatory system	0.07	> 0.20	C12orf47 (2.2)	FRK (2.1)	CETP (1.8)	ABO (1.7)	HAPLN4 (1.7)	NPC1L1 (1.6)	LPIN3 (1.6)	HLX (1.5)	ENSG00000228044 (1.5)	ITGB3 (1.3)
MP:0010831	partial lethality	0.07	> 0.20	HP (3.5)	MOSC1 (2.4)	SORT1 (2.3)	TXNL4B (2.2)	CBLC (2.1)	OGDH (2.0)	APOB (1.9)	TMEM116 (1.8)	LPAR2 (1.8)	GOT2P1 (1.6)
MP:0000689	abnormal spleen morphology	0.07	> 0.20	RHD (3.5)	RHCE (3.2)	RELB (3.1)	MAFB (2.9)	BCL3 (2.9)	CETP (2.7)	GMIP (2.5)	ZNF101 (2.2)	TIMD4 (2.1)	SLC44A2 (1.9)
ENSG00000073282	TP63 PPI subnetwork	0.07	> 0.20	BCAM (4.9)	C11orf9 (4.4)	PVRL2 (3.3)	MARK4 (3.1)	ENSG00000226645 (3.0)	CELSR2 (2.5)	NYNRIN (2.4)	TOP1 (2.3)	HP (1.9)	C1orf63 (1.8)
GO:0046461	neutral lipid catabolic process	0.07	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
GO:0046464	acylglycerol catabolic process	0.07	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
GO:0044269	glycerol ether catabolic process	0.07	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
ENSG00000100320	RBFOX2 PPI subnetwork	0.07	> 0.20	NYNRIN (3.1)	BCAM (2.9)	MYLIP (2.2)	ABO (2.0)	PLEKHH2 (1.7)	C12orf47 (1.6)	KANK2 (1.6)	TRAFD1 (1.6)	MAPKAPK5 (1.6)	KIAA1324 (1.5)
ENSG00000096171	VARS PPI subnetwork	0.07	> 0.20	SUGP1 (3.3)	SARS (3.2)	SMARCA4 (2.4)	ZNF180 (2.0)	ZNF101 (2.0)	NAA25 (2.0)	RHCE (1.9)	RHD (1.9)	CLPTM1 (1.9)	GPAM (1.8)
ENSG00000204394	VARS PPI subnetwork	0.07	> 0.20	SUGP1 (3.3)	SARS (3.2)	SMARCA4 (2.4)	ZNF180 (2.0)	ZNF101 (2.0)	NAA25 (2.0)	RHCE (1.9)	RHD (1.9)	CLPTM1 (1.9)	GPAM (1.8)
ENSG00000188157	AGRN PPI subnetwork	0.07	> 0.20	RHD (2.6)	NKPD1 (2.4)	PPP1R37 (2.3)	AMIGO1 (2.2)	ITGB3 (2.1)	ABO (2.0)	MOSC1 (1.9)	NCAN (1.9)	ANKRD31 (1.9)	ENSG00000254235 (1.9)
MP:0011204	abnormal visceral yolk sac blood island morphology	0.07	> 0.20	HLX (3.0)	ENSG00000228044 (2.1)	ANKRD31 (1.7)	NYNRIN (1.7)	ACAD10 (1.6)	OGDH (1.6)	ZNF180 (1.5)	GEMIN7 (1.5)	NT5DC1 (1.4)	BCAM (1.3)
ENSG00000184979	USP18 PPI subnetwork	0.07	> 0.20	OASL (3.2)	TIMD4 (2.8)	PLEKHH2 (2.1)	CETP (2.0)	C1orf63 (1.7)	TMEM57 (1.5)	DNAH11 (1.5)	SYPL2 (1.4)	BCAM (1.4)	ENSG00000228044 (1.3)
ENSG00000197858	GPAA1 PPI subnetwork	0.07	> 0.20	ATP13A1 (3.2)	CLPTM1 (3.2)	NT5DC1 (3.0)	ERP29 (2.9)	TMED4 (2.3)	RHCE (2.2)	GRINA (2.2)	CYB561D1 (2.1)	SORT1 (2.0)	RHD (1.9)
ENSG00000111725	PRKAB1 PPI subnetwork	0.07	> 0.20	SARS (4.0)	PSMA5 (3.9)	TOMM40 (3.5)	ILF3 (3.2)	NAA25 (2.9)	SMARCA4 (2.7)	NT5DC1 (2.2)	OGDH (2.1)	DOCK7 (2.0)	FADS1 (2.0)
MP:0001861	lung inflammation	0.07	> 0.20	RELB (3.8)	BCL3 (3.8)	MAFB (3.6)	GMIP (3.4)	PVR (2.1)	TRIB1 (2.1)	SH2B3 (2.1)	GRINA (1.9)	PARP10 (1.8)	TIMD4 (1.7)
ENSG00000126070	EIF2C3 PPI subnetwork	0.07	> 0.20	FADS1 (3.2)	NPC1L1 (3.1)	HMGCR (3.0)	FADS2 (2.8)	GATAD2A (2.1)	LDLR (2.0)	NYNRIN (2.0)	USP24 (1.9)	TM6SF2 (1.8)	GEMIN7 (1.8)
ENSG00000004975	DVL2 PPI subnetwork	0.07	> 0.20	BUD13 (2.5)	CARM1 (2.0)	GRINA (2.0)	LPAR2 (2.0)	MARK4 (1.9)	PVRL2 (1.7)	TXNL4B (1.5)	CELSR2 (1.5)	ATXN7L2 (1.4)	UBXN2B (1.4)
GO:0045939	negative regulation of steroid metabolic process	0.07	> 0.20	TRAPPC6A (2.9)	HMGCR (2.3)	ST3GAL4 (2.3)	TMEM50A (2.1)	LDLR (1.8)	ZNF101 (1.8)	PPP1R37 (1.8)	NPC1L1 (1.7)	FADS1 (1.7)	FADS2 (1.6)
GO:0010894	negative regulation of steroid biosynthetic process	0.07	> 0.20	TRAPPC6A (2.9)	HMGCR (2.3)	ST3GAL4 (2.3)	TMEM50A (2.1)	LDLR (1.8)	ZNF101 (1.8)	PPP1R37 (1.8)	NPC1L1 (1.7)	FADS1 (1.7)	FADS2 (1.6)
MP:0008499	increased IgG1 level	0.07	> 0.20	RELB (4.6)	BCL3 (4.3)	TRIB1 (2.6)	PBX4 (2.2)	GCNT4 (2.0)	GMIP (1.9)	POLK (1.8)	C17orf57 (1.8)	TIMD4 (1.8)	PARP10 (1.7)
MP:0005326	abnormal podocyte morphology	0.07	> 0.20	BCAM (3.6)	PVRL2 (3.6)	ST3GAL4 (3.4)	PLEKHH2 (3.3)	NT5DC1 (2.3)	C11orf9 (2.2)	TMED4 (1.7)	UBXN2B (1.6)	PCSK9 (1.6)	C17orf57 (1.5)
MP:0005554	decreased circulating creatinine level	0.07	> 0.20	TMEM116 (2.8)	PMFBP1 (2.5)	ABCG5 (2.2)	TRIB1 (2.2)	HAVCR1 (2.1)	TM6SF2 (2.0)	PBX4 (1.9)	TIMD4 (1.8)	DYNC2LI1 (1.8)	C19orf52 (1.8)
ENSG00000100056	DGCR14 PPI subnetwork	0.07	> 0.20	BRAP (3.4)	COL4A3BP (2.6)	C12orf51 (2.5)	TMEM57 (2.3)	POC5 (2.1)	DHX38 (2.1)	NAA25 (2.1)	ANKRD31 (1.8)	SH2B3 (1.7)	TMEM116 (1.5)
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	0.07	> 0.20	SLC22A1 (6.6)	CYP7A1 (5.4)	ABCG5 (5.3)	LPA (4.6)	ABCG8 (4.5)	APOC4 (4.4)	ANGPTL3 (4.2)	PLG (3.7)	TM6SF2 (3.7)	APOA5 (3.6)
ENSG00000168264	IRF2BP2 PPI subnetwork	0.07	> 0.20	COL4A3BP (3.3)	POLK (2.8)	ATXN2 (2.6)	C12orf51 (2.5)	MAPKAPK5 (2.4)	FRK (2.3)	POC5 (2.2)	MYLIP (2.1)	MAU2 (1.9)	C1orf63 (1.8)
ENSG00000212695	ENSG00000212695 PPI subnetwork	0.07	> 0.20	ZNF259 (4.3)	DDX56 (4.2)	NAA25 (3.9)	QTRT1 (3.5)	DHODH (3.1)	DHX38 (2.9)	TOMM40 (2.6)	C12orf43 (2.4)	ATP13A1 (2.2)	SUGP1 (2.1)
ENSG00000102030	NAA10 PPI subnetwork	0.07	> 0.20	DDX56 (3.1)	TOMM40 (2.5)	ALDH2 (2.3)	TOP1 (2.2)	GOT2P1 (2.2)	C19orf52 (2.1)	ATP13A1 (2.0)	LPA (1.9)	GATAD2A (1.8)	ILF3 (1.7)
ENSG00000010278	CD9 PPI subnetwork	0.07	> 0.20	PVRL2 (3.1)	PLEC (2.9)	ERP29 (2.5)	PVR (2.4)	ST3GAL4 (2.2)	TIMD4 (2.1)	BCAM (2.0)	APOE (1.9)	CLPTM1 (1.6)	KANK2 (1.6)
GO:0005913	cell-cell adherens junction	0.07	> 0.20	BCAM (4.8)	PVRL2 (3.9)	AP1M2 (3.6)	PLEC (3.3)	CBLC (3.3)	CELSR2 (2.8)	KANK2 (2.5)	LPIN3 (2.1)	DNM2 (1.8)	SORT1 (1.7)
GO:0042436	indole-containing compound catabolic process	0.07	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
GO:0006569	tryptophan catabolic process	0.07	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
GO:0046218	indolalkylamine catabolic process	0.07	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
ENSG00000134365	CFHR4 PPI subnetwork	0.07	> 0.20	TIMD4 (3.0)	OASL (2.9)	CETP (2.7)	PLEKHH2 (1.9)	C1orf63 (1.8)	DNAH11 (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.5)	HNF1A (1.4)	SYPL2 (1.4)
GO:0006525	arginine metabolic process	0.07	> 0.20	ABCG8 (3.7)	ENSG00000226645 (3.6)	C17orf57 (3.6)	TM6SF2 (3.2)	ABCG5 (2.8)	CEACAM19 (2.7)	CYP7A1 (2.7)	ZHX3 (2.6)	PCSK9 (2.2)	HP (2.1)
ENSG00000138326	RPS24 PPI subnetwork	0.07	> 0.20	NAA25 (4.1)	DDX56 (3.6)	ZNF259 (3.6)	QTRT1 (3.2)	TOMM40 (2.7)	C12orf43 (2.7)	SARS (2.5)	TOP1 (2.3)	DHX38 (2.3)	ADAM1 (2.1)
ENSG00000119630	PGF PPI subnetwork	0.07	> 0.20	MYLIP (4.7)	HLX (4.1)	C1orf63 (3.7)	C17orf57 (2.3)	DNAH11 (1.7)	ATXN7L2 (1.7)	SLC44A2 (1.7)	ENSG00000226648 (1.7)	LPA (1.5)	MAFB (1.5)
ENSG00000181856	SLC2A4 PPI subnetwork	0.07	> 0.20	ENSG00000228044 (2.5)	PTPN11 (2.3)	PVR (2.1)	C12orf43 (1.9)	BCAM (1.9)	KANK2 (1.9)	SYPL2 (1.8)	OASL (1.7)	TRAFD1 (1.7)	DNAH11 (1.7)
GO:0090312	positive regulation of protein deacetylation	0.07	> 0.20	TMEM57 (3.7)	FADS2 (3.0)	BLOC1S3 (2.8)	FADS1 (2.3)	ENSG00000228044 (2.2)	POLK (2.2)	PCSK9 (1.9)	PARP10 (1.8)	BRAP (1.8)	POC5 (1.8)
GO:0006568	tryptophan metabolic process	0.07	> 0.20	ENSG00000254235 (5.9)	CYP7A1 (3.3)	SLC22A1 (3.1)	LPA (3.0)	ENSG00000228044 (2.7)	APOA5 (2.3)	CYB561D1 (2.1)	ANGPTL3 (1.6)	ATXN7L2 (1.4)	APOC4 (1.4)
MP:0003356	impaired luteinization	0.08	> 0.20	FADS1 (4.1)	LDLR (2.7)	MOSC1 (2.2)	POLK (2.0)	HMGCR (1.9)	ANKRD31 (1.8)	PARP10 (1.8)	ITGB3 (1.7)	LPIN3 (1.5)	GPAM (1.5)
ENSG00000198517	MAFK PPI subnetwork	0.08	> 0.20	TRIB1 (5.1)	SARS (4.9)	PVR (2.9)	BCL3 (2.8)	RELB (2.6)	POC5 (2.5)	MAPKAPK5 (2.5)	LDLR (2.4)	TXNL4B (1.9)	LPAR2 (1.8)
REACTOME_SULFUR_AMINO_ACID_METABOLISM	REACTOME_SULFUR_AMINO_ACID_METABOLISM	0.08	> 0.20	SLC22A1 (3.5)	APOA5 (3.4)	PLG (3.4)	APOC4 (3.0)	ALDH2 (2.9)	ANGPTL3 (2.5)	HP (2.4)	CYP7A1 (2.4)	SARS (2.3)	C1orf63 (2.2)
ENSG00000067606	PRKCZ PPI subnetwork	0.08	> 0.20	DNM2 (3.0)	UBXN2B (2.7)	TMEM50A (2.3)	PTPN11 (2.3)	AP1M2 (2.2)	MARK4 (2.0)	GMIP (2.0)	CYB561D1 (2.0)	C11orf9 (1.9)	CELSR2 (1.8)
ENSG00000165731	RET PPI subnetwork	0.08	> 0.20	C11orf9 (2.6)	ABO (2.3)	PBX4 (2.2)	GATAD2A (2.1)	TMEM57 (2.1)	SH2B3 (2.0)	PVRL2 (2.0)	HAVCR1 (1.8)	KANK2 (1.7)	DOCK7 (1.7)
ENSG00000164270	HTR4 PPI subnetwork	0.08	> 0.20	MARK4 (3.1)	SMARCA4 (2.9)	TOP1 (2.5)	NT5DC1 (2.0)	ATXN2 (2.0)	DNM2 (1.9)	GATAD2A (1.9)	BUD13 (1.8)	C19orf52 (1.7)	ILF3 (1.6)
GO:0005149	interleukin-1 receptor binding	0.08	> 0.20	OASL (2.9)	NKPD1 (2.8)	PARP10 (2.5)	BCL3 (2.3)	ST3GAL4 (2.0)	GCNT4 (1.9)	ENSG00000254235 (1.7)	GMIP (1.6)	NYNRIN (1.6)	SMARCA4 (1.5)
MP:0003448	altered tumor morphology	0.08	> 0.20	TRIB1 (4.2)	UBXN2B (2.8)	GCNT4 (2.7)	SLC44A2 (2.5)	NYNRIN (2.5)	PBX4 (2.1)	LPIN3 (2.1)	ALDH2 (2.0)	COL4A3BP (2.0)	BCL3 (1.8)
GO:0008033	tRNA processing	0.08	> 0.20	QTRT1 (3.9)	DHODH (3.8)	C12orf43 (3.1)	NAA25 (2.8)	C19orf52 (2.7)	TXNL4B (2.7)	ZNF259 (2.7)	DDX56 (2.6)	ATXN7L2 (2.5)	ZNF180 (2.3)
ENSG00000112182	BACH2 PPI subnetwork	0.08	> 0.20	DOCK7 (3.2)	TRIB1 (3.2)	ACAD10 (2.4)	CETP (2.4)	LDLR (2.2)	ENSG00000228044 (1.9)	ATXN2 (1.9)	TMEM57 (1.9)	DNAH11 (1.8)	CILP2 (1.8)
ENSG00000183034	OTOP2 PPI subnetwork	0.08	> 0.20	NPC1L1 (3.1)	FADS1 (3.1)	HMGCR (2.9)	FADS2 (2.6)	NYNRIN (2.5)	USP24 (2.2)	GATAD2A (1.9)	TM6SF2 (1.9)	GOT2P1 (1.8)	COL4A3BP (1.7)
GO:0071378	cellular response to growth hormone stimulus	0.08	> 0.20	HNF1A (2.7)	PBX4 (2.5)	TRAFD1 (1.9)	KIAA1324 (1.8)	PLEKHH2 (1.6)	USP24 (1.6)	DNM2 (1.5)	ENSG00000228044 (1.4)	BRAP (1.4)	ZHX3 (1.4)
GO:0060396	growth hormone receptor signaling pathway	0.08	> 0.20	HNF1A (2.7)	PBX4 (2.5)	TRAFD1 (1.9)	KIAA1324 (1.8)	PLEKHH2 (1.6)	USP24 (1.6)	DNM2 (1.5)	ENSG00000228044 (1.4)	BRAP (1.4)	ZHX3 (1.4)
GO:0019838	growth factor binding	0.08	> 0.20	SLC44A2 (3.4)	BCAM (3.3)	APOE (2.9)	CILP2 (2.6)	PVRL2 (2.4)	HLX (2.4)	KANK2 (2.2)	KIAA1324 (1.9)	CELSR2 (1.8)	PLEC (1.6)
ENSG00000148942	SLC5A12 PPI subnetwork	0.08	> 0.20	TIMD4 (3.1)	OASL (3.1)	CETP (2.9)	PLEKHH2 (2.0)	TMEM57 (1.7)	DNAH11 (1.6)	TSSK6 (1.5)	C1orf63 (1.5)	HNF1A (1.4)	CEACAM19 (1.4)
ENSG00000147050	KDM6A PPI subnetwork	0.08	> 0.20	C19orf52 (3.0)	TXNL4B (2.8)	PLCG1 (2.2)	BRAP (2.0)	BUD13 (2.0)	SUGP1 (1.9)	CLPTM1 (1.8)	TMED4 (1.8)	APOA5 (1.6)	MOSC1 (1.5)
ENSG00000134759	ELP2 PPI subnetwork	0.08	> 0.20	TMEM50A (3.9)	TRAFD1 (3.1)	MYLIP (2.6)	SUGP1 (2.3)	TOP1 (2.1)	GEMIN7 (2.1)	DHX38 (2.1)	SMARCA4 (2.0)	ILF3 (2.0)	COL4A3BP (1.9)
ENSG00000141434	MEP1B PPI subnetwork	0.08	> 0.20	TM6SF2 (4.9)	NPC1L1 (3.8)	ABCG5 (3.4)	KIAA1324 (3.3)	ABCG8 (2.9)	PLEKHH2 (2.9)	PARP10 (2.6)	OASL (2.2)	MAPKAPK5 (2.1)	APOB (1.9)
MP:0002088	abnormal embryonic growth/weight/body size	0.08	> 0.20	APOE (2.3)	MAFB (2.3)	NYNRIN (2.0)	SLC22A1 (1.9)	ANKRD31 (1.9)	BCAM (1.8)	GRINA (1.7)	UBXN2B (1.7)	PLCG1 (1.6)	ENSG00000226648 (1.6)
MP:0001715	placental labyrinth hypoplasia	0.08	> 0.20	MOSC1 (2.3)	RELB (2.1)	QTRT1 (1.7)	CBLC (1.7)	LPIN3 (1.6)	CARM1 (1.6)	HP (1.6)	RHCE (1.5)	APOC4 (1.5)	TRIB1 (1.5)
GO:0019239	deaminase activity	0.08	> 0.20	OASL (3.9)	PARP10 (3.3)	SYPL2 (3.2)	NPC1L1 (3.2)	ABCG5 (3.2)	LPIN3 (3.0)	TM6SF2 (2.8)	TRAFD1 (2.7)	ABCG8 (2.1)	TSSK6 (2.0)
MP:0002416	abnormal proerythroblast morphology	0.08	> 0.20	RHD (5.0)	RHCE (4.5)	BCL3 (3.1)	CILP2 (2.9)	GRINA (2.6)	SH2B3 (2.5)	USP24 (2.4)	GMIP (2.2)	TIMD4 (2.1)	LPAR2 (1.9)
GO:0004869	cysteine-type endopeptidase inhibitor activity	0.08	> 0.20	PLG (3.9)	HP (3.6)	ANGPTL3 (3.3)	APOC4 (3.2)	APOB (3.1)	APOA5 (3.1)	SLC22A1 (3.1)	APOC1 (2.9)	LPA (2.8)	ALDH2 (1.9)
ENSG00000053372	MRTO4 PPI subnetwork	0.08	> 0.20	ZNF259 (5.2)	NAA25 (4.7)	DDX56 (4.5)	TOMM40 (3.9)	QTRT1 (3.0)	DHX38 (2.7)	DHODH (2.6)	ATP13A1 (2.5)	ENSG00000226645 (2.2)	MAPKAPK5 (2.2)
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	0.08	> 0.20	ZNF180 (8.6)	ZNF101 (4.0)	BLOC1S3 (2.0)	POC5 (1.7)	BRAP (1.7)	TXNL4B (1.6)	MAU2 (1.5)	BUD13 (1.3)	POLK (1.3)	C19orf52 (1.2)
ENSG00000072210	ALDH3A2 PPI subnetwork	0.08	> 0.20	ACAD10 (3.8)	NT5DC1 (2.7)	HNF1A (2.3)	C1orf63 (1.8)	PCSK9 (1.7)	TRAPPC6A (1.7)	SORT1 (1.7)	TIMD4 (1.7)	CETP (1.6)	GMPR (1.6)
ENSG00000163636	PSMD6 PPI subnetwork	0.08	> 0.20	PSMA5 (5.5)	TOMM40 (3.0)	TRAFD1 (2.5)	NAA25 (2.5)	NT5DC1 (2.4)	ENSG00000254235 (2.0)	DDX56 (1.6)	PTPN11 (1.5)	QTRT1 (1.4)	PARP10 (1.4)
ENSG00000140009	ESR2 PPI subnetwork	0.08	> 0.20	ATXN2 (3.5)	PLCG1 (3.4)	SLC44A2 (2.9)	PPP1R37 (2.8)	MAPKAPK5 (2.7)	MYLIP (2.5)	ZHX3 (2.4)	KANK2 (2.3)	KIAA1324 (2.3)	SMARCA4 (2.3)
ENSG00000129170	CSRP3 PPI subnetwork	0.08	> 0.20	SYPL2 (6.1)	GMPR (3.2)	OGDH (2.0)	ACAD10 (1.9)	LPIN3 (1.6)	RHCE (1.6)	PLEC (1.5)	RHD (1.5)	TMEM50A (1.5)	FADS1 (1.4)
ENSG00000151846	PABPC3 PPI subnetwork	0.08	> 0.20	SMARCA4 (2.3)	ILF3 (2.2)	DDX56 (2.2)	QTRT1 (2.1)	SARS (2.1)	TOMM40 (2.1)	TOP1 (1.8)	NAA25 (1.8)	DHX38 (1.7)	SUGP1 (1.7)
ENSG00000130338	TULP4 PPI subnetwork	0.08	> 0.20	ATP13A1 (3.8)	MAPKAPK5 (2.7)	PTPN11 (2.6)	DDX56 (2.4)	USP24 (2.4)	HNF1A (2.4)	CEACAM19 (2.3)	LPA (2.3)	BRAP (2.2)	TOMM40 (2.0)
GO:0004859	phospholipase inhibitor activity	0.08	> 0.20	HP (2.9)	ALDH2 (2.9)	APOE (2.8)	CYP7A1 (2.7)	COL4A3BP (2.4)	APOC4 (2.3)	PVR (2.2)	PLG (2.1)	PLEC (1.9)	GEMIN7 (1.8)
MP:0005123	increased circulating growth hormone level	0.08	> 0.20	GPAM (3.1)	KIAA1324 (2.3)	ADAM1 (2.1)	GEMIN7 (2.1)	C11orf9 (1.9)	ENSG00000254235 (1.9)	PCSK9 (1.8)	TIMD4 (1.8)	NPC1L1 (1.8)	PTPN11 (1.7)
ENSG00000109320	NFKB1 PPI subnetwork	0.08	> 0.20	RELB (4.7)	BCL3 (4.6)	GRINA (3.4)	TRIB1 (2.8)	PVR (2.1)	GEMIN7 (2.0)	PSMA5 (1.9)	GMIP (1.6)	PLEC (1.6)	C12orf51 (1.6)
ENSG00000141867	BRD4 PPI subnetwork	0.08	> 0.20	BRAP (3.2)	USP1 (3.1)	FEN1 (3.0)	FRK (2.5)	ATXN2 (1.9)	ANKRD31 (1.9)	ENSG00000226645 (1.8)	MAPKAPK5 (1.8)	C12orf43 (1.7)	ERP29 (1.7)
ENSG00000178363	CALML3 PPI subnetwork	0.08	> 0.20	SYPL2 (3.9)	GMPR (2.3)	GPAM (2.0)	RPH3A (1.9)	OGDH (1.8)	NCAN (1.7)	MOSC1 (1.6)	SORT1 (1.6)	PLEC (1.5)	ADAM1 (1.4)
ENSG00000140332	TLE3 PPI subnetwork	0.08	> 0.20	BUD13 (3.1)	PPP1R37 (2.4)	ABO (2.3)	MAU2 (2.2)	SUGP1 (2.2)	BLOC1S3 (1.9)	MARK4 (1.8)	FADS2 (1.7)	NYNRIN (1.7)	C19orf52 (1.7)
ENSG00000072952	MRVI1 PPI subnetwork	0.08	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.3)	C1orf63 (1.8)	PCSK9 (1.7)	TRAPPC6A (1.7)	CETP (1.5)	ATP13A1 (1.4)	TMED4 (1.4)	TIMD4 (1.4)
ENSG00000150630	VEGFC PPI subnetwork	0.08	> 0.20	MYLIP (4.1)	HLX (3.8)	C1orf63 (3.5)	PVRL2 (2.1)	SLC44A2 (2.0)	ENSG00000238078 (2.0)	C17orf57 (2.0)	ADAM1 (1.9)	CBLC (1.8)	ENSG00000226648 (1.6)
MP:0002495	increased IgA level	0.08	> 0.20	RELB (5.6)	GMIP (3.9)	BCL3 (3.5)	CETP (2.9)	SH2B3 (2.5)	MAFB (1.9)	PARP10 (1.8)	RHD (1.7)	SLC22A1 (1.6)	POLK (1.5)
MP:0000416	sparse hair	0.08	> 0.20	CBLC (4.8)	AP1M2 (4.4)	CELSR2 (2.6)	NPC1L1 (2.4)	BCAM (2.1)	CYB561D1 (2.0)	PLEC (1.8)	MARK4 (1.6)	ZNF180 (1.6)	C17orf57 (1.5)
MP:0000422	delayed hair appearance	0.08	> 0.20	RHD (4.6)	RHCE (3.6)	APOC1 (3.6)	MAFB (2.8)	APOE (2.7)	CETP (2.2)	TIMD4 (2.1)	PLG (2.0)	BCAM (2.0)	ABCG5 (2.0)
ENSG00000147065	MSN PPI subnetwork	0.08	> 0.20	RELB (3.4)	SH2B3 (2.6)	GMIP (2.4)	TIMD4 (2.3)	PVR (2.1)	LDLR (2.1)	LPAR2 (2.0)	BCL3 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)
REACTOME_ISG15_ANTIVIRAL_MECHANISM	REACTOME_ISG15_ANTIVIRAL_MECHANISM	0.08	> 0.20	OASL (11.7)	PARP10 (6.3)	TRAFD1 (3.5)	USP24 (2.5)	NAA25 (2.5)	DOCK7 (2.2)	GMPR (1.9)	ILF3 (1.8)	ATP13A1 (1.7)	USP1 (1.6)
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN:STIMULATED_GENES	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN:STIMULATED_GENES	0.08	> 0.20	OASL (11.7)	PARP10 (6.3)	TRAFD1 (3.5)	USP24 (2.5)	NAA25 (2.5)	DOCK7 (2.2)	GMPR (1.9)	ILF3 (1.8)	ATP13A1 (1.7)	USP1 (1.6)
GO:0050926	regulation of positive chemotaxis	0.08	> 0.20	ABO (3.4)	DNAH11 (2.9)	TMEM116 (2.0)	GCNT4 (1.8)	YIPF2 (1.7)	CYB561D1 (1.7)	ENSG00000226648 (1.5)	PPP1R37 (1.5)	PLEKHH2 (1.5)	CYP7A1 (1.4)
ENSG00000100906	NFKBIA PPI subnetwork	0.08	> 0.20	RELB (3.9)	BCL3 (3.7)	CARM1 (2.3)	GRINA (2.2)	GMIP (2.1)	CLPTM1 (2.1)	MYLIP (2.1)	DNM2 (2.0)	PTPN11 (1.9)	PLEC (1.8)
MP:0005478	decreased circulating thyroxine level	0.08	> 0.20	GOT2P1 (2.8)	C17orf57 (2.7)	MOSC1 (1.9)	NCAN (1.7)	GPAM (1.7)	TXNL4B (1.4)	APOA5 (1.4)	C11orf9 (1.4)	CETP (1.4)	COL4A3BP (1.4)
MP:0006267	abnormal intercalated disc morphology	0.08	> 0.20	SYPL2 (3.4)	DNM2 (2.0)	BLOC1S3 (1.7)	KANK2 (1.7)	GMPR (1.6)	LDLR (1.5)	OGDH (1.4)	FADS1 (1.4)	ERP29 (1.4)	TRAFD1 (1.4)
MP:0002680	decreased corpora lutea number	0.08	> 0.20	LPA (2.4)	ENSG00000235545 (2.2)	APOC4 (2.1)	C12orf51 (1.8)	TRAPPC6A (1.8)	CETP (1.7)	C17orf57 (1.7)	ITGB3 (1.7)	APOA5 (1.6)	HLX (1.5)
GO:2000146	negative regulation of cell motility	0.08	> 0.20	CEACAM19 (2.7)	PVRL2 (2.6)	KANK2 (2.4)	CILP2 (2.4)	ENSG00000254235 (2.3)	GCNT4 (2.1)	HLX (2.0)	ENSG00000226645 (1.7)	BCAM (1.6)	PLEKHH2 (1.6)
REACTOME_FATTY_ACYL:COA_BIOSYNTHESIS	REACTOME_FATTY_ACYL:COA_BIOSYNTHESIS	0.08	> 0.20	HMGCR (9.6)	FADS1 (9.4)	FADS2 (8.5)	LDLR (8.3)	GPAM (5.8)	PCSK9 (5.7)	MOSC1 (3.3)	BLOC1S3 (2.1)	SORT1 (2.0)	APOC1 (1.9)
ENSG00000108561	C1QBP PPI subnetwork	0.08	> 0.20	RELB (3.3)	ILF3 (2.8)	BCL3 (2.1)	CLPTM1 (2.0)	PPP1R37 (1.9)	PTPN11 (1.8)	NT5DC1 (1.8)	ENSG00000238078 (1.8)	MYLIP (1.7)	SARS (1.7)
ENSG00000160691	SHC1 PPI subnetwork	0.08	> 0.20	SLC44A2 (3.6)	GMIP (3.6)	DNM2 (2.8)	CETP (2.5)	SH2B3 (2.5)	PLEC (2.4)	TIMD4 (2.3)	PVRL2 (2.2)	ADAM1 (2.0)	APOE (2.0)
KEGG_PROSTATE_CANCER	KEGG_PROSTATE_CANCER	0.08	> 0.20	MYLIP (2.5)	RELB (2.4)	KIAA1324 (2.1)	TMEM50A (2.0)	ITGB3 (1.8)	PTPN11 (1.8)	MOSC1 (1.7)	MARK4 (1.6)	GATAD2A (1.5)	PLEC (1.5)
MP:0009402	decreased skeletal muscle fiber diameter	0.08	> 0.20	SYPL2 (3.5)	TRIB1 (2.5)	TMEM50A (2.4)	PVR (2.2)	ZHX3 (2.2)	KANK2 (1.9)	AMIGO1 (1.8)	NYNRIN (1.8)	OGDH (1.7)	GMPR (1.6)
GO:2000116	regulation of cysteine-type endopeptidase activity	0.08	> 0.20	POLK (3.2)	ENSG00000238078 (2.7)	C17orf57 (2.4)	TRAPPC6A (2.3)	OASL (2.1)	ITGB3 (2.0)	TRAFD1 (1.9)	GOT2P1 (1.7)	GEMIN7 (1.7)	ST3GAL4 (1.6)
GO:0007257	activation of JUN kinase activity	0.08	> 0.20	ENSG00000226645 (3.2)	GCNT4 (2.6)	LPAR2 (2.6)	ENSG00000235545 (2.5)	ST3GAL4 (2.3)	PPP1R37 (2.0)	ATXN7L2 (2.0)	ABO (1.5)	OGDH (1.5)	ZHX3 (1.5)
ENSG00000198053	SIRPA PPI subnetwork	0.08	> 0.20	USP24 (3.0)	DNM2 (2.7)	COL4A3BP (2.7)	PLEC (2.6)	GMIP (2.6)	OGDH (1.9)	BCL3 (1.9)	CELSR2 (1.7)	MAU2 (1.7)	SORT1 (1.7)
ENSG00000113810	SMC4 PPI subnetwork	0.08	> 0.20	USP1 (2.6)	C12orf43 (2.6)	ILF3 (2.5)	PSRC1 (2.4)	FEN1 (2.4)	C12orf47 (2.2)	DHX38 (2.2)	DDX56 (2.0)	ATP13A1 (1.9)	QTRT1 (1.9)
MP:0002191	abnormal artery morphology	0.08	> 0.20	MAFB (3.3)	PLCG1 (2.8)	CETP (2.7)	HLX (2.6)	SLC44A2 (2.4)	PVR (2.2)	PVRL2 (2.2)	KANK2 (2.1)	PLEKHH2 (2.0)	BCAM (1.9)
MP:0004045	abnormal cell cycle checkpoint function	0.08	> 0.20	PSRC1 (3.2)	FEN1 (2.6)	USP1 (2.2)	UBXN2B (2.2)	ENSG00000226645 (2.0)	POLK (1.9)	ATXN7L2 (1.8)	C1orf63 (1.7)	ILF3 (1.6)	BLOC1S3 (1.4)
MP:0001263	weight loss	0.08	> 0.20	PVR (4.2)	BCL3 (3.9)	HP (2.8)	SLC22A1 (2.6)	RELB (2.5)	OASL (2.5)	LPA (2.4)	TRIB1 (2.3)	ANGPTL3 (2.1)	TXNL4B (2.0)
ENSG00000008128	CDK11A PPI subnetwork	0.08	> 0.20	UBXN2B (3.4)	SMARCA4 (2.2)	C12orf47 (2.1)	GRINA (2.0)	PARP10 (1.9)	BCL3 (1.9)	TRAPPC6A (1.8)	COL4A3BP (1.8)	C1orf63 (1.7)	BUD13 (1.7)
ENSG00000119414	PPP6C PPI subnetwork	0.08	> 0.20	DHX38 (2.6)	NAA25 (2.3)	TOMM40 (2.2)	RELB (2.2)	PLG (2.0)	ANGPTL3 (2.0)	DDX56 (2.0)	ATP13A1 (1.8)	C19orf52 (1.8)	LDLR (1.7)
MP:0010264	increased hepatoma incidence	0.08	> 0.20	PSRC1 (3.6)	POLK (2.4)	ABCG8 (2.0)	HLX (1.9)	FEN1 (1.8)	ABCG5 (1.8)	ENSG00000228044 (1.7)	C1orf63 (1.6)	APOA5 (1.6)	DNAH11 (1.5)
ENSG00000125868	DSTN PPI subnetwork	0.08	> 0.20	NPC1L1 (3.9)	C11orf9 (3.5)	HNF1A (2.8)	TM6SF2 (2.4)	APOB (2.3)	OGDH (2.1)	PCSK9 (2.1)	NT5DC1 (1.9)	ADAM1 (1.8)	C1orf63 (1.7)
KEGG_LYSOSOME	KEGG_LYSOSOME	0.08	> 0.20	ERP29 (5.8)	APOE (4.0)	ATP13A1 (3.4)	SORT1 (3.4)	GRINA (3.2)	TMEM50A (3.1)	TMED4 (2.9)	CLPTM1 (2.8)	COL4A3BP (2.4)	APOC1 (2.2)
MP:0010067	increased red blood cell distribution width	0.08	> 0.20	RHCE (8.7)	RHD (6.6)	GMPR (3.4)	BRAP (3.0)	C12orf51 (1.9)	PLCG1 (1.8)	CETP (1.7)	KANK2 (1.7)	HNF1A (1.7)	LPIN3 (1.7)
ENSG00000100504	PYGL PPI subnetwork	0.08	> 0.20	SYPL2 (2.9)	GMPR (2.5)	PBX4 (2.2)	SORT1 (2.0)	CARM1 (1.8)	POLK (1.7)	SLC44A2 (1.7)	MARK4 (1.7)	ITGB3 (1.6)	ENSG00000238078 (1.6)
ENSG00000145781	COMMD10 PPI subnetwork	0.08	> 0.20	RELB (4.4)	GEMIN7 (3.3)	BCL3 (3.2)	TRAPPC6A (3.0)	CYB561D1 (2.2)	CLPTM1 (2.2)	GRINA (2.1)	PPP1R37 (2.0)	C12orf43 (1.8)	MAPKAPK5 (1.7)
REACTOME_ER:PHAGOSOME_PATHWAY	REACTOME_ER:PHAGOSOME_PATHWAY	0.08	> 0.20	PSMA5 (5.3)	TRAFD1 (3.9)	PARP10 (3.5)	NAA25 (2.0)	NT5DC1 (1.6)	TMEM50A (1.5)	TOMM40 (1.5)	RELB (1.4)	TMED4 (1.2)	DDX56 (1.2)
ENSG00000132646	PCNA PPI subnetwork	0.08	> 0.20	FEN1 (5.6)	USP1 (4.1)	POC5 (2.6)	PSRC1 (2.5)	SMARCA4 (2.0)	POLK (1.7)	BUD13 (1.6)	FADS1 (1.5)	ZNF180 (1.5)	KANK2 (1.4)
MP:0000039	abnormal otic capsule morphology	0.08	> 0.20	CILP2 (3.3)	CEACAM19 (2.2)	KIAA1324 (1.9)	MYLIP (1.8)	ENSG00000226648 (1.8)	CETP (1.7)	PLEKHH2 (1.5)	DYNC2LI1 (1.5)	TRIB1 (1.3)	HLX (1.3)
MP:0005596	increased susceptibility to type I hypersensitivity reaction	0.08	> 0.20	KANK2 (2.5)	MAFB (2.3)	PLEKHH2 (2.0)	ALDH2 (1.8)	MOSC1 (1.6)	KIAA1324 (1.6)	POLK (1.6)	PLCG1 (1.6)	OGDH (1.5)	TRIB1 (1.4)
ENSG00000141506	PIK3R5 PPI subnetwork	0.08	> 0.20	HLX (3.7)	C1orf63 (2.9)	SLC44A2 (2.8)	DOCK7 (2.8)	MYLIP (2.4)	PVRL2 (2.2)	GMIP (2.2)	DNM2 (1.9)	PLEC (1.8)	SH2B3 (1.7)
ENSG00000160213	CSTB PPI subnetwork	0.08	> 0.20	APOE (4.0)	GRINA (3.2)	RHD (3.1)	MAFB (2.3)	RHCE (2.2)	UBXN2B (2.1)	PLCG1 (1.9)	SARS (1.9)	GOT2P1 (1.9)	ALDH2 (1.8)
ENSG00000134871	COL4A2 PPI subnetwork	0.08	> 0.20	APOE (3.0)	CETP (2.0)	C17orf57 (1.9)	KANK2 (1.9)	ATP13A1 (1.5)	GCNT4 (1.5)	CILP2 (1.5)	TXNL4B (1.5)	MYLIP (1.4)	PCSK9 (1.3)
ENSG00000070756	PABPC1 PPI subnetwork	0.08	> 0.20	SMARCA4 (3.3)	ILF3 (3.3)	DHX38 (3.2)	ATP13A1 (3.0)	TOP1 (2.9)	SARS (2.6)	DDX56 (2.4)	NAA25 (2.4)	GATAD2A (2.4)	SUGP1 (2.3)
GO:0044058	regulation of digestive system process	0.08	> 0.20	NPC1L1 (5.5)	ABCG8 (4.6)	ABCG5 (4.6)	TM6SF2 (4.4)	APOB (2.9)	C17orf57 (2.8)	ADAM1 (2.6)	HAPLN4 (2.2)	MOSC1 (1.9)	LPIN3 (1.6)
GO:0046626	regulation of insulin receptor signaling pathway	0.08	> 0.20	ENSG00000226645 (3.5)	GCNT4 (2.2)	TRIB1 (1.8)	MOSC1 (1.7)	BCL3 (1.5)	C11orf9 (1.5)	PLEKHH2 (1.5)	TMED4 (1.3)	TSSK6 (1.3)	ZNF259 (1.2)
GO:0014037	Schwann cell differentiation	0.08	> 0.20	ENSG00000226645 (3.2)	DNAH11 (3.1)	ST3GAL4 (2.2)	ENSG00000254235 (2.0)	GCNT4 (1.9)	AMIGO1 (1.8)	ENSG00000226648 (1.8)	CYP7A1 (1.7)	ZHX3 (1.6)	PLEC (1.6)
ENSG00000138834	MAPK8IP3 PPI subnetwork	0.08	> 0.20	PARP10 (3.6)	OASL (3.3)	ZNF180 (3.2)	HAPLN4 (2.7)	PLEKHH2 (2.7)	PLCG1 (2.6)	MARK4 (2.3)	LPAR2 (2.2)	GMIP (2.1)	C11orf9 (1.9)
ENSG00000176406	RIMS2 PPI subnetwork	0.08	> 0.20	TMEM50A (3.0)	KIAA1324 (2.7)	GEMIN7 (2.6)	YIPF2 (2.3)	PBX4 (2.3)	GATAD2A (2.2)	C19orf52 (2.1)	TMEM57 (2.0)	APOC1 (2.0)	PVRL2 (1.9)
ENSG00000080345	RIF1 PPI subnetwork	0.08	> 0.20	PSMA5 (2.8)	TXNL4B (2.7)	TOMM40 (2.7)	GEMIN7 (2.6)	DYNC2LI1 (2.1)	PPP1R37 (2.1)	DHX38 (1.9)	CLPTM1 (1.9)	ATXN7L2 (1.8)	C12orf47 (1.7)
MP:0006094	increased fat cell size	0.08	> 0.20	GPAM (4.1)	MOSC1 (2.8)	COL4A3BP (1.7)	TSSK6 (1.7)	APOB (1.7)	TMED4 (1.7)	TIMD4 (1.6)	PPP1R37 (1.5)	ABCG5 (1.4)	OASL (1.4)
ENSG00000134243	SORT1 PPI subnetwork	0.08	> 0.20	TOMM40 (2.2)	SARS (2.2)	TOP1 (2.2)	GRINA (2.1)	GOT2P1 (2.1)	PSMA5 (2.0)	DHX38 (1.9)	CELSR2 (1.9)	GCNT4 (1.8)	ILF3 (1.8)
ENSG00000134882	UBAC2 PPI subnetwork	0.08	> 0.20	ACAD10 (4.3)	NT5DC1 (3.2)	HNF1A (3.0)	TMED4 (2.4)	C1orf63 (2.2)	TRAPPC6A (1.9)	PLEKHH2 (1.9)	ATXN7L2 (1.8)	TIMD4 (1.7)	GCNT4 (1.6)
MP:0004231	abnormal calcium ion homeostasis	0.08	> 0.20	CYB561D1 (2.5)	CBLC (2.4)	AMIGO1 (2.4)	BCAM (2.3)	NYNRIN (2.1)	SYPL2 (2.1)	ENSG00000228044 (2.0)	HAVCR1 (2.0)	PVRL2 (1.9)	SLC44A2 (1.9)
MP:0001242	hyperkeratosis	0.08	> 0.20	HMGCR (4.0)	LDLR (3.4)	PCSK9 (3.0)	FADS1 (2.9)	CBLC (2.9)	AP1M2 (2.8)	CELSR2 (2.7)	FADS2 (2.2)	NKPD1 (2.0)	APOC1 (1.6)
ENSG00000167840	ZNF232 PPI subnetwork	0.08	> 0.20	APOB (5.8)	APOE (4.4)	PLG (4.0)	APOA5 (4.0)	APOC4 (3.6)	HP (3.4)	PCSK9 (3.3)	APOC1 (3.2)	ANGPTL3 (3.0)	TIMD4 (2.8)
ENSG00000141068	KSR1 PPI subnetwork	0.08	> 0.20	DNM2 (4.3)	CARM1 (3.8)	PLEC (3.4)	LPAR2 (3.1)	ZHX3 (2.7)	C11orf9 (2.4)	CBLC (2.4)	AP1M2 (2.2)	SMARCA4 (2.2)	C12orf43 (2.0)
ENSG00000205517	RGL3 PPI subnetwork	0.08	> 0.20	COL4A3BP (2.6)	PTPN11 (2.5)	ILF3 (2.3)	MAPKAPK5 (2.2)	TOMM40 (2.1)	NAA25 (2.1)	GATAD2A (2.1)	ATP13A1 (2.0)	GMPR (1.6)	TSSK6 (1.5)
GO:0006509	membrane protein ectodomain proteolysis	0.08	> 0.20	ST3GAL4 (3.2)	CLPTM1 (2.5)	ENSG00000254235 (2.4)	TMEM50A (2.1)	SLC44A2 (1.9)	ENSG00000228044 (1.6)	ZNF101 (1.5)	NYNRIN (1.5)	CYB561D1 (1.4)	TMED4 (1.4)
ENSG00000170522	ELOVL6 PPI subnetwork	0.08	> 0.20	TMEM50A (4.2)	HMGCR (3.6)	FADS2 (3.2)	ATP13A1 (3.2)	CLPTM1 (3.2)	LDLR (3.2)	TMED4 (2.9)	FADS1 (2.8)	PCSK9 (2.5)	POC5 (2.1)
ENSG00000076924	XAB2 PPI subnetwork	0.08	> 0.20	BUD13 (3.9)	SUGP1 (3.7)	DHX38 (3.4)	ZNF259 (3.1)	BRAP (3.0)	POC5 (2.6)	C12orf43 (2.6)	DDX56 (2.5)	SARS (2.3)	ZNF180 (2.1)
ENSG00000180185	FAHD1 PPI subnetwork	0.08	> 0.20	ACAD10 (4.1)	TMED4 (3.2)	HNF1A (3.2)	NT5DC1 (2.5)	CETP (2.2)	TRAPPC6A (2.2)	TMEM50A (2.1)	CBLC (1.9)	ERP29 (1.8)	PCSK9 (1.6)
ENSG00000101608	MYL12A PPI subnetwork	0.08	> 0.20	MYLIP (2.5)	C1orf63 (2.4)	PVRL2 (2.1)	GMPR (2.0)	C19orf52 (2.0)	PVR (2.0)	POLK (2.0)	ITGB3 (1.8)	KANK2 (1.7)	PLEC (1.6)
ENSG00000155329	ZCCHC10 PPI subnetwork	0.08	> 0.20	TOP1 (2.9)	C1orf63 (2.9)	C17orf57 (2.2)	ZNF180 (2.2)	SMARCA4 (1.9)	ATXN7L2 (1.8)	CARM1 (1.8)	BLOC1S3 (1.7)	BRAP (1.6)	SLC44A2 (1.5)
MP:0002080	prenatal lethality	0.08	> 0.20	LDLR (2.5)	MYLIP (2.4)	HMGCR (2.4)	PCSK9 (2.3)	SLC44A2 (2.1)	USP24 (1.9)	MARK4 (1.9)	FADS2 (1.8)	BCL3 (1.8)	NYNRIN (1.8)
ENSG00000132005	RFX1 PPI subnetwork	0.08	> 0.20	ATXN2 (3.0)	ZHX3 (2.6)	GMPR (2.3)	KANK2 (2.2)	CARM1 (2.1)	C12orf51 (2.1)	ZNF101 (2.0)	BCL3 (1.9)	KIAA1324 (1.9)	NYNRIN (1.8)
GO:0019048	virus-host interaction	0.08	> 0.20	GCNT4 (2.7)	ENSG00000254235 (2.1)	OASL (2.1)	PPP1R37 (1.9)	ERP29 (1.9)	CYB561D1 (1.9)	PTPN11 (1.8)	CETP (1.8)	PARP10 (1.8)	NAA25 (1.8)
ENSG00000198300	ZIM2 PPI subnetwork	0.08	> 0.20	APOC1 (3.3)	ITGB3 (3.2)	APOB (2.5)	GMPR (2.4)	LPIN3 (2.2)	HAVCR1 (2.2)	TMEM50A (2.2)	C1orf63 (2.1)	MAPKAPK5 (2.1)	TMEM57 (1.9)
ENSG00000121741	ZMYM2 PPI subnetwork	0.08	> 0.20	TOP1 (3.2)	SMARCA4 (2.7)	ILF3 (2.5)	DHX38 (2.3)	KANK2 (2.2)	TRAFD1 (2.1)	GATAD2A (1.9)	MYLIP (1.9)	C1orf63 (1.8)	TMEM57 (1.8)
ENSG00000128739	SNRPN PPI subnetwork	0.08	> 0.20	TOMM40 (3.7)	ZNF180 (3.3)	PSMA5 (3.2)	BLOC1S3 (2.6)	BUD13 (2.0)	TRAPPC6A (1.9)	USP1 (1.9)	GEMIN7 (1.7)	PARP10 (1.7)	DHX38 (1.7)
ENSG00000149100	EIF3M PPI subnetwork	0.08	> 0.20	C19orf52 (3.2)	BRAP (3.0)	MAPKAPK5 (2.6)	C12orf47 (2.5)	C12orf43 (2.4)	BUD13 (2.3)	SH2B3 (2.1)	PTPN11 (2.0)	C1orf63 (2.0)	SARS (1.9)
ENSG00000133477	FAM83F PPI subnetwork	0.08	> 0.20	ACAD10 (4.0)	NT5DC1 (3.1)	HNF1A (2.2)	TRAPPC6A (1.7)	CETP (1.7)	C1orf63 (1.6)	GMPR (1.6)	SORT1 (1.5)	TIMD4 (1.5)	TMED4 (1.4)
MP:0004274	abnormal embryonic/fetal subventricular zone morphology	0.08	> 0.20	DHX38 (2.5)	MAU2 (2.2)	UBXN2B (2.0)	ENSG00000235545 (1.8)	PPP1R37 (1.8)	ATXN7L2 (1.8)	NCAN (1.7)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	POLK (1.6)
ENSG00000122870	BICC1 PPI subnetwork	0.08	> 0.20	MAPKAPK5 (2.8)	ATP13A1 (2.8)	LPA (2.7)	TOMM40 (2.4)	USP24 (2.2)	MAU2 (2.2)	CEACAM19 (2.1)	ANKRD31 (2.1)	DHODH (2.0)	CETP (2.0)
ENSG00000034693	PEX3 PPI subnetwork	0.08	> 0.20	CLPTM1 (4.2)	GPAM (2.9)	NT5DC1 (2.8)	MARK4 (2.5)	AMIGO1 (2.2)	ABCG8 (2.1)	DHODH (2.1)	MOSC1 (1.9)	YIPF2 (1.8)	PPP1R37 (1.7)
ENSG00000157514	TSC22D3 PPI subnetwork	0.08	> 0.20	TRIB1 (5.6)	RELB (5.4)	ENSG00000238078 (2.5)	MAPKAPK5 (2.3)	BCL3 (2.3)	PBX4 (2.2)	PARP10 (2.1)	LPAR2 (1.8)	BUD13 (1.7)	GEMIN7 (1.6)
GO:0009791	post-embryonic development	0.08	> 0.20	DNAH11 (4.9)	UBXN2B (2.3)	ENSG00000228044 (2.2)	PMFBP1 (1.9)	TRAPPC6A (1.8)	TSSK6 (1.7)	ST3GAL4 (1.6)	GCNT4 (1.6)	C11orf9 (1.5)	MARK4 (1.5)
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	REACTOME_GLYCOSPHINGOLIPID_METABOLISM	0.08	> 0.20	NKPD1 (4.7)	ERP29 (4.6)	HNF1A (3.7)	TMED4 (3.0)	COL4A3BP (2.5)	TM6SF2 (2.4)	TMEM50A (2.4)	ATP13A1 (2.3)	HAPLN4 (2.3)	APOE (2.3)
MP:0003227	abnormal vascular branching morphogenesis	0.08	> 0.20	BCAM (3.2)	NYNRIN (2.6)	HLX (2.4)	SH2B3 (2.2)	CETP (2.2)	SLC44A2 (2.2)	GATAD2A (2.1)	ITGB3 (2.0)	PVRL2 (1.8)	PLEC (1.8)
ENSG00000091127	PUS7 PPI subnetwork	0.08	> 0.20	DDX56 (3.5)	TOMM40 (3.4)	GPAM (3.2)	DHODH (2.9)	PTPN11 (2.7)	ADAM1 (2.5)	ATP13A1 (2.4)	NAA25 (2.3)	QTRT1 (2.3)	PPP1R37 (2.2)
MP:0005006	abnormal osteoblast physiology	0.08	> 0.20	CILP2 (4.9)	MAFB (2.2)	BCAM (2.2)	TMEM116 (2.1)	ANGPTL3 (1.9)	ITGB3 (1.8)	APOC1 (1.8)	MYLIP (1.7)	TMEM57 (1.5)	ANKRD31 (1.5)
MP:0008554	decreased circulating tumor necrosis factor level	0.08	> 0.20	MAFB (4.3)	RELB (4.2)	BCL3 (4.2)	GMIP (3.1)	HP (2.5)	TRIB1 (2.5)	TIMD4 (2.1)	ZNF101 (1.9)	FRK (1.9)	OASL (1.9)
ENSG00000164244	PRRC1 PPI subnetwork	0.08	> 0.20	SMARCA4 (4.4)	C1orf63 (2.9)	BUD13 (2.7)	DOCK7 (2.6)	ILF3 (2.5)	GATAD2A (2.4)	TMEM57 (2.2)	CARM1 (2.2)	SUGP1 (2.1)	MAU2 (2.0)
GO:0008026	ATP-dependent helicase activity	0.08	> 0.20	OASL (4.1)	SUGP1 (4.1)	DHX38 (3.9)	DHODH (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	NAA25 (2.4)	ZNF259 (2.3)	DDX56 (2.3)	SMARCA4 (2.1)
GO:0070035	purine NTP-dependent helicase activity	0.08	> 0.20	OASL (4.1)	SUGP1 (4.1)	DHX38 (3.9)	DHODH (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	NAA25 (2.4)	ZNF259 (2.3)	DDX56 (2.3)	SMARCA4 (2.1)
GO:0010269	response to selenium ion	0.08	> 0.20	ABCG8 (4.3)	ABCG5 (4.1)	NPC1L1 (3.9)	TM6SF2 (3.6)	GCNT4 (3.0)	ANKRD31 (2.3)	ENSG00000235545 (2.2)	C17orf57 (2.1)	HP (1.9)	ZHX3 (1.8)
ENSG00000083544	TDRD3 PPI subnetwork	0.08	> 0.20	ATP13A1 (4.2)	HNF1A (2.9)	DDX56 (2.8)	PTPN11 (2.6)	MAPKAPK5 (2.5)	DHODH (2.3)	BRAP (2.3)	CEACAM19 (2.2)	TOMM40 (2.1)	ANKRD31 (2.1)
ENSG00000170276	ENSG00000170276 PPI subnetwork	0.08	> 0.20	ADAM1 (3.3)	PTPN11 (2.8)	C1orf63 (2.6)	SYPL2 (2.5)	TRAFD1 (2.5)	OGDH (2.2)	ATXN7L2 (1.9)	BRAP (1.9)	CEACAM19 (1.9)	DNM2 (1.8)
MP:0001790	abnormal immune system physiology	0.08	> 0.20	BCL3 (5.4)	RELB (3.8)	GMIP (3.1)	TIMD4 (2.5)	CETP (2.3)	HLX (2.0)	MAFB (1.8)	C17orf57 (1.6)	PARP10 (1.5)	TRAFD1 (1.4)
ENSG00000114491	UMPS PPI subnetwork	0.08	> 0.20	NT5DC1 (2.7)	ATP13A1 (2.3)	ZNF180 (2.1)	DHODH (2.0)	LPA (1.9)	USP24 (1.9)	CETP (1.8)	QTRT1 (1.8)	GATAD2A (1.7)	CEACAM19 (1.6)
ENSG00000075426	FOSL2 PPI subnetwork	0.08	> 0.20	TRIB1 (7.8)	SARS (3.1)	MAPKAPK5 (2.5)	POLK (2.2)	BCL3 (2.0)	POC5 (1.9)	MYLIP (1.8)	BLOC1S3 (1.8)	MAFB (1.6)	ATXN2 (1.4)
GO:0033197	response to vitamin E	0.08	> 0.20	DNAH11 (6.1)	CEACAM19 (2.9)	GCNT4 (2.9)	FADS1 (2.5)	MOSC1 (2.5)	HMGCR (2.0)	FADS2 (1.9)	ENSG00000238078 (1.9)	LDLR (1.8)	TSSK6 (1.7)
ENSG00000165197	FIGF PPI subnetwork	0.08	> 0.20	MYLIP (4.2)	HLX (3.6)	C1orf63 (3.2)	C17orf57 (2.6)	SLC44A2 (2.2)	ENSG00000238078 (2.1)	ADAM1 (2.0)	PVRL2 (1.8)	LPIN3 (1.6)	ATXN7L2 (1.6)
GO:0030336	negative regulation of cell migration	0.08	> 0.20	CEACAM19 (2.9)	PVRL2 (2.6)	KANK2 (2.6)	CILP2 (2.3)	ENSG00000254235 (2.3)	HLX (2.1)	GCNT4 (1.9)	PLEKHH2 (1.7)	BCAM (1.6)	DNAH11 (1.6)
GO:0051223	regulation of protein transport	0.08	> 0.20	ZNF101 (2.4)	ST3GAL4 (1.7)	GEMIN7 (1.6)	OASL (1.5)	PBX4 (1.5)	HLX (1.5)	LPAR2 (1.4)	PLEKHH2 (1.3)	RELB (1.3)	ENSG00000226648 (1.3)
ENSG00000112964	GHR PPI subnetwork	0.08	> 0.20	BCL3 (3.4)	COL4A3BP (2.3)	PVR (2.1)	C17orf57 (2.0)	HLX (1.7)	CYP7A1 (1.6)	ZNF101 (1.5)	CETP (1.5)	ZHX3 (1.4)	SH2B3 (1.4)
GO:0046209	nitric oxide metabolic process	0.08	> 0.20	AMIGO1 (2.0)	PVR (1.9)	GCNT4 (1.9)	TXNL4B (1.7)	C17orf57 (1.6)	BCL3 (1.6)	TMEM116 (1.6)	ENSG00000228044 (1.6)	MAFB (1.5)	PLCG1 (1.4)
ENSG00000186575	NF2 PPI subnetwork	0.08	> 0.20	LPAR2 (3.7)	DNM2 (3.3)	ST3GAL4 (2.8)	PBX4 (2.5)	PTPN11 (2.3)	LDLR (2.2)	DOCK7 (2.0)	GMIP (2.0)	DHX38 (2.0)	PLEC (2.0)
ENSG00000188976	NOC2L PPI subnetwork	0.08	> 0.20	NAA25 (5.0)	ZNF259 (4.8)	TOMM40 (4.2)	QTRT1 (4.1)	DDX56 (4.0)	DHODH (3.1)	C12orf43 (3.0)	TOP1 (2.5)	DHX38 (2.4)	BRAP (2.3)
ENSG00000109111	SUPT6H PPI subnetwork	0.08	> 0.20	SARS (3.2)	BRAP (2.9)	CARM1 (2.8)	DNM2 (2.5)	DHX38 (2.4)	CYP7A1 (2.4)	SUGP1 (2.4)	ZNF259 (2.3)	C17orf57 (2.2)	TRAPPC6A (2.0)
ENSG00000107968	MAP3K8 PPI subnetwork	0.08	> 0.20	RELB (5.2)	BCL3 (3.5)	PVR (3.4)	PLEC (2.3)	GRINA (2.1)	MYLIP (1.9)	C1orf63 (1.8)	C12orf43 (1.6)	TRAFD1 (1.6)	PARP10 (1.5)
MP:0000220	increased monocyte cell number	0.08	> 0.20	RELB (4.1)	BCL3 (3.8)	GMIP (3.6)	CETP (3.3)	RHD (3.0)	RHCE (2.6)	SLC44A2 (2.4)	HP (2.2)	TIMD4 (2.2)	ST3GAL4 (1.7)
MP:0001554	increased circulating free fatty acid level	0.08	> 0.20	MOSC1 (3.7)	APOA5 (3.0)	GPAM (2.9)	TIMD4 (2.4)	SORT1 (2.4)	ABCG8 (2.1)	FRK (2.1)	HP (2.0)	CETP (1.7)	APOC1 (1.7)
MP:0001845	abnormal inflammatory response	0.08	> 0.20	HLX (3.7)	MAFB (3.1)	HP (3.1)	BCL3 (2.7)	GMIP (2.1)	MYLIP (1.9)	RELB (1.9)	ENSG00000228044 (1.8)	CILP2 (1.6)	TRIB1 (1.4)
ENSG00000172936	MYD88 PPI subnetwork	0.08	> 0.20	OASL (3.8)	PARP10 (3.2)	GMIP (3.0)	SH2B3 (2.9)	BCL3 (2.1)	POLK (2.0)	MAFB (1.9)	RELB (1.8)	TMEM50A (1.7)	CYB561D1 (1.6)
ENSG00000115484	CCT4 PPI subnetwork	0.08	> 0.20	NAA25 (4.2)	PSMA5 (3.0)	DDX56 (2.8)	SARS (2.4)	USP24 (2.4)	BRAP (2.1)	SMARCA4 (2.0)	C12orf43 (2.0)	MAPKAPK5 (2.0)	ZNF259 (2.0)
ENSG00000130479	MAP1S PPI subnetwork	0.08	> 0.20	SMARCA4 (4.0)	C1orf63 (3.1)	DOCK7 (2.9)	ILF3 (2.5)	BUD13 (2.5)	TOP1 (2.2)	NAA25 (2.0)	TMEM57 (2.0)	GATAD2A (1.8)	SUGP1 (1.8)
GO:0019433	triglyceride catabolic process	0.08	> 0.20	MOSC1 (4.3)	GPAM (4.0)	NPC1L1 (4.0)	TM6SF2 (3.2)	ABCG5 (2.6)	HP (2.2)	PMFBP1 (2.1)	APOC1 (2.0)	ABCG8 (1.9)	APOC4 (1.9)
MP:0001243	abnormal dermal layer morphology	0.08	> 0.20	ST3GAL4 (2.5)	PLEC (2.1)	SLC44A2 (1.9)	APOE (1.7)	CYB561D1 (1.6)	SYPL2 (1.5)	MAFB (1.5)	MYLIP (1.4)	C1orf63 (1.4)	C12orf51 (1.4)
GO:0000792	heterochromatin	0.08	> 0.20	NYNRIN (3.3)	ILF3 (2.8)	USP1 (2.7)	TOP1 (2.5)	CARM1 (2.3)	FEN1 (2.3)	ATXN2 (1.9)	PSRC1 (1.8)	LPAR2 (1.8)	KANK2 (1.8)
ENSG00000113456	RAD1 PPI subnetwork	0.08	> 0.20	FEN1 (3.8)	USP1 (3.1)	CLPTM1 (2.5)	POC5 (2.4)	ERP29 (2.2)	YIPF2 (2.1)	GATAD2A (1.9)	TMED4 (1.9)	PPP1R37 (1.9)	ENSG00000228044 (1.9)
KEGG_FATTY_ACID_METABOLISM	KEGG_FATTY_ACID_METABOLISM	0.08	> 0.20	ACAD10 (4.3)	MOSC1 (4.1)	APOC4 (4.1)	GPAM (4.0)	APOA5 (3.8)	LPA (3.7)	ALDH2 (3.5)	CYP7A1 (3.3)	PLG (3.2)	ANGPTL3 (3.2)
ENSG00000132507	EIF5A PPI subnetwork	0.08	> 0.20	GMPR (3.2)	SARS (2.8)	ZNF259 (2.4)	PVR (2.0)	ATP13A1 (2.0)	TOMM40 (1.9)	DDX56 (1.8)	PMFBP1 (1.6)	TRIB1 (1.5)	HMGCR (1.5)
ENSG00000211460	TSN PPI subnetwork	0.08	> 0.20	POC5 (2.7)	MYLIP (2.6)	GRINA (2.6)	BRAP (2.4)	MAPKAPK5 (2.2)	GMPR (2.1)	ZNF101 (2.1)	C12orf43 (2.0)	GEMIN7 (2.0)	TXNL4B (2.0)
ENSG00000072518	MARK2 PPI subnetwork	0.08	> 0.20	DNM2 (4.1)	MARK4 (4.0)	LPAR2 (2.6)	TSSK6 (2.5)	GMIP (2.1)	ABO (1.9)	ATXN7L2 (1.9)	C1orf63 (1.9)	CARM1 (1.9)	UBXN2B (1.8)
GO:0050727	regulation of inflammatory response	0.08	> 0.20	ENSG00000228044 (3.4)	DNAH11 (2.4)	ANKRD31 (2.1)	ALDH2 (2.1)	TIMD4 (2.0)	BCL3 (1.7)	PVR (1.6)	PARP10 (1.6)	SH2B3 (1.5)	PMFBP1 (1.5)
ENSG00000139687	RB1 PPI subnetwork	0.08	> 0.20	FEN1 (3.1)	USP1 (3.0)	TOP1 (2.6)	MAFB (2.6)	TRIB1 (2.0)	MAU2 (2.0)	MYLIP (1.9)	BUD13 (1.6)	KANK2 (1.6)	PSRC1 (1.5)
ENSG00000170889	RPS9 PPI subnetwork	0.08	> 0.20	QTRT1 (4.1)	DDX56 (3.8)	NAA25 (3.6)	ZNF259 (2.8)	C12orf43 (2.5)	ATP13A1 (2.5)	PTPN11 (2.5)	ILF3 (2.5)	SARS (2.4)	TOMM40 (2.3)
ENSG00000104833	TUBB4A PPI subnetwork	0.08	> 0.20	RELB (6.3)	BCL3 (3.8)	GRINA (2.3)	CLPTM1 (2.2)	PVR (2.2)	NAA25 (1.9)	TRAFD1 (1.8)	SMARCA4 (1.7)	SARS (1.6)	PBX4 (1.6)
MP:0000693	spleen hyperplasia	0.08	> 0.20	BCL3 (3.7)	GMIP (3.5)	MAFB (2.9)	TRIB1 (2.6)	CETP (2.5)	RELB (2.3)	TIMD4 (2.0)	SH2B3 (2.0)	HLX (1.8)	MYLIP (1.5)
GO:0071216	cellular response to biotic stimulus	0.08	> 0.20	PVR (3.3)	PARP10 (2.2)	GRINA (2.2)	OASL (2.1)	LPIN3 (2.1)	DNAH11 (1.9)	CEACAM19 (1.7)	MYLIP (1.7)	UBXN2B (1.7)	AMIGO1 (1.5)
ENSG00000106799	TGFBR1 PPI subnetwork	0.08	> 0.20	MYLIP (3.3)	SH2B3 (3.1)	DYNC2LI1 (2.6)	GATAD2A (2.2)	PVR (2.1)	POLK (2.0)	BLOC1S3 (2.0)	TRIB1 (1.8)	GCNT4 (1.8)	PTPN11 (1.6)
MP:0001071	abnormal facial nerve morphology	0.08	> 0.20	HLX (2.7)	BCAM (2.1)	MYLIP (1.7)	BLOC1S3 (1.6)	DYNC2LI1 (1.4)	TOP1 (1.4)	TSSK6 (1.4)	SORT1 (1.4)	ZHX3 (1.3)	ANKRD31 (1.3)
ENSG00000198677	TTC37 PPI subnetwork	0.08	> 0.20	DHX38 (3.5)	USP24 (3.3)	DDX56 (3.3)	NAA25 (2.8)	DHODH (2.6)	TOMM40 (2.5)	PTPN11 (2.3)	BRAP (2.2)	ATP13A1 (2.2)	ZNF259 (2.2)
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	0.09	> 0.20	BLOC1S3 (3.1)	CLPTM1 (2.6)	DNM2 (2.3)	GRINA (2.2)	ZNF180 (2.1)	PLEC (2.1)	PPP1R37 (2.0)	MARK4 (2.0)	MAU2 (1.9)	POLK (1.8)
ENSG00000085063	CD59 PPI subnetwork	0.09	> 0.20	LPA (5.2)	SLC22A1 (4.7)	APOC4 (4.3)	PLG (4.1)	ANGPTL3 (3.9)	APOA5 (3.5)	ITGB3 (3.5)	ABCG5 (3.0)	ADAM1 (2.6)	HP (2.5)
ENSG00000181656	GPR88 PPI subnetwork	0.09	> 0.20	ATXN2 (4.4)	PPP1R37 (3.8)	DHX38 (3.2)	CARM1 (3.1)	SUGP1 (3.1)	ILF3 (3.1)	SMARCA4 (3.0)	CLPTM1 (2.9)	BRAP (2.8)	BUD13 (2.8)
ENSG00000178035	IMPDH2 PPI subnetwork	0.09	> 0.20	CBLC (2.2)	PLEC (2.2)	TRAPPC6A (2.1)	KANK2 (2.0)	FRK (1.9)	NT5DC1 (1.8)	PCSK9 (1.8)	TOMM40 (1.7)	ENSG00000226645 (1.7)	PVRL2 (1.6)
MP:0008414	abnormal spatial reference memory	0.09	> 0.20	GCNT4 (3.2)	APOC1 (3.1)	RPH3A (2.5)	TMEM116 (2.5)	ABCG8 (2.2)	ABCG5 (2.1)	ENSG00000226645 (2.1)	APOA5 (1.9)	ZNF180 (1.9)	LPA (1.8)
GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	0.09	> 0.20	PARP10 (2.9)	ST3GAL4 (2.8)	SH2B3 (2.6)	CYB561D1 (2.5)	GRINA (2.2)	RELB (2.1)	GEMIN7 (1.8)	TRAFD1 (1.7)	OASL (1.7)	BLOC1S3 (1.6)
MP:0004938	dilated vasculature	0.09	> 0.20	SMARCA4 (2.8)	C12orf51 (2.7)	ENSG00000226648 (2.2)	DNM2 (2.0)	APOC4 (2.0)	PLG (2.0)	CARM1 (1.9)	ITGB3 (1.7)	MAU2 (1.7)	SLC44A2 (1.6)
REACTOME_REGULATION_OF_DNA_REPLICATION	REACTOME_REGULATION_OF_DNA_REPLICATION	0.09	> 0.20	PSMA5 (5.1)	FEN1 (3.6)	NT5DC1 (2.8)	TRAFD1 (2.5)	TOMM40 (2.0)	NAA25 (1.9)	USP1 (1.8)	SUGP1 (1.7)	DDX56 (1.3)	PARP10 (1.3)
ENSG00000117528	ABCD3 PPI subnetwork	0.09	> 0.20	C19orf52 (3.1)	SORT1 (2.7)	LPA (2.3)	GPAM (2.3)	ENSG00000226648 (2.3)	GRINA (2.0)	SLC44A2 (1.9)	MOSC1 (1.9)	ALDH2 (1.8)	SLC22A1 (1.8)
ENSG00000164050	PLXNB1 PPI subnetwork	0.09	> 0.20	HAVCR1 (3.3)	PVR (2.5)	BCL3 (2.3)	PVRL2 (2.1)	PLEC (2.1)	DOCK7 (2.1)	TRIB1 (2.0)	LDLR (1.9)	C12orf51 (1.9)	CELSR2 (1.8)
ENSG00000185507	IRF7 PPI subnetwork	0.09	> 0.20	PARP10 (4.0)	PLEKHH2 (3.0)	BCL3 (2.7)	LPAR2 (2.6)	COL4A3BP (2.2)	ZNF180 (2.2)	NT5DC1 (2.1)	C12orf51 (2.0)	PMFBP1 (2.0)	ATXN7L2 (1.9)
ENSG00000149016	TUT1 PPI subnetwork	0.09	> 0.20	SMARCA4 (4.3)	C1orf63 (2.9)	DOCK7 (2.8)	ILF3 (2.7)	BUD13 (2.6)	GATAD2A (2.5)	TOP1 (2.1)	CARM1 (2.1)	TMEM57 (2.1)	MAU2 (1.9)
ENSG00000206489	PPP1R10 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
ENSG00000206407	ENSG00000206407 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
ENSG00000204569	PPP1R10 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
GO:0051917	regulation of fibrinolysis	0.09	> 0.20	ANGPTL3 (5.0)	APOC4 (4.2)	PLG (4.2)	PCSK9 (3.8)	APOA5 (3.7)	HP (3.0)	LPA (2.9)	SLC22A1 (2.9)	CEACAM19 (2.7)	HNF1A (2.6)
ENSG00000132170	PPARG PPI subnetwork	0.09	> 0.20	C12orf51 (3.4)	TOP1 (2.6)	TRIB1 (2.6)	ABCG8 (2.6)	ABCG5 (2.3)	APOB (2.3)	MAPKAPK5 (2.2)	DOCK7 (1.8)	ALDH2 (1.7)	ATXN2 (1.7)
GO:0051568	histone H3-K4 methylation	0.09	> 0.20	C12orf51 (3.2)	ANKRD31 (2.8)	ZNF180 (2.7)	MAU2 (2.7)	C19orf52 (2.7)	ATXN2 (1.8)	C1orf63 (1.8)	BUD13 (1.7)	ATXN7L2 (1.7)	USP24 (1.6)
ENSG00000128594	LRRC4 PPI subnetwork	0.09	> 0.20	NPC1L1 (3.4)	FADS1 (2.9)	HMGCR (2.8)	FADS2 (2.8)	PCSK9 (2.6)	TMED4 (2.1)	NYNRIN (2.1)	GEMIN7 (2.0)	TM6SF2 (1.9)	GOT2P1 (1.9)
GO:0005773	vacuole	0.09	> 0.20	ERP29 (5.0)	APOE (3.3)	TMEM50A (3.2)	GRINA (3.1)	COL4A3BP (2.7)	SORT1 (2.7)	TMED4 (2.7)	ATP13A1 (2.6)	CLPTM1 (2.4)	YIPF2 (2.2)
MP:0011093	complete embryonic lethality at implantation	0.09	> 0.20	C12orf47 (3.5)	BUD13 (2.8)	TMED4 (2.5)	FRK (2.4)	GOT2P1 (2.2)	OGDH (1.9)	POC5 (1.9)	ERP29 (1.8)	USP1 (1.5)	FEN1 (1.4)
ENSG00000127022	CANX PPI subnetwork	0.09	> 0.20	TMED4 (3.3)	ERP29 (3.1)	APOB (2.6)	CLPTM1 (2.4)	HNF1A (2.3)	BCAM (2.2)	HP (2.2)	YIPF2 (2.0)	APOC1 (1.9)	ABCG5 (1.9)
ENSG00000103426	CORO7 PPI subnetwork	0.09	> 0.20	DHODH (3.9)	DNM2 (2.8)	CYP7A1 (2.8)	LPA (2.5)	APOC4 (2.3)	ANGPTL3 (2.3)	TRAPPC6A (2.1)	ILF3 (2.0)	GOT2P1 (1.9)	PMFBP1 (1.8)
MP:0002655	abnormal keratinocyte morphology	0.09	> 0.20	PLEC (4.0)	CBLC (3.9)	ENSG00000235545 (2.8)	RELB (2.4)	MAFB (2.0)	BCAM (2.0)	BCL3 (1.9)	LDLR (1.7)	LPAR2 (1.7)	AP1M2 (1.6)
ENSG00000160062	ZBTB8A PPI subnetwork	0.09	> 0.20	GRINA (2.7)	ATXN7L2 (2.4)	LPAR2 (2.3)	ATP13A1 (2.2)	BRAP (2.2)	C19orf52 (2.1)	ABCG8 (2.1)	FRK (2.0)	PARP10 (1.9)	SUGP1 (1.8)
GO:0004549	tRNA-specific ribonuclease activity	0.09	> 0.20	ZNF180 (3.4)	DHODH (3.2)	GEMIN7 (2.8)	POC5 (2.7)	C12orf43 (2.7)	QTRT1 (1.8)	TOMM40 (1.7)	PSMA5 (1.7)	NAA25 (1.7)	BLOC1S3 (1.6)
ENSG00000109805	NCAPG PPI subnetwork	0.09	> 0.20	PSRC1 (3.8)	POC5 (2.4)	ANKRD31 (2.3)	BLOC1S3 (2.2)	FEN1 (2.1)	ENSG00000228044 (1.7)	TRIB1 (1.7)	PMFBP1 (1.4)	NT5DC1 (1.4)	AP1M2 (1.2)
ENSG00000173876	TUBB8 PPI subnetwork	0.09	> 0.20	ACAD10 (3.8)	NT5DC1 (3.2)	HNF1A (2.4)	C1orf63 (2.1)	TMED4 (2.0)	PCSK9 (1.9)	TRAPPC6A (1.8)	KIAA1324 (1.7)	CETP (1.6)	SORT1 (1.6)
GO:0050819	negative regulation of coagulation	0.09	> 0.20	ANGPTL3 (3.9)	ENSG00000228044 (3.7)	PCSK9 (3.2)	ITGB3 (2.9)	PLG (2.9)	APOC4 (2.9)	SLC22A1 (2.9)	GMPR (2.6)	PVR (2.4)	CYP7A1 (2.3)
ENSG00000087245	MMP2 PPI subnetwork	0.09	> 0.20	MAFB (3.2)	APOE (3.1)	KANK2 (2.4)	TRIB1 (2.1)	CILP2 (2.0)	BCL3 (2.0)	APOC1 (1.9)	LPA (1.7)	CLPTM1 (1.5)	FRK (1.5)
MP:0010420	muscular ventricular septal defect	0.09	> 0.20	ST3GAL4 (2.7)	NYNRIN (2.6)	GPAM (2.3)	GMPR (1.9)	MYLIP (1.8)	KANK2 (1.7)	NPC1L1 (1.5)	TM6SF2 (1.4)	SLC22A1 (1.3)	USP24 (1.3)
GO:0015749	monosaccharide transport	0.09	> 0.20	GCNT4 (3.5)	NPC1L1 (3.1)	DOCK7 (2.9)	ABCG8 (2.2)	KIAA1324 (2.1)	ABCG5 (2.0)	POC5 (2.0)	ENSG00000235545 (2.0)	SORT1 (1.9)	TMED4 (1.9)
GO:0005501	retinoid binding	0.09	> 0.20	TM6SF2 (3.8)	ABCG5 (3.7)	APOB (3.6)	C11orf9 (3.0)	APOC4 (2.6)	NYNRIN (2.6)	APOA5 (2.4)	LPAR2 (2.4)	CYP7A1 (2.3)	ABCG8 (2.1)
MP:0011353	expanded mesangial matrix	0.09	> 0.20	BCAM (3.1)	PLEKHH2 (3.0)	PVRL2 (2.5)	APOC1 (2.1)	TMEM50A (2.1)	C1orf63 (2.0)	MAFB (1.8)	PLG (1.8)	KANK2 (1.7)	FADS1 (1.7)
ENSG00000170581	STAT2 PPI subnetwork	0.09	> 0.20	TMEM50A (4.5)	BCL3 (4.0)	C1orf63 (3.4)	TRAFD1 (3.2)	MAU2 (3.0)	DNM2 (2.7)	CARM1 (2.4)	ATXN2 (2.4)	RELB (2.3)	TRIB1 (2.1)
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	0.09	> 0.20	KIAA1324 (3.9)	HAPLN4 (2.9)	GPAM (2.7)	NPC1L1 (2.4)	MOSC1 (2.4)	COL4A3BP (2.1)	SORT1 (2.1)	HLX (2.0)	TMEM50A (1.9)	TM6SF2 (1.9)
ENSG00000123064	DDX54 PPI subnetwork	0.09	> 0.20	ZNF259 (5.2)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (4.0)	QTRT1 (3.7)	DHODH (3.3)	DHX38 (2.7)	ATP13A1 (2.4)	SUGP1 (2.3)	USP24 (2.1)
ENSG00000119888	EPCAM PPI subnetwork	0.09	> 0.20	NPC1L1 (5.0)	AP1M2 (4.2)	ABCG5 (2.9)	TM6SF2 (2.7)	KIAA1324 (2.7)	FRK (2.4)	ST3GAL4 (2.3)	HNF1A (2.2)	CBLC (2.0)	DNM2 (1.9)
GO:0009895	negative regulation of catabolic process	0.09	> 0.20	ENSG00000228044 (2.6)	GPAM (1.8)	ST3GAL4 (1.7)	ZHX3 (1.7)	ENSG00000226648 (1.6)	PBX4 (1.5)	ENSG00000238078 (1.4)	POC5 (1.3)	APOA5 (1.3)	KANK2 (1.2)
ENSG00000125352	RNF113A PPI subnetwork	0.09	> 0.20	BRAP (3.2)	BUD13 (3.0)	SUGP1 (2.8)	DHX38 (2.3)	POC5 (2.2)	ZNF259 (2.1)	QTRT1 (2.1)	MAU2 (2.0)	SMARCA4 (1.8)	TM6SF2 (1.7)
ENSG00000156697	UTP14A PPI subnetwork	0.09	> 0.20	DHODH (3.2)	QTRT1 (3.1)	ATXN7L2 (2.7)	TOMM40 (2.7)	ZNF259 (2.6)	NAA25 (2.6)	HAVCR1 (2.4)	DDX56 (2.4)	DHX38 (1.8)	MAPKAPK5 (1.8)
ENSG00000151702	FLI1 PPI subnetwork	0.09	> 0.20	RHCE (5.8)	RHD (5.2)	GMPR (3.7)	ABO (2.2)	PTPN11 (1.9)	TRAPPC6A (1.9)	ENSG00000228044 (1.7)	TOMM40 (1.3)	CEACAM19 (1.3)	FEN1 (1.3)
ENSG00000111845	PAK1IP1 PPI subnetwork	0.09	> 0.20	ZNF259 (5.3)	DDX56 (4.7)	NAA25 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.6)	ENSG00000226645 (2.6)	C12orf43 (2.4)	SUGP1 (2.3)	TOP1 (2.2)
ENSG00000166401	SERPINB8 PPI subnetwork	0.09	> 0.20	APOA5 (3.0)	HP (2.8)	APOB (2.7)	HNF1A (2.5)	KANK2 (2.4)	NPC1L1 (2.3)	PLG (2.2)	APOC4 (2.2)	SYPL2 (2.1)	ST3GAL4 (1.9)
GO:0006096	glycolysis	0.09	> 0.20	GOT2P1 (3.5)	PCSK9 (1.9)	TSSK6 (1.7)	HAPLN4 (1.7)	PMFBP1 (1.6)	ACAD10 (1.6)	ENSG00000254235 (1.4)	ENSG00000228044 (1.3)	DHODH (1.2)	GMPR (1.2)
MP:0009278	abnormal bone marrow cell physiology	0.09	> 0.20	CETP (3.6)	TRIB1 (3.5)	BCL3 (3.4)	TIMD4 (3.2)	RHCE (2.5)	MAFB (2.3)	PLEKHH2 (1.9)	KIAA1324 (1.9)	FEN1 (1.7)	AP1M2 (1.7)
ENSG00000172795	DCP2 PPI subnetwork	0.09	> 0.20	DHODH (4.1)	DHX38 (3.9)	ZNF259 (3.5)	DDX56 (3.5)	ATP13A1 (3.4)	USP24 (3.1)	NAA25 (2.9)	SUGP1 (2.7)	TXNL4B (2.6)	QTRT1 (2.1)
ENSG00000123405	NFE2 PPI subnetwork	0.09	> 0.20	PVR (2.8)	TMEM57 (2.5)	TRIB1 (2.3)	PVRL2 (2.2)	ALDH2 (2.1)	C11orf9 (2.1)	SH2B3 (2.1)	LDLR (1.9)	BCL3 (1.9)	ENSG00000226645 (1.7)
ENSG00000166233	ARIH1 PPI subnetwork	0.09	> 0.20	ZNF259 (2.9)	DDX56 (2.9)	ADAM1 (2.7)	SUGP1 (2.6)	USP24 (2.5)	DHODH (2.4)	C12orf43 (2.4)	OASL (2.4)	TOMM40 (2.4)	NAA25 (2.3)
GO:0016458	gene silencing	0.09	> 0.20	GCNT4 (2.6)	MAPKAPK5 (2.5)	DOCK7 (2.2)	ACAD10 (1.8)	ATXN2 (1.7)	GATAD2A (1.7)	C12orf51 (1.7)	TXNL4B (1.6)	BUD13 (1.5)	C19orf52 (1.4)
ENSG00000168477	TNXB PPI subnetwork	0.09	> 0.20	PTPN11 (2.9)	FRK (2.7)	ZNF180 (2.6)	PARP10 (2.6)	DOCK7 (2.4)	ENSG00000254235 (2.2)	ADAM1 (1.9)	ALDH2 (1.7)	TOMM40 (1.6)	C17orf57 (1.5)
REACTOME_DESTABILIZATION_OF_MRNA_BY_BUTYRATE_RESPONSE_FACTOR_1_BRF1	REACTOME_DESTABILIZATION_OF_MRNA_BY_BUTYRATE_RESPONSE_FACTOR_1_BRF1	0.09	> 0.20	TOMM40 (3.6)	DHODH (3.1)	GRINA (2.6)	TXNL4B (2.3)	C12orf43 (2.3)	TRAPPC6A (2.2)	ZNF259 (1.9)	TMEM50A (1.8)	BCL3 (1.8)	DDX56 (1.8)
GO:0006007	glucose catabolic process	0.09	> 0.20	GOT2P1 (3.0)	ACAD10 (2.1)	PCSK9 (1.9)	TRAPPC6A (1.8)	TSSK6 (1.7)	FADS2 (1.6)	FADS1 (1.5)	FRK (1.4)	GPAM (1.4)	GMPR (1.4)
ENSG00000108679	LGALS3BP PPI subnetwork	0.09	> 0.20	PLEC (2.3)	ATP13A1 (2.2)	OASL (2.1)	KANK2 (2.1)	FRK (1.8)	APOE (1.8)	DHODH (1.7)	C19orf52 (1.6)	BCL3 (1.5)	PVR (1.5)
GO:0019900	kinase binding	0.09	> 0.20	RELB (2.7)	PLCG1 (2.5)	GMIP (2.3)	PTPN11 (2.3)	POLK (2.2)	TRIB1 (2.1)	C11orf9 (2.0)	COL4A3BP (2.0)	DNM2 (2.0)	NCAN (1.9)
GO:0002576	platelet degranulation	0.09	> 0.20	ITGB3 (6.8)	ANGPTL3 (3.1)	GMPR (2.6)	ADAM1 (2.3)	APOE (2.2)	HP (2.2)	PLG (1.9)	ZNF101 (1.8)	HNF1A (1.8)	APOC4 (1.7)
MP:0001144	vagina atresia	0.09	> 0.20	OASL (3.7)	BCAM (3.6)	NYNRIN (3.1)	PMFBP1 (3.0)	HAVCR1 (2.9)	MYLIP (2.6)	MAFB (2.6)	NKPD1 (2.5)	PVRL2 (2.3)	AP1M2 (2.2)
ENSG00000114942	EEF1B2 PPI subnetwork	0.09	> 0.20	SARS (3.4)	OGDH (2.6)	MAPKAPK5 (2.4)	TXNL4B (1.9)	GRINA (1.9)	CYP7A1 (1.8)	ZNF101 (1.7)	ERP29 (1.5)	DHX38 (1.5)	GMPR (1.5)
MP:0004969	pale kidney	0.09	> 0.20	TRIB1 (3.5)	FRK (3.0)	PLEKHH2 (2.5)	PVR (2.3)	C17orf57 (2.3)	KANK2 (2.2)	NT5DC1 (2.1)	ENSG00000235545 (1.8)	MAU2 (1.6)	ENSG00000226645 (1.6)
ENSG00000206206	DAXX PPI subnetwork	0.09	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
ENSG00000204209	DAXX PPI subnetwork	0.09	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
ENSG00000206279	DAXX PPI subnetwork	0.09	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
MP:0001792	impaired wound healing	0.09	> 0.20	ANGPTL3 (3.4)	AP1M2 (2.8)	HP (2.5)	CBLC (2.5)	APOB (2.1)	ABCG5 (2.0)	APOA5 (2.0)	BCL3 (1.8)	KANK2 (1.7)	APOC4 (1.7)
MP:0000552	abnormal radius morphology	0.09	> 0.20	PLEKHH2 (2.3)	PCSK9 (1.9)	KANK2 (1.8)	NYNRIN (1.6)	ENSG00000228044 (1.5)	SYPL2 (1.5)	ANKRD31 (1.5)	LDLR (1.4)	PLEC (1.3)	TMEM116 (1.3)
GO:0009982	pseudouridine synthase activity	0.09	> 0.20	DHODH (4.2)	QTRT1 (4.0)	ZNF259 (3.8)	NAA25 (3.7)	BUD13 (3.4)	DDX56 (3.0)	TOMM40 (2.9)	C12orf43 (2.7)	ACAD10 (2.4)	ATXN7L2 (1.8)
GO:0015030	Cajal body	0.09	> 0.20	BUD13 (4.8)	ZNF259 (4.3)	DDX56 (2.8)	FEN1 (2.5)	C12orf47 (2.5)	USP1 (2.4)	DHODH (2.3)	NAA25 (2.1)	ZNF180 (2.1)	POC5 (2.0)
GO:0019748	secondary metabolic process	0.09	> 0.20	ST3GAL4 (2.2)	PMFBP1 (2.0)	CYP7A1 (2.0)	TM6SF2 (1.8)	C12orf47 (1.6)	FRK (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.5)	ABCG5 (1.4)	GMPR (1.4)
MP:0003721	increased tumor growth/size	0.09	> 0.20	RELB (4.3)	BCL3 (3.5)	ITGB3 (3.0)	SLC44A2 (2.6)	OASL (2.1)	TRAFD1 (2.0)	LDLR (2.0)	PVR (1.8)	ST3GAL4 (1.8)	PARP10 (1.7)
GO:0005925	focal adhesion	0.09	> 0.20	PLEC (4.1)	ITGB3 (3.6)	KANK2 (2.6)	PVRL2 (2.3)	GMIP (2.3)	BCAM (2.0)	C11orf9 (1.9)	SH2B3 (1.9)	DNM2 (1.9)	GPAM (1.7)
GO:0042312	regulation of vasodilation	0.09	> 0.20	LPIN3 (3.5)	NPC1L1 (2.3)	ANKRD31 (2.2)	TMEM116 (1.8)	ENSG00000226648 (1.7)	ENSG00000226645 (1.7)	POLK (1.7)	PMFBP1 (1.5)	C12orf47 (1.5)	GCNT4 (1.4)
ENSG00000162692	VCAM1 PPI subnetwork	0.09	> 0.20	TIMD4 (6.1)	CETP (5.8)	RHD (2.4)	PBX4 (2.4)	GMIP (1.9)	ST3GAL4 (1.9)	HP (1.8)	TRAPPC6A (1.7)	PTPN11 (1.7)	C19orf52 (1.5)
GO:0010212	response to ionizing radiation	0.09	> 0.20	POLK (3.5)	ZNF101 (2.6)	ENSG00000228044 (2.6)	UBXN2B (2.3)	ZNF180 (2.0)	FRK (1.9)	C17orf57 (1.9)	C12orf43 (1.9)	TRAPPC6A (1.7)	PSRC1 (1.6)
GO:0034599	cellular response to oxidative stress	0.09	> 0.20	GOT2P1 (3.2)	C17orf57 (2.8)	ACAD10 (2.8)	RHD (2.5)	RHCE (2.3)	DNAH11 (2.2)	PBX4 (2.1)	ALDH2 (2.0)	TMEM116 (1.6)	TRIB1 (1.5)
GO:0045940	positive regulation of steroid metabolic process	0.09	> 0.20	ENSG00000228044 (3.1)	MYLIP (3.0)	APOC1 (2.6)	COL4A3BP (2.4)	TMEM57 (2.3)	POC5 (2.2)	APOB (2.0)	SLC44A2 (1.9)	APOE (1.9)	ST3GAL4 (1.7)
ENSG00000151322	NPAS3 PPI subnetwork	0.09	> 0.20	OASL (2.9)	TIMD4 (2.7)	CETP (2.7)	PLEKHH2 (2.1)	TMEM57 (1.8)	DNAH11 (1.6)	SYPL2 (1.6)	C1orf63 (1.4)	SLC44A2 (1.4)	ENSG00000228044 (1.3)
ENSG00000151849	CENPJ PPI subnetwork	0.09	> 0.20	RHD (3.9)	RHCE (3.8)	GRINA (3.2)	NYNRIN (2.3)	AMIGO1 (2.1)	GMPR (1.9)	ANKRD31 (1.7)	ABO (1.6)	ITGB3 (1.6)	PPP1R37 (1.6)
REACTOME_ANTIGEN_PROCESSING:CROSS_PRESENTATION	REACTOME_ANTIGEN_PROCESSING:CROSS_PRESENTATION	0.09	> 0.20	PSMA5 (5.1)	TRAFD1 (4.0)	PARP10 (3.5)	NAA25 (2.2)	NT5DC1 (1.6)	TMED4 (1.6)	TMEM50A (1.5)	RELB (1.5)	TOMM40 (1.5)	DDX56 (1.2)
GO:0051098	regulation of binding	0.09	> 0.20	GATAD2A (2.7)	MAFB (2.5)	MARK4 (2.4)	MYLIP (2.3)	GRINA (2.1)	TMEM57 (2.0)	OASL (1.6)	ENSG00000238078 (1.6)	PLCG1 (1.5)	NYNRIN (1.4)
ENSG00000170727	BOP1 PPI subnetwork	0.09	> 0.20	ZNF259 (4.9)	NAA25 (4.6)	TOMM40 (4.2)	DDX56 (3.9)	DHX38 (3.5)	QTRT1 (3.4)	DHODH (3.4)	ATP13A1 (2.9)	C12orf43 (2.7)	PTPN11 (2.6)
MP:0000109	abnormal parietal bone morphology	0.09	> 0.20	NYNRIN (3.2)	CILP2 (2.6)	ST3GAL4 (2.0)	MYLIP (2.0)	NCAN (1.8)	MAU2 (1.6)	PVRL2 (1.5)	ALDH2 (1.5)	BCL3 (1.4)	SLC44A2 (1.4)
GO:0003755	peptidyl-prolyl cis-trans isomerase activity	0.09	> 0.20	YIPF2 (3.9)	ERP29 (3.2)	TOMM40 (2.8)	QTRT1 (2.6)	TMED4 (2.3)	TXNL4B (2.2)	OGDH (1.9)	CLPTM1 (1.9)	DYNC2LI1 (1.7)	DHODH (1.6)
ENSG00000196455	PIK3R4 PPI subnetwork	0.09	> 0.20	HLX (2.9)	DNM2 (2.5)	DOCK7 (2.3)	GMIP (2.2)	SLC44A2 (2.2)	C1orf63 (2.1)	ENSG00000226645 (2.1)	SH2B3 (2.0)	PVRL2 (1.9)	PLEC (1.9)
GO:0003823	antigen binding	0.09	> 0.20	LPA (3.6)	TM6SF2 (2.8)	CETP (2.7)	ALDH2 (2.2)	NPC1L1 (2.1)	RPH3A (2.0)	HMGCR (1.9)	ABCG8 (1.9)	MAFB (1.7)	PARP10 (1.5)
MP:0002446	abnormal macrophage morphology	0.09	> 0.20	TIMD4 (4.5)	APOC1 (3.7)	CETP (3.7)	HP (2.6)	SLC44A2 (2.5)	RELB (2.5)	APOE (2.3)	CYB561D1 (2.1)	SORT1 (2.1)	ACAD10 (1.9)
GO:0048872	homeostasis of number of cells	0.09	> 0.20	RHD (4.8)	RHCE (4.8)	C12orf51 (1.8)	MAFB (1.7)	SH2B3 (1.4)	DNM2 (1.3)	SLC44A2 (1.3)	GRINA (1.3)	TIMD4 (1.3)	TMEM57 (1.2)
MP:0002733	abnormal thermal nociception	0.09	> 0.20	APOC1 (3.5)	PCSK9 (2.7)	GCNT4 (2.7)	ABCG5 (2.3)	TM6SF2 (2.2)	NPC1L1 (2.2)	GEMIN7 (2.0)	PVRL2 (1.8)	BCAM (1.8)	LPAR2 (1.8)
ENSG00000187899	ENSG00000187899 PPI subnetwork	0.09	> 0.20	DDX56 (4.4)	QTRT1 (3.8)	ZNF259 (3.8)	NAA25 (3.7)	DHODH (3.3)	TOMM40 (3.1)	C12orf43 (2.8)	DHX38 (2.2)	BRAP (2.0)	SARS (2.0)
GO:0008134	transcription factor binding	0.09	> 0.20	TRIB1 (3.2)	ATXN2 (2.8)	KANK2 (2.5)	ATXN7L2 (2.4)	HLX (2.3)	DHX38 (2.2)	MARK4 (2.0)	MAFB (2.0)	PLEC (1.9)	PLCG1 (1.8)
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	0.09	> 0.20	OASL (10.1)	PARP10 (7.4)	TRAFD1 (5.3)	BCL3 (3.5)	RELB (3.4)	GMIP (1.8)	SH2B3 (1.8)	NAA25 (1.7)	GRINA (1.7)	HLX (1.5)
ENSG00000123975	CKS2 PPI subnetwork	0.09	> 0.20	TMEM57 (2.6)	CARM1 (2.6)	GRINA (2.3)	FEN1 (2.2)	DOCK7 (2.2)	LPIN3 (2.2)	GMPR (2.2)	RHCE (1.8)	BCAM (1.7)	CLPTM1 (1.6)
GO:0031016	pancreas development	0.09	> 0.20	HNF1A (2.8)	C11orf9 (2.6)	ANKRD31 (2.4)	KIAA1324 (2.2)	ABO (1.9)	PLEKHH2 (1.7)	DNAH11 (1.7)	CYP7A1 (1.5)	NPC1L1 (1.5)	DYNC2LI1 (1.4)
REACTOME_METABOLISM_OF_NON:CODING_RNA	REACTOME_METABOLISM_OF_NON:CODING_RNA	0.09	> 0.20	POC5 (3.3)	NAA25 (3.1)	BUD13 (2.8)	USP1 (2.6)	DDX56 (2.6)	PSMA5 (2.2)	MAPKAPK5 (2.0)	TOMM40 (2.0)	ILF3 (2.0)	FEN1 (2.0)
REACTOME_SNRNP_ASSEMBLY	REACTOME_SNRNP_ASSEMBLY	0.09	> 0.20	POC5 (3.3)	NAA25 (3.1)	BUD13 (2.8)	USP1 (2.6)	DDX56 (2.6)	PSMA5 (2.2)	MAPKAPK5 (2.0)	TOMM40 (2.0)	ILF3 (2.0)	FEN1 (2.0)
GO:0016861	intramolecular oxidoreductase activity, interconverting aldoses and ketoses	0.09	> 0.20	TRAPPC6A (3.5)	PMFBP1 (2.2)	QTRT1 (2.2)	NT5DC1 (1.8)	GRINA (1.7)	PARP10 (1.7)	PLCG1 (1.7)	C12orf43 (1.7)	CETP (1.6)	BLOC1S3 (1.6)
ENSG00000172164	SNTB1 PPI subnetwork	0.09	> 0.20	KANK2 (3.8)	SYPL2 (3.5)	PPP1R37 (3.4)	PLCG1 (2.1)	BCAM (2.1)	ATXN7L2 (2.0)	PBX4 (1.9)	SLC44A2 (1.8)	NKPD1 (1.8)	ZHX3 (1.7)
ENSG00000163956	LRPAP1 PPI subnetwork	0.09	> 0.20	FADS1 (3.2)	PCSK9 (2.9)	FADS2 (2.8)	DOCK7 (2.6)	HMGCR (2.5)	DNAH11 (2.5)	ATXN2 (2.3)	USP24 (2.2)	ITGB3 (2.1)	SARS (2.0)
GO:0050918	positive chemotaxis	0.09	> 0.20	ABO (2.9)	CYP7A1 (2.2)	TMEM116 (1.5)	PLEKHH2 (1.5)	GCNT4 (1.4)	DNAH11 (1.4)	HLX (1.3)	CETP (1.3)	ENSG00000228044 (1.3)	C12orf51 (1.2)
GO:0043168	anion binding	0.09	> 0.20	TM6SF2 (4.0)	NPC1L1 (3.9)	ABCG5 (3.6)	LPA (2.6)	HAPLN4 (2.6)	ABCG8 (2.4)	BCAM (2.4)	GCNT4 (2.2)	APOB (1.8)	PLG (1.8)
ENSG00000112186	CAP2 PPI subnetwork	0.09	> 0.20	USP24 (3.4)	NAA25 (2.8)	SARS (2.4)	SMARCA4 (2.4)	CLPTM1 (2.3)	OGDH (2.2)	GPAM (2.0)	DDX56 (1.9)	TOMM40 (1.7)	TOP1 (1.7)
ENSG00000137462	TLR2 PPI subnetwork	0.09	> 0.20	ERP29 (2.8)	MAFB (2.3)	BCL3 (2.3)	HP (2.0)	CYP7A1 (1.9)	CLPTM1 (1.7)	PARP10 (1.7)	DOCK7 (1.5)	BLOC1S3 (1.5)	MYLIP (1.5)
ENSG00000139343	SNRPF PPI subnetwork	0.09	> 0.20	BUD13 (3.5)	ILF3 (3.4)	C1orf63 (3.0)	DHX38 (2.9)	TOP1 (2.9)	SUGP1 (2.8)	SMARCA4 (2.6)	QTRT1 (2.5)	USP1 (2.4)	FEN1 (2.1)
MP:0004615	cervical vertebral transformation	0.09	> 0.20	NYNRIN (2.5)	HLX (2.3)	UBXN2B (2.2)	TRIB1 (1.8)	DOCK7 (1.7)	ENSG00000254235 (1.3)	BCAM (1.3)	PMFBP1 (1.3)	ATXN7L2 (1.2)	PLEKHH2 (1.2)
ENSG00000205571	SMN2 PPI subnetwork	0.09	> 0.20	GEMIN7 (3.5)	PSMA5 (3.1)	USP1 (2.2)	TOMM40 (1.9)	QTRT1 (1.9)	TRAPPC6A (1.9)	FEN1 (1.9)	C12orf43 (1.7)	ILF3 (1.7)	ZNF180 (1.7)
ENSG00000172062	SMN1 PPI subnetwork	0.09	> 0.20	GEMIN7 (3.5)	PSMA5 (3.1)	USP1 (2.2)	TOMM40 (1.9)	QTRT1 (1.9)	TRAPPC6A (1.9)	FEN1 (1.9)	C12orf43 (1.7)	ILF3 (1.7)	ZNF180 (1.7)
ENSG00000063438	AHRR PPI subnetwork	0.09	> 0.20	PLEC (2.8)	NT5DC1 (2.2)	TMEM50A (1.9)	TMEM57 (1.9)	POLK (1.8)	OGDH (1.7)	C17orf57 (1.6)	TOP1 (1.6)	SARS (1.4)	DNM2 (1.4)
ENSG00000077157	PPP1R12B PPI subnetwork	0.09	> 0.20	SYPL2 (3.5)	ENSG00000238078 (2.7)	ANKRD31 (2.6)	PTPN11 (2.1)	GOT2P1 (1.8)	CYP7A1 (1.6)	DYNC2LI1 (1.5)	SLC44A2 (1.5)	TMEM50A (1.4)	C12orf47 (1.3)
MP:0005013	increased lymphocyte cell number	0.09	> 0.20	RELB (5.7)	BCL3 (3.5)	CETP (3.1)	RHD (2.7)	GMIP (2.6)	SH2B3 (2.5)	RHCE (2.4)	APOE (2.0)	TRIB1 (1.8)	GRINA (1.6)
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	0.09	> 0.20	GMPR (2.7)	PSRC1 (2.6)	OASL (2.4)	PVRL2 (2.2)	ITGB3 (2.1)	TRAFD1 (1.9)	KANK2 (1.9)	C11orf9 (1.8)	SH2B3 (1.8)	RHCE (1.7)
ENSG00000157873	TNFRSF14 PPI subnetwork	0.09	> 0.20	PSMA5 (3.3)	TOMM40 (3.1)	ERP29 (2.3)	ATP13A1 (2.3)	QTRT1 (2.1)	TOP1 (1.9)	DHODH (1.9)	ILF3 (1.8)	PBX4 (1.7)	DDX56 (1.6)
GO:0045922	negative regulation of fatty acid metabolic process	0.09	> 0.20	FADS1 (2.9)	FADS2 (2.7)	NPC1L1 (2.4)	PCSK9 (2.4)	ZNF180 (2.1)	LPIN3 (2.0)	HMGCR (1.9)	TM6SF2 (1.9)	LDLR (1.8)	TRAPPC6A (1.7)
ENSG00000198836	OPA1 PPI subnetwork	0.09	> 0.20	ACAD10 (3.0)	TRAPPC6A (2.6)	TMEM50A (2.6)	NT5DC1 (2.6)	HNF1A (2.5)	TMED4 (2.4)	ERP29 (1.9)	POLK (1.9)	ATXN7L2 (1.7)	SORT1 (1.5)
GO:0004177	aminopeptidase activity	0.09	> 0.20	NPC1L1 (5.1)	TM6SF2 (3.1)	ERP29 (2.6)	HAVCR1 (2.1)	PMFBP1 (1.9)	ENSG00000254235 (1.9)	MAPKAPK5 (1.8)	ABCG5 (1.7)	ACAD10 (1.7)	C12orf43 (1.7)
ENSG00000100294	MCAT PPI subnetwork	0.09	> 0.20	BRAP (3.0)	ATXN2 (2.9)	MAPKAPK5 (2.8)	SMARCA4 (2.8)	TRAFD1 (2.6)	C12orf51 (2.4)	C12orf43 (2.2)	OGDH (2.1)	NAA25 (2.1)	ANKRD31 (2.0)
ENSG00000136352	NKX2-1 PPI subnetwork	0.09	> 0.20	DNM2 (2.6)	SH2B3 (2.5)	ZHX3 (2.4)	ATXN2 (2.3)	C11orf9 (2.1)	ABO (1.9)	BCL3 (1.9)	C12orf51 (1.8)	COL4A3BP (1.8)	PTPN11 (1.7)
ENSG00000135698	MPHOSPH6 PPI subnetwork	0.09	> 0.20	ILF3 (2.9)	QTRT1 (2.9)	DNM2 (2.8)	SUGP1 (2.5)	AP1M2 (2.2)	DOCK7 (2.2)	SARS (2.1)	POC5 (2.0)	TMEM57 (2.0)	MAU2 (2.0)
GO:0046915	transition metal ion transmembrane transporter activity	0.09	> 0.20	RHCE (2.7)	RHD (2.3)	NPC1L1 (2.3)	AP1M2 (2.2)	MAFB (2.2)	YIPF2 (1.7)	TMED4 (1.7)	TMEM116 (1.7)	ATP13A1 (1.6)	SLC44A2 (1.6)
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	0.09	> 0.20	TRAFD1 (2.7)	ST3GAL4 (2.4)	POLK (2.1)	PARP10 (2.0)	GATAD2A (2.0)	TRAPPC6A (1.9)	LPIN3 (1.7)	SH2B3 (1.7)	FEN1 (1.6)	RELB (1.6)
ENSG00000168298	HIST1H1E PPI subnetwork	0.09	> 0.20	C19orf52 (2.5)	POLK (2.4)	PCSK9 (2.2)	TSSK6 (2.2)	ACAD10 (1.8)	PSRC1 (1.8)	CYB561D1 (1.6)	NKPD1 (1.5)	USP1 (1.4)	ENSG00000226648 (1.4)
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	0.09	> 0.20	RELB (4.1)	CLPTM1 (3.5)	TMEM50A (2.4)	GMIP (2.1)	GRINA (2.0)	TMED4 (1.9)	CYB561D1 (1.9)	TRAPPC6A (1.9)	PLEC (1.9)	LDLR (1.9)
MP:0005658	increased susceptibility to diet-induced obesity	0.09	> 0.20	ABCG5 (3.9)	NPC1L1 (3.7)	ABCG8 (3.0)	KIAA1324 (3.0)	GPAM (2.6)	APOB (2.6)	TM6SF2 (2.4)	CELSR2 (1.9)	APOA5 (1.8)	LPIN3 (1.7)
GO:0001882	nucleoside binding	0.09	> 0.20	NPC1L1 (4.4)	TM6SF2 (2.8)	ABCG5 (2.5)	ABCG8 (2.4)	PVRL2 (2.0)	ALDH2 (2.0)	GCNT4 (1.9)	LPIN3 (1.9)	ZNF180 (1.9)	ZHX3 (1.8)
ENSG00000104812	GYS1 PPI subnetwork	0.09	> 0.20	PTPN11 (3.3)	C19orf52 (2.8)	ZHX3 (2.7)	BRAP (2.7)	MAU2 (2.4)	C12orf43 (2.3)	GPAM (1.9)	COL4A3BP (1.8)	MYLIP (1.7)	HP (1.7)
REACTOME_INTERFERON_SIGNALING	REACTOME_INTERFERON_SIGNALING	0.09	> 0.20	OASL (12.3)	PARP10 (8.4)	TRAFD1 (6.1)	NAA25 (2.1)	RELB (2.0)	BCL3 (1.9)	GMPR (1.9)	POLK (1.6)	ADAM1 (1.5)	PSMA5 (1.5)
ENSG00000136695	IL36RN PPI subnetwork	0.09	> 0.20	NYNRIN (2.9)	ENSG00000254235 (2.3)	CYB561D1 (2.1)	GCNT4 (2.0)	MAU2 (2.0)	ABO (1.9)	KANK2 (1.9)	NPC1L1 (1.8)	SYPL2 (1.8)	GEMIN7 (1.8)
ENSG00000162928	PEX13 PPI subnetwork	0.09	> 0.20	NT5DC1 (3.3)	C19orf52 (3.3)	YIPF2 (2.6)	TRAPPC6A (2.3)	COL4A3BP (2.1)	DYNC2LI1 (2.0)	FRK (1.9)	UBXN2B (1.7)	ENSG00000226648 (1.7)	AMIGO1 (1.6)
ENSG00000197747	S100A10 PPI subnetwork	0.09	> 0.20	APOE (2.2)	DNAH11 (2.1)	ANGPTL3 (1.9)	SLC22A1 (1.8)	PLEC (1.8)	KANK2 (1.6)	C12orf47 (1.6)	NT5DC1 (1.3)	APOC4 (1.3)	TRAPPC6A (1.3)
GO:0035150	regulation of tube size	0.09	> 0.20	C12orf47 (2.3)	LPIN3 (1.7)	TSSK6 (1.7)	CETP (1.7)	FRK (1.7)	ENSG00000228044 (1.6)	ABO (1.5)	HAPLN4 (1.5)	NPC1L1 (1.4)	GMPR (1.4)
ENSG00000073536	NLE1 PPI subnetwork	0.09	> 0.20	ZNF259 (5.1)	NAA25 (4.7)	DDX56 (4.1)	TOMM40 (3.7)	QTRT1 (3.5)	MAPKAPK5 (3.0)	DHX38 (2.8)	DHODH (2.8)	C12orf43 (2.6)	SUGP1 (2.4)
GO:0016627	oxidoreductase activity, acting on the CH-CH group of donors	0.09	> 0.20	ALDH2 (4.3)	FADS2 (4.1)	ACAD10 (4.0)	GPAM (3.6)	TRAPPC6A (3.4)	FADS1 (3.4)	MOSC1 (3.1)	HMGCR (2.4)	LPA (2.4)	NT5DC1 (2.3)
GO:0010817	regulation of hormone levels	0.09	> 0.20	KIAA1324 (3.8)	NPC1L1 (2.0)	CYP7A1 (2.0)	ABCG8 (1.9)	ABO (1.7)	ABCG5 (1.7)	ENSG00000228044 (1.7)	CYB561D1 (1.6)	TM6SF2 (1.5)	MOSC1 (1.5)
MP:0006264	decreased systemic arterial systolic blood pressure	0.09	> 0.20	C12orf47 (2.7)	HLX (2.6)	PLG (2.4)	ANGPTL3 (2.0)	HNF1A (1.6)	SLC22A1 (1.6)	ZHX3 (1.6)	TRIB1 (1.5)	BCAM (1.5)	HP (1.5)
GO:0009309	amine biosynthetic process	0.09	> 0.20	TM6SF2 (3.2)	CYP7A1 (3.1)	ANGPTL3 (2.6)	ABCG8 (2.5)	HNF1A (2.3)	SARS (2.3)	QTRT1 (2.1)	PLG (2.0)	GOT2P1 (1.9)	APOC4 (1.9)
ENSG00000034152	MAP2K3 PPI subnetwork	0.09	> 0.20	ATXN7L2 (2.3)	MARK4 (2.3)	PLEC (2.1)	MOSC1 (2.1)	PPP1R37 (1.9)	TRIB1 (1.9)	KANK2 (1.6)	SORT1 (1.6)	PBX4 (1.6)	GRINA (1.5)
GO:0006916	anti-apoptosis	0.09	> 0.20	GRINA (2.8)	ENSG00000238078 (2.7)	TRIB1 (2.3)	HAVCR1 (2.1)	PVR (1.7)	BCL3 (1.6)	KIAA1324 (1.4)	FRK (1.4)	ST3GAL4 (1.3)	MAFB (1.3)
MP:0000521	abnormal kidney cortex morphology	0.09	> 0.20	NYNRIN (3.5)	AMIGO1 (2.7)	BCAM (2.4)	C17orf57 (2.2)	APOB (1.9)	TMEM116 (1.9)	SYPL2 (1.8)	TMED4 (1.8)	ATXN7L2 (1.7)	ALDH2 (1.7)
ENSG00000010438	PRSS3 PPI subnetwork	0.09	> 0.20	APOC4 (2.7)	ANGPTL3 (2.6)	PLG (2.5)	DYNC2LI1 (2.3)	APOA5 (2.2)	ADAM1 (2.1)	ENSG00000228044 (2.0)	HP (1.9)	APOC1 (1.9)	ABO (1.9)
MP:0002957	intestinal adenocarcinoma	0.09	> 0.20	POLK (2.1)	ANKRD31 (2.1)	FEN1 (1.9)	MAPKAPK5 (1.9)	SLC44A2 (1.9)	PLEKHH2 (1.8)	ENSG00000228044 (1.8)	DNM2 (1.5)	BCL3 (1.5)	PPP1R37 (1.4)
ENSG00000119698	PPP4R4 PPI subnetwork	0.09	> 0.20	ATP13A1 (4.3)	DDX56 (2.9)	MAPKAPK5 (2.7)	TOMM40 (2.6)	BRAP (2.6)	PTPN11 (2.5)	HNF1A (2.4)	LPA (2.3)	CEACAM19 (2.2)	DHODH (2.1)
MP:0003720	abnormal neural tube closure	0.09	> 0.20	NYNRIN (2.6)	PVRL2 (2.4)	ATXN7L2 (2.3)	FADS2 (2.3)	BCAM (2.1)	HMGCR (2.1)	ZHX3 (2.0)	LDLR (2.0)	SLC44A2 (2.0)	DYNC2LI1 (1.8)
ENSG00000138764	CCNG2 PPI subnetwork	0.09	> 0.20	MYLIP (2.1)	CARM1 (1.9)	LPIN3 (1.6)	APOE (1.6)	MAPKAPK5 (1.6)	RHCE (1.6)	PVRL2 (1.5)	MAFB (1.5)	DNM2 (1.4)	GRINA (1.2)
ENSG00000112992	NNT PPI subnetwork	0.09	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.3)	C1orf63 (1.7)	CETP (1.6)	TMED4 (1.6)	TRAPPC6A (1.6)	PCSK9 (1.6)	SORT1 (1.5)	ATP13A1 (1.4)
GO:0032459	regulation of protein oligomerization	0.09	> 0.20	C12orf47 (3.4)	ZNF101 (2.1)	BRAP (2.1)	TMEM116 (2.1)	TXNL4B (1.8)	LPIN3 (1.7)	FRK (1.7)	POLK (1.6)	ANKRD31 (1.5)	C12orf43 (1.5)
ENSG00000156304	SCAF4 PPI subnetwork	0.09	> 0.20	SUGP1 (3.6)	ILF3 (3.5)	BUD13 (2.9)	SMARCA4 (2.9)	C1orf63 (2.6)	DHX38 (2.5)	MAU2 (2.1)	USP1 (2.0)	ST3GAL4 (1.9)	FEN1 (1.9)
GO:0043491	protein kinase B signaling cascade	0.09	> 0.20	TIMD4 (2.7)	CETP (2.4)	ZNF180 (2.2)	PVRL2 (2.2)	SORT1 (2.1)	NKPD1 (2.0)	CILP2 (1.8)	CLPTM1 (1.7)	BCAM (1.7)	SLC44A2 (1.5)
GO:0045088	regulation of innate immune response	0.10	> 0.20	PARP10 (3.2)	OASL (3.1)	TRAFD1 (2.8)	ZNF101 (2.7)	CYB561D1 (2.6)	ENSG00000228044 (2.2)	SH2B3 (2.1)	BCL3 (2.1)	RELB (1.9)	POLK (1.8)
MP:0009403	increased variability of skeletal muscle fiber size	0.10	> 0.20	SYPL2 (5.6)	PVR (2.7)	BCAM (2.3)	PLEC (2.1)	CYP7A1 (2.1)	MAU2 (1.7)	CYB561D1 (1.6)	AMIGO1 (1.5)	APOC4 (1.5)	KANK2 (1.5)
ENSG00000138378	STAT4 PPI subnetwork	0.10	> 0.20	HLX (3.6)	COL4A3BP (3.4)	BCL3 (3.2)	ENSG00000238078 (2.6)	ALDH2 (2.5)	DNM2 (2.4)	TRAFD1 (2.3)	PARP10 (2.3)	TRIB1 (2.0)	GMIP (2.0)
GO:0030203	glycosaminoglycan metabolic process	0.10	> 0.20	TMED4 (2.9)	ST3GAL4 (2.7)	TMEM50A (2.1)	ERP29 (2.1)	TMEM57 (2.0)	CILP2 (1.9)	ENSG00000228044 (1.9)	CEACAM19 (1.7)	NKPD1 (1.6)	YIPF2 (1.6)
ENSG00000170345	FOS PPI subnetwork	0.10	> 0.20	TRIB1 (4.3)	BCL3 (4.1)	MAPKAPK5 (3.0)	GRINA (2.7)	PARP10 (2.4)	RELB (2.4)	OASL (2.3)	HLX (2.3)	ATXN2 (2.2)	CARM1 (2.2)
ENSG00000128881	TTBK2 PPI subnetwork	0.10	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.4)	DNAH11 (2.1)	C1orf63 (1.8)	TMEM57 (1.7)	CEACAM19 (1.6)	SYPL2 (1.5)	HNF1A (1.5)	MOSC1 (1.4)
ENSG00000124198	ARFGEF2 PPI subnetwork	0.10	> 0.20	NAA25 (4.3)	DHX38 (3.6)	ZNF259 (3.3)	DDX56 (3.2)	USP24 (2.8)	OGDH (2.7)	TOP1 (2.4)	TOMM40 (2.0)	DOCK7 (1.9)	ATP13A1 (1.9)
GO:0008652	cellular amino acid biosynthetic process	0.10	> 0.20	CYP7A1 (3.4)	TM6SF2 (3.2)	ABCG8 (3.1)	SARS (3.0)	ANGPTL3 (2.8)	PLG (2.3)	APOC4 (2.1)	DHODH (2.1)	LPA (2.0)	APOA5 (2.0)
ENSG00000185104	FAF1 PPI subnetwork	0.10	> 0.20	TMEM57 (3.0)	SUGP1 (2.3)	BRAP (2.2)	USP24 (2.0)	RELB (1.9)	GATAD2A (1.8)	BLOC1S3 (1.7)	COL4A3BP (1.7)	CEACAM19 (1.7)	MAU2 (1.6)
ENSG00000206088	ENSG00000206088 PPI subnetwork	0.10	> 0.20	TRIB1 (2.6)	MYLIP (2.5)	CELSR2 (2.5)	BCL3 (2.4)	SMARCA4 (2.2)	POLK (2.0)	GATAD2A (1.9)	PARP10 (1.9)	BUD13 (1.9)	RELB (1.8)
ENSG00000185122	HSF1 PPI subnetwork	0.10	> 0.20	PPP1R37 (3.1)	TOMM40 (3.0)	GRINA (2.7)	MARK4 (2.2)	CLPTM1 (2.2)	TRIB1 (2.1)	CARM1 (2.1)	C12orf47 (2.0)	ATXN2 (2.0)	PSMA5 (1.9)
MP:0009237	kinked sperm flagellum	0.10	> 0.20	TSSK6 (3.6)	CEACAM19 (2.5)	TIMD4 (2.3)	PMFBP1 (2.1)	MARK4 (2.0)	NT5DC1 (1.8)	ENSG00000228044 (1.7)	FADS2 (1.7)	PCSK9 (1.5)	SLC44A2 (1.5)
GO:0040013	negative regulation of locomotion	0.10	> 0.20	CEACAM19 (3.0)	PVRL2 (2.6)	GCNT4 (2.5)	ENSG00000226645 (2.3)	PLEKHH2 (2.3)	ANKRD31 (2.3)	HLX (2.2)	CILP2 (2.0)	ENSG00000254235 (1.9)	KANK2 (1.9)
KEGG_ONE_CARBON_POOL_BY_FOLATE	KEGG_ONE_CARBON_POOL_BY_FOLATE	0.10	> 0.20	SARS (3.7)	CYP7A1 (3.4)	DHODH (3.0)	LPA (2.5)	SLC22A1 (2.5)	PLG (2.5)	GOT2P1 (2.4)	APOC4 (2.2)	QTRT1 (2.1)	CEACAM19 (2.1)
ENSG00000189403	HMGB1 PPI subnetwork	0.10	> 0.20	PCSK9 (3.1)	BCL3 (2.5)	FADS1 (2.5)	TRIB1 (2.3)	CELSR2 (2.0)	CARM1 (1.9)	FADS2 (1.8)	LDLR (1.7)	C12orf47 (1.7)	ENSG00000238078 (1.6)
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	0.10	> 0.20	FADS2 (10.3)	FADS1 (9.9)	HMGCR (7.2)	LDLR (6.8)	PCSK9 (4.7)	GPAM (3.8)	MOSC1 (3.2)	DOCK7 (2.4)	APOC1 (2.4)	ALDH2 (2.2)
MP:0008803	abnormal placental labyrinth vasculature morphology	0.10	> 0.20	AP1M2 (3.4)	DNM2 (2.9)	PVRL2 (2.3)	KANK2 (2.1)	C12orf51 (2.0)	CARM1 (2.0)	HLX (1.9)	CBLC (1.8)	MAU2 (1.8)	PLEC (1.7)
GO:0004540	ribonuclease activity	0.10	> 0.20	DHODH (3.3)	ZNF180 (2.4)	OASL (2.3)	C12orf43 (2.3)	QTRT1 (2.3)	DDX56 (2.1)	POC5 (2.0)	SUGP1 (1.8)	NT5DC1 (1.7)	TMEM50A (1.7)
GO:0030134	ER to Golgi transport vesicle	0.10	> 0.20	FADS2 (3.9)	YIPF2 (3.5)	LDLR (3.3)	HMGCR (2.9)	FADS1 (2.8)	TMED4 (2.1)	ABCG8 (2.0)	ENSG00000228044 (1.7)	NPC1L1 (1.7)	LPIN3 (1.5)
ENSG00000111602	TIMELESS PPI subnetwork	0.10	> 0.20	FEN1 (5.9)	USP1 (3.9)	ILF3 (2.2)	TMEM57 (2.2)	DHX38 (2.0)	MAFB (1.7)	ENSG00000228044 (1.5)	KANK2 (1.5)	ZHX3 (1.5)	CYP7A1 (1.4)
ENSG00000099917	MED15 PPI subnetwork	0.10	> 0.20	ATXN7L2 (2.8)	BUD13 (2.8)	GEMIN7 (2.7)	MAPKAPK5 (2.6)	LDLR (2.4)	C12orf51 (2.3)	ATXN2 (2.1)	FADS2 (2.1)	ENSG00000226648 (2.0)	HMGCR (1.9)
ENSG00000171311	EXOSC1 PPI subnetwork	0.10	> 0.20	USP24 (4.2)	DDX56 (3.4)	DHODH (3.1)	SUGP1 (2.9)	DHX38 (2.9)	NAA25 (2.4)	POC5 (2.3)	TOMM40 (2.2)	ZNF259 (2.1)	POLK (2.0)
ENSG00000109458	GAB1 PPI subnetwork	0.10	> 0.20	ITGB3 (3.5)	ZHX3 (3.4)	GATAD2A (2.9)	ATXN2 (2.3)	ABO (2.3)	SLC44A2 (2.3)	COL4A3BP (2.2)	SH2B3 (2.1)	PTPN11 (2.0)	DNM2 (1.9)
ENSG00000179218	CALR PPI subnetwork	0.10	> 0.20	ITGB3 (3.1)	ERP29 (2.7)	RPH3A (2.6)	TMED4 (2.5)	PCSK9 (2.2)	HAPLN4 (2.2)	HP (2.1)	BCAM (2.0)	ZNF101 (1.9)	APOA5 (1.8)
GO:0050764	regulation of phagocytosis	0.10	> 0.20	HP (2.8)	CILP2 (2.5)	ANKRD31 (1.7)	MAFB (1.7)	GPAM (1.6)	ERP29 (1.6)	LPA (1.6)	ALDH2 (1.6)	UBXN2B (1.6)	GOT2P1 (1.6)
MP:0001314	corneal opacity	0.10	> 0.20	MAFB (3.8)	APOC1 (2.9)	AMIGO1 (2.7)	CETP (2.6)	ENSG00000238078 (2.0)	PLCG1 (1.9)	ENSG00000226648 (1.9)	MYLIP (1.9)	APOE (1.8)	HAVCR1 (1.7)
ENSG00000138385	SSB PPI subnetwork	0.10	> 0.20	QTRT1 (2.6)	POLK (2.4)	TOP1 (2.2)	BLOC1S3 (2.1)	NAA25 (2.0)	PTPN11 (2.0)	UBXN2B (1.8)	GCNT4 (1.8)	PVR (1.8)	RELB (1.8)
GO:0005024	transforming growth factor beta-activated receptor activity	0.10	> 0.20	NYNRIN (2.8)	CEACAM19 (2.1)	TMED4 (2.0)	PLEC (2.0)	ZNF101 (1.8)	PVRL2 (1.8)	PVR (1.7)	BCAM (1.7)	AMIGO1 (1.5)	SLC44A2 (1.5)
ENSG00000126767	ELK1 PPI subnetwork	0.10	> 0.20	SH2B3 (3.0)	HLX (2.6)	GEMIN7 (2.6)	BCL3 (2.2)	PBX4 (2.1)	CEACAM19 (2.0)	TRIB1 (2.0)	ENSG00000238078 (1.8)	ALDH2 (1.8)	KANK2 (1.7)
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	0.10	> 0.20	CYP7A1 (4.5)	APOA5 (3.9)	HP (3.9)	PLG (3.8)	SLC22A1 (3.7)	ANGPTL3 (3.4)	APOC4 (3.2)	LPA (2.6)	APOC1 (2.5)	HAVCR1 (2.3)
ENSG00000113712	CSNK1A1 PPI subnetwork	0.10	> 0.20	GATAD2A (3.2)	DNM2 (2.4)	LPAR2 (2.0)	TRIB1 (2.0)	PVRL2 (1.9)	MARK4 (1.8)	ENSG00000226645 (1.8)	NYNRIN (1.8)	UBXN2B (1.7)	PPP1R37 (1.6)
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	0.10	> 0.20	HMGCR (14.2)	LDLR (13.4)	FADS2 (11.5)	FADS1 (11.0)	PCSK9 (8.8)	TRAPPC6A (2.0)	NKPD1 (1.8)	CYP7A1 (1.7)	LPAR2 (1.6)	GPAM (1.5)
GO:0012507	ER to Golgi transport vesicle membrane	0.10	> 0.20	FADS2 (4.2)	YIPF2 (3.5)	LDLR (3.4)	HMGCR (3.1)	FADS1 (2.9)	ABCG8 (2.3)	NPC1L1 (1.9)	TMED4 (1.7)	LPIN3 (1.7)	ENSG00000228044 (1.6)
ENSG00000174444	RPL4 PPI subnetwork	0.10	> 0.20	DDX56 (3.7)	NAA25 (3.7)	ZNF259 (3.3)	TOMM40 (3.1)	QTRT1 (2.9)	ILF3 (2.4)	TOP1 (2.2)	SUGP1 (2.1)	DHX38 (2.0)	DHODH (2.0)
MP:0004214	abnormal long bone diaphysis morphology	0.10	> 0.20	CILP2 (4.2)	NYNRIN (3.2)	CBLC (2.8)	BCAM (2.5)	APOE (2.2)	PLEC (2.0)	ENSG00000238078 (2.0)	ENSG00000228044 (2.0)	PLEKHH2 (2.0)	TRIB1 (1.9)
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCTTRIC	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCTTRIC	0.10	> 0.20	NAA25 (2.3)	GMPR (2.1)	SMARCA4 (2.1)	ITGB3 (1.9)	PSMA5 (1.8)	ZNF259 (1.7)	DDX56 (1.7)	RHD (1.7)	NKPD1 (1.7)	HMGCR (1.6)
MP:0002411	decreased susceptibility to bacterial infection	0.10	> 0.20	MAFB (3.2)	GMIP (2.7)	FRK (2.6)	C11orf9 (2.3)	APOE (2.1)	PARP10 (2.0)	BCL3 (1.7)	OASL (1.6)	CBLC (1.4)	RELB (1.4)
GO:0031300	intrinsic to organelle membrane	0.10	> 0.20	CLPTM1 (4.4)	TMED4 (3.3)	ATP13A1 (3.1)	YIPF2 (3.0)	AMIGO1 (2.7)	TMEM50A (2.5)	CYB561D1 (2.5)	ERP29 (2.5)	GRINA (2.4)	TMEM57 (2.0)
ENSG00000133124	IRS4 PPI subnetwork	0.10	> 0.20	CETP (2.7)	PVRL2 (2.5)	TIMD4 (2.3)	DNAH11 (2.2)	PLEKHH2 (2.1)	SLC44A2 (2.0)	ATP13A1 (1.8)	ERP29 (1.7)	ZHX3 (1.7)	PLCG1 (1.6)
ENSG00000105281	SLC1A5 PPI subnetwork	0.10	> 0.20	CEACAM19 (2.4)	TMEM50A (2.2)	TRAPPC6A (1.8)	PBX4 (1.8)	FRK (1.7)	ITGB3 (1.7)	PARP10 (1.7)	C1orf63 (1.6)	ZNF101 (1.5)	C11orf9 (1.5)
ENSG00000109906	ZBTB16 PPI subnetwork	0.10	> 0.20	DNM2 (3.1)	POLK (2.4)	YIPF2 (2.3)	PBX4 (2.2)	ACAD10 (2.1)	MAU2 (1.9)	PSRC1 (1.9)	PSMA5 (1.9)	PPP1R37 (1.9)	BCL3 (1.9)
MP:0001633	poor circulation	0.10	> 0.20	HNF1A (2.3)	PVRL2 (2.2)	DHODH (1.8)	LPIN3 (1.8)	MYLIP (1.7)	SLC22A1 (1.7)	DNM2 (1.6)	ENSG00000238078 (1.6)	SORT1 (1.4)	SH2B3 (1.4)
GO:0001871	pattern binding	0.10	> 0.20	CILP2 (5.2)	HP (4.4)	MAFB (3.0)	PLG (2.7)	ANGPTL3 (2.2)	TIMD4 (2.1)	APOC4 (2.0)	LPA (1.9)	APOE (1.9)	MOSC1 (1.8)
GO:0030247	polysaccharide binding	0.10	> 0.20	CILP2 (5.2)	HP (4.4)	MAFB (3.0)	PLG (2.7)	ANGPTL3 (2.2)	TIMD4 (2.1)	APOC4 (2.0)	LPA (1.9)	APOE (1.9)	MOSC1 (1.8)
MP:0009642	abnormal blood homeostasis	0.10	> 0.20	APOB (4.6)	PLG (4.6)	HP (4.2)	APOA5 (3.7)	APOC4 (3.1)	ANGPTL3 (3.0)	ABCG5 (3.0)	TM6SF2 (2.3)	GPAM (2.3)	SLC22A1 (2.0)
ENSG00000100767	PAPLN PPI subnetwork	0.10	> 0.20	MYLIP (3.0)	BUD13 (2.4)	PLEKHH2 (1.9)	HNF1A (1.5)	DOCK7 (1.4)	HLX (1.3)	PVRL2 (1.3)	ZHX3 (1.3)	TRIB1 (1.3)	SARS (1.2)
ENSG00000106105	GARS PPI subnetwork	0.10	> 0.20	SARS (3.1)	ZNF101 (2.3)	NT5DC1 (2.3)	NAA25 (2.1)	FADS1 (2.0)	PLEC (1.9)	PMFBP1 (1.8)	QTRT1 (1.8)	PCSK9 (1.7)	UBXN2B (1.7)
ENSG00000162298	SYVN1 PPI subnetwork	0.10	> 0.20	LDLR (3.4)	TMEM57 (2.0)	OGDH (2.0)	FADS2 (1.9)	FADS1 (1.8)	BRAP (1.7)	TMED4 (1.7)	PCSK9 (1.4)	PVR (1.4)	PSMA5 (1.4)
GO:0002065	columnar/cuboidal epithelial cell differentiation	0.10	> 0.20	GCNT4 (3.6)	C11orf9 (3.1)	KIAA1324 (2.7)	GOT2P1 (2.6)	ENSG00000235545 (2.4)	ABCG8 (2.3)	CBLC (2.1)	ANKRD31 (2.0)	LPAR2 (1.8)	ENSG00000254235 (1.6)
GO:0008645	hexose transport	0.10	> 0.20	GCNT4 (3.4)	NPC1L1 (3.0)	DOCK7 (3.0)	ABCG8 (2.3)	KIAA1324 (2.1)	ABCG5 (2.0)	SORT1 (2.0)	POC5 (2.0)	DNAH11 (1.9)	TMED4 (1.8)
GO:0015758	glucose transport	0.10	> 0.20	GCNT4 (3.4)	NPC1L1 (3.0)	DOCK7 (3.0)	ABCG8 (2.3)	KIAA1324 (2.1)	ABCG5 (2.0)	SORT1 (2.0)	POC5 (2.0)	DNAH11 (1.9)	TMED4 (1.8)
ENSG00000136271	DDX56 PPI subnetwork	0.10	> 0.20	ZNF259 (4.8)	TOMM40 (4.1)	NAA25 (4.1)	DDX56 (4.1)	QTRT1 (3.4)	DHODH (3.0)	DHX38 (2.8)	C12orf43 (2.8)	SUGP1 (2.7)	MAPKAPK5 (2.0)
MP:0001510	abnormal coat appearance	0.10	> 0.20	CBLC (3.3)	AP1M2 (3.2)	CEACAM19 (3.2)	GCNT4 (2.0)	TM6SF2 (1.9)	ENSG00000254235 (1.9)	CELSR2 (1.9)	TRAPPC6A (1.8)	YIPF2 (1.7)	ENSG00000238078 (1.6)
ENSG00000089159	PXN PPI subnetwork	0.10	> 0.20	PLEC (4.7)	ITGB3 (3.0)	SH2B3 (2.3)	KANK2 (2.2)	APOE (2.1)	TOP1 (2.0)	SLC44A2 (1.8)	SMARCA4 (1.8)	GATAD2A (1.8)	DNM2 (1.7)
MP:0003383	abnormal gluconeogenesis	0.10	> 0.20	GPAM (4.5)	PVR (2.9)	MAFB (2.4)	HP (2.3)	SORT1 (2.3)	ZHX3 (2.2)	ATXN2 (1.8)	CILP2 (1.8)	ATXN7L2 (1.8)	MOSC1 (1.8)
MP:0008019	increased liver tumor incidence	0.10	> 0.20	PBX4 (2.4)	CYP7A1 (2.4)	AMIGO1 (2.0)	DOCK7 (1.9)	APOC4 (1.7)	ABCG8 (1.7)	PSRC1 (1.7)	DNM2 (1.7)	POC5 (1.6)	FEN1 (1.6)
ENSG00000168488	ATXN2L PPI subnetwork	0.10	> 0.20	BRAP (2.4)	ENSG00000226648 (2.4)	DNAH11 (2.4)	YIPF2 (2.3)	C19orf52 (2.2)	ATXN2 (2.1)	ANKRD31 (2.0)	ST3GAL4 (2.0)	BLOC1S3 (1.9)	RHD (1.9)
GO:0000387	spliceosomal snRNP assembly	0.10	> 0.20	C12orf43 (2.9)	C19orf52 (2.6)	ENSG00000238078 (2.6)	GOT2P1 (2.6)	ZNF259 (2.5)	ZNF180 (2.3)	QTRT1 (2.0)	NKPD1 (2.0)	TOMM40 (1.8)	BUD13 (1.8)
ENSG00000141447	OSBPL1A PPI subnetwork	0.10	> 0.20	USP24 (3.1)	PARP10 (3.0)	MAU2 (2.9)	GMIP (2.5)	BCL3 (2.4)	ATXN2 (2.2)	MARK4 (2.2)	SMARCA4 (2.0)	DHX38 (1.8)	C12orf51 (1.8)
ENSG00000143867	OSR1 PPI subnetwork	0.10	> 0.20	USP24 (3.1)	PARP10 (3.0)	MAU2 (2.9)	GMIP (2.5)	BCL3 (2.4)	ATXN2 (2.2)	MARK4 (2.2)	SMARCA4 (2.0)	DHX38 (1.8)	C12orf51 (1.8)
MP:0004618	thoracic vertebral transformation	0.10	> 0.20	UBXN2B (2.1)	HLX (1.7)	NYNRIN (1.6)	HNF1A (1.6)	ATXN7L2 (1.4)	ATXN2 (1.1)	OASL (1.1)	HAVCR1 (1.1)	BCAM (1.1)	DYNC2LI1 (1.1)
GO:0009066	aspartate family amino acid metabolic process	0.10	> 0.20	ENSG00000254235 (3.0)	QTRT1 (2.6)	NT5DC1 (2.6)	CYP7A1 (2.0)	TXNL4B (2.0)	ACAD10 (1.9)	DHODH (1.9)	DYNC2LI1 (1.9)	GOT2P1 (1.9)	SLC22A1 (1.8)
ENSG00000117500	TMED5 PPI subnetwork	0.10	> 0.20	HMGCR (3.6)	FADS1 (3.6)	FADS2 (3.4)	LDLR (3.3)	TMED4 (3.2)	TMEM50A (2.5)	DNAH11 (2.0)	TMEM57 (1.9)	TXNL4B (1.9)	GCNT4 (1.9)
ENSG00000206233	ENSG00000206233 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
ENSG00000168394	TAP1 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
ENSG00000206297	TAP1 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
GO:0018024	histone-lysine N-methyltransferase activity	0.10	> 0.20	C12orf51 (4.4)	ATXN2 (3.4)	MAU2 (2.6)	C12orf43 (2.2)	BRAP (1.8)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	GOT2P1 (1.6)
MP:0005088	increased acute inflammation	0.10	> 0.20	SH2B3 (3.7)	PMFBP1 (3.1)	TRIB1 (2.8)	GMIP (2.3)	POLK (2.0)	BCL3 (1.8)	C11orf9 (1.5)	APOE (1.4)	RELB (1.4)	LDLR (1.3)
MP:0004762	increased anti-double stranded DNA antibody level	0.10	> 0.20	MAFB (3.5)	CETP (3.4)	GMIP (2.6)	RELB (2.5)	BCL3 (2.1)	ZNF101 (2.1)	TRIB1 (1.7)	GCNT4 (1.7)	TOP1 (1.6)	TIMD4 (1.5)
ENSG00000140939	NOL3 PPI subnetwork	0.10	> 0.20	BLOC1S3 (3.1)	GEMIN7 (2.9)	TRAPPC6A (2.9)	PPP1R37 (2.7)	LPAR2 (2.2)	ST3GAL4 (2.1)	ZNF180 (2.0)	PVRL2 (2.0)	CBLC (1.8)	PARP10 (1.7)
ENSG00000205420	KRT6A PPI subnetwork	0.10	> 0.20	CELSR2 (3.0)	ENSG00000228044 (2.3)	PLG (2.0)	APOC1 (1.9)	ANGPTL3 (1.9)	LPA (1.9)	GMPR (1.8)	PMFBP1 (1.7)	ALDH2 (1.7)	HP (1.6)
ENSG00000203747	FCGR3A PPI subnetwork	0.10	> 0.20	TIMD4 (2.6)	ITGB3 (2.5)	SLC22A1 (1.9)	CETP (1.8)	APOE (1.7)	PLCG1 (1.6)	APOC4 (1.6)	APOA5 (1.4)	HP (1.4)	SLC44A2 (1.3)
ENSG00000134954	ETS1 PPI subnetwork	0.10	> 0.20	TRIB1 (2.9)	MYLIP (2.7)	KIAA1324 (2.4)	MAFB (2.0)	ATXN2 (1.9)	GMIP (1.8)	BCL3 (1.8)	SH2B3 (1.7)	USP24 (1.6)	PARP10 (1.6)
GO:0070542	response to fatty acid	0.10	> 0.20	KIAA1324 (2.1)	FADS2 (2.1)	UBXN2B (2.1)	CYP7A1 (1.9)	TSSK6 (1.8)	PCSK9 (1.7)	GPAM (1.7)	HMGCR (1.6)	NPC1L1 (1.6)	FADS1 (1.6)
ENSG00000087152	ATXN7L3 PPI subnetwork	0.10	> 0.20	ATXN7L2 (3.1)	ZNF259 (2.3)	LDLR (2.1)	C17orf57 (1.7)	ANKRD31 (1.7)	YIPF2 (1.5)	TSSK6 (1.4)	ENSG00000226645 (1.4)	C11orf9 (1.4)	ACAD10 (1.3)
MP:0008288	abnormal adrenal cortex morphology	0.10	> 0.20	APOC1 (5.1)	ST3GAL4 (3.6)	PARP10 (2.8)	FADS1 (2.6)	DNAH11 (2.3)	UBXN2B (2.2)	FADS2 (2.0)	YIPF2 (1.8)	OASL (1.8)	GPAM (1.8)
ENSG00000091136	LAMB1 PPI subnetwork	0.10	> 0.20	BCAM (4.2)	KANK2 (3.3)	SLC44A2 (2.8)	PLEC (2.5)	PVRL2 (2.3)	PLEKHH2 (2.3)	OGDH (2.2)	ST3GAL4 (2.1)	CBLC (1.9)	HNF1A (1.8)
ENSG00000173110	HSPA6 PPI subnetwork	0.10	> 0.20	RELB (3.0)	BCL3 (2.5)	PVR (2.3)	MYLIP (2.2)	TXNL4B (1.9)	SARS (1.7)	PLEC (1.6)	GRINA (1.5)	CLPTM1 (1.5)	TRAFD1 (1.4)
MP:0003806	abnormal nucleotide metabolism	0.10	> 0.20	ABCG5 (3.5)	TM6SF2 (3.3)	C17orf57 (2.9)	ABCG8 (2.7)	LPA (2.7)	SLC22A1 (2.6)	ACAD10 (2.3)	ALDH2 (2.3)	PBX4 (2.2)	NPC1L1 (2.2)
ENSG00000112658	SRF PPI subnetwork	0.10	> 0.20	SH2B3 (3.7)	PLEC (2.7)	ENSG00000226648 (2.4)	TOP1 (2.3)	TRIB1 (2.1)	LPIN3 (2.1)	KANK2 (2.0)	HLX (1.9)	CEACAM19 (1.9)	NPC1L1 (1.7)
ENSG00000186868	MAPT PPI subnetwork	0.10	> 0.20	TMEM50A (3.1)	RPH3A (2.5)	COL4A3BP (2.2)	GATAD2A (2.0)	C1orf63 (2.0)	SMARCA4 (1.9)	CLPTM1 (1.9)	GRINA (1.8)	ENSG00000238078 (1.8)	DNM2 (1.7)
GO:0050661	NADP binding	0.10	> 0.20	FADS2 (4.0)	ALDH2 (3.7)	FADS1 (3.3)	ACAD10 (3.3)	LPIN3 (2.9)	KIAA1324 (2.8)	NT5DC1 (2.6)	PCSK9 (2.3)	SLC22A1 (2.2)	CYP7A1 (2.2)
MP:0001656	focal hepatic necrosis	0.10	> 0.20	RHD (5.3)	APOB (4.6)	HP (4.6)	PLG (4.6)	APOC1 (4.4)	APOA5 (4.0)	ANGPTL3 (3.8)	RHCE (3.8)	APOC4 (3.2)	APOE (2.9)
ENSG00000072958	AP1M1 PPI subnetwork	0.10	> 0.20	CLPTM1 (2.4)	CARM1 (2.4)	ERP29 (2.2)	YIPF2 (2.0)	ADAM1 (1.9)	COL4A3BP (1.8)	BRAP (1.8)	PTPN11 (1.7)	FRK (1.6)	SMARCA4 (1.6)
ENSG00000144867	SRPRB PPI subnetwork	0.10	> 0.20	LDLR (6.6)	FADS1 (5.6)	FADS2 (4.4)	HMGCR (4.2)	PCSK9 (3.3)	TRAPPC6A (2.2)	YIPF2 (2.1)	C12orf47 (1.9)	ATP13A1 (1.5)	SORT1 (1.5)
MP:0003449	abnormal intestinal goblet cell morphology	0.10	> 0.20	KIAA1324 (3.8)	NYNRIN (2.7)	MOSC1 (2.4)	PLCG1 (2.2)	HNF1A (2.1)	TMED4 (2.0)	C11orf9 (2.0)	BCAM (1.7)	PLEC (1.7)	PLEKHH2 (1.7)
MP:0005232	abnormal mesenteric lymph node morphology	0.10	> 0.20	BCL3 (4.6)	RELB (3.8)	GRINA (3.8)	NPC1L1 (2.8)	PARP10 (2.7)	ABO (2.6)	PLEC (2.5)	TM6SF2 (2.4)	GMIP (2.2)	SH2B3 (2.2)
MP:0002177	abnormal outer ear morphology	0.10	> 0.20	AP1M2 (2.6)	GCNT4 (2.6)	HAVCR1 (2.1)	CBLC (2.0)	CEACAM19 (2.0)	MYLIP (1.9)	DNAH11 (1.9)	PLCG1 (1.7)	DOCK7 (1.4)	CILP2 (1.3)
ENSG00000185338	SOCS1 PPI subnetwork	0.10	> 0.20	GMIP (3.6)	BCL3 (3.3)	HLX (3.2)	RELB (2.6)	TIMD4 (2.6)	SH2B3 (2.6)	PARP10 (2.5)	DNM2 (2.1)	CETP (2.1)	PLEKHH2 (1.9)
ENSG00000138297	TIMM23 PPI subnetwork	0.10	> 0.20	DHODH (3.2)	TOMM40 (2.7)	GEMIN7 (2.7)	TRAPPC6A (2.3)	C19orf52 (2.2)	QTRT1 (2.1)	ANGPTL3 (2.0)	POC5 (2.0)	DDX56 (1.9)	CYP7A1 (1.9)
ENSG00000115590	IL1R2 PPI subnetwork	0.10	> 0.20	ST3GAL4 (2.9)	UBXN2B (2.6)	OASL (2.2)	ENSG00000254235 (1.8)	PARP10 (1.8)	ABCG5 (1.8)	ABCG8 (1.7)	TRAFD1 (1.6)	HLX (1.6)	ENSG00000235545 (1.6)
REACTOME_DEATH_RECEPTOR__SIGNALLING	REACTOME_DEATH_RECEPTOR__SIGNALLING	0.10	> 0.20	RELB (4.0)	OASL (3.2)	TRAFD1 (3.1)	HAVCR1 (3.0)	PARP10 (2.5)	BCL3 (2.5)	FRK (2.5)	LPAR2 (2.5)	POC5 (1.8)	POLK (1.6)
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	0.10	> 0.20	RELB (4.0)	OASL (3.2)	TRAFD1 (3.1)	HAVCR1 (3.0)	PARP10 (2.5)	BCL3 (2.5)	FRK (2.5)	LPAR2 (2.5)	POC5 (1.8)	POLK (1.6)
GO:0016887	ATPase activity	0.10	> 0.20	DHX38 (3.9)	ATP13A1 (3.5)	SMARCA4 (3.0)	SUGP1 (2.9)	USP24 (2.6)	NAA25 (2.5)	MAU2 (2.2)	DOCK7 (2.2)	ILF3 (2.1)	COL4A3BP (2.1)
GO:0009792	embryo development ending in birth or egg hatching	0.10	> 0.20	ATXN7L2 (3.2)	PVRL2 (2.4)	NYNRIN (2.0)	ATXN2 (1.9)	CARM1 (1.8)	ENSG00000254235 (1.7)	BCAM (1.6)	PPP1R37 (1.4)	CILP2 (1.4)	HLX (1.4)
MP:0004564	enlarged myocardial fiber	0.10	> 0.20	MOSC1 (2.3)	ACAD10 (2.1)	ALDH2 (2.1)	NPC1L1 (2.0)	TM6SF2 (2.0)	DOCK7 (1.5)	GPAM (1.5)	NCAN (1.4)	DHX38 (1.4)	ERP29 (1.3)
GO:0048771	tissue remodeling	0.10	> 0.20	ENSG00000254235 (2.4)	CILP2 (2.3)	SLC22A1 (2.1)	BCAM (2.0)	PLEKHH2 (1.6)	ENSG00000235545 (1.5)	ST3GAL4 (1.4)	LPA (1.3)	PPP1R37 (1.3)	PVR (1.2)
GO:0046364	monosaccharide biosynthetic process	0.10	> 0.20	LPA (2.5)	MOSC1 (2.5)	GPAM (2.1)	TM6SF2 (2.1)	DHODH (1.9)	HAPLN4 (1.8)	ACAD10 (1.8)	SLC22A1 (1.7)	SYPL2 (1.7)	NT5DC1 (1.7)
GO:0042440	pigment metabolic process	0.10	> 0.20	RHCE (4.9)	RHD (4.6)	GMPR (2.6)	ADAM1 (2.4)	NT5DC1 (2.3)	DHODH (2.2)	TRAPPC6A (2.1)	ENSG00000235545 (2.0)	ACAD10 (1.5)	PMFBP1 (1.4)
GO:2000191	regulation of fatty acid transport	0.10	> 0.20	C12orf43 (2.1)	CBLC (2.1)	PPP1R37 (1.7)	ATXN7L2 (1.7)	ST3GAL4 (1.3)	MAFB (1.3)	PMFBP1 (1.3)	BLOC1S3 (1.3)	CLPTM1 (1.2)	PVR (1.2)
ENSG00000140464	PML PPI subnetwork	0.10	> 0.20	OASL (4.0)	TRAFD1 (3.5)	ATXN2 (3.5)	TRIB1 (3.2)	BRAP (3.1)	GATAD2A (2.7)	SH2B3 (2.7)	MAU2 (2.4)	PARP10 (2.3)	C12orf51 (1.8)
ENSG00000184967	NOC4L PPI subnetwork	0.10	> 0.20	DDX56 (4.8)	ZNF259 (4.5)	NAA25 (3.7)	TOMM40 (3.4)	QTRT1 (3.4)	DHODH (2.7)	MAPKAPK5 (2.1)	DHX38 (2.1)	BRAP (2.0)	SUGP1 (2.0)
ENSG00000137936	BCAR3 PPI subnetwork	0.10	> 0.20	GATAD2A (3.5)	TOMM40 (3.3)	SARS (3.1)	DDX56 (2.9)	SMARCA4 (2.7)	QTRT1 (2.6)	ILF3 (2.5)	C12orf43 (2.3)	FADS2 (2.2)	NAA25 (2.0)
GO:0000981	sequence-specific DNA binding RNA polymerase II transcription factor activity	0.10	> 0.20	TRIB1 (4.9)	KANK2 (2.5)	NYNRIN (2.1)	HNF1A (2.1)	SH2B3 (1.8)	ALDH2 (1.8)	MAFB (1.7)	ATXN2 (1.7)	PVRL2 (1.6)	BCL3 (1.6)
ENSG00000140682	TGFB1I1 PPI subnetwork	0.10	> 0.20	SH2B3 (4.1)	GATAD2A (3.0)	HAPLN4 (2.7)	CARM1 (2.4)	HNF1A (2.4)	POLK (2.3)	BRAP (2.0)	GMIP (2.0)	PLEC (1.9)	PMFBP1 (1.9)
ENSG00000188739	RBM34 PPI subnetwork	0.10	> 0.20	ZNF259 (4.8)	NAA25 (4.7)	TOMM40 (3.7)	DDX56 (3.6)	QTRT1 (3.0)	TOP1 (3.0)	DHODH (2.9)	DHX38 (2.5)	MAPKAPK5 (2.0)	ATP13A1 (2.0)
GO:0010181	FMN binding	0.10	> 0.20	PLG (3.6)	SLC22A1 (3.3)	ANGPTL3 (3.0)	LPA (2.9)	DHODH (2.7)	LPIN3 (2.6)	BLOC1S3 (2.6)	GRINA (2.3)	HP (2.3)	APOA5 (2.3)
GO:0000038	very long-chain fatty acid metabolic process	0.10	> 0.20	NKPD1 (3.2)	FADS2 (3.1)	CYB561D1 (2.3)	MOSC1 (1.7)	HMGCR (1.7)	DNM2 (1.6)	ABCG8 (1.5)	AMIGO1 (1.5)	GMPR (1.5)	FADS1 (1.4)
MP:0003231	abnormal placenta vasculature	0.10	> 0.20	DOCK7 (3.3)	BCAM (2.3)	NYNRIN (2.2)	KANK2 (2.2)	PVRL2 (2.1)	C12orf51 (2.0)	BCL3 (1.8)	CBLC (1.8)	ZHX3 (1.8)	APOE (1.8)
ENSG00000166170	BAG5 PPI subnetwork	0.10	> 0.20	FRK (2.9)	PARP10 (2.7)	ZNF180 (2.6)	PTPN11 (2.2)	DOCK7 (1.8)	TOMM40 (1.7)	SYPL2 (1.6)	ADAM1 (1.6)	C17orf57 (1.5)	PPP1R37 (1.5)
ENSG00000100342	APOL1 PPI subnetwork	0.10	> 0.20	HP (3.6)	APOB (3.2)	GMPR (2.5)	FRK (2.2)	APOE (2.2)	NPC1L1 (2.1)	BRAP (2.0)	TRIB1 (1.9)	APOA5 (1.9)	CELSR2 (1.8)
GO:0034446	substrate adhesion-dependent cell spreading	0.10	> 0.20	PLEKHH2 (3.4)	LPIN3 (2.7)	KANK2 (2.5)	AP1M2 (2.1)	GCNT4 (1.9)	NYNRIN (1.9)	HNF1A (1.7)	PMFBP1 (1.7)	BCAM (1.7)	TSSK6 (1.6)
ENSG00000116670	MAD2L2 PPI subnetwork	0.10	> 0.20	CLPTM1 (2.5)	PPP1R37 (2.3)	CBLC (2.3)	ABO (2.1)	BUD13 (2.0)	CETP (2.0)	TIMD4 (1.9)	C12orf51 (1.9)	KANK2 (1.8)	PSRC1 (1.8)
ENSG00000143418	CERS2 PPI subnetwork	0.10	> 0.20	HMGCR (6.7)	LDLR (6.6)	FADS1 (4.8)	PCSK9 (3.8)	FADS2 (3.6)	APOA5 (3.4)	HP (2.9)	LPA (2.9)	MOSC1 (2.5)	PLG (2.3)
ENSG00000120738	EGR1 PPI subnetwork	0.10	> 0.20	TRIB1 (4.3)	BCL3 (3.4)	UBXN2B (2.7)	CARM1 (2.4)	TOP1 (2.1)	ATXN2 (1.8)	MAFB (1.7)	GRINA (1.7)	ALDH2 (1.6)	BCAM (1.6)
MP:0002092	abnormal eye morphology	0.10	> 0.20	TRIB1 (2.5)	GPAM (1.9)	ST3GAL4 (1.7)	LPA (1.7)	MAFB (1.7)	ENSG00000254235 (1.5)	APOE (1.5)	PLEC (1.4)	TMEM116 (1.4)	PLCG1 (1.3)
ENSG00000161217	PCYT1A PPI subnetwork	0.10	> 0.20	ENSG00000254235 (2.9)	NT5DC1 (2.8)	RHCE (2.1)	NAA25 (2.1)	BRAP (2.0)	C12orf43 (2.0)	SYPL2 (1.9)	LPAR2 (1.9)	RHD (1.8)	FRK (1.7)
ENSG00000197170	PSMD12 PPI subnetwork	0.10	> 0.20	PSMA5 (5.7)	NAA25 (2.8)	TOMM40 (2.7)	TRAFD1 (2.7)	NT5DC1 (2.1)	DDX56 (1.9)	TOP1 (1.8)	HMGCR (1.4)	ENSG00000254235 (1.4)	CLPTM1 (1.3)
ENSG00000213341	CHUK PPI subnetwork	0.10	> 0.20	RELB (5.3)	BCL3 (4.0)	PARP10 (3.6)	OASL (3.5)	SH2B3 (2.8)	PTPN11 (2.5)	PLEC (2.3)	BCAM (2.2)	PPP1R37 (2.2)	TRIB1 (2.0)
ENSG00000164605	ENSG00000164605 PPI subnetwork	0.10	> 0.20	ATP13A1 (3.0)	MAPKAPK5 (2.8)	TOMM40 (2.4)	LPA (2.3)	HNF1A (2.3)	DHODH (2.1)	CEACAM19 (2.0)	USP24 (1.9)	DDX56 (1.8)	BRAP (1.8)
ENSG00000134588	USP26 PPI subnetwork	0.10	> 0.20	ILF3 (3.0)	HMGCR (2.6)	TOMM40 (2.6)	SMARCA4 (2.6)	FADS1 (2.2)	LDLR (1.9)	TMEM57 (1.9)	OGDH (1.9)	C1orf63 (1.7)	TMEM50A (1.6)
ENSG00000132522	GPS2 PPI subnetwork	0.10	> 0.20	UBXN2B (1.9)	PSRC1 (1.8)	SMARCA4 (1.8)	GMIP (1.7)	ITGB3 (1.6)	GCNT4 (1.6)	SH2B3 (1.6)	SLC44A2 (1.5)	OGDH (1.5)	AP1M2 (1.4)
REACTOME_METABOLISM_OF_PORPHYRINS	REACTOME_METABOLISM_OF_PORPHYRINS	0.10	> 0.20	RHCE (11.8)	RHD (11.7)	GMPR (2.9)	C12orf51 (2.4)	MAFB (2.4)	ALDH2 (2.3)	CETP (2.3)	NT5DC1 (2.1)	DHODH (1.9)	APOC1 (1.8)
REACTOME_TRAF3:DEPENDENT_IRF_ACTIVATION_PATHWAY	REACTOME_TRAF3:DEPENDENT_IRF_ACTIVATION_PATHWAY	0.10	> 0.20	OASL (13.0)	PARP10 (8.2)	TRAFD1 (4.0)	RELB (3.1)	CYB561D1 (2.4)	BLOC1S3 (2.3)	GEMIN7 (2.0)	BCL3 (1.8)	GMIP (1.6)	PVRL2 (1.4)
ENSG00000171824	EXOSC10 PPI subnetwork	0.10	> 0.20	DHX38 (3.1)	DHODH (2.8)	DDX56 (2.7)	ATP13A1 (2.7)	TOP1 (2.7)	TOMM40 (2.7)	USP1 (2.4)	SUGP1 (2.3)	ZNF259 (2.1)	UBXN2B (2.0)
ENSG00000114737	CISH PPI subnetwork	0.10	> 0.20	PARP10 (3.2)	USP24 (2.5)	TRAFD1 (2.2)	CYB561D1 (2.1)	BCL3 (2.0)	TMEM50A (1.8)	ALDH2 (1.6)	OASL (1.6)	PLEKHH2 (1.3)	ZHX3 (1.3)
GO:0042277	peptide binding	0.10	> 0.20	KIAA1324 (3.7)	YIPF2 (3.0)	ERP29 (2.9)	NPC1L1 (2.7)	TM6SF2 (2.4)	ABCG8 (2.1)	TOP1 (2.1)	ATP13A1 (1.9)	GPAM (1.9)	CETP (1.9)
GO:0010743	regulation of macrophage derived foam cell differentiation	0.10	> 0.20	TIMD4 (4.4)	MOSC1 (2.5)	APOE (2.4)	GEMIN7 (2.3)	APOC1 (2.1)	ENSG00000228044 (1.8)	ITGB3 (1.7)	HP (1.7)	GPAM (1.7)	CETP (1.6)
GO:0043130	ubiquitin binding	0.10	> 0.20	GRINA (3.7)	RELB (2.9)	HAVCR1 (2.1)	MAU2 (1.8)	SARS (1.7)	POC5 (1.7)	PVR (1.6)	ATXN2 (1.6)	PSMA5 (1.4)	BRAP (1.3)
ENSG00000143702	CEP170 PPI subnetwork	0.10	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.9)	DNM2 (2.5)	KIAA1324 (2.3)	HNF1A (2.2)	PLEC (2.0)	ITGB3 (2.0)	NYNRIN (1.9)	CETP (1.6)	C12orf47 (1.6)
ENSG00000147403	RPL10 PPI subnetwork	0.10	> 0.20	NAA25 (3.7)	DDX56 (3.5)	QTRT1 (3.4)	ZNF259 (3.0)	DHODH (2.5)	TOP1 (2.4)	ILF3 (2.2)	C12orf43 (2.1)	GATAD2A (2.1)	TOMM40 (2.1)
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON:LYMPHOID_CELL	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON:LYMPHOID_CELL	0.10	> 0.20	TIMD4 (3.6)	APOE (2.9)	SLC44A2 (2.9)	CETP (1.9)	RHD (1.8)	RELB (1.7)	PVR (1.5)	PLCG1 (1.4)	C19orf52 (1.3)	BCAM (1.3)
KEGG_BASE_EXCISION_REPAIR	KEGG_BASE_EXCISION_REPAIR	0.10	> 0.20	FEN1 (4.0)	USP1 (3.4)	ZNF180 (2.2)	DHODH (2.0)	ABO (1.8)	BUD13 (1.8)	ILF3 (1.8)	TRAPPC6A (1.7)	C12orf47 (1.7)	MAPKAPK5 (1.7)
ENSG00000009790	TRAF3IP3 PPI subnetwork	0.10	> 0.20	ZNF180 (3.4)	PARP10 (2.8)	MARK4 (2.6)	CBLC (2.5)	BCL3 (2.1)	GMIP (1.8)	OASL (1.7)	SMARCA4 (1.6)	PBX4 (1.6)	MAFB (1.6)
ENSG00000117480	FAAH PPI subnetwork	0.10	> 0.20	ACAD10 (3.7)	NT5DC1 (2.9)	HNF1A (2.1)	C1orf63 (1.9)	SORT1 (1.8)	CETP (1.8)	TIMD4 (1.7)	PLEC (1.6)	TRAPPC6A (1.6)	OGDH (1.5)
GO:0003993	acid phosphatase activity	0.10	> 0.20	CLPTM1 (2.6)	RHCE (2.4)	YIPF2 (2.3)	PMFBP1 (2.3)	ANKRD31 (2.3)	C12orf51 (2.1)	HNF1A (2.0)	RHD (2.0)	AMIGO1 (1.6)	APOC1 (1.6)
MP:0003059	decreased insulin secretion	0.10	> 0.20	KIAA1324 (5.3)	FRK (3.3)	GCNT4 (2.4)	COL4A3BP (2.2)	PLEKHH2 (2.1)	HAPLN4 (2.1)	TMEM57 (1.8)	TRIB1 (1.7)	LDLR (1.5)	POLK (1.4)
ENSG00000153113	CAST PPI subnetwork	0.10	> 0.20	ZHX3 (3.0)	ENSG00000238078 (2.9)	MAFB (2.5)	DNM2 (2.3)	RPH3A (2.2)	NCAN (1.8)	FRK (1.7)	SH2B3 (1.5)	ITGB3 (1.5)	PPP1R37 (1.5)
GO:0001954	positive regulation of cell-matrix adhesion	0.10	> 0.20	SLC44A2 (3.7)	GCNT4 (3.1)	CETP (2.9)	PLEKHH2 (2.4)	PBX4 (2.4)	YIPF2 (2.1)	AP1M2 (2.0)	ITGB3 (1.9)	CYP7A1 (1.7)	PVRL2 (1.6)
ENSG00000196549	MME PPI subnetwork	0.10	> 0.20	ACAD10 (2.6)	ABO (2.2)	TMED4 (2.1)	TRIB1 (2.0)	ERP29 (1.7)	CBLC (1.7)	TM6SF2 (1.5)	PVRL2 (1.4)	COL4A3BP (1.4)	BRAP (1.3)
MP:0001121	uterus hypoplasia	0.10	> 0.20	KIAA1324 (2.3)	PMFBP1 (2.2)	TXNL4B (2.1)	ENSG00000228044 (1.9)	BCAM (1.8)	CYB561D1 (1.7)	DNAH11 (1.7)	HAVCR1 (1.5)	NT5DC1 (1.5)	TMED4 (1.5)
ENSG00000007392	LUC7L PPI subnetwork	0.10	> 0.20	DHX38 (4.5)	ILF3 (4.1)	SMARCA4 (3.9)	SUGP1 (3.9)	TOP1 (3.2)	DDX56 (2.9)	BUD13 (2.4)	DOCK7 (2.0)	ATP13A1 (2.0)	NAA25 (1.9)
ENSG00000072062	PRKACA PPI subnetwork	0.10	> 0.20	HLX (2.6)	RELB (2.1)	RPH3A (2.0)	PLEC (1.9)	NCAN (1.9)	BCAM (1.9)	SH2B3 (1.8)	DNM2 (1.8)	GPAM (1.8)	PTPN11 (1.8)
GO:0043901	negative regulation of multi-organism process	0.11	> 0.20	DNAH11 (2.6)	HP (2.3)	RHD (2.2)	TIMD4 (1.9)	GEMIN7 (1.9)	ADAM1 (1.8)	TRAFD1 (1.8)	CETP (1.7)	RHCE (1.7)	OASL (1.6)
ENSG00000106123	EPHB6 PPI subnetwork	0.11	> 0.20	MAU2 (3.0)	GMIP (2.6)	USP24 (2.6)	PARP10 (2.6)	ATXN2 (2.3)	BCL3 (2.3)	MARK4 (2.2)	ZNF180 (2.1)	MAFB (2.1)	POLK (1.9)
MP:0005185	decreased circulating progesterone level	0.11	> 0.20	KIAA1324 (3.6)	APOB (3.2)	GPAM (2.8)	ST3GAL4 (2.4)	LPIN3 (1.9)	ABCG8 (1.7)	HNF1A (1.6)	MOSC1 (1.5)	ABO (1.4)	ABCG5 (1.4)
REACTOME_VIRAL_DSRNATLR3TRIF_COMPLEX_ACTIVATES_RIP1	REACTOME_VIRAL_DSRNATLR3TRIF_COMPLEX_ACTIVATES_RIP1	0.11	> 0.20	RELB (8.5)	BCL3 (5.7)	OASL (4.5)	PARP10 (4.0)	TRAFD1 (3.1)	GMIP (2.7)	PVR (2.2)	ST3GAL4 (2.0)	ATP13A1 (1.6)	C12orf43 (1.4)
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	0.11	> 0.20	PARP10 (5.0)	YIPF2 (3.2)	TMED4 (2.6)	TRAFD1 (1.7)	CEACAM19 (1.7)	HNF1A (1.6)	CBLC (1.5)	RELB (1.4)	NPC1L1 (1.4)	ERP29 (1.4)
REACTOME_DIABETES_PATHWAYS	REACTOME_DIABETES_PATHWAYS	0.11	> 0.20	YIPF2 (3.6)	ERP29 (3.5)	TMED4 (3.3)	SARS (2.9)	DHODH (1.8)	PVR (1.8)	KIAA1324 (1.7)	ATP13A1 (1.5)	SUGP1 (1.4)	GRINA (1.3)
GO:0055037	recycling endosome	0.11	> 0.20	TMEM116 (2.6)	PTPN11 (2.4)	SLC44A2 (2.2)	HMGCR (2.2)	CYB561D1 (2.2)	BLOC1S3 (1.9)	FADS2 (1.8)	DNM2 (1.6)	FADS1 (1.6)	COL4A3BP (1.5)
GO:0045913	positive regulation of carbohydrate metabolic process	0.11	> 0.20	CYP7A1 (1.9)	GOT2P1 (1.9)	ZHX3 (1.9)	TMEM116 (1.8)	FRK (1.8)	HNF1A (1.8)	GMPR (1.4)	PCSK9 (1.4)	GPAM (1.2)	ENSG00000254235 (1.2)
GO:0010676	positive regulation of cellular carbohydrate metabolic process	0.11	> 0.20	CYP7A1 (1.9)	GOT2P1 (1.9)	ZHX3 (1.9)	TMEM116 (1.8)	FRK (1.8)	HNF1A (1.8)	GMPR (1.4)	PCSK9 (1.4)	GPAM (1.2)	ENSG00000254235 (1.2)
REACTOME_SPHINGOLIPID_METABOLISM	REACTOME_SPHINGOLIPID_METABOLISM	0.11	> 0.20	NKPD1 (4.9)	ERP29 (3.7)	HNF1A (3.5)	TMEM50A (3.3)	COL4A3BP (3.3)	TMED4 (2.7)	HAVCR1 (2.7)	ATP13A1 (2.3)	ZHX3 (2.2)	TM6SF2 (2.1)
ENSG00000147955	SIGMAR1 PPI subnetwork	0.11	> 0.20	HMGCR (13.6)	LDLR (11.5)	FADS1 (10.4)	FADS2 (9.4)	PCSK9 (7.2)	TRAPPC6A (2.9)	ERP29 (2.3)	NPC1L1 (2.0)	GPAM (1.8)	CYP7A1 (1.7)
GO:0043086	negative regulation of catalytic activity	0.11	> 0.20	PSMA5 (1.9)	CELSR2 (1.8)	HP (1.6)	TRIB1 (1.6)	APOC4 (1.4)	PCSK9 (1.4)	GPAM (1.4)	PLG (1.4)	APOB (1.3)	ITGB3 (1.3)
ENSG00000121058	COIL PPI subnetwork	0.11	> 0.20	POLK (2.8)	C12orf43 (2.0)	C19orf52 (2.0)	RPH3A (1.8)	TOMM40 (1.8)	SARS (1.8)	ILF3 (1.7)	TSSK6 (1.6)	DHODH (1.6)	SUGP1 (1.5)
ENSG00000172352	CDY1B PPI subnetwork	0.11	> 0.20	TMEM57 (3.2)	MYLIP (2.2)	TSSK6 (2.0)	C19orf52 (1.8)	POLK (1.8)	GRINA (1.7)	BUD13 (1.6)	CYP7A1 (1.6)	TOMM40 (1.5)	TMEM116 (1.4)
ENSG00000172288	CDY1 PPI subnetwork	0.11	> 0.20	TMEM57 (3.2)	MYLIP (2.2)	TSSK6 (2.0)	C19orf52 (1.8)	POLK (1.8)	GRINA (1.7)	BUD13 (1.6)	CYP7A1 (1.6)	TOMM40 (1.5)	TMEM116 (1.4)
GO:0010638	positive regulation of organelle organization	0.11	> 0.20	POLK (2.8)	GCNT4 (2.4)	MYLIP (1.9)	ANKRD31 (1.9)	NYNRIN (1.9)	TMEM50A (1.6)	POC5 (1.5)	PLCG1 (1.5)	SH2B3 (1.3)	YIPF2 (1.3)
MP:0000702	enlarged lymph nodes	0.11	> 0.20	RELB (4.4)	GMIP (3.0)	TRIB1 (2.7)	BCL3 (2.6)	SH2B3 (2.6)	PARP10 (2.4)	MAFB (1.8)	POLK (1.6)	TIMD4 (1.4)	LPIN3 (1.3)
ENSG00000132356	PRKAA1 PPI subnetwork	0.11	> 0.20	GPAM (3.0)	SYPL2 (2.3)	CYB561D1 (2.3)	SORT1 (2.2)	ATXN7L2 (2.2)	SARS (2.1)	ACAD10 (2.0)	PLG (1.8)	HMGCR (1.7)	AMIGO1 (1.6)
MP:0001270	distended abdomen	0.11	> 0.20	GCNT4 (2.5)	HLX (2.4)	MAFB (2.1)	PLCG1 (2.0)	CILP2 (1.9)	TMEM57 (1.9)	KANK2 (1.7)	PLEKHH2 (1.6)	MYLIP (1.6)	YIPF2 (1.4)
ENSG00000021461	CYP3A43 PPI subnetwork	0.11	> 0.20	HMGCR (12.7)	LDLR (12.7)	FADS1 (9.6)	FADS2 (8.7)	PCSK9 (7.5)	GPAM (2.3)	SORT1 (2.0)	TRAPPC6A (1.8)	YIPF2 (1.6)	ATP13A1 (1.5)
ENSG00000106258	CYP3A5 PPI subnetwork	0.11	> 0.20	HMGCR (12.7)	LDLR (12.7)	FADS1 (9.6)	FADS2 (8.7)	PCSK9 (7.5)	GPAM (2.3)	SORT1 (2.0)	TRAPPC6A (1.8)	YIPF2 (1.6)	ATP13A1 (1.5)
ENSG00000092853	CLSPN PPI subnetwork	0.11	> 0.20	FEN1 (6.2)	USP1 (4.3)	NT5DC1 (2.3)	MAU2 (2.1)	TMEM116 (1.5)	ENSG00000228044 (1.5)	HAVCR1 (1.5)	DHODH (1.4)	FRK (1.2)	ZNF180 (1.2)
ENSG00000161057	PSMC2 PPI subnetwork	0.11	> 0.20	PSMA5 (5.8)	TOMM40 (3.5)	NT5DC1 (2.6)	TRAFD1 (2.3)	DDX56 (2.3)	NAA25 (2.3)	SARS (1.8)	SMARCA4 (1.7)	SUGP1 (1.7)	ZNF259 (1.6)
ENSG00000120509	PDZD11 PPI subnetwork	0.11	> 0.20	AP1M2 (3.4)	DNM2 (3.4)	LPAR2 (2.5)	ZHX3 (2.4)	ATXN7L2 (2.4)	CARM1 (2.4)	CBLC (2.4)	KANK2 (2.3)	GPAM (2.3)	OGDH (2.1)
ENSG00000123576	ESX1 PPI subnetwork	0.11	> 0.20	COL4A3BP (3.7)	ITGB3 (2.5)	ALDH2 (2.5)	ABCG8 (2.2)	HAVCR1 (2.1)	GOT2P1 (1.6)	ATXN2 (1.6)	CEACAM19 (1.5)	MAFB (1.5)	HAPLN4 (1.5)
MP:0002831	absent Peyer's patches	0.11	> 0.20	BCL3 (4.8)	RELB (4.4)	GRINA (3.7)	PLEC (3.2)	GMIP (2.8)	HAVCR1 (2.2)	PARP10 (2.1)	UBXN2B (2.0)	ZNF101 (1.8)	PBX4 (1.7)
GO:0000266	mitochondrial fission	0.11	> 0.20	TXNL4B (3.6)	POLK (3.2)	GOT2P1 (2.2)	TMEM57 (2.2)	TRAPPC6A (1.9)	PPP1R37 (1.7)	BRAP (1.7)	GEMIN7 (1.6)	ENSG00000226645 (1.6)	BLOC1S3 (1.4)
ENSG00000106125	FAM188B PPI subnetwork	0.11	> 0.20	FADS2 (6.6)	LDLR (5.9)	FADS1 (5.3)	HMGCR (5.3)	PCSK9 (3.6)	HAVCR1 (2.3)	PBX4 (1.8)	ENSG00000226648 (1.7)	ERP29 (1.7)	PVRL2 (1.6)
ENSG00000100138	NHP2L1 PPI subnetwork	0.11	> 0.20	ILF3 (3.9)	DHX38 (3.4)	TOP1 (3.0)	DDX56 (3.0)	TOMM40 (3.0)	QTRT1 (2.9)	DHODH (2.9)	SUGP1 (2.8)	SMARCA4 (2.7)	USP1 (2.6)
GO:0050994	regulation of lipid catabolic process	0.11	> 0.20	MOSC1 (3.2)	GPAM (2.7)	APOC4 (2.7)	ABCG8 (2.2)	APOB (2.1)	PLG (1.8)	APOA5 (1.8)	COL4A3BP (1.8)	TM6SF2 (1.7)	AMIGO1 (1.6)
ENSG00000196305	IARS PPI subnetwork	0.11	> 0.20	SARS (6.4)	RELB (4.0)	NAA25 (2.9)	PSMA5 (2.6)	ZNF259 (2.1)	GOT2P1 (2.0)	DDX56 (1.9)	BCL3 (1.6)	POC5 (1.6)	QTRT1 (1.6)
MP:0000479	abnormal enterocyte morphology	0.11	> 0.20	ABCG8 (2.4)	CBLC (2.3)	HLX (2.1)	FRK (2.0)	TIMD4 (1.9)	C1orf63 (1.8)	KIAA1324 (1.8)	PLEKHH2 (1.7)	ABCG5 (1.6)	ZNF101 (1.6)
MP:0008874	decreased physiological sensitivity to xenobiotic	0.11	> 0.20	SLC22A1 (3.7)	LPA (3.0)	HLX (3.0)	MAFB (2.6)	POLK (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	APOA5 (2.1)	ABCG8 (1.9)	BCL3 (1.8)
ENSG00000185634	SHC4 PPI subnetwork	0.11	> 0.20	MYLIP (4.5)	C1orf63 (3.6)	SLC44A2 (3.4)	HLX (2.7)	LPIN3 (2.6)	C17orf57 (2.6)	ENSG00000238078 (2.2)	ADAM1 (2.1)	PVRL2 (2.0)	CBLC (1.9)
MP:0000410	waved hair	0.11	> 0.20	PVR (1.8)	CELSR2 (1.5)	ANKRD31 (1.4)	POLK (1.4)	AP1M2 (1.3)	CYB561D1 (1.3)	NKPD1 (1.2)	BLOC1S3 (1.2)	ZNF180 (1.2)	MARK4 (1.1)
ENSG00000126883	NUP214 PPI subnetwork	0.11	> 0.20	NAA25 (3.7)	POC5 (3.6)	DOCK7 (3.0)	USP1 (2.9)	USP24 (2.7)	MAPKAPK5 (2.5)	ILF3 (2.1)	DDX56 (2.1)	ENSG00000235545 (1.5)	ENSG00000226648 (1.4)
ENSG00000153234	NR4A2 PPI subnetwork	0.11	> 0.20	SMARCA4 (2.4)	C19orf52 (2.3)	OGDH (2.3)	POLK (2.0)	SUGP1 (2.0)	DNM2 (2.0)	UBXN2B (1.9)	MAU2 (1.7)	PSMA5 (1.7)	BUD13 (1.7)
ENSG00000067842	ATP2B3 PPI subnetwork	0.11	> 0.20	COL4A3BP (3.4)	PPP1R37 (2.2)	SORT1 (2.1)	PMFBP1 (2.1)	TMEM50A (2.0)	SARS (2.0)	NKPD1 (1.9)	CYB561D1 (1.9)	ZHX3 (1.8)	HMGCR (1.8)
MP:0008670	decreased interleukin-12b secretion	0.11	> 0.20	MAFB (4.1)	RELB (3.9)	BCL3 (3.5)	SH2B3 (2.6)	OASL (2.6)	PARP10 (2.5)	GMIP (2.3)	PMFBP1 (2.0)	TRIB1 (1.7)	FRK (1.6)
ENSG00000156299	TIAM1 PPI subnetwork	0.11	> 0.20	PVRL2 (2.7)	LPAR2 (2.6)	MARK4 (2.6)	C11orf9 (2.3)	PLEC (2.3)	NPC1L1 (2.3)	APOC1 (2.2)	TOP1 (2.0)	SH2B3 (2.0)	NYNRIN (2.0)
ENSG00000091536	MYO15A PPI subnetwork	0.11	> 0.20	SYPL2 (3.3)	NT5DC1 (2.2)	ENSG00000235545 (2.1)	PPP1R37 (2.0)	DYNC2LI1 (1.9)	HAVCR1 (1.9)	KANK2 (1.6)	PVR (1.5)	DOCK7 (1.4)	C1orf63 (1.4)
ENSG00000178409	BEND3 PPI subnetwork	0.11	> 0.20	C19orf52 (2.3)	YIPF2 (2.1)	BRAP (2.0)	ATP13A1 (2.0)	GRINA (1.9)	SUGP1 (1.9)	DHX38 (1.9)	PARP10 (1.8)	TRAFD1 (1.8)	QTRT1 (1.7)
ENSG00000131788	PIAS3 PPI subnetwork	0.11	> 0.20	PARP10 (3.0)	OASL (3.0)	BCL3 (2.7)	KIAA1324 (2.5)	ATXN2 (2.1)	KANK2 (2.1)	USP24 (2.0)	PLEC (1.9)	ENSG00000226648 (1.8)	COL4A3BP (1.7)
MP:0003724	increased susceptibility to induced arthritis	0.11	> 0.20	BCL3 (4.4)	CETP (3.7)	TRIB1 (3.1)	ITGB3 (3.0)	MOSC1 (2.8)	HP (2.4)	TRAFD1 (2.4)	CILP2 (2.2)	ENSG00000238078 (2.0)	RELB (1.9)
GO:0043488	regulation of mRNA stability	0.11	> 0.20	ENSG00000238078 (3.7)	ADAM1 (3.2)	ENSG00000235545 (2.3)	ENSG00000226645 (2.0)	NT5DC1 (2.0)	TOP1 (1.8)	ILF3 (1.8)	TRIB1 (1.7)	ENSG00000226648 (1.5)	KANK2 (1.5)
ENSG00000149269	PAK1 PPI subnetwork	0.11	> 0.20	SH2B3 (3.3)	ENSG00000238078 (2.3)	PLEC (2.3)	CEACAM19 (2.2)	GATAD2A (2.1)	DNM2 (2.0)	LPIN3 (1.9)	DHX38 (1.9)	GCNT4 (1.8)	PPP1R37 (1.8)
GO:0005901	caveola	0.11	> 0.20	PLEC (2.6)	CELSR2 (2.4)	USP24 (2.2)	GMPR (2.1)	GRINA (2.1)	TRIB1 (2.0)	PVR (1.8)	BCAM (1.7)	ALDH2 (1.6)	COL4A3BP (1.6)
GO:0032813	tumor necrosis factor receptor superfamily binding	0.11	> 0.20	RELB (3.2)	SH2B3 (2.5)	PARP10 (2.4)	HAVCR1 (2.1)	BCL3 (1.8)	TIMD4 (1.8)	CETP (1.7)	GMIP (1.7)	SLC22A1 (1.6)	POLK (1.6)
ENSG00000185386	MAPK11 PPI subnetwork	0.11	> 0.20	TRIB1 (6.8)	POLK (2.6)	SH2B3 (2.2)	HLX (1.7)	MYLIP (1.7)	ATXN7L2 (1.7)	PVR (1.5)	SYPL2 (1.4)	NPC1L1 (1.3)	POC5 (1.2)
ENSG00000163554	SPTA1 PPI subnetwork	0.11	> 0.20	DNM2 (2.7)	PLEC (2.5)	C12orf51 (2.3)	SYPL2 (1.9)	C17orf57 (1.9)	GMIP (1.8)	HAVCR1 (1.8)	OGDH (1.7)	GOT2P1 (1.7)	PMFBP1 (1.6)
GO:0016408	C-acyltransferase activity	0.11	> 0.20	HMGCR (6.4)	LDLR (5.1)	NKPD1 (4.5)	FADS2 (4.4)	FADS1 (4.3)	PCSK9 (2.4)	TRAPPC6A (2.4)	ENSG00000235545 (1.8)	ACAD10 (1.8)	OGDH (1.8)
ENSG00000085721	RRN3 PPI subnetwork	0.11	> 0.20	ZNF259 (3.4)	C12orf43 (3.3)	HMGCR (3.0)	DDX56 (2.9)	DYNC2LI1 (2.8)	GEMIN7 (2.8)	DHODH (2.7)	TXNL4B (2.6)	QTRT1 (2.5)	NAA25 (1.9)
ENSG00000132603	NIP7 PPI subnetwork	0.11	> 0.20	ZNF259 (4.9)	NAA25 (4.5)	TOMM40 (3.7)	DDX56 (3.6)	QTRT1 (3.5)	DHODH (2.5)	DHX38 (2.4)	ATP13A1 (2.3)	SUGP1 (2.2)	C12orf43 (2.0)
GO:0004712	protein serine/threonine/tyrosine kinase activity	0.11	> 0.20	C1orf63 (4.4)	ATXN7L2 (2.9)	CEACAM19 (2.1)	SH2B3 (1.8)	MAU2 (1.8)	ABCG5 (1.8)	DNAH11 (1.7)	SORT1 (1.7)	BRAP (1.7)	PSRC1 (1.6)
MP:0005281	increased fatty acid level	0.11	> 0.20	GPAM (4.0)	APOC1 (2.4)	ACAD10 (2.3)	MOSC1 (2.2)	MAFB (2.1)	SYPL2 (1.8)	ABCG5 (1.8)	PARP10 (1.8)	ATXN7L2 (1.8)	HP (1.6)
MP:0004201	fetal growth retardation	0.11	> 0.20	LDLR (3.8)	HMGCR (2.8)	C17orf57 (2.1)	PCSK9 (1.9)	PVRL2 (1.8)	NYNRIN (1.8)	C11orf9 (1.8)	CARM1 (1.8)	NKPD1 (1.7)	ENSG00000228044 (1.7)
ENSG00000173889	PHC3 PPI subnetwork	0.11	> 0.20	CELSR2 (2.8)	MARK4 (2.2)	ST3GAL4 (2.1)	CYB561D1 (2.0)	TRAFD1 (1.8)	SH2B3 (1.7)	LPIN3 (1.7)	HP (1.6)	TMEM57 (1.6)	PLG (1.5)
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	0.11	> 0.20	RELB (2.7)	HLX (2.5)	BLOC1S3 (2.4)	BCL3 (2.2)	C19orf52 (1.9)	ENSG00000228044 (1.9)	SH2B3 (1.9)	CYB561D1 (1.8)	ZNF101 (1.7)	NT5DC1 (1.7)
ENSG00000087077	TRIP6 PPI subnetwork	0.11	> 0.20	ITGB3 (4.0)	LPIN3 (3.2)	RHCE (2.8)	SLC44A2 (2.3)	LPAR2 (2.2)	PLEC (2.2)	SYPL2 (2.1)	GMIP (2.0)	PLCG1 (2.0)	PLEKHH2 (1.9)
GO:0006400	tRNA modification	0.11	> 0.20	QTRT1 (3.6)	NAA25 (3.3)	C12orf43 (3.3)	DHODH (3.3)	ZNF259 (2.7)	MAPKAPK5 (2.6)	TOMM40 (2.4)	TXNL4B (2.4)	C19orf52 (2.3)	ATP13A1 (2.1)
ENSG00000136574	GATA4 PPI subnetwork	0.11	> 0.20	NYNRIN (4.6)	CARM1 (2.2)	COL4A3BP (2.2)	TRIB1 (2.1)	ENSG00000238078 (2.1)	HLX (2.1)	ATXN7L2 (1.8)	CETP (1.8)	CEACAM19 (1.7)	SH2B3 (1.6)
GO:0005385	zinc ion transmembrane transporter activity	0.11	> 0.20	NPC1L1 (3.5)	AP1M2 (2.5)	YIPF2 (2.3)	ATP13A1 (1.9)	TM6SF2 (1.8)	CYB561D1 (1.5)	RHCE (1.5)	ATXN7L2 (1.5)	APOB (1.4)	ERP29 (1.2)
MP:0005312	pericardial effusion	0.11	> 0.20	ATXN2 (3.3)	C12orf51 (3.1)	KANK2 (2.9)	USP24 (2.7)	HMGCR (2.4)	PTPN11 (2.3)	LDLR (1.9)	UBXN2B (1.8)	ACAD10 (1.7)	RHD (1.6)
GO:0006650	glycerophospholipid metabolic process	0.11	> 0.20	BLOC1S3 (3.4)	TSSK6 (2.7)	UBXN2B (2.1)	ATP13A1 (2.1)	HAVCR1 (2.1)	TMEM50A (1.9)	CYB561D1 (1.8)	LPAR2 (1.7)	YIPF2 (1.6)	CLPTM1 (1.5)
MP:0001046	abnormal enteric neuron morphology	0.11	> 0.20	HLX (2.8)	CELSR2 (2.3)	ZNF101 (2.2)	TRIB1 (2.2)	MYLIP (2.0)	CYP7A1 (1.9)	AMIGO1 (1.8)	ENSG00000254235 (1.8)	ABO (1.7)	KIAA1324 (1.6)
ENSG00000104695	PPP2CB PPI subnetwork	0.11	> 0.20	PSMA5 (3.7)	TMEM50A (2.2)	TRAFD1 (2.0)	NAA25 (2.0)	ZNF259 (2.0)	MARK4 (2.0)	ENSG00000235545 (1.8)	TOMM40 (1.8)	ENSG00000254235 (1.7)	CARM1 (1.7)
ENSG00000120690	ELF1 PPI subnetwork	0.11	> 0.20	BCL3 (3.1)	GMIP (2.9)	DHX38 (2.9)	USP24 (2.8)	PARP10 (2.5)	RELB (2.2)	MAU2 (2.0)	ATXN2 (1.8)	POLK (1.8)	SMARCA4 (1.6)
GO:0044445	cytosolic part	0.11	> 0.20	NKPD1 (2.1)	DNAH11 (2.1)	RHCE (1.9)	GMPR (1.8)	GEMIN7 (1.6)	POLK (1.6)	MOSC1 (1.5)	PLEKHH2 (1.5)	BRAP (1.3)	SARS (1.3)
GO:0042770	signal transduction in response to DNA damage	0.11	> 0.20	NT5DC1 (2.6)	PSMA5 (2.5)	TRAFD1 (2.5)	ENSG00000238078 (1.9)	NAA25 (1.9)	BUD13 (1.8)	PARP10 (1.8)	BRAP (1.7)	SUGP1 (1.6)	C12orf47 (1.6)
ENSG00000157077	ZFYVE9 PPI subnetwork	0.11	> 0.20	PTPN11 (3.2)	DNM2 (2.5)	BRAP (2.1)	ADAM1 (2.1)	PARP10 (2.1)	ATXN2 (2.0)	CLPTM1 (2.0)	TMEM50A (1.9)	TRAFD1 (1.9)	MAPKAPK5 (1.8)
GO:0043009	chordate embryonic development	0.11	> 0.20	ATXN7L2 (3.2)	PVRL2 (2.4)	NYNRIN (2.0)	ATXN2 (1.9)	CARM1 (1.9)	ENSG00000254235 (1.8)	BCAM (1.6)	PPP1R37 (1.5)	HLX (1.5)	CILP2 (1.4)
GO:0001817	regulation of cytokine production	0.11	> 0.20	OASL (3.1)	PARP10 (2.7)	SH2B3 (2.5)	RELB (2.3)	ZNF101 (2.2)	TIMD4 (2.0)	GMIP (2.0)	POLK (1.7)	BCL3 (1.7)	ST3GAL4 (1.6)
ENSG00000171490	RSL1D1 PPI subnetwork	0.11	> 0.20	DDX56 (4.6)	ZNF259 (4.5)	NAA25 (4.1)	QTRT1 (4.0)	TOMM40 (3.5)	DHODH (3.0)	C12orf43 (2.7)	ILF3 (2.5)	GATAD2A (2.4)	SUGP1 (2.3)
ENSG00000102780	DGKH PPI subnetwork	0.11	> 0.20	GPAM (2.9)	C12orf51 (2.5)	CETP (2.4)	ENSG00000228044 (2.4)	LDLR (2.3)	MOSC1 (2.0)	HAVCR1 (1.8)	PCSK9 (1.8)	KANK2 (1.8)	PTPN11 (1.6)
ENSG00000124587	PEX6 PPI subnetwork	0.11	> 0.20	MYLIP (2.5)	ATXN2 (2.4)	C19orf52 (2.1)	FRK (2.0)	YIPF2 (2.0)	GPAM (1.9)	DOCK7 (1.9)	ENSG00000228044 (1.8)	QTRT1 (1.7)	AMIGO1 (1.6)
GO:0005730	nucleolus	0.11	> 0.20	ZNF259 (4.1)	QTRT1 (3.7)	DDX56 (3.6)	NAA25 (3.5)	DHODH (3.5)	TOMM40 (3.3)	C12orf43 (3.2)	DHX38 (2.3)	ILF3 (2.1)	TOP1 (2.1)
ENSG00000105618	PRPF31 PPI subnetwork	0.11	> 0.20	DHX38 (4.4)	SUGP1 (3.5)	QTRT1 (3.2)	SMARCA4 (2.9)	BUD13 (2.9)	DDX56 (2.8)	ZNF259 (2.3)	MAU2 (2.3)	ILF3 (2.2)	TOP1 (2.1)
MP:0002073	abnormal hair growth	0.11	> 0.20	AP1M2 (3.3)	PCSK9 (2.1)	CELSR2 (2.1)	BCAM (2.0)	APOC1 (1.9)	LPA (1.8)	PLEKHH2 (1.8)	NYNRIN (1.7)	AMIGO1 (1.6)	ABO (1.5)
GO:0070064	proline-rich region binding	0.11	> 0.20	ZHX3 (2.9)	CETP (2.4)	GEMIN7 (2.3)	LPIN3 (2.0)	TRAPPC6A (2.0)	ABO (2.0)	CARM1 (1.9)	PVR (1.8)	ANGPTL3 (1.6)	KANK2 (1.6)
ENSG00000186115	CYP4F2 PPI subnetwork	0.11	> 0.20	HMGCR (10.9)	LDLR (10.3)	FADS1 (7.8)	FADS2 (6.6)	PCSK9 (5.9)	ABO (3.0)	TRAPPC6A (2.5)	ADAM1 (2.1)	C12orf47 (1.8)	TMED4 (1.7)
MP:0005181	decreased circulating estradiol level	0.11	> 0.20	MYLIP (2.7)	KANK2 (2.6)	GPAM (2.4)	ST3GAL4 (2.2)	LDLR (1.7)	PMFBP1 (1.5)	GCNT4 (1.5)	ABCG8 (1.4)	TOP1 (1.3)	ENSG00000238078 (1.3)
GO:0046165	alcohol biosynthetic process	0.11	> 0.20	TSSK6 (2.6)	LPA (2.3)	MOSC1 (2.3)	TM6SF2 (2.2)	DHODH (1.9)	SORT1 (1.9)	PMFBP1 (1.8)	GPAM (1.8)	ENSG00000254235 (1.7)	OGDH (1.5)
GO:0016235	aggresome	0.11	> 0.20	CILP2 (3.2)	BCAM (2.1)	YIPF2 (1.9)	ZNF101 (1.8)	TMEM116 (1.8)	APOE (1.7)	RHCE (1.7)	CYP7A1 (1.6)	ENSG00000226645 (1.6)	TRAFD1 (1.6)
MP:0009321	increased histiocytic sarcoma incidence	0.11	> 0.20	ATXN7L2 (2.6)	FEN1 (2.3)	USP1 (2.1)	C17orf57 (1.8)	MAPKAPK5 (1.6)	GMIP (1.6)	LPIN3 (1.5)	ZHX3 (1.4)	GOT2P1 (1.4)	PTPN11 (1.3)
ENSG00000172379	ARNT2 PPI subnetwork	0.11	> 0.20	USP24 (3.0)	MAFB (2.8)	GMIP (2.6)	BCL3 (2.6)	PARP10 (2.5)	MAU2 (2.4)	PLEKHH2 (2.1)	SMARCA4 (2.0)	DHX38 (1.8)	POLK (1.8)
ENSG00000105371	ICAM4 PPI subnetwork	0.11	> 0.20	RHD (3.9)	APOC1 (2.8)	RHCE (2.7)	BCAM (2.4)	APOE (2.3)	HP (2.2)	DOCK7 (2.0)	RPH3A (2.0)	ALDH2 (1.9)	APOB (1.7)
MP:0001721	absent visceral yolk sac blood islands	0.11	> 0.20	HLX (2.8)	RHD (2.6)	PLCG1 (2.6)	MAFB (2.6)	ENSG00000226648 (2.5)	APOE (2.3)	TMEM57 (2.2)	MYLIP (2.2)	CETP (2.1)	HNF1A (2.1)
ENSG00000090659	CD209 PPI subnetwork	0.11	> 0.20	ATP13A1 (4.1)	MAPKAPK5 (2.7)	DDX56 (2.6)	BRAP (2.6)	HNF1A (2.6)	PTPN11 (2.3)	CETP (2.3)	TOMM40 (2.3)	CEACAM19 (2.2)	ANKRD31 (2.0)
GO:0043274	phospholipase binding	0.11	> 0.20	ITGB3 (2.9)	PPP1R37 (2.9)	PVR (2.8)	ENSG00000228044 (2.5)	GATAD2A (2.3)	COL4A3BP (2.0)	HAVCR1 (1.9)	DNAH11 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)
MP:0002279	abnormal diaphragm morphology	0.11	> 0.20	C11orf9 (4.0)	SYPL2 (3.7)	GMPR (2.6)	PLEC (2.1)	PLEKHH2 (1.8)	KANK2 (1.8)	DOCK7 (1.6)	COL4A3BP (1.6)	MOSC1 (1.5)	PVRL2 (1.4)
MP:0004921	decreased placenta weight	0.11	> 0.20	PVRL2 (2.5)	PCSK9 (2.1)	TRIB1 (2.1)	LPA (2.0)	MYLIP (1.9)	PVR (1.9)	NYNRIN (1.7)	DHODH (1.6)	CBLC (1.6)	ATXN7L2 (1.6)
GO:0031269	pseudopodium assembly	0.11	> 0.20	ENSG00000235545 (4.0)	PVRL2 (2.9)	CBLC (2.8)	CETP (2.7)	BLOC1S3 (2.3)	C11orf9 (2.1)	BRAP (2.0)	SLC44A2 (1.8)	SYPL2 (1.8)	ZNF101 (1.6)
ENSG00000158828	PINK1 PPI subnetwork	0.11	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.6)	PLEKHH2 (1.8)	TMEM57 (1.7)	C1orf63 (1.7)	DNAH11 (1.5)	BCAM (1.4)	GOT2P1 (1.3)	HNF1A (1.3)
REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	0.11	> 0.20	NAA25 (3.8)	POC5 (3.3)	DDX56 (3.2)	USP1 (3.1)	ILF3 (2.4)	FEN1 (2.4)	DOCK7 (2.3)	USP24 (2.3)	BUD13 (2.1)	TOMM40 (2.0)
GO:0006544	glycine metabolic process	0.11	> 0.20	CYP7A1 (4.1)	SLC22A1 (3.7)	ENSG00000254235 (3.4)	TXNL4B (3.4)	ANGPTL3 (2.9)	UBXN2B (2.9)	GOT2P1 (2.6)	DHODH (2.6)	APOA5 (2.5)	PLG (2.3)
ENSG00000107537	PHYH PPI subnetwork	0.11	> 0.20	NT5DC1 (3.4)	RHD (2.9)	HAPLN4 (2.6)	RHCE (2.5)	ZNF180 (2.2)	OGDH (2.1)	CELSR2 (2.0)	SLC44A2 (1.9)	CETP (1.8)	UBXN2B (1.7)
ENSG00000167930	ITFG3 PPI subnetwork	0.11	> 0.20	ACAD10 (3.6)	NT5DC1 (2.9)	HNF1A (2.3)	PCSK9 (1.8)	TRAPPC6A (1.7)	C1orf63 (1.6)	GMPR (1.6)	SORT1 (1.5)	TIMD4 (1.5)	CETP (1.4)
MP:0000291	enlarged pericardium	0.11	> 0.20	SLC44A2 (2.9)	PVRL2 (2.3)	ENSG00000235545 (2.3)	KANK2 (2.2)	BCAM (2.0)	CBLC (2.0)	ATXN2 (2.0)	GRINA (1.9)	GPAM (1.8)	LDLR (1.7)
ENSG00000135046	ANXA1 PPI subnetwork	0.11	> 0.20	PVR (3.0)	BCL3 (2.5)	DNM2 (2.3)	ALDH2 (2.1)	TMEM50A (2.0)	PARP10 (1.8)	MARK4 (1.8)	SORT1 (1.8)	HAVCR1 (1.7)	NKPD1 (1.7)
ENSG00000169710	FASN PPI subnetwork	0.11	> 0.20	PLEC (3.6)	HMGCR (2.5)	GRINA (2.4)	PCSK9 (2.2)	C1orf63 (1.9)	ILF3 (1.9)	OGDH (1.9)	CLPTM1 (1.8)	LPAR2 (1.6)	UBXN2B (1.6)
MP:0001212	skin lesions	0.11	> 0.20	MAFB (3.2)	APOC1 (2.8)	BCL3 (2.6)	GRINA (2.6)	PARP10 (2.5)	CYB561D1 (2.0)	HLX (1.8)	ENSG00000235545 (1.7)	GMIP (1.7)	UBXN2B (1.5)
GO:0004303	estradiol 17-beta-dehydrogenase activity	0.11	> 0.20	APOC1 (3.8)	SLC22A1 (3.4)	APOC4 (3.2)	CBLC (2.7)	ANGPTL3 (2.5)	APOA5 (2.4)	ALDH2 (2.4)	ABCG5 (2.2)	LPA (2.0)	PMFBP1 (2.0)
GO:0071902	positive regulation of protein serine/threonine kinase activity	0.11	> 0.20	SLC44A2 (2.6)	ENSG00000228044 (2.3)	HLX (2.1)	LPAR2 (2.1)	PTPN11 (2.0)	ABO (1.9)	ENSG00000226645 (1.7)	AMIGO1 (1.7)	ST3GAL4 (1.7)	GCNT4 (1.5)
GO:0048020	CCR chemokine receptor binding	0.11	> 0.20	CETP (4.0)	RELB (3.3)	OASL (2.9)	TIMD4 (2.9)	BCL3 (2.8)	ZNF101 (2.4)	GRINA (2.0)	MAFB (2.0)	TM6SF2 (2.0)	PVR (1.9)
ENSG00000180176	TH PPI subnetwork	0.11	> 0.20	GRINA (3.5)	CARM1 (3.4)	ATXN2 (2.1)	GOT2P1 (2.1)	ENSG00000238078 (2.1)	MARK4 (2.0)	GMPR (1.9)	BCAM (1.7)	SLC44A2 (1.7)	NT5DC1 (1.7)
ENSG00000173473	SMARCC1 PPI subnetwork	0.11	> 0.20	CARM1 (3.9)	ATXN2 (3.2)	SMARCA4 (2.8)	RHCE (2.4)	C12orf51 (2.3)	ILF3 (2.2)	USP1 (2.1)	NYNRIN (2.0)	MAU2 (2.0)	TRAFD1 (2.0)
ENSG00000136286	MYO1G PPI subnetwork	0.11	> 0.20	USP24 (3.5)	DNM2 (3.5)	PLEC (3.2)	COL4A3BP (2.4)	GMIP (2.3)	POLK (2.1)	SORT1 (2.1)	ALDH2 (1.9)	OGDH (1.7)	PTPN11 (1.7)
GO:0006605	protein targeting	0.11	> 0.20	PTPN11 (2.1)	ZNF101 (2.1)	ENSG00000238078 (1.9)	GATAD2A (1.7)	GRINA (1.7)	AMIGO1 (1.7)	USP24 (1.6)	ENSG00000235545 (1.6)	ENSG00000254235 (1.6)	NAA25 (1.5)
ENSG00000125503	PPP1R12C PPI subnetwork	0.11	> 0.20	USP24 (3.8)	PLEC (3.6)	DNM2 (3.0)	GMIP (2.9)	COL4A3BP (2.4)	POLK (2.3)	SORT1 (2.1)	ALDH2 (2.0)	CYB561D1 (1.8)	PVR (1.8)
ENSG00000166165	CKB PPI subnetwork	0.11	> 0.20	RELB (2.9)	C12orf43 (2.6)	BUD13 (2.4)	HAVCR1 (2.2)	SYPL2 (2.0)	ILF3 (1.8)	DHX38 (1.8)	GEMIN7 (1.7)	QTRT1 (1.7)	ANKRD31 (1.5)
ENSG00000172399	MYOZ2 PPI subnetwork	0.11	> 0.20	SYPL2 (4.1)	GMPR (3.1)	OGDH (2.6)	C1orf63 (2.0)	TMEM50A (1.9)	ACAD10 (1.8)	PLEC (1.6)	BCAM (1.5)	PVRL2 (1.4)	FADS1 (1.4)
ENSG00000130810	PPAN PPI subnetwork	0.11	> 0.20	ZNF259 (5.3)	NAA25 (4.2)	DDX56 (4.0)	TOMM40 (3.7)	QTRT1 (3.2)	DHODH (2.8)	MAPKAPK5 (2.7)	DHX38 (2.7)	C12orf43 (2.1)	SUGP1 (2.1)
ENSG00000109534	GAR1 PPI subnetwork	0.11	> 0.20	QTRT1 (4.1)	TOMM40 (4.1)	DDX56 (4.1)	NAA25 (4.0)	ZNF259 (3.9)	DHODH (3.2)	C12orf43 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	TOP1 (2.2)
MP:0005290	decreased oxygen consumption	0.11	> 0.20	MOSC1 (3.2)	CETP (2.8)	SORT1 (2.5)	PPP1R37 (2.4)	CELSR2 (2.2)	GEMIN7 (2.1)	SYPL2 (1.9)	ALDH2 (1.8)	HAPLN4 (1.8)	AMIGO1 (1.8)
GO:0051347	positive regulation of transferase activity	0.11	> 0.20	ENSG00000228044 (4.0)	PTPN11 (2.2)	AMIGO1 (2.1)	HLX (2.1)	PVR (2.1)	SLC44A2 (2.0)	ST3GAL4 (1.9)	POLK (1.7)	ENSG00000235545 (1.6)	SH2B3 (1.6)
MP:0000008	increased white adipose tissue amount	0.11	> 0.20	ST3GAL4 (3.0)	GPAM (2.9)	KIAA1324 (2.8)	MOSC1 (2.5)	APOC1 (1.9)	DYNC2LI1 (1.8)	GOT2P1 (1.7)	C12orf47 (1.6)	DNAH11 (1.5)	OASL (1.4)
ENSG00000109971	HSPA8 PPI subnetwork	0.11	> 0.20	PSMA5 (3.4)	TOMM40 (3.2)	SMARCA4 (3.0)	SARS (2.8)	NAA25 (2.7)	CLPTM1 (2.5)	GATAD2A (2.5)	DDX56 (2.3)	CARM1 (2.1)	ILF3 (2.1)
MP:0008140	podocyte foot process effacement	0.11	> 0.20	BCAM (4.4)	PVRL2 (3.8)	NT5DC1 (3.0)	ENSG00000238078 (2.7)	PLEKHH2 (2.1)	C11orf9 (2.1)	ANKRD31 (2.0)	FRK (2.0)	HNF1A (1.7)	OGDH (1.6)
GO:0070301	cellular response to hydrogen peroxide	0.11	> 0.20	DNAH11 (3.7)	GOT2P1 (2.9)	PBX4 (2.5)	MOSC1 (2.2)	C17orf57 (2.1)	RHD (1.9)	ALDH2 (1.8)	RHCE (1.8)	GPAM (1.7)	ACAD10 (1.6)
MP:0003567	abnormal fetal cardiomyocyte proliferation	0.11	> 0.20	NYNRIN (3.4)	BCAM (2.5)	C11orf9 (2.3)	ATXN7L2 (2.2)	PVR (1.9)	GPAM (1.7)	GCNT4 (1.7)	TMED4 (1.7)	HP (1.7)	NT5DC1 (1.7)
ENSG00000136111	TBC1D4 PPI subnetwork	0.11	> 0.20	PLEC (3.2)	BLOC1S3 (2.8)	C11orf9 (2.8)	SMARCA4 (2.8)	CARM1 (2.6)	LPAR2 (2.5)	MARK4 (2.5)	C12orf51 (2.4)	AP1M2 (2.4)	UBXN2B (2.3)
GO:0009084	glutamine family amino acid biosynthetic process	0.11	> 0.20	CYP7A1 (3.6)	TM6SF2 (3.1)	ABCG8 (3.0)	ABO (2.8)	ANGPTL3 (2.7)	PCSK9 (2.1)	APOC4 (2.0)	PLG (2.0)	DHODH (1.9)	ZHX3 (1.8)
REACTOME_MG1_TRANSITION	REACTOME_MG1_TRANSITION	0.11	> 0.20	PSMA5 (4.9)	FEN1 (4.6)	USP1 (2.8)	NT5DC1 (2.8)	TRAFD1 (2.1)	NAA25 (1.9)	ENSG00000235545 (1.6)	TOMM40 (1.4)	ZNF180 (1.4)	DDX56 (1.4)
REACTOME_DNA_REPLICATION_PRE:INITIATION	REACTOME_DNA_REPLICATION_PRE:INITIATION	0.11	> 0.20	PSMA5 (4.9)	FEN1 (4.6)	USP1 (2.8)	NT5DC1 (2.8)	TRAFD1 (2.1)	NAA25 (1.9)	ENSG00000235545 (1.6)	TOMM40 (1.4)	ZNF180 (1.4)	DDX56 (1.4)
ENSG00000178053	MLF1 PPI subnetwork	0.11	> 0.20	TXNL4B (3.3)	C19orf52 (3.1)	QTRT1 (2.4)	SUGP1 (2.2)	UBXN2B (2.2)	ENSG00000226645 (2.2)	AMIGO1 (2.1)	YIPF2 (2.1)	MYLIP (2.0)	BRAP (2.0)
GO:0070411	I-SMAD binding	0.11	> 0.20	KANK2 (4.0)	ALDH2 (2.3)	PLCG1 (2.1)	ENSG00000226648 (1.9)	ABO (1.6)	PCSK9 (1.6)	ENSG00000228044 (1.6)	MARK4 (1.5)	MAPKAPK5 (1.4)	TMEM50A (1.4)
ENSG00000184985	SORCS2 PPI subnetwork	0.11	> 0.20	PSMA5 (2.4)	TOP1 (2.3)	SARS (2.3)	GOT2P1 (2.3)	TOMM40 (2.2)	DHX38 (2.2)	ILF3 (1.9)	GRINA (1.8)	NPC1L1 (1.7)	MAPKAPK5 (1.7)
MP:0000939	decreased motor neuron number	0.11	> 0.20	TRIB1 (2.5)	ABO (2.4)	CELSR2 (2.1)	TIMD4 (2.1)	BCAM (1.9)	CILP2 (1.9)	TMEM116 (1.7)	SH2B3 (1.7)	PMFBP1 (1.5)	DYNC2LI1 (1.4)
ENSG00000123992	DNPEP PPI subnetwork	0.11	> 0.20	PLCG1 (2.0)	LPIN3 (2.0)	ATXN7L2 (2.0)	FADS2 (1.9)	TRIB1 (1.8)	ZNF101 (1.7)	CBLC (1.6)	APOC1 (1.5)	TRAFD1 (1.5)	HP (1.5)
GO:0015936	coenzyme A metabolic process	0.11	> 0.20	PCSK9 (3.9)	LDLR (3.6)	FADS2 (3.2)	FADS1 (3.0)	HMGCR (2.6)	ENSG00000228044 (2.1)	TRAPPC6A (2.1)	GPAM (2.1)	TMEM57 (1.9)	TMEM116 (1.9)
GO:0004198	calcium-dependent cysteine-type endopeptidase activity	0.11	> 0.20	DNM2 (3.1)	PLEC (2.4)	NYNRIN (2.3)	DNAH11 (2.1)	OASL (2.1)	CBLC (1.8)	LPIN3 (1.8)	PVRL2 (1.7)	ZNF180 (1.7)	PPP1R37 (1.6)
ENSG00000031823	RANBP3 PPI subnetwork	0.11	> 0.20	TMEM50A (3.2)	QTRT1 (2.6)	BRAP (2.4)	C12orf43 (2.3)	TOMM40 (2.2)	ZNF180 (2.1)	CLPTM1 (2.1)	TXNL4B (2.0)	LPIN3 (1.9)	ILF3 (1.9)
ENSG00000131473	ACLY PPI subnetwork	0.11	> 0.20	FADS2 (2.5)	FADS1 (2.3)	C19orf52 (2.1)	LDLR (2.1)	GOT2P1 (2.1)	ILF3 (1.8)	TMEM50A (1.7)	HMGCR (1.7)	GATAD2A (1.7)	TMEM57 (1.6)
MP:0005033	abnormal trophoblast giant cells	0.11	> 0.20	DNM2 (2.3)	CLPTM1 (2.2)	MAFB (2.0)	BUD13 (1.9)	DHX38 (1.8)	PLEC (1.8)	ACAD10 (1.6)	LPIN3 (1.6)	PPP1R37 (1.5)	MARK4 (1.4)
ENSG00000063761	ADCK1 PPI subnetwork	0.11	> 0.20	CARM1 (4.5)	ILF3 (2.7)	NKPD1 (2.7)	CEACAM19 (2.6)	GOT2P1 (2.5)	GRINA (2.4)	TSSK6 (2.3)	MARK4 (2.1)	DNM2 (2.1)	SMARCA4 (2.1)
ENSG00000105429	MEGF8 PPI subnetwork	0.12	> 0.20	FRK (3.5)	PARP10 (2.8)	ZNF180 (2.4)	DOCK7 (2.1)	PTPN11 (1.9)	ABO (1.9)	OASL (1.6)	PPP1R37 (1.5)	USP24 (1.4)	HNF1A (1.4)
MP:0005169	abnormal male meiosis	0.12	> 0.20	ANKRD31 (4.7)	TMEM116 (2.6)	PBX4 (2.0)	FEN1 (1.8)	SUGP1 (1.7)	BRAP (1.6)	MAU2 (1.6)	LPAR2 (1.4)	ENSG00000238078 (1.4)	LPIN3 (1.2)
REACTOME_NF:KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	REACTOME_NF:KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	0.12	> 0.20	RELB (5.7)	BCL3 (3.1)	GMIP (2.2)	SH2B3 (2.2)	PVR (2.1)	PARP10 (2.0)	BLOC1S3 (1.7)	PCSK9 (1.7)	TRIB1 (1.5)	GRINA (1.5)
MP:0003656	abnormal erythrocyte physiology	0.12	> 0.20	RHD (10.9)	RHCE (9.6)	GMPR (2.8)	C12orf51 (2.5)	TRAPPC6A (2.3)	TXNL4B (2.1)	FADS2 (1.9)	HP (1.8)	BLOC1S3 (1.8)	ZNF180 (1.7)
ENSG00000173113	TRMT112 PPI subnetwork	0.12	> 0.20	C19orf52 (4.2)	NKPD1 (3.8)	MAU2 (3.2)	NT5DC1 (2.5)	PCSK9 (2.2)	RHD (2.1)	HAVCR1 (2.0)	KANK2 (1.8)	DNM2 (1.7)	SUGP1 (1.7)
GO:0005123	death receptor binding	0.12	> 0.20	ZNF180 (2.7)	SH2B3 (2.4)	BRAP (1.9)	BLOC1S3 (1.9)	ZNF101 (1.7)	GMIP (1.5)	PARP10 (1.5)	ENSG00000228044 (1.5)	PMFBP1 (1.5)	BCL3 (1.4)
ENSG00000182093	WRB PPI subnetwork	0.12	> 0.20	C12orf51 (4.7)	UBXN2B (3.1)	ATXN2 (3.1)	ZHX3 (2.9)	ENSG00000254235 (2.3)	OGDH (2.2)	USP24 (2.2)	CYP7A1 (2.0)	SMARCA4 (1.8)	GOT2P1 (1.7)
ENSG00000116489	CAPZA1 PPI subnetwork	0.12	> 0.20	SH2B3 (3.5)	TMEM50A (2.9)	DNM2 (2.3)	POLK (2.2)	CYB561D1 (1.9)	MARK4 (1.8)	GMPR (1.8)	NPC1L1 (1.8)	PVR (1.8)	GEMIN7 (1.7)
ENSG00000148082	SHC3 PPI subnetwork	0.12	> 0.20	MYLIP (3.9)	SLC44A2 (3.2)	HLX (3.0)	C1orf63 (2.9)	C17orf57 (2.8)	ABCG8 (2.5)	PVRL2 (2.0)	LPA (1.9)	LPIN3 (1.9)	TIMD4 (1.8)
GO:0002526	acute inflammatory response	0.12	> 0.20	ENSG00000228044 (3.2)	HP (3.1)	FRK (2.5)	LPA (2.4)	TIMD4 (2.4)	SLC22A1 (2.2)	ST3GAL4 (2.1)	ENSG00000235545 (2.1)	APOA5 (2.0)	ANGPTL3 (1.9)
GO:0051702	interaction with symbiont	0.12	> 0.20	CEACAM19 (2.9)	RHD (2.4)	ENSG00000235545 (2.3)	HP (2.2)	ADAM1 (1.6)	ZNF101 (1.6)	ENSG00000226645 (1.6)	PBX4 (1.6)	GOT2P1 (1.5)	BUD13 (1.5)
ENSG00000183684	ALYREF PPI subnetwork	0.12	> 0.20	ILF3 (4.4)	TOP1 (3.9)	QTRT1 (3.3)	SMARCA4 (3.2)	USP1 (3.1)	TOMM40 (2.8)	C1orf63 (2.7)	DHX38 (2.7)	BUD13 (2.7)	SUGP1 (2.7)
MP:0003572	abnormal uterus development	0.12	> 0.20	DYNC2LI1 (2.6)	HAVCR1 (2.1)	BCAM (1.9)	NCAN (1.7)	ITGB3 (1.7)	ST3GAL4 (1.4)	C12orf47 (1.3)	GMPR (1.2)	CELSR2 (1.1)	AP1M2 (1.0)
GO:0042813	Wnt-activated receptor activity	0.12	> 0.20	CILP2 (4.7)	BCAM (2.8)	CELSR2 (2.6)	PVRL2 (2.5)	AMIGO1 (2.2)	LPAR2 (2.1)	DYNC2LI1 (1.7)	YIPF2 (1.6)	KIAA1324 (1.5)	PLEKHH2 (1.3)
GO:0015924	mannosyl-oligosaccharide mannosidase activity	0.12	> 0.20	ERP29 (3.0)	TMEM57 (2.2)	C17orf57 (2.1)	YIPF2 (2.1)	TRAPPC6A (2.1)	TMEM50A (1.8)	ENSG00000235545 (1.7)	ENSG00000254235 (1.5)	CYB561D1 (1.4)	C1orf63 (1.4)
GO:0001892	embryonic placenta development	0.12	> 0.20	CBLC (2.4)	ATXN2 (2.1)	UBXN2B (1.9)	C12orf51 (1.9)	ENSG00000226645 (1.7)	TRIB1 (1.6)	PVRL2 (1.6)	ADAM1 (1.5)	SLC44A2 (1.5)	ENSG00000228044 (1.4)
ENSG00000173917	HOXB2 PPI subnetwork	0.12	> 0.20	ANKRD31 (3.0)	C12orf51 (2.9)	POC5 (2.2)	CEACAM19 (2.1)	COL4A3BP (1.9)	HLX (1.9)	DNAH11 (1.9)	MAU2 (1.9)	ENSG00000238078 (1.8)	PLEC (1.8)
MP:0002362	abnormal spleen marginal zone morphology	0.12	> 0.20	TIMD4 (4.7)	RELB (4.5)	CETP (2.9)	GMIP (2.2)	PBX4 (2.2)	ZNF101 (1.8)	MAFB (1.8)	KIAA1324 (1.6)	NPC1L1 (1.6)	BCL3 (1.6)
MP:0000443	abnormal snout morphology	0.12	> 0.20	CILP2 (2.3)	NPC1L1 (2.0)	MAPKAPK5 (1.9)	ENSG00000235545 (1.8)	AP1M2 (1.8)	CBLC (1.6)	MYLIP (1.4)	NCAN (1.4)	GCNT4 (1.3)	ALDH2 (1.2)
GO:0003713	transcription coactivator activity	0.12	> 0.20	BUD13 (3.6)	ATXN2 (2.9)	NYNRIN (2.8)	SMARCA4 (2.7)	TMEM57 (2.6)	TRIB1 (2.6)	CARM1 (2.4)	MAU2 (2.4)	C12orf51 (2.0)	MAPKAPK5 (2.0)
ENSG00000071537	SEL1L PPI subnetwork	0.12	> 0.20	ERP29 (3.2)	LDLR (3.2)	CLPTM1 (2.9)	DNM2 (2.6)	YIPF2 (2.6)	TMED4 (2.5)	CYB561D1 (2.4)	ATP13A1 (2.1)	TMEM57 (1.9)	CYP7A1 (1.9)
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	0.12	> 0.20	ITGB3 (10.7)	CETP (4.3)	GMPR (3.3)	RHD (2.7)	MAFB (1.8)	APOE (1.7)	ENSG00000228044 (1.7)	ENSG00000238078 (1.7)	TIMD4 (1.7)	ST3GAL4 (1.6)
GO:0016891	endoribonuclease activity, producing 5'-phosphomonoesters	0.12	> 0.20	ZNF180 (3.7)	C12orf43 (3.1)	BUD13 (2.3)	DHODH (2.3)	FEN1 (2.0)	QTRT1 (1.8)	C19orf52 (1.8)	LPA (1.7)	CARM1 (1.7)	GEMIN7 (1.7)
REACTOME_METAL_ION_SLC_TRANSPORTERS	REACTOME_METAL_ION_SLC_TRANSPORTERS	0.12	> 0.20	YIPF2 (2.8)	ERP29 (2.2)	NPC1L1 (2.1)	RHD (1.8)	ATP13A1 (1.8)	TMED4 (1.8)	AP1M2 (1.7)	SORT1 (1.6)	RHCE (1.5)	TM6SF2 (1.5)
ENSG00000164776	PHKG1 PPI subnetwork	0.12	> 0.20	CILP2 (3.4)	SYPL2 (2.8)	ZNF180 (2.4)	SORT1 (2.3)	GPAM (2.2)	GMPR (2.1)	NCAN (2.0)	KIAA1324 (1.9)	TXNL4B (1.6)	ZHX3 (1.6)
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.12	> 0.20	RPH3A (2.0)	GOT2P1 (2.0)	AMIGO1 (1.9)	HAPLN4 (1.8)	CBLC (1.7)	GEMIN7 (1.6)	SYPL2 (1.6)	GRINA (1.6)	TRAFD1 (1.6)	BRAP (1.5)
MP:0001209	spontaneous skin ulceration	0.12	> 0.20	FADS1 (4.8)	LDLR (3.8)	CBLC (2.9)	GMIP (2.4)	APOC1 (2.2)	HMGCR (1.9)	CYB561D1 (1.8)	AP1M2 (1.8)	APOE (1.7)	BCL3 (1.7)
MP:0008597	decreased circulating interleukin-6 level	0.12	> 0.20	MAFB (4.6)	RELB (2.9)	BCL3 (2.9)	C11orf9 (2.5)	APOE (2.5)	GMIP (2.4)	TIMD4 (2.4)	TRIB1 (2.1)	FRK (1.9)	HLX (1.8)
ENSG00000206492	GNL1 PPI subnetwork	0.12	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000204590	GNL1 PPI subnetwork	0.12	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000206412	GNL1 PPI subnetwork	0.12	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000163781	TOPBP1 PPI subnetwork	0.12	> 0.20	PLCG1 (3.1)	FEN1 (2.8)	APOA5 (2.5)	USP1 (2.2)	ENSG00000238078 (2.0)	SMARCA4 (1.9)	DOCK7 (1.8)	APOC4 (1.7)	PTPN11 (1.6)	ENSG00000254235 (1.6)
GO:0005520	insulin-like growth factor binding	0.12	> 0.20	CILP2 (4.1)	APOE (2.5)	KANK2 (2.3)	PPP1R37 (2.0)	PVRL2 (1.9)	BCAM (1.9)	ADAM1 (1.6)	YIPF2 (1.5)	TMED4 (1.4)	APOB (1.3)
ENSG00000137486	ARRB1 PPI subnetwork	0.12	> 0.20	GMIP (3.1)	DNM2 (2.8)	TOP1 (2.3)	PTPN11 (2.2)	CARM1 (2.1)	COL4A3BP (2.1)	SH2B3 (2.0)	DHX38 (2.0)	C1orf63 (1.9)	CLPTM1 (1.8)
GO:0002262	myeloid cell homeostasis	0.12	> 0.20	ENSG00000254235 (2.9)	DNAH11 (2.6)	TRAFD1 (2.1)	TXNL4B (2.0)	ERP29 (1.7)	C17orf57 (1.7)	LPAR2 (1.6)	C12orf43 (1.5)	CYB561D1 (1.4)	PPP1R37 (1.4)
GO:0019213	deacetylase activity	0.12	> 0.20	PLCG1 (3.4)	ATXN7L2 (2.5)	HNF1A (2.1)	ACAD10 (2.0)	TXNL4B (2.0)	BUD13 (1.9)	NT5DC1 (1.8)	ANGPTL3 (1.6)	PSRC1 (1.6)	YIPF2 (1.6)
MP:0002925	abnormal cardiovascular development	0.12	> 0.20	MYLIP (2.7)	C19orf52 (2.5)	BCAM (2.3)	ENSG00000238078 (2.0)	DYNC2LI1 (1.9)	HLX (1.8)	CETP (1.8)	ABCG5 (1.7)	SYPL2 (1.7)	PPP1R37 (1.7)
GO:0031056	regulation of histone modification	0.12	> 0.20	TMEM57 (3.7)	SH2B3 (2.1)	C12orf51 (1.9)	PCSK9 (1.8)	MYLIP (1.8)	FADS1 (1.7)	ABO (1.6)	ZNF180 (1.4)	GOT2P1 (1.4)	ATXN2 (1.3)
GO:0006721	terpenoid metabolic process	0.12	> 0.20	LPA (4.0)	ABCG8 (3.9)	TM6SF2 (3.7)	CYP7A1 (3.6)	ABCG5 (3.2)	NPC1L1 (3.1)	SLC22A1 (3.0)	APOC4 (2.3)	APOA5 (2.3)	NKPD1 (2.1)
GO:0001959	regulation of cytokine-mediated signaling pathway	0.12	> 0.20	ZNF101 (3.2)	PARP10 (2.7)	CEACAM19 (2.6)	GRINA (2.6)	OASL (2.6)	ENSG00000238078 (2.4)	C17orf57 (2.2)	TRAFD1 (2.0)	NKPD1 (2.0)	MAU2 (1.9)
ENSG00000082146	STRADB PPI subnetwork	0.12	> 0.20	ILF3 (3.4)	MAU2 (2.7)	C19orf52 (2.5)	DNM2 (2.5)	BRAP (2.5)	CARM1 (2.3)	HAPLN4 (2.1)	ATP13A1 (1.9)	SLC44A2 (1.8)	GMPR (1.8)
ENSG00000101076	HNF4A PPI subnetwork	0.12	> 0.20	ATXN2 (3.0)	APOB (2.3)	CYP7A1 (2.2)	HNF1A (2.1)	GCNT4 (2.1)	HMGCR (1.8)	USP24 (1.7)	C12orf51 (1.7)	BRAP (1.5)	SH2B3 (1.5)
ENSG00000134313	KIDINS220 PPI subnetwork	0.12	> 0.20	SARS (2.8)	ZNF180 (2.0)	SH2B3 (1.9)	ABCG8 (1.9)	AMIGO1 (1.9)	ABCG5 (1.9)	PLG (1.8)	TMEM50A (1.8)	APOC4 (1.7)	SLC44A2 (1.7)
ENSG00000132964	CDK8 PPI subnetwork	0.12	> 0.20	ATXN2 (3.1)	GEMIN7 (3.0)	C12orf51 (2.7)	ATXN7L2 (2.5)	BUD13 (2.3)	POC5 (2.2)	TMEM57 (2.1)	USP24 (1.8)	DHX38 (1.8)	BRAP (1.7)
GO:0005539	glycosaminoglycan binding	0.12	> 0.20	CILP2 (5.3)	HP (4.2)	PLG (3.0)	MAFB (2.7)	ANGPTL3 (2.3)	APOC4 (2.2)	TIMD4 (2.1)	LPA (2.0)	APOE (1.9)	MOSC1 (1.8)
ENSG00000142655	PEX14 PPI subnetwork	0.12	> 0.20	NT5DC1 (3.2)	ACAD10 (2.8)	DYNC2LI1 (2.2)	RHCE (2.1)	TMEM57 (2.0)	TMEM116 (2.0)	ENSG00000226645 (1.9)	GPAM (1.8)	DOCK7 (1.8)	MYLIP (1.8)
ENSG00000082512	TRAF5 PPI subnetwork	0.12	> 0.20	RELB (5.0)	BCL3 (3.5)	ZNF180 (2.6)	PBX4 (2.6)	LPAR2 (2.1)	NT5DC1 (1.9)	PVR (1.9)	AMIGO1 (1.8)	CYB561D1 (1.8)	PARP10 (1.8)
MP:0003044	impaired basement membrane formation	0.12	> 0.20	PVRL2 (3.2)	BCAM (2.8)	PVR (2.5)	ERP29 (2.4)	TMED4 (2.1)	ATP13A1 (2.1)	CELSR2 (2.1)	APOE (1.8)	CBLC (1.7)	HAVCR1 (1.6)
ENSG00000198841	KTI12 PPI subnetwork	0.12	> 0.20	RHD (2.3)	RHCE (2.1)	PCSK9 (2.0)	UBXN2B (1.8)	ENSG00000254235 (1.8)	TXNL4B (1.8)	HNF1A (1.6)	NT5DC1 (1.5)	SUGP1 (1.4)	PLCG1 (1.4)
ENSG00000114315	HES1 PPI subnetwork	0.12	> 0.20	MYLIP (2.9)	NCAN (2.7)	ALDH2 (2.5)	ZHX3 (2.3)	GPAM (1.8)	PLCG1 (1.8)	MAFB (1.8)	CEACAM19 (1.6)	TM6SF2 (1.5)	TOP1 (1.4)
GO:0044454	nuclear chromosome part	0.12	> 0.20	USP1 (4.1)	FEN1 (4.0)	PSRC1 (2.4)	POC5 (2.1)	BUD13 (1.9)	NYNRIN (1.8)	ILF3 (1.8)	ATXN2 (1.6)	TOP1 (1.5)	ATXN7L2 (1.5)
ENSG00000101439	CST3 PPI subnetwork	0.12	> 0.20	ERP29 (3.4)	APOE (3.1)	APOC1 (3.0)	RPH3A (2.7)	CELSR2 (2.7)	NCAN (2.3)	TIMD4 (2.2)	BCAM (2.1)	APOC4 (1.9)	HP (1.8)
MP:0008943	increased sensitivity to induced cell death	0.12	> 0.20	SARS (3.3)	SLC44A2 (3.1)	TRAPPC6A (2.5)	CYP7A1 (2.4)	RELB (2.2)	MAPKAPK5 (2.1)	ENSG00000226648 (1.8)	PVR (1.8)	ZHX3 (1.7)	OASL (1.7)
ENSG00000163823	CCR1 PPI subnetwork	0.12	> 0.20	OASL (4.5)	RELB (2.9)	PARP10 (2.8)	PVR (2.8)	MAFB (2.8)	BCL3 (2.8)	TRAFD1 (2.2)	TMEM50A (1.9)	AMIGO1 (1.9)	PSMA5 (1.4)
MP:0004974	decreased regulatory T cell number	0.12	> 0.20	RELB (4.1)	SH2B3 (2.1)	PBX4 (2.0)	PARP10 (1.9)	GMIP (1.9)	BCL3 (1.8)	CYB561D1 (1.7)	MAFB (1.6)	PLCG1 (1.5)	TRAFD1 (1.2)
MP:0011107	partial embryonic lethality before turning of embryo	0.12	> 0.20	C17orf57 (3.0)	SYPL2 (2.1)	ATXN2 (1.7)	PMFBP1 (1.5)	ABCG5 (1.5)	GCNT4 (1.5)	POLK (1.5)	ENSG00000228044 (1.5)	LPA (1.5)	HAVCR1 (1.4)
GO:0042743	hydrogen peroxide metabolic process	0.12	> 0.20	GOT2P1 (3.5)	ADAM1 (2.6)	C19orf52 (2.5)	ALDH2 (2.3)	PBX4 (2.2)	TMED4 (2.1)	MOSC1 (1.9)	RHCE (1.9)	C17orf57 (1.9)	SLC22A1 (1.8)
ENSG00000171720	HDAC3 PPI subnetwork	0.12	> 0.20	MAPKAPK5 (2.9)	ATXN2 (2.2)	GATAD2A (2.2)	USP24 (2.2)	MAU2 (2.2)	PTPN11 (2.1)	RELB (1.9)	BCL3 (1.9)	TRIB1 (1.9)	PARP10 (1.7)
MP:0005065	abnormal neutrophil morphology	0.12	> 0.20	HP (5.3)	TRIB1 (4.3)	ABCG8 (4.0)	HLX (2.6)	MAFB (2.5)	CYP7A1 (2.0)	APOB (2.0)	AMIGO1 (1.9)	SORT1 (1.9)	CYB561D1 (1.8)
ENSG00000130227	XPO7 PPI subnetwork	0.12	> 0.20	NAA25 (2.2)	ENSG00000254235 (2.0)	MAPKAPK5 (2.0)	POC5 (1.9)	HLX (1.8)	SLC22A1 (1.8)	GATAD2A (1.7)	USP24 (1.7)	SARS (1.7)	ENSG00000226648 (1.7)
ENSG00000121753	BAI2 PPI subnetwork	0.12	> 0.20	LDLR (4.9)	FADS1 (3.1)	COL4A3BP (3.1)	C12orf51 (2.5)	OGDH (2.5)	HNF1A (2.5)	PCSK9 (2.4)	DNAH11 (2.3)	FADS2 (2.2)	SORT1 (2.0)
GO:0045599	negative regulation of fat cell differentiation	0.12	> 0.20	ENSG00000238078 (2.3)	ENSG00000254235 (1.9)	TMEM116 (1.6)	SH2B3 (1.6)	LDLR (1.6)	GCNT4 (1.5)	FADS1 (1.4)	ZNF180 (1.4)	ITGB3 (1.3)	HMGCR (1.3)
MP:0005093	decreased B cell proliferation	0.12	> 0.20	GMIP (5.0)	RELB (4.3)	BCL3 (3.3)	SH2B3 (3.2)	MYLIP (2.5)	MAFB (2.1)	TIMD4 (1.9)	CETP (1.7)	GEMIN7 (1.7)	SLC44A2 (1.7)
GO:0034708	methyltransferase complex	0.12	> 0.20	BUD13 (3.2)	ATXN2 (3.2)	QTRT1 (2.6)	C12orf51 (2.5)	C12orf43 (2.5)	OGDH (2.4)	ATXN7L2 (2.1)	ZNF180 (2.1)	ILF3 (1.9)	USP1 (1.9)
GO:0035097	histone methyltransferase complex	0.12	> 0.20	BUD13 (3.2)	ATXN2 (3.2)	QTRT1 (2.6)	C12orf51 (2.5)	C12orf43 (2.5)	OGDH (2.4)	ATXN7L2 (2.1)	ZNF180 (2.1)	ILF3 (1.9)	USP1 (1.9)
ENSG00000133657	ATP13A3 PPI subnetwork	0.12	> 0.20	ATP13A1 (4.1)	BRAP (3.0)	MAPKAPK5 (2.9)	DDX56 (2.7)	HNF1A (2.6)	TOMM40 (2.3)	DHODH (2.2)	C12orf51 (2.1)	ANKRD31 (2.1)	CETP (2.1)
ENSG00000108010	GLRX3 PPI subnetwork	0.12	> 0.20	ABCG5 (2.6)	PLCG1 (2.1)	ENSG00000235545 (1.8)	ABCG8 (1.8)	TRAFD1 (1.7)	HAVCR1 (1.7)	LPA (1.7)	LPIN3 (1.6)	FADS1 (1.6)	TM6SF2 (1.5)
ENSG00000121057	AKAP1 PPI subnetwork	0.12	> 0.20	KANK2 (2.9)	ADAM1 (2.5)	DYNC2LI1 (2.2)	PTPN11 (2.1)	ITGB3 (1.8)	TRIB1 (1.8)	SH2B3 (1.4)	QTRT1 (1.3)	AMIGO1 (1.3)	GMPR (1.3)
GO:0005681	spliceosomal complex	0.12	> 0.20	DHX38 (4.2)	BUD13 (3.5)	TOP1 (3.4)	SUGP1 (3.2)	C1orf63 (2.9)	ILF3 (2.8)	USP1 (2.4)	MAPKAPK5 (2.4)	SMARCA4 (2.1)	C12orf43 (2.1)
GO:0005667	transcription factor complex	0.12	> 0.20	ATXN2 (2.7)	MAPKAPK5 (2.7)	ATXN7L2 (2.6)	KANK2 (2.6)	CARM1 (2.4)	TRIB1 (2.0)	BUD13 (1.9)	HLX (1.8)	ALDH2 (1.7)	PLCG1 (1.6)
KEGG_CIRCADIAN_RHYTHM_MAMMAL	KEGG_CIRCADIAN_RHYTHM_MAMMAL	0.12	> 0.20	CILP2 (3.1)	TRIB1 (2.7)	GPAM (2.0)	ZHX3 (1.9)	C17orf57 (1.8)	LPIN3 (1.5)	TMEM57 (1.5)	LDLR (1.3)	SH2B3 (1.3)	MAPKAPK5 (1.3)
ENSG00000056345	ENSG00000056345 PPI subnetwork	0.12	> 0.20	ITGB3 (5.4)	APOB (3.1)	APOE (2.7)	KANK2 (2.5)	HP (2.4)	PLEC (2.2)	PLG (2.1)	C17orf57 (1.9)	APOC4 (1.8)	PCSK9 (1.7)
GO:0031965	nuclear membrane	0.12	> 0.20	LDLR (3.3)	NAA25 (2.7)	DDX56 (2.6)	TMED4 (2.4)	ATP13A1 (2.2)	ERP29 (2.2)	HAVCR1 (2.2)	USP1 (2.0)	PSRC1 (1.8)	DHODH (1.7)
MP:0000255	vasculature congestion	0.12	> 0.20	RHD (3.3)	ATXN2 (3.1)	GATAD2A (2.7)	RHCE (2.5)	TRIB1 (2.4)	GEMIN7 (2.0)	GCNT4 (2.0)	ADAM1 (2.0)	MARK4 (1.9)	DNAH11 (1.8)
MP:0005452	abnormal adipose tissue amount	0.12	> 0.20	KIAA1324 (2.7)	PMFBP1 (2.4)	MOSC1 (1.9)	USP24 (1.9)	NPC1L1 (1.8)	GPAM (1.7)	ENSG00000226648 (1.7)	HNF1A (1.6)	TSSK6 (1.5)	MAFB (1.5)
ENSG00000173726	TOMM20 PPI subnetwork	0.12	> 0.20	TM6SF2 (3.7)	APOB (3.6)	ABCG5 (3.3)	ZNF259 (3.0)	ABCG8 (2.9)	APOA5 (2.7)	APOC4 (2.4)	TMED4 (2.3)	GCNT4 (2.3)	NPC1L1 (2.1)
ENSG00000090061	CCNK PPI subnetwork	0.12	> 0.20	GCNT4 (2.8)	TRAPPC6A (2.6)	BUD13 (2.5)	PARP10 (1.7)	SUGP1 (1.5)	OGDH (1.4)	CARM1 (1.4)	GMPR (1.4)	MARK4 (1.4)	CELSR2 (1.3)
ENSG00000025770	NCAPH2 PPI subnetwork	0.12	> 0.20	USP1 (3.2)	FEN1 (3.0)	OGDH (2.5)	SYPL2 (2.5)	ENSG00000226645 (2.4)	ILF3 (2.3)	C12orf47 (2.2)	PSRC1 (1.9)	ABCG8 (1.7)	ZNF180 (1.5)
MP:0002970	abnormal white adipose tissue morphology	0.12	> 0.20	MOSC1 (4.5)	SORT1 (2.7)	TM6SF2 (2.4)	SYPL2 (2.3)	CETP (2.1)	GPAM (2.1)	APOC1 (2.0)	ABCG5 (1.8)	APOB (1.7)	NPC1L1 (1.7)
ENSG00000164985	PSIP1 PPI subnetwork	0.12	> 0.20	DOCK7 (3.2)	NAA25 (3.2)	BUD13 (3.2)	USP24 (3.1)	DDX56 (2.7)	USP1 (2.6)	POC5 (2.6)	ILF3 (2.4)	FEN1 (2.3)	C12orf51 (2.1)
GO:0002221	pattern recognition receptor signaling pathway	0.12	> 0.20	SH2B3 (3.0)	RELB (2.3)	GMIP (2.1)	OASL (2.0)	PARP10 (2.0)	CYB561D1 (1.9)	MAFB (1.9)	TRIB1 (1.8)	BCL3 (1.8)	BLOC1S3 (1.7)
ENSG00000107338	SHB PPI subnetwork	0.12	> 0.20	PLCG1 (3.6)	ITGB3 (3.6)	HAVCR1 (3.4)	CETP (2.6)	MYLIP (2.3)	DNM2 (2.3)	ZHX3 (2.1)	COL4A3BP (2.1)	GMIP (2.0)	SLC44A2 (1.9)
GO:0035304	regulation of protein dephosphorylation	0.12	> 0.20	GRINA (2.0)	GOT2P1 (1.8)	RPH3A (1.7)	PPP1R37 (1.6)	ENSG00000228044 (1.6)	GCNT4 (1.6)	SORT1 (1.6)	COL4A3BP (1.5)	AP1M2 (1.4)	ENSG00000238078 (1.4)
ENSG00000130560	UBAC1 PPI subnetwork	0.12	> 0.20	RHCE (1.9)	ENSG00000235545 (1.9)	PTPN11 (1.9)	ZNF180 (1.9)	C12orf51 (1.7)	SYPL2 (1.7)	NPC1L1 (1.5)	UBXN2B (1.5)	SH2B3 (1.5)	ERP29 (1.5)
GO:0005902	microvillus	0.12	> 0.20	HNF1A (3.3)	TM6SF2 (2.9)	NPC1L1 (2.7)	C11orf9 (2.7)	APOB (2.5)	APOE (2.3)	KIAA1324 (2.0)	AP1M2 (2.0)	CBLC (2.0)	BCAM (1.9)
GO:0051188	cofactor biosynthetic process	0.12	> 0.20	NT5DC1 (3.6)	RHCE (3.3)	RHD (3.1)	ACAD10 (3.0)	DHODH (2.8)	GPAM (2.6)	TRAPPC6A (2.5)	FADS1 (2.5)	PCSK9 (2.4)	C19orf52 (2.4)
MP:0008519	thin retinal outer plexiform layer	0.12	> 0.20	KIAA1324 (1.8)	FRK (1.7)	MAPKAPK5 (1.7)	GEMIN7 (1.6)	PVRL2 (1.4)	TSSK6 (1.4)	YIPF2 (1.4)	C12orf47 (1.3)	MYLIP (1.3)	HNF1A (1.3)
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE:REPLICATIVE_COMPLEX	0.12	> 0.20	FEN1 (3.8)	LPAR2 (3.0)	USP1 (2.7)	TMEM116 (2.3)	ENSG00000226645 (2.0)	GOT2P1 (1.8)	KANK2 (1.5)	NT5DC1 (1.5)	GMPR (1.5)	LPIN3 (1.4)
ENSG00000157557	ETS2 PPI subnetwork	0.12	> 0.20	TRIB1 (3.3)	MAFB (3.2)	PLCG1 (3.2)	MYLIP (2.7)	DHX38 (2.5)	PPP1R37 (2.5)	DOCK7 (2.4)	USP24 (2.2)	GATAD2A (2.1)	HLX (2.1)
GO:0031143	pseudopodium	0.12	> 0.20	SYPL2 (5.9)	AP1M2 (3.4)	PVRL2 (3.1)	CBLC (2.9)	GMPR (1.8)	BLOC1S3 (1.8)	SORT1 (1.6)	HNF1A (1.6)	CLPTM1 (1.4)	NPC1L1 (1.4)
GO:0010039	response to iron ion	0.12	> 0.20	RHD (3.9)	RHCE (3.8)	GEMIN7 (2.7)	C12orf51 (2.1)	FRK (1.8)	ABO (1.7)	ENSG00000254235 (1.5)	TMEM116 (1.5)	ADAM1 (1.4)	AP1M2 (1.4)
GO:0070723	response to cholesterol	0.12	> 0.20	PCSK9 (4.3)	ENSG00000254235 (3.9)	HMGCR (3.7)	LDLR (3.4)	FADS1 (2.8)	FADS2 (2.8)	TXNL4B (2.2)	GPAM (1.9)	TMEM50A (1.8)	UBXN2B (1.6)
MP:0004067	abnormal trabecula carnea morphology	0.12	> 0.20	ABO (2.8)	TMEM116 (2.0)	BLOC1S3 (1.8)	PVR (1.8)	UBXN2B (1.8)	KANK2 (1.6)	HAVCR1 (1.6)	C1orf63 (1.5)	MARK4 (1.5)	ALDH2 (1.4)
ENSG00000132467	UTP3 PPI subnetwork	0.12	> 0.20	DDX56 (4.0)	ZNF259 (4.0)	DHODH (3.2)	NAA25 (3.2)	QTRT1 (2.7)	DHX38 (2.2)	C12orf43 (1.9)	TOP1 (1.7)	ATXN7L2 (1.6)	SARS (1.6)
ENSG00000177791	MYOZ1 PPI subnetwork	0.12	> 0.20	SYPL2 (5.0)	PVR (2.7)	PVRL2 (2.3)	GMPR (2.2)	PLEC (2.1)	ZNF180 (1.7)	CLPTM1 (1.6)	TOMM40 (1.6)	MARK4 (1.5)	HNF1A (1.5)
ENSG00000142166	IFNAR1 PPI subnetwork	0.12	> 0.20	BCL3 (3.3)	COL4A3BP (2.5)	PARP10 (1.7)	ZNF101 (1.7)	CYP7A1 (1.6)	OASL (1.6)	PVR (1.6)	RELB (1.4)	TIMD4 (1.3)	TRAFD1 (1.3)
ENSG00000173120	KDM2A PPI subnetwork	0.12	> 0.20	PARP10 (3.1)	MAU2 (2.5)	MYLIP (2.3)	MARK4 (2.1)	GMIP (2.0)	POLK (1.9)	USP24 (1.9)	ZHX3 (1.9)	MAFB (1.7)	BCL3 (1.7)
MP:0008782	increased B cell apoptosis	0.12	> 0.20	MAFB (3.4)	GMIP (2.8)	TRIB1 (2.6)	MYLIP (2.3)	ALDH2 (2.3)	AP1M2 (2.1)	CETP (2.0)	TIMD4 (1.9)	FRK (1.8)	SH2B3 (1.7)
MP:0001344	blepharoptosis	0.12	> 0.20	NKPD1 (2.3)	DYNC2LI1 (2.2)	SYPL2 (2.1)	FADS2 (1.9)	AMIGO1 (1.7)	CELSR2 (1.7)	GOT2P1 (1.6)	ABCG5 (1.6)	SH2B3 (1.5)	TIMD4 (1.4)
GO:0031018	endocrine pancreas development	0.12	> 0.20	ANKRD31 (2.4)	HNF1A (2.1)	ABO (2.0)	KIAA1324 (1.9)	DNAH11 (1.8)	CEACAM19 (1.7)	FRK (1.5)	CYP7A1 (1.5)	C11orf9 (1.5)	UBXN2B (1.4)
KEGG_PROPANOATE_METABOLISM	KEGG_PROPANOATE_METABOLISM	0.12	> 0.20	ACAD10 (5.1)	ALDH2 (4.0)	MOSC1 (4.0)	GPAM (3.9)	FADS2 (3.8)	FADS1 (3.6)	TRAPPC6A (2.9)	NT5DC1 (2.8)	PCSK9 (2.8)	OGDH (2.8)
GO:0050830	defense response to Gram-positive bacterium	0.12	> 0.20	HP (2.8)	ENSG00000228044 (2.7)	GOT2P1 (2.4)	C17orf57 (2.3)	DNAH11 (2.2)	ADAM1 (2.0)	PMFBP1 (1.9)	LPA (1.9)	CEACAM19 (1.8)	CYB561D1 (1.6)
ENSG00000105610	KLF1 PPI subnetwork	0.12	> 0.20	CARM1 (6.4)	SMARCA4 (3.9)	MAU2 (3.5)	MARK4 (3.5)	ATXN2 (3.4)	GATAD2A (3.1)	MAPKAPK5 (2.6)	NYNRIN (2.4)	ILF3 (2.2)	BRAP (2.2)
ENSG00000179335	CLK3 PPI subnetwork	0.12	> 0.20	ATXN2 (3.4)	SMARCA4 (2.6)	BRAP (2.6)	NAA25 (2.4)	C12orf43 (2.3)	MAPKAPK5 (2.2)	CLPTM1 (2.2)	C12orf51 (2.1)	ANKRD31 (2.1)	TRAFD1 (1.9)
MP:0008102	lymph node hyperplasia	0.12	> 0.20	RELB (6.1)	BCL3 (4.4)	RHD (3.4)	PARP10 (3.1)	RHCE (2.7)	NT5DC1 (1.8)	GMIP (1.7)	LDLR (1.7)	SH2B3 (1.6)	TIMD4 (1.5)
GO:0016646	oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor	0.12	> 0.20	SARS (3.3)	DHODH (2.9)	TRAPPC6A (2.6)	PVRL2 (2.3)	FADS2 (2.2)	PLG (2.2)	FADS1 (2.2)	ENSG00000238078 (2.2)	APOC4 (2.0)	CYP7A1 (1.9)
GO:0051384	response to glucocorticoid stimulus	0.12	> 0.20	LPA (3.0)	ABCG5 (2.5)	SLC22A1 (2.5)	APOC4 (2.1)	APOA5 (2.1)	ABCG8 (2.0)	HP (1.9)	ATXN7L2 (1.8)	PLG (1.7)	HAPLN4 (1.7)
ENSG00000197498	RPF2 PPI subnetwork	0.12	> 0.20	ZNF259 (5.1)	NAA25 (4.6)	DDX56 (4.2)	QTRT1 (3.9)	TOMM40 (3.8)	DHODH (3.2)	DHX38 (2.7)	ATP13A1 (2.6)	C12orf43 (2.4)	MAPKAPK5 (2.4)
MP:0011096	complete embryonic lethality before somite formation	0.12	> 0.20	FEN1 (3.6)	USP1 (3.3)	PSRC1 (2.9)	PSMA5 (2.1)	ILF3 (2.0)	BUD13 (1.8)	DHX38 (1.7)	SMARCA4 (1.7)	DDX56 (1.6)	CARM1 (1.6)
ENSG00000072110	ACTN1 PPI subnetwork	0.12	> 0.20	AP1M2 (3.1)	SYPL2 (2.9)	PTPN11 (2.8)	GMPR (2.7)	OGDH (2.7)	PLEC (2.7)	PVRL2 (2.6)	CARM1 (2.4)	GATAD2A (2.3)	ITGB3 (2.3)
GO:0030132	clathrin coat of coated pit	0.12	> 0.20	CLPTM1 (2.9)	GRINA (2.8)	SARS (2.6)	ZHX3 (2.4)	C1orf63 (2.2)	ENSG00000235545 (1.9)	TMEM50A (1.9)	CEACAM19 (1.8)	GEMIN7 (1.8)	PVRL2 (1.8)
GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	0.12	> 0.20	FADS1 (4.1)	ALDH2 (4.0)	FADS2 (3.9)	SLC22A1 (3.2)	TRAPPC6A (2.7)	CYP7A1 (2.4)	ANGPTL3 (2.3)	APOC4 (2.3)	PLG (2.2)	APOC1 (2.1)
ENSG00000135387	CAPRIN1 PPI subnetwork	0.12	> 0.20	C1orf63 (3.7)	GATAD2A (3.0)	BUD13 (2.7)	CARM1 (2.7)	GEMIN7 (2.6)	TRAPPC6A (2.5)	ILF3 (2.4)	DHX38 (2.3)	NT5DC1 (2.2)	TOP1 (2.1)
GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	0.12	> 0.20	MOSC1 (3.2)	HP (2.2)	ATXN7L2 (2.2)	KANK2 (1.9)	RELB (1.7)	PLG (1.7)	GPAM (1.6)	TRAFD1 (1.6)	NPC1L1 (1.6)	OASL (1.6)
GO:0070306	lens fiber cell differentiation	0.12	> 0.20	ABO (2.8)	TMEM57 (1.7)	PLEC (1.7)	CILP2 (1.4)	C17orf57 (1.4)	CEACAM19 (1.3)	PBX4 (1.1)	CLPTM1 (1.0)	PVR (0.9)	GOT2P1 (0.9)
ENSG00000165732	DDX21 PPI subnetwork	0.12	> 0.20	RELB (2.9)	USP1 (2.6)	PVR (2.5)	ILF3 (2.4)	NAA25 (2.4)	SMARCA4 (2.2)	ATP13A1 (2.1)	TRIB1 (2.0)	FEN1 (2.0)	TOMM40 (2.0)
MP:0008722	abnormal chemokine secretion	0.12	> 0.20	PVR (3.5)	TRIB1 (3.3)	BCL3 (3.2)	ALDH2 (2.5)	HP (2.4)	MAFB (2.2)	SORT1 (2.1)	CEACAM19 (1.8)	GMIP (1.8)	PMFBP1 (1.6)
MP:0008997	increased blood osmolality	0.12	> 0.20	SLC22A1 (2.1)	PLG (2.0)	BCAM (1.9)	ANGPTL3 (1.8)	CELSR2 (1.8)	MOSC1 (1.7)	ABCG5 (1.5)	AMIGO1 (1.5)	AP1M2 (1.5)	NYNRIN (1.3)
ENSG00000104835	FBXO17 PPI subnetwork	0.13	> 0.20	PSMA5 (3.4)	NAA25 (3.2)	ENSG00000235545 (2.7)	CARM1 (2.5)	TOP1 (2.3)	TRAFD1 (2.2)	HMGCR (2.1)	ABCG5 (2.0)	SUGP1 (2.0)	TOMM40 (1.9)
GO:0002224	toll-like receptor signaling pathway	0.13	> 0.20	SH2B3 (3.0)	RELB (2.4)	OASL (2.1)	GMIP (2.1)	TRIB1 (2.1)	BLOC1S3 (2.0)	CYB561D1 (2.0)	PARP10 (1.9)	BCL3 (1.9)	ENSG00000228044 (1.9)
ENSG00000162191	UBXN1 PPI subnetwork	0.13	> 0.20	COL4A3BP (2.7)	CYP7A1 (2.6)	TMEM57 (2.5)	GRINA (2.1)	BLOC1S3 (2.0)	YIPF2 (1.9)	C19orf52 (1.8)	SLC22A1 (1.8)	TMED4 (1.8)	CARM1 (1.6)
GO:0001885	endothelial cell development	0.13	> 0.20	DNAH11 (4.2)	CILP2 (4.1)	ENSG00000226645 (2.2)	ANKRD31 (2.2)	ENSG00000226648 (1.9)	PBX4 (1.8)	BCAM (1.8)	CEACAM19 (1.7)	ABO (1.6)	UBXN2B (1.6)
ENSG00000064601	CTSA PPI subnetwork	0.13	> 0.20	OASL (4.7)	ERP29 (3.0)	HNF1A (2.9)	PARP10 (2.8)	TMEM50A (2.5)	C1orf63 (2.5)	ATP13A1 (2.3)	NKPD1 (2.2)	PLCG1 (1.8)	ZHX3 (1.7)
ENSG00000104365	IKBKB PPI subnetwork	0.13	> 0.20	RELB (5.9)	PARP10 (3.7)	OASL (3.4)	BCL3 (3.1)	SH2B3 (2.1)	ILF3 (2.1)	GMIP (2.0)	TRIB1 (2.0)	TRAFD1 (2.0)	PVR (1.9)
ENSG00000081237	PTPRC PPI subnetwork	0.13	> 0.20	PLCG1 (2.9)	GMIP (2.7)	SLC44A2 (2.7)	LPA (2.6)	DNM2 (2.0)	ZNF101 (1.9)	APOA5 (1.7)	MAFB (1.7)	LPAR2 (1.6)	TIMD4 (1.6)
MP:0009395	increased nucleated erythrocyte cell number	0.13	> 0.20	RHD (6.9)	RHCE (5.5)	C12orf51 (3.0)	SLC44A2 (3.0)	GMPR (3.0)	TRIB1 (2.9)	ENSG00000238078 (2.3)	KANK2 (2.2)	DNM2 (2.1)	ZNF101 (1.9)
ENSG00000136891	TEX10 PPI subnetwork	0.13	> 0.20	ZNF259 (5.1)	DDX56 (4.4)	NAA25 (4.1)	QTRT1 (3.6)	DHODH (3.3)	TOMM40 (3.2)	DHX38 (3.2)	C12orf43 (3.0)	SUGP1 (2.4)	ENSG00000226645 (2.4)
ENSG00000174720	LARP7 PPI subnetwork	0.13	> 0.20	ZNF259 (5.3)	NAA25 (4.8)	DDX56 (4.0)	TOMM40 (3.5)	QTRT1 (3.0)	TOP1 (2.8)	MAPKAPK5 (2.4)	DHX38 (2.4)	DHODH (2.3)	C12orf43 (2.3)
ENSG00000171608	PIK3CD PPI subnetwork	0.13	> 0.20	HLX (3.4)	DNM2 (3.1)	SLC44A2 (3.0)	MYLIP (2.9)	GMIP (2.8)	DOCK7 (2.6)	C1orf63 (2.4)	PLEKHH2 (2.0)	SH2B3 (1.7)	COL4A3BP (1.6)
GO:0042246	tissue regeneration	0.13	> 0.20	ENSG00000226648 (2.5)	PBX4 (2.2)	CEACAM19 (2.1)	ABCG5 (2.1)	SYPL2 (2.1)	LPIN3 (2.0)	CBLC (2.0)	HAPLN4 (2.0)	ENSG00000235545 (1.8)	GOT2P1 (1.7)
MP:0004251	failure of heart looping	0.13	> 0.20	ATXN2 (2.8)	PLCG1 (2.4)	NYNRIN (2.4)	KANK2 (2.1)	GATAD2A (1.9)	MARK4 (1.8)	PMFBP1 (1.5)	ENSG00000226648 (1.5)	C12orf51 (1.4)	ADAM1 (1.4)
MP:0005025	abnormal response to infection	0.13	> 0.20	BCL3 (4.4)	PARP10 (3.3)	OASL (2.5)	RELB (2.2)	HLX (2.0)	MAFB (1.9)	TRIB1 (1.7)	TRAFD1 (1.4)	GMIP (1.3)	COL4A3BP (1.3)
ENSG00000165119	HNRNPK PPI subnetwork	0.13	> 0.20	TOP1 (3.5)	C1orf63 (3.2)	ILF3 (3.1)	SMARCA4 (3.0)	USP1 (2.5)	DHX38 (2.0)	TOMM40 (2.0)	FEN1 (2.0)	PSMA5 (1.9)	QTRT1 (1.8)
ENSG00000123159	GIPC1 PPI subnetwork	0.13	> 0.20	CELSR2 (3.8)	PVRL2 (3.3)	SARS (3.0)	NYNRIN (2.8)	MARK4 (2.7)	PLEC (2.6)	BCAM (2.5)	ENSG00000235545 (2.3)	SLC44A2 (2.3)	DNAH11 (2.1)
MP:0002192	hydrops fetalis	0.13	> 0.20	HLX (4.4)	NYNRIN (3.1)	PPP1R37 (2.6)	PVRL2 (2.1)	C11orf9 (1.9)	KANK2 (1.7)	ATXN7L2 (1.4)	PLEKHH2 (1.3)	MYLIP (1.2)	TOMM40 (1.2)
ENSG00000112312	GMNN PPI subnetwork	0.13	> 0.20	FEN1 (3.4)	USP1 (2.8)	KANK2 (2.0)	ANKRD31 (1.9)	TMEM116 (1.9)	HLX (1.9)	GCNT4 (1.6)	ENSG00000235545 (1.6)	POLK (1.4)	ATXN7L2 (1.3)
ENSG00000096060	FKBP5 PPI subnetwork	0.13	> 0.20	HAPLN4 (3.0)	FRK (2.6)	RELB (2.2)	MAU2 (2.0)	GMIP (1.8)	C19orf52 (1.8)	POLK (1.7)	CARM1 (1.7)	MYLIP (1.6)	BUD13 (1.4)
GO:0016634	oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor	0.13	> 0.20	RHCE (3.6)	ACAD10 (3.1)	RHD (3.1)	MOSC1 (3.0)	LPA (2.5)	TM6SF2 (2.4)	GPAM (2.3)	APOA5 (2.2)	SLC22A1 (2.1)	ALDH2 (2.0)
ENSG00000120833	SOCS2 PPI subnetwork	0.13	> 0.20	BCL3 (5.0)	HLX (3.5)	RELB (3.1)	CETP (2.3)	GMIP (2.2)	TRIB1 (2.1)	TIMD4 (2.1)	ALDH2 (1.9)	GRINA (1.7)	PVRL2 (1.4)
ENSG00000171223	JUNB PPI subnetwork	0.13	> 0.20	TRIB1 (6.3)	BCL3 (4.8)	TRAFD1 (2.2)	ACAD10 (2.1)	MAFB (2.1)	ENSG00000228044 (1.9)	PVR (1.9)	RELB (1.8)	HLX (1.7)	POLK (1.5)
ENSG00000143622	RIT1 PPI subnetwork	0.13	> 0.20	NKPD1 (2.3)	MARK4 (2.3)	ABO (2.0)	PMFBP1 (2.0)	PVRL2 (2.0)	PPP1R37 (2.0)	ATXN7L2 (1.8)	BCL3 (1.8)	POLK (1.6)	MYLIP (1.6)
ENSG00000106443	PHF14 PPI subnetwork	0.13	> 0.20	ATP13A1 (4.2)	MAPKAPK5 (2.8)	HNF1A (2.7)	PTPN11 (2.5)	DHODH (2.4)	CEACAM19 (2.3)	DDX56 (2.3)	BRAP (2.2)	TOMM40 (2.2)	ANKRD31 (2.0)
ENSG00000109618	SEPSECS PPI subnetwork	0.13	> 0.20	ATP13A1 (3.9)	MAPKAPK5 (2.8)	BRAP (2.7)	HNF1A (2.7)	DDX56 (2.7)	PTPN11 (2.3)	TOMM40 (2.3)	CEACAM19 (2.3)	DHODH (2.1)	LPA (2.0)
MP:0005450	abnormal energy expenditure	0.13	> 0.20	ABO (2.9)	GPAM (2.8)	ZHX3 (2.2)	CILP2 (2.1)	HP (2.1)	PPP1R37 (1.9)	ALDH2 (1.9)	TOP1 (1.7)	SH2B3 (1.7)	GCNT4 (1.6)
ENSG00000123384	LRP1 PPI subnetwork	0.13	> 0.20	HP (4.1)	PVRL2 (3.0)	ITGB3 (2.2)	ANGPTL3 (2.2)	CLPTM1 (2.0)	APOC1 (2.0)	YIPF2 (1.8)	PPP1R37 (1.8)	PLG (1.8)	FRK (1.7)
GO:0043393	regulation of protein binding	0.13	> 0.20	TMEM57 (3.1)	AMIGO1 (2.7)	TXNL4B (2.0)	SLC44A2 (1.9)	GATAD2A (1.9)	GRINA (1.8)	OASL (1.6)	GCNT4 (1.6)	TMEM116 (1.4)	PLCG1 (1.4)
GO:0034660	ncRNA metabolic process	0.13	> 0.20	QTRT1 (3.8)	NAA25 (3.6)	ZNF259 (3.6)	DDX56 (3.6)	DHODH (3.3)	C12orf43 (3.0)	MAPKAPK5 (2.8)	TOMM40 (2.7)	POC5 (2.6)	C19orf52 (2.2)
GO:0072224	metanephric glomerulus development	0.13	> 0.20	PLEKHH2 (2.6)	DYNC2LI1 (2.0)	DNAH11 (2.0)	AMIGO1 (2.0)	NYNRIN (1.8)	ENSG00000254235 (1.8)	ATXN7L2 (1.6)	BCAM (1.6)	C11orf9 (1.6)	ANKRD31 (1.5)
ENSG00000185551	NR2F2 PPI subnetwork	0.13	> 0.20	PLCG1 (2.7)	MYLIP (2.4)	ATXN2 (2.3)	ZNF180 (2.1)	MAU2 (2.0)	POLK (2.0)	PBX4 (1.7)	USP24 (1.7)	CEACAM19 (1.6)	PLEC (1.5)
ENSG00000186895	FGF3 PPI subnetwork	0.13	> 0.20	HAVCR1 (4.9)	HAPLN4 (3.9)	PLEKHH2 (3.2)	ZHX3 (2.9)	C11orf9 (2.8)	C17orf57 (2.6)	CBLC (2.5)	NYNRIN (2.2)	CEACAM19 (2.1)	NCAN (1.9)
MP:0002052	decreased tumor incidence	0.13	> 0.20	SLC44A2 (2.8)	HLX (2.1)	TRAFD1 (2.0)	CETP (1.9)	BCL3 (1.8)	C17orf57 (1.7)	GEMIN7 (1.7)	FEN1 (1.6)	PSRC1 (1.6)	NYNRIN (1.5)
GO:2000377	regulation of reactive oxygen species metabolic process	0.13	> 0.20	ENSG00000226645 (3.0)	CEACAM19 (2.7)	ANKRD31 (2.5)	PVR (2.2)	ALDH2 (2.0)	BRAP (1.8)	HNF1A (1.6)	CBLC (1.6)	PCSK9 (1.5)	DYNC2LI1 (1.4)
MP:0000266	abnormal heart morphology	0.13	> 0.20	KANK2 (2.5)	BCAM (2.5)	MAFB (2.3)	ATXN2 (2.3)	PTPN11 (2.1)	ACAD10 (1.6)	APOB (1.6)	PVRL2 (1.5)	GPAM (1.4)	ALDH2 (1.4)
GO:0071013	catalytic step 2 spliceosome	0.13	> 0.20	SUGP1 (4.5)	DHX38 (4.5)	TOP1 (3.5)	ILF3 (3.4)	BUD13 (3.0)	SMARCA4 (2.9)	C1orf63 (2.4)	DDX56 (2.2)	USP1 (2.1)	QTRT1 (1.9)
GO:0000302	response to reactive oxygen species	0.13	> 0.20	ACAD10 (2.7)	DNAH11 (2.5)	ALDH2 (2.4)	GOT2P1 (2.3)	C12orf47 (2.2)	TRIB1 (2.1)	CEACAM19 (2.0)	RHD (1.6)	PVR (1.6)	MOSC1 (1.5)
MP:0005014	increased B cell number	0.13	> 0.20	RELB (4.0)	TIMD4 (3.5)	CETP (3.2)	BCL3 (3.1)	GMIP (3.0)	MAFB (3.0)	ZNF101 (2.7)	PLCG1 (2.0)	LPIN3 (1.9)	POLK (1.6)
ENSG00000152464	RPP38 PPI subnetwork	0.13	> 0.20	ZNF180 (3.1)	GEMIN7 (2.4)	POC5 (2.3)	C12orf43 (2.2)	ANKRD31 (1.8)	APOE (1.7)	ITGB3 (1.7)	COL4A3BP (1.7)	C12orf47 (1.7)	SLC44A2 (1.7)
REACTOME_ZINC_TRANSPORTERS	REACTOME_ZINC_TRANSPORTERS	0.13	> 0.20	YIPF2 (3.5)	AP1M2 (2.6)	NPC1L1 (2.5)	ERP29 (2.2)	ATP13A1 (2.2)	ST3GAL4 (1.8)	TMED4 (1.7)	PMFBP1 (1.7)	QTRT1 (1.6)	LPAR2 (1.5)
MP:0000790	abnormal stratification in cerebral cortex	0.13	> 0.20	PTPN11 (2.9)	NCAN (2.1)	ENSG00000235545 (2.0)	CYB561D1 (1.8)	LPIN3 (1.8)	GCNT4 (1.8)	PPP1R37 (1.8)	NYNRIN (1.7)	ENSG00000226645 (1.6)	CLPTM1 (1.6)
ENSG00000137154	RPS6 PPI subnetwork	0.13	> 0.20	NAA25 (3.6)	DDX56 (3.3)	C12orf43 (2.9)	QTRT1 (2.8)	ILF3 (2.7)	ZNF259 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	TOP1 (2.3)	SARS (2.3)
ENSG00000163346	PBXIP1 PPI subnetwork	0.13	> 0.20	ATXN2 (3.8)	MAPKAPK5 (3.5)	BRAP (3.1)	C12orf51 (3.0)	TRAFD1 (2.6)	C12orf43 (2.5)	ENSG00000226648 (2.2)	SMARCA4 (2.2)	ANKRD31 (2.0)	PCSK9 (1.7)
GO:0001890	placenta development	0.13	> 0.20	ENSG00000226645 (2.7)	CBLC (2.7)	AP1M2 (2.1)	UBXN2B (2.0)	ATXN7L2 (1.8)	PVRL2 (1.8)	ENSG00000228044 (1.7)	C12orf51 (1.6)	CYP7A1 (1.5)	SLC22A1 (1.3)
GO:0032365	intracellular lipid transport	0.13	> 0.20	POLK (3.1)	C19orf52 (2.8)	AMIGO1 (2.2)	NKPD1 (2.1)	BRAP (2.0)	ENSG00000238078 (1.9)	ENSG00000235545 (1.9)	ACAD10 (1.9)	FRK (1.9)	TMEM50A (1.7)
GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	0.13	> 0.20	KANK2 (3.0)	MYLIP (1.9)	POC5 (1.7)	ALDH2 (1.6)	MAPKAPK5 (1.5)	BCL3 (1.4)	NYNRIN (1.4)	MAU2 (1.4)	PVR (1.3)	MAFB (1.2)
ENSG00000067066	SP100 PPI subnetwork	0.13	> 0.20	ZNF180 (3.4)	ADAM1 (3.1)	C19orf52 (2.9)	ZNF101 (2.7)	FRK (2.5)	PTPN11 (2.4)	TMEM50A (2.2)	NT5DC1 (2.1)	TRAFD1 (1.9)	ENSG00000235545 (1.7)
ENSG00000184451	CCR10 PPI subnetwork	0.13	> 0.20	CETP (6.2)	TIMD4 (6.2)	MAFB (3.3)	ZNF101 (2.7)	RELB (2.7)	GRINA (2.3)	PPP1R37 (2.0)	BCL3 (1.9)	APOE (1.7)	PVRL2 (1.7)
REACTOME_PI3KAKT_ACTIVATION	REACTOME_PI3KAKT_ACTIVATION	0.13	> 0.20	ZHX3 (3.1)	ZNF180 (2.6)	MARK4 (1.8)	TRIB1 (1.8)	PTPN11 (1.8)	GRINA (1.8)	MAU2 (1.8)	CLPTM1 (1.7)	DNM2 (1.6)	HLX (1.6)
ENSG00000099797	TECR PPI subnetwork	0.13	> 0.20	HMGCR (5.9)	LDLR (5.2)	FADS1 (4.8)	FADS2 (4.3)	TMEM50A (3.7)	PCSK9 (3.3)	CLPTM1 (3.1)	ERP29 (3.1)	ATP13A1 (2.6)	BRAP (2.5)
ENSG00000129214	SHBG PPI subnetwork	0.13	> 0.20	GMPR (3.4)	GRINA (2.5)	ADAM1 (2.4)	BCL3 (2.2)	PLEC (2.2)	CLPTM1 (2.0)	PVRL2 (1.9)	BCAM (1.8)	OGDH (1.8)	CBLC (1.8)
ENSG00000173848	NET1 PPI subnetwork	0.13	> 0.20	QTRT1 (3.9)	TOMM40 (2.6)	DDX56 (2.4)	CARM1 (2.4)	DHODH (2.4)	TRIB1 (2.2)	TOP1 (2.1)	OGDH (2.0)	NAA25 (1.9)	GATAD2A (1.9)
GO:0050912	detection of chemical stimulus involved in sensory perception of taste	0.13	> 0.20	GCNT4 (3.1)	ANKRD31 (2.8)	ENSG00000228044 (2.6)	ADAM1 (1.9)	CYP7A1 (1.9)	GOT2P1 (1.8)	OASL (1.8)	ENSG00000235545 (1.6)	PMFBP1 (1.5)	TSSK6 (1.4)
ENSG00000102226	USP11 PPI subnetwork	0.13	> 0.20	DNM2 (3.4)	SUGP1 (3.4)	BRAP (3.2)	ILF3 (3.2)	MAU2 (3.0)	C19orf52 (2.3)	TRAFD1 (2.3)	DYNC2LI1 (2.1)	MARK4 (2.1)	HAPLN4 (2.0)
ENSG00000182578	CSF1R PPI subnetwork	0.13	> 0.20	DNM2 (4.0)	GMIP (3.6)	MAFB (3.4)	BCL3 (2.6)	MARK4 (2.4)	TRIB1 (2.3)	ITGB3 (2.2)	CETP (2.2)	ST3GAL4 (2.1)	PPP1R37 (2.0)
ENSG00000086205	FOLH1 PPI subnetwork	0.13	> 0.20	ACAD10 (3.9)	TMED4 (3.3)	HNF1A (2.9)	TRAPPC6A (2.7)	CBLC (2.4)	ERP29 (2.4)	NT5DC1 (2.4)	ATXN7L2 (1.7)	PCSK9 (1.6)	BUD13 (1.4)
MP:0005078	abnormal cytotoxic T cell physiology	0.13	> 0.20	RELB (4.2)	PARP10 (4.0)	HAVCR1 (2.4)	TRAFD1 (2.4)	ST3GAL4 (1.9)	GMIP (1.8)	CETP (1.7)	BCL3 (1.7)	ENSG00000228044 (1.5)	NT5DC1 (1.4)
ENSG00000163002	NUP35 PPI subnetwork	0.13	> 0.20	NAA25 (3.6)	USP1 (3.4)	POC5 (3.1)	DOCK7 (2.9)	DDX56 (2.5)	BUD13 (2.4)	ILF3 (2.4)	USP24 (2.3)	FEN1 (2.2)	ENSG00000226648 (2.0)
GO:0034138	toll-like receptor 3 signaling pathway	0.13	> 0.20	SH2B3 (2.7)	ENSG00000226645 (2.6)	PARP10 (2.3)	GEMIN7 (2.3)	RELB (2.2)	ENSG00000228044 (2.2)	BLOC1S3 (2.0)	OASL (1.9)	TRIB1 (1.8)	GMIP (1.8)
ENSG00000153006	SREK1IP1 PPI subnetwork	0.13	> 0.20	C1orf63 (3.1)	ADAM1 (3.0)	COL4A3BP (2.9)	PMFBP1 (2.1)	ERP29 (2.0)	APOE (1.9)	POLK (1.7)	C19orf52 (1.6)	TMEM50A (1.6)	TOP1 (1.6)
GO:0003950	NAD+ ADP-ribosyltransferase activity	0.13	> 0.20	PARP10 (7.1)	OASL (6.3)	TRAFD1 (4.3)	ENSG00000235545 (2.1)	SYPL2 (1.9)	FRK (1.5)	MYLIP (1.4)	YIPF2 (1.3)	MAPKAPK5 (1.3)	PBX4 (1.3)
ENSG00000005156	LIG3 PPI subnetwork	0.13	> 0.20	GCNT4 (2.7)	SMARCA4 (2.6)	NT5DC1 (2.4)	KANK2 (2.4)	ZHX3 (2.3)	PLCG1 (2.3)	ANKRD31 (2.1)	GPAM (1.9)	SUGP1 (1.6)	LPIN3 (1.5)
MP:0000248	macrocytosis	0.13	> 0.20	RHD (6.4)	RHCE (4.1)	FADS1 (2.7)	ZNF180 (2.4)	FADS2 (2.3)	FEN1 (2.0)	GMPR (2.0)	C12orf51 (1.9)	TMEM57 (1.8)	TRAPPC6A (1.8)
ENSG00000075886	TUBA3D PPI subnetwork	0.13	> 0.20	RELB (9.0)	BCL3 (6.2)	MAPKAPK5 (2.5)	PBX4 (2.4)	SH2B3 (2.3)	PVR (2.3)	TRAFD1 (2.2)	OASL (2.1)	PARP10 (2.1)	GMIP (2.0)
ENSG00000198033	TUBA3C PPI subnetwork	0.13	> 0.20	RELB (9.0)	BCL3 (6.2)	MAPKAPK5 (2.5)	PBX4 (2.4)	SH2B3 (2.3)	PVR (2.3)	TRAFD1 (2.2)	OASL (2.1)	PARP10 (2.1)	GMIP (2.0)
GO:0004675	transmembrane receptor protein serine/threonine kinase activity	0.13	> 0.20	CEACAM19 (2.3)	NYNRIN (2.3)	PVRL2 (2.1)	TMED4 (2.0)	MAFB (1.8)	PLEC (1.8)	PVR (1.7)	BCAM (1.7)	SLC44A2 (1.6)	ZNF101 (1.5)
MP:0002424	abnormal reticulocyte morphology	0.13	> 0.20	RHD (7.6)	RHCE (6.9)	C12orf51 (2.7)	PTPN11 (2.1)	ENSG00000226645 (2.1)	DHODH (1.8)	TIMD4 (1.6)	CYB561D1 (1.6)	C12orf47 (1.6)	TOP1 (1.4)
GO:0043560	insulin receptor substrate binding	0.13	> 0.20	COL4A3BP (3.3)	DNM2 (2.2)	TMEM57 (2.0)	ENSG00000238078 (1.9)	ERP29 (1.8)	ENSG00000226645 (1.7)	USP24 (1.6)	PVRL2 (1.5)	C17orf57 (1.5)	TMED4 (1.5)
ENSG00000100346	CACNA1I PPI subnetwork	0.13	> 0.20	APOB (5.0)	PLG (4.0)	APOE (3.9)	APOA5 (3.6)	PCSK9 (3.6)	APOC1 (3.4)	ANGPTL3 (3.4)	APOC4 (3.4)	HP (2.8)	GPAM (2.1)
GO:0003013	circulatory system process	0.13	> 0.20	ABO (3.2)	RHD (1.7)	BCAM (1.7)	C12orf47 (1.7)	C17orf57 (1.7)	RHCE (1.7)	CEACAM19 (1.7)	SORT1 (1.5)	ACAD10 (1.4)	HLX (1.4)
GO:0070741	response to interleukin-6	0.13	> 0.20	FRK (2.6)	ZNF101 (2.2)	HNF1A (1.9)	TXNL4B (1.9)	CYP7A1 (1.5)	PVR (1.5)	CEACAM19 (1.3)	KIAA1324 (1.3)	ENSG00000235545 (1.3)	ERP29 (1.2)
GO:0048557	embryonic digestive tract morphogenesis	0.13	> 0.20	PLEKHH2 (4.0)	ENSG00000228044 (3.5)	ENSG00000254235 (3.0)	ENSG00000226648 (2.9)	LPAR2 (2.4)	ENSG00000235545 (2.3)	C11orf9 (2.1)	CBLC (2.1)	BLOC1S3 (2.1)	PBX4 (2.1)
GO:0008201	heparin binding	0.13	> 0.20	HP (4.8)	CILP2 (4.1)	PLG (3.4)	ANGPTL3 (2.7)	APOC4 (2.4)	CYP7A1 (2.3)	APOC1 (2.2)	APOE (2.1)	MAFB (2.1)	PCSK9 (1.9)
ENSG00000170606	HSPA4 PPI subnetwork	0.13	> 0.20	CYP7A1 (2.8)	TOMM40 (2.6)	CLPTM1 (2.5)	GRINA (2.2)	ZNF259 (2.1)	RELB (2.0)	TOP1 (2.0)	ILF3 (1.8)	SARS (1.7)	DHX38 (1.6)
GO:0032800	receptor biosynthetic process	0.13	> 0.20	PMFBP1 (2.7)	FRK (2.6)	TIMD4 (2.5)	CEACAM19 (2.3)	ENSG00000238078 (1.9)	NKPD1 (1.8)	CETP (1.8)	ANKRD31 (1.8)	ZNF101 (1.6)	TM6SF2 (1.5)
GO:0051536	iron-sulfur cluster binding	0.13	> 0.20	ACAD10 (3.9)	RHCE (2.9)	NT5DC1 (2.4)	TOMM40 (2.1)	RHD (2.0)	LPIN3 (1.9)	GMPR (1.8)	SARS (1.7)	OASL (1.7)	DHODH (1.7)
GO:0051540	metal cluster binding	0.13	> 0.20	ACAD10 (3.9)	RHCE (2.9)	NT5DC1 (2.4)	TOMM40 (2.1)	RHD (2.0)	LPIN3 (1.9)	GMPR (1.8)	SARS (1.7)	OASL (1.7)	DHODH (1.7)
ENSG00000133056	PIK3C2B PPI subnetwork	0.13	> 0.20	CBLC (4.9)	DNM2 (2.9)	PVRL2 (2.6)	SLC44A2 (2.5)	AP1M2 (2.5)	PLEC (2.5)	DOCK7 (2.5)	PPP1R37 (2.3)	LPAR2 (2.0)	BCL3 (1.9)
ENSG00000071539	TRIP13 PPI subnetwork	0.13	> 0.20	NYNRIN (2.8)	ABCG8 (2.1)	LPIN3 (2.0)	TM6SF2 (2.0)	HNF1A (2.0)	CBLC (1.8)	ACAD10 (1.8)	TMEM116 (1.7)	CEACAM19 (1.6)	TMEM57 (1.3)
ENSG00000083845	RPS5 PPI subnetwork	0.13	> 0.20	QTRT1 (3.6)	DDX56 (3.6)	NAA25 (3.3)	C12orf43 (2.7)	ZNF259 (2.6)	TOMM40 (2.6)	SARS (2.5)	NKPD1 (2.2)	DHX38 (2.1)	ILF3 (2.0)
GO:0031663	lipopolysaccharide-mediated signaling pathway	0.13	> 0.20	ENSG00000228044 (3.1)	UBXN2B (2.9)	PARP10 (2.4)	BLOC1S3 (2.4)	PVR (2.2)	GRINA (2.1)	BCL3 (1.6)	PMFBP1 (1.5)	MAU2 (1.5)	LPIN3 (1.5)
ENSG00000116213	WRAP73 PPI subnetwork	0.13	> 0.20	SARS (3.7)	TOMM40 (2.9)	ILF3 (2.5)	FEN1 (2.1)	ZNF259 (1.9)	PSMA5 (1.9)	OGDH (1.9)	DHX38 (1.7)	CLPTM1 (1.7)	HAPLN4 (1.7)
ENSG00000025434	NR1H3 PPI subnetwork	0.13	> 0.20	HNF1A (3.5)	CBLC (2.8)	PVRL2 (2.5)	MAFB (2.2)	NPC1L1 (2.1)	TM6SF2 (2.1)	MARK4 (2.1)	CEACAM19 (2.0)	TRAPPC6A (1.9)	ABCG5 (1.9)
ENSG00000136153	LMO7 PPI subnetwork	0.13	> 0.20	PLEC (3.8)	CBLC (3.0)	BCAM (2.7)	KANK2 (2.5)	AP1M2 (2.4)	PVRL2 (2.3)	ENSG00000238078 (2.3)	TOP1 (1.8)	PBX4 (1.8)	SYPL2 (1.6)
REACTOME_STEROID_HORMONES	REACTOME_STEROID_HORMONES	0.13	> 0.20	FADS1 (3.4)	FADS2 (3.2)	APOC1 (3.2)	LDLR (3.2)	ST3GAL4 (2.9)	HMGCR (2.8)	PLG (2.6)	ANGPTL3 (2.4)	CYP7A1 (2.0)	APOA5 (1.9)
ENSG00000123091	RNF11 PPI subnetwork	0.13	> 0.20	MAU2 (3.0)	FRK (2.6)	MAPKAPK5 (2.5)	CARM1 (2.3)	ATXN2 (2.2)	OGDH (2.2)	BRAP (2.1)	ENSG00000226645 (2.1)	USP24 (2.1)	RELB (2.1)
MP:0008033	impaired lipolysis	0.13	> 0.20	MOSC1 (3.9)	GPAM (3.7)	SORT1 (2.8)	HP (2.5)	APOC1 (1.8)	BCAM (1.8)	GRINA (1.8)	NAA25 (1.8)	COL4A3BP (1.7)	CELSR2 (1.7)
GO:0042809	vitamin D receptor binding	0.13	> 0.20	BUD13 (3.0)	ACAD10 (1.8)	ATXN2 (1.7)	CEACAM19 (1.6)	MAU2 (1.6)	TMEM57 (1.6)	PLEC (1.5)	DHX38 (1.4)	MAPKAPK5 (1.4)	GMIP (1.3)
REACTOME_ETHANOL_OXIDATION	REACTOME_ETHANOL_OXIDATION	0.13	> 0.20	LPA (5.1)	APOC4 (4.4)	GPAM (3.4)	CYP7A1 (3.0)	ABCG5 (2.8)	HP (2.8)	APOA5 (2.8)	KIAA1324 (2.8)	ALDH2 (2.7)	ANGPTL3 (2.5)
GO:0071214	cellular response to abiotic stimulus	0.13	> 0.20	C12orf43 (2.4)	TRAFD1 (2.2)	ZNF101 (2.1)	HAVCR1 (2.0)	FRK (1.8)	UBXN2B (1.7)	LPIN3 (1.7)	POLK (1.6)	BLOC1S3 (1.5)	GEMIN7 (1.5)
ENSG00000173145	NOC3L PPI subnetwork	0.13	> 0.20	ZNF259 (5.0)	NAA25 (4.8)	DDX56 (4.2)	TOMM40 (3.7)	DHODH (3.2)	QTRT1 (3.1)	DHX38 (2.8)	ADAM1 (2.6)	C12orf43 (2.5)	MAPKAPK5 (2.2)
GO:0000785	chromatin	0.13	> 0.20	USP1 (3.1)	TSSK6 (2.4)	FEN1 (2.3)	BUD13 (2.1)	TRIB1 (2.0)	GATAD2A (2.0)	SMARCA4 (1.9)	TOP1 (1.9)	PSRC1 (1.7)	TMEM57 (1.7)
ENSG00000095319	NUP188 PPI subnetwork	0.13	> 0.20	NAA25 (3.7)	POC5 (3.5)	USP1 (3.5)	DDX56 (2.6)	DOCK7 (2.5)	USP24 (2.3)	FEN1 (2.3)	BUD13 (2.2)	ILF3 (2.1)	CARM1 (1.9)
ENSG00000133316	WDR74 PPI subnetwork	0.13	> 0.20	ZNF259 (4.7)	NAA25 (4.6)	TOMM40 (4.0)	DDX56 (3.7)	DHX38 (3.2)	QTRT1 (3.1)	DHODH (2.9)	ATP13A1 (2.7)	C12orf43 (2.2)	MAPKAPK5 (2.2)
GO:0000299	integral to membrane of membrane fraction	0.13	> 0.20	CLPTM1 (2.5)	GCNT4 (1.8)	DHODH (1.6)	BLOC1S3 (1.6)	GPAM (1.6)	MARK4 (1.4)	CEACAM19 (1.4)	AMIGO1 (1.4)	PLCG1 (1.4)	NKPD1 (1.4)
ENSG00000171475	WIPF2 PPI subnetwork	0.13	> 0.20	CARM1 (3.7)	PPP1R37 (3.6)	GMIP (3.0)	CLPTM1 (2.8)	GATAD2A (2.7)	MARK4 (2.7)	GRINA (2.4)	DNM2 (2.3)	SMARCA4 (2.0)	ATXN2 (1.9)
MP:0001939	secondary sex reversal	0.13	> 0.20	TSSK6 (3.3)	ST3GAL4 (3.1)	C11orf9 (2.6)	NYNRIN (2.2)	PLEKHH2 (1.7)	LPAR2 (1.6)	NPC1L1 (1.5)	ATXN7L2 (1.4)	ALDH2 (1.3)	NKPD1 (1.3)
MP:0000784	forebrain hypoplasia	0.13	> 0.20	PPP1R37 (2.7)	NCAN (2.6)	PLCG1 (2.0)	TMEM116 (2.0)	MARK4 (1.8)	ATXN2 (1.7)	ACAD10 (1.6)	DYNC2LI1 (1.6)	PSRC1 (1.5)	TXNL4B (1.4)
ENSG00000174697	LEP PPI subnetwork	0.13	> 0.20	BCL3 (4.2)	CETP (2.9)	RELB (2.8)	TIMD4 (2.8)	HLX (2.6)	LPA (2.2)	ALDH2 (2.1)	GMIP (2.0)	APOA5 (1.7)	HP (1.7)
ENSG00000151090	THRB PPI subnetwork	0.13	> 0.20	ATXN2 (3.7)	C12orf51 (2.5)	DNM2 (2.2)	CARM1 (2.1)	USP24 (2.1)	MAU2 (2.0)	MARK4 (1.9)	PPP1R37 (1.9)	TRIB1 (1.8)	ILF3 (1.8)
ENSG00000116754	SRSF11 PPI subnetwork	0.13	> 0.20	C1orf63 (4.0)	ILF3 (3.7)	BUD13 (3.0)	TOP1 (2.9)	SMARCA4 (2.8)	DHX38 (2.4)	SUGP1 (2.2)	USP1 (2.2)	FEN1 (2.0)	QTRT1 (1.9)
GO:0060760	positive regulation of response to cytokine stimulus	0.13	> 0.20	C17orf57 (2.8)	COL4A3BP (2.6)	CEACAM19 (2.5)	POLK (2.5)	ENSG00000235545 (2.0)	ZNF101 (1.8)	GRINA (1.7)	CYB561D1 (1.6)	TM6SF2 (1.3)	HNF1A (1.2)
ENSG00000133794	ARNTL PPI subnetwork	0.13	> 0.20	TRIB1 (3.3)	GPAM (2.7)	LDLR (2.4)	TMEM57 (2.3)	TOP1 (2.3)	CYP7A1 (2.1)	SH2B3 (2.0)	ABCG8 (1.9)	BCL3 (1.9)	ZHX3 (1.8)
GO:0016831	carboxy-lyase activity	0.13	> 0.20	DHODH (3.3)	FADS2 (2.8)	HMGCR (2.7)	PLG (2.5)	SARS (2.3)	GPAM (2.2)	TXNL4B (2.1)	DNAH11 (1.8)	LDLR (1.8)	FADS1 (1.7)
MP:0004890	decreased energy expenditure	0.13	> 0.20	CELSR2 (3.2)	APOB (3.0)	CETP (2.9)	ABCG5 (2.6)	C12orf47 (2.3)	TIMD4 (2.2)	APOC1 (2.0)	APOA5 (1.8)	ATXN2 (1.8)	NPC1L1 (1.8)
ENSG00000117394	SLC2A1 PPI subnetwork	0.13	> 0.20	LDLR (3.8)	FADS1 (3.6)	FADS2 (3.4)	BRAP (3.3)	PCSK9 (3.2)	HMGCR (3.1)	SARS (2.7)	SORT1 (2.7)	SYPL2 (2.7)	GMPR (2.4)
GO:0007141	male meiosis I	0.13	> 0.20	ANKRD31 (3.8)	TMEM116 (1.7)	GOT2P1 (1.6)	TSSK6 (1.6)	ENSG00000238078 (1.5)	POC5 (1.2)	ENSG00000226645 (1.2)	PLEKHH2 (1.2)	BRAP (1.1)	PBX4 (1.1)
MP:0008713	abnormal cytokine level	0.13	> 0.20	BCL3 (3.6)	TRAFD1 (3.6)	HLX (3.3)	PARP10 (3.1)	MAFB (2.9)	ST3GAL4 (2.3)	ENSG00000228044 (1.8)	MYLIP (1.8)	GRINA (1.7)	PLEKHH2 (1.7)
GO:0002312	B cell activation involved in immune response	0.13	> 0.20	GCNT4 (2.6)	NT5DC1 (2.3)	ZNF101 (2.2)	DYNC2LI1 (1.9)	GOT2P1 (1.6)	HAVCR1 (1.5)	ANKRD31 (1.4)	ZNF180 (1.4)	NKPD1 (1.2)	DNAH11 (1.2)
MP:0005505	increased platelet cell number	0.13	> 0.20	ITGB3 (2.4)	LPIN3 (2.2)	RHD (2.2)	POLK (2.1)	PCSK9 (1.9)	NT5DC1 (1.8)	CYB561D1 (1.8)	GPAM (1.7)	RELB (1.7)	OASL (1.7)
ENSG00000100994	PYGB PPI subnetwork	0.13	> 0.20	SYPL2 (3.3)	SORT1 (2.7)	GMPR (2.4)	ITGB3 (2.2)	DHODH (1.9)	KIAA1324 (1.9)	PMFBP1 (1.8)	ST3GAL4 (1.8)	SLC44A2 (1.8)	AMIGO1 (1.7)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	0.13	> 0.20	ST3GAL4 (3.4)	GCNT4 (2.7)	DOCK7 (2.4)	PVRL2 (2.1)	MARK4 (2.1)	AMIGO1 (2.0)	ENSG00000254235 (1.9)	YIPF2 (1.8)	CETP (1.8)	PSRC1 (1.8)
GO:0006022	aminoglycan metabolic process	0.13	> 0.20	TMED4 (3.4)	ERP29 (2.6)	NKPD1 (2.6)	ST3GAL4 (2.1)	CEACAM19 (2.0)	TMEM50A (1.9)	PMFBP1 (1.9)	ADAM1 (1.9)	CILP2 (1.8)	ENSG00000228044 (1.8)
ENSG00000047315	POLR2B PPI subnetwork	0.13	> 0.20	ILF3 (3.5)	TOP1 (3.2)	DHX38 (3.0)	SUGP1 (2.9)	USP1 (2.7)	SMARCA4 (2.6)	DDX56 (2.6)	BUD13 (2.6)	FEN1 (2.3)	PSMA5 (2.1)
GO:0031668	cellular response to extracellular stimulus	0.13	> 0.20	BLOC1S3 (2.5)	POLK (2.2)	TXNL4B (2.0)	BRAP (1.9)	CEACAM19 (1.8)	AP1M2 (1.8)	ABO (1.8)	HNF1A (1.7)	TRAPPC6A (1.6)	LPIN3 (1.5)
GO:0006026	aminoglycan catabolic process	0.13	> 0.20	NKPD1 (4.3)	PMFBP1 (4.0)	CEACAM19 (3.7)	ENSG00000228044 (3.1)	TMED4 (3.1)	ERP29 (2.4)	CETP (2.2)	TIMD4 (1.9)	PBX4 (1.8)	CYB561D1 (1.8)
ENSG00000131368	MRPS25 PPI subnetwork	0.13	> 0.20	ACAD10 (3.6)	NT5DC1 (3.3)	TMED4 (3.1)	HNF1A (3.1)	TRAPPC6A (1.8)	OGDH (1.7)	C1orf63 (1.7)	PCSK9 (1.5)	GCNT4 (1.5)	CETP (1.5)
MP:0005087	decreased acute inflammation	0.13	> 0.20	GMIP (3.0)	HLX (2.4)	MAFB (2.4)	SORT1 (1.8)	TMEM116 (1.7)	DHODH (1.6)	SH2B3 (1.6)	CYB561D1 (1.5)	PMFBP1 (1.5)	HP (1.5)
ENSG00000123643	SLC36A1 PPI subnetwork	0.13	> 0.20	HMGCR (5.9)	LDLR (5.4)	FADS1 (4.5)	FADS2 (4.4)	TM6SF2 (2.8)	NPC1L1 (2.3)	GPAM (2.1)	ABCG8 (2.0)	TMEM57 (2.0)	GATAD2A (1.9)
MP:0003910	decreased eating behavior	0.13	> 0.20	PLEKHH2 (3.0)	C12orf47 (2.9)	CETP (2.4)	RPH3A (2.4)	ABCG8 (2.1)	ZHX3 (2.1)	ABCG5 (2.1)	ABO (2.1)	CELSR2 (2.0)	FADS1 (1.9)
ENSG00000159388	BTG2 PPI subnetwork	0.13	> 0.20	CETP (3.8)	GCNT4 (3.4)	TMED4 (2.3)	HNF1A (2.2)	DHODH (1.9)	TIMD4 (1.8)	TRAPPC6A (1.7)	PCSK9 (1.7)	PLCG1 (1.5)	ABO (1.4)
ENSG00000183765	CHEK2 PPI subnetwork	0.13	> 0.20	USP1 (4.8)	FEN1 (4.2)	PSRC1 (3.6)	PLCG1 (2.3)	ZNF101 (2.0)	POC5 (1.9)	POLK (1.8)	DOCK7 (1.8)	RHCE (1.8)	TOP1 (1.5)
REACTOME_NF:KB_ACTIVATION_THROUGH_FADDRIP:1_PATHWAY_MEDIATED_BY_CASPASE:8_AND_:10	REACTOME_NF:KB_ACTIVATION_THROUGH_FADDRIP:1_PATHWAY_MEDIATED_BY_CASPASE:8_AND_:10	0.13	> 0.20	OASL (9.3)	PARP10 (6.8)	TRAFD1 (2.9)	CYB561D1 (2.3)	ZNF180 (2.3)	BLOC1S3 (2.3)	FRK (1.8)	ZNF101 (1.4)	ENSG00000235545 (1.4)	C19orf52 (1.4)
GO:0005924	cell-substrate adherens junction	0.13	> 0.20	PLEC (4.2)	ITGB3 (3.6)	KANK2 (2.5)	GMIP (2.3)	PVRL2 (2.2)	SH2B3 (1.9)	BCAM (1.9)	DNM2 (1.8)	C11orf9 (1.7)	GPAM (1.5)
ENSG00000132357	CARD6 PPI subnetwork	0.13	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.4)	C1orf63 (1.9)	TMEM57 (1.6)	DNAH11 (1.6)	SYPL2 (1.5)	PLEKHH2 (1.4)	GOT2P1 (1.4)	HNF1A (1.3)
GO:0071564	npBAF complex	0.13	> 0.20	CARM1 (5.2)	NYNRIN (3.0)	GRINA (2.8)	SMARCA4 (2.6)	TMEM57 (2.4)	ATXN2 (2.3)	MAU2 (2.2)	SUGP1 (2.2)	MARK4 (2.1)	C12orf51 (2.0)
ENSG00000133216	EPHB2 PPI subnetwork	0.13	> 0.20	LPAR2 (2.5)	MARK4 (2.5)	PVRL2 (2.4)	PBX4 (2.1)	TRIB1 (2.0)	MAFB (2.0)	YIPF2 (1.9)	PPP1R37 (1.9)	AMIGO1 (1.9)	SLC44A2 (1.8)
ENSG00000169220	RGS14 PPI subnetwork	0.13	> 0.20	DNM2 (3.9)	USP24 (2.6)	GMIP (2.5)	POLK (2.5)	COL4A3BP (2.4)	TMEM50A (2.1)	MAU2 (2.1)	SORT1 (2.0)	BCL3 (2.0)	SLC44A2 (2.0)
ENSG00000112062	MAPK14 PPI subnetwork	0.13	> 0.20	TRIB1 (4.3)	PVR (2.6)	GRINA (2.4)	MARK4 (2.4)	CARM1 (2.4)	PTPN11 (2.2)	HLX (2.2)	SH2B3 (2.1)	SARS (2.1)	MAU2 (1.9)
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	0.14	> 0.20	TRAPPC6A (3.1)	ST3GAL4 (2.1)	PMFBP1 (2.1)	KIAA1324 (2.0)	NT5DC1 (2.0)	YIPF2 (2.0)	ERP29 (1.9)	BLOC1S3 (1.9)	APOE (1.7)	COL4A3BP (1.6)
MP:0001211	wrinkled skin	0.14	> 0.20	AP1M2 (4.9)	CBLC (3.9)	CELSR2 (3.1)	CEACAM19 (2.3)	FRK (2.3)	YIPF2 (2.2)	NYNRIN (2.1)	ABCG8 (2.0)	APOA5 (1.9)	ANGPTL3 (1.8)
GO:0048534	hemopoietic or lymphoid organ development	0.14	> 0.20	ZNF101 (4.1)	RHCE (3.4)	RHD (3.3)	PBX4 (2.6)	HLX (2.4)	PLCG1 (2.0)	SH2B3 (1.7)	GMIP (1.7)	MAFB (1.6)	SLC44A2 (1.5)
ENSG00000103653	CSK PPI subnetwork	0.14	> 0.20	ITGB3 (3.1)	PLEC (2.9)	SLC44A2 (2.9)	GMIP (2.9)	SH2B3 (2.9)	CETP (2.7)	TIMD4 (2.1)	ST3GAL4 (2.0)	MAFB (2.0)	KANK2 (1.7)
ENSG00000143621	ILF2 PPI subnetwork	0.14	> 0.20	QTRT1 (4.4)	TOMM40 (3.5)	SUGP1 (2.7)	ILF3 (2.6)	OASL (2.4)	GATAD2A (2.3)	DHODH (2.3)	CARM1 (2.2)	TOP1 (2.2)	SMARCA4 (2.2)
GO:0002756	MyD88-independent toll-like receptor signaling pathway	0.14	> 0.20	SH2B3 (2.9)	ENSG00000228044 (2.3)	GEMIN7 (2.2)	ENSG00000226645 (2.2)	PARP10 (2.2)	RELB (1.9)	PVR (1.9)	OASL (1.9)	BLOC1S3 (1.9)	CYB561D1 (1.9)
ENSG00000101004	NINL PPI subnetwork	0.14	> 0.20	BRAP (3.1)	ENSG00000226648 (2.3)	MAU2 (2.0)	TSSK6 (2.0)	DHX38 (1.9)	POC5 (1.9)	ITGB3 (1.8)	TRIB1 (1.7)	TRAFD1 (1.7)	C12orf47 (1.6)
REACTOME_PHASE_II_CONJUGATION	REACTOME_PHASE_II_CONJUGATION	0.14	> 0.20	SLC22A1 (5.1)	CYP7A1 (4.9)	TM6SF2 (4.7)	ABCG5 (3.8)	ABCG8 (3.6)	APOC4 (3.5)	ANGPTL3 (3.5)	LPA (3.2)	APOA5 (2.8)	ALDH2 (2.8)
ENSG00000167815	PRDX2 PPI subnetwork	0.14	> 0.20	RHD (2.7)	RHCE (2.3)	COL4A3BP (2.2)	GPAM (2.1)	PSMA5 (2.0)	NT5DC1 (1.9)	CYP7A1 (1.8)	DYNC2LI1 (1.6)	DOCK7 (1.5)	CEACAM19 (1.5)
ENSG00000108515	ENO3 PPI subnetwork	0.14	> 0.20	OGDH (3.5)	TOMM40 (2.9)	ERP29 (2.5)	SARS (2.2)	TOP1 (2.2)	ALDH2 (1.9)	SMARCA4 (1.8)	TSSK6 (1.7)	NT5DC1 (1.6)	SYPL2 (1.6)
MP:0000336	decreased mast cell number	0.14	> 0.20	BCL3 (2.5)	RELB (2.0)	PVR (1.8)	CYB561D1 (1.7)	PMFBP1 (1.5)	ENSG00000228044 (1.4)	GMPR (1.4)	ITGB3 (1.4)	TRAPPC6A (1.3)	TRIB1 (1.3)
ENSG00000164597	COG5 PPI subnetwork	0.14	> 0.20	SUGP1 (3.6)	DHX38 (3.2)	MAU2 (3.1)	TRAFD1 (2.3)	DYNC2LI1 (2.3)	DNM2 (2.2)	YIPF2 (2.0)	CETP (2.0)	C12orf43 (1.7)	LPIN3 (1.7)
ENSG00000129691	ASH2L PPI subnetwork	0.14	> 0.20	ATXN2 (4.1)	C12orf51 (2.7)	BUD13 (2.6)	GATAD2A (2.4)	TOP1 (2.2)	SMARCA4 (2.2)	CARM1 (2.2)	ILF3 (2.2)	USP1 (2.2)	C19orf52 (2.1)
ENSG00000133895	MEN1 PPI subnetwork	0.14	> 0.20	RELB (4.9)	BCL3 (3.5)	PLEC (2.9)	BUD13 (2.2)	POC5 (2.0)	USP1 (2.0)	C19orf52 (1.7)	KIAA1324 (1.7)	FEN1 (1.5)	MAPKAPK5 (1.5)
ENSG00000174125	TLR1 PPI subnetwork	0.14	> 0.20	MAFB (3.3)	C1orf63 (1.9)	MYLIP (1.8)	UBXN2B (1.8)	ERP29 (1.7)	POLK (1.6)	PMFBP1 (1.6)	PARP10 (1.5)	SH2B3 (1.5)	LPIN3 (1.5)
ENSG00000135097	MSI1 PPI subnetwork	0.14	> 0.20	USP24 (4.0)	BRAP (3.5)	PSMA5 (3.1)	NAA25 (2.8)	ATP13A1 (2.8)	ATXN2 (2.4)	DDX56 (2.4)	CLPTM1 (2.3)	DNM2 (2.3)	QTRT1 (2.2)
GO:0008015	blood circulation	0.14	> 0.20	ABO (3.3)	RHD (1.7)	C12orf47 (1.7)	CEACAM19 (1.7)	RHCE (1.7)	BCAM (1.7)	C17orf57 (1.6)	HLX (1.5)	SORT1 (1.5)	TMEM116 (1.4)
ENSG00000160199	PKNOX1 PPI subnetwork	0.14	> 0.20	NYNRIN (3.1)	SYPL2 (3.0)	ENSG00000238078 (2.5)	CARM1 (2.2)	TOMM40 (1.9)	KANK2 (1.8)	SMARCA4 (1.7)	LPIN3 (1.6)	ATXN7L2 (1.6)	ANKRD31 (1.6)
GO:0045736	negative regulation of cyclin-dependent protein kinase activity	0.14	> 0.20	ZHX3 (2.8)	ENSG00000254235 (2.6)	ENSG00000226645 (2.5)	BLOC1S3 (2.0)	GCNT4 (1.9)	KANK2 (1.7)	ENSG00000226648 (1.7)	C17orf57 (1.7)	MYLIP (1.5)	ANKRD31 (1.4)
GO:0003085	negative regulation of systemic arterial blood pressure	0.14	> 0.20	ENSG00000235545 (3.6)	AMIGO1 (2.9)	ENSG00000254235 (2.4)	TMEM116 (2.4)	POLK (2.3)	ENSG00000226645 (2.0)	TSSK6 (1.9)	ENSG00000228044 (1.9)	GOT2P1 (1.5)	MAFB (1.4)
ENSG00000119866	BCL11A PPI subnetwork	0.14	> 0.20	MAU2 (2.7)	PARP10 (2.7)	USP24 (2.7)	ATXN2 (2.5)	GMIP (2.2)	BCL3 (2.2)	MARK4 (2.1)	SMARCA4 (2.1)	ZHX3 (1.9)	DHX38 (1.8)
MP:0004966	abnormal inner cell mass proliferation	0.14	> 0.20	FEN1 (3.8)	USP1 (3.4)	BUD13 (2.3)	UBXN2B (2.2)	DHX38 (2.0)	ST3GAL4 (1.9)	C19orf52 (1.8)	TOMM40 (1.7)	POC5 (1.7)	BLOC1S3 (1.6)
GO:0051092	positive regulation of NF-kappaB transcription factor activity	0.14	> 0.20	ENSG00000226645 (4.3)	BLOC1S3 (3.8)	RELB (3.2)	ENSG00000228044 (2.5)	ST3GAL4 (2.4)	GMIP (2.4)	BCL3 (2.2)	PARP10 (2.1)	SH2B3 (2.1)	PVR (1.8)
ENSG00000008710	PKD1 PPI subnetwork	0.14	> 0.20	PVRL2 (3.8)	PLEC (3.7)	AP1M2 (2.5)	DOCK7 (2.0)	C11orf9 (2.0)	FADS1 (1.9)	BCAM (1.9)	ITGB3 (1.8)	FADS2 (1.7)	LPIN3 (1.7)
GO:0009069	serine family amino acid metabolic process	0.14	> 0.20	TXNL4B (2.9)	SLC22A1 (2.9)	CYP7A1 (2.8)	GOT2P1 (2.8)	SARS (2.7)	PMFBP1 (2.6)	ANGPTL3 (2.4)	TMEM116 (2.4)	LPA (2.3)	ENSG00000254235 (2.3)
ENSG00000142675	CNKSR1 PPI subnetwork	0.14	> 0.20	MARK4 (2.2)	DNM2 (2.1)	GATAD2A (2.1)	LPAR2 (2.0)	GRINA (1.8)	KANK2 (1.7)	PVRL2 (1.6)	MAU2 (1.6)	MAPKAPK5 (1.5)	FADS2 (1.5)
MP:0000295	trabecula carnea hypoplasia	0.14	> 0.20	ENSG00000235545 (2.7)	CARM1 (2.5)	BCAM (2.4)	KANK2 (2.2)	DNM2 (2.2)	NYNRIN (2.1)	SH2B3 (2.0)	BLOC1S3 (2.0)	MARK4 (1.7)	PLG (1.7)
GO:0005160	transforming growth factor beta receptor binding	0.14	> 0.20	KANK2 (3.9)	PVR (2.9)	C11orf9 (2.7)	MYLIP (2.6)	PLEKHH2 (2.5)	ZNF180 (2.1)	SLC44A2 (1.9)	SH2B3 (1.7)	SORT1 (1.5)	PLCG1 (1.4)
ENSG00000099804	CDC34 PPI subnetwork	0.14	> 0.20	TRIB1 (2.6)	ENSG00000254235 (2.0)	PVR (2.0)	ZHX3 (1.9)	PTPN11 (1.9)	MAPKAPK5 (1.8)	ENSG00000238078 (1.6)	BRAP (1.6)	GCNT4 (1.4)	ENSG00000235545 (1.2)
GO:0050900	leukocyte migration	0.14	> 0.20	TIMD4 (3.2)	MAFB (3.1)	ENSG00000228044 (2.4)	APOE (2.2)	GMIP (2.0)	CETP (1.9)	PVR (1.7)	CEACAM19 (1.7)	ADAM1 (1.6)	ST3GAL4 (1.6)
GO:0033549	MAP kinase phosphatase activity	0.14	> 0.20	TRIB1 (7.7)	TSSK6 (2.4)	PVR (2.3)	ENSG00000226645 (2.0)	LDLR (1.8)	SYPL2 (1.7)	POLK (1.6)	ENSG00000235545 (1.5)	SH2B3 (1.5)	DNAH11 (1.3)
MP:0011089	complete perinatal lethality	0.14	> 0.20	NYNRIN (2.5)	BCAM (2.5)	CELSR2 (2.4)	PVRL2 (2.1)	MYLIP (1.9)	ENSG00000254235 (1.8)	ATXN2 (1.6)	PLEC (1.6)	DOCK7 (1.6)	CILP2 (1.5)
GO:0008175	tRNA methyltransferase activity	0.14	> 0.20	QTRT1 (4.9)	NAA25 (3.5)	TOMM40 (2.8)	ATP13A1 (2.7)	C12orf43 (2.7)	DHODH (2.6)	DDX56 (2.5)	MAPKAPK5 (2.3)	YIPF2 (2.3)	ZNF259 (2.1)
ENSG00000120659	TNFSF11 PPI subnetwork	0.14	> 0.20	RELB (4.4)	TOMM40 (2.0)	SH2B3 (2.0)	TMEM50A (1.7)	PVR (1.6)	BCL3 (1.6)	NPC1L1 (1.6)	BLOC1S3 (1.5)	ENSG00000226645 (1.5)	ENSG00000228044 (1.4)
ENSG00000154767	XPC PPI subnetwork	0.14	> 0.20	SUGP1 (3.4)	PSMA5 (2.9)	TXNL4B (2.5)	NT5DC1 (2.3)	POC5 (2.1)	MAU2 (2.1)	FEN1 (2.0)	TOMM40 (2.0)	CLPTM1 (1.9)	DYNC2LI1 (1.9)
ENSG00000142252	GEMIN7 PPI subnetwork	0.14	> 0.20	POC5 (3.2)	ZNF180 (2.9)	GEMIN7 (2.4)	QTRT1 (2.2)	C12orf43 (2.2)	TOMM40 (1.9)	BUD13 (1.9)	C12orf47 (1.8)	DHODH (1.6)	FEN1 (1.5)
GO:0043487	regulation of RNA stability	0.14	> 0.20	ADAM1 (3.3)	ENSG00000238078 (2.8)	ENSG00000235545 (1.9)	ILF3 (1.8)	QTRT1 (1.7)	KANK2 (1.7)	TOP1 (1.7)	NT5DC1 (1.6)	TRIB1 (1.6)	LPAR2 (1.5)
GO:0030897	HOPS complex	0.14	> 0.20	BRAP (3.6)	ACAD10 (3.1)	TRAFD1 (3.1)	YIPF2 (3.0)	SUGP1 (3.0)	LPIN3 (2.9)	BLOC1S3 (2.6)	LPAR2 (2.3)	C12orf43 (2.2)	AP1M2 (2.2)
ENSG00000116337	AMPD2 PPI subnetwork	0.14	> 0.20	AMIGO1 (3.3)	C19orf52 (3.2)	DNM2 (2.6)	USP24 (2.5)	FRK (2.5)	YIPF2 (2.4)	SUGP1 (2.3)	C12orf47 (2.1)	GEMIN7 (2.0)	NCAN (1.9)
GO:0033674	positive regulation of kinase activity	0.14	> 0.20	ENSG00000228044 (4.0)	PTPN11 (2.2)	AMIGO1 (2.2)	HLX (2.1)	SLC44A2 (2.1)	PVR (2.1)	ST3GAL4 (1.9)	SH2B3 (1.6)	CYB561D1 (1.5)	POLK (1.5)
ENSG00000152795	HNRPDL PPI subnetwork	0.14	> 0.20	SYPL2 (3.1)	PLCG1 (2.6)	QTRT1 (2.5)	ILF3 (2.2)	TMEM50A (2.2)	OGDH (1.9)	SMARCA4 (1.8)	C1orf63 (1.8)	ACAD10 (1.8)	SUGP1 (1.7)
ENSG00000106004	HOXA5 PPI subnetwork	0.14	> 0.20	C11orf9 (2.7)	HLX (2.6)	KANK2 (2.0)	ALDH2 (2.0)	PVRL2 (1.9)	PLCG1 (1.9)	CARM1 (1.7)	NYNRIN (1.6)	ANKRD31 (1.6)	DNAH11 (1.5)
MP:0008475	intermingled spleen red and white pulp	0.14	> 0.20	RELB (5.6)	RHCE (3.5)	TIMD4 (3.2)	GRINA (3.1)	BCL3 (2.6)	HLX (2.5)	TRIB1 (2.2)	ST3GAL4 (2.2)	LPAR2 (2.2)	GMIP (2.1)
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	0.14	> 0.20	ANGPTL3 (4.4)	PLG (3.5)	DHODH (3.3)	SLC22A1 (3.2)	APOC4 (2.9)	LPA (2.4)	CYP7A1 (2.4)	ALDH2 (2.4)	FADS1 (2.4)	C12orf47 (2.2)
ENSG00000215328	HSPA1A PPI subnetwork	0.14	> 0.20	OGDH (3.4)	AP1M2 (3.0)	PLEC (2.5)	ILF3 (2.3)	SMARCA4 (2.3)	CARM1 (2.1)	SARS (2.0)	POLK (1.9)	TOP1 (1.7)	TOMM40 (1.7)
ENSG00000136231	IGF2BP3 PPI subnetwork	0.14	> 0.20	ILF3 (3.3)	DDX56 (2.9)	CARM1 (2.8)	BRAP (2.7)	ATP13A1 (2.6)	MAPKAPK5 (2.5)	GATAD2A (2.4)	TOMM40 (2.4)	TRAFD1 (1.9)	QTRT1 (1.9)
ENSG00000170677	SOCS6 PPI subnetwork	0.14	> 0.20	BCL3 (3.8)	RELB (2.9)	HLX (2.9)	GMIP (2.4)	TIMD4 (2.1)	GRINA (1.8)	PARP10 (1.7)	TMEM50A (1.7)	TRIB1 (1.6)	SH2B3 (1.5)
REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	0.14	> 0.20	NAA25 (3.7)	POC5 (3.1)	USP1 (3.1)	DDX56 (3.1)	DOCK7 (2.8)	BUD13 (2.6)	ILF3 (2.4)	USP24 (2.3)	FEN1 (2.2)	MAPKAPK5 (1.8)
ENSG00000160712	IL6R PPI subnetwork	0.14	> 0.20	BCL3 (3.5)	COL4A3BP (2.3)	PVR (1.7)	ZNF101 (1.7)	CYP7A1 (1.6)	C17orf57 (1.6)	RELB (1.6)	SLC22A1 (1.5)	CETP (1.3)	BCAM (1.2)
ENSG00000114026	OGG1 PPI subnetwork	0.14	> 0.20	ZNF180 (2.5)	SUGP1 (2.3)	MAU2 (2.2)	DYNC2LI1 (2.1)	MAPKAPK5 (2.0)	KIAA1324 (2.0)	BRAP (1.9)	AMIGO1 (1.9)	FEN1 (1.7)	TM6SF2 (1.7)
GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	0.14	> 0.20	PLG (3.4)	MOSC1 (3.3)	APOC4 (3.3)	CYP7A1 (3.3)	GPAM (3.2)	ANGPTL3 (3.1)	ALDH2 (2.8)	TRAPPC6A (2.8)	SLC22A1 (2.8)	LPA (2.6)
MP:0008476	increased spleen red pulp amount	0.14	> 0.20	RHCE (4.8)	RHD (3.6)	RELB (3.5)	BCL3 (3.1)	PBX4 (2.6)	FADS1 (2.6)	SH2B3 (2.3)	GRINA (2.2)	DNM2 (2.0)	C12orf51 (1.9)
ENSG00000117020	AKT3 PPI subnetwork	0.14	> 0.20	RELB (2.6)	DNM2 (2.5)	MAU2 (2.5)	COL4A3BP (2.2)	KANK2 (1.9)	MOSC1 (1.9)	ZHX3 (1.9)	PARP10 (1.9)	USP24 (1.8)	PTPN11 (1.6)
GO:0010470	regulation of gastrulation	0.14	> 0.20	DYNC2LI1 (2.5)	HNF1A (2.2)	LPAR2 (2.2)	FRK (1.6)	KANK2 (1.6)	PMFBP1 (1.5)	AP1M2 (1.4)	TMEM116 (1.3)	TSSK6 (1.3)	ANKRD31 (1.3)
ENSG00000141696	LEPREL4 PPI subnetwork	0.14	> 0.20	OASL (3.0)	TIMD4 (3.0)	CETP (2.7)	PLEKHH2 (1.8)	TMEM57 (1.8)	DNAH11 (1.7)	C1orf63 (1.7)	TSSK6 (1.4)	POLK (1.4)	SYPL2 (1.3)
ENSG00000135930	EIF4E2 PPI subnetwork	0.14	> 0.20	CARM1 (3.8)	DNM2 (3.7)	LPAR2 (3.1)	GPAM (2.7)	C11orf9 (2.6)	ZHX3 (2.5)	USP24 (2.4)	GATAD2A (2.2)	PLEC (2.1)	PCSK9 (1.9)
ENSG00000077942	FBLN1 PPI subnetwork	0.14	> 0.20	CILP2 (3.8)	BCAM (2.3)	C17orf57 (2.0)	ZNF101 (1.7)	CEACAM19 (1.6)	LPA (1.6)	ITGB3 (1.6)	ALDH2 (1.5)	HAVCR1 (1.5)	RHCE (1.4)
MP:0001194	dermatitis	0.14	> 0.20	BCL3 (2.9)	TRIB1 (2.8)	NKPD1 (2.8)	GMIP (2.7)	OASL (2.5)	LPAR2 (2.4)	MAFB (2.4)	PARP10 (2.3)	LDLR (2.1)	CYB561D1 (2.0)
MP:0006262	testis tumor	0.14	> 0.20	ST3GAL4 (3.5)	ABO (2.1)	KANK2 (2.0)	ENSG00000226645 (1.9)	ALDH2 (1.8)	NYNRIN (1.8)	ATXN7L2 (1.6)	FADS2 (1.6)	MARK4 (1.4)	FADS1 (1.4)
MP:0008883	abnormal enterocyte proliferation	0.14	> 0.20	CBLC (3.3)	TM6SF2 (2.7)	ABCG8 (2.3)	PLEC (2.0)	MAPKAPK5 (1.8)	SLC44A2 (1.8)	AMIGO1 (1.7)	ENSG00000226648 (1.7)	APOC4 (1.6)	TMED4 (1.6)
ENSG00000102678	FGF9 PPI subnetwork	0.14	> 0.20	HAPLN4 (4.4)	PLEKHH2 (3.9)	HAVCR1 (3.7)	C11orf9 (3.1)	ZHX3 (2.7)	NYNRIN (2.4)	CBLC (2.4)	CEACAM19 (2.1)	C17orf57 (2.0)	ENSG00000235545 (1.7)
ENSG00000013297	CLDN11 PPI subnetwork	0.14	> 0.20	USP24 (3.8)	PLEC (3.1)	DNM2 (2.8)	COL4A3BP (2.5)	ALDH2 (2.4)	GMIP (2.1)	POLK (2.1)	PVR (1.9)	SORT1 (1.9)	PTPN11 (1.8)
MP:0011294	renal glomerulus hypertrophy	0.14	> 0.20	MAFB (2.8)	SH2B3 (2.6)	C17orf57 (2.5)	POLK (2.2)	ENSG00000228044 (2.2)	TRIB1 (2.2)	TMEM50A (2.1)	FRK (2.1)	COL4A3BP (2.0)	GOT2P1 (1.9)
ENSG00000164683	HEY1 PPI subnetwork	0.14	> 0.20	SLC44A2 (3.0)	RHCE (2.1)	SH2B3 (1.9)	MYLIP (1.9)	ITGB3 (1.8)	KANK2 (1.8)	LPIN3 (1.7)	ZHX3 (1.7)	GCNT4 (1.5)	TMEM57 (1.5)
MP:0011094	complete embryonic lethality before implantation	0.14	> 0.20	PSRC1 (3.2)	FEN1 (3.0)	USP1 (2.9)	DHX38 (2.4)	ILF3 (2.4)	USP24 (2.4)	BUD13 (2.4)	SUGP1 (2.3)	ZNF259 (1.9)	DDX56 (1.9)
MP:0004616	lumbar vertebral transformation	0.14	> 0.20	ATXN2 (2.0)	PLCG1 (1.9)	HAVCR1 (1.8)	NYNRIN (1.8)	DYNC2LI1 (1.7)	ZHX3 (1.6)	UBXN2B (1.6)	ZNF180 (1.4)	ENSG00000238078 (1.3)	HNF1A (1.2)
GO:0070528	protein kinase C signaling cascade	0.14	> 0.20	GCNT4 (2.8)	C17orf57 (2.8)	CEACAM19 (2.6)	ENSG00000226645 (2.5)	ATXN7L2 (2.1)	GOT2P1 (1.8)	ENSG00000235545 (1.8)	C11orf9 (1.6)	NKPD1 (1.3)	ST3GAL4 (1.3)
ENSG00000175793	SFN PPI subnetwork	0.14	> 0.20	CBLC (4.7)	AP1M2 (3.1)	BCAM (2.6)	PLEC (2.4)	PVRL2 (2.4)	CELSR2 (2.2)	ATXN2 (2.1)	KANK2 (2.1)	TRIB1 (2.0)	SMARCA4 (1.9)
MP:0002947	hemangioma	0.14	> 0.20	NCAN (2.3)	UBXN2B (2.0)	ABO (1.8)	SLC44A2 (1.8)	DDX56 (1.7)	POLK (1.6)	BCL3 (1.5)	MYLIP (1.5)	GCNT4 (1.4)	ALDH2 (1.3)
GO:0051537	2 iron, 2 sulfur cluster binding	0.14	> 0.20	RHD (3.9)	RHCE (3.7)	GMPR (2.5)	APOC4 (2.3)	NT5DC1 (2.0)	ATXN7L2 (1.8)	CYP7A1 (1.7)	OGDH (1.6)	DNAH11 (1.5)	HP (1.5)
MP:0001862	interstitial pneumonia	0.14	> 0.20	RHCE (4.8)	RHD (4.7)	DNM2 (3.3)	TMEM57 (2.3)	APOC1 (2.2)	CLPTM1 (2.1)	GMIP (2.1)	TOP1 (2.1)	PLEC (2.0)	RELB (2.0)
MP:0000692	small spleen	0.14	> 0.20	PBX4 (2.7)	COL4A3BP (2.6)	HLX (2.5)	RHCE (1.9)	POLK (1.9)	CILP2 (1.9)	MYLIP (1.7)	SLC22A1 (1.6)	PLEC (1.6)	SH2B3 (1.5)
GO:0045226	extracellular polysaccharide biosynthetic process	0.14	> 0.20	NT5DC1 (2.7)	BLOC1S3 (2.5)	ENSG00000254235 (2.2)	HMGCR (2.2)	TMEM50A (2.0)	CYB561D1 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	FADS2 (1.8)	YIPF2 (1.8)
GO:0046379	extracellular polysaccharide metabolic process	0.14	> 0.20	NT5DC1 (2.7)	BLOC1S3 (2.5)	ENSG00000254235 (2.2)	HMGCR (2.2)	TMEM50A (2.0)	CYB561D1 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	FADS2 (1.8)	YIPF2 (1.8)
GO:0070412	R-SMAD binding	0.14	> 0.20	TRIB1 (4.2)	KANK2 (3.0)	MAPKAPK5 (2.7)	ENSG00000226648 (2.5)	ILF3 (2.4)	ATXN7L2 (2.3)	DOCK7 (2.2)	ENSG00000226645 (2.1)	AMIGO1 (2.0)	PLCG1 (1.7)
GO:0048536	spleen development	0.14	> 0.20	ENSG00000228044 (2.7)	ABO (2.2)	RHCE (2.1)	ENSG00000226648 (1.9)	RHD (1.8)	GCNT4 (1.7)	DYNC2LI1 (1.6)	PLEKHH2 (1.5)	LPAR2 (1.5)	MAFB (1.4)
GO:0005518	collagen binding	0.14	> 0.20	ITGB3 (4.8)	CILP2 (4.4)	KANK2 (2.6)	APOE (2.2)	PLEKHH2 (1.9)	ENSG00000238078 (1.7)	CETP (1.6)	SH2B3 (1.5)	TIMD4 (1.4)	MOSC1 (1.4)
MP:0002497	increased IgE level	0.14	> 0.20	BCL3 (3.8)	RELB (3.1)	C17orf57 (3.0)	GMIP (2.9)	SH2B3 (2.1)	ZNF101 (1.9)	PARP10 (1.7)	NT5DC1 (1.6)	TIMD4 (1.3)	ENSG00000226645 (1.2)
ENSG00000147168	IL2RG PPI subnetwork	0.14	> 0.20	BCL3 (3.9)	RELB (2.2)	PVR (2.0)	COL4A3BP (1.9)	ZNF101 (1.8)	C17orf57 (1.8)	TRAFD1 (1.8)	PARP10 (1.5)	SLC22A1 (1.4)	TIMD4 (1.4)
ENSG00000005882	PDK2 PPI subnetwork	0.14	> 0.20	CLPTM1 (3.7)	SYPL2 (3.5)	TOMM40 (3.1)	GPAM (3.0)	MARK4 (2.8)	OGDH (2.8)	TRAPPC6A (2.1)	PVRL2 (1.8)	CARM1 (1.7)	ZNF180 (1.7)
GO:0032094	response to food	0.14	> 0.20	NPC1L1 (2.5)	ABCG8 (2.4)	ENSG00000228044 (2.2)	KIAA1324 (2.2)	TMED4 (2.1)	ADAM1 (1.9)	GCNT4 (1.6)	ABCG5 (1.6)	AP1M2 (1.6)	TM6SF2 (1.3)
ENSG00000116285	ERRFI1 PPI subnetwork	0.14	> 0.20	CBLC (4.5)	AP1M2 (2.8)	PSRC1 (2.5)	DOCK7 (2.4)	PVRL2 (2.4)	BCAM (2.0)	LPIN3 (1.8)	KANK2 (1.7)	PPP1R37 (1.6)	SLC44A2 (1.6)
GO:0046849	bone remodeling	0.14	> 0.20	ENSG00000226645 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.8)	ENSG00000254235 (1.8)	CILP2 (1.8)	HNF1A (1.7)	ABO (1.6)	C11orf9 (1.5)	MAU2 (1.4)	RHCE (1.1)
ENSG00000129152	MYOD1 PPI subnetwork	0.14	> 0.20	KANK2 (2.8)	MYLIP (2.4)	MAFB (2.2)	TRIB1 (2.1)	PTPN11 (1.8)	ATXN2 (1.7)	ATXN7L2 (1.7)	ALDH2 (1.7)	BCL3 (1.6)	GCNT4 (1.5)
ENSG00000111737	RAB35 PPI subnetwork	0.14	> 0.20	PARP10 (3.7)	ABCG5 (2.8)	TM6SF2 (2.5)	OASL (2.5)	PBX4 (2.2)	ABCG8 (1.9)	ENSG00000228044 (1.9)	PLEKHH2 (1.8)	LPAR2 (1.7)	NT5DC1 (1.6)
MP:0004742	abnormal vestibular system physiology	0.14	> 0.20	PBX4 (3.7)	AP1M2 (2.6)	C12orf47 (2.6)	BCL3 (1.8)	PVRL2 (1.7)	ENSG00000228044 (1.7)	HNF1A (1.7)	TRIB1 (1.6)	ZNF180 (1.4)	LPAR2 (1.4)
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	0.14	> 0.20	ITGB3 (4.0)	APOE (3.5)	MAFB (2.4)	HP (2.2)	APOC1 (1.9)	GMIP (1.7)	NCAN (1.6)	C11orf9 (1.6)	SORT1 (1.4)	TIMD4 (1.4)
ENSG00000138448	ITGAV PPI subnetwork	0.14	> 0.20	ITGB3 (4.3)	CLPTM1 (3.1)	PVRL2 (2.6)	APOE (2.4)	ST3GAL4 (2.4)	C17orf57 (2.0)	PLEC (2.0)	SLC44A2 (1.9)	USP24 (1.9)	CILP2 (1.8)
MP:0010413	complete atrioventricular septal defect	0.14	> 0.20	C11orf9 (3.6)	PVR (2.7)	APOB (2.6)	NYNRIN (2.3)	PVRL2 (2.2)	BCAM (2.2)	ST3GAL4 (2.1)	DOCK7 (1.9)	PLCG1 (1.8)	PPP1R37 (1.5)
ENSG00000124222	STX16 PPI subnetwork	0.14	> 0.20	CELSR2 (2.7)	C19orf52 (2.6)	GOT2P1 (2.5)	CLPTM1 (2.3)	YIPF2 (2.2)	TXNL4B (2.2)	MAU2 (2.1)	SARS (2.1)	CYB561D1 (2.1)	ATP13A1 (2.0)
REACTOME_TERMINATION_OF_O:GLYCAN_BIOSYNTHESIS	REACTOME_TERMINATION_OF_O:GLYCAN_BIOSYNTHESIS	0.14	> 0.20	ST3GAL4 (4.8)	KIAA1324 (3.4)	ABO (1.8)	PMFBP1 (1.6)	AP1M2 (1.6)	PVRL2 (1.6)	FADS1 (1.4)	ITGB3 (1.2)	ENSG00000254235 (1.1)	FADS2 (1.1)
ENSG00000085872	CHERP PPI subnetwork	0.14	> 0.20	C1orf63 (3.6)	CARM1 (3.0)	BUD13 (2.7)	SMARCA4 (2.2)	GMIP (2.2)	ATXN2 (1.9)	ENSG00000254235 (1.9)	USP1 (1.8)	DNM2 (1.6)	ILF3 (1.6)
MP:0006082	CNS inflammation	0.14	> 0.20	OASL (3.8)	TRAFD1 (3.2)	MAFB (2.2)	COL4A3BP (2.0)	ERP29 (2.0)	APOE (1.9)	PARP10 (1.6)	APOC1 (1.6)	HAVCR1 (1.6)	GCNT4 (1.5)
GO:0007565	female pregnancy	0.14	> 0.20	CEACAM19 (3.7)	ENSG00000226645 (2.5)	ATXN7L2 (1.8)	KIAA1324 (1.8)	ENSG00000228044 (1.6)	GCNT4 (1.5)	FRK (1.5)	ENSG00000238078 (1.4)	LPIN3 (1.4)	AP1M2 (1.4)
GO:0060135	maternal process involved in female pregnancy	0.14	> 0.20	CEACAM19 (3.9)	GCNT4 (3.2)	UBXN2B (3.1)	CYP7A1 (2.9)	DNAH11 (2.5)	ENSG00000226645 (2.0)	ABO (1.9)	KIAA1324 (1.7)	TSSK6 (1.7)	TXNL4B (1.6)
GO:0030308	negative regulation of cell growth	0.14	> 0.20	GCNT4 (2.9)	TXNL4B (2.3)	C19orf52 (2.3)	POLK (2.2)	ENSG00000254235 (1.8)	C12orf47 (1.7)	C1orf63 (1.7)	AMIGO1 (1.6)	ANKRD31 (1.6)	TMED4 (1.6)
ENSG00000066654	THUMPD1 PPI subnetwork	0.14	> 0.20	ATXN7L2 (3.3)	TMEM50A (2.3)	APOA5 (2.2)	APOC4 (2.0)	SARS (1.8)	C1orf63 (1.8)	PSMA5 (1.7)	ZNF259 (1.7)	BLOC1S3 (1.6)	SLC22A1 (1.6)
MP:0003984	embryonic growth retardation	0.14	> 0.20	GATAD2A (3.3)	PVR (2.8)	LDLR (2.7)	HMGCR (2.4)	KANK2 (2.2)	ATXN2 (2.1)	USP24 (2.0)	DOCK7 (2.0)	PTPN11 (1.9)	ENSG00000226648 (1.9)
ENSG00000104852	SNRNP70 PPI subnetwork	0.14	> 0.20	DHX38 (4.3)	TOP1 (3.8)	ILF3 (3.8)	SMARCA4 (3.4)	BUD13 (2.8)	USP1 (2.7)	PTPN11 (2.6)	SUGP1 (2.5)	QTRT1 (2.4)	C1orf63 (2.3)
GO:0070613	regulation of protein processing	0.14	> 0.20	ENSG00000228044 (2.9)	CEACAM19 (2.2)	PCSK9 (2.1)	HAVCR1 (2.0)	HP (1.5)	TXNL4B (1.5)	TMED4 (1.5)	C17orf57 (1.5)	RHCE (1.4)	TMEM116 (1.4)
MP:0002641	anisopoikilocytosis	0.14	> 0.20	RHCE (12.2)	RHD (11.3)	GMPR (3.6)	C12orf51 (2.7)	USP24 (1.9)	APOC1 (1.8)	RPH3A (1.5)	TMEM57 (1.4)	TIMD4 (1.3)	BLOC1S3 (1.2)
REACTOME_GAB1_SIGNALOSOME	REACTOME_GAB1_SIGNALOSOME	0.14	> 0.20	ZHX3 (4.1)	PLEC (2.4)	BRAP (2.2)	DNM2 (2.2)	MAU2 (1.9)	CLPTM1 (1.8)	TRIB1 (1.8)	PTPN11 (1.8)	MARK4 (1.7)	FADS2 (1.7)
MP:0000417	short hair	0.14	> 0.20	AP1M2 (3.6)	LDLR (3.1)	HMGCR (3.1)	ENSG00000235545 (2.9)	PCSK9 (2.7)	CELSR2 (2.6)	GCNT4 (2.5)	ABO (2.4)	ENSG00000238078 (2.4)	CBLC (2.3)
GO:0007589	body fluid secretion	0.14	> 0.20	KIAA1324 (3.5)	GOT2P1 (2.9)	GEMIN7 (2.2)	LPIN3 (2.2)	PMFBP1 (1.7)	ATXN7L2 (1.7)	NPC1L1 (1.6)	TRAPPC6A (1.6)	HAPLN4 (1.5)	NKPD1 (1.5)
KEGG_ADHERENS_JUNCTION	KEGG_ADHERENS_JUNCTION	0.14	> 0.20	PLEC (2.8)	DOCK7 (2.7)	PVRL2 (2.6)	SLC44A2 (2.6)	GATAD2A (2.6)	MARK4 (2.5)	ATXN2 (2.1)	SH2B3 (2.1)	PLCG1 (2.1)	KANK2 (2.0)
ENSG00000007866	TEAD3 PPI subnetwork	0.14	> 0.20	LPAR2 (3.2)	CARM1 (2.9)	DNM2 (2.9)	C11orf9 (2.7)	KANK2 (2.6)	PLEC (2.5)	COL4A3BP (2.5)	PTPN11 (2.4)	ZHX3 (2.4)	GPAM (2.4)
ENSG00000108590	MED31 PPI subnetwork	0.14	> 0.20	GEMIN7 (3.9)	TXNL4B (3.2)	TRAPPC6A (2.6)	BRAP (2.2)	CLPTM1 (2.1)	MARK4 (2.0)	C12orf47 (1.9)	ATXN7L2 (1.9)	TOMM40 (1.9)	PBX4 (1.8)
GO:0016849	phosphorus-oxygen lyase activity	0.14	> 0.20	NYNRIN (3.4)	CETP (2.6)	ITGB3 (2.4)	HLX (2.3)	ABCG8 (1.8)	CYP7A1 (1.8)	BCAM (1.7)	HAVCR1 (1.5)	MYLIP (1.5)	ENSG00000254235 (1.5)
GO:0002758	innate immune response-activating signal transduction	0.14	> 0.20	SH2B3 (3.1)	RELB (2.4)	GMIP (2.4)	PARP10 (2.0)	OASL (1.9)	MAFB (1.9)	BCL3 (1.9)	CYB561D1 (1.9)	TRIB1 (1.8)	MYLIP (1.7)
ENSG00000186676	ENSG00000186676 PPI subnetwork	0.14	> 0.20	SARS (4.4)	PSMA5 (3.9)	ZNF259 (2.8)	TOMM40 (2.5)	HMGCR (2.3)	QTRT1 (2.2)	DHX38 (2.1)	SMARCA4 (2.1)	NAA25 (2.1)	DDX56 (2.0)
ENSG00000121031	ENSG00000121031 PPI subnetwork	0.14	> 0.20	SMARCA4 (3.1)	DHX38 (2.8)	PLEC (2.7)	ILF3 (2.3)	TOP1 (2.1)	OASL (2.0)	OGDH (1.9)	USP1 (1.9)	PARP10 (1.8)	DOCK7 (1.8)
ENSG00000164404	GDF9 PPI subnetwork	0.14	> 0.20	PSRC1 (2.7)	TRAPPC6A (2.7)	ALDH2 (2.3)	CEACAM19 (2.0)	PVRL2 (2.0)	DOCK7 (2.0)	MARK4 (2.0)	GEMIN7 (1.8)	ABO (1.8)	USP1 (1.6)
ENSG00000124795	DEK PPI subnetwork	0.14	> 0.20	BUD13 (3.8)	TSSK6 (2.3)	MYLIP (2.3)	USP1 (2.1)	DOCK7 (1.9)	SMARCA4 (1.7)	C19orf52 (1.6)	NYNRIN (1.6)	FEN1 (1.5)	FADS2 (1.4)
ENSG00000197429	IPP PPI subnetwork	0.14	> 0.20	ATXN7L2 (3.2)	ZNF180 (2.5)	BUD13 (2.0)	USP1 (2.0)	UBXN2B (1.9)	BRAP (1.7)	KANK2 (1.7)	TMEM116 (1.6)	DNM2 (1.5)	POC5 (1.5)
ENSG00000143033	MTF2 PPI subnetwork	0.14	> 0.20	FRK (2.7)	HLX (2.5)	PVRL2 (1.6)	ATXN2 (1.6)	NT5DC1 (1.5)	USP1 (1.4)	TIMD4 (1.4)	TRIB1 (1.4)	ENSG00000228044 (1.3)	OASL (1.3)
GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	0.14	> 0.20	PLEKHH2 (2.1)	KANK2 (2.1)	ATXN7L2 (1.7)	GCNT4 (1.6)	CEACAM19 (1.6)	MARK4 (1.6)	ENSG00000254235 (1.3)	SORT1 (1.3)	ITGB3 (1.3)	ENSG00000226645 (1.3)
GO:0050660	flavin adenine dinucleotide binding	0.14	> 0.20	ALDH2 (4.5)	ACAD10 (3.8)	MOSC1 (3.3)	PLG (3.1)	HP (3.1)	GPAM (2.8)	LPIN3 (2.5)	SLC22A1 (2.5)	ANGPTL3 (2.1)	FADS2 (2.1)
ENSG00000133704	IPO8 PPI subnetwork	0.14	> 0.20	ATXN2 (2.3)	ENSG00000235545 (1.9)	OGDH (1.9)	ABO (1.8)	GOT2P1 (1.7)	NAA25 (1.7)	TXNL4B (1.7)	PLEC (1.7)	DHODH (1.7)	ITGB3 (1.6)
ENSG00000183091	NEB PPI subnetwork	0.14	> 0.20	SYPL2 (7.1)	GMPR (3.4)	TRAPPC6A (2.0)	CYB561D1 (1.8)	KANK2 (1.8)	BLOC1S3 (1.7)	TMEM50A (1.5)	HNF1A (1.5)	TM6SF2 (1.5)	AP1M2 (1.4)
ENSG00000175575	PAAF1 PPI subnetwork	0.14	> 0.20	TOMM40 (4.2)	PSMA5 (4.2)	SUGP1 (2.7)	CLPTM1 (2.6)	FADS2 (2.2)	OGDH (2.2)	DHX38 (2.1)	NT5DC1 (1.9)	NAA25 (1.9)	SARS (1.9)
GO:0051004	regulation of lipoprotein lipase activity	0.14	> 0.20	APOE (2.9)	TSSK6 (2.3)	TM6SF2 (2.0)	APOC4 (1.9)	ABCG5 (1.8)	ENSG00000228044 (1.8)	APOC1 (1.7)	CLPTM1 (1.7)	HP (1.6)	PMFBP1 (1.6)
MP:0001719	absent vitelline blood vessels	0.14	> 0.20	HLX (3.5)	SH2B3 (3.5)	KANK2 (2.3)	SLC44A2 (2.3)	GATAD2A (2.1)	MYLIP (1.9)	ITGB3 (1.9)	LPA (1.7)	RHCE (1.7)	NYNRIN (1.6)
ENSG00000167670	CHAF1A PPI subnetwork	0.14	> 0.20	FEN1 (3.6)	USP1 (3.3)	SMARCA4 (2.7)	TMEM57 (2.4)	ATP13A1 (2.3)	PTPN11 (2.2)	BRAP (2.1)	ZNF180 (2.1)	MAU2 (2.1)	GATAD2A (1.8)
ENSG00000121671	CRY2 PPI subnetwork	0.14	> 0.20	ZHX3 (2.8)	TMEM57 (2.6)	KANK2 (2.3)	CYP7A1 (2.1)	TMEM116 (1.9)	GPAM (1.9)	ZNF180 (1.6)	ENSG00000254235 (1.5)	CILP2 (1.4)	C12orf43 (1.4)
GO:0006984	ER-nucleus signaling pathway	0.14	> 0.20	FADS2 (3.3)	LDLR (3.2)	GCNT4 (3.1)	HMGCR (2.9)	FADS1 (2.8)	SARS (2.5)	PCSK9 (2.3)	YIPF2 (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (1.9)
GO:0016571	histone methylation	0.14	> 0.20	C12orf51 (3.5)	ZNF180 (2.6)	ATXN7L2 (2.4)	MAU2 (2.3)	ATXN2 (2.2)	C19orf52 (2.2)	QTRT1 (2.0)	BUD13 (2.0)	GOT2P1 (1.8)	USP24 (1.8)
MP:0000352	decreased cell proliferation	0.15	> 0.20	USP1 (3.2)	FEN1 (2.6)	TRIB1 (2.2)	DOCK7 (2.2)	PSRC1 (2.0)	KANK2 (2.0)	SMARCA4 (2.0)	CARM1 (1.9)	TOMM40 (1.9)	GATAD2A (1.8)
ENSG00000198626	RYR2 PPI subnetwork	0.15	> 0.20	ENSG00000238078 (2.3)	SYPL2 (2.2)	ZNF180 (2.0)	CYB561D1 (2.0)	ST3GAL4 (1.9)	GPAM (1.9)	GMPR (1.8)	LPIN3 (1.8)	NKPD1 (1.7)	ADAM1 (1.7)
ENSG00000013275	PSMC4 PPI subnetwork	0.15	> 0.20	PSMA5 (5.0)	NAA25 (3.5)	TOMM40 (2.7)	DDX56 (2.6)	TRAFD1 (2.3)	NT5DC1 (2.2)	SARS (1.9)	SMARCA4 (1.8)	PTPN11 (1.7)	BRAP (1.7)
ENSG00000006062	MAP3K14 PPI subnetwork	0.15	> 0.20	ZNF259 (2.8)	NAA25 (2.7)	RELB (2.6)	ILF3 (2.6)	BCL3 (2.3)	SARS (2.2)	TOMM40 (1.9)	TOP1 (1.8)	PVRL2 (1.8)	PVR (1.7)
ENSG00000150455	TIRAP PPI subnetwork	0.15	> 0.20	OASL (3.8)	MAFB (2.5)	PARP10 (2.4)	GMIP (2.0)	UBXN2B (1.8)	TRIB1 (1.8)	ZNF101 (1.8)	BLOC1S3 (1.5)	PMFBP1 (1.5)	ENSG00000238078 (1.3)
GO:0031272	regulation of pseudopodium assembly	0.15	> 0.20	ENSG00000235545 (4.0)	CBLC (2.8)	PVRL2 (2.8)	CETP (2.8)	SLC44A2 (2.2)	C11orf9 (2.1)	BRAP (1.9)	SYPL2 (1.9)	BLOC1S3 (1.7)	HNF1A (1.7)
MP:0002499	chronic inflammation	0.15	> 0.20	MAFB (3.9)	TIMD4 (3.1)	CETP (2.7)	GMIP (2.6)	BCL3 (2.5)	ZNF101 (2.4)	ENSG00000254235 (2.4)	TRIB1 (2.0)	PBX4 (2.0)	HLX (1.8)
ENSG00000123836	PFKFB2 PPI subnetwork	0.15	> 0.20	ZHX3 (3.5)	DNM2 (3.5)	CARM1 (3.3)	PLEC (3.0)	LPAR2 (3.0)	PTPN11 (2.7)	OGDH (2.7)	GPAM (2.7)	KANK2 (2.4)	USP24 (2.4)
ENSG00000129460	NGDN PPI subnetwork	0.15	> 0.20	ZNF259 (4.6)	DDX56 (4.2)	NAA25 (3.6)	QTRT1 (3.6)	TOMM40 (3.3)	DHODH (3.2)	C12orf43 (3.2)	SARS (2.2)	GATAD2A (2.0)	BRAP (1.9)
MP:0001690	failure of somite differentiation	0.15	> 0.20	C17orf57 (5.7)	ATP13A1 (2.4)	GCNT4 (2.4)	NYNRIN (2.3)	ITGB3 (2.2)	ABO (2.2)	HAVCR1 (2.1)	C1orf63 (2.1)	CLPTM1 (1.9)	DNM2 (1.8)
REACTOME_BASE_EXCISION_REPAIR	REACTOME_BASE_EXCISION_REPAIR	0.15	> 0.20	USP1 (3.1)	FEN1 (2.8)	TRAPPC6A (2.4)	BUD13 (2.1)	DDX56 (1.8)	LPIN3 (1.8)	ZNF180 (1.7)	GOT2P1 (1.7)	ERP29 (1.7)	BLOC1S3 (1.6)
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	0.15	> 0.20	USP1 (3.1)	FEN1 (2.8)	TRAPPC6A (2.4)	BUD13 (2.1)	DDX56 (1.8)	LPIN3 (1.8)	ZNF180 (1.7)	GOT2P1 (1.7)	ERP29 (1.7)	BLOC1S3 (1.6)
ENSG00000055332	EIF2AK2 PPI subnetwork	0.15	> 0.20	PARP10 (4.1)	TRAFD1 (3.9)	OASL (3.3)	BRAP (2.9)	FRK (2.7)	CYB561D1 (2.4)	ENSG00000228044 (2.2)	RELB (2.1)	C1orf63 (1.9)	C12orf43 (1.9)
GO:0045861	negative regulation of proteolysis	0.15	> 0.20	ST3GAL4 (2.3)	PLEKHH2 (2.1)	DYNC2LI1 (2.0)	ENSG00000228044 (1.9)	ATP13A1 (1.8)	TMEM57 (1.6)	CYB561D1 (1.6)	KANK2 (1.3)	PMFBP1 (1.3)	APOE (1.3)
MP:0008058	abnormal DNA repair	0.15	> 0.20	POC5 (4.5)	ZNF180 (2.0)	FEN1 (2.0)	UBXN2B (1.9)	KANK2 (1.7)	GEMIN7 (1.6)	PSRC1 (1.6)	MAPKAPK5 (1.6)	NT5DC1 (1.5)	CBLC (1.5)
ENSG00000155438	MKI67IP PPI subnetwork	0.15	> 0.20	ZNF259 (5.1)	NAA25 (4.3)	DDX56 (4.3)	TOMM40 (3.6)	QTRT1 (3.3)	DHODH (3.1)	DHX38 (2.5)	C12orf43 (2.2)	MAPKAPK5 (2.1)	ENSG00000226645 (1.8)
REACTOME_NEGATIVE_REGULATORS_OF_RIG:IMDA5_SIGNALING	REACTOME_NEGATIVE_REGULATORS_OF_RIG:IMDA5_SIGNALING	0.15	> 0.20	OASL (11.2)	PARP10 (8.6)	TRAFD1 (4.4)	RELB (3.4)	MAU2 (2.1)	ZNF101 (1.8)	BCL3 (1.8)	C19orf52 (1.6)	GMIP (1.6)	ATP13A1 (1.6)
MP:0000048	abnormal stria vascularis morphology	0.15	> 0.20	APOC1 (2.7)	SORT1 (2.1)	TMEM116 (2.0)	ANKRD31 (1.9)	PTPN11 (1.9)	GMPR (1.8)	MYLIP (1.7)	PMFBP1 (1.7)	NKPD1 (1.7)	HNF1A (1.7)
ENSG00000134107	BHLHE40 PPI subnetwork	0.15	> 0.20	BCL3 (3.7)	PARP10 (2.7)	RELB (2.6)	GRINA (2.2)	GMIP (2.1)	PLEC (2.0)	GPAM (1.7)	UBXN2B (1.5)	C17orf57 (1.4)	KIAA1324 (1.4)
ENSG00000205339	IPO7 PPI subnetwork	0.15	> 0.20	SARS (3.5)	PLEC (3.2)	BRAP (2.7)	DHX38 (2.6)	ATP13A1 (2.6)	USP24 (2.5)	PSMA5 (2.2)	ZNF259 (2.0)	PTPN11 (1.9)	NT5DC1 (1.8)
ENSG00000122965	RBM19 PPI subnetwork	0.15	> 0.20	QTRT1 (3.7)	DDX56 (3.4)	TOP1 (3.2)	DHODH (3.2)	NAA25 (3.1)	DHX38 (2.9)	TOMM40 (2.8)	ZNF259 (2.8)	USP24 (2.5)	ANKRD31 (2.2)
ENSG00000108963	DPH1 PPI subnetwork	0.15	> 0.20	DHODH (2.8)	TXNL4B (2.6)	PPP1R37 (2.5)	DDX56 (2.2)	YIPF2 (2.1)	LPAR2 (1.9)	ERP29 (1.7)	COL4A3BP (1.6)	ATXN7L2 (1.5)	C19orf52 (1.5)
GO:0032880	regulation of protein localization	0.15	> 0.20	PBX4 (1.8)	ST3GAL4 (1.7)	ZNF101 (1.7)	C17orf57 (1.6)	AP1M2 (1.5)	PLEKHH2 (1.5)	ENSG00000238078 (1.4)	PVRL2 (1.4)	PLCG1 (1.3)	ENSG00000228044 (1.2)
MP:0010378	increased respiratory quotient	0.15	> 0.20	MOSC1 (2.6)	TRIB1 (2.3)	PMFBP1 (1.9)	TMED4 (1.8)	GPAM (1.7)	BLOC1S3 (1.7)	C1orf63 (1.6)	ATXN7L2 (1.6)	SORT1 (1.6)	APOC1 (1.5)
ENSG00000144381	HSPD1 PPI subnetwork	0.15	> 0.20	TOMM40 (2.4)	PSMA5 (2.3)	OGDH (2.1)	DDX56 (1.9)	SMARCA4 (1.7)	TOP1 (1.7)	NAA25 (1.6)	GMPR (1.5)	DOCK7 (1.4)	HMGCR (1.4)
GO:0009068	aspartate family amino acid catabolic process	0.15	> 0.20	QTRT1 (2.8)	DYNC2LI1 (2.5)	ENSG00000254235 (2.4)	ACAD10 (2.3)	C19orf52 (2.0)	TMED4 (1.8)	GOT2P1 (1.7)	OGDH (1.6)	NT5DC1 (1.6)	MOSC1 (1.6)
ENSG00000161960	EIF4A1 PPI subnetwork	0.15	> 0.20	TOMM40 (3.5)	PSMA5 (3.3)	NAA25 (3.1)	SARS (2.9)	DDX56 (2.7)	SUGP1 (2.2)	SMARCA4 (2.2)	TOP1 (1.9)	ZNF259 (1.8)	DHX38 (1.7)
GO:0007250	activation of NF-kappaB-inducing kinase activity	0.15	> 0.20	ANKRD31 (3.7)	HNF1A (2.6)	PMFBP1 (2.3)	HAVCR1 (2.2)	FRK (1.9)	PCSK9 (1.7)	LPIN3 (1.7)	CBLC (1.6)	DNAH11 (1.6)	GEMIN7 (1.5)
GO:0008625	induction of apoptosis via death domain receptors	0.15	> 0.20	ANKRD31 (4.4)	ENSG00000228044 (2.6)	TRAFD1 (2.3)	FRK (2.2)	C12orf43 (2.2)	POLK (1.9)	ADAM1 (1.9)	SH2B3 (1.8)	UBXN2B (1.7)	BLOC1S3 (1.7)
REACTOME_FRS2:MEDIATED_ACTIVATION	REACTOME_FRS2:MEDIATED_ACTIVATION	0.15	> 0.20	CARM1 (2.1)	HLX (2.0)	DNM2 (1.9)	MAPKAPK5 (1.8)	GATAD2A (1.8)	CLPTM1 (1.7)	CYB561D1 (1.7)	SLC44A2 (1.7)	SH2B3 (1.7)	PTPN11 (1.6)
ENSG00000163624	CDS1 PPI subnetwork	0.15	> 0.20	ATP13A1 (3.7)	HNF1A (3.1)	MAPKAPK5 (2.6)	PTPN11 (2.4)	DHODH (2.4)	DDX56 (2.4)	BRAP (2.3)	TOMM40 (2.1)	CEACAM19 (2.1)	ANKRD31 (2.1)
ENSG00000158815	FGF17 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000111241	FGF6 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000156427	FGF18 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000070388	FGF22 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000107831	FGF8 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000162344	FGF19 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
MP:0004892	increased adiponectin level	0.15	> 0.20	SH2B3 (2.7)	MOSC1 (2.6)	CETP (2.4)	PLEC (2.3)	ST3GAL4 (2.2)	GPAM (2.2)	OASL (2.2)	TRIB1 (2.2)	LDLR (1.9)	KANK2 (1.8)
ENSG00000178177	LCORL PPI subnetwork	0.15	> 0.20	TIMD4 (3.1)	OASL (2.9)	CETP (2.6)	PLEKHH2 (2.0)	C1orf63 (1.7)	TMEM57 (1.7)	SLC44A2 (1.6)	DNAH11 (1.6)	CEACAM19 (1.4)	SYPL2 (1.3)
MP:0005605	increased bone mass	0.15	> 0.20	MAFB (3.7)	MOSC1 (2.5)	POLK (2.3)	TRIB1 (1.9)	SORT1 (1.8)	CELSR2 (1.8)	PARP10 (1.6)	ENSG00000226648 (1.6)	PLCG1 (1.6)	CILP2 (1.5)
ENSG00000130522	JUND PPI subnetwork	0.15	> 0.20	TRIB1 (4.7)	BCL3 (4.0)	ATXN2 (2.5)	PVR (2.1)	SARS (2.0)	HLX (1.9)	PARP10 (1.7)	TRAFD1 (1.6)	ALDH2 (1.5)	AMIGO1 (1.5)
GO:0044433	cytoplasmic vesicle part	0.15	> 0.20	ITGB3 (2.6)	SORT1 (2.5)	YIPF2 (2.4)	CLPTM1 (2.4)	APOE (2.4)	RPH3A (2.3)	KIAA1324 (2.2)	ANGPTL3 (2.0)	HP (1.9)	APOB (1.8)
ENSG00000170178	HOXD12 PPI subnetwork	0.15	> 0.20	TRIB1 (4.4)	NPC1L1 (2.5)	PVR (2.3)	POLK (1.9)	BCL3 (1.7)	MAPKAPK5 (1.7)	COL4A3BP (1.7)	C17orf57 (1.7)	LDLR (1.6)	LPIN3 (1.4)
GO:0030097	hemopoiesis	0.15	> 0.20	ZNF101 (4.3)	RHCE (3.6)	RHD (3.4)	PBX4 (2.6)	HLX (2.4)	PLCG1 (2.1)	SH2B3 (1.8)	GMIP (1.7)	TRIB1 (1.5)	MAFB (1.5)
ENSG00000173153	ESRRA PPI subnetwork	0.15	> 0.20	SORT1 (3.3)	C12orf51 (3.1)	ZHX3 (2.5)	TOP1 (2.5)	GOT2P1 (2.5)	CELSR2 (1.9)	MAFB (1.9)	DOCK7 (1.8)	ST3GAL4 (1.7)	CETP (1.5)
GO:0017091	AU-rich element binding	0.15	> 0.20	MAPKAPK5 (2.9)	ENSG00000226645 (2.6)	TRIB1 (2.5)	NPC1L1 (2.1)	ENSG00000228044 (1.8)	TM6SF2 (1.8)	CBLC (1.6)	C12orf43 (1.6)	BCL3 (1.5)	BUD13 (1.4)
MP:0001191	abnormal skin condition	0.15	> 0.20	HMGCR (5.2)	LDLR (4.8)	CBLC (3.4)	FADS2 (3.3)	FADS1 (3.2)	PLEC (2.3)	NKPD1 (2.2)	NPC1L1 (2.2)	LPAR2 (2.0)	PCSK9 (2.0)
GO:0032182	small conjugating protein binding	0.15	> 0.20	GRINA (3.7)	RELB (2.7)	HAVCR1 (2.4)	MAU2 (2.1)	PARP10 (1.8)	ATXN2 (1.8)	PSMA5 (1.7)	SARS (1.7)	TMEM57 (1.7)	BRAP (1.6)
MP:0005058	abnormal lysosome morphology	0.15	> 0.20	ERP29 (4.9)	TMEM50A (3.0)	SORT1 (3.0)	ATP13A1 (2.8)	COL4A3BP (2.6)	MAFB (2.3)	NT5DC1 (2.2)	CYB561D1 (2.1)	PSRC1 (2.1)	PLCG1 (2.0)
ENSG00000158987	RAPGEF6 PPI subnetwork	0.15	> 0.20	C1orf63 (3.5)	DYNC2LI1 (3.2)	MYLIP (2.8)	BRAP (2.8)	C12orf43 (2.8)	PLEKHH2 (2.7)	BLOC1S3 (2.2)	ZHX3 (2.1)	C17orf57 (1.7)	TRAFD1 (1.6)
ENSG00000135144	DTX1 PPI subnetwork	0.15	> 0.20	PBX4 (2.9)	PARP10 (2.7)	ENSG00000226645 (2.5)	ENSG00000254235 (2.5)	MAFB (2.1)	NKPD1 (2.1)	ABO (2.0)	PLEC (1.8)	TOP1 (1.7)	NYNRIN (1.7)
ENSG00000105698	USF2 PPI subnetwork	0.15	> 0.20	MAFB (3.5)	TRIB1 (3.0)	ATXN7L2 (2.3)	CEACAM19 (2.3)	BCL3 (1.8)	PPP1R37 (1.5)	TOP1 (1.5)	CLPTM1 (1.5)	HP (1.4)	TOMM40 (1.4)
GO:0010035	response to inorganic substance	0.15	> 0.20	RHD (2.6)	HP (2.1)	RHCE (1.9)	TM6SF2 (1.9)	SLC22A1 (1.8)	ABCG5 (1.8)	ADAM1 (1.8)	GOT2P1 (1.8)	ALDH2 (1.7)	ANGPTL3 (1.7)
GO:0004861	cyclin-dependent protein kinase inhibitor activity	0.15	> 0.20	MYLIP (2.5)	ENSG00000254235 (2.3)	SORT1 (2.0)	TMED4 (2.0)	ITGB3 (1.8)	SLC44A2 (1.7)	HLX (1.7)	PARP10 (1.6)	C1orf63 (1.6)	MAFB (1.6)
ENSG00000173207	CKS1B PPI subnetwork	0.15	> 0.20	TRIB1 (3.3)	PSRC1 (3.1)	LPA (2.2)	SLC22A1 (2.2)	GCNT4 (1.8)	FEN1 (1.7)	APOA5 (1.7)	HLX (1.7)	NKPD1 (1.6)	BRAP (1.6)
ENSG00000103187	COTL1 PPI subnetwork	0.15	> 0.20	ACAD10 (2.6)	C19orf52 (2.6)	C12orf43 (2.4)	TMED4 (2.3)	LPIN3 (2.2)	C12orf47 (2.2)	BRAP (2.1)	ENSG00000238078 (2.0)	GMPR (2.0)	TMEM116 (1.9)
GO:0002684	positive regulation of immune system process	0.15	> 0.20	TIMD4 (4.1)	ZNF101 (3.4)	CETP (2.9)	GMIP (2.8)	CYB561D1 (2.1)	MAFB (2.1)	LPA (2.1)	RELB (2.0)	BCL3 (1.7)	PBX4 (1.7)
MP:0008484	decreased spleen germinal center size	0.15	> 0.20	RELB (3.4)	CETP (3.1)	GMIP (3.0)	CLPTM1 (2.5)	TIMD4 (2.5)	HAVCR1 (2.3)	PVRL2 (2.2)	ZNF101 (2.1)	APOE (1.8)	ATP13A1 (1.5)
ENSG00000012223	LTF PPI subnetwork	0.15	> 0.20	MAFB (5.3)	APOE (3.0)	KIAA1324 (2.6)	LPA (2.3)	APOC1 (2.2)	ALDH2 (2.0)	ADAM1 (1.9)	NPC1L1 (1.9)	DOCK7 (1.9)	TRIB1 (1.9)
MP:0008973	decreased erythroid progenitor cell number	0.15	> 0.20	TOP1 (2.8)	RHD (2.5)	RHCE (2.5)	C12orf51 (2.2)	TRIB1 (2.1)	SH2B3 (2.1)	TMEM57 (2.0)	HLX (1.9)	ATXN2 (1.8)	OASL (1.7)
ENSG00000142208	AKT1 PPI subnetwork	0.15	> 0.20	BCL3 (2.9)	PTPN11 (2.8)	TRIB1 (2.6)	RELB (2.4)	PLEC (2.0)	SH2B3 (1.9)	DNM2 (1.8)	KANK2 (1.8)	MAU2 (1.7)	GRINA (1.7)
GO:0046112	nucleobase biosynthetic process	0.15	> 0.20	DHODH (3.6)	ANKRD31 (2.9)	TXNL4B (2.5)	ENSG00000228044 (2.4)	QTRT1 (2.2)	NKPD1 (1.8)	ENSG00000226648 (1.6)	ENSG00000235545 (1.6)	LPA (1.5)	ACAD10 (1.5)
ENSG00000163283	ALPP PPI subnetwork	0.15	> 0.20	BRAP (2.3)	SORT1 (2.2)	YIPF2 (2.2)	USP24 (2.0)	C19orf52 (1.9)	SUGP1 (1.8)	DHX38 (1.8)	GRINA (1.8)	ATP13A1 (1.8)	TMEM57 (1.7)
ENSG00000163629	PTPN13 PPI subnetwork	0.15	> 0.20	SLC44A2 (3.3)	BCAM (2.6)	PLEC (2.5)	PBX4 (2.3)	ENSG00000238078 (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	CBLC (1.8)	LPAR2 (1.7)	UBXN2B (1.6)
MP:0011346	renal tubule atrophy	0.15	> 0.20	TMED4 (3.2)	PLG (2.8)	BCAM (2.6)	PLEKHH2 (2.3)	NT5DC1 (2.2)	HNF1A (2.0)	C17orf57 (2.0)	ABCG5 (2.0)	ERP29 (1.5)	APOB (1.4)
REACTOME_CASPASE:MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	REACTOME_CASPASE:MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	0.15	> 0.20	PARP10 (2.8)	FRK (2.6)	ACAD10 (1.9)	C12orf51 (1.9)	PLEC (1.8)	HLX (1.8)	ZNF101 (1.7)	OGDH (1.6)	SH2B3 (1.6)	ANKRD31 (1.4)
ENSG00000100911	PSME2 PPI subnetwork	0.15	> 0.20	PSMA5 (6.4)	TRAFD1 (3.7)	NT5DC1 (2.4)	NAA25 (2.2)	TOMM40 (1.8)	PARP10 (1.7)	SUGP1 (1.6)	DDX56 (1.6)	TMEM50A (1.4)	ABCG8 (1.2)
MP:0002813	microcytosis	0.15	> 0.20	RHD (11.8)	RHCE (10.9)	GMPR (4.2)	C12orf51 (2.8)	GRINA (2.3)	ABO (1.9)	ADAM1 (1.7)	RPH3A (1.5)	USP24 (1.5)	ERP29 (1.4)
GO:0042035	regulation of cytokine biosynthetic process	0.15	> 0.20	ENSG00000228044 (2.3)	ENSG00000226645 (1.9)	GMIP (1.7)	BCL3 (1.6)	TIMD4 (1.6)	HLX (1.6)	DNAH11 (1.5)	RELB (1.4)	PVR (1.3)	TRIB1 (1.3)
GO:0016813	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	0.15	> 0.20	HP (3.4)	MOSC1 (2.7)	PLG (2.5)	CBLC (2.3)	AP1M2 (2.0)	ANGPTL3 (2.0)	PMFBP1 (1.9)	SLC44A2 (1.9)	PBX4 (1.9)	ABCG8 (1.7)
MP:0000696	abnormal Peyer's patch morphology	0.15	> 0.20	RELB (6.3)	BCL3 (5.5)	GMIP (5.1)	GRINA (3.6)	PBX4 (2.7)	PLEC (2.4)	PARP10 (2.3)	CLPTM1 (2.3)	CETP (1.9)	UBXN2B (1.9)
ENSG00000129347	KRI1 PPI subnetwork	0.15	> 0.20	ZNF259 (4.6)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.0)	ILF3 (2.7)	DHX38 (2.7)	ATP13A1 (2.5)	TOP1 (2.4)
ENSG00000147130	ZMYM3 PPI subnetwork	0.15	> 0.20	SMARCA4 (3.2)	MARK4 (2.8)	TOP1 (2.2)	DNM2 (2.2)	NT5DC1 (2.1)	GATAD2A (1.8)	ATXN2 (1.8)	BUD13 (1.6)	TMEM57 (1.5)	TSSK6 (1.5)
MP:0002833	increased heart weight	0.15	> 0.20	BCAM (3.0)	CEACAM19 (2.2)	OGDH (2.1)	SYPL2 (2.0)	SORT1 (2.0)	GPAM (1.7)	GMPR (1.5)	TMEM116 (1.5)	PVRL2 (1.5)	PLEC (1.3)
ENSG00000117751	PPP1R8 PPI subnetwork	0.15	> 0.20	BRAP (2.8)	FADS2 (2.7)	ENSG00000238078 (2.1)	USP1 (2.0)	BUD13 (2.0)	CYP7A1 (2.0)	FADS1 (1.9)	TIMD4 (1.7)	SUGP1 (1.7)	CARM1 (1.5)
ENSG00000100722	ZC3H14 PPI subnetwork	0.15	> 0.20	BRAP (3.8)	NAA25 (3.3)	MAPKAPK5 (3.3)	DDX56 (2.9)	QTRT1 (2.9)	PTPN11 (2.8)	ATXN2 (2.3)	SUGP1 (1.9)	AMIGO1 (1.8)	DHX38 (1.8)
ENSG00000107560	RAB11FIP2 PPI subnetwork	0.15	> 0.20	CARM1 (3.7)	AP1M2 (3.4)	LPAR2 (3.4)	DNM2 (3.2)	CBLC (3.2)	COL4A3BP (2.8)	ZHX3 (2.7)	PLEC (2.7)	OGDH (2.5)	MAU2 (2.4)
ENSG00000175084	DES PPI subnetwork	0.15	> 0.20	SYPL2 (4.6)	BLOC1S3 (2.1)	GOT2P1 (1.8)	PLEC (1.7)	ST3GAL4 (1.7)	BCAM (1.7)	GMPR (1.4)	C17orf57 (1.4)	PVR (1.3)	CELSR2 (1.3)
GO:0014044	Schwann cell development	0.15	> 0.20	ENSG00000226645 (3.7)	DNAH11 (3.1)	PBX4 (2.2)	AMIGO1 (2.1)	ZHX3 (1.8)	KANK2 (1.6)	ENSG00000226648 (1.5)	ZNF101 (1.5)	ST3GAL4 (1.4)	COL4A3BP (1.4)
ENSG00000164327	RICTOR PPI subnetwork	0.15	> 0.20	CBLC (4.2)	AP1M2 (3.2)	DHX38 (2.8)	PVRL2 (2.0)	DOCK7 (1.9)	ENSG00000226648 (1.9)	CARM1 (1.9)	DNM2 (1.8)	CELSR2 (1.6)	PSRC1 (1.6)
GO:0000178	exosome (RNase complex)	0.15	> 0.20	DHODH (3.6)	POC5 (2.7)	DDX56 (2.7)	MAPKAPK5 (2.3)	SUGP1 (2.2)	DHX38 (2.0)	QTRT1 (2.0)	TOMM40 (1.9)	NT5DC1 (1.9)	C12orf43 (1.8)
ENSG00000143401	ANP32E PPI subnetwork	0.15	> 0.20	TMED4 (2.9)	QTRT1 (2.6)	TOMM40 (2.4)	DHODH (2.3)	DDX56 (2.3)	POC5 (2.1)	HMGCR (1.9)	BLOC1S3 (1.9)	ATXN2 (1.9)	ZNF180 (1.7)
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	0.15	> 0.20	ZHX3 (2.8)	NT5DC1 (2.3)	HP (2.3)	TM6SF2 (2.2)	SYPL2 (1.8)	OGDH (1.8)	LPIN3 (1.5)	FADS2 (1.5)	ITGB3 (1.3)	ZNF259 (1.3)
GO:0031058	positive regulation of histone modification	0.15	> 0.20	TMEM57 (3.2)	PCSK9 (2.3)	SH2B3 (2.1)	FADS2 (2.0)	FADS1 (2.0)	DNM2 (1.9)	C12orf51 (1.9)	MYLIP (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.4)
REACTOME_SLC:MEDIATED_TRANSMEMBRANE_TRANSPORT	REACTOME_SLC:MEDIATED_TRANSMEMBRANE_TRANSPORT	0.15	> 0.20	TM6SF2 (3.4)	TMEM116 (3.0)	PLG (3.0)	ANGPTL3 (2.6)	SORT1 (2.5)	ATP13A1 (2.4)	CLPTM1 (2.1)	ABCG8 (2.0)	NPC1L1 (1.8)	NCAN (1.6)
ENSG00000159110	IFNAR2 PPI subnetwork	0.15	> 0.20	BCL3 (3.4)	OASL (3.2)	PARP10 (2.3)	COL4A3BP (2.2)	TRAFD1 (2.0)	CYP7A1 (1.7)	C17orf57 (1.7)	RELB (1.5)	ZNF101 (1.5)	BCAM (1.3)
ENSG00000113569	NUP155 PPI subnetwork	0.15	> 0.20	USP1 (3.0)	BUD13 (3.0)	DOCK7 (3.0)	DDX56 (3.0)	NAA25 (3.0)	POC5 (2.8)	ZNF259 (2.7)	ILF3 (2.5)	CARM1 (2.3)	FEN1 (2.0)
ENSG00000120705	ETF1 PPI subnetwork	0.15	> 0.20	NKPD1 (4.1)	GPAM (2.4)	MOSC1 (2.2)	BRAP (2.1)	PTPN11 (2.1)	DHX38 (2.0)	NAA25 (1.9)	DHODH (1.8)	CEACAM19 (1.7)	GATAD2A (1.7)
ENSG00000166402	TUB PPI subnetwork	0.15	> 0.20	ZHX3 (3.9)	COL4A3BP (2.9)	ZNF101 (2.2)	ABCG8 (2.1)	DNM2 (1.9)	GMIP (1.8)	ALDH2 (1.7)	MAFB (1.6)	LPAR2 (1.6)	PLCG1 (1.6)
ENSG00000204351	SKIV2L PPI subnetwork	0.15	> 0.20	TOMM40 (4.3)	DDX56 (4.2)	NAA25 (4.1)	ZNF259 (3.9)	DHODH (3.5)	USP24 (3.5)	QTRT1 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	SUGP1 (1.9)
ENSG00000206267	ENSG00000206267 PPI subnetwork	0.15	> 0.20	TOMM40 (4.3)	DDX56 (4.2)	NAA25 (4.1)	ZNF259 (3.9)	DHODH (3.5)	USP24 (3.5)	QTRT1 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	SUGP1 (1.9)
ENSG00000196961	AP2A1 PPI subnetwork	0.15	> 0.20	SMARCA4 (2.8)	C1orf63 (2.7)	KANK2 (2.2)	DNM2 (2.1)	ZNF101 (2.1)	PLEC (2.0)	TOP1 (2.0)	GRINA (2.0)	DOCK7 (1.9)	CETP (1.9)
GO:0051235	maintenance of location	0.15	> 0.20	TIMD4 (2.5)	CLPTM1 (2.0)	CETP (2.0)	ZNF101 (1.9)	RHD (1.8)	GRINA (1.7)	OGDH (1.6)	C17orf57 (1.5)	RHCE (1.4)	RPH3A (1.4)
MP:0004057	thin myocardium compact layer	0.15	> 0.20	HLX (2.7)	HNF1A (2.5)	SH2B3 (1.9)	C12orf51 (1.8)	NCAN (1.7)	MAPKAPK5 (1.6)	ALDH2 (1.5)	MYLIP (1.5)	C1orf63 (1.5)	BLOC1S3 (1.4)
ENSG00000142273	CBLC PPI subnetwork	0.15	> 0.20	BCL3 (3.6)	HLX (3.4)	RELB (3.1)	CETP (2.7)	GMIP (2.7)	SH2B3 (2.4)	TIMD4 (2.0)	ALDH2 (1.7)	LPA (1.6)	TRIB1 (1.5)
ENSG00000146535	GNA12 PPI subnetwork	0.15	> 0.20	DNM2 (2.8)	CLPTM1 (2.6)	HLX (1.9)	ITGB3 (1.9)	TOMM40 (1.9)	MARK4 (1.9)	MAFB (1.7)	TOP1 (1.6)	PTPN11 (1.5)	SLC44A2 (1.5)
GO:0043296	apical junction complex	0.15	> 0.20	AP1M2 (6.6)	CBLC (4.9)	PVRL2 (4.1)	FRK (3.4)	BCAM (3.4)	PVR (2.2)	DYNC2LI1 (2.1)	LPAR2 (2.0)	PLEKHH2 (1.9)	C11orf9 (1.8)
ENSG00000182498	ENSG00000182498 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
ENSG00000206212	ENSG00000206212 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
ENSG00000096150	RPS18 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
MP:0004154	renal tubular necrosis	0.15	> 0.20	RHD (5.2)	RHCE (3.9)	DNAH11 (3.8)	MAFB (2.9)	CETP (2.3)	TIMD4 (2.1)	ABCG5 (2.1)	NPC1L1 (1.7)	C12orf51 (1.7)	GATAD2A (1.6)
REACTOME_DEFENSINS	REACTOME_DEFENSINS	0.15	> 0.20	PMFBP1 (3.5)	ABCG5 (2.7)	TSSK6 (1.9)	APOB (1.7)	NKPD1 (1.6)	SYPL2 (1.4)	ALDH2 (1.4)	TM6SF2 (1.3)	NPC1L1 (1.1)	HP (1.1)
ENSG00000173567	GPR113 PPI subnetwork	0.15	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.5)	PLEKHH2 (1.9)	TMEM57 (1.9)	DNAH11 (1.6)	C1orf63 (1.5)	SLC44A2 (1.5)	POLK (1.3)	CEACAM19 (1.3)
MP:0008014	increased lung tumor incidence	0.15	> 0.20	DNM2 (2.6)	TSSK6 (2.6)	FEN1 (2.2)	USP1 (2.1)	PSRC1 (2.0)	SORT1 (1.9)	LPIN3 (1.8)	ACAD10 (1.8)	DHX38 (1.7)	ZNF180 (1.7)
MP:0008135	small Peyer's patches	0.15	> 0.20	RELB (6.1)	BCL3 (4.0)	TIMD4 (4.0)	GMIP (3.7)	CETP (2.8)	PARP10 (2.7)	OASL (2.1)	ENSG00000235545 (1.9)	GRINA (1.8)	KIAA1324 (1.4)
ENSG00000197063	MAFG PPI subnetwork	0.15	> 0.20	TRIB1 (4.2)	BCL3 (2.6)	MAFB (2.5)	RELB (2.4)	TXNL4B (2.4)	HLX (2.4)	GCNT4 (2.4)	POC5 (2.0)	LPAR2 (1.8)	TMEM116 (1.6)
ENSG00000088826	SMOX PPI subnetwork	0.15	> 0.20	ATP13A1 (3.6)	HNF1A (2.9)	MAPKAPK5 (2.9)	DDX56 (2.7)	BRAP (2.3)	ADAM1 (2.2)	PTPN11 (2.2)	DHODH (2.0)	ANKRD31 (2.0)	MAU2 (1.8)
ENSG00000095485	CWF19L1 PPI subnetwork	0.15	> 0.20	NT5DC1 (3.4)	ENSG00000226645 (3.2)	ZNF259 (3.0)	DYNC2LI1 (2.5)	SARS (2.1)	ATXN7L2 (2.1)	BRAP (1.9)	FRK (1.8)	YIPF2 (1.6)	TXNL4B (1.6)
GO:0046685	response to arsenic-containing substance	0.15	> 0.20	RHCE (5.4)	RHD (5.0)	FRK (4.1)	POLK (2.2)	HAVCR1 (2.1)	TXNL4B (2.1)	C19orf52 (1.5)	ENSG00000228044 (1.3)	GOT2P1 (1.3)	GEMIN7 (1.3)
REACTOME_P75NTR_SIGNALS_VIA_NF:KB	REACTOME_P75NTR_SIGNALS_VIA_NF:KB	0.15	> 0.20	RELB (5.9)	BCL3 (3.7)	PVR (2.8)	PARP10 (2.8)	SH2B3 (2.0)	GMIP (1.9)	GATAD2A (1.8)	BLOC1S3 (1.5)	TRIB1 (1.4)	GRINA (1.4)
MP:0002371	abnormal thymus cortex morphology	0.15	> 0.20	PBX4 (4.1)	FADS1 (3.7)	ZNF101 (3.5)	RELB (3.4)	PLCG1 (3.3)	BCL3 (3.1)	LDLR (2.7)	LPAR2 (2.2)	HMGCR (2.0)	FRK (2.0)
ENSG00000123358	NR4A1 PPI subnetwork	0.15	> 0.20	UBXN2B (2.8)	TRIB1 (2.6)	MYLIP (2.5)	PLEC (2.4)	MARK4 (2.2)	SH2B3 (2.1)	BLOC1S3 (2.0)	OGDH (1.9)	CARM1 (1.9)	DNM2 (1.8)
ENSG00000125107	CNOT1 PPI subnetwork	0.15	> 0.20	BRAP (2.8)	BUD13 (2.5)	FRK (2.5)	LPIN3 (2.3)	ATXN2 (2.3)	ENSG00000228044 (2.2)	SARS (1.9)	FEN1 (1.8)	ENSG00000254235 (1.7)	TOP1 (1.7)
REACTOME_SIGNALING_BY_INTERLEUKINS	REACTOME_SIGNALING_BY_INTERLEUKINS	0.15	> 0.20	BCL3 (4.8)	RELB (4.0)	GMIP (3.2)	HLX (2.8)	GRINA (2.4)	DNM2 (2.3)	CYB561D1 (2.1)	PARP10 (2.1)	SH2B3 (1.8)	TRAFD1 (1.7)
GO:0019955	cytokine binding	0.15	> 0.20	HLX (3.7)	TIMD4 (3.6)	PVR (2.3)	ZNF101 (2.1)	ENSG00000235545 (1.8)	CYB561D1 (1.8)	ANKRD31 (1.7)	CEACAM19 (1.7)	BCL3 (1.5)	GPAM (1.5)
GO:0042982	amyloid precursor protein metabolic process	0.15	> 0.20	NKPD1 (2.7)	DNAH11 (2.7)	CLPTM1 (2.6)	CYB561D1 (2.5)	CEACAM19 (2.4)	TMEM50A (2.3)	ST3GAL4 (2.0)	TMEM57 (1.9)	SLC44A2 (1.8)	SORT1 (1.8)
GO:0034470	ncRNA processing	0.15	> 0.20	QTRT1 (3.7)	DHODH (3.6)	DDX56 (3.6)	NAA25 (3.5)	ZNF259 (3.4)	C12orf43 (3.1)	TOMM40 (2.7)	MAPKAPK5 (2.6)	C19orf52 (2.5)	POC5 (2.4)
MP:0002264	abnormal bronchus morphology	0.16	> 0.20	C17orf57 (3.3)	PVR (2.4)	TMED4 (2.1)	C12orf47 (1.9)	PLCG1 (1.9)	TMEM57 (1.7)	SMARCA4 (1.6)	TRIB1 (1.6)	RELB (1.6)	CEACAM19 (1.5)
ENSG00000101966	XIAP PPI subnetwork	0.16	> 0.20	TRAFD1 (3.0)	PARP10 (2.7)	ST3GAL4 (2.6)	UBXN2B (2.5)	NT5DC1 (1.8)	FRK (1.7)	ENSG00000226645 (1.7)	OASL (1.7)	C1orf63 (1.5)	PTPN11 (1.3)
ENSG00000151148	UBE3B PPI subnetwork	0.16	> 0.20	PSMA5 (4.6)	SUGP1 (3.5)	TOMM40 (2.8)	NAA25 (2.7)	DDX56 (2.4)	SARS (2.1)	ZNF180 (2.0)	TXNL4B (1.9)	CLPTM1 (1.9)	C12orf43 (1.7)
ENSG00000204469	PRRC2A PPI subnetwork	0.16	> 0.20	ERP29 (2.4)	C19orf52 (2.3)	QTRT1 (2.2)	CLPTM1 (2.1)	ACAD10 (2.1)	PLEC (2.0)	ATP13A1 (1.9)	ATXN7L2 (1.8)	HP (1.7)	GRINA (1.7)
GO:0033687	osteoblast proliferation	0.16	> 0.20	SLC44A2 (4.1)	PLEKHH2 (3.4)	ENSG00000238078 (3.1)	DYNC2LI1 (1.8)	GCNT4 (1.8)	OASL (1.7)	ST3GAL4 (1.7)	YIPF2 (1.6)	HAVCR1 (1.6)	ENSG00000235545 (1.5)
ENSG00000125743	SNRPD2 PPI subnetwork	0.16	> 0.20	ILF3 (3.7)	QTRT1 (3.2)	TOP1 (3.1)	BUD13 (3.0)	SUGP1 (3.0)	DHX38 (2.9)	USP1 (2.7)	SMARCA4 (2.7)	C1orf63 (2.5)	FEN1 (2.4)
GO:0034968	histone lysine methylation	0.16	> 0.20	C12orf51 (3.4)	MAU2 (2.5)	ZNF180 (2.4)	ATXN2 (2.2)	USP24 (2.1)	ANKRD31 (2.0)	C19orf52 (1.8)	C1orf63 (1.7)	GOT2P1 (1.6)	BUD13 (1.6)
GO:0030544	Hsp70 protein binding	0.16	> 0.20	HMGCR (5.2)	LDLR (4.1)	FADS2 (3.9)	PCSK9 (3.8)	FADS1 (3.6)	GRINA (3.0)	RHD (2.9)	RHCE (2.8)	CARM1 (2.7)	CYP7A1 (2.6)
ENSG00000129048	CCRL1 PPI subnetwork	0.16	> 0.20	TIMD4 (4.0)	CETP (3.0)	OASL (3.0)	RELB (2.9)	TM6SF2 (2.0)	NPC1L1 (2.0)	MAFB (1.9)	BCL3 (1.8)	PVRL2 (1.7)	PVR (1.5)
ENSG00000105953	OGDH PPI subnetwork	0.16	> 0.20	ATP13A1 (3.7)	CLPTM1 (3.5)	OGDH (3.5)	QTRT1 (3.4)	GATAD2A (3.0)	C19orf52 (2.7)	DDX56 (2.3)	TXNL4B (2.3)	YIPF2 (2.3)	BRAP (2.1)
ENSG00000135968	GCC2 PPI subnetwork	0.16	> 0.20	MAPKAPK5 (3.0)	HNF1A (2.5)	BRAP (2.4)	CEACAM19 (2.3)	TOMM40 (2.3)	ATP13A1 (2.2)	MAU2 (2.1)	ADAM1 (2.0)	DHODH (1.9)	CETP (1.9)
ENSG00000186432	KPNA4 PPI subnetwork	0.16	> 0.20	USP1 (2.8)	FADS2 (2.5)	FADS1 (2.5)	ATXN7L2 (2.4)	PCSK9 (2.3)	TMEM116 (2.2)	C12orf43 (2.1)	FEN1 (2.0)	ST3GAL4 (1.9)	ALDH2 (1.8)
ENSG00000105723	GSK3A PPI subnetwork	0.16	> 0.20	TRIB1 (3.9)	MARK4 (3.2)	GMIP (2.6)	GRINA (2.4)	SH2B3 (2.2)	PVRL2 (2.2)	MAPKAPK5 (2.2)	MAFB (1.9)	CARM1 (1.8)	UBXN2B (1.7)
ENSG00000135597	REPS1 PPI subnetwork	0.16	> 0.20	KIAA1324 (2.8)	GMIP (2.5)	LPAR2 (2.5)	PLEC (2.2)	GATAD2A (2.1)	ABO (1.9)	AP1M2 (1.8)	ST3GAL4 (1.7)	ANKRD31 (1.7)	COL4A3BP (1.7)
GO:0004745	retinol dehydrogenase activity	0.16	> 0.20	SLC22A1 (4.2)	CYP7A1 (3.8)	LPA (3.8)	APOC4 (3.4)	APOA5 (3.3)	MOSC1 (2.3)	TM6SF2 (2.3)	ANGPTL3 (2.1)	PCSK9 (2.1)	ABCG5 (2.1)
ENSG00000151748	SAV1 PPI subnetwork	0.16	> 0.20	CBLC (5.2)	AP1M2 (4.0)	PVRL2 (3.1)	CELSR2 (2.7)	PSRC1 (2.5)	DHX38 (2.5)	GOT2P1 (2.0)	FRK (2.0)	ST3GAL4 (1.9)	ANKRD31 (1.7)
ENSG00000111640	GAPDH PPI subnetwork	0.16	> 0.20	PLEC (2.5)	SARS (2.4)	PSMA5 (2.1)	SMARCA4 (2.1)	TOMM40 (2.1)	DOCK7 (2.0)	NAA25 (2.0)	COL4A3BP (1.9)	HMGCR (1.9)	OGDH (1.7)
ENSG00000176273	SLC35G1 PPI subnetwork	0.16	> 0.20	LDLR (8.6)	FADS1 (7.7)	FADS2 (6.9)	HMGCR (6.6)	PCSK9 (4.2)	ATP13A1 (2.8)	ERP29 (2.6)	TMEM57 (2.5)	SORT1 (2.2)	TMEM50A (2.0)
ENSG00000137876	RSL24D1 PPI subnetwork	0.16	> 0.20	ZNF259 (5.2)	NAA25 (4.1)	DDX56 (3.8)	TOMM40 (3.8)	DHODH (3.2)	QTRT1 (3.1)	MAPKAPK5 (2.5)	C12orf43 (2.5)	ENSG00000226645 (2.2)	DHX38 (1.9)
ENSG00000163453	IGFBP7 PPI subnetwork	0.16	> 0.20	CILP2 (6.3)	OASL (3.1)	PVR (2.7)	BCAM (2.2)	PVRL2 (2.0)	CETP (1.9)	RELB (1.5)	MYLIP (1.5)	SLC22A1 (1.4)	ANKRD31 (1.4)
ENSG00000152818	UTRN PPI subnetwork	0.16	> 0.20	ACAD10 (3.2)	HNF1A (3.0)	KANK2 (2.5)	ERP29 (2.2)	NT5DC1 (2.2)	PLCG1 (2.1)	SYPL2 (2.0)	ENSG00000235545 (1.8)	C17orf57 (1.8)	PTPN11 (1.8)
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	0.16	> 0.20	ZHX3 (2.8)	ZNF180 (2.3)	CLPTM1 (2.3)	MARK4 (2.0)	TRIB1 (2.0)	UBXN2B (1.7)	TOMM40 (1.7)	MAU2 (1.7)	SARS (1.6)	HLX (1.6)
ENSG00000206181	TCEB3B PPI subnetwork	0.16	> 0.20	FRK (3.1)	LPAR2 (3.0)	YIPF2 (2.5)	ANKRD31 (2.4)	PBX4 (2.3)	HAVCR1 (2.3)	AP1M2 (2.0)	UBXN2B (1.8)	MAU2 (1.8)	SLC44A2 (1.7)
ENSG00000172766	NAA16 PPI subnetwork	0.16	> 0.20	TOMM40 (3.6)	DDX56 (3.4)	NAA25 (3.3)	ZNF259 (2.8)	SUGP1 (2.7)	OGDH (2.5)	DHX38 (2.5)	PSMA5 (2.4)	SMARCA4 (2.3)	QTRT1 (2.3)
ENSG00000142657	PGD PPI subnetwork	0.16	> 0.20	ZNF259 (4.2)	NAA25 (4.0)	DDX56 (3.2)	TOMM40 (3.2)	SARS (2.7)	OGDH (2.6)	ADAM1 (2.5)	QTRT1 (2.2)	PSMA5 (2.1)	MAPKAPK5 (1.9)
ENSG00000051382	PIK3CB PPI subnetwork	0.16	> 0.20	HLX (3.1)	DOCK7 (3.0)	SLC44A2 (2.5)	MYLIP (2.4)	PVRL2 (2.4)	GMIP (2.3)	C1orf63 (2.3)	PPP1R37 (2.2)	DNM2 (2.1)	COL4A3BP (2.1)
GO:0004716	receptor signaling protein tyrosine kinase activity	0.16	> 0.20	SLC44A2 (2.3)	MAFB (1.9)	GPAM (1.7)	NYNRIN (1.6)	HLX (1.6)	NCAN (1.6)	MYLIP (1.5)	TRIB1 (1.5)	USP24 (1.5)	LPIN3 (1.5)
MP:0004499	increased incidence of chemically-induced tumors	0.16	> 0.20	TRIB1 (3.5)	BCL3 (2.8)	NKPD1 (2.8)	PBX4 (2.5)	POLK (2.4)	BRAP (2.1)	C1orf63 (1.8)	MAU2 (1.8)	ENSG00000254235 (1.8)	ALDH2 (1.8)
ENSG00000181467	RAP2B PPI subnetwork	0.16	> 0.20	ACAD10 (4.0)	OGDH (3.1)	TMED4 (2.8)	NT5DC1 (2.7)	HNF1A (2.5)	TRAPPC6A (2.3)	CETP (2.2)	TMEM50A (1.8)	ATXN7L2 (1.7)	GMPR (1.7)
REACTOME_REV:MEDIATED_NUCLEAR_EXPORT_OF_HIV:1_RNA	REACTOME_REV:MEDIATED_NUCLEAR_EXPORT_OF_HIV:1_RNA	0.16	> 0.20	NAA25 (3.7)	POC5 (3.4)	DDX56 (3.2)	USP1 (3.0)	FEN1 (2.4)	ILF3 (2.4)	USP24 (2.3)	DOCK7 (2.3)	BUD13 (2.2)	DHX38 (2.1)
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.16	> 0.20	TIMD4 (3.7)	RELB (3.2)	BCL3 (3.1)	CETP (2.8)	HLX (2.2)	ZNF101 (1.8)	PVR (1.8)	SLC22A1 (1.5)	GMIP (1.2)	PVRL2 (1.2)
ENSG00000099937	SERPIND1 PPI subnetwork	0.16	> 0.20	RHD (4.0)	HP (3.4)	MOSC1 (2.3)	DYNC2LI1 (2.2)	RHCE (2.2)	APOB (2.2)	PLG (2.1)	CILP2 (2.1)	C12orf51 (2.0)	CYP7A1 (1.8)
GO:0008629	induction of apoptosis by intracellular signals	0.16	> 0.20	POLK (3.0)	BLOC1S3 (2.9)	C17orf57 (2.2)	ZNF101 (2.1)	ZNF259 (2.1)	BRAP (2.0)	BUD13 (1.9)	LPIN3 (1.8)	ST3GAL4 (1.5)	TRAFD1 (1.5)
MP:0005553	increased circulating creatinine level	0.16	> 0.20	C17orf57 (2.8)	PLG (2.6)	GRINA (2.1)	PLEKHH2 (2.0)	UBXN2B (2.0)	SYPL2 (2.0)	TMEM57 (1.9)	SLC22A1 (1.9)	BCAM (1.8)	FRK (1.8)
ENSG00000113302	IL12B PPI subnetwork	0.16	> 0.20	BCL3 (4.7)	RELB (4.5)	HLX (3.3)	TRIB1 (2.9)	TIMD4 (2.1)	GMIP (2.0)	PVR (1.9)	ALDH2 (1.8)	CETP (1.8)	ATXN7L2 (1.6)
GO:0019901	protein kinase binding	0.16	> 0.20	RELB (2.5)	PLCG1 (2.4)	DNM2 (2.2)	C11orf9 (2.1)	TRIB1 (2.1)	GMIP (2.1)	PTPN11 (2.0)	NCAN (1.9)	PLEC (1.8)	BCL3 (1.8)
ENSG00000178184	PARD6G PPI subnetwork	0.16	> 0.20	PVRL2 (2.6)	LPAR2 (2.3)	ILF3 (2.0)	PLCG1 (1.9)	C1orf63 (1.9)	BCAM (1.7)	ENSG00000228044 (1.7)	GOT2P1 (1.7)	PSRC1 (1.6)	PVR (1.5)
MP:0000685	abnormal immune system morphology	0.16	> 0.20	RELB (5.1)	BCL3 (4.0)	CETP (4.0)	TIMD4 (3.3)	GMIP (2.6)	TRAFD1 (2.2)	GRINA (2.0)	GEMIN7 (2.0)	HAVCR1 (1.9)	PARP10 (1.9)
ENSG00000119953	SMNDC1 PPI subnetwork	0.16	> 0.20	BUD13 (3.2)	DHX38 (3.1)	ZNF259 (2.8)	DDX56 (2.7)	ANKRD31 (2.7)	ILF3 (2.5)	ATP13A1 (2.2)	TOP1 (2.1)	FADS1 (2.1)	NAA25 (2.1)
MP:0001606	impaired hematopoiesis	0.16	> 0.20	RHCE (4.3)	RHD (3.7)	SH2B3 (2.8)	KANK2 (2.5)	GMPR (2.5)	ITGB3 (2.4)	HLX (1.9)	FADS1 (1.7)	SLC44A2 (1.7)	PARP10 (1.7)
ENSG00000143977	SNRPG PPI subnetwork	0.16	> 0.20	ILF3 (3.8)	BUD13 (3.8)	DHX38 (3.2)	SUGP1 (3.0)	C1orf63 (2.9)	TOP1 (2.8)	QTRT1 (2.4)	DDX56 (2.4)	SMARCA4 (2.4)	USP1 (2.3)
GO:0006732	coenzyme metabolic process	0.16	> 0.20	ACAD10 (4.1)	NT5DC1 (3.2)	GPAM (3.2)	FADS2 (3.0)	DHODH (3.0)	PCSK9 (3.0)	OGDH (2.9)	TRAPPC6A (2.8)	FADS1 (2.8)	MOSC1 (2.5)
GO:0010812	negative regulation of cell-substrate adhesion	0.16	> 0.20	ENSG00000254235 (3.3)	ANKRD31 (2.8)	DNAH11 (2.5)	GCNT4 (2.1)	SLC44A2 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)	HLX (1.6)	PPP1R37 (1.6)	ITGB3 (1.5)
GO:0050927	positive regulation of positive chemotaxis	0.16	> 0.20	ABO (3.5)	PLEKHH2 (2.2)	TMEM116 (2.1)	DNAH11 (1.9)	YIPF2 (1.8)	CYB561D1 (1.6)	ENSG00000226648 (1.5)	PPP1R37 (1.3)	C19orf52 (1.3)	CYP7A1 (1.3)
MP:0004771	increased anti-single stranded DNA antibody level	0.16	> 0.20	ZNF101 (3.9)	C17orf57 (2.9)	POLK (2.7)	PVR (2.6)	ITGB3 (2.5)	TRIB1 (2.4)	GRINA (2.4)	ENSG00000226648 (2.2)	FRK (2.0)	BCL3 (2.0)
ENSG00000169398	PTK2 PPI subnetwork	0.16	> 0.20	SLC44A2 (4.5)	PLEC (3.2)	DNM2 (3.1)	SH2B3 (2.9)	GMIP (2.8)	PVRL2 (2.3)	ZNF101 (2.0)	ITGB3 (1.9)	USP24 (1.8)	C1orf63 (1.8)
GO:0005689	U12-type spliceosomal complex	0.16	> 0.20	GEMIN7 (3.1)	C12orf47 (3.0)	DHX38 (3.0)	C12orf43 (2.6)	BUD13 (2.6)	ZNF180 (2.4)	MAPKAPK5 (2.3)	TRAPPC6A (2.1)	ADAM1 (2.1)	ANKRD31 (1.8)
MP:0000495	abnormal colon morphology	0.16	> 0.20	HLX (3.2)	KIAA1324 (3.0)	BCL3 (2.7)	CBLC (2.4)	ABO (2.3)	CYP7A1 (2.3)	PLEC (2.2)	TRIB1 (2.2)	PLEKHH2 (2.1)	RELB (2.1)
ENSG00000106348	IMPDH1 PPI subnetwork	0.16	> 0.20	TOMM40 (3.5)	QTRT1 (2.7)	CARM1 (2.6)	SUGP1 (2.5)	TOP1 (2.3)	PSMA5 (2.0)	FADS2 (2.0)	ILF3 (2.0)	SMARCA4 (1.9)	DHODH (1.9)
ENSG00000144218	AFF3 PPI subnetwork	0.16	> 0.20	NAA25 (3.0)	ST3GAL4 (2.5)	ITGB3 (2.3)	SORT1 (2.2)	GOT2P1 (2.0)	MAFB (1.8)	SARS (1.8)	GATAD2A (1.8)	ILF3 (1.7)	GRINA (1.6)
ENSG00000159216	RUNX1 PPI subnetwork	0.16	> 0.20	TRIB1 (3.2)	ATXN2 (3.2)	GATAD2A (2.3)	PLCG1 (2.1)	FRK (2.1)	TOP1 (1.9)	HLX (1.9)	C12orf51 (1.8)	SMARCA4 (1.7)	MAFB (1.7)
ENSG00000116044	NFE2L2 PPI subnetwork	0.16	> 0.20	TRIB1 (6.4)	LDLR (2.3)	C1orf63 (1.9)	ENSG00000238078 (1.9)	TRAPPC6A (1.9)	SH2B3 (1.7)	HMGCR (1.7)	DOCK7 (1.7)	BCAM (1.6)	MAU2 (1.6)
GO:0019867	outer membrane	0.16	> 0.20	FADS1 (3.2)	FADS2 (3.0)	GPAM (2.9)	GMPR (2.8)	MOSC1 (2.8)	ALDH2 (2.6)	PTPN11 (2.1)	PCSK9 (2.0)	LPIN3 (2.0)	GRINA (2.0)
GO:0010573	vascular endothelial growth factor production	0.16	> 0.20	PMFBP1 (2.7)	ST3GAL4 (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)	ATXN7L2 (1.3)	OASL (1.3)	PVR (1.3)	TXNL4B (1.3)
GO:0010574	regulation of vascular endothelial growth factor production	0.16	> 0.20	PMFBP1 (2.7)	ST3GAL4 (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)	ATXN7L2 (1.3)	OASL (1.3)	PVR (1.3)	TXNL4B (1.3)
KEGG_SMALL_CELL_LUNG_CANCER	KEGG_SMALL_CELL_LUNG_CANCER	0.16	> 0.20	RELB (4.2)	ITGB3 (3.0)	KANK2 (2.4)	MAU2 (1.9)	ST3GAL4 (1.9)	BCL3 (1.8)	GATAD2A (1.7)	PVRL2 (1.7)	PLEC (1.7)	GMIP (1.6)
MP:0003853	dry skin	0.16	> 0.20	CBLC (4.7)	AP1M2 (4.3)	NKPD1 (4.2)	MOSC1 (2.6)	GPAM (2.5)	HMGCR (2.5)	PLG (2.5)	ENSG00000254235 (2.4)	APOC4 (2.3)	RELB (2.1)
ENSG00000168255	POLR2J3 PPI subnetwork	0.16	> 0.20	GEMIN7 (4.8)	CLPTM1 (3.8)	TOMM40 (2.8)	TRAPPC6A (2.5)	UBXN2B (2.4)	C12orf47 (1.9)	BLOC1S3 (1.6)	TMEM50A (1.6)	GATAD2A (1.6)	TXNL4B (1.5)
ENSG00000197373	ENSG00000197373 PPI subnetwork	0.16	> 0.20	GEMIN7 (4.8)	CLPTM1 (3.8)	TOMM40 (2.8)	TRAPPC6A (2.5)	UBXN2B (2.4)	C12orf47 (1.9)	BLOC1S3 (1.6)	TMEM50A (1.6)	GATAD2A (1.6)	TXNL4B (1.5)
ENSG00000102554	KLF5 PPI subnetwork	0.16	> 0.20	BCL3 (3.2)	SH2B3 (3.1)	RELB (2.9)	CARM1 (2.8)	TRIB1 (2.6)	ATXN2 (2.1)	TOP1 (2.0)	BUD13 (1.8)	PLEC (1.6)	ALDH2 (1.6)
MP:0002123	abnormal hematopoiesis	0.16	> 0.20	ITGB3 (3.7)	SH2B3 (2.7)	RHCE (2.6)	GMIP (2.4)	CETP (2.3)	PTPN11 (2.0)	BCL3 (2.0)	RHD (2.0)	HLX (1.8)	USP24 (1.8)
GO:0030262	apoptotic nuclear change	0.16	> 0.20	C1orf63 (2.5)	POLK (2.3)	ENSG00000238078 (2.3)	TRAPPC6A (2.1)	ENSG00000226645 (2.1)	ST3GAL4 (1.8)	AMIGO1 (1.7)	C19orf52 (1.6)	LPAR2 (1.5)	ZNF101 (1.3)
GO:0050431	transforming growth factor beta binding	0.16	> 0.20	PLEKHH2 (2.3)	KANK2 (1.9)	GPAM (1.9)	SH2B3 (1.8)	ENSG00000235545 (1.8)	PVR (1.7)	NYNRIN (1.6)	BCAM (1.6)	CEACAM19 (1.5)	ALDH2 (1.5)
GO:0060711	labyrinthine layer development	0.16	> 0.20	CBLC (3.7)	ENSG00000228044 (2.6)	ENSG00000235545 (2.2)	ENSG00000226645 (2.1)	C12orf51 (2.1)	ZNF101 (2.0)	MYLIP (2.0)	AP1M2 (1.9)	PVRL2 (1.6)	ENSG00000254235 (1.6)
MP:0006055	abnormal vascular endothelial cell morphology	0.16	> 0.20	SH2B3 (2.6)	HLX (2.3)	ITGB3 (2.1)	SLC44A2 (2.1)	TRIB1 (1.8)	KANK2 (1.8)	PLEC (1.4)	CETP (1.4)	OGDH (1.2)	C17orf57 (1.2)
MP:0003141	cardiac fibrosis	0.16	> 0.20	TRIB1 (2.9)	SYPL2 (2.7)	NPC1L1 (2.4)	ABCG8 (2.3)	APOB (2.3)	TM6SF2 (2.2)	PVR (1.6)	ABO (1.6)	PTPN11 (1.5)	BCAM (1.5)
GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	0.16	> 0.20	FADS1 (4.2)	ALDH2 (4.0)	FADS2 (3.9)	SLC22A1 (2.7)	TRAPPC6A (2.6)	GPAM (2.1)	APOC1 (2.1)	ABCG5 (2.1)	ACAD10 (2.1)	CYP7A1 (1.8)
ENSG00000101082	SLA2 PPI subnetwork	0.16	> 0.20	APOB (2.9)	APOC1 (2.8)	HAVCR1 (2.5)	TMEM50A (2.4)	ZNF101 (2.4)	LPIN3 (2.3)	ITGB3 (2.3)	PLCG1 (2.3)	LPAR2 (1.8)	C1orf63 (1.8)
ENSG00000165025	SYK PPI subnetwork	0.16	> 0.20	GMIP (5.2)	DNM2 (3.3)	MAFB (2.8)	SLC44A2 (2.6)	SH2B3 (2.4)	APOE (2.3)	OGDH (1.8)	CYB561D1 (1.8)	MAU2 (1.7)	TIMD4 (1.6)
ENSG00000134352	IL6ST PPI subnetwork	0.16	> 0.20	BCL3 (3.8)	COL4A3BP (2.2)	PVR (2.1)	BCAM (2.0)	HLX (1.8)	CYP7A1 (1.7)	SLC22A1 (1.7)	RELB (1.6)	C17orf57 (1.4)	ENSG00000238078 (1.3)
ENSG00000100764	PSMC1 PPI subnetwork	0.16	> 0.20	PSMA5 (5.6)	NT5DC1 (2.8)	TOMM40 (2.4)	NAA25 (2.0)	TRAFD1 (2.0)	OGDH (1.7)	ENSG00000254235 (1.6)	SARS (1.5)	CLPTM1 (1.4)	DDX56 (1.3)
ENSG00000113272	THG1L PPI subnetwork	0.16	> 0.20	USP24 (2.9)	PSMA5 (2.2)	POLK (2.0)	TMEM57 (2.0)	CYP7A1 (2.0)	UBXN2B (1.9)	HNF1A (1.7)	PBX4 (1.7)	ERP29 (1.5)	ENSG00000254235 (1.4)
MP:0002682	decreased mature ovarian follicle number	0.16	> 0.20	FADS1 (4.0)	ANKRD31 (3.9)	PLEKHH2 (2.7)	LDLR (2.1)	CYP7A1 (2.1)	TRAPPC6A (1.9)	MAU2 (1.7)	ENSG00000238078 (1.6)	PCSK9 (1.6)	BRAP (1.5)
ENSG00000185043	CIB1 PPI subnetwork	0.16	> 0.20	ITGB3 (3.9)	OASL (3.2)	TRIB1 (2.4)	LPIN3 (2.4)	GCNT4 (2.3)	PLCG1 (2.2)	GMPR (2.2)	POLK (2.1)	ABO (2.0)	ATXN2 (1.9)
MP:0010454	abnormal truncus arteriosus septation	0.16	> 0.20	NYNRIN (3.1)	BCAM (2.4)	C11orf9 (2.2)	TRIB1 (2.1)	TRAPPC6A (1.9)	TMED4 (1.9)	DOCK7 (1.8)	PLCG1 (1.7)	ENSG00000238078 (1.7)	MAFB (1.6)
ENSG00000100596	SPTLC2 PPI subnetwork	0.16	> 0.20	ZNF180 (2.7)	CLPTM1 (2.3)	USP24 (2.3)	C12orf47 (2.2)	MAU2 (2.0)	POLK (1.8)	NKPD1 (1.8)	BCL3 (1.6)	LPAR2 (1.6)	SLC44A2 (1.5)
GO:0051597	response to methylmercury	0.16	> 0.20	RHCE (6.0)	RHD (5.8)	ANKRD31 (2.3)	DNAH11 (2.1)	C12orf51 (1.9)	GMPR (1.7)	ZNF180 (1.5)	CEACAM19 (1.4)	COL4A3BP (1.3)	BLOC1S3 (1.3)
GO:0010906	regulation of glucose metabolic process	0.16	> 0.20	ENSG00000254235 (4.1)	LPA (2.8)	HNF1A (2.6)	CYP7A1 (2.3)	GPAM (2.2)	PCSK9 (1.9)	KANK2 (1.9)	ZHX3 (1.7)	ZNF180 (1.6)	MOSC1 (1.5)
ENSG00000161395	PGAP3 PPI subnetwork	0.16	> 0.20	TMEM50A (3.6)	TMED4 (3.6)	CLPTM1 (3.3)	ERP29 (3.2)	YIPF2 (3.0)	ATP13A1 (3.0)	LPAR2 (2.2)	MAU2 (2.2)	HAVCR1 (2.1)	SORT1 (1.8)
ENSG00000137767	SQRDL PPI subnetwork	0.16	> 0.20	PLEC (3.0)	ATP13A1 (2.8)	ENSG00000226648 (2.2)	ENSG00000235545 (2.0)	FADS2 (1.9)	ATXN2 (1.8)	POLK (1.6)	SLC44A2 (1.6)	NYNRIN (1.6)	ST3GAL4 (1.6)
KEGG_PHENYLALANINE_METABOLISM	KEGG_PHENYLALANINE_METABOLISM	0.16	> 0.20	PLG (4.9)	ANGPTL3 (3.8)	APOA5 (3.7)	MOSC1 (3.6)	ALDH2 (3.3)	SLC22A1 (3.0)	HP (3.0)	APOC4 (3.0)	FRK (2.1)	APOB (1.8)
ENSG00000115946	PNO1 PPI subnetwork	0.16	> 0.20	DDX56 (4.6)	ZNF259 (4.6)	NAA25 (3.8)	QTRT1 (3.8)	TOMM40 (3.3)	DHODH (2.6)	C12orf43 (2.4)	DHX38 (2.3)	SARS (2.1)	PVR (2.0)
GO:0051591	response to cAMP	0.16	> 0.20	CYP7A1 (3.9)	ENSG00000238078 (3.7)	ABO (3.4)	ATXN7L2 (2.8)	SLC22A1 (2.3)	ST3GAL4 (2.2)	APOC4 (1.8)	LPA (1.7)	PLG (1.7)	ANGPTL3 (1.6)
MP:0005154	increased B cell proliferation	0.16	> 0.20	RELB (4.9)	GMIP (4.1)	SH2B3 (2.8)	TIMD4 (2.5)	SLC44A2 (2.4)	BCL3 (2.2)	CETP (2.1)	GCNT4 (1.8)	MAFB (1.5)	RHCE (1.5)
GO:0010611	regulation of cardiac muscle hypertrophy	0.16	> 0.20	CEACAM19 (3.7)	HNF1A (3.1)	ENSG00000254235 (2.1)	TRAPPC6A (2.1)	DNAH11 (2.0)	HAVCR1 (1.9)	GCNT4 (1.8)	ANKRD31 (1.7)	TXNL4B (1.7)	LPIN3 (1.6)
GO:0009266	response to temperature stimulus	0.16	> 0.20	ENSG00000235545 (4.0)	AMIGO1 (2.7)	SYPL2 (1.9)	PVR (1.7)	DNAH11 (1.6)	C12orf51 (1.6)	ACAD10 (1.5)	TRIB1 (1.3)	ENSG00000228044 (1.2)	BCL3 (1.1)
ENSG00000009954	BAZ1B PPI subnetwork	0.16	> 0.20	CARM1 (3.6)	SMARCA4 (3.5)	NYNRIN (2.8)	ILF3 (2.6)	ATXN2 (2.1)	FEN1 (2.0)	CELSR2 (1.9)	AP1M2 (1.9)	USP1 (1.8)	C12orf47 (1.8)
GO:0031330	negative regulation of cellular catabolic process	0.16	> 0.20	ENSG00000226648 (2.0)	ST3GAL4 (1.9)	APOE (1.8)	SLC22A1 (1.4)	ZHX3 (1.4)	TMEM57 (1.4)	GRINA (1.2)	ATXN7L2 (1.2)	POC5 (1.1)	MARK4 (1.1)
ENSG00000066336	SPI1 PPI subnetwork	0.16	> 0.20	MAFB (3.7)	TRIB1 (3.5)	SH2B3 (3.3)	PTPN11 (2.1)	BUD13 (1.9)	BCL3 (1.9)	HLX (1.9)	RELB (1.9)	MYLIP (1.9)	KANK2 (1.8)
ENSG00000169031	COL4A3 PPI subnetwork	0.16	> 0.20	APOE (2.7)	FRK (2.6)	KANK2 (2.5)	PVR (2.1)	CEACAM19 (1.9)	PTPN11 (1.9)	PARP10 (1.8)	HNF1A (1.6)	TMED4 (1.3)	BCAM (1.3)
ENSG00000081014	AP4E1 PPI subnetwork	0.16	> 0.20	APOC1 (3.5)	ITGB3 (3.0)	APOB (2.8)	C1orf63 (2.4)	GMPR (2.4)	LPIN3 (2.3)	TMEM50A (2.2)	ZNF101 (1.8)	HAVCR1 (1.7)	TOP1 (1.5)
ENSG00000168906	MAT2A PPI subnetwork	0.16	> 0.20	C19orf52 (3.0)	BRAP (2.8)	TOMM40 (2.4)	ZNF101 (2.1)	DDX56 (2.0)	MAPKAPK5 (2.0)	NAA25 (2.0)	HAPLN4 (1.9)	ENSG00000226645 (1.9)	ADAM1 (1.7)
REACTOME_POST:ELONGATION_PROCESSING_OF_INTRONLESS_PRE:MRNA	REACTOME_POST:ELONGATION_PROCESSING_OF_INTRONLESS_PRE:MRNA	0.16	> 0.20	ENSG00000226645 (3.2)	C1orf63 (2.7)	MYLIP (2.3)	ZNF180 (2.2)	C12orf47 (2.1)	ZNF259 (2.1)	TXNL4B (2.0)	UBXN2B (1.9)	FEN1 (1.9)	ENSG00000235545 (1.7)
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE:MRNA	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE:MRNA	0.16	> 0.20	ENSG00000226645 (3.2)	C1orf63 (2.7)	MYLIP (2.3)	ZNF180 (2.2)	C12orf47 (2.1)	ZNF259 (2.1)	TXNL4B (2.0)	UBXN2B (1.9)	FEN1 (1.9)	ENSG00000235545 (1.7)
MP:0004893	decreased adiponectin level	0.16	> 0.20	TIMD4 (3.3)	ATXN7L2 (3.3)	CETP (3.1)	SORT1 (2.6)	MOSC1 (2.2)	GPAM (1.9)	HP (1.9)	DNM2 (1.9)	NAA25 (1.8)	TOP1 (1.8)
ENSG00000119541	VPS4B PPI subnetwork	0.16	> 0.20	TXNL4B (3.9)	GEMIN7 (2.7)	SUGP1 (2.6)	MARK4 (2.1)	DHODH (2.0)	C12orf43 (2.0)	MAU2 (1.8)	BLOC1S3 (1.8)	TRAPPC6A (1.8)	FRK (1.7)
ENSG00000160202	CRYAA PPI subnetwork	0.16	> 0.20	ANGPTL3 (3.2)	APOB (2.7)	PLG (2.6)	PVR (2.1)	CELSR2 (2.0)	APOA5 (1.9)	CEACAM19 (1.9)	ATXN2 (1.9)	APOC4 (1.7)	HP (1.6)
ENSG00000151208	DLG5 PPI subnetwork	0.16	> 0.20	UBXN2B (3.6)	CLPTM1 (2.8)	GATAD2A (2.4)	BCAM (2.3)	MYLIP (2.2)	BUD13 (2.2)	GRINA (2.2)	ZHX3 (2.1)	PPP1R37 (2.1)	LPIN3 (1.9)
GO:0045815	positive regulation of gene expression, epigenetic	0.16	> 0.20	FRK (3.2)	C17orf57 (3.1)	GOT2P1 (2.7)	NT5DC1 (2.4)	TMEM116 (2.1)	ATXN2 (2.0)	ANKRD31 (1.9)	CARM1 (1.8)	TSSK6 (1.7)	MAU2 (1.7)
MP:0005330	cardiomyopathy	0.16	> 0.20	ABCG8 (4.3)	ACAD10 (3.0)	SYPL2 (2.6)	NPC1L1 (2.3)	CBLC (2.0)	GMPR (2.0)	TM6SF2 (1.9)	BCAM (1.9)	C1orf63 (1.9)	OGDH (1.6)
GO:0046688	response to copper ion	0.16	> 0.20	PBX4 (2.1)	ZHX3 (2.0)	SLC44A2 (2.0)	SLC22A1 (2.0)	ENSG00000235545 (2.0)	TMEM57 (1.9)	BCAM (1.8)	ENSG00000254235 (1.8)	RHD (1.7)	RHCE (1.5)
ENSG00000169180	XPO6 PPI subnetwork	0.16	> 0.20	GATAD2A (2.4)	BUD13 (2.2)	SUGP1 (2.2)	BRAP (2.0)	MAPKAPK5 (2.0)	ADAM1 (1.8)	DNAH11 (1.8)	HAVCR1 (1.7)	TXNL4B (1.7)	GMIP (1.6)
GO:0006541	glutamine metabolic process	0.16	> 0.20	ENSG00000254235 (2.9)	ENSG00000238078 (2.9)	CYP7A1 (2.8)	HAPLN4 (2.5)	HAVCR1 (2.2)	CARM1 (1.9)	ADAM1 (1.9)	DYNC2LI1 (1.9)	ACAD10 (1.7)	DNAH11 (1.6)
GO:0031968	organelle outer membrane	0.16	> 0.20	FADS2 (3.0)	FADS1 (2.9)	GPAM (2.7)	MOSC1 (2.7)	GMPR (2.6)	ALDH2 (2.6)	GRINA (2.1)	AMIGO1 (2.1)	BRAP (2.0)	PARP10 (2.0)
ENSG00000123124	WWP1 PPI subnetwork	0.16	> 0.20	SLC44A2 (4.7)	GRINA (3.1)	HAVCR1 (2.6)	AP1M2 (2.5)	SH2B3 (2.2)	TXNL4B (1.8)	PPP1R37 (1.5)	HNF1A (1.5)	CBLC (1.5)	C1orf63 (1.4)
ENSG00000171942	OR10H2 PPI subnetwork	0.16	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.6)	PLEKHH2 (1.9)	TMEM57 (1.9)	DNAH11 (1.8)	C1orf63 (1.6)	POLK (1.4)	SLC44A2 (1.4)	SYPL2 (1.3)
MP:0004096	abnormal midbrain-hindbrain boundary development	0.16	> 0.20	ABO (3.3)	TSSK6 (2.5)	CARM1 (2.4)	GRINA (1.8)	PLCG1 (1.8)	GEMIN7 (1.7)	NT5DC1 (1.7)	GATAD2A (1.6)	MYLIP (1.3)	TMEM57 (1.3)
ENSG00000186867	QRFPR PPI subnetwork	0.16	> 0.20	OASL (3.2)	TIMD4 (3.0)	CETP (2.4)	PLEKHH2 (2.2)	POLK (1.6)	TMEM57 (1.5)	C1orf63 (1.5)	SYPL2 (1.5)	CEACAM19 (1.4)	DNAH11 (1.4)
GO:0008299	isoprenoid biosynthetic process	0.16	> 0.20	HMGCR (7.2)	LDLR (7.0)	PCSK9 (6.8)	FADS2 (6.4)	FADS1 (5.9)	CYP7A1 (2.9)	BLOC1S3 (2.1)	LPAR2 (1.8)	ENSG00000226645 (1.7)	GEMIN7 (1.7)
GO:0042559	pteridine-containing compound biosynthetic process	0.16	> 0.20	TXNL4B (2.6)	DHODH (2.5)	NT5DC1 (2.5)	GOT2P1 (2.4)	HNF1A (2.2)	DNAH11 (2.1)	TRAPPC6A (1.9)	ENSG00000226645 (1.8)	ENSG00000235545 (1.8)	CYP7A1 (1.7)
ENSG00000004660	CAMKK1 PPI subnetwork	0.16	> 0.20	LDLR (2.9)	CYP7A1 (2.4)	FADS1 (2.3)	HMGCR (2.0)	MAPKAPK5 (2.0)	CARM1 (1.8)	PLCG1 (1.7)	NPC1L1 (1.7)	MAFB (1.6)	HLX (1.6)
ENSG00000005469	CROT PPI subnetwork	0.16	> 0.20	APOC1 (3.3)	APOB (2.7)	GMPR (2.6)	ITGB3 (2.5)	GPAM (2.1)	TMEM50A (2.1)	HAVCR1 (2.0)	BRAP (2.0)	TMEM57 (2.0)	LPIN3 (1.8)
ENSG00000168530	MYL1 PPI subnetwork	0.16	> 0.20	ADAM1 (3.0)	SYPL2 (2.5)	ENSG00000238078 (2.4)	KANK2 (2.4)	ITGB3 (2.2)	AP1M2 (2.1)	C12orf51 (2.0)	FADS2 (2.0)	ERP29 (1.9)	ANKRD31 (1.8)
GO:0031268	pseudopodium organization	0.16	> 0.20	CBLC (4.9)	AP1M2 (3.9)	ENSG00000235545 (3.6)	PVRL2 (3.0)	SLC44A2 (2.6)	CETP (2.4)	BRAP (2.0)	LPIN3 (2.0)	BLOC1S3 (1.9)	SYPL2 (1.6)
ENSG00000144895	EIF2A PPI subnetwork	0.16	> 0.20	DDX56 (3.8)	ZNF259 (3.4)	NAA25 (3.1)	ATP13A1 (2.6)	QTRT1 (2.4)	TOMM40 (2.4)	DHX38 (2.2)	DHODH (2.1)	GATAD2A (2.0)	SUGP1 (2.0)
ENSG00000111364	DDX55 PPI subnetwork	0.16	> 0.20	ZNF259 (5.2)	NAA25 (4.6)	DDX56 (4.1)	TOMM40 (3.8)	DHODH (2.8)	DHX38 (2.8)	QTRT1 (2.8)	MAPKAPK5 (2.6)	SARS (2.1)	USP24 (2.0)
GO:0019210	kinase inhibitor activity	0.16	> 0.20	BCL3 (2.3)	APOB (2.1)	MYLIP (2.1)	NCAN (2.0)	ABCG5 (1.8)	ZNF101 (1.8)	LDLR (1.7)	TRIB1 (1.7)	SLC44A2 (1.6)	MAFB (1.6)
MP:0008567	decreased interferon-gamma secretion	0.16	> 0.20	PARP10 (3.6)	RELB (2.9)	BCL3 (2.7)	TRAFD1 (2.5)	OASL (2.1)	GMIP (1.9)	HLX (1.9)	MAFB (1.8)	TIMD4 (1.5)	CETP (1.2)
GO:0016888	endodeoxyribonuclease activity, producing 5'-phosphomonoesters	0.17	> 0.20	CETP (3.2)	NKPD1 (3.0)	TIMD4 (2.4)	TMEM116 (2.4)	NT5DC1 (2.0)	HAVCR1 (1.7)	LPIN3 (1.4)	HNF1A (1.4)	TSSK6 (1.4)	MAFB (1.3)
MP:0000434	megacephaly	0.17	> 0.20	NYNRIN (4.5)	KANK2 (2.5)	C11orf9 (2.5)	ENSG00000235545 (2.2)	CBLC (2.2)	PPP1R37 (2.0)	YIPF2 (2.0)	HAPLN4 (1.9)	TM6SF2 (1.8)	CETP (1.7)
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	0.17	> 0.20	SH2B3 (3.2)	HLX (3.1)	TRIB1 (3.1)	PVR (2.4)	MARK4 (2.1)	CARM1 (1.8)	ENSG00000228044 (1.5)	COL4A3BP (1.4)	MAPKAPK5 (1.3)	BLOC1S3 (1.2)
ENSG00000087157	PGS1 PPI subnetwork	0.17	> 0.20	HNF1A (3.6)	ATP13A1 (3.5)	DDX56 (2.6)	ANKRD31 (2.4)	PTPN11 (2.2)	USP24 (2.1)	GATAD2A (2.0)	BRAP (1.9)	DHODH (1.9)	MAPKAPK5 (1.8)
GO:0005637	nuclear inner membrane	0.17	> 0.20	TMED4 (3.2)	SYPL2 (2.4)	LDLR (2.3)	TMEM50A (1.9)	TRIB1 (1.6)	AMIGO1 (1.5)	C1orf63 (1.5)	COL4A3BP (1.4)	QTRT1 (1.4)	USP1 (1.4)
GO:0007586	digestion	0.17	> 0.20	NPC1L1 (6.4)	TM6SF2 (4.7)	ABCG8 (3.9)	KIAA1324 (3.7)	ABCG5 (3.5)	TMED4 (2.0)	GCNT4 (2.0)	FRK (1.9)	APOB (1.8)	ENSG00000226645 (1.8)
GO:0072329	monocarboxylic acid catabolic process	0.17	> 0.20	ACAD10 (4.9)	LPA (3.1)	NT5DC1 (2.8)	MOSC1 (2.5)	SLC22A1 (2.3)	TRAPPC6A (2.0)	GPAM (2.0)	ABCG8 (1.9)	ALDH2 (1.9)	APOC4 (1.8)
ENSG00000125398	SOX9 PPI subnetwork	0.17	> 0.20	ATXN2 (3.7)	CELSR2 (3.4)	C12orf51 (2.7)	C1orf63 (2.4)	HLX (2.0)	TXNL4B (1.9)	APOE (1.8)	MAFB (1.8)	PLEC (1.7)	NAA25 (1.6)
ENSG00000137574	TGS1 PPI subnetwork	0.17	> 0.20	C12orf51 (3.4)	ZHX3 (3.0)	ENSG00000254235 (2.6)	ATXN2 (2.5)	USP24 (2.2)	OGDH (2.1)	USP1 (1.9)	DOCK7 (1.7)	TOP1 (1.5)	NAA25 (1.4)
MP:0008751	abnormal interleukin level	0.17	> 0.20	PARP10 (4.9)	OASL (3.1)	RELB (2.8)	MAFB (2.4)	BCL3 (2.4)	SH2B3 (2.2)	APOE (2.2)	TRAFD1 (2.1)	TRIB1 (1.7)	GCNT4 (1.6)
MP:0000074	abnormal neurocranium morphology	0.17	> 0.20	CILP2 (3.8)	MAFB (3.0)	NYNRIN (2.1)	MYLIP (2.1)	KANK2 (2.0)	PLEC (1.9)	DOCK7 (1.4)	PLEKHH2 (1.4)	ALDH2 (1.4)	LDLR (1.3)
GO:0046625	sphingolipid binding	0.17	> 0.20	POLK (4.4)	ERP29 (2.7)	ENSG00000226645 (2.6)	C17orf57 (2.5)	NYNRIN (2.1)	SH2B3 (1.8)	HMGCR (1.6)	POC5 (1.5)	SLC44A2 (1.5)	HAVCR1 (1.5)
ENSG00000149273	RPS3 PPI subnetwork	0.17	> 0.20	QTRT1 (3.6)	DDX56 (3.5)	NAA25 (3.3)	TOMM40 (3.1)	ZNF259 (3.0)	ILF3 (3.0)	TOP1 (2.5)	DHX38 (2.4)	SUGP1 (2.4)	SARS (2.4)
MP:0005165	increased susceptibility to injury	0.17	> 0.20	KIAA1324 (2.4)	BCAM (2.1)	CETP (2.0)	C11orf9 (2.0)	ITGB3 (1.8)	PVRL2 (1.7)	TMED4 (1.6)	TM6SF2 (1.6)	C17orf57 (1.6)	HAPLN4 (1.3)
ENSG00000165280	VCP PPI subnetwork	0.17	> 0.20	TMEM57 (2.5)	RELB (2.1)	ABO (2.0)	GRINA (1.8)	TRIB1 (1.7)	TMEM50A (1.6)	FEN1 (1.4)	PVR (1.4)	TRAFD1 (1.3)	NT5DC1 (1.3)
ENSG00000136448	NMT1 PPI subnetwork	0.17	> 0.20	SARS (2.8)	GOT2P1 (2.6)	GATAD2A (2.3)	PPP1R37 (2.2)	MARK4 (2.2)	C11orf9 (2.1)	PLCG1 (2.1)	OGDH (2.1)	CLPTM1 (2.0)	PLEC (2.0)
GO:0002253	activation of immune response	0.17	> 0.20	TIMD4 (3.7)	LPA (3.2)	GMIP (3.1)	ZNF101 (3.1)	MAFB (2.9)	CYB561D1 (2.4)	CETP (2.1)	SH2B3 (1.9)	LPAR2 (1.8)	APOC4 (1.6)
ENSG00000167306	MYO5B PPI subnetwork	0.17	> 0.20	USP24 (3.2)	SMARCA4 (2.7)	COL4A3BP (2.6)	MAPKAPK5 (2.1)	NAA25 (2.0)	C12orf51 (1.9)	POLK (1.8)	PTPN11 (1.6)	ILF3 (1.5)	AP1M2 (1.5)
GO:0051019	mitogen-activated protein kinase binding	0.17	> 0.20	PMFBP1 (3.7)	HAVCR1 (2.8)	TRIB1 (2.6)	POLK (2.5)	C12orf51 (2.4)	GPAM (2.3)	TOP1 (2.0)	DNM2 (1.7)	MYLIP (1.7)	LPIN3 (1.5)
ENSG00000103152	MPG PPI subnetwork	0.17	> 0.20	PSMA5 (3.1)	CARM1 (3.1)	GOT2P1 (2.5)	NT5DC1 (2.1)	C19orf52 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	NKPD1 (1.5)	GPAM (1.5)	ILF3 (1.4)
MP:0003814	vascular smooth muscle cell hypoplasia	0.17	> 0.20	PLEC (3.2)	SH2B3 (2.6)	HLX (2.6)	TRIB1 (1.6)	USP24 (1.5)	PCSK9 (1.5)	PLEKHH2 (1.3)	MYLIP (1.3)	BCL3 (1.3)	LDLR (1.2)
MP:0002871	albuminuria	0.17	> 0.20	BCAM (4.4)	NT5DC1 (2.4)	PVRL2 (2.0)	TMEM116 (1.9)	POLK (1.9)	TMEM50A (1.9)	OGDH (1.7)	GPAM (1.6)	C17orf57 (1.5)	ST3GAL4 (1.3)
MP:0000753	paralysis	0.17	> 0.20	HAVCR1 (4.3)	ATP13A1 (2.8)	SYPL2 (2.6)	RPH3A (2.2)	ERP29 (2.1)	TMEM57 (1.8)	NPC1L1 (1.8)	USP24 (1.7)	DOCK7 (1.7)	CELSR2 (1.6)
GO:0031227	intrinsic to endoplasmic reticulum membrane	0.17	> 0.20	CLPTM1 (4.4)	ATP13A1 (4.3)	YIPF2 (3.2)	TMEM50A (3.1)	TMED4 (3.1)	ERP29 (3.1)	CYB561D1 (3.0)	CYP7A1 (2.5)	HMGCR (2.4)	GRINA (2.4)
MP:0004556	enlarged allantois	0.17	> 0.20	GATAD2A (3.5)	RPH3A (1.9)	LPA (1.8)	APOE (1.7)	TRIB1 (1.7)	C17orf57 (1.7)	HAPLN4 (1.6)	CLPTM1 (1.6)	BLOC1S3 (1.6)	CARM1 (1.5)
ENSG00000139219	COL2A1 PPI subnetwork	0.17	> 0.20	CILP2 (8.1)	MAFB (3.3)	ITGB3 (3.2)	PLEKHH2 (2.2)	APOE (2.1)	SH2B3 (1.6)	C17orf57 (1.5)	APOC1 (1.5)	BCAM (1.3)	ST3GAL4 (1.3)
ENSG00000196092	PAX5 PPI subnetwork	0.17	> 0.20	MYLIP (3.1)	BUD13 (2.0)	HLX (1.9)	TMEM50A (1.8)	TRIB1 (1.8)	PLCG1 (1.8)	PBX4 (1.8)	C19orf52 (1.7)	KANK2 (1.7)	NCAN (1.6)
GO:0005080	protein kinase C binding	0.17	> 0.20	GRINA (2.9)	RELB (2.7)	PLEC (2.1)	ITGB3 (1.9)	GMIP (1.8)	APOE (1.7)	SMARCA4 (1.7)	CETP (1.7)	FADS1 (1.7)	KANK2 (1.6)
GO:0043526	neuroprotection	0.17	> 0.20	TSSK6 (2.7)	GOT2P1 (2.6)	NKPD1 (2.4)	ZNF180 (2.1)	DNAH11 (1.8)	ENSG00000238078 (1.7)	C17orf57 (1.7)	GCNT4 (1.5)	BLOC1S3 (1.4)	PPP1R37 (1.4)
ENSG00000141644	MBD1 PPI subnetwork	0.17	> 0.20	KANK2 (3.2)	TRAFD1 (2.7)	MYLIP (2.6)	ENSG00000238078 (2.4)	ATXN2 (2.3)	FRK (2.2)	NKPD1 (2.0)	SH2B3 (1.9)	CETP (1.7)	MARK4 (1.7)
GO:0009116	nucleoside metabolic process	0.17	> 0.20	DHODH (2.9)	TXNL4B (2.8)	LPA (2.3)	NT5DC1 (2.1)	TRAPPC6A (2.1)	TSSK6 (1.7)	CYP7A1 (1.7)	SLC22A1 (1.6)	ENSG00000228044 (1.5)	ANKRD31 (1.5)
MP:0001729	impaired embryo implantation	0.17	> 0.20	ENSG00000228044 (2.7)	ZHX3 (2.2)	HP (2.0)	C11orf9 (1.9)	DHX38 (1.8)	PVR (1.7)	GPAM (1.6)	HLX (1.6)	ENSG00000254235 (1.5)	PARP10 (1.5)
ENSG00000197157	SND1 PPI subnetwork	0.17	> 0.20	ITGB3 (3.0)	ST3GAL4 (2.6)	ZNF101 (2.0)	NAA25 (2.0)	C12orf47 (1.9)	DHX38 (1.7)	ATXN2 (1.7)	BUD13 (1.6)	SMARCA4 (1.5)	GRINA (1.5)
ENSG00000147202	DIAPH2 PPI subnetwork	0.17	> 0.20	CARM1 (2.9)	BUD13 (2.6)	ATXN2 (2.4)	ENSG00000254235 (2.3)	UBXN2B (1.8)	C11orf9 (1.7)	OGDH (1.6)	GATAD2A (1.5)	HAVCR1 (1.5)	GRINA (1.5)
ENSG00000106052	TAX1BP1 PPI subnetwork	0.17	> 0.20	LDLR (4.3)	COL4A3BP (2.8)	OGDH (2.3)	FADS1 (2.1)	ZNF180 (1.9)	PCSK9 (1.6)	FRK (1.6)	GRINA (1.6)	RELB (1.6)	SYPL2 (1.5)
ENSG00000147905	ZCCHC7 PPI subnetwork	0.17	> 0.20	ZNF180 (2.8)	PLEKHH2 (2.0)	COL4A3BP (2.0)	DHX38 (1.8)	ENSG00000228044 (1.6)	ABCG8 (1.5)	USP24 (1.5)	PPP1R37 (1.5)	POC5 (1.5)	USP1 (1.4)
GO:0009411	response to UV	0.17	> 0.20	ZNF180 (3.5)	BLOC1S3 (3.3)	MAU2 (2.4)	DNAH11 (2.3)	SUGP1 (2.2)	CEACAM19 (2.0)	POLK (1.7)	ENSG00000235545 (1.6)	TRAPPC6A (1.6)	TMEM57 (1.6)
GO:0005125	cytokine activity	0.17	> 0.20	TIMD4 (3.2)	RELB (2.5)	BCL3 (2.3)	OASL (2.1)	CYP7A1 (1.9)	CETP (1.9)	PVR (1.8)	SLC22A1 (1.7)	ZNF101 (1.7)	PVRL2 (1.5)
MP:0004042	decreased susceptibility to kidney reperfusion injury	0.17	> 0.20	MAFB (4.0)	PMFBP1 (2.2)	PSRC1 (1.8)	NCAN (1.7)	AP1M2 (1.5)	BLOC1S3 (1.5)	PLEKHH2 (1.5)	POLK (1.4)	RHCE (1.4)	ENSG00000238078 (1.3)
ENSG00000100385	IL2RB PPI subnetwork	0.17	> 0.20	BCL3 (3.4)	COL4A3BP (2.1)	RELB (1.8)	TRAFD1 (1.7)	C17orf57 (1.7)	ZNF101 (1.6)	HLX (1.6)	PARP10 (1.6)	CYP7A1 (1.4)	PVR (1.2)
ENSG00000204673	AKT1S1 PPI subnetwork	0.17	> 0.20	DNM2 (3.3)	PLEC (3.2)	ZHX3 (3.2)	GPAM (2.8)	PTPN11 (2.7)	C11orf9 (2.7)	CARM1 (2.7)	KANK2 (2.4)	COL4A3BP (2.4)	USP24 (2.3)
ENSG00000183963	SMTN PPI subnetwork	0.17	> 0.20	OASL (2.9)	TIMD4 (2.9)	CETP (2.2)	SYPL2 (2.1)	C1orf63 (1.7)	TMEM57 (1.7)	DNAH11 (1.6)	ANKRD31 (1.5)	PLEKHH2 (1.4)	TMEM50A (1.4)
GO:0009988	cell-cell recognition	0.17	> 0.20	TSSK6 (4.6)	ENSG00000228044 (4.0)	CETP (3.1)	PMFBP1 (3.0)	GCNT4 (3.0)	ENSG00000238078 (2.3)	C17orf57 (1.5)	TIMD4 (1.4)	PBX4 (1.4)	LPA (1.3)
MP:0001787	pericardial edema	0.17	> 0.20	RHD (2.5)	COL4A3BP (2.4)	HLX (2.2)	PLCG1 (2.2)	ACAD10 (2.1)	UBXN2B (2.1)	C11orf9 (2.0)	GATAD2A (2.0)	DNM2 (1.6)	SH2B3 (1.6)
MP:0010876	decreased bone volume	0.17	> 0.20	CILP2 (2.8)	KANK2 (2.5)	PLEKHH2 (2.1)	ADAM1 (2.1)	YIPF2 (1.6)	LDLR (1.5)	PTPN11 (1.5)	ENSG00000238078 (1.5)	CBLC (1.4)	ST3GAL4 (1.4)
GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity	0.17	> 0.20	TRIB1 (7.7)	TSSK6 (2.5)	ENSG00000226645 (1.9)	LDLR (1.9)	PVR (1.8)	ENSG00000235545 (1.7)	SH2B3 (1.6)	SYPL2 (1.6)	DNAH11 (1.4)	POLK (1.4)
MP:0006050	pulmonary fibrosis	0.17	> 0.20	RHD (2.9)	APOE (2.8)	ANGPTL3 (2.8)	APOC4 (2.6)	HP (2.4)	TRIB1 (2.3)	APOC1 (2.3)	BCL3 (2.2)	KANK2 (2.0)	APOA5 (1.9)
ENSG00000175745	NR2F1 PPI subnetwork	0.17	> 0.20	ENSG00000254235 (2.1)	PLEC (2.0)	C12orf51 (1.9)	GCNT4 (1.9)	ZHX3 (1.8)	TOP1 (1.7)	MAFB (1.5)	APOB (1.5)	AMIGO1 (1.5)	ENSG00000235545 (1.5)
ENSG00000175029	CTBP2 PPI subnetwork	0.17	> 0.20	TMEM57 (3.2)	CARM1 (3.0)	USP24 (2.2)	NYNRIN (2.2)	ILF3 (1.9)	TRAFD1 (1.9)	TOP1 (1.9)	ATXN7L2 (1.8)	DHX38 (1.6)	DNM2 (1.6)
ENSG00000183405	ENSG00000183405 PPI subnetwork	0.17	> 0.20	DDX56 (4.2)	NAA25 (4.0)	ZNF259 (3.8)	QTRT1 (3.7)	TOMM40 (3.0)	DHODH (3.0)	C12orf43 (2.4)	SUGP1 (2.3)	DHX38 (2.3)	GATAD2A (2.1)
ENSG00000086015	MAST2 PPI subnetwork	0.17	> 0.20	DNM2 (3.6)	PLEC (3.3)	ZHX3 (3.3)	CARM1 (3.0)	LPAR2 (2.9)	MAU2 (2.5)	COL4A3BP (2.5)	ATXN7L2 (2.4)	C11orf9 (2.1)	USP24 (2.1)
GO:0072531	pyrimidine-containing compound transmembrane transport	0.17	> 0.20	GCNT4 (4.6)	GOT2P1 (3.0)	TMED4 (2.5)	ADAM1 (2.3)	NKPD1 (2.3)	PMFBP1 (2.3)	TMEM57 (2.0)	CILP2 (1.8)	SLC44A2 (1.8)	SLC22A1 (1.7)
MP:0011088	partial neonatal lethality	0.17	> 0.20	MAFB (3.0)	LDLR (2.4)	NYNRIN (2.2)	TRIB1 (1.9)	MYLIP (1.8)	HLX (1.7)	FADS2 (1.7)	MARK4 (1.6)	ALDH2 (1.6)	DOCK7 (1.5)
ENSG00000113916	BCL6 PPI subnetwork	0.17	> 0.20	BCL3 (3.4)	TRIB1 (3.3)	MAU2 (3.2)	USP24 (3.1)	PARP10 (2.7)	GMIP (2.6)	POLK (2.1)	SMARCA4 (2.1)	MAFB (2.1)	ZNF180 (1.6)
GO:0045471	response to ethanol	0.17	> 0.20	GPAM (2.4)	ALDH2 (2.2)	LPA (2.1)	ENSG00000235545 (2.0)	ABO (2.0)	GOT2P1 (1.8)	ABCG5 (1.4)	ACAD10 (1.4)	C17orf57 (1.4)	RHCE (1.4)
ENSG00000108604	SMARCD2 PPI subnetwork	0.17	> 0.20	CARM1 (4.1)	MAU2 (3.1)	SMARCA4 (3.1)	GOT2P1 (2.2)	BCL3 (2.1)	C12orf51 (2.1)	ATXN2 (2.0)	NYNRIN (1.9)	MARK4 (1.7)	NT5DC1 (1.6)
ENSG00000159377	PSMB4 PPI subnetwork	0.17	> 0.20	PSMA5 (5.9)	TRAFD1 (2.8)	NAA25 (2.5)	NT5DC1 (2.2)	ENSG00000254235 (1.8)	TOMM40 (1.7)	DDX56 (1.6)	SARS (1.3)	PARP10 (1.3)	ZNF101 (1.2)
MP:0003290	intestinal hypoperistalsis	0.17	> 0.20	KANK2 (3.8)	ITGB3 (3.2)	CETP (3.1)	PLEKHH2 (2.6)	HLX (2.3)	TIMD4 (2.2)	ENSG00000228044 (2.2)	TRIB1 (2.0)	ENSG00000254235 (1.8)	C17orf57 (1.4)
ENSG00000186318	BACE1 PPI subnetwork	0.17	> 0.20	ALDH2 (4.0)	CLPTM1 (4.0)	ERP29 (3.9)	TMED4 (3.1)	GRINA (3.0)	TMEM50A (2.4)	SORT1 (2.2)	NYNRIN (2.0)	TMEM57 (1.9)	GMPR (1.7)
MP:0005534	decreased body temperature	0.17	> 0.20	MOSC1 (2.8)	APOA5 (2.5)	TRIB1 (2.5)	GPAM (2.2)	CETP (2.1)	GCNT4 (2.1)	ANGPTL3 (1.9)	ALDH2 (1.9)	SLC22A1 (1.8)	POLK (1.6)
MP:0003216	absence seizures	0.17	> 0.20	RPH3A (5.1)	HAPLN4 (3.9)	PPP1R37 (2.9)	APOE (2.4)	CLPTM1 (2.0)	APOC1 (1.8)	CYP7A1 (1.8)	GRINA (1.7)	ABCG8 (1.5)	TMEM57 (1.5)
GO:0045787	positive regulation of cell cycle	0.17	> 0.20	ANKRD31 (2.8)	DNAH11 (2.7)	ENSG00000228044 (2.4)	PSRC1 (2.0)	TMED4 (1.9)	ENSG00000238078 (1.7)	ATXN2 (1.5)	PTPN11 (1.5)	RHD (1.3)	RHCE (1.3)
MP:0003048	abnormal cervical vertebrae morphology	0.17	> 0.20	MYLIP (2.4)	NYNRIN (2.1)	PLEKHH2 (2.0)	DYNC2LI1 (1.7)	PLCG1 (1.6)	TMED4 (1.6)	SYPL2 (1.5)	CILP2 (1.4)	ENSG00000238078 (1.4)	C19orf52 (1.3)
ENSG00000108654	DDX5 PPI subnetwork	0.17	> 0.20	SMARCA4 (3.6)	ILF3 (3.3)	DDX56 (2.8)	TOP1 (2.7)	GATAD2A (2.7)	CARM1 (2.6)	NAA25 (2.4)	TOMM40 (2.3)	QTRT1 (2.3)	SUGP1 (2.1)
GO:0002761	regulation of myeloid leukocyte differentiation	0.17	> 0.20	ITGB3 (2.8)	DNAH11 (2.6)	PBX4 (2.2)	RHCE (2.1)	RHD (2.0)	ENSG00000235545 (2.0)	ST3GAL4 (1.9)	C1orf63 (1.6)	GCNT4 (1.5)	ENSG00000238078 (1.4)
MP:0002705	dilated renal tubules	0.17	> 0.20	BCAM (4.6)	PLEKHH2 (3.9)	NYNRIN (2.5)	DYNC2LI1 (2.5)	PLG (2.2)	CELSR2 (2.0)	PVRL2 (1.8)	ENSG00000228044 (1.8)	C17orf57 (1.6)	TMED4 (1.6)
GO:0001772	immunological synapse	0.17	> 0.20	ZNF101 (3.1)	BCL3 (3.0)	RELB (2.9)	ITGB3 (2.0)	C11orf9 (2.0)	HAVCR1 (2.0)	PBX4 (1.9)	CYB561D1 (1.8)	ENSG00000228044 (1.6)	SLC44A2 (1.5)
ENSG00000140650	PMM2 PPI subnetwork	0.17	> 0.20	NAA25 (5.1)	DDX56 (4.2)	TOMM40 (3.7)	ZNF259 (3.3)	SARS (2.8)	QTRT1 (2.4)	PSMA5 (2.3)	PTPN11 (1.9)	SMARCA4 (1.9)	TOP1 (1.8)
GO:0009595	detection of biotic stimulus	0.17	> 0.20	OASL (3.3)	PARP10 (2.5)	CEACAM19 (2.3)	DNAH11 (2.2)	PMFBP1 (2.0)	TRAFD1 (1.8)	FRK (1.7)	ENSG00000228044 (1.5)	UBXN2B (1.4)	ADAM1 (1.4)
ENSG00000163909	HEYL PPI subnetwork	0.17	> 0.20	NYNRIN (3.1)	C11orf9 (3.1)	MYLIP (2.8)	KANK2 (2.5)	SH2B3 (2.3)	PTPN11 (2.1)	SLC44A2 (1.7)	C1orf63 (1.7)	ENSG00000238078 (1.6)	DNM2 (1.5)
MP:0004024	aneuploidy	0.17	> 0.20	PSRC1 (4.1)	FEN1 (3.4)	USP1 (2.7)	POC5 (2.5)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	RHD (1.6)	CBLC (1.4)	GOT2P1 (1.4)	DHX38 (1.4)
GO:0034754	cellular hormone metabolic process	0.17	> 0.20	CYP7A1 (3.8)	ABCG5 (2.7)	LPA (2.6)	NKPD1 (2.6)	ABCG8 (2.5)	ST3GAL4 (2.3)	TM6SF2 (2.3)	SLC22A1 (2.3)	CYB561D1 (2.2)	APOC4 (2.0)
ENSG00000057294	PKP2 PPI subnetwork	0.17	> 0.20	AP1M2 (3.5)	DNM2 (3.1)	CELSR2 (3.0)	C11orf9 (2.9)	MARK4 (2.7)	PLEC (2.6)	OGDH (2.4)	CBLC (2.4)	LPAR2 (2.4)	PVRL2 (2.2)
ENSG00000105229	PIAS4 PPI subnetwork	0.17	> 0.20	PARP10 (3.9)	BCL3 (2.7)	OASL (2.7)	TRAFD1 (2.6)	MYLIP (2.1)	KANK2 (2.0)	BUD13 (1.7)	C17orf57 (1.7)	ATXN2 (1.6)	DNM2 (1.6)
ENSG00000123338	NCKAP1L PPI subnetwork	0.17	> 0.20	GMIP (4.5)	ENSG00000235545 (2.8)	DOCK7 (2.6)	C1orf63 (2.5)	SMARCA4 (2.3)	GOT2P1 (1.8)	DNM2 (1.8)	PLEC (1.7)	OGDH (1.6)	ST3GAL4 (1.5)
ENSG00000206560	ANKRD28 PPI subnetwork	0.17	> 0.20	RELB (7.3)	BCL3 (3.5)	PPP1R37 (2.8)	GRINA (2.4)	CLPTM1 (2.3)	PTPN11 (2.1)	MARK4 (2.1)	SH2B3 (2.0)	GMIP (1.9)	PARP10 (1.8)
GO:0043236	laminin binding	0.17	> 0.20	PVRL2 (4.3)	BCAM (3.7)	PBX4 (2.5)	PLEC (2.5)	KANK2 (2.3)	CBLC (2.3)	SLC44A2 (2.0)	CLPTM1 (1.9)	ABO (1.8)	ENSG00000254235 (1.8)
ENSG00000082898	XPO1 PPI subnetwork	0.17	> 0.20	PSRC1 (3.8)	FEN1 (3.4)	POC5 (3.3)	USP1 (2.7)	NAA25 (2.0)	TOP1 (2.0)	HMGCR (1.9)	DHX38 (1.7)	DDX56 (1.7)	ILF3 (1.6)
GO:0060330	regulation of response to interferon-gamma	0.17	> 0.20	TRAFD1 (3.5)	PBX4 (2.7)	ADAM1 (2.6)	ENSG00000228044 (2.6)	ZNF101 (2.1)	NKPD1 (2.0)	ENSG00000238078 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.8)	PARP10 (1.8)
GO:0060334	regulation of interferon-gamma-mediated signaling pathway	0.17	> 0.20	TRAFD1 (3.5)	PBX4 (2.7)	ADAM1 (2.6)	ENSG00000228044 (2.6)	ZNF101 (2.1)	NKPD1 (2.0)	ENSG00000238078 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.8)	PARP10 (1.8)
GO:0060056	mammary gland involution	0.17	> 0.20	PPP1R37 (3.3)	ST3GAL4 (2.7)	C17orf57 (2.6)	CBLC (2.4)	CILP2 (2.2)	LPAR2 (2.1)	C12orf47 (2.0)	LPIN3 (1.9)	ENSG00000228044 (1.8)	SLC44A2 (1.8)
GO:0030055	cell-substrate junction	0.17	> 0.20	PLEC (4.6)	ITGB3 (3.3)	KANK2 (2.5)	BCAM (2.2)	GMIP (2.2)	PVRL2 (2.0)	DNM2 (1.9)	C11orf9 (1.5)	SH2B3 (1.5)	GPAM (1.4)
GO:0001568	blood vessel development	0.17	> 0.20	HLX (2.9)	PVR (2.8)	PVRL2 (2.6)	NYNRIN (2.1)	BCAM (2.1)	SH2B3 (2.0)	KANK2 (1.9)	C17orf57 (1.8)	CEACAM19 (1.7)	MAFB (1.7)
ENSG00000172301	C17orf79 PPI subnetwork	0.17	> 0.20	TSSK6 (2.8)	BUD13 (2.7)	POLK (2.5)	QTRT1 (2.1)	PPP1R37 (2.0)	GCNT4 (1.6)	GEMIN7 (1.5)	PBX4 (1.5)	ENSG00000226648 (1.4)	FADS2 (1.4)
ENSG00000162702	ZNF281 PPI subnetwork	0.17	> 0.20	ATP13A1 (3.0)	ATXN2 (2.4)	CYB561D1 (2.2)	C12orf43 (2.2)	USP1 (1.9)	DHX38 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	ILF3 (1.6)	POLK (1.6)
GO:0032462	regulation of protein homooligomerization	0.17	> 0.20	C12orf47 (3.7)	TMEM116 (2.3)	ANKRD31 (2.2)	C19orf52 (2.0)	ZNF101 (1.9)	TXNL4B (1.8)	HAVCR1 (1.7)	ENSG00000226645 (1.6)	ALDH2 (1.5)	BRAP (1.4)
ENSG00000166986	MARS PPI subnetwork	0.17	> 0.20	SARS (5.2)	DNM2 (3.0)	ATP13A1 (2.9)	PVRL2 (2.8)	CARM1 (2.5)	SUGP1 (2.4)	QTRT1 (2.4)	RHCE (2.1)	POLK (2.1)	YIPF2 (2.0)
GO:0009744	response to sucrose stimulus	0.17	> 0.20	NPC1L1 (4.6)	TM6SF2 (4.1)	FADS2 (3.8)	HAPLN4 (3.5)	ABCG8 (3.5)	ABCG5 (3.4)	ANKRD31 (2.7)	BLOC1S3 (2.5)	CBLC (2.2)	ZHX3 (1.5)
GO:0034285	response to disaccharide stimulus	0.17	> 0.20	NPC1L1 (4.6)	TM6SF2 (4.1)	FADS2 (3.8)	HAPLN4 (3.5)	ABCG8 (3.5)	ABCG5 (3.4)	ANKRD31 (2.7)	BLOC1S3 (2.5)	CBLC (2.2)	ZHX3 (1.5)
ENSG00000156709	AIFM1 PPI subnetwork	0.17	> 0.20	C19orf52 (2.5)	TRAFD1 (2.5)	GRINA (2.1)	LPAR2 (2.1)	TRIB1 (2.1)	PARP10 (2.1)	HLX (2.0)	C1orf63 (1.9)	SUGP1 (1.7)	BCL3 (1.7)
GO:0002920	regulation of humoral immune response	0.17	> 0.20	ENSG00000228044 (4.2)	TIMD4 (3.4)	ENSG00000235545 (2.7)	HAVCR1 (2.4)	DYNC2LI1 (2.2)	ENSG00000238078 (2.1)	GMIP (1.9)	CETP (1.8)	GEMIN7 (1.8)	CEACAM19 (1.8)
ENSG00000147162	OGT PPI subnetwork	0.17	> 0.20	OASL (4.3)	MAU2 (3.0)	BUD13 (3.0)	PLCG1 (2.7)	KANK2 (2.7)	C19orf52 (2.4)	CARM1 (2.4)	BRAP (2.4)	GATAD2A (2.3)	C12orf51 (2.3)
GO:0001961	positive regulation of cytokine-mediated signaling pathway	0.17	> 0.20	CEACAM19 (2.7)	C17orf57 (2.6)	ENSG00000235545 (1.9)	CYB561D1 (1.9)	GRINA (1.8)	POLK (1.8)	ZNF101 (1.7)	COL4A3BP (1.7)	TM6SF2 (1.5)	HNF1A (1.3)
ENSG00000121653	MAPK8IP1 PPI subnetwork	0.17	> 0.20	RPH3A (2.1)	TRIB1 (2.0)	LDLR (1.8)	PPP1R37 (1.7)	PVR (1.7)	SLC44A2 (1.7)	BCAM (1.6)	SORT1 (1.6)	DNAH11 (1.6)	HAVCR1 (1.5)
GO:0010596	negative regulation of endothelial cell migration	0.17	> 0.20	DNAH11 (3.1)	GCNT4 (2.9)	ADAM1 (2.6)	APOC1 (2.1)	TRAPPC6A (1.9)	PMFBP1 (1.9)	CETP (1.7)	HNF1A (1.6)	CEACAM19 (1.6)	HLX (1.6)
MP:0006354	abnormal fourth branchial arch artery morphology	0.17	> 0.20	PLCG1 (3.1)	PVR (3.0)	CEACAM19 (2.6)	HLX (2.5)	PVRL2 (2.4)	MAFB (1.8)	KANK2 (1.7)	KIAA1324 (1.4)	C19orf52 (1.3)	ABO (1.2)
ENSG00000108518	PFN1 PPI subnetwork	0.17	> 0.20	NPC1L1 (3.4)	GMIP (3.2)	FADS2 (2.4)	PLEC (2.3)	C11orf9 (2.3)	LDLR (2.3)	HMGCR (2.0)	AP1M2 (1.9)	ST3GAL4 (1.9)	HNF1A (1.7)
ENSG00000136634	IL10 PPI subnetwork	0.17	> 0.20	BCL3 (4.2)	HLX (3.3)	TIMD4 (2.9)	CETP (2.7)	RELB (2.6)	GMIP (2.0)	TRIB1 (1.6)	LPA (1.5)	ZNF101 (1.5)	PARP10 (1.4)
ENSG00000109046	WSB1 PPI subnetwork	0.17	> 0.20	ST3GAL4 (2.2)	GRINA (2.1)	TRAPPC6A (2.0)	ANKRD31 (1.9)	ZNF101 (1.8)	CBLC (1.8)	SORT1 (1.7)	CLPTM1 (1.7)	ZHX3 (1.5)	FRK (1.4)
REACTOME_G1S_DNA_DAMAGE_CHECKPOINTS	REACTOME_G1S_DNA_DAMAGE_CHECKPOINTS	0.17	> 0.20	PSMA5 (5.9)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	PARP10 (1.9)	TOMM40 (1.7)	FEN1 (1.6)	DDX56 (1.5)	SUGP1 (1.5)	SARS (1.4)
GO:0009975	cyclase activity	0.17	> 0.20	NYNRIN (3.1)	HLX (2.6)	ITGB3 (2.4)	CETP (2.1)	CYP7A1 (2.0)	ABCG8 (1.7)	ENSG00000254235 (1.6)	BCAM (1.6)	ENSG00000228044 (1.5)	MOSC1 (1.4)
ENSG00000101057	MYBL2 PPI subnetwork	0.17	> 0.20	GATAD2A (3.0)	SMARCA4 (2.8)	USP1 (2.7)	RHD (2.5)	FEN1 (2.3)	KANK2 (2.0)	RHCE (1.9)	PSRC1 (1.9)	ATXN2 (1.7)	GCNT4 (1.5)
MP:0001239	abnormal epidermis stratum granulosum morphology	0.17	> 0.20	NKPD1 (3.7)	CBLC (3.6)	MAFB (2.8)	PLEC (2.6)	AP1M2 (2.4)	TRIB1 (2.1)	CELSR2 (1.9)	ENSG00000254235 (1.8)	BLOC1S3 (1.8)	TOMM40 (1.6)
MP:0001731	abnormal postnatal growth	0.17	> 0.20	APOC1 (3.0)	ALDH2 (2.8)	MOSC1 (2.3)	USP24 (2.3)	NKPD1 (2.1)	NYNRIN (2.0)	KIAA1324 (1.7)	LPA (1.5)	BLOC1S3 (1.5)	GEMIN7 (1.4)
ENSG00000011052	NME2 PPI subnetwork	0.17	> 0.20	TOMM40 (2.9)	PSMA5 (2.6)	ITGB3 (2.4)	TMEM50A (2.2)	NAA25 (2.1)	C19orf52 (2.1)	PBX4 (2.0)	ZNF180 (2.0)	MYLIP (1.7)	GEMIN7 (1.7)
GO:0016782	transferase activity, transferring sulfur-containing groups	0.17	> 0.20	ABCG5 (2.5)	APOB (2.0)	ZHX3 (1.9)	ABCG8 (1.9)	ST3GAL4 (1.8)	GCNT4 (1.7)	DYNC2LI1 (1.7)	MARK4 (1.6)	C12orf47 (1.6)	TXNL4B (1.6)
GO:0046434	organophosphate catabolic process	0.17	> 0.20	CYP7A1 (2.9)	TSSK6 (2.2)	ZNF180 (2.1)	SLC22A1 (2.0)	UBXN2B (2.0)	AMIGO1 (1.9)	HAPLN4 (1.8)	MOSC1 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)
MP:0002948	abnormal neuron specification	0.17	> 0.20	ANKRD31 (2.8)	HAPLN4 (2.6)	PSRC1 (2.5)	ENSG00000226648 (2.0)	PLEKHH2 (1.7)	PLCG1 (1.6)	DNAH11 (1.5)	PMFBP1 (1.5)	NCAN (1.5)	GEMIN7 (1.5)
ENSG00000130402	ACTN4 PPI subnetwork	0.17	> 0.20	OGDH (3.6)	PLEC (3.1)	SYPL2 (3.1)	GMPR (3.0)	BCAM (2.6)	NPC1L1 (2.4)	CARM1 (1.9)	KANK2 (1.8)	PVRL2 (1.8)	ITGB3 (1.8)
ENSG00000188130	MAPK12 PPI subnetwork	0.17	> 0.20	TRIB1 (6.4)	SH2B3 (2.7)	PLCG1 (1.7)	HLX (1.6)	MYLIP (1.6)	PPP1R37 (1.6)	MAFB (1.5)	ENSG00000226645 (1.5)	SYPL2 (1.4)	ZHX3 (1.4)
REACTOME_P53:INDEPENDENT_DNA_DAMAGE_RESPONSE	REACTOME_P53:INDEPENDENT_DNA_DAMAGE_RESPONSE	0.17	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A	REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A	0.17	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
REACTOME_P53:INDEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	REACTOME_P53:INDEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	0.17	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
ENSG00000136813	KIAA0368 PPI subnetwork	0.17	> 0.20	PSMA5 (5.1)	NAA25 (4.3)	SARS (4.0)	DDX56 (3.0)	PTPN11 (2.6)	TOMM40 (2.3)	NT5DC1 (2.1)	SMARCA4 (2.1)	CLPTM1 (2.0)	ZNF259 (1.9)
GO:0042987	amyloid precursor protein catabolic process	0.17	> 0.20	CLPTM1 (2.7)	DNAH11 (2.7)	TMEM50A (2.2)	TRAPPC6A (2.0)	TMEM116 (2.0)	SORT1 (1.7)	ANKRD31 (1.6)	TMED4 (1.6)	TMEM57 (1.6)	MAU2 (1.5)
ENSG00000061936	SFSWAP PPI subnetwork	0.17	> 0.20	DHODH (2.9)	MAPKAPK5 (2.5)	ATP13A1 (2.5)	LPA (2.4)	CEACAM19 (2.4)	HNF1A (2.2)	TOMM40 (2.2)	ANKRD31 (2.1)	CETP (1.9)	DDX56 (1.5)
ENSG00000116062	MSH6 PPI subnetwork	0.17	> 0.20	USP1 (3.7)	FEN1 (3.4)	SMARCA4 (2.2)	BUD13 (2.1)	ZNF180 (2.1)	C12orf51 (1.9)	POC5 (1.9)	NYNRIN (1.9)	ILF3 (1.7)	ENSG00000226648 (1.3)
ENSG00000110721	CHKA PPI subnetwork	0.17	> 0.20	CETP (2.9)	TIMD4 (2.8)	OASL (2.7)	PLEKHH2 (2.0)	TMEM57 (1.7)	CEACAM19 (1.6)	TMEM50A (1.6)	C1orf63 (1.6)	POLK (1.6)	SYPL2 (1.5)
MP:0001858	intestinal inflammation	0.17	> 0.20	BCL3 (4.0)	ZNF101 (2.6)	GRINA (2.1)	C17orf57 (1.9)	RELB (1.9)	PBX4 (1.9)	TRIB1 (1.8)	PLEC (1.7)	PARP10 (1.7)	CEACAM19 (1.6)
ENSG00000100485	SOS2 PPI subnetwork	0.17	> 0.20	ZHX3 (3.7)	PLEKHH2 (3.0)	HAVCR1 (2.5)	C11orf9 (2.3)	SLC44A2 (2.3)	CBLC (2.2)	ABO (2.1)	KANK2 (2.1)	ITGB3 (2.1)	C17orf57 (2.1)
ENSG00000162869	PPP1R21 PPI subnetwork	0.17	> 0.20	MAPKAPK5 (3.1)	ATP13A1 (2.7)	TOMM40 (2.3)	LPA (2.1)	ADAM1 (2.0)	HNF1A (2.0)	DHODH (2.0)	USP24 (1.9)	DYNC2LI1 (1.8)	BRAP (1.8)
ENSG00000183207	RUVBL2 PPI subnetwork	0.18	> 0.20	ZNF180 (2.8)	SMARCA4 (2.8)	DDX56 (2.3)	PSMA5 (2.3)	TOMM40 (2.2)	SUGP1 (2.0)	DHX38 (2.0)	USP1 (2.0)	QTRT1 (1.8)	BUD13 (1.6)
ENSG00000089902	RCOR1 PPI subnetwork	0.18	> 0.20	SMARCA4 (3.3)	MARK4 (3.2)	PPP1R37 (2.7)	TOP1 (2.6)	CARM1 (2.6)	PLCG1 (2.5)	GATAD2A (2.5)	ATXN2 (2.2)	KANK2 (2.1)	NYNRIN (2.0)
MP:0000136	abnormal microglial cell morphology	0.18	> 0.20	APOE (3.5)	GMIP (2.5)	BCL3 (2.4)	SORT1 (2.2)	APOC1 (2.2)	GRINA (2.2)	ERP29 (2.1)	HLX (2.1)	TMED4 (2.0)	MAFB (1.9)
ENSG00000115290	GRB14 PPI subnetwork	0.18	> 0.20	C17orf57 (2.9)	AP1M2 (2.2)	APOE (2.1)	CLPTM1 (2.0)	TRIB1 (1.9)	PLCG1 (1.8)	QTRT1 (1.6)	PPP1R37 (1.6)	KANK2 (1.6)	MYLIP (1.6)
ENSG00000129521	EGLN3 PPI subnetwork	0.18	> 0.20	GRINA (4.3)	BCL3 (2.2)	TSSK6 (2.2)	CETP (2.1)	GOT2P1 (1.9)	PVRL2 (1.9)	TMEM57 (1.8)	C1orf63 (1.4)	BCAM (1.4)	GATAD2A (1.4)
MP:0002401	abnormal lymphopoiesis	0.18	> 0.20	GMIP (3.7)	ZNF101 (3.3)	GCNT4 (2.7)	SMARCA4 (2.5)	PBX4 (2.4)	TRIB1 (2.1)	PLCG1 (1.8)	MAU2 (1.8)	MAFB (1.8)	CYB561D1 (1.7)
ENSG00000084073	ZMPSTE24 PPI subnetwork	0.18	> 0.20	LDLR (4.4)	FADS1 (3.5)	HMGCR (3.2)	FADS2 (3.2)	TMED4 (2.9)	ERP29 (2.4)	PCSK9 (2.2)	TMEM50A (2.2)	HNF1A (1.8)	ATXN7L2 (1.7)
GO:0007016	cytoskeletal anchoring at plasma membrane	0.18	> 0.20	RHD (3.6)	RHCE (3.5)	C17orf57 (3.4)	GOT2P1 (3.1)	LPIN3 (2.9)	PLEC (2.6)	OGDH (2.6)	ANKRD31 (2.4)	GEMIN7 (1.8)	PBX4 (1.6)
REACTOME_NEPNS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	REACTOME_NEPNS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	0.18	> 0.20	NAA25 (3.7)	POC5 (3.3)	USP1 (3.0)	DDX56 (2.9)	DOCK7 (2.7)	BUD13 (2.5)	USP24 (2.4)	ILF3 (2.2)	MAPKAPK5 (2.1)	FEN1 (2.0)
MP:0002058	neonatal lethality	0.18	> 0.20	MYLIP (2.9)	ZHX3 (2.5)	SYPL2 (1.8)	PLEKHH2 (1.7)	SORT1 (1.7)	PLCG1 (1.6)	BCAM (1.3)	HAVCR1 (1.3)	CELSR2 (1.3)	KANK2 (1.2)
ENSG00000077063	CTTNBP2 PPI subnetwork	0.18	> 0.20	ZNF180 (2.9)	MARK4 (2.6)	PSMA5 (2.5)	C11orf9 (2.5)	NAA25 (2.3)	CLPTM1 (2.3)	PVRL2 (2.2)	PVR (2.1)	TOMM40 (2.0)	ITGB3 (1.7)
ENSG00000198265	HELZ PPI subnetwork	0.18	> 0.20	MAPKAPK5 (3.2)	SMARCA4 (2.9)	BRAP (2.8)	C12orf43 (2.4)	C12orf51 (2.3)	C19orf52 (2.2)	NAA25 (2.1)	TRAFD1 (2.1)	PCSK9 (2.0)	ATXN2 (2.0)
MP:0009400	decreased skeletal muscle fiber size	0.18	> 0.20	SYPL2 (5.5)	USP24 (3.2)	TRIB1 (3.0)	PLEC (2.2)	AMIGO1 (2.1)	C1orf63 (1.9)	GRINA (1.6)	UBXN2B (1.6)	OGDH (1.5)	TMEM50A (1.5)
GO:0051099	positive regulation of binding	0.18	> 0.20	ANKRD31 (2.0)	HLX (1.9)	DNAH11 (1.8)	MARK4 (1.7)	SH2B3 (1.7)	C17orf57 (1.7)	ENSG00000238078 (1.6)	SARS (1.4)	MAFB (1.4)	C1orf63 (1.3)
ENSG00000169891	REPS2 PPI subnetwork	0.18	> 0.20	MARK4 (3.2)	LPAR2 (2.7)	PPP1R37 (2.7)	HLX (2.6)	GMIP (2.6)	PSRC1 (2.4)	GEMIN7 (2.2)	PVRL2 (1.9)	DNM2 (1.8)	TMEM116 (1.8)
GO:0043903	regulation of symbiosis, encompassing mutualism through parasitism	0.18	> 0.20	DNAH11 (2.5)	HP (2.4)	RHD (2.3)	TIMD4 (2.1)	RHCE (1.9)	ENSG00000238078 (1.8)	GOT2P1 (1.8)	ENSG00000228044 (1.8)	CETP (1.7)	ANKRD31 (1.6)
ENSG00000134419	RPS15A PPI subnetwork	0.18	> 0.20	NAA25 (3.6)	DDX56 (3.5)	QTRT1 (3.0)	C12orf43 (2.8)	ZNF259 (2.7)	ILF3 (2.7)	TOMM40 (2.6)	SARS (2.4)	DHX38 (2.3)	TOP1 (2.3)
MP:0008872	abnormal physiological response to xenobiotic	0.18	> 0.20	CETP (2.4)	TM6SF2 (2.3)	RPH3A (2.2)	POLK (2.2)	SH2B3 (2.2)	SLC22A1 (2.2)	ABCG8 (2.1)	KIAA1324 (1.8)	BCAM (1.8)	BCL3 (1.8)
ENSG00000121931	LRIF1 PPI subnetwork	0.18	> 0.20	TOMM40 (2.8)	TXNL4B (2.5)	PSMA5 (2.5)	ZNF180 (2.3)	GEMIN7 (2.1)	ATXN7L2 (2.0)	PPP1R37 (2.0)	CLPTM1 (2.0)	DHX38 (1.9)	PVR (1.8)
GO:0006760	folic acid-containing compound metabolic process	0.18	> 0.20	TXNL4B (2.8)	GOT2P1 (2.8)	CYP7A1 (2.7)	ENSG00000238078 (2.5)	ENSG00000254235 (2.4)	DHODH (2.4)	ABCG8 (2.3)	CEACAM19 (1.9)	LPA (1.8)	HNF1A (1.7)
ENSG00000167526	RPL13 PPI subnetwork	0.18	> 0.20	NAA25 (2.7)	SARS (2.3)	ATP13A1 (2.2)	ZNF259 (2.1)	DHX38 (2.1)	DDX56 (1.9)	GATAD2A (1.8)	TOMM40 (1.8)	ILF3 (1.8)	SUGP1 (1.8)
MP:0008496	decreased IgG2a level	0.18	> 0.20	RELB (5.9)	CETP (3.5)	BCL3 (2.8)	GMIP (2.7)	TIMD4 (2.6)	ZNF101 (2.2)	SH2B3 (1.9)	TRAFD1 (1.7)	PARP10 (1.7)	TRIB1 (1.6)
GO:0060333	interferon-gamma-mediated signaling pathway	0.18	> 0.20	TRAFD1 (5.2)	PARP10 (4.9)	OASL (3.7)	ADAM1 (3.4)	C12orf43 (2.1)	ENSG00000228044 (2.0)	CEACAM19 (1.9)	CYB561D1 (1.9)	BCL3 (1.9)	RELB (1.8)
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	0.18	> 0.20	DHODH (4.7)	ST3GAL4 (4.4)	ZNF259 (3.4)	QTRT1 (2.9)	ENSG00000226645 (2.5)	TOMM40 (2.5)	DDX56 (2.4)	TRAPPC6A (2.0)	SUGP1 (1.8)	FEN1 (1.7)
ENSG00000134109	EDEM1 PPI subnetwork	0.18	> 0.20	C19orf52 (3.2)	SARS (3.1)	ST3GAL4 (2.2)	ERP29 (2.1)	NCAN (2.0)	DHODH (1.8)	RPH3A (1.7)	ENSG00000238078 (1.6)	TIMD4 (1.6)	PMFBP1 (1.6)
MP:0002940	variable body spotting	0.18	> 0.20	HMGCR (3.2)	PCSK9 (3.0)	PLEKHH2 (2.8)	LDLR (2.4)	MYLIP (2.0)	APOE (2.0)	FADS1 (1.9)	KANK2 (1.8)	ENSG00000235545 (1.8)	ST3GAL4 (1.6)
ENSG00000182004	SNRPE PPI subnetwork	0.18	> 0.20	ILF3 (3.8)	TOP1 (3.0)	BUD13 (2.9)	C1orf63 (2.8)	USP1 (2.8)	SMARCA4 (2.6)	DHX38 (2.6)	FEN1 (2.5)	QTRT1 (2.3)	SUGP1 (2.0)
GO:0042346	positive regulation of NF-kappaB import into nucleus	0.18	> 0.20	ENSG00000228044 (2.9)	ENSG00000238078 (2.9)	ENSG00000235545 (2.2)	SH2B3 (2.2)	MYLIP (1.9)	OASL (1.8)	ZNF180 (1.7)	DNAH11 (1.5)	ST3GAL4 (1.4)	LPAR2 (1.3)
MP:0004809	increased hematopoietic stem cell number	0.18	> 0.20	ITGB3 (4.8)	HLX (3.2)	GMIP (2.5)	ATXN2 (2.2)	HAVCR1 (2.0)	NYNRIN (1.9)	SH2B3 (1.9)	POLK (1.8)	C12orf51 (1.7)	SLC44A2 (1.6)
ENSG00000107937	GTPBP4 PPI subnetwork	0.18	> 0.20	ZNF259 (4.7)	NAA25 (4.5)	DDX56 (4.3)	TOMM40 (3.9)	QTRT1 (3.3)	DHX38 (2.8)	DHODH (2.6)	ATP13A1 (2.5)	ILF3 (2.4)	TOP1 (2.2)
MP:0002223	lymphoid hypoplasia	0.18	> 0.20	FADS1 (6.1)	BLOC1S3 (2.8)	LDLR (2.8)	HMGCR (2.5)	UBXN2B (2.2)	GMIP (2.0)	LPIN3 (1.9)	OGDH (1.7)	SYPL2 (1.7)	ABCG8 (1.7)
MP:0005189	abnormal anogenital distance	0.18	> 0.20	LPAR2 (2.6)	PBX4 (2.5)	ALDH2 (1.9)	ATXN7L2 (1.9)	CYP7A1 (1.8)	TMED4 (1.8)	PVRL2 (1.6)	KIAA1324 (1.6)	YIPF2 (1.5)	MARK4 (1.5)
ENSG00000165525	NEMF PPI subnetwork	0.18	> 0.20	NAA25 (3.3)	ZNF259 (3.2)	SARS (2.5)	DDX56 (2.5)	QTRT1 (2.3)	GATAD2A (2.1)	DNAH11 (2.0)	TOMM40 (1.9)	TOP1 (1.8)	TMEM57 (1.7)
ENSG00000144648	CCBP2 PPI subnetwork	0.18	> 0.20	OASL (3.6)	RELB (2.7)	CETP (2.6)	MAFB (2.0)	TIMD4 (1.8)	TM6SF2 (1.7)	NPC1L1 (1.7)	BCL3 (1.7)	ZNF101 (1.5)	HLX (1.3)
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	0.18	> 0.20	TM6SF2 (3.6)	TMEM116 (3.3)	SORT1 (3.1)	ATP13A1 (3.0)	CLPTM1 (2.8)	ABCG8 (2.4)	ANGPTL3 (2.4)	PLG (2.4)	RHD (2.0)	HAPLN4 (2.0)
ENSG00000105379	ETFB PPI subnetwork	0.18	> 0.20	TRAPPC6A (3.3)	PSMA5 (3.0)	APOC4 (2.1)	ACAD10 (2.0)	APOC1 (1.9)	ATXN7L2 (1.7)	DYNC2LI1 (1.6)	OGDH (1.5)	HNF1A (1.5)	APOA5 (1.4)
ENSG00000205937	RNPS1 PPI subnetwork	0.18	> 0.20	TOP1 (4.5)	ILF3 (4.0)	C1orf63 (3.8)	DHX38 (3.1)	SMARCA4 (3.1)	BUD13 (3.0)	SUGP1 (2.8)	USP1 (2.7)	GATAD2A (2.4)	PTPN11 (2.1)
ENSG00000100028	SNRPD3 PPI subnetwork	0.18	> 0.20	ILF3 (3.5)	DHX38 (3.4)	BUD13 (3.3)	TOP1 (3.1)	SUGP1 (2.8)	C1orf63 (2.6)	SMARCA4 (2.5)	QTRT1 (2.4)	FEN1 (2.4)	USP1 (2.4)
MP:0008029	abnormal paraxial mesoderm morphology	0.18	> 0.20	PLCG1 (3.3)	NYNRIN (2.4)	C17orf57 (2.2)	GATAD2A (2.2)	KANK2 (1.8)	CEACAM19 (1.7)	ALDH2 (1.6)	ATXN2 (1.6)	UBXN2B (1.6)	FADS2 (1.5)
ENSG00000105376	ICAM5 PPI subnetwork	0.18	> 0.20	GMIP (3.4)	DNM2 (3.3)	USP24 (2.9)	PLEC (2.6)	PVR (2.4)	POLK (2.3)	ALDH2 (2.2)	COL4A3BP (2.0)	SORT1 (1.8)	MAU2 (1.7)
GO:0021602	cranial nerve morphogenesis	0.18	> 0.20	ANKRD31 (3.9)	HAVCR1 (2.5)	PMFBP1 (2.2)	BLOC1S3 (2.2)	TSSK6 (1.9)	FRK (1.6)	GOT2P1 (1.6)	DYNC2LI1 (1.6)	CEACAM19 (1.5)	NKPD1 (1.4)
GO:0016604	nuclear body	0.18	> 0.20	BUD13 (4.0)	TOP1 (3.6)	USP1 (3.6)	C1orf63 (3.2)	BRAP (2.5)	DHX38 (2.4)	ILF3 (2.3)	FEN1 (2.3)	ATXN2 (2.0)	GATAD2A (1.9)
ENSG00000087111	PIGS PPI subnetwork	0.18	> 0.20	ATP13A1 (3.8)	CYB561D1 (3.1)	HAVCR1 (3.0)	ERP29 (2.9)	SORT1 (2.5)	CLPTM1 (2.4)	YIPF2 (2.2)	C12orf51 (2.1)	NT5DC1 (2.1)	ATXN7L2 (2.0)
GO:0033865	nucleoside bisphosphate metabolic process	0.18	> 0.20	ENSG00000228044 (2.9)	LDLR (2.7)	PCSK9 (2.5)	CYP7A1 (2.5)	FADS2 (2.5)	TM6SF2 (2.3)	HMGCR (2.1)	ABCG5 (2.0)	FADS1 (1.8)	ABCG8 (1.6)
GO:0005161	platelet-derived growth factor receptor binding	0.18	> 0.20	C17orf57 (3.7)	ITGB3 (3.3)	KANK2 (2.6)	HLX (2.4)	LDLR (1.9)	SH2B3 (1.9)	AP1M2 (1.4)	BCL3 (1.3)	C11orf9 (1.2)	MAPKAPK5 (1.2)
MP:0008396	abnormal osteoclast differentiation	0.18	> 0.20	GMIP (3.3)	TRIB1 (3.1)	SH2B3 (2.7)	PARP10 (2.3)	HLX (2.3)	PVR (2.3)	MYLIP (2.2)	BCL3 (2.2)	MAFB (2.1)	RELB (1.9)
MP:0008502	increased IgG3 level	0.18	> 0.20	RELB (4.4)	BCL3 (3.3)	SH2B3 (2.4)	GMIP (2.3)	PBX4 (1.9)	MAFB (1.6)	POLK (1.5)	ALDH2 (1.4)	ZNF101 (1.4)	PVR (1.4)
MP:0011260	abnormal head mesenchyme morphology	0.18	> 0.20	GATAD2A (3.6)	ATP13A1 (3.2)	C17orf57 (3.1)	DOCK7 (2.9)	QTRT1 (2.7)	ITGB3 (2.7)	ABO (2.4)	CLPTM1 (2.2)	ANKRD31 (2.1)	PLCG1 (1.8)
REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	0.18	> 0.20	NAA25 (3.6)	POC5 (3.4)	DDX56 (3.0)	USP1 (2.8)	DOCK7 (2.6)	BUD13 (2.4)	USP24 (2.4)	ILF3 (2.3)	FEN1 (2.0)	DHX38 (1.8)
MP:0004068	dilated dorsal aorta	0.18	> 0.20	CETP (2.2)	SH2B3 (2.2)	BCAM (2.2)	RHD (2.0)	PVR (1.8)	BLOC1S3 (1.6)	ZNF180 (1.6)	HLX (1.6)	SLC44A2 (1.6)	NYNRIN (1.5)
ENSG00000129473	BCL2L2 PPI subnetwork	0.18	> 0.20	FRK (3.3)	PARP10 (2.9)	TRAPPC6A (2.8)	OASL (2.2)	RELB (2.2)	TOMM40 (1.9)	CBLC (1.8)	PTPN11 (1.8)	CLPTM1 (1.7)	ZNF180 (1.7)
GO:0042623	ATPase activity, coupled	0.18	> 0.20	ATP13A1 (3.6)	DHX38 (3.5)	SUGP1 (3.1)	SMARCA4 (2.8)	MAU2 (2.5)	ILF3 (2.5)	OASL (2.4)	NAA25 (2.4)	USP24 (2.3)	DOCK7 (2.0)
GO:0060525	prostate glandular acinus development	0.18	> 0.20	ENSG00000254235 (3.1)	GOT2P1 (2.9)	DNAH11 (2.5)	AMIGO1 (2.2)	ANKRD31 (2.1)	ADAM1 (1.9)	KIAA1324 (1.8)	C19orf52 (1.6)	CBLC (1.6)	GCNT4 (1.5)
KEGG_ETHER_LIPID_METABOLISM	KEGG_ETHER_LIPID_METABOLISM	0.18	> 0.20	NKPD1 (4.7)	TIMD4 (3.4)	CETP (2.6)	APOE (2.1)	COL4A3BP (2.0)	DOCK7 (1.9)	TMEM116 (1.8)	ST3GAL4 (1.8)	TMEM57 (1.7)	DYNC2LI1 (1.6)
REACTOME_POST:TRANSLATIONAL_PROTEIN_MODIFICATION	REACTOME_POST:TRANSLATIONAL_PROTEIN_MODIFICATION	0.18	> 0.20	YIPF2 (4.4)	ERP29 (3.7)	TMED4 (3.6)	ATP13A1 (3.1)	ST3GAL4 (2.4)	CLPTM1 (2.3)	TMEM57 (2.3)	KIAA1324 (2.2)	TMEM50A (2.2)	PVRL2 (1.8)
ENSG00000167258	CDK12 PPI subnetwork	0.18	> 0.20	TOP1 (3.2)	SMARCA4 (3.0)	GEMIN7 (3.0)	GATAD2A (2.8)	SUGP1 (2.5)	BUD13 (2.2)	TRAFD1 (1.8)	MAU2 (1.8)	NYNRIN (1.7)	PPP1R37 (1.7)
REACTOME_PROSTANOID_METABOLISM	REACTOME_PROSTANOID_METABOLISM	0.18	> 0.20	ALDH2 (3.7)	GMPR (2.7)	HLX (2.1)	NT5DC1 (2.1)	BCAM (2.0)	NYNRIN (2.0)	ADAM1 (2.0)	PLEKHH2 (1.9)	ITGB3 (1.9)	C12orf43 (1.7)
REACTOME_SEMA3A:PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	REACTOME_SEMA3A:PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	0.18	> 0.20	PVRL2 (3.1)	NYNRIN (2.9)	PVR (2.8)	HLX (2.8)	SH2B3 (2.7)	PLEC (2.5)	ENSG00000254235 (2.3)	MARK4 (1.9)	OGDH (1.8)	ENSG00000226645 (1.8)
MP:0009115	abnormal fat cell morphology	0.18	> 0.20	MOSC1 (3.9)	APOC1 (3.0)	SORT1 (2.8)	GPAM (2.7)	GCNT4 (2.7)	PPP1R37 (2.4)	TMEM57 (1.9)	ST3GAL4 (1.8)	MYLIP (1.8)	HP (1.8)
GO:0004518	nuclease activity	0.18	> 0.20	ZNF180 (2.5)	DHODH (2.3)	POC5 (2.3)	FEN1 (2.3)	C12orf43 (2.2)	NT5DC1 (2.0)	DDX56 (2.0)	ZNF259 (2.0)	BUD13 (1.9)	NKPD1 (1.8)
ENSG00000115307	AUP1 PPI subnetwork	0.18	> 0.20	ITGB3 (6.2)	C1orf63 (2.1)	PVR (2.0)	PTPN11 (1.9)	TXNL4B (1.8)	ALDH2 (1.7)	LDLR (1.7)	SH2B3 (1.6)	MOSC1 (1.4)	COL4A3BP (1.3)
MP:0005350	increased susceptibility to autoimmune disorder	0.18	> 0.20	GOT2P1 (2.4)	GCNT4 (2.1)	PBX4 (2.0)	RELB (2.0)	C12orf47 (1.5)	CELSR2 (1.5)	SLC22A1 (1.4)	TRAFD1 (1.3)	ENSG00000254235 (1.3)	PPP1R37 (1.3)
GO:0002762	negative regulation of myeloid leukocyte differentiation	0.18	> 0.20	ST3GAL4 (3.5)	GCNT4 (3.2)	DNAH11 (2.2)	LPIN3 (2.1)	DYNC2LI1 (1.9)	ENSG00000235545 (1.5)	GPAM (1.5)	ENSG00000226645 (1.4)	ATXN7L2 (1.4)	C19orf52 (1.4)
GO:0034130	toll-like receptor 1 signaling pathway	0.18	> 0.20	SH2B3 (2.7)	BLOC1S3 (2.3)	TRIB1 (2.2)	ENSG00000226645 (2.0)	CYB561D1 (1.9)	HLX (1.9)	RELB (1.8)	ENSG00000228044 (1.8)	LPAR2 (1.7)	BUD13 (1.6)
ENSG00000166200	COPS2 PPI subnetwork	0.18	> 0.20	ATXN7L2 (2.1)	PSRC1 (1.9)	POC5 (1.8)	ENSG00000226648 (1.8)	BUD13 (1.7)	QTRT1 (1.7)	DYNC2LI1 (1.6)	NT5DC1 (1.6)	GRINA (1.6)	TIMD4 (1.5)
REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	0.18	> 0.20	AP1M2 (3.4)	YIPF2 (3.0)	ERP29 (2.6)	QTRT1 (2.3)	ENSG00000228044 (2.2)	LPAR2 (2.0)	PMFBP1 (1.9)	ST3GAL4 (1.8)	LPIN3 (1.8)	GATAD2A (1.7)
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	0.18	> 0.20	PSMA5 (6.0)	TRAFD1 (3.5)	NAA25 (2.4)	NT5DC1 (2.4)	SUGP1 (1.7)	TOMM40 (1.7)	PARP10 (1.6)	DDX56 (1.5)	TMEM50A (1.2)	DHX38 (1.2)
GO:0010627	regulation of intracellular protein kinase cascade	0.18	> 0.20	PVR (2.7)	POLK (2.6)	SH2B3 (2.2)	ST3GAL4 (2.1)	GRINA (2.0)	TRIB1 (1.9)	PARP10 (1.8)	HLX (1.7)	PTPN11 (1.5)	ENSG00000226645 (1.5)
GO:0009067	aspartate family amino acid biosynthetic process	0.18	> 0.20	ENSG00000254235 (3.0)	GOT2P1 (2.6)	SARS (2.3)	DNAH11 (2.0)	TXNL4B (1.9)	TMED4 (1.8)	DHODH (1.7)	TMEM116 (1.7)	NT5DC1 (1.6)	CYP7A1 (1.5)
MP:0003638	abnormal response/metabolism to endogenous compounds	0.18	> 0.20	ABCG5 (2.3)	NCAN (1.9)	CBLC (1.9)	BCAM (1.8)	CYP7A1 (1.8)	DNAH11 (1.8)	ABCG8 (1.7)	AP1M2 (1.7)	ERP29 (1.7)	POLK (1.7)
ENSG00000163435	ELF3 PPI subnetwork	0.18	> 0.20	OASL (3.9)	PARP10 (2.7)	TRAFD1 (2.3)	TMEM57 (2.2)	SARS (2.2)	GMPR (2.1)	SMARCA4 (1.9)	LPIN3 (1.7)	ATP13A1 (1.7)	ERP29 (1.6)
ENSG00000147852	VLDLR PPI subnetwork	0.18	> 0.20	APOC1 (4.4)	CETP (2.8)	GPAM (2.7)	TIMD4 (2.5)	ENSG00000254235 (2.4)	SYPL2 (2.3)	TMED4 (2.1)	APOE (1.9)	ERP29 (1.7)	RHD (1.7)
MP:0005670	abnormal white adipose tissue physiology	0.18	> 0.20	MOSC1 (4.3)	GPAM (4.0)	SORT1 (2.8)	HP (2.7)	ST3GAL4 (2.7)	MAU2 (2.1)	ALDH2 (2.0)	MAPKAPK5 (1.9)	SH2B3 (1.7)	LPIN3 (1.7)
ENSG00000141956	PRDM15 PPI subnetwork	0.18	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.7)	PLEKHH2 (2.1)	TMEM57 (1.8)	DNAH11 (1.6)	C1orf63 (1.5)	CEACAM19 (1.3)	SYPL2 (1.3)	TSSK6 (1.3)
REACTOME_STABILIZATION_OF_P53	REACTOME_STABILIZATION_OF_P53	0.18	> 0.20	PSMA5 (6.2)	TRAFD1 (3.7)	NAA25 (2.6)	NT5DC1 (2.5)	PARP10 (2.2)	SARS (1.7)	DDX56 (1.7)	SUGP1 (1.7)	TOMM40 (1.7)	ZNF259 (1.3)
ENSG00000065054	SLC9A3R2 PPI subnetwork	0.18	> 0.20	PLEC (2.8)	ST3GAL4 (2.1)	SLC44A2 (2.0)	MAU2 (1.9)	TMEM116 (1.9)	MYLIP (1.9)	GEMIN7 (1.8)	ABO (1.6)	PLG (1.6)	MOSC1 (1.6)
GO:0043548	phosphatidylinositol 3-kinase binding	0.18	> 0.20	DNAH11 (2.4)	ZNF180 (2.3)	MYLIP (2.3)	SLC44A2 (2.1)	PBX4 (2.1)	COL4A3BP (1.9)	HLX (1.8)	ZNF101 (1.7)	CELSR2 (1.7)	FRK (1.6)
GO:0014743	regulation of muscle hypertrophy	0.18	> 0.20	CEACAM19 (4.2)	HNF1A (2.8)	ENSG00000235545 (2.4)	ANKRD31 (2.4)	TRAPPC6A (2.0)	SYPL2 (1.8)	DNAH11 (1.8)	HAVCR1 (1.8)	ENSG00000254235 (1.7)	AMIGO1 (1.6)
GO:0033137	negative regulation of peptidyl-serine phosphorylation	0.18	> 0.20	DNAH11 (2.9)	CYB561D1 (2.6)	PPP1R37 (2.3)	ABO (2.2)	BLOC1S3 (2.2)	LPAR2 (2.0)	ENSG00000254235 (1.8)	TSSK6 (1.8)	TRAPPC6A (1.7)	YIPF2 (1.6)
GO:0050750	low-density lipoprotein particle receptor binding	0.18	> 0.20	APOC1 (3.7)	ERP29 (3.0)	ABCG5 (2.9)	TMED4 (2.6)	NPC1L1 (2.5)	HNF1A (2.4)	PLG (2.2)	APOC4 (2.1)	FRK (2.0)	HP (1.9)
GO:0005164	tumor necrosis factor receptor binding	0.18	> 0.20	RELB (2.7)	DNAH11 (2.2)	GCNT4 (1.9)	PARP10 (1.9)	TIMD4 (1.9)	CETP (1.9)	HAVCR1 (1.9)	SH2B3 (1.8)	TRAPPC6A (1.7)	ENSG00000228044 (1.6)
MP:0000914	exencephaly	0.18	> 0.20	ATXN2 (2.7)	DYNC2LI1 (2.4)	CARM1 (2.4)	DOCK7 (2.4)	PVRL2 (2.3)	TRIB1 (2.3)	MARK4 (2.1)	NYNRIN (2.0)	PLCG1 (1.8)	KANK2 (1.6)
MP:0001313	increased incidence of corneal inflammation	0.18	> 0.20	AMIGO1 (2.5)	DNAH11 (2.4)	C17orf57 (1.8)	LPIN3 (1.8)	NKPD1 (1.5)	OASL (1.4)	ST3GAL4 (1.4)	CELSR2 (1.3)	LPAR2 (1.3)	PVR (1.2)
GO:0042826	histone deacetylase binding	0.18	> 0.20	HLX (2.9)	CARM1 (2.0)	MAU2 (1.9)	C12orf51 (1.8)	SH2B3 (1.6)	KANK2 (1.5)	DNM2 (1.5)	MARK4 (1.5)	MAFB (1.5)	TMEM57 (1.5)
ENSG00000163602	RYBP PPI subnetwork	0.18	> 0.20	PMFBP1 (2.5)	TOP1 (1.9)	ENSG00000238078 (1.8)	C11orf9 (1.7)	TXNL4B (1.6)	BCL3 (1.6)	GATAD2A (1.5)	LDLR (1.5)	HNF1A (1.4)	BUD13 (1.3)
ENSG00000126001	CEP250 PPI subnetwork	0.18	> 0.20	DNM2 (3.3)	GPAM (3.1)	PLEC (3.0)	COL4A3BP (2.9)	C11orf9 (2.7)	ZHX3 (2.6)	LPAR2 (2.6)	CARM1 (2.5)	KANK2 (2.3)	OGDH (2.3)
MP:0002490	abnormal immunoglobulin level	0.18	> 0.20	RELB (5.0)	CETP (3.2)	BCL3 (2.9)	GMIP (2.3)	PARP10 (2.2)	PBX4 (2.2)	TRAFD1 (2.0)	SLC44A2 (1.8)	TIMD4 (1.8)	LPAR2 (1.6)
ENSG00000204217	BMPR2 PPI subnetwork	0.18	> 0.20	LPIN3 (2.5)	APOA5 (2.3)	NYNRIN (2.0)	PLEKHH2 (2.0)	ENSG00000228044 (1.9)	CARM1 (1.8)	DOCK7 (1.7)	FRK (1.7)	C11orf9 (1.7)	ABCG8 (1.6)
ENSG00000112335	SNX3 PPI subnetwork	0.18	> 0.20	ZNF101 (2.0)	TXNL4B (1.9)	TMEM50A (1.9)	RELB (1.8)	NYNRIN (1.8)	POC5 (1.7)	MOSC1 (1.7)	ABO (1.6)	GMIP (1.5)	DNM2 (1.5)
ENSG00000119535	CSF3R PPI subnetwork	0.18	> 0.20	BCL3 (3.7)	COL4A3BP (2.3)	HLX (1.8)	C17orf57 (1.6)	RELB (1.6)	PVR (1.5)	CYP7A1 (1.5)	ZNF101 (1.4)	HP (1.2)	SH2B3 (1.1)
ENSG00000136243	NUPL2 PPI subnetwork	0.18	> 0.20	NAA25 (3.8)	USP1 (3.6)	POC5 (2.9)	DOCK7 (2.7)	BUD13 (2.5)	FEN1 (2.3)	ILF3 (2.2)	DDX56 (2.2)	USP24 (2.1)	ENSG00000226648 (1.8)
ENSG00000140396	NCOA2 PPI subnetwork	0.18	> 0.20	TRIB1 (3.3)	MAU2 (2.8)	UBXN2B (2.5)	MAFB (2.4)	MYLIP (2.3)	BCL3 (1.7)	KANK2 (1.7)	OASL (1.5)	ATXN2 (1.4)	COL4A3BP (1.3)
ENSG00000107882	SUFU PPI subnetwork	0.18	> 0.20	NYNRIN (3.1)	TRIB1 (2.4)	PPP1R37 (2.2)	FADS2 (2.1)	BLOC1S3 (2.0)	COL4A3BP (1.8)	MARK4 (1.7)	PLEKHH2 (1.6)	PLCG1 (1.6)	ENSG00000235545 (1.5)
ENSG00000204264	PSMB8 PPI subnetwork	0.18	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
ENSG00000206234	ENSG00000206234 PPI subnetwork	0.18	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
ENSG00000206298	PSMB8 PPI subnetwork	0.18	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
GO:0033017	sarcoplasmic reticulum membrane	0.18	> 0.20	SYPL2 (7.4)	HAVCR1 (2.5)	C17orf57 (2.5)	GMPR (2.3)	CYB561D1 (1.8)	ABO (1.6)	CARM1 (1.6)	OGDH (1.5)	TMED4 (1.4)	C12orf47 (1.4)
MP:0002896	abnormal bone mineralization	0.18	> 0.20	CILP2 (4.4)	MAFB (2.5)	KIAA1324 (2.4)	MYLIP (1.7)	APOE (1.6)	HLX (1.6)	YIPF2 (1.5)	FRK (1.5)	TMEM116 (1.5)	ANKRD31 (1.4)
MP:0004838	abnormal neural fold elevation formation	0.18	> 0.20	PPP1R37 (2.4)	TOP1 (2.4)	HMGCR (2.3)	TRIB1 (2.3)	CBLC (2.1)	ABCG8 (1.8)	ST3GAL4 (1.6)	BLOC1S3 (1.5)	ENSG00000226648 (1.5)	ALDH2 (1.4)
ENSG00000168066	SF1 PPI subnetwork	0.18	> 0.20	SUGP1 (3.1)	C1orf63 (3.0)	BUD13 (2.9)	DHX38 (2.9)	SMARCA4 (2.8)	CLPTM1 (2.8)	ATXN2 (2.5)	GATAD2A (2.5)	ILF3 (2.5)	MAU2 (2.1)
ENSG00000141232	TOB1 PPI subnetwork	0.18	> 0.20	DOCK7 (2.7)	MAFB (2.0)	ATXN2 (1.9)	CETP (1.7)	ADAM1 (1.6)	SH2B3 (1.5)	ALDH2 (1.5)	GRINA (1.5)	ENSG00000235545 (1.5)	ABCG8 (1.4)
MP:0005362	abnormal Langerhans cell physiology	0.18	> 0.20	MAFB (3.5)	HLX (2.3)	MYLIP (2.2)	BCL3 (2.2)	TRAFD1 (2.2)	CETP (1.8)	TIMD4 (1.7)	TRIB1 (1.5)	ENSG00000238078 (1.5)	PLEKHH2 (1.4)
MP:0001126	abnormal ovary morphology	0.18	> 0.20	ST3GAL4 (2.6)	TMEM57 (2.4)	OASL (2.2)	PLEKHH2 (2.1)	LPIN3 (2.0)	KANK2 (1.9)	FRK (1.7)	APOE (1.6)	NYNRIN (1.6)	NKPD1 (1.6)
ENSG00000198909	MAP3K3 PPI subnetwork	0.18	> 0.20	SARS (4.3)	PLEC (3.0)	SMARCA4 (2.8)	OGDH (2.7)	TOMM40 (2.5)	PSMA5 (2.4)	PVR (2.3)	ATXN2 (1.9)	GATAD2A (1.8)	ATP13A1 (1.8)
GO:0043202	lysosomal lumen	0.18	> 0.20	MAFB (4.2)	APOE (4.1)	ERP29 (3.8)	ATP13A1 (2.9)	GRINA (2.4)	HNF1A (2.3)	CLPTM1 (2.2)	TMEM50A (1.9)	TMED4 (1.8)	PMFBP1 (1.7)
MP:0003698	abnormal male reproductive system physiology	0.18	> 0.20	KIAA1324 (3.1)	NKPD1 (2.5)	PCSK9 (2.3)	ABCG5 (2.3)	GMPR (2.2)	TRAPPC6A (2.1)	RHCE (2.0)	PARP10 (1.9)	ALDH2 (1.8)	APOB (1.7)
GO:0042594	response to starvation	0.18	> 0.20	BRAP (3.5)	ACAD10 (3.4)	NPC1L1 (2.3)	ABCG8 (2.3)	HNF1A (2.2)	TXNL4B (2.2)	SARS (2.2)	FADS2 (2.1)	ABCG5 (2.0)	TM6SF2 (1.9)
ENSG00000163558	PRKCI PPI subnetwork	0.19	> 0.20	DNM2 (2.8)	COL4A3BP (2.6)	CELSR2 (2.6)	UBXN2B (2.5)	PLEC (2.5)	C11orf9 (2.4)	GRINA (2.2)	POLK (2.0)	AP1M2 (1.9)	C12orf51 (1.9)
MP:0008721	abnormal chemokine level	0.19	> 0.20	HP (3.5)	MAFB (3.2)	BCL3 (2.7)	TRIB1 (2.6)	RELB (2.3)	TIMD4 (2.3)	CETP (2.2)	HLX (2.0)	PMFBP1 (1.8)	GMIP (1.6)
GO:0022613	ribonucleoprotein complex biogenesis	0.19	> 0.20	ZNF259 (3.9)	C12orf43 (3.5)	DDX56 (3.3)	QTRT1 (3.3)	NAA25 (3.1)	TOMM40 (2.8)	DHODH (2.8)	MAPKAPK5 (2.6)	SUGP1 (2.5)	BRAP (2.3)
ENSG00000044115	CTNNA1 PPI subnetwork	0.19	> 0.20	DOCK7 (3.2)	BCAM (3.2)	C11orf9 (3.0)	PVRL2 (3.0)	PLEC (2.8)	APOE (2.1)	PVR (2.1)	GMPR (1.9)	POLK (1.6)	OGDH (1.5)
ENSG00000138767	CNOT6L PPI subnetwork	0.19	> 0.20	ATP13A1 (4.0)	DDX56 (2.7)	MAPKAPK5 (2.6)	HNF1A (2.4)	BRAP (2.4)	TOMM40 (2.2)	MAU2 (2.1)	TRIB1 (2.0)	PTPN11 (1.9)	DHODH (1.9)
ENSG00000161513	FDXR PPI subnetwork	0.19	> 0.20	TRAPPC6A (3.7)	ACAD10 (3.0)	APOC1 (2.6)	GOT2P1 (2.0)	ATXN2 (2.0)	APOC4 (1.7)	APOE (1.7)	GPAM (1.7)	ADAM1 (1.6)	COL4A3BP (1.6)
ENSG00000080815	PSEN1 PPI subnetwork	0.19	> 0.20	DNM2 (3.4)	NYNRIN (2.6)	CELSR2 (2.6)	CLPTM1 (2.3)	PLEC (2.3)	ENSG00000226645 (2.1)	GRINA (2.0)	YIPF2 (2.0)	NCAN (2.0)	DNAH11 (2.0)
ENSG00000167513	CDT1 PPI subnetwork	0.19	> 0.20	FEN1 (6.6)	USP1 (4.9)	HLX (1.8)	PSRC1 (1.8)	NT5DC1 (1.6)	BUD13 (1.6)	MAU2 (1.3)	MYLIP (1.2)	GMPR (1.2)	FADS1 (1.1)
MP:0005616	decreased susceptibility to type IV hypersensitivity reaction	0.19	> 0.20	BCL3 (4.2)	RELB (3.5)	HLX (3.0)	MAFB (2.7)	PVR (1.9)	ZNF101 (1.9)	OASL (1.9)	TRAFD1 (1.7)	TIMD4 (1.7)	TRIB1 (1.6)
ENSG00000134697	GNL2 PPI subnetwork	0.19	> 0.20	ZNF259 (4.9)	NAA25 (4.5)	DDX56 (4.1)	DHX38 (3.2)	TOMM40 (3.1)	QTRT1 (2.8)	DHODH (2.7)	ATP13A1 (2.4)	ENSG00000226645 (2.3)	SUGP1 (2.2)
ENSG00000108296	CWC25 PPI subnetwork	0.19	> 0.20	BRAP (3.8)	SUGP1 (3.2)	BUD13 (3.1)	ZNF259 (2.6)	C12orf43 (2.5)	ENSG00000226645 (2.4)	TOP1 (2.4)	POC5 (2.3)	SARS (2.3)	QTRT1 (2.1)
ENSG00000213024	NUP62 PPI subnetwork	0.19	> 0.20	POC5 (2.9)	CARM1 (2.8)	DOCK7 (2.8)	USP1 (2.7)	NAA25 (2.6)	USP24 (2.5)	ILF3 (2.1)	MAPKAPK5 (2.1)	DDX56 (2.0)	BUD13 (2.0)
GO:0035254	glutamate receptor binding	0.19	> 0.20	KIAA1324 (2.8)	RPH3A (2.5)	GCNT4 (2.4)	CELSR2 (2.3)	GOT2P1 (2.2)	HAPLN4 (2.1)	HNF1A (1.9)	ENSG00000238078 (1.8)	FRK (1.7)	SORT1 (1.6)
GO:0051403	stress-activated MAPK cascade	0.19	> 0.20	HLX (2.4)	ENSG00000228044 (2.0)	PVR (1.9)	MAU2 (1.8)	SH2B3 (1.8)	ENSG00000226645 (1.6)	POLK (1.6)	ZNF180 (1.5)	TRIB1 (1.5)	MARK4 (1.4)
MP:0000217	abnormal leukocyte cell number	0.19	> 0.20	MAFB (4.9)	RHCE (3.7)	RHD (3.4)	TIMD4 (3.0)	CETP (2.9)	SH2B3 (2.6)	TRIB1 (2.6)	GMIP (2.1)	RELB (2.1)	ZNF101 (1.7)
ENSG00000178896	EXOSC4 PPI subnetwork	0.19	> 0.20	SUGP1 (3.7)	DHODH (3.1)	USP24 (2.9)	DDX56 (2.9)	SMARCA4 (2.3)	ZNF259 (2.3)	TOMM40 (2.1)	C12orf43 (2.0)	DHX38 (1.9)	QTRT1 (1.9)
MP:0000751	myopathy	0.19	> 0.20	SYPL2 (5.8)	BCAM (3.5)	CILP2 (2.4)	PLEC (2.3)	SORT1 (1.9)	CELSR2 (1.9)	KANK2 (1.7)	GMPR (1.6)	RPH3A (1.5)	ENSG00000238078 (1.5)
GO:0045136	development of secondary sexual characteristics	0.19	> 0.20	BLOC1S3 (3.1)	ST3GAL4 (2.9)	DNAH11 (2.5)	C17orf57 (2.3)	COL4A3BP (1.9)	NT5DC1 (1.8)	ZNF180 (1.8)	ABO (1.7)	NKPD1 (1.6)	SH2B3 (1.5)
GO:0042445	hormone metabolic process	0.19	> 0.20	CYP7A1 (2.6)	NKPD1 (2.5)	ABCG5 (2.4)	LPA (2.3)	SLC22A1 (2.1)	CYB561D1 (2.1)	ST3GAL4 (2.0)	ABCG8 (2.0)	PMFBP1 (1.9)	TM6SF2 (1.6)
ENSG00000100815	TRIP11 PPI subnetwork	0.19	> 0.20	DNM2 (3.6)	PTPN11 (3.2)	ZHX3 (3.1)	KANK2 (3.0)	CARM1 (2.9)	C11orf9 (2.9)	PLEC (2.8)	COL4A3BP (2.4)	LPAR2 (2.4)	USP24 (2.3)
GO:0032869	cellular response to insulin stimulus	0.19	> 0.20	COL4A3BP (3.0)	SORT1 (2.5)	PTPN11 (2.4)	TMEM57 (2.3)	BRAP (1.8)	GPAM (1.8)	C11orf9 (1.8)	PPP1R37 (1.8)	MOSC1 (1.7)	USP24 (1.6)
ENSG00000186298	PPP1CC PPI subnetwork	0.19	> 0.20	PSRC1 (4.6)	FEN1 (3.8)	USP1 (3.0)	POC5 (2.9)	ENSG00000226645 (1.9)	ZHX3 (1.5)	ILF3 (1.5)	GATAD2A (1.4)	TOP1 (1.3)	CARM1 (1.3)
ENSG00000138430	OLA1 PPI subnetwork	0.19	> 0.20	NAA25 (3.6)	SARS (3.5)	HMGCR (3.1)	ZNF259 (3.1)	PSMA5 (2.8)	FADS1 (2.5)	DDX56 (2.1)	MAPKAPK5 (2.1)	FEN1 (1.9)	USP1 (1.9)
GO:0071843	cellular component biogenesis at cellular level	0.19	> 0.20	ZNF259 (3.8)	C12orf43 (3.5)	DDX56 (3.3)	QTRT1 (3.1)	NAA25 (3.0)	DHODH (2.9)	TOMM40 (2.9)	SUGP1 (2.5)	MAPKAPK5 (2.5)	BRAP (2.2)
GO:0006399	tRNA metabolic process	0.19	> 0.20	QTRT1 (4.0)	DHODH (3.7)	NAA25 (3.4)	DDX56 (3.0)	ZNF259 (3.0)	C12orf43 (2.9)	SARS (2.9)	POC5 (2.4)	NT5DC1 (2.4)	MAPKAPK5 (2.4)
MP:0004510	myositis	0.19	> 0.20	BCL3 (5.0)	SH2B3 (3.4)	GRINA (2.9)	ST3GAL4 (2.4)	LPIN3 (2.3)	CLPTM1 (2.3)	PARP10 (2.2)	SYPL2 (2.2)	PLEC (1.9)	GMIP (1.8)
ENSG00000069702	TGFBR3 PPI subnetwork	0.19	> 0.20	DNM2 (2.9)	ENSG00000235545 (2.5)	PVR (2.2)	AMIGO1 (2.2)	SLC44A2 (2.0)	GPAM (2.0)	ITGB3 (1.9)	KANK2 (1.8)	ZNF180 (1.8)	HLX (1.8)
GO:0002573	myeloid leukocyte differentiation	0.19	> 0.20	ITGB3 (2.9)	ST3GAL4 (2.5)	SH2B3 (2.4)	RHCE (2.2)	RHD (2.1)	DNAH11 (2.0)	ENSG00000235545 (2.0)	TMEM57 (1.6)	GCNT4 (1.6)	TMEM50A (1.6)
ENSG00000142539	SPIB PPI subnetwork	0.19	> 0.20	TRIB1 (3.9)	ATXN7L2 (2.9)	GOT2P1 (2.8)	CARM1 (2.6)	GRINA (2.5)	MAFB (2.3)	RELB (2.3)	MAPKAPK5 (2.0)	BCL3 (1.9)	HLX (1.7)
ENSG00000138675	FGF5 PPI subnetwork	0.19	> 0.20	HAVCR1 (4.6)	HAPLN4 (3.3)	PLEKHH2 (3.1)	C11orf9 (3.0)	ZHX3 (2.6)	CBLC (2.6)	C17orf57 (2.3)	NCAN (2.3)	NYNRIN (2.0)	CEACAM19 (1.9)
ENSG00000108465	CDK5RAP3 PPI subnetwork	0.19	> 0.20	ACAD10 (3.3)	HNF1A (3.3)	BRAP (2.8)	ERP29 (2.4)	TMED4 (2.3)	PLCG1 (2.0)	NT5DC1 (1.6)	BLOC1S3 (1.6)	KIAA1324 (1.6)	ENSG00000254235 (1.5)
GO:0006917	induction of apoptosis	0.19	> 0.20	ENSG00000238078 (2.8)	ZNF101 (2.7)	POLK (2.4)	BLOC1S3 (2.1)	PARP10 (2.0)	MARK4 (1.9)	CYB561D1 (1.9)	C12orf43 (1.6)	TRAFD1 (1.6)	CEACAM19 (1.5)
GO:0019751	polyol metabolic process	0.19	> 0.20	TM6SF2 (3.8)	ABCG8 (2.5)	ENSG00000254235 (2.4)	ENSG00000226645 (2.1)	LPAR2 (1.9)	ACAD10 (1.9)	ABCG5 (1.9)	GCNT4 (1.8)	NPC1L1 (1.8)	MOSC1 (1.8)
ENSG00000168811	IL12A PPI subnetwork	0.19	> 0.20	BCL3 (4.7)	RELB (4.5)	HLX (3.1)	TRIB1 (2.7)	TIMD4 (2.5)	CETP (2.4)	GMIP (1.9)	PVR (1.8)	ALDH2 (1.8)	GRINA (1.6)
ENSG00000170860	LSM3 PPI subnetwork	0.19	> 0.20	POC5 (3.1)	DHX38 (2.7)	MAU2 (2.6)	QTRT1 (2.3)	DHODH (2.2)	BUD13 (2.0)	SUGP1 (2.0)	ADAM1 (1.9)	ZNF259 (1.9)	TRAFD1 (1.8)
ENSG00000114854	TNNC1 PPI subnetwork	0.19	> 0.20	SYPL2 (5.0)	GMPR (2.5)	TMEM50A (2.1)	ACAD10 (1.8)	C12orf47 (1.5)	OGDH (1.4)	BCAM (1.2)	RHCE (1.1)	FADS1 (1.0)	C1orf63 (1.0)
ENSG00000132694	ARHGEF11 PPI subnetwork	0.19	> 0.20	KANK2 (4.1)	PTPN11 (3.1)	APOE (3.0)	ZHX3 (2.8)	PBX4 (2.1)	MYLIP (2.1)	PMFBP1 (1.9)	SLC44A2 (1.9)	DOCK7 (1.9)	FADS2 (1.7)
ENSG00000084463	WBP11 PPI subnetwork	0.19	> 0.20	SUGP1 (3.0)	C19orf52 (2.9)	CARM1 (2.8)	C1orf63 (2.4)	DHX38 (2.1)	ATXN2 (2.0)	SMARCA4 (1.9)	MAU2 (1.8)	BUD13 (1.8)	C12orf43 (1.6)
REACTOME_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS	REACTOME_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS	0.19	> 0.20	PSMA5 (5.3)	FEN1 (3.3)	NT5DC1 (2.9)	TRAFD1 (2.7)	NAA25 (2.0)	TOMM40 (1.9)	SUGP1 (1.8)	USP1 (1.6)	DDX56 (1.5)	PARP10 (1.5)
GO:0005178	integrin binding	0.19	> 0.20	SLC44A2 (2.9)	CILP2 (2.8)	APOE (2.6)	BCAM (2.5)	ITGB3 (2.5)	ENSG00000238078 (2.5)	KANK2 (2.1)	PVRL2 (2.1)	PVR (1.9)	CLPTM1 (1.7)
GO:0005849	mRNA cleavage factor complex	0.19	> 0.20	PTPN11 (3.1)	DHX38 (3.1)	SUGP1 (2.3)	TOP1 (2.0)	MAPKAPK5 (2.0)	NKPD1 (1.9)	ENSG00000226645 (1.8)	GATAD2A (1.7)	TXNL4B (1.7)	NT5DC1 (1.6)
GO:0034134	toll-like receptor 2 signaling pathway	0.19	> 0.20	SH2B3 (2.7)	TRIB1 (2.3)	BLOC1S3 (2.1)	ENSG00000226645 (2.0)	RELB (2.0)	ENSG00000228044 (1.9)	CYB561D1 (1.8)	HLX (1.7)	MAPKAPK5 (1.6)	BUD13 (1.6)
ENSG00000168807	SNTB2 PPI subnetwork	0.19	> 0.20	KANK2 (3.5)	PPP1R37 (3.0)	SYPL2 (2.7)	BCAM (2.5)	COL4A3BP (2.4)	ATXN7L2 (2.2)	ZHX3 (2.1)	GPAM (2.1)	C12orf51 (2.1)	NKPD1 (2.0)
GO:0043277	apoptotic cell clearance	0.19	> 0.20	APOE (2.5)	GRINA (2.3)	TMED4 (2.2)	HAVCR1 (2.2)	ALDH2 (2.0)	TIMD4 (2.0)	MAFB (1.9)	CILP2 (1.8)	PVRL2 (1.7)	PMFBP1 (1.7)
GO:0045309	protein phosphorylated amino acid binding	0.19	> 0.20	C17orf57 (3.9)	C1orf63 (2.8)	CLPTM1 (2.7)	SLC44A2 (2.6)	MARK4 (2.5)	CARM1 (2.3)	ENSG00000226645 (1.9)	PVRL2 (1.9)	ATXN2 (1.8)	PLEKHH2 (1.8)
ENSG00000137275	RIPK1 PPI subnetwork	0.19	> 0.20	RELB (6.2)	BCL3 (3.7)	PVR (3.1)	PARP10 (3.0)	TRAFD1 (2.5)	FRK (2.2)	POLK (1.8)	SH2B3 (1.6)	PBX4 (1.6)	OASL (1.5)
GO:0016445	somatic diversification of immunoglobulins	0.19	> 0.20	GCNT4 (3.1)	ZNF101 (2.5)	NT5DC1 (2.3)	C17orf57 (2.1)	ANKRD31 (2.0)	DYNC2LI1 (1.9)	ENSG00000226648 (1.9)	UBXN2B (1.6)	PBX4 (1.6)	MAPKAPK5 (1.5)
ENSG00000014641	MDH1 PPI subnetwork	0.19	> 0.20	ALDH2 (3.4)	ERP29 (2.9)	DOCK7 (2.7)	SARS (2.6)	UBXN2B (2.4)	GMPR (2.1)	PSMA5 (2.0)	TMED4 (1.9)	RHD (1.9)	GPAM (1.8)
ENSG00000116678	LEPR PPI subnetwork	0.19	> 0.20	BCL3 (3.4)	COL4A3BP (2.7)	C17orf57 (1.8)	TRAFD1 (1.5)	BCAM (1.5)	PVR (1.4)	RELB (1.4)	TIMD4 (1.3)	POLK (1.3)	ENSG00000238078 (1.3)
GO:0015026	coreceptor activity	0.19	> 0.20	PLCG1 (3.1)	MAFB (2.6)	NYNRIN (2.4)	HLX (2.3)	BCAM (2.1)	ZNF101 (2.1)	APOE (2.1)	MARK4 (2.0)	APOC1 (1.9)	TIMD4 (1.7)
ENSG00000070193	FGF10 PPI subnetwork	0.19	> 0.20	HAVCR1 (4.4)	HAPLN4 (3.5)	C11orf9 (3.4)	PLEKHH2 (3.4)	CBLC (2.6)	ZHX3 (2.4)	NYNRIN (2.3)	C17orf57 (2.3)	CEACAM19 (1.9)	MYLIP (1.7)
GO:0080135	regulation of cellular response to stress	0.19	> 0.20	MAU2 (2.0)	POLK (1.9)	LPAR2 (1.8)	ZNF180 (1.6)	ENSG00000226645 (1.6)	C11orf9 (1.5)	NT5DC1 (1.5)	UBXN2B (1.5)	ST3GAL4 (1.4)	GATAD2A (1.4)
ENSG00000112742	TTK PPI subnetwork	0.19	> 0.20	NYNRIN (2.9)	FRK (2.8)	ITGB3 (2.1)	MAFB (2.0)	PSRC1 (1.9)	C19orf52 (1.8)	ENSG00000226648 (1.8)	AMIGO1 (1.8)	C1orf63 (1.7)	TMEM57 (1.6)
ENSG00000119729	RHOQ PPI subnetwork	0.19	> 0.20	SLC44A2 (3.5)	PVRL2 (3.3)	CLPTM1 (2.2)	SORT1 (2.1)	PVR (2.1)	BCAM (2.1)	PLEC (2.0)	GMIP (1.9)	SARS (1.9)	DNM2 (1.9)
ENSG00000112033	PPARD PPI subnetwork	0.19	> 0.20	C12orf51 (3.5)	TRIB1 (3.3)	USP24 (3.1)	SMARCA4 (2.4)	TOP1 (2.2)	ATXN2 (2.1)	BCL3 (2.0)	CELSR2 (2.0)	PVR (2.0)	TSSK6 (1.9)
ENSG00000104969	SGTA PPI subnetwork	0.19	> 0.20	ST3GAL4 (3.1)	AMIGO1 (2.0)	CLPTM1 (2.0)	PPP1R37 (2.0)	TMED4 (1.9)	APOE (1.8)	TMEM57 (1.8)	PARP10 (1.7)	ATP13A1 (1.6)	CYP7A1 (1.6)
ENSG00000076321	KLHL20 PPI subnetwork	0.19	> 0.20	LDLR (3.1)	PCSK9 (2.9)	FADS1 (2.4)	NPC1L1 (2.4)	FADS2 (2.4)	HMGCR (2.3)	TRAFD1 (2.2)	ENSG00000254235 (2.0)	UBXN2B (1.8)	TMEM50A (1.7)
GO:0050766	positive regulation of phagocytosis	0.19	> 0.20	PMFBP1 (2.3)	UBXN2B (2.2)	HP (2.2)	GOT2P1 (1.9)	TMED4 (1.9)	CILP2 (1.9)	MAFB (1.8)	LPA (1.7)	ENSG00000235545 (1.7)	CEACAM19 (1.6)
GO:0045814	negative regulation of gene expression, epigenetic	0.19	> 0.20	TSSK6 (3.8)	GCNT4 (2.5)	MAU2 (2.4)	MAPKAPK5 (2.0)	SUGP1 (1.8)	FRK (1.8)	C19orf52 (1.8)	NT5DC1 (1.5)	TMEM116 (1.5)	ILF3 (1.3)
ENSG00000149187	CELF1 PPI subnetwork	0.19	> 0.20	ITGB3 (3.7)	TMED4 (2.2)	C1orf63 (2.2)	UBXN2B (2.1)	ENSG00000226645 (2.0)	CELSR2 (1.8)	FADS1 (1.4)	CYP7A1 (1.4)	TIMD4 (1.3)	MAFB (1.3)
GO:0060068	vagina development	0.19	> 0.20	LPAR2 (2.9)	PPP1R37 (2.8)	BLOC1S3 (2.2)	CYB561D1 (1.9)	LPIN3 (1.7)	POLK (1.5)	QTRT1 (1.5)	NKPD1 (1.4)	HAVCR1 (1.4)	ST3GAL4 (1.4)
GO:0048486	parasympathetic nervous system development	0.19	> 0.20	TSSK6 (2.4)	BLOC1S3 (2.1)	ENSG00000254235 (2.0)	ENSG00000238078 (1.8)	CEACAM19 (1.8)	TMED4 (1.7)	ENSG00000226648 (1.5)	ENSG00000228044 (1.3)	ZNF101 (1.3)	ANKRD31 (1.3)
GO:0006111	regulation of gluconeogenesis	0.19	> 0.20	ENSG00000226645 (2.8)	ENSG00000254235 (2.6)	ZNF180 (2.4)	MOSC1 (2.3)	CYP7A1 (2.3)	GPAM (2.2)	HNF1A (1.8)	GCNT4 (1.5)	ACAD10 (1.5)	LPA (1.4)
MP:0002633	persistent truncus arteriosis	0.19	> 0.20	TRIB1 (2.9)	ANKRD31 (2.6)	BCAM (2.5)	KANK2 (2.1)	PLCG1 (2.0)	DOCK7 (1.8)	PVR (1.7)	HLX (1.7)	MAFB (1.6)	PVRL2 (1.5)
ENSG00000135775	COG2 PPI subnetwork	0.19	> 0.20	MAU2 (4.4)	SUGP1 (3.2)	YIPF2 (3.2)	DHX38 (2.9)	CYB561D1 (2.8)	ENSG00000228044 (2.4)	DNM2 (2.2)	TXNL4B (2.1)	MAPKAPK5 (2.0)	TRAFD1 (1.9)
ENSG00000113649	TCERG1 PPI subnetwork	0.19	> 0.20	DHX38 (3.0)	ILF3 (2.8)	SMARCA4 (2.8)	NYNRIN (2.4)	SUGP1 (2.4)	ERP29 (2.2)	ATP13A1 (2.1)	DNM2 (2.0)	CARM1 (1.9)	TOP1 (1.9)
MP:0000195	hypocalcemia	0.19	> 0.20	TMEM116 (3.6)	AP1M2 (2.6)	BCAM (2.3)	TXNL4B (1.9)	SLC22A1 (1.9)	TOP1 (1.7)	KIAA1324 (1.7)	C17orf57 (1.7)	ENSG00000226648 (1.5)	FRK (1.5)
GO:0045649	regulation of macrophage differentiation	0.19	> 0.20	ITGB3 (3.7)	ST3GAL4 (2.3)	TMED4 (1.8)	CILP2 (1.7)	ENSG00000228044 (1.6)	CEACAM19 (1.6)	GOT2P1 (1.5)	ABO (1.5)	CYB561D1 (1.5)	TIMD4 (1.4)
ENSG00000173757	STAT5B PPI subnetwork	0.19	> 0.20	BCL3 (3.0)	PARP10 (2.9)	HLX (2.5)	PBX4 (2.5)	PLCG1 (2.3)	DNM2 (2.2)	MAU2 (2.2)	TRIB1 (2.0)	USP24 (1.9)	TRAFD1 (1.9)
MP:0011506	glomerular crescent	0.19	> 0.20	MAFB (5.2)	TIMD4 (3.8)	CETP (2.9)	APOE (2.5)	PVR (2.2)	GCNT4 (2.0)	ACAD10 (1.9)	TRIB1 (1.7)	C11orf9 (1.4)	APOC1 (1.4)
ENSG00000142892	PIGK PPI subnetwork	0.19	> 0.20	CLPTM1 (5.6)	ATP13A1 (4.6)	TMEM50A (4.2)	ERP29 (3.0)	CYB561D1 (2.9)	TMED4 (2.8)	TMEM57 (2.7)	SORT1 (2.4)	HMGCR (2.1)	FADS1 (1.9)
MP:0002467	impaired neutrophil phagocytosis	0.19	> 0.20	CEACAM19 (2.9)	GMIP (2.8)	SH2B3 (2.7)	HP (2.2)	BCL3 (2.2)	MAFB (2.1)	GRINA (1.8)	ALDH2 (1.7)	ADAM1 (1.6)	UBXN2B (1.4)
GO:0046942	carboxylic acid transport	0.19	> 0.20	TM6SF2 (3.5)	ABCG8 (3.3)	HAPLN4 (2.2)	TMEM116 (2.1)	GCNT4 (2.0)	ABCG5 (1.9)	CLPTM1 (1.7)	LPAR2 (1.6)	NPC1L1 (1.5)	PBX4 (1.5)
GO:0050778	positive regulation of immune response	0.19	> 0.20	TIMD4 (3.7)	ZNF101 (3.3)	GMIP (2.8)	LPA (2.5)	CETP (2.2)	MAFB (2.1)	CYB561D1 (2.1)	SLC22A1 (1.7)	PARP10 (1.7)	APOE (1.6)
ENSG00000172270	BSG PPI subnetwork	0.19	> 0.20	SYPL2 (3.8)	GMPR (3.4)	CLPTM1 (3.2)	PBX4 (2.5)	DNM2 (2.5)	PLEC (2.4)	OGDH (2.4)	LPAR2 (2.4)	ATXN7L2 (2.3)	C17orf57 (2.3)
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	0.19	> 0.20	ERP29 (3.4)	ENSG00000254235 (2.3)	PVRL2 (2.2)	CYB561D1 (2.1)	PCSK9 (2.1)	LPIN3 (2.0)	CBLC (2.0)	TMEM50A (1.9)	NYNRIN (1.8)	RHCE (1.8)
GO:0046949	fatty-acyl-CoA biosynthetic process	0.19	> 0.20	FADS1 (5.4)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.7)	BLOC1S3 (2.8)	NKPD1 (2.3)	MOSC1 (2.1)	DOCK7 (1.8)
GO:0035337	fatty-acyl-CoA metabolic process	0.19	> 0.20	FADS1 (5.4)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.7)	BLOC1S3 (2.8)	NKPD1 (2.3)	MOSC1 (2.1)	DOCK7 (1.8)
ENSG00000126351	THRA PPI subnetwork	0.19	> 0.20	C12orf51 (4.0)	ATXN2 (2.3)	TOP1 (2.1)	SMARCA4 (2.0)	OASL (1.9)	MAU2 (1.8)	OGDH (1.6)	PPP1R37 (1.6)	C17orf57 (1.6)	CEACAM19 (1.6)
ENSG00000149743	TRPT1 PPI subnetwork	0.19	> 0.20	QTRT1 (3.3)	TOMM40 (2.7)	TRAPPC6A (2.4)	CBLC (2.3)	SARS (2.3)	ST3GAL4 (2.1)	DDX56 (2.0)	ZNF259 (2.0)	NT5DC1 (1.9)	RELB (1.7)
GO:0008276	protein methyltransferase activity	0.19	> 0.20	C12orf51 (2.9)	DHODH (2.8)	C12orf43 (2.6)	ATXN2 (2.2)	QTRT1 (2.1)	ZNF180 (1.9)	NAA25 (1.9)	C19orf52 (1.8)	BUD13 (1.8)	SMARCA4 (1.7)
GO:0045766	positive regulation of angiogenesis	0.19	> 0.20	ENSG00000226648 (2.1)	ENSG00000235545 (2.1)	MAFB (1.9)	FRK (1.8)	PVR (1.8)	GCNT4 (1.7)	CEACAM19 (1.6)	ATXN7L2 (1.4)	LPIN3 (1.4)	DOCK7 (1.3)
ENSG00000118260	CREB1 PPI subnetwork	0.19	> 0.20	DNM2 (3.0)	GOT2P1 (3.0)	CARM1 (2.8)	LDLR (2.5)	PLEC (2.4)	DHX38 (2.4)	ABO (2.1)	CYB561D1 (2.0)	HLX (1.9)	HMGCR (1.9)
ENSG00000197369	ENSG00000197369 PPI subnetwork	0.19	> 0.20	SLC44A2 (2.5)	TMEM50A (2.2)	SMARCA4 (2.2)	DNM2 (2.0)	KIAA1324 (1.8)	TRIB1 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	MARK4 (1.5)	LPAR2 (1.5)
ENSG00000197003	ENSG00000197003 PPI subnetwork	0.19	> 0.20	SLC44A2 (2.5)	TMEM50A (2.2)	SMARCA4 (2.2)	DNM2 (2.0)	KIAA1324 (1.8)	TRIB1 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	MARK4 (1.5)	LPAR2 (1.5)
ENSG00000150991	UBC PPI subnetwork	0.19	> 0.20	SMARCA4 (2.4)	TOP1 (2.3)	FEN1 (2.3)	PSMA5 (2.3)	GRINA (2.1)	PTPN11 (2.0)	TMEM57 (2.0)	TRIB1 (1.9)	C1orf63 (1.8)	GATAD2A (1.8)
ENSG00000163166	IWS1 PPI subnetwork	0.19	> 0.20	HNF1A (2.9)	C12orf47 (2.6)	ATP13A1 (2.2)	PTPN11 (2.1)	NT5DC1 (2.1)	BRAP (2.1)	ATXN2 (2.0)	DNM2 (1.9)	MARK4 (1.8)	CARM1 (1.8)
REACTOME_P53:DEPENDENT_G1_DNA_DAMAGE_RESPONSE	REACTOME_P53:DEPENDENT_G1_DNA_DAMAGE_RESPONSE	0.19	> 0.20	PSMA5 (6.1)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	PARP10 (2.0)	TOMM40 (1.7)	SARS (1.7)	DDX56 (1.5)	SUGP1 (1.5)	ENSG00000254235 (1.0)
REACTOME_P53:DEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	REACTOME_P53:DEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	0.19	> 0.20	PSMA5 (6.1)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	PARP10 (2.0)	TOMM40 (1.7)	SARS (1.7)	DDX56 (1.5)	SUGP1 (1.5)	ENSG00000254235 (1.0)
GO:0071616	acyl-CoA biosynthetic process	0.19	> 0.20	FADS1 (5.3)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.5)	BLOC1S3 (2.9)	MOSC1 (2.1)	NKPD1 (2.0)	SORT1 (1.7)
GO:0035384	thioester biosynthetic process	0.19	> 0.20	FADS1 (5.3)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.5)	BLOC1S3 (2.9)	MOSC1 (2.1)	NKPD1 (2.0)	SORT1 (1.7)
ENSG00000184634	MED12 PPI subnetwork	0.19	> 0.20	BRAP (2.9)	OASL (2.8)	BUD13 (2.3)	TIMD4 (2.2)	GEMIN7 (2.2)	BLOC1S3 (2.1)	C19orf52 (2.0)	C12orf51 (2.0)	TXNL4B (2.0)	POC5 (1.8)
ENSG00000136488	CSH1 PPI subnetwork	0.19	> 0.20	BCL3 (4.1)	RELB (2.9)	HLX (2.7)	ALDH2 (2.2)	TIMD4 (2.1)	GMIP (2.1)	CETP (1.8)	SH2B3 (1.6)	LPA (1.4)	TRIB1 (1.4)
ENSG00000087365	SF3B2 PPI subnetwork	0.19	> 0.20	ILF3 (3.9)	SUGP1 (3.4)	C1orf63 (3.4)	DHX38 (3.2)	BUD13 (3.1)	SMARCA4 (2.7)	QTRT1 (2.7)	TOP1 (2.6)	USP1 (2.5)	FEN1 (2.4)
ENSG00000215440	NPEPL1 PPI subnetwork	0.19	> 0.20	MAU2 (2.8)	C19orf52 (2.6)	CLPTM1 (2.4)	GRINA (2.3)	YIPF2 (2.3)	ENSG00000238078 (2.3)	SLC44A2 (2.2)	TMED4 (2.1)	CYB561D1 (2.1)	ATP13A1 (2.1)
ENSG00000115524	SF3B1 PPI subnetwork	0.19	> 0.20	ILF3 (3.8)	C1orf63 (3.5)	BUD13 (3.3)	SUGP1 (3.2)	DHX38 (3.1)	TOP1 (2.9)	SMARCA4 (2.9)	QTRT1 (2.6)	USP1 (2.6)	FEN1 (2.5)
ENSG00000062038	CDH3 PPI subnetwork	0.19	> 0.20	AP1M2 (4.2)	PVRL2 (3.8)	BCAM (3.5)	CBLC (2.8)	LPAR2 (2.5)	DOCK7 (2.3)	FRK (2.1)	ENSG00000226648 (2.0)	C11orf9 (2.0)	MAFB (1.9)
ENSG00000108773	KAT2A PPI subnetwork	0.19	> 0.20	ATXN2 (3.5)	PARP10 (2.8)	MAU2 (2.6)	ATXN7L2 (2.5)	MAPKAPK5 (2.5)	C12orf51 (2.4)	BUD13 (2.3)	TRAFD1 (2.1)	CARM1 (2.0)	UBXN2B (2.0)
ENSG00000166747	AP1G1 PPI subnetwork	0.19	> 0.20	CLPTM1 (4.1)	PPP1R37 (3.1)	GRINA (3.0)	SMARCA4 (2.9)	C12orf51 (2.7)	YIPF2 (2.5)	DHX38 (2.2)	COL4A3BP (2.0)	SH2B3 (1.9)	TOP1 (1.8)
KEGG_JAK_STAT_SIGNALING_PATHWAY	KEGG_JAK_STAT_SIGNALING_PATHWAY	0.19	> 0.20	BCL3 (4.0)	HLX (2.8)	COL4A3BP (2.6)	RELB (2.0)	SH2B3 (1.7)	CETP (1.6)	ZNF101 (1.6)	TRIB1 (1.5)	PARP10 (1.5)	TRAFD1 (1.5)
ENSG00000087086	FTL PPI subnetwork	0.19	> 0.20	GRINA (3.5)	ALDH2 (3.0)	HP (2.6)	ANGPTL3 (2.4)	PLG (2.2)	UBXN2B (2.0)	ACAD10 (1.8)	BCL3 (1.6)	APOB (1.6)	FADS1 (1.5)
MP:0005216	abnormal pancreatic alpha cell morphology	0.19	> 0.20	KIAA1324 (3.6)	TRIB1 (2.5)	HAPLN4 (2.0)	ABCG8 (1.7)	MARK4 (1.7)	TMEM57 (1.7)	PVR (1.6)	C11orf9 (1.5)	NPC1L1 (1.4)	TM6SF2 (1.3)
ENSG00000177463	NR2C2 PPI subnetwork	0.19	> 0.20	HNF1A (2.9)	ZHX3 (2.9)	UBXN2B (2.2)	PTPN11 (2.1)	CYP7A1 (2.1)	KIAA1324 (2.0)	BRAP (1.9)	USP24 (1.8)	MAU2 (1.8)	NAA25 (1.8)
GO:0060419	heart growth	0.19	> 0.20	CEACAM19 (2.7)	C11orf9 (2.5)	BLOC1S3 (2.1)	PLEKHH2 (1.9)	ENSG00000235545 (1.6)	GCNT4 (1.5)	NYNRIN (1.5)	ALDH2 (1.5)	C19orf52 (1.4)	HLX (1.4)
MP:0006355	abnormal sixth branchial arch artery morphology	0.19	> 0.20	HLX (3.6)	MYLIP (2.6)	ANKRD31 (1.9)	HNF1A (1.8)	APOE (1.6)	PLCG1 (1.5)	ABO (1.5)	BCAM (1.5)	CETP (1.4)	PVRL2 (1.3)
GO:0007160	cell-matrix adhesion	0.19	> 0.20	SLC44A2 (4.2)	ITGB3 (3.9)	C17orf57 (2.9)	GCNT4 (2.7)	ENSG00000226648 (2.4)	KANK2 (2.4)	PLEKHH2 (2.2)	SORT1 (2.0)	CETP (2.0)	PLEC (1.9)
GO:0042742	defense response to bacterium	0.19	> 0.20	PMFBP1 (2.2)	HP (2.2)	TIMD4 (1.9)	ENSG00000235545 (1.7)	MOSC1 (1.6)	HLX (1.5)	ABCG5 (1.5)	ADAM1 (1.4)	ABCG8 (1.3)	RHCE (1.2)
ENSG00000125740	FOSB PPI subnetwork	0.20	> 0.20	TRIB1 (6.8)	BCL3 (3.2)	MYLIP (2.7)	MAPKAPK5 (2.7)	POLK (2.2)	SARS (1.9)	TMED4 (1.8)	ATXN2 (1.8)	GRINA (1.7)	MAU2 (1.6)
ENSG00000181222	POLR2A PPI subnetwork	0.20	> 0.20	ILF3 (3.5)	SUGP1 (3.5)	SMARCA4 (3.4)	TOP1 (3.4)	DHX38 (3.2)	USP1 (2.9)	BUD13 (2.8)	GATAD2A (2.2)	MAPKAPK5 (2.0)	FEN1 (1.9)
ENSG00000137807	KIF23 PPI subnetwork	0.20	> 0.20	ZHX3 (3.2)	DNM2 (3.1)	CARM1 (3.1)	LPAR2 (2.4)	UBXN2B (2.3)	PLEC (2.2)	PTPN11 (2.2)	MARK4 (2.0)	COL4A3BP (2.0)	ATXN2 (1.9)
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	0.20	> 0.20	PTPN11 (2.1)	HLX (2.0)	CARM1 (2.0)	DNM2 (1.9)	CYB561D1 (1.9)	TMEM50A (1.8)	ZHX3 (1.8)	SLC44A2 (1.8)	MARK4 (1.7)	DHX38 (1.7)
ENSG00000100811	YY1 PPI subnetwork	0.20	> 0.20	PARP10 (2.8)	PSRC1 (2.6)	GMIP (2.6)	USP24 (2.5)	BCL3 (2.4)	POLK (2.3)	ATXN7L2 (2.1)	ATXN2 (1.9)	TOP1 (1.7)	PLCG1 (1.7)
MP:0000259	abnormal vascular development	0.20	> 0.20	HLX (4.1)	PVR (2.8)	SH2B3 (2.5)	PLCG1 (2.2)	NYNRIN (2.2)	PLEC (2.2)	CETP (2.1)	TRIB1 (2.1)	BCAM (1.9)	ENSG00000226648 (1.8)
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	0.20	> 0.20	NAA25 (3.4)	POC5 (3.1)	DDX56 (3.0)	USP24 (2.7)	DOCK7 (2.7)	USP1 (2.7)	BUD13 (2.6)	ILF3 (2.2)	FEN1 (2.0)	MAPKAPK5 (1.9)
ENSG00000183311	TUBB PPI subnetwork	0.20	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
ENSG00000137379	ENSG00000137379 PPI subnetwork	0.20	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
ENSG00000196230	TUBB PPI subnetwork	0.20	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
ENSG00000131153	GINS2 PPI subnetwork	0.20	> 0.20	FEN1 (6.7)	USP1 (4.3)	ZNF180 (1.8)	DHODH (1.7)	ENSG00000228044 (1.5)	ILF3 (1.4)	PSRC1 (1.1)	ERP29 (1.1)	ANKRD31 (1.1)	CYP7A1 (1.0)
MP:0004505	decreased renal glomerulus number	0.20	> 0.20	NYNRIN (2.7)	BCAM (2.4)	ENSG00000228044 (2.3)	PLEKHH2 (2.1)	C11orf9 (2.0)	TMEM57 (1.8)	PVRL2 (1.7)	ENSG00000235545 (1.6)	CETP (1.5)	GCNT4 (1.4)
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	0.20	> 0.20	RELB (8.4)	BCL3 (4.9)	GRINA (2.2)	ENSG00000228044 (2.1)	PVR (2.0)	BLOC1S3 (1.9)	PARP10 (1.9)	GMIP (1.9)	PTPN11 (1.7)	UBXN2B (1.7)
MP:0005156	bradykinesia	0.20	> 0.20	C12orf51 (2.4)	ERP29 (2.3)	USP24 (2.1)	ACAD10 (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PLEC (1.8)	COL4A3BP (1.8)	GOT2P1 (1.8)	GMPR (1.7)
ENSG00000082516	GEMIN5 PPI subnetwork	0.20	> 0.20	BLOC1S3 (2.2)	C12orf43 (2.1)	GEMIN7 (1.8)	TIMD4 (1.8)	ILF3 (1.7)	TOMM40 (1.7)	DYNC2LI1 (1.6)	ZNF180 (1.5)	MAPKAPK5 (1.5)	C19orf52 (1.4)
ENSG00000111802	TDP2 PPI subnetwork	0.20	> 0.20	RELB (3.7)	ZNF180 (3.4)	PBX4 (3.2)	MYLIP (2.4)	BCL3 (2.0)	GEMIN7 (2.0)	LPA (1.8)	ABCG8 (1.8)	UBXN2B (1.8)	C19orf52 (1.8)
GO:0009086	methionine biosynthetic process	0.20	> 0.20	DNAH11 (3.2)	ENSG00000254235 (2.7)	DHODH (1.8)	UBXN2B (1.8)	C1orf63 (1.8)	TSSK6 (1.5)	TMED4 (1.5)	ST3GAL4 (1.5)	ANGPTL3 (1.3)	CEACAM19 (1.3)
GO:0009886	post-embryonic morphogenesis	0.20	> 0.20	GEMIN7 (3.3)	DNAH11 (3.2)	LPAR2 (2.8)	PPP1R37 (2.4)	C12orf43 (2.0)	NPC1L1 (1.9)	GOT2P1 (1.7)	BRAP (1.7)	MAFB (1.6)	QTRT1 (1.5)
MP:0000292	distended pericardium	0.20	> 0.20	GATAD2A (2.7)	NYNRIN (2.5)	PLCG1 (2.5)	ENSG00000238078 (2.4)	MARK4 (2.3)	KANK2 (2.3)	ATXN2 (2.2)	ENSG00000226648 (2.2)	C17orf57 (1.9)	ENSG00000235545 (1.8)
MP:0008181	increased marginal zone B cell number	0.20	> 0.20	TIMD4 (3.7)	RELB (3.3)	CETP (3.1)	GMIP (3.1)	APOC1 (3.0)	SH2B3 (2.9)	MAFB (2.5)	APOE (1.6)	TRAPPC6A (1.5)	ZNF101 (1.5)
ENSG00000196611	MMP1 PPI subnetwork	0.20	> 0.20	CILP2 (2.7)	BCL3 (2.1)	NCAN (2.1)	PVR (1.9)	PMFBP1 (1.7)	NPC1L1 (1.7)	PVRL2 (1.6)	FRK (1.6)	HAPLN4 (1.5)	TIMD4 (1.3)
GO:0071331	cellular response to hexose stimulus	0.20	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
GO:0071333	cellular response to glucose stimulus	0.20	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
GO:0071326	cellular response to monosaccharide stimulus	0.20	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
MP:0004722	abnormal platelet dense granule number	0.20	> 0.20	ZNF101 (3.2)	BLOC1S3 (3.0)	GMPR (2.6)	ENSG00000228044 (2.3)	GMIP (2.1)	CYB561D1 (2.0)	ITGB3 (1.9)	ZNF180 (1.9)	COL4A3BP (1.8)	MARK4 (1.8)
ENSG00000196975	ANXA4 PPI subnetwork	0.20	> 0.20	HNF1A (4.2)	KIAA1324 (3.3)	NPC1L1 (3.1)	TMEM50A (2.9)	C11orf9 (2.8)	PCSK9 (2.7)	OGDH (2.5)	TMED4 (2.2)	TM6SF2 (2.1)	HMGCR (1.7)
GO:0012502	induction of programmed cell death	0.20	> 0.20	ENSG00000238078 (2.7)	ZNF101 (2.6)	POLK (2.5)	BLOC1S3 (2.0)	PARP10 (1.9)	MARK4 (1.9)	CYB561D1 (1.9)	TRAFD1 (1.6)	CEACAM19 (1.6)	HAVCR1 (1.6)
ENSG00000146904	EPHA1 PPI subnetwork	0.20	> 0.20	PLEKHH2 (3.5)	PARP10 (3.0)	BCL3 (2.5)	LPAR2 (2.3)	OASL (2.3)	NT5DC1 (2.1)	TRAFD1 (2.0)	GMIP (2.0)	TRIB1 (2.0)	PLCG1 (1.9)
GO:0042168	heme metabolic process	0.20	> 0.20	RHCE (7.6)	RHD (7.1)	ADAM1 (2.9)	C12orf51 (2.7)	GMPR (2.1)	TRAPPC6A (2.1)	BLOC1S3 (1.9)	NT5DC1 (1.9)	ACAD10 (1.8)	DHODH (1.8)
ENSG00000138030	KHK PPI subnetwork	0.20	> 0.20	HNF1A (3.4)	TRAPPC6A (3.1)	TXNL4B (2.9)	BUD13 (2.4)	NPC1L1 (2.3)	SUGP1 (2.1)	GEMIN7 (2.0)	ZNF180 (2.0)	APOB (1.7)	YIPF2 (1.6)
ENSG00000143106	PSMA5 PPI subnetwork	0.20	> 0.20	PSMA5 (6.3)	TRAFD1 (2.8)	NT5DC1 (2.5)	NAA25 (2.5)	TOMM40 (1.8)	C19orf52 (1.8)	ENSG00000254235 (1.7)	DDX56 (1.5)	PARP10 (1.3)	SUGP1 (1.3)
GO:0002755	MyD88-dependent toll-like receptor signaling pathway	0.20	> 0.20	SH2B3 (2.7)	BLOC1S3 (2.1)	TRIB1 (2.1)	LPAR2 (1.8)	RELB (1.7)	HLX (1.7)	ENSG00000226645 (1.6)	CYB561D1 (1.6)	BUD13 (1.6)	BCL3 (1.5)
ENSG00000182054	IDH2 PPI subnetwork	0.20	> 0.20	PSMA5 (2.5)	ABCG5 (2.2)	TM6SF2 (2.1)	CEACAM19 (1.9)	ENSG00000235545 (1.9)	TOMM40 (1.9)	HAPLN4 (1.6)	DDX56 (1.5)	PVR (1.4)	CARM1 (1.4)
ENSG00000067533	RRP15 PPI subnetwork	0.20	> 0.20	ZNF259 (4.5)	QTRT1 (3.3)	TOMM40 (3.2)	NAA25 (3.1)	DDX56 (2.9)	DHODH (2.5)	SARS (2.4)	GATAD2A (2.1)	MAPKAPK5 (2.0)	ATP13A1 (1.9)
GO:0009635	response to herbicide	0.20	> 0.20	PMFBP1 (2.6)	DNAH11 (2.5)	GOT2P1 (2.4)	ST3GAL4 (2.3)	FRK (1.9)	COL4A3BP (1.5)	ABCG8 (1.5)	HP (1.4)	TXNL4B (1.4)	TMED4 (1.4)
ENSG00000136997	MYC PPI subnetwork	0.20	> 0.20	ATXN2 (3.5)	ILF3 (3.1)	SMARCA4 (2.8)	DHX38 (2.8)	C12orf51 (2.4)	MAU2 (2.4)	DNM2 (2.4)	MAPKAPK5 (2.3)	BRAP (2.1)	BUD13 (2.1)
GO:0050920	regulation of chemotaxis	0.20	> 0.20	GCNT4 (2.6)	CETP (2.4)	PLEKHH2 (2.3)	TIMD4 (2.2)	ZNF101 (2.1)	PVR (2.0)	MAFB (1.7)	YIPF2 (1.7)	APOE (1.6)	HLX (1.6)
GO:0045089	positive regulation of innate immune response	0.20	> 0.20	OASL (2.3)	SH2B3 (2.3)	CYB561D1 (2.2)	ZNF101 (2.0)	ENSG00000228044 (2.0)	GMIP (1.9)	PVR (1.9)	RELB (1.8)	PARP10 (1.8)	HLX (1.7)
GO:0016575	histone deacetylation	0.20	> 0.20	TMEM57 (2.7)	ATXN7L2 (2.6)	C17orf57 (2.1)	PLCG1 (2.0)	FADS2 (1.7)	HNF1A (1.6)	NT5DC1 (1.6)	C1orf63 (1.5)	USP24 (1.5)	PPP1R37 (1.5)
ENSG00000135679	MDM2 PPI subnetwork	0.20	> 0.20	POLK (2.0)	CELSR2 (1.9)	TMEM50A (1.7)	HMGCR (1.6)	PSRC1 (1.5)	GMPR (1.4)	TRIB1 (1.4)	BLOC1S3 (1.4)	C12orf51 (1.2)	USP1 (1.2)
ENSG00000162517	PEF1 PPI subnetwork	0.20	> 0.20	PBX4 (3.3)	MAU2 (3.2)	SYPL2 (2.6)	BLOC1S3 (2.4)	KANK2 (2.1)	TMED4 (1.9)	YIPF2 (1.9)	ZNF259 (1.8)	C19orf52 (1.8)	QTRT1 (1.7)
GO:0050839	cell adhesion molecule binding	0.20	> 0.20	HAVCR1 (2.5)	NCAN (2.5)	GCNT4 (2.4)	TIMD4 (2.1)	C11orf9 (2.1)	BCAM (2.1)	SLC44A2 (1.9)	APOE (1.9)	PVRL2 (1.9)	TRIB1 (1.9)
ENSG00000135845	PIGC PPI subnetwork	0.20	> 0.20	HMGCR (5.2)	LDLR (4.8)	ATP13A1 (4.0)	FADS1 (4.0)	FADS2 (3.8)	CLPTM1 (2.4)	ERP29 (2.1)	TMED4 (2.1)	SORT1 (2.0)	TMEM57 (2.0)
ENSG00000074319	TSG101 PPI subnetwork	0.20	> 0.20	POLK (4.3)	MYLIP (2.1)	PLEC (2.1)	GMIP (2.1)	MAPKAPK5 (2.1)	CARM1 (2.0)	UBXN2B (1.9)	C12orf43 (1.8)	BRAP (1.8)	SUGP1 (1.7)
ENSG00000149948	HMGA2 PPI subnetwork	0.20	> 0.20	RELB (4.4)	SH2B3 (2.5)	ATXN2 (2.4)	GMIP (2.4)	MARK4 (2.4)	BCL3 (2.3)	DNM2 (2.2)	BLOC1S3 (2.0)	PSRC1 (2.0)	CYB561D1 (2.0)
ENSG00000183791	TCEB3C PPI subnetwork	0.20	> 0.20	OASL (3.1)	TIMD4 (3.0)	CETP (2.7)	PLEKHH2 (1.9)	C1orf63 (1.8)	DNAH11 (1.8)	TMEM57 (1.8)	POLK (1.7)	CEACAM19 (1.5)	SLC44A2 (1.4)
MP:0000613	abnormal salivary gland morphology	0.20	> 0.20	ATXN7L2 (2.8)	KIAA1324 (2.8)	GOT2P1 (2.4)	RELB (2.3)	SLC22A1 (2.1)	ANKRD31 (2.0)	ADAM1 (1.9)	LDLR (1.7)	TRAFD1 (1.7)	PLEKHH2 (1.6)
GO:0001525	angiogenesis	0.20	> 0.20	PVR (3.2)	HLX (3.1)	C17orf57 (2.3)	SH2B3 (2.2)	PVRL2 (2.1)	MAFB (1.7)	BCAM (1.7)	SLC44A2 (1.6)	CEACAM19 (1.6)	ENSG00000226648 (1.4)
ENSG00000149084	HSD17B12 PPI subnetwork	0.20	> 0.20	LDLR (7.1)	FADS1 (6.6)	FADS2 (5.3)	HMGCR (5.3)	ERP29 (4.6)	ATP13A1 (4.0)	PCSK9 (4.0)	TMEM50A (3.2)	SORT1 (3.1)	TMEM57 (2.4)
GO:0009071	serine family amino acid catabolic process	0.20	> 0.20	ENSG00000254235 (3.5)	TXNL4B (3.2)	PMFBP1 (3.1)	UBXN2B (2.9)	LPIN3 (2.8)	SLC22A1 (2.5)	ANGPTL3 (2.4)	LPA (2.4)	ATXN7L2 (2.4)	DHODH (2.4)
ENSG00000198001	IRAK4 PPI subnetwork	0.20	> 0.20	MAFB (3.1)	TRIB1 (2.2)	SH2B3 (2.1)	UBXN2B (2.0)	PMFBP1 (1.9)	OASL (1.8)	FRK (1.8)	MYLIP (1.7)	GMIP (1.6)	NYNRIN (1.6)
MP:0003988	disorganized embryonic tissue	0.20	> 0.20	TRIB1 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.0)	ABO (2.0)	TOP1 (1.9)	DOCK7 (1.8)	FEN1 (1.6)	ENSG00000254235 (1.5)	ATXN7L2 (1.5)	ZHX3 (1.5)
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	0.20	> 0.20	PSMA5 (5.4)	NT5DC1 (3.0)	FEN1 (3.0)	TRAFD1 (2.8)	NAA25 (2.1)	TOMM40 (2.0)	SUGP1 (1.8)	DDX56 (1.6)	PARP10 (1.6)	USP1 (1.3)
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST:REPLICATIVE_STATE	REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST:REPLICATIVE_STATE	0.20	> 0.20	PSMA5 (5.4)	NT5DC1 (3.0)	FEN1 (3.0)	TRAFD1 (2.8)	NAA25 (2.1)	TOMM40 (2.0)	SUGP1 (1.8)	DDX56 (1.6)	PARP10 (1.6)	USP1 (1.3)
GO:0031060	regulation of histone methylation	0.20	> 0.20	ZNF180 (3.4)	USP24 (2.0)	C1orf63 (1.9)	C12orf51 (1.9)	ITGB3 (1.7)	CILP2 (1.6)	ENSG00000254235 (1.6)	TMEM57 (1.6)	C19orf52 (1.5)	ANKRD31 (1.4)
ENSG00000143375	CGN PPI subnetwork	0.20	> 0.20	CBLC (4.9)	AP1M2 (4.2)	DNM2 (3.1)	LPAR2 (2.9)	PLEC (2.6)	BCAM (2.3)	KANK2 (2.1)	CELSR2 (1.9)	DOCK7 (1.9)	CARM1 (1.9)
GO:0051353	positive regulation of oxidoreductase activity	0.20	> 0.20	ENSG00000235545 (4.1)	TRAPPC6A (1.9)	ENSG00000228044 (1.9)	ENSG00000226645 (1.7)	COL4A3BP (1.6)	AMIGO1 (1.6)	ST3GAL4 (1.3)	FADS2 (1.3)	ATXN7L2 (1.3)	TXNL4B (1.2)
GO:0005905	coated pit	0.20	> 0.20	CLPTM1 (4.2)	GRINA (4.1)	PPP1R37 (3.8)	CEACAM19 (2.6)	SARS (2.3)	DNM2 (2.2)	ERP29 (2.2)	SH2B3 (2.1)	C12orf51 (2.0)	HNF1A (2.0)
GO:0046519	sphingoid metabolic process	0.20	> 0.20	NKPD1 (4.9)	COL4A3BP (3.4)	HAVCR1 (3.3)	CYB561D1 (3.2)	TMEM50A (3.0)	TMED4 (2.6)	ERP29 (2.3)	POLK (2.2)	ATP13A1 (2.1)	GCNT4 (1.8)
ENSG00000101003	GINS1 PPI subnetwork	0.20	> 0.20	FEN1 (6.7)	USP1 (4.7)	ZNF180 (2.9)	ENSG00000228044 (1.8)	ENSG00000238078 (1.4)	DHODH (1.4)	FADS1 (1.2)	ANKRD31 (1.2)	FRK (1.0)	ILF3 (1.0)
MP:0010379	decreased respiratory quotient	0.20	> 0.20	GPAM (3.0)	MOSC1 (3.0)	ACAD10 (2.2)	ALDH2 (2.1)	PLEKHH2 (2.1)	CILP2 (2.0)	AMIGO1 (1.9)	TM6SF2 (1.7)	KANK2 (1.5)	DHODH (1.5)
GO:0001944	vasculature development	0.20	> 0.20	HLX (2.8)	PVR (2.7)	PVRL2 (2.6)	BCAM (2.2)	KANK2 (1.9)	MAFB (1.8)	NYNRIN (1.8)	SH2B3 (1.7)	TRIB1 (1.7)	SLC44A2 (1.6)
ENSG00000204713	TRIM27 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
ENSG00000112448	ENSG00000112448 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
ENSG00000215641	TRIM27 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
GO:0032592	integral to mitochondrial membrane	0.20	> 0.20	RHD (3.0)	OGDH (3.0)	GEMIN7 (2.7)	TRAPPC6A (2.5)	RHCE (2.4)	ALDH2 (2.3)	C19orf52 (2.2)	ACAD10 (2.1)	GOT2P1 (2.0)	TOMM40 (2.0)
ENSG00000145901	TNIP1 PPI subnetwork	0.20	> 0.20	RELB (7.1)	BCL3 (3.6)	SH2B3 (2.1)	ENSG00000228044 (2.0)	SYPL2 (2.0)	CEACAM19 (1.7)	MYLIP (1.6)	CILP2 (1.4)	FRK (1.3)	MAPKAPK5 (1.3)
ENSG00000206353	SKIV2L PPI subnetwork	0.20	> 0.20	TOMM40 (4.5)	DDX56 (4.3)	NAA25 (3.9)	ZNF259 (3.7)	USP24 (3.7)	DHODH (3.4)	QTRT1 (2.8)	DHX38 (2.6)	ATP13A1 (2.5)	SUGP1 (1.8)
ENSG00000162924	REL PPI subnetwork	0.20	> 0.20	RELB (7.1)	BCL3 (5.9)	GRINA (2.5)	ABO (2.1)	PVRL2 (2.0)	PVR (2.0)	TOP1 (1.7)	PLEC (1.7)	MYLIP (1.6)	GMIP (1.6)
ENSG00000185630	PBX1 PPI subnetwork	0.20	> 0.20	ANKRD31 (3.2)	ATXN7L2 (2.7)	HLX (2.6)	ENSG00000228044 (2.5)	SYPL2 (2.0)	C19orf52 (1.4)	PSRC1 (1.4)	OGDH (1.3)	C11orf9 (1.3)	PLCG1 (1.3)
MP:0001805	decreased IgG level	0.20	> 0.20	RELB (3.6)	BCL3 (2.6)	CETP (2.6)	TIMD4 (2.5)	ZNF101 (2.2)	GMIP (2.0)	HAVCR1 (1.9)	MAFB (1.9)	PARP10 (1.7)	APOE (1.6)
GO:0010888	negative regulation of lipid storage	0.20	> 0.20	ENSG00000238078 (2.7)	TIMD4 (2.4)	CETP (2.2)	MYLIP (2.2)	MOSC1 (1.8)	GEMIN7 (1.7)	APOC1 (1.7)	APOE (1.7)	COL4A3BP (1.6)	PVR (1.6)
ENSG00000068654	POLR1A PPI subnetwork	0.20	> 0.20	ZNF259 (3.3)	C12orf43 (3.2)	MAPKAPK5 (3.1)	BUD13 (3.1)	BRAP (3.0)	DDX56 (2.9)	ILF3 (2.9)	DHX38 (2.8)	GEMIN7 (2.8)	SUGP1 (2.7)
GO:0030275	LRR domain binding	0.20	> 0.20	BRAP (2.9)	CEACAM19 (2.5)	PLEC (2.0)	PVRL2 (1.7)	ZNF259 (1.7)	RELB (1.7)	TRAPPC6A (1.5)	TMEM57 (1.5)	C12orf51 (1.4)	TRIB1 (1.4)
GO:0005903	brush border	0.20	> 0.20	TM6SF2 (6.6)	NPC1L1 (5.5)	AP1M2 (3.9)	ABCG5 (3.9)	APOB (3.6)	TMEM116 (2.9)	ABCG8 (2.5)	PLG (2.4)	KIAA1324 (2.1)	FRK (1.8)
ENSG00000158092	NCK1 PPI subnetwork	0.20	> 0.20	GMIP (2.4)	USP24 (2.4)	SLC44A2 (2.4)	CARM1 (2.4)	MARK4 (2.2)	ATXN2 (2.1)	DNM2 (2.0)	GATAD2A (1.8)	SH2B3 (1.7)	ATXN7L2 (1.7)
ENSG00000146232	NFKBIE PPI subnetwork	0.20	> 0.20	RELB (5.3)	SARS (3.7)	BCL3 (3.4)	GRINA (2.2)	CLPTM1 (2.0)	PLEC (1.8)	CYP7A1 (1.7)	ENSG00000235545 (1.7)	USP24 (1.6)	PSMA5 (1.6)
ENSG00000099956	SMARCB1 PPI subnetwork	0.20	> 0.20	BUD13 (3.0)	SMARCA4 (2.9)	GATAD2A (2.6)	TRIB1 (2.6)	ATXN2 (2.4)	TOP1 (2.3)	CARM1 (2.2)	USP1 (2.2)	C12orf51 (1.9)	ENSG00000238078 (1.8)
GO:0010288	response to lead ion	0.20	> 0.20	RHD (3.2)	RHCE (3.0)	ENSG00000235545 (2.1)	DHODH (2.0)	NPC1L1 (1.9)	DNAH11 (1.9)	GOT2P1 (1.9)	ANGPTL3 (1.9)	FADS2 (1.7)	FADS1 (1.6)
ENSG00000197043	ANXA6 PPI subnetwork	0.20	> 0.20	PLEC (3.6)	C1orf63 (3.3)	OGDH (3.0)	ENSG00000238078 (2.4)	APOE (2.2)	CLPTM1 (1.8)	PVR (1.6)	HAVCR1 (1.6)	PARP10 (1.5)	MOSC1 (1.3)
ENSG00000103275	UBE2I PPI subnetwork	0.20	> 0.20	MYLIP (2.8)	BUD13 (2.6)	BCL3 (2.6)	RELB (2.4)	TRIB1 (2.3)	CELSR2 (2.2)	GATAD2A (2.0)	TRAPPC6A (1.9)	SMARCA4 (1.7)	PLCG1 (1.6)
GO:0009072	aromatic amino acid family metabolic process	0.20	> 0.20	ENSG00000254235 (4.0)	SLC22A1 (3.6)	LPA (3.0)	ANGPTL3 (2.8)	CYP7A1 (2.7)	APOA5 (2.7)	APOC4 (2.3)	PLG (2.3)	ATXN7L2 (1.8)	HNF1A (1.8)
ENSG00000175054	ATR PPI subnetwork	0.20	> 0.20	FEN1 (5.2)	USP1 (3.7)	TOMM40 (2.7)	SMARCA4 (2.7)	CLPTM1 (1.9)	USP24 (1.8)	ILF3 (1.7)	ENSG00000226648 (1.6)	ZNF180 (1.4)	DNM2 (1.3)
GO:0016814	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines	0.20	> 0.20	OASL (4.4)	PARP10 (3.6)	SYPL2 (3.2)	NPC1L1 (3.0)	LPIN3 (2.6)	TSSK6 (2.4)	ABCG5 (2.3)	TRAFD1 (2.3)	TM6SF2 (2.1)	ABCG8 (1.6)
MP:0004025	polyploidy	0.20	> 0.20	RHD (3.1)	RHCE (3.1)	MARK4 (2.6)	NKPD1 (2.5)	PVR (2.4)	PSRC1 (2.3)	PTPN11 (1.7)	ENSG00000226648 (1.7)	PVRL2 (1.7)	GATAD2A (1.5)
ENSG00000105851	PIK3CG PPI subnetwork	0.20	> 0.20	HLX (3.5)	SLC44A2 (3.0)	GMIP (2.6)	MYLIP (2.5)	C1orf63 (2.3)	DOCK7 (2.2)	DNM2 (2.0)	PLEC (2.0)	SH2B3 (1.8)	C17orf57 (1.8)
ENSG00000124535	WRNIP1 PPI subnetwork	0.20	> 0.20	FRK (3.0)	ZNF180 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	C19orf52 (2.4)	USP1 (2.2)	BLOC1S3 (2.2)	GEMIN7 (2.2)	TRAPPC6A (1.9)	GATAD2A (1.8)
ENSG00000077312	SNRPA PPI subnetwork	0.20	> 0.20	ILF3 (4.0)	DHX38 (3.7)	SUGP1 (3.4)	BUD13 (3.3)	SMARCA4 (3.2)	TOP1 (2.9)	QTRT1 (2.6)	DDX56 (2.4)	C1orf63 (2.3)	FEN1 (2.2)
ENSG00000196924	FLNA PPI subnetwork	0.20	> 0.20	PLEC (4.1)	PVRL2 (2.1)	PVR (2.1)	ITGB3 (2.0)	DNM2 (1.9)	DOCK7 (1.9)	OGDH (1.8)	GATAD2A (1.7)	KANK2 (1.7)	GMIP (1.6)
MP:0002389	abnormal Peyer's patch follicle morphology	0.20	> 0.20	RELB (6.7)	KIAA1324 (3.4)	BCL3 (2.8)	GMIP (2.4)	ST3GAL4 (2.3)	PLEC (2.0)	PVR (1.5)	HNF1A (1.5)	HAVCR1 (1.5)	PVRL2 (1.4)
ENSG00000135316	SYNCRIP PPI subnetwork	0.20	> 0.20	C12orf43 (3.2)	ILF3 (3.1)	BRAP (3.0)	SMARCA4 (2.9)	ABO (2.8)	SARS (2.7)	CARM1 (2.7)	GATAD2A (2.6)	HAPLN4 (2.6)	PSMA5 (2.5)
GO:0051015	actin filament binding	0.20	> 0.20	RHCE (4.0)	RHD (3.6)	PLEC (2.5)	PCSK9 (2.5)	NPC1L1 (2.3)	DOCK7 (2.3)	ENSG00000235545 (2.2)	ITGB3 (2.1)	AP1M2 (2.1)	SORT1 (2.0)
MP:0000062	increased bone mineral density	0.20	> 0.20	APOC1 (3.6)	APOE (3.3)	MAFB (2.8)	ITGB3 (2.5)	SH2B3 (2.5)	KIAA1324 (2.3)	GMIP (2.2)	ENSG00000226645 (2.0)	CETP (1.9)	MYLIP (1.8)
ENSG00000121274	PAPD5 PPI subnetwork	0.20	> 0.20	DHODH (4.0)	USP24 (2.8)	NT5DC1 (2.6)	USP1 (2.6)	QTRT1 (2.3)	DHX38 (2.1)	GPAM (2.0)	DDX56 (2.0)	ATXN7L2 (2.0)	MAPKAPK5 (1.9)
ENSG00000105289	TJP3 PPI subnetwork	0.20	> 0.20	APOB (3.1)	AP1M2 (2.9)	FRK (2.8)	CBLC (2.5)	APOC1 (2.3)	SORT1 (1.7)	APOC4 (1.6)	C17orf57 (1.5)	PVRL2 (1.5)	TRAPPC6A (1.4)
ENSG00000169194	IL13 PPI subnetwork	0.20	> 0.20	BCL3 (4.0)	TIMD4 (3.7)	CETP (3.1)	RELB (3.0)	HLX (2.9)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.8)	TRIB1 (1.2)	GRINA (1.1)
MP:0004028	chromosome breakage	0.20	> 0.20	FEN1 (3.3)	USP1 (2.5)	PTPN11 (2.3)	POC5 (2.2)	ADAM1 (2.1)	BUD13 (2.0)	PVR (1.7)	PSRC1 (1.6)	POLK (1.5)	UBXN2B (1.4)
ENSG00000135486	HNRNPA1 PPI subnetwork	0.20	> 0.20	ILF3 (3.5)	C1orf63 (3.3)	TOP1 (3.2)	SMARCA4 (3.0)	QTRT1 (2.8)	DHX38 (2.6)	USP1 (2.5)	SUGP1 (2.1)	GATAD2A (2.0)	TOMM40 (2.0)
KEGG_BETA_ALANINE_METABOLISM	KEGG_BETA_ALANINE_METABOLISM	0.20	> 0.20	PLG (4.8)	MOSC1 (4.2)	SLC22A1 (3.9)	ANGPTL3 (3.8)	ACAD10 (3.5)	APOA5 (3.1)	ABCG8 (3.0)	LPA (3.0)	APOC4 (2.7)	HP (2.7)
GO:0004601	peroxidase activity	0.20	> 0.20	MOSC1 (3.9)	ALDH2 (3.6)	RHD (3.1)	NYNRIN (3.0)	HLX (2.5)	HP (2.4)	PSMA5 (2.1)	RHCE (2.0)	AP1M2 (1.9)	GOT2P1 (1.9)
GO:0016684	oxidoreductase activity, acting on peroxide as acceptor	0.20	> 0.20	MOSC1 (3.9)	ALDH2 (3.6)	RHD (3.1)	NYNRIN (3.0)	HLX (2.5)	HP (2.4)	PSMA5 (2.1)	RHCE (2.0)	AP1M2 (1.9)	GOT2P1 (1.9)
ENSG00000129757	CDKN1C PPI subnetwork	0.20	> 0.20	FEN1 (3.5)	USP1 (3.3)	LPIN3 (2.1)	AMIGO1 (1.9)	GCNT4 (1.9)	PSRC1 (1.9)	GATAD2A (1.8)	HLX (1.7)	HAPLN4 (1.6)	CETP (1.5)
KEGG_GNRH_SIGNALING_PATHWAY	KEGG_GNRH_SIGNALING_PATHWAY	0.20	> 0.20	KIAA1324 (3.1)	CEACAM19 (2.1)	MARK4 (2.0)	PVR (2.0)	CYB561D1 (1.7)	ST3GAL4 (1.6)	ENSG00000238078 (1.6)	GATAD2A (1.6)	PLCG1 (1.5)	MOSC1 (1.5)
MP:0002590	increased mean corpuscular volume	0.20	> 0.20	RHCE (5.4)	RHD (5.0)	TRAPPC6A (2.8)	C12orf51 (2.7)	GMPR (2.2)	TMEM57 (1.9)	ZNF180 (1.7)	TOP1 (1.6)	PLEC (1.5)	GOT2P1 (1.4)
ENSG00000118402	ELOVL4 PPI subnetwork	0.21	> 0.20	LDLR (7.1)	HMGCR (6.2)	FADS1 (6.1)	FADS2 (5.1)	PCSK9 (4.6)	TMEM50A (3.8)	ERP29 (3.3)	SORT1 (3.2)	ATP13A1 (2.7)	CLPTM1 (2.6)
MP:0002074	abnormal hair texture	0.21	> 0.20	BLOC1S3 (2.2)	PBX4 (1.8)	ENSG00000235545 (1.8)	AMIGO1 (1.6)	GCNT4 (1.6)	DNAH11 (1.6)	ZNF101 (1.5)	ZNF180 (1.3)	POLK (1.3)	ANKRD31 (1.3)
MP:0001011	abnormal superior cervical ganglion morphology	0.21	> 0.20	TRIB1 (3.3)	KANK2 (2.4)	POLK (2.4)	YIPF2 (2.2)	KIAA1324 (2.2)	AMIGO1 (2.2)	TSSK6 (2.1)	ADAM1 (2.0)	CELSR2 (1.9)	CBLC (1.9)
ENSG00000114520	SNX4 PPI subnetwork	0.21	> 0.20	TMEM50A (3.1)	NYNRIN (2.9)	HAVCR1 (2.6)	MYLIP (2.2)	USP24 (1.9)	ENSG00000235545 (1.8)	ZNF259 (1.8)	POLK (1.8)	SYPL2 (1.7)	TRAFD1 (1.7)
GO:0030674	protein binding, bridging	0.21	> 0.20	PLEC (2.6)	GMIP (2.2)	ITGB3 (1.9)	C11orf9 (1.8)	LPAR2 (1.7)	MAFB (1.6)	COL4A3BP (1.6)	ST3GAL4 (1.6)	APOC1 (1.5)	ZNF101 (1.4)
GO:0090003	regulation of establishment of protein localization in plasma membrane	0.21	> 0.20	ENSG00000226645 (3.0)	PTPN11 (2.6)	ZHX3 (1.9)	ENSG00000238078 (1.9)	AP1M2 (1.8)	CBLC (1.5)	COL4A3BP (1.5)	HAVCR1 (1.5)	ANKRD31 (1.4)	PLEKHH2 (1.4)
ENSG00000179271	GADD45GIP1 PPI subnetwork	0.21	> 0.20	TRIB1 (4.3)	BCL3 (2.0)	RHCE (1.7)	PVR (1.7)	GMPR (1.6)	TRAFD1 (1.5)	UBXN2B (1.5)	LPA (1.4)	TOP1 (1.4)	TSSK6 (1.4)
ENSG00000166793	YPEL4 PPI subnetwork	0.21	> 0.20	NAA25 (3.4)	TOP1 (3.2)	TOMM40 (3.1)	QTRT1 (2.9)	ZNF259 (2.8)	DDX56 (2.6)	ANKRD31 (2.3)	ADAM1 (2.1)	RHD (2.0)	TMEM57 (2.0)
MP:0009336	increased splenocyte proliferation	0.21	> 0.20	CETP (5.2)	PBX4 (1.9)	RHD (1.9)	HAVCR1 (1.8)	APOC1 (1.8)	DNM2 (1.4)	RHCE (1.4)	FEN1 (1.3)	TOMM40 (1.3)	COL4A3BP (1.3)
ENSG00000109193	SULT1E1 PPI subnetwork	0.21	> 0.20	PCSK9 (2.2)	FADS1 (2.1)	C12orf47 (2.0)	FEN1 (2.0)	BLOC1S3 (1.9)	FADS2 (1.8)	USP1 (1.8)	MYLIP (1.7)	C11orf9 (1.6)	GMIP (1.6)
ENSG00000018408	WWTR1 PPI subnetwork	0.21	> 0.20	BCAM (3.8)	PPP1R37 (2.5)	NYNRIN (2.3)	NKPD1 (2.1)	KANK2 (2.0)	PLEKHH2 (2.0)	ENSG00000228044 (1.9)	GCNT4 (1.9)	SORT1 (1.7)	TMEM116 (1.6)
ENSG00000127831	VIL1 PPI subnetwork	0.21	> 0.20	TM6SF2 (5.5)	NPC1L1 (5.3)	ABCG5 (4.6)	ABCG8 (3.1)	PVRL2 (2.7)	TMEM116 (2.3)	APOB (2.3)	LPIN3 (2.3)	PLEC (2.0)	TMEM57 (2.0)
MP:0001548	hyperlipidemia	0.21	> 0.20	APOC1 (5.5)	TIMD4 (3.3)	COL4A3BP (2.5)	GPAM (2.4)	CETP (2.3)	MOSC1 (2.1)	TRAPPC6A (2.0)	UBXN2B (1.6)	USP24 (1.6)	POLK (1.4)
MP:0008190	decreased transitional stage B cell number	0.21	> 0.20	GMIP (2.7)	TIMD4 (2.7)	RELB (2.5)	GPAM (2.2)	NT5DC1 (2.0)	MAFB (2.0)	CETP (1.8)	C17orf57 (1.6)	FRK (1.5)	CILP2 (1.5)
ENSG00000173801	JUP PPI subnetwork	0.21	> 0.20	PVRL2 (3.5)	AP1M2 (3.0)	CEACAM19 (2.8)	C11orf9 (2.5)	CELSR2 (2.4)	LPIN3 (2.2)	DOCK7 (2.1)	CBLC (2.1)	CLPTM1 (1.8)	BCAM (1.7)
KEGG_TYPE_II_DIABETES_MELLITUS	KEGG_TYPE_II_DIABETES_MELLITUS	0.21	> 0.20	HLX (2.8)	KIAA1324 (2.4)	COL4A3BP (2.3)	HAPLN4 (2.2)	SORT1 (2.0)	MYLIP (1.9)	TMEM57 (1.9)	BCL3 (1.9)	GMIP (1.8)	GPAM (1.7)
ENSG00000109339	MAPK10 PPI subnetwork	0.21	> 0.20	TRIB1 (7.0)	POLK (2.4)	LDLR (2.0)	ENSG00000226645 (1.9)	PBX4 (1.8)	PLCG1 (1.6)	MYLIP (1.6)	LPAR2 (1.5)	SH2B3 (1.5)	SORT1 (1.4)
MP:0006319	abnormal epididymal fat pad morphology	0.21	> 0.20	APOC1 (3.6)	USP24 (2.9)	SORT1 (2.4)	LDLR (2.1)	POLK (1.9)	PSRC1 (1.9)	MOSC1 (1.7)	HP (1.5)	GCNT4 (1.5)	PVR (1.4)
ENSG00000138442	WDR12 PPI subnetwork	0.21	> 0.20	NAA25 (4.9)	ZNF259 (4.7)	TOMM40 (4.2)	DDX56 (4.1)	DHX38 (3.4)	QTRT1 (3.3)	DHODH (3.0)	ATP13A1 (2.7)	C12orf43 (2.5)	MAPKAPK5 (2.1)
ENSG00000157191	NECAP2 PPI subnetwork	0.21	> 0.20	USP24 (4.3)	PARP10 (3.9)	OASL (3.6)	PPP1R37 (3.2)	HNF1A (2.7)	GRINA (2.7)	CLPTM1 (2.3)	RELB (1.7)	TXNL4B (1.7)	DHX38 (1.6)
GO:0071549	cellular response to dexamethasone stimulus	0.21	> 0.20	RHCE (4.1)	RHD (3.3)	GMPR (2.4)	TXNL4B (2.3)	ENSG00000226645 (2.0)	LPIN3 (2.0)	TMEM57 (1.9)	ABCG8 (1.8)	CEACAM19 (1.7)	C19orf52 (1.7)
ENSG00000088038	CNOT3 PPI subnetwork	0.21	> 0.20	TXNL4B (2.7)	ADAM1 (2.3)	DDX56 (2.2)	BUD13 (2.1)	DHX38 (1.8)	BRAP (1.8)	TMED4 (1.7)	ATXN7L2 (1.6)	ATXN2 (1.6)	ENSG00000254235 (1.6)
MP:0001156	abnormal spermatogenesis	0.21	> 0.20	TSSK6 (2.7)	PBX4 (2.4)	GATAD2A (2.3)	ST3GAL4 (2.1)	LPAR2 (2.1)	LDLR (1.7)	FADS1 (1.7)	FADS2 (1.6)	GMPR (1.6)	PCSK9 (1.5)
ENSG00000133101	CCNA1 PPI subnetwork	0.21	> 0.20	FEN1 (4.3)	FADS1 (3.3)	USP1 (3.3)	FADS2 (2.5)	HMGCR (2.3)	ILF3 (2.0)	GATAD2A (1.8)	LDLR (1.8)	GOT2P1 (1.7)	PSRC1 (1.4)
GO:0045598	regulation of fat cell differentiation	0.21	> 0.20	ENSG00000238078 (2.7)	ENSG00000254235 (2.1)	CILP2 (1.9)	MAFB (1.8)	LDLR (1.6)	MYLIP (1.4)	FADS1 (1.4)	ST3GAL4 (1.2)	SH2B3 (1.1)	PCSK9 (1.1)
ENSG00000170917	NUDT6 PPI subnetwork	0.21	> 0.20	C1orf63 (2.5)	TXNL4B (2.1)	GRINA (1.8)	ENSG00000254235 (1.8)	PLEKHH2 (1.8)	MYLIP (1.7)	DNM2 (1.6)	CLPTM1 (1.6)	UBXN2B (1.5)	C12orf47 (1.5)
ENSG00000100038	TOP3B PPI subnetwork	0.21	> 0.20	HNF1A (3.3)	BRAP (3.1)	TRAPPC6A (2.7)	ATP13A1 (2.6)	ERP29 (2.5)	CLPTM1 (2.3)	C19orf52 (2.1)	ANKRD31 (2.0)	SLC44A2 (1.9)	PLEKHH2 (1.9)
GO:0010332	response to gamma radiation	0.21	> 0.20	ZNF101 (3.1)	ENSG00000228044 (2.9)	BLOC1S3 (2.4)	UBXN2B (2.3)	ZNF180 (2.1)	GCNT4 (1.9)	CBLC (1.8)	ENSG00000235545 (1.8)	AMIGO1 (1.7)	TRAPPC6A (1.7)
GO:0030099	myeloid cell differentiation	0.21	> 0.20	RHCE (4.3)	RHD (4.2)	SH2B3 (2.3)	HLX (1.9)	ITGB3 (1.7)	TMEM57 (1.6)	DNM2 (1.5)	ZNF101 (1.4)	GEMIN7 (1.3)	C12orf51 (1.3)
ENSG00000075785	RAB7A PPI subnetwork	0.21	> 0.20	TMEM50A (3.2)	GEMIN7 (2.8)	C12orf43 (2.8)	SARS (2.4)	COL4A3BP (2.3)	GOT2P1 (2.1)	SUGP1 (2.1)	CLPTM1 (2.0)	TRAPPC6A (1.7)	HAPLN4 (1.7)
ENSG00000170653	ATF7 PPI subnetwork	0.21	> 0.20	TRIB1 (6.2)	BCL3 (3.7)	MAFB (3.2)	PARP10 (3.0)	PVR (2.9)	POLK (2.1)	MAPKAPK5 (1.8)	OASL (1.7)	SARS (1.7)	ATXN2 (1.5)
ENSG00000127666	TICAM1 PPI subnetwork	0.21	> 0.20	PARP10 (3.6)	TRAFD1 (3.1)	FRK (2.8)	OASL (2.6)	RELB (2.5)	NT5DC1 (2.5)	CYB561D1 (2.0)	LPAR2 (1.9)	TSSK6 (1.9)	ZNF101 (1.8)
ENSG00000143850	PLEKHA6 PPI subnetwork	0.21	> 0.20	HNF1A (2.7)	ST3GAL4 (2.7)	DNM2 (2.5)	AP1M2 (2.2)	CETP (2.0)	CBLC (1.8)	CYB561D1 (1.8)	NT5DC1 (1.7)	ITGB3 (1.7)	POLK (1.7)
GO:0046474	glycerophospholipid biosynthetic process	0.21	> 0.20	TSSK6 (2.7)	BLOC1S3 (2.2)	ATP13A1 (2.1)	TRAPPC6A (1.9)	CYB561D1 (1.8)	NKPD1 (1.7)	UBXN2B (1.6)	TMED4 (1.5)	NPC1L1 (1.5)	TMEM50A (1.5)
ENSG00000130159	ECSIT PPI subnetwork	0.21	> 0.20	TMEM116 (3.1)	MAPKAPK5 (2.3)	SH2B3 (2.2)	TRIB1 (2.0)	ENSG00000226648 (2.0)	BRAP (1.9)	MAU2 (1.8)	ZNF101 (1.8)	ATXN2 (1.7)	C12orf43 (1.6)
ENSG00000164346	NSA2 PPI subnetwork	0.21	> 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.2)	TOMM40 (3.9)	QTRT1 (3.1)	DHODH (2.6)	ATP13A1 (2.2)	DHX38 (2.2)	SARS (2.2)	SUGP1 (2.1)
GO:0010460	positive regulation of heart rate	0.21	> 0.20	LPIN3 (3.4)	CEACAM19 (3.0)	FRK (2.3)	GCNT4 (2.3)	ENSG00000254235 (2.3)	ENSG00000226648 (2.2)	NKPD1 (1.8)	TM6SF2 (1.8)	HAPLN4 (1.5)	ITGB3 (1.4)
ENSG00000117335	CD46 PPI subnetwork	0.21	> 0.20	PVRL2 (2.9)	ITGB3 (2.7)	TMEM50A (2.7)	PLEC (2.7)	APOE (2.6)	POLK (2.5)	PTPN11 (2.5)	BCAM (2.4)	APOC1 (2.2)	NCAN (2.2)
GO:0060351	cartilage development involved in endochondral bone morphogenesis	0.21	> 0.20	CILP2 (7.2)	PLEKHH2 (2.0)	YIPF2 (2.0)	NYNRIN (1.9)	ATXN7L2 (1.9)	ANKRD31 (1.8)	PMFBP1 (1.4)	QTRT1 (1.4)	SLC44A2 (1.2)	UBXN2B (1.1)
ENSG00000155926	SLA PPI subnetwork	0.21	> 0.20	PLCG1 (3.0)	HAVCR1 (2.6)	SLC44A2 (2.2)	ZNF101 (2.0)	BUD13 (1.8)	LPAR2 (1.7)	C19orf52 (1.6)	PVR (1.6)	ENSG00000226645 (1.6)	GMIP (1.5)
ENSG00000132139	GAS2L2 PPI subnetwork	0.21	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.5)	PLEKHH2 (1.9)	TMEM57 (1.8)	C1orf63 (1.6)	SLC44A2 (1.5)	HNF1A (1.4)	POLK (1.3)	GOT2P1 (1.3)
MP:0000642	enlarged adrenal glands	0.21	> 0.20	FADS1 (3.6)	ST3GAL4 (2.7)	FADS2 (2.6)	HAVCR1 (2.3)	GPAM (1.9)	APOC1 (1.9)	MYLIP (1.8)	KANK2 (1.7)	APOC4 (1.6)	DNAH11 (1.5)
KEGG_PENTOSE_PHOSPHATE_PATHWAY	KEGG_PENTOSE_PHOSPHATE_PATHWAY	0.21	> 0.20	NT5DC1 (3.5)	TRAPPC6A (3.3)	NPC1L1 (3.0)	FADS1 (2.7)	FADS2 (2.5)	LPA (2.0)	TM6SF2 (1.9)	ENSG00000228044 (1.8)	SYPL2 (1.7)	DHODH (1.7)
ENSG00000079950	STX7 PPI subnetwork	0.21	> 0.20	BLOC1S3 (3.5)	ZNF259 (3.2)	BRAP (2.9)	SLC44A2 (2.3)	TRAPPC6A (2.2)	LPIN3 (2.1)	PPP1R37 (2.0)	ENSG00000228044 (1.8)	HNF1A (1.8)	ENSG00000226645 (1.7)
GO:0006397	mRNA processing	0.21	> 0.20	BUD13 (3.3)	TOP1 (3.3)	C1orf63 (3.1)	DHX38 (2.9)	SUGP1 (2.8)	ILF3 (2.7)	C12orf43 (2.4)	MAPKAPK5 (2.4)	QTRT1 (1.8)	SMARCA4 (1.7)
GO:0006476	protein deacetylation	0.21	> 0.20	ATXN7L2 (2.4)	TMEM57 (2.3)	C1orf63 (2.3)	C17orf57 (2.1)	HNF1A (1.9)	MYLIP (1.5)	PLCG1 (1.3)	UBXN2B (1.3)	TXNL4B (1.3)	BUD13 (1.3)
ENSG00000102145	GATA1 PPI subnetwork	0.21	> 0.20	CARM1 (3.5)	SMARCA4 (3.0)	MARK4 (2.7)	TMEM57 (2.6)	GRINA (2.2)	ATXN2 (2.0)	SH2B3 (1.9)	MAU2 (1.9)	HLX (1.8)	DNM2 (1.7)
REACTOME_METABOLISM_OF_MRNA	REACTOME_METABOLISM_OF_MRNA	0.21	> 0.20	PSMA5 (3.0)	TRAFD1 (2.8)	NAA25 (2.6)	TXNL4B (2.5)	DHX38 (2.3)	TOMM40 (2.0)	SUGP1 (1.9)	BRAP (1.8)	DDX56 (1.8)	ZNF259 (1.7)
ENSG00000136807	CDK9 PPI subnetwork	0.21	> 0.20	BUD13 (2.8)	DNM2 (2.8)	DHX38 (2.3)	CARM1 (2.1)	ATXN2 (2.1)	SMARCA4 (2.1)	GEMIN7 (2.0)	SUGP1 (2.0)	TOP1 (1.8)	PSMA5 (1.8)
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.21	> 0.20	GMIP (4.4)	SH2B3 (3.1)	RELB (3.0)	GATAD2A (2.4)	MYLIP (2.3)	GEMIN7 (2.0)	MAFB (1.7)	ENSG00000226645 (1.6)	SLC44A2 (1.5)	CARM1 (1.4)
ENSG00000169679	BUB1 PPI subnetwork	0.21	> 0.20	PSRC1 (5.0)	POC5 (3.4)	ZHX3 (2.7)	CLPTM1 (2.5)	GEMIN7 (2.3)	FEN1 (2.1)	PLCG1 (2.0)	ACAD10 (1.9)	USP1 (1.7)	DNM2 (1.7)
MP:0003915	increased left ventricle weight	0.21	> 0.20	SYPL2 (3.4)	MOSC1 (2.6)	TM6SF2 (2.0)	TMEM50A (2.0)	PLEKHH2 (1.9)	GMPR (1.9)	NPC1L1 (1.8)	ABCG8 (1.4)	SORT1 (1.4)	ACAD10 (1.4)
GO:0000228	nuclear chromosome	0.21	> 0.20	USP1 (4.5)	FEN1 (4.5)	PSRC1 (2.3)	POC5 (2.1)	NYNRIN (2.1)	ILF3 (1.8)	SMARCA4 (1.6)	TOP1 (1.5)	BUD13 (1.5)	ANKRD31 (1.2)
ENSG00000114739	ACVR2B PPI subnetwork	0.21	> 0.20	MARK4 (2.4)	ABO (2.3)	PVR (2.0)	PVRL2 (2.0)	POLK (1.8)	SLC22A1 (1.8)	ENSG00000226645 (1.7)	SLC44A2 (1.7)	PTPN11 (1.7)	KANK2 (1.5)
ENSG00000109846	CRYAB PPI subnetwork	0.21	> 0.20	SYPL2 (2.3)	HAPLN4 (2.0)	GMPR (2.0)	PVR (1.7)	ERP29 (1.7)	GRINA (1.6)	RPH3A (1.6)	ENSG00000254235 (1.6)	C11orf9 (1.6)	APOA5 (1.5)
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	0.21	> 0.20	ZNF101 (2.1)	ABO (1.8)	ENSG00000254235 (1.6)	FADS1 (1.6)	FADS2 (1.6)	C19orf52 (1.5)	TMEM57 (1.5)	CBLC (1.5)	DNAH11 (1.4)	ABCG8 (1.4)
REACTOME_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR	REACTOME_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR	0.21	> 0.20	ZNF101 (2.1)	ABO (1.8)	ENSG00000254235 (1.6)	FADS1 (1.6)	FADS2 (1.6)	C19orf52 (1.5)	TMEM57 (1.5)	CBLC (1.5)	DNAH11 (1.4)	ABCG8 (1.4)
ENSG00000102981	PARD6A PPI subnetwork	0.21	> 0.20	PVRL2 (3.8)	AP1M2 (3.2)	CBLC (2.8)	PSRC1 (2.1)	FRK (1.9)	C11orf9 (1.8)	ZNF180 (1.7)	BCAM (1.5)	PVR (1.5)	PLCG1 (1.5)
ENSG00000141380	SS18 PPI subnetwork	0.21	> 0.20	CARM1 (4.2)	SMARCA4 (3.4)	DOCK7 (2.7)	TMEM57 (2.7)	MAPKAPK5 (2.4)	NYNRIN (2.3)	ILF3 (2.2)	MARK4 (2.1)	ZNF101 (2.0)	MAU2 (1.8)
ENSG00000132676	DAP3 PPI subnetwork	0.21	> 0.20	FRK (2.6)	RELB (2.2)	BCL3 (2.2)	PARP10 (2.0)	GOT2P1 (2.0)	AMIGO1 (1.9)	ZNF101 (1.9)	KIAA1324 (1.8)	PLEC (1.7)	DHODH (1.6)
ENSG00000184486	POU3F2 PPI subnetwork	0.21	> 0.20	NCAN (3.2)	CELSR2 (2.4)	BUD13 (1.6)	SORT1 (1.6)	TRIB1 (1.5)	APOE (1.5)	TOP1 (1.4)	DOCK7 (1.4)	C12orf51 (1.4)	CYP7A1 (1.3)
ENSG00000187109	NAP1L1 PPI subnetwork	0.21	> 0.20	SMARCA4 (3.5)	DDX56 (2.9)	ZNF259 (2.5)	QTRT1 (2.4)	ILF3 (2.3)	TOMM40 (2.1)	NAA25 (1.9)	BUD13 (1.9)	ENSG00000226645 (1.8)	GATAD2A (1.8)
GO:0008028	monocarboxylic acid transmembrane transporter activity	0.21	> 0.20	TM6SF2 (3.9)	APOC4 (2.9)	CYP7A1 (2.7)	APOA5 (2.6)	ABCG8 (2.5)	ANGPTL3 (2.3)	HP (2.2)	PLEC (2.1)	CILP2 (2.0)	CLPTM1 (1.9)
ENSG00000131023	LATS1 PPI subnetwork	0.21	> 0.20	PBX4 (3.3)	RHD (2.1)	LPAR2 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)	KANK2 (1.7)	RHCE (1.7)	PVRL2 (1.7)	CETP (1.6)	SH2B3 (1.6)
MP:0001045	abnormal enteric ganglia morphology	0.21	> 0.20	HLX (3.7)	TRIB1 (2.1)	ENSG00000254235 (1.8)	MYLIP (1.7)	AMIGO1 (1.7)	KANK2 (1.6)	ENSG00000238078 (1.6)	ABCG5 (1.5)	C17orf57 (1.4)	ABO (1.4)
GO:0000096	sulfur amino acid metabolic process	0.21	> 0.20	SLC22A1 (2.9)	GOT2P1 (2.2)	LPA (2.2)	DNAH11 (2.0)	APOA5 (1.8)	CYP7A1 (1.8)	NT5DC1 (1.7)	APOC4 (1.7)	ABCG8 (1.7)	UBXN2B (1.7)
ENSG00000215425	DDX39B PPI subnetwork	0.21	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000215412	ENSG00000215412 PPI subnetwork	0.21	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000198563	DDX39B PPI subnetwork	0.21	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000145555	MYO10 PPI subnetwork	0.21	> 0.20	GOT2P1 (2.6)	ILF3 (2.3)	PBX4 (2.1)	PVR (2.0)	BCAM (1.8)	CILP2 (1.8)	FRK (1.7)	TMED4 (1.4)	PTPN11 (1.4)	TMEM50A (1.4)
GO:0051651	maintenance of location in cell	0.21	> 0.20	C17orf57 (2.8)	RHD (2.1)	ZNF101 (2.0)	GOT2P1 (1.8)	RHCE (1.7)	CBLC (1.7)	PSRC1 (1.7)	CLPTM1 (1.6)	C12orf51 (1.6)	PBX4 (1.6)
MP:0001120	abnormal uterus morphology	0.21	> 0.20	ST3GAL4 (3.9)	PLEKHH2 (2.2)	GPAM (2.1)	PVRL2 (2.0)	HAPLN4 (1.7)	FRK (1.6)	KIAA1324 (1.5)	ABCG8 (1.4)	KANK2 (1.3)	GCNT4 (1.1)
ENSG00000131475	VPS25 PPI subnetwork	0.21	> 0.20	POLK (2.8)	DYNC2LI1 (2.4)	GRINA (2.2)	C12orf43 (2.2)	HAVCR1 (2.2)	TRAPPC6A (2.2)	UBXN2B (2.2)	SARS (1.9)	GEMIN7 (1.7)	SUGP1 (1.6)
GO:0002690	positive regulation of leukocyte chemotaxis	0.21	> 0.20	TIMD4 (2.5)	ENSG00000228044 (2.4)	ZNF101 (2.1)	CETP (2.1)	MAFB (2.0)	PVR (1.9)	ST3GAL4 (1.9)	APOE (1.9)	ENSG00000238078 (1.5)	RELB (1.4)
MP:0009703	decreased birth body size	0.21	> 0.20	ATXN2 (3.5)	C12orf51 (2.2)	ALDH2 (2.1)	C11orf9 (1.9)	LDLR (1.8)	NYNRIN (1.7)	PVRL2 (1.7)	TOP1 (1.7)	SORT1 (1.7)	TMEM50A (1.6)
REACTOME_PYRIMIDINE_CATABOLISM	REACTOME_PYRIMIDINE_CATABOLISM	0.21	> 0.20	PLG (5.4)	APOC4 (4.8)	ANGPTL3 (4.8)	SLC22A1 (3.8)	APOA5 (3.1)	LPA (3.0)	CYP7A1 (2.9)	HP (1.7)	GEMIN7 (1.5)	TRAPPC6A (1.5)
ENSG00000130520	LSM4 PPI subnetwork	0.21	> 0.20	DHX38 (5.1)	SUGP1 (3.4)	SMARCA4 (2.9)	MAU2 (2.9)	BUD13 (2.7)	TOP1 (2.4)	ATP13A1 (2.4)	ILF3 (2.3)	DHODH (2.2)	FEN1 (2.1)
ENSG00000182199	SHMT2 PPI subnetwork	0.21	> 0.20	C12orf43 (3.1)	BRAP (3.0)	HAPLN4 (3.0)	TM6SF2 (2.6)	ZHX3 (2.6)	SH2B3 (2.3)	SARS (2.1)	PTPN11 (2.1)	PVR (2.1)	NPC1L1 (2.1)
ENSG00000174371	EXO1 PPI subnetwork	0.21	> 0.20	ENSG00000235545 (2.7)	ANKRD31 (2.7)	USP1 (2.5)	FEN1 (2.5)	DOCK7 (2.1)	NPC1L1 (1.9)	ERP29 (1.8)	DNAH11 (1.6)	ZNF180 (1.6)	AP1M2 (1.5)
GO:0046148	pigment biosynthetic process	0.21	> 0.20	RHCE (4.5)	RHD (4.4)	ADAM1 (2.6)	GMPR (2.4)	NT5DC1 (2.4)	DHODH (2.1)	ENSG00000235545 (1.9)	TRAPPC6A (1.6)	ANKRD31 (1.4)	ACAD10 (1.3)
GO:0019400	alditol metabolic process	0.21	> 0.20	TM6SF2 (3.6)	ENSG00000254235 (2.7)	GCNT4 (2.7)	ABCG8 (2.6)	ENSG00000226645 (2.5)	MOSC1 (2.2)	NPC1L1 (1.9)	PMFBP1 (1.9)	ABCG5 (1.8)	GPAM (1.8)
MP:0005466	abnormal T-helper 2 physiology	0.21	> 0.20	BCL3 (4.0)	TRIB1 (3.0)	RELB (3.0)	MAFB (3.0)	PARP10 (1.8)	PBX4 (1.8)	PVR (1.6)	GMIP (1.6)	PLCG1 (1.6)	ZNF101 (1.5)
ENSG00000120333	MRPS14 PPI subnetwork	0.21	> 0.20	OASL (3.5)	TMED4 (3.2)	PARP10 (3.2)	ZNF101 (2.3)	USP24 (1.9)	MAPKAPK5 (1.7)	NAA25 (1.6)	DHX38 (1.5)	SUGP1 (1.4)	PLEC (1.4)
ENSG00000143520	FLG2 PPI subnetwork	0.21	> 0.20	ATP13A1 (4.4)	ILF3 (4.0)	CARM1 (3.1)	TOMM40 (3.0)	DDX56 (3.0)	SMARCA4 (2.9)	ANKRD31 (2.9)	GATAD2A (2.6)	QTRT1 (2.1)	ENSG00000238078 (2.0)
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6ORCORIGIN_COMPLEX	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6ORCORIGIN_COMPLEX	0.21	> 0.20	PSMA5 (6.2)	TRAFD1 (3.1)	NT5DC1 (3.1)	NAA25 (2.4)	SUGP1 (2.0)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.7)	TXNL4B (1.5)	FEN1 (1.4)
MP:0003659	abnormal lymph circulation	0.21	> 0.20	CETP (6.1)	TIMD4 (3.7)	PVRL2 (3.4)	BCAM (2.5)	SH2B3 (2.5)	C11orf9 (2.1)	HLX (1.8)	SLC44A2 (1.8)	ATXN7L2 (1.7)	ZNF180 (1.5)
MP:0008664	decreased interleukin-12 secretion	0.21	> 0.20	RELB (5.3)	BCL3 (3.3)	PVR (2.8)	HLX (2.7)	GMIP (2.6)	TRIB1 (2.2)	HAVCR1 (2.0)	CETP (2.0)	SH2B3 (1.9)	PARP10 (1.7)
ENSG00000092621	PHGDH PPI subnetwork	0.21	> 0.20	RHD (3.8)	RHCE (3.4)	HMGCR (2.7)	ADAM1 (2.6)	FADS1 (2.4)	LDLR (2.4)	ENSG00000226645 (2.2)	NT5DC1 (1.9)	SLC44A2 (1.8)	SARS (1.7)
ENSG00000134460	IL2RA PPI subnetwork	0.21	> 0.20	BCL3 (4.0)	RELB (2.4)	COL4A3BP (2.0)	PVR (1.8)	ZNF101 (1.6)	C17orf57 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.5)	CETP (1.4)	HLX (1.3)
ENSG00000170260	ZNF212 PPI subnetwork	0.21	> 0.20	TRIB1 (4.8)	HNF1A (2.4)	BUD13 (2.3)	PVR (2.2)	RELB (2.2)	ACAD10 (2.1)	ST3GAL4 (1.9)	TRAFD1 (1.9)	SUGP1 (1.9)	BCL3 (1.7)
ENSG00000065559	MAP2K4 PPI subnetwork	0.21	> 0.20	PLCG1 (2.7)	PARP10 (2.5)	HLX (2.5)	BCL3 (2.3)	TRIB1 (2.0)	LPAR2 (2.0)	PVR (1.9)	SH2B3 (1.9)	ZNF180 (1.9)	COL4A3BP (1.9)
ENSG00000116478	HDAC1 PPI subnetwork	0.21	> 0.20	ATXN2 (3.0)	MYLIP (2.9)	BUD13 (2.8)	MAU2 (2.8)	GATAD2A (2.7)	USP1 (2.6)	SMARCA4 (2.4)	TOP1 (2.3)	CARM1 (2.3)	ILF3 (2.2)
ENSG00000165516	KLHDC2 PPI subnetwork	0.21	> 0.20	CBLC (5.3)	AP1M2 (2.9)	LPAR2 (2.7)	PVRL2 (2.2)	DHX38 (2.1)	PSRC1 (2.0)	DOCK7 (1.9)	CELSR2 (1.9)	ZNF180 (1.6)	MARK4 (1.6)
MP:0001674	abnormal triploblastic development	0.21	> 0.20	TMEM50A (2.2)	C17orf57 (1.9)	FRK (1.9)	PSMA5 (1.9)	ENSG00000238078 (1.8)	CETP (1.6)	C1orf63 (1.6)	HMGCR (1.4)	PVR (1.4)	SARS (1.3)
ENSG00000197303	ENSG00000197303 PPI subnetwork	0.21	> 0.20	DDX56 (2.9)	NAA25 (2.9)	ILF3 (2.7)	NKPD1 (2.6)	QTRT1 (2.6)	DHX38 (2.5)	ZNF259 (2.4)	SARS (2.3)	C12orf43 (2.2)	ANKRD31 (2.2)
GO:0007159	leukocyte cell-cell adhesion	0.21	> 0.20	TIMD4 (2.6)	SLC44A2 (2.5)	GMIP (2.1)	GCNT4 (2.0)	TMEM116 (2.0)	CETP (1.9)	CEACAM19 (1.9)	LPA (1.7)	CILP2 (1.6)	ENSG00000228044 (1.6)
GO:0006342	chromatin silencing	0.21	> 0.20	TSSK6 (3.5)	MAU2 (2.3)	GCNT4 (2.2)	MAPKAPK5 (1.9)	SUGP1 (1.9)	FRK (1.9)	C17orf57 (1.7)	C19orf52 (1.7)	TMEM116 (1.7)	NT5DC1 (1.6)
ENSG00000171148	TADA3 PPI subnetwork	0.21	> 0.20	ATXN7L2 (3.3)	DHODH (2.5)	UBXN2B (2.5)	ILF3 (2.3)	CLPTM1 (2.1)	C19orf52 (2.1)	BUD13 (2.0)	DDX56 (1.8)	SMARCA4 (1.8)	DHX38 (1.7)
ENSG00000180008	SOCS4 PPI subnetwork	0.21	> 0.20	BCL3 (4.4)	RELB (3.2)	HLX (3.1)	GMIP (2.6)	CETP (2.3)	TIMD4 (2.2)	ALDH2 (1.9)	PARP10 (1.6)	GRINA (1.5)	LPA (1.5)
ENSG00000026025	VIM PPI subnetwork	0.21	> 0.20	PLEC (2.8)	ILF3 (2.3)	SMARCA4 (2.1)	C1orf63 (1.8)	CARM1 (1.7)	NYNRIN (1.7)	ST3GAL4 (1.6)	SH2B3 (1.6)	TRAFD1 (1.6)	DNM2 (1.6)
KEGG_RENIN_ANGIOTENSIN_SYSTEM	KEGG_RENIN_ANGIOTENSIN_SYSTEM	0.21	> 0.20	TM6SF2 (4.0)	NPC1L1 (3.7)	ANKRD31 (2.7)	ABCG5 (2.1)	TMED4 (2.0)	PMFBP1 (1.9)	ZHX3 (1.8)	ATXN7L2 (1.8)	ABCG8 (1.4)	GOT2P1 (1.4)
ENSG00000182287	AP1S2 PPI subnetwork	0.21	> 0.20	CLPTM1 (3.1)	YIPF2 (2.9)	GATAD2A (2.5)	CARM1 (2.2)	GMIP (2.2)	ATP13A1 (2.2)	SMARCA4 (2.1)	C12orf51 (2.0)	DNM2 (2.0)	PPP1R37 (1.9)
MP:0001613	abnormal vasodilation	0.21	> 0.20	HLX (2.9)	HAVCR1 (2.7)	ITGB3 (2.6)	BCAM (2.4)	MOSC1 (2.4)	GPAM (2.3)	C17orf57 (2.1)	HP (2.0)	KIAA1324 (1.8)	MAFB (1.8)
MP:0008501	increased IgG2b level	0.21	> 0.20	CETP (5.2)	RELB (4.1)	GMIP (2.8)	BCL3 (2.6)	TIMD4 (2.3)	SH2B3 (1.6)	HAVCR1 (1.6)	POLK (1.4)	PBX4 (1.4)	COL4A3BP (1.3)
GO:0048514	blood vessel morphogenesis	0.21	> 0.20	PVR (2.9)	HLX (2.8)	PVRL2 (2.6)	NYNRIN (2.1)	BCAM (2.1)	SH2B3 (2.0)	KANK2 (1.8)	C17orf57 (1.8)	CEACAM19 (1.7)	MAFB (1.7)
ENSG00000183072	NKX2-5 PPI subnetwork	0.21	> 0.20	ATXN7L2 (2.9)	CARM1 (2.6)	PTPN11 (2.6)	HLX (2.4)	C11orf9 (2.2)	ZHX3 (1.8)	NPC1L1 (1.7)	SORT1 (1.7)	MARK4 (1.7)	CYB561D1 (1.7)
GO:0008380	RNA splicing	0.21	> 0.20	C1orf63 (4.5)	TOP1 (3.3)	BUD13 (3.3)	SUGP1 (2.8)	DHX38 (2.8)	ILF3 (2.7)	QTRT1 (2.4)	C12orf43 (2.1)	MAPKAPK5 (2.0)	MAU2 (1.9)
GO:0009306	protein secretion	0.21	> 0.20	GEMIN7 (1.9)	KIAA1324 (1.9)	DNAH11 (1.5)	C17orf57 (1.5)	C12orf43 (1.4)	APOE (1.4)	HAVCR1 (1.3)	ENSG00000228044 (1.2)	ST3GAL4 (1.2)	AMIGO1 (1.2)
GO:0015909	long-chain fatty acid transport	0.21	> 0.20	CYB561D1 (3.1)	NKPD1 (3.0)	TM6SF2 (2.5)	ACAD10 (2.5)	ENSG00000235545 (2.3)	AMIGO1 (2.0)	ABCG8 (1.9)	GCNT4 (1.9)	ABO (1.7)	TMEM116 (1.6)
MP:0005536	Leydig cell hypoplasia	0.22	> 0.20	GCNT4 (3.3)	DOCK7 (2.6)	UBXN2B (2.1)	ATXN7L2 (2.0)	LPIN3 (2.0)	C12orf47 (2.0)	DNAH11 (2.0)	COL4A3BP (1.8)	AMIGO1 (1.5)	PMFBP1 (1.5)
ENSG00000173530	TNFRSF10D PPI subnetwork	0.22	> 0.20	ATP13A1 (3.4)	SARS (3.3)	TOMM40 (3.3)	NAA25 (2.8)	FADS2 (2.7)	SMARCA4 (2.6)	FADS1 (2.5)	OGDH (2.3)	LDLR (2.3)	DHODH (2.2)
ENSG00000171863	RPS7 PPI subnetwork	0.22	> 0.20	DDX56 (3.7)	QTRT1 (3.3)	NAA25 (3.1)	C12orf43 (2.9)	DHX38 (2.7)	ZNF259 (2.7)	SARS (2.6)	ILF3 (2.3)	SUGP1 (2.3)	PTPN11 (2.2)
ENSG00000140750	ARHGAP17 PPI subnetwork	0.22	> 0.20	C11orf9 (2.7)	COL4A3BP (2.4)	KANK2 (2.2)	SH2B3 (1.9)	DNM2 (1.9)	ALDH2 (1.8)	DNAH11 (1.7)	ITGB3 (1.7)	PTPN11 (1.5)	CARM1 (1.5)
ENSG00000172053	QARS PPI subnetwork	0.22	> 0.20	SARS (5.4)	NAA25 (3.8)	QTRT1 (3.4)	DDX56 (2.4)	PLEC (2.2)	ATP13A1 (2.2)	ZNF259 (2.2)	PSMA5 (2.1)	RELB (2.1)	GCNT4 (1.8)
GO:0044452	nucleolar part	0.22	> 0.20	ZNF259 (3.2)	NAA25 (3.2)	QTRT1 (2.8)	DDX56 (2.7)	DHODH (2.7)	TOMM40 (2.5)	C12orf43 (2.5)	TXNL4B (2.4)	MAPKAPK5 (2.4)	ZNF180 (2.2)
ENSG00000144028	SNRNP200 PPI subnetwork	0.22	> 0.20	ILF3 (3.8)	SUGP1 (3.7)	SMARCA4 (3.3)	C1orf63 (3.3)	DHX38 (3.3)	TOP1 (3.2)	FEN1 (2.5)	BUD13 (2.5)	DDX56 (2.5)	USP1 (2.3)
MP:0003140	dilated heart atrium	0.22	> 0.20	GMPR (2.5)	ATXN7L2 (1.8)	GRINA (1.8)	BLOC1S3 (1.8)	OGDH (1.7)	BCAM (1.7)	PLEC (1.6)	NYNRIN (1.6)	ENSG00000226648 (1.6)	SLC22A1 (1.5)
ENSG00000092529	CAPN3 PPI subnetwork	0.22	> 0.20	SYPL2 (2.9)	PLEC (2.8)	TMEM50A (2.3)	PVR (2.2)	ENSG00000235545 (1.8)	UBXN2B (1.7)	CYP7A1 (1.7)	SLC22A1 (1.6)	PLCG1 (1.4)	PBX4 (1.4)
MP:0009288	increased epididymal fat pad weight	0.22	> 0.20	GCNT4 (3.9)	KIAA1324 (2.5)	GOT2P1 (2.1)	CELSR2 (2.1)	ABO (1.8)	C12orf47 (1.7)	ABCG5 (1.7)	NT5DC1 (1.6)	FRK (1.6)	TM6SF2 (1.5)
ENSG00000093000	NUP50 PPI subnetwork	0.22	> 0.20	POC5 (3.3)	USP24 (3.2)	DDX56 (3.2)	NAA25 (3.1)	USP1 (3.0)	DOCK7 (2.8)	BUD13 (2.7)	ILF3 (2.2)	MAPKAPK5 (2.0)	ENSG00000226648 (1.9)
GO:0033014	tetrapyrrole biosynthetic process	0.22	> 0.20	RHCE (7.4)	RHD (7.3)	ADAM1 (3.2)	C12orf51 (2.8)	NT5DC1 (2.5)	GMPR (2.1)	ABO (1.9)	ACAD10 (1.9)	TRAPPC6A (1.5)	TMEM116 (1.4)
GO:0006779	porphyrin-containing compound biosynthetic process	0.22	> 0.20	RHCE (7.4)	RHD (7.3)	ADAM1 (3.2)	C12orf51 (2.8)	NT5DC1 (2.5)	GMPR (2.1)	ABO (1.9)	ACAD10 (1.9)	TRAPPC6A (1.5)	TMEM116 (1.4)
ENSG00000140564	FURIN PPI subnetwork	0.22	> 0.20	DNAH11 (2.5)	PLEC (2.4)	ITGB3 (2.3)	ADAM1 (2.0)	CELSR2 (1.8)	HAPLN4 (1.7)	SLC44A2 (1.6)	CYB561D1 (1.6)	PVR (1.5)	ERP29 (1.4)
GO:0055072	iron ion homeostasis	0.22	> 0.20	RHD (3.4)	RHCE (3.3)	TMEM116 (2.6)	FRK (2.6)	GRINA (2.3)	ENSG00000228044 (2.0)	DHODH (1.7)	GMPR (1.5)	PMFBP1 (1.3)	HP (1.3)
ENSG00000110492	MDK PPI subnetwork	0.22	> 0.20	HAVCR1 (2.9)	TRAFD1 (2.6)	USP24 (2.6)	APOE (2.4)	CELSR2 (2.4)	NKPD1 (1.8)	DOCK7 (1.8)	OASL (1.8)	MAFB (1.7)	TMEM50A (1.7)
GO:0051879	Hsp90 protein binding	0.22	> 0.20	HLX (2.8)	C1orf63 (2.0)	ENSG00000228044 (1.9)	TMEM50A (1.9)	FRK (1.7)	OGDH (1.4)	ITGB3 (1.4)	CLPTM1 (1.3)	CETP (1.2)	PLEKHH2 (1.2)
ENSG00000120071	KIAA1267 PPI subnetwork	0.22	> 0.20	OGDH (2.6)	C12orf43 (2.5)	GEMIN7 (2.5)	ATXN2 (2.3)	BUD13 (2.2)	QTRT1 (2.1)	GOT2P1 (2.0)	SUGP1 (1.9)	MAPKAPK5 (1.7)	C19orf52 (1.7)
ENSG00000112357	PEX7 PPI subnetwork	0.22	> 0.20	NT5DC1 (3.8)	MAPKAPK5 (2.1)	ACAD10 (1.9)	FRK (1.9)	LPAR2 (1.8)	PSMA5 (1.8)	DYNC2LI1 (1.6)	DHX38 (1.6)	OGDH (1.6)	TRAFD1 (1.6)
ENSG00000088356	PDRG1 PPI subnetwork	0.22	> 0.20	DYNC2LI1 (3.2)	DHODH (2.6)	POC5 (2.4)	ATXN2 (2.3)	BLOC1S3 (2.2)	QTRT1 (2.2)	MARK4 (2.2)	TOMM40 (2.1)	ZNF180 (2.1)	GEMIN7 (2.1)
ENSG00000101665	SMAD7 PPI subnetwork	0.22	> 0.20	PLCG1 (2.9)	POLK (2.3)	ENSG00000226645 (2.2)	ATXN2 (2.2)	MYLIP (2.1)	PLEC (1.9)	MARK4 (1.9)	SH2B3 (1.9)	BUD13 (1.8)	DOCK7 (1.7)
ENSG00000047410	TPR PPI subnetwork	0.22	> 0.20	USP1 (2.7)	DHX38 (2.5)	POC5 (2.4)	FEN1 (2.4)	MAPKAPK5 (2.2)	NAA25 (2.2)	DDX56 (2.2)	C12orf51 (2.2)	ZNF180 (1.9)	USP24 (1.7)
ENSG00000126561	STAT5A PPI subnetwork	0.22	> 0.20	PARP10 (2.7)	BCL3 (2.5)	TMEM50A (2.2)	DNM2 (2.1)	USP24 (2.1)	MAU2 (1.8)	HLX (1.7)	RHD (1.7)	PLCG1 (1.6)	SLC44A2 (1.6)
MP:0005491	pancreatic islet hyperplasia	0.22	> 0.20	MOSC1 (3.0)	ALDH2 (2.9)	KIAA1324 (2.8)	GPAM (2.8)	CELSR2 (2.3)	POLK (1.9)	PLEKHH2 (1.7)	GCNT4 (1.7)	LPIN3 (1.7)	NAA25 (1.6)
ENSG00000112208	BAG2 PPI subnetwork	0.22	> 0.20	RELB (6.2)	BCL3 (3.4)	BLOC1S3 (3.0)	CYB561D1 (2.8)	PVR (2.1)	GRINA (2.1)	CLPTM1 (2.1)	CELSR2 (1.9)	AMIGO1 (1.9)	ZNF180 (1.8)
ENSG00000205250	E2F4 PPI subnetwork	0.22	> 0.20	ATXN2 (3.8)	C12orf51 (2.9)	FEN1 (2.7)	USP1 (2.7)	KANK2 (2.5)	MAPKAPK5 (2.2)	GOT2P1 (2.0)	USP24 (1.6)	SMARCA4 (1.6)	DNM2 (1.5)
ENSG00000198755	RPL10A PPI subnetwork	0.22	> 0.20	NAA25 (3.6)	ZNF259 (3.2)	DDX56 (3.1)	NKPD1 (2.5)	DHX38 (2.4)	SUGP1 (2.3)	SARS (2.2)	ATP13A1 (2.0)	QTRT1 (1.9)	C12orf43 (1.9)
ENSG00000102753	KPNA3 PPI subnetwork	0.22	> 0.20	C12orf43 (3.2)	USP1 (2.7)	TXNL4B (2.4)	ZNF180 (2.4)	FEN1 (1.9)	FADS2 (1.8)	PSRC1 (1.7)	PTPN11 (1.7)	DHX38 (1.7)	RELB (1.7)
GO:0051896	regulation of protein kinase B signaling cascade	0.22	> 0.20	TSSK6 (2.3)	CETP (2.3)	TIMD4 (2.1)	CILP2 (2.0)	NKPD1 (1.9)	SORT1 (1.8)	ZNF180 (1.7)	PTPN11 (1.7)	PVRL2 (1.7)	PVR (1.7)
GO:0051100	negative regulation of binding	0.22	> 0.20	OASL (2.6)	GATAD2A (2.5)	ENSG00000238078 (2.4)	PLCG1 (2.3)	LPAR2 (2.2)	MARK4 (2.0)	TMEM57 (1.9)	ABO (1.9)	MAFB (1.9)	ENSG00000226645 (1.7)
GO:0007031	peroxisome organization	0.22	> 0.20	NT5DC1 (3.7)	YIPF2 (2.3)	C19orf52 (2.3)	AMIGO1 (2.2)	ACAD10 (2.0)	TRAPPC6A (1.9)	GPAM (1.8)	TSSK6 (1.8)	CYP7A1 (1.6)	TMED4 (1.5)
ENSG00000118965	WDR35 PPI subnetwork	0.22	> 0.20	MAU2 (3.0)	USP24 (2.9)	PARP10 (2.8)	MARK4 (2.4)	ATXN2 (2.4)	BCL3 (2.3)	GMIP (2.1)	SMARCA4 (1.9)	DHX38 (1.9)	ZNF180 (1.6)
MP:0003945	abnormal lymphocyte physiology	0.22	> 0.20	BCL3 (3.7)	RELB (3.1)	GMIP (3.0)	TRAFD1 (2.5)	PARP10 (2.4)	PBX4 (1.7)	SLC44A2 (1.5)	MYLIP (1.5)	DNM2 (1.4)	GCNT4 (1.3)
ENSG00000077380	DYNC1I2 PPI subnetwork	0.22	> 0.20	CILP2 (4.5)	TMEM50A (2.4)	NPC1L1 (2.0)	GMPR (1.9)	GOT2P1 (1.7)	C12orf43 (1.6)	COL4A3BP (1.5)	MAFB (1.4)	TXNL4B (1.4)	ZNF180 (1.4)
ENSG00000100567	PSMA3 PPI subnetwork	0.22	> 0.20	PSMA5 (5.1)	TRAFD1 (2.5)	TOMM40 (2.1)	NAA25 (2.0)	NT5DC1 (1.7)	DDX56 (1.6)	TRIB1 (1.5)	SARS (1.5)	ENSG00000254235 (1.5)	CLPTM1 (1.4)
GO:0002718	regulation of cytokine production involved in immune response	0.22	> 0.20	ZNF101 (2.7)	GCNT4 (2.7)	HAVCR1 (1.8)	NPC1L1 (1.7)	CETP (1.7)	MAFB (1.7)	TIMD4 (1.7)	SH2B3 (1.4)	PVR (1.3)	BCL3 (1.3)
GO:0051445	regulation of meiotic cell cycle	0.22	> 0.20	ENSG00000228044 (2.9)	TMED4 (2.3)	PLEKHH2 (1.8)	CEACAM19 (1.6)	NKPD1 (1.5)	PMFBP1 (1.5)	ATXN7L2 (1.5)	C1orf63 (1.4)	GOT2P1 (1.4)	HAPLN4 (1.3)
GO:0032461	positive regulation of protein oligomerization	0.22	> 0.20	C12orf47 (2.9)	ENSG00000226648 (2.4)	FRK (2.4)	ANKRD31 (2.1)	ZNF101 (2.0)	BRAP (1.9)	LPIN3 (1.8)	POLK (1.5)	TMEM116 (1.4)	SH2B3 (1.4)
ENSG00000185532	PRKG1 PPI subnetwork	0.22	> 0.20	ITGB3 (3.1)	KANK2 (2.6)	HLX (2.6)	PLEKHH2 (2.5)	BCAM (2.0)	AP1M2 (1.9)	ABO (1.9)	NPC1L1 (1.8)	SYPL2 (1.7)	ANKRD31 (1.6)
MP:0010249	lactation failure	0.22	> 0.20	KIAA1324 (4.2)	GEMIN7 (2.6)	SH2B3 (2.3)	NKPD1 (1.9)	DNAH11 (1.8)	PARP10 (1.6)	NPC1L1 (1.5)	PMFBP1 (1.5)	TIMD4 (1.4)	PPP1R37 (1.4)
ENSG00000131051	RBM39 PPI subnetwork	0.22	> 0.20	C1orf63 (3.4)	HNF1A (3.3)	ACAD10 (3.1)	ABO (2.6)	KIAA1324 (2.2)	TRIB1 (2.1)	NYNRIN (2.0)	CBLC (2.0)	ATXN7L2 (2.0)	BUD13 (1.7)
ENSG00000008838	MED24 PPI subnetwork	0.22	> 0.20	GEMIN7 (3.0)	C12orf51 (2.9)	BUD13 (2.6)	BRAP (2.5)	TXNL4B (2.4)	ATXN2 (2.4)	MAPKAPK5 (2.2)	TOP1 (2.1)	ZHX3 (1.8)	BLOC1S3 (1.7)
ENSG00000065485	PDIA5 PPI subnetwork	0.22	> 0.20	ACAD10 (3.8)	HNF1A (3.0)	NT5DC1 (2.8)	TMED4 (2.4)	C1orf63 (1.8)	TRAPPC6A (1.8)	ATXN7L2 (1.5)	OGDH (1.4)	PLEKHH2 (1.3)	CETP (1.3)
ENSG00000182944	EWSR1 PPI subnetwork	0.22	> 0.20	FADS2 (2.8)	RHD (2.7)	GATAD2A (2.7)	SUGP1 (2.3)	ILF3 (2.2)	UBXN2B (2.1)	SLC44A2 (2.1)	FADS1 (2.1)	SMARCA4 (2.1)	C1orf63 (2.1)
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	0.22	> 0.20	PSMA5 (6.4)	TRAFD1 (3.6)	NAA25 (2.6)	NT5DC1 (2.5)	PARP10 (2.0)	SUGP1 (1.8)	TOMM40 (1.7)	DDX56 (1.7)	SARS (1.7)	ZNF259 (1.3)
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORCORIGIN_COMPLEX	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORCORIGIN_COMPLEX	0.22	> 0.20	FEN1 (3.3)	GOT2P1 (2.4)	USP1 (2.2)	NT5DC1 (2.2)	TMEM116 (2.1)	RHD (1.8)	LPAR2 (1.6)	TXNL4B (1.5)	DHODH (1.5)	ABO (1.3)
ENSG00000161634	DCD PPI subnetwork	0.22	> 0.20	PLEC (2.6)	PTPN11 (2.6)	ANGPTL3 (2.2)	HP (2.1)	ABO (2.0)	CEACAM19 (2.0)	ADAM1 (1.9)	ILF3 (1.9)	APOA5 (1.9)	SLC22A1 (1.9)
GO:0046966	thyroid hormone receptor binding	0.22	> 0.20	C12orf51 (2.8)	TRAFD1 (2.7)	USP24 (2.1)	SMARCA4 (2.0)	ATXN2 (1.9)	MAPKAPK5 (1.9)	DHX38 (1.8)	DOCK7 (1.6)	PSMA5 (1.6)	GMIP (1.5)
ENSG00000100644	HIF1A PPI subnetwork	0.22	> 0.20	PLCG1 (3.0)	TRIB1 (2.2)	UBXN2B (2.2)	GRINA (2.1)	BCL3 (1.6)	MARK4 (1.6)	GOT2P1 (1.6)	HLX (1.6)	ATXN2 (1.5)	MAU2 (1.4)
ENSG00000138095	LRPPRC PPI subnetwork	0.22	> 0.20	TMEM50A (2.7)	HLX (2.3)	TRAPPC6A (1.9)	CYB561D1 (1.9)	TRIB1 (1.8)	POLK (1.8)	C1orf63 (1.8)	NYNRIN (1.8)	ENSG00000226648 (1.6)	QTRT1 (1.6)
REACTOME_SCF:BETA:TRCP_MEDIATED_DEGRADATION_OF_EMI1	REACTOME_SCF:BETA:TRCP_MEDIATED_DEGRADATION_OF_EMI1	0.22	> 0.20	PSMA5 (6.5)	TRAFD1 (3.3)	NT5DC1 (2.3)	NAA25 (2.3)	SUGP1 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	PARP10 (1.5)	SARS (1.5)	TMEM50A (1.3)
ENSG00000090339	ICAM1 PPI subnetwork	0.22	> 0.20	CEACAM19 (2.2)	APOE (2.1)	AP1M2 (2.0)	APOB (1.9)	OGDH (1.9)	PCSK9 (1.9)	SARS (1.9)	HP (1.8)	PLEC (1.8)	HAVCR1 (1.8)
MP:0001730	embryonic growth arrest	0.22	> 0.20	ATXN2 (3.9)	ATP13A1 (2.9)	GATAD2A (2.8)	C12orf51 (2.4)	C17orf57 (2.3)	SMARCA4 (2.2)	USP1 (2.1)	BRAP (1.9)	DHX38 (1.8)	CLPTM1 (1.8)
KEGG_SULFUR_METABOLISM	KEGG_SULFUR_METABOLISM	0.22	> 0.20	ALDH2 (2.7)	TM6SF2 (2.6)	ENSG00000254235 (2.5)	ABCG5 (2.2)	HAPLN4 (2.1)	ABCG8 (2.1)	CYP7A1 (2.0)	NKPD1 (1.8)	TMED4 (1.7)	APOB (1.7)
ENSG00000114978	MOB1A PPI subnetwork	0.22	> 0.20	ZNF180 (2.6)	CYB561D1 (2.5)	SLC44A2 (1.8)	GEMIN7 (1.8)	NCAN (1.8)	ZHX3 (1.6)	ATP13A1 (1.6)	GCNT4 (1.6)	QTRT1 (1.6)	POC5 (1.5)
MP:0000823	abnormal lateral ventricle morphology	0.22	> 0.20	NYNRIN (3.7)	LPA (1.9)	ABCG5 (1.9)	CELSR2 (1.8)	SMARCA4 (1.8)	MARK4 (1.8)	TM6SF2 (1.5)	APOE (1.4)	FRK (1.4)	ATP13A1 (1.4)
ENSG00000172977	KAT5 PPI subnetwork	0.22	> 0.20	BUD13 (2.7)	USP1 (2.4)	MYLIP (1.9)	GEMIN7 (1.8)	TRAFD1 (1.7)	PSRC1 (1.7)	ZNF180 (1.6)	BCL3 (1.4)	DNAH11 (1.4)	C12orf47 (1.4)
ENSG00000137996	RTCD1 PPI subnetwork	0.22	> 0.20	BLOC1S3 (4.8)	ZNF180 (3.0)	GATAD2A (2.9)	GEMIN7 (2.8)	TOMM40 (2.3)	USP1 (2.3)	PVRL2 (1.8)	TRAPPC6A (1.8)	SUGP1 (1.8)	ABCG8 (1.7)
MP:0003944	abnormal T cell subpopulation ratio	0.22	> 0.20	PLCG1 (4.2)	GMIP (3.9)	TIMD4 (2.9)	RELB (2.3)	GRINA (2.0)	ZNF101 (1.8)	BCL3 (1.6)	NPC1L1 (1.5)	C19orf52 (1.4)	APOC1 (1.4)
ENSG00000134014	ELP3 PPI subnetwork	0.22	> 0.20	MYLIP (3.1)	GEMIN7 (2.6)	MAPKAPK5 (2.4)	TMEM50A (2.3)	COL4A3BP (2.0)	ATXN2 (1.9)	SUGP1 (1.8)	TMED4 (1.8)	C17orf57 (1.6)	ZNF180 (1.5)
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	0.22	> 0.20	ITGB3 (3.0)	ST3GAL4 (2.9)	SH2B3 (2.7)	SORT1 (2.6)	AMIGO1 (1.8)	PMFBP1 (1.8)	ENSG00000228044 (1.8)	GMPR (1.7)	KANK2 (1.7)	ENSG00000238078 (1.7)
GO:0050995	negative regulation of lipid catabolic process	0.22	> 0.20	ENSG00000228044 (4.1)	MOSC1 (2.8)	GPAM (2.2)	CETP (2.1)	APOB (1.7)	CBLC (1.6)	APOA5 (1.5)	AMIGO1 (1.5)	APOE (1.5)	APOC4 (1.4)
ENSG00000054523	KIF1B PPI subnetwork	0.22	> 0.20	C11orf9 (3.4)	OGDH (3.0)	ZHX3 (3.0)	LDLR (2.8)	COL4A3BP (2.8)	PLEC (2.4)	CBLC (2.4)	SORT1 (2.3)	AP1M2 (2.2)	DNM2 (2.2)
GO:0005759	mitochondrial matrix	0.22	> 0.20	ACAD10 (4.5)	OGDH (3.0)	DHODH (2.8)	ALDH2 (2.6)	TOMM40 (2.4)	NT5DC1 (2.3)	C19orf52 (2.2)	TRAPPC6A (2.1)	GPAM (2.0)	QTRT1 (1.8)
GO:0043627	response to estrogen stimulus	0.22	> 0.20	KIAA1324 (2.8)	POLK (2.5)	PVR (1.6)	TMED4 (1.6)	NPC1L1 (1.5)	TMEM57 (1.5)	C11orf9 (1.4)	PVRL2 (1.3)	PLEKHH2 (1.3)	RHD (1.2)
ENSG00000056558	TRAF1 PPI subnetwork	0.22	> 0.20	RELB (4.4)	BCL3 (3.4)	PBX4 (2.6)	ENSG00000238078 (2.1)	C12orf43 (2.1)	PARP10 (2.0)	TRAFD1 (2.0)	LPAR2 (2.0)	FRK (1.8)	PVR (1.7)
MP:0006309	decreased retinal ganglion cell number	0.22	> 0.20	ENSG00000238078 (1.9)	APOE (1.8)	APOC1 (1.8)	LPAR2 (1.7)	DNAH11 (1.7)	ENSG00000226645 (1.6)	ZHX3 (1.5)	MOSC1 (1.5)	HAVCR1 (1.5)	LPIN3 (1.4)
GO:0032784	regulation of transcription elongation, DNA-dependent	0.22	> 0.20	BLOC1S3 (2.9)	C12orf47 (2.6)	MAU2 (2.2)	TRAPPC6A (2.0)	PMFBP1 (1.8)	BUD13 (1.6)	GCNT4 (1.6)	PBX4 (1.6)	ENSG00000254235 (1.6)	DNM2 (1.5)
ENSG00000126456	IRF3 PPI subnetwork	0.22	> 0.20	OASL (7.2)	TRAFD1 (6.5)	PARP10 (4.5)	RELB (2.6)	ATP13A1 (2.5)	GRINA (2.4)	CYP7A1 (2.1)	TOP1 (1.8)	PSMA5 (1.6)	GMIP (1.5)
ENSG00000072274	TFRC PPI subnetwork	0.22	> 0.20	GRINA (3.5)	ZNF101 (3.1)	ENSG00000254235 (2.7)	PARP10 (2.5)	GMIP (2.4)	ITGB3 (1.9)	BCL3 (1.9)	PVR (1.8)	CETP (1.8)	CYB561D1 (1.7)
ENSG00000101204	CHRNA4 PPI subnetwork	0.22	> 0.20	ATP13A1 (2.7)	TOMM40 (2.5)	MAPKAPK5 (2.4)	LPA (2.2)	HNF1A (2.0)	PCSK9 (2.0)	ANKRD31 (1.9)	CEACAM19 (1.8)	HAPLN4 (1.7)	USP24 (1.7)
ENSG00000197711	ENSG00000197711 PPI subnetwork	0.22	> 0.20	TIMD4 (2.9)	MAFB (2.8)	ZNF180 (2.8)	ENSG00000228044 (2.2)	HP (2.0)	PCSK9 (1.7)	APOC1 (1.6)	APOE (1.6)	ST3GAL4 (1.4)	ALDH2 (1.4)
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	0.22	> 0.20	PSMA5 (6.1)	TRAFD1 (3.6)	NAA25 (2.6)	NT5DC1 (2.6)	PARP10 (1.9)	DDX56 (1.9)	SUGP1 (1.8)	TOMM40 (1.7)	BRAP (1.4)	SARS (1.4)
GO:0005381	iron ion transmembrane transporter activity	0.22	> 0.20	C12orf43 (3.2)	TOMM40 (3.1)	LPIN3 (2.5)	ENSG00000226645 (2.2)	ZNF259 (2.1)	PVR (1.9)	BLOC1S3 (1.9)	TMED4 (1.7)	MAPKAPK5 (1.6)	APOE (1.6)
ENSG00000137752	CASP1 PPI subnetwork	0.22	> 0.20	GRINA (2.5)	NT5DC1 (2.3)	ST3GAL4 (2.2)	ENSG00000228044 (2.1)	BCL3 (2.1)	PLEC (1.9)	UBXN2B (1.7)	ABO (1.3)	POLK (1.3)	DOCK7 (1.3)
MP:0001967	deafness	0.22	> 0.20	HNF1A (2.8)	ANKRD31 (2.1)	ABO (1.8)	ZHX3 (1.7)	ENSG00000226648 (1.7)	LPAR2 (1.6)	NCAN (1.5)	APOC1 (1.5)	GCNT4 (1.5)	AP1M2 (1.5)
ENSG00000163541	SUCLG1 PPI subnetwork	0.22	> 0.20	ATP13A1 (3.2)	QTRT1 (2.7)	GPAM (2.6)	OGDH (2.2)	TOMM40 (2.1)	POC5 (2.0)	PSMA5 (1.9)	NT5DC1 (1.9)	SARS (1.7)	ENSG00000226648 (1.7)
ENSG00000137843	PAK6 PPI subnetwork	0.22	> 0.20	TIMD4 (2.8)	CETP (2.7)	OASL (2.6)	KIAA1324 (1.9)	SYPL2 (1.8)	BCAM (1.8)	TMEM50A (1.8)	ANKRD31 (1.8)	ENSG00000238078 (1.7)	C1orf63 (1.7)
ENSG00000183431	SF3A3 PPI subnetwork	0.22	> 0.20	ILF3 (3.9)	SUGP1 (3.6)	DHX38 (3.6)	TOP1 (3.3)	C1orf63 (3.2)	BUD13 (3.1)	SMARCA4 (2.9)	FEN1 (2.5)	USP1 (2.4)	QTRT1 (2.2)
GO:0010869	regulation of receptor biosynthetic process	0.22	> 0.20	PMFBP1 (2.5)	CEACAM19 (2.4)	FRK (2.2)	TIMD4 (2.0)	LPIN3 (1.9)	ATXN2 (1.8)	ENSG00000226648 (1.8)	ENSG00000235545 (1.8)	MOSC1 (1.7)	C17orf57 (1.5)
MP:0002691	small stomach	0.22	> 0.20	RELB (3.1)	ABO (2.6)	LDLR (2.1)	C11orf9 (2.1)	YIPF2 (2.0)	SMARCA4 (2.0)	LPAR2 (1.9)	CBLC (1.8)	ALDH2 (1.8)	C19orf52 (1.8)
GO:0035383	thioester metabolic process	0.22	> 0.20	FADS2 (4.1)	FADS1 (4.1)	PCSK9 (3.9)	HMGCR (3.9)	GPAM (3.6)	LDLR (3.2)	BLOC1S3 (3.0)	TRAPPC6A (2.4)	MOSC1 (2.3)	CYP7A1 (2.2)
GO:0006637	acyl-CoA metabolic process	0.22	> 0.20	FADS2 (4.1)	FADS1 (4.1)	PCSK9 (3.9)	HMGCR (3.9)	GPAM (3.6)	LDLR (3.2)	BLOC1S3 (3.0)	TRAPPC6A (2.4)	MOSC1 (2.3)	CYP7A1 (2.2)
ENSG00000101017	CD40 PPI subnetwork	0.22	> 0.20	RELB (4.5)	BCL3 (3.6)	PSMA5 (3.0)	NT5DC1 (2.8)	PBX4 (2.5)	PARP10 (2.4)	TRAFD1 (2.4)	UBXN2B (1.8)	ZNF180 (1.7)	ZNF101 (1.6)
MP:0003427	parakeratosis	0.22	> 0.20	CBLC (3.0)	CELSR2 (2.9)	KIAA1324 (2.5)	PLEC (2.4)	NKPD1 (2.1)	MAFB (2.0)	CEACAM19 (2.0)	AP1M2 (1.9)	CYB561D1 (1.7)	ENSG00000226648 (1.4)
ENSG00000169375	SIN3A PPI subnetwork	0.22	> 0.20	CARM1 (4.7)	ATXN2 (3.1)	BRAP (3.1)	DHX38 (3.0)	MAU2 (2.8)	SMARCA4 (2.7)	ILF3 (2.7)	MARK4 (2.2)	GATAD2A (2.2)	DNM2 (2.2)
ENSG00000113070	HBEGF PPI subnetwork	0.22	> 0.20	ZHX3 (2.9)	SLC44A2 (2.8)	ENSG00000226648 (2.6)	TMED4 (2.3)	PLEC (2.0)	ITGB3 (2.0)	CELSR2 (1.9)	CILP2 (1.9)	MAPKAPK5 (1.9)	BCAM (1.8)
GO:0032606	type I interferon production	0.22	> 0.20	OASL (6.3)	PARP10 (6.0)	TRAFD1 (3.0)	CYB561D1 (2.9)	ADAM1 (2.7)	FRK (2.5)	MAU2 (2.4)	BRAP (2.2)	C12orf43 (2.1)	ENSG00000226645 (1.9)
GO:0016790	thiolester hydrolase activity	0.22	> 0.20	USP24 (3.9)	TMEM57 (2.6)	OASL (2.2)	BRAP (2.0)	ACAD10 (1.8)	CARM1 (1.8)	COL4A3BP (1.7)	NT5DC1 (1.6)	CYP7A1 (1.6)	C12orf51 (1.5)
MP:0002842	increased systemic arterial blood pressure	0.22	> 0.20	HLX (2.9)	POLK (2.3)	BCAM (2.0)	RPH3A (1.4)	PLEKHH2 (1.3)	MAFB (1.3)	AMIGO1 (1.3)	NPC1L1 (1.2)	DNAH11 (1.2)	KANK2 (1.1)
ENSG00000070882	OSBPL3 PPI subnetwork	0.22	> 0.20	ZHX3 (3.9)	CARM1 (3.5)	DNM2 (3.4)	PLEC (3.2)	LPAR2 (2.8)	GPAM (2.7)	USP24 (2.6)	OGDH (2.6)	AP1M2 (2.4)	CBLC (2.4)
GO:0031960	response to corticosteroid stimulus	0.22	> 0.20	LPA (3.3)	SLC22A1 (2.5)	ABCG5 (2.3)	APOC4 (2.0)	APOA5 (1.9)	ATXN7L2 (1.9)	ABCG8 (1.8)	HP (1.7)	CBLC (1.7)	PLG (1.7)
ENSG00000078900	TP73 PPI subnetwork	0.22	> 0.20	ATXN2 (3.9)	C12orf51 (3.2)	C12orf43 (3.2)	C11orf9 (2.6)	MAPKAPK5 (2.5)	POLK (2.5)	PTPN11 (2.4)	NYNRIN (2.2)	PVRL2 (2.1)	ADAM1 (2.0)
GO:0010038	response to metal ion	0.22	> 0.20	TM6SF2 (3.0)	ABCG5 (2.7)	NPC1L1 (2.6)	RHD (2.5)	ANGPTL3 (2.1)	RHCE (2.0)	HP (2.0)	APOB (2.0)	SLC22A1 (1.9)	ABCG8 (1.8)
GO:0033002	muscle cell proliferation	0.22	> 0.20	PVR (3.1)	PLEKHH2 (2.3)	ALDH2 (2.2)	CEACAM19 (2.1)	HLX (2.0)	NYNRIN (1.9)	ENSG00000254235 (1.8)	MAFB (1.5)	ENSG00000228044 (1.3)	ZNF101 (1.3)
GO:0044259	multicellular organismal macromolecule metabolic process	0.22	> 0.20	CEACAM19 (3.4)	FRK (3.1)	PLEKHH2 (2.1)	NPC1L1 (1.8)	ENSG00000228044 (1.7)	CILP2 (1.6)	ENSG00000226645 (1.6)	C11orf9 (1.5)	PVRL2 (1.5)	ENSG00000238078 (1.2)
MP:0001648	abnormal apoptosis	0.22	> 0.20	GRINA (3.0)	PSRC1 (2.6)	CLPTM1 (2.1)	PARP10 (1.9)	FEN1 (1.9)	MAFB (1.8)	TRIB1 (1.7)	LPAR2 (1.5)	USP1 (1.5)	APOE (1.3)
MP:0002461	increased immunoglobulin level	0.22	> 0.20	GMIP (3.9)	RELB (3.9)	SH2B3 (3.1)	MYLIP (2.6)	LPAR2 (2.2)	MAFB (2.2)	BCL3 (2.1)	APOC1 (2.1)	COL4A3BP (1.9)	PARP10 (1.9)
ENSG00000164708	PGAM2 PPI subnetwork	0.22	> 0.20	SARS (2.7)	ALDH2 (2.3)	COL4A3BP (2.1)	FRK (2.0)	CYP7A1 (1.9)	PLEC (1.8)	SYPL2 (1.8)	OGDH (1.7)	GMPR (1.7)	BRAP (1.6)
GO:0006555	methionine metabolic process	0.22	> 0.20	ENSG00000254235 (3.8)	DNAH11 (3.0)	UBXN2B (2.3)	SLC22A1 (2.2)	DHODH (2.0)	C1orf63 (2.0)	LPA (1.9)	ANGPTL3 (1.8)	NT5DC1 (1.8)	APOA5 (1.7)
GO:0034483	heparan sulfate sulfotransferase activity	0.22	> 0.20	ST3GAL4 (3.8)	CETP (3.0)	PMFBP1 (2.6)	ANKRD31 (2.4)	MAFB (2.3)	GCNT4 (2.2)	PCSK9 (2.0)	DOCK7 (1.8)	SH2B3 (1.7)	APOE (1.6)
MP:0005030	absent amnion	0.22	> 0.20	MAPKAPK5 (2.2)	HNF1A (1.8)	BUD13 (1.8)	SH2B3 (1.7)	MYLIP (1.6)	TM6SF2 (1.6)	ANGPTL3 (1.5)	PLG (1.5)	ST3GAL4 (1.4)	ENSG00000226648 (1.4)
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	0.22	> 0.20	DHODH (2.6)	SORT1 (2.2)	TM6SF2 (2.1)	KIAA1324 (2.1)	NPC1L1 (2.0)	GOT2P1 (2.0)	TRAPPC6A (1.9)	PBX4 (1.5)	ALDH2 (1.5)	ABCG5 (1.4)
ENSG00000065526	SPEN PPI subnetwork	0.22	> 0.20	GMIP (3.2)	GATAD2A (2.9)	MAFB (2.5)	TOP1 (2.3)	MARK4 (2.3)	OASL (2.2)	PSRC1 (2.2)	BCL3 (2.2)	USP24 (2.1)	CARM1 (1.8)
GO:0043405	regulation of MAP kinase activity	0.22	> 0.20	ENSG00000226645 (3.6)	TRIB1 (2.9)	HLX (2.8)	LPAR2 (2.3)	PVR (2.2)	CEACAM19 (1.9)	ENSG00000238078 (1.7)	AMIGO1 (1.5)	ENSG00000228044 (1.4)	SH2B3 (1.3)
REACTOME_APOPTOTIC_EXECUTION__PHASE	REACTOME_APOPTOTIC_EXECUTION__PHASE	0.22	> 0.20	PLEC (2.6)	DOCK7 (2.2)	CBLC (2.1)	ZNF101 (2.0)	AP1M2 (1.9)	COL4A3BP (1.9)	ENSG00000226645 (1.6)	DHX38 (1.6)	ABO (1.5)	SMARCA4 (1.3)
ENSG00000117594	HSD11B1 PPI subnetwork	0.22	> 0.20	DHX38 (4.5)	USP24 (3.4)	DDX56 (3.4)	SUGP1 (3.3)	C12orf43 (2.9)	DHODH (2.6)	NAA25 (2.2)	ZNF259 (2.0)	SARS (2.0)	TMEM57 (1.8)
KEGG_ECM_RECEPTOR_INTERACTION	KEGG_ECM_RECEPTOR_INTERACTION	0.22	> 0.20	ITGB3 (5.4)	CILP2 (4.9)	BCAM (2.8)	APOE (2.6)	PLEC (2.6)	KANK2 (2.4)	C17orf57 (2.0)	CBLC (1.8)	PLEKHH2 (1.8)	CELSR2 (1.7)
MP:0004560	abnormal chorionic plate morphology	0.22	> 0.20	CBLC (3.3)	CETP (2.7)	YIPF2 (2.6)	AP1M2 (2.6)	DNM2 (2.3)	TRIB1 (2.1)	ATP13A1 (2.0)	LDLR (1.9)	GMIP (1.8)	DYNC2LI1 (1.8)
MP:0005070	impaired NK cell cytolysis	0.22	> 0.20	TRAFD1 (3.3)	PARP10 (2.1)	BCL3 (1.9)	RELB (1.9)	USP24 (1.6)	ST3GAL4 (1.4)	PSMA5 (1.3)	ADAM1 (1.1)	MYLIP (1.1)	ANKRD31 (1.1)
MP:0003828	pulmonary edema	0.22	> 0.20	MAFB (4.5)	TRIB1 (4.0)	MYLIP (2.9)	GPAM (2.8)	PBX4 (2.0)	C12orf47 (2.0)	ATXN7L2 (2.0)	POLK (1.9)	AMIGO1 (1.9)	FRK (1.8)
GO:0043566	structure-specific DNA binding	0.23	> 0.20	USP1 (3.9)	TRIB1 (2.6)	FEN1 (2.6)	ZNF101 (1.9)	NYNRIN (1.5)	KANK2 (1.3)	ANKRD31 (1.2)	GATAD2A (1.2)	ILF3 (1.2)	DHODH (1.2)
ENSG00000123143	PKN1 PPI subnetwork	0.23	> 0.20	ST3GAL4 (2.6)	SYPL2 (2.5)	ZNF180 (2.3)	ZNF101 (1.8)	CEACAM19 (1.8)	PCSK9 (1.6)	GOT2P1 (1.5)	C12orf51 (1.4)	GCNT4 (1.4)	PMFBP1 (1.2)
MP:0008174	decreased follicular B cell number	0.23	> 0.20	RELB (3.8)	TIMD4 (3.0)	SH2B3 (2.7)	GMIP (2.4)	APOC1 (2.3)	MAFB (2.2)	CETP (1.5)	BCL3 (1.5)	GPAM (1.4)	ALDH2 (1.4)
ENSG00000123728	RAP2C PPI subnetwork	0.23	> 0.20	HLX (2.8)	HNF1A (2.8)	PARP10 (2.3)	GPAM (2.2)	LPIN3 (1.8)	ANKRD31 (1.8)	TIMD4 (1.7)	ATXN7L2 (1.7)	C12orf51 (1.7)	CYB561D1 (1.7)
GO:0031080	Nup107-160 complex	0.23	> 0.20	POC5 (3.5)	MAPKAPK5 (3.2)	USP1 (2.7)	ENSG00000235545 (2.2)	CARM1 (2.2)	FEN1 (2.1)	NAA25 (2.1)	DOCK7 (2.1)	USP24 (2.1)	MOSC1 (1.9)
GO:0005544	calcium-dependent phospholipid binding	0.23	> 0.20	PLEC (3.5)	HAPLN4 (2.7)	RPH3A (2.7)	HLX (2.5)	ALDH2 (2.4)	C11orf9 (2.1)	PVR (1.9)	DYNC2LI1 (1.7)	AMIGO1 (1.7)	NPC1L1 (1.6)
KEGG_HISTIDINE_METABOLISM	KEGG_HISTIDINE_METABOLISM	0.23	> 0.20	TM6SF2 (3.8)	MOSC1 (3.7)	ALDH2 (3.2)	PLG (3.1)	ABCG8 (3.1)	ANGPTL3 (2.9)	HNF1A (2.4)	ABCG5 (2.3)	C11orf9 (2.1)	ABO (2.1)
MP:0002812	spherocytosis	0.23	> 0.20	RHCE (13.0)	RHD (11.6)	C12orf51 (4.9)	GMPR (4.7)	GRINA (1.7)	ENSG00000238078 (1.7)	TOP1 (1.5)	USP24 (1.5)	FADS2 (1.5)	SLC44A2 (1.5)
MP:0004091	abnormal Z lines	0.23	> 0.20	SYPL2 (6.1)	GMPR (2.5)	C12orf47 (2.3)	LPAR2 (1.8)	PVRL2 (1.8)	ERP29 (1.7)	BCAM (1.5)	PCSK9 (1.5)	TM6SF2 (1.5)	C11orf9 (1.4)
MP:0009640	abnormal renal tubule epithelium morphology	0.23	> 0.20	TM6SF2 (2.9)	TRAPPC6A (2.8)	APOC4 (2.6)	SLC22A1 (2.1)	PLG (2.0)	LPA (2.0)	HNF1A (1.9)	ENSG00000235545 (1.9)	CARM1 (1.9)	AP1M2 (1.8)
MP:0010868	increased bone trabecula number	0.23	> 0.20	APOC1 (3.8)	MAFB (3.3)	PPP1R37 (2.4)	CETP (2.4)	TRIB1 (2.0)	ITGB3 (1.9)	ENSG00000228044 (1.9)	POC5 (1.7)	CLPTM1 (1.5)	SH2B3 (1.5)
MP:0002398	abnormal bone marrow cell morphology/development	0.23	> 0.20	BCL3 (2.8)	PVR (2.6)	RHD (2.5)	GMIP (2.4)	RELB (2.4)	PARP10 (2.3)	CETP (2.0)	HP (2.0)	TOP1 (1.9)	HLX (1.8)
MP:0005153	abnormal B cell proliferation	0.23	> 0.20	GMIP (3.8)	C17orf57 (2.7)	CYB561D1 (2.5)	SLC44A2 (1.8)	BCL3 (1.7)	RELB (1.6)	TIMD4 (1.4)	SH2B3 (1.3)	CETP (1.3)	PARP10 (1.3)
ENSG00000032514	ENSG00000032514 PPI subnetwork	0.23	> 0.20	SUGP1 (3.1)	MARK4 (3.1)	MAPKAPK5 (2.7)	TOMM40 (2.6)	ATXN2 (2.5)	BUD13 (2.2)	POC5 (1.9)	CBLC (1.8)	CLPTM1 (1.7)	NT5DC1 (1.6)
GO:0044272	sulfur compound biosynthetic process	0.23	> 0.20	TXNL4B (2.2)	ENSG00000254235 (1.9)	ZHX3 (1.9)	ST3GAL4 (1.7)	NT5DC1 (1.6)	DYNC2LI1 (1.6)	TMED4 (1.6)	SLC22A1 (1.5)	CYP7A1 (1.5)	TM6SF2 (1.5)
GO:0030225	macrophage differentiation	0.23	> 0.20	ITGB3 (3.1)	ST3GAL4 (2.5)	GEMIN7 (1.8)	ENSG00000228044 (1.8)	ABO (1.7)	TIMD4 (1.7)	DNAH11 (1.5)	CYB561D1 (1.5)	GMIP (1.4)	BLOC1S3 (1.3)
ENSG00000102606	ARHGEF7 PPI subnetwork	0.23	> 0.20	MARK4 (3.1)	GMIP (2.7)	SH2B3 (2.7)	ATXN2 (2.6)	ENSG00000226645 (2.0)	TMEM116 (1.8)	CLPTM1 (1.7)	CARM1 (1.6)	OGDH (1.6)	C12orf43 (1.6)
ENSG00000164867	NOS3 PPI subnetwork	0.23	> 0.20	TIMD4 (2.5)	PPP1R37 (2.4)	ENSG00000228044 (2.4)	C17orf57 (2.2)	BCAM (2.2)	TXNL4B (2.0)	PLEKHH2 (2.0)	GOT2P1 (1.8)	SYPL2 (1.8)	HLX (1.8)
ENSG00000075415	SLC25A3 PPI subnetwork	0.23	> 0.20	QTRT1 (3.2)	ILF3 (3.1)	ENSG00000226645 (2.3)	TOP1 (2.0)	SARS (2.0)	SMARCA4 (1.9)	PBX4 (1.9)	DHX38 (1.8)	DDX56 (1.7)	NKPD1 (1.7)
ENSG00000105997	HOXA3 PPI subnetwork	0.23	> 0.20	OASL (2.9)	TIMD4 (2.9)	CETP (2.4)	TMEM57 (1.8)	C1orf63 (1.7)	CELSR2 (1.6)	POLK (1.6)	DNAH11 (1.5)	PLEKHH2 (1.5)	SLC44A2 (1.5)
ENSG00000131979	GCH1 PPI subnetwork	0.23	> 0.20	TMEM57 (2.6)	ALDH2 (2.3)	LPIN3 (2.2)	HAPLN4 (2.0)	HNF1A (1.9)	PPP1R37 (1.9)	TXNL4B (1.6)	BLOC1S3 (1.5)	UBXN2B (1.4)	CYP7A1 (1.4)
ENSG00000187266	EPOR PPI subnetwork	0.23	> 0.20	BCL3 (3.0)	COL4A3BP (2.2)	HLX (2.2)	C17orf57 (1.6)	CETP (1.5)	CYP7A1 (1.4)	GMIP (1.4)	PVR (1.3)	TIMD4 (1.3)	RELB (1.3)
ENSG00000147507	ENSG00000147507 PPI subnetwork	0.23	> 0.20	GMIP (4.5)	DNM2 (2.9)	ITGB3 (2.5)	SLC44A2 (2.5)	MAFB (2.5)	SH2B3 (2.3)	CETP (2.3)	TIMD4 (1.9)	LPAR2 (1.6)	GATAD2A (1.5)
ENSG00000215021	PHB2 PPI subnetwork	0.23	> 0.20	SARS (3.2)	ATP13A1 (2.7)	C12orf51 (2.7)	DNM2 (2.1)	ENSG00000226648 (2.0)	PLCG1 (1.9)	ILF3 (1.9)	PSMA5 (1.7)	DDX56 (1.7)	ST3GAL4 (1.7)
ENSG00000125731	SH2D3A PPI subnetwork	0.23	> 0.20	CBLC (6.1)	AP1M2 (4.3)	LPIN3 (2.5)	CELSR2 (2.4)	LPAR2 (2.4)	PVRL2 (2.0)	ST3GAL4 (1.7)	PPP1R37 (1.7)	DOCK7 (1.6)	DNM2 (1.6)
ENSG00000060138	CSDA PPI subnetwork	0.23	> 0.20	ADAM1 (3.9)	GOT2P1 (2.6)	BRAP (2.5)	MAPKAPK5 (2.4)	COL4A3BP (2.4)	PTPN11 (2.1)	PCSK9 (2.0)	C12orf47 (1.9)	C11orf9 (1.8)	DNAH11 (1.8)
ENSG00000166135	HIF1AN PPI subnetwork	0.23	> 0.20	PLCG1 (3.4)	NT5DC1 (3.3)	PCSK9 (2.5)	HNF1A (2.2)	FRK (2.1)	DOCK7 (1.9)	ENSG00000226645 (1.6)	POLK (1.5)	TOP1 (1.5)	USP24 (1.4)
ENSG00000094914	AAAS PPI subnetwork	0.23	> 0.20	USP1 (3.7)	NAA25 (3.6)	POC5 (2.8)	DOCK7 (2.8)	USP24 (2.5)	FEN1 (2.4)	BUD13 (2.2)	ILF3 (2.0)	DDX56 (1.9)	MOSC1 (1.9)
GO:0033574	response to testosterone stimulus	0.23	> 0.20	TMED4 (2.4)	C19orf52 (2.3)	C17orf57 (2.3)	CEACAM19 (1.9)	ENSG00000226648 (1.8)	POLK (1.7)	PCSK9 (1.7)	NT5DC1 (1.7)	NKPD1 (1.6)	ATXN7L2 (1.6)
GO:0046677	response to antibiotic	0.23	> 0.20	ENSG00000254235 (3.1)	DNAH11 (2.7)	PMFBP1 (2.3)	ZNF180 (2.3)	FRK (2.1)	ZNF101 (2.0)	CEACAM19 (1.8)	ST3GAL4 (1.6)	ENSG00000235545 (1.4)	GCNT4 (1.4)
ENSG00000138069	RAB1A PPI subnetwork	0.23	> 0.20	SARS (3.3)	YIPF2 (3.3)	TMEM50A (3.0)	CYB561D1 (2.9)	PSMA5 (2.8)	GEMIN7 (2.7)	CLPTM1 (2.6)	ZNF259 (1.8)	AP1M2 (1.8)	PPP1R37 (1.5)
GO:0005811	lipid particle	0.23	> 0.20	GPAM (5.5)	MOSC1 (4.8)	COL4A3BP (2.7)	NKPD1 (2.2)	CLPTM1 (1.7)	GRINA (1.7)	OGDH (1.6)	HP (1.6)	SORT1 (1.5)	PARP10 (1.5)
MP:0011086	partial postnatal lethality	0.23	> 0.20	NYNRIN (3.3)	HLX (2.9)	LDLR (2.7)	PCSK9 (2.0)	BCAM (1.8)	PLEC (1.8)	APOE (1.8)	USP24 (1.7)	KANK2 (1.6)	PLEKHH2 (1.5)
MP:0001750	increased circulating follicle stimulating hormone level	0.23	> 0.20	ST3GAL4 (3.2)	BLOC1S3 (2.4)	LDLR (2.2)	MARK4 (1.9)	APOB (1.6)	TMED4 (1.4)	PVRL2 (1.3)	TRIB1 (1.3)	GPAM (1.2)	DNAH11 (1.2)
GO:0002685	regulation of leukocyte migration	0.23	> 0.20	ENSG00000228044 (3.6)	TIMD4 (3.4)	CETP (2.4)	MAFB (2.2)	PVR (2.1)	ZNF101 (2.0)	RELB (1.7)	ENSG00000238078 (1.7)	APOE (1.5)	NKPD1 (1.4)
ENSG00000118513	MYB PPI subnetwork	0.23	> 0.20	TOMM40 (2.6)	ATXN2 (2.5)	MAU2 (2.5)	SMARCA4 (2.4)	CARM1 (2.3)	HNF1A (2.2)	MAPKAPK5 (2.0)	C12orf51 (2.0)	CEACAM19 (1.9)	ZHX3 (1.7)
GO:0071901	negative regulation of protein serine/threonine kinase activity	0.23	> 0.20	ENSG00000226645 (4.3)	TRIB1 (3.8)	ENSG00000238078 (2.4)	C17orf57 (2.0)	HLX (1.8)	MYLIP (1.6)	ZNF180 (1.6)	KANK2 (1.5)	ENSG00000226648 (1.4)	ZHX3 (1.4)
GO:0072202	cell differentiation involved in metanephros development	0.23	> 0.20	HAVCR1 (3.3)	PLEKHH2 (2.7)	BCAM (2.6)	TSSK6 (2.6)	DYNC2LI1 (1.9)	HNF1A (1.7)	CELSR2 (1.6)	ENSG00000228044 (1.4)	ST3GAL4 (1.4)	AMIGO1 (1.3)
GO:0043021	ribonucleoprotein complex binding	0.23	> 0.20	ZNF259 (3.4)	SUGP1 (2.9)	SARS (2.8)	TOMM40 (2.7)	CLPTM1 (2.6)	DHODH (2.3)	ATP13A1 (2.2)	DDX56 (2.1)	PSMA5 (2.0)	DHX38 (2.0)
MP:0004989	decreased osteoblast cell number	0.23	> 0.20	KIAA1324 (2.7)	MYLIP (2.7)	CBLC (2.4)	CILP2 (1.9)	TMEM116 (1.5)	HNF1A (1.5)	CELSR2 (1.5)	PLEKHH2 (1.5)	ALDH2 (1.5)	YIPF2 (1.5)
ENSG00000126005	ENSG00000126005 PPI subnetwork	0.23	> 0.20	ZNF259 (4.8)	TOMM40 (4.1)	QTRT1 (3.7)	NAA25 (3.7)	SARS (3.4)	DDX56 (3.2)	PSMA5 (2.8)	C12orf43 (2.6)	DHODH (2.4)	TOP1 (2.3)
REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D1	REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D1	0.23	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	TOMM40 (1.9)	PARP10 (1.8)	SUGP1 (1.7)	DDX56 (1.7)	SARS (1.6)	TMEM50A (1.1)
REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D	REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D	0.23	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	TOMM40 (1.9)	PARP10 (1.8)	SUGP1 (1.7)	DDX56 (1.7)	SARS (1.6)	TMEM50A (1.1)
ENSG00000137193	PIM1 PPI subnetwork	0.23	> 0.20	TRAFD1 (2.9)	POLK (2.1)	MAFB (1.9)	HLX (1.8)	OGDH (1.5)	ACAD10 (1.4)	ABCG8 (1.2)	GRINA (1.2)	TM6SF2 (1.2)	GOT2P1 (1.2)
ENSG00000134058	CDK7 PPI subnetwork	0.23	> 0.20	BUD13 (2.5)	ZNF259 (2.3)	FEN1 (2.1)	POC5 (2.0)	SUGP1 (2.0)	USP1 (1.9)	MAPKAPK5 (1.9)	SMARCA4 (1.7)	CARM1 (1.7)	POLK (1.6)
GO:0060761	negative regulation of response to cytokine stimulus	0.23	> 0.20	ANKRD31 (3.6)	CEACAM19 (2.7)	PBX4 (2.6)	MOSC1 (2.2)	MAU2 (2.0)	ENSG00000238078 (1.9)	TMEM116 (1.9)	NKPD1 (1.7)	TRAPPC6A (1.5)	DYNC2LI1 (1.5)
GO:0009896	positive regulation of catabolic process	0.23	> 0.20	ZNF180 (2.3)	BLOC1S3 (2.1)	POLK (1.9)	MAU2 (1.8)	GRINA (1.7)	TRIB1 (1.6)	CLPTM1 (1.6)	GPAM (1.4)	ENSG00000235545 (1.3)	MYLIP (1.3)
GO:0006879	cellular iron ion homeostasis	0.23	> 0.20	TMEM116 (2.8)	RHD (2.5)	RHCE (2.0)	FRK (2.0)	GRINA (1.9)	ERP29 (1.7)	BLOC1S3 (1.5)	MAFB (1.5)	TMEM57 (1.4)	ADAM1 (1.4)
GO:0016577	histone demethylation	0.23	> 0.20	TMEM57 (3.0)	ATXN7L2 (2.5)	BLOC1S3 (2.4)	ENSG00000254235 (2.3)	C12orf47 (2.1)	LPAR2 (2.1)	GCNT4 (1.9)	C12orf51 (1.8)	TOP1 (1.7)	LPA (1.7)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	0.23	> 0.20	C12orf43 (3.4)	GEMIN7 (3.1)	DDX56 (2.5)	POC5 (2.4)	ATXN2 (2.4)	ZNF259 (2.3)	C19orf52 (2.3)	SUGP1 (2.2)	ENSG00000226645 (2.0)	MAPKAPK5 (1.9)
REACTOME_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION	REACTOME_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION	0.23	> 0.20	C12orf43 (3.4)	GEMIN7 (3.1)	DDX56 (2.5)	POC5 (2.4)	ATXN2 (2.4)	ZNF259 (2.3)	C19orf52 (2.3)	SUGP1 (2.2)	ENSG00000226645 (2.0)	MAPKAPK5 (1.9)
ENSG00000121858	TNFSF10 PPI subnetwork	0.23	> 0.20	FRK (2.6)	LPAR2 (2.4)	BCL3 (2.0)	POLK (1.9)	PVR (1.8)	ZNF101 (1.8)	TRIB1 (1.8)	RELB (1.8)	ENSG00000235545 (1.6)	ITGB3 (1.4)
GO:0044130	negative regulation of growth of symbiont in host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044146	negative regulation of growth of symbiont involved in interaction with host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044126	regulation of growth of symbiont in host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044116	growth of symbiont involved in interaction with host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044110	growth involved in symbiotic interaction	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044117	growth of symbiont in host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044144	modulation of growth of symbiont involved in interaction with host	0.23	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
ENSG00000135829	DHX9 PPI subnetwork	0.23	> 0.20	ILF3 (4.0)	C1orf63 (3.6)	SMARCA4 (3.1)	TOP1 (3.1)	USP1 (3.0)	QTRT1 (2.6)	FEN1 (2.4)	DHX38 (2.3)	SUGP1 (2.2)	GATAD2A (2.2)
GO:0016620	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	0.23	> 0.20	ALDH2 (3.1)	TRAPPC6A (3.0)	ABCG8 (2.8)	CYP7A1 (2.7)	MOSC1 (2.7)	PLG (2.6)	GPAM (2.5)	KIAA1324 (2.5)	APOC4 (2.4)	ANGPTL3 (2.1)
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	0.23	> 0.20	CLPTM1 (2.7)	GATAD2A (2.5)	CYB561D1 (2.3)	PVR (2.2)	TMEM50A (2.2)	ANKRD31 (2.0)	MAU2 (1.9)	TMED4 (1.9)	TMEM57 (1.9)	ZNF101 (1.8)
ENSG00000118503	TNFAIP3 PPI subnetwork	0.23	> 0.20	RELB (5.8)	BCL3 (3.7)	PVR (2.6)	GRINA (2.3)	FRK (2.2)	TMEM50A (1.9)	ZNF259 (1.8)	BUD13 (1.5)	C1orf63 (1.5)	GMIP (1.4)
REACTOME_MRNA_PROCESSING	REACTOME_MRNA_PROCESSING	0.23	> 0.20	ILF3 (4.2)	BUD13 (3.0)	TOP1 (2.9)	DHX38 (2.8)	C1orf63 (2.8)	USP1 (2.8)	SMARCA4 (2.5)	FEN1 (2.4)	DDX56 (2.4)	SUGP1 (2.3)
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	0.23	> 0.20	SH2B3 (3.7)	MARK4 (2.7)	HLX (2.5)	COL4A3BP (2.0)	CLPTM1 (1.9)	TRIB1 (1.7)	OGDH (1.7)	TOMM40 (1.6)	DNM2 (1.6)	CARM1 (1.6)
MP:0004991	decreased bone strength	0.23	> 0.20	OASL (6.1)	MAFB (4.2)	PARP10 (2.6)	CILP2 (2.2)	CETP (2.1)	KANK2 (2.0)	TRIB1 (2.0)	MYLIP (1.9)	ZNF101 (1.8)	APOE (1.7)
GO:0005775	vacuolar lumen	0.23	> 0.20	APOE (3.8)	MAFB (3.7)	ERP29 (3.7)	ATP13A1 (2.8)	GRINA (2.4)	CLPTM1 (2.1)	HNF1A (1.9)	TMEM50A (1.8)	TMED4 (1.7)	PMFBP1 (1.6)
GO:0003727	single-stranded RNA binding	0.23	> 0.20	NT5DC1 (2.7)	TRIB1 (2.4)	DHODH (2.4)	C1orf63 (2.3)	UBXN2B (2.2)	PARP10 (2.1)	MYLIP (1.9)	ILF3 (1.9)	PPP1R37 (1.8)	CYB561D1 (1.7)
MP:0003934	abnormal pancreas development	0.23	> 0.20	KIAA1324 (2.4)	TRIB1 (1.7)	ENSG00000254235 (1.7)	ENSG00000238078 (1.5)	ABCG8 (1.4)	TRAFD1 (1.3)	TIMD4 (1.3)	DNAH11 (1.3)	POLK (1.2)	C17orf57 (1.2)
MP:0005223	abnormal anterior-posterior polarity of the somites	0.23	> 0.20	PLEC (3.2)	ABO (2.9)	ATXN2 (2.7)	MAU2 (2.6)	SLC44A2 (2.5)	GMIP (2.3)	LPAR2 (1.7)	HNF1A (1.6)	USP24 (1.6)	PLCG1 (1.5)
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	0.23	> 0.20	YIPF2 (3.4)	ENSG00000235545 (2.1)	ABCG8 (2.1)	TMED4 (2.1)	NPC1L1 (1.9)	TMEM57 (1.9)	TM6SF2 (1.8)	LPIN3 (1.7)	ABCG5 (1.7)	ERP29 (1.5)
REACTOME_NEPHRIN_INTERACTIONS	REACTOME_NEPHRIN_INTERACTIONS	0.23	> 0.20	DOCK7 (2.6)	GCNT4 (2.5)	PVRL2 (2.4)	TMEM50A (2.4)	ZNF101 (2.4)	SYPL2 (2.3)	HAVCR1 (2.1)	FRK (2.1)	ZNF180 (1.8)	ITGB3 (1.6)
MP:0002696	decreased circulating glucagon level	0.23	> 0.20	KIAA1324 (5.1)	SH2B3 (2.3)	ZHX3 (2.1)	ENSG00000254235 (2.1)	GCNT4 (2.1)	C12orf47 (1.7)	MOSC1 (1.7)	C1orf63 (1.6)	HLX (1.6)	C12orf43 (1.6)
ENSG00000167601	AXL PPI subnetwork	0.23	> 0.20	ZHX3 (3.4)	ZNF101 (2.4)	PLEKHH2 (2.3)	MYLIP (2.1)	TRAFD1 (1.9)	COL4A3BP (1.8)	MARK4 (1.8)	PARP10 (1.8)	TOP1 (1.7)	DNAH11 (1.7)
ENSG00000169682	SPNS1 PPI subnetwork	0.23	> 0.20	ZNF101 (3.8)	GMIP (3.3)	LPAR2 (2.6)	ZHX3 (2.5)	PLCG1 (2.1)	ITGB3 (2.1)	TOP1 (2.1)	MAFB (2.0)	PBX4 (1.7)	ENSG00000226645 (1.7)
ENSG00000068394	GPKOW PPI subnetwork	0.23	> 0.20	OASL (4.2)	PARP10 (2.3)	FRK (1.7)	BRAP (1.6)	TMED4 (1.6)	DYNC2LI1 (1.6)	POLK (1.5)	C1orf63 (1.5)	MAPKAPK5 (1.4)	NT5DC1 (1.4)
GO:0009108	coenzyme biosynthetic process	0.23	> 0.20	GPAM (3.3)	PCSK9 (3.2)	NT5DC1 (3.2)	FADS1 (3.0)	DHODH (3.0)	FADS2 (3.0)	ACAD10 (2.9)	OGDH (2.7)	HMGCR (2.7)	TXNL4B (2.5)
MP:0002095	abnormal skin pigmentation	0.23	> 0.20	RHCE (3.4)	RHD (3.2)	PLEKHH2 (2.8)	GMPR (2.5)	ENSG00000235545 (2.1)	HAVCR1 (2.1)	DOCK7 (2.0)	MYLIP (1.8)	CEACAM19 (1.6)	CELSR2 (1.4)
MP:0003009	abnormal cytokine secretion	0.23	> 0.20	RELB (4.5)	BCL3 (3.4)	PARP10 (3.2)	TRIB1 (3.0)	GMIP (2.9)	TRAFD1 (2.6)	MAFB (2.3)	OASL (1.9)	TIMD4 (1.4)	SH2B3 (1.3)
GO:0090316	positive regulation of intracellular protein transport	0.23	> 0.20	ENSG00000238078 (3.9)	TMEM116 (2.7)	PLEKHH2 (2.5)	OASL (2.5)	AP1M2 (2.4)	GCNT4 (1.8)	ENSG00000254235 (1.8)	MYLIP (1.7)	ZNF101 (1.7)	SLC44A2 (1.6)
GO:0042430	indole-containing compound metabolic process	0.23	> 0.20	ENSG00000254235 (4.0)	CYP7A1 (2.4)	LPA (2.3)	CYB561D1 (2.2)	SLC22A1 (2.2)	GOT2P1 (2.1)	FRK (2.1)	APOA5 (1.7)	DYNC2LI1 (1.7)	ATXN7L2 (1.5)
GO:0006586	indolalkylamine metabolic process	0.23	> 0.20	ENSG00000254235 (4.0)	CYP7A1 (2.4)	LPA (2.3)	CYB561D1 (2.2)	SLC22A1 (2.2)	GOT2P1 (2.1)	FRK (2.1)	APOA5 (1.7)	DYNC2LI1 (1.7)	ATXN7L2 (1.5)
MP:0001340	abnormal eyelid morphology	0.23	> 0.20	AP1M2 (2.2)	LPIN3 (2.2)	PLEC (1.9)	TRIB1 (1.8)	PCSK9 (1.6)	CBLC (1.6)	PLCG1 (1.6)	GCNT4 (1.6)	MYLIP (1.5)	ENSG00000254235 (1.4)
ENSG00000096968	JAK2 PPI subnetwork	0.23	> 0.20	GMIP (3.7)	BCL3 (3.5)	DNM2 (2.7)	RELB (2.7)	TRIB1 (2.2)	HLX (2.2)	CYB561D1 (2.1)	ALDH2 (2.1)	PBX4 (1.9)	PARP10 (1.9)
MP:0001658	increased mortality induced by gamma-irradiation	0.23	> 0.20	BUD13 (3.6)	PSRC1 (3.3)	POLK (3.2)	UBXN2B (2.6)	FEN1 (2.6)	ILF3 (2.2)	SMARCA4 (2.2)	ATXN7L2 (2.0)	KANK2 (1.8)	ZNF180 (1.6)
GO:0005765	lysosomal membrane	0.23	> 0.20	ATP13A1 (3.5)	GRINA (3.5)	ERP29 (3.4)	CLPTM1 (3.2)	SORT1 (3.1)	TMEM50A (2.9)	COL4A3BP (2.2)	YIPF2 (2.0)	SLC44A2 (1.9)	APOE (1.8)
ENSG00000163399	ATP1A1 PPI subnetwork	0.23	> 0.20	NPC1L1 (6.3)	TM6SF2 (5.1)	ABCG5 (4.6)	ABCG8 (3.3)	GCNT4 (2.9)	FRK (2.9)	APOB (2.8)	C11orf9 (2.5)	OGDH (2.4)	AP1M2 (2.1)
MP:0004136	abnormal tongue muscle morphology	0.23	> 0.20	CEACAM19 (2.6)	ZHX3 (2.3)	PVR (2.0)	HAVCR1 (1.9)	ST3GAL4 (1.5)	ATXN7L2 (1.5)	CILP2 (1.4)	ENSG00000226648 (1.4)	PSRC1 (1.4)	HLX (1.2)
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	0.23	> 0.20	TM6SF2 (3.1)	PLG (3.0)	RHD (2.8)	RHCE (2.6)	TMEM116 (2.3)	ANGPTL3 (2.1)	SORT1 (2.0)	ABO (1.8)	ABCG8 (1.8)	SYPL2 (1.7)
ENSG00000111537	IFNG PPI subnetwork	0.23	> 0.20	BCL3 (3.4)	HLX (2.9)	ALDH2 (2.6)	TIMD4 (2.5)	CETP (2.5)	RELB (2.2)	GMIP (1.5)	ST3GAL4 (1.3)	PARP10 (1.3)	LPA (1.3)
ENSG00000114127	XRN1 PPI subnetwork	0.23	> 0.20	DDX56 (3.2)	SUGP1 (2.9)	TOMM40 (2.9)	GATAD2A (2.9)	DHX38 (2.8)	ILF3 (2.8)	TOP1 (2.6)	SMARCA4 (2.6)	ZNF259 (2.4)	USP24 (2.3)
REACTOME_INTERFERON_GAMMA_SIGNALING	REACTOME_INTERFERON_GAMMA_SIGNALING	0.23	> 0.20	TRAFD1 (6.6)	PARP10 (6.2)	OASL (4.9)	BCL3 (3.6)	RELB (3.3)	SH2B3 (1.8)	ADAM1 (1.7)	GRINA (1.6)	APOE (1.5)	ALDH2 (1.4)
MP:0005669	increased circulating leptin level	0.23	> 0.20	GPAM (4.2)	MOSC1 (2.9)	PLEKHH2 (2.7)	ABCG5 (2.6)	KIAA1324 (2.4)	ABCG8 (1.9)	TIMD4 (1.9)	C12orf47 (1.8)	DYNC2LI1 (1.7)	CETP (1.7)
ENSG00000106554	CHCHD3 PPI subnetwork	0.23	> 0.20	SYPL2 (3.0)	OGDH (2.9)	GMPR (2.7)	ACAD10 (2.7)	TMEM50A (2.0)	APOE (1.8)	BCAM (1.8)	RHD (1.3)	PSMA5 (1.3)	C1orf63 (1.2)
ENSG00000184226	PCDH9 PPI subnetwork	0.23	> 0.20	USP24 (2.9)	PARP10 (2.8)	MAU2 (2.7)	MARK4 (2.6)	BCL3 (2.4)	ATXN2 (2.3)	SMARCA4 (2.3)	GMIP (2.0)	DHX38 (1.8)	C12orf51 (1.7)
ENSG00000075413	MARK3 PPI subnetwork	0.23	> 0.20	CBLC (3.8)	AP1M2 (3.0)	CELSR2 (2.3)	BCAM (2.2)	UBXN2B (2.1)	PVRL2 (2.1)	LPIN3 (2.0)	CARM1 (1.9)	BUD13 (1.9)	ZNF259 (1.9)
MP:0008388	hypochromic microcytic anemia	0.23	> 0.20	RHD (8.6)	RHCE (6.6)	USP24 (2.3)	APOC1 (2.1)	PCSK9 (1.9)	GPAM (1.8)	APOE (1.7)	PARP10 (1.5)	C12orf47 (1.4)	PPP1R37 (1.4)
ENSG00000146457	WTAP PPI subnetwork	0.23	> 0.20	C11orf9 (3.1)	NYNRIN (2.5)	UBXN2B (2.3)	PVRL2 (2.1)	ENSG00000235545 (2.1)	USP24 (1.8)	MARK4 (1.8)	TOP1 (1.5)	CEACAM19 (1.4)	BCAM (1.4)
ENSG00000100453	GZMB PPI subnetwork	0.23	> 0.20	ENSG00000228044 (2.7)	UBXN2B (2.1)	ABCG8 (2.0)	TMEM57 (1.9)	FRK (1.9)	TMEM50A (1.6)	TRAFD1 (1.6)	RPH3A (1.4)	TXNL4B (1.4)	BUD13 (1.4)
ENSG00000186803	IFNA10 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000147885	IFNA16 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000188379	IFNA2 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000137080	IFNA21 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000120247	ENSG00000120247 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000147877	ENSG00000147877 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000186809	ENSG00000186809 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000147873	IFNA5 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000120242	IFNA8 PPI subnetwork	0.23	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
REACTOME_CDK:MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	REACTOME_CDK:MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	0.23	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.4)	PARP10 (1.9)	DDX56 (1.8)	SUGP1 (1.8)	TOMM40 (1.6)	SARS (1.4)	TMEM50A (1.2)
GO:0005640	nuclear outer membrane	0.23	> 0.20	LDLR (4.1)	FADS1 (3.4)	FADS2 (3.3)	KIAA1324 (2.8)	HAVCR1 (2.6)	YIPF2 (2.5)	LPIN3 (2.5)	HMGCR (2.1)	NKPD1 (2.0)	LPAR2 (2.0)
ENSG00000028839	TBPL1 PPI subnetwork	0.23	> 0.20	OGDH (3.3)	C19orf52 (2.6)	CLPTM1 (2.6)	ST3GAL4 (2.2)	TXNL4B (2.1)	ERP29 (2.0)	LDLR (1.8)	ENSG00000226648 (1.8)	ACAD10 (1.7)	C17orf57 (1.7)
ENSG00000168924	LETM1 PPI subnetwork	0.24	> 0.20	GEMIN7 (2.8)	TOMM40 (2.4)	QTRT1 (2.1)	TRIB1 (2.0)	HAVCR1 (1.8)	C12orf47 (1.8)	ENSG00000254235 (1.7)	CARM1 (1.7)	AP1M2 (1.7)	OGDH (1.3)
ENSG00000168438	CDC40 PPI subnetwork	0.24	> 0.20	ILF3 (3.6)	C1orf63 (3.5)	DHX38 (3.3)	TOP1 (3.1)	SUGP1 (3.0)	BUD13 (2.8)	SMARCA4 (2.7)	USP1 (2.6)	FEN1 (2.4)	MAU2 (2.3)
GO:0001501	skeletal system development	0.24	> 0.20	CILP2 (5.6)	PLEKHH2 (2.5)	NYNRIN (2.2)	MAFB (2.1)	MYLIP (1.6)	CEACAM19 (1.4)	ABO (1.4)	TMEM57 (1.4)	ATXN7L2 (1.2)	HLX (1.2)
ENSG00000131931	THAP1 PPI subnetwork	0.24	> 0.20	BLOC1S3 (4.0)	C19orf52 (3.5)	CLPTM1 (2.9)	PPP1R37 (2.8)	ZNF180 (2.5)	UBXN2B (2.2)	DNM2 (1.8)	ANKRD31 (1.6)	MARK4 (1.6)	TOMM40 (1.6)
ENSG00000162402	USP24 PPI subnetwork	0.24	> 0.20	ENSG00000228044 (2.4)	GPAM (2.0)	KANK2 (1.9)	SORT1 (1.8)	ST3GAL4 (1.7)	FADS2 (1.6)	PSRC1 (1.6)	CEACAM19 (1.5)	RPH3A (1.5)	FADS1 (1.4)
GO:0048255	mRNA stabilization	0.24	> 0.20	ENSG00000238078 (4.1)	ENSG00000226648 (2.9)	TOP1 (2.5)	ADAM1 (2.5)	ILF3 (2.4)	NT5DC1 (2.3)	ENSG00000226645 (2.0)	ENSG00000228044 (1.8)	ENSG00000235545 (1.7)	SUGP1 (1.5)
GO:0043489	RNA stabilization	0.24	> 0.20	ENSG00000238078 (4.1)	ENSG00000226648 (2.9)	TOP1 (2.5)	ADAM1 (2.5)	ILF3 (2.4)	NT5DC1 (2.3)	ENSG00000226645 (2.0)	ENSG00000228044 (1.8)	ENSG00000235545 (1.7)	SUGP1 (1.5)
GO:0002688	regulation of leukocyte chemotaxis	0.24	> 0.20	TIMD4 (2.5)	ENSG00000228044 (2.3)	ENSG00000238078 (2.0)	ZNF101 (2.0)	MAFB (1.9)	ST3GAL4 (1.8)	APOE (1.8)	CETP (1.8)	PVR (1.7)	TMEM116 (1.6)
GO:2000379	positive regulation of reactive oxygen species metabolic process	0.24	> 0.20	ENSG00000226645 (2.9)	ANKRD31 (2.8)	PVR (2.1)	POLK (2.0)	FRK (1.9)	CYB561D1 (1.9)	ALDH2 (1.9)	HAVCR1 (1.8)	BRAP (1.8)	LPIN3 (1.4)
ENSG00000158792	SPATA2L PPI subnetwork	0.24	> 0.20	ENSG00000228044 (3.0)	NAA25 (2.2)	OASL (2.1)	BUD13 (1.9)	ZNF180 (1.6)	ENSG00000254235 (1.6)	DDX56 (1.6)	SH2B3 (1.5)	DOCK7 (1.5)	C11orf9 (1.4)
GO:0006109	regulation of carbohydrate metabolic process	0.24	> 0.20	ENSG00000254235 (3.9)	HNF1A (2.5)	GPAM (2.4)	CYP7A1 (2.3)	ENSG00000238078 (2.3)	LPA (2.3)	PCSK9 (2.1)	TMEM116 (1.8)	KANK2 (1.7)	ZHX3 (1.7)
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	0.24	> 0.20	FRK (2.9)	TSSK6 (2.6)	MAU2 (2.2)	RELB (2.1)	SH2B3 (2.1)	GMIP (1.9)	LPAR2 (1.8)	OASL (1.8)	UBXN2B (1.7)	ENSG00000226645 (1.7)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	0.24	> 0.20	FRK (2.9)	TSSK6 (2.6)	MAU2 (2.2)	RELB (2.1)	SH2B3 (2.1)	GMIP (1.9)	LPAR2 (1.8)	OASL (1.8)	UBXN2B (1.7)	ENSG00000226645 (1.7)
KEGG_SPHINGOLIPID_METABOLISM	KEGG_SPHINGOLIPID_METABOLISM	0.24	> 0.20	NKPD1 (5.7)	HNF1A (3.6)	COL4A3BP (3.0)	TMEM50A (2.9)	HAPLN4 (2.6)	LPIN3 (2.5)	ABCG8 (2.4)	TM6SF2 (2.4)	TMED4 (2.3)	ABCG5 (2.1)
GO:0004860	protein kinase inhibitor activity	0.24	> 0.20	BCL3 (2.3)	APOB (2.1)	NCAN (2.1)	ABCG5 (1.9)	MYLIP (1.7)	TRIB1 (1.7)	LDLR (1.6)	ZNF101 (1.6)	TRAFD1 (1.6)	HLX (1.6)
ENSG00000074201	CLNS1A PPI subnetwork	0.24	> 0.20	ITGB3 (3.0)	NYNRIN (2.6)	BUD13 (2.5)	GOT2P1 (2.3)	ZNF259 (2.3)	PSMA5 (2.2)	SARS (2.2)	ILF3 (2.2)	TOMM40 (1.8)	USP1 (1.8)
ENSG00000110422	HIPK3 PPI subnetwork	0.24	> 0.20	TRAFD1 (2.5)	GOT2P1 (2.3)	FADS2 (1.8)	TSSK6 (1.8)	HNF1A (1.6)	ENSG00000228044 (1.5)	LPIN3 (1.5)	NYNRIN (1.5)	BRAP (1.5)	BLOC1S3 (1.5)
ENSG00000120235	IFNA6 PPI subnetwork	0.24	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	CETP (2.2)	GMIP (2.1)	PARP10 (1.6)	ALDH2 (1.5)	LPA (1.5)	GRINA (1.4)
MP:0000477	abnormal intestine morphology	0.24	> 0.20	C11orf9 (4.2)	KANK2 (2.7)	MOSC1 (2.6)	PVRL2 (2.3)	HLX (2.1)	CETP (1.9)	NYNRIN (1.8)	MYLIP (1.8)	OGDH (1.6)	CBLC (1.6)
ENSG00000003400	CASP10 PPI subnetwork	0.24	> 0.20	FRK (3.5)	RELB (2.9)	TRAFD1 (2.8)	BCL3 (2.2)	LPAR2 (1.9)	ST3GAL4 (1.9)	ENSG00000228044 (1.8)	UBXN2B (1.8)	CEACAM19 (1.6)	PVR (1.5)
ENSG00000117450	PRDX1 PPI subnetwork	0.24	> 0.20	ADAM1 (2.5)	PVRL2 (2.3)	UBXN2B (2.1)	PLG (1.9)	ANGPTL3 (1.8)	TMEM50A (1.7)	PARP10 (1.7)	PLEC (1.7)	OGDH (1.6)	APOC4 (1.6)
REACTOME_VPR:MEDIATED_NUCLEAR_IMPORT_OF_PICS	REACTOME_VPR:MEDIATED_NUCLEAR_IMPORT_OF_PICS	0.24	> 0.20	POC5 (3.3)	NAA25 (3.2)	USP1 (2.9)	USP24 (2.8)	DOCK7 (2.7)	BUD13 (2.7)	DDX56 (2.6)	ILF3 (2.2)	FEN1 (2.1)	MAPKAPK5 (1.9)
ENSG00000166197	NOLC1 PPI subnetwork	0.24	> 0.20	ILF3 (3.0)	TOP1 (2.7)	QTRT1 (2.7)	C12orf43 (2.6)	SMARCA4 (2.6)	NAA25 (2.5)	GATAD2A (2.0)	PLEC (2.0)	SARS (1.9)	TRIB1 (1.9)
ENSG00000091592	NLRP1 PPI subnetwork	0.24	> 0.20	TRAFD1 (2.4)	BLOC1S3 (2.3)	TIMD4 (2.2)	ST3GAL4 (2.0)	DNAH11 (1.9)	POLK (1.7)	APOE (1.6)	GCNT4 (1.6)	ALDH2 (1.6)	NT5DC1 (1.5)
GO:0005912	adherens junction	0.24	> 0.20	PLEC (4.3)	PVRL2 (3.9)	BCAM (3.9)	KANK2 (2.5)	ITGB3 (2.4)	AP1M2 (2.2)	PVR (2.0)	C11orf9 (1.9)	CBLC (1.8)	DNM2 (1.6)
GO:0004702	receptor signaling protein serine/threonine kinase activity	0.24	> 0.20	PVR (2.9)	PLCG1 (2.3)	BCL3 (2.3)	ZHX3 (2.1)	SH2B3 (2.1)	GCNT4 (1.9)	MARK4 (1.9)	LPAR2 (1.8)	CYB561D1 (1.8)	RELB (1.7)
ENSG00000206427	PRRC2A PPI subnetwork	0.24	> 0.20	C19orf52 (2.4)	QTRT1 (2.3)	PLEC (2.2)	ERP29 (2.1)	ACAD10 (1.9)	ATXN7L2 (1.9)	PSMA5 (1.8)	ILF3 (1.8)	CLPTM1 (1.7)	ALDH2 (1.7)
ENSG00000206318	ENSG00000206318 PPI subnetwork	0.24	> 0.20	C19orf52 (2.4)	QTRT1 (2.3)	PLEC (2.2)	ERP29 (2.1)	ACAD10 (1.9)	ATXN7L2 (1.9)	PSMA5 (1.8)	ILF3 (1.8)	CLPTM1 (1.7)	ALDH2 (1.7)
MP:0000280	thin ventricular wall	0.24	> 0.20	BCAM (2.8)	TRIB1 (2.7)	PLEC (2.0)	MARK4 (1.8)	ENSG00000228044 (1.6)	ATXN7L2 (1.5)	SH2B3 (1.4)	HLX (1.4)	MAFB (1.4)	BCL3 (1.3)
ENSG00000145777	TSLP PPI subnetwork	0.24	> 0.20	BCL3 (4.3)	RELB (3.1)	HLX (2.9)	CETP (2.2)	ALDH2 (2.1)	TIMD4 (2.1)	GMIP (1.9)	PARP10 (1.6)	LPA (1.3)	ANKRD31 (1.3)
MP:0002209	decreased germ cell number	0.24	> 0.20	LPAR2 (3.0)	TSSK6 (2.5)	C11orf9 (2.2)	ABO (2.2)	PMFBP1 (2.0)	PLEKHH2 (1.5)	FRK (1.5)	HAPLN4 (1.4)	KIAA1324 (1.3)	TXNL4B (1.2)
GO:0014074	response to purine-containing compound	0.24	> 0.20	HMGCR (2.8)	CYP7A1 (2.5)	LDLR (2.4)	AMIGO1 (2.2)	FADS1 (2.0)	ANKRD31 (1.9)	SYPL2 (1.8)	C17orf57 (1.7)	PCSK9 (1.6)	GCNT4 (1.6)
GO:0046620	regulation of organ growth	0.24	> 0.20	GCNT4 (2.7)	CEACAM19 (2.1)	BLOC1S3 (2.0)	C11orf9 (1.9)	HAPLN4 (1.8)	ENSG00000226648 (1.8)	ANKRD31 (1.5)	DNAH11 (1.4)	ENSG00000238078 (1.2)	PLEKHH2 (1.2)
ENSG00000094916	CBX5 PPI subnetwork	0.24	> 0.20	FEN1 (3.3)	PSRC1 (3.2)	USP1 (3.1)	BUD13 (2.2)	ZNF101 (2.1)	SMARCA4 (1.8)	ZNF180 (1.8)	MAU2 (1.6)	C19orf52 (1.6)	ZHX3 (1.5)
ENSG00000162688	AGL PPI subnetwork	0.24	> 0.20	C12orf43 (2.4)	PLEKHH2 (2.1)	BRAP (1.9)	C12orf47 (1.9)	DYNC2LI1 (1.9)	MYLIP (1.9)	GEMIN7 (1.8)	ABO (1.6)	ZHX3 (1.5)	CEACAM19 (1.4)
ENSG00000123131	PRDX4 PPI subnetwork	0.24	> 0.20	ADAM1 (3.8)	PSMA5 (3.3)	RHD (2.7)	RHCE (2.4)	ALDH2 (2.2)	CYP7A1 (2.0)	ACAD10 (1.9)	C1orf63 (1.9)	SLC44A2 (1.8)	PVRL2 (1.7)
MP:0001131	abnormal ovarian follicle morphology	0.24	> 0.20	FADS1 (4.2)	ST3GAL4 (2.4)	TRAPPC6A (2.4)	FADS2 (2.2)	LDLR (2.1)	HMGCR (2.1)	NCAN (2.0)	CELSR2 (1.9)	ABO (1.8)	KIAA1324 (1.8)
ENSG00000148175	STOM PPI subnetwork	0.24	> 0.20	QTRT1 (2.3)	BRAP (2.2)	GRINA (2.1)	YIPF2 (2.1)	C19orf52 (2.0)	BLOC1S3 (1.9)	AMIGO1 (1.8)	PPP1R37 (1.7)	ATP13A1 (1.6)	DNAH11 (1.5)
MP:0008466	enlarged mesenteric lymph nodes	0.24	> 0.20	SH2B3 (2.9)	RELB (2.5)	MAFB (1.9)	SLC44A2 (1.9)	RHD (1.9)	DNAH11 (1.8)	PLEKHH2 (1.7)	HAVCR1 (1.6)	MAPKAPK5 (1.6)	PBX4 (1.4)
MP:0008146	asymmetric rib-sternum attachment	0.24	> 0.20	TRIB1 (3.6)	DOCK7 (2.2)	ENSG00000238078 (2.0)	FRK (2.0)	NYNRIN (1.8)	C11orf9 (1.5)	TMEM57 (1.4)	TMED4 (1.3)	PVRL2 (1.3)	BCAM (1.3)
ENSG00000206328	ENSG00000206328 PPI subnetwork	0.24	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
ENSG00000204490	TNF PPI subnetwork	0.24	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
ENSG00000206439	TNF PPI subnetwork	0.24	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
GO:0000146	microfilament motor activity	0.24	> 0.20	SYPL2 (4.0)	ANKRD31 (1.7)	LDLR (1.6)	AP1M2 (1.5)	BCAM (1.5)	CBLC (1.3)	ENSG00000238078 (1.3)	NPC1L1 (1.2)	C11orf9 (1.2)	FADS2 (1.2)
ENSG00000058262	SEC61A1 PPI subnetwork	0.24	> 0.20	POLK (2.9)	YIPF2 (2.9)	ATP13A1 (2.8)	PSMA5 (2.1)	ERP29 (2.0)	DOCK7 (1.9)	TMED4 (1.9)	CLPTM1 (1.8)	OGDH (1.7)	SARS (1.7)
GO:0002274	myeloid leukocyte activation	0.24	> 0.20	C17orf57 (3.4)	GMIP (2.3)	ZNF101 (1.9)	ANKRD31 (1.8)	MAFB (1.5)	C12orf47 (1.5)	GEMIN7 (1.5)	ITGB3 (1.4)	SH2B3 (1.3)	BCL3 (1.3)
ENSG00000166164	BRD7 PPI subnetwork	0.24	> 0.20	CARM1 (4.3)	GRINA (2.9)	MARK4 (2.4)	ZNF180 (2.4)	SMARCA4 (2.1)	GOT2P1 (1.9)	NYNRIN (1.9)	BUD13 (1.9)	BCL3 (1.8)	ILF3 (1.7)
GO:0015849	organic acid transport	0.24	> 0.20	TM6SF2 (3.5)	ABCG8 (3.2)	TMEM116 (2.2)	HAPLN4 (2.1)	GCNT4 (1.8)	ABCG5 (1.8)	CLPTM1 (1.7)	LPAR2 (1.6)	GRINA (1.5)	PBX4 (1.5)
GO:0010962	regulation of glucan biosynthetic process	0.24	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
GO:0032885	regulation of polysaccharide biosynthetic process	0.24	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
GO:0005979	regulation of glycogen biosynthetic process	0.24	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
ENSG00000106070	GRB10 PPI subnetwork	0.24	> 0.20	HLX (2.9)	CETP (2.5)	SH2B3 (2.4)	GPAM (2.0)	ANKRD31 (1.7)	LPIN3 (1.7)	NPC1L1 (1.6)	LPA (1.4)	USP24 (1.4)	FADS2 (1.3)
ENSG00000117400	MPL PPI subnetwork	0.24	> 0.20	BCL3 (3.3)	COL4A3BP (1.8)	C17orf57 (1.8)	PVR (1.7)	RELB (1.5)	SLC22A1 (1.5)	CYP7A1 (1.5)	BCAM (1.4)	ZNF101 (1.3)	HLX (1.2)
MP:0001651	necrosis	0.24	> 0.20	APOB (3.6)	RHD (3.1)	SH2B3 (3.1)	RHCE (3.1)	HLX (3.0)	APOA5 (2.2)	ITGB3 (2.0)	ABCG5 (2.0)	APOC4 (1.6)	TM6SF2 (1.5)
GO:0046332	SMAD binding	0.24	> 0.20	KANK2 (4.7)	TRIB1 (2.9)	GATAD2A (2.5)	ATXN2 (2.3)	ENSG00000226645 (2.1)	DOCK7 (2.1)	SH2B3 (2.0)	MYLIP (1.9)	NYNRIN (1.8)	PLEC (1.5)
ENSG00000105647	PIK3R2 PPI subnetwork	0.24	> 0.20	DOCK7 (3.0)	GMIP (2.9)	SH2B3 (2.6)	USP24 (2.4)	SLC44A2 (2.3)	PLEC (2.2)	DNM2 (2.1)	PLEKHH2 (2.0)	C1orf63 (1.9)	PVRL2 (1.7)
ENSG00000143753	DEGS1 PPI subnetwork	0.24	> 0.20	SARS (3.2)	TXNL4B (2.8)	LPAR2 (2.6)	CARM1 (2.3)	C19orf52 (2.1)	ANKRD31 (2.0)	NT5DC1 (1.8)	ADAM1 (1.8)	DHX38 (1.7)	YIPF2 (1.6)
ENSG00000184489	PTP4A3 PPI subnetwork	0.24	> 0.20	ATP13A1 (4.2)	NAA25 (3.2)	DHX38 (2.8)	DDX56 (2.6)	FEN1 (2.5)	SARS (2.2)	TMEM57 (2.1)	ILF3 (2.1)	CLPTM1 (2.0)	HAVCR1 (2.0)
ENSG00000205302	SNX2 PPI subnetwork	0.24	> 0.20	HAVCR1 (3.8)	TMEM50A (3.3)	USP24 (2.3)	CEACAM19 (2.2)	DOCK7 (1.8)	TMEM57 (1.8)	HNF1A (1.8)	PTPN11 (1.7)	C17orf57 (1.5)	CETP (1.5)
ENSG00000116750	UCHL5 PPI subnetwork	0.24	> 0.20	PSMA5 (6.0)	TRAFD1 (2.6)	NAA25 (2.2)	TOMM40 (2.1)	SUGP1 (2.0)	NT5DC1 (1.9)	DDX56 (1.8)	SARS (1.7)	TXNL4B (1.5)	CELSR2 (1.4)
GO:0060412	ventricular septum morphogenesis	0.24	> 0.20	ENSG00000238078 (3.4)	C19orf52 (2.7)	ABO (2.5)	ATXN7L2 (2.2)	C11orf9 (2.0)	ENSG00000235545 (1.9)	ZNF180 (1.8)	C17orf57 (1.7)	ABCG8 (1.7)	NYNRIN (1.6)
ENSG00000183386	FHL3 PPI subnetwork	0.24	> 0.20	CEACAM19 (3.5)	PVRL2 (2.9)	CARM1 (2.9)	CBLC (2.2)	ATXN7L2 (2.2)	PVR (2.1)	LPIN3 (1.9)	PLEC (1.9)	C11orf9 (1.8)	GCNT4 (1.7)
GO:0090004	positive regulation of establishment of protein localization in plasma membrane	0.24	> 0.20	ENSG00000226645 (3.0)	HAVCR1 (1.6)	PTPN11 (1.6)	ENSG00000238078 (1.5)	ZHX3 (1.5)	AP1M2 (1.4)	TMEM57 (1.3)	C11orf9 (1.2)	ST3GAL4 (1.1)	ANKRD31 (1.1)
ENSG00000198223	CSF2RA PPI subnetwork	0.24	> 0.20	BCL3 (3.0)	COL4A3BP (1.9)	CYP7A1 (1.9)	HLX (1.8)	C17orf57 (1.6)	PVR (1.6)	SLC22A1 (1.5)	ZNF101 (1.5)	RELB (1.3)	TIMD4 (1.1)
MP:0003453	abnormal keratinocyte physiology	0.24	> 0.20	CBLC (3.8)	PLEC (3.4)	BCL3 (2.9)	PVRL2 (2.6)	CEACAM19 (2.1)	HNF1A (2.1)	BCAM (2.0)	OASL (1.7)	NKPD1 (1.6)	LDLR (1.5)
ENSG00000142676	RPL11 PPI subnetwork	0.24	> 0.20	DDX56 (3.9)	NAA25 (3.9)	ZNF259 (3.2)	TOMM40 (2.9)	QTRT1 (2.7)	C12orf43 (2.6)	DHX38 (2.4)	TOP1 (2.1)	DHODH (2.1)	ATP13A1 (2.1)
ENSG00000165309	ARMC3 PPI subnetwork	0.24	> 0.20	GCNT4 (2.4)	SLC22A1 (2.3)	GOT2P1 (2.3)	PVR (2.0)	DNAH11 (2.0)	LPA (1.9)	DDX56 (1.7)	NT5DC1 (1.6)	ENSG00000226648 (1.6)	NPC1L1 (1.6)
MP:0003883	enlarged stomach	0.24	> 0.20	C11orf9 (3.1)	CETP (2.2)	ABO (2.2)	ITGB3 (1.9)	SLC44A2 (1.8)	CLPTM1 (1.7)	OASL (1.6)	C12orf47 (1.5)	HLX (1.5)	PPP1R37 (1.4)
ENSG00000122566	HNRNPA2B1 PPI subnetwork	0.24	> 0.20	ILF3 (3.8)	C1orf63 (3.8)	SMARCA4 (3.0)	TOP1 (2.9)	TOMM40 (2.3)	USP1 (2.1)	QTRT1 (2.0)	BUD13 (2.0)	SUGP1 (1.9)	DHX38 (1.9)
ENSG00000170608	FOXA3 PPI subnetwork	0.24	> 0.20	DHODH (3.9)	DHX38 (3.7)	ATP13A1 (2.4)	PLCG1 (1.8)	ENSG00000238078 (1.7)	ABO (1.7)	ZHX3 (1.6)	LPA (1.6)	GOT2P1 (1.4)	PLEKHH2 (1.4)
ENSG00000123094	RASSF8 PPI subnetwork	0.24	> 0.20	LPAR2 (3.3)	ZHX3 (2.9)	UBXN2B (2.9)	KANK2 (2.9)	CBLC (2.9)	GPAM (2.5)	COL4A3BP (2.4)	PLEC (2.4)	CARM1 (2.4)	C11orf9 (2.2)
GO:0001784	phosphotyrosine binding	0.24	> 0.20	C17orf57 (3.8)	SLC44A2 (2.7)	CYB561D1 (2.4)	GMIP (2.2)	PLEKHH2 (2.2)	PVRL2 (2.1)	PBX4 (2.0)	AMIGO1 (2.0)	MAFB (1.9)	C1orf63 (1.8)
ENSG00000143947	RPS27A PPI subnetwork	0.24	> 0.20	TOP1 (2.5)	PSMA5 (2.4)	SMARCA4 (2.4)	PTPN11 (2.3)	FEN1 (2.1)	DHX38 (2.0)	NAA25 (1.9)	ILF3 (1.9)	GRINA (1.8)	MAU2 (1.8)
ENSG00000198242	RPL23A PPI subnetwork	0.24	> 0.20	ZNF259 (3.6)	NAA25 (3.5)	DDX56 (2.8)	QTRT1 (2.7)	GATAD2A (2.6)	SUGP1 (2.0)	TOMM40 (1.9)	C12orf43 (1.8)	ILF3 (1.8)	SARS (1.7)
ENSG00000145604	SKP2 PPI subnetwork	0.24	> 0.20	FEN1 (2.7)	TOMM40 (2.7)	TRIB1 (2.1)	PSRC1 (2.1)	POLK (2.1)	USP1 (2.0)	PVR (1.8)	ENSG00000226645 (1.7)	GCNT4 (1.4)	KANK2 (1.4)
ENSG00000206452	HLA-C PPI subnetwork	0.24	> 0.20	PSMA5 (3.9)	PLCG1 (2.8)	HAVCR1 (2.7)	AMIGO1 (2.4)	CLPTM1 (2.3)	ENSG00000228044 (1.8)	PARP10 (1.6)	TMED4 (1.6)	QTRT1 (1.5)	ERP29 (1.4)
GO:0016569	covalent chromatin modification	0.24	> 0.20	ATXN7L2 (3.9)	BUD13 (2.7)	ILF3 (2.7)	C12orf51 (2.3)	MAU2 (2.0)	SMARCA4 (1.9)	ATXN2 (1.9)	TMEM57 (1.9)	TOP1 (1.8)	USP24 (1.8)
ENSG00000117395	EBNA1BP2 PPI subnetwork	0.24	> 0.20	NAA25 (4.7)	ZNF259 (4.7)	DDX56 (3.9)	TOMM40 (3.7)	QTRT1 (3.6)	DHODH (3.1)	DHX38 (2.4)	C12orf43 (2.4)	ILF3 (2.3)	ATP13A1 (2.2)
MP:0005036	diarrhea	0.24	> 0.20	BCL3 (3.6)	RELB (2.7)	PARP10 (2.3)	NPC1L1 (2.3)	UBXN2B (2.3)	ST3GAL4 (2.2)	ABCG5 (1.8)	KIAA1324 (1.8)	TM6SF2 (1.7)	ABO (1.6)
ENSG00000106992	AK1 PPI subnetwork	0.24	> 0.20	USP24 (3.9)	DNM2 (3.6)	PLEC (3.1)	GMIP (2.7)	COL4A3BP (2.6)	POLK (2.0)	SORT1 (1.9)	CELSR2 (1.8)	ALDH2 (1.8)	C12orf51 (1.7)
GO:0010740	positive regulation of intracellular protein kinase cascade	0.24	> 0.20	SH2B3 (2.3)	ST3GAL4 (2.3)	PVR (2.1)	POLK (2.0)	PARP10 (1.9)	GEMIN7 (1.8)	GRINA (1.8)	HLX (1.7)	RELB (1.4)	PVRL2 (1.4)
ENSG00000108671	PSMD11 PPI subnetwork	0.24	> 0.20	PSMA5 (5.2)	NAA25 (2.6)	NT5DC1 (2.3)	TRAFD1 (2.3)	TOMM40 (2.1)	DDX56 (1.5)	TOP1 (1.4)	SARS (1.3)	ENSG00000254235 (1.2)	SMARCA4 (1.2)
ENSG00000182195	LDOC1 PPI subnetwork	0.24	> 0.20	UBXN2B (3.3)	ATP13A1 (2.2)	DNAH11 (2.1)	C12orf43 (2.0)	ATXN7L2 (1.9)	QTRT1 (1.8)	CEACAM19 (1.7)	GRINA (1.7)	TMEM57 (1.6)	HAPLN4 (1.6)
MP:0005182	increased circulating estradiol level	0.24	> 0.20	APOC1 (2.8)	ST3GAL4 (2.5)	LPIN3 (2.4)	CETP (2.3)	MARK4 (2.2)	ABCG5 (1.9)	APOE (1.9)	DNAH11 (1.6)	APOA5 (1.5)	ENSG00000228044 (1.5)
GO:0003705	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	0.24	> 0.20	TRIB1 (3.1)	HNF1A (2.9)	HLX (2.7)	KANK2 (2.4)	ALDH2 (2.0)	ST3GAL4 (1.8)	PVR (1.7)	LPIN3 (1.6)	C11orf9 (1.5)	COL4A3BP (1.5)
ENSG00000055208	TAB2 PPI subnetwork	0.24	> 0.20	PARP10 (4.2)	PTPN11 (3.0)	TOMM40 (2.5)	RELB (2.4)	SARS (2.1)	HAVCR1 (2.0)	PSMA5 (1.9)	PLEC (1.9)	FRK (1.7)	DOCK7 (1.6)
ENSG00000178573	MAF PPI subnetwork	0.24	> 0.20	TRIB1 (6.6)	MAFB (2.9)	PLCG1 (2.8)	DNAH11 (2.0)	CELSR2 (1.9)	ATXN2 (1.9)	HLX (1.9)	ABCG8 (1.8)	ATXN7L2 (1.6)	NPC1L1 (1.5)
MP:0008663	increased interleukin-12 secretion	0.24	> 0.20	MAFB (3.8)	GMIP (2.6)	APOC1 (2.5)	APOE (2.5)	ERP29 (2.3)	ADAM1 (2.2)	C12orf43 (2.1)	UBXN2B (1.9)	POLK (1.7)	ATP13A1 (1.6)
GO:0035821	modification of morphology or physiology of other organism	0.24	> 0.20	HP (2.3)	KANK2 (2.1)	ANKRD31 (2.0)	RHD (2.0)	C1orf63 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.7)	LPA (1.6)	DHODH (1.5)	ANGPTL3 (1.5)
GO:0051817	modification of morphology or physiology of other organism involved in symbiotic interaction	0.24	> 0.20	HP (2.3)	KANK2 (2.1)	ANKRD31 (2.0)	RHD (2.0)	C1orf63 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.7)	LPA (1.6)	DHODH (1.5)	ANGPTL3 (1.5)
MP:0000592	short tail	0.24	> 0.20	PLCG1 (2.7)	LDLR (2.3)	CILP2 (2.0)	NYNRIN (1.8)	HMGCR (1.7)	HAPLN4 (1.7)	APOB (1.7)	TMEM50A (1.5)	TMEM57 (1.4)	ABO (1.4)
ENSG00000131876	SNRPA1 PPI subnetwork	0.24	> 0.20	ILF3 (3.8)	SUGP1 (3.4)	C1orf63 (3.3)	DHX38 (3.3)	BUD13 (3.3)	TOP1 (2.8)	SMARCA4 (2.7)	USP1 (2.5)	FEN1 (2.5)	QTRT1 (2.2)
ENSG00000102054	RBBP7 PPI subnetwork	0.24	> 0.20	OASL (4.9)	BUD13 (2.6)	GATAD2A (2.4)	SMARCA4 (2.2)	SUGP1 (2.2)	DHX38 (2.2)	ATP13A1 (2.2)	CARM1 (2.0)	ATXN7L2 (2.0)	C19orf52 (1.9)
GO:0005643	nuclear pore	0.24	> 0.20	NAA25 (3.4)	POC5 (3.0)	DDX56 (2.9)	USP24 (2.9)	USP1 (2.6)	ILF3 (2.4)	CARM1 (2.4)	FEN1 (2.2)	MAPKAPK5 (2.1)	DHX38 (2.1)
ENSG00000179889	PDXDC1 PPI subnetwork	0.24	> 0.20	SORT1 (2.2)	MYLIP (1.9)	TRIB1 (1.9)	GMPR (1.9)	POLK (1.8)	DNM2 (1.6)	BCAM (1.5)	TRAPPC6A (1.5)	C11orf9 (1.5)	TOMM40 (1.5)
MP:0001219	thick epidermis	0.24	> 0.20	CBLC (6.5)	AP1M2 (3.7)	PMFBP1 (2.4)	PLEC (2.1)	CELSR2 (2.0)	NKPD1 (1.9)	CEACAM19 (1.8)	BCAM (1.8)	ZNF101 (1.6)	DNM2 (1.6)
ENSG00000076604	TRAF4 PPI subnetwork	0.24	> 0.20	PVRL2 (3.1)	KANK2 (3.0)	ITGB3 (2.7)	PLCG1 (2.2)	ENSG00000254235 (2.0)	FADS1 (1.9)	CARM1 (1.9)	KIAA1324 (1.5)	GEMIN7 (1.5)	CETP (1.5)
MP:0008114	abnormal Kupffer cell morphology	0.24	> 0.20	PARP10 (2.7)	ACAD10 (2.2)	BCAM (2.1)	CYB561D1 (2.0)	ATP13A1 (1.8)	PCSK9 (1.7)	SLC22A1 (1.7)	RELB (1.7)	HP (1.6)	ERP29 (1.6)
MP:0001125	abnormal oocyte morphology	0.24	> 0.20	FADS1 (3.6)	PCSK9 (2.6)	CELSR2 (2.4)	GMPR (2.1)	LDLR (2.0)	APOA5 (1.8)	RHCE (1.7)	ABCG5 (1.7)	ZHX3 (1.6)	LPIN3 (1.5)
GO:0051130	positive regulation of cellular component organization	0.24	> 0.20	PLEC (2.4)	POLK (2.0)	PVRL2 (1.8)	SH2B3 (1.7)	PBX4 (1.7)	NYNRIN (1.6)	ANKRD31 (1.6)	LPIN3 (1.6)	TMEM50A (1.4)	KANK2 (1.4)
ENSG00000075151	EIF4G3 PPI subnetwork	0.24	> 0.20	NAA25 (4.5)	TOP1 (3.8)	ZNF259 (3.8)	QTRT1 (3.5)	DDX56 (3.3)	TOMM40 (3.0)	CARM1 (2.9)	GATAD2A (2.7)	DHODH (2.6)	ILF3 (2.5)
GO:0004843	ubiquitin-specific protease activity	0.24	> 0.20	ZNF180 (4.0)	USP24 (3.9)	OASL (3.7)	CARM1 (2.6)	TRAFD1 (2.3)	PARP10 (2.1)	NAA25 (1.9)	MAU2 (1.5)	ATXN7L2 (1.5)	TMEM57 (1.4)
ENSG00000131462	TUBG1 PPI subnetwork	0.24	> 0.20	PSRC1 (3.1)	POC5 (2.7)	POLK (2.7)	LPAR2 (2.5)	GATAD2A (2.0)	LDLR (2.0)	ATXN7L2 (2.0)	DNM2 (1.9)	FADS2 (1.8)	C11orf9 (1.8)
GO:0000122	negative regulation of transcription from RNA polymerase II promoter	0.24	> 0.20	MYLIP (2.7)	ATXN7L2 (2.3)	NYNRIN (1.9)	TRIB1 (1.7)	ATXN2 (1.7)	PPP1R37 (1.6)	KANK2 (1.6)	ENSG00000254235 (1.5)	ABO (1.5)	ENSG00000226648 (1.5)
MP:0000069	kyphoscoliosis	0.25	> 0.20	PLEC (3.8)	ST3GAL4 (2.6)	ATP13A1 (2.4)	LDLR (2.2)	ERP29 (2.1)	SYPL2 (2.0)	ABO (1.8)	PVR (1.7)	CLPTM1 (1.7)	C11orf9 (1.5)
GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	0.25	> 0.20	ENSG00000235545 (3.1)	TMED4 (2.4)	AMIGO1 (2.2)	C12orf47 (2.2)	GOT2P1 (2.0)	LPIN3 (1.8)	C17orf57 (1.8)	ZHX3 (1.7)	ENSG00000228044 (1.7)	TM6SF2 (1.6)
ENSG00000139505	MTMR6 PPI subnetwork	0.25	> 0.20	PARP10 (2.8)	MAU2 (2.8)	USP24 (2.8)	ATXN2 (2.5)	SMARCA4 (2.5)	MARK4 (2.5)	BCL3 (2.3)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
MP:0000932	absent notochord	0.25	> 0.20	ATXN7L2 (2.4)	ENSG00000254235 (2.4)	APOE (2.3)	APOC4 (2.2)	ADAM1 (2.1)	PMFBP1 (2.0)	ZNF101 (2.0)	HNF1A (1.9)	BCAM (1.9)	HAVCR1 (1.7)
GO:0035145	exon-exon junction complex	0.25	> 0.20	TXNL4B (4.8)	C1orf63 (2.9)	ILF3 (2.7)	MAU2 (2.5)	CYB561D1 (2.2)	SUGP1 (2.1)	BRAP (2.1)	KIAA1324 (2.0)	USP1 (1.8)	TOP1 (1.6)
MP:0001245	thick dermal layer	0.25	> 0.20	BCL3 (3.4)	TRIB1 (3.1)	HLX (2.8)	CETP (2.5)	CILP2 (2.2)	PVRL2 (2.2)	SH2B3 (2.0)	C11orf9 (1.9)	RELB (1.9)	ZNF101 (1.7)
ENSG00000103507	BCKDK PPI subnetwork	0.25	> 0.20	C19orf52 (3.0)	QTRT1 (2.1)	USP24 (2.1)	SORT1 (2.0)	ZNF180 (1.9)	GRINA (1.9)	BRAP (1.7)	OASL (1.7)	AMIGO1 (1.6)	DOCK7 (1.5)
ENSG00000090382	LYZ PPI subnetwork	0.25	> 0.20	RELB (3.5)	ALDH2 (2.8)	GEMIN7 (2.4)	TM6SF2 (2.2)	CYB561D1 (2.1)	BCAM (2.0)	BCL3 (2.0)	APOE (1.8)	BLOC1S3 (1.7)	CBLC (1.7)
ENSG00000136273	HUS1 PPI subnetwork	0.25	> 0.20	USP1 (4.4)	FEN1 (4.4)	PPP1R37 (2.8)	ZNF180 (2.4)	TXNL4B (2.2)	ERP29 (2.1)	CLPTM1 (2.0)	ANGPTL3 (1.9)	PSMA5 (1.8)	TMED4 (1.7)
MP:0005408	hypopigmentation	0.25	> 0.20	DOCK7 (3.3)	ACAD10 (2.6)	COL4A3BP (2.5)	LPA (2.2)	PLG (2.0)	ENSG00000235545 (1.8)	C12orf47 (1.7)	APOA5 (1.6)	ANGPTL3 (1.6)	PLEKHH2 (1.6)
MP:0008500	increased IgG2a level	0.25	> 0.20	RELB (4.1)	BCL3 (3.0)	CETP (2.9)	GMIP (2.8)	TIMD4 (2.8)	C17orf57 (1.9)	PBX4 (1.5)	MAFB (1.4)	SH2B3 (1.3)	POLK (1.2)
ENSG00000130702	LAMA5 PPI subnetwork	0.25	> 0.20	BCAM (3.3)	GPAM (2.6)	PLEC (2.5)	PVRL2 (2.4)	KANK2 (2.3)	CELSR2 (2.2)	CBLC (1.9)	SLC44A2 (1.7)	ST3GAL4 (1.6)	DOCK7 (1.5)
GO:0071359	cellular response to dsRNA	0.25	> 0.20	OASL (3.0)	ADAM1 (2.6)	MAPKAPK5 (2.5)	PARP10 (2.5)	MYLIP (2.3)	C12orf43 (1.9)	ENSG00000228044 (1.8)	GOT2P1 (1.8)	GCNT4 (1.7)	CYB561D1 (1.6)
MP:0009503	abnormal mammary gland duct morphology	0.25	> 0.20	TRIB1 (2.6)	CELSR2 (2.4)	PLEKHH2 (2.3)	UBXN2B (2.1)	MAFB (2.1)	RELB (1.9)	C17orf57 (1.8)	GOT2P1 (1.8)	NKPD1 (1.4)	PVR (1.4)
ENSG00000123737	EXOSC9 PPI subnetwork	0.25	> 0.20	DDX56 (4.0)	DHODH (3.3)	QTRT1 (3.3)	ZNF259 (3.2)	NAA25 (2.8)	SUGP1 (2.8)	USP24 (2.7)	TOMM40 (2.6)	DHX38 (2.5)	MAPKAPK5 (2.1)
GO:0045765	regulation of angiogenesis	0.25	> 0.20	PVR (2.6)	ENSG00000226648 (2.6)	C17orf57 (2.5)	CEACAM19 (2.4)	ENSG00000235545 (2.3)	CILP2 (2.3)	MAFB (2.1)	TRIB1 (1.6)	PVRL2 (1.5)	SH2B3 (1.4)
MP:0002834	decreased heart weight	0.25	> 0.20	PVR (2.4)	BCL3 (2.2)	BCAM (2.0)	KIAA1324 (1.8)	AMIGO1 (1.7)	PPP1R37 (1.7)	LDLR (1.7)	GRINA (1.4)	HP (1.4)	OASL (1.4)
REACTOME_CHAPERONIN:MEDIATED_PROTEIN_FOLDING	REACTOME_CHAPERONIN:MEDIATED_PROTEIN_FOLDING	0.25	> 0.20	ENSG00000238078 (2.6)	QTRT1 (2.0)	SMARCA4 (2.0)	ZNF259 (1.9)	ZHX3 (1.9)	LPIN3 (1.9)	DDX56 (1.7)	GMPR (1.7)	RHD (1.7)	ITGB3 (1.6)
GO:0022407	regulation of cell-cell adhesion	0.25	> 0.20	ANKRD31 (3.7)	GCNT4 (2.5)	FRK (2.1)	ENSG00000228044 (1.6)	ENSG00000238078 (1.6)	SLC44A2 (1.4)	CYB561D1 (1.4)	PLEKHH2 (1.4)	AP1M2 (1.4)	TMEM50A (1.2)
ENSG00000187514	PTMA PPI subnetwork	0.25	> 0.20	USP1 (2.5)	PSRC1 (2.4)	MYLIP (1.9)	FEN1 (1.7)	TXNL4B (1.7)	BUD13 (1.7)	HLX (1.5)	ABO (1.4)	TMEM50A (1.4)	TRIB1 (1.4)
MP:0000709	enlarged thymus	0.25	> 0.20	PLCG1 (3.0)	ST3GAL4 (2.1)	GOT2P1 (2.0)	HAPLN4 (2.0)	NT5DC1 (1.9)	PBX4 (1.8)	ATXN7L2 (1.6)	LPAR2 (1.6)	GCNT4 (1.5)	MOSC1 (1.5)
GO:0032844	regulation of homeostatic process	0.25	> 0.20	ENSG00000226648 (3.4)	RHCE (2.3)	ENSG00000235545 (2.2)	ABO (2.0)	HAVCR1 (1.9)	RHD (1.7)	PLCG1 (1.7)	MARK4 (1.6)	MYLIP (1.5)	NYNRIN (1.5)
MP:0005517	decreased liver regeneration	0.25	> 0.20	TRIB1 (4.3)	HP (3.0)	MAFB (2.7)	BCL3 (2.4)	APOB (2.4)	APOE (2.4)	C11orf9 (2.3)	APOC1 (2.2)	HNF1A (2.0)	LDLR (1.7)
GO:0071377	cellular response to glucagon stimulus	0.25	> 0.20	ST3GAL4 (2.7)	ITGB3 (2.7)	ENSG00000254235 (2.4)	PMFBP1 (2.3)	TM6SF2 (2.1)	GCNT4 (1.9)	ABCG8 (1.8)	CYP7A1 (1.5)	LPA (1.3)	ABCG5 (1.3)
ENSG00000072849	DERL2 PPI subnetwork	0.25	> 0.20	SARS (2.7)	TMED4 (2.5)	BLOC1S3 (2.1)	BRAP (2.0)	YIPF2 (1.9)	ERP29 (1.8)	TMEM57 (1.6)	APOB (1.5)	GOT2P1 (1.4)	PLEC (1.4)
MP:0008115	abnormal dendritic cell differentiation	0.25	> 0.20	BCL3 (3.3)	HLX (2.2)	GMIP (2.1)	C12orf47 (2.1)	ENSG00000228044 (2.1)	PARP10 (2.0)	NYNRIN (1.8)	TRAFD1 (1.6)	LPA (1.6)	RELB (1.6)
GO:0003281	ventricular septum development	0.25	> 0.20	ENSG00000238078 (3.7)	ATXN7L2 (3.2)	NYNRIN (2.5)	ZNF180 (2.0)	PVRL2 (2.0)	C19orf52 (1.8)	C11orf9 (1.6)	PBX4 (1.6)	BLOC1S3 (1.5)	C17orf57 (1.4)
ENSG00000125691	RPL23 PPI subnetwork	0.25	> 0.20	NAA25 (3.1)	ZNF259 (2.7)	DHX38 (2.2)	QTRT1 (2.2)	TOP1 (2.1)	PTPN11 (2.1)	ATP13A1 (2.1)	DDX56 (1.9)	C12orf43 (1.8)	ADAM1 (1.8)
ENSG00000211614	ENSG00000211614 PPI subnetwork	0.25	> 0.20	TIMD4 (5.5)	MAFB (2.9)	APOE (2.9)	PTPN11 (2.0)	DOCK7 (2.0)	ENSG00000238078 (2.0)	CETP (1.8)	APOC1 (1.7)	NKPD1 (1.6)	GRINA (1.6)
MP:0002573	behavioral despair	0.25	> 0.20	GCNT4 (2.5)	PCSK9 (2.5)	TMEM50A (1.9)	C11orf9 (1.8)	CETP (1.7)	HAPLN4 (1.6)	DNAH11 (1.4)	APOB (1.4)	AMIGO1 (1.4)	RPH3A (1.2)
GO:0070161	anchoring junction	0.25	> 0.20	PLEC (4.2)	BCAM (4.0)	PVRL2 (3.8)	AP1M2 (2.5)	CBLC (2.4)	ITGB3 (2.2)	KANK2 (2.0)	C11orf9 (1.9)	PVR (1.7)	DNM2 (1.7)
ENSG00000204256	BRD2 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
ENSG00000215077	BRD2 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
ENSG00000112526	ENSG00000112526 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
MP:0009814	increased prostaglandin level	0.25	> 0.20	APOC1 (3.8)	TRIB1 (3.1)	ALDH2 (2.7)	GMPR (2.2)	UBXN2B (2.1)	ITGB3 (1.7)	C11orf9 (1.7)	TMEM57 (1.6)	ENSG00000238078 (1.4)	ANGPTL3 (1.4)
ENSG00000044446	PHKA2 PPI subnetwork	0.25	> 0.20	ZNF180 (2.6)	ENSG00000238078 (2.3)	SORT1 (1.8)	NYNRIN (1.6)	MOSC1 (1.6)	TXNL4B (1.5)	ZHX3 (1.5)	MYLIP (1.4)	GMPR (1.4)	KIAA1324 (1.3)
ENSG00000100029	PES1 PPI subnetwork	0.25	> 0.20	NAA25 (5.0)	ZNF259 (4.5)	DDX56 (4.3)	TOMM40 (4.0)	QTRT1 (3.6)	C12orf43 (2.7)	DHODH (2.7)	ATP13A1 (2.6)	TOP1 (2.3)	DHX38 (2.1)
ENSG00000011422	PLAUR PPI subnetwork	0.25	> 0.20	MAFB (3.6)	APOE (2.8)	SLC22A1 (2.3)	PLG (2.2)	SH2B3 (2.2)	FRK (1.9)	LPA (1.9)	ANGPTL3 (1.7)	CEACAM19 (1.5)	RELB (1.5)
MP:0008593	increased circulating interleukin-10 level	0.25	> 0.20	TRIB1 (5.2)	PVR (2.6)	BCL3 (2.6)	POC5 (2.3)	GMIP (2.1)	MAFB (1.8)	ENSG00000228044 (1.8)	OASL (1.8)	TSSK6 (1.5)	PARP10 (1.5)
ENSG00000134602	ENSG00000134602 PPI subnetwork	0.25	> 0.20	ZNF180 (3.6)	C11orf9 (2.2)	PVRL2 (2.2)	PLEKHH2 (2.0)	MARK4 (2.0)	CYB561D1 (1.9)	DNM2 (1.7)	GEMIN7 (1.7)	PVR (1.5)	ATXN7L2 (1.5)
MP:0000371	diluted coat color	0.25	> 0.20	DOCK7 (2.5)	ST3GAL4 (2.3)	GMPR (2.1)	ENSG00000235545 (1.8)	PPP1R37 (1.7)	DNM2 (1.6)	CELSR2 (1.5)	MYLIP (1.4)	ZNF259 (1.4)	GPAM (1.4)
REACTOME_ERKMAPK_TARGETS	REACTOME_ERKMAPK_TARGETS	0.25	> 0.20	SH2B3 (3.6)	MARK4 (3.1)	HLX (2.5)	CLPTM1 (2.1)	COL4A3BP (2.1)	TRIB1 (1.7)	DNM2 (1.7)	ENSG00000226648 (1.6)	TMEM57 (1.6)	ENSG00000226645 (1.6)
GO:0009065	glutamine family amino acid catabolic process	0.25	> 0.20	COL4A3BP (2.5)	ANGPTL3 (2.0)	DYNC2LI1 (1.8)	UBXN2B (1.8)	ENSG00000226648 (1.8)	ZHX3 (1.8)	C17orf57 (1.7)	PCSK9 (1.6)	ACAD10 (1.5)	DHODH (1.5)
GO:0060669	embryonic placenta morphogenesis	0.25	> 0.20	ENSG00000228044 (2.9)	CETP (2.5)	CBLC (2.2)	TIMD4 (2.1)	ENSG00000226645 (2.0)	BCL3 (2.0)	HAVCR1 (1.9)	ZNF101 (1.5)	MYLIP (1.5)	ENSG00000238078 (1.4)
MP:0005591	decreased vasodilation	0.25	> 0.20	HLX (3.0)	APOC1 (2.9)	MYLIP (2.7)	C17orf57 (2.6)	TRIB1 (1.8)	C12orf47 (1.6)	MAFB (1.4)	ST3GAL4 (1.4)	ENSG00000235545 (1.3)	TRAPPC6A (1.3)
REACTOME_SYNTHESIS_OF_DNA	REACTOME_SYNTHESIS_OF_DNA	0.25	> 0.20	FEN1 (5.2)	PSMA5 (4.1)	USP1 (3.6)	NT5DC1 (2.6)	TRAFD1 (2.0)	TOMM40 (1.7)	ZNF180 (1.5)	NAA25 (1.4)	DDX56 (1.3)	PARP10 (1.3)
ENSG00000167996	FTH1 PPI subnetwork	0.25	> 0.20	ALDH2 (2.5)	NCAN (1.8)	ABO (1.8)	ENSG00000226645 (1.8)	FADS2 (1.7)	MARK4 (1.6)	HAPLN4 (1.4)	MAFB (1.3)	TXNL4B (1.3)	TOMM40 (1.3)
ENSG00000160633	SAFB PPI subnetwork	0.25	> 0.20	C1orf63 (5.0)	TOP1 (3.2)	GATAD2A (3.0)	QTRT1 (2.9)	ATXN2 (2.6)	ILF3 (2.6)	ADAM1 (2.0)	ACAD10 (2.0)	AP1M2 (1.9)	BRAP (1.9)
MP:0001179	thick pulmonary interalveolar septum	0.25	> 0.20	MAFB (2.5)	TRIB1 (2.4)	HLX (2.4)	CLPTM1 (1.8)	CETP (1.7)	PPP1R37 (1.6)	PVR (1.6)	GPAM (1.6)	BCAM (1.6)	UBXN2B (1.3)
MP:0010909	pulmonary alveolar hemorrhage	0.25	> 0.20	PVRL2 (2.6)	PVR (2.3)	BCL3 (2.3)	PBX4 (2.2)	ENSG00000238078 (1.9)	CYB561D1 (1.8)	KIAA1324 (1.7)	BCAM (1.6)	AMIGO1 (1.6)	SORT1 (1.5)
MP:0001666	abnormal intestinal absorption	0.25	> 0.20	TM6SF2 (4.8)	NPC1L1 (4.2)	ABCG5 (3.2)	ABCG8 (3.1)	TMED4 (2.9)	CBLC (2.0)	APOB (1.9)	FRK (1.9)	ABO (1.8)	HNF1A (1.7)
MP:0002750	exophthalmos	0.25	> 0.20	KANK2 (3.4)	HAPLN4 (2.0)	COL4A3BP (2.0)	ENSG00000235545 (1.9)	POLK (1.9)	ENSG00000228044 (1.8)	ST3GAL4 (1.7)	CYB561D1 (1.7)	PBX4 (1.6)	DYNC2LI1 (1.5)
ENSG00000138771	SHROOM3 PPI subnetwork	0.25	> 0.20	CBLC (6.9)	AP1M2 (3.9)	LPAR2 (2.8)	ST3GAL4 (2.2)	HNF1A (1.8)	PVRL2 (1.7)	CELSR2 (1.5)	ALDH2 (1.4)	DNM2 (1.3)	DOCK7 (1.3)
GO:0030139	endocytic vesicle	0.25	> 0.20	CLPTM1 (3.5)	C11orf9 (2.4)	PPP1R37 (2.3)	NCAN (1.8)	GRINA (1.8)	APOE (1.7)	NPC1L1 (1.7)	YIPF2 (1.7)	SLC44A2 (1.6)	SARS (1.5)
ENSG00000174197	MGA PPI subnetwork	0.25	> 0.20	ATXN7L2 (2.6)	BUD13 (2.6)	C19orf52 (2.6)	ATXN2 (2.4)	TRAFD1 (2.1)	GATAD2A (2.0)	TMEM57 (1.9)	QTRT1 (1.9)	MARK4 (1.8)	NAA25 (1.7)
GO:0051320	S phase	0.25	> 0.20	PSMA5 (2.6)	NT5DC1 (2.3)	USP1 (2.3)	ENSG00000235545 (2.1)	ZNF180 (2.1)	FEN1 (2.1)	TXNL4B (1.7)	ENSG00000228044 (1.5)	TRAFD1 (1.4)	BRAP (1.4)
MP:0002667	decreased circulating aldosterone level	0.25	> 0.20	ST3GAL4 (4.5)	DNAH11 (3.5)	FADS2 (3.2)	ZHX3 (2.6)	LPIN3 (2.5)	SYPL2 (2.5)	FADS1 (2.2)	APOC1 (1.9)	CYB561D1 (1.7)	GOT2P1 (1.6)
ENSG00000107789	MINPP1 PPI subnetwork	0.25	> 0.20	NYNRIN (2.6)	GRINA (2.3)	HNF1A (2.2)	GEMIN7 (2.2)	ALDH2 (2.1)	NKPD1 (2.0)	RHCE (2.0)	RHD (1.9)	ACAD10 (1.8)	ANKRD31 (1.7)
GO:0008217	regulation of blood pressure	0.25	> 0.20	ABO (3.7)	C12orf47 (2.6)	CEACAM19 (2.2)	KIAA1324 (2.2)	TSSK6 (2.0)	ACAD10 (1.9)	TMED4 (1.7)	NKPD1 (1.5)	COL4A3BP (1.4)	HAVCR1 (1.4)
GO:0042226	interleukin-6 biosynthetic process	0.25	> 0.20	HLX (2.5)	ENSG00000254235 (2.3)	ENSG00000228044 (2.3)	ENSG00000235545 (1.9)	BUD13 (1.8)	ENSG00000226645 (1.8)	HNF1A (1.8)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)	TRIB1 (1.5)
GO:0032432	actin filament bundle	0.25	> 0.20	PVRL2 (3.5)	KANK2 (3.3)	PLEC (3.2)	ITGB3 (2.3)	AP1M2 (2.2)	NPC1L1 (2.2)	CBLC (1.9)	DNM2 (1.9)	PLEKHH2 (1.6)	POLK (1.6)
ENSG00000099139	PCSK5 PPI subnetwork	0.25	> 0.20	C12orf47 (2.0)	OGDH (1.9)	ST3GAL4 (1.9)	ZNF101 (1.9)	MARK4 (1.9)	ADAM1 (1.6)	DDX56 (1.5)	MYLIP (1.5)	HNF1A (1.5)	C12orf43 (1.4)
REACTOME_PROTEIN_FOLDING	REACTOME_PROTEIN_FOLDING	0.25	> 0.20	ENSG00000238078 (2.6)	SMARCA4 (2.0)	SUGP1 (2.0)	QTRT1 (2.0)	LPIN3 (1.9)	C12orf47 (1.9)	ZNF259 (1.8)	TOMM40 (1.6)	ITGB3 (1.6)	ZHX3 (1.5)
ENSG00000128408	RIBC2 PPI subnetwork	0.25	> 0.20	LPAR2 (3.4)	CELSR2 (3.3)	YIPF2 (2.6)	TSSK6 (2.4)	UBXN2B (2.3)	PLCG1 (2.3)	C17orf57 (2.3)	SUGP1 (2.1)	RELB (2.1)	ANKRD31 (2.0)
ENSG00000184185	KCNJ12 PPI subnetwork	0.25	> 0.20	ZHX3 (3.3)	PPP1R37 (2.8)	FRK (2.4)	ALDH2 (2.2)	SYPL2 (2.0)	RPH3A (1.9)	PTPN11 (1.9)	HNF1A (1.7)	COL4A3BP (1.7)	PLCG1 (1.6)
ENSG00000143333	RGS16 PPI subnetwork	0.25	> 0.20	HAVCR1 (3.3)	NCAN (3.1)	MARK4 (2.0)	ZHX3 (1.9)	TMEM50A (1.8)	ITGB3 (1.8)	CLPTM1 (1.8)	PPP1R37 (1.7)	DNM2 (1.7)	CARM1 (1.6)
GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	0.25	> 0.20	KANK2 (2.9)	ENSG00000226645 (2.4)	GCNT4 (2.3)	TMED4 (2.2)	ENSG00000254235 (2.0)	NYNRIN (1.9)	C19orf52 (1.9)	DNM2 (1.6)	GATAD2A (1.5)	SLC44A2 (1.5)
GO:0016538	cyclin-dependent protein kinase regulator activity	0.25	> 0.20	MYLIP (2.6)	FEN1 (2.1)	TMEM57 (2.1)	KANK2 (2.1)	ENSG00000254235 (2.0)	USP1 (1.9)	TMED4 (1.8)	C1orf63 (1.7)	HLX (1.7)	SLC44A2 (1.7)
ENSG00000083750	RRAGB PPI subnetwork	0.25	> 0.20	QTRT1 (2.8)	YIPF2 (2.4)	GEMIN7 (2.4)	PPP1R37 (2.0)	ILF3 (1.9)	C19orf52 (1.8)	ZNF259 (1.5)	COL4A3BP (1.5)	GRINA (1.4)	DHX38 (1.3)
ENSG00000050748	MAPK9 PPI subnetwork	0.25	> 0.20	TRIB1 (5.9)	PVR (3.0)	SH2B3 (2.9)	POLK (2.2)	LDLR (2.1)	MARK4 (2.0)	ATXN2 (2.0)	MAU2 (2.0)	GATAD2A (1.9)	PLCG1 (1.9)
ENSG00000160224	AIRE PPI subnetwork	0.25	> 0.20	ZHX3 (3.4)	MYLIP (2.2)	PMFBP1 (1.9)	GATAD2A (1.9)	C19orf52 (1.8)	C12orf47 (1.6)	ZNF101 (1.6)	PPP1R37 (1.6)	MAFB (1.5)	TMEM57 (1.4)
GO:0071345	cellular response to cytokine stimulus	0.25	> 0.20	OASL (5.9)	PARP10 (5.5)	TRAFD1 (3.9)	CYB561D1 (2.6)	BCL3 (2.4)	RELB (2.0)	GRINA (1.7)	GMIP (1.6)	CEACAM19 (1.5)	ATP13A1 (1.4)
MP:0001931	abnormal oogenesis	0.25	> 0.20	GOT2P1 (2.1)	LPIN3 (1.9)	TMEM116 (1.6)	NPC1L1 (1.5)	HAVCR1 (1.4)	NKPD1 (1.4)	CEACAM19 (1.4)	TIMD4 (1.2)	ENSG00000226645 (1.2)	ANKRD31 (1.1)
MP:0000157	abnormal sternum morphology	0.25	> 0.20	NYNRIN (4.7)	PVRL2 (2.9)	TRIB1 (2.7)	PLEKHH2 (2.2)	PVR (2.2)	C11orf9 (1.6)	LDLR (1.5)	DOCK7 (1.5)	SYPL2 (1.4)	GOT2P1 (1.3)
GO:0032856	activation of Ras GTPase activity	0.25	> 0.20	ENSG00000238078 (2.9)	CEACAM19 (2.8)	AP1M2 (2.7)	CETP (2.7)	PBX4 (2.5)	HNF1A (2.1)	TIMD4 (2.0)	ENSG00000228044 (1.8)	LPIN3 (1.7)	UBXN2B (1.7)
GO:0004004	ATP-dependent RNA helicase activity	0.25	> 0.20	SUGP1 (3.1)	ATP13A1 (2.7)	DHX38 (2.6)	TOP1 (2.6)	NAA25 (2.1)	ZNF259 (2.1)	ILF3 (2.1)	BUD13 (2.1)	SMARCA4 (2.1)	NT5DC1 (1.7)
ENSG00000102225	CDK16 PPI subnetwork	0.25	> 0.20	CARM1 (3.2)	GATAD2A (2.3)	OGDH (2.3)	GRINA (2.1)	GOT2P1 (2.0)	SMARCA4 (1.7)	ENSG00000238078 (1.7)	HNF1A (1.7)	ZNF101 (1.6)	YIPF2 (1.6)
ENSG00000106638	TBL2 PPI subnetwork	0.25	> 0.20	CARM1 (3.6)	ILF3 (3.1)	TRAFD1 (3.1)	BRAP (2.7)	ATP13A1 (2.4)	MAPKAPK5 (2.2)	TOMM40 (2.2)	DDX56 (2.1)	C12orf43 (2.1)	SMARCA4 (2.0)
ENSG00000123612	ACVR1C PPI subnetwork	0.25	> 0.20	SH2B3 (4.2)	PVR (3.2)	KANK2 (2.9)	SLC44A2 (2.6)	BRAP (2.3)	POLK (2.2)	GEMIN7 (2.2)	PTPN11 (2.0)	MYLIP (2.0)	MARK4 (1.9)
GO:0050821	protein stabilization	0.25	> 0.20	ENSG00000238078 (2.3)	ADAM1 (2.2)	ZNF259 (2.1)	POLK (2.1)	NPC1L1 (1.8)	MYLIP (1.7)	ABCG5 (1.6)	DYNC2LI1 (1.6)	BRAP (1.6)	C19orf52 (1.6)
MP:0000267	abnormal heart development	0.25	> 0.20	C11orf9 (3.3)	NYNRIN (2.8)	ATXN2 (2.8)	PVRL2 (2.7)	KANK2 (2.6)	MARK4 (2.5)	SH2B3 (2.4)	BCAM (2.3)	HLX (2.0)	TRIB1 (1.8)
ENSG00000204628	GNB2L1 PPI subnetwork	0.25	> 0.20	NAA25 (4.5)	QTRT1 (4.1)	DDX56 (4.1)	PTPN11 (3.4)	ZNF259 (3.3)	TOP1 (3.3)	C12orf43 (3.1)	DHODH (2.8)	DHX38 (2.6)	GATAD2A (2.6)
MP:0004946	abnormal regulatory T cell physiology	0.25	> 0.20	TIMD4 (2.8)	ZNF101 (2.7)	PLCG1 (2.7)	PBX4 (1.6)	SLC44A2 (1.4)	SLC22A1 (1.4)	CETP (1.3)	TRIB1 (1.2)	MAFB (1.1)	GMIP (1.1)
REACTOME_SYNTHESIS_OF_VERY_LONG:CHAIN_FATTY_ACYL:COAS	REACTOME_SYNTHESIS_OF_VERY_LONG:CHAIN_FATTY_ACYL:COAS	0.25	> 0.20	HMGCR (7.2)	FADS1 (6.9)	FADS2 (6.1)	LDLR (5.4)	PCSK9 (3.8)	GPAM (3.3)	MOSC1 (1.9)	SORT1 (1.9)	NKPD1 (1.9)	SYPL2 (1.8)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	0.25	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION	0.25	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
REACTOME_POST:ELONGATION_PROCESSING_OF_THE_TRANSCRIPT	REACTOME_POST:ELONGATION_PROCESSING_OF_THE_TRANSCRIPT	0.25	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
ENSG00000177455	CD19 PPI subnetwork	0.25	> 0.20	SLC44A2 (3.3)	TIMD4 (3.3)	GMIP (2.9)	APOE (2.6)	CETP (2.1)	C19orf52 (1.9)	ITGB3 (1.8)	TMED4 (1.7)	PTPN11 (1.7)	PMFBP1 (1.7)
MP:0005122	increased circulating thyroid-stimulating hormone level	0.25	> 0.20	C17orf57 (3.5)	ZHX3 (3.1)	PBX4 (2.7)	COL4A3BP (2.3)	MOSC1 (2.2)	CELSR2 (2.0)	BCAM (1.9)	NKPD1 (1.8)	TRIB1 (1.8)	MYLIP (1.7)
ENSG00000095002	MSH2 PPI subnetwork	0.25	> 0.20	FEN1 (4.1)	USP1 (3.4)	ZNF180 (2.8)	BUD13 (2.5)	POC5 (2.1)	POLK (2.1)	SMARCA4 (2.0)	ENSG00000226648 (2.0)	ILF3 (1.8)	ZNF101 (1.8)
GO:0008210	estrogen metabolic process	0.25	> 0.20	ST3GAL4 (3.2)	NKPD1 (2.0)	FRK (1.9)	TM6SF2 (1.8)	CYB561D1 (1.8)	ABCG5 (1.8)	ABCG8 (1.7)	PMFBP1 (1.7)	CBLC (1.7)	TRAPPC6A (1.7)
GO:0008637	apoptotic mitochondrial changes	0.25	> 0.20	ENSG00000226645 (2.4)	TRAPPC6A (2.1)	ENSG00000235545 (1.7)	BRAP (1.6)	C12orf47 (1.6)	BLOC1S3 (1.5)	ERP29 (1.4)	C12orf43 (1.4)	CBLC (1.3)	ST3GAL4 (1.3)
GO:0032757	positive regulation of interleukin-8 production	0.25	> 0.20	ZNF180 (2.6)	FRK (2.0)	PMFBP1 (1.9)	DNAH11 (1.8)	OASL (1.5)	C17orf57 (1.5)	PVR (1.4)	ENSG00000228044 (1.4)	POLK (1.3)	GOT2P1 (1.2)
MP:0000230	abnormal systemic arterial blood pressure	0.25	> 0.20	BCAM (3.2)	ITGB3 (2.8)	CETP (2.3)	ANKRD31 (1.8)	ENSG00000235545 (1.8)	GOT2P1 (1.7)	C17orf57 (1.7)	C12orf47 (1.6)	LDLR (1.6)	POLK (1.4)
ENSG00000142798	HSPG2 PPI subnetwork	0.25	> 0.20	ITGB3 (2.9)	KANK2 (2.8)	CILP2 (2.7)	APOE (2.3)	BCAM (2.1)	SLC44A2 (1.9)	C17orf57 (1.8)	SH2B3 (1.6)	ST3GAL4 (1.6)	PVRL2 (1.3)
GO:0006979	response to oxidative stress	0.25	> 0.20	ALDH2 (3.3)	ACAD10 (3.1)	GOT2P1 (2.2)	LPIN3 (2.0)	RHD (1.9)	PVR (1.6)	RHCE (1.6)	C17orf57 (1.6)	TRAPPC6A (1.5)	LPA (1.4)
MP:0000116	abnormal tooth development	0.25	> 0.20	CILP2 (4.2)	PLEKHH2 (2.9)	MAFB (2.2)	ST3GAL4 (2.1)	BCAM (2.0)	KANK2 (1.8)	GCNT4 (1.8)	NKPD1 (1.7)	MYLIP (1.7)	PPP1R37 (1.6)
ENSG00000143153	ATP1B1 PPI subnetwork	0.25	> 0.20	NPC1L1 (5.3)	TM6SF2 (3.8)	ABCG5 (3.2)	AP1M2 (2.7)	ABCG8 (2.6)	APOB (2.4)	SARS (2.2)	TMEM50A (2.0)	MAFB (1.9)	FRK (1.9)
ENSG00000159346	ADIPOR1 PPI subnetwork	0.25	> 0.20	TIMD4 (3.6)	OASL (2.6)	CETP (2.4)	MOSC1 (2.1)	SYPL2 (2.0)	C1orf63 (1.4)	ATXN7L2 (1.4)	TMEM50A (1.3)	DNAH11 (1.3)	ANKRD31 (1.3)
MP:0005410	abnormal fertilization	0.25	> 0.20	PMFBP1 (3.6)	TSSK6 (3.4)	NKPD1 (2.1)	ENSG00000228044 (2.0)	C12orf47 (1.9)	CEACAM19 (1.9)	PVRL2 (1.9)	CYB561D1 (1.3)	PCSK9 (1.3)	ST3GAL4 (1.1)
ENSG00000133997	MED6 PPI subnetwork	0.25	> 0.20	GEMIN7 (4.0)	BLOC1S3 (2.6)	C12orf51 (2.3)	BUD13 (2.2)	MAPKAPK5 (2.1)	POC5 (2.1)	ATXN7L2 (2.1)	C12orf47 (2.0)	HMGCR (1.8)	FADS2 (1.7)
ENSG00000055732	MCOLN3 PPI subnetwork	0.25	> 0.20	PTPN11 (3.3)	PARP10 (2.9)	FRK (2.7)	ADAM1 (2.2)	ZNF180 (2.0)	HNF1A (1.9)	BRAP (1.8)	C17orf57 (1.8)	C12orf43 (1.8)	ENSG00000254235 (1.8)
GO:0005665	DNA-directed RNA polymerase II, core complex	0.25	> 0.20	GEMIN7 (4.9)	TOMM40 (3.1)	CLPTM1 (2.5)	QTRT1 (2.3)	MARK4 (1.9)	DHX38 (1.7)	PVRL2 (1.5)	UBXN2B (1.5)	SUGP1 (1.5)	TRAPPC6A (1.4)
ENSG00000144021	CIAO1 PPI subnetwork	0.25	> 0.20	DHX38 (3.3)	ATP13A1 (2.7)	OGDH (2.6)	ILF3 (2.1)	DDX56 (1.9)	GMPR (1.8)	SMARCA4 (1.7)	PSMA5 (1.7)	SARS (1.7)	DNM2 (1.6)
GO:0002714	positive regulation of B cell mediated immunity	0.25	> 0.20	ENSG00000235545 (3.3)	GEMIN7 (2.6)	AMIGO1 (2.2)	GOT2P1 (1.9)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HAVCR1 (1.4)	DYNC2LI1 (1.3)	PMFBP1 (1.3)	TRAPPC6A (1.3)
GO:0002891	positive regulation of immunoglobulin mediated immune response	0.25	> 0.20	ENSG00000235545 (3.3)	GEMIN7 (2.6)	AMIGO1 (2.2)	GOT2P1 (1.9)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HAVCR1 (1.4)	DYNC2LI1 (1.3)	PMFBP1 (1.3)	TRAPPC6A (1.3)
ENSG00000106803	SEC61B PPI subnetwork	0.25	> 0.20	NPC1L1 (3.6)	TMEM50A (3.1)	ATP13A1 (3.1)	TMEM57 (2.4)	ERP29 (2.3)	GRINA (2.2)	TMED4 (2.2)	ABCG5 (2.1)	TIMD4 (2.1)	FRK (1.7)
ENSG00000168135	KCNJ4 PPI subnetwork	0.25	> 0.20	PPP1R37 (2.8)	ALDH2 (2.6)	CYB561D1 (2.1)	POLK (2.1)	ENSG00000238078 (2.0)	MAPKAPK5 (1.7)	RPH3A (1.7)	DNAH11 (1.6)	TMEM116 (1.5)	HLX (1.4)
ENSG00000011275	RNF216 PPI subnetwork	0.25	> 0.20	PARP10 (3.9)	OASL (3.8)	GMPR (3.6)	RHCE (2.8)	FRK (2.7)	LPIN3 (2.5)	DYNC2LI1 (2.2)	RHD (2.1)	MYLIP (1.8)	ZNF180 (1.8)
ENSG00000168685	IL7R PPI subnetwork	0.26	> 0.20	BCL3 (3.2)	COL4A3BP (2.4)	C17orf57 (1.7)	CYP7A1 (1.6)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	ZNF101 (1.3)	PVR (1.2)	CETP (1.2)
ENSG00000173418	NAA20 PPI subnetwork	0.26	> 0.20	PVR (3.0)	TRAFD1 (2.5)	PSMA5 (2.5)	TOMM40 (2.2)	POC5 (2.0)	MAPKAPK5 (1.9)	PVRL2 (1.9)	NAA25 (1.7)	HMGCR (1.5)	ADAM1 (1.5)
MP:0005358	abnormal incisor morphology	0.26	> 0.20	MYLIP (2.7)	PLCG1 (2.3)	KANK2 (2.2)	CILP2 (2.0)	PLEC (1.7)	MAFB (1.7)	CELSR2 (1.6)	PLEKHH2 (1.5)	BCAM (1.5)	HNF1A (1.4)
ENSG00000119689	DLST PPI subnetwork	0.26	> 0.20	ZHX3 (2.4)	PLEC (2.4)	GATAD2A (2.2)	ATXN2 (2.2)	ENSG00000238078 (2.1)	USP24 (2.1)	OGDH (2.1)	NAA25 (1.9)	DDX56 (1.8)	SH2B3 (1.7)
ENSG00000114867	EIF4G1 PPI subnetwork	0.26	> 0.20	TOP1 (3.7)	QTRT1 (3.6)	GATAD2A (3.5)	NAA25 (3.5)	ZNF259 (3.2)	DDX56 (3.2)	ILF3 (2.8)	CARM1 (2.6)	TOMM40 (2.4)	DHX38 (2.3)
ENSG00000143344	RGL1 PPI subnetwork	0.26	> 0.20	CYB561D1 (3.1)	ST3GAL4 (2.9)	LPAR2 (2.4)	USP24 (2.2)	MAPKAPK5 (2.1)	SLC44A2 (2.1)	ATXN7L2 (2.0)	CETP (1.7)	PSMA5 (1.6)	SARS (1.5)
MP:0003658	abnormal capillary morphology	0.26	> 0.20	DNAH11 (2.8)	GPAM (1.8)	BCL3 (1.8)	PVR (1.7)	ST3GAL4 (1.6)	SLC44A2 (1.5)	ACAD10 (1.5)	ITGB3 (1.4)	HLX (1.4)	PARP10 (1.3)
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	0.26	> 0.20	TIMD4 (4.1)	RELB (3.5)	MAFB (3.0)	BCL3 (2.6)	CETP (2.5)	OASL (2.3)	ZNF101 (2.1)	ENSG00000228044 (1.4)	GMIP (1.3)	TRAFD1 (1.3)
GO:0045860	positive regulation of protein kinase activity	0.26	> 0.20	ENSG00000228044 (3.7)	AMIGO1 (2.4)	PTPN11 (2.1)	PVR (2.1)	SLC44A2 (2.1)	HLX (2.0)	ST3GAL4 (1.8)	SH2B3 (1.7)	CYB561D1 (1.4)	ENSG00000235545 (1.4)
REACTOME_MUSCLE_CONTRACTION	REACTOME_MUSCLE_CONTRACTION	0.26	> 0.20	SYPL2 (6.1)	GMPR (2.8)	KANK2 (2.7)	ITGB3 (1.5)	PVRL2 (1.5)	SORT1 (1.4)	UBXN2B (1.3)	C17orf57 (1.2)	TMEM50A (1.2)	HNF1A (1.1)
GO:0043235	receptor complex	0.26	> 0.20	SLC44A2 (2.7)	PLCG1 (2.2)	RELB (2.2)	PVR (2.1)	TIMD4 (2.0)	SH2B3 (1.9)	PLEC (1.8)	ZNF101 (1.8)	LDLR (1.7)	GMIP (1.7)
ENSG00000139117	CPNE8 PPI subnetwork	0.26	> 0.20	GPAM (2.8)	ENSG00000228044 (2.5)	FADS2 (2.3)	HMGCR (2.2)	AMIGO1 (2.2)	LDLR (2.2)	C12orf51 (2.1)	MOSC1 (2.1)	HAVCR1 (2.0)	CETP (1.9)
GO:0055007	cardiac muscle cell differentiation	0.26	> 0.20	HNF1A (2.7)	ANKRD31 (2.6)	CEACAM19 (2.2)	SYPL2 (2.1)	NYNRIN (2.0)	C11orf9 (1.9)	GCNT4 (1.9)	ST3GAL4 (1.8)	GMPR (1.6)	ABO (1.5)
GO:0006000	fructose metabolic process	0.26	> 0.20	NPC1L1 (2.8)	PBX4 (2.7)	GOT2P1 (2.4)	TM6SF2 (2.2)	ENSG00000228044 (2.2)	LPA (1.9)	ACAD10 (1.7)	ENSG00000238078 (1.5)	ENSG00000254235 (1.5)	TRAFD1 (1.5)
GO:0048659	smooth muscle cell proliferation	0.26	> 0.20	PVR (2.6)	HLX (2.0)	ENSG00000228044 (1.9)	MAFB (1.8)	TRIB1 (1.7)	ZNF101 (1.7)	ALDH2 (1.6)	PLEKHH2 (1.5)	NYNRIN (1.4)	ENSG00000254235 (1.4)
MP:0010308	decreased tumor latency	0.26	> 0.20	TRIB1 (4.0)	ENSG00000226648 (2.9)	NYNRIN (2.1)	AMIGO1 (2.1)	TOP1 (2.0)	POC5 (1.9)	TRAFD1 (1.9)	ENSG00000228044 (1.8)	PVR (1.8)	PSRC1 (1.7)
MP:0006011	abnormal endolymphatic duct morphology	0.26	> 0.20	MYLIP (3.1)	GCNT4 (2.0)	ENSG00000238078 (1.9)	ENSG00000226645 (1.8)	LPA (1.7)	PPP1R37 (1.7)	TMEM116 (1.6)	CILP2 (1.5)	PVRL2 (1.4)	BCAM (1.4)
GO:0002922	positive regulation of humoral immune response	0.26	> 0.20	ENSG00000235545 (2.9)	ENSG00000228044 (2.7)	TIMD4 (2.5)	DYNC2LI1 (2.3)	HAVCR1 (2.2)	AMIGO1 (2.1)	ZNF101 (1.9)	LPAR2 (1.7)	CEACAM19 (1.6)	SLC44A2 (1.6)
MP:0010551	abnormal coronary vessel morphology	0.26	> 0.20	C11orf9 (3.5)	BCAM (3.1)	ENSG00000238078 (2.4)	NYNRIN (2.3)	CETP (2.0)	TMED4 (1.9)	GMPR (1.8)	TMEM57 (1.7)	APOB (1.7)	HLX (1.6)
GO:0035265	organ growth	0.26	> 0.20	GCNT4 (2.8)	HAPLN4 (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	PLEKHH2 (1.8)	CEACAM19 (1.8)	DNAH11 (1.7)	ENSG00000226648 (1.6)	LPA (1.4)	C19orf52 (1.4)
ENSG00000138642	HERC6 PPI subnetwork	0.26	> 0.20	GOT2P1 (2.7)	BLOC1S3 (2.6)	TMEM57 (2.4)	CLPTM1 (2.1)	AMIGO1 (1.9)	ENSG00000238078 (1.9)	GRINA (1.9)	ERP29 (1.8)	OGDH (1.8)	NKPD1 (1.8)
ENSG00000132341	RAN PPI subnetwork	0.26	> 0.20	NAA25 (3.6)	CARM1 (3.2)	ILF3 (3.1)	DDX56 (3.0)	DOCK7 (2.9)	TOMM40 (2.7)	USP1 (2.6)	USP24 (2.1)	DHX38 (2.1)	POC5 (2.0)
ENSG00000105663	ENSG00000105663 PPI subnetwork	0.26	> 0.20	GMIP (3.2)	MAU2 (2.6)	ZHX3 (2.5)	PARP10 (2.3)	MAFB (2.1)	USP24 (2.0)	DHX38 (1.8)	PLEKHH2 (1.7)	OASL (1.6)	MYLIP (1.6)
GO:0002687	positive regulation of leukocyte migration	0.26	> 0.20	ENSG00000228044 (3.4)	TIMD4 (2.7)	ZNF101 (2.2)	PVR (2.1)	CETP (2.1)	RELB (2.0)	MAFB (1.9)	APOE (1.5)	BCL3 (1.5)	GMIP (1.3)
ENSG00000089693	MLF2 PPI subnetwork	0.26	> 0.20	HAVCR1 (2.5)	PSMA5 (2.2)	OGDH (2.1)	HMGCR (2.1)	GPAM (1.9)	GMPR (1.9)	FADS1 (1.8)	TMEM116 (1.6)	USP24 (1.6)	LDLR (1.6)
GO:0006518	peptide metabolic process	0.26	> 0.20	GOT2P1 (3.4)	KIAA1324 (3.1)	ERP29 (2.7)	TM6SF2 (2.4)	NT5DC1 (2.2)	NPC1L1 (2.1)	ALDH2 (2.0)	TMED4 (2.0)	ABCG8 (1.9)	AMIGO1 (1.9)
GO:0033135	regulation of peptidyl-serine phosphorylation	0.26	> 0.20	C17orf57 (3.1)	ENSG00000238078 (2.1)	DNAH11 (2.1)	ENSG00000228044 (1.8)	MYLIP (1.6)	TMEM57 (1.5)	ST3GAL4 (1.4)	ENSG00000254235 (1.3)	PLEKHH2 (1.3)	GCNT4 (1.1)
MP:0000161	scoliosis	0.26	> 0.20	KANK2 (2.6)	HMGCR (2.2)	TRIB1 (2.0)	HAPLN4 (1.9)	PCSK9 (1.8)	LDLR (1.7)	PLEC (1.7)	ZNF101 (1.7)	KIAA1324 (1.7)	ENSG00000226648 (1.5)
ENSG00000124575	HIST1H1D PPI subnetwork	0.26	> 0.20	SYPL2 (3.5)	GMPR (3.1)	TMEM50A (2.1)	BCAM (2.0)	ACAD10 (1.7)	OGDH (1.7)	PSMA5 (1.6)	C1orf63 (1.5)	KANK2 (1.5)	RHD (1.5)
ENSG00000119392	GLE1 PPI subnetwork	0.26	> 0.20	DDX56 (4.1)	ZNF259 (3.9)	NAA25 (3.5)	DHX38 (2.8)	DHODH (2.7)	QTRT1 (2.6)	PTPN11 (2.4)	ILF3 (2.3)	TOP1 (2.3)	SUGP1 (2.3)
ENSG00000184900	SUMO3 PPI subnetwork	0.26	> 0.20	SMARCA4 (2.5)	ENSG00000238078 (2.4)	CETP (2.2)	PPP1R37 (2.1)	NCAN (1.8)	MAPKAPK5 (1.8)	TRIB1 (1.8)	PLCG1 (1.6)	RHD (1.6)	ADAM1 (1.5)
GO:0007140	male meiosis	0.26	> 0.20	ANKRD31 (3.3)	ENSG00000238078 (3.0)	PBX4 (2.1)	TMEM116 (1.7)	POC5 (1.3)	CILP2 (1.3)	NKPD1 (1.2)	ADAM1 (1.1)	PLEKHH2 (1.1)	MAPKAPK5 (1.1)
ENSG00000187735	TCEA1 PPI subnetwork	0.26	> 0.20	SUGP1 (4.6)	DHX38 (2.7)	DNM2 (2.5)	MAPKAPK5 (2.4)	ZNF259 (2.4)	SMARCA4 (2.2)	TXNL4B (2.2)	MAU2 (2.1)	CLPTM1 (2.1)	BUD13 (2.1)
GO:0035601	protein deacylation	0.26	> 0.20	C1orf63 (2.3)	ATXN7L2 (2.3)	TMEM57 (2.2)	HNF1A (2.2)	C17orf57 (2.0)	UBXN2B (1.7)	MYLIP (1.7)	PLCG1 (1.5)	TXNL4B (1.4)	BUD13 (1.2)
ENSG00000164105	SAP30 PPI subnetwork	0.26	> 0.20	OASL (5.0)	SMARCA4 (3.0)	GATAD2A (2.8)	MAU2 (2.4)	TOP1 (2.4)	SUGP1 (2.3)	BUD13 (2.2)	DNM2 (2.2)	PARP10 (2.1)	ATP13A1 (2.0)
MP:0003077	abnormal cell cycle	0.26	> 0.20	PSRC1 (3.6)	USP1 (3.4)	FEN1 (3.4)	TRIB1 (2.6)	ILF3 (2.2)	ATXN7L2 (2.0)	ADAM1 (1.7)	OASL (1.4)	BCL3 (1.3)	ENSG00000254235 (1.3)
ENSG00000141837	CACNA1A PPI subnetwork	0.26	> 0.20	USP24 (2.4)	MAU2 (2.3)	MARK4 (2.3)	HAPLN4 (2.3)	SMARCA4 (2.2)	GMIP (2.1)	PPP1R37 (2.0)	CARM1 (1.6)	BCL3 (1.6)	POLK (1.5)
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	0.26	> 0.20	GMIP (4.5)	SH2B3 (3.3)	GATAD2A (3.0)	DNM2 (2.9)	ITGB3 (2.3)	DOCK7 (2.3)	PPP1R37 (2.1)	CYB561D1 (1.8)	ZHX3 (1.8)	SMARCA4 (1.7)
MP:0001828	abnormal T cell activation	0.26	> 0.20	RELB (2.6)	GMIP (2.3)	PBX4 (2.1)	PARP10 (2.0)	PLCG1 (2.0)	CETP (1.9)	POLK (1.8)	SH2B3 (1.8)	TIMD4 (1.7)	SLC44A2 (1.6)
GO:0043255	regulation of carbohydrate biosynthetic process	0.26	> 0.20	GPAM (2.8)	ZNF180 (2.7)	ENSG00000254235 (2.3)	ENSG00000238078 (2.0)	MOSC1 (1.9)	GCNT4 (1.7)	CYP7A1 (1.7)	ENSG00000226645 (1.7)	GMPR (1.6)	LPA (1.5)
ENSG00000112576	CCND3 PPI subnetwork	0.26	> 0.20	TRIB1 (2.6)	NYNRIN (2.6)	MAU2 (2.4)	GRINA (2.0)	MYLIP (1.7)	BLOC1S3 (1.7)	PPP1R37 (1.7)	KANK2 (1.6)	TRAPPC6A (1.6)	TMED4 (1.6)
GO:0008146	sulfotransferase activity	0.26	> 0.20	ABCG5 (3.1)	SH2B3 (2.2)	ST3GAL4 (2.1)	ABCG8 (2.1)	APOB (2.1)	MARK4 (2.0)	NPC1L1 (2.0)	GCNT4 (1.9)	TM6SF2 (1.7)	APOE (1.6)
ENSG00000028528	SNX1 PPI subnetwork	0.26	> 0.20	HAVCR1 (3.0)	ENSG00000235545 (2.3)	SARS (2.3)	ABO (1.8)	DHODH (1.8)	POC5 (1.7)	TMEM50A (1.7)	DOCK7 (1.7)	COL4A3BP (1.6)	TOP1 (1.6)
ENSG00000104824	HNRNPL PPI subnetwork	0.26	> 0.20	ILF3 (4.2)	C1orf63 (3.7)	QTRT1 (2.8)	SMARCA4 (2.8)	TOP1 (2.7)	DHX38 (2.6)	BUD13 (2.2)	ATP13A1 (2.1)	MAU2 (2.1)	USP1 (2.1)
ENSG00000175505	CLCF1 PPI subnetwork	0.26	> 0.20	BCL3 (3.9)	HLX (3.0)	RELB (2.6)	TIMD4 (2.5)	CETP (2.0)	ALDH2 (2.0)	GMIP (1.9)	PVR (1.5)	LPA (1.4)	SH2B3 (1.4)
ENSG00000120802	TMPO PPI subnetwork	0.26	> 0.20	NAA25 (2.8)	ILF3 (2.6)	TOMM40 (2.2)	TOP1 (2.1)	SMARCA4 (2.0)	DHX38 (2.0)	DDX56 (2.0)	C19orf52 (1.7)	USP1 (1.7)	PBX4 (1.6)
ENSG00000167978	SRRM2 PPI subnetwork	0.26	> 0.20	GATAD2A (3.2)	C1orf63 (3.1)	TOP1 (2.8)	SMARCA4 (2.3)	DOCK7 (2.1)	CARM1 (2.0)	LPAR2 (1.9)	FRK (1.8)	ILF3 (1.8)	USP1 (1.7)
MP:0000554	abnormal carpal bone morphology	0.26	> 0.20	PLEKHH2 (3.6)	NYNRIN (2.7)	DNAH11 (2.6)	DYNC2LI1 (2.6)	KANK2 (2.3)	PLCG1 (2.0)	MYLIP (1.9)	GCNT4 (1.4)	CILP2 (1.4)	ATXN7L2 (1.3)
MP:0002442	abnormal leukocyte physiology	0.26	> 0.20	GMIP (4.1)	HLX (3.0)	BCL3 (2.2)	SH2B3 (2.1)	HAVCR1 (2.0)	LPA (2.0)	PARP10 (2.0)	MYLIP (1.8)	RELB (1.7)	CYB561D1 (1.6)
GO:0002889	regulation of immunoglobulin mediated immune response	0.26	> 0.20	HAVCR1 (2.0)	ENSG00000235545 (2.0)	GEMIN7 (1.3)	AMIGO1 (1.2)	ENSG00000228044 (1.2)	LPAR2 (1.2)	DNAH11 (1.2)	GCNT4 (1.1)	GMIP (1.1)	SLC22A1 (1.1)
ENSG00000113594	LIFR PPI subnetwork	0.26	> 0.20	BCL3 (2.8)	COL4A3BP (2.1)	PVR (1.8)	C17orf57 (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.4)	HLX (1.3)	RELB (1.3)	BCAM (1.2)
GO:0034374	low-density lipoprotein particle remodeling	0.26	> 0.20	APOC1 (4.2)	TIMD4 (3.7)	HAVCR1 (2.5)	CETP (2.3)	APOE (2.3)	APOB (2.1)	ANGPTL3 (2.1)	APOC4 (2.1)	ENSG00000228044 (2.1)	APOA5 (2.1)
GO:0071565	nBAF complex	0.26	> 0.20	CARM1 (5.1)	NYNRIN (3.7)	NCAN (3.4)	C12orf51 (3.0)	GRINA (2.7)	MARK4 (2.7)	SMARCA4 (2.6)	MAU2 (2.2)	ATXN2 (2.1)	TMEM57 (2.0)
GO:0050777	negative regulation of immune response	0.26	> 0.20	ADAM1 (2.2)	CYB561D1 (2.0)	GMIP (1.8)	ENSG00000235545 (1.7)	OASL (1.6)	PARP10 (1.5)	HAVCR1 (1.5)	PBX4 (1.2)	ABO (1.2)	HNF1A (1.2)
ENSG00000133265	HSPBP1 PPI subnetwork	0.26	> 0.20	PARP10 (3.3)	PVR (2.0)	FRK (2.0)	PPP1R37 (1.9)	TRIB1 (1.8)	BRAP (1.7)	CELSR2 (1.6)	C1orf63 (1.5)	POLK (1.2)	OGDH (1.2)
ENSG00000140829	DHX38 PPI subnetwork	0.26	> 0.20	C1orf63 (4.0)	ILF3 (3.9)	TOP1 (3.3)	DHX38 (3.2)	USP1 (2.7)	SMARCA4 (2.6)	BUD13 (2.5)	QTRT1 (2.5)	SUGP1 (2.2)	ATP13A1 (2.1)
MP:0002032	sarcoma	0.26	> 0.20	PLEKHH2 (2.1)	FEN1 (2.0)	POC5 (2.0)	KANK2 (1.9)	SLC44A2 (1.9)	POLK (1.8)	PSRC1 (1.7)	ZHX3 (1.7)	ADAM1 (1.6)	USP1 (1.6)
ENSG00000170515	PA2G4 PPI subnetwork	0.26	> 0.20	MYLIP (3.3)	BRAP (2.7)	APOC1 (2.6)	TRAPPC6A (2.2)	C1orf63 (2.0)	ADAM1 (2.0)	C12orf43 (1.9)	ZHX3 (1.8)	FEN1 (1.6)	POC5 (1.4)
MP:0001541	abnormal osteoclast physiology	0.26	> 0.20	ITGB3 (2.7)	MAFB (2.7)	CILP2 (2.5)	MYLIP (2.2)	TRIB1 (2.1)	C17orf57 (1.9)	APOE (1.8)	GMIP (1.8)	SH2B3 (1.6)	BCL3 (1.5)
ENSG00000110324	IL10RA PPI subnetwork	0.26	> 0.20	BCL3 (3.4)	COL4A3BP (2.1)	C17orf57 (1.8)	PVR (1.6)	RELB (1.5)	ZNF101 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.4)	HLX (1.3)	BCAM (1.3)
ENSG00000177105	RHOG PPI subnetwork	0.26	> 0.20	OGDH (1.9)	MARK4 (1.9)	CLPTM1 (1.8)	GOT2P1 (1.8)	BCL3 (1.8)	DNM2 (1.8)	POC5 (1.6)	GATAD2A (1.5)	PVRL2 (1.4)	C11orf9 (1.3)
GO:0002218	activation of innate immune response	0.26	> 0.20	SH2B3 (2.9)	CYB561D1 (2.6)	GMIP (2.2)	RELB (2.2)	PARP10 (2.0)	MAFB (2.0)	HLX (1.9)	MYLIP (1.8)	TRIB1 (1.8)	BCL3 (1.8)
GO:0031301	integral to organelle membrane	0.26	> 0.20	CLPTM1 (4.1)	TMED4 (3.3)	YIPF2 (3.3)	ATP13A1 (3.2)	GRINA (3.0)	ERP29 (2.7)	CYB561D1 (2.2)	TMEM50A (2.2)	AMIGO1 (2.2)	TMEM57 (1.8)
MP:0000786	abnormal embryonic neuroepithelial layer differentiation	0.26	> 0.20	ABCG8 (2.3)	C11orf9 (1.8)	ACAD10 (1.7)	HNF1A (1.7)	LPIN3 (1.5)	CYB561D1 (1.4)	GOT2P1 (1.4)	POLK (1.4)	YIPF2 (1.3)	MOSC1 (1.3)
MP:0001382	abnormal nursing	0.26	> 0.20	APOC1 (3.9)	CELSR2 (2.9)	TRIB1 (2.6)	NCAN (2.3)	NPC1L1 (1.7)	DOCK7 (1.5)	MYLIP (1.5)	CBLC (1.5)	NYNRIN (1.4)	PSRC1 (1.3)
GO:0050663	cytokine secretion	0.26	> 0.20	HAVCR1 (2.6)	DNAH11 (2.1)	ZNF101 (1.8)	C17orf57 (1.5)	ENSG00000238078 (1.5)	GOT2P1 (1.4)	APOE (1.3)	HLX (1.3)	ENSG00000228044 (1.2)	CYB561D1 (1.2)
MP:0008688	decreased interleukin-2 secretion	0.26	> 0.20	RELB (3.3)	GMIP (2.4)	CETP (2.4)	SH2B3 (1.9)	BCL3 (1.9)	TIMD4 (1.5)	HAVCR1 (1.5)	ZNF101 (1.3)	PBX4 (1.3)	PARP10 (1.2)
ENSG00000147010	SH3KBP1 PPI subnetwork	0.26	> 0.20	ATXN2 (3.9)	DNM2 (3.9)	SH2B3 (3.0)	USP24 (2.7)	CARM1 (2.7)	C17orf57 (2.6)	PPP1R37 (2.4)	MARK4 (2.3)	SMARCA4 (2.2)	GMIP (2.1)
ENSG00000001167	NFYA PPI subnetwork	0.26	> 0.20	PPP1R37 (2.9)	TRIB1 (2.5)	AMIGO1 (2.5)	USP1 (2.3)	ADAM1 (2.2)	PVR (2.2)	PTPN11 (2.0)	HNF1A (1.8)	PSRC1 (1.7)	BLOC1S3 (1.7)
MP:0008539	decreased susceptibility to induced colitis	0.26	> 0.20	RELB (4.2)	BCL3 (3.9)	TRAFD1 (2.6)	ST3GAL4 (2.4)	TRIB1 (2.0)	KIAA1324 (2.0)	PVR (1.7)	PBX4 (1.5)	GRINA (1.5)	LDLR (1.3)
MP:0002679	abnormal corpus luteum morphology	0.26	> 0.20	APOC1 (3.0)	NYNRIN (2.9)	MOSC1 (2.6)	KIAA1324 (2.1)	MYLIP (2.0)	ALDH2 (1.9)	BCAM (1.8)	AP1M2 (1.8)	PLEKHH2 (1.7)	APOE (1.7)
ENSG00000111679	PTPN6 PPI subnetwork	0.26	> 0.20	GMIP (3.8)	CETP (2.4)	HLX (2.4)	BCL3 (2.3)	TIMD4 (2.1)	RELB (2.1)	SH2B3 (1.9)	ZNF101 (1.5)	MAFB (1.5)	CYB561D1 (1.5)
MP:0009293	decreased inguinal fat pad weight	0.26	> 0.20	GPAM (5.0)	MOSC1 (4.5)	HP (2.4)	SYPL2 (2.1)	ALDH2 (2.0)	GEMIN7 (1.9)	APOC1 (1.7)	TRAFD1 (1.7)	SORT1 (1.6)	KIAA1324 (1.5)
ENSG00000006468	ETV1 PPI subnetwork	0.26	> 0.20	GMIP (3.4)	OGDH (2.6)	YIPF2 (2.6)	DNM2 (2.5)	TOP1 (2.5)	GRINA (2.4)	BCL3 (2.3)	ZHX3 (2.1)	C1orf63 (1.9)	SH2B3 (1.9)
MP:0004247	small pancreas	0.26	> 0.20	DYNC2LI1 (3.9)	C11orf9 (2.3)	PLEKHH2 (2.2)	SLC22A1 (1.9)	CEACAM19 (1.8)	ANKRD31 (1.6)	CYP7A1 (1.6)	ENSG00000235545 (1.6)	KIAA1324 (1.5)	DHODH (1.2)
MP:0003324	increased liver adenoma incidence	0.26	> 0.20	TMEM57 (2.9)	ZNF180 (2.7)	MYLIP (2.2)	ANGPTL3 (2.1)	CYP7A1 (2.1)	AMIGO1 (1.9)	PARP10 (1.8)	NT5DC1 (1.7)	BRAP (1.5)	TSSK6 (1.4)
ENSG00000101161	PRPF6 PPI subnetwork	0.26	> 0.20	DHX38 (3.8)	ILF3 (3.6)	TOP1 (3.2)	SUGP1 (3.1)	SMARCA4 (2.7)	C1orf63 (2.5)	FEN1 (2.5)	MAU2 (2.4)	QTRT1 (2.4)	USP1 (2.4)
GO:0017134	fibroblast growth factor binding	0.26	> 0.20	PLEKHH2 (3.9)	PCSK9 (3.5)	CELSR2 (2.5)	NCAN (2.2)	LDLR (2.0)	SLC44A2 (1.9)	BCAM (1.8)	FADS1 (1.8)	GPAM (1.8)	ZNF101 (1.7)
ENSG00000186193	C9orf140 PPI subnetwork	0.26	> 0.20	MYLIP (3.2)	GCNT4 (2.4)	PLCG1 (2.1)	OGDH (1.8)	GEMIN7 (1.7)	ACAD10 (1.7)	GOT2P1 (1.5)	FRK (1.5)	MAPKAPK5 (1.4)	DNAH11 (1.2)
ENSG00000077238	IL4R PPI subnetwork	0.26	> 0.20	BCL3 (3.1)	COL4A3BP (2.0)	RELB (1.9)	CYP7A1 (1.8)	C17orf57 (1.6)	SLC22A1 (1.5)	PVR (1.5)	HLX (1.5)	BCAM (1.3)	CETP (1.2)
ENSG00000157933	SKI PPI subnetwork	0.26	> 0.20	TRIB1 (3.1)	NYNRIN (2.6)	KANK2 (2.5)	ZHX3 (2.4)	DOCK7 (2.4)	PLEC (2.1)	ATXN2 (1.9)	TMEM57 (1.7)	GCNT4 (1.6)	ENSG00000235545 (1.4)
ENSG00000125630	POLR1B PPI subnetwork	0.26	> 0.20	ZNF259 (3.8)	DDX56 (3.7)	NAA25 (3.1)	C12orf43 (3.1)	QTRT1 (3.0)	BUD13 (2.6)	MAPKAPK5 (2.3)	PSMA5 (2.2)	TOMM40 (2.2)	SUGP1 (2.2)
MP:0002038	carcinoma	0.26	> 0.20	SARS (2.3)	LPIN3 (2.2)	AP1M2 (2.2)	POLK (1.8)	ATXN7L2 (1.7)	PLEKHH2 (1.7)	C17orf57 (1.7)	PSRC1 (1.6)	KANK2 (1.6)	GMIP (1.6)
GO:0030166	proteoglycan biosynthetic process	0.26	> 0.20	GCNT4 (4.4)	CILP2 (4.4)	ST3GAL4 (3.0)	ANKRD31 (2.6)	ENSG00000226645 (2.1)	GEMIN7 (2.1)	C12orf47 (1.9)	ZHX3 (1.7)	ENSG00000235545 (1.7)	ENSG00000254235 (1.6)
MP:0008474	absent spleen germinal center	0.26	> 0.20	RELB (8.1)	BCL3 (4.1)	GRINA (4.0)	GMIP (3.0)	PARP10 (2.8)	HAVCR1 (2.1)	PLEC (2.0)	TRAFD1 (2.0)	PBX4 (1.6)	LPAR2 (1.6)
MP:0005028	abnormal trophectoderm morphology	0.26	> 0.20	BUD13 (2.8)	MAPKAPK5 (2.3)	ENSG00000226645 (2.3)	USP1 (2.3)	COL4A3BP (2.3)	BLOC1S3 (2.1)	DHX38 (1.9)	HNF1A (1.9)	ALDH2 (1.7)	ENSG00000228044 (1.7)
GO:0050829	defense response to Gram-negative bacterium	0.26	> 0.20	PVR (2.8)	DNAH11 (2.8)	PBX4 (2.1)	HP (2.0)	SLC22A1 (1.8)	FRK (1.7)	TXNL4B (1.6)	UBXN2B (1.5)	RHCE (1.4)	RHD (1.3)
ENSG00000159113	ENSG00000159113 PPI subnetwork	0.26	> 0.20	BCL3 (3.1)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	ZNF101 (1.5)	RELB (1.4)	HLX (1.4)	PVR (1.4)	SLC22A1 (1.4)	BCAM (1.2)
GO:0043331	response to dsRNA	0.26	> 0.20	OASL (3.2)	PARP10 (3.1)	MYLIP (2.7)	ADAM1 (2.4)	MAPKAPK5 (2.2)	TRAFD1 (2.0)	ENSG00000228044 (1.8)	C12orf43 (1.7)	ENSG00000226648 (1.7)	GOT2P1 (1.6)
MP:0003156	abnormal leukocyte migration	0.26	> 0.20	SH2B3 (3.4)	GMIP (3.0)	HLX (2.8)	TIMD4 (2.4)	ITGB3 (2.2)	CETP (1.8)	RELB (1.8)	BCL3 (1.6)	SLC44A2 (1.6)	OGDH (1.5)
GO:0001819	positive regulation of cytokine production	0.26	> 0.20	OASL (2.4)	SH2B3 (2.3)	ZNF101 (2.2)	ST3GAL4 (2.0)	PARP10 (1.9)	POLK (1.8)	RELB (1.7)	COL4A3BP (1.6)	CYB561D1 (1.5)	BCL3 (1.4)
ENSG00000106366	SERPINE1 PPI subnetwork	0.26	> 0.20	ANGPTL3 (3.5)	HP (3.1)	PVR (3.1)	CEACAM19 (2.9)	PVRL2 (2.8)	APOC4 (2.5)	PLG (2.4)	SLC22A1 (2.4)	LPIN3 (2.3)	APOA5 (2.0)
MP:0000652	enlarged sebaceous gland	0.26	> 0.20	NKPD1 (2.6)	APOC1 (2.2)	AMIGO1 (2.2)	BLOC1S3 (2.2)	CELSR2 (2.0)	APOE (1.9)	ENSG00000235545 (1.9)	SYPL2 (1.7)	CYB561D1 (1.7)	BCAM (1.6)
MP:0002136	abnormal kidney physiology	0.26	> 0.20	PLG (3.2)	ANGPTL3 (3.1)	SLC22A1 (2.0)	UBXN2B (2.0)	GRINA (1.9)	BCAM (1.8)	TMEM116 (1.7)	MAFB (1.7)	TM6SF2 (1.5)	CEACAM19 (1.5)
ENSG00000020426	MNAT1 PPI subnetwork	0.26	> 0.20	BUD13 (3.3)	SUGP1 (2.8)	ZNF259 (2.5)	POC5 (2.2)	TXNL4B (2.1)	FEN1 (2.0)	POLK (1.9)	PSMA5 (1.8)	ILF3 (1.7)	DHX38 (1.7)
ENSG00000118495	PLAGL1 PPI subnetwork	0.26	> 0.20	CYP7A1 (3.0)	UBXN2B (2.9)	KIAA1324 (2.7)	MYLIP (2.2)	LPA (2.1)	MOSC1 (2.0)	ATXN2 (1.8)	TRIB1 (1.8)	BCL3 (1.7)	GPAM (1.7)
ENSG00000113282	CLINT1 PPI subnetwork	0.26	> 0.20	AP1M2 (3.9)	KIAA1324 (3.2)	ST3GAL4 (2.6)	DOCK7 (2.0)	ERP29 (2.0)	CETP (2.0)	PLCG1 (2.0)	C1orf63 (1.9)	DNM2 (1.8)	CLPTM1 (1.8)
ENSG00000164330	EBF1 PPI subnetwork	0.26	> 0.20	PLCG1 (2.4)	GMIP (2.3)	PBX4 (2.0)	USP24 (2.0)	LPAR2 (1.9)	MAU2 (1.9)	NYNRIN (1.9)	DHX38 (1.8)	ALDH2 (1.7)	SMARCA4 (1.7)
ENSG00000213949	ITGA1 PPI subnetwork	0.26	> 0.20	PVR (3.0)	C17orf57 (2.7)	OGDH (2.6)	ITGB3 (1.9)	ST3GAL4 (1.9)	APOE (1.9)	ATP13A1 (1.8)	PLEKHH2 (1.8)	FADS1 (1.7)	SYPL2 (1.7)
MP:0000377	abnormal hair follicle morphology	0.26	> 0.20	CELSR2 (2.6)	BCAM (2.4)	CBLC (2.2)	AP1M2 (1.9)	MAFB (1.8)	CYB561D1 (1.8)	NYNRIN (1.7)	LPIN3 (1.7)	PLEC (1.6)	APOC1 (1.6)
GO:0016835	carbon-oxygen lyase activity	0.26	> 0.20	RHD (4.6)	RHCE (3.5)	DHODH (3.3)	MOSC1 (3.2)	ACAD10 (3.1)	ALDH2 (2.7)	GPAM (2.7)	NT5DC1 (2.4)	ENSG00000235545 (2.1)	DOCK7 (2.0)
ENSG00000145623	OSMR PPI subnetwork	0.26	> 0.20	BCL3 (3.1)	COL4A3BP (2.2)	C17orf57 (1.7)	PVR (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	BCAM (1.3)
ENSG00000137070	IL11RA PPI subnetwork	0.26	> 0.20	BCL3 (3.1)	COL4A3BP (2.2)	C17orf57 (1.7)	PVR (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	BCAM (1.3)
ENSG00000136485	DCAF7 PPI subnetwork	0.26	> 0.20	CARM1 (3.6)	BRAP (2.6)	LPAR2 (2.5)	COL4A3BP (2.3)	MARK4 (2.3)	GATAD2A (2.1)	TRIB1 (2.1)	PLEC (1.9)	AP1M2 (1.9)	CBLC (1.8)
ENSG00000176095	IP6K1 PPI subnetwork	0.26	> 0.20	ABO (3.2)	TSSK6 (2.7)	GOT2P1 (2.7)	GRINA (2.0)	DYNC2LI1 (1.7)	CARM1 (1.6)	NKPD1 (1.6)	MYLIP (1.4)	DHODH (1.3)	SYPL2 (1.3)
MP:0000172	abnormal bone marrow cell number	0.27	> 0.20	RHCE (6.4)	RHD (5.3)	KIAA1324 (2.1)	GRINA (1.7)	BCAM (1.6)	ENSG00000226645 (1.5)	ABO (1.4)	NYNRIN (1.4)	YIPF2 (1.3)	GMPR (1.3)
ENSG00000120500	ARR3 PPI subnetwork	0.27	> 0.20	LPA (2.9)	MARK4 (2.5)	SH2B3 (2.0)	FADS2 (2.0)	ENSG00000228044 (1.8)	COL4A3BP (1.8)	PPP1R37 (1.8)	CARM1 (1.7)	OGDH (1.5)	GOT2P1 (1.3)
MP:0005277	abnormal brainstem morphology	0.27	> 0.20	HAPLN4 (2.9)	ATP13A1 (2.7)	RPH3A (2.5)	CYP7A1 (2.5)	ENSG00000235545 (2.2)	CELSR2 (1.9)	GRINA (1.7)	AMIGO1 (1.6)	C1orf63 (1.5)	CEACAM19 (1.5)
GO:0051569	regulation of histone H3-K4 methylation	0.27	> 0.20	ZNF180 (2.8)	C1orf63 (2.0)	ANKRD31 (2.0)	USP24 (2.0)	ITGB3 (1.9)	C12orf51 (1.7)	ENSG00000254235 (1.7)	HNF1A (1.5)	RHD (1.4)	CILP2 (1.4)
ENSG00000142864	SERBP1 PPI subnetwork	0.27	> 0.20	C1orf63 (2.9)	ST3GAL4 (2.4)	UBXN2B (2.2)	SUGP1 (2.0)	TMEM57 (2.0)	PBX4 (1.9)	ZNF180 (1.7)	MYLIP (1.4)	BUD13 (1.4)	HMGCR (1.4)
ENSG00000107371	EXOSC3 PPI subnetwork	0.27	> 0.20	DDX56 (4.5)	SUGP1 (3.6)	DHODH (3.6)	NAA25 (3.3)	C12orf43 (3.1)	ZNF259 (2.8)	USP24 (2.8)	DHX38 (2.6)	QTRT1 (2.5)	BRAP (2.4)
MP:0003643	spleen atrophy	0.27	> 0.20	RELB (5.6)	HNF1A (3.4)	ENSG00000226645 (2.9)	PBX4 (2.6)	BCL3 (2.4)	C12orf47 (2.1)	PARP10 (1.6)	TOMM40 (1.5)	AMIGO1 (1.5)	GEMIN7 (1.4)
MP:0005029	abnormal amnion morphology	0.27	> 0.20	C17orf57 (2.7)	HLX (2.3)	GEMIN7 (2.3)	TRAPPC6A (2.0)	KANK2 (2.0)	PTPN11 (1.8)	PSRC1 (1.7)	UBXN2B (1.6)	HNF1A (1.6)	POLK (1.5)
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	0.27	> 0.20	TMED4 (3.3)	ERP29 (2.9)	ST3GAL4 (2.5)	GRINA (1.9)	ITGB3 (1.9)	YIPF2 (1.8)	SH2B3 (1.8)	RHCE (1.6)	ENSG00000254235 (1.6)	COL4A3BP (1.6)
MP:0001246	mixed cellular infiltration to dermis	0.27	> 0.20	DNM2 (3.2)	GMIP (3.1)	RHCE (2.4)	RHD (2.3)	TM6SF2 (2.3)	ILF3 (2.2)	YIPF2 (2.1)	CBLC (2.1)	PARP10 (2.0)	LPAR2 (2.0)
ENSG00000179950	PUF60 PPI subnetwork	0.27	> 0.20	CARM1 (2.9)	DDX56 (2.5)	TOP1 (2.2)	PTPN11 (2.1)	DOCK7 (2.0)	ILF3 (2.0)	SMARCA4 (2.0)	TOMM40 (2.0)	NAA25 (1.9)	PPP1R37 (1.9)
ENSG00000139514	SLC7A1 PPI subnetwork	0.27	> 0.20	USP24 (2.7)	DNM2 (2.7)	GMIP (2.4)	ALDH2 (2.3)	COL4A3BP (2.1)	PLEC (1.8)	SORT1 (1.8)	TMEM50A (1.7)	POLK (1.6)	LDLR (1.5)
MP:0000783	abnormal forebrain morphology	0.27	> 0.20	NYNRIN (2.1)	PLCG1 (2.1)	GATAD2A (1.9)	NCAN (1.8)	DHX38 (1.8)	DOCK7 (1.6)	PBX4 (1.5)	DHODH (1.5)	TMEM57 (1.4)	CILP2 (1.3)
KEGG_NON_SMALL_CELL_LUNG_CANCER	KEGG_NON_SMALL_CELL_LUNG_CANCER	0.27	> 0.20	DNM2 (2.9)	SLC44A2 (2.3)	MAU2 (2.2)	SORT1 (2.2)	TRAPPC6A (2.1)	GMIP (2.1)	ZHX3 (2.1)	GATAD2A (2.1)	PPP1R37 (2.0)	PTPN11 (1.9)
ENSG00000096746	HNRNPH3 PPI subnetwork	0.27	> 0.20	LDLR (3.1)	ABO (2.6)	HMGCR (2.3)	FADS2 (2.2)	CARM1 (2.2)	PCSK9 (2.1)	FADS1 (2.1)	CYB561D1 (2.0)	ITGB3 (1.8)	ANGPTL3 (1.8)
GO:0044236	multicellular organismal metabolic process	0.27	> 0.20	FRK (3.3)	CEACAM19 (3.0)	ENSG00000228044 (2.4)	NPC1L1 (1.9)	ENSG00000226645 (1.8)	PLEKHH2 (1.7)	C11orf9 (1.6)	MAFB (1.3)	ENSG00000238078 (1.2)	PVRL2 (1.2)
GO:0019199	transmembrane receptor protein kinase activity	0.27	> 0.20	PVRL2 (3.6)	NYNRIN (2.7)	PLEKHH2 (2.6)	MYLIP (2.2)	BCAM (2.2)	LPAR2 (2.2)	SLC44A2 (2.1)	MAFB (1.7)	PLCG1 (1.7)	CLPTM1 (1.6)
ENSG00000115008	IL1A PPI subnetwork	0.27	> 0.20	BCL3 (3.4)	RELB (2.8)	ST3GAL4 (2.8)	CBLC (2.4)	NYNRIN (1.8)	ENSG00000254235 (1.5)	ANKRD31 (1.5)	CYB561D1 (1.5)	GRINA (1.4)	HP (1.3)
ENSG00000111775	COX6A1 PPI subnetwork	0.27	> 0.20	TRAPPC6A (3.1)	TOMM40 (2.7)	GOT2P1 (2.5)	ATP13A1 (2.3)	CEACAM19 (2.0)	MAU2 (1.9)	ZNF180 (1.9)	HNF1A (1.8)	FRK (1.8)	ACAD10 (1.6)
GO:0016558	protein import into peroxisome matrix	0.27	> 0.20	C19orf52 (3.5)	YIPF2 (2.9)	NT5DC1 (2.6)	BLOC1S3 (2.1)	BRAP (2.1)	QTRT1 (2.0)	AMIGO1 (2.0)	ACAD10 (1.9)	TRAPPC6A (1.8)	PPP1R37 (1.7)
GO:0015850	organic alcohol transport	0.27	> 0.20	ABO (2.8)	AMIGO1 (1.9)	GOT2P1 (1.8)	GMPR (1.7)	TSSK6 (1.7)	ST3GAL4 (1.5)	YIPF2 (1.4)	ZHX3 (1.4)	C19orf52 (1.4)	MOSC1 (1.3)
GO:0045638	negative regulation of myeloid cell differentiation	0.27	> 0.20	GCNT4 (2.3)	C19orf52 (2.3)	ST3GAL4 (1.9)	DNAH11 (1.8)	ZHX3 (1.8)	ABO (1.6)	ZNF180 (1.6)	HLX (1.5)	MAU2 (1.5)	ITGB3 (1.5)
ENSG00000130726	TRIM28 PPI subnetwork	0.27	> 0.20	ZNF180 (2.8)	ACAD10 (2.3)	POLK (1.9)	DHX38 (1.9)	USP1 (1.8)	SH2B3 (1.7)	PLCG1 (1.6)	C19orf52 (1.6)	FADS1 (1.6)	ENSG00000238078 (1.6)
ENSG00000049759	NEDD4L PPI subnetwork	0.27	> 0.20	SMARCA4 (3.1)	DNM2 (3.0)	TMEM50A (2.5)	PSMA5 (2.1)	USP24 (2.1)	C1orf63 (2.0)	ATP13A1 (1.9)	COL4A3BP (1.9)	CBLC (1.8)	NKPD1 (1.8)
ENSG00000139496	NUPL1 PPI subnetwork	0.27	> 0.20	NAA25 (3.9)	POC5 (3.6)	DDX56 (3.0)	USP1 (2.9)	CARM1 (2.8)	POLK (2.6)	USP24 (2.6)	DOCK7 (2.5)	ILF3 (2.4)	BUD13 (2.2)
MP:0002674	abnormal sperm motility	0.27	> 0.20	TSSK6 (4.6)	PMFBP1 (4.2)	ABCG8 (2.4)	ABCG5 (1.4)	GRINA (1.3)	ENSG00000254235 (1.2)	AP1M2 (1.2)	BRAP (1.1)	DHODH (1.1)	MYLIP (1.0)
GO:0043406	positive regulation of MAP kinase activity	0.27	> 0.20	LPAR2 (2.8)	ENSG00000226645 (2.6)	ENSG00000228044 (2.4)	ABO (2.3)	HLX (2.1)	SLC44A2 (2.0)	PTPN11 (2.0)	GCNT4 (1.8)	CYB561D1 (1.6)	ST3GAL4 (1.5)
GO:0060674	placenta blood vessel development	0.27	> 0.20	CBLC (3.3)	ENSG00000235545 (2.9)	AP1M2 (2.2)	ZNF101 (2.0)	PVR (1.9)	LDLR (1.8)	MAPKAPK5 (1.8)	DYNC2LI1 (1.7)	PVRL2 (1.6)	ENSG00000228044 (1.5)
ENSG00000075914	EXOSC7 PPI subnetwork	0.27	> 0.20	SUGP1 (3.5)	DHODH (2.9)	DDX56 (2.8)	GRINA (2.3)	TRAPPC6A (2.3)	ZNF259 (2.2)	POC5 (2.1)	TMEM57 (1.9)	CEACAM19 (1.8)	SARS (1.6)
ENSG00000099783	HNRNPM PPI subnetwork	0.27	> 0.20	ILF3 (4.1)	TOP1 (3.2)	C1orf63 (3.1)	QTRT1 (3.1)	DHX38 (3.0)	SMARCA4 (2.7)	PTPN11 (2.6)	SUGP1 (2.6)	GATAD2A (2.5)	USP1 (2.5)
ENSG00000140451	PIF1 PPI subnetwork	0.27	> 0.20	CBLC (3.4)	TRAPPC6A (2.8)	ABCG8 (2.8)	ABCG5 (2.7)	FEN1 (2.4)	POLK (1.9)	POC5 (1.8)	SUGP1 (1.7)	DHODH (1.6)	TM6SF2 (1.6)
GO:0002027	regulation of heart rate	0.27	> 0.20	PPP1R37 (2.4)	ABO (2.2)	KIAA1324 (2.1)	ENSG00000226648 (2.0)	C12orf47 (1.6)	ENSG00000254235 (1.6)	ZNF101 (1.4)	TMEM116 (1.4)	CEACAM19 (1.4)	MYLIP (1.4)
ENSG00000111653	ING4 PPI subnetwork	0.27	> 0.20	SMARCA4 (3.1)	BUD13 (2.7)	USP1 (2.4)	TXNL4B (2.1)	ILF3 (1.8)	ZNF259 (1.7)	ATXN2 (1.6)	PSRC1 (1.6)	UBXN2B (1.3)	BCAM (1.3)
ENSG00000116171	SCP2 PPI subnetwork	0.27	> 0.20	TM6SF2 (2.4)	GPAM (1.8)	MOSC1 (1.7)	COL4A3BP (1.7)	ANGPTL3 (1.7)	APOB (1.6)	ACAD10 (1.6)	PLEC (1.5)	KANK2 (1.5)	NPC1L1 (1.4)
ENSG00000162594	IL23R PPI subnetwork	0.27	> 0.20	BCL3 (3.4)	COL4A3BP (2.0)	C17orf57 (1.7)	ZNF101 (1.5)	RELB (1.5)	PVR (1.4)	CYP7A1 (1.4)	SLC22A1 (1.3)	HLX (1.3)	BCAM (1.2)
ENSG00000197045	GMFB PPI subnetwork	0.27	> 0.20	KANK2 (2.7)	TRAFD1 (2.4)	PLEC (2.2)	TM6SF2 (2.1)	PVRL2 (2.0)	GATAD2A (1.9)	HLX (1.8)	CARM1 (1.8)	ABO (1.8)	DNM2 (1.7)
ENSG00000120697	ALG5 PPI subnetwork	0.27	> 0.20	HMGCR (5.2)	LDLR (4.9)	TMED4 (3.4)	FADS1 (3.2)	ERP29 (3.2)	TMEM50A (3.1)	FADS2 (2.8)	CLPTM1 (2.5)	TMEM57 (2.5)	ATP13A1 (2.5)
ENSG00000083312	TNPO1 PPI subnetwork	0.27	> 0.20	NAA25 (2.3)	DDX56 (2.2)	GMPR (2.2)	GATAD2A (1.8)	ILF3 (1.8)	QTRT1 (1.8)	ERP29 (1.7)	TOMM40 (1.7)	AP1M2 (1.6)	KIAA1324 (1.5)
GO:0006898	receptor-mediated endocytosis	0.27	> 0.20	TIMD4 (2.2)	APOE (1.8)	CETP (1.8)	NPC1L1 (1.6)	USP24 (1.6)	PCSK9 (1.5)	CILP2 (1.4)	ACAD10 (1.3)	MAFB (1.3)	YIPF2 (1.3)
ENSG00000164403	SHROOM1 PPI subnetwork	0.27	> 0.20	CBLC (4.4)	AP1M2 (3.9)	MARK4 (2.5)	FRK (2.5)	LPIN3 (2.3)	CELSR2 (2.3)	PSRC1 (2.2)	PVRL2 (1.9)	DHX38 (1.6)	DOCK7 (1.6)
GO:0016894	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters	0.27	> 0.20	PMFBP1 (2.9)	YIPF2 (2.6)	APOC1 (2.6)	TIMD4 (2.4)	HP (2.3)	CEACAM19 (2.1)	TMEM116 (2.0)	ERP29 (2.0)	MOSC1 (1.7)	APOE (1.5)
ENSG00000130713	EXOSC2 PPI subnetwork	0.27	> 0.20	USP24 (4.0)	SUGP1 (3.5)	DHX38 (2.7)	DHODH (2.5)	BRAP (2.5)	CARM1 (2.3)	ZNF259 (2.2)	C12orf43 (2.2)	TOMM40 (2.2)	DDX56 (2.1)
GO:0070307	lens fiber cell development	0.27	> 0.20	CEACAM19 (1.8)	CILP2 (1.7)	ABO (1.5)	GOT2P1 (1.5)	TMED4 (1.5)	ENSG00000226645 (1.3)	TMEM57 (1.2)	NCAN (1.2)	PBX4 (1.2)	C19orf52 (1.1)
ENSG00000026508	CD44 PPI subnetwork	0.27	> 0.20	SLC44A2 (3.1)	SH2B3 (2.7)	APOE (2.4)	ITGB3 (2.2)	PVR (2.2)	ENSG00000226648 (2.1)	GMIP (2.0)	PLEC (1.9)	GATAD2A (1.9)	HAVCR1 (1.5)
GO:0008565	protein transporter activity	0.27	> 0.20	ATXN2 (2.6)	DDX56 (2.6)	DNM2 (2.4)	CLPTM1 (2.2)	CARM1 (2.2)	OGDH (2.1)	ERP29 (2.0)	ILF3 (2.0)	POLK (2.0)	USP24 (2.0)
ENSG00000021488	SLC7A9 PPI subnetwork	0.27	> 0.20	ABO (2.9)	NPC1L1 (2.4)	ZNF180 (2.2)	TM6SF2 (1.8)	COL4A3BP (1.7)	ABCG5 (1.6)	TOP1 (1.6)	PSMA5 (1.4)	ANGPTL3 (1.4)	CYB561D1 (1.3)
ENSG00000140285	FGF7 PPI subnetwork	0.27	> 0.20	HAVCR1 (3.4)	PLEKHH2 (3.3)	HAPLN4 (2.8)	C17orf57 (2.8)	C11orf9 (2.7)	NYNRIN (2.6)	APOE (2.4)	CILP2 (2.2)	BCAM (1.9)	CBLC (1.9)
ENSG00000104825	NFKBIB PPI subnetwork	0.27	> 0.20	PVR (2.8)	SARS (2.7)	RELB (2.7)	PLEC (1.7)	TIMD4 (1.7)	ZNF259 (1.6)	ILF3 (1.5)	TXNL4B (1.5)	PSMA5 (1.4)	TMEM57 (1.4)
ENSG00000197279	ZNF165 PPI subnetwork	0.27	> 0.20	PBX4 (2.9)	BLOC1S3 (2.7)	BRAP (1.9)	PARP10 (1.9)	GRINA (1.8)	SUGP1 (1.7)	ZNF180 (1.6)	PPP1R37 (1.6)	PTPN11 (1.6)	UBXN2B (1.5)
MP:0002703	abnormal renal tubule morphology	0.27	> 0.20	NYNRIN (2.8)	PLEKHH2 (2.5)	TMEM116 (1.7)	MAFB (1.6)	DYNC2LI1 (1.6)	BCAM (1.6)	KANK2 (1.5)	TRIB1 (1.5)	FRK (1.4)	ABCG5 (1.4)
ENSG00000108826	MRPL27 PPI subnetwork	0.27	> 0.20	QTRT1 (3.8)	TOMM40 (3.4)	DDX56 (3.3)	GEMIN7 (2.2)	DHODH (2.2)	NAA25 (2.2)	TOP1 (2.1)	ATP13A1 (2.0)	ZNF259 (2.0)	BUD13 (2.0)
ENSG00000105221	AKT2 PPI subnetwork	0.27	> 0.20	RELB (2.7)	MOSC1 (2.4)	DNM2 (2.3)	GPAM (2.0)	GMIP (1.9)	PLEC (1.9)	GRINA (1.9)	SLC22A1 (1.9)	ZNF180 (1.9)	HLX (1.8)
MP:0000358	abnormal cell morphology	0.27	> 0.20	BLOC1S3 (2.8)	DYNC2LI1 (2.8)	CLPTM1 (2.6)	DOCK7 (2.4)	TMEM50A (2.2)	DNM2 (2.2)	POC5 (2.0)	ATP13A1 (2.0)	POLK (1.7)	MARK4 (1.7)
ENSG00000066427	ATXN3 PPI subnetwork	0.27	> 0.20	MAU2 (2.8)	PSMA5 (2.4)	C19orf52 (2.1)	ENSG00000238078 (2.0)	TOMM40 (1.9)	NKPD1 (1.9)	TXNL4B (1.8)	DHX38 (1.6)	CARM1 (1.5)	CYP7A1 (1.5)
ENSG00000110367	DDX6 PPI subnetwork	0.27	> 0.20	DHX38 (3.5)	ZNF259 (3.3)	MAU2 (2.8)	SARS (2.7)	DDX56 (2.6)	GEMIN7 (2.6)	NAA25 (2.6)	SUGP1 (2.5)	PSMA5 (2.4)	ATP13A1 (2.4)
GO:0051918	negative regulation of fibrinolysis	0.27	> 0.20	ANGPTL3 (4.7)	PLG (3.6)	APOC4 (3.4)	APOA5 (3.4)	PCSK9 (3.3)	HP (3.0)	SLC22A1 (2.7)	CEACAM19 (2.3)	APOB (2.3)	APOC1 (2.0)
MP:0002233	abnormal nose morphology	0.27	> 0.20	NYNRIN (2.6)	LDLR (2.3)	FADS2 (1.7)	MYLIP (1.7)	HMGCR (1.6)	APOB (1.6)	TMEM116 (1.5)	AP1M2 (1.4)	AMIGO1 (1.3)	DYNC2LI1 (1.2)
GO:0043046	DNA methylation involved in gamete generation	0.27	> 0.20	ANKRD31 (4.0)	ENSG00000238078 (2.7)	DNAH11 (2.0)	CEACAM19 (2.0)	PBX4 (1.8)	FRK (1.8)	LPAR2 (1.6)	C17orf57 (1.3)	CILP2 (1.2)	ADAM1 (1.2)
ENSG00000170348	TMED10 PPI subnetwork	0.27	> 0.20	YIPF2 (4.0)	TMED4 (3.6)	C19orf52 (2.7)	CLPTM1 (2.7)	TMEM50A (2.5)	ABCG8 (2.2)	ATP13A1 (1.8)	FADS2 (1.8)	PVR (1.8)	TXNL4B (1.7)
ENSG00000104814	MAP4K1 PPI subnetwork	0.27	> 0.20	PLCG1 (2.6)	SH2B3 (2.3)	TRAFD1 (1.9)	FRK (1.7)	C1orf63 (1.7)	PPP1R37 (1.6)	GMIP (1.6)	ITGB3 (1.5)	OGDH (1.5)	BLOC1S3 (1.4)
ENSG00000103266	STUB1 PPI subnetwork	0.27	> 0.20	RELB (2.4)	MYLIP (2.4)	LDLR (2.3)	CYP7A1 (2.2)	TRIB1 (2.2)	ST3GAL4 (2.1)	TRAFD1 (2.1)	BCL3 (2.1)	AMIGO1 (2.1)	C1orf63 (1.9)
ENSG00000196776	CD47 PPI subnetwork	0.27	> 0.20	RHD (6.1)	RHCE (5.0)	ITGB3 (3.6)	FADS1 (2.0)	LDLR (1.9)	CETP (1.9)	GMPR (1.9)	DOCK7 (1.8)	ALDH2 (1.7)	TMED4 (1.7)
ENSG00000130589	RP4-697K14.7 PPI subnetwork	0.27	> 0.20	USP24 (2.8)	MARK4 (2.7)	ATXN2 (2.6)	MAU2 (2.6)	SMARCA4 (2.3)	PARP10 (2.1)	BCL3 (2.1)	DHX38 (1.9)	GMIP (1.8)	C12orf51 (1.7)
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	0.27	> 0.20	PLEC (2.9)	DOCK7 (1.8)	AP1M2 (1.8)	COL4A3BP (1.8)	DHX38 (1.7)	UBXN2B (1.6)	TRAFD1 (1.5)	ST3GAL4 (1.5)	SMARCA4 (1.4)	ENSG00000226645 (1.3)
GO:0031640	killing of cells of other organism	0.27	> 0.20	LPA (3.7)	HP (2.9)	ABCG5 (2.8)	CEACAM19 (2.1)	APOA5 (2.0)	C17orf57 (1.9)	APOC4 (1.9)	MOSC1 (1.9)	RHD (1.8)	ANGPTL3 (1.6)
ENSG00000150768	DLAT PPI subnetwork	0.27	> 0.20	OGDH (3.6)	GPAM (2.6)	TSSK6 (2.4)	HAPLN4 (2.1)	DOCK7 (2.0)	TOMM40 (1.7)	GMPR (1.7)	QTRT1 (1.5)	CLPTM1 (1.5)	TIMD4 (1.4)
ENSG00000165782	TMEM55B PPI subnetwork	0.27	> 0.20	ST3GAL4 (2.2)	DNM2 (2.1)	GMIP (2.0)	PMFBP1 (1.9)	ATP13A1 (1.8)	TOP1 (1.7)	RELB (1.7)	NCAN (1.6)	BCL3 (1.5)	CYB561D1 (1.5)
MP:0003085	abnormal egg cylinder morphology	0.27	> 0.20	USP24 (2.6)	C17orf57 (2.2)	ZHX3 (2.2)	UBXN2B (2.0)	DOCK7 (1.9)	ITGB3 (1.9)	ABO (1.9)	HAVCR1 (1.8)	PLCG1 (1.7)	GPAM (1.6)
ENSG00000152518	ZFP36L2 PPI subnetwork	0.27	> 0.20	PLEC (3.4)	CARM1 (3.0)	ZHX3 (3.0)	DNM2 (2.9)	C11orf9 (2.9)	COL4A3BP (2.6)	C12orf51 (2.5)	USP24 (2.4)	LPAR2 (2.3)	PTPN11 (2.2)
ENSG00000159128	IFNGR2 PPI subnetwork	0.27	> 0.20	BCL3 (3.0)	COL4A3BP (2.3)	C17orf57 (1.7)	PVR (1.6)	CYP7A1 (1.6)	HLX (1.5)	RELB (1.5)	BCAM (1.4)	POLK (1.3)	ZNF101 (1.3)
GO:0030880	RNA polymerase complex	0.27	> 0.20	GEMIN7 (4.7)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.4)	MAPKAPK5 (2.0)	DDX56 (1.9)	BLOC1S3 (1.8)	PVR (1.8)	BUD13 (1.7)	NAA25 (1.6)
ENSG00000205609	EIF3CL PPI subnetwork	0.27	> 0.20	ZNF259 (4.1)	QTRT1 (3.8)	TOMM40 (3.8)	NAA25 (3.8)	DDX56 (3.6)	DHX38 (3.5)	SARS (3.4)	ATP13A1 (2.6)	TOP1 (2.6)	ILF3 (2.3)
ENSG00000101146	RAE1 PPI subnetwork	0.27	> 0.20	NAA25 (4.1)	DOCK7 (2.9)	USP24 (2.8)	DDX56 (2.8)	USP1 (2.8)	BUD13 (2.6)	POC5 (2.5)	TOP1 (2.4)	DHX38 (2.1)	ZNF259 (2.1)
GO:0050710	negative regulation of cytokine secretion	0.27	> 0.20	MOSC1 (2.2)	DNAH11 (2.2)	ENSG00000238078 (2.2)	ADAM1 (2.1)	APOB (1.8)	NPC1L1 (1.7)	COL4A3BP (1.5)	ENSG00000228044 (1.4)	C12orf47 (1.4)	HLX (1.3)
GO:0033613	activating transcription factor binding	0.27	> 0.20	MARK4 (2.6)	ATXN2 (2.5)	SH2B3 (2.2)	ENSG00000226648 (2.0)	ATXN7L2 (1.9)	KANK2 (1.8)	DNM2 (1.7)	TRIB1 (1.7)	C1orf63 (1.6)	PCSK9 (1.6)
GO:0042228	interleukin-8 biosynthetic process	0.27	> 0.20	C17orf57 (2.8)	BLOC1S3 (1.9)	NT5DC1 (1.9)	HP (1.8)	HLX (1.8)	POC5 (1.5)	C12orf47 (1.4)	RHCE (1.4)	CEACAM19 (1.3)	RHD (1.3)
ENSG00000139083	ETV6 PPI subnetwork	0.27	> 0.20	C19orf52 (3.1)	BUD13 (2.8)	DHX38 (2.6)	SH2B3 (2.5)	SMARCA4 (2.3)	LPA (2.3)	GEMIN7 (2.3)	POC5 (2.1)	GATAD2A (1.8)	COL4A3BP (1.7)
GO:0008213	protein alkylation	0.27	> 0.20	C12orf51 (2.7)	ZNF180 (2.5)	C19orf52 (2.4)	QTRT1 (2.0)	DHODH (2.0)	USP24 (1.8)	ILF3 (1.7)	BUD13 (1.7)	ATXN2 (1.6)	SMARCA4 (1.4)
GO:0006479	protein methylation	0.27	> 0.20	C12orf51 (2.7)	ZNF180 (2.5)	C19orf52 (2.4)	QTRT1 (2.0)	DHODH (2.0)	USP24 (1.8)	ILF3 (1.7)	BUD13 (1.7)	ATXN2 (1.6)	SMARCA4 (1.4)
MP:0008720	impaired neutrophil chemotaxis	0.27	> 0.20	GMIP (3.6)	HLX (3.6)	MYLIP (2.6)	ST3GAL4 (1.8)	OGDH (1.7)	DNM2 (1.6)	BCL3 (1.6)	TRAFD1 (1.4)	ALDH2 (1.4)	SORT1 (1.3)
ENSG00000138592	USP8 PPI subnetwork	0.27	> 0.20	CBLC (5.1)	AP1M2 (3.8)	LPAR2 (3.5)	DNM2 (3.3)	PLEC (2.4)	SLC44A2 (2.1)	C12orf51 (2.1)	PVRL2 (2.0)	MARK4 (2.0)	CELSR2 (1.8)
ENSG00000110700	RPS13 PPI subnetwork	0.27	> 0.20	QTRT1 (3.8)	DDX56 (3.7)	NAA25 (3.6)	ZNF259 (2.9)	C12orf43 (2.6)	SARS (2.6)	TOP1 (2.5)	ILF3 (2.5)	ATP13A1 (2.5)	TOMM40 (2.4)
GO:0051222	positive regulation of protein transport	0.27	> 0.20	ENSG00000238078 (2.4)	PLEKHH2 (2.0)	OASL (1.7)	ENSG00000228044 (1.6)	AP1M2 (1.5)	KIAA1324 (1.5)	POLK (1.5)	GEMIN7 (1.4)	MAFB (1.3)	HLX (1.3)
ENSG00000213625	LEPROT PPI subnetwork	0.27	> 0.20	BCL3 (5.2)	TRAFD1 (3.3)	TRIB1 (2.4)	USP24 (2.2)	DOCK7 (1.8)	HAVCR1 (1.8)	GRINA (1.8)	COL4A3BP (1.7)	BRAP (1.6)	GPAM (1.4)
MP:0002989	small kidney	0.27	> 0.20	BCAM (4.7)	PLEKHH2 (3.8)	PVRL2 (3.7)	NYNRIN (3.6)	C11orf9 (2.3)	KANK2 (1.9)	MYLIP (1.8)	TRIB1 (1.7)	MAFB (1.6)	AP1M2 (1.5)
ENSG00000142453	CARM1 PPI subnetwork	0.27	> 0.20	MYLIP (2.4)	C12orf51 (2.0)	TRIB1 (2.0)	ILF3 (1.7)	MARK4 (1.6)	SMARCA4 (1.6)	GATAD2A (1.6)	TOP1 (1.6)	GMIP (1.5)	CARM1 (1.5)
GO:0016854	racemase and epimerase activity	0.27	> 0.20	PMFBP1 (2.9)	FADS1 (2.6)	NT5DC1 (2.4)	TRAPPC6A (2.3)	ST3GAL4 (2.1)	SLC22A1 (2.1)	DYNC2LI1 (1.9)	NYNRIN (1.7)	APOC4 (1.5)	FADS2 (1.5)
GO:0060249	anatomical structure homeostasis	0.27	> 0.20	POLK (2.8)	TMEM116 (2.3)	ZNF180 (2.0)	SLC44A2 (1.8)	ZNF101 (1.7)	ENSG00000235545 (1.7)	DNAH11 (1.6)	USP1 (1.5)	ENSG00000228044 (1.4)	ENSG00000226648 (1.3)
ENSG00000162734	PEA15 PPI subnetwork	0.27	> 0.20	ENSG00000238078 (3.4)	TMEM50A (2.7)	C1orf63 (2.4)	ST3GAL4 (2.1)	USP24 (2.0)	NPC1L1 (2.0)	GOT2P1 (1.8)	POLK (1.7)	PVRL2 (1.6)	DHODH (1.3)
MP:0003924	herniated diaphragm	0.27	> 0.20	C11orf9 (5.5)	PLEKHH2 (4.2)	LPAR2 (2.6)	DYNC2LI1 (2.3)	NYNRIN (2.2)	YIPF2 (2.1)	MYLIP (1.9)	HP (1.7)	MOSC1 (1.6)	PVRL2 (1.4)
ENSG00000179222	MAGED1 PPI subnetwork	0.27	> 0.20	ATP13A1 (3.6)	SARS (3.0)	DDX56 (2.9)	PLEC (2.4)	QTRT1 (2.2)	DHX38 (2.1)	ZNF259 (2.0)	DNM2 (1.8)	SMARCA4 (1.8)	ILF3 (1.7)
ENSG00000115919	KYNU PPI subnetwork	0.27	> 0.20	QTRT1 (2.7)	PMFBP1 (2.3)	TOMM40 (2.0)	C19orf52 (2.0)	ILF3 (1.9)	C12orf43 (1.9)	ENSG00000238078 (1.8)	CYP7A1 (1.5)	ST3GAL4 (1.4)	GATAD2A (1.4)
MP:0011092	complete embryonic lethality	0.27	> 0.20	ENSG00000226648 (3.2)	USP24 (2.9)	SMARCA4 (2.6)	MAU2 (2.6)	HLX (2.6)	ATXN2 (2.6)	KANK2 (2.5)	ILF3 (2.4)	DHX38 (2.3)	PTPN11 (2.2)
GO:0034340	response to type I interferon	0.27	> 0.20	OASL (8.6)	PARP10 (6.7)	TRAFD1 (4.4)	GMPR (1.8)	ENSG00000228044 (1.8)	ATP13A1 (1.8)	ADAM1 (1.7)	CYB561D1 (1.7)	FRK (1.5)	TMEM50A (1.5)
MP:0002932	abnormal joint morphology	0.27	> 0.20	CILP2 (5.3)	PLEKHH2 (2.2)	PLEC (2.1)	PVR (1.8)	TM6SF2 (1.7)	LPA (1.6)	PLG (1.6)	APOA5 (1.5)	CLPTM1 (1.5)	NPC1L1 (1.4)
MP:0000492	abnormal rectum morphology	0.27	> 0.20	ANGPTL3 (3.0)	LPA (2.4)	ATXN7L2 (1.9)	LDLR (1.7)	APOC4 (1.6)	MOSC1 (1.5)	ENSG00000238078 (1.5)	PLEKHH2 (1.5)	GOT2P1 (1.5)	UBXN2B (1.4)
MP:0004374	bowed radius	0.27	> 0.20	C11orf9 (2.7)	HMGCR (2.6)	LDLR (2.2)	ALDH2 (2.1)	PCSK9 (2.0)	FADS1 (1.9)	TRAFD1 (1.9)	ENSG00000254235 (1.8)	FADS2 (1.8)	NYNRIN (1.8)
ENSG00000111875	ASF1A PPI subnetwork	0.28	> 0.20	FEN1 (2.5)	GATAD2A (2.3)	C19orf52 (2.3)	USP1 (2.2)	DNAH11 (1.9)	LPAR2 (1.9)	BUD13 (1.7)	TRAPPC6A (1.7)	ZNF101 (1.7)	TMEM57 (1.5)
ENSG00000181163	NPM1 PPI subnetwork	0.28	> 0.20	ILF3 (3.8)	SMARCA4 (3.3)	TOP1 (3.0)	GATAD2A (2.6)	USP1 (2.4)	C1orf63 (1.9)	DDX56 (1.8)	QTRT1 (1.8)	NAA25 (1.7)	TOMM40 (1.6)
ENSG00000141279	NPEPPS PPI subnetwork	0.28	> 0.20	C19orf52 (3.5)	OASL (3.4)	MYLIP (2.9)	PARP10 (2.4)	ZHX3 (1.8)	GMPR (1.8)	KANK2 (1.6)	NT5DC1 (1.5)	COL4A3BP (1.4)	BLOC1S3 (1.4)
ENSG00000145241	CENPC1 PPI subnetwork	0.28	> 0.20	PSRC1 (5.7)	FEN1 (4.0)	USP1 (3.5)	POC5 (3.3)	OASL (1.7)	TIMD4 (1.7)	ENSG00000228044 (1.7)	CETP (1.6)	ENSG00000226648 (1.2)	ZNF180 (1.2)
GO:0030865	cortical cytoskeleton organization	0.28	> 0.20	ABO (3.7)	NYNRIN (2.1)	GRINA (1.7)	GATAD2A (1.6)	ENSG00000254235 (1.6)	OGDH (1.5)	YIPF2 (1.5)	ERP29 (1.2)	MYLIP (1.2)	ZNF101 (1.2)
GO:0071357	cellular response to type I interferon	0.28	> 0.20	OASL (8.7)	PARP10 (6.5)	TRAFD1 (4.4)	GMPR (1.8)	ATP13A1 (1.8)	ENSG00000228044 (1.8)	ADAM1 (1.7)	CYB561D1 (1.6)	TMEM50A (1.5)	FRK (1.5)
GO:0060337	type I interferon-mediated signaling pathway	0.28	> 0.20	OASL (8.7)	PARP10 (6.5)	TRAFD1 (4.4)	GMPR (1.8)	ATP13A1 (1.8)	ENSG00000228044 (1.8)	ADAM1 (1.7)	CYB561D1 (1.6)	TMEM50A (1.5)	FRK (1.5)
ENSG00000184575	XPOT PPI subnetwork	0.28	> 0.20	DDX56 (2.8)	TOMM40 (2.7)	NAA25 (2.6)	GOT2P1 (2.2)	QTRT1 (2.2)	ILF3 (2.0)	USP1 (2.0)	PSMA5 (1.8)	SARS (1.8)	ATXN2 (1.5)
ENSG00000127824	TUBA4A PPI subnetwork	0.28	> 0.20	PSMA5 (3.9)	SARS (3.4)	OGDH (3.0)	SMARCA4 (3.0)	TOMM40 (2.6)	CLPTM1 (2.6)	TOP1 (2.4)	NAA25 (2.3)	TMEM50A (2.2)	GRINA (2.0)
ENSG00000185624	P4HB PPI subnetwork	0.28	> 0.20	ERP29 (2.8)	PARP10 (2.7)	NPC1L1 (2.3)	SARS (2.1)	HNF1A (2.1)	TRAFD1 (1.9)	TMED4 (1.8)	TM6SF2 (1.8)	ITGB3 (1.7)	CILP2 (1.7)
ENSG00000108504	ENSG00000108504 PPI subnetwork	0.28	> 0.20	FEN1 (2.8)	USP1 (2.7)	PSRC1 (2.6)	MAU2 (2.1)	TMEM57 (2.0)	PTPN11 (1.8)	C19orf52 (1.6)	POC5 (1.6)	OGDH (1.5)	DOCK7 (1.5)
ENSG00000100299	ARSA PPI subnetwork	0.28	> 0.20	C11orf9 (4.0)	HAVCR1 (3.1)	APOA5 (2.6)	ABCG5 (2.2)	APOC1 (2.0)	FRK (2.0)	FEN1 (1.8)	TMEM50A (1.7)	APOC4 (1.6)	HAPLN4 (1.6)
ENSG00000069345	DNAJA2 PPI subnetwork	0.28	> 0.20	SARS (3.1)	PSMA5 (2.4)	DDX56 (2.3)	HMGCR (2.1)	OASL (2.1)	ANGPTL3 (2.0)	NAA25 (1.9)	TOMM40 (1.9)	OGDH (1.9)	TOP1 (1.8)
GO:0007162	negative regulation of cell adhesion	0.28	> 0.20	ANKRD31 (3.5)	ENSG00000238078 (2.7)	HLX (2.7)	ENSG00000254235 (2.3)	ST3GAL4 (1.9)	SLC44A2 (1.9)	GCNT4 (1.5)	SH2B3 (1.3)	SORT1 (1.2)	APOE (1.2)
ENSG00000147082	CCNB3 PPI subnetwork	0.28	> 0.20	PSRC1 (4.1)	PVR (2.6)	FEN1 (2.6)	ACAD10 (2.6)	TRIB1 (2.5)	POC5 (2.1)	TXNL4B (1.9)	USP1 (1.9)	ENSG00000226648 (1.7)	CETP (1.5)
MP:0008042	abnormal NK T cell physiology	0.28	> 0.20	PARP10 (2.5)	MAFB (2.3)	SH2B3 (1.9)	C17orf57 (1.8)	GCNT4 (1.7)	GMIP (1.6)	GATAD2A (1.6)	NKPD1 (1.5)	ZNF101 (1.4)	DNAH11 (1.3)
MP:0010299	increased mammary gland tumor incidence	0.28	> 0.20	FEN1 (3.3)	BLOC1S3 (3.0)	UBXN2B (2.5)	POC5 (2.2)	MAU2 (2.0)	GOT2P1 (2.0)	BCL3 (1.6)	MARK4 (1.5)	PTPN11 (1.5)	USP1 (1.5)
ENSG00000092199	HNRNPC PPI subnetwork	0.28	> 0.20	ILF3 (4.6)	SMARCA4 (3.4)	C1orf63 (3.3)	TOP1 (3.3)	QTRT1 (2.8)	DHX38 (2.7)	USP1 (2.5)	SUGP1 (2.3)	BUD13 (2.2)	TOMM40 (2.2)
GO:0005741	mitochondrial outer membrane	0.28	> 0.20	GMPR (2.7)	MOSC1 (2.7)	TRAFD1 (2.7)	ALDH2 (2.7)	GPAM (2.4)	BRAP (2.4)	PARP10 (2.4)	ACAD10 (2.2)	GRINA (2.1)	PTPN11 (1.9)
GO:0032091	negative regulation of protein binding	0.28	> 0.20	OASL (2.8)	TMEM57 (2.7)	SLC44A2 (2.4)	GCNT4 (2.3)	GATAD2A (2.1)	BLOC1S3 (2.1)	LPAR2 (2.1)	PLCG1 (2.0)	MARK4 (1.9)	AMIGO1 (1.8)
KEGG_CHRONIC_MYELOID_LEUKEMIA	KEGG_CHRONIC_MYELOID_LEUKEMIA	0.28	> 0.20	GATAD2A (3.1)	SLC44A2 (3.0)	DNM2 (2.8)	RELB (2.5)	PTPN11 (2.4)	PVR (2.1)	SORT1 (2.1)	SH2B3 (2.0)	GMIP (2.0)	MAU2 (1.9)
REACTOME_STRIATED_MUSCLE_CONTRACTION	REACTOME_STRIATED_MUSCLE_CONTRACTION	0.28	> 0.20	SYPL2 (6.9)	GMPR (2.8)	RHCE (1.3)	TMEM50A (1.2)	UBXN2B (0.9)	HMGCR (0.9)	RPH3A (0.9)	PLEC (0.9)	RHD (0.9)	LPAR2 (0.8)
GO:0042542	response to hydrogen peroxide	0.28	> 0.20	DNAH11 (3.0)	ENSG00000226648 (2.6)	CYB561D1 (2.1)	ACAD10 (2.1)	C12orf47 (2.1)	ALDH2 (2.0)	GOT2P1 (1.9)	TRIB1 (1.8)	MOSC1 (1.8)	CEACAM19 (1.8)
GO:0010675	regulation of cellular carbohydrate metabolic process	0.28	> 0.20	ENSG00000254235 (4.2)	LPA (2.4)	GPAM (2.4)	HNF1A (2.3)	CYP7A1 (2.3)	ENSG00000238078 (2.2)	PCSK9 (1.9)	KANK2 (1.8)	TMEM116 (1.7)	ZHX3 (1.6)
GO:0061099	negative regulation of protein tyrosine kinase activity	0.28	> 0.20	ABO (2.9)	NT5DC1 (2.2)	NKPD1 (1.9)	GCNT4 (1.7)	DDX56 (1.5)	LPA (1.4)	TMEM116 (1.4)	DNAH11 (1.4)	TSSK6 (1.4)	TM6SF2 (1.4)
ENSG00000115392	FANCL PPI subnetwork	0.28	> 0.20	POC5 (3.1)	C17orf57 (2.2)	DHODH (2.0)	ENSG00000254235 (2.0)	UBXN2B (1.9)	ZNF180 (1.8)	ST3GAL4 (1.6)	LPA (1.6)	ABO (1.4)	DOCK7 (1.3)
ENSG00000120907	ADRA1A PPI subnetwork	0.28	> 0.20	ST3GAL4 (3.2)	HLX (2.5)	SH2B3 (2.5)	PVR (2.2)	PLEC (2.2)	KANK2 (2.1)	ZHX3 (1.8)	PPP1R37 (1.6)	ALDH2 (1.4)	DOCK7 (1.4)
GO:0009113	purine base biosynthetic process	0.28	> 0.20	DHODH (3.4)	ENSG00000228044 (2.9)	ENSG00000226648 (2.7)	TXNL4B (2.4)	ANKRD31 (2.2)	TRAPPC6A (2.1)	NKPD1 (1.8)	DNAH11 (1.8)	NT5DC1 (1.6)	QTRT1 (1.5)
ENSG00000124789	NUP153 PPI subnetwork	0.28	> 0.20	USP1 (3.2)	NAA25 (3.2)	POC5 (2.8)	DOCK7 (2.7)	ILF3 (2.5)	BUD13 (2.4)	CARM1 (2.3)	DDX56 (2.2)	USP24 (2.1)	FEN1 (1.8)
MP:0003215	renal interstitial fibrosis	0.28	> 0.20	BCAM (4.4)	HNF1A (2.6)	TMED4 (2.5)	PLEKHH2 (2.0)	PVR (1.9)	ANKRD31 (1.8)	C11orf9 (1.8)	PCSK9 (1.7)	C17orf57 (1.6)	ERP29 (1.6)
ENSG00000115875	SRSF7 PPI subnetwork	0.28	> 0.20	ILF3 (3.8)	C1orf63 (3.6)	TOP1 (2.8)	BUD13 (2.8)	DHX38 (2.8)	USP1 (2.6)	SMARCA4 (2.5)	FEN1 (2.3)	QTRT1 (2.2)	MAU2 (2.2)
GO:0019059	initiation of viral infection	0.28	> 0.20	ZNF101 (4.2)	GCNT4 (3.4)	ENSG00000254235 (2.9)	CETP (2.7)	ENSG00000228044 (2.5)	TMEM116 (2.2)	DYNC2LI1 (2.2)	LPA (2.0)	PVR (2.0)	MAPKAPK5 (1.8)
ENSG00000143556	S100A7 PPI subnetwork	0.28	> 0.20	CARM1 (2.8)	DYNC2LI1 (2.4)	MAU2 (2.2)	NYNRIN (2.1)	YIPF2 (1.9)	PVR (1.9)	PLEC (1.9)	TXNL4B (1.8)	HAVCR1 (1.8)	GRINA (1.8)
GO:0008536	Ran GTPase binding	0.28	> 0.20	ILF3 (2.5)	USP1 (2.1)	USP24 (2.0)	TOP1 (2.0)	KANK2 (2.0)	CEACAM19 (1.7)	ENSG00000226648 (1.7)	FEN1 (1.7)	CARM1 (1.5)	SMARCA4 (1.5)
GO:0048568	embryonic organ development	0.28	> 0.20	PVRL2 (1.9)	CEACAM19 (1.7)	ABO (1.7)	PLEKHH2 (1.7)	ATXN2 (1.7)	ENSG00000238078 (1.7)	ATXN7L2 (1.6)	NYNRIN (1.5)	MARK4 (1.4)	HLX (1.4)
ENSG00000157764	BRAF PPI subnetwork	0.28	> 0.20	CARM1 (3.7)	DNM2 (3.2)	MARK4 (3.0)	PLEC (2.5)	GATAD2A (2.5)	SMARCA4 (2.3)	TOP1 (2.2)	CBLC (2.1)	MAU2 (2.1)	PPP1R37 (2.0)
REACTOME_PKA_ACTIVATION	REACTOME_PKA_ACTIVATION	0.28	> 0.20	ITGB3 (3.0)	ST3GAL4 (3.0)	SH2B3 (2.6)	SORT1 (2.5)	ENSG00000228044 (2.0)	GMPR (1.9)	KANK2 (1.9)	MYLIP (1.6)	PMFBP1 (1.6)	GOT2P1 (1.6)
MP:0002075	abnormal coat/hair pigmentation	0.28	> 0.20	DOCK7 (2.7)	ST3GAL4 (2.3)	CELSR2 (2.3)	MYLIP (2.2)	GMPR (1.5)	GPAM (1.5)	FRK (1.4)	FEN1 (1.3)	APOE (1.3)	TRIB1 (1.2)
MP:0008082	increased single-positive T cell number	0.28	> 0.20	CILP2 (3.5)	RELB (2.5)	CETP (2.4)	TIMD4 (1.9)	KANK2 (1.9)	LPAR2 (1.9)	ENSG00000238078 (1.9)	PBX4 (1.9)	CARM1 (1.7)	PLEKHH2 (1.6)
ENSG00000184779	RPS17 PPI subnetwork	0.28	> 0.20	NAA25 (3.9)	DDX56 (3.7)	QTRT1 (3.1)	ZNF259 (2.5)	ATP13A1 (2.4)	DHX38 (2.3)	C12orf43 (2.3)	NKPD1 (2.2)	SARS (2.2)	TOMM40 (2.1)
ENSG00000182774	RPS17L PPI subnetwork	0.28	> 0.20	NAA25 (3.9)	DDX56 (3.7)	QTRT1 (3.1)	ZNF259 (2.5)	ATP13A1 (2.4)	DHX38 (2.3)	C12orf43 (2.3)	NKPD1 (2.2)	SARS (2.2)	TOMM40 (2.1)
ENSG00000133226	SRRM1 PPI subnetwork	0.28	> 0.20	ILF3 (4.0)	C1orf63 (3.7)	TOP1 (3.4)	DHX38 (3.1)	SMARCA4 (3.0)	USP1 (2.9)	SUGP1 (2.6)	BUD13 (2.4)	FEN1 (2.4)	GATAD2A (1.9)
ENSG00000070501	POLB PPI subnetwork	0.28	> 0.20	BLOC1S3 (5.5)	BUD13 (2.7)	PLEKHH2 (2.3)	AP1M2 (2.2)	ZNF180 (2.1)	SMARCA4 (1.9)	CBLC (1.9)	AMIGO1 (1.9)	FEN1 (1.8)	QTRT1 (1.8)
ENSG00000189079	ARID2 PPI subnetwork	0.28	> 0.20	CARM1 (4.4)	SMARCA4 (2.5)	GATAD2A (2.5)	GOT2P1 (2.4)	TRAFD1 (2.1)	PMFBP1 (2.0)	SUGP1 (1.9)	MARK4 (1.9)	MAPKAPK5 (1.7)	C12orf47 (1.6)
GO:0003009	skeletal muscle contraction	0.28	> 0.20	SYPL2 (6.6)	C17orf57 (2.3)	GMPR (2.3)	CYB561D1 (2.0)	UBXN2B (1.5)	C12orf43 (1.4)	POC5 (1.4)	C12orf47 (1.3)	ANKRD31 (1.3)	ENSG00000228044 (1.3)
MP:0003420	delayed intramembranous bone ossification	0.28	> 0.20	C11orf9 (2.4)	CLPTM1 (2.1)	ANKRD31 (2.0)	BCAM (1.9)	TRAFD1 (1.8)	MAU2 (1.7)	NT5DC1 (1.6)	TRAPPC6A (1.5)	TMEM116 (1.5)	C17orf57 (1.5)
ENSG00000114686	MRPL3 PPI subnetwork	0.28	> 0.20	GEMIN7 (3.0)	QTRT1 (2.9)	CARM1 (2.7)	ATP13A1 (2.7)	C12orf47 (2.2)	MAU2 (2.1)	ABO (1.9)	DDX56 (1.8)	NAA25 (1.8)	TOMM40 (1.7)
ENSG00000162434	JAK1 PPI subnetwork	0.28	> 0.20	BCL3 (3.8)	GMIP (3.5)	HLX (2.8)	PARP10 (2.7)	RELB (2.4)	TRIB1 (2.0)	DNM2 (1.8)	ZNF101 (1.6)	MYLIP (1.5)	LPA (1.5)
MP:0001704	abnormal dorsal-ventral axis patterning	0.28	> 0.20	AP1M2 (2.5)	NYNRIN (2.1)	BCAM (1.9)	CARM1 (1.5)	KANK2 (1.5)	LPAR2 (1.5)	SLC44A2 (1.4)	PVRL2 (1.3)	CLPTM1 (1.3)	ENSG00000254235 (1.2)
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	REACTOME_SIGNALING_BY_EGFR_IN_CANCER	0.28	> 0.20	DNM2 (3.4)	CLPTM1 (3.2)	MARK4 (3.1)	ZHX3 (3.0)	SH2B3 (2.9)	PLEC (2.8)	SMARCA4 (2.5)	CARM1 (2.4)	MAU2 (2.1)	HLX (2.0)
ENSG00000007174	DNAH9 PPI subnetwork	0.28	> 0.20	USP24 (2.8)	MAU2 (2.7)	PARP10 (2.7)	MARK4 (2.6)	BCL3 (2.4)	SMARCA4 (2.3)	ATXN2 (2.2)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
GO:0016836	hydro-lyase activity	0.28	> 0.20	RHD (5.0)	RHCE (3.7)	MOSC1 (3.5)	ALDH2 (3.0)	ACAD10 (2.9)	DHODH (2.6)	GPAM (2.5)	UBXN2B (2.5)	NT5DC1 (2.2)	DOCK7 (2.0)
GO:0021545	cranial nerve development	0.28	> 0.20	TSSK6 (2.7)	PMFBP1 (2.7)	ANKRD31 (2.3)	HAVCR1 (2.3)	ENSG00000238078 (2.3)	NKPD1 (2.2)	ABO (2.0)	DNAH11 (1.6)	BLOC1S3 (1.5)	C17orf57 (1.5)
GO:0030176	integral to endoplasmic reticulum membrane	0.28	> 0.20	CLPTM1 (4.5)	ATP13A1 (4.4)	ERP29 (3.5)	YIPF2 (3.5)	GRINA (3.1)	TMEM50A (3.0)	TMED4 (3.0)	CYB561D1 (2.8)	HMGCR (2.5)	SORT1 (2.3)
ENSG00000185615	PDIA2 PPI subnetwork	0.28	> 0.20	ZHX3 (4.0)	COL4A3BP (2.4)	DNM2 (2.4)	MAFB (2.3)	OGDH (2.2)	PMFBP1 (2.1)	POC5 (2.0)	C12orf47 (1.8)	MOSC1 (1.7)	ABO (1.6)
ENSG00000072310	SREBF1 PPI subnetwork	0.28	> 0.20	MYLIP (3.2)	PLEC (2.8)	UBXN2B (2.7)	C12orf51 (2.2)	ATXN2 (2.0)	ENSG00000254235 (1.9)	NT5DC1 (1.5)	COL4A3BP (1.5)	LDLR (1.5)	KANK2 (1.3)
ENSG00000157344	ENSG00000157344 PPI subnetwork	0.28	> 0.20	POC5 (3.7)	MAPKAPK5 (2.9)	DHODH (2.1)	TOP1 (2.0)	GEMIN7 (1.8)	POLK (1.7)	C19orf52 (1.7)	USP24 (1.6)	NT5DC1 (1.6)	GCNT4 (1.3)
MP:0001923	reduced female fertility	0.28	> 0.20	KANK2 (2.8)	LDLR (2.5)	RHD (2.2)	TRIB1 (2.2)	PLEC (1.9)	APOB (1.9)	RHCE (1.8)	ANGPTL3 (1.8)	C11orf9 (1.8)	TOP1 (1.7)
MP:0003014	abnormal kidney medulla morphology	0.28	> 0.20	NYNRIN (3.5)	CBLC (2.9)	NPC1L1 (2.8)	AP1M2 (2.8)	BCAM (2.5)	APOB (2.1)	C12orf47 (2.0)	TRAPPC6A (2.0)	PLG (1.9)	C11orf9 (1.7)
GO:0002440	production of molecular mediator of immune response	0.28	> 0.20	ZNF101 (3.1)	GCNT4 (2.3)	C17orf57 (2.3)	HAVCR1 (1.9)	PBX4 (1.9)	POC5 (1.8)	DYNC2LI1 (1.6)	NT5DC1 (1.6)	C12orf43 (1.3)	ADAM1 (1.3)
MP:0002780	decreased circulating testosterone level	0.28	> 0.20	MOSC1 (3.2)	GPAM (2.8)	PMFBP1 (2.1)	KIAA1324 (1.5)	GCNT4 (1.4)	MYLIP (1.3)	APOB (1.3)	ALDH2 (1.3)	HLX (1.2)	APOC1 (1.2)
MP:0009285	increased gonadal fat pad weight	0.28	> 0.20	ST3GAL4 (2.7)	C12orf47 (2.6)	GPAM (2.0)	C12orf51 (1.8)	BRAP (1.8)	DYNC2LI1 (1.7)	MAPKAPK5 (1.5)	PLEKHH2 (1.4)	MOSC1 (1.4)	APOA5 (1.4)
ENSG00000134001	EIF2S1 PPI subnetwork	0.28	> 0.20	ILF3 (2.6)	ZNF259 (2.6)	QTRT1 (2.6)	TXNL4B (2.5)	DDX56 (2.4)	ATP13A1 (2.3)	TOP1 (2.3)	DHX38 (2.2)	NKPD1 (2.2)	PTPN11 (2.2)
GO:0006801	superoxide metabolic process	0.28	> 0.20	ALDH2 (2.9)	TRAPPC6A (2.3)	RHD (2.3)	ENSG00000235545 (2.0)	RHCE (1.8)	ERP29 (1.7)	PMFBP1 (1.6)	LPIN3 (1.5)	HNF1A (1.4)	CILP2 (1.4)
MP:0004543	abnormal sperm physiology	0.28	> 0.20	PMFBP1 (3.8)	TSSK6 (3.7)	FADS2 (1.6)	PBX4 (1.5)	BRAP (1.5)	LDLR (1.4)	HP (1.3)	AP1M2 (1.3)	ST3GAL4 (1.3)	TMED4 (1.2)
ENSG00000131323	TRAF3 PPI subnetwork	0.28	> 0.20	RELB (5.2)	BCL3 (3.8)	PBX4 (3.6)	LPAR2 (2.6)	PVR (2.6)	ZNF180 (2.2)	TRAFD1 (2.0)	BLOC1S3 (1.7)	PVRL2 (1.5)	GMIP (1.5)
MP:0000813	abnormal hippocampus layer morphology	0.28	> 0.20	RPH3A (2.9)	CETP (2.4)	PBX4 (2.4)	ST3GAL4 (2.2)	C17orf57 (2.1)	HMGCR (1.8)	ABCG5 (1.8)	ZNF101 (1.7)	MOSC1 (1.7)	TSSK6 (1.7)
REACTOME_ARMS:MEDIATED_ACTIVATION	REACTOME_ARMS:MEDIATED_ACTIVATION	0.28	> 0.20	CARM1 (2.2)	DNM2 (2.2)	TMEM50A (2.1)	CYB561D1 (2.1)	HLX (1.9)	MARK4 (1.7)	MAPKAPK5 (1.7)	SH2B3 (1.6)	SLC44A2 (1.6)	AMIGO1 (1.6)
GO:0030867	rough endoplasmic reticulum membrane	0.28	> 0.20	ERP29 (3.2)	FRK (2.5)	TMED4 (2.4)	YIPF2 (1.9)	TMEM57 (1.9)	BUD13 (1.9)	ST3GAL4 (1.6)	SLC22A1 (1.5)	ENSG00000226645 (1.5)	PLG (1.4)
ENSG00000186468	RPS23 PPI subnetwork	0.28	> 0.20	NKPD1 (2.6)	PLEC (1.9)	TOP1 (1.9)	ILF3 (1.8)	NAA25 (1.8)	ATP13A1 (1.8)	MYLIP (1.7)	SARS (1.6)	QTRT1 (1.6)	ANKRD31 (1.5)
MP:0006400	decreased molar number	0.28	> 0.20	ENSG00000235545 (3.0)	GCNT4 (2.8)	MYLIP (2.6)	DNAH11 (2.2)	ABO (1.7)	ENSG00000238078 (1.6)	C19orf52 (1.5)	MAFB (1.3)	ZNF101 (1.2)	ACAD10 (1.1)
ENSG00000148334	PTGES2 PPI subnetwork	0.28	> 0.20	ATP13A1 (3.6)	QTRT1 (2.6)	YIPF2 (2.5)	ILF3 (2.4)	DNM2 (2.2)	SARS (2.2)	OGDH (2.0)	C19orf52 (1.7)	LDLR (1.6)	DOCK7 (1.5)
GO:0002712	regulation of B cell mediated immunity	0.28	> 0.20	HAVCR1 (2.1)	ENSG00000235545 (2.0)	GEMIN7 (1.4)	DNAH11 (1.4)	GMIP (1.2)	AMIGO1 (1.2)	ENSG00000228044 (1.1)	ADAM1 (1.1)	C17orf57 (1.1)	ZNF101 (1.1)
GO:0006260	DNA replication	0.28	> 0.20	USP1 (3.2)	FEN1 (2.6)	ENSG00000228044 (2.5)	ZNF180 (2.4)	TXNL4B (2.2)	BUD13 (1.8)	POLK (1.8)	DHODH (1.8)	POC5 (1.7)	GOT2P1 (1.4)
GO:0060644	mammary gland epithelial cell differentiation	0.28	> 0.20	ENSG00000226648 (2.8)	BLOC1S3 (2.7)	NKPD1 (2.5)	HLX (2.0)	ENSG00000254235 (1.8)	GOT2P1 (1.8)	TRAPPC6A (1.8)	HAVCR1 (1.6)	DYNC2LI1 (1.6)	PLEKHH2 (1.5)
ENSG00000114416	FXR1 PPI subnetwork	0.28	> 0.20	OASL (3.2)	FADS1 (3.0)	ENSG00000226645 (2.5)	USP24 (2.4)	NPC1L1 (2.4)	FADS2 (2.3)	LDLR (2.0)	TRAFD1 (1.8)	CYB561D1 (1.7)	HMGCR (1.6)
GO:0032102	negative regulation of response to external stimulus	0.28	> 0.20	GCNT4 (3.6)	ANKRD31 (3.6)	DNAH11 (2.6)	HLX (1.8)	NKPD1 (1.5)	PPP1R37 (1.5)	APOC1 (1.3)	LPIN3 (1.3)	SH2B3 (1.2)	ABO (1.2)
GO:0016765	transferase activity, transferring alkyl or aryl (other than methyl) groups	0.28	> 0.20	HMGCR (4.0)	PCSK9 (3.5)	LDLR (3.5)	FADS1 (3.0)	FADS2 (2.1)	NT5DC1 (2.1)	ALDH2 (1.9)	GPAM (1.8)	YIPF2 (1.8)	PSMA5 (1.7)
ENSG00000130762	ARHGEF16 PPI subnetwork	0.28	> 0.20	CBLC (4.2)	AP1M2 (3.1)	MARK4 (2.7)	LPIN3 (2.3)	FRK (2.2)	PSRC1 (2.2)	CELSR2 (2.1)	PVRL2 (1.7)	C12orf51 (1.7)	ST3GAL4 (1.6)
GO:0006071	glycerol metabolic process	0.28	> 0.20	TM6SF2 (3.5)	ENSG00000254235 (3.0)	ENSG00000226645 (2.7)	GCNT4 (2.6)	ABCG8 (2.4)	MOSC1 (2.3)	HAPLN4 (1.9)	PMFBP1 (1.9)	GPAM (1.9)	CBLC (1.8)
GO:0016327	apicolateral plasma membrane	0.28	> 0.20	AP1M2 (6.3)	CBLC (4.5)	PVRL2 (4.1)	BCAM (3.6)	FRK (3.2)	DYNC2LI1 (2.4)	PVR (2.1)	LPAR2 (2.0)	PLEKHH2 (1.9)	C11orf9 (1.9)
MP:0002843	decreased systemic arterial blood pressure	0.28	> 0.20	ITGB3 (4.3)	PMFBP1 (2.8)	HLX (2.4)	TIMD4 (2.1)	PLG (2.1)	ANGPTL3 (2.1)	SORT1 (2.0)	HP (2.0)	ZHX3 (1.8)	HAVCR1 (1.8)
GO:0031331	positive regulation of cellular catabolic process	0.28	> 0.20	BLOC1S3 (2.6)	BRAP (1.9)	TRAFD1 (1.9)	CLPTM1 (1.8)	GRINA (1.5)	MAPKAPK5 (1.5)	GPAM (1.5)	TRIB1 (1.4)	ST3GAL4 (1.3)	ZNF180 (1.3)
ENSG00000100784	RPS6KA5 PPI subnetwork	0.28	> 0.20	TSSK6 (2.8)	SH2B3 (2.7)	PARP10 (2.5)	BCL3 (2.2)	TRIB1 (1.9)	HLX (1.7)	MYLIP (1.7)	PLEC (1.6)	GEMIN7 (1.6)	GMPR (1.5)
ENSG00000174231	PRPF8 PPI subnetwork	0.28	> 0.20	DHX38 (3.9)	ILF3 (3.6)	SUGP1 (3.5)	TOP1 (3.3)	SMARCA4 (3.3)	BUD13 (2.9)	FEN1 (2.7)	MAU2 (2.6)	C1orf63 (2.5)	USP1 (2.5)
ENSG00000035403	VCL PPI subnetwork	0.28	> 0.20	GATAD2A (3.4)	PLEC (2.8)	ADAM1 (2.7)	BCAM (2.6)	PVRL2 (2.3)	CLPTM1 (2.2)	C1orf63 (2.0)	OGDH (2.0)	PTPN11 (1.8)	SMARCA4 (1.7)
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.28	> 0.20	KANK2 (3.8)	ITGB3 (3.1)	HLX (2.4)	PLEKHH2 (2.3)	ZHX3 (2.0)	SORT1 (1.8)	BCAM (1.7)	SH2B3 (1.7)	KIAA1324 (1.6)	PTPN11 (1.5)
GO:0006767	water-soluble vitamin metabolic process	0.28	> 0.20	NT5DC1 (2.9)	ABCG8 (2.3)	DHODH (2.1)	ACAD10 (2.1)	ENSG00000226645 (2.0)	TM6SF2 (2.0)	UBXN2B (1.9)	C19orf52 (1.9)	MOSC1 (1.8)	TMEM116 (1.8)
ENSG00000119401	TRIM32 PPI subnetwork	0.28	> 0.20	CBLC (5.7)	AP1M2 (3.2)	LPAR2 (2.4)	PSRC1 (2.4)	DOCK7 (1.8)	PVRL2 (1.8)	LPIN3 (1.7)	KANK2 (1.7)	FRK (1.6)	CELSR2 (1.4)
ENSG00000117118	SDHB PPI subnetwork	0.28	> 0.20	SYPL2 (3.5)	GMPR (3.2)	ACAD10 (2.3)	RHD (1.9)	OGDH (1.7)	C12orf47 (1.6)	BCAM (1.5)	LPAR2 (1.3)	PMFBP1 (1.3)	SLC44A2 (1.2)
ENSG00000130222	GADD45G PPI subnetwork	0.28	> 0.20	PSRC1 (3.0)	TXNL4B (2.8)	TRIB1 (2.2)	BUD13 (2.0)	POC5 (1.9)	LPA (1.8)	ATXN7L2 (1.6)	FEN1 (1.5)	MYLIP (1.4)	HLX (1.3)
MP:0005435	hemoperitoneum	0.28	> 0.20	HP (5.2)	APOB (3.9)	ANGPTL3 (3.4)	PLG (2.9)	PVR (2.3)	APOA5 (2.3)	APOC4 (2.2)	HNF1A (2.1)	ENSG00000226648 (2.1)	HLX (1.7)
MP:0000747	muscle weakness	0.28	> 0.20	SYPL2 (5.9)	COL4A3BP (2.4)	RPH3A (1.9)	HAPLN4 (1.8)	C12orf47 (1.8)	GMPR (1.7)	CARM1 (1.6)	GRINA (1.6)	NPC1L1 (1.5)	ATXN7L2 (1.4)
ENSG00000106683	LIMK1 PPI subnetwork	0.28	> 0.20	GMIP (2.9)	DNM2 (2.6)	PLEC (2.2)	ST3GAL4 (2.1)	CARM1 (2.1)	BCL3 (2.1)	NYNRIN (1.9)	PTPN11 (1.9)	MARK4 (1.8)	PVRL2 (1.8)
REACTOME_SCFSKP2:MEDIATED_DEGRADATION_OF_P27P21	REACTOME_SCFSKP2:MEDIATED_DEGRADATION_OF_P27P21	0.28	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.3)	NT5DC1 (2.0)	TOMM40 (1.8)	DDX56 (1.7)	SUGP1 (1.6)	PARP10 (1.5)	SARS (1.4)	BRAP (1.2)
ENSG00000170296	GABARAP PPI subnetwork	0.28	> 0.20	COL4A3BP (2.6)	C12orf51 (2.6)	GRINA (2.5)	SARS (2.2)	TRAPPC6A (2.2)	C12orf43 (2.1)	SUGP1 (1.9)	CLPTM1 (1.9)	BRAP (1.8)	ENSG00000228044 (1.7)
ENSG00000069275	NUCKS1 PPI subnetwork	0.28	> 0.20	ACAD10 (4.0)	HNF1A (3.3)	NT5DC1 (3.1)	TMED4 (2.4)	C1orf63 (2.4)	KIAA1324 (1.8)	TRAPPC6A (1.8)	ATXN7L2 (1.6)	PLEKHH2 (1.6)	TMEM50A (1.5)
GO:0030673	axolemma	0.28	> 0.20	NCAN (4.0)	RPH3A (3.3)	HAPLN4 (3.2)	FRK (2.6)	CYP7A1 (2.4)	ABCG8 (2.3)	ABO (1.8)	C17orf57 (1.6)	PPP1R37 (1.6)	GCNT4 (1.6)
ENSG00000171862	PTEN PPI subnetwork	0.28	> 0.20	KIAA1324 (2.9)	PLEC (2.7)	CARM1 (2.2)	BCAM (2.2)	SH2B3 (2.1)	PPP1R37 (2.0)	KANK2 (1.8)	DNM2 (1.7)	MYLIP (1.7)	GATAD2A (1.5)
ENSG00000055609	MLL3 PPI subnetwork	0.28	> 0.20	PLEC (2.2)	C12orf51 (2.1)	ZHX3 (1.8)	MAU2 (1.7)	KANK2 (1.7)	ITGB3 (1.7)	C19orf52 (1.6)	GMIP (1.6)	ENSG00000226648 (1.5)	HNF1A (1.5)
GO:0055017	cardiac muscle tissue growth	0.28	> 0.20	CEACAM19 (2.9)	BLOC1S3 (2.3)	C19orf52 (2.1)	PLEKHH2 (1.9)	GCNT4 (1.4)	C11orf9 (1.4)	ALDH2 (1.3)	PVR (1.3)	NYNRIN (1.3)	ZNF180 (1.2)
ENSG00000114126	TFDP2 PPI subnetwork	0.28	> 0.20	GOT2P1 (3.5)	GATAD2A (2.8)	USP1 (2.8)	MAPKAPK5 (2.6)	FEN1 (2.5)	RHD (2.5)	ATXN2 (2.4)	CLPTM1 (2.1)	RHCE (2.0)	ADAM1 (2.0)
ENSG00000119408	NEK6 PPI subnetwork	0.28	> 0.20	ILF3 (3.6)	SARS (2.8)	DHX38 (2.7)	QTRT1 (2.4)	DDX56 (2.4)	ATP13A1 (2.4)	FEN1 (2.2)	CARM1 (2.0)	PTPN11 (2.0)	NAA25 (2.0)
ENSG00000100603	SNW1 PPI subnetwork	0.28	> 0.20	DHX38 (4.3)	SMARCA4 (3.6)	USP24 (2.8)	BUD13 (2.3)	CARM1 (2.3)	SARS (2.0)	SUGP1 (1.9)	USP1 (1.7)	MAU2 (1.7)	BRAP (1.7)
ENSG00000108829	LRRC59 PPI subnetwork	0.28	> 0.20	ERP29 (3.2)	C12orf43 (2.7)	NT5DC1 (2.6)	ITGB3 (2.6)	ENSG00000226648 (2.4)	SH2B3 (2.2)	FADS1 (1.6)	PVRL2 (1.5)	BRAP (1.5)	ST3GAL4 (1.5)
ENSG00000100227	POLDIP3 PPI subnetwork	0.28	> 0.20	NAA25 (3.0)	DDX56 (2.4)	SORT1 (2.2)	ILF3 (2.2)	FEN1 (1.9)	SARS (1.9)	DHODH (1.8)	C12orf43 (1.6)	ST3GAL4 (1.6)	ENSG00000238078 (1.5)
MP:0003795	abnormal bone structure	0.28	> 0.20	CILP2 (3.3)	MAFB (2.6)	PLEC (2.2)	MAU2 (2.1)	MYLIP (2.1)	TMEM116 (1.7)	FRK (1.6)	PLEKHH2 (1.4)	TIMD4 (1.3)	GMIP (1.3)
ENSG00000169217	CD2BP2 PPI subnetwork	0.28	> 0.20	ILF3 (4.3)	C1orf63 (4.0)	TOP1 (2.8)	USP1 (2.7)	SMARCA4 (2.6)	BUD13 (2.5)	DHX38 (2.5)	SUGP1 (2.5)	PTPN11 (2.2)	FEN1 (2.1)
ENSG00000126067	PSMB2 PPI subnetwork	0.29	> 0.20	PSMA5 (4.7)	TRAFD1 (2.2)	NAA25 (2.2)	DDX56 (1.9)	NT5DC1 (1.8)	TMEM57 (1.8)	SUGP1 (1.6)	TOP1 (1.4)	DHX38 (1.4)	TOMM40 (1.4)
GO:0046717	acid secretion	0.29	> 0.20	NKPD1 (3.1)	TMEM116 (2.0)	ADAM1 (1.9)	LPIN3 (1.7)	C17orf57 (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.6)	FRK (1.6)	ABO (1.6)	CYB561D1 (1.5)
REACTOME_PROCESSING_OF_CAPPED_INTRON:CONTAINING_PRE:MRNA	REACTOME_PROCESSING_OF_CAPPED_INTRON:CONTAINING_PRE:MRNA	0.29	> 0.20	ILF3 (4.2)	C1orf63 (3.2)	USP1 (3.0)	TOP1 (2.9)	BUD13 (2.9)	DHX38 (2.9)	FEN1 (2.5)	SMARCA4 (2.4)	DDX56 (2.2)	SUGP1 (2.1)
ENSG00000133706	LARS PPI subnetwork	0.29	> 0.20	SARS (4.4)	NAA25 (3.1)	HMGCR (2.8)	PSMA5 (2.4)	ZNF259 (2.4)	DDX56 (2.2)	QTRT1 (1.8)	RHCE (1.6)	SMARCA4 (1.5)	HP (1.5)
GO:0030168	platelet activation	0.29	> 0.20	ITGB3 (8.4)	CETP (2.9)	GMPR (2.3)	TIMD4 (1.9)	SORT1 (1.6)	PTPN11 (1.6)	APOE (1.5)	SH2B3 (1.4)	TMEM50A (1.3)	ZNF101 (1.3)
ENSG00000138293	NCOA4 PPI subnetwork	0.29	> 0.20	C12orf51 (2.8)	MOSC1 (2.4)	COL4A3BP (2.4)	CYP7A1 (2.3)	PLEC (2.3)	RHD (2.1)	POLK (2.0)	RHCE (1.9)	DOCK7 (1.7)	PPP1R37 (1.6)
GO:0003724	RNA helicase activity	0.29	> 0.20	SUGP1 (3.3)	ZNF259 (3.1)	TOP1 (2.6)	BUD13 (2.6)	DDX56 (2.4)	NAA25 (2.4)	DHX38 (2.4)	DHODH (2.3)	ILF3 (2.2)	ATP13A1 (1.9)
ENSG00000100836	PABPN1 PPI subnetwork	0.29	> 0.20	ILF3 (4.3)	TOP1 (3.2)	DHX38 (3.2)	SMARCA4 (3.1)	C1orf63 (3.0)	SUGP1 (2.4)	USP1 (2.4)	DHODH (2.1)	BUD13 (2.1)	PTPN11 (2.0)
GO:0022011	myelination in peripheral nervous system	0.29	> 0.20	ENSG00000226645 (3.7)	DNAH11 (2.6)	PBX4 (2.2)	ENSG00000226648 (2.1)	AMIGO1 (1.7)	ZHX3 (1.7)	COL4A3BP (1.5)	PLEC (1.4)	ANKRD31 (1.4)	GCNT4 (1.4)
GO:0032292	peripheral nervous system axon ensheathment	0.29	> 0.20	ENSG00000226645 (3.7)	DNAH11 (2.6)	PBX4 (2.2)	ENSG00000226648 (2.1)	AMIGO1 (1.7)	ZHX3 (1.7)	COL4A3BP (1.5)	PLEC (1.4)	ANKRD31 (1.4)	GCNT4 (1.4)
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	0.29	> 0.20	PSMA5 (5.1)	NAA25 (3.2)	DDX56 (2.8)	TOMM40 (2.3)	CLPTM1 (2.1)	DHX38 (2.0)	SMARCA4 (2.0)	TRAFD1 (1.8)	NT5DC1 (1.7)	SARS (1.6)
ENSG00000113161	HMGCR PPI subnetwork	0.29	> 0.20	LDLR (9.4)	FADS1 (7.9)	HMGCR (7.3)	FADS2 (6.5)	PCSK9 (4.2)	OGDH (2.2)	SORT1 (1.8)	ATP13A1 (1.6)	TMED4 (1.3)	HNF1A (1.3)
MP:0001929	abnormal gametogenesis	0.29	> 0.20	PLEKHH2 (2.6)	FADS1 (2.3)	PCSK9 (2.3)	PBX4 (2.2)	ALDH2 (2.0)	TMEM116 (1.7)	PLCG1 (1.6)	UBXN2B (1.6)	PLG (1.5)	ANKRD31 (1.4)
ENSG00000136936	XPA PPI subnetwork	0.29	> 0.20	FEN1 (3.3)	NT5DC1 (2.6)	SUGP1 (2.4)	POC5 (2.3)	POLK (1.8)	USP1 (1.7)	DHODH (1.6)	NYNRIN (1.6)	MAPKAPK5 (1.6)	BUD13 (1.5)
ENSG00000117632	STMN1 PPI subnetwork	0.29	> 0.20	UBXN2B (3.3)	BCL3 (2.7)	ZNF101 (1.8)	NCAN (1.8)	BLOC1S3 (1.7)	PVRL2 (1.7)	MAU2 (1.5)	MYLIP (1.5)	RPH3A (1.5)	C11orf9 (1.4)
ENSG00000174748	RPL15 PPI subnetwork	0.29	> 0.20	NAA25 (3.1)	ZNF259 (2.8)	QTRT1 (2.7)	DDX56 (2.5)	ILF3 (2.1)	TOP1 (2.0)	ATP13A1 (2.0)	C12orf43 (2.0)	SUGP1 (2.0)	TOMM40 (1.9)
ENSG00000184557	SOCS3 PPI subnetwork	0.29	> 0.20	HLX (3.8)	BCL3 (3.7)	RELB (2.9)	TRIB1 (2.2)	TIMD4 (2.2)	GMIP (1.9)	ALDH2 (1.8)	CETP (1.8)	SLC44A2 (1.7)	LPA (1.5)
MP:0000690	absent spleen	0.29	> 0.20	NYNRIN (4.1)	C11orf9 (3.5)	PVRL2 (2.8)	PLEKHH2 (2.6)	GCNT4 (2.5)	DYNC2LI1 (2.4)	HLX (2.1)	TMED4 (1.7)	ABO (1.7)	DOCK7 (1.6)
ENSG00000134470	IL15RA PPI subnetwork	0.29	> 0.20	BCL3 (3.0)	COL4A3BP (2.0)	RELB (1.8)	C17orf57 (1.6)	CYP7A1 (1.6)	TIMD4 (1.5)	PVR (1.5)	ZNF101 (1.5)	SLC22A1 (1.4)	HLX (1.3)
MP:0003419	delayed endochondral bone ossification	0.29	> 0.20	CILP2 (3.3)	MAFB (3.3)	KANK2 (2.6)	PLCG1 (2.2)	NYNRIN (1.7)	PLEKHH2 (1.6)	CEACAM19 (1.4)	PPP1R37 (1.3)	ENSG00000254235 (1.2)	TMEM57 (1.2)
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING__PRESENTATION	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING__PRESENTATION	0.29	> 0.20	TRAFD1 (4.8)	PSMA5 (3.9)	PARP10 (3.0)	NAA25 (1.9)	CARM1 (1.7)	SUGP1 (1.6)	BRAP (1.6)	C12orf51 (1.5)	GEMIN7 (1.5)	ATXN2 (1.5)
ENSG00000173744	AGFG1 PPI subnetwork	0.29	> 0.20	NT5DC1 (3.8)	MAU2 (3.4)	UBXN2B (2.4)	PBX4 (2.4)	C12orf51 (2.3)	LPAR2 (2.3)	NAA25 (2.2)	BRAP (2.0)	CARM1 (1.9)	USP24 (1.8)
GO:0048608	reproductive structure development	0.29	> 0.20	LPAR2 (2.6)	DNAH11 (2.5)	ABO (2.4)	ST3GAL4 (2.4)	NYNRIN (2.0)	PVRL2 (1.7)	AMIGO1 (1.5)	CELSR2 (1.4)	YIPF2 (1.3)	AP1M2 (1.3)
ENSG00000163882	POLR2H PPI subnetwork	0.29	> 0.20	BUD13 (3.8)	DHX38 (3.4)	ILF3 (3.2)	SUGP1 (3.1)	TOP1 (2.6)	MAPKAPK5 (2.5)	C1orf63 (2.2)	DDX56 (2.2)	C12orf43 (2.2)	SMARCA4 (2.2)
GO:0015926	glucosidase activity	0.29	> 0.20	SORT1 (3.8)	ABCG5 (2.6)	ACAD10 (2.5)	TM6SF2 (2.3)	SYPL2 (2.3)	OGDH (2.3)	TMED4 (2.1)	ZNF101 (2.0)	YIPF2 (2.0)	ABCG8 (2.0)
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	0.29	> 0.20	POC5 (2.5)	ANKRD31 (2.0)	TMEM57 (2.0)	TRAPPC6A (1.8)	C17orf57 (1.7)	C12orf43 (1.6)	MAPKAPK5 (1.6)	CEACAM19 (1.6)	DHODH (1.6)	LPIN3 (1.5)
MP:0004014	abnormal uterine environment	0.29	> 0.20	ANGPTL3 (2.5)	GRINA (2.4)	PLG (2.0)	MOSC1 (2.0)	KIAA1324 (1.8)	APOC4 (1.8)	TOMM40 (1.7)	CBLC (1.7)	APOA5 (1.7)	APOB (1.7)
ENSG00000188229	TUBB4B PPI subnetwork	0.29	> 0.20	GATAD2A (2.5)	SARS (2.1)	SMARCA4 (2.0)	DOCK7 (1.9)	FADS1 (1.8)	TOMM40 (1.7)	DDX56 (1.4)	NAA25 (1.4)	GMPR (1.4)	PSMA5 (1.4)
GO:0031072	heat shock protein binding	0.29	> 0.20	OGDH (2.8)	TMEM57 (2.7)	CLPTM1 (2.1)	PPP1R37 (2.0)	HMGCR (1.9)	LDLR (1.9)	GATAD2A (1.7)	ENSG00000226645 (1.6)	GOT2P1 (1.5)	CYP7A1 (1.5)
ENSG00000105726	ATP13A1 PPI subnetwork	0.29	> 0.20	TMEM57 (3.8)	CYB561D1 (2.9)	TMEM50A (2.8)	TMED4 (2.5)	YIPF2 (2.3)	TSSK6 (2.1)	CLPTM1 (1.7)	QTRT1 (1.6)	NT5DC1 (1.6)	TXNL4B (1.5)
GO:0002446	neutrophil mediated immunity	0.29	> 0.20	UBXN2B (3.3)	CYB561D1 (2.6)	LPAR2 (1.9)	ENSG00000238078 (1.7)	ANKRD31 (1.7)	CEACAM19 (1.7)	GMIP (1.6)	HLX (1.6)	HP (1.5)	C19orf52 (1.5)
ENSG00000136937	NCBP1 PPI subnetwork	0.29	> 0.20	ILF3 (4.1)	TOP1 (3.5)	SMARCA4 (3.1)	C1orf63 (2.7)	DHX38 (2.7)	GATAD2A (2.7)	USP1 (2.6)	SUGP1 (2.3)	BUD13 (2.3)	PTPN11 (2.2)
ENSG00000113643	RARS PPI subnetwork	0.29	> 0.20	SARS (4.6)	RELB (4.4)	NAA25 (3.4)	QTRT1 (2.4)	DDX56 (2.2)	ST3GAL4 (2.1)	DHODH (2.0)	GOT2P1 (2.0)	PVRL2 (1.7)	BCL3 (1.7)
ENSG00000120437	ACAT2 PPI subnetwork	0.29	> 0.20	FADS1 (4.2)	FADS2 (3.9)	LDLR (3.8)	HMGCR (3.2)	PCSK9 (3.1)	HAPLN4 (2.5)	PBX4 (1.9)	MAPKAPK5 (1.8)	BRAP (1.8)	SH2B3 (1.8)
ENSG00000213588	ZBTB9 PPI subnetwork	0.29	> 0.20	GEMIN7 (3.6)	TXNL4B (3.0)	TOP1 (2.3)	ZNF180 (2.2)	NKPD1 (2.0)	MAPKAPK5 (2.0)	BUD13 (1.9)	BRAP (1.9)	C12orf43 (1.7)	POC5 (1.7)
GO:0032479	regulation of type I interferon production	0.29	> 0.20	OASL (6.4)	PARP10 (5.7)	TRAFD1 (3.2)	ADAM1 (2.9)	CYB561D1 (2.7)	MAU2 (2.5)	FRK (2.3)	BRAP (2.3)	ENSG00000226645 (2.2)	C12orf43 (2.1)
KEGG_SPLICEOSOME	KEGG_SPLICEOSOME	0.29	> 0.20	DHX38 (3.8)	SUGP1 (3.4)	BUD13 (3.3)	ILF3 (3.2)	TOP1 (2.9)	USP1 (2.5)	SMARCA4 (2.4)	C1orf63 (2.2)	DDX56 (2.2)	MAPKAPK5 (2.1)
ENSG00000180855	ZNF443 PPI subnetwork	0.29	> 0.20	USP24 (2.8)	MAU2 (2.8)	PARP10 (2.7)	MARK4 (2.5)	BCL3 (2.3)	ATXN2 (2.3)	SMARCA4 (2.3)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
ENSG00000173465	SSSCA1 PPI subnetwork	0.29	> 0.20	DNAH11 (2.5)	CLPTM1 (2.1)	BCAM (2.1)	DDX56 (2.1)	TOMM40 (1.9)	MARK4 (1.7)	PMFBP1 (1.6)	TM6SF2 (1.6)	CBLC (1.5)	SUGP1 (1.5)
ENSG00000105639	JAK3 PPI subnetwork	0.29	> 0.20	BCL3 (4.5)	PARP10 (4.1)	GMIP (3.5)	RELB (2.8)	HLX (2.4)	PBX4 (2.0)	TRAFD1 (2.0)	TRIB1 (1.9)	ZNF101 (1.9)	PLEKHH2 (1.8)
ENSG00000073921	PICALM PPI subnetwork	0.29	> 0.20	ZHX3 (2.9)	SARS (2.5)	PPP1R37 (2.2)	GRINA (2.2)	C1orf63 (2.1)	CEACAM19 (2.1)	ENSG00000226648 (2.0)	C12orf47 (2.0)	BLOC1S3 (1.9)	HAPLN4 (1.7)
ENSG00000167658	EEF2 PPI subnetwork	0.29	> 0.20	TOMM40 (3.3)	NAA25 (3.2)	SARS (3.1)	ILF3 (2.6)	SMARCA4 (2.6)	PSMA5 (2.5)	ADAM1 (2.3)	CARM1 (2.1)	ATP13A1 (2.0)	DDX56 (2.0)
MP:0004402	decreased cochlear outer hair cell number	0.29	> 0.20	MOSC1 (2.4)	C12orf47 (2.1)	CELSR2 (1.9)	BCAM (1.8)	HNF1A (1.7)	SORT1 (1.5)	TRIB1 (1.5)	LPAR2 (1.5)	ANKRD31 (1.5)	ENSG00000226648 (1.4)
MP:0000364	abnormal vascular regression	0.29	> 0.20	HLX (3.6)	FRK (2.4)	POLK (2.1)	TRAPPC6A (2.1)	SH2B3 (1.8)	ENSG00000238078 (1.7)	DNAH11 (1.7)	PCSK9 (1.6)	KANK2 (1.6)	PLCG1 (1.6)
KEGG_PROTEASOME	KEGG_PROTEASOME	0.29	> 0.20	PSMA5 (6.7)	TRAFD1 (4.3)	NAA25 (2.5)	NT5DC1 (2.0)	TOMM40 (1.8)	PARP10 (1.8)	SUGP1 (1.6)	DDX56 (1.4)	SARS (1.3)	TMEM50A (1.3)
ENSG00000118491	C6orf94 PPI subnetwork	0.29	> 0.20	BCAM (2.9)	SLC44A2 (2.2)	TSSK6 (1.9)	HMGCR (1.9)	ZHX3 (1.8)	FADS1 (1.7)	CBLC (1.7)	FADS2 (1.7)	AP1M2 (1.6)	HAPLN4 (1.3)
ENSG00000179295	PTPN11 PPI subnetwork	0.29	> 0.20	ITGB3 (3.4)	HLX (2.7)	CETP (2.5)	TRIB1 (2.2)	BCL3 (2.1)	SLC44A2 (1.9)	SH2B3 (1.9)	USP24 (1.8)	DNM2 (1.8)	SORT1 (1.8)
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	0.29	> 0.20	GMIP (3.1)	TMEM57 (2.3)	GATAD2A (2.3)	SH2B3 (2.2)	GCNT4 (2.2)	MYLIP (2.0)	MARK4 (1.9)	DNM2 (1.9)	PLEKHH2 (1.5)	ABCG8 (1.5)
ENSG00000068354	TBC1D25 PPI subnetwork	0.29	> 0.20	BUD13 (3.0)	GOT2P1 (2.7)	DHODH (2.2)	TXNL4B (2.1)	ZNF259 (2.1)	SUGP1 (1.8)	SLC44A2 (1.6)	APOC1 (1.6)	PLEKHH2 (1.6)	QTRT1 (1.5)
ENSG00000129514	FOXA1 PPI subnetwork	0.29	> 0.20	DHODH (3.8)	DHX38 (3.6)	ABO (2.2)	ATP13A1 (1.9)	GOT2P1 (1.7)	ENSG00000238078 (1.7)	LPAR2 (1.7)	ENSG00000254235 (1.6)	TXNL4B (1.5)	UBXN2B (1.5)
ENSG00000152455	SUV39H2 PPI subnetwork	0.29	> 0.20	TOP1 (2.4)	MYLIP (2.3)	GATAD2A (2.1)	PTPN11 (2.1)	ZHX3 (2.0)	CYP7A1 (1.8)	ENSG00000226645 (1.6)	SMARCA4 (1.6)	NYNRIN (1.5)	C19orf52 (1.5)
ENSG00000156873	PHKG2 PPI subnetwork	0.29	> 0.20	SYPL2 (2.4)	DHODH (2.1)	ZNF180 (2.1)	PPP1R37 (2.0)	HP (2.0)	TXNL4B (1.9)	GPAM (1.7)	FADS2 (1.5)	ZHX3 (1.4)	ST3GAL4 (1.4)
ENSG00000110713	NUP98 PPI subnetwork	0.29	> 0.20	PSRC1 (4.8)	FEN1 (4.2)	USP1 (4.0)	POC5 (3.6)	USP24 (2.0)	ILF3 (2.0)	NAA25 (1.7)	DDX56 (1.5)	DHX38 (1.2)	CARM1 (1.2)
ENSG00000143384	MCL1 PPI subnetwork	0.29	> 0.20	TRAPPC6A (2.9)	TRIB1 (2.9)	CBLC (2.2)	GEMIN7 (2.0)	SH2B3 (2.0)	RELB (2.0)	TMEM50A (1.8)	LPIN3 (1.6)	FEN1 (1.3)	BCL3 (1.3)
ENSG00000134363	FST PPI subnetwork	0.29	> 0.20	SLC22A1 (2.6)	ST3GAL4 (2.6)	APOA5 (2.5)	CYP7A1 (2.5)	PVR (2.5)	ABCG8 (2.1)	APOB (1.7)	APOC4 (1.6)	LPA (1.5)	ABO (1.5)
ENSG00000172172	MRPL13 PPI subnetwork	0.29	> 0.20	CARM1 (3.5)	QTRT1 (3.2)	TOMM40 (2.8)	MAU2 (2.4)	ATP13A1 (2.0)	DDX56 (2.0)	DHODH (2.0)	YIPF2 (2.0)	BUD13 (1.9)	NAA25 (1.8)
GO:0006278	RNA-dependent DNA replication	0.29	> 0.20	TXNL4B (3.5)	GOT2P1 (2.9)	POLK (2.8)	ENSG00000235545 (2.5)	DHODH (2.4)	POC5 (2.3)	DHX38 (1.8)	UBXN2B (1.7)	GCNT4 (1.6)	C12orf43 (1.6)
ENSG00000111676	ATN1 PPI subnetwork	0.29	> 0.20	BCAM (3.8)	NYNRIN (3.6)	ATXN2 (2.5)	MARK4 (2.4)	PPP1R37 (2.3)	GRINA (2.3)	ENSG00000238078 (2.1)	SMARCA4 (2.1)	CELSR2 (2.0)	PLEC (2.0)
ENSG00000138768	USO1 PPI subnetwork	0.29	> 0.20	SUGP1 (3.6)	SARS (2.4)	ATXN2 (2.2)	ENSG00000226648 (2.2)	TMEM57 (2.1)	BRAP (2.1)	DHX38 (2.1)	TRAFD1 (2.1)	PBX4 (2.0)	YIPF2 (1.9)
MP:0004030	induced chromosome breakage	0.29	> 0.20	ZNF180 (2.6)	FEN1 (2.4)	GEMIN7 (2.2)	BUD13 (1.9)	DHODH (1.7)	POC5 (1.7)	UBXN2B (1.5)	DOCK7 (1.4)	ZNF101 (1.4)	ENSG00000254235 (1.3)
MP:0002273	abnormal pulmonary alveolus epithelial cell morphology	0.29	> 0.20	TMEM116 (2.4)	LPIN3 (2.3)	BCAM (2.3)	KIAA1324 (2.3)	DNAH11 (2.2)	TOP1 (1.8)	ERP29 (1.5)	PLEKHH2 (1.5)	PVR (1.4)	MYLIP (1.3)
GO:0031293	membrane protein intracellular domain proteolysis	0.29	> 0.20	ANKRD31 (3.0)	GCNT4 (2.6)	CYB561D1 (2.6)	CLPTM1 (2.4)	TMED4 (2.0)	ENSG00000254235 (2.0)	TMEM50A (2.0)	BLOC1S3 (1.9)	TRAPPC6A (1.8)	MAU2 (1.7)
MP:0001044	abnormal enteric nervous system morphology	0.29	> 0.20	HLX (3.0)	AMIGO1 (2.6)	ENSG00000228044 (2.2)	ENSG00000254235 (2.0)	ZNF101 (2.0)	TRIB1 (1.8)	TMED4 (1.6)	DOCK7 (1.4)	FRK (1.2)	CELSR2 (1.2)
ENSG00000215769	ENSG00000215769 PPI subnetwork	0.29	> 0.20	OASL (3.1)	NAA25 (2.6)	PARP10 (2.6)	USP1 (2.2)	SMARCA4 (2.2)	TOP1 (2.0)	ILF3 (1.6)	DHX38 (1.5)	ABCG5 (1.5)	TOMM40 (1.4)
ENSG00000182481	KPNA2 PPI subnetwork	0.29	> 0.20	OASL (3.1)	NAA25 (2.6)	PARP10 (2.6)	USP1 (2.2)	SMARCA4 (2.2)	TOP1 (2.0)	ILF3 (1.6)	DHX38 (1.5)	ABCG5 (1.5)	TOMM40 (1.4)
ENSG00000156675	RAB11FIP1 PPI subnetwork	0.29	> 0.20	PLEC (3.8)	COL4A3BP (3.2)	DNM2 (3.2)	ZHX3 (3.2)	C11orf9 (3.0)	LPAR2 (2.8)	CARM1 (2.7)	C12orf51 (2.5)	PTPN11 (2.5)	USP24 (2.4)
MP:0002463	abnormal neutrophil physiology	0.29	> 0.20	HP (5.3)	GMIP (3.1)	HLX (2.7)	BCL3 (2.4)	MAFB (2.0)	CEACAM19 (1.3)	DNM2 (1.3)	ITGB3 (1.2)	TIMD4 (1.2)	TRIB1 (1.1)
ENSG00000102898	NUTF2 PPI subnetwork	0.29	> 0.20	USP1 (2.5)	CARM1 (2.3)	FEN1 (2.1)	ILF3 (2.0)	TOMM40 (2.0)	C12orf43 (2.0)	PSRC1 (1.8)	NAA25 (1.7)	MAU2 (1.6)	ENSG00000226645 (1.5)
GO:0031349	positive regulation of defense response	0.29	> 0.20	ENSG00000228044 (2.9)	SH2B3 (2.4)	PVR (2.0)	HLX (2.0)	RELB (1.9)	OASL (1.9)	ZNF101 (1.9)	BCL3 (1.8)	PARP10 (1.7)	GMIP (1.6)
MP:0006269	abnormal mammary gland growth during pregnancy	0.29	> 0.20	GEMIN7 (2.6)	CELSR2 (2.4)	SH2B3 (2.2)	RELB (2.0)	KIAA1324 (1.9)	POLK (1.9)	PARP10 (1.8)	TIMD4 (1.7)	ABO (1.5)	C19orf52 (1.4)
GO:0031570	DNA integrity checkpoint	0.29	> 0.20	PSMA5 (2.6)	NT5DC1 (2.4)	ZNF180 (2.1)	POLK (2.0)	SUGP1 (1.8)	NAA25 (1.7)	TRAFD1 (1.7)	C12orf47 (1.6)	BRAP (1.6)	PSRC1 (1.6)
GO:0008584	male gonad development	0.29	> 0.20	LPAR2 (3.1)	DNAH11 (2.7)	ST3GAL4 (2.5)	ABO (2.3)	C11orf9 (2.0)	FRK (1.9)	GCNT4 (1.6)	PLEKHH2 (1.6)	PVRL2 (1.6)	YIPF2 (1.6)
ENSG00000142684	ZNF593 PPI subnetwork	0.29	> 0.20	ZNF259 (4.7)	NAA25 (4.2)	DDX56 (3.7)	TOMM40 (3.6)	QTRT1 (2.8)	DHODH (2.5)	SUGP1 (2.0)	BRAP (1.7)	ENSG00000226645 (1.6)	BUD13 (1.6)
GO:0008238	exopeptidase activity	0.29	> 0.20	NPC1L1 (3.9)	ERP29 (3.3)	TM6SF2 (3.0)	PMFBP1 (2.7)	TMED4 (2.0)	APOB (2.0)	FRK (2.0)	HAPLN4 (1.9)	ALDH2 (1.8)	HNF1A (1.7)
ENSG00000101349	PAK7 PPI subnetwork	0.29	> 0.20	PTPN11 (2.2)	DNM2 (2.0)	RHCE (2.0)	CLPTM1 (2.0)	ATXN2 (2.0)	SYPL2 (1.8)	MARK4 (1.7)	TXNL4B (1.6)	GEMIN7 (1.5)	HLX (1.5)
ENSG00000071794	HLTF PPI subnetwork	0.29	> 0.20	FEN1 (3.9)	PSRC1 (2.4)	DNAH11 (2.4)	USP1 (2.1)	POLK (1.9)	BRAP (1.8)	ATXN2 (1.8)	RHCE (1.7)	ZNF180 (1.7)	SUGP1 (1.6)
GO:0001952	regulation of cell-matrix adhesion	0.29	> 0.20	SLC44A2 (4.2)	GCNT4 (3.6)	ITGB3 (3.3)	PLEKHH2 (2.6)	USP24 (2.0)	PBX4 (2.0)	ZHX3 (1.8)	YIPF2 (1.8)	C17orf57 (1.7)	AP1M2 (1.6)
ENSG00000169083	AR PPI subnetwork	0.29	> 0.20	ATXN2 (3.7)	TOP1 (2.5)	MAU2 (2.4)	BCL3 (2.3)	PLCG1 (2.3)	TRIB1 (2.1)	TRAFD1 (2.1)	SMARCA4 (2.0)	GATAD2A (1.9)	KIAA1324 (1.8)
ENSG00000214869	ENSG00000214869 PPI subnetwork	0.29	> 0.20	PLEC (3.1)	ST3GAL4 (2.5)	AP1M2 (2.0)	HNF1A (1.8)	KANK2 (1.7)	NPC1L1 (1.6)	GMPR (1.5)	LDLR (1.4)	SORT1 (1.4)	BCL3 (1.3)
MP:0002494	increased IgM level	0.29	> 0.20	RELB (5.2)	GMIP (4.0)	CETP (2.9)	SH2B3 (2.9)	TIMD4 (2.9)	BCL3 (2.7)	GRINA (2.1)	HAVCR1 (1.6)	ALDH2 (1.3)	C17orf57 (1.3)
GO:0042537	benzene-containing compound metabolic process	0.29	> 0.20	DNAH11 (3.7)	TSSK6 (2.2)	ENSG00000254235 (2.1)	ANKRD31 (1.9)	PMFBP1 (1.7)	GCNT4 (1.6)	ST3GAL4 (1.5)	CYP7A1 (1.5)	ENSG00000235545 (1.5)	ABO (1.4)
MP:0009404	centrally nucleated skeletal muscle fibers	0.29	> 0.20	SYPL2 (5.1)	PLEC (3.3)	PVR (2.6)	BCAM (2.5)	SLC44A2 (2.5)	OGDH (2.4)	KANK2 (2.4)	CLPTM1 (2.4)	CILP2 (2.0)	AMIGO1 (2.0)
GO:0042474	middle ear morphogenesis	0.29	> 0.20	NYNRIN (2.3)	NKPD1 (2.2)	CEACAM19 (2.0)	ENSG00000228044 (1.9)	AMIGO1 (1.9)	MYLIP (1.8)	CILP2 (1.7)	HMGCR (1.5)	FADS1 (1.5)	ATXN7L2 (1.5)
ENSG00000110955	ATP5B PPI subnetwork	0.29	> 0.20	PSMA5 (2.7)	ACAD10 (2.2)	OGDH (2.1)	TOMM40 (2.0)	NAA25 (1.9)	GMPR (1.9)	TMED4 (1.9)	PLEC (1.7)	TOP1 (1.6)	ENSG00000238078 (1.5)
GO:0014061	regulation of norepinephrine secretion	0.29	> 0.20	ANKRD31 (2.7)	ZHX3 (2.4)	GMPR (2.3)	ABO (2.0)	GEMIN7 (1.8)	DNAH11 (1.6)	GOT2P1 (1.5)	PMFBP1 (1.5)	ITGB3 (1.4)	CEACAM19 (1.4)
GO:0031647	regulation of protein stability	0.29	> 0.20	YIPF2 (2.8)	BRAP (2.5)	POLK (2.4)	MYLIP (2.2)	POC5 (1.9)	ZNF259 (1.7)	ENSG00000238078 (1.7)	ADAM1 (1.7)	MAU2 (1.6)	RHCE (1.6)
ENSG00000113013	HSPA9 PPI subnetwork	0.29	> 0.20	RELB (3.6)	BCL3 (3.3)	C12orf43 (2.4)	TOMM40 (2.3)	NAA25 (2.0)	SARS (1.9)	GRINA (1.9)	NT5DC1 (1.9)	DDX56 (1.5)	PSMA5 (1.5)
ENSG00000111530	CAND1 PPI subnetwork	0.29	> 0.20	NAA25 (2.6)	GRINA (2.5)	ITGB3 (2.1)	ATXN2 (2.0)	OASL (1.8)	PARP10 (1.8)	GATAD2A (1.7)	PVRL2 (1.7)	C12orf47 (1.7)	CLPTM1 (1.6)
GO:0044427	chromosomal part	0.29	> 0.20	USP1 (5.0)	FEN1 (4.8)	PSRC1 (4.0)	POC5 (2.9)	BUD13 (1.7)	ILF3 (1.3)	ZNF180 (1.3)	SMARCA4 (1.2)	DHX38 (1.1)	KANK2 (1.0)
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	0.29	> 0.20	SARS (3.3)	NAA25 (2.5)	GOT2P1 (2.4)	GPAM (2.3)	QTRT1 (2.2)	USP24 (2.1)	DHODH (2.0)	TOMM40 (2.0)	ACAD10 (2.0)	CARM1 (1.9)
ENSG00000185420	SMYD3 PPI subnetwork	0.29	> 0.20	NYNRIN (4.5)	C12orf47 (2.7)	ATXN2 (2.7)	UBXN2B (2.3)	PPP1R37 (1.8)	C17orf57 (1.7)	OGDH (1.7)	TOP1 (1.7)	GRINA (1.6)	PLEC (1.5)
ENSG00000166441	RPL27A PPI subnetwork	0.29	> 0.20	NKPD1 (3.1)	ZNF259 (3.0)	NAA25 (2.8)	TOP1 (2.3)	C12orf43 (2.3)	DDX56 (2.2)	DHX38 (2.1)	SUGP1 (2.0)	ANKRD31 (1.9)	QTRT1 (1.9)
ENSG00000186660	ZFP91 PPI subnetwork	0.29	> 0.20	CETP (3.3)	BCL3 (3.3)	RELB (3.1)	HLX (3.1)	TIMD4 (2.9)	ALDH2 (2.1)	PARP10 (1.7)	GMIP (1.7)	PVRL2 (1.6)	PLEKHH2 (1.6)
ENSG00000171855	IFNB1 PPI subnetwork	0.29	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.8)	TIMD4 (2.5)	CETP (2.2)	ALDH2 (1.9)	GMIP (1.8)	LPA (1.6)	PARP10 (1.3)	PVRL2 (1.3)
ENSG00000129991	TNNI3 PPI subnetwork	0.29	> 0.20	SYPL2 (4.3)	TMEM50A (3.4)	GMPR (2.8)	ACAD10 (2.3)	C1orf63 (1.9)	APOE (1.6)	C12orf47 (1.1)	LPIN3 (1.1)	NKPD1 (1.1)	HNF1A (1.1)
MP:0002408	abnormal double-positive T cell morphology	0.29	> 0.20	TIMD4 (4.9)	CETP (3.3)	MAFB (3.1)	GMIP (2.8)	PLCG1 (2.5)	SLC44A2 (2.0)	APOC1 (1.8)	GCNT4 (1.7)	LPA (1.6)	APOE (1.5)
GO:0032231	regulation of actin filament bundle assembly	0.29	> 0.20	C17orf57 (2.9)	USP24 (2.5)	HNF1A (2.2)	ENSG00000226645 (1.8)	NYNRIN (1.8)	GCNT4 (1.8)	C11orf9 (1.7)	ABO (1.6)	ITGB3 (1.6)	PBX4 (1.6)
GO:0030878	thyroid gland development	0.29	> 0.20	C17orf57 (4.7)	PMFBP1 (2.7)	TSSK6 (2.6)	ANKRD31 (2.5)	ABO (2.1)	PBX4 (2.0)	NKPD1 (1.7)	BCAM (1.7)	BLOC1S3 (1.6)	HLX (1.4)
MP:0002774	small prostate gland	0.29	> 0.20	LPIN3 (2.2)	TRIB1 (2.2)	ST3GAL4 (2.2)	ATXN7L2 (1.9)	ENSG00000254235 (1.9)	LPA (1.8)	CYP7A1 (1.6)	DNAH11 (1.5)	DHODH (1.5)	COL4A3BP (1.5)
ENSG00000118523	CTGF PPI subnetwork	0.29	> 0.20	QTRT1 (2.4)	PLEC (1.9)	CILP2 (1.7)	BCAM (1.7)	UBXN2B (1.6)	C1orf63 (1.6)	DNM2 (1.6)	SMARCA4 (1.4)	LDLR (1.3)	C12orf51 (1.3)
ENSG00000186879	ENSG00000186879 PPI subnetwork	0.29	> 0.20	FRK (3.6)	PARP10 (3.0)	ZNF180 (2.4)	PTPN11 (2.4)	DOCK7 (2.1)	OASL (1.9)	TOMM40 (1.6)	PVR (1.3)	ENSG00000254235 (1.3)	C1orf63 (1.3)
ENSG00000117360	PRPF3 PPI subnetwork	0.29	> 0.20	DHX38 (4.5)	SUGP1 (3.4)	MAU2 (3.2)	BUD13 (3.1)	ATP13A1 (3.1)	ILF3 (3.1)	SMARCA4 (3.0)	DDX56 (2.4)	C12orf43 (2.4)	FEN1 (2.3)
ENSG00000154143	PANX3 PPI subnetwork	0.29	> 0.20	USP24 (3.0)	PARP10 (2.7)	MAU2 (2.6)	MARK4 (2.5)	ATXN2 (2.4)	BCL3 (2.4)	SMARCA4 (2.3)	GMIP (1.9)	C12orf51 (1.8)	DHX38 (1.8)
ENSG00000118689	FOXO3 PPI subnetwork	0.29	> 0.20	PLEC (2.7)	UBXN2B (2.6)	OGDH (2.3)	C11orf9 (2.3)	SLC44A2 (2.2)	DNM2 (2.1)	AP1M2 (2.0)	GMIP (1.9)	ATXN7L2 (1.9)	ZHX3 (1.7)
MP:0009409	abnormal skeletal muscle fiber type ratio	0.29	> 0.20	SYPL2 (6.8)	MOSC1 (2.8)	BCAM (2.2)	GMPR (1.9)	HNF1A (1.8)	GPAM (1.4)	GOT2P1 (1.4)	TMEM50A (1.3)	CELSR2 (1.2)	ST3GAL4 (1.1)
GO:0005057	receptor signaling protein activity	0.29	> 0.20	PVR (3.0)	SH2B3 (2.7)	MARK4 (2.5)	NYNRIN (2.1)	GMIP (2.1)	LPAR2 (1.9)	ENSG00000228044 (1.9)	MAPKAPK5 (1.8)	LPIN3 (1.8)	GATAD2A (1.7)
ENSG00000065548	ZC3H15 PPI subnetwork	0.29	> 0.20	ZNF259 (4.3)	NAA25 (4.1)	DDX56 (3.6)	TOMM40 (3.0)	QTRT1 (2.8)	TOP1 (2.8)	DHODH (2.8)	DHX38 (2.3)	BUD13 (2.2)	MAPKAPK5 (2.1)
REACTOME_TIE2_SIGNALING	REACTOME_TIE2_SIGNALING	0.29	> 0.20	COL4A3BP (3.0)	USP24 (2.2)	ITGB3 (2.1)	LPIN3 (2.0)	ZHX3 (1.7)	DNAH11 (1.6)	TMEM57 (1.5)	DNM2 (1.5)	MAPKAPK5 (1.3)	NCAN (1.1)
ENSG00000105141	CASP14 PPI subnetwork	0.29	> 0.20	FRK (2.9)	UBXN2B (2.4)	MARK4 (2.2)	LPAR2 (2.1)	ENSG00000228044 (2.1)	ST3GAL4 (2.1)	BCL3 (2.1)	NYNRIN (2.0)	CYB561D1 (1.8)	BLOC1S3 (1.6)
ENSG00000175334	BANF1 PPI subnetwork	0.29	> 0.20	USP1 (3.3)	POC5 (3.0)	NAA25 (2.8)	BUD13 (2.8)	MAPKAPK5 (2.6)	FEN1 (2.3)	DDX56 (2.3)	DOCK7 (2.1)	ILF3 (2.1)	DHX38 (2.0)
ENSG00000113494	PRLR PPI subnetwork	0.29	> 0.20	BCL3 (3.2)	COL4A3BP (2.4)	CYP7A1 (1.8)	C17orf57 (1.7)	PVR (1.7)	ZNF101 (1.6)	RELB (1.5)	SLC22A1 (1.3)	TIMD4 (1.2)	BCAM (1.2)
ENSG00000105173	CCNE1 PPI subnetwork	0.29	> 0.20	MAU2 (3.5)	MARK4 (2.4)	SMARCA4 (2.2)	USP1 (2.1)	C12orf51 (2.1)	MAFB (2.0)	BUD13 (2.0)	NYNRIN (1.9)	ENSG00000254235 (1.9)	CARM1 (1.9)
ENSG00000044524	EPHA3 PPI subnetwork	0.29	> 0.20	ITGB3 (2.7)	TMEM50A (2.6)	HMGCR (2.3)	FADS1 (2.3)	ILF3 (2.0)	GCNT4 (1.7)	USP1 (1.7)	LDLR (1.7)	FADS2 (1.6)	SLC44A2 (1.6)
MP:0004910	decreased seminal vesicle weight	0.29	> 0.20	DNAH11 (2.7)	GPAM (2.2)	LDLR (1.7)	MYLIP (1.6)	PMFBP1 (1.6)	POLK (1.6)	LPA (1.5)	KANK2 (1.5)	ALDH2 (1.2)	ENSG00000228044 (1.2)
MP:0004016	decreased bone mass	0.29	> 0.20	KIAA1324 (3.3)	CILP2 (3.0)	MOSC1 (2.8)	AP1M2 (2.8)	TMED4 (2.3)	NT5DC1 (2.0)	ERP29 (2.0)	SH2B3 (1.7)	PCSK9 (1.7)	YIPF2 (1.7)
GO:0005605	basal lamina	0.29	> 0.20	BCAM (5.5)	CBLC (4.3)	CELSR2 (2.6)	AP1M2 (2.6)	PVRL2 (2.4)	APOE (2.1)	PLEC (1.9)	SLC44A2 (1.9)	KANK2 (1.8)	OGDH (1.7)
MP:0000120	malocclusion	0.29	> 0.20	NYNRIN (2.4)	KANK2 (2.3)	CILP2 (2.1)	PLEC (2.0)	PBX4 (1.8)	ATXN2 (1.5)	HNF1A (1.5)	ZHX3 (1.5)	TMEM116 (1.4)	LDLR (1.4)
ENSG00000173267	SNCG PPI subnetwork	0.30	> 0.20	TMEM50A (2.7)	C1orf63 (2.6)	PLCG1 (2.1)	PVR (2.1)	PSRC1 (1.7)	FEN1 (1.6)	NKPD1 (1.6)	GCNT4 (1.6)	ITGB3 (1.6)	ST3GAL4 (1.5)
ENSG00000087338	GMCL1 PPI subnetwork	0.30	> 0.20	TMED4 (2.6)	TMEM57 (2.2)	ENSG00000238078 (2.1)	CYP7A1 (2.1)	AMIGO1 (2.0)	GATAD2A (1.8)	RHCE (1.8)	POC5 (1.8)	GEMIN7 (1.7)	ZNF259 (1.6)
GO:0048732	gland development	0.30	> 0.20	KIAA1324 (2.5)	BCAM (2.1)	PPP1R37 (2.0)	AP1M2 (1.9)	ATXN7L2 (1.8)	MYLIP (1.7)	PVRL2 (1.7)	ENSG00000238078 (1.7)	ANKRD31 (1.6)	GOT2P1 (1.5)
GO:0015012	heparan sulfate proteoglycan biosynthetic process	0.30	> 0.20	GCNT4 (4.0)	ANKRD31 (3.6)	ST3GAL4 (2.5)	GEMIN7 (2.3)	ZNF180 (2.2)	NKPD1 (1.8)	ZHX3 (1.7)	DYNC2LI1 (1.5)	AMIGO1 (1.4)	LPIN3 (1.3)
ENSG00000138794	CASP6 PPI subnetwork	0.30	> 0.20	BCL3 (2.8)	FRK (2.5)	RELB (2.3)	PVRL2 (2.0)	PLEC (1.8)	GRINA (1.7)	GMIP (1.7)	UBXN2B (1.6)	ST3GAL4 (1.5)	ABO (1.5)
ENSG00000110680	CALCA PPI subnetwork	0.30	> 0.20	ABO (3.6)	FADS1 (2.4)	CELSR2 (2.0)	ALDH2 (2.0)	NYNRIN (1.9)	LPIN3 (1.9)	OGDH (1.9)	ATXN7L2 (1.7)	TMEM50A (1.7)	PMFBP1 (1.7)
ENSG00000170017	ALCAM PPI subnetwork	0.30	> 0.20	AP1M2 (2.8)	SARS (2.5)	PCSK9 (2.3)	FRK (2.3)	CEACAM19 (1.9)	SLC44A2 (1.9)	ERP29 (1.8)	CELSR2 (1.8)	COL4A3BP (1.7)	SORT1 (1.6)
MP:0006414	decreased T cell apoptosis	0.30	> 0.20	PARP10 (2.8)	PBX4 (2.3)	MYLIP (1.8)	SYPL2 (1.8)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ZNF101 (1.6)	PLCG1 (1.6)	MAFB (1.4)	POC5 (1.3)
ENSG00000109501	WFS1 PPI subnetwork	0.30	> 0.20	APOB (2.8)	TRAPPC6A (2.8)	CBLC (2.7)	AP1M2 (2.7)	DOCK7 (2.1)	APOC1 (2.0)	SORT1 (1.9)	ANKRD31 (1.8)	KIAA1324 (1.8)	APOC4 (1.6)
MP:0000571	interdigital webbing	0.30	> 0.20	MOSC1 (2.4)	MAFB (2.4)	LPIN3 (1.7)	UBXN2B (1.7)	NYNRIN (1.6)	ZHX3 (1.5)	ABCG5 (1.5)	ITGB3 (1.5)	POLK (1.3)	GOT2P1 (1.3)
GO:0070491	repressing transcription factor binding	0.30	> 0.20	HLX (2.6)	ALDH2 (2.4)	BUD13 (2.2)	TRIB1 (2.1)	RELB (1.7)	SMARCA4 (1.6)	ENSG00000226645 (1.6)	HNF1A (1.6)	FADS1 (1.6)	PCSK9 (1.5)
GO:0045335	phagocytic vesicle	0.30	> 0.20	MAFB (2.0)	HLX (1.9)	ENSG00000238078 (1.8)	OASL (1.7)	PMFBP1 (1.6)	APOE (1.5)	HAPLN4 (1.5)	GMIP (1.5)	PARP10 (1.5)	UBXN2B (1.4)
GO:0051345	positive regulation of hydrolase activity	0.30	> 0.20	ST3GAL4 (2.3)	CBLC (1.8)	PLEKHH2 (1.5)	POLK (1.5)	LPIN3 (1.4)	HAVCR1 (1.3)	ZNF101 (1.3)	SH2B3 (1.2)	MARK4 (1.2)	GOT2P1 (1.1)
ENSG00000132688	NES PPI subnetwork	0.30	> 0.20	HMGCR (4.2)	LDLR (2.7)	CELSR2 (2.6)	PCSK9 (2.4)	FADS2 (2.0)	HAPLN4 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)	NCAN (1.7)	RPH3A (1.7)
ENSG00000104177	MYEF2 PPI subnetwork	0.30	> 0.20	NAA25 (2.6)	DOCK7 (2.4)	NT5DC1 (2.1)	OASL (1.9)	PSMA5 (1.9)	MOSC1 (1.8)	GPAM (1.8)	PARP10 (1.6)	CYP7A1 (1.6)	ENSG00000235545 (1.6)
ENSG00000162374	ELAVL4 PPI subnetwork	0.30	> 0.20	ATXN2 (3.1)	UBXN2B (2.8)	COL4A3BP (2.7)	PTPN11 (2.1)	DHX38 (2.1)	C1orf63 (2.1)	ENSG00000238078 (1.9)	ATP13A1 (1.9)	C12orf47 (1.9)	TOP1 (1.7)
ENSG00000112818	MEP1A PPI subnetwork	0.30	> 0.20	TM6SF2 (4.4)	ABCG5 (3.7)	NPC1L1 (3.7)	APOB (3.4)	ABCG8 (2.5)	KIAA1324 (2.4)	PLEKHH2 (2.0)	CYP7A1 (1.8)	HLX (1.8)	TSSK6 (1.8)
GO:0032469	endoplasmic reticulum calcium ion homeostasis	0.30	> 0.20	PPP1R37 (3.0)	CLPTM1 (2.7)	BLOC1S3 (2.5)	YIPF2 (2.4)	CYB561D1 (2.2)	C17orf57 (1.9)	BRAP (1.9)	GATAD2A (1.8)	ANKRD31 (1.8)	ERP29 (1.8)
GO:0030159	receptor signaling complex scaffold activity	0.30	> 0.20	PLCG1 (3.9)	CBLC (2.4)	ZNF180 (2.2)	MARK4 (2.1)	C17orf57 (1.9)	AMIGO1 (1.8)	KIAA1324 (1.7)	LPAR2 (1.7)	ZNF101 (1.6)	POLK (1.5)
GO:0045453	bone resorption	0.30	> 0.20	ENSG00000226645 (3.0)	ENSG00000235545 (2.2)	ENSG00000226648 (1.8)	TMEM116 (1.7)	ENSG00000254235 (1.6)	POLK (1.4)	RHCE (1.4)	ITGB3 (1.4)	FRK (1.3)	CETP (1.3)
ENSG00000107863	ARHGAP21 PPI subnetwork	0.30	> 0.20	AP1M2 (2.1)	NT5DC1 (2.1)	MYLIP (1.9)	GATAD2A (1.8)	TOP1 (1.8)	PLEC (1.8)	C1orf63 (1.7)	DOCK7 (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
ENSG00000156508	EEF1A1 PPI subnetwork	0.30	> 0.20	SARS (3.5)	SMARCA4 (3.1)	ILF3 (3.1)	TOMM40 (2.6)	NAA25 (2.5)	ZNF259 (2.4)	QTRT1 (2.2)	TOP1 (2.2)	PSMA5 (2.1)	DHX38 (2.1)
GO:0042177	negative regulation of protein catabolic process	0.30	> 0.20	PBX4 (2.9)	ENSG00000226648 (2.4)	CYB561D1 (2.3)	GOT2P1 (1.9)	GEMIN7 (1.7)	PLEKHH2 (1.7)	ENSG00000238078 (1.6)	GCNT4 (1.4)	ZNF101 (1.3)	ST3GAL4 (1.2)
ENSG00000150907	FOXO1 PPI subnetwork	0.30	> 0.20	UBXN2B (3.2)	GCNT4 (2.3)	PLEC (2.2)	GOT2P1 (1.8)	ENSG00000226648 (1.8)	ALDH2 (1.6)	ENSG00000238078 (1.6)	APOA5 (1.5)	ATXN2 (1.4)	DOCK7 (1.3)
ENSG00000185129	PURA PPI subnetwork	0.30	> 0.20	OASL (2.7)	FADS1 (2.6)	ENSG00000226648 (2.2)	NT5DC1 (2.2)	SORT1 (2.2)	PARP10 (2.2)	FADS2 (2.0)	DOCK7 (1.9)	MOSC1 (1.8)	C17orf57 (1.8)
REACTOME_DEGRADATION_OF_BETA:CATENIN_BY_THE_DESTRUCTION_COMPLEX	REACTOME_DEGRADATION_OF_BETA:CATENIN_BY_THE_DESTRUCTION_COMPLEX	0.30	> 0.20	PSMA5 (6.4)	TRAFD1 (3.2)	NAA25 (2.4)	NT5DC1 (1.9)	SUGP1 (1.8)	DDX56 (1.7)	SARS (1.7)	PARP10 (1.6)	TOMM40 (1.5)	COL4A3BP (1.4)
REACTOME_SIGNALING_BY_WNT	REACTOME_SIGNALING_BY_WNT	0.30	> 0.20	PSMA5 (6.4)	TRAFD1 (3.2)	NAA25 (2.4)	NT5DC1 (1.9)	SUGP1 (1.8)	DDX56 (1.7)	SARS (1.7)	PARP10 (1.6)	TOMM40 (1.5)	COL4A3BP (1.4)
GO:0019221	cytokine-mediated signaling pathway	0.30	> 0.20	OASL (6.1)	PARP10 (5.6)	TRAFD1 (3.8)	BCL3 (2.5)	CYB561D1 (2.5)	RELB (2.1)	GRINA (1.8)	GMIP (1.7)	TMEM50A (1.5)	CEACAM19 (1.4)
ENSG00000112715	VEGFA PPI subnetwork	0.30	> 0.20	HLX (3.2)	MYLIP (3.1)	C1orf63 (2.3)	PVRL2 (2.3)	ENSG00000254235 (2.3)	ALDH2 (2.0)	MOSC1 (1.9)	LPA (1.9)	DNAH11 (1.9)	ENSG00000238078 (1.9)
GO:0015932	nucleobase-containing compound transmembrane transporter activity	0.30	> 0.20	GCNT4 (2.4)	TM6SF2 (2.4)	ABCG8 (2.4)	ABCG5 (2.1)	TOMM40 (2.1)	HAPLN4 (2.1)	SLC44A2 (2.1)	CEACAM19 (2.0)	TMEM57 (1.9)	GOT2P1 (1.8)
GO:0009408	response to heat	0.30	> 0.20	ENSG00000235545 (3.3)	AMIGO1 (2.1)	ENSG00000226645 (2.1)	SYPL2 (1.9)	C12orf51 (1.8)	NAA25 (1.8)	TMEM57 (1.7)	DDX56 (1.4)	BCL3 (1.3)	C17orf57 (1.3)
ENSG00000196083	IL1RAP PPI subnetwork	0.30	> 0.20	BCL3 (4.1)	HP (2.5)	GPAM (2.1)	ENSG00000235545 (1.9)	OASL (1.8)	COL4A3BP (1.7)	MAFB (1.6)	PMFBP1 (1.5)	PLEKHH2 (1.5)	SLC22A1 (1.4)
ENSG00000109471	IL2 PPI subnetwork	0.30	> 0.20	BCL3 (3.1)	TIMD4 (2.9)	RELB (2.7)	HLX (2.6)	CETP (2.1)	SH2B3 (1.9)	LPA (1.7)	GMIP (1.7)	ALDH2 (1.3)	PBX4 (1.3)
ENSG00000023171	GRAMD1B PPI subnetwork	0.30	> 0.20	NPC1L1 (3.5)	TM6SF2 (2.6)	ENSG00000235545 (2.6)	SYPL2 (2.5)	ABCG8 (2.3)	ZNF101 (2.2)	C12orf47 (2.1)	HAPLN4 (2.0)	AMIGO1 (1.8)	ABCG5 (1.8)
ENSG00000137699	TRIM29 PPI subnetwork	0.30	> 0.20	C19orf52 (1.9)	NYNRIN (1.8)	POC5 (1.8)	DNM2 (1.7)	BLOC1S3 (1.7)	TMED4 (1.7)	SH2B3 (1.6)	PPP1R37 (1.6)	ENSG00000226648 (1.5)	PSRC1 (1.5)
GO:0051348	negative regulation of transferase activity	0.30	> 0.20	TRIB1 (3.8)	ENSG00000226645 (3.6)	PVR (2.0)	KANK2 (1.8)	HLX (1.4)	POC5 (1.4)	ENSG00000238078 (1.3)	GPAM (1.3)	GCNT4 (1.3)	ENSG00000254235 (1.3)
ENSG00000196591	HDAC2 PPI subnetwork	0.30	> 0.20	SMARCA4 (3.9)	ILF3 (2.8)	USP1 (2.8)	DNM2 (2.7)	BUD13 (2.7)	CARM1 (2.7)	DHX38 (2.5)	BRAP (2.5)	MAU2 (2.4)	PLCG1 (2.4)
GO:0051010	microtubule plus-end binding	0.30	> 0.20	USP24 (2.8)	PTPN11 (2.7)	C12orf51 (2.7)	NCAN (2.6)	PSRC1 (2.5)	POLK (2.3)	ACAD10 (1.9)	POC5 (1.8)	CEACAM19 (1.8)	ATXN2 (1.6)
MP:0009660	abnormal induced retinal neovascularization	0.30	> 0.20	DNAH11 (3.3)	CBLC (2.7)	PVRL2 (2.2)	PVR (2.2)	KIAA1324 (1.9)	NCAN (1.7)	BCL3 (1.5)	TRIB1 (1.5)	BCAM (1.5)	C17orf57 (1.4)
MP:0001807	decreased IgA level	0.30	> 0.20	RELB (6.1)	BCL3 (4.1)	GMIP (2.5)	GRINA (2.3)	TIMD4 (2.2)	ZNF101 (2.2)	CETP (2.0)	TRAFD1 (1.8)	PBX4 (1.8)	ENSG00000235545 (1.6)
ENSG00000147274	RBMX PPI subnetwork	0.30	> 0.20	ILF3 (4.0)	C1orf63 (3.3)	SMARCA4 (2.9)	SUGP1 (2.8)	TOP1 (2.8)	DHX38 (2.5)	USP1 (2.4)	QTRT1 (2.4)	BUD13 (2.3)	FEN1 (2.0)
GO:0002697	regulation of immune effector process	0.30	> 0.20	PARP10 (2.2)	GEMIN7 (2.2)	GMIP (1.8)	TIMD4 (1.8)	SH2B3 (1.7)	OASL (1.7)	ZNF101 (1.7)	GRINA (1.6)	RELB (1.6)	C17orf57 (1.5)
GO:0016570	histone modification	0.30	> 0.20	ATXN7L2 (3.9)	BUD13 (2.8)	ILF3 (2.6)	C12orf51 (2.3)	TMEM57 (2.2)	SMARCA4 (2.0)	MAU2 (1.9)	ATXN2 (1.9)	C1orf63 (1.9)	USP24 (1.9)
GO:0044437	vacuolar part	0.30	> 0.20	GRINA (4.2)	CLPTM1 (3.4)	ERP29 (3.3)	ATP13A1 (3.3)	TMEM50A (3.0)	SORT1 (2.9)	YIPF2 (2.1)	APOE (2.1)	COL4A3BP (1.8)	TMED4 (1.8)
GO:0032964	collagen biosynthetic process	0.30	> 0.20	GEMIN7 (2.1)	FRK (2.1)	HNF1A (2.1)	ST3GAL4 (1.9)	ENSG00000226645 (1.7)	CEACAM19 (1.7)	C11orf9 (1.4)	C17orf57 (1.4)	PVRL2 (1.4)	APOE (1.2)
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE:NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE:NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	0.30	> 0.20	USP1 (3.4)	FEN1 (3.0)	TRAPPC6A (1.9)	BUD13 (1.8)	POC5 (1.8)	LPIN3 (1.7)	TMEM57 (1.6)	ABO (1.6)	DHODH (1.6)	ERP29 (1.6)
REACTOME_REMOVAL_OF_DNA_PATCH_CONTAINING_ABASIC_RESIDUE	REACTOME_REMOVAL_OF_DNA_PATCH_CONTAINING_ABASIC_RESIDUE	0.30	> 0.20	USP1 (3.4)	FEN1 (3.0)	TRAPPC6A (1.9)	BUD13 (1.8)	POC5 (1.8)	LPIN3 (1.7)	TMEM57 (1.6)	ABO (1.6)	DHODH (1.6)	ERP29 (1.6)
GO:0017069	snRNA binding	0.30	> 0.20	MYLIP (3.1)	C1orf63 (2.7)	C17orf57 (2.3)	ITGB3 (2.3)	TMED4 (1.8)	PARP10 (1.8)	ZHX3 (1.6)	GCNT4 (1.4)	PLEKHH2 (1.3)	HLX (1.2)
ENSG00000118985	ELL2 PPI subnetwork	0.30	> 0.20	TXNL4B (4.4)	BLOC1S3 (3.0)	TOP1 (2.5)	ZNF180 (2.2)	DHX38 (2.2)	BRAP (2.1)	ENSG00000226648 (2.1)	TRAPPC6A (2.0)	C19orf52 (2.0)	TRAFD1 (1.6)
GO:0016289	CoA hydrolase activity	0.30	> 0.20	ANGPTL3 (3.4)	SLC22A1 (3.3)	PLG (3.1)	ABCG8 (2.6)	ACAD10 (2.6)	CYP7A1 (2.5)	PCSK9 (2.1)	TM6SF2 (1.9)	APOC4 (1.8)	NT5DC1 (1.7)
ENSG00000148303	RPL7A PPI subnetwork	0.30	> 0.20	NAA25 (3.9)	ZNF259 (3.5)	QTRT1 (3.4)	DDX56 (3.3)	TOMM40 (2.7)	DHX38 (2.3)	TOP1 (2.2)	PTPN11 (2.1)	ATP13A1 (1.9)	ILF3 (1.8)
GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	0.30	> 0.20	FADS1 (5.5)	FADS2 (5.3)	HMGCR (5.3)	LDLR (4.6)	PCSK9 (4.5)	GPAM (3.3)	BLOC1S3 (3.0)	NKPD1 (2.6)	MOSC1 (1.9)	DOCK7 (1.8)
GO:0035336	long-chain fatty-acyl-CoA metabolic process	0.30	> 0.20	FADS1 (5.5)	FADS2 (5.3)	HMGCR (5.3)	LDLR (4.6)	PCSK9 (4.5)	GPAM (3.3)	BLOC1S3 (3.0)	NKPD1 (2.6)	MOSC1 (1.9)	DOCK7 (1.8)
MP:0001260	increased body weight	0.30	> 0.20	KIAA1324 (2.9)	ABCG8 (2.4)	GPAM (2.3)	ABO (2.1)	SORT1 (1.9)	MOSC1 (1.9)	CBLC (1.9)	TRIB1 (1.7)	ABCG5 (1.6)	C12orf47 (1.5)
REACTOME_REGULATION_OF_ACTIVATED_PAK:2P34_BY_PROTEASOME_MEDIATED_DEGRADATION	REACTOME_REGULATION_OF_ACTIVATED_PAK:2P34_BY_PROTEASOME_MEDIATED_DEGRADATION	0.30	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	SUGP1 (1.8)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	SARS (1.4)	ZNF259 (1.1)
ENSG00000016402	IL20RA PPI subnetwork	0.30	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	CYP7A1 (1.5)	C17orf57 (1.5)	PVR (1.5)	ZNF101 (1.4)	HLX (1.4)	RELB (1.4)	SLC22A1 (1.3)	BCAM (1.2)
GO:0002263	cell activation involved in immune response	0.30	> 0.20	GMIP (2.5)	C17orf57 (2.2)	DNAH11 (2.1)	ZNF101 (1.9)	CYB561D1 (1.9)	SH2B3 (1.7)	NT5DC1 (1.5)	ANKRD31 (1.5)	BCL3 (1.4)	PARP10 (1.3)
GO:0002366	leukocyte activation involved in immune response	0.30	> 0.20	GMIP (2.5)	C17orf57 (2.2)	DNAH11 (2.1)	ZNF101 (1.9)	CYB561D1 (1.9)	SH2B3 (1.7)	NT5DC1 (1.5)	ANKRD31 (1.5)	BCL3 (1.4)	PARP10 (1.3)
GO:0042108	positive regulation of cytokine biosynthetic process	0.30	> 0.20	TIMD4 (2.1)	HLX (1.6)	CYB561D1 (1.6)	ENSG00000226645 (1.6)	GMIP (1.5)	RELB (1.5)	ENSG00000228044 (1.3)	BCL3 (1.2)	TM6SF2 (1.2)	TRAFD1 (1.1)
ENSG00000007237	GAS7 PPI subnetwork	0.30	> 0.20	ATXN2 (2.4)	GMIP (2.3)	TMEM50A (2.3)	ENSG00000235545 (2.2)	NPC1L1 (2.0)	C1orf63 (2.0)	ABCG5 (1.9)	DOCK7 (1.8)	HAVCR1 (1.8)	ABO (1.7)
ENSG00000067082	KLF6 PPI subnetwork	0.30	> 0.20	SARS (2.8)	PSRC1 (2.3)	SORT1 (2.3)	PSMA5 (2.2)	GEMIN7 (2.1)	CYB561D1 (1.9)	POLK (1.8)	LPIN3 (1.8)	MAFB (1.8)	ENSG00000235545 (1.7)
GO:0060055	angiogenesis involved in wound healing	0.30	> 0.20	ST3GAL4 (3.2)	ENSG00000254235 (2.9)	PPP1R37 (2.4)	NKPD1 (2.3)	ENSG00000238078 (2.3)	PVR (2.2)	CEACAM19 (2.2)	ENSG00000226648 (2.1)	FRK (2.1)	TMEM116 (1.7)
ENSG00000212908	ENSG00000212908 PPI subnetwork	0.30	> 0.20	ZNF101 (2.8)	CBLC (1.7)	CEACAM19 (1.6)	SUGP1 (1.6)	TSSK6 (1.4)	PSRC1 (1.4)	PPP1R37 (1.3)	CILP2 (1.3)	DDX56 (1.3)	PVRL2 (1.3)
ENSG00000213416	KRTAP4-12 PPI subnetwork	0.30	> 0.20	ZNF101 (2.8)	CBLC (1.7)	CEACAM19 (1.6)	SUGP1 (1.6)	TSSK6 (1.4)	PSRC1 (1.4)	PPP1R37 (1.3)	CILP2 (1.3)	DDX56 (1.3)	PVRL2 (1.3)
GO:0032799	low-density lipoprotein receptor particle metabolic process	0.30	> 0.20	MOSC1 (3.1)	ENSG00000235545 (3.1)	C17orf57 (2.6)	APOC1 (2.5)	GPAM (2.4)	HAVCR1 (2.4)	FRK (2.3)	ANKRD31 (2.1)	ENSG00000238078 (1.7)	LPIN3 (1.7)
GO:0010469	regulation of receptor activity	0.30	> 0.20	ENSG00000226645 (3.4)	GCNT4 (3.1)	ABO (2.6)	RPH3A (2.4)	ANKRD31 (2.2)	PPP1R37 (1.6)	CELSR2 (1.5)	SLC44A2 (1.5)	NCAN (1.5)	ENSG00000228044 (1.5)
ENSG00000131437	KIF3A PPI subnetwork	0.30	> 0.20	DYNC2LI1 (3.0)	POC5 (2.6)	TOP1 (2.3)	DOCK7 (2.3)	PLCG1 (1.6)	ENSG00000226645 (1.5)	TSSK6 (1.4)	CETP (1.4)	UBXN2B (1.3)	BCAM (1.2)
MP:0008750	abnormal interferon level	0.30	> 0.20	OASL (10.2)	PARP10 (7.0)	TRAFD1 (3.8)	BCL3 (3.2)	GMIP (2.2)	SH2B3 (2.2)	FRK (2.1)	RELB (2.0)	PVR (1.9)	CEACAM19 (1.5)
ENSG00000196084	ENSG00000196084 PPI subnetwork	0.30	> 0.20	FEN1 (2.3)	PTPN11 (2.3)	TOP1 (2.2)	PSMA5 (2.1)	SMARCA4 (1.9)	GRINA (1.8)	TMEM57 (1.8)	DHX38 (1.7)	NAA25 (1.6)	GATAD2A (1.6)
KEGG_BLADDER_CANCER	KEGG_BLADDER_CANCER	0.30	> 0.20	GRINA (2.5)	ENSG00000228044 (2.2)	CBLC (2.1)	ATXN7L2 (1.9)	PVR (1.6)	DNM2 (1.4)	SARS (1.4)	MAPKAPK5 (1.4)	CARM1 (1.3)	CELSR2 (1.3)
ENSG00000100934	SEC23A PPI subnetwork	0.30	> 0.20	YIPF2 (3.2)	PSMA5 (2.4)	ABCG8 (2.3)	SUGP1 (2.0)	USP24 (2.0)	ATXN2 (2.0)	TMEM57 (2.0)	DDX56 (1.8)	PLCG1 (1.8)	OGDH (1.8)
GO:0048660	regulation of smooth muscle cell proliferation	0.30	> 0.20	PVR (2.6)	HLX (2.1)	MAFB (1.8)	TRIB1 (1.8)	ALDH2 (1.6)	ENSG00000228044 (1.5)	ZNF101 (1.5)	NYNRIN (1.5)	ENSG00000254235 (1.5)	TIMD4 (1.5)
GO:0043011	myeloid dendritic cell differentiation	0.30	> 0.20	SH2B3 (2.7)	GEMIN7 (2.6)	ZNF180 (2.5)	ZNF101 (2.5)	GCNT4 (1.6)	C12orf47 (1.6)	GOT2P1 (1.6)	PBX4 (1.5)	CLPTM1 (1.3)	ABCG8 (1.3)
ENSG00000125912	NCLN PPI subnetwork	0.30	> 0.20	HNF1A (2.8)	MAPKAPK5 (2.7)	LPA (2.3)	TRAPPC6A (2.2)	ATP13A1 (2.0)	PTPN11 (2.0)	CEACAM19 (2.0)	ANKRD31 (1.9)	BRAP (1.8)	USP24 (1.8)
GO:0050869	negative regulation of B cell activation	0.30	> 0.20	ZNF101 (3.1)	ENSG00000238078 (2.7)	PBX4 (2.2)	GOT2P1 (1.8)	GCNT4 (1.7)	ENSG00000254235 (1.6)	NT5DC1 (1.6)	CEACAM19 (1.6)	ENSG00000228044 (1.6)	ENSG00000226645 (1.5)
ENSG00000118058	MLL PPI subnetwork	0.30	> 0.20	BUD13 (3.5)	C12orf43 (3.0)	ATXN7L2 (2.7)	ATXN2 (2.4)	POC5 (2.0)	ILF3 (1.9)	UBXN2B (1.8)	ZNF259 (1.7)	C12orf47 (1.7)	GOT2P1 (1.7)
ENSG00000157227	MMP14 PPI subnetwork	0.30	> 0.20	FRK (3.2)	MAFB (3.2)	CILP2 (3.0)	C11orf9 (2.0)	KANK2 (1.7)	SLC22A1 (1.6)	GPAM (1.5)	APOA5 (1.3)	C12orf47 (1.2)	APOE (1.1)
ENSG00000131469	RPL27 PPI subnetwork	0.30	> 0.20	ZNF259 (3.3)	NAA25 (2.9)	DHX38 (2.8)	DDX56 (2.6)	SUGP1 (2.4)	NKPD1 (2.4)	GATAD2A (2.3)	QTRT1 (2.3)	MAPKAPK5 (1.9)	ADAM1 (1.8)
MP:0003722	absent ureter	0.30	> 0.20	ZHX3 (3.1)	KANK2 (3.1)	FADS1 (2.3)	ITGB3 (2.0)	PVRL2 (2.0)	ENSG00000238078 (2.0)	CELSR2 (1.9)	FADS2 (1.8)	SORT1 (1.8)	BCAM (1.7)
ENSG00000111674	ENO2 PPI subnetwork	0.30	> 0.20	SLC44A2 (2.2)	PLEC (2.1)	ENSG00000228044 (2.0)	RHD (2.0)	RPH3A (1.8)	KANK2 (1.8)	SUGP1 (1.7)	PSRC1 (1.7)	MARK4 (1.7)	CARM1 (1.7)
REACTOME_VPU_MEDIATED_DEGRADATION_OF_CD4	REACTOME_VPU_MEDIATED_DEGRADATION_OF_CD4	0.30	> 0.20	PSMA5 (6.4)	TRAFD1 (3.4)	NT5DC1 (2.4)	NAA25 (2.3)	SUGP1 (1.9)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	SARS (1.5)	TMEM50A (1.3)
MP:0008682	decreased interleukin-17 secretion	0.30	> 0.20	PBX4 (4.0)	MYLIP (1.9)	SLC22A1 (1.8)	BCL3 (1.7)	HLX (1.7)	ENSG00000235545 (1.6)	TRAFD1 (1.6)	COL4A3BP (1.5)	RELB (1.4)	PVR (1.4)
REACTOME_METABOLISM_OF_PROTEINS	REACTOME_METABOLISM_OF_PROTEINS	0.30	> 0.20	ERP29 (4.4)	YIPF2 (4.0)	ATP13A1 (3.8)	TMED4 (2.9)	TMEM57 (2.6)	TMEM50A (2.4)	KIAA1324 (2.3)	CLPTM1 (2.1)	ST3GAL4 (1.9)	QTRT1 (1.6)
GO:0002467	germinal center formation	0.30	> 0.20	RELB (2.7)	ENSG00000228044 (2.4)	GMIP (1.9)	DNAH11 (1.9)	GCNT4 (1.7)	PBX4 (1.7)	GRINA (1.4)	DYNC2LI1 (1.4)	TIMD4 (1.3)	TXNL4B (1.3)
ENSG00000100345	MYH9 PPI subnetwork	0.30	> 0.20	KANK2 (3.3)	PLEC (3.1)	OGDH (2.7)	ITGB3 (2.4)	AP1M2 (2.3)	SLC44A2 (2.0)	TMEM50A (2.0)	ILF3 (1.6)	POLK (1.4)	GMIP (1.3)
ENSG00000186654	PRR5 PPI subnetwork	0.30	> 0.20	DHX38 (3.9)	MAU2 (2.9)	ILF3 (2.3)	SMARCA4 (2.3)	DNM2 (2.2)	MARK4 (2.1)	CARM1 (2.1)	USP24 (2.1)	TMEM50A (2.0)	ATP13A1 (1.9)
MP:0002786	abnormal Leydig cell morphology	0.30	> 0.20	TRIB1 (2.5)	ABO (2.5)	ATXN7L2 (2.2)	ST3GAL4 (2.2)	DNAH11 (2.2)	FADS2 (2.0)	GCNT4 (2.0)	ABCG8 (1.8)	ALDH2 (1.7)	HAPLN4 (1.6)
ENSG00000090863	GLG1 PPI subnetwork	0.30	> 0.20	RELB (8.0)	BCL3 (6.5)	GRINA (2.3)	ENSG00000254235 (2.2)	C12orf43 (1.9)	PVR (1.8)	ENSG00000228044 (1.8)	CLPTM1 (1.7)	ZNF259 (1.7)	PBX4 (1.6)
ENSG00000095752	IL11 PPI subnetwork	0.30	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.7)	TIMD4 (2.3)	CETP (2.2)	GMIP (1.9)	ALDH2 (1.9)	LPA (1.6)	PARP10 (1.2)	TRIB1 (1.1)
GO:0060349	bone morphogenesis	0.30	> 0.20	CILP2 (6.3)	PLEKHH2 (2.7)	YIPF2 (2.4)	NYNRIN (2.3)	MYLIP (1.7)	ATXN2 (1.5)	MAFB (1.4)	ALDH2 (1.3)	PCSK9 (1.3)	PMFBP1 (1.2)
MP:0008495	decreased IgG1 level	0.30	> 0.20	RELB (5.4)	GMIP (4.0)	BCL3 (3.3)	CETP (3.0)	TIMD4 (2.9)	SH2B3 (2.1)	PARP10 (1.8)	OASL (1.6)	MAFB (1.5)	PLCG1 (1.5)
GO:0002285	lymphocyte activation involved in immune response	0.30	> 0.20	NT5DC1 (2.4)	ZNF101 (2.0)	ENSG00000235545 (1.8)	GMIP (1.7)	ANKRD31 (1.7)	BCL3 (1.3)	RELB (1.3)	CYB561D1 (1.3)	DNAH11 (1.2)	PVR (1.2)
ENSG00000108669	CYTH1 PPI subnetwork	0.30	> 0.20	CYB561D1 (4.1)	GMIP (3.0)	C19orf52 (2.7)	TRAPPC6A (2.3)	LPIN3 (2.0)	COL4A3BP (2.0)	C1orf63 (1.8)	OASL (1.8)	PLEC (1.7)	PSMA5 (1.7)
MP:0002884	abnormal branchial arch morphology	0.30	> 0.20	PLCG1 (2.2)	DOCK7 (2.1)	PVR (1.8)	UBXN2B (1.7)	PTPN11 (1.7)	HLX (1.6)	CEACAM19 (1.6)	COL4A3BP (1.6)	DNAH11 (1.5)	BCAM (1.5)
GO:0070302	regulation of stress-activated protein kinase signaling cascade	0.30	> 0.20	ST3GAL4 (3.0)	LPAR2 (2.5)	UBXN2B (2.4)	POLK (1.9)	C11orf9 (1.9)	FRK (1.8)	ENSG00000226645 (1.7)	ENSG00000235545 (1.6)	TRAFD1 (1.5)	ZNF180 (1.5)
ENSG00000197943	PLCG2 PPI subnetwork	0.30	> 0.20	SH2B3 (3.7)	MAFB (3.1)	SLC44A2 (2.7)	PLEKHH2 (2.5)	GMIP (2.5)	USP24 (2.4)	APOE (2.3)	MYLIP (2.2)	TIMD4 (2.2)	LPA (2.1)
GO:0015101	organic cation transmembrane transporter activity	0.30	> 0.20	RHD (5.1)	PLG (4.1)	RHCE (3.8)	MOSC1 (2.9)	ENSG00000238078 (2.8)	ANGPTL3 (2.7)	TM6SF2 (2.0)	TMEM116 (1.9)	CEACAM19 (1.5)	PBX4 (1.5)
GO:0016208	AMP binding	0.30	> 0.20	PCSK9 (2.9)	MOSC1 (2.8)	OGDH (2.6)	NCAN (2.4)	FADS1 (1.7)	ST3GAL4 (1.7)	GMPR (1.7)	ABO (1.7)	SYPL2 (1.6)	ENSG00000254235 (1.4)
MP:0004875	increased mean systemic arterial blood pressure	0.30	> 0.20	ITGB3 (2.6)	KIAA1324 (2.2)	SLC44A2 (1.9)	ZHX3 (1.7)	BCAM (1.6)	TMEM50A (1.6)	ERP29 (1.5)	C12orf47 (1.5)	ZNF180 (1.5)	GMPR (1.5)
GO:0051897	positive regulation of protein kinase B signaling cascade	0.30	> 0.20	CETP (2.8)	TIMD4 (2.5)	PTPN11 (1.8)	CILP2 (1.6)	SORT1 (1.6)	TSSK6 (1.6)	ENSG00000228044 (1.5)	NKPD1 (1.4)	SLC22A1 (1.4)	ITGB3 (1.3)
GO:0007004	telomere maintenance via telomerase	0.30	> 0.20	TXNL4B (3.6)	POLK (3.0)	GOT2P1 (2.6)	DHODH (2.5)	POC5 (2.2)	ENSG00000235545 (2.1)	DHX38 (1.8)	UBXN2B (1.7)	TMEM57 (1.6)	GCNT4 (1.6)
ENSG00000110786	PTPN5 PPI subnetwork	0.30	> 0.20	PBX4 (2.7)	MOSC1 (2.5)	APOE (2.2)	NPC1L1 (2.1)	MAFB (2.0)	ENSG00000226645 (2.0)	SH2B3 (2.0)	AMIGO1 (2.0)	RPH3A (1.8)	MARK4 (1.6)
MP:0001240	abnormal epidermis stratum corneum morphology	0.31	> 0.20	NKPD1 (4.9)	CBLC (3.7)	AP1M2 (2.4)	CEACAM19 (2.4)	MAFB (2.3)	PMFBP1 (1.8)	CELSR2 (1.8)	LPIN3 (1.8)	PLEC (1.5)	C17orf57 (1.4)
MP:0002855	abnormal cochlear ganglion morphology	0.31	> 0.20	TM6SF2 (2.8)	HNF1A (2.7)	KIAA1324 (2.5)	MAU2 (2.1)	TRAPPC6A (2.0)	AP1M2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.9)	BCAM (1.8)	PCSK9 (1.8)
GO:0007005	mitochondrion organization	0.31	> 0.20	GOT2P1 (3.0)	TOMM40 (2.8)	ACAD10 (2.8)	DHODH (2.7)	TRAPPC6A (2.3)	C19orf52 (2.0)	TMEM116 (2.0)	C12orf43 (1.9)	BLOC1S3 (1.8)	TXNL4B (1.7)
GO:0032393	MHC class I receptor activity	0.31	> 0.20	FRK (2.4)	POLK (1.9)	ENSG00000228044 (1.9)	OASL (1.7)	PLEKHH2 (1.7)	ADAM1 (1.4)	PARP10 (1.3)	YIPF2 (1.3)	LPIN3 (1.3)	SH2B3 (1.3)
ENSG00000115705	TPO PPI subnetwork	0.31	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.5)	TIMD4 (2.2)	ALDH2 (2.0)	CETP (2.0)	GMIP (1.7)	LPA (1.7)	TRIB1 (1.3)	ST3GAL4 (1.2)
GO:0016805	dipeptidase activity	0.31	> 0.20	NPC1L1 (4.7)	TM6SF2 (4.0)	HNF1A (2.6)	NT5DC1 (2.5)	PMFBP1 (2.2)	ABCG8 (2.1)	BLOC1S3 (2.0)	MOSC1 (2.0)	ABCG5 (1.9)	AP1M2 (1.8)
GO:0000097	sulfur amino acid biosynthetic process	0.31	> 0.20	DNAH11 (2.1)	SARS (1.9)	DHODH (1.8)	UBXN2B (1.7)	SLC22A1 (1.6)	ANGPTL3 (1.6)	CYP7A1 (1.5)	GOT2P1 (1.5)	APOA5 (1.5)	C17orf57 (1.5)
ENSG00000121691	CAT PPI subnetwork	0.31	> 0.20	GPAM (3.3)	TMEM57 (3.2)	CYP7A1 (2.5)	ZHX3 (2.3)	NAA25 (1.8)	USP24 (1.7)	ENSG00000254235 (1.7)	PVR (1.6)	BRAP (1.6)	KANK2 (1.5)
ENSG00000138439	FAM117B PPI subnetwork	0.31	> 0.20	CBLC (4.5)	AP1M2 (3.5)	PSRC1 (2.4)	LPIN3 (2.3)	FRK (1.9)	CELSR2 (1.9)	MARK4 (1.8)	ANKRD31 (1.7)	DOCK7 (1.7)	ST3GAL4 (1.7)
ENSG00000160007	ARHGAP35 PPI subnetwork	0.31	> 0.20	GMIP (3.2)	PARP10 (2.8)	ATXN2 (2.5)	USP24 (2.5)	MARK4 (2.4)	MAU2 (2.2)	MAFB (2.1)	C17orf57 (1.9)	SMARCA4 (1.8)	POLK (1.7)
ENSG00000121390	PSPC1 PPI subnetwork	0.31	> 0.20	ATXN2 (2.8)	GMIP (2.7)	C1orf63 (2.4)	ABO (2.3)	BUD13 (2.1)	CYP7A1 (2.0)	SMARCA4 (1.8)	C12orf47 (1.8)	ILF3 (1.8)	FADS2 (1.7)
GO:0008214	protein dealkylation	0.31	> 0.20	TMEM57 (3.2)	BLOC1S3 (2.9)	ATXN7L2 (2.8)	C12orf51 (2.2)	ENSG00000254235 (2.1)	TOP1 (1.9)	GCNT4 (1.9)	LPA (1.6)	CYB561D1 (1.6)	LPAR2 (1.6)
GO:0006482	protein demethylation	0.31	> 0.20	TMEM57 (3.2)	BLOC1S3 (2.9)	ATXN7L2 (2.8)	C12orf51 (2.2)	ENSG00000254235 (2.1)	TOP1 (1.9)	GCNT4 (1.9)	LPA (1.6)	CYB561D1 (1.6)	LPAR2 (1.6)
ENSG00000141738	GRB7 PPI subnetwork	0.31	> 0.20	KANK2 (2.4)	AP1M2 (2.3)	TRIB1 (2.2)	LDLR (2.2)	PBX4 (1.9)	PSRC1 (1.7)	BCAM (1.6)	HAPLN4 (1.5)	GATAD2A (1.5)	SH2B3 (1.5)
GO:0008630	DNA damage response, signal transduction resulting in induction of apoptosis	0.31	> 0.20	C17orf57 (2.4)	BLOC1S3 (2.2)	C12orf47 (2.0)	ZNF101 (1.8)	ZNF180 (1.8)	BUD13 (1.7)	POLK (1.5)	DOCK7 (1.4)	AMIGO1 (1.3)	NYNRIN (1.2)
GO:0060090	binding, bridging	0.31	> 0.20	PLEC (2.8)	GMIP (2.2)	C11orf9 (1.7)	CBLC (1.6)	COL4A3BP (1.6)	ST3GAL4 (1.5)	LPAR2 (1.5)	ITGB3 (1.5)	APOC1 (1.4)	FRK (1.4)
ENSG00000198034	RPS4X PPI subnetwork	0.31	> 0.20	DDX56 (3.9)	ZNF259 (3.6)	NAA25 (3.6)	QTRT1 (3.2)	SARS (2.7)	DHX38 (2.7)	TOMM40 (2.4)	ATP13A1 (2.3)	SUGP1 (2.1)	ILF3 (2.1)
MP:0009746	enhanced behavioral response to xenobiotic	0.31	> 0.20	LPA (3.8)	CYP7A1 (3.7)	SLC22A1 (3.3)	APOC4 (3.1)	RPH3A (2.7)	APOA5 (2.6)	PLG (2.1)	ANGPTL3 (2.0)	TM6SF2 (1.8)	HP (1.8)
MP:0003149	abnormal tectorial membrane morphology	0.31	> 0.20	TMEM116 (2.9)	HNF1A (2.7)	APOC1 (2.7)	AP1M2 (2.5)	MYLIP (2.0)	PBX4 (1.9)	CETP (1.6)	ZHX3 (1.5)	SLC22A1 (1.5)	MAFB (1.5)
ENSG00000167553	TUBA1C PPI subnetwork	0.31	> 0.20	OGDH (3.1)	PLEC (2.2)	KANK2 (2.1)	SARS (2.0)	POLK (1.9)	SMARCA4 (1.8)	CARM1 (1.7)	NYNRIN (1.7)	C1orf63 (1.7)	ITGB3 (1.5)
ENSG00000142677	IL22RA1 PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.5)	PVR (1.5)	RELB (1.4)	ZNF101 (1.4)	SLC22A1 (1.4)	OASL (1.4)	HLX (1.3)
GO:0008514	organic anion transmembrane transporter activity	0.31	> 0.20	PLG (6.5)	ANGPTL3 (6.4)	SLC22A1 (5.2)	APOA5 (3.1)	APOC4 (3.0)	CYP7A1 (2.9)	TIMD4 (2.2)	APOE (2.0)	APOC1 (1.7)	HNF1A (1.7)
ENSG00000091181	IL5RA PPI subnetwork	0.31	> 0.20	BCL3 (3.2)	COL4A3BP (2.2)	RELB (1.6)	CYP7A1 (1.6)	HLX (1.4)	C17orf57 (1.4)	ZNF101 (1.4)	SLC22A1 (1.3)	BCAM (1.2)	TRAFD1 (1.2)
GO:0019207	kinase regulator activity	0.31	> 0.20	NCAN (2.4)	SH2B3 (2.2)	MYLIP (2.1)	ITGB3 (1.8)	TOP1 (1.8)	TRAFD1 (1.8)	DYNC2LI1 (1.8)	TRIB1 (1.7)	MAFB (1.6)	COL4A3BP (1.5)
GO:0016045	detection of bacterium	0.31	> 0.20	CEACAM19 (4.3)	C17orf57 (2.5)	PMFBP1 (2.1)	GOT2P1 (1.8)	SORT1 (1.7)	DNAH11 (1.7)	LPAR2 (1.5)	BLOC1S3 (1.3)	HP (1.2)	NKPD1 (1.2)
REACTOME_CROSS:PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	REACTOME_CROSS:PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	0.31	> 0.20	PSMA5 (6.3)	TRAFD1 (3.9)	NAA25 (2.5)	NT5DC1 (2.4)	PARP10 (1.9)	TOMM40 (1.8)	SUGP1 (1.7)	DDX56 (1.6)	TMEM50A (1.4)	SARS (1.3)
ENSG00000099381	SETD1A PPI subnetwork	0.31	> 0.20	C19orf52 (3.0)	KIAA1324 (3.0)	BUD13 (2.9)	C1orf63 (2.6)	PSMA5 (2.1)	BRAP (1.8)	USP1 (1.8)	ACAD10 (1.7)	CARM1 (1.7)	NAA25 (1.5)
GO:0015093	ferrous iron transmembrane transporter activity	0.31	> 0.20	C12orf43 (3.6)	TOMM40 (3.3)	ZNF259 (2.4)	TMED4 (2.4)	MAPKAPK5 (2.1)	DDX56 (2.0)	ENSG00000226645 (1.9)	PBX4 (1.9)	PVR (1.7)	CLPTM1 (1.7)
ENSG00000175445	LPL PPI subnetwork	0.31	> 0.20	TIMD4 (4.4)	CILP2 (2.3)	BCAM (2.3)	TMEM116 (2.1)	KIAA1324 (2.0)	CLPTM1 (1.9)	MOSC1 (1.8)	ERP29 (1.8)	PPP1R37 (1.8)	DNAH11 (1.7)
MP:0000383	abnormal hair follicle orientation	0.31	> 0.20	CELSR2 (3.4)	CBLC (3.0)	AP1M2 (2.7)	PVR (2.7)	BCAM (2.5)	CEACAM19 (2.3)	LPIN3 (1.8)	PLEC (1.6)	OASL (1.6)	PVRL2 (1.5)
ENSG00000159217	IGF2BP1 PPI subnetwork	0.31	> 0.20	ILF3 (3.6)	SMARCA4 (3.4)	DDX56 (3.4)	QTRT1 (3.2)	SARS (3.1)	ATP13A1 (2.7)	ZNF259 (2.4)	C12orf43 (2.3)	TOMM40 (2.3)	GATAD2A (2.3)
ENSG00000169372	CRADD PPI subnetwork	0.31	> 0.20	HMGCR (3.6)	FADS2 (2.6)	ZNF180 (2.4)	ST3GAL4 (2.3)	PCSK9 (2.2)	LDLR (2.1)	FADS1 (2.1)	ZNF101 (2.1)	BLOC1S3 (2.0)	ANKRD31 (1.6)
GO:0001776	leukocyte homeostasis	0.31	> 0.20	GEMIN7 (2.2)	ENSG00000226645 (2.1)	SH2B3 (2.0)	TRAPPC6A (1.8)	GCNT4 (1.8)	GMIP (1.6)	CYB561D1 (1.6)	PBX4 (1.5)	POLK (1.4)	FRK (1.4)
MP:0001134	absent corpus luteum	0.31	> 0.20	GPAM (2.8)	GCNT4 (2.6)	KIAA1324 (2.4)	LDLR (2.0)	MOSC1 (1.9)	PMFBP1 (1.8)	CELSR2 (1.8)	TRIB1 (1.8)	AMIGO1 (1.8)	APOE (1.7)
ENSG00000103365	GGA2 PPI subnetwork	0.31	> 0.20	COL4A3BP (3.3)	ENSG00000226645 (3.2)	CYB561D1 (2.3)	BLOC1S3 (2.2)	YIPF2 (2.2)	C19orf52 (2.0)	PTPN11 (1.8)	POLK (1.7)	MYLIP (1.7)	PLEKHH2 (1.6)
GO:0071322	cellular response to carbohydrate stimulus	0.31	> 0.20	ENSG00000254235 (2.4)	ADAM1 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.9)	NT5DC1 (1.6)	UBXN2B (1.3)	ERP29 (1.3)	PCSK9 (1.2)	ENSG00000238078 (1.2)	KIAA1324 (1.1)
ENSG00000123496	IL13RA2 PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
ENSG00000103522	IL21R PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
ENSG00000164485	IL22RA2 PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
ENSG00000076984	MAP2K7 PPI subnetwork	0.31	> 0.20	PARP10 (3.3)	TRIB1 (3.2)	BCL3 (2.5)	OASL (2.4)	ATXN7L2 (2.4)	HLX (2.3)	LPAR2 (2.2)	PLEKHH2 (2.1)	ABCG8 (2.1)	SARS (2.0)
ENSG00000005884	ITGA3 PPI subnetwork	0.31	> 0.20	BCAM (3.9)	ST3GAL4 (3.2)	PVRL2 (3.0)	APOE (3.0)	PLEC (2.7)	GRINA (2.6)	CLPTM1 (2.3)	KANK2 (2.1)	PMFBP1 (1.8)	ITGB3 (1.8)
ENSG00000135605	TEC PPI subnetwork	0.31	> 0.20	GATAD2A (2.7)	GMIP (2.7)	MYLIP (2.3)	DNM2 (1.9)	LPAR2 (1.9)	GRINA (1.8)	ATXN7L2 (1.7)	ST3GAL4 (1.7)	GMPR (1.6)	CYB561D1 (1.5)
ENSG00000160746	ANO10 PPI subnetwork	0.31	> 0.20	ATP13A1 (2.6)	QTRT1 (2.4)	C19orf52 (2.3)	DDX56 (2.2)	LPAR2 (2.1)	DNM2 (2.1)	ILF3 (2.0)	SUGP1 (1.9)	TMEM57 (1.8)	SARS (1.8)
ENSG00000119041	GTF3C3 PPI subnetwork	0.31	> 0.20	DDX56 (2.8)	GEMIN7 (2.8)	ENSG00000226645 (2.7)	ATXN2 (2.6)	ATP13A1 (2.5)	BUD13 (2.5)	TOMM40 (2.3)	MAU2 (2.2)	POC5 (2.0)	C12orf43 (1.9)
MP:0000125	absent incisors	0.31	> 0.20	ENSG00000238078 (2.2)	PLCG1 (2.0)	CILP2 (1.7)	ANKRD31 (1.5)	ZNF101 (1.4)	ITGB3 (1.4)	ABO (1.4)	FRK (1.4)	CELSR2 (1.3)	AMIGO1 (1.2)
MP:0004220	abnormal peripheral nervous system regeneration	0.31	> 0.20	HP (3.0)	CELSR2 (2.5)	CETP (2.1)	ST3GAL4 (1.9)	GPAM (1.7)	TXNL4B (1.5)	APOE (1.5)	BCAM (1.4)	PCSK9 (1.3)	TIMD4 (1.3)
GO:0006766	vitamin metabolic process	0.31	> 0.20	TM6SF2 (2.8)	ABCG8 (2.7)	GPAM (2.1)	ALDH2 (2.0)	ENSG00000235545 (1.9)	CYP7A1 (1.8)	LPAR2 (1.8)	ACAD10 (1.8)	ANGPTL3 (1.7)	ABCG5 (1.6)
MP:0009790	decreased susceptibility to viral infection induced morbidity/mortality	0.31	> 0.20	OASL (4.3)	RELB (3.1)	TRAFD1 (3.0)	PARP10 (2.5)	BCL3 (2.2)	GMIP (2.0)	FRK (1.8)	POLK (1.8)	C12orf43 (1.6)	NAA25 (1.6)
ENSG00000212874	ENSG00000212874 PPI subnetwork	0.31	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.5)	HAVCR1 (2.1)	OGDH (2.1)	C12orf47 (2.1)	ACAD10 (1.9)	C19orf52 (1.8)	ZNF180 (1.6)	PVRL2 (1.5)	TOMM40 (1.4)
ENSG00000198712	MT-CO2 PPI subnetwork	0.31	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.5)	HAVCR1 (2.1)	OGDH (2.1)	C12orf47 (2.1)	ACAD10 (1.9)	C19orf52 (1.8)	ZNF180 (1.6)	PVRL2 (1.5)	TOMM40 (1.4)
ENSG00000197555	SIPA1L1 PPI subnetwork	0.31	> 0.20	CBLC (6.4)	AP1M2 (4.4)	ST3GAL4 (2.5)	CELSR2 (2.3)	LPAR2 (2.1)	LPIN3 (1.8)	PPP1R37 (1.6)	HNF1A (1.6)	PLEC (1.5)	DNM2 (1.4)
ENSG00000110075	PPP6R3 PPI subnetwork	0.31	> 0.20	TOMM40 (2.9)	C19orf52 (2.4)	PPP1R37 (1.9)	RELB (1.9)	USP24 (1.9)	ENSG00000226648 (1.8)	TXNL4B (1.8)	SMARCA4 (1.8)	ZNF101 (1.7)	BUD13 (1.6)
ENSG00000113140	SPARC PPI subnetwork	0.31	> 0.20	APOE (2.9)	ITGB3 (2.9)	CILP2 (2.7)	PVRL2 (2.5)	SH2B3 (2.2)	KANK2 (2.1)	BCAM (1.9)	APOC1 (1.9)	ANGPTL3 (1.9)	C17orf57 (1.8)
ENSG00000197746	PSAP PPI subnetwork	0.31	> 0.20	SORT1 (2.5)	PLCG1 (2.5)	PVR (2.5)	TRAPPC6A (2.3)	CELSR2 (2.3)	PVRL2 (2.1)	SARS (2.0)	ANKRD31 (1.6)	DOCK7 (1.5)	ADAM1 (1.5)
GO:0016624	oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	0.31	> 0.20	ACAD10 (3.1)	MOSC1 (2.4)	GPAM (2.3)	NT5DC1 (2.1)	TRAPPC6A (1.8)	LPA (1.7)	DHODH (1.6)	OGDH (1.5)	PLG (1.5)	GOT2P1 (1.4)
ENSG00000095637	SORBS1 PPI subnetwork	0.31	> 0.20	PLEC (3.4)	GMIP (3.2)	DNM2 (3.1)	GRINA (2.5)	SORT1 (2.4)	PVRL2 (2.4)	OGDH (2.2)	ACAD10 (2.1)	CEACAM19 (1.9)	SH2B3 (1.7)
ENSG00000130332	LSM7 PPI subnetwork	0.31	> 0.20	DHX38 (2.9)	BUD13 (2.8)	SUGP1 (2.6)	FEN1 (2.6)	MAU2 (2.5)	TOP1 (2.3)	BRAP (2.3)	ILF3 (2.2)	DDX56 (1.9)	POC5 (1.9)
MP:0001272	increased metastatic potential	0.31	> 0.20	POLK (2.3)	CETP (1.8)	TRAFD1 (1.7)	RELB (1.7)	ITGB3 (1.6)	PVR (1.5)	MOSC1 (1.4)	ALDH2 (1.3)	LPIN3 (1.2)	CILP2 (1.1)
ENSG00000158042	MRPL17 PPI subnetwork	0.31	> 0.20	GEMIN7 (3.0)	MAPKAPK5 (2.9)	TOMM40 (2.8)	QTRT1 (2.6)	DHX38 (2.2)	MAU2 (2.1)	ST3GAL4 (2.0)	DDX56 (1.9)	SMARCA4 (1.9)	SUGP1 (1.8)
GO:0034101	erythrocyte homeostasis	0.31	> 0.20	RHCE (6.2)	RHD (5.8)	C12orf51 (2.5)	TMEM57 (2.4)	C19orf52 (2.2)	BLOC1S3 (2.1)	DNM2 (1.8)	UBXN2B (1.6)	ZNF180 (1.5)	GMPR (1.5)
ENSG00000168497	SDPR PPI subnetwork	0.31	> 0.20	NAA25 (2.3)	SARS (2.2)	SORT1 (2.2)	ST3GAL4 (2.1)	BUD13 (1.9)	ERP29 (1.8)	GATAD2A (1.8)	GRINA (1.6)	ENSG00000238078 (1.6)	HAVCR1 (1.5)
ENSG00000196396	PTPN1 PPI subnetwork	0.31	> 0.20	DNM2 (3.6)	C1orf63 (2.3)	PVRL2 (2.3)	PLEC (2.1)	TRAFD1 (2.1)	PLCG1 (2.0)	SLC44A2 (1.9)	CARM1 (1.9)	BLOC1S3 (1.8)	LDLR (1.7)
GO:2001251	negative regulation of chromosome organization	0.31	> 0.20	RHCE (2.6)	TXNL4B (2.5)	BLOC1S3 (2.4)	ENSG00000235545 (2.0)	ZNF180 (1.9)	ENSG00000226648 (1.7)	MAU2 (1.6)	RHD (1.6)	GOT2P1 (1.4)	C17orf57 (1.4)
GO:0016447	somatic recombination of immunoglobulin gene segments	0.31	> 0.20	NT5DC1 (2.3)	ZNF101 (2.1)	GCNT4 (2.0)	C17orf57 (2.0)	DYNC2LI1 (1.7)	GOT2P1 (1.5)	POC5 (1.5)	ENSG00000226648 (1.4)	UBXN2B (1.4)	ZNF180 (1.3)
GO:0008173	RNA methyltransferase activity	0.31	> 0.20	QTRT1 (5.2)	NAA25 (3.3)	DDX56 (2.9)	MAPKAPK5 (2.9)	C19orf52 (2.8)	DHODH (2.5)	C12orf43 (2.4)	TOMM40 (2.2)	ZNF259 (2.1)	YIPF2 (2.0)
MP:0004256	abnormal maternal decidual layer morphology	0.31	> 0.20	NCAN (3.1)	APOE (2.9)	APOC1 (2.6)	DNM2 (1.9)	ST3GAL4 (1.6)	RHD (1.6)	TIMD4 (1.6)	SLC22A1 (1.6)	APOA5 (1.5)	TRAFD1 (1.5)
GO:0071339	MLL1 complex	0.31	> 0.20	C12orf43 (3.0)	BUD13 (3.0)	ATXN2 (2.9)	QTRT1 (2.5)	MAPKAPK5 (2.4)	DHX38 (2.3)	DDX56 (2.1)	OGDH (2.1)	ZNF180 (2.1)	C12orf47 (2.0)
ENSG00000100823	APEX1 PPI subnetwork	0.31	> 0.20	USP1 (2.6)	PSRC1 (2.4)	HLX (2.0)	CELSR2 (1.9)	MAFB (1.9)	UBXN2B (1.8)	TOMM40 (1.7)	BLOC1S3 (1.6)	GRINA (1.6)	BCAM (1.5)
ENSG00000010818	HIVEP2 PPI subnetwork	0.31	> 0.20	FRK (2.9)	PTPN11 (2.5)	PARP10 (2.4)	C17orf57 (2.2)	KANK2 (1.9)	HNF1A (1.9)	ZNF180 (1.9)	ENSG00000254235 (1.8)	ADAM1 (1.8)	TOMM40 (1.7)
ENSG00000146701	MDH2 PPI subnetwork	0.31	> 0.20	SARS (2.9)	ACAD10 (2.7)	ZNF259 (2.6)	NAA25 (2.6)	DHODH (2.5)	TRAPPC6A (2.3)	GOT2P1 (2.1)	FADS2 (2.1)	DOCK7 (2.0)	TOMM40 (1.8)
ENSG00000003756	RBM5 PPI subnetwork	0.31	> 0.20	ILF3 (4.1)	C1orf63 (3.5)	TOP1 (3.0)	USP1 (2.9)	DHX38 (2.6)	BUD13 (2.6)	SMARCA4 (2.6)	FEN1 (2.3)	SUGP1 (2.2)	PTPN11 (2.0)
ENSG00000055130	CUL1 PPI subnetwork	0.31	> 0.20	PTPN11 (2.6)	GMPR (2.2)	BRAP (2.1)	OASL (2.0)	FEN1 (2.0)	SUGP1 (1.9)	ZNF180 (1.8)	GRINA (1.5)	RELB (1.4)	ENSG00000226645 (1.3)
GO:0015238	drug transmembrane transporter activity	0.31	> 0.20	ANGPTL3 (3.2)	HAVCR1 (2.8)	TM6SF2 (2.5)	ATP13A1 (2.0)	TMED4 (1.8)	PLG (1.8)	SLC22A1 (1.7)	HMGCR (1.6)	BCAM (1.5)	SYPL2 (1.4)
MP:0002132	abnormal respiratory system morphology	0.31	> 0.20	PLEKHH2 (3.3)	ENSG00000226648 (2.6)	HLX (2.5)	TIMD4 (2.2)	GCNT4 (2.2)	DNAH11 (1.9)	ALDH2 (1.7)	MOSC1 (1.6)	ENSG00000228044 (1.6)	GPAM (1.6)
ENSG00000104897	SF3A2 PPI subnetwork	0.31	> 0.20	ILF3 (3.9)	DHX38 (3.6)	C1orf63 (3.6)	BUD13 (3.6)	TOP1 (3.5)	SUGP1 (3.5)	SMARCA4 (3.3)	USP1 (2.8)	QTRT1 (2.6)	FEN1 (2.3)
GO:0006359	regulation of transcription from RNA polymerase III promoter	0.31	> 0.20	BRAP (2.6)	AMIGO1 (2.4)	ADAM1 (2.0)	COL4A3BP (1.9)	CYP7A1 (1.7)	ABCG8 (1.5)	CEACAM19 (1.4)	ATXN7L2 (1.3)	HNF1A (1.3)	C12orf47 (1.3)
MP:0004696	abnormal thyroid follicle morphology	0.31	> 0.20	MOSC1 (3.4)	PBX4 (3.1)	C17orf57 (3.0)	GOT2P1 (2.7)	NKPD1 (1.8)	ZHX3 (1.8)	YIPF2 (1.5)	PLCG1 (1.3)	GCNT4 (1.3)	PMFBP1 (1.1)
ENSG00000161920	MED11 PPI subnetwork	0.31	> 0.20	TXNL4B (3.7)	GEMIN7 (3.6)	BRAP (2.5)	MAPKAPK5 (2.4)	BUD13 (2.3)	BLOC1S3 (2.1)	DHX38 (2.0)	ZNF180 (2.0)	POC5 (1.9)	TOP1 (1.7)
GO:0007260	tyrosine phosphorylation of STAT protein	0.31	> 0.20	ENSG00000228044 (2.2)	TRAFD1 (1.9)	TIMD4 (1.9)	PBX4 (1.9)	ENSG00000254235 (1.8)	GEMIN7 (1.6)	ENSG00000238078 (1.6)	PARP10 (1.6)	COL4A3BP (1.6)	PVR (1.5)
GO:0051321	meiotic cell cycle	0.31	> 0.20	ANKRD31 (3.9)	ENSG00000228044 (2.4)	POC5 (1.9)	USP1 (1.4)	PSRC1 (1.3)	ZHX3 (1.3)	TMEM116 (1.2)	ENSG00000238078 (1.1)	PLEKHH2 (1.1)	FEN1 (1.1)
MP:0010380	inner cell mass apoptosis	0.31	> 0.20	USP1 (2.9)	UBXN2B (2.7)	HAVCR1 (2.7)	POC5 (1.7)	CETP (1.6)	DDX56 (1.6)	TOP1 (1.5)	PSRC1 (1.4)	TOMM40 (1.4)	AMIGO1 (1.3)
REACTOME_FANCONI_ANEMIA_PATHWAY	REACTOME_FANCONI_ANEMIA_PATHWAY	0.31	> 0.20	FEN1 (3.9)	ZNF180 (2.8)	USP1 (2.5)	POC5 (2.2)	PSRC1 (2.1)	C17orf57 (1.6)	TMEM116 (1.6)	NKPD1 (1.5)	MAU2 (1.4)	DHODH (1.2)
MP:0000030	abnormal tympanic ring morphology	0.31	> 0.20	NYNRIN (2.5)	CILP2 (2.1)	ATXN7L2 (1.8)	OGDH (1.6)	TSSK6 (1.5)	ZHX3 (1.5)	ENSG00000254235 (1.5)	BCAM (1.2)	MAFB (1.2)	ANKRD31 (1.2)
REACTOME_INTERLEUKIN:1_SIGNALING	REACTOME_INTERLEUKIN:1_SIGNALING	0.31	> 0.20	BCL3 (3.8)	RELB (3.3)	HLX (2.5)	ENSG00000235545 (2.2)	BLOC1S3 (2.2)	OASL (2.1)	MYLIP (2.1)	CYB561D1 (1.8)	GRINA (1.5)	PVR (1.3)
GO:0005528	FK506 binding	0.31	> 0.20	YIPF2 (4.1)	CLPTM1 (2.5)	GATAD2A (2.4)	OGDH (2.4)	ERP29 (2.3)	TOMM40 (2.2)	ZHX3 (2.1)	GRINA (1.9)	QTRT1 (1.8)	PPP1R37 (1.7)
GO:0005527	macrolide binding	0.31	> 0.20	YIPF2 (4.1)	CLPTM1 (2.5)	GATAD2A (2.4)	OGDH (2.4)	ERP29 (2.3)	TOMM40 (2.2)	ZHX3 (2.1)	GRINA (1.9)	QTRT1 (1.8)	PPP1R37 (1.7)
MP:0004783	abnormal cardinal vein morphology	0.31	> 0.20	BCAM (3.5)	CETP (3.2)	SLC44A2 (2.7)	PVRL2 (2.4)	SH2B3 (2.0)	NYNRIN (1.9)	PVR (1.8)	LPA (1.8)	MARK4 (1.6)	HLX (1.5)
ENSG00000100985	MMP9 PPI subnetwork	0.31	> 0.20	ITGB3 (2.8)	PVR (2.5)	SLC22A1 (2.5)	FRK (2.4)	PLEKHH2 (1.9)	PVRL2 (1.8)	ABCG5 (1.7)	HP (1.7)	DYNC2LI1 (1.7)	ANGPTL3 (1.7)
ENSG00000117266	CDK18 PPI subnetwork	0.31	> 0.20	CARM1 (3.6)	PLEC (3.4)	DNM2 (3.0)	ZHX3 (2.9)	COL4A3BP (2.4)	PTPN11 (2.4)	USP24 (2.3)	C12orf51 (2.2)	LPAR2 (2.2)	KANK2 (2.2)
ENSG00000136068	FLNB PPI subnetwork	0.31	> 0.20	PLEC (4.1)	ITGB3 (3.0)	ZHX3 (2.6)	PLCG1 (2.6)	DNM2 (2.5)	PVR (2.5)	NPC1L1 (2.0)	SH2B3 (1.8)	POLK (1.7)	PTPN11 (1.7)
ENSG00000072134	EPN2 PPI subnetwork	0.31	> 0.20	DHX38 (2.3)	COL4A3BP (2.2)	TXNL4B (2.1)	MYLIP (2.1)	USP24 (2.1)	ENSG00000235545 (2.0)	GOT2P1 (1.6)	APOE (1.6)	CLPTM1 (1.6)	FRK (1.5)
ENSG00000155897	ADCY8 PPI subnetwork	0.31	> 0.20	AP1M2 (3.0)	CBLC (2.3)	APOC1 (2.3)	SORT1 (2.0)	PLEC (1.8)	APOB (1.8)	FRK (1.5)	TMEM57 (1.5)	CLPTM1 (1.4)	APOE (1.4)
ENSG00000163207	IVL PPI subnetwork	0.31	> 0.20	NKPD1 (3.7)	PMFBP1 (2.3)	LPIN3 (1.9)	UBXN2B (1.7)	BRAP (1.6)	DHX38 (1.4)	CBLC (1.4)	PVRL2 (1.2)	TOMM40 (1.2)	COL4A3BP (1.2)
ENSG00000179094	PER1 PPI subnetwork	0.31	> 0.20	ZHX3 (2.6)	TMEM57 (2.5)	KANK2 (2.4)	ENSG00000254235 (2.3)	PVRL2 (2.0)	C17orf57 (1.8)	ATXN2 (1.7)	GPAM (1.7)	COL4A3BP (1.5)	PBX4 (1.4)
ENSG00000104164	PLDN PPI subnetwork	0.31	> 0.20	COL4A3BP (2.9)	ENSG00000226645 (2.8)	GMPR (2.5)	TXNL4B (2.4)	TRAPPC6A (2.3)	C12orf43 (2.3)	POC5 (2.3)	CYB561D1 (2.0)	C17orf57 (1.8)	BRAP (1.6)
GO:0043467	regulation of generation of precursor metabolites and energy	0.31	> 0.20	ZHX3 (2.6)	ENSG00000254235 (2.1)	HNF1A (2.1)	PCSK9 (1.8)	KANK2 (1.7)	LPA (1.7)	NT5DC1 (1.5)	GPAM (1.4)	TSSK6 (1.4)	SORT1 (1.4)
ENSG00000164400	CSF2 PPI subnetwork	0.31	> 0.20	BCL3 (3.4)	HLX (3.3)	RELB (2.9)	TIMD4 (2.6)	CETP (1.9)	ALDH2 (1.8)	LPA (1.8)	GMIP (1.6)	PLEKHH2 (1.5)	PARP10 (1.2)
GO:0032881	regulation of polysaccharide metabolic process	0.31	> 0.20	LPA (2.2)	ZHX3 (2.1)	MYLIP (1.8)	AMIGO1 (1.7)	CYB561D1 (1.7)	ZNF180 (1.7)	GPAM (1.6)	KANK2 (1.5)	PCSK9 (1.4)	CYP7A1 (1.3)
GO:0070873	regulation of glycogen metabolic process	0.31	> 0.20	LPA (2.2)	ZHX3 (2.1)	MYLIP (1.8)	AMIGO1 (1.7)	CYB561D1 (1.7)	ZNF180 (1.7)	GPAM (1.6)	KANK2 (1.5)	PCSK9 (1.4)	CYP7A1 (1.3)
ENSG00000160789	LMNA PPI subnetwork	0.31	> 0.20	OGDH (2.4)	ILF3 (2.1)	TOP1 (1.8)	ITGB3 (1.8)	TOMM40 (1.6)	SARS (1.5)	NAA25 (1.5)	PSMA5 (1.5)	KANK2 (1.3)	ENSG00000238078 (1.3)
MP:0004956	decreased thymus weight	0.31	> 0.20	CILP2 (3.8)	C17orf57 (2.3)	POLK (2.1)	UBXN2B (2.0)	ZNF101 (1.7)	FRK (1.4)	SYPL2 (1.4)	PLEC (1.3)	AP1M2 (1.2)	SLC22A1 (1.2)
MP:0000750	abnormal muscle regeneration	0.31	> 0.20	SYPL2 (5.2)	LPIN3 (3.0)	PVR (2.9)	AMIGO1 (2.4)	TRIB1 (2.0)	BCAM (1.9)	MAFB (1.8)	TSSK6 (1.7)	GOT2P1 (1.4)	SLC44A2 (1.4)
GO:0020027	hemoglobin metabolic process	0.31	> 0.20	RHCE (7.1)	RHD (4.9)	GMPR (3.0)	ADAM1 (2.4)	BLOC1S3 (1.9)	CEACAM19 (1.8)	C12orf51 (1.7)	ATXN7L2 (1.6)	LPIN3 (1.5)	GRINA (1.2)
MP:0003036	vertebral transformation	0.31	> 0.20	NYNRIN (3.2)	UBXN2B (2.4)	PLCG1 (1.9)	POLK (1.6)	ATXN7L2 (1.5)	TRIB1 (1.4)	ENSG00000254235 (1.3)	CARM1 (1.3)	PCSK9 (1.2)	CILP2 (1.2)
MP:0000825	dilated lateral ventricles	0.31	> 0.20	NYNRIN (2.4)	C12orf51 (2.3)	MARK4 (2.3)	GRINA (2.3)	ATP13A1 (2.2)	DYNC2LI1 (2.2)	CELSR2 (2.1)	HMGCR (1.9)	PCSK9 (1.9)	ATXN7L2 (1.9)
ENSG00000099964	ENSG00000099964 PPI subnetwork	0.31	> 0.20	GEMIN7 (2.4)	PVRL2 (2.2)	RELB (2.2)	NYNRIN (2.1)	ABO (2.0)	SH2B3 (2.0)	GRINA (1.9)	ZNF101 (1.7)	TRAPPC6A (1.7)	C12orf43 (1.6)
ENSG00000092010	PSME1 PPI subnetwork	0.31	> 0.20	PSMA5 (5.8)	TRAFD1 (2.9)	NT5DC1 (2.6)	NAA25 (2.1)	TOMM40 (2.0)	TMEM50A (1.6)	DHX38 (1.5)	DDX56 (1.5)	SUGP1 (1.3)	SARS (1.2)
ENSG00000163464	CXCR1 PPI subnetwork	0.31	> 0.20	ITGB3 (3.2)	BCL3 (2.7)	MAFB (2.1)	ENSG00000254235 (1.8)	UBXN2B (1.7)	SLC22A1 (1.7)	ANGPTL3 (1.7)	RELB (1.6)	HP (1.5)	TIMD4 (1.5)
MP:0005458	increased percent body fat	0.31	> 0.20	GPAM (2.8)	LPA (2.6)	C12orf47 (2.4)	MOSC1 (2.4)	TIMD4 (2.1)	HP (2.0)	C11orf9 (2.0)	FRK (1.8)	MAFB (1.8)	TRIB1 (1.7)
ENSG00000070367	EXOC5 PPI subnetwork	0.31	> 0.20	SARS (2.7)	COL4A3BP (2.6)	OGDH (2.3)	USP24 (2.2)	ENSG00000238078 (1.7)	GOT2P1 (1.7)	DNM2 (1.7)	PSMA5 (1.7)	ACAD10 (1.6)	FRK (1.5)
GO:0010770	positive regulation of cell morphogenesis involved in differentiation	0.32	> 0.20	ENSG00000226648 (2.8)	MYLIP (2.6)	ITGB3 (2.4)	SH2B3 (2.3)	ENSG00000254235 (2.3)	ABO (2.2)	GCNT4 (2.0)	PLEKHH2 (1.9)	ANKRD31 (1.8)	KANK2 (1.8)
ENSG00000120948	TARDBP PPI subnetwork	0.32	> 0.20	CLPTM1 (4.6)	QTRT1 (3.8)	SUGP1 (3.1)	ILF3 (3.1)	GATAD2A (2.8)	PPP1R37 (2.4)	PLCG1 (2.3)	TOP1 (2.1)	DHX38 (2.1)	SMARCA4 (1.9)
GO:0045806	negative regulation of endocytosis	0.32	> 0.20	ANKRD31 (2.4)	GEMIN7 (2.3)	APOE (2.3)	TIMD4 (2.2)	ST3GAL4 (2.1)	CETP (1.8)	ENSG00000226645 (1.7)	TM6SF2 (1.6)	ENSG00000228044 (1.6)	CLPTM1 (1.5)
ENSG00000105887	MTPN PPI subnetwork	0.32	> 0.20	RELB (5.1)	CYB561D1 (3.0)	BCL3 (3.0)	SH2B3 (2.5)	C12orf43 (2.4)	RHD (2.1)	GEMIN7 (1.9)	MAU2 (1.9)	TMEM50A (1.8)	DNM2 (1.7)
ENSG00000108272	DHRS11 PPI subnetwork	0.32	> 0.20	PSMA5 (2.7)	NAA25 (2.4)	ENSG00000235545 (2.3)	HMGCR (2.2)	CARM1 (2.2)	ABCG5 (1.8)	USP24 (1.7)	SUGP1 (1.7)	PLCG1 (1.6)	TMEM57 (1.5)
GO:0006349	regulation of gene expression by genetic imprinting	0.32	> 0.20	ZNF180 (2.9)	GOT2P1 (2.9)	TXNL4B (2.6)	NYNRIN (2.5)	DHODH (2.3)	ATXN7L2 (2.3)	COL4A3BP (2.2)	LPAR2 (1.7)	ENSG00000254235 (1.4)	HAVCR1 (1.4)
ENSG00000114030	KPNA1 PPI subnetwork	0.32	> 0.20	USP1 (3.1)	BCL3 (2.8)	TOP1 (2.6)	PSMA5 (2.5)	PARP10 (2.4)	ILF3 (2.2)	PSRC1 (2.2)	ENSG00000238078 (1.9)	RELB (1.9)	SMARCA4 (1.8)
GO:0002521	leukocyte differentiation	0.32	> 0.20	ZNF101 (4.6)	PBX4 (3.0)	PLCG1 (2.4)	GMIP (2.0)	DNAH11 (1.7)	SH2B3 (1.6)	TRIB1 (1.6)	TIMD4 (1.5)	HLX (1.4)	LPAR2 (1.4)
ENSG00000011405	PIK3C2A PPI subnetwork	0.32	> 0.20	BCL3 (3.0)	DNM2 (2.3)	ALDH2 (2.2)	DOCK7 (2.1)	SLC44A2 (2.1)	GATAD2A (2.0)	C12orf47 (2.0)	PLEC (2.0)	PVRL2 (1.8)	MARK4 (1.7)
ENSG00000144061	NPHP1 PPI subnetwork	0.32	> 0.20	PLEC (4.4)	KANK2 (2.9)	PVR (2.8)	C11orf9 (2.1)	C17orf57 (2.1)	POLK (1.7)	HAVCR1 (1.6)	PVRL2 (1.6)	LPIN3 (1.5)	DYNC2LI1 (1.5)
GO:0000502	proteasome complex	0.32	> 0.20	PSMA5 (6.0)	TRAFD1 (3.2)	NAA25 (2.7)	NT5DC1 (2.6)	TOMM40 (1.7)	SUGP1 (1.7)	DDX56 (1.6)	SARS (1.5)	DHX38 (1.4)	SMARCA4 (1.3)
MP:0005011	increased eosinophil cell number	0.32	> 0.20	BCL3 (4.3)	GMIP (3.5)	RELB (3.0)	SH2B3 (2.0)	PLEC (1.9)	PVR (1.9)	ITGB3 (1.6)	PLEKHH2 (1.5)	ABCG8 (1.3)	HP (1.2)
REACTOME_METABOLISM_OF_NITRIC_OXIDE	REACTOME_METABOLISM_OF_NITRIC_OXIDE	0.32	> 0.20	NT5DC1 (2.6)	PPP1R37 (2.6)	SH2B3 (2.0)	TOMM40 (2.0)	C1orf63 (1.9)	ST3GAL4 (1.6)	TRAPPC6A (1.5)	APOA5 (1.4)	HLX (1.3)	BCAM (1.2)
REACTOME_ENOS_ACTIVATION_AND_REGULATION	REACTOME_ENOS_ACTIVATION_AND_REGULATION	0.32	> 0.20	NT5DC1 (2.6)	PPP1R37 (2.6)	SH2B3 (2.0)	TOMM40 (2.0)	C1orf63 (1.9)	ST3GAL4 (1.6)	TRAPPC6A (1.5)	APOA5 (1.4)	HLX (1.3)	BCAM (1.2)
ENSG00000116106	EPHA4 PPI subnetwork	0.32	> 0.20	PLEKHH2 (3.3)	PLCG1 (2.7)	C11orf9 (2.5)	PBX4 (2.5)	CILP2 (2.1)	HNF1A (2.0)	ABO (1.9)	PVRL2 (1.8)	MARK4 (1.8)	BCAM (1.7)
ENSG00000204843	DCTN1 PPI subnetwork	0.32	> 0.20	C12orf51 (3.7)	MAU2 (3.5)	SMARCA4 (2.5)	ENSG00000238078 (2.4)	PBX4 (2.0)	PLCG1 (2.0)	CARM1 (2.0)	DHX38 (1.9)	PLEC (1.7)	SUGP1 (1.7)
MP:0000470	abnormal stomach morphology	0.32	> 0.20	C12orf47 (2.9)	KIAA1324 (2.6)	ANGPTL3 (2.3)	C11orf9 (2.0)	LDLR (1.8)	PPP1R37 (1.7)	OASL (1.5)	NCAN (1.4)	CETP (1.3)	ATXN7L2 (1.3)
MP:0002745	abnormal atrioventricular valve morphology	0.32	> 0.20	MYLIP (3.2)	PVR (2.5)	SORT1 (2.5)	TMEM57 (2.3)	CEACAM19 (1.6)	ENSG00000226648 (1.6)	SYPL2 (1.6)	TRIB1 (1.6)	TM6SF2 (1.6)	HLX (1.5)
ENSG00000171885	AQP4 PPI subnetwork	0.32	> 0.20	HMGCR (7.0)	FADS1 (5.9)	LDLR (5.6)	FADS2 (5.6)	PCSK9 (3.4)	BLOC1S3 (3.3)	SYPL2 (2.8)	TXNL4B (2.6)	SORT1 (2.3)	CEACAM19 (2.2)
ENSG00000065978	YBX1 PPI subnetwork	0.32	> 0.20	ILF3 (3.9)	C1orf63 (3.5)	TOP1 (3.0)	SMARCA4 (2.9)	USP1 (2.6)	DHX38 (2.6)	PTPN11 (2.5)	QTRT1 (2.4)	GATAD2A (2.3)	BUD13 (2.2)
GO:0009451	RNA modification	0.32	> 0.20	DHODH (3.8)	QTRT1 (3.6)	ZNF259 (3.2)	NAA25 (3.1)	C12orf43 (2.6)	TXNL4B (2.5)	DDX56 (2.4)	TOMM40 (2.1)	MAPKAPK5 (2.1)	GOT2P1 (2.0)
ENSG00000154310	TNIK PPI subnetwork	0.32	> 0.20	PSMA5 (3.3)	TOMM40 (3.0)	TMEM50A (2.6)	NT5DC1 (2.4)	CLPTM1 (2.4)	HMGCR (2.3)	LDLR (2.1)	FADS1 (1.9)	ST3GAL4 (1.8)	C12orf47 (1.7)
MP:0004704	short vertebral column	0.32	> 0.20	CILP2 (5.8)	FADS2 (3.5)	FADS1 (3.5)	HMGCR (3.3)	PLEKHH2 (2.6)	NPC1L1 (2.1)	PCSK9 (2.0)	LDLR (2.0)	CEACAM19 (1.6)	HAVCR1 (1.5)
ENSG00000095380	NANS PPI subnetwork	0.32	> 0.20	SARS (4.3)	ERP29 (3.7)	ALDH2 (3.1)	TMEM116 (2.9)	RHD (2.0)	GMPR (2.0)	DOCK7 (1.9)	HAVCR1 (1.9)	RHCE (1.7)	UBXN2B (1.5)
MP:0008844	decreased subcutaneous adipose tissue amount	0.32	> 0.20	GPAM (4.6)	MOSC1 (3.8)	POLK (2.3)	PVR (1.6)	SH2B3 (1.6)	PCSK9 (1.5)	FADS1 (1.5)	PLEC (1.5)	PSRC1 (1.5)	LDLR (1.4)
GO:0002709	regulation of T cell mediated immunity	0.32	> 0.20	ZNF180 (3.1)	NKPD1 (2.1)	PARP10 (1.8)	CEACAM19 (1.7)	OASL (1.6)	CBLC (1.5)	FRK (1.5)	DNAH11 (1.5)	PVR (1.3)	GEMIN7 (1.3)
GO:0009314	response to radiation	0.32	> 0.20	ZNF180 (2.2)	POLK (2.0)	ATXN7L2 (1.9)	BLOC1S3 (1.9)	TRIB1 (1.8)	TRAPPC6A (1.4)	ENSG00000235545 (1.3)	BUD13 (1.3)	DNAH11 (1.3)	PVR (1.3)
GO:0005516	calmodulin binding	0.32	> 0.20	SYPL2 (3.9)	RPH3A (2.5)	C12orf51 (2.2)	HLX (1.9)	NCAN (1.7)	KANK2 (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.6)	AMIGO1 (1.6)	PLEC (1.5)
MP:0002739	abnormal olfactory bulb development	0.32	> 0.20	NCAN (3.0)	RPH3A (2.7)	APOE (2.0)	MAFB (1.9)	CETP (1.7)	BLOC1S3 (1.7)	HLX (1.6)	ENSG00000238078 (1.5)	DNAH11 (1.4)	GCNT4 (1.4)
GO:0070076	histone lysine demethylation	0.32	> 0.20	TMEM57 (2.9)	ATXN7L2 (2.8)	GCNT4 (2.2)	BLOC1S3 (2.2)	LPAR2 (2.0)	ENSG00000254235 (1.9)	C12orf47 (1.9)	ZNF180 (1.9)	MAU2 (1.9)	CYB561D1 (1.9)
ENSG00000111987	ENSG00000111987 PPI subnetwork	0.32	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
ENSG00000204392	LSM2 PPI subnetwork	0.32	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
ENSG00000172850	LSM2 PPI subnetwork	0.32	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
GO:0042588	zymogen granule	0.32	> 0.20	KIAA1324 (4.2)	C12orf47 (2.3)	SORT1 (1.9)	YIPF2 (1.8)	ADAM1 (1.8)	ZNF180 (1.8)	ITGB3 (1.7)	TMED4 (1.7)	TMEM50A (1.6)	TSSK6 (1.6)
ENSG00000113196	HAND1 PPI subnetwork	0.32	> 0.20	CARM1 (3.4)	DNM2 (2.1)	KANK2 (1.8)	SYPL2 (1.8)	OGDH (1.7)	CEACAM19 (1.7)	ENSG00000238078 (1.7)	RHCE (1.5)	MARK4 (1.5)	FRK (1.5)
KEGG_LEISHMANIA_INFECTION	KEGG_LEISHMANIA_INFECTION	0.32	> 0.20	BCL3 (3.7)	RELB (3.3)	SH2B3 (2.5)	TRIB1 (2.5)	GMIP (2.3)	MAFB (2.0)	MYLIP (1.9)	APOE (1.8)	TRAFD1 (1.8)	GEMIN7 (1.7)
GO:0050921	positive regulation of chemotaxis	0.32	> 0.20	ZNF101 (2.6)	TIMD4 (2.3)	PVR (2.1)	TMEM116 (1.9)	CETP (1.9)	PLEKHH2 (1.8)	APOE (1.8)	ENSG00000228044 (1.8)	AP1M2 (1.6)	KIAA1324 (1.4)
ENSG00000186081	KRT5 PPI subnetwork	0.32	> 0.20	NKPD1 (2.2)	ANGPTL3 (2.1)	CELSR2 (2.1)	GMPR (2.0)	C11orf9 (1.8)	NT5DC1 (1.8)	APOC1 (1.7)	PCSK9 (1.7)	LPAR2 (1.6)	ALDH2 (1.6)
MP:0000462	abnormal digestive system morphology	0.32	> 0.20	CBLC (3.3)	KANK2 (3.1)	PLEKHH2 (2.6)	AP1M2 (2.3)	KIAA1324 (2.1)	ENSG00000254235 (2.1)	CILP2 (2.0)	FRK (1.8)	HNF1A (1.8)	CYP7A1 (1.7)
GO:0055093	response to hyperoxia	0.32	> 0.20	C17orf57 (3.2)	TMEM116 (3.1)	LPIN3 (3.0)	ENSG00000228044 (2.6)	ANKRD31 (2.3)	GOT2P1 (2.2)	C11orf9 (1.5)	CEACAM19 (1.4)	FRK (1.3)	BLOC1S3 (1.2)
GO:0002444	myeloid leukocyte mediated immunity	0.32	> 0.20	CYB561D1 (2.9)	UBXN2B (2.3)	GMIP (2.0)	ALDH2 (2.0)	ST3GAL4 (1.6)	C19orf52 (1.5)	HP (1.4)	BLOC1S3 (1.4)	CEACAM19 (1.3)	CILP2 (1.1)
MP:0003403	absent placental labyrinth	0.32	> 0.20	BCAM (4.5)	CBLC (3.2)	CLPTM1 (2.6)	CARM1 (2.4)	SORT1 (2.2)	ATXN2 (2.2)	LDLR (2.1)	AP1M2 (2.0)	GATAD2A (2.0)	TMEM116 (1.7)
MP:0009171	enlarged pancreatic islets	0.32	> 0.20	GPAM (4.5)	MOSC1 (4.5)	GCNT4 (2.9)	ALDH2 (2.7)	CBLC (2.0)	AP1M2 (1.9)	KANK2 (1.6)	LPAR2 (1.5)	PLEC (1.4)	YIPF2 (1.4)
GO:0005839	proteasome core complex	0.32	> 0.20	PSMA5 (6.0)	TRAFD1 (4.4)	PARP10 (3.4)	NT5DC1 (2.2)	TMEM50A (1.9)	C12orf47 (1.7)	NAA25 (1.5)	ENSG00000254235 (1.5)	LPA (1.1)	CYB561D1 (1.1)
GO:0031669	cellular response to nutrient levels	0.32	> 0.20	BLOC1S3 (3.6)	BRAP (2.6)	TXNL4B (2.4)	LPIN3 (2.2)	AP1M2 (2.0)	MAPKAPK5 (1.7)	HNF1A (1.6)	POLK (1.4)	FADS2 (1.4)	TRAPPC6A (1.3)
GO:0005487	nucleocytoplasmic transporter activity	0.32	> 0.20	C1orf63 (3.1)	POC5 (2.5)	USP1 (2.1)	BUD13 (2.0)	DOCK7 (1.8)	FEN1 (1.7)	TMED4 (1.5)	POLK (1.5)	DDX56 (1.5)	ILF3 (1.4)
ENSG00000138798	EGF PPI subnetwork	0.32	> 0.20	MYLIP (4.7)	HLX (3.2)	PPP1R37 (2.9)	C1orf63 (2.9)	PLEKHH2 (2.5)	C17orf57 (2.4)	DNM2 (2.4)	COL4A3BP (2.2)	DOCK7 (2.1)	C12orf51 (2.1)
ENSG00000174111	SOCS7 PPI subnetwork	0.32	> 0.20	ZHX3 (2.8)	HAVCR1 (2.7)	PLEKHH2 (2.2)	TMEM50A (1.9)	TOP1 (1.8)	ZNF101 (1.6)	FADS2 (1.6)	COL4A3BP (1.5)	ABO (1.5)	RPH3A (1.4)
ENSG00000072501	SMC1A PPI subnetwork	0.32	> 0.20	ILF3 (4.4)	USP1 (4.3)	DHX38 (3.6)	FEN1 (3.3)	SMARCA4 (3.1)	TOP1 (3.1)	PTPN11 (2.7)	C1orf63 (2.4)	SUGP1 (2.4)	BUD13 (2.0)
MP:0008025	brain vacuoles	0.32	> 0.20	ZHX3 (3.0)	ABO (2.8)	GRINA (2.5)	HNF1A (2.3)	PTPN11 (2.3)	ACAD10 (2.3)	MAPKAPK5 (2.1)	CEACAM19 (2.1)	COL4A3BP (2.0)	ST3GAL4 (1.7)
REACTOME_TIGHT_JUNCTION_INTERACTIONS	REACTOME_TIGHT_JUNCTION_INTERACTIONS	0.32	> 0.20	AP1M2 (6.9)	FRK (5.0)	CBLC (3.7)	BCAM (3.3)	PVRL2 (2.9)	YIPF2 (2.4)	DYNC2LI1 (2.3)	CYP7A1 (2.0)	PVR (1.9)	HAVCR1 (1.9)
ENSG00000141027	NCOR1 PPI subnetwork	0.32	> 0.20	DHX38 (2.8)	PPP1R37 (2.7)	ATXN2 (2.6)	TMEM57 (2.5)	MYLIP (2.3)	SMARCA4 (2.3)	USP1 (2.2)	USP24 (2.0)	ILF3 (1.9)	MAPKAPK5 (1.8)
ENSG00000104221	BRF2 PPI subnetwork	0.32	> 0.20	TOMM40 (3.4)	ATP13A1 (3.4)	ZNF259 (3.1)	POC5 (3.0)	DDX56 (2.9)	DHX38 (2.9)	NAA25 (2.7)	PSMA5 (2.3)	SARS (2.2)	ATXN2 (2.1)
GO:0000060	protein import into nucleus, translocation	0.32	> 0.20	ENSG00000254235 (3.9)	UBXN2B (2.0)	ENSG00000226645 (1.9)	ENSG00000238078 (1.9)	ENSG00000228044 (1.7)	TRAFD1 (1.5)	LPA (1.5)	TXNL4B (1.3)	RELB (1.3)	BCL3 (1.3)
GO:0007350	blastoderm segmentation	0.32	> 0.20	DYNC2LI1 (2.5)	CEACAM19 (2.4)	ABO (2.3)	ANKRD31 (2.2)	ENSG00000254235 (2.2)	ENSG00000238078 (2.2)	PVRL2 (1.5)	DNAH11 (1.5)	NKPD1 (1.5)	KANK2 (1.4)
REACTOME_TRANSCRIPTION	REACTOME_TRANSCRIPTION	0.32	> 0.20	BUD13 (3.2)	SUGP1 (2.6)	TOP1 (2.4)	ZNF259 (2.2)	ENSG00000226645 (2.2)	DDX56 (2.1)	C1orf63 (2.1)	C19orf52 (2.1)	GEMIN7 (2.0)	ILF3 (2.0)
GO:0071845	cellular component disassembly at cellular level	0.32	> 0.20	ENSG00000226645 (2.4)	UBXN2B (2.1)	C1orf63 (2.0)	CBLC (1.7)	TSSK6 (1.7)	SLC44A2 (1.7)	DOCK7 (1.7)	ABO (1.6)	GATAD2A (1.6)	ANKRD31 (1.6)
ENSG00000122756	CNTFR PPI subnetwork	0.32	> 0.20	BCL3 (3.1)	COL4A3BP (2.3)	C17orf57 (1.8)	ZNF101 (1.7)	TIMD4 (1.4)	CYP7A1 (1.4)	RELB (1.4)	HLX (1.3)	CETP (1.3)	PVR (1.3)
ENSG00000164506	STXBP5 PPI subnetwork	0.32	> 0.20	HAVCR1 (2.7)	ENSG00000228044 (2.5)	LDLR (2.3)	C12orf51 (2.0)	CETP (1.9)	PVR (1.7)	FADS2 (1.7)	RPH3A (1.7)	PSMA5 (1.7)	PVRL2 (1.7)
GO:0001704	formation of primary germ layer	0.32	> 0.20	ENSG00000226648 (3.3)	ENSG00000238078 (3.1)	ENSG00000254235 (3.0)	TRIB1 (2.2)	NYNRIN (1.8)	ATXN7L2 (1.7)	CILP2 (1.5)	ABO (1.5)	ANKRD31 (1.5)	PVR (1.4)
KEGG_LONG_TERM_DEPRESSION	KEGG_LONG_TERM_DEPRESSION	0.32	> 0.20	TMEM50A (2.3)	ABCG8 (2.2)	LPIN3 (2.2)	GCNT4 (2.0)	NCAN (2.0)	HLX (1.9)	PLEKHH2 (1.8)	BLOC1S3 (1.7)	MARK4 (1.7)	ABCG5 (1.6)
MP:0003920	abnormal heart right ventricle morphology	0.32	> 0.20	C11orf9 (3.6)	HLX (2.2)	C17orf57 (1.9)	MOSC1 (1.7)	ANKRD31 (1.6)	NYNRIN (1.5)	TRAFD1 (1.5)	C12orf43 (1.4)	NCAN (1.4)	SYPL2 (1.4)
GO:0002367	cytokine production involved in immune response	0.32	> 0.20	GCNT4 (3.0)	MAFB (1.9)	ZNF101 (1.7)	TIMD4 (1.5)	CETP (1.5)	SH2B3 (1.4)	NPC1L1 (1.2)	POLK (1.2)	HAVCR1 (1.2)	POC5 (1.1)
ENSG00000117245	KIF17 PPI subnetwork	0.32	> 0.20	PPP1R37 (4.7)	GEMIN7 (2.8)	C11orf9 (2.4)	TSSK6 (2.3)	NKPD1 (2.0)	TXNL4B (1.9)	ZNF180 (1.9)	ENSG00000226648 (1.7)	BCAM (1.7)	CILP2 (1.7)
ENSG00000137709	POU2F3 PPI subnetwork	0.32	> 0.20	USP24 (2.9)	MAU2 (2.8)	PARP10 (2.6)	SMARCA4 (2.5)	ATXN2 (2.5)	MARK4 (2.4)	BCL3 (2.3)	C12orf51 (2.2)	DHX38 (2.0)	GMIP (1.9)
GO:0048532	anatomical structure arrangement	0.32	> 0.20	ANKRD31 (2.5)	TMED4 (2.3)	DYNC2LI1 (1.9)	DOCK7 (1.7)	ENSG00000254235 (1.6)	FRK (1.4)	HAVCR1 (1.3)	UBXN2B (1.1)	CEACAM19 (1.1)	SYPL2 (1.1)
GO:0032388	positive regulation of intracellular transport	0.32	> 0.20	ENSG00000238078 (3.6)	PLEKHH2 (2.5)	OASL (2.4)	AP1M2 (2.3)	TMEM116 (2.3)	ENSG00000254235 (2.0)	GCNT4 (1.7)	KANK2 (1.6)	FRK (1.5)	ENSG00000228044 (1.4)
GO:0043687	post-translational protein modification	0.32	> 0.20	YIPF2 (4.8)	ERP29 (3.8)	TMED4 (3.6)	ATP13A1 (3.1)	TMEM57 (2.4)	CLPTM1 (2.3)	CYB561D1 (2.1)	TMEM50A (1.8)	C19orf52 (1.6)	TSSK6 (1.4)
ENSG00000101109	STK4 PPI subnetwork	0.32	> 0.20	UBXN2B (2.8)	PARP10 (2.6)	TRAFD1 (2.0)	C19orf52 (1.9)	NKPD1 (1.8)	GCNT4 (1.7)	CBLC (1.6)	CEACAM19 (1.6)	DNAH11 (1.6)	MYLIP (1.5)
GO:0090305	nucleic acid phosphodiester bond hydrolysis	0.32	> 0.20	POLK (3.6)	AMIGO1 (1.8)	ST3GAL4 (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	QTRT1 (1.6)	TXNL4B (1.5)	ENSG00000226645 (1.5)	ENSG00000226648 (1.4)	TSSK6 (1.4)
ENSG00000124160	NCOA5 PPI subnetwork	0.32	> 0.20	HMGCR (3.5)	LDLR (3.0)	BRAP (2.6)	TMEM116 (2.1)	ENSG00000228044 (1.9)	MAU2 (1.9)	SYPL2 (1.7)	C12orf51 (1.7)	DHX38 (1.7)	ATXN2 (1.6)
ENSG00000120094	HOXB1 PPI subnetwork	0.32	> 0.20	DHODH (2.2)	ZHX3 (2.0)	ENSG00000228044 (2.0)	TMEM50A (1.7)	NYNRIN (1.5)	C12orf51 (1.5)	DOCK7 (1.4)	BRAP (1.4)	C1orf63 (1.4)	UBXN2B (1.4)
ENSG00000099875	MKNK2 PPI subnetwork	0.32	> 0.20	ALDH2 (2.2)	PLEC (2.2)	USP24 (2.1)	ENSG00000226648 (1.9)	POLK (1.8)	NKPD1 (1.8)	PARP10 (1.8)	MARK4 (1.8)	DNM2 (1.7)	TMEM50A (1.7)
GO:0033119	negative regulation of RNA splicing	0.32	> 0.20	ADAM1 (3.6)	C1orf63 (3.5)	ATXN2 (3.0)	C12orf43 (2.8)	C17orf57 (2.7)	MAPKAPK5 (2.7)	BRAP (2.6)	MAU2 (1.9)	PPP1R37 (1.8)	ENSG00000226648 (1.8)
MP:0002282	abnormal trachea morphology	0.32	> 0.20	APOC4 (2.8)	KIAA1324 (2.6)	HLX (2.3)	LPA (2.1)	CBLC (2.1)	ALDH2 (2.0)	PMFBP1 (1.9)	DNAH11 (1.9)	CYP7A1 (1.8)	ANGPTL3 (1.7)
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY:ACID_OXIDATION_IN_MUSCLE	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY:ACID_OXIDATION_IN_MUSCLE	0.32	> 0.20	BRAP (4.5)	C19orf52 (2.9)	SYPL2 (2.7)	ACAD10 (2.6)	GMPR (2.5)	AMIGO1 (2.2)	OGDH (2.1)	MOSC1 (1.9)	PTPN11 (1.8)	LPAR2 (1.7)
ENSG00000178188	SH2B1 PPI subnetwork	0.32	> 0.20	C17orf57 (3.1)	TRAFD1 (2.4)	NYNRIN (2.4)	ABO (2.2)	CBLC (1.9)	PLEKHH2 (1.9)	ZHX3 (1.9)	GPAM (1.8)	NPC1L1 (1.8)	AMIGO1 (1.7)
GO:0007351	tripartite regional subdivision	0.32	> 0.20	CEACAM19 (2.8)	ENSG00000238078 (2.7)	ANKRD31 (2.5)	PVRL2 (2.4)	ENSG00000254235 (2.1)	ABO (1.8)	C11orf9 (1.8)	FRK (1.4)	MOSC1 (1.3)	NKPD1 (1.2)
GO:0008595	anterior/posterior axis specification, embryo	0.32	> 0.20	CEACAM19 (2.8)	ENSG00000238078 (2.7)	ANKRD31 (2.5)	PVRL2 (2.4)	ENSG00000254235 (2.1)	ABO (1.8)	C11orf9 (1.8)	FRK (1.4)	MOSC1 (1.3)	NKPD1 (1.2)
GO:0019395	fatty acid oxidation	0.32	> 0.20	ACAD10 (4.6)	NT5DC1 (3.1)	MOSC1 (2.6)	OGDH (2.4)	AMIGO1 (2.1)	TMEM116 (1.9)	ALDH2 (1.8)	C19orf52 (1.8)	TRAPPC6A (1.8)	ENSG00000238078 (1.8)
ENSG00000136875	PRPF4 PPI subnetwork	0.32	> 0.20	TOP1 (3.8)	ILF3 (3.7)	DHX38 (3.5)	C1orf63 (3.3)	SMARCA4 (3.0)	SUGP1 (2.9)	QTRT1 (2.8)	BUD13 (2.7)	FEN1 (2.5)	USP1 (2.3)
ENSG00000185621	LMLN PPI subnetwork	0.32	> 0.20	BRAP (2.5)	PLG (2.1)	ANGPTL3 (1.9)	GATAD2A (1.6)	TRAFD1 (1.5)	KANK2 (1.5)	SUGP1 (1.4)	SYPL2 (1.4)	MARK4 (1.4)	BLOC1S3 (1.4)
ENSG00000107562	CXCL12 PPI subnetwork	0.32	> 0.20	TIMD4 (3.8)	HP (2.6)	CETP (2.4)	HLX (2.4)	CILP2 (2.0)	APOE (2.0)	RHD (1.9)	MAFB (1.8)	MOSC1 (1.8)	C12orf47 (1.8)
ENSG00000196911	KPNA5 PPI subnetwork	0.32	> 0.20	TOMM40 (4.3)	DDX56 (3.1)	NAA25 (2.9)	ILF3 (2.7)	FEN1 (2.6)	GATAD2A (2.6)	TOP1 (2.5)	DHODH (2.5)	DHX38 (2.4)	ZNF259 (2.3)
ENSG00000169567	HINT1 PPI subnetwork	0.32	> 0.20	GOT2P1 (3.1)	ABCG8 (2.7)	C12orf51 (2.6)	HMGCR (2.6)	POC5 (2.5)	MAU2 (2.1)	ABCG5 (2.1)	BUD13 (1.9)	ERP29 (1.7)	ZNF101 (1.5)
MP:0002631	abnormal epididymis morphology	0.32	> 0.20	ST3GAL4 (2.9)	TMED4 (2.8)	NT5DC1 (2.4)	ERP29 (2.1)	TSSK6 (2.1)	FRK (2.0)	NKPD1 (1.7)	PVRL2 (1.5)	OGDH (1.5)	ABO (1.3)
GO:0017046	peptide hormone binding	0.32	> 0.20	GPAM (2.7)	CETP (2.6)	C12orf47 (2.4)	KIAA1324 (2.1)	PLEKHH2 (2.0)	SYPL2 (1.7)	MYLIP (1.7)	SLC44A2 (1.6)	ANGPTL3 (1.6)	CEACAM19 (1.6)
ENSG00000114423	CBLB PPI subnetwork	0.32	> 0.20	HLX (3.7)	SH2B3 (3.0)	CETP (2.9)	TIMD4 (2.6)	BCL3 (2.4)	MYLIP (1.9)	RELB (1.8)	GMIP (1.8)	PBX4 (1.6)	ZNF101 (1.6)
ENSG00000107404	DVL1 PPI subnetwork	0.32	> 0.20	MARK4 (2.9)	ABO (2.0)	PVRL2 (2.0)	PLEC (1.9)	CELSR2 (1.9)	DOCK7 (1.8)	CARM1 (1.8)	SORT1 (1.7)	LPAR2 (1.6)	SLC44A2 (1.6)
GO:2001020	regulation of response to DNA damage stimulus	0.32	> 0.20	ANKRD31 (2.3)	BUD13 (2.3)	ENSG00000226645 (2.1)	HAVCR1 (2.0)	NT5DC1 (1.8)	C19orf52 (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	ZNF259 (1.5)	DYNC2LI1 (1.5)
GO:0040014	regulation of multicellular organism growth	0.32	> 0.20	KIAA1324 (2.6)	C12orf51 (2.5)	C12orf47 (2.3)	USP24 (2.0)	AMIGO1 (1.9)	ACAD10 (1.8)	CETP (1.7)	ANKRD31 (1.7)	ENSG00000228044 (1.2)	PLCG1 (1.2)
ENSG00000014138	POLA2 PPI subnetwork	0.32	> 0.20	USP1 (5.3)	FEN1 (5.3)	ENSG00000228044 (2.5)	ERP29 (1.9)	TXNL4B (1.8)	AMIGO1 (1.8)	PSRC1 (1.6)	ZNF180 (1.5)	ENSG00000235545 (1.4)	POC5 (1.2)
GO:0008320	protein transmembrane transporter activity	0.32	> 0.20	DHODH (2.2)	TXNL4B (2.1)	GEMIN7 (1.9)	YIPF2 (1.9)	ILF3 (1.9)	ERP29 (1.8)	APOA5 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	OGDH (1.6)
GO:0022884	macromolecule transmembrane transporter activity	0.32	> 0.20	DHODH (2.2)	TXNL4B (2.1)	GEMIN7 (1.9)	YIPF2 (1.9)	ILF3 (1.9)	ERP29 (1.8)	APOA5 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	OGDH (1.6)
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	0.33	> 0.20	PVR (2.9)	GATAD2A (2.3)	PARP10 (2.3)	RELB (2.2)	CYB561D1 (1.8)	ANKRD31 (1.7)	NKPD1 (1.7)	BCL3 (1.5)	SLC22A1 (1.5)	BRAP (1.5)
MP:0001728	failure of embryo implantation	0.33	> 0.20	PVR (2.8)	BLOC1S3 (2.6)	ENSG00000254235 (1.9)	PLEKHH2 (1.7)	MOSC1 (1.6)	SUGP1 (1.5)	CBLC (1.5)	HLX (1.4)	TXNL4B (1.4)	HAVCR1 (1.4)
MP:0001259	abnormal body weight	0.33	> 0.20	ANGPTL3 (2.6)	GPAM (2.5)	TRIB1 (2.3)	MOSC1 (2.0)	ZHX3 (1.7)	PVR (1.6)	GCNT4 (1.6)	LPIN3 (1.6)	PCSK9 (1.5)	POC5 (1.5)
ENSG00000116095	PLEKHA3 PPI subnetwork	0.33	> 0.20	PARP10 (2.7)	C17orf57 (2.5)	PTPN11 (2.4)	FRK (2.3)	HNF1A (2.0)	KANK2 (1.7)	DHX38 (1.6)	OGDH (1.6)	ADAM1 (1.6)	ZNF180 (1.5)
ENSG00000035115	SH3YL1 PPI subnetwork	0.33	> 0.20	ATXN2 (4.3)	HAVCR1 (2.8)	NCAN (2.8)	APOE (2.5)	APOC1 (2.2)	CLPTM1 (2.1)	TOMM40 (2.0)	C12orf43 (2.0)	ENSG00000235545 (2.0)	LPIN3 (1.8)
MP:0001422	abnormal drinking behavior	0.33	> 0.20	ABO (3.9)	BCAM (3.3)	ALDH2 (2.9)	CBLC (2.5)	PLEKHH2 (2.1)	HNF1A (2.1)	GMPR (2.0)	NPC1L1 (2.0)	HLX (2.0)	YIPF2 (1.8)
ENSG00000174123	TLR10 PPI subnetwork	0.33	> 0.20	GMIP (3.3)	PARP10 (2.4)	HLX (2.2)	BCL3 (2.0)	OASL (1.9)	PCSK9 (1.8)	UBXN2B (1.7)	MAFB (1.5)	CYB561D1 (1.5)	NCAN (1.4)
GO:0060347	heart trabecula formation	0.33	> 0.20	CEACAM19 (3.3)	CARM1 (2.7)	HAVCR1 (2.5)	ATXN7L2 (2.1)	GOT2P1 (1.8)	TMEM116 (1.8)	AP1M2 (1.7)	ZNF101 (1.6)	ENSG00000254235 (1.6)	TSSK6 (1.4)
KEGG_GLIOMA	KEGG_GLIOMA	0.33	> 0.20	SLC44A2 (2.6)	MARK4 (2.5)	PTPN11 (2.3)	NCAN (2.2)	ITGB3 (2.2)	SMARCA4 (2.1)	ATXN7L2 (2.1)	ZHX3 (2.0)	CELSR2 (1.9)	HLX (1.9)
ENSG00000197892	KIF13B PPI subnetwork	0.33	> 0.20	USP24 (2.9)	PARP10 (2.9)	MAU2 (2.6)	BCL3 (2.2)	ATXN2 (2.2)	MARK4 (2.1)	GMIP (2.0)	SMARCA4 (2.0)	ZNF180 (1.7)	C12orf51 (1.6)
GO:0033157	regulation of intracellular protein transport	0.33	> 0.20	ZNF101 (2.8)	ENSG00000238078 (2.6)	OASL (2.0)	ENSG00000254235 (1.8)	MYLIP (1.6)	TMEM116 (1.5)	LPAR2 (1.5)	GRINA (1.4)	SH2B3 (1.3)	ABO (1.3)
ENSG00000129250	KIF1C PPI subnetwork	0.33	> 0.20	CARM1 (3.8)	DNM2 (3.5)	PLEC (3.3)	PTPN11 (2.9)	COL4A3BP (2.9)	ZHX3 (2.9)	ATXN2 (2.5)	MARK4 (2.4)	C11orf9 (2.2)	OGDH (2.2)
MP:0009146	abnormal pancreatic acinar cell morphology	0.33	> 0.20	DYNC2LI1 (2.5)	ATP13A1 (2.4)	CYB561D1 (2.0)	TMEM57 (2.0)	C11orf9 (1.9)	KIAA1324 (1.8)	NPC1L1 (1.8)	ENSG00000254235 (1.7)	SLC22A1 (1.6)	PLG (1.6)
GO:0050840	extracellular matrix binding	0.33	> 0.20	BCAM (4.3)	CILP2 (3.5)	PVRL2 (3.0)	APOE (2.2)	ITGB3 (2.2)	KANK2 (2.1)	SLC44A2 (2.0)	PBX4 (1.9)	ST3GAL4 (1.9)	MAFB (1.8)
GO:0050709	negative regulation of protein secretion	0.33	> 0.20	ADAM1 (2.1)	MOSC1 (1.9)	CETP (1.6)	ENSG00000238078 (1.6)	NKPD1 (1.6)	DNAH11 (1.5)	COL4A3BP (1.5)	APOE (1.4)	APOC1 (1.3)	NPC1L1 (1.3)
GO:0051270	regulation of cellular component movement	0.33	> 0.20	PVR (3.2)	PVRL2 (3.2)	ENSG00000254235 (2.5)	HLX (2.4)	MAFB (2.1)	KANK2 (1.9)	CETP (1.9)	APOE (1.8)	SLC44A2 (1.8)	PTPN11 (1.7)
GO:0048753	pigment granule organization	0.33	> 0.20	ZNF101 (2.8)	C19orf52 (2.2)	NKPD1 (2.2)	ZNF180 (2.1)	GMPR (1.9)	BLOC1S3 (1.9)	ST3GAL4 (1.8)	TSSK6 (1.6)	PMFBP1 (1.6)	PPP1R37 (1.6)
ENSG00000103490	PYCARD PPI subnetwork	0.33	> 0.20	ST3GAL4 (2.8)	SORT1 (1.9)	GMPR (1.7)	ENSG00000238078 (1.7)	MOSC1 (1.6)	BCAM (1.5)	TOP1 (1.4)	AP1M2 (1.3)	TRAPPC6A (1.3)	GRINA (1.2)
ENSG00000008294	SPAG9 PPI subnetwork	0.33	> 0.20	RELB (6.2)	BCL3 (2.8)	MAPKAPK5 (2.5)	GEMIN7 (2.4)	TMEM57 (2.3)	MYLIP (2.1)	BLOC1S3 (2.0)	PBX4 (1.9)	C12orf43 (1.9)	SH2B3 (1.9)
ENSG00000169439	SDC2 PPI subnetwork	0.33	> 0.20	APOE (3.4)	ITGB3 (3.1)	TIMD4 (2.6)	APOC1 (2.4)	CILP2 (2.2)	CYP7A1 (2.1)	ALDH2 (2.1)	PLEKHH2 (2.1)	APOC4 (2.0)	ABCG5 (2.0)
ENSG00000039650	PNKP PPI subnetwork	0.33	> 0.20	SYPL2 (3.6)	SMARCA4 (3.2)	AMIGO1 (2.4)	POC5 (2.2)	SUGP1 (2.0)	DYNC2LI1 (1.9)	DHX38 (1.8)	DHODH (1.8)	CEACAM19 (1.7)	BLOC1S3 (1.7)
ENSG00000204592	HLA-E PPI subnetwork	0.33	> 0.20	PARP10 (4.5)	HNF1A (2.1)	TMED4 (2.0)	YIPF2 (2.0)	ENSG00000228044 (1.9)	LPIN3 (1.7)	PPP1R37 (1.7)	ERP29 (1.6)	ABCG8 (1.5)	SLC22A1 (1.5)
GO:0003382	epithelial cell morphogenesis	0.33	> 0.20	CILP2 (3.7)	HNF1A (3.0)	ENSG00000238078 (2.6)	NYNRIN (2.6)	ABO (2.5)	ENSG00000254235 (2.3)	ENSG00000226645 (2.3)	BCAM (1.9)	C11orf9 (1.8)	PVRL2 (1.7)
ENSG00000139144	PIK3C2G PPI subnetwork	0.33	> 0.20	BCL3 (3.6)	DOCK7 (2.7)	RELB (2.6)	DNM2 (2.6)	SLC44A2 (2.5)	SH2B3 (2.3)	MARK4 (2.0)	HLX (2.0)	GMIP (1.9)	GATAD2A (1.9)
ENSG00000174547	MRPL11 PPI subnetwork	0.33	> 0.20	QTRT1 (4.3)	ATP13A1 (3.4)	C19orf52 (3.1)	CARM1 (2.7)	TOMM40 (2.5)	GEMIN7 (2.4)	MAU2 (2.1)	OGDH (1.6)	PBX4 (1.6)	ENSG00000235545 (1.6)
ENSG00000151292	CSNK1G3 PPI subnetwork	0.33	> 0.20	C12orf43 (2.7)	MAPKAPK5 (2.3)	NAA25 (2.0)	TOMM40 (1.8)	CEACAM19 (1.6)	CYP7A1 (1.5)	POLK (1.5)	HLX (1.5)	NT5DC1 (1.4)	ENSG00000254235 (1.4)
GO:0001725	stress fiber	0.33	> 0.20	PVRL2 (3.4)	KANK2 (3.4)	PLEC (3.4)	ITGB3 (2.2)	AP1M2 (2.0)	CARM1 (1.8)	DNM2 (1.8)	CBLC (1.4)	GMIP (1.4)	PLEKHH2 (1.4)
MP:0000198	hypophosphatemia	0.33	> 0.20	AP1M2 (3.8)	TMEM116 (2.7)	FRK (2.6)	SLC22A1 (2.0)	C19orf52 (1.8)	SYPL2 (1.8)	PLG (1.7)	CILP2 (1.6)	TM6SF2 (1.6)	ZNF101 (1.6)
GO:0031641	regulation of myelination	0.33	> 0.20	NKPD1 (2.8)	ANKRD31 (2.7)	PBX4 (2.4)	C12orf43 (2.1)	BLOC1S3 (2.1)	TRAFD1 (1.9)	DNAH11 (1.8)	CEACAM19 (1.4)	PPP1R37 (1.4)	GOT2P1 (1.4)
GO:0043534	blood vessel endothelial cell migration	0.33	> 0.20	ENSG00000226645 (2.4)	PVR (2.2)	ENSG00000228044 (2.1)	HLX (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.5)	ATXN7L2 (1.4)	CETP (1.4)	SH2B3 (1.4)	BCAM (1.4)
ENSG00000066379	ZNRD1 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
ENSG00000206429	ENSG00000206429 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
ENSG00000206502	ZNRD1 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
MP:0003409	decreased width of hypertrophic chondrocyte zone	0.33	> 0.20	PLEKHH2 (3.7)	ZHX3 (3.1)	CILP2 (2.9)	C11orf9 (2.8)	DYNC2LI1 (2.0)	CEACAM19 (1.8)	MAFB (1.8)	NYNRIN (1.7)	PPP1R37 (1.6)	PLCG1 (1.5)
GO:0051928	positive regulation of calcium ion transport	0.33	> 0.20	ABO (3.3)	DNAH11 (1.8)	CYB561D1 (1.6)	C12orf47 (1.5)	C12orf43 (1.5)	ST3GAL4 (1.4)	GRINA (1.3)	PLCG1 (1.3)	YIPF2 (1.3)	ENSG00000228044 (1.2)
ENSG00000072803	FBXW11 PPI subnetwork	0.33	> 0.20	RELB (5.1)	TMEM57 (2.3)	PLEC (2.0)	USP24 (2.0)	ENSG00000235545 (1.7)	TRIB1 (1.5)	BUD13 (1.5)	PBX4 (1.5)	BCL3 (1.5)	LDLR (1.4)
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	0.33	> 0.20	KIAA1324 (6.2)	ST3GAL4 (2.9)	SLC22A1 (1.9)	CYP7A1 (1.9)	YIPF2 (1.8)	ABCG5 (1.6)	MOSC1 (1.6)	TSSK6 (1.5)	APOA5 (1.5)	ABCG8 (1.5)
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	0.33	> 0.20	ACAD10 (5.2)	ALDH2 (3.7)	TRAPPC6A (3.1)	FADS2 (2.9)	MOSC1 (2.8)	NT5DC1 (2.7)	FADS1 (2.5)	GPAM (2.5)	PLG (2.4)	OGDH (2.2)
ENSG00000108342	CSF3 PPI subnetwork	0.33	> 0.20	BCL3 (3.5)	HLX (3.4)	RELB (2.8)	TIMD4 (2.4)	CETP (2.3)	GMIP (2.1)	ALDH2 (2.0)	LPA (1.5)	CEACAM19 (1.3)	HP (1.2)
REACTOME_SIGNALING_BY_EGFR	REACTOME_SIGNALING_BY_EGFR	0.33	> 0.20	CLPTM1 (3.2)	MARK4 (3.1)	ZHX3 (3.1)	SH2B3 (3.0)	DNM2 (3.0)	PLEC (2.7)	SMARCA4 (2.2)	CARM1 (2.1)	MAU2 (2.0)	C12orf51 (2.0)
GO:0006672	ceramide metabolic process	0.33	> 0.20	NKPD1 (4.4)	COL4A3BP (3.5)	CYB561D1 (3.1)	HAVCR1 (3.0)	TMEM50A (3.0)	TMED4 (2.9)	ERP29 (2.4)	POLK (2.1)	PMFBP1 (2.1)	ATP13A1 (2.0)
GO:0042446	hormone biosynthetic process	0.33	> 0.20	ST3GAL4 (3.2)	GOT2P1 (2.6)	ABO (2.2)	PMFBP1 (1.8)	BLOC1S3 (1.7)	CYB561D1 (1.7)	CYP7A1 (1.7)	LPIN3 (1.7)	ATXN7L2 (1.7)	FADS2 (1.7)
GO:0000428	DNA-directed RNA polymerase complex	0.33	> 0.20	GEMIN7 (4.8)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.3)	MAPKAPK5 (2.0)	DDX56 (1.9)	BUD13 (1.8)	PVR (1.7)	BLOC1S3 (1.6)	NAA25 (1.6)
GO:0055029	nuclear DNA-directed RNA polymerase complex	0.33	> 0.20	GEMIN7 (4.8)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.3)	MAPKAPK5 (2.0)	DDX56 (1.9)	BUD13 (1.8)	PVR (1.7)	BLOC1S3 (1.6)	NAA25 (1.6)
ENSG00000111142	METAP2 PPI subnetwork	0.33	> 0.20	OASL (3.5)	C12orf47 (2.4)	FEN1 (2.3)	PLG (2.1)	APOA5 (2.0)	ATXN2 (2.0)	APOB (1.9)	TMEM50A (1.9)	ANGPTL3 (1.9)	PARP10 (1.8)
MP:0002907	abnormal parturition	0.33	> 0.20	ATXN7L2 (2.6)	CYB561D1 (2.2)	MYLIP (1.8)	ABCG8 (1.6)	BLOC1S3 (1.6)	GMPR (1.6)	DNM2 (1.5)	GEMIN7 (1.5)	DNAH11 (1.5)	FADS1 (1.5)
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	0.33	> 0.20	ABCG5 (5.1)	TM6SF2 (4.5)	ABCG8 (3.4)	HAPLN4 (2.8)	APOB (2.7)	CYP7A1 (2.6)	APOC4 (2.5)	SLC22A1 (2.5)	APOA5 (2.1)	NKPD1 (1.9)
MP:0002784	abnormal Sertoli cell morphology	0.33	> 0.20	MARK4 (3.5)	NYNRIN (2.3)	FADS1 (2.2)	ABO (2.1)	LPAR2 (2.0)	TSSK6 (1.9)	CYP7A1 (1.9)	TMED4 (1.6)	ST3GAL4 (1.6)	PVRL2 (1.5)
ENSG00000152804	HHEX PPI subnetwork	0.33	> 0.20	PPP1R37 (3.1)	TSSK6 (2.5)	TRIB1 (2.5)	C11orf9 (2.4)	SLC44A2 (2.1)	GOT2P1 (2.0)	PVRL2 (1.6)	PVR (1.6)	ANKRD31 (1.6)	BCAM (1.5)
ENSG00000172179	PRL PPI subnetwork	0.33	> 0.20	BCL3 (3.6)	HLX (2.8)	RELB (2.7)	TIMD4 (2.4)	CETP (2.2)	GMIP (1.8)	ALDH2 (1.8)	LPA (1.5)	GRINA (1.1)	CEACAM19 (1.1)
ENSG00000125818	PSMF1 PPI subnetwork	0.33	> 0.20	PSMA5 (6.4)	TRAFD1 (4.2)	NAA25 (2.3)	NT5DC1 (2.3)	TOMM40 (1.9)	SUGP1 (1.9)	DHX38 (1.6)	SARS (1.6)	PARP10 (1.5)	TXNL4B (1.4)
MP:0002619	abnormal lymphocyte morphology	0.33	> 0.20	SLC44A2 (3.5)	PARP10 (3.2)	RELB (3.0)	GMIP (2.8)	OASL (2.8)	ZNF101 (1.8)	CETP (1.7)	PBX4 (1.7)	SH2B3 (1.6)	TRAFD1 (1.6)
ENSG00000183709	IL28A PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000128342	LIF PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000162892	IL24 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000142224	IL19 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000197110	IL28B PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000138684	IL21 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000184995	IFNE PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000104432	IL7 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000147896	IFNK PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000177047	IFNW1 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000111536	IL26 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000145839	IL9 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000164136	IL15 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000182393	IL29 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
GO:0045177	apical part of cell	0.33	> 0.20	AP1M2 (3.6)	TMEM116 (3.4)	FRK (3.4)	TM6SF2 (3.2)	BCAM (2.6)	NPC1L1 (2.3)	SORT1 (2.2)	TMED4 (2.1)	CELSR2 (2.0)	SLC22A1 (1.8)
GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	0.33	> 0.20	ENSG00000254235 (3.4)	CEACAM19 (2.4)	ZNF180 (2.1)	BLOC1S3 (2.1)	ALDH2 (1.7)	TSSK6 (1.7)	HNF1A (1.5)	MAPKAPK5 (1.4)	UBXN2B (1.4)	CILP2 (1.3)
GO:0016579	protein deubiquitination	0.33	> 0.20	ZNF180 (4.3)	USP24 (3.6)	MAU2 (2.5)	TMEM57 (2.2)	BRAP (2.2)	CARM1 (2.1)	ENSG00000226648 (1.9)	ATXN7L2 (1.9)	C12orf51 (1.5)	AMIGO1 (1.4)
REACTOME_VIF:MEDIATED_DEGRADATION_OF_APOBEC3G	REACTOME_VIF:MEDIATED_DEGRADATION_OF_APOBEC3G	0.33	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.8)	DDX56 (1.6)	SARS (1.4)	ZNF259 (1.2)
ENSG00000127318	IL22 PPI subnetwork	0.33	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.4)	CETP (2.0)	GMIP (1.9)	ALDH2 (1.8)	LPA (1.6)	SH2B3 (1.1)	PARP10 (1.1)
ENSG00000078902	TOLLIP PPI subnetwork	0.33	> 0.20	UBXN2B (3.8)	ZHX3 (3.0)	MAFB (2.5)	PLEKHH2 (2.0)	PARP10 (1.9)	GRINA (1.9)	GMPR (1.8)	PTPN11 (1.7)	GPAM (1.5)	MYLIP (1.5)
GO:0043900	regulation of multi-organism process	0.33	> 0.20	OASL (2.7)	ZNF101 (2.5)	MAU2 (2.2)	TIMD4 (2.2)	GEMIN7 (2.1)	ATP13A1 (1.9)	CETP (1.9)	PARP10 (1.8)	PBX4 (1.7)	CYB561D1 (1.7)
GO:0032438	melanosome organization	0.33	> 0.20	ZNF101 (2.4)	NKPD1 (2.3)	BLOC1S3 (2.1)	ZNF180 (2.1)	GMPR (1.9)	ST3GAL4 (1.8)	C19orf52 (1.8)	C11orf9 (1.8)	PMFBP1 (1.7)	PPP1R37 (1.6)
ENSG00000177733	HNRNPA0 PPI subnetwork	0.33	> 0.20	ILF3 (3.6)	C1orf63 (3.2)	TOP1 (3.1)	SMARCA4 (3.0)	DHX38 (2.6)	USP1 (2.4)	SUGP1 (2.2)	TOMM40 (2.0)	FEN1 (1.9)	PTPN11 (1.9)
MP:0008182	decreased marginal zone B cell number	0.33	> 0.20	RELB (5.3)	GMIP (3.5)	BCL3 (2.9)	SH2B3 (2.5)	CETP (1.9)	TIMD4 (1.8)	SLC44A2 (1.8)	MAFB (1.8)	GRINA (1.7)	NT5DC1 (1.7)
ENSG00000164134	NAA15 PPI subnetwork	0.33	> 0.20	DDX56 (3.5)	TOMM40 (3.0)	NAA25 (2.7)	PSMA5 (2.6)	SUGP1 (2.6)	SMARCA4 (2.5)	ZNF259 (2.3)	OGDH (2.2)	MAPKAPK5 (2.2)	DHODH (2.1)
MP:0000351	increased cell proliferation	0.33	> 0.20	POLK (3.1)	ZNF101 (2.1)	C17orf57 (2.0)	MAFB (1.9)	GATAD2A (1.8)	BCL3 (1.7)	MAPKAPK5 (1.7)	KANK2 (1.5)	RELB (1.5)	MYLIP (1.3)
ENSG00000148218	ALAD PPI subnetwork	0.33	> 0.20	BRAP (2.9)	RHCE (2.6)	RHD (2.6)	ADAM1 (2.5)	CYP7A1 (2.4)	ERP29 (2.2)	ALDH2 (1.8)	YIPF2 (1.7)	NAA25 (1.6)	C19orf52 (1.6)
ENSG00000175592	FOSL1 PPI subnetwork	0.33	> 0.20	TRIB1 (7.5)	SARS (3.1)	TMED4 (2.1)	BLOC1S3 (2.1)	GRINA (2.0)	BCL3 (2.0)	MAPKAPK5 (1.8)	CARM1 (1.6)	MAU2 (1.6)	MYLIP (1.6)
ENSG00000146950	SHROOM2 PPI subnetwork	0.33	> 0.20	DNM2 (3.9)	PLEC (3.8)	COL4A3BP (3.0)	ZHX3 (2.8)	C11orf9 (2.8)	USP24 (2.6)	PTPN11 (2.4)	CARM1 (2.3)	C12orf51 (2.3)	ATXN2 (2.3)
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	0.33	> 0.20	CYP7A1 (3.2)	RPH3A (3.0)	HAPLN4 (2.8)	NCAN (2.8)	ABCG8 (2.3)	C12orf51 (2.2)	APOC4 (2.2)	AMIGO1 (1.9)	PLG (1.8)	MARK4 (1.8)
MP:0001685	abnormal endoderm development	0.33	> 0.20	APOE (2.6)	ABO (2.1)	LPAR2 (2.1)	COL4A3BP (2.0)	KIAA1324 (1.9)	ERP29 (1.8)	HNF1A (1.8)	PVRL2 (1.8)	UBXN2B (1.8)	PLCG1 (1.8)
ENSG00000170027	YWHAG PPI subnetwork	0.33	> 0.20	TOP1 (3.3)	SMARCA4 (3.3)	PLEC (2.9)	C1orf63 (2.8)	C12orf51 (2.6)	ATXN2 (2.2)	PTPN11 (2.1)	ILF3 (1.9)	DNM2 (1.9)	DOCK7 (1.9)
ENSG00000132906	CASP9 PPI subnetwork	0.33	> 0.20	BCL3 (2.6)	ST3GAL4 (2.4)	TRAFD1 (2.3)	GRINA (2.0)	PTPN11 (1.8)	DNM2 (1.8)	FRK (1.8)	RELB (1.8)	CARM1 (1.7)	HMGCR (1.7)
ENSG00000183117	CSMD1 PPI subnetwork	0.33	> 0.20	MAU2 (2.8)	PARP10 (2.8)	USP24 (2.8)	MARK4 (2.6)	BCL3 (2.4)	ATXN2 (2.3)	SMARCA4 (2.2)	GMIP (2.0)	DHX38 (1.9)	C12orf51 (1.7)
ENSG00000131724	IL13RA1 PPI subnetwork	0.33	> 0.20	BCL3 (3.1)	COL4A3BP (2.1)	C17orf57 (1.8)	CYP7A1 (1.6)	PVR (1.6)	HLX (1.6)	RELB (1.5)	ZNF101 (1.5)	SLC22A1 (1.3)	ENSG00000226645 (1.1)
ENSG00000140992	PDPK1 PPI subnetwork	0.33	> 0.20	DNM2 (3.5)	COL4A3BP (2.7)	MARK4 (2.6)	MAU2 (2.2)	CELSR2 (2.2)	SMARCA4 (2.2)	MYLIP (2.1)	CARM1 (2.0)	GRINA (2.0)	PVRL2 (2.0)
GO:0030163	protein catabolic process	0.33	> 0.20	BRAP (3.1)	TRAFD1 (2.7)	MAU2 (2.5)	USP24 (2.3)	ZNF180 (2.1)	TMEM57 (2.0)	NAA25 (2.0)	DHX38 (1.9)	SUGP1 (1.8)	LPIN3 (1.6)
ENSG00000017797	RALBP1 PPI subnetwork	0.33	> 0.20	PPP1R37 (2.9)	FRK (2.4)	OGDH (2.1)	GOT2P1 (2.1)	PVRL2 (2.1)	COL4A3BP (2.1)	RELB (2.0)	BCL3 (2.0)	DDX56 (1.8)	LPAR2 (1.8)
GO:0070646	protein modification by small protein removal	0.33	> 0.20	ZNF180 (4.3)	USP24 (2.9)	ATXN7L2 (2.5)	BRAP (2.3)	ENSG00000226648 (2.3)	CARM1 (2.0)	MAU2 (1.8)	TMEM57 (1.5)	CEACAM19 (1.4)	ANKRD31 (1.3)
ENSG00000132300	PTCD3 PPI subnetwork	0.33	> 0.20	SUGP1 (3.0)	GMPR (3.0)	LPAR2 (2.8)	NT5DC1 (2.8)	TMEM116 (2.7)	PBX4 (2.3)	GATAD2A (2.1)	HAPLN4 (1.9)	GOT2P1 (1.8)	TRAPPC6A (1.7)
ENSG00000162552	WNT4 PPI subnetwork	0.33	> 0.20	CILP2 (3.9)	OASL (2.9)	TMEM116 (2.1)	MOSC1 (1.9)	ATP13A1 (1.8)	PLEKHH2 (1.7)	CELSR2 (1.7)	KIAA1324 (1.6)	TXNL4B (1.6)	AMIGO1 (1.5)
GO:0051272	positive regulation of cellular component movement	0.33	> 0.20	PVR (3.6)	PVRL2 (2.6)	MAFB (2.4)	AP1M2 (2.1)	APOE (1.9)	ENSG00000228044 (1.9)	CETP (1.8)	ENSG00000254235 (1.8)	PTPN11 (1.8)	ITGB3 (1.6)
ENSG00000143393	PI4KB PPI subnetwork	0.33	> 0.20	CBLC (5.7)	AP1M2 (2.9)	TSSK6 (2.5)	HNF1A (2.2)	LPAR2 (2.0)	DOCK7 (1.8)	FRK (1.7)	CELSR2 (1.7)	LPIN3 (1.7)	BCAM (1.6)
MP:0001672	abnormal embryogenesis/ development	0.33	> 0.20	GATAD2A (1.9)	PVRL2 (1.7)	LDLR (1.6)	NYNRIN (1.5)	PSRC1 (1.4)	DOCK7 (1.3)	ABO (1.3)	APOB (1.3)	ATXN2 (1.3)	USP1 (1.3)
GO:0002208	somatic diversification of immunoglobulins involved in immune response	0.33	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
GO:0045190	isotype switching	0.33	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	0.33	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
ENSG00000007372	PAX6 PPI subnetwork	0.33	> 0.20	CARM1 (2.9)	CELSR2 (2.7)	DOCK7 (2.4)	ATXN2 (2.3)	TMED4 (2.0)	PLCG1 (1.9)	ST3GAL4 (1.9)	C11orf9 (1.9)	DHX38 (1.9)	NCAN (1.8)
GO:0002708	positive regulation of lymphocyte mediated immunity	0.33	> 0.20	GEMIN7 (2.0)	ENSG00000235545 (1.9)	POLK (1.6)	PBX4 (1.5)	PARP10 (1.4)	MAU2 (1.3)	SLC22A1 (1.1)	ZNF180 (1.1)	TRAFD1 (1.1)	ZNF101 (1.1)
GO:0002705	positive regulation of leukocyte mediated immunity	0.33	> 0.20	GEMIN7 (2.0)	ENSG00000235545 (1.9)	POLK (1.6)	PBX4 (1.5)	PARP10 (1.4)	MAU2 (1.3)	SLC22A1 (1.1)	ZNF180 (1.1)	TRAFD1 (1.1)	ZNF101 (1.1)
ENSG00000126581	BECN1 PPI subnetwork	0.33	> 0.20	POC5 (2.9)	RHCE (2.5)	RHD (2.5)	ITGB3 (2.4)	ERP29 (1.9)	GMPR (1.7)	NT5DC1 (1.6)	COL4A3BP (1.5)	SH2B3 (1.5)	TSSK6 (1.4)
ENSG00000129515	SNX6 PPI subnetwork	0.33	> 0.20	TMEM50A (3.0)	ABO (3.0)	DOCK7 (2.8)	AMIGO1 (2.6)	COL4A3BP (2.1)	NYNRIN (2.0)	C12orf47 (2.0)	ZHX3 (1.7)	HLX (1.6)	GCNT4 (1.5)
GO:0001773	myeloid dendritic cell activation	0.33	> 0.20	ZNF101 (4.6)	ZNF180 (2.2)	PBX4 (2.1)	GEMIN7 (1.9)	SH2B3 (1.8)	CYB561D1 (1.7)	ENSG00000238078 (1.5)	C12orf47 (1.4)	C17orf57 (1.3)	ANKRD31 (1.2)
GO:0006643	membrane lipid metabolic process	0.33	> 0.20	NKPD1 (5.6)	HAVCR1 (3.5)	TMEM50A (3.5)	CYB561D1 (3.3)	ERP29 (2.9)	COL4A3BP (2.5)	CLPTM1 (2.2)	LPIN3 (2.1)	TMED4 (2.1)	PPP1R37 (2.1)
MP:0000188	abnormal circulating glucose level	0.33	> 0.20	MOSC1 (3.3)	SORT1 (2.3)	GPAM (2.3)	PLEKHH2 (1.7)	HLX (1.4)	GRINA (1.4)	DOCK7 (1.4)	MAFB (1.4)	AMIGO1 (1.4)	LPIN3 (1.3)
GO:0005179	hormone activity	0.33	> 0.20	KIAA1324 (4.9)	NPC1L1 (3.7)	TM6SF2 (2.1)	APOB (2.0)	C12orf47 (1.9)	ABCG5 (1.6)	YIPF2 (1.5)	PMFBP1 (1.4)	ABO (1.4)	HAPLN4 (1.4)
ENSG00000083168	KAT6A PPI subnetwork	0.33	> 0.20	C1orf63 (3.0)	MYLIP (2.9)	GMIP (1.9)	C17orf57 (1.9)	PPP1R37 (1.9)	SUGP1 (1.8)	CLPTM1 (1.6)	DYNC2LI1 (1.6)	ATXN7L2 (1.5)	GRINA (1.4)
GO:0034061	DNA polymerase activity	0.33	> 0.20	FEN1 (3.6)	USP1 (3.1)	PARP10 (2.6)	DNAH11 (2.1)	DDX56 (2.1)	ILF3 (2.0)	MAPKAPK5 (1.7)	USP24 (1.5)	PSRC1 (1.5)	ACAD10 (1.4)
ENSG00000099817	POLR2E PPI subnetwork	0.33	> 0.20	ILF3 (3.2)	SUGP1 (3.0)	DHX38 (3.0)	TOP1 (2.9)	BUD13 (2.9)	DDX56 (2.6)	SMARCA4 (2.3)	QTRT1 (2.2)	C1orf63 (2.1)	TOMM40 (2.1)
ENSG00000126945	HNRNPH2 PPI subnetwork	0.33	> 0.20	C1orf63 (4.3)	ILF3 (3.9)	SMARCA4 (3.0)	TOP1 (2.8)	PTPN11 (2.7)	SUGP1 (2.7)	USP1 (2.4)	DHX38 (2.4)	QTRT1 (2.1)	BUD13 (1.9)
ENSG00000164329	PAPD4 PPI subnetwork	0.33	> 0.20	ENSG00000226648 (2.8)	ANGPTL3 (2.7)	TSSK6 (2.0)	GMPR (2.0)	MOSC1 (1.9)	ACAD10 (1.8)	PLG (1.8)	DOCK7 (1.5)	TMEM116 (1.4)	MYLIP (1.4)
MP:0001847	brain inflammation	0.33	> 0.20	MAFB (3.4)	APOE (2.0)	RELB (1.9)	TMEM50A (1.8)	BCL3 (1.8)	GMIP (1.5)	SLC44A2 (1.5)	MYLIP (1.3)	ST3GAL4 (1.2)	ENSG00000228044 (1.2)
MP:0008497	decreased IgG2b level	0.33	> 0.20	RELB (4.4)	CETP (3.9)	TIMD4 (3.5)	GMIP (3.1)	BCL3 (2.5)	SH2B3 (1.9)	MAFB (1.8)	ZNF101 (1.7)	GCNT4 (1.7)	PLCG1 (1.1)
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON:CONTAINING_TRANSCRIPT	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON:CONTAINING_TRANSCRIPT	0.33	> 0.20	TOP1 (3.5)	USP1 (3.4)	ILF3 (3.3)	BUD13 (3.1)	C1orf63 (3.1)	DDX56 (2.8)	NAA25 (2.7)	DHODH (2.5)	DOCK7 (2.4)	ADAM1 (2.2)
ENSG00000065150	IPO5 PPI subnetwork	0.33	> 0.20	PSMA5 (2.6)	BUD13 (2.5)	NAA25 (2.5)	TOMM40 (2.4)	GMPR (2.4)	C19orf52 (1.9)	GATAD2A (1.8)	ZNF259 (1.7)	CLPTM1 (1.7)	NT5DC1 (1.6)
GO:0030879	mammary gland development	0.33	> 0.20	KIAA1324 (3.8)	PPP1R37 (2.3)	AP1M2 (2.0)	PLEKHH2 (2.0)	TRAPPC6A (1.9)	MYLIP (1.7)	ANKRD31 (1.6)	CELSR2 (1.6)	ENSG00000226648 (1.5)	NKPD1 (1.4)
GO:0031941	filamentous actin	0.33	> 0.20	PVRL2 (3.0)	TM6SF2 (2.2)	POLK (2.2)	PVR (2.1)	ENSG00000228044 (2.0)	NPC1L1 (1.9)	CBLC (1.8)	ABO (1.7)	PMFBP1 (1.4)	LPAR2 (1.4)
MP:0005202	lethargy	0.33	> 0.20	BCAM (2.3)	ALDH2 (2.1)	HAVCR1 (2.1)	TMEM116 (1.8)	ZHX3 (1.8)	CILP2 (1.8)	PTPN11 (1.6)	ERP29 (1.6)	SLC44A2 (1.5)	GRINA (1.5)
MP:0004207	squamous cell carcinoma	0.33	> 0.20	PSRC1 (2.3)	FEN1 (2.2)	ENSG00000226648 (2.2)	PBX4 (1.8)	C12orf51 (1.7)	LDLR (1.6)	CBLC (1.6)	HAVCR1 (1.5)	POLK (1.4)	TSSK6 (1.4)
ENSG00000186810	CXCR3 PPI subnetwork	0.33	> 0.20	OASL (4.4)	TRAFD1 (3.6)	TIMD4 (2.6)	RELB (2.4)	MAFB (2.3)	PARP10 (2.2)	APOE (1.9)	APOC1 (1.3)	ZNF101 (1.3)	PVR (1.2)
GO:0032233	positive regulation of actin filament bundle assembly	0.33	> 0.20	HNF1A (2.6)	PBX4 (2.5)	C17orf57 (2.5)	HAVCR1 (2.2)	ABO (1.9)	NYNRIN (1.9)	C11orf9 (1.8)	AMIGO1 (1.7)	ENSG00000226645 (1.6)	ADAM1 (1.6)
ENSG00000100097	LGALS1 PPI subnetwork	0.33	> 0.20	PLEC (3.2)	SLC44A2 (3.1)	APOE (2.4)	AP1M2 (2.0)	PVR (2.0)	APOC1 (1.9)	ST3GAL4 (1.9)	ITGB3 (1.5)	BCAM (1.5)	ZNF101 (1.5)
ENSG00000106636	YKT6 PPI subnetwork	0.33	> 0.20	SUGP1 (3.6)	YIPF2 (2.8)	ZNF259 (2.8)	SARS (2.7)	PSMA5 (2.5)	DDX56 (2.5)	TRAFD1 (2.3)	CYB561D1 (2.1)	C19orf52 (2.1)	DHX38 (2.0)
ENSG00000149503	INCENP PPI subnetwork	0.33	> 0.20	PSRC1 (5.4)	FEN1 (4.9)	USP1 (3.9)	POC5 (3.3)	DHX38 (2.0)	ILF3 (1.5)	ZNF180 (1.4)	DDX56 (1.2)	SUGP1 (1.2)	BUD13 (1.1)
ENSG00000132970	WASF3 PPI subnetwork	0.33	> 0.20	DYNC2LI1 (3.1)	DNM2 (2.6)	CEACAM19 (2.4)	ATXN7L2 (2.3)	PPP1R37 (2.2)	ENSG00000226648 (2.1)	SUGP1 (2.1)	BLOC1S3 (1.8)	LPIN3 (1.8)	DNAH11 (1.8)
ENSG00000096696	DSP PPI subnetwork	0.33	> 0.20	CBLC (3.7)	AP1M2 (2.7)	BCL3 (2.2)	BCAM (2.0)	CEACAM19 (1.9)	TRAPPC6A (1.8)	LPIN3 (1.7)	RELB (1.7)	CELSR2 (1.5)	GEMIN7 (1.4)
ENSG00000138029	HADHB PPI subnetwork	0.33	> 0.20	TOMM40 (3.1)	OGDH (2.9)	ACAD10 (2.2)	POLK (1.8)	TOP1 (1.8)	PSMA5 (1.8)	CLPTM1 (1.6)	ENSG00000226648 (1.5)	GCNT4 (1.5)	PLEC (1.4)
ENSG00000153395	LPCAT1 PPI subnetwork	0.33	> 0.20	OASL (7.8)	PARP10 (3.7)	USP1 (2.3)	ATP13A1 (2.2)	TXNL4B (1.8)	MAU2 (1.7)	PSMA5 (1.6)	SUGP1 (1.6)	TOP1 (1.6)	GATAD2A (1.6)
ENSG00000171793	CTPS PPI subnetwork	0.33	> 0.20	DDX56 (3.1)	SARS (2.9)	PSMA5 (2.7)	TOMM40 (2.5)	SUGP1 (2.3)	NAA25 (2.2)	OGDH (2.1)	ENSG00000235545 (1.7)	GPAM (1.7)	SMARCA4 (1.7)
ENSG00000196150	ZNF250 PPI subnetwork	0.33	> 0.20	FRK (3.8)	YIPF2 (3.8)	AP1M2 (3.3)	LPAR2 (3.2)	QTRT1 (1.8)	TMED4 (1.8)	MOSC1 (1.8)	SUGP1 (1.7)	HAVCR1 (1.6)	KANK2 (1.5)
ENSG00000025293	PHF20 PPI subnetwork	0.33	> 0.20	BUD13 (3.8)	C19orf52 (3.6)	GEMIN7 (2.0)	GCNT4 (2.0)	GATAD2A (1.8)	ATXN2 (1.8)	DHX38 (1.7)	C12orf43 (1.7)	SUGP1 (1.6)	ZNF259 (1.5)
GO:0000049	tRNA binding	0.34	> 0.20	SARS (6.9)	ZNF259 (3.9)	DHODH (3.7)	DDX56 (3.3)	QTRT1 (3.2)	POC5 (2.7)	TXNL4B (2.6)	C12orf43 (2.5)	TOMM40 (2.4)	NAA25 (2.4)
GO:0019783	small conjugating protein-specific protease activity	0.34	> 0.20	USP24 (3.8)	ZNF180 (3.7)	OASL (3.4)	CARM1 (2.8)	TRAFD1 (2.1)	PARP10 (2.0)	NAA25 (1.7)	ATXN7L2 (1.6)	BRAP (1.5)	TMEM57 (1.3)
MP:0002128	abnormal blood circulation	0.34	> 0.20	PVR (2.8)	PVRL2 (2.6)	TMEM116 (2.3)	NYNRIN (2.3)	ALDH2 (2.1)	ENSG00000226648 (2.0)	C11orf9 (2.0)	BCAM (2.0)	FRK (1.6)	MAFB (1.5)
MP:0001297	microphthalmia	0.34	> 0.20	ATXN2 (1.9)	TMED4 (1.8)	DYNC2LI1 (1.8)	UBXN2B (1.8)	NYNRIN (1.7)	ABO (1.6)	PVRL2 (1.5)	PLG (1.4)	PBX4 (1.4)	TRIB1 (1.4)
ENSG00000061987	MON2 PPI subnetwork	0.34	> 0.20	TM6SF2 (3.2)	SLC22A1 (3.1)	ACAD10 (2.7)	C12orf43 (2.5)	ADAM1 (2.5)	ABCG8 (2.2)	HNF1A (2.0)	DHODH (1.9)	ANGPTL3 (1.8)	LPA (1.8)
GO:0031903	microbody membrane	0.34	> 0.20	GPAM (4.3)	MOSC1 (4.2)	FADS2 (2.2)	CLPTM1 (2.1)	ALDH2 (2.1)	YIPF2 (2.0)	GRINA (1.8)	TRAPPC6A (1.8)	ACAD10 (1.7)	SORT1 (1.7)
GO:0005778	peroxisomal membrane	0.34	> 0.20	GPAM (4.3)	MOSC1 (4.2)	FADS2 (2.2)	CLPTM1 (2.1)	ALDH2 (2.1)	YIPF2 (2.0)	GRINA (1.8)	TRAPPC6A (1.8)	ACAD10 (1.7)	SORT1 (1.7)
ENSG00000125870	SNRPB2 PPI subnetwork	0.34	> 0.20	ILF3 (3.9)	C1orf63 (3.7)	BUD13 (2.8)	SMARCA4 (2.7)	DHX38 (2.7)	USP1 (2.7)	SUGP1 (2.6)	TOP1 (2.6)	QTRT1 (2.2)	FEN1 (2.1)
ENSG00000138668	HNRNPD PPI subnetwork	0.34	> 0.20	ILF3 (4.3)	C1orf63 (3.7)	SMARCA4 (3.3)	TOP1 (3.2)	DHX38 (2.4)	BUD13 (2.4)	USP1 (2.3)	QTRT1 (2.3)	GATAD2A (2.3)	SUGP1 (2.1)
GO:0010827	regulation of glucose transport	0.34	> 0.20	NPC1L1 (3.0)	POC5 (2.9)	DOCK7 (2.7)	ABCG8 (2.3)	GPAM (2.0)	NAA25 (2.0)	ENSG00000235545 (1.8)	MOSC1 (1.8)	ABCG5 (1.8)	GCNT4 (1.7)
ENSG00000131149	KIAA0182 PPI subnetwork	0.34	> 0.20	SMARCA4 (2.8)	NT5DC1 (2.4)	BUD13 (2.3)	MARK4 (2.2)	KIAA1324 (2.0)	C19orf52 (2.0)	PLCG1 (1.9)	KANK2 (1.8)	ACAD10 (1.6)	DNM2 (1.6)
ENSG00000174780	SRP72 PPI subnetwork	0.34	> 0.20	LPIN3 (2.3)	ENSG00000254235 (2.3)	C12orf43 (2.2)	TMEM57 (2.2)	SUGP1 (2.0)	DYNC2LI1 (2.0)	C1orf63 (1.8)	FRK (1.8)	DHX38 (1.6)	YIPF2 (1.6)
MP:0001154	seminiferous tubule degeneration	0.34	> 0.20	ATXN7L2 (2.3)	ABO (2.2)	LDLR (1.8)	ST3GAL4 (1.8)	PVRL2 (1.5)	HNF1A (1.5)	FEN1 (1.4)	USP1 (1.4)	PBX4 (1.3)	FADS1 (1.3)
ENSG00000181991	MRPS11 PPI subnetwork	0.34	> 0.20	OASL (3.5)	PARP10 (2.6)	TMED4 (2.2)	ZNF180 (2.1)	NAA25 (2.0)	MAPKAPK5 (1.8)	C12orf43 (1.5)	BUD13 (1.5)	FRK (1.4)	USP24 (1.3)
ENSG00000147145	LPAR4 PPI subnetwork	0.34	> 0.20	USP24 (2.9)	MAU2 (2.7)	MARK4 (2.6)	PARP10 (2.6)	SMARCA4 (2.4)	ATXN2 (2.3)	BCL3 (2.3)	GMIP (2.2)	DHX38 (1.9)	ZNF180 (1.6)
MP:0008566	increased interferon-gamma secretion	0.34	> 0.20	CETP (3.7)	OASL (3.0)	GMIP (3.0)	BCL3 (2.5)	PARP10 (2.1)	RELB (2.1)	TIMD4 (1.8)	MAFB (1.6)	TRAFD1 (1.5)	ZNF101 (1.5)
GO:0035270	endocrine system development	0.34	> 0.20	ANKRD31 (2.4)	C11orf9 (2.4)	KIAA1324 (2.3)	ABO (2.1)	ATXN7L2 (1.6)	TSSK6 (1.6)	NKPD1 (1.4)	CEACAM19 (1.4)	HNF1A (1.4)	CYP7A1 (1.3)
GO:0051953	negative regulation of amine transport	0.34	> 0.20	MOSC1 (2.5)	TSSK6 (2.3)	ABO (2.3)	ENSG00000235545 (2.0)	GMPR (1.9)	GCNT4 (1.8)	PCSK9 (1.6)	ITGB3 (1.4)	HNF1A (1.2)	PLEKHH2 (1.1)
ENSG00000095261	PSMD5 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (3.5)	NT5DC1 (2.3)	NAA25 (2.2)	PARP10 (1.9)	TOMM40 (1.8)	TMEM50A (1.7)	SUGP1 (1.7)	DDX56 (1.6)	SARS (1.4)
GO:0051043	regulation of membrane protein ectodomain proteolysis	0.34	> 0.20	ENSG00000235545 (3.2)	ENSG00000228044 (2.8)	ST3GAL4 (2.2)	CETP (2.0)	GEMIN7 (1.9)	ENSG00000254235 (1.7)	DYNC2LI1 (1.5)	TRAFD1 (1.4)	ENSG00000238078 (1.4)	SUGP1 (1.3)
ENSG00000066777	ARFGEF1 PPI subnetwork	0.34	> 0.20	TRAPPC6A (3.6)	TOMM40 (2.8)	CYB561D1 (2.2)	ST3GAL4 (2.0)	ERP29 (1.8)	RPH3A (1.8)	CLPTM1 (1.8)	UBXN2B (1.7)	QTRT1 (1.7)	PPP1R37 (1.6)
ENSG00000096063	SRPK1 PPI subnetwork	0.34	> 0.20	TOP1 (4.2)	ILF3 (3.6)	C1orf63 (3.3)	USP1 (3.0)	QTRT1 (2.6)	SMARCA4 (2.3)	SUGP1 (2.2)	BUD13 (2.2)	TMEM57 (2.1)	TOMM40 (1.8)
ENSG00000171365	CLCN5 PPI subnetwork	0.34	> 0.20	TXNL4B (2.8)	UBXN2B (2.6)	C12orf51 (2.5)	ATP13A1 (2.4)	GRINA (2.4)	CLPTM1 (2.4)	CARM1 (2.3)	GOT2P1 (2.3)	SLC44A2 (2.2)	C12orf43 (1.7)
GO:0046822	regulation of nucleocytoplasmic transport	0.34	> 0.20	ENSG00000238078 (2.8)	ZNF101 (2.2)	OASL (2.1)	GRINA (1.9)	MYLIP (1.8)	ENSG00000235545 (1.7)	GCNT4 (1.6)	TRAFD1 (1.6)	ENSG00000254235 (1.6)	TMEM116 (1.6)
GO:0005774	vacuolar membrane	0.34	> 0.20	GRINA (4.3)	CLPTM1 (3.4)	ATP13A1 (3.2)	SORT1 (3.1)	ERP29 (3.1)	TMEM50A (2.9)	YIPF2 (2.4)	COL4A3BP (2.1)	SLC44A2 (1.9)	TMED4 (1.9)
MP:0005465	abnormal T-helper 1 physiology	0.34	> 0.20	BCL3 (2.4)	MAFB (2.2)	PBX4 (2.1)	RELB (1.8)	TRAFD1 (1.6)	PVR (1.5)	DNAH11 (1.5)	SLC22A1 (1.5)	MAU2 (1.5)	C19orf52 (1.4)
GO:0001101	response to acid	0.34	> 0.20	C17orf57 (4.3)	C11orf9 (2.2)	ANKRD31 (2.2)	SARS (2.0)	COL4A3BP (1.7)	NPC1L1 (1.7)	FRK (1.7)	ABCG5 (1.6)	YIPF2 (1.6)	AP1M2 (1.5)
GO:0008180	signalosome	0.34	> 0.20	SARS (2.2)	OGDH (2.2)	TXNL4B (2.1)	MAFB (1.9)	PSMA5 (1.8)	GMPR (1.8)	C12orf43 (1.8)	C12orf51 (1.4)	TMED4 (1.3)	SYPL2 (1.3)
ENSG00000017260	ATP2C1 PPI subnetwork	0.34	> 0.20	CLPTM1 (3.6)	YIPF2 (3.0)	TMEM50A (2.7)	TMEM57 (2.5)	TMED4 (2.4)	ERP29 (2.4)	ATP13A1 (2.3)	MAU2 (1.7)	SLC44A2 (1.6)	CYB561D1 (1.6)
REACTOME_SIGNALING_BY_ERBB4	REACTOME_SIGNALING_BY_ERBB4	0.34	> 0.20	CLPTM1 (3.4)	CELSR2 (2.7)	MARK4 (2.5)	ATXN2 (2.2)	ENSG00000226645 (2.2)	PLEC (2.1)	SARS (1.7)	ZHX3 (1.6)	DNM2 (1.6)	PVR (1.5)
MP:0000538	abnormal urinary bladder morphology	0.34	> 0.20	ABCG5 (3.9)	TM6SF2 (3.4)	NPC1L1 (2.5)	HLX (2.3)	FRK (1.9)	ABCG8 (1.8)	CBLC (1.8)	APOB (1.6)	ZHX3 (1.6)	ITGB3 (1.5)
MP:0009969	abnormal cerebral cortex pyramidal cell morphology	0.34	> 0.20	NCAN (3.5)	ABCG5 (2.7)	ABCG8 (2.3)	NKPD1 (2.3)	PLEKHH2 (2.2)	ITGB3 (2.1)	CYP7A1 (2.1)	DYNC2LI1 (2.1)	APOC4 (2.0)	C17orf57 (2.0)
ENSG00000173011	TADA2B PPI subnetwork	0.34	> 0.20	ATXN7L2 (4.1)	BUD13 (3.6)	ATXN2 (2.5)	POC5 (2.4)	MAU2 (2.2)	MAPKAPK5 (2.1)	CARM1 (1.7)	SUGP1 (1.7)	DDX56 (1.4)	TMEM57 (1.3)
GO:0017048	Rho GTPase binding	0.34	> 0.20	PLEC (3.1)	PVRL2 (2.5)	DNM2 (2.3)	AP1M2 (2.2)	MARK4 (2.2)	GMIP (2.2)	CARM1 (2.2)	LPIN3 (2.2)	C11orf9 (2.0)	ENSG00000235545 (2.0)
ENSG00000133121	STARD13 PPI subnetwork	0.34	> 0.20	LDLR (4.4)	FADS1 (3.7)	COL4A3BP (3.0)	GMPR (2.5)	PCSK9 (2.4)	FADS2 (2.4)	C11orf9 (2.0)	SORT1 (1.9)	ENSG00000238078 (1.7)	RPH3A (1.5)
ENSG00000072195	SPEG PPI subnetwork	0.34	> 0.20	GMIP (3.3)	MARK4 (3.1)	LPAR2 (3.0)	USP24 (2.9)	C12orf51 (2.9)	DNM2 (2.8)	ATXN2 (2.8)	SLC44A2 (2.2)	MAU2 (2.0)	POLK (1.9)
ENSG00000124614	RPS10 PPI subnetwork	0.34	> 0.20	NKPD1 (3.0)	ERP29 (1.8)	ILF3 (1.5)	ANKRD31 (1.5)	SARS (1.5)	TRAPPC6A (1.4)	ADAM1 (1.2)	LPAR2 (1.2)	COL4A3BP (1.1)	ATP13A1 (1.1)
GO:0060348	bone development	0.34	> 0.20	CILP2 (5.6)	PLEKHH2 (2.2)	NYNRIN (2.2)	YIPF2 (2.1)	MAFB (1.7)	PCSK9 (1.6)	ALDH2 (1.6)	MYLIP (1.4)	MAPKAPK5 (1.1)	SLC22A1 (1.1)
GO:0005952	cAMP-dependent protein kinase complex	0.34	> 0.20	ITGB3 (3.4)	TSSK6 (2.9)	GPAM (2.4)	PTPN11 (2.2)	ADAM1 (2.1)	GMPR (2.0)	SH2B3 (1.9)	C19orf52 (1.9)	SORT1 (1.9)	BCAM (1.9)
GO:0060411	cardiac septum morphogenesis	0.34	> 0.20	ABO (3.4)	C11orf9 (3.0)	ENSG00000238078 (2.7)	C19orf52 (2.5)	NYNRIN (2.2)	ATXN7L2 (2.1)	PVRL2 (1.8)	ENSG00000235545 (1.6)	C17orf57 (1.4)	ABCG8 (1.3)
KEGG_RENAL_CELL_CARCINOMA	KEGG_RENAL_CELL_CARCINOMA	0.34	> 0.20	DNM2 (3.6)	DOCK7 (2.2)	HLX (2.0)	PLEC (1.9)	MARK4 (1.9)	MYLIP (1.8)	CARM1 (1.8)	PTPN11 (1.8)	COL4A3BP (1.7)	DNAH11 (1.7)
ENSG00000141759	TXNL4A PPI subnetwork	0.34	> 0.20	ILF3 (3.9)	DHX38 (3.6)	TOP1 (3.3)	SUGP1 (3.1)	C1orf63 (3.0)	SMARCA4 (3.0)	FEN1 (2.7)	QTRT1 (2.6)	BUD13 (2.5)	USP1 (2.4)
GO:0005326	neurotransmitter transporter activity	0.34	> 0.20	TM6SF2 (4.1)	HAPLN4 (3.3)	ABCG5 (3.2)	ABCG8 (3.0)	NPC1L1 (2.5)	APOC4 (2.2)	CYP7A1 (2.1)	RPH3A (2.1)	LPA (2.0)	GEMIN7 (1.8)
ENSG00000170759	KIF5B PPI subnetwork	0.34	> 0.20	CBLC (4.8)	DNM2 (3.6)	PLEC (3.2)	AP1M2 (3.1)	LPAR2 (2.8)	MARK4 (2.7)	HNF1A (2.2)	C12orf51 (2.0)	ATXN2 (1.9)	CARM1 (1.8)
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	0.34	> 0.20	NKPD1 (2.7)	TMEM50A (2.6)	ZHX3 (2.2)	COL4A3BP (2.2)	LDLR (2.2)	POLK (2.1)	HMGCR (2.1)	CYB561D1 (2.0)	PVR (2.0)	ABCG8 (1.9)
GO:0031047	gene silencing by RNA	0.34	> 0.20	DOCK7 (2.4)	ENSG00000228044 (2.3)	MAPKAPK5 (2.0)	ADAM1 (1.9)	ANKRD31 (1.9)	USP24 (1.8)	C1orf63 (1.7)	ENSG00000238078 (1.6)	ENSG00000226648 (1.5)	GCNT4 (1.4)
ENSG00000099810	MTAP PPI subnetwork	0.34	> 0.20	C1orf63 (2.6)	PPP1R37 (2.3)	GMPR (2.3)	PLCG1 (2.1)	KANK2 (1.9)	MAU2 (1.8)	TRAFD1 (1.7)	GCNT4 (1.5)	FRK (1.4)	ITGB3 (1.3)
ENSG00000100650	SRSF5 PPI subnetwork	0.34	> 0.20	ILF3 (4.2)	C1orf63 (3.8)	TOP1 (3.1)	DHX38 (2.9)	SMARCA4 (2.8)	USP1 (2.7)	BUD13 (2.4)	PTPN11 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)
MP:0009414	skeletal muscle fiber necrosis	0.34	> 0.20	SYPL2 (6.9)	PVR (2.7)	KANK2 (2.5)	SLC44A2 (2.3)	CYB561D1 (2.0)	GMPR (1.7)	TSSK6 (1.7)	RPH3A (1.5)	HAVCR1 (1.5)	MAU2 (1.5)
GO:0030100	regulation of endocytosis	0.34	> 0.20	GOT2P1 (2.0)	CLPTM1 (1.9)	ANKRD31 (1.8)	HP (1.7)	HNF1A (1.6)	CILP2 (1.6)	ERP29 (1.6)	APOE (1.4)	ALDH2 (1.4)	CETP (1.4)
ENSG00000090006	LTBP4 PPI subnetwork	0.34	> 0.20	RHD (2.9)	MAPKAPK5 (2.1)	RHCE (2.1)	ATP13A1 (1.9)	TMEM57 (1.8)	ITGB3 (1.8)	GPAM (1.8)	NT5DC1 (1.7)	FADS2 (1.6)	RPH3A (1.5)
ENSG00000206380	C6orf48 PPI subnetwork	0.34	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
ENSG00000204387	C6orf48 PPI subnetwork	0.34	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
ENSG00000206271	ENSG00000206271 PPI subnetwork	0.34	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
ENSG00000206296	ENSG00000206296 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
ENSG00000204261	ENSG00000204261 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
ENSG00000206232	ENSG00000206232 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
MP:0001304	cataracts	0.34	> 0.20	HMGCR (2.5)	LDLR (2.0)	UBXN2B (1.6)	USP24 (1.6)	TMEM116 (1.6)	FADS1 (1.5)	PCSK9 (1.4)	TRIB1 (1.3)	TMED4 (1.3)	CILP2 (1.3)
MP:0005329	abnormal myocardium layer morphology	0.34	> 0.20	BCAM (3.4)	PVR (2.0)	PVRL2 (2.0)	HP (1.9)	C11orf9 (1.8)	SORT1 (1.7)	APOB (1.6)	ENSG00000228044 (1.6)	CYP7A1 (1.5)	TIMD4 (1.4)
REACTOME_INFLUENZA_INFECTION	REACTOME_INFLUENZA_INFECTION	0.34	> 0.20	ILF3 (2.8)	DOCK7 (2.0)	NAA25 (1.9)	MOSC1 (1.9)	NKPD1 (1.8)	DDX56 (1.7)	GATAD2A (1.6)	USP1 (1.5)	DHX38 (1.4)	ANKRD31 (1.4)
MP:0000060	delayed bone ossification	0.34	> 0.20	MAFB (3.0)	CILP2 (2.8)	NYNRIN (2.2)	FADS2 (1.6)	BCAM (1.6)	MYLIP (1.6)	PVRL2 (1.4)	PLCG1 (1.4)	PLEKHH2 (1.4)	FRK (1.3)
ENSG00000122122	SASH3 PPI subnetwork	0.34	> 0.20	YIPF2 (2.5)	TMEM57 (2.3)	ENSG00000228044 (2.2)	TM6SF2 (1.8)	DNM2 (1.7)	GRINA (1.7)	ABCG8 (1.5)	MAU2 (1.5)	CLPTM1 (1.4)	BLOC1S3 (1.4)
MP:0000079	abnormal basioccipital bone morphology	0.34	> 0.20	CILP2 (3.1)	PLEC (2.2)	ENSG00000254235 (2.1)	MAFB (2.1)	NYNRIN (1.6)	LPIN3 (1.5)	CEACAM19 (1.2)	ACAD10 (1.2)	PLEKHH2 (1.1)	RHCE (1.0)
GO:0046459	short-chain fatty acid metabolic process	0.34	> 0.20	ACAD10 (4.3)	TRAPPC6A (2.8)	CYP7A1 (2.7)	BLOC1S3 (1.9)	TMEM116 (1.9)	AMIGO1 (1.8)	PBX4 (1.8)	BRAP (1.6)	ZNF101 (1.6)	ANGPTL3 (1.6)
ENSG00000148377	IDI2 PPI subnetwork	0.34	> 0.20	MAU2 (2.8)	USP24 (2.8)	PARP10 (2.7)	MARK4 (2.6)	ATXN2 (2.4)	BCL3 (2.4)	SMARCA4 (2.3)	GMIP (2.0)	DHX38 (1.9)	C12orf51 (1.8)
MP:0004189	abnormal alveolar process morphology	0.34	> 0.20	ANKRD31 (2.5)	CILP2 (2.3)	TRAFD1 (1.9)	SLC22A1 (1.8)	ITGB3 (1.7)	PPP1R37 (1.6)	KANK2 (1.6)	ST3GAL4 (1.6)	APOE (1.5)	ENSG00000238078 (1.4)
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	0.34	> 0.20	TRAFD1 (3.4)	PSMA5 (3.1)	RELB (2.7)	PARP10 (2.5)	TIMD4 (2.1)	USP24 (1.8)	APOE (1.7)	GEMIN7 (1.4)	BCL3 (1.3)	NAA25 (1.3)
MP:0002740	heart hypoplasia	0.34	> 0.20	C12orf51 (2.7)	MAFB (2.1)	BCAM (1.8)	ZHX3 (1.8)	USP24 (1.8)	PVR (1.7)	SMARCA4 (1.7)	ACAD10 (1.5)	ENSG00000254235 (1.4)	ATXN7L2 (1.4)
MP:0002375	abnormal thymus medulla morphology	0.34	> 0.20	BCL3 (4.5)	RELB (3.6)	ZNF101 (3.4)	PLEC (2.7)	PARP10 (2.5)	PLCG1 (2.5)	GMIP (2.3)	PBX4 (2.3)	CYB561D1 (2.0)	PVR (1.8)
MP:0008111	abnormal granulocyte differentiation	0.34	> 0.20	GMIP (3.9)	MAU2 (2.4)	DNM2 (2.0)	MYLIP (2.0)	LPAR2 (2.0)	RELB (2.0)	UBXN2B (1.5)	PARP10 (1.5)	KANK2 (1.4)	SLC44A2 (1.3)
ENSG00000091409	ITGA6 PPI subnetwork	0.34	> 0.20	BCAM (4.9)	PLEC (4.3)	ST3GAL4 (3.1)	PVRL2 (3.0)	CLPTM1 (2.9)	ERP29 (2.6)	GRINA (2.5)	APOE (2.4)	KANK2 (2.0)	OGDH (2.0)
REACTOME_IRON_UPTAKE_AND_TRANSPORT	REACTOME_IRON_UPTAKE_AND_TRANSPORT	0.34	> 0.20	GRINA (3.0)	TMEM116 (3.0)	APOE (2.7)	SORT1 (2.7)	RHD (2.2)	MAFB (2.2)	FRK (2.0)	ERP29 (1.8)	TIMD4 (1.7)	TMEM50A (1.7)
MP:0002493	increased IgG level	0.34	> 0.20	RELB (3.4)	GMIP (3.0)	BCL3 (2.9)	MAFB (2.8)	SH2B3 (2.4)	PARP10 (2.0)	HAVCR1 (1.5)	LPAR2 (1.4)	TRIB1 (1.3)	RHD (1.2)
GO:0009295	nucleoid	0.34	> 0.20	ACAD10 (4.1)	DHODH (3.4)	C19orf52 (2.6)	TMEM116 (2.5)	ABCG5 (2.5)	ABCG8 (2.5)	NAA25 (2.4)	SARS (2.2)	OGDH (2.2)	BRAP (2.0)
ENSG00000069431	ABCC9 PPI subnetwork	0.34	> 0.20	C12orf51 (3.9)	UBXN2B (3.2)	ZHX3 (3.0)	ATXN2 (2.6)	OGDH (1.9)	NPC1L1 (1.8)	USP24 (1.7)	SMARCA4 (1.7)	ABCG8 (1.6)	CYP7A1 (1.5)
GO:0042306	regulation of protein import into nucleus	0.34	> 0.20	OASL (2.2)	MYLIP (1.9)	ENSG00000238078 (1.8)	ZNF101 (1.7)	SH2B3 (1.6)	GRINA (1.6)	ENSG00000235545 (1.5)	TMEM116 (1.5)	DOCK7 (1.5)	GCNT4 (1.4)
ENSG00000074054	CLASP1 PPI subnetwork	0.34	> 0.20	PSRC1 (6.0)	FEN1 (3.8)	USP1 (3.3)	POC5 (3.2)	ZHX3 (2.0)	ENSG00000228044 (1.7)	C11orf9 (1.5)	DNM2 (1.4)	USP24 (1.3)	PLEC (1.3)
GO:0001570	vasculogenesis	0.34	> 0.20	BCAM (2.3)	NYNRIN (2.3)	ENSG00000238078 (2.3)	ATXN7L2 (2.0)	HLX (1.7)	KANK2 (1.7)	CYB561D1 (1.6)	SH2B3 (1.6)	PVRL2 (1.6)	PVR (1.4)
MP:0002731	megacolon	0.34	> 0.20	HLX (3.7)	ABO (3.5)	KANK2 (2.1)	ENSG00000254235 (1.6)	MOSC1 (1.6)	MAU2 (1.5)	ST3GAL4 (1.3)	LPAR2 (1.3)	CEACAM19 (1.3)	KIAA1324 (1.1)
ENSG00000110395	CBL PPI subnetwork	0.34	> 0.20	GMIP (3.9)	SH2B3 (3.6)	DNM2 (3.2)	CETP (2.8)	PBX4 (2.3)	PLEKHH2 (2.2)	TIMD4 (2.2)	SLC44A2 (2.1)	RELB (2.0)	LPAR2 (2.0)
ENSG00000125944	HNRNPR PPI subnetwork	0.34	> 0.20	TOP1 (4.1)	ILF3 (3.5)	SMARCA4 (3.2)	USP1 (2.9)	DHX38 (2.8)	C1orf63 (2.7)	GATAD2A (2.5)	DDX56 (2.4)	SUGP1 (2.4)	FEN1 (2.1)
ENSG00000095066	HOOK2 PPI subnetwork	0.34	> 0.20	UBXN2B (3.1)	ZNF180 (2.7)	GRINA (2.4)	MYLIP (2.3)	AP1M2 (2.3)	ZHX3 (2.2)	TMEM57 (2.2)	GMPR (2.0)	DNAH11 (1.9)	USP1 (1.8)
ENSG00000149532	CPSF7 PPI subnetwork	0.34	> 0.20	ILF3 (4.2)	C1orf63 (3.9)	SMARCA4 (3.2)	DHX38 (3.1)	SUGP1 (3.0)	TOP1 (2.7)	BUD13 (2.6)	USP1 (2.2)	MAU2 (2.0)	FEN1 (2.0)
ENSG00000122691	TWIST1 PPI subnetwork	0.34	> 0.20	HLX (2.9)	TSSK6 (2.0)	RELB (2.0)	TMED4 (2.0)	CARM1 (2.0)	BCL3 (1.9)	MYLIP (1.8)	C11orf9 (1.7)	MAFB (1.7)	LDLR (1.6)
GO:0044246	regulation of multicellular organismal metabolic process	0.34	> 0.20	ENSG00000226645 (2.3)	ST3GAL4 (2.2)	GEMIN7 (2.1)	ENSG00000228044 (2.0)	FRK (2.0)	ALDH2 (1.9)	NKPD1 (1.6)	BLOC1S3 (1.6)	GMPR (1.5)	ENSG00000254235 (1.5)
GO:0022408	negative regulation of cell-cell adhesion	0.34	> 0.20	ANKRD31 (5.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.4)	GOT2P1 (2.3)	ENSG00000226645 (1.8)	TRAPPC6A (1.7)	AP1M2 (1.7)	MOSC1 (1.6)	C19orf52 (1.3)	CILP2 (1.3)
MP:0002420	abnormal adaptive immunity	0.34	> 0.20	CETP (3.5)	APOE (2.8)	TIMD4 (2.8)	GCNT4 (2.0)	MAFB (1.6)	APOC1 (1.6)	HNF1A (1.5)	OASL (1.5)	TXNL4B (1.3)	ZNF101 (1.3)
ENSG00000096996	IL12RB1 PPI subnetwork	0.35	> 0.20	BCL3 (2.9)	COL4A3BP (2.0)	PVR (1.9)	C17orf57 (1.7)	RELB (1.6)	OASL (1.4)	TIMD4 (1.3)	PARP10 (1.3)	CYP7A1 (1.3)	HLX (1.3)
ENSG00000185291	IL3RA PPI subnetwork	0.35	> 0.20	COL4A3BP (2.8)	BCL3 (2.8)	HLX (1.7)	ZNF101 (1.5)	SH2B3 (1.4)	TIMD4 (1.4)	POLK (1.4)	GMIP (1.3)	RELB (1.3)	CYP7A1 (1.2)
ENSG00000167552	TUBA1A PPI subnetwork	0.35	> 0.20	SMARCA4 (3.2)	PLEC (3.0)	CLPTM1 (2.7)	CARM1 (2.3)	TOMM40 (2.2)	ILF3 (2.0)	TOP1 (1.9)	PVR (1.8)	RPH3A (1.8)	C1orf63 (1.5)
KEGG_PATHWAYS_IN_CANCER	KEGG_PATHWAYS_IN_CANCER	0.35	> 0.20	RELB (3.2)	BCAM (2.3)	KANK2 (2.2)	PVRL2 (2.2)	MARK4 (2.0)	GATAD2A (1.9)	PTPN11 (1.9)	PVR (1.9)	PLEC (1.8)	LPAR2 (1.7)
MP:0010869	decreased bone trabecula number	0.35	> 0.20	MAFB (3.4)	TMEM57 (2.2)	CILP2 (1.8)	APOE (1.8)	ANKRD31 (1.7)	BCL3 (1.7)	TRIB1 (1.6)	ATXN7L2 (1.5)	LPAR2 (1.4)	LDLR (1.4)
ENSG00000146731	CCT6A PPI subnetwork	0.35	> 0.20	DDX56 (3.8)	NAA25 (3.7)	ZNF259 (3.4)	PSMA5 (2.8)	TOMM40 (2.8)	SARS (2.7)	TOP1 (2.1)	NT5DC1 (2.0)	OGDH (1.7)	QTRT1 (1.6)
ENSG00000184371	CSF1 PPI subnetwork	0.35	> 0.20	POLK (2.8)	GMIP (2.6)	DNM2 (2.6)	CELSR2 (2.4)	BCL3 (2.4)	NCAN (2.4)	MARK4 (2.3)	PLEC (2.3)	TSSK6 (2.3)	PARP10 (2.1)
ENSG00000196655	TRAPPC4 PPI subnetwork	0.35	> 0.20	CLPTM1 (3.4)	YIPF2 (3.3)	BLOC1S3 (3.1)	GEMIN7 (3.1)	TMEM50A (2.8)	ZNF180 (2.3)	QTRT1 (2.0)	MARK4 (1.9)	C19orf52 (1.8)	KIAA1324 (1.8)
GO:0008013	beta-catenin binding	0.35	> 0.20	PLCG1 (3.0)	PVRL2 (2.8)	MARK4 (2.7)	C11orf9 (2.7)	KANK2 (2.1)	BCAM (2.1)	TRIB1 (2.1)	AP1M2 (2.1)	CELSR2 (2.1)	PLEC (2.0)
ENSG00000073711	PPP2R3A PPI subnetwork	0.35	> 0.20	SYPL2 (2.7)	TOMM40 (2.7)	CLPTM1 (2.1)	LPIN3 (2.0)	GOT2P1 (1.9)	ADAM1 (1.8)	ZNF180 (1.6)	SLC44A2 (1.6)	AMIGO1 (1.6)	CELSR2 (1.5)
GO:0034097	response to cytokine stimulus	0.35	> 0.20	OASL (5.4)	PARP10 (4.9)	TRAFD1 (3.3)	BCL3 (2.5)	RELB (1.9)	PVR (1.7)	CYB561D1 (1.7)	TRIB1 (1.7)	GMIP (1.6)	GRINA (1.4)
GO:0033059	cellular pigmentation	0.35	> 0.20	C12orf43 (2.7)	POLK (2.0)	PPP1R37 (1.9)	DYNC2LI1 (1.8)	C19orf52 (1.7)	BLOC1S3 (1.7)	ZNF101 (1.6)	C12orf47 (1.5)	GMPR (1.5)	ENSG00000228044 (1.5)
MP:0003071	decreased vascular permeability	0.35	> 0.20	HLX (3.7)	BCAM (2.1)	C17orf57 (2.1)	NYNRIN (1.7)	ITGB3 (1.6)	GMPR (1.5)	POLK (1.3)	CELSR2 (1.2)	DNAH11 (1.2)	ENSG00000228044 (1.2)
ENSG00000175104	TRAF6 PPI subnetwork	0.35	> 0.20	PSMA5 (4.4)	TOMM40 (4.1)	NAA25 (3.1)	SARS (2.9)	PTPN11 (2.4)	CLPTM1 (2.4)	CARM1 (2.2)	TMEM50A (2.2)	SMARCA4 (2.1)	OGDH (1.8)
ENSG00000067182	TNFRSF1A PPI subnetwork	0.35	> 0.20	PSMA5 (3.2)	PARP10 (2.8)	ACAD10 (2.4)	SARS (2.4)	TOMM40 (2.4)	RELB (2.3)	ZNF259 (2.1)	HAVCR1 (2.0)	TRAFD1 (2.0)	ATP13A1 (2.0)
MP:0001008	abnormal sympathetic ganglion morphology	0.35	> 0.20	CELSR2 (3.0)	AMIGO1 (2.5)	AP1M2 (2.1)	FADS2 (2.1)	ANKRD31 (1.9)	LPIN3 (1.8)	KIAA1324 (1.8)	NPC1L1 (1.6)	BCAM (1.6)	PMFBP1 (1.5)
GO:0051495	positive regulation of cytoskeleton organization	0.35	> 0.20	PBX4 (2.5)	HNF1A (2.2)	DOCK7 (2.0)	ZNF101 (1.9)	ANKRD31 (1.6)	C17orf57 (1.6)	PLEC (1.6)	PLCG1 (1.5)	PVRL2 (1.5)	POLK (1.5)
ENSG00000101138	CSTF1 PPI subnetwork	0.35	> 0.20	ILF3 (4.1)	C1orf63 (3.2)	USP1 (3.0)	TOP1 (2.9)	DHX38 (2.8)	BUD13 (2.8)	SMARCA4 (2.7)	FEN1 (2.6)	SUGP1 (2.4)	QTRT1 (2.0)
GO:0010243	response to organic nitrogen	0.35	> 0.20	C17orf57 (3.4)	C12orf51 (2.2)	ABCG5 (1.7)	ENSG00000235545 (1.5)	DNAH11 (1.4)	ABCG8 (1.4)	NPC1L1 (1.3)	TSSK6 (1.3)	GMPR (1.3)	AP1M2 (1.3)
GO:0048246	macrophage chemotaxis	0.35	> 0.20	TMEM116 (3.5)	ZNF101 (2.7)	HAVCR1 (2.4)	ST3GAL4 (2.3)	AMIGO1 (2.0)	C17orf57 (1.9)	MAFB (1.9)	TMED4 (1.4)	KIAA1324 (1.3)	ENSG00000238078 (1.3)
ENSG00000144642	RBMS3 PPI subnetwork	0.35	> 0.20	DOCK7 (2.4)	NAA25 (2.1)	OASL (2.0)	FADS1 (1.9)	MOSC1 (1.9)	GPAM (1.9)	PARP10 (1.8)	FADS2 (1.8)	PSMA5 (1.8)	OGDH (1.8)
ENSG00000008018	PSMB1 PPI subnetwork	0.35	> 0.20	PSMA5 (5.7)	TRAFD1 (2.4)	NAA25 (2.3)	NT5DC1 (2.2)	DDX56 (1.6)	COL4A3BP (1.4)	HMGCR (1.4)	TXNL4B (1.4)	SARS (1.4)	ENSG00000254235 (1.3)
MP:0008279	arrest of spermiogenesis	0.35	> 0.20	FADS1 (4.9)	LDLR (3.0)	HMGCR (2.5)	BRAP (2.1)	ENSG00000226645 (2.0)	ABCG5 (2.0)	ABCG8 (2.0)	TMED4 (1.8)	NKPD1 (1.7)	TIMD4 (1.5)
GO:0005283	sodium:amino acid symporter activity	0.35	> 0.20	NCAN (4.6)	ABCG8 (3.1)	CYP7A1 (3.0)	APOC4 (2.8)	HAPLN4 (2.5)	GEMIN7 (2.2)	APOA5 (2.2)	ENSG00000235545 (1.9)	ABCG5 (1.9)	ZHX3 (1.7)
MP:0002754	dilated heart right ventricle	0.35	> 0.20	BCAM (3.4)	SYPL2 (3.0)	CEACAM19 (2.7)	KANK2 (2.7)	PVR (2.2)	MAFB (1.8)	GMPR (1.7)	ENSG00000228044 (1.7)	ENSG00000226645 (1.7)	HNF1A (1.7)
ENSG00000140022	STON2 PPI subnetwork	0.35	> 0.20	HAPLN4 (3.3)	ENSG00000235545 (2.7)	TIMD4 (2.5)	SARS (2.4)	ABO (2.1)	ATXN2 (2.1)	USP24 (1.9)	PBX4 (1.8)	CETP (1.8)	CARM1 (1.7)
MP:0003718	maternal effect	0.35	> 0.20	AP1M2 (2.8)	ABCG8 (2.8)	TM6SF2 (2.5)	ABCG5 (2.3)	CBLC (2.1)	HMGCR (1.9)	FADS2 (1.8)	APOB (1.6)	GOT2P1 (1.6)	CYP7A1 (1.5)
GO:0055038	recycling endosome membrane	0.35	> 0.20	HMGCR (3.7)	FADS2 (3.4)	FADS1 (2.9)	TMEM116 (2.5)	PLEC (1.9)	BLOC1S3 (1.9)	CYB561D1 (1.8)	ENSG00000226645 (1.7)	ZNF259 (1.6)	USP24 (1.6)
ENSG00000135404	CD63 PPI subnetwork	0.35	> 0.20	ST3GAL4 (3.2)	APOE (2.4)	SLC44A2 (2.1)	PMFBP1 (2.0)	TMEM50A (1.9)	ABO (1.8)	CYB561D1 (1.7)	PVR (1.7)	BCAM (1.6)	FADS2 (1.6)
ENSG00000113525	IL5 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.6)	TIMD4 (2.1)	CETP (2.1)	GMIP (2.0)	ALDH2 (1.8)	LPA (1.7)	PBX4 (1.3)	PARP10 (1.2)
GO:0033044	regulation of chromosome organization	0.35	> 0.20	ENSG00000226648 (2.7)	TMEM57 (2.4)	BLOC1S3 (2.2)	RHD (1.8)	RHCE (1.7)	C12orf51 (1.6)	GOT2P1 (1.6)	PSRC1 (1.5)	ATXN2 (1.5)	ABO (1.4)
GO:0009267	cellular response to starvation	0.35	> 0.20	BRAP (3.7)	BLOC1S3 (3.4)	LPIN3 (2.5)	SARS (2.4)	TXNL4B (2.1)	HNF1A (2.0)	C1orf63 (2.0)	ACAD10 (1.9)	FADS2 (1.8)	ERP29 (1.6)
ENSG00000152944	MED21 PPI subnetwork	0.35	> 0.20	GEMIN7 (3.0)	BRAP (2.8)	TXNL4B (2.7)	POC5 (2.5)	BUD13 (2.5)	SMARCA4 (2.1)	C12orf51 (2.0)	TMEM57 (2.0)	C17orf57 (1.9)	MAPKAPK5 (1.8)
MP:0002359	abnormal spleen germinal center morphology	0.35	> 0.20	CETP (3.5)	TIMD4 (3.1)	RELB (2.9)	ZNF101 (2.7)	GMIP (2.6)	BCL3 (2.1)	ENSG00000235545 (1.7)	TMEM116 (1.5)	DNM2 (1.4)	PLEC (1.3)
GO:0072331	signal transduction by p53 class mediator	0.35	> 0.20	PSMA5 (2.7)	NT5DC1 (2.5)	NAA25 (2.4)	TRAFD1 (2.3)	ENSG00000238078 (1.9)	PARP10 (1.8)	TOMM40 (1.6)	BUD13 (1.5)	POC5 (1.5)	ZNF259 (1.5)
MP:0002908	delayed wound healing	0.35	> 0.20	SLC22A1 (2.1)	BCL3 (1.9)	TRIB1 (1.6)	MAFB (1.5)	C11orf9 (1.5)	HP (1.4)	ENSG00000228044 (1.4)	PVR (1.3)	HNF1A (1.2)	ABCG5 (1.1)
GO:0044253	positive regulation of multicellular organismal metabolic process	0.35	> 0.20	NKPD1 (2.1)	ST3GAL4 (2.0)	HNF1A (1.7)	GEMIN7 (1.6)	C17orf57 (1.6)	ENSG00000226645 (1.6)	FRK (1.6)	ENSG00000235545 (1.5)	BLOC1S3 (1.4)	POLK (1.4)
ENSG00000113141	IK PPI subnetwork	0.35	> 0.20	COL4A3BP (3.6)	CLPTM1 (3.3)	PPP1R37 (2.7)	CYB561D1 (2.5)	POC5 (2.4)	LPA (2.3)	DHX38 (2.3)	GEMIN7 (2.1)	SUGP1 (2.0)	TRAPPC6A (1.8)
GO:0032612	interleukin-1 production	0.35	> 0.20	ST3GAL4 (2.1)	CYB561D1 (2.1)	ENSG00000238078 (1.7)	C12orf43 (1.3)	HLX (1.3)	OASL (1.3)	PLEKHH2 (1.2)	SH2B3 (1.2)	ENSG00000228044 (1.2)	MAFB (1.2)
MP:0003054	spina bifida	0.35	> 0.20	NYNRIN (2.4)	KANK2 (2.0)	SLC44A2 (2.0)	LPAR2 (2.0)	DOCK7 (1.9)	PLCG1 (1.9)	ENSG00000254235 (1.8)	GMPR (1.7)	MYLIP (1.6)	ST3GAL4 (1.5)
GO:0016234	inclusion body	0.35	> 0.20	CILP2 (2.4)	GRINA (2.3)	C1orf63 (2.2)	SYPL2 (1.8)	APOE (1.8)	CYP7A1 (1.7)	RPH3A (1.7)	BCAM (1.6)	GMPR (1.5)	YIPF2 (1.4)
ENSG00000185745	IFIT1 PPI subnetwork	0.35	> 0.20	OASL (5.3)	PARP10 (3.0)	USP1 (2.3)	TOP1 (2.1)	ATP13A1 (2.0)	PSMA5 (1.9)	LPAR2 (1.9)	GCNT4 (1.8)	ENSG00000226648 (1.8)	SARS (1.7)
GO:0032321	positive regulation of Rho GTPase activity	0.35	> 0.20	ENSG00000226645 (2.7)	CBLC (2.5)	PPP1R37 (2.4)	ST3GAL4 (2.2)	AP1M2 (2.1)	PLEKHH2 (2.0)	HNF1A (2.0)	LPIN3 (1.9)	BUD13 (1.7)	LPAR2 (1.6)
ENSG00000169188	APEX2 PPI subnetwork	0.35	> 0.20	TRAPPC6A (3.1)	CELSR2 (2.2)	PBX4 (2.2)	YIPF2 (2.2)	PVRL2 (2.1)	QTRT1 (2.1)	NT5DC1 (2.0)	SUGP1 (1.8)	ZNF180 (1.7)	DYNC2LI1 (1.7)
GO:2001022	positive regulation of response to DNA damage stimulus	0.35	> 0.20	GCNT4 (2.1)	HAVCR1 (2.1)	TRAPPC6A (2.0)	ENSG00000226645 (2.0)	NT5DC1 (1.9)	DYNC2LI1 (1.8)	C17orf57 (1.6)	QTRT1 (1.5)	BLOC1S3 (1.4)	C12orf43 (1.4)
MP:0000042	abnormal organ of Corti morphology	0.35	> 0.20	CILP2 (3.1)	HNF1A (3.1)	BCAM (2.6)	PLEKHH2 (2.5)	TRIB1 (2.4)	ZHX3 (2.4)	C11orf9 (2.4)	ANKRD31 (2.3)	PLCG1 (2.0)	LPA (1.7)
ENSG00000064961	HMG20B PPI subnetwork	0.35	> 0.20	MARK4 (2.3)	SMARCA4 (2.2)	PSRC1 (2.1)	ACAD10 (1.9)	DHX38 (1.9)	BUD13 (1.7)	ILF3 (1.7)	DNM2 (1.7)	PLCG1 (1.7)	PPP1R37 (1.6)
GO:0051047	positive regulation of secretion	0.35	> 0.20	KIAA1324 (3.4)	ENSG00000228044 (2.1)	GEMIN7 (1.7)	ENSG00000235545 (1.7)	NPC1L1 (1.6)	YIPF2 (1.5)	COL4A3BP (1.5)	ABO (1.5)	GCNT4 (1.3)	C11orf9 (1.2)
REACTOME_S_PHASE	REACTOME_S_PHASE	0.35	> 0.20	FEN1 (5.3)	PSMA5 (4.0)	USP1 (3.9)	NT5DC1 (1.9)	TOMM40 (1.8)	TRAFD1 (1.5)	ENSG00000235545 (1.4)	DDX56 (1.3)	ZNF180 (1.2)	NAA25 (1.2)
MP:0011104	partial embryonic lethality before implantation	0.35	> 0.20	FEN1 (2.7)	PSRC1 (2.7)	USP1 (2.6)	MAFB (1.9)	ENSG00000238078 (1.8)	AMIGO1 (1.6)	ABO (1.5)	MOSC1 (1.5)	CETP (1.4)	APOE (1.3)
ENSG00000108468	CBX1 PPI subnetwork	0.35	> 0.20	USP1 (2.9)	BUD13 (2.1)	PSRC1 (2.0)	FEN1 (1.9)	ZNF180 (1.8)	GATAD2A (1.7)	FADS2 (1.7)	HLX (1.6)	FADS1 (1.6)	TMEM57 (1.5)
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	0.35	> 0.20	MARK4 (3.7)	SH2B3 (2.9)	CLPTM1 (2.7)	ZHX3 (2.7)	OGDH (2.4)	PLEC (2.3)	GRINA (2.2)	PTPN11 (2.1)	PPP1R37 (2.1)	DNM2 (2.1)
GO:0043507	positive regulation of JUN kinase activity	0.35	> 0.20	LPAR2 (3.1)	ENSG00000235545 (2.2)	ENSG00000226645 (2.1)	ST3GAL4 (2.1)	CYB561D1 (1.7)	GMIP (1.6)	BRAP (1.6)	GCNT4 (1.6)	PPP1R37 (1.5)	FRK (1.3)
ENSG00000153187	HNRNPU PPI subnetwork	0.35	> 0.20	ILF3 (4.0)	TOP1 (3.6)	C1orf63 (3.3)	SMARCA4 (2.8)	DHX38 (2.8)	USP1 (2.6)	QTRT1 (2.6)	BUD13 (2.3)	GATAD2A (2.1)	TOMM40 (2.0)
ENSG00000132669	RIN2 PPI subnetwork	0.35	> 0.20	PTPN11 (2.8)	TMEM50A (2.2)	GATAD2A (2.1)	ANKRD31 (2.1)	HMGCR (2.0)	PLEKHH2 (1.9)	PPP1R37 (1.9)	FADS2 (1.8)	TMEM57 (1.8)	NPC1L1 (1.8)
ENSG00000079435	LIPE PPI subnetwork	0.35	> 0.20	ST3GAL4 (3.9)	GPAM (2.2)	SH2B3 (2.2)	APOC1 (2.2)	ENSG00000226645 (2.1)	SYPL2 (1.8)	CYB561D1 (1.7)	ITGB3 (1.6)	GMPR (1.5)	DYNC2LI1 (1.4)
ENSG00000147382	FAM58A PPI subnetwork	0.35	> 0.20	APOC1 (3.0)	NKPD1 (2.4)	NPC1L1 (2.3)	APOE (2.3)	C19orf52 (2.2)	PBX4 (2.0)	TXNL4B (2.0)	ABO (1.9)	COL4A3BP (1.8)	ABCG8 (1.8)
ENSG00000004478	FKBP4 PPI subnetwork	0.35	> 0.20	C17orf57 (2.8)	CARM1 (2.7)	SH2B3 (2.2)	HLX (2.1)	TRIB1 (2.1)	GOT2P1 (2.1)	ZNF259 (1.8)	PLEC (1.8)	GRINA (1.7)	ZNF101 (1.7)
GO:0051327	M phase of meiotic cell cycle	0.35	> 0.20	ANKRD31 (3.8)	ENSG00000228044 (2.3)	POC5 (1.8)	USP1 (1.4)	PSRC1 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ENSG00000238078 (1.1)	DYNC2LI1 (1.1)	FEN1 (1.1)
GO:0007126	meiosis	0.35	> 0.20	ANKRD31 (3.8)	ENSG00000228044 (2.3)	POC5 (1.8)	USP1 (1.4)	PSRC1 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ENSG00000238078 (1.1)	DYNC2LI1 (1.1)	FEN1 (1.1)
MP:0002663	failure to form blastocele	0.35	> 0.20	CBLC (3.3)	BRAP (2.8)	PLEKHH2 (2.7)	AP1M2 (2.2)	LPAR2 (1.9)	PVRL2 (1.8)	ABCG5 (1.5)	DOCK7 (1.2)	ABO (1.2)	FEN1 (1.2)
REACTOME_DNA_REPLICATION	REACTOME_DNA_REPLICATION	0.35	> 0.20	FEN1 (5.8)	USP1 (4.5)	PSRC1 (4.2)	POC5 (2.5)	PSMA5 (2.2)	ZNF180 (1.6)	ENSG00000228044 (0.9)	ENSG00000226648 (0.9)	LPIN3 (0.8)	BUD13 (0.8)
GO:0046129	purine ribonucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
GO:0042451	purine nucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
GO:0042455	ribonucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
MP:0008217	abnormal B cell activation	0.35	> 0.20	ZNF101 (3.0)	TIMD4 (2.9)	CETP (2.6)	SLC44A2 (2.0)	GMIP (1.9)	GEMIN7 (1.5)	HAVCR1 (1.5)	RELB (1.4)	CYB561D1 (1.3)	GCNT4 (1.2)
GO:0022411	cellular component disassembly	0.35	> 0.20	ENSG00000226645 (2.4)	UBXN2B (2.1)	C1orf63 (2.0)	CBLC (1.8)	SLC44A2 (1.8)	ABO (1.8)	TSSK6 (1.7)	GATAD2A (1.6)	ENSG00000238078 (1.5)	TMEM50A (1.4)
MP:0001759	increased urine glucose level	0.35	> 0.20	ERP29 (2.0)	CEACAM19 (2.0)	MOSC1 (1.8)	COL4A3BP (1.8)	TMED4 (1.6)	HAVCR1 (1.6)	TMEM116 (1.5)	SYPL2 (1.5)	PMFBP1 (1.5)	YIPF2 (1.4)
ENSG00000100206	DMC1 PPI subnetwork	0.35	> 0.20	ANKRD31 (2.7)	FEN1 (2.5)	NAA25 (2.0)	USP1 (2.0)	C17orf57 (1.9)	TOMM40 (1.9)	SUGP1 (1.8)	GOT2P1 (1.6)	POLK (1.5)	TMEM57 (1.5)
MP:0001732	postnatal growth retardation	0.35	> 0.20	LDLR (2.2)	TRIB1 (2.1)	PLEC (1.8)	CELSR2 (1.8)	CLPTM1 (1.7)	CARM1 (1.6)	KANK2 (1.5)	NYNRIN (1.4)	BCL3 (1.4)	ATXN2 (1.3)
ENSG00000116266	STXBP3 PPI subnetwork	0.35	> 0.20	TSSK6 (2.8)	C12orf43 (2.7)	HNF1A (2.2)	PLEKHH2 (2.1)	POC5 (2.0)	GCNT4 (1.8)	GEMIN7 (1.8)	SH2B3 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.5)
ENSG00000151320	AKAP6 PPI subnetwork	0.35	> 0.20	C17orf57 (2.9)	COL4A3BP (2.6)	MYLIP (2.5)	OGDH (2.4)	ZNF101 (2.2)	DNM2 (2.1)	C19orf52 (1.9)	PPP1R37 (1.7)	POC5 (1.7)	PMFBP1 (1.6)
ENSG00000129465	RIPK3 PPI subnetwork	0.35	> 0.20	SARS (3.5)	DOCK7 (2.8)	HAVCR1 (2.7)	SMARCA4 (2.6)	OGDH (2.4)	PSMA5 (2.3)	PLEC (2.2)	FRK (1.8)	TOMM40 (1.7)	ILF3 (1.6)
ENSG00000183625	CCR3 PPI subnetwork	0.35	> 0.20	OASL (5.0)	MAFB (3.6)	TRAFD1 (3.0)	PARP10 (2.0)	TIMD4 (2.0)	RELB (1.9)	PMFBP1 (1.8)	ST3GAL4 (1.3)	APOE (1.2)	ABO (1.2)
ENSG00000089041	P2RX7 PPI subnetwork	0.35	> 0.20	PLEC (3.1)	CYP7A1 (2.6)	OGDH (2.3)	APOE (2.1)	C17orf57 (1.8)	DNM2 (1.6)	GMIP (1.6)	ABCG8 (1.5)	FADS2 (1.5)	APOC1 (1.5)
MP:0002718	abnormal inner cell mass morphology	0.35	> 0.20	FEN1 (3.0)	USP1 (2.7)	BUD13 (2.6)	ATXN7L2 (1.8)	ENSG00000254235 (1.8)	PPP1R37 (1.7)	GEMIN7 (1.5)	CBLC (1.4)	GATAD2A (1.4)	GOT2P1 (1.2)
ENSG00000053918	KCNQ1 PPI subnetwork	0.35	> 0.20	ZNF101 (2.2)	MAU2 (1.8)	SLC44A2 (1.7)	C19orf52 (1.7)	GATAD2A (1.6)	DNAH11 (1.5)	ZHX3 (1.5)	TM6SF2 (1.5)	GMIP (1.4)	KANK2 (1.4)
ENSG00000011243	AKAP8L PPI subnetwork	0.35	> 0.20	ATP13A1 (3.2)	DNM2 (2.6)	MAU2 (2.4)	C19orf52 (2.1)	SLC44A2 (2.1)	YIPF2 (2.0)	QTRT1 (1.9)	OGDH (1.8)	ILF3 (1.7)	DHODH (1.6)
MP:0003037	increased infarction size	0.35	> 0.20	TIMD4 (3.2)	PVR (3.0)	CETP (2.5)	PLEKHH2 (2.3)	PARP10 (1.9)	C17orf57 (1.9)	BCL3 (1.7)	CEACAM19 (1.7)	ALDH2 (1.6)	OASL (1.5)
MP:0001829	increased activated T cell number	0.35	> 0.20	PARP10 (3.7)	OASL (2.8)	PBX4 (2.6)	TRAFD1 (2.6)	RELB (2.2)	ITGB3 (2.0)	ZNF101 (1.9)	PLCG1 (1.8)	CETP (1.6)	POLK (1.4)
GO:0045502	dynein binding	0.35	> 0.20	RHCE (2.8)	DHX38 (2.7)	MAPKAPK5 (2.6)	DYNC2LI1 (2.5)	PBX4 (2.5)	DNAH11 (2.3)	TMEM57 (2.1)	POC5 (2.1)	TOP1 (2.0)	C12orf51 (1.9)
GO:0006281	DNA repair	0.35	> 0.20	ZNF180 (3.2)	POC5 (3.2)	BUD13 (2.6)	SUGP1 (2.4)	USP1 (1.9)	MAPKAPK5 (1.8)	NT5DC1 (1.8)	FEN1 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)
GO:0055006	cardiac cell development	0.35	> 0.20	ENSG00000226648 (2.2)	SYPL2 (2.2)	CEACAM19 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)	ST3GAL4 (1.6)	ENSG00000254235 (1.6)	HNF1A (1.5)	SH2B3 (1.1)	HAPLN4 (1.1)
GO:0055013	cardiac muscle cell development	0.35	> 0.20	ENSG00000226648 (2.2)	SYPL2 (2.2)	CEACAM19 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)	ST3GAL4 (1.6)	ENSG00000254235 (1.6)	HNF1A (1.5)	SH2B3 (1.1)	HAPLN4 (1.1)
ENSG00000120063	GNA13 PPI subnetwork	0.35	> 0.20	DNM2 (3.1)	HLX (2.5)	CETP (2.3)	MARK4 (2.3)	SH2B3 (2.2)	MAFB (2.1)	GATAD2A (2.1)	PBX4 (2.1)	SLC44A2 (1.9)	GMIP (1.8)
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR78_OR_9_STIMULATION	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR78_OR_9_STIMULATION	0.35	> 0.20	FRK (3.8)	TSSK6 (2.7)	OASL (2.4)	RELB (2.3)	MAU2 (2.3)	PARP10 (2.1)	LPAR2 (2.1)	ENSG00000226645 (1.7)	PLEKHH2 (1.5)	TMEM57 (1.5)
ENSG00000169967	MAP3K2 PPI subnetwork	0.35	> 0.20	LPAR2 (3.4)	DNM2 (3.3)	GMIP (2.9)	MARK4 (2.7)	UBXN2B (2.2)	ATXN7L2 (2.1)	CBLC (2.0)	GATAD2A (1.9)	TRIB1 (1.8)	PLEC (1.7)
GO:0070160	occluding junction	0.35	> 0.20	AP1M2 (6.1)	CBLC (4.2)	FRK (3.7)	PVRL2 (3.6)	DYNC2LI1 (2.5)	BCAM (2.5)	PVR (2.1)	PLEKHH2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.6)
GO:0005923	tight junction	0.35	> 0.20	AP1M2 (6.1)	CBLC (4.2)	FRK (3.7)	PVRL2 (3.6)	DYNC2LI1 (2.5)	BCAM (2.5)	PVR (2.1)	PLEKHH2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.6)
GO:0050775	positive regulation of dendrite morphogenesis	0.35	> 0.20	DOCK7 (4.1)	ENSG00000235545 (3.8)	ABO (2.9)	GCNT4 (2.5)	ENSG00000226648 (2.3)	TSSK6 (1.8)	ABCG8 (1.6)	LPIN3 (1.5)	C11orf9 (1.5)	GEMIN7 (1.4)
ENSG00000100368	CSF2RB PPI subnetwork	0.35	> 0.20	BCL3 (3.1)	COL4A3BP (2.3)	HLX (2.3)	SH2B3 (2.1)	CETP (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	RELB (1.3)	ENSG00000238078 (1.3)
ENSG00000166913	YWHAB PPI subnetwork	0.35	> 0.20	C12orf51 (3.5)	TOP1 (3.2)	PLEC (3.0)	SMARCA4 (2.9)	ATXN2 (2.7)	CBLC (2.6)	CELSR2 (2.3)	OGDH (2.3)	TRIB1 (2.1)	CARM1 (2.0)
KEGG_RNA_DEGRADATION	KEGG_RNA_DEGRADATION	0.35	> 0.20	DHODH (4.1)	POC5 (3.3)	DHX38 (2.9)	ZNF259 (2.7)	ST3GAL4 (2.3)	TXNL4B (2.2)	MAPKAPK5 (2.0)	DDX56 (2.0)	TOMM40 (2.0)	SUGP1 (1.9)
ENSG00000158769	F11R PPI subnetwork	0.35	> 0.20	ITGB3 (4.0)	C11orf9 (2.8)	APOE (2.5)	CBLC (2.4)	ENSG00000238078 (2.3)	AP1M2 (2.2)	CETP (2.1)	FRK (2.1)	PLCG1 (2.0)	PVRL2 (1.8)
GO:0070003	threonine-type peptidase activity	0.35	> 0.20	PSMA5 (6.1)	TRAFD1 (4.4)	PARP10 (3.3)	TMEM50A (2.4)	NT5DC1 (2.3)	C12orf47 (1.6)	NAA25 (1.6)	LPA (1.2)	C11orf9 (1.1)	CYB561D1 (1.1)
GO:0004298	threonine-type endopeptidase activity	0.35	> 0.20	PSMA5 (6.1)	TRAFD1 (4.4)	PARP10 (3.3)	TMEM50A (2.4)	NT5DC1 (2.3)	C12orf47 (1.6)	NAA25 (1.6)	LPA (1.2)	C11orf9 (1.1)	CYB561D1 (1.1)
GO:0007339	binding of sperm to zona pellucida	0.35	> 0.20	TSSK6 (4.4)	PMFBP1 (3.7)	ENSG00000228044 (3.1)	ENSG00000238078 (3.1)	GCNT4 (2.3)	PBX4 (1.6)	C17orf57 (1.5)	BRAP (1.0)	ANKRD31 (0.9)	PCSK9 (0.9)
ENSG00000113739	STC2 PPI subnetwork	0.35	> 0.20	TXNL4B (2.8)	C12orf47 (2.7)	GCNT4 (2.4)	MAPKAPK5 (2.3)	QTRT1 (2.2)	KANK2 (1.8)	BRAP (1.7)	C12orf43 (1.6)	USP1 (1.5)	TMED4 (1.5)
GO:0034764	positive regulation of transmembrane transport	0.35	> 0.20	GCNT4 (2.6)	AP1M2 (2.4)	OASL (2.4)	TMEM116 (2.2)	FRK (2.1)	ENSG00000238078 (2.0)	ENSG00000235545 (2.0)	PLEKHH2 (1.9)	MYLIP (1.8)	ENSG00000228044 (1.7)
GO:0016884	carbon-nitrogen ligase activity, with glutamine as amido-N-donor	0.35	> 0.20	DDX56 (3.4)	SARS (3.3)	QTRT1 (2.9)	C12orf43 (2.6)	NT5DC1 (2.6)	ACAD10 (2.1)	ANKRD31 (2.0)	DHODH (1.8)	FRK (1.7)	ATP13A1 (1.6)
GO:0045408	regulation of interleukin-6 biosynthetic process	0.35	> 0.20	ENSG00000254235 (2.6)	HLX (2.4)	ENSG00000235545 (2.1)	ENSG00000228044 (2.1)	HNF1A (1.8)	ENSG00000226645 (1.7)	BUD13 (1.6)	ENSG00000238078 (1.5)	PMFBP1 (1.4)	TRIB1 (1.3)
GO:0051646	mitochondrion localization	0.35	> 0.20	CYP7A1 (2.0)	TMEM57 (2.0)	GOT2P1 (1.9)	DNAH11 (1.6)	OGDH (1.5)	ZNF180 (1.5)	COL4A3BP (1.4)	ACAD10 (1.4)	PLEKHH2 (1.3)	GMPR (1.3)
GO:0006809	nitric oxide biosynthetic process	0.35	> 0.20	ENSG00000228044 (1.9)	PVR (1.6)	BCL3 (1.6)	TMEM116 (1.6)	MAFB (1.5)	AMIGO1 (1.5)	TXNL4B (1.5)	GCNT4 (1.5)	C17orf57 (1.4)	PLCG1 (1.2)
ENSG00000120265	PCMT1 PPI subnetwork	0.35	> 0.20	ABCG5 (2.9)	PLEC (2.8)	NPC1L1 (2.6)	APOB (2.6)	TM6SF2 (2.5)	KANK2 (2.1)	SH2B3 (2.0)	ABCG8 (1.7)	RELB (1.7)	PVR (1.5)
REACTOME_PAUSING_AND_RECOVERY_OF_TAT:MEDIATED_HIV:1_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_TAT:MEDIATED_HIV:1_ELONGATION	0.35	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.4)	BUD13 (2.2)	DNM2 (2.2)	ZNF259 (2.0)	GEMIN7 (2.0)	PTPN11 (1.9)	MAPKAPK5 (1.9)	GATAD2A (1.7)
REACTOME_TAT:MEDIATED_HIV:1_ELONGATION_ARREST_AND_RECOVERY	REACTOME_TAT:MEDIATED_HIV:1_ELONGATION_ARREST_AND_RECOVERY	0.35	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.4)	BUD13 (2.2)	DNM2 (2.2)	ZNF259 (2.0)	GEMIN7 (2.0)	PTPN11 (1.9)	MAPKAPK5 (1.9)	GATAD2A (1.7)
GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	0.35	> 0.20	ENSG00000226645 (2.8)	BLOC1S3 (2.4)	RELB (2.3)	GMIP (2.2)	BCL3 (2.0)	OASL (2.0)	PLEKHH2 (1.9)	ATXN7L2 (1.6)	PARP10 (1.6)	SH2B3 (1.5)
MP:0002953	thick ventricular wall	0.35	> 0.20	KANK2 (2.5)	GMPR (2.2)	OGDH (1.8)	NKPD1 (1.6)	SYPL2 (1.5)	SH2B3 (1.5)	CEACAM19 (1.4)	ACAD10 (1.4)	TMED4 (1.3)	TSSK6 (1.3)
GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	0.35	> 0.20	ANKRD31 (3.6)	MYLIP (2.3)	C1orf63 (2.2)	POLK (2.0)	ENSG00000238078 (1.7)	C12orf47 (1.7)	NT5DC1 (1.6)	POC5 (1.5)	DYNC2LI1 (1.5)	PMFBP1 (1.4)
ENSG00000174446	SNAPC5 PPI subnetwork	0.35	> 0.20	C12orf43 (3.6)	ADAM1 (3.4)	GEMIN7 (3.2)	SUGP1 (2.5)	ZNF259 (2.4)	MAPKAPK5 (2.3)	POC5 (2.2)	C19orf52 (2.2)	DDX56 (2.0)	ATXN2 (2.0)
ENSG00000185436	IL28RA PPI subnetwork	0.35	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.5)	PVR (1.5)	RELB (1.4)	HLX (1.4)	ZNF101 (1.3)	BCAM (1.3)	SLC22A1 (1.2)
ENSG00000104626	ERI1 PPI subnetwork	0.35	> 0.20	DOCK7 (2.6)	NT5DC1 (2.4)	NAA25 (2.1)	OASL (2.0)	FADS1 (2.0)	GPAM (1.9)	FADS2 (1.9)	PSMA5 (1.8)	MOSC1 (1.8)	GMPR (1.6)
MP:0005168	abnormal female meiosis	0.35	> 0.20	ANKRD31 (2.9)	TMEM116 (2.6)	USP1 (1.9)	NYNRIN (1.8)	PCSK9 (1.7)	PSRC1 (1.5)	C17orf57 (1.5)	AP1M2 (1.4)	CEACAM19 (1.4)	ATXN7L2 (1.4)
MP:0009009	absent estrous cycle	0.35	> 0.20	TOP1 (2.5)	KIAA1324 (2.3)	PMFBP1 (2.1)	PBX4 (1.7)	ENSG00000226648 (1.5)	ABO (1.5)	TRIB1 (1.4)	CYP7A1 (1.4)	LDLR (1.4)	ZHX3 (1.3)
ENSG00000155561	NUP205 PPI subnetwork	0.35	> 0.20	POC5 (3.0)	USP1 (2.9)	BUD13 (2.8)	DDX56 (2.7)	NAA25 (2.7)	CARM1 (2.3)	DOCK7 (2.3)	ENSG00000226648 (2.2)	ADAM1 (2.1)	ILF3 (2.0)
ENSG00000114125	RNF7 PPI subnetwork	0.35	> 0.20	GMPR (2.4)	BUD13 (2.1)	TIMD4 (1.9)	HLX (1.7)	CETP (1.5)	CARM1 (1.4)	CILP2 (1.3)	CEACAM19 (1.3)	BRAP (1.3)	TMED4 (1.2)
ENSG00000161654	LSM12 PPI subnetwork	0.35	> 0.20	C12orf43 (2.7)	TOMM40 (2.4)	ENSG00000226645 (2.2)	ENSG00000238078 (2.2)	DOCK7 (2.0)	ATXN2 (1.8)	OGDH (1.8)	DDX56 (1.7)	NAA25 (1.7)	ADAM1 (1.6)
GO:0061097	regulation of protein tyrosine kinase activity	0.35	> 0.20	ENSG00000228044 (2.9)	ENSG00000226645 (2.2)	TMED4 (2.2)	ANKRD31 (2.1)	CYB561D1 (1.8)	TSSK6 (1.7)	ZNF259 (1.5)	C19orf52 (1.5)	AP1M2 (1.3)	ACAD10 (1.3)
MP:0008022	dilated heart ventricle	0.35	> 0.20	BCAM (2.6)	ENSG00000235545 (2.6)	PLEKHH2 (2.5)	NYNRIN (2.4)	ALDH2 (2.3)	TSSK6 (2.1)	TRIB1 (2.1)	GEMIN7 (2.0)	LPA (1.8)	TIMD4 (1.8)
ENSG00000143498	TAF1A PPI subnetwork	0.35	> 0.20	C12orf43 (3.7)	ZNF259 (3.0)	MAPKAPK5 (2.7)	NAA25 (2.7)	TXNL4B (2.3)	DDX56 (2.2)	DYNC2LI1 (2.2)	BUD13 (2.2)	GEMIN7 (2.1)	POLK (1.9)
GO:0008417	fucosyltransferase activity	0.35	> 0.20	CBLC (2.7)	FRK (2.6)	YIPF2 (2.3)	ERP29 (2.0)	HNF1A (1.8)	LPIN3 (1.8)	MYLIP (1.5)	ABO (1.4)	SLC44A2 (1.3)	TMED4 (1.3)
MP:0011106	partial embryonic lethality before somite formation	0.36	> 0.20	FRK (3.8)	APOB (1.9)	PTPN11 (1.8)	CELSR2 (1.7)	HNF1A (1.7)	ABO (1.5)	PVRL2 (1.5)	MAFB (1.2)	YIPF2 (1.2)	DHX38 (1.1)
GO:0090068	positive regulation of cell cycle process	0.36	> 0.20	PSMA5 (2.6)	TMED4 (2.1)	NAA25 (1.9)	PSRC1 (1.8)	TRAFD1 (1.7)	POLK (1.7)	POC5 (1.7)	TMEM50A (1.6)	DDX56 (1.4)	SUGP1 (1.3)
MP:0000748	progressive muscle weakness	0.36	> 0.20	SYPL2 (2.7)	BCAM (2.2)	HAPLN4 (2.1)	DOCK7 (2.1)	PLEC (2.0)	ENSG00000235545 (1.5)	RPH3A (1.5)	HMGCR (1.5)	SORT1 (1.5)	CYP7A1 (1.4)
ENSG00000126217	MCF2L PPI subnetwork	0.36	> 0.20	CARM1 (3.9)	TMEM50A (3.3)	GATAD2A (2.8)	DDX56 (2.6)	ILF3 (2.5)	BRAP (2.5)	ATP13A1 (2.5)	PVR (2.3)	QTRT1 (2.2)	C11orf9 (2.1)
GO:0031650	regulation of heat generation	0.36	> 0.20	ENSG00000235545 (3.4)	ENSG00000228044 (2.7)	DNAH11 (2.3)	BLOC1S3 (2.0)	ZNF180 (1.7)	CETP (1.6)	HLX (1.6)	OASL (1.5)	ENSG00000226645 (1.4)	TSSK6 (1.3)
GO:0031652	positive regulation of heat generation	0.36	> 0.20	ENSG00000235545 (3.4)	ENSG00000228044 (2.7)	DNAH11 (2.3)	BLOC1S3 (2.0)	ZNF180 (1.7)	CETP (1.6)	HLX (1.6)	OASL (1.5)	ENSG00000226645 (1.4)	TSSK6 (1.3)
GO:0015643	toxin binding	0.36	> 0.20	ANGPTL3 (2.8)	ALDH2 (2.8)	APOB (2.7)	PLG (2.5)	HP (2.4)	PBX4 (2.2)	CEACAM19 (2.0)	ATXN7L2 (1.8)	APOA5 (1.8)	APOC4 (1.7)
GO:0045840	positive regulation of mitosis	0.36	> 0.20	ENSG00000228044 (2.3)	TMED4 (2.3)	POLK (2.0)	POC5 (1.8)	PSRC1 (1.6)	ANKRD31 (1.6)	KANK2 (1.5)	YIPF2 (1.5)	GCNT4 (1.4)	DNAH11 (1.3)
GO:0051785	positive regulation of nuclear division	0.36	> 0.20	ENSG00000228044 (2.3)	TMED4 (2.3)	POLK (2.0)	POC5 (1.8)	PSRC1 (1.6)	ANKRD31 (1.6)	KANK2 (1.5)	YIPF2 (1.5)	GCNT4 (1.4)	DNAH11 (1.3)
GO:0035036	sperm-egg recognition	0.36	> 0.20	TSSK6 (4.5)	PMFBP1 (4.2)	ENSG00000228044 (3.8)	ENSG00000238078 (3.0)	GCNT4 (2.6)	PBX4 (1.8)	C17orf57 (1.7)	PCSK9 (1.1)	HNF1A (1.0)	BRAP (1.0)
REACTOME_GPVI:MEDIATED_ACTIVATION_CASCADE	REACTOME_GPVI:MEDIATED_ACTIVATION_CASCADE	0.36	> 0.20	ITGB3 (3.1)	GMIP (3.0)	GATAD2A (2.6)	SH2B3 (2.2)	CETP (2.1)	TMEM57 (2.0)	DNM2 (1.9)	MYLIP (1.8)	SLC44A2 (1.8)	OGDH (1.7)
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.36	> 0.20	TIMD4 (2.2)	SH2B3 (2.1)	ABCG8 (1.8)	BCL3 (1.8)	PBX4 (1.7)	RELB (1.7)	CETP (1.7)	TRAFD1 (1.5)	ABCG5 (1.5)	TM6SF2 (1.5)
ENSG00000023191	RNH1 PPI subnetwork	0.36	> 0.20	ATP13A1 (3.0)	ILF3 (2.0)	YIPF2 (1.9)	DNM2 (1.9)	OGDH (1.8)	ENSG00000235545 (1.6)	ACAD10 (1.5)	LDLR (1.5)	DOCK7 (1.4)	DHODH (1.4)
ENSG00000131467	PSME3 PPI subnetwork	0.36	> 0.20	GMPR (2.5)	MYLIP (2.1)	TMED4 (2.1)	BRAP (1.9)	C12orf43 (1.9)	PARP10 (1.9)	ZNF101 (1.7)	PLCG1 (1.7)	NT5DC1 (1.4)	TRAFD1 (1.4)
GO:0016328	lateral plasma membrane	0.36	> 0.20	AP1M2 (6.4)	CBLC (5.0)	CELSR2 (2.8)	BCAM (2.8)	PVRL2 (2.4)	LPIN3 (2.4)	ABCG5 (2.0)	TRAPPC6A (2.0)	NYNRIN (1.9)	FRK (1.7)
GO:0006469	negative regulation of protein kinase activity	0.36	> 0.20	ENSG00000226645 (4.1)	TRIB1 (4.0)	PVR (2.2)	ENSG00000238078 (1.8)	MYLIP (1.7)	HLX (1.6)	KANK2 (1.5)	LDLR (1.2)	TOP1 (1.2)	BCAM (1.2)
GO:0030595	leukocyte chemotaxis	0.36	> 0.20	MAFB (3.2)	ZNF101 (2.8)	TIMD4 (2.2)	ST3GAL4 (2.1)	APOE (1.9)	HLX (1.9)	GMIP (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	AMIGO1 (1.5)
GO:0042169	SH2 domain binding	0.36	> 0.20	PBX4 (3.0)	PLCG1 (2.7)	GPAM (2.6)	ABO (2.1)	PPP1R37 (1.8)	FADS1 (1.5)	ENSG00000238078 (1.5)	TRIB1 (1.4)	GMIP (1.3)	CETP (1.3)
GO:0033673	negative regulation of kinase activity	0.36	> 0.20	ENSG00000226645 (4.2)	TRIB1 (3.9)	PVR (2.0)	ENSG00000238078 (1.8)	KANK2 (1.7)	HLX (1.6)	MYLIP (1.5)	BCAM (1.4)	GPAM (1.3)	LDLR (1.3)
ENSG00000073584	SMARCE1 PPI subnetwork	0.36	> 0.20	RHCE (3.1)	C12orf51 (2.7)	SMARCA4 (2.6)	ATXN2 (2.6)	CARM1 (2.6)	TOP1 (2.4)	GRINA (2.3)	RHD (2.1)	KANK2 (2.0)	GATAD2A (2.0)
GO:0050433	regulation of catecholamine secretion	0.36	> 0.20	ABO (3.1)	CEACAM19 (2.4)	BLOC1S3 (1.8)	GOT2P1 (1.7)	PMFBP1 (1.6)	CETP (1.6)	PPP1R37 (1.6)	C19orf52 (1.5)	TSSK6 (1.4)	GMPR (1.4)
GO:2001252	positive regulation of chromosome organization	0.36	> 0.20	TMEM57 (3.1)	ENSG00000226648 (2.7)	SH2B3 (2.1)	FADS1 (2.0)	PCSK9 (2.0)	C12orf51 (1.9)	FADS2 (1.8)	DNM2 (1.8)	MYLIP (1.6)	RHD (1.6)
ENSG00000006744	ELAC2 PPI subnetwork	0.36	> 0.20	CARM1 (3.5)	DDX56 (2.7)	GMPR (2.4)	SMARCA4 (2.3)	TMEM57 (1.9)	ILF3 (1.8)	TOMM40 (1.7)	GATAD2A (1.7)	ACAD10 (1.7)	QTRT1 (1.6)
ENSG00000116741	RGS2 PPI subnetwork	0.36	> 0.20	GCNT4 (2.9)	GOT2P1 (2.9)	TOP1 (2.2)	MARK4 (1.9)	YIPF2 (1.9)	C19orf52 (1.9)	AMIGO1 (1.8)	FADS1 (1.8)	SORT1 (1.8)	C11orf9 (1.6)
ENSG00000198569	SLC34A3 PPI subnetwork	0.36	> 0.20	NCAN (2.8)	TMEM57 (2.4)	ADAM1 (2.2)	RPH3A (2.1)	MYLIP (2.1)	APOC1 (1.9)	SUGP1 (1.8)	TRAFD1 (1.7)	ENSG00000238078 (1.7)	ST3GAL4 (1.7)
MP:0006033	abnormal external auditory canal morphology	0.36	> 0.20	MYLIP (2.7)	LPIN3 (2.7)	CEACAM19 (2.4)	BCAM (2.2)	DYNC2LI1 (2.0)	CILP2 (1.9)	HAVCR1 (1.9)	MAFB (1.8)	NKPD1 (1.6)	PLEC (1.6)
ENSG00000110711	AIP PPI subnetwork	0.36	> 0.20	CYP7A1 (2.4)	OGDH (2.1)	MYLIP (1.9)	ABCG8 (1.9)	GPAM (1.9)	MAFB (1.8)	PTPN11 (1.7)	TIMD4 (1.5)	PBX4 (1.5)	FRK (1.5)
ENSG00000172572	PDE3A PPI subnetwork	0.36	> 0.20	ST3GAL4 (3.2)	ITGB3 (2.6)	ENSG00000238078 (2.5)	GATAD2A (2.4)	GMPR (2.3)	MARK4 (2.1)	SLC44A2 (2.0)	SYPL2 (1.9)	SH2B3 (1.8)	BLOC1S3 (1.7)
GO:0030855	epithelial cell differentiation	0.36	> 0.20	AP1M2 (3.0)	ENSG00000226648 (2.8)	NKPD1 (2.8)	CBLC (2.4)	CEACAM19 (2.3)	PMFBP1 (1.8)	BCAM (1.7)	CELSR2 (1.5)	C17orf57 (1.5)	LPIN3 (1.4)
ENSG00000185432	METTL7A PPI subnetwork	0.36	> 0.20	ACAD10 (3.0)	ABO (2.3)	HNF1A (2.3)	TMED4 (2.0)	TRAPPC6A (2.0)	ATXN7L2 (2.0)	ERP29 (2.0)	BUD13 (1.9)	CBLC (1.7)	NYNRIN (1.6)
ENSG00000143006	DMRTB1 PPI subnetwork	0.36	> 0.20	NYNRIN (2.6)	PLEC (2.2)	RPH3A (1.9)	PPP1R37 (1.9)	BCAM (1.7)	ST3GAL4 (1.7)	ILF3 (1.7)	CARM1 (1.5)	DHODH (1.4)	SUGP1 (1.3)
MP:0008866	chromosomal instability	0.36	> 0.20	FEN1 (5.6)	USP1 (3.5)	GOT2P1 (2.7)	ZNF180 (2.1)	PSRC1 (2.1)	ANKRD31 (1.7)	ENSG00000228044 (1.5)	BUD13 (1.5)	AMIGO1 (1.3)	POC5 (1.2)
GO:0016594	glycine binding	0.36	> 0.20	APOC4 (2.8)	LPA (2.5)	GMPR (2.3)	RHD (2.2)	APOA5 (2.1)	RHCE (2.0)	CETP (1.9)	ANGPTL3 (1.9)	PBX4 (1.9)	TM6SF2 (1.8)
MP:0010956	abnormal mitochondrial ATP synthesis coupled electron transport	0.36	> 0.20	GOT2P1 (2.9)	POC5 (2.6)	DNAH11 (2.0)	COL4A3BP (2.0)	ACAD10 (2.0)	TXNL4B (2.0)	NT5DC1 (1.9)	ENSG00000226645 (1.6)	GPAM (1.5)	GMPR (1.4)
ENSG00000182718	ANXA2 PPI subnetwork	0.36	> 0.20	PLEC (3.5)	C1orf63 (2.2)	TMEM50A (2.2)	GATAD2A (2.1)	OGDH (1.8)	TOP1 (1.8)	PVR (1.8)	ADAM1 (1.5)	PTPN11 (1.5)	ENSG00000238078 (1.5)
ENSG00000178921	PFAS PPI subnetwork	0.36	> 0.20	ZNF101 (2.2)	FRK (2.2)	ZNF180 (2.1)	HAPLN4 (2.1)	ATP13A1 (2.0)	GPAM (2.0)	TRIB1 (2.0)	RELB (1.7)	HNF1A (1.7)	MAU2 (1.6)
ENSG00000105011	ASF1B PPI subnetwork	0.36	> 0.20	USP1 (4.3)	FEN1 (4.2)	C19orf52 (2.1)	BUD13 (1.9)	GATAD2A (1.9)	TMEM116 (1.6)	ILF3 (1.5)	SMARCA4 (1.5)	C12orf51 (1.5)	ATXN2 (1.4)
REACTOME_MITOTIC_M:MG1_PHASES	REACTOME_MITOTIC_M:MG1_PHASES	0.36	> 0.20	FEN1 (5.4)	PSRC1 (4.1)	USP1 (4.1)	POC5 (2.7)	PSMA5 (2.6)	ZNF180 (1.4)	ENSG00000228044 (1.0)	TRAFD1 (1.0)	LPIN3 (0.8)	DDX56 (0.8)
GO:0009615	response to virus	0.36	> 0.20	OASL (7.7)	PARP10 (5.4)	TRAFD1 (4.6)	ENSG00000235545 (3.2)	ATP13A1 (2.3)	CYB561D1 (2.2)	TXNL4B (1.9)	BLOC1S3 (1.7)	GRINA (1.6)	MAU2 (1.6)
MP:0005592	abnormal vascular smooth muscle morphology	0.36	> 0.20	KANK2 (3.5)	PVR (3.2)	SH2B3 (2.7)	HLX (2.5)	BCAM (2.2)	SLC44A2 (2.0)	CYB561D1 (2.0)	PLCG1 (1.8)	PLEC (1.7)	GCNT4 (1.6)
ENSG00000163161	ERCC3 PPI subnetwork	0.36	> 0.20	BUD13 (3.1)	SUGP1 (2.7)	ZNF259 (2.6)	PSMA5 (2.2)	POC5 (2.2)	TXNL4B (2.1)	MAPKAPK5 (2.1)	QTRT1 (1.8)	DNM2 (1.7)	DHX38 (1.6)
ENSG00000155508	CNOT8 PPI subnetwork	0.36	> 0.20	ATXN2 (3.0)	BRAP (3.0)	FEN1 (2.7)	USP1 (2.4)	BUD13 (2.1)	HMGCR (2.0)	DHX38 (1.9)	ILF3 (1.9)	C12orf51 (1.7)	OGDH (1.7)
MP:0002410	decreased susceptibility to viral infection	0.36	> 0.20	OASL (6.8)	GMIP (3.4)	PARP10 (3.2)	TRAFD1 (2.5)	FRK (2.5)	MAFB (1.9)	TRIB1 (1.6)	LPAR2 (1.4)	C12orf43 (1.3)	SH2B3 (1.2)
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	0.36	> 0.20	ITGB3 (4.0)	ST3GAL4 (2.7)	ENSG00000254235 (2.1)	KIAA1324 (1.9)	TM6SF2 (1.9)	SH2B3 (1.8)	KANK2 (1.7)	PMFBP1 (1.6)	ABCG8 (1.4)	GCNT4 (1.4)
MP:0004985	decreased osteoclast cell number	0.36	> 0.20	MAFB (3.7)	CILP2 (2.6)	APOE (2.5)	APOC1 (2.1)	GMIP (2.0)	TMEM116 (2.0)	ITGB3 (1.7)	SH2B3 (1.6)	TRIB1 (1.6)	TIMD4 (1.5)
ENSG00000105939	ZC3HAV1 PPI subnetwork	0.36	> 0.20	OASL (7.0)	PARP10 (2.7)	USP1 (2.4)	ATP13A1 (2.2)	ENSG00000226648 (1.9)	ENSG00000235545 (1.9)	TOP1 (1.8)	PSMA5 (1.7)	SUGP1 (1.6)	ILF3 (1.6)
ENSG00000152214	RIT2 PPI subnetwork	0.36	> 0.20	PMFBP1 (3.2)	MARK4 (2.8)	PPP1R37 (2.6)	NKPD1 (2.3)	COL4A3BP (2.3)	PVRL2 (1.8)	TOP1 (1.7)	PLEKHH2 (1.7)	ABO (1.6)	ANKRD31 (1.6)
MP:0002621	delayed neural tube closure	0.36	> 0.20	NYNRIN (4.5)	PVRL2 (3.3)	HAVCR1 (2.4)	CBLC (2.4)	BCAM (2.1)	SLC44A2 (1.5)	TMEM116 (1.4)	CELSR2 (1.4)	PLEKHH2 (1.3)	MARK4 (1.3)
ENSG00000129315	CCNT1 PPI subnetwork	0.36	> 0.20	SUGP1 (3.0)	DHX38 (2.7)	BUD13 (2.2)	SMARCA4 (2.2)	ZNF259 (2.0)	ATXN2 (2.0)	ATP13A1 (1.9)	C12orf43 (1.9)	TOP1 (1.8)	QTRT1 (1.7)
GO:0060742	epithelial cell differentiation involved in prostate gland development	0.36	> 0.20	GCNT4 (4.0)	DNAH11 (3.4)	ENSG00000226648 (2.9)	ANKRD31 (2.7)	GOT2P1 (2.6)	AMIGO1 (2.0)	COL4A3BP (1.7)	CBLC (1.5)	TRAPPC6A (1.4)	ALDH2 (1.4)
ENSG00000144668	ITGA9 PPI subnetwork	0.36	> 0.20	APOE (4.0)	TIMD4 (3.2)	CETP (3.0)	MAFB (3.0)	HLX (2.5)	GMIP (2.4)	SH2B3 (2.4)	APOC1 (2.1)	FRK (1.9)	ITGB3 (1.8)
ENSG00000071626	DAZAP1 PPI subnetwork	0.36	> 0.20	HAVCR1 (2.1)	DYNC2LI1 (2.0)	GATAD2A (1.9)	SUGP1 (1.8)	RPH3A (1.8)	NT5DC1 (1.7)	HAPLN4 (1.7)	CEACAM19 (1.7)	AP1M2 (1.6)	TRAFD1 (1.4)
MP:0002769	abnormal vas deferens morphology	0.36	> 0.20	LPAR2 (3.0)	KANK2 (2.2)	GCNT4 (2.0)	GMPR (1.8)	FADS1 (1.8)	YIPF2 (1.7)	FADS2 (1.5)	SYPL2 (1.4)	FRK (1.4)	KIAA1324 (1.4)
GO:0000077	DNA damage checkpoint	0.36	> 0.20	PSMA5 (2.7)	NT5DC1 (2.3)	POLK (2.1)	SUGP1 (1.8)	NAA25 (1.8)	TRAFD1 (1.8)	BRAP (1.7)	ZNF180 (1.7)	PSRC1 (1.6)	C12orf47 (1.6)
ENSG00000185513	L3MBTL1 PPI subnetwork	0.36	> 0.20	POLK (2.6)	C19orf52 (2.4)	ST3GAL4 (2.1)	TSSK6 (1.8)	ZNF101 (1.7)	DNAH11 (1.7)	ENSG00000226648 (1.7)	BUD13 (1.6)	GCNT4 (1.6)	GEMIN7 (1.5)
GO:0016500	protein-hormone receptor activity	0.36	> 0.20	PMFBP1 (2.6)	CELSR2 (2.4)	HAVCR1 (2.4)	PCSK9 (2.2)	DNAH11 (1.9)	MOSC1 (1.9)	HMGCR (1.8)	C17orf57 (1.8)	SORT1 (1.7)	GPAM (1.7)
GO:0031998	regulation of fatty acid beta-oxidation	0.36	> 0.20	C17orf57 (2.1)	MARK4 (1.7)	MAU2 (1.7)	OGDH (1.7)	ENSG00000238078 (1.7)	DHX38 (1.6)	ABCG8 (1.6)	AMIGO1 (1.6)	DHODH (1.6)	ACAD10 (1.4)
MP:0003157	impaired muscle relaxation	0.36	> 0.20	SYPL2 (5.0)	APOC1 (2.9)	GOT2P1 (2.4)	GMPR (2.1)	SLC22A1 (1.9)	COL4A3BP (1.7)	RPH3A (1.6)	ALDH2 (1.4)	ENSG00000238078 (1.4)	KANK2 (1.4)
MP:0002654	spongiform encephalopathy	0.36	> 0.20	CLPTM1 (2.5)	DOCK7 (2.4)	OGDH (2.4)	GCNT4 (2.1)	FRK (2.0)	COL4A3BP (2.0)	BCL3 (1.9)	CARM1 (1.8)	GRINA (1.7)	TMEM116 (1.6)
GO:0030529	ribonucleoprotein complex	0.36	> 0.20	TOMM40 (2.9)	GEMIN7 (2.8)	DDX56 (2.6)	C12orf43 (2.4)	QTRT1 (2.3)	DHODH (2.3)	PSMA5 (2.2)	ILF3 (2.2)	DHX38 (2.2)	SMARCA4 (2.0)
ENSG00000186852	ENSG00000186852 PPI subnetwork	0.36	> 0.20	MAU2 (2.7)	TSSK6 (2.4)	ZNF101 (1.8)	BLOC1S3 (1.8)	PMFBP1 (1.6)	CILP2 (1.5)	HAVCR1 (1.4)	C11orf9 (1.4)	BUD13 (1.4)	PVR (1.4)
REACTOME_REGULATION_OF_APOPTOSIS	REACTOME_REGULATION_OF_APOPTOSIS	0.36	> 0.20	PSMA5 (6.1)	TRAFD1 (3.9)	NT5DC1 (2.7)	NAA25 (2.2)	SUGP1 (1.9)	PARP10 (1.7)	TOMM40 (1.6)	DDX56 (1.6)	TMEM50A (1.5)	SARS (1.3)
GO:0045909	positive regulation of vasodilation	0.36	> 0.20	TMEM116 (2.8)	LPIN3 (2.7)	ENSG00000226648 (2.4)	C12orf47 (2.3)	TMED4 (1.5)	ENSG00000226645 (1.4)	CETP (1.4)	POLK (1.3)	TXNL4B (1.3)	GEMIN7 (1.3)
ENSG00000157540	DYRK1A PPI subnetwork	0.36	> 0.20	CBLC (2.2)	PLCG1 (2.0)	C17orf57 (2.0)	CARM1 (1.9)	MARK4 (1.8)	ZNF101 (1.8)	LPIN3 (1.7)	HAPLN4 (1.7)	PPP1R37 (1.6)	SMARCA4 (1.6)
MP:0002824	abnormal chorioallantoic fusion	0.36	> 0.20	TIMD4 (3.8)	CETP (2.6)	TMED4 (2.5)	ENSG00000235545 (2.3)	HAVCR1 (2.1)	ENSG00000228044 (1.9)	PVRL2 (1.8)	TMEM50A (1.8)	FRK (1.7)	TRAFD1 (1.7)
GO:0042345	regulation of NF-kappaB import into nucleus	0.36	> 0.20	ENSG00000228044 (3.2)	ENSG00000235545 (2.7)	ENSG00000238078 (2.5)	ZNF101 (2.3)	MYLIP (2.3)	OASL (1.8)	ZNF180 (1.7)	SH2B3 (1.6)	RELB (1.6)	LPAR2 (1.4)
GO:0042348	NF-kappaB import into nucleus	0.36	> 0.20	ENSG00000228044 (3.2)	ENSG00000235545 (2.7)	ENSG00000238078 (2.5)	ZNF101 (2.3)	MYLIP (2.3)	OASL (1.8)	ZNF180 (1.7)	SH2B3 (1.6)	RELB (1.6)	LPAR2 (1.4)
ENSG00000107186	MPDZ PPI subnetwork	0.36	> 0.20	ENSG00000226648 (3.1)	APOE (2.9)	CELSR2 (2.8)	HAVCR1 (2.3)	C17orf57 (2.2)	GCNT4 (1.9)	PVRL2 (1.8)	MYLIP (1.7)	KANK2 (1.7)	GPAM (1.6)
ENSG00000129219	PLD2 PPI subnetwork	0.36	> 0.20	DNM2 (2.4)	PLEC (2.2)	ITGB3 (1.9)	ZNF101 (1.9)	GATAD2A (1.8)	ENSG00000238078 (1.8)	PLCG1 (1.8)	TOP1 (1.7)	MOSC1 (1.7)	ADAM1 (1.5)
ENSG00000148356	LRSAM1 PPI subnetwork	0.36	> 0.20	MAU2 (2.8)	DOCK7 (2.4)	ENSG00000235545 (2.4)	ST3GAL4 (2.1)	GRINA (2.0)	RELB (1.9)	ATXN7L2 (1.6)	CEACAM19 (1.5)	AMIGO1 (1.4)	TMEM50A (1.4)
MP:0004180	failure of initiation of embryo turning	0.36	> 0.20	ATXN2 (3.3)	MAPKAPK5 (2.8)	TOP1 (2.1)	C12orf51 (2.0)	PLEKHH2 (2.0)	HAVCR1 (2.0)	MAU2 (1.9)	NAA25 (1.9)	BCL3 (1.9)	DOCK7 (1.7)
REACTOME_PKA:MEDIATED_PHOSPHORYLATION_OF_CREB	REACTOME_PKA:MEDIATED_PHOSPHORYLATION_OF_CREB	0.36	> 0.20	ST3GAL4 (3.0)	ITGB3 (2.8)	SH2B3 (2.7)	SORT1 (2.3)	KANK2 (2.0)	ENSG00000228044 (1.8)	PMFBP1 (1.8)	OGDH (1.7)	ENSG00000238078 (1.5)	GOT2P1 (1.4)
ENSG00000101400	SNTA1 PPI subnetwork	0.36	> 0.20	AMIGO1 (3.4)	KANK2 (2.7)	SYPL2 (2.5)	PBX4 (2.4)	ZHX3 (2.3)	RPH3A (2.2)	GPAM (2.2)	PLEC (2.2)	SORT1 (1.8)	CELSR2 (1.8)
MP:0000708	thymus hyperplasia	0.36	> 0.20	PARP10 (3.0)	BCL3 (2.5)	ZNF101 (2.3)	RELB (1.9)	CELSR2 (1.7)	PBX4 (1.5)	PMFBP1 (1.5)	TRIB1 (1.4)	GMIP (1.3)	ENSG00000228044 (1.3)
ENSG00000075884	ARHGAP15 PPI subnetwork	0.36	> 0.20	DDX56 (4.3)	NAA25 (4.1)	ZNF259 (4.0)	DHX38 (3.3)	TOMM40 (3.2)	QTRT1 (3.1)	BRAP (2.5)	TOP1 (2.3)	PTPN11 (2.3)	DHODH (2.3)
ENSG00000135862	LAMC1 PPI subnetwork	0.36	> 0.20	BCAM (3.8)	PLEKHH2 (3.2)	KANK2 (3.0)	CELSR2 (2.3)	DOCK7 (2.2)	PVRL2 (2.1)	OGDH (2.0)	PLEC (2.0)	SLC44A2 (2.0)	PLCG1 (1.9)
MP:0000606	decreased hepatocyte number	0.36	> 0.20	USP24 (3.3)	MARK4 (2.8)	C12orf51 (2.8)	ALDH2 (2.6)	MAPKAPK5 (2.2)	DOCK7 (2.1)	MAFB (2.0)	PSRC1 (2.0)	APOB (1.9)	TMEM50A (1.9)
ENSG00000171497	PPID PPI subnetwork	0.36	> 0.20	TOMM40 (4.5)	PSMA5 (3.0)	NAA25 (2.9)	CLPTM1 (2.8)	DDX56 (2.5)	OGDH (2.4)	GOT2P1 (1.7)	ZNF259 (1.6)	SARS (1.6)	CARM1 (1.5)
GO:0045637	regulation of myeloid cell differentiation	0.36	> 0.20	RHCE (2.7)	ITGB3 (2.3)	RHD (2.1)	PBX4 (2.0)	ENSG00000226648 (2.0)	ENSG00000226645 (2.0)	ENSG00000235545 (1.9)	MYLIP (1.9)	DNAH11 (1.7)	MAFB (1.6)
ENSG00000177426	TGIF1 PPI subnetwork	0.36	> 0.20	DOCK7 (2.4)	ENSG00000226648 (2.0)	GEMIN7 (2.0)	GATAD2A (1.9)	ATXN2 (1.9)	BCAM (1.9)	TRIB1 (1.7)	UBXN2B (1.6)	MYLIP (1.5)	POC5 (1.5)
ENSG00000120708	TGFBI PPI subnetwork	0.36	> 0.20	APOE (3.8)	C17orf57 (3.5)	APOC1 (2.5)	PVRL2 (1.9)	CETP (1.8)	SYPL2 (1.5)	CILP2 (1.4)	BCAM (1.3)	SORT1 (1.3)	FADS2 (1.3)
GO:0032611	interleukin-1 beta production	0.36	> 0.20	ST3GAL4 (2.0)	ENSG00000238078 (2.0)	CYB561D1 (1.6)	ENSG00000228044 (1.5)	OASL (1.3)	C12orf43 (1.2)	HLX (1.2)	ALDH2 (1.2)	DOCK7 (1.1)	C11orf9 (1.1)
GO:0006417	regulation of translation	0.36	> 0.20	BRAP (2.9)	C12orf43 (2.7)	PTPN11 (2.5)	C12orf51 (2.4)	MAPKAPK5 (2.1)	ILF3 (2.0)	ANKRD31 (2.0)	TXNL4B (1.8)	ADAM1 (1.8)	MYLIP (1.8)
REACTOME_DARPP:32_EVENTS	REACTOME_DARPP:32_EVENTS	0.36	> 0.20	OGDH (2.0)	ITGB3 (1.8)	CLPTM1 (1.6)	MYLIP (1.6)	SORT1 (1.6)	MOSC1 (1.4)	GMPR (1.4)	GPAM (1.3)	PTPN11 (1.3)	GOT2P1 (1.3)
ENSG00000131746	TNS4 PPI subnetwork	0.36	> 0.20	CBLC (5.6)	AP1M2 (3.8)	CELSR2 (2.5)	FRK (2.3)	LPIN3 (2.1)	ST3GAL4 (2.0)	DNM2 (1.9)	C12orf51 (1.8)	PLEC (1.7)	LPAR2 (1.7)
ENSG00000166603	MC4R PPI subnetwork	0.36	> 0.20	DNAH11 (2.9)	CETP (2.5)	FRK (2.3)	GMIP (2.3)	TSSK6 (2.0)	FADS2 (1.5)	C12orf47 (1.5)	GOT2P1 (1.5)	SLC44A2 (1.5)	CELSR2 (1.4)
MP:0003049	abnormal lumbar vertebrae morphology	0.36	> 0.20	NYNRIN (3.9)	LPAR2 (1.9)	CILP2 (1.7)	CLPTM1 (1.6)	PPP1R37 (1.5)	PLCG1 (1.4)	CEACAM19 (1.4)	MARK4 (1.3)	NCAN (1.3)	PCSK9 (1.3)
GO:0015874	norepinephrine transport	0.36	> 0.20	GMPR (2.7)	TSSK6 (2.1)	ZHX3 (2.1)	ABO (2.0)	DNAH11 (1.7)	ITGB3 (1.7)	PMFBP1 (1.5)	ANKRD31 (1.5)	LPIN3 (1.3)	MOSC1 (1.2)
ENSG00000143878	RHOB PPI subnetwork	0.36	> 0.20	CLPTM1 (2.6)	OGDH (2.4)	PLEC (2.2)	MARK4 (2.2)	SLC44A2 (2.1)	DNM2 (2.0)	GMIP (1.9)	DNAH11 (1.8)	CARM1 (1.6)	CBLC (1.5)
ENSG00000162891	IL20 PPI subnetwork	0.36	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.7)	TIMD4 (2.1)	CETP (2.1)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	PARP10 (1.3)	TRIB1 (1.2)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	0.36	> 0.20	GEMIN7 (3.5)	C12orf43 (3.4)	ZNF259 (3.2)	POC5 (2.7)	ADAM1 (2.6)	MAPKAPK5 (2.3)	BUD13 (2.2)	DDX56 (2.1)	SUGP1 (2.0)	ENSG00000226645 (1.8)
REACTOME_SOS:MEDIATED_SIGNALLING	REACTOME_SOS:MEDIATED_SIGNALLING	0.36	> 0.20	GEMIN7 (2.3)	DNM2 (2.2)	MARK4 (2.2)	CARM1 (2.1)	BLOC1S3 (1.9)	MAPKAPK5 (1.9)	PBX4 (1.9)	ATXN2 (1.6)	ENSG00000238078 (1.6)	MYLIP (1.5)
MP:0004608	abnormal cervical axis morphology	0.36	> 0.20	CILP2 (4.3)	ENSG00000254235 (2.3)	MAFB (2.3)	NYNRIN (2.1)	C17orf57 (1.7)	TMEM50A (1.6)	ENSG00000238078 (1.6)	PLCG1 (1.5)	PCSK9 (1.4)	GMPR (1.4)
ENSG00000105701	FKBP8 PPI subnetwork	0.36	> 0.20	GRINA (3.0)	CYB561D1 (2.1)	DNAH11 (2.0)	FRK (1.9)	MYLIP (1.9)	BCAM (1.8)	DNM2 (1.8)	TRAPPC6A (1.7)	TXNL4B (1.6)	C12orf43 (1.6)
MP:0005631	decreased lung weight	0.36	> 0.20	LDLR (4.1)	HMGCR (3.7)	FADS2 (3.5)	FADS1 (3.2)	GPAM (2.2)	ENSG00000226648 (2.0)	PCSK9 (2.0)	LPIN3 (1.9)	GOT2P1 (1.8)	GEMIN7 (1.6)
ENSG00000100170	SLC5A1 PPI subnetwork	0.36	> 0.20	AP1M2 (4.7)	CELSR2 (3.3)	PSRC1 (2.5)	FRK (2.4)	NPC1L1 (2.2)	ABCG5 (2.0)	ZHX3 (2.0)	BCAM (1.9)	TXNL4B (1.9)	APOB (1.9)
GO:0000940	condensed chromosome outer kinetochore	0.36	> 0.20	PSRC1 (6.1)	POC5 (3.1)	FEN1 (2.5)	USP1 (2.4)	MAU2 (1.6)	ZHX3 (1.4)	ENSG00000228044 (1.1)	GEMIN7 (1.1)	COL4A3BP (0.9)	DNAH11 (0.7)
MP:0000752	dystrophic muscle	0.36	> 0.20	SYPL2 (4.3)	KANK2 (2.9)	SORT1 (2.5)	PVR (2.2)	PLEC (2.1)	ZHX3 (2.1)	ENSG00000238078 (2.0)	SLC44A2 (1.9)	TMEM50A (1.9)	AMIGO1 (1.8)
ENSG00000126267	COX6B1 PPI subnetwork	0.36	> 0.20	GOT2P1 (3.2)	TRAPPC6A (2.9)	RHD (2.2)	SARS (1.6)	OGDH (1.6)	RHCE (1.5)	C1orf63 (1.4)	ACAD10 (1.4)	TMED4 (1.3)	CLPTM1 (1.3)
ENSG00000174243	DDX23 PPI subnetwork	0.36	> 0.20	ILF3 (4.1)	C1orf63 (3.6)	TOP1 (3.4)	DHX38 (3.1)	USP1 (2.9)	SMARCA4 (2.9)	SUGP1 (2.6)	BUD13 (2.6)	FEN1 (2.5)	MAU2 (2.1)
ENSG00000185811	IKZF1 PPI subnetwork	0.36	> 0.20	ATXN7L2 (4.6)	CARM1 (3.1)	MARK4 (3.1)	ATXN2 (3.0)	ADAM1 (2.6)	SMARCA4 (2.4)	DNM2 (2.0)	MAU2 (1.9)	PPP1R37 (1.9)	PLCG1 (1.8)
ENSG00000135547	HEY2 PPI subnetwork	0.36	> 0.20	BLOC1S3 (1.9)	ITGB3 (1.7)	LDLR (1.5)	CBLC (1.5)	POLK (1.4)	PVRL2 (1.3)	C11orf9 (1.3)	CETP (1.3)	DNAH11 (1.3)	TRIB1 (1.3)
MP:0009866	abnormal aorta wall morphology	0.36	> 0.20	APOC1 (3.1)	SLC44A2 (1.9)	KANK2 (1.7)	PLEKHH2 (1.6)	NYNRIN (1.5)	ENSG00000226648 (1.5)	DYNC2LI1 (1.3)	ATXN7L2 (1.3)	ST3GAL4 (1.3)	CARM1 (1.1)
MP:0000276	heart right ventricle hypertrophy	0.37	> 0.20	BCAM (2.9)	APOE (2.3)	C11orf9 (2.3)	HNF1A (2.2)	PLEKHH2 (2.1)	KANK2 (2.0)	GRINA (1.9)	ENSG00000254235 (1.7)	MYLIP (1.6)	ANKRD31 (1.6)
ENSG00000184216	IRAK1 PPI subnetwork	0.37	> 0.20	UBXN2B (2.9)	MYLIP (2.6)	OASL (2.6)	BCL3 (2.4)	RELB (2.3)	PARP10 (2.2)	ST3GAL4 (2.0)	ALDH2 (1.8)	GRINA (1.8)	MAFB (1.7)
ENSG00000206509	HLA-F PPI subnetwork	0.37	> 0.20	PARP10 (4.1)	ERP29 (2.4)	ENSG00000228044 (2.2)	YIPF2 (2.0)	TMED4 (2.0)	TRAFD1 (1.8)	DHODH (1.7)	CYB561D1 (1.7)	HNF1A (1.6)	OASL (1.5)
GO:0030866	cortical actin cytoskeleton organization	0.37	> 0.20	ABO (3.0)	NYNRIN (2.1)	GATAD2A (1.8)	GRINA (1.7)	OGDH (1.6)	YIPF2 (1.4)	ENSG00000254235 (1.3)	MYLIP (1.2)	CARM1 (1.1)	TMED4 (1.1)
ENSG00000122679	RAMP3 PPI subnetwork	0.37	> 0.20	CETP (4.0)	LPIN3 (2.7)	TIMD4 (2.7)	ENSG00000254235 (2.7)	PPP1R37 (1.9)	SYPL2 (1.8)	BLOC1S3 (1.8)	MAFB (1.8)	DNAH11 (1.4)	ERP29 (1.4)
MP:0000274	enlarged heart	0.37	> 0.20	BCAM (3.1)	KANK2 (2.6)	PLEC (2.3)	OGDH (2.2)	ATXN2 (2.0)	C11orf9 (2.0)	PVRL2 (1.9)	ACAD10 (1.8)	RHD (1.7)	TMED4 (1.7)
GO:0006401	RNA catabolic process	0.37	> 0.20	TXNL4B (3.1)	UBXN2B (3.0)	MAPKAPK5 (2.8)	BUD13 (2.5)	ADAM1 (2.5)	BRAP (2.1)	ZNF259 (2.0)	NT5DC1 (1.9)	USP24 (1.9)	ILF3 (1.8)
MP:0001714	absent trophoblast giant cells	0.37	> 0.20	ENSG00000228044 (3.2)	PSRC1 (3.0)	PVRL2 (2.2)	ACAD10 (1.9)	ABO (1.8)	CBLC (1.8)	HNF1A (1.5)	USP1 (1.5)	ILF3 (1.3)	CEACAM19 (1.3)
GO:0007176	regulation of epidermal growth factor-activated receptor activity	0.37	> 0.20	ENSG00000228044 (2.6)	TMED4 (2.1)	CYB561D1 (2.0)	GCNT4 (2.0)	TSSK6 (1.8)	ABO (1.6)	C17orf57 (1.6)	CETP (1.5)	ENSG00000226645 (1.5)	C19orf52 (1.5)
ENSG00000160967	ENSG00000160967 PPI subnetwork	0.37	> 0.20	DHX38 (2.5)	POC5 (2.4)	CETP (2.3)	MAFB (2.3)	TOMM40 (2.2)	MAU2 (2.1)	LPIN3 (1.9)	ACAD10 (1.8)	COL4A3BP (1.7)	TIMD4 (1.6)
GO:0000084	S phase of mitotic cell cycle	0.37	> 0.20	PSMA5 (2.6)	NT5DC1 (2.3)	ENSG00000235545 (2.1)	USP1 (2.0)	FEN1 (2.0)	ZNF180 (1.9)	ENSG00000228044 (1.7)	TXNL4B (1.6)	TRAFD1 (1.5)	ENSG00000226648 (1.5)
ENSG00000145675	PIK3R1 PPI subnetwork	0.37	> 0.20	GMIP (3.2)	DNM2 (2.5)	PLEC (2.4)	DOCK7 (2.4)	TIMD4 (2.3)	SH2B3 (2.2)	SLC44A2 (2.1)	MAFB (2.0)	PLCG1 (1.9)	ITGB3 (1.9)
ENSG00000114503	NCBP2 PPI subnetwork	0.37	> 0.20	ILF3 (3.9)	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.9)	C1orf63 (2.7)	DHX38 (2.5)	GATAD2A (2.4)	SUGP1 (2.4)	BUD13 (2.2)	FEN1 (2.1)
ENSG00000125676	THOC2 PPI subnetwork	0.37	> 0.20	C1orf63 (5.4)	ILF3 (3.3)	ATXN2 (2.7)	QTRT1 (2.7)	TOP1 (2.2)	ADAM1 (2.2)	NAA25 (2.1)	ERP29 (1.8)	PMFBP1 (1.8)	DOCK7 (1.8)
GO:0060713	labyrinthine layer morphogenesis	0.37	> 0.20	ENSG00000228044 (3.5)	CBLC (3.0)	CETP (2.7)	ENSG00000238078 (2.6)	ENSG00000226645 (1.9)	AMIGO1 (1.7)	ZNF101 (1.6)	TIMD4 (1.6)	HAVCR1 (1.5)	ANKRD31 (1.5)
ENSG00000181090	EHMT1 PPI subnetwork	0.37	> 0.20	USP24 (2.2)	GMIP (2.2)	PARP10 (2.2)	BLOC1S3 (2.0)	BCL3 (1.9)	MARK4 (1.9)	PSRC1 (1.8)	CARM1 (1.6)	ZNF180 (1.6)	GATAD2A (1.6)
GO:0030330	DNA damage response, signal transduction by p53 class mediator	0.37	> 0.20	PSMA5 (2.8)	TRAFD1 (2.5)	NT5DC1 (2.5)	NAA25 (2.3)	PARP10 (1.8)	ENSG00000238078 (1.6)	BUD13 (1.5)	TOMM40 (1.4)	ZNF180 (1.4)	POC5 (1.4)
GO:0035051	cardiac cell differentiation	0.37	> 0.20	NYNRIN (2.7)	HNF1A (2.5)	CEACAM19 (2.2)	ANKRD31 (2.2)	GCNT4 (1.9)	C11orf9 (1.8)	BCAM (1.8)	SYPL2 (1.7)	ENSG00000238078 (1.6)	CILP2 (1.6)
GO:0006665	sphingolipid metabolic process	0.37	> 0.20	NKPD1 (5.8)	TMEM50A (3.6)	CYB561D1 (3.4)	HAVCR1 (3.1)	ERP29 (2.8)	COL4A3BP (2.7)	CLPTM1 (2.2)	TMED4 (2.2)	LPIN3 (2.1)	PPP1R37 (2.1)
GO:0042176	regulation of protein catabolic process	0.37	> 0.20	ENSG00000235545 (3.1)	POLK (2.8)	GEMIN7 (2.1)	ZNF180 (2.0)	CLPTM1 (2.0)	CARM1 (2.0)	ENSG00000238078 (1.9)	SUGP1 (1.9)	GRINA (1.8)	ENSG00000254235 (1.6)
ENSG00000168476	REEP4 PPI subnetwork	0.37	> 0.20	CBLC (6.1)	AP1M2 (4.3)	ST3GAL4 (2.4)	LPAR2 (2.0)	CELSR2 (1.9)	FRK (1.7)	DOCK7 (1.6)	LPIN3 (1.5)	HNF1A (1.5)	PPP1R37 (1.4)
REACTOME_HIV:1_ELONGATION_ARREST_AND_RECOVERY	REACTOME_HIV:1_ELONGATION_ARREST_AND_RECOVERY	0.37	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_PAUSING_AND_RECOVERY_OF_HIV:1_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_HIV:1_ELONGATION	0.37	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_PAUSING_AND_RECOVERY_OF_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_ELONGATION	0.37	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_ELONGATION_ARREST_AND_RECOVERY	REACTOME_ELONGATION_ARREST_AND_RECOVERY	0.37	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
GO:0046943	carboxylic acid transmembrane transporter activity	0.37	> 0.20	TM6SF2 (3.8)	ABCG8 (3.6)	ABCG5 (2.4)	GRINA (2.3)	HAPLN4 (2.3)	ATP13A1 (2.3)	NPC1L1 (2.2)	PLG (2.1)	SARS (2.1)	TMEM116 (2.0)
ENSG00000148672	GLUD1 PPI subnetwork	0.37	> 0.20	HAVCR1 (2.5)	NCAN (2.5)	BRAP (2.3)	UBXN2B (2.2)	SYPL2 (2.2)	USP24 (2.1)	TRAFD1 (2.0)	GMPR (1.9)	RHD (1.7)	C12orf43 (1.7)
GO:0042116	macrophage activation	0.37	> 0.20	C17orf57 (3.1)	ENSG00000226645 (1.9)	DHODH (1.7)	PMFBP1 (1.7)	GCNT4 (1.6)	ANKRD31 (1.4)	ADAM1 (1.4)	AMIGO1 (1.4)	TMED4 (1.3)	DNAH11 (1.2)
ENSG00000178741	COX5A PPI subnetwork	0.37	> 0.20	TRAPPC6A (4.7)	GOT2P1 (3.2)	C19orf52 (2.2)	DDX56 (2.0)	TOMM40 (1.8)	QTRT1 (1.8)	TXNL4B (1.6)	DHODH (1.6)	HAVCR1 (1.5)	ZNF259 (1.5)
GO:0000956	nuclear-transcribed mRNA catabolic process	0.37	> 0.20	TXNL4B (4.0)	BUD13 (2.7)	ADAM1 (2.6)	MAPKAPK5 (2.5)	UBXN2B (2.5)	ZNF259 (2.2)	BRAP (2.2)	ENSG00000226645 (2.1)	MAU2 (1.8)	DHX38 (1.7)
ENSG00000100867	DHRS2 PPI subnetwork	0.37	> 0.20	TMEM50A (2.8)	TMEM57 (2.6)	C1orf63 (2.3)	ERP29 (1.9)	PSMA5 (1.9)	SARS (1.8)	ADAM1 (1.7)	QTRT1 (1.6)	MYLIP (1.6)	C19orf52 (1.5)
ENSG00000071894	CPSF1 PPI subnetwork	0.37	> 0.20	ILF3 (3.8)	SMARCA4 (3.2)	TOP1 (3.1)	DHX38 (2.9)	C1orf63 (2.6)	PTPN11 (2.6)	USP1 (2.2)	BUD13 (2.1)	SUGP1 (2.1)	FEN1 (2.1)
GO:0001569	patterning of blood vessels	0.37	> 0.20	ABO (2.3)	TSSK6 (1.8)	ENSG00000254235 (1.8)	MYLIP (1.7)	NKPD1 (1.6)	HNF1A (1.6)	CEACAM19 (1.6)	HLX (1.6)	NYNRIN (1.5)	CYB561D1 (1.5)
ENSG00000137312	FLOT1 PPI subnetwork	0.37	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000206379	FLOT1 PPI subnetwork	0.37	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000206480	FLOT1 PPI subnetwork	0.37	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000138162	TACC2 PPI subnetwork	0.37	> 0.20	PSRC1 (2.6)	USP1 (1.9)	NCAN (1.9)	ZHX3 (1.7)	ENSG00000228044 (1.7)	TOMM40 (1.7)	BUD13 (1.6)	MAPKAPK5 (1.6)	BCL3 (1.5)	DHX38 (1.5)
MP:0008481	increased spleen germinal center number	0.37	> 0.20	TIMD4 (3.3)	MAFB (3.0)	CETP (2.9)	GMIP (2.5)	C17orf57 (2.2)	SH2B3 (2.2)	TRIB1 (1.7)	ITGB3 (1.5)	KIAA1324 (1.4)	AP1M2 (1.4)
ENSG00000119138	KLF9 PPI subnetwork	0.37	> 0.20	TMEM57 (3.0)	SMARCA4 (2.5)	MAU2 (2.5)	BUD13 (2.4)	CARM1 (2.2)	KIAA1324 (2.1)	ATXN2 (2.0)	C12orf51 (1.9)	TMEM116 (1.8)	C19orf52 (1.8)
MP:0002022	increased lymphoma incidence	0.37	> 0.20	FEN1 (4.2)	POLK (2.7)	USP1 (2.5)	KANK2 (2.2)	DYNC2LI1 (1.9)	RELB (1.8)	TMEM57 (1.7)	PSRC1 (1.7)	C12orf43 (1.6)	RHD (1.4)
MP:0003447	decreased tumor growth/size	0.37	> 0.20	BCL3 (2.9)	NYNRIN (2.7)	CELSR2 (2.1)	CBLC (2.1)	MAFB (2.0)	HLX (1.7)	PLEC (1.6)	ENSG00000254235 (1.6)	ATXN7L2 (1.5)	ABO (1.5)
ENSG00000115738	ID2 PPI subnetwork	0.37	> 0.20	NCAN (2.5)	HLX (2.2)	SYPL2 (2.2)	TSSK6 (2.1)	DNM2 (1.8)	LPIN3 (1.7)	TRAPPC6A (1.6)	ABO (1.5)	BUD13 (1.2)	MYLIP (1.2)
ENSG00000135604	STX11 PPI subnetwork	0.37	> 0.20	MAU2 (2.4)	ENSG00000228044 (2.3)	NT5DC1 (2.2)	SARS (2.0)	GOT2P1 (1.9)	LDLR (1.8)	RPH3A (1.7)	SUGP1 (1.7)	TSSK6 (1.4)	C12orf47 (1.4)
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	0.37	> 0.20	TOP1 (3.4)	USP1 (3.3)	ILF3 (3.3)	BUD13 (3.0)	C1orf63 (2.9)	DDX56 (2.7)	DOCK7 (2.5)	NAA25 (2.5)	DHODH (2.5)	USP24 (2.3)
GO:0001974	blood vessel remodeling	0.37	> 0.20	PVR (2.8)	CEACAM19 (2.6)	PLEKHH2 (2.3)	BCAM (2.1)	BLOC1S3 (1.9)	ALDH2 (1.7)	PPP1R37 (1.6)	CILP2 (1.5)	TSSK6 (1.5)	CBLC (1.4)
ENSG00000146143	ENSG00000146143 PPI subnetwork	0.37	> 0.20	FEN1 (5.7)	USP1 (5.6)	ZNF180 (2.4)	ENSG00000228044 (2.2)	GOT2P1 (1.8)	TXNL4B (1.4)	FADS1 (1.4)	DHODH (1.3)	PSRC1 (1.3)	POLK (1.2)
GO:0009378	four-way junction helicase activity	0.37	> 0.20	MAPKAPK5 (5.0)	BRAP (3.9)	POC5 (3.8)	SUGP1 (2.8)	DHX38 (2.6)	TXNL4B (2.5)	SARS (2.2)	TOMM40 (2.2)	ZNF180 (2.1)	UBXN2B (1.6)
GO:0048678	response to axon injury	0.37	> 0.20	ENSG00000228044 (3.7)	ENSG00000235545 (2.6)	ERP29 (1.8)	ALDH2 (1.8)	RHCE (1.5)	NPC1L1 (1.5)	ENSG00000238078 (1.5)	TRAPPC6A (1.4)	LPIN3 (1.4)	COL4A3BP (1.4)
ENSG00000027697	IFNGR1 PPI subnetwork	0.37	> 0.20	BCL3 (3.2)	COL4A3BP (2.2)	RELB (1.9)	PVR (1.7)	C17orf57 (1.7)	ZNF101 (1.4)	OASL (1.3)	CYP7A1 (1.3)	BCAM (1.3)	TRAFD1 (1.3)
MP:0001073	abnormal glossopharyngeal nerve morphology	0.37	> 0.20	BCAM (3.2)	CEACAM19 (2.4)	HAVCR1 (2.1)	MARK4 (2.0)	PVRL2 (1.9)	ANKRD31 (1.8)	PPP1R37 (1.7)	TSSK6 (1.7)	ENSG00000226648 (1.4)	UBXN2B (1.4)
GO:0008186	RNA-dependent ATPase activity	0.37	> 0.20	SUGP1 (2.9)	ATP13A1 (2.7)	DHX38 (2.6)	TOP1 (2.5)	NAA25 (2.2)	ILF3 (2.0)	ZNF259 (1.9)	SMARCA4 (1.9)	BUD13 (1.8)	DDX56 (1.7)
ENSG00000089022	MAPKAPK5 PPI subnetwork	0.37	> 0.20	PVR (2.4)	MARK4 (2.1)	AMIGO1 (1.9)	HLX (1.7)	MYLIP (1.6)	CARM1 (1.5)	NYNRIN (1.4)	SARS (1.4)	CBLC (1.3)	NPC1L1 (1.3)
GO:0016757	transferase activity, transferring glycosyl groups	0.37	> 0.20	TMED4 (2.8)	ST3GAL4 (2.8)	YIPF2 (2.8)	ATP13A1 (2.8)	ERP29 (2.4)	OASL (2.1)	TMEM50A (2.1)	SLC44A2 (2.0)	ENSG00000235545 (1.7)	LDLR (1.7)
ENSG00000105323	HNRNPUL1 PPI subnetwork	0.37	> 0.20	ILF3 (3.7)	C1orf63 (3.6)	TOP1 (2.9)	QTRT1 (2.9)	SUGP1 (2.8)	PTPN11 (2.6)	DHX38 (2.5)	SMARCA4 (2.5)	USP1 (2.5)	GATAD2A (2.3)
ENSG00000150672	DLG2 PPI subnetwork	0.37	> 0.20	RPH3A (3.7)	CELSR2 (2.7)	PPP1R37 (2.6)	GCNT4 (2.6)	AMIGO1 (2.5)	HAVCR1 (2.2)	NCAN (1.7)	MOSC1 (1.6)	MYLIP (1.4)	ABO (1.3)
ENSG00000175792	RUVBL1 PPI subnetwork	0.37	> 0.20	SMARCA4 (3.0)	DHX38 (2.4)	TOMM40 (2.2)	DDX56 (2.1)	USP1 (2.1)	ILF3 (2.0)	BUD13 (1.9)	TOP1 (1.9)	ZNF180 (1.8)	ATXN2 (1.8)
ENSG00000107554	DNMBP PPI subnetwork	0.37	> 0.20	HAPLN4 (2.6)	PPP1R37 (2.6)	MARK4 (2.0)	PVRL2 (2.0)	LPIN3 (1.9)	GATAD2A (1.9)	PLEC (1.7)	HAVCR1 (1.5)	CYP7A1 (1.5)	C11orf9 (1.4)
ENSG00000198231	DDX42 PPI subnetwork	0.37	> 0.20	DHX38 (2.6)	ATXN7L2 (2.5)	TXNL4B (2.4)	ATP13A1 (2.3)	DHODH (2.3)	LPIN3 (2.3)	SUGP1 (2.2)	ABO (2.0)	PBX4 (1.9)	GOT2P1 (1.8)
GO:0032355	response to estradiol stimulus	0.37	> 0.20	POLK (2.9)	GEMIN7 (2.6)	KIAA1324 (2.0)	PLEKHH2 (1.5)	ABO (1.4)	ZNF101 (1.3)	TMEM57 (1.3)	BLOC1S3 (1.3)	CBLC (1.2)	TSSK6 (1.2)
GO:0034440	lipid oxidation	0.37	> 0.20	ACAD10 (4.6)	MOSC1 (3.0)	NT5DC1 (3.0)	OGDH (2.2)	AMIGO1 (2.1)	GPAM (1.9)	ENSG00000238078 (1.9)	ALDH2 (1.9)	TMEM116 (1.8)	C19orf52 (1.7)
ENSG00000124334	IL9R PPI subnetwork	0.37	> 0.20	BCL3 (2.9)	COL4A3BP (2.3)	C17orf57 (1.6)	RELB (1.6)	CYP7A1 (1.5)	PVR (1.5)	ZNF101 (1.4)	SLC22A1 (1.4)	BCAM (1.3)	HLX (1.2)
GO:0042094	interleukin-2 biosynthetic process	0.37	> 0.20	ENSG00000235545 (3.1)	ENSG00000254235 (2.5)	PBX4 (2.1)	CYB561D1 (1.9)	SLC44A2 (1.8)	POLK (1.7)	DYNC2LI1 (1.7)	PLCG1 (1.5)	ST3GAL4 (1.5)	ANKRD31 (1.4)
ENSG00000165030	NFIL3 PPI subnetwork	0.37	> 0.20	SARS (5.1)	PVRL2 (2.8)	PVR (2.7)	BCL3 (2.6)	TM6SF2 (2.6)	MAPKAPK5 (2.5)	TXNL4B (2.4)	TRAFD1 (2.1)	HLX (1.9)	KIAA1324 (1.9)
GO:0031672	A band	0.37	> 0.20	SYPL2 (5.1)	GMPR (3.4)	RHCE (1.5)	ENSG00000238078 (1.3)	RHD (1.3)	POC5 (1.2)	LPAR2 (1.1)	ZNF101 (1.1)	ENSG00000226648 (1.1)	HP (1.1)
GO:0005732	small nucleolar ribonucleoprotein complex	0.37	> 0.20	QTRT1 (3.8)	TOMM40 (3.6)	DHODH (3.1)	DDX56 (3.0)	TRAPPC6A (2.5)	ZNF259 (2.4)	GEMIN7 (2.4)	GATAD2A (1.9)	PVR (1.8)	FEN1 (1.5)
ENSG00000127511	SIN3B PPI subnetwork	0.37	> 0.20	OASL (5.7)	BRAP (3.1)	PARP10 (3.1)	TOP1 (2.8)	CARM1 (2.7)	MAU2 (2.6)	TRAFD1 (2.5)	C12orf51 (2.4)	CELSR2 (2.2)	SMARCA4 (2.1)
GO:0001836	release of cytochrome c from mitochondria	0.37	> 0.20	TRAPPC6A (2.3)	BLOC1S3 (2.2)	ENSG00000235545 (2.2)	C12orf43 (2.0)	FRK (2.0)	BRAP (1.8)	TRAFD1 (1.7)	CBLC (1.7)	ERP29 (1.6)	CILP2 (1.5)
ENSG00000213246	SUPT4H1 PPI subnetwork	0.37	> 0.20	SUGP1 (3.2)	ZNF259 (2.7)	DHX38 (2.6)	MAPKAPK5 (2.5)	BUD13 (2.4)	PTPN11 (2.4)	TOMM40 (2.4)	GEMIN7 (2.4)	TOP1 (2.3)	TXNL4B (2.1)
GO:0031649	heat generation	0.37	> 0.20	ENSG00000235545 (3.7)	ENSG00000228044 (2.5)	ST3GAL4 (2.4)	BLOC1S3 (2.4)	DNAH11 (2.2)	POLK (1.9)	GCNT4 (1.3)	OASL (1.2)	CETP (1.2)	TXNL4B (1.2)
ENSG00000182132	KCNIP1 PPI subnetwork	0.37	> 0.20	ERP29 (2.8)	POC5 (2.5)	C17orf57 (2.1)	ENSG00000226645 (2.0)	GEMIN7 (1.9)	QTRT1 (1.9)	POLK (1.7)	ZNF180 (1.7)	COL4A3BP (1.6)	CLPTM1 (1.6)
GO:0005548	phospholipid transporter activity	0.37	> 0.20	TIMD4 (2.9)	COL4A3BP (2.4)	MYLIP (2.1)	AMIGO1 (1.9)	KANK2 (1.8)	GATAD2A (1.7)	ATP13A1 (1.6)	C17orf57 (1.6)	SLC44A2 (1.5)	GMIP (1.5)
GO:0016032	viral reproduction	0.37	> 0.20	BUD13 (2.5)	PSMA5 (2.2)	ZNF101 (2.1)	ZNF180 (2.1)	GEMIN7 (1.9)	SUGP1 (1.9)	NKPD1 (1.8)	BRAP (1.7)	PTPN11 (1.7)	MAU2 (1.7)
ENSG00000100410	PHF5A PPI subnetwork	0.37	> 0.20	ILF3 (4.0)	C1orf63 (3.8)	TOP1 (3.0)	BUD13 (2.8)	USP1 (2.7)	DHX38 (2.6)	SMARCA4 (2.6)	SUGP1 (2.3)	FEN1 (2.1)	QTRT1 (1.8)
GO:0071158	positive regulation of cell cycle arrest	0.37	> 0.20	PSMA5 (3.5)	TRAFD1 (2.5)	NAA25 (2.3)	NT5DC1 (2.2)	ENSG00000254235 (1.9)	SUGP1 (1.6)	SARS (1.4)	ZNF259 (1.3)	C12orf43 (1.3)	ENSG00000226645 (1.3)
GO:0003678	DNA helicase activity	0.37	> 0.20	BRAP (3.2)	SUGP1 (3.1)	POC5 (2.9)	DHX38 (2.8)	FEN1 (2.6)	MAPKAPK5 (2.4)	ZNF180 (2.4)	DHODH (2.2)	SMARCA4 (2.2)	DDX56 (2.1)
MP:0000827	dilated third ventricle	0.37	> 0.20	DYNC2LI1 (4.2)	FADS1 (3.9)	FADS2 (2.9)	ATXN2 (2.8)	LDLR (2.5)	GRINA (2.5)	UBXN2B (2.4)	CARM1 (2.3)	C12orf51 (2.3)	HMGCR (2.0)
GO:0002700	regulation of production of molecular mediator of immune response	0.37	> 0.20	GCNT4 (2.3)	C17orf57 (2.1)	HAVCR1 (2.0)	ZNF101 (1.7)	SH2B3 (1.5)	TIMD4 (1.4)	MOSC1 (1.3)	CETP (1.3)	BCL3 (1.2)	POC5 (1.2)
ENSG00000092969	TGFB2 PPI subnetwork	0.37	> 0.20	CILP2 (6.1)	SLC44A2 (2.2)	KANK2 (2.1)	YIPF2 (2.0)	PVR (2.0)	LPA (1.8)	SLC22A1 (1.7)	MAFB (1.6)	ZNF180 (1.5)	APOA5 (1.5)
GO:0030133	transport vesicle	0.37	> 0.20	KIAA1324 (4.8)	YIPF2 (3.2)	LDLR (2.5)	FADS2 (2.1)	COL4A3BP (1.7)	ERP29 (1.6)	POLK (1.6)	CEACAM19 (1.6)	GRINA (1.5)	FRK (1.5)
ENSG00000169045	HNRNPH1 PPI subnetwork	0.37	> 0.20	C1orf63 (3.8)	ILF3 (3.4)	SMARCA4 (3.3)	TOP1 (2.8)	DHX38 (2.4)	QTRT1 (2.3)	GATAD2A (2.3)	SUGP1 (2.2)	BUD13 (2.1)	USP1 (2.0)
GO:0045069	regulation of viral genome replication	0.37	> 0.20	OASL (6.0)	MAU2 (3.1)	FRK (2.8)	GCNT4 (2.5)	PARP10 (2.1)	ENSG00000228044 (1.8)	ENSG00000235545 (1.6)	ATP13A1 (1.4)	HAVCR1 (1.3)	PLCG1 (1.2)
GO:0030218	erythrocyte differentiation	0.37	> 0.20	RHCE (6.3)	RHD (5.9)	C12orf51 (2.5)	TMEM57 (2.4)	C19orf52 (2.2)	DNM2 (1.9)	GMPR (1.8)	BLOC1S3 (1.6)	ENSG00000228044 (1.6)	UBXN2B (1.5)
ENSG00000137673	MMP7 PPI subnetwork	0.37	> 0.20	ABCG5 (2.2)	APOB (2.1)	SLC22A1 (2.0)	PVR (1.9)	APOE (1.8)	ENSG00000228044 (1.8)	APOA5 (1.7)	APOC1 (1.7)	C11orf9 (1.6)	NCAN (1.6)
ENSG00000196782	MAML3 PPI subnetwork	0.37	> 0.20	NYNRIN (2.7)	BCAM (2.5)	PSRC1 (2.4)	NCAN (2.1)	ENSG00000254235 (1.7)	SH2B3 (1.7)	USP24 (1.7)	GATAD2A (1.5)	USP1 (1.5)	BUD13 (1.4)
ENSG00000151743	AMN1 PPI subnetwork	0.37	> 0.20	COL4A3BP (2.6)	SLC44A2 (2.5)	PSRC1 (2.4)	DOCK7 (2.0)	TMEM50A (1.9)	ENSG00000226645 (1.9)	USP1 (1.9)	ILF3 (1.8)	POC5 (1.8)	DHX38 (1.8)
ENSG00000134480	CCNH PPI subnetwork	0.37	> 0.20	SUGP1 (3.2)	ZNF259 (2.9)	BUD13 (2.7)	TXNL4B (2.2)	ILF3 (2.1)	PSMA5 (2.1)	MAPKAPK5 (1.9)	POC5 (1.9)	CARM1 (1.8)	DHX38 (1.8)
ENSG00000171873	ADRA1D PPI subnetwork	0.37	> 0.20	ZHX3 (3.4)	COL4A3BP (3.1)	ENSG00000235545 (2.5)	KANK2 (2.4)	ITGB3 (2.0)	RHCE (1.9)	SH2B3 (1.8)	PPP1R37 (1.8)	SYPL2 (1.7)	FADS2 (1.5)
GO:0002377	immunoglobulin production	0.37	> 0.20	ZNF101 (2.6)	PBX4 (2.4)	NT5DC1 (2.0)	POC5 (1.9)	DYNC2LI1 (1.9)	C12orf43 (1.7)	GEMIN7 (1.3)	ADAM1 (1.3)	HAVCR1 (1.3)	C17orf57 (1.2)
ENSG00000212789	ENSG00000212789 PPI subnetwork	0.37	> 0.20	DOCK7 (2.8)	NAA25 (2.1)	GPAM (2.1)	OASL (2.0)	NT5DC1 (1.9)	PSMA5 (1.8)	MOSC1 (1.7)	OGDH (1.7)	FADS1 (1.7)	FADS2 (1.6)
ENSG00000134248	HBXIP PPI subnetwork	0.37	> 0.20	HNF1A (2.7)	ZHX3 (2.5)	ZNF180 (2.4)	BLOC1S3 (2.1)	MAFB (1.9)	UBXN2B (1.8)	PLEC (1.8)	POC5 (1.6)	C17orf57 (1.5)	CYB561D1 (1.4)
ENSG00000198793	MTOR PPI subnetwork	0.37	> 0.20	USP24 (3.2)	DNM2 (2.6)	AP1M2 (2.5)	C12orf51 (2.5)	DOCK7 (2.4)	NAA25 (2.2)	PTPN11 (2.2)	SMARCA4 (2.2)	DHX38 (1.9)	GATAD2A (1.8)
GO:0006913	nucleocytoplasmic transport	0.37	> 0.20	GATAD2A (3.6)	PTPN11 (2.6)	ENSG00000254235 (2.5)	NAA25 (2.2)	C12orf43 (2.2)	ILF3 (1.8)	TRAFD1 (1.7)	MAPKAPK5 (1.7)	ADAM1 (1.7)	ATXN2 (1.7)
ENSG00000198805	PNP PPI subnetwork	0.37	> 0.20	RELB (2.4)	LPA (1.9)	KIAA1324 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)	ZNF180 (1.6)	MYLIP (1.6)	ZNF101 (1.6)	GMIP (1.5)	NYNRIN (1.4)
MP:0008225	abnormal anterior commissure morphology	0.37	> 0.20	PLCG1 (3.3)	GRINA (2.7)	C12orf47 (2.6)	PPP1R37 (2.4)	PVRL2 (2.2)	CELSR2 (1.9)	C12orf51 (1.9)	NYNRIN (1.7)	CYP7A1 (1.4)	CLPTM1 (1.3)
ENSG00000132424	PNISR PPI subnetwork	0.37	> 0.20	C1orf63 (4.9)	C12orf43 (3.2)	MAPKAPK5 (2.6)	C12orf51 (2.4)	ATXN2 (2.1)	USP1 (2.0)	TOP1 (2.0)	C19orf52 (1.9)	ADAM1 (1.9)	BUD13 (1.8)
ENSG00000167085	PHB PPI subnetwork	0.38	> 0.20	ERP29 (3.1)	ENSG00000226648 (2.3)	PLCG1 (1.9)	NAA25 (1.9)	USP1 (1.8)	ADAM1 (1.8)	ALDH2 (1.8)	GOT2P1 (1.6)	SARS (1.6)	MAFB (1.5)
GO:0045823	positive regulation of heart contraction	0.38	> 0.20	LPIN3 (3.2)	CEACAM19 (2.8)	ENSG00000226648 (2.7)	HAPLN4 (1.9)	FRK (1.9)	GEMIN7 (1.8)	CYB561D1 (1.6)	PPP1R37 (1.5)	RPH3A (1.5)	TMED4 (1.4)
GO:0045429	positive regulation of nitric oxide biosynthetic process	0.38	> 0.20	ENSG00000228044 (3.2)	AMIGO1 (2.5)	BCL3 (1.8)	PVR (1.7)	C12orf43 (1.6)	TXNL4B (1.6)	RELB (1.6)	MAFB (1.4)	ENSG00000254235 (1.4)	DNAH11 (1.4)
ENSG00000197976	AKAP17A PPI subnetwork	0.38	> 0.20	C1orf63 (2.2)	ENSG00000228044 (2.0)	AMIGO1 (2.0)	CELSR2 (1.8)	PLCG1 (1.8)	NYNRIN (1.7)	PPP1R37 (1.6)	ERP29 (1.6)	ENSG00000254235 (1.5)	ZHX3 (1.3)
ENSG00000113300	CNOT6 PPI subnetwork	0.38	> 0.20	MAPKAPK5 (4.2)	ATXN2 (3.9)	BRAP (3.3)	C12orf51 (2.7)	C12orf43 (2.4)	USP24 (2.1)	BUD13 (2.0)	POC5 (2.0)	PSRC1 (1.9)	DNAH11 (1.9)
MP:0000427	abnormal hair cycle	0.38	> 0.20	AMIGO1 (3.6)	CELSR2 (2.4)	PVR (2.3)	ABO (2.1)	CEACAM19 (2.1)	ENSG00000254235 (2.0)	PMFBP1 (1.7)	CYB561D1 (1.6)	NPC1L1 (1.5)	GOT2P1 (1.4)
MP:0009305	decreased retroperitoneal fat pad weight	0.38	> 0.20	MOSC1 (6.3)	GPAM (3.5)	HP (2.7)	SORT1 (2.7)	GEMIN7 (2.2)	APOA5 (2.1)	TM6SF2 (2.1)	HAPLN4 (2.0)	LPA (2.0)	C12orf47 (1.9)
ENSG00000092094	OSGEP PPI subnetwork	0.38	> 0.20	ITGB3 (3.4)	PPP1R37 (2.6)	CLPTM1 (2.0)	CETP (1.8)	GATAD2A (1.7)	HNF1A (1.7)	GEMIN7 (1.5)	TIMD4 (1.5)	BLOC1S3 (1.4)	C17orf57 (1.4)
ENSG00000205220	PSMB10 PPI subnetwork	0.38	> 0.20	PSMA5 (6.3)	TRAFD1 (3.3)	NAA25 (2.3)	NT5DC1 (2.2)	TOMM40 (1.8)	SUGP1 (1.8)	SARS (1.7)	DDX56 (1.7)	TMEM50A (1.6)	CLPTM1 (1.2)
GO:0050795	regulation of behavior	0.38	> 0.20	GCNT4 (2.4)	CETP (2.3)	ENSG00000226648 (2.3)	HLX (2.1)	ZNF101 (1.8)	MAFB (1.6)	DNAH11 (1.6)	APOE (1.5)	TIMD4 (1.5)	ENSG00000228044 (1.4)
ENSG00000156273	BACH1 PPI subnetwork	0.38	> 0.20	MAFB (2.7)	TMEM116 (2.2)	TIMD4 (2.1)	TRIB1 (1.9)	NPC1L1 (1.9)	BCAM (1.9)	ATXN2 (1.7)	DOCK7 (1.7)	POLK (1.7)	BRAP (1.6)
MP:0003691	abnormal microglial cell physiology	0.38	> 0.20	TRIB1 (3.7)	PVR (3.4)	MAFB (3.2)	OASL (2.8)	GPAM (2.5)	SH2B3 (2.2)	SORT1 (2.0)	ERP29 (1.9)	AMIGO1 (1.6)	NCAN (1.5)
MP:0001303	abnormal lens morphology	0.38	> 0.20	ATXN2 (1.6)	CETP (1.4)	MYLIP (1.4)	OASL (1.3)	CELSR2 (1.3)	SYPL2 (1.2)	GOT2P1 (1.2)	TIMD4 (1.2)	SORT1 (1.2)	NPC1L1 (1.2)
MP:0008078	increased CD8-positive T cell number	0.38	> 0.20	TIMD4 (4.6)	CETP (3.9)	PLCG1 (2.6)	MAFB (2.5)	RELB (2.3)	RHD (2.3)	APOC1 (2.2)	GMIP (2.1)	RHCE (2.0)	SLC44A2 (1.9)
ENSG00000196419	XRCC6 PPI subnetwork	0.38	> 0.20	SMARCA4 (3.3)	FEN1 (2.5)	ILF3 (2.5)	DHX38 (2.3)	USP1 (2.2)	TOP1 (2.2)	PLEC (1.9)	MYLIP (1.8)	PSMA5 (1.6)	BUD13 (1.5)
MP:0002795	dilated cardiomyopathy	0.38	> 0.20	SYPL2 (2.9)	KANK2 (2.6)	GMPR (2.4)	ENSG00000226648 (1.7)	SORT1 (1.6)	PLEC (1.5)	BCAM (1.4)	ST3GAL4 (1.4)	TMEM50A (1.4)	MAFB (1.2)
ENSG00000085760	MTIF2 PPI subnetwork	0.38	> 0.20	OASL (4.1)	PARP10 (3.3)	PLEKHH2 (2.5)	COL4A3BP (2.1)	ABCG5 (2.1)	PLCG1 (2.1)	PBX4 (2.0)	ABCG8 (1.9)	C12orf43 (1.8)	TM6SF2 (1.8)
MP:0003704	abnormal hair follicle development	0.38	> 0.20	MAFB (2.4)	AP1M2 (2.2)	ANKRD31 (2.2)	CELSR2 (2.1)	CBLC (2.1)	CILP2 (2.0)	ZNF101 (1.9)	DNAH11 (1.7)	ENSG00000254235 (1.6)	C19orf52 (1.6)
GO:0008023	transcription elongation factor complex	0.38	> 0.20	SUGP1 (2.6)	ZNF259 (2.6)	DDX56 (2.4)	GCNT4 (2.3)	TOP1 (2.0)	ATXN7L2 (2.0)	ZHX3 (1.8)	C19orf52 (1.8)	KIAA1324 (1.8)	BUD13 (1.8)
ENSG00000114982	KANSL3 PPI subnetwork	0.38	> 0.20	GEMIN7 (4.4)	BRAP (2.8)	TXNL4B (2.6)	C12orf47 (2.1)	BUD13 (2.1)	MAPKAPK5 (2.1)	POC5 (1.9)	BLOC1S3 (1.9)	C19orf52 (1.7)	MAU2 (1.6)
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	0.38	> 0.20	POC5 (3.3)	NAA25 (2.9)	BUD13 (2.7)	USP1 (2.7)	DOCK7 (2.6)	USP24 (2.3)	ILF3 (2.3)	DDX56 (2.2)	FEN1 (2.1)	MAPKAPK5 (2.0)
ENSG00000105364	MRPL4 PPI subnetwork	0.38	> 0.20	BUD13 (3.0)	MAPKAPK5 (2.8)	DHX38 (2.7)	MAU2 (2.7)	ATP13A1 (2.7)	DDX56 (2.3)	BRAP (2.1)	ILF3 (2.1)	C12orf51 (2.1)	SUGP1 (2.1)
ENSG00000111300	NAA25 PPI subnetwork	0.38	> 0.20	MAPKAPK5 (3.0)	ATP13A1 (2.3)	LPA (2.2)	FRK (1.9)	HNF1A (1.8)	TOMM40 (1.8)	BRAP (1.7)	DHODH (1.7)	USP24 (1.6)	ADAM1 (1.6)
ENSG00000100304	TTLL12 PPI subnetwork	0.38	> 0.20	OASL (7.8)	PARP10 (3.4)	USP1 (2.3)	ATP13A1 (1.8)	PSRC1 (1.7)	TRAFD1 (1.7)	GCNT4 (1.7)	GATAD2A (1.7)	SUGP1 (1.6)	ENSG00000226648 (1.6)
ENSG00000166889	PATL1 PPI subnetwork	0.38	> 0.20	DHX38 (3.2)	ILF3 (2.9)	TOP1 (2.9)	DDX56 (2.8)	SMARCA4 (2.6)	SUGP1 (2.5)	FEN1 (2.3)	MAU2 (2.2)	BUD13 (2.0)	ZNF259 (1.8)
ENSG00000164118	CEP44 PPI subnetwork	0.38	> 0.20	ITGB3 (3.2)	GMPR (2.8)	TMEM57 (2.5)	TMEM50A (2.3)	APOC1 (2.2)	HAVCR1 (1.8)	LPIN3 (1.7)	POC5 (1.7)	BRAP (1.6)	PLCG1 (1.5)
ENSG00000127688	GAN PPI subnetwork	0.38	> 0.20	CBLC (6.0)	AP1M2 (4.7)	LPAR2 (2.4)	CELSR2 (2.2)	DOCK7 (2.0)	LPIN3 (1.9)	PVRL2 (1.9)	MARK4 (1.6)	DNM2 (1.5)	BCAM (1.5)
ENSG00000127388	ENSG00000127388 PPI subnetwork	0.38	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.4)	KANK2 (1.8)	ADAM1 (1.8)	HNF1A (1.7)	UBXN2B (1.5)	DHX38 (1.4)	ZNF180 (1.4)
ENSG00000197558	ENSG00000197558 PPI subnetwork	0.38	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.4)	KANK2 (1.8)	ADAM1 (1.8)	HNF1A (1.7)	UBXN2B (1.5)	DHX38 (1.4)	ZNF180 (1.4)
GO:0042058	regulation of epidermal growth factor receptor signaling pathway	0.38	> 0.20	PPP1R37 (2.9)	C17orf57 (2.4)	CLPTM1 (2.2)	ABO (1.9)	DOCK7 (1.8)	CETP (1.8)	MARK4 (1.7)	ENSG00000235545 (1.7)	PVRL2 (1.7)	ENSG00000226645 (1.6)
GO:0046520	sphingoid biosynthetic process	0.38	> 0.20	NKPD1 (3.8)	HAVCR1 (3.4)	COL4A3BP (2.7)	POLK (2.2)	CYB561D1 (2.1)	SLC44A2 (2.1)	ATP13A1 (1.7)	PVR (1.7)	TM6SF2 (1.5)	ANKRD31 (1.5)
KEGG_NITROGEN_METABOLISM	KEGG_NITROGEN_METABOLISM	0.38	> 0.20	RHD (3.7)	RHCE (3.6)	DNAH11 (3.3)	MOSC1 (2.8)	ENSG00000235545 (2.7)	SARS (2.5)	HAPLN4 (2.3)	UBXN2B (2.2)	APOC4 (2.0)	APOE (2.0)
ENSG00000154001	PPP2R5E PPI subnetwork	0.38	> 0.20	OASL (2.6)	PSRC1 (2.3)	COL4A3BP (2.3)	PARP10 (2.3)	NT5DC1 (2.2)	PLCG1 (2.1)	LPAR2 (2.1)	ADAM1 (2.0)	PLEKHH2 (2.0)	ERP29 (1.7)
MP:0002724	enhanced wound healing	0.38	> 0.20	BCL3 (2.9)	PLEC (2.8)	PVRL2 (2.8)	PVR (2.5)	CBLC (2.0)	ENSG00000238078 (1.9)	TRIB1 (1.8)	PTPN11 (1.7)	AP1M2 (1.5)	ITGB3 (1.5)
KEGG_CHEMOKINE_SIGNALING_PATHWAY	KEGG_CHEMOKINE_SIGNALING_PATHWAY	0.38	> 0.20	GMIP (3.9)	RELB (3.8)	BCL3 (3.1)	TIMD4 (2.9)	OASL (2.6)	MAFB (2.4)	SH2B3 (2.1)	CETP (2.1)	GRINA (2.0)	TRAFD1 (1.9)
GO:0046661	male sex differentiation	0.38	> 0.20	LPAR2 (2.7)	ST3GAL4 (2.6)	ABO (2.6)	DNAH11 (2.5)	PLEKHH2 (2.0)	C11orf9 (1.7)	TSSK6 (1.6)	AP1M2 (1.4)	NYNRIN (1.4)	FRK (1.4)
GO:0017148	negative regulation of translation	0.38	> 0.20	HNF1A (2.1)	TMEM57 (2.1)	ANKRD31 (1.9)	NYNRIN (1.8)	GCNT4 (1.8)	USP24 (1.7)	ILF3 (1.7)	RHCE (1.5)	PMFBP1 (1.5)	C12orf51 (1.5)
MP:0004031	insulitis	0.38	> 0.20	MAFB (4.5)	TIMD4 (2.0)	APOC1 (1.9)	GOT2P1 (1.9)	APOE (1.8)	POLK (1.6)	CETP (1.5)	NYNRIN (1.5)	NKPD1 (1.4)	ERP29 (1.2)
ENSG00000100842	EFS PPI subnetwork	0.38	> 0.20	PPP1R37 (2.9)	DNM2 (2.8)	ZHX3 (2.5)	GATAD2A (2.1)	C17orf57 (2.1)	SH2B3 (2.0)	PVRL2 (1.9)	ABO (1.8)	SLC44A2 (1.8)	PLEC (1.8)
ENSG00000171431	KRT20 PPI subnetwork	0.38	> 0.20	ENSG00000228044 (2.9)	GEMIN7 (2.6)	TRAPPC6A (2.1)	LPA (2.0)	TMED4 (1.8)	C19orf52 (1.7)	UBXN2B (1.7)	ACAD10 (1.6)	ENSG00000254235 (1.6)	MARK4 (1.5)
ENSG00000119638	NEK9 PPI subnetwork	0.38	> 0.20	ZNF180 (3.7)	PTPN11 (2.8)	C11orf9 (2.5)	USP1 (2.5)	DHX38 (2.4)	FEN1 (2.3)	PSRC1 (2.1)	ENSG00000235545 (1.7)	NYNRIN (1.7)	TRAPPC6A (1.6)
ENSG00000121774	KHDRBS1 PPI subnetwork	0.38	> 0.20	GMIP (4.2)	PPP1R37 (3.2)	ITGB3 (2.9)	OGDH (2.5)	ZNF101 (2.3)	ATXN2 (2.2)	SMARCA4 (2.2)	MAFB (2.2)	C1orf63 (2.0)	COL4A3BP (1.7)
ENSG00000134308	YWHAQ PPI subnetwork	0.38	> 0.20	TOP1 (3.0)	BCAM (2.7)	SARS (2.6)	ATXN2 (2.5)	OGDH (2.3)	COL4A3BP (2.2)	SMARCA4 (2.1)	DOCK7 (2.0)	PVRL2 (1.9)	CBLC (1.9)
MP:0011110	partial preweaning lethality	0.38	> 0.20	MYLIP (3.1)	CETP (2.5)	RHD (2.1)	C12orf51 (2.1)	ITGB3 (2.0)	RHCE (1.9)	C1orf63 (1.8)	TMEM50A (1.8)	BCL3 (1.7)	CELSR2 (1.6)
ENSG00000169813	HNRNPF PPI subnetwork	0.38	> 0.20	ILF3 (3.8)	C1orf63 (3.5)	TOP1 (3.1)	SMARCA4 (2.9)	DHX38 (2.4)	QTRT1 (2.4)	TOMM40 (2.3)	PSMA5 (2.2)	USP1 (2.2)	PTPN11 (2.2)
GO:0002706	regulation of lymphocyte mediated immunity	0.38	> 0.20	DNAH11 (1.5)	PARP10 (1.5)	HAVCR1 (1.4)	ZNF101 (1.4)	GEMIN7 (1.4)	ENSG00000235545 (1.4)	TRAFD1 (1.3)	C12orf43 (1.2)	PBX4 (1.2)	AMIGO1 (1.2)
ENSG00000140538	NTRK3 PPI subnetwork	0.38	> 0.20	TRIB1 (3.8)	PBX4 (2.7)	MAFB (2.3)	ZNF101 (2.3)	ENSG00000238078 (1.9)	PSRC1 (1.6)	MARK4 (1.5)	PVR (1.5)	ZHX3 (1.4)	ADAM1 (1.1)
ENSG00000108175	ZMIZ1 PPI subnetwork	0.38	> 0.20	ATXN2 (4.3)	C12orf51 (3.8)	C12orf43 (2.9)	CARM1 (2.8)	BRAP (2.7)	GRINA (2.6)	C19orf52 (2.2)	MAPKAPK5 (2.2)	PLCG1 (2.1)	MYLIP (2.0)
MP:0008236	decreased susceptibility to neuronal excitotoxicity	0.38	> 0.20	TRIB1 (3.6)	OASL (3.2)	PVR (2.8)	ANGPTL3 (2.5)	PARP10 (2.4)	AMIGO1 (2.1)	BCL3 (1.9)	GRINA (1.7)	PPP1R37 (1.7)	APOC4 (1.7)
ENSG00000118898	PPL PPI subnetwork	0.38	> 0.20	TMEM57 (3.2)	C1orf63 (2.6)	PLEC (2.5)	C11orf9 (2.1)	NT5DC1 (2.0)	LPIN3 (1.9)	CBLC (1.9)	OGDH (1.6)	ABO (1.5)	CELSR2 (1.4)
ENSG00000130312	MRPL34 PPI subnetwork	0.38	> 0.20	GEMIN7 (3.1)	QTRT1 (2.7)	MAPKAPK5 (2.2)	TOMM40 (2.1)	ATXN7L2 (1.9)	NAA25 (1.8)	PSMA5 (1.7)	CARM1 (1.6)	BUD13 (1.5)	HAVCR1 (1.4)
REACTOME_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION	0.38	> 0.20	DDX56 (2.5)	C19orf52 (2.3)	ZNF259 (2.2)	GMPR (2.2)	SUGP1 (2.2)	GEMIN7 (2.2)	BUD13 (2.0)	ATXN2 (1.9)	C12orf43 (1.8)	ENSG00000226645 (1.8)
ENSG00000165966	PDZRN4 PPI subnetwork	0.38	> 0.20	ITGB3 (3.3)	APOC1 (3.1)	GMPR (2.6)	TMEM50A (2.5)	ZNF101 (2.3)	LPIN3 (2.0)	GPAM (1.8)	HAVCR1 (1.8)	C1orf63 (1.7)	PLCG1 (1.5)
MP:0000873	thin external granule cell layer	0.38	> 0.20	TIMD4 (3.3)	CETP (3.1)	APOE (2.5)	ATXN7L2 (2.4)	ENSG00000226645 (2.0)	NYNRIN (1.9)	PCSK9 (1.9)	ABO (1.9)	ADAM1 (1.7)	OGDH (1.5)
ENSG00000034713	GABARAPL2 PPI subnetwork	0.38	> 0.20	SARS (3.8)	OGDH (3.5)	NAA25 (2.1)	PSMA5 (2.0)	ATXN2 (2.0)	NT5DC1 (1.8)	HAPLN4 (1.8)	SMARCA4 (1.6)	ILF3 (1.6)	ATP13A1 (1.6)
GO:0051937	catecholamine transport	0.38	> 0.20	ABO (2.4)	CETP (1.8)	AMIGO1 (1.6)	GMPR (1.6)	LPA (1.5)	RPH3A (1.4)	C19orf52 (1.3)	TSSK6 (1.3)	PMFBP1 (1.3)	GOT2P1 (1.2)
GO:0021782	glial cell development	0.38	> 0.20	NCAN (3.0)	C11orf9 (2.7)	ENSG00000226648 (1.7)	SORT1 (1.7)	CEACAM19 (1.7)	ENSG00000254235 (1.7)	C19orf52 (1.6)	DYNC2LI1 (1.6)	ENSG00000235545 (1.5)	HAPLN4 (1.4)
MP:0009417	skeletal muscle atrophy	0.38	> 0.20	BCAM (3.1)	SYPL2 (2.6)	GRINA (2.3)	CELSR2 (2.2)	DYNC2LI1 (2.2)	HAVCR1 (1.8)	BLOC1S3 (1.6)	SLC44A2 (1.5)	HLX (1.2)	PLEC (1.2)
ENSG00000099622	CIRBP PPI subnetwork	0.38	> 0.20	NCAN (2.5)	RPH3A (2.4)	APOC1 (2.0)	QTRT1 (1.7)	ADAM1 (1.5)	CARM1 (1.4)	GPAM (1.4)	MOSC1 (1.3)	NKPD1 (1.3)	GOT2P1 (1.2)
GO:0002698	negative regulation of immune effector process	0.38	> 0.20	PARP10 (1.9)	GCNT4 (1.7)	BLOC1S3 (1.5)	OASL (1.4)	ENSG00000235545 (1.4)	DNAH11 (1.3)	GMIP (1.3)	ZNF101 (1.3)	TRAFD1 (1.3)	C12orf47 (1.2)
ENSG00000104964	AES PPI subnetwork	0.38	> 0.20	FADS2 (2.7)	GRINA (2.3)	RHCE (1.9)	KIAA1324 (1.8)	RHD (1.7)	DYNC2LI1 (1.5)	BCL3 (1.5)	ANKRD31 (1.5)	ENSG00000238078 (1.4)	ALDH2 (1.4)
ENSG00000117322	CR2 PPI subnetwork	0.38	> 0.20	CETP (4.5)	TIMD4 (2.9)	GMIP (2.5)	ZNF101 (2.3)	HP (1.8)	SLC44A2 (1.7)	GCNT4 (1.7)	PVRL2 (1.6)	GATAD2A (1.6)	GEMIN7 (1.6)
GO:0001522	pseudouridine synthesis	0.38	> 0.20	ZNF259 (3.5)	DHODH (3.4)	QTRT1 (3.4)	BUD13 (3.1)	NAA25 (2.8)	GOT2P1 (2.4)	DDX56 (2.3)	TOMM40 (2.1)	NKPD1 (2.1)	ANKRD31 (1.9)
MP:0008133	decreased Peyer's patch number	0.38	> 0.20	RELB (4.4)	BCL3 (3.3)	GMIP (3.3)	PARP10 (3.0)	TIMD4 (2.6)	PVRL2 (2.6)	KIAA1324 (2.5)	OASL (2.5)	PVR (2.0)	CETP (1.8)
MP:0002841	impaired skeletal muscle contractility	0.38	> 0.20	SYPL2 (9.0)	GMPR (2.5)	ATXN7L2 (1.5)	PLEC (1.4)	PBX4 (1.3)	AMIGO1 (1.3)	CEACAM19 (1.2)	ENSG00000226645 (1.2)	CYB561D1 (1.0)	NPC1L1 (1.0)
MP:0004984	increased osteoclast cell number	0.38	> 0.20	TRIB1 (3.3)	HAVCR1 (2.8)	ENSG00000228044 (2.2)	ITGB3 (2.2)	SH2B3 (1.9)	FRK (1.8)	MAFB (1.6)	TMEM57 (1.4)	ENSG00000254235 (1.4)	PVR (1.4)
MP:0004814	reduced linear vestibular evoked potential	0.38	> 0.20	LPIN3 (2.6)	FADS2 (1.9)	TSSK6 (1.8)	PCSK9 (1.6)	CBLC (1.6)	TM6SF2 (1.6)	ABO (1.6)	DNAH11 (1.5)	MOSC1 (1.5)	RPH3A (1.5)
ENSG00000070018	LRP6 PPI subnetwork	0.38	> 0.20	LPAR2 (2.9)	CILP2 (2.2)	DOCK7 (1.8)	PVRL2 (1.7)	KANK2 (1.6)	PLEKHH2 (1.6)	PCSK9 (1.6)	ENSG00000254235 (1.4)	PVR (1.3)	MOSC1 (1.3)
REACTOME_REGULATION_OF_IFNG_SIGNALING	REACTOME_REGULATION_OF_IFNG_SIGNALING	0.38	> 0.20	TRAFD1 (6.0)	BCL3 (4.8)	RELB (3.2)	PARP10 (3.2)	ENSG00000228044 (2.6)	TRIB1 (2.2)	COL4A3BP (2.0)	NAA25 (2.0)	GRINA (2.0)	TMEM50A (1.5)
ENSG00000117461	PIK3R3 PPI subnetwork	0.38	> 0.20	DOCK7 (3.3)	HLX (3.1)	PVRL2 (2.7)	C1orf63 (2.6)	SLC44A2 (2.6)	SH2B3 (2.1)	GMIP (2.1)	MYLIP (2.0)	DNM2 (1.9)	CELSR2 (1.8)
ENSG00000103126	AXIN1 PPI subnetwork	0.38	> 0.20	MARK4 (3.4)	MYLIP (2.6)	ENSG00000226645 (2.4)	ATXN2 (2.0)	DNM2 (1.9)	TMEM57 (1.8)	ATXN7L2 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	NYNRIN (1.6)
ENSG00000081985	IL12RB2 PPI subnetwork	0.38	> 0.20	BCL3 (3.0)	COL4A3BP (2.0)	C17orf57 (1.7)	HLX (1.5)	ZNF101 (1.5)	CYP7A1 (1.4)	RELB (1.3)	PVR (1.3)	SLC22A1 (1.2)	POLK (1.1)
ENSG00000143761	ARF1 PPI subnetwork	0.38	> 0.20	YIPF2 (4.0)	CLPTM1 (3.8)	DHX38 (2.4)	MAU2 (2.4)	DNM2 (2.1)	KIAA1324 (2.0)	BLOC1S3 (2.0)	OGDH (2.0)	SUGP1 (1.8)	ATP13A1 (1.7)
REACTOME_SIGNALING_BY_PDGF	REACTOME_SIGNALING_BY_PDGF	0.38	> 0.20	PLEC (2.5)	ITGB3 (2.5)	MYLIP (2.4)	ZHX3 (2.2)	PLEKHH2 (1.7)	SH2B3 (1.7)	CLPTM1 (1.6)	MARK4 (1.6)	OGDH (1.6)	SORT1 (1.6)
GO:0022603	regulation of anatomical structure morphogenesis	0.38	> 0.20	PVRL2 (2.9)	BCAM (2.3)	PPP1R37 (2.1)	NYNRIN (1.9)	PLEKHH2 (1.9)	ENSG00000235545 (1.8)	C11orf9 (1.8)	SLC44A2 (1.8)	PVR (1.7)	MAFB (1.6)
GO:0048643	positive regulation of skeletal muscle tissue development	0.38	> 0.20	COL4A3BP (3.3)	POLK (2.8)	PMFBP1 (2.2)	LDLR (2.0)	DNAH11 (1.9)	CYP7A1 (1.6)	ENSG00000226648 (1.5)	SLC44A2 (1.4)	GMPR (1.3)	FADS1 (1.3)
REACTOME_DOWNREGULATION_OF_ERRB2ERBB3_SIGNALING	REACTOME_DOWNREGULATION_OF_ERRB2ERBB3_SIGNALING	0.38	> 0.20	ANKRD31 (2.6)	PPP1R37 (2.4)	YIPF2 (2.4)	CLPTM1 (2.3)	DOCK7 (2.3)	AMIGO1 (2.2)	ENSG00000238078 (2.0)	BCAM (1.9)	ABCG8 (1.8)	SH2B3 (1.7)
ENSG00000150281	CTF1 PPI subnetwork	0.38	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.8)	TIMD4 (2.2)	CETP (2.1)	GMIP (1.9)	ALDH2 (1.7)	LPA (1.5)	TRIB1 (1.3)	PARP10 (1.3)
ENSG00000168827	GFM1 PPI subnetwork	0.38	> 0.20	TOMM40 (2.7)	CYP7A1 (2.3)	ATP13A1 (2.1)	TXNL4B (2.1)	UBXN2B (2.0)	PLEC (1.8)	TOP1 (1.8)	DHODH (1.8)	TRAPPC6A (1.7)	ENSG00000228044 (1.7)
GO:0000375	RNA splicing, via transesterification reactions	0.38	> 0.20	TOP1 (3.4)	BUD13 (3.2)	C1orf63 (3.2)	SUGP1 (3.0)	ILF3 (2.9)	DHX38 (2.9)	QTRT1 (2.3)	C12orf43 (2.0)	MAU2 (2.0)	SMARCA4 (1.8)
GO:0042158	lipoprotein biosynthetic process	0.38	> 0.20	CYB561D1 (3.2)	ATP13A1 (2.4)	TRAPPC6A (2.2)	TMEM116 (2.2)	TMED4 (2.0)	ERP29 (2.0)	ADAM1 (1.9)	TSSK6 (1.9)	CEACAM19 (1.9)	TXNL4B (1.7)
GO:0001779	natural killer cell differentiation	0.38	> 0.20	CEACAM19 (2.9)	GEMIN7 (2.3)	C17orf57 (2.3)	CYB561D1 (2.2)	PBX4 (2.0)	ZNF180 (2.0)	TIMD4 (1.6)	C12orf43 (1.6)	BLOC1S3 (1.5)	ENSG00000228044 (1.4)
MP:0000662	abnormal branching of the mammary ductal tree	0.38	> 0.20	KIAA1324 (2.1)	GPAM (1.9)	CELSR2 (1.8)	PMFBP1 (1.7)	PLEKHH2 (1.7)	MYLIP (1.7)	MOSC1 (1.6)	AMIGO1 (1.6)	BUD13 (1.5)	TOP1 (1.4)
GO:0005100	Rho GTPase activator activity	0.38	> 0.20	PLEKHH2 (2.9)	NYNRIN (2.7)	GMIP (2.6)	PPP1R37 (2.3)	DNM2 (2.3)	TRIB1 (2.1)	ATXN2 (2.0)	PVRL2 (1.9)	CBLC (1.8)	ENSG00000226645 (1.5)
ENSG00000060339	CCAR1 PPI subnetwork	0.38	> 0.20	ILF3 (4.5)	C1orf63 (3.9)	DHX38 (3.0)	SMARCA4 (2.8)	TOP1 (2.7)	USP1 (2.7)	SUGP1 (2.6)	BUD13 (2.5)	PTPN11 (2.3)	FEN1 (2.2)
ENSG00000140319	SRP14 PPI subnetwork	0.38	> 0.20	FRK (2.9)	QTRT1 (2.8)	GATAD2A (2.6)	ADAM1 (2.5)	C12orf43 (2.2)	ZNF101 (2.1)	OGDH (2.0)	ERP29 (2.0)	TMEM57 (1.9)	ENSG00000226645 (1.9)
GO:0052745	inositol phosphate phosphatase activity	0.38	> 0.20	UBXN2B (2.4)	SH2B3 (2.2)	C12orf51 (2.1)	ZNF180 (2.1)	BLOC1S3 (1.9)	HAPLN4 (1.9)	NT5DC1 (1.8)	MYLIP (1.8)	TSSK6 (1.6)	POC5 (1.6)
GO:0046902	regulation of mitochondrial membrane permeability	0.38	> 0.20	GEMIN7 (3.2)	TRAPPC6A (2.6)	ENSG00000226648 (2.5)	POLK (2.2)	C12orf43 (2.2)	PPP1R37 (2.0)	TMEM116 (1.9)	GOT2P1 (1.7)	ZNF259 (1.7)	SLC44A2 (1.6)
REACTOME_SIGNALLING_BY_NGF	REACTOME_SIGNALLING_BY_NGF	0.38	> 0.20	MARK4 (3.7)	CLPTM1 (3.3)	PLEC (3.1)	SH2B3 (3.1)	DNM2 (2.7)	GATAD2A (2.6)	GRINA (2.4)	GMIP (2.2)	RELB (1.9)	CELSR2 (1.8)
ENSG00000148396	SEC16A PPI subnetwork	0.38	> 0.20	MARK4 (2.6)	HMGCR (2.5)	ENSG00000226648 (2.4)	LDLR (2.2)	ZNF180 (2.2)	GATAD2A (1.8)	C12orf51 (1.8)	USP24 (1.8)	PCSK9 (1.7)	FADS1 (1.7)
GO:0015629	actin cytoskeleton	0.38	> 0.20	SYPL2 (4.8)	PLEC (2.8)	GMPR (2.4)	KANK2 (2.2)	C11orf9 (2.1)	PVRL2 (1.8)	SH2B3 (1.6)	AP1M2 (1.5)	GMIP (1.4)	SORT1 (1.3)
ENSG00000136244	IL6 PPI subnetwork	0.38	> 0.20	BCL3 (5.4)	RELB (4.6)	TRIB1 (3.3)	HLX (2.5)	PVR (1.9)	GMIP (1.9)	CETP (1.7)	TIMD4 (1.7)	PARP10 (1.7)	GRINA (1.7)
ENSG00000112531	QKI PPI subnetwork	0.38	> 0.20	HAVCR1 (3.3)	ACAD10 (2.3)	DNM2 (2.2)	KANK2 (1.9)	CLPTM1 (1.6)	CARM1 (1.6)	HNF1A (1.6)	AMIGO1 (1.4)	C11orf9 (1.4)	ATXN2 (1.4)
ENSG00000118972	FGF23 PPI subnetwork	0.38	> 0.20	HAVCR1 (4.7)	PLEKHH2 (3.9)	HAPLN4 (3.5)	C11orf9 (2.5)	ZHX3 (2.3)	NCAN (2.0)	C17orf57 (1.9)	CBLC (1.9)	CEACAM19 (1.8)	ENSG00000235545 (1.7)
GO:0030917	midbrain-hindbrain boundary development	0.38	> 0.20	ANKRD31 (4.5)	DNAH11 (3.0)	C12orf47 (2.4)	AMIGO1 (2.1)	ENSG00000238078 (1.9)	CARM1 (1.7)	TSSK6 (1.7)	PMFBP1 (1.6)	ENSG00000254235 (1.5)	PBX4 (1.5)
GO:2000145	regulation of cell motility	0.39	> 0.20	PVR (3.1)	PVRL2 (3.0)	HLX (2.4)	ENSG00000254235 (2.4)	KANK2 (2.2)	MAFB (2.1)	CETP (1.9)	APOE (1.8)	SLC44A2 (1.7)	PTPN11 (1.6)
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	0.39	> 0.20	TXNL4B (3.5)	CARM1 (2.5)	SH2B3 (2.3)	GATAD2A (2.0)	CLPTM1 (2.0)	MAU2 (1.9)	YIPF2 (1.9)	LPAR2 (1.8)	PBX4 (1.7)	DHX38 (1.7)
REACTOME_A_THIRD_PROTEOLYTIC_CLEAVAGE_RELEASES_NICD	REACTOME_A_THIRD_PROTEOLYTIC_CLEAVAGE_RELEASES_NICD	0.39	> 0.20	CLPTM1 (3.7)	NYNRIN (3.1)	ENSG00000254235 (2.6)	MAU2 (2.4)	TMEM50A (2.3)	SLC44A2 (2.2)	SORT1 (2.0)	CYB561D1 (2.0)	CELSR2 (1.9)	GATAD2A (1.9)
ENSG00000172201	ID4 PPI subnetwork	0.39	> 0.20	NCAN (4.1)	ZHX3 (2.5)	MAFB (2.3)	ENSG00000226645 (2.0)	ALDH2 (1.9)	HAPLN4 (1.9)	MYLIP (1.7)	ABO (1.7)	GEMIN7 (1.6)	TOP1 (1.3)
ENSG00000173599	PC PPI subnetwork	0.39	> 0.20	C19orf52 (3.1)	ENSG00000235545 (2.8)	OASL (2.8)	QTRT1 (2.6)	DOCK7 (2.6)	NT5DC1 (2.6)	YIPF2 (2.3)	OGDH (2.3)	SUGP1 (2.2)	AP1M2 (1.8)
ENSG00000164818	HEATR2 PPI subnetwork	0.39	> 0.20	SUGP1 (2.7)	TRAPPC6A (2.3)	BCAM (1.7)	HAPLN4 (1.7)	GRINA (1.6)	CBLC (1.6)	GEMIN7 (1.5)	GMPR (1.5)	KANK2 (1.5)	PSRC1 (1.4)
ENSG00000130193	C8orf55 PPI subnetwork	0.39	> 0.20	BCAM (3.4)	ENSG00000235545 (2.0)	PLEKHH2 (1.6)	MAFB (1.6)	PBX4 (1.5)	C11orf9 (1.5)	SLC22A1 (1.5)	LPAR2 (1.5)	POC5 (1.5)	C1orf63 (1.3)
MP:0004787	abnormal dorsal aorta morphology	0.39	> 0.20	HLX (4.3)	SH2B3 (3.2)	PVR (2.3)	SLC44A2 (2.1)	KANK2 (2.0)	PVRL2 (1.8)	MAFB (1.8)	PLCG1 (1.6)	BCAM (1.6)	CETP (1.5)
ENSG00000167880	EVPL PPI subnetwork	0.39	> 0.20	NKPD1 (3.4)	PMFBP1 (2.7)	CEACAM19 (2.7)	DNAH11 (2.0)	CELSR2 (1.7)	MAFB (1.7)	CBLC (1.6)	C17orf57 (1.4)	ENSG00000226648 (1.4)	GMPR (1.2)
ENSG00000130024	PHF10 PPI subnetwork	0.39	> 0.20	CARM1 (3.2)	GOT2P1 (2.6)	MARK4 (2.6)	SMARCA4 (2.3)	ATXN2 (2.2)	NYNRIN (2.1)	MAU2 (1.9)	ADAM1 (1.8)	GRINA (1.7)	SORT1 (1.7)
ENSG00000171747	LGALS4 PPI subnetwork	0.39	> 0.20	KIAA1324 (3.9)	AP1M2 (2.6)	C11orf9 (2.5)	HNF1A (2.4)	NPC1L1 (2.3)	ST3GAL4 (2.0)	DNAH11 (2.0)	PCSK9 (1.7)	PLEC (1.7)	TMEM50A (1.6)
GO:0048332	mesoderm morphogenesis	0.39	> 0.20	ENSG00000238078 (3.0)	ENSG00000254235 (2.6)	ENSG00000226648 (2.5)	NYNRIN (2.4)	ABO (1.6)	ANKRD31 (1.6)	GOT2P1 (1.5)	ATXN7L2 (1.5)	CARM1 (1.5)	CILP2 (1.3)
ENSG00000164362	TERT PPI subnetwork	0.39	> 0.20	ANKRD31 (2.8)	SMARCA4 (2.7)	TOMM40 (2.5)	PTPN11 (2.4)	ZNF259 (2.0)	DHODH (1.8)	USP24 (1.7)	NPC1L1 (1.5)	DOCK7 (1.5)	LPIN3 (1.5)
MP:0005010	abnormal CD8-positive T cell morphology	0.39	> 0.20	PLCG1 (4.0)	ZNF101 (2.6)	MYLIP (1.8)	PBX4 (1.4)	GMIP (1.4)	TMEM50A (1.4)	KIAA1324 (1.3)	RELB (1.3)	LPA (1.2)	HAVCR1 (1.2)
GO:0003887	DNA-directed DNA polymerase activity	0.39	> 0.20	FEN1 (3.9)	USP1 (3.2)	PARP10 (2.6)	DNAH11 (2.6)	DDX56 (2.0)	ILF3 (1.7)	NT5DC1 (1.5)	PSRC1 (1.5)	USP24 (1.4)	ZNF180 (1.4)
ENSG00000169976	SF3B5 PPI subnetwork	0.39	> 0.20	ILF3 (4.2)	C1orf63 (3.4)	TOP1 (3.1)	DHX38 (2.9)	USP1 (2.7)	SMARCA4 (2.7)	BUD13 (2.4)	SUGP1 (2.3)	QTRT1 (2.1)	FEN1 (2.0)
ENSG00000206385	ENSG00000206385 PPI subnetwork	0.39	> 0.20	POLK (3.0)	FEN1 (2.9)	NYNRIN (2.3)	UBXN2B (2.2)	BUD13 (2.0)	BLOC1S3 (1.9)	DHODH (1.8)	USP1 (1.6)	DHX38 (1.6)	SMARCA4 (1.5)
ENSG00000137337	MDC1 PPI subnetwork	0.39	> 0.20	POLK (3.0)	FEN1 (2.9)	NYNRIN (2.3)	UBXN2B (2.2)	BUD13 (2.0)	BLOC1S3 (1.9)	DHODH (1.8)	USP1 (1.6)	DHX38 (1.6)	SMARCA4 (1.5)
GO:2000147	positive regulation of cell motility	0.39	> 0.20	PVR (3.5)	PVRL2 (2.6)	MAFB (2.4)	AP1M2 (2.2)	CETP (1.8)	APOE (1.7)	PTPN11 (1.7)	ENSG00000254235 (1.7)	HLX (1.7)	ENSG00000228044 (1.6)
GO:0032039	integrator complex	0.39	> 0.20	POC5 (2.9)	GEMIN7 (2.7)	UBXN2B (2.5)	DHX38 (2.5)	ATP13A1 (2.0)	MAU2 (1.9)	NT5DC1 (1.8)	NKPD1 (1.8)	TOP1 (1.7)	BUD13 (1.6)
GO:0009897	external side of plasma membrane	0.39	> 0.20	CETP (3.5)	TIMD4 (3.5)	APOE (2.7)	PLCG1 (2.3)	RELB (2.2)	APOC1 (1.9)	BCL3 (1.8)	SLC44A2 (1.4)	PBX4 (1.4)	MAFB (1.3)
GO:0006091	generation of precursor metabolites and energy	0.39	> 0.20	OGDH (4.3)	GOT2P1 (3.6)	ACAD10 (3.3)	ENSG00000238078 (2.6)	SYPL2 (2.1)	GMPR (1.9)	HAPLN4 (1.8)	GPAM (1.8)	TRAPPC6A (1.8)	C12orf47 (1.7)
ENSG00000078399	HOXA9 PPI subnetwork	0.39	> 0.20	NYNRIN (2.5)	KANK2 (2.5)	ATXN7L2 (2.3)	MAPKAPK5 (2.3)	ENSG00000228044 (1.9)	ZNF101 (1.7)	TRAFD1 (1.5)	BCL3 (1.5)	MAU2 (1.5)	TXNL4B (1.4)
ENSG00000211455	STK38L PPI subnetwork	0.39	> 0.20	TOP1 (2.4)	GATAD2A (2.3)	ZNF101 (2.3)	ATP13A1 (1.9)	MARK4 (1.7)	CILP2 (1.7)	MYLIP (1.6)	ABO (1.6)	BRAP (1.5)	PTPN11 (1.5)
ENSG00000105397	TYK2 PPI subnetwork	0.39	> 0.20	BCL3 (4.0)	GMIP (2.9)	PARP10 (2.5)	RELB (2.4)	HLX (2.3)	SLC44A2 (2.0)	DNM2 (1.9)	CYB561D1 (1.8)	PBX4 (1.6)	TRAFD1 (1.6)
ENSG00000070366	SMG6 PPI subnetwork	0.39	> 0.20	MAU2 (3.0)	SUGP1 (2.6)	BRAP (2.5)	HNF1A (2.2)	GATAD2A (2.1)	C1orf63 (2.1)	ENSG00000238078 (2.0)	ATXN2 (2.0)	SMARCA4 (1.9)	LPIN3 (1.9)
GO:0071346	cellular response to interferon-gamma	0.39	> 0.20	TRAFD1 (5.3)	PARP10 (4.6)	OASL (3.5)	ADAM1 (2.7)	CEACAM19 (2.0)	CYB561D1 (1.8)	BCL3 (1.7)	NAA25 (1.7)	FRK (1.7)	C19orf52 (1.6)
GO:0071715	icosanoid transport	0.39	> 0.20	NKPD1 (3.0)	DNAH11 (2.7)	CYB561D1 (2.6)	ST3GAL4 (2.2)	ADAM1 (1.9)	PMFBP1 (1.8)	ZNF180 (1.7)	LPIN3 (1.7)	YIPF2 (1.5)	ENSG00000228044 (1.5)
GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	0.39	> 0.20	TRAPPC6A (2.5)	GEMIN7 (2.4)	POLK (2.3)	TRAFD1 (2.3)	ENSG00000226648 (2.0)	BLOC1S3 (2.0)	GOT2P1 (2.0)	CYB561D1 (1.8)	BRAP (1.7)	ST3GAL4 (1.6)
GO:0000413	protein peptidyl-prolyl isomerization	0.39	> 0.20	YIPF2 (4.2)	QTRT1 (2.3)	ERP29 (2.3)	TOMM40 (2.2)	TRAPPC6A (2.0)	CEACAM19 (1.9)	TXNL4B (1.7)	DHODH (1.6)	OGDH (1.6)	CLPTM1 (1.5)
ENSG00000102362	SYTL4 PPI subnetwork	0.39	> 0.20	ITGB3 (3.4)	KIAA1324 (2.9)	ST3GAL4 (2.8)	PBX4 (2.6)	GATAD2A (2.3)	GMPR (2.3)	TMEM57 (2.3)	CELSR2 (1.9)	CYB561D1 (1.9)	YIPF2 (1.7)
ENSG00000100813	ACIN1 PPI subnetwork	0.39	> 0.20	C1orf63 (3.0)	TOP1 (2.9)	ZNF180 (2.5)	POC5 (2.3)	BLOC1S3 (2.2)	BUD13 (2.1)	CARM1 (2.0)	TXNL4B (1.7)	GEMIN7 (1.3)	DDX56 (1.3)
ENSG00000188986	COBRA1 PPI subnetwork	0.39	> 0.20	SUGP1 (2.6)	BUD13 (2.5)	MAPKAPK5 (2.4)	TOP1 (2.1)	ENSG00000226645 (1.9)	DHX38 (1.9)	ZNF259 (1.7)	C12orf47 (1.6)	GATAD2A (1.6)	COL4A3BP (1.6)
ENSG00000077721	UBE2A PPI subnetwork	0.39	> 0.20	ENSG00000235545 (1.8)	TMEM57 (1.6)	ENSG00000226645 (1.6)	PBX4 (1.5)	POC5 (1.4)	PSRC1 (1.4)	TOP1 (1.4)	PSMA5 (1.4)	FEN1 (1.4)	USP1 (1.2)
ENSG00000131941	RHPN2 PPI subnetwork	0.39	> 0.20	CBLC (6.6)	AP1M2 (4.5)	LPAR2 (2.3)	PVRL2 (1.9)	HNF1A (1.8)	PCSK9 (1.7)	FRK (1.5)	GEMIN7 (1.4)	PLEC (1.4)	ALDH2 (1.3)
ENSG00000136715	SAP130 PPI subnetwork	0.39	> 0.20	OASL (7.2)	PARP10 (3.0)	ATXN7L2 (2.8)	QTRT1 (2.0)	GEMIN7 (2.0)	MAU2 (2.0)	ENSG00000226648 (1.9)	BUD13 (1.9)	ILF3 (1.8)	ATXN2 (1.8)
GO:0051169	nuclear transport	0.39	> 0.20	GATAD2A (3.6)	PTPN11 (2.6)	ENSG00000254235 (2.5)	C12orf43 (2.2)	NAA25 (2.2)	ILF3 (1.8)	TRAFD1 (1.8)	MAPKAPK5 (1.7)	ADAM1 (1.7)	ATXN2 (1.6)
ENSG00000105447	GRWD1 PPI subnetwork	0.39	> 0.20	QTRT1 (2.0)	CEACAM19 (2.0)	BUD13 (1.8)	NKPD1 (1.8)	BCL3 (1.7)	DOCK7 (1.7)	ILF3 (1.6)	GATAD2A (1.5)	KANK2 (1.4)	MYLIP (1.4)
ENSG00000001497	LAS1L PPI subnetwork	0.39	> 0.20	C19orf52 (3.0)	C12orf43 (2.7)	ZNF259 (2.5)	DDX56 (2.5)	GATAD2A (2.5)	BUD13 (2.1)	GOT2P1 (1.9)	ILF3 (1.8)	ANKRD31 (1.8)	ATXN7L2 (1.6)
GO:0043500	muscle adaptation	0.39	> 0.20	LPIN3 (3.1)	ENSG00000254235 (2.7)	SYPL2 (2.3)	CEACAM19 (2.2)	TXNL4B (1.9)	ENSG00000235545 (1.8)	CYB561D1 (1.6)	MAFB (1.5)	C17orf57 (1.5)	ATXN7L2 (1.5)
ENSG00000132016	C19orf57 PPI subnetwork	0.39	> 0.20	MAU2 (3.0)	DDX56 (2.9)	SARS (2.3)	TMEM57 (2.3)	PBX4 (2.0)	AP1M2 (2.0)	GMPR (1.9)	TMED4 (1.8)	GEMIN7 (1.8)	QTRT1 (1.6)
MP:0005222	abnormal somite size	0.39	> 0.20	PLCG1 (2.7)	ABO (2.3)	NCAN (2.2)	ATXN2 (2.2)	GATAD2A (2.2)	SLC44A2 (2.1)	ATXN7L2 (2.0)	TOP1 (2.0)	C17orf57 (1.9)	C11orf9 (1.7)
ENSG00000168040	FADD PPI subnetwork	0.39	> 0.20	RELB (4.9)	PARP10 (3.5)	BCL3 (3.1)	PVR (2.3)	OASL (2.3)	SH2B3 (1.9)	HAVCR1 (1.9)	ADAM1 (1.9)	ZNF180 (1.9)	TRAFD1 (1.8)
GO:0008195	phosphatidate phosphatase activity	0.39	> 0.20	TMEM57 (3.5)	ZHX3 (3.4)	FADS2 (2.8)	C12orf47 (2.3)	FADS1 (2.2)	HMGCR (2.0)	NCAN (2.0)	LPAR2 (1.9)	LDLR (1.9)	FRK (1.6)
GO:0043496	regulation of protein homodimerization activity	0.39	> 0.20	POLK (3.3)	GEMIN7 (3.2)	DNAH11 (2.7)	PPP1R37 (2.7)	ENSG00000226648 (2.6)	ABO (2.3)	PMFBP1 (2.2)	COL4A3BP (2.1)	QTRT1 (2.1)	ST3GAL4 (2.0)
ENSG00000206476	ENSG00000206476 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000215476	ENSG00000215476 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000213780	GTF2H4 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000029363	BCLAF1 PPI subnetwork	0.39	> 0.20	C1orf63 (4.3)	SMARCA4 (2.9)	PLEC (2.8)	TOP1 (2.7)	GATAD2A (2.6)	KANK2 (2.5)	OGDH (2.4)	FRK (2.0)	ADAM1 (1.9)	GCNT4 (1.9)
ENSG00000075391	RASAL2 PPI subnetwork	0.39	> 0.20	RELB (5.7)	ZNF259 (3.2)	C12orf43 (2.8)	GEMIN7 (2.4)	BCL3 (2.3)	MAPKAPK5 (2.1)	DDX56 (1.9)	TOMM40 (1.9)	BLOC1S3 (1.8)	CLPTM1 (1.8)
GO:0007369	gastrulation	0.39	> 0.20	ENSG00000238078 (2.8)	NYNRIN (2.8)	ABO (2.8)	LPAR2 (1.8)	ENSG00000254235 (1.7)	ATXN7L2 (1.7)	TRIB1 (1.6)	C19orf52 (1.5)	PVRL2 (1.2)	CILP2 (1.2)
ENSG00000185989	RASA3 PPI subnetwork	0.39	> 0.20	ENSG00000226648 (4.3)	ZHX3 (4.2)	HLX (3.1)	TRIB1 (2.6)	SH2B3 (2.4)	TOP1 (2.3)	DOCK7 (2.1)	MAFB (2.0)	DHX38 (1.8)	SORT1 (1.7)
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	0.39	> 0.20	GMIP (2.2)	RELB (2.2)	SH2B3 (2.2)	CYP7A1 (2.0)	ENSG00000228044 (1.9)	COL4A3BP (1.6)	GOT2P1 (1.6)	GATAD2A (1.6)	NCAN (1.5)	MYLIP (1.4)
GO:0070403	NAD+ binding	0.39	> 0.20	ACAD10 (2.3)	C1orf63 (2.2)	TRAPPC6A (2.0)	SLC22A1 (1.9)	BLOC1S3 (1.8)	UBXN2B (1.8)	LPA (1.7)	TXNL4B (1.6)	C12orf51 (1.6)	DNM2 (1.6)
MP:0010763	abnormal hematopoietic stem cell physiology	0.39	> 0.20	UBXN2B (2.6)	CEACAM19 (2.2)	NYNRIN (1.9)	SLC44A2 (1.9)	KANK2 (1.7)	HLX (1.6)	PSRC1 (1.4)	GOT2P1 (1.4)	GEMIN7 (1.3)	DOCK7 (1.3)
GO:0032309	icosanoid secretion	0.39	> 0.20	NKPD1 (3.1)	CYB561D1 (2.4)	DNAH11 (2.4)	ADAM1 (2.3)	ST3GAL4 (2.0)	PMFBP1 (1.8)	LPIN3 (1.7)	ZNF180 (1.6)	ENSG00000235545 (1.5)	YIPF2 (1.5)
GO:0032963	collagen metabolic process	0.39	> 0.20	CEACAM19 (3.3)	FRK (3.1)	PLEKHH2 (2.2)	C11orf9 (1.7)	ENSG00000226645 (1.7)	CILP2 (1.7)	ENSG00000228044 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.4)	HP (1.3)
GO:0030334	regulation of cell migration	0.39	> 0.20	PVR (3.2)	PVRL2 (3.1)	HLX (2.3)	ENSG00000254235 (2.3)	MAFB (2.0)	KANK2 (2.0)	CETP (2.0)	APOE (1.9)	SLC44A2 (1.7)	PLEKHH2 (1.5)
ENSG00000214655	KIAA0913 PPI subnetwork	0.39	> 0.20	CILP2 (3.6)	ABO (3.4)	PPP1R37 (2.7)	ENSG00000254235 (2.4)	SORT1 (2.3)	CARM1 (2.0)	PSRC1 (2.0)	ENSG00000235545 (2.0)	LPIN3 (2.0)	GCNT4 (1.9)
GO:0006270	DNA-dependent DNA replication initiation	0.39	> 0.20	ZNF180 (3.0)	AMIGO1 (2.5)	USP1 (2.5)	FEN1 (2.5)	ENSG00000235545 (1.9)	TMEM116 (1.9)	ENSG00000228044 (1.7)	ERP29 (1.6)	NT5DC1 (1.6)	GOT2P1 (1.5)
GO:0002260	lymphocyte homeostasis	0.39	> 0.20	GEMIN7 (2.1)	SH2B3 (2.0)	TRAPPC6A (2.0)	CYB561D1 (1.8)	GCNT4 (1.8)	POLK (1.8)	PBX4 (1.7)	GMIP (1.7)	FRK (1.4)	ENSG00000226645 (1.3)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	0.39	> 0.20	GEMIN7 (3.2)	ZNF259 (3.1)	QTRT1 (2.4)	ZHX3 (2.3)	CARM1 (2.1)	GMPR (2.0)	C12orf43 (1.9)	ENSG00000226645 (1.9)	DDX56 (1.8)	ADAM1 (1.7)
ENSG00000198700	IPO9 PPI subnetwork	0.39	> 0.20	USP1 (2.5)	FEN1 (2.5)	ERP29 (2.4)	DDX56 (2.3)	PSMA5 (2.1)	ATP13A1 (1.9)	GMPR (1.8)	SMARCA4 (1.7)	BUD13 (1.7)	PSRC1 (1.7)
ENSG00000108813	DLX4 PPI subnetwork	0.39	> 0.20	ZHX3 (2.6)	GATAD2A (2.4)	TMED4 (2.3)	TOP1 (1.8)	ERP29 (1.8)	SH2B3 (1.6)	TMEM57 (1.6)	PMFBP1 (1.5)	MAFB (1.4)	DNM2 (1.4)
ENSG00000163828	ENSG00000163828 PPI subnetwork	0.39	> 0.20	PMFBP1 (2.0)	CEACAM19 (1.9)	LPA (1.5)	BUD13 (1.4)	APOA5 (1.3)	ZNF180 (1.3)	MOSC1 (1.2)	ALDH2 (1.1)	APOC4 (1.0)	YIPF2 (1.0)
REACTOME_CELL_CYCLE_CHECKPOINTS	REACTOME_CELL_CYCLE_CHECKPOINTS	0.39	> 0.20	FEN1 (5.1)	PSMA5 (4.2)	USP1 (2.9)	PSRC1 (2.2)	TRAFD1 (2.1)	POC5 (2.1)	NAA25 (1.7)	LPIN3 (1.7)	DDX56 (1.6)	NT5DC1 (1.5)
MP:0005566	decreased blood urea nitrogen level	0.39	> 0.20	C19orf52 (2.9)	CYB561D1 (2.2)	BCL3 (1.9)	PBX4 (1.9)	KANK2 (1.5)	BRAP (1.5)	PTPN11 (1.4)	ZHX3 (1.4)	PLEKHH2 (1.4)	DNAH11 (1.3)
ENSG00000112118	MCM3 PPI subnetwork	0.39	> 0.20	FEN1 (6.3)	USP1 (4.0)	PSRC1 (2.0)	SUGP1 (1.7)	ENSG00000228044 (1.7)	NT5DC1 (1.5)	ENSG00000235545 (1.4)	ZNF180 (1.3)	TMEM50A (1.2)	POC5 (1.1)
ENSG00000070770	CSNK2A2 PPI subnetwork	0.39	> 0.20	ILF3 (3.5)	SMARCA4 (3.4)	CARM1 (3.3)	TOP1 (3.3)	GATAD2A (3.3)	TOMM40 (2.7)	PTPN11 (2.6)	ZNF259 (2.5)	C12orf43 (2.4)	DHX38 (2.3)
ENSG00000133961	NUMB PPI subnetwork	0.39	> 0.20	GATAD2A (2.6)	MYLIP (2.4)	KANK2 (2.4)	HLX (2.3)	USP24 (1.9)	MAFB (1.9)	PLEC (1.8)	TSSK6 (1.7)	LPIN3 (1.6)	CILP2 (1.6)
KEGG_HEMATOPOIETIC_CELL_LINEAGE	KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.39	> 0.20	ITGB3 (3.2)	TIMD4 (3.1)	CETP (2.8)	RHD (2.6)	ZNF101 (2.2)	GMIP (2.0)	BCL3 (2.0)	RHCE (2.0)	PLCG1 (2.0)	MAFB (1.8)
ENSG00000130669	PAK4 PPI subnetwork	0.39	> 0.20	DNM2 (3.8)	GATAD2A (3.4)	LPAR2 (2.6)	CBLC (2.5)	GMIP (2.2)	CLPTM1 (2.1)	ILF3 (1.8)	SH2B3 (1.6)	TOP1 (1.6)	UBXN2B (1.6)
GO:0051082	unfolded protein binding	0.39	> 0.20	TMED4 (3.2)	TMEM57 (2.9)	ERP29 (2.6)	CYP7A1 (1.8)	DHODH (1.8)	OGDH (1.6)	TXNL4B (1.6)	NAA25 (1.6)	SARS (1.5)	PSMA5 (1.5)
ENSG00000100401	RANGAP1 PPI subnetwork	0.39	> 0.20	PSRC1 (5.1)	FEN1 (4.4)	USP1 (4.0)	POC5 (2.9)	ZNF180 (1.8)	ILF3 (1.8)	ENSG00000226648 (1.2)	ZHX3 (1.1)	DHX38 (1.0)	PTPN11 (0.9)
GO:0002673	regulation of acute inflammatory response	0.39	> 0.20	ENSG00000228044 (3.4)	ENSG00000235545 (3.3)	LPA (1.7)	TIMD4 (1.5)	CETP (1.5)	MOSC1 (1.5)	ST3GAL4 (1.3)	POC5 (1.3)	C12orf47 (1.3)	DNAH11 (1.2)
ENSG00000137992	DBT PPI subnetwork	0.39	> 0.20	FRK (2.9)	PARP10 (2.4)	ZNF180 (2.2)	PTPN11 (2.2)	ABO (1.8)	UBXN2B (1.7)	TOMM40 (1.7)	ENSG00000254235 (1.7)	TRAPPC6A (1.4)	DOCK7 (1.4)
ENSG00000198324	FAM109A PPI subnetwork	0.39	> 0.20	BRAP (2.5)	ZNF101 (2.4)	ENSG00000254235 (2.3)	TIMD4 (2.1)	CETP (1.9)	PLCG1 (1.8)	MAFB (1.8)	TOP1 (1.7)	APOE (1.7)	TMED4 (1.7)
ENSG00000179151	EDC3 PPI subnetwork	0.39	> 0.20	CBLC (5.4)	AP1M2 (3.5)	LPAR2 (2.7)	CYB561D1 (2.2)	CELSR2 (2.1)	CARM1 (2.1)	PVRL2 (1.9)	PLEC (1.9)	TSSK6 (1.7)	DNM2 (1.5)
ENSG00000162419	GMEB1 PPI subnetwork	0.39	> 0.20	MAU2 (2.9)	UBXN2B (2.0)	TRIB1 (1.8)	SYPL2 (1.7)	SH2B3 (1.6)	KANK2 (1.6)	DOCK7 (1.5)	HNF1A (1.4)	ENSG00000226648 (1.4)	TOP1 (1.4)
ENSG00000111642	CHD4 PPI subnetwork	0.39	> 0.20	CARM1 (4.2)	ATXN2 (4.0)	SMARCA4 (3.4)	DNM2 (2.9)	ATP13A1 (2.6)	ATXN7L2 (2.6)	PPP1R37 (2.6)	TOP1 (2.4)	ILF3 (2.4)	MARK4 (2.3)
ENSG00000104312	RIPK2 PPI subnetwork	0.39	> 0.20	C1orf63 (2.7)	PARP10 (2.3)	RELB (2.2)	HAVCR1 (2.0)	FRK (1.9)	GRINA (1.9)	ENSG00000238078 (1.7)	PBX4 (1.6)	NT5DC1 (1.4)	ZNF101 (1.4)
ENSG00000110944	IL23A PPI subnetwork	0.39	> 0.20	BCL3 (3.5)	RELB (3.0)	HLX (3.0)	TIMD4 (2.3)	CETP (2.1)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	SH2B3 (1.4)	PBX4 (1.3)
ENSG00000056972	TRAF3IP2 PPI subnetwork	0.39	> 0.20	RELB (5.9)	BCL3 (2.8)	CYB561D1 (2.7)	NT5DC1 (2.3)	PBX4 (2.2)	TRAFD1 (2.1)	LPAR2 (2.0)	BLOC1S3 (2.0)	SH2B3 (1.8)	UBXN2B (1.7)
GO:0005865	striated muscle thin filament	0.39	> 0.20	SYPL2 (5.6)	GMPR (1.9)	PVRL2 (1.8)	ITGB3 (1.2)	LPAR2 (1.2)	C12orf47 (1.1)	RPH3A (1.0)	TMEM50A (1.0)	UBXN2B (1.0)	HMGCR (0.9)
MP:0001689	incomplete somite formation	0.39	> 0.20	KANK2 (3.0)	SH2B3 (2.8)	DOCK7 (2.1)	USP24 (2.0)	C12orf51 (1.7)	ATXN2 (1.6)	NYNRIN (1.6)	TOP1 (1.5)	HNF1A (1.5)	MAFB (1.5)
ENSG00000131795	RBM8A PPI subnetwork	0.39	> 0.20	ILF3 (3.8)	C1orf63 (3.4)	TOP1 (3.0)	DHX38 (2.9)	USP1 (2.8)	SMARCA4 (2.6)	BUD13 (2.4)	FEN1 (2.3)	SUGP1 (2.2)	PTPN11 (2.1)
MP:0002160	abnormal reproductive system morphology	0.39	> 0.20	TMEM116 (2.9)	PVRL2 (2.0)	ANKRD31 (2.0)	ZHX3 (1.9)	FRK (1.8)	ENSG00000254235 (1.8)	ST3GAL4 (1.8)	TOMM40 (1.7)	KANK2 (1.5)	GOT2P1 (1.5)
MP:0001726	abnormal allantois morphology	0.39	> 0.20	CETP (3.4)	ATXN2 (2.4)	KANK2 (2.3)	GATAD2A (2.0)	MARK4 (2.0)	ADAM1 (1.9)	PPP1R37 (1.9)	TIMD4 (1.6)	ABO (1.6)	SH2B3 (1.4)
MP:0005463	abnormal CD4-positive T cell physiology	0.39	> 0.20	RELB (2.8)	GMIP (2.2)	SH2B3 (2.1)	PBX4 (2.0)	TIMD4 (1.9)	BCL3 (1.7)	SLC22A1 (1.7)	ENSG00000235545 (1.6)	SLC44A2 (1.4)	ZNF101 (1.3)
ENSG00000117560	FASLG PPI subnetwork	0.39	> 0.20	FRK (2.7)	OGDH (2.7)	GATAD2A (2.6)	PLCG1 (2.5)	ITGB3 (2.5)	DNM2 (2.4)	LPAR2 (1.9)	TMEM50A (1.9)	ZNF101 (1.9)	PBX4 (1.8)
MP:0001299	abnormal eye distance/ position	0.39	> 0.20	ZNF101 (2.4)	GMPR (2.3)	DOCK7 (1.7)	KANK2 (1.6)	GEMIN7 (1.5)	TMED4 (1.5)	NAA25 (1.4)	ENSG00000254235 (1.2)	USP24 (1.2)	ACAD10 (1.2)
GO:0001933	negative regulation of protein phosphorylation	0.39	> 0.20	DNAH11 (3.3)	ENSG00000238078 (3.1)	ACAD10 (2.7)	GCNT4 (2.5)	PPP1R37 (2.3)	ABO (2.2)	TRIB1 (2.1)	ADAM1 (1.7)	YIPF2 (1.7)	MYLIP (1.6)
ENSG00000164944	KIAA1429 PPI subnetwork	0.39	> 0.20	FRK (3.2)	C19orf52 (2.8)	ATXN7L2 (2.6)	SMARCA4 (2.5)	BLOC1S3 (2.4)	BUD13 (2.3)	GEMIN7 (2.3)	ZNF101 (2.2)	ST3GAL4 (2.1)	LPAR2 (2.1)
ENSG00000126698	DNAJC8 PPI subnetwork	0.39	> 0.20	ILF3 (4.1)	C1orf63 (3.6)	TOP1 (3.1)	DHX38 (2.8)	USP1 (2.7)	BUD13 (2.6)	SMARCA4 (2.6)	SUGP1 (2.2)	FEN1 (2.1)	QTRT1 (2.0)
MP:0002396	abnormal hematopoietic system morphology/development	0.40	> 0.20	ST3GAL4 (2.8)	HLX (2.7)	TIMD4 (2.3)	ATXN7L2 (2.3)	CETP (2.0)	ENSG00000235545 (2.0)	TOMM40 (1.9)	KANK2 (1.9)	GMIP (1.6)	DNM2 (1.6)
MP:0001216	abnormal epidermal layer morphology	0.40	> 0.20	CBLC (4.9)	AP1M2 (3.7)	CELSR2 (3.5)	PLEC (2.8)	BCAM (2.6)	C17orf57 (1.9)	ABCG8 (1.7)	PMFBP1 (1.6)	NYNRIN (1.5)	MAFB (1.5)
GO:0003779	actin binding	0.40	> 0.20	SYPL2 (4.5)	PLEC (3.5)	KANK2 (2.5)	GMPR (2.1)	GMIP (2.0)	ITGB3 (1.9)	SH2B3 (1.8)	DNM2 (1.7)	C11orf9 (1.6)	AP1M2 (1.6)
ENSG00000160299	PCNT PPI subnetwork	0.40	> 0.20	ZNF180 (2.5)	POC5 (2.3)	ABCG5 (2.3)	USP1 (1.7)	PSRC1 (1.7)	RPH3A (1.7)	SMARCA4 (1.7)	TM6SF2 (1.5)	NPC1L1 (1.4)	FEN1 (1.4)
GO:0031589	cell-substrate adhesion	0.40	> 0.20	SLC44A2 (4.2)	ITGB3 (3.1)	KANK2 (2.5)	C17orf57 (2.4)	PLEKHH2 (2.4)	SORT1 (2.2)	GCNT4 (2.0)	CILP2 (1.9)	PLEC (1.9)	ZHX3 (1.8)
ENSG00000152270	PDE3B PPI subnetwork	0.40	> 0.20	ST3GAL4 (2.9)	MARK4 (2.5)	SH2B3 (2.4)	ENSG00000238078 (2.3)	ITGB3 (2.3)	GMPR (2.2)	GATAD2A (1.9)	ENSG00000226645 (1.8)	SLC44A2 (1.8)	GPAM (1.8)
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.40	> 0.20	RELB (5.8)	BCL3 (4.1)	OASL (2.7)	PARP10 (2.3)	PVR (2.1)	ENSG00000228044 (1.7)	MAFB (1.5)	TRAFD1 (1.4)	GRINA (1.4)	GMIP (1.3)
GO:0016874	ligase activity	0.40	> 0.20	SARS (4.2)	BRAP (3.1)	ATXN2 (3.1)	USP24 (2.5)	MAPKAPK5 (2.3)	NT5DC1 (2.2)	TRAFD1 (2.1)	NAA25 (1.9)	C12orf51 (1.9)	C19orf52 (1.8)
GO:0006664	glycolipid metabolic process	0.40	> 0.20	HAVCR1 (4.0)	COL4A3BP (2.3)	TMEM50A (2.2)	TRAPPC6A (2.2)	ERP29 (2.1)	CYB561D1 (2.1)	ABO (2.0)	HNF1A (1.9)	NKPD1 (1.8)	TMED4 (1.7)
ENSG00000171241	SHCBP1 PPI subnetwork	0.40	> 0.20	CBLC (6.1)	AP1M2 (4.5)	CELSR2 (2.3)	LPAR2 (2.0)	PVRL2 (1.9)	ST3GAL4 (1.8)	FRK (1.7)	PSRC1 (1.7)	LPIN3 (1.5)	PLEC (1.5)
GO:0031102	neuron projection regeneration	0.40	> 0.20	ENSG00000228044 (3.0)	ENSG00000238078 (3.0)	ENSG00000235545 (2.5)	GCNT4 (2.3)	LPIN3 (2.1)	HAPLN4 (2.0)	ANKRD31 (1.7)	MAFB (1.3)	FRK (1.3)	NCAN (1.3)
GO:0021675	nerve development	0.40	> 0.20	TSSK6 (3.0)	ENSG00000238078 (2.5)	HAVCR1 (2.4)	CELSR2 (1.7)	PMFBP1 (1.6)	ABO (1.6)	CEACAM19 (1.6)	NKPD1 (1.6)	ACAD10 (1.6)	HNF1A (1.4)
MP:0008406	increased cellular sensitivity to hydrogen peroxide	0.40	> 0.20	ALDH2 (2.7)	CELSR2 (2.2)	ACAD10 (1.8)	SARS (1.7)	PVRL2 (1.6)	NCAN (1.6)	RHCE (1.5)	HP (1.5)	RHD (1.5)	PSMA5 (1.3)
ENSG00000011304	PTBP1 PPI subnetwork	0.40	> 0.20	ILF3 (4.5)	C1orf63 (3.9)	TOP1 (3.3)	SMARCA4 (3.3)	PTPN11 (2.7)	USP1 (2.6)	DHX38 (2.6)	QTRT1 (2.6)	GATAD2A (2.3)	SUGP1 (2.2)
ENSG00000166595	FAM96B PPI subnetwork	0.40	> 0.20	TOMM40 (2.6)	PPP1R37 (2.5)	NKPD1 (2.4)	DDX56 (2.2)	POLK (2.2)	ATP13A1 (1.9)	CEACAM19 (1.8)	MOSC1 (1.8)	PSRC1 (1.7)	GCNT4 (1.7)
MP:0001684	abnormal axial mesoderm	0.40	> 0.20	GATAD2A (2.7)	ABO (2.3)	QTRT1 (2.1)	HNF1A (2.0)	ZHX3 (2.0)	COL4A3BP (1.8)	APOE (1.8)	C11orf9 (1.7)	DHX38 (1.6)	LPA (1.4)
GO:0031490	chromatin DNA binding	0.40	> 0.20	SH2B3 (3.8)	ABO (2.3)	BLOC1S3 (1.8)	QTRT1 (1.8)	PLCG1 (1.8)	TRIB1 (1.8)	PLEKHH2 (1.7)	PLEC (1.7)	BCL3 (1.6)	GATAD2A (1.5)
ENSG00000130175	PRKCSH PPI subnetwork	0.40	> 0.20	ST3GAL4 (2.5)	AP1M2 (2.0)	C1orf63 (1.9)	MYLIP (1.9)	ENSG00000226645 (1.8)	LPA (1.8)	UBXN2B (1.7)	KIAA1324 (1.6)	LPIN3 (1.6)	TMED4 (1.5)
REACTOME_PLC:GAMMA1_SIGNALLING	REACTOME_PLC:GAMMA1_SIGNALLING	0.40	> 0.20	ZHX3 (2.6)	SH2B3 (2.6)	SORT1 (2.6)	AMIGO1 (2.3)	ST3GAL4 (2.1)	ITGB3 (1.9)	GOT2P1 (1.8)	KANK2 (1.7)	ENSG00000238078 (1.7)	ZNF101 (1.7)
ENSG00000012660	ELOVL5 PPI subnetwork	0.40	> 0.20	HMGCR (7.2)	LDLR (6.7)	FADS1 (6.1)	FADS2 (5.1)	PCSK9 (4.2)	SORT1 (3.1)	ERP29 (2.7)	CELSR2 (2.6)	GMPR (2.1)	CYB561D1 (2.1)
ENSG00000215467	ENSG00000215467 PPI subnetwork	0.40	> 0.20	ZNF259 (3.4)	NAA25 (3.0)	DDX56 (2.5)	TOMM40 (2.2)	GATAD2A (2.1)	NKPD1 (2.0)	QTRT1 (2.0)	PLEKHH2 (1.8)	C12orf43 (1.8)	TOP1 (1.8)
MP:0001300	ocular hypertelorism	0.40	> 0.20	NYNRIN (2.4)	PLEKHH2 (2.3)	GPAM (2.3)	HAPLN4 (2.0)	ZHX3 (1.9)	ATXN2 (1.7)	TMEM116 (1.6)	APOB (1.4)	KANK2 (1.3)	GATAD2A (1.3)
ENSG00000149311	ATM PPI subnetwork	0.40	> 0.20	FEN1 (4.3)	USP1 (3.2)	UBXN2B (2.5)	POC5 (2.5)	SMARCA4 (2.3)	ZNF180 (2.0)	POLK (1.9)	ZNF259 (1.9)	ILF3 (1.4)	CLPTM1 (1.4)
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	0.40	> 0.20	PVRL2 (3.5)	BCAM (3.1)	SLC44A2 (2.9)	PLEC (2.7)	KANK2 (2.2)	PVR (2.0)	C11orf9 (1.9)	GEMIN7 (1.9)	PPP1R37 (1.9)	CBLC (1.8)
ENSG00000174953	DHX36 PPI subnetwork	0.40	> 0.20	QTRT1 (2.5)	DDX56 (2.5)	TXNL4B (2.1)	SUGP1 (2.1)	CARM1 (1.8)	ENSG00000226645 (1.8)	SLC22A1 (1.7)	TRAPPC6A (1.7)	C12orf43 (1.6)	C19orf52 (1.5)
MP:0000926	absent floor plate	0.40	> 0.20	DYNC2LI1 (8.5)	PLEKHH2 (4.6)	ACAD10 (1.8)	TMEM116 (1.8)	NT5DC1 (1.6)	HAVCR1 (1.5)	DOCK7 (1.5)	C11orf9 (1.4)	DHODH (1.4)	FRK (1.3)
MP:0004362	cochlear hair cell degeneration	0.40	> 0.20	GPAM (2.5)	PBX4 (2.4)	ZNF101 (2.3)	CYP7A1 (1.9)	CELSR2 (1.9)	SLC44A2 (1.8)	APOE (1.7)	LPAR2 (1.6)	LPA (1.5)	FRK (1.5)
GO:0045121	membrane raft	0.40	> 0.20	MAFB (2.5)	PLEC (2.5)	SH2B3 (2.4)	SLC44A2 (2.2)	TMEM50A (2.1)	COL4A3BP (2.0)	BCAM (1.7)	PVRL2 (1.6)	RELB (1.5)	GMPR (1.5)
ENSG00000104879	CKM PPI subnetwork	0.40	> 0.20	SYPL2 (3.4)	ACAD10 (2.9)	TMEM50A (2.4)	GMPR (2.3)	OGDH (1.9)	BCAM (1.7)	CILP2 (1.4)	C12orf47 (1.3)	TMED4 (1.3)	C1orf63 (1.3)
ENSG00000198951	NAGA PPI subnetwork	0.40	> 0.20	BRAP (2.8)	ST3GAL4 (2.4)	TRAFD1 (2.3)	SLC44A2 (1.9)	PBX4 (1.7)	DYNC2LI1 (1.7)	LPAR2 (1.6)	PMFBP1 (1.6)	ADAM1 (1.6)	ANKRD31 (1.5)
ENSG00000104960	PTOV1 PPI subnetwork	0.40	> 0.20	CBLC (6.1)	AP1M2 (4.1)	LPAR2 (2.9)	CELSR2 (1.9)	PVRL2 (1.7)	FRK (1.6)	LPIN3 (1.5)	PLEC (1.5)	KANK2 (1.5)	ST3GAL4 (1.5)
MP:0003564	abnormal insulin secretion	0.40	> 0.20	KIAA1324 (3.5)	MOSC1 (3.3)	HAPLN4 (2.8)	GPAM (2.4)	HNF1A (2.2)	NPC1L1 (2.2)	CYP7A1 (1.7)	PLEKHH2 (1.6)	COL4A3BP (1.5)	TM6SF2 (1.5)
MP:0005602	decreased angiogenesis	0.40	> 0.20	PVR (4.0)	SH2B3 (3.5)	BCAM (2.5)	HLX (2.2)	KANK2 (2.2)	BCL3 (2.2)	TOP1 (2.1)	PVRL2 (2.0)	ENSG00000254235 (1.8)	PLEC (1.6)
ENSG00000153944	MSI2 PPI subnetwork	0.40	> 0.20	PSRC1 (2.9)	GCNT4 (2.3)	TRAPPC6A (2.1)	FEN1 (1.8)	GEMIN7 (1.6)	APOE (1.5)	APOC1 (1.4)	SLC44A2 (1.4)	ENSG00000226645 (1.3)	CETP (1.3)
ENSG00000130427	EPO PPI subnetwork	0.40	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.7)	TIMD4 (2.5)	CETP (2.2)	GMIP (2.1)	ALDH2 (1.9)	LPA (1.7)	SH2B3 (1.3)	ANKRD31 (1.2)
MP:0003954	abnormal Reichert's membrane morphology	0.40	> 0.20	ATP13A1 (3.2)	ERP29 (3.1)	PVRL2 (3.1)	CELSR2 (2.5)	KIAA1324 (2.4)	ENSG00000254235 (2.3)	APOE (2.2)	PVR (2.1)	ITGB3 (2.0)	TMEM116 (2.0)
ENSG00000122884	P4HA1 PPI subnetwork	0.40	> 0.20	ATP13A1 (3.6)	OGDH (3.2)	YIPF2 (3.1)	ILF3 (3.1)	DNM2 (3.0)	QTRT1 (2.8)	DHX38 (2.3)	ACAD10 (2.2)	FEN1 (1.9)	NT5DC1 (1.7)
MP:0002929	abnormal bile duct development	0.40	> 0.20	DYNC2LI1 (5.4)	TRIB1 (2.6)	ENSG00000254235 (2.2)	MAFB (1.8)	ACAD10 (1.7)	C11orf9 (1.7)	CYP7A1 (1.5)	KIAA1324 (1.5)	BUD13 (1.4)	PVRL2 (1.4)
ENSG00000153201	RANBP2 PPI subnetwork	0.40	> 0.20	PSRC1 (5.7)	FEN1 (4.3)	USP1 (4.0)	POC5 (3.6)	ILF3 (1.3)	ENSG00000228044 (1.3)	ZNF180 (1.2)	ENSG00000226648 (1.0)	USP24 (1.0)	NAA25 (0.9)
MP:0002944	increased lactate dehydrogenase level	0.40	> 0.20	DYNC2LI1 (3.1)	PVRL2 (2.5)	TMED4 (1.9)	SLC44A2 (1.9)	NPC1L1 (1.8)	ZHX3 (1.7)	TMEM116 (1.6)	NCAN (1.6)	ENSG00000238078 (1.5)	PLEKHH2 (1.5)
ENSG00000139372	TDG PPI subnetwork	0.40	> 0.20	TRIB1 (3.7)	KIAA1324 (2.6)	BUD13 (2.5)	TMEM50A (2.1)	CELSR2 (2.1)	BCL3 (1.8)	UBXN2B (1.6)	TRAFD1 (1.6)	NYNRIN (1.6)	BCAM (1.5)
ENSG00000178252	WDR6 PPI subnetwork	0.40	> 0.20	CELSR2 (3.9)	PSRC1 (2.9)	TOP1 (2.8)	PLCG1 (2.5)	CARM1 (2.2)	FADS1 (2.2)	BCAM (2.1)	AP1M2 (1.9)	GRINA (1.9)	POLK (1.8)
ENSG00000165476	REEP3 PPI subnetwork	0.40	> 0.20	CBLC (5.9)	AP1M2 (4.3)	ST3GAL4 (2.5)	PPP1R37 (2.0)	CELSR2 (1.9)	LPAR2 (1.9)	LPIN3 (1.8)	PSRC1 (1.7)	PLEC (1.7)	DOCK7 (1.6)
ENSG00000168765	GSTM4 PPI subnetwork	0.40	> 0.20	PSRC1 (2.7)	GEMIN7 (2.4)	BCAM (2.4)	ATXN7L2 (2.2)	BLOC1S3 (2.0)	SLC44A2 (1.9)	ZHX3 (1.8)	AMIGO1 (1.8)	SORT1 (1.7)	C17orf57 (1.7)
GO:0005793	endoplasmic reticulum-Golgi intermediate compartment	0.40	> 0.20	YIPF2 (6.5)	ERP29 (4.7)	TMED4 (3.4)	TMEM50A (2.4)	CLPTM1 (2.3)	ATP13A1 (2.2)	PVRL2 (1.9)	KIAA1324 (1.9)	TSSK6 (1.1)	ADAM1 (1.1)
ENSG00000115685	PPP1R7 PPI subnetwork	0.40	> 0.20	TOP1 (2.4)	CARM1 (2.2)	KANK2 (2.1)	DHX38 (1.9)	BUD13 (1.8)	DYNC2LI1 (1.7)	DOCK7 (1.6)	TM6SF2 (1.6)	TMEM50A (1.5)	BRAP (1.4)
GO:0030335	positive regulation of cell migration	0.40	> 0.20	PVR (3.5)	PVRL2 (2.6)	MAFB (2.3)	AP1M2 (2.2)	CETP (1.9)	APOE (1.8)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HLX (1.6)	PTPN11 (1.6)
MP:0003026	decreased vasoconstriction	0.40	> 0.20	HLX (3.0)	SYPL2 (2.8)	KANK2 (2.5)	SLC22A1 (1.8)	QTRT1 (1.6)	LPA (1.5)	ITGB3 (1.3)	C17orf57 (1.2)	CETP (1.2)	PLEKHH2 (1.2)
MP:0004204	absent stapes	0.40	> 0.20	MYLIP (3.2)	CEACAM19 (2.3)	TMEM57 (2.2)	KIAA1324 (2.1)	DYNC2LI1 (2.0)	TMED4 (1.6)	PVRL2 (1.4)	PLCG1 (1.4)	RHCE (1.4)	ENSG00000238078 (1.3)
GO:0034199	activation of protein kinase A activity	0.40	> 0.20	ST3GAL4 (2.7)	ENSG00000228044 (2.6)	GOT2P1 (2.1)	ITGB3 (2.1)	PMFBP1 (2.1)	ENSG00000238078 (1.9)	SORT1 (1.7)	ADAM1 (1.5)	AMIGO1 (1.5)	SH2B3 (1.5)
GO:0009070	serine family amino acid biosynthetic process	0.40	> 0.20	SARS (4.5)	TMEM116 (2.7)	DNAH11 (2.3)	CYP7A1 (2.1)	ERP29 (2.1)	TXNL4B (2.0)	PMFBP1 (1.9)	TM6SF2 (1.9)	ABCG8 (1.8)	LPA (1.8)
GO:0042393	histone binding	0.40	> 0.20	USP1 (4.6)	ILF3 (3.0)	FEN1 (2.8)	SMARCA4 (2.6)	BUD13 (2.4)	C19orf52 (2.2)	GATAD2A (2.2)	TOP1 (1.8)	C1orf63 (1.8)	COL4A3BP (1.8)
GO:0006921	cellular component disassembly involved in apoptotic process	0.40	> 0.20	ENSG00000226645 (2.7)	ST3GAL4 (2.4)	ZNF101 (2.3)	C1orf63 (2.1)	POLK (2.0)	ENSG00000238078 (1.9)	AP1M2 (1.7)	CBLC (1.6)	UBXN2B (1.4)	TRAPPC6A (1.3)
GO:0050922	negative regulation of chemotaxis	0.40	> 0.20	ANKRD31 (3.2)	GCNT4 (3.2)	C17orf57 (2.4)	DNAH11 (2.2)	CEACAM19 (2.1)	TMEM57 (2.0)	PLEKHH2 (2.0)	ATXN7L2 (1.9)	PBX4 (1.8)	ENSG00000226648 (1.8)
REACTOME_MRNA_SPLICING	REACTOME_MRNA_SPLICING	0.40	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	TOP1 (2.9)	USP1 (2.7)	DHX38 (2.7)	SMARCA4 (2.7)	BUD13 (2.5)	SUGP1 (2.5)	FEN1 (2.2)	QTRT1 (2.1)
REACTOME_MRNA_SPLICING_:_MAJOR_PATHWAY	REACTOME_MRNA_SPLICING_:_MAJOR_PATHWAY	0.40	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	TOP1 (2.9)	USP1 (2.7)	DHX38 (2.7)	SMARCA4 (2.7)	BUD13 (2.5)	SUGP1 (2.5)	FEN1 (2.2)	QTRT1 (2.1)
GO:0030291	protein serine/threonine kinase inhibitor activity	0.40	> 0.20	KANK2 (2.3)	ENSG00000254235 (2.1)	TRAFD1 (1.9)	AP1M2 (1.9)	TMED4 (1.8)	GMPR (1.7)	MYLIP (1.6)	ITGB3 (1.5)	SORT1 (1.5)	SLC44A2 (1.4)
ENSG00000108953	YWHAE PPI subnetwork	0.40	> 0.20	SMARCA4 (3.6)	TRIB1 (2.8)	GATAD2A (2.5)	TOP1 (2.2)	PLEC (2.0)	DNM2 (2.0)	OGDH (2.0)	PLCG1 (1.8)	ENSG00000238078 (1.6)	SARS (1.6)
GO:0002711	positive regulation of T cell mediated immunity	0.40	> 0.20	ZNF180 (2.6)	PARP10 (1.9)	ENSG00000226645 (1.7)	PBX4 (1.6)	NKPD1 (1.6)	NAA25 (1.5)	MAU2 (1.4)	HNF1A (1.2)	LPIN3 (1.2)	GEMIN7 (1.1)
ENSG00000136518	ACTL6A PPI subnetwork	0.40	> 0.20	SMARCA4 (3.5)	BUD13 (3.4)	ILF3 (3.2)	ATXN7L2 (3.0)	BRAP (2.7)	CARM1 (2.6)	NYNRIN (2.6)	ATXN2 (2.3)	DHX38 (2.1)	MAU2 (2.0)
GO:0031400	negative regulation of protein modification process	0.40	> 0.20	PSMA5 (2.9)	TRAFD1 (2.6)	NAA25 (2.1)	TMEM57 (1.8)	TMEM50A (1.8)	NT5DC1 (1.7)	C12orf43 (1.7)	DNAH11 (1.5)	PARP10 (1.5)	DDX56 (1.5)
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	0.40	> 0.20	GMIP (4.0)	APOC1 (2.2)	ITGB3 (2.2)	ADAM1 (2.1)	MAFB (1.9)	APOE (1.8)	ALDH2 (1.8)	C11orf9 (1.7)	SLC44A2 (1.6)	PARP10 (1.5)
ENSG00000145736	GTF2H2 PPI subnetwork	0.40	> 0.20	SUGP1 (3.1)	BUD13 (2.9)	TXNL4B (2.8)	ZNF259 (2.3)	MAPKAPK5 (2.3)	POC5 (2.3)	DHX38 (2.2)	PSMA5 (2.0)	POLK (1.6)	BRAP (1.5)
KEGG_PANCREATIC_CANCER	KEGG_PANCREATIC_CANCER	0.40	> 0.20	RELB (3.3)	DNM2 (2.6)	SLC44A2 (2.5)	GATAD2A (2.4)	TMEM57 (2.3)	TMEM50A (2.2)	SH2B3 (2.1)	PARP10 (2.0)	BCL3 (1.9)	GRINA (1.8)
GO:0031163	metallo-sulfur cluster assembly	0.40	> 0.20	C12orf43 (3.3)	GEMIN7 (3.1)	C12orf47 (2.4)	TMEM116 (2.2)	C19orf52 (2.1)	NT5DC1 (1.7)	PBX4 (1.7)	BRAP (1.6)	ZNF180 (1.6)	RHCE (1.5)
GO:0016226	iron-sulfur cluster assembly	0.40	> 0.20	C12orf43 (3.3)	GEMIN7 (3.1)	C12orf47 (2.4)	TMEM116 (2.2)	C19orf52 (2.1)	NT5DC1 (1.7)	PBX4 (1.7)	BRAP (1.6)	ZNF180 (1.6)	RHCE (1.5)
ENSG00000112081	SRSF3 PPI subnetwork	0.40	> 0.20	C1orf63 (4.9)	TOP1 (4.0)	ILF3 (3.7)	USP1 (2.6)	SMARCA4 (2.6)	DHX38 (2.5)	BUD13 (2.4)	FEN1 (1.9)	QTRT1 (1.9)	SUGP1 (1.8)
MP:0004047	abnormal milk composition	0.40	> 0.20	KIAA1324 (3.2)	NPC1L1 (2.2)	MAFB (1.9)	HAVCR1 (1.7)	LPA (1.7)	PPP1R37 (1.5)	GPAM (1.5)	ZNF101 (1.3)	TMED4 (1.3)	FADS1 (1.3)
ENSG00000132326	PER2 PPI subnetwork	0.40	> 0.20	C17orf57 (2.7)	ZHX3 (2.5)	GPAM (2.2)	TMEM57 (2.1)	CILP2 (1.6)	MYLIP (1.6)	KANK2 (1.5)	PBX4 (1.4)	ENSG00000254235 (1.4)	MAPKAPK5 (1.4)
ENSG00000168003	SLC3A2 PPI subnetwork	0.40	> 0.20	ALDH2 (3.1)	C19orf52 (2.5)	HAVCR1 (2.4)	PCSK9 (2.3)	BCAM (2.0)	DDX56 (2.0)	PLEC (1.9)	ENSG00000226648 (1.9)	SARS (1.8)	AP1M2 (1.8)
GO:0032673	regulation of interleukin-4 production	0.40	> 0.20	ZNF101 (2.3)	GCNT4 (2.1)	ENSG00000254235 (1.9)	TMEM57 (1.8)	ENSG00000226645 (1.7)	ENSG00000235545 (1.6)	POLK (1.5)	DNAH11 (1.4)	HNF1A (1.4)	PLCG1 (1.3)
ENSG00000119203	CPSF3 PPI subnetwork	0.40	> 0.20	ILF3 (3.7)	BUD13 (3.3)	SMARCA4 (3.2)	DHX38 (3.0)	TOP1 (2.7)	C1orf63 (2.7)	GATAD2A (2.4)	SUGP1 (2.3)	QTRT1 (2.3)	USP1 (2.2)
ENSG00000139269	INHBE PPI subnetwork	0.40	> 0.20	OASL (3.0)	TIMD4 (2.3)	TMEM57 (2.0)	CETP (2.0)	BCAM (1.9)	POLK (1.6)	PLEKHH2 (1.6)	PVRL2 (1.5)	SYPL2 (1.5)	CILP2 (1.5)
ENSG00000135249	RINT1 PPI subnetwork	0.40	> 0.20	RHD (3.9)	RHCE (2.8)	BRAP (2.8)	ITGB3 (2.5)	ZNF259 (2.3)	TRAPPC6A (2.2)	GMPR (2.2)	TMEM57 (2.1)	TXNL4B (2.0)	TMEM116 (2.0)
GO:0017053	transcriptional repressor complex	0.40	> 0.20	CARM1 (3.9)	SMARCA4 (2.3)	SH2B3 (2.2)	PLCG1 (2.1)	ENSG00000238078 (1.9)	USP1 (1.9)	ENSG00000226645 (1.9)	MYLIP (1.8)	HNF1A (1.7)	PPP1R37 (1.7)
GO:0022617	extracellular matrix disassembly	0.40	> 0.20	CEACAM19 (2.8)	HNF1A (2.7)	FRK (2.7)	ENSG00000226645 (2.3)	CBLC (2.3)	PLCG1 (2.1)	ENSG00000254235 (2.0)	ZHX3 (1.7)	CYP7A1 (1.6)	NPC1L1 (1.5)
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	0.40	> 0.20	TMEM50A (2.9)	CLPTM1 (2.9)	SORT1 (2.8)	SLC44A2 (2.4)	DNM2 (2.0)	ATXN7L2 (1.9)	COL4A3BP (1.8)	CYB561D1 (1.8)	AMIGO1 (1.7)	ST3GAL4 (1.7)
ENSG00000130119	GNL3L PPI subnetwork	0.40	> 0.20	OASL (3.5)	PARP10 (2.7)	FRK (2.3)	ZNF180 (2.2)	NAA25 (2.0)	SUGP1 (1.6)	MAPKAPK5 (1.4)	TMED4 (1.4)	C12orf43 (1.3)	PSMA5 (1.2)
GO:0008406	gonad development	0.40	> 0.20	ST3GAL4 (2.7)	DNAH11 (2.4)	ABO (2.2)	LPAR2 (2.0)	HNF1A (1.8)	TSSK6 (1.8)	AMIGO1 (1.6)	PVRL2 (1.5)	C11orf9 (1.5)	NYNRIN (1.4)
MP:0000585	kinked tail	0.40	> 0.20	CILP2 (3.1)	LPAR2 (2.7)	PCSK9 (2.6)	LDLR (2.5)	MAFB (2.3)	HMGCR (1.9)	PVRL2 (1.8)	PLCG1 (1.7)	FADS1 (1.7)	NYNRIN (1.6)
MP:0005102	abnormal iris pigmentation	0.40	> 0.20	DOCK7 (2.1)	MYLIP (2.1)	GMPR (2.0)	APOE (2.0)	C19orf52 (1.6)	TMEM116 (1.6)	PPP1R37 (1.6)	ACAD10 (1.5)	COL4A3BP (1.4)	CELSR2 (1.3)
GO:0051247	positive regulation of protein metabolic process	0.40	> 0.20	GEMIN7 (2.0)	TRAFD1 (2.0)	ENSG00000228044 (1.8)	TIMD4 (1.8)	SH2B3 (1.7)	POC5 (1.7)	PSMA5 (1.7)	PTPN11 (1.6)	COL4A3BP (1.6)	CETP (1.5)
ENSG00000127616	SMARCA4 PPI subnetwork	0.40	> 0.20	SMARCA4 (3.1)	USP1 (2.8)	TOP1 (2.8)	ATXN2 (2.7)	GATAD2A (2.5)	CARM1 (2.5)	C12orf51 (1.8)	C12orf47 (1.8)	TRIB1 (1.6)	MAU2 (1.6)
ENSG00000183093	ENSG00000183093 PPI subnetwork	0.40	> 0.20	ZNF259 (3.9)	NAA25 (3.7)	TOMM40 (3.3)	DDX56 (2.8)	QTRT1 (2.8)	CARM1 (2.5)	DHODH (1.8)	ADAM1 (1.6)	MAPKAPK5 (1.5)	C12orf43 (1.5)
ENSG00000215120	ENSG00000215120 PPI subnetwork	0.40	> 0.20	TOP1 (2.8)	MAPKAPK5 (2.8)	C1orf63 (2.5)	TRIB1 (2.3)	BUD13 (2.2)	ZNF101 (2.2)	POC5 (2.0)	MAU2 (1.9)	USP1 (1.9)	TMED4 (1.7)
MP:0006346	small branchial arch	0.40	> 0.20	LPAR2 (3.3)	CBLC (3.0)	CETP (2.3)	PLEC (2.2)	CYB561D1 (2.1)	AP1M2 (1.8)	GMIP (1.8)	APOE (1.5)	LPIN3 (1.4)	HLX (1.3)
GO:0050708	regulation of protein secretion	0.40	> 0.20	GEMIN7 (2.3)	ENSG00000228044 (2.1)	KIAA1324 (1.9)	ST3GAL4 (1.8)	PBX4 (1.3)	HLX (1.3)	MOSC1 (1.2)	NT5DC1 (1.2)	CYP7A1 (1.2)	ZNF180 (1.1)
ENSG00000188620	HMX3 PPI subnetwork	0.40	> 0.20	MYLIP (3.5)	ENSG00000226645 (2.9)	ZNF101 (2.6)	TM6SF2 (2.3)	TRIB1 (2.3)	MAU2 (2.1)	DNAH11 (2.0)	LDLR (1.9)	LPAR2 (1.6)	PBX4 (1.5)
MP:0006107	abnormal fetal atrioventricular canal morphology	0.40	> 0.20	BCAM (4.3)	C11orf9 (2.1)	GMPR (1.9)	TSSK6 (1.9)	NYNRIN (1.8)	SORT1 (1.4)	UBXN2B (1.4)	PVRL2 (1.3)	MYLIP (1.2)	SYPL2 (1.2)
MP:0009335	decreased splenocyte proliferation	0.40	> 0.20	PLCG1 (2.9)	RELB (2.4)	PBX4 (2.3)	GMPR (2.2)	LPAR2 (2.1)	ZNF101 (2.1)	TRIB1 (1.9)	OASL (1.8)	PARP10 (1.7)	BCL3 (1.7)
ENSG00000196411	EPHB4 PPI subnetwork	0.40	> 0.20	FRK (3.3)	CETP (3.1)	PSRC1 (2.9)	OASL (2.4)	TIMD4 (2.3)	GRINA (2.1)	HAPLN4 (2.0)	C11orf9 (1.9)	MARK4 (1.9)	ABO (1.9)
GO:0010744	positive regulation of macrophage derived foam cell differentiation	0.41	> 0.20	ENSG00000228044 (2.8)	ITGB3 (2.5)	GOT2P1 (2.2)	TIMD4 (1.9)	PMFBP1 (1.7)	C12orf47 (1.6)	MOSC1 (1.6)	MAPKAPK5 (1.5)	GEMIN7 (1.5)	GCNT4 (1.4)
ENSG00000178913	TAF7 PPI subnetwork	0.41	> 0.20	MAPKAPK5 (3.8)	ATXN2 (2.4)	BUD13 (2.2)	SUGP1 (2.1)	GATAD2A (1.9)	TMED4 (1.8)	TOP1 (1.8)	ADAM1 (1.7)	POC5 (1.6)	ZNF259 (1.6)
GO:0019079	viral genome replication	0.41	> 0.20	OASL (5.0)	MAU2 (2.3)	ENSG00000228044 (2.0)	ENSG00000235545 (1.9)	FRK (1.8)	NKPD1 (1.7)	ATP13A1 (1.6)	GCNT4 (1.4)	PARP10 (1.4)	TIMD4 (1.4)
ENSG00000111445	RFC5 PPI subnetwork	0.41	> 0.20	FEN1 (5.0)	USP1 (4.2)	NT5DC1 (2.0)	PSRC1 (1.9)	POC5 (1.9)	PSMA5 (1.7)	ILF3 (1.6)	TMEM116 (1.6)	SMARCA4 (1.6)	ZNF180 (1.5)
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION	0.41	> 0.20	C12orf43 (4.0)	DYNC2LI1 (3.1)	MAPKAPK5 (2.8)	TXNL4B (2.7)	ZNF259 (2.6)	GEMIN7 (2.5)	DHX38 (2.4)	NAA25 (2.3)	POLK (2.2)	ATXN7L2 (2.1)
ENSG00000177469	PTRF PPI subnetwork	0.41	> 0.20	C12orf43 (3.7)	DYNC2LI1 (3.2)	POLK (2.9)	TXNL4B (2.6)	ATXN7L2 (2.4)	MAPKAPK5 (2.3)	ZNF259 (2.1)	DHX38 (1.9)	COL4A3BP (1.9)	GEMIN7 (1.8)
MP:0001056	abnormal cranial nerve morphology	0.41	> 0.20	BCAM (2.6)	ANKRD31 (2.6)	CELSR2 (2.4)	NCAN (2.2)	HLX (2.1)	TMEM116 (2.1)	ATXN2 (2.0)	SORT1 (1.8)	TSSK6 (1.7)	MAFB (1.6)
GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	0.41	> 0.20	ENSG00000226645 (3.1)	BLOC1S3 (2.4)	KANK2 (1.9)	RELB (1.9)	BCL3 (1.8)	ENSG00000254235 (1.7)	GMIP (1.6)	PVR (1.5)	OASL (1.5)	ATXN7L2 (1.4)
MP:0006144	increased systemic arterial systolic blood pressure	0.41	> 0.20	BCAM (3.4)	AP1M2 (1.8)	POLK (1.6)	ABO (1.6)	ERP29 (1.5)	CILP2 (1.5)	C12orf47 (1.4)	MAFB (1.3)	RHCE (1.3)	HLX (1.3)
MP:0010954	abnormal cellular respiration	0.41	> 0.20	ACAD10 (3.4)	C1orf63 (2.6)	BRAP (2.5)	AMIGO1 (2.4)	C12orf47 (2.2)	SYPL2 (2.2)	TRIB1 (2.2)	OGDH (2.0)	PBX4 (1.7)	ERP29 (1.7)
MP:0009172	small pancreatic islets	0.41	> 0.20	HAPLN4 (2.7)	KIAA1324 (2.7)	DNAH11 (2.5)	TRAPPC6A (2.4)	PLEKHH2 (1.7)	MOSC1 (1.7)	GCNT4 (1.7)	PMFBP1 (1.6)	C11orf9 (1.5)	ABO (1.5)
GO:0071241	cellular response to inorganic substance	0.41	> 0.20	KANK2 (2.3)	TSSK6 (1.9)	HAVCR1 (1.8)	RHD (1.6)	DYNC2LI1 (1.6)	C1orf63 (1.5)	POLK (1.4)	C19orf52 (1.3)	GCNT4 (1.3)	ANKRD31 (1.3)
ENSG00000101452	DHX35 PPI subnetwork	0.41	> 0.20	CLPTM1 (3.6)	PPP1R37 (2.5)	SUGP1 (2.2)	CYB561D1 (2.0)	DNAH11 (2.0)	MOSC1 (1.9)	C17orf57 (1.8)	DNM2 (1.8)	ATXN7L2 (1.7)	SARS (1.7)
MP:0001851	eye inflammation	0.41	> 0.20	ITGB3 (4.1)	CYP7A1 (2.8)	ANGPTL3 (2.3)	BCL3 (2.2)	TXNL4B (2.1)	RELB (2.0)	APOC4 (1.9)	ENSG00000254235 (1.8)	ENSG00000228044 (1.7)	LPA (1.7)
GO:0009062	fatty acid catabolic process	0.41	> 0.20	ACAD10 (5.2)	NT5DC1 (3.1)	MOSC1 (2.4)	TRAPPC6A (2.0)	OGDH (1.9)	GPAM (1.9)	ALDH2 (1.8)	LPA (1.7)	ABCG8 (1.6)	SLC22A1 (1.6)
GO:0045933	positive regulation of muscle contraction	0.41	> 0.20	CYB561D1 (2.6)	ABO (2.5)	ITGB3 (2.4)	NKPD1 (2.3)	LPIN3 (2.2)	GOT2P1 (2.1)	TXNL4B (1.9)	SYPL2 (1.9)	KIAA1324 (1.7)	ENSG00000226648 (1.6)
REACTOME_PYRIMIDINE_METABOLISM	REACTOME_PYRIMIDINE_METABOLISM	0.41	> 0.20	PLG (3.7)	SLC22A1 (3.4)	ANGPTL3 (3.4)	LPA (3.2)	APOC4 (3.2)	DHODH (2.3)	APOA5 (2.3)	TXNL4B (2.2)	CYP7A1 (1.9)	HP (1.9)
ENSG00000100142	POLR2F PPI subnetwork	0.41	> 0.20	BUD13 (3.4)	DHX38 (3.1)	ILF3 (3.0)	SUGP1 (3.0)	TOP1 (2.7)	USP1 (2.4)	DDX56 (2.4)	SMARCA4 (2.2)	C1orf63 (2.1)	QTRT1 (2.0)
GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	0.41	> 0.20	NYNRIN (3.2)	BUD13 (2.3)	DHODH (2.3)	SH2B3 (2.0)	PSRC1 (1.7)	KANK2 (1.5)	ABO (1.5)	ANKRD31 (1.3)	PLEKHH2 (1.1)	BLOC1S3 (1.1)
ENSG00000015475	BID PPI subnetwork	0.41	> 0.20	MARK4 (2.5)	C11orf9 (2.4)	GOT2P1 (2.3)	BLOC1S3 (2.3)	PPP1R37 (2.0)	PVR (2.0)	FRK (1.7)	PTPN11 (1.6)	OGDH (1.6)	RELB (1.5)
GO:0015278	calcium-release channel activity	0.41	> 0.20	PLEC (2.4)	ITGB3 (2.2)	SH2B3 (2.1)	SLC44A2 (2.0)	LPIN3 (1.9)	SYPL2 (1.9)	MAU2 (1.8)	OGDH (1.8)	RPH3A (1.7)	ANKRD31 (1.7)
GO:0042310	vasoconstriction	0.41	> 0.20	C12orf47 (2.6)	ITGB3 (2.3)	ENSG00000228044 (1.9)	ABO (1.9)	C17orf57 (1.6)	TSSK6 (1.6)	GMPR (1.5)	ADAM1 (1.4)	PLEKHH2 (1.3)	HAPLN4 (1.1)
GO:0046686	response to cadmium ion	0.41	> 0.20	ZHX3 (2.6)	CYP7A1 (2.0)	ENSG00000238078 (2.0)	ABO (2.0)	PMFBP1 (1.8)	HNF1A (1.6)	DNAH11 (1.6)	ITGB3 (1.5)	PBX4 (1.5)	C1orf63 (1.4)
GO:0010719	negative regulation of epithelial to mesenchymal transition	0.41	> 0.20	ENSG00000254235 (2.5)	NT5DC1 (2.5)	PLEKHH2 (2.4)	DNAH11 (2.4)	TMEM116 (2.4)	ABO (2.1)	ENSG00000226645 (2.0)	KANK2 (1.6)	NYNRIN (1.6)	AP1M2 (1.5)
ENSG00000078579	FGF20 PPI subnetwork	0.41	> 0.20	HAVCR1 (2.7)	HAPLN4 (2.6)	PLEKHH2 (2.3)	TOMM40 (2.0)	CBLC (1.9)	SARS (1.9)	DOCK7 (1.8)	AP1M2 (1.5)	HNF1A (1.4)	ZHX3 (1.4)
MP:0005455	increased susceptibility to weight gain	0.41	> 0.20	APOC1 (3.1)	C12orf47 (3.1)	ATP13A1 (2.2)	ST3GAL4 (1.9)	HMGCR (1.9)	PCSK9 (1.8)	MAPKAPK5 (1.8)	ENSG00000228044 (1.7)	GMPR (1.5)	GPAM (1.3)
ENSG00000175073	VCPIP1 PPI subnetwork	0.41	> 0.20	TMEM57 (4.2)	BRAP (2.9)	GRINA (2.6)	YIPF2 (2.6)	SUGP1 (2.3)	DNM2 (2.1)	SARS (2.0)	C19orf52 (1.9)	ALDH2 (1.7)	TOMM40 (1.6)
ENSG00000136842	TMOD1 PPI subnetwork	0.41	> 0.20	SYPL2 (4.9)	TMEM50A (2.6)	GMPR (2.2)	C12orf47 (1.7)	OGDH (1.7)	ACAD10 (1.7)	C1orf63 (1.5)	PSMA5 (1.2)	ADAM1 (1.1)	TIMD4 (1.1)
ENSG00000184363	PKP3 PPI subnetwork	0.41	> 0.20	CBLC (5.1)	AP1M2 (3.5)	CELSR2 (2.7)	PVRL2 (2.2)	ALDH2 (2.1)	LPAR2 (1.9)	ST3GAL4 (1.6)	FRK (1.5)	HNF1A (1.3)	PCSK9 (1.3)
ENSG00000168490	PHYHIP PPI subnetwork	0.41	> 0.20	FADS1 (3.3)	APOC1 (3.3)	FADS2 (2.5)	RPH3A (2.2)	ENSG00000226645 (2.1)	NCAN (2.0)	BUD13 (2.0)	TRAPPC6A (1.9)	C12orf43 (1.8)	HAPLN4 (1.6)
GO:0060706	cell differentiation involved in embryonic placenta development	0.41	> 0.20	ST3GAL4 (2.1)	LPA (2.0)	POC5 (1.9)	AMIGO1 (1.7)	ENSG00000254235 (1.6)	CBLC (1.6)	MARK4 (1.5)	TMEM116 (1.4)	UBXN2B (1.4)	CYB561D1 (1.4)
MP:0008699	increased interleukin-4 secretion	0.41	> 0.20	OASL (2.9)	C11orf9 (2.3)	RELB (2.1)	TRIB1 (2.1)	ZNF101 (2.0)	GCNT4 (2.0)	HAVCR1 (1.9)	BCL3 (1.9)	COL4A3BP (1.8)	GMIP (1.8)
REACTOME_ERKS_ARE_INACTIVATED	REACTOME_ERKS_ARE_INACTIVATED	0.41	> 0.20	MARK4 (3.3)	TRIB1 (2.6)	CLPTM1 (2.1)	SH2B3 (1.9)	PBX4 (1.7)	SORT1 (1.7)	COL4A3BP (1.6)	PVRL2 (1.6)	TOMM40 (1.6)	PVR (1.4)
MP:0006108	abnormal hindbrain development	0.41	> 0.20	PLCG1 (3.0)	GATAD2A (2.7)	TRIB1 (2.4)	PPP1R37 (1.9)	MARK4 (1.8)	GEMIN7 (1.7)	ZHX3 (1.7)	DNAH11 (1.7)	DYNC2LI1 (1.7)	CILP2 (1.5)
ENSG00000122140	MRPS2 PPI subnetwork	0.41	> 0.20	TOMM40 (4.9)	DHODH (4.6)	CARM1 (3.4)	QTRT1 (2.9)	DDX56 (2.8)	ATP13A1 (2.7)	NAA25 (2.6)	ATXN2 (2.5)	HAVCR1 (2.0)	GPAM (1.9)
GO:0046131	pyrimidine ribonucleoside metabolic process	0.41	> 0.20	DYNC2LI1 (2.7)	C12orf43 (2.4)	TSSK6 (2.4)	ANKRD31 (2.3)	PBX4 (2.1)	PMFBP1 (2.0)	SYPL2 (1.7)	ACAD10 (1.5)	GOT2P1 (1.4)	LPA (1.4)
ENSG00000167005	NUDT21 PPI subnetwork	0.41	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	BUD13 (2.9)	TOP1 (2.7)	SMARCA4 (2.5)	QTRT1 (2.2)	DHX38 (2.2)	PTPN11 (2.1)	USP1 (2.1)	SUGP1 (2.1)
MP:0002332	abnormal exercise endurance	0.41	> 0.20	SYPL2 (6.7)	GMPR (3.0)	TRIB1 (2.8)	HLX (2.3)	OGDH (2.2)	ATXN7L2 (1.6)	SH2B3 (1.4)	NPC1L1 (1.4)	PVR (1.3)	POC5 (1.2)
GO:0015844	monoamine transport	0.41	> 0.20	ABO (2.6)	GMPR (2.4)	PMFBP1 (1.7)	TSSK6 (1.5)	ABCG8 (1.5)	CETP (1.4)	MOSC1 (1.3)	GOT2P1 (1.2)	LPA (1.1)	RPH3A (1.1)
REACTOME_UNWINDING_OF_DNA	REACTOME_UNWINDING_OF_DNA	0.41	> 0.20	FEN1 (7.2)	USP1 (4.9)	ZNF180 (2.0)	ENSG00000228044 (1.9)	FADS1 (1.4)	ENSG00000238078 (1.3)	MAU2 (1.2)	DHODH (1.2)	ILF3 (1.1)	HAPLN4 (1.1)
GO:0009914	hormone transport	0.41	> 0.20	KIAA1324 (4.8)	ANKRD31 (2.8)	ABO (2.2)	MOSC1 (1.9)	HNF1A (1.9)	AMIGO1 (1.8)	ENSG00000228044 (1.7)	GPAM (1.6)	TMED4 (1.5)	HAPLN4 (1.5)
GO:0060716	labyrinthine layer blood vessel development	0.41	> 0.20	CBLC (2.5)	ENSG00000235545 (2.4)	MAPKAPK5 (2.0)	LDLR (1.9)	SLC44A2 (1.8)	ATXN2 (1.8)	ZNF101 (1.8)	LPAR2 (1.7)	ENSG00000226648 (1.6)	AP1M2 (1.6)
ENSG00000073910	FRY PPI subnetwork	0.41	> 0.20	CARM1 (3.0)	GATAD2A (2.9)	TOP1 (2.8)	BRAP (2.7)	TOMM40 (2.4)	ENSG00000226645 (2.2)	DHX38 (2.2)	ALDH2 (2.1)	PTPN11 (2.0)	USP24 (1.6)
MP:0005044	sepsis	0.41	> 0.20	CETP (4.0)	TIMD4 (3.0)	HP (2.7)	RHD (2.7)	HLX (2.3)	ALDH2 (2.3)	C17orf57 (2.3)	TMEM57 (2.0)	AP1M2 (2.0)	GMIP (1.9)
ENSG00000094631	HDAC6 PPI subnetwork	0.41	> 0.20	USP24 (3.0)	PLEC (2.9)	TMEM57 (2.8)	C12orf51 (2.6)	ZNF180 (2.6)	BRAP (2.5)	ATXN2 (2.2)	BCL3 (1.8)	BUD13 (1.8)	SMARCA4 (1.7)
MP:0002651	abnormal sciatic nerve morphology	0.41	> 0.20	DOCK7 (2.7)	TIMD4 (2.6)	APOC1 (2.5)	SARS (2.3)	USP24 (2.1)	FADS1 (2.0)	CETP (1.9)	LDLR (1.9)	HMGCR (1.8)	PCSK9 (1.8)
GO:0004812	aminoacyl-tRNA ligase activity	0.41	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
GO:0016875	ligase activity, forming carbon-oxygen bonds	0.41	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
GO:0016876	ligase activity, forming aminoacyl-tRNA and related compounds	0.41	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
ENSG00000126803	HSPA2 PPI subnetwork	0.41	> 0.20	MYLIP (2.8)	CLPTM1 (2.4)	ATXN2 (2.1)	HLX (2.0)	BRAP (1.9)	ENSG00000235545 (1.8)	BLOC1S3 (1.8)	CYP7A1 (1.8)	TOMM40 (1.8)	TRAPPC6A (1.7)
ENSG00000153391	INO80C PPI subnetwork	0.41	> 0.20	BUD13 (3.2)	C12orf43 (2.5)	ATXN2 (2.5)	QTRT1 (2.4)	GOT2P1 (2.4)	DDX56 (2.1)	ZNF180 (2.1)	SUGP1 (2.0)	ANKRD31 (2.0)	ZNF259 (1.9)
ENSG00000008130	NADK PPI subnetwork	0.41	> 0.20	DNM2 (3.4)	CARM1 (3.4)	ZHX3 (3.2)	LPAR2 (3.1)	PLEC (3.1)	GPAM (2.7)	COL4A3BP (2.4)	AP1M2 (2.2)	OGDH (2.2)	C11orf9 (2.1)
GO:0016578	histone deubiquitination	0.41	> 0.20	ATXN7L2 (4.3)	ZNF180 (3.2)	UBXN2B (2.6)	TMEM57 (2.1)	MAPKAPK5 (1.8)	C17orf57 (1.8)	GEMIN7 (1.7)	ATP13A1 (1.6)	ENSG00000226648 (1.6)	LPIN3 (1.6)
ENSG00000156313	RPGR PPI subnetwork	0.41	> 0.20	DYNC2LI1 (2.8)	MARK4 (2.4)	SARS (2.3)	DNM2 (1.8)	DOCK7 (1.8)	SMARCA4 (1.8)	CLPTM1 (1.8)	ANKRD31 (1.7)	TOP1 (1.6)	TMEM57 (1.2)
ENSG00000122565	CBX3 PPI subnetwork	0.41	> 0.20	USP1 (3.3)	TMEM57 (2.7)	PSRC1 (2.6)	BUD13 (2.4)	ZNF180 (1.9)	TOP1 (1.8)	C19orf52 (1.8)	FEN1 (1.6)	TRAFD1 (1.6)	KANK2 (1.3)
REACTOME_POST:CHAPERONIN_TUBULIN_FOLDING_PATHWAY	REACTOME_POST:CHAPERONIN_TUBULIN_FOLDING_PATHWAY	0.41	> 0.20	ITGB3 (2.3)	HMGCR (2.1)	C12orf47 (2.0)	BLOC1S3 (2.0)	GMPR (1.8)	ENSG00000226645 (1.6)	PVR (1.5)	RHD (1.4)	SUGP1 (1.4)	SMARCA4 (1.3)
GO:0046135	pyrimidine nucleoside catabolic process	0.41	> 0.20	C17orf57 (2.6)	TSSK6 (2.3)	SYPL2 (2.2)	SLC22A1 (1.9)	DNAH11 (1.8)	GEMIN7 (1.7)	LPA (1.6)	ABO (1.5)	APOC4 (1.5)	ANGPTL3 (1.5)
GO:0004713	protein tyrosine kinase activity	0.41	> 0.20	MARK4 (3.3)	LPIN3 (2.2)	PTPN11 (2.2)	DNM2 (2.2)	GMIP (2.2)	NKPD1 (2.1)	LPAR2 (2.1)	SH2B3 (2.1)	CARM1 (2.0)	PVRL2 (2.0)
ENSG00000087250	MT3 PPI subnetwork	0.41	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.3)	HNF1A (1.8)	KANK2 (1.8)	ADAM1 (1.6)	DHX38 (1.5)	UBXN2B (1.5)	ZNF180 (1.4)
ENSG00000163486	SRGAP2 PPI subnetwork	0.41	> 0.20	PLEC (4.2)	DNM2 (3.3)	COL4A3BP (3.1)	C11orf9 (2.9)	CARM1 (2.8)	LPAR2 (2.6)	ZHX3 (2.5)	USP24 (2.4)	MAU2 (2.3)	PTPN11 (2.3)
MP:0000780	abnormal corpus callosum morphology	0.41	> 0.20	NCAN (3.7)	GRINA (3.5)	FADS2 (2.9)	NYNRIN (2.6)	FADS1 (2.3)	PCSK9 (1.9)	HMGCR (1.8)	LDLR (1.8)	CELSR2 (1.8)	PVRL2 (1.7)
ENSG00000108179	PPIF PPI subnetwork	0.41	> 0.20	TSSK6 (2.4)	C19orf52 (2.3)	TRAPPC6A (2.2)	BUD13 (2.1)	TOMM40 (2.1)	CLPTM1 (1.8)	TXNL4B (1.8)	SMARCA4 (1.7)	ZNF180 (1.6)	GEMIN7 (1.4)
GO:0040020	regulation of meiosis	0.41	> 0.20	ENSG00000228044 (2.7)	TMED4 (2.4)	CEACAM19 (1.9)	C1orf63 (1.7)	PLEKHH2 (1.6)	ENSG00000226645 (1.5)	ATXN7L2 (1.5)	ZNF180 (1.4)	CYB561D1 (1.3)	PMFBP1 (1.3)
ENSG00000086598	TMED2 PPI subnetwork	0.41	> 0.20	YIPF2 (4.2)	HMGCR (3.6)	LDLR (3.3)	TMED4 (3.2)	FADS2 (2.9)	ATP13A1 (2.3)	ABCG8 (2.2)	FADS1 (2.2)	SARS (2.1)	TMEM50A (2.0)
GO:0002369	T cell cytokine production	0.41	> 0.20	GCNT4 (3.0)	NKPD1 (2.2)	LPAR2 (1.6)	COL4A3BP (1.6)	POLK (1.6)	TRAPPC6A (1.6)	GOT2P1 (1.5)	BRAP (1.5)	PBX4 (1.4)	ZNF180 (1.4)
ENSG00000143632	ACTA1 PPI subnetwork	0.41	> 0.20	ITGB3 (3.0)	SYPL2 (2.4)	PLEC (2.4)	HNF1A (2.2)	DOCK7 (2.1)	SORT1 (2.1)	C11orf9 (2.0)	KANK2 (2.0)	SH2B3 (1.9)	DNM2 (1.8)
ENSG00000108294	PSMB3 PPI subnetwork	0.41	> 0.20	PSMA5 (5.5)	TRAFD1 (2.5)	NAA25 (2.3)	NT5DC1 (2.3)	SARS (1.9)	C19orf52 (1.9)	DDX56 (1.6)	SMARCA4 (1.4)	SUGP1 (1.3)	ENSG00000254235 (1.2)
ENSG00000105664	COMP PPI subnetwork	0.41	> 0.20	CILP2 (5.6)	SYPL2 (3.3)	GRINA (2.3)	PLEKHH2 (2.1)	MARK4 (1.8)	LPAR2 (1.7)	ITGB3 (1.6)	PLEC (1.4)	GEMIN7 (1.4)	PVR (1.4)
ENSG00000081052	COL4A4 PPI subnetwork	0.41	> 0.20	APOE (2.3)	ATXN7L2 (2.2)	TXNL4B (1.7)	C17orf57 (1.6)	KANK2 (1.5)	C11orf9 (1.5)	ZHX3 (1.4)	APOB (1.4)	ANGPTL3 (1.3)	TMED4 (1.3)
MP:0004753	abnormal miniature excitatory postsynaptic currents	0.41	> 0.20	RPH3A (4.6)	HAPLN4 (3.1)	PPP1R37 (2.2)	CELSR2 (2.0)	TRIB1 (1.8)	AMIGO1 (1.7)	ENSG00000226648 (1.6)	C12orf51 (1.6)	GRINA (1.3)	NCAN (1.3)
ENSG00000144837	PLA1A PPI subnetwork	0.41	> 0.20	ENSG00000228044 (2.6)	GPAM (2.1)	FADS2 (2.0)	CEACAM19 (2.0)	SORT1 (1.8)	LDLR (1.7)	PLEC (1.5)	C12orf51 (1.5)	CARM1 (1.4)	PVR (1.4)
ENSG00000165304	MELK PPI subnetwork	0.41	> 0.20	USP1 (2.4)	ZNF180 (2.4)	PMFBP1 (2.3)	ST3GAL4 (2.1)	GATAD2A (2.0)	BUD13 (1.8)	PLCG1 (1.7)	ZNF101 (1.5)	ERP29 (1.4)	OASL (1.3)
ENSG00000099308	MAST3 PPI subnetwork	0.41	> 0.20	PLEC (3.6)	DNM2 (3.1)	ZHX3 (3.1)	COL4A3BP (3.1)	C11orf9 (3.0)	CARM1 (2.7)	USP24 (2.6)	LPAR2 (2.4)	C12orf51 (2.4)	PTPN11 (2.3)
MP:0003845	abnormal decidualization	0.41	> 0.20	KIAA1324 (2.9)	FRK (2.7)	CELSR2 (2.2)	ENSG00000228044 (2.1)	ENSG00000238078 (2.0)	PLEKHH2 (2.0)	CBLC (2.0)	CEACAM19 (1.9)	HAPLN4 (1.8)	PVRL2 (1.8)
REACTOME_UNFOLDED_PROTEIN_RESPONSE	REACTOME_UNFOLDED_PROTEIN_RESPONSE	0.41	> 0.20	YIPF2 (4.6)	ERP29 (3.5)	SARS (3.5)	TMED4 (2.4)	DHODH (1.9)	GRINA (1.7)	PVR (1.7)	ATP13A1 (1.6)	DHX38 (1.5)	PCSK9 (1.5)
GO:0002703	regulation of leukocyte mediated immunity	0.41	> 0.20	DNAH11 (1.9)	GEMIN7 (1.6)	GMIP (1.5)	ENSG00000235545 (1.5)	PARP10 (1.4)	ZNF101 (1.3)	LPAR2 (1.3)	NKPD1 (1.2)	TRAFD1 (1.2)	TIMD4 (1.0)
ENSG00000124356	STAMBP PPI subnetwork	0.41	> 0.20	ADAM1 (3.1)	GMIP (2.4)	ITGB3 (2.2)	DOCK7 (2.1)	MAPKAPK5 (2.1)	ENSG00000226645 (2.0)	TMEM57 (1.9)	COL4A3BP (1.7)	PLCG1 (1.5)	GCNT4 (1.4)
ENSG00000173894	CBX2 PPI subnetwork	0.41	> 0.20	TMEM57 (2.5)	USP1 (2.0)	TOP1 (2.0)	HLX (1.9)	MARK4 (1.9)	ATXN2 (1.9)	GATAD2A (1.8)	NT5DC1 (1.8)	TRIB1 (1.7)	NAA25 (1.6)
GO:0001664	G-protein coupled receptor binding	0.41	> 0.20	CETP (2.8)	RELB (2.5)	MAFB (2.5)	KIAA1324 (2.1)	BCL3 (2.1)	PVRL2 (2.0)	OASL (2.0)	TIMD4 (2.0)	ENSG00000226645 (1.7)	NPC1L1 (1.6)
MP:0005300	abnormal corneal stroma morphology	0.41	> 0.20	CILP2 (4.4)	MAFB (3.6)	APOE (2.7)	PLCG1 (2.4)	ANGPTL3 (2.3)	APOA5 (2.0)	APOC1 (1.8)	LPA (1.7)	SLC22A1 (1.7)	MOSC1 (1.5)
GO:0000216	M/G1 transition of mitotic cell cycle	0.41	> 0.20	PSMA5 (3.5)	NT5DC1 (3.2)	ENSG00000235545 (2.3)	ZNF180 (2.1)	NAA25 (1.9)	TXNL4B (1.7)	TRAFD1 (1.7)	FEN1 (1.7)	USP1 (1.5)	SUGP1 (1.4)
ENSG00000198176	TFDP1 PPI subnetwork	0.41	> 0.20	ATXN2 (3.5)	USP1 (3.1)	C12orf51 (2.4)	MAPKAPK5 (2.4)	TMEM57 (2.4)	GATAD2A (2.3)	MARK4 (2.2)	FEN1 (2.2)	RHD (1.9)	KANK2 (1.8)
GO:0045026	plasma membrane fusion	0.41	> 0.20	GCNT4 (4.0)	PMFBP1 (3.9)	ENSG00000238078 (2.5)	CEACAM19 (2.4)	TSSK6 (2.3)	ENSG00000228044 (2.1)	DNAH11 (2.0)	NKPD1 (1.5)	ANKRD31 (1.2)	POLK (1.2)
MP:0002699	abnormal vitreous body morphology	0.41	> 0.20	PVRL2 (3.5)	C11orf9 (2.1)	GMPR (1.7)	ST3GAL4 (1.7)	NYNRIN (1.5)	PLEKHH2 (1.5)	GEMIN7 (1.5)	TMEM116 (1.4)	APOE (1.4)	ABCG5 (1.4)
ENSG00000104884	ERCC2 PPI subnetwork	0.41	> 0.20	SUGP1 (3.9)	PSMA5 (3.1)	DHX38 (3.1)	TXNL4B (2.7)	POC5 (2.7)	ZNF259 (2.7)	BUD13 (2.6)	MAPKAPK5 (2.5)	DDX56 (2.3)	BRAP (1.8)
GO:0060039	pericardium development	0.41	> 0.20	C11orf9 (3.2)	SLC44A2 (2.5)	ENSG00000238078 (2.1)	ATXN2 (2.0)	ENSG00000226645 (1.9)	MAPKAPK5 (1.8)	ATXN7L2 (1.7)	CILP2 (1.6)	ZNF180 (1.6)	PLEKHH2 (1.6)
ENSG00000102871	TRADD PPI subnetwork	0.41	> 0.20	HAVCR1 (3.7)	TRAFD1 (3.6)	RELB (2.7)	PTPN11 (2.5)	PARP10 (2.4)	PSMA5 (2.2)	C11orf9 (2.2)	BCL3 (2.1)	GRINA (1.8)	ZNF101 (1.7)
MP:0000757	herniated abdominal wall	0.41	> 0.20	CILP2 (2.6)	MOSC1 (2.5)	MAFB (2.3)	TM6SF2 (2.3)	ATXN2 (2.2)	MYLIP (2.1)	ABO (1.9)	ENSG00000254235 (1.8)	SLC44A2 (1.7)	AP1M2 (1.7)
MP:0008280	male germ cell apoptosis	0.41	> 0.20	ANKRD31 (2.7)	PBX4 (2.5)	BRAP (1.6)	OASL (1.2)	GATAD2A (1.2)	MYLIP (1.0)	PLEKHH2 (1.0)	KANK2 (1.0)	KIAA1324 (0.9)	SH2B3 (0.9)
GO:0019934	cGMP-mediated signaling	0.41	> 0.20	HAVCR1 (3.0)	TMED4 (2.5)	TMEM116 (2.0)	SORT1 (1.7)	ATXN7L2 (1.6)	CELSR2 (1.6)	AMIGO1 (1.6)	C12orf47 (1.5)	DYNC2LI1 (1.5)	ACAD10 (1.4)
MP:0009504	abnormal mammary gland epithelium morphology	0.41	> 0.20	CELSR2 (2.9)	PSRC1 (2.1)	POLK (1.8)	KANK2 (1.7)	FRK (1.6)	UBXN2B (1.6)	ABO (1.6)	AP1M2 (1.5)	KIAA1324 (1.4)	ACAD10 (1.3)
GO:0042401	cellular biogenic amine biosynthetic process	0.41	> 0.20	BLOC1S3 (2.9)	HNF1A (2.4)	TSSK6 (2.2)	C12orf47 (2.1)	PMFBP1 (1.9)	CILP2 (1.9)	GMPR (1.7)	TRAPPC6A (1.7)	QTRT1 (1.6)	GEMIN7 (1.6)
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1APCC	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1APCC	0.41	> 0.20	PSMA5 (6.1)	TRAFD1 (3.7)	NAA25 (2.6)	SUGP1 (2.4)	DDX56 (2.0)	PARP10 (1.6)	POC5 (1.5)	DHX38 (1.4)	NT5DC1 (1.4)	SARS (1.4)
GO:0051282	regulation of sequestering of calcium ion	0.41	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
GO:0051283	negative regulation of sequestering of calcium ion	0.41	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
GO:0051209	release of sequestered calcium ion into cytosol	0.41	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
MP:0004992	increased bone resorption	0.41	> 0.20	PARP10 (2.9)	OASL (2.7)	BCL3 (2.7)	ZHX3 (2.4)	TRIB1 (2.1)	ENSG00000228044 (2.0)	ENSG00000254235 (1.8)	HNF1A (1.8)	ST3GAL4 (1.8)	LPA (1.4)
ENSG00000063177	RPL18 PPI subnetwork	0.41	> 0.20	DDX56 (3.1)	NAA25 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	ERP29 (2.2)	DHX38 (2.2)	SUGP1 (2.2)	SARS (2.1)	TOMM40 (2.0)	ADAM1 (2.0)
ENSG00000110931	CAMKK2 PPI subnetwork	0.41	> 0.20	MAPKAPK5 (3.2)	CARM1 (1.9)	ALDH2 (1.9)	DNM2 (1.9)	MARK4 (1.9)	LDLR (1.8)	HMGCR (1.8)	NKPD1 (1.7)	GMIP (1.7)	SLC44A2 (1.5)
ENSG00000137710	RDX PPI subnetwork	0.41	> 0.20	SH2B3 (2.8)	RELB (2.4)	ZHX3 (2.1)	ST3GAL4 (2.0)	CETP (2.0)	HLX (1.9)	DNM2 (1.8)	APOB (1.8)	C11orf9 (1.8)	APOE (1.7)
GO:0046638	positive regulation of alpha-beta T cell differentiation	0.42	> 0.20	ZNF101 (2.7)	NT5DC1 (2.1)	HLX (1.7)	MYLIP (1.7)	ENSG00000254235 (1.6)	NKPD1 (1.5)	ENSG00000235545 (1.4)	GOT2P1 (1.4)	ANKRD31 (1.3)	TSSK6 (1.3)
ENSG00000154429	C1orf96 PPI subnetwork	0.42	> 0.20	NCAN (2.8)	TMEM57 (2.5)	MYLIP (2.2)	ADAM1 (2.1)	APOC1 (1.8)	RPH3A (1.8)	SUGP1 (1.8)	ENSG00000238078 (1.6)	TRAFD1 (1.6)	C1orf63 (1.6)
obsolete_molecular_function	obsolete_molecular_function	0.42	> 0.20	SLC44A2 (2.4)	DNM2 (2.4)	GMIP (2.2)	PPP1R37 (2.1)	BLOC1S3 (2.0)	MARK4 (1.9)	C11orf9 (1.8)	SH2B3 (1.8)	POC5 (1.7)	CYB561D1 (1.6)
ENSG00000168495	POLR3D PPI subnetwork	0.42	> 0.20	C12orf43 (3.9)	DDX56 (3.2)	GEMIN7 (3.1)	ZNF259 (2.5)	MAPKAPK5 (2.4)	SUGP1 (2.3)	BUD13 (2.2)	POC5 (2.2)	QTRT1 (2.0)	ADAM1 (1.9)
MP:0001284	absent vibrissae	0.42	> 0.20	AP1M2 (4.7)	CBLC (2.5)	BCAM (2.3)	MAFB (1.8)	CELSR2 (1.8)	TRAPPC6A (1.6)	GCNT4 (1.6)	SLC44A2 (1.5)	RHCE (1.5)	NKPD1 (1.5)
MP:0008088	abnormal T-helper 1 cell differentiation	0.42	> 0.20	RELB (3.3)	TRAFD1 (2.8)	ABO (2.0)	PARP10 (2.0)	PBX4 (1.9)	BCL3 (1.8)	GMIP (1.6)	C12orf47 (1.5)	TRIB1 (1.5)	PPP1R37 (1.3)
MP:0008498	decreased IgG3 level	0.42	> 0.20	RELB (4.1)	GMIP (3.8)	TIMD4 (3.2)	CETP (3.2)	SH2B3 (2.1)	BCL3 (1.9)	MAFB (1.6)	ZNF101 (1.1)	HAVCR1 (1.0)	GEMIN7 (1.0)
ENSG00000144744	UBA3 PPI subnetwork	0.42	> 0.20	CARM1 (4.2)	MARK4 (2.4)	ZNF180 (2.2)	GOT2P1 (1.9)	SLC44A2 (1.8)	NYNRIN (1.7)	TOMM40 (1.7)	SARS (1.6)	GMIP (1.5)	LPAR2 (1.5)
MP:0001116	small gonad	0.42	> 0.20	GCNT4 (2.6)	PBX4 (2.5)	LPAR2 (2.2)	HNF1A (1.9)	C12orf47 (1.7)	TRIB1 (1.6)	ACAD10 (1.6)	DYNC2LI1 (1.5)	USP1 (1.5)	NT5DC1 (1.4)
ENSG00000067334	DNTTIP2 PPI subnetwork	0.42	> 0.20	C19orf52 (2.6)	ZNF259 (1.7)	BUD13 (1.7)	HNF1A (1.6)	CBLC (1.6)	GPAM (1.6)	ENSG00000226648 (1.6)	NAA25 (1.5)	NKPD1 (1.5)	TIMD4 (1.4)
ENSG00000137074	APTX PPI subnetwork	0.42	> 0.20	PBX4 (2.7)	MARK4 (1.9)	TRAPPC6A (1.7)	RPH3A (1.7)	DNAH11 (1.7)	PSRC1 (1.4)	TRAFD1 (1.3)	SLC44A2 (1.3)	PVRL2 (1.3)	HAPLN4 (1.3)
ENSG00000198000	NOL8 PPI subnetwork	0.42	> 0.20	ZNF180 (2.7)	GEMIN7 (2.6)	DHX38 (2.5)	TXNL4B (2.5)	TOP1 (2.3)	BUD13 (2.2)	C19orf52 (2.1)	C1orf63 (2.0)	BRAP (1.9)	BLOC1S3 (1.9)
ENSG00000100014	SPECC1L PPI subnetwork	0.42	> 0.20	PLEC (3.1)	PVR (2.3)	LPIN3 (2.2)	PVRL2 (2.1)	TRAFD1 (2.0)	SYPL2 (1.9)	ABO (1.8)	PPP1R37 (1.8)	ALDH2 (1.7)	DOCK7 (1.6)
MP:0003797	abnormal compact bone morphology	0.42	> 0.20	MAFB (2.5)	ITGB3 (2.4)	APOE (2.4)	CILP2 (1.9)	MYLIP (1.8)	TMEM57 (1.8)	ANKRD31 (1.7)	TRIB1 (1.7)	CETP (1.5)	PCSK9 (1.4)
GO:0010564	regulation of cell cycle process	0.42	> 0.20	PSRC1 (3.2)	POC5 (3.0)	FEN1 (2.5)	USP1 (2.5)	ENSG00000228044 (2.3)	POLK (1.8)	ZNF180 (1.7)	MAU2 (1.6)	BUD13 (1.5)	SUGP1 (1.5)
GO:0046887	positive regulation of hormone secretion	0.42	> 0.20	KIAA1324 (3.1)	LPIN3 (2.4)	ABO (2.4)	GCNT4 (2.4)	ENSG00000254235 (2.4)	NPC1L1 (2.3)	ANKRD31 (2.1)	GPAM (1.8)	COL4A3BP (1.7)	HNF1A (1.6)
ENSG00000163902	RPN1 PPI subnetwork	0.42	> 0.20	ATP13A1 (3.7)	PSMA5 (3.3)	QTRT1 (2.9)	YIPF2 (2.8)	OGDH (2.6)	DDX56 (2.5)	SARS (2.2)	NAA25 (2.1)	AP1M2 (2.1)	TMED4 (2.0)
ENSG00000125351	UPF3B PPI subnetwork	0.42	> 0.20	ILF3 (4.1)	TOP1 (3.7)	C1orf63 (3.4)	DHX38 (2.9)	USP1 (2.8)	SMARCA4 (2.8)	SUGP1 (2.6)	BUD13 (2.3)	FEN1 (2.1)	PTPN11 (2.0)
ENSG00000141480	ARRB2 PPI subnetwork	0.42	> 0.20	PTPN11 (3.6)	CLPTM1 (2.7)	TOMM40 (2.5)	C17orf57 (2.3)	HLX (2.1)	BLOC1S3 (2.0)	MYLIP (1.9)	CARM1 (1.8)	DHX38 (1.7)	DNM2 (1.7)
ENSG00000164442	CITED2 PPI subnetwork	0.42	> 0.20	CELSR2 (2.2)	KIAA1324 (1.9)	ANKRD31 (1.8)	LPAR2 (1.7)	ATXN2 (1.7)	C17orf57 (1.7)	ENSG00000226645 (1.3)	TSSK6 (1.3)	BUD13 (1.3)	APOC4 (1.2)
MP:0001074	abnormal vagus nerve morphology	0.42	> 0.20	TMED4 (2.2)	HLX (2.1)	HAVCR1 (1.9)	ABO (1.7)	ANKRD31 (1.6)	MAFB (1.5)	TSSK6 (1.5)	ENSG00000228044 (1.4)	CEACAM19 (1.4)	COL4A3BP (1.3)
ENSG00000188687	SLC4A5 PPI subnetwork	0.42	> 0.20	HMGCR (4.7)	LDLR (4.3)	FADS1 (3.9)	PCSK9 (2.8)	ILF3 (2.5)	FADS2 (2.5)	QTRT1 (2.4)	ZNF259 (2.0)	ATP13A1 (1.9)	NAA25 (1.8)
GO:0005911	cell-cell junction	0.42	> 0.20	AP1M2 (5.5)	BCAM (4.6)	CBLC (4.5)	PVRL2 (4.3)	PLEC (2.7)	CELSR2 (2.7)	C11orf9 (2.2)	KANK2 (1.9)	PVR (1.7)	FRK (1.5)
ENSG00000066933	MYO9A PPI subnetwork	0.42	> 0.20	ATP13A1 (3.3)	QTRT1 (3.0)	ILF3 (2.9)	YIPF2 (2.7)	DNM2 (2.6)	OGDH (2.5)	DHX38 (1.7)	ACAD10 (1.7)	SARS (1.6)	DHODH (1.5)
ENSG00000150867	PIP4K2A PPI subnetwork	0.42	> 0.20	CARM1 (3.6)	ALDH2 (3.1)	POLK (2.5)	PVRL2 (2.3)	ITGB3 (2.2)	TOMM40 (2.1)	ATXN2 (2.1)	SORT1 (1.9)	PLEC (1.7)	ANKRD31 (1.7)
ENSG00000006715	VPS41 PPI subnetwork	0.42	> 0.20	BRAP (3.2)	ATP13A1 (2.9)	ZNF259 (2.8)	MAU2 (2.5)	DDX56 (2.4)	DNM2 (2.4)	SUGP1 (2.3)	C1orf63 (2.2)	ERP29 (2.1)	DHX38 (1.7)
GO:0043001	Golgi to plasma membrane protein transport	0.42	> 0.20	FRK (2.7)	USP24 (2.5)	C17orf57 (2.2)	ENSG00000228044 (1.9)	AP1M2 (1.6)	NKPD1 (1.6)	C11orf9 (1.5)	ZNF180 (1.5)	C12orf51 (1.5)	TMEM57 (1.5)
ENSG00000140481	CCDC33 PPI subnetwork	0.42	> 0.20	DNM2 (4.0)	LPAR2 (3.0)	YIPF2 (2.9)	MARK4 (2.5)	SUGP1 (2.2)	CARM1 (2.2)	HAVCR1 (2.2)	FADS2 (2.0)	QTRT1 (2.0)	ATP13A1 (2.0)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION	0.42	> 0.20	C12orf43 (3.9)	GEMIN7 (3.4)	POC5 (2.8)	ZNF259 (2.6)	DDX56 (2.6)	MAPKAPK5 (2.5)	SUGP1 (2.3)	BUD13 (2.1)	ENSG00000226645 (2.0)	ADAM1 (1.9)
ENSG00000155229	MMS19 PPI subnetwork	0.42	> 0.20	TOMM40 (2.9)	PSMA5 (2.7)	NAA25 (2.4)	NT5DC1 (2.1)	DHX38 (2.1)	FEN1 (2.0)	CLPTM1 (1.7)	ENSG00000235545 (1.7)	OGDH (1.7)	ALDH2 (1.6)
MP:0005565	increased blood urea nitrogen level	0.42	> 0.20	BCAM (3.2)	FRK (2.3)	TRIB1 (2.2)	ZHX3 (2.0)	AP1M2 (2.0)	NT5DC1 (1.9)	PLEC (1.9)	SLC22A1 (1.8)	HAVCR1 (1.8)	PVR (1.7)
GO:0004714	transmembrane receptor protein tyrosine kinase activity	0.42	> 0.20	PVRL2 (3.2)	PLEKHH2 (2.5)	LPAR2 (2.5)	MYLIP (2.2)	NYNRIN (2.1)	CELSR2 (2.0)	APOE (1.9)	BCAM (1.7)	SLC44A2 (1.7)	NKPD1 (1.7)
GO:0005159	insulin-like growth factor receptor binding	0.42	> 0.20	KANK2 (2.8)	MYLIP (2.0)	LDLR (2.0)	TRIB1 (1.8)	HLX (1.8)	PVRL2 (1.5)	PLG (1.5)	C12orf47 (1.4)	SLC22A1 (1.4)	HNF1A (1.3)
MP:0008049	increased memory T cell number	0.42	> 0.20	PARP10 (3.3)	BCL3 (3.2)	GMIP (3.0)	ZNF101 (2.9)	RELB (2.7)	OASL (2.6)	TRIB1 (2.3)	TRAFD1 (2.0)	UBXN2B (1.4)	POLK (1.3)
GO:0071156	regulation of cell cycle arrest	0.42	> 0.20	PSRC1 (2.7)	POC5 (2.5)	FEN1 (2.3)	USP1 (2.2)	ZNF180 (2.1)	SUGP1 (1.9)	PSMA5 (1.8)	ENSG00000228044 (1.7)	POLK (1.7)	MAU2 (1.7)
GO:0018105	peptidyl-serine phosphorylation	0.42	> 0.20	C1orf63 (2.1)	ZHX3 (1.9)	PLEKHH2 (1.8)	USP24 (1.8)	PLCG1 (1.8)	C17orf57 (1.7)	GCNT4 (1.7)	PTPN11 (1.5)	DOCK7 (1.4)	CYB561D1 (1.4)
GO:0060420	regulation of heart growth	0.42	> 0.20	C11orf9 (3.4)	GCNT4 (2.2)	PLEKHH2 (1.8)	ENSG00000254235 (1.7)	ANKRD31 (1.6)	ALDH2 (1.5)	TXNL4B (1.5)	HAPLN4 (1.4)	CEACAM19 (1.4)	BLOC1S3 (1.3)
ENSG00000105705	SUGP1 PPI subnetwork	0.42	> 0.20	ILF3 (3.8)	C1orf63 (3.7)	TOP1 (3.0)	USP1 (2.8)	DHX38 (2.5)	BUD13 (2.4)	SMARCA4 (2.4)	SUGP1 (2.2)	FEN1 (2.1)	PTPN11 (1.9)
GO:0042307	positive regulation of protein import into nucleus	0.42	> 0.20	ENSG00000238078 (2.8)	OASL (2.7)	TMEM116 (2.7)	AP1M2 (2.2)	PLEKHH2 (2.2)	GCNT4 (2.2)	ENSG00000228044 (2.0)	FRK (1.9)	MYLIP (1.8)	ENSG00000235545 (1.6)
MP:0005306	abnormal phalanx morphology	0.42	> 0.20	NYNRIN (4.5)	FADS1 (1.9)	MAFB (1.7)	PCSK9 (1.5)	MARK4 (1.5)	LDLR (1.5)	CILP2 (1.4)	CBLC (1.4)	DYNC2LI1 (1.4)	GOT2P1 (1.4)
ENSG00000198130	HIBCH PPI subnetwork	0.42	> 0.20	TOMM40 (3.7)	NAA25 (3.3)	QTRT1 (3.1)	ZNF259 (3.1)	DHODH (3.0)	MAPKAPK5 (2.8)	CARM1 (2.5)	DDX56 (2.4)	ADAM1 (2.1)	C12orf43 (1.8)
ENSG00000171208	NETO2 PPI subnetwork	0.42	> 0.20	POLK (2.4)	C12orf43 (2.3)	CARM1 (1.9)	PPP1R37 (1.6)	C1orf63 (1.5)	NKPD1 (1.5)	COL4A3BP (1.5)	DNAH11 (1.4)	GCNT4 (1.3)	APOC1 (1.3)
GO:0009636	response to toxin	0.42	> 0.20	TM6SF2 (2.5)	ABCG8 (2.3)	ALDH2 (1.9)	ABCG5 (1.9)	DNAH11 (1.9)	CYP7A1 (1.7)	TRAPPC6A (1.7)	RHCE (1.6)	TXNL4B (1.6)	RHD (1.5)
GO:0006677	glycosylceramide metabolic process	0.42	> 0.20	NKPD1 (3.6)	HAVCR1 (2.7)	DNAH11 (2.3)	CYB561D1 (2.2)	COL4A3BP (2.1)	LPIN3 (2.0)	ATP13A1 (1.9)	BLOC1S3 (1.6)	C1orf63 (1.5)	UBXN2B (1.5)
GO:0045072	regulation of interferon-gamma biosynthetic process	0.42	> 0.20	DNAH11 (3.1)	GCNT4 (2.9)	ENSG00000226645 (2.4)	ZNF180 (2.2)	ST3GAL4 (2.1)	TMED4 (1.8)	CYB561D1 (1.8)	BLOC1S3 (1.6)	TXNL4B (1.2)	PVR (1.2)
MP:0004179	transmission ratio distortion	0.42	> 0.20	KIAA1324 (3.3)	PMFBP1 (3.2)	LDLR (2.6)	ABCG8 (1.8)	TSSK6 (1.7)	POC5 (1.6)	BUD13 (1.6)	ITGB3 (1.5)	HMGCR (1.5)	CYP7A1 (1.4)
ENSG00000107854	TNKS2 PPI subnetwork	0.42	> 0.20	PBX4 (3.6)	UBXN2B (3.4)	TMEM116 (2.2)	ENSG00000226645 (2.1)	HAVCR1 (2.0)	COL4A3BP (2.0)	ABO (1.9)	KIAA1324 (1.8)	ENSG00000226648 (1.7)	AMIGO1 (1.7)
ENSG00000189091	SF3B3 PPI subnetwork	0.42	> 0.20	ILF3 (4.1)	C1orf63 (3.5)	DHX38 (3.4)	TOP1 (3.2)	SUGP1 (3.2)	SMARCA4 (3.1)	BUD13 (3.0)	USP1 (2.3)	QTRT1 (2.2)	FEN1 (2.2)
GO:0051052	regulation of DNA metabolic process	0.42	> 0.20	POLK (3.4)	HAVCR1 (2.5)	C17orf57 (2.1)	POC5 (2.0)	BUD13 (2.0)	ENSG00000226645 (1.9)	GCNT4 (1.8)	GEMIN7 (1.8)	BLOC1S3 (1.7)	USP1 (1.3)
ENSG00000023287	RB1CC1 PPI subnetwork	0.42	> 0.20	OASL (2.6)	PARP10 (2.4)	TRAFD1 (2.4)	ZNF180 (2.3)	NT5DC1 (2.1)	CYB561D1 (2.0)	CETP (1.8)	ENSG00000238078 (1.8)	TXNL4B (1.6)	FRK (1.5)
MP:0005348	increased T cell proliferation	0.42	> 0.20	RELB (3.0)	PBX4 (2.6)	GMIP (2.2)	RHCE (2.1)	RHD (2.0)	CETP (2.0)	BCL3 (1.9)	SLC44A2 (1.9)	TRAFD1 (1.8)	PARP10 (1.6)
GO:0040012	regulation of locomotion	0.42	> 0.20	PVR (3.0)	PVRL2 (2.9)	HLX (2.6)	ENSG00000254235 (2.5)	CETP (2.2)	MAFB (2.2)	KANK2 (1.8)	APOE (1.7)	SLC44A2 (1.5)	PLEKHH2 (1.5)
GO:0045351	type I interferon biosynthetic process	0.42	> 0.20	PARP10 (3.8)	OASL (3.5)	TRAFD1 (3.0)	ATP13A1 (1.9)	ZNF180 (1.8)	GEMIN7 (1.8)	CYB561D1 (1.7)	ENSG00000228044 (1.5)	ZNF101 (1.5)	C17orf57 (1.4)
ENSG00000141968	VAV1 PPI subnetwork	0.42	> 0.20	GMIP (3.4)	GATAD2A (2.6)	DNM2 (2.5)	SLC44A2 (2.5)	SMARCA4 (2.4)	SH2B3 (2.2)	PLCG1 (2.1)	C1orf63 (1.9)	ZNF101 (1.8)	MAFB (1.8)
MP:0003809	abnormal hair shaft morphology	0.42	> 0.20	AP1M2 (3.9)	CBLC (2.8)	CYB561D1 (2.2)	CELSR2 (2.1)	HMGCR (2.0)	NKPD1 (1.8)	LDLR (1.8)	BCAM (1.5)	FADS1 (1.5)	MAFB (1.3)
MP:0001377	abnormal mating frequency	0.42	> 0.20	GCNT4 (3.5)	ST3GAL4 (2.5)	C17orf57 (2.4)	ENSG00000238078 (2.1)	PCSK9 (2.0)	ANKRD31 (1.9)	NKPD1 (1.8)	ITGB3 (1.7)	SLC44A2 (1.7)	TMED4 (1.6)
GO:0042626	ATPase activity, coupled to transmembrane movement of substances	0.42	> 0.20	CLPTM1 (3.4)	ATP13A1 (3.4)	GRINA (2.9)	TMEM116 (2.8)	SORT1 (2.6)	HAPLN4 (2.2)	COL4A3BP (2.1)	C12orf51 (2.0)	GMPR (2.0)	USP24 (1.9)
GO:0015833	peptide transport	0.42	> 0.20	KIAA1324 (4.7)	HNF1A (2.7)	ANKRD31 (2.5)	ENSG00000228044 (2.2)	COL4A3BP (2.0)	HAPLN4 (2.0)	ABO (1.8)	ENSG00000254235 (1.8)	PLEKHH2 (1.8)	NPC1L1 (1.8)
MP:0000067	osteopetrosis	0.42	> 0.20	GMIP (3.7)	APOE (3.5)	ITGB3 (3.0)	APOC1 (2.9)	SORT1 (2.5)	MAFB (2.4)	SH2B3 (2.2)	DNM2 (1.7)	PARP10 (1.7)	TOMM40 (1.7)
MP:0001236	abnormal epidermis stratum spinosum morphology	0.42	> 0.20	CBLC (4.3)	CELSR2 (3.8)	AP1M2 (3.8)	C17orf57 (2.7)	BCAM (2.5)	NKPD1 (2.4)	PLEC (2.3)	YIPF2 (1.7)	DNM2 (1.7)	TM6SF2 (1.6)
ENSG00000177606	JUN PPI subnetwork	0.42	> 0.20	TRIB1 (5.8)	BCL3 (3.7)	HLX (3.1)	ATXN2 (2.8)	MAFB (1.8)	CARM1 (1.8)	RELB (1.7)	MAU2 (1.6)	SMARCA4 (1.5)	GRINA (1.5)
KEGG_RIBOFLAVIN_METABOLISM	KEGG_RIBOFLAVIN_METABOLISM	0.42	> 0.20	ST3GAL4 (3.0)	SORT1 (2.1)	CYB561D1 (1.9)	APOE (1.8)	ZNF101 (1.7)	APOC1 (1.7)	ABO (1.6)	TM6SF2 (1.5)	YIPF2 (1.4)	CILP2 (1.4)
ENSG00000197386	HTT PPI subnetwork	0.42	> 0.20	PPP1R37 (3.7)	SMARCA4 (2.9)	CARM1 (2.6)	C12orf51 (2.3)	PLCG1 (2.3)	ATXN2 (2.1)	SARS (2.0)	MARK4 (1.9)	FADS1 (1.5)	ATXN7L2 (1.4)
GO:0022624	proteasome accessory complex	0.42	> 0.20	PSMA5 (5.0)	TOMM40 (2.5)	NT5DC1 (2.3)	TRAFD1 (2.3)	NAA25 (1.8)	SUGP1 (1.7)	ENSG00000235545 (1.6)	TXNL4B (1.5)	SARS (1.5)	PTPN11 (1.4)
REACTOME_GAP_JUNCTION_DEGRADATION	REACTOME_GAP_JUNCTION_DEGRADATION	0.42	> 0.20	TIMD4 (2.5)	HAVCR1 (2.2)	CETP (2.1)	C1orf63 (2.1)	FRK (2.1)	APOE (2.0)	CLPTM1 (2.0)	SUGP1 (1.8)	SARS (1.7)	COL4A3BP (1.6)
GO:0090136	epithelial cell-cell adhesion	0.42	> 0.20	HNF1A (3.0)	CBLC (2.8)	ENSG00000254235 (2.2)	AMIGO1 (2.2)	ENSG00000226648 (2.1)	LPIN3 (2.1)	PMFBP1 (2.0)	PBX4 (2.0)	BLOC1S3 (1.7)	CILP2 (1.7)
GO:0006004	fucose metabolic process	0.42	> 0.20	FRK (3.9)	CYB561D1 (2.8)	CBLC (2.5)	LPIN3 (2.3)	ERP29 (1.8)	NT5DC1 (1.7)	TMEM57 (1.7)	YIPF2 (1.6)	ZNF180 (1.6)	TMEM50A (1.6)
ENSG00000161203	AP2M1 PPI subnetwork	0.42	> 0.20	CETP (3.8)	CLPTM1 (3.4)	TIMD4 (3.1)	MARK4 (3.1)	OGDH (2.6)	PPP1R37 (2.3)	DNM2 (2.1)	GRINA (2.1)	TRAPPC6A (1.9)	SLC44A2 (1.9)
ENSG00000119917	IFIT3 PPI subnetwork	0.42	> 0.20	OASL (10.1)	PARP10 (3.7)	TRAFD1 (2.7)	USP1 (2.4)	TXNL4B (2.2)	ATP13A1 (2.0)	DHODH (2.0)	SUGP1 (1.7)	LPAR2 (1.7)	ENSG00000226648 (1.7)
GO:0042744	hydrogen peroxide catabolic process	0.42	> 0.20	GOT2P1 (2.9)	MOSC1 (2.6)	DNAH11 (2.6)	PBX4 (2.4)	C19orf52 (2.2)	ADAM1 (2.1)	RHCE (1.9)	AMIGO1 (1.9)	LPIN3 (1.8)	RHD (1.8)
ENSG00000196586	MYO6 PPI subnetwork	0.42	> 0.20	FRK (2.8)	SH2B3 (2.3)	NPC1L1 (2.2)	KANK2 (2.1)	PVR (2.1)	PTPN11 (1.9)	ADAM1 (1.8)	HLX (1.8)	TMEM116 (1.7)	BRAP (1.7)
GO:0019887	protein kinase regulator activity	0.42	> 0.20	ITGB3 (2.4)	NCAN (2.3)	MYLIP (1.9)	TRAFD1 (1.9)	TRIB1 (1.7)	DYNC2LI1 (1.6)	TSSK6 (1.6)	APOB (1.4)	ST3GAL4 (1.4)	SORT1 (1.4)
ENSG00000163599	CTLA4 PPI subnetwork	0.42	> 0.20	PBX4 (3.3)	TRAFD1 (2.6)	COL4A3BP (2.4)	GRINA (2.1)	ZNF101 (2.0)	GPAM (1.9)	TIMD4 (1.9)	MOSC1 (1.8)	PLCG1 (1.8)	SLC44A2 (1.6)
ENSG00000164399	IL3 PPI subnetwork	0.42	> 0.20	BCL3 (3.4)	HLX (3.3)	RELB (3.0)	TIMD4 (2.4)	GMIP (2.2)	CETP (2.0)	SH2B3 (1.5)	GRINA (1.3)	LPA (1.2)	PARP10 (1.2)
ENSG00000130956	HABP4 PPI subnetwork	0.42	> 0.20	BUD13 (2.3)	C11orf9 (2.3)	MYLIP (2.1)	NYNRIN (2.0)	RELB (1.8)	ZNF259 (1.7)	PLCG1 (1.6)	ATXN7L2 (1.6)	SMARCA4 (1.5)	C12orf43 (1.5)
GO:0045907	positive regulation of vasoconstriction	0.42	> 0.20	C17orf57 (3.4)	ENSG00000254235 (3.0)	C12orf47 (2.6)	ITGB3 (2.5)	GCNT4 (2.0)	POLK (2.0)	GMPR (1.9)	SYPL2 (1.8)	TSSK6 (1.7)	CETP (1.7)
MP:0000474	abnormal foregut morphology	0.42	> 0.20	C11orf9 (3.2)	PVRL2 (3.1)	ABO (3.0)	BCAM (2.4)	LPAR2 (2.4)	PLEKHH2 (2.3)	KANK2 (2.1)	AP1M2 (2.0)	NYNRIN (2.0)	ENSG00000226648 (1.8)
MP:0008477	decreased spleen red pulp amount	0.42	> 0.20	CILP2 (3.5)	RHD (2.8)	GMIP (2.5)	RHCE (2.4)	MAFB (2.4)	BCL3 (2.1)	GMPR (1.6)	TRAPPC6A (1.5)	HLX (1.3)	AMIGO1 (1.3)
MP:0001196	shiny skin	0.42	> 0.20	NKPD1 (5.1)	CBLC (4.7)	AP1M2 (3.3)	CEACAM19 (2.8)	BCAM (2.3)	LPIN3 (2.3)	CELSR2 (2.2)	C17orf57 (2.0)	ERP29 (1.7)	PLEC (1.4)
MP:0001802	arrested B cell differentiation	0.42	> 0.20	GMIP (2.9)	SMARCA4 (2.8)	ZNF101 (2.5)	HLX (2.1)	CYB561D1 (1.8)	GPAM (1.7)	GCNT4 (1.6)	GRINA (1.4)	TIMD4 (1.3)	RELB (1.3)
KEGG_RNA_POLYMERASE	KEGG_RNA_POLYMERASE	0.42	> 0.20	GEMIN7 (4.1)	ZNF259 (3.3)	DHODH (2.5)	QTRT1 (2.5)	DDX56 (2.2)	ENSG00000226645 (2.1)	C12orf43 (2.0)	TXNL4B (1.9)	TOMM40 (1.9)	DNAH11 (1.9)
GO:0022412	cellular process involved in reproduction in multicellular organism	0.42	> 0.20	GCNT4 (3.9)	PMFBP1 (3.9)	CEACAM19 (3.0)	ENSG00000226645 (2.9)	TSSK6 (2.3)	ENSG00000228044 (2.2)	DNAH11 (1.7)	ANKRD31 (1.5)	POLK (1.2)	NKPD1 (1.1)
MP:0000711	thymus cortex hypoplasia	0.42	> 0.20	ATP13A1 (2.5)	CYB561D1 (2.5)	DNM2 (2.5)	GMIP (2.3)	BCL3 (2.2)	PBX4 (2.2)	PARP10 (2.0)	RELB (2.0)	PLEC (1.9)	KANK2 (1.8)
ENSG00000111596	CNOT2 PPI subnetwork	0.42	> 0.20	ATXN2 (2.7)	SARS (2.2)	TXNL4B (2.1)	TMEM57 (2.0)	C1orf63 (1.9)	DNAH11 (1.8)	BUD13 (1.7)	TRAPPC6A (1.6)	C17orf57 (1.6)	BLOC1S3 (1.6)
GO:0015980	energy derivation by oxidation of organic compounds	0.42	> 0.20	OGDH (4.5)	ACAD10 (3.8)	GOT2P1 (3.1)	ENSG00000238078 (2.5)	HAPLN4 (2.2)	C12orf47 (2.1)	GMPR (2.0)	SYPL2 (1.8)	GPAM (1.6)	SORT1 (1.6)
MP:0004830	short incisors	0.42	> 0.20	CILP2 (3.1)	MYLIP (2.8)	GCNT4 (2.2)	PLEC (2.1)	FRK (2.0)	MAFB (2.0)	DNAH11 (1.8)	HNF1A (1.6)	ABO (1.5)	APOE (1.3)
ENSG00000140600	SH3GL3 PPI subnetwork	0.42	> 0.20	DNM2 (4.1)	PPP1R37 (2.7)	OASL (2.3)	ERP29 (2.2)	YIPF2 (2.2)	CLPTM1 (2.0)	SARS (2.0)	COL4A3BP (2.0)	NT5DC1 (1.9)	PARP10 (1.8)
GO:0033238	regulation of cellular amine metabolic process	0.42	> 0.20	PSMA5 (4.1)	TRAFD1 (2.4)	NT5DC1 (2.1)	NAA25 (2.1)	C12orf47 (2.1)	TXNL4B (1.6)	ENSG00000254235 (1.5)	TOMM40 (1.4)	SUGP1 (1.4)	TMEM50A (1.1)
ENSG00000147536	GINS4 PPI subnetwork	0.42	> 0.20	FEN1 (7.4)	USP1 (4.6)	ZNF180 (2.4)	DHX38 (1.9)	ILF3 (1.8)	DNAH11 (1.7)	DHODH (1.6)	HAPLN4 (1.2)	ENSG00000238078 (1.1)	GOT2P1 (1.1)
GO:0044003	modification by symbiont of host morphology or physiology	0.42	> 0.20	ANKRD31 (2.4)	ST3GAL4 (2.0)	DNAH11 (1.9)	OASL (1.9)	ANGPTL3 (1.7)	POLK (1.6)	LPA (1.5)	SLC22A1 (1.5)	GMPR (1.5)	C1orf63 (1.4)
ENSG00000166855	CLPX PPI subnetwork	0.42	> 0.20	GMPR (3.0)	SARS (2.8)	C19orf52 (2.2)	TXNL4B (2.2)	QTRT1 (2.0)	DDX56 (1.8)	ZNF259 (1.6)	HAVCR1 (1.5)	DHODH (1.5)	CEACAM19 (1.4)
ENSG00000142937	RPS8 PPI subnetwork	0.42	> 0.20	DDX56 (4.2)	QTRT1 (3.2)	NAA25 (3.1)	ZNF259 (2.7)	TOMM40 (2.5)	TOP1 (2.4)	SARS (2.3)	DHX38 (2.3)	SUGP1 (2.1)	DHODH (2.1)
ENSG00000101096	NFATC2 PPI subnetwork	0.42	> 0.20	TRIB1 (5.9)	PVR (2.5)	ANKRD31 (2.5)	TMEM50A (2.4)	GEMIN7 (2.0)	POC5 (1.9)	ENSG00000228044 (1.8)	RPH3A (1.7)	COL4A3BP (1.6)	BCL3 (1.5)
GO:0006289	nucleotide-excision repair	0.42	> 0.20	NT5DC1 (2.8)	ZNF180 (2.4)	SUGP1 (2.2)	GEMIN7 (2.2)	BLOC1S3 (2.1)	TRAPPC6A (2.0)	DYNC2LI1 (1.9)	TXNL4B (1.9)	UBXN2B (1.8)	GOT2P1 (1.6)
GO:0071108	protein K48-linked deubiquitination	0.42	> 0.20	ZNF180 (3.3)	NKPD1 (2.6)	GCNT4 (2.3)	ENSG00000238078 (2.3)	USP24 (2.2)	AMIGO1 (1.9)	CYB561D1 (1.7)	HAVCR1 (1.7)	CEACAM19 (1.7)	YIPF2 (1.6)
MP:0010024	increased total body fat amount	0.42	> 0.20	GPAM (3.3)	MOSC1 (2.5)	CETP (2.4)	AMIGO1 (2.4)	TIMD4 (2.1)	KIAA1324 (2.0)	PLEKHH2 (1.9)	ABCG5 (1.8)	ZHX3 (1.8)	CELSR2 (1.7)
GO:0006182	cGMP biosynthetic process	0.42	> 0.20	TSSK6 (3.4)	HAVCR1 (3.0)	C12orf47 (2.2)	ENSG00000226648 (2.0)	NKPD1 (2.0)	ANKRD31 (1.6)	POC5 (1.5)	TMEM116 (1.5)	PMFBP1 (1.4)	MYLIP (1.3)
GO:0048011	nerve growth factor receptor signaling pathway	0.42	> 0.20	MARK4 (3.0)	DNM2 (2.3)	ZHX3 (2.2)	CLPTM1 (2.2)	CYB561D1 (2.1)	SH2B3 (2.0)	ADAM1 (2.0)	MAU2 (1.9)	GATAD2A (1.9)	PLEC (1.7)
ENSG00000168148	HIST3H3 PPI subnetwork	0.43	> 0.20	USP1 (3.8)	FEN1 (3.2)	TXNL4B (2.1)	BUD13 (1.8)	TOP1 (1.8)	UBXN2B (1.7)	DHX38 (1.7)	MAU2 (1.7)	C19orf52 (1.6)	NT5DC1 (1.5)
ENSG00000124762	CDKN1A PPI subnetwork	0.43	> 0.20	FEN1 (4.3)	USP1 (3.4)	HLX (2.3)	TRIB1 (2.2)	PSRC1 (2.2)	GMPR (1.6)	PSMA5 (1.6)	MAFB (1.4)	RHD (1.4)	TOMM40 (1.3)
ENSG00000083896	YTHDC1 PPI subnetwork	0.43	> 0.20	ADAM1 (4.0)	ITGB3 (2.9)	GATAD2A (2.6)	TRIB1 (1.9)	PPP1R37 (1.8)	TIMD4 (1.8)	SH2B3 (1.6)	ILF3 (1.6)	CETP (1.5)	FADS1 (1.3)
GO:0051117	ATPase binding	0.43	> 0.20	ST3GAL4 (3.2)	ENSG00000254235 (2.3)	BCAM (2.1)	C1orf63 (2.0)	SORT1 (1.8)	TMEM116 (1.7)	TMED4 (1.6)	AP1M2 (1.6)	TMEM50A (1.5)	PLG (1.5)
ENSG00000138193	PLCE1 PPI subnetwork	0.43	> 0.20	PARP10 (2.9)	CYB561D1 (2.4)	FRK (2.2)	PTPN11 (2.1)	OASL (2.0)	ZNF180 (1.9)	TOMM40 (1.8)	PVR (1.6)	DOCK7 (1.6)	USP24 (1.5)
MP:0002836	abnormal chorion morphology	0.43	> 0.20	PVRL2 (2.5)	ATXN2 (2.0)	ABO (1.9)	TSSK6 (1.8)	BCAM (1.7)	HLX (1.6)	CLPTM1 (1.6)	PPP1R37 (1.6)	LDLR (1.6)	TRIB1 (1.5)
GO:0048610	cellular process involved in reproduction	0.43	> 0.20	TSSK6 (3.9)	PMFBP1 (2.6)	ANKRD31 (2.4)	ENSG00000228044 (1.7)	NKPD1 (1.2)	PLEKHH2 (1.1)	ABO (1.0)	UBXN2B (0.9)	USP1 (0.9)	ATXN7L2 (0.8)
MP:0006387	abnormal T cell number	0.43	> 0.20	RELB (5.8)	BCL3 (4.8)	PARP10 (4.1)	GMIP (3.3)	GRINA (2.6)	APOC1 (2.6)	C12orf47 (2.0)	MAFB (2.0)	LPAR2 (1.7)	FRK (1.7)
ENSG00000159063	ALG8 PPI subnetwork	0.43	> 0.20	LDLR (2.6)	KIAA1324 (2.6)	HMGCR (2.6)	FADS2 (2.4)	CYP7A1 (2.2)	ATP13A1 (1.9)	COL4A3BP (1.8)	TMED4 (1.7)	TMEM50A (1.6)	SLC44A2 (1.6)
GO:0048384	retinoic acid receptor signaling pathway	0.43	> 0.20	ST3GAL4 (2.3)	BLOC1S3 (2.2)	CILP2 (2.1)	PMFBP1 (2.1)	CYP7A1 (1.9)	ENSG00000228044 (1.8)	ENSG00000235545 (1.8)	PPP1R37 (1.4)	TSSK6 (1.4)	MAU2 (1.4)
MP:0001222	epidermal hyperplasia	0.43	> 0.20	CBLC (6.1)	PLEC (3.4)	AP1M2 (3.1)	BCAM (2.2)	APOC1 (2.1)	GMIP (2.0)	DNM2 (1.9)	BCL3 (1.7)	LPIN3 (1.6)	CYB561D1 (1.6)
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	REACTOME_ACTIVATION_OF_GENES_BY_ATF4	0.43	> 0.20	SARS (5.0)	PVR (3.4)	TXNL4B (3.0)	POC5 (2.8)	TRIB1 (2.7)	DHODH (2.7)	MAPKAPK5 (2.6)	PMFBP1 (1.8)	TRAPPC6A (1.7)	TMEM116 (1.6)
ENSG00000114054	PCCB PPI subnetwork	0.43	> 0.20	FADS1 (3.2)	FADS2 (2.8)	NT5DC1 (2.4)	COL4A3BP (2.4)	PSMA5 (2.2)	GPAM (2.0)	OASL (1.9)	DOCK7 (1.9)	SARS (1.8)	DYNC2LI1 (1.8)
ENSG00000150093	ITGB1 PPI subnetwork	0.43	> 0.20	KANK2 (3.6)	APOE (3.2)	ITGB3 (3.2)	PVRL2 (2.8)	PLEC (2.6)	BCAM (2.4)	ST3GAL4 (2.4)	PLEKHH2 (2.2)	SH2B3 (2.1)	CETP (2.0)
ENSG00000075945	KIFAP3 PPI subnetwork	0.43	> 0.20	PLCG1 (3.1)	DYNC2LI1 (2.8)	COL4A3BP (2.6)	MARK4 (2.3)	POC5 (2.2)	UBXN2B (2.1)	DOCK7 (2.0)	SLC44A2 (1.8)	ABO (1.7)	SARS (1.7)
GO:0002026	regulation of the force of heart contraction	0.43	> 0.20	ENSG00000226648 (2.7)	ACAD10 (2.6)	PPP1R37 (2.2)	TXNL4B (2.1)	ENSG00000235545 (2.0)	ST3GAL4 (1.7)	TMEM116 (1.7)	HAPLN4 (1.7)	C12orf47 (1.5)	ERP29 (1.5)
KEGG_P53_SIGNALING_PATHWAY	KEGG_P53_SIGNALING_PATHWAY	0.43	> 0.20	POLK (4.5)	PSRC1 (3.3)	FEN1 (2.1)	PARP10 (1.4)	TRAFD1 (1.4)	CETP (1.2)	MYLIP (1.2)	ENSG00000228044 (1.1)	KANK2 (1.0)	AP1M2 (1.0)
GO:0040017	positive regulation of locomotion	0.43	> 0.20	PVR (3.3)	PVRL2 (2.5)	AP1M2 (2.3)	MAFB (2.3)	HLX (2.0)	CETP (1.8)	ZNF101 (1.8)	APOE (1.7)	PTPN11 (1.7)	ENSG00000228044 (1.6)
GO:0006790	sulfur compound metabolic process	0.43	> 0.20	TM6SF2 (2.5)	SLC22A1 (2.5)	ALDH2 (2.3)	ABCG8 (2.2)	LPA (1.9)	NT5DC1 (1.8)	TMEM116 (1.7)	TMED4 (1.6)	CYP7A1 (1.5)	MOSC1 (1.4)
ENSG00000108055	SMC3 PPI subnetwork	0.43	> 0.20	ILF3 (2.8)	USP1 (2.5)	SMARCA4 (2.5)	POC5 (2.4)	ACAD10 (2.1)	SUGP1 (1.7)	FEN1 (1.6)	BRAP (1.6)	ATXN2 (1.6)	TOP1 (1.6)
ENSG00000162188	GNG3 PPI subnetwork	0.43	> 0.20	ITGB3 (3.8)	TM6SF2 (1.9)	TMEM50A (1.9)	CETP (1.7)	TXNL4B (1.5)	DNM2 (1.4)	ENSG00000235545 (1.4)	CYP7A1 (1.4)	HLX (1.3)	GCNT4 (1.3)
GO:0007623	circadian rhythm	0.43	> 0.20	ENSG00000226648 (2.9)	HNF1A (2.2)	ENSG00000228044 (2.1)	HAPLN4 (2.1)	ENSG00000235545 (1.9)	ENSG00000254235 (1.8)	TRIB1 (1.7)	ABO (1.4)	DNAH11 (1.4)	ZHX3 (1.3)
GO:0051324	prophase	0.43	> 0.20	ANKRD31 (4.3)	C17orf57 (2.3)	TSSK6 (1.9)	ENSG00000238078 (1.7)	NKPD1 (1.7)	ENSG00000228044 (1.5)	LPIN3 (1.4)	GOT2P1 (1.3)	AP1M2 (1.3)	TMEM116 (1.3)
ENSG00000147669	POLR2K PPI subnetwork	0.43	> 0.20	BUD13 (3.5)	ILF3 (3.3)	DHX38 (3.2)	SUGP1 (2.9)	TOP1 (2.6)	C1orf63 (2.3)	MAPKAPK5 (2.3)	SMARCA4 (2.3)	DDX56 (2.2)	USP1 (2.1)
ENSG00000130340	SNX9 PPI subnetwork	0.43	> 0.20	AP1M2 (3.9)	PLEC (2.1)	GMIP (2.0)	KIAA1324 (1.9)	PTPN11 (1.9)	DNM2 (1.9)	ENSG00000238078 (1.8)	CETP (1.7)	YIPF2 (1.5)	HNF1A (1.5)
ENSG00000088035	ALG6 PPI subnetwork	0.43	> 0.20	ACAD10 (3.4)	ERP29 (2.4)	YIPF2 (2.3)	CLPTM1 (2.3)	MAU2 (2.2)	TMEM50A (2.1)	ENSG00000235545 (2.0)	KIAA1324 (2.0)	QTRT1 (2.0)	TSSK6 (1.9)
GO:0002347	response to tumor cell	0.43	> 0.20	DNAH11 (4.0)	ADAM1 (2.5)	ZNF180 (2.1)	ZNF101 (1.9)	LPIN3 (1.9)	CYB561D1 (1.8)	BLOC1S3 (1.8)	CEACAM19 (1.6)	GEMIN7 (1.5)	HAVCR1 (1.3)
ENSG00000099246	RAB18 PPI subnetwork	0.43	> 0.20	COL4A3BP (3.9)	TMEM50A (3.0)	PSMA5 (2.6)	DYNC2LI1 (1.8)	SLC44A2 (1.8)	MARK4 (1.8)	POLK (1.7)	OGDH (1.6)	KANK2 (1.6)	DNAH11 (1.4)
GO:0006521	regulation of cellular amino acid metabolic process	0.43	> 0.20	PSMA5 (4.2)	NT5DC1 (2.6)	TRAFD1 (2.4)	NAA25 (2.3)	C17orf57 (1.6)	TXNL4B (1.6)	SUGP1 (1.5)	ZNF180 (1.5)	CYB561D1 (1.5)	ENSG00000254235 (1.5)
ENSG00000135218	CD36 PPI subnetwork	0.43	> 0.20	ITGB3 (5.8)	FADS2 (4.0)	FADS1 (2.6)	PLEC (2.6)	ENSG00000238078 (2.6)	CILP2 (2.6)	APOE (2.5)	HMGCR (2.5)	APOC1 (1.7)	SLC44A2 (1.7)
GO:0001676	long-chain fatty acid metabolic process	0.43	> 0.20	ENSG00000254235 (3.7)	CYB561D1 (2.5)	NKPD1 (2.4)	CYP7A1 (2.1)	GMPR (1.8)	AMIGO1 (1.8)	PMFBP1 (1.6)	HAPLN4 (1.5)	ENSG00000238078 (1.5)	FRK (1.5)
MP:0005095	decreased T cell proliferation	0.43	> 0.20	RELB (3.5)	GMIP (3.2)	BCL3 (2.7)	SH2B3 (1.8)	ZNF101 (1.7)	PARP10 (1.6)	PBX4 (1.6)	CETP (1.2)	MAFB (1.2)	HAVCR1 (1.2)
GO:0004180	carboxypeptidase activity	0.43	> 0.20	ERP29 (3.7)	NPC1L1 (2.8)	TMED4 (2.3)	APOB (2.1)	FRK (2.0)	NKPD1 (2.0)	TM6SF2 (2.0)	ALDH2 (1.9)	PMFBP1 (1.9)	HAPLN4 (1.8)
ENSG00000033327	GAB2 PPI subnetwork	0.43	> 0.20	SLC44A2 (2.8)	ITGB3 (2.7)	DNM2 (2.6)	PLCG1 (2.5)	GMIP (2.3)	MARK4 (2.1)	DHX38 (1.6)	ZHX3 (1.6)	OGDH (1.5)	PTPN11 (1.5)
GO:0007062	sister chromatid cohesion	0.43	> 0.20	ABO (2.7)	ANKRD31 (2.5)	POC5 (2.1)	USP1 (1.8)	C19orf52 (1.6)	ENSG00000226648 (1.5)	C12orf47 (1.4)	BUD13 (1.4)	ILF3 (1.3)	PSRC1 (1.3)
ENSG00000073111	MCM2 PPI subnetwork	0.43	> 0.20	FEN1 (5.9)	USP1 (5.2)	ENSG00000235545 (1.9)	PSRC1 (1.8)	MAU2 (1.5)	POC5 (1.3)	DHODH (1.3)	TMEM116 (1.2)	ILF3 (1.1)	ST3GAL4 (1.1)
MP:0008578	decreased circulating interferon-gamma level	0.43	> 0.20	OASL (5.7)	PARP10 (4.4)	TRAFD1 (3.7)	TIMD4 (3.2)	ZNF101 (2.2)	RELB (2.0)	BCL3 (1.7)	ATP13A1 (1.7)	HLX (1.6)	PBX4 (1.5)
ENSG00000167657	DAPK3 PPI subnetwork	0.43	> 0.20	PVR (3.7)	KANK2 (2.8)	PVRL2 (2.7)	BRAP (2.6)	FRK (2.3)	TRAFD1 (1.9)	AP1M2 (1.8)	LPIN3 (1.8)	ITGB3 (1.8)	SLC22A1 (1.8)
ENSG00000100297	MCM5 PPI subnetwork	0.43	> 0.20	FEN1 (5.8)	USP1 (4.7)	HAPLN4 (2.0)	ENSG00000235545 (2.0)	FADS1 (1.9)	PSRC1 (1.8)	BRAP (1.3)	DDX56 (1.2)	GMPR (1.1)	ENSG00000228044 (1.1)
MP:0002768	small adrenal glands	0.43	> 0.20	GCNT4 (2.6)	FADS1 (2.4)	NYNRIN (2.2)	YIPF2 (2.1)	FADS2 (2.1)	ST3GAL4 (2.0)	MOSC1 (1.8)	DNAH11 (1.7)	TSSK6 (1.5)	GPAM (1.4)
ENSG00000081026	MAGI3 PPI subnetwork	0.43	> 0.20	CELSR2 (3.0)	ST3GAL4 (2.9)	CEACAM19 (2.5)	NCAN (2.2)	PVRL2 (2.2)	TIMD4 (2.0)	ANKRD31 (1.9)	ENSG00000238078 (1.9)	AMIGO1 (1.8)	PVR (1.6)
ENSG00000116604	MEF2D PPI subnetwork	0.43	> 0.20	HLX (2.5)	ANKRD31 (2.4)	ENSG00000226648 (2.2)	SH2B3 (2.2)	DOCK7 (2.1)	CARM1 (2.1)	C12orf51 (2.0)	TRIB1 (1.7)	C17orf57 (1.6)	CEACAM19 (1.5)
GO:0045931	positive regulation of mitotic cell cycle	0.43	> 0.20	DNAH11 (2.4)	CEACAM19 (1.9)	RHD (1.8)	RHCE (1.7)	UBXN2B (1.7)	PSRC1 (1.7)	ENSG00000228044 (1.5)	PMFBP1 (1.5)	ZNF101 (1.5)	BLOC1S3 (1.5)
ENSG00000168439	STIP1 PPI subnetwork	0.43	> 0.20	TOMM40 (3.8)	DDX56 (2.5)	OGDH (2.5)	PSMA5 (2.4)	CLPTM1 (2.4)	NAA25 (2.4)	DHX38 (1.9)	QTRT1 (1.9)	TXNL4B (1.6)	SARS (1.6)
ENSG00000101160	CTSZ PPI subnetwork	0.43	> 0.20	OASL (3.7)	PARP10 (2.3)	TOMM40 (1.7)	CLPTM1 (1.7)	OGDH (1.6)	C12orf43 (1.6)	TMED4 (1.6)	ZNF180 (1.5)	PSRC1 (1.4)	C12orf47 (1.4)
ENSG00000154889	MPPE1 PPI subnetwork	0.43	> 0.20	MAFB (3.0)	CYB561D1 (2.2)	C11orf9 (2.1)	GCNT4 (1.9)	ENSG00000228044 (1.7)	RHCE (1.7)	ANKRD31 (1.6)	TRAFD1 (1.6)	NPC1L1 (1.5)	BLOC1S3 (1.5)
ENSG00000113558	SKP1 PPI subnetwork	0.43	> 0.20	MYLIP (2.1)	FEN1 (1.8)	PSMA5 (1.8)	PTPN11 (1.8)	PSRC1 (1.7)	ZNF180 (1.6)	SARS (1.6)	GATAD2A (1.5)	DOCK7 (1.5)	TRIB1 (1.4)
MP:0004358	bowed tibia	0.43	> 0.20	HMGCR (3.5)	C11orf9 (2.4)	CILP2 (2.1)	FADS1 (2.1)	FADS2 (1.9)	LDLR (1.8)	C17orf57 (1.8)	ENSG00000254235 (1.8)	GPAM (1.8)	PVR (1.6)
ENSG00000182247	UBE2E2 PPI subnetwork	0.43	> 0.20	USP24 (3.0)	TMEM57 (2.9)	BRAP (2.6)	C19orf52 (2.3)	DHX38 (2.2)	CETP (2.2)	PPP1R37 (2.2)	BLOC1S3 (2.1)	CLPTM1 (2.1)	DOCK7 (2.0)
GO:0051219	phosphoprotein binding	0.43	> 0.20	C17orf57 (2.6)	MARK4 (2.6)	TMEM50A (2.2)	PPP1R37 (1.8)	GRINA (1.8)	TSSK6 (1.8)	COL4A3BP (1.6)	CARM1 (1.5)	DHODH (1.5)	CLPTM1 (1.5)
GO:0010042	response to manganese ion	0.43	> 0.20	ABO (2.4)	PBX4 (2.1)	BLOC1S3 (2.0)	C12orf51 (1.9)	HNF1A (1.7)	ENSG00000254235 (1.6)	TSSK6 (1.5)	ALDH2 (1.4)	ENSG00000228044 (1.4)	HP (1.3)
ENSG00000213658	LAT PPI subnetwork	0.43	> 0.20	LPAR2 (3.2)	GMIP (3.1)	ZNF101 (2.6)	MAFB (2.0)	PBX4 (2.0)	PLCG1 (1.9)	ZHX3 (1.9)	TOP1 (1.6)	ITGB3 (1.6)	ABCG8 (1.5)
MP:0006413	increased T cell apoptosis	0.43	> 0.20	ZNF101 (2.9)	PLCG1 (2.8)	APOC4 (2.7)	PBX4 (2.3)	TIMD4 (2.3)	LPA (2.1)	MAFB (2.0)	SLC44A2 (1.8)	ABCG8 (1.6)	SLC22A1 (1.6)
KEGG_N_GLYCAN_BIOSYNTHESIS	KEGG_N_GLYCAN_BIOSYNTHESIS	0.43	> 0.20	ERP29 (4.5)	ATP13A1 (4.1)	CLPTM1 (3.9)	YIPF2 (3.6)	TMEM50A (3.2)	TMED4 (2.9)	CYB561D1 (2.1)	SORT1 (2.0)	TMEM57 (1.9)	SLC44A2 (1.7)
ENSG00000113520	IL4 PPI subnetwork	0.43	> 0.20	BCL3 (3.5)	HLX (3.0)	RELB (2.8)	GMIP (2.5)	TIMD4 (2.4)	CETP (2.1)	ALDH2 (1.7)	LPA (1.6)	SH2B3 (1.3)	PARP10 (1.1)
GO:0050907	detection of chemical stimulus involved in sensory perception	0.43	> 0.20	ENSG00000228044 (3.8)	ENSG00000235545 (3.7)	GOT2P1 (2.2)	DNAH11 (2.0)	PMFBP1 (1.6)	ADAM1 (1.4)	C17orf57 (1.3)	ANKRD31 (1.3)	GCNT4 (1.3)	CYP7A1 (1.1)
REACTOME_MRNA_3:END_PROCESSING	REACTOME_MRNA_3:END_PROCESSING	0.43	> 0.20	C1orf63 (6.0)	TOP1 (3.4)	ILF3 (2.9)	BUD13 (2.5)	USP1 (2.5)	DHODH (2.5)	ENSG00000226645 (2.0)	FEN1 (2.0)	SUGP1 (1.7)	ENSG00000226648 (1.6)
REACTOME_POST:ELONGATION_PROCESSING_OF_INTRON:CONTAINING_PRE:MRNA	REACTOME_POST:ELONGATION_PROCESSING_OF_INTRON:CONTAINING_PRE:MRNA	0.43	> 0.20	C1orf63 (6.0)	TOP1 (3.4)	ILF3 (2.9)	BUD13 (2.5)	USP1 (2.5)	DHODH (2.5)	ENSG00000226645 (2.0)	FEN1 (2.0)	SUGP1 (1.7)	ENSG00000226648 (1.6)
GO:0030826	regulation of cGMP biosynthetic process	0.43	> 0.20	ANKRD31 (3.4)	C12orf47 (2.6)	TSSK6 (2.3)	ENSG00000228044 (2.3)	PMFBP1 (2.1)	MYLIP (1.9)	ZNF180 (1.8)	HAVCR1 (1.6)	ST3GAL4 (1.5)	NKPD1 (1.4)
ENSG00000105048	TNNT1 PPI subnetwork	0.43	> 0.20	SYPL2 (4.9)	ENSG00000228044 (2.4)	GMPR (2.3)	PVRL2 (1.7)	PTPN11 (1.6)	ENSG00000226648 (1.4)	KANK2 (1.3)	BRAP (1.2)	POC5 (1.2)	LPIN3 (1.2)
GO:0008360	regulation of cell shape	0.43	> 0.20	PVRL2 (2.6)	C11orf9 (2.3)	SLC44A2 (2.2)	ENSG00000254235 (1.8)	BCAM (1.6)	SH2B3 (1.6)	ENSG00000235545 (1.5)	RHCE (1.5)	KANK2 (1.5)	AP1M2 (1.5)
ENSG00000183305	MAGEA2B PPI subnetwork	0.43	> 0.20	ATP13A1 (3.1)	OGDH (2.9)	SMARCA4 (2.9)	ILF3 (2.7)	DDX56 (2.6)	CLPTM1 (2.6)	PPP1R37 (2.4)	SARS (2.4)	ACAD10 (2.2)	TMEM57 (2.1)
MP:0004097	abnormal cerebellar cortex morphology	0.43	> 0.20	ATP13A1 (2.7)	ERP29 (2.5)	ALDH2 (2.1)	CETP (2.0)	SORT1 (1.9)	APOE (1.9)	GRINA (1.8)	HAVCR1 (1.8)	PARP10 (1.8)	APOC4 (1.7)
ENSG00000099995	SF3A1 PPI subnetwork	0.43	> 0.20	ILF3 (4.0)	DHX38 (3.6)	SUGP1 (3.3)	C1orf63 (3.2)	BUD13 (3.1)	SMARCA4 (3.0)	MAU2 (2.8)	TOP1 (2.7)	PTPN11 (2.4)	USP1 (2.2)
MP:0004261	abnormal embryonic neuroepithelium morphology	0.43	> 0.20	GATAD2A (3.8)	DOCK7 (3.0)	ATXN2 (2.9)	CLPTM1 (2.6)	MARK4 (2.6)	COL4A3BP (2.3)	DYNC2LI1 (2.3)	ABO (1.8)	MAPKAPK5 (1.8)	SLC44A2 (1.6)
MP:0003799	impaired macrophage chemotaxis	0.43	> 0.20	BCL3 (3.1)	GMIP (2.9)	RELB (2.7)	POLK (2.4)	ITGB3 (2.3)	SH2B3 (2.2)	DNM2 (2.0)	PVR (2.0)	DNAH11 (1.9)	C17orf57 (1.9)
ENSG00000004897	CDC27 PPI subnetwork	0.43	> 0.20	PSRC1 (5.4)	POC5 (3.6)	FEN1 (3.3)	USP1 (2.5)	SUGP1 (1.5)	LPIN3 (1.4)	BRAP (1.4)	ILF3 (1.3)	C1orf63 (1.3)	GEMIN7 (1.3)
MP:0004174	abnormal spine curvature	0.43	> 0.20	NYNRIN (5.5)	SYPL2 (3.6)	CARM1 (2.5)	PLEC (2.3)	NCAN (2.2)	ENSG00000235545 (2.1)	DOCK7 (2.0)	PCSK9 (1.5)	KANK2 (1.5)	ENSG00000226648 (1.4)
MP:0004837	abnormal neural fold formation	0.43	> 0.20	NYNRIN (3.0)	HAPLN4 (2.0)	CARM1 (1.9)	ATP13A1 (1.8)	ABO (1.7)	MARK4 (1.7)	PVRL2 (1.6)	TRIB1 (1.6)	PLCG1 (1.5)	APOE (1.4)
GO:0016072	rRNA metabolic process	0.43	> 0.20	ZNF259 (3.8)	DDX56 (3.5)	TOMM40 (3.2)	DHODH (3.0)	QTRT1 (3.0)	NAA25 (3.0)	C12orf43 (2.6)	POC5 (2.4)	C19orf52 (2.4)	MAPKAPK5 (2.4)
GO:0010761	fibroblast migration	0.43	> 0.20	TMEM116 (3.2)	GCNT4 (2.9)	ENSG00000226648 (2.6)	KANK2 (2.4)	PMFBP1 (2.1)	CYB561D1 (2.0)	DOCK7 (1.8)	AMIGO1 (1.7)	ZNF101 (1.6)	NKPD1 (1.5)
ENSG00000188342	GTF2F2 PPI subnetwork	0.43	> 0.20	ILF3 (3.2)	BUD13 (3.1)	TOP1 (2.9)	SUGP1 (2.9)	USP1 (2.8)	C1orf63 (2.8)	DHX38 (2.5)	SMARCA4 (2.2)	PTPN11 (2.0)	FEN1 (1.9)
ENSG00000103510	KAT8 PPI subnetwork	0.43	> 0.20	BUD13 (3.5)	ATXN2 (2.9)	QTRT1 (2.8)	ATXN7L2 (2.7)	GOT2P1 (2.6)	OGDH (2.5)	C12orf43 (2.4)	DHX38 (2.3)	MAPKAPK5 (2.3)	ZNF259 (1.9)
MP:0005418	abnormal circulating hormone level	0.43	> 0.20	GPAM (4.6)	MOSC1 (3.6)	KIAA1324 (2.2)	ZHX3 (2.0)	C12orf47 (1.9)	ENSG00000254235 (1.7)	ATXN7L2 (1.5)	SORT1 (1.4)	HLX (1.4)	COL4A3BP (1.4)
GO:0031011	Ino80 complex	0.43	> 0.20	SUGP1 (4.1)	MAPKAPK5 (3.7)	TOMM40 (3.2)	ZNF259 (3.0)	ZNF180 (2.8)	C12orf43 (2.6)	POC5 (2.6)	DDX56 (1.8)	DYNC2LI1 (1.7)	MARK4 (1.6)
GO:0033202	DNA helicase complex	0.43	> 0.20	SUGP1 (4.1)	MAPKAPK5 (3.7)	TOMM40 (3.2)	ZNF259 (3.0)	ZNF180 (2.8)	C12orf43 (2.6)	POC5 (2.6)	DDX56 (1.8)	DYNC2LI1 (1.7)	MARK4 (1.6)
GO:0016514	SWI/SNF complex	0.43	> 0.20	CARM1 (4.8)	SMARCA4 (2.8)	NYNRIN (2.6)	GRINA (2.5)	ATXN2 (2.5)	MAU2 (2.4)	SUGP1 (2.3)	C12orf51 (2.3)	CELSR2 (2.3)	MARK4 (1.9)
ENSG00000153317	ASAP1 PPI subnetwork	0.43	> 0.20	ITGB3 (3.1)	SH2B3 (2.8)	PMFBP1 (2.8)	ZHX3 (2.6)	SLC44A2 (2.4)	GMIP (2.3)	DNM2 (2.2)	GATAD2A (2.0)	ABO (1.9)	ADAM1 (1.8)
GO:0001659	temperature homeostasis	0.43	> 0.20	ENSG00000235545 (2.9)	POLK (2.0)	AMIGO1 (1.9)	BLOC1S3 (1.8)	ENSG00000228044 (1.6)	RPH3A (1.6)	ZNF180 (1.5)	CETP (1.4)	ST3GAL4 (1.4)	ACAD10 (1.3)
ENSG00000184787	UBE2G2 PPI subnetwork	0.43	> 0.20	TMED4 (3.1)	COL4A3BP (2.3)	YIPF2 (2.2)	POLK (2.1)	ABCG8 (2.0)	ABCG5 (1.9)	ATP13A1 (1.8)	C12orf51 (1.7)	ATXN2 (1.7)	GRINA (1.7)
ENSG00000124208	TMEM189-UBE2V1 PPI subnetwork	0.43	> 0.20	ZNF101 (4.9)	ENSG00000238078 (2.6)	NCAN (2.1)	PTPN11 (1.8)	OGDH (1.8)	GRINA (1.7)	TMEM116 (1.7)	HNF1A (1.6)	TRAPPC6A (1.5)	ACAD10 (1.5)
ENSG00000136021	SCYL2 PPI subnetwork	0.43	> 0.20	SMARCA4 (3.8)	GATAD2A (3.4)	QTRT1 (3.3)	ILF3 (2.4)	TMEM57 (2.4)	ATP13A1 (2.2)	ERP29 (2.2)	CARM1 (2.1)	TOP1 (2.0)	SARS (2.0)
REACTOME_INFLUENZA_LIFE_CYCLE	REACTOME_INFLUENZA_LIFE_CYCLE	0.43	> 0.20	ILF3 (2.6)	DOCK7 (2.3)	NAA25 (2.0)	DDX56 (1.9)	MOSC1 (1.8)	NKPD1 (1.8)	USP24 (1.6)	USP1 (1.6)	GATAD2A (1.5)	DHX38 (1.4)
ENSG00000012124	CD22 PPI subnetwork	0.43	> 0.20	GMIP (3.7)	MAFB (2.8)	ZHX3 (2.3)	OGDH (2.3)	GPAM (2.2)	SH2B3 (2.0)	ENSG00000226645 (1.9)	KANK2 (1.8)	MARK4 (1.7)	NYNRIN (1.7)
MP:0008826	abnormal splenic cell ratio	0.43	> 0.20	TIMD4 (5.1)	RHD (3.4)	ZNF101 (3.2)	RHCE (2.7)	CETP (2.6)	GMIP (2.4)	BCL3 (2.0)	RELB (1.9)	HAVCR1 (1.8)	SLC44A2 (1.8)
ENSG00000188419	CHM PPI subnetwork	0.43	> 0.20	CEACAM19 (2.9)	AP1M2 (2.5)	ENSG00000238078 (2.2)	COL4A3BP (1.9)	C19orf52 (1.9)	YIPF2 (1.8)	ATXN2 (1.6)	GOT2P1 (1.5)	AMIGO1 (1.5)	CILP2 (1.5)
ENSG00000039319	ZFYVE16 PPI subnetwork	0.43	> 0.20	DOCK7 (3.3)	AMIGO1 (2.1)	CYB561D1 (2.0)	LPIN3 (1.9)	MAFB (1.9)	ENSG00000226648 (1.7)	ENSG00000228044 (1.5)	BRAP (1.5)	ATXN2 (1.4)	POC5 (1.3)
ENSG00000115904	SOS1 PPI subnetwork	0.43	> 0.20	SLC44A2 (4.2)	ZHX3 (3.5)	ITGB3 (2.7)	PLCG1 (2.6)	MAFB (2.5)	KANK2 (2.2)	C11orf9 (2.2)	MYLIP (2.0)	CBLC (2.0)	DNM2 (2.0)
MP:0008246	abnormal leukocyte morphology	0.43	> 0.20	ZNF101 (3.4)	TIMD4 (2.8)	GMIP (2.3)	TRIB1 (2.1)	MYLIP (2.1)	CETP (1.8)	HAVCR1 (1.7)	APOC1 (1.7)	BCL3 (1.7)	APOE (1.3)
REACTOME_ACTIVATION_OF_BH3:ONLY_PROTEINS	REACTOME_ACTIVATION_OF_BH3:ONLY_PROTEINS	0.43	> 0.20	MYLIP (3.3)	RELB (2.0)	FEN1 (1.8)	TRAPPC6A (1.7)	GATAD2A (1.7)	PBX4 (1.6)	PLCG1 (1.5)	ENSG00000254235 (1.5)	LPIN3 (1.5)	MARK4 (1.5)
ENSG00000076003	MCM6 PPI subnetwork	0.43	> 0.20	FEN1 (6.1)	USP1 (5.1)	FADS1 (1.9)	TXNL4B (1.8)	MAU2 (1.6)	DHODH (1.5)	PSRC1 (1.4)	ILF3 (1.4)	FADS2 (1.3)	BRAP (1.2)
GO:0006090	pyruvate metabolic process	0.43	> 0.20	OGDH (3.2)	ACAD10 (2.8)	GOT2P1 (2.5)	TMEM116 (1.9)	GPAM (1.9)	ENSG00000226648 (1.8)	TXNL4B (1.8)	DHODH (1.7)	PMFBP1 (1.6)	UBXN2B (1.6)
ENSG00000165934	CPSF2 PPI subnetwork	0.43	> 0.20	ILF3 (3.8)	DHX38 (3.6)	SMARCA4 (3.0)	TOP1 (3.0)	BUD13 (2.9)	C1orf63 (2.7)	SUGP1 (2.5)	USP1 (2.4)	GATAD2A (2.3)	TOMM40 (2.3)
GO:0048243	norepinephrine secretion	0.43	> 0.20	ZHX3 (2.5)	ANKRD31 (2.4)	GMPR (2.1)	ABO (2.1)	TSSK6 (1.6)	DNAH11 (1.5)	ITGB3 (1.4)	LPIN3 (1.4)	PMFBP1 (1.3)	GOT2P1 (1.3)
MP:0006138	congestive heart failure	0.43	> 0.20	BCAM (2.7)	GPAM (2.4)	SORT1 (2.2)	ANKRD31 (1.7)	UBXN2B (1.6)	POLK (1.5)	PLEC (1.4)	OGDH (1.3)	ACAD10 (1.2)	CEACAM19 (1.0)
GO:0005721	centromeric heterochromatin	0.43	> 0.20	FEN1 (3.5)	USP1 (3.3)	SMARCA4 (2.8)	ILF3 (2.8)	KANK2 (2.6)	FADS1 (2.0)	PTPN11 (1.9)	C12orf51 (1.8)	DNM2 (1.8)	SLC44A2 (1.7)
GO:0016338	calcium-independent cell-cell adhesion	0.43	> 0.20	AP1M2 (5.3)	FRK (3.8)	CBLC (2.5)	ENSG00000228044 (2.3)	YIPF2 (2.1)	CYP7A1 (2.1)	DYNC2LI1 (2.1)	ENSG00000226648 (1.8)	ENSG00000254235 (1.7)	BCAM (1.7)
ENSG00000004864	SLC25A13 PPI subnetwork	0.43	> 0.20	PSMA5 (3.8)	TOMM40 (3.2)	ATP13A1 (3.1)	ATXN2 (2.8)	NYNRIN (2.6)	BRAP (2.1)	NAA25 (1.9)	DDX56 (1.9)	AMIGO1 (1.9)	QTRT1 (1.9)
MP:0000848	abnormal pons morphology	0.43	> 0.20	PBX4 (1.9)	PMFBP1 (1.9)	APOC1 (1.9)	HMGCR (1.8)	ITGB3 (1.8)	DHODH (1.8)	OGDH (1.8)	COL4A3BP (1.8)	FADS1 (1.5)	MAPKAPK5 (1.5)
MP:0008908	increased total fat pad weight	0.43	> 0.20	TIMD4 (2.8)	GPAM (2.4)	APOC1 (2.0)	PVR (2.0)	ALDH2 (2.0)	CETP (1.9)	HP (1.9)	OASL (1.9)	LPIN3 (1.7)	APOE (1.6)
ENSG00000176658	MYO1D PPI subnetwork	0.43	> 0.20	POLK (3.1)	POC5 (2.4)	ITGB3 (2.3)	GEMIN7 (1.8)	HAVCR1 (1.6)	PPP1R37 (1.6)	HLX (1.6)	RELB (1.5)	TMEM50A (1.5)	MOSC1 (1.4)
ENSG00000121989	ACVR2A PPI subnetwork	0.43	> 0.20	PVRL2 (3.3)	SLC22A1 (2.4)	MYLIP (2.0)	ENSG00000226645 (1.9)	NYNRIN (1.8)	PVR (1.8)	ALDH2 (1.6)	ABO (1.6)	MARK4 (1.3)	TMEM57 (1.3)
MP:0001077	abnormal spinal nerve morphology	0.43	> 0.20	PLEKHH2 (2.5)	FADS1 (2.4)	DYNC2LI1 (2.1)	PVR (1.8)	PMFBP1 (1.7)	KANK2 (1.7)	BCAM (1.7)	TRIB1 (1.7)	PVRL2 (1.5)	FADS2 (1.5)
MP:0002027	lung adenocarcinoma	0.43	> 0.20	FEN1 (2.4)	NYNRIN (2.3)	USP1 (2.0)	UBXN2B (2.0)	LPIN3 (1.9)	GMIP (1.8)	MAFB (1.6)	ZNF101 (1.5)	KANK2 (1.4)	CETP (1.3)
MP:0004087	abnormal muscle fiber morphology	0.43	> 0.20	SYPL2 (5.2)	CILP2 (2.4)	ATXN7L2 (1.9)	CEACAM19 (1.9)	USP24 (1.9)	CYB561D1 (1.7)	MYLIP (1.6)	HP (1.5)	AMIGO1 (1.4)	RHD (1.2)
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	0.43	> 0.20	TRIB1 (4.4)	SH2B3 (3.0)	HLX (2.5)	MARK4 (2.3)	PVR (2.1)	COL4A3BP (1.6)	MAPKAPK5 (1.6)	CLPTM1 (1.4)	TOMM40 (1.4)	MAFB (1.4)
MP:0010769	abnormal survival	0.43	> 0.20	ZNF180 (2.6)	TRAPPC6A (2.5)	ENSG00000254235 (1.7)	DYNC2LI1 (1.6)	MYLIP (1.5)	NYNRIN (1.5)	C11orf9 (1.3)	NT5DC1 (1.3)	NKPD1 (1.3)	C1orf63 (1.3)
ENSG00000122778	KIAA1549 PPI subnetwork	0.43	> 0.20	ZHX3 (3.5)	HNF1A (3.5)	CBLC (1.8)	SLC22A1 (1.8)	ST3GAL4 (1.7)	HAVCR1 (1.7)	C12orf51 (1.7)	TMED4 (1.6)	KIAA1324 (1.6)	BCL3 (1.5)
GO:0006360	transcription from RNA polymerase I promoter	0.43	> 0.20	C12orf43 (2.9)	TXNL4B (2.6)	ANKRD31 (2.0)	ZNF259 (1.9)	GEMIN7 (1.9)	DYNC2LI1 (1.9)	MAPKAPK5 (1.7)	POLK (1.6)	DHX38 (1.5)	NAA25 (1.5)
ENSG00000156711	MAPK13 PPI subnetwork	0.43	> 0.20	TRIB1 (7.1)	PVR (2.1)	SH2B3 (1.9)	POLK (1.7)	MYLIP (1.6)	RPH3A (1.3)	ERP29 (1.3)	MAPKAPK5 (1.2)	MAFB (1.2)	NPC1L1 (1.1)
MP:0006341	small first branchial arch	0.43	> 0.20	GATAD2A (3.5)	PLCG1 (2.7)	SLC44A2 (2.5)	RHCE (1.9)	MARK4 (1.8)	ANKRD31 (1.7)	ATXN2 (1.6)	ATP13A1 (1.6)	ENSG00000226648 (1.6)	KANK2 (1.6)
MP:0003222	increased cardiomyocyte apoptosis	0.43	> 0.20	C1orf63 (2.4)	MAFB (2.3)	UBXN2B (2.2)	BCL3 (1.8)	C17orf57 (1.8)	SORT1 (1.7)	HP (1.7)	PLCG1 (1.6)	ACAD10 (1.5)	OGDH (1.4)
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6:ALPHA	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6:ALPHA	0.43	> 0.20	TMED4 (3.7)	ERP29 (3.1)	SARS (2.7)	ADAM1 (2.7)	C12orf47 (2.7)	POC5 (2.3)	MAPKAPK5 (2.3)	DHODH (2.2)	TXNL4B (2.1)	PMFBP1 (2.0)
KEGG_DNA_REPLICATION	KEGG_DNA_REPLICATION	0.43	> 0.20	FEN1 (6.9)	USP1 (5.8)	ZNF180 (2.5)	FADS1 (1.6)	ENSG00000235545 (1.5)	ENSG00000228044 (1.5)	DHODH (1.2)	ILF3 (1.2)	TMEM116 (1.2)	AMIGO1 (1.1)
ENSG00000211895	ENSG00000211895 PPI subnetwork	0.43	> 0.20	DYNC2LI1 (2.5)	MAFB (2.4)	PLEC (2.2)	POLK (2.0)	TRIB1 (1.8)	OGDH (1.8)	BCAM (1.8)	C11orf9 (1.7)	AP1M2 (1.5)	MYLIP (1.4)
ENSG00000115170	ACVR1 PPI subnetwork	0.43	> 0.20	AP1M2 (3.0)	MYLIP (2.6)	CELSR2 (2.6)	CBLC (2.2)	MOSC1 (2.1)	SLC22A1 (2.0)	LPIN3 (2.0)	BLOC1S3 (2.0)	ZNF101 (1.6)	PVRL2 (1.5)
GO:0004437	inositol or phosphatidylinositol phosphatase activity	0.43	> 0.20	C12orf51 (2.5)	SH2B3 (1.9)	TM6SF2 (1.9)	UBXN2B (1.7)	PBX4 (1.7)	POC5 (1.6)	HAPLN4 (1.6)	AMIGO1 (1.5)	BLOC1S3 (1.5)	ST3GAL4 (1.4)
ENSG00000111786	SRSF9 PPI subnetwork	0.43	> 0.20	C1orf63 (4.1)	ILF3 (3.9)	TOP1 (3.0)	DHX38 (2.9)	SMARCA4 (2.6)	USP1 (2.6)	SUGP1 (2.4)	FEN1 (2.2)	QTRT1 (2.2)	BUD13 (2.2)
GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	0.43	> 0.20	C1orf63 (3.3)	BUD13 (3.2)	TOP1 (3.2)	SUGP1 (3.1)	ILF3 (3.0)	DHX38 (2.9)	QTRT1 (2.4)	C12orf43 (2.1)	MAU2 (1.9)	SMARCA4 (1.9)
GO:0000398	nuclear mRNA splicing, via spliceosome	0.43	> 0.20	C1orf63 (3.3)	BUD13 (3.2)	TOP1 (3.2)	SUGP1 (3.1)	ILF3 (3.0)	DHX38 (2.9)	QTRT1 (2.4)	C12orf43 (2.1)	MAU2 (1.9)	SMARCA4 (1.9)
GO:0030522	intracellular receptor mediated signaling pathway	0.43	> 0.20	ENSG00000226648 (2.8)	ATXN2 (2.6)	MAPKAPK5 (2.3)	CYP7A1 (1.9)	FRK (1.8)	MAU2 (1.7)	COL4A3BP (1.5)	TRIB1 (1.5)	C1orf63 (1.3)	SH2B3 (1.3)
GO:0007266	Rho protein signal transduction	0.44	> 0.20	ENSG00000235545 (3.3)	CBLC (3.1)	AP1M2 (2.4)	PVRL2 (2.3)	LPIN3 (2.3)	LPAR2 (2.1)	PLCG1 (2.1)	GATAD2A (2.0)	SLC44A2 (1.9)	PBX4 (1.7)
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	0.44	> 0.20	NAA25 (3.1)	DDX56 (2.9)	DOCK7 (2.8)	POC5 (2.6)	ILF3 (2.4)	MAPKAPK5 (2.4)	USP24 (2.3)	BUD13 (2.2)	DHX38 (2.2)	USP1 (2.1)
ENSG00000142168	SOD1 PPI subnetwork	0.44	> 0.20	KIAA1324 (4.2)	AP1M2 (2.6)	C19orf52 (2.3)	ENSG00000235545 (2.2)	TXNL4B (2.0)	C1orf63 (1.9)	MYLIP (1.9)	HAPLN4 (1.6)	RPH3A (1.5)	CYP7A1 (1.4)
ENSG00000214114	MYCBP PPI subnetwork	0.44	> 0.20	NCAN (2.9)	ENSG00000235545 (2.6)	ABO (2.1)	NYNRIN (2.0)	ZNF101 (1.7)	NPC1L1 (1.6)	MYLIP (1.4)	HLX (1.4)	PMFBP1 (1.4)	RPH3A (1.4)
MP:0008522	abnormal lymph node germinal center morphology	0.44	> 0.20	RELB (3.1)	GMIP (2.5)	ZNF101 (2.3)	SH2B3 (2.0)	SLC44A2 (2.0)	APOE (1.9)	CETP (1.8)	TIMD4 (1.7)	PVRL2 (1.4)	ALDH2 (1.4)
MP:0006410	abnormal common myeloid progenitor cell morphology	0.44	> 0.20	RHD (3.4)	HLX (3.2)	PARP10 (2.8)	TRAFD1 (2.8)	BCL3 (2.8)	GMIP (2.7)	RHCE (2.6)	C12orf51 (2.4)	PBX4 (1.9)	DNM2 (1.8)
ENSG00000111961	SASH1 PPI subnetwork	0.44	> 0.20	CBLC (6.4)	AP1M2 (4.3)	ST3GAL4 (2.3)	LPAR2 (2.2)	FRK (2.2)	CELSR2 (2.2)	LPIN3 (1.7)	PVRL2 (1.7)	PLEC (1.7)	PSRC1 (1.4)
GO:0009566	fertilization	0.44	> 0.20	PMFBP1 (5.2)	TSSK6 (4.2)	ENSG00000238078 (3.4)	ENSG00000228044 (2.9)	GCNT4 (1.7)	PBX4 (1.1)	HNF1A (1.0)	NPC1L1 (1.0)	POLK (1.0)	CILP2 (0.9)
ENSG00000107290	SETX PPI subnetwork	0.44	> 0.20	BRAP (3.4)	LPIN3 (2.7)	C1orf63 (2.5)	NYNRIN (2.5)	POLK (2.2)	ZNF101 (2.1)	NPC1L1 (1.8)	FRK (1.8)	ATXN7L2 (1.8)	TRAFD1 (1.6)
GO:0002456	T cell mediated immunity	0.44	> 0.20	ZNF180 (2.5)	NKPD1 (1.9)	LPAR2 (1.6)	PARP10 (1.6)	POLK (1.5)	PBX4 (1.5)	GCNT4 (1.4)	OASL (1.3)	CBLC (1.2)	PVR (1.2)
MP:0000167	decreased chondrocyte cell number	0.44	> 0.20	NYNRIN (2.6)	ALDH2 (1.7)	KIAA1324 (1.7)	PLEKHH2 (1.6)	YIPF2 (1.6)	ENSG00000254235 (1.6)	FRK (1.6)	GOT2P1 (1.5)	KANK2 (1.5)	PLEC (1.4)
ENSG00000161939	C17orf49 PPI subnetwork	0.44	> 0.20	BUD13 (3.0)	C12orf43 (3.0)	ATXN2 (2.5)	C19orf52 (2.3)	OGDH (2.3)	GOT2P1 (2.2)	QTRT1 (2.2)	MAPKAPK5 (2.0)	DHX38 (2.0)	DDX56 (1.8)
GO:0032958	inositol phosphate biosynthetic process	0.44	> 0.20	GMPR (3.1)	CEACAM19 (2.2)	ZHX3 (2.2)	ENSG00000235545 (2.2)	FRK (1.9)	ENSG00000238078 (1.8)	ITGB3 (1.5)	TMEM57 (1.4)	KIAA1324 (1.3)	GCNT4 (1.3)
GO:0090407	organophosphate biosynthetic process	0.44	> 0.20	GMPR (3.1)	CEACAM19 (2.2)	ZHX3 (2.2)	ENSG00000235545 (2.2)	FRK (1.9)	ENSG00000238078 (1.8)	ITGB3 (1.5)	TMEM57 (1.4)	KIAA1324 (1.3)	GCNT4 (1.3)
ENSG00000130724	CHMP2A PPI subnetwork	0.44	> 0.20	TRAPPC6A (2.5)	FRK (2.4)	TRAFD1 (2.2)	UBXN2B (2.0)	LDLR (1.8)	FADS2 (1.8)	HMGCR (1.6)	TXNL4B (1.6)	DHODH (1.6)	YIPF2 (1.5)
GO:0042095	interferon-gamma biosynthetic process	0.44	> 0.20	DNAH11 (2.9)	GCNT4 (2.7)	ST3GAL4 (2.5)	ENSG00000226645 (2.2)	CYB561D1 (1.9)	ZNF180 (1.8)	TMED4 (1.4)	BLOC1S3 (1.3)	DYNC2LI1 (1.3)	PVR (1.3)
ENSG00000145220	LYAR PPI subnetwork	0.44	> 0.20	ZNF259 (3.6)	QTRT1 (3.4)	TOMM40 (3.3)	NAA25 (3.0)	PTPN11 (3.0)	DDX56 (2.8)	ILF3 (2.7)	TOP1 (2.7)	SMARCA4 (2.5)	SUGP1 (2.4)
GO:0017147	Wnt-protein binding	0.44	> 0.20	CILP2 (4.0)	BCAM (2.5)	PVRL2 (2.2)	LPAR2 (2.1)	DYNC2LI1 (1.8)	CELSR2 (1.7)	PLEKHH2 (1.6)	AMIGO1 (1.5)	NYNRIN (1.3)	MOSC1 (1.3)
ENSG00000157985	AGAP1 PPI subnetwork	0.44	> 0.20	MAU2 (2.6)	CETP (2.5)	ITGB3 (2.4)	PLEKHH2 (2.4)	ABO (2.2)	MYLIP (2.2)	BLOC1S3 (2.1)	C12orf51 (2.0)	YIPF2 (1.4)	CBLC (1.4)
ENSG00000104973	MED25 PPI subnetwork	0.44	> 0.20	TXNL4B (3.0)	GEMIN7 (2.8)	BRAP (2.7)	BUD13 (2.3)	POC5 (2.0)	MAPKAPK5 (1.8)	DHX38 (1.8)	BLOC1S3 (1.7)	C17orf57 (1.7)	TMEM57 (1.7)
ENSG00000104313	EYA1 PPI subnetwork	0.44	> 0.20	TRAFD1 (2.5)	NYNRIN (2.4)	TXNL4B (2.1)	GOT2P1 (1.9)	MOSC1 (1.8)	GATAD2A (1.7)	ENSG00000238078 (1.5)	MAPKAPK5 (1.5)	FRK (1.4)	COL4A3BP (1.4)
MP:0003690	abnormal glial cell physiology	0.44	> 0.20	APOC1 (3.8)	MYLIP (3.1)	GPAM (2.8)	AMIGO1 (1.9)	POC5 (1.8)	OASL (1.7)	PVR (1.6)	ALDH2 (1.5)	ZHX3 (1.4)	RPH3A (1.3)
MP:0000223	decreased monocyte cell number	0.44	> 0.20	MAFB (2.4)	SH2B3 (2.4)	CYP7A1 (2.4)	LPA (2.1)	TIMD4 (1.9)	NCAN (1.8)	HLX (1.8)	MYLIP (1.6)	PVR (1.6)	RHCE (1.4)
GO:0031334	positive regulation of protein complex assembly	0.44	> 0.20	ANKRD31 (2.9)	ENSG00000254235 (2.2)	CETP (1.6)	LPIN3 (1.6)	HAVCR1 (1.6)	ZNF101 (1.4)	HNF1A (1.4)	ENSG00000226648 (1.4)	PLCG1 (1.3)	ZHX3 (1.3)
MP:0003207	decreased cellular sensitivity to gamma-irradiation	0.44	> 0.20	POLK (3.5)	PCSK9 (2.7)	UBXN2B (2.2)	TMEM116 (1.9)	ABCG8 (1.7)	LPAR2 (1.6)	DNAH11 (1.6)	ERP29 (1.4)	GMIP (1.3)	PARP10 (1.3)
MP:0000754	paresis	0.44	> 0.20	TMEM116 (2.1)	APOC4 (2.0)	TMED4 (1.9)	CELSR2 (1.9)	MAFB (1.9)	OGDH (1.9)	ALDH2 (1.8)	GCNT4 (1.8)	ENSG00000235545 (1.5)	LPA (1.3)
ENSG00000110237	ARHGEF17 PPI subnetwork	0.44	> 0.20	CBLC (5.7)	AP1M2 (3.9)	CELSR2 (2.3)	LPAR2 (2.1)	ST3GAL4 (2.1)	PSRC1 (1.7)	DOCK7 (1.6)	LPIN3 (1.6)	DNM2 (1.6)	FRK (1.5)
ENSG00000189319	FAM53B PPI subnetwork	0.44	> 0.20	CBLC (5.5)	AP1M2 (4.1)	CELSR2 (2.5)	LPAR2 (2.0)	ST3GAL4 (1.9)	LPIN3 (1.8)	DOCK7 (1.7)	FRK (1.6)	PLEC (1.6)	PVRL2 (1.6)
ENSG00000126522	ASL PPI subnetwork	0.44	> 0.20	ZNF259 (3.3)	DDX56 (3.2)	GEMIN7 (3.0)	QTRT1 (2.8)	C12orf43 (2.2)	BUD13 (2.1)	MAPKAPK5 (2.0)	ADAM1 (1.9)	ACAD10 (1.9)	NAA25 (1.8)
GO:0048520	positive regulation of behavior	0.44	> 0.20	ZNF101 (2.7)	ENSG00000228044 (2.4)	TMEM116 (2.0)	CETP (2.0)	TIMD4 (1.8)	PLEKHH2 (1.7)	APOE (1.5)	PVR (1.5)	KIAA1324 (1.5)	RELB (1.3)
GO:0007076	mitotic chromosome condensation	0.44	> 0.20	ENSG00000226648 (3.3)	C19orf52 (3.3)	DNAH11 (3.2)	PSRC1 (3.0)	ENSG00000228044 (2.5)	MAU2 (2.3)	BLOC1S3 (2.1)	ILF3 (1.8)	PMFBP1 (1.8)	CYB561D1 (1.7)
GO:0051048	negative regulation of secretion	0.44	> 0.20	KIAA1324 (4.1)	GPAM (2.8)	MOSC1 (2.6)	ANKRD31 (2.3)	AMIGO1 (1.8)	CELSR2 (1.7)	ENSG00000228044 (1.6)	LPIN3 (1.4)	NPC1L1 (1.3)	HNF1A (1.3)
ENSG00000206258	TNXB PPI subnetwork	0.44	> 0.20	PARP10 (2.6)	PTPN11 (2.5)	C17orf57 (2.4)	FRK (2.3)	KANK2 (1.8)	ADAM1 (1.6)	UBXN2B (1.5)	ZNF180 (1.4)	DHX38 (1.4)	OGDH (1.4)
ENSG00000160917	CPSF4 PPI subnetwork	0.44	> 0.20	DHX38 (2.9)	SMARCA4 (2.4)	USP24 (2.4)	NT5DC1 (2.3)	DHODH (2.2)	PTPN11 (2.2)	MAPKAPK5 (2.2)	TOP1 (1.9)	C1orf63 (1.9)	ATXN2 (1.9)
GO:0032635	interleukin-6 production	0.44	> 0.20	HLX (2.3)	C17orf57 (2.2)	TRIB1 (1.8)	ENSG00000228044 (1.8)	MAFB (1.6)	OASL (1.4)	POC5 (1.4)	SH2B3 (1.3)	PMFBP1 (1.3)	ZNF101 (1.3)
ENSG00000152942	RAD17 PPI subnetwork	0.44	> 0.20	FEN1 (4.0)	USP1 (3.3)	PARP10 (2.5)	NT5DC1 (2.5)	OASL (2.2)	C12orf43 (2.1)	PLEKHH2 (1.9)	TMEM116 (1.9)	ENSG00000228044 (1.8)	ZNF180 (1.7)
ENSG00000138594	TMOD3 PPI subnetwork	0.44	> 0.20	PLEC (3.5)	KANK2 (3.1)	ADAM1 (2.6)	SMARCA4 (2.4)	C1orf63 (2.0)	OGDH (2.0)	DOCK7 (1.9)	TRAFD1 (1.8)	ITGB3 (1.7)	PVR (1.7)
ENSG00000171421	MRPL36 PPI subnetwork	0.44	> 0.20	QTRT1 (3.8)	NAA25 (2.6)	CARM1 (2.6)	MAU2 (2.5)	ATP13A1 (2.5)	GEMIN7 (2.1)	MAPKAPK5 (1.8)	SMARCA4 (1.7)	DDX56 (1.6)	TMEM116 (1.6)
MP:0000121	failure of tooth eruption	0.44	> 0.20	FRK (3.3)	GMIP (2.8)	GRINA (2.7)	HLX (2.6)	MAFB (2.1)	CLPTM1 (2.1)	TRIB1 (2.1)	DNM2 (1.9)	APOE (1.8)	TIMD4 (1.7)
GO:0070830	tight junction assembly	0.44	> 0.20	FRK (4.2)	AP1M2 (2.9)	GCNT4 (2.6)	ENSG00000254235 (2.6)	TMEM116 (2.4)	LPAR2 (2.3)	TSSK6 (2.0)	YIPF2 (1.9)	C17orf57 (1.7)	PTPN11 (1.7)
GO:0046328	regulation of JNK cascade	0.44	> 0.20	ST3GAL4 (3.4)	LPAR2 (2.6)	UBXN2B (2.5)	FRK (2.2)	C11orf9 (2.0)	ENSG00000235545 (1.9)	ENSG00000226645 (1.8)	POLK (1.6)	CYB561D1 (1.4)	GMIP (1.3)
REACTOME_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA	REACTOME_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA	0.44	> 0.20	NAA25 (3.1)	DDX56 (3.0)	POC5 (2.8)	DOCK7 (2.7)	BUD13 (2.5)	ILF3 (2.4)	USP1 (2.3)	MAPKAPK5 (2.1)	FEN1 (2.0)	USP24 (2.0)
ENSG00000144048	DUSP11 PPI subnetwork	0.44	> 0.20	GPAM (2.6)	ATXN2 (2.4)	OASL (2.4)	FADS1 (2.4)	FADS2 (2.1)	ERP29 (2.1)	PARP10 (2.0)	ENSG00000235545 (1.9)	ALDH2 (1.9)	MOSC1 (1.8)
MP:0001952	increased airway responsiveness	0.44	> 0.20	C17orf57 (3.2)	SLC44A2 (2.1)	ENSG00000226648 (1.9)	ST3GAL4 (1.8)	APOB (1.6)	TMEM116 (1.6)	KIAA1324 (1.5)	NPC1L1 (1.5)	LPAR2 (1.4)	PMFBP1 (1.3)
MP:0005595	abnormal vascular smooth muscle physiology	0.44	> 0.20	GCNT4 (2.1)	ENSG00000235545 (2.0)	ERP29 (1.9)	NCAN (1.9)	AMIGO1 (1.7)	DNAH11 (1.6)	KANK2 (1.6)	MYLIP (1.6)	SLC44A2 (1.5)	KIAA1324 (1.5)
GO:0003300	cardiac muscle hypertrophy	0.44	> 0.20	ENSG00000226648 (3.2)	CEACAM19 (3.0)	HNF1A (2.6)	GCNT4 (2.4)	DNAH11 (2.1)	ENSG00000254235 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.4)	NPC1L1 (1.4)	C12orf51 (1.3)
GO:0014897	striated muscle hypertrophy	0.44	> 0.20	ENSG00000226648 (3.2)	CEACAM19 (3.0)	HNF1A (2.6)	GCNT4 (2.4)	DNAH11 (2.1)	ENSG00000254235 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.4)	NPC1L1 (1.4)	C12orf51 (1.3)
ENSG00000140307	GTF2A2 PPI subnetwork	0.44	> 0.20	MAPKAPK5 (3.4)	PSMA5 (2.6)	SUGP1 (2.5)	POC5 (2.5)	ATXN2 (2.4)	GEMIN7 (2.4)	TOP1 (2.3)	MARK4 (1.8)	ZNF259 (1.7)	ILF3 (1.6)
ENSG00000103423	DNAJA3 PPI subnetwork	0.44	> 0.20	SARS (3.2)	NAA25 (2.9)	DDX56 (2.3)	C12orf43 (2.2)	RELB (2.1)	ENSG00000226648 (2.0)	OGDH (1.9)	TOMM40 (1.8)	TOP1 (1.8)	PLEC (1.7)
GO:0002819	regulation of adaptive immune response	0.44	> 0.20	DNAH11 (1.9)	ENSG00000235545 (1.9)	POLK (1.7)	PARP10 (1.7)	HAVCR1 (1.5)	PBX4 (1.4)	RELB (1.4)	GEMIN7 (1.2)	ZNF101 (1.2)	NKPD1 (1.2)
ENSG00000105223	PLD3 PPI subnetwork	0.44	> 0.20	MAFB (2.9)	APOE (2.7)	APOC1 (2.3)	C19orf52 (2.2)	ST3GAL4 (2.1)	LPIN3 (1.8)	GEMIN7 (1.7)	TIMD4 (1.7)	NPC1L1 (1.7)	GCNT4 (1.4)
GO:0010833	telomere maintenance via telomere lengthening	0.44	> 0.20	GOT2P1 (2.6)	USP1 (2.6)	ENSG00000235545 (2.3)	TXNL4B (2.3)	ZNF180 (2.2)	ENSG00000226648 (2.1)	ENSG00000228044 (2.1)	AMIGO1 (2.0)	FEN1 (2.0)	POLK (2.0)
ENSG00000095585	BLNK PPI subnetwork	0.44	> 0.20	GMIP (3.7)	COL4A3BP (3.1)	SH2B3 (2.5)	GATAD2A (2.4)	DNM2 (2.2)	MAFB (1.9)	APOE (1.9)	SLC44A2 (1.7)	ENSG00000226645 (1.6)	MYLIP (1.6)
ENSG00000163605	PPP4R2 PPI subnetwork	0.44	> 0.20	PARP10 (3.0)	OASL (2.9)	USP1 (1.9)	BUD13 (1.8)	ZNF180 (1.8)	TMED4 (1.7)	TOMM40 (1.4)	PSMA5 (1.4)	ZNF101 (1.4)	C12orf43 (1.3)
GO:0002507	tolerance induction	0.44	> 0.20	GCNT4 (3.3)	C12orf47 (2.7)	PBX4 (2.5)	ENSG00000228044 (1.8)	PMFBP1 (1.6)	TSSK6 (1.4)	POLK (1.3)	HNF1A (1.2)	GMIP (1.2)	FRK (1.1)
ENSG00000022267	FHL1 PPI subnetwork	0.44	> 0.20	SYPL2 (3.1)	TRIB1 (2.8)	BCL3 (2.1)	GMPR (2.0)	RELB (1.9)	CEACAM19 (1.7)	KANK2 (1.7)	RHCE (1.6)	C12orf51 (1.6)	DNM2 (1.6)
ENSG00000137267	TUBB2A PPI subnetwork	0.44	> 0.20	GEMIN7 (3.4)	GATAD2A (2.8)	TMEM50A (2.7)	CLPTM1 (2.1)	QTRT1 (1.9)	ABO (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.6)	KANK2 (1.6)	NCAN (1.5)
GO:0005342	organic acid transmembrane transporter activity	0.44	> 0.20	TM6SF2 (3.7)	ABCG8 (3.5)	GRINA (2.4)	PLG (2.3)	ATP13A1 (2.3)	HAPLN4 (2.2)	ABCG5 (2.2)	TMEM116 (2.1)	SARS (2.1)	NCAN (2.0)
MP:0008531	increased chemical nociceptive threshold	0.44	> 0.20	BCAM (3.4)	GMPR (2.4)	ENSG00000226648 (2.3)	PBX4 (2.1)	AMIGO1 (2.0)	TMEM116 (2.0)	HLX (1.8)	ITGB3 (1.7)	ENSG00000226645 (1.7)	TRIB1 (1.6)
ENSG00000204175	GPRIN2 PPI subnetwork	0.44	> 0.20	CBLC (6.7)	AP1M2 (2.9)	LPAR2 (2.4)	PVRL2 (2.3)	PSRC1 (2.1)	ST3GAL4 (2.1)	BCAM (1.9)	PPP1R37 (1.7)	FRK (1.6)	CELSR2 (1.6)
GO:0018208	peptidyl-proline modification	0.44	> 0.20	YIPF2 (3.6)	ERP29 (2.9)	TRAPPC6A (2.4)	TOMM40 (2.2)	CEACAM19 (2.1)	TXNL4B (2.0)	DHODH (2.0)	QTRT1 (2.0)	HNF1A (1.6)	TMED4 (1.5)
ENSG00000107485	GATA3 PPI subnetwork	0.44	> 0.20	HLX (4.3)	RHD (2.9)	GMPR (2.5)	MYLIP (2.2)	USP24 (2.2)	SH2B3 (2.2)	MAFB (1.8)	NCAN (1.8)	RHCE (1.5)	ITGB3 (1.2)
ENSG00000105176	URI1 PPI subnetwork	0.44	> 0.20	BLOC1S3 (3.1)	ATXN2 (2.6)	GMPR (2.5)	TRAPPC6A (2.5)	POC5 (2.2)	GATAD2A (2.0)	DDX56 (2.0)	MAPKAPK5 (1.9)	SUGP1 (1.9)	TOMM40 (1.9)
MP:0002725	abnormal vein morphology	0.44	> 0.20	RHD (2.6)	RHCE (2.1)	DNAH11 (2.0)	GCNT4 (1.9)	HLX (1.7)	NYNRIN (1.6)	TSSK6 (1.5)	MYLIP (1.5)	C11orf9 (1.5)	HAVCR1 (1.3)
GO:0060191	regulation of lipase activity	0.44	> 0.20	AMIGO1 (3.1)	PMFBP1 (2.3)	ST3GAL4 (1.9)	PLEKHH2 (1.9)	ZHX3 (1.7)	GOT2P1 (1.6)	ENSG00000235545 (1.4)	APOE (1.3)	ITGB3 (1.3)	COL4A3BP (1.3)
ENSG00000069667	RORA PPI subnetwork	0.44	> 0.20	COL4A3BP (3.1)	UBXN2B (2.8)	C17orf57 (2.2)	DNAH11 (1.8)	TMED4 (1.6)	PBX4 (1.4)	ALDH2 (1.4)	PLEC (1.3)	MAFB (1.3)	TOP1 (1.2)
ENSG00000213380	COG8 PPI subnetwork	0.44	> 0.20	PSMA5 (2.7)	ENSG00000226648 (2.6)	SUGP1 (2.6)	DOCK7 (2.5)	CYB561D1 (2.5)	ATXN7L2 (2.5)	MAPKAPK5 (2.1)	DNM2 (2.0)	POC5 (2.0)	NT5DC1 (2.0)
GO:0006783	heme biosynthetic process	0.44	> 0.20	RHCE (7.8)	RHD (7.2)	ADAM1 (3.6)	C12orf51 (3.0)	NT5DC1 (2.2)	ABO (2.2)	C19orf52 (2.1)	GMPR (1.8)	TMEM116 (1.6)	ACAD10 (1.6)
ENSG00000182533	CAV3 PPI subnetwork	0.44	> 0.20	MAFB (2.4)	SYPL2 (2.2)	PLEC (2.0)	SLC44A2 (2.0)	OGDH (1.9)	BCAM (1.8)	ENSG00000238078 (1.7)	PVR (1.7)	TIMD4 (1.7)	PTPN11 (1.5)
GO:0033158	regulation of protein import into nucleus, translocation	0.44	> 0.20	ENSG00000238078 (2.5)	HNF1A (1.6)	TRIB1 (1.6)	CILP2 (1.4)	ATXN2 (1.3)	TSSK6 (1.2)	GRINA (1.1)	BCL3 (1.1)	PBX4 (1.1)	PVR (1.1)
ENSG00000166411	IDH3A PPI subnetwork	0.44	> 0.20	TOMM40 (3.5)	NAA25 (3.2)	PSMA5 (3.1)	SARS (3.0)	CLPTM1 (2.5)	DDX56 (2.3)	DHX38 (2.2)	OGDH (2.1)	SUGP1 (2.1)	NT5DC1 (2.0)
GO:0090150	establishment of protein localization in membrane	0.44	> 0.20	PTPN11 (3.0)	BCAM (2.4)	C11orf9 (2.2)	C12orf47 (2.0)	AP1M2 (2.0)	ZHX3 (1.7)	CBLC (1.6)	ENSG00000226645 (1.6)	TSSK6 (1.4)	CELSR2 (1.4)
MP:0001433	polyphagia	0.44	> 0.20	MOSC1 (2.7)	KIAA1324 (2.5)	ST3GAL4 (2.5)	SORT1 (2.4)	GPAM (2.4)	DYNC2LI1 (2.1)	PMFBP1 (1.9)	CELSR2 (1.8)	ABO (1.8)	TIMD4 (1.7)
ENSG00000168502	CCDC165 PPI subnetwork	0.44	> 0.20	ZNF101 (3.3)	ATXN2 (3.2)	DOCK7 (2.9)	GATAD2A (2.9)	CEACAM19 (2.7)	ENSG00000235545 (2.6)	ILF3 (2.6)	CARM1 (2.5)	SORT1 (2.0)	CELSR2 (1.9)
ENSG00000154188	ANGPT1 PPI subnetwork	0.44	> 0.20	ITGB3 (2.3)	GCNT4 (2.3)	DNAH11 (2.1)	COL4A3BP (2.1)	SH2B3 (2.0)	DNM2 (1.9)	NYNRIN (1.8)	TMEM57 (1.8)	ZHX3 (1.6)	GATAD2A (1.5)
ENSG00000176986	SEC24C PPI subnetwork	0.44	> 0.20	YIPF2 (4.6)	CLPTM1 (3.1)	GEMIN7 (2.2)	DNM2 (2.0)	SUGP1 (1.8)	TOP1 (1.8)	ENSG00000226648 (1.5)	MARK4 (1.5)	C19orf52 (1.1)	TMED4 (1.1)
GO:0035255	ionotropic glutamate receptor binding	0.44	> 0.20	GCNT4 (2.2)	HNF1A (2.1)	KIAA1324 (1.8)	ANKRD31 (1.7)	PCSK9 (1.7)	RPH3A (1.6)	AMIGO1 (1.6)	GOT2P1 (1.5)	PTPN11 (1.5)	DOCK7 (1.5)
GO:0007127	meiosis I	0.44	> 0.20	ANKRD31 (3.9)	ENSG00000238078 (2.5)	ENSG00000228044 (1.9)	C17orf57 (1.5)	LPIN3 (1.5)	POC5 (1.4)	TSSK6 (1.3)	ZHX3 (1.2)	DYNC2LI1 (1.1)	HAVCR1 (1.0)
ENSG00000099940	SNAP29 PPI subnetwork	0.44	> 0.20	TRAPPC6A (2.6)	ENSG00000226645 (2.5)	TMEM57 (2.3)	SLC44A2 (2.3)	C1orf63 (2.1)	DNM2 (2.0)	TMEM50A (2.0)	CLPTM1 (1.7)	PVRL2 (1.6)	UBXN2B (1.6)
ENSG00000160200	CBS PPI subnetwork	0.44	> 0.20	TOMM40 (3.2)	NAA25 (2.8)	ZNF259 (2.7)	MAPKAPK5 (2.6)	QTRT1 (2.3)	SARS (2.2)	DHODH (2.2)	DHX38 (2.0)	TXNL4B (1.9)	DDX56 (1.8)
ENSG00000080503	SMARCA2 PPI subnetwork	0.44	> 0.20	SMARCA4 (2.9)	TOP1 (2.6)	BUD13 (2.5)	TRIB1 (2.4)	USP1 (2.4)	TMEM57 (2.3)	CARM1 (2.2)	ATXN2 (2.1)	GATAD2A (1.9)	FEN1 (1.7)
MP:0008965	increased basal metabolism	0.44	> 0.20	CELSR2 (2.6)	CETP (2.4)	SH2B3 (2.2)	TIMD4 (2.1)	TRIB1 (2.0)	LPA (1.8)	ZNF101 (1.7)	TSSK6 (1.7)	COL4A3BP (1.6)	MAFB (1.5)
GO:0003684	damaged DNA binding	0.44	> 0.20	FEN1 (3.3)	ZNF180 (2.7)	SUGP1 (2.6)	BUD13 (2.4)	DYNC2LI1 (2.2)	TRAPPC6A (2.0)	USP1 (2.0)	POC5 (1.7)	ILF3 (1.7)	PSRC1 (1.5)
GO:0030286	dynein complex	0.44	> 0.20	DNAH11 (5.7)	DYNC2LI1 (1.7)	KIAA1324 (1.6)	C1orf63 (1.3)	MARK4 (1.1)	CEACAM19 (1.1)	PLCG1 (1.0)	COL4A3BP (1.0)	PLEC (0.9)	C12orf51 (0.9)
ENSG00000116918	TSNAX PPI subnetwork	0.44	> 0.20	MAPKAPK5 (2.9)	RHCE (2.6)	C12orf51 (2.6)	POC5 (2.4)	RHD (2.2)	ENSG00000226645 (2.2)	SYPL2 (2.0)	SUGP1 (1.9)	SMARCA4 (1.8)	ZNF101 (1.5)
MP:0002828	abnormal renal glomerular capsule morphology	0.44	> 0.20	ACAD10 (2.1)	C17orf57 (2.0)	POC5 (2.0)	POLK (2.0)	TMED4 (1.9)	PVRL2 (1.8)	YIPF2 (1.7)	BCAM (1.5)	PLEKHH2 (1.5)	PVR (1.5)
GO:0042119	neutrophil activation	0.44	> 0.20	UBXN2B (3.0)	CYB561D1 (2.5)	GMIP (2.3)	ANKRD31 (2.2)	LPAR2 (2.1)	C17orf57 (1.8)	HLX (1.8)	AMIGO1 (1.6)	ENSG00000226645 (1.6)	NT5DC1 (1.4)
KEGG_ENDOMETRIAL_CANCER	KEGG_ENDOMETRIAL_CANCER	0.44	> 0.20	DNM2 (3.1)	UBXN2B (2.6)	AP1M2 (2.4)	DOCK7 (2.3)	PLEC (2.2)	SORT1 (2.1)	PTPN11 (2.0)	SLC44A2 (1.9)	GATAD2A (1.9)	BLOC1S3 (1.7)
ENSG00000214026	MRPL23 PPI subnetwork	0.44	> 0.20	QTRT1 (3.7)	MAU2 (3.2)	GEMIN7 (2.8)	ATP13A1 (2.2)	C19orf52 (2.2)	CARM1 (2.1)	TOMM40 (2.0)	DDX56 (2.0)	NAA25 (1.9)	C12orf47 (1.8)
GO:0051923	sulfation	0.44	> 0.20	ABCG5 (2.8)	C17orf57 (2.8)	GCNT4 (2.2)	ABCG8 (2.2)	TM6SF2 (2.1)	FRK (1.8)	SLC22A1 (1.7)	ZNF180 (1.7)	ANKRD31 (1.5)	ENSG00000228044 (1.5)
GO:0016675	oxidoreductase activity, acting on a heme group of donors	0.44	> 0.20	TRAPPC6A (3.4)	C12orf47 (2.7)	TMEM116 (2.4)	GOT2P1 (2.3)	ACAD10 (2.3)	OGDH (2.1)	ABCG8 (1.5)	UBXN2B (1.4)	KANK2 (1.4)	SYPL2 (1.4)
GO:0045821	positive regulation of glycolysis	0.44	> 0.20	PMFBP1 (3.3)	HNF1A (3.0)	ENSG00000254235 (2.3)	TSSK6 (1.8)	GPAM (1.7)	CYP7A1 (1.6)	ENSG00000228044 (1.6)	FRK (1.6)	PCSK9 (1.3)	HAPLN4 (1.3)
MP:0009583	increased keratinocyte proliferation	0.44	> 0.20	CBLC (5.8)	AP1M2 (3.1)	PLEC (2.7)	BCL3 (2.6)	YIPF2 (2.6)	PMFBP1 (2.5)	PVRL2 (2.2)	CEACAM19 (2.0)	PARP10 (1.7)	LPIN3 (1.7)
ENSG00000177963	RIC8A PPI subnetwork	0.44	> 0.20	MARK4 (2.3)	HAVCR1 (1.9)	SH2B3 (1.7)	CARM1 (1.7)	DNM2 (1.7)	NCAN (1.4)	C12orf43 (1.4)	TMEM57 (1.4)	POLK (1.3)	RPH3A (1.3)
ENSG00000125450	NUP85 PPI subnetwork	0.44	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.1)	POC5 (3.9)	ZNF180 (1.5)	ENSG00000226648 (1.5)	ENSG00000228044 (1.3)	ENSG00000238078 (1.0)	USP24 (0.8)	CEACAM19 (0.8)
ENSG00000101811	CSTF2 PPI subnetwork	0.44	> 0.20	ILF3 (3.9)	SMARCA4 (3.3)	DHX38 (3.0)	BUD13 (3.0)	SUGP1 (2.7)	C1orf63 (2.6)	USP1 (2.5)	TOP1 (2.5)	CLPTM1 (2.2)	FEN1 (2.0)
GO:0008624	induction of apoptosis by extracellular signals	0.44	> 0.20	LPAR2 (2.9)	CYB561D1 (2.4)	ADAM1 (2.1)	FRK (2.1)	ENSG00000238078 (2.0)	HAVCR1 (1.9)	LPIN3 (1.7)	GMIP (1.6)	ANKRD31 (1.5)	TRAFD1 (1.4)
GO:0001541	ovarian follicle development	0.44	> 0.20	ST3GAL4 (2.8)	ABO (2.6)	YIPF2 (2.2)	CEACAM19 (2.1)	ENSG00000235545 (2.0)	FRK (1.6)	AMIGO1 (1.5)	RHCE (1.4)	GEMIN7 (1.4)	NYNRIN (1.3)
MP:0002993	arthritis	0.44	> 0.20	CILP2 (2.4)	TRIB1 (2.2)	ENSG00000238078 (1.9)	PLCG1 (1.8)	LPIN3 (1.7)	PLEKHH2 (1.7)	CEACAM19 (1.6)	PVR (1.6)	BCL3 (1.5)	MAFB (1.4)
ENSG00000177700	POLR2L PPI subnetwork	0.44	> 0.20	BUD13 (3.4)	SUGP1 (3.1)	DHX38 (3.0)	ILF3 (3.0)	TOP1 (2.6)	C12orf43 (2.3)	DDX56 (2.3)	SMARCA4 (2.3)	USP1 (2.2)	MAPKAPK5 (2.1)
GO:0030684	preribosome	0.44	> 0.20	DDX56 (3.8)	QTRT1 (3.7)	NAA25 (3.2)	TOMM40 (2.7)	SUGP1 (2.7)	ZNF259 (2.6)	C12orf43 (2.4)	POC5 (2.0)	TOP1 (1.9)	ENSG00000235545 (1.8)
ENSG00000169062	UPF3A PPI subnetwork	0.44	> 0.20	TXNL4B (3.4)	C1orf63 (3.3)	MAU2 (3.2)	BRAP (2.7)	TOP1 (2.5)	SUGP1 (2.5)	UBXN2B (2.4)	ATP13A1 (2.3)	USP24 (2.0)	C19orf52 (1.9)
GO:0033598	mammary gland epithelial cell proliferation	0.45	> 0.20	ENSG00000254235 (2.1)	DNAH11 (2.1)	C17orf57 (2.0)	ENSG00000226645 (2.0)	NKPD1 (1.7)	PPP1R37 (1.7)	BLOC1S3 (1.5)	HLX (1.5)	ST3GAL4 (1.3)	SH2B3 (1.3)
ENSG00000163362	C1orf106 PPI subnetwork	0.45	> 0.20	CBLC (5.0)	AP1M2 (3.6)	CELSR2 (2.2)	ST3GAL4 (2.0)	LPIN3 (1.8)	PSRC1 (1.8)	C12orf51 (1.8)	DOCK7 (1.7)	LPAR2 (1.7)	PLEC (1.4)
GO:0014911	positive regulation of smooth muscle cell migration	0.45	> 0.20	C19orf52 (2.6)	NKPD1 (2.5)	ZNF101 (2.3)	AMIGO1 (2.1)	ST3GAL4 (2.0)	MYLIP (2.0)	TMEM116 (1.7)	C12orf47 (1.6)	HLX (1.3)	DNAH11 (1.2)
ENSG00000099985	OSM PPI subnetwork	0.45	> 0.20	BCL3 (3.7)	CETP (2.7)	RELB (2.6)	HLX (2.6)	TIMD4 (2.2)	PVR (1.9)	GMIP (1.9)	PVRL2 (1.6)	PLEKHH2 (1.5)	TRIB1 (1.5)
MP:0009593	absent chorion	0.45	> 0.20	ST3GAL4 (2.3)	PLG (2.1)	ANGPTL3 (1.9)	ATXN7L2 (1.8)	DOCK7 (1.7)	MYLIP (1.7)	CEACAM19 (1.7)	SH2B3 (1.7)	ATXN2 (1.7)	PVR (1.6)
GO:0003417	growth plate cartilage development	0.45	> 0.20	CILP2 (7.4)	UBXN2B (2.5)	YIPF2 (2.2)	ANKRD31 (2.0)	SLC44A2 (1.9)	TSSK6 (1.9)	QTRT1 (1.6)	ABO (1.5)	PBX4 (1.2)	GMPR (1.2)
ENSG00000133026	MYH10 PPI subnetwork	0.45	> 0.20	PLEC (3.3)	TMEM50A (3.1)	PVR (2.7)	KANK2 (2.6)	ITGB3 (2.3)	HAVCR1 (2.1)	DNM2 (2.0)	SLC44A2 (1.8)	GMIP (1.8)	GATAD2A (1.8)
ENSG00000090470	PDCD7 PPI subnetwork	0.45	> 0.20	PMFBP1 (2.3)	TOP1 (2.3)	TIMD4 (2.0)	ADAM1 (2.0)	C12orf47 (1.7)	USP1 (1.7)	GEMIN7 (1.7)	ILF3 (1.6)	ENSG00000238078 (1.6)	ZNF180 (1.4)
ENSG00000134259	NGF PPI subnetwork	0.45	> 0.20	BRAP (2.4)	DOCK7 (2.3)	GRINA (2.0)	SARS (1.9)	GATAD2A (1.8)	CELSR2 (1.8)	PTPN11 (1.7)	KANK2 (1.4)	C12orf43 (1.4)	PCSK9 (1.3)
MP:0010123	increased bone mineral content	0.45	> 0.20	MAFB (3.3)	PVR (2.8)	KIAA1324 (2.7)	AMIGO1 (2.4)	TIMD4 (2.4)	DHODH (2.3)	APOC1 (2.3)	APOE (2.2)	ENSG00000226648 (2.0)	CYB561D1 (1.9)
ENSG00000145349	CAMK2D PPI subnetwork	0.45	> 0.20	PLEC (2.9)	PVR (2.6)	OGDH (2.6)	C1orf63 (2.3)	HAVCR1 (2.3)	GOT2P1 (2.0)	HMGCR (2.0)	KANK2 (1.9)	LDLR (1.8)	KIAA1324 (1.8)
ENSG00000057657	PRDM1 PPI subnetwork	0.45	> 0.20	TM6SF2 (3.1)	HAPLN4 (2.7)	DNAH11 (2.4)	MYLIP (2.2)	ABCG8 (2.2)	LDLR (1.9)	ABCG5 (1.8)	ZNF101 (1.8)	PPP1R37 (1.7)	SYPL2 (1.7)
GO:0016324	apical plasma membrane	0.45	> 0.20	TM6SF2 (3.5)	AP1M2 (3.3)	TMEM116 (3.1)	FRK (3.0)	BCAM (2.6)	NPC1L1 (2.5)	TMED4 (2.1)	SORT1 (2.1)	ABCG5 (1.9)	ANGPTL3 (1.7)
GO:0006364	rRNA processing	0.45	> 0.20	ZNF259 (3.6)	DDX56 (3.5)	TOMM40 (3.2)	DHODH (3.1)	QTRT1 (3.1)	NAA25 (2.9)	C12orf43 (2.5)	MAPKAPK5 (2.4)	C19orf52 (2.4)	POC5 (2.3)
MP:0002111	abnormal tail morphology	0.45	> 0.20	CILP2 (4.2)	PCSK9 (3.0)	PLCG1 (1.9)	HAPLN4 (1.9)	ALDH2 (1.8)	TRIB1 (1.7)	ENSG00000254235 (1.6)	PLEKHH2 (1.5)	LDLR (1.4)	MAFB (1.4)
ENSG00000143190	POU2F1 PPI subnetwork	0.45	> 0.20	BUD13 (2.5)	ATXN2 (2.2)	C12orf43 (2.1)	POLK (1.8)	ADAM1 (1.7)	TRIB1 (1.6)	DHODH (1.6)	ACAD10 (1.6)	ENSG00000226645 (1.5)	ZNF259 (1.5)
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	0.45	> 0.20	C12orf43 (3.5)	DHX38 (3.0)	TXNL4B (2.9)	ZNF259 (2.8)	DYNC2LI1 (2.6)	MAPKAPK5 (2.3)	NAA25 (2.1)	DDX56 (2.0)	ZNF180 (1.9)	POLK (1.7)
ENSG00000182934	SRPR PPI subnetwork	0.45	> 0.20	YIPF2 (3.7)	FRK (3.2)	CLPTM1 (2.6)	POC5 (2.4)	SLC44A2 (2.2)	KIAA1324 (2.0)	ENSG00000228044 (2.0)	ERP29 (1.9)	C12orf47 (1.8)	ST3GAL4 (1.7)
ENSG00000168496	FEN1 PPI subnetwork	0.45	> 0.20	FEN1 (5.0)	USP1 (4.1)	PSRC1 (1.8)	DHODH (1.7)	ZNF180 (1.6)	POC5 (1.4)	BLOC1S3 (1.4)	RHD (1.4)	ENSG00000226648 (1.2)	TXNL4B (1.2)
GO:0090066	regulation of anatomical structure size	0.45	> 0.20	ABO (3.2)	TSSK6 (2.2)	CETP (1.9)	C17orf57 (1.9)	TMEM50A (1.7)	ENSG00000226645 (1.7)	HAVCR1 (1.5)	HAPLN4 (1.4)	C12orf47 (1.4)	LPIN3 (1.4)
GO:0031529	ruffle organization	0.45	> 0.20	ENSG00000228044 (3.4)	ZNF101 (2.7)	DOCK7 (2.3)	CETP (2.0)	HAVCR1 (1.8)	TIMD4 (1.5)	AP1M2 (1.4)	TMEM57 (1.3)	FADS1 (1.2)	PCSK9 (1.2)
MP:0005599	increased cardiac muscle contractility	0.45	> 0.20	ST3GAL4 (2.2)	ANKRD31 (1.5)	ENSG00000238078 (1.4)	OASL (1.4)	CILP2 (1.4)	UBXN2B (1.3)	GPAM (1.3)	GMPR (1.3)	NKPD1 (1.3)	DNAH11 (1.3)
ENSG00000104081	BMF PPI subnetwork	0.45	> 0.20	C11orf9 (3.4)	TRIB1 (3.0)	GMPR (2.3)	ENSG00000226645 (1.9)	GCNT4 (1.9)	PLEKHH2 (1.8)	PPP1R37 (1.7)	TXNL4B (1.6)	TMEM57 (1.5)	BCAM (1.2)
ENSG00000178209	PLEC PPI subnetwork	0.45	> 0.20	PLEC (4.5)	KANK2 (2.8)	GATAD2A (2.7)	OGDH (2.4)	RHD (2.3)	PLCG1 (2.0)	HLX (1.9)	BCAM (1.8)	C12orf51 (1.7)	HAPLN4 (1.6)
MP:0002837	dystrophic cardiac calcinosis	0.45	> 0.20	KANK2 (2.5)	COL4A3BP (2.2)	TSSK6 (2.1)	GMPR (2.0)	KIAA1324 (2.0)	ACAD10 (2.0)	SLC22A1 (1.7)	ENSG00000254235 (1.5)	CYB561D1 (1.5)	DNM2 (1.4)
ENSG00000213397	HAUS7 PPI subnetwork	0.45	> 0.20	GEMIN7 (2.6)	C19orf52 (2.4)	BLOC1S3 (2.4)	TXNL4B (2.1)	TRAPPC6A (2.0)	KIAA1324 (1.8)	C1orf63 (1.7)	BRAP (1.6)	POC5 (1.6)	C12orf51 (1.6)
ENSG00000170315	UBB PPI subnetwork	0.45	> 0.20	FEN1 (2.4)	PTPN11 (2.2)	GRINA (2.0)	MYLIP (2.0)	MAU2 (2.0)	SMARCA4 (1.9)	TOP1 (1.9)	RELB (1.9)	PSMA5 (1.8)	TRIB1 (1.7)
ENSG00000138802	SEC24B PPI subnetwork	0.45	> 0.20	YIPF2 (4.1)	TMED4 (2.9)	CLPTM1 (2.5)	LPIN3 (2.4)	ZHX3 (2.1)	NPC1L1 (2.1)	ADAM1 (2.0)	SUGP1 (1.9)	ABCG8 (1.9)	KIAA1324 (1.8)
GO:0090398	cellular senescence	0.45	> 0.20	POLK (2.5)	TMED4 (1.9)	NAA25 (1.8)	GOT2P1 (1.8)	ZNF259 (1.7)	PBX4 (1.7)	ENSG00000254235 (1.6)	AMIGO1 (1.6)	DHODH (1.5)	PMFBP1 (1.5)
GO:0031098	stress-activated protein kinase signaling cascade	0.45	> 0.20	ST3GAL4 (2.7)	LPAR2 (2.3)	POLK (2.3)	HLX (1.7)	UBXN2B (1.7)	SH2B3 (1.7)	MARK4 (1.6)	FRK (1.5)	YIPF2 (1.4)	ZNF180 (1.4)
GO:0043492	ATPase activity, coupled to movement of substances	0.45	> 0.20	CLPTM1 (3.4)	ATP13A1 (3.3)	GRINA (2.8)	TMEM116 (2.7)	SORT1 (2.5)	C12orf51 (2.1)	COL4A3BP (2.1)	HAPLN4 (2.1)	GMPR (2.1)	USP24 (2.0)
ENSG00000136279	DBNL PPI subnetwork	0.45	> 0.20	PARP10 (3.0)	UBXN2B (2.6)	TRAFD1 (2.4)	LPIN3 (2.4)	DNM2 (2.0)	LPAR2 (1.8)	GMIP (1.8)	FRK (1.8)	OASL (1.7)	CYP7A1 (1.7)
GO:0005545	1-phosphatidylinositol binding	0.45	> 0.20	DOCK7 (3.8)	PTPN11 (3.1)	COL4A3BP (2.9)	BRAP (2.2)	ENSG00000254235 (2.2)	C12orf51 (1.9)	PMFBP1 (1.7)	SH2B3 (1.7)	MYLIP (1.6)	TRAFD1 (1.6)
GO:0010717	regulation of epithelial to mesenchymal transition	0.45	> 0.20	KANK2 (2.8)	ENSG00000254235 (2.5)	SLC44A2 (2.4)	ANKRD31 (2.1)	PLEKHH2 (2.1)	ENSG00000226648 (2.0)	ABO (1.9)	MYLIP (1.8)	SH2B3 (1.8)	TMEM116 (1.5)
GO:0001818	negative regulation of cytokine production	0.45	> 0.20	OASL (4.7)	PARP10 (3.5)	TIMD4 (2.5)	MAU2 (2.1)	TRAFD1 (2.0)	ZNF101 (1.9)	GRINA (1.8)	ADAM1 (1.7)	GMIP (1.7)	RELB (1.5)
REACTOME_PROCESSING_OF_INTRONLESS_PRE:MRNAS	REACTOME_PROCESSING_OF_INTRONLESS_PRE:MRNAS	0.45	> 0.20	C1orf63 (3.8)	ENSG00000226645 (2.6)	UBXN2B (2.5)	ENSG00000235545 (2.0)	TXNL4B (1.7)	FEN1 (1.7)	NYNRIN (1.5)	ZNF259 (1.4)	NKPD1 (1.3)	FADS1 (1.3)
GO:0005740	mitochondrial envelope	0.45	> 0.20	ACAD10 (4.4)	OGDH (4.0)	ALDH2 (2.7)	GMPR (2.5)	GPAM (2.3)	TRAPPC6A (2.2)	TOMM40 (2.1)	MOSC1 (1.8)	C19orf52 (1.7)	ABCG8 (1.6)
ENSG00000177169	ULK1 PPI subnetwork	0.45	> 0.20	ILF3 (3.7)	CARM1 (3.5)	GATAD2A (3.4)	MAU2 (3.4)	GOT2P1 (2.9)	YIPF2 (2.7)	AP1M2 (2.6)	DNM2 (2.6)	SLC44A2 (2.2)	GRINA (2.2)
ENSG00000189037	DUSP21 PPI subnetwork	0.45	> 0.20	MYLIP (3.5)	TM6SF2 (2.5)	ZNF101 (2.5)	ENSG00000226645 (2.4)	MAU2 (2.4)	TRIB1 (2.1)	PBX4 (2.0)	LPAR2 (2.0)	LDLR (2.0)	LPIN3 (1.8)
ENSG00000125952	MAX PPI subnetwork	0.45	> 0.20	BUD13 (2.8)	MAPKAPK5 (2.4)	ILF3 (2.3)	QTRT1 (2.0)	ATXN7L2 (1.9)	BRAP (1.8)	C12orf43 (1.6)	GATAD2A (1.5)	ZNF101 (1.4)	DYNC2LI1 (1.3)
GO:0048871	multicellular organismal homeostasis	0.45	> 0.20	ENSG00000235545 (2.2)	DNAH11 (2.2)	POLK (2.0)	CILP2 (1.8)	SLC44A2 (1.8)	KIAA1324 (1.7)	TMEM116 (1.5)	TSSK6 (1.2)	MAFB (1.1)	RHCE (1.1)
MP:0001273	decreased metastatic potential	0.45	> 0.20	ST3GAL4 (3.1)	HLX (1.8)	SLC44A2 (1.8)	OASL (1.7)	MAFB (1.4)	GMIP (1.2)	TRIB1 (1.2)	CYB561D1 (1.2)	DOCK7 (1.1)	SH2B3 (1.1)
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	REACTOME_REGULATION_OF_SIGNALING_BY_CBL	0.45	> 0.20	GMIP (3.0)	SH2B3 (2.9)	MAFB (2.6)	DNM2 (2.5)	GATAD2A (2.4)	TIMD4 (2.0)	ERP29 (2.0)	MAU2 (2.0)	UBXN2B (1.7)	C19orf52 (1.5)
MP:0000841	abnormal hindbrain morphology	0.45	> 0.20	PLCG1 (2.3)	CARM1 (2.0)	ADAM1 (2.0)	PVRL2 (1.9)	ZHX3 (1.9)	OGDH (1.7)	ATXN2 (1.6)	PCSK9 (1.5)	PTPN11 (1.4)	MARK4 (1.3)
GO:0000291	nuclear-transcribed mRNA catabolic process, exonucleolytic	0.45	> 0.20	TXNL4B (3.7)	GEMIN7 (3.1)	DHODH (2.9)	ST3GAL4 (2.9)	TRAPPC6A (2.4)	C19orf52 (2.3)	ZNF259 (2.3)	UBXN2B (2.2)	SUGP1 (2.1)	DDX56 (2.0)
GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	0.45	> 0.20	TXNL4B (3.7)	GEMIN7 (3.1)	DHODH (2.9)	ST3GAL4 (2.9)	TRAPPC6A (2.4)	C19orf52 (2.3)	ZNF259 (2.3)	UBXN2B (2.2)	SUGP1 (2.1)	DDX56 (2.0)
MP:0010879	decreased trabecular bone volume	0.45	> 0.20	OASL (6.3)	TRIB1 (3.0)	MAFB (2.7)	PARP10 (2.5)	TRAFD1 (2.3)	CYB561D1 (2.1)	MOSC1 (1.9)	CILP2 (1.6)	TSSK6 (1.5)	ERP29 (1.4)
GO:0051020	GTPase binding	0.45	> 0.20	DNM2 (2.7)	SH2B3 (2.5)	COL4A3BP (2.4)	GMIP (2.4)	KANK2 (2.2)	PLEC (2.1)	PTPN11 (2.0)	USP24 (2.0)	CARM1 (2.0)	ABO (1.9)
REACTOME_NOD12_SIGNALING_PATHWAY	REACTOME_NOD12_SIGNALING_PATHWAY	0.45	> 0.20	RELB (4.4)	PARP10 (2.5)	BCL3 (2.3)	ZNF101 (2.2)	ST3GAL4 (1.8)	TRAFD1 (1.8)	ENSG00000228044 (1.7)	ENSG00000226645 (1.7)	FRK (1.7)	ZNF259 (1.6)
ENSG00000101306	MYLK2 PPI subnetwork	0.45	> 0.20	UBXN2B (3.1)	SYPL2 (3.0)	ZNF180 (2.5)	CEACAM19 (2.1)	TMEM50A (2.0)	PPP1R37 (1.6)	PBX4 (1.6)	KIAA1324 (1.5)	BCL3 (1.4)	C1orf63 (1.3)
ENSG00000142494	SLC47A1 PPI subnetwork	0.45	> 0.20	TM6SF2 (3.2)	DNAH11 (2.3)	MYLIP (2.3)	ST3GAL4 (2.2)	ENSG00000226645 (2.2)	NPC1L1 (2.1)	LPIN3 (2.0)	ZNF101 (1.9)	ABCG8 (1.8)	HAPLN4 (1.7)
GO:0000287	magnesium ion binding	0.45	> 0.20	TSSK6 (3.2)	NT5DC1 (2.6)	ALDH2 (2.1)	PMFBP1 (2.0)	HAPLN4 (1.9)	ENSG00000228044 (1.8)	OGDH (1.6)	LDLR (1.5)	USP1 (1.4)	HMGCR (1.4)
ENSG00000155363	MOV10 PPI subnetwork	0.45	> 0.20	ILF3 (3.8)	CARM1 (3.5)	BRAP (3.0)	DDX56 (2.7)	ATP13A1 (2.7)	SUGP1 (2.2)	SMARCA4 (2.2)	C19orf52 (2.1)	MAPKAPK5 (2.0)	TOMM40 (2.0)
ENSG00000156261	CCT8 PPI subnetwork	0.45	> 0.20	SARS (3.4)	NAA25 (3.2)	PSMA5 (3.1)	DDX56 (3.0)	SMARCA4 (2.2)	ZNF259 (1.9)	TOMM40 (1.9)	TOP1 (1.8)	OGDH (1.8)	PTPN11 (1.8)
GO:0051044	positive regulation of membrane protein ectodomain proteolysis	0.45	> 0.20	ENSG00000235545 (4.2)	ENSG00000228044 (3.5)	ENSG00000254235 (2.2)	GEMIN7 (2.1)	CBLC (1.9)	TRAFD1 (1.7)	SUGP1 (1.5)	CETP (1.5)	SLC44A2 (1.4)	LPAR2 (1.4)
ENSG00000182319	SGK223 PPI subnetwork	0.45	> 0.20	CBLC (5.8)	AP1M2 (3.6)	ST3GAL4 (2.8)	CELSR2 (2.4)	FRK (2.3)	LPIN3 (2.2)	DNM2 (1.8)	C12orf51 (1.8)	LPAR2 (1.8)	PLEC (1.6)
ENSG00000215104	ENSG00000215104 PPI subnetwork	0.45	> 0.20	TRAPPC6A (3.4)	TXNL4B (3.0)	C1orf63 (2.9)	KIAA1324 (2.7)	TMEM50A (1.9)	CYB561D1 (1.8)	CBLC (1.7)	ZNF180 (1.7)	C12orf43 (1.6)	DHX38 (1.6)
GO:0048487	beta-tubulin binding	0.45	> 0.20	RHCE (2.6)	C12orf51 (2.2)	GMPR (2.1)	PPP1R37 (2.0)	GATAD2A (2.0)	ILF3 (1.9)	COL4A3BP (1.8)	RHD (1.7)	MAU2 (1.7)	SLC22A1 (1.7)
MP:0002211	abnormal primary sex determination	0.45	> 0.20	ST3GAL4 (3.1)	C11orf9 (2.9)	DYNC2LI1 (2.0)	GCNT4 (1.3)	GPAM (1.3)	OGDH (1.2)	NYNRIN (1.2)	FRK (1.0)	TSSK6 (1.0)	ENSG00000254235 (0.9)
GO:0007129	synapsis	0.45	> 0.20	ANKRD31 (2.9)	ENSG00000238078 (2.7)	DNAH11 (2.0)	LPIN3 (1.9)	GCNT4 (1.3)	ADAM1 (1.2)	PBX4 (1.2)	ATP13A1 (1.0)	C17orf57 (1.0)	MAPKAPK5 (0.9)
MP:0003271	abnormal duodenum morphology	0.45	> 0.20	HNF1A (3.2)	C11orf9 (2.7)	HLX (1.9)	RHCE (1.7)	NPC1L1 (1.7)	COL4A3BP (1.7)	PCSK9 (1.7)	DOCK7 (1.6)	AP1M2 (1.6)	HAVCR1 (1.4)
GO:0032092	positive regulation of protein binding	0.45	> 0.20	TMEM57 (3.0)	ENSG00000226648 (2.2)	C12orf51 (1.8)	DNAH11 (1.8)	TMEM116 (1.6)	SARS (1.6)	GRINA (1.6)	HLX (1.5)	HAVCR1 (1.5)	SH2B3 (1.5)
ENSG00000100612	DHRS7 PPI subnetwork	0.45	> 0.20	DHX38 (2.9)	SMARCA4 (2.7)	ILF3 (2.5)	USP24 (2.5)	CARM1 (2.2)	TOMM40 (2.2)	CLPTM1 (2.1)	C12orf51 (1.9)	ATP13A1 (1.6)	DNM2 (1.6)
ENSG00000129625	REEP5 PPI subnetwork	0.45	> 0.20	HMGCR (5.5)	LDLR (5.0)	TMEM50A (3.8)	FADS1 (3.5)	FADS2 (2.9)	PCSK9 (2.7)	CLPTM1 (2.5)	TRAPPC6A (2.0)	CEACAM19 (1.8)	MOSC1 (1.8)
ENSG00000092841	MYL6 PPI subnetwork	0.45	> 0.20	TMEM50A (3.2)	KANK2 (2.7)	ADAM1 (2.5)	ENSG00000238078 (2.4)	PLEC (2.1)	C1orf63 (1.9)	PVR (1.9)	ITGB3 (1.9)	ILF3 (1.6)	MYLIP (1.5)
GO:0005416	cation:amino acid symporter activity	0.45	> 0.20	NCAN (4.7)	ABCG8 (3.2)	HAPLN4 (2.7)	CYP7A1 (2.6)	APOC4 (2.3)	RPH3A (2.0)	C12orf51 (2.0)	APOA5 (1.9)	ABCG5 (1.9)	GEMIN7 (1.8)
GO:0048636	positive regulation of muscle organ development	0.45	> 0.20	DNAH11 (2.7)	POLK (2.6)	COL4A3BP (2.5)	LDLR (1.9)	PMFBP1 (1.8)	PLEKHH2 (1.8)	TMEM116 (1.6)	GMPR (1.5)	CYP7A1 (1.1)	NKPD1 (1.1)
GO:0045844	positive regulation of striated muscle tissue development	0.45	> 0.20	DNAH11 (2.7)	POLK (2.6)	COL4A3BP (2.5)	LDLR (1.9)	PMFBP1 (1.8)	PLEKHH2 (1.8)	TMEM116 (1.6)	GMPR (1.5)	CYP7A1 (1.1)	NKPD1 (1.1)
GO:0043270	positive regulation of ion transport	0.45	> 0.20	ABO (2.5)	KIAA1324 (2.2)	DNAH11 (1.8)	YIPF2 (1.6)	CYB561D1 (1.6)	SLC44A2 (1.4)	MARK4 (1.3)	CETP (1.3)	RPH3A (1.3)	PLCG1 (1.2)
GO:0016441	posttranscriptional gene silencing	0.45	> 0.20	DOCK7 (3.2)	ENSG00000226648 (2.7)	USP24 (2.6)	MAPKAPK5 (2.4)	UBXN2B (2.0)	ENSG00000235545 (1.9)	ADAM1 (1.6)	GOT2P1 (1.6)	C1orf63 (1.5)	BUD13 (1.4)
GO:0035194	posttranscriptional gene silencing by RNA	0.45	> 0.20	DOCK7 (3.2)	ENSG00000226648 (2.7)	USP24 (2.6)	MAPKAPK5 (2.4)	UBXN2B (2.0)	ENSG00000235545 (1.9)	ADAM1 (1.6)	GOT2P1 (1.6)	C1orf63 (1.5)	BUD13 (1.4)
ENSG00000100941	PNN PPI subnetwork	0.45	> 0.20	C1orf63 (3.8)	TOP1 (3.6)	USP1 (2.6)	C17orf57 (1.9)	SMARCA4 (1.9)	BUD13 (1.8)	TMEM57 (1.7)	ENSG00000238078 (1.6)	NAA25 (1.5)	ILF3 (1.3)
ENSG00000152256	PDK1 PPI subnetwork	0.45	> 0.20	GPAM (3.7)	OGDH (3.5)	CLPTM1 (2.6)	DOCK7 (2.2)	KANK2 (2.0)	USP24 (1.8)	FADS1 (1.7)	MARK4 (1.5)	BCL3 (1.1)	MOSC1 (1.1)
ENSG00000187391	MAGI2 PPI subnetwork	0.45	> 0.20	CELSR2 (3.5)	NCAN (3.1)	MARK4 (2.8)	PPP1R37 (2.5)	RPH3A (2.5)	LPIN3 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.6)	BCAM (1.6)	PLCG1 (1.5)
ENSG00000167965	MLST8 PPI subnetwork	0.45	> 0.20	DHX38 (2.6)	AP1M2 (2.5)	COL4A3BP (2.3)	MAPKAPK5 (2.1)	CLPTM1 (2.0)	ATP13A1 (1.9)	PCSK9 (1.8)	ANKRD31 (1.7)	ENSG00000228044 (1.6)	YIPF2 (1.5)
ENSG00000107242	PIP5K1B PPI subnetwork	0.45	> 0.20	ITGB3 (3.5)	KANK2 (2.8)	ALDH2 (2.7)	ATXN2 (2.3)	PTPN11 (2.3)	TRAFD1 (2.2)	FADS1 (2.1)	C1orf63 (1.9)	SARS (1.8)	TXNL4B (1.7)
REACTOME_CYCLIN_ACDK2:ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	REACTOME_CYCLIN_ACDK2:ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	0.45	> 0.20	PSMA5 (6.2)	TRAFD1 (2.8)	TOMM40 (2.1)	NAA25 (1.9)	DDX56 (1.7)	NT5DC1 (1.5)	FEN1 (1.4)	SUGP1 (1.4)	SARS (1.3)	TMEM50A (1.1)
ENSG00000170542	SERPINB9 PPI subnetwork	0.45	> 0.20	FADS2 (2.6)	FADS1 (2.2)	TRAPPC6A (2.0)	CEACAM19 (1.9)	ATXN7L2 (1.8)	SLC44A2 (1.6)	HMGCR (1.4)	NT5DC1 (1.3)	ANKRD31 (1.3)	PCSK9 (1.3)
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C:STRAND_OF_THE_TELOMERE	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C:STRAND_OF_THE_TELOMERE	0.45	> 0.20	USP1 (5.2)	FEN1 (4.8)	ZNF180 (2.2)	GOT2P1 (2.1)	AMIGO1 (1.8)	KIAA1324 (1.6)	BLOC1S3 (1.6)	TOMM40 (1.6)	OGDH (1.6)	TMED4 (1.4)
ENSG00000173273	TNKS PPI subnetwork	0.45	> 0.20	GOT2P1 (2.7)	UBXN2B (2.6)	POC5 (2.0)	SH2B3 (2.0)	QTRT1 (2.0)	PTPN11 (1.9)	ACAD10 (1.9)	COL4A3BP (1.8)	POLK (1.8)	PLEC (1.7)
GO:0010543	regulation of platelet activation	0.45	> 0.20	ITGB3 (5.6)	CETP (2.7)	GMPR (2.1)	CYP7A1 (2.1)	ANGPTL3 (1.7)	PMFBP1 (1.6)	PVR (1.5)	SLC22A1 (1.5)	TIMD4 (1.5)	TXNL4B (1.4)
GO:0006284	base-excision repair	0.45	> 0.20	ZNF180 (2.4)	BUD13 (2.0)	ADAM1 (1.9)	TRAPPC6A (1.8)	LPIN3 (1.7)	AMIGO1 (1.4)	USP1 (1.4)	ANKRD31 (1.3)	DHODH (1.2)	FEN1 (1.2)
GO:0060326	cell chemotaxis	0.45	> 0.20	MAFB (3.4)	HLX (2.9)	ZNF101 (2.7)	TIMD4 (2.5)	APOE (2.2)	ST3GAL4 (2.1)	TMEM116 (2.0)	ADAM1 (1.7)	AMIGO1 (1.7)	CETP (1.4)
MP:0004139	abnormal gastric parietal cell morphology	0.45	> 0.20	C11orf9 (2.6)	OASL (2.4)	ABO (2.2)	GCNT4 (2.0)	KIAA1324 (1.9)	HNF1A (1.8)	TMED4 (1.6)	KANK2 (1.5)	SLC44A2 (1.5)	DOCK7 (1.5)
ENSG00000173546	CSPG4 PPI subnetwork	0.45	> 0.20	TIMD4 (3.9)	APOE (3.6)	CETP (3.6)	MAFB (2.7)	APOC1 (2.6)	USP24 (2.6)	CEACAM19 (1.6)	ENSG00000238078 (1.5)	NCAN (1.5)	PVRL2 (1.5)
ENSG00000134453	RBM17 PPI subnetwork	0.45	> 0.20	CARM1 (2.8)	ABO (2.6)	SMARCA4 (2.3)	ILF3 (2.2)	ZNF259 (2.1)	C12orf47 (2.1)	ATP13A1 (2.0)	SUGP1 (1.8)	GATAD2A (1.8)	DHX38 (1.7)
MP:0008725	enlarged heart atrium	0.45	> 0.20	BCAM (3.0)	GMPR (2.0)	DHODH (2.0)	ABCG5 (1.8)	PVRL2 (1.8)	POC5 (1.7)	C11orf9 (1.5)	ABCG8 (1.5)	NPC1L1 (1.5)	NYNRIN (1.4)
GO:0048662	negative regulation of smooth muscle cell proliferation	0.45	> 0.20	ENSG00000254235 (2.7)	TIMD4 (2.4)	POC5 (1.6)	CEACAM19 (1.6)	ST3GAL4 (1.4)	MOSC1 (1.3)	PMFBP1 (1.3)	TRAFD1 (1.2)	PPP1R37 (1.2)	NYNRIN (1.1)
MP:0002168	other aberrant phenotype	0.45	> 0.20	ANGPTL3 (3.4)	PVR (2.9)	APOC4 (2.5)	HP (2.4)	PLG (2.2)	PLEC (2.1)	APOA5 (2.0)	KANK2 (1.9)	TRIB1 (1.8)	NYNRIN (1.6)
ENSG00000142856	ITGB3BP PPI subnetwork	0.45	> 0.20	PSRC1 (5.2)	FEN1 (4.5)	USP1 (3.8)	POC5 (3.6)	ACAD10 (1.2)	AMIGO1 (1.0)	ZNF180 (0.9)	SORT1 (0.8)	TXNL4B (0.8)	BUD13 (0.8)
ENSG00000151498	ACAD8 PPI subnetwork	0.45	> 0.20	DHX38 (2.8)	BUD13 (2.5)	USP24 (2.2)	ATXN7L2 (2.1)	C17orf57 (2.1)	CEACAM19 (2.0)	ANKRD31 (1.8)	MAPKAPK5 (1.7)	POC5 (1.7)	ATXN2 (1.7)
GO:0002544	chronic inflammatory response	0.45	> 0.20	ENSG00000228044 (3.9)	TIMD4 (2.1)	CETP (1.8)	DYNC2LI1 (1.7)	FRK (1.5)	GCNT4 (1.4)	BCL3 (1.3)	GMIP (1.2)	ENSG00000238078 (1.1)	ST3GAL4 (1.0)
MP:0002069	abnormal eating/drinking behavior	0.45	> 0.20	APOC1 (3.5)	ZHX3 (1.6)	FADS1 (1.6)	BLOC1S3 (1.6)	PMFBP1 (1.5)	RHD (1.5)	RPH3A (1.4)	USP24 (1.4)	KIAA1324 (1.4)	FADS2 (1.3)
ENSG00000213123	TCTEX1D2 PPI subnetwork	0.45	> 0.20	GCNT4 (2.2)	BLOC1S3 (2.2)	GPAM (2.0)	NKPD1 (1.8)	POC5 (1.6)	SLC22A1 (1.6)	OGDH (1.6)	TOP1 (1.5)	ENSG00000238078 (1.4)	ZHX3 (1.3)
GO:0043297	apical junction assembly	0.45	> 0.20	FRK (3.6)	AP1M2 (3.1)	GCNT4 (2.6)	TMEM116 (2.3)	LPAR2 (2.1)	PTPN11 (2.1)	TSSK6 (1.9)	ENSG00000254235 (1.9)	CEACAM19 (1.9)	YIPF2 (1.9)
MP:0008642	decreased circulating interleukin-1 beta level	0.45	> 0.20	HLX (2.3)	RPH3A (2.1)	BCL3 (2.0)	RELB (2.0)	PMFBP1 (1.7)	OASL (1.5)	PVR (1.5)	PSRC1 (1.5)	ATXN7L2 (1.5)	MAFB (1.5)
MP:0004275	abnormal postnatal subventricular zone morphology	0.45	> 0.20	CELSR2 (3.4)	NCAN (2.6)	ST3GAL4 (2.2)	ATP13A1 (1.8)	CYB561D1 (1.8)	ENSG00000254235 (1.7)	FRK (1.6)	FADS2 (1.5)	RPH3A (1.5)	SORT1 (1.5)
ENSG00000163931	TKT PPI subnetwork	0.45	> 0.20	OASL (2.9)	QTRT1 (2.4)	CEACAM19 (2.2)	COL4A3BP (2.1)	ANGPTL3 (2.1)	PARP10 (1.9)	MAU2 (1.9)	TXNL4B (1.9)	GPAM (1.8)	TMEM50A (1.7)
ENSG00000160916	ENSG00000160916 PPI subnetwork	0.45	> 0.20	ACAD10 (4.1)	AP1M2 (2.8)	TOMM40 (2.6)	TRAPPC6A (2.6)	ERP29 (2.3)	PSMA5 (2.2)	OGDH (2.1)	TMED4 (2.0)	ATP13A1 (2.0)	BRAP (1.9)
ENSG00000196998	WDR45 PPI subnetwork	0.45	> 0.20	PPP1R37 (2.5)	TXNL4B (2.4)	GEMIN7 (2.0)	HAPLN4 (2.0)	PLCG1 (1.9)	MOSC1 (1.9)	GATAD2A (1.8)	AMIGO1 (1.7)	SARS (1.7)	APOC4 (1.7)
MP:0001106	abnormal Schwann cell morphology	0.45	> 0.20	RPH3A (2.4)	CELSR2 (2.4)	TSSK6 (2.3)	GRINA (2.3)	FADS1 (2.2)	LDLR (1.8)	PLEC (1.8)	SORT1 (1.8)	C12orf47 (1.8)	TMED4 (1.6)
GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	0.45	> 0.20	CELSR2 (3.4)	TRAFD1 (2.9)	PARP10 (2.3)	CYB561D1 (1.9)	MYLIP (1.7)	HAVCR1 (1.7)	SORT1 (1.7)	TSSK6 (1.6)	FRK (1.5)	GRINA (1.4)
ENSG00000136931	NR5A1 PPI subnetwork	0.45	> 0.20	COL4A3BP (2.5)	APOB (2.4)	GCNT4 (1.8)	APOE (1.8)	C19orf52 (1.6)	TMED4 (1.6)	ABCG5 (1.5)	ALDH2 (1.4)	ENSG00000235545 (1.3)	APOC1 (1.2)
ENSG00000133627	ACTR3B PPI subnetwork	0.45	> 0.20	CARM1 (2.7)	NPC1L1 (2.4)	SMARCA4 (2.3)	GMIP (2.3)	ENSG00000235545 (2.0)	GATAD2A (2.0)	ATP13A1 (1.8)	ERP29 (1.7)	FRK (1.6)	LPIN3 (1.6)
ENSG00000016490	CLCA1 PPI subnetwork	0.45	> 0.20	CBLC (2.7)	AP1M2 (2.7)	HNF1A (2.6)	APOC1 (2.4)	SORT1 (2.4)	TRAPPC6A (2.3)	APOB (2.1)	ERP29 (1.8)	GOT2P1 (1.8)	FRK (1.8)
ENSG00000109670	FBXW7 PPI subnetwork	0.45	> 0.20	LDLR (3.6)	ATXN2 (2.7)	HMGCR (2.6)	BLOC1S3 (2.6)	TRIB1 (2.4)	ATXN7L2 (2.3)	ACAD10 (2.1)	FADS2 (1.9)	PPP1R37 (1.8)	PSRC1 (1.7)
ENSG00000064995	TAF11 PPI subnetwork	0.46	> 0.20	MAPKAPK5 (3.2)	PSMA5 (2.9)	TXNL4B (2.4)	SUGP1 (2.3)	POC5 (2.1)	MAU2 (2.0)	COL4A3BP (2.0)	ATXN2 (2.0)	TOP1 (1.7)	USP1 (1.7)
MP:0001182	lung hemorrhage	0.46	> 0.20	PVRL2 (3.5)	HLX (3.5)	BCAM (3.0)	BCL3 (1.9)	KANK2 (1.9)	APOE (1.6)	ABO (1.6)	C11orf9 (1.5)	MYLIP (1.4)	ST3GAL4 (1.4)
MP:0000333	decreased bone marrow cell number	0.46	> 0.20	GMIP (2.8)	BCL3 (2.8)	ZNF101 (2.6)	MAFB (2.5)	MAU2 (2.3)	PBX4 (2.1)	SMARCA4 (2.1)	HLX (1.6)	RELB (1.5)	ZHX3 (1.5)
ENSG00000188191	PRKAR1B PPI subnetwork	0.46	> 0.20	TRIB1 (2.8)	PLEKHH2 (2.5)	TOP1 (2.4)	OGDH (2.2)	C1orf63 (2.2)	MOSC1 (2.1)	PMFBP1 (2.0)	SORT1 (1.9)	POLK (1.9)	KIAA1324 (1.7)
GO:0003158	endothelium development	0.46	> 0.20	DNAH11 (3.1)	CILP2 (2.7)	ENSG00000226645 (2.4)	CETP (2.2)	HLX (2.1)	BCAM (2.0)	HNF1A (1.9)	PLCG1 (1.8)	ANKRD31 (1.7)	SLC44A2 (1.7)
GO:0004715	non-membrane spanning protein tyrosine kinase activity	0.46	> 0.20	GMIP (3.7)	OASL (2.6)	PARP10 (2.3)	LPIN3 (2.0)	ZNF101 (1.9)	FRK (1.8)	DNM2 (1.7)	ALDH2 (1.6)	TRAFD1 (1.6)	GATAD2A (1.6)
ENSG00000197958	RPL12 PPI subnetwork	0.46	> 0.20	NAA25 (3.3)	ZNF259 (3.1)	DDX56 (2.7)	TOP1 (2.4)	QTRT1 (2.4)	ILF3 (2.2)	NKPD1 (2.2)	ANKRD31 (2.2)	TOMM40 (1.9)	DHODH (1.8)
GO:0004003	ATP-dependent DNA helicase activity	0.46	> 0.20	FEN1 (3.0)	USP1 (2.3)	ILF3 (2.3)	SUGP1 (2.3)	TRAPPC6A (1.9)	DHX38 (1.9)	ZNF180 (1.8)	GCNT4 (1.7)	NT5DC1 (1.6)	SMARCA4 (1.6)
ENSG00000168487	BMP1 PPI subnetwork	0.46	> 0.20	CBLC (3.9)	BCAM (3.4)	AP1M2 (3.0)	PLEC (2.8)	ENSG00000254235 (2.1)	KANK2 (1.9)	HAVCR1 (1.8)	APOE (1.8)	C17orf57 (1.7)	CYP7A1 (1.5)
GO:0031966	mitochondrial membrane	0.46	> 0.20	ACAD10 (4.3)	OGDH (4.1)	ALDH2 (2.6)	GMPR (2.5)	GPAM (2.2)	TRAPPC6A (2.2)	TOMM40 (2.1)	ABCG8 (1.7)	C19orf52 (1.7)	PSMA5 (1.6)
ENSG00000169564	PCBP1 PPI subnetwork	0.46	> 0.20	ILF3 (4.2)	C1orf63 (3.3)	TOP1 (3.0)	DHX38 (2.7)	PTPN11 (2.6)	SMARCA4 (2.5)	BUD13 (2.4)	USP1 (2.3)	SUGP1 (2.1)	QTRT1 (2.0)
ENSG00000108883	EFTUD2 PPI subnetwork	0.46	> 0.20	ILF3 (3.8)	SMARCA4 (3.2)	TOP1 (3.1)	C1orf63 (3.1)	USP1 (2.9)	DHX38 (2.6)	TOMM40 (2.2)	FEN1 (2.2)	SUGP1 (2.0)	BUD13 (2.0)
GO:0006275	regulation of DNA replication	0.46	> 0.20	POLK (3.6)	ENSG00000228044 (2.4)	BLOC1S3 (1.9)	BUD13 (1.8)	USP1 (1.4)	C17orf57 (1.3)	POC5 (1.3)	PSRC1 (1.3)	PLEKHH2 (1.1)	TOP1 (1.1)
ENSG00000164494	PDSS2 PPI subnetwork	0.46	> 0.20	GCNT4 (2.8)	ENSG00000235545 (2.7)	RPH3A (2.7)	GPAM (1.9)	COL4A3BP (1.8)	PPP1R37 (1.8)	PTPN11 (1.8)	C12orf43 (1.7)	ENSG00000226645 (1.6)	C17orf57 (1.6)
ENSG00000188612	SUMO2 PPI subnetwork	0.46	> 0.20	TMED4 (2.5)	TRIB1 (2.2)	MAFB (1.9)	TMEM57 (1.9)	PVRL2 (1.9)	PPP1R37 (1.9)	PVR (1.8)	USP1 (1.8)	PARP10 (1.7)	SMARCA4 (1.6)
GO:0042509	regulation of tyrosine phosphorylation of STAT protein	0.46	> 0.20	ENSG00000228044 (2.3)	TIMD4 (2.0)	ENSG00000238078 (2.0)	ENSG00000254235 (1.9)	GEMIN7 (1.9)	PBX4 (1.8)	COL4A3BP (1.6)	TRAFD1 (1.5)	DNAH11 (1.4)	PVR (1.4)
ENSG00000080845	DLGAP4 PPI subnetwork	0.46	> 0.20	ENSG00000238078 (2.6)	POLK (2.4)	ENSG00000254235 (2.4)	LPIN3 (2.4)	FRK (2.3)	NCAN (2.2)	RPH3A (2.2)	COL4A3BP (2.1)	PPP1R37 (2.1)	POC5 (1.6)
MP:0011495	abnormal head shape	0.46	> 0.20	NYNRIN (3.4)	DOCK7 (3.1)	CILP2 (3.0)	ALDH2 (2.5)	UBXN2B (2.5)	GOT2P1 (2.1)	PLEKHH2 (1.9)	MARK4 (1.9)	PVRL2 (1.9)	NPC1L1 (1.8)
MP:0002544	brachydactyly	0.46	> 0.20	CILP2 (4.9)	HMGCR (2.8)	PLEKHH2 (2.5)	NYNRIN (2.5)	FADS2 (2.4)	LDLR (2.2)	PCSK9 (2.0)	FADS1 (2.0)	ALDH2 (1.8)	NKPD1 (1.6)
MP:0000279	ventricular hypoplasia	0.46	> 0.20	C12orf51 (2.8)	RHD (2.0)	NYNRIN (1.9)	ACAD10 (1.8)	SMARCA4 (1.8)	LPA (1.8)	SYPL2 (1.6)	ENSG00000235545 (1.6)	COL4A3BP (1.5)	ENSG00000226648 (1.5)
MP:0003243	abnormal dopaminergic neuron morphology	0.46	> 0.20	GMPR (3.4)	RHCE (2.2)	ABO (2.1)	ENSG00000254235 (2.0)	BLOC1S3 (1.8)	HNF1A (1.5)	DNAH11 (1.5)	PMFBP1 (1.4)	TMEM50A (1.4)	RHD (1.3)
ENSG00000152137	HSPB8 PPI subnetwork	0.46	> 0.20	SYPL2 (4.5)	ZNF101 (2.8)	PLEKHH2 (2.6)	ZHX3 (2.5)	PLEC (1.8)	PTPN11 (1.7)	CARM1 (1.5)	KANK2 (1.5)	PVR (1.4)	CEACAM19 (1.0)
MP:0004200	decreased fetal size	0.46	> 0.20	NYNRIN (1.9)	GATAD2A (1.8)	PLEKHH2 (1.7)	BCAM (1.7)	MAFB (1.6)	KANK2 (1.5)	SMARCA4 (1.5)	KIAA1324 (1.5)	ATP13A1 (1.4)	TRIB1 (1.4)
GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	0.46	> 0.20	KANK2 (2.8)	C19orf52 (2.5)	ENSG00000226645 (2.2)	TMED4 (2.0)	ZNF180 (2.0)	GCNT4 (1.6)	ENSG00000254235 (1.5)	CYP7A1 (1.4)	TMEM50A (1.4)	DNM2 (1.2)
ENSG00000047621	C12orf4 PPI subnetwork	0.46	> 0.20	YIPF2 (3.6)	COL4A3BP (3.4)	ERP29 (3.3)	C19orf52 (2.9)	BRAP (2.3)	C12orf43 (2.2)	DDX56 (2.1)	HNF1A (2.1)	CLPTM1 (2.0)	ATP13A1 (2.0)
ENSG00000137054	POLR1E PPI subnetwork	0.46	> 0.20	ZNF259 (3.8)	TOMM40 (3.2)	DDX56 (3.1)	C12orf43 (3.0)	QTRT1 (3.0)	PVR (2.9)	GEMIN7 (2.8)	DHX38 (2.5)	ILF3 (2.3)	SUGP1 (2.0)
ENSG00000090060	PAPOLA PPI subnetwork	0.46	> 0.20	ILF3 (3.6)	DHX38 (3.4)	BUD13 (3.2)	SMARCA4 (3.0)	TOP1 (2.6)	SUGP1 (2.6)	C1orf63 (2.4)	GATAD2A (2.4)	USP1 (2.4)	PTPN11 (2.1)
MP:0009133	decreased white fat cell size	0.46	> 0.20	MOSC1 (4.0)	GPAM (3.6)	HP (2.6)	ZNF101 (2.2)	APOA5 (2.0)	SYPL2 (1.9)	SORT1 (1.9)	MAU2 (1.9)	AMIGO1 (1.8)	POLK (1.7)
ENSG00000147044	CASK PPI subnetwork	0.46	> 0.20	RPH3A (3.1)	CETP (2.7)	BCAM (2.4)	CELSR2 (2.3)	C11orf9 (1.6)	FRK (1.6)	PPP1R37 (1.5)	CYP7A1 (1.3)	APOE (1.3)	MARK4 (1.3)
GO:0033327	Leydig cell differentiation	0.46	> 0.20	DNAH11 (4.7)	ST3GAL4 (2.5)	TSSK6 (2.2)	ABO (2.2)	PMFBP1 (2.1)	FRK (2.0)	SLC44A2 (1.6)	LPAR2 (1.6)	TMED4 (1.4)	FADS1 (1.2)
REACTOME_APCCCDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APCCCDH1_TARGETED_PROTEINS_IN_LATE_MITOSISEARLY_G1	REACTOME_APCCCDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APCCCDH1_TARGETED_PROTEINS_IN_LATE_MITOSISEARLY_G1	0.46	> 0.20	PSMA5 (5.8)	TRAFD1 (3.7)	NAA25 (2.2)	SUGP1 (2.2)	DDX56 (1.9)	POC5 (1.8)	PSRC1 (1.8)	FEN1 (1.5)	LPIN3 (1.4)	TOMM40 (1.3)
GO:0010799	regulation of peptidyl-threonine phosphorylation	0.46	> 0.20	FRK (3.0)	ENSG00000226645 (2.8)	DNAH11 (2.1)	CYB561D1 (1.8)	MAPKAPK5 (1.5)	C19orf52 (1.4)	GCNT4 (1.3)	C17orf57 (1.3)	ENSG00000238078 (1.3)	ENSG00000254235 (1.1)
GO:0004016	adenylate cyclase activity	0.46	> 0.20	PMFBP1 (2.1)	ENSG00000228044 (2.0)	C12orf51 (1.9)	CYP7A1 (1.8)	ZNF180 (1.8)	ABCG8 (1.6)	GOT2P1 (1.5)	PVR (1.4)	ST3GAL4 (1.4)	ENSG00000226645 (1.4)
ENSG00000136011	STAB2 PPI subnetwork	0.46	> 0.20	OASL (3.2)	TMEM57 (2.2)	POLK (1.8)	PLEKHH2 (1.8)	TMEM50A (1.6)	C1orf63 (1.5)	BCAM (1.5)	CEACAM19 (1.4)	PVRL2 (1.3)	SLC44A2 (1.2)
MP:0003172	abnormal lysosome physiology	0.46	> 0.20	ERP29 (3.0)	COL4A3BP (2.8)	UBXN2B (2.2)	NKPD1 (2.1)	PPP1R37 (2.1)	CYB561D1 (1.8)	NT5DC1 (1.7)	ACAD10 (1.6)	GRINA (1.6)	ATP13A1 (1.6)
MP:0009230	abnormal sperm head morphology	0.46	> 0.20	TSSK6 (4.7)	BRAP (2.8)	ADAM1 (2.5)	GCNT4 (2.2)	PMFBP1 (2.1)	TMEM116 (2.1)	MAPKAPK5 (1.9)	LPAR2 (1.8)	MARK4 (1.7)	TXNL4B (1.6)
ENSG00000106588	PSMA2 PPI subnetwork	0.46	> 0.20	PSMA5 (6.1)	NT5DC1 (2.8)	NAA25 (2.5)	TRAFD1 (2.0)	DDX56 (2.0)	TOMM40 (1.9)	ENSG00000254235 (1.6)	C19orf52 (1.4)	SARS (1.3)	ITGB3 (1.2)
GO:0060341	regulation of cellular localization	0.46	> 0.20	KIAA1324 (3.2)	ABO (2.2)	COL4A3BP (2.0)	PLEKHH2 (1.9)	AP1M2 (1.7)	AMIGO1 (1.7)	HLX (1.5)	C11orf9 (1.4)	HNF1A (1.4)	C12orf47 (1.3)
ENSG00000158169	FANCC PPI subnetwork	0.46	> 0.20	OASL (2.6)	RHD (2.6)	TRAFD1 (2.5)	C1orf63 (2.5)	PARP10 (2.3)	HMGCR (2.1)	RHCE (1.8)	TOP1 (1.8)	TRIB1 (1.6)	USP1 (1.3)
GO:0030325	adrenal gland development	0.46	> 0.20	GCNT4 (2.8)	C11orf9 (2.6)	NYNRIN (2.3)	ST3GAL4 (2.3)	ATXN7L2 (1.8)	TSSK6 (1.6)	FRK (1.6)	DYNC2LI1 (1.5)	ENSG00000226645 (1.3)	MYLIP (1.1)
ENSG00000206557	TRIM71 PPI subnetwork	0.46	> 0.20	OASL (3.6)	PARP10 (3.1)	TMED4 (2.1)	ZNF180 (1.8)	NAA25 (1.8)	FRK (1.5)	SUGP1 (1.5)	C12orf43 (1.3)	BUD13 (1.3)	MAPKAPK5 (1.3)
REACTOME_PERK_REGULATED_GENE_EXPRESSION	REACTOME_PERK_REGULATED_GENE_EXPRESSION	0.46	> 0.20	SARS (5.2)	PVR (3.4)	TXNL4B (2.9)	TRIB1 (2.8)	MAPKAPK5 (2.6)	DHODH (2.6)	POC5 (2.4)	PMFBP1 (2.0)	ERP29 (2.0)	TMED4 (1.7)
GO:0051053	negative regulation of DNA metabolic process	0.46	> 0.20	POLK (3.3)	BLOC1S3 (3.2)	POC5 (2.7)	SUGP1 (2.2)	ENSG00000235545 (1.9)	C17orf57 (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.5)	USP1 (1.4)	BUD13 (1.3)
ENSG00000069011	PITX1 PPI subnetwork	0.46	> 0.20	TRIB1 (3.5)	HNF1A (2.7)	DYNC2LI1 (2.4)	GCNT4 (2.2)	RHD (1.8)	ATXN2 (1.8)	ATXN7L2 (1.8)	CYB561D1 (1.6)	LDLR (1.6)	AMIGO1 (1.5)
GO:0035411	catenin import into nucleus	0.46	> 0.20	CILP2 (2.2)	DOCK7 (2.0)	TMEM116 (1.8)	NKPD1 (1.7)	ENSG00000226648 (1.7)	DNAH11 (1.6)	ST3GAL4 (1.6)	GEMIN7 (1.6)	ZHX3 (1.5)	HAVCR1 (1.5)
GO:0002861	regulation of inflammatory response to antigenic stimulus	0.46	> 0.20	ENSG00000235545 (3.3)	ZNF101 (2.0)	TRAPPC6A (2.0)	DNAH11 (1.7)	ANKRD31 (1.5)	TIMD4 (1.3)	ENSG00000228044 (1.3)	GOT2P1 (1.2)	HAVCR1 (1.2)	ADAM1 (1.1)
MP:0002110	abnormal digit morphology	0.46	> 0.20	PCSK9 (2.3)	NYNRIN (2.2)	PLEKHH2 (2.2)	ZHX3 (2.1)	HMGCR (2.1)	LDLR (1.9)	CBLC (1.9)	MAFB (1.8)	FADS1 (1.6)	KANK2 (1.6)
ENSG00000080819	CPOX PPI subnetwork	0.46	> 0.20	RHCE (3.2)	CARM1 (2.9)	TMEM57 (2.8)	SARS (2.6)	ATXN2 (2.4)	SUGP1 (2.2)	ILF3 (2.1)	ATP13A1 (2.1)	C12orf51 (2.0)	RHD (2.0)
ENSG00000181061	HIGD1A PPI subnetwork	0.46	> 0.20	ATP13A1 (3.0)	OGDH (2.4)	ILF3 (2.3)	YIPF2 (2.0)	DNM2 (1.7)	LDLR (1.7)	ACAD10 (1.7)	TMEM116 (1.6)	QTRT1 (1.5)	PCSK9 (1.4)
ENSG00000145321	GC PPI subnetwork	0.46	> 0.20	ANGPTL3 (3.9)	PLG (3.5)	HP (2.3)	PCSK9 (2.1)	TMEM116 (1.9)	SYPL2 (1.9)	HNF1A (1.8)	APOB (1.8)	APOC1 (1.7)	GOT2P1 (1.7)
REACTOME_MICRORNA_MIRNA_BIOGENESIS	REACTOME_MICRORNA_MIRNA_BIOGENESIS	0.46	> 0.20	GEMIN7 (3.4)	C12orf51 (2.6)	USP24 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	C12orf47 (2.1)	ATXN2 (1.9)	TOMM40 (1.8)	TXNL4B (1.8)	UBXN2B (1.7)
REACTOME_REGULATORY_RNA_PATHWAYS	REACTOME_REGULATORY_RNA_PATHWAYS	0.46	> 0.20	GEMIN7 (3.4)	C12orf51 (2.6)	USP24 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	C12orf47 (2.1)	ATXN2 (1.9)	TOMM40 (1.8)	TXNL4B (1.8)	UBXN2B (1.7)
ENSG00000120699	EXOSC8 PPI subnetwork	0.46	> 0.20	DHODH (3.4)	SUGP1 (3.1)	MAPKAPK5 (3.0)	POC5 (2.7)	USP24 (2.5)	DDX56 (2.3)	POLK (2.1)	DHX38 (2.0)	GRINA (1.5)	KANK2 (1.5)
ENSG00000155966	AFF2 PPI subnetwork	0.46	> 0.20	MAFB (3.3)	LPIN3 (2.9)	GATAD2A (2.5)	FRK (2.0)	ENSG00000226648 (1.8)	MYLIP (1.8)	GCNT4 (1.7)	HAPLN4 (1.6)	TOP1 (1.5)	ZHX3 (1.5)
GO:0061039	ovum-producing ovary development	0.46	> 0.20	ST3GAL4 (2.2)	DNAH11 (2.1)	ABO (2.1)	ENSG00000235545 (1.7)	AMIGO1 (1.6)	YIPF2 (1.6)	CEACAM19 (1.5)	NYNRIN (1.5)	FRK (1.4)	TSSK6 (1.4)
REACTOME_CALCITONIN:LIKE_LIGAND_RECEPTORS	REACTOME_CALCITONIN:LIKE_LIGAND_RECEPTORS	0.46	> 0.20	LPIN3 (2.7)	ABO (2.6)	HLX (2.2)	PVRL2 (1.8)	ERP29 (1.7)	RPH3A (1.5)	CETP (1.4)	BCAM (1.4)	GEMIN7 (1.3)	NKPD1 (1.2)
GO:0000079	regulation of cyclin-dependent protein kinase activity	0.46	> 0.20	C1orf63 (3.2)	ANKRD31 (3.0)	ENSG00000226648 (2.5)	TXNL4B (2.3)	PSRC1 (2.1)	PBX4 (2.1)	ENSG00000226645 (1.8)	TOP1 (1.6)	ENSG00000254235 (1.6)	BLOC1S3 (1.5)
MP:0008482	decreased spleen germinal center number	0.46	> 0.20	RELB (3.2)	GMIP (2.5)	ZNF101 (2.4)	CETP (2.2)	TIMD4 (1.9)	CLPTM1 (1.8)	PBX4 (1.6)	USP24 (1.6)	TMED4 (1.5)	PLCG1 (1.4)
GO:0048661	positive regulation of smooth muscle cell proliferation	0.46	> 0.20	PVR (2.8)	ZNF101 (2.2)	MAFB (2.2)	TRIB1 (2.0)	ENSG00000228044 (1.9)	HLX (1.5)	C19orf52 (1.4)	TSSK6 (1.3)	ADAM1 (1.3)	PLEKHH2 (1.1)
MP:0000435	shortened head	0.46	> 0.20	CILP2 (3.4)	MYLIP (3.0)	PLEKHH2 (2.6)	ANKRD31 (2.1)	USP1 (1.7)	PLCG1 (1.7)	KANK2 (1.5)	NPC1L1 (1.5)	ALDH2 (1.3)	GATAD2A (1.1)
ENSG00000136149	ENSG00000136149 PPI subnetwork	0.46	> 0.20	ZNF259 (3.3)	NAA25 (3.3)	DDX56 (3.0)	TOMM40 (3.0)	GATAD2A (2.5)	QTRT1 (2.3)	DHODH (2.2)	ILF3 (2.0)	DHX38 (1.9)	SUGP1 (1.7)
ENSG00000105991	HOXA1 PPI subnetwork	0.46	> 0.20	NYNRIN (2.6)	MARK4 (2.4)	LPIN3 (2.2)	TRAPPC6A (1.9)	ERP29 (1.9)	GATAD2A (1.7)	APOE (1.6)	SMARCA4 (1.5)	CLPTM1 (1.5)	PVRL2 (1.5)
MP:0000547	short limbs	0.46	> 0.20	CILP2 (5.6)	MAFB (3.3)	PLEKHH2 (3.0)	HMGCR (2.3)	PCSK9 (2.2)	PLCG1 (1.5)	LDLR (1.5)	NPC1L1 (1.4)	YIPF2 (1.2)	FADS1 (1.2)
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.46	> 0.20	AP1M2 (4.3)	SLC44A2 (3.4)	DNM2 (3.4)	GMIP (2.9)	SH2B3 (2.9)	PVRL2 (2.9)	ITGB3 (2.4)	BCAM (2.2)	GATAD2A (2.1)	CYP7A1 (2.1)
GO:0045932	negative regulation of muscle contraction	0.46	> 0.20	C17orf57 (2.8)	ENSG00000226648 (2.5)	C12orf51 (2.1)	TXNL4B (2.1)	SYPL2 (2.1)	ANKRD31 (2.0)	GMPR (1.9)	BLOC1S3 (1.8)	ERP29 (1.7)	TMEM116 (1.5)
GO:0018298	protein-chromophore linkage	0.46	> 0.20	HNF1A (2.1)	ENSG00000235545 (2.0)	BLOC1S3 (1.7)	MAPKAPK5 (1.6)	ABO (1.6)	C12orf47 (1.4)	CEACAM19 (1.4)	DNAH11 (1.3)	GOT2P1 (1.2)	HAVCR1 (1.2)
ENSG00000079785	DDX1 PPI subnetwork	0.46	> 0.20	PLCG1 (3.1)	ILF3 (2.7)	TOP1 (2.6)	GATAD2A (2.6)	SMARCA4 (2.4)	SARS (2.1)	C1orf63 (1.9)	CLPTM1 (1.9)	QTRT1 (1.8)	ADAM1 (1.8)
GO:0035091	phosphatidylinositol binding	0.47	> 0.20	COL4A3BP (3.0)	CYB561D1 (2.4)	HLX (2.1)	DOCK7 (2.0)	SH2B3 (2.0)	UBXN2B (1.9)	MAFB (1.7)	ZHX3 (1.6)	PPP1R37 (1.6)	LPIN3 (1.5)
GO:0050691	regulation of defense response to virus by host	0.47	> 0.20	OASL (4.4)	PARP10 (4.2)	ENSG00000235545 (2.9)	FRK (2.5)	MAU2 (2.5)	CYB561D1 (2.4)	GEMIN7 (2.1)	TRAFD1 (1.9)	POLK (1.6)	MYLIP (1.4)
GO:0032587	ruffle membrane	0.47	> 0.20	PVR (3.7)	SLC44A2 (3.3)	SH2B3 (3.3)	C11orf9 (3.2)	NCAN (3.2)	ITGB3 (2.4)	PVRL2 (2.2)	PLEC (2.1)	AP1M2 (1.9)	GATAD2A (1.7)
MP:0008000	increased ovary tumor incidence	0.47	> 0.20	NT5DC1 (2.1)	BLOC1S3 (1.9)	ST3GAL4 (1.8)	ABO (1.8)	LPIN3 (1.6)	POC5 (1.4)	ZHX3 (1.3)	ENSG00000226648 (1.3)	PLEC (1.3)	NYNRIN (1.2)
ENSG00000114302	PRKAR2A PPI subnetwork	0.47	> 0.20	OGDH (3.2)	KANK2 (2.8)	DNM2 (2.7)	GMPR (2.6)	GPAM (2.5)	QTRT1 (2.3)	PTPN11 (2.3)	C19orf52 (2.2)	USP24 (2.2)	MAU2 (2.1)
ENSG00000101413	RPRD1B PPI subnetwork	0.47	> 0.20	USP24 (4.1)	SUGP1 (2.9)	SMARCA4 (2.9)	CARM1 (2.4)	POLK (2.3)	ATXN2 (1.9)	C12orf43 (1.8)	TMEM57 (1.7)	C1orf63 (1.6)	NT5DC1 (1.6)
GO:0034104	negative regulation of tissue remodeling	0.47	> 0.20	HNF1A (2.8)	ENSG00000228044 (2.4)	CEACAM19 (2.1)	ANKRD31 (2.0)	GOT2P1 (1.9)	ABO (1.5)	ENSG00000235545 (1.5)	HAPLN4 (1.5)	ERP29 (1.2)	ENSG00000226645 (1.2)
ENSG00000026103	FAS PPI subnetwork	0.47	> 0.20	TMEM50A (2.3)	FRK (2.3)	GMIP (2.2)	PARP10 (2.1)	OGDH (2.0)	LDLR (2.0)	ENSG00000238078 (2.0)	SH2B3 (1.9)	ZNF180 (1.9)	TRAFD1 (1.8)
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION__PROTEASOME_DEGRADATION	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION__PROTEASOME_DEGRADATION	0.47	> 0.20	TRAFD1 (4.6)	PSMA5 (3.9)	SUGP1 (2.2)	NAA25 (2.2)	BRAP (2.0)	C12orf43 (2.0)	GEMIN7 (2.0)	CARM1 (1.9)	ATXN2 (1.9)	PARP10 (1.7)
MP:0003634	abnormal glial cell morphology	0.47	> 0.20	BCL3 (2.2)	ENSG00000254235 (2.0)	TSSK6 (1.9)	CELSR2 (1.7)	LPAR2 (1.7)	PLEKHH2 (1.6)	TRIB1 (1.6)	RELB (1.5)	ENSG00000226645 (1.5)	ITGB3 (1.5)
ENSG00000162616	DNAJB4 PPI subnetwork	0.47	> 0.20	TOMM40 (2.4)	ZNF180 (2.4)	BLOC1S3 (2.3)	PVR (2.1)	PTPN11 (2.1)	DOCK7 (2.0)	FRK (1.7)	TRAPPC6A (1.7)	CEACAM19 (1.6)	C19orf52 (1.5)
ENSG00000135409	AMHR2 PPI subnetwork	0.47	> 0.20	OASL (2.5)	TMEM57 (2.3)	PLEKHH2 (2.3)	TIMD4 (2.1)	CETP (1.7)	ATP13A1 (1.6)	CILP2 (1.5)	SLC22A1 (1.5)	ABO (1.5)	POLK (1.5)
ENSG00000159692	CTBP1 PPI subnetwork	0.47	> 0.20	ATXN2 (3.7)	ATXN7L2 (3.4)	C12orf51 (3.1)	PPP1R37 (2.4)	SMARCA4 (2.3)	USP24 (2.2)	KANK2 (1.9)	CELSR2 (1.9)	CARM1 (1.8)	APOC4 (1.8)
ENSG00000126756	UXT PPI subnetwork	0.47	> 0.20	TRAPPC6A (3.8)	BLOC1S3 (3.7)	ANKRD31 (2.7)	PVR (2.3)	ATXN2 (2.1)	POC5 (1.7)	PSMA5 (1.7)	TOMM40 (1.7)	GMPR (1.6)	TXNL4B (1.6)
ENSG00000101745	ANKRD12 PPI subnetwork	0.47	> 0.20	ATXN2 (3.5)	C19orf52 (2.9)	USP24 (2.6)	NAA25 (2.3)	TMEM57 (2.2)	BRAP (1.8)	ILF3 (1.7)	PCSK9 (1.6)	GCNT4 (1.5)	MAU2 (1.5)
GO:0045070	positive regulation of viral genome replication	0.47	> 0.20	GCNT4 (3.1)	OASL (3.0)	YIPF2 (2.3)	MAU2 (2.3)	ENSG00000226645 (1.9)	C12orf43 (1.7)	NKPD1 (1.7)	ADAM1 (1.5)	ANKRD31 (1.4)	ATP13A1 (1.4)
GO:0022409	positive regulation of cell-cell adhesion	0.47	> 0.20	ENSG00000228044 (2.9)	TSSK6 (2.2)	GCNT4 (2.1)	KANK2 (1.9)	ENSG00000238078 (1.8)	C1orf63 (1.4)	FRK (1.4)	TMEM116 (1.3)	ZNF101 (1.3)	SLC44A2 (1.3)
GO:0005581	collagen	0.47	> 0.20	CILP2 (6.3)	APOE (3.1)	APOC1 (2.3)	LPA (2.2)	MYLIP (2.0)	PLEKHH2 (1.9)	MAFB (1.8)	TIMD4 (1.6)	CETP (1.6)	AP1M2 (1.5)
GO:0035102	PRC1 complex	0.47	> 0.20	MARK4 (2.4)	ENSG00000235545 (1.9)	ATXN7L2 (1.9)	TMEM116 (1.8)	GRINA (1.7)	PPP1R37 (1.6)	ENSG00000254235 (1.5)	BCAM (1.4)	C12orf47 (1.4)	LPAR2 (1.3)
GO:0006402	mRNA catabolic process	0.47	> 0.20	TXNL4B (4.0)	UBXN2B (2.8)	MAPKAPK5 (2.6)	BUD13 (2.5)	BRAP (2.4)	ADAM1 (2.3)	ZNF259 (1.9)	ILF3 (1.7)	DHX38 (1.7)	DHODH (1.6)
MP:0000288	abnormal pericardium morphology	0.47	> 0.20	BCAM (3.2)	MAFB (2.5)	TSSK6 (2.2)	NYNRIN (2.1)	BLOC1S3 (2.1)	LPAR2 (1.5)	MOSC1 (1.5)	CEACAM19 (1.4)	HAPLN4 (1.3)	PVRL2 (1.3)
GO:0003682	chromatin binding	0.47	> 0.20	USP1 (3.0)	PLCG1 (2.7)	GATAD2A (2.5)	SMARCA4 (2.5)	ILF3 (2.3)	CARM1 (2.1)	MARK4 (2.1)	SH2B3 (1.9)	NYNRIN (1.9)	ATXN2 (1.9)
GO:0008252	nucleotidase activity	0.47	> 0.20	TMED4 (2.8)	UBXN2B (2.7)	FRK (2.3)	ITGB3 (2.0)	NT5DC1 (1.8)	GMPR (1.7)	CEACAM19 (1.6)	TXNL4B (1.5)	DDX56 (1.4)	SARS (1.3)
ENSG00000079102	RUNX1T1 PPI subnetwork	0.47	> 0.20	ATXN2 (2.8)	SMARCA4 (2.4)	CARM1 (2.2)	PLCG1 (2.1)	PTPN11 (2.1)	ZHX3 (2.1)	C12orf47 (1.9)	KANK2 (1.7)	GATAD2A (1.7)	UBXN2B (1.5)
MP:0008092	abnormal T-helper 2 cell differentiation	0.47	> 0.20	OASL (6.3)	PARP10 (3.6)	GMIP (3.1)	SH2B3 (1.9)	CYB561D1 (1.7)	DNM2 (1.7)	MAFB (1.3)	TRAFD1 (1.2)	GOT2P1 (1.1)	POC5 (1.0)
MP:0008097	increased plasma cell number	0.47	> 0.20	RELB (3.3)	TIMD4 (2.5)	ZNF101 (2.4)	GMIP (2.4)	PBX4 (2.2)	SLC44A2 (1.8)	BCL3 (1.8)	COL4A3BP (1.3)	NT5DC1 (1.3)	PLCG1 (1.3)
ENSG00000024048	UBR2 PPI subnetwork	0.47	> 0.20	POC5 (2.1)	PSMA5 (2.0)	SMARCA4 (2.0)	COL4A3BP (2.0)	BRAP (1.9)	NAA25 (1.9)	ATXN2 (1.9)	NT5DC1 (1.8)	USP24 (1.7)	TOMM40 (1.5)
MP:0011368	increased kidney apoptosis	0.47	> 0.20	CELSR2 (4.1)	BCAM (3.8)	TMEM116 (2.9)	AP1M2 (2.4)	NYNRIN (2.3)	HAVCR1 (2.3)	MYLIP (2.1)	PLEC (2.0)	PLEKHH2 (1.8)	SLC22A1 (1.8)
GO:0051412	response to corticosterone stimulus	0.47	> 0.20	DNAH11 (2.9)	TSSK6 (2.2)	GMPR (2.1)	ZHX3 (1.8)	POLK (1.8)	PMFBP1 (1.7)	GOT2P1 (1.7)	LPA (1.6)	ENSG00000254235 (1.4)	ABCG5 (1.3)
MP:0001614	abnormal blood vessel morphology	0.47	> 0.20	HLX (3.4)	KANK2 (3.1)	SH2B3 (2.9)	ITGB3 (2.7)	BCAM (2.2)	PLEC (2.1)	MYLIP (1.6)	GATAD2A (1.6)	LPA (1.4)	MAFB (1.4)
GO:0032456	endocytic recycling	0.47	> 0.20	GCNT4 (2.5)	ENSG00000226645 (2.2)	ZHX3 (1.6)	USP24 (1.4)	DOCK7 (1.4)	PBX4 (1.3)	TMEM57 (1.2)	SH2B3 (1.2)	ST3GAL4 (1.2)	GEMIN7 (1.1)
ENSG00000165178	ENSG00000165178 PPI subnetwork	0.47	> 0.20	GMIP (3.9)	NCAN (2.5)	RELB (2.5)	DNM2 (2.0)	TMEM50A (1.7)	SH2B3 (1.7)	PMFBP1 (1.7)	ATP13A1 (1.6)	TRAPPC6A (1.6)	ZNF259 (1.5)
ENSG00000100697	DICER1 PPI subnetwork	0.47	> 0.20	RHD (2.5)	ACAD10 (2.3)	PLCG1 (2.2)	ATXN2 (2.1)	LPAR2 (2.0)	ADAM1 (1.9)	BRAP (1.9)	MAPKAPK5 (1.8)	ENSG00000235545 (1.5)	ERP29 (1.5)
MP:0000135	decreased compact bone thickness	0.47	> 0.20	OASL (2.8)	MAFB (2.5)	KIAA1324 (2.1)	TMEM57 (2.1)	TRIB1 (2.0)	CYB561D1 (1.9)	ENSG00000254235 (1.9)	FRK (1.8)	TRAFD1 (1.6)	YIPF2 (1.5)
ENSG00000151693	ASAP2 PPI subnetwork	0.47	> 0.20	OGDH (3.7)	COL4A3BP (3.0)	ADAM1 (2.7)	ZHX3 (2.5)	SLC44A2 (2.5)	GATAD2A (2.5)	PBX4 (2.3)	PMFBP1 (2.3)	C12orf47 (2.0)	DDX56 (2.0)
GO:0000922	spindle pole	0.47	> 0.20	PSRC1 (5.3)	POC5 (4.8)	USP1 (3.5)	FEN1 (3.4)	BUD13 (1.9)	ENSG00000228044 (1.7)	DYNC2LI1 (1.5)	ZNF180 (1.5)	PBX4 (1.4)	POLK (1.4)
GO:0033146	regulation of intracellular estrogen receptor signaling pathway	0.47	> 0.20	GCNT4 (3.3)	AP1M2 (2.1)	QTRT1 (2.0)	ENSG00000254235 (1.7)	YIPF2 (1.7)	COL4A3BP (1.6)	ENSG00000238078 (1.6)	ATXN2 (1.5)	HAVCR1 (1.5)	C19orf52 (1.5)
ENSG00000113263	ITK PPI subnetwork	0.47	> 0.20	PLCG1 (3.6)	GMIP (3.3)	PLEKHH2 (2.4)	PARP10 (2.4)	PBX4 (2.2)	ABCG8 (2.1)	COL4A3BP (2.1)	LPAR2 (2.0)	ZNF101 (1.9)	ABCG5 (1.9)
MP:0002188	small heart	0.47	> 0.20	NYNRIN (3.4)	C11orf9 (2.3)	BCAM (2.2)	PVRL2 (2.2)	COL4A3BP (1.9)	GCNT4 (1.4)	PCSK9 (1.4)	OGDH (1.3)	ACAD10 (1.3)	CARM1 (1.2)
GO:0032480	negative regulation of type I interferon production	0.47	> 0.20	OASL (6.1)	PARP10 (5.7)	TRAFD1 (3.2)	MAU2 (2.7)	CYB561D1 (2.4)	C19orf52 (2.3)	FRK (2.0)	ADAM1 (2.0)	ZNF180 (2.0)	ZNF101 (1.9)
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	0.47	> 0.20	FEN1 (5.5)	USP1 (5.3)	ZNF180 (2.3)	AMIGO1 (2.3)	TOMM40 (1.5)	GOT2P1 (1.5)	ENSG00000235545 (1.5)	KIAA1324 (1.5)	FADS1 (1.4)	ENSG00000228044 (1.3)
MP:0004819	decreased skeletal muscle mass	0.47	> 0.20	SYPL2 (5.5)	AMIGO1 (2.5)	PVR (2.4)	CARM1 (2.4)	PLEC (2.0)	SLC44A2 (1.7)	BCAM (1.7)	KIAA1324 (1.6)	PVRL2 (1.3)	GPAM (1.3)
MP:0003878	abnormal ear physiology	0.47	> 0.20	BCAM (3.2)	HNF1A (2.4)	LPIN3 (2.0)	AP1M2 (1.7)	POLK (1.7)	C12orf47 (1.6)	PVRL2 (1.6)	HAPLN4 (1.5)	NPC1L1 (1.5)	PBX4 (1.5)
MP:0009254	disorganized pancreatic islets	0.47	> 0.20	DNAH11 (3.2)	NCAN (2.9)	C11orf9 (2.7)	HAPLN4 (2.2)	ENSG00000226648 (1.6)	ENSG00000226645 (1.4)	COL4A3BP (1.4)	TRIB1 (1.3)	RPH3A (1.2)	ABCG8 (1.2)
ENSG00000101843	PSMD10 PPI subnetwork	0.47	> 0.20	PSMA5 (5.5)	TRAFD1 (2.7)	NAA25 (2.3)	NT5DC1 (2.1)	TOMM40 (2.0)	DDX56 (1.5)	SARS (1.5)	DHX38 (1.5)	PARP10 (1.4)	TMEM50A (1.3)
ENSG00000101654	RNMT PPI subnetwork	0.47	> 0.20	SUGP1 (3.4)	GEMIN7 (3.0)	C12orf43 (3.0)	TRAPPC6A (2.9)	ZNF259 (2.3)	DHX38 (1.8)	DYNC2LI1 (1.8)	SARS (1.8)	TXNL4B (1.7)	MARK4 (1.6)
ENSG00000110880	CORO1C PPI subnetwork	0.47	> 0.20	PLEC (4.3)	PVR (2.4)	LPIN3 (2.4)	ABCG8 (2.2)	KANK2 (2.1)	GATAD2A (2.0)	TM6SF2 (1.9)	DOCK7 (1.8)	PLCG1 (1.7)	BRAP (1.6)
ENSG00000145723	GIN1 PPI subnetwork	0.47	> 0.20	OASL (3.7)	PARP10 (2.7)	TMED4 (2.2)	ZNF180 (1.6)	C12orf43 (1.6)	MAPKAPK5 (1.6)	USP24 (1.5)	NAA25 (1.3)	USP1 (1.3)	ENSG00000228044 (1.2)
GO:0048617	embryonic foregut morphogenesis	0.47	> 0.20	LPAR2 (4.2)	ABO (2.8)	ENSG00000226648 (2.7)	LPIN3 (2.3)	TMEM116 (2.1)	C11orf9 (2.0)	UBXN2B (1.9)	HNF1A (1.9)	PVRL2 (1.8)	BCAM (1.6)
GO:2000242	negative regulation of reproductive process	0.47	> 0.20	OASL (4.8)	ENSG00000235545 (3.3)	C11orf9 (2.5)	GCNT4 (1.9)	ZNF101 (1.8)	GMPR (1.8)	PARP10 (1.7)	ENSG00000226645 (1.6)	C1orf63 (1.5)	MAU2 (1.4)
GO:0032507	maintenance of protein location in cell	0.47	> 0.20	GOT2P1 (2.1)	ZNF101 (2.0)	CBLC (1.8)	RHD (1.8)	PBX4 (1.8)	CEACAM19 (1.7)	C17orf57 (1.7)	PSRC1 (1.7)	PLEC (1.7)	CLPTM1 (1.6)
ENSG00000160999	SH2B2 PPI subnetwork	0.47	> 0.20	SH2B3 (3.8)	USP24 (3.2)	C17orf57 (2.7)	PBX4 (2.7)	GMIP (2.5)	DNM2 (2.0)	MARK4 (1.9)	SLC44A2 (1.8)	RHD (1.6)	GMPR (1.5)
REACTOME_SIGNALING_BY_NOTCH	REACTOME_SIGNALING_BY_NOTCH	0.47	> 0.20	CELSR2 (2.8)	NYNRIN (2.3)	TRAPPC6A (2.3)	PLEC (2.2)	BCAM (2.1)	GRINA (2.0)	MAU2 (2.0)	CLPTM1 (1.8)	GATAD2A (1.8)	TMEM50A (1.8)
MP:0010819	primary atelectasis	0.47	> 0.20	PVRL2 (3.2)	C11orf9 (3.0)	ABO (2.8)	HNF1A (2.6)	ENSG00000238078 (2.2)	BCAM (2.0)	ENSG00000254235 (1.8)	KIAA1324 (1.7)	COL4A3BP (1.7)	PVR (1.7)
MP:0003710	abnormal physiological neovascularization	0.47	> 0.20	BCL3 (3.2)	PVR (3.1)	GRINA (2.2)	C17orf57 (2.0)	CEACAM19 (1.9)	LDLR (1.8)	HAVCR1 (1.6)	YIPF2 (1.6)	ITGB3 (1.5)	RELB (1.5)
GO:0004364	glutathione transferase activity	0.47	> 0.20	ALDH2 (3.8)	TM6SF2 (2.3)	TRAPPC6A (2.0)	PSRC1 (1.9)	C11orf9 (1.6)	ACAD10 (1.5)	PSMA5 (1.5)	GPAM (1.5)	AMIGO1 (1.5)	ABCG8 (1.4)
GO:0032640	tumor necrosis factor production	0.47	> 0.20	GRINA (2.1)	MAFB (2.0)	PVR (1.7)	HLX (1.7)	ALDH2 (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	ST3GAL4 (1.5)	FRK (1.4)
GO:0032680	regulation of tumor necrosis factor production	0.47	> 0.20	GRINA (2.1)	MAFB (2.0)	PVR (1.7)	HLX (1.7)	ALDH2 (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	ST3GAL4 (1.5)	FRK (1.4)
GO:0005770	late endosome	0.47	> 0.20	TMEM50A (3.5)	COL4A3BP (2.7)	ERP29 (2.3)	TRAFD1 (2.3)	GRINA (2.2)	MAFB (2.1)	APOC1 (1.9)	APOE (1.7)	CETP (1.6)	ATP13A1 (1.3)
ENSG00000171992	SYNPO PPI subnetwork	0.47	> 0.20	PLEC (4.3)	GATAD2A (3.0)	LPIN3 (2.6)	PVR (2.3)	DOCK7 (2.1)	PLCG1 (2.0)	ABCG8 (2.0)	OGDH (1.9)	SARS (1.8)	LDLR (1.7)
ENSG00000116833	NR5A2 PPI subnetwork	0.47	> 0.20	APOB (2.6)	ABCG5 (2.3)	HNF1A (2.0)	TSSK6 (1.8)	MARK4 (1.7)	MAPKAPK5 (1.7)	BCL3 (1.6)	ABCG8 (1.6)	NPC1L1 (1.5)	APOA5 (1.5)
GO:0042645	mitochondrial nucleoid	0.47	> 0.20	ACAD10 (4.0)	DHODH (3.2)	C19orf52 (2.7)	NAA25 (2.4)	OGDH (2.4)	BRAP (2.4)	TMEM116 (2.3)	ABCG5 (2.2)	ABCG8 (2.2)	TOMM40 (2.1)
GO:0002821	positive regulation of adaptive immune response	0.47	> 0.20	NKPD1 (2.3)	ENSG00000235545 (2.0)	CEACAM19 (1.6)	GEMIN7 (1.6)	PBX4 (1.5)	MAU2 (1.3)	DNAH11 (1.3)	TRAPPC6A (1.3)	ZNF180 (1.3)	PARP10 (1.2)
MP:0004181	abnormal carotid artery morphology	0.47	> 0.20	PLCG1 (2.4)	C12orf43 (2.4)	PVRL2 (1.8)	BRAP (1.6)	KIAA1324 (1.6)	PCSK9 (1.4)	MYLIP (1.4)	C12orf47 (1.4)	ADAM1 (1.4)	PVR (1.3)
GO:0051087	chaperone binding	0.47	> 0.20	ERP29 (3.2)	CYP7A1 (2.5)	TOMM40 (2.1)	ZNF259 (2.0)	BRAP (1.9)	ANGPTL3 (1.9)	APOC4 (1.9)	GATAD2A (1.9)	GOT2P1 (1.7)	APOB (1.7)
GO:0007128	meiotic prophase I	0.47	> 0.20	ANKRD31 (4.5)	C17orf57 (2.4)	ENSG00000238078 (2.3)	ENSG00000228044 (1.9)	TSSK6 (1.7)	NKPD1 (1.7)	TMEM116 (1.3)	LPIN3 (1.3)	PBX4 (1.3)	HAVCR1 (1.2)
ENSG00000117877	CD3EAP PPI subnetwork	0.47	> 0.20	QTRT1 (2.6)	ZNF259 (2.5)	ZNF180 (2.4)	C12orf43 (2.4)	BUD13 (2.3)	DHODH (2.1)	GEMIN7 (1.9)	MOSC1 (1.8)	DHX38 (1.8)	DYNC2LI1 (1.5)
ENSG00000114391	RPL24 PPI subnetwork	0.47	> 0.20	NKPD1 (2.9)	GATAD2A (1.9)	ANKRD31 (1.9)	ZNF259 (1.9)	NAA25 (1.6)	PTPN11 (1.5)	C1orf63 (1.5)	SUGP1 (1.5)	SARS (1.5)	TOMM40 (1.4)
ENSG00000186446	ZNF501 PPI subnetwork	0.47	> 0.20	TM6SF2 (2.9)	ENSG00000226645 (2.7)	MYLIP (2.5)	TRIB1 (2.4)	LDLR (2.2)	ABCG5 (1.8)	MAU2 (1.8)	ABCG8 (1.8)	NPC1L1 (1.8)	DNAH11 (1.7)
MP:0005590	increased vasodilation	0.47	> 0.20	PVR (2.4)	SYPL2 (1.7)	PLEC (1.6)	LPIN3 (1.6)	PVRL2 (1.5)	TRIB1 (1.4)	SH2B3 (1.3)	PSRC1 (1.3)	ATP13A1 (1.2)	ENSG00000254235 (1.2)
ENSG00000125965	GDF5 PPI subnetwork	0.47	> 0.20	AMIGO1 (3.5)	ENSG00000228044 (2.5)	PVRL2 (2.2)	DOCK7 (2.1)	ZNF101 (1.9)	LPAR2 (1.9)	LPIN3 (1.8)	MAFB (1.6)	ATP13A1 (1.6)	ATXN2 (1.5)
ENSG00000115091	ACTR3 PPI subnetwork	0.47	> 0.20	TMEM50A (3.0)	ITGB3 (2.8)	AP1M2 (2.3)	C1orf63 (2.2)	FRK (2.2)	ERP29 (1.7)	MYLIP (1.7)	SH2B3 (1.6)	GATAD2A (1.5)	TOP1 (1.4)
GO:0006337	nucleosome disassembly	0.47	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0031498	chromatin disassembly	0.47	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0032986	protein-DNA complex disassembly	0.47	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0090218	positive regulation of lipid kinase activity	0.47	> 0.20	HAVCR1 (2.7)	CETP (2.6)	DOCK7 (2.5)	CYB561D1 (2.1)	ANKRD31 (2.0)	ENSG00000228044 (2.0)	ZNF101 (1.9)	PBX4 (1.6)	TIMD4 (1.5)	CELSR2 (1.5)
GO:0051567	histone H3-K9 methylation	0.47	> 0.20	ZNF180 (2.3)	SLC44A2 (1.9)	TMEM57 (1.8)	KANK2 (1.8)	TSSK6 (1.7)	SMARCA4 (1.6)	ABO (1.5)	ILF3 (1.3)	C12orf51 (1.3)	DNM2 (1.2)
GO:0045880	positive regulation of smoothened signaling pathway	0.47	> 0.20	NYNRIN (2.8)	CYB561D1 (2.1)	ENSG00000235545 (1.9)	ENSG00000228044 (1.9)	LPAR2 (1.7)	PLEKHH2 (1.6)	AMIGO1 (1.6)	LPIN3 (1.5)	ATXN7L2 (1.5)	TMEM116 (1.5)
MP:0002500	granulomatous inflammation	0.47	> 0.20	BCL3 (3.0)	C17orf57 (2.3)	MAFB (2.2)	HLX (2.2)	RELB (1.6)	ABO (1.5)	GMIP (1.4)	C12orf47 (1.4)	PBX4 (1.4)	SH2B3 (1.2)
ENSG00000213741	RPS29 PPI subnetwork	0.48	> 0.20	NKPD1 (2.4)	SARS (1.9)	ANKRD31 (1.7)	ILF3 (1.6)	ENSG00000226645 (1.6)	PTPN11 (1.5)	DDX56 (1.4)	C19orf52 (1.4)	SUGP1 (1.4)	GATAD2A (1.4)
ENSG00000115844	DLX2 PPI subnetwork	0.48	> 0.20	MAFB (2.7)	MYLIP (2.4)	GCNT4 (2.3)	ACAD10 (1.6)	KIAA1324 (1.5)	ENSG00000238078 (1.5)	CYP7A1 (1.4)	CETP (1.3)	DNAH11 (1.1)	GPAM (1.1)
ENSG00000133112	TPT1 PPI subnetwork	0.48	> 0.20	PTPN11 (3.4)	POC5 (2.7)	BRAP (2.7)	NCAN (2.5)	TRAFD1 (2.1)	GPAM (2.1)	FADS2 (2.0)	TMEM50A (2.0)	DOCK7 (1.9)	GCNT4 (1.8)
GO:0003416	endochondral bone growth	0.48	> 0.20	CILP2 (6.9)	YIPF2 (2.3)	UBXN2B (2.2)	ABO (2.0)	TSSK6 (1.6)	PBX4 (1.5)	NYNRIN (1.5)	PLEC (1.4)	QTRT1 (1.4)	SLC44A2 (1.3)
GO:0048705	skeletal system morphogenesis	0.48	> 0.20	CILP2 (5.0)	PLEKHH2 (2.5)	NYNRIN (2.5)	CEACAM19 (1.7)	MYLIP (1.6)	ATXN7L2 (1.5)	ANKRD31 (1.3)	MAFB (1.1)	PMFBP1 (1.0)	BCAM (1.0)
ENSG00000197757	HOXC6 PPI subnetwork	0.48	> 0.20	NYNRIN (3.3)	MAU2 (2.6)	BCAM (2.6)	C12orf51 (2.2)	CELSR2 (2.1)	CBLC (2.0)	SLC44A2 (1.8)	MOSC1 (1.7)	GRINA (1.7)	PSRC1 (1.7)
MP:0002127	abnormal cardiovascular system morphology	0.48	> 0.20	HLX (2.3)	NYNRIN (2.2)	PVRL2 (1.9)	BCAM (1.9)	SYPL2 (1.7)	HNF1A (1.5)	COL4A3BP (1.4)	TM6SF2 (1.3)	KANK2 (1.2)	DYNC2LI1 (1.2)
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	0.48	> 0.20	DHODH (3.8)	ACAD10 (3.1)	NT5DC1 (3.0)	MAPKAPK5 (2.1)	SARS (2.1)	NAA25 (2.0)	C19orf52 (1.9)	DOCK7 (1.8)	DDX56 (1.7)	SMARCA4 (1.7)
GO:0030183	B cell differentiation	0.48	> 0.20	GMIP (2.4)	ERP29 (2.3)	ENSG00000254235 (2.2)	PBX4 (2.0)	CYB561D1 (1.9)	GEMIN7 (1.8)	ZNF101 (1.8)	CEACAM19 (1.6)	TIMD4 (1.4)	DYNC2LI1 (1.2)
ENSG00000205307	SAP25 PPI subnetwork	0.48	> 0.20	OASL (7.3)	PARP10 (3.1)	ATP13A1 (2.1)	USP1 (2.0)	ENSG00000235545 (1.7)	LPAR2 (1.7)	PLCG1 (1.7)	GATAD2A (1.7)	GCNT4 (1.6)	TOP1 (1.6)
ENSG00000077454	LRCH4 PPI subnetwork	0.48	> 0.20	OASL (7.3)	PARP10 (3.1)	ATP13A1 (2.1)	USP1 (2.0)	ENSG00000235545 (1.7)	LPAR2 (1.7)	PLCG1 (1.7)	GATAD2A (1.7)	GCNT4 (1.6)	TOP1 (1.6)
MP:0004148	increased compact bone thickness	0.48	> 0.20	BCAM (2.6)	FRK (2.5)	APOC1 (2.4)	KIAA1324 (2.3)	PLEC (1.9)	MYLIP (1.9)	CBLC (1.8)	ENSG00000228044 (1.8)	PARP10 (1.8)	CILP2 (1.5)
GO:0003006	developmental process involved in reproduction	0.48	> 0.20	TSSK6 (3.4)	ABO (2.0)	PMFBP1 (2.0)	DNAH11 (2.0)	LPAR2 (1.6)	PLEKHH2 (1.5)	NYNRIN (1.3)	CELSR2 (1.3)	MARK4 (1.2)	ST3GAL4 (1.2)
GO:0034341	response to interferon-gamma	0.48	> 0.20	TRAFD1 (5.1)	PARP10 (4.5)	OASL (3.5)	ADAM1 (2.4)	GRINA (1.7)	C12orf43 (1.7)	PBX4 (1.6)	BCL3 (1.6)	RELB (1.6)	MAU2 (1.5)
MP:0001916	intracerebral hemorrhage	0.48	> 0.20	OASL (5.8)	FRK (3.3)	PARP10 (2.9)	NCAN (2.6)	PVRL2 (2.4)	TMED4 (2.4)	ENSG00000235545 (1.7)	POC5 (1.7)	GMIP (1.6)	GOT2P1 (1.5)
ENSG00000164109	MAD2L1 PPI subnetwork	0.48	> 0.20	PSRC1 (5.3)	FEN1 (4.3)	POC5 (3.8)	USP1 (2.9)	ILF3 (1.0)	DHX38 (0.9)	ENSG00000228044 (0.8)	HMGCR (0.7)	CBLC (0.7)	LDLR (0.6)
ENSG00000172175	MALT1 PPI subnetwork	0.48	> 0.20	RELB (3.3)	CYB561D1 (3.1)	PTPN11 (2.2)	ZNF101 (2.2)	HAVCR1 (2.1)	SH2B3 (2.1)	PVR (1.9)	BRAP (1.8)	FRK (1.7)	NAA25 (1.6)
ENSG00000162368	CMPK1 PPI subnetwork	0.48	> 0.20	TXNL4B (2.4)	MAPKAPK5 (2.4)	C19orf52 (2.1)	BRAP (2.1)	ADAM1 (1.8)	POC5 (1.8)	TMEM57 (1.8)	PTPN11 (1.7)	GMPR (1.5)	GATAD2A (1.5)
GO:0030730	sequestering of triglyceride	0.48	> 0.20	MOSC1 (3.4)	GPAM (2.4)	CYP7A1 (2.0)	SORT1 (1.9)	GCNT4 (1.7)	TIMD4 (1.5)	ENSG00000228044 (1.5)	AMIGO1 (1.4)	TXNL4B (1.4)	ABCG8 (1.4)
ENSG00000163162	RNF149 PPI subnetwork	0.48	> 0.20	HMGCR (4.5)	FADS1 (3.8)	LDLR (3.8)	ILF3 (2.6)	FADS2 (2.4)	NAA25 (2.4)	QTRT1 (2.2)	ZNF259 (2.2)	PBX4 (2.0)	PCSK9 (2.0)
ENSG00000116161	CACYBP PPI subnetwork	0.48	> 0.20	ST3GAL4 (3.5)	BCL3 (2.1)	RELB (1.8)	PTPN11 (1.7)	NCAN (1.6)	BUD13 (1.5)	ITGB3 (1.5)	HAPLN4 (1.5)	ABO (1.5)	PLEC (1.4)
MP:0002722	abnormal immune system organ morphology	0.48	> 0.20	GMIP (3.1)	MAFB (2.6)	ZNF101 (2.5)	TMEM57 (2.5)	C17orf57 (2.2)	PBX4 (2.1)	BCL3 (2.1)	CETP (1.9)	PLEC (1.8)	PLCG1 (1.8)
GO:0032386	regulation of intracellular transport	0.48	> 0.20	ENSG00000238078 (3.3)	ZNF101 (2.6)	GRINA (2.3)	OASL (1.9)	TRAFD1 (1.7)	MYLIP (1.6)	GCNT4 (1.5)	TMEM116 (1.5)	KANK2 (1.4)	PBX4 (1.4)
GO:0002200	somatic diversification of immune receptors	0.48	> 0.20	ZNF101 (3.9)	GCNT4 (2.9)	ANKRD31 (2.7)	NT5DC1 (2.5)	PLCG1 (2.1)	PBX4 (2.0)	C17orf57 (1.8)	ENSG00000226648 (1.6)	UBXN2B (1.5)	DYNC2LI1 (1.4)
ENSG00000182866	LCK PPI subnetwork	0.48	> 0.20	PLCG1 (3.5)	GMIP (3.4)	ZNF101 (2.4)	TIMD4 (2.2)	SLC44A2 (2.2)	PBX4 (2.0)	CETP (1.9)	DNM2 (1.9)	MAFB (1.7)	PLEC (1.7)
REACTOME_SHC:MEDIATED_SIGNALLING	REACTOME_SHC:MEDIATED_SIGNALLING	0.48	> 0.20	MARK4 (3.1)	GEMIN7 (2.3)	PBX4 (2.2)	BLOC1S3 (2.0)	MAPKAPK5 (1.9)	CARM1 (1.9)	DNM2 (1.9)	ENSG00000238078 (1.8)	PSRC1 (1.7)	PVRL2 (1.7)
GO:0031231	intrinsic to peroxisomal membrane	0.48	> 0.20	NT5DC1 (3.0)	YIPF2 (2.8)	BLOC1S3 (2.7)	GPAM (2.6)	GRINA (1.9)	TRAPPC6A (1.8)	AMIGO1 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	ACAD10 (1.5)
GO:0005779	integral to peroxisomal membrane	0.48	> 0.20	NT5DC1 (3.0)	YIPF2 (2.8)	BLOC1S3 (2.7)	GPAM (2.6)	GRINA (1.9)	TRAPPC6A (1.8)	AMIGO1 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	ACAD10 (1.5)
ENSG00000135365	PHF21A PPI subnetwork	0.48	> 0.20	TOP1 (2.6)	KIAA1324 (2.5)	NT5DC1 (2.5)	ACAD10 (2.4)	SMARCA4 (2.4)	ATXN2 (2.3)	PLCG1 (2.2)	CELSR2 (2.0)	ENSG00000238078 (1.9)	ILF3 (1.7)
ENSG00000197111	PCBP2 PPI subnetwork	0.48	> 0.20	ILF3 (4.4)	C1orf63 (3.4)	TOP1 (3.3)	SMARCA4 (2.9)	DHX38 (2.7)	USP1 (2.6)	SUGP1 (2.5)	BUD13 (2.4)	MAU2 (2.3)	PTPN11 (2.2)
GO:0001891	phagocytic cup	0.48	> 0.20	CETP (3.0)	ENSG00000228044 (2.2)	SH2B3 (2.2)	TIMD4 (1.9)	TSSK6 (1.8)	HAVCR1 (1.8)	ENSG00000254235 (1.7)	RELB (1.6)	GMIP (1.6)	PLCG1 (1.6)
GO:0071478	cellular response to radiation	0.48	> 0.20	NYNRIN (2.8)	BLOC1S3 (2.6)	HAVCR1 (2.6)	GEMIN7 (2.5)	TRAPPC6A (2.3)	C12orf43 (2.2)	C19orf52 (2.1)	DNAH11 (1.9)	CILP2 (1.6)	GATAD2A (1.5)
ENSG00000182901	RGS7 PPI subnetwork	0.48	> 0.20	ZHX3 (4.1)	ITGB3 (3.1)	PSMA5 (1.7)	ENSG00000226648 (1.7)	C11orf9 (1.7)	TXNL4B (1.6)	PTPN11 (1.6)	TMEM50A (1.6)	PSRC1 (1.5)	DOCK7 (1.5)
ENSG00000105085	MED26 PPI subnetwork	0.48	> 0.20	GEMIN7 (4.4)	TXNL4B (2.9)	BUD13 (2.3)	MAPKAPK5 (2.1)	POC5 (1.9)	BLOC1S3 (1.8)	BRAP (1.7)	C12orf47 (1.7)	DHX38 (1.6)	TOP1 (1.4)
GO:0007044	cell-substrate junction assembly	0.48	> 0.20	C17orf57 (3.8)	PLEC (3.0)	CBLC (2.8)	BCAM (2.7)	ITGB3 (2.0)	SLC44A2 (1.9)	AP1M2 (1.8)	GCNT4 (1.7)	KANK2 (1.7)	PVRL2 (1.6)
ENSG00000133398	MED10 PPI subnetwork	0.48	> 0.20	GEMIN7 (4.0)	MAPKAPK5 (2.7)	TRAPPC6A (2.4)	TXNL4B (2.3)	BRAP (2.2)	BUD13 (1.9)	BLOC1S3 (1.8)	C12orf51 (1.8)	DHX38 (1.7)	ATXN7L2 (1.7)
MP:0005399	increased susceptibility to fungal infection	0.48	> 0.20	MAFB (2.9)	HLX (2.5)	GOT2P1 (2.3)	PMFBP1 (2.1)	HP (2.1)	TRIB1 (1.9)	BCL3 (1.7)	SH2B3 (1.5)	CYP7A1 (1.4)	ADAM1 (1.3)
GO:0005768	endosome	0.48	> 0.20	COL4A3BP (3.1)	TMEM50A (2.5)	GRINA (2.5)	BLOC1S3 (1.8)	FRK (1.8)	GMIP (1.8)	PTPN11 (1.7)	TRAFD1 (1.7)	CLPTM1 (1.7)	MAU2 (1.6)
MP:0000920	abnormal myelination	0.48	> 0.20	C11orf9 (3.3)	APOE (3.0)	RPH3A (2.1)	ST3GAL4 (1.9)	HAPLN4 (1.7)	NCAN (1.7)	APOC1 (1.6)	FADS1 (1.6)	HNF1A (1.4)	DNM2 (1.3)
GO:0016918	retinal binding	0.48	> 0.20	C11orf9 (3.6)	APOB (3.5)	ABCG5 (3.3)	TM6SF2 (3.3)	NKPD1 (2.7)	NYNRIN (2.2)	LPAR2 (2.1)	APOC4 (1.8)	APOA5 (1.8)	ABCG8 (1.8)
ENSG00000187778	MCRS1 PPI subnetwork	0.48	> 0.20	C12orf43 (3.5)	QTRT1 (2.5)	BUD13 (2.4)	C19orf52 (2.3)	TRAFD1 (2.1)	DHX38 (2.0)	ATXN7L2 (2.0)	GATAD2A (2.0)	MAPKAPK5 (1.8)	GEMIN7 (1.7)
ENSG00000015479	MATR3 PPI subnetwork	0.48	> 0.20	ILF3 (3.4)	PTPN11 (2.4)	RELB (2.3)	SMARCA4 (2.2)	DHX38 (2.1)	PLEC (2.0)	NAA25 (1.8)	C1orf63 (1.7)	DOCK7 (1.6)	SARS (1.6)
GO:0001824	blastocyst development	0.48	> 0.20	SUGP1 (3.1)	QTRT1 (2.3)	ATP13A1 (2.2)	MAU2 (2.0)	ATXN7L2 (2.0)	DHX38 (1.7)	UBXN2B (1.7)	CARM1 (1.6)	LPIN3 (1.6)	YIPF2 (1.6)
GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	0.48	> 0.20	ABO (2.6)	ST3GAL4 (2.1)	TRAPPC6A (2.0)	C12orf43 (1.8)	BLOC1S3 (1.8)	PCSK9 (1.4)	C17orf57 (1.3)	LPIN3 (1.3)	HNF1A (1.2)	ENSG00000254235 (1.2)
MP:0000737	abnormal myotome development	0.48	> 0.20	MYLIP (2.9)	TMEM116 (2.4)	FRK (2.2)	SYPL2 (2.1)	TRAPPC6A (2.0)	C17orf57 (1.8)	TMED4 (1.6)	ENSG00000228044 (1.5)	TM6SF2 (1.5)	HLX (1.4)
ENSG00000099901	RANBP1 PPI subnetwork	0.48	> 0.20	GATAD2A (2.2)	C12orf47 (2.1)	C19orf52 (2.1)	PVR (2.0)	TMEM50A (1.6)	CARM1 (1.6)	ERP29 (1.5)	C12orf43 (1.5)	TMEM57 (1.5)	GEMIN7 (1.4)
GO:0016581	NuRD complex	0.48	> 0.20	CARM1 (4.1)	PLCG1 (3.2)	SMARCA4 (2.9)	PPP1R37 (2.7)	ILF3 (2.3)	KANK2 (2.2)	PTPN11 (1.9)	MARK4 (1.9)	DNM2 (1.9)	ATXN7L2 (1.8)
GO:0060045	positive regulation of cardiac muscle cell proliferation	0.48	> 0.20	GCNT4 (3.2)	ENSG00000226648 (2.8)	C11orf9 (2.5)	HAPLN4 (2.0)	DYNC2LI1 (1.6)	CEACAM19 (1.5)	ABCG8 (1.5)	NYNRIN (1.4)	POC5 (1.4)	TM6SF2 (1.4)
ENSG00000184009	ACTG1 PPI subnetwork	0.48	> 0.20	PLEC (2.7)	ITGB3 (2.2)	SMARCA4 (1.7)	RELB (1.7)	CBLC (1.7)	OGDH (1.6)	TMEM50A (1.6)	CLPTM1 (1.6)	DOCK7 (1.5)	TOMM40 (1.4)
GO:0032103	positive regulation of response to external stimulus	0.48	> 0.20	ENSG00000228044 (3.3)	TIMD4 (2.3)	PLEKHH2 (2.0)	CETP (1.9)	KIAA1324 (1.8)	PVR (1.6)	HLX (1.6)	APOE (1.5)	ST3GAL4 (1.3)	PMFBP1 (1.2)
GO:0032608	interferon-beta production	0.48	> 0.20	DNAH11 (3.7)	PARP10 (3.4)	OASL (3.3)	CYB561D1 (2.7)	GEMIN7 (2.7)	FRK (2.0)	C12orf43 (2.0)	MAU2 (2.0)	ZNF180 (1.9)	ADAM1 (1.8)
GO:0043551	regulation of phosphatidylinositol 3-kinase activity	0.48	> 0.20	HAVCR1 (2.8)	DOCK7 (2.4)	CETP (2.1)	ZNF101 (2.1)	CYB561D1 (2.0)	ANKRD31 (1.9)	PBX4 (1.9)	ENSG00000228044 (1.6)	HLX (1.3)	ENSG00000226645 (1.2)
REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	0.48	> 0.20	NAA25 (2.9)	DDX56 (2.8)	DOCK7 (2.7)	ILF3 (2.4)	POC5 (2.3)	USP1 (2.3)	BUD13 (2.3)	MAPKAPK5 (2.2)	USP24 (2.2)	FEN1 (2.1)
ENSG00000124193	SRSF6 PPI subnetwork	0.48	> 0.20	C1orf63 (4.6)	ILF3 (4.0)	TOP1 (3.1)	USP1 (2.6)	DHX38 (2.5)	SMARCA4 (2.4)	QTRT1 (2.3)	BUD13 (2.3)	FEN1 (2.1)	SUGP1 (2.0)
ENSG00000097046	CDC7 PPI subnetwork	0.48	> 0.20	FEN1 (6.1)	USP1 (4.4)	ENSG00000235545 (1.5)	NT5DC1 (1.4)	APOC4 (1.1)	TXNL4B (1.0)	ERP29 (1.0)	CYP7A1 (1.0)	SLC22A1 (0.9)	DDX56 (0.9)
ENSG00000065268	WDR18 PPI subnetwork	0.48	> 0.20	ILF3 (3.5)	ATP13A1 (2.7)	MAPKAPK5 (2.4)	DDX56 (2.4)	CARM1 (2.3)	BRAP (2.2)	GATAD2A (2.1)	BUD13 (2.0)	NAA25 (2.0)	TRAFD1 (1.9)
MP:0003871	abnormal myelin sheath morphology	0.48	> 0.20	APOC1 (3.5)	C11orf9 (2.9)	RPH3A (2.4)	APOE (2.4)	SORT1 (2.3)	NT5DC1 (2.0)	TMEM116 (1.8)	HAPLN4 (1.6)	FADS1 (1.6)	HMGCR (1.6)
ENSG00000111667	USP5 PPI subnetwork	0.48	> 0.20	DHX38 (3.1)	SARS (2.7)	HAVCR1 (2.3)	PPP1R37 (2.3)	PTPN11 (2.3)	TXNL4B (2.3)	QTRT1 (1.9)	DOCK7 (1.6)	C12orf47 (1.6)	YIPF2 (1.6)
GO:0045428	regulation of nitric oxide biosynthetic process	0.48	> 0.20	ENSG00000228044 (2.4)	AMIGO1 (1.8)	BCL3 (1.8)	PVR (1.7)	GCNT4 (1.6)	ENSG00000226645 (1.6)	MAFB (1.4)	TRIB1 (1.3)	RELB (1.3)	TXNL4B (1.3)
ENSG00000014216	CAPN1 PPI subnetwork	0.48	> 0.20	PVR (3.1)	SYPL2 (2.4)	TMEM50A (2.3)	PLG (2.3)	CEACAM19 (2.0)	PLEC (1.7)	APOE (1.5)	UBXN2B (1.5)	ANGPTL3 (1.4)	ACAD10 (1.3)
ENSG00000183155	RABIF PPI subnetwork	0.48	> 0.20	CYB561D1 (3.3)	PSMA5 (2.8)	TMED4 (2.7)	SARS (2.7)	TMEM50A (2.3)	DNAH11 (2.3)	AMIGO1 (2.3)	ABO (2.3)	PSRC1 (1.9)	TRAFD1 (1.8)
MP:0000703	abnormal thymus morphology	0.48	> 0.20	ZNF101 (4.1)	PLCG1 (3.4)	APOE (2.3)	HAVCR1 (2.0)	BCL3 (2.0)	SLC44A2 (1.8)	RELB (1.6)	MAFB (1.6)	PBX4 (1.5)	GMIP (1.5)
GO:0015405	P-P-bond-hydrolysis-driven transmembrane transporter activity	0.48	> 0.20	ATP13A1 (3.6)	CLPTM1 (3.4)	TMEM116 (2.9)	GRINA (2.8)	SORT1 (2.5)	HAPLN4 (2.2)	MAU2 (2.0)	OGDH (1.9)	GMPR (1.8)	DNM2 (1.8)
GO:0015399	primary active transmembrane transporter activity	0.48	> 0.20	ATP13A1 (3.6)	CLPTM1 (3.4)	TMEM116 (2.9)	GRINA (2.8)	SORT1 (2.5)	HAPLN4 (2.2)	MAU2 (2.0)	OGDH (1.9)	GMPR (1.8)	DNM2 (1.8)
ENSG00000076944	STXBP2 PPI subnetwork	0.48	> 0.20	CARM1 (2.5)	TSSK6 (2.4)	DNM2 (2.2)	ABO (2.0)	C17orf57 (1.9)	SARS (1.9)	TOMM40 (1.7)	QTRT1 (1.7)	MAPKAPK5 (1.7)	GEMIN7 (1.6)
ENSG00000160741	CRTC2 PPI subnetwork	0.48	> 0.20	CBLC (4.4)	AP1M2 (2.8)	MARK4 (2.8)	PVRL2 (2.2)	ATXN2 (2.0)	CELSR2 (1.8)	ANKRD31 (1.8)	ZHX3 (1.7)	LPIN3 (1.7)	GEMIN7 (1.7)
GO:0070509	calcium ion import	0.48	> 0.20	ENSG00000226645 (3.1)	DNAH11 (2.3)	ST3GAL4 (2.0)	ITGB3 (1.9)	KIAA1324 (1.7)	NKPD1 (1.7)	AP1M2 (1.7)	GCNT4 (1.5)	FRK (1.5)	C19orf52 (1.5)
ENSG00000180818	HOXC10 PPI subnetwork	0.48	> 0.20	SARS (3.6)	AP1M2 (2.9)	ERP29 (2.5)	YIPF2 (2.4)	SUGP1 (2.1)	COL4A3BP (2.1)	PSRC1 (2.0)	POC5 (1.9)	C19orf52 (1.8)	FRK (1.7)
GO:0071248	cellular response to metal ion	0.48	> 0.20	KANK2 (2.2)	TSSK6 (1.9)	HAVCR1 (1.8)	POLK (1.6)	ANKRD31 (1.6)	POC5 (1.5)	GCNT4 (1.5)	UBXN2B (1.5)	DYNC2LI1 (1.4)	ATXN7L2 (1.4)
ENSG00000138398	PPIG PPI subnetwork	0.48	> 0.20	C1orf63 (4.7)	TOP1 (2.6)	TXNL4B (2.4)	ZNF180 (2.2)	GEMIN7 (2.1)	BUD13 (1.9)	FEN1 (1.8)	DHX38 (1.7)	C12orf51 (1.6)	MAU2 (1.5)
MP:0004841	abnormal small intestine crypts of Lieberkuhn morphology	0.48	> 0.20	HNF1A (3.1)	ABCG8 (3.0)	C11orf9 (2.4)	HLX (2.4)	ABCG5 (2.4)	PLEKHH2 (2.3)	DNAH11 (2.2)	ENSG00000235545 (2.1)	GMPR (1.8)	TM6SF2 (1.7)
GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	0.48	> 0.20	C19orf52 (2.2)	AMIGO1 (2.0)	C1orf63 (1.9)	GOT2P1 (1.7)	CYB561D1 (1.6)	BLOC1S3 (1.5)	LPIN3 (1.5)	UBXN2B (1.4)	HNF1A (1.4)	PSMA5 (1.3)
GO:0005540	hyaluronic acid binding	0.48	> 0.20	CILP2 (3.7)	CETP (3.2)	TIMD4 (3.2)	MAFB (2.7)	NCAN (2.6)	PSRC1 (2.1)	ENSG00000254235 (2.0)	LPA (1.9)	NKPD1 (1.9)	HAPLN4 (1.7)
ENSG00000148848	ADAM12 PPI subnetwork	0.48	> 0.20	SYPL2 (3.6)	TMEM116 (2.8)	CETP (2.8)	ST3GAL4 (2.8)	ITGB3 (2.7)	C19orf52 (2.3)	LPAR2 (2.1)	TIMD4 (2.0)	PLCG1 (2.0)	FRK (1.9)
GO:0032770	positive regulation of monooxygenase activity	0.48	> 0.20	ST3GAL4 (3.2)	ENSG00000235545 (2.8)	ATXN7L2 (2.1)	COL4A3BP (2.0)	ENSG00000226645 (1.8)	TMEM116 (1.7)	ENSG00000228044 (1.7)	TXNL4B (1.5)	MAFB (1.2)	HMGCR (1.1)
GO:0046068	cGMP metabolic process	0.48	> 0.20	TSSK6 (2.6)	CEACAM19 (2.3)	C12orf47 (2.1)	ENSG00000226648 (2.0)	HAVCR1 (2.0)	ZNF180 (1.9)	NKPD1 (1.8)	TMEM116 (1.6)	LPIN3 (1.4)	POC5 (1.3)
ENSG00000206313	ENSG00000206313 PPI subnetwork	0.48	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
ENSG00000096155	BAG6 PPI subnetwork	0.48	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
ENSG00000204463	BAG6 PPI subnetwork	0.48	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
GO:0004659	prenyltransferase activity	0.48	> 0.20	HMGCR (4.7)	LDLR (3.8)	FADS1 (3.7)	FADS2 (2.8)	UBXN2B (2.6)	PCSK9 (2.5)	ATXN7L2 (2.2)	NAA25 (1.9)	USP24 (1.9)	PVR (1.8)
ENSG00000031544	ENSG00000031544 PPI subnetwork	0.48	> 0.20	ATXN7L2 (2.6)	DHODH (2.4)	DHX38 (2.4)	TOMM40 (2.3)	SUGP1 (1.9)	ENSG00000238078 (1.8)	BUD13 (1.8)	LPIN3 (1.6)	USP1 (1.5)	MARK4 (1.5)
ENSG00000100280	AP1B1 PPI subnetwork	0.48	> 0.20	AP1M2 (2.5)	MYLIP (2.4)	DHX38 (2.2)	SH2B3 (1.9)	C12orf51 (1.7)	DNM2 (1.7)	MAU2 (1.6)	KIAA1324 (1.6)	GMIP (1.6)	ZNF101 (1.5)
REACTOME_SIGNALLING_TO_RAS	REACTOME_SIGNALLING_TO_RAS	0.48	> 0.20	MARK4 (3.9)	PVRL2 (2.4)	MAPKAPK5 (2.3)	GATAD2A (2.2)	LPAR2 (2.1)	CARM1 (1.9)	LPIN3 (1.9)	PLEC (1.9)	DNM2 (1.8)	COL4A3BP (1.7)
ENSG00000079462	PAFAH1B3 PPI subnetwork	0.48	> 0.20	TRAPPC6A (2.3)	ATXN7L2 (2.3)	ZNF259 (2.2)	ZNF180 (1.9)	TOP1 (1.7)	C17orf57 (1.6)	FADS1 (1.5)	BUD13 (1.4)	FADS2 (1.4)	NKPD1 (1.4)
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	0.48	> 0.20	MAPKAPK5 (3.3)	POC5 (2.9)	PSMA5 (2.9)	BUD13 (2.7)	DDX56 (2.5)	DHX38 (2.1)	ILF3 (2.0)	USP1 (2.0)	TOP1 (1.8)	ZNF259 (1.7)
ENSG00000100632	ERH PPI subnetwork	0.48	> 0.20	C19orf52 (3.0)	TXNL4B (3.0)	BUD13 (2.7)	GEMIN7 (2.7)	SARS (2.0)	GATAD2A (1.9)	MYLIP (1.7)	QTRT1 (1.6)	DDX56 (1.6)	POC5 (1.5)
GO:0003690	double-stranded DNA binding	0.48	> 0.20	TRIB1 (3.4)	USP1 (2.9)	ANKRD31 (1.9)	ENSG00000226645 (1.8)	ZNF101 (1.8)	KANK2 (1.8)	HLX (1.5)	HNF1A (1.5)	NYNRIN (1.5)	MAPKAPK5 (1.4)
GO:0010893	positive regulation of steroid biosynthetic process	0.48	> 0.20	MYLIP (3.1)	ENSG00000238078 (2.9)	SLC44A2 (2.8)	COL4A3BP (2.4)	TMEM57 (2.3)	POC5 (2.1)	ST3GAL4 (2.0)	ENSG00000228044 (1.6)	TMED4 (1.6)	POLK (1.5)
MP:0002260	abnormal thyroid cartilage morphology	0.48	> 0.20	CILP2 (2.4)	CEACAM19 (1.6)	ENSG00000238078 (1.6)	MYLIP (1.6)	FRK (1.6)	KIAA1324 (1.5)	PLCG1 (1.4)	DYNC2LI1 (1.4)	HLX (1.4)	SORT1 (1.3)
GO:0043330	response to exogenous dsRNA	0.48	> 0.20	OASL (4.3)	PARP10 (4.0)	MYLIP (2.0)	CYB561D1 (1.8)	TRAFD1 (1.8)	TSSK6 (1.8)	TMEM50A (1.7)	AMIGO1 (1.5)	GEMIN7 (1.4)	FRK (1.3)
ENSG00000155868	MED7 PPI subnetwork	0.48	> 0.20	GEMIN7 (4.1)	MAPKAPK5 (3.2)	BRAP (2.8)	BUD13 (2.4)	BLOC1S3 (2.2)	C19orf52 (2.1)	C12orf51 (2.0)	TXNL4B (1.9)	C12orf43 (1.7)	POC5 (1.6)
ENSG00000153827	TRIP12 PPI subnetwork	0.48	> 0.20	OGDH (3.8)	ZHX3 (3.0)	PLCG1 (2.4)	QTRT1 (2.1)	GATAD2A (2.1)	TOMM40 (2.0)	CLPTM1 (1.9)	NAA25 (1.7)	TOP1 (1.7)	ENSG00000226645 (1.6)
ENSG00000116954	RRAGC PPI subnetwork	0.48	> 0.20	COL4A3BP (2.8)	QTRT1 (2.6)	BLOC1S3 (2.6)	TOMM40 (2.1)	ILF3 (2.1)	ZNF180 (2.0)	POC5 (2.0)	BRAP (1.8)	MAU2 (1.6)	DOCK7 (1.6)
ENSG00000171219	CDC42BPG PPI subnetwork	0.48	> 0.20	CBLC (6.4)	AP1M2 (4.2)	ST3GAL4 (2.4)	LPAR2 (2.1)	CELSR2 (2.1)	PVRL2 (1.7)	DOCK7 (1.7)	FRK (1.6)	ALDH2 (1.5)	PSRC1 (1.5)
ENSG00000116455	WDR77 PPI subnetwork	0.48	> 0.20	TOMM40 (3.1)	ILF3 (2.4)	PSMA5 (2.4)	C12orf43 (2.3)	DHX38 (2.1)	SMARCA4 (2.0)	CLPTM1 (1.7)	GATAD2A (1.7)	MAPKAPK5 (1.7)	FEN1 (1.6)
ENSG00000196236	XPNPEP3 PPI subnetwork	0.48	> 0.20	C1orf63 (2.7)	CBLC (2.4)	DOCK7 (2.0)	ABCG5 (1.9)	ENSG00000226648 (1.8)	AP1M2 (1.8)	ZNF180 (1.7)	NPC1L1 (1.7)	PLCG1 (1.6)	TM6SF2 (1.5)
GO:0042254	ribosome biogenesis	0.48	> 0.20	ZNF259 (4.0)	DDX56 (3.4)	DHODH (3.2)	TOMM40 (3.1)	NAA25 (3.1)	C12orf43 (3.0)	QTRT1 (3.0)	MAPKAPK5 (2.4)	SUGP1 (2.0)	POC5 (1.9)
MP:0000717	abnormal lymphocyte cell number	0.48	> 0.20	RELB (3.6)	TIMD4 (3.0)	BCL3 (2.8)	GMIP (2.8)	PBX4 (2.5)	ENSG00000228044 (2.2)	MAFB (2.2)	CETP (1.9)	PLCG1 (1.6)	ZNF101 (1.6)
ENSG00000103089	FA2H PPI subnetwork	0.48	> 0.20	TMEM57 (3.5)	TMEM50A (2.9)	CYB561D1 (2.8)	CLPTM1 (2.6)	TMED4 (2.3)	PVR (2.3)	ERP29 (2.2)	ATP13A1 (2.1)	C19orf52 (2.0)	CYP7A1 (1.8)
GO:0001562	response to protozoan	0.48	> 0.20	ENSG00000235545 (2.7)	ST3GAL4 (2.0)	ENSG00000254235 (1.9)	ADAM1 (1.7)	DNAH11 (1.7)	PVR (1.6)	CEACAM19 (1.6)	C17orf57 (1.4)	POC5 (1.3)	DOCK7 (1.3)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	0.48	> 0.20	BUD13 (3.2)	C1orf63 (3.0)	TOP1 (2.9)	USP1 (2.4)	MAPKAPK5 (2.4)	SUGP1 (2.3)	ILF3 (2.3)	TXNL4B (2.3)	PSMA5 (2.1)	PTPN11 (1.8)
GO:0019866	organelle inner membrane	0.48	> 0.20	OGDH (4.2)	ACAD10 (3.9)	TOMM40 (2.3)	ALDH2 (2.2)	TRAPPC6A (2.1)	GMPR (2.1)	C19orf52 (2.0)	ABCG8 (2.0)	GPAM (1.8)	SYPL2 (1.8)
MP:0002893	ketoaciduria	0.48	> 0.20	TRAPPC6A (3.0)	KIAA1324 (2.6)	DYNC2LI1 (2.5)	QTRT1 (2.2)	TOMM40 (2.1)	KANK2 (2.1)	HNF1A (2.0)	ANGPTL3 (1.8)	ALDH2 (1.7)	TMEM116 (1.6)
GO:0030130	clathrin coat of trans-Golgi network vesicle	0.49	> 0.20	COL4A3BP (2.9)	POLK (2.5)	GRINA (2.5)	AMIGO1 (2.3)	GEMIN7 (2.1)	KIAA1324 (1.9)	ERP29 (1.9)	ZNF101 (1.8)	CLPTM1 (1.7)	TMEM57 (1.7)
GO:0000781	chromosome, telomeric region	0.49	> 0.20	POLK (4.3)	DHODH (3.0)	POC5 (2.7)	FEN1 (2.6)	PSRC1 (2.1)	BUD13 (2.0)	NYNRIN (1.8)	USP1 (1.8)	DOCK7 (1.7)	SARS (1.7)
ENSG00000065883	CDK13 PPI subnetwork	0.49	> 0.20	ANKRD31 (2.4)	PPP1R37 (2.0)	SMARCA4 (1.9)	PMFBP1 (1.9)	PBX4 (1.9)	USP24 (1.7)	ZNF180 (1.7)	POLK (1.4)	NCAN (1.4)	ILF3 (1.3)
GO:0000075	cell cycle checkpoint	0.49	> 0.20	PSRC1 (2.6)	POC5 (2.5)	FEN1 (2.3)	USP1 (2.1)	ZNF180 (2.1)	PSMA5 (1.9)	SUGP1 (1.8)	BRAP (1.7)	POLK (1.7)	BUD13 (1.7)
GO:0048306	calcium-dependent protein binding	0.49	> 0.20	LPA (4.0)	PLEC (3.1)	ST3GAL4 (2.8)	CILP2 (2.8)	RPH3A (2.8)	TMEM50A (2.7)	APOC4 (2.2)	APOA5 (1.9)	TMEM57 (1.9)	ABCG5 (1.8)
ENSG00000112144	ICK PPI subnetwork	0.49	> 0.20	HMGCR (3.1)	PCSK9 (3.0)	BLOC1S3 (2.9)	LDLR (2.6)	TXNL4B (2.5)	TMEM57 (2.3)	FEN1 (2.2)	FADS1 (2.1)	POC5 (2.0)	FADS2 (1.9)
GO:2000241	regulation of reproductive process	0.49	> 0.20	OASL (2.7)	SUGP1 (2.6)	BUD13 (2.6)	TXNL4B (2.4)	MAU2 (2.2)	QTRT1 (1.7)	MAPKAPK5 (1.7)	C1orf63 (1.7)	NKPD1 (1.6)	PTPN11 (1.6)
MP:0002432	abnormal CD4-positive T cell morphology	0.49	> 0.20	GMIP (3.2)	ITGB3 (2.9)	PLCG1 (2.3)	BCL3 (2.2)	CETP (2.0)	DNM2 (1.7)	ZNF101 (1.7)	SLC44A2 (1.6)	POLK (1.5)	CYB561D1 (1.5)
ENSG00000213699	C2orf18 PPI subnetwork	0.49	> 0.20	APOE (3.1)	ERP29 (2.6)	APOC1 (2.2)	C19orf52 (2.1)	NYNRIN (2.0)	ALDH2 (1.9)	TMEM57 (1.7)	CYB561D1 (1.7)	ANKRD31 (1.6)	UBXN2B (1.6)
ENSG00000198961	PJA2 PPI subnetwork	0.49	> 0.20	USP24 (4.9)	GRINA (2.2)	ATXN2 (2.2)	DOCK7 (2.1)	C12orf51 (2.1)	COL4A3BP (2.0)	TMEM57 (2.0)	CARM1 (2.0)	SUGP1 (1.5)	NKPD1 (1.3)
ENSG00000198286	CARD11 PPI subnetwork	0.49	> 0.20	ZNF101 (3.0)	RELB (2.2)	PBX4 (2.1)	CYB561D1 (2.0)	PTPN11 (1.9)	SH2B3 (1.9)	NT5DC1 (1.9)	PLEKHH2 (1.8)	HAVCR1 (1.6)	PLCG1 (1.5)
MP:0005042	abnormal level of surface class II molecules	0.49	> 0.20	PARP10 (4.0)	TRAFD1 (2.9)	GMIP (2.2)	SH2B3 (2.1)	RELB (1.8)	USP24 (1.8)	MAFB (1.7)	HLX (1.6)	OASL (1.6)	BCL3 (1.5)
ENSG00000107175	CREB3 PPI subnetwork	0.49	> 0.20	SARS (3.9)	PVRL2 (3.4)	ZNF259 (3.1)	PVR (3.0)	KIAA1324 (2.1)	MAPKAPK5 (2.1)	MAFB (2.0)	BCL3 (2.0)	HLX (1.9)	TM6SF2 (1.9)
GO:0000151	ubiquitin ligase complex	0.49	> 0.20	BRAP (2.8)	SUGP1 (2.7)	GRINA (2.6)	TRAFD1 (2.5)	CARM1 (2.5)	MAU2 (2.4)	BUD13 (2.2)	POC5 (2.1)	LPIN3 (2.0)	TMEM116 (1.7)
ENSG00000159459	UBR1 PPI subnetwork	0.49	> 0.20	COL4A3BP (4.0)	USP24 (2.2)	KANK2 (1.8)	TMEM57 (1.8)	TMEM50A (1.8)	SUGP1 (1.6)	C17orf57 (1.4)	CARM1 (1.3)	GRINA (1.2)	HMGCR (1.2)
ENSG00000091483	FH PPI subnetwork	0.49	> 0.20	OGDH (2.1)	KIAA1324 (2.0)	GOT2P1 (1.8)	PMFBP1 (1.6)	ACAD10 (1.5)	RELB (1.5)	NT5DC1 (1.4)	QTRT1 (1.4)	SH2B3 (1.4)	PBX4 (1.2)
GO:0008171	O-methyltransferase activity	0.49	> 0.20	TRAPPC6A (2.5)	NT5DC1 (2.4)	GEMIN7 (2.2)	NKPD1 (1.9)	C19orf52 (1.9)	TMEM50A (1.7)	ZHX3 (1.6)	AMIGO1 (1.4)	PVRL2 (1.3)	GOT2P1 (1.3)
GO:0033605	positive regulation of catecholamine secretion	0.49	> 0.20	ABO (2.6)	BLOC1S3 (2.4)	CEACAM19 (2.3)	ERP29 (2.2)	GOT2P1 (2.0)	NKPD1 (1.9)	KIAA1324 (1.9)	CETP (1.8)	PPP1R37 (1.6)	ZHX3 (1.5)
ENSG00000136754	ABI1 PPI subnetwork	0.49	> 0.20	ATXN2 (3.9)	PPP1R37 (2.3)	ZHX3 (2.2)	MARK4 (2.2)	GATAD2A (2.0)	ABO (2.0)	CBLC (1.9)	USP24 (1.8)	ITGB3 (1.7)	SYPL2 (1.6)
GO:0003995	acyl-CoA dehydrogenase activity	0.49	> 0.20	ALDH2 (4.8)	ACAD10 (4.6)	GPAM (3.0)	MOSC1 (2.8)	ABCG8 (2.0)	NT5DC1 (1.9)	APOA5 (1.9)	OGDH (1.8)	TRAPPC6A (1.7)	APOC1 (1.6)
ENSG00000173163	COMMD1 PPI subnetwork	0.49	> 0.20	RELB (6.7)	BCL3 (4.8)	GEMIN7 (3.3)	C12orf43 (3.0)	GRINA (2.5)	PARP10 (2.0)	GMIP (1.9)	PSMA5 (1.9)	CLPTM1 (1.8)	C12orf47 (1.6)
REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	0.49	> 0.20	NAA25 (2.9)	DDX56 (2.8)	DOCK7 (2.7)	USP1 (2.6)	BUD13 (2.5)	POC5 (2.5)	ILF3 (2.4)	FEN1 (2.2)	MAPKAPK5 (2.0)	USP24 (1.9)
GO:0043403	skeletal muscle tissue regeneration	0.49	> 0.20	SYPL2 (3.9)	LPIN3 (2.9)	ENSG00000235545 (2.7)	CILP2 (1.9)	CBLC (1.8)	TMEM116 (1.8)	GCNT4 (1.8)	GOT2P1 (1.6)	ENSG00000226645 (1.5)	AMIGO1 (1.4)
GO:0007292	female gamete generation	0.49	> 0.20	CEACAM19 (4.0)	ANKRD31 (2.8)	NKPD1 (2.2)	AP1M2 (2.0)	HNF1A (1.8)	CBLC (1.8)	TSSK6 (1.6)	LPIN3 (1.4)	NYNRIN (1.2)	AMIGO1 (1.1)
ENSG00000110651	CD81 PPI subnetwork	0.49	> 0.20	TIMD4 (3.3)	APOE (3.2)	GRINA (3.0)	CETP (2.8)	TMEM50A (2.6)	CYB561D1 (2.4)	BCAM (2.3)	SLC44A2 (2.3)	CILP2 (2.1)	ADAM1 (1.8)
ENSG00000165699	TSC1 PPI subnetwork	0.49	> 0.20	PLEC (2.9)	KANK2 (2.8)	GATAD2A (2.5)	DNM2 (2.1)	PTPN11 (2.1)	COL4A3BP (2.0)	SMARCA4 (2.0)	AP1M2 (2.0)	SLC44A2 (1.9)	PVRL2 (1.9)
MP:0003866	abnormal defecation	0.49	> 0.20	PMFBP1 (2.2)	NYNRIN (2.0)	LPIN3 (1.7)	NKPD1 (1.6)	CILP2 (1.6)	HNF1A (1.5)	AMIGO1 (1.4)	YIPF2 (1.4)	LPAR2 (1.4)	KANK2 (1.3)
REACTOME_CALNEXINCALRETICULIN_CYCLE	REACTOME_CALNEXINCALRETICULIN_CYCLE	0.49	> 0.20	ERP29 (5.6)	YIPF2 (3.6)	ATP13A1 (3.5)	CLPTM1 (3.3)	TMED4 (2.5)	OGDH (2.1)	TMEM57 (2.0)	PVRL2 (1.5)	TRAPPC6A (1.4)	ST3GAL4 (1.4)
ENSG00000162889	MAPKAPK2 PPI subnetwork	0.49	> 0.20	GATAD2A (3.1)	TRIB1 (2.9)	SH2B3 (2.6)	SYPL2 (2.4)	CARM1 (2.3)	ATXN7L2 (2.0)	HLX (2.0)	MARK4 (1.9)	PLEC (1.9)	BCL3 (1.8)
ENSG00000172809	RPL38 PPI subnetwork	0.49	> 0.20	NKPD1 (2.8)	ZNF259 (1.6)	HAVCR1 (1.6)	ANKRD31 (1.6)	BCL3 (1.5)	ADAM1 (1.5)	PTPN11 (1.5)	MOSC1 (1.4)	NAA25 (1.4)	ZNF101 (1.4)
MP:0003503	decreased activity of thyroid	0.49	> 0.20	MOSC1 (5.0)	PBX4 (2.5)	KIAA1324 (2.3)	GPAM (2.2)	AMIGO1 (1.8)	HP (1.8)	HNF1A (1.7)	ANGPTL3 (1.7)	MYLIP (1.6)	USP24 (1.4)
REACTOME_SMOOTH_MUSCLE_CONTRACTION	REACTOME_SMOOTH_MUSCLE_CONTRACTION	0.49	> 0.20	KANK2 (4.7)	ITGB3 (3.6)	PVRL2 (2.4)	SORT1 (2.0)	HLX (1.9)	ADAM1 (1.9)	HNF1A (1.9)	PLEKHH2 (1.7)	C17orf57 (1.5)	ZNF101 (1.5)
ENSG00000144029	MRPS5 PPI subnetwork	0.49	> 0.20	TOMM40 (4.5)	C12orf43 (3.5)	ERP29 (3.2)	NAA25 (3.1)	GEMIN7 (2.8)	OGDH (2.8)	MAPKAPK5 (2.5)	ADAM1 (2.4)	ZNF259 (2.3)	C12orf47 (2.2)
GO:0050805	negative regulation of synaptic transmission	0.49	> 0.20	ENSG00000254235 (2.7)	ENSG00000226648 (2.2)	CETP (2.2)	RPH3A (2.1)	ABO (2.1)	BLOC1S3 (1.7)	ABCG8 (1.4)	CEACAM19 (1.3)	GOT2P1 (1.3)	C12orf51 (1.2)
REACTOME_N:GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIALTRANS:GOLGI	REACTOME_N:GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIALTRANS:GOLGI	0.49	> 0.20	ENSG00000235545 (2.1)	FADS2 (2.0)	ERP29 (2.0)	PCSK9 (1.9)	C12orf47 (1.9)	DOCK7 (1.9)	PVRL2 (1.8)	SLC44A2 (1.8)	ITGB3 (1.7)	FRK (1.7)
ENSG00000100084	HIRA PPI subnetwork	0.49	> 0.20	MAU2 (3.7)	FEN1 (3.3)	USP1 (3.0)	C19orf52 (2.6)	GATAD2A (2.5)	KANK2 (2.2)	SUGP1 (2.2)	QTRT1 (2.0)	ATP13A1 (1.9)	TMEM50A (1.8)
MP:0002258	abnormal cricoid cartilage morphology	0.49	> 0.20	HLX (2.8)	HAPLN4 (2.3)	ABCG8 (2.0)	PLEKHH2 (1.8)	NYNRIN (1.7)	BLOC1S3 (1.7)	MARK4 (1.5)	MYLIP (1.4)	CEACAM19 (1.3)	MAFB (1.3)
ENSG00000179262	RAD23A PPI subnetwork	0.49	> 0.20	TMEM57 (3.0)	BRAP (2.7)	TRAFD1 (2.6)	SUGP1 (2.4)	NAA25 (2.0)	PSMA5 (1.9)	NT5DC1 (1.7)	RPH3A (1.6)	SARS (1.6)	TMEM50A (1.6)
ENSG00000037965	HOXC8 PPI subnetwork	0.49	> 0.20	ENSG00000238078 (3.1)	TRIB1 (2.8)	MAFB (2.6)	ADAM1 (2.2)	POC5 (2.1)	TMED4 (2.1)	POLK (2.0)	PLCG1 (1.7)	MYLIP (1.6)	TRAFD1 (1.6)
GO:0043550	regulation of lipid kinase activity	0.49	> 0.20	HAVCR1 (3.1)	CETP (2.2)	ENSG00000228044 (2.0)	CYB561D1 (1.9)	ZHX3 (1.8)	DOCK7 (1.6)	CELSR2 (1.5)	ZNF101 (1.5)	PBX4 (1.4)	TIMD4 (1.3)
GO:0032965	regulation of collagen biosynthetic process	0.49	> 0.20	HNF1A (2.9)	FRK (2.1)	ST3GAL4 (2.0)	GEMIN7 (1.9)	ENSG00000226645 (1.9)	ENSG00000228044 (1.6)	C11orf9 (1.6)	ALDH2 (1.5)	NKPD1 (1.3)	PMFBP1 (1.2)
ENSG00000132849	INADL PPI subnetwork	0.49	> 0.20	NCAN (3.2)	RPH3A (3.2)	CELSR2 (1.9)	GCNT4 (1.9)	AP1M2 (1.7)	FRK (1.7)	LPA (1.7)	ENSG00000228044 (1.7)	ENSG00000226648 (1.6)	HAPLN4 (1.5)
GO:0046546	development of primary male sexual characteristics	0.49	> 0.20	DNAH11 (2.6)	LPAR2 (2.6)	ST3GAL4 (2.6)	ABO (2.3)	PLEKHH2 (1.8)	C11orf9 (1.6)	TSSK6 (1.6)	AP1M2 (1.5)	FRK (1.5)	PVRL2 (1.4)
GO:0051017	actin filament bundle assembly	0.49	> 0.20	HNF1A (2.8)	HAVCR1 (2.4)	CARM1 (2.0)	USP24 (2.0)	C11orf9 (1.9)	C17orf57 (1.9)	ITGB3 (1.7)	POLK (1.4)	ABO (1.3)	ENSG00000235545 (1.3)
ENSG00000115128	ENSG00000115128 PPI subnetwork	0.49	> 0.20	ILF3 (4.0)	C1orf63 (3.4)	TOP1 (2.8)	SMARCA4 (2.7)	BUD13 (2.6)	DHX38 (2.5)	USP1 (2.5)	SUGP1 (2.5)	PTPN11 (2.2)	FEN1 (2.1)
ENSG00000138101	DTNB PPI subnetwork	0.49	> 0.20	ENSG00000238078 (2.5)	PLCG1 (2.4)	DOCK7 (2.3)	AMIGO1 (2.1)	KANK2 (2.0)	MOSC1 (1.9)	PVRL2 (1.9)	SYPL2 (1.9)	ENSG00000228044 (1.7)	TSSK6 (1.7)
ENSG00000135744	AGT PPI subnetwork	0.49	> 0.20	PMFBP1 (2.9)	TM6SF2 (2.9)	PLG (2.6)	FRK (2.4)	NPC1L1 (2.3)	ABCG5 (2.1)	APOB (2.1)	ANGPTL3 (2.0)	HAVCR1 (1.9)	TRAFD1 (1.9)
REACTOME_EXTENSION_OF_TELOMERES	REACTOME_EXTENSION_OF_TELOMERES	0.49	> 0.20	FEN1 (5.8)	USP1 (5.4)	ZNF180 (2.5)	TOMM40 (1.7)	DHODH (1.7)	AMIGO1 (1.6)	ENSG00000235545 (1.4)	ENSG00000228044 (1.4)	GOT2P1 (1.3)	ERP29 (1.3)
ENSG00000111252	SH2B3 PPI subnetwork	0.49	> 0.20	ZHX3 (2.7)	ZNF101 (2.7)	PLCG1 (2.5)	PLEKHH2 (2.1)	DNM2 (1.9)	LPAR2 (1.9)	ADAM1 (1.9)	OGDH (1.7)	PLEC (1.6)	GATAD2A (1.6)
GO:0030552	cAMP binding	0.49	> 0.20	MOSC1 (2.7)	ENSG00000254235 (2.2)	ITGB3 (2.2)	ABO (2.0)	PCSK9 (1.9)	SORT1 (1.6)	CEACAM19 (1.6)	RPH3A (1.5)	CETP (1.4)	CYP7A1 (1.4)
GO:0016568	chromatin modification	0.49	> 0.20	ATXN7L2 (2.7)	ILF3 (2.5)	MAU2 (2.5)	SMARCA4 (2.4)	ATXN2 (2.4)	C12orf51 (2.4)	BUD13 (2.3)	TOP1 (2.2)	TMEM57 (1.8)	ENSG00000226648 (1.6)
GO:0051378	serotonin binding	0.49	> 0.20	RPH3A (2.7)	ABO (2.2)	GOT2P1 (2.1)	ABCG8 (2.1)	DNAH11 (1.8)	ABCG5 (1.8)	GPAM (1.7)	GCNT4 (1.7)	ENSG00000226648 (1.4)	MYLIP (1.4)
ENSG00000142627	EPHA2 PPI subnetwork	0.49	> 0.20	PVRL2 (3.4)	CBLC (2.2)	LPAR2 (2.2)	MAFB (2.1)	ST3GAL4 (1.9)	SLC44A2 (1.7)	SH2B3 (1.7)	LPIN3 (1.6)	NAA25 (1.5)	TRAFD1 (1.4)
GO:0016791	phosphatase activity	0.49	> 0.20	TRIB1 (2.9)	SH2B3 (2.3)	AMIGO1 (2.3)	PVR (2.3)	GMPR (1.9)	ZHX3 (1.9)	SORT1 (1.7)	SYPL2 (1.6)	PTPN11 (1.5)	LDLR (1.2)
MP:0001806	decreased IgM level	0.49	> 0.20	RELB (4.0)	GMIP (3.7)	SH2B3 (2.5)	TIMD4 (2.3)	CETP (2.3)	BCL3 (2.1)	ACAD10 (1.8)	GCNT4 (1.8)	ZNF101 (1.4)	PLCG1 (1.3)
ENSG00000079739	PGM1 PPI subnetwork	0.49	> 0.20	SARS (3.2)	PSMA5 (2.8)	SUGP1 (2.6)	ZNF259 (2.4)	ZNF101 (2.2)	ENSG00000238078 (2.1)	QTRT1 (2.1)	NT5DC1 (2.0)	NAA25 (2.0)	ENSG00000254235 (1.9)
ENSG00000152894	PTPRK PPI subnetwork	0.49	> 0.20	OASL (2.9)	PARP10 (2.7)	LPAR2 (2.6)	TRIB1 (2.5)	ABCG8 (2.3)	PLEKHH2 (2.0)	PBX4 (2.0)	ABCG5 (1.8)	COL4A3BP (1.8)	SLC22A1 (1.6)
GO:0022625	cytosolic large ribosomal subunit	0.49	> 0.20	ENSG00000226645 (2.2)	DNAH11 (1.9)	CEACAM19 (1.8)	C1orf63 (1.7)	MARK4 (1.6)	ERP29 (1.6)	UBXN2B (1.5)	TMEM57 (1.5)	AMIGO1 (1.5)	NKPD1 (1.5)
ENSG00000173598	NUDT4 PPI subnetwork	0.49	> 0.20	NCAN (2.7)	TMEM57 (2.4)	APOC1 (1.9)	RPH3A (1.9)	ADAM1 (1.7)	ENSG00000238078 (1.6)	SUGP1 (1.6)	C1orf63 (1.6)	TMEM50A (1.5)	DHODH (1.5)
ENSG00000182923	CEP63 PPI subnetwork	0.49	> 0.20	MAU2 (3.9)	GATAD2A (2.3)	C12orf47 (1.9)	RPH3A (1.9)	DNAH11 (1.9)	NT5DC1 (1.8)	KANK2 (1.8)	CYB561D1 (1.7)	SMARCA4 (1.7)	ATXN2 (1.6)
GO:0045739	positive regulation of DNA repair	0.49	> 0.20	HAVCR1 (2.5)	TRAPPC6A (2.4)	NT5DC1 (2.1)	UBXN2B (2.0)	GCNT4 (1.9)	BLOC1S3 (1.9)	BUD13 (1.8)	SUGP1 (1.6)	C19orf52 (1.6)	DYNC2LI1 (1.5)
MP:0001925	male infertility	0.49	> 0.20	TSSK6 (3.4)	PMFBP1 (2.7)	FADS1 (1.8)	PLEKHH2 (1.8)	PBX4 (1.7)	ANKRD31 (1.4)	PCSK9 (1.4)	FADS2 (1.4)	TMEM57 (1.3)	GATAD2A (1.3)
ENSG00000174485	DENND4A PPI subnetwork	0.49	> 0.20	PLEC (3.3)	DNM2 (3.3)	C11orf9 (2.8)	ZHX3 (2.8)	CARM1 (2.8)	LPAR2 (2.6)	PTPN11 (2.6)	COL4A3BP (2.4)	GPAM (2.2)	BCAM (2.2)
GO:0051539	4 iron, 4 sulfur cluster binding	0.49	> 0.20	ACAD10 (4.1)	LPIN3 (2.2)	DHODH (2.1)	NT5DC1 (2.0)	ALDH2 (2.0)	PBX4 (1.8)	GOT2P1 (1.8)	SARS (1.8)	C12orf47 (1.6)	OGDH (1.5)
GO:0033559	unsaturated fatty acid metabolic process	0.49	> 0.20	NKPD1 (4.5)	CYB561D1 (3.6)	ALDH2 (2.9)	FADS2 (1.8)	GMPR (1.7)	CEACAM19 (1.7)	PMFBP1 (1.7)	C11orf9 (1.6)	ITGB3 (1.6)	HNF1A (1.5)
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	0.49	> 0.20	BLOC1S3 (2.5)	CYB561D1 (2.3)	MAPKAPK5 (2.1)	TMEM50A (2.0)	CARM1 (1.9)	HLX (1.9)	TXNL4B (1.7)	DNM2 (1.6)	LPIN3 (1.5)	PMFBP1 (1.5)
GO:0051340	regulation of ligase activity	0.49	> 0.20	PSMA5 (3.6)	POC5 (2.7)	TRAFD1 (2.2)	SUGP1 (2.1)	NAA25 (1.9)	BRAP (1.8)	NT5DC1 (1.7)	DDX56 (1.6)	C19orf52 (1.6)	ENSG00000226645 (1.4)
GO:0000976	transcription regulatory region sequence-specific DNA binding	0.49	> 0.20	MARK4 (2.2)	RHD (2.2)	ENSG00000226648 (2.0)	CELSR2 (1.8)	C19orf52 (1.5)	MYLIP (1.5)	TRIB1 (1.4)	GMPR (1.4)	HLX (1.3)	PARP10 (1.2)
MP:0000065	abnormal bone marrow cavity morphology	0.49	> 0.20	CILP2 (6.6)	NPC1L1 (2.4)	NYNRIN (2.1)	PLEC (2.0)	RHCE (1.8)	PVRL2 (1.8)	BCAM (1.6)	ANKRD31 (1.6)	GOT2P1 (1.6)	TRIB1 (1.6)
GO:0050881	musculoskeletal movement	0.49	> 0.20	SYPL2 (5.7)	C17orf57 (3.1)	ANKRD31 (2.6)	CYB561D1 (2.0)	GMPR (1.9)	UBXN2B (1.8)	ZHX3 (1.3)	HAPLN4 (1.3)	COL4A3BP (1.1)	LPIN3 (1.1)
GO:0050879	multicellular organismal movement	0.49	> 0.20	SYPL2 (5.7)	C17orf57 (3.1)	ANKRD31 (2.6)	CYB561D1 (2.0)	GMPR (1.9)	UBXN2B (1.8)	ZHX3 (1.3)	HAPLN4 (1.3)	COL4A3BP (1.1)	LPIN3 (1.1)
GO:0016799	hydrolase activity, hydrolyzing N-glycosyl compounds	0.49	> 0.20	AMIGO1 (2.3)	TRIB1 (2.0)	DHODH (1.7)	MOSC1 (1.7)	FEN1 (1.6)	MYLIP (1.5)	TRAPPC6A (1.4)	TMEM50A (1.3)	ENSG00000235545 (1.3)	ABCG5 (1.3)
GO:0072395	signal transduction involved in cell cycle checkpoint	0.49	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.4)	NAA25 (2.2)	ENSG00000254235 (1.6)	C12orf47 (1.5)	SUGP1 (1.4)	BRAP (1.4)	ZNF180 (1.3)	PARP10 (1.2)
GO:0072404	signal transduction involved in G1/S transition checkpoint	0.49	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.4)	NAA25 (2.2)	ENSG00000254235 (1.6)	C12orf47 (1.5)	SUGP1 (1.4)	BRAP (1.4)	ZNF180 (1.3)	PARP10 (1.2)
ENSG00000158161	EYA3 PPI subnetwork	0.49	> 0.20	MYLIP (2.6)	LPA (2.4)	KIAA1324 (2.3)	PPP1R37 (2.2)	FRK (2.1)	HAPLN4 (1.9)	ENSG00000254235 (1.7)	PVRL2 (1.5)	ATXN2 (1.4)	ENSG00000238078 (1.4)
GO:0050432	catecholamine secretion	0.49	> 0.20	ABO (3.2)	TSSK6 (2.0)	CEACAM19 (1.8)	C19orf52 (1.7)	PPP1R37 (1.6)	GMPR (1.6)	CETP (1.4)	ZHX3 (1.4)	RPH3A (1.2)	PMFBP1 (1.2)
ENSG00000182180	MRPS16 PPI subnetwork	0.49	> 0.20	TOMM40 (3.6)	NAA25 (3.2)	MAPKAPK5 (3.1)	ZNF259 (2.8)	DHODH (2.7)	DDX56 (2.6)	C12orf43 (2.5)	QTRT1 (2.5)	BRAP (2.3)	ATXN2 (2.3)
REACTOME_TELOMERE_C:STRAND_LAGGING_STRAND_SYNTHESIS	REACTOME_TELOMERE_C:STRAND_LAGGING_STRAND_SYNTHESIS	0.49	> 0.20	FEN1 (6.2)	USP1 (5.7)	ZNF180 (2.6)	ENSG00000235545 (1.8)	ENSG00000228044 (1.7)	AMIGO1 (1.6)	ERP29 (1.5)	FADS1 (1.5)	GOT2P1 (1.4)	NT5DC1 (1.3)
ENSG00000089597	GANAB PPI subnetwork	0.49	> 0.20	CLPTM1 (2.8)	MYLIP (1.9)	SLC44A2 (1.9)	ZNF101 (1.8)	AP1M2 (1.7)	TMED4 (1.6)	BUD13 (1.4)	RPH3A (1.4)	ATP13A1 (1.4)	ZHX3 (1.3)
ENSG00000087460	GNAS PPI subnetwork	0.49	> 0.20	ST3GAL4 (2.8)	SH2B3 (2.3)	RPH3A (2.2)	HLX (2.1)	MOSC1 (2.1)	ABCG8 (1.8)	ENSG00000254235 (1.7)	ENSG00000226648 (1.7)	CYP7A1 (1.7)	HMGCR (1.6)
GO:0032633	interleukin-4 production	0.49	> 0.20	ZNF101 (3.7)	PLCG1 (2.1)	ENSG00000254235 (1.9)	PBX4 (1.8)	ENSG00000238078 (1.7)	TMEM57 (1.6)	POLK (1.6)	GRINA (1.4)	ENSG00000226645 (1.4)	HNF1A (1.3)
GO:0042641	actomyosin	0.49	> 0.20	PLEC (3.7)	KANK2 (3.7)	PVRL2 (2.8)	ITGB3 (2.2)	CARM1 (1.8)	DNM2 (1.7)	PLCG1 (1.6)	ENSG00000238078 (1.5)	PTPN11 (1.5)	NPC1L1 (1.4)
GO:0030838	positive regulation of actin filament polymerization	0.49	> 0.20	HNF1A (2.8)	ENSG00000226648 (2.7)	ANKRD31 (2.5)	ZNF101 (2.1)	ZHX3 (2.1)	ST3GAL4 (1.8)	HAVCR1 (1.8)	DOCK7 (1.7)	PMFBP1 (1.5)	CBLC (1.5)
ENSG00000160791	CCR5 PPI subnetwork	0.49	> 0.20	OASL (3.5)	RELB (3.0)	TRAFD1 (2.7)	GRINA (2.5)	PARP10 (2.4)	GMIP (2.3)	MAFB (2.3)	TMEM50A (2.2)	BCL3 (2.2)	USP24 (1.9)
ENSG00000215778	ENSG00000215778 PPI subnetwork	0.49	> 0.20	OASL (3.5)	RELB (3.0)	TRAFD1 (2.7)	GRINA (2.5)	PARP10 (2.4)	GMIP (2.3)	MAFB (2.3)	TMEM50A (2.2)	BCL3 (2.2)	USP24 (1.9)
ENSG00000100804	PSMB5 PPI subnetwork	0.49	> 0.20	PSMA5 (5.7)	TRAFD1 (2.8)	NT5DC1 (2.7)	NAA25 (2.3)	SARS (2.0)	TOMM40 (1.5)	HMGCR (1.3)	DDX56 (1.3)	COL4A3BP (1.3)	TMEM50A (1.1)
ENSG00000102572	STK24 PPI subnetwork	0.49	> 0.20	NT5DC1 (2.5)	FRK (2.1)	PSMA5 (1.8)	TRAFD1 (1.8)	CEACAM19 (1.7)	ZNF180 (1.7)	TOP1 (1.5)	ZNF101 (1.5)	NAA25 (1.4)	PVR (1.4)
GO:0008373	sialyltransferase activity	0.49	> 0.20	ENSG00000254235 (2.4)	FADS2 (2.2)	TMEM57 (2.1)	ITGB3 (2.1)	TRIB1 (1.9)	SH2B3 (1.8)	ABO (1.7)	PPP1R37 (1.6)	GMPR (1.5)	PVRL2 (1.4)
KEGG_DORSO_VENTRAL_AXIS_FORMATION	KEGG_DORSO_VENTRAL_AXIS_FORMATION	0.49	> 0.20	CBLC (2.4)	CEACAM19 (2.0)	PBX4 (1.9)	GATAD2A (1.8)	TRAFD1 (1.7)	MARK4 (1.6)	GCNT4 (1.5)	NCAN (1.4)	NKPD1 (1.4)	ENSG00000254235 (1.4)
GO:0043186	P granule	0.49	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
GO:0045495	pole plasm	0.49	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
GO:0060293	germ plasm	0.49	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
REACTOME_ASPARAGINE_N:LINKED_GLYCOSYLATION	REACTOME_ASPARAGINE_N:LINKED_GLYCOSYLATION	0.49	> 0.20	YIPF2 (4.9)	ERP29 (4.0)	TMED4 (3.0)	ATP13A1 (2.9)	CLPTM1 (2.8)	TMEM57 (2.0)	TMEM50A (1.7)	ENSG00000235545 (1.1)	TOP1 (1.1)	C19orf52 (1.1)
MP:0002673	abnormal sperm number	0.49	> 0.20	TSSK6 (3.0)	ENSG00000228044 (2.9)	TRAFD1 (2.4)	NCAN (1.9)	PLEKHH2 (1.6)	SLC44A2 (1.4)	TRIB1 (1.3)	PVRL2 (1.3)	GRINA (1.2)	ATXN7L2 (1.1)
ENSG00000125651	GTF2F1 PPI subnetwork	0.49	> 0.20	ILF3 (3.3)	BUD13 (3.3)	TOP1 (3.0)	C1orf63 (2.7)	USP1 (2.7)	DHX38 (2.7)	SUGP1 (2.5)	SMARCA4 (2.4)	FEN1 (2.0)	PTPN11 (1.8)
ENSG00000204361	FAM55B PPI subnetwork	0.49	> 0.20	PLEC (4.5)	GATAD2A (2.8)	SARS (2.4)	AP1M2 (2.1)	DOCK7 (2.1)	KANK2 (2.0)	ABCG8 (1.9)	QTRT1 (1.8)	KIAA1324 (1.8)	LPIN3 (1.8)
ENSG00000166478	ZNF143 PPI subnetwork	0.50	> 0.20	GEMIN7 (3.6)	C12orf43 (3.3)	POC5 (3.1)	ADAM1 (2.7)	C19orf52 (2.2)	TOMM40 (2.2)	ZNF259 (2.2)	SUGP1 (2.1)	DDX56 (2.1)	MAPKAPK5 (2.1)
ENSG00000161547	SRSF2 PPI subnetwork	0.50	> 0.20	C1orf63 (4.6)	ILF3 (3.9)	TOP1 (3.3)	USP1 (3.0)	DHX38 (2.7)	BUD13 (2.7)	SMARCA4 (2.3)	SUGP1 (2.3)	FEN1 (2.2)	QTRT1 (2.0)
ENSG00000166925	TSC22D4 PPI subnetwork	0.50	> 0.20	GEMIN7 (2.8)	ILF3 (2.3)	PBX4 (2.1)	C19orf52 (2.1)	DYNC2LI1 (2.0)	QTRT1 (2.0)	ANKRD31 (2.0)	ATP13A1 (1.9)	NKPD1 (1.8)	TOMM40 (1.8)
GO:0070192	chromosome organization involved in meiosis	0.50	> 0.20	ANKRD31 (3.2)	ENSG00000238078 (2.4)	DNAH11 (1.5)	LPIN3 (1.4)	POC5 (1.3)	GCNT4 (1.3)	C17orf57 (1.2)	PBX4 (1.2)	DYNC2LI1 (1.1)	ADAM1 (1.0)
ENSG00000189229	ENSG00000189229 PPI subnetwork	0.50	> 0.20	UBXN2B (2.9)	DYNC2LI1 (2.6)	ENSG00000238078 (2.4)	C1orf63 (2.3)	TOP1 (2.0)	PARP10 (1.9)	TRAPPC6A (1.5)	PVRL2 (1.4)	C12orf47 (1.2)	LPIN3 (1.1)
ENSG00000153233	PTPRR PPI subnetwork	0.50	> 0.20	GATAD2A (2.9)	CBLC (2.7)	MARK4 (2.1)	MYLIP (1.7)	AMIGO1 (1.6)	CARM1 (1.5)	MAPKAPK5 (1.5)	PBX4 (1.4)	GCNT4 (1.3)	SLC44A2 (1.2)
ENSG00000130254	SAFB2 PPI subnetwork	0.50	> 0.20	NPC1L1 (2.5)	FRK (2.4)	PLCG1 (2.3)	ZHX3 (2.3)	BRAP (2.2)	TM6SF2 (2.0)	SH2B3 (1.7)	PLEC (1.7)	HAPLN4 (1.7)	KANK2 (1.6)
ENSG00000196235	SUPT5H PPI subnetwork	0.50	> 0.20	ZNF259 (4.1)	SUGP1 (3.8)	DDX56 (3.6)	TOP1 (3.3)	QTRT1 (3.3)	DHX38 (3.2)	ILF3 (3.1)	TOMM40 (3.1)	PTPN11 (2.9)	SMARCA4 (2.8)
GO:0000041	transition metal ion transport	0.50	> 0.20	TMEM116 (2.8)	BLOC1S3 (2.7)	ATP13A1 (2.1)	GRINA (2.0)	TMED4 (2.0)	FRK (1.9)	RHD (1.8)	AP1M2 (1.7)	TMEM57 (1.7)	LPIN3 (1.6)
MP:0005409	darkened coat color	0.50	> 0.20	SH2B3 (2.4)	CELSR2 (2.3)	POLK (1.9)	ENSG00000254235 (1.8)	BCAM (1.8)	ATXN2 (1.8)	MARK4 (1.5)	RPH3A (1.5)	PLCG1 (1.4)	CEACAM19 (1.4)
MP:0009887	abnormal palatal shelf fusion at midline	0.50	> 0.20	PLEC (3.0)	KANK2 (2.8)	GATAD2A (2.5)	ATXN2 (2.3)	MYLIP (1.7)	DNM2 (1.6)	MARK4 (1.6)	MAFB (1.5)	PLCG1 (1.4)	ENSG00000226648 (1.4)
ENSG00000140575	IQGAP1 PPI subnetwork	0.50	> 0.20	PLEC (3.2)	PVR (3.2)	SH2B3 (2.6)	TMEM50A (2.5)	TOP1 (1.8)	OGDH (1.8)	DNM2 (1.7)	KANK2 (1.7)	PVRL2 (1.6)	PTPN11 (1.6)
ENSG00000158710	TAGLN2 PPI subnetwork	0.50	> 0.20	ZNF101 (3.3)	C19orf52 (2.0)	HLX (2.0)	FRK (1.8)	NYNRIN (1.7)	ENSG00000226648 (1.6)	C12orf43 (1.5)	CETP (1.3)	NT5DC1 (1.3)	NCAN (1.3)
ENSG00000206281	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000112493	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000206208	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000121552	CSTA PPI subnetwork	0.50	> 0.20	MAFB (2.9)	NKPD1 (2.8)	APOE (2.5)	PMFBP1 (2.0)	TMEM116 (1.7)	ALDH2 (1.7)	APOC1 (1.5)	CEACAM19 (1.5)	GMPR (1.4)	ENSG00000226648 (1.3)
ENSG00000092847	EIF2C1 PPI subnetwork	0.50	> 0.20	ATXN2 (3.3)	C12orf51 (2.8)	C12orf43 (2.3)	COL4A3BP (2.2)	NAA25 (2.1)	OASL (2.1)	USP24 (1.9)	TMED4 (1.9)	ERP29 (1.8)	NKPD1 (1.7)
MP:0009543	abnormal thymus corticomedullary boundary morphology	0.50	> 0.20	RELB (4.0)	BCL3 (3.2)	PLEC (2.6)	ATP13A1 (2.1)	PBX4 (2.0)	GRINA (2.0)	ENSG00000226648 (1.9)	CLPTM1 (1.9)	GMIP (1.9)	PARP10 (1.8)
ENSG00000206247	ENSG00000206247 PPI subnetwork	0.50	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000204304	PBX2 PPI subnetwork	0.50	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000206315	PBX2 PPI subnetwork	0.50	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000130699	TAF4 PPI subnetwork	0.50	> 0.20	MAPKAPK5 (3.4)	ATXN2 (3.4)	BUD13 (2.9)	SUGP1 (2.5)	C12orf43 (2.4)	TXNL4B (2.4)	DHX38 (2.4)	ATXN7L2 (1.9)	TOP1 (1.9)	GEMIN7 (1.9)
MP:0001065	abnormal trigeminal nerve morphology	0.50	> 0.20	PVR (2.5)	PVRL2 (2.1)	LPA (2.1)	SLC22A1 (2.1)	CELSR2 (2.1)	SARS (1.9)	TSSK6 (1.9)	APOE (1.9)	TMED4 (1.8)	PPP1R37 (1.8)
MP:0001244	thin dermal layer	0.50	> 0.20	LPA (3.6)	APOC4 (2.8)	SLC22A1 (2.3)	AP1M2 (2.2)	ENSG00000254235 (2.0)	NYNRIN (1.9)	KIAA1324 (1.8)	APOA5 (1.7)	HAPLN4 (1.5)	ABCG8 (1.4)
MP:0003662	abnormal long bone epiphyseal plate proliferative zone	0.50	> 0.20	CILP2 (7.9)	PLEKHH2 (3.6)	MAFB (2.3)	APOE (1.8)	GPAM (1.7)	PLCG1 (1.6)	YIPF2 (1.6)	NPC1L1 (1.6)	HNF1A (1.3)	ACAD10 (1.2)
GO:0030823	regulation of cGMP metabolic process	0.50	> 0.20	C12orf47 (2.9)	PMFBP1 (2.3)	ANKRD31 (2.3)	TSSK6 (2.2)	CEACAM19 (1.9)	ZHX3 (1.9)	ZNF180 (1.8)	ENSG00000228044 (1.7)	MYLIP (1.6)	NYNRIN (1.6)
REACTOME_DEADENYLATION:DEPENDENT_MRNA_DECAY	REACTOME_DEADENYLATION:DEPENDENT_MRNA_DECAY	0.50	> 0.20	TXNL4B (3.3)	BUD13 (2.9)	MAPKAPK5 (2.9)	DHODH (2.6)	DHX38 (2.4)	ST3GAL4 (2.3)	DDX56 (2.1)	ZNF259 (2.1)	GEMIN7 (1.9)	C12orf43 (1.8)
ENSG00000163635	ATXN7 PPI subnetwork	0.50	> 0.20	TMEM57 (2.6)	PMFBP1 (2.2)	ATP13A1 (1.7)	C19orf52 (1.6)	C12orf51 (1.6)	ATXN7L2 (1.6)	GMPR (1.6)	SMARCA4 (1.3)	ATXN2 (1.2)	ANGPTL3 (1.2)
ENSG00000152234	ATP5A1 PPI subnetwork	0.50	> 0.20	OGDH (3.9)	C1orf63 (2.7)	TMEM50A (2.6)	PSMA5 (2.5)	PLEC (2.4)	ADAM1 (2.2)	ACAD10 (2.0)	TOMM40 (1.8)	ENSG00000238078 (1.7)	SARS (1.7)
ENSG00000148200	NR6A1 PPI subnetwork	0.50	> 0.20	PPP1R37 (2.4)	ATXN2 (2.4)	POLK (2.0)	MARK4 (1.9)	SH2B3 (1.8)	C12orf51 (1.7)	PSRC1 (1.7)	ST3GAL4 (1.7)	PLEKHH2 (1.5)	SMARCA4 (1.4)
GO:0010712	regulation of collagen metabolic process	0.50	> 0.20	HNF1A (3.2)	ENSG00000226645 (2.2)	FRK (2.2)	CEACAM19 (2.1)	GEMIN7 (2.0)	ALDH2 (1.8)	ENSG00000228044 (1.8)	ST3GAL4 (1.7)	C11orf9 (1.6)	GMPR (1.5)
GO:0046580	negative regulation of Ras protein signal transduction	0.50	> 0.20	ENSG00000238078 (2.6)	C17orf57 (2.5)	PPP1R37 (2.4)	MAU2 (2.3)	ENSG00000254235 (2.3)	COL4A3BP (1.9)	DNAH11 (1.5)	CYB561D1 (1.4)	RPH3A (1.4)	SH2B3 (1.3)
ENSG00000168078	PBK PPI subnetwork	0.50	> 0.20	PSRC1 (3.4)	POC5 (3.2)	MAU2 (2.4)	DNAH11 (2.0)	GMPR (1.7)	FEN1 (1.6)	PCSK9 (1.5)	DNM2 (1.4)	KIAA1324 (1.3)	DDX56 (1.2)
ENSG00000129682	FGF13 PPI subnetwork	0.50	> 0.20	CBLC (4.0)	PLEKHH2 (3.7)	C11orf9 (2.9)	KIAA1324 (2.4)	HAPLN4 (2.3)	APOE (2.3)	HAVCR1 (2.3)	MYLIP (2.2)	AP1M2 (2.2)	NCAN (2.1)
MP:0003868	abnormal feces composition	0.50	> 0.20	RHD (2.5)	RHCE (2.2)	ABCG5 (2.1)	C12orf51 (1.9)	NKPD1 (1.9)	MAFB (1.9)	CETP (1.8)	TM6SF2 (1.8)	GATAD2A (1.7)	MOSC1 (1.5)
GO:0022415	viral reproductive process	0.50	> 0.20	NKPD1 (3.2)	MAU2 (2.3)	OASL (2.2)	MAPKAPK5 (1.8)	ENSG00000226645 (1.7)	GATAD2A (1.7)	ILF3 (1.6)	SUGP1 (1.6)	PTPN11 (1.6)	GEMIN7 (1.4)
ENSG00000165912	PACSIN3 PPI subnetwork	0.50	> 0.20	PPP1R37 (3.7)	CLPTM1 (2.6)	ATXN2 (2.4)	GATAD2A (2.2)	PTPN11 (2.1)	PLEC (1.9)	ST3GAL4 (1.6)	RPH3A (1.6)	HAPLN4 (1.4)	PLEKHH2 (1.3)
ENSG00000115138	POMC PPI subnetwork	0.50	> 0.20	ENSG00000228044 (3.0)	PMFBP1 (2.9)	ENSG00000254235 (1.9)	C12orf47 (1.9)	FRK (1.7)	COL4A3BP (1.7)	NKPD1 (1.6)	NPC1L1 (1.5)	LPIN3 (1.5)	HP (1.5)
GO:0022829	wide pore channel activity	0.50	> 0.20	CBLC (2.7)	NKPD1 (2.6)	C11orf9 (2.2)	CLPTM1 (2.1)	CYP7A1 (2.0)	ANGPTL3 (1.8)	CEACAM19 (1.7)	DNAH11 (1.7)	GOT2P1 (1.5)	PLG (1.5)
ENSG00000101557	USP14 PPI subnetwork	0.50	> 0.20	PSMA5 (5.3)	TRAFD1 (2.6)	NAA25 (2.6)	SARS (1.7)	DDX56 (1.7)	TOMM40 (1.6)	NT5DC1 (1.6)	SUGP1 (1.5)	TMEM57 (1.4)	BRAP (1.2)
MP:0001675	abnormal ectoderm development	0.50	> 0.20	APOE (2.9)	NAA25 (2.6)	GEMIN7 (2.2)	C17orf57 (2.1)	ENSG00000254235 (2.0)	DOCK7 (2.0)	APOB (1.6)	COL4A3BP (1.6)	HNF1A (1.5)	ABO (1.4)
ENSG00000185247	MAGEA11 PPI subnetwork	0.50	> 0.20	C12orf43 (2.4)	PBX4 (2.2)	RELB (1.9)	DYNC2LI1 (1.8)	ZNF259 (1.8)	GCNT4 (1.7)	ACAD10 (1.5)	PSRC1 (1.4)	SUGP1 (1.4)	YIPF2 (1.3)
GO:0061384	heart trabecula morphogenesis	0.50	> 0.20	CEACAM19 (3.0)	GOT2P1 (2.3)	CARM1 (2.2)	ATXN7L2 (2.1)	ENSG00000254235 (2.0)	ENSG00000238078 (1.9)	KIAA1324 (1.9)	C19orf52 (1.9)	TMEM116 (1.6)	UBXN2B (1.5)
MP:0009331	absent primitive node	0.50	> 0.20	AP1M2 (3.3)	HNF1A (2.0)	MAPKAPK5 (1.9)	HAVCR1 (1.8)	PMFBP1 (1.8)	APOE (1.7)	CEACAM19 (1.7)	PARP10 (1.7)	YIPF2 (1.7)	PVRL2 (1.6)
GO:0000803	sex chromosome	0.50	> 0.20	LPAR2 (3.5)	ENSG00000238078 (2.3)	NYNRIN (2.2)	ILF3 (2.0)	PBX4 (2.0)	USP1 (1.9)	CARM1 (1.8)	TOP1 (1.7)	MARK4 (1.5)	FEN1 (1.4)
ENSG00000175602	CCDC85B PPI subnetwork	0.50	> 0.20	BUD13 (2.7)	GMPR (2.6)	PSRC1 (2.3)	POC5 (2.3)	MYLIP (2.2)	ENSG00000226648 (1.9)	BRAP (1.9)	BLOC1S3 (1.6)	POLK (1.5)	USP1 (1.5)
GO:0055123	digestive system development	0.50	> 0.20	C11orf9 (4.5)	TM6SF2 (2.7)	PLEKHH2 (2.6)	NPC1L1 (2.3)	ABCG8 (2.1)	ABCG5 (2.0)	NYNRIN (1.9)	LPAR2 (1.9)	ENSG00000235545 (1.7)	HLX (1.7)
REACTOME_N:GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXINCALRETICULIN_CYCLE	REACTOME_N:GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXINCALRETICULIN_CYCLE	0.50	> 0.20	ERP29 (6.1)	YIPF2 (4.4)	CLPTM1 (3.7)	ATP13A1 (3.7)	TMED4 (2.7)	OGDH (1.8)	TMEM57 (1.7)	SORT1 (1.5)	HNF1A (1.4)	ACAD10 (1.3)
ENSG00000166228	PCBD1 PPI subnetwork	0.50	> 0.20	ANGPTL3 (3.4)	PLG (3.1)	GRINA (2.5)	PCSK9 (2.2)	CARM1 (2.0)	TMED4 (1.9)	ENSG00000226645 (1.7)	YIPF2 (1.6)	MARK4 (1.5)	APOC4 (1.5)
ENSG00000180871	CXCR2 PPI subnetwork	0.50	> 0.20	ITGB3 (4.0)	NYNRIN (2.5)	BCL3 (2.4)	GRINA (2.4)	MAFB (2.2)	UBXN2B (1.9)	CYP7A1 (1.9)	PVRL2 (1.4)	ANGPTL3 (1.4)	ENSG00000254235 (1.4)
ENSG00000128591	FLNC PPI subnetwork	0.50	> 0.20	SYPL2 (6.3)	ZHX3 (2.6)	PPP1R37 (2.4)	LPA (2.3)	ENSG00000226645 (1.9)	COL4A3BP (1.7)	SH2B3 (1.5)	FRK (1.5)	ENSG00000254235 (1.3)	LPIN3 (1.3)
MP:0004566	myocardial fiber degeneration	0.50	> 0.20	SYPL2 (3.1)	PLEC (2.4)	GMPR (2.1)	GOT2P1 (2.1)	HAPLN4 (2.0)	OGDH (2.0)	ATXN2 (1.9)	AMIGO1 (1.9)	KANK2 (1.9)	ENSG00000235545 (1.6)
GO:0042383	sarcolemma	0.50	> 0.20	SYPL2 (3.6)	KANK2 (3.2)	GMPR (3.0)	SORT1 (2.7)	PLEC (2.6)	BCAM (1.9)	AMIGO1 (1.9)	COL4A3BP (1.6)	OGDH (1.3)	RPH3A (1.2)
GO:0070742	C2H2 zinc finger domain binding	0.50	> 0.20	ENSG00000238078 (2.6)	ABO (2.3)	RHD (2.0)	GMPR (2.0)	NYNRIN (2.0)	SH2B3 (1.9)	ITGB3 (1.8)	SLC44A2 (1.6)	RHCE (1.5)	BLOC1S3 (1.5)
GO:0070410	co-SMAD binding	0.50	> 0.20	DOCK7 (3.8)	ATXN2 (1.8)	TRIB1 (1.8)	ATXN7L2 (1.6)	ENSG00000226648 (1.6)	MYLIP (1.6)	KANK2 (1.5)	GMPR (1.4)	BCL3 (1.4)	TSSK6 (1.3)
GO:0014896	muscle hypertrophy	0.50	> 0.20	ENSG00000226648 (3.0)	CEACAM19 (2.7)	ENSG00000235545 (2.6)	HNF1A (2.4)	ENSG00000254235 (2.0)	TRAPPC6A (1.8)	DNAH11 (1.7)	TXNL4B (1.6)	GCNT4 (1.6)	SYPL2 (1.4)
GO:0000722	telomere maintenance via recombination	0.50	> 0.20	ZNF180 (3.1)	USP1 (3.0)	ENSG00000228044 (2.6)	FEN1 (2.4)	AMIGO1 (2.4)	GOT2P1 (2.2)	ENSG00000235545 (2.1)	ERP29 (1.8)	ENSG00000226648 (1.8)	TMEM116 (1.8)
ENSG00000033011	ALG1 PPI subnetwork	0.50	> 0.20	HMGCR (5.6)	LDLR (5.1)	FADS1 (4.6)	FADS2 (4.5)	TMEM50A (3.3)	PCSK9 (3.1)	ERP29 (3.0)	SORT1 (2.7)	CYB561D1 (2.1)	AMIGO1 (1.9)
KEGG_MAPK_SIGNALING_PATHWAY	KEGG_MAPK_SIGNALING_PATHWAY	0.50	> 0.20	PVR (4.2)	TRIB1 (4.1)	RELB (3.0)	BCL3 (3.0)	PTPN11 (2.6)	LDLR (2.1)	SH2B3 (2.0)	PLEKHH2 (2.0)	MARK4 (1.8)	HLX (1.8)
ENSG00000143614	GATAD2B PPI subnetwork	0.50	> 0.20	C19orf52 (2.2)	GMPR (2.1)	TMEM57 (1.8)	MYLIP (1.6)	USP1 (1.5)	ZNF180 (1.3)	PMFBP1 (1.3)	BUD13 (1.1)	NT5DC1 (1.1)	ENSG00000226648 (1.0)
ENSG00000135052	GOLM1 PPI subnetwork	0.50	> 0.20	C1orf63 (3.4)	C12orf47 (2.4)	TMEM57 (2.3)	TXNL4B (2.3)	SARS (2.2)	APOE (2.1)	ACAD10 (1.6)	DDX56 (1.5)	MYLIP (1.5)	USP24 (1.5)
GO:0072594	establishment of protein localization to organelle	0.50	> 0.20	BRAP (2.4)	ZNF259 (2.2)	YIPF2 (2.0)	ACAD10 (2.0)	GOT2P1 (1.9)	TRAPPC6A (1.9)	DHODH (1.7)	QTRT1 (1.7)	NT5DC1 (1.6)	ENSG00000226645 (1.5)
GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	0.50	> 0.20	ENSG00000228044 (1.9)	ENSG00000235545 (1.6)	TSSK6 (1.5)	FRK (1.5)	CETP (1.5)	POLK (1.5)	GOT2P1 (1.4)	POC5 (1.3)	SYPL2 (1.2)	ENSG00000254235 (1.2)
GO:0005858	axonemal dynein complex	0.50	> 0.20	DNAH11 (4.5)	DYNC2LI1 (1.8)	PBX4 (1.7)	CEACAM19 (1.2)	ST3GAL4 (1.2)	KIAA1324 (1.2)	YIPF2 (1.2)	ABO (0.9)	NKPD1 (0.8)	RHCE (0.7)
ENSG00000090621	PABPC4 PPI subnetwork	0.50	> 0.20	PVR (2.9)	TMEM57 (1.8)	BRAP (1.8)	AMIGO1 (1.7)	SARS (1.5)	GRINA (1.5)	TRAPPC6A (1.4)	PVRL2 (1.4)	PTPN11 (1.4)	SUGP1 (1.3)
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.50	> 0.20	ENSG00000235545 (2.1)	DNAH11 (2.0)	PARP10 (1.7)	HAVCR1 (1.6)	NKPD1 (1.4)	POLK (1.4)	RELB (1.4)	GEMIN7 (1.2)	ZNF101 (1.2)	TRAFD1 (1.2)
MP:0003132	increased pre-B cell number	0.50	> 0.20	ERP29 (2.5)	GMIP (2.4)	C17orf57 (2.2)	GEMIN7 (2.1)	FRK (1.9)	SH2B3 (1.9)	MAFB (1.9)	RELB (1.7)	NYNRIN (1.6)	CETP (1.3)
ENSG00000100505	TRIM9 PPI subnetwork	0.50	> 0.20	HAVCR1 (2.8)	CYB561D1 (2.4)	NCAN (2.1)	KIAA1324 (2.1)	TRAPPC6A (1.6)	LDLR (1.6)	PMFBP1 (1.6)	AMIGO1 (1.6)	POC5 (1.6)	HMGCR (1.5)
MP:0008189	increased transitional stage B cell number	0.50	> 0.20	RELB (4.1)	SH2B3 (2.6)	GMIP (2.6)	CETP (2.4)	GPAM (2.0)	TIMD4 (1.7)	BCL3 (1.7)	MAFB (1.7)	C12orf47 (1.6)	ALDH2 (1.4)
ENSG00000172845	SP3 PPI subnetwork	0.50	> 0.20	SYPL2 (3.0)	CELSR2 (2.6)	MAU2 (2.5)	ATXN7L2 (2.3)	ADAM1 (1.9)	NT5DC1 (1.9)	CARM1 (1.9)	UBXN2B (1.9)	C1orf63 (1.8)	BRAP (1.6)
ENSG00000196628	TCF4 PPI subnetwork	0.50	> 0.20	HLX (4.1)	MYLIP (3.3)	GMPR (2.2)	RHD (2.0)	TMEM57 (2.0)	PLCG1 (1.8)	RHCE (1.7)	CILP2 (1.6)	LPIN3 (1.5)	KANK2 (1.4)
MP:0002968	increased circulating alkaline phosphatase level	0.50	> 0.20	PLG (3.1)	ANGPTL3 (2.9)	SLC22A1 (2.6)	RHCE (2.4)	TMEM116 (2.3)	ZHX3 (2.1)	GMPR (2.0)	DYNC2LI1 (1.9)	KIAA1324 (1.9)	RHD (1.5)
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	0.50	> 0.20	SARS (8.7)	DHODH (3.3)	NAA25 (3.1)	ZNF259 (2.8)	SUGP1 (2.6)	DDX56 (2.6)	QTRT1 (2.3)	MAPKAPK5 (2.2)	POC5 (2.2)	PSMA5 (2.1)
MP:0003055	abnormal long bone epiphyseal plate morphology	0.50	> 0.20	CILP2 (6.9)	PLEKHH2 (2.8)	MAFB (2.8)	GOT2P1 (1.6)	YIPF2 (1.3)	ALDH2 (1.2)	PLCG1 (1.2)	MYLIP (1.1)	TIMD4 (1.1)	KANK2 (1.0)
MP:0002339	abnormal lymph node morphology	0.50	> 0.20	RELB (3.7)	BCL3 (3.3)	GMIP (3.2)	PBX4 (2.9)	GCNT4 (2.6)	CYB561D1 (2.5)	PLEC (2.4)	CETP (2.2)	TIMD4 (1.8)	RHCE (1.8)
MP:0004982	abnormal osteoclast morphology	0.50	> 0.20	PLEKHH2 (3.2)	CETP (2.4)	FRK (2.3)	COL4A3BP (2.2)	TIMD4 (2.2)	ENSG00000228044 (2.1)	CELSR2 (1.9)	MYLIP (1.8)	TMEM116 (1.8)	MAFB (1.7)
GO:0060992	response to fungicide	0.50	> 0.20	DNAH11 (4.6)	HNF1A (2.2)	ABO (2.0)	HAPLN4 (1.6)	CEACAM19 (1.5)	ZNF180 (1.5)	ENSG00000254235 (1.4)	ENSG00000235545 (1.3)	NCAN (1.2)	ZHX3 (1.2)
GO:0050909	sensory perception of taste	0.50	> 0.20	GOT2P1 (3.2)	ENSG00000228044 (2.2)	DNAH11 (2.0)	PMFBP1 (2.0)	ABO (1.9)	CYB561D1 (1.5)	ADAM1 (1.3)	ANKRD31 (1.0)	GCNT4 (1.0)	OASL (0.9)
ENSG00000122490	PQLC1 PPI subnetwork	0.50	> 0.20	TMED4 (3.3)	YIPF2 (3.2)	BUD13 (2.7)	C19orf52 (2.5)	ZNF259 (2.4)	MAU2 (2.3)	PMFBP1 (1.9)	TRAFD1 (1.8)	BRAP (1.7)	ERP29 (1.7)
ENSG00000176102	CSTF3 PPI subnetwork	0.50	> 0.20	ILF3 (4.0)	SMARCA4 (3.3)	BUD13 (3.1)	DHX38 (3.0)	TOP1 (2.8)	USP1 (2.6)	GATAD2A (2.5)	SUGP1 (2.5)	C1orf63 (2.2)	ATP13A1 (2.1)
REACTOME_DNA_STRAND_ELONGATION	REACTOME_DNA_STRAND_ELONGATION	0.50	> 0.20	FEN1 (7.1)	USP1 (5.9)	ZNF180 (2.6)	ENSG00000228044 (1.7)	FADS1 (1.5)	ENSG00000235545 (1.3)	AMIGO1 (1.2)	GOT2P1 (1.2)	DHODH (1.1)	ERP29 (1.0)
GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	0.50	> 0.20	ATXN2 (3.8)	MAU2 (3.3)	SMARCA4 (3.1)	CARM1 (2.6)	OGDH (2.5)	C12orf51 (2.5)	GMPR (2.2)	BUD13 (2.1)	ATXN7L2 (2.0)	TRIB1 (1.9)
ENSG00000184916	JAG2 PPI subnetwork	0.50	> 0.20	NCAN (2.8)	SLC44A2 (2.8)	BCAM (2.2)	USP24 (2.2)	CELSR2 (2.2)	NYNRIN (2.0)	TSSK6 (2.0)	C12orf47 (1.9)	ENSG00000254235 (1.8)	GRINA (1.6)
GO:0071385	cellular response to glucocorticoid stimulus	0.50	> 0.20	RHCE (2.9)	TXNL4B (2.5)	RHD (2.4)	ENSG00000226645 (2.4)	TMEM57 (2.1)	ATXN7L2 (2.1)	LPIN3 (2.1)	GMPR (2.1)	ABCG8 (2.0)	FRK (2.0)
GO:0071384	cellular response to corticosteroid stimulus	0.50	> 0.20	RHCE (2.9)	TXNL4B (2.5)	RHD (2.4)	ENSG00000226645 (2.4)	TMEM57 (2.1)	ATXN7L2 (2.1)	LPIN3 (2.1)	GMPR (2.1)	ABCG8 (2.0)	FRK (2.0)
ENSG00000138018	EPT1 PPI subnetwork	0.50	> 0.20	LDLR (6.9)	HMGCR (6.6)	FADS1 (5.6)	FADS2 (5.4)	PCSK9 (2.9)	TMEM50A (2.2)	YIPF2 (2.2)	TMED4 (2.1)	ERP29 (2.0)	MAPKAPK5 (1.9)
ENSG00000196405	EVL PPI subnetwork	0.50	> 0.20	GMIP (3.9)	ATXN2 (3.0)	DNM2 (2.7)	RHD (2.5)	SMARCA4 (2.4)	HAVCR1 (2.4)	PLEC (2.1)	MARK4 (2.1)	C12orf51 (2.1)	GATAD2A (2.0)
ENSG00000166206	GABRB3 PPI subnetwork	0.50	> 0.20	C11orf9 (2.3)	ANKRD31 (2.0)	ABO (1.7)	RPH3A (1.6)	GCNT4 (1.4)	ATP13A1 (1.2)	MYLIP (1.1)	ERP29 (1.1)	GOT2P1 (1.1)	KIAA1324 (1.1)
ENSG00000039123	SKIV2L2 PPI subnetwork	0.50	> 0.20	MAPKAPK5 (3.5)	SUGP1 (3.0)	BRAP (2.9)	C12orf43 (2.6)	DHODH (2.5)	DDX56 (2.4)	USP24 (2.3)	TOMM40 (2.3)	PLEKHH2 (2.2)	DHX38 (2.1)
ENSG00000117758	STX12 PPI subnetwork	0.50	> 0.20	SARS (3.1)	TRAFD1 (3.0)	AP1M2 (2.7)	SUGP1 (2.7)	BRAP (2.6)	GRINA (2.6)	ENSG00000228044 (2.2)	COL4A3BP (2.1)	C12orf43 (2.1)	ABO (2.0)
ENSG00000149091	DGKZ PPI subnetwork	0.50	> 0.20	ZHX3 (4.4)	PLEKHH2 (3.5)	PLCG1 (2.6)	TMEM50A (2.1)	CELSR2 (2.1)	NCAN (2.1)	USP24 (2.0)	LPIN3 (1.8)	ZNF101 (1.7)	TOP1 (1.7)
GO:0002053	positive regulation of mesenchymal cell proliferation	0.50	> 0.20	ENSG00000238078 (2.9)	NYNRIN (1.7)	MYLIP (1.7)	PPP1R37 (1.5)	CBLC (1.5)	DYNC2LI1 (1.5)	NKPD1 (1.4)	ENSG00000254235 (1.4)	TMEM116 (1.3)	ENSG00000226648 (1.2)
MP:0002954	abnormal aerobic energy metabolism	0.50	> 0.20	GPAM (3.1)	OGDH (2.7)	SYPL2 (2.5)	MOSC1 (2.4)	ACAD10 (2.2)	HAVCR1 (2.1)	NT5DC1 (2.0)	HP (2.0)	ALDH2 (1.7)	TMEM116 (1.6)
GO:0016820	hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances	0.50	> 0.20	ATP13A1 (3.4)	CLPTM1 (3.3)	GRINA (2.8)	TMEM116 (2.7)	SORT1 (2.5)	HAPLN4 (2.3)	COL4A3BP (2.1)	C12orf51 (2.0)	TMEM50A (1.9)	GMPR (1.8)
ENSG00000129245	FXR2 PPI subnetwork	0.50	> 0.20	C17orf57 (2.6)	GMPR (2.1)	UBXN2B (2.0)	SUGP1 (1.9)	ILF3 (1.9)	C12orf43 (1.8)	PVRL2 (1.7)	AP1M2 (1.7)	TRAPPC6A (1.5)	SARS (1.5)
ENSG00000160201	U2AF1 PPI subnetwork	0.50	> 0.20	C1orf63 (4.2)	ILF3 (4.1)	TOP1 (3.2)	SMARCA4 (2.9)	DHX38 (2.6)	USP1 (2.5)	SUGP1 (2.4)	BUD13 (2.4)	PTPN11 (2.3)	QTRT1 (2.2)
ENSG00000134899	ERCC5 PPI subnetwork	0.50	> 0.20	PARP10 (2.6)	MAU2 (2.3)	SUGP1 (2.2)	ZNF180 (2.0)	GMIP (1.8)	POLK (1.8)	POC5 (1.6)	TXNL4B (1.6)	CBLC (1.4)	BCL3 (1.4)
MP:0001922	reduced male fertility	0.50	> 0.20	PMFBP1 (3.0)	TSSK6 (2.2)	UBXN2B (1.8)	NCAN (1.7)	ALDH2 (1.5)	MYLIP (1.5)	USP24 (1.4)	MAFB (1.4)	TOP1 (1.4)	MOSC1 (1.3)
ENSG00000100266	PACSIN2 PPI subnetwork	0.50	> 0.20	PPP1R37 (3.1)	SH2B3 (2.6)	LPIN3 (2.6)	PLEC (2.1)	GATAD2A (2.0)	COL4A3BP (1.9)	HAVCR1 (1.7)	DNM2 (1.6)	BLOC1S3 (1.6)	ST3GAL4 (1.5)
GO:0032760	positive regulation of tumor necrosis factor production	0.50	> 0.20	ST3GAL4 (2.6)	MAFB (2.5)	FRK (2.3)	TRAFD1 (2.0)	MYLIP (1.8)	ZNF101 (1.7)	HLX (1.6)	PARP10 (1.5)	ENSG00000235545 (1.5)	C19orf52 (1.3)
MP:0001957	apnea	0.50	> 0.20	FADS1 (3.9)	HMGCR (3.4)	LDLR (3.2)	FADS2 (2.9)	PBX4 (2.4)	CILP2 (2.2)	PCSK9 (2.0)	ATXN2 (1.9)	LPA (1.9)	CEACAM19 (1.8)
MP:0002886	abnormal glutamate-mediated receptor currents	0.50	> 0.20	FADS2 (5.1)	FADS1 (4.3)	HMGCR (4.2)	LDLR (4.0)	RPH3A (3.6)	PCSK9 (3.2)	ENSG00000226648 (2.7)	MARK4 (2.3)	HAPLN4 (2.2)	ITGB3 (1.8)
ENSG00000113318	MSH3 PPI subnetwork	0.50	> 0.20	FEN1 (4.0)	USP1 (2.9)	POLK (2.5)	ZNF180 (2.3)	ATP13A1 (1.8)	TMEM116 (1.8)	ENSG00000226645 (1.7)	BRAP (1.5)	BUD13 (1.5)	POC5 (1.2)
ENSG00000183598	HIST2H3D PPI subnetwork	0.50	> 0.20	C19orf52 (2.8)	SMARCA4 (2.5)	ATXN2 (2.2)	USP1 (2.2)	GATAD2A (2.2)	PSRC1 (2.0)	FEN1 (1.9)	TOP1 (1.8)	PLCG1 (1.7)	ILF3 (1.5)
ENSG00000203811	HIST2H3C PPI subnetwork	0.50	> 0.20	C19orf52 (2.8)	SMARCA4 (2.5)	ATXN2 (2.2)	USP1 (2.2)	GATAD2A (2.2)	PSRC1 (2.0)	FEN1 (1.9)	TOP1 (1.8)	PLCG1 (1.7)	ILF3 (1.5)
ENSG00000185963	BICD2 PPI subnetwork	0.50	> 0.20	OGDH (2.4)	DOCK7 (2.3)	ENSG00000235545 (2.3)	DNM2 (2.2)	C12orf51 (2.2)	SMARCA4 (1.9)	MARK4 (1.9)	CLPTM1 (1.8)	PLEC (1.7)	AMIGO1 (1.6)
GO:0006826	iron ion transport	0.50	> 0.20	TMEM116 (3.2)	BLOC1S3 (2.3)	GRINA (2.0)	FRK (1.9)	AP1M2 (1.7)	LPIN3 (1.7)	TMED4 (1.6)	CLPTM1 (1.6)	RHD (1.4)	SARS (1.4)
ENSG00000187840	EIF4EBP1 PPI subnetwork	0.50	> 0.20	HMGCR (3.5)	DHX38 (3.2)	PTPN11 (3.0)	LDLR (2.6)	C12orf43 (2.4)	FADS2 (2.3)	ATXN2 (2.3)	SMARCA4 (2.3)	CLPTM1 (2.0)	MAU2 (2.0)
REACTOME_N:GLYCAN_ANTENNAE_ELONGATION	REACTOME_N:GLYCAN_ANTENNAE_ELONGATION	0.50	> 0.20	ST3GAL4 (2.6)	DOCK7 (2.0)	PVRL2 (1.9)	ERP29 (1.7)	FADS2 (1.7)	ITGB3 (1.6)	LPIN3 (1.6)	ENSG00000235545 (1.6)	PPP1R37 (1.6)	SLC44A2 (1.4)
MP:0003628	abnormal leukocyte adhesion	0.50	> 0.20	BCL3 (2.7)	PVR (2.7)	GMIP (2.3)	PLEC (1.9)	TIMD4 (1.9)	RELB (1.7)	HLX (1.7)	TMEM116 (1.6)	SH2B3 (1.6)	LDLR (1.5)
GO:0046883	regulation of hormone secretion	0.51	> 0.20	KIAA1324 (4.8)	ABO (2.4)	ANKRD31 (2.3)	HAPLN4 (2.1)	HNF1A (2.0)	ENSG00000254235 (1.8)	GPAM (1.8)	TMED4 (1.7)	ENSG00000228044 (1.7)	MOSC1 (1.7)
ENSG00000106615	RHEB PPI subnetwork	0.51	> 0.20	USP24 (3.2)	MAPKAPK5 (3.0)	C12orf51 (3.0)	DOCK7 (2.0)	SMARCA4 (1.9)	C12orf43 (1.8)	DHX38 (1.8)	ATXN2 (1.7)	MARK4 (1.6)	GEMIN7 (1.6)
ENSG00000125970	RALY PPI subnetwork	0.51	> 0.20	ILF3 (3.9)	QTRT1 (3.6)	PPP1R37 (3.2)	DHX38 (3.0)	SMARCA4 (2.8)	SUGP1 (2.6)	PLCG1 (2.3)	GATAD2A (2.2)	C1orf63 (2.0)	CLPTM1 (1.9)
MP:0003051	curly tail	0.51	> 0.20	NYNRIN (4.9)	FADS2 (2.8)	LPAR2 (2.5)	FADS1 (2.4)	MARK4 (2.3)	PCSK9 (2.2)	LDLR (2.1)	NCAN (2.0)	HMGCR (1.7)	ABO (1.6)
ENSG00000077514	POLD3 PPI subnetwork	0.51	> 0.20	FEN1 (5.2)	USP1 (4.8)	AMIGO1 (2.4)	ZNF180 (2.2)	ENSG00000235545 (2.0)	DHODH (1.7)	FADS1 (1.6)	ENSG00000228044 (1.5)	TOMM40 (1.3)	LPA (1.3)
MP:0000933	abnormal rhombomere morphology	0.51	> 0.20	PLCG1 (1.8)	ENSG00000254235 (1.6)	CILP2 (1.6)	HLX (1.5)	ANKRD31 (1.5)	APOE (1.2)	MAFB (1.1)	ENSG00000228044 (1.1)	PMFBP1 (1.1)	CYP7A1 (1.0)
ENSG00000105258	POLR2I PPI subnetwork	0.51	> 0.20	ILF3 (3.5)	BUD13 (3.2)	TOP1 (3.1)	SUGP1 (2.9)	DHX38 (2.8)	C1orf63 (2.7)	USP1 (2.5)	SMARCA4 (2.4)	MAPKAPK5 (2.2)	PTPN11 (2.2)
MP:0005167	abnormal blood-brain barrier function	0.51	> 0.20	APOC1 (2.6)	NCAN (2.6)	HLX (2.4)	GPAM (2.2)	BCAM (2.0)	PLCG1 (2.0)	CLPTM1 (1.8)	NYNRIN (1.7)	ENSG00000235545 (1.7)	ZHX3 (1.6)
GO:0014823	response to activity	0.51	> 0.20	SYPL2 (4.1)	DNAH11 (2.4)	TXNL4B (2.1)	FRK (1.9)	ZNF101 (1.8)	ZHX3 (1.7)	ENSG00000226645 (1.7)	AMIGO1 (1.6)	C17orf57 (1.5)	MAFB (1.3)
MP:0004568	fusion of glossopharyngeal and vagus nerve	0.51	> 0.20	TSSK6 (3.3)	HLX (2.8)	CEACAM19 (2.4)	BLOC1S3 (2.2)	C11orf9 (1.9)	DYNC2LI1 (1.8)	ANKRD31 (1.7)	SORT1 (1.7)	UBXN2B (1.3)	POC5 (1.3)
GO:0051851	modification by host of symbiont morphology or physiology	0.51	> 0.20	ENSG00000235545 (2.9)	RHD (2.5)	HP (2.2)	CEACAM19 (2.0)	BUD13 (1.8)	RHCE (1.7)	C1orf63 (1.6)	GOT2P1 (1.5)	PBX4 (1.5)	ENSG00000226645 (1.4)
MP:0002672	abnormal branchial arch artery morphology	0.51	> 0.20	MYLIP (3.1)	HLX (2.9)	MAFB (2.8)	BCAM (2.2)	SLC44A2 (2.2)	CEACAM19 (2.0)	PLCG1 (1.7)	SH2B3 (1.6)	PVRL2 (1.5)	ANKRD31 (1.4)
ENSG00000136504	KAT7 PPI subnetwork	0.51	> 0.20	UBXN2B (3.1)	DYNC2LI1 (1.9)	FRK (1.9)	C17orf57 (1.9)	HNF1A (1.8)	PSRC1 (1.6)	LPAR2 (1.6)	ZNF180 (1.5)	AP1M2 (1.4)	HAVCR1 (1.4)
GO:0022612	gland morphogenesis	0.51	> 0.20	PLEKHH2 (2.3)	CELSR2 (2.1)	BCAM (2.1)	PPP1R37 (2.0)	AP1M2 (1.9)	ENSG00000254235 (1.8)	AMIGO1 (1.8)	ST3GAL4 (1.7)	CBLC (1.7)	PLEC (1.6)
ENSG00000104689	TNFRSF10A PPI subnetwork	0.51	> 0.20	PVR (3.1)	HAVCR1 (3.1)	CILP2 (2.6)	FRK (2.4)	ZNF101 (2.1)	ERP29 (2.0)	PVRL2 (1.9)	OASL (1.8)	GMIP (1.7)	TRAFD1 (1.7)
GO:0032675	regulation of interleukin-6 production	0.51	> 0.20	HLX (2.2)	C17orf57 (2.1)	TRIB1 (1.7)	ENSG00000228044 (1.7)	MAFB (1.7)	PMFBP1 (1.5)	OASL (1.5)	POC5 (1.3)	GMIP (1.3)	SH2B3 (1.2)
ENSG00000004487	KDM1A PPI subnetwork	0.51	> 0.20	MARK4 (2.6)	SMARCA4 (2.2)	NT5DC1 (2.0)	ATXN2 (1.9)	TMEM57 (1.9)	DOCK7 (1.9)	ATXN7L2 (1.9)	TRAFD1 (1.8)	TOP1 (1.7)	PLCG1 (1.6)
GO:0009593	detection of chemical stimulus	0.51	> 0.20	ENSG00000228044 (4.8)	PMFBP1 (2.7)	DNAH11 (1.8)	ENSG00000235545 (1.8)	GOT2P1 (1.8)	CYB561D1 (1.8)	FRK (1.2)	ANKRD31 (1.2)	ADAM1 (1.2)	CYP7A1 (1.1)
ENSG00000139618	BRCA2 PPI subnetwork	0.51	> 0.20	FEN1 (3.6)	PSRC1 (2.5)	DNM2 (2.2)	USP1 (1.9)	ILF3 (1.9)	PBX4 (1.6)	POC5 (1.4)	SLC44A2 (1.4)	ITGB3 (1.4)	MAU2 (1.4)
ENSG00000103723	AP3B2 PPI subnetwork	0.51	> 0.20	C17orf57 (2.3)	ENSG00000228044 (2.0)	RHD (2.0)	DYNC2LI1 (1.9)	C12orf51 (1.6)	PLEC (1.6)	PARP10 (1.6)	ST3GAL4 (1.5)	ZNF259 (1.3)	HNF1A (1.3)
GO:0002831	regulation of response to biotic stimulus	0.51	> 0.20	ZNF101 (2.6)	BLOC1S3 (2.6)	OASL (2.6)	ATP13A1 (2.4)	GEMIN7 (2.2)	PBX4 (2.2)	CLPTM1 (2.1)	MAU2 (2.1)	ENSG00000235545 (2.1)	PARP10 (1.9)
ENSG00000078668	VDAC3 PPI subnetwork	0.51	> 0.20	PSMA5 (3.3)	DDX56 (3.2)	NAA25 (2.8)	TOMM40 (2.6)	SARS (2.3)	ENSG00000235545 (2.2)	ZNF259 (2.2)	CLPTM1 (1.9)	OASL (1.8)	LPIN3 (1.6)
GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.51	> 0.20	NKPD1 (2.4)	ENSG00000235545 (2.2)	GEMIN7 (1.6)	PBX4 (1.5)	CEACAM19 (1.5)	MAU2 (1.4)	DNAH11 (1.4)	TRAPPC6A (1.4)	ZNF180 (1.3)	PARP10 (1.3)
GO:0009409	response to cold	0.51	> 0.20	DNAH11 (3.7)	ENSG00000228044 (2.7)	ENSG00000226648 (2.2)	ACAD10 (2.0)	NCAN (1.9)	PMFBP1 (1.8)	MAU2 (1.6)	OASL (1.6)	TRIB1 (1.5)	HAPLN4 (1.4)
GO:0001960	negative regulation of cytokine-mediated signaling pathway	0.51	> 0.20	ANKRD31 (3.5)	PBX4 (2.8)	CEACAM19 (2.6)	MOSC1 (2.1)	NKPD1 (1.8)	MAU2 (1.8)	TMEM116 (1.8)	ENSG00000238078 (1.8)	DYNC2LI1 (1.4)	TRAPPC6A (1.4)
GO:0072525	pyridine-containing compound biosynthetic process	0.51	> 0.20	LPIN3 (2.7)	PMFBP1 (2.6)	TM6SF2 (2.3)	ACAD10 (2.0)	TSSK6 (1.8)	TRAPPC6A (1.7)	SYPL2 (1.6)	TMEM116 (1.6)	NT5DC1 (1.6)	CYP7A1 (1.5)
GO:0019363	pyridine nucleotide biosynthetic process	0.51	> 0.20	LPIN3 (2.7)	PMFBP1 (2.6)	TM6SF2 (2.3)	ACAD10 (2.0)	TSSK6 (1.8)	TRAPPC6A (1.7)	SYPL2 (1.6)	TMEM116 (1.6)	NT5DC1 (1.6)	CYP7A1 (1.5)
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	0.51	> 0.20	RPH3A (3.0)	GRINA (2.4)	MARK4 (1.9)	FRK (1.7)	HNF1A (1.6)	POC5 (1.4)	C12orf51 (1.3)	HAPLN4 (1.3)	CEACAM19 (1.2)	C12orf43 (1.2)
GO:0006081	cellular aldehyde metabolic process	0.51	> 0.20	TRAPPC6A (3.5)	SLC22A1 (3.3)	ALDH2 (2.7)	CYP7A1 (2.5)	ANGPTL3 (2.2)	LPA (2.2)	C11orf9 (2.1)	ABCG8 (2.1)	APOA5 (1.9)	PLG (1.9)
GO:0014068	positive regulation of phosphatidylinositol 3-kinase cascade	0.51	> 0.20	ANKRD31 (2.3)	ENSG00000226645 (2.0)	NPC1L1 (2.0)	C17orf57 (1.8)	NKPD1 (1.4)	ENSG00000226648 (1.3)	GEMIN7 (1.2)	LPIN3 (1.1)	DOCK7 (1.1)	PBX4 (1.1)
ENSG00000133740	E2F5 PPI subnetwork	0.51	> 0.20	USP1 (3.3)	KANK2 (2.6)	FEN1 (2.5)	RHD (2.3)	C12orf51 (2.1)	RHCE (2.1)	PTPN11 (2.0)	TMEM50A (2.0)	PLCG1 (1.9)	ATXN2 (1.9)
MP:0008918	microgliosis	0.51	> 0.20	NCAN (3.2)	CYB561D1 (2.5)	ERP29 (2.4)	TMEM116 (2.3)	POLK (2.0)	SORT1 (1.9)	ATXN7L2 (1.9)	GCNT4 (1.8)	PCSK9 (1.8)	SLC44A2 (1.8)
ENSG00000162521	RBBP4 PPI subnetwork	0.51	> 0.20	USP1 (3.5)	BUD13 (3.0)	SMARCA4 (2.9)	GATAD2A (2.9)	ATXN2 (2.6)	PSRC1 (2.3)	DHX38 (2.2)	CARM1 (2.1)	MARK4 (1.8)	CELSR2 (1.7)
GO:0010822	positive regulation of mitochondrion organization	0.51	> 0.20	BRAP (3.1)	C19orf52 (2.3)	LPAR2 (2.0)	TRAFD1 (1.8)	C12orf43 (1.7)	TMEM116 (1.7)	CBLC (1.7)	POLK (1.7)	C12orf47 (1.6)	TXNL4B (1.6)
ENSG00000101856	PGRMC1 PPI subnetwork	0.51	> 0.20	TMEM50A (3.4)	ZNF101 (3.1)	ERP29 (2.4)	PSMA5 (2.1)	HNF1A (2.1)	BLOC1S3 (1.9)	TMED4 (1.9)	CYB561D1 (1.7)	ATP13A1 (1.6)	NPC1L1 (1.6)
REACTOME_ACTIVATION_OF_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ACTIVATION_OF_THE_PRE:REPLICATIVE_COMPLEX	0.51	> 0.20	FEN1 (6.7)	USP1 (5.1)	NT5DC1 (1.9)	ENSG00000228044 (1.9)	TMEM116 (1.7)	DHODH (1.7)	ENSG00000235545 (1.6)	AMIGO1 (1.4)	ZNF180 (1.3)	FADS1 (1.0)
GO:0009100	glycoprotein metabolic process	0.51	> 0.20	YIPF2 (4.1)	TMED4 (3.2)	ERP29 (3.2)	TMEM57 (3.0)	TMEM50A (2.8)	CILP2 (2.6)	ATP13A1 (2.3)	CLPTM1 (2.3)	ST3GAL4 (2.3)	SLC44A2 (2.2)
MP:0010792	abnormal stomach mucosa morphology	0.51	> 0.20	KIAA1324 (3.3)	SLC44A2 (2.3)	C11orf9 (2.2)	GCNT4 (1.9)	OASL (1.9)	ZNF101 (1.6)	AP1M2 (1.3)	DNAH11 (1.3)	HNF1A (1.3)	NPC1L1 (1.3)
ENSG00000135940	COX5B PPI subnetwork	0.51	> 0.20	TRAPPC6A (3.2)	GOT2P1 (3.2)	GRINA (2.2)	UBXN2B (1.9)	GMPR (1.8)	ACAD10 (1.8)	C19orf52 (1.8)	KANK2 (1.6)	OGDH (1.5)	KIAA1324 (1.5)
GO:0032024	positive regulation of insulin secretion	0.51	> 0.20	ANKRD31 (2.7)	KIAA1324 (2.5)	NPC1L1 (2.1)	ABCG8 (1.9)	ENSG00000254235 (1.9)	HNF1A (1.8)	COL4A3BP (1.8)	HAPLN4 (1.8)	GCNT4 (1.5)	NCAN (1.4)
MP:0002161	abnormal fertility/fecundity	0.51	> 0.20	GMPR (1.7)	NYNRIN (1.5)	ANKRD31 (1.4)	HLX (1.3)	MYLIP (1.3)	PLCG1 (1.2)	TIMD4 (1.2)	POC5 (1.2)	PPP1R37 (1.2)	POLK (1.2)
MP:0010878	increased trabecular bone volume	0.51	> 0.20	ITGB3 (3.7)	PARP10 (3.0)	RHD (2.5)	RHCE (2.4)	CEACAM19 (2.3)	GMIP (2.1)	GMPR (1.9)	MAFB (1.9)	TRAFD1 (1.6)	OASL (1.5)
ENSG00000178950	GAK PPI subnetwork	0.51	> 0.20	LPAR2 (2.6)	COL4A3BP (2.4)	PMFBP1 (2.2)	ILF3 (2.0)	YIPF2 (2.0)	GMIP (1.8)	DHX38 (1.7)	GRINA (1.7)	NYNRIN (1.7)	ZNF101 (1.6)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	0.51	> 0.20	GEMIN7 (3.7)	C12orf43 (3.1)	DDX56 (2.8)	ZNF259 (2.6)	ENSG00000226645 (2.2)	MAPKAPK5 (1.9)	POC5 (1.8)	BUD13 (1.7)	TOMM40 (1.7)	C19orf52 (1.6)
MP:0008658	decreased interleukin-1 beta secretion	0.51	> 0.20	OASL (5.4)	MAFB (3.4)	PARP10 (2.8)	BCL3 (2.8)	TRIB1 (1.6)	RELB (1.5)	GMIP (1.3)	TRAFD1 (1.2)	NKPD1 (1.2)	TIMD4 (1.1)
ENSG00000006638	TBXA2R PPI subnetwork	0.51	> 0.20	C17orf57 (2.9)	ITGB3 (2.9)	GATAD2A (2.1)	SH2B3 (2.0)	PMFBP1 (1.8)	CETP (1.8)	TMEM50A (1.7)	LDLR (1.6)	ST3GAL4 (1.6)	BLOC1S3 (1.6)
GO:0060038	cardiac muscle cell proliferation	0.51	> 0.20	CEACAM19 (2.8)	BLOC1S3 (2.4)	C19orf52 (2.2)	PLEKHH2 (2.0)	TXNL4B (1.4)	NYNRIN (1.4)	ALDH2 (1.3)	C11orf9 (1.3)	ZNF180 (1.3)	LPA (1.3)
GO:0004221	ubiquitin thiolesterase activity	0.51	> 0.20	USP24 (4.5)	ZNF180 (2.9)	BRAP (2.8)	NAA25 (2.8)	TMEM57 (2.7)	OASL (2.6)	MAU2 (2.1)	PTPN11 (1.9)	TRAFD1 (1.6)	CARM1 (1.6)
MP:0001596	hypotension	0.51	> 0.20	ZHX3 (2.8)	TM6SF2 (2.6)	ABO (2.4)	NPC1L1 (2.3)	PLEKHH2 (1.7)	CBLC (1.7)	PVR (1.6)	APOB (1.5)	HNF1A (1.4)	KANK2 (1.3)
GO:0045321	leukocyte activation	0.51	> 0.20	ZNF101 (4.0)	TIMD4 (2.5)	PLCG1 (2.2)	GMIP (2.2)	CYB561D1 (1.9)	POLK (1.9)	PBX4 (1.8)	CETP (1.8)	MAFB (1.6)	SH2B3 (1.6)
ENSG00000146733	PSPH PPI subnetwork	0.51	> 0.20	TRAPPC6A (4.8)	QTRT1 (2.4)	GATAD2A (2.0)	NT5DC1 (2.0)	YIPF2 (1.6)	BLOC1S3 (1.6)	LPAR2 (1.5)	TRAFD1 (1.4)	SUGP1 (1.3)	TMEM50A (1.3)
ENSG00000166908	PIP4K2C PPI subnetwork	0.51	> 0.20	MARK4 (3.6)	ATXN2 (3.2)	PVRL2 (3.1)	C12orf51 (2.9)	USP24 (2.0)	GMIP (1.9)	SORT1 (1.9)	GATAD2A (1.8)	POLK (1.7)	ENSG00000226648 (1.7)
MP:0011100	complete preweaning lethality	0.51	> 0.20	PTPN11 (2.4)	C11orf9 (2.3)	CETP (2.1)	ATP13A1 (2.1)	CLPTM1 (2.1)	UBXN2B (1.9)	RHD (1.8)	SLC44A2 (1.8)	ILF3 (1.8)	TMEM50A (1.8)
GO:0051279	regulation of release of sequestered calcium ion into cytosol	0.51	> 0.20	ABO (2.1)	TRAPPC6A (2.0)	SYPL2 (1.7)	ENSG00000254235 (1.7)	GEMIN7 (1.6)	GCNT4 (1.5)	ZNF180 (1.4)	GMPR (1.4)	C17orf57 (1.4)	TSSK6 (1.3)
MP:0000260	abnormal angiogenesis	0.51	> 0.20	HLX (3.2)	KANK2 (2.8)	PLEC (2.7)	PVRL2 (2.3)	GATAD2A (2.3)	SH2B3 (2.2)	NYNRIN (1.8)	PLCG1 (1.8)	BCAM (1.7)	MAFB (1.6)
ENSG00000112592	TBP PPI subnetwork	0.51	> 0.20	BUD13 (3.0)	ATXN2 (2.7)	SUGP1 (2.3)	MAPKAPK5 (2.2)	TOP1 (2.1)	DHX38 (1.9)	DDX56 (1.7)	ILF3 (1.7)	POC5 (1.7)	TOMM40 (1.7)
ENSG00000137403	HLA-F PPI subnetwork	0.51	> 0.20	PARP10 (2.9)	ENSG00000228044 (2.0)	OASL (1.8)	TMED4 (1.7)	DHODH (1.7)	YIPF2 (1.6)	ERP29 (1.6)	MARK4 (1.4)	HNF1A (1.2)	TMEM50A (1.2)
GO:0000723	telomere maintenance	0.51	> 0.20	POLK (3.2)	ZNF180 (2.6)	ENSG00000226648 (2.4)	USP1 (2.3)	TXNL4B (2.1)	POC5 (2.1)	AMIGO1 (1.9)	BLOC1S3 (1.9)	NKPD1 (1.8)	FEN1 (1.7)
GO:0009101	glycoprotein biosynthetic process	0.51	> 0.20	YIPF2 (4.0)	TMED4 (3.3)	ERP29 (3.1)	TMEM57 (3.0)	ST3GAL4 (2.5)	ATP13A1 (2.4)	TMEM50A (2.3)	CYB561D1 (2.3)	CLPTM1 (2.1)	ABO (2.0)
ENSG00000128692	ENSG00000128692 PPI subnetwork	0.51	> 0.20	DDX56 (4.7)	QTRT1 (3.7)	TOMM40 (3.1)	NAA25 (3.0)	SARS (2.7)	SUGP1 (2.7)	ZNF259 (2.6)	DHX38 (2.5)	TXNL4B (2.4)	PTPN11 (2.3)
MP:0003644	thymus atrophy	0.51	> 0.20	RELB (5.0)	BCL3 (3.4)	GRINA (2.2)	PBX4 (2.1)	GEMIN7 (1.8)	SYPL2 (1.7)	CETP (1.6)	HAPLN4 (1.6)	ABO (1.6)	C12orf47 (1.4)
ENSG00000117713	ARID1A PPI subnetwork	0.51	> 0.20	SMARCA4 (3.5)	CARM1 (3.1)	GMIP (2.9)	RHCE (2.7)	RHD (2.7)	MAU2 (2.4)	ILF3 (2.3)	BCL3 (2.2)	HAPLN4 (2.1)	DHX38 (1.9)
MP:0004597	increased susceptibility to noise-induced hearing loss	0.51	> 0.20	RPH3A (3.0)	RELB (3.0)	CYP7A1 (2.4)	NCAN (2.1)	APOE (1.9)	SLC22A1 (1.9)	APOC1 (1.6)	HAPLN4 (1.6)	APOC4 (1.5)	LPAR2 (1.5)
ENSG00000134046	MBD2 PPI subnetwork	0.51	> 0.20	SMARCA4 (5.0)	BUD13 (3.6)	ILF3 (3.2)	PLCG1 (2.8)	KANK2 (2.7)	USP1 (2.5)	TOP1 (2.5)	DNM2 (2.5)	FRK (1.8)	ATXN2 (1.8)
GO:0048511	rhythmic process	0.51	> 0.20	ABO (3.1)	CEACAM19 (2.2)	ENSG00000226648 (2.1)	ENSG00000235545 (1.9)	GPAM (1.8)	HNF1A (1.7)	TRIB1 (1.7)	KIAA1324 (1.6)	DNAH11 (1.5)	ENSG00000228044 (1.4)
GO:0032768	regulation of monooxygenase activity	0.51	> 0.20	ENSG00000235545 (2.7)	TXNL4B (2.1)	ENSG00000228044 (2.0)	ZNF101 (1.9)	ATXN7L2 (1.9)	ENSG00000226645 (1.7)	FRK (1.7)	TMEM50A (1.7)	TMEM116 (1.7)	COL4A3BP (1.4)
ENSG00000166477	LEO1 PPI subnetwork	0.51	> 0.20	SMARCA4 (3.5)	SUGP1 (3.3)	ILF3 (3.0)	C19orf52 (2.6)	BUD13 (2.5)	DHX38 (2.5)	PTPN11 (2.3)	TOMM40 (2.3)	COL4A3BP (2.3)	BRAP (2.2)
MP:0001680	abnormal mesoderm development	0.51	> 0.20	PVRL2 (2.6)	NYNRIN (2.1)	APOB (2.0)	LDLR (1.9)	APOE (1.9)	ITGB3 (1.5)	PLCG1 (1.5)	MARK4 (1.4)	PVR (1.4)	DOCK7 (1.2)
REACTOME_SIGNAL_ATTENUATION	REACTOME_SIGNAL_ATTENUATION	0.51	> 0.20	PBX4 (2.8)	MARK4 (2.7)	ATXN2 (2.5)	PLEKHH2 (2.4)	PVRL2 (2.3)	KANK2 (2.1)	ABO (2.0)	LDLR (1.9)	C11orf9 (1.6)	ENSG00000238078 (1.5)
ENSG00000120438	TCP1 PPI subnetwork	0.51	> 0.20	NAA25 (3.2)	PSMA5 (2.9)	DDX56 (2.6)	SARS (2.0)	ZNF180 (1.9)	POLK (1.9)	TOMM40 (1.9)	POC5 (1.6)	ZNF101 (1.6)	OGDH (1.4)
ENSG00000168028	RPSA PPI subnetwork	0.51	> 0.20	NAA25 (4.1)	SARS (3.3)	DDX56 (3.2)	QTRT1 (2.5)	ZNF259 (2.4)	TOMM40 (2.3)	DHX38 (1.8)	C12orf43 (1.7)	SUGP1 (1.6)	PSMA5 (1.6)
ENSG00000196367	TRRAP PPI subnetwork	0.51	> 0.20	SMARCA4 (2.9)	BUD13 (2.3)	USP1 (2.2)	ATXN2 (1.9)	SUGP1 (1.9)	GMPR (1.8)	ILF3 (1.8)	POC5 (1.8)	DHX38 (1.7)	ZNF180 (1.7)
ENSG00000145782	ATG12 PPI subnetwork	0.51	> 0.20	ANKRD31 (2.6)	DDX56 (2.5)	GATAD2A (2.5)	USP1 (1.8)	C19orf52 (1.8)	DHX38 (1.7)	TOP1 (1.6)	SMARCA4 (1.6)	NKPD1 (1.5)	SUGP1 (1.5)
ENSG00000076641	PAG1 PPI subnetwork	0.51	> 0.20	GMIP (3.4)	SH2B3 (3.2)	ENSG00000226645 (2.1)	COL4A3BP (1.7)	CETP (1.7)	LPA (1.5)	ZHX3 (1.5)	SLC44A2 (1.5)	ABO (1.4)	ZNF101 (1.4)
GO:0007040	lysosome organization	0.51	> 0.20	ERP29 (4.4)	LPAR2 (3.0)	NKPD1 (2.5)	ENSG00000228044 (2.5)	YIPF2 (2.4)	ATP13A1 (2.3)	TMED4 (2.0)	TRAPPC6A (1.9)	QTRT1 (1.8)	ENSG00000238078 (1.8)
GO:0033189	response to vitamin A	0.51	> 0.20	ENSG00000235545 (2.2)	TSSK6 (1.9)	AP1M2 (1.8)	NPC1L1 (1.7)	TM6SF2 (1.6)	LPAR2 (1.6)	C11orf9 (1.6)	HAPLN4 (1.6)	ATXN7L2 (1.5)	MOSC1 (1.4)
ENSG00000135069	PSAT1 PPI subnetwork	0.51	> 0.20	PSMA5 (2.8)	SARS (2.6)	SMARCA4 (2.2)	ALDH2 (2.2)	COL4A3BP (2.1)	PTPN11 (2.0)	ERP29 (1.8)	PVR (1.8)	OGDH (1.7)	PLEKHH2 (1.6)
ENSG00000126457	PRMT1 PPI subnetwork	0.51	> 0.20	QTRT1 (4.1)	GATAD2A (2.8)	SMARCA4 (2.8)	ILF3 (2.2)	TOMM40 (1.9)	TRIB1 (1.7)	GEMIN7 (1.6)	C19orf52 (1.6)	PTPN11 (1.6)	HAVCR1 (1.3)
GO:0050707	regulation of cytokine secretion	0.51	> 0.20	ZNF101 (1.9)	ENSG00000228044 (1.9)	DNAH11 (1.7)	HAVCR1 (1.7)	HLX (1.6)	MOSC1 (1.2)	CYP7A1 (1.2)	NKPD1 (1.2)	ZNF180 (1.2)	ST3GAL4 (1.1)
ENSG00000078403	MLLT10 PPI subnetwork	0.51	> 0.20	MAU2 (3.2)	MAPKAPK5 (2.4)	DOCK7 (2.4)	PTPN11 (2.4)	LDLR (2.3)	C12orf43 (1.8)	BRAP (1.6)	DYNC2LI1 (1.6)	FADS2 (1.6)	ACAD10 (1.5)
MP:0005272	abnormal temporal bone morphology	0.51	> 0.20	MYLIP (2.2)	CEACAM19 (1.9)	MAFB (1.7)	ENSG00000254235 (1.6)	ST3GAL4 (1.4)	TMEM57 (1.4)	PLEC (1.4)	GPAM (1.3)	C19orf52 (1.2)	TMEM116 (1.2)
ENSG00000042429	MED17 PPI subnetwork	0.51	> 0.20	GEMIN7 (2.9)	BRAP (2.7)	C12orf51 (2.4)	BUD13 (2.3)	CARM1 (2.2)	MAU2 (2.1)	BLOC1S3 (1.9)	DHX38 (1.8)	ATXN2 (1.7)	C17orf57 (1.7)
GO:0014075	response to amine stimulus	0.51	> 0.20	C17orf57 (3.7)	C12orf51 (2.3)	SARS (1.8)	ABCG5 (1.7)	COL4A3BP (1.6)	NPC1L1 (1.5)	C11orf9 (1.5)	TSSK6 (1.4)	ABCG8 (1.4)	DNAH11 (1.3)
MP:0005269	abnormal occipital bone morphology	0.51	> 0.20	NYNRIN (2.9)	CILP2 (2.9)	ALDH2 (2.5)	C19orf52 (2.3)	PLEKHH2 (2.0)	NCAN (1.6)	PLCG1 (1.6)	CEACAM19 (1.6)	TMEM57 (1.5)	MAFB (1.5)
GO:0006354	transcription elongation, DNA-dependent	0.51	> 0.20	TXNL4B (2.9)	MAPKAPK5 (2.9)	ATXN7L2 (2.7)	ZNF259 (2.6)	BUD13 (2.5)	C12orf43 (2.1)	SUGP1 (2.0)	GEMIN7 (1.9)	DHX38 (1.8)	C19orf52 (1.8)
ENSG00000105655	ISYNA1 PPI subnetwork	0.52	> 0.20	PSMA5 (3.0)	TMEM50A (2.6)	SARS (2.4)	QTRT1 (2.2)	NYNRIN (2.0)	TSSK6 (1.8)	SUGP1 (1.7)	ENSG00000235545 (1.7)	ATP13A1 (1.4)	OGDH (1.4)
GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072422	signal transduction involved in DNA damage checkpoint	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072401	signal transduction involved in DNA integrity checkpoint	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072431	signal transduction involved in mitotic cell cycle G1/S transition DNA damage checkpoint	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072474	signal transduction involved in mitotic cell cycle G1/S checkpoint	0.52	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0007173	epidermal growth factor receptor signaling pathway	0.52	> 0.20	PPP1R37 (3.1)	ABO (2.3)	DOCK7 (2.3)	COL4A3BP (2.2)	C17orf57 (2.0)	MARK4 (2.0)	DNM2 (1.9)	PVRL2 (1.9)	ATXN2 (1.8)	ENSG00000235545 (1.8)
ENSG00000108424	KPNB1 PPI subnetwork	0.52	> 0.20	NAA25 (3.1)	DDX56 (3.1)	ILF3 (3.0)	TOP1 (2.7)	USP1 (2.5)	DOCK7 (2.5)	ATXN2 (2.2)	USP24 (2.2)	TOMM40 (2.1)	SARS (2.1)
ENSG00000166794	PPIB PPI subnetwork	0.52	> 0.20	CLPTM1 (3.9)	GRINA (3.3)	ERP29 (3.1)	RPH3A (3.1)	ATP13A1 (2.7)	YIPF2 (2.6)	CELSR2 (2.4)	PCSK9 (2.2)	TMED4 (2.1)	ZNF101 (2.0)
ENSG00000162227	TAF6L PPI subnetwork	0.52	> 0.20	ATXN2 (3.4)	ATXN7L2 (2.7)	MAPKAPK5 (2.3)	TOP1 (2.2)	C12orf51 (2.2)	ZHX3 (1.9)	C17orf57 (1.8)	GEMIN7 (1.8)	TXNL4B (1.7)	BUD13 (1.7)
GO:0050999	regulation of nitric-oxide synthase activity	0.52	> 0.20	FRK (2.5)	ZNF180 (2.2)	CYB561D1 (2.1)	ENSG00000226645 (2.1)	PPP1R37 (2.0)	ATXN7L2 (2.0)	TXNL4B (1.8)	ENSG00000235545 (1.7)	AMIGO1 (1.7)	C17orf57 (1.6)
GO:0006369	termination of RNA polymerase II transcription	0.52	> 0.20	C1orf63 (5.5)	ENSG00000226645 (3.7)	ADAM1 (2.6)	TOP1 (2.4)	BUD13 (2.4)	ILF3 (2.1)	C12orf47 (2.1)	TXNL4B (2.0)	ENSG00000226648 (2.0)	ENSG00000235545 (1.8)
MP:0000242	impaired fertilization	0.52	> 0.20	PMFBP1 (4.1)	TSSK6 (2.7)	BCAM (2.0)	HP (1.7)	NPC1L1 (1.6)	ENSG00000228044 (1.6)	GRINA (1.5)	BCL3 (1.5)	FADS2 (1.5)	PBX4 (1.4)
GO:0003899	DNA-directed RNA polymerase activity	0.52	> 0.20	GEMIN7 (4.7)	ZNF259 (3.4)	DDX56 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)	QTRT1 (2.4)	C12orf43 (2.2)	TXNL4B (2.2)	TOMM40 (1.8)	C12orf47 (1.5)
GO:0034062	RNA polymerase activity	0.52	> 0.20	GEMIN7 (4.7)	ZNF259 (3.4)	DDX56 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)	QTRT1 (2.4)	C12orf43 (2.2)	TXNL4B (2.2)	TOMM40 (1.8)	C12orf47 (1.5)
MP:0002059	abnormal seminal vesicle morphology	0.52	> 0.20	MAFB (1.9)	NYNRIN (1.8)	BRAP (1.8)	MYLIP (1.6)	ALDH2 (1.6)	PCSK9 (1.6)	CELSR2 (1.5)	GMPR (1.3)	ATXN7L2 (1.2)	COL4A3BP (0.9)
ENSG00000177688	SUMO4 PPI subnetwork	0.52	> 0.20	TOMM40 (2.4)	PSMA5 (2.3)	SARS (2.3)	OGDH (2.1)	CLPTM1 (1.8)	ERP29 (1.7)	PARP10 (1.7)	ADAM1 (1.6)	FEN1 (1.6)	NAA25 (1.5)
ENSG00000109472	CPE PPI subnetwork	0.52	> 0.20	ERP29 (3.2)	TMED4 (2.6)	NCAN (2.2)	CELSR2 (2.2)	HAPLN4 (2.1)	PCSK9 (2.0)	CLPTM1 (2.0)	BCAM (1.9)	TIMD4 (1.8)	YIPF2 (1.7)
ENSG00000095794	CREM PPI subnetwork	0.52	> 0.20	ATXN2 (3.6)	CARM1 (3.1)	HLX (2.9)	BCL3 (2.7)	MARK4 (2.4)	TXNL4B (2.2)	ZHX3 (2.0)	ABO (1.7)	MAPKAPK5 (1.7)	PVRL2 (1.6)
MP:0002762	ectopic cerebellar granule cells	0.52	> 0.20	NCAN (2.2)	DOCK7 (2.1)	PVR (1.6)	AMIGO1 (1.5)	MAFB (1.5)	CEACAM19 (1.4)	TMED4 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ALDH2 (1.2)
GO:0046879	hormone secretion	0.52	> 0.20	KIAA1324 (5.0)	ANKRD31 (2.6)	ABO (2.4)	HNF1A (2.2)	MOSC1 (2.0)	ENSG00000228044 (1.8)	GPAM (1.7)	AMIGO1 (1.7)	COL4A3BP (1.7)	AP1M2 (1.6)
ENSG00000107201	DDX58 PPI subnetwork	0.52	> 0.20	OASL (2.6)	GPAM (2.4)	FADS1 (2.3)	PARP10 (2.2)	FADS2 (2.1)	C17orf57 (1.9)	ATXN2 (1.8)	MOSC1 (1.6)	ENSG00000235545 (1.5)	NAA25 (1.4)
MP:0005449	abnormal food intake	0.52	> 0.20	CETP (4.2)	TIMD4 (3.0)	GPAM (2.7)	PMFBP1 (2.0)	C12orf47 (2.0)	TSSK6 (1.9)	MOSC1 (1.7)	COL4A3BP (1.5)	MAFB (1.4)	SYPL2 (1.4)
ENSG00000108823	SGCA PPI subnetwork	0.52	> 0.20	SYPL2 (3.5)	KANK2 (3.0)	ST3GAL4 (2.6)	SLC44A2 (2.3)	NPC1L1 (2.1)	TMED4 (2.0)	CBLC (1.6)	FRK (1.6)	GPAM (1.5)	GMPR (1.5)
ENSG00000138413	IDH1 PPI subnetwork	0.52	> 0.20	PSMA5 (2.2)	TM6SF2 (2.1)	ABCG5 (1.9)	C17orf57 (1.8)	NAA25 (1.7)	HAPLN4 (1.6)	TOMM40 (1.5)	CEACAM19 (1.5)	NYNRIN (1.4)	TOP1 (1.4)
ENSG00000178585	CTNNBIP1 PPI subnetwork	0.52	> 0.20	TMED4 (2.7)	ERP29 (2.5)	MAFB (2.4)	LPIN3 (2.3)	ACAD10 (1.9)	DYNC2LI1 (1.7)	COL4A3BP (1.7)	NYNRIN (1.7)	BCAM (1.6)	PSMA5 (1.6)
ENSG00000061273	HDAC7 PPI subnetwork	0.52	> 0.20	DNM2 (4.0)	CARM1 (3.4)	ZHX3 (3.0)	PLEC (2.9)	USP24 (2.4)	OGDH (2.2)	AP1M2 (1.9)	UBXN2B (1.9)	MARK4 (1.8)	GMIP (1.8)
MP:0001663	abnormal digestive system physiology	0.52	> 0.20	KIAA1324 (5.6)	MOSC1 (1.8)	CBLC (1.7)	DOCK7 (1.6)	PMFBP1 (1.5)	HLX (1.5)	SORT1 (1.4)	HNF1A (1.4)	ABO (1.3)	PPP1R37 (1.2)
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	0.52	> 0.20	RELB (3.6)	GATAD2A (3.0)	GMIP (2.8)	SLC44A2 (2.7)	DNM2 (2.5)	MARK4 (2.4)	PTPN11 (2.1)	BCL3 (2.0)	ZHX3 (2.0)	GRINA (1.8)
REACTOME_CD28_DEPENDENT_PI3KAKT_SIGNALING	REACTOME_CD28_DEPENDENT_PI3KAKT_SIGNALING	0.52	> 0.20	OGDH (2.2)	ZHX3 (2.0)	TMEM57 (1.9)	USP24 (1.8)	POC5 (1.7)	UBXN2B (1.6)	SARS (1.6)	MYLIP (1.6)	MAFB (1.5)	POLK (1.5)
REACTOME_DNA_REPAIR	REACTOME_DNA_REPAIR	0.52	> 0.20	FEN1 (4.6)	USP1 (3.6)	POC5 (2.9)	ZNF180 (2.2)	POLK (2.2)	BUD13 (2.1)	NT5DC1 (1.8)	PSRC1 (1.7)	DHODH (1.6)	SUGP1 (1.6)
ENSG00000198742	SMURF1 PPI subnetwork	0.52	> 0.20	GATAD2A (2.1)	ENSG00000226645 (1.9)	TMEM57 (1.8)	KANK2 (1.8)	C19orf52 (1.7)	FRK (1.6)	ITGB3 (1.6)	ZNF180 (1.6)	ENSG00000226648 (1.4)	ATXN7L2 (1.3)
ENSG00000172466	ZNF24 PPI subnetwork	0.52	> 0.20	ZNF180 (2.9)	POC5 (2.2)	FADS2 (2.2)	TRAPPC6A (2.0)	GEMIN7 (1.9)	SLC44A2 (1.8)	ATXN7L2 (1.7)	QTRT1 (1.7)	FADS1 (1.6)	PBX4 (1.5)
ENSG00000117906	RCN2 PPI subnetwork	0.52	> 0.20	ERP29 (3.5)	RPH3A (3.0)	NCAN (2.1)	AMIGO1 (2.0)	GRINA (1.9)	YIPF2 (1.9)	ENSG00000226645 (1.8)	MYLIP (1.8)	TMED4 (1.8)	BCAM (1.8)
MP:0003339	decreased pancreatic beta cell number	0.52	> 0.20	KIAA1324 (3.6)	HAPLN4 (2.2)	MOSC1 (2.1)	C11orf9 (2.0)	NPC1L1 (2.0)	PCSK9 (1.8)	SORT1 (1.5)	AMIGO1 (1.5)	DNAH11 (1.4)	FRK (1.4)
MP:0010301	increased stomach tumor incidence	0.52	> 0.20	COL4A3BP (2.2)	BLOC1S3 (2.0)	PLCG1 (1.9)	TM6SF2 (1.9)	PLEC (1.9)	POLK (1.8)	ENSG00000226648 (1.7)	KANK2 (1.5)	TMED4 (1.5)	SH2B3 (1.5)
ENSG00000100129	EIF3L PPI subnetwork	0.52	> 0.20	NKPD1 (2.0)	C1orf63 (1.9)	QTRT1 (1.8)	GEMIN7 (1.7)	ILF3 (1.6)	C19orf52 (1.6)	NAA25 (1.6)	DHX38 (1.6)	ATP13A1 (1.5)	SH2B3 (1.5)
ENSG00000132002	DNAJB1 PPI subnetwork	0.52	> 0.20	TRIB1 (2.6)	PLEC (2.3)	TOP1 (1.9)	ATP13A1 (1.9)	GATAD2A (1.8)	GOT2P1 (1.7)	POLK (1.5)	SARS (1.4)	TXNL4B (1.4)	PBX4 (1.3)
ENSG00000189283	FHIT PPI subnetwork	0.52	> 0.20	TRAPPC6A (2.9)	ABO (2.7)	PLCG1 (1.9)	APOC1 (1.8)	ZNF101 (1.8)	ADAM1 (1.7)	NKPD1 (1.7)	ACAD10 (1.7)	LPAR2 (1.7)	GOT2P1 (1.6)
ENSG00000197785	ATAD3A PPI subnetwork	0.52	> 0.20	TRAFD1 (3.4)	FRK (2.4)	TXNL4B (2.3)	ITGB3 (2.1)	NPC1L1 (1.9)	PLEC (1.9)	BRAP (1.8)	C19orf52 (1.7)	NT5DC1 (1.7)	ANKRD31 (1.6)
GO:0045807	positive regulation of endocytosis	0.52	> 0.20	CILP2 (2.3)	ZNF101 (1.9)	ENSG00000238078 (1.7)	PMFBP1 (1.7)	GOT2P1 (1.6)	TMEM116 (1.5)	TMED4 (1.5)	CEACAM19 (1.5)	HP (1.5)	RPH3A (1.4)
GO:0048008	platelet-derived growth factor receptor signaling pathway	0.52	> 0.20	ABO (2.6)	GCNT4 (2.5)	FRK (2.4)	ENSG00000226645 (2.3)	DOCK7 (2.2)	C11orf9 (2.1)	C17orf57 (2.0)	DNAH11 (1.7)	KANK2 (1.4)	TSSK6 (1.4)
MP:0004810	decreased hematopoietic stem cell number	0.52	> 0.20	KANK2 (2.8)	PTPN11 (1.9)	GMIP (1.9)	ATXN2 (1.9)	ENSG00000226645 (1.8)	CEACAM19 (1.7)	BCL3 (1.6)	PLCG1 (1.6)	HLX (1.6)	CETP (1.6)
ENSG00000138376	BARD1 PPI subnetwork	0.52	> 0.20	FEN1 (3.7)	RELB (2.8)	USP1 (2.4)	ILF3 (2.2)	CLPTM1 (2.1)	SMARCA4 (2.1)	BUD13 (2.0)	ATXN2 (1.9)	ZNF180 (1.9)	ENSG00000228044 (1.7)
ENSG00000121486	TRMT1L PPI subnetwork	0.52	> 0.20	ATP13A1 (3.2)	OGDH (2.8)	SARS (2.5)	SMARCA4 (2.5)	ILF3 (2.4)	FEN1 (2.3)	NAA25 (2.1)	QTRT1 (2.0)	PSMA5 (1.9)	YIPF2 (1.8)
ENSG00000161202	DVL3 PPI subnetwork	0.52	> 0.20	CARM1 (3.3)	LPAR2 (2.8)	MARK4 (2.8)	PLCG1 (2.5)	CELSR2 (2.5)	ABO (2.3)	ENSG00000254235 (2.0)	PPP1R37 (2.0)	ATXN2 (1.7)	MAPKAPK5 (1.6)
MP:0001625	cardiac hypertrophy	0.52	> 0.20	SYPL2 (4.4)	RHD (2.6)	GMPR (2.6)	NYNRIN (2.5)	RHCE (2.1)	BCAM (1.7)	ACAD10 (1.7)	HP (1.6)	CBLC (1.5)	AP1M2 (1.5)
ENSG00000011465	DCN PPI subnetwork	0.52	> 0.20	APOE (2.7)	BCAM (2.1)	CILP2 (2.1)	AP1M2 (2.0)	HP (1.8)	PLEKHH2 (1.7)	APOC1 (1.6)	APOB (1.4)	ABCG5 (1.4)	APOA5 (1.3)
ENSG00000131238	PPT1 PPI subnetwork	0.52	> 0.20	ATP13A1 (3.2)	ILF3 (3.1)	YIPF2 (3.0)	DNM2 (2.6)	QTRT1 (2.6)	OGDH (2.6)	ACAD10 (2.2)	SARS (2.1)	DHX38 (2.0)	SMARCA4 (1.7)
GO:0034644	cellular response to UV	0.52	> 0.20	GEMIN7 (2.5)	HAVCR1 (2.2)	DNAH11 (2.2)	BLOC1S3 (2.2)	CBLC (2.1)	MAU2 (2.1)	PPP1R37 (2.0)	GATAD2A (1.9)	GOT2P1 (1.8)	TRAPPC6A (1.7)
ENSG00000198730	CTR9 PPI subnetwork	0.52	> 0.20	SUGP1 (2.6)	TOP1 (2.6)	ILF3 (2.4)	TOMM40 (2.1)	DDX56 (2.1)	BRAP (1.8)	PTPN11 (1.8)	TMEM57 (1.8)	ZNF259 (1.7)	SMARCA4 (1.6)
MP:0000296	absent trabeculae carneae	0.52	> 0.20	TSSK6 (2.5)	ABCG8 (2.0)	BCAM (2.0)	ENSG00000226648 (1.9)	SLC44A2 (1.8)	ATXN7L2 (1.7)	APOE (1.6)	PVR (1.6)	TMEM50A (1.5)	ANKRD31 (1.4)
ENSG00000146425	DYNLT1 PPI subnetwork	0.52	> 0.20	GOT2P1 (2.9)	CYP7A1 (2.5)	DOCK7 (2.4)	TSSK6 (2.4)	NPC1L1 (1.9)	CARM1 (1.8)	MOSC1 (1.7)	ENSG00000238078 (1.7)	LPIN3 (1.7)	PSRC1 (1.7)
ENSG00000145147	SLIT2 PPI subnetwork	0.52	> 0.20	CETP (4.7)	TIMD4 (3.9)	OASL (2.6)	TMEM116 (2.1)	DNAH11 (2.1)	ATP13A1 (2.0)	PLEKHH2 (1.8)	YIPF2 (1.7)	ACAD10 (1.7)	PVRL2 (1.6)
ENSG00000141736	ERBB2 PPI subnetwork	0.52	> 0.20	ITGB3 (3.0)	GMIP (2.3)	DNM2 (2.2)	PARP10 (2.2)	DOCK7 (2.0)	COL4A3BP (1.9)	PLEC (1.7)	PPP1R37 (1.7)	C17orf57 (1.5)	SLC44A2 (1.5)
ENSG00000010030	ETV7 PPI subnetwork	0.52	> 0.20	TOP1 (3.3)	TRIB1 (2.9)	PLEC (2.2)	ATXN2 (2.2)	ZHX3 (2.2)	PSRC1 (2.1)	TSSK6 (2.0)	ANKRD31 (1.8)	C17orf57 (1.7)	RHCE (1.6)
MP:0010124	decreased bone mineral content	0.52	> 0.20	MAFB (3.1)	KANK2 (2.7)	AP1M2 (2.7)	BCAM (2.5)	TRIB1 (2.5)	CILP2 (2.4)	CETP (2.0)	TIMD4 (1.7)	CBLC (1.7)	CELSR2 (1.7)
MP:0004158	right aortic arch	0.52	> 0.20	ANKRD31 (3.2)	PVRL2 (2.9)	CEACAM19 (2.7)	TRIB1 (2.6)	PLCG1 (2.0)	PVR (2.0)	BCAM (2.0)	HLX (1.8)	TRAPPC6A (1.8)	DOCK7 (1.7)
GO:0003229	ventricular cardiac muscle tissue development	0.52	> 0.20	ENSG00000254235 (2.5)	ENSG00000238078 (2.5)	CEACAM19 (2.1)	TSSK6 (2.1)	CILP2 (2.0)	ACAD10 (1.7)	GMPR (1.7)	NKPD1 (1.5)	TRAPPC6A (1.4)	BLOC1S3 (1.3)
MP:0001302	eyelids open at birth	0.52	> 0.20	MYLIP (3.4)	TRIB1 (2.5)	NYNRIN (2.0)	PLCG1 (1.9)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)	MARK4 (1.4)	ENSG00000235545 (1.4)	PPP1R37 (1.2)
GO:0019058	viral infectious cycle	0.52	> 0.20	NKPD1 (3.4)	OASL (2.3)	MAU2 (2.1)	GATAD2A (2.0)	MAPKAPK5 (2.0)	ANKRD31 (2.0)	ENSG00000226645 (1.8)	SUGP1 (1.7)	GEMIN7 (1.6)	ZNF101 (1.6)
GO:0005604	basement membrane	0.52	> 0.20	BCAM (4.8)	APOE (2.7)	PLEKHH2 (2.5)	CBLC (2.3)	CELSR2 (2.3)	AP1M2 (2.2)	PVR (2.2)	CILP2 (2.1)	PLEC (1.9)	KANK2 (1.9)
MP:0010144	abnormal tumor vascularization	0.52	> 0.20	BCL3 (3.0)	RELB (2.8)	GRINA (2.3)	TSSK6 (2.3)	ENSG00000235545 (2.0)	CBLC (1.9)	KANK2 (1.9)	PVR (1.5)	ATXN7L2 (1.4)	CELSR2 (1.3)
MP:0000432	abnormal head morphology	0.52	> 0.20	CILP2 (2.6)	AP1M2 (2.4)	DOCK7 (2.2)	MARK4 (2.2)	PLEKHH2 (2.1)	GATAD2A (1.7)	C17orf57 (1.6)	UBXN2B (1.6)	NCAN (1.6)	LPAR2 (1.5)
ENSG00000058600	POLR3E PPI subnetwork	0.52	> 0.20	C12orf43 (4.1)	GEMIN7 (2.9)	POC5 (2.8)	ATXN2 (2.5)	SUGP1 (2.5)	DDX56 (2.4)	MAPKAPK5 (2.3)	ADAM1 (2.2)	C19orf52 (2.2)	DHX38 (1.6)
ENSG00000128513	POT1 PPI subnetwork	0.52	> 0.20	TXNL4B (3.6)	NKPD1 (2.4)	POLK (2.2)	TSSK6 (2.2)	DHX38 (2.1)	KANK2 (2.1)	PBX4 (2.0)	SUGP1 (1.8)	NYNRIN (1.7)	C19orf52 (1.7)
ENSG00000106459	NRF1 PPI subnetwork	0.52	> 0.20	TRIB1 (3.3)	DOCK7 (2.4)	PVR (2.2)	ADAM1 (1.6)	OGDH (1.5)	CEACAM19 (1.5)	USP1 (1.5)	ZNF259 (1.4)	GMPR (1.4)	ILF3 (1.4)
ENSG00000175324	LSM1 PPI subnetwork	0.52	> 0.20	ZNF259 (3.1)	DHX38 (2.6)	BUD13 (2.3)	TRAFD1 (2.3)	SUGP1 (2.2)	GEMIN7 (2.2)	SARS (2.0)	TOP1 (1.8)	MAU2 (1.8)	PTPN11 (1.7)
KEGG_PYRIMIDINE_METABOLISM	KEGG_PYRIMIDINE_METABOLISM	0.52	> 0.20	FEN1 (3.0)	GEMIN7 (2.9)	DHODH (2.9)	DDX56 (2.4)	LPA (2.3)	USP1 (2.3)	TXNL4B (2.0)	QTRT1 (1.9)	PARP10 (1.7)	TOMM40 (1.7)
GO:0072524	pyridine-containing compound metabolic process	0.52	> 0.20	ACAD10 (3.0)	TRAPPC6A (3.0)	NT5DC1 (2.2)	OGDH (2.1)	DNAH11 (2.0)	LPIN3 (2.0)	FRK (1.9)	ALDH2 (1.9)	BLOC1S3 (1.9)	SYPL2 (1.8)
GO:0019362	pyridine nucleotide metabolic process	0.52	> 0.20	ACAD10 (3.0)	TRAPPC6A (3.0)	NT5DC1 (2.2)	OGDH (2.1)	DNAH11 (2.0)	LPIN3 (2.0)	FRK (1.9)	ALDH2 (1.9)	BLOC1S3 (1.9)	SYPL2 (1.8)
ENSG00000115616	SLC9A2 PPI subnetwork	0.52	> 0.20	RHD (3.2)	RHCE (2.6)	GMIP (2.4)	DNM2 (2.3)	COL4A3BP (2.3)	SLC44A2 (2.2)	FRK (2.2)	PLCG1 (2.0)	HMGCR (2.0)	HAVCR1 (1.9)
GO:0007179	transforming growth factor beta receptor signaling pathway	0.52	> 0.20	KANK2 (3.4)	ENSG00000226645 (2.8)	CEACAM19 (2.5)	NYNRIN (1.8)	TMED4 (1.8)	PVR (1.7)	GATAD2A (1.6)	CILP2 (1.4)	MAPKAPK5 (1.4)	AMIGO1 (1.3)
ENSG00000131196	NFATC1 PPI subnetwork	0.52	> 0.20	BCL3 (2.5)	TOP1 (2.1)	GRINA (2.0)	PLEC (2.0)	DNM2 (1.7)	CARM1 (1.6)	GMIP (1.5)	PCSK9 (1.5)	C1orf63 (1.4)	TRIB1 (1.4)
GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	0.52	> 0.20	BUD13 (2.6)	TXNL4B (2.5)	MAPKAPK5 (2.5)	GEMIN7 (2.4)	UBXN2B (2.3)	DHODH (2.0)	ADAM1 (1.9)	ST3GAL4 (1.8)	ENSG00000226645 (1.7)	MAU2 (1.7)
ENSG00000131263	RLIM PPI subnetwork	0.52	> 0.20	USP24 (3.9)	TMEM57 (2.6)	DHX38 (2.6)	CARM1 (2.5)	COL4A3BP (2.2)	MARK4 (1.7)	BRAP (1.7)	BUD13 (1.5)	ITGB3 (1.5)	PBX4 (1.4)
GO:0001046	core promoter sequence-specific DNA binding	0.52	> 0.20	CELSR2 (3.3)	TRAFD1 (2.8)	HAVCR1 (2.0)	PARP10 (1.7)	TRIB1 (1.7)	MYLIP (1.7)	NCAN (1.6)	TRAPPC6A (1.5)	SORT1 (1.5)	FRK (1.5)
GO:0018022	peptidyl-lysine methylation	0.52	> 0.20	ENSG00000228044 (3.4)	MAU2 (1.9)	TXNL4B (1.7)	C12orf51 (1.7)	C1orf63 (1.7)	ENSG00000238078 (1.5)	DNAH11 (1.5)	ATXN2 (1.4)	USP24 (1.4)	BUD13 (1.3)
GO:0006310	DNA recombination	0.52	> 0.20	POC5 (2.3)	MAPKAPK5 (2.1)	USP1 (2.0)	ZNF180 (2.0)	FEN1 (1.9)	ZNF101 (1.9)	BUD13 (1.8)	C17orf57 (1.7)	C12orf43 (1.6)	ANKRD31 (1.3)
GO:0005372	water transmembrane transporter activity	0.52	> 0.20	NCAN (3.2)	ENSG00000228044 (2.4)	ST3GAL4 (2.4)	HP (2.3)	RHD (2.1)	PLEC (2.1)	RHCE (1.9)	TSSK6 (1.8)	NYNRIN (1.7)	PLG (1.7)
ENSG00000117000	RLF PPI subnetwork	0.52	> 0.20	ATXN2 (2.4)	PCSK9 (2.3)	C19orf52 (2.2)	TXNL4B (1.9)	ENSG00000226648 (1.9)	NYNRIN (1.9)	KANK2 (1.9)	OGDH (1.9)	DNAH11 (1.7)	BRAP (1.6)
ENSG00000167986	DDB1 PPI subnetwork	0.52	> 0.20	BUD13 (3.0)	TXNL4B (2.4)	USP24 (2.3)	BLOC1S3 (2.2)	ILF3 (2.1)	SUGP1 (2.1)	USP1 (2.0)	BRAP (1.9)	TRAPPC6A (1.8)	ZNF180 (1.8)
GO:0046824	positive regulation of nucleocytoplasmic transport	0.52	> 0.20	ENSG00000238078 (2.7)	TMEM116 (2.6)	PLEKHH2 (2.4)	OASL (2.4)	AP1M2 (2.3)	GCNT4 (1.9)	SLC44A2 (1.8)	MYLIP (1.6)	KANK2 (1.6)	ENSG00000254235 (1.5)
ENSG00000177602	GSG2 PPI subnetwork	0.52	> 0.20	ATP13A1 (3.3)	OGDH (2.7)	SMARCA4 (2.5)	SARS (2.5)	ILF3 (2.5)	FEN1 (2.2)	NAA25 (2.1)	QTRT1 (2.0)	ATXN2 (1.9)	PSMA5 (1.8)
GO:0090200	positive regulation of release of cytochrome c from mitochondria	0.52	> 0.20	BRAP (2.9)	FRK (2.1)	CYB561D1 (2.1)	C19orf52 (2.0)	LPAR2 (1.9)	TMEM116 (1.9)	C12orf47 (1.9)	TXNL4B (1.9)	TRAFD1 (1.8)	C12orf43 (1.7)
GO:0001707	mesoderm formation	0.52	> 0.20	ENSG00000226648 (2.7)	ENSG00000238078 (2.7)	ENSG00000254235 (2.7)	NYNRIN (2.2)	GOT2P1 (2.0)	ATXN7L2 (1.7)	ABO (1.5)	CILP2 (1.5)	C19orf52 (1.5)	CARM1 (1.4)
MP:0002182	abnormal astrocyte morphology	0.52	> 0.20	FADS1 (2.9)	APOE (2.7)	HAVCR1 (2.2)	GRINA (1.9)	HAPLN4 (1.8)	RELB (1.8)	BCL3 (1.8)	PARP10 (1.8)	NCAN (1.5)	CELSR2 (1.5)
ENSG00000111199	TRPV4 PPI subnetwork	0.52	> 0.20	LPIN3 (2.9)	PPP1R37 (2.6)	ST3GAL4 (2.1)	PLEKHH2 (2.0)	SH2B3 (1.9)	MAPKAPK5 (1.8)	SLC44A2 (1.7)	NT5DC1 (1.7)	ABCG8 (1.6)	TMEM116 (1.6)
GO:0070207	protein homotrimerization	0.52	> 0.20	ENSG00000226648 (2.7)	C1orf63 (2.6)	CYP7A1 (2.4)	LPAR2 (2.3)	HP (2.0)	PBX4 (1.9)	ANKRD31 (1.8)	UBXN2B (1.7)	TM6SF2 (1.6)	C17orf57 (1.6)
GO:0014829	vascular smooth muscle contraction	0.52	> 0.20	ENSG00000228044 (2.6)	LPIN3 (2.2)	HNF1A (2.0)	ABO (1.9)	C12orf47 (1.8)	BLOC1S3 (1.8)	HAPLN4 (1.7)	NKPD1 (1.6)	AMIGO1 (1.5)	ADAM1 (1.5)
ENSG00000127191	TRAF2 PPI subnetwork	0.52	> 0.20	PBX4 (4.4)	RELB (4.4)	BCL3 (3.1)	LPAR2 (2.3)	ENSG00000238078 (2.1)	GRINA (1.9)	CARM1 (1.8)	PARP10 (1.8)	PTPN11 (1.7)	NT5DC1 (1.6)
ENSG00000110321	EIF4G2 PPI subnetwork	0.52	> 0.20	TMEM57 (2.7)	C1orf63 (2.7)	TOP1 (2.6)	TRIB1 (2.1)	C12orf43 (1.9)	POLK (1.7)	GATAD2A (1.7)	ENSG00000226645 (1.6)	ENSG00000254235 (1.5)	TXNL4B (1.5)
ENSG00000130204	TOMM40 PPI subnetwork	0.52	> 0.20	GEMIN7 (4.4)	DDX56 (3.1)	TOMM40 (3.1)	TRAPPC6A (2.7)	CLPTM1 (2.5)	MARK4 (2.2)	DHODH (2.2)	QTRT1 (2.0)	CBLC (1.9)	ZNF259 (1.6)
GO:0032352	positive regulation of hormone metabolic process	0.52	> 0.20	ATXN7L2 (2.0)	DNAH11 (1.9)	BCAM (1.9)	ENSG00000226645 (1.9)	TMED4 (1.9)	BLOC1S3 (1.8)	TMEM57 (1.5)	PMFBP1 (1.5)	CYB561D1 (1.4)	CEACAM19 (1.4)
GO:0000080	G1 phase of mitotic cell cycle	0.52	> 0.20	TMED4 (2.0)	POLK (1.8)	KANK2 (1.8)	PBX4 (1.8)	SLC44A2 (1.7)	ATXN7L2 (1.6)	TSSK6 (1.4)	TXNL4B (1.3)	DNM2 (1.3)	SORT1 (1.2)
ENSG00000205022	PABPN1L PPI subnetwork	0.52	> 0.20	DNM2 (3.9)	ILF3 (3.7)	CARM1 (3.1)	SMARCA4 (3.1)	ATXN2 (2.9)	BRAP (2.8)	DHX38 (2.6)	YIPF2 (2.6)	USP24 (2.5)	DOCK7 (2.4)
GO:0035267	NuA4 histone acetyltransferase complex	0.52	> 0.20	ADAM1 (3.0)	BUD13 (2.7)	USP24 (2.7)	SUGP1 (2.7)	QTRT1 (2.4)	C12orf43 (2.3)	MAPKAPK5 (2.2)	SMARCA4 (2.1)	BRAP (2.0)	ZNF180 (1.8)
GO:0032845	negative regulation of homeostatic process	0.52	> 0.20	ENSG00000235545 (3.2)	BLOC1S3 (2.5)	POLK (2.4)	ENSG00000228044 (2.2)	TXNL4B (2.1)	ENSG00000226648 (2.0)	CEACAM19 (1.7)	GOT2P1 (1.6)	SUGP1 (1.6)	MARK4 (1.5)
MP:0004852	decreased testis weight	0.52	> 0.20	PBX4 (2.4)	KIAA1324 (1.8)	LDLR (1.6)	ANKRD31 (1.5)	FADS2 (1.5)	FADS1 (1.4)	TSSK6 (1.4)	GATAD2A (1.2)	PCSK9 (1.1)	HMGCR (1.1)
ENSG00000124486	USP9X PPI subnetwork	0.52	> 0.20	BCL3 (3.9)	RELB (3.1)	LPAR2 (2.3)	PSMA5 (2.0)	LDLR (2.0)	AMIGO1 (1.7)	CEACAM19 (1.6)	TRIB1 (1.6)	BCAM (1.6)	C12orf47 (1.6)
GO:0045078	positive regulation of interferon-gamma biosynthetic process	0.52	> 0.20	GCNT4 (2.6)	DNAH11 (2.6)	DOCK7 (1.9)	ZNF180 (1.9)	TRAFD1 (1.6)	TMED4 (1.5)	ENSG00000226645 (1.5)	TM6SF2 (1.4)	DYNC2LI1 (1.3)	CYB561D1 (1.3)
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	0.52	> 0.20	GRINA (2.7)	PVR (2.5)	RELB (2.4)	TRIB1 (2.2)	TMEM50A (2.1)	ENSG00000228044 (2.1)	TMED4 (2.0)	SORT1 (1.9)	ITGB3 (1.8)	GATAD2A (1.7)
ENSG00000154710	RABGEF1 PPI subnetwork	0.52	> 0.20	ANKRD31 (2.7)	TXNL4B (2.2)	PTPN11 (2.2)	LPAR2 (2.0)	MAU2 (2.0)	POLK (1.9)	COL4A3BP (1.9)	SUGP1 (1.6)	BRAP (1.6)	DHX38 (1.5)
GO:0071514	genetic imprinting	0.52	> 0.20	GOT2P1 (3.7)	ATXN7L2 (2.8)	ZNF180 (2.6)	NYNRIN (2.5)	COL4A3BP (2.1)	TXNL4B (1.9)	LPAR2 (1.9)	DHODH (1.9)	GEMIN7 (1.8)	MAPKAPK5 (1.4)
ENSG00000170604	IRF2BP1 PPI subnetwork	0.52	> 0.20	SH2B3 (3.0)	DOCK7 (2.9)	HLX (2.7)	BUD13 (2.6)	ENSG00000254235 (2.1)	TRAFD1 (1.6)	POC5 (1.6)	ENSG00000226648 (1.6)	C1orf63 (1.5)	C17orf57 (1.5)
ENSG00000136930	PSMB7 PPI subnetwork	0.52	> 0.20	PSMA5 (6.3)	TRAFD1 (3.1)	NAA25 (2.2)	NT5DC1 (2.0)	TOMM40 (1.7)	DDX56 (1.6)	SARS (1.5)	ENSG00000254235 (1.3)	DHX38 (1.3)	SUGP1 (1.3)
GO:0043029	T cell homeostasis	0.52	> 0.20	POLK (2.6)	C17orf57 (2.6)	PBX4 (2.3)	ENSG00000226645 (1.8)	TRAPPC6A (1.6)	TRAFD1 (1.6)	GEMIN7 (1.5)	SH2B3 (1.4)	DNAH11 (1.3)	PLCG1 (1.3)
MP:0002275	abnormal type II pneumocyte morphology	0.53	> 0.20	BCAM (3.0)	YIPF2 (2.8)	CYP7A1 (2.3)	TMEM116 (2.1)	DOCK7 (2.1)	PVRL2 (2.0)	AMIGO1 (1.9)	ERP29 (1.9)	KANK2 (1.7)	KIAA1324 (1.6)
ENSG00000187555	USP7 PPI subnetwork	0.53	> 0.20	DHX38 (3.0)	SARS (3.0)	LPAR2 (2.4)	SUGP1 (2.3)	MAPKAPK5 (2.2)	TRAFD1 (2.1)	ATP13A1 (1.9)	C12orf43 (1.8)	TXNL4B (1.7)	TOMM40 (1.6)
ENSG00000182979	MTA1 PPI subnetwork	0.53	> 0.20	TOP1 (3.1)	MARK4 (2.5)	PSRC1 (2.2)	ILF3 (2.1)	CARM1 (2.1)	DDX56 (2.0)	SMARCA4 (1.7)	NT5DC1 (1.7)	DNM2 (1.6)	PVRL2 (1.5)
MP:0004804	decreased susceptibility to autoimmune diabetes	0.53	> 0.20	MAFB (4.1)	RELB (3.6)	BCL3 (2.3)	APOE (2.1)	TIMD4 (1.9)	GRINA (1.8)	TRAFD1 (1.7)	GMIP (1.5)	TMEM57 (1.4)	APOC1 (1.4)
REACTOME_NEF:MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	REACTOME_NEF:MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	0.53	> 0.20	CLPTM1 (3.8)	GRINA (3.5)	PPP1R37 (2.8)	PLCG1 (2.7)	TXNL4B (2.4)	OGDH (2.1)	CETP (2.0)	APOE (1.8)	MARK4 (1.8)	DNM2 (1.7)
ENSG00000065609	SNAP91 PPI subnetwork	0.53	> 0.20	PPP1R37 (3.2)	ENSG00000226648 (2.6)	DOCK7 (2.5)	FRK (2.3)	USP24 (2.3)	C1orf63 (2.3)	PARP10 (2.2)	HNF1A (2.1)	KANK2 (1.9)	C12orf51 (1.7)
ENSG00000029534	ANK1 PPI subnetwork	0.53	> 0.20	RHD (8.1)	RHCE (6.6)	GMPR (3.4)	PLEC (2.8)	SYPL2 (2.7)	CELSR2 (2.6)	LPIN3 (2.0)	AMIGO1 (1.9)	CYB561D1 (1.6)	C12orf51 (1.6)
ENSG00000155366	RHOC PPI subnetwork	0.53	> 0.20	OGDH (2.2)	AP1M2 (2.0)	NYNRIN (1.9)	GMIP (1.8)	CBLC (1.6)	SLC44A2 (1.6)	DNM2 (1.5)	ENSG00000254235 (1.4)	TMED4 (1.3)	ZNF101 (1.3)
GO:0003729	mRNA binding	0.53	> 0.20	C1orf63 (5.2)	ANKRD31 (1.9)	TRAFD1 (1.8)	TOP1 (1.8)	ILF3 (1.8)	ADAM1 (1.7)	APOB (1.7)	ENSG00000238078 (1.5)	AP1M2 (1.5)	DHODH (1.4)
ENSG00000105327	BBC3 PPI subnetwork	0.53	> 0.20	ITGB3 (3.3)	GMPR (2.6)	BCAM (2.5)	PLCG1 (2.2)	LPAR2 (1.8)	ZNF101 (1.7)	C11orf9 (1.7)	RHCE (1.7)	PBX4 (1.5)	QTRT1 (1.4)
MP:0000925	abnormal floor plate morphology	0.53	> 0.20	NYNRIN (4.0)	DYNC2LI1 (3.6)	ATXN7L2 (3.3)	ENSG00000235545 (3.0)	PLEKHH2 (3.0)	PLCG1 (2.5)	DHX38 (2.3)	NCAN (2.1)	AMIGO1 (2.0)	DNAH11 (1.9)
ENSG00000170365	SMAD1 PPI subnetwork	0.53	> 0.20	ATXN2 (3.1)	ATXN7L2 (2.4)	CARM1 (2.2)	PLCG1 (2.1)	DHX38 (1.9)	C19orf52 (1.9)	ZNF101 (1.9)	MARK4 (1.8)	MAU2 (1.8)	DOCK7 (1.8)
ENSG00000153922	CHD1 PPI subnetwork	0.53	> 0.20	TOP1 (3.5)	ATXN2 (3.1)	SMARCA4 (2.9)	SUGP1 (2.8)	COL4A3BP (2.7)	ILF3 (2.7)	BUD13 (2.6)	C19orf52 (2.4)	POC5 (2.1)	USP1 (1.9)
ENSG00000179364	PACS2 PPI subnetwork	0.53	> 0.20	CBLC (6.0)	AP1M2 (4.2)	LPAR2 (2.1)	LPIN3 (2.0)	ST3GAL4 (2.0)	CELSR2 (1.9)	PSRC1 (1.7)	C12orf51 (1.7)	DOCK7 (1.6)	PVRL2 (1.6)
ENSG00000166226	CCT2 PPI subnetwork	0.53	> 0.20	TOMM40 (3.4)	DDX56 (2.7)	SARS (2.4)	PSMA5 (2.3)	OGDH (2.0)	NAA25 (2.0)	ZNF259 (1.9)	NT5DC1 (1.9)	C19orf52 (1.7)	QTRT1 (1.6)
ENSG00000167193	CRK PPI subnetwork	0.53	> 0.20	SLC44A2 (3.5)	DOCK7 (2.2)	NT5DC1 (2.1)	ABO (2.1)	MARK4 (2.1)	USP24 (2.0)	RPH3A (1.9)	SORT1 (1.8)	CARM1 (1.7)	MYLIP (1.6)
GO:0030175	filopodium	0.53	> 0.20	NCAN (3.6)	C11orf9 (3.2)	PLEC (2.5)	ST3GAL4 (2.2)	OGDH (2.1)	SLC44A2 (2.0)	TIMD4 (1.9)	ENSG00000235545 (1.8)	APOE (1.8)	LPAR2 (1.8)
ENSG00000128016	ZFP36 PPI subnetwork	0.53	> 0.20	TXNL4B (4.0)	OASL (3.6)	ENSG00000228044 (2.7)	TRAFD1 (2.6)	ATXN2 (2.6)	DHX38 (2.5)	PARP10 (2.4)	TOP1 (2.2)	UBXN2B (2.1)	C1orf63 (2.1)
ENSG00000005022	SLC25A5 PPI subnetwork	0.53	> 0.20	SARS (2.8)	OGDH (2.8)	PSMA5 (2.8)	C12orf43 (2.7)	QTRT1 (2.3)	ADAM1 (2.2)	NAA25 (2.2)	ACAD10 (2.1)	RELB (2.1)	C1orf63 (2.0)
ENSG00000204967	PCDHA4 PPI subnetwork	0.53	> 0.20	FADS2 (2.2)	ATXN7L2 (1.9)	PCSK9 (1.8)	GMIP (1.8)	CEACAM19 (1.5)	FADS1 (1.5)	HMGCR (1.5)	RPH3A (1.5)	CYP7A1 (1.4)	TRAPPC6A (1.3)
ENSG00000105287	PRKD2 PPI subnetwork	0.53	> 0.20	MARK4 (2.4)	PTPN11 (2.2)	DOCK7 (2.0)	ATXN2 (1.9)	SORT1 (1.7)	BUD13 (1.7)	ZNF180 (1.6)	ENSG00000226648 (1.6)	POLK (1.6)	PVRL2 (1.5)
MP:0001431	abnormal eating behavior	0.53	> 0.20	C11orf9 (3.5)	PMFBP1 (2.2)	CBLC (2.1)	FRK (2.0)	TM6SF2 (1.8)	MARK4 (1.6)	ABO (1.5)	C17orf57 (1.4)	GCNT4 (1.4)	TSSK6 (1.3)
ENSG00000106263	EIF3B PPI subnetwork	0.53	> 0.20	ZNF259 (3.8)	DDX56 (3.2)	NAA25 (2.8)	DHX38 (2.7)	SARS (2.5)	QTRT1 (2.5)	TOP1 (2.4)	ILF3 (2.3)	TMEM57 (2.1)	TOMM40 (2.1)
GO:0042165	neurotransmitter binding	0.53	> 0.20	ANKRD31 (2.7)	GEMIN7 (2.7)	SYPL2 (2.7)	RPH3A (2.5)	GOT2P1 (2.5)	ATXN7L2 (2.3)	CILP2 (1.9)	ABO (1.7)	SORT1 (1.7)	PMFBP1 (1.6)
GO:0070918	production of small RNA involved in gene silencing by RNA	0.53	> 0.20	ENSG00000226648 (3.4)	DOCK7 (3.3)	MAPKAPK5 (3.0)	GOT2P1 (2.9)	ADAM1 (2.3)	USP24 (2.2)	C12orf43 (1.7)	ENSG00000228044 (1.6)	UBXN2B (1.2)	ATXN2 (1.2)
GO:0031050	dsRNA fragmentation	0.53	> 0.20	ENSG00000226648 (3.4)	DOCK7 (3.3)	MAPKAPK5 (3.0)	GOT2P1 (2.9)	ADAM1 (2.3)	USP24 (2.2)	C12orf43 (1.7)	ENSG00000228044 (1.6)	UBXN2B (1.2)	ATXN2 (1.2)
ENSG00000187098	MITF PPI subnetwork	0.53	> 0.20	ATXN2 (2.2)	GMIP (2.2)	LPAR2 (2.2)	PLEC (2.2)	MAFB (2.1)	UBXN2B (2.0)	CARM1 (1.9)	C19orf52 (1.8)	TRIB1 (1.7)	GRINA (1.5)
MP:0000471	abnormal stomach epithelium morphology	0.53	> 0.20	GRINA (2.6)	PLEC (2.1)	SLC44A2 (1.8)	MYLIP (1.7)	BCAM (1.6)	PPP1R37 (1.5)	DNAH11 (1.5)	CLPTM1 (1.3)	ADAM1 (1.2)	DNM2 (1.1)
MP:0003998	decreased thermal nociceptive threshold	0.53	> 0.20	RPH3A (4.9)	NYNRIN (2.0)	C12orf47 (1.9)	HAPLN4 (1.8)	GOT2P1 (1.8)	AMIGO1 (1.6)	PCSK9 (1.6)	FRK (1.5)	NCAN (1.5)	CEACAM19 (1.5)
GO:0044257	cellular protein catabolic process	0.53	> 0.20	BRAP (3.3)	TRAFD1 (2.6)	TMEM57 (2.5)	USP24 (2.3)	ZNF180 (2.2)	NAA25 (2.1)	MAU2 (1.9)	PSMA5 (1.8)	DHX38 (1.8)	LPIN3 (1.7)
MP:0003719	abnormal pericyte morphology	0.53	> 0.20	ITGB3 (2.6)	PLEC (2.4)	PVRL2 (2.2)	KIAA1324 (2.1)	HLX (2.0)	ZNF101 (1.8)	C17orf57 (1.5)	HAPLN4 (1.5)	AMIGO1 (1.5)	MAFB (1.4)
ENSG00000135801	TAF5L PPI subnetwork	0.53	> 0.20	ATXN2 (3.5)	ATXN7L2 (2.4)	C17orf57 (2.4)	C12orf51 (2.3)	ACAD10 (2.0)	BUD13 (1.9)	ZNF101 (1.9)	TOP1 (1.9)	MAPKAPK5 (1.8)	ZHX3 (1.8)
MP:0006126	abnormal outflow tract development	0.53	> 0.20	PVRL2 (1.9)	HLX (1.8)	GEMIN7 (1.7)	PLEC (1.6)	NYNRIN (1.6)	ATXN2 (1.5)	BCAM (1.5)	LPIN3 (1.5)	PVR (1.4)	APOB (1.4)
GO:0042771	DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis	0.53	> 0.20	AMIGO1 (2.4)	BLOC1S3 (2.3)	PPP1R37 (2.0)	MARK4 (1.9)	PARP10 (1.6)	ZNF101 (1.5)	GOT2P1 (1.3)	ZNF180 (1.3)	BUD13 (1.3)	CARM1 (1.3)
GO:0030027	lamellipodium	0.53	> 0.20	DOCK7 (3.7)	GMIP (3.1)	OGDH (2.6)	PVRL2 (2.5)	KANK2 (2.4)	SLC44A2 (2.3)	ST3GAL4 (2.1)	PPP1R37 (2.1)	SH2B3 (2.0)	PLCG1 (1.9)
MP:0004521	abnormal cochlear hair cell stereociliary bundle morphology	0.53	> 0.20	HAVCR1 (3.5)	CELSR2 (2.4)	HNF1A (2.1)	DNAH11 (1.8)	TM6SF2 (1.7)	TIMD4 (1.7)	BCAM (1.6)	NT5DC1 (1.5)	LPIN3 (1.4)	SORT1 (1.2)
MP:0006379	abnormal spermatocyte morphology	0.53	> 0.20	ANKRD31 (2.6)	TMEM57 (1.8)	GATAD2A (1.6)	CEACAM19 (1.5)	TMEM116 (1.4)	PBX4 (1.3)	LDLR (1.1)	BRAP (1.0)	ENSG00000238078 (1.0)	KANK2 (1.0)
ENSG00000163468	CCT3 PPI subnetwork	0.53	> 0.20	NAA25 (3.4)	PSMA5 (3.2)	C12orf43 (2.8)	BRAP (2.7)	ZNF259 (2.6)	SARS (2.4)	DDX56 (2.4)	NT5DC1 (2.2)	DYNC2LI1 (1.8)	ZNF180 (1.6)
GO:0007183	SMAD protein complex assembly	0.53	> 0.20	ENSG00000226648 (2.7)	C19orf52 (2.1)	GCNT4 (2.0)	DOCK7 (2.0)	MAPKAPK5 (1.9)	PTPN11 (1.8)	GOT2P1 (1.7)	ZNF180 (1.7)	LPIN3 (1.6)	TMED4 (1.6)
ENSG00000169621	APLF PPI subnetwork	0.53	> 0.20	SMARCA4 (3.6)	ZNF101 (3.3)	NT5DC1 (2.8)	GCNT4 (2.2)	ENSG00000228044 (2.0)	ANKRD31 (2.0)	PLCG1 (2.0)	POLK (1.7)	GMPR (1.7)	FEN1 (1.7)
ENSG00000113522	RAD50 PPI subnetwork	0.53	> 0.20	FEN1 (4.2)	USP1 (3.3)	POLK (2.0)	DHODH (1.8)	BUD13 (1.8)	SMARCA4 (1.8)	DHX38 (1.7)	C1orf63 (1.6)	PLCG1 (1.5)	ANKRD31 (1.4)
ENSG00000163950	SLBP PPI subnetwork	0.53	> 0.20	UBXN2B (2.5)	ZNF180 (2.0)	CYB561D1 (2.0)	PVR (2.0)	TXNL4B (2.0)	TOP1 (2.0)	ENSG00000235545 (1.9)	C12orf47 (1.9)	MYLIP (1.5)	BLOC1S3 (1.4)
ENSG00000215902	ENSG00000215902 PPI subnetwork	0.53	> 0.20	ABO (2.6)	DHX38 (2.6)	ILF3 (2.2)	ATP13A1 (2.2)	TOMM40 (2.2)	ANKRD31 (2.1)	BCAM (1.9)	TOP1 (1.8)	DDX56 (1.7)	ENSG00000238078 (1.7)
ENSG00000169727	GPS1 PPI subnetwork	0.53	> 0.20	ATXN7L2 (2.9)	ENSG00000226648 (2.1)	BUD13 (2.0)	CARM1 (1.8)	SUGP1 (1.5)	ZNF180 (1.4)	NT5DC1 (1.4)	TXNL4B (1.4)	MYLIP (1.3)	DYNC2LI1 (1.3)
GO:0055021	regulation of cardiac muscle tissue growth	0.53	> 0.20	C11orf9 (2.2)	GCNT4 (2.2)	PLEKHH2 (1.8)	C19orf52 (1.6)	GEMIN7 (1.6)	HAPLN4 (1.5)	ALDH2 (1.5)	KIAA1324 (1.4)	DYNC2LI1 (1.4)	ENSG00000254235 (1.4)
ENSG00000132589	FLOT2 PPI subnetwork	0.53	> 0.20	ACAD10 (3.4)	ST3GAL4 (2.4)	HNF1A (2.4)	ITGB3 (2.2)	KIAA1324 (2.1)	ERP29 (2.0)	YIPF2 (1.9)	MOSC1 (1.8)	SORT1 (1.8)	TMED4 (1.7)
ENSG00000116711	PLA2G4A PPI subnetwork	0.53	> 0.20	SORT1 (2.9)	NCAN (2.3)	TRAFD1 (2.1)	C1orf63 (2.0)	RPH3A (1.9)	ABCG5 (1.6)	TMEM50A (1.6)	CLPTM1 (1.6)	CYB561D1 (1.5)	UBXN2B (1.5)
ENSG00000162337	LRP5 PPI subnetwork	0.53	> 0.20	CILP2 (2.5)	SORT1 (2.4)	LPAR2 (2.1)	PVRL2 (2.0)	PLEKHH2 (1.8)	MOSC1 (1.7)	CELSR2 (1.7)	TMED4 (1.7)	HAVCR1 (1.7)	AMIGO1 (1.4)
MP:0000965	abnormal sensory neuron morphology	0.53	> 0.20	HAPLN4 (2.5)	GMPR (2.5)	CEACAM19 (2.5)	SARS (2.2)	PLEC (1.9)	COL4A3BP (1.7)	ENSG00000238078 (1.7)	ALDH2 (1.5)	PVR (1.5)	ENSG00000228044 (1.4)
GO:0034405	response to fluid shear stress	0.53	> 0.20	GCNT4 (2.5)	TMEM57 (2.5)	MYLIP (2.4)	MAFB (2.2)	SLC44A2 (1.8)	ADAM1 (1.6)	TMEM50A (1.5)	KANK2 (1.5)	TRAPPC6A (1.5)	TRIB1 (1.4)
ENSG00000179041	RRS1 PPI subnetwork	0.53	> 0.20	ZNF259 (4.5)	NAA25 (4.3)	DDX56 (3.3)	TOMM40 (3.0)	TOP1 (2.2)	MAPKAPK5 (2.2)	GATAD2A (2.1)	DYNC2LI1 (2.0)	POC5 (1.9)	DHODH (1.8)
ENSG00000158417	EIF5B PPI subnetwork	0.53	> 0.20	NAA25 (3.6)	ZNF259 (3.1)	ATP13A1 (3.0)	DDX56 (2.7)	TOMM40 (2.7)	QTRT1 (2.5)	ILF3 (2.3)	GATAD2A (2.3)	DHX38 (2.2)	NKPD1 (2.1)
GO:0001709	cell fate determination	0.53	> 0.20	ENSG00000226648 (2.8)	ABO (2.4)	CEACAM19 (2.3)	DNAH11 (2.1)	ANKRD31 (2.0)	PBX4 (1.9)	HNF1A (1.9)	ATXN7L2 (1.6)	ENSG00000254235 (1.5)	PMFBP1 (1.4)
MP:0002018	malignant tumors	0.53	> 0.20	AP1M2 (2.3)	CYB561D1 (2.2)	C12orf51 (2.2)	NYNRIN (2.0)	C17orf57 (1.6)	NAA25 (1.6)	UBXN2B (1.5)	ZNF180 (1.5)	CARM1 (1.4)	LPIN3 (1.3)
ENSG00000152291	TGOLN2 PPI subnetwork	0.53	> 0.20	OGDH (3.1)	ZHX3 (2.9)	PTPN11 (2.8)	KANK2 (2.5)	SLC44A2 (2.2)	DNM2 (2.1)	COL4A3BP (2.1)	GATAD2A (1.7)	ENSG00000235545 (1.5)	ENSG00000238078 (1.5)
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	0.53	> 0.20	ABCG8 (4.4)	ABCG5 (3.7)	ANGPTL3 (3.6)	CYP7A1 (3.5)	MOSC1 (2.8)	APOC4 (2.5)	APOB (2.4)	SLC22A1 (2.3)	PLG (2.2)	TM6SF2 (2.2)
GO:0006200	ATP catabolic process	0.53	> 0.20	NKPD1 (3.3)	PSMA5 (2.3)	OGDH (2.1)	HAPLN4 (2.1)	BRAP (2.0)	ENSG00000238078 (1.9)	SARS (1.7)	USP24 (1.7)	ACAD10 (1.7)	CLPTM1 (1.6)
ENSG00000105088	OLFM2 PPI subnetwork	0.53	> 0.20	ENSG00000228044 (3.0)	OGDH (2.6)	GRINA (2.3)	SARS (1.9)	ENSG00000235545 (1.9)	LPAR2 (1.9)	FRK (1.8)	QTRT1 (1.6)	PBX4 (1.5)	ST3GAL4 (1.2)
ENSG00000184110	EIF3C PPI subnetwork	0.53	> 0.20	ZNF259 (3.5)	SARS (3.4)	DDX56 (3.3)	NAA25 (3.0)	TOMM40 (2.8)	DHX38 (2.7)	QTRT1 (2.6)	TOP1 (2.4)	ATP13A1 (2.3)	PTPN11 (2.2)
GO:0006383	transcription from RNA polymerase III promoter	0.53	> 0.20	ADAM1 (3.4)	C12orf43 (2.7)	GEMIN7 (2.5)	POC5 (2.4)	MAPKAPK5 (2.4)	BRAP (2.3)	ATXN2 (2.0)	DHX38 (1.9)	SUGP1 (1.8)	DDX56 (1.6)
ENSG00000172534	HCFC1 PPI subnetwork	0.53	> 0.20	ATXN2 (3.2)	BUD13 (3.2)	ATP13A1 (2.7)	ILF3 (2.6)	BRAP (2.5)	USP1 (2.4)	POC5 (2.2)	SUGP1 (2.0)	C19orf52 (2.0)	TOMM40 (1.9)
ENSG00000156735	BAG4 PPI subnetwork	0.53	> 0.20	CELSR2 (2.3)	PLCG1 (2.0)	NPC1L1 (1.8)	ACAD10 (1.8)	DNAH11 (1.5)	PLEC (1.4)	SLC44A2 (1.4)	MYLIP (1.4)	AMIGO1 (1.4)	AP1M2 (1.4)
ENSG00000100150	DEPDC5 PPI subnetwork	0.53	> 0.20	SMARCA4 (3.2)	TOMM40 (2.8)	TOP1 (2.7)	ILF3 (2.6)	CARM1 (2.5)	QTRT1 (2.4)	BUD13 (2.3)	DHX38 (2.2)	PTPN11 (2.0)	COL4A3BP (1.9)
GO:0002699	positive regulation of immune effector process	0.53	> 0.20	GEMIN7 (1.6)	PARP10 (1.4)	TIMD4 (1.3)	SH2B3 (1.3)	ENSG00000226645 (1.3)	BCL3 (1.2)	RELB (1.2)	GMIP (1.1)	POLK (1.0)	TRAFD1 (1.0)
ENSG00000167325	RRM1 PPI subnetwork	0.53	> 0.20	POC5 (2.7)	TMEM57 (2.3)	HAPLN4 (1.8)	GMPR (1.7)	C12orf43 (1.7)	NT5DC1 (1.6)	ENSG00000226645 (1.6)	TXNL4B (1.5)	BRAP (1.5)	SUGP1 (1.3)
GO:0002080	acrosomal membrane	0.53	> 0.20	ENSG00000228044 (3.1)	PCSK9 (1.9)	TMED4 (1.8)	COL4A3BP (1.8)	TSSK6 (1.8)	LPAR2 (1.7)	PLEC (1.6)	ENSG00000238078 (1.5)	LPA (1.3)	OGDH (1.3)
GO:0034103	regulation of tissue remodeling	0.53	> 0.20	ENSG00000235545 (2.7)	DNAH11 (2.1)	C11orf9 (1.8)	CETP (1.7)	C17orf57 (1.6)	RHCE (1.5)	TMED4 (1.5)	ENSG00000226645 (1.4)	YIPF2 (1.3)	HNF1A (1.2)
ENSG00000170421	KRT8 PPI subnetwork	0.53	> 0.20	PLEC (4.5)	PVR (3.3)	BCAM (2.3)	KANK2 (2.2)	CEACAM19 (2.0)	SORT1 (2.0)	SARS (1.7)	GATAD2A (1.6)	PVRL2 (1.5)	TRAFD1 (1.5)
ENSG00000088833	NSFL1C PPI subnetwork	0.53	> 0.20	TMEM57 (2.4)	SUGP1 (1.9)	SMARCA4 (1.8)	CLPTM1 (1.8)	C19orf52 (1.7)	SARS (1.6)	TOMM40 (1.5)	PSMA5 (1.4)	NKPD1 (1.2)	TOP1 (1.2)
MP:0001515	abnormal grip strength	0.53	> 0.20	MAU2 (2.4)	CYB561D1 (2.3)	USP24 (2.3)	GPAM (2.2)	TMED4 (2.0)	ATP13A1 (2.0)	DOCK7 (1.9)	PTPN11 (1.8)	PCSK9 (1.7)	PVR (1.7)
GO:0046886	positive regulation of hormone biosynthetic process	0.53	> 0.20	ST3GAL4 (2.4)	TMED4 (2.1)	ATXN7L2 (2.1)	BLOC1S3 (2.0)	ENSG00000226645 (1.7)	CEACAM19 (1.6)	TMEM57 (1.5)	DNAH11 (1.5)	HNF1A (1.4)	BUD13 (1.2)
MP:0001435	no suckling reflex	0.53	> 0.20	LDLR (4.0)	CELSR2 (3.3)	HMGCR (3.3)	FADS1 (3.0)	PLCG1 (2.7)	FADS2 (2.5)	C11orf9 (2.4)	NCAN (2.1)	C17orf57 (2.0)	ATP13A1 (1.8)
GO:0009148	pyrimidine nucleoside triphosphate biosynthetic process	0.53	> 0.20	DYNC2LI1 (4.2)	C12orf43 (3.0)	PMFBP1 (2.6)	ENSG00000226648 (2.3)	DNAH11 (2.2)	GEMIN7 (2.0)	TMEM116 (1.7)	POLK (1.6)	ENSG00000254235 (1.5)	GCNT4 (1.5)
ENSG00000183763	TRAIP PPI subnetwork	0.53	> 0.20	PBX4 (5.1)	TRAFD1 (2.0)	RELB (2.0)	GMIP (1.7)	ITGB3 (1.7)	BRAP (1.7)	POC5 (1.7)	OGDH (1.6)	PSRC1 (1.6)	SUGP1 (1.6)
ENSG00000011451	WIZ PPI subnetwork	0.53	> 0.20	DHX38 (3.0)	USP24 (2.5)	SMARCA4 (2.1)	CLPTM1 (2.0)	ILF3 (2.0)	TOMM40 (1.8)	C12orf51 (1.8)	COL4A3BP (1.6)	CARM1 (1.5)	HLX (1.5)
REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	0.53	> 0.20	NKPD1 (3.1)	UBXN2B (1.9)	GATAD2A (1.6)	MOSC1 (1.5)	ERP29 (1.3)	ANKRD31 (1.3)	DNAH11 (1.2)	GPAM (1.2)	CEACAM19 (1.2)	ILF3 (1.1)
ENSG00000084623	EIF3I PPI subnetwork	0.53	> 0.20	TMEM57 (2.7)	MYLIP (2.6)	NKPD1 (2.3)	DDX56 (2.2)	GATAD2A (1.9)	SARS (1.9)	TRIB1 (1.7)	ZNF259 (1.6)	TOP1 (1.6)	ILF3 (1.6)
ENSG00000131269	ABCB7 PPI subnetwork	0.53	> 0.20	ATP13A1 (3.0)	RHD (2.0)	OGDH (2.0)	RHCE (1.9)	DNM2 (1.8)	ACAD10 (1.8)	YIPF2 (1.7)	ILF3 (1.7)	ENSG00000235545 (1.7)	QTRT1 (1.7)
ENSG00000126261	UBA2 PPI subnetwork	0.53	> 0.20	TRAPPC6A (3.8)	ZNF180 (3.2)	TMEM50A (2.9)	MARK4 (2.0)	TOMM40 (1.9)	ZNF101 (1.8)	PVRL2 (1.8)	RELB (1.7)	GOT2P1 (1.7)	GEMIN7 (1.6)
GO:0048821	erythrocyte development	0.53	> 0.20	RHCE (6.5)	RHD (6.3)	GMPR (3.2)	C12orf51 (2.2)	ENSG00000228044 (2.0)	ERP29 (1.5)	TMEM116 (1.4)	BLOC1S3 (1.3)	GEMIN7 (1.3)	ATXN7L2 (1.0)
REACTOME_BETA:CATENIN_PHOSPHORYLATION_CASCADE	REACTOME_BETA:CATENIN_PHOSPHORYLATION_CASCADE	0.53	> 0.20	COL4A3BP (2.6)	C19orf52 (2.4)	MARK4 (2.4)	MOSC1 (1.9)	UBXN2B (1.8)	ENSG00000226645 (1.8)	PTPN11 (1.7)	CYB561D1 (1.6)	DNM2 (1.5)	CARM1 (1.4)
REACTOME_E2F:ENABLED_INHIBITION_OF_PRE:REPLICATION_COMPLEX_FORMATION	REACTOME_E2F:ENABLED_INHIBITION_OF_PRE:REPLICATION_COMPLEX_FORMATION	0.53	> 0.20	POC5 (3.4)	FEN1 (3.2)	USP1 (2.2)	NT5DC1 (2.2)	TMEM116 (2.0)	MAU2 (1.8)	PSRC1 (1.7)	RHD (1.6)	TXNL4B (1.3)	ENSG00000226645 (1.2)
ENSG00000101868	POLA1 PPI subnetwork	0.53	> 0.20	FEN1 (6.2)	USP1 (5.1)	PSRC1 (2.4)	ILF3 (1.8)	ZNF180 (1.5)	ENSG00000235545 (1.4)	ENSG00000228044 (1.2)	GOT2P1 (1.2)	DHODH (1.1)	BUD13 (1.0)
ENSG00000110768	GTF2H1 PPI subnetwork	0.53	> 0.20	SUGP1 (3.4)	BUD13 (2.8)	DHX38 (2.4)	TXNL4B (2.3)	PSMA5 (2.2)	ZNF259 (2.1)	POC5 (2.0)	FEN1 (2.0)	MAPKAPK5 (1.9)	TOP1 (1.7)
GO:0070498	interleukin-1-mediated signaling pathway	0.53	> 0.20	ENSG00000228044 (3.0)	ZNF180 (2.5)	ANKRD31 (2.3)	UBXN2B (2.3)	CYB561D1 (2.1)	BLOC1S3 (2.0)	NKPD1 (1.7)	ZNF101 (1.7)	PMFBP1 (1.6)	PLEKHH2 (1.5)
ENSG00000068878	PSME4 PPI subnetwork	0.53	> 0.20	PSMA5 (5.9)	NAA25 (3.0)	TOMM40 (2.9)	DDX56 (2.5)	ZNF259 (2.0)	SARS (2.0)	NT5DC1 (1.8)	QTRT1 (1.7)	TRAFD1 (1.5)	SMARCA4 (1.3)
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1S_TRANSITION	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1S_TRANSITION	0.53	> 0.20	PSMA5 (6.2)	TRAFD1 (2.9)	TOMM40 (2.1)	NAA25 (2.0)	DDX56 (1.7)	FEN1 (1.6)	NT5DC1 (1.5)	SUGP1 (1.4)	SARS (1.3)	TXNL4B (1.2)
GO:0060444	branching involved in mammary gland duct morphogenesis	0.53	> 0.20	KIAA1324 (2.7)	PVRL2 (1.9)	AP1M2 (1.9)	TOP1 (1.7)	PPP1R37 (1.5)	PLEKHH2 (1.4)	BCAM (1.4)	PLEC (1.4)	CBLC (1.3)	FRK (1.2)
GO:0090002	establishment of protein localization in plasma membrane	0.53	> 0.20	PTPN11 (3.0)	BCAM (2.6)	C11orf9 (2.5)	AP1M2 (2.0)	ZHX3 (1.8)	ENSG00000226645 (1.8)	C12orf47 (1.7)	TSSK6 (1.6)	CBLC (1.5)	TMEM57 (1.4)
GO:0034620	cellular response to unfolded protein	0.53	> 0.20	BLOC1S3 (3.4)	GCNT4 (3.3)	SARS (2.8)	TXNL4B (2.7)	C12orf47 (2.1)	YIPF2 (2.1)	TMED4 (1.7)	ERP29 (1.5)	ENSG00000238078 (1.4)	TMEM116 (1.2)
GO:0030968	endoplasmic reticulum unfolded protein response	0.53	> 0.20	BLOC1S3 (3.4)	GCNT4 (3.3)	SARS (2.8)	TXNL4B (2.7)	C12orf47 (2.1)	YIPF2 (2.1)	TMED4 (1.7)	ERP29 (1.5)	ENSG00000238078 (1.4)	TMEM116 (1.2)
GO:0032088	negative regulation of NF-kappaB transcription factor activity	0.53	> 0.20	PMFBP1 (2.5)	PARP10 (2.2)	ZNF180 (1.9)	BLOC1S3 (1.8)	GMIP (1.8)	CEACAM19 (1.8)	GEMIN7 (1.7)	YIPF2 (1.7)	ENSG00000238078 (1.6)	LPAR2 (1.5)
MP:0001326	retinal degeneration	0.53	> 0.20	NCAN (2.2)	DYNC2LI1 (2.2)	ST3GAL4 (2.2)	SORT1 (1.7)	HAVCR1 (1.6)	PSRC1 (1.5)	ENSG00000235545 (1.5)	CLPTM1 (1.5)	MYLIP (1.3)	PMFBP1 (1.2)
MP:0002835	abnormal cranial suture morphology	0.53	> 0.20	CILP2 (3.4)	NYNRIN (3.3)	NCAN (1.7)	PLCG1 (1.7)	C11orf9 (1.7)	ENSG00000235545 (1.6)	PLEC (1.6)	BCAM (1.5)	DOCK7 (1.4)	PPP1R37 (1.4)
ENSG00000088538	DOCK3 PPI subnetwork	0.53	> 0.20	ABO (2.8)	C17orf57 (2.4)	COL4A3BP (2.0)	C19orf52 (1.8)	DNM2 (1.7)	POC5 (1.7)	PMFBP1 (1.7)	TMEM57 (1.6)	MAFB (1.5)	APOE (1.3)
MP:0002151	abnormal neural tube morphology/development	0.53	> 0.20	DOCK7 (3.4)	NYNRIN (3.0)	DYNC2LI1 (2.7)	ATXN2 (2.6)	ATXN7L2 (2.1)	PVRL2 (1.9)	KANK2 (1.9)	GATAD2A (1.9)	ABO (1.6)	PLCG1 (1.6)
ENSG00000164815	ORC5 PPI subnetwork	0.53	> 0.20	FEN1 (6.6)	USP1 (5.2)	PSRC1 (2.2)	ENSG00000235545 (1.5)	POC5 (1.4)	TMEM116 (1.3)	LPAR2 (1.1)	TXNL4B (1.1)	RHD (1.0)	SLC44A2 (1.0)
REACTOME_PECAM1_INTERACTIONS	REACTOME_PECAM1_INTERACTIONS	0.54	> 0.20	GMIP (3.6)	CETP (2.9)	GPAM (2.4)	SH2B3 (2.4)	DOCK7 (2.2)	GATAD2A (2.1)	NCAN (2.0)	ENSG00000226648 (2.0)	MAFB (1.9)	ZHX3 (1.9)
MP:0002270	abnormal pulmonary alveolus morphology	0.54	> 0.20	APOC1 (2.4)	CLPTM1 (2.4)	HLX (2.2)	TMEM116 (2.2)	BCAM (1.8)	GPAM (1.6)	PLEKHH2 (1.6)	TIMD4 (1.6)	NYNRIN (1.5)	ANKRD31 (1.5)
ENSG00000138663	COPS4 PPI subnetwork	0.54	> 0.20	ATXN7L2 (3.2)	C19orf52 (2.1)	C12orf47 (1.9)	BUD13 (1.8)	QTRT1 (1.8)	OASL (1.8)	UBXN2B (1.6)	NT5DC1 (1.5)	NAA25 (1.5)	OGDH (1.4)
GO:0004683	calmodulin-dependent protein kinase activity	0.54	> 0.20	RPH3A (3.2)	SYPL2 (2.9)	AMIGO1 (2.8)	SORT1 (2.1)	C12orf43 (2.1)	DNAH11 (2.0)	ABCG8 (2.0)	DHODH (1.8)	MOSC1 (1.8)	CEACAM19 (1.8)
MP:0001891	hydroencephaly	0.54	> 0.20	DYNC2LI1 (2.6)	OASL (2.6)	PVRL2 (2.3)	ENSG00000235545 (1.9)	TRAFD1 (1.9)	CELSR2 (1.5)	DOCK7 (1.5)	ABCG5 (1.5)	CILP2 (1.4)	ANKRD31 (1.4)
MP:0000273	overriding aorta	0.54	> 0.20	CEACAM19 (2.3)	TRIB1 (2.1)	BCAM (1.7)	GMPR (1.6)	MYLIP (1.6)	PVRL2 (1.4)	SLC44A2 (1.3)	C1orf63 (1.3)	PLCG1 (1.3)	C17orf57 (1.3)
KEGG_CITRATE_CYCLE_TCA_CYCLE	KEGG_CITRATE_CYCLE_TCA_CYCLE	0.54	> 0.20	OGDH (4.3)	ACAD10 (4.1)	GPAM (2.6)	GMPR (2.1)	ALDH2 (1.9)	FADS1 (1.9)	FADS2 (1.9)	MOSC1 (1.8)	CLPTM1 (1.7)	HAPLN4 (1.6)
ENSG00000005007	UPF1 PPI subnetwork	0.54	> 0.20	TOP1 (3.5)	GATAD2A (2.8)	ZNF259 (2.6)	SUGP1 (2.6)	DHX38 (2.2)	TXNL4B (2.1)	ATXN7L2 (2.1)	ADAM1 (2.1)	TRAFD1 (2.1)	ATP13A1 (2.1)
ENSG00000143322	ABL2 PPI subnetwork	0.54	> 0.20	ZHX3 (2.8)	MAFB (2.2)	NCAN (2.0)	NYNRIN (2.0)	LPIN3 (1.9)	GMIP (1.7)	PMFBP1 (1.7)	CEACAM19 (1.6)	GPAM (1.6)	SH2B3 (1.6)
MP:0002267	abnormal bronchiole morphology	0.54	> 0.20	ITGB3 (2.7)	PLEKHH2 (2.6)	RHCE (2.5)	SLC44A2 (2.2)	ENSG00000235545 (2.0)	FADS2 (1.7)	ENSG00000228044 (1.7)	APOE (1.7)	RHD (1.4)	APOC1 (1.3)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	0.54	> 0.20	ST3GAL4 (3.1)	TMEM116 (2.4)	C17orf57 (2.2)	PVRL2 (2.1)	POLK (2.0)	DHODH (1.9)	SH2B3 (1.9)	YIPF2 (1.8)	SLC44A2 (1.7)	ITGB3 (1.7)
MP:0001502	abnormal circadian rhythm	0.54	> 0.20	CILP2 (3.1)	C17orf57 (2.7)	ZHX3 (2.3)	ERP29 (1.8)	ENSG00000228044 (1.6)	APOA5 (1.6)	ENSG00000235545 (1.5)	TIMD4 (1.5)	ST3GAL4 (1.5)	LPIN3 (1.4)
ENSG00000172315	TP53RK PPI subnetwork	0.54	> 0.20	ENSG00000235545 (2.8)	TM6SF2 (2.1)	PSMA5 (2.1)	HMGCR (1.9)	CARM1 (1.8)	NYNRIN (1.7)	ABCG5 (1.6)	TOMM40 (1.6)	PLCG1 (1.4)	DDX56 (1.4)
ENSG00000141543	EIF4A3 PPI subnetwork	0.54	> 0.20	ILF3 (3.3)	PTPN11 (3.2)	C12orf43 (2.9)	QTRT1 (2.6)	SUGP1 (2.4)	TOP1 (2.3)	ENSG00000226645 (2.1)	SMARCA4 (2.0)	BRAP (2.0)	TXNL4B (1.9)
ENSG00000215693	ENSG00000215693 PPI subnetwork	0.54	> 0.20	MAU2 (3.5)	UBXN2B (3.1)	CELSR2 (2.2)	KIAA1324 (2.2)	CARM1 (2.0)	C11orf9 (2.0)	GATAD2A (1.6)	GMIP (1.5)	PLEC (1.4)	BCL3 (1.3)
ENSG00000168395	ING5 PPI subnetwork	0.54	> 0.20	MAU2 (3.5)	UBXN2B (3.1)	CELSR2 (2.2)	KIAA1324 (2.2)	CARM1 (2.0)	C11orf9 (2.0)	GATAD2A (1.6)	GMIP (1.5)	PLEC (1.4)	BCL3 (1.3)
GO:0032200	telomere organization	0.54	> 0.20	POLK (3.4)	ZNF180 (2.5)	USP1 (2.2)	ENSG00000226648 (2.2)	TXNL4B (2.1)	POC5 (2.1)	AMIGO1 (1.8)	BLOC1S3 (1.8)	DHODH (1.8)	NKPD1 (1.8)
ENSG00000213905	ENSG00000213905 PPI subnetwork	0.54	> 0.20	ITGB3 (3.2)	GMPR (3.0)	APOC1 (2.6)	TMEM50A (2.3)	TMEM57 (1.9)	ZNF101 (1.9)	LPIN3 (1.8)	LPAR2 (1.4)	GPAM (1.4)	PLCG1 (1.4)
GO:0014910	regulation of smooth muscle cell migration	0.54	> 0.20	ZNF101 (2.1)	NKPD1 (1.7)	ST3GAL4 (1.7)	PMFBP1 (1.6)	ANKRD31 (1.6)	AMIGO1 (1.5)	KIAA1324 (1.5)	ADAM1 (1.5)	LPIN3 (1.5)	HLX (1.4)
GO:0006144	purine base metabolic process	0.54	> 0.20	ENSG00000228044 (2.5)	NT5DC1 (2.5)	DHODH (2.5)	LPIN3 (2.4)	TRAPPC6A (2.1)	SYPL2 (2.1)	QTRT1 (2.0)	ENSG00000226648 (1.9)	NKPD1 (1.7)	CEACAM19 (1.6)
MP:0008034	enhanced lipolysis	0.54	> 0.20	MOSC1 (6.6)	GPAM (5.7)	HAPLN4 (2.6)	HP (2.4)	SORT1 (2.2)	SYPL2 (2.0)	AMIGO1 (1.9)	NT5DC1 (1.6)	PVRL2 (1.5)	TM6SF2 (1.4)
GO:0007346	regulation of mitotic cell cycle	0.54	> 0.20	ENSG00000228044 (3.1)	PSRC1 (2.8)	POC5 (2.7)	PSMA5 (2.0)	SUGP1 (1.8)	TRAFD1 (1.8)	FEN1 (1.6)	BRAP (1.5)	PTPN11 (1.5)	NAA25 (1.4)
GO:0001741	XY body	0.54	> 0.20	LPAR2 (3.8)	MAU2 (3.2)	CARM1 (2.2)	C12orf47 (1.8)	SUGP1 (1.7)	DNAH11 (1.7)	ZNF101 (1.6)	DNM2 (1.5)	ENSG00000238078 (1.5)	ENSG00000226645 (1.5)
ENSG00000204086	RPA4 PPI subnetwork	0.54	> 0.20	FEN1 (6.0)	USP1 (5.3)	NT5DC1 (2.6)	MAU2 (1.6)	TMEM116 (1.6)	ENSG00000228044 (1.5)	AMIGO1 (1.4)	DHODH (1.4)	ENSG00000235545 (1.3)	ZNF180 (1.3)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	0.54	> 0.20	ST3GAL4 (2.8)	CILP2 (2.4)	HLX (2.3)	ERP29 (2.2)	NCAN (2.1)	TMED4 (1.6)	MARK4 (1.5)	ZHX3 (1.4)	YIPF2 (1.4)	GCNT4 (1.4)
GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	0.54	> 0.20	MYLIP (2.4)	DOCK7 (2.1)	ST3GAL4 (1.9)	MOSC1 (1.8)	SORT1 (1.7)	GMIP (1.6)	POLK (1.6)	MAFB (1.4)	PSRC1 (1.4)	HLX (1.4)
ENSG00000138835	RGS3 PPI subnetwork	0.54	> 0.20	BCAM (2.9)	CETP (2.4)	SLC22A1 (2.0)	NYNRIN (1.9)	CYP7A1 (1.9)	PCSK9 (1.8)	CELSR2 (1.5)	CARM1 (1.5)	TSSK6 (1.4)	AMIGO1 (1.4)
MP:0005601	increased angiogenesis	0.54	> 0.20	SH2B3 (2.6)	PVR (2.3)	PVRL2 (2.1)	BCL3 (1.9)	POLK (1.8)	KANK2 (1.8)	SYPL2 (1.7)	C12orf47 (1.7)	PMFBP1 (1.6)	ATXN7L2 (1.5)
ENSG00000198925	ATG9A PPI subnetwork	0.54	> 0.20	ZNF259 (4.0)	SARS (3.9)	DDX56 (3.4)	SUGP1 (3.4)	QTRT1 (3.0)	ATP13A1 (2.8)	GATAD2A (2.7)	DHX38 (2.4)	ILF3 (2.4)	ENSG00000226645 (2.3)
ENSG00000163918	RFC4 PPI subnetwork	0.54	> 0.20	FEN1 (6.0)	USP1 (5.1)	BLOC1S3 (2.0)	ZNF180 (1.8)	ILF3 (1.7)	TMEM116 (1.7)	ENSG00000228044 (1.7)	AMIGO1 (1.6)	NT5DC1 (1.2)	SMARCA4 (1.2)
ENSG00000173581	CCDC106 PPI subnetwork	0.54	> 0.20	FADS1 (3.2)	FADS2 (3.2)	HMGCR (3.0)	PCSK9 (2.6)	SARS (2.4)	LDLR (2.3)	SLC44A2 (2.0)	GEMIN7 (2.0)	ATXN7L2 (1.8)	BUD13 (1.8)
GO:0060766	negative regulation of androgen receptor signaling pathway	0.54	> 0.20	C19orf52 (2.6)	NT5DC1 (2.4)	KANK2 (2.1)	ENSG00000226648 (1.9)	NKPD1 (1.7)	ENSG00000226645 (1.7)	AMIGO1 (1.7)	TMEM116 (1.6)	C12orf47 (1.5)	PMFBP1 (1.4)
ENSG00000092067	CEBPE PPI subnetwork	0.54	> 0.20	SARS (3.0)	MAFB (2.2)	MAPKAPK5 (1.9)	BCL3 (1.9)	TRIB1 (1.8)	ATXN2 (1.8)	GRINA (1.8)	HLX (1.7)	POC5 (1.6)	RHD (1.4)
GO:0008307	structural constituent of muscle	0.54	> 0.20	SYPL2 (7.3)	GMPR (2.6)	KANK2 (1.4)	PVRL2 (1.0)	UBXN2B (0.9)	TMEM50A (0.9)	LPAR2 (0.9)	ITGB3 (0.9)	C12orf47 (0.8)	HNF1A (0.8)
ENSG00000177380	PPFIA3 PPI subnetwork	0.54	> 0.20	C11orf9 (2.5)	LPA (2.3)	MYLIP (2.3)	TMEM57 (2.2)	CILP2 (2.2)	PPP1R37 (2.2)	POC5 (1.8)	TSSK6 (1.8)	LPAR2 (1.7)	MAFB (1.7)
ENSG00000166971	AKTIP PPI subnetwork	0.54	> 0.20	SARS (2.9)	SMARCA4 (2.5)	OGDH (2.0)	PTPN11 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	ZNF180 (1.7)	C12orf43 (1.6)	ATP13A1 (1.6)	AP1M2 (1.6)
MP:0001290	delayed eyelid opening	0.54	> 0.20	APOC4 (3.4)	ENSG00000254235 (3.1)	COL4A3BP (2.5)	ABCG8 (2.4)	HLX (2.1)	APOA5 (2.1)	CEACAM19 (1.9)	FADS2 (1.8)	LPA (1.8)	ABCG5 (1.7)
GO:0030131	clathrin adaptor complex	0.54	> 0.20	CLPTM1 (3.5)	PPP1R37 (2.9)	DNM2 (2.6)	YIPF2 (2.6)	OGDH (2.3)	CYB561D1 (2.1)	GRINA (2.0)	C1orf63 (1.9)	COL4A3BP (1.7)	ZHX3 (1.7)
GO:0045124	regulation of bone resorption	0.54	> 0.20	ENSG00000226648 (2.8)	ENSG00000235545 (2.6)	RHCE (1.8)	TSSK6 (1.7)	ENSG00000254235 (1.4)	CETP (1.4)	ENSG00000228044 (1.4)	RHD (1.3)	DNAH11 (1.3)	PMFBP1 (1.2)
ENSG00000171357	C1orf190 PPI subnetwork	0.54	> 0.20	ABO (2.6)	BLOC1S3 (2.1)	CYB561D1 (1.9)	MARK4 (1.7)	CLPTM1 (1.6)	TMEM116 (1.6)	CARM1 (1.5)	PPP1R37 (1.4)	MYLIP (1.4)	NT5DC1 (1.3)
ENSG00000188985	ENSG00000188985 PPI subnetwork	0.54	> 0.20	ANGPTL3 (3.2)	CYP7A1 (2.3)	RPH3A (2.3)	HP (2.3)	APOA5 (2.2)	APOC4 (2.1)	PLG (1.9)	TMEM50A (1.8)	ALDH2 (1.7)	SLC22A1 (1.7)
REACTOME_PEROXISOMAL_LIPID_METABOLISM	REACTOME_PEROXISOMAL_LIPID_METABOLISM	0.54	> 0.20	MOSC1 (4.1)	GPAM (2.7)	UBXN2B (2.5)	APOA5 (2.4)	ACAD10 (2.3)	ALDH2 (2.3)	NT5DC1 (2.3)	TM6SF2 (2.2)	ABCG8 (2.1)	ABCG5 (2.0)
ENSG00000115694	STK25 PPI subnetwork	0.54	> 0.20	MARK4 (2.9)	ZNF180 (2.7)	UBXN2B (2.3)	DNM2 (2.0)	TMEM50A (1.9)	PVRL2 (1.8)	C11orf9 (1.8)	PSMA5 (1.7)	C17orf57 (1.7)	CLPTM1 (1.6)
MP:0001824	abnormal thymus involution	0.54	> 0.20	PLCG1 (2.5)	ENSG00000235545 (2.4)	RELB (2.3)	PBX4 (2.0)	GCNT4 (1.8)	ZHX3 (1.7)	C12orf47 (1.7)	CYB561D1 (1.5)	BCL3 (1.5)	DNAH11 (1.5)
ENSG00000177728	KIAA0195 PPI subnetwork	0.54	> 0.20	MARK4 (3.8)	C12orf51 (3.0)	ATXN2 (2.9)	GMIP (2.5)	LPAR2 (2.2)	GATAD2A (2.0)	USP24 (1.9)	ZNF180 (1.9)	DNM2 (1.8)	PVRL2 (1.7)
GO:0071706	tumor necrosis factor superfamily cytokine production	0.54	> 0.20	MAFB (2.1)	GRINA (1.9)	HLX (1.9)	GMIP (1.8)	TIMD4 (1.7)	PVR (1.7)	ST3GAL4 (1.6)	ALDH2 (1.6)	RELB (1.4)	ZNF101 (1.4)
MP:0002230	abnormal primitive streak formation	0.54	> 0.20	ABO (2.6)	ATXN7L2 (2.6)	PVRL2 (1.7)	APOB (1.6)	DOCK7 (1.5)	HNF1A (1.5)	APOE (1.4)	MARK4 (1.4)	FADS2 (1.3)	ADAM1 (1.3)
ENSG00000197223	C1D PPI subnetwork	0.54	> 0.20	DDX56 (3.0)	SUGP1 (2.8)	C19orf52 (2.5)	AP1M2 (2.4)	YIPF2 (2.4)	TOMM40 (2.3)	ENSG00000226645 (2.1)	QTRT1 (2.0)	GRINA (1.9)	TMEM50A (1.9)
GO:0042130	negative regulation of T cell proliferation	0.54	> 0.20	ENSG00000228044 (2.3)	ENSG00000254235 (1.9)	DNAH11 (1.9)	HNF1A (1.9)	COL4A3BP (1.6)	TRAFD1 (1.6)	ABO (1.3)	CYB561D1 (1.3)	GCNT4 (1.3)	C17orf57 (1.3)
MP:0003864	abnormal midbrain development	0.54	> 0.20	GMPR (2.1)	NYNRIN (2.0)	CARM1 (2.0)	PSRC1 (1.9)	DOCK7 (1.7)	DYNC2LI1 (1.7)	TRIB1 (1.7)	MARK4 (1.7)	OASL (1.6)	PPP1R37 (1.5)
GO:0042092	type 2 immune response	0.54	> 0.20	C17orf57 (2.0)	ZNF101 (1.6)	GRINA (1.5)	TRAFD1 (1.5)	BCL3 (1.4)	OASL (1.3)	C11orf9 (1.3)	NKPD1 (1.2)	DNAH11 (1.1)	GMIP (1.1)
MP:0001701	incomplete embryo turning	0.54	> 0.20	DOCK7 (2.5)	LPIN3 (1.9)	NYNRIN (1.8)	DHX38 (1.7)	ENSG00000254235 (1.6)	ATXN2 (1.5)	PLCG1 (1.5)	HLX (1.4)	SMARCA4 (1.3)	GATAD2A (1.3)
MP:0008947	increased neuron number	0.54	> 0.20	CELSR2 (2.5)	ATXN7L2 (1.7)	PMFBP1 (1.6)	GOT2P1 (1.5)	TMED4 (1.4)	PVR (1.4)	NPC1L1 (1.4)	FADS1 (1.3)	POLK (1.3)	CILP2 (1.3)
ENSG00000075142	SRI PPI subnetwork	0.54	> 0.20	BCL3 (2.6)	NT5DC1 (2.4)	PCSK9 (1.8)	ABO (1.8)	C17orf57 (1.7)	TMED4 (1.7)	TMEM50A (1.5)	CILP2 (1.4)	CEACAM19 (1.3)	QTRT1 (1.2)
ENSG00000100324	TAB1 PPI subnetwork	0.54	> 0.20	PTPN11 (2.2)	FRK (2.0)	MYLIP (1.9)	TRIB1 (1.9)	GATAD2A (1.8)	GRINA (1.7)	TOMM40 (1.5)	QTRT1 (1.4)	HAVCR1 (1.4)	BCL3 (1.4)
ENSG00000087266	SH3BP2 PPI subnetwork	0.54	> 0.20	GMIP (2.5)	ZNF101 (1.8)	MAFB (1.7)	SLC44A2 (1.7)	PLCG1 (1.6)	TIMD4 (1.5)	ZHX3 (1.5)	ENSG00000226645 (1.5)	OGDH (1.5)	TMED4 (1.4)
MP:0003270	intestinal obstruction	0.54	> 0.20	NCAN (2.2)	TMEM57 (1.8)	MYLIP (1.8)	HAVCR1 (1.7)	KANK2 (1.7)	TRIB1 (1.7)	ATXN2 (1.6)	HLX (1.6)	ZHX3 (1.6)	LPAR2 (1.5)
GO:0046851	negative regulation of bone remodeling	0.54	> 0.20	ENSG00000228044 (2.2)	HNF1A (2.0)	GOT2P1 (1.8)	ENSG00000254235 (1.8)	KIAA1324 (1.7)	ANKRD31 (1.7)	ABO (1.5)	POLK (1.3)	ENSG00000226645 (1.2)	CEACAM19 (1.1)
ENSG00000164163	ABCE1 PPI subnetwork	0.54	> 0.20	ZNF259 (3.2)	SARS (3.1)	DDX56 (3.1)	GATAD2A (3.1)	TOP1 (2.9)	ATP13A1 (2.5)	ILF3 (2.5)	NAA25 (2.5)	TMEM57 (2.4)	SUGP1 (2.3)
ENSG00000205542	TMSB4X PPI subnetwork	0.54	> 0.20	TIMD4 (3.2)	CETP (3.2)	PVRL2 (2.2)	FADS2 (2.1)	ITGB3 (2.0)	CEACAM19 (1.8)	RHD (1.5)	BCAM (1.5)	GEMIN7 (1.2)	TOMM40 (1.2)
GO:0006363	termination of RNA polymerase I transcription	0.54	> 0.20	C12orf43 (3.9)	TXNL4B (2.9)	DYNC2LI1 (2.8)	GEMIN7 (2.7)	MAPKAPK5 (2.5)	ZNF259 (2.3)	ATXN7L2 (2.3)	POLK (2.2)	DHX38 (1.8)	NAA25 (1.8)
ENSG00000166681	NGFRAP1 PPI subnetwork	0.54	> 0.20	RELB (3.9)	PBX4 (2.9)	GRINA (2.7)	PMFBP1 (1.7)	CLPTM1 (1.7)	PTPN11 (1.7)	GEMIN7 (1.5)	NKPD1 (1.4)	CELSR2 (1.4)	GCNT4 (1.3)
ENSG00000109332	UBE2D3 PPI subnetwork	0.54	> 0.20	BRAP (3.0)	USP24 (2.9)	ATXN2 (2.6)	C12orf51 (2.0)	PSMA5 (1.9)	SARS (1.9)	GATAD2A (1.8)	PTPN11 (1.7)	MYLIP (1.7)	TMEM57 (1.5)
MP:0010402	ventricular septal defect	0.54	> 0.20	NYNRIN (3.5)	TRIB1 (3.2)	PVRL2 (3.0)	ATXN2 (2.3)	HLX (1.9)	DOCK7 (1.9)	PLCG1 (1.8)	APOB (1.7)	C11orf9 (1.7)	PVR (1.5)
GO:0051168	nuclear export	0.54	> 0.20	ADAM1 (4.6)	C1orf63 (3.5)	BRAP (3.3)	TOP1 (3.1)	MAPKAPK5 (3.0)	ILF3 (2.8)	ATXN7L2 (2.4)	ENSG00000254235 (2.4)	GATAD2A (2.1)	TXNL4B (2.0)
GO:0007259	JAK-STAT cascade	0.54	> 0.20	TRAFD1 (2.6)	PARP10 (2.3)	ENSG00000254235 (1.7)	PVR (1.7)	BCL3 (1.6)	DYNC2LI1 (1.5)	ZNF101 (1.5)	HLX (1.4)	GEMIN7 (1.3)	PBX4 (1.3)
GO:0006261	DNA-dependent DNA replication	0.54	> 0.20	USP1 (3.2)	ZNF180 (2.9)	FEN1 (2.7)	AMIGO1 (2.0)	TXNL4B (2.0)	DHODH (2.0)	ENSG00000228044 (1.9)	NT5DC1 (1.6)	GOT2P1 (1.6)	ENSG00000235545 (1.6)
GO:0030119	AP-type membrane coat adaptor complex	0.54	> 0.20	CLPTM1 (3.4)	PPP1R37 (2.9)	YIPF2 (2.4)	DNM2 (2.4)	COL4A3BP (2.2)	OGDH (2.1)	C1orf63 (2.1)	GRINA (1.9)	CYB561D1 (1.8)	BLOC1S3 (1.6)
MP:0002106	abnormal muscle physiology	0.54	> 0.20	SYPL2 (7.5)	GMPR (2.3)	COL4A3BP (1.7)	SORT1 (1.7)	ZHX3 (1.6)	NPC1L1 (1.5)	ENSG00000226645 (1.5)	BCAM (1.4)	SLC44A2 (1.2)	PLEC (1.2)
GO:0048407	platelet-derived growth factor binding	0.54	> 0.20	APOE (3.2)	C17orf57 (2.6)	AP1M2 (2.1)	HLX (1.9)	MYLIP (1.9)	CILP2 (1.6)	KANK2 (1.6)	NPC1L1 (1.5)	KIAA1324 (1.5)	ITGB3 (1.4)
MP:0001157	small seminal vesicle	0.54	> 0.20	KIAA1324 (3.2)	LPA (2.1)	ATXN7L2 (1.9)	ST3GAL4 (1.9)	CYP7A1 (1.8)	SLC22A1 (1.8)	MOSC1 (1.5)	GPAM (1.4)	ENSG00000254235 (1.3)	LPIN3 (1.3)
GO:0008301	DNA binding, bending	0.54	> 0.20	HNF1A (2.7)	KANK2 (2.4)	CEACAM19 (2.3)	TRIB1 (2.1)	ANKRD31 (1.6)	RHCE (1.6)	HLX (1.6)	ALDH2 (1.3)	MOSC1 (1.3)	PLEKHH2 (1.3)
ENSG00000136942	RPL35 PPI subnetwork	0.54	> 0.20	NKPD1 (2.5)	ZNF259 (2.1)	GATAD2A (1.8)	ANKRD31 (1.7)	ENSG00000226645 (1.4)	UBXN2B (1.4)	MOSC1 (1.3)	GEMIN7 (1.2)	NAA25 (1.1)	ILF3 (1.1)
ENSG00000206419	ENSG00000206419 PPI subnetwork	0.54	> 0.20	ZHX3 (2.6)	PMFBP1 (2.6)	SLC44A2 (2.2)	ABO (2.1)	C19orf52 (1.8)	GATAD2A (1.8)	SYPL2 (1.7)	SH2B3 (1.7)	APOE (1.6)	MOSC1 (1.4)
ENSG00000206495	TRIM39 PPI subnetwork	0.54	> 0.20	ZHX3 (2.6)	PMFBP1 (2.6)	SLC44A2 (2.2)	ABO (2.1)	C19orf52 (1.8)	GATAD2A (1.8)	SYPL2 (1.7)	SH2B3 (1.7)	APOE (1.6)	MOSC1 (1.4)
ENSG00000204599	TRIM39 PPI subnetwork	0.54	> 0.20	ZHX3 (2.6)	PMFBP1 (2.6)	SLC44A2 (2.2)	ABO (2.1)	C19orf52 (1.8)	GATAD2A (1.8)	SYPL2 (1.7)	SH2B3 (1.7)	APOE (1.6)	MOSC1 (1.4)
GO:0005743	mitochondrial inner membrane	0.54	> 0.20	OGDH (4.2)	ACAD10 (4.1)	TRAPPC6A (2.2)	GMPR (2.2)	ALDH2 (2.2)	TOMM40 (2.2)	GPAM (1.9)	ABCG8 (1.9)	C19orf52 (1.8)	PSMA5 (1.8)
GO:0030219	megakaryocyte differentiation	0.54	> 0.20	ENSG00000226648 (2.8)	RHCE (2.7)	GMPR (2.6)	ITGB3 (2.6)	ZNF180 (2.3)	TSSK6 (2.1)	BRAP (2.0)	RHD (2.0)	TMEM57 (1.8)	BUD13 (1.6)
MP:0001850	increased susceptibility to otitis media	0.54	> 0.20	BCAM (2.3)	DOCK7 (1.9)	MYLIP (1.7)	DYNC2LI1 (1.7)	DNAH11 (1.5)	CILP2 (1.4)	CBLC (1.4)	CYB561D1 (1.4)	KANK2 (1.4)	TRAPPC6A (1.3)
MP:0006279	abnormal limb development	0.54	> 0.20	HMGCR (3.3)	LDLR (3.0)	PLEKHH2 (2.3)	CILP2 (2.2)	DYNC2LI1 (2.0)	GOT2P1 (1.8)	AP1M2 (1.7)	ANKRD31 (1.7)	FADS1 (1.5)	CBLC (1.4)
GO:0070536	protein K63-linked deubiquitination	0.54	> 0.20	NKPD1 (3.7)	ZNF180 (3.0)	GCNT4 (2.7)	TMEM57 (2.4)	MAU2 (2.3)	NT5DC1 (2.2)	ZNF101 (2.1)	AMIGO1 (2.0)	YIPF2 (1.6)	ENSG00000228044 (1.6)
ENSG00000185721	DRG1 PPI subnetwork	0.54	> 0.20	TOMM40 (3.1)	GMPR (2.8)	QTRT1 (2.7)	DDX56 (2.6)	TOP1 (2.6)	TMEM57 (2.4)	TRAPPC6A (2.3)	GATAD2A (2.2)	FRK (2.1)	PLCG1 (2.0)
MP:0002796	impaired skin barrier function	0.54	> 0.20	NKPD1 (5.2)	CEACAM19 (2.9)	CELSR2 (2.2)	AP1M2 (2.0)	CBLC (1.9)	BLOC1S3 (1.6)	BCAM (1.2)	ENSG00000226648 (1.2)	C17orf57 (1.2)	PLCG1 (1.1)
MP:0001927	abnormal estrous cycle	0.54	> 0.20	ABO (2.8)	APOB (2.6)	NYNRIN (2.4)	KIAA1324 (1.7)	TMEM116 (1.6)	LPIN3 (1.6)	ZHX3 (1.6)	NT5DC1 (1.4)	ZNF180 (1.2)	APOC4 (1.2)
GO:0070373	negative regulation of ERK1 and ERK2 cascade	0.54	> 0.20	PLEKHH2 (2.4)	TRIB1 (2.1)	SORT1 (2.0)	HAVCR1 (1.8)	PVR (1.7)	C17orf57 (1.7)	PMFBP1 (1.5)	DYNC2LI1 (1.4)	COL4A3BP (1.3)	DNAH11 (1.3)
GO:0048589	developmental growth	0.54	> 0.20	PPP1R37 (2.6)	CILP2 (2.6)	NYNRIN (1.7)	CELSR2 (1.6)	GOT2P1 (1.5)	ATXN7L2 (1.4)	ENSG00000228044 (1.3)	ATXN2 (1.3)	GCNT4 (1.3)	MAFB (1.2)
ENSG00000185236	RAB11B PPI subnetwork	0.54	> 0.20	YIPF2 (4.1)	GRINA (3.8)	CLPTM1 (3.7)	TMEM57 (2.7)	TMEM50A (2.5)	PPP1R37 (2.3)	POC5 (1.9)	AP1M2 (1.7)	C1orf63 (1.7)	ZHX3 (1.6)
MP:0000026	abnormal inner ear morphology	0.54	> 0.20	TMEM116 (2.7)	CILP2 (2.4)	DYNC2LI1 (2.4)	MYLIP (2.1)	PPP1R37 (1.7)	C17orf57 (1.5)	PLCG1 (1.4)	PLEC (1.2)	ST3GAL4 (1.2)	TM6SF2 (1.1)
GO:0042359	vitamin D metabolic process	0.54	> 0.20	ENSG00000228044 (3.7)	ANGPTL3 (2.0)	ANKRD31 (1.7)	GCNT4 (1.6)	ATXN7L2 (1.6)	TM6SF2 (1.6)	LPAR2 (1.5)	TRAFD1 (1.4)	POC5 (1.3)	GEMIN7 (1.2)
ENSG00000166530	ENSG00000166530 PPI subnetwork	0.54	> 0.20	GOT2P1 (3.2)	GRINA (2.9)	MAPKAPK5 (2.4)	RHD (2.2)	PSRC1 (2.1)	CEACAM19 (1.9)	UBXN2B (1.9)	PLCG1 (1.8)	ATXN2 (1.7)	POLK (1.6)
ENSG00000005075	POLR2J PPI subnetwork	0.54	> 0.20	ILF3 (3.4)	BUD13 (3.3)	TOP1 (3.1)	DHX38 (2.8)	SUGP1 (2.7)	USP1 (2.6)	C1orf63 (2.4)	SMARCA4 (2.2)	FEN1 (2.1)	MAPKAPK5 (2.0)
ENSG00000167491	GATAD2A PPI subnetwork	0.54	> 0.20	GMPR (2.1)	C19orf52 (2.0)	TMEM57 (1.9)	ZNF180 (1.6)	C11orf9 (1.3)	BUD13 (1.3)	MYLIP (1.2)	DNAH11 (1.1)	PMFBP1 (1.1)	FADS1 (1.1)
REACTOME_PEPTIDE_CHAIN_ELONGATION	REACTOME_PEPTIDE_CHAIN_ELONGATION	0.54	> 0.20	NKPD1 (3.0)	MOSC1 (1.7)	GATAD2A (1.5)	UBXN2B (1.5)	ANKRD31 (1.4)	ERP29 (1.2)	DNAH11 (1.2)	ILF3 (1.2)	GPAM (1.2)	CEACAM19 (1.1)
ENSG00000116350	SRSF4 PPI subnetwork	0.54	> 0.20	C1orf63 (4.8)	ILF3 (4.0)	TOP1 (3.2)	USP1 (2.6)	DHX38 (2.5)	QTRT1 (2.3)	SMARCA4 (2.3)	BUD13 (2.2)	FEN1 (2.2)	PTPN11 (2.0)
MP:0000897	abnormal midbrain morphology	0.54	> 0.20	CARM1 (2.6)	ATXN2 (2.4)	CLPTM1 (2.1)	C17orf57 (2.0)	PPP1R37 (1.8)	ABO (1.6)	COL4A3BP (1.6)	HAVCR1 (1.6)	ZHX3 (1.5)	AMIGO1 (1.5)
GO:0031398	positive regulation of protein ubiquitination	0.54	> 0.20	PSMA5 (3.7)	TRAFD1 (2.7)	BRAP (2.1)	POC5 (2.0)	NAA25 (2.0)	NT5DC1 (1.7)	HAVCR1 (1.6)	TXNL4B (1.5)	ZNF180 (1.5)	SUGP1 (1.5)
GO:0043408	regulation of MAPK cascade	0.54	> 0.20	TRIB1 (2.4)	PVR (2.3)	C11orf9 (2.3)	ENSG00000226645 (2.2)	PLEKHH2 (1.9)	HLX (1.7)	POLK (1.5)	ST3GAL4 (1.4)	PTPN11 (1.3)	KANK2 (1.1)
GO:0006611	protein export from nucleus	0.54	> 0.20	ADAM1 (3.1)	TMEM116 (1.9)	CARM1 (1.8)	ENSG00000254235 (1.8)	ATXN7L2 (1.8)	POC5 (1.8)	GATAD2A (1.8)	BRAP (1.7)	DDX56 (1.7)	ATXN2 (1.7)
ENSG00000070785	EIF2B3 PPI subnetwork	0.54	> 0.20	SARS (5.5)	DDX56 (4.4)	TXNL4B (3.5)	DHODH (3.0)	TOMM40 (2.4)	ZNF259 (2.1)	SUGP1 (2.1)	QTRT1 (2.0)	PSMA5 (2.0)	KIAA1324 (2.0)
GO:0008138	protein tyrosine/serine/threonine phosphatase activity	0.54	> 0.20	TRIB1 (5.6)	SYPL2 (3.6)	TSSK6 (2.3)	PVR (2.2)	HLX (1.6)	SH2B3 (1.6)	ENSG00000226645 (1.6)	POLK (1.6)	SORT1 (1.4)	MAPKAPK5 (1.4)
MP:0003460	decreased fear-related response	0.54	> 0.20	ATXN7L2 (2.8)	ENSG00000226645 (2.1)	TRIB1 (2.0)	TRAFD1 (2.0)	AMIGO1 (1.9)	NCAN (1.8)	ENSG00000235545 (1.8)	CYP7A1 (1.8)	FRK (1.6)	MARK4 (1.6)
ENSG00000111049	MYF5 PPI subnetwork	0.55	> 0.20	MAPKAPK5 (2.6)	CYB561D1 (1.8)	BUD13 (1.7)	HLX (1.7)	TSSK6 (1.6)	PPP1R37 (1.6)	MYLIP (1.6)	PLCG1 (1.6)	DYNC2LI1 (1.5)	ATXN7L2 (1.5)
REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC:NER	REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC:NER	0.55	> 0.20	FEN1 (5.9)	USP1 (5.8)	ZNF180 (2.5)	GOT2P1 (1.8)	ENSG00000235545 (1.7)	ERP29 (1.6)	ENSG00000228044 (1.6)	NT5DC1 (1.3)	FADS1 (1.2)	TMEM116 (1.2)
REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG:NER	REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG:NER	0.55	> 0.20	FEN1 (5.9)	USP1 (5.8)	ZNF180 (2.5)	GOT2P1 (1.8)	ENSG00000235545 (1.7)	ERP29 (1.6)	ENSG00000228044 (1.6)	NT5DC1 (1.3)	FADS1 (1.2)	TMEM116 (1.2)
ENSG00000171681	ATF7IP PPI subnetwork	0.55	> 0.20	PVRL2 (3.2)	USP24 (2.7)	PLEC (2.0)	BCAM (2.0)	NYNRIN (1.9)	HNF1A (1.9)	SH2B3 (1.6)	KANK2 (1.6)	PPP1R37 (1.6)	PVR (1.5)
MP:0008186	increased pro-B cell number	0.55	> 0.20	GMIP (2.9)	RELB (2.4)	ENSG00000226645 (2.3)	ERP29 (2.1)	TIMD4 (1.8)	CETP (1.7)	MAFB (1.7)	PBX4 (1.6)	ZNF101 (1.4)	FRK (1.4)
ENSG00000016082	ISL1 PPI subnetwork	0.55	> 0.20	C19orf52 (2.4)	GMPR (1.9)	COL4A3BP (1.7)	TMEM57 (1.6)	BCAM (1.6)	MARK4 (1.5)	RHD (1.5)	RPH3A (1.4)	FADS2 (1.4)	C12orf43 (1.3)
ENSG00000107625	DDX50 PPI subnetwork	0.55	> 0.20	QTRT1 (2.5)	USP1 (2.1)	ZNF259 (2.1)	ILF3 (2.0)	TOMM40 (2.0)	SMARCA4 (1.9)	ATP13A1 (1.8)	FEN1 (1.7)	NKPD1 (1.7)	DDX56 (1.7)
ENSG00000147133	TAF1 PPI subnetwork	0.55	> 0.20	ATXN2 (2.5)	SUGP1 (2.5)	TOP1 (2.3)	DHX38 (2.1)	BUD13 (2.1)	SMARCA4 (1.8)	MAPKAPK5 (1.7)	USP1 (1.6)	PSMA5 (1.5)	FEN1 (1.4)
GO:0017025	TBP-class protein binding	0.55	> 0.20	NYNRIN (2.8)	C1orf63 (2.3)	SH2B3 (2.3)	ATXN2 (2.1)	ERP29 (2.0)	ACAD10 (2.0)	DOCK7 (1.7)	MAPKAPK5 (1.7)	TRAFD1 (1.7)	C17orf57 (1.7)
MP:0005075	abnormal melanosome morphology	0.55	> 0.20	DOCK7 (2.5)	NKPD1 (2.2)	PPP1R37 (2.0)	ACAD10 (1.9)	GMPR (1.9)	MYLIP (1.8)	ST3GAL4 (1.7)	TMEM116 (1.6)	BRAP (1.6)	BLOC1S3 (1.5)
ENSG00000184708	EIF4ENIF1 PPI subnetwork	0.55	> 0.20	PSRC1 (2.3)	KANK2 (2.3)	MYLIP (2.0)	CARM1 (2.0)	ENSG00000254235 (1.8)	DOCK7 (1.6)	DYNC2LI1 (1.5)	POLK (1.4)	ENSG00000226645 (1.3)	ALDH2 (1.2)
ENSG00000124207	CSE1L PPI subnetwork	0.55	> 0.20	NAA25 (3.2)	SARS (3.1)	OGDH (2.6)	TOP1 (2.6)	ATXN2 (2.2)	DDX56 (2.1)	GRINA (2.0)	HMGCR (2.0)	USP24 (2.0)	DHX38 (2.0)
GO:0031526	brush border membrane	0.55	> 0.20	TM6SF2 (3.8)	PLG (3.6)	TMEM116 (3.3)	AP1M2 (3.1)	NPC1L1 (2.9)	ANGPTL3 (2.5)	KIAA1324 (2.2)	APOB (1.8)	ENSG00000226648 (1.6)	FRK (1.5)
GO:0044420	extracellular matrix part	0.55	> 0.20	CILP2 (4.9)	APOE (3.2)	BCAM (2.8)	PLEKHH2 (2.7)	AP1M2 (2.1)	APOC1 (1.8)	KANK2 (1.7)	MAFB (1.7)	CBLC (1.4)	MYLIP (1.3)
MP:0000084	abnormal fontanelle morphology	0.55	> 0.20	MYLIP (2.4)	NPC1L1 (2.4)	APOE (2.0)	ITGB3 (1.9)	CILP2 (1.7)	ABO (1.6)	GCNT4 (1.5)	PPP1R37 (1.4)	GPAM (1.4)	FRK (1.3)
ENSG00000126247	CAPNS1 PPI subnetwork	0.55	> 0.20	GRINA (2.9)	ENSG00000235545 (2.8)	PLEC (2.7)	ANKRD31 (2.4)	AP1M2 (2.2)	ST3GAL4 (1.8)	GOT2P1 (1.7)	CBLC (1.7)	SLC44A2 (1.6)	DOCK7 (1.6)
ENSG00000126602	TRAP1 PPI subnetwork	0.55	> 0.20	NYNRIN (2.3)	DHX38 (2.1)	CLPTM1 (1.8)	TOMM40 (1.8)	ATP13A1 (1.7)	ENSG00000238078 (1.7)	BUD13 (1.6)	ABO (1.6)	SH2B3 (1.5)	TMEM50A (1.4)
ENSG00000128833	MYO5C PPI subnetwork	0.55	> 0.20	ATP13A1 (3.2)	OGDH (2.7)	SARS (2.5)	SMARCA4 (2.4)	ILF3 (2.4)	FEN1 (2.2)	NAA25 (2.1)	ATXN2 (1.9)	QTRT1 (1.9)	USP24 (1.8)
ENSG00000157110	RBPMS PPI subnetwork	0.55	> 0.20	PPP1R37 (3.0)	GRINA (2.3)	PSRC1 (1.9)	ENSG00000238078 (1.9)	C19orf52 (1.7)	ANKRD31 (1.7)	DNM2 (1.6)	ABO (1.5)	MARK4 (1.5)	ATXN7L2 (1.5)
GO:0030728	ovulation	0.55	> 0.20	HNF1A (2.2)	FRK (1.7)	GPAM (1.6)	PVR (1.4)	MOSC1 (1.4)	HAVCR1 (1.3)	GCNT4 (1.3)	ST3GAL4 (1.2)	TRIB1 (1.2)	TMEM57 (1.1)
ENSG00000073792	IGF2BP2 PPI subnetwork	0.55	> 0.20	PSMA5 (3.3)	AP1M2 (2.5)	TOP1 (2.2)	QTRT1 (2.1)	SARS (2.1)	SORT1 (2.1)	BCAM (1.9)	ZNF101 (1.6)	C19orf52 (1.6)	ILF3 (1.6)
ENSG00000168374	ARF4 PPI subnetwork	0.55	> 0.20	ATP13A1 (3.2)	ILF3 (3.1)	QTRT1 (2.8)	OGDH (2.7)	YIPF2 (2.6)	DNM2 (2.5)	ACAD10 (2.1)	SARS (2.0)	DHX38 (1.8)	SMARCA4 (1.8)
ENSG00000090776	EFNB1 PPI subnetwork	0.55	> 0.20	CBLC (3.0)	ENSG00000226648 (2.7)	CETP (2.7)	LPAR2 (2.7)	SARS (2.5)	CELSR2 (2.0)	PLEC (2.0)	DDX56 (1.8)	NCAN (1.6)	ALDH2 (1.6)
GO:2001021	negative regulation of response to DNA damage stimulus	0.55	> 0.20	ANKRD31 (4.6)	POLK (2.5)	MYLIP (2.3)	BLOC1S3 (1.7)	BUD13 (1.5)	SH2B3 (1.5)	C12orf47 (1.3)	NYNRIN (1.3)	NT5DC1 (1.3)	C1orf63 (1.2)
ENSG00000106305	AIMP2 PPI subnetwork	0.55	> 0.20	SARS (6.3)	ZNF259 (3.3)	NAA25 (2.3)	C12orf47 (2.1)	NCAN (2.0)	DYNC2LI1 (1.9)	DDX56 (1.8)	QTRT1 (1.8)	DNAH11 (1.7)	RHCE (1.6)
GO:0000775	chromosome, centromeric region	0.55	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.2)	POC5 (3.8)	ZNF180 (1.4)	DHX38 (1.1)	BUD13 (1.1)	ILF3 (0.8)	COL4A3BP (0.6)	KANK2 (0.6)
ENSG00000162129	CLPB PPI subnetwork	0.55	> 0.20	OGDH (2.8)	TOP1 (2.3)	PBX4 (2.1)	TOMM40 (2.1)	ILF3 (1.9)	POLK (1.8)	GOT2P1 (1.6)	GMPR (1.5)	NYNRIN (1.5)	NAA25 (1.4)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER	0.55	> 0.20	GEMIN7 (3.7)	C12orf43 (3.2)	ZNF259 (2.8)	DDX56 (2.7)	MAPKAPK5 (2.2)	ENSG00000226645 (2.1)	POC5 (1.8)	BUD13 (1.8)	TOMM40 (1.8)	QTRT1 (1.5)
GO:0048738	cardiac muscle tissue development	0.55	> 0.20	CEACAM19 (2.8)	SYPL2 (2.1)	C11orf9 (2.1)	ENSG00000238078 (2.0)	GMPR (1.7)	C17orf57 (1.5)	C19orf52 (1.4)	CILP2 (1.3)	BCAM (1.3)	NYNRIN (1.3)
GO:0046466	membrane lipid catabolic process	0.55	> 0.20	NKPD1 (7.1)	ERP29 (3.3)	CYB561D1 (3.1)	PMFBP1 (2.9)	HNF1A (2.8)	LPIN3 (2.2)	TMEM50A (2.2)	GCNT4 (2.1)	ENSG00000238078 (2.0)	TMED4 (1.9)
GO:0030149	sphingolipid catabolic process	0.55	> 0.20	NKPD1 (7.1)	ERP29 (3.3)	CYB561D1 (3.1)	PMFBP1 (2.9)	HNF1A (2.8)	LPIN3 (2.2)	TMEM50A (2.2)	GCNT4 (2.1)	ENSG00000238078 (2.0)	TMED4 (1.9)
ENSG00000137601	NEK1 PPI subnetwork	0.55	> 0.20	KANK2 (2.1)	ATXN2 (1.9)	DYNC2LI1 (1.9)	ZNF259 (1.8)	CETP (1.6)	PLEKHH2 (1.5)	ENSG00000235545 (1.3)	COL4A3BP (1.2)	ANKRD31 (1.1)	GOT2P1 (1.1)
MP:0008451	retinal rod cell degeneration	0.55	> 0.20	ENSG00000235545 (2.9)	GPAM (2.4)	ST3GAL4 (2.1)	GCNT4 (1.9)	DYNC2LI1 (1.7)	GEMIN7 (1.2)	MAFB (1.2)	CEACAM19 (1.2)	ZNF180 (1.0)	NYNRIN (1.0)
ENSG00000100292	HMOX1 PPI subnetwork	0.55	> 0.20	SYPL2 (2.6)	GRINA (2.2)	MAFB (1.9)	ALDH2 (1.9)	TIMD4 (1.8)	TOMM40 (1.6)	RHD (1.6)	HP (1.5)	PVR (1.5)	BLOC1S3 (1.4)
MP:0008006	increased stomach pH	0.55	> 0.20	OASL (2.3)	ABO (2.1)	GCNT4 (2.0)	C11orf9 (1.9)	SLC44A2 (1.8)	TMEM116 (1.7)	KIAA1324 (1.7)	TMED4 (1.4)	DOCK7 (1.4)	COL4A3BP (1.4)
REACTOME_RAFMAP_KINASE_CASCADE	REACTOME_RAFMAP_KINASE_CASCADE	0.55	> 0.20	MAPKAPK5 (2.6)	BLOC1S3 (2.5)	CARM1 (2.2)	DNM2 (2.2)	CYB561D1 (2.1)	PBX4 (1.9)	GEMIN7 (1.7)	TMEM50A (1.4)	HLX (1.4)	SMARCA4 (1.4)
GO:0090199	regulation of release of cytochrome c from mitochondria	0.55	> 0.20	C12orf47 (2.4)	TMEM116 (2.3)	LPAR2 (1.9)	BRAP (1.9)	GOT2P1 (1.8)	C12orf43 (1.7)	TRAPPC6A (1.6)	FRK (1.5)	ERP29 (1.4)	C19orf52 (1.3)
MP:0009546	absent gastric milk in neonates	0.55	> 0.20	PCSK9 (2.8)	HMGCR (2.7)	FADS2 (2.5)	FADS1 (2.4)	ALDH2 (2.3)	LDLR (2.2)	DNAH11 (1.9)	LPA (1.8)	ABO (1.8)	PLCG1 (1.7)
GO:0043502	regulation of muscle adaptation	0.55	> 0.20	CEACAM19 (2.4)	HNF1A (2.1)	ENSG00000254235 (2.0)	LPIN3 (1.9)	SYPL2 (1.7)	TRAPPC6A (1.6)	C12orf43 (1.5)	TXNL4B (1.5)	GCNT4 (1.5)	HAVCR1 (1.5)
ENSG00000107438	PDLIM1 PPI subnetwork	0.55	> 0.20	HAVCR1 (2.3)	ENSG00000238078 (2.3)	UBXN2B (2.2)	C11orf9 (1.9)	SORT1 (1.8)	NYNRIN (1.7)	CARM1 (1.6)	PVR (1.6)	C1orf63 (1.6)	GEMIN7 (1.5)
GO:0051654	establishment of mitochondrion localization	0.55	> 0.20	GEMIN7 (2.0)	ACAD10 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	CYB561D1 (1.4)	C12orf47 (1.4)	GCNT4 (1.3)	POLK (1.3)	OGDH (1.2)	ENSG00000226648 (1.2)
REACTOME_SIGNALING_BY_ERBB2	REACTOME_SIGNALING_BY_ERBB2	0.55	> 0.20	ZHX3 (2.9)	PLEC (2.6)	MARK4 (2.4)	SH2B3 (2.3)	DNM2 (2.1)	CLPTM1 (2.0)	TRIB1 (2.0)	ZNF101 (1.9)	PTPN11 (1.7)	POLK (1.7)
ENSG00000151923	TIAL1 PPI subnetwork	0.55	> 0.20	SYPL2 (2.7)	TMEM50A (2.2)	ILF3 (2.1)	SMARCA4 (1.7)	GMPR (1.7)	CARM1 (1.6)	ENSG00000238078 (1.6)	OGDH (1.6)	PTPN11 (1.5)	DYNC2LI1 (1.4)
ENSG00000197961	ZNF121 PPI subnetwork	0.55	> 0.20	ATP13A1 (3.2)	OGDH (2.7)	SARS (2.5)	SMARCA4 (2.4)	ILF3 (2.4)	FEN1 (2.3)	NAA25 (2.1)	QTRT1 (2.0)	ATXN2 (1.9)	PSMA5 (1.8)
GO:0006024	glycosaminoglycan biosynthetic process	0.55	> 0.20	ST3GAL4 (2.8)	HAVCR1 (2.1)	CILP2 (2.1)	ENSG00000254235 (2.0)	GCNT4 (1.9)	FRK (1.7)	LPIN3 (1.6)	TMEM57 (1.6)	ZNF180 (1.5)	CYB561D1 (1.5)
REACTOME_LAGGING_STRAND_SYNTHESIS	REACTOME_LAGGING_STRAND_SYNTHESIS	0.55	> 0.20	FEN1 (6.1)	USP1 (5.8)	ZNF180 (2.7)	ENSG00000235545 (1.9)	AMIGO1 (1.8)	ERP29 (1.4)	FADS1 (1.4)	GOT2P1 (1.4)	ENSG00000228044 (1.4)	KIAA1324 (1.2)
MP:0000792	abnormal cortical marginal zone morphology	0.55	> 0.20	GRINA (2.5)	NPC1L1 (2.3)	CLPTM1 (2.2)	C1orf63 (2.1)	RPH3A (1.9)	APOB (1.8)	ABCG8 (1.8)	HAVCR1 (1.8)	ABCG5 (1.7)	C12orf51 (1.7)
ENSG00000075388	FGF4 PPI subnetwork	0.55	> 0.20	HAVCR1 (4.6)	HAPLN4 (3.4)	PLEKHH2 (2.7)	NCAN (2.6)	C11orf9 (2.4)	C17orf57 (2.4)	PPP1R37 (2.1)	ZHX3 (2.0)	CBLC (2.0)	APOE (2.0)
ENSG00000134255	CEPT1 PPI subnetwork	0.55	> 0.20	ATP13A1 (3.1)	OGDH (2.7)	SMARCA4 (2.5)	ILF3 (2.5)	FEN1 (2.3)	SARS (2.3)	NAA25 (2.0)	ATXN2 (1.9)	QTRT1 (1.9)	DNM2 (1.8)
ENSG00000058404	CAMK2B PPI subnetwork	0.55	> 0.20	KIAA1324 (2.2)	RPH3A (2.1)	CYB561D1 (2.0)	SORT1 (2.0)	ZNF180 (1.9)	PVR (1.8)	ENSG00000226648 (1.7)	HAVCR1 (1.6)	ATXN7L2 (1.6)	C1orf63 (1.6)
ENSG00000049246	PER3 PPI subnetwork	0.55	> 0.20	ZHX3 (2.8)	CILP2 (2.2)	C17orf57 (1.7)	MAPKAPK5 (1.7)	GPAM (1.7)	UBXN2B (1.6)	KANK2 (1.5)	PBX4 (1.4)	TMEM116 (1.3)	BUD13 (1.2)
GO:0007494	midgut development	0.55	> 0.20	ABCG5 (3.5)	TM6SF2 (2.9)	CYP7A1 (2.9)	ABCG8 (2.9)	LPIN3 (2.5)	ANKRD31 (2.2)	NPC1L1 (2.1)	ENSG00000238078 (2.0)	LPA (1.8)	AMIGO1 (1.7)
ENSG00000188843	ENSG00000188843 PPI subnetwork	0.55	> 0.20	TSSK6 (2.6)	BCAM (2.4)	LPIN3 (2.3)	PPP1R37 (2.3)	PVRL2 (2.2)	ATXN7L2 (1.8)	CBLC (1.7)	BLOC1S3 (1.6)	SORT1 (1.5)	HAVCR1 (1.4)
GO:0002702	positive regulation of production of molecular mediator of immune response	0.55	> 0.20	GCNT4 (2.6)	SH2B3 (2.0)	ZNF101 (2.0)	HAVCR1 (1.9)	C17orf57 (1.5)	MOSC1 (1.4)	HLX (1.4)	DYNC2LI1 (1.3)	ENSG00000226645 (1.2)	MAU2 (1.0)
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	0.55	> 0.20	NYNRIN (3.6)	SH2B3 (2.8)	HLX (2.8)	GMIP (2.0)	ENSG00000254235 (1.8)	MAFB (1.8)	OGDH (1.7)	ADAM1 (1.7)	CILP2 (1.6)	GATAD2A (1.5)
REACTOME_G1S_TRANSITION	REACTOME_G1S_TRANSITION	0.55	> 0.20	FEN1 (5.4)	PSMA5 (4.3)	USP1 (3.4)	NT5DC1 (1.9)	TOMM40 (1.6)	TRAFD1 (1.5)	ENSG00000235545 (1.5)	TXNL4B (1.4)	PSRC1 (1.4)	DDX56 (1.3)
ENSG00000124813	RUNX2 PPI subnetwork	0.55	> 0.20	TRIB1 (4.4)	PLCG1 (4.1)	MAFB (3.2)	DOCK7 (2.9)	ENSG00000238078 (2.6)	ENSG00000226648 (2.6)	ENSG00000226645 (2.4)	ATXN2 (2.1)	MAPKAPK5 (1.7)	DHX38 (1.5)
GO:0000982	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity	0.55	> 0.20	TRIB1 (5.7)	SH2B3 (2.4)	NYNRIN (2.3)	PVRL2 (1.7)	MAFB (1.6)	CELSR2 (1.5)	BCL3 (1.5)	PSRC1 (1.5)	ENSG00000254235 (1.5)	ENSG00000226648 (1.4)
ENSG00000065518	NDUFB4 PPI subnetwork	0.55	> 0.20	ACAD10 (4.1)	TRAPPC6A (3.1)	OGDH (3.1)	C12orf47 (2.4)	HNF1A (1.7)	TMED4 (1.6)	GMPR (1.6)	C1orf63 (1.6)	NT5DC1 (1.4)	PTPN11 (1.4)
ENSG00000215727	ENSG00000215727 PPI subnetwork	0.55	> 0.20	ACAD10 (4.1)	TRAPPC6A (3.1)	OGDH (3.1)	C12orf47 (2.4)	HNF1A (1.7)	TMED4 (1.6)	GMPR (1.6)	C1orf63 (1.6)	NT5DC1 (1.4)	PTPN11 (1.4)
GO:0006353	transcription termination, DNA-dependent	0.55	> 0.20	C1orf63 (3.9)	ENSG00000226645 (3.6)	C12orf43 (3.6)	GEMIN7 (2.8)	BUD13 (2.8)	ADAM1 (2.5)	TXNL4B (2.5)	ILF3 (2.4)	MAPKAPK5 (2.3)	TOP1 (2.0)
ENSG00000169756	LIMS1 PPI subnetwork	0.55	> 0.20	ITGB3 (3.1)	ST3GAL4 (2.0)	ZNF101 (1.9)	KANK2 (1.9)	ENSG00000228044 (1.8)	ZHX3 (1.8)	ABO (1.7)	PBX4 (1.6)	PTPN11 (1.5)	DNM2 (1.5)
ENSG00000146648	EGFR PPI subnetwork	0.55	> 0.20	TRIB1 (2.5)	DNM2 (2.4)	DOCK7 (2.3)	GMIP (2.3)	AP1M2 (2.1)	COL4A3BP (2.1)	PVRL2 (2.0)	CARM1 (2.0)	PLEC (1.8)	ENSG00000238078 (1.8)
MP:0002406	increased susceptibility to infection	0.55	> 0.20	RELB (3.1)	GCNT4 (2.8)	BCL3 (2.7)	AMIGO1 (2.4)	CYB561D1 (2.3)	ZNF101 (2.1)	HLX (1.7)	C12orf47 (1.7)	ANKRD31 (1.6)	NAA25 (1.6)
GO:0006607	NLS-bearing substrate import into nucleus	0.55	> 0.20	ENSG00000254235 (3.0)	USP24 (2.6)	ATXN2 (2.4)	C17orf57 (2.1)	CARM1 (2.1)	GCNT4 (1.9)	TXNL4B (1.6)	ENSG00000226645 (1.5)	DNAH11 (1.5)	C19orf52 (1.5)
GO:0015108	chloride transmembrane transporter activity	0.55	> 0.20	HNF1A (3.2)	PLG (2.6)	TMEM116 (2.5)	PBX4 (2.3)	NT5DC1 (2.2)	ANGPTL3 (2.1)	CLPTM1 (2.1)	ATP13A1 (2.0)	GRINA (1.8)	HLX (1.7)
GO:0003697	single-stranded DNA binding	0.55	> 0.20	FEN1 (4.0)	USP1 (3.4)	C1orf63 (2.3)	ENSG00000235545 (2.0)	DYNC2LI1 (2.0)	ILF3 (1.8)	DHODH (1.8)	POLK (1.7)	NT5DC1 (1.7)	CARM1 (1.6)
GO:0002637	regulation of immunoglobulin production	0.55	> 0.20	GCNT4 (1.9)	HAVCR1 (1.7)	PBX4 (1.5)	ENSG00000226645 (1.5)	ENSG00000238078 (1.3)	SLC22A1 (1.2)	ZNF101 (1.2)	C17orf57 (1.1)	MOSC1 (1.1)	LPAR2 (1.1)
GO:0072595	maintenance of protein localization to organelle	0.55	> 0.20	CEACAM19 (3.3)	GOT2P1 (2.4)	TMED4 (2.3)	YIPF2 (2.2)	BLOC1S3 (2.0)	CLPTM1 (2.0)	CYB561D1 (1.9)	TMEM50A (1.6)	ENSG00000254235 (1.5)	ZNF101 (1.3)
ENSG00000042980	ADAM28 PPI subnetwork	0.55	> 0.20	MARK4 (3.7)	GMIP (3.1)	C12orf51 (2.9)	USP24 (2.6)	SLC44A2 (2.4)	LPAR2 (2.3)	ATXN2 (2.3)	DNM2 (2.0)	ZNF180 (1.9)	PVRL2 (1.9)
ENSG00000111358	GTF2H3 PPI subnetwork	0.55	> 0.20	SUGP1 (3.2)	BUD13 (2.8)	TXNL4B (2.7)	ZNF259 (2.7)	DHX38 (2.2)	MAPKAPK5 (2.0)	PSMA5 (1.9)	POC5 (1.9)	TOP1 (1.7)	QTRT1 (1.6)
ENSG00000163440	PDCL2 PPI subnetwork	0.55	> 0.20	NAA25 (3.6)	PSMA5 (3.2)	ZNF259 (2.5)	ZNF101 (2.1)	DDX56 (1.9)	ERP29 (1.8)	SMARCA4 (1.7)	ENSG00000238078 (1.7)	TOMM40 (1.6)	SARS (1.6)
ENSG00000135446	CDK4 PPI subnetwork	0.55	> 0.20	OASL (3.8)	FEN1 (3.2)	USP1 (3.1)	SLC44A2 (2.4)	DNM2 (1.8)	PSRC1 (1.6)	ILF3 (1.5)	PLCG1 (1.5)	CETP (1.5)	PARP10 (1.4)
ENSG00000197930	ERO1L PPI subnetwork	0.55	> 0.20	ERP29 (4.8)	TRAPPC6A (3.3)	DHODH (2.5)	TMED4 (2.4)	YIPF2 (2.3)	PVR (1.9)	PMFBP1 (1.7)	ADAM1 (1.5)	HNF1A (1.4)	QTRT1 (1.4)
GO:0032722	positive regulation of chemokine production	0.55	> 0.20	ST3GAL4 (3.2)	PMFBP1 (1.9)	OASL (1.7)	FRK (1.6)	POLK (1.6)	BCL3 (1.5)	PVR (1.4)	GMIP (1.3)	CYB561D1 (1.3)	HP (1.1)
MP:0000035	abnormal membranous labyrinth morphology	0.55	> 0.20	LPA (2.1)	PLCG1 (1.9)	C17orf57 (1.9)	CEACAM19 (1.9)	TSSK6 (1.8)	ENSG00000228044 (1.8)	OGDH (1.7)	PMFBP1 (1.6)	KIAA1324 (1.6)	LPAR2 (1.2)
MP:0001129	impaired ovarian folliculogenesis	0.55	> 0.20	KIAA1324 (3.1)	ST3GAL4 (2.9)	NT5DC1 (2.2)	FADS1 (2.1)	ENSG00000226648 (1.8)	LDLR (1.6)	CEACAM19 (1.5)	LPA (1.4)	PARP10 (1.4)	MOSC1 (1.3)
ENSG00000105855	ITGB8 PPI subnetwork	0.55	> 0.20	SH2B3 (3.3)	APOE (3.0)	ITGB3 (2.6)	PLEC (2.6)	CLPTM1 (2.6)	DNM2 (2.0)	KANK2 (1.9)	SYPL2 (1.9)	HAVCR1 (1.8)	FRK (1.8)
ENSG00000176476	CCDC101 PPI subnetwork	0.55	> 0.20	CBLC (4.7)	AP1M2 (2.9)	PSRC1 (2.4)	CELSR2 (2.1)	DOCK7 (2.1)	BCAM (2.1)	LPIN3 (2.0)	PVRL2 (1.8)	PMFBP1 (1.5)	MARK4 (1.5)
MP:0002085	abnormal embryonic tissue morphology	0.55	> 0.20	NYNRIN (3.1)	PSRC1 (2.6)	PVRL2 (2.1)	SMARCA4 (2.0)	SLC44A2 (1.9)	ATXN2 (1.7)	LPAR2 (1.7)	LDLR (1.6)	AP1M2 (1.6)	ILF3 (1.6)
MP:0002636	delayed vaginal opening	0.55	> 0.20	PLEKHH2 (2.4)	ATXN7L2 (2.3)	PBX4 (2.3)	PMFBP1 (1.6)	GCNT4 (1.6)	TOP1 (1.6)	ANKRD31 (1.6)	KIAA1324 (1.4)	NT5DC1 (1.4)	CILP2 (1.3)
ENSG00000100462	PRMT5 PPI subnetwork	0.55	> 0.20	SMARCA4 (3.1)	ILF3 (2.8)	PSMA5 (2.1)	BUD13 (2.0)	DNM2 (1.9)	PLEC (1.6)	ZNF259 (1.6)	QTRT1 (1.5)	USP1 (1.5)	FEN1 (1.5)
MP:0003084	abnormal skeletal muscle fiber morphology	0.55	> 0.20	SYPL2 (6.3)	PVR (2.5)	GMPR (2.1)	KANK2 (1.9)	MAU2 (1.8)	PLEC (1.7)	CYB561D1 (1.6)	AMIGO1 (1.5)	OGDH (1.5)	BCAM (1.4)
GO:0051438	regulation of ubiquitin-protein ligase activity	0.55	> 0.20	PSMA5 (3.5)	POC5 (2.4)	TRAFD1 (2.3)	SUGP1 (2.2)	NAA25 (2.0)	BRAP (1.9)	ENSG00000226645 (1.7)	DDX56 (1.7)	GEMIN7 (1.5)	C19orf52 (1.5)
ENSG00000065882	TBC1D1 PPI subnetwork	0.55	> 0.20	PLEC (4.2)	DNM2 (3.1)	ZHX3 (2.9)	COL4A3BP (2.8)	CARM1 (2.8)	C12orf51 (2.7)	USP24 (2.5)	ATXN2 (2.4)	LPAR2 (2.3)	BCAM (2.2)
REACTOME_G2M_CHECKPOINTS	REACTOME_G2M_CHECKPOINTS	0.55	> 0.20	FEN1 (6.6)	USP1 (4.8)	PSRC1 (2.2)	TMEM116 (2.1)	POC5 (2.1)	ENSG00000226645 (1.5)	LPIN3 (1.2)	ENSG00000228044 (1.1)	NT5DC1 (1.0)	DNAH11 (1.0)
GO:0043292	contractile fiber	0.55	> 0.20	SYPL2 (7.2)	GMPR (2.5)	TMEM50A (1.2)	KANK2 (1.2)	PLEC (1.1)	NPC1L1 (1.1)	PVRL2 (1.1)	RPH3A (0.9)	PVR (0.8)	ENSG00000226648 (0.7)
GO:0070252	actin-mediated cell contraction	0.55	> 0.20	SYPL2 (6.5)	GMPR (2.7)	HNF1A (2.0)	C17orf57 (1.9)	UBXN2B (1.6)	ENSG00000226648 (1.4)	NKPD1 (1.3)	TMEM50A (1.3)	LPAR2 (1.2)	CEACAM19 (1.2)
MP:0002090	abnormal vision	0.55	> 0.20	SORT1 (3.1)	TRIB1 (2.6)	COL4A3BP (2.5)	GMPR (2.4)	APOE (2.3)	APOC4 (2.2)	APOC1 (2.0)	PMFBP1 (1.9)	HNF1A (1.8)	APOA5 (1.6)
ENSG00000198523	PLN PPI subnetwork	0.55	> 0.20	SYPL2 (2.5)	GMPR (2.2)	KIAA1324 (2.0)	OGDH (1.8)	SORT1 (1.8)	ACAD10 (1.6)	BCAM (1.5)	ENSG00000226645 (1.4)	ADAM1 (1.4)	ZNF101 (1.4)
MP:0002335	decreased airway responsiveness	0.55	> 0.20	MAFB (3.2)	TIMD4 (2.7)	PBX4 (2.3)	CETP (1.4)	NYNRIN (1.2)	NKPD1 (1.2)	GCNT4 (1.2)	BCAM (1.1)	APOE (1.1)	POC5 (1.1)
MP:0010810	increased type II pneumocyte number	0.55	> 0.20	TMEM116 (3.1)	KIAA1324 (2.5)	C11orf9 (2.3)	HP (2.2)	GPAM (2.1)	HLX (1.9)	APOC1 (1.9)	TIMD4 (1.8)	HAPLN4 (1.8)	DYNC2LI1 (1.7)
ENSG00000168002	POLR2G PPI subnetwork	0.55	> 0.20	ILF3 (3.5)	BUD13 (3.3)	SUGP1 (3.0)	TOP1 (2.9)	DHX38 (2.9)	USP1 (2.6)	C1orf63 (2.4)	SMARCA4 (2.2)	FEN1 (2.1)	PTPN11 (2.0)
ENSG00000175110	MRPS22 PPI subnetwork	0.55	> 0.20	PSMA5 (4.6)	DNAH11 (2.4)	ATP13A1 (2.2)	TOMM40 (2.2)	DHODH (2.0)	BUD13 (1.9)	SARS (1.9)	NYNRIN (1.8)	KIAA1324 (1.8)	ZNF180 (1.8)
ENSG00000138071	ACTR2 PPI subnetwork	0.55	> 0.20	GATAD2A (3.1)	PSMA5 (2.6)	OGDH (2.4)	ITGB3 (2.2)	CLPTM1 (2.2)	QTRT1 (2.0)	TOMM40 (1.8)	TOP1 (1.6)	ZNF101 (1.6)	TMEM50A (1.6)
ENSG00000135074	ADAM19 PPI subnetwork	0.55	> 0.20	CILP2 (1.9)	ENSG00000254235 (1.8)	CETP (1.8)	SH2B3 (1.8)	APOE (1.5)	ABO (1.4)	HNF1A (1.4)	AP1M2 (1.3)	TSSK6 (1.3)	CEACAM19 (1.3)
MP:0000003	abnormal adipose tissue morphology	0.55	> 0.20	PLEKHH2 (2.6)	TIMD4 (2.4)	ENSG00000238078 (2.0)	KANK2 (1.9)	GCNT4 (1.9)	CETP (1.8)	ALDH2 (1.7)	SORT1 (1.7)	ZHX3 (1.5)	OGDH (1.4)
ENSG00000063322	MED29 PPI subnetwork	0.55	> 0.20	GEMIN7 (4.1)	TXNL4B (3.4)	DHX38 (2.3)	BUD13 (2.2)	MAPKAPK5 (2.1)	BRAP (2.0)	POC5 (1.6)	BLOC1S3 (1.6)	ZNF180 (1.6)	TRAFD1 (1.6)
GO:0001782	B cell homeostasis	0.55	> 0.20	CYB561D1 (3.0)	TRAPPC6A (2.5)	GCNT4 (2.2)	ENSG00000235545 (2.1)	ENSG00000226648 (2.1)	GMIP (1.9)	FRK (1.8)	ZNF259 (1.7)	BLOC1S3 (1.7)	TOP1 (1.7)
MP:0001324	abnormal eye pigmentation	0.55	> 0.20	DOCK7 (3.6)	ST3GAL4 (2.5)	GMPR (2.2)	MYLIP (2.2)	CYB561D1 (1.9)	ZNF101 (1.7)	NYNRIN (1.5)	BRAP (1.5)	CELSR2 (1.5)	SORT1 (1.5)
ENSG00000068323	TFE3 PPI subnetwork	0.55	> 0.20	SARS (2.9)	NAA25 (2.8)	PSMA5 (2.7)	DOCK7 (2.6)	FADS1 (2.4)	GOT2P1 (2.1)	ATXN2 (2.1)	TOMM40 (2.0)	FADS2 (1.9)	PLEKHH2 (1.9)
GO:0019438	aromatic compound biosynthetic process	0.55	> 0.20	HNF1A (3.6)	GOT2P1 (3.5)	NT5DC1 (2.7)	TXNL4B (2.7)	TRAPPC6A (1.9)	DHODH (1.9)	PMFBP1 (1.8)	ACAD10 (1.6)	ENSG00000254235 (1.5)	CYP7A1 (1.3)
GO:0016459	myosin complex	0.55	> 0.20	SYPL2 (5.4)	GMPR (1.9)	AP1M2 (1.7)	LPAR2 (1.4)	NPC1L1 (1.4)	KANK2 (1.2)	HNF1A (1.1)	CBLC (0.9)	PCSK9 (0.8)	TRAPPC6A (0.8)
MP:0004803	increased susceptibility to autoimmune diabetes	0.55	> 0.20	KIAA1324 (2.5)	TIMD4 (2.3)	RELB (1.7)	TRAFD1 (1.6)	POLK (1.6)	NYNRIN (1.3)	MAFB (1.3)	NAA25 (1.1)	ALDH2 (1.0)	DNAH11 (1.0)
GO:0032270	positive regulation of cellular protein metabolic process	0.55	> 0.20	TRAFD1 (2.0)	PTPN11 (1.9)	GEMIN7 (1.9)	POC5 (1.7)	TMEM57 (1.6)	PSMA5 (1.6)	SH2B3 (1.5)	ENSG00000228044 (1.4)	SMARCA4 (1.4)	TMEM50A (1.4)
ENSG00000065361	ERBB3 PPI subnetwork	0.55	> 0.20	ZHX3 (3.7)	TRIB1 (3.1)	NCAN (2.6)	ZNF101 (2.3)	TOP1 (2.2)	PLEC (2.1)	GCNT4 (1.9)	MAFB (1.9)	PLEKHH2 (1.8)	DOCK7 (1.8)
MP:0009791	increased susceptibility to viral infection induced morbidity/mortality	0.55	> 0.20	OASL (7.1)	TRAFD1 (6.0)	PARP10 (5.5)	POLK (2.1)	TMEM50A (1.9)	ST3GAL4 (1.5)	ATP13A1 (1.4)	HLX (1.3)	C1orf63 (1.3)	RPH3A (1.3)
REACTOME_REGULATION_OF_APCC_ACTIVATORS_BETWEEN_G1S_AND_EARLY_ANAPHASE	REACTOME_REGULATION_OF_APCC_ACTIVATORS_BETWEEN_G1S_AND_EARLY_ANAPHASE	0.55	> 0.20	PSMA5 (5.6)	TRAFD1 (3.3)	NAA25 (2.2)	SUGP1 (2.2)	POC5 (2.0)	PSRC1 (1.9)	FEN1 (1.9)	DDX56 (1.8)	LPIN3 (1.5)	BRAP (1.0)
GO:0006636	unsaturated fatty acid biosynthetic process	0.55	> 0.20	NKPD1 (4.6)	CYB561D1 (3.3)	ALDH2 (3.0)	GMPR (2.2)	FADS2 (1.7)	ITGB3 (1.6)	GOT2P1 (1.5)	FADS1 (1.5)	ERP29 (1.4)	C11orf9 (1.4)
GO:0010821	regulation of mitochondrion organization	0.55	> 0.20	GOT2P1 (2.2)	BRAP (2.0)	C12orf43 (1.9)	C12orf47 (1.9)	TMEM116 (1.8)	C19orf52 (1.8)	LPAR2 (1.5)	TXNL4B (1.3)	CBLC (1.3)	ERP29 (1.3)
MP:0004937	dilated heart	0.55	> 0.20	LPIN3 (2.6)	C1orf63 (2.3)	C11orf9 (1.9)	ITGB3 (1.8)	NPC1L1 (1.8)	OGDH (1.8)	C17orf57 (1.8)	UBXN2B (1.8)	CARM1 (1.7)	ADAM1 (1.6)
ENSG00000163754	GYG1 PPI subnetwork	0.55	> 0.20	MOSC1 (2.4)	ZNF101 (2.2)	HP (2.2)	GPAM (2.1)	SYPL2 (2.0)	OGDH (1.9)	ENSG00000235545 (1.8)	C19orf52 (1.8)	LPAR2 (1.7)	GCNT4 (1.6)
MP:0003936	abnormal reproductive system development	0.55	> 0.20	LPAR2 (2.6)	LPA (2.4)	HNF1A (2.1)	CYP7A1 (1.8)	ATP13A1 (1.7)	MARK4 (1.5)	CARM1 (1.5)	ENSG00000254235 (1.5)	NYNRIN (1.5)	ABO (1.4)
ENSG00000131374	TBC1D5 PPI subnetwork	0.55	> 0.20	TMEM50A (3.0)	HNF1A (2.8)	C12orf43 (2.6)	LPIN3 (2.6)	GCNT4 (2.3)	ENSG00000235545 (2.3)	TRAFD1 (2.2)	ADAM1 (2.1)	ABO (2.0)	C12orf51 (2.0)
ENSG00000158869	FCER1G PPI subnetwork	0.56	> 0.20	ITGB3 (4.9)	GMIP (2.3)	ENSG00000228044 (2.2)	GMPR (2.1)	TRAPPC6A (2.1)	ALDH2 (1.8)	MAFB (1.4)	SH2B3 (1.3)	C12orf47 (1.3)	BLOC1S3 (1.3)
MP:0001052	abnormal muscle innervation	0.56	> 0.20	PPP1R37 (2.0)	BCAM (2.0)	CELSR2 (1.8)	SYPL2 (1.8)	TMED4 (1.6)	AMIGO1 (1.5)	GEMIN7 (1.4)	HLX (1.3)	BLOC1S3 (1.3)	NYNRIN (1.3)
GO:0060442	branching involved in prostate gland morphogenesis	0.56	> 0.20	GOT2P1 (2.5)	C19orf52 (2.3)	ENSG00000254235 (2.1)	AMIGO1 (1.9)	BLOC1S3 (1.5)	DNAH11 (1.5)	PMFBP1 (1.5)	TRAPPC6A (1.5)	SLC22A1 (1.4)	KIAA1324 (1.2)
GO:0045987	positive regulation of smooth muscle contraction	0.56	> 0.20	ABO (3.2)	ITGB3 (2.7)	NKPD1 (2.7)	LPIN3 (2.0)	TXNL4B (1.9)	CYB561D1 (1.9)	BLOC1S3 (1.8)	CBLC (1.8)	C17orf57 (1.7)	ENSG00000226648 (1.7)
ENSG00000196839	ADA PPI subnetwork	0.56	> 0.20	OASL (5.6)	TOP1 (2.7)	NPC1L1 (2.6)	PARP10 (2.6)	HAVCR1 (2.6)	TMEM50A (2.1)	NCAN (1.7)	TXNL4B (1.7)	DHODH (1.6)	ENSG00000226648 (1.5)
GO:0007548	sex differentiation	0.56	> 0.20	DNAH11 (2.5)	ABO (2.3)	ST3GAL4 (2.2)	LPAR2 (1.9)	NYNRIN (1.8)	TSSK6 (1.6)	ENSG00000238078 (1.5)	AP1M2 (1.4)	PVRL2 (1.4)	ALDH2 (1.4)
MP:0000018	small ears	0.56	> 0.20	AP1M2 (2.4)	C17orf57 (2.4)	PLEKHH2 (2.4)	CELSR2 (2.2)	ZHX3 (2.1)	HAPLN4 (1.8)	NYNRIN (1.7)	PLCG1 (1.7)	HAVCR1 (1.6)	TSSK6 (1.5)
ENSG00000168274	HIST1H2AE PPI subnetwork	0.56	> 0.20	ILF3 (2.7)	SMARCA4 (2.2)	BUD13 (2.0)	TOP1 (1.9)	USP1 (1.8)	DDX56 (1.7)	CARM1 (1.6)	ZNF259 (1.5)	TOMM40 (1.4)	NAA25 (1.4)
ENSG00000137259	HIST1H2AB PPI subnetwork	0.56	> 0.20	ILF3 (2.7)	SMARCA4 (2.2)	BUD13 (2.0)	TOP1 (1.9)	USP1 (1.8)	DDX56 (1.7)	CARM1 (1.6)	ZNF259 (1.5)	TOMM40 (1.4)	NAA25 (1.4)
MP:0008661	decreased interleukin-10 secretion	0.56	> 0.20	TRIB1 (2.8)	BCL3 (1.9)	GMIP (1.7)	ST3GAL4 (1.7)	LPAR2 (1.7)	SH2B3 (1.6)	MAFB (1.6)	HLX (1.5)	ENSG00000226645 (1.3)	PMFBP1 (1.3)
ENSG00000124181	PLCG1 PPI subnetwork	0.56	> 0.20	GMIP (2.9)	USP24 (2.7)	ITGB3 (2.3)	LPAR2 (1.9)	GATAD2A (1.9)	DOCK7 (1.8)	SH2B3 (1.8)	ENSG00000238078 (1.7)	PLCG1 (1.7)	ANKRD31 (1.7)
ENSG00000070159	PTPN3 PPI subnetwork	0.56	> 0.20	CBLC (6.4)	AP1M2 (3.1)	LPAR2 (3.0)	PLCG1 (2.5)	PLEC (2.4)	PVRL2 (2.2)	DNM2 (1.8)	LPIN3 (1.7)	PPP1R37 (1.7)	GMIP (1.6)
GO:0031057	negative regulation of histone modification	0.56	> 0.20	ABO (3.2)	TMEM57 (2.9)	RHCE (2.5)	ZNF180 (2.1)	RHD (1.9)	ZNF101 (1.7)	CARM1 (1.7)	LPAR2 (1.7)	ENSG00000254235 (1.6)	PMFBP1 (1.5)
MP:0004073	caudal body truncation	0.56	> 0.20	HNF1A (2.3)	TM6SF2 (2.1)	ACAD10 (2.0)	ENSG00000254235 (1.9)	AMIGO1 (1.9)	CETP (1.7)	ANKRD31 (1.7)	DOCK7 (1.6)	C12orf47 (1.6)	HAVCR1 (1.6)
REACTOME_HORMONE:SENSITIVE_LIPASE_HSL:MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	REACTOME_HORMONE:SENSITIVE_LIPASE_HSL:MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	0.56	> 0.20	GPAM (4.6)	MOSC1 (4.2)	SORT1 (2.3)	TIMD4 (2.1)	PMFBP1 (2.1)	HP (1.9)	ENSG00000238078 (1.4)	MAU2 (1.4)	NKPD1 (1.4)	KIAA1324 (1.4)
MP:0000141	abnormal vertebral body morphology	0.56	> 0.20	CILP2 (5.6)	NYNRIN (3.5)	PVRL2 (2.3)	CLPTM1 (2.3)	MAFB (2.2)	PPP1R37 (1.9)	ENSG00000254235 (1.9)	YIPF2 (1.7)	BCAM (1.5)	FADS2 (1.4)
GO:0001906	cell killing	0.56	> 0.20	PBX4 (2.4)	ITGB3 (1.8)	ABCG5 (1.8)	LPA (1.8)	POLK (1.7)	CEACAM19 (1.7)	HP (1.6)	MOSC1 (1.6)	RHD (1.3)	SLC22A1 (1.2)
GO:0031401	positive regulation of protein modification process	0.56	> 0.20	POC5 (2.5)	ENSG00000226645 (2.5)	TMEM57 (1.7)	TRAFD1 (1.7)	PLEKHH2 (1.7)	SH2B3 (1.7)	PTPN11 (1.6)	PSMA5 (1.6)	TMEM50A (1.4)	NAA25 (1.4)
ENSG00000074266	EED PPI subnetwork	0.56	> 0.20	USP1 (3.1)	C1orf63 (2.5)	PTPN11 (2.4)	TMEM50A (2.4)	TOP1 (2.3)	ZNF180 (2.2)	USP24 (2.0)	SUGP1 (1.9)	CYB561D1 (1.8)	ILF3 (1.7)
ENSG00000138396	ENSG00000138396 PPI subnetwork	0.56	> 0.20	NKPD1 (2.5)	GATAD2A (2.1)	ATP13A1 (1.6)	CBLC (1.5)	CEACAM19 (1.4)	ZNF180 (1.3)	MOSC1 (1.1)	ILF3 (1.1)	ZNF101 (1.1)	ERP29 (1.1)
GO:0001990	regulation of systemic arterial blood pressure by hormone	0.56	> 0.20	TMED4 (2.9)	C12orf47 (2.4)	ADAM1 (2.4)	HNF1A (2.4)	LPIN3 (2.4)	PMFBP1 (2.0)	ZHX3 (2.0)	TM6SF2 (1.8)	AMIGO1 (1.8)	ENSG00000235545 (1.6)
ENSG00000134057	CCNB1 PPI subnetwork	0.56	> 0.20	PSRC1 (3.3)	FEN1 (3.1)	POC5 (2.8)	MAU2 (2.2)	SUGP1 (2.0)	USP1 (1.9)	TXNL4B (1.8)	MYLIP (1.7)	BRAP (1.6)	HLX (1.6)
GO:0002275	myeloid cell activation involved in immune response	0.56	> 0.20	C17orf57 (2.9)	DNAH11 (2.4)	GMIP (2.1)	CYB561D1 (2.0)	UBXN2B (1.8)	GEMIN7 (1.8)	GMPR (1.4)	ALDH2 (1.4)	SH2B3 (1.2)	ST3GAL4 (1.2)
ENSG00000054118	THRAP3 PPI subnetwork	0.56	> 0.20	SMARCA4 (3.7)	FRK (2.8)	TRAFD1 (2.7)	KANK2 (2.7)	C1orf63 (2.2)	PTPN11 (2.1)	GATAD2A (2.0)	ILF3 (2.0)	ITGB3 (1.9)	TOP1 (1.9)
GO:0002230	positive regulation of defense response to virus by host	0.56	> 0.20	OASL (2.9)	PARP10 (2.8)	ENSG00000235545 (2.8)	FRK (2.1)	MAU2 (1.9)	MYLIP (1.9)	BLOC1S3 (1.7)	ABO (1.7)	PBX4 (1.7)	TRAFD1 (1.3)
ENSG00000184825	HIST1H2AH PPI subnetwork	0.56	> 0.20	DDX56 (2.8)	SMARCA4 (2.7)	BUD13 (2.4)	ZNF259 (2.3)	ILF3 (2.3)	QTRT1 (2.2)	NAA25 (2.2)	TOMM40 (2.2)	CARM1 (2.1)	TOP1 (2.0)
ENSG00000124642	ENSG00000124642 PPI subnetwork	0.56	> 0.20	DDX56 (2.8)	SMARCA4 (2.7)	BUD13 (2.4)	ZNF259 (2.3)	ILF3 (2.3)	QTRT1 (2.2)	NAA25 (2.2)	TOMM40 (2.2)	CARM1 (2.1)	TOP1 (2.0)
ENSG00000126858	RHOT1 PPI subnetwork	0.56	> 0.20	GRINA (4.2)	SARS (3.3)	CLPTM1 (2.8)	COL4A3BP (2.2)	POC5 (2.0)	TMEM57 (1.9)	SLC44A2 (1.9)	RHCE (1.7)	PPP1R37 (1.7)	RHD (1.4)
MP:0005107	abnormal stapes morphology	0.56	> 0.20	NCAN (2.6)	MYLIP (2.3)	DYNC2LI1 (2.0)	BCAM (1.7)	CEACAM19 (1.4)	C19orf52 (1.2)	SLC44A2 (1.2)	TRAFD1 (1.1)	AMIGO1 (1.1)	ABO (1.1)
GO:0046320	regulation of fatty acid oxidation	0.56	> 0.20	AMIGO1 (3.4)	ACAD10 (3.0)	BRAP (2.8)	OGDH (2.8)	SYPL2 (2.4)	GMPR (2.1)	MOSC1 (1.8)	PTPN11 (1.8)	C19orf52 (1.6)	ZHX3 (1.5)
GO:0051603	proteolysis involved in cellular protein catabolic process	0.56	> 0.20	BRAP (3.4)	TRAFD1 (2.7)	TMEM57 (2.5)	USP24 (2.3)	NAA25 (2.2)	ZNF180 (2.1)	MAU2 (2.0)	PSMA5 (1.8)	DHX38 (1.8)	LPIN3 (1.5)
GO:0002790	peptide secretion	0.56	> 0.20	KIAA1324 (4.9)	ANKRD31 (2.5)	HNF1A (2.4)	COL4A3BP (2.1)	ENSG00000228044 (2.0)	HAPLN4 (2.0)	ABO (1.8)	AMIGO1 (1.7)	ENSG00000238078 (1.6)	ENSG00000254235 (1.6)
ENSG00000130147	SH3BP4 PPI subnetwork	0.56	> 0.20	CBLC (6.0)	AP1M2 (3.9)	LPAR2 (2.5)	ST3GAL4 (2.3)	CELSR2 (2.2)	MARK4 (1.9)	DNM2 (1.9)	LPIN3 (1.8)	DOCK7 (1.8)	PVRL2 (1.7)
ENSG00000152422	XRCC4 PPI subnetwork	0.56	> 0.20	NT5DC1 (2.6)	UBXN2B (2.5)	MAPKAPK5 (2.1)	ANKRD31 (2.1)	ZNF101 (2.1)	GOT2P1 (1.9)	PLEC (1.8)	ZNF180 (1.8)	CYB561D1 (1.5)	C11orf9 (1.5)
MP:0006303	abnormal retinal nerve fiber layer morphology	0.56	> 0.20	NYNRIN (2.0)	LPIN3 (1.9)	KANK2 (1.8)	GCNT4 (1.8)	BCAM (1.6)	TM6SF2 (1.4)	TXNL4B (1.4)	PVRL2 (1.3)	ENSG00000226648 (1.3)	AMIGO1 (1.2)
GO:0048521	negative regulation of behavior	0.56	> 0.20	ENSG00000226648 (3.5)	ANKRD31 (3.2)	GCNT4 (2.9)	LPIN3 (2.8)	PPP1R37 (2.2)	HLX (1.8)	TMED4 (1.7)	DNAH11 (1.6)	PVRL2 (1.4)	PLEKHH2 (1.3)
ENSG00000138346	DNA2 PPI subnetwork	0.56	> 0.20	USP1 (4.8)	FEN1 (4.7)	FADS1 (2.5)	POC5 (2.2)	ENSG00000235545 (1.8)	ZNF180 (1.6)	DHODH (1.5)	FADS2 (1.5)	AMIGO1 (1.1)	FRK (1.1)
GO:0045596	negative regulation of cell differentiation	0.56	> 0.20	NYNRIN (3.3)	MYLIP (2.0)	ENSG00000254235 (1.7)	PPP1R37 (1.7)	CELSR2 (1.6)	KANK2 (1.6)	MARK4 (1.4)	BCAM (1.3)	GCNT4 (1.3)	TSSK6 (1.3)
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	0.56	> 0.20	TM6SF2 (3.6)	NPC1L1 (3.5)	SARS (3.4)	ABCG8 (2.8)	ABCG5 (2.3)	ALDH2 (2.2)	NCAN (2.0)	ERP29 (1.9)	TMEM116 (1.8)	HAPLN4 (1.8)
ENSG00000107281	NPDC1 PPI subnetwork	0.56	> 0.20	GATAD2A (2.7)	NYNRIN (2.6)	HLX (2.2)	PVRL2 (2.0)	ST3GAL4 (1.7)	FEN1 (1.6)	KANK2 (1.4)	GOT2P1 (1.4)	USP1 (1.4)	SLC44A2 (1.4)
GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	0.56	> 0.20	ENSG00000254235 (2.3)	GEMIN7 (1.9)	PBX4 (1.7)	SH2B3 (1.6)	ENSG00000228044 (1.6)	SLC22A1 (1.4)	DNAH11 (1.4)	TIMD4 (1.3)	NKPD1 (1.3)	MOSC1 (1.2)
ENSG00000119718	EIF2B2 PPI subnetwork	0.56	> 0.20	TXNL4B (3.6)	SARS (3.5)	QTRT1 (3.4)	DHODH (3.0)	DDX56 (2.7)	ZNF259 (2.2)	NAA25 (2.2)	TOMM40 (2.1)	C12orf43 (2.0)	C19orf52 (1.6)
ENSG00000115020	PIKFYVE PPI subnetwork	0.56	> 0.20	PMFBP1 (2.1)	CEACAM19 (2.0)	C17orf57 (1.7)	PTPN11 (1.6)	CARM1 (1.5)	TOMM40 (1.5)	GPAM (1.4)	KANK2 (1.4)	HNF1A (1.3)	USP24 (1.3)
KEGG_CELL_CYCLE	KEGG_CELL_CYCLE	0.56	> 0.20	FEN1 (4.8)	USP1 (4.5)	PSRC1 (4.3)	ILF3 (1.6)	SLC44A2 (1.6)	SMARCA4 (1.5)	POC5 (1.5)	KANK2 (1.4)	RHCE (1.4)	RHD (1.3)
MP:0010519	atrioventricular block	0.56	> 0.20	POC5 (2.3)	AMIGO1 (2.2)	SORT1 (1.7)	NYNRIN (1.7)	GOT2P1 (1.7)	KANK2 (1.7)	BCAM (1.6)	RHCE (1.6)	ENSG00000226648 (1.4)	UBXN2B (1.4)
GO:0004520	endodeoxyribonuclease activity	0.56	> 0.20	POLK (3.0)	ZNF180 (2.8)	POC5 (2.1)	LPAR2 (2.0)	TMEM116 (2.0)	SH2B3 (1.6)	CETP (1.6)	GATAD2A (1.4)	NT5DC1 (1.3)	GMIP (1.3)
ENSG00000147889	CDKN2A PPI subnetwork	0.56	> 0.20	OASL (3.7)	FEN1 (3.6)	USP1 (3.5)	PSRC1 (1.7)	ZNF180 (1.7)	ADAM1 (1.6)	BUD13 (1.6)	TRAPPC6A (1.6)	PARP10 (1.4)	ENSG00000226645 (1.4)
GO:0006283	transcription-coupled nucleotide-excision repair	0.56	> 0.20	ZNF180 (2.8)	POC5 (2.3)	TXNL4B (2.2)	POLK (2.2)	ENSG00000235545 (2.1)	GEMIN7 (2.1)	GOT2P1 (2.1)	MAPKAPK5 (2.0)	USP1 (2.0)	BLOC1S3 (1.9)
GO:0031571	mitotic cell cycle G1/S transition DNA damage checkpoint	0.56	> 0.20	PSMA5 (3.7)	TRAFD1 (2.7)	NT5DC1 (2.6)	NAA25 (2.4)	BRAP (1.8)	SUGP1 (1.8)	TXNL4B (1.4)	ENSG00000254235 (1.4)	C12orf47 (1.3)	PARP10 (1.3)
ENSG00000144118	RALB PPI subnetwork	0.56	> 0.20	SLC44A2 (3.2)	ZNF180 (2.3)	PPP1R37 (2.3)	AMIGO1 (2.2)	UBXN2B (2.1)	NT5DC1 (2.0)	USP24 (2.0)	MYLIP (1.9)	CBLC (1.9)	ZNF101 (1.7)
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.56	> 0.20	APOE (2.9)	PARP10 (2.7)	MYLIP (2.6)	TMED4 (2.0)	C1orf63 (1.6)	MAFB (1.6)	CYP7A1 (1.6)	BCL3 (1.6)	RELB (1.6)	APOC1 (1.5)
ENSG00000081189	MEF2C PPI subnetwork	0.56	> 0.20	ENSG00000226648 (3.1)	HLX (2.6)	LDLR (2.1)	ATXN7L2 (2.0)	PSRC1 (2.0)	HMGCR (1.9)	FADS2 (1.9)	MARK4 (1.9)	NCAN (1.7)	GCNT4 (1.6)
GO:0006687	glycosphingolipid metabolic process	0.56	> 0.20	HAVCR1 (3.7)	COL4A3BP (2.4)	TMEM50A (2.3)	TRAPPC6A (2.2)	CYB561D1 (2.1)	ERP29 (2.1)	HNF1A (2.1)	NKPD1 (2.0)	TMED4 (2.0)	LPIN3 (1.9)
MP:0002082	postnatal lethality	0.56	> 0.20	TRIB1 (3.7)	MAFB (2.4)	KANK2 (2.3)	HLX (2.0)	TOP1 (1.9)	HAPLN4 (1.9)	APOE (1.8)	C11orf9 (1.7)	LPA (1.6)	TM6SF2 (1.6)
ENSG00000136709	WDR33 PPI subnetwork	0.56	> 0.20	ZHX3 (2.7)	ZNF180 (2.2)	BUD13 (2.2)	TXNL4B (2.1)	GATAD2A (2.0)	NAA25 (2.0)	ZNF259 (1.9)	DHX38 (1.8)	QTRT1 (1.6)	YIPF2 (1.5)
ENSG00000105810	CDK6 PPI subnetwork	0.56	> 0.20	SLC44A2 (2.5)	ILF3 (2.0)	C19orf52 (1.8)	DNM2 (1.8)	FEN1 (1.8)	DHX38 (1.6)	TMEM50A (1.5)	SORT1 (1.5)	GCNT4 (1.4)	LDLR (1.4)
REACTOME_NONSENSE:MEDIATED_DECAY	REACTOME_NONSENSE:MEDIATED_DECAY	0.56	> 0.20	NKPD1 (2.8)	TXNL4B (2.6)	ILF3 (2.1)	ATXN7L2 (1.9)	UBXN2B (1.9)	MAU2 (1.8)	ADAM1 (1.6)	ANKRD31 (1.6)	C1orf63 (1.5)	BRAP (1.4)
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	0.56	> 0.20	NKPD1 (2.8)	TXNL4B (2.6)	ILF3 (2.1)	ATXN7L2 (1.9)	UBXN2B (1.9)	MAU2 (1.8)	ADAM1 (1.6)	ANKRD31 (1.6)	C1orf63 (1.5)	BRAP (1.4)
MP:0004964	absent inner cell mass	0.56	> 0.20	OGDH (2.2)	BUD13 (2.1)	DNAH11 (1.9)	ABCG5 (1.8)	ATP13A1 (1.8)	DOCK7 (1.8)	ENSG00000235545 (1.7)	ENSG00000226648 (1.7)	ST3GAL4 (1.7)	USP1 (1.6)
GO:0051208	sequestering of calcium ion	0.56	> 0.20	NKPD1 (3.0)	SYPL2 (2.1)	ADAM1 (2.0)	TIMD4 (1.9)	ZNF101 (1.9)	HAVCR1 (1.6)	ANKRD31 (1.4)	TRAFD1 (1.4)	ABO (1.3)	C1orf63 (1.2)
GO:0030658	transport vesicle membrane	0.56	> 0.20	YIPF2 (2.9)	FADS2 (2.8)	LDLR (2.1)	KIAA1324 (2.1)	C12orf51 (2.0)	HMGCR (1.9)	GRINA (1.7)	POLK (1.6)	FADS1 (1.6)	FRK (1.5)
REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_SECURIN	REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_SECURIN	0.56	> 0.20	PSMA5 (6.1)	TRAFD1 (3.8)	NAA25 (2.5)	SUGP1 (2.4)	DDX56 (1.9)	PARP10 (1.4)	NT5DC1 (1.4)	POC5 (1.4)	LPIN3 (1.3)	BRAP (1.2)
ENSG00000074590	NUAK1 PPI subnetwork	0.56	> 0.20	C17orf57 (3.7)	HP (2.6)	C12orf51 (2.2)	MAFB (2.0)	AP1M2 (2.0)	HLX (1.6)	ZHX3 (1.5)	ENSG00000254235 (1.3)	LPA (1.3)	TMED4 (1.2)
MP:0003545	increased alcohol consumption	0.56	> 0.20	CYP7A1 (2.1)	TRIB1 (2.0)	ENSG00000254235 (2.0)	TSSK6 (1.9)	FRK (1.8)	PVR (1.7)	LPA (1.7)	AMIGO1 (1.4)	CEACAM19 (1.3)	HAVCR1 (1.3)
GO:0002089	lens morphogenesis in camera-type eye	0.56	> 0.20	ANKRD31 (3.3)	C11orf9 (2.5)	COL4A3BP (1.8)	HNF1A (1.7)	C19orf52 (1.4)	ZHX3 (1.3)	C17orf57 (1.2)	UBXN2B (1.0)	PPP1R37 (1.0)	TMED4 (1.0)
GO:0050792	regulation of viral reproduction	0.56	> 0.20	OASL (3.1)	MAPKAPK5 (2.8)	SUGP1 (2.7)	MAU2 (2.7)	BUD13 (2.5)	TXNL4B (2.5)	ENSG00000226645 (2.0)	GATAD2A (1.8)	C12orf43 (1.7)	TMEM50A (1.7)
GO:0060968	regulation of gene silencing	0.56	> 0.20	C19orf52 (3.4)	NT5DC1 (2.4)	GCNT4 (1.9)	TSSK6 (1.8)	FRK (1.8)	TXNL4B (1.7)	BUD13 (1.5)	POC5 (1.3)	MYLIP (1.2)	TMEM116 (1.1)
GO:0070461	SAGA-type complex	0.56	> 0.20	ATXN7L2 (3.0)	UBXN2B (2.6)	ATXN2 (2.5)	PARP10 (2.1)	MAPKAPK5 (2.0)	C19orf52 (2.0)	ILF3 (1.7)	C12orf51 (1.7)	C17orf57 (1.6)	PLCG1 (1.6)
ENSG00000128052	KDR PPI subnetwork	0.56	> 0.20	CETP (2.8)	SH2B3 (2.6)	MAFB (2.1)	SLC44A2 (2.0)	GATAD2A (2.0)	HLX (1.9)	APOE (1.7)	POLK (1.4)	FADS2 (1.4)	DNAH11 (1.3)
GO:0010008	endosome membrane	0.56	> 0.20	COL4A3BP (3.1)	TMEM50A (2.8)	MAU2 (2.4)	GRINA (2.2)	FRK (2.0)	TRAFD1 (2.0)	ERP29 (2.0)	GMIP (1.9)	ATP13A1 (1.7)	PTPN11 (1.6)
ENSG00000168309	FAM107A PPI subnetwork	0.56	> 0.20	C17orf57 (2.5)	HAVCR1 (2.4)	NAA25 (2.0)	TRAFD1 (1.9)	C19orf52 (1.8)	LPAR2 (1.8)	ACAD10 (1.7)	KIAA1324 (1.7)	FADS2 (1.6)	PBX4 (1.6)
KEGG_GLUTATHIONE_METABOLISM	KEGG_GLUTATHIONE_METABOLISM	0.56	> 0.20	ALDH2 (4.1)	KIAA1324 (2.5)	ACAD10 (2.5)	FADS1 (2.4)	TM6SF2 (2.3)	LPIN3 (2.3)	ABCG8 (2.0)	FADS2 (2.0)	PSMA5 (2.0)	RHD (1.9)
GO:0050886	endocrine process	0.56	> 0.20	TMED4 (3.1)	LPIN3 (3.0)	ADAM1 (2.6)	HNF1A (2.5)	ENSG00000235545 (2.3)	AMIGO1 (2.1)	KIAA1324 (2.0)	C12orf47 (1.6)	ABO (1.6)	ENSG00000228044 (1.5)
ENSG00000185499	MUC1 PPI subnetwork	0.56	> 0.20	LPIN3 (2.9)	DNM2 (2.8)	PVRL2 (2.7)	SLC44A2 (2.5)	ALDH2 (2.3)	PLEC (2.2)	COL4A3BP (2.2)	NYNRIN (2.1)	GMIP (2.0)	TMED4 (2.0)
ENSG00000163516	ANKZF1 PPI subnetwork	0.56	> 0.20	GOT2P1 (2.6)	ITGB3 (2.5)	LPIN3 (2.2)	SARS (2.1)	C19orf52 (2.1)	RHCE (2.0)	PSRC1 (1.9)	TMEM57 (1.8)	CEACAM19 (1.8)	DDX56 (1.7)
GO:0070633	transepithelial transport	0.56	> 0.20	TMEM116 (2.8)	TXNL4B (2.6)	PMFBP1 (2.6)	CEACAM19 (2.3)	GCNT4 (2.0)	TSSK6 (1.9)	ANKRD31 (1.6)	C12orf47 (1.6)	CYP7A1 (1.5)	NKPD1 (1.4)
GO:0051861	glycolipid binding	0.56	> 0.20	SH2B3 (2.1)	TSSK6 (2.0)	NYNRIN (2.0)	ENSG00000226645 (1.9)	TMEM116 (1.6)	ABO (1.5)	CELSR2 (1.5)	PLEKHH2 (1.5)	PLEC (1.4)	ST3GAL4 (1.4)
MP:0000822	abnormal brain ventricle morphology	0.56	> 0.20	DYNC2LI1 (2.9)	ATXN2 (2.4)	CELSR2 (2.3)	FADS2 (2.3)	FADS1 (2.2)	NYNRIN (2.1)	GRINA (2.0)	PBX4 (2.0)	SORT1 (2.0)	DHODH (2.0)
REACTOME_SIGNALLING_TO_ERKS	REACTOME_SIGNALLING_TO_ERKS	0.56	> 0.20	MARK4 (3.5)	GATAD2A (2.5)	MAPKAPK5 (2.1)	LPAR2 (2.0)	PVRL2 (2.0)	DNM2 (1.9)	HLX (1.8)	COL4A3BP (1.7)	LPIN3 (1.7)	PTPN11 (1.6)
GO:0030016	myofibril	0.56	> 0.20	SYPL2 (7.3)	GMPR (2.6)	TMEM50A (1.4)	PLEC (1.3)	NPC1L1 (1.1)	PVRL2 (1.1)	KANK2 (1.0)	PVR (0.9)	RPH3A (0.8)	C17orf57 (0.8)
GO:0090189	regulation of branching involved in ureteric bud morphogenesis	0.56	> 0.20	HAVCR1 (3.4)	ENSG00000228044 (3.4)	HNF1A (2.2)	AMIGO1 (1.8)	DNAH11 (1.7)	TSSK6 (1.6)	TMED4 (1.5)	ENSG00000235545 (1.3)	DYNC2LI1 (1.2)	ENSG00000254235 (1.2)
ENSG00000090539	CHRD PPI subnetwork	0.56	> 0.20	ABO (3.4)	LPIN3 (2.3)	TMED4 (1.6)	ADAM1 (1.6)	C12orf47 (1.6)	PVR (1.6)	MAFB (1.5)	HNF1A (1.4)	TRAFD1 (1.4)	GMPR (1.4)
ENSG00000198910	L1CAM PPI subnetwork	0.56	> 0.20	C11orf9 (2.7)	SORT1 (2.3)	TIMD4 (2.0)	RPH3A (2.0)	SH2B3 (1.8)	GMPR (1.8)	GOT2P1 (1.8)	CETP (1.7)	MARK4 (1.6)	PVR (1.5)
GO:0006684	sphingomyelin metabolic process	0.56	> 0.20	NKPD1 (4.8)	FRK (2.8)	BLOC1S3 (2.7)	TMEM57 (2.4)	ANKRD31 (2.1)	GCNT4 (2.1)	LPIN3 (2.0)	POLK (1.9)	NT5DC1 (1.9)	ATP13A1 (1.9)
GO:0071696	ectodermal placode development	0.56	> 0.20	C19orf52 (2.8)	ANKRD31 (2.6)	TSSK6 (2.4)	DOCK7 (2.0)	ENSG00000226648 (1.9)	PMFBP1 (1.8)	FRK (1.6)	CEACAM19 (1.6)	ENSG00000238078 (1.6)	ADAM1 (1.6)
GO:0071697	ectodermal placode morphogenesis	0.56	> 0.20	C19orf52 (2.8)	ANKRD31 (2.6)	TSSK6 (2.4)	DOCK7 (2.0)	ENSG00000226648 (1.9)	PMFBP1 (1.8)	FRK (1.6)	CEACAM19 (1.6)	ENSG00000238078 (1.6)	ADAM1 (1.6)
GO:0060788	ectodermal placode formation	0.56	> 0.20	C19orf52 (2.8)	ANKRD31 (2.6)	TSSK6 (2.4)	DOCK7 (2.0)	ENSG00000226648 (1.9)	PMFBP1 (1.8)	FRK (1.6)	CEACAM19 (1.6)	ENSG00000238078 (1.6)	ADAM1 (1.6)
ENSG00000105193	RPS16 PPI subnetwork	0.56	> 0.20	NKPD1 (2.6)	C12orf43 (1.9)	NAA25 (1.9)	SARS (1.8)	C19orf52 (1.7)	ZNF259 (1.7)	GATAD2A (1.7)	ILF3 (1.6)	DDX56 (1.6)	RELB (1.5)
ENSG00000163288	GABRB1 PPI subnetwork	0.56	> 0.20	GCNT4 (2.6)	ENSG00000235545 (2.3)	ZNF101 (2.0)	ABO (1.9)	ENSG00000226648 (1.8)	LPIN3 (1.7)	HAVCR1 (1.7)	ANKRD31 (1.6)	ERP29 (1.5)	MYLIP (1.3)
ENSG00000153989	NUS1 PPI subnetwork	0.56	> 0.20	ATP13A1 (3.3)	ADAM1 (3.2)	C12orf43 (2.7)	CLPTM1 (2.5)	C12orf51 (2.4)	TXNL4B (2.4)	MAU2 (2.2)	MOSC1 (2.2)	BRAP (2.2)	ERP29 (2.1)
ENSG00000079277	MKNK1 PPI subnetwork	0.56	> 0.20	PTPN11 (2.4)	GMIP (1.9)	DNM2 (1.8)	CARM1 (1.7)	GATAD2A (1.7)	CETP (1.4)	PLEC (1.4)	DHX38 (1.2)	TOMM40 (1.2)	GPAM (1.2)
GO:0016607	nuclear speck	0.56	> 0.20	C1orf63 (4.9)	TOP1 (4.3)	BUD13 (3.9)	USP1 (3.0)	DHX38 (2.6)	SUGP1 (2.5)	ILF3 (2.3)	QTRT1 (2.1)	BRAP (2.0)	TRAFD1 (1.9)
ENSG00000182117	NOP10 PPI subnetwork	0.56	> 0.20	AMIGO1 (2.8)	C1orf63 (2.3)	ENSG00000235545 (2.0)	ENSG00000254235 (1.9)	TOP1 (1.9)	TOMM40 (1.8)	ENSG00000228044 (1.7)	MAPKAPK5 (1.6)	BUD13 (1.5)	DDX56 (1.5)
ENSG00000134138	MEIS2 PPI subnetwork	0.56	> 0.20	TMED4 (2.6)	HLX (2.2)	ENSG00000254235 (2.0)	FADS2 (2.0)	DYNC2LI1 (1.8)	PCSK9 (1.5)	MARK4 (1.5)	ACAD10 (1.4)	LPA (1.4)	ZNF101 (1.4)
ENSG00000198467	TPM2 PPI subnetwork	0.56	> 0.20	KANK2 (3.3)	PLEC (2.6)	PVR (2.5)	ABO (1.7)	ITGB3 (1.7)	PVRL2 (1.6)	GATAD2A (1.6)	LPIN3 (1.3)	TM6SF2 (1.3)	BRAP (1.2)
GO:0042098	T cell proliferation	0.56	> 0.20	TIMD4 (3.2)	PBX4 (3.0)	CETP (2.3)	TRAFD1 (1.6)	ENSG00000254235 (1.6)	ZNF101 (1.5)	SLC22A1 (1.3)	POLK (1.2)	ADAM1 (1.2)	ANKRD31 (1.2)
ENSG00000129993	CBFA2T3 PPI subnetwork	0.56	> 0.20	PLCG1 (4.2)	RHD (3.5)	SMARCA4 (2.6)	RHCE (2.2)	ILF3 (2.1)	ATXN7L2 (2.1)	TMEM57 (2.0)	ENSG00000228044 (1.8)	ZHX3 (1.8)	HNF1A (1.8)
MP:0009541	increased thymocyte apoptosis	0.56	> 0.20	AP1M2 (2.5)	TMEM50A (1.9)	CBLC (1.9)	RELB (1.8)	USP24 (1.5)	PARP10 (1.3)	BCL3 (1.3)	MYLIP (1.3)	TOP1 (1.2)	C19orf52 (1.2)
MP:0004617	sacral vertebral transformation	0.56	> 0.20	SYPL2 (2.3)	ZHX3 (2.1)	NYNRIN (1.9)	ATXN2 (1.9)	PLCG1 (1.8)	MOSC1 (1.5)	TMED4 (1.4)	ENSG00000238078 (1.4)	MAFB (1.3)	UBXN2B (1.3)
REACTOME_SHC:RELATED_EVENTS	REACTOME_SHC:RELATED_EVENTS	0.56	> 0.20	MARK4 (3.1)	CARM1 (2.2)	GEMIN7 (2.1)	PBX4 (2.1)	MAPKAPK5 (1.7)	ATXN2 (1.7)	DNM2 (1.7)	SH2B3 (1.7)	ENSG00000238078 (1.5)	C1orf63 (1.4)
ENSG00000106399	RPA3 PPI subnetwork	0.56	> 0.20	FEN1 (6.3)	USP1 (4.6)	POC5 (2.0)	TMEM116 (2.0)	ZNF180 (1.9)	ENSG00000235545 (1.3)	TXNL4B (1.3)	PSRC1 (1.3)	AMIGO1 (1.2)	FADS1 (1.2)
ENSG00000076248	UNG PPI subnetwork	0.56	> 0.20	NAA25 (2.3)	ST3GAL4 (2.2)	FEN1 (2.1)	ILF3 (2.0)	ITGB3 (1.9)	SORT1 (1.9)	ENSG00000226648 (1.7)	SARS (1.7)	HAVCR1 (1.5)	USP1 (1.5)
REACTOME_FORMATION_OF_TRANSCRIPTION:COUPLED_NER_TC:NER_REPAIR_COMPLEX	REACTOME_FORMATION_OF_TRANSCRIPTION:COUPLED_NER_TC:NER_REPAIR_COMPLEX	0.56	> 0.20	SUGP1 (3.1)	MARK4 (3.0)	UBXN2B (2.8)	POLK (2.7)	POC5 (2.6)	TRAPPC6A (2.5)	MAPKAPK5 (2.4)	TXNL4B (2.1)	BLOC1S3 (2.1)	GEMIN7 (1.9)
REACTOME_DUAL_INCISION_REACTION_IN_TC:NER	REACTOME_DUAL_INCISION_REACTION_IN_TC:NER	0.56	> 0.20	SUGP1 (3.1)	MARK4 (3.0)	UBXN2B (2.8)	POLK (2.7)	POC5 (2.6)	TRAPPC6A (2.5)	MAPKAPK5 (2.4)	TXNL4B (2.1)	BLOC1S3 (2.1)	GEMIN7 (1.9)
ENSG00000134686	PHC2 PPI subnetwork	0.56	> 0.20	TMEM57 (2.9)	USP24 (2.2)	ATXN7L2 (2.1)	ATXN2 (2.1)	TRAFD1 (2.1)	ILF3 (1.8)	USP1 (1.8)	BUD13 (1.7)	C19orf52 (1.7)	AMIGO1 (1.6)
GO:0046605	regulation of centrosome cycle	0.56	> 0.20	POC5 (3.0)	POLK (2.4)	ZNF180 (2.3)	GOT2P1 (2.2)	UBXN2B (2.2)	BUD13 (2.1)	DYNC2LI1 (2.0)	CEACAM19 (2.0)	PSRC1 (1.8)	TXNL4B (1.6)
ENSG00000008196	TFAP2B PPI subnetwork	0.56	> 0.20	MYLIP (3.0)	GEMIN7 (2.8)	KIAA1324 (2.5)	TSSK6 (2.3)	MAFB (1.9)	ENSG00000226645 (1.8)	ABO (1.7)	ZNF259 (1.7)	AMIGO1 (1.7)	C12orf47 (1.5)
MP:0005597	decreased susceptibility to type I hypersensitivity reaction	0.56	> 0.20	ALDH2 (2.5)	SH2B3 (2.2)	HP (1.9)	POLK (1.5)	HLX (1.4)	HAVCR1 (1.4)	APOE (1.4)	SORT1 (1.3)	TRAPPC6A (1.1)	GMIP (1.1)
ENSG00000118194	TNNT2 PPI subnetwork	0.56	> 0.20	SYPL2 (2.8)	PVR (2.2)	PVRL2 (1.8)	BLOC1S3 (1.5)	PLCG1 (1.5)	ENSG00000238078 (1.5)	TIMD4 (1.4)	MARK4 (1.4)	OGDH (1.4)	C17orf57 (1.4)
ENSG00000135424	ITGA7 PPI subnetwork	0.56	> 0.20	BCAM (3.9)	KANK2 (2.6)	ENSG00000226648 (2.4)	PLEC (2.2)	SORT1 (2.0)	TSSK6 (1.9)	SLC44A2 (1.8)	PVR (1.7)	CILP2 (1.7)	CELSR2 (1.6)
GO:0043240	Fanconi anaemia nuclear complex	0.57	> 0.20	ZNF180 (3.7)	DHODH (3.0)	NKPD1 (2.7)	BLOC1S3 (2.5)	USP1 (2.0)	FEN1 (1.9)	ABO (1.7)	TXNL4B (1.7)	POC5 (1.6)	ENSG00000254235 (1.6)
GO:0031396	regulation of protein ubiquitination	0.57	> 0.20	PSMA5 (3.0)	TRAFD1 (2.6)	BRAP (2.5)	ENSG00000226645 (2.2)	POC5 (2.2)	NT5DC1 (2.0)	NAA25 (1.9)	SUGP1 (1.8)	SARS (1.5)	C12orf43 (1.4)
ENSG00000106392	C1GALT1 PPI subnetwork	0.57	> 0.20	UBXN2B (3.8)	MAPKAPK5 (2.2)	C19orf52 (2.1)	GRINA (2.1)	SUGP1 (2.0)	MARK4 (2.0)	CARM1 (1.9)	MAU2 (1.8)	TIMD4 (1.7)	ATXN2 (1.7)
ENSG00000170043	TRAPPC1 PPI subnetwork	0.57	> 0.20	TMED4 (3.0)	YIPF2 (3.0)	BLOC1S3 (2.9)	TMEM50A (2.8)	ZNF180 (2.7)	RHD (2.5)	RHCE (2.4)	GEMIN7 (2.3)	CYB561D1 (1.9)	TRAPPC6A (1.9)
GO:0009629	response to gravity	0.57	> 0.20	CILP2 (2.3)	CEACAM19 (2.1)	ZHX3 (2.1)	CYB561D1 (2.0)	ITGB3 (1.9)	SLC44A2 (1.7)	PBX4 (1.7)	DNAH11 (1.6)	ENSG00000226648 (1.6)	AMIGO1 (1.5)
GO:0051354	negative regulation of oxidoreductase activity	0.57	> 0.20	CEACAM19 (3.2)	C17orf57 (2.5)	PBX4 (2.3)	TXNL4B (2.3)	SYPL2 (2.1)	ATXN7L2 (2.0)	ABCG8 (1.9)	ENSG00000228044 (1.8)	C12orf47 (1.8)	PMFBP1 (1.5)
ENSG00000148688	RPP30 PPI subnetwork	0.57	> 0.20	DHODH (2.7)	RHD (2.3)	RHCE (2.2)	ATP13A1 (2.1)	QTRT1 (1.8)	ENSG00000226645 (1.5)	DOCK7 (1.4)	SLC44A2 (1.2)	OGDH (1.2)	NAA25 (1.2)
ENSG00000087586	AURKA PPI subnetwork	0.57	> 0.20	PSRC1 (3.7)	FEN1 (2.6)	POC5 (2.6)	GMPR (2.1)	SUGP1 (1.9)	ATP13A1 (1.8)	C1orf63 (1.8)	MYLIP (1.8)	USP1 (1.6)	ENSG00000226648 (1.6)
ENSG00000170144	HNRNPA3 PPI subnetwork	0.57	> 0.20	ILF3 (4.1)	C1orf63 (3.2)	TOP1 (2.9)	USP1 (2.7)	SUGP1 (2.6)	SMARCA4 (2.5)	DHX38 (2.4)	BUD13 (2.3)	QTRT1 (2.2)	PTPN11 (2.2)
ENSG00000162624	LHX8 PPI subnetwork	0.57	> 0.20	ABCG8 (2.9)	TM6SF2 (2.6)	ABO (2.5)	NPC1L1 (2.2)	MYLIP (2.0)	NKPD1 (1.7)	GATAD2A (1.7)	ABCG5 (1.6)	ACAD10 (1.4)	SYPL2 (1.4)
MP:0002098	abnormal vibrissa morphology	0.57	> 0.20	BCAM (2.9)	CBLC (2.5)	AP1M2 (2.5)	ABO (2.1)	ENSG00000235545 (2.0)	CILP2 (1.7)	ALDH2 (1.7)	KIAA1324 (1.6)	CELSR2 (1.5)	PCSK9 (1.2)
ENSG00000102003	SYP PPI subnetwork	0.57	> 0.20	C12orf51 (3.4)	RHD (2.5)	BRAP (2.0)	ENSG00000226645 (2.0)	TXNL4B (1.8)	CELSR2 (1.7)	HNF1A (1.7)	NKPD1 (1.6)	MAPKAPK5 (1.5)	ENSG00000228044 (1.5)
GO:0048483	autonomic nervous system development	0.57	> 0.20	ANKRD31 (3.2)	TSSK6 (3.1)	TMED4 (1.8)	CEACAM19 (1.7)	C17orf57 (1.7)	ENSG00000254235 (1.6)	ABO (1.5)	C19orf52 (1.4)	ZNF101 (1.4)	HLX (1.3)
GO:0042403	thyroid hormone metabolic process	0.57	> 0.20	C17orf57 (3.8)	ANKRD31 (3.6)	HAVCR1 (3.0)	PBX4 (2.6)	DNAH11 (2.3)	PMFBP1 (1.9)	TSSK6 (1.5)	MYLIP (1.4)	ITGB3 (1.4)	ENSG00000235545 (1.3)
ENSG00000130255	RPL36 PPI subnetwork	0.57	> 0.20	NKPD1 (2.6)	ZNF259 (2.5)	ENSG00000226645 (1.8)	GATAD2A (1.7)	NAA25 (1.4)	MOSC1 (1.4)	C1orf63 (1.4)	ADAM1 (1.3)	DNAH11 (1.3)	HAVCR1 (1.3)
GO:0014855	striated muscle cell proliferation	0.57	> 0.20	CEACAM19 (2.6)	C19orf52 (2.4)	BLOC1S3 (2.4)	PLEKHH2 (2.1)	TXNL4B (1.5)	C11orf9 (1.4)	ENSG00000254235 (1.4)	LPA (1.3)	ALDH2 (1.3)	PVR (1.2)
ENSG00000198838	RYR3 PPI subnetwork	0.57	> 0.20	SYPL2 (4.3)	ZNF180 (2.3)	OGDH (2.3)	AMIGO1 (1.9)	HAPLN4 (1.9)	TMED4 (1.8)	HAVCR1 (1.7)	MARK4 (1.7)	BCAM (1.6)	ATXN7L2 (1.6)
GO:0051414	response to cortisol stimulus	0.57	> 0.20	RHCE (3.5)	RHD (2.8)	TXNL4B (2.4)	DNAH11 (2.3)	TMEM57 (2.1)	CEACAM19 (2.0)	C11orf9 (1.7)	LPAR2 (1.6)	GMPR (1.6)	YIPF2 (1.6)
ENSG00000009413	REV3L PPI subnetwork	0.57	> 0.20	TMEM57 (3.0)	FEN1 (2.5)	ZNF180 (2.3)	GEMIN7 (2.1)	PBX4 (2.1)	POLK (2.0)	HNF1A (1.8)	USP1 (1.7)	ZNF101 (1.5)	DYNC2LI1 (1.4)
REACTOME_SIGNALING_BY_NODAL	REACTOME_SIGNALING_BY_NODAL	0.57	> 0.20	PVRL2 (2.6)	MAPKAPK5 (2.3)	TMEM57 (1.9)	LPAR2 (1.7)	SH2B3 (1.7)	MOSC1 (1.4)	TMED4 (1.4)	ENSG00000226645 (1.3)	CARM1 (1.2)	ENSG00000235545 (1.2)
ENSG00000004059	ARF5 PPI subnetwork	0.57	> 0.20	CLPTM1 (3.9)	PPP1R37 (3.1)	KIAA1324 (3.0)	DNM2 (2.4)	PLCG1 (2.3)	ACAD10 (2.2)	ENSG00000235545 (2.1)	DOCK7 (2.1)	ZHX3 (2.0)	YIPF2 (1.9)
ENSG00000112983	BRD8 PPI subnetwork	0.57	> 0.20	USP1 (2.7)	SMARCA4 (2.6)	PCSK9 (2.1)	ATXN7L2 (2.1)	C12orf43 (2.1)	MAPKAPK5 (1.8)	ADAM1 (1.8)	ILF3 (1.8)	TRIB1 (1.7)	PSRC1 (1.6)
MP:0004000	impaired passive avoidance behavior	0.57	> 0.20	ABCG5 (2.8)	ABO (2.7)	HAPLN4 (2.5)	NPC1L1 (2.3)	RPH3A (2.2)	C17orf57 (2.1)	CYP7A1 (2.1)	CELSR2 (1.9)	LPA (1.9)	ABCG8 (1.8)
GO:0001832	blastocyst growth	0.57	> 0.20	PPP1R37 (3.3)	MAU2 (2.8)	SUGP1 (2.6)	UBXN2B (2.5)	QTRT1 (2.5)	BLOC1S3 (2.4)	YIPF2 (2.4)	ENSG00000226648 (2.2)	AMIGO1 (2.1)	GOT2P1 (1.9)
MP:0002026	leukemia	0.57	> 0.20	GMIP (2.2)	PARP10 (2.0)	RHD (1.7)	SLC44A2 (1.6)	C12orf47 (1.5)	HLX (1.5)	RHCE (1.4)	ENSG00000235545 (1.4)	OASL (1.3)	ACAD10 (1.3)
GO:0045185	maintenance of protein location	0.57	> 0.20	C17orf57 (2.3)	PSRC1 (1.8)	CLPTM1 (1.8)	CBLC (1.8)	UBXN2B (1.7)	PLEC (1.7)	TMEM50A (1.7)	RHD (1.6)	GOT2P1 (1.6)	C11orf9 (1.5)
GO:0043200	response to amino acid stimulus	0.57	> 0.20	C17orf57 (3.4)	AP1M2 (2.0)	ABCG5 (2.0)	SARS (1.9)	NPC1L1 (1.8)	COL4A3BP (1.7)	C11orf9 (1.7)	C12orf51 (1.6)	DNAH11 (1.6)	ANKRD31 (1.5)
ENSG00000103168	TAF1C PPI subnetwork	0.57	> 0.20	ZNF259 (3.4)	C12orf43 (3.2)	MAPKAPK5 (2.8)	GEMIN7 (2.5)	POLK (2.2)	DYNC2LI1 (2.1)	DDX56 (2.1)	NAA25 (2.1)	BUD13 (2.1)	DHODH (1.7)
ENSG00000094796	KRT31 PPI subnetwork	0.57	> 0.20	ENSG00000226645 (2.5)	PSRC1 (2.4)	TRAFD1 (2.2)	FRK (2.2)	TOP1 (2.0)	CBLC (1.9)	ABO (1.8)	ENSG00000254235 (1.7)	NCAN (1.5)	OASL (1.5)
ENSG00000206503	HLA-A PPI subnetwork	0.57	> 0.20	PLCG1 (4.3)	ZNF101 (3.1)	PPP1R37 (2.0)	CLPTM1 (1.9)	HAVCR1 (1.8)	TXNL4B (1.8)	ENSG00000235545 (1.7)	YIPF2 (1.7)	GATAD2A (1.6)	DNM2 (1.6)
GO:0006107	oxaloacetate metabolic process	0.57	> 0.20	SARS (2.7)	GPAM (1.9)	HAPLN4 (1.9)	ALDH2 (1.8)	GOT2P1 (1.8)	AMIGO1 (1.6)	PMFBP1 (1.5)	MOSC1 (1.4)	ACAD10 (1.4)	ANKRD31 (1.4)
GO:0044440	endosomal part	0.57	> 0.20	COL4A3BP (3.1)	TMEM50A (2.8)	MAU2 (2.4)	GRINA (2.2)	FRK (2.1)	TRAFD1 (2.1)	ERP29 (2.0)	GMIP (1.9)	ATP13A1 (1.7)	PTPN11 (1.6)
GO:0031103	axon regeneration	0.57	> 0.20	ENSG00000238078 (2.6)	GCNT4 (2.5)	ENSG00000228044 (2.0)	DNAH11 (1.7)	TMEM50A (1.7)	ALDH2 (1.6)	ANKRD31 (1.5)	HAPLN4 (1.3)	RPH3A (1.2)	COL4A3BP (1.1)
GO:0071855	neuropeptide receptor binding	0.57	> 0.20	KIAA1324 (2.3)	ABO (1.9)	LPIN3 (1.9)	ENSG00000254235 (1.8)	PMFBP1 (1.5)	DNAH11 (1.5)	YIPF2 (1.5)	TSSK6 (1.4)	NKPD1 (1.4)	HAPLN4 (1.3)
GO:0060008	Sertoli cell differentiation	0.57	> 0.20	ABO (2.5)	LPAR2 (2.1)	ST3GAL4 (2.0)	C11orf9 (2.0)	HNF1A (1.9)	DOCK7 (1.6)	ENSG00000254235 (1.6)	ACAD10 (1.6)	UBXN2B (1.5)	FRK (1.5)
GO:0000784	nuclear chromosome, telomeric region	0.57	> 0.20	POLK (4.0)	DHODH (2.7)	UBXN2B (2.6)	TXNL4B (2.5)	POC5 (2.2)	SARS (2.1)	ENSG00000235545 (1.8)	NYNRIN (1.8)	SUGP1 (1.7)	DHX38 (1.7)
GO:0032201	telomere maintenance via semi-conservative replication	0.57	> 0.20	ZNF180 (3.6)	USP1 (3.1)	ENSG00000235545 (2.6)	GOT2P1 (2.4)	FEN1 (2.3)	ENSG00000228044 (2.2)	TMEM116 (1.9)	AMIGO1 (1.8)	NT5DC1 (1.6)	ERP29 (1.5)
ENSG00000197694	SPTAN1 PPI subnetwork	0.57	> 0.20	PLEC (2.7)	OGDH (2.4)	DNM2 (2.2)	HAVCR1 (2.2)	CARM1 (1.9)	KANK2 (1.9)	RHD (1.9)	ENSG00000238078 (1.9)	FRK (1.8)	DOCK7 (1.7)
ENSG00000164758	MED30 PPI subnetwork	0.57	> 0.20	GEMIN7 (3.2)	TXNL4B (2.8)	BRAP (2.8)	BUD13 (2.3)	MAPKAPK5 (2.1)	BLOC1S3 (2.1)	POC5 (2.0)	DHX38 (1.8)	ZNF180 (1.8)	TOP1 (1.5)
ENSG00000148297	MED22 PPI subnetwork	0.57	> 0.20	GEMIN7 (3.1)	TXNL4B (2.8)	POC5 (2.6)	BRAP (2.3)	BLOC1S3 (2.2)	C19orf52 (2.2)	ZNF180 (2.1)	SMARCA4 (1.6)	MAPKAPK5 (1.6)	DYNC2LI1 (1.5)
GO:0005310	dicarboxylic acid transmembrane transporter activity	0.57	> 0.20	ENSG00000228044 (2.7)	TMEM116 (2.1)	GCNT4 (2.0)	SYPL2 (2.0)	TM6SF2 (2.0)	PLG (1.9)	NCAN (1.9)	HNF1A (1.8)	GRINA (1.5)	PPP1R37 (1.5)
MP:0008489	slow postnatal weight gain	0.57	> 0.20	KIAA1324 (3.6)	TRIB1 (3.4)	APOE (2.5)	DOCK7 (2.4)	TIMD4 (2.3)	CETP (2.2)	SYPL2 (2.1)	MAFB (1.9)	TOP1 (1.8)	ATXN2 (1.8)
GO:0002886	regulation of myeloid leukocyte mediated immunity	0.57	> 0.20	BLOC1S3 (2.6)	ENSG00000235545 (2.5)	ALDH2 (2.4)	GMIP (1.9)	ST3GAL4 (1.8)	DNAH11 (1.7)	GMPR (1.6)	CILP2 (1.6)	ENSG00000226645 (1.5)	LPA (1.4)
ENSG00000166046	TCP11L2 PPI subnetwork	0.57	> 0.20	TM6SF2 (4.0)	ABCG8 (2.8)	NPC1L1 (2.6)	ENSG00000226645 (2.5)	LDLR (2.4)	DNAH11 (2.3)	ST3GAL4 (2.2)	TMEM116 (2.1)	HAPLN4 (2.0)	ABCG5 (1.9)
ENSG00000024422	EHD2 PPI subnetwork	0.57	> 0.20	BCAM (2.5)	KANK2 (2.4)	GRINA (2.0)	DNM2 (2.0)	COL4A3BP (1.9)	CELSR2 (1.9)	CARM1 (1.8)	TSSK6 (1.7)	SLC44A2 (1.7)	BLOC1S3 (1.7)
GO:0006825	copper ion transport	0.57	> 0.20	ENSG00000254235 (2.8)	NKPD1 (2.4)	BLOC1S3 (2.1)	ENSG00000235545 (2.0)	GEMIN7 (1.9)	TRAPPC6A (1.7)	CILP2 (1.7)	RHD (1.6)	HNF1A (1.5)	TMEM116 (1.5)
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	0.57	> 0.20	NT5DC1 (2.7)	HLX (2.0)	APOA5 (1.9)	MOSC1 (1.7)	SH2B3 (1.7)	TM6SF2 (1.7)	C1orf63 (1.6)	ABCG8 (1.6)	SLC22A1 (1.5)	ZNF259 (1.5)
MP:0005090	increased double-negative T cell number	0.57	> 0.20	PLCG1 (4.6)	ZNF101 (3.7)	RELB (2.6)	GMIP (2.5)	PBX4 (1.7)	RHD (1.7)	MAFB (1.6)	CILP2 (1.6)	HAVCR1 (1.5)	USP24 (1.4)
ENSG00000070087	PFN2 PPI subnetwork	0.57	> 0.20	PBX4 (2.2)	UBXN2B (2.1)	PLEC (1.9)	TMEM50A (1.8)	KANK2 (1.8)	HAVCR1 (1.7)	ST3GAL4 (1.6)	TXNL4B (1.5)	GATAD2A (1.5)	DOCK7 (1.5)
MP:0003896	prolonged PR interval	0.57	> 0.20	KANK2 (2.5)	BCAM (2.5)	PPP1R37 (2.1)	GOT2P1 (2.1)	BLOC1S3 (1.7)	PBX4 (1.7)	QTRT1 (1.5)	ENSG00000226648 (1.5)	NYNRIN (1.3)	NKPD1 (1.1)
ENSG00000117242	ENSG00000117242 PPI subnetwork	0.57	> 0.20	ATP13A1 (4.1)	TMEM50A (3.7)	YIPF2 (3.4)	TMED4 (3.1)	NT5DC1 (2.2)	ERP29 (2.2)	LDLR (2.2)	TRAPPC6A (2.1)	FADS2 (2.0)	FADS1 (1.9)
GO:0048770	pigment granule	0.57	> 0.20	ERP29 (5.0)	CLPTM1 (3.5)	APOE (2.9)	SORT1 (2.8)	SARS (2.6)	GRINA (2.2)	ADAM1 (2.1)	CELSR2 (2.1)	PPP1R37 (2.0)	GMPR (2.0)
GO:0042470	melanosome	0.57	> 0.20	ERP29 (5.0)	CLPTM1 (3.5)	APOE (2.9)	SORT1 (2.8)	SARS (2.6)	GRINA (2.2)	ADAM1 (2.1)	CELSR2 (2.1)	PPP1R37 (2.0)	GMPR (2.0)
ENSG00000119699	TGFB3 PPI subnetwork	0.57	> 0.20	CILP2 (5.5)	SLC44A2 (2.3)	YIPF2 (2.2)	PVR (2.1)	KANK2 (2.0)	GPAM (1.8)	SORT1 (1.7)	TMED4 (1.6)	CYP7A1 (1.6)	AP1M2 (1.4)
ENSG00000120868	APAF1 PPI subnetwork	0.57	> 0.20	TRIB1 (2.2)	ST3GAL4 (1.8)	C1orf63 (1.8)	TRAFD1 (1.7)	TOP1 (1.7)	FRK (1.6)	BLOC1S3 (1.6)	PTPN11 (1.5)	TXNL4B (1.4)	GRINA (1.4)
GO:0061138	morphogenesis of a branching epithelium	0.57	> 0.20	PLEKHH2 (2.9)	PVRL2 (2.6)	BCAM (2.4)	MYLIP (2.0)	NYNRIN (2.0)	ENSG00000254235 (1.9)	KANK2 (1.8)	AP1M2 (1.7)	HNF1A (1.7)	CBLC (1.5)
ENSG00000075618	FSCN1 PPI subnetwork	0.57	> 0.20	ZHX3 (2.3)	ZNF101 (2.1)	PLCG1 (1.9)	C19orf52 (1.9)	NPC1L1 (1.6)	PVR (1.6)	HAPLN4 (1.6)	BRAP (1.5)	ENSG00000238078 (1.4)	GATAD2A (1.4)
ENSG00000006075	CCL3 PPI subnetwork	0.57	> 0.20	MAFB (4.3)	SH2B3 (2.3)	TRIB1 (2.2)	APOE (1.4)	LPAR2 (1.4)	TXNL4B (1.4)	KIAA1324 (1.3)	BCL3 (1.3)	GMIP (1.2)	GCNT4 (1.2)
ENSG00000109062	SLC9A3R1 PPI subnetwork	0.57	> 0.20	ABO (2.9)	ST3GAL4 (2.5)	FRK (2.0)	ANGPTL3 (2.0)	HNF1A (1.9)	PLG (1.8)	LDLR (1.5)	ATXN7L2 (1.4)	MYLIP (1.4)	C11orf9 (1.4)
MP:0004701	decreased circulating insulin-like growth factor I level	0.57	> 0.20	KIAA1324 (4.5)	C11orf9 (2.4)	NKPD1 (2.1)	USP24 (1.9)	PPP1R37 (1.7)	GPAM (1.7)	ENSG00000254235 (1.7)	PMFBP1 (1.7)	AP1M2 (1.6)	ZHX3 (1.5)
GO:0004602	glutathione peroxidase activity	0.57	> 0.20	ALDH2 (4.0)	LPIN3 (3.2)	MOSC1 (2.5)	APOC1 (2.5)	APOE (2.2)	DYNC2LI1 (2.1)	GPAM (1.7)	AP1M2 (1.7)	GCNT4 (1.6)	ENSG00000238078 (1.5)
MP:0002582	disorganized extraembryonic tissue	0.57	> 0.20	HAVCR1 (3.1)	CELSR2 (2.8)	ENSG00000254235 (2.6)	TRIB1 (2.4)	PVR (2.0)	LPIN3 (1.9)	SH2B3 (1.8)	TOP1 (1.8)	ZHX3 (1.5)	DOCK7 (1.5)
GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	0.57	> 0.20	DOCK7 (2.8)	CETP (2.5)	HAVCR1 (2.3)	ENSG00000228044 (2.3)	ZNF101 (2.3)	CYB561D1 (2.3)	ANKRD31 (2.1)	PBX4 (1.9)	NKPD1 (1.4)	HLX (1.3)
ENSG00000143507	DUSP10 PPI subnetwork	0.57	> 0.20	HLX (2.4)	ALDH2 (2.3)	PLCG1 (2.0)	ENSG00000226645 (2.0)	TMEM57 (2.0)	MOSC1 (1.9)	CBLC (1.9)	MYLIP (1.8)	AMIGO1 (1.6)	ZNF180 (1.6)
GO:0045910	negative regulation of DNA recombination	0.57	> 0.20	POC5 (3.2)	ZNF101 (2.9)	ENSG00000235545 (2.7)	TXNL4B (2.1)	TMEM116 (1.9)	ENSG00000226648 (1.8)	C17orf57 (1.8)	DYNC2LI1 (1.7)	POLK (1.6)	ENSG00000226645 (1.6)
ENSG00000072133	RPS6KA6 PPI subnetwork	0.57	> 0.20	TRIB1 (3.4)	GMIP (2.7)	PLEKHH2 (2.3)	KIAA1324 (2.2)	LPAR2 (2.2)	TSSK6 (1.8)	CARM1 (1.7)	HLX (1.7)	LPA (1.6)	ST3GAL4 (1.5)
ENSG00000112242	E2F3 PPI subnetwork	0.57	> 0.20	BCL3 (2.5)	GMIP (2.4)	MAU2 (2.4)	USP24 (2.4)	PARP10 (2.2)	PSRC1 (2.0)	CBLC (1.8)	NYNRIN (1.8)	MAFB (1.8)	C12orf51 (1.7)
GO:0070555	response to interleukin-1	0.57	> 0.20	ENSG00000228044 (2.9)	GCNT4 (2.2)	BCL3 (2.2)	ANKRD31 (1.9)	PVR (1.8)	RELB (1.8)	TRIB1 (1.7)	ENSG00000254235 (1.7)	PMFBP1 (1.4)	ZNF101 (1.3)
GO:0061035	regulation of cartilage development	0.57	> 0.20	CILP2 (2.5)	PLEKHH2 (2.5)	MAFB (2.0)	LPIN3 (1.7)	LPAR2 (1.6)	NYNRIN (1.4)	ABO (1.3)	KANK2 (1.2)	YIPF2 (1.1)	PVRL2 (1.1)
GO:0031267	small GTPase binding	0.57	> 0.20	DNM2 (2.6)	USP24 (2.3)	GMIP (2.3)	COL4A3BP (2.3)	PTPN11 (2.2)	SH2B3 (2.1)	PLEC (2.1)	KANK2 (2.0)	CARM1 (1.9)	C12orf51 (1.8)
MP:0008210	increased mature B cell number	0.57	> 0.20	MAFB (2.8)	C17orf57 (1.8)	ERP29 (1.8)	RELB (1.7)	PLEKHH2 (1.7)	ENSG00000254235 (1.6)	ALDH2 (1.6)	TIMD4 (1.5)	TRIB1 (1.5)	SLC44A2 (1.3)
ENSG00000162290	ENSG00000162290 PPI subnetwork	0.57	> 0.20	TXNL4B (2.5)	CARM1 (2.5)	POLK (2.4)	DHX38 (2.2)	ILF3 (2.0)	DHODH (1.9)	MAU2 (1.9)	SMARCA4 (1.6)	UBXN2B (1.6)	ATP13A1 (1.5)
ENSG00000104805	NUCB1 PPI subnetwork	0.57	> 0.20	NYNRIN (3.5)	ITGB3 (2.8)	ALDH2 (2.5)	PLEKHH2 (2.3)	GMPR (2.3)	NCAN (1.7)	TSSK6 (1.6)	SH2B3 (1.5)	ERP29 (1.4)	POLK (1.3)
GO:0050866	negative regulation of cell activation	0.57	> 0.20	ZNF101 (2.4)	TIMD4 (2.2)	PBX4 (2.2)	GCNT4 (1.8)	CETP (1.7)	CEACAM19 (1.6)	C17orf57 (1.6)	ANKRD31 (1.6)	PLCG1 (1.6)	APOE (1.5)
ENSG00000106991	ENG PPI subnetwork	0.57	> 0.20	HLX (2.6)	PVR (2.5)	ZNF180 (2.3)	ITGB3 (1.8)	SH2B3 (1.7)	SLC44A2 (1.7)	MAFB (1.7)	CYB561D1 (1.6)	BCAM (1.6)	MYLIP (1.5)
GO:0005275	amine transmembrane transporter activity	0.57	> 0.20	ABCG8 (3.4)	TM6SF2 (2.8)	SARS (2.7)	ABCG5 (2.5)	NPC1L1 (2.4)	HAPLN4 (2.1)	ATP13A1 (2.0)	ALDH2 (2.0)	NCAN (2.0)	GRINA (1.7)
MP:0003703	abnormal vestibulocochlear ganglion morphology	0.57	> 0.20	HAVCR1 (2.4)	BCAM (2.2)	C11orf9 (2.1)	ZHX3 (2.1)	DYNC2LI1 (2.1)	CEACAM19 (1.9)	TSSK6 (1.8)	TMEM116 (1.7)	PVRL2 (1.5)	CBLC (1.5)
MP:0008395	abnormal osteoblast differentiation	0.57	> 0.20	OASL (2.7)	POLK (2.5)	MAFB (2.4)	PARP10 (2.1)	BCL3 (1.9)	HLX (1.9)	CILP2 (1.7)	PLEKHH2 (1.6)	PVRL2 (1.6)	BCAM (1.5)
ENSG00000140443	IGF1R PPI subnetwork	0.57	> 0.20	USP24 (2.5)	GRINA (2.4)	NCAN (2.4)	DNM2 (2.1)	SH2B3 (2.0)	FADS2 (1.9)	CETP (1.8)	ATXN2 (1.8)	PLEC (1.8)	HLX (1.7)
ENSG00000122367	LDB3 PPI subnetwork	0.57	> 0.20	SYPL2 (5.4)	GMPR (2.7)	TMEM50A (2.0)	SH2B3 (1.9)	UBXN2B (1.7)	RHD (1.6)	PLEC (1.6)	RHCE (1.6)	LPIN3 (1.4)	C1orf63 (1.4)
GO:0030098	lymphocyte differentiation	0.57	> 0.20	ZNF101 (5.8)	PBX4 (3.2)	PLCG1 (2.7)	GMIP (1.8)	DNAH11 (1.6)	TIMD4 (1.6)	CYB561D1 (1.4)	ENSG00000254235 (1.2)	BLOC1S3 (1.2)	SLC44A2 (1.2)
GO:0008239	dipeptidyl-peptidase activity	0.57	> 0.20	HAPLN4 (2.4)	HNF1A (2.1)	NPC1L1 (1.9)	HAVCR1 (1.8)	LPAR2 (1.8)	AP1M2 (1.8)	FRK (1.7)	GCNT4 (1.7)	PMFBP1 (1.7)	NCAN (1.7)
ENSG00000131183	SLC34A1 PPI subnetwork	0.57	> 0.20	PVRL2 (2.1)	BCAM (2.0)	TMED4 (1.9)	C11orf9 (1.8)	MYLIP (1.7)	TMEM116 (1.6)	AP1M2 (1.5)	KIAA1324 (1.5)	POLK (1.5)	FRK (1.4)
GO:0016101	diterpenoid metabolic process	0.57	> 0.20	ABCG8 (3.0)	NKPD1 (2.8)	TM6SF2 (2.7)	CYP7A1 (2.3)	CYB561D1 (2.1)	C11orf9 (2.0)	ABCG5 (1.9)	LPAR2 (1.9)	NPC1L1 (1.8)	ENSG00000235545 (1.7)
ENSG00000184678	HIST2H2BE PPI subnetwork	0.57	> 0.20	SMARCA4 (2.6)	BUD13 (2.1)	DNAH11 (2.1)	DOCK7 (2.1)	ILF3 (2.0)	TMEM57 (2.0)	USP1 (1.9)	GATAD2A (1.5)	DDX56 (1.4)	TOP1 (1.4)
REACTOME_TRANSCRIPTION:COUPLED_NER_TC:NER	REACTOME_TRANSCRIPTION:COUPLED_NER_TC:NER	0.57	> 0.20	FEN1 (4.2)	USP1 (4.1)	ZNF180 (2.3)	POC5 (2.3)	POLK (2.1)	SUGP1 (1.9)	MAPKAPK5 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.7)	TRAPPC6A (1.7)
ENSG00000158773	USF1 PPI subnetwork	0.57	> 0.20	HLX (2.5)	ADAM1 (2.5)	ENSG00000254235 (1.9)	PPP1R37 (1.8)	ZNF101 (1.7)	HAVCR1 (1.6)	GRINA (1.6)	PLCG1 (1.5)	TRAPPC6A (1.5)	GATAD2A (1.4)
GO:0051593	response to folic acid	0.57	> 0.20	ENSG00000226648 (5.7)	ZHX3 (2.1)	CYP7A1 (2.0)	ENSG00000238078 (1.9)	DYNC2LI1 (1.8)	GPAM (1.7)	LPA (1.5)	TMEM116 (1.4)	ITGB3 (1.4)	C17orf57 (1.3)
GO:0032720	negative regulation of tumor necrosis factor production	0.57	> 0.20	GRINA (2.9)	ABO (2.2)	ALDH2 (1.9)	MOSC1 (1.6)	UBXN2B (1.4)	ZNF259 (1.4)	HP (1.3)	TSSK6 (1.3)	GMIP (1.3)	LPAR2 (1.3)
ENSG00000196218	RYR1 PPI subnetwork	0.57	> 0.20	SYPL2 (4.1)	OGDH (2.6)	ZNF180 (2.1)	AMIGO1 (2.0)	HAPLN4 (2.0)	TMED4 (1.8)	ZHX3 (1.8)	GMPR (1.8)	ENSG00000226648 (1.7)	ATXN7L2 (1.6)
ENSG00000116761	CTH PPI subnetwork	0.57	> 0.20	NT5DC1 (3.1)	SARS (2.7)	GATAD2A (1.8)	PSMA5 (1.7)	ENSG00000235545 (1.7)	C12orf43 (1.6)	OGDH (1.5)	ZNF259 (1.5)	SLC22A1 (1.5)	ABCG5 (1.4)
ENSG00000086102	NFX1 PPI subnetwork	0.57	> 0.20	ILF3 (4.0)	TOP1 (3.4)	C1orf63 (3.3)	SMARCA4 (2.6)	BUD13 (2.5)	USP1 (2.5)	DHX38 (2.5)	SUGP1 (2.1)	FEN1 (2.0)	PTPN11 (1.8)
ENSG00000177879	AP3S1 PPI subnetwork	0.57	> 0.20	MAU2 (3.4)	CYB561D1 (2.5)	C12orf51 (2.1)	C17orf57 (1.8)	ATP13A1 (1.7)	YIPF2 (1.6)	SORT1 (1.5)	C19orf52 (1.4)	TXNL4B (1.3)	KIAA1324 (1.3)
ENSG00000172380	GNG12 PPI subnetwork	0.57	> 0.20	PPP1R37 (2.5)	FRK (2.1)	OASL (1.9)	TOMM40 (1.8)	ENSG00000238078 (1.7)	CYB561D1 (1.6)	BLOC1S3 (1.5)	PTPN11 (1.5)	C12orf43 (1.5)	PARP10 (1.4)
ENSG00000111424	VDR PPI subnetwork	0.57	> 0.20	C12orf51 (3.5)	TRIB1 (3.4)	MAU2 (3.2)	ATXN2 (3.1)	SMARCA4 (2.9)	CARM1 (2.6)	ZHX3 (2.3)	ILF3 (2.2)	PTPN11 (2.1)	MAPKAPK5 (2.1)
GO:0032420	stereocilium	0.57	> 0.20	HNF1A (2.2)	TM6SF2 (2.1)	ABO (2.0)	CBLC (1.9)	LPIN3 (1.9)	PMFBP1 (1.6)	NKPD1 (1.4)	HAVCR1 (1.4)	FADS1 (1.3)	PVR (1.3)
ENSG00000133119	RFC3 PPI subnetwork	0.57	> 0.20	FEN1 (5.3)	USP1 (4.2)	PSRC1 (1.9)	ERP29 (1.9)	ATP13A1 (1.8)	ILF3 (1.7)	PSMA5 (1.6)	SMARCA4 (1.4)	AMIGO1 (1.4)	CLPTM1 (1.4)
ENSG00000085231	TAF9 PPI subnetwork	0.57	> 0.20	BUD13 (2.9)	TOP1 (2.7)	ATXN2 (2.5)	SUGP1 (2.4)	MAPKAPK5 (2.2)	ILF3 (2.1)	C19orf52 (1.9)	PSMA5 (1.8)	GEMIN7 (1.8)	TXNL4B (1.6)
GO:0043189	H4/H2A histone acetyltransferase complex	0.57	> 0.20	ADAM1 (3.1)	C12orf43 (2.8)	MAPKAPK5 (2.7)	BUD13 (2.6)	SUGP1 (2.6)	USP24 (2.4)	QTRT1 (2.1)	SMARCA4 (2.0)	ILF3 (2.0)	USP1 (1.9)
GO:0090329	regulation of DNA-dependent DNA replication	0.57	> 0.20	BUD13 (2.5)	POC5 (2.1)	BLOC1S3 (1.9)	ZNF180 (1.8)	TMEM57 (1.8)	USP1 (1.7)	UBXN2B (1.5)	NKPD1 (1.4)	AMIGO1 (1.4)	DHX38 (1.4)
GO:0009147	pyrimidine nucleoside triphosphate metabolic process	0.57	> 0.20	DYNC2LI1 (3.8)	C12orf43 (2.9)	ENSG00000226648 (2.5)	PMFBP1 (2.5)	DNAH11 (2.2)	GEMIN7 (1.8)	TMEM116 (1.6)	POLK (1.5)	GCNT4 (1.4)	AMIGO1 (1.2)
REACTOME_BASE:FREE_SUGAR:PHOSPHATE_REMOVAL_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	REACTOME_BASE:FREE_SUGAR:PHOSPHATE_REMOVAL_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	0.57	> 0.20	POC5 (3.0)	TMEM57 (2.3)	C12orf43 (1.7)	DHODH (1.7)	TMEM116 (1.6)	C17orf57 (1.6)	MAPKAPK5 (1.5)	ANKRD31 (1.4)	LPIN3 (1.2)	ERP29 (1.2)
GO:0003743	translation initiation factor activity	0.57	> 0.20	SARS (3.9)	C12orf43 (3.1)	DDX56 (2.9)	TMEM57 (2.7)	PSMA5 (2.7)	ZNF259 (2.5)	SUGP1 (2.4)	MYLIP (2.1)	C19orf52 (2.1)	QTRT1 (2.0)
ENSG00000115963	RND3 PPI subnetwork	0.57	> 0.20	CBLC (5.8)	AP1M2 (3.8)	CELSR2 (2.8)	LPAR2 (1.8)	LPIN3 (1.7)	ST3GAL4 (1.6)	FRK (1.5)	PLEC (1.4)	PVRL2 (1.4)	DOCK7 (1.3)
GO:0046716	muscle cell homeostasis	0.57	> 0.20	SYPL2 (2.9)	AMIGO1 (2.7)	C17orf57 (1.9)	GOT2P1 (1.8)	TMEM116 (1.7)	CYB561D1 (1.7)	COL4A3BP (1.7)	ATXN7L2 (1.5)	C12orf51 (1.4)	TXNL4B (1.4)
ENSG00000100479	POLE2 PPI subnetwork	0.57	> 0.20	FEN1 (5.0)	USP1 (3.8)	ZHX3 (2.4)	FADS2 (1.9)	BRAP (1.7)	USP24 (1.7)	DNAH11 (1.6)	FADS1 (1.6)	DHODH (1.6)	ZNF180 (1.4)
GO:0006457	protein folding	0.57	> 0.20	ERP29 (4.0)	TMED4 (3.3)	YIPF2 (2.7)	TXNL4B (2.4)	TOMM40 (1.8)	CLPTM1 (1.6)	TSSK6 (1.5)	QTRT1 (1.5)	TMEM57 (1.4)	TOP1 (1.4)
ENSG00000215760	ENSG00000215760 PPI subnetwork	0.58	> 0.20	ATXN7L2 (3.3)	MAPKAPK5 (2.4)	POC5 (2.3)	ATXN2 (2.3)	C1orf63 (2.1)	ZNF101 (2.0)	TOP1 (2.0)	COL4A3BP (2.0)	C17orf57 (1.9)	BLOC1S3 (1.7)
ENSG00000187325	TAF9B PPI subnetwork	0.58	> 0.20	ATXN7L2 (3.3)	MAPKAPK5 (2.4)	POC5 (2.3)	ATXN2 (2.3)	C1orf63 (2.1)	ZNF101 (2.0)	TOP1 (2.0)	COL4A3BP (2.0)	C17orf57 (1.9)	BLOC1S3 (1.7)
ENSG00000165494	PCF11 PPI subnetwork	0.58	> 0.20	ILF3 (4.3)	C1orf63 (3.5)	TOP1 (3.1)	SMARCA4 (3.1)	BUD13 (2.8)	DHX38 (2.7)	USP1 (2.6)	PTPN11 (2.4)	SUGP1 (2.2)	FEN1 (2.1)
GO:0016528	sarcoplasm	0.58	> 0.20	SYPL2 (7.4)	GMPR (3.4)	C17orf57 (2.1)	HAVCR1 (1.7)	SORT1 (1.6)	TMED4 (1.5)	CARM1 (1.4)	CYB561D1 (1.3)	ST3GAL4 (1.3)	OGDH (1.2)
ENSG00000105971	CAV2 PPI subnetwork	0.58	> 0.20	PLEC (3.5)	BCAM (2.5)	SLC44A2 (2.5)	AP1M2 (2.2)	CBLC (2.1)	MAFB (2.0)	FRK (1.9)	CEACAM19 (1.8)	SARS (1.6)	OGDH (1.5)
ENSG00000152484	USP12 PPI subnetwork	0.58	> 0.20	BRAP (3.3)	DDX56 (2.8)	ATP13A1 (2.4)	HNF1A (2.1)	PTPN11 (2.0)	C12orf47 (1.9)	GPAM (1.8)	CEACAM19 (1.8)	MAU2 (1.7)	MAPKAPK5 (1.6)
GO:0050796	regulation of insulin secretion	0.58	> 0.20	KIAA1324 (4.9)	HNF1A (2.2)	HAPLN4 (2.2)	ENSG00000238078 (2.1)	ABO (2.1)	ANKRD31 (1.9)	COL4A3BP (1.8)	PLEKHH2 (1.7)	ENSG00000228044 (1.4)	GPAM (1.4)
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	0.58	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	PSRC1 (2.9)	FEN1 (2.3)	POC5 (2.2)	SUGP1 (1.9)	NAA25 (1.9)	DDX56 (1.7)	LPIN3 (1.4)	ABCG8 (1.0)
REACTOME_APCC:MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	REACTOME_APCC:MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	0.58	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	PSRC1 (2.9)	FEN1 (2.3)	POC5 (2.2)	SUGP1 (1.9)	NAA25 (1.9)	DDX56 (1.7)	LPIN3 (1.4)	ABCG8 (1.0)
MP:0006304	abnormal seminiferous epithelium morphology	0.58	> 0.20	ST3GAL4 (3.8)	TSSK6 (2.0)	BUD13 (1.7)	NT5DC1 (1.6)	PMFBP1 (1.5)	MYLIP (1.3)	HMGCR (1.3)	FADS2 (1.3)	APOE (1.2)	POC5 (1.2)
GO:0060402	calcium ion transport into cytosol	0.58	> 0.20	ABO (2.4)	SYPL2 (2.0)	HAVCR1 (2.0)	GEMIN7 (1.8)	RPH3A (1.6)	GCNT4 (1.5)	SLC44A2 (1.5)	ZNF180 (1.5)	TRAPPC6A (1.4)	ZNF101 (1.4)
MP:0003892	abnormal gastric gland morphology	0.58	> 0.20	C11orf9 (3.4)	ABO (2.3)	OASL (2.3)	DOCK7 (2.3)	GCNT4 (2.2)	HNF1A (2.2)	KIAA1324 (2.1)	C12orf47 (1.5)	NPC1L1 (1.5)	TMEM116 (1.4)
GO:0045446	endothelial cell differentiation	0.58	> 0.20	DNAH11 (3.0)	CILP2 (2.6)	ENSG00000226645 (2.2)	CETP (2.0)	BCAM (2.0)	HLX (1.9)	PLCG1 (1.7)	HNF1A (1.7)	CEACAM19 (1.7)	ANKRD31 (1.7)
ENSG00000105993	DNAJB6 PPI subnetwork	0.58	> 0.20	ATP13A1 (2.6)	YIPF2 (2.1)	DNM2 (1.9)	C19orf52 (1.8)	OGDH (1.7)	QTRT1 (1.7)	DHODH (1.7)	MAU2 (1.5)	AP1M2 (1.5)	ACAD10 (1.3)
ENSG00000162385	MAGOH PPI subnetwork	0.58	> 0.20	ILF3 (3.9)	C1orf63 (3.3)	TOP1 (3.0)	SMARCA4 (2.6)	USP1 (2.6)	DHX38 (2.5)	BUD13 (2.2)	PTPN11 (2.2)	SUGP1 (2.1)	FEN1 (2.1)
ENSG00000137822	TUBGCP4 PPI subnetwork	0.58	> 0.20	PPP1R37 (3.6)	PLEC (2.7)	ZNF101 (2.6)	POLK (2.4)	GEMIN7 (2.2)	KIAA1324 (2.1)	LPA (2.1)	GOT2P1 (2.0)	ENSG00000228044 (2.0)	YIPF2 (1.9)
MP:0001175	abnormal lung morphology	0.58	> 0.20	BCAM (3.3)	LDLR (3.2)	PLEKHH2 (2.3)	KANK2 (2.1)	HLX (1.7)	PVR (1.7)	NYNRIN (1.6)	SLC44A2 (1.5)	BCL3 (1.4)	AP1M2 (1.1)
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	0.58	> 0.20	FEN1 (4.3)	USP1 (3.9)	NT5DC1 (2.4)	SUGP1 (2.4)	ZNF180 (2.2)	TRAPPC6A (2.1)	POC5 (1.7)	CLPTM1 (1.6)	TXNL4B (1.6)	GOT2P1 (1.6)
MP:0002113	abnormal skeleton development	0.58	> 0.20	CILP2 (3.7)	MYLIP (2.7)	NYNRIN (2.7)	MAFB (2.4)	PLEKHH2 (2.3)	ANGPTL3 (1.8)	ALDH2 (1.6)	BCAM (1.4)	PVRL2 (1.4)	SYPL2 (1.3)
ENSG00000102978	POLR2C PPI subnetwork	0.58	> 0.20	ILF3 (3.2)	BUD13 (3.2)	TOP1 (3.0)	C1orf63 (2.7)	USP1 (2.6)	SUGP1 (2.6)	DHX38 (2.3)	SMARCA4 (2.2)	QTRT1 (2.0)	FEN1 (1.9)
MP:0008700	decreased interleukin-4 secretion	0.58	> 0.20	RELB (3.1)	BCL3 (3.0)	CETP (2.4)	OASL (2.2)	MAFB (2.1)	GMIP (2.1)	PARP10 (2.0)	HLX (1.6)	SH2B3 (1.4)	PBX4 (1.2)
ENSG00000144231	POLR2D PPI subnetwork	0.58	> 0.20	ILF3 (3.6)	BUD13 (3.2)	DHX38 (2.9)	SUGP1 (2.8)	TOP1 (2.8)	USP1 (2.5)	SMARCA4 (2.5)	C1orf63 (2.3)	FEN1 (2.1)	PTPN11 (2.0)
GO:0071277	cellular response to calcium ion	0.58	> 0.20	TRIB1 (4.0)	ENSG00000226645 (2.0)	UBXN2B (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.8)	GCNT4 (1.6)	KANK2 (1.6)	AMIGO1 (1.3)	DYNC2LI1 (1.2)	TSSK6 (1.2)
ENSG00000114166	KAT2B PPI subnetwork	0.58	> 0.20	ATXN2 (2.9)	BUD13 (2.2)	TOP1 (2.2)	SMARCA4 (2.1)	MYLIP (1.8)	KANK2 (1.8)	TRIB1 (1.6)	C19orf52 (1.6)	USP1 (1.5)	PLCG1 (1.4)
ENSG00000139567	ACVRL1 PPI subnetwork	0.58	> 0.20	CYB561D1 (3.3)	GPAM (2.6)	SH2B3 (2.4)	ZNF180 (2.3)	SLC44A2 (2.2)	HLX (1.9)	NYNRIN (1.8)	AMIGO1 (1.8)	PLCG1 (1.7)	BCAM (1.6)
ENSG00000115808	STRN PPI subnetwork	0.58	> 0.20	PSMA5 (3.9)	TMEM50A (2.2)	COL4A3BP (2.2)	MARK4 (2.1)	DYNC2LI1 (1.9)	ZNF180 (1.6)	SMARCA4 (1.5)	SARS (1.5)	C11orf9 (1.5)	PVRL2 (1.4)
GO:0006887	exocytosis	0.58	> 0.20	ITGB3 (4.3)	CYB561D1 (2.3)	GMPR (2.2)	TSSK6 (2.1)	AP1M2 (1.9)	LPA (1.6)	ANGPTL3 (1.6)	RPH3A (1.5)	PTPN11 (1.3)	POLK (1.3)
ENSG00000188170	ENSG00000188170 PPI subnetwork	0.58	> 0.20	RHD (3.6)	ERP29 (2.9)	ALDH2 (2.7)	RHCE (2.6)	PSMA5 (2.5)	C12orf51 (2.0)	HAVCR1 (2.0)	UBXN2B (1.9)	DOCK7 (1.9)	MYLIP (1.8)
GO:0035195	gene silencing by miRNA	0.58	> 0.20	DOCK7 (2.8)	MAPKAPK5 (2.5)	USP24 (2.5)	ENSG00000226648 (2.5)	ADAM1 (2.2)	ENSG00000235545 (2.1)	UBXN2B (1.9)	CYB561D1 (1.7)	GEMIN7 (1.6)	GOT2P1 (1.5)
ENSG00000120253	NUP43 PPI subnetwork	0.58	> 0.20	PSRC1 (5.6)	FEN1 (4.4)	POC5 (4.0)	USP1 (4.0)	ZNF180 (1.4)	ILF3 (1.2)	USP24 (1.2)	ENSG00000228044 (1.2)	ENSG00000226648 (1.2)	BUD13 (1.0)
GO:0048285	organelle fission	0.58	> 0.20	POC5 (4.9)	PSRC1 (4.9)	USP1 (2.6)	FEN1 (2.0)	ENSG00000228044 (1.9)	GEMIN7 (1.9)	PBX4 (1.7)	BUD13 (1.4)	DNAH11 (1.4)	ILF3 (1.4)
GO:0060767	epithelial cell proliferation involved in prostate gland development	0.58	> 0.20	C19orf52 (2.2)	HNF1A (1.9)	C1orf63 (1.8)	LPIN3 (1.7)	GOT2P1 (1.6)	NCAN (1.5)	GEMIN7 (1.4)	UBXN2B (1.4)	GCNT4 (1.4)	CELSR2 (1.2)
GO:0051051	negative regulation of transport	0.58	> 0.20	KIAA1324 (2.1)	PPP1R37 (2.1)	NPC1L1 (2.0)	GPAM (2.0)	LPIN3 (1.9)	ITGB3 (1.9)	PVR (1.8)	ENSG00000226645 (1.6)	MOSC1 (1.6)	CETP (1.5)
GO:0010771	negative regulation of cell morphogenesis involved in differentiation	0.58	> 0.20	DNAH11 (2.6)	ABO (2.5)	PLEKHH2 (2.2)	ENSG00000226645 (2.2)	TMEM116 (2.0)	NT5DC1 (1.9)	KIAA1324 (1.7)	HNF1A (1.6)	NYNRIN (1.5)	ENSG00000254235 (1.4)
MP:0003224	neuron degeneration	0.58	> 0.20	ENSG00000235545 (2.8)	GOT2P1 (2.7)	DOCK7 (2.7)	SORT1 (2.4)	ST3GAL4 (1.7)	CELSR2 (1.6)	LPA (1.5)	ENSG00000226648 (1.5)	APOE (1.5)	USP24 (1.3)
GO:0033540	fatty acid beta-oxidation using acyl-CoA oxidase	0.58	> 0.20	ACAD10 (3.1)	ABCG8 (2.5)	UBXN2B (2.4)	NKPD1 (2.3)	NT5DC1 (2.3)	ABO (2.1)	TM6SF2 (2.1)	ENSG00000235545 (2.1)	ALDH2 (1.7)	C1orf63 (1.5)
GO:0001953	negative regulation of cell-matrix adhesion	0.58	> 0.20	ITGB3 (2.5)	GCNT4 (2.2)	DNAH11 (2.0)	PPP1R37 (1.9)	COL4A3BP (1.7)	ZHX3 (1.7)	PLEKHH2 (1.7)	SLC44A2 (1.6)	PVR (1.5)	ENSG00000254235 (1.5)
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE	0.58	> 0.20	USP1 (5.3)	FEN1 (5.2)	AMIGO1 (2.3)	ZNF180 (2.0)	ENSG00000235545 (1.8)	FADS1 (1.5)	ENSG00000228044 (1.4)	KIAA1324 (1.4)	FRK (1.4)	TOMM40 (1.3)
MP:0000313	abnormal cell death	0.58	> 0.20	ENSG00000226648 (2.2)	ATXN7L2 (2.1)	GRINA (1.9)	LPA (1.7)	BCL3 (1.7)	USP1 (1.6)	HAPLN4 (1.5)	PLEC (1.5)	PCSK9 (1.5)	CYP7A1 (1.5)
ENSG00000068305	MEF2A PPI subnetwork	0.58	> 0.20	CARM1 (2.0)	ANKRD31 (1.7)	ATXN7L2 (1.7)	MAPKAPK5 (1.6)	MAU2 (1.5)	COL4A3BP (1.5)	MARK4 (1.4)	PARP10 (1.3)	PCSK9 (1.3)	CEACAM19 (1.3)
ENSG00000076928	ARHGEF1 PPI subnetwork	0.58	> 0.20	SH2B3 (4.0)	USP24 (3.7)	SLC44A2 (2.5)	DNM2 (2.5)	PTPN11 (2.4)	PLEC (2.4)	MARK4 (2.3)	LDLR (2.1)	AP1M2 (2.0)	ATXN2 (1.9)
GO:0005791	rough endoplasmic reticulum	0.58	> 0.20	ERP29 (4.8)	TMED4 (2.5)	PCSK9 (2.5)	LDLR (2.3)	YIPF2 (2.2)	FADS1 (2.2)	PLG (2.2)	TSSK6 (1.9)	FADS2 (1.9)	TMEM57 (1.8)
GO:0006213	pyrimidine nucleoside metabolic process	0.58	> 0.20	TSSK6 (2.4)	LPA (2.2)	TXNL4B (2.0)	DYNC2LI1 (1.9)	ANKRD31 (1.9)	SYPL2 (1.8)	ACAD10 (1.6)	PMFBP1 (1.6)	AMIGO1 (1.5)	ENSG00000228044 (1.3)
ENSG00000142871	CYR61 PPI subnetwork	0.58	> 0.20	ATP13A1 (3.8)	QTRT1 (3.1)	DNM2 (2.5)	ILF3 (2.5)	YIPF2 (2.5)	OGDH (2.2)	DOCK7 (2.1)	SARS (1.8)	ACAD10 (1.6)	DHX38 (1.5)
ENSG00000070371	CLTCL1 PPI subnetwork	0.58	> 0.20	ERP29 (3.7)	AP1M2 (3.6)	SARS (2.9)	SORT1 (2.6)	MAFB (2.4)	GRINA (2.1)	CELSR2 (1.9)	YIPF2 (1.7)	NPC1L1 (1.7)	CLPTM1 (1.6)
GO:0032623	interleukin-2 production	0.58	> 0.20	PBX4 (3.2)	ENSG00000235545 (2.0)	TIMD4 (1.9)	ENSG00000254235 (1.9)	PMFBP1 (1.8)	POLK (1.7)	ENSG00000226648 (1.5)	ANKRD31 (1.2)	SLC44A2 (1.1)	RELB (1.1)
GO:0002070	epithelial cell maturation	0.58	> 0.20	DNAH11 (3.1)	FRK (2.8)	GOT2P1 (2.4)	ENSG00000226648 (2.2)	KIAA1324 (2.0)	ANKRD31 (1.9)	C19orf52 (1.5)	PMFBP1 (1.4)	UBXN2B (1.4)	GCNT4 (1.4)
GO:0030201	heparan sulfate proteoglycan metabolic process	0.58	> 0.20	ANKRD31 (4.6)	GCNT4 (2.5)	GEMIN7 (2.2)	ST3GAL4 (2.1)	ZNF180 (1.7)	AMIGO1 (1.6)	CYB561D1 (1.6)	ZHX3 (1.4)	DYNC2LI1 (1.3)	LPIN3 (1.3)
ENSG00000155957	TMBIM4 PPI subnetwork	0.58	> 0.20	TMEM50A (4.9)	ERP29 (4.4)	CLPTM1 (3.7)	TMED4 (3.2)	ATP13A1 (2.2)	LPAR2 (1.9)	SORT1 (1.8)	C1orf63 (1.8)	PSMA5 (1.8)	PBX4 (1.8)
GO:0008585	female gonad development	0.58	> 0.20	ABO (2.4)	NYNRIN (2.3)	ST3GAL4 (2.1)	ANKRD31 (1.9)	TSSK6 (1.9)	DNAH11 (1.8)	HNF1A (1.8)	C11orf9 (1.8)	AMIGO1 (1.6)	YIPF2 (1.5)
ENSG00000160868	CYP3A4 PPI subnetwork	0.58	> 0.20	MOSC1 (3.4)	NKPD1 (2.7)	DNAH11 (2.5)	SYPL2 (1.9)	PLG (1.9)	ANGPTL3 (1.9)	NT5DC1 (1.8)	ADAM1 (1.7)	ENSG00000228044 (1.7)	ATXN7L2 (1.5)
GO:0051351	positive regulation of ligase activity	0.58	> 0.20	PSMA5 (4.0)	POC5 (2.5)	TRAFD1 (2.5)	NAA25 (2.0)	SUGP1 (2.0)	BRAP (1.8)	NT5DC1 (1.6)	DDX56 (1.5)	C12orf47 (1.5)	LPIN3 (1.5)
ENSG00000174989	FBXW8 PPI subnetwork	0.58	> 0.20	ILF3 (3.2)	ATP13A1 (3.2)	YIPF2 (2.7)	QTRT1 (2.6)	OGDH (2.5)	SARS (2.1)	ACAD10 (2.0)	DNM2 (1.9)	DHX38 (1.8)	SMARCA4 (1.7)
ENSG00000168286	THAP11 PPI subnetwork	0.58	> 0.20	SUGP1 (1.9)	TXNL4B (1.7)	PLCG1 (1.6)	BUD13 (1.6)	ATXN7L2 (1.5)	TOMM40 (1.5)	DHODH (1.5)	TRAPPC6A (1.5)	ZNF180 (1.5)	DHX38 (1.4)
REACTOME_HIV_LIFE_CYCLE	REACTOME_HIV_LIFE_CYCLE	0.58	> 0.20	MAPKAPK5 (3.2)	PSMA5 (3.0)	POC5 (2.8)	DDX56 (2.5)	BUD13 (2.4)	DHX38 (2.2)	USP1 (2.2)	ILF3 (2.1)	FEN1 (2.1)	SMARCA4 (2.0)
ENSG00000113578	FGF1 PPI subnetwork	0.58	> 0.20	HAVCR1 (2.9)	PLEKHH2 (2.7)	CBLC (2.4)	HAPLN4 (2.4)	C17orf57 (2.3)	NKPD1 (2.2)	SLC44A2 (2.1)	ZHX3 (1.9)	CEACAM19 (1.8)	BCAM (1.7)
ENSG00000068366	ACSL4 PPI subnetwork	0.58	> 0.20	BRAP (2.7)	SARS (2.5)	DDX56 (1.9)	GMPR (1.7)	PLCG1 (1.7)	C19orf52 (1.6)	AMIGO1 (1.6)	PTPN11 (1.6)	ZNF101 (1.6)	NAA25 (1.6)
ENSG00000180182	MED14 PPI subnetwork	0.58	> 0.20	GEMIN7 (3.3)	TXNL4B (2.7)	BRAP (2.4)	POC5 (2.2)	BUD13 (2.1)	BLOC1S3 (2.0)	C12orf47 (2.0)	C17orf57 (1.9)	MAPKAPK5 (1.8)	TOP1 (1.7)
GO:0004536	deoxyribonuclease activity	0.58	> 0.20	NKPD1 (3.4)	POLK (2.7)	BLOC1S3 (2.3)	ZNF180 (2.3)	TMEM116 (1.8)	POC5 (1.8)	LPIN3 (1.8)	TSSK6 (1.4)	FEN1 (1.4)	PSRC1 (1.4)
ENSG00000136603	SKIL PPI subnetwork	0.58	> 0.20	KANK2 (3.3)	LPIN3 (2.5)	DOCK7 (2.1)	C12orf51 (2.1)	PSMA5 (2.0)	PLCG1 (2.0)	MYLIP (1.8)	ATXN7L2 (1.8)	CELSR2 (1.8)	FRK (1.7)
ENSG00000108946	PRKAR1A PPI subnetwork	0.58	> 0.20	MOSC1 (2.9)	OGDH (2.5)	ADAM1 (2.4)	ST3GAL4 (2.3)	TSSK6 (2.2)	CLPTM1 (2.0)	NCAN (1.8)	APOE (1.8)	DNM2 (1.6)	GMPR (1.5)
ENSG00000070010	UFD1L PPI subnetwork	0.58	> 0.20	TMEM57 (3.6)	BRAP (2.9)	USP24 (2.3)	YIPF2 (2.2)	SARS (2.0)	PSMA5 (1.9)	ABCG8 (1.8)	NT5DC1 (1.8)	C19orf52 (1.8)	SUGP1 (1.8)
REACTOME_GLUTATHIONE_CONJUGATION	REACTOME_GLUTATHIONE_CONJUGATION	0.58	> 0.20	TM6SF2 (3.2)	ALDH2 (3.0)	ACAD10 (2.5)	RHD (2.1)	AP1M2 (2.1)	NT5DC1 (2.0)	TXNL4B (2.0)	KIAA1324 (2.0)	NPC1L1 (2.0)	GRINA (2.0)
ENSG00000143933	CALM2 PPI subnetwork	0.58	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
ENSG00000160014	CALM3 PPI subnetwork	0.58	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
ENSG00000198668	CALM1 PPI subnetwork	0.58	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
REACTOME_SEROTONIN_RECEPTORS	REACTOME_SEROTONIN_RECEPTORS	0.58	> 0.20	GOT2P1 (4.5)	ABO (3.2)	RPH3A (2.6)	ANKRD31 (2.5)	ENSG00000226648 (1.8)	HAPLN4 (1.7)	GCNT4 (1.6)	DNAH11 (1.6)	PMFBP1 (1.3)	ABCG8 (1.3)
ENSG00000198959	TGM2 PPI subnetwork	0.58	> 0.20	ITGB3 (3.2)	PLEC (3.1)	ENSG00000235545 (2.3)	PVR (2.3)	GMPR (2.3)	POLK (1.9)	APOE (1.9)	KANK2 (1.3)	CETP (1.3)	DOCK7 (1.3)
MP:0008584	photoreceptor outer segment degeneration	0.58	> 0.20	HMGCR (4.4)	ENSG00000235545 (2.9)	FADS1 (2.8)	FADS2 (2.7)	NCAN (2.7)	PMFBP1 (1.8)	GCNT4 (1.8)	DYNC2LI1 (1.6)	SORT1 (1.4)	KIAA1324 (1.4)
MP:0008209	decreased pre-B cell number	0.58	> 0.20	TIMD4 (2.7)	GMIP (2.4)	HLX (2.1)	RHD (1.9)	CETP (1.9)	KANK2 (1.8)	TMEM57 (1.8)	SMARCA4 (1.6)	TOP1 (1.6)	RHCE (1.5)
GO:0030850	prostate gland development	0.58	> 0.20	GOT2P1 (2.0)	C19orf52 (1.9)	AMIGO1 (1.8)	ENSG00000254235 (1.6)	KIAA1324 (1.5)	BLOC1S3 (1.3)	NYNRIN (1.3)	CYP7A1 (1.3)	MAFB (1.1)	DNAH11 (1.1)
ENSG00000020633	RUNX3 PPI subnetwork	0.58	> 0.20	TRIB1 (3.0)	ATXN2 (2.8)	ENSG00000226648 (2.4)	ENSG00000226645 (2.3)	FRK (2.1)	SH2B3 (1.8)	USP24 (1.7)	DHX38 (1.7)	CARM1 (1.6)	MARK4 (1.6)
ENSG00000100519	PSMC6 PPI subnetwork	0.58	> 0.20	PSMA5 (5.2)	NAA25 (2.9)	NT5DC1 (2.7)	TOMM40 (2.5)	DDX56 (2.1)	ZNF259 (1.9)	TRAFD1 (1.8)	SARS (1.8)	OGDH (1.1)	ENSG00000254235 (1.1)
ENSG00000120088	CRHR1 PPI subnetwork	0.58	> 0.20	HAPLN4 (2.8)	PPP1R37 (2.4)	RPH3A (2.2)	DNAH11 (1.7)	HLX (1.6)	PBX4 (1.6)	ZNF180 (1.4)	GEMIN7 (1.3)	ENSG00000254235 (1.2)	C12orf43 (1.2)
ENSG00000115053	NCL PPI subnetwork	0.58	> 0.20	ILF3 (3.7)	SMARCA4 (3.4)	TOP1 (3.0)	DHX38 (2.7)	QTRT1 (2.5)	C1orf63 (2.2)	ERP29 (2.1)	TOMM40 (1.9)	SARS (1.9)	GATAD2A (1.9)
GO:0030914	STAGA complex	0.58	> 0.20	ATXN7L2 (3.3)	C19orf52 (2.6)	GEMIN7 (2.5)	ATXN2 (2.1)	ACAD10 (2.0)	C17orf57 (1.9)	MAPKAPK5 (1.8)	ILF3 (1.8)	TMEM116 (1.8)	ENSG00000226648 (1.6)
MP:0003694	failure to hatch from the zona pellucida	0.58	> 0.20	BUD13 (3.4)	ZNF259 (2.9)	PSRC1 (2.6)	PMFBP1 (2.5)	USP1 (2.0)	FEN1 (1.9)	ATP13A1 (1.7)	PVR (1.7)	NAA25 (1.4)	TOP1 (1.4)
REACTOME_CHROMOSOME_MAINTENANCE	REACTOME_CHROMOSOME_MAINTENANCE	0.58	> 0.20	USP1 (5.3)	FEN1 (4.9)	PSRC1 (2.5)	POC5 (1.6)	ZNF180 (1.5)	DHODH (1.1)	TXNL4B (1.1)	KANK2 (1.1)	AMIGO1 (1.0)	FADS1 (0.9)
REACTOME_ACTIVATION_OF_CHAPERONES_BY_IRE1ALPHA	REACTOME_ACTIVATION_OF_CHAPERONES_BY_IRE1ALPHA	0.58	> 0.20	YIPF2 (4.6)	ERP29 (3.1)	ATP13A1 (1.8)	OGDH (1.7)	SARS (1.7)	TMED4 (1.6)	TMEM57 (1.3)	PCSK9 (1.2)	FEN1 (1.2)	GRINA (1.1)
ENSG00000162992	NEUROD1 PPI subnetwork	0.58	> 0.20	PPP1R37 (2.3)	TMED4 (2.0)	PBX4 (2.0)	CELSR2 (1.9)	DNAH11 (1.8)	PMFBP1 (1.8)	USP24 (1.7)	ZNF101 (1.6)	AMIGO1 (1.5)	KANK2 (1.4)
GO:0003279	cardiac septum development	0.58	> 0.20	C11orf9 (3.1)	ENSG00000238078 (2.9)	NYNRIN (2.6)	ATXN7L2 (2.5)	C19orf52 (2.4)	PVRL2 (2.1)	ABO (2.1)	BLOC1S3 (1.6)	PBX4 (1.6)	LPAR2 (1.5)
MP:0001078	abnormal phrenic nerve morphology	0.58	> 0.20	HLX (1.9)	CELSR2 (1.8)	COL4A3BP (1.7)	C17orf57 (1.7)	ENSG00000228044 (1.6)	ANKRD31 (1.6)	PLCG1 (1.5)	GATAD2A (1.5)	ABO (1.4)	GEMIN7 (1.3)
GO:0018212	peptidyl-tyrosine modification	0.58	> 0.20	TIMD4 (2.1)	C17orf57 (1.8)	C1orf63 (1.8)	PLEKHH2 (1.8)	MYLIP (1.8)	SH2B3 (1.7)	GPAM (1.4)	ADAM1 (1.4)	ANKRD31 (1.3)	ALDH2 (1.3)
ENSG00000184381	PLA2G6 PPI subnetwork	0.58	> 0.20	TRAPPC6A (3.1)	BLOC1S3 (1.8)	ITGB3 (1.8)	TMED4 (1.6)	DOCK7 (1.6)	POLK (1.5)	PVR (1.5)	GCNT4 (1.5)	C11orf9 (1.4)	SARS (1.4)
ENSG00000116809	ZBTB17 PPI subnetwork	0.58	> 0.20	ALDH2 (2.1)	DHODH (2.1)	UBXN2B (1.8)	MYLIP (1.8)	ENSG00000226645 (1.6)	MAFB (1.6)	TOP1 (1.5)	ABO (1.5)	CBLC (1.4)	C17orf57 (1.3)
MP:0002001	blindness	0.58	> 0.20	NCAN (2.9)	SORT1 (2.7)	MAFB (2.2)	ST3GAL4 (2.2)	AMIGO1 (2.1)	NKPD1 (2.0)	CELSR2 (1.9)	GCNT4 (1.9)	LPIN3 (1.9)	ERP29 (1.9)
ENSG00000108774	RAB5C PPI subnetwork	0.58	> 0.20	GEMIN7 (2.8)	TRAPPC6A (2.2)	CYB561D1 (2.1)	HAVCR1 (2.0)	HLX (1.9)	BLOC1S3 (1.8)	AMIGO1 (1.8)	GRINA (1.8)	SORT1 (1.7)	TMEM50A (1.5)
ENSG00000186184	POLR1D PPI subnetwork	0.58	> 0.20	GEMIN7 (3.9)	C12orf43 (3.6)	ZNF259 (3.5)	MAPKAPK5 (3.0)	BUD13 (2.8)	QTRT1 (2.8)	DDX56 (2.5)	NAA25 (2.4)	TXNL4B (2.0)	BRAP (2.0)
MP:0009292	increased inguinal fat pad weight	0.58	> 0.20	MOSC1 (3.6)	GPAM (2.9)	POLK (2.0)	BCL3 (1.7)	ENSG00000254235 (1.5)	SORT1 (1.4)	TSSK6 (1.3)	DYNC2LI1 (1.3)	C12orf51 (1.2)	YIPF2 (1.1)
ENSG00000101473	ACOT8 PPI subnetwork	0.58	> 0.20	ATP13A1 (3.3)	ILF3 (2.4)	OGDH (2.2)	TRAFD1 (2.1)	ATXN2 (1.9)	DNM2 (1.9)	ACAD10 (1.7)	BRAP (1.7)	LDLR (1.6)	QTRT1 (1.6)
GO:0015934	large ribosomal subunit	0.58	> 0.20	GEMIN7 (3.2)	TOMM40 (1.9)	TRAPPC6A (1.7)	DDX56 (1.6)	CEACAM19 (1.6)	ENSG00000226645 (1.4)	UBXN2B (1.3)	ZNF259 (1.2)	MOSC1 (1.1)	SARS (1.0)
ENSG00000112559	MDFI PPI subnetwork	0.58	> 0.20	ATP13A1 (3.2)	SUGP1 (2.8)	ZNF101 (2.7)	LPAR2 (2.4)	PBX4 (2.3)	QTRT1 (2.2)	LPIN3 (1.9)	TSSK6 (1.9)	BLOC1S3 (1.9)	PARP10 (1.8)
GO:0005523	tropomyosin binding	0.58	> 0.20	SYPL2 (6.4)	KANK2 (2.5)	GMPR (2.1)	CEACAM19 (2.0)	SORT1 (1.6)	C17orf57 (1.5)	RHCE (1.4)	FRK (1.3)	RPH3A (1.3)	PLEC (1.2)
ENSG00000139626	ITGB7 PPI subnetwork	0.58	> 0.20	TIMD4 (4.3)	CETP (3.9)	SH2B3 (2.4)	HAVCR1 (2.4)	APOE (2.2)	PLEKHH2 (2.0)	C11orf9 (1.9)	KANK2 (1.8)	C12orf47 (1.6)	ITGB3 (1.6)
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	0.58	> 0.20	DHODH (3.5)	TOMM40 (3.1)	C12orf43 (2.2)	ST3GAL4 (2.2)	TMEM50A (2.1)	QTRT1 (2.1)	GRINA (1.9)	UBXN2B (1.8)	ZNF259 (1.8)	ENSG00000226645 (1.7)
MP:0010179	rough coat	0.58	> 0.20	AP1M2 (3.5)	SLC44A2 (2.1)	LDLR (1.9)	KIAA1324 (1.8)	RELB (1.6)	CBLC (1.6)	CYB561D1 (1.6)	OASL (1.5)	BCAM (1.4)	ENSG00000226648 (1.3)
ENSG00000166167	BTRC PPI subnetwork	0.58	> 0.20	RELB (4.1)	TRIB1 (2.9)	BCL3 (2.5)	KIAA1324 (1.8)	CARM1 (1.6)	ATXN2 (1.5)	PSRC1 (1.4)	GATAD2A (1.3)	GRINA (1.3)	TMEM57 (1.2)
GO:0032890	regulation of organic acid transport	0.58	> 0.20	C12orf43 (1.9)	MOSC1 (1.5)	CBLC (1.5)	C12orf51 (1.5)	ERP29 (1.5)	CETP (1.5)	PMFBP1 (1.4)	NCAN (1.2)	TXNL4B (1.2)	GEMIN7 (1.1)
ENSG00000109917	ZNF259 PPI subnetwork	0.58	> 0.20	ENSG00000226648 (2.7)	TMEM50A (2.4)	BUD13 (2.2)	GOT2P1 (2.2)	ENSG00000226645 (2.1)	PLCG1 (1.9)	BLOC1S3 (1.7)	MARK4 (1.4)	TXNL4B (1.4)	TRAFD1 (1.3)
GO:0035510	DNA dealkylation	0.58	> 0.20	TSSK6 (3.1)	C17orf57 (2.4)	NT5DC1 (2.0)	ENSG00000226648 (1.8)	TRAPPC6A (1.7)	ABO (1.7)	NKPD1 (1.5)	C12orf43 (1.5)	FRK (1.4)	TMEM116 (1.4)
ENSG00000109065	NAT9 PPI subnetwork	0.58	> 0.20	HMGCR (2.5)	PCSK9 (2.5)	FADS1 (2.2)	LDLR (2.2)	FADS2 (2.0)	ENSG00000226648 (1.9)	ENSG00000254235 (1.9)	ERP29 (1.9)	ENSG00000228044 (1.9)	KANK2 (1.8)
MP:0004279	abnormal rostral migratory stream morphology	0.58	> 0.20	NCAN (2.1)	ST3GAL4 (1.7)	CILP2 (1.7)	CELSR2 (1.6)	ALDH2 (1.6)	TMEM116 (1.6)	UBXN2B (1.5)	ENSG00000254235 (1.5)	CYB561D1 (1.5)	ENSG00000235545 (1.4)
GO:0022616	DNA strand elongation	0.58	> 0.20	ZNF180 (3.3)	USP1 (3.2)	FEN1 (2.8)	ENSG00000228044 (2.4)	GOT2P1 (2.1)	AMIGO1 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.5)	ENSG00000226648 (1.2)	DNAH11 (1.2)
ENSG00000002745	WNT16 PPI subnetwork	0.58	> 0.20	CELSR2 (2.5)	CILP2 (2.4)	MAU2 (2.3)	SMARCA4 (2.0)	MARK4 (1.9)	ATXN2 (1.9)	ZNF180 (1.9)	MAFB (1.8)	USP24 (1.8)	PARP10 (1.8)
GO:0032755	positive regulation of interleukin-6 production	0.58	> 0.20	C17orf57 (2.3)	PMFBP1 (2.1)	ENSG00000235545 (1.7)	OASL (1.6)	HLX (1.5)	ST3GAL4 (1.5)	DYNC2LI1 (1.3)	ENSG00000228044 (1.3)	MYLIP (1.2)	ATXN7L2 (1.2)
ENSG00000177084	POLE PPI subnetwork	0.58	> 0.20	FEN1 (4.7)	USP1 (4.7)	ZNF180 (2.3)	SMARCA4 (2.0)	PSRC1 (1.5)	GMPR (1.4)	ENSG00000226648 (1.4)	TOMM40 (1.3)	DHODH (1.3)	MYLIP (1.2)
MP:0002452	abnormal antigen presenting cell physiology	0.58	> 0.20	RELB (3.9)	MAFB (3.3)	GMIP (2.3)	MYLIP (2.2)	SH2B3 (2.1)	BCL3 (1.8)	C12orf47 (1.6)	C12orf43 (1.5)	QTRT1 (1.4)	CETP (1.4)
MP:0008603	decreased circulating interleukin-4 level	0.58	> 0.20	TRAPPC6A (2.6)	PBX4 (2.1)	BCL3 (2.0)	PLCG1 (2.0)	TIMD4 (2.0)	RHD (1.8)	SLC44A2 (1.7)	ZNF101 (1.7)	AMIGO1 (1.6)	GMIP (1.5)
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	0.58	> 0.20	TRIB1 (3.1)	CLPTM1 (2.3)	PVR (2.2)	POLK (2.0)	MARK4 (1.9)	ZHX3 (1.8)	PLEC (1.8)	UBXN2B (1.6)	HLX (1.5)	MOSC1 (1.5)
ENSG00000105404	RABAC1 PPI subnetwork	0.58	> 0.20	BLOC1S3 (3.4)	CYB561D1 (2.7)	YIPF2 (2.7)	TMEM50A (2.4)	LDLR (2.3)	CLPTM1 (2.3)	TRAPPC6A (1.8)	HNF1A (1.7)	FADS1 (1.7)	PBX4 (1.7)
MP:0004813	absent linear vestibular evoked potential	0.58	> 0.20	FRK (2.7)	LPIN3 (2.2)	NPC1L1 (1.9)	APOE (1.8)	C11orf9 (1.7)	HNF1A (1.7)	CELSR2 (1.7)	RPH3A (1.6)	NKPD1 (1.4)	ZNF180 (1.4)
ENSG00000125170	DOK4 PPI subnetwork	0.58	> 0.20	SLC44A2 (2.9)	ATXN2 (2.5)	PLEC (1.9)	SH2B3 (1.9)	DOCK7 (1.8)	ITGB3 (1.8)	PVRL2 (1.7)	GATAD2A (1.7)	MOSC1 (1.6)	CELSR2 (1.6)
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION__PROTEINS	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION__PROTEINS	0.59	> 0.20	AP1M2 (3.4)	FRK (2.0)	PVRL2 (1.9)	CELSR2 (1.8)	CBLC (1.7)	ABCG8 (1.5)	TMEM116 (1.5)	HMGCR (1.4)	APOC1 (1.4)	TM6SF2 (1.3)
REACTOME_CELL_CYCLE	REACTOME_CELL_CYCLE	0.59	> 0.20	FEN1 (5.5)	PSRC1 (4.3)	USP1 (4.3)	POC5 (3.0)	PSMA5 (1.5)	BUD13 (1.2)	SMARCA4 (1.1)	RHD (1.0)	ZNF180 (0.9)	RHCE (0.9)
ENSG00000064313	TAF2 PPI subnetwork	0.59	> 0.20	MAPKAPK5 (3.2)	ATXN2 (2.6)	C1orf63 (2.4)	TOP1 (2.3)	ADAM1 (1.9)	UBXN2B (1.9)	SUGP1 (1.8)	ATXN7L2 (1.8)	MAU2 (1.8)	DHX38 (1.8)
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE__TO_CCTTRIC	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE__TO_CCTTRIC	0.59	> 0.20	GMPR (2.1)	SMARCA4 (1.9)	NAA25 (1.8)	ZNF259 (1.8)	PSMA5 (1.8)	ENSG00000238078 (1.7)	ITGB3 (1.7)	DDX56 (1.6)	TOMM40 (1.5)	SARS (1.5)
REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRICCCT__IN_ACTIN_AND_TUBULIN_FOLDING	REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRICCCT__IN_ACTIN_AND_TUBULIN_FOLDING	0.59	> 0.20	GMPR (2.1)	SMARCA4 (1.9)	NAA25 (1.8)	ZNF259 (1.8)	PSMA5 (1.8)	ENSG00000238078 (1.7)	ITGB3 (1.7)	DDX56 (1.6)	TOMM40 (1.5)	SARS (1.5)
GO:0006739	NADP metabolic process	0.59	> 0.20	TRAPPC6A (3.8)	BLOC1S3 (3.0)	FADS2 (2.3)	ALDH2 (2.2)	FRK (2.1)	NT5DC1 (2.1)	DNAH11 (2.1)	MOSC1 (1.9)	ACAD10 (1.9)	GPAM (1.9)
ENSG00000139613	SMARCC2 PPI subnetwork	0.59	> 0.20	SMARCA4 (3.8)	CARM1 (3.6)	GATAD2A (3.2)	BUD13 (2.7)	ILF3 (2.7)	USP1 (2.6)	ATXN2 (2.5)	TOP1 (2.5)	MAPKAPK5 (2.5)	FEN1 (1.9)
GO:0010522	regulation of calcium ion transport into cytosol	0.59	> 0.20	ABO (3.2)	C12orf43 (2.7)	GEMIN7 (2.2)	GCNT4 (2.1)	C12orf47 (1.8)	ADAM1 (1.7)	TRAPPC6A (1.7)	SLC44A2 (1.3)	GRINA (1.3)	RPH3A (1.2)
GO:0032589	neuron projection membrane	0.59	> 0.20	CELSR2 (3.3)	RPH3A (3.2)	AMIGO1 (3.0)	NCAN (2.1)	HAVCR1 (2.0)	SORT1 (1.9)	LPAR2 (1.8)	ENSG00000226648 (1.8)	PBX4 (1.6)	PCSK9 (1.6)
GO:0070206	protein trimerization	0.59	> 0.20	ENSG00000226648 (2.6)	LPAR2 (2.5)	C1orf63 (2.3)	PARP10 (2.2)	OASL (1.9)	FRK (1.9)	ANKRD31 (1.5)	CYP7A1 (1.5)	HP (1.4)	UBXN2B (1.3)
REACTOME_TRNA_AMINOACYLATION	REACTOME_TRNA_AMINOACYLATION	0.59	> 0.20	SARS (8.8)	NAA25 (3.5)	DHODH (3.1)	DDX56 (3.0)	ZNF259 (3.0)	QTRT1 (2.7)	PSMA5 (2.6)	SUGP1 (2.2)	SMARCA4 (2.2)	ATP13A1 (2.2)
GO:0015116	sulfate transmembrane transporter activity	0.59	> 0.20	TMEM116 (3.6)	MOSC1 (2.6)	NT5DC1 (2.4)	FRK (2.2)	PBX4 (2.2)	CYB561D1 (1.9)	TM6SF2 (1.5)	ENSG00000228044 (1.5)	MYLIP (1.5)	HMGCR (1.4)
ENSG00000082258	CCNT2 PPI subnetwork	0.59	> 0.20	SUGP1 (3.7)	DHX38 (3.0)	DNM2 (2.3)	MAPKAPK5 (2.2)	ZNF259 (2.1)	TXNL4B (2.1)	BUD13 (2.1)	GEMIN7 (1.8)	CLPTM1 (1.7)	PSMA5 (1.7)
ENSG00000149257	SERPINH1 PPI subnetwork	0.59	> 0.20	PLEC (3.4)	KANK2 (3.2)	ITGB3 (3.1)	BRAP (2.7)	PVR (2.6)	ADAM1 (2.4)	GATAD2A (2.1)	PTPN11 (2.1)	SLC44A2 (1.8)	CEACAM19 (1.7)
ENSG00000178952	TUFM PPI subnetwork	0.59	> 0.20	QTRT1 (3.4)	TOMM40 (2.7)	ACAD10 (2.7)	C19orf52 (2.5)	OGDH (2.1)	ERP29 (2.1)	ILF3 (2.0)	SMARCA4 (2.0)	TOP1 (1.8)	ENSG00000238078 (1.8)
ENSG00000118181	RPS25 PPI subnetwork	0.59	> 0.20	NKPD1 (2.3)	GATAD2A (2.2)	TOP1 (2.0)	ILF3 (1.9)	ATP13A1 (1.6)	MYLIP (1.6)	DDX56 (1.4)	C19orf52 (1.4)	SARS (1.4)	ANKRD31 (1.4)
ENSG00000113758	DBN1 PPI subnetwork	0.59	> 0.20	OGDH (2.7)	TMEM50A (2.7)	DNM2 (2.7)	KANK2 (2.4)	C1orf63 (2.2)	CLPTM1 (2.1)	ITGB3 (2.1)	AP1M2 (2.0)	GATAD2A (1.9)	PLEC (1.9)
GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	0.59	> 0.20	PSMA5 (3.4)	TRAFD1 (2.7)	PARP10 (2.4)	NT5DC1 (2.2)	TMED4 (1.9)	NAA25 (1.8)	CYB561D1 (1.5)	ENSG00000254235 (1.3)	BRAP (1.2)	ABCG8 (1.2)
MP:0010984	abnormal metanephric mesenchyme morphology	0.59	> 0.20	MYLIP (2.3)	NYNRIN (2.3)	C11orf9 (1.9)	FRK (1.8)	AMIGO1 (1.7)	CELSR2 (1.7)	PVRL2 (1.7)	AP1M2 (1.7)	PLEKHH2 (1.6)	HNF1A (1.6)
ENSG00000137831	UACA PPI subnetwork	0.59	> 0.20	PVR (2.3)	LPIN3 (2.2)	PLCG1 (2.1)	PLEC (2.0)	TM6SF2 (2.0)	RELB (1.8)	TRAFD1 (1.7)	ZHX3 (1.7)	ABO (1.6)	KANK2 (1.6)
ENSG00000164171	ITGA2 PPI subnetwork	0.59	> 0.20	CILP2 (3.5)	TMEM50A (3.4)	ITGB3 (2.5)	BCAM (2.3)	LPIN3 (1.7)	CELSR2 (1.6)	PVRL2 (1.6)	CEACAM19 (1.6)	KANK2 (1.5)	GMPR (1.5)
GO:0071482	cellular response to light stimulus	0.59	> 0.20	HAVCR1 (2.4)	PPP1R37 (2.2)	GEMIN7 (2.0)	BLOC1S3 (2.0)	C19orf52 (1.9)	GATAD2A (1.8)	C12orf43 (1.8)	DNAH11 (1.7)	TRAPPC6A (1.6)	NYNRIN (1.4)
MP:0006362	abnormal male germ cell morphology	0.59	> 0.20	NKPD1 (2.6)	TMED4 (2.1)	TMEM57 (2.0)	GMPR (1.5)	PCSK9 (1.5)	ENSG00000238078 (1.2)	ZNF180 (1.2)	USP24 (1.2)	PSRC1 (1.1)	SLC22A1 (1.1)
ENSG00000116701	NCF2 PPI subnetwork	0.59	> 0.20	GMIP (3.1)	SLC44A2 (3.0)	HP (2.4)	ALDH2 (2.4)	AP1M2 (1.7)	CELSR2 (1.6)	LPAR2 (1.6)	OASL (1.6)	TSSK6 (1.6)	HLX (1.5)
ENSG00000043355	ZIC2 PPI subnetwork	0.59	> 0.20	NYNRIN (2.7)	BCAM (2.5)	BLOC1S3 (2.3)	PPP1R37 (2.3)	MARK4 (2.3)	PSRC1 (2.3)	GOT2P1 (2.2)	CILP2 (2.1)	TXNL4B (1.8)	DHODH (1.6)
GO:0032892	positive regulation of organic acid transport	0.59	> 0.20	C12orf43 (2.4)	CBLC (2.2)	HAPLN4 (1.8)	ERP29 (1.7)	PMFBP1 (1.5)	CETP (1.4)	GEMIN7 (1.4)	NCAN (1.3)	ADAM1 (1.3)	C12orf47 (1.2)
ENSG00000108395	TRIM37 PPI subnetwork	0.59	> 0.20	RELB (3.4)	PSRC1 (2.9)	FEN1 (2.7)	DNAH11 (1.8)	TRAFD1 (1.8)	PBX4 (1.5)	TSSK6 (1.4)	POC5 (1.3)	PVR (1.3)	CBLC (1.3)
GO:0048562	embryonic organ morphogenesis	0.59	> 0.20	PLEKHH2 (1.9)	CEACAM19 (1.9)	NYNRIN (1.8)	ABO (1.7)	PLCG1 (1.7)	TMED4 (1.5)	CILP2 (1.4)	C19orf52 (1.3)	NKPD1 (1.3)	TSSK6 (1.3)
GO:0010559	regulation of glycoprotein biosynthetic process	0.59	> 0.20	ENSG00000226648 (3.4)	CETP (3.3)	ZNF101 (2.3)	NKPD1 (1.9)	TIMD4 (1.8)	UBXN2B (1.7)	CYB561D1 (1.7)	TMEM116 (1.6)	ABO (1.5)	PBX4 (1.5)
GO:0042510	regulation of tyrosine phosphorylation of Stat1 protein	0.59	> 0.20	PLEKHH2 (2.2)	PBX4 (2.1)	TRAFD1 (2.0)	SLC22A1 (1.8)	PVR (1.4)	ENSG00000235545 (1.4)	HNF1A (1.4)	C11orf9 (1.2)	TMEM57 (1.2)	ST3GAL4 (1.2)
ENSG00000116984	MTR PPI subnetwork	0.59	> 0.20	ITGB3 (3.0)	FADS1 (2.6)	HAVCR1 (2.5)	SMARCA4 (2.5)	FADS2 (2.5)	HMGCR (2.4)	LDLR (1.9)	PLEKHH2 (1.8)	ILF3 (1.8)	SARS (1.7)
GO:0072089	stem cell proliferation	0.59	> 0.20	ENSG00000226648 (3.0)	GCNT4 (2.7)	ABCG8 (2.3)	ENSG00000226645 (2.0)	ADAM1 (1.8)	BCAM (1.7)	ABO (1.7)	NYNRIN (1.5)	BLOC1S3 (1.5)	ABCG5 (1.5)
GO:0051018	protein kinase A binding	0.59	> 0.20	TSSK6 (4.4)	C19orf52 (2.6)	MAU2 (2.5)	GCNT4 (1.8)	LPAR2 (1.5)	KIAA1324 (1.5)	KANK2 (1.4)	HNF1A (1.3)	COL4A3BP (1.2)	YIPF2 (1.2)
GO:0006998	nuclear envelope organization	0.59	> 0.20	PPP1R37 (3.2)	GATAD2A (3.0)	BLOC1S3 (2.6)	QTRT1 (1.8)	DOCK7 (1.6)	CLPTM1 (1.6)	ZNF259 (1.5)	GCNT4 (1.3)	ATXN7L2 (1.2)	POLK (1.2)
GO:0048260	positive regulation of receptor-mediated endocytosis	0.59	> 0.20	CILP2 (2.5)	ZNF101 (2.4)	ENSG00000254235 (2.3)	ENSG00000238078 (2.3)	LPIN3 (1.9)	C12orf47 (1.6)	CETP (1.6)	CEACAM19 (1.4)	GOT2P1 (1.3)	UBXN2B (1.2)
MP:0005217	abnormal pancreatic beta cell morphology	0.59	> 0.20	LPIN3 (3.1)	MOSC1 (2.4)	DYNC2LI1 (2.0)	PARP10 (1.9)	ENSG00000238078 (1.7)	TOP1 (1.6)	ANGPTL3 (1.5)	APOC4 (1.4)	ALDH2 (1.4)	OASL (1.4)
GO:0051093	negative regulation of developmental process	0.59	> 0.20	NYNRIN (2.8)	CILP2 (1.9)	MYLIP (1.9)	TSSK6 (1.6)	ATXN7L2 (1.6)	BCAM (1.5)	ABO (1.5)	KANK2 (1.4)	PPP1R37 (1.4)	CELSR2 (1.4)
ENSG00000213199	ACCN3 PPI subnetwork	0.59	> 0.20	PPP1R37 (3.2)	AMIGO1 (2.8)	FRK (2.8)	C11orf9 (2.7)	RPH3A (2.3)	PVRL2 (1.9)	POLK (1.7)	GRINA (1.7)	BCAM (1.6)	NAA25 (1.6)
ENSG00000164070	HSPA4L PPI subnetwork	0.59	> 0.20	BLOC1S3 (4.0)	C19orf52 (2.7)	C12orf43 (2.6)	TRAPPC6A (2.2)	TIMD4 (2.0)	MAPKAPK5 (1.9)	C12orf47 (1.6)	MYLIP (1.5)	COL4A3BP (1.5)	ZHX3 (1.4)
GO:0032846	positive regulation of homeostatic process	0.59	> 0.20	ENSG00000235545 (3.5)	C12orf47 (3.2)	ABO (1.9)	GCNT4 (1.7)	RHCE (1.5)	ENSG00000226645 (1.5)	TRAPPC6A (1.4)	RHD (1.2)	C12orf43 (1.2)	POLK (1.2)
ENSG00000154380	ENAH PPI subnetwork	0.59	> 0.20	ATXN2 (2.8)	ENSG00000254235 (2.3)	GMIP (2.2)	CEACAM19 (2.1)	ITGB3 (2.1)	TOP1 (2.0)	PVR (2.0)	PBX4 (1.9)	C12orf51 (1.8)	TIMD4 (1.8)
GO:0033081	regulation of T cell differentiation in thymus	0.59	> 0.20	PBX4 (4.3)	PPP1R37 (2.5)	ZNF101 (2.1)	DNAH11 (2.0)	NPC1L1 (1.9)	ENSG00000235545 (1.8)	HNF1A (1.7)	AMIGO1 (1.7)	PLCG1 (1.6)	ATXN7L2 (1.5)
ENSG00000163877	SNIP1 PPI subnetwork	0.59	> 0.20	USP1 (2.8)	BUD13 (2.7)	ATXN2 (2.5)	BRAP (2.1)	MAU2 (2.1)	GATAD2A (2.0)	TMEM50A (2.0)	TRAFD1 (1.9)	TOP1 (1.9)	USP24 (1.7)
ENSG00000134184	GSTM1 PPI subnetwork	0.59	> 0.20	PLEC (3.4)	LPIN3 (2.7)	PVR (2.3)	PLCG1 (2.1)	KANK2 (2.1)	BRAP (2.0)	DOCK7 (1.8)	ITGB3 (1.7)	ABCG8 (1.6)	FRK (1.6)
REACTOME_DAG_AND_IP3_SIGNALING	REACTOME_DAG_AND_IP3_SIGNALING	0.59	> 0.20	SH2B3 (2.9)	ITGB3 (2.6)	ZHX3 (2.6)	SORT1 (2.6)	ST3GAL4 (2.3)	GCNT4 (1.8)	ZNF101 (1.7)	OGDH (1.7)	KANK2 (1.6)	AMIGO1 (1.6)
GO:0045576	mast cell activation	0.59	> 0.20	BLOC1S3 (2.0)	GEMIN7 (2.0)	NKPD1 (1.8)	C17orf57 (1.8)	ST3GAL4 (1.6)	GMIP (1.5)	GMPR (1.4)	CYB561D1 (1.4)	HAVCR1 (1.3)	DNAH11 (1.3)
REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE	REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE	0.59	> 0.20	C12orf43 (3.7)	TXNL4B (3.1)	ZNF259 (3.0)	DYNC2LI1 (2.9)	MAPKAPK5 (2.6)	NAA25 (2.4)	ATXN7L2 (2.3)	DHX38 (2.1)	QTRT1 (2.1)	DDX56 (2.0)
REACTOME_ASSEMBLY_OF_HIV_VIRION	REACTOME_ASSEMBLY_OF_HIV_VIRION	0.59	> 0.20	CYB561D1 (2.4)	BRAP (2.4)	GMPR (2.4)	TMEM57 (2.3)	MAU2 (2.3)	TRIB1 (2.2)	LPAR2 (1.9)	POLK (1.8)	PSMA5 (1.7)	ADAM1 (1.6)
GO:0048185	activin binding	0.59	> 0.20	PVRL2 (3.4)	MARK4 (2.4)	PVR (2.3)	TMEM116 (1.9)	NYNRIN (1.9)	CARM1 (1.7)	LPIN3 (1.7)	PLEC (1.6)	SH2B3 (1.6)	KANK2 (1.5)
ENSG00000102119	EMD PPI subnetwork	0.59	> 0.20	ILF3 (2.7)	DNAH11 (2.5)	TOP1 (2.3)	COL4A3BP (1.9)	PLEC (1.9)	DNM2 (1.8)	QTRT1 (1.6)	BCAM (1.6)	NT5DC1 (1.5)	SARS (1.5)
GO:0035272	exocrine system development	0.59	> 0.20	PLEKHH2 (3.0)	ENSG00000226645 (2.1)	BCAM (2.0)	DOCK7 (1.9)	ENSG00000228044 (1.9)	TMED4 (1.7)	GCNT4 (1.7)	PVRL2 (1.7)	AMIGO1 (1.7)	TSSK6 (1.7)
ENSG00000206357	RDBP PPI subnetwork	0.59	> 0.20	SUGP1 (2.9)	MAPKAPK5 (2.5)	TXNL4B (2.4)	DHX38 (2.4)	ZNF259 (2.3)	BUD13 (2.1)	DNM2 (2.1)	PTPN11 (1.9)	SMARCA4 (1.8)	DDX56 (1.7)
ENSG00000204356	RDBP PPI subnetwork	0.59	> 0.20	SUGP1 (2.9)	MAPKAPK5 (2.5)	TXNL4B (2.4)	DHX38 (2.4)	ZNF259 (2.3)	BUD13 (2.1)	DNM2 (2.1)	PTPN11 (1.9)	SMARCA4 (1.8)	DDX56 (1.7)
ENSG00000206268	RDBP PPI subnetwork	0.59	> 0.20	SUGP1 (2.9)	MAPKAPK5 (2.5)	TXNL4B (2.4)	DHX38 (2.4)	ZNF259 (2.3)	BUD13 (2.1)	DNM2 (2.1)	PTPN11 (1.9)	SMARCA4 (1.8)	DDX56 (1.7)
ENSG00000137841	PLCB2 PPI subnetwork	0.59	> 0.20	COL4A3BP (2.5)	ABCG8 (2.5)	PLEKHH2 (2.1)	PLCG1 (1.9)	PARP10 (1.9)	ABCG5 (1.8)	C11orf9 (1.7)	HAPLN4 (1.7)	HLX (1.7)	SH2B3 (1.6)
ENSG00000184897	H1FX PPI subnetwork	0.59	> 0.20	ILF3 (3.9)	SMARCA4 (3.7)	QTRT1 (3.3)	TOP1 (2.9)	C1orf63 (2.5)	PTPN11 (2.5)	GATAD2A (2.2)	USP1 (2.2)	DHX38 (2.0)	TMEM57 (2.0)
ENSG00000168291	PDHB PPI subnetwork	0.59	> 0.20	C19orf52 (2.9)	ACAD10 (2.3)	DNAH11 (1.9)	PSMA5 (1.7)	OGDH (1.7)	PLEC (1.6)	DOCK7 (1.6)	ENSG00000226648 (1.5)	ILF3 (1.5)	GMPR (1.4)
MP:0005501	abnormal skin physiology	0.59	> 0.20	LDLR (2.4)	NKPD1 (2.3)	BCAM (2.2)	C17orf57 (2.2)	SLC44A2 (2.1)	CBLC (2.0)	PCSK9 (2.0)	GCNT4 (1.9)	LPAR2 (1.8)	PLEC (1.6)
ENSG00000091140	DLD PPI subnetwork	0.59	> 0.20	GPAM (3.3)	QTRT1 (2.5)	CLPTM1 (2.4)	MOSC1 (2.2)	DHODH (2.2)	OGDH (2.2)	DNAH11 (1.9)	DOCK7 (1.8)	FADS1 (1.6)	FADS2 (1.6)
ENSG00000076043	REXO2 PPI subnetwork	0.59	> 0.20	CARM1 (2.6)	NYNRIN (2.4)	BUD13 (2.3)	ZNF101 (2.2)	MARK4 (1.9)	HLX (1.9)	ERP29 (1.8)	TM6SF2 (1.5)	UBXN2B (1.5)	NCAN (1.5)
GO:0019898	extrinsic to membrane	0.59	> 0.20	ITGB3 (2.4)	SH2B3 (2.3)	CETP (1.9)	TMEM50A (1.9)	RPH3A (1.9)	KANK2 (1.7)	DNM2 (1.6)	DOCK7 (1.5)	AP1M2 (1.5)	ANKRD31 (1.4)
GO:0045670	regulation of osteoclast differentiation	0.59	> 0.20	DNAH11 (2.9)	GCNT4 (2.4)	PBX4 (1.7)	DYNC2LI1 (1.7)	MYLIP (1.4)	ZNF180 (1.1)	ENSG00000235545 (1.1)	TMEM116 (1.0)	ANKRD31 (1.0)	POLK (1.0)
ENSG00000147853	AK3 PPI subnetwork	0.59	> 0.20	RHD (2.8)	HAVCR1 (2.6)	ERP29 (2.6)	C12orf47 (2.4)	DOCK7 (2.3)	ANKRD31 (2.0)	RHCE (1.9)	ALDH2 (1.9)	PSMA5 (1.8)	UBXN2B (1.7)
MP:0003843	abnormal sagittal suture morphology	0.59	> 0.20	ENSG00000228044 (2.2)	TRAFD1 (2.2)	ST3GAL4 (2.0)	NYNRIN (2.0)	PLEC (1.9)	TMEM50A (1.8)	GATAD2A (1.7)	TSSK6 (1.6)	C11orf9 (1.6)	TMEM116 (1.4)
MP:0003938	abnormal ear development	0.59	> 0.20	NYNRIN (3.3)	PVRL2 (2.0)	PLEKHH2 (1.8)	C11orf9 (1.8)	BCAM (1.6)	CILP2 (1.4)	DNAH11 (1.3)	POC5 (1.3)	ALDH2 (1.3)	AMIGO1 (1.2)
GO:0072659	protein localization in plasma membrane	0.59	> 0.20	AP1M2 (3.2)	PTPN11 (3.0)	CBLC (2.2)	BCAM (2.1)	C11orf9 (2.0)	HAVCR1 (1.9)	SORT1 (1.7)	TSSK6 (1.6)	PVRL2 (1.5)	C19orf52 (1.5)
MP:0001691	abnormal somite shape	0.59	> 0.20	ABO (3.0)	GATAD2A (2.7)	PLCG1 (2.3)	NYNRIN (2.2)	MARK4 (1.9)	CLPTM1 (1.7)	GRINA (1.7)	C11orf9 (1.4)	TMEM57 (1.4)	GPAM (1.3)
ENSG00000115966	ATF2 PPI subnetwork	0.59	> 0.20	TRIB1 (5.9)	MAPKAPK5 (3.8)	SARS (3.4)	ATXN2 (3.1)	BCL3 (2.9)	PVR (2.8)	MAFB (1.8)	CARM1 (1.5)	MARK4 (1.5)	MAU2 (1.5)
ENSG00000149930	TAOK2 PPI subnetwork	0.59	> 0.20	PLCG1 (3.1)	PLEC (2.5)	LPIN3 (2.4)	SYPL2 (2.3)	PVR (2.0)	HLX (2.0)	KANK2 (1.9)	GATAD2A (1.7)	ZHX3 (1.4)	AP1M2 (1.4)
GO:0071695	anatomical structure maturation	0.59	> 0.20	ANKRD31 (2.5)	BLOC1S3 (2.1)	ENSG00000254235 (1.9)	ABO (1.9)	ADAM1 (1.7)	GEMIN7 (1.6)	ENSG00000226645 (1.6)	NKPD1 (1.5)	PBX4 (1.4)	PVR (1.4)
ENSG00000172349	IL16 PPI subnetwork	0.59	> 0.20	NCAN (3.5)	RPH3A (2.5)	HAVCR1 (2.5)	CETP (2.2)	ENSG00000228044 (1.8)	GCNT4 (1.5)	BLOC1S3 (1.5)	BRAP (1.5)	TOP1 (1.4)	CYB561D1 (1.4)
ENSG00000173636	ENSG00000173636 PPI subnetwork	0.59	> 0.20	FEN1 (2.4)	APOB (2.2)	USP1 (1.9)	GMPR (1.8)	CELSR2 (1.8)	HP (1.8)	ERP29 (1.6)	ALDH2 (1.5)	TMEM50A (1.5)	POC5 (1.4)
GO:0010741	negative regulation of intracellular protein kinase cascade	0.59	> 0.20	TRIB1 (3.2)	ENSG00000238078 (2.4)	PVR (2.1)	MYLIP (1.8)	SH2B3 (1.5)	CILP2 (1.3)	ZNF180 (1.2)	SYPL2 (1.2)	AMIGO1 (1.2)	C11orf9 (1.0)
GO:0048730	epidermis morphogenesis	0.59	> 0.20	ANKRD31 (3.7)	ABO (2.0)	C17orf57 (1.9)	ENSG00000254235 (1.7)	CYB561D1 (1.6)	LPAR2 (1.3)	CARM1 (1.2)	POLK (1.2)	BCAM (1.1)	NYNRIN (1.0)
ENSG00000180573	HIST1H2AC PPI subnetwork	0.59	> 0.20	DDX56 (2.8)	SMARCA4 (2.7)	BUD13 (2.5)	ZNF259 (2.4)	ILF3 (2.3)	QTRT1 (2.2)	TOMM40 (2.2)	NAA25 (2.1)	CARM1 (2.1)	TOP1 (2.0)
MP:0005100	abnormal choroid pigmentation	0.59	> 0.20	ST3GAL4 (2.6)	ZNF101 (2.2)	ACAD10 (2.0)	HLX (1.9)	MYLIP (1.9)	DOCK7 (1.8)	COL4A3BP (1.8)	GMIP (1.6)	TXNL4B (1.6)	GMPR (1.5)
GO:0000279	M phase	0.59	> 0.20	POC5 (4.4)	PSRC1 (4.2)	ENSG00000228044 (2.6)	USP1 (2.5)	FEN1 (2.0)	PBX4 (1.5)	BUD13 (1.5)	ANKRD31 (1.2)	ZNF180 (1.1)	ILF3 (1.0)
MP:0003974	abnormal endocardium morphology	0.59	> 0.20	SH2B3 (2.4)	NYNRIN (2.3)	MAFB (2.3)	TMEM57 (2.2)	HLX (2.1)	SLC44A2 (2.0)	CETP (1.9)	LPIN3 (1.8)	KANK2 (1.8)	BCAM (1.7)
GO:0045732	positive regulation of protein catabolic process	0.59	> 0.20	ZNF180 (3.8)	ENSG00000235545 (3.5)	GEMIN7 (2.0)	BLOC1S3 (1.9)	GRINA (1.8)	MAU2 (1.5)	ENSG00000228044 (1.5)	POLK (1.4)	HAVCR1 (1.3)	NYNRIN (1.3)
GO:0002294	CD4-positive, alpha-beta T cell differentiation involved in immune response	0.59	> 0.20	ENSG00000254235 (2.2)	BLOC1S3 (1.8)	ST3GAL4 (1.6)	BCL3 (1.5)	ENSG00000235545 (1.5)	CETP (1.5)	TMEM57 (1.5)	RELB (1.2)	NT5DC1 (1.2)	PBX4 (1.2)
GO:0042093	T-helper cell differentiation	0.59	> 0.20	ENSG00000254235 (2.2)	BLOC1S3 (1.8)	ST3GAL4 (1.6)	BCL3 (1.5)	ENSG00000235545 (1.5)	CETP (1.5)	TMEM57 (1.5)	RELB (1.2)	NT5DC1 (1.2)	PBX4 (1.2)
ENSG00000102096	PIM2 PPI subnetwork	0.59	> 0.20	SYPL2 (2.4)	TSSK6 (2.2)	TRAPPC6A (2.1)	TRIB1 (1.8)	NPC1L1 (1.7)	C12orf47 (1.7)	ABCG8 (1.7)	DOCK7 (1.7)	C17orf57 (1.6)	UBXN2B (1.5)
GO:0045912	negative regulation of carbohydrate metabolic process	0.59	> 0.20	PCSK9 (2.8)	ENSG00000254235 (2.4)	GPAM (2.3)	ST3GAL4 (2.1)	ENSG00000226645 (2.1)	BLOC1S3 (2.0)	CYP7A1 (1.8)	TRIB1 (1.7)	PVR (1.7)	PBX4 (1.6)
GO:0010677	negative regulation of cellular carbohydrate metabolic process	0.59	> 0.20	PCSK9 (2.8)	ENSG00000254235 (2.4)	GPAM (2.3)	ST3GAL4 (2.1)	ENSG00000226645 (2.1)	BLOC1S3 (2.0)	CYP7A1 (1.8)	TRIB1 (1.7)	PVR (1.7)	PBX4 (1.6)
MP:0009338	increased splenocyte number	0.59	> 0.20	RHCE (4.3)	RHD (3.6)	SH2B3 (1.9)	C12orf47 (1.8)	HLX (1.7)	FRK (1.6)	C12orf51 (1.6)	PBX4 (1.5)	RELB (1.5)	HP (1.4)
GO:0001660	fever generation	0.59	> 0.20	ENSG00000228044 (3.2)	ENSG00000235545 (2.8)	PMFBP1 (1.5)	TSSK6 (1.5)	OASL (1.5)	BLOC1S3 (1.4)	POLK (1.4)	TXNL4B (1.3)	DNAH11 (1.2)	TIMD4 (1.1)
ENSG00000181218	HIST3H2A PPI subnetwork	0.59	> 0.20	DDX56 (2.7)	SMARCA4 (2.6)	BUD13 (2.3)	ZNF259 (2.3)	NAA25 (2.2)	TOMM40 (2.1)	QTRT1 (2.1)	TOP1 (2.1)	ILF3 (2.1)	CARM1 (2.0)
ENSG00000145386	CCNA2 PPI subnetwork	0.59	> 0.20	FEN1 (4.6)	USP1 (4.0)	PSRC1 (2.8)	ZNF101 (2.4)	KANK2 (2.2)	GATAD2A (1.7)	BUD13 (1.7)	MYLIP (1.5)	MAU2 (1.4)	UBXN2B (1.2)
MP:0001132	absent mature ovarian follicles	0.59	> 0.20	FADS1 (3.9)	LDLR (3.0)	PMFBP1 (2.2)	HMGCR (2.1)	KIAA1324 (1.9)	TM6SF2 (1.8)	GCNT4 (1.6)	TRIB1 (1.5)	RELB (1.4)	TXNL4B (1.3)
ENSG00000105369	CD79A PPI subnetwork	0.59	> 0.20	GMIP (2.9)	ZNF101 (2.8)	SLC44A2 (2.4)	MAFB (2.2)	APOB (2.0)	MOSC1 (1.7)	TIMD4 (1.7)	APOA5 (1.6)	KIAA1324 (1.6)	ATXN7L2 (1.3)
MP:0002543	brachyphalangia	0.59	> 0.20	PLEKHH2 (2.2)	ZHX3 (2.2)	NYNRIN (2.1)	MAFB (1.8)	ENSG00000228044 (1.4)	NKPD1 (1.4)	CBLC (1.1)	GOT2P1 (1.1)	TRIB1 (1.0)	ENSG00000254235 (1.0)
ENSG00000094804	CDC6 PPI subnetwork	0.59	> 0.20	FEN1 (4.4)	PSMA5 (3.7)	USP1 (3.2)	MAU2 (2.2)	NT5DC1 (1.8)	ENSG00000235545 (1.8)	TXNL4B (1.8)	TOMM40 (1.8)	PSRC1 (1.6)	DDX56 (1.6)
ENSG00000134202	GSTM3 PPI subnetwork	0.59	> 0.20	ZHX3 (2.8)	KANK2 (2.4)	FRK (2.4)	HAPLN4 (2.3)	PLCG1 (2.2)	HLX (2.1)	TM6SF2 (2.1)	NPC1L1 (1.9)	BRAP (1.9)	PLEKHH2 (1.8)
ENSG00000164078	MST1R PPI subnetwork	0.59	> 0.20	RHD (3.4)	GRINA (2.5)	TOP1 (2.4)	DNM2 (1.9)	MARK4 (1.9)	LPAR2 (1.8)	C19orf52 (1.7)	SLC44A2 (1.6)	ZHX3 (1.5)	TMEM50A (1.5)
GO:0034661	ncRNA catabolic process	0.59	> 0.20	USP24 (3.1)	MAPKAPK5 (2.8)	CEACAM19 (2.4)	NT5DC1 (2.0)	UBXN2B (1.9)	DDX56 (1.8)	POLK (1.7)	DOCK7 (1.6)	MAU2 (1.5)	PARP10 (1.5)
GO:0001881	receptor recycling	0.59	> 0.20	ABO (2.9)	LPIN3 (2.9)	TMED4 (2.8)	HNF1A (2.6)	TMEM57 (2.5)	TMEM50A (2.5)	ZNF101 (2.0)	TSSK6 (1.9)	AMIGO1 (1.6)	PTPN11 (1.5)
ENSG00000153914	SREK1 PPI subnetwork	0.59	> 0.20	C1orf63 (5.2)	ILF3 (5.1)	TOP1 (3.5)	QTRT1 (3.1)	USP1 (2.6)	SMARCA4 (2.5)	BUD13 (2.4)	SUGP1 (2.0)	PLCG1 (1.7)	ENSG00000226645 (1.6)
ENSG00000143368	SF3B4 PPI subnetwork	0.59	> 0.20	ILF3 (4.1)	C1orf63 (3.6)	TOP1 (3.4)	BUD13 (3.1)	SMARCA4 (2.9)	DHX38 (2.8)	SUGP1 (2.7)	USP1 (2.6)	FEN1 (2.4)	QTRT1 (1.9)
MP:0005287	narrow eye opening	0.59	> 0.20	NYNRIN (3.8)	UBXN2B (1.9)	ENSG00000228044 (1.9)	LDLR (1.6)	PLEKHH2 (1.6)	MARK4 (1.6)	CARM1 (1.5)	ST3GAL4 (1.2)	BCAM (1.2)	BCL3 (1.2)
GO:0005776	autophagic vacuole	0.59	> 0.20	BRAP (3.6)	C12orf51 (3.2)	ACAD10 (2.5)	PPP1R37 (2.5)	TMEM57 (2.2)	DHX38 (2.1)	GRINA (2.0)	ENSG00000228044 (1.9)	TRAFD1 (1.9)	YIPF2 (1.9)
GO:0015370	solute:sodium symporter activity	0.59	> 0.20	TM6SF2 (4.9)	ABCG5 (3.7)	ABCG8 (3.2)	HAPLN4 (2.6)	NPC1L1 (2.6)	TMEM116 (2.3)	NCAN (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.7)	APOC4 (1.7)
GO:0003073	regulation of systemic arterial blood pressure	0.59	> 0.20	C12orf47 (3.2)	CEACAM19 (2.7)	TMED4 (2.4)	ENSG00000228044 (1.9)	PMFBP1 (1.8)	FRK (1.7)	AMIGO1 (1.6)	TMEM116 (1.6)	NKPD1 (1.5)	LPIN3 (1.4)
GO:0030666	endocytic vesicle membrane	0.59	> 0.20	CLPTM1 (2.7)	HAPLN4 (2.5)	SORT1 (2.1)	RPH3A (2.0)	PPP1R37 (2.0)	TM6SF2 (1.9)	SARS (1.8)	GRINA (1.8)	HMGCR (1.7)	NCAN (1.6)
MP:0001325	abnormal retina morphology	0.59	> 0.20	APOE (1.8)	SORT1 (1.7)	GRINA (1.6)	ENSG00000226648 (1.6)	NCAN (1.6)	MAFB (1.4)	ST3GAL4 (1.4)	NYNRIN (1.3)	PLCG1 (1.3)	PSRC1 (1.3)
ENSG00000138433	CIR1 PPI subnetwork	0.59	> 0.20	C1orf63 (5.1)	MAPKAPK5 (2.6)	TOP1 (2.4)	TMEM57 (2.1)	ADAM1 (2.0)	TRAPPC6A (2.0)	NT5DC1 (2.0)	C12orf43 (1.8)	DOCK7 (1.7)	BUD13 (1.7)
GO:0048665	neuron fate specification	0.59	> 0.20	DNAH11 (2.6)	TSSK6 (2.4)	PMFBP1 (2.3)	ATXN7L2 (2.2)	GOT2P1 (2.1)	ANKRD31 (2.0)	KIAA1324 (1.9)	HAPLN4 (1.8)	C12orf47 (1.8)	NKPD1 (1.7)
ENSG00000089280	FUS PPI subnetwork	0.59	> 0.20	C1orf63 (3.9)	ILF3 (3.5)	TOP1 (3.3)	DHX38 (2.9)	SMARCA4 (2.7)	SUGP1 (2.6)	PTPN11 (2.5)	QTRT1 (2.1)	CLPTM1 (2.0)	USP1 (1.9)
ENSG00000130414	NDUFA10 PPI subnetwork	0.59	> 0.20	ACAD10 (4.0)	OGDH (3.4)	TRAPPC6A (3.1)	C12orf47 (2.5)	TMED4 (2.1)	FRK (1.8)	HNF1A (1.7)	C1orf63 (1.7)	GMPR (1.5)	NT5DC1 (1.5)
GO:0071347	cellular response to interleukin-1	0.59	> 0.20	CEACAM19 (3.4)	ANKRD31 (2.8)	ENSG00000228044 (2.6)	PVR (2.2)	BCL3 (2.2)	TRIB1 (1.6)	GCNT4 (1.5)	RELB (1.4)	ZNF180 (1.3)	ZNF101 (1.3)
GO:0050755	chemokine metabolic process	0.59	> 0.20	ST3GAL4 (2.4)	ENSG00000228044 (2.4)	OASL (1.6)	ATXN7L2 (1.6)	ENSG00000254235 (1.5)	FRK (1.5)	CYP7A1 (1.4)	TIMD4 (1.4)	DNAH11 (1.1)	DYNC2LI1 (1.1)
MP:0000440	domed cranium	0.59	> 0.20	NYNRIN (3.2)	CILP2 (2.9)	PLEKHH2 (2.7)	DYNC2LI1 (2.2)	DHX38 (2.2)	CBLC (1.8)	MAFB (1.8)	PPP1R37 (1.7)	ENSG00000235545 (1.6)	HAVCR1 (1.6)
GO:0043648	dicarboxylic acid metabolic process	0.59	> 0.20	ACAD10 (2.6)	ALDH2 (2.2)	ANGPTL3 (2.0)	DNAH11 (1.9)	OGDH (1.9)	PMFBP1 (1.6)	SYPL2 (1.6)	AMIGO1 (1.6)	SARS (1.5)	APOC4 (1.5)
GO:0051054	positive regulation of DNA metabolic process	0.59	> 0.20	HAVCR1 (3.0)	GCNT4 (2.5)	DYNC2LI1 (2.3)	POLK (2.2)	GEMIN7 (2.0)	ENSG00000226645 (1.9)	ENSG00000228044 (1.9)	C17orf57 (1.7)	HNF1A (1.7)	C12orf43 (1.6)
GO:0032649	regulation of interferon-gamma production	0.59	> 0.20	DNAH11 (2.9)	TIMD4 (1.8)	ZNF101 (1.7)	ATXN7L2 (1.6)	ENSG00000235545 (1.5)	GRINA (1.5)	PBX4 (1.5)	TXNL4B (1.2)	POLK (1.1)	ADAM1 (1.1)
ENSG00000067560	RHOA PPI subnetwork	0.59	> 0.20	PLEC (3.2)	DNM2 (3.1)	MARK4 (2.5)	OGDH (1.9)	LDLR (1.8)	PLEKHH2 (1.7)	KANK2 (1.7)	GMIP (1.6)	C11orf9 (1.6)	ZHX3 (1.6)
ENSG00000101265	RASSF2 PPI subnetwork	0.59	> 0.20	CARM1 (3.1)	TOMM40 (2.5)	GATAD2A (2.5)	ST3GAL4 (2.4)	POLK (2.2)	DNM2 (2.2)	MARK4 (2.1)	COL4A3BP (2.0)	FRK (1.7)	GEMIN7 (1.7)
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	0.59	> 0.20	KIAA1324 (4.3)	NPC1L1 (3.3)	ABCG5 (3.0)	ABCG8 (2.4)	MOSC1 (2.4)	TM6SF2 (2.4)	ERP29 (2.2)	TMED4 (2.2)	C11orf9 (1.8)	ST3GAL4 (1.8)
ENSG00000078699	CBFA2T2 PPI subnetwork	0.59	> 0.20	GMPR (2.7)	KIAA1324 (2.5)	RHD (2.4)	MARK4 (2.3)	NYNRIN (2.0)	DHODH (2.0)	GATAD2A (2.0)	ITGB3 (1.9)	ATXN2 (1.9)	ENSG00000228044 (1.9)
GO:0015295	solute:hydrogen symporter activity	0.59	> 0.20	BLOC1S3 (2.8)	ATP13A1 (2.4)	NCAN (2.2)	ABO (2.0)	TM6SF2 (1.8)	COL4A3BP (1.8)	ERP29 (1.7)	YIPF2 (1.6)	POLK (1.6)	FRK (1.6)
GO:0000794	condensed nuclear chromosome	0.59	> 0.20	FEN1 (4.1)	PSRC1 (3.8)	USP1 (3.1)	ANKRD31 (2.1)	POC5 (1.4)	HAVCR1 (1.3)	MAU2 (1.3)	CLPTM1 (1.1)	ZHX3 (1.0)	FADS2 (1.0)
MP:0005172	reduced eye pigmentation	0.59	> 0.20	GMPR (2.7)	DOCK7 (2.6)	ST3GAL4 (2.4)	ENSG00000235545 (1.8)	PLEKHH2 (1.7)	C11orf9 (1.6)	ENSG00000228044 (1.6)	CELSR2 (1.4)	ZNF101 (1.3)	GMIP (1.2)
ENSG00000101365	IDH3B PPI subnetwork	0.59	> 0.20	ATP13A1 (3.1)	ACAD10 (2.8)	OGDH (2.4)	DNM2 (2.4)	ILF3 (2.4)	ATXN2 (2.0)	YIPF2 (1.9)	SARS (1.8)	QTRT1 (1.8)	C19orf52 (1.7)
GO:0010714	positive regulation of collagen metabolic process	0.59	> 0.20	HNF1A (3.6)	C11orf9 (2.1)	NKPD1 (2.0)	FRK (1.7)	ENSG00000226645 (1.5)	GEMIN7 (1.4)	TMEM57 (1.4)	ST3GAL4 (1.3)	TMEM50A (1.1)	GMPR (1.1)
GO:0032967	positive regulation of collagen biosynthetic process	0.59	> 0.20	HNF1A (3.6)	C11orf9 (2.1)	NKPD1 (2.0)	FRK (1.7)	ENSG00000226645 (1.5)	GEMIN7 (1.4)	TMEM57 (1.4)	ST3GAL4 (1.3)	TMEM50A (1.1)	GMPR (1.1)
GO:0006103	2-oxoglutarate metabolic process	0.59	> 0.20	C19orf52 (2.1)	GOT2P1 (2.1)	DHODH (2.0)	ALDH2 (2.0)	ACAD10 (1.8)	OGDH (1.7)	SLC22A1 (1.6)	PMFBP1 (1.6)	AMIGO1 (1.5)	ABCG8 (1.4)
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	0.59	> 0.20	SYPL2 (3.8)	C12orf51 (2.8)	SORT1 (2.6)	ITGB3 (2.3)	HAVCR1 (2.0)	ANKRD31 (1.9)	RPH3A (1.9)	BRAP (1.6)	ATP13A1 (1.5)	GMPR (1.5)
MP:0006036	abnormal mitochondrial physiology	0.59	> 0.20	GMPR (3.1)	ABCG8 (2.8)	ACAD10 (2.6)	OGDH (2.5)	PARP10 (2.4)	ALDH2 (2.4)	C1orf63 (2.0)	BCL3 (1.9)	GRINA (1.8)	POLK (1.7)
ENSG00000162367	TAL1 PPI subnetwork	0.59	> 0.20	PLCG1 (3.4)	TMEM57 (3.1)	SMARCA4 (2.8)	RHD (2.5)	NYNRIN (2.4)	RHCE (2.3)	GMPR (2.2)	KANK2 (2.1)	ATXN2 (2.0)	MAFB (1.9)
ENSG00000197879	MYO1C PPI subnetwork	0.59	> 0.20	PLEC (3.4)	DNM2 (3.1)	SMARCA4 (2.7)	OGDH (2.1)	ATP13A1 (2.1)	PVR (2.1)	C1orf63 (2.1)	KANK2 (1.9)	ILF3 (1.8)	ITGB3 (1.7)
GO:0090257	regulation of muscle system process	0.60	> 0.20	SYPL2 (4.4)	ENSG00000226648 (2.4)	GMPR (2.0)	ITGB3 (1.9)	KANK2 (1.7)	CEACAM19 (1.7)	NKPD1 (1.6)	C17orf57 (1.5)	ABO (1.5)	ATXN7L2 (1.5)
ENSG00000132670	PTPRA PPI subnetwork	0.60	> 0.20	PVRL2 (2.5)	CELSR2 (2.4)	ALDH2 (2.3)	SLC44A2 (2.2)	GMIP (2.0)	ATXN2 (1.8)	MAFB (1.7)	MAPKAPK5 (1.7)	MARK4 (1.7)	GPAM (1.6)
ENSG00000122133	PAEP PPI subnetwork	0.60	> 0.20	GEMIN7 (2.6)	SYPL2 (2.2)	PSMA5 (2.0)	PCSK9 (1.8)	SARS (1.7)	C1orf63 (1.4)	SLC44A2 (1.4)	USP24 (1.3)	SH2B3 (1.3)	APOE (1.3)
ENSG00000101367	MAPRE1 PPI subnetwork	0.60	> 0.20	PSRC1 (5.7)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ZNF180 (1.3)	ZHX3 (1.2)	C12orf47 (1.1)	C12orf51 (0.9)	DHX38 (0.8)	TXNL4B (0.7)
MP:0004784	abnormal anterior cardinal vein morphology	0.60	> 0.20	SLC44A2 (2.3)	TMEM57 (2.2)	KANK2 (2.2)	HLX (2.1)	NYNRIN (2.0)	PLCG1 (1.8)	CETP (1.8)	GCNT4 (1.8)	BCAM (1.7)	TMEM50A (1.6)
ENSG00000132664	POLR3F PPI subnetwork	0.60	> 0.20	GEMIN7 (3.0)	DDX56 (2.9)	C12orf43 (2.9)	POC5 (2.6)	ZNF259 (2.4)	SUGP1 (2.1)	NAA25 (2.0)	ADAM1 (1.8)	BUD13 (1.7)	GOT2P1 (1.7)
MP:0002840	abnormal lens fiber morphology	0.60	> 0.20	NPC1L1 (1.4)	HMGCR (1.3)	C19orf52 (1.3)	GOT2P1 (1.1)	FADS2 (1.1)	OASL (1.0)	TIMD4 (1.0)	TRAPPC6A (1.0)	PBX4 (0.9)	LDLR (0.9)
GO:0005884	actin filament	0.60	> 0.20	ITGB3 (2.8)	KANK2 (2.3)	GMIP (2.0)	SYPL2 (1.9)	PVRL2 (1.5)	PMFBP1 (1.4)	LDLR (1.3)	POLK (1.2)	CYP7A1 (1.1)	GMPR (1.1)
ENSG00000141404	GNAL PPI subnetwork	0.60	> 0.20	ST3GAL4 (3.1)	SH2B3 (2.4)	GOT2P1 (2.1)	C12orf51 (1.9)	ENSG00000226645 (1.9)	BLOC1S3 (1.8)	ANKRD31 (1.8)	ABO (1.6)	AMIGO1 (1.6)	GCNT4 (1.6)
GO:0030140	trans-Golgi network transport vesicle	0.60	> 0.20	COL4A3BP (3.7)	POLK (2.4)	GRINA (2.2)	FRK (2.0)	CYB561D1 (1.8)	GMPR (1.8)	BLOC1S3 (1.8)	ENSG00000254235 (1.8)	AMIGO1 (1.7)	CELSR2 (1.6)
GO:0031000	response to caffeine	0.60	> 0.20	AMIGO1 (2.3)	ZNF180 (2.3)	FRK (2.0)	SYPL2 (1.9)	ANKRD31 (1.9)	C17orf57 (1.6)	ENSG00000228044 (1.4)	ZNF259 (1.4)	ENSG00000238078 (1.3)	HAVCR1 (1.3)
ENSG00000020577	SAMD4A PPI subnetwork	0.60	> 0.20	CBLC (4.8)	AP1M2 (3.0)	PSRC1 (2.3)	CELSR2 (2.3)	DOCK7 (2.1)	FRK (2.0)	LPIN3 (1.9)	ST3GAL4 (1.7)	PVRL2 (1.6)	LPAR2 (1.6)
ENSG00000198211	TUBB3 PPI subnetwork	0.60	> 0.20	TOP1 (2.9)	ILF3 (2.8)	SMARCA4 (2.6)	OGDH (2.5)	ERP29 (2.5)	C1orf63 (2.4)	KANK2 (2.1)	TMEM50A (2.1)	DOCK7 (1.6)	KIAA1324 (1.5)
ENSG00000179583	CIITA PPI subnetwork	0.60	> 0.20	MAU2 (2.6)	PARP10 (2.3)	ENSG00000238078 (2.3)	CARM1 (2.2)	OGDH (2.1)	SUGP1 (2.1)	ENSG00000226648 (1.9)	ZHX3 (1.8)	SMARCA4 (1.7)	ATXN2 (1.7)
GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	0.60	> 0.20	ZNF180 (3.8)	TMEM116 (2.7)	TXNL4B (2.4)	ENSG00000228044 (2.1)	USP1 (2.0)	DNAH11 (1.8)	LPAR2 (1.7)	FEN1 (1.7)	POLK (1.4)	LPIN3 (1.3)
ENSG00000150459	SAP18 PPI subnetwork	0.60	> 0.20	TOP1 (3.5)	ENSG00000226648 (3.1)	NAA25 (2.3)	SMARCA4 (2.2)	DNM2 (2.0)	CARM1 (1.9)	NCAN (1.8)	ZHX3 (1.6)	ATXN2 (1.6)	PSMA5 (1.6)
ENSG00000136383	ALPK3 PPI subnetwork	0.60	> 0.20	MARK4 (3.4)	GMIP (2.9)	ATXN2 (2.7)	LPAR2 (2.5)	C12orf51 (2.5)	USP24 (2.4)	DNM2 (2.4)	POLK (2.2)	SH2B3 (2.0)	PVRL2 (1.9)
GO:0017016	Ras GTPase binding	0.60	> 0.20	DNM2 (2.6)	C11orf9 (2.3)	PTPN11 (2.1)	COL4A3BP (2.0)	USP24 (2.0)	AP1M2 (1.9)	GMIP (1.8)	PLEC (1.8)	CARM1 (1.7)	C12orf51 (1.7)
ENSG00000105607	GCDH PPI subnetwork	0.60	> 0.20	C19orf52 (2.9)	QTRT1 (2.8)	DHODH (2.2)	DOCK7 (2.1)	SORT1 (2.1)	ACAD10 (2.1)	ATXN2 (2.0)	PSMA5 (2.0)	ILF3 (2.0)	ENSG00000235545 (1.9)
REACTOME_MITOTIC_G1:G1S_PHASES	REACTOME_MITOTIC_G1:G1S_PHASES	0.60	> 0.20	FEN1 (5.3)	PSMA5 (3.7)	USP1 (3.6)	TOMM40 (1.6)	PSRC1 (1.5)	ENSG00000235545 (1.5)	NT5DC1 (1.3)	LPIN3 (1.2)	TRAFD1 (1.2)	RHD (1.2)
MP:0004188	delayed embryo turning	0.60	> 0.20	UBXN2B (3.8)	DYNC2LI1 (3.5)	HLX (2.5)	ATXN2 (2.5)	COL4A3BP (2.0)	ANKRD31 (2.0)	LPIN3 (1.9)	MYLIP (1.9)	ATP13A1 (1.9)	HNF1A (1.7)
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	0.60	> 0.20	SARS (4.4)	NPC1L1 (3.6)	TM6SF2 (3.0)	ABCG8 (2.1)	ALDH2 (1.9)	ABCG5 (1.9)	ERP29 (1.8)	PVR (1.8)	ATP13A1 (1.8)	PCSK9 (1.7)
GO:2000104	negative regulation of DNA-dependent DNA replication	0.60	> 0.20	ENSG00000226645 (2.7)	POC5 (2.3)	BUD13 (2.0)	POLK (1.9)	TMEM57 (1.9)	GCNT4 (1.9)	TOP1 (1.8)	NKPD1 (1.8)	DNAH11 (1.6)	USP1 (1.5)
MP:0003648	abnormal radial glial cell morphology	0.60	> 0.20	NYNRIN (3.9)	CELSR2 (2.7)	BCAM (2.2)	NCAN (2.1)	HAVCR1 (2.0)	TMED4 (1.9)	ALDH2 (1.9)	PLEC (1.8)	CYB561D1 (1.7)	BLOC1S3 (1.7)
GO:0016307	phosphatidylinositol phosphate kinase activity	0.60	> 0.20	BLOC1S3 (3.4)	GATAD2A (3.2)	C12orf43 (2.8)	PPP1R37 (2.5)	PLCG1 (2.4)	LPAR2 (2.3)	HAPLN4 (2.0)	C11orf9 (2.0)	CETP (1.7)	C12orf51 (1.6)
GO:0005881	cytoplasmic microtubule	0.60	> 0.20	POLK (3.1)	C12orf51 (2.3)	PSRC1 (2.3)	PTPN11 (2.2)	RHCE (2.0)	RHD (1.9)	NCAN (1.9)	POC5 (1.8)	PLEKHH2 (1.6)	PLEC (1.6)
GO:0014003	oligodendrocyte development	0.60	> 0.20	NCAN (2.8)	C11orf9 (2.4)	CEACAM19 (2.4)	HAPLN4 (2.1)	GEMIN7 (1.9)	TMEM57 (1.8)	C12orf43 (1.8)	ALDH2 (1.7)	DYNC2LI1 (1.7)	SORT1 (1.7)
MP:0000729	abnormal myogenesis	0.60	> 0.20	PVR (3.0)	PLEC (2.5)	LPIN3 (1.9)	CARM1 (1.6)	SYPL2 (1.6)	KANK2 (1.5)	ZHX3 (1.4)	TMED4 (1.4)	USP24 (1.3)	ATXN2 (1.3)
GO:2000736	regulation of stem cell differentiation	0.60	> 0.20	ENSG00000254235 (2.8)	ENSG00000238078 (2.6)	CELSR2 (2.3)	DNAH11 (2.1)	NYNRIN (1.7)	C17orf57 (1.6)	CARM1 (1.5)	ITGB3 (1.5)	USP24 (1.3)	RHD (1.3)
ENSG00000085511	MAP3K4 PPI subnetwork	0.60	> 0.20	C12orf51 (2.6)	ENSG00000238078 (2.0)	BUD13 (2.0)	ILF3 (1.8)	SORT1 (1.8)	USP24 (1.7)	ENSG00000226648 (1.6)	ABO (1.6)	MAPKAPK5 (1.5)	PSRC1 (1.4)
GO:0005859	muscle myosin complex	0.60	> 0.20	SYPL2 (5.5)	GMPR (3.0)	C12orf47 (1.2)	KANK2 (1.2)	LPAR2 (1.0)	TMEM50A (0.8)	RHCE (0.8)	NPC1L1 (0.8)	TMEM116 (0.8)	HMGCR (0.7)
MP:0004110	transposition of great arteries	0.60	> 0.20	NYNRIN (2.9)	HAPLN4 (2.2)	DNAH11 (2.1)	PVRL2 (1.8)	KANK2 (1.8)	BCAM (1.7)	COL4A3BP (1.7)	DOCK7 (1.7)	CEACAM19 (1.6)	MARK4 (1.5)
ENSG00000104872	PIH1D1 PPI subnetwork	0.60	> 0.20	TXNL4B (3.7)	BRAP (3.1)	C1orf63 (2.3)	DYNC2LI1 (2.1)	SLC22A1 (2.0)	APOC4 (2.0)	TOP1 (1.9)	ATXN2 (1.7)	MAPKAPK5 (1.7)	UBXN2B (1.6)
ENSG00000120899	PTK2B PPI subnetwork	0.60	> 0.20	PLEC (3.1)	SH2B3 (2.7)	PLCG1 (2.5)	ITGB3 (2.2)	RPH3A (2.2)	SORT1 (2.0)	MARK4 (1.9)	HAPLN4 (1.8)	C11orf9 (1.8)	PLEKHH2 (1.8)
REACTOME_AMINE:DERIVED_HORMONES	REACTOME_AMINE:DERIVED_HORMONES	0.60	> 0.20	KIAA1324 (3.7)	GOT2P1 (2.6)	PBX4 (2.4)	PMFBP1 (1.7)	ABO (1.6)	TM6SF2 (1.5)	DNAH11 (1.5)	C17orf57 (1.5)	TSSK6 (1.4)	ABCG5 (1.4)
ENSG00000131982	ENSG00000131982 PPI subnetwork	0.60	> 0.20	ZHX3 (2.6)	OGDH (2.3)	BRAP (1.8)	ACAD10 (1.7)	USP24 (1.6)	CETP (1.6)	MAU2 (1.6)	POLK (1.6)	C19orf52 (1.5)	BUD13 (1.5)
GO:0000795	synaptonemal complex	0.60	> 0.20	ANKRD31 (3.0)	TMEM116 (1.9)	FEN1 (1.7)	HAPLN4 (1.6)	USP1 (1.6)	C11orf9 (1.5)	PLEKHH2 (1.4)	ITGB3 (1.3)	C17orf57 (1.2)	PCSK9 (1.2)
ENSG00000196535	MYO18A PPI subnetwork	0.60	> 0.20	CARM1 (3.6)	ATXN2 (3.1)	ILF3 (3.1)	ENSG00000235545 (2.9)	DOCK7 (2.8)	DNM2 (2.7)	BCAM (2.5)	TOMM40 (2.3)	PVRL2 (2.3)	KANK2 (2.0)
ENSG00000115806	GORASP2 PPI subnetwork	0.60	> 0.20	COL4A3BP (2.5)	CYB561D1 (2.4)	TMEM50A (2.2)	PMFBP1 (1.9)	ANKRD31 (1.9)	POC5 (1.9)	TMED4 (1.8)	ST3GAL4 (1.8)	C12orf47 (1.7)	UBXN2B (1.7)
GO:0043039	tRNA aminoacylation	0.60	> 0.20	SARS (5.3)	NAA25 (2.9)	ZNF259 (2.8)	DHODH (2.8)	QTRT1 (2.7)	DDX56 (2.5)	MAPKAPK5 (2.4)	C12orf43 (2.2)	POC5 (2.2)	NT5DC1 (2.0)
GO:0043038	amino acid activation	0.60	> 0.20	SARS (5.3)	NAA25 (2.9)	ZNF259 (2.8)	DHODH (2.8)	QTRT1 (2.7)	DDX56 (2.5)	MAPKAPK5 (2.4)	C12orf43 (2.2)	POC5 (2.2)	NT5DC1 (2.0)
GO:0035196	production of miRNAs involved in gene silencing by miRNA	0.60	> 0.20	ENSG00000226648 (3.3)	MAPKAPK5 (3.0)	ADAM1 (2.4)	GOT2P1 (2.4)	DOCK7 (2.3)	USP24 (2.2)	C12orf43 (1.7)	ENSG00000228044 (1.5)	C17orf57 (1.3)	UBXN2B (1.3)
ENSG00000009335	UBE3C PPI subnetwork	0.60	> 0.20	ATP13A1 (3.2)	OGDH (2.0)	DNM2 (1.9)	PSMA5 (1.7)	ILF3 (1.6)	SARS (1.6)	ENSG00000235545 (1.4)	ATXN2 (1.4)	C19orf52 (1.4)	NAA25 (1.3)
ENSG00000145592	RPL37 PPI subnetwork	0.60	> 0.20	NKPD1 (2.5)	ANKRD31 (1.8)	CEACAM19 (1.7)	DOCK7 (1.6)	PTPN11 (1.4)	ZNF101 (1.4)	CBLC (1.3)	UBXN2B (1.3)	ENSG00000226645 (1.2)	DNAH11 (1.2)
ENSG00000135631	RAB11FIP5 PPI subnetwork	0.60	> 0.20	AP1M2 (3.8)	CBLC (2.8)	C19orf52 (2.5)	MAU2 (2.1)	COL4A3BP (2.1)	ENSG00000226645 (2.1)	ENSG00000228044 (1.8)	MARK4 (1.5)	SLC44A2 (1.5)	C17orf57 (1.2)
MP:0009858	abnormal cellular extravasation	0.60	> 0.20	HLX (2.3)	PVR (2.2)	TRIB1 (2.1)	GMIP (2.1)	SLC44A2 (2.1)	CEACAM19 (1.9)	BCL3 (1.7)	ST3GAL4 (1.7)	TMEM116 (1.7)	ZNF180 (1.7)
GO:0002011	morphogenesis of an epithelial sheet	0.60	> 0.20	ATXN7L2 (3.5)	C19orf52 (2.8)	ENSG00000254235 (2.2)	TMED4 (2.1)	ENSG00000238078 (1.7)	CEACAM19 (1.6)	LPAR2 (1.6)	TMEM116 (1.6)	FRK (1.5)	DOCK7 (1.4)
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	0.60	> 0.20	RHD (4.2)	RHCE (2.9)	ST3GAL4 (2.4)	GMPR (2.3)	ABO (2.2)	SORT1 (2.1)	NCAN (1.9)	ZHX3 (1.9)	C12orf51 (1.8)	CILP2 (1.8)
ENSG00000167136	ENDOG PPI subnetwork	0.60	> 0.20	GMPR (3.4)	TMEM57 (2.3)	C19orf52 (2.2)	MYLIP (1.4)	TSSK6 (1.2)	PMFBP1 (1.1)	SUGP1 (1.1)	FADS1 (1.0)	ANGPTL3 (1.0)	KIAA1324 (0.9)
MP:0005164	abnormal response to injury	0.60	> 0.20	TRIB1 (3.5)	PVR (2.2)	HP (2.2)	OASL (2.0)	PLEKHH2 (1.8)	MAFB (1.6)	HLX (1.6)	BCL3 (1.6)	MYLIP (1.4)	ALDH2 (1.2)
ENSG00000118971	CCND2 PPI subnetwork	0.60	> 0.20	TMED4 (2.6)	KANK2 (2.5)	PLCG1 (2.3)	MAU2 (2.0)	PVR (1.9)	ZNF101 (1.8)	TRIB1 (1.8)	SORT1 (1.4)	CETP (1.3)	POLK (1.3)
ENSG00000173482	PTPRM PPI subnetwork	0.60	> 0.20	HAVCR1 (2.6)	TMEM116 (1.9)	AP1M2 (1.8)	BCAM (1.8)	ENSG00000226645 (1.7)	DOCK7 (1.6)	LDLR (1.5)	ANKRD31 (1.3)	ABCG8 (1.3)	PVRL2 (1.3)
MP:0001155	arrest of spermatogenesis	0.60	> 0.20	PBX4 (2.7)	ANKRD31 (2.7)	FADS2 (2.1)	GATAD2A (1.9)	ITGB3 (1.9)	TSSK6 (1.8)	HAVCR1 (1.8)	CELSR2 (1.7)	KIAA1324 (1.4)	PLEKHH2 (1.3)
ENSG00000170876	TMEM43 PPI subnetwork	0.60	> 0.20	HMGCR (4.0)	LDLR (3.2)	LPAR2 (2.0)	FRK (1.8)	PCSK9 (1.8)	BCAM (1.6)	MOSC1 (1.4)	FADS2 (1.4)	PLCG1 (1.4)	ENSG00000226648 (1.3)
ENSG00000163017	ACTG2 PPI subnetwork	0.60	> 0.20	SMARCA4 (3.2)	PLEC (3.0)	ADAM1 (2.9)	PTPN11 (2.7)	C1orf63 (2.7)	ILF3 (2.5)	TOP1 (2.5)	KANK2 (2.4)	QTRT1 (2.4)	TMEM50A (2.4)
ENSG00000077264	PAK3 PPI subnetwork	0.60	> 0.20	TRAFD1 (2.8)	SH2B3 (2.7)	BRAP (2.5)	GATAD2A (2.3)	PPP1R37 (2.0)	C12orf43 (2.0)	TMEM50A (1.9)	NCAN (1.9)	COL4A3BP (1.7)	ANKRD31 (1.7)
ENSG00000120129	DUSP1 PPI subnetwork	0.60	> 0.20	MAPKAPK5 (2.4)	GCNT4 (2.3)	AMIGO1 (2.1)	TMEM57 (2.0)	CARM1 (1.9)	ENSG00000226645 (1.9)	HLX (1.8)	MARK4 (1.7)	ALDH2 (1.7)	PLCG1 (1.7)
ENSG00000159166	LAD1 PPI subnetwork	0.60	> 0.20	CBLC (5.6)	AP1M2 (3.8)	CELSR2 (2.3)	ST3GAL4 (2.1)	LPAR2 (1.9)	LPIN3 (1.8)	PSRC1 (1.7)	MARK4 (1.6)	C12orf51 (1.6)	PLEC (1.6)
ENSG00000134215	VAV3 PPI subnetwork	0.60	> 0.20	GATAD2A (2.8)	SH2B3 (2.5)	DNM2 (2.3)	ZHX3 (2.3)	KANK2 (2.2)	PLEC (2.1)	BRAP (2.1)	DOCK7 (2.0)	PPP1R37 (2.0)	HLX (1.9)
MP:0003408	increased width of hypertrophic chondrocyte zone	0.60	> 0.20	CILP2 (6.1)	MAFB (2.4)	TMEM116 (2.2)	PLEKHH2 (2.2)	APOE (2.0)	PPP1R37 (1.9)	GOT2P1 (1.8)	BCAM (1.6)	YIPF2 (1.4)	ITGB3 (1.2)
REACTOME_CELL_CYCLE_MITOTIC	REACTOME_CELL_CYCLE_MITOTIC	0.60	> 0.20	FEN1 (5.5)	PSRC1 (4.3)	USP1 (4.2)	POC5 (3.1)	PSMA5 (1.6)	BUD13 (1.0)	RHD (1.0)	SMARCA4 (1.0)	ZNF180 (1.0)	ENSG00000226648 (0.9)
ENSG00000085117	CD82 PPI subnetwork	0.60	> 0.20	ADAM1 (3.4)	PVRL2 (3.4)	DOCK7 (3.3)	PVR (3.1)	TIMD4 (3.0)	BCAM (2.8)	SLC44A2 (2.8)	ALDH2 (2.7)	TMED4 (2.6)	ERP29 (2.3)
GO:0030667	secretory granule membrane	0.60	> 0.20	ITGB3 (3.9)	KIAA1324 (2.9)	TMED4 (2.5)	GMPR (2.4)	SORT1 (1.9)	MOSC1 (1.8)	ABO (1.7)	ADAM1 (1.7)	ST3GAL4 (1.6)	ENSG00000228044 (1.4)
GO:0048841	regulation of axon extension involved in axon guidance	0.60	> 0.20	NKPD1 (1.9)	GCNT4 (1.9)	PLEKHH2 (1.9)	CETP (1.8)	TMED4 (1.8)	NYNRIN (1.6)	LPAR2 (1.6)	C17orf57 (1.5)	C1orf63 (1.5)	ATXN7L2 (1.4)
ENSG00000013375	PGM3 PPI subnetwork	0.60	> 0.20	C19orf52 (3.0)	FRK (2.1)	ZNF259 (2.0)	SYPL2 (1.8)	BLOC1S3 (1.5)	ST3GAL4 (1.4)	LDLR (1.4)	GPAM (1.4)	HP (1.4)	C11orf9 (1.3)
GO:0006282	regulation of DNA repair	0.60	> 0.20	ENSG00000226645 (2.4)	BLOC1S3 (2.3)	BUD13 (2.2)	HAVCR1 (2.1)	GCNT4 (2.0)	C19orf52 (1.9)	NT5DC1 (1.8)	ENSG00000226648 (1.7)	TXNL4B (1.7)	TRAPPC6A (1.6)
ENSG00000162704	ARPC5 PPI subnetwork	0.60	> 0.20	PLEC (3.7)	KANK2 (2.7)	OGDH (2.3)	ITGB3 (1.8)	SH2B3 (1.5)	TMEM50A (1.5)	TXNL4B (1.5)	ADAM1 (1.4)	GCNT4 (1.4)	FRK (1.4)
ENSG00000155506	LARP1 PPI subnetwork	0.60	> 0.20	PLEC (3.2)	DNM2 (3.2)	ZHX3 (3.0)	PTPN11 (3.0)	CARM1 (2.5)	LPAR2 (2.5)	C11orf9 (2.3)	GPAM (2.2)	KANK2 (2.2)	COL4A3BP (2.1)
REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	0.60	> 0.20	SYPL2 (3.0)	RPH3A (2.4)	ENSG00000226645 (2.0)	BRAP (1.9)	CYB561D1 (1.8)	HAVCR1 (1.8)	SORT1 (1.8)	ERP29 (1.7)	PLEC (1.7)	HNF1A (1.6)
ENSG00000061337	LZTS1 PPI subnetwork	0.60	> 0.20	C12orf43 (4.1)	POC5 (3.4)	GEMIN7 (3.0)	SUGP1 (2.4)	DDX56 (2.4)	MAPKAPK5 (2.2)	ATXN2 (2.2)	C19orf52 (2.0)	ADAM1 (1.8)	TOMM40 (1.7)
GO:0001783	B cell apoptotic process	0.60	> 0.20	BLOC1S3 (2.9)	DNAH11 (2.8)	PPP1R37 (2.6)	GEMIN7 (2.6)	ENSG00000226648 (1.8)	CYB561D1 (1.5)	GCNT4 (1.5)	FRK (1.4)	TOP1 (1.3)	LPAR2 (1.3)
GO:0045936	negative regulation of phosphate metabolic process	0.60	> 0.20	DNAH11 (2.6)	PPP1R37 (2.4)	GCNT4 (2.2)	ADAM1 (2.1)	MYLIP (2.0)	ENSG00000238078 (2.0)	ABO (1.9)	TRIB1 (1.9)	ENSG00000226645 (1.9)	C19orf52 (1.8)
GO:0010563	negative regulation of phosphorus metabolic process	0.60	> 0.20	DNAH11 (2.6)	PPP1R37 (2.4)	GCNT4 (2.2)	ADAM1 (2.1)	MYLIP (2.0)	ENSG00000238078 (2.0)	ABO (1.9)	TRIB1 (1.9)	ENSG00000226645 (1.9)	C19orf52 (1.8)
MP:0002427	disproportionate dwarf	0.60	> 0.20	CILP2 (8.8)	PLEKHH2 (2.4)	UBXN2B (1.6)	PLCG1 (1.6)	HNF1A (1.6)	MAFB (1.5)	NPC1L1 (1.5)	ATP13A1 (1.3)	PPP1R37 (1.3)	BCAM (1.1)
ENSG00000173991	TCAP PPI subnetwork	0.60	> 0.20	SYPL2 (9.5)	GMPR (2.8)	PVR (1.5)	POLK (1.2)	HNF1A (1.2)	LPIN3 (1.2)	RPH3A (1.1)	ZHX3 (1.1)	NCAN (1.1)	TMEM50A (1.0)
MP:0004763	absent brainstem auditory evoked potential	0.60	> 0.20	HNF1A (3.4)	AP1M2 (2.7)	CBLC (2.3)	BCAM (2.3)	NT5DC1 (1.9)	KIAA1324 (1.8)	ABO (1.7)	TMEM116 (1.6)	NPC1L1 (1.5)	TM6SF2 (1.4)
GO:0032897	negative regulation of viral transcription	0.60	> 0.20	ENSG00000235545 (3.2)	ENSG00000226645 (2.6)	ENSG00000238078 (2.5)	ADAM1 (2.4)	OASL (2.0)	C1orf63 (1.7)	BUD13 (1.6)	ZNF101 (1.6)	ZNF180 (1.4)	CEACAM19 (1.4)
GO:0043425	bHLH transcription factor binding	0.60	> 0.20	KANK2 (2.4)	ATXN7L2 (2.2)	GEMIN7 (1.8)	MOSC1 (1.7)	TRAFD1 (1.7)	MAFB (1.6)	PPP1R37 (1.5)	C12orf47 (1.4)	MYLIP (1.3)	ILF3 (1.3)
REACTOME_HIV_INFECTION	REACTOME_HIV_INFECTION	0.60	> 0.20	PSMA5 (5.2)	DDX56 (2.6)	SMARCA4 (2.4)	SUGP1 (2.3)	DHX38 (2.2)	NAA25 (2.1)	POC5 (2.0)	TOMM40 (1.9)	BUD13 (1.9)	PTPN11 (1.7)
MP:0004509	abnormal pelvic girdle bone morphology	0.60	> 0.20	CILP2 (7.7)	PLEKHH2 (2.5)	MOSC1 (2.1)	GOT2P1 (2.1)	BCAM (2.1)	NYNRIN (2.0)	CARM1 (1.8)	HAVCR1 (1.5)	KANK2 (1.3)	NPC1L1 (1.2)
REACTOME_REGULATION_OF_KIT_SIGNALING	REACTOME_REGULATION_OF_KIT_SIGNALING	0.60	> 0.20	GMIP (3.3)	GATAD2A (2.3)	MAFB (2.3)	LPAR2 (1.9)	MARK4 (1.8)	PLEKHH2 (1.5)	ENSG00000238078 (1.5)	ABCG8 (1.4)	TRIB1 (1.3)	DNM2 (1.2)
ENSG00000137947	GTF2B PPI subnetwork	0.60	> 0.20	OASL (2.9)	GEMIN7 (2.8)	PSMA5 (2.7)	BUD13 (2.5)	TXNL4B (2.2)	DHX38 (2.2)	SUGP1 (2.2)	TOMM40 (2.0)	TOP1 (1.8)	DDX56 (1.8)
ENSG00000186111	PIP5K1C PPI subnetwork	0.60	> 0.20	PLEC (3.1)	PVRL2 (2.9)	OGDH (2.9)	GATAD2A (2.0)	ITGB3 (1.8)	CARM1 (1.7)	DNM2 (1.6)	ATXN2 (1.6)	HAVCR1 (1.5)	KANK2 (1.5)
ENSG00000175203	DCTN2 PPI subnetwork	0.60	> 0.20	SMARCA4 (2.6)	SARS (2.2)	PTPN11 (2.2)	TMEM50A (1.9)	TXNL4B (1.8)	ZNF259 (1.8)	TMEM57 (1.7)	MAU2 (1.7)	PVR (1.6)	PBX4 (1.6)
GO:0016758	transferase activity, transferring hexosyl groups	0.60	> 0.20	ERP29 (3.4)	TMED4 (3.0)	ATP13A1 (2.8)	YIPF2 (2.7)	ST3GAL4 (2.6)	SLC44A2 (2.5)	TMEM50A (2.3)	TMEM57 (2.0)	CLPTM1 (1.8)	SORT1 (1.7)
MP:0001153	small seminiferous tubules	0.60	> 0.20	MARK4 (2.4)	PPP1R37 (2.0)	ANKRD31 (1.9)	PBX4 (1.9)	KIAA1324 (1.8)	GATAD2A (1.8)	ST3GAL4 (1.6)	SH2B3 (1.4)	OASL (1.3)	NT5DC1 (1.3)
ENSG00000181019	NQO1 PPI subnetwork	0.60	> 0.20	TRIB1 (2.7)	PSRC1 (2.7)	TXNL4B (2.6)	CELSR2 (2.3)	MYLIP (2.3)	AP1M2 (2.2)	C1orf63 (1.8)	SLC44A2 (1.6)	BLOC1S3 (1.6)	PLEC (1.6)
MP:0001762	polyuria	0.60	> 0.20	AP1M2 (2.6)	TMEM116 (2.5)	ST3GAL4 (2.2)	CBLC (2.1)	PLG (2.0)	BCAM (2.0)	ERP29 (1.7)	HAVCR1 (1.6)	ZHX3 (1.5)	SORT1 (1.4)
ENSG00000105204	DYRK1B PPI subnetwork	0.60	> 0.20	FADS2 (2.3)	MYLIP (2.2)	DNAH11 (2.0)	TMEM57 (2.0)	CETP (1.9)	USP24 (1.8)	GRINA (1.8)	NCAN (1.7)	SH2B3 (1.6)	TMED4 (1.6)
MP:0004799	increased susceptibility to experimental autoimmune encephalomyelitis	0.60	> 0.20	TRAFD1 (3.3)	OASL (2.2)	BCL3 (1.8)	PARP10 (1.8)	PBX4 (1.8)	APOE (1.7)	COL4A3BP (1.4)	CYP7A1 (1.3)	RELB (1.2)	C11orf9 (1.2)
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	0.61	> 0.20	CLPTM1 (4.0)	PPP1R37 (3.7)	GRINA (2.8)	GEMIN7 (2.0)	SARS (1.9)	BLOC1S3 (1.8)	AP1M2 (1.7)	COL4A3BP (1.7)	C12orf51 (1.6)	YIPF2 (1.6)
MP:0008687	increased interleukin-2 secretion	0.61	> 0.20	TRAFD1 (3.1)	RELB (2.8)	BCL3 (2.7)	GMIP (2.1)	OGDH (2.1)	TIMD4 (1.8)	LPAR2 (1.7)	APOE (1.6)	ST3GAL4 (1.4)	CYB561D1 (1.4)
ENSG00000143851	PTPN7 PPI subnetwork	0.61	> 0.20	AMIGO1 (2.5)	CBLC (2.1)	GATAD2A (2.1)	PBX4 (2.1)	MARK4 (2.1)	PLCG1 (1.9)	PMFBP1 (1.9)	MAPKAPK5 (1.6)	LPAR2 (1.5)	CARM1 (1.5)
GO:0000076	DNA replication checkpoint	0.61	> 0.20	ZNF180 (3.8)	TXNL4B (2.4)	TMEM116 (2.4)	USP1 (2.0)	ENSG00000228044 (2.0)	DNAH11 (1.9)	LPAR2 (1.8)	FEN1 (1.8)	LPIN3 (1.6)	C12orf47 (1.5)
ENSG00000136944	LMX1B PPI subnetwork	0.61	> 0.20	ATXN7L2 (3.4)	C19orf52 (3.1)	C12orf43 (2.5)	DYNC2LI1 (2.5)	DNM2 (2.1)	C1orf63 (2.1)	TXNL4B (2.0)	TOP1 (1.9)	DNAH11 (1.9)	SMARCA4 (1.5)
ENSG00000109133	TMEM33 PPI subnetwork	0.61	> 0.20	YIPF2 (2.5)	NYNRIN (2.2)	DHODH (2.1)	TMEM50A (2.0)	CYB561D1 (2.0)	PSMA5 (1.9)	TXNL4B (1.7)	C11orf9 (1.7)	HNF1A (1.7)	TOP1 (1.6)
ENSG00000132383	RPA1 PPI subnetwork	0.61	> 0.20	FEN1 (5.8)	USP1 (4.2)	ZNF180 (1.8)	TMEM116 (1.5)	DHODH (1.5)	POLK (1.4)	NT5DC1 (1.3)	ENSG00000235545 (1.3)	POC5 (1.3)	ILF3 (1.3)
MP:0004227	increased cellular sensitivity to ionizing radiation	0.61	> 0.20	UBXN2B (2.9)	SMARCA4 (2.6)	ZNF101 (2.5)	ENSG00000254235 (2.5)	NYNRIN (2.4)	DOCK7 (2.2)	ZNF259 (1.7)	ANKRD31 (1.6)	GMIP (1.4)	ILF3 (1.4)
ENSG00000082175	PGR PPI subnetwork	0.61	> 0.20	ZHX3 (3.8)	TOP1 (3.4)	ATXN2 (3.0)	PLCG1 (2.9)	MAPKAPK5 (2.4)	PTPN11 (2.2)	BRAP (2.1)	CELSR2 (1.8)	PSRC1 (1.6)	BUD13 (1.5)
GO:0015931	nucleobase-containing compound transport	0.61	> 0.20	C1orf63 (3.3)	ADAM1 (2.8)	MAPKAPK5 (2.6)	NAA25 (2.5)	ILF3 (2.5)	TOP1 (2.2)	DHODH (2.1)	USP24 (2.0)	POC5 (2.0)	DDX56 (1.9)
MP:0000559	abnormal femur morphology	0.61	> 0.20	CILP2 (6.3)	NYNRIN (1.8)	PLEKHH2 (1.7)	MAFB (1.7)	BCAM (1.6)	KIAA1324 (1.5)	AP1M2 (1.4)	CBLC (1.3)	BCL3 (1.3)	TMEM116 (1.2)
ENSG00000104325	DECR1 PPI subnetwork	0.61	> 0.20	SYPL2 (4.1)	OGDH (3.2)	GMPR (2.9)	C1orf63 (2.7)	TMEM50A (2.6)	ACAD10 (2.5)	ENSG00000238078 (1.5)	BCAM (1.4)	PSMA5 (1.4)	ADAM1 (1.3)
GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	0.61	> 0.20	DYNC2LI1 (2.0)	PBX4 (1.9)	FRK (1.9)	HAVCR1 (1.8)	NT5DC1 (1.6)	POLK (1.5)	ZNF101 (1.5)	POC5 (1.4)	GOT2P1 (1.4)	ZNF180 (1.1)
ENSG00000150760	DOCK1 PPI subnetwork	0.61	> 0.20	GATAD2A (2.9)	MARK4 (2.8)	LPAR2 (2.5)	SH2B3 (2.4)	ENSG00000226645 (1.9)	SLC44A2 (1.8)	ITGB3 (1.6)	MAFB (1.6)	C17orf57 (1.6)	DNM2 (1.6)
GO:0006312	mitotic recombination	0.61	> 0.20	ZNF180 (3.3)	ENSG00000235545 (2.9)	USP1 (2.8)	ENSG00000228044 (2.5)	FEN1 (2.3)	ENSG00000226648 (2.1)	AMIGO1 (1.9)	TMEM116 (1.9)	POC5 (1.7)	POLK (1.6)
GO:0018108	peptidyl-tyrosine phosphorylation	0.61	> 0.20	TIMD4 (2.1)	C1orf63 (2.0)	MYLIP (1.7)	C17orf57 (1.7)	PLEKHH2 (1.7)	SH2B3 (1.6)	ADAM1 (1.5)	GPAM (1.4)	ANKRD31 (1.4)	ALDH2 (1.3)
ENSG00000196363	WDR5 PPI subnetwork	0.61	> 0.20	BUD13 (3.5)	MAPKAPK5 (2.8)	ATXN2 (2.5)	C19orf52 (2.2)	BRAP (2.0)	DOCK7 (1.9)	GATAD2A (1.8)	ATXN7L2 (1.7)	USP1 (1.7)	SMARCA4 (1.7)
GO:0043279	response to alkaloid	0.61	> 0.20	C12orf47 (2.9)	ADAM1 (2.4)	ANKRD31 (2.1)	ABO (1.6)	ZHX3 (1.4)	GOT2P1 (1.3)	ENSG00000228044 (1.0)	LPIN3 (1.0)	HNF1A (1.0)	CYP7A1 (1.0)
MP:0003666	impaired sperm capacitation	0.61	> 0.20	PMFBP1 (3.4)	TSSK6 (3.1)	CYP7A1 (2.4)	PPP1R37 (2.1)	CLPTM1 (2.0)	BCAM (2.0)	ZNF180 (1.9)	PVR (1.7)	ENSG00000238078 (1.6)	TMEM57 (1.5)
ENSG00000166484	MAPK7 PPI subnetwork	0.61	> 0.20	GATAD2A (2.9)	COL4A3BP (2.5)	TRIB1 (2.4)	C1orf63 (2.3)	DHODH (2.0)	ATXN2 (1.9)	MYLIP (1.8)	DDX56 (1.5)	HMGCR (1.5)	MAFB (1.4)
ENSG00000167565	SERTAD3 PPI subnetwork	0.61	> 0.20	MAFB (3.0)	CILP2 (2.8)	TIMD4 (2.8)	APOE (2.2)	HAVCR1 (2.0)	DYNC2LI1 (1.6)	CETP (1.6)	TMEM116 (1.6)	MYLIP (1.6)	AMIGO1 (1.5)
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	0.61	> 0.20	FEN1 (6.5)	USP1 (4.9)	TMEM116 (2.3)	POC5 (1.8)	NT5DC1 (1.6)	ZNF180 (1.5)	PSRC1 (1.3)	ENSG00000226645 (1.2)	DHODH (1.1)	TXNL4B (1.0)
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS	0.61	> 0.20	ENSG00000235545 (3.2)	HP (2.4)	ST3GAL4 (2.3)	NCAN (2.0)	TSSK6 (1.8)	ENSG00000228044 (1.8)	PLG (1.7)	NYNRIN (1.6)	ADAM1 (1.6)	PLEC (1.5)
GO:0010828	positive regulation of glucose transport	0.61	> 0.20	NPC1L1 (4.1)	GPAM (3.2)	ABCG8 (2.8)	COL4A3BP (2.4)	ABCG5 (2.1)	C11orf9 (1.7)	SORT1 (1.7)	MOSC1 (1.6)	ENSG00000235545 (1.3)	PTPN11 (1.3)
ENSG00000204120	GIGYF2 PPI subnetwork	0.61	> 0.20	C19orf52 (2.9)	RHD (2.8)	TMEM50A (2.7)	ILF3 (2.5)	SMARCA4 (2.4)	RHCE (2.1)	ATP13A1 (2.1)	PBX4 (2.1)	C12orf43 (1.8)	QTRT1 (1.8)
GO:0030670	phagocytic vesicle membrane	0.61	> 0.20	UBXN2B (2.7)	LPAR2 (2.0)	ENSG00000254235 (1.7)	HAPLN4 (1.5)	HP (1.5)	SORT1 (1.4)	GMIP (1.4)	AP1M2 (1.4)	KIAA1324 (1.3)	TMED4 (1.2)
MP:0001940	testis hypoplasia	0.61	> 0.20	ENSG00000235545 (3.1)	GCNT4 (2.5)	BLOC1S3 (2.0)	NYNRIN (2.0)	MARK4 (1.7)	TMED4 (1.6)	OGDH (1.4)	DYNC2LI1 (1.4)	LPAR2 (1.3)	FRK (1.3)
ENSG00000168067	MAP4K2 PPI subnetwork	0.61	> 0.20	ABO (2.4)	OASL (1.8)	ZNF180 (1.7)	GMIP (1.7)	POLK (1.7)	ST3GAL4 (1.6)	LPAR2 (1.5)	ENSG00000226648 (1.4)	MAU2 (1.4)	ILF3 (1.3)
ENSG00000144597	EAF1 PPI subnetwork	0.61	> 0.20	GEMIN7 (2.7)	SUGP1 (2.7)	PPP1R37 (2.6)	ZNF180 (2.0)	TOMM40 (1.9)	PCSK9 (1.9)	TMEM57 (1.8)	MAPKAPK5 (1.8)	ATXN7L2 (1.7)	POC5 (1.7)
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR	0.61	> 0.20	FEN1 (4.8)	USP1 (3.7)	AMIGO1 (2.4)	POLK (2.3)	PSRC1 (2.2)	ENSG00000228044 (1.6)	BUD13 (1.6)	ENSG00000226648 (1.5)	ZNF180 (1.5)	ILF3 (1.2)
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION:INDEPENDENT_DOUBLE:STRAND_BREAKS	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION:INDEPENDENT_DOUBLE:STRAND_BREAKS	0.61	> 0.20	FEN1 (4.8)	USP1 (3.7)	AMIGO1 (2.4)	POLK (2.3)	PSRC1 (2.2)	ENSG00000228044 (1.6)	BUD13 (1.6)	ENSG00000226648 (1.5)	ZNF180 (1.5)	ILF3 (1.2)
GO:0042733	embryonic digit morphogenesis	0.61	> 0.20	DNAH11 (3.7)	DYNC2LI1 (2.8)	MYLIP (2.3)	ATXN7L2 (2.1)	ZHX3 (1.9)	KANK2 (1.8)	PLCG1 (1.7)	GCNT4 (1.4)	DOCK7 (1.4)	UBXN2B (1.3)
GO:0030048	actin filament-based movement	0.61	> 0.20	SYPL2 (6.1)	GMPR (2.4)	C17orf57 (2.3)	ANKRD31 (1.7)	HNF1A (1.5)	TMEM50A (1.5)	UBXN2B (1.5)	LPAR2 (1.3)	CEACAM19 (1.2)	CYB561D1 (1.2)
ENSG00000133059	DSTYK PPI subnetwork	0.61	> 0.20	PSMA5 (3.9)	GATAD2A (2.9)	CLPTM1 (2.7)	C17orf57 (2.5)	C19orf52 (2.2)	PPP1R37 (1.9)	DYNC2LI1 (1.8)	PTPN11 (1.6)	BLOC1S3 (1.5)	ATXN2 (1.3)
GO:0008354	germ cell migration	0.61	> 0.20	ZNF180 (3.1)	LPAR2 (3.0)	CYB561D1 (2.3)	BLOC1S3 (2.3)	TRAPPC6A (2.2)	GATAD2A (2.1)	HAVCR1 (1.9)	FRK (1.8)	UBXN2B (1.8)	FADS1 (1.6)
ENSG00000188153	COL4A5 PPI subnetwork	0.61	> 0.20	ATXN7L2 (2.3)	C17orf57 (2.2)	PTPN11 (2.2)	APOE (2.2)	ZHX3 (1.6)	BRAP (1.6)	C11orf9 (1.5)	ST3GAL4 (1.4)	TXNL4B (1.4)	FADS1 (1.2)
REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	0.61	> 0.20	PSMA5 (5.9)	TRAFD1 (3.6)	SUGP1 (2.4)	NAA25 (2.3)	DDX56 (1.9)	POC5 (1.8)	FEN1 (1.8)	PSRC1 (1.5)	LPIN3 (1.4)	PARP10 (1.3)
GO:0033005	positive regulation of mast cell activation	0.61	> 0.20	ENSG00000235545 (3.0)	GEMIN7 (2.7)	ST3GAL4 (2.1)	BLOC1S3 (2.0)	GMPR (1.9)	C12orf47 (1.6)	PMFBP1 (1.6)	DHODH (1.5)	ENSG00000226645 (1.4)	CILP2 (1.3)
MP:0003733	abnormal retinal inner nuclear layer morphology	0.61	> 0.20	APOC1 (3.5)	NCAN (3.3)	APOB (2.4)	HP (2.1)	ST3GAL4 (1.8)	APOE (1.8)	TIMD4 (1.8)	CETP (1.7)	GPAM (1.5)	ZHX3 (1.5)
ENSG00000100325	ASCC2 PPI subnetwork	0.61	> 0.20	SUGP1 (3.2)	SARS (3.1)	TMEM57 (2.7)	NT5DC1 (2.2)	SLC44A2 (2.0)	TRAFD1 (2.0)	C12orf43 (1.8)	DDX56 (1.8)	BUD13 (1.7)	POC5 (1.6)
GO:0031576	G2/M transition checkpoint	0.61	> 0.20	PSRC1 (3.1)	ENSG00000226648 (2.8)	HAVCR1 (2.4)	POLK (2.3)	ENSG00000235545 (2.2)	ZHX3 (2.1)	DYNC2LI1 (1.9)	TSSK6 (1.5)	UBXN2B (1.5)	C11orf9 (1.4)
GO:0021575	hindbrain morphogenesis	0.61	> 0.20	ENSG00000238078 (3.1)	TMEM116 (2.8)	HAPLN4 (2.6)	C17orf57 (2.1)	ENSG00000226648 (2.1)	ENSG00000235545 (2.0)	NCAN (1.6)	ERP29 (1.6)	ZHX3 (1.4)	USP24 (1.4)
ENSG00000166337	TAF10 PPI subnetwork	0.61	> 0.20	MAPKAPK5 (3.4)	TXNL4B (2.9)	ATXN2 (2.7)	SUGP1 (2.6)	PSMA5 (2.3)	BUD13 (2.1)	GEMIN7 (2.0)	ATXN7L2 (2.0)	COL4A3BP (1.9)	DYNC2LI1 (1.9)
ENSG00000152689	RASGRP3 PPI subnetwork	0.61	> 0.20	GEMIN7 (2.6)	SLC44A2 (2.3)	PVRL2 (2.2)	MAPKAPK5 (2.2)	ABO (2.1)	MARK4 (1.9)	C11orf9 (1.9)	GATAD2A (1.7)	LDLR (1.6)	RELB (1.4)
ENSG00000093009	CDC45 PPI subnetwork	0.61	> 0.20	FEN1 (6.1)	USP1 (5.3)	DHODH (1.6)	PSRC1 (1.4)	ENSG00000235545 (1.4)	TMEM116 (1.3)	TXNL4B (1.2)	KANK2 (1.1)	ENSG00000228044 (1.1)	FADS1 (1.0)
ENSG00000172660	TAF15 PPI subnetwork	0.61	> 0.20	C1orf63 (3.5)	ILF3 (3.3)	DHX38 (2.7)	QTRT1 (2.6)	TOP1 (2.6)	BUD13 (2.6)	SMARCA4 (2.6)	SUGP1 (2.5)	PLCG1 (1.8)	PSMA5 (1.7)
MP:0009304	increased retroperitoneal fat pad weight	0.61	> 0.20	CETP (3.4)	DYNC2LI1 (2.4)	PLEKHH2 (2.3)	KIAA1324 (2.2)	FRK (2.2)	C12orf47 (2.0)	TSSK6 (1.9)	ENSG00000254235 (1.9)	C12orf51 (1.7)	LPA (1.6)
MP:0004532	abnormal inner hair cell stereociliary bundle morphology	0.61	> 0.20	HNF1A (3.9)	CYP7A1 (2.2)	C11orf9 (2.1)	TM6SF2 (2.0)	LPAR2 (2.0)	PTPN11 (1.9)	ENSG00000226645 (1.8)	NPC1L1 (1.6)	PMFBP1 (1.5)	PBX4 (1.5)
GO:0051233	spindle midzone	0.61	> 0.20	PSRC1 (3.1)	CETP (2.4)	FEN1 (1.8)	HNF1A (1.8)	TMEM50A (1.7)	GRINA (1.6)	C1orf63 (1.3)	GATAD2A (1.3)	C11orf9 (1.2)	HAPLN4 (1.2)
ENSG00000105135	ILVBL PPI subnetwork	0.61	> 0.20	ATP13A1 (2.9)	SARS (2.6)	OGDH (2.6)	SMARCA4 (2.4)	FEN1 (2.3)	ILF3 (2.3)	NAA25 (2.1)	PSMA5 (2.0)	ATXN2 (1.9)	USP24 (1.9)
ENSG00000114107	CEP70 PPI subnetwork	0.61	> 0.20	ZNF180 (2.9)	ENSG00000238078 (2.2)	BRAP (1.9)	USP1 (1.8)	FRK (1.7)	BUD13 (1.7)	TMEM116 (1.5)	ENSG00000226648 (1.4)	SLC44A2 (1.3)	POC5 (1.3)
GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	0.61	> 0.20	ENSG00000238078 (3.0)	TMED4 (2.1)	TRAPPC6A (1.7)	HNF1A (1.6)	ALDH2 (1.5)	ADAM1 (1.5)	ITGB3 (1.4)	CEACAM19 (1.2)	TRIB1 (1.2)	LDLR (1.2)
GO:0046329	negative regulation of JNK cascade	0.61	> 0.20	UBXN2B (2.6)	ATXN2 (2.2)	FRK (2.0)	LPIN3 (1.9)	CILP2 (1.9)	DOCK7 (1.8)	PTPN11 (1.6)	ATXN7L2 (1.6)	CYB561D1 (1.5)	ENSG00000238078 (1.5)
ENSG00000198356	ASNA1 PPI subnetwork	0.61	> 0.20	SARS (3.5)	YIPF2 (3.1)	SLC44A2 (2.5)	DNM2 (2.3)	ATP13A1 (2.1)	ATXN7L2 (2.0)	SUGP1 (1.8)	LPAR2 (1.8)	CYB561D1 (1.7)	PVRL2 (1.7)
ENSG00000166710	B2M PPI subnetwork	0.61	> 0.20	PLCG1 (2.9)	ZNF101 (2.7)	CLPTM1 (2.1)	PARP10 (1.7)	YIPF2 (1.7)	GOT2P1 (1.3)	GATAD2A (1.3)	TMED4 (1.3)	RHD (1.2)	ATP13A1 (1.2)
MP:0004734	small thoracic cavity	0.61	> 0.20	CILP2 (4.6)	C11orf9 (2.7)	BCAM (2.0)	ALDH2 (1.8)	CBLC (1.7)	DOCK7 (1.6)	ABCG8 (1.6)	TRAFD1 (1.5)	ENSG00000226645 (1.3)	PCSK9 (1.3)
GO:0019894	kinesin binding	0.61	> 0.20	C1orf63 (2.2)	PBX4 (2.0)	TXNL4B (2.0)	C11orf9 (2.0)	CELSR2 (1.9)	TMEM57 (1.6)	HMGCR (1.5)	PLEKHH2 (1.5)	CETP (1.4)	GMPR (1.3)
GO:0050482	arachidonic acid secretion	0.61	> 0.20	NKPD1 (3.5)	CYB561D1 (2.7)	DNAH11 (2.6)	TMEM116 (2.3)	ABO (2.2)	ENSG00000235545 (2.1)	ZNF180 (2.0)	GCNT4 (1.9)	ADAM1 (1.6)	LPIN3 (1.6)
GO:0048002	antigen processing and presentation of peptide antigen	0.61	> 0.20	PSMA5 (3.1)	TRAFD1 (2.7)	PARP10 (2.3)	NT5DC1 (2.0)	TMED4 (1.8)	NAA25 (1.5)	CYB561D1 (1.5)	ENSG00000254235 (1.5)	ABCG8 (1.4)	C19orf52 (1.3)
ENSG00000172893	DHCR7 PPI subnetwork	0.61	> 0.20	FADS2 (6.7)	HMGCR (2.8)	ITGB3 (2.5)	LDLR (2.4)	ATXN2 (2.4)	KANK2 (2.0)	PCSK9 (1.9)	ST3GAL4 (1.7)	DOCK7 (1.6)	ABCG8 (1.4)
ENSG00000175390	EIF3F PPI subnetwork	0.61	> 0.20	NKPD1 (2.6)	QTRT1 (2.3)	DDX56 (2.0)	ZNF259 (2.0)	SARS (2.0)	MAU2 (1.9)	DHX38 (1.9)	C12orf43 (1.9)	ILF3 (1.8)	SUGP1 (1.7)
GO:0006110	regulation of glycolysis	0.61	> 0.20	HNF1A (2.9)	ENSG00000254235 (2.3)	PMFBP1 (1.9)	ZHX3 (1.7)	PCSK9 (1.6)	ST3GAL4 (1.5)	TSSK6 (1.4)	KANK2 (1.4)	PPP1R37 (1.3)	HAPLN4 (1.3)
ENSG00000186834	HEXIM1 PPI subnetwork	0.61	> 0.20	C1orf63 (2.0)	SH2B3 (1.9)	CYB561D1 (1.8)	ADAM1 (1.8)	C19orf52 (1.7)	ENSG00000228044 (1.7)	GRINA (1.6)	TMED4 (1.5)	GMIP (1.4)	BRAP (1.4)
GO:0008022	protein C-terminus binding	0.61	> 0.20	NYNRIN (2.7)	PPP1R37 (2.7)	PLCG1 (2.5)	SMARCA4 (2.3)	CLPTM1 (1.8)	MARK4 (1.8)	C12orf43 (1.7)	PTPN11 (1.7)	C12orf51 (1.6)	COL4A3BP (1.6)
ENSG00000006747	SCIN PPI subnetwork	0.61	> 0.20	PLEC (4.3)	PVR (2.6)	ALDH2 (2.2)	SARS (2.0)	BRAP (1.9)	KANK2 (1.9)	PTPN11 (1.9)	GATAD2A (1.6)	LPIN3 (1.6)	DNM2 (1.6)
MP:0001458	abnormal object recognition memory	0.61	> 0.20	MARK4 (2.3)	GRINA (2.0)	GCNT4 (2.0)	HNF1A (1.9)	GOT2P1 (1.9)	ABO (1.9)	PPP1R37 (1.8)	PMFBP1 (1.7)	RPH3A (1.6)	TSSK6 (1.6)
MP:0004046	abnormal mitosis	0.61	> 0.20	PSRC1 (5.7)	FEN1 (4.1)	USP1 (3.3)	POC5 (2.4)	GEMIN7 (1.8)	PVR (1.7)	TRIB1 (1.6)	RHD (1.5)	AMIGO1 (1.4)	RHCE (1.3)
MP:0002460	decreased immunoglobulin level	0.61	> 0.20	RELB (4.5)	TIMD4 (3.0)	GMIP (2.6)	CETP (2.5)	BCL3 (2.1)	SH2B3 (2.0)	ZNF101 (1.6)	GRINA (1.6)	MAFB (1.6)	HAVCR1 (1.5)
GO:0016925	protein sumoylation	0.61	> 0.20	NKPD1 (3.3)	ZNF180 (2.9)	PMFBP1 (2.7)	ATXN7L2 (2.5)	C19orf52 (2.3)	TMEM57 (2.0)	MARK4 (1.8)	CLPTM1 (1.6)	CEACAM19 (1.6)	GEMIN7 (1.6)
ENSG00000073050	XRCC1 PPI subnetwork	0.61	> 0.20	FEN1 (2.6)	NT5DC1 (2.2)	SMARCA4 (1.9)	PLCG1 (1.6)	ILF3 (1.5)	CBLC (1.4)	DHODH (1.4)	USP1 (1.3)	RHD (1.3)	ENSG00000226648 (1.3)
GO:0015179	L-amino acid transmembrane transporter activity	0.61	> 0.20	ABCG8 (4.2)	ABCG5 (3.2)	HAPLN4 (3.2)	NCAN (3.1)	TM6SF2 (2.9)	NPC1L1 (2.6)	SARS (2.2)	CYP7A1 (2.0)	ALDH2 (1.8)	CELSR2 (1.8)
MP:0009542	decreased thymocyte apoptosis	0.61	> 0.20	SLC44A2 (2.4)	ZNF101 (1.8)	PLCG1 (1.7)	UBXN2B (1.5)	MAU2 (1.5)	NYNRIN (1.5)	PBX4 (1.5)	ITGB3 (1.5)	ATXN7L2 (1.4)	CYB561D1 (1.3)
ENSG00000130772	MED18 PPI subnetwork	0.61	> 0.20	GEMIN7 (3.0)	TXNL4B (3.0)	BRAP (2.9)	POC5 (2.2)	DHX38 (2.0)	MAPKAPK5 (1.9)	BLOC1S3 (1.9)	BUD13 (1.9)	ZNF180 (1.8)	SMARCA4 (1.6)
ENSG00000123268	ATF1 PPI subnetwork	0.61	> 0.20	TRIB1 (2.9)	PVR (2.6)	HLX (2.5)	BCL3 (2.2)	HNF1A (2.1)	CARM1 (2.1)	HAVCR1 (2.0)	C12orf43 (1.8)	MAPKAPK5 (1.7)	ATXN2 (1.6)
ENSG00000128951	DUT PPI subnetwork	0.61	> 0.20	TM6SF2 (1.9)	PMFBP1 (1.9)	GATAD2A (1.8)	PLCG1 (1.7)	ZHX3 (1.7)	SORT1 (1.6)	CBLC (1.5)	ANKRD31 (1.5)	HAPLN4 (1.5)	MAPKAPK5 (1.5)
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	0.61	> 0.20	GRINA (3.7)	TMEM116 (3.0)	SORT1 (2.5)	ERP29 (2.2)	SARS (2.1)	TMEM50A (2.0)	APOE (2.0)	ENSG00000254235 (1.9)	CLPTM1 (1.8)	COL4A3BP (1.6)
ENSG00000029725	RABEP1 PPI subnetwork	0.61	> 0.20	LPAR2 (3.3)	CARM1 (2.3)	COL4A3BP (2.3)	DNM2 (2.0)	ANKRD31 (1.9)	HNF1A (1.7)	USP24 (1.7)	GMIP (1.7)	GPAM (1.6)	TRAFD1 (1.6)
ENSG00000110801	PSMD9 PPI subnetwork	0.61	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.4)	NT5DC1 (2.3)	TMEM50A (1.7)	SUGP1 (1.7)	TOMM40 (1.7)	DHX38 (1.7)	SARS (1.6)	DDX56 (1.6)
MP:0001661	extended life span	0.61	> 0.20	GPAM (3.1)	ST3GAL4 (2.6)	DNAH11 (2.0)	ATXN7L2 (1.9)	HAVCR1 (1.9)	KIAA1324 (1.5)	GCNT4 (1.5)	CETP (1.4)	HP (1.4)	TXNL4B (1.4)
GO:0051325	interphase	0.61	> 0.20	POC5 (2.5)	USP1 (2.5)	PSRC1 (2.4)	FEN1 (2.3)	ZNF180 (2.2)	ENSG00000226648 (2.1)	BUD13 (2.0)	SUGP1 (1.6)	SMARCA4 (1.6)	MAU2 (1.6)
ENSG00000006125	AP2B1 PPI subnetwork	0.61	> 0.20	C1orf63 (2.5)	CLPTM1 (1.9)	TRAFD1 (1.8)	SH2B3 (1.8)	C17orf57 (1.7)	OGDH (1.7)	KANK2 (1.6)	GRINA (1.6)	ZNF101 (1.5)	PLEC (1.4)
GO:0032652	regulation of interleukin-1 production	0.61	> 0.20	CYB561D1 (2.1)	PLEKHH2 (1.9)	LPIN3 (1.8)	CEACAM19 (1.6)	NPC1L1 (1.5)	ST3GAL4 (1.5)	HLX (1.4)	NKPD1 (1.3)	TMEM116 (1.2)	C12orf43 (1.2)
GO:0007229	integrin-mediated signaling pathway	0.61	> 0.20	GCNT4 (2.9)	SLC44A2 (2.8)	ITGB3 (2.3)	FRK (2.1)	TSSK6 (2.0)	CEACAM19 (1.9)	PMFBP1 (1.7)	ST3GAL4 (1.5)	C17orf57 (1.5)	TMED4 (1.5)
ENSG00000112029	FBXO5 PPI subnetwork	0.61	> 0.20	PSRC1 (4.3)	RHCE (2.4)	POC5 (2.2)	TMEM57 (2.0)	RHD (1.8)	ENSG00000254235 (1.8)	PSMA5 (1.6)	CARM1 (1.6)	CLPTM1 (1.4)	DOCK7 (1.3)
ENSG00000078043	PIAS2 PPI subnetwork	0.62	> 0.20	TRAFD1 (4.1)	KIAA1324 (2.7)	PARP10 (2.6)	HAPLN4 (2.5)	ABO (2.2)	PLCG1 (2.2)	NKPD1 (1.7)	CELSR2 (1.6)	ENSG00000228044 (1.6)	OASL (1.5)
MP:0004592	small mandible	0.62	> 0.20	CARM1 (3.3)	NYNRIN (2.4)	LDLR (2.4)	YIPF2 (1.8)	PPP1R37 (1.8)	KANK2 (1.5)	CBLC (1.4)	SMARCA4 (1.4)	PLEC (1.4)	TMEM116 (1.3)
ENSG00000008311	AASS PPI subnetwork	0.62	> 0.20	DHODH (3.1)	SLC44A2 (2.7)	QTRT1 (2.5)	NT5DC1 (2.3)	BUD13 (1.8)	GPAM (1.6)	ATP13A1 (1.5)	ALDH2 (1.5)	POLK (1.5)	ENSG00000235545 (1.5)
ENSG00000100413	POLR3H PPI subnetwork	0.62	> 0.20	C12orf43 (3.4)	DDX56 (3.2)	ZNF259 (2.9)	GEMIN7 (2.7)	MAPKAPK5 (2.5)	ADAM1 (2.3)	POC5 (2.2)	QTRT1 (2.2)	BUD13 (2.2)	SUGP1 (2.0)
ENSG00000211899	ENSG00000211899 PPI subnetwork	0.62	> 0.20	ERP29 (2.2)	DOCK7 (2.0)	TMED4 (2.0)	NKPD1 (2.0)	SMARCA4 (1.6)	RHD (1.4)	ATXN7L2 (1.3)	ITGB3 (1.3)	ALDH2 (1.3)	GPAM (1.2)
ENSG00000124145	SDC4 PPI subnetwork	0.62	> 0.20	CILP2 (2.6)	APOE (2.3)	ZNF101 (2.1)	OASL (2.1)	PBX4 (1.8)	ENSG00000238078 (1.7)	PLEC (1.7)	YIPF2 (1.7)	CYP7A1 (1.6)	SYPL2 (1.6)
REACTOME_PURINE_METABOLISM	REACTOME_PURINE_METABOLISM	0.62	> 0.20	SYPL2 (3.0)	DHODH (2.6)	NT5DC1 (2.5)	LPIN3 (2.3)	QTRT1 (2.0)	TRAPPC6A (1.9)	RHCE (1.9)	ENSG00000228044 (1.7)	DDX56 (1.7)	ABCG5 (1.6)
ENSG00000007171	NOS2 PPI subnetwork	0.62	> 0.20	OGDH (2.6)	PVRL2 (2.2)	DNM2 (2.0)	MARK4 (1.8)	PVR (1.8)	SYPL2 (1.7)	TIMD4 (1.7)	TOMM40 (1.7)	CARM1 (1.7)	PLEC (1.4)
GO:0031256	leading edge membrane	0.62	> 0.20	NCAN (4.1)	PVR (3.2)	DOCK7 (2.5)	SLC44A2 (2.5)	C11orf9 (2.3)	PLEKHH2 (2.2)	AMIGO1 (2.2)	PVRL2 (2.1)	AP1M2 (2.0)	CELSR2 (2.0)
ENSG00000143553	SNAPIN PPI subnetwork	0.62	> 0.20	UBXN2B (3.8)	GRINA (2.5)	ILF3 (2.0)	ZNF101 (1.9)	C17orf57 (1.8)	TXNL4B (1.8)	ATXN7L2 (1.7)	TMED4 (1.7)	GOT2P1 (1.7)	PVR (1.6)
ENSG00000184270	HIST2H2AB PPI subnetwork	0.62	> 0.20	BUD13 (3.2)	C19orf52 (3.1)	TMEM116 (2.3)	MARK4 (2.2)	PLCG1 (2.1)	TSSK6 (1.9)	KANK2 (1.8)	POLK (1.7)	MAU2 (1.7)	ENSG00000228044 (1.6)
REACTOME_M_PHASE	REACTOME_M_PHASE	0.62	> 0.20	PSRC1 (6.0)	FEN1 (4.2)	USP1 (3.8)	POC5 (3.6)	ZNF180 (1.0)	ENSG00000226648 (1.0)	ZHX3 (1.0)	USP24 (0.9)	ENSG00000228044 (0.9)	ACAD10 (0.8)
ENSG00000182492	BGN PPI subnetwork	0.62	> 0.20	CILP2 (3.7)	NPC1L1 (3.2)	BCAM (2.8)	C11orf9 (2.2)	ST3GAL4 (1.7)	ABCG5 (1.6)	ABO (1.6)	HNF1A (1.5)	CYB561D1 (1.3)	BLOC1S3 (1.2)
ENSG00000057663	ATG5 PPI subnetwork	0.62	> 0.20	NT5DC1 (3.0)	PSMA5 (2.5)	HMGCR (2.4)	FADS1 (2.2)	FADS2 (2.2)	TMEM50A (2.1)	TXNL4B (1.9)	LDLR (1.9)	PCSK9 (1.9)	SARS (1.8)
ENSG00000115540	MOB4 PPI subnetwork	0.62	> 0.20	ZNF180 (3.6)	MARK4 (2.9)	GOT2P1 (2.6)	UBXN2B (2.5)	SARS (2.3)	PPP1R37 (2.2)	NCAN (1.8)	PSMA5 (1.7)	NYNRIN (1.4)	ENSG00000235545 (1.4)
GO:2000243	positive regulation of reproductive process	0.62	> 0.20	SUGP1 (2.6)	MAPKAPK5 (2.5)	BUD13 (2.2)	ANKRD31 (2.2)	C12orf43 (2.1)	GEMIN7 (2.0)	TXNL4B (2.0)	QTRT1 (1.8)	ATP13A1 (1.7)	MAU2 (1.7)
ENSG00000128656	CHN1 PPI subnetwork	0.62	> 0.20	ABCG8 (3.0)	PBX4 (2.5)	TM6SF2 (2.4)	TSSK6 (2.3)	NPC1L1 (2.2)	CELSR2 (2.2)	ABCG5 (1.8)	ANKRD31 (1.8)	NKPD1 (1.8)	NCAN (1.7)
MP:0005324	ascites	0.62	> 0.20	SH2B3 (3.0)	HLX (2.7)	DNAH11 (2.3)	ABO (2.1)	CETP (2.0)	MAFB (1.7)	COL4A3BP (1.4)	TMEM50A (1.4)	APOE (1.3)	TOP1 (1.2)
GO:0043034	costamere	0.62	> 0.20	KANK2 (3.4)	ITGB3 (3.0)	SYPL2 (2.6)	PLEC (2.6)	PLEKHH2 (2.3)	COL4A3BP (2.0)	TXNL4B (1.8)	C17orf57 (1.7)	TOP1 (1.6)	LDLR (1.4)
GO:0010824	regulation of centrosome duplication	0.62	> 0.20	POLK (3.7)	ZNF180 (2.5)	POC5 (2.3)	UBXN2B (2.2)	ENSG00000226648 (1.9)	GOT2P1 (1.9)	DYNC2LI1 (1.8)	CEACAM19 (1.7)	PSRC1 (1.6)	TXNL4B (1.6)
ENSG00000170035	UBE2E3 PPI subnetwork	0.62	> 0.20	USP24 (3.1)	C12orf51 (2.2)	ATXN2 (1.9)	ZHX3 (1.9)	MYLIP (1.8)	MAU2 (1.7)	DOCK7 (1.6)	ZNF180 (1.5)	PTPN11 (1.5)	PVR (1.5)
ENSG00000117724	CENPF PPI subnetwork	0.62	> 0.20	PLCG1 (2.9)	CEACAM19 (2.7)	C12orf43 (2.5)	NKPD1 (2.3)	MAU2 (2.3)	PSRC1 (2.2)	CELSR2 (2.1)	ATXN2 (2.1)	MAPKAPK5 (1.7)	AP1M2 (1.5)
REACTOME_CDC20PHOSPHO:APCC_MEDIATED_DEGRADATION_OF_CYCLIN_A	REACTOME_CDC20PHOSPHO:APCC_MEDIATED_DEGRADATION_OF_CYCLIN_A	0.62	> 0.20	PSMA5 (5.9)	TRAFD1 (3.6)	NAA25 (2.4)	SUGP1 (2.3)	DDX56 (1.8)	FEN1 (1.6)	POC5 (1.5)	LPIN3 (1.3)	NT5DC1 (1.3)	PARP10 (1.3)
ENSG00000143768	LEFTY2 PPI subnetwork	0.62	> 0.20	CARM1 (4.7)	SMARCA4 (2.7)	NT5DC1 (2.6)	GRINA (2.5)	GATAD2A (2.3)	MAU2 (2.1)	MARK4 (2.0)	ATXN2 (2.0)	CLPTM1 (1.9)	TRAFD1 (1.8)
GO:0048048	embryonic eye morphogenesis	0.62	> 0.20	TMED4 (2.1)	ADAM1 (2.0)	ZHX3 (2.0)	ABO (1.8)	MAU2 (1.8)	PPP1R37 (1.7)	C19orf52 (1.5)	CEACAM19 (1.5)	C17orf57 (1.5)	FRK (1.4)
GO:0005916	fascia adherens	0.62	> 0.20	SYPL2 (2.7)	PLEC (2.4)	KANK2 (1.9)	FADS1 (1.9)	BCAM (1.8)	PVRL2 (1.8)	PTPN11 (1.7)	OGDH (1.5)	ENSG00000226648 (1.4)	C1orf63 (1.4)
ENSG00000163904	SENP2 PPI subnetwork	0.62	> 0.20	MARK4 (3.3)	ILF3 (2.3)	PARP10 (2.2)	POLK (2.2)	ABO (1.9)	GATAD2A (1.9)	ENSG00000238078 (1.7)	ZNF180 (1.6)	TMEM50A (1.6)	NAA25 (1.5)
ENSG00000065534	MYLK PPI subnetwork	0.62	> 0.20	SYPL2 (3.1)	PPP1R37 (2.1)	PLCG1 (1.9)	GMIP (1.9)	LPAR2 (1.9)	ENSG00000238078 (1.8)	OASL (1.7)	ZNF180 (1.7)	COL4A3BP (1.6)	C12orf43 (1.5)
GO:0010718	positive regulation of epithelial to mesenchymal transition	0.62	> 0.20	ENSG00000226648 (2.9)	MYLIP (2.6)	ANKRD31 (2.6)	SLC44A2 (2.5)	MAFB (2.2)	SH2B3 (2.1)	ENSG00000254235 (2.0)	KANK2 (2.0)	ITGB3 (1.8)	PLCG1 (1.6)
MP:0004190	abnormal direction of embryo turning	0.62	> 0.20	DYNC2LI1 (4.6)	GCNT4 (4.0)	UBXN2B (3.5)	ACAD10 (3.0)	DOCK7 (2.6)	PLEKHH2 (2.3)	AMIGO1 (2.0)	CYP7A1 (1.9)	MARK4 (1.8)	ZNF101 (1.7)
GO:0045740	positive regulation of DNA replication	0.62	> 0.20	ENSG00000228044 (4.2)	DYNC2LI1 (2.1)	POLK (2.0)	GCNT4 (1.6)	PLEKHH2 (1.5)	HNF1A (1.4)	GEMIN7 (1.3)	NPC1L1 (1.1)	ST3GAL4 (1.0)	C11orf9 (1.0)
MP:0008392	decreased primordial germ cell number	0.62	> 0.20	TRIB1 (2.2)	PLEKHH2 (2.0)	HLX (1.8)	C11orf9 (1.6)	PVR (1.5)	TMED4 (1.3)	ANKRD31 (1.3)	C12orf47 (1.0)	KANK2 (1.0)	TMEM50A (1.0)
MP:0002978	absent otoliths	0.62	> 0.20	PMFBP1 (2.6)	ENSG00000228044 (2.6)	ST3GAL4 (2.2)	TXNL4B (2.0)	HNF1A (1.9)	NT5DC1 (1.9)	ZNF180 (1.8)	CBLC (1.7)	FRK (1.7)	HLX (1.6)
GO:0006361	transcription initiation from RNA polymerase I promoter	0.62	> 0.20	C12orf43 (3.4)	TXNL4B (3.1)	DYNC2LI1 (2.5)	ZNF259 (2.5)	MAPKAPK5 (2.2)	GEMIN7 (2.2)	POLK (2.1)	DHX38 (2.0)	ZNF180 (2.0)	ATXN7L2 (1.4)
GO:0031645	negative regulation of neurological system process	0.62	> 0.20	NKPD1 (2.2)	ENSG00000254235 (2.1)	ABO (2.1)	CEACAM19 (2.0)	GOT2P1 (1.9)	CETP (1.9)	BLOC1S3 (1.9)	RPH3A (1.8)	ANKRD31 (1.8)	C12orf43 (1.4)
ENSG00000105849	TWISTNB PPI subnetwork	0.62	> 0.20	MOSC1 (2.7)	TOP1 (2.0)	RHCE (1.9)	AMIGO1 (1.9)	CILP2 (1.8)	SH2B3 (1.7)	GRINA (1.6)	GOT2P1 (1.6)	DNAH11 (1.6)	MAFB (1.4)
GO:0060740	prostate gland epithelium morphogenesis	0.62	> 0.20	ENSG00000254235 (2.3)	AMIGO1 (2.2)	C19orf52 (2.0)	ABO (2.0)	BLOC1S3 (1.8)	NYNRIN (1.7)	KIAA1324 (1.7)	LPAR2 (1.4)	ANKRD31 (1.2)	ENSG00000228044 (1.2)
ENSG00000169249	ZRSR2 PPI subnetwork	0.62	> 0.20	BUD13 (3.0)	C1orf63 (3.0)	ILF3 (1.9)	DHX38 (1.8)	TOP1 (1.8)	ADAM1 (1.8)	BLOC1S3 (1.8)	HAPLN4 (1.7)	FEN1 (1.5)	USP1 (1.5)
ENSG00000068024	HDAC4 PPI subnetwork	0.62	> 0.20	CBLC (3.5)	CARM1 (3.2)	DNM2 (3.0)	PLEC (2.3)	MARK4 (2.2)	AP1M2 (2.1)	SMARCA4 (1.9)	KANK2 (1.7)	PMFBP1 (1.7)	LPAR2 (1.6)
GO:0002704	negative regulation of leukocyte mediated immunity	0.62	> 0.20	DNAH11 (2.8)	CEACAM19 (2.4)	OASL (1.9)	ZNF180 (1.9)	ABO (1.7)	HAVCR1 (1.5)	PARP10 (1.5)	NKPD1 (1.2)	HNF1A (1.2)	GMIP (1.2)
GO:0002707	negative regulation of lymphocyte mediated immunity	0.62	> 0.20	DNAH11 (2.8)	CEACAM19 (2.4)	OASL (1.9)	ZNF180 (1.9)	ABO (1.7)	HAVCR1 (1.5)	PARP10 (1.5)	NKPD1 (1.2)	HNF1A (1.2)	GMIP (1.2)
ENSG00000048052	HDAC9 PPI subnetwork	0.62	> 0.20	MAU2 (2.6)	PSRC1 (2.4)	USP24 (2.1)	BCL3 (2.0)	POLK (1.9)	ZHX3 (1.9)	MAFB (1.8)	DHX38 (1.8)	ZNF180 (1.8)	MARK4 (1.7)
GO:0015802	basic amino acid transport	0.62	> 0.20	LPAR2 (2.9)	ATP13A1 (1.9)	HAVCR1 (1.7)	TMEM116 (1.6)	UBXN2B (1.6)	SARS (1.6)	ERP29 (1.5)	TXNL4B (1.5)	QTRT1 (1.4)	BLOC1S3 (1.4)
MP:0009760	abnormal mitotic spindle morphology	0.62	> 0.20	PSRC1 (6.0)	FEN1 (3.5)	POC5 (2.6)	USP1 (2.4)	RHCE (2.1)	PVRL2 (1.9)	RHD (1.9)	C12orf51 (1.8)	PLEKHH2 (1.5)	BUD13 (1.5)
ENSG00000137497	NUMA1 PPI subnetwork	0.62	> 0.20	DOCK7 (2.9)	USP1 (2.7)	SARS (2.1)	SLC44A2 (2.1)	PTPN11 (2.1)	AMIGO1 (1.9)	C12orf51 (1.8)	USP24 (1.7)	SMARCA4 (1.6)	NYNRIN (1.6)
GO:0060021	palate development	0.62	> 0.20	ENSG00000235545 (2.5)	MYLIP (2.3)	KANK2 (2.2)	NKPD1 (2.1)	CILP2 (2.0)	ATXN7L2 (1.8)	HLX (1.5)	CYB561D1 (1.5)	C17orf57 (1.5)	ANKRD31 (1.5)
MP:0010363	increased fibrosarcoma incidence	0.62	> 0.20	SLC44A2 (3.1)	HP (2.9)	RHCE (2.3)	RHD (2.0)	PTPN11 (2.0)	HLX (1.8)	GMIP (1.8)	TMEM50A (1.6)	GATAD2A (1.6)	TRIB1 (1.5)
ENSG00000060069	CTDP1 PPI subnetwork	0.62	> 0.20	PSMA5 (2.9)	SUGP1 (2.7)	TXNL4B (2.5)	QTRT1 (2.4)	TOMM40 (2.3)	DHX38 (2.3)	MAPKAPK5 (2.2)	BUD13 (2.1)	CLPTM1 (2.0)	ILF3 (2.0)
GO:0046888	negative regulation of hormone secretion	0.62	> 0.20	KIAA1324 (4.3)	AMIGO1 (3.0)	GPAM (2.6)	TMED4 (2.4)	ENSG00000228044 (2.2)	MOSC1 (2.2)	ENSG00000254235 (1.9)	ANKRD31 (1.7)	AP1M2 (1.6)	CELSR2 (1.6)
GO:0060216	definitive hemopoiesis	0.62	> 0.20	ENSG00000226648 (3.5)	GMPR (2.4)	KANK2 (2.2)	RHCE (1.9)	ITGB3 (1.9)	C19orf52 (1.9)	BRAP (1.9)	SH2B3 (1.7)	RHD (1.6)	SLC44A2 (1.6)
ENSG00000170624	SGCD PPI subnetwork	0.62	> 0.20	SYPL2 (3.7)	KANK2 (3.6)	NPC1L1 (2.2)	DOCK7 (2.0)	GMPR (2.0)	HNF1A (1.9)	TMED4 (1.7)	ST3GAL4 (1.5)	PLEC (1.4)	GOT2P1 (1.4)
GO:0005035	death receptor activity	0.62	> 0.20	PBX4 (3.0)	TRAFD1 (2.5)	RELB (2.3)	POLK (2.0)	LPAR2 (1.9)	CYB561D1 (1.9)	CETP (1.7)	NYNRIN (1.6)	PARP10 (1.5)	ADAM1 (1.4)
ENSG00000142156	COL6A1 PPI subnetwork	0.62	> 0.20	APOE (2.4)	OASL (2.3)	PLEKHH2 (1.9)	SORT1 (1.7)	HAVCR1 (1.6)	C17orf57 (1.6)	CETP (1.6)	CILP2 (1.5)	MYLIP (1.4)	APOC1 (1.3)
GO:0008207	C21-steroid hormone metabolic process	0.62	> 0.20	ST3GAL4 (3.2)	CYP7A1 (2.6)	LPIN3 (2.6)	PMFBP1 (1.8)	APOC1 (1.6)	CYB561D1 (1.5)	ABCG5 (1.3)	FADS1 (1.3)	ZNF180 (1.3)	APOB (1.3)
GO:0001786	phosphatidylserine binding	0.62	> 0.20	PLCG1 (2.6)	NKPD1 (2.5)	ITGB3 (2.4)	ZNF101 (2.2)	ATXN2 (2.2)	PLEKHH2 (2.0)	ENSG00000226648 (1.8)	BCAM (1.8)	HNF1A (1.8)	ZHX3 (1.7)
ENSG00000175482	POLD4 PPI subnetwork	0.62	> 0.20	FEN1 (5.4)	USP1 (4.8)	ZNF180 (2.3)	AMIGO1 (2.2)	ENSG00000235545 (1.9)	GOT2P1 (1.6)	DHODH (1.5)	FADS1 (1.4)	LPA (1.4)	POC5 (1.4)
ENSG00000153207	AHCTF1 PPI subnetwork	0.62	> 0.20	PSRC1 (5.6)	FEN1 (4.6)	USP1 (3.8)	POC5 (3.7)	ZNF180 (1.3)	ILF3 (1.0)	TXNL4B (0.9)	DHX38 (0.9)	ENSG00000228044 (0.8)	ENSG00000226648 (0.8)
ENSG00000168538	TRAPPC11 PPI subnetwork	0.62	> 0.20	BRAP (2.6)	MAPKAPK5 (2.5)	CEACAM19 (2.4)	HNF1A (2.1)	FRK (2.0)	ZHX3 (1.9)	LPIN3 (1.8)	HAVCR1 (1.7)	ITGB3 (1.7)	ZNF101 (1.6)
MP:0003620	oliguria	0.62	> 0.20	ZHX3 (3.5)	MAFB (1.9)	C12orf51 (1.7)	ENSG00000254235 (1.6)	FRK (1.5)	TRIB1 (1.5)	NKPD1 (1.4)	UBXN2B (1.3)	C12orf47 (1.3)	DOCK7 (1.3)
GO:0005086	ARF guanyl-nucleotide exchange factor activity	0.62	> 0.20	C12orf51 (3.4)	MAPKAPK5 (2.9)	PPP1R37 (2.7)	MAU2 (2.6)	TMEM57 (2.5)	GMIP (2.5)	DNM2 (2.3)	DHX38 (2.2)	HAPLN4 (2.0)	NCAN (1.9)
ENSG00000065833	ME1 PPI subnetwork	0.62	> 0.20	OGDH (3.4)	DDX56 (2.8)	DHX38 (2.3)	USP24 (2.1)	BRAP (2.0)	NAA25 (2.0)	PSMA5 (1.8)	SARS (1.8)	ATP13A1 (1.8)	TMEM57 (1.7)
ENSG00000068615	REEP1 PPI subnetwork	0.62	> 0.20	PLEC (3.6)	ZHX3 (3.1)	DNM2 (3.1)	CARM1 (3.0)	USP24 (2.5)	C12orf51 (2.4)	LPAR2 (2.4)	COL4A3BP (2.3)	ATXN2 (2.3)	PTPN11 (2.3)
GO:0055065	metal ion homeostasis	0.62	> 0.20	ERP29 (2.1)	C12orf47 (1.7)	TMEM116 (1.6)	RPH3A (1.5)	SYPL2 (1.5)	ABO (1.4)	AMIGO1 (1.4)	RHCE (1.3)	RHD (1.3)	CETP (1.3)
ENSG00000064999	ANKS1A PPI subnetwork	0.62	> 0.20	CBLC (6.5)	AP1M2 (4.3)	PVRL2 (2.7)	LPAR2 (2.7)	CELSR2 (2.7)	ALDH2 (1.8)	PSRC1 (1.6)	LPIN3 (1.6)	FRK (1.4)	SLC44A2 (1.4)
GO:0031365	N-terminal protein amino acid modification	0.62	> 0.20	ANKRD31 (4.0)	C12orf51 (3.2)	ADAM1 (2.2)	PMFBP1 (2.0)	USP24 (2.0)	C19orf52 (1.9)	MAPKAPK5 (1.8)	BRAP (1.7)	TOP1 (1.6)	HAVCR1 (1.6)
GO:0001078	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription	0.62	> 0.20	SH2B3 (2.3)	NYNRIN (2.2)	ENSG00000226648 (2.1)	SLC44A2 (2.0)	RHCE (2.0)	RHD (2.0)	TRIB1 (1.9)	PSRC1 (1.8)	KANK2 (1.7)	LPAR2 (1.7)
GO:0035258	steroid hormone receptor binding	0.62	> 0.20	MAFB (2.6)	PLCG1 (2.4)	DNM2 (1.9)	KANK2 (1.8)	ATXN2 (1.8)	COL4A3BP (1.8)	POC5 (1.7)	GOT2P1 (1.6)	TOP1 (1.6)	RHD (1.4)
MP:0011085	complete postnatal lethality	0.62	> 0.20	HAPLN4 (3.2)	NCAN (2.6)	CELSR2 (2.5)	MAFB (2.2)	CBLC (1.7)	PLG (1.7)	ZHX3 (1.7)	BCAM (1.6)	KANK2 (1.6)	SLC22A1 (1.4)
GO:0042611	MHC protein complex	0.62	> 0.20	PARP10 (3.0)	APOE (2.5)	ALDH2 (2.5)	SH2B3 (1.9)	APOC1 (1.6)	YIPF2 (1.5)	TMED4 (1.4)	MYLIP (1.3)	CBLC (1.1)	POLK (1.0)
GO:0019229	regulation of vasoconstriction	0.62	> 0.20	C12orf47 (2.5)	ENSG00000228044 (2.0)	ITGB3 (1.9)	C17orf57 (1.7)	TSSK6 (1.6)	POLK (1.5)	FRK (1.4)	ADAM1 (1.4)	ABO (1.4)	LPIN3 (1.4)
ENSG00000146963	LUC7L2 PPI subnetwork	0.62	> 0.20	QTRT1 (2.8)	TOP1 (2.7)	ITGB3 (1.8)	ADAM1 (1.7)	PLCG1 (1.7)	FRK (1.7)	TXNL4B (1.7)	SMARCA4 (1.7)	GMPR (1.6)	TMEM116 (1.6)
ENSG00000154447	SH3RF1 PPI subnetwork	0.62	> 0.20	MARK4 (2.7)	FADS2 (2.6)	GATAD2A (2.3)	TRAPPC6A (2.0)	PPP1R37 (1.8)	DYNC2LI1 (1.8)	LPIN3 (1.8)	NT5DC1 (1.7)	PSRC1 (1.7)	TRIB1 (1.4)
GO:0046496	nicotinamide nucleotide metabolic process	0.62	> 0.20	TRAPPC6A (3.0)	ACAD10 (2.8)	ALDH2 (2.1)	NT5DC1 (2.0)	OGDH (1.9)	FRK (1.9)	BLOC1S3 (1.8)	DNAH11 (1.8)	PMFBP1 (1.7)	FADS2 (1.7)
GO:0048471	perinuclear region of cytoplasm	0.62	> 0.20	POLK (3.0)	AP1M2 (2.7)	C11orf9 (2.7)	SORT1 (2.5)	DNM2 (2.5)	PTPN11 (1.8)	PPP1R37 (1.7)	CELSR2 (1.7)	ST3GAL4 (1.6)	BCAM (1.5)
MP:0001724	abnormal extraembryonic endoderm formation	0.62	> 0.20	ATXN7L2 (2.3)	ZNF180 (2.2)	ATP13A1 (2.0)	C17orf57 (1.7)	CLPTM1 (1.7)	HAVCR1 (1.5)	ITGB3 (1.4)	ENSG00000238078 (1.4)	SYPL2 (1.4)	ERP29 (1.3)
GO:0090276	regulation of peptide hormone secretion	0.62	> 0.20	KIAA1324 (4.8)	ABO (2.3)	HNF1A (2.3)	ANKRD31 (2.2)	HAPLN4 (2.2)	ENSG00000238078 (1.8)	COL4A3BP (1.8)	PLEKHH2 (1.7)	AP1M2 (1.5)	ENSG00000254235 (1.5)
ENSG00000090861	AARS PPI subnetwork	0.62	> 0.20	SARS (4.5)	DHX38 (2.6)	ATXN2 (2.4)	GOT2P1 (2.4)	CARM1 (2.3)	SUGP1 (2.0)	SMARCA4 (2.0)	AP1M2 (2.0)	HAPLN4 (1.9)	ENSG00000235545 (1.5)
ENSG00000161970	RPL26 PPI subnetwork	0.62	> 0.20	NAA25 (2.3)	NKPD1 (2.1)	ZNF259 (2.1)	ILF3 (2.1)	GATAD2A (1.9)	ADAM1 (1.8)	TOP1 (1.8)	SARS (1.8)	SUGP1 (1.6)	DDX56 (1.6)
ENSG00000166033	HTRA1 PPI subnetwork	0.62	> 0.20	KANK2 (3.1)	HLX (2.5)	FRK (2.3)	PVRL2 (2.2)	PVR (2.2)	PLCG1 (2.0)	CEACAM19 (1.9)	GATAD2A (1.6)	SLC44A2 (1.6)	CLPTM1 (1.5)
GO:0005790	smooth endoplasmic reticulum	0.62	> 0.20	SYPL2 (3.4)	CILP2 (2.0)	HAPLN4 (1.9)	ALDH2 (1.8)	TM6SF2 (1.7)	ADAM1 (1.7)	FADS1 (1.6)	C1orf63 (1.6)	CYB561D1 (1.6)	RPH3A (1.5)
ENSG00000067057	PFKP PPI subnetwork	0.62	> 0.20	NCAN (3.3)	PLEC (2.4)	BRAP (2.3)	HAVCR1 (1.9)	ACAD10 (1.9)	SYPL2 (1.7)	C12orf51 (1.5)	DOCK7 (1.4)	GPAM (1.4)	OGDH (1.4)
GO:0006013	mannose metabolic process	0.62	> 0.20	TRAPPC6A (3.8)	ENSG00000235545 (2.4)	PMFBP1 (1.9)	PBX4 (1.9)	QTRT1 (1.8)	YIPF2 (1.8)	NT5DC1 (1.8)	ATP13A1 (1.7)	LPAR2 (1.6)	BLOC1S3 (1.6)
MP:0004418	small parietal bone	0.62	> 0.20	CILP2 (2.5)	NCAN (1.4)	PVR (1.3)	PLCG1 (1.2)	TMEM57 (1.2)	C17orf57 (1.2)	CETP (1.2)	ABO (1.1)	ENSG00000228044 (1.1)	TRAFD1 (1.0)
ENSG00000130165	ELOF1 PPI subnetwork	0.62	> 0.20	BLOC1S3 (3.1)	COL4A3BP (2.6)	GATAD2A (2.6)	PTPN11 (2.3)	SARS (2.2)	MAPKAPK5 (2.2)	GOT2P1 (2.0)	NKPD1 (2.0)	UBXN2B (1.9)	ENSG00000254235 (1.7)
ENSG00000198042	MAK16 PPI subnetwork	0.62	> 0.20	ZNF259 (4.5)	NAA25 (3.0)	QTRT1 (2.9)	DDX56 (2.8)	DHODH (2.7)	ENSG00000226645 (2.4)	TOMM40 (2.3)	SARS (1.9)	ATP13A1 (1.8)	SUGP1 (1.5)
GO:0000959	mitochondrial RNA metabolic process	0.62	> 0.20	DHODH (2.5)	ACAD10 (2.3)	NT5DC1 (2.2)	C19orf52 (2.2)	ATP13A1 (2.1)	GOT2P1 (1.9)	DDX56 (1.9)	BRAP (1.7)	NAA25 (1.7)	TMEM116 (1.5)
GO:0051970	negative regulation of transmission of nerve impulse	0.62	> 0.20	ENSG00000254235 (2.5)	ABO (2.2)	CETP (2.1)	GOT2P1 (1.9)	RPH3A (1.6)	BLOC1S3 (1.5)	CEACAM19 (1.3)	C17orf57 (1.2)	C12orf47 (1.2)	NKPD1 (1.2)
ENSG00000134574	DDB2 PPI subnetwork	0.62	> 0.20	ENSG00000226648 (2.7)	BLOC1S3 (2.3)	SUGP1 (2.1)	FEN1 (2.0)	BRAP (2.0)	PPP1R37 (1.8)	KANK2 (1.8)	NT5DC1 (1.8)	POC5 (1.7)	ZNF180 (1.7)
ENSG00000160563	MED27 PPI subnetwork	0.62	> 0.20	GEMIN7 (3.2)	TXNL4B (3.1)	BLOC1S3 (2.5)	BRAP (2.3)	BUD13 (2.2)	MAPKAPK5 (2.0)	C1orf63 (1.8)	DHX38 (1.6)	ZNF180 (1.5)	DYNC2LI1 (1.4)
REACTOME_ACTIVATION_OF_APCC_AND_APCCCDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	REACTOME_ACTIVATION_OF_APCC_AND_APCCCDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	0.62	> 0.20	PSMA5 (5.8)	TRAFD1 (3.5)	SUGP1 (2.4)	NAA25 (2.2)	POC5 (1.9)	DDX56 (1.9)	FEN1 (1.8)	PSRC1 (1.8)	LPIN3 (1.4)	PARP10 (1.2)
ENSG00000071051	NCK2 PPI subnetwork	0.62	> 0.20	MARK4 (2.7)	PVRL2 (2.4)	BCAM (2.1)	ATXN2 (2.1)	DOCK7 (2.1)	C17orf57 (1.9)	MAFB (1.6)	GRINA (1.6)	PPP1R37 (1.6)	GATAD2A (1.5)
MP:0004725	decreased platelet serotonin level	0.62	> 0.20	ITGB3 (3.0)	DOCK7 (2.2)	TXNL4B (2.2)	BLOC1S3 (2.1)	GMPR (2.0)	ZNF101 (2.0)	GMIP (1.9)	POLK (1.7)	ENSG00000228044 (1.7)	C17orf57 (1.6)
ENSG00000122641	INHBA PPI subnetwork	0.62	> 0.20	PVRL2 (3.2)	PVR (2.5)	MARK4 (2.2)	BCAM (1.8)	PLEC (1.8)	LPIN3 (1.8)	SLC44A2 (1.7)	AMIGO1 (1.6)	SLC22A1 (1.6)	ST3GAL4 (1.5)
GO:0019882	antigen processing and presentation	0.62	> 0.20	TRAFD1 (2.9)	PSMA5 (2.7)	PARP10 (2.3)	NT5DC1 (1.8)	YIPF2 (1.4)	NAA25 (1.4)	TMED4 (1.4)	CYB561D1 (1.3)	C19orf52 (1.2)	ENSG00000235545 (1.2)
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	0.62	> 0.20	RPH3A (3.9)	SYPL2 (3.6)	NCAN (2.8)	HAPLN4 (2.4)	AMIGO1 (2.2)	CYB561D1 (2.0)	HAVCR1 (1.9)	CELSR2 (1.9)	C12orf43 (1.8)	CEACAM19 (1.6)
MP:0003793	abnormal submandibular gland morphology	0.62	> 0.20	ZNF101 (3.4)	DOCK7 (2.8)	PLCG1 (2.6)	FRK (2.5)	PBX4 (2.5)	KANK2 (2.2)	LPAR2 (1.9)	PLEKHH2 (1.6)	CLPTM1 (1.6)	GOT2P1 (1.3)
GO:0002683	negative regulation of immune system process	0.62	> 0.20	PBX4 (2.4)	ZNF101 (2.4)	TIMD4 (2.1)	APOE (1.9)	ADAM1 (1.6)	ENSG00000235545 (1.6)	CEACAM19 (1.6)	ENSG00000228044 (1.5)	PLCG1 (1.5)	GCNT4 (1.3)
GO:0006733	oxidoreduction coenzyme metabolic process	0.62	> 0.20	ACAD10 (3.8)	NT5DC1 (2.9)	OGDH (2.7)	TRAPPC6A (2.6)	FRK (2.2)	LPIN3 (2.1)	DNAH11 (1.9)	GMPR (1.8)	DHODH (1.8)	SYPL2 (1.7)
GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	0.62	> 0.20	HNF1A (2.8)	ALDH2 (2.3)	ITGB3 (1.9)	ERP29 (1.6)	SH2B3 (1.5)	RHD (1.5)	PCSK9 (1.5)	GPAM (1.4)	NPC1L1 (1.3)	APOB (1.3)
ENSG00000184357	HIST1H1B PPI subnetwork	0.62	> 0.20	MYLIP (2.5)	C19orf52 (2.3)	USP1 (2.0)	GMPR (2.0)	BUD13 (1.7)	PSRC1 (1.4)	KIAA1324 (1.3)	GCNT4 (1.3)	C11orf9 (1.3)	DNAH11 (1.2)
ENSG00000104892	KLC3 PPI subnetwork	0.62	> 0.20	PLEC (3.3)	C11orf9 (2.9)	CARM1 (2.9)	DNM2 (2.8)	USP24 (2.8)	PTPN11 (2.8)	COL4A3BP (2.7)	ZHX3 (2.6)	C12orf51 (2.6)	LPAR2 (2.6)
GO:0000087	M phase of mitotic cell cycle	0.62	> 0.20	POC5 (4.9)	PSRC1 (4.9)	USP1 (2.6)	FEN1 (2.1)	ENSG00000228044 (1.9)	GEMIN7 (1.8)	PBX4 (1.7)	BUD13 (1.5)	ILF3 (1.3)	COL4A3BP (1.3)
ENSG00000074071	MRPS34 PPI subnetwork	0.62	> 0.20	ATP13A1 (3.5)	OGDH (2.7)	ILF3 (2.2)	DNM2 (1.9)	ENSG00000235545 (1.7)	QTRT1 (1.7)	YIPF2 (1.7)	ACAD10 (1.7)	ATXN2 (1.5)	LDLR (1.5)
ENSG00000105325	FZR1 PPI subnetwork	0.62	> 0.20	PSRC1 (4.3)	FEN1 (3.1)	POC5 (2.7)	LPIN3 (2.1)	USP1 (1.6)	RHD (1.5)	DOCK7 (1.4)	SLC44A2 (1.3)	ILF3 (1.3)	RHCE (1.2)
KEGG_TGF_BETA_SIGNALING_PATHWAY	KEGG_TGF_BETA_SIGNALING_PATHWAY	0.62	> 0.20	CILP2 (3.4)	PVR (2.1)	MYLIP (2.1)	KANK2 (1.9)	SLC44A2 (1.7)	PTPN11 (1.7)	ATXN2 (1.6)	CARM1 (1.4)	MAPKAPK5 (1.4)	ALDH2 (1.4)
GO:0048565	digestive tract development	0.62	> 0.20	C11orf9 (4.6)	PLEKHH2 (3.0)	TM6SF2 (2.3)	LPAR2 (2.0)	NYNRIN (1.9)	HLX (1.8)	CEACAM19 (1.8)	DYNC2LI1 (1.8)	ABCG8 (1.7)	ENSG00000235545 (1.7)
ENSG00000104419	NDRG1 PPI subnetwork	0.63	> 0.20	SARS (4.0)	SMARCA4 (3.0)	TOP1 (2.9)	ERP29 (2.7)	SUGP1 (2.4)	CLPTM1 (2.4)	ILF3 (2.3)	HMGCR (2.3)	OGDH (2.3)	PSMA5 (2.2)
KEGG_INOSITOL_PHOSPHATE_METABOLISM	KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.63	> 0.20	MARK4 (2.4)	BLOC1S3 (2.2)	AMIGO1 (2.2)	KANK2 (2.2)	SORT1 (2.1)	C12orf51 (2.1)	GMIP (1.9)	TSSK6 (1.8)	HAPLN4 (1.8)	ZHX3 (1.7)
ENSG00000108061	SHOC2 PPI subnetwork	0.63	> 0.20	ATP13A1 (2.7)	ILF3 (2.4)	TMEM116 (2.2)	DNM2 (2.1)	OGDH (2.0)	LDLR (1.7)	SLC44A2 (1.6)	ENSG00000235545 (1.6)	SORT1 (1.6)	DOCK7 (1.6)
ENSG00000087095	NLK PPI subnetwork	0.63	> 0.20	FRK (2.0)	ALDH2 (2.0)	C12orf51 (1.9)	PLCG1 (1.9)	MARK4 (1.8)	SMARCA4 (1.7)	MAFB (1.5)	PTPN11 (1.4)	NT5DC1 (1.4)	CYB561D1 (1.3)
MP:0004113	abnormal aortic arch morphology	0.63	> 0.20	MYLIP (3.1)	NYNRIN (2.5)	CEACAM19 (2.4)	HAVCR1 (1.9)	ATXN2 (1.9)	KIAA1324 (1.5)	ATXN7L2 (1.5)	POC5 (1.5)	LPIN3 (1.4)	ANKRD31 (1.3)
ENSG00000116747	TROVE2 PPI subnetwork	0.63	> 0.20	PARP10 (3.4)	OASL (3.4)	FADS1 (2.4)	DHODH (2.2)	NT5DC1 (1.9)	FADS2 (1.9)	GMPR (1.9)	NAA25 (1.8)	GPAM (1.7)	AMIGO1 (1.6)
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	0.63	> 0.20	YIPF2 (4.8)	ERP29 (2.8)	ATP13A1 (2.0)	OGDH (1.6)	TMEM57 (1.5)	SARS (1.5)	TMED4 (1.4)	GRINA (1.3)	ZHX3 (1.3)	FEN1 (1.3)
ENSG00000142875	PRKACB PPI subnetwork	0.63	> 0.20	PLEC (2.7)	OGDH (2.2)	ST3GAL4 (2.1)	CLPTM1 (1.9)	C12orf47 (1.8)	BCAM (1.8)	AMIGO1 (1.6)	PLEKHH2 (1.6)	RPH3A (1.5)	NYNRIN (1.5)
ENSG00000128908	INO80 PPI subnetwork	0.63	> 0.20	BUD13 (2.4)	SUGP1 (2.4)	GMPR (2.3)	ZNF180 (2.1)	TMEM57 (2.0)	SMARCA4 (1.9)	TOP1 (1.5)	ZNF259 (1.4)	C19orf52 (1.4)	ATXN7L2 (1.2)
ENSG00000135480	KRT7 PPI subnetwork	0.63	> 0.20	ENSG00000226648 (2.5)	CELSR2 (2.3)	NKPD1 (1.8)	DNAH11 (1.8)	ZHX3 (1.4)	PLCG1 (1.4)	PMFBP1 (1.4)	PSRC1 (1.3)	ENSG00000228044 (1.2)	MOSC1 (1.2)
GO:0007168	receptor guanylyl cyclase signaling pathway	0.63	> 0.20	TSSK6 (3.2)	CEACAM19 (3.0)	HAVCR1 (2.9)	NKPD1 (2.5)	C12orf47 (2.0)	UBXN2B (1.9)	NYNRIN (1.8)	TMEM116 (1.7)	HNF1A (1.6)	ACAD10 (1.4)
MP:0005103	abnormal retinal pigmentation	0.63	> 0.20	DYNC2LI1 (2.7)	HAVCR1 (1.9)	ST3GAL4 (1.9)	APOE (1.8)	SORT1 (1.6)	FRK (1.6)	C12orf47 (1.6)	ZNF180 (1.5)	ENSG00000235545 (1.4)	DOCK7 (1.4)
ENSG00000141198	TOM1L1 PPI subnetwork	0.63	> 0.20	TMED4 (2.5)	LPAR2 (2.3)	PLEKHH2 (2.0)	COL4A3BP (1.9)	CLPTM1 (1.8)	TOP1 (1.8)	PPP1R37 (1.7)	APOE (1.6)	BRAP (1.5)	CYP7A1 (1.5)
GO:0032648	regulation of interferon-beta production	0.63	> 0.20	OASL (3.2)	DNAH11 (3.2)	PARP10 (2.9)	GEMIN7 (2.8)	CYB561D1 (2.7)	ADAM1 (1.9)	TSSK6 (1.9)	C12orf43 (1.8)	TRAFD1 (1.8)	ZNF180 (1.8)
MP:0008108	abnormal small intestinal villus morphology	0.63	> 0.20	HLX (3.2)	GCNT4 (2.3)	PVR (2.0)	NPC1L1 (1.9)	GEMIN7 (1.9)	C11orf9 (1.7)	MYLIP (1.7)	MAU2 (1.7)	POLK (1.6)	C1orf63 (1.5)
ENSG00000104976	SNAPC2 PPI subnetwork	0.63	> 0.20	C12orf43 (3.7)	ADAM1 (3.1)	GEMIN7 (3.1)	POC5 (2.8)	MAPKAPK5 (2.4)	ATXN2 (2.2)	DDX56 (2.1)	SUGP1 (2.1)	ZNF259 (2.0)	BUD13 (2.0)
ENSG00000063244	U2AF2 PPI subnetwork	0.63	> 0.20	C1orf63 (5.0)	ILF3 (4.2)	TOP1 (3.5)	BUD13 (2.9)	USP1 (2.6)	SMARCA4 (2.6)	DHX38 (2.4)	PTPN11 (2.1)	QTRT1 (2.1)	SUGP1 (1.8)
ENSG00000175550	DRAP1 PPI subnetwork	0.63	> 0.20	PSRC1 (2.9)	POLK (2.8)	C19orf52 (2.5)	PSMA5 (2.5)	C12orf47 (2.4)	ZHX3 (2.1)	TMEM116 (2.1)	USP1 (2.1)	AMIGO1 (1.8)	POC5 (1.7)
ENSG00000140474	ULK3 PPI subnetwork	0.63	> 0.20	BCAM (2.4)	NAA25 (2.3)	MARK4 (1.9)	CARM1 (1.8)	NKPD1 (1.6)	C19orf52 (1.5)	ATXN7L2 (1.5)	TMED4 (1.5)	ZNF101 (1.5)	OGDH (1.5)
GO:0042113	B cell activation	0.63	> 0.20	ZNF101 (2.5)	PBX4 (2.3)	GMIP (1.9)	TIMD4 (1.8)	GCNT4 (1.7)	C17orf57 (1.5)	NT5DC1 (1.4)	SH2B3 (1.4)	ERP29 (1.2)	ENSG00000238078 (1.2)
MP:0002176	increased brain weight	0.63	> 0.20	SARS (2.5)	ZHX3 (2.1)	POLK (2.0)	SLC44A2 (1.8)	GRINA (1.8)	GMPR (1.7)	FADS1 (1.6)	ATXN2 (1.5)	SLC22A1 (1.4)	TXNL4B (1.3)
MP:0008515	thin retinal outer nuclear layer	0.63	> 0.20	DYNC2LI1 (2.0)	ENSG00000235545 (1.6)	MAPKAPK5 (1.6)	GPAM (1.4)	GEMIN7 (1.4)	ZNF180 (1.4)	RHCE (1.2)	GOT2P1 (1.2)	ST3GAL4 (1.2)	PSRC1 (1.1)
ENSG00000104722	NEFM PPI subnetwork	0.63	> 0.20	ALDH2 (3.4)	RPH3A (2.8)	APOC1 (2.6)	CELSR2 (2.2)	C11orf9 (2.2)	HAPLN4 (2.2)	NCAN (1.9)	GRINA (1.9)	NT5DC1 (1.8)	MOSC1 (1.6)
ENSG00000173534	ENSG00000173534 PPI subnetwork	0.63	> 0.20	ILF3 (2.4)	SUGP1 (2.4)	NKPD1 (2.2)	QTRT1 (2.2)	C1orf63 (1.8)	DHX38 (1.7)	MAU2 (1.7)	UBXN2B (1.7)	ANKRD31 (1.6)	C12orf43 (1.4)
ENSG00000170847	ENSG00000170847 PPI subnetwork	0.63	> 0.20	ILF3 (2.4)	SUGP1 (2.4)	NKPD1 (2.2)	QTRT1 (2.2)	C1orf63 (1.8)	DHX38 (1.7)	MAU2 (1.7)	UBXN2B (1.7)	ANKRD31 (1.6)	C12orf43 (1.4)
GO:0004693	cyclin-dependent protein kinase activity	0.63	> 0.20	DYNC2LI1 (2.6)	POLK (2.0)	PBX4 (1.9)	PSRC1 (1.9)	DNAH11 (1.8)	C11orf9 (1.8)	HLX (1.7)	SORT1 (1.6)	TOMM40 (1.4)	GATAD2A (1.3)
GO:0005212	structural constituent of eye lens	0.63	> 0.20	GOT2P1 (3.0)	C12orf47 (1.8)	NPC1L1 (1.4)	C19orf52 (1.4)	SYPL2 (1.3)	PLEC (1.0)	NCAN (1.0)	ST3GAL4 (1.0)	GCNT4 (0.9)	RHCE (0.9)
ENSG00000150787	PTS PPI subnetwork	0.63	> 0.20	C12orf51 (2.8)	USP24 (2.8)	ABCG8 (2.3)	NPC1L1 (2.3)	TM6SF2 (2.1)	ABCG5 (2.0)	ZNF259 (1.8)	GPAM (1.8)	NT5DC1 (1.8)	ENSG00000254235 (1.8)
GO:0002548	monocyte chemotaxis	0.63	> 0.20	ENSG00000226645 (2.5)	PMFBP1 (2.4)	CETP (2.3)	ZNF180 (2.0)	CEACAM19 (2.0)	DNAH11 (1.9)	MAFB (1.7)	PVR (1.7)	BLOC1S3 (1.6)	YIPF2 (1.5)
GO:0032526	response to retinoic acid	0.63	> 0.20	TSSK6 (2.3)	AP1M2 (1.8)	ATXN7L2 (1.8)	LPAR2 (1.7)	ENSG00000235545 (1.7)	HAPLN4 (1.7)	ABO (1.5)	C11orf9 (1.5)	MYLIP (1.5)	C19orf52 (1.4)
ENSG00000105216	ENSG00000105216 PPI subnetwork	0.63	> 0.20	MARK4 (3.6)	GMIP (3.0)	C12orf51 (2.7)	ATXN2 (2.6)	LPAR2 (2.6)	USP24 (2.5)	DNM2 (2.5)	PVRL2 (2.3)	SLC44A2 (2.2)	POLK (2.0)
GO:0010494	cytoplasmic stress granule	0.63	> 0.20	BRAP (2.4)	MAPKAPK5 (2.2)	COL4A3BP (2.1)	TOP1 (2.1)	GATAD2A (1.7)	ABCG8 (1.7)	PLCG1 (1.7)	MYLIP (1.6)	SUGP1 (1.6)	PPP1R37 (1.5)
MP:0008076	abnormal CD4-positive T cell differentiation	0.63	> 0.20	GMIP (2.2)	PLCG1 (2.2)	BCL3 (2.2)	PBX4 (2.0)	MYLIP (2.0)	USP24 (1.9)	RELB (1.7)	C19orf52 (1.5)	MAFB (1.4)	HAVCR1 (1.3)
GO:0060343	trabecula formation	0.63	> 0.20	CEACAM19 (3.2)	ATXN7L2 (3.1)	CARM1 (2.9)	ENSG00000254235 (2.3)	HAVCR1 (1.8)	CBLC (1.7)	GOT2P1 (1.7)	CILP2 (1.7)	AP1M2 (1.6)	C19orf52 (1.6)
MP:0001127	small ovary	0.63	> 0.20	KIAA1324 (2.2)	NYNRIN (2.0)	GATAD2A (1.5)	ABO (1.4)	ANKRD31 (1.4)	AP1M2 (1.4)	ATXN7L2 (1.3)	PCSK9 (1.3)	CYP7A1 (1.2)	LDLR (1.1)
ENSG00000060688	SNRNP40 PPI subnetwork	0.63	> 0.20	ILF3 (4.3)	C1orf63 (3.4)	TOP1 (2.9)	BUD13 (2.7)	SMARCA4 (2.7)	USP1 (2.6)	FEN1 (2.6)	DHX38 (2.5)	SUGP1 (2.4)	QTRT1 (2.2)
ENSG00000196220	SRGAP3 PPI subnetwork	0.63	> 0.20	ERP29 (3.9)	CLPTM1 (3.5)	TMED4 (2.8)	YIPF2 (2.7)	CELSR2 (2.6)	BCAM (2.4)	GRINA (2.4)	RPH3A (2.3)	PCSK9 (2.2)	TMEM50A (2.1)
ENSG00000116898	MRPS15 PPI subnetwork	0.63	> 0.20	HNF1A (2.7)	HAPLN4 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	GPAM (2.0)	NT5DC1 (2.0)	DDX56 (1.9)	BRAP (1.8)	ITGB3 (1.7)	FRK (1.6)
ENSG00000077809	GTF2I PPI subnetwork	0.63	> 0.20	BCL3 (3.0)	ATXN7L2 (2.8)	TRAFD1 (2.5)	NT5DC1 (2.1)	DNM2 (2.1)	CARM1 (2.0)	ATP13A1 (1.9)	ACAD10 (1.9)	RELB (1.7)	PVRL2 (1.6)
ENSG00000161016	RPL8 PPI subnetwork	0.63	> 0.20	ZNF259 (3.6)	NAA25 (3.4)	DDX56 (2.7)	DHX38 (2.6)	SARS (2.2)	TOMM40 (2.1)	QTRT1 (2.0)	NKPD1 (2.0)	SUGP1 (2.0)	GATAD2A (1.9)
ENSG00000135506	OS9 PPI subnetwork	0.63	> 0.20	TM6SF2 (2.9)	FRK (2.7)	NT5DC1 (2.4)	TXNL4B (2.1)	CYB561D1 (2.1)	ABCG5 (2.0)	ENSG00000226645 (1.8)	ZNF101 (1.7)	NPC1L1 (1.6)	ENSG00000226648 (1.5)
ENSG00000112096	SOD2 PPI subnetwork	0.63	> 0.20	ENSG00000228044 (3.2)	PSRC1 (2.8)	GOT2P1 (2.6)	TOMM40 (2.4)	ENSG00000235545 (2.2)	MARK4 (1.8)	BLOC1S3 (1.8)	FEN1 (1.8)	PVR (1.6)	ZHX3 (1.5)
GO:0007567	parturition	0.63	> 0.20	PVR (2.3)	FRK (2.2)	ENSG00000226645 (2.0)	ENSG00000228044 (1.8)	NKPD1 (1.5)	GEMIN7 (1.3)	CYB561D1 (1.3)	KIAA1324 (1.3)	BLOC1S3 (1.3)	PMFBP1 (1.3)
ENSG00000165659	DACH1 PPI subnetwork	0.63	> 0.20	MYLIP (2.6)	USP24 (2.5)	TMEM57 (2.4)	SH2B3 (2.4)	KIAA1324 (2.1)	ABO (1.9)	TRAFD1 (1.8)	LPA (1.5)	PPP1R37 (1.4)	LPIN3 (1.3)
GO:0009112	nucleobase metabolic process	0.63	> 0.20	DHODH (3.0)	ENSG00000228044 (2.7)	ANKRD31 (2.5)	NT5DC1 (2.2)	LPA (2.2)	QTRT1 (2.2)	LPIN3 (2.2)	ACAD10 (1.9)	TRAPPC6A (1.9)	TXNL4B (1.9)
GO:0016525	negative regulation of angiogenesis	0.63	> 0.20	CILP2 (3.4)	ITGB3 (2.1)	PVR (1.9)	PMFBP1 (1.8)	C17orf57 (1.8)	CEACAM19 (1.7)	POLK (1.6)	SH2B3 (1.5)	ENSG00000226648 (1.4)	MOSC1 (1.3)
ENSG00000197905	TEAD4 PPI subnetwork	0.63	> 0.20	ST3GAL4 (2.7)	FRK (2.1)	TSSK6 (1.9)	SH2B3 (1.8)	NYNRIN (1.7)	ENSG00000228044 (1.7)	ENSG00000226648 (1.7)	GPAM (1.6)	TMEM116 (1.5)	LPA (1.5)
GO:0043407	negative regulation of MAP kinase activity	0.63	> 0.20	TRIB1 (3.9)	ENSG00000226645 (3.2)	ENSG00000238078 (2.3)	SYPL2 (1.7)	AMIGO1 (1.6)	HLX (1.6)	SH2B3 (1.4)	ZNF180 (1.3)	SORT1 (1.3)	ATXN7L2 (1.2)
GO:0002791	regulation of peptide secretion	0.63	> 0.20	KIAA1324 (4.8)	HNF1A (2.3)	HAPLN4 (2.2)	ANKRD31 (2.2)	ABO (2.2)	ENSG00000238078 (1.9)	COL4A3BP (1.8)	PLEKHH2 (1.7)	AP1M2 (1.5)	MOSC1 (1.3)
GO:0090087	regulation of peptide transport	0.63	> 0.20	KIAA1324 (4.8)	HNF1A (2.3)	HAPLN4 (2.2)	ANKRD31 (2.2)	ABO (2.2)	ENSG00000238078 (1.9)	COL4A3BP (1.8)	PLEKHH2 (1.7)	AP1M2 (1.5)	MOSC1 (1.3)
ENSG00000124074	C16orf48 PPI subnetwork	0.63	> 0.20	MARK4 (2.5)	HAVCR1 (2.4)	ST3GAL4 (2.4)	PPP1R37 (2.3)	PVRL2 (2.3)	ENSG00000226648 (2.0)	FRK (1.9)	GRINA (1.8)	UBXN2B (1.8)	HLX (1.8)
GO:0030258	lipid modification	0.63	> 0.20	ACAD10 (3.5)	MOSC1 (3.2)	NT5DC1 (2.3)	GPAM (2.1)	APOC4 (1.8)	ANGPTL3 (1.8)	APOA5 (1.7)	ENSG00000238078 (1.7)	C19orf52 (1.7)	ABCG5 (1.7)
MP:0004754	abnormal kidney collecting duct morphology	0.63	> 0.20	NYNRIN (4.1)	KANK2 (2.2)	AP1M2 (2.0)	CBLC (2.0)	ENSG00000228044 (1.9)	ST3GAL4 (1.7)	DOCK7 (1.6)	PLEKHH2 (1.6)	NPC1L1 (1.2)	FRK (1.2)
GO:0051492	regulation of stress fiber assembly	0.63	> 0.20	USP24 (2.3)	C17orf57 (2.2)	PBX4 (2.0)	NYNRIN (1.9)	ABO (1.8)	KANK2 (1.8)	GCNT4 (1.6)	PLEKHH2 (1.5)	ITGB3 (1.3)	ENSG00000226645 (1.2)
REACTOME_POLYMERASE_SWITCHING_ON_THE_C:STRAND_OF_THE_TELOMERE	REACTOME_POLYMERASE_SWITCHING_ON_THE_C:STRAND_OF_THE_TELOMERE	0.63	> 0.20	FEN1 (6.0)	USP1 (5.7)	ZNF180 (2.7)	ENSG00000228044 (1.9)	ENSG00000235545 (1.8)	AMIGO1 (1.5)	FADS1 (1.5)	TMEM116 (1.5)	ERP29 (1.2)	DHODH (1.2)
REACTOME_LEADING_STRAND_SYNTHESIS	REACTOME_LEADING_STRAND_SYNTHESIS	0.63	> 0.20	FEN1 (6.0)	USP1 (5.7)	ZNF180 (2.7)	ENSG00000228044 (1.9)	ENSG00000235545 (1.8)	AMIGO1 (1.5)	FADS1 (1.5)	TMEM116 (1.5)	ERP29 (1.2)	DHODH (1.2)
REACTOME_POLYMERASE_SWITCHING	REACTOME_POLYMERASE_SWITCHING	0.63	> 0.20	FEN1 (6.0)	USP1 (5.7)	ZNF180 (2.7)	ENSG00000228044 (1.9)	ENSG00000235545 (1.8)	AMIGO1 (1.5)	FADS1 (1.5)	TMEM116 (1.5)	ERP29 (1.2)	DHODH (1.2)
ENSG00000189162	ENSG00000189162 PPI subnetwork	0.63	> 0.20	PSMA5 (2.9)	CLPTM1 (2.3)	NT5DC1 (2.1)	BCL3 (1.9)	HLX (1.8)	TIMD4 (1.8)	RELB (1.6)	TMEM50A (1.6)	PBX4 (1.5)	ZNF101 (1.5)
ENSG00000086475	SEPHS1 PPI subnetwork	0.63	> 0.20	CEACAM19 (2.3)	FADS2 (2.2)	CYB561D1 (1.9)	PCSK9 (1.6)	PVR (1.6)	FRK (1.6)	TMEM116 (1.5)	NCAN (1.4)	LDLR (1.4)	HAPLN4 (1.3)
ENSG00000181852	RNF41 PPI subnetwork	0.63	> 0.20	ATXN2 (3.8)	CELSR2 (3.3)	CARM1 (2.9)	DNM2 (2.8)	DOCK7 (2.7)	PVRL2 (2.6)	ZNF101 (2.5)	GATAD2A (2.4)	SORT1 (2.4)	USP24 (2.2)
GO:0006776	vitamin A metabolic process	0.63	> 0.20	NKPD1 (2.7)	ENSG00000235545 (2.3)	TM6SF2 (2.2)	PMFBP1 (2.1)	C11orf9 (2.1)	ABCG8 (2.0)	LPAR2 (1.9)	CYP7A1 (1.9)	ABCG5 (1.7)	ALDH2 (1.4)
GO:0046697	decidualization	0.63	> 0.20	PLEKHH2 (2.7)	TMED4 (2.5)	ATXN7L2 (2.1)	ENSG00000228044 (2.0)	YIPF2 (2.0)	CEACAM19 (1.8)	UBXN2B (1.6)	AP1M2 (1.5)	KIAA1324 (1.4)	BLOC1S3 (1.4)
ENSG00000005194	CIAPIN1 PPI subnetwork	0.63	> 0.20	PARP10 (2.6)	PPP1R37 (2.6)	TOMM40 (2.4)	ENSG00000226648 (2.2)	DOCK7 (2.1)	PTPN11 (2.0)	PVR (2.0)	BLOC1S3 (1.9)	CYB561D1 (1.8)	ZNF180 (1.8)
ENSG00000075188	NUP37 PPI subnetwork	0.63	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.0)	POC5 (3.7)	ZNF180 (1.4)	ILF3 (1.3)	ENSG00000226648 (1.3)	USP24 (1.2)	DDX56 (1.0)	ENSG00000228044 (1.0)
GO:0004722	protein serine/threonine phosphatase activity	0.63	> 0.20	AMIGO1 (2.2)	GMPR (1.9)	OGDH (1.7)	C19orf52 (1.7)	ZNF180 (1.6)	SORT1 (1.6)	HLX (1.4)	USP1 (1.4)	KANK2 (1.4)	PTPN11 (1.4)
MP:0001560	abnormal circulating insulin level	0.63	> 0.20	MOSC1 (2.8)	ZNF101 (2.7)	GPAM (2.6)	PMFBP1 (2.2)	ENSG00000238078 (2.1)	ABO (2.1)	SORT1 (2.0)	CYP7A1 (2.0)	ENSG00000226645 (1.7)	HLX (1.7)
ENSG00000147689	FAM83A PPI subnetwork	0.63	> 0.20	MARK4 (3.5)	GMIP (3.1)	C12orf51 (2.7)	LPAR2 (2.6)	ATXN2 (2.6)	USP24 (2.5)	DNM2 (2.5)	PVRL2 (2.4)	SLC44A2 (2.2)	POLK (2.0)
GO:0032982	myosin filament	0.63	> 0.20	SYPL2 (6.7)	GMPR (2.8)	NPC1L1 (1.0)	KANK2 (0.9)	RPH3A (0.8)	SH2B3 (0.7)	C12orf47 (0.7)	KIAA1324 (0.7)	UBXN2B (0.7)	NKPD1 (0.7)
ENSG00000176105	YES1 PPI subnetwork	0.63	> 0.20	PVRL2 (3.1)	SH2B3 (2.8)	CETP (2.7)	MAFB (2.7)	PLEC (2.4)	C11orf9 (2.2)	ITGB3 (2.1)	CBLC (1.6)	LDLR (1.6)	DOCK7 (1.6)
ENSG00000183558	HIST2H2AA3 PPI subnetwork	0.63	> 0.20	SMARCA4 (2.7)	ILF3 (2.4)	CARM1 (2.2)	USP1 (2.2)	DDX56 (2.1)	BUD13 (2.1)	TOMM40 (2.0)	TOP1 (1.9)	TXNL4B (1.8)	SUGP1 (1.7)
ENSG00000203812	HIST2H2AA4 PPI subnetwork	0.63	> 0.20	SMARCA4 (2.7)	ILF3 (2.4)	CARM1 (2.2)	USP1 (2.2)	DDX56 (2.1)	BUD13 (2.1)	TOMM40 (2.0)	TOP1 (1.9)	TXNL4B (1.8)	SUGP1 (1.7)
MP:0002024	T cell derived lymphoma	0.63	> 0.20	FEN1 (3.8)	USP1 (3.0)	POLK (2.3)	SMARCA4 (2.0)	ATXN7L2 (1.7)	TMEM57 (1.7)	NYNRIN (1.5)	UBXN2B (1.4)	TRIB1 (1.4)	HLX (1.3)
GO:0000793	condensed chromosome	0.63	> 0.20	PSRC1 (5.1)	FEN1 (4.9)	USP1 (4.3)	POC5 (2.9)	ILF3 (1.6)	MAU2 (1.1)	ANKRD31 (1.0)	DHX38 (1.0)	ENSG00000228044 (1.0)	BUD13 (0.9)
MP:0006143	increased systemic arterial diastolic blood pressure	0.63	> 0.20	BCAM (3.4)	RHCE (2.4)	RHD (2.3)	MAFB (2.2)	GOT2P1 (1.7)	CILP2 (1.6)	ATXN7L2 (1.4)	PVRL2 (1.4)	CYP7A1 (1.3)	SLC22A1 (1.3)
GO:0006875	cellular metal ion homeostasis	0.63	> 0.20	ERP29 (2.1)	C12orf47 (2.1)	SYPL2 (1.7)	AMIGO1 (1.6)	ABO (1.6)	TMEM116 (1.4)	RHD (1.4)	RHCE (1.4)	RPH3A (1.3)	CETP (1.3)
ENSG00000115163	CENPA PPI subnetwork	0.63	> 0.20	PSRC1 (5.5)	FEN1 (4.6)	POC5 (3.8)	USP1 (3.7)	ZNF180 (1.3)	ZHX3 (0.9)	LPIN3 (0.9)	USP24 (0.9)	ENSG00000226648 (0.9)	ENSG00000228044 (0.7)
MP:0000359	abnormal mast cell morphology	0.63	> 0.20	GMIP (2.1)	GPAM (2.0)	MOSC1 (1.7)	HLX (1.6)	CYB561D1 (1.6)	SH2B3 (1.6)	GOT2P1 (1.3)	PARP10 (1.3)	LPAR2 (1.1)	ABCG8 (1.1)
ENSG00000197971	MBP PPI subnetwork	0.63	> 0.20	SORT1 (2.5)	C11orf9 (2.3)	PTPN11 (1.9)	PSRC1 (1.7)	CELSR2 (1.7)	RPH3A (1.7)	NPC1L1 (1.5)	NYNRIN (1.5)	ADAM1 (1.5)	DNAH11 (1.4)
GO:0016073	snRNA metabolic process	0.63	> 0.20	POC5 (2.9)	UBXN2B (2.4)	DHX38 (2.1)	GEMIN7 (2.0)	NKPD1 (1.9)	GCNT4 (1.8)	ATXN7L2 (1.7)	SUGP1 (1.6)	BUD13 (1.6)	NT5DC1 (1.5)
ENSG00000167548	MLL2 PPI subnetwork	0.63	> 0.20	C12orf51 (2.7)	KIAA1324 (1.9)	ZHX3 (1.9)	C19orf52 (1.7)	BUD13 (1.6)	GCNT4 (1.6)	PLEC (1.5)	KANK2 (1.5)	SMARCA4 (1.4)	POC5 (1.3)
ENSG00000100591	AHSA1 PPI subnetwork	0.63	> 0.20	POLK (3.4)	DDX56 (2.1)	ENSG00000235545 (2.0)	NAA25 (2.0)	TOMM40 (1.9)	ZNF259 (1.6)	SARS (1.5)	OGDH (1.5)	C12orf43 (1.5)	PSMA5 (1.5)
ENSG00000058272	PPP1R12A PPI subnetwork	0.63	> 0.20	PLEC (3.3)	KANK2 (3.2)	OGDH (2.7)	PTPN11 (2.5)	C1orf63 (2.1)	TMEM50A (2.0)	ITGB3 (2.0)	SYPL2 (1.9)	TOP1 (1.9)	SMARCA4 (1.6)
GO:0034976	response to endoplasmic reticulum stress	0.63	> 0.20	SARS (2.9)	TXNL4B (2.6)	YIPF2 (2.5)	GCNT4 (2.3)	ENSG00000238078 (2.2)	C12orf47 (2.1)	ERP29 (1.8)	TMED4 (1.6)	TMEM57 (1.3)	BLOC1S3 (1.3)
GO:0060043	regulation of cardiac muscle cell proliferation	0.63	> 0.20	C11orf9 (2.5)	GCNT4 (1.9)	C19orf52 (1.8)	PLEKHH2 (1.7)	ALDH2 (1.6)	TXNL4B (1.5)	ENSG00000254235 (1.5)	GOT2P1 (1.5)	DYNC2LI1 (1.4)	C17orf57 (1.4)
ENSG00000176108	CHMP6 PPI subnetwork	0.63	> 0.20	C12orf43 (3.6)	DYNC2LI1 (2.6)	UBXN2B (2.5)	TRAPPC6A (2.4)	GEMIN7 (2.3)	TMEM50A (2.2)	CYB561D1 (2.1)	CBLC (2.1)	PPP1R37 (2.0)	BRAP (1.9)
ENSG00000137834	SMAD6 PPI subnetwork	0.63	> 0.20	MAPKAPK5 (2.1)	ATXN2 (1.8)	PPP1R37 (1.8)	MARK4 (1.8)	ABO (1.7)	POLK (1.6)	PLCG1 (1.5)	SH2B3 (1.4)	RELB (1.3)	MYLIP (1.2)
MP:0000716	abnormal immune system cell morphology	0.63	> 0.20	HAVCR1 (2.9)	GMIP (2.4)	PARP10 (2.3)	POLK (2.2)	ZNF101 (2.2)	PLEC (2.1)	SLC44A2 (2.1)	MAFB (1.9)	TMEM57 (1.9)	HLX (1.9)
GO:0033261	regulation of S phase	0.63	> 0.20	MAU2 (3.8)	ENSG00000228044 (2.0)	GATAD2A (1.9)	ZNF101 (1.8)	TXNL4B (1.8)	C19orf52 (1.8)	KANK2 (1.5)	ILF3 (1.4)	UBXN2B (1.3)	USP1 (1.3)
MP:0006359	absent startle reflex	0.63	> 0.20	TRIB1 (3.6)	C12orf47 (2.4)	CEACAM19 (2.1)	LPAR2 (2.1)	NCAN (1.9)	ANKRD31 (1.8)	GCNT4 (1.8)	TRAFD1 (1.8)	PBX4 (1.7)	ENSG00000238078 (1.6)
ENSG00000142528	ZNF473 PPI subnetwork	0.63	> 0.20	ZNF259 (3.8)	ENSG00000226645 (3.1)	TXNL4B (2.3)	CYB561D1 (2.2)	C12orf47 (2.2)	ADAM1 (1.7)	ERP29 (1.5)	HNF1A (1.5)	ILF3 (1.4)	NKPD1 (1.4)
ENSG00000166508	MCM7 PPI subnetwork	0.63	> 0.20	FEN1 (5.3)	USP1 (4.5)	POC5 (2.8)	PSRC1 (2.2)	DHODH (2.0)	TXNL4B (1.6)	ENSG00000235545 (1.4)	NT5DC1 (1.2)	TMEM116 (1.2)	NCAN (1.1)
GO:0032225	regulation of synaptic transmission, dopaminergic	0.63	> 0.20	BLOC1S3 (2.9)	GCNT4 (2.9)	ABO (2.8)	DNAH11 (2.0)	GMPR (1.9)	PMFBP1 (1.9)	TSSK6 (1.8)	ADAM1 (1.3)	ST3GAL4 (1.2)	ZNF180 (1.1)
ENSG00000140525	FANCI PPI subnetwork	0.63	> 0.20	TRIB1 (2.3)	C19orf52 (2.3)	POC5 (2.1)	CARM1 (2.1)	ABO (2.0)	GMPR (2.0)	ENSG00000226648 (1.8)	KIAA1324 (1.8)	GEMIN7 (1.7)	HLX (1.7)
MP:0001784	abnormal fluid regulation	0.63	> 0.20	CILP2 (2.6)	ENSG00000228044 (2.4)	PLEKHH2 (2.2)	HP (2.1)	GOT2P1 (2.1)	PLEC (1.9)	SLC22A1 (1.9)	SYPL2 (1.7)	ENSG00000235545 (1.6)	NYNRIN (1.5)
GO:0042633	hair cycle	0.63	> 0.20	ANKRD31 (3.1)	CELSR2 (2.8)	BCAM (2.1)	ABO (2.0)	BLOC1S3 (1.9)	ENSG00000254235 (1.7)	SLC44A2 (1.5)	CBLC (1.5)	NYNRIN (1.5)	AP1M2 (1.3)
GO:0042303	molting cycle	0.63	> 0.20	ANKRD31 (3.1)	CELSR2 (2.8)	BCAM (2.1)	ABO (2.0)	BLOC1S3 (1.9)	ENSG00000254235 (1.7)	SLC44A2 (1.5)	CBLC (1.5)	NYNRIN (1.5)	AP1M2 (1.3)
GO:0032607	interferon-alpha production	0.63	> 0.20	OASL (6.1)	PARP10 (4.9)	TRAFD1 (3.6)	ZNF101 (2.2)	FRK (2.0)	GMPR (1.7)	ZNF180 (1.6)	CYB561D1 (1.6)	DYNC2LI1 (1.4)	MYLIP (1.2)
GO:0032647	regulation of interferon-alpha production	0.63	> 0.20	OASL (6.1)	PARP10 (4.9)	TRAFD1 (3.6)	ZNF101 (2.2)	FRK (2.0)	GMPR (1.7)	ZNF180 (1.6)	CYB561D1 (1.6)	DYNC2LI1 (1.4)	MYLIP (1.2)
MP:0008208	decreased pro-B cell number	0.63	> 0.20	MYLIP (3.1)	TMEM57 (3.0)	HLX (2.5)	RHD (2.0)	ENSG00000238078 (1.7)	KANK2 (1.6)	PLCG1 (1.6)	DYNC2LI1 (1.5)	GMIP (1.4)	RHCE (1.4)
GO:0008047	enzyme activator activity	0.63	> 0.20	SH2B3 (3.7)	HLX (3.1)	GMIP (3.0)	C12orf51 (2.2)	ZHX3 (2.0)	CBLC (1.9)	DNM2 (1.9)	LPIN3 (1.8)	APOE (1.7)	ATXN2 (1.5)
MP:0001199	thin skin	0.63	> 0.20	MARK4 (3.0)	PPP1R37 (2.5)	CBLC (1.9)	YIPF2 (1.8)	PVRL2 (1.8)	C1orf63 (1.6)	CLPTM1 (1.3)	GATAD2A (1.3)	C17orf57 (1.3)	AP1M2 (1.2)
MP:0002048	increased lung adenoma incidence	0.63	> 0.20	ENSG00000226648 (3.1)	NYNRIN (2.4)	TSSK6 (2.3)	C12orf51 (2.0)	PBX4 (2.0)	GCNT4 (1.8)	ABO (1.8)	TRAPPC6A (1.8)	NT5DC1 (1.6)	KANK2 (1.6)
MP:0002664	decreased circulating adrenocorticotropin level	0.63	> 0.20	PLEKHH2 (2.6)	C12orf47 (2.4)	POLK (2.0)	KIAA1324 (1.9)	GEMIN7 (1.7)	MOSC1 (1.6)	ABO (1.6)	POC5 (1.5)	PPP1R37 (1.5)	CELSR2 (1.5)
MP:0003884	decreased macrophage cell number	0.63	> 0.20	RELB (3.6)	HAVCR1 (3.1)	BCL3 (2.4)	MAFB (2.2)	GMIP (1.8)	ENSG00000228044 (1.6)	ZNF180 (1.5)	PLEC (1.4)	TRIB1 (1.3)	SH2B3 (1.2)
GO:0021903	rostrocaudal neural tube patterning	0.63	> 0.20	ANKRD31 (3.8)	DNAH11 (3.5)	ENSG00000226648 (2.7)	C12orf47 (2.2)	ENSG00000254235 (1.8)	PBX4 (1.7)	CARM1 (1.6)	TSSK6 (1.4)	LPAR2 (1.4)	MAPKAPK5 (1.3)
ENSG00000158941	KIAA1967 PPI subnetwork	0.63	> 0.20	BCL3 (3.6)	RELB (3.4)	TRAPPC6A (2.0)	BCAM (1.9)	ATP13A1 (1.8)	GMIP (1.8)	C12orf43 (1.7)	DHODH (1.7)	POLK (1.6)	CILP2 (1.5)
GO:0000779	condensed chromosome, centromeric region	0.63	> 0.20	PSRC1 (6.0)	FEN1 (4.2)	POC5 (4.1)	USP1 (3.4)	ILF3 (0.9)	PBX4 (0.9)	GCNT4 (0.8)	BUD13 (0.7)	ENSG00000228044 (0.7)	ACAD10 (0.7)
ENSG00000120656	TAF12 PPI subnetwork	0.63	> 0.20	MAU2 (2.9)	C19orf52 (2.8)	SUGP1 (2.8)	MAPKAPK5 (2.7)	ATXN2 (2.6)	ILF3 (2.4)	TOP1 (2.3)	TXNL4B (2.3)	C12orf51 (2.1)	BUD13 (2.1)
ENSG00000129084	PSMA1 PPI subnetwork	0.63	> 0.20	PSMA5 (5.8)	TRAFD1 (3.2)	NT5DC1 (2.7)	NAA25 (2.6)	ENSG00000254235 (1.6)	PARP10 (1.5)	TOMM40 (1.5)	SARS (1.4)	DDX56 (1.3)	C17orf57 (1.3)
MP:0001388	abnormal stationary movement	0.63	> 0.20	USP24 (2.4)	ACAD10 (2.3)	DNAH11 (2.0)	GOT2P1 (1.9)	ATXN7L2 (1.6)	PVRL2 (1.6)	TMEM50A (1.6)	SLC22A1 (1.5)	RHD (1.4)	HAVCR1 (1.4)
GO:0030852	regulation of granulocyte differentiation	0.63	> 0.20	PBX4 (2.4)	C1orf63 (2.4)	C17orf57 (2.1)	ENSG00000235545 (1.8)	TIMD4 (1.8)	GPAM (1.7)	ENSG00000226648 (1.6)	ENSG00000238078 (1.5)	ITGB3 (1.5)	RHCE (1.4)
REACTOME_O:LINKED_GLYCOSYLATION_OF_MUCINS	REACTOME_O:LINKED_GLYCOSYLATION_OF_MUCINS	0.64	> 0.20	ST3GAL4 (3.9)	KIAA1324 (3.7)	PMFBP1 (2.0)	ABO (1.9)	TMED4 (1.8)	AP1M2 (1.7)	PVRL2 (1.7)	DNAH11 (1.6)	SLC44A2 (1.5)	C11orf9 (1.5)
MP:0001442	decreased grooming behavior	0.64	> 0.20	NPC1L1 (3.5)	ABCG5 (2.6)	HNF1A (2.5)	ABCG8 (2.5)	CYP7A1 (2.2)	TM6SF2 (2.2)	RPH3A (2.1)	ABO (1.8)	C11orf9 (1.7)	APOA5 (1.7)
GO:0000724	double-strand break repair via homologous recombination	0.64	> 0.20	BUD13 (2.6)	POLK (2.2)	BLOC1S3 (2.1)	C12orf43 (2.0)	AMIGO1 (1.7)	TMEM116 (1.6)	USP1 (1.6)	FEN1 (1.5)	ZHX3 (1.5)	ENSG00000235545 (1.5)
MP:0006380	abnormal spermatid morphology	0.64	> 0.20	KIAA1324 (2.3)	BRAP (2.3)	PBX4 (2.2)	TSSK6 (2.2)	ABCG8 (1.9)	ENSG00000226645 (1.8)	NT5DC1 (1.7)	GPAM (1.5)	ANKRD31 (1.5)	TMED4 (1.4)
GO:0006023	aminoglycan biosynthetic process	0.64	> 0.20	ST3GAL4 (2.5)	HAVCR1 (2.1)	CILP2 (1.9)	GCNT4 (1.9)	ENSG00000254235 (1.7)	ZNF180 (1.6)	TMED4 (1.6)	TMEM57 (1.6)	FRK (1.5)	CYB561D1 (1.5)
ENSG00000186340	THBS2 PPI subnetwork	0.64	> 0.20	CILP2 (2.6)	KANK2 (2.3)	APOE (2.3)	APOC1 (2.0)	APOC4 (1.9)	ITGB3 (1.7)	CYP7A1 (1.4)	C17orf57 (1.4)	ATP13A1 (1.4)	SLC44A2 (1.4)
ENSG00000171858	RPS21 PPI subnetwork	0.64	> 0.20	NKPD1 (2.9)	PTPN11 (2.0)	ADAM1 (1.9)	SUGP1 (1.5)	NAA25 (1.4)	ILF3 (1.3)	CEACAM19 (1.3)	C12orf43 (1.3)	MYLIP (1.3)	TMEM57 (1.3)
ENSG00000153140	CETN3 PPI subnetwork	0.64	> 0.20	USP1 (3.0)	FEN1 (3.0)	ZNF180 (2.7)	NAA25 (2.6)	POC5 (2.2)	NT5DC1 (2.0)	PBX4 (1.9)	PSMA5 (1.8)	PSRC1 (1.6)	RHCE (1.6)
ENSG00000128683	GAD1 PPI subnetwork	0.64	> 0.20	POC5 (2.7)	COL4A3BP (2.3)	ADAM1 (2.2)	ABO (2.1)	PMFBP1 (1.6)	C17orf57 (1.6)	TRAFD1 (1.6)	ATXN7L2 (1.5)	C12orf51 (1.5)	APOA5 (1.4)
MP:0011024	abnormal branching involved in lung morphogenesis	0.64	> 0.20	PLEKHH2 (4.0)	BCAM (2.7)	SLC44A2 (2.5)	HLX (2.4)	NYNRIN (2.1)	TMEM116 (1.9)	PVRL2 (1.9)	DYNC2LI1 (1.8)	HAPLN4 (1.7)	SORT1 (1.6)
GO:0035967	cellular response to topologically incorrect protein	0.64	> 0.20	BLOC1S3 (3.2)	SARS (2.8)	GCNT4 (2.7)	TXNL4B (2.1)	YIPF2 (2.0)	TMED4 (1.8)	C12orf47 (1.8)	ERP29 (1.6)	ANKRD31 (1.3)	TMEM116 (1.0)
ENSG00000196730	DAPK1 PPI subnetwork	0.64	> 0.20	MARK4 (3.5)	TMEM50A (2.9)	NYNRIN (2.8)	CYB561D1 (2.3)	C11orf9 (2.2)	HLX (2.1)	PVRL2 (2.0)	FRK (1.7)	PLCG1 (1.7)	POLK (1.7)
ENSG00000125753	VASP PPI subnetwork	0.64	> 0.20	GMIP (3.9)	RHD (3.6)	GATAD2A (3.1)	CARM1 (2.8)	OGDH (2.6)	RHCE (2.5)	PLEC (2.4)	LPAR2 (2.0)	ITGB3 (1.9)	UBXN2B (1.8)
GO:0060976	coronary vasculature development	0.64	> 0.20	TSSK6 (2.7)	CEACAM19 (2.7)	C11orf9 (2.5)	NYNRIN (2.1)	PPP1R37 (1.8)	ANKRD31 (1.7)	MAPKAPK5 (1.6)	TMEM116 (1.6)	ATXN7L2 (1.6)	C17orf57 (1.6)
MP:0002882	abnormal neuron morphology	0.64	> 0.20	CELSR2 (2.5)	ERP29 (2.3)	NCAN (2.2)	COL4A3BP (2.1)	RPH3A (1.8)	ACAD10 (1.6)	APOE (1.6)	DOCK7 (1.5)	FADS1 (1.5)	ST3GAL4 (1.4)
GO:0006271	DNA strand elongation involved in DNA replication	0.64	> 0.20	ZNF180 (3.5)	USP1 (3.3)	FEN1 (2.9)	ENSG00000228044 (2.7)	GOT2P1 (1.7)	TMEM116 (1.6)	ENSG00000235545 (1.6)	AMIGO1 (1.5)	FRK (1.4)	ERP29 (1.2)
MP:0002455	abnormal dendritic cell antigen presentation	0.64	> 0.20	HLX (2.5)	TRAFD1 (2.1)	CETP (2.0)	BCL3 (2.0)	GMIP (1.6)	PARP10 (1.6)	COL4A3BP (1.5)	RELB (1.5)	MYLIP (1.3)	ENSG00000226645 (1.3)
GO:0006418	tRNA aminoacylation for protein translation	0.64	> 0.20	SARS (5.6)	ZNF259 (3.0)	NAA25 (3.0)	DHODH (2.9)	QTRT1 (2.8)	DDX56 (2.4)	MAPKAPK5 (2.3)	POC5 (2.2)	SUGP1 (1.9)	NT5DC1 (1.8)
ENSG00000168615	ADAM9 PPI subnetwork	0.64	> 0.20	DOCK7 (3.1)	ST3GAL4 (2.9)	ITGB3 (2.6)	KANK2 (2.6)	PBX4 (2.5)	APOE (2.1)	MAPKAPK5 (1.9)	TIMD4 (1.9)	GMPR (1.8)	PTPN11 (1.5)
ENSG00000108312	UBTF PPI subnetwork	0.64	> 0.20	TXNL4B (2.9)	DHX38 (2.8)	ILF3 (2.6)	C12orf43 (2.4)	ZNF259 (2.1)	DHODH (2.0)	DDX56 (1.8)	BUD13 (1.8)	PLEKHH2 (1.7)	MAPKAPK5 (1.5)
ENSG00000160844	GATS PPI subnetwork	0.64	> 0.20	SUGP1 (3.3)	C12orf43 (3.3)	ATXN7L2 (3.2)	MAPKAPK5 (2.7)	ZNF180 (2.4)	POC5 (2.4)	BRAP (2.2)	ZNF259 (1.9)	DHX38 (1.9)	ADAM1 (1.7)
KEGG_TASTE_TRANSDUCTION	KEGG_TASTE_TRANSDUCTION	0.64	> 0.20	PMFBP1 (2.4)	NYNRIN (2.1)	HAPLN4 (1.9)	YIPF2 (1.8)	ABO (1.8)	DNAH11 (1.7)	KANK2 (1.5)	ENSG00000228044 (1.5)	AP1M2 (1.5)	ST3GAL4 (1.4)
MP:0001426	polydipsia	0.64	> 0.20	PLG (3.0)	ERP29 (2.3)	ANGPTL3 (2.2)	C12orf47 (1.9)	SORT1 (1.9)	PLEKHH2 (1.6)	SLC22A1 (1.6)	PMFBP1 (1.5)	HAVCR1 (1.4)	BCAM (1.4)
GO:0012510	trans-Golgi network transport vesicle membrane	0.64	> 0.20	COL4A3BP (3.1)	POLK (2.3)	GRINA (2.1)	AMIGO1 (2.0)	GEMIN7 (1.9)	ERP29 (1.8)	CLPTM1 (1.7)	KIAA1324 (1.7)	ZNF101 (1.6)	C17orf57 (1.6)
MP:0006059	decreased susceptibility to ischemic brain injury	0.64	> 0.20	GMPR (3.2)	SORT1 (2.9)	NCAN (2.5)	ALDH2 (2.5)	ENSG00000254235 (2.4)	ATXN7L2 (2.4)	SYPL2 (2.3)	CELSR2 (2.1)	PLCG1 (2.0)	FADS1 (1.8)
ENSG00000135336	ORC3 PPI subnetwork	0.64	> 0.20	FEN1 (6.8)	USP1 (5.0)	TMEM116 (1.8)	PSRC1 (1.7)	ENSG00000235545 (1.4)	ENSG00000228044 (1.2)	LPIN3 (1.1)	ZNF180 (1.1)	MAU2 (1.0)	RHD (1.0)
GO:0022626	cytosolic ribosome	0.64	> 0.20	NKPD1 (2.4)	CEACAM19 (1.8)	MOSC1 (1.8)	GEMIN7 (1.6)	UBXN2B (1.4)	MARK4 (1.4)	DNAH11 (1.3)	GATAD2A (1.3)	ENSG00000226645 (1.3)	ERP29 (1.3)
GO:0035329	hippo signaling cascade	0.64	> 0.20	UBXN2B (2.4)	BLOC1S3 (2.3)	PTPN11 (2.1)	DOCK7 (2.1)	C17orf57 (2.0)	CYB561D1 (2.0)	C19orf52 (1.9)	ENSG00000238078 (1.9)	ZNF180 (1.7)	PBX4 (1.7)
MP:0003723	abnormal long bone morphology	0.64	> 0.20	CILP2 (4.1)	PLEKHH2 (2.2)	PVRL2 (2.1)	ENSG00000226648 (2.1)	APOE (2.0)	MAFB (1.9)	LPAR2 (1.7)	BCAM (1.6)	PPP1R37 (1.5)	KIAA1324 (1.5)
ENSG00000113194	FAF2 PPI subnetwork	0.64	> 0.20	TMEM57 (2.8)	USP24 (2.4)	TMED4 (2.4)	BRAP (2.3)	TMEM50A (2.3)	OASL (2.3)	GRINA (2.2)	CYP7A1 (2.2)	COL4A3BP (2.1)	ATXN2 (2.1)
ENSG00000120709	FAM53C PPI subnetwork	0.64	> 0.20	PLEC (3.7)	DNM2 (3.2)	ZHX3 (3.1)	CARM1 (2.9)	USP24 (2.6)	LPAR2 (2.5)	C12orf51 (2.5)	ATXN2 (2.4)	C11orf9 (2.3)	BCAM (2.2)
MP:0001261	obese	0.64	> 0.20	KIAA1324 (3.6)	C12orf47 (2.6)	DYNC2LI1 (2.6)	CELSR2 (2.3)	CETP (1.6)	GPAM (1.6)	SLC44A2 (1.5)	PCSK9 (1.4)	USP24 (1.4)	BCL3 (1.3)
GO:0010043	response to zinc ion	0.64	> 0.20	ABCG5 (2.4)	TM6SF2 (2.4)	ABCG8 (2.3)	HAPLN4 (2.2)	ADAM1 (2.1)	RHCE (2.1)	NPC1L1 (1.9)	PMFBP1 (1.9)	ALDH2 (1.9)	ATXN7L2 (1.8)
MP:0001883	mammary adenocarcinoma	0.64	> 0.20	POLK (3.1)	UBXN2B (2.7)	NYNRIN (2.5)	CARM1 (2.0)	ATXN7L2 (1.8)	TOMM40 (1.8)	GRINA (1.7)	AMIGO1 (1.5)	FEN1 (1.4)	USP1 (1.4)
GO:0009110	vitamin biosynthetic process	0.64	> 0.20	ATXN7L2 (2.2)	CYP7A1 (1.5)	QTRT1 (1.5)	C12orf43 (1.5)	ZHX3 (1.4)	SLC22A1 (1.3)	ANKRD31 (1.3)	ENSG00000235545 (1.3)	BLOC1S3 (1.3)	COL4A3BP (1.2)
GO:0051329	interphase of mitotic cell cycle	0.64	> 0.20	POC5 (2.7)	USP1 (2.4)	PSRC1 (2.4)	FEN1 (2.4)	ZNF180 (2.1)	ENSG00000226648 (2.0)	BUD13 (1.9)	SUGP1 (1.7)	MAU2 (1.6)	SMARCA4 (1.5)
ENSG00000110092	CCND1 PPI subnetwork	0.64	> 0.20	PLCG1 (2.6)	USP1 (2.5)	MAU2 (2.5)	SLC44A2 (2.1)	OASL (2.0)	KIAA1324 (2.0)	ZHX3 (1.7)	C1orf63 (1.6)	PARP10 (1.6)	FEN1 (1.5)
ENSG00000198802	ENSG00000198802 PPI subnetwork	0.64	> 0.20	MAFB (3.0)	GMIP (2.4)	CETP (2.3)	ENSG00000226648 (2.2)	APOE (2.2)	PLCG1 (1.8)	SMARCA4 (1.8)	LPAR2 (1.8)	PTPN11 (1.8)	GPAM (1.8)
GO:0008641	small protein activating enzyme activity	0.64	> 0.20	ZNF180 (3.9)	CLPTM1 (2.6)	MARK4 (2.4)	SUGP1 (2.3)	TOMM40 (2.2)	DHX38 (2.2)	GEMIN7 (1.7)	DOCK7 (1.6)	PARP10 (1.5)	MAU2 (1.5)
MP:0003886	abnormal embryonic epiblast morphology	0.64	> 0.20	C17orf57 (2.9)	COL4A3BP (1.8)	DDX56 (1.6)	DOCK7 (1.5)	ATXN7L2 (1.3)	TSSK6 (1.3)	ENSG00000254235 (1.3)	POLK (1.3)	ITGB3 (1.3)	PLCG1 (1.3)
MP:0003627	abnormal leukocyte tethering or rolling	0.64	> 0.20	BCL3 (3.4)	PLEC (2.9)	PVR (2.5)	RELB (2.2)	ERP29 (2.2)	LDLR (1.6)	TRIB1 (1.4)	HLX (1.4)	GMIP (1.3)	POLK (1.3)
ENSG00000139625	MAP3K12 PPI subnetwork	0.64	> 0.20	ATXN7L2 (3.1)	APOE (2.8)	C11orf9 (2.6)	DYNC2LI1 (2.3)	APOC1 (2.2)	BCAM (2.0)	PPP1R37 (1.9)	TRIB1 (1.8)	PLEKHH2 (1.8)	MAU2 (1.6)
MP:0003960	increased lean body mass	0.64	> 0.20	MAFB (2.3)	ST3GAL4 (2.3)	HAPLN4 (1.9)	MOSC1 (1.7)	SYPL2 (1.7)	PLEKHH2 (1.5)	GPAM (1.4)	AP1M2 (1.3)	ATXN7L2 (1.3)	SORT1 (1.2)
ENSG00000136450	SRSF1 PPI subnetwork	0.64	> 0.20	C1orf63 (4.9)	ILF3 (3.9)	TOP1 (3.7)	USP1 (2.8)	SMARCA4 (2.5)	BUD13 (2.5)	DHX38 (2.3)	FEN1 (2.2)	SUGP1 (2.2)	QTRT1 (2.0)
ENSG00000083290	ULK2 PPI subnetwork	0.64	> 0.20	FRK (3.0)	PARP10 (2.7)	USP1 (1.9)	TRAFD1 (1.9)	MAU2 (1.5)	ENSG00000228044 (1.4)	FEN1 (1.3)	ADAM1 (1.2)	BCL3 (1.2)	FADS1 (1.2)
REACTOME_DEVELOPMENTAL_BIOLOGY	REACTOME_DEVELOPMENTAL_BIOLOGY	0.64	> 0.20	PLEC (2.8)	MARK4 (2.5)	HLX (2.2)	NCAN (2.1)	CARM1 (2.0)	CELSR2 (1.8)	C12orf51 (1.8)	SH2B3 (1.7)	SMARCA4 (1.6)	PLEKHH2 (1.6)
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE	0.64	> 0.20	TXNL4B (4.0)	GEMIN7 (2.6)	DHX38 (2.5)	MAU2 (2.4)	TRAPPC6A (2.0)	C19orf52 (1.9)	ATP13A1 (1.8)	POC5 (1.7)	SUGP1 (1.6)	ENSG00000254235 (1.6)
ENSG00000077097	TOP2B PPI subnetwork	0.64	> 0.20	PLCG1 (2.9)	CARM1 (2.8)	ILF3 (2.6)	SMARCA4 (2.5)	USP1 (2.5)	NYNRIN (2.4)	FEN1 (2.2)	ATXN2 (2.1)	GATAD2A (1.9)	MARK4 (1.5)
ENSG00000116473	RAP1A PPI subnetwork	0.64	> 0.20	TMEM50A (4.4)	MARK4 (2.7)	COL4A3BP (2.6)	GATAD2A (2.5)	DNM2 (2.2)	SLC44A2 (2.1)	PMFBP1 (2.0)	HLX (1.5)	USP24 (1.4)	SH2B3 (1.4)
GO:0045737	positive regulation of cyclin-dependent protein kinase activity	0.64	> 0.20	ANKRD31 (4.7)	BLOC1S3 (1.9)	TMED4 (1.6)	SLC44A2 (1.6)	ENSG00000228044 (1.5)	DNAH11 (1.4)	PBX4 (1.3)	TRAPPC6A (1.3)	C19orf52 (1.2)	TSSK6 (1.1)
MP:0004486	decreased response of heart to induced stress	0.64	> 0.20	TRIB1 (3.4)	PVR (3.2)	PLEKHH2 (2.7)	SYPL2 (2.4)	ABCG5 (1.9)	ATXN7L2 (1.9)	ZHX3 (1.8)	SORT1 (1.6)	TM6SF2 (1.3)	ABCG8 (1.3)
GO:0080111	DNA demethylation	0.64	> 0.20	TSSK6 (3.2)	C17orf57 (2.0)	NT5DC1 (1.8)	NPC1L1 (1.6)	FRK (1.5)	TXNL4B (1.5)	ENSG00000235545 (1.5)	TMEM116 (1.5)	ZNF180 (1.3)	MAPKAPK5 (1.3)
GO:0003012	muscle system process	0.64	> 0.20	SYPL2 (6.2)	ENSG00000226648 (2.5)	GMPR (2.3)	KANK2 (2.2)	C17orf57 (2.2)	ITGB3 (1.4)	SORT1 (1.4)	SLC44A2 (1.1)	NKPD1 (1.1)	PPP1R37 (0.9)
ENSG00000171444	MCC PPI subnetwork	0.64	> 0.20	SARS (4.3)	PSMA5 (3.4)	TOMM40 (3.4)	USP1 (2.2)	NT5DC1 (2.0)	FEN1 (2.0)	NAA25 (2.0)	CLPTM1 (1.8)	FADS1 (1.8)	TMEM50A (1.7)
ENSG00000113645	WWC1 PPI subnetwork	0.64	> 0.20	BLOC1S3 (4.0)	RPH3A (3.4)	ZNF180 (2.8)	CYB561D1 (2.0)	NCAN (1.9)	PSMA5 (1.6)	TOP1 (1.5)	C17orf57 (1.5)	POC5 (1.4)	ZNF259 (1.3)
ENSG00000137177	KIF13A PPI subnetwork	0.64	> 0.20	TXNL4B (3.2)	COL4A3BP (2.7)	ZHX3 (2.7)	MYLIP (2.3)	DHX38 (2.3)	ATP13A1 (2.2)	POC5 (2.0)	ENSG00000226645 (1.9)	APOE (1.9)	OGDH (1.9)
GO:0016410	N-acyltransferase activity	0.64	> 0.20	C19orf52 (2.2)	COL4A3BP (2.2)	PLCG1 (2.1)	UBXN2B (2.0)	TMEM57 (2.0)	ANGPTL3 (1.9)	ABCG8 (1.8)	ATXN7L2 (1.8)	DHODH (1.6)	ABCG5 (1.6)
GO:0003746	translation elongation factor activity	0.64	> 0.20	SARS (2.8)	UBXN2B (2.4)	RHCE (2.2)	SUGP1 (2.1)	CLPTM1 (2.0)	GRINA (1.9)	TMEM57 (1.8)	OGDH (1.6)	MARK4 (1.5)	NT5DC1 (1.5)
ENSG00000132155	RAF1 PPI subnetwork	0.64	> 0.20	CARM1 (2.3)	MARK4 (2.3)	SMARCA4 (2.3)	BCAM (2.3)	CLPTM1 (2.2)	AP1M2 (2.2)	DNM2 (2.2)	PLEC (2.1)	PVRL2 (1.9)	SLC44A2 (1.7)
MP:0000063	decreased bone mineral density	0.64	> 0.20	FRK (2.2)	TRIB1 (2.1)	BCAM (2.0)	CILP2 (1.9)	NYNRIN (1.8)	BCL3 (1.7)	ST3GAL4 (1.7)	PVRL2 (1.5)	CETP (1.4)	PLEC (1.3)
REACTOME_PEPTIDE_LIGAND:BINDING_RECEPTORS	REACTOME_PEPTIDE_LIGAND:BINDING_RECEPTORS	0.64	> 0.20	KIAA1324 (2.6)	CETP (2.4)	RELB (2.1)	C12orf47 (2.1)	MAFB (2.0)	TIMD4 (1.7)	APOC1 (1.7)	HNF1A (1.6)	TRIB1 (1.6)	GMIP (1.6)
GO:0030224	monocyte differentiation	0.64	> 0.20	ENSG00000238078 (4.0)	PMFBP1 (1.7)	ENSG00000235545 (1.6)	PBX4 (1.6)	POC5 (1.5)	MAPKAPK5 (1.5)	GCNT4 (1.5)	DNAH11 (1.4)	UBXN2B (1.4)	MOSC1 (1.3)
MP:0002108	abnormal muscle morphology	0.64	> 0.20	SYPL2 (4.0)	BCAM (2.6)	KIAA1324 (2.5)	SLC44A2 (2.1)	PLEC (1.8)	CELSR2 (1.8)	GPAM (1.7)	KANK2 (1.4)	COL4A3BP (1.4)	PVRL2 (1.3)
ENSG00000197956	S100A6 PPI subnetwork	0.64	> 0.20	PLEC (3.2)	ABO (2.4)	FRK (2.4)	UBXN2B (2.2)	PMFBP1 (1.8)	C19orf52 (1.7)	MYLIP (1.6)	CEACAM19 (1.5)	GATAD2A (1.5)	RPH3A (1.5)
GO:0003730	mRNA 3'-UTR binding	0.64	> 0.20	HAVCR1 (2.2)	CARM1 (2.2)	TRAPPC6A (1.8)	NT5DC1 (1.7)	BRAP (1.5)	GMPR (1.3)	DHODH (1.3)	GATAD2A (1.3)	C11orf9 (1.3)	ENSG00000238078 (1.3)
ENSG00000143549	TPM3 PPI subnetwork	0.64	> 0.20	PLEC (3.0)	PVR (2.9)	GMPR (1.8)	NPC1L1 (1.8)	POLK (1.7)	ADAM1 (1.7)	CARM1 (1.5)	MAPKAPK5 (1.4)	SH2B3 (1.4)	ITGB3 (1.3)
GO:0046850	regulation of bone remodeling	0.64	> 0.20	ENSG00000226648 (2.4)	ENSG00000235545 (2.3)	RHCE (1.8)	ENSG00000254235 (1.6)	TSSK6 (1.5)	RHD (1.3)	ENSG00000226645 (1.2)	C11orf9 (1.2)	SLC44A2 (1.2)	HNF1A (1.2)
GO:0002832	negative regulation of response to biotic stimulus	0.64	> 0.20	ZNF101 (2.2)	C12orf47 (2.1)	ADAM1 (2.1)	BLOC1S3 (1.9)	ENSG00000254235 (1.9)	ENSG00000228044 (1.9)	ATP13A1 (1.5)	OASL (1.4)	GEMIN7 (1.2)	PARP10 (1.2)
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA:OXIDATION	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA:OXIDATION	0.64	> 0.20	ACAD10 (6.0)	ALDH2 (3.5)	OGDH (3.3)	TRAPPC6A (3.2)	NT5DC1 (2.3)	MOSC1 (1.9)	DYNC2LI1 (1.6)	GPAM (1.6)	ENSG00000238078 (1.4)	GMPR (1.4)
GO:0032320	positive regulation of Ras GTPase activity	0.64	> 0.20	ENSG00000226645 (3.0)	CBLC (2.4)	PPP1R37 (2.3)	ST3GAL4 (2.0)	DNM2 (1.9)	ABO (1.9)	AP1M2 (1.6)	ZNF101 (1.5)	ATXN2 (1.5)	LPIN3 (1.5)
ENSG00000203879	GDI1 PPI subnetwork	0.64	> 0.20	CLPTM1 (2.7)	GEMIN7 (2.5)	COL4A3BP (2.5)	CEACAM19 (2.4)	MARK4 (2.2)	GATAD2A (1.9)	ENSG00000238078 (1.8)	PVRL2 (1.6)	TMEM50A (1.6)	TOMM40 (1.5)
GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	0.64	> 0.20	GEMIN7 (2.6)	ZNF101 (2.5)	ENSG00000235545 (2.1)	AMIGO1 (1.7)	ENSG00000228044 (1.5)	CEACAM19 (1.5)	PBX4 (1.4)	ADAM1 (1.3)	NAA25 (1.2)	TMED4 (1.2)
GO:0002717	positive regulation of natural killer cell mediated immunity	0.64	> 0.20	GEMIN7 (2.6)	ZNF101 (2.5)	ENSG00000235545 (2.1)	AMIGO1 (1.7)	ENSG00000228044 (1.5)	CEACAM19 (1.5)	PBX4 (1.4)	ADAM1 (1.3)	NAA25 (1.2)	TMED4 (1.2)
MP:0009050	dilated proximal convoluted tubules	0.64	> 0.20	DYNC2LI1 (2.8)	PVR (2.8)	BCAM (2.6)	PLEKHH2 (2.4)	SLC22A1 (2.2)	CELSR2 (2.0)	KANK2 (2.0)	ENSG00000226648 (1.9)	DOCK7 (1.5)	PVRL2 (1.5)
ENSG00000125885	MCM8 PPI subnetwork	0.64	> 0.20	FEN1 (6.6)	USP1 (4.9)	PSRC1 (1.9)	TMEM116 (1.9)	ENSG00000235545 (1.6)	LPIN3 (1.6)	NT5DC1 (1.2)	TXNL4B (1.2)	ERP29 (1.1)	ENSG00000228044 (1.1)
ENSG00000151348	EXT2 PPI subnetwork	0.64	> 0.20	LPIN3 (2.1)	HP (1.8)	ATXN7L2 (1.7)	ZHX3 (1.7)	CETP (1.6)	RHCE (1.5)	MOSC1 (1.5)	NKPD1 (1.4)	ST3GAL4 (1.3)	PCSK9 (1.3)
ENSG00000180616	SSTR2 PPI subnetwork	0.64	> 0.20	PPP1R37 (3.4)	C11orf9 (3.1)	ZHX3 (2.6)	MYLIP (2.4)	KIAA1324 (1.9)	KANK2 (1.8)	RHCE (1.7)	PTPN11 (1.6)	DYNC2LI1 (1.6)	COL4A3BP (1.5)
GO:0015684	ferrous iron transport	0.64	> 0.20	C12orf43 (3.5)	ENSG00000226645 (2.7)	TOMM40 (2.5)	TMED4 (2.4)	ZNF259 (2.2)	BLOC1S3 (2.2)	PBX4 (2.1)	MAPKAPK5 (1.9)	LPIN3 (1.6)	TMEM116 (1.5)
ENSG00000166947	EPB42 PPI subnetwork	0.64	> 0.20	RHD (3.8)	C12orf51 (3.4)	RHCE (3.3)	GMPR (2.9)	TMEM50A (2.3)	GRINA (2.2)	RPH3A (2.1)	SLC44A2 (1.7)	COL4A3BP (1.5)	C11orf9 (1.5)
GO:0070717	poly-purine tract binding	0.64	> 0.20	C1orf63 (3.2)	ILF3 (2.9)	TOP1 (2.5)	UBXN2B (2.5)	NT5DC1 (2.4)	DHODH (2.3)	DYNC2LI1 (2.1)	PARP10 (2.0)	ANKRD31 (2.0)	MAPKAPK5 (1.9)
GO:0042110	T cell activation	0.64	> 0.20	ZNF101 (4.8)	PLCG1 (3.7)	TIMD4 (2.3)	PBX4 (2.3)	CETP (1.8)	GMIP (1.5)	DNAH11 (1.5)	POLK (1.5)	CYB561D1 (1.5)	ANKRD31 (1.4)
REACTOME_GTP_HYDROLYSIS_AND_JOINING_OF_THE_60S_RIBOSOMAL_SUBUNIT	REACTOME_GTP_HYDROLYSIS_AND_JOINING_OF_THE_60S_RIBOSOMAL_SUBUNIT	0.64	> 0.20	NKPD1 (3.2)	ILF3 (1.8)	GATAD2A (1.7)	SARS (1.7)	ANKRD31 (1.6)	ADAM1 (1.5)	SUGP1 (1.4)	ATP13A1 (1.4)	TMEM57 (1.4)	C12orf43 (1.3)
ENSG00000142599	RERE PPI subnetwork	0.64	> 0.20	PPP1R37 (3.1)	NYNRIN (3.1)	SMARCA4 (2.4)	ATXN2 (2.2)	GRINA (2.2)	CARM1 (1.9)	PLCG1 (1.9)	KANK2 (1.8)	LPAR2 (1.7)	HAVCR1 (1.6)
GO:2000107	negative regulation of leukocyte apoptotic process	0.64	> 0.20	CETP (3.9)	TIMD4 (2.6)	ZNF101 (2.2)	PBX4 (2.1)	CYB561D1 (1.8)	BLOC1S3 (1.6)	C19orf52 (1.4)	TRAFD1 (1.3)	GMIP (1.2)	TXNL4B (1.1)
GO:0042508	tyrosine phosphorylation of Stat1 protein	0.64	> 0.20	TRAFD1 (2.4)	PBX4 (2.0)	PLEKHH2 (2.0)	ST3GAL4 (1.8)	HNF1A (1.6)	SLC22A1 (1.3)	PVR (1.2)	ENSG00000226648 (1.2)	TMEM57 (1.0)	ENSG00000235545 (1.0)
GO:0019843	rRNA binding	0.64	> 0.20	GEMIN7 (3.4)	GMPR (1.9)	APOC1 (1.7)	AMIGO1 (1.6)	PSMA5 (1.6)	C12orf47 (1.5)	ALDH2 (1.5)	DNAH11 (1.4)	ERP29 (1.4)	ENSG00000226648 (1.3)
MP:0002444	abnormal T cell physiology	0.64	> 0.20	RELB (4.1)	ZNF101 (3.5)	BCL3 (3.3)	GMIP (3.2)	SLC44A2 (2.7)	PBX4 (2.3)	PLCG1 (2.0)	PARP10 (1.7)	TRAFD1 (1.7)	TIMD4 (1.6)
GO:0031258	lamellipodium membrane	0.64	> 0.20	PVR (2.9)	NCAN (2.4)	FRK (2.3)	C11orf9 (2.3)	TMEM50A (2.1)	CILP2 (2.1)	LPAR2 (1.7)	NPC1L1 (1.7)	PMFBP1 (1.7)	DOCK7 (1.6)
ENSG00000114745	GORASP1 PPI subnetwork	0.64	> 0.20	YIPF2 (2.9)	ERP29 (2.4)	PSRC1 (2.4)	CBLC (2.2)	TRAFD1 (2.2)	AP1M2 (2.2)	FEN1 (2.1)	TMED4 (1.9)	KIAA1324 (1.8)	ABCG8 (1.7)
GO:0051457	maintenance of protein location in nucleus	0.64	> 0.20	ENSG00000254235 (2.2)	GOT2P1 (2.0)	FRK (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ENSG00000226645 (1.7)	CEACAM19 (1.6)	DYNC2LI1 (1.6)	AMIGO1 (1.6)	ANKRD31 (1.5)
ENSG00000136731	UGGT1 PPI subnetwork	0.64	> 0.20	TMEM50A (2.7)	PARP10 (2.5)	APOB (1.9)	TMED4 (1.9)	BCL3 (1.8)	RELB (1.5)	NT5DC1 (1.4)	ADAM1 (1.3)	CLPTM1 (1.3)	ERP29 (1.3)
MP:0002656	abnormal keratinocyte differentiation	0.64	> 0.20	CBLC (4.6)	AP1M2 (4.5)	BCAM (2.4)	ALDH2 (1.9)	CELSR2 (1.7)	PMFBP1 (1.6)	C17orf57 (1.4)	APOC1 (1.4)	GCNT4 (1.4)	APOE (1.3)
REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1	REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1	0.64	> 0.20	BRAP (4.9)	GMPR (3.2)	PTPN11 (2.9)	AMIGO1 (2.7)	C12orf47 (2.6)	SYPL2 (2.5)	C19orf52 (2.4)	C12orf51 (1.9)	LPIN3 (1.8)	ZHX3 (1.8)
GO:0032729	positive regulation of interferon-gamma production	0.64	> 0.20	DNAH11 (2.4)	ENSG00000235545 (2.3)	ATXN7L2 (2.0)	TIMD4 (1.5)	ENSG00000254235 (1.3)	PBX4 (1.3)	NKPD1 (1.3)	GRINA (1.1)	HAVCR1 (1.1)	POLK (1.0)
ENSG00000134717	BTF3L4 PPI subnetwork	0.64	> 0.20	HAVCR1 (3.2)	TXNL4B (2.8)	MAPKAPK5 (2.8)	GOT2P1 (2.8)	TMEM57 (2.6)	C11orf9 (2.1)	ATXN2 (2.1)	ENSG00000228044 (1.9)	ADAM1 (1.9)	BRAP (1.7)
GO:0060401	cytosolic calcium ion transport	0.64	> 0.20	ABO (2.3)	GEMIN7 (2.1)	SYPL2 (1.9)	SLC44A2 (1.7)	HAVCR1 (1.7)	ZNF180 (1.6)	RPH3A (1.6)	GCNT4 (1.4)	TRAPPC6A (1.4)	ZNF101 (1.4)
ENSG00000030066	NUP160 PPI subnetwork	0.64	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.0)	POC5 (3.9)	ZNF180 (1.3)	ENSG00000226648 (1.2)	ILF3 (1.2)	ENSG00000228044 (1.2)	DDX56 (1.0)	USP24 (0.9)
MP:0002782	abnormal testes secretion	0.64	> 0.20	PMFBP1 (3.2)	GPAM (2.9)	HLX (2.6)	MOSC1 (2.0)	ZNF180 (1.8)	ST3GAL4 (1.6)	C12orf47 (1.6)	TSSK6 (1.5)	MAFB (1.4)	KANK2 (1.4)
ENSG00000107819	SFXN3 PPI subnetwork	0.64	> 0.20	PLEC (2.3)	ATXN2 (1.8)	TOP1 (1.8)	OGDH (1.7)	SLC22A1 (1.7)	CLPTM1 (1.6)	TXNL4B (1.6)	C1orf63 (1.5)	HMGCR (1.4)	AP1M2 (1.3)
MP:0002950	abnormal neural crest cell migration	0.64	> 0.20	BCAM (3.5)	TRIB1 (2.5)	CELSR2 (2.4)	DOCK7 (2.2)	PVRL2 (2.1)	HAVCR1 (2.1)	ANKRD31 (2.1)	KIAA1324 (2.0)	TSSK6 (1.8)	PLEC (1.7)
ENSG00000090054	SPTLC1 PPI subnetwork	0.64	> 0.20	ATP13A1 (2.9)	NAA25 (2.6)	ENSG00000226648 (2.2)	PSMA5 (1.9)	NKPD1 (1.9)	OGDH (1.9)	SARS (1.8)	ENSG00000235545 (1.8)	GOT2P1 (1.7)	TOMM40 (1.5)
ENSG00000117748	RPA2 PPI subnetwork	0.64	> 0.20	FEN1 (6.0)	USP1 (4.2)	ZNF180 (2.8)	POC5 (2.5)	TMEM116 (2.0)	NT5DC1 (1.8)	ENSG00000235545 (1.4)	BLOC1S3 (1.3)	BUD13 (1.3)	KIAA1324 (1.2)
GO:0022804	active transmembrane transporter activity	0.64	> 0.20	TMEM116 (3.5)	ATP13A1 (3.4)	TM6SF2 (3.1)	HAPLN4 (2.9)	CLPTM1 (2.8)	GRINA (2.4)	SORT1 (2.3)	ABCG8 (2.3)	ANGPTL3 (2.1)	PLG (2.0)
ENSG00000086589	RBM22 PPI subnetwork	0.64	> 0.20	PPP1R37 (3.0)	LPAR2 (2.3)	TOMM40 (2.2)	CYB561D1 (2.2)	CBLC (2.0)	GMIP (1.8)	LPIN3 (1.7)	BUD13 (1.5)	DNM2 (1.5)	GMPR (1.5)
GO:0070303	negative regulation of stress-activated protein kinase signaling cascade	0.65	> 0.20	LPIN3 (2.4)	UBXN2B (2.1)	FRK (2.0)	CILP2 (1.7)	ATXN2 (1.7)	ZNF180 (1.1)	HNF1A (1.1)	ATXN7L2 (1.1)	TMEM57 (1.1)	PTPN11 (1.0)
MP:0000382	underdeveloped hair follicles	0.65	> 0.20	AP1M2 (2.9)	LPIN3 (2.9)	SLC44A2 (2.9)	CBLC (2.8)	APOC1 (2.2)	SYPL2 (2.0)	CELSR2 (1.9)	APOE (1.4)	LPA (1.4)	DOCK7 (1.4)
ENSG00000168243	GNG4 PPI subnetwork	0.65	> 0.20	ITGB3 (3.2)	TMEM50A (1.6)	TM6SF2 (1.4)	CYP7A1 (1.4)	CETP (1.2)	DNM2 (1.1)	SLC44A2 (1.1)	SLC22A1 (1.1)	APOC4 (1.0)	LPA (1.0)
MP:0002650	abnormal ameloblast morphology	0.65	> 0.20	FRK (2.7)	MAFB (2.3)	ST3GAL4 (2.1)	CBLC (2.0)	ENSG00000226648 (1.8)	ENSG00000254235 (1.8)	BLOC1S3 (1.6)	ABO (1.5)	NPC1L1 (1.5)	HNF1A (1.3)
ENSG00000212915	ENSG00000212915 PPI subnetwork	0.65	> 0.20	ITGB3 (2.6)	HMGCR (2.6)	FADS2 (2.5)	FADS1 (2.5)	SMARCA4 (2.4)	HAVCR1 (2.0)	LDLR (1.9)	ILF3 (1.8)	SARS (1.8)	PLEKHH2 (1.7)
ENSG00000142945	KIF2C PPI subnetwork	0.65	> 0.20	PSRC1 (6.0)	FEN1 (4.2)	USP1 (3.4)	POC5 (3.4)	ENSG00000228044 (1.6)	ZNF180 (0.9)	CETP (0.8)	ENSG00000226648 (0.8)	LPIN3 (0.7)	HMGCR (0.7)
GO:0031572	G2/M transition DNA damage checkpoint	0.65	> 0.20	ENSG00000226648 (3.1)	PSRC1 (2.8)	POLK (2.3)	HAVCR1 (2.2)	DYNC2LI1 (2.1)	ZNF180 (1.9)	ENSG00000235545 (1.9)	ZHX3 (1.8)	C11orf9 (1.7)	HAPLN4 (1.5)
ENSG00000185883	ATP6V0C PPI subnetwork	0.65	> 0.20	ERP29 (2.7)	TMEM57 (2.3)	SARS (2.1)	TMEM50A (2.1)	C1orf63 (2.0)	SORT1 (1.9)	CLPTM1 (1.8)	TXNL4B (1.7)	ZNF259 (1.7)	ENSG00000228044 (1.6)
ENSG00000180353	HCLS1 PPI subnetwork	0.65	> 0.20	ST3GAL4 (2.4)	GCNT4 (2.3)	DNM2 (1.8)	TOMM40 (1.5)	ADAM1 (1.5)	ABCG5 (1.5)	NPC1L1 (1.4)	GATAD2A (1.4)	LPIN3 (1.3)	CLPTM1 (1.3)
GO:0007440	foregut morphogenesis	0.65	> 0.20	LPAR2 (4.3)	ABO (3.1)	ENSG00000226648 (3.0)	LPIN3 (2.3)	UBXN2B (2.0)	ATXN2 (1.9)	HNF1A (1.7)	GCNT4 (1.7)	TMEM116 (1.6)	C11orf9 (1.6)
ENSG00000035928	RFC1 PPI subnetwork	0.65	> 0.20	FEN1 (5.5)	USP1 (4.7)	OASL (3.0)	ZNF180 (2.3)	ILF3 (1.9)	PSRC1 (1.9)	FADS1 (1.8)	GEMIN7 (1.7)	SMARCA4 (1.7)	GATAD2A (1.6)
ENSG00000144554	FANCD2 PPI subnetwork	0.65	> 0.20	BUD13 (3.4)	FEN1 (2.9)	USP1 (2.7)	DHODH (2.5)	PSRC1 (1.9)	DOCK7 (1.7)	ILF3 (1.5)	AMIGO1 (1.5)	TMEM116 (1.5)	SLC44A2 (1.4)
GO:0042953	lipoprotein transport	0.65	> 0.20	TM6SF2 (3.7)	NPC1L1 (3.5)	ABCG5 (2.9)	ADAM1 (2.1)	ABCG8 (2.1)	GCNT4 (2.0)	MAPKAPK5 (2.0)	ATXN7L2 (1.6)	PMFBP1 (1.6)	HNF1A (1.3)
ENSG00000169925	BRD3 PPI subnetwork	0.65	> 0.20	BUD13 (3.0)	TXNL4B (3.0)	ATXN2 (2.4)	SMARCA4 (2.2)	MAPKAPK5 (2.2)	TMEM50A (1.9)	GEMIN7 (1.6)	PSRC1 (1.6)	ILF3 (1.4)	ZNF180 (1.3)
GO:0016180	snRNA processing	0.65	> 0.20	POC5 (3.3)	GEMIN7 (2.7)	UBXN2B (2.5)	ATXN7L2 (2.4)	DHX38 (2.0)	C12orf47 (1.9)	NKPD1 (1.8)	ZNF101 (1.7)	NT5DC1 (1.7)	SUGP1 (1.6)
ENSG00000168061	SAC3D1 PPI subnetwork	0.65	> 0.20	MAPKAPK5 (3.1)	POC5 (2.8)	BUD13 (2.8)	ILF3 (2.6)	DOCK7 (2.4)	DHX38 (2.3)	USP1 (2.2)	MAU2 (2.1)	DHODH (1.8)	ADAM1 (1.8)
MP:0001695	abnormal gastrulation	0.65	> 0.20	USP24 (2.3)	C12orf51 (2.0)	NYNRIN (1.7)	MARK4 (1.6)	ILF3 (1.6)	ATXN2 (1.6)	CARM1 (1.6)	DHX38 (1.6)	COL4A3BP (1.4)	APOE (1.4)
MP:0000836	abnormal substantia nigra morphology	0.65	> 0.20	FRK (2.4)	MYLIP (2.1)	ENSG00000254235 (2.0)	DNAH11 (1.9)	HAPLN4 (1.6)	C11orf9 (1.6)	TRIB1 (1.6)	ENSG00000228044 (1.5)	KIAA1324 (1.4)	AMIGO1 (1.3)
ENSG00000115840	SLC25A12 PPI subnetwork	0.65	> 0.20	ENSG00000226648 (3.3)	NYNRIN (2.9)	PPP1R37 (2.6)	NT5DC1 (2.6)	PSMA5 (2.6)	PSRC1 (2.5)	ATP13A1 (2.4)	ATXN7L2 (2.4)	SORT1 (2.2)	CELSR2 (2.1)
MP:0004978	decreased B-1 B cell number	0.65	> 0.20	GMIP (3.6)	SLC44A2 (2.6)	TIMD4 (2.4)	SH2B3 (2.1)	MAFB (1.8)	CETP (1.8)	CYB561D1 (1.7)	GRINA (1.6)	RELB (1.5)	ZNF101 (1.5)
ENSG00000008952	SEC62 PPI subnetwork	0.65	> 0.20	YIPF2 (4.1)	CLPTM1 (3.1)	ATP13A1 (2.6)	CYB561D1 (2.4)	SORT1 (2.1)	FRK (2.1)	DHX38 (2.0)	ERP29 (1.9)	DNM2 (1.8)	SUGP1 (1.7)
KEGG_MTOR_SIGNALING_PATHWAY	KEGG_MTOR_SIGNALING_PATHWAY	0.65	> 0.20	DNM2 (2.6)	COL4A3BP (2.3)	TMEM57 (2.3)	PTPN11 (2.1)	C12orf51 (2.1)	USP24 (1.9)	SARS (1.8)	UBXN2B (1.7)	GPAM (1.5)	BRAP (1.4)
ENSG00000152056	AP1S3 PPI subnetwork	0.65	> 0.20	C12orf51 (2.8)	SMARCA4 (2.7)	CARM1 (2.5)	MAU2 (2.5)	DHX38 (2.2)	SH2B3 (2.2)	YIPF2 (2.1)	GRINA (2.1)	PBX4 (2.0)	TXNL4B (2.0)
ENSG00000180104	EXOC3 PPI subnetwork	0.65	> 0.20	MAU2 (2.7)	COL4A3BP (2.6)	POLK (2.1)	SMARCA4 (2.0)	KIAA1324 (2.0)	FRK (1.9)	PSMA5 (1.9)	NCAN (1.8)	SUGP1 (1.8)	DYNC2LI1 (1.7)
REACTOME_G0_AND_EARLY_G1	REACTOME_G0_AND_EARLY_G1	0.65	> 0.20	FEN1 (4.8)	USP1 (4.4)	AMIGO1 (2.4)	RHD (1.9)	PSRC1 (1.8)	RHCE (1.7)	ZNF101 (1.7)	BUD13 (1.5)	HLX (1.3)	GOT2P1 (1.3)
GO:0072530	purine-containing compound transmembrane transport	0.65	> 0.20	GOT2P1 (2.6)	CEACAM19 (2.1)	LPAR2 (2.0)	ENSG00000238078 (1.9)	NKPD1 (1.6)	FRK (1.5)	TMEM116 (1.5)	CYP7A1 (1.4)	ANGPTL3 (1.4)	GMPR (1.3)
GO:0019941	modification-dependent protein catabolic process	0.65	> 0.20	BRAP (3.3)	TRAFD1 (2.7)	TMEM57 (2.4)	USP24 (2.3)	NAA25 (2.2)	ZNF180 (2.2)	MAU2 (2.0)	DHX38 (1.9)	PSMA5 (1.8)	BUD13 (1.6)
GO:0000280	nuclear division	0.65	> 0.20	POC5 (4.9)	PSRC1 (4.8)	USP1 (2.6)	FEN1 (2.1)	ENSG00000228044 (2.0)	PBX4 (1.8)	GEMIN7 (1.7)	BUD13 (1.5)	DNAH11 (1.4)	ILF3 (1.3)
GO:0007067	mitosis	0.65	> 0.20	POC5 (4.9)	PSRC1 (4.8)	USP1 (2.6)	FEN1 (2.1)	ENSG00000228044 (2.0)	PBX4 (1.8)	GEMIN7 (1.7)	BUD13 (1.5)	DNAH11 (1.4)	ILF3 (1.3)
ENSG00000172409	CLP1 PPI subnetwork	0.65	> 0.20	ILF3 (3.9)	TOP1 (2.8)	C1orf63 (2.8)	SMARCA4 (2.8)	USP1 (2.6)	BUD13 (2.6)	DHX38 (2.6)	SUGP1 (2.4)	FEN1 (2.2)	PTPN11 (2.1)
GO:0014065	phosphatidylinositol 3-kinase cascade	0.65	> 0.20	DNAH11 (1.9)	MYLIP (1.7)	C17orf57 (1.7)	ENSG00000226645 (1.5)	HAVCR1 (1.3)	NPC1L1 (1.3)	KIAA1324 (1.3)	USP24 (1.2)	HAPLN4 (1.1)	PLCG1 (1.1)
GO:0009163	nucleoside biosynthetic process	0.65	> 0.20	TXNL4B (3.3)	DHODH (2.9)	DHX38 (1.8)	ANKRD31 (1.8)	DDX56 (1.7)	NKPD1 (1.5)	QTRT1 (1.4)	LPIN3 (1.3)	C17orf57 (1.3)	CEACAM19 (1.2)
ENSG00000131828	PDHA1 PPI subnetwork	0.65	> 0.20	OGDH (3.4)	TOMM40 (2.5)	GMPR (2.2)	ZNF180 (2.1)	CLPTM1 (2.0)	UBXN2B (1.9)	PSMA5 (1.9)	CARM1 (1.8)	GPAM (1.6)	PLEKHH2 (1.4)
ENSG00000108840	HDAC5 PPI subnetwork	0.65	> 0.20	MAU2 (2.6)	USP24 (2.4)	GMIP (2.4)	BCL3 (1.9)	MAFB (1.8)	DNM2 (1.8)	CARM1 (1.8)	MYLIP (1.8)	ABO (1.7)	SLC44A2 (1.6)
GO:0006635	fatty acid beta-oxidation	0.65	> 0.20	ACAD10 (5.2)	NT5DC1 (3.4)	OGDH (2.5)	ALDH2 (2.2)	TRAPPC6A (2.1)	GPAM (2.1)	MOSC1 (2.0)	TMEM116 (1.9)	C19orf52 (1.7)	ABCG8 (1.5)
ENSG00000085840	ORC1 PPI subnetwork	0.65	> 0.20	FEN1 (6.4)	USP1 (5.3)	PSRC1 (2.1)	TMEM116 (1.7)	ENSG00000235545 (1.6)	ENSG00000238078 (1.6)	POC5 (1.5)	HLX (1.3)	LPIN3 (1.3)	CYP7A1 (1.2)
ENSG00000133116	KL PPI subnetwork	0.65	> 0.20	HAPLN4 (2.8)	C17orf57 (2.0)	PPP1R37 (1.8)	ZHX3 (1.6)	TMED4 (1.5)	PVRL2 (1.5)	TSSK6 (1.5)	CEACAM19 (1.4)	HAVCR1 (1.3)	POC5 (1.3)
ENSG00000083857	FAT1 PPI subnetwork	0.65	> 0.20	PPP1R37 (2.7)	MARK4 (2.4)	POLK (2.0)	TOMM40 (1.9)	DHODH (1.9)	YIPF2 (1.8)	OGDH (1.8)	AP1M2 (1.7)	PVR (1.6)	BLOC1S3 (1.6)
ENSG00000182580	EPHB3 PPI subnetwork	0.65	> 0.20	OASL (3.4)	ABCG8 (2.8)	LPAR2 (2.4)	SH2B3 (2.4)	PARP10 (2.3)	MAPKAPK5 (2.1)	POLK (2.0)	PLEKHH2 (2.0)	TM6SF2 (2.0)	PBX4 (2.0)
REACTOME_MITOTIC_PROMETAPHASE	REACTOME_MITOTIC_PROMETAPHASE	0.65	> 0.20	PSRC1 (5.8)	FEN1 (4.3)	USP1 (3.9)	POC5 (3.7)	ZNF180 (1.1)	ENSG00000228044 (1.0)	USP24 (1.0)	ZHX3 (1.0)	ENSG00000226648 (1.0)	CEACAM19 (0.7)
ENSG00000141456	ENSG00000141456 PPI subnetwork	0.65	> 0.20	BUD13 (2.7)	ATXN2 (2.6)	DHX38 (2.5)	C12orf51 (1.9)	ZNF259 (1.9)	ATXN7L2 (1.8)	C12orf43 (1.8)	OGDH (1.8)	C19orf52 (1.7)	QTRT1 (1.7)
MP:0005341	decreased susceptibility to atherosclerosis	0.65	> 0.20	APOC1 (5.9)	SORT1 (2.8)	HLX (2.1)	TIMD4 (2.0)	ITGB3 (1.8)	PSRC1 (1.8)	TXNL4B (1.5)	APOE (1.5)	AP1M2 (1.5)	GRINA (1.4)
MP:0011087	complete neonatal lethality	0.65	> 0.20	CELSR2 (2.1)	HLX (2.0)	PLCG1 (1.8)	FADS1 (1.7)	NYNRIN (1.5)	LDLR (1.4)	MARK4 (1.3)	HMGCR (1.3)	TMEM57 (1.3)	ATXN2 (1.3)
GO:0050702	interleukin-1 beta secretion	0.65	> 0.20	ENSG00000238078 (2.9)	ZNF101 (2.8)	BLOC1S3 (2.3)	CYB561D1 (2.3)	NKPD1 (1.8)	CEACAM19 (1.6)	NPC1L1 (1.5)	ST3GAL4 (1.5)	ABCG5 (1.4)	DOCK7 (1.3)
MP:0009238	coiled sperm flagellum	0.65	> 0.20	TSSK6 (6.1)	PCSK9 (2.8)	NT5DC1 (2.4)	PMFBP1 (2.1)	HMGCR (2.0)	LDLR (2.0)	FADS1 (1.7)	CYB561D1 (1.5)	ANKRD31 (1.5)	BLOC1S3 (1.5)
ENSG00000143382	ADAMTSL4 PPI subnetwork	0.65	> 0.20	CEACAM19 (2.1)	LPIN3 (1.8)	PMFBP1 (1.6)	HNF1A (1.6)	DYNC2LI1 (1.6)	SH2B3 (1.5)	GEMIN7 (1.4)	KIAA1324 (1.3)	NYNRIN (1.3)	SYPL2 (1.2)
GO:0001047	core promoter binding	0.65	> 0.20	CELSR2 (3.6)	TRAFD1 (3.2)	NCAN (1.7)	TRIB1 (1.6)	C17orf57 (1.5)	GATAD2A (1.5)	SMARCA4 (1.4)	ENSG00000226648 (1.4)	SORT1 (1.4)	HAVCR1 (1.4)
GO:2000758	positive regulation of peptidyl-lysine acetylation	0.65	> 0.20	GOT2P1 (2.6)	ST3GAL4 (2.4)	FRK (2.0)	GCNT4 (1.9)	ENSG00000228044 (1.9)	TMEM57 (1.5)	ZNF180 (1.5)	TRAPPC6A (1.4)	SH2B3 (1.4)	RPH3A (1.3)
ENSG00000119760	SUPT7L PPI subnetwork	0.65	> 0.20	ATXN7L2 (3.2)	PLCG1 (2.3)	PLEKHH2 (2.2)	ACAD10 (2.2)	ATXN2 (2.2)	TXNL4B (2.1)	GEMIN7 (2.1)	QTRT1 (2.0)	ZHX3 (1.9)	ILF3 (1.7)
GO:0046689	response to mercury ion	0.65	> 0.20	ANGPTL3 (2.9)	PLG (2.4)	RHD (2.4)	SLC22A1 (2.3)	RHCE (2.3)	SYPL2 (2.1)	TXNL4B (2.0)	ENSG00000235545 (1.9)	TMEM57 (1.9)	TMEM116 (1.7)
GO:0043506	regulation of JUN kinase activity	0.65	> 0.20	LPAR2 (3.0)	ENSG00000226645 (2.5)	ABO (1.6)	BRAP (1.6)	ST3GAL4 (1.6)	FRK (1.5)	C11orf9 (1.4)	PPP1R37 (1.2)	GMIP (1.2)	NT5DC1 (1.1)
ENSG00000164022	AIMP1 PPI subnetwork	0.65	> 0.20	SARS (5.6)	QTRT1 (2.7)	NAA25 (2.4)	SUGP1 (2.1)	DDX56 (2.0)	PSMA5 (1.8)	ZNF259 (1.7)	SMARCA4 (1.6)	ATP13A1 (1.5)	PLEC (1.4)
GO:0034623	cellular macromolecular complex disassembly	0.65	> 0.20	TSSK6 (2.5)	UBXN2B (2.3)	CARM1 (1.9)	ABO (1.9)	ANKRD31 (1.9)	PMFBP1 (1.7)	ADAM1 (1.7)	SLC44A2 (1.6)	TMEM57 (1.6)	ATXN7L2 (1.5)
MP:0008898	abnormal acrosome morphology	0.65	> 0.20	TSSK6 (3.6)	GCNT4 (2.2)	BCAM (1.6)	ABO (1.6)	LPIN3 (1.6)	PCSK9 (1.5)	NT5DC1 (1.5)	ANKRD31 (1.5)	PMFBP1 (1.4)	NKPD1 (1.4)
ENSG00000145375	SPATA5 PPI subnetwork	0.65	> 0.20	ZNF259 (3.0)	TOMM40 (2.9)	NAA25 (2.6)	DOCK7 (2.2)	DYNC2LI1 (2.1)	QTRT1 (2.0)	MAPKAPK5 (1.9)	ADAM1 (1.7)	DDX56 (1.7)	BRAP (1.6)
GO:0019897	extrinsic to plasma membrane	0.65	> 0.20	RPH3A (2.5)	ITGB3 (2.4)	CETP (2.1)	KANK2 (1.6)	SH2B3 (1.6)	TMEM50A (1.6)	LPIN3 (1.4)	APOC1 (1.3)	AP1M2 (1.2)	ANGPTL3 (1.1)
ENSG00000166851	PLK1 PPI subnetwork	0.65	> 0.20	PSRC1 (5.5)	FEN1 (4.6)	USP1 (3.6)	POC5 (3.6)	ILF3 (1.3)	PSMA5 (1.1)	RHCE (0.9)	ADAM1 (0.9)	ENSG00000226648 (0.8)	DDX56 (0.8)
ENSG00000174622	ENSG00000174622 PPI subnetwork	0.65	> 0.20	PSMA5 (3.3)	TRIB1 (2.1)	POC5 (1.8)	AMIGO1 (1.8)	BUD13 (1.7)	TOP1 (1.7)	USP1 (1.6)	MAPKAPK5 (1.6)	ZNF180 (1.6)	ADAM1 (1.5)
ENSG00000166848	TERF2IP PPI subnetwork	0.65	> 0.20	POLK (3.0)	TXNL4B (2.5)	DHODH (2.2)	UBXN2B (2.0)	FEN1 (1.6)	USP1 (1.6)	PLCG1 (1.5)	BUD13 (1.5)	TMEM116 (1.4)	TMEM57 (1.4)
ENSG00000006712	PAF1 PPI subnetwork	0.65	> 0.20	SUGP1 (2.6)	COL4A3BP (2.6)	ATXN2 (2.5)	PTPN11 (2.5)	MAPKAPK5 (2.5)	TMEM57 (2.3)	BRAP (2.3)	NKPD1 (2.3)	SARS (2.1)	CARM1 (1.9)
ENSG00000138083	SIX3 PPI subnetwork	0.65	> 0.20	MAU2 (2.4)	DNM2 (1.9)	HAVCR1 (1.6)	TMED4 (1.6)	TRIB1 (1.6)	C17orf57 (1.5)	BRAP (1.5)	PPP1R37 (1.5)	OASL (1.4)	LPAR2 (1.4)
GO:0050673	epithelial cell proliferation	0.65	> 0.20	ENSG00000226645 (2.2)	CILP2 (2.2)	HLX (1.7)	MAFB (1.7)	SLC44A2 (1.6)	KANK2 (1.6)	ENSG00000254235 (1.6)	CBLC (1.5)	C19orf52 (1.4)	PLEKHH2 (1.2)
ENSG00000206493	HLA-E PPI subnetwork	0.65	> 0.20	PARP10 (3.0)	PLCG1 (2.9)	ENSG00000228044 (1.9)	PPP1R37 (1.6)	ZNF101 (1.5)	LPIN3 (1.5)	TMED4 (1.4)	HNF1A (1.4)	YIPF2 (1.3)	HAVCR1 (1.2)
ENSG00000206413	ENSG00000206413 PPI subnetwork	0.65	> 0.20	PARP10 (3.0)	PLCG1 (2.9)	ENSG00000228044 (1.9)	PPP1R37 (1.6)	ZNF101 (1.5)	LPIN3 (1.5)	TMED4 (1.4)	HNF1A (1.4)	YIPF2 (1.3)	HAVCR1 (1.2)
GO:0044449	contractile fiber part	0.65	> 0.20	SYPL2 (7.0)	GMPR (2.4)	TMEM50A (1.2)	PLEC (1.2)	PVRL2 (1.2)	KANK2 (1.0)	NPC1L1 (1.0)	RPH3A (0.9)	PVR (0.8)	AP1M2 (0.8)
ENSG00000106211	HSPB1 PPI subnetwork	0.65	> 0.20	ATXN2 (2.6)	NAA25 (2.1)	AP1M2 (1.9)	SARS (1.9)	ENSG00000226648 (1.8)	ACAD10 (1.7)	C12orf43 (1.7)	ENSG00000226645 (1.6)	PLEC (1.6)	BRAP (1.5)
GO:0035136	forelimb morphogenesis	0.65	> 0.20	ABO (2.6)	MYLIP (2.4)	DNAH11 (2.3)	NYNRIN (1.7)	TSSK6 (1.7)	DYNC2LI1 (1.7)	FRK (1.6)	PMFBP1 (1.5)	ATXN2 (1.5)	LPIN3 (1.3)
MP:0003935	abnormal craniofacial development	0.65	> 0.20	NYNRIN (2.5)	AP1M2 (1.8)	CBLC (1.7)	CARM1 (1.6)	PLCG1 (1.5)	PLEC (1.5)	LDLR (1.4)	GRINA (1.4)	BCAM (1.2)	KANK2 (1.1)
GO:0051443	positive regulation of ubiquitin-protein ligase activity	0.65	> 0.20	PSMA5 (3.9)	TRAFD1 (2.6)	POC5 (2.2)	NAA25 (2.2)	SUGP1 (2.1)	BRAP (2.0)	C12orf47 (1.7)	LPIN3 (1.6)	DDX56 (1.6)	SARS (1.3)
GO:0018958	phenol-containing compound metabolic process	0.65	> 0.20	DNAH11 (3.8)	ENSG00000254235 (2.2)	TSSK6 (2.0)	ANKRD31 (2.0)	PMFBP1 (1.9)	ENSG00000235545 (1.8)	ABO (1.5)	POLK (1.5)	CILP2 (1.2)	MOSC1 (1.1)
REACTOME_ACTIVATION_OF_THE_AP:1_FAMILY_OF_TRANSCRIPTION_FACTORS	REACTOME_ACTIVATION_OF_THE_AP:1_FAMILY_OF_TRANSCRIPTION_FACTORS	0.65	> 0.20	TRIB1 (4.0)	PLCG1 (2.4)	ENSG00000238078 (2.3)	AMIGO1 (2.0)	PVR (1.7)	POLK (1.7)	C1orf63 (1.6)	PBX4 (1.5)	HLX (1.5)	MAPKAPK5 (1.5)
ENSG00000135828	RNASEL PPI subnetwork	0.65	> 0.20	CELSR2 (2.8)	SARS (2.0)	HLX (1.8)	USP1 (1.8)	MARK4 (1.8)	LPIN3 (1.6)	GCNT4 (1.6)	PSRC1 (1.4)	KIAA1324 (1.4)	GRINA (1.4)
GO:0021522	spinal cord motor neuron differentiation	0.65	> 0.20	DNAH11 (3.6)	ANKRD31 (3.4)	C12orf47 (2.2)	ATXN7L2 (2.1)	GCNT4 (2.0)	PMFBP1 (1.8)	DYNC2LI1 (1.6)	TMED4 (1.5)	MAPKAPK5 (1.3)	C19orf52 (1.3)
ENSG00000129810	SGOL1 PPI subnetwork	0.65	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	USP1 (3.7)	POC5 (3.5)	ENSG00000228044 (1.2)	ENSG00000226648 (1.1)	ZNF180 (1.1)	ZHX3 (1.0)	LPIN3 (0.8)	C17orf57 (0.6)
GO:0045076	regulation of interleukin-2 biosynthetic process	0.65	> 0.20	PBX4 (2.2)	ENSG00000235545 (2.2)	ENSG00000254235 (2.1)	SLC44A2 (2.0)	CYB561D1 (1.9)	POLK (1.7)	PLCG1 (1.7)	DYNC2LI1 (1.6)	ANKRD31 (1.4)	ZNF101 (1.3)
ENSG00000111052	LIN7A PPI subnetwork	0.65	> 0.20	RPH3A (3.2)	ALDH2 (3.0)	C11orf9 (2.9)	CELSR2 (2.3)	CYP7A1 (1.9)	NCAN (1.8)	PTPN11 (1.8)	FRK (1.6)	ZNF101 (1.6)	APOE (1.5)
ENSG00000115947	ORC4 PPI subnetwork	0.65	> 0.20	FEN1 (6.2)	USP1 (4.5)	PSRC1 (2.1)	ENSG00000235545 (1.9)	TMEM116 (1.6)	MAU2 (1.4)	LPAR2 (1.3)	NT5DC1 (1.3)	GMPR (1.3)	DHODH (1.1)
ENSG00000111328	CDK2AP1 PPI subnetwork	0.65	> 0.20	SORT1 (2.6)	TMED4 (2.1)	FEN1 (2.1)	MARK4 (1.5)	ENSG00000254235 (1.5)	TMEM50A (1.5)	DDX56 (1.5)	ATXN2 (1.4)	USP1 (1.4)	CELSR2 (1.4)
MP:0003699	abnormal female reproductive system physiology	0.65	> 0.20	ZHX3 (2.3)	LPA (2.1)	ENSG00000254235 (1.8)	KIAA1324 (1.8)	ENSG00000226648 (1.8)	MAFB (1.6)	PPP1R37 (1.5)	APOA5 (1.4)	GMPR (1.4)	CYP7A1 (1.1)
REACTOME_CD28_CO:STIMULATION	REACTOME_CD28_CO:STIMULATION	0.65	> 0.20	POLK (2.0)	OGDH (1.9)	TMEM50A (1.8)	USP24 (1.8)	MAFB (1.8)	COL4A3BP (1.7)	UBXN2B (1.7)	DNM2 (1.6)	FADS2 (1.6)	TMEM57 (1.5)
GO:0046660	female sex differentiation	0.65	> 0.20	NYNRIN (2.5)	ABO (2.4)	ST3GAL4 (1.6)	C11orf9 (1.5)	TSSK6 (1.5)	YIPF2 (1.5)	HNF1A (1.4)	DNAH11 (1.3)	ANKRD31 (1.3)	AP1M2 (1.2)
REACTOME_PLCG1_EVENTS_IN_ERBB2_SIGNALING	REACTOME_PLCG1_EVENTS_IN_ERBB2_SIGNALING	0.65	> 0.20	ITGB3 (3.3)	ST3GAL4 (2.7)	SH2B3 (2.7)	ZHX3 (2.7)	SORT1 (2.6)	AMIGO1 (2.3)	OGDH (1.9)	ZNF101 (1.7)	ENSG00000238078 (1.6)	USP24 (1.5)
GO:0006970	response to osmotic stress	0.65	> 0.20	DNAH11 (2.7)	ABO (2.4)	RHD (2.1)	TSSK6 (1.8)	RHCE (1.8)	ZHX3 (1.7)	BUD13 (1.6)	SLC44A2 (1.4)	UBXN2B (1.2)	ST3GAL4 (1.2)
GO:0070193	synaptonemal complex organization	0.65	> 0.20	ENSG00000238078 (2.5)	LPIN3 (1.9)	ANKRD31 (1.8)	PBX4 (1.5)	DNAH11 (1.5)	DYNC2LI1 (1.4)	HAVCR1 (1.4)	ADAM1 (1.2)	ZNF180 (1.0)	MAPKAPK5 (1.0)
GO:0045730	respiratory burst	0.65	> 0.20	ADAM1 (2.5)	PCSK9 (1.9)	SLC44A2 (1.7)	PBX4 (1.6)	ALDH2 (1.6)	DOCK7 (1.6)	GOT2P1 (1.6)	C19orf52 (1.4)	DYNC2LI1 (1.4)	DNAH11 (1.4)
GO:0009986	cell surface	0.65	> 0.20	SLC44A2 (2.5)	CELSR2 (2.4)	PVR (2.3)	APOE (2.0)	BCAM (2.0)	PLCG1 (2.0)	PBX4 (1.9)	RELB (1.9)	ITGB3 (1.7)	CETP (1.6)
REACTOME_GRB2_EVENTS_IN_EGFR_SIGNALING	REACTOME_GRB2_EVENTS_IN_EGFR_SIGNALING	0.65	> 0.20	DNM2 (2.2)	GEMIN7 (2.2)	MARK4 (1.9)	MAPKAPK5 (1.9)	BLOC1S3 (1.8)	PBX4 (1.8)	PSMA5 (1.8)	TMEM50A (1.8)	CARM1 (1.7)	AP1M2 (1.5)
GO:0032651	regulation of interleukin-1 beta production	0.65	> 0.20	LPIN3 (2.0)	CYB561D1 (1.8)	CEACAM19 (1.7)	PLEKHH2 (1.7)	ST3GAL4 (1.6)	NPC1L1 (1.3)	ALDH2 (1.3)	NT5DC1 (1.3)	NKPD1 (1.3)	HLX (1.2)
GO:0045767	regulation of anti-apoptosis	0.65	> 0.20	ENSG00000238078 (2.9)	HAVCR1 (2.6)	TRIB1 (2.3)	MAFB (1.8)	GRINA (1.6)	LPIN3 (1.5)	TRAPPC6A (1.5)	POLK (1.4)	CETP (1.4)	DNAH11 (1.4)
ENSG00000165702	GFI1B PPI subnetwork	0.65	> 0.20	AMIGO1 (2.9)	NYNRIN (2.7)	CELSR2 (2.5)	PVRL2 (2.4)	BCAM (2.2)	PLEC (2.1)	PLCG1 (2.1)	PLEKHH2 (2.0)	ALDH2 (1.8)	C12orf43 (1.8)
GO:0005762	mitochondrial large ribosomal subunit	0.65	> 0.20	GEMIN7 (4.1)	TRAPPC6A (2.5)	TOMM40 (2.4)	DDX56 (2.3)	PSMA5 (1.4)	PTPN11 (1.4)	DHODH (1.3)	TMED4 (1.3)	C12orf43 (1.2)	MOSC1 (1.2)
GO:0000315	organellar large ribosomal subunit	0.65	> 0.20	GEMIN7 (4.1)	TRAPPC6A (2.5)	TOMM40 (2.4)	DDX56 (2.3)	PSMA5 (1.4)	PTPN11 (1.4)	DHODH (1.3)	TMED4 (1.3)	C12orf43 (1.2)	MOSC1 (1.2)
ENSG00000181029	TRAPPC5 PPI subnetwork	0.65	> 0.20	TRAPPC6A (3.8)	BLOC1S3 (3.7)	TMEM50A (3.1)	GEMIN7 (3.0)	CYB561D1 (2.8)	TMED4 (2.3)	CLPTM1 (2.2)	ZNF180 (2.0)	YIPF2 (1.9)	NKPD1 (1.9)
ENSG00000197442	MAP3K5 PPI subnetwork	0.65	> 0.20	PARP10 (2.9)	CELSR2 (2.5)	PVR (2.4)	TRAFD1 (2.4)	RELB (2.4)	POLK (2.3)	BCL3 (2.1)	PLEC (2.1)	OASL (1.9)	GRINA (1.8)
MP:0005017	decreased B cell number	0.65	> 0.20	GMIP (4.3)	RELB (3.0)	ZNF101 (2.5)	TIMD4 (2.4)	CETP (2.3)	BCL3 (1.7)	HLX (1.7)	SH2B3 (1.5)	USP24 (1.2)	GRINA (1.2)
ENSG00000100302	RASD2 PPI subnetwork	0.65	> 0.20	DOCK7 (2.6)	MAPKAPK5 (2.5)	ENSG00000228044 (2.3)	TMEM57 (2.0)	GCNT4 (1.8)	ATXN2 (1.4)	SH2B3 (1.4)	TMEM50A (1.4)	ENSG00000226648 (1.4)	LDLR (1.3)
GO:0003725	double-stranded RNA binding	0.65	> 0.20	OASL (8.9)	PARP10 (6.3)	TRAFD1 (4.6)	DOCK7 (2.0)	ATP13A1 (1.8)	BRAP (1.7)	TXNL4B (1.6)	HNF1A (1.6)	NAA25 (1.6)	C12orf43 (1.5)
ENSG00000181555	SETD2 PPI subnetwork	0.65	> 0.20	MAPKAPK5 (3.3)	UBXN2B (2.5)	TXNL4B (2.4)	GPAM (2.2)	PTPN11 (2.0)	DHX38 (2.0)	C12orf51 (1.8)	ATXN2 (1.7)	COL4A3BP (1.7)	C19orf52 (1.7)
ENSG00000132612	VPS4A PPI subnetwork	0.65	> 0.20	BLOC1S3 (3.1)	CBLC (2.7)	CLPTM1 (2.6)	TRAPPC6A (2.5)	MARK4 (2.2)	FRK (1.9)	PLEC (1.8)	UBXN2B (1.8)	NYNRIN (1.8)	C12orf43 (1.8)
MP:0000272	abnormal aorta morphology	0.65	> 0.20	KANK2 (2.2)	PCSK9 (2.0)	C11orf9 (2.0)	NYNRIN (1.5)	SLC44A2 (1.4)	NPC1L1 (1.3)	LDLR (1.3)	PVR (1.3)	TMEM57 (1.2)	HLX (1.2)
GO:0051385	response to mineralocorticoid stimulus	0.65	> 0.20	DNAH11 (2.7)	ZHX3 (2.0)	GOT2P1 (2.0)	CBLC (1.9)	GMPR (1.8)	SLC44A2 (1.8)	LPIN3 (1.6)	POLK (1.5)	HAPLN4 (1.5)	LPA (1.5)
GO:0005099	Ras GTPase activator activity	0.65	> 0.20	DNM2 (2.6)	GMIP (2.6)	ENSG00000226645 (2.1)	NYNRIN (2.0)	CBLC (2.0)	C12orf51 (2.0)	HLX (1.9)	COL4A3BP (1.9)	PPP1R37 (1.7)	CYB561D1 (1.6)
ENSG00000171453	POLR1C PPI subnetwork	0.65	> 0.20	C12orf43 (3.3)	DDX56 (3.2)	ZNF259 (2.9)	DHX38 (2.6)	GEMIN7 (2.6)	POLK (2.5)	SUGP1 (2.5)	BUD13 (2.5)	QTRT1 (2.4)	TOMM40 (2.2)
MP:0002021	increased incidence of induced tumors	0.65	> 0.20	POC5 (2.0)	ZNF180 (1.9)	GEMIN7 (1.9)	MARK4 (1.8)	TRAPPC6A (1.8)	ENSG00000235545 (1.8)	PLEKHH2 (1.8)	BLOC1S3 (1.8)	NCAN (1.7)	KIAA1324 (1.6)
MP:0001286	abnormal eye development	0.66	> 0.20	PLEKHH2 (2.3)	CILP2 (2.2)	NYNRIN (1.8)	TXNL4B (1.8)	MYLIP (1.6)	TRIB1 (1.5)	APOB (1.5)	ATXN2 (1.4)	MAFB (1.3)	ABO (1.3)
GO:0043632	modification-dependent macromolecule catabolic process	0.66	> 0.20	BRAP (3.4)	TRAFD1 (2.7)	USP24 (2.4)	TMEM57 (2.4)	NAA25 (2.3)	ZNF180 (2.1)	MAU2 (2.0)	DHX38 (1.9)	PSMA5 (1.7)	OASL (1.7)
GO:0005328	neurotransmitter:sodium symporter activity	0.66	> 0.20	TM6SF2 (3.4)	HAPLN4 (2.7)	ABCG5 (2.6)	ABCG8 (2.2)	NPC1L1 (2.0)	TMEM116 (1.8)	GEMIN7 (1.8)	ZHX3 (1.8)	ST3GAL4 (1.8)	CYP7A1 (1.8)
ENSG00000177954	RPS27 PPI subnetwork	0.66	> 0.20	PSRC1 (4.1)	FEN1 (3.4)	USP1 (2.8)	POC5 (2.0)	NKPD1 (1.6)	DHX38 (1.5)	ILF3 (1.4)	ZNF180 (1.1)	ADAM1 (1.1)	CEACAM19 (1.0)
ENSG00000130041	ENSG00000130041 PPI subnetwork	0.66	> 0.20	PSRC1 (4.1)	FEN1 (3.4)	USP1 (2.8)	POC5 (2.0)	NKPD1 (1.6)	DHX38 (1.5)	ILF3 (1.4)	ZNF180 (1.1)	ADAM1 (1.1)	CEACAM19 (1.0)
ENSG00000090020	SLC9A1 PPI subnetwork	0.66	> 0.20	SLC44A2 (2.6)	ITGB3 (2.4)	PBX4 (2.3)	GATAD2A (2.1)	ALDH2 (2.1)	CBLC (2.0)	ENSG00000235545 (1.9)	RHD (1.8)	C11orf9 (1.7)	RHCE (1.6)
ENSG00000137076	TLN1 PPI subnetwork	0.66	> 0.20	PLEC (3.8)	ITGB3 (3.0)	GMIP (2.6)	SLC44A2 (2.0)	GATAD2A (1.8)	OGDH (1.7)	SMARCA4 (1.7)	PVR (1.6)	TMEM50A (1.6)	DOCK7 (1.6)
GO:0009311	oligosaccharide metabolic process	0.66	> 0.20	YIPF2 (3.4)	ERP29 (2.7)	GCNT4 (2.6)	ATP13A1 (2.6)	TMED4 (2.5)	BLOC1S3 (2.3)	TMEM116 (2.2)	CYB561D1 (2.1)	CLPTM1 (1.9)	TMEM50A (1.9)
ENSG00000001626	CFTR PPI subnetwork	0.66	> 0.20	PLEC (3.1)	SORT1 (3.1)	KIAA1324 (2.9)	PBX4 (2.5)	AP1M2 (2.5)	SLC44A2 (2.1)	ST3GAL4 (1.9)	PLCG1 (1.8)	LDLR (1.8)	PVR (1.7)
ENSG00000203852	HIST2H3A PPI subnetwork	0.66	> 0.20	USP1 (2.9)	C19orf52 (2.8)	SMARCA4 (2.8)	FEN1 (2.4)	PSRC1 (2.4)	ATXN2 (1.9)	ILF3 (1.8)	MYLIP (1.7)	TOP1 (1.4)	KIAA1324 (1.4)
GO:0042129	regulation of T cell proliferation	0.66	> 0.20	TIMD4 (2.6)	PBX4 (2.4)	CETP (1.8)	TRAFD1 (1.7)	ENSG00000235545 (1.7)	ENSG00000254235 (1.6)	ZNF101 (1.5)	ENSG00000226645 (1.5)	ENSG00000228044 (1.4)	ANKRD31 (1.3)
MP:0005608	cardiac interstitial fibrosis	0.66	> 0.20	BCAM (2.6)	ACAD10 (2.0)	TM6SF2 (1.5)	ENSG00000238078 (1.5)	SYPL2 (1.4)	GMPR (1.3)	ADAM1 (1.3)	SORT1 (1.2)	PTPN11 (1.1)	ATXN2 (1.1)
GO:0033003	regulation of mast cell activation	0.66	> 0.20	BLOC1S3 (2.6)	ENSG00000235545 (2.5)	GEMIN7 (1.9)	GMPR (1.8)	PMFBP1 (1.7)	DHODH (1.7)	NKPD1 (1.6)	ERP29 (1.6)	C12orf47 (1.5)	ALDH2 (1.3)
GO:0035066	positive regulation of histone acetylation	0.66	> 0.20	ST3GAL4 (2.6)	GOT2P1 (2.6)	ENSG00000228044 (2.0)	SH2B3 (1.8)	GCNT4 (1.6)	FRK (1.4)	ZNF180 (1.4)	ENSG00000254235 (1.4)	PLEKHH2 (1.2)	RPH3A (1.1)
ENSG00000065328	MCM10 PPI subnetwork	0.66	> 0.20	FEN1 (5.8)	USP1 (4.8)	PSRC1 (1.5)	FADS1 (1.4)	TMEM116 (1.3)	HLX (1.2)	POC5 (1.1)	ENSG00000228044 (1.1)	DHODH (1.1)	ILF3 (1.1)
ENSG00000124422	USP22 PPI subnetwork	0.66	> 0.20	TRAPPC6A (2.7)	RHCE (2.3)	TMEM57 (2.1)	CARM1 (2.1)	C12orf51 (2.0)	RHD (1.8)	C19orf52 (1.8)	ATXN2 (1.8)	PARP10 (1.7)	NT5DC1 (1.6)
ENSG00000161980	POLR3K PPI subnetwork	0.66	> 0.20	ZNF259 (3.8)	DDX56 (2.9)	QTRT1 (2.9)	GEMIN7 (2.3)	DYNC2LI1 (2.1)	ACAD10 (2.0)	C12orf43 (2.0)	DHODH (2.0)	ADAM1 (1.7)	CARM1 (1.7)
MP:0008411	decreased cellular sensitivity to ultraviolet irradiation	0.66	> 0.20	TRIB1 (3.1)	PSRC1 (2.5)	C11orf9 (2.1)	C12orf43 (2.0)	POLK (1.8)	PPP1R37 (1.7)	SH2B3 (1.6)	AMIGO1 (1.6)	ATXN7L2 (1.5)	PBX4 (1.5)
KEGG_FOCAL_ADHESION	KEGG_FOCAL_ADHESION	0.66	> 0.20	ITGB3 (4.2)	PLEC (3.8)	KANK2 (3.2)	SH2B3 (2.3)	SLC44A2 (2.2)	CILP2 (2.2)	PVRL2 (2.0)	OGDH (2.0)	BCAM (1.9)	ENSG00000238078 (1.7)
ENSG00000153044	CENPH PPI subnetwork	0.66	> 0.20	PSRC1 (5.8)	FEN1 (4.5)	POC5 (3.6)	USP1 (3.5)	ENSG00000226648 (1.1)	ENSG00000228044 (1.0)	ZHX3 (0.9)	HMGCR (0.9)	ZNF180 (0.9)	LDLR (0.8)
ENSG00000106028	SSBP1 PPI subnetwork	0.66	> 0.20	BRAP (4.5)	PLCG1 (2.6)	ADAM1 (2.4)	PVR (2.2)	SH2B3 (2.0)	GATAD2A (2.0)	KANK2 (2.0)	ITGB3 (1.9)	PLEC (1.9)	PTPN11 (1.8)
GO:0042288	MHC class I protein binding	0.66	> 0.20	PARP10 (3.5)	OASL (2.2)	TRAFD1 (2.0)	GRINA (1.7)	BUD13 (1.6)	LPIN3 (1.5)	ACAD10 (1.5)	PSRC1 (1.3)	C19orf52 (1.3)	NKPD1 (1.3)
GO:0030148	sphingolipid biosynthetic process	0.66	> 0.20	NKPD1 (3.8)	HAVCR1 (3.8)	CYB561D1 (3.0)	TMEM50A (2.7)	COL4A3BP (2.5)	SLC44A2 (2.4)	LPIN3 (2.1)	ZHX3 (1.9)	AMIGO1 (1.6)	ATP13A1 (1.6)
ENSG00000153208	MERTK PPI subnetwork	0.66	> 0.20	MAFB (3.3)	APOE (2.5)	NYNRIN (2.5)	TIMD4 (2.4)	ALDH2 (2.1)	ERP29 (2.1)	TMED4 (1.7)	SORT1 (1.5)	APOC1 (1.5)	NKPD1 (1.5)
MP:0005574	decreased pulmonary respiratory rate	0.66	> 0.20	FADS2 (4.0)	FADS1 (3.9)	LDLR (3.8)	HMGCR (3.4)	NCAN (3.1)	CEACAM19 (3.0)	PBX4 (2.5)	PCSK9 (2.3)	C11orf9 (2.1)	LPAR2 (2.1)
GO:0032508	DNA duplex unwinding	0.66	> 0.20	BUD13 (2.5)	AMIGO1 (2.1)	NT5DC1 (2.0)	SUGP1 (1.6)	FEN1 (1.6)	POLK (1.6)	USP1 (1.6)	DYNC2LI1 (1.5)	LPIN3 (1.5)	MAPKAPK5 (1.5)
GO:0032392	DNA geometric change	0.66	> 0.20	BUD13 (2.5)	AMIGO1 (2.1)	NT5DC1 (2.0)	SUGP1 (1.6)	FEN1 (1.6)	POLK (1.6)	USP1 (1.6)	DYNC2LI1 (1.5)	LPIN3 (1.5)	MAPKAPK5 (1.5)
GO:0051058	negative regulation of small GTPase mediated signal transduction	0.66	> 0.20	ENSG00000238078 (3.0)	MAU2 (2.3)	PPP1R37 (2.3)	C17orf57 (2.2)	ENSG00000254235 (2.0)	DNAH11 (1.9)	COL4A3BP (1.9)	RPH3A (1.3)	CYB561D1 (1.2)	SH2B3 (1.2)
MP:0004145	abnormal muscle electrophysiology	0.66	> 0.20	SYPL2 (4.9)	GOT2P1 (2.5)	NYNRIN (1.8)	BCAM (1.8)	RPH3A (1.6)	PPP1R37 (1.6)	PLEC (1.4)	ATXN7L2 (1.4)	SLC22A1 (1.3)	TMEM57 (1.3)
ENSG00000162664	ZNF326 PPI subnetwork	0.66	> 0.20	TMED4 (2.7)	DDX56 (2.3)	CARM1 (2.0)	PMFBP1 (1.9)	ILF3 (1.8)	C12orf43 (1.8)	C19orf52 (1.6)	ERP29 (1.6)	OGDH (1.4)	ATP13A1 (1.3)
ENSG00000174437	ATP2A2 PPI subnetwork	0.66	> 0.20	C17orf57 (2.4)	HLX (2.0)	SORT1 (2.0)	ST3GAL4 (1.9)	OGDH (1.7)	PLEC (1.6)	QTRT1 (1.5)	SARS (1.5)	ATP13A1 (1.4)	AP1M2 (1.2)
GO:0032330	regulation of chondrocyte differentiation	0.66	> 0.20	PLEKHH2 (2.9)	CILP2 (2.2)	NYNRIN (1.9)	MAFB (1.5)	ENSG00000226648 (1.5)	LPIN3 (1.3)	TMED4 (1.3)	PMFBP1 (1.3)	LPAR2 (1.2)	ALDH2 (1.2)
ENSG00000022840	RNF10 PPI subnetwork	0.66	> 0.20	ATXN7L2 (2.3)	CYP7A1 (1.9)	FRK (1.8)	NT5DC1 (1.8)	DOCK7 (1.7)	UBXN2B (1.6)	LPAR2 (1.6)	ERP29 (1.5)	TSSK6 (1.4)	FADS2 (1.4)
ENSG00000122705	CLTA PPI subnetwork	0.66	> 0.20	PBX4 (2.7)	DNM2 (2.6)	PPP1R37 (2.5)	SMARCA4 (2.4)	AP1M2 (2.3)	GRINA (2.0)	CARM1 (2.0)	YIPF2 (1.9)	GMIP (1.8)	CLPTM1 (1.8)
ENSG00000151422	FER PPI subnetwork	0.66	> 0.20	FRK (2.7)	DOCK7 (2.6)	AP1M2 (2.4)	CELSR2 (2.2)	FADS2 (2.0)	CETP (1.7)	SLC44A2 (1.6)	YIPF2 (1.6)	ITGB3 (1.6)	LDLR (1.5)
REACTOME_REPAIR_SYNTHESIS_FOR_GAP:FILLING_BY_DNA_POLYMERASE_IN_TC:NER	REACTOME_REPAIR_SYNTHESIS_FOR_GAP:FILLING_BY_DNA_POLYMERASE_IN_TC:NER	0.66	> 0.20	USP1 (5.9)	FEN1 (5.7)	ZNF180 (2.2)	ENSG00000235545 (1.8)	ENSG00000228044 (1.7)	ERP29 (1.5)	GOT2P1 (1.4)	DHODH (1.3)	FADS1 (1.3)	NT5DC1 (1.2)
REACTOME_REPAIR_SYNTHESIS_OF_PATCH_27:30_BASES_LONG__BY_DNA_POLYMERASE	REACTOME_REPAIR_SYNTHESIS_OF_PATCH_27:30_BASES_LONG__BY_DNA_POLYMERASE	0.66	> 0.20	USP1 (5.9)	FEN1 (5.7)	ZNF180 (2.2)	ENSG00000235545 (1.8)	ENSG00000228044 (1.7)	ERP29 (1.5)	GOT2P1 (1.4)	DHODH (1.3)	FADS1 (1.3)	NT5DC1 (1.2)
MP:0009661	abnormal pregnancy	0.66	> 0.20	ZHX3 (2.6)	SH2B3 (2.0)	CYP7A1 (1.8)	FRK (1.6)	PPP1R37 (1.6)	LPIN3 (1.6)	CARM1 (1.6)	ABCG8 (1.6)	DHX38 (1.4)	GATAD2A (1.2)
ENSG00000113448	PDE4D PPI subnetwork	0.66	> 0.20	GMIP (3.1)	NCAN (2.4)	ITGB3 (2.1)	HAVCR1 (2.0)	GATAD2A (1.9)	SYPL2 (1.8)	OGDH (1.7)	SORT1 (1.6)	RPH3A (1.5)	NYNRIN (1.5)
ENSG00000143398	PIP5K1A PPI subnetwork	0.66	> 0.20	TOP1 (2.0)	ST3GAL4 (1.8)	CEACAM19 (1.8)	ALDH2 (1.6)	GMPR (1.6)	QTRT1 (1.4)	TOMM40 (1.3)	ABO (1.3)	C17orf57 (1.3)	ITGB3 (1.3)
GO:0043409	negative regulation of MAPK cascade	0.66	> 0.20	TRIB1 (3.1)	ENSG00000238078 (2.0)	PVR (1.8)	SYPL2 (1.7)	DNAH11 (1.5)	DYNC2LI1 (1.5)	MYLIP (1.5)	AMIGO1 (1.4)	CILP2 (1.4)	ENSG00000226645 (1.4)
ENSG00000093167	LRRFIP2 PPI subnetwork	0.66	> 0.20	TRAFD1 (2.5)	ENSG00000238078 (2.2)	PLEC (2.2)	ITGB3 (2.1)	KANK2 (1.9)	PLCG1 (1.9)	NPC1L1 (1.8)	PTPN11 (1.8)	ST3GAL4 (1.7)	ENSG00000228044 (1.6)
ENSG00000184922	FMNL1 PPI subnetwork	0.66	> 0.20	GMIP (4.6)	OGDH (2.6)	GATAD2A (2.2)	CARM1 (1.9)	SMARCA4 (1.9)	CYB561D1 (1.8)	PLEC (1.7)	SLC44A2 (1.7)	C11orf9 (1.5)	GRINA (1.5)
MP:0001944	abnormal pancreas morphology	0.66	> 0.20	DYNC2LI1 (3.0)	TMED4 (2.0)	C11orf9 (2.0)	KIAA1324 (1.9)	MARK4 (1.7)	FRK (1.7)	NCAN (1.6)	SORT1 (1.6)	NYNRIN (1.5)	SLC22A1 (1.4)
REACTOME_BIOSYNTHESIS_OF_THE_N:GLYCAN_PRECURSOR_DOLICHOL_LIPID:LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	REACTOME_BIOSYNTHESIS_OF_THE_N:GLYCAN_PRECURSOR_DOLICHOL_LIPID:LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	0.66	> 0.20	YIPF2 (4.0)	ATP13A1 (2.3)	BLOC1S3 (2.2)	CLPTM1 (2.1)	QTRT1 (2.1)	ZNF259 (2.0)	KIAA1324 (1.9)	C12orf43 (1.8)	TMEM116 (1.7)	TMED4 (1.6)
MP:0006382	abnormal lung epithelium morphology	0.66	> 0.20	LDLR (4.2)	NYNRIN (3.1)	HMGCR (3.1)	FADS1 (3.1)	FADS2 (2.9)	PLEKHH2 (2.8)	HLX (2.2)	PCSK9 (2.0)	SLC44A2 (1.9)	FRK (1.8)
MP:0001176	abnormal lung development	0.66	> 0.20	PLEKHH2 (4.2)	C11orf9 (2.7)	BCAM (2.6)	CYP7A1 (2.3)	HLX (2.1)	NYNRIN (2.0)	LDLR (2.0)	FADS1 (1.9)	FADS2 (1.6)	HAPLN4 (1.4)
GO:0051721	protein phosphatase 2A binding	0.66	> 0.20	MARK4 (3.5)	SLC44A2 (3.1)	PPP1R37 (2.9)	GOT2P1 (2.4)	PVRL2 (2.1)	AP1M2 (2.1)	CARM1 (1.9)	RHD (1.7)	CELSR2 (1.7)	TOMM40 (1.6)
GO:0004896	cytokine receptor activity	0.66	> 0.20	TIMD4 (3.1)	BCL3 (2.8)	GMIP (2.3)	PBX4 (2.0)	CETP (1.9)	HLX (1.8)	ZNF101 (1.8)	RELB (1.8)	ANKRD31 (1.7)	TRIB1 (1.4)
ENSG00000062485	CS PPI subnetwork	0.66	> 0.20	ZHX3 (2.6)	ZNF101 (2.2)	SYPL2 (1.8)	GMPR (1.8)	SARS (1.7)	NCAN (1.7)	SMARCA4 (1.7)	HAVCR1 (1.5)	ATP13A1 (1.5)	ENSG00000254235 (1.3)
ENSG00000131558	EXOC4 PPI subnetwork	0.66	> 0.20	PTPN11 (2.4)	NCAN (2.3)	MYLIP (2.1)	POLK (2.0)	SMARCA4 (1.9)	ATXN2 (1.8)	LPAR2 (1.7)	SORT1 (1.6)	OGDH (1.6)	AP1M2 (1.5)
GO:0000776	kinetochore	0.66	> 0.20	PSRC1 (5.6)	FEN1 (4.1)	POC5 (4.0)	USP1 (3.4)	PBX4 (0.9)	ZNF180 (0.9)	C12orf51 (0.9)	BUD13 (0.8)	GEMIN7 (0.8)	ENSG00000228044 (0.8)
ENSG00000076053	RBM7 PPI subnetwork	0.66	> 0.20	ADAM1 (2.6)	DHODH (2.5)	C12orf43 (2.3)	CEACAM19 (1.8)	TRIB1 (1.6)	GCNT4 (1.6)	SUGP1 (1.6)	FRK (1.5)	POC5 (1.3)	SMARCA4 (1.3)
MP:0005176	eyelids fail to open	0.66	> 0.20	PMFBP1 (2.4)	MYLIP (2.2)	C19orf52 (2.0)	SYPL2 (2.0)	AMIGO1 (1.9)	RHD (1.8)	RHCE (1.7)	NYNRIN (1.7)	BCAM (1.5)	APOE (1.5)
ENSG00000169696	ASPSCR1 PPI subnetwork	0.66	> 0.20	SUGP1 (2.7)	BRAP (2.7)	ATXN2 (2.6)	C19orf52 (2.3)	TMEM57 (2.1)	GRINA (1.8)	TMEM50A (1.7)	SARS (1.5)	ABO (1.2)	POC5 (1.2)
MP:0002492	decreased IgE level	0.66	> 0.20	BCL3 (4.0)	RELB (3.3)	GMIP (2.2)	PBX4 (2.2)	HLX (1.3)	SH2B3 (1.2)	SLC44A2 (1.1)	TRAFD1 (0.9)	NT5DC1 (0.9)	PARP10 (0.8)
ENSG00000152520	PAN3 PPI subnetwork	0.66	> 0.20	MAPKAPK5 (3.5)	OASL (3.3)	C12orf43 (3.0)	DYNC2LI1 (2.8)	BLOC1S3 (2.6)	BRAP (2.4)	UBXN2B (1.9)	TXNL4B (1.9)	PARP10 (1.7)	DHODH (1.7)
ENSG00000134852	CLOCK PPI subnetwork	0.66	> 0.20	ZHX3 (2.9)	GPAM (2.6)	TMEM57 (2.4)	TOP1 (2.2)	CYP7A1 (2.1)	C12orf51 (1.8)	KANK2 (1.7)	ENSG00000254235 (1.5)	C1orf63 (1.5)	PCSK9 (1.3)
ENSG00000106541	AGR2 PPI subnetwork	0.66	> 0.20	C11orf9 (4.8)	NPC1L1 (3.8)	PCSK9 (2.9)	HNF1A (2.5)	OGDH (2.2)	TMEM50A (1.7)	PLEC (1.7)	BUD13 (1.4)	ZNF259 (1.4)	DYNC2LI1 (1.3)
GO:0045668	negative regulation of osteoblast differentiation	0.66	> 0.20	ANKRD31 (2.4)	NYNRIN (2.3)	CILP2 (2.1)	ATXN7L2 (2.1)	AMIGO1 (1.7)	MYLIP (1.6)	ATXN2 (1.5)	ENSG00000226648 (1.4)	PLCG1 (1.4)	PLEKHH2 (1.3)
GO:0045884	regulation of survival gene product expression	0.66	> 0.20	KIAA1324 (4.0)	GEMIN7 (3.3)	CYB561D1 (2.7)	TRAPPC6A (2.1)	PPP1R37 (2.1)	ZNF180 (1.9)	BLOC1S3 (1.8)	SORT1 (1.7)	DNAH11 (1.6)	AP1M2 (1.6)
ENSG00000144566	RAB5A PPI subnetwork	0.66	> 0.20	CLPTM1 (2.5)	C12orf43 (2.3)	USP24 (2.1)	BLOC1S3 (1.9)	SARS (1.9)	MAU2 (1.8)	PTPN11 (1.7)	UBXN2B (1.6)	HAPLN4 (1.6)	GMIP (1.6)
MP:0005215	abnormal pancreatic islet morphology	0.66	> 0.20	KIAA1324 (3.2)	C11orf9 (2.9)	DYNC2LI1 (2.3)	FRK (2.1)	COL4A3BP (1.9)	POLK (1.8)	HAPLN4 (1.7)	MOSC1 (1.7)	DNAH11 (1.7)	TRIB1 (1.4)
GO:0051952	regulation of amine transport	0.66	> 0.20	ABO (2.9)	RPH3A (1.8)	MOSC1 (1.6)	PMFBP1 (1.5)	CETP (1.4)	ABCG8 (1.3)	GPAM (1.3)	ERP29 (1.3)	CEACAM19 (1.3)	ZHX3 (1.2)
ENSG00000132561	MATN2 PPI subnetwork	0.66	> 0.20	PLEKHH2 (2.9)	C17orf57 (2.6)	FADS2 (2.1)	BCAM (1.9)	APOE (1.8)	MOSC1 (1.8)	CEACAM19 (1.8)	OGDH (1.5)	CETP (1.4)	PLCG1 (1.4)
MP:0008211	decreased mature B cell number	0.66	> 0.20	GMIP (3.8)	RELB (3.2)	TIMD4 (2.5)	CETP (2.1)	SH2B3 (1.6)	ERP29 (1.5)	ZNF101 (1.4)	BCL3 (1.3)	GRINA (1.3)	PARP10 (1.2)
ENSG00000008405	CRY1 PPI subnetwork	0.66	> 0.20	GPAM (1.8)	LPIN3 (1.6)	MAPKAPK5 (1.6)	ZHX3 (1.5)	PVRL2 (1.4)	CILP2 (1.4)	CYP7A1 (1.3)	PBX4 (1.3)	TMEM57 (1.2)	BUD13 (1.2)
GO:0043647	inositol phosphate metabolic process	0.66	> 0.20	GMPR (2.7)	ENSG00000235545 (2.4)	C17orf57 (1.6)	ENSG00000238078 (1.5)	PMFBP1 (1.4)	ST3GAL4 (1.4)	KANK2 (1.3)	ATXN7L2 (1.3)	ZHX3 (1.3)	ZNF180 (1.2)
MP:0009406	decreased skeletal muscle fiber number	0.66	> 0.20	SYPL2 (4.9)	PVR (3.6)	SARS (2.5)	CYB561D1 (2.3)	GMPR (2.1)	PLEC (2.1)	OGDH (1.9)	KANK2 (1.8)	NAA25 (1.8)	ZHX3 (1.6)
ENSG00000100239	PPP6R2 PPI subnetwork	0.66	> 0.20	RELB (7.3)	BCL3 (4.1)	CLPTM1 (3.2)	GRINA (2.3)	SH2B3 (1.8)	ENSG00000235545 (1.8)	GEMIN7 (1.7)	PTPN11 (1.7)	GMIP (1.6)	USP24 (1.6)
GO:0042533	tumor necrosis factor biosynthetic process	0.66	> 0.20	C17orf57 (2.2)	HLX (2.1)	PVR (2.0)	ZNF101 (1.9)	TRIB1 (1.8)	GMIP (1.5)	ZNF180 (1.4)	PLEKHH2 (1.3)	C12orf47 (1.3)	MAFB (1.2)
GO:0042534	regulation of tumor necrosis factor biosynthetic process	0.66	> 0.20	C17orf57 (2.2)	HLX (2.1)	PVR (2.0)	ZNF101 (1.9)	TRIB1 (1.8)	GMIP (1.5)	ZNF180 (1.4)	PLEKHH2 (1.3)	C12orf47 (1.3)	MAFB (1.2)
ENSG00000099389	ENSG00000099389 PPI subnetwork	0.66	> 0.20	ILF3 (3.0)	PPP1R37 (2.2)	TMEM57 (2.2)	USP1 (2.0)	ZNF101 (1.8)	C1orf63 (1.7)	YIPF2 (1.7)	DNM2 (1.6)	TMEM116 (1.6)	ENSG00000254235 (1.6)
ENSG00000168385	SEPT2 PPI subnetwork	0.66	> 0.20	CETP (1.9)	RHCE (1.8)	BLOC1S3 (1.8)	NYNRIN (1.7)	RHD (1.7)	PTPN11 (1.7)	DNM2 (1.7)	PLEC (1.6)	FRK (1.5)	TRAPPC6A (1.4)
GO:0007099	centriole replication	0.66	> 0.20	UBXN2B (4.1)	POC5 (3.0)	DYNC2LI1 (2.7)	ZNF180 (2.6)	DNAH11 (2.5)	BUD13 (2.5)	POLK (2.2)	ADAM1 (1.5)	PMFBP1 (1.5)	PLEKHH2 (1.5)
ENSG00000123374	CDK2 PPI subnetwork	0.66	> 0.20	FEN1 (5.7)	USP1 (4.6)	PSRC1 (2.6)	ILF3 (2.2)	MAU2 (2.1)	GATAD2A (1.5)	TOMM40 (1.4)	MYLIP (1.4)	ZNF180 (1.3)	SUGP1 (1.2)
ENSG00000140326	CDAN1 PPI subnetwork	0.66	> 0.20	PVR (2.1)	FEN1 (2.0)	RHD (1.9)	ABCG8 (1.7)	MYLIP (1.6)	TRIB1 (1.6)	USP1 (1.5)	MAFB (1.5)	TOP1 (1.5)	TXNL4B (1.3)
MP:0008215	decreased immature B cell number	0.66	> 0.20	RELB (2.8)	ZNF101 (2.6)	GMIP (1.7)	PBX4 (1.6)	PTPN11 (1.5)	TIMD4 (1.5)	ZNF259 (1.3)	PLCG1 (1.3)	SMARCA4 (1.3)	POLK (1.3)
GO:0001942	hair follicle development	0.66	> 0.20	ANKRD31 (3.3)	CELSR2 (2.7)	ABO (2.0)	BCAM (1.9)	ENSG00000254235 (1.7)	BLOC1S3 (1.7)	SLC44A2 (1.4)	NYNRIN (1.3)	CBLC (1.2)	LPAR2 (1.2)
GO:0022405	hair cycle process	0.66	> 0.20	ANKRD31 (3.3)	CELSR2 (2.7)	ABO (2.0)	BCAM (1.9)	ENSG00000254235 (1.7)	BLOC1S3 (1.7)	SLC44A2 (1.4)	NYNRIN (1.3)	CBLC (1.2)	LPAR2 (1.2)
GO:0022404	molting cycle process	0.66	> 0.20	ANKRD31 (3.3)	CELSR2 (2.7)	ABO (2.0)	BCAM (1.9)	ENSG00000254235 (1.7)	BLOC1S3 (1.7)	SLC44A2 (1.4)	NYNRIN (1.3)	CBLC (1.2)	LPAR2 (1.2)
ENSG00000106367	AP1S1 PPI subnetwork	0.66	> 0.20	YIPF2 (2.8)	ATP13A1 (2.7)	GMIP (2.6)	TXNL4B (2.5)	CARM1 (2.4)	DNM2 (2.3)	MAU2 (2.3)	DHX38 (2.2)	SMARCA4 (2.1)	CLPTM1 (1.9)
ENSG00000134025	ENSG00000134025 PPI subnetwork	0.66	> 0.20	TMEM57 (2.6)	C12orf51 (2.3)	PLCG1 (2.3)	HAVCR1 (1.9)	ALDH2 (1.9)	GATAD2A (1.8)	QTRT1 (1.8)	FADS2 (1.7)	PLEKHH2 (1.7)	PPP1R37 (1.6)
GO:0042398	cellular modified amino acid biosynthetic process	0.66	> 0.20	TM6SF2 (2.7)	ABCG8 (2.7)	LPIN3 (2.5)	AMIGO1 (2.4)	CYB561D1 (2.2)	C1orf63 (2.2)	SYPL2 (2.1)	ABCG5 (2.0)	PMFBP1 (1.6)	NPC1L1 (1.5)
ENSG00000105656	ELL PPI subnetwork	0.66	> 0.20	SUGP1 (3.5)	MAPKAPK5 (2.9)	TRAPPC6A (2.7)	DHX38 (2.5)	BUD13 (2.3)	PSMA5 (2.3)	ZNF259 (2.2)	C12orf43 (2.1)	TXNL4B (2.1)	MARK4 (2.0)
GO:0001912	positive regulation of leukocyte mediated cytotoxicity	0.66	> 0.20	PBX4 (2.0)	PARP10 (1.9)	GEMIN7 (1.8)	ENSG00000235545 (1.6)	TRAFD1 (1.5)	POLK (1.5)	TMED4 (1.3)	ENSG00000228044 (1.2)	ZNF180 (1.2)	BLOC1S3 (1.1)
MP:0000473	abnormal stomach glandular epithelium morphology	0.66	> 0.20	KIAA1324 (4.8)	AP1M2 (2.6)	DNM2 (2.6)	OASL (2.6)	POLK (1.9)	C11orf9 (1.7)	MAU2 (1.6)	CBLC (1.6)	TMEM57 (1.6)	TMED4 (1.6)
MP:0000460	mandible hypoplasia	0.66	> 0.20	NYNRIN (2.2)	LDLR (2.0)	FADS1 (1.9)	TMEM57 (1.9)	PLCG1 (1.8)	HMGCR (1.8)	AMIGO1 (1.7)	TMED4 (1.4)	LPIN3 (1.4)	APOB (1.4)
ENSG00000130706	ADRM1 PPI subnetwork	0.66	> 0.20	PSMA5 (4.6)	TOMM40 (2.4)	NT5DC1 (2.2)	CELSR2 (1.8)	ITGB3 (1.8)	NAA25 (1.8)	SUGP1 (1.7)	CLPTM1 (1.7)	ENSG00000238078 (1.6)	TMEM57 (1.6)
ENSG00000158560	DYNC1I1 PPI subnetwork	0.66	> 0.20	TOP1 (2.6)	ITGB3 (2.4)	TMEM50A (2.3)	PLCG1 (2.3)	DOCK7 (2.2)	COL4A3BP (2.1)	KANK2 (1.9)	CELSR2 (1.8)	PLEC (1.7)	CYB561D1 (1.6)
ENSG00000135916	ITM2C PPI subnetwork	0.66	> 0.20	ERP29 (3.6)	PSMA5 (2.1)	ZNF259 (1.9)	ENSG00000254235 (1.9)	ATP13A1 (1.7)	YIPF2 (1.6)	SARS (1.6)	OGDH (1.5)	DNM2 (1.4)	CLPTM1 (1.4)
ENSG00000102387	TAF7L PPI subnetwork	0.66	> 0.20	ATXN2 (4.1)	C12orf51 (3.6)	MAU2 (2.3)	SMARCA4 (2.1)	MAPKAPK5 (2.1)	CARM1 (2.1)	RHCE (1.9)	ILF3 (1.8)	PTPN11 (1.7)	C1orf63 (1.7)
MP:0008586	disorganized photoreceptor outer segment	0.66	> 0.20	ABO (2.8)	MAPKAPK5 (2.7)	ENSG00000235545 (2.6)	ATXN7L2 (2.1)	DYNC2LI1 (1.9)	ST3GAL4 (1.8)	ACAD10 (1.6)	CETP (1.5)	GCNT4 (1.4)	ATXN2 (1.3)
GO:0090103	cochlea morphogenesis	0.66	> 0.20	GCNT4 (3.1)	ENSG00000235545 (2.7)	ABO (2.4)	ATXN7L2 (2.3)	ENSG00000254235 (2.3)	C19orf52 (2.1)	CARM1 (1.7)	DYNC2LI1 (1.6)	NYNRIN (1.5)	TMED4 (1.5)
GO:0045777	positive regulation of blood pressure	0.66	> 0.20	HAVCR1 (2.8)	ENSG00000228044 (2.7)	CEACAM19 (2.6)	ENSG00000235545 (2.1)	GOT2P1 (1.9)	C17orf57 (1.9)	HNF1A (1.8)	C12orf47 (1.7)	ZHX3 (1.6)	TMEM116 (1.5)
MP:0004739	conductive hearing loss	0.66	> 0.20	AMIGO1 (2.1)	MYLIP (1.9)	DNAH11 (1.6)	MOSC1 (1.6)	NCAN (1.4)	NKPD1 (1.3)	MAPKAPK5 (1.3)	C17orf57 (1.3)	PVRL2 (1.3)	GPAM (1.3)
GO:0051607	defense response to virus	0.66	> 0.20	OASL (6.0)	PARP10 (3.9)	ENSG00000235545 (2.9)	TRAFD1 (2.9)	ATP13A1 (2.5)	GRINA (1.8)	MAU2 (1.7)	TXNL4B (1.6)	HAVCR1 (1.6)	ZNF101 (1.6)
ENSG00000151461	UPF2 PPI subnetwork	0.66	> 0.20	TOP1 (2.7)	POC5 (2.7)	GATAD2A (2.5)	SUGP1 (2.4)	C1orf63 (2.4)	MAPKAPK5 (2.2)	MAU2 (2.2)	DDX56 (2.1)	CARM1 (2.0)	UBXN2B (2.0)
MP:0001346	abnormal lacrimal gland morphology	0.66	> 0.20	GOT2P1 (3.5)	ZNF101 (2.3)	CYB561D1 (2.0)	KIAA1324 (1.9)	PLCG1 (1.7)	C17orf57 (1.5)	CILP2 (1.5)	ATXN7L2 (1.5)	DYNC2LI1 (1.3)	SLC22A1 (1.1)
ENSG00000175416	CLTB PPI subnetwork	0.66	> 0.20	CYB561D1 (2.1)	NCAN (2.1)	PTPN11 (2.0)	COL4A3BP (2.0)	ZNF180 (2.0)	C12orf51 (2.0)	HAVCR1 (1.8)	C1orf63 (1.8)	C12orf47 (1.7)	SMARCA4 (1.6)
ENSG00000068903	SIRT2 PPI subnetwork	0.66	> 0.20	NCAN (2.7)	SORT1 (2.0)	C12orf43 (1.8)	LPIN3 (1.7)	C12orf47 (1.6)	DNAH11 (1.6)	HAPLN4 (1.6)	RPH3A (1.6)	HAVCR1 (1.5)	GOT2P1 (1.5)
MP:0001876	decreased inflammatory response	0.66	> 0.20	SH2B3 (2.5)	HLX (2.2)	TRIB1 (1.7)	LPAR2 (1.6)	TIMD4 (1.5)	GMIP (1.5)	PARP10 (1.4)	ST3GAL4 (1.2)	MAFB (1.1)	TRAFD1 (1.1)
GO:0010524	positive regulation of calcium ion transport into cytosol	0.66	> 0.20	ABO (3.6)	C12orf43 (2.8)	TRAPPC6A (2.0)	ADAM1 (1.8)	BLOC1S3 (1.6)	HAVCR1 (1.6)	GEMIN7 (1.5)	LPIN3 (1.3)	GRINA (1.2)	PLCG1 (1.1)
ENSG00000162231	NXF1 PPI subnetwork	0.66	> 0.20	ILF3 (4.0)	USP1 (3.8)	TOP1 (3.5)	C1orf63 (3.0)	NAA25 (2.8)	BUD13 (2.5)	FEN1 (2.4)	DHODH (2.3)	SMARCA4 (2.2)	DDX56 (2.1)
ENSG00000075340	ADD2 PPI subnetwork	0.66	> 0.20	SLC44A2 (3.7)	NCAN (3.1)	RHCE (2.9)	OGDH (2.2)	C12orf51 (2.1)	ITGB3 (2.0)	ENSG00000238078 (2.0)	RPH3A (2.0)	PPP1R37 (1.9)	RHD (1.9)
ENSG00000102893	PHKB PPI subnetwork	0.66	> 0.20	GOT2P1 (2.3)	SORT1 (2.2)	NCAN (2.2)	ZNF180 (2.1)	C12orf43 (2.0)	AMIGO1 (2.0)	DNAH11 (1.8)	RPH3A (1.6)	C12orf47 (1.5)	CILP2 (1.5)
ENSG00000196331	HIST1H2BO PPI subnetwork	0.66	> 0.20	DOCK7 (2.6)	SMARCA4 (2.6)	TMEM57 (2.0)	ILF3 (1.9)	USP1 (1.7)	DDX56 (1.7)	TOP1 (1.6)	BUD13 (1.6)	SUGP1 (1.4)	DNAH11 (1.3)
GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	0.66	> 0.20	ANKRD31 (2.9)	C12orf47 (2.2)	PPP1R37 (2.2)	KIAA1324 (1.9)	ENSG00000228044 (1.9)	MYLIP (1.6)	ENSG00000254235 (1.5)	ATXN2 (1.5)	HNF1A (1.2)	CILP2 (1.2)
MP:0002594	low mean erythrocyte cell number	0.66	> 0.20	RHCE (8.3)	RHD (7.9)	NYNRIN (2.9)	GMPR (2.7)	SYPL2 (2.3)	KANK2 (2.0)	C12orf51 (2.0)	PTPN11 (1.9)	TIMD4 (1.7)	MYLIP (1.5)
GO:0001523	retinoid metabolic process	0.66	> 0.20	NKPD1 (2.7)	ABCG8 (2.7)	TM6SF2 (2.7)	CYB561D1 (2.1)	C11orf9 (2.1)	CYP7A1 (2.0)	ABCG5 (1.9)	NPC1L1 (1.8)	LPAR2 (1.8)	ENSG00000235545 (1.6)
ENSG00000177731	FLII PPI subnetwork	0.66	> 0.20	GATAD2A (4.1)	KANK2 (2.7)	PLCG1 (2.5)	FRK (2.0)	ABO (1.6)	YIPF2 (1.6)	PVRL2 (1.6)	PVR (1.5)	QTRT1 (1.5)	LDLR (1.5)
MP:0005618	decreased urine potassium level	0.66	> 0.20	HAVCR1 (3.7)	ZHX3 (3.3)	CBLC (2.0)	TMED4 (1.7)	AP1M2 (1.6)	GOT2P1 (1.6)	BCAM (1.5)	ERP29 (1.5)	TMEM116 (1.4)	ENSG00000254235 (1.2)
GO:0002437	inflammatory response to antigenic stimulus	0.66	> 0.20	ZNF101 (2.6)	ENSG00000235545 (2.6)	TRAPPC6A (1.7)	C19orf52 (1.7)	DNAH11 (1.7)	ANKRD31 (1.4)	HLX (1.4)	GMIP (1.3)	AMIGO1 (1.2)	PBX4 (1.0)
GO:0016010	dystrophin-associated glycoprotein complex	0.66	> 0.20	KANK2 (3.6)	SYPL2 (2.9)	SLC44A2 (2.1)	NPC1L1 (2.1)	COL4A3BP (2.1)	ZHX3 (2.0)	AMIGO1 (1.9)	GPAM (1.7)	BCAM (1.7)	SORT1 (1.6)
ENSG00000143727	ACP1 PPI subnetwork	0.66	> 0.20	CETP (2.2)	TIMD4 (2.1)	ENSG00000238078 (1.9)	PLCG1 (1.9)	GPAM (1.7)	C12orf51 (1.7)	PBX4 (1.6)	RHCE (1.6)	MOSC1 (1.4)	PVR (1.4)
ENSG00000102158	MAGT1 PPI subnetwork	0.66	> 0.20	ATP13A1 (4.6)	CLPTM1 (3.2)	TMEM50A (2.6)	TMED4 (2.5)	ERP29 (2.5)	YIPF2 (2.4)	QTRT1 (1.8)	KIAA1324 (1.8)	CYB561D1 (1.7)	MAU2 (1.6)
GO:0002793	positive regulation of peptide secretion	0.66	> 0.20	KIAA1324 (3.1)	ANKRD31 (2.8)	NPC1L1 (2.3)	ENSG00000254235 (2.1)	ABCG8 (1.8)	HNF1A (1.8)	C12orf47 (1.7)	FRK (1.6)	PLEKHH2 (1.4)	HAPLN4 (1.4)
GO:0033275	actin-myosin filament sliding	0.67	> 0.20	SYPL2 (6.5)	GMPR (2.7)	C17orf57 (1.8)	UBXN2B (1.4)	ENSG00000226648 (1.4)	NKPD1 (1.4)	TMEM50A (1.3)	LPAR2 (1.3)	CEACAM19 (1.2)	RHCE (1.2)
GO:0030049	muscle filament sliding	0.67	> 0.20	SYPL2 (6.5)	GMPR (2.7)	C17orf57 (1.8)	UBXN2B (1.4)	ENSG00000226648 (1.4)	NKPD1 (1.4)	TMEM50A (1.3)	LPAR2 (1.3)	CEACAM19 (1.2)	RHCE (1.2)
MP:0002864	abnormal ocular fundus morphology	0.67	> 0.20	TMEM116 (1.8)	DHODH (1.8)	DYNC2LI1 (1.8)	CELSR2 (1.6)	PLCG1 (1.5)	ST3GAL4 (1.5)	PSRC1 (1.4)	MYLIP (1.4)	GMPR (1.3)	UBXN2B (1.3)
REACTOME_CELL:EXTRACELLULAR_MATRIX_INTERACTIONS	REACTOME_CELL:EXTRACELLULAR_MATRIX_INTERACTIONS	0.67	> 0.20	ITGB3 (5.3)	KANK2 (3.1)	PLEC (2.9)	PVRL2 (2.8)	PVR (2.3)	KIAA1324 (1.9)	BCAM (1.8)	GEMIN7 (1.6)	CARM1 (1.6)	SH2B3 (1.6)
ENSG00000083642	PDS5B PPI subnetwork	0.67	> 0.20	USP1 (4.3)	COL4A3BP (2.3)	POLK (2.1)	ZNF180 (1.9)	TOP1 (1.8)	USP24 (1.7)	MAU2 (1.4)	PTPN11 (1.4)	DOCK7 (1.3)	C19orf52 (1.3)
GO:0002228	natural killer cell mediated immunity	0.67	> 0.20	GEMIN7 (2.3)	CEACAM19 (2.0)	ENSG00000228044 (1.7)	ZNF180 (1.7)	POLK (1.7)	ENSG00000235545 (1.3)	BLOC1S3 (1.3)	PBX4 (1.3)	CYB561D1 (1.3)	AMIGO1 (1.2)
GO:0042267	natural killer cell mediated cytotoxicity	0.67	> 0.20	GEMIN7 (2.3)	CEACAM19 (2.0)	ENSG00000228044 (1.7)	ZNF180 (1.7)	POLK (1.7)	ENSG00000235545 (1.3)	BLOC1S3 (1.3)	PBX4 (1.3)	CYB561D1 (1.3)	AMIGO1 (1.2)
GO:0070008	serine-type exopeptidase activity	0.67	> 0.20	HNF1A (2.7)	ERP29 (2.7)	PMFBP1 (2.3)	NT5DC1 (2.1)	ALDH2 (2.1)	MYLIP (1.9)	MAFB (1.9)	SORT1 (1.8)	CILP2 (1.7)	CELSR2 (1.7)
ENSG00000187790	FANCM PPI subnetwork	0.67	> 0.20	FEN1 (3.4)	ZNF180 (3.4)	ENSG00000235545 (2.7)	USP1 (2.5)	C1orf63 (2.1)	UBXN2B (1.8)	POC5 (1.6)	MAU2 (1.6)	DHODH (1.5)	PPP1R37 (1.5)
GO:0050701	interleukin-1 secretion	0.67	> 0.20	ENSG00000238078 (2.7)	CYB561D1 (2.6)	ZNF101 (2.6)	BLOC1S3 (2.3)	ST3GAL4 (1.8)	NKPD1 (1.7)	DNAH11 (1.5)	ABCG5 (1.3)	HAVCR1 (1.3)	NPC1L1 (1.3)
GO:0035035	histone acetyltransferase binding	0.67	> 0.20	TRIB1 (3.8)	CYB561D1 (3.1)	PVR (2.4)	BCL3 (2.3)	MAU2 (2.0)	POLK (1.9)	RHCE (1.6)	CARM1 (1.5)	SORT1 (1.4)	ATXN2 (1.4)
ENSG00000156795	WDYHV1 PPI subnetwork	0.67	> 0.20	TRAPPC6A (3.5)	CBLC (3.3)	NYNRIN (2.8)	AP1M2 (2.6)	LPAR2 (2.5)	ENSG00000254235 (2.2)	BCAM (2.1)	BLOC1S3 (2.0)	APOE (1.8)	C17orf57 (1.7)
REACTOME_CALMODULIN_INDUCED_EVENTS	REACTOME_CALMODULIN_INDUCED_EVENTS	0.67	> 0.20	SORT1 (2.9)	SH2B3 (2.8)	ST3GAL4 (2.7)	ITGB3 (2.3)	GCNT4 (2.2)	KANK2 (2.2)	ENSG00000238078 (1.9)	AMIGO1 (1.9)	GOT2P1 (1.8)	ZHX3 (1.5)
REACTOME_CAM_PATHWAY	REACTOME_CAM_PATHWAY	0.67	> 0.20	SORT1 (2.9)	SH2B3 (2.8)	ST3GAL4 (2.7)	ITGB3 (2.3)	GCNT4 (2.2)	KANK2 (2.2)	ENSG00000238078 (1.9)	AMIGO1 (1.9)	GOT2P1 (1.8)	ZHX3 (1.5)
MP:0004076	abnormal vitelline vascular remodeling	0.67	> 0.20	SH2B3 (2.3)	PVRL2 (2.1)	KANK2 (2.0)	HLX (1.9)	SLC44A2 (1.9)	LDLR (1.8)	PLCG1 (1.8)	PVR (1.7)	ZNF180 (1.7)	USP24 (1.6)
ENSG00000158195	WASF2 PPI subnetwork	0.67	> 0.20	GMIP (4.6)	SH2B3 (3.6)	CYB561D1 (2.9)	GATAD2A (2.5)	SMARCA4 (1.8)	DNM2 (1.7)	MARK4 (1.6)	CARM1 (1.6)	ITGB3 (1.6)	ATXN2 (1.5)
ENSG00000189285	ENSG00000189285 PPI subnetwork	0.67	> 0.20	PSRC1 (2.7)	USP24 (2.0)	NPC1L1 (2.0)	ENSG00000228044 (1.9)	ATXN2 (1.7)	GEMIN7 (1.7)	NCAN (1.6)	MAPKAPK5 (1.4)	USP1 (1.4)	DOCK7 (1.4)
ENSG00000168412	MTNR1A PPI subnetwork	0.67	> 0.20	ERP29 (3.1)	TMEM50A (2.8)	TMED4 (2.1)	DNM2 (2.0)	GATAD2A (1.6)	CLPTM1 (1.5)	SARS (1.4)	SH2B3 (1.4)	PSMA5 (1.4)	CYB561D1 (1.3)
ENSG00000028137	TNFRSF1B PPI subnetwork	0.67	> 0.20	TOMM40 (3.0)	SARS (2.9)	OGDH (2.6)	PSMA5 (2.6)	ATP13A1 (2.5)	PLEC (2.0)	NAA25 (2.0)	CLPTM1 (2.0)	HMGCR (1.9)	ADAM1 (1.8)
ENSG00000171861	RNMTL1 PPI subnetwork	0.67	> 0.20	POLK (2.8)	BRAP (2.5)	TXNL4B (2.2)	C19orf52 (2.1)	DYNC2LI1 (2.1)	MAPKAPK5 (1.9)	NT5DC1 (1.7)	PTPN11 (1.7)	C12orf43 (1.6)	DDX56 (1.6)
REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS	REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS	0.67	> 0.20	NKPD1 (3.1)	ANKRD31 (1.8)	TMEM57 (1.5)	GATAD2A (1.5)	ATP13A1 (1.4)	ILF3 (1.3)	SUGP1 (1.3)	C19orf52 (1.3)	ADAM1 (1.2)	UBXN2B (1.2)
MP:0006020	decreased tympanic ring size	0.67	> 0.20	MYLIP (3.0)	NYNRIN (2.1)	LPIN3 (1.4)	KIAA1324 (1.4)	TRAFD1 (1.4)	KANK2 (1.4)	NKPD1 (1.3)	TMEM57 (1.2)	CILP2 (1.2)	PPP1R37 (1.2)
GO:0046622	positive regulation of organ growth	0.67	> 0.20	ANKRD31 (3.0)	DNAH11 (2.5)	C11orf9 (2.2)	ST3GAL4 (1.8)	GCNT4 (1.7)	ENSG00000235545 (1.5)	ENSG00000238078 (1.5)	HAPLN4 (1.3)	TXNL4B (1.2)	UBXN2B (1.2)
GO:0060350	endochondral bone morphogenesis	0.67	> 0.20	CILP2 (6.3)	PLEKHH2 (2.4)	YIPF2 (2.2)	ALDH2 (1.9)	NYNRIN (1.8)	SLC44A2 (1.4)	GMPR (1.3)	MAPKAPK5 (1.3)	ATXN2 (1.3)	MARK4 (1.2)
ENSG00000111275	ALDH2 PPI subnetwork	0.67	> 0.20	FADS2 (2.8)	TRAPPC6A (2.6)	ACAD10 (2.5)	PCSK9 (2.3)	DYNC2LI1 (2.2)	UBXN2B (2.0)	GPAM (1.7)	APOC1 (1.7)	NT5DC1 (1.5)	LPAR2 (1.5)
ENSG00000184937	WT1 PPI subnetwork	0.67	> 0.20	BCAM (2.5)	MAU2 (2.5)	ABO (2.4)	PPP1R37 (2.1)	ATXN7L2 (2.1)	C12orf47 (1.8)	PMFBP1 (1.7)	TRAPPC6A (1.6)	ILF3 (1.6)	NYNRIN (1.6)
ENSG00000170312	CDK1 PPI subnetwork	0.67	> 0.20	PSRC1 (4.9)	FEN1 (4.9)	USP1 (3.7)	POC5 (1.6)	ILF3 (1.5)	TOMM40 (1.4)	TOP1 (1.3)	SLC44A2 (1.3)	GEMIN7 (1.2)	SUGP1 (1.2)
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	0.67	> 0.20	ITGB3 (2.9)	FRK (2.8)	TMEM50A (2.7)	TIMD4 (2.0)	GATAD2A (1.8)	PVR (1.6)	C11orf9 (1.6)	SH2B3 (1.4)	GMIP (1.3)	C1orf63 (1.2)
ENSG00000203813	HIST1H3H PPI subnetwork	0.67	> 0.20	USP1 (3.0)	SMARCA4 (2.8)	C19orf52 (2.8)	FEN1 (2.4)	PSRC1 (2.3)	ATXN2 (1.9)	ILF3 (1.7)	MYLIP (1.7)	TOP1 (1.5)	KIAA1324 (1.4)
REACTOME_PKB:MEDIATED_EVENTS	REACTOME_PKB:MEDIATED_EVENTS	0.67	> 0.20	BRAP (3.8)	USP24 (3.2)	PTPN11 (3.2)	C12orf43 (3.2)	TMEM57 (2.8)	AMIGO1 (2.2)	SARS (2.1)	SYPL2 (2.0)	ZHX3 (2.0)	GPAM (2.0)
GO:0007059	chromosome segregation	0.67	> 0.20	PSRC1 (4.4)	POC5 (4.0)	USP1 (2.3)	ENSG00000228044 (2.2)	FEN1 (2.0)	ILF3 (1.3)	ANKRD31 (1.2)	ZNF180 (1.2)	ENSG00000226648 (1.2)	BUD13 (1.2)
MP:0001688	abnormal somite development	0.67	> 0.20	NYNRIN (2.8)	PLCG1 (2.1)	HLX (2.0)	ATXN7L2 (1.7)	ABO (1.6)	MARK4 (1.6)	ENSG00000226648 (1.4)	PVRL2 (1.2)	PCSK9 (1.2)	SLC44A2 (1.2)
ENSG00000142611	PRDM16 PPI subnetwork	0.67	> 0.20	TM6SF2 (2.9)	MYLIP (2.9)	DNAH11 (2.2)	ADAM1 (2.0)	ZNF101 (2.0)	ABCG8 (1.8)	AMIGO1 (1.8)	ENSG00000226645 (1.7)	LDLR (1.6)	ABCG5 (1.6)
GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	0.67	> 0.20	ZNF101 (3.9)	GCNT4 (2.7)	NT5DC1 (2.5)	ANKRD31 (2.3)	PLCG1 (2.1)	PBX4 (1.7)	C17orf57 (1.6)	UBXN2B (1.5)	ENSG00000226648 (1.5)	DYNC2LI1 (1.1)
GO:0016444	somatic cell DNA recombination	0.67	> 0.20	ZNF101 (3.9)	GCNT4 (2.7)	NT5DC1 (2.5)	ANKRD31 (2.3)	PLCG1 (2.1)	PBX4 (1.7)	C17orf57 (1.6)	UBXN2B (1.5)	ENSG00000226648 (1.5)	DYNC2LI1 (1.1)
ENSG00000153561	RMND5A PPI subnetwork	0.67	> 0.20	C12orf51 (2.0)	BUD13 (1.8)	TMEM57 (1.7)	RHD (1.7)	ENSG00000238078 (1.7)	POC5 (1.7)	MAPKAPK5 (1.6)	HAVCR1 (1.6)	BRAP (1.6)	NYNRIN (1.6)
ENSG00000213719	CLIC1 PPI subnetwork	0.67	> 0.20	CILP2 (3.1)	NT5DC1 (2.2)	GMPR (1.9)	TSSK6 (1.8)	ST3GAL4 (1.8)	RELB (1.7)	TRAPPC6A (1.6)	C19orf52 (1.5)	C11orf9 (1.5)	CBLC (1.5)
ENSG00000206394	CLIC1 PPI subnetwork	0.67	> 0.20	CILP2 (3.1)	NT5DC1 (2.2)	GMPR (1.9)	TSSK6 (1.8)	ST3GAL4 (1.8)	RELB (1.7)	TRAPPC6A (1.6)	C19orf52 (1.5)	C11orf9 (1.5)	CBLC (1.5)
ENSG00000096238	ENSG00000096238 PPI subnetwork	0.67	> 0.20	CILP2 (3.1)	NT5DC1 (2.2)	GMPR (1.9)	TSSK6 (1.8)	ST3GAL4 (1.8)	RELB (1.7)	TRAPPC6A (1.6)	C19orf52 (1.5)	C11orf9 (1.5)	CBLC (1.5)
GO:0060512	prostate gland morphogenesis	0.67	> 0.20	ENSG00000254235 (2.2)	AMIGO1 (2.1)	C19orf52 (2.0)	BLOC1S3 (2.0)	ABO (1.8)	KIAA1324 (1.7)	LPAR2 (1.6)	NYNRIN (1.5)	CBLC (1.4)	DNAH11 (1.3)
MP:0010019	liver vascular congestion	0.67	> 0.20	RHCE (3.8)	RHD (3.2)	POLK (2.1)	SLC22A1 (1.7)	UBXN2B (1.7)	MYLIP (1.6)	DNAH11 (1.6)	BCAM (1.6)	APOC1 (1.5)	KANK2 (1.5)
GO:0060986	endocrine hormone secretion	0.67	> 0.20	GCNT4 (3.3)	ENSG00000226645 (2.6)	LPIN3 (2.1)	MOSC1 (2.0)	BLOC1S3 (1.9)	ST3GAL4 (1.8)	C12orf43 (1.7)	KIAA1324 (1.6)	GPAM (1.6)	TMED4 (1.5)
GO:0043209	myelin sheath	0.67	> 0.20	C11orf9 (6.6)	HAPLN4 (3.0)	RPH3A (2.6)	TSSK6 (2.2)	SORT1 (2.0)	CELSR2 (1.3)	LDLR (1.3)	PLEC (1.3)	ENSG00000228044 (1.2)	ZNF180 (1.2)
ENSG00000145794	MEGF10 PPI subnetwork	0.67	> 0.20	C12orf51 (2.8)	ILF3 (2.0)	SMARCA4 (2.0)	ATXN2 (1.9)	OGDH (1.8)	MAU2 (1.6)	TMEM116 (1.6)	CEACAM19 (1.6)	FRK (1.5)	ZHX3 (1.5)
GO:0021511	spinal cord patterning	0.67	> 0.20	ENSG00000254235 (2.9)	DNAH11 (2.1)	ANKRD31 (2.0)	TMEM116 (1.6)	GOT2P1 (1.6)	ATXN7L2 (1.5)	ZHX3 (1.5)	NYNRIN (1.4)	HAVCR1 (1.4)	C12orf47 (1.3)
ENSG00000141026	MED9 PPI subnetwork	0.67	> 0.20	TXNL4B (3.4)	GEMIN7 (3.4)	BUD13 (2.3)	MAPKAPK5 (2.2)	BRAP (2.2)	DHX38 (2.1)	BLOC1S3 (2.0)	POC5 (1.9)	C12orf47 (1.6)	C19orf52 (1.6)
ENSG00000198612	COPS8 PPI subnetwork	0.67	> 0.20	ATXN7L2 (2.7)	C19orf52 (2.4)	ZNF259 (2.3)	ENSG00000226648 (2.0)	QTRT1 (2.0)	BUD13 (2.0)	DYNC2LI1 (1.9)	DDX56 (1.6)	NAA25 (1.6)	NT5DC1 (1.5)
MP:0000704	abnormal thymus development	0.67	> 0.20	HAPLN4 (2.3)	TRAPPC6A (2.1)	KANK2 (2.0)	ANKRD31 (1.9)	RHCE (1.9)	AMIGO1 (1.8)	TMED4 (1.7)	PLEKHH2 (1.7)	PMFBP1 (1.7)	C19orf52 (1.7)
GO:0046825	regulation of protein export from nucleus	0.67	> 0.20	ENSG00000254235 (2.8)	ADAM1 (2.4)	SLC44A2 (2.3)	ZNF101 (2.1)	ENSG00000238078 (1.9)	DNAH11 (1.8)	PLCG1 (1.7)	LPAR2 (1.3)	TRIB1 (1.3)	C19orf52 (1.3)
ENSG00000108469	RECQL5 PPI subnetwork	0.67	> 0.20	MAU2 (2.7)	TXNL4B (2.1)	ATXN7L2 (1.9)	PSRC1 (1.7)	PLEKHH2 (1.7)	C11orf9 (1.6)	USP1 (1.6)	LPIN3 (1.6)	KIAA1324 (1.5)	PVR (1.4)
ENSG00000104529	EEF1D PPI subnetwork	0.67	> 0.20	POC5 (3.1)	PARP10 (3.1)	SARS (2.6)	MAPKAPK5 (2.0)	OASL (1.7)	CBLC (1.6)	NCAN (1.6)	C11orf9 (1.6)	ZNF259 (1.6)	ENSG00000226645 (1.4)
GO:0032007	negative regulation of TOR signaling cascade	0.67	> 0.20	BLOC1S3 (4.2)	MAU2 (2.8)	UBXN2B (2.3)	USP24 (2.2)	TMEM57 (1.9)	PPP1R37 (1.8)	C12orf51 (1.8)	DNAH11 (1.6)	ZNF180 (1.6)	ZHX3 (1.5)
GO:0004993	serotonin receptor activity	0.67	> 0.20	GOT2P1 (3.9)	RPH3A (2.5)	ABO (2.3)	GCNT4 (2.0)	ANKRD31 (1.8)	ENSG00000226648 (1.7)	APOE (1.6)	ABCG8 (1.4)	ENSG00000226645 (1.4)	MYLIP (1.3)
ENSG00000184432	COPB2 PPI subnetwork	0.67	> 0.20	SARS (2.7)	PSMA5 (2.5)	YIPF2 (2.2)	DHX38 (2.1)	CLPTM1 (2.0)	OGDH (1.9)	DDX56 (1.8)	ATP13A1 (1.8)	TOMM40 (1.7)	HAPLN4 (1.6)
GO:0043601	nuclear replisome	0.67	> 0.20	FEN1 (5.4)	USP1 (5.1)	ENSG00000235545 (2.4)	NT5DC1 (2.0)	AMIGO1 (1.7)	ST3GAL4 (1.6)	BLOC1S3 (1.6)	C17orf57 (1.5)	FRK (1.4)	PARP10 (1.3)
GO:0030894	replisome	0.67	> 0.20	FEN1 (5.4)	USP1 (5.1)	ENSG00000235545 (2.4)	NT5DC1 (2.0)	AMIGO1 (1.7)	ST3GAL4 (1.6)	BLOC1S3 (1.6)	C17orf57 (1.5)	FRK (1.4)	PARP10 (1.3)
ENSG00000130653	PNPLA7 PPI subnetwork	0.67	> 0.20	TM6SF2 (2.9)	ABCG8 (2.8)	DNAH11 (2.1)	MYLIP (2.0)	ABCG5 (1.8)	ACAD10 (1.8)	HAPLN4 (1.7)	ABO (1.6)	GCNT4 (1.5)	NPC1L1 (1.5)
MP:0004484	altered response of heart to induced stress	0.67	> 0.20	GMPR (2.7)	ALDH2 (2.7)	SYPL2 (2.3)	BCAM (1.9)	ADAM1 (1.7)	OASL (1.6)	AP1M2 (1.5)	C11orf9 (1.5)	LPAR2 (1.3)	TMEM116 (1.3)
MP:0002857	cochlear ganglion degeneration	0.67	> 0.20	HNF1A (2.9)	GCNT4 (2.2)	TM6SF2 (1.9)	APOE (1.8)	NPC1L1 (1.8)	RELB (1.7)	BCAM (1.6)	CBLC (1.5)	TIMD4 (1.5)	ANKRD31 (1.5)
ENSG00000138039	LHCGR PPI subnetwork	0.67	> 0.20	GCNT4 (2.6)	KIAA1324 (2.5)	ST3GAL4 (2.4)	YIPF2 (1.8)	GATAD2A (1.7)	BLOC1S3 (1.6)	MARK4 (1.6)	LDLR (1.6)	DNAH11 (1.5)	ITGB3 (1.4)
ENSG00000158528	PPP1R9A PPI subnetwork	0.67	> 0.20	OGDH (2.4)	MYLIP (2.3)	PLEKHH2 (2.3)	PVR (2.1)	ENSG00000238078 (2.0)	C12orf43 (1.8)	C1orf63 (1.7)	DYNC2LI1 (1.6)	SORT1 (1.5)	TMEM50A (1.5)
ENSG00000117222	RBBP5 PPI subnetwork	0.67	> 0.20	BUD13 (3.5)	MAPKAPK5 (2.8)	ADAM1 (2.5)	ATXN2 (2.4)	C19orf52 (2.1)	SMARCA4 (2.1)	ILF3 (2.0)	C12orf51 (1.9)	USP1 (1.8)	FEN1 (1.7)
MP:0004471	short nasal bone	0.67	> 0.20	CILP2 (3.2)	NYNRIN (2.7)	KANK2 (2.3)	ANKRD31 (1.6)	PLEKHH2 (1.6)	SMARCA4 (1.3)	TXNL4B (1.3)	HAPLN4 (1.3)	CEACAM19 (1.3)	ST3GAL4 (1.3)
REACTOME_METABOLISM_OF_NUCLEOTIDES	REACTOME_METABOLISM_OF_NUCLEOTIDES	0.67	> 0.20	DHODH (2.6)	SYPL2 (2.6)	LPIN3 (2.4)	ACAD10 (2.3)	SLC22A1 (2.2)	LPA (1.9)	NT5DC1 (1.9)	PLG (1.7)	PSMA5 (1.7)	ANGPTL3 (1.6)
GO:0033043	regulation of organelle organization	0.67	> 0.20	POC5 (3.0)	PSRC1 (2.7)	POLK (2.5)	CBLC (1.8)	NYNRIN (1.8)	PLEC (1.8)	TMEM50A (1.7)	C12orf51 (1.7)	RHD (1.7)	SLC44A2 (1.6)
GO:0015450	P-P-bond-hydrolysis-driven protein transmembrane transporter activity	0.67	> 0.20	ILF3 (3.2)	OGDH (2.2)	AP1M2 (2.1)	YIPF2 (2.0)	ERP29 (1.9)	DNM2 (1.7)	TMED4 (1.6)	TXNL4B (1.6)	ACAD10 (1.6)	LPA (1.5)
MP:0000930	wavy neural tube	0.67	> 0.20	ATXN2 (3.4)	MARK4 (2.6)	ENSG00000235545 (2.5)	CLPTM1 (2.3)	DOCK7 (2.0)	PVRL2 (1.8)	KANK2 (1.7)	ENSG00000226648 (1.6)	CARM1 (1.6)	DNAH11 (1.6)
MP:0001119	abnormal female reproductive system morphology	0.67	> 0.20	KIAA1324 (3.0)	ANKRD31 (2.4)	GCNT4 (2.2)	PBX4 (2.1)	FADS1 (2.1)	C12orf47 (2.0)	PLEKHH2 (1.8)	CELSR2 (1.8)	ABCG8 (1.7)	FADS2 (1.6)
GO:0045296	cadherin binding	0.67	> 0.20	GCNT4 (2.5)	SORT1 (2.4)	DNM2 (2.3)	DOCK7 (2.1)	LPIN3 (2.0)	AP1M2 (2.0)	ABO (1.6)	LPAR2 (1.5)	PLEC (1.5)	TRAPPC6A (1.5)
MP:0001723	disorganized yolk sac vascular plexus	0.67	> 0.20	RHD (3.3)	GATAD2A (2.1)	RHCE (2.0)	C19orf52 (2.0)	ENSG00000226648 (1.9)	MYLIP (1.8)	ENSG00000235545 (1.8)	HLX (1.7)	TRIB1 (1.7)	PSRC1 (1.6)
GO:0008334	histone mRNA metabolic process	0.67	> 0.20	TXNL4B (2.7)	USP24 (2.7)	ENSG00000226645 (2.4)	UBXN2B (2.3)	BRAP (2.2)	ZNF259 (1.8)	C12orf47 (1.7)	C19orf52 (1.7)	BLOC1S3 (1.6)	ZNF101 (1.6)
ENSG00000140400	MAN2C1 PPI subnetwork	0.67	> 0.20	GMPR (3.0)	DDX56 (2.5)	ZNF259 (2.4)	QTRT1 (1.8)	ENSG00000226645 (1.8)	BUD13 (1.5)	C19orf52 (1.5)	GEMIN7 (1.3)	C12orf47 (1.2)	DHODH (1.2)
ENSG00000102144	PGK1 PPI subnetwork	0.67	> 0.20	TOMM40 (3.3)	PSMA5 (3.0)	SARS (2.9)	SMARCA4 (2.4)	NAA25 (2.1)	SUGP1 (2.0)	DDX56 (2.0)	OGDH (1.9)	CLPTM1 (1.8)	C17orf57 (1.7)
GO:0016529	sarcoplasmic reticulum	0.67	> 0.20	SYPL2 (7.4)	GMPR (3.2)	C17orf57 (2.0)	SORT1 (1.6)	TMED4 (1.6)	HAVCR1 (1.5)	CARM1 (1.3)	ITGB3 (1.3)	ST3GAL4 (1.3)	RPH3A (1.2)
GO:0030072	peptide hormone secretion	0.67	> 0.20	KIAA1324 (5.0)	HNF1A (2.6)	ANKRD31 (2.3)	ABO (2.1)	COL4A3BP (2.0)	HAPLN4 (1.9)	ENSG00000228044 (1.8)	PLEKHH2 (1.7)	AMIGO1 (1.6)	ENSG00000238078 (1.5)
GO:0060688	regulation of morphogenesis of a branching structure	0.67	> 0.20	PLEKHH2 (2.5)	ENSG00000228044 (2.5)	DYNC2LI1 (2.3)	ENSG00000254235 (2.0)	HAPLN4 (1.7)	HAVCR1 (1.7)	DOCK7 (1.6)	AMIGO1 (1.5)	MYLIP (1.4)	TSSK6 (1.3)
ENSG00000130177	CDC16 PPI subnetwork	0.67	> 0.20	PSRC1 (5.6)	FEN1 (3.8)	POC5 (3.1)	USP1 (1.8)	GEMIN7 (1.6)	LPIN3 (1.5)	CBLC (1.3)	SUGP1 (1.3)	ILF3 (1.2)	ATXN2 (1.0)
REACTOME_NUCLEOTIDE:LIKE_PURINERGIC_RECEPTORS	REACTOME_NUCLEOTIDE:LIKE_PURINERGIC_RECEPTORS	0.67	> 0.20	MAFB (2.8)	NCAN (2.6)	PMFBP1 (2.1)	ST3GAL4 (1.8)	POLK (1.8)	CETP (1.6)	TIMD4 (1.6)	TRIB1 (1.5)	ALDH2 (1.3)	CBLC (1.3)
REACTOME_CELL:CELL_COMMUNICATION	REACTOME_CELL:CELL_COMMUNICATION	0.67	> 0.20	BCAM (5.4)	AP1M2 (4.6)	PVRL2 (4.3)	CBLC (4.3)	PLEC (3.1)	ITGB3 (2.4)	PVR (2.2)	FRK (2.1)	LPIN3 (1.8)	LPAR2 (1.6)
ENSG00000064419	TNPO3 PPI subnetwork	0.67	> 0.20	USP1 (3.2)	ENSG00000226648 (2.8)	C1orf63 (2.6)	C12orf47 (2.2)	MAPKAPK5 (2.1)	POC5 (2.0)	BUD13 (1.8)	TOP1 (1.7)	ILF3 (1.7)	POLK (1.6)
ENSG00000170214	ADRA1B PPI subnetwork	0.67	> 0.20	TIMD4 (1.9)	C11orf9 (1.8)	RPH3A (1.8)	RHCE (1.7)	RHD (1.6)	ENSG00000235545 (1.6)	FADS2 (1.5)	PCSK9 (1.5)	DNAH11 (1.4)	NAA25 (1.4)
ENSG00000157193	LRP8 PPI subnetwork	0.67	> 0.20	APOC1 (3.7)	CLPTM1 (2.9)	APOB (2.8)	NCAN (2.4)	RPH3A (2.3)	ZNF101 (2.2)	PLG (2.1)	ABCG5 (2.1)	CELSR2 (2.1)	APOC4 (1.9)
ENSG00000180370	PAK2 PPI subnetwork	0.67	> 0.20	TMEM50A (3.3)	ENSG00000238078 (2.2)	CLPTM1 (2.0)	TMEM57 (1.9)	GATAD2A (1.9)	TRAFD1 (1.8)	PSMA5 (1.7)	DNM2 (1.7)	C19orf52 (1.1)	GCNT4 (1.1)
MP:0006029	abnormal sclerotome morphology	0.67	> 0.20	TMEM116 (2.8)	TMEM57 (2.2)	CILP2 (2.1)	PPP1R37 (2.1)	C11orf9 (2.0)	PLEKHH2 (1.9)	PLEC (1.6)	TMED4 (1.5)	GATAD2A (1.5)	HAVCR1 (1.4)
ENSG00000166128	RAB8B PPI subnetwork	0.67	> 0.20	AP1M2 (2.6)	SARS (2.5)	TMEM50A (2.4)	TMED4 (2.2)	SUGP1 (2.1)	HAVCR1 (2.0)	YIPF2 (2.0)	C12orf51 (2.0)	C11orf9 (1.9)	POLK (1.7)
ENSG00000144580	RQCD1 PPI subnetwork	0.67	> 0.20	USP1 (2.8)	ITGB3 (2.1)	ENSG00000235545 (2.1)	ENSG00000228044 (2.1)	BUD13 (2.0)	FEN1 (1.9)	ATXN2 (1.8)	TXNL4B (1.7)	SARS (1.7)	ST3GAL4 (1.6)
MP:0000343	altered response to myocardial infarction	0.67	> 0.20	PVR (2.4)	ITGB3 (2.4)	BCL3 (1.9)	HP (1.6)	MAFB (1.4)	KIAA1324 (1.4)	ENSG00000235545 (1.3)	GMPR (1.3)	RHCE (1.1)	SH2B3 (1.0)
MP:0003122	maternal imprinting	0.67	> 0.20	NYNRIN (2.9)	CEACAM19 (2.2)	PCSK9 (1.4)	PLEKHH2 (1.4)	COL4A3BP (1.1)	TMED4 (1.1)	LDLR (1.1)	TOMM40 (1.0)	MOSC1 (1.0)	YIPF2 (1.0)
GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	0.67	> 0.20	ENSG00000228044 (3.4)	HAVCR1 (2.3)	AMIGO1 (2.0)	TMED4 (1.8)	DNAH11 (1.8)	TSSK6 (1.6)	HNF1A (1.5)	ENSG00000235545 (1.3)	CILP2 (1.3)	TMEM116 (1.1)
ENSG00000149557	FEZ1 PPI subnetwork	0.67	> 0.20	ILF3 (2.0)	NCAN (1.8)	SMARCA4 (1.7)	TMEM57 (1.7)	TMEM116 (1.6)	POC5 (1.6)	BUD13 (1.6)	C12orf43 (1.6)	ST3GAL4 (1.5)	DNM2 (1.5)
ENSG00000196277	GRM7 PPI subnetwork	0.67	> 0.20	ITGB3 (2.7)	AP1M2 (1.8)	FADS2 (1.7)	LDLR (1.5)	C12orf47 (1.5)	PLEC (1.5)	PVR (1.4)	PLEKHH2 (1.4)	KIAA1324 (1.3)	SMARCA4 (1.3)
ENSG00000122025	FLT3 PPI subnetwork	0.67	> 0.20	GMIP (3.6)	C17orf57 (2.8)	ZHX3 (2.3)	PBX4 (2.2)	MAFB (2.0)	SH2B3 (2.0)	COL4A3BP (1.9)	MYLIP (1.8)	LPAR2 (1.8)	TOP1 (1.6)
GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	0.67	> 0.20	TXNL4B (4.4)	BRAP (3.4)	CYB561D1 (2.9)	ATXN7L2 (2.9)	ADAM1 (2.4)	UBXN2B (2.4)	MAU2 (2.4)	ZNF259 (2.4)	C19orf52 (2.0)	ENSG00000238078 (1.9)
MP:0000108	midline facial cleft	0.67	> 0.20	NYNRIN (2.5)	ATXN2 (2.1)	ABCG8 (2.0)	PSRC1 (1.9)	KANK2 (1.9)	DOCK7 (1.8)	POLK (1.8)	DYNC2LI1 (1.8)	BCL3 (1.5)	HAVCR1 (1.5)
GO:0005070	SH3/SH2 adaptor activity	0.67	> 0.20	GMIP (3.4)	ITGB3 (2.8)	C17orf57 (2.0)	ENSG00000235545 (1.9)	ZNF101 (1.9)	LPAR2 (1.8)	PLEKHH2 (1.8)	C1orf63 (1.8)	ANKRD31 (1.6)	MAU2 (1.4)
ENSG00000071994	PDCD2 PPI subnetwork	0.67	> 0.20	CLPTM1 (2.7)	ANKRD31 (2.2)	SORT1 (2.1)	GATAD2A (2.1)	PLEKHH2 (2.0)	PLCG1 (2.0)	PTPN11 (1.9)	USP24 (1.8)	QTRT1 (1.7)	MARK4 (1.7)
MP:0004086	absent heartbeat	0.67	> 0.20	PLCG1 (2.3)	KANK2 (2.1)	PVRL2 (2.1)	GMPR (2.0)	BCAM (2.0)	SLC44A2 (2.0)	SH2B3 (1.9)	NAA25 (1.6)	SORT1 (1.4)	SYPL2 (1.4)
ENSG00000103351	CLUAP1 PPI subnetwork	0.67	> 0.20	ZNF180 (2.7)	TXNL4B (2.6)	BUD13 (2.1)	GEMIN7 (2.0)	MYLIP (2.0)	ZNF259 (1.9)	TIMD4 (1.8)	CILP2 (1.7)	UBXN2B (1.6)	BCAM (1.5)
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.67	> 0.20	ITGB3 (3.3)	PTPN11 (3.2)	SH2B3 (3.0)	GATAD2A (2.8)	KANK2 (2.6)	SLC44A2 (2.4)	PLEC (2.2)	GMIP (2.1)	LDLR (1.9)	DNM2 (1.8)
MP:0005104	abnormal tarsal bone morphology	0.67	> 0.20	DYNC2LI1 (3.6)	ZHX3 (2.5)	MAFB (2.4)	CILP2 (1.9)	NYNRIN (1.9)	PMFBP1 (1.8)	PPP1R37 (1.7)	LPIN3 (1.6)	PVR (1.2)	DNAH11 (1.1)
ENSG00000137726	FXYD6 PPI subnetwork	0.67	> 0.20	LPAR2 (3.6)	GMIP (2.6)	BLOC1S3 (2.6)	PVRL2 (2.1)	MAU2 (1.9)	DNM2 (1.9)	TSSK6 (1.8)	YIPF2 (1.7)	SLC44A2 (1.7)	GATAD2A (1.5)
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	0.67	> 0.20	ZHX3 (4.1)	PTPN11 (2.7)	MARK4 (2.1)	SORT1 (2.1)	PLEKHH2 (1.8)	CLPTM1 (1.8)	SH2B3 (1.8)	CARM1 (1.7)	KANK2 (1.6)	MYLIP (1.6)
GO:0048259	regulation of receptor-mediated endocytosis	0.67	> 0.20	CILP2 (1.7)	ZNF101 (1.7)	ENSG00000238078 (1.6)	ST3GAL4 (1.5)	CETP (1.4)	ENSG00000254235 (1.4)	PTPN11 (1.4)	APOE (1.3)	PVR (1.3)	GOT2P1 (1.3)
MP:0000762	abnormal tongue morphology	0.67	> 0.20	AP1M2 (2.9)	CELSR2 (2.9)	CBLC (2.0)	HAVCR1 (1.7)	KANK2 (1.7)	HAPLN4 (1.7)	BCAM (1.7)	LDLR (1.4)	PLEKHH2 (1.4)	KIAA1324 (1.3)
GO:0032984	macromolecular complex disassembly	0.67	> 0.20	TSSK6 (2.5)	UBXN2B (2.2)	ABO (2.0)	TMEM57 (1.8)	SLC44A2 (1.8)	CARM1 (1.7)	ADAM1 (1.7)	ATXN7L2 (1.6)	PMFBP1 (1.6)	ANKRD31 (1.5)
ENSG00000132475	H3F3B PPI subnetwork	0.67	> 0.20	SMARCA4 (2.7)	FEN1 (2.4)	BUD13 (2.3)	C19orf52 (2.3)	USP1 (2.3)	TOP1 (2.1)	ILF3 (2.1)	KIAA1324 (1.8)	PSRC1 (1.6)	GATAD2A (1.4)
ENSG00000163041	H3F3A PPI subnetwork	0.67	> 0.20	SMARCA4 (2.7)	FEN1 (2.4)	BUD13 (2.3)	C19orf52 (2.3)	USP1 (2.3)	TOP1 (2.1)	ILF3 (2.1)	KIAA1324 (1.8)	PSRC1 (1.6)	GATAD2A (1.4)
ENSG00000196285	ENSG00000196285 PPI subnetwork	0.67	> 0.20	SMARCA4 (2.7)	FEN1 (2.4)	BUD13 (2.3)	C19orf52 (2.3)	USP1 (2.3)	TOP1 (2.1)	ILF3 (2.1)	KIAA1324 (1.8)	PSRC1 (1.6)	GATAD2A (1.4)
GO:0030530	heterogeneous nuclear ribonucleoprotein complex	0.67	> 0.20	ILF3 (3.4)	C1orf63 (3.1)	TOP1 (2.5)	USP1 (2.0)	ADAM1 (1.9)	GATAD2A (1.9)	SMARCA4 (1.9)	GCNT4 (1.8)	PTPN11 (1.6)	PLCG1 (1.6)
MP:0002459	abnormal B cell physiology	0.67	> 0.20	TIMD4 (3.3)	GMIP (3.3)	CETP (2.8)	ZNF101 (2.6)	RELB (2.1)	MAFB (2.1)	SLC44A2 (2.0)	SH2B3 (1.4)	ERP29 (1.1)	DNM2 (1.0)
ENSG00000137757	CASP5 PPI subnetwork	0.68	> 0.20	ST3GAL4 (2.6)	UBXN2B (2.4)	BLOC1S3 (2.2)	PTPN11 (2.1)	NYNRIN (1.8)	MARK4 (1.8)	NT5DC1 (1.6)	FRK (1.6)	CYB561D1 (1.5)	TRAFD1 (1.5)
MP:0003670	dilated renal glomerular capsule	0.68	> 0.20	BCAM (3.4)	TRAPPC6A (2.3)	LPIN3 (2.0)	TM6SF2 (1.8)	PVRL2 (1.6)	C11orf9 (1.5)	NPC1L1 (1.5)	C17orf57 (1.4)	NT5DC1 (1.4)	QTRT1 (1.4)
ENSG00000102755	FLT1 PPI subnetwork	0.68	> 0.20	FADS2 (3.5)	HMGCR (2.5)	SH2B3 (2.2)	CETP (2.2)	APOE (2.0)	DNAH11 (1.8)	ITGB3 (1.8)	NCAN (1.7)	PARP10 (1.6)	SLC44A2 (1.6)
ENSG00000198554	WDHD1 PPI subnetwork	0.68	> 0.20	FEN1 (4.2)	USP1 (3.3)	ENSG00000235545 (1.8)	DNAH11 (1.8)	ZNF180 (1.8)	FADS1 (1.5)	AMIGO1 (1.4)	DOCK7 (1.3)	TRAPPC6A (1.3)	NYNRIN (1.3)
ENSG00000096717	SIRT1 PPI subnetwork	0.68	> 0.20	TRIB1 (2.1)	ATXN2 (1.6)	BUD13 (1.4)	UBXN2B (1.4)	TOP1 (1.4)	MYLIP (1.3)	PLCG1 (1.3)	RELB (1.3)	GATAD2A (1.2)	GRINA (1.2)
ENSG00000138696	BMPR1B PPI subnetwork	0.68	> 0.20	NYNRIN (2.8)	PVRL2 (2.6)	MYLIP (2.3)	ABO (2.2)	AP1M2 (2.1)	TRIB1 (2.1)	LPIN3 (1.9)	C11orf9 (1.7)	DYNC2LI1 (1.6)	PLEKHH2 (1.6)
GO:0008037	cell recognition	0.68	> 0.20	TSSK6 (3.8)	PMFBP1 (2.8)	GCNT4 (2.6)	CETP (2.6)	ENSG00000228044 (2.4)	PBX4 (2.1)	PLCG1 (1.9)	HAVCR1 (1.4)	TIMD4 (1.4)	TXNL4B (1.3)
MP:0000293	absent myocardial trabeculae	0.68	> 0.20	BCAM (2.7)	SORT1 (2.4)	PVRL2 (2.2)	SLC44A2 (2.2)	NYNRIN (1.8)	ACAD10 (1.6)	MAFB (1.5)	ENSG00000226648 (1.5)	CBLC (1.4)	PLEKHH2 (1.4)
GO:0003785	actin monomer binding	0.68	> 0.20	SYPL2 (2.8)	HNF1A (2.5)	NKPD1 (2.3)	C12orf47 (2.3)	GMPR (1.8)	RHCE (1.6)	PMFBP1 (1.5)	TRIB1 (1.4)	LDLR (1.3)	RHD (1.2)
ENSG00000145365	TIFA PPI subnetwork	0.68	> 0.20	C19orf52 (2.9)	BLOC1S3 (2.9)	RELB (2.7)	CYB561D1 (2.6)	C12orf47 (2.1)	LPAR2 (1.8)	USP24 (1.5)	HAVCR1 (1.5)	ANKRD31 (1.5)	PSRC1 (1.5)
ENSG00000164975	SNAPC3 PPI subnetwork	0.68	> 0.20	GEMIN7 (3.4)	C12orf43 (3.3)	POC5 (3.2)	C19orf52 (2.9)	ADAM1 (2.5)	TXNL4B (2.3)	ATXN2 (2.3)	SUGP1 (2.0)	TOMM40 (1.9)	BUD13 (1.8)
MP:0006337	abnormal first branchial arch morphology	0.68	> 0.20	TMEM57 (1.8)	TSSK6 (1.7)	ATP13A1 (1.5)	ATXN2 (1.4)	HNF1A (1.4)	MAU2 (1.3)	HMGCR (1.3)	TMED4 (1.2)	C17orf57 (1.2)	ENSG00000235545 (1.1)
GO:0002360	T cell lineage commitment	0.68	> 0.20	PBX4 (2.8)	DNAH11 (2.8)	ATXN7L2 (2.5)	ZNF101 (2.3)	ENSG00000235545 (2.2)	ENSG00000254235 (2.1)	UBXN2B (1.8)	HNF1A (1.8)	TRAPPC6A (1.6)	BLOC1S3 (1.2)
ENSG00000031698	SARS PPI subnetwork	0.68	> 0.20	SARS (2.5)	ZNF259 (2.4)	HNF1A (2.3)	NPC1L1 (2.0)	TM6SF2 (2.0)	USP24 (1.7)	ABCG8 (1.6)	ATXN7L2 (1.6)	ABCG5 (1.5)	ALDH2 (1.5)
ENSG00000121879	PIK3CA PPI subnetwork	0.68	> 0.20	HLX (3.2)	SLC44A2 (2.9)	SH2B3 (2.6)	C1orf63 (2.6)	GMIP (2.6)	CELSR2 (2.4)	MYLIP (2.1)	SORT1 (2.1)	PLEC (1.9)	USP24 (1.9)
ENSG00000099960	SLC7A4 PPI subnetwork	0.68	> 0.20	CLPTM1 (3.5)	FADS1 (3.3)	HMGCR (3.2)	FADS2 (2.9)	TMEM50A (2.6)	GEMIN7 (2.6)	TMED4 (1.9)	LDLR (1.9)	ABCG8 (1.8)	CEACAM19 (1.7)
ENSG00000013293	SLC7A14 PPI subnetwork	0.68	> 0.20	CLPTM1 (3.5)	FADS1 (3.3)	HMGCR (3.2)	FADS2 (2.9)	TMEM50A (2.6)	GEMIN7 (2.6)	TMED4 (1.9)	LDLR (1.9)	ABCG8 (1.8)	CEACAM19 (1.7)
MP:0008261	arrest of male meiosis	0.68	> 0.20	ANKRD31 (2.4)	PBX4 (2.2)	TMEM116 (1.4)	USP1 (1.2)	RHD (1.2)	ENSG00000228044 (1.2)	KIAA1324 (1.1)	ENSG00000238078 (1.1)	CILP2 (1.1)	FEN1 (1.0)
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	0.68	> 0.20	KIAA1324 (4.1)	ERP29 (3.2)	TMEM50A (2.9)	MOSC1 (2.8)	TMED4 (2.5)	GPAM (2.5)	COL4A3BP (2.0)	MAFB (1.7)	PLEKHH2 (1.5)	TRIB1 (1.5)
REACTOME_SEMAPHORIN_INTERACTIONS	REACTOME_SEMAPHORIN_INTERACTIONS	0.68	> 0.20	NCAN (2.5)	PVRL2 (2.4)	PLEC (2.3)	HLX (2.2)	OGDH (2.0)	ADAM1 (2.0)	SLC44A2 (1.9)	PVR (1.9)	GMIP (1.9)	MARK4 (1.7)
ENSG00000085415	SEH1L PPI subnetwork	0.68	> 0.20	PSRC1 (5.3)	FEN1 (4.5)	USP1 (3.8)	POC5 (3.8)	OASL (1.9)	DDX56 (1.6)	BUD13 (1.3)	DHX38 (1.3)	ILF3 (1.3)	USP24 (1.3)
MP:0000373	belly spot	0.68	> 0.20	APOE (2.7)	MYLIP (2.7)	DOCK7 (2.6)	NYNRIN (2.4)	ENSG00000226648 (2.4)	GMPR (2.2)	TMED4 (2.1)	CELSR2 (2.1)	TRIB1 (2.0)	ST3GAL4 (1.9)
GO:0006308	DNA catabolic process	0.68	> 0.20	NT5DC1 (2.8)	TRAPPC6A (2.6)	POLK (2.5)	ENSG00000226648 (2.3)	LPIN3 (1.9)	TMEM116 (1.9)	AMIGO1 (1.6)	MAPKAPK5 (1.6)	TSSK6 (1.6)	SUGP1 (1.5)
GO:0042362	fat-soluble vitamin biosynthetic process	0.68	> 0.20	ENSG00000228044 (2.9)	ATXN7L2 (2.5)	MYLIP (1.6)	CYB561D1 (1.6)	POC5 (1.6)	BLOC1S3 (1.5)	TRAFD1 (1.5)	GEMIN7 (1.5)	DYNC2LI1 (1.4)	PLEKHH2 (1.3)
ENSG00000153807	ENSG00000153807 PPI subnetwork	0.68	> 0.20	MAU2 (2.4)	HLX (2.3)	NYNRIN (2.3)	USP1 (2.3)	ZHX3 (2.2)	KANK2 (1.8)	SMARCA4 (1.8)	BUD13 (1.8)	MYLIP (1.8)	GMPR (1.7)
ENSG00000146276	GABRR1 PPI subnetwork	0.68	> 0.20	SARS (2.4)	PTPN11 (2.2)	GMPR (1.8)	PMFBP1 (1.6)	MAU2 (1.6)	GATAD2A (1.5)	ILF3 (1.4)	FADS2 (1.4)	PVR (1.4)	ST3GAL4 (1.3)
ENSG00000059728	MXD1 PPI subnetwork	0.68	> 0.20	KIAA1324 (2.9)	BLOC1S3 (2.5)	GATAD2A (2.4)	TOP1 (2.1)	MAFB (2.0)	DNM2 (1.8)	ATP13A1 (1.7)	SMARCA4 (1.7)	MYLIP (1.7)	MAU2 (1.6)
ENSG00000115268	RPS15 PPI subnetwork	0.68	> 0.20	NKPD1 (3.1)	ADAM1 (2.0)	ANKRD31 (1.7)	ILF3 (1.6)	DHX38 (1.6)	ATP13A1 (1.6)	SUGP1 (1.5)	CEACAM19 (1.4)	TOP1 (1.3)	GATAD2A (1.3)
KEGG_NUCLEOTIDE_EXCISION_REPAIR	KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.68	> 0.20	FEN1 (4.8)	USP1 (4.0)	ZNF180 (2.5)	NT5DC1 (2.2)	POC5 (1.8)	TRAPPC6A (1.7)	SUGP1 (1.6)	GOT2P1 (1.4)	ENSG00000235545 (1.4)	ENSG00000226648 (1.4)
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS	0.68	> 0.20	DHODH (3.1)	NT5DC1 (2.5)	ANKRD31 (2.5)	QTRT1 (2.4)	DDX56 (2.2)	ZNF259 (2.0)	ENSG00000228044 (1.9)	NAA25 (1.9)	GOT2P1 (1.6)	ILF3 (1.4)
ENSG00000101773	RBBP8 PPI subnetwork	0.68	> 0.20	TMEM57 (2.6)	ENSG00000228044 (2.5)	CELSR2 (2.2)	GATAD2A (1.8)	USP1 (1.8)	DNM2 (1.6)	TRAPPC6A (1.6)	MARK4 (1.6)	DHODH (1.6)	SARS (1.6)
ENSG00000142039	CCDC97 PPI subnetwork	0.68	> 0.20	GMIP (3.4)	CARM1 (3.3)	ENSG00000254235 (2.5)	SMARCA4 (2.4)	GRINA (2.3)	C12orf47 (2.0)	BUD13 (1.9)	ZNF259 (1.7)	ATXN2 (1.6)	MAPKAPK5 (1.6)
GO:0009894	regulation of catabolic process	0.68	> 0.20	ZHX3 (2.6)	C12orf51 (2.0)	DNM2 (1.7)	HLX (1.5)	PPP1R37 (1.5)	USP24 (1.4)	CBLC (1.4)	SH2B3 (1.3)	PTPN11 (1.3)	ENSG00000228044 (1.3)
ENSG00000091513	TF PPI subnetwork	0.68	> 0.20	BCAM (3.2)	PLG (2.9)	CILP2 (2.6)	ADAM1 (2.5)	ANGPTL3 (2.4)	PLEKHH2 (2.2)	NYNRIN (2.1)	APOC4 (1.7)	C11orf9 (1.7)	GRINA (1.6)
ENSG00000105821	DNAJC2 PPI subnetwork	0.68	> 0.20	CARM1 (2.7)	QTRT1 (2.5)	DDX56 (2.4)	SLC44A2 (2.0)	SMARCA4 (1.9)	YIPF2 (1.8)	SARS (1.7)	DHX38 (1.7)	OGDH (1.6)	TOMM40 (1.6)
ENSG00000087303	NID2 PPI subnetwork	0.68	> 0.20	NYNRIN (2.9)	BCAM (2.9)	CILP2 (2.4)	PLEC (2.0)	KANK2 (2.0)	PBX4 (1.9)	LPA (1.8)	ALDH2 (1.7)	OGDH (1.5)	CLPTM1 (1.5)
GO:0007050	cell cycle arrest	0.68	> 0.20	PSRC1 (2.7)	POC5 (2.5)	SUGP1 (2.3)	FEN1 (2.2)	POLK (2.1)	USP1 (2.1)	BUD13 (1.8)	BRAP (1.8)	MAU2 (1.7)	LPIN3 (1.7)
ENSG00000206376	EHMT2 PPI subnetwork	0.68	> 0.20	PPP1R37 (2.3)	RHD (2.3)	TMEM50A (2.2)	GATAD2A (2.0)	DOCK7 (1.9)	USP24 (1.9)	MAFB (1.8)	ATXN7L2 (1.8)	CARM1 (1.5)	C17orf57 (1.4)
ENSG00000204371	EHMT2 PPI subnetwork	0.68	> 0.20	PPP1R37 (2.3)	RHD (2.3)	TMEM50A (2.2)	GATAD2A (2.0)	DOCK7 (1.9)	USP24 (1.9)	MAFB (1.8)	ATXN7L2 (1.8)	CARM1 (1.5)	C17orf57 (1.4)
ENSG00000137324	ENSG00000137324 PPI subnetwork	0.68	> 0.20	PPP1R37 (2.3)	RHD (2.3)	TMEM50A (2.2)	GATAD2A (2.0)	DOCK7 (1.9)	USP24 (1.9)	MAFB (1.8)	ATXN7L2 (1.8)	CARM1 (1.5)	C17orf57 (1.4)
ENSG00000094880	CDC23 PPI subnetwork	0.68	> 0.20	PSRC1 (5.4)	FEN1 (4.3)	POC5 (2.9)	USP1 (1.9)	TSSK6 (1.7)	ILF3 (1.5)	RHCE (1.2)	LPAR2 (1.2)	LPIN3 (1.2)	BRAP (1.2)
MP:0004157	interrupted aortic arch	0.68	> 0.20	PVR (3.7)	PLEC (2.1)	CEACAM19 (2.0)	TRAPPC6A (1.9)	PLCG1 (1.9)	ITGB3 (1.7)	TRIB1 (1.5)	PVRL2 (1.5)	HLX (1.4)	DNAH11 (1.2)
GO:0019359	nicotinamide nucleotide biosynthetic process	0.68	> 0.20	PMFBP1 (3.1)	LPIN3 (2.6)	TM6SF2 (2.1)	ENSG00000226645 (2.0)	ACAD10 (1.7)	TRAPPC6A (1.6)	NT5DC1 (1.6)	HAPLN4 (1.5)	FADS2 (1.4)	PCSK9 (1.4)
GO:0071621	granulocyte chemotaxis	0.68	> 0.20	GCNT4 (3.0)	ST3GAL4 (2.3)	MAFB (2.3)	TMEM116 (2.0)	ZNF101 (1.4)	AP1M2 (1.3)	HAVCR1 (1.2)	APOE (1.2)	ENSG00000228044 (1.1)	OASL (1.1)
GO:0071622	regulation of granulocyte chemotaxis	0.68	> 0.20	GCNT4 (3.0)	ST3GAL4 (2.3)	MAFB (2.3)	TMEM116 (2.0)	ZNF101 (1.4)	AP1M2 (1.3)	HAVCR1 (1.2)	APOE (1.2)	ENSG00000228044 (1.1)	OASL (1.1)
GO:0006084	acetyl-CoA metabolic process	0.68	> 0.20	OGDH (4.7)	ACAD10 (4.1)	TMEM116 (2.3)	GPAM (2.3)	PCSK9 (2.0)	FADS1 (1.9)	GMPR (1.9)	HMGCR (1.9)	NT5DC1 (1.9)	FADS2 (1.8)
MP:0006280	abnormal digit development	0.68	> 0.20	CBLC (1.9)	C19orf52 (1.8)	ENSG00000254235 (1.6)	ANKRD31 (1.6)	MAFB (1.6)	HNF1A (1.6)	NYNRIN (1.5)	PLEC (1.4)	DNAH11 (1.4)	AP1M2 (1.2)
ENSG00000165458	INPPL1 PPI subnetwork	0.68	> 0.20	USP24 (2.7)	DOCK7 (1.9)	POLK (1.8)	MARK4 (1.8)	C12orf51 (1.8)	SORT1 (1.7)	GMIP (1.7)	PVRL2 (1.7)	PTPN11 (1.6)	DHX38 (1.5)
ENSG00000148925	BTBD10 PPI subnetwork	0.68	> 0.20	C12orf43 (2.8)	TRAFD1 (2.6)	ANKRD31 (2.3)	GRINA (1.9)	DHX38 (1.9)	PTPN11 (1.8)	CELSR2 (1.5)	BCAM (1.5)	POC5 (1.4)	ENSG00000226645 (1.3)
GO:0032421	stereocilium bundle	0.68	> 0.20	LPIN3 (2.2)	HNF1A (2.2)	TRAFD1 (2.1)	ABO (2.1)	PVRL2 (1.9)	ST3GAL4 (1.7)	HLX (1.7)	CBLC (1.6)	TM6SF2 (1.6)	PMFBP1 (1.6)
GO:0006362	transcription elongation from RNA polymerase I promoter	0.68	> 0.20	C12orf43 (3.8)	TXNL4B (3.2)	DYNC2LI1 (2.8)	ATXN7L2 (2.8)	MAPKAPK5 (2.5)	GEMIN7 (2.5)	ZNF259 (2.4)	QTRT1 (1.9)	NAA25 (1.9)	ZNF180 (1.6)
ENSG00000101084	C20orf24 PPI subnetwork	0.68	> 0.20	ATP13A1 (4.7)	DDX56 (2.4)	TOMM40 (2.3)	QTRT1 (2.3)	SMARCA4 (2.1)	PTPN11 (2.0)	ERP29 (1.8)	DHX38 (1.8)	DOCK7 (1.8)	HAVCR1 (1.7)
ENSG00000136003	ISCU PPI subnetwork	0.68	> 0.20	GOT2P1 (3.8)	ZNF101 (2.9)	GRINA (2.8)	UBXN2B (2.7)	FEN1 (2.4)	RHCE (2.2)	RHD (2.0)	GCNT4 (1.7)	CBLC (1.7)	TXNL4B (1.6)
GO:0003774	motor activity	0.68	> 0.20	DNAH11 (4.1)	PSRC1 (3.0)	C12orf51 (1.5)	AP1M2 (1.3)	PLEC (1.3)	SYPL2 (1.3)	COL4A3BP (1.3)	PLCG1 (1.2)	SMARCA4 (1.1)	C1orf63 (1.1)
ENSG00000137815	RTF1 PPI subnetwork	0.68	> 0.20	BUD13 (3.1)	SUGP1 (2.9)	ATXN2 (2.7)	ENSG00000226645 (2.5)	SMARCA4 (2.3)	ILF3 (2.2)	PTPN11 (2.1)	ZNF259 (2.0)	C12orf43 (2.0)	DOCK7 (1.9)
GO:0004033	aldo-keto reductase (NADP) activity	0.68	> 0.20	ALDH2 (3.7)	ABCG8 (3.4)	FADS1 (2.8)	ABCG5 (2.3)	SLC22A1 (2.1)	FADS2 (2.0)	TRAPPC6A (1.9)	C11orf9 (1.9)	KIAA1324 (1.8)	APOC4 (1.8)
REACTOME_L13A:MEDIATED_TRANSLATIONAL_SILENCING_OF_CERULOPLASMIN_EXPRESSION	REACTOME_L13A:MEDIATED_TRANSLATIONAL_SILENCING_OF_CERULOPLASMIN_EXPRESSION	0.68	> 0.20	NKPD1 (3.0)	ANKRD31 (1.8)	ILF3 (1.8)	SARS (1.7)	ADAM1 (1.6)	GATAD2A (1.5)	ATP13A1 (1.5)	UBXN2B (1.4)	C12orf43 (1.3)	SUGP1 (1.3)
REACTOME_3_:UTR:MEDIATED_TRANSLATIONAL_REGULATION	REACTOME_3_:UTR:MEDIATED_TRANSLATIONAL_REGULATION	0.68	> 0.20	NKPD1 (3.0)	ANKRD31 (1.8)	ILF3 (1.8)	SARS (1.7)	ADAM1 (1.6)	GATAD2A (1.5)	ATP13A1 (1.5)	UBXN2B (1.4)	C12orf43 (1.3)	SUGP1 (1.3)
GO:0051023	regulation of immunoglobulin secretion	0.68	> 0.20	PBX4 (2.8)	GCNT4 (2.2)	ENSG00000226645 (1.9)	TXNL4B (1.9)	DNAH11 (1.7)	MOSC1 (1.4)	C11orf9 (1.3)	CETP (1.2)	RELB (1.2)	NT5DC1 (1.2)
ENSG00000175216	CKAP5 PPI subnetwork	0.68	> 0.20	PSRC1 (3.6)	POC5 (3.3)	FEN1 (2.5)	MYLIP (2.0)	ZNF101 (1.9)	USP1 (1.9)	PBX4 (1.8)	HAVCR1 (1.7)	OGDH (1.6)	ZHX3 (1.4)
GO:0030520	intracellular estrogen receptor signaling pathway	0.68	> 0.20	ATXN2 (3.5)	ENSG00000226648 (2.3)	C12orf51 (2.3)	ENSG00000254235 (2.1)	AP1M2 (1.8)	KIAA1324 (1.7)	COL4A3BP (1.7)	ILF3 (1.5)	QTRT1 (1.5)	PPP1R37 (1.4)
ENSG00000104408	EIF3E PPI subnetwork	0.68	> 0.20	ATP13A1 (2.4)	ILF3 (2.3)	NKPD1 (2.0)	C12orf43 (2.0)	SARS (1.9)	CLPTM1 (1.8)	C19orf52 (1.8)	TRIB1 (1.5)	QTRT1 (1.5)	MYLIP (1.5)
GO:0048820	hair follicle maturation	0.68	> 0.20	ANKRD31 (2.8)	BLOC1S3 (2.7)	NKPD1 (2.2)	ENSG00000254235 (1.9)	PMFBP1 (1.7)	PVR (1.4)	AMIGO1 (1.4)	CEACAM19 (1.4)	ENSG00000226648 (1.3)	TRAPPC6A (1.2)
GO:0046425	regulation of JAK-STAT cascade	0.68	> 0.20	ENSG00000238078 (1.9)	DNAH11 (1.9)	ENSG00000254235 (1.9)	ENSG00000226645 (1.8)	GEMIN7 (1.5)	TRAFD1 (1.5)	PBX4 (1.4)	DYNC2LI1 (1.4)	TIMD4 (1.2)	HLX (1.2)
MP:0000876	Purkinje cell degeneration	0.68	> 0.20	ERP29 (5.1)	TMED4 (2.6)	SORT1 (2.5)	APOE (2.4)	COL4A3BP (2.4)	TMEM57 (2.2)	SARS (2.2)	TMEM50A (2.1)	YIPF2 (1.8)	TRAPPC6A (1.8)
GO:0030316	osteoclast differentiation	0.68	> 0.20	DNAH11 (2.2)	GCNT4 (1.9)	TSSK6 (1.6)	ANKRD31 (1.6)	ENSG00000235545 (1.5)	LPAR2 (1.3)	ENSG00000226645 (1.3)	AMIGO1 (1.1)	LPIN3 (1.1)	ZNF101 (1.1)
REACTOME_GAP_JUNCTION_ASSEMBLY	REACTOME_GAP_JUNCTION_ASSEMBLY	0.68	> 0.20	CBLC (3.0)	NKPD1 (2.8)	ENSG00000228044 (2.3)	PMFBP1 (1.9)	BCAM (1.8)	C11orf9 (1.8)	APOC1 (1.7)	CEACAM19 (1.4)	ST3GAL4 (1.4)	CETP (1.3)
GO:0045786	negative regulation of cell cycle	0.68	> 0.20	SUGP1 (2.7)	PSRC1 (2.2)	FEN1 (2.1)	POLK (2.1)	ENSG00000228044 (2.1)	BRAP (2.1)	ENSG00000226645 (2.0)	BUD13 (2.0)	POC5 (2.0)	USP1 (1.9)
MP:0003130	anal atresia	0.68	> 0.20	LPAR2 (3.1)	C17orf57 (2.3)	AP1M2 (2.1)	CBLC (1.7)	CELSR2 (1.6)	MAFB (1.5)	DOCK7 (1.4)	LPIN3 (1.4)	NYNRIN (1.3)	PBX4 (1.3)
ENSG00000163485	ADORA1 PPI subnetwork	0.68	> 0.20	ITGB3 (3.4)	NCAN (2.3)	GCNT4 (2.2)	CETP (2.0)	RPH3A (2.0)	CYB561D1 (2.0)	LPIN3 (1.9)	ENSG00000235545 (1.7)	PSMA5 (1.7)	ZHX3 (1.6)
MP:0009845	abnormal neural crest cell morphology	0.68	> 0.20	MYLIP (3.5)	PLEKHH2 (2.5)	KIAA1324 (2.1)	ITGB3 (1.9)	C17orf57 (1.8)	MAFB (1.8)	CILP2 (1.7)	LPIN3 (1.7)	HLX (1.7)	GCNT4 (1.5)
GO:0031581	hemidesmosome assembly	0.68	> 0.20	CBLC (4.3)	C17orf57 (2.7)	BCAM (2.7)	HAVCR1 (2.2)	AP1M2 (1.9)	PLEC (1.9)	ZNF180 (1.4)	CELSR2 (1.3)	OGDH (1.2)	ENSG00000238078 (1.1)
ENSG00000197299	BLM PPI subnetwork	0.68	> 0.20	FEN1 (5.0)	USP1 (4.9)	ZNF180 (2.9)	BUD13 (2.0)	ENSG00000235545 (1.9)	PSRC1 (1.8)	POLK (1.8)	OASL (1.7)	KANK2 (1.3)	TMEM57 (1.2)
ENSG00000049540	ELN PPI subnetwork	0.68	> 0.20	MOSC1 (2.7)	HP (2.4)	RHCE (2.4)	RHD (2.2)	CILP2 (2.1)	NYNRIN (2.1)	PBX4 (2.1)	YIPF2 (1.8)	ATXN7L2 (1.5)	RPH3A (1.4)
GO:0001573	ganglioside metabolic process	0.68	> 0.20	TMED4 (3.2)	GCNT4 (2.8)	ERP29 (2.4)	COL4A3BP (2.4)	PMFBP1 (2.2)	TRAPPC6A (2.1)	NKPD1 (2.1)	ADAM1 (2.1)	ZNF180 (1.8)	HAVCR1 (1.7)
ENSG00000175906	ARL4D PPI subnetwork	0.68	> 0.20	BRAP (2.5)	PVRL2 (2.3)	ATXN2 (2.2)	DNM2 (2.2)	TMEM116 (2.1)	ERP29 (2.1)	DOCK7 (2.1)	ALDH2 (1.9)	CYP7A1 (1.7)	ACAD10 (1.6)
ENSG00000126778	SIX1 PPI subnetwork	0.68	> 0.20	NKPD1 (2.8)	TMEM57 (2.4)	MYLIP (2.4)	TSSK6 (1.9)	PPP1R37 (1.9)	DHX38 (1.6)	GMPR (1.5)	ENSG00000238078 (1.3)	ALDH2 (1.3)	PLEC (1.3)
GO:0050832	defense response to fungus	0.68	> 0.20	PBX4 (2.0)	ABCG5 (1.9)	GCNT4 (1.8)	MOSC1 (1.7)	HP (1.6)	GOT2P1 (1.5)	LPAR2 (1.5)	RHD (1.5)	CILP2 (1.4)	LPA (1.4)
ENSG00000115661	STK16 PPI subnetwork	0.68	> 0.20	ABO (2.2)	PLCG1 (2.1)	TMED4 (2.1)	ZNF101 (2.0)	MOSC1 (2.0)	HNF1A (1.8)	ST3GAL4 (1.8)	DYNC2LI1 (1.6)	LPIN3 (1.4)	HAPLN4 (1.3)
ENSG00000063046	EIF4B PPI subnetwork	0.68	> 0.20	SUGP1 (2.6)	ATP13A1 (2.4)	GATAD2A (2.1)	ILF3 (2.1)	NKPD1 (2.0)	ANKRD31 (2.0)	SARS (1.9)	CBLC (1.8)	ADAM1 (1.8)	TMEM57 (1.8)
ENSG00000159259	CHAF1B PPI subnetwork	0.68	> 0.20	FEN1 (3.2)	BRAP (2.1)	USP1 (2.0)	DNAH11 (1.8)	ZNF101 (1.5)	TMEM116 (1.5)	MAU2 (1.5)	C19orf52 (1.4)	NT5DC1 (1.4)	TMEM57 (1.3)
ENSG00000073756	PTGS2 PPI subnetwork	0.68	> 0.20	SYPL2 (2.4)	GRINA (2.3)	PVR (1.9)	TOMM40 (1.9)	BLOC1S3 (1.8)	OGDH (1.7)	MARK4 (1.7)	PVRL2 (1.6)	CARM1 (1.5)	CLPTM1 (1.5)
ENSG00000171634	BPTF PPI subnetwork	0.68	> 0.20	C19orf52 (3.6)	MAPKAPK5 (2.5)	POC5 (2.5)	COL4A3BP (2.4)	C1orf63 (2.2)	DYNC2LI1 (1.8)	USP1 (1.8)	TMED4 (1.7)	UBXN2B (1.7)	TOP1 (1.6)
MP:0010254	nuclear cataracts	0.68	> 0.20	FADS2 (2.6)	HMGCR (2.4)	NPC1L1 (2.4)	FADS1 (2.1)	LDLR (1.8)	CELSR2 (1.8)	TM6SF2 (1.4)	GOT2P1 (1.3)	GCNT4 (1.2)	ABCG8 (0.9)
REACTOME_GAP_JUNCTION_TRAFFICKING	REACTOME_GAP_JUNCTION_TRAFFICKING	0.68	> 0.20	NKPD1 (2.8)	CBLC (2.0)	C11orf9 (2.0)	CLPTM1 (1.9)	CETP (1.9)	C17orf57 (1.8)	ST3GAL4 (1.8)	APOC1 (1.7)	ENSG00000228044 (1.6)	PLEKHH2 (1.6)
ENSG00000107187	LHX3 PPI subnetwork	0.68	> 0.20	ATXN7L2 (2.0)	RPH3A (1.8)	TSSK6 (1.8)	C1orf63 (1.7)	GMPR (1.6)	MARK4 (1.5)	RHD (1.5)	BCAM (1.5)	SH2B3 (1.4)	COL4A3BP (1.3)
GO:0006690	icosanoid metabolic process	0.68	> 0.20	NKPD1 (4.4)	CYB561D1 (3.6)	ALDH2 (2.8)	CEACAM19 (1.8)	GMPR (1.8)	PMFBP1 (1.7)	HNF1A (1.7)	FADS2 (1.7)	C11orf9 (1.5)	ITGB3 (1.5)
ENSG00000105185	PDCD5 PPI subnetwork	0.68	> 0.20	ZNF180 (3.1)	GEMIN7 (2.6)	POC5 (2.4)	BUD13 (1.9)	APOE (1.9)	RELB (1.7)	TXNL4B (1.7)	ZNF259 (1.6)	ERP29 (1.4)	YIPF2 (1.4)
REACTOME_NONSENSE_MEDIATED_DECAY_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX	REACTOME_NONSENSE_MEDIATED_DECAY_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX	0.68	> 0.20	NKPD1 (2.8)	UBXN2B (2.2)	MOSC1 (1.9)	ENSG00000226645 (1.7)	ILF3 (1.7)	GATAD2A (1.6)	ANKRD31 (1.5)	MAU2 (1.4)	ATP13A1 (1.3)	GPAM (1.3)
GO:0042471	ear morphogenesis	0.68	> 0.20	CILP2 (2.6)	NKPD1 (2.0)	C17orf57 (1.9)	DYNC2LI1 (1.9)	CEACAM19 (1.9)	NYNRIN (1.7)	ENSG00000238078 (1.7)	TMED4 (1.6)	AMIGO1 (1.6)	PLEKHH2 (1.4)
GO:0033108	mitochondrial respiratory chain complex assembly	0.68	> 0.20	C12orf47 (2.8)	GOT2P1 (2.3)	DHODH (2.1)	GEMIN7 (1.8)	ZNF180 (1.7)	POC5 (1.4)	TOMM40 (1.4)	ACAD10 (1.4)	HAVCR1 (1.3)	TRAPPC6A (1.2)
ENSG00000149428	HYOU1 PPI subnetwork	0.68	> 0.20	TMED4 (3.5)	ERP29 (3.2)	BCAM (2.5)	CELSR2 (2.4)	RPH3A (2.2)	CLPTM1 (2.1)	NCAN (2.0)	YIPF2 (1.7)	MYLIP (1.7)	GRINA (1.5)
ENSG00000147099	HDAC8 PPI subnetwork	0.69	> 0.20	SMARCA4 (2.5)	TMEM57 (2.3)	PBX4 (2.1)	GATAD2A (1.9)	POLK (1.9)	ATXN2 (1.8)	GMPR (1.8)	DNM2 (1.8)	PSRC1 (1.6)	CARM1 (1.5)
MP:0008719	impaired neutrophil recruitment	0.69	> 0.20	GMIP (3.2)	TIMD4 (2.9)	HP (2.9)	MAFB (2.6)	BCL3 (2.6)	HLX (2.4)	TRIB1 (2.2)	MYLIP (1.7)	LPAR2 (1.6)	RELB (1.5)
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	0.69	> 0.20	ZHX3 (3.5)	DNM2 (2.5)	ENSG00000226645 (2.4)	SLC44A2 (2.3)	ZNF101 (2.2)	LPAR2 (2.2)	PLEKHH2 (2.1)	TOP1 (2.1)	SMARCA4 (2.1)	GATAD2A (2.0)
ENSG00000181191	PJA1 PPI subnetwork	0.69	> 0.20	ABO (2.4)	PBX4 (2.2)	NYNRIN (1.6)	KIAA1324 (1.6)	LPAR2 (1.5)	PSRC1 (1.5)	CBLC (1.5)	HAVCR1 (1.4)	ST3GAL4 (1.4)	GMPR (1.3)
GO:0070265	necrotic cell death	0.69	> 0.20	FRK (2.1)	LPAR2 (1.8)	HAVCR1 (1.7)	TMEM57 (1.7)	UBXN2B (1.6)	TRAPPC6A (1.5)	TMEM50A (1.4)	ZNF180 (1.3)	C1orf63 (1.3)	NT5DC1 (1.2)
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	0.69	> 0.20	TRIB1 (3.2)	CLPTM1 (2.2)	ZHX3 (2.2)	PLEC (2.1)	PVR (1.9)	POLK (1.8)	MARK4 (1.5)	ATXN2 (1.5)	AMIGO1 (1.5)	PPP1R37 (1.4)
GO:0016862	intramolecular oxidoreductase activity, interconverting keto- and enol-groups	0.69	> 0.20	ERP29 (5.1)	TMED4 (3.3)	YIPF2 (2.7)	KIAA1324 (2.5)	HNF1A (2.0)	DHODH (1.9)	ATP13A1 (1.9)	ADAM1 (1.8)	PVRL2 (1.4)	PPP1R37 (1.4)
ENSG00000115221	ITGB6 PPI subnetwork	0.69	> 0.20	SH2B3 (4.0)	PLEC (3.7)	ITGB3 (3.4)	DNM2 (2.3)	KANK2 (2.1)	APOE (2.0)	GMIP (1.7)	CELSR2 (1.6)	C17orf57 (1.5)	MARK4 (1.5)
GO:0032602	chemokine production	0.69	> 0.20	ST3GAL4 (2.7)	FRK (1.7)	MAFB (1.6)	BCL3 (1.5)	OASL (1.5)	POLK (1.5)	ALDH2 (1.3)	TIMD4 (1.3)	HLX (1.2)	HP (1.2)
MP:0000049	abnormal middle ear morphology	0.69	> 0.20	CILP2 (3.1)	CEACAM19 (3.0)	MYLIP (2.1)	GOT2P1 (1.6)	PLCG1 (1.6)	HAVCR1 (1.6)	AMIGO1 (1.4)	DNAH11 (1.4)	BCAM (1.4)	NKPD1 (1.3)
GO:0032943	mononuclear cell proliferation	0.69	> 0.20	TIMD4 (3.0)	PBX4 (2.9)	ZNF101 (2.1)	CETP (2.0)	HLX (1.8)	POLK (1.8)	GMIP (1.5)	TRAFD1 (1.4)	ADAM1 (1.4)	PLCG1 (1.1)
MP:0000929	open neural tube	0.69	> 0.20	ATXN2 (3.3)	DOCK7 (2.7)	MAFB (2.6)	MARK4 (2.2)	DYNC2LI1 (2.1)	CARM1 (2.0)	SMARCA4 (1.8)	GATAD2A (1.8)	NYNRIN (1.7)	KANK2 (1.6)
GO:0090030	regulation of steroid hormone biosynthetic process	0.69	> 0.20	BLOC1S3 (2.5)	ENSG00000226645 (2.3)	ATXN7L2 (2.2)	TMED4 (1.9)	ST3GAL4 (1.8)	ZNF180 (1.5)	SLC44A2 (1.5)	CEACAM19 (1.5)	DNAH11 (1.5)	BCAM (1.5)
ENSG00000133243	BTBD2 PPI subnetwork	0.69	> 0.20	HMGCR (2.6)	TRAFD1 (2.1)	FADS2 (2.0)	FADS1 (1.8)	BUD13 (1.8)	USP24 (1.7)	NCAN (1.5)	PARP10 (1.5)	PLCG1 (1.4)	OASL (1.4)
ENSG00000143155	TIPRL PPI subnetwork	0.69	> 0.20	BLOC1S3 (3.0)	GEMIN7 (2.9)	TRAPPC6A (2.7)	CLPTM1 (2.7)	ENSG00000235545 (2.3)	TOMM40 (2.3)	COL4A3BP (2.1)	ZNF180 (2.0)	PPP1R37 (1.7)	ZNF101 (1.3)
ENSG00000172732	MUS81 PPI subnetwork	0.69	> 0.20	SUGP1 (3.7)	TOMM40 (2.9)	FEN1 (2.8)	DDX56 (2.6)	PSRC1 (2.5)	CARM1 (2.4)	ENSG00000226648 (2.3)	C19orf52 (2.3)	QTRT1 (2.3)	USP1 (2.1)
MP:0002818	abnormal dentin morphology	0.69	> 0.20	FRK (3.9)	CILP2 (2.7)	ABO (2.4)	ST3GAL4 (2.4)	MAFB (1.8)	ENSG00000254235 (1.7)	MYLIP (1.7)	NT5DC1 (1.6)	ENSG00000226648 (1.6)	BLOC1S3 (1.6)
ENSG00000173402	DAG1 PPI subnetwork	0.69	> 0.20	SYPL2 (3.6)	KANK2 (3.4)	PLEC (3.1)	BCAM (3.1)	RPH3A (2.9)	ZHX3 (2.6)	CELSR2 (2.6)	LPIN3 (1.7)	SLC44A2 (1.6)	PBX4 (1.6)
GO:0018198	peptidyl-cysteine modification	0.69	> 0.20	CEACAM19 (3.6)	ENSG00000226645 (3.5)	CYB561D1 (2.1)	C19orf52 (1.8)	C12orf47 (1.8)	BLOC1S3 (1.6)	YIPF2 (1.6)	PLEKHH2 (1.5)	ENSG00000238078 (1.5)	CILP2 (1.5)
GO:0031970	organelle envelope lumen	0.69	> 0.20	RHD (2.9)	ACAD10 (2.5)	GEMIN7 (2.0)	USP24 (1.9)	TOMM40 (1.8)	GPAM (1.8)	GMPR (1.8)	DHODH (1.7)	RHCE (1.6)	TRAPPC6A (1.6)
REACTOME_P75_NTR_RECEPTOR:MEDIATED_SIGNALLING	REACTOME_P75_NTR_RECEPTOR:MEDIATED_SIGNALLING	0.69	> 0.20	GMIP (3.4)	RELB (3.2)	PLEC (2.7)	GATAD2A (2.6)	CLPTM1 (2.5)	DNM2 (2.1)	LPAR2 (2.0)	SH2B3 (2.0)	MARK4 (1.9)	CELSR2 (1.8)
ENSG00000149136	SSRP1 PPI subnetwork	0.69	> 0.20	FEN1 (2.7)	USP1 (2.6)	SMARCA4 (2.5)	BUD13 (2.5)	TOP1 (2.2)	DHX38 (2.1)	SUGP1 (2.1)	GMPR (1.9)	ENSG00000226645 (1.8)	ILF3 (1.7)
ENSG00000104765	BNIP3L PPI subnetwork	0.69	> 0.20	RHCE (3.3)	TMEM57 (3.3)	GMPR (3.1)	ENSG00000226645 (2.0)	PLEC (1.9)	CEACAM19 (1.7)	DHODH (1.6)	LPIN3 (1.5)	YIPF2 (1.5)	DNAH11 (1.5)
ENSG00000120498	TEX11 PPI subnetwork	0.69	> 0.20	DNAH11 (2.7)	POLK (2.3)	NPC1L1 (2.1)	DYNC2LI1 (2.1)	PSRC1 (2.0)	TSSK6 (1.8)	HLX (1.8)	SUGP1 (1.8)	ADAM1 (1.7)	ATXN2 (1.5)
ENSG00000048828	FAM120A PPI subnetwork	0.69	> 0.20	PLEC (2.9)	OGDH (1.7)	TXNL4B (1.7)	SLC22A1 (1.7)	CLPTM1 (1.6)	AP1M2 (1.4)	HMGCR (1.4)	C1orf63 (1.3)	FRK (1.3)	ATXN2 (1.2)
GO:0031397	negative regulation of protein ubiquitination	0.69	> 0.20	PSMA5 (3.5)	SUGP1 (2.4)	TRAFD1 (2.3)	NT5DC1 (2.2)	POC5 (2.1)	C12orf43 (2.0)	NAA25 (2.0)	DDX56 (1.9)	BRAP (1.9)	C12orf47 (1.8)
ENSG00000172137	CALB2 PPI subnetwork	0.69	> 0.20	HAPLN4 (3.1)	ALDH2 (3.0)	RPH3A (2.7)	NCAN (2.1)	GRINA (2.0)	ENSG00000226648 (1.8)	MOSC1 (1.8)	CELSR2 (1.7)	NT5DC1 (1.7)	C11orf9 (1.6)
ENSG00000135503	ACVR1B PPI subnetwork	0.69	> 0.20	MARK4 (2.8)	SH2B3 (2.6)	SLC44A2 (2.4)	PVR (2.0)	PVRL2 (1.9)	MAPKAPK5 (1.6)	SORT1 (1.5)	POLK (1.5)	ZNF180 (1.5)	MYLIP (1.5)
ENSG00000153094	BCL2L11 PPI subnetwork	0.69	> 0.20	PLCG1 (3.7)	MARK4 (2.3)	TOP1 (2.0)	AMIGO1 (2.0)	TRIB1 (1.8)	TMEM57 (1.5)	GMPR (1.4)	PVR (1.4)	C11orf9 (1.4)	ZHX3 (1.3)
ENSG00000112290	WASF1 PPI subnetwork	0.69	> 0.20	GATAD2A (3.0)	ENSG00000254235 (2.3)	PBX4 (2.2)	GMIP (2.1)	DNM2 (2.1)	TMEM50A (2.0)	LPIN3 (1.8)	SLC44A2 (1.6)	COL4A3BP (1.5)	ENSG00000238078 (1.5)
ENSG00000115361	ACADL PPI subnetwork	0.69	> 0.20	ACAD10 (2.7)	PSMA5 (2.3)	GMPR (2.1)	GPAM (1.9)	DYNC2LI1 (1.8)	NKPD1 (1.8)	FADS2 (1.7)	OGDH (1.7)	DOCK7 (1.5)	COL4A3BP (1.4)
MP:0000706	small thymus	0.69	> 0.20	GMIP (3.1)	ZNF101 (2.7)	PLCG1 (2.6)	FADS1 (2.1)	DNM2 (2.1)	SMARCA4 (1.9)	PBX4 (1.7)	CYB561D1 (1.4)	SLC44A2 (1.3)	BCL3 (1.3)
ENSG00000051128	HOMER3 PPI subnetwork	0.69	> 0.20	PLEKHH2 (2.8)	C17orf57 (2.3)	SYPL2 (2.2)	POC5 (2.0)	ENSG00000226648 (1.7)	ENSG00000226645 (1.6)	MAPKAPK5 (1.6)	ZHX3 (1.6)	NCAN (1.4)	PTPN11 (1.4)
GO:0043535	regulation of blood vessel endothelial cell migration	0.69	> 0.20	ENSG00000226645 (2.7)	DNAH11 (2.4)	ENSG00000228044 (2.4)	ENSG00000235545 (2.2)	PVR (2.0)	GCNT4 (1.5)	LPIN3 (1.3)	HLX (1.2)	TMED4 (1.2)	HNF1A (1.0)
ENSG00000092108	SCFD1 PPI subnetwork	0.69	> 0.20	YIPF2 (2.9)	OGDH (2.8)	TMEM57 (2.6)	CYB561D1 (2.5)	ITGB3 (2.2)	PSMA5 (1.9)	DHX38 (1.9)	QTRT1 (1.8)	SUGP1 (1.8)	AP1M2 (1.6)
MP:0002566	abnormal sexual interaction	0.69	> 0.20	TRIB1 (3.4)	HAPLN4 (2.4)	APOE (2.3)	TMED4 (2.1)	GPAM (1.9)	NCAN (1.8)	HMGCR (1.8)	APOB (1.6)	KIAA1324 (1.5)	CELSR2 (1.4)
ENSG00000163191	S100A11 PPI subnetwork	0.69	> 0.20	MYLIP (2.4)	GMPR (2.2)	C19orf52 (2.1)	ANGPTL3 (1.7)	ENSG00000238078 (1.7)	DDX56 (1.7)	MOSC1 (1.6)	PMFBP1 (1.6)	ACAD10 (1.4)	GRINA (1.3)
GO:0051496	positive regulation of stress fiber assembly	0.69	> 0.20	PBX4 (2.7)	C17orf57 (2.1)	ABO (1.9)	NYNRIN (1.8)	HAVCR1 (1.6)	NKPD1 (1.4)	USP24 (1.4)	GCNT4 (1.3)	AMIGO1 (1.2)	HNF1A (1.2)
ENSG00000104064	GABPB1 PPI subnetwork	0.69	> 0.20	MAPKAPK5 (2.2)	ZNF180 (2.2)	USP1 (1.9)	OASL (1.8)	BRAP (1.8)	COL4A3BP (1.6)	NT5DC1 (1.6)	USP24 (1.5)	PARP10 (1.5)	ATXN2 (1.4)
REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS	REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS	0.69	> 0.20	FRK (2.1)	ABO (1.9)	TMEM50A (1.8)	HAVCR1 (1.8)	TRAFD1 (1.8)	PVRL2 (1.6)	SORT1 (1.5)	TRAPPC6A (1.4)	YIPF2 (1.4)	NCAN (1.4)
GO:0072509	divalent inorganic cation transmembrane transporter activity	0.69	> 0.20	AP1M2 (3.0)	ATP13A1 (2.4)	CLPTM1 (2.1)	MAPKAPK5 (1.9)	CYB561D1 (1.9)	NCAN (1.9)	TMED4 (1.9)	HMGCR (1.7)	POC5 (1.7)	NPC1L1 (1.7)
GO:0071705	nitrogen compound transport	0.69	> 0.20	HAPLN4 (2.7)	ABCG8 (2.6)	GCNT4 (2.6)	GMPR (2.4)	TM6SF2 (2.2)	ATP13A1 (2.0)	ERP29 (1.9)	PMFBP1 (1.8)	LPAR2 (1.8)	RHCE (1.6)
GO:0032609	interferon-gamma production	0.69	> 0.20	DNAH11 (2.6)	ZNF101 (2.2)	PBX4 (1.7)	TIMD4 (1.7)	ATXN7L2 (1.6)	ENSG00000235545 (1.6)	GRINA (1.3)	PVR (1.3)	ADAM1 (1.1)	TXNL4B (1.1)
ENSG00000100364	KIAA0930 PPI subnetwork	0.69	> 0.20	CBLC (5.3)	AP1M2 (3.7)	CELSR2 (2.3)	LPAR2 (1.9)	DNM2 (1.7)	ST3GAL4 (1.7)	DOCK7 (1.7)	LPIN3 (1.6)	MARK4 (1.5)	PVRL2 (1.5)
REACTOME_RIBOSOMAL_SCANNING_AND_START_CODON_RECOGNITION	REACTOME_RIBOSOMAL_SCANNING_AND_START_CODON_RECOGNITION	0.69	> 0.20	NKPD1 (3.2)	ILF3 (2.1)	DDX56 (2.0)	QTRT1 (1.9)	SARS (1.9)	ATP13A1 (1.8)	ANKRD31 (1.8)	C19orf52 (1.8)	GATAD2A (1.7)	C12orf43 (1.7)
MP:0001312	abnormal cornea morphology	0.69	> 0.20	APOE (2.8)	LPA (2.0)	MAFB (2.0)	CILP2 (1.9)	HAVCR1 (1.5)	ATXN2 (1.3)	APOC1 (1.2)	ENSG00000254235 (1.1)	PARP10 (1.0)	ZNF101 (0.9)
GO:0051216	cartilage development	0.69	> 0.20	CILP2 (6.3)	PLEKHH2 (3.0)	NYNRIN (1.7)	MAFB (1.7)	CEACAM19 (1.2)	ABO (1.2)	ANKRD31 (1.2)	ATXN7L2 (1.0)	KANK2 (1.0)	SLC44A2 (1.0)
REACTOME_SIGNAL_AMPLIFICATION	REACTOME_SIGNAL_AMPLIFICATION	0.69	> 0.20	ITGB3 (4.7)	TMEM50A (2.9)	CETP (2.5)	HLX (2.1)	DNM2 (1.7)	SH2B3 (1.6)	ENSG00000235545 (1.6)	MYLIP (1.5)	POLK (1.1)	PVRL2 (1.0)
REACTOME_VEGF_LIGAND:RECEPTOR_INTERACTIONS	REACTOME_VEGF_LIGAND:RECEPTOR_INTERACTIONS	0.69	> 0.20	HLX (4.2)	CETP (3.5)	GRINA (2.0)	SH2B3 (1.7)	KANK2 (1.7)	MAPKAPK5 (1.5)	PVRL2 (1.4)	DNAH11 (1.4)	DHODH (1.2)	ENSG00000226648 (1.2)
REACTOME_SIGNALING_BY_VEGF	REACTOME_SIGNALING_BY_VEGF	0.69	> 0.20	HLX (4.2)	CETP (3.5)	GRINA (2.0)	SH2B3 (1.7)	KANK2 (1.7)	MAPKAPK5 (1.5)	PVRL2 (1.4)	DNAH11 (1.4)	DHODH (1.2)	ENSG00000226648 (1.2)
GO:0035872	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	0.69	> 0.20	FRK (2.2)	ZNF101 (2.1)	BLOC1S3 (2.1)	UBXN2B (2.1)	ENSG00000235545 (2.0)	MAU2 (1.9)	ENSG00000226645 (1.9)	RELB (1.8)	ENSG00000228044 (1.7)	PARP10 (1.6)
GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	0.69	> 0.20	FRK (2.2)	ZNF101 (2.1)	BLOC1S3 (2.1)	UBXN2B (2.1)	ENSG00000235545 (2.0)	MAU2 (1.9)	ENSG00000226645 (1.9)	RELB (1.8)	ENSG00000228044 (1.7)	PARP10 (1.6)
GO:0002753	cytoplasmic pattern recognition receptor signaling pathway	0.69	> 0.20	FRK (2.2)	ZNF101 (2.1)	BLOC1S3 (2.1)	UBXN2B (2.1)	ENSG00000235545 (2.0)	MAU2 (1.9)	ENSG00000226645 (1.9)	RELB (1.8)	ENSG00000228044 (1.7)	PARP10 (1.6)
GO:0072215	regulation of metanephros development	0.69	> 0.20	TSSK6 (2.9)	PLEKHH2 (2.3)	BCAM (2.2)	HNF1A (2.2)	PMFBP1 (2.2)	C11orf9 (2.0)	ENSG00000226645 (1.9)	ABO (1.9)	HAVCR1 (1.7)	ATXN7L2 (1.7)
GO:0048524	positive regulation of viral reproduction	0.69	> 0.20	MAPKAPK5 (2.8)	SUGP1 (2.7)	BUD13 (2.4)	TXNL4B (2.1)	MAU2 (2.0)	GATAD2A (1.9)	ENSG00000226645 (1.9)	C12orf43 (1.8)	QTRT1 (1.7)	GEMIN7 (1.5)
GO:0006403	RNA localization	0.69	> 0.20	C1orf63 (3.3)	MAPKAPK5 (3.1)	TOP1 (3.0)	ILF3 (2.8)	NAA25 (2.6)	ADAM1 (2.4)	DOCK7 (2.4)	USP24 (2.2)	ENSG00000226648 (2.1)	POC5 (2.1)
ENSG00000143801	PSEN2 PPI subnetwork	0.69	> 0.20	ABO (3.7)	LPIN3 (2.9)	NCAN (2.8)	CBLC (2.4)	CELSR2 (2.4)	DNM2 (2.2)	PLCG1 (1.8)	CLPTM1 (1.8)	TMED4 (1.7)	TMEM50A (1.5)
ENSG00000171843	MLLT3 PPI subnetwork	0.69	> 0.20	ZNF180 (2.7)	ZNF101 (1.9)	USP1 (1.9)	C17orf57 (1.9)	TMEM57 (1.8)	ENSG00000226645 (1.7)	NT5DC1 (1.6)	POLK (1.6)	KIAA1324 (1.4)	POC5 (1.4)
GO:0002279	mast cell activation involved in immune response	0.69	> 0.20	CYB561D1 (2.4)	BLOC1S3 (2.1)	GEMIN7 (2.1)	NKPD1 (2.0)	DNAH11 (1.8)	GMPR (1.6)	C17orf57 (1.5)	GMIP (1.3)	ALDH2 (1.3)	ST3GAL4 (1.3)
ENSG00000078747	ITCH PPI subnetwork	0.69	> 0.20	CBLC (5.5)	AP1M2 (4.1)	LPAR2 (3.0)	CELSR2 (2.2)	SLC44A2 (2.2)	HNF1A (1.9)	TRIB1 (1.8)	PPP1R37 (1.8)	LPIN3 (1.7)	ALDH2 (1.4)
ENSG00000127922	SHFM1 PPI subnetwork	0.69	> 0.20	PSMA5 (4.7)	NAA25 (3.0)	TOMM40 (2.7)	SUGP1 (2.3)	TMEM57 (2.2)	SARS (2.2)	DDX56 (1.9)	C17orf57 (1.9)	TRAFD1 (1.7)	CLPTM1 (1.6)
GO:0016248	channel inhibitor activity	0.69	> 0.20	PLG (2.3)	APOB (2.3)	HNF1A (2.2)	CEACAM19 (1.7)	NKPD1 (1.6)	ANGPTL3 (1.5)	RHCE (1.4)	MYLIP (1.4)	NPC1L1 (1.3)	HP (1.2)
GO:0008200	ion channel inhibitor activity	0.69	> 0.20	PLG (2.3)	APOB (2.3)	HNF1A (2.2)	CEACAM19 (1.7)	NKPD1 (1.6)	ANGPTL3 (1.5)	RHCE (1.4)	MYLIP (1.4)	NPC1L1 (1.3)	HP (1.2)
REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C:GAMMA	REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C:GAMMA	0.69	> 0.20	ITGB3 (3.4)	ZHX3 (2.9)	SH2B3 (2.7)	SORT1 (2.4)	ST3GAL4 (2.4)	AMIGO1 (2.1)	ZNF101 (1.8)	OGDH (1.8)	USP24 (1.6)	GCNT4 (1.5)
GO:0006936	muscle contraction	0.69	> 0.20	SYPL2 (6.2)	ENSG00000226648 (2.7)	GMPR (2.4)	KANK2 (2.3)	C17orf57 (2.0)	ITGB3 (1.4)	SORT1 (1.4)	NKPD1 (1.4)	SLC44A2 (1.1)	ABO (1.0)
ENSG00000174442	ZWILCH PPI subnetwork	0.69	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ENSG00000226648 (1.2)	ZNF180 (1.1)	ENSG00000228044 (1.0)	ZHX3 (0.9)	LPIN3 (0.8)	USP24 (0.7)
ENSG00000152661	GJA1 PPI subnetwork	0.69	> 0.20	TIMD4 (1.7)	CETP (1.7)	RPH3A (1.7)	BCAM (1.7)	PLEC (1.6)	C17orf57 (1.6)	SH2B3 (1.5)	MARK4 (1.4)	SORT1 (1.3)	CEACAM19 (1.2)
GO:0090109	regulation of cell-substrate junction assembly	0.69	> 0.20	ITGB3 (3.1)	GCNT4 (2.5)	SLC44A2 (2.4)	PBX4 (2.2)	USP24 (2.1)	PLEKHH2 (1.9)	DNAH11 (1.6)	PVRL2 (1.4)	KANK2 (1.3)	POLK (1.2)
GO:0051893	regulation of focal adhesion assembly	0.69	> 0.20	ITGB3 (3.1)	GCNT4 (2.5)	SLC44A2 (2.4)	PBX4 (2.2)	USP24 (2.1)	PLEKHH2 (1.9)	DNAH11 (1.6)	PVRL2 (1.4)	KANK2 (1.3)	POLK (1.2)
GO:0032615	interleukin-12 production	0.69	> 0.20	ZNF101 (2.7)	TRAFD1 (2.6)	GRINA (2.2)	PBX4 (2.1)	ST3GAL4 (1.9)	RELB (1.8)	PARP10 (1.8)	SH2B3 (1.5)	GMIP (1.4)	MYLIP (1.3)
ENSG00000213023	SYT3 PPI subnetwork	0.69	> 0.20	RPH3A (3.2)	CEACAM19 (2.9)	ENSG00000226645 (2.5)	HAPLN4 (2.3)	C12orf51 (2.3)	MARK4 (2.2)	FRK (2.1)	ABO (2.0)	KIAA1324 (1.7)	ATXN7L2 (1.6)
ENSG00000197102	DYNC1H1 PPI subnetwork	0.69	> 0.20	SARS (2.8)	SMARCA4 (2.4)	PSMA5 (2.3)	PLEC (2.1)	ZHX3 (2.0)	ZNF259 (2.0)	GATAD2A (1.7)	DNAH11 (1.6)	TMEM50A (1.5)	HAVCR1 (1.5)
REACTOME_ABORTIVE_ELONGATION_OF_HIV:1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	REACTOME_ABORTIVE_ELONGATION_OF_HIV:1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	0.69	> 0.20	SUGP1 (2.9)	GEMIN7 (2.8)	DNM2 (2.3)	QTRT1 (2.2)	CLPTM1 (2.2)	ZNF259 (2.2)	C19orf52 (2.1)	DHX38 (2.0)	SMARCA4 (1.9)	C12orf43 (1.9)
GO:0014909	smooth muscle cell migration	0.69	> 0.20	C17orf57 (2.8)	LPIN3 (2.5)	ST3GAL4 (1.7)	C12orf47 (1.6)	PMFBP1 (1.6)	PVRL2 (1.6)	NKPD1 (1.6)	ANKRD31 (1.5)	ZNF101 (1.3)	QTRT1 (1.3)
ENSG00000197635	DPP4 PPI subnetwork	0.69	> 0.20	TIMD4 (3.4)	OASL (3.2)	TRAFD1 (2.9)	APOE (2.3)	MAFB (2.3)	PBX4 (1.7)	CETP (1.6)	CILP2 (1.6)	GMIP (1.4)	PARP10 (1.4)
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	0.69	> 0.20	ANGPTL3 (3.3)	ABCG5 (3.2)	ABCG8 (3.1)	SLC22A1 (3.1)	CYP7A1 (2.7)	TM6SF2 (2.4)	KIAA1324 (2.0)	APOB (2.0)	APOC4 (2.0)	ALDH2 (1.7)
ENSG00000088179	PTPN4 PPI subnetwork	0.69	> 0.20	COL4A3BP (2.7)	PMFBP1 (2.5)	OGDH (2.1)	APOE (1.8)	ABO (1.7)	MYLIP (1.7)	POC5 (1.7)	ENSG00000238078 (1.6)	MOSC1 (1.6)	TIMD4 (1.4)
ENSG00000151623	NR3C2 PPI subnetwork	0.69	> 0.20	CYP7A1 (2.3)	POLK (2.2)	ATXN2 (2.0)	COL4A3BP (2.0)	UBXN2B (1.7)	KANK2 (1.6)	NYNRIN (1.6)	MYLIP (1.4)	CARM1 (1.4)	NPC1L1 (1.3)
ENSG00000077235	GTF3C1 PPI subnetwork	0.69	> 0.20	DDX56 (3.5)	C12orf43 (3.4)	ZNF259 (2.6)	TOMM40 (2.3)	ATP13A1 (2.1)	SARS (2.1)	BUD13 (2.1)	ENSG00000226645 (2.0)	GEMIN7 (2.0)	SUGP1 (2.0)
ENSG00000165806	CASP7 PPI subnetwork	0.69	> 0.20	PTPN11 (3.4)	ST3GAL4 (2.4)	PLEC (2.4)	ZNF101 (2.1)	BCL3 (2.0)	UBXN2B (2.0)	C1orf63 (1.9)	RELB (1.8)	C12orf51 (1.5)	PARP10 (1.4)
GO:0032204	regulation of telomere maintenance	0.69	> 0.20	TXNL4B (3.5)	BLOC1S3 (3.3)	ENSG00000226648 (2.3)	UBXN2B (2.3)	DHODH (2.1)	POC5 (2.1)	GEMIN7 (2.1)	POLK (2.0)	SUGP1 (2.0)	GOT2P1 (1.7)
MP:0005619	increased urine potassium level	0.69	> 0.20	AP1M2 (4.1)	CBLC (3.5)	TMEM116 (2.4)	PLG (2.1)	ZHX3 (2.1)	BCAM (2.0)	LPAR2 (1.7)	KIAA1324 (1.7)	PMFBP1 (1.6)	ABO (1.6)
ENSG00000135821	GLUL PPI subnetwork	0.69	> 0.20	CYP7A1 (3.1)	PCSK9 (2.6)	ALDH2 (2.0)	HMGCR (1.6)	CELSR2 (1.6)	FRK (1.6)	TXNL4B (1.6)	TRAPPC6A (1.5)	NT5DC1 (1.5)	C11orf9 (1.5)
GO:0006775	fat-soluble vitamin metabolic process	0.69	> 0.20	LPAR2 (2.4)	TM6SF2 (2.4)	CYP7A1 (2.0)	PMFBP1 (1.9)	ENSG00000235545 (1.8)	ENSG00000228044 (1.7)	ABCG8 (1.7)	ANGPTL3 (1.7)	APOC4 (1.4)	PBX4 (1.4)
ENSG00000123066	MED13L PPI subnetwork	0.69	> 0.20	GEMIN7 (3.0)	BLOC1S3 (2.8)	TXNL4B (2.1)	C1orf63 (2.1)	POC5 (2.1)	BUD13 (1.9)	ZNF180 (1.9)	C19orf52 (1.7)	TMEM57 (1.6)	MAPKAPK5 (1.5)
GO:0015002	heme-copper terminal oxidase activity	0.69	> 0.20	TRAPPC6A (3.3)	C12orf47 (2.6)	TMEM116 (2.3)	GOT2P1 (2.3)	ACAD10 (2.2)	OGDH (1.8)	UBXN2B (1.5)	C19orf52 (1.5)	KANK2 (1.5)	CILP2 (1.3)
GO:0004129	cytochrome-c oxidase activity	0.69	> 0.20	TRAPPC6A (3.3)	C12orf47 (2.6)	TMEM116 (2.3)	GOT2P1 (2.3)	ACAD10 (2.2)	OGDH (1.8)	UBXN2B (1.5)	C19orf52 (1.5)	KANK2 (1.5)	CILP2 (1.3)
GO:0016676	oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor	0.69	> 0.20	TRAPPC6A (3.3)	C12orf47 (2.6)	TMEM116 (2.3)	GOT2P1 (2.3)	ACAD10 (2.2)	OGDH (1.8)	UBXN2B (1.5)	C19orf52 (1.5)	KANK2 (1.5)	CILP2 (1.3)
ENSG00000184348	HIST1H2AK PPI subnetwork	0.69	> 0.20	SMARCA4 (2.6)	BUD13 (2.5)	ILF3 (2.3)	USP1 (1.8)	TOP1 (1.8)	DDX56 (1.7)	CARM1 (1.7)	TXNL4B (1.5)	GMPR (1.5)	ENSG00000226645 (1.5)
ENSG00000196866	HIST1H2AD PPI subnetwork	0.69	> 0.20	SMARCA4 (2.6)	BUD13 (2.5)	ILF3 (2.3)	USP1 (1.8)	TOP1 (1.8)	DDX56 (1.7)	CARM1 (1.7)	TXNL4B (1.5)	GMPR (1.5)	ENSG00000226645 (1.5)
ENSG00000196787	HIST1H2AG PPI subnetwork	0.69	> 0.20	SMARCA4 (2.6)	BUD13 (2.5)	ILF3 (2.3)	USP1 (1.8)	TOP1 (1.8)	DDX56 (1.7)	CARM1 (1.7)	TXNL4B (1.5)	GMPR (1.5)	ENSG00000226645 (1.5)
ENSG00000198374	HIST1H2AL PPI subnetwork	0.69	> 0.20	SMARCA4 (2.6)	BUD13 (2.5)	ILF3 (2.3)	USP1 (1.8)	TOP1 (1.8)	DDX56 (1.7)	CARM1 (1.7)	TXNL4B (1.5)	GMPR (1.5)	ENSG00000226645 (1.5)
ENSG00000196747	HIST1H2AI PPI subnetwork	0.69	> 0.20	SMARCA4 (2.6)	BUD13 (2.5)	ILF3 (2.3)	USP1 (1.8)	TOP1 (1.8)	DDX56 (1.7)	CARM1 (1.7)	TXNL4B (1.5)	GMPR (1.5)	ENSG00000226645 (1.5)
ENSG00000104613	INTS10 PPI subnetwork	0.69	> 0.20	MAPKAPK5 (4.0)	BUD13 (3.3)	TMEM116 (2.5)	POC5 (2.2)	DDX56 (1.8)	LPAR2 (1.8)	PSRC1 (1.6)	SUGP1 (1.6)	ADAM1 (1.5)	ABO (1.4)
ENSG00000042753	AP2S1 PPI subnetwork	0.69	> 0.20	PLCG1 (3.3)	TXNL4B (2.6)	ZHX3 (2.5)	GRINA (2.5)	ABO (2.2)	UBXN2B (2.1)	BRAP (2.1)	AP1M2 (1.8)	C12orf51 (1.8)	TMEM116 (1.7)
MP:0006325	impaired hearing	0.69	> 0.20	CILP2 (3.1)	BCAM (2.5)	AP1M2 (2.2)	PVRL2 (2.2)	ENSG00000228044 (2.1)	NT5DC1 (1.9)	NCAN (1.6)	HNF1A (1.6)	TRIB1 (1.6)	RPH3A (1.5)
ENSG00000111581	NUP107 PPI subnetwork	0.69	> 0.20	PSRC1 (5.6)	FEN1 (4.3)	USP1 (3.9)	POC5 (3.6)	BUD13 (1.4)	ILF3 (1.3)	USP24 (1.1)	DDX56 (1.0)	ENSG00000226648 (1.0)	NAA25 (1.0)
ENSG00000160678	S100A1 PPI subnetwork	0.69	> 0.20	SYPL2 (4.1)	NCAN (2.7)	RPH3A (2.1)	ST3GAL4 (1.9)	GMPR (1.8)	ENSG00000226648 (1.7)	HAPLN4 (1.6)	ATXN7L2 (1.6)	PLEC (1.4)	NT5DC1 (1.2)
GO:0042326	negative regulation of phosphorylation	0.69	> 0.20	DNAH11 (2.6)	PPP1R37 (2.4)	ENSG00000238078 (2.3)	ADAM1 (2.0)	ABO (2.0)	GCNT4 (1.9)	TRIB1 (1.9)	ENSG00000226645 (1.9)	C19orf52 (1.8)	MYLIP (1.8)
REACTOME_SIGNALING_BY_FGFR	REACTOME_SIGNALING_BY_FGFR	0.69	> 0.20	ZHX3 (3.9)	PTPN11 (2.5)	MARK4 (2.1)	SORT1 (2.1)	ENSG00000226645 (2.1)	PLEKHH2 (2.1)	SH2B3 (1.9)	CARM1 (1.7)	KANK2 (1.7)	PVR (1.7)
GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	0.69	> 0.20	ZNF101 (1.7)	ENSG00000254235 (1.6)	ATP13A1 (1.6)	ENSG00000226648 (1.5)	ILF3 (1.4)	DHX38 (1.4)	PMFBP1 (1.3)	TXNL4B (1.3)	DNM2 (1.2)	GOT2P1 (1.2)
GO:0015939	pantothenate metabolic process	0.69	> 0.20	NT5DC1 (2.7)	UBXN2B (2.3)	C19orf52 (2.3)	BRAP (2.2)	GPAM (2.0)	DHODH (1.7)	AMIGO1 (1.4)	TSSK6 (1.3)	NPC1L1 (1.3)	ST3GAL4 (1.2)
ENSG00000165684	SNAPC4 PPI subnetwork	0.69	> 0.20	C12orf43 (3.8)	GEMIN7 (3.1)	ADAM1 (2.6)	POC5 (2.6)	C19orf52 (2.5)	SUGP1 (2.1)	TOMM40 (2.1)	ZNF259 (2.0)	MAPKAPK5 (1.9)	DDX56 (1.9)
ENSG00000078142	PIK3C3 PPI subnetwork	0.69	> 0.20	BCL3 (3.1)	PTPN11 (2.7)	DNM2 (2.7)	RELB (2.5)	SH2B3 (2.3)	CYB561D1 (2.2)	GMIP (2.1)	USP24 (2.0)	GMPR (1.9)	DOCK7 (1.9)
GO:0021587	cerebellum morphogenesis	0.69	> 0.20	TMEM116 (3.1)	HAPLN4 (2.6)	ENSG00000238078 (2.3)	ENSG00000235545 (2.2)	ENSG00000226648 (1.9)	ERP29 (1.8)	NCAN (1.7)	C17orf57 (1.7)	DNAH11 (1.6)	ZHX3 (1.5)
ENSG00000106397	PLOD3 PPI subnetwork	0.69	> 0.20	ATP13A1 (3.4)	DNM2 (2.3)	QTRT1 (2.3)	ILF3 (1.9)	DHODH (1.8)	YIPF2 (1.8)	ZNF101 (1.6)	OGDH (1.6)	ACAD10 (1.5)	ENSG00000235545 (1.4)
ENSG00000135999	EPC2 PPI subnetwork	0.69	> 0.20	ADAM1 (2.8)	C12orf43 (2.8)	SMARCA4 (2.5)	SUGP1 (2.4)	MAPKAPK5 (2.3)	ILF3 (2.2)	ATXN7L2 (2.0)	PCSK9 (1.7)	USP1 (1.6)	DHX38 (1.6)
MP:0009339	decreased splenocyte number	0.69	> 0.20	HLX (2.9)	MYLIP (2.7)	USP24 (2.4)	AMIGO1 (2.2)	SORT1 (2.0)	GPAM (1.8)	KANK2 (1.7)	DOCK7 (1.6)	MOSC1 (1.6)	ZHX3 (1.6)
GO:0009161	ribonucleoside monophosphate metabolic process	0.69	> 0.20	ANKRD31 (3.0)	NT5DC1 (2.7)	DHODH (2.5)	ENSG00000228044 (2.3)	QTRT1 (2.0)	PMFBP1 (1.9)	ZNF259 (1.8)	SYPL2 (1.7)	ENSG00000226648 (1.5)	NAA25 (1.3)
GO:0030889	negative regulation of B cell proliferation	0.69	> 0.20	ZNF101 (3.3)	C17orf57 (2.6)	GCNT4 (1.7)	TRIB1 (1.7)	PMFBP1 (1.5)	ENSG00000238078 (1.5)	PBX4 (1.4)	TIMD4 (1.3)	ENSG00000226645 (1.2)	C12orf47 (1.1)
MP:0003178	left pulmonary isomerism	0.69	> 0.20	DNAH11 (2.8)	CEACAM19 (2.7)	ANKRD31 (2.5)	PVR (2.0)	DYNC2LI1 (2.0)	HLX (1.8)	PBX4 (1.8)	POLK (1.6)	HNF1A (1.3)	TMEM57 (1.1)
ENSG00000080986	NDC80 PPI subnetwork	0.69	> 0.20	PSRC1 (5.7)	FEN1 (4.6)	USP1 (3.6)	POC5 (3.6)	ENSG00000228044 (1.2)	ENSG00000226648 (1.1)	ZHX3 (1.0)	LPIN3 (1.0)	ACAD10 (0.9)	TXNL4B (0.8)
GO:0006352	transcription initiation, DNA-dependent	0.69	> 0.20	GEMIN7 (2.9)	MAPKAPK5 (2.7)	BUD13 (2.7)	ATXN7L2 (2.4)	TXNL4B (2.4)	DHX38 (2.2)	SUGP1 (2.2)	TOP1 (1.9)	MAU2 (1.8)	C19orf52 (1.6)
MP:0001362	abnormal anxiety-related response	0.69	> 0.20	RPH3A (3.2)	NCAN (2.9)	PPP1R37 (2.3)	PCSK9 (2.0)	NPC1L1 (2.0)	ATXN7L2 (2.0)	C11orf9 (1.9)	ENSG00000226645 (1.8)	C12orf43 (1.5)	C12orf51 (1.4)
ENSG00000151929	BAG3 PPI subnetwork	0.69	> 0.20	CELSR2 (4.1)	AMIGO1 (2.5)	ZHX3 (2.2)	GMPR (2.2)	BRAP (2.2)	BCAM (1.9)	PSRC1 (1.9)	GRINA (1.9)	PLCG1 (1.8)	MYLIP (1.7)
GO:0051783	regulation of nuclear division	0.69	> 0.20	POC5 (4.1)	PSRC1 (3.3)	ENSG00000228044 (2.2)	GEMIN7 (2.0)	TMEM50A (1.6)	CBLC (1.5)	TMED4 (1.5)	COL4A3BP (1.5)	C1orf63 (1.4)	POLK (1.3)
GO:0007088	regulation of mitosis	0.69	> 0.20	POC5 (4.1)	PSRC1 (3.3)	ENSG00000228044 (2.2)	GEMIN7 (2.0)	TMEM50A (1.6)	CBLC (1.5)	TMED4 (1.5)	COL4A3BP (1.5)	C1orf63 (1.4)	POLK (1.3)
MP:0000013	abnormal adipose tissue distribution	0.69	> 0.20	CETP (3.3)	KANK2 (3.2)	AP1M2 (2.8)	CBLC (2.5)	KIAA1324 (2.4)	C12orf47 (2.3)	MOSC1 (1.9)	DNM2 (1.9)	LPIN3 (1.7)	PLEC (1.5)
GO:0008544	epidermis development	0.69	> 0.20	NKPD1 (3.3)	CBLC (3.1)	CELSR2 (2.6)	C17orf57 (2.2)	AP1M2 (2.1)	CEACAM19 (1.9)	ENSG00000254235 (1.6)	ENSG00000226648 (1.6)	BCAM (1.6)	PMFBP1 (1.2)
GO:0046649	lymphocyte activation	0.69	> 0.20	ZNF101 (4.1)	PBX4 (2.4)	PLCG1 (2.3)	TIMD4 (2.2)	GMIP (2.1)	CYB561D1 (1.8)	CETP (1.7)	POLK (1.7)	SH2B3 (1.7)	RELB (1.4)
ENSG00000132824	SERINC3 PPI subnetwork	0.69	> 0.20	TMED4 (3.6)	CLPTM1 (2.6)	YIPF2 (2.4)	ATP13A1 (2.3)	TOMM40 (2.1)	C11orf9 (1.5)	MARK4 (1.4)	TMEM50A (1.4)	FADS1 (1.3)	MAU2 (1.3)
MP:0001954	respiratory distress	0.69	> 0.20	HLX (3.5)	CILP2 (2.7)	MAFB (2.3)	BCAM (2.1)	OGDH (1.8)	PLEC (1.7)	NCAN (1.6)	PPP1R37 (1.4)	CLPTM1 (1.4)	GPAM (1.3)
ENSG00000160948	VPS28 PPI subnetwork	0.69	> 0.20	TRIB1 (2.1)	NT5DC1 (1.8)	GMPR (1.7)	POLK (1.6)	FRK (1.6)	PPP1R37 (1.5)	PLEKHH2 (1.5)	ENSG00000254235 (1.4)	TMEM50A (1.3)	POC5 (1.3)
MP:0000010	abnormal abdominal fat pad morphology	0.69	> 0.20	MARK4 (2.9)	ST3GAL4 (2.8)	ALDH2 (2.6)	MAPKAPK5 (2.5)	KANK2 (2.4)	GPAM (1.8)	MOSC1 (1.7)	GCNT4 (1.6)	PTPN11 (1.5)	SLC44A2 (1.5)
ENSG00000135972	MRPS9 PPI subnetwork	0.69	> 0.20	DHODH (3.6)	TOMM40 (3.5)	GEMIN7 (3.2)	ANKRD31 (2.6)	ATXN2 (2.5)	ATXN7L2 (2.0)	QTRT1 (1.9)	CARM1 (1.9)	ATP13A1 (1.7)	DDX56 (1.7)
GO:0032769	negative regulation of monooxygenase activity	0.69	> 0.20	C17orf57 (3.3)	CEACAM19 (3.0)	BLOC1S3 (2.6)	SYPL2 (2.6)	TXNL4B (2.4)	PBX4 (2.3)	ZNF180 (2.0)	PMFBP1 (1.8)	GCNT4 (1.7)	TMEM50A (1.6)
GO:0032642	regulation of chemokine production	0.69	> 0.20	ST3GAL4 (3.0)	MAFB (1.8)	BCL3 (1.6)	OASL (1.5)	FRK (1.4)	TIMD4 (1.4)	POLK (1.3)	HP (1.3)	GMIP (1.2)	CETP (1.1)
GO:2000602	regulation of interphase of mitotic cell cycle	0.69	> 0.20	PSMA5 (2.7)	TRAFD1 (2.2)	MAU2 (2.1)	SUGP1 (2.0)	TXNL4B (2.0)	BRAP (1.7)	ZNF180 (1.6)	PTPN11 (1.6)	NAA25 (1.6)	NT5DC1 (1.6)
ENSG00000184445	KNTC1 PPI subnetwork	0.69	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ENSG00000226648 (1.2)	ENSG00000228044 (1.1)	ZNF180 (1.0)	ZHX3 (0.9)	TXNL4B (0.7)	LPIN3 (0.7)
GO:0035825	reciprocal DNA recombination	0.69	> 0.20	ANKRD31 (5.4)	TMEM116 (2.2)	POLK (1.6)	DYNC2LI1 (1.6)	HAVCR1 (1.4)	UBXN2B (1.4)	ZNF180 (1.3)	USP1 (1.1)	POC5 (1.1)	FEN1 (1.0)
GO:0007131	reciprocal meiotic recombination	0.69	> 0.20	ANKRD31 (5.4)	TMEM116 (2.2)	POLK (1.6)	DYNC2LI1 (1.6)	HAVCR1 (1.4)	UBXN2B (1.4)	ZNF180 (1.3)	USP1 (1.1)	POC5 (1.1)	FEN1 (1.0)
GO:0045137	development of primary sexual characteristics	0.69	> 0.20	ST3GAL4 (2.5)	DNAH11 (2.3)	ABO (1.9)	LPAR2 (1.7)	NYNRIN (1.6)	TSSK6 (1.6)	HNF1A (1.5)	PVRL2 (1.5)	AMIGO1 (1.4)	LDLR (1.4)
MP:0000558	abnormal tibia morphology	0.70	> 0.20	CILP2 (3.9)	PLEKHH2 (2.8)	MAFB (2.6)	NKPD1 (2.3)	KIAA1324 (1.7)	ZNF101 (1.5)	TRIB1 (1.5)	PARP10 (1.5)	UBXN2B (1.4)	NYNRIN (1.3)
MP:0001575	cyanosis	0.70	> 0.20	LDLR (2.3)	HLX (2.2)	PLCG1 (2.0)	TOP1 (1.9)	ATXN2 (1.8)	BCAM (1.6)	PVRL2 (1.6)	MARK4 (1.5)	CELSR2 (1.5)	ENSG00000228044 (1.5)
GO:0019674	NAD metabolic process	0.70	> 0.20	OGDH (3.6)	HAPLN4 (2.7)	ACAD10 (2.5)	ENSG00000226645 (2.4)	TM6SF2 (2.3)	PMFBP1 (2.0)	ENSG00000254235 (1.8)	SYPL2 (1.6)	GMPR (1.6)	LPIN3 (1.5)
GO:0018107	peptidyl-threonine phosphorylation	0.70	> 0.20	C1orf63 (2.7)	PTPN11 (2.0)	CYB561D1 (1.9)	CEACAM19 (1.9)	C12orf51 (1.8)	ZHX3 (1.7)	ENSG00000226645 (1.6)	PLCG1 (1.6)	GCNT4 (1.5)	SORT1 (1.4)
GO:0009156	ribonucleoside monophosphate biosynthetic process	0.70	> 0.20	ANKRD31 (3.1)	ENSG00000228044 (2.7)	DHODH (2.5)	QTRT1 (2.3)	NT5DC1 (2.1)	PMFBP1 (2.0)	SYPL2 (1.9)	ZNF259 (1.7)	ENSG00000235545 (1.6)	NAA25 (1.3)
GO:0034109	homotypic cell-cell adhesion	0.70	> 0.20	CYB561D1 (2.3)	ST3GAL4 (2.3)	CETP (1.8)	ITGB3 (1.7)	SH2B3 (1.5)	RHCE (1.4)	ENSG00000238078 (1.4)	TMEM116 (1.3)	GMPR (1.3)	RHD (1.3)
ENSG00000165943	MOAP1 PPI subnetwork	0.70	> 0.20	PPP1R37 (3.0)	ZNF101 (2.8)	ERP29 (2.5)	YIPF2 (2.5)	GEMIN7 (2.2)	TRAPPC6A (2.1)	AMIGO1 (2.0)	LPAR2 (2.0)	QTRT1 (1.8)	MARK4 (1.7)
MP:0001386	abnormal maternal nurturing	0.70	> 0.20	HAPLN4 (3.3)	HMGCR (2.6)	LDLR (2.4)	RPH3A (2.4)	CELSR2 (2.2)	RHD (2.0)	NCAN (2.0)	SORT1 (1.9)	FADS2 (1.9)	FADS1 (1.8)
GO:0005868	cytoplasmic dynein complex	0.70	> 0.20	TMEM50A (2.8)	PLCG1 (2.0)	DNAH11 (1.8)	C1orf63 (1.8)	MARK4 (1.8)	C12orf51 (1.7)	DYNC2LI1 (1.7)	KIAA1324 (1.6)	ATXN2 (1.5)	PLEC (1.5)
GO:0072332	signal transduction by p53 class mediator resulting in induction of apoptosis	0.70	> 0.20	BLOC1S3 (2.5)	AMIGO1 (2.2)	POLK (2.0)	ZNF101 (1.6)	PPP1R37 (1.5)	PARP10 (1.5)	ZNF259 (1.4)	MARK4 (1.3)	CARM1 (1.2)	CELSR2 (1.2)
MP:0005016	decreased lymphocyte cell number	0.70	> 0.20	GMIP (2.5)	ZNF101 (2.4)	MAFB (2.3)	TIMD4 (2.3)	GRINA (2.0)	RHCE (1.8)	RELB (1.8)	TOP1 (1.7)	HLX (1.7)	PBX4 (1.6)
GO:0000070	mitotic sister chromatid segregation	0.70	> 0.20	PSRC1 (4.3)	POC5 (4.1)	ENSG00000228044 (2.3)	DNAH11 (2.2)	BUD13 (2.0)	USP1 (1.9)	C19orf52 (1.9)	FEN1 (1.7)	ILF3 (1.6)	AMIGO1 (1.6)
GO:0070372	regulation of ERK1 and ERK2 cascade	0.70	> 0.20	CETP (2.5)	GEMIN7 (2.3)	PVR (2.3)	PLEKHH2 (2.1)	ENSG00000228044 (2.1)	KIAA1324 (1.8)	TSSK6 (1.8)	ENSG00000254235 (1.7)	PVRL2 (1.6)	ENSG00000226645 (1.4)
GO:0021794	thalamus development	0.70	> 0.20	ABO (2.7)	PCSK9 (2.3)	ENSG00000238078 (2.1)	ABCG8 (2.1)	HNF1A (1.9)	TMEM116 (1.9)	GCNT4 (1.8)	TM6SF2 (1.5)	ATXN2 (1.4)	C12orf51 (1.4)
ENSG00000103197	TSC2 PPI subnetwork	0.70	> 0.20	COL4A3BP (3.2)	SLC44A2 (3.0)	CARM1 (2.6)	PTPN11 (2.6)	MARK4 (2.5)	PLEC (2.3)	DNM2 (2.1)	LPAR2 (1.9)	AP1M2 (1.9)	OGDH (1.8)
ENSG00000135945	REV1 PPI subnetwork	0.70	> 0.20	GMPR (2.8)	KANK2 (1.7)	MYLIP (1.6)	PMFBP1 (1.6)	ZNF180 (1.5)	PARP10 (1.5)	DNAH11 (1.4)	NT5DC1 (1.4)	TRAPPC6A (1.3)	PLEC (1.2)
GO:0072160	nephron tubule epithelial cell differentiation	0.70	> 0.20	HAVCR1 (3.6)	DNAH11 (2.7)	BCAM (2.3)	PMFBP1 (1.8)	TMEM116 (1.6)	GCNT4 (1.4)	DYNC2LI1 (1.4)	CYP7A1 (1.3)	C17orf57 (1.3)	ITGB3 (1.2)
GO:0042033	chemokine biosynthetic process	0.70	> 0.20	ENSG00000228044 (2.4)	OASL (1.6)	TIMD4 (1.6)	ENSG00000254235 (1.5)	FRK (1.4)	CETP (1.4)	ATXN7L2 (1.4)	C12orf43 (1.2)	DYNC2LI1 (1.2)	MAFB (1.2)
ENSG00000011007	TCEB3 PPI subnetwork	0.70	> 0.20	BUD13 (3.2)	SUGP1 (3.1)	ZNF259 (2.3)	DHX38 (2.2)	DNM2 (2.1)	PSMA5 (2.0)	MAU2 (2.0)	TOP1 (1.9)	TRAPPC6A (1.8)	MAPKAPK5 (1.7)
MP:0000166	abnormal chondrocyte morphology	0.70	> 0.20	CILP2 (8.2)	PLEKHH2 (4.0)	MAFB (1.7)	PLEC (1.4)	LDLR (1.4)	KIAA1324 (1.4)	SLC22A1 (1.2)	ACAD10 (1.1)	ALDH2 (1.1)	HNF1A (1.0)
GO:0006893	Golgi to plasma membrane transport	0.70	> 0.20	FRK (3.1)	USP24 (2.6)	C17orf57 (2.3)	ZNF180 (2.1)	MAU2 (1.9)	NKPD1 (1.8)	AP1M2 (1.7)	BLOC1S3 (1.6)	TMEM57 (1.5)	PBX4 (1.5)
GO:0048844	artery morphogenesis	0.70	> 0.20	CEACAM19 (3.0)	BLOC1S3 (1.9)	FRK (1.9)	TSSK6 (1.7)	ATXN7L2 (1.6)	NYNRIN (1.6)	ALDH2 (1.4)	MYLIP (1.4)	KANK2 (1.4)	TMEM57 (1.3)
MP:0004522	abnormal orientation of cochlear hair cell stereociliary bundles	0.70	> 0.20	NYNRIN (5.1)	HNF1A (3.2)	PLEC (2.4)	GRINA (2.3)	MARK4 (2.3)	PVRL2 (1.8)	MAFB (1.6)	C12orf51 (1.6)	BCAM (1.5)	ABO (1.5)
GO:0055001	muscle cell development	0.70	> 0.20	SYPL2 (4.6)	ENSG00000226648 (2.6)	ANKRD31 (2.1)	CEACAM19 (2.0)	KANK2 (1.9)	GMPR (1.8)	OGDH (1.8)	HNF1A (1.7)	AMIGO1 (1.2)	ATXN7L2 (1.2)
MP:0004632	abnormal cochlear OHC efferent innervation pattern	0.70	> 0.20	ST3GAL4 (2.4)	C11orf9 (2.1)	NCAN (2.0)	APOE (1.9)	MAFB (1.6)	GCNT4 (1.4)	MOSC1 (1.3)	NKPD1 (1.3)	HAVCR1 (1.3)	CEACAM19 (1.2)
GO:0010800	positive regulation of peptidyl-threonine phosphorylation	0.70	> 0.20	FRK (2.5)	CYB561D1 (2.0)	ENSG00000226645 (1.9)	C17orf57 (1.7)	GCNT4 (1.6)	DNAH11 (1.4)	ZHX3 (1.3)	COL4A3BP (1.2)	DOCK7 (1.1)	LPIN3 (1.1)
MP:0005542	corneal vascularization	0.70	> 0.20	LPA (3.9)	NCAN (1.9)	ANGPTL3 (1.9)	UBXN2B (1.9)	PLCG1 (1.8)	GPAM (1.6)	ENSG00000226648 (1.5)	GRINA (1.5)	SLC22A1 (1.4)	ENSG00000254235 (1.3)
ENSG00000127947	PTPN12 PPI subnetwork	0.70	> 0.20	GMIP (3.2)	TRAFD1 (3.1)	SH2B3 (2.7)	HAPLN4 (2.3)	SLC44A2 (2.0)	DNM2 (1.9)	ENSG00000238078 (1.7)	CARM1 (1.6)	GPAM (1.6)	GATAD2A (1.5)
MP:0002081	perinatal lethality	0.70	> 0.20	MYLIP (2.8)	MAFB (2.7)	TMEM57 (1.9)	NYNRIN (1.8)	HMGCR (1.7)	CILP2 (1.5)	KIAA1324 (1.4)	CYB561D1 (1.3)	PBX4 (1.3)	PSRC1 (1.3)
ENSG00000136738	STAM PPI subnetwork	0.70	> 0.20	DNM2 (3.0)	C1orf63 (3.0)	USP24 (2.2)	DOCK7 (2.0)	GRINA (2.0)	CARM1 (1.9)	SH2B3 (1.9)	GMIP (1.8)	MARK4 (1.8)	MAU2 (1.7)
ENSG00000174766	ENSG00000174766 PPI subnetwork	0.70	> 0.20	ZNF259 (4.2)	NAA25 (3.4)	DDX56 (2.9)	DHODH (2.5)	NKPD1 (2.5)	QTRT1 (2.3)	TOMM40 (2.2)	ADAM1 (2.0)	DHX38 (1.7)	DYNC2LI1 (1.6)
ENSG00000212802	ENSG00000212802 PPI subnetwork	0.70	> 0.20	ZNF259 (4.2)	NAA25 (3.4)	DDX56 (2.9)	DHODH (2.5)	NKPD1 (2.5)	QTRT1 (2.3)	TOMM40 (2.2)	ADAM1 (2.0)	DHX38 (1.7)	DYNC2LI1 (1.6)
GO:0006511	ubiquitin-dependent protein catabolic process	0.70	> 0.20	BRAP (3.4)	TRAFD1 (2.4)	TMEM57 (2.4)	USP24 (2.2)	NAA25 (2.2)	ZNF180 (2.2)	MAU2 (2.0)	DHX38 (1.8)	PSMA5 (1.7)	BUD13 (1.7)
GO:0001894	tissue homeostasis	0.70	> 0.20	CILP2 (2.8)	DNAH11 (2.6)	SLC44A2 (2.3)	TMEM116 (1.9)	KIAA1324 (1.7)	ENSG00000226645 (1.7)	RHCE (1.3)	POLK (1.2)	TSSK6 (1.2)	ITGB3 (1.1)
ENSG00000213066	FGFR1OP PPI subnetwork	0.70	> 0.20	COL4A3BP (4.0)	GATAD2A (2.8)	TMEM50A (2.8)	SMARCA4 (1.8)	C19orf52 (1.8)	PSMA5 (1.8)	ENSG00000238078 (1.6)	POLK (1.6)	ALDH2 (1.6)	RHD (1.4)
REACTOME_PI:3K_CASCADE	REACTOME_PI:3K_CASCADE	0.70	> 0.20	ZHX3 (3.3)	PTPN11 (2.8)	HAPLN4 (1.9)	PLEKHH2 (1.8)	ZNF180 (1.8)	PVR (1.7)	CLPTM1 (1.7)	GPAM (1.7)	ENSG00000226645 (1.5)	PPP1R37 (1.4)
ENSG00000069248	NUP133 PPI subnetwork	0.70	> 0.20	PSRC1 (5.3)	FEN1 (4.2)	USP1 (3.9)	POC5 (3.7)	ILF3 (1.5)	ENSG00000226648 (1.3)	ENSG00000228044 (1.0)	USP24 (0.9)	BUD13 (0.9)	TMEM116 (0.8)
ENSG00000089685	BIRC5 PPI subnetwork	0.70	> 0.20	PSRC1 (5.5)	FEN1 (4.6)	USP1 (3.6)	POC5 (3.4)	ENSG00000226648 (1.1)	ZNF180 (1.0)	ENSG00000228044 (0.9)	ZHX3 (0.8)	PBX4 (0.6)	ILF3 (0.6)
GO:0051028	mRNA transport	0.70	> 0.20	C1orf63 (3.3)	ILF3 (2.8)	TOP1 (2.6)	USP24 (2.4)	DHODH (2.3)	NAA25 (2.3)	DOCK7 (2.2)	MAPKAPK5 (2.2)	POC5 (2.0)	DHX38 (1.9)
ENSG00000134371	CDC73 PPI subnetwork	0.70	> 0.20	TMEM57 (2.9)	MARK4 (2.5)	ATXN7L2 (2.4)	PPP1R37 (2.4)	TRAFD1 (2.3)	ATXN2 (2.3)	CARM1 (1.8)	SMARCA4 (1.8)	ENSG00000235545 (1.6)	AMIGO1 (1.6)
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	0.70	> 0.20	MARK4 (2.4)	PSRC1 (2.1)	GEMIN7 (2.0)	DNM2 (1.9)	MAPKAPK5 (1.8)	PBX4 (1.7)	PSMA5 (1.7)	CARM1 (1.7)	BLOC1S3 (1.7)	TMEM50A (1.6)
ENSG00000164086	DUSP7 PPI subnetwork	0.70	> 0.20	PLCG1 (2.6)	TMEM57 (2.6)	PMFBP1 (2.5)	MAPKAPK5 (1.9)	PBX4 (1.6)	TOMM40 (1.6)	GCNT4 (1.6)	KIAA1324 (1.4)	MYLIP (1.3)	NAA25 (1.3)
ENSG00000163539	CLASP2 PPI subnetwork	0.70	> 0.20	PSRC1 (5.8)	FEN1 (4.2)	POC5 (3.1)	USP1 (2.9)	ZNF180 (1.5)	AP1M2 (1.4)	DNAH11 (1.1)	C12orf43 (1.0)	C11orf9 (1.0)	HAPLN4 (1.0)
GO:0042692	muscle cell differentiation	0.70	> 0.20	SYPL2 (3.8)	ANKRD31 (2.7)	HNF1A (2.4)	KANK2 (2.1)	GMPR (1.9)	BCAM (1.7)	ATXN7L2 (1.5)	CEACAM19 (1.5)	NYNRIN (1.5)	OGDH (1.3)
GO:0008083	growth factor activity	0.70	> 0.20	PVR (3.7)	PLEKHH2 (1.8)	SLC22A1 (1.8)	ENSG00000226645 (1.6)	TIMD4 (1.5)	BCAM (1.4)	ENSG00000228044 (1.4)	KANK2 (1.3)	APOC4 (1.3)	TMED4 (1.3)
MP:0003932	abnormal molar crown morphology	0.70	> 0.20	ST3GAL4 (2.4)	ENSG00000235545 (2.3)	MYLIP (2.1)	BCAM (2.0)	GCNT4 (1.9)	SORT1 (1.7)	HNF1A (1.6)	COL4A3BP (1.6)	CELSR2 (1.6)	NKPD1 (1.4)
ENSG00000079335	CDC14A PPI subnetwork	0.70	> 0.20	ZNF259 (4.7)	DDX56 (4.5)	TOMM40 (3.4)	NAA25 (3.3)	QTRT1 (3.0)	DHODH (2.3)	ADAM1 (2.3)	ENSG00000226645 (2.1)	C12orf43 (2.0)	ACAD10 (1.8)
GO:0022602	ovulation cycle process	0.70	> 0.20	AMIGO1 (2.1)	ABO (2.1)	ST3GAL4 (2.0)	KIAA1324 (2.0)	CEACAM19 (1.9)	ENSG00000235545 (1.9)	YIPF2 (1.7)	DNAH11 (1.7)	FRK (1.7)	GPAM (1.4)
GO:0042088	T-helper 1 type immune response	0.70	> 0.20	PBX4 (2.3)	CETP (2.2)	ENSG00000235545 (2.0)	ST3GAL4 (2.0)	BLOC1S3 (1.9)	ZNF180 (1.8)	ZNF101 (1.6)	TIMD4 (1.5)	GRINA (1.5)	PVR (1.4)
REACTOME_CLASS_A1_RHODOPSIN:LIKE_RECEPTORS	REACTOME_CLASS_A1_RHODOPSIN:LIKE_RECEPTORS	0.70	> 0.20	KIAA1324 (2.7)	CETP (2.2)	MAFB (2.0)	C12orf47 (1.9)	ENSG00000235545 (1.9)	HLX (1.7)	ABO (1.5)	RELB (1.4)	GMIP (1.4)	TRIB1 (1.4)
ENSG00000079805	DNM2 PPI subnetwork	0.70	> 0.20	DNM2 (2.4)	DOCK7 (2.3)	C12orf51 (2.1)	CETP (1.8)	RHD (1.8)	SH2B3 (1.7)	SARS (1.7)	ITGB3 (1.7)	SYPL2 (1.6)	GRINA (1.6)
ENSG00000153071	DAB2 PPI subnetwork	0.70	> 0.20	DNM2 (2.6)	PLEC (2.5)	GMIP (2.3)	AP1M2 (2.3)	GATAD2A (1.9)	HMGCR (1.9)	MAFB (1.9)	SH2B3 (1.9)	SLC44A2 (1.8)	PPP1R37 (1.7)
ENSG00000114812	VIPR1 PPI subnetwork	0.70	> 0.20	HLX (2.5)	AMIGO1 (2.5)	BCAM (2.0)	ZHX3 (1.7)	RPH3A (1.5)	ABO (1.5)	ZNF180 (1.3)	PCSK9 (1.3)	HAPLN4 (1.3)	ERP29 (1.3)
GO:0055012	ventricular cardiac muscle cell differentiation	0.70	> 0.20	CEACAM19 (2.5)	TXNL4B (2.4)	SLC22A1 (1.7)	PSRC1 (1.6)	HNF1A (1.6)	ENSG00000254235 (1.2)	LPA (1.2)	PLEC (1.1)	POLK (1.0)	SH2B3 (1.0)
REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION	REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION	0.70	> 0.20	GEMIN7 (3.8)	ZNF259 (3.7)	C12orf43 (2.6)	QTRT1 (2.1)	ADAM1 (2.0)	ENSG00000226645 (1.9)	DDX56 (1.9)	MAPKAPK5 (1.8)	ZHX3 (1.8)	TOMM40 (1.7)
GO:0072657	protein localization in membrane	0.70	> 0.20	CELSR2 (2.8)	AP1M2 (2.7)	PPP1R37 (2.4)	HAVCR1 (2.2)	BCAM (2.1)	PTPN11 (2.1)	LPIN3 (2.0)	CBLC (2.0)	TSSK6 (1.8)	ZHX3 (1.6)
ENSG00000135750	KCNK1 PPI subnetwork	0.70	> 0.20	MAU2 (3.3)	ENSG00000226648 (2.7)	C19orf52 (2.6)	TMEM116 (2.2)	DNM2 (2.1)	MYLIP (2.0)	UBXN2B (2.0)	ATP13A1 (1.9)	DNAH11 (1.9)	SARS (1.9)
GO:0090277	positive regulation of peptide hormone secretion	0.70	> 0.20	KIAA1324 (3.1)	ANKRD31 (2.7)	NPC1L1 (2.3)	ENSG00000254235 (2.1)	HNF1A (1.8)	ABCG8 (1.7)	C12orf47 (1.7)	PLEKHH2 (1.4)	COL4A3BP (1.4)	FRK (1.3)
ENSG00000131773	KHDRBS3 PPI subnetwork	0.70	> 0.20	ADAM1 (3.2)	PPP1R37 (2.6)	YIPF2 (2.4)	ACAD10 (2.2)	BUD13 (2.1)	BRAP (1.7)	CEACAM19 (1.7)	PARP10 (1.7)	LPIN3 (1.6)	C1orf63 (1.6)
GO:0043968	histone H2A acetylation	0.70	> 0.20	ADAM1 (3.5)	ZNF180 (2.6)	BRAP (2.6)	USP24 (2.4)	MAPKAPK5 (2.3)	C12orf43 (2.2)	GEMIN7 (1.9)	SUGP1 (1.8)	BUD13 (1.8)	DYNC2LI1 (1.7)
ENSG00000115241	PPM1G PPI subnetwork	0.70	> 0.20	ERP29 (4.1)	TOMM40 (2.6)	DOCK7 (2.4)	ATP13A1 (2.1)	NAA25 (1.9)	CLPTM1 (1.8)	TMEM50A (1.7)	PLEC (1.7)	TRAPPC6A (1.7)	TMEM57 (1.4)
ENSG00000183873	SCN5A PPI subnetwork	0.70	> 0.20	ITGB3 (2.4)	LPIN3 (2.2)	NYNRIN (2.1)	POC5 (1.7)	GPAM (1.7)	ZHX3 (1.6)	PBX4 (1.5)	TSSK6 (1.5)	UBXN2B (1.5)	GMPR (1.4)
ENSG00000105662	CRTC1 PPI subnetwork	0.70	> 0.20	PLEC (3.6)	DNM2 (3.0)	ZHX3 (2.9)	CARM1 (2.9)	ATXN2 (2.5)	USP24 (2.4)	C12orf51 (2.4)	LPAR2 (2.3)	COL4A3BP (2.3)	C11orf9 (2.3)
GO:0001533	cornified envelope	0.70	> 0.20	NKPD1 (4.6)	CEACAM19 (2.5)	CBLC (2.3)	CELSR2 (1.7)	ENSG00000226648 (1.5)	C17orf57 (1.4)	BCAM (1.3)	AP1M2 (1.3)	HAVCR1 (1.3)	PMFBP1 (1.3)
GO:0050864	regulation of B cell activation	0.70	> 0.20	DNAH11 (2.9)	PBX4 (2.6)	GCNT4 (2.2)	C17orf57 (1.7)	NT5DC1 (1.5)	ENSG00000226645 (1.4)	POLK (1.4)	GMIP (1.3)	ZNF101 (1.0)	TIMD4 (1.0)
GO:0032872	regulation of stress-activated MAPK cascade	0.70	> 0.20	ENSG00000235545 (2.4)	MAU2 (2.3)	MYLIP (1.9)	LPIN3 (1.7)	DYNC2LI1 (1.4)	C17orf57 (1.3)	HLX (1.3)	BRAP (1.3)	POC5 (1.2)	ABCG8 (1.2)
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	0.70	> 0.20	NKPD1 (2.9)	ATP13A1 (2.0)	ANKRD31 (2.0)	QTRT1 (2.0)	DDX56 (1.9)	SARS (1.9)	GATAD2A (1.7)	TMEM57 (1.7)	ILF3 (1.7)	ZNF259 (1.6)
MP:0004751	increased length of allograft survival	0.70	> 0.20	PBX4 (1.9)	CYB561D1 (1.9)	UBXN2B (1.8)	GMIP (1.6)	ENSG00000235545 (1.5)	ENSG00000228044 (1.5)	CEACAM19 (1.4)	ENSG00000226645 (1.3)	ZNF101 (1.3)	HLX (1.2)
ENSG00000197728	RPS26 PPI subnetwork	0.70	> 0.20	NKPD1 (2.8)	QTRT1 (2.3)	SUGP1 (2.3)	ILF3 (2.2)	TOP1 (2.2)	DHX38 (2.1)	ADAM1 (2.0)	C12orf43 (2.0)	SARS (1.8)	DDX56 (1.7)
ENSG00000196656	ENSG00000196656 PPI subnetwork	0.70	> 0.20	NKPD1 (2.8)	QTRT1 (2.3)	SUGP1 (2.3)	ILF3 (2.2)	TOP1 (2.2)	DHX38 (2.1)	ADAM1 (2.0)	C12orf43 (2.0)	SARS (1.8)	DDX56 (1.7)
ENSG00000159461	AMFR PPI subnetwork	0.70	> 0.20	USP24 (4.3)	COL4A3BP (3.4)	TMEM57 (2.5)	CARM1 (2.2)	SUGP1 (1.9)	DOCK7 (1.8)	ATXN2 (1.8)	SARS (1.7)	MAU2 (1.7)	DHX38 (1.5)
MP:0001183	overexpanded pulmonary alveoli	0.70	> 0.20	TMEM116 (2.9)	DYNC2LI1 (2.6)	BCAM (2.5)	PLEKHH2 (2.5)	ZHX3 (2.2)	ERP29 (2.1)	NYNRIN (2.1)	KIAA1324 (1.7)	PLEC (1.6)	SLC44A2 (1.6)
ENSG00000160584	SIK3 PPI subnetwork	0.70	> 0.20	MARK4 (3.4)	C12orf51 (3.3)	GMIP (2.4)	USP24 (2.4)	ATXN2 (2.1)	SLC44A2 (1.9)	LPAR2 (1.7)	GRINA (1.7)	PTPN11 (1.6)	ZNF180 (1.6)
GO:0008242	omega peptidase activity	0.70	> 0.20	TOMM40 (2.6)	CEACAM19 (2.5)	CLPTM1 (2.4)	TRAPPC6A (2.3)	ZNF180 (2.1)	GRINA (2.1)	UBXN2B (1.9)	TSSK6 (1.9)	HAVCR1 (1.5)	CARM1 (1.4)
GO:0035115	embryonic forelimb morphogenesis	0.70	> 0.20	MYLIP (2.5)	ABO (2.2)	TSSK6 (2.1)	NYNRIN (1.9)	ATXN2 (1.8)	DYNC2LI1 (1.8)	FRK (1.7)	DNAH11 (1.6)	C19orf52 (1.5)	LPIN3 (1.3)
ENSG00000159176	CSRP1 PPI subnetwork	0.70	> 0.20	SORT1 (2.6)	AMIGO1 (2.1)	DOCK7 (1.9)	BRAP (1.7)	ENSG00000235545 (1.6)	POC5 (1.4)	TXNL4B (1.3)	ACAD10 (1.2)	NT5DC1 (1.2)	NKPD1 (1.2)
ENSG00000164687	FABP5 PPI subnetwork	0.70	> 0.20	C11orf9 (3.1)	HAPLN4 (2.9)	ZNF101 (2.5)	NCAN (2.3)	PSRC1 (2.0)	POC5 (1.9)	MOSC1 (1.9)	ST3GAL4 (1.8)	ALDH2 (1.7)	TRAFD1 (1.7)
GO:0051236	establishment of RNA localization	0.70	> 0.20	C1orf63 (3.3)	ADAM1 (2.9)	MAPKAPK5 (2.8)	ILF3 (2.7)	NAA25 (2.6)	TOP1 (2.5)	POC5 (2.3)	USP24 (2.2)	DOCK7 (2.0)	C12orf51 (1.9)
GO:0050657	nucleic acid transport	0.70	> 0.20	C1orf63 (3.3)	ADAM1 (2.9)	MAPKAPK5 (2.8)	ILF3 (2.7)	NAA25 (2.6)	TOP1 (2.5)	POC5 (2.3)	USP24 (2.2)	DOCK7 (2.0)	C12orf51 (1.9)
GO:0050658	RNA transport	0.70	> 0.20	C1orf63 (3.3)	ADAM1 (2.9)	MAPKAPK5 (2.8)	ILF3 (2.7)	NAA25 (2.6)	TOP1 (2.5)	POC5 (2.3)	USP24 (2.2)	DOCK7 (2.0)	C12orf51 (1.9)
GO:0000159	protein phosphatase type 2A complex	0.70	> 0.20	MARK4 (3.3)	CEACAM19 (3.1)	CLPTM1 (2.8)	TOMM40 (2.6)	CARM1 (2.3)	ENSG00000226645 (2.1)	PPP1R37 (1.8)	CBLC (1.8)	OGDH (1.8)	ZNF180 (1.8)
ENSG00000119421	NDUFA8 PPI subnetwork	0.70	> 0.20	OGDH (3.9)	ACAD10 (3.3)	TRAPPC6A (2.3)	MAU2 (2.2)	C12orf47 (2.0)	ATP13A1 (1.9)	PSMA5 (1.7)	TOMM40 (1.4)	YIPF2 (1.4)	TMED4 (1.3)
MP:0005012	decreased eosinophil cell number	0.70	> 0.20	BCL3 (2.2)	HP (1.9)	HLX (1.6)	GMIP (1.4)	TOP1 (1.2)	RHCE (1.2)	TRIB1 (1.1)	NT5DC1 (1.1)	RHD (1.1)	GCNT4 (1.1)
GO:0030261	chromosome condensation	0.70	> 0.20	TSSK6 (5.7)	PMFBP1 (4.3)	PSRC1 (3.1)	ENSG00000228044 (2.0)	DNAH11 (2.0)	ENSG00000226648 (1.8)	MAU2 (1.6)	ACAD10 (1.5)	USP1 (1.5)	AMIGO1 (1.4)
ENSG00000160783	PMF1 PPI subnetwork	0.70	> 0.20	PSRC1 (6.0)	FEN1 (4.0)	POC5 (3.8)	USP1 (3.4)	ENSG00000228044 (1.2)	ACAD10 (0.9)	ZNF180 (0.9)	APOE (0.8)	ENSG00000226648 (0.8)	TMEM116 (0.7)
GO:0060445	branching involved in salivary gland morphogenesis	0.70	> 0.20	TSSK6 (2.7)	PLEKHH2 (2.7)	GCNT4 (2.3)	BCAM (2.3)	HAVCR1 (1.9)	PVR (1.6)	ENSG00000226645 (1.5)	C12orf47 (1.5)	CELSR2 (1.3)	LPAR2 (1.3)
MP:0000627	abnormal mammary gland morphology	0.70	> 0.20	LPAR2 (1.8)	ATXN7L2 (1.8)	ABO (1.7)	CEACAM19 (1.6)	AP1M2 (1.6)	CELSR2 (1.5)	HAVCR1 (1.5)	MOSC1 (1.3)	APOE (1.3)	ENSG00000238078 (1.2)
ENSG00000100490	CDKL1 PPI subnetwork	0.70	> 0.20	MAU2 (2.8)	SORT1 (2.6)	PBX4 (2.5)	ENSG00000238078 (2.5)	LPAR2 (2.4)	GATAD2A (2.2)	NYNRIN (2.2)	ENSG00000235545 (2.1)	TMEM57 (1.8)	MARK4 (1.7)
ENSG00000147604	RPL7 PPI subnetwork	0.70	> 0.20	C1orf63 (2.7)	PLEC (2.4)	PTPN11 (2.0)	ILF3 (1.8)	UBXN2B (1.7)	ADAM1 (1.6)	TRAFD1 (1.6)	SARS (1.6)	HMGCR (1.5)	SMARCA4 (1.4)
GO:0001667	ameboidal cell migration	0.70	> 0.20	KANK2 (2.6)	ABO (2.5)	C17orf57 (2.1)	PLEKHH2 (2.0)	DOCK7 (1.9)	COL4A3BP (1.8)	ENSG00000226648 (1.7)	ENSG00000254235 (1.7)	ENSG00000235545 (1.6)	TSSK6 (1.5)
ENSG00000116141	MARK1 PPI subnetwork	0.70	> 0.20	CBLC (5.6)	AP1M2 (3.5)	CELSR2 (3.1)	LPIN3 (2.8)	LPAR2 (2.7)	PMFBP1 (1.9)	PVRL2 (1.9)	PLCG1 (1.8)	PSRC1 (1.7)	FRK (1.7)
ENSG00000170004	CHD3 PPI subnetwork	0.70	> 0.20	ILF3 (2.8)	SMARCA4 (2.6)	C1orf63 (2.1)	USP1 (2.1)	CARM1 (1.6)	PARP10 (1.6)	NT5DC1 (1.4)	PCSK9 (1.4)	TOP1 (1.4)	TMEM57 (1.4)
GO:0019321	pentose metabolic process	0.70	> 0.20	TRAPPC6A (3.4)	NT5DC1 (2.5)	BLOC1S3 (2.2)	DNAH11 (2.1)	LPAR2 (1.9)	C1orf63 (1.9)	ACAD10 (1.7)	ERP29 (1.5)	ALDH2 (1.5)	PBX4 (1.4)
ENSG00000101336	HCK PPI subnetwork	0.70	> 0.20	GMIP (4.1)	SH2B3 (3.5)	SLC44A2 (2.3)	MAFB (2.2)	DOCK7 (2.1)	DNAH11 (2.0)	GATAD2A (2.0)	DNM2 (1.9)	HLX (1.8)	USP24 (1.7)
ENSG00000196531	NACA PPI subnetwork	0.70	> 0.20	ZNF259 (3.5)	NAA25 (2.9)	DDX56 (2.9)	TOMM40 (2.6)	ADAM1 (2.3)	MAFB (2.1)	TRIB1 (2.1)	TOP1 (2.0)	DHODH (2.0)	QTRT1 (1.8)
GO:0046467	membrane lipid biosynthetic process	0.70	> 0.20	HAVCR1 (3.8)	NKPD1 (3.7)	CYB561D1 (2.9)	TMEM50A (2.6)	SLC44A2 (2.4)	COL4A3BP (2.3)	LPIN3 (2.1)	ZHX3 (1.7)	ATP13A1 (1.6)	AMIGO1 (1.5)
ENSG00000175333	ENSG00000175333 PPI subnetwork	0.70	> 0.20	ZNF259 (2.9)	DDX56 (2.7)	SUGP1 (2.1)	DHODH (2.0)	NKPD1 (1.9)	CEACAM19 (1.8)	QTRT1 (1.7)	DNAH11 (1.7)	NAA25 (1.7)	GATAD2A (1.6)
ENSG00000197275	RAD54B PPI subnetwork	0.70	> 0.20	DNAH11 (3.0)	BLOC1S3 (1.9)	BRAP (1.8)	MYLIP (1.7)	TRAPPC6A (1.6)	NKPD1 (1.6)	ABO (1.5)	CLPTM1 (1.4)	TMEM116 (1.3)	TRAFD1 (1.2)
GO:0006378	mRNA polyadenylation	0.70	> 0.20	UBXN2B (2.6)	ADAM1 (2.0)	DOCK7 (2.0)	ATP13A1 (1.9)	TSSK6 (1.9)	NT5DC1 (1.9)	ZNF180 (1.8)	ATXN7L2 (1.5)	HAVCR1 (1.5)	MAPKAPK5 (1.4)
GO:0034121	regulation of toll-like receptor signaling pathway	0.70	> 0.20	PMFBP1 (3.2)	ENSG00000228044 (2.5)	FRK (2.4)	LPAR2 (1.9)	MYLIP (1.7)	DNAH11 (1.4)	DHODH (1.3)	UBXN2B (1.3)	CEACAM19 (1.2)	AMIGO1 (1.2)
MP:0011501	increased glomerular capsule space	0.70	> 0.20	PLEKHH2 (2.7)	KANK2 (2.7)	GMPR (2.6)	BCAM (2.3)	ATXN7L2 (2.1)	C11orf9 (2.0)	HAVCR1 (1.9)	HLX (1.7)	FRK (1.6)	NPC1L1 (1.6)
GO:0000777	condensed chromosome kinetochore	0.70	> 0.20	PSRC1 (5.9)	FEN1 (4.1)	POC5 (4.0)	USP1 (3.4)	ILF3 (0.9)	BUD13 (0.9)	C12orf43 (0.8)	ENSG00000228044 (0.8)	PBX4 (0.8)	GCNT4 (0.8)
GO:0030517	negative regulation of axon extension	0.70	> 0.20	GCNT4 (2.8)	C17orf57 (2.5)	PLEKHH2 (2.3)	DYNC2LI1 (2.0)	PMFBP1 (1.9)	ANKRD31 (1.8)	CYB561D1 (1.7)	TMEM57 (1.7)	ENSG00000254235 (1.7)	DNAH11 (1.7)
MP:0005238	increased brain size	0.70	> 0.20	UBXN2B (3.2)	CELSR2 (2.3)	HNF1A (2.1)	ATXN2 (1.9)	ENSG00000254235 (1.9)	GRINA (1.9)	MAU2 (1.8)	PLEC (1.7)	NAA25 (1.6)	NT5DC1 (1.5)
GO:0060231	mesenchymal to epithelial transition	0.70	> 0.20	ENSG00000238078 (2.5)	NYNRIN (2.3)	PLEKHH2 (2.1)	PMFBP1 (1.9)	HNF1A (1.8)	C11orf9 (1.8)	BCAM (1.7)	TMED4 (1.6)	ABO (1.6)	C17orf57 (1.5)
GO:0051000	positive regulation of nitric-oxide synthase activity	0.70	> 0.20	ST3GAL4 (2.2)	ATXN7L2 (2.1)	ENSG00000226645 (1.8)	TRAPPC6A (1.6)	APOC1 (1.5)	ENSG00000235545 (1.4)	PLCG1 (1.4)	NT5DC1 (1.3)	TMEM116 (1.2)	PVR (1.1)
REACTOME_DEADENYLATION_OF_MRNA	REACTOME_DEADENYLATION_OF_MRNA	0.70	> 0.20	MAPKAPK5 (3.5)	ILF3 (2.6)	BUD13 (2.4)	NT5DC1 (2.2)	ADAM1 (2.0)	BRAP (1.9)	ATXN2 (1.9)	TOP1 (1.6)	PPP1R37 (1.5)	ATXN7L2 (1.5)
GO:0045687	positive regulation of glial cell differentiation	0.70	> 0.20	ENSG00000254235 (3.6)	ABO (2.8)	HAPLN4 (2.4)	NCAN (2.2)	HAVCR1 (2.0)	CEACAM19 (1.9)	ANKRD31 (1.6)	DNAH11 (1.4)	ENSG00000228044 (1.3)	NKPD1 (1.2)
GO:0032993	protein-DNA complex	0.71	> 0.20	TSSK6 (3.2)	USP1 (2.7)	FEN1 (2.6)	MYLIP (1.7)	PMFBP1 (1.6)	PSRC1 (1.6)	KANK2 (1.5)	POLK (1.5)	GMPR (1.2)	TMEM57 (1.2)
REACTOME_GLOBAL_GENOMIC_NER_GG:NER	REACTOME_GLOBAL_GENOMIC_NER_GG:NER	0.71	> 0.20	FEN1 (5.2)	USP1 (4.3)	ZNF180 (2.4)	NT5DC1 (2.3)	GOT2P1 (1.9)	TRAPPC6A (1.8)	SUGP1 (1.8)	ENSG00000235545 (1.7)	PPP1R37 (1.7)	ENSG00000226648 (1.6)
ENSG00000121621	KIF18A PPI subnetwork	0.71	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ENSG00000228044 (1.1)	ZNF180 (1.1)	ENSG00000226648 (0.9)	ZHX3 (0.7)	LPIN3 (0.7)	USP24 (0.6)
GO:0051352	negative regulation of ligase activity	0.71	> 0.20	PSMA5 (3.8)	TRAFD1 (2.3)	SUGP1 (2.3)	NAA25 (2.1)	POC5 (1.9)	NT5DC1 (1.8)	DDX56 (1.8)	LPIN3 (1.6)	TMEM50A (1.5)	BRAP (1.4)
GO:0051444	negative regulation of ubiquitin-protein ligase activity	0.71	> 0.20	PSMA5 (3.8)	TRAFD1 (2.3)	SUGP1 (2.3)	NAA25 (2.1)	POC5 (1.9)	NT5DC1 (1.8)	DDX56 (1.8)	LPIN3 (1.6)	TMEM50A (1.5)	BRAP (1.4)
GO:0048009	insulin-like growth factor receptor signaling pathway	0.71	> 0.20	ANKRD31 (3.9)	KIAA1324 (3.9)	PPP1R37 (2.5)	ENSG00000238078 (2.3)	ATXN7L2 (2.0)	MYLIP (1.9)	CYP7A1 (1.7)	BLOC1S3 (1.3)	CILP2 (1.3)	ENSG00000254235 (1.2)
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE:DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE:DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP	0.71	> 0.20	NPC1L1 (4.0)	ABCG5 (3.9)	TMED4 (3.1)	ERP29 (3.0)	KIAA1324 (2.9)	C11orf9 (2.8)	TMEM50A (2.7)	ABCG8 (2.7)	TM6SF2 (2.3)	YIPF2 (1.9)
GO:0008135	translation factor activity, nucleic acid binding	0.71	> 0.20	SARS (4.2)	C12orf43 (3.5)	TMEM57 (3.4)	DDX56 (2.9)	ZNF259 (2.8)	SUGP1 (2.5)	PSMA5 (2.4)	PTPN11 (2.1)	BRAP (1.9)	ATXN2 (1.8)
GO:0048640	negative regulation of developmental growth	0.71	> 0.20	C17orf57 (2.9)	PLEKHH2 (2.4)	DYNC2LI1 (2.1)	ANKRD31 (1.9)	CEACAM19 (1.9)	C12orf47 (1.8)	NYNRIN (1.8)	ATXN7L2 (1.8)	GCNT4 (1.8)	TMEM57 (1.7)
GO:0090192	regulation of glomerulus development	0.71	> 0.20	AMIGO1 (4.1)	CILP2 (2.7)	ENSG00000226645 (2.3)	BCAM (2.2)	PMFBP1 (2.1)	C11orf9 (1.7)	ATXN7L2 (1.5)	DNAH11 (1.5)	ZNF101 (1.5)	ANKRD31 (1.4)
ENSG00000006634	DBF4 PPI subnetwork	0.71	> 0.20	FEN1 (6.8)	USP1 (4.9)	DHODH (1.7)	ENSG00000235545 (1.4)	NT5DC1 (1.3)	TMEM116 (1.3)	POC5 (1.1)	ENSG00000226645 (1.0)	AMIGO1 (1.0)	GOT2P1 (1.0)
GO:0001823	mesonephros development	0.71	> 0.20	BCAM (3.1)	AP1M2 (2.6)	HNF1A (2.6)	ABO (2.5)	NYNRIN (2.3)	PLEKHH2 (1.8)	C11orf9 (1.7)	ZHX3 (1.7)	MYLIP (1.6)	PMFBP1 (1.6)
ENSG00000105464	GRIN2D PPI subnetwork	0.71	> 0.20	RPH3A (4.1)	PPP1R37 (2.4)	PLCG1 (2.3)	FRK (2.2)	ZHX3 (2.2)	LPIN3 (2.2)	C11orf9 (1.9)	TMEM116 (1.8)	C17orf57 (1.8)	ABO (1.7)
GO:0001916	positive regulation of T cell mediated cytotoxicity	0.71	> 0.20	PARP10 (2.4)	ZNF180 (2.1)	LPIN3 (2.0)	NKPD1 (1.6)	ADAM1 (1.6)	CEACAM19 (1.5)	NAA25 (1.4)	TMED4 (1.4)	ENSG00000235545 (1.4)	PVR (1.3)
ENSG00000140368	PSTPIP1 PPI subnetwork	0.71	> 0.20	GMIP (2.7)	LDLR (2.2)	HMGCR (2.1)	TOP1 (1.7)	ENSG00000226645 (1.5)	NAA25 (1.5)	C17orf57 (1.4)	ANKRD31 (1.4)	TRAPPC6A (1.4)	FRK (1.3)
GO:0000737	DNA catabolic process, endonucleolytic	0.71	> 0.20	POLK (2.9)	ENSG00000226645 (2.6)	ST3GAL4 (2.1)	AMIGO1 (1.9)	C19orf52 (1.8)	ERP29 (1.7)	ENSG00000238078 (1.7)	TRAPPC6A (1.6)	PCSK9 (1.5)	LPAR2 (1.4)
GO:0006309	apoptotic DNA fragmentation	0.71	> 0.20	POLK (2.9)	ENSG00000226645 (2.6)	ST3GAL4 (2.1)	AMIGO1 (1.9)	C19orf52 (1.8)	ERP29 (1.7)	ENSG00000238078 (1.7)	TRAPPC6A (1.6)	PCSK9 (1.5)	LPAR2 (1.4)
GO:0006513	protein monoubiquitination	0.71	> 0.20	DNAH11 (2.5)	GCNT4 (2.0)	TRAFD1 (1.8)	PARP10 (1.7)	UBXN2B (1.7)	DYNC2LI1 (1.7)	CYB561D1 (1.6)	TOP1 (1.4)	BRAP (1.4)	ANKRD31 (1.4)
ENSG00000148737	TCF7L2 PPI subnetwork	0.71	> 0.20	PLCG1 (3.0)	DHODH (2.4)	SMARCA4 (2.3)	C1orf63 (2.1)	NYNRIN (1.9)	CETP (1.6)	CBLC (1.6)	ILF3 (1.5)	PTPN11 (1.5)	MAPKAPK5 (1.5)
GO:0046427	positive regulation of JAK-STAT cascade	0.71	> 0.20	DNAH11 (2.0)	ENSG00000254235 (1.8)	GEMIN7 (1.8)	PBX4 (1.6)	SH2B3 (1.4)	DYNC2LI1 (1.2)	SLC22A1 (1.2)	ENSG00000238078 (1.1)	NCAN (1.1)	ENSG00000226645 (1.1)
GO:0000780	condensed nuclear chromosome, centromeric region	0.71	> 0.20	PSRC1 (6.8)	POC5 (3.0)	FEN1 (2.4)	C1orf63 (2.4)	C11orf9 (1.6)	USP1 (1.5)	PLEKHH2 (1.4)	PBX4 (1.4)	ENSG00000226648 (1.3)	ACAD10 (1.2)
ENSG00000023608	SNAPC1 PPI subnetwork	0.71	> 0.20	C12orf43 (3.3)	GEMIN7 (3.2)	ADAM1 (3.0)	POC5 (2.8)	SUGP1 (2.1)	ATXN2 (2.1)	MAPKAPK5 (2.1)	TOMM40 (2.1)	C19orf52 (2.0)	ZNF259 (1.8)
ENSG00000186230	ZNF749 PPI subnetwork	0.71	> 0.20	POLK (3.6)	ANKRD31 (2.9)	ACAD10 (2.4)	DYNC2LI1 (1.9)	BLOC1S3 (1.8)	COL4A3BP (1.8)	ZNF101 (1.6)	ZNF180 (1.6)	SUGP1 (1.5)	ENSG00000238078 (1.5)
ENSG00000103154	NECAB2 PPI subnetwork	0.71	> 0.20	ENSG00000226645 (2.8)	ATXN2 (2.8)	C12orf43 (2.5)	CARM1 (2.1)	DNAH11 (2.1)	CYP7A1 (1.8)	TMEM57 (1.8)	CYB561D1 (1.8)	BRAP (1.8)	TOMM40 (1.6)
ENSG00000105290	APLP1 PPI subnetwork	0.71	> 0.20	PLEKHH2 (3.0)	SARS (2.6)	TXNL4B (2.1)	HAVCR1 (2.0)	ZNF101 (1.8)	MYLIP (1.7)	NCAN (1.7)	RPH3A (1.4)	ENSG00000254235 (1.3)	AP1M2 (1.3)
ENSG00000104643	MTMR9 PPI subnetwork	0.71	> 0.20	APOB (3.5)	DYNC2LI1 (2.9)	ST3GAL4 (2.5)	BUD13 (2.4)	AP1M2 (1.8)	YIPF2 (1.6)	TXNL4B (1.6)	HLX (1.5)	ZNF259 (1.5)	SUGP1 (1.5)
ENSG00000127928	GNGT1 PPI subnetwork	0.71	> 0.20	ITGB3 (3.5)	ENSG00000254235 (1.8)	TM6SF2 (1.6)	TMEM50A (1.6)	ABCG8 (1.4)	PMFBP1 (1.4)	CETP (1.3)	ENSG00000235545 (1.2)	GCNT4 (1.2)	C1orf63 (1.1)
MP:0002792	abnormal retinal vasculature morphology	0.71	> 0.20	DYNC2LI1 (2.5)	BCAM (2.2)	NCAN (2.1)	LPIN3 (2.1)	GPAM (1.8)	ENSG00000226648 (1.8)	SLC44A2 (1.7)	PLEKHH2 (1.6)	SH2B3 (1.4)	POLK (1.3)
ENSG00000101144	BMP7 PPI subnetwork	0.71	> 0.20	AMIGO1 (2.8)	MAFB (2.7)	PVRL2 (2.4)	ENSG00000254235 (2.2)	LPAR2 (1.9)	TRIB1 (1.8)	PPP1R37 (1.7)	NYNRIN (1.7)	ZNF101 (1.7)	SLC44A2 (1.6)
MP:0002084	abnormal developmental patterning	0.71	> 0.20	DOCK7 (2.6)	ABO (2.4)	UBXN2B (2.4)	PLCG1 (1.8)	KANK2 (1.6)	LPAR2 (1.6)	ATXN2 (1.5)	PTPN11 (1.5)	PSRC1 (1.4)	DHX38 (1.3)
ENSG00000109911	ELP4 PPI subnetwork	0.71	> 0.20	TXNL4B (2.4)	POC5 (2.3)	C19orf52 (2.3)	TMEM50A (2.2)	SUGP1 (2.2)	C17orf57 (2.1)	MYLIP (2.0)	DYNC2LI1 (1.9)	MAPKAPK5 (1.7)	BRAP (1.7)
ENSG00000010256	UQCRC1 PPI subnetwork	0.71	> 0.20	SYPL2 (3.1)	C12orf47 (2.5)	TRAPPC6A (1.8)	ERP29 (1.8)	TOMM40 (1.7)	ACAD10 (1.7)	PSMA5 (1.6)	ZNF180 (1.6)	PARP10 (1.5)	OGDH (1.4)
GO:0007223	Wnt receptor signaling pathway, calcium modulating pathway	0.71	> 0.20	ZHX3 (2.3)	C17orf57 (2.2)	LPAR2 (1.9)	TMEM116 (1.9)	AMIGO1 (1.8)	PMFBP1 (1.6)	ANKRD31 (1.5)	PBX4 (1.4)	PLEKHH2 (1.4)	DOCK7 (1.0)
GO:0016605	PML body	0.71	> 0.20	BRAP (3.3)	GATAD2A (3.1)	ATXN2 (2.2)	USP1 (2.2)	FEN1 (2.1)	OASL (1.9)	PARP10 (1.9)	MAU2 (1.9)	SH2B3 (1.8)	PTPN11 (1.6)
ENSG00000100347	SAMM50 PPI subnetwork	0.71	> 0.20	PLEKHH2 (2.7)	DHODH (2.4)	GOT2P1 (2.2)	OGDH (2.1)	TOMM40 (2.1)	PLCG1 (2.0)	C17orf57 (1.9)	ABO (1.7)	PBX4 (1.6)	PMFBP1 (1.6)
GO:0033032	regulation of myeloid cell apoptotic process	0.71	> 0.20	C12orf47 (3.0)	ANKRD31 (2.5)	DNAH11 (2.4)	C19orf52 (2.0)	TIMD4 (1.7)	MOSC1 (1.6)	GEMIN7 (1.5)	AMIGO1 (1.4)	MYLIP (1.4)	TXNL4B (1.4)
MP:0008045	decreased NK cell number	0.71	> 0.20	MYLIP (2.4)	CYB561D1 (2.4)	TMEM50A (2.3)	C1orf63 (2.1)	SLC44A2 (2.0)	USP24 (1.8)	PARP10 (1.6)	DNAH11 (1.6)	BLOC1S3 (1.5)	TRAFD1 (1.4)
ENSG00000175895	PLEKHF2 PPI subnetwork	0.71	> 0.20	TRAPPC6A (3.8)	CYP7A1 (3.2)	TMEM50A (2.6)	ITGB3 (2.3)	C17orf57 (2.3)	ALDH2 (2.0)	LPA (1.8)	C12orf43 (1.7)	BLOC1S3 (1.6)	APOC4 (1.5)
ENSG00000135269	TES PPI subnetwork	0.71	> 0.20	GMIP (2.8)	ITGB3 (2.2)	PLCG1 (2.1)	PLEC (2.0)	PVRL2 (1.9)	PLEKHH2 (1.7)	ENSG00000228044 (1.6)	CEACAM19 (1.3)	HAPLN4 (1.3)	TSSK6 (1.2)
GO:0042976	activation of Janus kinase activity	0.71	> 0.20	CYB561D1 (2.2)	MYLIP (2.1)	ANKRD31 (2.0)	FRK (2.0)	ENSG00000235545 (2.0)	DNAH11 (1.9)	PBX4 (1.8)	BLOC1S3 (1.3)	ADAM1 (1.3)	SLC22A1 (1.1)
GO:0009435	NAD biosynthetic process	0.71	> 0.20	PMFBP1 (2.6)	LPIN3 (2.4)	ENSG00000226645 (2.4)	TM6SF2 (2.0)	TRAPPC6A (1.6)	TSSK6 (1.5)	ENSG00000254235 (1.5)	ACAD10 (1.4)	HAPLN4 (1.4)	HNF1A (1.3)
MP:0008173	increased follicular B cell number	0.71	> 0.20	POLK (3.0)	RELB (2.9)	GMIP (2.2)	SH2B3 (1.8)	C17orf57 (1.8)	TRIB1 (1.7)	TRAFD1 (1.7)	PBX4 (1.4)	C12orf47 (1.4)	LPIN3 (1.4)
ENSG00000066032	CTNNA2 PPI subnetwork	0.71	> 0.20	PVRL2 (3.9)	PVR (2.6)	ITGB3 (2.3)	POLK (1.9)	ATXN2 (1.9)	SORT1 (1.7)	LDLR (1.6)	CARM1 (1.6)	NT5DC1 (1.4)	GCNT4 (1.3)
ENSG00000154473	BUB3 PPI subnetwork	0.71	> 0.20	PSRC1 (5.7)	FEN1 (4.3)	POC5 (4.0)	USP1 (3.2)	ILF3 (0.9)	ENSG00000228044 (0.9)	LPIN3 (0.9)	ENSG00000226648 (0.8)	ATXN2 (0.7)	LPAR2 (0.7)
ENSG00000163349	HIPK1 PPI subnetwork	0.71	> 0.20	BUD13 (2.7)	USP24 (2.4)	MARK4 (2.2)	C12orf51 (2.2)	SORT1 (2.0)	GMIP (2.0)	ZNF180 (1.9)	TRAFD1 (1.8)	PVRL2 (1.8)	PSRC1 (1.7)
MP:0003237	abnormal lens epithelium morphology	0.71	> 0.20	MAFB (2.0)	ABO (1.8)	TSSK6 (1.7)	FADS1 (1.7)	ENSG00000254235 (1.6)	FADS2 (1.6)	ANKRD31 (1.3)	COL4A3BP (1.2)	TRAFD1 (1.2)	TXNL4B (1.2)
GO:0021517	ventral spinal cord development	0.71	> 0.20	DNAH11 (3.8)	ANKRD31 (3.2)	C12orf47 (2.4)	ATXN7L2 (2.3)	PMFBP1 (1.7)	DYNC2LI1 (1.6)	RPH3A (1.5)	C19orf52 (1.5)	TMED4 (1.4)	CYB561D1 (1.3)
GO:0005844	polysome	0.71	> 0.20	SARS (1.8)	MYLIP (1.8)	BRAP (1.7)	KANK2 (1.5)	ZNF259 (1.2)	CELSR2 (1.0)	ST3GAL4 (1.0)	RHCE (1.0)	CARM1 (1.0)	ABO (1.0)
GO:0031527	filopodium membrane	0.71	> 0.20	NCAN (2.8)	C11orf9 (2.3)	TRAPPC6A (2.1)	LPAR2 (2.1)	PBX4 (2.1)	ABO (1.9)	PVR (1.9)	MARK4 (1.8)	KANK2 (1.6)	ENSG00000238078 (1.3)
ENSG00000197860	SGTB PPI subnetwork	0.71	> 0.20	C12orf43 (2.4)	APOE (2.3)	NCAN (2.1)	FEN1 (1.9)	BRAP (1.7)	ENSG00000226648 (1.7)	RPH3A (1.6)	ENSG00000254235 (1.5)	KANK2 (1.5)	ZHX3 (1.5)
GO:0000123	histone acetyltransferase complex	0.71	> 0.20	MAPKAPK5 (3.0)	BUD13 (2.7)	UBXN2B (2.7)	ATXN7L2 (2.7)	USP1 (2.4)	ATXN2 (2.1)	ILF3 (2.1)	USP24 (1.9)	ZNF180 (1.8)	BRAP (1.7)
ENSG00000151247	EIF4E PPI subnetwork	0.71	> 0.20	TOP1 (3.6)	PTPN11 (2.9)	NAA25 (2.8)	GATAD2A (2.7)	ZNF259 (2.7)	DDX56 (2.7)	SMARCA4 (2.4)	ILF3 (2.2)	QTRT1 (2.1)	ADAM1 (1.9)
GO:0046545	development of primary female sexual characteristics	0.71	> 0.20	ABO (2.8)	NYNRIN (2.6)	YIPF2 (1.8)	HNF1A (1.8)	TSSK6 (1.7)	ST3GAL4 (1.6)	C11orf9 (1.5)	DNAH11 (1.5)	ANKRD31 (1.5)	AP1M2 (1.3)
ENSG00000136560	TANK PPI subnetwork	0.71	> 0.20	PMFBP1 (2.6)	ILF3 (2.3)	SARS (2.2)	RELB (2.2)	USP24 (2.1)	ZNF180 (1.8)	NAA25 (1.5)	TSSK6 (1.4)	ENSG00000238078 (1.4)	ST3GAL4 (1.3)
GO:0048598	embryonic morphogenesis	0.71	> 0.20	NYNRIN (2.8)	ATXN7L2 (1.9)	DYNC2LI1 (1.9)	PLCG1 (1.8)	CILP2 (1.7)	ENSG00000238078 (1.7)	PVRL2 (1.6)	MYLIP (1.4)	MARK4 (1.4)	HLX (1.3)
ENSG00000130816	DNMT1 PPI subnetwork	0.71	> 0.20	HAVCR1 (2.3)	FEN1 (2.2)	USP1 (2.2)	SMARCA4 (2.1)	PSRC1 (2.0)	ENSG00000238078 (1.9)	TRAFD1 (1.8)	PSMA5 (1.7)	MAPKAPK5 (1.7)	BUD13 (1.7)
ENSG00000165392	WRN PPI subnetwork	0.71	> 0.20	FEN1 (3.3)	USP1 (2.5)	SMARCA4 (1.8)	NKPD1 (1.8)	TMED4 (1.8)	FADS2 (1.5)	PCSK9 (1.4)	FRK (1.4)	FADS1 (1.3)	PSRC1 (1.3)
MP:0002152	abnormal brain morphology	0.71	> 0.20	GRINA (3.3)	CLPTM1 (2.5)	DOCK7 (2.4)	CELSR2 (2.3)	MARK4 (2.1)	APOC1 (2.0)	NCAN (1.8)	APOE (1.7)	RELB (1.6)	ATP13A1 (1.6)
GO:0005771	multivesicular body	0.71	> 0.20	APOE (2.7)	ALDH2 (2.6)	DOCK7 (2.2)	APOC1 (2.2)	TMEM57 (1.9)	GMPR (1.8)	MAFB (1.5)	CEACAM19 (1.5)	ERP29 (1.4)	KIAA1324 (1.4)
ENSG00000128266	GNAZ PPI subnetwork	0.71	> 0.20	KIAA1324 (3.8)	GMPR (2.7)	ITGB3 (2.6)	NCAN (2.5)	RPH3A (2.2)	CLPTM1 (2.0)	C17orf57 (1.7)	C12orf51 (1.6)	BCAM (1.5)	TOP1 (1.5)
MP:0001921	reduced fertility	0.71	> 0.20	COL4A3BP (1.9)	PVR (1.9)	RPH3A (1.8)	PLEC (1.7)	MARK4 (1.7)	BCL3 (1.7)	SORT1 (1.6)	NYNRIN (1.5)	KANK2 (1.5)	AMIGO1 (1.5)
REACTOME_NUCLEOTIDE:BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	REACTOME_NUCLEOTIDE:BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	0.71	> 0.20	RELB (3.7)	ZNF101 (3.1)	PARP10 (2.2)	CYB561D1 (1.9)	BCL3 (1.9)	TRAFD1 (1.7)	ZNF259 (1.7)	LPAR2 (1.6)	ENSG00000228044 (1.5)	BUD13 (1.5)
ENSG00000166483	WEE1 PPI subnetwork	0.71	> 0.20	CBLC (3.9)	PSRC1 (2.9)	PLCG1 (2.4)	GATAD2A (1.9)	NCAN (1.9)	GCNT4 (1.8)	RPH3A (1.7)	AP1M2 (1.7)	LPIN3 (1.7)	LDLR (1.4)
GO:0033138	positive regulation of peptidyl-serine phosphorylation	0.71	> 0.20	C17orf57 (3.0)	ENSG00000228044 (2.1)	ST3GAL4 (1.9)	DOCK7 (1.7)	POC5 (1.4)	ENSG00000238078 (1.4)	TMEM57 (1.3)	ATXN7L2 (1.3)	COL4A3BP (1.2)	MYLIP (1.2)
GO:0002763	positive regulation of myeloid leukocyte differentiation	0.71	> 0.20	ITGB3 (2.9)	PBX4 (2.2)	RHCE (2.1)	RHD (2.0)	ENSG00000238078 (1.9)	C1orf63 (1.7)	DNAH11 (1.6)	MYLIP (1.5)	TMEM50A (1.4)	ADAM1 (1.3)
GO:2000311	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	0.71	> 0.20	GOT2P1 (3.4)	NCAN (3.3)	ENSG00000226645 (2.9)	ANKRD31 (2.8)	RPH3A (2.5)	AMIGO1 (2.4)	CELSR2 (2.0)	GCNT4 (1.9)	PPP1R37 (1.8)	ABO (1.8)
GO:0045191	regulation of isotype switching	0.71	> 0.20	HAVCR1 (1.8)	C17orf57 (1.7)	PBX4 (1.5)	C12orf43 (1.3)	GCNT4 (1.2)	TRAFD1 (1.2)	NT5DC1 (1.1)	ENSG00000238078 (1.1)	COL4A3BP (1.1)	SLC22A1 (1.0)
ENSG00000037241	RPL26L1 PPI subnetwork	0.71	> 0.20	NKPD1 (2.8)	NAA25 (2.2)	GATAD2A (1.7)	ZNF259 (1.6)	HAVCR1 (1.5)	ANKRD31 (1.4)	ENSG00000226645 (1.4)	MOSC1 (1.3)	ILF3 (1.3)	ATP13A1 (1.3)
GO:0017075	syntaxin-1 binding	0.71	> 0.20	SORT1 (2.5)	CYB561D1 (2.4)	HAPLN4 (2.3)	RPH3A (2.2)	ABCG5 (2.1)	ATXN7L2 (2.0)	KIAA1324 (2.0)	CELSR2 (2.0)	NT5DC1 (1.8)	AMIGO1 (1.6)
GO:0033143	regulation of intracellular steroid hormone receptor signaling pathway	0.71	> 0.20	C19orf52 (2.2)	C12orf47 (2.1)	NT5DC1 (2.0)	ENSG00000254235 (1.7)	AP1M2 (1.7)	C1orf63 (1.6)	TOP1 (1.6)	NYNRIN (1.5)	KIAA1324 (1.3)	KANK2 (1.2)
GO:0031252	cell leading edge	0.71	> 0.20	PLEC (3.7)	C11orf9 (3.1)	SLC44A2 (3.1)	PVRL2 (2.8)	SH2B3 (2.6)	AP1M2 (2.6)	DOCK7 (2.5)	NCAN (2.3)	PVR (2.0)	GMIP (2.0)
GO:0034763	negative regulation of transmembrane transport	0.71	> 0.20	PPP1R37 (2.6)	PBX4 (1.7)	ENSG00000235545 (1.6)	MAFB (1.5)	ZNF101 (1.4)	CLPTM1 (1.3)	PLCG1 (1.2)	GATAD2A (1.2)	ABO (1.1)	PMFBP1 (1.1)
GO:0030017	sarcomere	0.71	> 0.20	SYPL2 (6.9)	GMPR (2.4)	TMEM50A (1.5)	PLEC (1.1)	RPH3A (1.0)	NPC1L1 (1.0)	PVRL2 (0.9)	PVR (0.9)	ENSG00000226648 (0.8)	LPAR2 (0.8)
ENSG00000101849	TBL1X PPI subnetwork	0.71	> 0.20	TMEM57 (2.4)	POLK (1.9)	SMARCA4 (1.8)	USP24 (1.8)	MYLIP (1.6)	PLEC (1.4)	PLCG1 (1.2)	CELSR2 (1.2)	RHCE (1.2)	ABO (1.2)
GO:0005343	organic acid:sodium symporter activity	0.71	> 0.20	NCAN (3.0)	TM6SF2 (2.9)	APOC4 (2.7)	ABCG8 (2.3)	GEMIN7 (2.1)	PLG (2.1)	CYP7A1 (2.0)	SARS (2.0)	HAPLN4 (1.9)	APOA5 (1.8)
GO:0019209	kinase activator activity	0.71	> 0.20	CETP (2.4)	C17orf57 (2.3)	PTPN11 (2.3)	SH2B3 (1.7)	TSSK6 (1.7)	GMPR (1.7)	GMIP (1.7)	ITGB3 (1.6)	SYPL2 (1.6)	POLK (1.4)
ENSG00000185697	MYBL1 PPI subnetwork	0.71	> 0.20	RHD (3.2)	PLCG1 (2.9)	RHCE (2.3)	UBXN2B (1.6)	USP1 (1.5)	SMARCA4 (1.5)	SUGP1 (1.5)	GOT2P1 (1.4)	PTPN11 (1.2)	GRINA (1.1)
ENSG00000067900	ROCK1 PPI subnetwork	0.71	> 0.20	KANK2 (3.5)	GATAD2A (2.7)	DOCK7 (2.4)	PTPN11 (2.3)	ADAM1 (2.2)	OGDH (2.2)	DNM2 (2.2)	C12orf51 (2.0)	C11orf9 (2.0)	NCAN (1.9)
GO:0019005	SCF ubiquitin ligase complex	0.71	> 0.20	TRAFD1 (3.0)	ZHX3 (2.4)	MAPKAPK5 (1.8)	SUGP1 (1.8)	BLOC1S3 (1.8)	TMEM116 (1.6)	ST3GAL4 (1.6)	LPIN3 (1.6)	COL4A3BP (1.5)	GCNT4 (1.5)
ENSG00000196532	HIST1H3C PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000182572	HIST1H3I PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000178458	ENSG00000178458 PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000198366	HIST1H3A PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000124693	HIST1H3B PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000112727	ENSG00000112727 PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000196966	HIST1H3E PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000197409	HIST1H3D PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
ENSG00000197153	HIST1H3J PPI subnetwork	0.71	> 0.20	FEN1 (2.7)	SMARCA4 (2.6)	USP1 (2.6)	C19orf52 (2.5)	PSRC1 (2.1)	ILF3 (1.6)	TMEM57 (1.4)	TOP1 (1.4)	ATXN2 (1.3)	MYLIP (1.2)
GO:0033077	T cell differentiation in thymus	0.71	> 0.20	PBX4 (4.9)	ZNF101 (4.6)	PLCG1 (3.7)	LPAR2 (1.9)	DNAH11 (1.8)	SLC44A2 (1.7)	C19orf52 (1.5)	TMEM116 (1.4)	PPP1R37 (1.2)	AMIGO1 (1.2)
GO:0002823	negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.71	> 0.20	DNAH11 (2.7)	ABO (2.6)	ZNF180 (1.7)	ENSG00000235545 (1.6)	HNF1A (1.5)	CEACAM19 (1.5)	HAVCR1 (1.4)	TSSK6 (1.4)	OASL (1.3)	GOT2P1 (1.3)
ENSG00000127329	PTPRB PPI subnetwork	0.71	> 0.20	CETP (3.2)	PVR (2.4)	CYP7A1 (2.2)	AMIGO1 (1.9)	ZHX3 (1.8)	CELSR2 (1.4)	PLCG1 (1.4)	GEMIN7 (1.3)	ENSG00000226645 (1.2)	KIAA1324 (1.1)
MP:0008040	decreased NK T cell number	0.71	> 0.20	PBX4 (3.0)	TRAFD1 (2.7)	BCL3 (2.6)	RELB (2.2)	CYB561D1 (2.2)	GMIP (2.0)	PARP10 (1.8)	MAFB (1.7)	ZNF101 (1.7)	DNM2 (1.6)
ENSG00000138741	TRPC3 PPI subnetwork	0.71	> 0.20	OASL (3.3)	PLEKHH2 (2.4)	PARP10 (2.3)	SORT1 (2.0)	ZHX3 (1.8)	ATP13A1 (1.8)	KANK2 (1.8)	SH2B3 (1.6)	GRINA (1.5)	GOT2P1 (1.4)
ENSG00000137547	MRPL15 PPI subnetwork	0.71	> 0.20	YIPF2 (3.3)	CARM1 (3.1)	QTRT1 (2.6)	BUD13 (2.6)	MAU2 (2.4)	MAPKAPK5 (2.3)	DNM2 (2.3)	DHX38 (2.0)	ZNF259 (1.9)	NAA25 (1.9)
GO:0043596	nuclear replication fork	0.71	> 0.20	USP1 (5.7)	FEN1 (5.2)	NT5DC1 (2.3)	OGDH (1.9)	AMIGO1 (1.8)	ST3GAL4 (1.6)	ENSG00000235545 (1.6)	BLOC1S3 (1.4)	TMEM116 (1.3)	FRK (1.3)
REACTOME_CA:DEPENDENT_EVENTS	REACTOME_CA:DEPENDENT_EVENTS	0.71	> 0.20	SORT1 (3.2)	SH2B3 (2.8)	ST3GAL4 (2.6)	ITGB3 (2.1)	KANK2 (2.1)	GCNT4 (2.0)	ENSG00000238078 (1.9)	AMIGO1 (1.8)	MYLIP (1.6)	POLK (1.6)
GO:0015682	ferric iron transport	0.71	> 0.20	TMEM116 (3.4)	ENSG00000254235 (2.5)	GRINA (2.5)	NKPD1 (2.2)	SORT1 (2.0)	ERP29 (2.0)	BLOC1S3 (1.9)	COL4A3BP (1.8)	TMEM57 (1.7)	TMEM50A (1.7)
GO:0033572	transferrin transport	0.71	> 0.20	TMEM116 (3.4)	ENSG00000254235 (2.5)	GRINA (2.5)	NKPD1 (2.2)	SORT1 (2.0)	ERP29 (2.0)	BLOC1S3 (1.9)	COL4A3BP (1.8)	TMEM57 (1.7)	TMEM50A (1.7)
MP:0011084	partial lethality at weaning	0.71	> 0.20	PLEC (2.6)	FADS2 (2.4)	NCAN (2.4)	ATP13A1 (1.9)	CELSR2 (1.7)	ENSG00000235545 (1.7)	YIPF2 (1.6)	TOP1 (1.6)	RHCE (1.6)	OGDH (1.6)
ENSG00000121481	RNF2 PPI subnetwork	0.71	> 0.20	ATXN2 (2.8)	C19orf52 (2.4)	MAPKAPK5 (2.3)	GATAD2A (2.3)	BUD13 (2.1)	C12orf43 (2.1)	TRAFD1 (2.1)	BRAP (2.0)	NAA25 (1.9)	ILF3 (1.7)
GO:0033006	regulation of mast cell activation involved in immune response	0.71	> 0.20	BLOC1S3 (2.7)	NKPD1 (2.0)	ALDH2 (1.9)	GMPR (1.8)	ENSG00000235545 (1.8)	GEMIN7 (1.6)	GMIP (1.4)	ERP29 (1.4)	ST3GAL4 (1.4)	ANKRD31 (1.3)
ENSG00000091073	ENSG00000091073 PPI subnetwork	0.71	> 0.20	CBLC (4.9)	CELSR2 (2.8)	LPAR2 (2.7)	AP1M2 (2.5)	PSRC1 (2.4)	SLC44A2 (2.1)	PLEC (1.8)	BCAM (1.7)	TSSK6 (1.6)	C12orf51 (1.6)
GO:0008237	metallopeptidase activity	0.71	> 0.20	NPC1L1 (3.8)	TM6SF2 (3.3)	FRK (2.8)	ACAD10 (2.1)	ABCG5 (2.1)	PMFBP1 (2.1)	HAPLN4 (1.6)	LPIN3 (1.6)	ABCG8 (1.5)	KIAA1324 (1.5)
ENSG00000206505	HLA-A PPI subnetwork	0.71	> 0.20	SLC44A2 (2.7)	GRINA (2.3)	ZNF101 (2.1)	PLCG1 (2.1)	YIPF2 (2.0)	ATP13A1 (1.9)	CLPTM1 (1.8)	PARP10 (1.8)	GATAD2A (1.5)	TMED4 (1.4)
ENSG00000163517	HDAC11 PPI subnetwork	0.72	> 0.20	PLEC (2.4)	GRINA (2.1)	LPIN3 (2.0)	TRIB1 (1.9)	UBXN2B (1.8)	PSRC1 (1.7)	DNM2 (1.7)	POLK (1.7)	ZHX3 (1.6)	USP24 (1.6)
ENSG00000163220	S100A9 PPI subnetwork	0.72	> 0.20	CEACAM19 (2.5)	PCSK9 (2.3)	GRINA (2.2)	SARS (2.2)	ERP29 (2.1)	MOSC1 (1.9)	SORT1 (1.8)	PVR (1.7)	HP (1.7)	CLPTM1 (1.7)
ENSG00000072415	MPP5 PPI subnetwork	0.72	> 0.20	UBXN2B (2.9)	LPAR2 (2.6)	TMED4 (2.2)	PVRL2 (2.0)	TMEM116 (1.9)	AP1M2 (1.9)	ATP13A1 (1.9)	ENSG00000238078 (1.6)	DOCK7 (1.5)	PLCG1 (1.4)
REACTOME_INHIBITION_OF_ADENYLATE_CYCLASE_PATHWAY	REACTOME_INHIBITION_OF_ADENYLATE_CYCLASE_PATHWAY	0.72	> 0.20	CYP7A1 (1.9)	NYNRIN (1.9)	SH2B3 (1.7)	HLX (1.6)	ENSG00000228044 (1.5)	MYLIP (1.5)	ZNF180 (1.5)	CLPTM1 (1.4)	ABCG8 (1.4)	PVR (1.4)
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	0.72	> 0.20	CYP7A1 (1.9)	NYNRIN (1.9)	SH2B3 (1.7)	HLX (1.6)	ENSG00000228044 (1.5)	MYLIP (1.5)	ZNF180 (1.5)	CLPTM1 (1.4)	ABCG8 (1.4)	PVR (1.4)
GO:0005922	connexon complex	0.72	> 0.20	CBLC (3.0)	NKPD1 (2.6)	PMFBP1 (2.2)	ENSG00000228044 (2.1)	C11orf9 (1.9)	BCAM (1.7)	APOC1 (1.6)	ST3GAL4 (1.3)	CEACAM19 (1.3)	YIPF2 (1.1)
ENSG00000086827	ZW10 PPI subnetwork	0.72	> 0.20	MAPKAPK5 (3.1)	BRAP (3.0)	SUGP1 (2.7)	C19orf52 (2.2)	YIPF2 (2.1)	C12orf47 (2.1)	PSRC1 (2.0)	GMPR (2.0)	ADAM1 (2.0)	GEMIN7 (2.0)
GO:0070647	protein modification by small protein conjugation or removal	0.72	> 0.20	BRAP (3.9)	TRAFD1 (3.0)	ZNF180 (2.9)	C19orf52 (2.4)	MAU2 (2.2)	TMEM57 (2.2)	SUGP1 (1.9)	ENSG00000226645 (1.9)	BUD13 (1.6)	POC5 (1.6)
ENSG00000158517	NCF1 PPI subnetwork	0.72	> 0.20	GMIP (3.3)	DNM2 (3.0)	RELB (2.8)	SH2B3 (2.4)	NCAN (2.2)	C11orf9 (2.1)	ALDH2 (2.1)	TMEM50A (2.0)	GATAD2A (1.6)	HAVCR1 (1.5)
GO:0007338	single fertilization	0.72	> 0.20	PMFBP1 (5.3)	TSSK6 (5.0)	ENSG00000228044 (2.4)	ENSG00000238078 (2.4)	GCNT4 (1.8)	HNF1A (1.1)	POLK (1.0)	PBX4 (0.9)	CILP2 (0.8)	ERP29 (0.7)
ENSG00000123700	KCNJ2 PPI subnetwork	0.72	> 0.20	HAVCR1 (4.8)	FRK (3.0)	CYB561D1 (3.0)	TMEM116 (2.0)	CELSR2 (1.9)	ENSG00000226648 (1.8)	C11orf9 (1.8)	GOT2P1 (1.8)	KANK2 (1.7)	AP1M2 (1.5)
ENSG00000128534	NAA38 PPI subnetwork	0.72	> 0.20	GEMIN7 (3.7)	TRAPPC6A (3.0)	MAU2 (2.8)	QTRT1 (2.6)	ABO (2.0)	DDX56 (1.6)	DHODH (1.5)	GATAD2A (1.5)	ILF3 (1.5)	ERP29 (1.5)
GO:0048103	somatic stem cell division	0.72	> 0.20	ENSG00000235545 (2.9)	DNAH11 (2.7)	ANKRD31 (2.7)	SLC44A2 (2.5)	PLEKHH2 (2.2)	PLCG1 (2.1)	PMFBP1 (1.8)	GCNT4 (1.8)	CELSR2 (1.7)	ENSG00000226648 (1.7)
ENSG00000171759	PAH PPI subnetwork	0.72	> 0.20	DYNC2LI1 (4.3)	PSMA5 (3.1)	PLG (2.2)	ANGPTL3 (2.2)	TRAPPC6A (2.0)	CBLC (1.8)	KIAA1324 (1.8)	GPAM (1.7)	UBXN2B (1.6)	MOSC1 (1.5)
ENSG00000100162	CENPM PPI subnetwork	0.72	> 0.20	PSRC1 (5.8)	FEN1 (4.4)	POC5 (3.6)	USP1 (3.5)	ENSG00000228044 (1.2)	ENSG00000226648 (1.1)	ZNF180 (1.0)	ZHX3 (0.9)	USP24 (0.7)	LPIN3 (0.6)
ENSG00000206450	HLA-B PPI subnetwork	0.72	> 0.20	PLCG1 (3.2)	PARP10 (2.9)	HAVCR1 (2.1)	ZNF101 (2.0)	ENSG00000228044 (1.5)	PPP1R37 (1.4)	USP24 (1.4)	MOSC1 (1.3)	MAFB (1.2)	YIPF2 (1.1)
ENSG00000124171	PARD6B PPI subnetwork	0.72	> 0.20	UBXN2B (2.9)	DYNC2LI1 (2.1)	SARS (1.7)	TXNL4B (1.7)	PSRC1 (1.7)	PVRL2 (1.6)	C19orf52 (1.6)	KANK2 (1.6)	C11orf9 (1.4)	PTPN11 (1.4)
GO:0043300	regulation of leukocyte degranulation	0.72	> 0.20	ALDH2 (2.6)	BLOC1S3 (2.4)	NKPD1 (1.8)	GMIP (1.8)	ENSG00000235545 (1.7)	ST3GAL4 (1.7)	DNAH11 (1.6)	GMPR (1.5)	CILP2 (1.4)	ERP29 (1.4)
GO:0000725	recombinational repair	0.72	> 0.20	BUD13 (2.5)	BLOC1S3 (2.1)	POLK (2.0)	C12orf43 (2.0)	TMEM116 (1.7)	AMIGO1 (1.6)	USP1 (1.6)	FEN1 (1.5)	ENSG00000228044 (1.5)	ENSG00000235545 (1.5)
MP:0000921	demyelination	0.72	> 0.20	APOE (3.2)	C11orf9 (2.9)	APOC1 (2.5)	MAFB (2.3)	RPH3A (1.9)	HAPLN4 (1.8)	OASL (1.7)	SORT1 (1.6)	ANKRD31 (1.4)	ENSG00000228044 (1.3)
MP:0009232	abnormal sperm nucleus morphology	0.72	> 0.20	TSSK6 (7.7)	PMFBP1 (5.0)	MARK4 (2.0)	BCAM (2.0)	ABO (1.8)	GCNT4 (1.8)	GOT2P1 (1.7)	CEACAM19 (1.3)	PVR (1.3)	ZNF180 (1.3)
MP:0004748	increased susceptibility to age-related hearing loss	0.72	> 0.20	PBX4 (2.6)	BCAM (2.0)	SLC44A2 (1.9)	AMIGO1 (1.9)	APOE (1.6)	CYP7A1 (1.5)	PLEC (1.5)	CELSR2 (1.5)	HNF1A (1.4)	TIMD4 (1.4)
ENSG00000073614	KDM5A PPI subnetwork	0.72	> 0.20	CARM1 (2.4)	TOP1 (2.3)	COL4A3BP (2.3)	C1orf63 (2.2)	POC5 (2.2)	MAPKAPK5 (2.1)	ATXN2 (2.1)	C17orf57 (2.1)	BUD13 (2.0)	C19orf52 (1.8)
KEGG_MISMATCH_REPAIR	KEGG_MISMATCH_REPAIR	0.72	> 0.20	FEN1 (5.6)	USP1 (5.1)	ZNF180 (2.6)	ENSG00000235545 (2.3)	POC5 (1.6)	ERP29 (1.5)	TMEM116 (1.4)	ENSG00000226648 (1.3)	ENSG00000228044 (1.2)	GOT2P1 (1.2)
GO:0032655	regulation of interleukin-12 production	0.72	> 0.20	ZNF101 (2.9)	TRAFD1 (2.6)	PBX4 (2.1)	GRINA (2.1)	RELB (1.7)	ST3GAL4 (1.7)	PARP10 (1.7)	MYLIP (1.4)	SH2B3 (1.3)	BCL3 (1.3)
MP:0000764	abnormal tongue epithelium morphology	0.72	> 0.20	BCAM (3.9)	CBLC (3.7)	CELSR2 (3.0)	AP1M2 (2.1)	PLEC (1.9)	PMFBP1 (1.4)	SLC44A2 (1.2)	RELB (1.0)	ST3GAL4 (1.0)	ZNF180 (0.9)
GO:0070534	protein K63-linked ubiquitination	0.72	> 0.20	BRAP (2.7)	C19orf52 (2.7)	MAPKAPK5 (2.4)	DNAH11 (2.3)	ZHX3 (2.0)	ATXN2 (1.9)	TMED4 (1.9)	HAVCR1 (1.9)	CILP2 (1.8)	ZNF180 (1.7)
GO:0009651	response to salt stress	0.72	> 0.20	DNAH11 (3.1)	ABO (2.8)	TSSK6 (2.0)	AMIGO1 (1.9)	GOT2P1 (1.8)	ST3GAL4 (1.7)	ZHX3 (1.4)	FADS2 (1.3)	C12orf43 (1.3)	NKPD1 (1.3)
GO:0006325	chromatin organization	0.72	> 0.20	BUD13 (2.4)	SMARCA4 (2.4)	ATXN7L2 (2.2)	ILF3 (2.2)	ATXN2 (2.0)	TMEM57 (2.0)	ENSG00000226648 (2.0)	C12orf51 (2.0)	MAU2 (1.8)	TOP1 (1.7)
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	0.72	> 0.20	SARS (10.9)	NAA25 (3.3)	ZNF259 (3.3)	DDX56 (3.1)	PSMA5 (2.8)	QTRT1 (2.7)	SUGP1 (2.7)	ATP13A1 (2.1)	POC5 (1.8)	SMARCA4 (1.8)
ENSG00000112685	EXOC2 PPI subnetwork	0.72	> 0.20	BLOC1S3 (2.8)	COL4A3BP (2.7)	DNAH11 (2.4)	USP24 (2.4)	NYNRIN (2.2)	POLK (2.2)	UBXN2B (2.0)	POC5 (1.9)	C12orf51 (1.7)	GEMIN7 (1.7)
ENSG00000137845	ADAM10 PPI subnetwork	0.72	> 0.20	AMIGO1 (2.5)	PSMA5 (2.0)	KIAA1324 (2.0)	PLEC (1.9)	CBLC (1.9)	ST3GAL4 (1.8)	LPIN3 (1.7)	TIMD4 (1.5)	LPA (1.5)	DNAH11 (1.4)
MP:0008168	decreased B-1a cell number	0.72	> 0.20	CETP (3.1)	GMIP (2.9)	TIMD4 (2.5)	ERP29 (2.4)	HAVCR1 (1.9)	ALDH2 (1.8)	HNF1A (1.6)	SLC44A2 (1.6)	C17orf57 (1.6)	ZNF101 (1.2)
MP:0008126	increased dendritic cell number	0.72	> 0.20	TIMD4 (2.8)	GMIP (2.6)	APOC1 (2.3)	MYLIP (2.1)	NKPD1 (2.1)	SH2B3 (2.1)	APOE (2.0)	LPIN3 (1.9)	OASL (1.8)	PARP10 (1.5)
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP:BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP:BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	0.72	> 0.20	NKPD1 (2.7)	SARS (2.6)	ILF3 (2.1)	ANKRD31 (2.0)	ATP13A1 (2.0)	DDX56 (1.9)	QTRT1 (1.8)	GATAD2A (1.7)	C12orf43 (1.6)	ADAM1 (1.5)
MP:0002116	abnormal craniofacial bone morphology	0.72	> 0.20	CILP2 (4.9)	MAFB (2.3)	PLCG1 (2.0)	FRK (1.9)	CARM1 (1.6)	MAU2 (1.6)	NYNRIN (1.5)	PLEKHH2 (1.4)	KANK2 (1.3)	C19orf52 (1.2)
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	0.72	> 0.20	ADAM1 (2.7)	DNM2 (2.5)	MAU2 (2.5)	ATXN2 (2.3)	COL4A3BP (2.2)	ENSG00000226645 (2.0)	PVRL2 (1.8)	DOCK7 (1.8)	C11orf9 (1.7)	LPAR2 (1.6)
ENSG00000117425	PTCH2 PPI subnetwork	0.72	> 0.20	NYNRIN (2.2)	HNF1A (2.2)	MOSC1 (2.0)	ENSG00000235545 (1.9)	ANGPTL3 (1.7)	CYP7A1 (1.5)	ABO (1.2)	CETP (1.2)	RHD (1.1)	HAVCR1 (1.1)
ENSG00000176974	SHMT1 PPI subnetwork	0.72	> 0.20	SARS (3.0)	NT5DC1 (1.9)	OGDH (1.8)	GOT2P1 (1.8)	PSMA5 (1.7)	CILP2 (1.7)	PMFBP1 (1.7)	ATXN7L2 (1.5)	RHCE (1.5)	POLK (1.4)
ENSG00000133313	CNDP2 PPI subnetwork	0.72	> 0.20	NAA25 (2.9)	SARS (2.6)	USP24 (2.5)	NPC1L1 (2.2)	OGDH (2.1)	BRAP (2.0)	PTPN11 (2.0)	ACAD10 (1.9)	ZNF259 (1.8)	DNM2 (1.8)
ENSG00000115750	TAF1B PPI subnetwork	0.72	> 0.20	MAPKAPK5 (3.2)	ZNF259 (2.4)	TXNL4B (2.3)	POC5 (2.1)	ATXN7L2 (2.1)	C12orf43 (2.0)	DYNC2LI1 (1.9)	BUD13 (1.8)	TOP1 (1.6)	COL4A3BP (1.4)
ENSG00000148308	GTF3C5 PPI subnetwork	0.72	> 0.20	DDX56 (3.5)	C12orf43 (3.4)	GEMIN7 (2.9)	ZNF259 (2.4)	ENSG00000226645 (2.1)	C12orf47 (2.0)	MAPKAPK5 (2.0)	POC5 (1.9)	TOMM40 (1.8)	SUGP1 (1.6)
MP:0001928	abnormal ovulation	0.72	> 0.20	KIAA1324 (2.8)	APOB (2.4)	ENSG00000228044 (2.3)	ABCG5 (2.0)	TM6SF2 (1.8)	BCAM (1.8)	GCNT4 (1.7)	ABCG8 (1.6)	HAPLN4 (1.4)	TIMD4 (1.3)
GO:0015293	symporter activity	0.72	> 0.20	TM6SF2 (4.7)	TMEM116 (3.4)	HAPLN4 (3.1)	ABCG8 (2.7)	ABCG5 (2.4)	PLG (2.3)	NCAN (2.2)	ANGPTL3 (2.1)	ABO (1.6)	SLC22A1 (1.6)
GO:0045582	positive regulation of T cell differentiation	0.72	> 0.20	PBX4 (3.7)	ZNF101 (2.8)	NKPD1 (1.9)	ENSG00000254235 (1.8)	DNAH11 (1.7)	ENSG00000226645 (1.5)	GMIP (1.5)	NT5DC1 (1.4)	ANKRD31 (1.4)	MYLIP (1.4)
ENSG00000163993	S100P PPI subnetwork	0.72	> 0.20	PLEC (3.9)	DYNC2LI1 (2.6)	ST3GAL4 (2.3)	AP1M2 (2.1)	TMEM116 (2.0)	PBX4 (1.8)	BCAM (1.7)	C11orf9 (1.7)	NT5DC1 (1.5)	POLK (1.5)
ENSG00000156136	DCK PPI subnetwork	0.72	> 0.20	MARK4 (4.0)	C12orf51 (2.9)	BUD13 (2.6)	GMIP (2.4)	SLC44A2 (2.3)	LPAR2 (2.3)	SORT1 (2.0)	MAU2 (2.0)	PSRC1 (1.9)	ZNF180 (1.8)
REACTOME_CLATHRIN_DERIVED_VESICLE_BUDDING	REACTOME_CLATHRIN_DERIVED_VESICLE_BUDDING	0.72	> 0.20	CLPTM1 (3.7)	YIPF2 (3.0)	COL4A3BP (2.9)	DNM2 (2.6)	GRINA (2.5)	CYB561D1 (2.3)	BLOC1S3 (2.3)	AP1M2 (2.1)	PPP1R37 (1.9)	PTPN11 (1.9)
REACTOME_TRANS:GOLGI_NETWORK_VESICLE_BUDDING	REACTOME_TRANS:GOLGI_NETWORK_VESICLE_BUDDING	0.72	> 0.20	CLPTM1 (3.7)	YIPF2 (3.0)	COL4A3BP (2.9)	DNM2 (2.6)	GRINA (2.5)	CYB561D1 (2.3)	BLOC1S3 (2.3)	AP1M2 (2.1)	PPP1R37 (1.9)	PTPN11 (1.9)
ENSG00000076242	MLH1 PPI subnetwork	0.72	> 0.20	FEN1 (3.5)	USP1 (3.3)	ZNF180 (2.7)	POLK (2.3)	DHODH (1.6)	BLOC1S3 (1.6)	POC5 (1.6)	ENSG00000228044 (1.4)	BRAP (1.3)	TMEM116 (1.3)
ENSG00000137812	CASC5 PPI subnetwork	0.72	> 0.20	PSRC1 (5.7)	FEN1 (4.6)	POC5 (3.7)	USP1 (3.7)	ENSG00000228044 (1.0)	ZNF180 (0.9)	ZHX3 (0.9)	ENSG00000226648 (0.9)	LPIN3 (0.6)	HMGCR (0.6)
GO:0050715	positive regulation of cytokine secretion	0.72	> 0.20	ENSG00000228044 (2.6)	MAFB (1.6)	ZNF101 (1.4)	PMFBP1 (1.3)	GEMIN7 (1.2)	HAVCR1 (1.1)	ZNF180 (1.1)	ENSG00000226648 (1.1)	POLK (1.1)	HLX (1.0)
GO:0007528	neuromuscular junction development	0.72	> 0.20	PLEKHH2 (2.5)	SYPL2 (2.5)	ZHX3 (2.3)	ENSG00000228044 (2.2)	AMIGO1 (2.1)	ANKRD31 (1.9)	OGDH (1.7)	DOCK7 (1.7)	ENSG00000235545 (1.6)	SLC44A2 (1.6)
REACTOME_CELL_JUNCTION_ORGANIZATION	REACTOME_CELL_JUNCTION_ORGANIZATION	0.72	> 0.20	BCAM (6.1)	PVRL2 (4.7)	AP1M2 (4.7)	CBLC (4.5)	PLEC (3.0)	PVR (2.4)	LPIN3 (1.9)	ITGB3 (1.7)	LPAR2 (1.7)	KANK2 (1.7)
GO:0051046	regulation of secretion	0.72	> 0.20	KIAA1324 (4.1)	ABO (2.1)	AMIGO1 (2.0)	HNF1A (1.9)	PLEKHH2 (1.6)	C12orf47 (1.6)	HAPLN4 (1.6)	ENSG00000228044 (1.5)	NPC1L1 (1.5)	C11orf9 (1.5)
ENSG00000185049	WHSC2 PPI subnetwork	0.72	> 0.20	SUGP1 (3.0)	ZNF259 (2.5)	TXNL4B (2.4)	MAPKAPK5 (2.4)	DHX38 (2.2)	PSMA5 (1.9)	BUD13 (1.9)	PTPN11 (1.8)	QTRT1 (1.8)	DNM2 (1.8)
GO:0014066	regulation of phosphatidylinositol 3-kinase cascade	0.72	> 0.20	POLK (1.6)	SH2B3 (1.4)	NPC1L1 (1.4)	ANKRD31 (1.4)	ENSG00000226645 (1.3)	USP24 (1.3)	HLX (1.2)	KIAA1324 (1.2)	NKPD1 (1.1)	C17orf57 (1.0)
ENSG00000112078	KCTD20 PPI subnetwork	0.72	> 0.20	ATXN2 (3.0)	ENSG00000235545 (2.6)	DOCK7 (2.3)	ILF3 (2.3)	ZNF101 (2.3)	CARM1 (2.3)	GATAD2A (2.2)	USP24 (2.0)	TMEM50A (2.0)	NYNRIN (1.8)
MP:0004930	small epididymis	0.72	> 0.20	NT5DC1 (2.5)	ABO (2.1)	DNAH11 (1.9)	LPAR2 (1.8)	MOSC1 (1.7)	YIPF2 (1.3)	TMED4 (1.3)	BCAM (1.3)	PMFBP1 (1.3)	ENSG00000226648 (1.3)
ENSG00000134769	DTNA PPI subnetwork	0.72	> 0.20	SYPL2 (3.7)	KANK2 (2.9)	ZHX3 (2.6)	ITGB3 (2.6)	COL4A3BP (2.6)	GPAM (2.3)	RHCE (1.7)	RPH3A (1.6)	PLCG1 (1.5)	ENSG00000238078 (1.5)
GO:0001909	leukocyte mediated cytotoxicity	0.72	> 0.20	PBX4 (2.6)	CEACAM19 (2.1)	POLK (1.9)	ZNF180 (1.7)	GEMIN7 (1.6)	PARP10 (1.6)	YIPF2 (1.4)	ENSG00000235545 (1.2)	RHD (1.1)	DNAH11 (1.1)
GO:0046637	regulation of alpha-beta T cell differentiation	0.72	> 0.20	ENSG00000235545 (2.3)	ANKRD31 (2.0)	ENSG00000254235 (2.0)	PBX4 (1.9)	MYLIP (1.8)	NKPD1 (1.5)	GMIP (1.5)	ZNF101 (1.5)	BLOC1S3 (1.4)	HLX (1.2)
GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	0.72	> 0.20	SH2B3 (1.9)	TIMD4 (1.7)	GEMIN7 (1.7)	ENSG00000226645 (1.7)	ADAM1 (1.6)	PVR (1.6)	MOSC1 (1.6)	GCNT4 (1.5)	PLEKHH2 (1.5)	GPAM (1.5)
GO:0034505	tooth mineralization	0.72	> 0.20	CYB561D1 (2.5)	MYLIP (2.1)	PBX4 (1.8)	CILP2 (1.8)	C19orf52 (1.5)	TMEM57 (1.4)	LPA (1.4)	NKPD1 (1.3)	ENSG00000226648 (1.3)	TRAPPC6A (1.3)
GO:0000175	3'-5'-exoribonuclease activity	0.72	> 0.20	DHODH (3.8)	PARP10 (3.1)	OASL (2.9)	QTRT1 (2.4)	MAPKAPK5 (2.2)	TRAPPC6A (2.1)	GRINA (2.1)	DDX56 (2.0)	POC5 (2.0)	ZNF259 (1.9)
REACTOME_MTOR_SIGNALLING	REACTOME_MTOR_SIGNALLING	0.72	> 0.20	BRAP (4.1)	PTPN11 (3.6)	C12orf43 (3.3)	USP24 (3.3)	TMEM57 (2.5)	SARS (2.3)	ZHX3 (2.2)	SYPL2 (2.0)	C12orf51 (2.0)	AMIGO1 (2.0)
GO:0016460	myosin II complex	0.72	> 0.20	SYPL2 (5.4)	GMPR (2.3)	AP1M2 (1.3)	KANK2 (1.3)	POLK (1.2)	LPAR2 (1.1)	RHCE (1.0)	TMEM50A (0.9)	ANGPTL3 (0.9)	SORT1 (0.9)
GO:0031424	keratinization	0.72	> 0.20	NKPD1 (6.5)	CEACAM19 (4.6)	ENSG00000226648 (2.4)	PMFBP1 (1.9)	CBLC (1.9)	BLOC1S3 (1.7)	C17orf57 (1.6)	LPIN3 (1.6)	DNAH11 (1.5)	ADAM1 (1.1)
ENSG00000161956	SENP3 PPI subnetwork	0.72	> 0.20	BUD13 (2.9)	C12orf43 (2.3)	ATXN2 (2.2)	SUGP1 (2.1)	ZNF180 (1.8)	TMEM50A (1.8)	MAPKAPK5 (1.7)	GATAD2A (1.6)	QTRT1 (1.5)	TOP1 (1.5)
ENSG00000113555	PCDH12 PPI subnetwork	0.72	> 0.20	SYPL2 (3.9)	OGDH (3.3)	GMPR (3.1)	ACAD10 (2.8)	C1orf63 (2.5)	TMEM50A (2.4)	PSMA5 (1.7)	ENSG00000238078 (1.5)	BCAM (1.3)	C19orf52 (1.3)
GO:0019104	DNA N-glycosylase activity	0.72	> 0.20	ABO (2.0)	AMIGO1 (1.9)	NKPD1 (1.9)	FEN1 (1.9)	KANK2 (1.8)	POC5 (1.7)	C12orf43 (1.6)	TMEM116 (1.5)	GEMIN7 (1.4)	BLOC1S3 (1.3)
GO:0008286	insulin receptor signaling pathway	0.72	> 0.20	COL4A3BP (3.0)	PTPN11 (2.8)	SORT1 (2.6)	ENSG00000226645 (2.5)	BRAP (2.1)	TMEM57 (2.0)	ZHX3 (1.9)	GRINA (1.8)	USP24 (1.7)	PPP1R37 (1.7)
MP:0002753	dilated heart left ventricle	0.72	> 0.20	SYPL2 (2.5)	BCAM (2.1)	PVR (1.9)	KANK2 (1.8)	GPAM (1.7)	HP (1.5)	ENSG00000228044 (1.5)	OGDH (1.5)	BCL3 (1.4)	ACAD10 (1.3)
ENSG00000148180	GSN PPI subnetwork	0.72	> 0.20	ITGB3 (3.3)	KANK2 (3.0)	PVRL2 (2.6)	GMIP (2.6)	ADAM1 (2.4)	FRK (2.1)	GATAD2A (2.1)	PLEC (1.8)	DNM2 (1.8)	OGDH (1.7)
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	0.72	> 0.20	POC5 (3.0)	FEN1 (2.8)	RHCE (2.3)	ATP13A1 (2.2)	ENSG00000235545 (2.2)	PSRC1 (2.2)	MAU2 (2.0)	POLK (2.0)	ENSG00000228044 (2.0)	PLEC (1.6)
ENSG00000160087	UBE2J2 PPI subnetwork	0.72	> 0.20	DHX38 (2.7)	ATP13A1 (2.6)	PSMA5 (2.2)	ZHX3 (2.2)	PTPN11 (2.1)	NAA25 (2.1)	DOCK7 (2.0)	ACAD10 (1.8)	ENSG00000235545 (1.7)	DNM2 (1.7)
ENSG00000196923	PDLIM7 PPI subnetwork	0.72	> 0.20	NPC1L1 (2.7)	KANK2 (2.7)	PLEKHH2 (2.5)	PMFBP1 (2.2)	HAPLN4 (2.2)	NCAN (2.2)	BRAP (1.9)	SH2B3 (1.8)	PLEC (1.7)	HLX (1.7)
ENSG00000164045	CDC25A PPI subnetwork	0.72	> 0.20	FEN1 (2.6)	PSRC1 (2.4)	ZHX3 (2.0)	GATAD2A (1.9)	AMIGO1 (1.9)	HLX (1.9)	SLC44A2 (1.7)	RHCE (1.6)	MARK4 (1.6)	RHD (1.6)
ENSG00000113575	PPP2CA PPI subnetwork	0.72	> 0.20	PSMA5 (3.0)	MARK4 (2.9)	TRAFD1 (2.2)	TMEM50A (1.9)	DNM2 (1.7)	SORT1 (1.7)	PVRL2 (1.5)	COL4A3BP (1.4)	TOMM40 (1.4)	GOT2P1 (1.4)
MP:0004542	impaired acrosome reaction	0.72	> 0.20	TSSK6 (5.4)	PMFBP1 (4.6)	SORT1 (1.8)	BCAM (1.5)	PVR (1.5)	APOC1 (1.4)	LDLR (1.4)	FADS1 (1.4)	AP1M2 (1.4)	ABCG8 (1.3)
GO:0061377	mammary gland lobule development	0.72	> 0.20	KIAA1324 (3.3)	GOT2P1 (1.7)	AP1M2 (1.7)	HAPLN4 (1.5)	TMED4 (1.5)	DNAH11 (1.4)	GEMIN7 (1.3)	NT5DC1 (1.2)	ADAM1 (1.2)	PPP1R37 (1.2)
GO:0060749	mammary gland alveolus development	0.72	> 0.20	KIAA1324 (3.3)	GOT2P1 (1.7)	AP1M2 (1.7)	HAPLN4 (1.5)	TMED4 (1.5)	DNAH11 (1.4)	GEMIN7 (1.3)	NT5DC1 (1.2)	ADAM1 (1.2)	PPP1R37 (1.2)
MP:0005498	hyporesponsive to tactile stimuli	0.72	> 0.20	POC5 (2.5)	KIAA1324 (2.5)	RPH3A (2.4)	GMPR (2.0)	ABO (2.0)	RHD (1.6)	POLK (1.5)	HAVCR1 (1.4)	DYNC2LI1 (1.4)	C12orf47 (1.4)
ENSG00000167283	ATP5L PPI subnetwork	0.72	> 0.20	OGDH (3.7)	ACAD10 (2.7)	PSMA5 (2.5)	HAVCR1 (2.4)	GOT2P1 (2.2)	C12orf47 (2.1)	ENSG00000238078 (2.0)	C12orf51 (2.0)	CLPTM1 (2.0)	TOMM40 (1.9)
ENSG00000104320	NBN PPI subnetwork	0.72	> 0.20	FEN1 (3.8)	POLK (2.5)	USP1 (2.5)	DHODH (2.4)	POC5 (2.1)	DYNC2LI1 (2.1)	BLOC1S3 (2.0)	C17orf57 (1.6)	BUD13 (1.5)	UBXN2B (1.5)
ENSG00000154096	THY1 PPI subnetwork	0.72	> 0.20	ERP29 (3.6)	TMED4 (3.0)	CLPTM1 (2.9)	RPH3A (2.8)	NCAN (2.6)	CELSR2 (2.1)	GRINA (2.1)	BCAM (2.1)	YIPF2 (2.1)	CEACAM19 (1.6)
REACTOME_CYCLIN_AB1_ASSOCIATED_EVENTS_DURING_G2M_TRANSITION	REACTOME_CYCLIN_AB1_ASSOCIATED_EVENTS_DURING_G2M_TRANSITION	0.72	> 0.20	PSRC1 (5.8)	FEN1 (3.3)	POC5 (2.8)	ENSG00000226648 (2.6)	USP1 (2.5)	COL4A3BP (1.7)	PBX4 (1.5)	DYNC2LI1 (1.3)	ABCG8 (1.2)	ENSG00000226645 (1.2)
REACTOME_MEIOTIC_SYNAPSIS	REACTOME_MEIOTIC_SYNAPSIS	0.72	> 0.20	USP1 (2.6)	PBX4 (1.6)	FEN1 (1.3)	C1orf63 (1.3)	TMEM116 (1.1)	MYLIP (1.1)	SUGP1 (1.1)	ENSG00000235545 (1.1)	PLEKHH2 (1.0)	DOCK7 (1.0)
GO:0042104	positive regulation of activated T cell proliferation	0.72	> 0.20	PBX4 (2.7)	ANKRD31 (2.3)	HNF1A (1.7)	ENSG00000254235 (1.5)	CILP2 (1.3)	TRAFD1 (1.2)	NAA25 (1.1)	NKPD1 (1.1)	SLC22A1 (1.0)	TIMD4 (1.0)
GO:0070603	SWI/SNF-type complex	0.72	> 0.20	CARM1 (4.0)	SMARCA4 (2.9)	C12orf51 (2.8)	ATXN2 (2.7)	NCAN (2.4)	NYNRIN (2.3)	CELSR2 (2.2)	ILF3 (2.1)	GRINA (2.0)	TMEM57 (2.0)
ENSG00000087903	RFX2 PPI subnetwork	0.72	> 0.20	ATXN2 (2.5)	C12orf51 (1.9)	TOP1 (1.9)	CARM1 (1.9)	USP24 (1.8)	USP1 (1.8)	NCAN (1.6)	DOCK7 (1.5)	LPIN3 (1.4)	MARK4 (1.4)
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	0.72	> 0.20	GEMIN7 (3.6)	C12orf43 (2.0)	QTRT1 (1.9)	TMED4 (1.9)	TXNL4B (1.9)	TRAPPC6A (1.8)	TOMM40 (1.7)	SUGP1 (1.7)	MARK4 (1.7)	DHX38 (1.6)
ENSG00000134440	NARS PPI subnetwork	0.72	> 0.20	C19orf52 (3.2)	TRAPPC6A (2.7)	PLEC (2.5)	RELB (2.5)	MAPKAPK5 (2.0)	SH2B3 (1.7)	QTRT1 (1.7)	ENSG00000254235 (1.7)	BRAP (1.6)	C12orf43 (1.4)
GO:0016591	DNA-directed RNA polymerase II, holoenzyme	0.72	> 0.20	GEMIN7 (3.2)	SUGP1 (2.8)	POC5 (2.7)	MAPKAPK5 (2.6)	UBXN2B (2.5)	ATXN2 (2.3)	BUD13 (2.2)	TOP1 (2.1)	ATXN7L2 (1.8)	ZNF259 (1.8)
GO:0040008	regulation of growth	0.72	> 0.20	CILP2 (2.8)	AMIGO1 (2.6)	TMED4 (2.2)	PVR (2.0)	PVRL2 (1.6)	C12orf43 (1.5)	C11orf9 (1.3)	KIAA1324 (1.3)	PPP1R37 (1.3)	HP (1.2)
MP:0003052	omphalocele	0.72	> 0.20	NYNRIN (4.5)	C11orf9 (2.6)	BCAM (2.0)	MARK4 (1.9)	PVRL2 (1.8)	PLEKHH2 (1.8)	HLX (1.7)	CILP2 (1.7)	GRINA (1.7)	CLPTM1 (1.7)
ENSG00000140740	UQCRC2 PPI subnetwork	0.72	> 0.20	ACAD10 (3.3)	OGDH (2.5)	C19orf52 (2.3)	TRAPPC6A (2.1)	GMPR (1.9)	ABO (1.6)	TOMM40 (1.4)	UBXN2B (1.4)	FADS2 (1.4)	MOSC1 (1.3)
GO:0033280	response to vitamin D	0.72	> 0.20	TMEM116 (1.9)	BLOC1S3 (1.8)	ZNF180 (1.6)	TRAFD1 (1.6)	C17orf57 (1.6)	HLX (1.6)	ENSG00000228044 (1.5)	AP1M2 (1.4)	ENSG00000235545 (1.4)	TMEM57 (1.4)
GO:0031638	zymogen activation	0.72	> 0.20	ENSG00000254235 (3.9)	PCSK9 (2.8)	ENSG00000226648 (2.4)	HNF1A (2.0)	CEACAM19 (1.9)	YIPF2 (1.6)	ANKRD31 (1.4)	PLG (1.4)	ANGPTL3 (1.3)	ENSG00000226645 (1.2)
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	0.72	> 0.20	GATAD2A (2.8)	GMIP (2.7)	LPAR2 (2.5)	CLPTM1 (2.4)	PLEC (2.3)	PBX4 (2.1)	CELSR2 (2.0)	DNM2 (1.6)	TMEM57 (1.6)	SORT1 (1.5)
ENSG00000160145	KALRN PPI subnetwork	0.72	> 0.20	RHD (3.4)	PVRL2 (2.5)	ABO (2.4)	RHCE (2.4)	CETP (2.1)	CEACAM19 (1.9)	ENSG00000238078 (1.5)	ZNF180 (1.5)	CILP2 (1.4)	NKPD1 (1.3)
GO:0006835	dicarboxylic acid transport	0.72	> 0.20	ENSG00000228044 (3.7)	ENSG00000235545 (1.9)	TMEM116 (1.9)	GCNT4 (1.6)	HNF1A (1.6)	SYPL2 (1.6)	PLG (1.5)	PMFBP1 (1.4)	GEMIN7 (1.2)	LPAR2 (1.2)
MP:0002734	abnormal mechanical nociception	0.72	> 0.20	BCAM (2.5)	GCNT4 (2.0)	DNAH11 (1.8)	ENSG00000228044 (1.6)	RPH3A (1.5)	FRK (1.5)	BCL3 (1.4)	AMIGO1 (1.4)	PMFBP1 (1.3)	MOSC1 (1.3)
ENSG00000113319	RASGRF2 PPI subnetwork	0.72	> 0.20	LDLR (2.4)	PVRL2 (2.2)	C11orf9 (2.2)	MAPKAPK5 (2.0)	RELB (1.9)	GEMIN7 (1.9)	TRAPPC6A (1.7)	MOSC1 (1.7)	HMGCR (1.6)	ENSG00000226645 (1.6)
ENSG00000166592	RRAD PPI subnetwork	0.73	> 0.20	CARM1 (2.6)	SYPL2 (2.3)	PLEKHH2 (2.3)	GOT2P1 (2.2)	PTPN11 (1.9)	ENSG00000238078 (1.7)	ZNF101 (1.6)	RPH3A (1.6)	C11orf9 (1.4)	HAPLN4 (1.3)
ENSG00000112305	SMAP1 PPI subnetwork	0.73	> 0.20	TM6SF2 (3.6)	ABCG8 (2.6)	NPC1L1 (2.6)	SYPL2 (2.5)	DNAH11 (1.9)	ALDH2 (1.8)	ST3GAL4 (1.8)	ABCG5 (1.8)	LPIN3 (1.7)	LDLR (1.6)
GO:0048645	organ formation	0.73	> 0.20	ENSG00000238078 (2.8)	PLEKHH2 (2.6)	NYNRIN (2.3)	ATXN7L2 (2.2)	C11orf9 (1.8)	DYNC2LI1 (1.7)	BCAM (1.5)	ZHX3 (1.4)	ANKRD31 (1.4)	ABO (1.3)
GO:0051129	negative regulation of cellular component organization	0.73	> 0.20	NYNRIN (2.5)	C11orf9 (2.2)	PSRC1 (2.1)	TMEM57 (2.0)	C17orf57 (1.8)	TMEM50A (1.5)	RHCE (1.4)	C1orf63 (1.4)	CBLC (1.4)	RHD (1.4)
MP:0000715	decreased thymocyte number	0.73	> 0.20	PLCG1 (3.8)	ZNF101 (3.8)	GMIP (2.3)	TIMD4 (1.8)	RELB (1.8)	BCL3 (1.7)	PBX4 (1.6)	USP24 (1.6)	GCNT4 (1.5)	CETP (1.4)
GO:0045646	regulation of erythrocyte differentiation	0.73	> 0.20	RHCE (3.6)	TMEM57 (3.4)	RHD (2.7)	ENSG00000226648 (1.9)	ENSG00000226645 (1.8)	ABO (1.8)	PBX4 (1.7)	ITGB3 (1.7)	C19orf52 (1.7)	CYB561D1 (1.6)
MP:0002765	short fibula	0.73	> 0.20	PLEKHH2 (2.8)	HAPLN4 (2.3)	DYNC2LI1 (1.6)	CBLC (1.6)	GOT2P1 (1.5)	NYNRIN (1.4)	ST3GAL4 (1.4)	ZHX3 (1.3)	YIPF2 (1.3)	CILP2 (1.2)
GO:0007398	ectoderm development	0.73	> 0.20	NKPD1 (3.0)	ABO (2.9)	TMEM116 (2.9)	PMFBP1 (2.8)	C19orf52 (2.0)	TMEM57 (1.8)	ENSG00000254235 (1.7)	BLOC1S3 (1.7)	LPAR2 (1.7)	ZHX3 (1.6)
ENSG00000149806	FAU PPI subnetwork	0.73	> 0.20	NKPD1 (2.8)	SARS (2.1)	ADAM1 (2.0)	NAA25 (1.9)	ANKRD31 (1.8)	C12orf43 (1.7)	ILF3 (1.5)	DDX56 (1.5)	CEACAM19 (1.4)	SUGP1 (1.3)
ENSG00000110436	SLC1A2 PPI subnetwork	0.73	> 0.20	HAPLN4 (3.2)	RPH3A (2.8)	ALDH2 (2.7)	MOSC1 (2.0)	ENSG00000235545 (1.8)	C11orf9 (1.8)	NCAN (1.7)	NT5DC1 (1.6)	ENSG00000254235 (1.5)	CELSR2 (1.4)
ENSG00000101444	AHCY PPI subnetwork	0.73	> 0.20	ZNF259 (4.3)	NAA25 (3.2)	DDX56 (3.1)	TOMM40 (2.8)	SARS (2.5)	QTRT1 (2.3)	ENSG00000226645 (1.9)	ADAM1 (1.9)	MAPKAPK5 (1.7)	PSMA5 (1.5)
GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB cascade	0.73	> 0.20	GOT2P1 (2.9)	C17orf57 (1.5)	ABO (1.5)	FRK (1.5)	POLK (1.4)	GEMIN7 (1.4)	PMFBP1 (1.4)	CYB561D1 (1.4)	TRAPPC6A (1.3)	ZNF259 (1.3)
GO:0008156	negative regulation of DNA replication	0.73	> 0.20	POLK (3.0)	BLOC1S3 (2.8)	BUD13 (2.0)	POC5 (2.0)	DNAH11 (1.7)	SUGP1 (1.5)	USP1 (1.5)	UBXN2B (1.3)	ENSG00000235545 (1.3)	GOT2P1 (1.1)
GO:0045672	positive regulation of osteoclast differentiation	0.73	> 0.20	ADAM1 (2.0)	DNAH11 (1.9)	C19orf52 (1.5)	SLC22A1 (1.4)	MYLIP (1.4)	ENSG00000235545 (1.3)	RHCE (1.3)	SH2B3 (1.2)	PBX4 (1.2)	NKPD1 (1.1)
ENSG00000148516	ZEB1 PPI subnetwork	0.73	> 0.20	ATXN7L2 (2.2)	DOCK7 (2.1)	BUD13 (2.0)	FADS2 (1.9)	CYB561D1 (1.7)	ATXN2 (1.7)	ST3GAL4 (1.7)	FADS1 (1.6)	LDLR (1.5)	MYLIP (1.5)
ENSG00000105613	MAST1 PPI subnetwork	0.73	> 0.20	C12orf51 (2.9)	ZHX3 (2.3)	ENSG00000235545 (2.1)	KANK2 (1.9)	COL4A3BP (1.8)	GPAM (1.8)	SYPL2 (1.7)	MAFB (1.6)	PTPN11 (1.6)	MYLIP (1.5)
ENSG00000159348	CYB5R1 PPI subnetwork	0.73	> 0.20	CLPTM1 (3.3)	FADS2 (2.5)	ATP13A1 (1.8)	ST3GAL4 (1.8)	SORT1 (1.8)	TMEM50A (1.8)	HMGCR (1.7)	ENSG00000228044 (1.6)	BLOC1S3 (1.6)	LDLR (1.5)
GO:0048754	branching morphogenesis of a tube	0.73	> 0.20	PLEKHH2 (2.9)	PVRL2 (2.7)	MYLIP (2.4)	BCAM (2.3)	NYNRIN (2.2)	KIAA1324 (2.1)	HNF1A (2.0)	AP1M2 (1.8)	ENSG00000254235 (1.7)	KANK2 (1.5)
GO:0000819	sister chromatid segregation	0.73	> 0.20	PSRC1 (4.3)	POC5 (3.8)	ENSG00000228044 (2.2)	DNAH11 (2.1)	USP1 (2.0)	C19orf52 (1.7)	ILF3 (1.7)	FEN1 (1.7)	AMIGO1 (1.6)	MAU2 (1.6)
GO:0030101	natural killer cell activation	0.73	> 0.20	CYB561D1 (2.6)	GEMIN7 (2.1)	ANKRD31 (2.0)	BLOC1S3 (1.7)	ZNF180 (1.7)	PBX4 (1.7)	TIMD4 (1.6)	ENSG00000228044 (1.5)	LPIN3 (1.4)	C12orf43 (1.4)
ENSG00000143256	PFDN2 PPI subnetwork	0.73	> 0.20	MAPKAPK5 (2.4)	GEMIN7 (2.4)	C12orf43 (2.4)	POC5 (1.9)	ADAM1 (1.8)	PSRC1 (1.6)	C12orf47 (1.6)	TMED4 (1.6)	USP1 (1.6)	TOP1 (1.5)
GO:0005085	guanyl-nucleotide exchange factor activity	0.73	> 0.20	SH2B3 (3.4)	C12orf51 (3.1)	DNM2 (2.9)	USP24 (2.9)	PLCG1 (2.6)	GMIP (2.3)	PLEC (2.0)	ZHX3 (2.0)	HLX (2.0)	PPP1R37 (1.7)
GO:0035815	positive regulation of renal sodium excretion	0.73	> 0.20	CEACAM19 (2.6)	HNF1A (2.3)	C11orf9 (1.8)	ANGPTL3 (1.7)	GOT2P1 (1.5)	LPA (1.5)	HAVCR1 (1.5)	NKPD1 (1.5)	PLG (1.4)	PMFBP1 (1.4)
ENSG00000108298	RPL19 PPI subnetwork	0.73	> 0.20	NAA25 (2.6)	ZNF259 (2.1)	DDX56 (2.0)	SUGP1 (1.9)	NKPD1 (1.9)	SARS (1.8)	ADAM1 (1.7)	C12orf43 (1.6)	GATAD2A (1.6)	TOP1 (1.5)
MP:0011083	complete lethality at weaning	0.73	> 0.20	HAPLN4 (3.0)	RPH3A (2.5)	CLPTM1 (2.2)	HAVCR1 (1.9)	OASL (1.8)	CELSR2 (1.7)	GRINA (1.6)	BCAM (1.6)	PCSK9 (1.5)	PARP10 (1.5)
ENSG00000143228	NUF2 PPI subnetwork	0.73	> 0.20	PSRC1 (5.7)	FEN1 (4.4)	POC5 (4.0)	USP1 (3.5)	ENSG00000226648 (1.0)	ZNF180 (0.9)	ENSG00000228044 (0.9)	LPIN3 (0.8)	ZHX3 (0.7)	HMGCR (0.6)
GO:0032129	histone deacetylase activity (H3-K9 specific)	0.73	> 0.20	ATXN7L2 (2.7)	HNF1A (2.3)	PLCG1 (1.5)	SUGP1 (1.4)	NT5DC1 (1.4)	ST3GAL4 (1.2)	DHX38 (1.1)	RELB (1.1)	C1orf63 (1.1)	PSRC1 (1.1)
GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	0.73	> 0.20	ATXN7L2 (2.7)	HNF1A (2.3)	PLCG1 (1.5)	SUGP1 (1.4)	NT5DC1 (1.4)	ST3GAL4 (1.2)	DHX38 (1.1)	RELB (1.1)	C1orf63 (1.1)	PSRC1 (1.1)
ENSG00000197535	MYO5A PPI subnetwork	0.73	> 0.20	KIAA1324 (3.9)	PPP1R37 (2.3)	KANK2 (1.6)	RPH3A (1.6)	MYLIP (1.5)	TMEM116 (1.5)	COL4A3BP (1.5)	POLK (1.4)	ATXN2 (1.4)	ALDH2 (1.4)
GO:0003206	cardiac chamber morphogenesis	0.73	> 0.20	ENSG00000238078 (2.8)	ATXN7L2 (2.3)	C11orf9 (2.1)	C19orf52 (1.7)	NYNRIN (1.5)	CEACAM19 (1.4)	CILP2 (1.3)	ENSG00000254235 (1.3)	ALDH2 (1.2)	PVRL2 (1.1)
GO:0005657	replication fork	0.73	> 0.20	FEN1 (6.0)	USP1 (5.7)	ENSG00000235545 (2.5)	AMIGO1 (1.8)	PSRC1 (1.4)	ILF3 (1.4)	BUD13 (1.3)	PPP1R37 (1.3)	ZNF180 (1.3)	NT5DC1 (1.3)
ENSG00000198056	PRIM1 PPI subnetwork	0.73	> 0.20	FEN1 (5.7)	USP1 (4.8)	ENSG00000228044 (1.8)	GOT2P1 (1.6)	ZNF180 (1.6)	ILF3 (1.6)	DHODH (1.6)	POC5 (1.4)	NT5DC1 (1.4)	PSRC1 (1.3)
GO:0032147	activation of protein kinase activity	0.73	> 0.20	ENSG00000228044 (3.0)	SH2B3 (2.2)	PTPN11 (2.0)	CYB561D1 (2.0)	POLK (2.0)	AMIGO1 (1.9)	LPIN3 (1.8)	ITGB3 (1.7)	MARK4 (1.4)	PVR (1.4)
ENSG00000163235	TGFA PPI subnetwork	0.73	> 0.20	YIPF2 (2.4)	HP (2.4)	SORT1 (2.4)	AMIGO1 (2.1)	PTPN11 (2.1)	NCAN (2.0)	TMED4 (1.8)	ENSG00000226648 (1.6)	LPIN3 (1.6)	CBLC (1.6)
ENSG00000138081	FBXO11 PPI subnetwork	0.73	> 0.20	CLPTM1 (1.8)	GOT2P1 (1.8)	NT5DC1 (1.8)	DYNC2LI1 (1.8)	PSMA5 (1.7)	GRINA (1.7)	ADAM1 (1.6)	MARK4 (1.5)	TRAPPC6A (1.4)	ENSG00000238078 (1.3)
ENSG00000140403	DNAJA4 PPI subnetwork	0.73	> 0.20	UBXN2B (3.0)	GMPR (2.6)	CYP7A1 (1.8)	DNAH11 (1.8)	MYLIP (1.7)	PBX4 (1.6)	SARS (1.5)	GRINA (1.5)	ENSG00000238078 (1.4)	C11orf9 (1.3)
GO:0003084	positive regulation of systemic arterial blood pressure	0.73	> 0.20	ENSG00000228044 (2.8)	CEACAM19 (2.4)	ZHX3 (2.3)	ST3GAL4 (2.0)	ENSG00000235545 (2.0)	TMEM116 (1.7)	LPIN3 (1.7)	NKPD1 (1.1)	C12orf47 (0.9)	NYNRIN (0.9)
MP:0000297	abnormal atrioventricular cushion morphology	0.73	> 0.20	HAVCR1 (3.3)	NYNRIN (2.4)	C11orf9 (2.1)	BCAM (1.9)	APOB (1.8)	TMEM57 (1.8)	C17orf57 (1.7)	TRIB1 (1.5)	PCSK9 (1.3)	MYLIP (1.3)
ENSG00000100599	RIN3 PPI subnetwork	0.73	> 0.20	GATAD2A (3.9)	PPP1R37 (3.7)	ZHX3 (3.0)	C17orf57 (2.4)	CLPTM1 (2.1)	SH2B3 (1.9)	PTPN11 (1.9)	PMFBP1 (1.8)	COL4A3BP (1.7)	ABO (1.7)
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	0.73	> 0.20	SYPL2 (3.4)	NCAN (2.5)	CYB561D1 (2.1)	AMIGO1 (2.1)	MAPKAPK5 (2.0)	RPH3A (1.9)	CELSR2 (1.9)	NT5DC1 (1.9)	NPC1L1 (1.6)	C12orf43 (1.6)
ENSG00000092330	TINF2 PPI subnetwork	0.73	> 0.20	TXNL4B (3.1)	POLK (2.6)	UBXN2B (2.2)	TMEM116 (2.0)	DHODH (2.0)	TMEM57 (1.8)	USP1 (1.7)	NKPD1 (1.6)	SUGP1 (1.6)	DHX38 (1.4)
ENSG00000122952	ZWINT PPI subnetwork	0.73	> 0.20	PSRC1 (5.8)	FEN1 (4.5)	POC5 (3.8)	USP1 (3.7)	ENSG00000226648 (1.1)	ZHX3 (1.0)	ENSG00000228044 (1.0)	ZNF180 (0.8)	TMEM116 (0.6)	CEACAM19 (0.6)
GO:0005852	eukaryotic translation initiation factor 3 complex	0.73	> 0.20	C19orf52 (2.7)	QTRT1 (2.7)	SARS (2.6)	ANKRD31 (2.4)	ZNF259 (2.3)	PSMA5 (2.3)	DDX56 (2.2)	PLEC (2.1)	ADAM1 (2.1)	UBXN2B (2.0)
ENSG00000104067	TJP1 PPI subnetwork	0.73	> 0.20	AP1M2 (5.0)	PVRL2 (3.0)	BCAM (2.9)	CBLC (2.8)	CELSR2 (2.3)	C1orf63 (1.9)	HAPLN4 (1.9)	CLPTM1 (1.8)	SORT1 (1.7)	PVR (1.6)
ENSG00000198722	UNC13B PPI subnetwork	0.73	> 0.20	RPH3A (2.6)	PBX4 (2.3)	HNF1A (2.1)	C12orf43 (1.9)	AMIGO1 (1.6)	C12orf51 (1.6)	ENSG00000238078 (1.5)	ZNF180 (1.5)	ABCG8 (1.4)	C12orf47 (1.3)
MP:0004272	abnormal basement membrane morphology	0.73	> 0.20	PVRL2 (3.8)	BCAM (2.9)	AP1M2 (2.6)	KANK2 (2.6)	ERP29 (2.4)	PVR (2.1)	APOE (1.6)	PLEC (1.6)	ST3GAL4 (1.5)	NYNRIN (1.5)
ENSG00000120334	CENPL PPI subnetwork	0.73	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.4)	ENSG00000228044 (1.1)	ENSG00000226648 (1.1)	ZNF180 (0.9)	ZHX3 (0.9)	USP24 (0.7)	LPIN3 (0.7)
GO:0001893	maternal placenta development	0.73	> 0.20	TMED4 (2.6)	PLEKHH2 (2.5)	ENSG00000228044 (2.5)	UBXN2B (1.7)	YIPF2 (1.6)	ATXN7L2 (1.6)	LPIN3 (1.4)	AP1M2 (1.4)	TRIB1 (1.3)	KIAA1324 (1.3)
GO:0061180	mammary gland epithelium development	0.73	> 0.20	KIAA1324 (2.8)	PPP1R37 (2.4)	PLEKHH2 (2.2)	AP1M2 (1.7)	ENSG00000226648 (1.4)	TRAPPC6A (1.4)	ENSG00000254235 (1.3)	MYLIP (1.3)	CLPTM1 (1.2)	CELSR2 (1.2)
GO:0061098	positive regulation of protein tyrosine kinase activity	0.73	> 0.20	ANKRD31 (3.0)	ENSG00000228044 (3.0)	AP1M2 (2.2)	TSSK6 (1.9)	TMED4 (1.9)	CEACAM19 (1.7)	FRK (1.7)	SYPL2 (1.3)	CELSR2 (1.2)	HNF1A (1.2)
GO:0051291	protein heterooligomerization	0.73	> 0.20	ADAM1 (2.7)	ABO (2.7)	ENSG00000228044 (2.0)	NT5DC1 (1.9)	FRK (1.8)	PTPN11 (1.7)	OGDH (1.6)	C12orf43 (1.6)	C12orf47 (1.4)	PLEC (1.4)
GO:0030851	granulocyte differentiation	0.73	> 0.20	RHCE (3.0)	RHD (2.7)	TMEM57 (2.4)	ITGB3 (2.4)	C1orf63 (2.0)	ST3GAL4 (1.8)	GMPR (1.7)	ENSG00000238078 (1.5)	SH2B3 (1.3)	ANKRD31 (1.2)
GO:0043631	RNA polyadenylation	0.73	> 0.20	UBXN2B (2.3)	ZNF180 (1.9)	C17orf57 (1.8)	NT5DC1 (1.8)	ATP13A1 (1.6)	ADAM1 (1.6)	DOCK7 (1.5)	TSSK6 (1.5)	HAVCR1 (1.4)	ATXN7L2 (1.4)
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	0.73	> 0.20	OGDH (5.4)	ACAD10 (4.2)	GMPR (2.7)	CLPTM1 (2.4)	GPAM (2.0)	TOMM40 (1.6)	C19orf52 (1.6)	GOT2P1 (1.5)	SYPL2 (1.5)	NT5DC1 (1.5)
REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	0.73	> 0.20	NKPD1 (3.2)	SARS (3.0)	DDX56 (2.3)	C12orf43 (2.0)	ANKRD31 (1.9)	SUGP1 (1.9)	ILF3 (1.8)	TMEM57 (1.8)	ATP13A1 (1.8)	NAA25 (1.7)
REACTOME_CAP:DEPENDENT_TRANSLATION_INITIATION	REACTOME_CAP:DEPENDENT_TRANSLATION_INITIATION	0.73	> 0.20	NKPD1 (3.2)	SARS (3.0)	DDX56 (2.3)	C12orf43 (2.0)	ANKRD31 (1.9)	SUGP1 (1.9)	ILF3 (1.8)	TMEM57 (1.8)	ATP13A1 (1.8)	NAA25 (1.7)
GO:0003016	respiratory system process	0.73	> 0.20	ANKRD31 (3.3)	TSSK6 (3.0)	AMIGO1 (2.4)	ENSG00000228044 (2.0)	HAVCR1 (2.0)	HAPLN4 (1.9)	NCAN (1.9)	BLOC1S3 (1.7)	ENSG00000226648 (1.6)	PBX4 (1.5)
ENSG00000143669	LYST PPI subnetwork	0.73	> 0.20	MARK4 (2.1)	ZHX3 (1.9)	TOMM40 (1.8)	RPH3A (1.8)	SMARCA4 (1.7)	ILF3 (1.7)	CLPTM1 (1.7)	CARM1 (1.6)	PPP1R37 (1.5)	HLX (1.4)
MP:0003992	increased mortality induced by ionizing radiation	0.73	> 0.20	POLK (2.8)	ENSG00000226648 (2.3)	DOCK7 (2.3)	UBXN2B (2.0)	PTPN11 (1.9)	PSRC1 (1.8)	C12orf47 (1.8)	ENSG00000235545 (1.7)	GEMIN7 (1.7)	FEN1 (1.5)
ENSG00000125447	GGA3 PPI subnetwork	0.73	> 0.20	C12orf51 (3.5)	COL4A3BP (2.9)	BRAP (2.5)	CLPTM1 (2.4)	SH2B3 (2.2)	ATXN2 (2.1)	UBXN2B (2.0)	PPP1R37 (1.9)	ATP13A1 (1.9)	NAA25 (1.7)
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	0.73	> 0.20	CARM1 (3.9)	ATXN2 (3.4)	TRAFD1 (3.3)	C12orf51 (2.2)	GEMIN7 (2.0)	POLK (1.8)	MAU2 (1.8)	COL4A3BP (1.7)	ENSG00000226645 (1.7)	USP24 (1.6)
GO:0043470	regulation of carbohydrate catabolic process	0.73	> 0.20	HNF1A (2.6)	ZHX3 (2.2)	ST3GAL4 (1.7)	PMFBP1 (1.7)	PCSK9 (1.5)	ENSG00000254235 (1.5)	TSSK6 (1.5)	TXNL4B (1.4)	KANK2 (1.4)	HAPLN4 (1.4)
GO:0043471	regulation of cellular carbohydrate catabolic process	0.73	> 0.20	HNF1A (2.6)	ZHX3 (2.2)	ST3GAL4 (1.7)	PMFBP1 (1.7)	PCSK9 (1.5)	ENSG00000254235 (1.5)	TSSK6 (1.5)	TXNL4B (1.4)	KANK2 (1.4)	HAPLN4 (1.4)
ENSG00000174791	RIN1 PPI subnetwork	0.73	> 0.20	PVRL2 (2.5)	GRINA (2.2)	DNM2 (2.1)	BCAM (1.9)	ABO (1.8)	TOP1 (1.8)	LDLR (1.7)	NAA25 (1.6)	COL4A3BP (1.6)	C11orf9 (1.5)
GO:0042578	phosphoric ester hydrolase activity	0.73	> 0.20	SORT1 (2.7)	AMIGO1 (2.5)	TRIB1 (2.5)	SH2B3 (2.1)	LPIN3 (1.7)	ZHX3 (1.6)	HLX (1.5)	NT5DC1 (1.5)	ST3GAL4 (1.4)	GMPR (1.3)
MP:0002184	abnormal innervation	0.73	> 0.20	CELSR2 (2.0)	HLX (2.0)	CILP2 (2.0)	BCAM (1.8)	NCAN (1.8)	LDLR (1.7)	MAFB (1.6)	DNAH11 (1.6)	TSSK6 (1.6)	RPH3A (1.6)
ENSG00000071127	WDR1 PPI subnetwork	0.73	> 0.20	NPC1L1 (2.5)	PVR (2.0)	CYB561D1 (1.9)	TXNL4B (1.8)	FRK (1.7)	HAPLN4 (1.7)	KANK2 (1.7)	TM6SF2 (1.6)	PLCG1 (1.6)	HLX (1.5)
MP:0004404	cochlear outer hair cell degeneration	0.73	> 0.20	HNF1A (2.4)	FRK (2.3)	AP1M2 (2.2)	BCAM (2.1)	GPAM (2.0)	ABO (2.0)	APOC1 (1.9)	SLC44A2 (1.5)	ZNF101 (1.5)	SORT1 (1.4)
GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	0.73	> 0.20	USP24 (3.6)	ATXN2 (3.2)	ADAM1 (3.1)	BRAP (2.5)	ZNF180 (2.3)	C12orf51 (2.3)	ZHX3 (2.1)	GCNT4 (1.8)	C19orf52 (1.7)	NKPD1 (1.7)
MP:0002041	increased pituitary adenoma incidence	0.73	> 0.20	GEMIN7 (2.8)	C12orf47 (2.4)	MAU2 (2.2)	YIPF2 (2.1)	C19orf52 (2.1)	ZHX3 (1.9)	HAVCR1 (1.9)	C1orf63 (1.6)	MOSC1 (1.5)	ENSG00000238078 (1.4)
MP:0000516	abnormal renal/urinary system morphology	0.73	> 0.20	NYNRIN (3.9)	KANK2 (3.4)	HLX (2.6)	C11orf9 (2.5)	ABCG8 (2.4)	PVRL2 (2.1)	ABCG5 (2.0)	TMED4 (1.6)	CYP7A1 (1.4)	CYB561D1 (1.4)
MP:0009655	abnormal secondary palate development	0.73	> 0.20	ANKRD31 (2.8)	APOE (2.2)	HLX (1.7)	CBLC (1.6)	PTPN11 (1.6)	SLC22A1 (1.5)	TRAFD1 (1.5)	DOCK7 (1.4)	TIMD4 (1.4)	PLEKHH2 (1.3)
ENSG00000137764	MAP2K5 PPI subnetwork	0.73	> 0.20	TXNL4B (2.5)	DYNC2LI1 (2.3)	UBXN2B (1.9)	CYB561D1 (1.8)	BLOC1S3 (1.5)	BRAP (1.4)	COL4A3BP (1.3)	PLEKHH2 (1.2)	ENSG00000226645 (1.2)	KIAA1324 (1.2)
ENSG00000002822	MAD1L1 PPI subnetwork	0.73	> 0.20	PSRC1 (5.9)	FEN1 (4.2)	USP1 (3.6)	POC5 (3.5)	ENSG00000228044 (1.3)	ZNF180 (1.2)	C17orf57 (1.1)	ENSG00000226648 (0.9)	ILF3 (0.7)	CEACAM19 (0.7)
REACTOME_JNK_C:JUN_KINASES_PHOSPHORYLATION_AND__ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	REACTOME_JNK_C:JUN_KINASES_PHOSPHORYLATION_AND__ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	0.73	> 0.20	BLOC1S3 (2.4)	UBXN2B (2.3)	RELB (2.2)	ENSG00000228044 (2.0)	NT5DC1 (2.0)	PVR (1.7)	PARP10 (1.5)	GEMIN7 (1.5)	PTPN11 (1.5)	MAPKAPK5 (1.4)
MP:0003632	abnormal nervous system morphology	0.73	> 0.20	SORT1 (2.3)	NCAN (2.2)	CELSR2 (2.1)	MAFB (2.0)	APOE (1.7)	GRINA (1.7)	CETP (1.6)	HAVCR1 (1.5)	TIMD4 (1.4)	USP24 (1.3)
GO:0070661	leukocyte proliferation	0.73	> 0.20	TIMD4 (3.1)	PBX4 (3.0)	CETP (2.2)	ZNF101 (1.8)	HLX (1.7)	POLK (1.6)	GMIP (1.5)	TRAFD1 (1.4)	ADAM1 (1.3)	GCNT4 (1.2)
GO:0032947	protein complex scaffold	0.73	> 0.20	PLCG1 (2.9)	OGDH (2.5)	C17orf57 (2.4)	POLK (1.9)	PPP1R37 (1.8)	C12orf51 (1.8)	GOT2P1 (1.7)	GCNT4 (1.7)	MARK4 (1.7)	AMIGO1 (1.5)
MP:0001544	abnormal cardiovascular system physiology	0.73	> 0.20	BCAM (3.3)	ALDH2 (1.9)	KANK2 (1.6)	NYNRIN (1.5)	HAVCR1 (1.3)	PVR (1.2)	LPA (1.1)	BCL3 (1.1)	MARK4 (1.1)	GPAM (1.1)
GO:0005614	interstitial matrix	0.73	> 0.20	CILP2 (3.8)	ABO (2.2)	KIAA1324 (2.2)	CEACAM19 (2.0)	TIMD4 (1.6)	BCAM (1.6)	KANK2 (1.4)	APOE (1.3)	MAPKAPK5 (1.3)	NPC1L1 (1.2)
MP:0010903	abnormal pulmonary alveolus wall morphology	0.73	> 0.20	RHD (3.0)	RHCE (3.0)	ST3GAL4 (2.3)	TMEM57 (2.2)	YIPF2 (2.2)	NYNRIN (1.8)	PLEKHH2 (1.6)	SLC44A2 (1.6)	PLEC (1.5)	CARM1 (1.5)
GO:0006968	cellular defense response	0.73	> 0.20	TIMD4 (2.0)	ANKRD31 (1.9)	CEACAM19 (1.9)	MAFB (1.8)	C19orf52 (1.6)	CYB561D1 (1.5)	TMEM116 (1.2)	GMIP (1.1)	AMIGO1 (1.1)	SLC44A2 (1.0)
ENSG00000181789	COPG PPI subnetwork	0.73	> 0.20	PSMA5 (3.0)	YIPF2 (2.8)	DDX56 (2.5)	ZNF259 (2.5)	NAA25 (2.5)	HMGCR (2.3)	TMEM57 (1.9)	SARS (1.9)	C12orf43 (1.9)	MAPKAPK5 (1.8)
ENSG00000141720	PIP4K2B PPI subnetwork	0.73	> 0.20	ITGB3 (2.6)	TOMM40 (2.2)	PTPN11 (2.2)	ATXN2 (2.1)	CARM1 (2.1)	PVRL2 (2.1)	PLEC (2.0)	USP24 (1.9)	KANK2 (1.8)	ALDH2 (1.7)
ENSG00000141959	PFKL PPI subnetwork	0.73	> 0.20	CLPTM1 (2.4)	GOT2P1 (2.3)	PPP1R37 (2.3)	BCL3 (2.0)	OGDH (1.7)	C1orf63 (1.7)	ATXN2 (1.6)	C12orf51 (1.6)	ANKRD31 (1.6)	CELSR2 (1.6)
ENSG00000124802	EEF1E1 PPI subnetwork	0.73	> 0.20	SARS (7.1)	ZNF259 (3.4)	NAA25 (3.1)	QTRT1 (2.4)	DDX56 (2.0)	C12orf47 (2.0)	SUGP1 (1.9)	PSMA5 (1.9)	POC5 (1.9)	YIPF2 (1.8)
ENSG00000138190	EXOC6 PPI subnetwork	0.73	> 0.20	POLK (3.6)	ENSG00000238078 (2.0)	NT5DC1 (2.0)	FRK (2.0)	PSMA5 (1.9)	COL4A3BP (1.8)	CYB561D1 (1.7)	PTPN11 (1.7)	MAU2 (1.6)	NKPD1 (1.6)
GO:0043218	compact myelin	0.73	> 0.20	C11orf9 (5.7)	HAPLN4 (3.0)	FRK (2.1)	TSSK6 (1.9)	PLEC (1.9)	TXNL4B (1.8)	AP1M2 (1.6)	APOE (1.5)	SORT1 (1.5)	GCNT4 (1.4)
ENSG00000205918	ENSG00000205918 PPI subnetwork	0.73	> 0.20	TM6SF2 (2.9)	MYLIP (2.8)	ABCG8 (2.3)	ENSG00000226645 (2.3)	ABCG5 (1.9)	NPC1L1 (1.8)	MAU2 (1.7)	TRIB1 (1.6)	LDLR (1.6)	ADAM1 (1.6)
ENSG00000138411	HECW2 PPI subnetwork	0.73	> 0.20	TSSK6 (3.3)	ALDH2 (2.4)	SUGP1 (2.2)	MAPKAPK5 (2.1)	ENSG00000254235 (1.8)	ABO (1.8)	OGDH (1.6)	YIPF2 (1.6)	TMEM57 (1.6)	SMARCA4 (1.5)
GO:0031532	actin cytoskeleton reorganization	0.73	> 0.20	ENSG00000228044 (2.7)	COL4A3BP (1.9)	FRK (1.8)	ENSG00000254235 (1.7)	PLEKHH2 (1.7)	ANKRD31 (1.7)	ABO (1.4)	DNAH11 (1.4)	LPAR2 (1.3)	GMIP (1.2)
REACTOME_NOTCH:HLH_TRANSCRIPTION_PATHWAY	REACTOME_NOTCH:HLH_TRANSCRIPTION_PATHWAY	0.73	> 0.20	SH2B3 (2.8)	PLCG1 (2.6)	USP24 (2.4)	CELSR2 (2.1)	NYNRIN (2.1)	NCAN (2.0)	GATAD2A (2.0)	HLX (1.9)	PLEC (1.8)	C12orf51 (1.6)
REACTOME_NICD_TRAFFICS_TO_NUCLEUS	REACTOME_NICD_TRAFFICS_TO_NUCLEUS	0.73	> 0.20	SH2B3 (2.8)	PLCG1 (2.6)	USP24 (2.4)	CELSR2 (2.1)	NYNRIN (2.1)	NCAN (2.0)	GATAD2A (2.0)	HLX (1.9)	PLEC (1.8)	C12orf51 (1.6)
MP:0000788	abnormal cerebral cortex morphology	0.73	> 0.20	NCAN (4.5)	CELSR2 (3.3)	OASL (2.0)	SORT1 (2.0)	GRINA (1.7)	CLPTM1 (1.6)	APOC1 (1.5)	APOE (1.5)	DOCK7 (1.5)	PTPN11 (1.5)
GO:0051287	NAD binding	0.73	> 0.20	ACAD10 (3.5)	ALDH2 (2.8)	GMPR (2.4)	GPAM (2.3)	TRAPPC6A (1.9)	C19orf52 (1.9)	MOSC1 (1.8)	OGDH (1.8)	SARS (1.5)	HAPLN4 (1.5)
GO:0035909	aorta morphogenesis	0.73	> 0.20	TSSK6 (2.4)	BLOC1S3 (1.7)	PPP1R37 (1.7)	CEACAM19 (1.5)	ATXN7L2 (1.4)	CARM1 (1.4)	FRK (1.3)	C19orf52 (1.3)	ENSG00000238078 (1.3)	KIAA1324 (1.1)
GO:0035904	aorta development	0.73	> 0.20	TSSK6 (2.4)	BLOC1S3 (1.7)	PPP1R37 (1.7)	CEACAM19 (1.5)	ATXN7L2 (1.4)	CARM1 (1.4)	FRK (1.3)	C19orf52 (1.3)	ENSG00000238078 (1.3)	KIAA1324 (1.1)
GO:0017124	SH3 domain binding	0.73	> 0.20	SH2B3 (3.9)	GMIP (3.0)	PPP1R37 (2.8)	DNM2 (2.6)	C12orf51 (2.2)	MAFB (2.1)	NT5DC1 (2.0)	MARK4 (1.9)	PARP10 (1.9)	AP1M2 (1.7)
MP:0005159	azoospermia	0.73	> 0.20	PBX4 (2.5)	PLEKHH2 (2.0)	GATAD2A (1.7)	TSSK6 (1.6)	ANKRD31 (1.5)	PCSK9 (1.5)	TMEM116 (1.4)	C11orf9 (1.4)	BRAP (1.3)	KANK2 (1.3)
GO:0006473	protein acetylation	0.73	> 0.20	ATXN7L2 (3.5)	ILF3 (2.6)	BUD13 (2.5)	ZNF180 (2.2)	BRAP (2.0)	ZNF101 (1.8)	MAPKAPK5 (1.6)	PLCG1 (1.5)	UBXN2B (1.5)	CARM1 (1.4)
GO:0048546	digestive tract morphogenesis	0.73	> 0.20	C11orf9 (3.6)	NYNRIN (3.3)	PLEKHH2 (2.9)	LPAR2 (2.5)	ENSG00000235545 (2.3)	ENSG00000228044 (2.1)	DYNC2LI1 (1.9)	CBLC (1.7)	ABO (1.6)	NKPD1 (1.4)
GO:0009620	response to fungus	0.73	> 0.20	CYB561D1 (2.5)	PMFBP1 (2.1)	GCNT4 (2.0)	GOT2P1 (1.7)	HP (1.7)	ABCG5 (1.7)	GMIP (1.4)	MOSC1 (1.4)	HLX (1.4)	C19orf52 (1.2)
MP:0009397	increased trophoblast giant cell number	0.73	> 0.20	BCL3 (2.9)	C12orf51 (2.0)	MAPKAPK5 (2.0)	LDLR (1.9)	ADAM1 (1.9)	TRIB1 (1.5)	CILP2 (1.5)	PVR (1.5)	ATXN2 (1.4)	ENSG00000254235 (1.4)
ENSG00000164053	ATRIP PPI subnetwork	0.73	> 0.20	USP1 (4.2)	FEN1 (3.3)	ZNF180 (1.9)	NT5DC1 (1.8)	C1orf63 (1.8)	ENSG00000235545 (1.6)	AMIGO1 (1.5)	DNAH11 (1.5)	ERP29 (1.4)	HAVCR1 (1.3)
ENSG00000188021	UBQLN2 PPI subnetwork	0.73	> 0.20	TMED4 (3.0)	NAA25 (3.0)	TMEM57 (2.9)	DDX56 (2.1)	YIPF2 (1.9)	USP24 (1.9)	TMEM50A (1.8)	ENSG00000228044 (1.7)	CLPTM1 (1.7)	OGDH (1.6)
ENSG00000173914	RBM4B PPI subnetwork	0.73	> 0.20	RPH3A (2.9)	PTPN11 (2.2)	ADAM1 (2.1)	ENSG00000226645 (1.8)	ST3GAL4 (1.8)	APOC1 (1.8)	MOSC1 (1.8)	NKPD1 (1.8)	NCAN (1.7)	MYLIP (1.6)
MP:0001800	abnormal humoral immune response	0.73	> 0.20	GMIP (4.2)	RELB (3.6)	TIMD4 (2.5)	MAFB (2.0)	SH2B3 (1.9)	CETP (1.8)	BCL3 (1.6)	ENSG00000235545 (1.4)	ZNF101 (1.4)	GRINA (1.3)
ENSG00000100461	RBM23 PPI subnetwork	0.73	> 0.20	KIAA1324 (4.0)	CELSR2 (3.0)	FRK (2.2)	PLEKHH2 (1.9)	GMPR (1.8)	POLK (1.7)	GEMIN7 (1.5)	FEN1 (1.5)	NT5DC1 (1.5)	ANKRD31 (1.5)
ENSG00000115884	SDC1 PPI subnetwork	0.73	> 0.20	CILP2 (4.5)	HP (2.3)	ITGB3 (2.3)	CYP7A1 (2.3)	APOE (2.2)	NCAN (2.2)	TIMD4 (2.1)	MOSC1 (1.9)	ENSG00000238078 (1.8)	APOC4 (1.7)
ENSG00000065665	SEC61A2 PPI subnetwork	0.73	> 0.20	ABCG5 (2.6)	NPC1L1 (2.5)	AP1M2 (2.4)	ABCG8 (2.1)	TXNL4B (1.8)	OGDH (1.8)	ZHX3 (1.5)	DHX38 (1.5)	NCAN (1.5)	YIPF2 (1.5)
GO:0006297	nucleotide-excision repair, DNA gap filling	0.73	> 0.20	ZNF180 (3.1)	ENSG00000228044 (2.8)	USP1 (2.8)	GOT2P1 (2.3)	FEN1 (2.1)	TMEM116 (1.7)	ENSG00000235545 (1.6)	ERP29 (1.4)	PPP1R37 (1.2)	NT5DC1 (1.2)
GO:0032835	glomerulus development	0.73	> 0.20	PLEKHH2 (2.2)	NYNRIN (2.1)	BCAM (2.0)	DYNC2LI1 (1.7)	ANKRD31 (1.6)	ENSG00000226645 (1.6)	SLC44A2 (1.4)	AMIGO1 (1.4)	PVRL2 (1.2)	ATXN7L2 (1.2)
GO:0032273	positive regulation of protein polymerization	0.73	> 0.20	ANKRD31 (3.1)	HNF1A (2.1)	ENSG00000226648 (2.1)	ZNF101 (1.8)	ZHX3 (1.6)	CYB561D1 (1.6)	POC5 (1.3)	ENSG00000254235 (1.3)	DOCK7 (1.3)	POLK (1.2)
MP:0004462	small basisphenoid bone	0.73	> 0.20	CILP2 (2.2)	NYNRIN (2.0)	MAFB (2.0)	PLCG1 (1.8)	AMIGO1 (1.6)	LPIN3 (1.5)	PLEKHH2 (1.4)	MYLIP (1.4)	TMED4 (1.3)	CARM1 (1.2)
GO:0044304	main axon	0.73	> 0.20	RPH3A (6.1)	HAPLN4 (5.8)	C11orf9 (4.0)	CELSR2 (2.4)	FRK (2.0)	GCNT4 (1.9)	NCAN (1.6)	SORT1 (1.4)	APOC4 (1.3)	ABCG8 (1.3)
ENSG00000092201	SUPT16H PPI subnetwork	0.73	> 0.20	SMARCA4 (3.4)	ILF3 (2.7)	SUGP1 (2.5)	C19orf52 (2.5)	FEN1 (2.5)	BUD13 (2.4)	TOP1 (2.3)	GATAD2A (2.3)	TOMM40 (2.2)	USP1 (2.2)
MP:0003912	decreased drinking behavior	0.73	> 0.20	LPIN3 (2.6)	ABO (2.0)	PMFBP1 (1.9)	NPC1L1 (1.9)	BCL3 (1.8)	ST3GAL4 (1.7)	PPP1R37 (1.7)	AMIGO1 (1.7)	CEACAM19 (1.7)	TRIB1 (1.6)
ENSG00000129824	RPS4Y1 PPI subnetwork	0.73	> 0.20	NKPD1 (3.1)	ANKRD31 (1.8)	ADAM1 (1.7)	ILF3 (1.5)	PTPN11 (1.5)	SARS (1.4)	ATP13A1 (1.4)	GATAD2A (1.4)	C12orf43 (1.4)	CEACAM19 (1.4)
ENSG00000213555	ENSG00000213555 PPI subnetwork	0.73	> 0.20	ENSG00000235545 (3.0)	KANK2 (2.8)	NPC1L1 (2.2)	PLCG1 (2.2)	PVR (2.1)	ADAM1 (2.0)	ZHX3 (1.9)	BRAP (1.6)	CEACAM19 (1.6)	C12orf47 (1.5)
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	0.73	> 0.20	ATP13A1 (3.8)	CYB561D1 (2.6)	ERP29 (2.3)	TMEM50A (2.3)	TMED4 (2.2)	CEACAM19 (2.1)	TRAPPC6A (2.1)	YIPF2 (2.0)	CLPTM1 (1.8)	UBXN2B (1.6)
GO:0009168	purine ribonucleoside monophosphate biosynthetic process	0.73	> 0.20	ANKRD31 (3.3)	ENSG00000228044 (2.6)	NT5DC1 (2.5)	DHODH (2.4)	SYPL2 (2.1)	QTRT1 (2.1)	PMFBP1 (1.7)	ENSG00000226648 (1.7)	ZNF259 (1.5)	POLK (1.3)
GO:0009127	purine nucleoside monophosphate biosynthetic process	0.73	> 0.20	ANKRD31 (3.3)	ENSG00000228044 (2.6)	NT5DC1 (2.5)	DHODH (2.4)	SYPL2 (2.1)	QTRT1 (2.1)	PMFBP1 (1.7)	ENSG00000226648 (1.7)	ZNF259 (1.5)	POLK (1.3)
GO:0000030	mannosyltransferase activity	0.73	> 0.20	ATP13A1 (3.6)	YIPF2 (3.3)	ERP29 (2.7)	TMEM50A (2.5)	CLPTM1 (2.1)	TMED4 (2.1)	TMEM57 (2.1)	QTRT1 (1.9)	TRAPPC6A (1.8)	TMEM116 (1.7)
ENSG00000005810	MYCBP2 PPI subnetwork	0.73	> 0.20	BLOC1S3 (3.1)	CARM1 (2.5)	LPIN3 (2.3)	GEMIN7 (2.1)	CYB561D1 (1.9)	LDLR (1.9)	GATAD2A (1.7)	PLCG1 (1.6)	CBLC (1.5)	BRAP (1.4)
ENSG00000138180	CEP55 PPI subnetwork	0.73	> 0.20	PSRC1 (3.2)	PLEC (2.7)	C12orf51 (2.1)	FEN1 (2.0)	POC5 (1.8)	GRINA (1.8)	ENSG00000226645 (1.7)	GMPR (1.7)	CBLC (1.5)	TMEM50A (1.5)
MP:0000952	abnormal CNS glial cell morphology	0.73	> 0.20	HMGCR (3.0)	FADS1 (3.0)	APOE (2.9)	PVR (2.9)	NCAN (2.9)	SORT1 (2.2)	CELSR2 (2.1)	FADS2 (2.1)	GPAM (1.9)	ENSG00000228044 (1.6)
GO:0031069	hair follicle morphogenesis	0.73	> 0.20	ANKRD31 (3.5)	ENSG00000254235 (1.8)	POLK (1.4)	ABO (1.4)	C17orf57 (1.3)	NYNRIN (1.3)	LPAR2 (1.3)	PMFBP1 (1.3)	CYB561D1 (1.1)	ENSG00000235545 (1.1)
ENSG00000013374	NUB1 PPI subnetwork	0.73	> 0.20	LPAR2 (3.0)	BRAP (2.8)	TMEM50A (2.7)	SUGP1 (2.5)	ENSG00000238078 (2.2)	MAU2 (2.1)	ZNF180 (1.6)	C12orf47 (1.5)	C19orf52 (1.5)	DHX38 (1.4)
ENSG00000093217	XYLB PPI subnetwork	0.73	> 0.20	TXNL4B (4.5)	DDX56 (4.1)	SARS (3.8)	ZNF259 (3.2)	DHODH (2.8)	PSMA5 (2.4)	NAA25 (2.2)	QTRT1 (2.1)	SUGP1 (2.0)	C12orf43 (2.0)
GO:0042274	ribosomal small subunit biogenesis	0.74	> 0.20	BLOC1S3 (2.6)	ANKRD31 (2.2)	QTRT1 (2.1)	C12orf43 (2.1)	ZNF101 (1.9)	TSSK6 (1.6)	MAPKAPK5 (1.6)	HAVCR1 (1.5)	ADAM1 (1.5)	CEACAM19 (1.4)
ENSG00000127554	GFER PPI subnetwork	0.74	> 0.20	TMEM116 (2.2)	DDX56 (2.2)	TOMM40 (1.6)	PLEKHH2 (1.5)	GRINA (1.4)	GMPR (1.4)	MAPKAPK5 (1.3)	ENSG00000226645 (1.2)	ANKRD31 (1.1)	PSMA5 (1.1)
ENSG00000007968	E2F2 PPI subnetwork	0.74	> 0.20	RHCE (2.4)	RHD (2.4)	PTPN11 (2.2)	MAPKAPK5 (2.1)	TXNL4B (1.9)	TMEM116 (1.6)	ATXN2 (1.5)	TOP1 (1.5)	C12orf51 (1.4)	USP1 (1.3)
ENSG00000100664	EIF5 PPI subnetwork	0.74	> 0.20	ZNF259 (3.2)	DDX56 (3.1)	ATP13A1 (2.8)	SARS (2.8)	GATAD2A (2.6)	TMEM57 (2.1)	ILF3 (2.0)	TOP1 (1.9)	ENSG00000226645 (1.8)	C19orf52 (1.8)
GO:0000245	spliceosomal complex assembly	0.74	> 0.20	BRAP (4.2)	SUGP1 (2.7)	C12orf43 (2.3)	TOP1 (2.2)	ADAM1 (2.1)	MAU2 (2.1)	BUD13 (1.9)	ERP29 (1.7)	MAPKAPK5 (1.6)	ILF3 (1.4)
ENSG00000162614	NEXN PPI subnetwork	0.74	> 0.20	PLEC (3.8)	FRK (2.7)	GATAD2A (2.3)	PLCG1 (2.2)	LPIN3 (2.0)	DOCK7 (1.9)	BRAP (1.7)	PVR (1.7)	ITGB3 (1.7)	HAVCR1 (1.6)
GO:0007098	centrosome cycle	0.74	> 0.20	POC5 (3.7)	UBXN2B (3.3)	POLK (2.8)	DYNC2LI1 (2.5)	PSRC1 (2.2)	PLEKHH2 (2.1)	BUD13 (2.1)	ENSG00000226648 (1.7)	DNAH11 (1.7)	ZNF180 (1.7)
ENSG00000188312	CENPP PPI subnetwork	0.74	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.5)	ENSG00000228044 (1.1)	ZNF180 (1.1)	ENSG00000226648 (1.0)	ZHX3 (0.8)	LPIN3 (0.7)	USP24 (0.6)
ENSG00000109519	GRPEL1 PPI subnetwork	0.74	> 0.20	BRAP (3.8)	SARS (3.2)	TXNL4B (3.0)	C12orf43 (2.5)	ACAD10 (2.3)	ILF3 (2.2)	TMEM116 (2.2)	USP1 (2.0)	ZNF259 (1.8)	DHODH (1.7)
ENSG00000169783	LINGO1 PPI subnetwork	0.74	> 0.20	ERP29 (3.6)	RPH3A (3.0)	BCAM (2.7)	CELSR2 (2.7)	CLPTM1 (2.6)	TMED4 (2.5)	GRINA (2.2)	HAPLN4 (2.2)	YIPF2 (2.2)	NCAN (1.9)
ENSG00000122585	NPY PPI subnetwork	0.74	> 0.20	TM6SF2 (3.2)	CETP (3.0)	NPC1L1 (2.6)	KIAA1324 (2.5)	ABCG5 (2.3)	FRK (2.2)	ABCG8 (1.8)	ENSG00000228044 (1.8)	HNF1A (1.7)	DNAH11 (1.4)
GO:0008375	acetylglucosaminyltransferase activity	0.74	> 0.20	CYB561D1 (3.1)	GCNT4 (2.7)	GEMIN7 (2.5)	ERP29 (1.9)	ADAM1 (1.9)	TMED4 (1.8)	AMIGO1 (1.6)	HAVCR1 (1.6)	ENSG00000226645 (1.5)	PLEC (1.3)
ENSG00000173867	ENSG00000173867 PPI subnetwork	0.74	> 0.20	GEMIN7 (3.4)	QTRT1 (2.7)	TOMM40 (2.5)	YIPF2 (2.2)	MAU2 (2.1)	ZNF259 (1.9)	MAPKAPK5 (1.9)	ATP13A1 (1.9)	DDX56 (1.8)	CARM1 (1.8)
GO:0015114	phosphate ion transmembrane transporter activity	0.74	> 0.20	ANGPTL3 (3.8)	SLC22A1 (3.6)	PLG (3.4)	TMEM116 (3.1)	HAVCR1 (3.0)	SH2B3 (2.8)	TM6SF2 (2.3)	CYP7A1 (2.3)	SYPL2 (1.9)	APOA5 (1.7)
ENSG00000107614	TRDMT1 PPI subnetwork	0.74	> 0.20	POC5 (2.4)	ENSG00000226645 (1.9)	DDX56 (1.8)	ATXN7L2 (1.7)	GMIP (1.6)	ZNF180 (1.6)	NT5DC1 (1.5)	TOP1 (1.3)	SARS (1.3)	POLK (1.1)
ENSG00000159200	RCAN1 PPI subnetwork	0.74	> 0.20	DNM2 (3.2)	CYB561D1 (2.4)	BLOC1S3 (2.3)	LPAR2 (2.2)	COL4A3BP (1.9)	MAU2 (1.8)	SLC44A2 (1.7)	NT5DC1 (1.6)	CARM1 (1.3)	OGDH (1.3)
ENSG00000141034	C17orf39 PPI subnetwork	0.74	> 0.20	BUD13 (3.0)	MYLIP (2.2)	NT5DC1 (2.0)	GATAD2A (1.9)	ENSG00000226645 (1.8)	TOP1 (1.8)	CARM1 (1.7)	C1orf63 (1.6)	NKPD1 (1.6)	ILF3 (1.5)
ENSG00000170579	DLGAP1 PPI subnetwork	0.74	> 0.20	RPH3A (3.0)	PPP1R37 (2.4)	ENSG00000238078 (2.2)	GCNT4 (2.0)	ENSG00000226645 (2.0)	MAFB (1.9)	ZHX3 (1.7)	PLCG1 (1.7)	COL4A3BP (1.7)	PTPN11 (1.6)
ENSG00000109220	CHIC2 PPI subnetwork	0.74	> 0.20	BLOC1S3 (2.6)	DHX38 (1.9)	CYB561D1 (1.8)	ENSG00000226648 (1.6)	TRIB1 (1.6)	HAVCR1 (1.6)	PPP1R37 (1.5)	ANKRD31 (1.3)	CLPTM1 (1.3)	TMEM116 (1.2)
ENSG00000038427	VCAN PPI subnetwork	0.74	> 0.20	OASL (3.3)	PVR (3.0)	BCL3 (2.9)	RELB (2.6)	CILP2 (2.5)	MAFB (2.1)	TIMD4 (1.5)	HAVCR1 (1.4)	NCAN (1.3)	TRAFD1 (1.2)
GO:0051875	pigment granule localization	0.74	> 0.20	C12orf43 (2.8)	ENSG00000228044 (2.5)	PMFBP1 (1.8)	DYNC2LI1 (1.8)	ENSG00000254235 (1.5)	CEACAM19 (1.4)	ANKRD31 (1.4)	POLK (1.3)	TXNL4B (1.3)	GOT2P1 (1.3)
GO:0043256	laminin complex	0.74	> 0.20	CBLC (5.3)	BCAM (3.8)	KANK2 (2.8)	AP1M2 (2.8)	CELSR2 (2.2)	PLEC (2.1)	HAVCR1 (2.1)	CYP7A1 (2.0)	PLEKHH2 (2.0)	PVR (1.7)
GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	0.74	> 0.20	PMFBP1 (2.9)	C12orf47 (2.4)	ENSG00000226645 (2.3)	DNAH11 (2.3)	TMEM116 (2.1)	NKPD1 (2.0)	NPC1L1 (1.8)	ENSG00000228044 (1.8)	TXNL4B (1.6)	CEACAM19 (1.6)
ENSG00000105819	PMPCB PPI subnetwork	0.74	> 0.20	SARS (4.3)	TMEM57 (3.0)	ATXN7L2 (2.1)	SUGP1 (2.0)	C12orf43 (2.0)	FEN1 (1.9)	C19orf52 (1.6)	CARM1 (1.4)	USP1 (1.4)	MAPKAPK5 (1.2)
GO:0015291	secondary active transmembrane transporter activity	0.74	> 0.20	TM6SF2 (3.8)	TMEM116 (3.6)	HAPLN4 (2.7)	PLG (2.6)	ANGPTL3 (2.3)	ATP13A1 (2.3)	ABCG8 (2.1)	SLC22A1 (2.0)	NCAN (1.9)	CLPTM1 (1.7)
GO:0071674	mononuclear cell migration	0.74	> 0.20	TMEM116 (2.5)	ANKRD31 (2.2)	MAFB (1.9)	ST3GAL4 (1.6)	ENSG00000238078 (1.6)	PMFBP1 (1.3)	APOE (1.3)	ZNF101 (1.3)	OASL (1.2)	APOC1 (1.1)
GO:0001708	cell fate specification	0.74	> 0.20	ENSG00000254235 (3.0)	KIAA1324 (2.5)	C19orf52 (2.2)	DNAH11 (2.1)	ENSG00000226648 (2.1)	PMFBP1 (2.0)	TSSK6 (1.9)	PPP1R37 (1.8)	ANKRD31 (1.7)	AP1M2 (1.4)
GO:0001825	blastocyst formation	0.74	> 0.20	ATXN7L2 (2.4)	CEACAM19 (2.3)	NKPD1 (2.2)	LPIN3 (2.1)	ENSG00000254235 (2.0)	HAVCR1 (1.7)	TRIB1 (1.6)	BUD13 (1.4)	TSSK6 (1.4)	ENSG00000226648 (1.3)
MP:0001177	atelectasis	0.74	> 0.20	LDLR (3.1)	CELSR2 (2.6)	HMGCR (2.5)	BCAM (2.1)	PLEKHH2 (2.0)	GPAM (1.9)	FADS2 (1.8)	KIAA1324 (1.8)	PVR (1.8)	NCAN (1.7)
ENSG00000079432	CIC PPI subnetwork	0.74	> 0.20	DHODH (2.7)	ABO (2.5)	UBXN2B (2.5)	PARP10 (1.8)	DYNC2LI1 (1.8)	BLOC1S3 (1.8)	SUGP1 (1.6)	COL4A3BP (1.5)	KIAA1324 (1.5)	ANGPTL3 (1.5)
GO:0002828	regulation of type 2 immune response	0.74	> 0.20	ZNF101 (2.4)	DNAH11 (2.1)	BLOC1S3 (1.5)	C17orf57 (1.5)	CEACAM19 (1.4)	ALDH2 (1.4)	OASL (1.4)	GRINA (1.4)	BCL3 (1.3)	TRAFD1 (1.0)
ENSG00000163535	SGOL2 PPI subnetwork	0.74	> 0.20	PSRC1 (5.3)	FEN1 (4.1)	USP1 (3.4)	POC5 (3.3)	LPIN3 (1.3)	ENSG00000228044 (1.2)	ENSG00000226648 (1.1)	TMEM50A (1.1)	ITGB3 (1.1)	ZHX3 (1.0)
ENSG00000165417	GTF2A1 PPI subnetwork	0.74	> 0.20	MAPKAPK5 (4.0)	PSMA5 (2.6)	ATXN2 (2.5)	POC5 (2.5)	TXNL4B (2.4)	MARK4 (2.3)	SUGP1 (2.2)	GEMIN7 (2.0)	TOP1 (2.0)	DNM2 (1.7)
GO:0019953	sexual reproduction	0.74	> 0.20	TSSK6 (5.6)	PMFBP1 (4.0)	ENSG00000228044 (2.1)	PLEKHH2 (0.9)	CEACAM19 (0.8)	MARK4 (0.8)	NKPD1 (0.7)	FRK (0.7)	CILP2 (0.7)	PCSK9 (0.7)
ENSG00000010610	CD4 PPI subnetwork	0.74	> 0.20	PLCG1 (3.4)	HAVCR1 (2.5)	GRINA (2.5)	APOE (2.4)	ZNF101 (2.2)	TIMD4 (2.1)	OGDH (1.8)	CLPTM1 (1.8)	MAFB (1.7)	ENSG00000254235 (1.4)
ENSG00000198561	CTNND1 PPI subnetwork	0.74	> 0.20	PVRL2 (3.5)	BCAM (2.8)	DOCK7 (2.6)	AP1M2 (1.9)	MAFB (1.8)	PLCG1 (1.7)	ITGB3 (1.7)	TOP1 (1.6)	KIAA1324 (1.5)	PLEC (1.5)
ENSG00000163875	MEAF6 PPI subnetwork	0.74	> 0.20	TMED4 (2.1)	ENSG00000226645 (2.1)	PCSK9 (2.0)	ZNF180 (2.0)	USP1 (1.8)	SMARCA4 (1.6)	PSRC1 (1.5)	POC5 (1.5)	BCAM (1.4)	SUGP1 (1.4)
GO:0046970	NAD-dependent histone deacetylase activity (H4-K16 specific)	0.74	> 0.20	ATXN7L2 (2.7)	PLCG1 (2.5)	HNF1A (1.8)	ST3GAL4 (1.5)	FRK (1.4)	TMED4 (1.4)	PSRC1 (1.3)	DHX38 (1.3)	SMARCA4 (1.3)	SLC22A1 (1.2)
GO:0031078	histone deacetylase activity (H3-K14 specific)	0.74	> 0.20	ATXN7L2 (2.7)	PLCG1 (2.5)	HNF1A (1.8)	ST3GAL4 (1.5)	FRK (1.4)	TMED4 (1.4)	PSRC1 (1.3)	DHX38 (1.3)	SMARCA4 (1.3)	SLC22A1 (1.2)
GO:0034739	histone deacetylase activity (H4-K16 specific)	0.74	> 0.20	ATXN7L2 (2.7)	PLCG1 (2.5)	HNF1A (1.8)	ST3GAL4 (1.5)	FRK (1.4)	TMED4 (1.4)	PSRC1 (1.3)	DHX38 (1.3)	SMARCA4 (1.3)	SLC22A1 (1.2)
GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	0.74	> 0.20	ATXN7L2 (2.7)	PLCG1 (2.5)	HNF1A (1.8)	ST3GAL4 (1.5)	FRK (1.4)	TMED4 (1.4)	PSRC1 (1.3)	DHX38 (1.3)	SMARCA4 (1.3)	SLC22A1 (1.2)
MP:0001751	increased circulating luteinizing hormone level	0.74	> 0.20	KIAA1324 (2.8)	ST3GAL4 (2.4)	LDLR (2.3)	APOB (2.1)	TMEM57 (1.4)	FADS2 (1.3)	BLOC1S3 (1.3)	PCSK9 (1.3)	ALDH2 (1.1)	AP1M2 (1.1)
GO:0048484	enteric nervous system development	0.74	> 0.20	TSSK6 (2.8)	ABO (2.5)	ENSG00000254235 (2.1)	MYLIP (1.7)	COL4A3BP (1.5)	CEACAM19 (1.4)	ANKRD31 (1.4)	ZNF101 (1.4)	MAU2 (1.3)	ENSG00000228044 (1.3)
GO:0043473	pigmentation	0.74	> 0.20	DOCK7 (3.0)	ZNF101 (2.6)	ST3GAL4 (2.3)	C12orf43 (2.1)	ENSG00000228044 (1.8)	C17orf57 (1.7)	NKPD1 (1.6)	MYLIP (1.5)	GMPR (1.4)	BLOC1S3 (1.4)
MP:0004411	decreased endocochlear potential	0.74	> 0.20	ZNF101 (2.7)	CELSR2 (1.9)	SLC44A2 (1.8)	GMPR (1.7)	PBX4 (1.7)	BCAM (1.6)	ABO (1.6)	NKPD1 (1.4)	C17orf57 (1.3)	SORT1 (1.2)
ENSG00000130176	CNN1 PPI subnetwork	0.74	> 0.20	PTPN11 (2.2)	DHX38 (2.0)	C1orf63 (2.0)	NPC1L1 (1.9)	AP1M2 (1.8)	USP24 (1.8)	PSRC1 (1.7)	ENSG00000238078 (1.7)	TM6SF2 (1.7)	ILF3 (1.4)
ENSG00000166866	MYO1A PPI subnetwork	0.74	> 0.20	PLEC (3.3)	KANK2 (2.6)	PVR (2.5)	SH2B3 (2.3)	DNM2 (2.2)	PLCG1 (2.2)	SORT1 (2.0)	POLK (2.0)	BCAM (1.9)	NPC1L1 (1.8)
GO:0003015	heart process	0.74	> 0.20	ENSG00000226648 (2.9)	PPP1R37 (2.6)	TMEM116 (1.8)	KIAA1324 (1.6)	OGDH (1.6)	ACAD10 (1.5)	C17orf57 (1.5)	C12orf47 (1.5)	ABO (1.4)	SYPL2 (1.4)
ENSG00000135932	CAB39 PPI subnetwork	0.74	> 0.20	ZHX3 (2.1)	GMPR (2.0)	ABO (1.9)	ZNF101 (1.8)	TMEM116 (1.6)	SYPL2 (1.5)	ENSG00000226645 (1.5)	HAPLN4 (1.5)	BLOC1S3 (1.4)	BRAP (1.4)
MP:0001819	abnormal immune cell physiology	0.74	> 0.20	MAFB (3.7)	SH2B3 (3.0)	RELB (2.6)	GMIP (2.0)	CELSR2 (1.9)	ENSG00000254235 (1.8)	TMED4 (1.7)	ATXN7L2 (1.5)	BCL3 (1.4)	UBXN2B (1.4)
GO:0007530	sex determination	0.74	> 0.20	TSSK6 (2.7)	ST3GAL4 (2.0)	DNAH11 (1.8)	C11orf9 (1.8)	ATXN7L2 (1.6)	GMPR (1.6)	LPAR2 (1.6)	TXNL4B (1.3)	FRK (1.3)	PLEKHH2 (1.1)
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	0.74	> 0.20	ITGB3 (3.0)	DNM2 (2.8)	CLPTM1 (2.5)	CARM1 (2.3)	PTPN11 (2.0)	GRINA (1.8)	SARS (1.8)	PLEC (1.8)	TIMD4 (1.6)	HLX (1.6)
MP:0004607	abnormal cervical atlas morphology	0.74	> 0.20	ENSG00000254235 (2.2)	FRK (1.9)	CILP2 (1.9)	NYNRIN (1.8)	ENSG00000238078 (1.6)	PLCG1 (1.5)	C17orf57 (1.5)	TMEM50A (1.5)	BCAM (1.4)	ATXN2 (1.2)
ENSG00000108443	RPS6KB1 PPI subnetwork	0.74	> 0.20	PTPN11 (3.1)	DOCK7 (2.4)	TMEM57 (2.2)	SMARCA4 (2.0)	ILF3 (1.9)	DHX38 (1.8)	DDX56 (1.7)	ALDH2 (1.7)	GPAM (1.7)	SH2B3 (1.7)
GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	0.74	> 0.20	ST3GAL4 (2.1)	NT5DC1 (1.9)	C19orf52 (1.7)	NKPD1 (1.5)	C12orf47 (1.3)	KANK2 (1.2)	TOP1 (1.2)	CILP2 (1.2)	ENSG00000226648 (1.2)	NYNRIN (1.2)
ENSG00000156110	ADK PPI subnetwork	0.74	> 0.20	YIPF2 (2.2)	NT5DC1 (2.0)	ST3GAL4 (1.9)	SARS (1.6)	CBLC (1.5)	ZNF180 (1.5)	ENSG00000226648 (1.4)	NYNRIN (1.3)	PMFBP1 (1.3)	TM6SF2 (1.1)
ENSG00000105127	AKAP8 PPI subnetwork	0.74	> 0.20	ATP13A1 (3.1)	OGDH (2.4)	DNM2 (2.1)	ENSG00000235545 (2.0)	QTRT1 (2.0)	TRAFD1 (1.5)	SLC44A2 (1.5)	ILF3 (1.4)	HLX (1.4)	TOMM40 (1.3)
ENSG00000049167	ERCC8 PPI subnetwork	0.74	> 0.20	POC5 (3.6)	SUGP1 (3.5)	POLK (2.6)	BLOC1S3 (2.5)	MARK4 (2.3)	SARS (2.3)	MAPKAPK5 (2.0)	PPP1R37 (1.9)	ZNF259 (1.8)	GRINA (1.6)
GO:0042575	DNA polymerase complex	0.74	> 0.20	USP1 (2.5)	GEMIN7 (2.2)	FEN1 (2.0)	PARP10 (1.8)	ENSG00000235545 (1.6)	CILP2 (1.6)	TXNL4B (1.6)	DNM2 (1.5)	ZNF180 (1.4)	UBXN2B (1.4)
MP:0002051	skin papilloma	0.74	> 0.20	PTPN11 (3.3)	TRIB1 (2.9)	CBLC (2.5)	ALDH2 (2.5)	RELB (2.1)	SH2B3 (2.0)	PVR (2.0)	HMGCR (1.7)	BCL3 (1.7)	ERP29 (1.6)
REACTOME_TRANSLATION_INITIATION_COMPLEX_FORMATION	REACTOME_TRANSLATION_INITIATION_COMPLEX_FORMATION	0.74	> 0.20	NKPD1 (3.0)	ILF3 (2.3)	ANKRD31 (2.0)	ATP13A1 (2.0)	DDX56 (1.9)	SARS (1.9)	QTRT1 (1.9)	C12orf43 (1.7)	C19orf52 (1.6)	GATAD2A (1.6)
GO:0021697	cerebellar cortex formation	0.74	> 0.20	DNAH11 (3.6)	BRAP (2.8)	ADAM1 (2.7)	TMEM116 (2.6)	HAPLN4 (2.3)	C12orf51 (2.1)	TMEM57 (2.0)	ERP29 (1.9)	DYNC2LI1 (1.7)	ANKRD31 (1.7)
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	0.74	> 0.20	C12orf51 (2.1)	ENSG00000228044 (1.8)	GOT2P1 (1.7)	PVR (1.6)	CYP7A1 (1.6)	NYNRIN (1.5)	ZNF180 (1.5)	ABCG8 (1.4)	ENSG00000226645 (1.4)	ST3GAL4 (1.3)
ENSG00000128609	NDUFA5 PPI subnetwork	0.74	> 0.20	OGDH (3.8)	ACAD10 (3.2)	TRAPPC6A (2.5)	PSMA5 (2.1)	MAU2 (2.0)	ATP13A1 (1.9)	C12orf47 (1.9)	TOMM40 (1.4)	TMED4 (1.4)	YIPF2 (1.3)
ENSG00000157916	RER1 PPI subnetwork	0.74	> 0.20	YIPF2 (3.6)	MAU2 (3.1)	CLPTM1 (2.4)	PBX4 (2.3)	TMED4 (2.0)	C11orf9 (2.0)	ZNF101 (1.8)	ERP29 (1.7)	DNM2 (1.7)	TMEM57 (1.6)
GO:0045776	negative regulation of blood pressure	0.74	> 0.20	TSSK6 (2.2)	ENSG00000235545 (2.2)	TMEM116 (1.9)	DNAH11 (1.8)	KIAA1324 (1.6)	CILP2 (1.6)	GOT2P1 (1.5)	ENSG00000226645 (1.4)	ABO (1.4)	FRK (1.3)
GO:2000178	negative regulation of neural precursor cell proliferation	0.74	> 0.20	ENSG00000235545 (2.8)	ZNF180 (2.0)	ENSG00000226648 (1.9)	UBXN2B (1.9)	CYB561D1 (1.8)	GOT2P1 (1.8)	TMEM116 (1.6)	NCAN (1.4)	DNAH11 (1.4)	PMFBP1 (1.4)
GO:0070374	positive regulation of ERK1 and ERK2 cascade	0.74	> 0.20	TSSK6 (2.4)	GEMIN7 (2.4)	CETP (2.2)	ENSG00000254235 (2.1)	ENSG00000226645 (2.0)	ST3GAL4 (1.9)	ENSG00000228044 (1.8)	KIAA1324 (1.6)	AP1M2 (1.5)	HLX (1.3)
ENSG00000075856	SART3 PPI subnetwork	0.74	> 0.20	DDX56 (2.4)	TMED4 (2.3)	PSMA5 (2.0)	ILF3 (1.7)	PMFBP1 (1.7)	C12orf43 (1.7)	TMEM116 (1.5)	CARM1 (1.5)	ATXN7L2 (1.5)	DHODH (1.3)
GO:0001191	RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription	0.74	> 0.20	FRK (2.4)	KIAA1324 (2.3)	CELSR2 (2.2)	MYLIP (2.1)	ATXN2 (2.0)	TSSK6 (1.8)	PLCG1 (1.8)	GATAD2A (1.6)	C19orf52 (1.6)	ZHX3 (1.6)
GO:0001106	RNA polymerase II transcription corepressor activity	0.74	> 0.20	FRK (2.4)	KIAA1324 (2.3)	CELSR2 (2.2)	MYLIP (2.1)	ATXN2 (2.0)	TSSK6 (1.8)	PLCG1 (1.8)	GATAD2A (1.6)	C19orf52 (1.6)	ZHX3 (1.6)
GO:0007043	cell-cell junction assembly	0.74	> 0.20	AP1M2 (2.9)	FRK (2.3)	GCNT4 (2.2)	C11orf9 (2.1)	TSSK6 (2.1)	SORT1 (1.9)	PTPN11 (1.7)	YIPF2 (1.7)	C17orf57 (1.7)	ENSG00000228044 (1.6)
ENSG00000112306	RPS12 PPI subnetwork	0.74	> 0.20	NKPD1 (3.1)	SARS (1.9)	QTRT1 (1.8)	SUGP1 (1.7)	ILF3 (1.6)	ADAM1 (1.6)	ANKRD31 (1.6)	MYLIP (1.6)	PTPN11 (1.5)	TMEM57 (1.4)
ENSG00000112941	PAPD7 PPI subnetwork	0.74	> 0.20	COL4A3BP (2.8)	POLK (2.0)	UBXN2B (1.9)	SUGP1 (1.8)	TOMM40 (1.8)	ZNF259 (1.8)	QTRT1 (1.7)	NKPD1 (1.6)	TMEM57 (1.5)	MAU2 (1.5)
ENSG00000139352	ASCL1 PPI subnetwork	0.74	> 0.20	NCAN (4.0)	HLX (2.1)	TOP1 (2.0)	MAFB (1.8)	POLK (1.8)	ABO (1.7)	NPC1L1 (1.6)	SMARCA4 (1.4)	TRAFD1 (1.4)	CARM1 (1.4)
REACTOME_BETA_DEFENSINS	REACTOME_BETA_DEFENSINS	0.74	> 0.20	PMFBP1 (3.9)	TSSK6 (2.4)	NKPD1 (1.6)	FRK (1.4)	BRAP (1.3)	GPAM (1.2)	GOT2P1 (1.1)	TMEM116 (1.0)	ALDH2 (0.9)	OASL (0.8)
GO:0060896	neural plate pattern specification	0.74	> 0.20	CYB561D1 (3.3)	CEACAM19 (2.5)	LPAR2 (2.4)	ENSG00000228044 (2.2)	ZNF180 (2.1)	ANKRD31 (1.9)	DOCK7 (1.9)	FRK (1.6)	AMIGO1 (1.5)	MARK4 (1.5)
GO:0050729	positive regulation of inflammatory response	0.74	> 0.20	ENSG00000228044 (2.9)	DNAH11 (2.5)	PLEKHH2 (1.9)	ENSG00000235545 (1.8)	ST3GAL4 (1.6)	FRK (1.6)	AMIGO1 (1.5)	PMFBP1 (1.4)	TIMD4 (1.2)	PVR (1.1)
MP:0000277	abnormal heart shape	0.74	> 0.20	C11orf9 (3.4)	BCAM (3.2)	PVRL2 (2.3)	NYNRIN (2.2)	GMPR (2.1)	RHD (1.9)	ALDH2 (1.7)	TMED4 (1.6)	RHCE (1.5)	C1orf63 (1.4)
MP:0005671	abnormal response to transplant	0.74	> 0.20	GCNT4 (2.7)	POLK (2.5)	PLCG1 (2.2)	MAFB (1.8)	PBX4 (1.5)	TIMD4 (1.4)	KIAA1324 (1.4)	MYLIP (1.3)	TMEM116 (1.3)	HAVCR1 (1.3)
ENSG00000169057	MECP2 PPI subnetwork	0.74	> 0.20	TMEM57 (3.3)	SMARCA4 (3.2)	TOP1 (2.6)	NT5DC1 (2.5)	TMEM50A (2.4)	CARM1 (2.3)	PLCG1 (1.9)	USP1 (1.9)	BRAP (1.7)	PCSK9 (1.6)
GO:0050672	negative regulation of lymphocyte proliferation	0.74	> 0.20	DNAH11 (1.9)	HNF1A (1.7)	ENSG00000254235 (1.7)	TRAFD1 (1.7)	GCNT4 (1.6)	ADAM1 (1.5)	PBX4 (1.4)	ENSG00000228044 (1.4)	C17orf57 (1.4)	ZNF101 (1.2)
GO:0032945	negative regulation of mononuclear cell proliferation	0.74	> 0.20	DNAH11 (1.9)	HNF1A (1.7)	ENSG00000254235 (1.7)	TRAFD1 (1.7)	GCNT4 (1.6)	ADAM1 (1.5)	PBX4 (1.4)	ENSG00000228044 (1.4)	C17orf57 (1.4)	ZNF101 (1.2)
GO:0060047	heart contraction	0.74	> 0.20	ENSG00000226648 (3.0)	PPP1R37 (2.6)	TMEM116 (1.9)	KIAA1324 (1.6)	OGDH (1.5)	C12orf47 (1.5)	ABO (1.5)	ACAD10 (1.5)	C17orf57 (1.4)	SYPL2 (1.4)
GO:0002820	negative regulation of adaptive immune response	0.74	> 0.20	DNAH11 (2.7)	ABO (2.4)	ENSG00000235545 (1.7)	TSSK6 (1.6)	HNF1A (1.6)	ZNF180 (1.6)	CEACAM19 (1.6)	C17orf57 (1.4)	HAVCR1 (1.4)	OASL (1.3)
GO:0046006	regulation of activated T cell proliferation	0.74	> 0.20	ANKRD31 (3.0)	PBX4 (2.2)	HNF1A (2.1)	TRAFD1 (2.1)	ENSG00000254235 (1.7)	TIMD4 (1.2)	ENSG00000226645 (1.1)	SLC22A1 (1.0)	APOE (1.0)	TRAPPC6A (1.0)
GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	0.74	> 0.20	ST3GAL4 (3.2)	ENSG00000235545 (2.8)	UBXN2B (2.3)	POLK (1.7)	DYNC2LI1 (1.5)	LPAR2 (1.4)	BLOC1S3 (1.4)	TRAFD1 (1.3)	CETP (1.3)	MARK4 (1.3)
GO:0030593	neutrophil chemotaxis	0.74	> 0.20	MAFB (2.4)	ENSG00000228044 (2.2)	ZNF101 (1.7)	UBXN2B (1.5)	AMIGO1 (1.5)	ST3GAL4 (1.3)	TMED4 (1.2)	HLX (1.2)	PVR (1.1)	APOE (1.1)
MP:0010766	abnormal NK cell physiology	0.74	> 0.20	TRAFD1 (2.5)	SLC44A2 (2.1)	MAFB (2.0)	ZNF101 (1.9)	MYLIP (1.6)	APOE (1.6)	PBX4 (1.4)	CYB561D1 (1.4)	PARP10 (1.2)	POLK (1.2)
MP:0000270	abnormal heart tube morphology	0.74	> 0.20	C11orf9 (2.7)	GOT2P1 (2.3)	UBXN2B (2.1)	KANK2 (1.9)	BCAM (1.8)	ENSG00000226648 (1.6)	ABO (1.3)	SH2B3 (1.2)	APOB (1.2)	BLOC1S3 (1.2)
GO:2000273	positive regulation of receptor activity	0.74	> 0.20	ENSG00000238078 (2.4)	TMED4 (2.0)	POC5 (1.7)	C17orf57 (1.5)	FRK (1.5)	ENSG00000228044 (1.4)	ENSG00000226645 (1.4)	RPH3A (1.3)	CETP (1.1)	SYPL2 (1.0)
ENSG00000138795	LEF1 PPI subnetwork	0.74	> 0.20	MYLIP (3.2)	ATXN2 (2.5)	ZNF101 (1.9)	BCL3 (1.6)	ABO (1.6)	HAVCR1 (1.5)	GATAD2A (1.5)	BUD13 (1.4)	TRAPPC6A (1.3)	ENSG00000254235 (1.3)
GO:0002695	negative regulation of leukocyte activation	0.74	> 0.20	ZNF101 (2.5)	PBX4 (2.5)	TIMD4 (1.9)	DNAH11 (1.8)	GCNT4 (1.8)	ANKRD31 (1.7)	CEACAM19 (1.5)	TRAFD1 (1.4)	PLCG1 (1.4)	APOE (1.3)
ENSG00000148229	POLE3 PPI subnetwork	0.74	> 0.20	USP1 (2.7)	FEN1 (2.3)	GMPR (2.1)	PMFBP1 (1.8)	ENSG00000226645 (1.4)	ILF3 (1.4)	SUGP1 (1.3)	GATAD2A (1.3)	SMARCA4 (1.3)	POC5 (1.3)
ENSG00000141384	TAF4B PPI subnetwork	0.74	> 0.20	MAPKAPK5 (2.8)	TXNL4B (2.7)	PSMA5 (2.5)	UBXN2B (2.3)	COL4A3BP (2.2)	TOP1 (2.1)	SUGP1 (1.9)	DYNC2LI1 (1.8)	ATXN2 (1.8)	POC5 (1.6)
GO:0051238	sequestering of metal ion	0.74	> 0.20	NKPD1 (2.1)	SYPL2 (1.9)	ABO (1.8)	ENSG00000226648 (1.7)	ADAM1 (1.7)	TIMD4 (1.7)	C1orf63 (1.5)	RPH3A (1.4)	CILP2 (1.3)	ZNF101 (1.2)
KEGG_BASAL_TRANSCRIPTION_FACTORS	KEGG_BASAL_TRANSCRIPTION_FACTORS	0.74	> 0.20	MAPKAPK5 (3.1)	ATXN2 (2.3)	C19orf52 (2.1)	PSMA5 (2.0)	TXNL4B (2.0)	POC5 (1.9)	ATXN7L2 (1.7)	TOP1 (1.5)	CYB561D1 (1.4)	NT5DC1 (1.3)
GO:0033522	histone H2A ubiquitination	0.74	> 0.20	TMEM57 (3.4)	DNAH11 (2.5)	PBX4 (2.0)	MAPKAPK5 (1.5)	BLOC1S3 (1.4)	ZNF180 (1.4)	AMIGO1 (1.3)	BRAP (1.2)	TMEM50A (1.2)	ATXN7L2 (1.2)
ENSG00000102384	CENPI PPI subnetwork	0.74	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.6)	ENSG00000228044 (1.1)	ENSG00000226648 (1.1)	ZNF180 (1.0)	ZHX3 (0.8)	LPIN3 (0.6)	USP24 (0.6)
GO:0002715	regulation of natural killer cell mediated immunity	0.74	> 0.20	ZNF101 (2.1)	AMIGO1 (2.1)	CEACAM19 (2.0)	ENSG00000228044 (2.0)	GEMIN7 (2.0)	TRAFD1 (1.6)	ENSG00000235545 (1.5)	ADAM1 (1.4)	TMED4 (1.2)	DNAH11 (1.2)
GO:0042269	regulation of natural killer cell mediated cytotoxicity	0.74	> 0.20	ZNF101 (2.1)	AMIGO1 (2.1)	CEACAM19 (2.0)	ENSG00000228044 (2.0)	GEMIN7 (2.0)	TRAFD1 (1.6)	ENSG00000235545 (1.5)	ADAM1 (1.4)	TMED4 (1.2)	DNAH11 (1.2)
ENSG00000129282	MRM1 PPI subnetwork	0.74	> 0.20	YIPF2 (3.0)	QTRT1 (2.5)	BUD13 (2.4)	MAU2 (2.3)	DNM2 (2.3)	ZNF259 (2.2)	TOMM40 (2.1)	DOCK7 (1.8)	MAPKAPK5 (1.6)	CARM1 (1.4)
GO:0009612	response to mechanical stimulus	0.74	> 0.20	TRAFD1 (2.2)	ENSG00000238078 (2.0)	ANKRD31 (1.9)	CILP2 (1.8)	PLEKHH2 (1.6)	NCAN (1.5)	C12orf43 (1.5)	POLK (1.5)	TRIB1 (1.5)	BCL3 (1.4)
ENSG00000188404	SELL PPI subnetwork	0.74	> 0.20	PVR (1.9)	C11orf9 (1.9)	BCAM (1.8)	CYP7A1 (1.8)	HLX (1.8)	LPA (1.7)	GMIP (1.3)	TIMD4 (1.2)	ENSG00000254235 (1.1)	ENSG00000228044 (1.1)
ENSG00000112851	ERBB2IP PPI subnetwork	0.74	> 0.20	DOCK7 (2.6)	CELSR2 (2.2)	PLEC (2.2)	PTPN11 (1.6)	KANK2 (1.5)	BCAM (1.5)	LPIN3 (1.5)	AP1M2 (1.4)	ST3GAL4 (1.4)	LPAR2 (1.4)
ENSG00000156931	VPS8 PPI subnetwork	0.74	> 0.20	ZNF259 (2.6)	ENSG00000226645 (2.5)	BRAP (2.5)	ADAM1 (2.4)	C12orf43 (2.3)	DDX56 (2.1)	GMPR (1.8)	GCNT4 (1.8)	C12orf47 (1.8)	TMEM116 (1.6)
ENSG00000156603	MED19 PPI subnetwork	0.74	> 0.20	GEMIN7 (4.4)	TXNL4B (2.7)	MAPKAPK5 (2.4)	BUD13 (2.4)	BLOC1S3 (2.0)	POC5 (1.9)	C12orf47 (1.9)	BRAP (1.9)	DHX38 (1.7)	TRAFD1 (1.6)
GO:0006412	translation	0.74	> 0.20	C12orf43 (3.6)	SARS (3.1)	ADAM1 (2.4)	QTRT1 (2.4)	GEMIN7 (2.1)	ZNF259 (2.1)	MAPKAPK5 (2.0)	DDX56 (1.9)	NAA25 (1.9)	ANKRD31 (1.8)
ENSG00000090989	EXOC1 PPI subnetwork	0.74	> 0.20	USP24 (3.2)	POLK (3.2)	ACAD10 (2.3)	COL4A3BP (2.0)	DNM2 (1.8)	SUGP1 (1.6)	SMARCA4 (1.6)	MAU2 (1.4)	OGDH (1.3)	DOCK7 (1.3)
ENSG00000179632	MAF1 PPI subnetwork	0.74	> 0.20	ZNF259 (3.7)	DDX56 (3.4)	GEMIN7 (3.1)	QTRT1 (2.3)	ADAM1 (2.3)	PSMA5 (2.1)	BUD13 (2.0)	ZHX3 (1.9)	C12orf43 (1.9)	ATXN7L2 (1.9)
GO:0071320	cellular response to cAMP	0.74	> 0.20	CYP7A1 (3.4)	ATXN7L2 (3.0)	ABO (2.3)	ENSG00000238078 (2.1)	CYB561D1 (2.0)	APOC4 (1.8)	GMPR (1.7)	DNAH11 (1.4)	ENSG00000228044 (1.4)	C11orf9 (1.3)
GO:0035085	cilium axoneme	0.74	> 0.20	DYNC2LI1 (5.1)	DNAH11 (4.9)	POLK (1.3)	HAVCR1 (1.1)	NKPD1 (1.0)	PLEKHH2 (1.0)	DOCK7 (0.9)	NT5DC1 (0.9)	PBX4 (0.8)	POC5 (0.8)
GO:0015020	glucuronosyltransferase activity	0.74	> 0.20	ABCG5 (3.2)	ABCG8 (2.5)	HP (2.3)	SLC22A1 (2.1)	NCAN (1.8)	FRK (1.7)	ST3GAL4 (1.6)	CILP2 (1.5)	CYP7A1 (1.5)	APOB (1.4)
GO:0002757	immune response-activating signal transduction	0.74	> 0.20	ZNF101 (3.5)	GMIP (3.5)	MAFB (2.6)	SH2B3 (2.5)	CYB561D1 (2.1)	TIMD4 (2.0)	PBX4 (2.0)	LPAR2 (1.8)	RELB (1.6)	PARP10 (1.5)
ENSG00000134287	ARF3 PPI subnetwork	0.74	> 0.20	HAPLN4 (3.0)	ALDH2 (2.8)	RPH3A (2.3)	NT5DC1 (2.2)	C11orf9 (2.1)	MOSC1 (2.1)	GRINA (1.9)	NCAN (1.8)	PSRC1 (1.7)	MARK4 (1.4)
GO:0016585	chromatin remodeling complex	0.74	> 0.20	SMARCA4 (3.4)	SUGP1 (2.8)	ATXN2 (2.8)	DHX38 (2.8)	MAPKAPK5 (2.6)	CARM1 (2.5)	ILF3 (2.4)	ATXN7L2 (2.2)	TOP1 (2.1)	MARK4 (1.9)
GO:0045747	positive regulation of Notch signaling pathway	0.74	> 0.20	ANKRD31 (4.1)	GOT2P1 (2.3)	C12orf47 (2.3)	NCAN (2.1)	CEACAM19 (2.0)	KIAA1324 (1.8)	BLOC1S3 (1.7)	DYNC2LI1 (1.6)	CELSR2 (1.5)	TSSK6 (1.4)
ENSG00000115942	ORC2 PPI subnetwork	0.74	> 0.20	FEN1 (6.4)	USP1 (4.9)	PSRC1 (2.7)	POC5 (1.8)	TXNL4B (1.7)	ENSG00000235545 (1.3)	RHD (1.3)	ENSG00000226645 (1.2)	GMPR (1.1)	SUGP1 (1.1)
ENSG00000047249	ATP6V1H PPI subnetwork	0.74	> 0.20	GRINA (4.8)	SARS (3.1)	GEMIN7 (2.9)	CLPTM1 (2.6)	PPP1R37 (2.5)	TXNL4B (2.4)	COL4A3BP (2.2)	POLK (2.1)	SORT1 (1.9)	PLCG1 (1.8)
GO:0042149	cellular response to glucose starvation	0.74	> 0.20	SARS (3.3)	DNAH11 (3.2)	ENSG00000238078 (2.4)	CEACAM19 (2.1)	ZNF259 (1.8)	AMIGO1 (1.6)	DDX56 (1.4)	POLK (1.4)	CYP7A1 (1.4)	NAA25 (1.3)
GO:0030502	negative regulation of bone mineralization	0.74	> 0.20	RHCE (2.9)	GOT2P1 (2.3)	RHD (2.1)	CILP2 (2.0)	TRAPPC6A (1.6)	ANKRD31 (1.6)	TMEM116 (1.4)	ENSG00000226648 (1.2)	ITGB3 (1.2)	DOCK7 (1.2)
ENSG00000088256	GNA11 PPI subnetwork	0.74	> 0.20	ITGB3 (2.9)	ST3GAL4 (2.2)	DNAH11 (2.2)	HLX (1.8)	GCNT4 (1.7)	C12orf47 (1.6)	TSSK6 (1.5)	KIAA1324 (1.4)	ABO (1.4)	NCAN (1.4)
GO:0023061	signal release	0.74	> 0.20	KIAA1324 (3.2)	ABO (3.2)	HAPLN4 (3.1)	RPH3A (2.6)	HNF1A (2.4)	AMIGO1 (2.3)	ENSG00000228044 (1.8)	COL4A3BP (1.7)	CELSR2 (1.5)	PCSK9 (1.4)
GO:0003001	generation of a signal involved in cell-cell signaling	0.74	> 0.20	KIAA1324 (3.2)	ABO (3.2)	HAPLN4 (3.1)	RPH3A (2.6)	HNF1A (2.4)	AMIGO1 (2.3)	ENSG00000228044 (1.8)	COL4A3BP (1.7)	CELSR2 (1.5)	PCSK9 (1.4)
ENSG00000120616	EPC1 PPI subnetwork	0.74	> 0.20	ADAM1 (3.2)	C12orf43 (2.9)	SMARCA4 (2.9)	USP1 (2.7)	MAPKAPK5 (2.3)	ILF3 (2.2)	PSRC1 (2.1)	SUGP1 (2.0)	TMED4 (1.9)	DYNC2LI1 (1.8)
MP:0001436	abnormal suckling behavior	0.74	> 0.20	MAFB (2.0)	NCAN (1.9)	FADS1 (1.9)	HMGCR (1.8)	PCSK9 (1.8)	APOB (1.8)	CARM1 (1.8)	PLCG1 (1.7)	ABCG8 (1.6)	ALDH2 (1.6)
ENSG00000177542	SLC25A22 PPI subnetwork	0.74	> 0.20	ALDH2 (3.1)	NT5DC1 (2.6)	NCAN (2.4)	HAPLN4 (2.3)	RPH3A (1.9)	MOSC1 (1.9)	PTPN11 (1.6)	CYP7A1 (1.6)	ST3GAL4 (1.6)	ZNF101 (1.5)
ENSG00000157020	SEC13 PPI subnetwork	0.74	> 0.20	PSRC1 (5.2)	FEN1 (4.1)	USP1 (3.2)	POC5 (3.1)	ENSG00000228044 (1.4)	DHX38 (1.2)	YIPF2 (1.2)	ENSG00000226648 (1.2)	CEACAM19 (0.8)	PCSK9 (0.8)
ENSG00000117697	NSL1 PPI subnetwork	0.74	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.5)	ENSG00000228044 (1.1)	ENSG00000226648 (0.9)	ZHX3 (0.9)	ZNF180 (0.9)	PBX4 (0.6)	LPIN3 (0.6)
ENSG00000159186	ENSG00000159186 PPI subnetwork	0.74	> 0.20	OGDH (2.8)	C19orf52 (2.6)	HNF1A (2.4)	C12orf47 (2.2)	PSMA5 (2.1)	ACAD10 (2.1)	TRAPPC6A (1.8)	ZNF180 (1.8)	ENSG00000238078 (1.8)	GOT2P1 (1.7)
GO:0000236	mitotic prometaphase	0.74	> 0.20	POC5 (4.7)	PSRC1 (4.6)	USP1 (2.5)	ENSG00000226648 (2.3)	FEN1 (2.0)	ZNF180 (1.8)	ENSG00000228044 (1.7)	ZHX3 (1.2)	PBX4 (1.2)	CEACAM19 (1.1)
ENSG00000134690	CDCA8 PPI subnetwork	0.74	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	USP1 (3.5)	POC5 (3.5)	ENSG00000228044 (1.1)	ENSG00000226648 (1.0)	ZNF180 (1.0)	ZHX3 (0.9)	LPIN3 (0.6)	USP24 (0.6)
ENSG00000169641	LUZP1 PPI subnetwork	0.74	> 0.20	PLEC (3.6)	FRK (2.9)	GATAD2A (2.2)	PLCG1 (1.9)	LPIN3 (1.9)	PVR (1.8)	ITGB3 (1.8)	HAVCR1 (1.8)	DOCK7 (1.7)	ADAM1 (1.7)
GO:0046651	lymphocyte proliferation	0.74	> 0.20	TIMD4 (3.1)	PBX4 (3.0)	ZNF101 (2.1)	CETP (2.1)	HLX (1.8)	POLK (1.8)	GMIP (1.6)	TRAFD1 (1.5)	PLCG1 (1.2)	ADAM1 (1.1)
ENSG00000169895	SYAP1 PPI subnetwork	0.74	> 0.20	OGDH (2.4)	GOT2P1 (2.4)	TMEM116 (2.0)	SARS (1.8)	TXNL4B (1.7)	TMEM57 (1.7)	C11orf9 (1.7)	PVR (1.6)	HAVCR1 (1.6)	DDX56 (1.6)
KEGG_NON_HOMOLOGOUS_END_JOINING	KEGG_NON_HOMOLOGOUS_END_JOINING	0.74	> 0.20	UBXN2B (2.7)	SMARCA4 (2.6)	ACAD10 (2.5)	ANKRD31 (2.4)	BLOC1S3 (1.9)	POC5 (1.8)	ZNF101 (1.7)	DDX56 (1.6)	POLK (1.5)	ENSG00000254235 (1.5)
GO:0002675	positive regulation of acute inflammatory response	0.74	> 0.20	ENSG00000235545 (4.4)	ENSG00000228044 (3.4)	DNAH11 (1.9)	PLEKHH2 (1.7)	TSSK6 (1.5)	AMIGO1 (1.4)	MAFB (1.3)	HLX (1.2)	POC5 (1.1)	GMIP (1.1)
ENSG00000178028	DMAP1 PPI subnetwork	0.74	> 0.20	SMARCA4 (2.9)	BUD13 (2.3)	ATXN7L2 (1.7)	PSRC1 (1.6)	GMPR (1.5)	ZNF180 (1.5)	TXNL4B (1.5)	SUGP1 (1.4)	USP1 (1.4)	TMED4 (1.3)
GO:0048038	quinone binding	0.75	> 0.20	ACAD10 (3.6)	ENSG00000228044 (2.7)	HNF1A (2.0)	OGDH (1.8)	GPAM (1.6)	ALDH2 (1.5)	ENSG00000226645 (1.5)	UBXN2B (1.4)	KANK2 (1.4)	C1orf63 (1.3)
ENSG00000125845	BMP2 PPI subnetwork	0.75	> 0.20	NYNRIN (3.0)	MARK4 (2.3)	PVRL2 (2.2)	SLC44A2 (1.9)	ATXN2 (1.9)	ABO (1.9)	MAFB (1.6)	CARM1 (1.6)	PVR (1.6)	KANK2 (1.6)
REACTOME_CELL:CELL_JUNCTION_ORGANIZATION	REACTOME_CELL:CELL_JUNCTION_ORGANIZATION	0.75	> 0.20	AP1M2 (5.4)	BCAM (5.4)	PVRL2 (4.5)	CBLC (4.0)	FRK (2.9)	YIPF2 (2.2)	LPIN3 (2.1)	LPAR2 (2.1)	CELSR2 (2.0)	PVR (1.7)
MP:0005425	increased macrophage cell number	0.75	> 0.20	RELB (3.2)	BCL3 (2.7)	HP (2.1)	PMFBP1 (2.0)	GMIP (2.0)	C11orf9 (1.9)	APOE (1.8)	SH2B3 (1.7)	PARP10 (1.6)	GCNT4 (1.5)
ENSG00000169714	CNBP PPI subnetwork	0.75	> 0.20	ILF3 (2.7)	USP1 (2.3)	GATAD2A (2.2)	TOMM40 (2.1)	NT5DC1 (2.1)	DDX56 (1.9)	NKPD1 (1.8)	ZNF259 (1.8)	TOP1 (1.7)	DHODH (1.7)
ENSG00000186842	ENSG00000186842 PPI subnetwork	0.75	> 0.20	DHX38 (2.3)	TOMM40 (2.3)	ABO (2.3)	ILF3 (2.1)	ATP13A1 (2.1)	BUD13 (1.9)	DDX56 (1.8)	TOP1 (1.7)	BCAM (1.7)	DOCK7 (1.7)
GO:0001726	ruffle	0.75	> 0.20	C11orf9 (4.2)	PLEC (3.8)	SH2B3 (3.6)	SLC44A2 (2.9)	ITGB3 (2.4)	PVR (2.2)	NCAN (2.2)	PTPN11 (2.2)	AP1M2 (2.1)	GATAD2A (2.0)
MP:0000239	absent common myeloid progenitor cells	0.75	> 0.20	HLX (3.1)	RHD (2.3)	ITGB3 (2.3)	NYNRIN (2.3)	GMPR (2.2)	TRAFD1 (2.2)	OASL (2.1)	USP24 (1.5)	GRINA (1.5)	DHODH (1.4)
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	0.75	> 0.20	GMPR (2.0)	DYNC2LI1 (2.0)	BUD13 (2.0)	ZNF180 (1.8)	ZNF259 (1.8)	TXNL4B (1.7)	DHX38 (1.5)	ENSG00000235545 (1.4)	ENSG00000226645 (1.4)	PLEKHH2 (1.3)
ENSG00000176124	DLEU1 PPI subnetwork	0.75	> 0.20	DDX56 (2.3)	ATXN7L2 (2.1)	SARS (1.7)	HAPLN4 (1.6)	SUGP1 (1.5)	DNAH11 (1.5)	BUD13 (1.4)	TXNL4B (1.3)	TM6SF2 (1.3)	OGDH (1.3)
ENSG00000086232	EIF2AK1 PPI subnetwork	0.75	> 0.20	USP24 (2.3)	POLK (2.0)	ILF3 (1.8)	ABO (1.8)	C12orf51 (1.8)	ST3GAL4 (1.7)	SORT1 (1.6)	QTRT1 (1.6)	CILP2 (1.4)	PTPN11 (1.3)
ENSG00000161681	SHANK1 PPI subnetwork	0.75	> 0.20	CELSR2 (3.8)	MARK4 (3.0)	GRINA (2.8)	RPH3A (2.7)	NCAN (2.7)	ATXN7L2 (1.9)	PLEC (1.8)	PBX4 (1.8)	CLPTM1 (1.7)	ANKRD31 (1.6)
ENSG00000175221	MED16 PPI subnetwork	0.75	> 0.20	GEMIN7 (3.4)	TXNL4B (2.6)	BRAP (2.6)	BUD13 (2.3)	POC5 (2.2)	MAPKAPK5 (2.1)	BLOC1S3 (2.0)	C17orf57 (2.0)	C12orf51 (1.9)	C12orf47 (1.7)
GO:0005874	microtubule	0.75	> 0.20	PSRC1 (4.5)	DNAH11 (3.1)	POC5 (2.2)	DYNC2LI1 (2.2)	POLK (2.0)	PBX4 (2.0)	SMARCA4 (1.7)	FEN1 (1.6)	C12orf51 (1.5)	MARK4 (1.5)
REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION	REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION	0.75	> 0.20	NKPD1 (3.0)	MOSC1 (1.7)	UBXN2B (1.7)	ENSG00000226645 (1.5)	ANKRD31 (1.5)	CEACAM19 (1.3)	GATAD2A (1.2)	DNAH11 (1.2)	ADAM1 (1.1)	CBLC (1.0)
ENSG00000065427	KARS PPI subnetwork	0.75	> 0.20	SARS (6.7)	SUGP1 (3.1)	NAA25 (3.1)	PSMA5 (2.8)	MAPKAPK5 (2.7)	DDX56 (2.3)	QTRT1 (2.1)	SMARCA4 (1.8)	ATP13A1 (1.7)	HMGCR (1.6)
ENSG00000196154	S100A4 PPI subnetwork	0.75	> 0.20	SYPL2 (4.5)	PLEC (2.8)	GMIP (2.0)	CARM1 (1.8)	FADS2 (1.6)	GMPR (1.6)	POC5 (1.5)	SH2B3 (1.4)	POLK (1.3)	ST3GAL4 (1.1)
REACTOME_SIGNALING_BY_BMP	REACTOME_SIGNALING_BY_BMP	0.75	> 0.20	ENSG00000228044 (2.6)	KANK2 (2.2)	ABO (1.9)	MAPKAPK5 (1.8)	NYNRIN (1.8)	MAFB (1.8)	PVRL2 (1.6)	DOCK7 (1.6)	ATXN2 (1.6)	ADAM1 (1.5)
MP:0000480	increased rib number	0.75	> 0.20	HLX (2.2)	UBXN2B (2.0)	PLCG1 (1.6)	OASL (1.6)	MOSC1 (1.6)	ZHX3 (1.5)	ENSG00000235545 (1.5)	DYNC2LI1 (1.5)	ATXN7L2 (1.3)	USP24 (1.3)
MP:0001602	impaired myelopoiesis	0.75	> 0.20	HP (2.5)	HLX (2.4)	ENSG00000228044 (2.3)	GMIP (2.3)	MYLIP (1.9)	TSSK6 (1.7)	BCL3 (1.6)	MAFB (1.5)	C17orf57 (1.5)	TIMD4 (1.4)
ENSG00000120805	ARL1 PPI subnetwork	0.75	> 0.20	YIPF2 (3.5)	AP1M2 (2.9)	ATP13A1 (2.8)	SARS (2.7)	ACAD10 (2.7)	SORT1 (2.2)	KIAA1324 (2.1)	QTRT1 (1.9)	POLK (1.8)	BLOC1S3 (1.8)
GO:0006220	pyrimidine nucleotide metabolic process	0.75	> 0.20	DYNC2LI1 (3.5)	ANKRD31 (2.7)	AMIGO1 (2.6)	C12orf43 (1.9)	GEMIN7 (1.7)	ADAM1 (1.6)	TSSK6 (1.6)	TXNL4B (1.4)	PBX4 (1.3)	UBXN2B (1.2)
GO:0005243	gap junction channel activity	0.75	> 0.20	CBLC (2.6)	NKPD1 (2.5)	C11orf9 (2.4)	CYP7A1 (2.0)	LPAR2 (1.9)	ZNF259 (1.7)	DNAH11 (1.6)	PMFBP1 (1.3)	ANGPTL3 (1.3)	RPH3A (1.3)
GO:0000421	autophagic vacuole membrane	0.75	> 0.20	GRINA (3.6)	ENSG00000228044 (2.5)	GEMIN7 (2.4)	HNF1A (2.4)	PPP1R37 (2.3)	ZHX3 (2.0)	ACAD10 (1.9)	RHCE (1.9)	GOT2P1 (1.6)	YIPF2 (1.5)
ENSG00000204133	ENSG00000204133 PPI subnetwork	0.75	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.5)	POC5 (3.5)	ENSG00000228044 (1.1)	ENSG00000226648 (1.0)	ZNF180 (1.0)	ZHX3 (0.9)	LPIN3 (0.6)	USP24 (0.6)
ENSG00000107263	RAPGEF1 PPI subnetwork	0.75	> 0.20	SLC44A2 (2.9)	COL4A3BP (2.7)	PLEKHH2 (2.4)	ZHX3 (2.0)	C17orf57 (2.0)	PTPN11 (2.0)	C11orf9 (1.9)	SH2B3 (1.8)	USP24 (1.8)	ABO (1.7)
REACTOME_MRNA_SPLICING_:_MINOR_PATHWAY	REACTOME_MRNA_SPLICING_:_MINOR_PATHWAY	0.75	> 0.20	ILF3 (2.7)	DHX38 (2.4)	GEMIN7 (2.2)	SMARCA4 (2.0)	DDX56 (2.0)	TOMM40 (1.8)	C12orf47 (1.7)	ATP13A1 (1.7)	ZNF259 (1.7)	SUGP1 (1.6)
GO:0030834	regulation of actin filament depolymerization	0.75	> 0.20	RHD (3.1)	RHCE (3.1)	ENSG00000238078 (2.6)	ADAM1 (2.3)	PMFBP1 (2.1)	TSSK6 (1.7)	GMPR (1.7)	C1orf63 (1.6)	C17orf57 (1.6)	TMEM50A (1.5)
ENSG00000108510	MED13 PPI subnetwork	0.75	> 0.20	GEMIN7 (2.7)	BRAP (2.7)	BUD13 (2.7)	C1orf63 (2.4)	TXNL4B (2.2)	MAPKAPK5 (2.2)	POC5 (1.9)	ZNF180 (1.9)	BLOC1S3 (1.9)	DHX38 (1.7)
MP:0010825	abnormal lung saccule morphology	0.75	> 0.20	BCAM (3.7)	LDLR (3.4)	PLEKHH2 (3.0)	FADS1 (2.6)	CELSR2 (2.5)	FADS2 (2.2)	TMEM116 (2.2)	SLC44A2 (2.2)	HMGCR (2.1)	C11orf9 (1.9)
GO:0018209	peptidyl-serine modification	0.75	> 0.20	C1orf63 (2.1)	USP24 (1.8)	PLEKHH2 (1.8)	ZHX3 (1.7)	DOCK7 (1.6)	PLCG1 (1.4)	PTPN11 (1.3)	GCNT4 (1.3)	GATAD2A (1.2)	ENSG00000228044 (1.2)
GO:0010562	positive regulation of phosphorus metabolic process	0.75	> 0.20	ENSG00000226645 (3.2)	GCNT4 (2.3)	SH2B3 (2.2)	COL4A3BP (1.7)	PVR (1.7)	PLEKHH2 (1.7)	HLX (1.5)	ENSG00000228044 (1.4)	PTPN11 (1.3)	GPAM (1.2)
GO:0045937	positive regulation of phosphate metabolic process	0.75	> 0.20	ENSG00000226645 (3.2)	GCNT4 (2.3)	SH2B3 (2.2)	COL4A3BP (1.7)	PVR (1.7)	PLEKHH2 (1.7)	HLX (1.5)	ENSG00000228044 (1.4)	PTPN11 (1.3)	GPAM (1.2)
MP:0003651	abnormal axon outgrowth	0.75	> 0.20	CETP (2.0)	COL4A3BP (1.9)	GCNT4 (1.8)	TIMD4 (1.8)	ST3GAL4 (1.7)	CYP7A1 (1.7)	ATXN7L2 (1.5)	HLX (1.5)	CILP2 (1.4)	TMEM57 (1.3)
GO:0045073	regulation of chemokine biosynthetic process	0.75	> 0.20	ENSG00000228044 (2.2)	ENSG00000254235 (1.8)	OASL (1.5)	ATXN7L2 (1.3)	CYP7A1 (1.2)	MAFB (1.2)	ENSG00000226645 (1.1)	RHD (1.1)	BCL3 (1.1)	DYNC2LI1 (1.0)
GO:0003231	cardiac ventricle development	0.75	> 0.20	ENSG00000238078 (3.4)	ATXN7L2 (2.5)	NYNRIN (1.8)	C17orf57 (1.5)	CEACAM19 (1.5)	C11orf9 (1.3)	CILP2 (1.3)	TSSK6 (1.3)	PVRL2 (1.2)	BLOC1S3 (1.2)
MP:0009873	abnormal aorta tunica media morphology	0.75	> 0.20	SLC44A2 (2.9)	PPP1R37 (2.2)	ZHX3 (1.8)	C11orf9 (1.5)	GCNT4 (1.5)	TMEM57 (1.4)	LPIN3 (1.4)	DYNC2LI1 (1.4)	MAFB (1.3)	ATXN7L2 (1.3)
ENSG00000068028	RASSF1 PPI subnetwork	0.75	> 0.20	AMIGO1 (2.0)	FEN1 (2.0)	GEMIN7 (1.9)	SUGP1 (1.8)	NYNRIN (1.8)	TMED4 (1.8)	ZNF101 (1.8)	C12orf47 (1.8)	USP1 (1.7)	TRAFD1 (1.6)
ENSG00000099331	MYO9B PPI subnetwork	0.75	> 0.20	ATP13A1 (2.9)	OGDH (1.8)	YIPF2 (1.7)	ILF3 (1.7)	DOCK7 (1.6)	QTRT1 (1.5)	LDLR (1.5)	DNM2 (1.5)	UBXN2B (1.4)	ACAD10 (1.4)
ENSG00000132842	AP3B1 PPI subnetwork	0.75	> 0.20	GEMIN7 (2.2)	PSRC1 (2.1)	TOP1 (2.1)	DNM2 (1.9)	DOCK7 (1.9)	ENSG00000228044 (1.8)	FEN1 (1.7)	YIPF2 (1.4)	PMFBP1 (1.3)	COL4A3BP (1.3)
ENSG00000099204	ABLIM1 PPI subnetwork	0.75	> 0.20	AP1M2 (2.7)	PLEC (2.6)	OGDH (2.5)	BCAM (1.9)	C1orf63 (1.9)	FRK (1.8)	NYNRIN (1.8)	PPP1R37 (1.8)	HAVCR1 (1.7)	SMARCA4 (1.4)
ENSG00000054116	TRAPPC3 PPI subnetwork	0.75	> 0.20	CLPTM1 (3.3)	YIPF2 (3.3)	BLOC1S3 (2.5)	GRINA (2.4)	AP1M2 (2.2)	QTRT1 (2.1)	TMED4 (2.0)	BCAM (1.8)	TRAPPC6A (1.7)	TMEM50A (1.7)
ENSG00000123219	CENPK PPI subnetwork	0.75	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	POC5 (3.5)	USP1 (3.5)	ENSG00000228044 (1.2)	ENSG00000226648 (1.0)	ZNF180 (0.9)	ZHX3 (0.8)	USP24 (0.7)	RHD (0.6)
ENSG00000084207	GSTP1 PPI subnetwork	0.75	> 0.20	PVR (2.8)	BRAP (2.7)	PLCG1 (2.1)	FRK (2.1)	KANK2 (1.9)	LPIN3 (1.9)	ITGB3 (1.9)	GATAD2A (1.8)	HLX (1.7)	SYPL2 (1.7)
ENSG00000041982	TNC PPI subnetwork	0.75	> 0.20	CEACAM19 (3.7)	FRK (2.2)	ENSG00000254235 (2.1)	ST3GAL4 (1.7)	SLC44A2 (1.7)	APOE (1.6)	PTPN11 (1.6)	USP24 (1.6)	PVR (1.5)	C17orf57 (1.5)
MP:0010465	aberrant origin of the right subclavian artery	0.75	> 0.20	PVRL2 (3.5)	PLCG1 (2.1)	PLEKHH2 (2.0)	PVR (2.0)	NYNRIN (1.9)	HLX (1.7)	KIAA1324 (1.5)	TSSK6 (1.5)	BCAM (1.5)	C19orf52 (1.3)
MP:0006009	abnormal neuronal migration	0.75	> 0.20	NCAN (3.2)	CELSR2 (2.7)	PSRC1 (2.1)	C17orf57 (1.9)	KIAA1324 (1.9)	NYNRIN (1.8)	MARK4 (1.7)	LDLR (1.7)	ENSG00000226648 (1.4)	ABO (1.3)
GO:0043392	negative regulation of DNA binding	0.75	> 0.20	ENSG00000226648 (3.3)	ENSG00000238078 (2.3)	ENSG00000226645 (2.1)	ENSG00000235545 (2.1)	PBX4 (1.8)	MAFB (1.7)	DOCK7 (1.7)	PLCG1 (1.6)	RHCE (1.6)	MYLIP (1.5)
GO:0048566	embryonic digestive tract development	0.75	> 0.20	PLEKHH2 (4.2)	ENSG00000228044 (3.7)	C11orf9 (3.6)	ENSG00000235545 (3.3)	ENSG00000226648 (2.5)	PBX4 (2.1)	LPAR2 (1.9)	DYNC2LI1 (1.9)	TM6SF2 (1.8)	NYNRIN (1.7)
ENSG00000185651	UBE2L3 PPI subnetwork	0.75	> 0.20	C19orf52 (3.0)	TXNL4B (2.4)	RHD (2.3)	RHCE (2.2)	MAU2 (2.2)	BUD13 (2.1)	TMEM116 (1.9)	BRAP (1.8)	ACAD10 (1.6)	HAVCR1 (1.6)
ENSG00000105699	LSR PPI subnetwork	0.75	> 0.20	PLEC (3.8)	ZHX3 (3.1)	DNM2 (3.0)	CARM1 (2.7)	C12orf51 (2.4)	USP24 (2.4)	ATXN2 (2.4)	PTPN11 (2.2)	LPAR2 (2.1)	KANK2 (2.1)
MP:0002183	gliosis	0.75	> 0.20	GRINA (2.8)	APOE (2.4)	PLCG1 (2.3)	GCNT4 (2.3)	C12orf51 (2.1)	USP24 (2.1)	CELSR2 (2.0)	TMEM57 (1.8)	ATP13A1 (1.7)	RHD (1.6)
MP:0000097	short maxilla	0.75	> 0.20	MYLIP (2.6)	KANK2 (2.4)	PLEC (2.1)	CILP2 (1.9)	HLX (1.9)	DYNC2LI1 (1.8)	MAFB (1.8)	ALDH2 (1.6)	DOCK7 (1.5)	HAPLN4 (1.4)
ENSG00000161533	ACOX1 PPI subnetwork	0.75	> 0.20	MAPKAPK5 (2.6)	ACAD10 (2.3)	DNAH11 (2.2)	NT5DC1 (2.1)	PLCG1 (2.0)	DDX56 (1.9)	UBXN2B (1.7)	LPAR2 (1.6)	POC5 (1.6)	LPIN3 (1.4)
ENSG00000198380	GFPT1 PPI subnetwork	0.75	> 0.20	MARK4 (3.1)	GATAD2A (2.8)	GMIP (2.6)	LPAR2 (2.5)	C12orf51 (2.4)	SLC44A2 (2.1)	SORT1 (1.9)	ATXN2 (1.9)	BUD13 (1.8)	PSRC1 (1.7)
GO:0016471	vacuolar proton-transporting V-type ATPase complex	0.75	> 0.20	TMEM116 (3.1)	SARS (2.7)	GRINA (1.9)	AP1M2 (1.7)	TMEM57 (1.7)	ENSG00000238078 (1.6)	NKPD1 (1.5)	PMFBP1 (1.5)	MAU2 (1.5)	TMEM50A (1.5)
MP:0003645	increased pancreatic beta cell number	0.75	> 0.20	MOSC1 (2.9)	GPAM (2.3)	GCNT4 (2.1)	KANK2 (1.7)	C12orf51 (1.6)	C12orf43 (1.6)	ABCG8 (1.5)	ERP29 (1.5)	MARK4 (1.4)	PVRL2 (1.4)
GO:0071479	cellular response to ionizing radiation	0.75	> 0.20	NYNRIN (2.3)	TRAPPC6A (2.3)	GEMIN7 (1.9)	UBXN2B (1.8)	BLOC1S3 (1.8)	C12orf43 (1.8)	ZNF101 (1.7)	C17orf57 (1.6)	TRIB1 (1.5)	HAVCR1 (1.4)
GO:0050798	activated T cell proliferation	0.75	> 0.20	ANKRD31 (2.8)	PBX4 (2.6)	ENSG00000254235 (1.8)	TRAFD1 (1.8)	TIMD4 (1.8)	HNF1A (1.3)	CETP (1.3)	SH2B3 (1.2)	GOT2P1 (1.0)	SLC22A1 (1.0)
MP:0003047	abnormal thoracic vertebrae morphology	0.75	> 0.20	NYNRIN (2.2)	CEACAM19 (1.7)	C19orf52 (1.7)	DOCK7 (1.6)	CILP2 (1.5)	C11orf9 (1.4)	FADS1 (1.4)	TMED4 (1.4)	ATXN7L2 (1.3)	PLEKHH2 (1.2)
ENSG00000070814	TCOF1 PPI subnetwork	0.75	> 0.20	ILF3 (4.0)	DHX38 (3.4)	SMARCA4 (3.3)	QTRT1 (3.0)	PTPN11 (2.9)	TOP1 (2.8)	USP1 (2.3)	DNM2 (2.2)	ATP13A1 (2.0)	SARS (1.9)
GO:0032481	positive regulation of type I interferon production	0.75	> 0.20	OASL (5.3)	PARP10 (4.3)	ADAM1 (2.7)	FRK (2.2)	TRAFD1 (2.2)	BRAP (2.0)	DNAH11 (2.0)	CYB561D1 (2.0)	TSSK6 (1.9)	GEMIN7 (1.9)
ENSG00000085662	AKR1B1 PPI subnetwork	0.75	> 0.20	SYPL2 (2.2)	MAFB (2.1)	C12orf47 (2.1)	PVR (1.9)	RHD (1.9)	PVRL2 (1.9)	BCL3 (1.8)	ZNF101 (1.6)	ALDH2 (1.6)	ERP29 (1.4)
ENSG00000167842	MIS12 PPI subnetwork	0.75	> 0.20	PSRC1 (5.8)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ENSG00000228044 (1.0)	ZHX3 (0.9)	ENSG00000226648 (0.9)	ZNF180 (0.8)	PBX4 (0.6)	ILF3 (0.6)
ENSG00000149636	DSN1 PPI subnetwork	0.75	> 0.20	PSRC1 (5.8)	FEN1 (4.5)	POC5 (3.7)	USP1 (3.6)	ENSG00000228044 (1.0)	ZHX3 (0.9)	ENSG00000226648 (0.9)	ZNF180 (0.8)	PBX4 (0.6)	ILF3 (0.6)
MP:0000633	abnormal pituitary gland morphology	0.75	> 0.20	ZNF101 (2.1)	NKPD1 (2.0)	PPP1R37 (2.0)	TMED4 (1.9)	TSSK6 (1.8)	C12orf47 (1.8)	ATXN7L2 (1.8)	KIAA1324 (1.7)	CELSR2 (1.7)	TXNL4B (1.6)
GO:0015103	inorganic anion transmembrane transporter activity	0.75	> 0.20	TMEM116 (4.4)	ANGPTL3 (3.0)	PLG (2.9)	SLC22A1 (2.4)	ATP13A1 (2.1)	FRK (2.1)	CLPTM1 (1.8)	CYB561D1 (1.7)	TM6SF2 (1.5)	BCAM (1.5)
ENSG00000131508	UBE2D2 PPI subnetwork	0.75	> 0.20	USP24 (3.0)	ATXN2 (2.5)	C12orf51 (1.8)	PTPN11 (1.6)	PARP10 (1.5)	SARS (1.5)	ENSG00000254235 (1.5)	BRAP (1.4)	DOCK7 (1.4)	TRAFD1 (1.4)
ENSG00000139436	GIT2 PPI subnetwork	0.75	> 0.20	SH2B3 (4.0)	GMIP (3.1)	DHX38 (3.0)	C12orf51 (2.6)	ATXN2 (2.5)	LPIN3 (2.5)	BRAP (2.4)	USP24 (2.1)	DNM2 (2.0)	TMEM116 (2.0)
ENSG00000100387	RBX1 PPI subnetwork	0.75	> 0.20	CARM1 (2.4)	GRINA (2.4)	DOCK7 (2.4)	SUGP1 (2.1)	SARS (1.8)	TMEM57 (1.7)	GMPR (1.6)	C1orf63 (1.6)	OASL (1.5)	ATXN2 (1.5)
ENSG00000137413	TAF8 PPI subnetwork	0.75	> 0.20	COL4A3BP (3.0)	MAPKAPK5 (2.6)	POC5 (2.3)	C19orf52 (2.1)	DYNC2LI1 (1.9)	C1orf63 (1.9)	UBXN2B (1.8)	USP1 (1.7)	ZHX3 (1.7)	TOP1 (1.6)
GO:0006937	regulation of muscle contraction	0.75	> 0.20	SYPL2 (4.4)	ABO (2.2)	ENSG00000226648 (2.2)	GMPR (2.0)	ITGB3 (2.0)	NKPD1 (1.9)	KANK2 (1.7)	ENSG00000238078 (1.7)	BLOC1S3 (1.7)	TXNL4B (1.4)
GO:0008378	galactosyltransferase activity	0.75	> 0.20	ST3GAL4 (4.1)	SLC44A2 (2.7)	ENSG00000254235 (2.3)	YIPF2 (2.1)	LPAR2 (2.0)	AMIGO1 (1.9)	CBLC (1.8)	ERP29 (1.6)	C12orf47 (1.6)	FRK (1.5)
GO:0001948	glycoprotein binding	0.75	> 0.20	CILP2 (3.3)	PLEC (3.3)	PLG (2.5)	CYP7A1 (2.4)	BCAM (2.2)	APOC1 (2.1)	APOC4 (2.0)	HP (1.9)	ANGPTL3 (1.9)	APOB (1.8)
GO:0035586	purinergic receptor activity	0.75	> 0.20	PMFBP1 (2.8)	MAFB (2.2)	POLK (1.9)	TIMD4 (1.9)	NKPD1 (1.8)	NCAN (1.8)	LDLR (1.5)	ST3GAL4 (1.4)	APOE (1.4)	CETP (1.3)
GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	0.75	> 0.20	CELSR2 (2.5)	RHD (2.5)	PARP10 (2.1)	RHCE (2.1)	MYLIP (1.7)	ENSG00000226648 (1.7)	PMFBP1 (1.5)	GMPR (1.4)	HLX (1.3)	ITGB3 (1.3)
GO:0002287	alpha-beta T cell activation involved in immune response	0.75	> 0.20	BLOC1S3 (2.1)	ENSG00000254235 (1.9)	ENSG00000235545 (1.7)	PBX4 (1.6)	ST3GAL4 (1.6)	NT5DC1 (1.4)	BCL3 (1.3)	TRAFD1 (1.3)	CETP (1.2)	ANKRD31 (1.2)
GO:0002293	alpha-beta T cell differentiation involved in immune response	0.75	> 0.20	BLOC1S3 (2.1)	ENSG00000254235 (1.9)	ENSG00000235545 (1.7)	PBX4 (1.6)	ST3GAL4 (1.6)	NT5DC1 (1.4)	BCL3 (1.3)	TRAFD1 (1.3)	CETP (1.2)	ANKRD31 (1.2)
GO:0046513	ceramide biosynthetic process	0.75	> 0.20	NKPD1 (3.8)	HAVCR1 (3.2)	COL4A3BP (2.5)	SLC44A2 (2.1)	CYB561D1 (2.1)	POLK (1.9)	TMEM116 (1.9)	LPIN3 (1.7)	PVR (1.7)	ITGB3 (1.7)
ENSG00000196712	NF1 PPI subnetwork	0.75	> 0.20	CELSR2 (2.5)	NCAN (2.3)	RPH3A (2.1)	SORT1 (1.8)	CYB561D1 (1.8)	MARK4 (1.7)	PPP1R37 (1.6)	C12orf51 (1.6)	PLEC (1.6)	GOT2P1 (1.6)
GO:0051318	G1 phase	0.75	> 0.20	KANK2 (1.9)	TMED4 (1.9)	POLK (1.8)	ATXN7L2 (1.8)	SORT1 (1.5)	TXNL4B (1.5)	SLC44A2 (1.5)	PBX4 (1.5)	DNM2 (1.2)	YIPF2 (1.1)
ENSG00000198938	MT-CO3 PPI subnetwork	0.75	> 0.20	TRAPPC6A (4.0)	GOT2P1 (2.6)	C12orf47 (2.4)	ACAD10 (2.1)	TMEM116 (1.9)	GMPR (1.6)	OGDH (1.4)	TSSK6 (1.3)	RHD (1.2)	C19orf52 (1.1)
ENSG00000009307	CSDE1 PPI subnetwork	0.75	> 0.20	BRAP (3.4)	PTPN11 (3.0)	C12orf43 (2.9)	MYLIP (2.4)	ADAM1 (2.3)	ZNF259 (2.0)	TIMD4 (2.0)	ENSG00000226645 (1.9)	BUD13 (1.8)	SH2B3 (1.8)
ENSG00000163637	PRICKLE2 PPI subnetwork	0.75	> 0.20	NYNRIN (3.8)	CELSR2 (2.9)	LPAR2 (2.9)	CARM1 (2.5)	FADS2 (2.4)	MARK4 (2.3)	AMIGO1 (1.9)	PSRC1 (1.8)	NCAN (1.6)	OGDH (1.6)
MP:0000889	abnormal cerebellar molecular layer	0.75	> 0.20	NCAN (3.3)	ZHX3 (2.6)	APOE (2.6)	ENSG00000226645 (2.6)	RPH3A (2.3)	AMIGO1 (2.2)	PLCG1 (2.2)	C12orf51 (1.8)	GCNT4 (1.8)	ENSG00000235545 (1.8)
GO:0042056	chemoattractant activity	0.75	> 0.20	PLEKHH2 (2.9)	CYP7A1 (2.5)	OASL (1.8)	ALDH2 (1.8)	KANK2 (1.6)	MAPKAPK5 (1.2)	PSRC1 (1.1)	APOA5 (1.1)	ENSG00000228044 (1.1)	KIAA1324 (1.1)
GO:0030239	myofibril assembly	0.75	> 0.20	SYPL2 (3.5)	ENSG00000226648 (2.6)	HNF1A (2.5)	CEACAM19 (2.1)	GMPR (1.8)	ANKRD31 (1.6)	ENSG00000254235 (1.6)	TMEM50A (1.4)	C17orf57 (1.3)	KANK2 (1.3)
ENSG00000106290	TAF6 PPI subnetwork	0.75	> 0.20	SMARCA4 (2.1)	TOP1 (2.1)	SUGP1 (2.0)	BUD13 (2.0)	ATXN2 (1.8)	ILF3 (1.7)	C1orf63 (1.7)	DHX38 (1.7)	PSMA5 (1.6)	DDX56 (1.5)
GO:0042133	neurotransmitter metabolic process	0.75	> 0.20	DNAH11 (2.6)	ABO (2.2)	C12orf51 (2.1)	COL4A3BP (2.0)	UBXN2B (2.0)	RPH3A (1.8)	ADAM1 (1.7)	HNF1A (1.7)	ACAD10 (1.7)	GCNT4 (1.5)
ENSG00000170310	STX8 PPI subnetwork	0.75	> 0.20	ZNF259 (3.1)	SLC44A2 (2.1)	TMEM50A (2.1)	BRAP (2.1)	YIPF2 (2.0)	SARS (1.9)	C19orf52 (1.8)	MYLIP (1.7)	HNF1A (1.7)	FRK (1.6)
ENSG00000078967	UBE2D4 PPI subnetwork	0.75	> 0.20	ATXN2 (4.0)	USP24 (3.4)	TMEM57 (3.3)	C12orf51 (3.0)	PTPN11 (2.3)	GATAD2A (2.0)	MAPKAPK5 (2.0)	PSMA5 (1.8)	DHX38 (1.6)	BRAP (1.6)
KEGG_ALZHEIMERS_DISEASE	KEGG_ALZHEIMERS_DISEASE	0.75	> 0.20	OGDH (3.8)	C12orf47 (3.3)	TRAPPC6A (2.7)	ACAD10 (2.6)	GOT2P1 (2.4)	C1orf63 (1.7)	CLPTM1 (1.5)	PSMA5 (1.3)	MAU2 (1.3)	SYPL2 (1.3)
ENSG00000156970	BUB1B PPI subnetwork	0.75	> 0.20	PSRC1 (5.3)	FEN1 (4.4)	POC5 (4.1)	USP1 (2.7)	LPIN3 (1.3)	ZHX3 (0.9)	ENSG00000238078 (0.9)	ENSG00000228044 (0.8)	CBLC (0.8)	ACAD10 (0.8)
GO:0071779	G1/S transition checkpoint	0.75	> 0.20	PSMA5 (3.2)	TRAFD1 (2.5)	NT5DC1 (2.4)	NAA25 (2.1)	POLK (1.7)	BRAP (1.7)	SUGP1 (1.5)	TXNL4B (1.4)	ZNF180 (1.4)	TOMM40 (1.4)
GO:0045600	positive regulation of fat cell differentiation	0.75	> 0.20	CILP2 (2.5)	MAFB (1.7)	ENSG00000226645 (1.7)	DNM2 (1.6)	MARK4 (1.6)	ENSG00000254235 (1.5)	PLEKHH2 (1.5)	YIPF2 (1.3)	GATAD2A (1.3)	ST3GAL4 (1.3)
ENSG00000161888	SPC24 PPI subnetwork	0.75	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	POC5 (3.7)	USP1 (3.6)	ENSG00000228044 (1.1)	ENSG00000226648 (1.0)	ZNF180 (0.9)	ZHX3 (0.9)	LPIN3 (0.6)	PBX4 (0.6)
GO:0007422	peripheral nervous system development	0.75	> 0.20	TSSK6 (2.6)	ANKRD31 (2.2)	TMED4 (2.0)	COL4A3BP (2.0)	ATXN7L2 (2.0)	AMIGO1 (2.0)	CELSR2 (1.6)	TMEM116 (1.6)	DOCK7 (1.5)	ENSG00000228044 (1.5)
GO:0048729	tissue morphogenesis	0.75	> 0.20	ENSG00000254235 (2.7)	BCAM (2.6)	PVRL2 (2.6)	KANK2 (2.5)	PLEKHH2 (2.3)	NYNRIN (2.2)	AP1M2 (1.8)	ENSG00000238078 (1.7)	CBLC (1.5)	ANKRD31 (1.4)
ENSG00000196313	POM121 PPI subnetwork	0.75	> 0.20	POLK (2.8)	TSSK6 (2.2)	KIAA1324 (2.0)	FRK (1.9)	PPP1R37 (1.9)	C17orf57 (1.7)	COL4A3BP (1.6)	KANK2 (1.4)	PSRC1 (1.4)	GOT2P1 (1.4)
GO:0005088	Ras guanyl-nucleotide exchange factor activity	0.75	> 0.20	PLCG1 (3.2)	SH2B3 (2.4)	HLX (2.3)	C12orf51 (2.0)	GMIP (2.0)	LPAR2 (1.9)	PLEKHH2 (1.9)	MAFB (1.9)	GATAD2A (1.9)	DNM2 (1.7)
MP:0000107	abnormal frontal bone morphology	0.75	> 0.20	MYLIP (2.9)	NYNRIN (2.2)	MAFB (1.9)	CILP2 (1.9)	ABO (1.7)	ALDH2 (1.6)	ATXN2 (1.6)	PLEC (1.5)	NKPD1 (1.4)	TRAFD1 (1.4)
ENSG00000141446	ESCO1 PPI subnetwork	0.75	> 0.20	USP1 (5.6)	FEN1 (4.7)	PSRC1 (2.6)	POC5 (1.9)	ST3GAL4 (1.6)	BRAP (1.6)	ZNF180 (1.5)	ACAD10 (1.5)	ILF3 (1.3)	OASL (1.3)
ENSG00000141200	KIF2B PPI subnetwork	0.75	> 0.20	PSRC1 (6.0)	FEN1 (4.4)	USP1 (3.5)	POC5 (3.4)	ENSG00000226648 (1.2)	ENSG00000228044 (1.0)	ZNF180 (0.9)	ZHX3 (0.9)	ILF3 (0.7)	LPIN3 (0.6)
ENSG00000144736	SHQ1 PPI subnetwork	0.75	> 0.20	PVR (2.9)	AMIGO1 (2.4)	C12orf43 (2.3)	DDX56 (2.1)	TMEM57 (2.1)	DHODH (2.0)	POLK (2.0)	C17orf57 (1.6)	CYB561D1 (1.6)	NAA25 (1.6)
ENSG00000130638	ATXN10 PPI subnetwork	0.75	> 0.20	PLEC (2.9)	GRINA (2.9)	CBLC (2.7)	SARS (2.7)	OGDH (2.0)	DDX56 (1.9)	BCAM (1.9)	CLPTM1 (1.8)	ATP13A1 (1.6)	AP1M2 (1.6)
KEGG_AUTOIMMUNE_THYROID_DISEASE	KEGG_AUTOIMMUNE_THYROID_DISEASE	0.75	> 0.20	PBX4 (2.3)	CYP7A1 (1.9)	COL4A3BP (1.8)	GOT2P1 (1.8)	TRAFD1 (1.6)	POLK (1.4)	C17orf57 (1.2)	TMED4 (1.1)	MYLIP (1.1)	BCAM (0.9)
REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS	0.75	> 0.20	GMPR (2.6)	TRIB1 (2.4)	MAU2 (2.3)	TMEM57 (2.2)	LPAR2 (2.1)	CYB561D1 (2.0)	BRAP (1.8)	ADAM1 (1.7)	GRINA (1.7)	POLK (1.5)
MP:0001655	multifocal hepatic necrosis	0.75	> 0.20	PARP10 (4.4)	OASL (2.6)	SH2B3 (2.0)	TRAFD1 (1.8)	ATP13A1 (1.7)	ERP29 (1.7)	ENSG00000238078 (1.7)	NT5DC1 (1.5)	TMEM50A (1.5)	TRAPPC6A (1.5)
GO:0001935	endothelial cell proliferation	0.75	> 0.20	ENSG00000226645 (3.7)	HLX (2.4)	PVR (2.3)	CILP2 (2.3)	CETP (1.8)	ADAM1 (1.8)	PMFBP1 (1.5)	TIMD4 (1.5)	ZNF180 (1.5)	C17orf57 (1.4)
GO:0000786	nucleosome	0.75	> 0.20	TSSK6 (4.3)	PMFBP1 (2.8)	C19orf52 (1.8)	TMEM57 (1.8)	PSRC1 (1.7)	GMPR (1.5)	MYLIP (1.5)	C12orf47 (1.3)	PLEKHH2 (1.2)	USP1 (1.2)
ENSG00000104267	CA2 PPI subnetwork	0.75	> 0.20	ALDH2 (2.5)	SMARCA4 (2.5)	HAVCR1 (2.5)	C12orf51 (2.3)	PBX4 (2.2)	NCAN (2.1)	C1orf63 (2.1)	TMEM116 (2.1)	ILF3 (1.9)	ATP13A1 (1.9)
GO:0045165	cell fate commitment	0.75	> 0.20	ABO (2.8)	ENSG00000226648 (2.8)	ENSG00000254235 (2.1)	C19orf52 (2.0)	ENSG00000238078 (1.7)	KIAA1324 (1.6)	TSSK6 (1.4)	PVRL2 (1.3)	ANKRD31 (1.2)	NYNRIN (1.2)
MP:0002231	abnormal primitive streak morphology	0.75	> 0.20	APOE (2.4)	GATAD2A (2.4)	PLCG1 (2.3)	ALDH2 (1.9)	ABO (1.9)	NYNRIN (1.6)	KANK2 (1.4)	UBXN2B (1.3)	ANKRD31 (1.2)	ADAM1 (1.2)
GO:0048041	focal adhesion assembly	0.75	> 0.20	SLC44A2 (2.7)	ITGB3 (2.6)	PVRL2 (2.1)	GCNT4 (2.1)	KANK2 (1.8)	PLEC (1.7)	ENSG00000226648 (1.6)	PBX4 (1.5)	POLK (1.5)	NT5DC1 (1.4)
ENSG00000196072	BLOC1S2 PPI subnetwork	0.75	> 0.20	TRAPPC6A (2.7)	C17orf57 (2.7)	C12orf43 (2.5)	CYB561D1 (2.4)	TXNL4B (2.2)	DYNC2LI1 (2.0)	ZNF180 (1.9)	PLEKHH2 (1.7)	ZNF101 (1.5)	MAPKAPK5 (1.4)
ENSG00000137171	KLC4 PPI subnetwork	0.75	> 0.20	PLEC (4.2)	CARM1 (3.1)	DNM2 (3.1)	ZHX3 (2.8)	USP24 (2.5)	LPAR2 (2.5)	PTPN11 (2.4)	C12orf51 (2.3)	COL4A3BP (2.3)	BCAM (2.3)
GO:0002292	T cell differentiation involved in immune response	0.75	> 0.20	BLOC1S3 (2.3)	ENSG00000235545 (1.8)	ENSG00000254235 (1.8)	ST3GAL4 (1.5)	PBX4 (1.5)	NT5DC1 (1.4)	BCL3 (1.3)	TRAFD1 (1.3)	ANKRD31 (1.3)	CETP (1.2)
GO:0002062	chondrocyte differentiation	0.75	> 0.20	CILP2 (5.8)	PLEKHH2 (3.9)	NYNRIN (2.4)	PMFBP1 (1.6)	GOT2P1 (1.6)	ENSG00000254235 (1.5)	MAFB (1.2)	NPC1L1 (1.1)	YIPF2 (1.1)	ALDH2 (1.0)
ENSG00000159228	CBR1 PPI subnetwork	0.75	> 0.20	PLCG1 (2.7)	BRAP (2.4)	KANK2 (2.2)	SH2B3 (2.1)	ZHX3 (2.1)	TM6SF2 (1.8)	HLX (1.7)	GMPR (1.7)	PTPN11 (1.5)	RHCE (1.4)
GO:2000106	regulation of leukocyte apoptotic process	0.76	> 0.20	CETP (3.0)	GMIP (2.3)	ZNF101 (2.0)	TIMD4 (2.0)	HLX (1.9)	PBX4 (1.9)	ENSG00000235545 (1.6)	PARP10 (1.3)	BCL3 (1.0)	TRAFD1 (1.0)
MP:0010018	pulmonary vascular congestion	0.76	> 0.20	GPAM (3.0)	SORT1 (2.5)	MOSC1 (2.4)	HP (2.3)	TMEM116 (2.1)	CEACAM19 (1.6)	NT5DC1 (1.5)	KIAA1324 (1.4)	CELSR2 (1.3)	CYB561D1 (1.3)
GO:0046456	icosanoid biosynthetic process	0.76	> 0.20	NKPD1 (4.6)	CYB561D1 (3.3)	ALDH2 (2.9)	GMPR (2.4)	FADS2 (1.6)	CEACAM19 (1.6)	ERP29 (1.5)	PMFBP1 (1.4)	ITGB3 (1.4)	C11orf9 (1.3)
ENSG00000100749	VRK1 PPI subnetwork	0.76	> 0.20	TRIB1 (2.5)	C12orf43 (2.4)	GATAD2A (2.3)	USP1 (2.3)	PVR (2.3)	ZNF180 (2.2)	BUD13 (2.0)	C12orf51 (1.7)	RPH3A (1.7)	PLCG1 (1.6)
ENSG00000100353	EIF3D PPI subnetwork	0.76	> 0.20	NKPD1 (2.9)	ILF3 (2.4)	C12orf43 (1.7)	ADAM1 (1.6)	TOP1 (1.6)	SARS (1.6)	C19orf52 (1.5)	ANKRD31 (1.5)	CBLC (1.5)	TRIB1 (1.5)
ENSG00000131037	EPS8L1 PPI subnetwork	0.76	> 0.20	UBXN2B (3.2)	SYPL2 (2.9)	HNF1A (2.5)	TXNL4B (2.2)	MARK4 (1.9)	TMEM50A (1.8)	NPC1L1 (1.6)	TRAFD1 (1.6)	C1orf63 (1.4)	LPAR2 (1.4)
MP:0002746	abnormal semilunar valve morphology	0.76	> 0.20	PVR (3.6)	NYNRIN (2.2)	FRK (2.2)	CEACAM19 (2.1)	MAFB (1.8)	TMEM57 (1.8)	ENSG00000226648 (1.6)	NCAN (1.6)	TMED4 (1.6)	TSSK6 (1.5)
ENSG00000124783	SSR1 PPI subnetwork	0.76	> 0.20	HNF1A (3.2)	ERP29 (2.4)	C12orf47 (2.2)	KIAA1324 (2.1)	PCSK9 (2.0)	CYB561D1 (1.9)	GCNT4 (1.8)	TRAPPC6A (1.8)	FRK (1.7)	NCAN (1.6)
ENSG00000141252	VPS53 PPI subnetwork	0.76	> 0.20	CELSR2 (3.2)	ADAM1 (3.1)	BRAP (2.9)	ERP29 (2.8)	PTPN11 (2.6)	SUGP1 (2.4)	ACAD10 (2.4)	HAPLN4 (2.2)	C12orf43 (2.2)	YIPF2 (2.2)
GO:0016339	calcium-dependent cell-cell adhesion	0.76	> 0.20	ENSG00000226648 (3.2)	HNF1A (2.5)	ANKRD31 (1.8)	FRK (1.5)	UBXN2B (1.5)	GOT2P1 (1.5)	ENSG00000254235 (1.4)	HAPLN4 (1.4)	TM6SF2 (1.3)	ZHX3 (1.2)
ENSG00000115211	EIF2B4 PPI subnetwork	0.76	> 0.20	TXNL4B (4.1)	DDX56 (3.9)	SARS (3.0)	QTRT1 (2.9)	DHODH (2.7)	ZNF259 (2.5)	C12orf43 (2.4)	BRAP (2.3)	NKPD1 (1.9)	TRAPPC6A (1.8)
ENSG00000055163	CYFIP2 PPI subnetwork	0.76	> 0.20	ATXN2 (3.5)	KANK2 (3.0)	DOCK7 (2.8)	TMEM50A (2.5)	CEACAM19 (2.2)	BRAP (2.1)	MARK4 (2.0)	C12orf43 (1.9)	MAFB (1.7)	ENSG00000235545 (1.5)
GO:0051101	regulation of DNA binding	0.76	> 0.20	ENSG00000238078 (3.5)	MARK4 (2.3)	ZNF101 (2.1)	MAFB (2.1)	C1orf63 (2.0)	UBXN2B (2.0)	MYLIP (2.0)	ZNF180 (1.8)	PBX4 (1.7)	GATAD2A (1.6)
ENSG00000118640	VAMP8 PPI subnetwork	0.76	> 0.20	DNM2 (3.2)	C11orf9 (2.9)	ZHX3 (2.7)	COL4A3BP (2.4)	C1orf63 (2.3)	CARM1 (2.2)	MARK4 (1.8)	HNF1A (1.7)	AP1M2 (1.7)	USP24 (1.7)
ENSG00000165632	TAF3 PPI subnetwork	0.76	> 0.20	COL4A3BP (2.9)	MAPKAPK5 (2.6)	UBXN2B (2.5)	C19orf52 (2.3)	C1orf63 (2.3)	POC5 (2.2)	DYNC2LI1 (1.7)	TXNL4B (1.7)	ZHX3 (1.7)	ATXN7L2 (1.6)
REACTOME_AMINE_LIGAND:BINDING_RECEPTORS	REACTOME_AMINE_LIGAND:BINDING_RECEPTORS	0.76	> 0.20	ABO (3.0)	GOT2P1 (2.9)	RPH3A (2.4)	PPP1R37 (1.5)	GCNT4 (1.5)	ENSG00000235545 (1.4)	DNAH11 (1.2)	KIAA1324 (1.2)	AMIGO1 (1.2)	TSSK6 (1.1)
ENSG00000129675	ARHGEF6 PPI subnetwork	0.76	> 0.20	MARK4 (3.2)	PVRL2 (3.1)	CLPTM1 (2.9)	CARM1 (2.4)	PLEC (2.2)	SH2B3 (1.7)	FADS2 (1.7)	POLK (1.7)	BCAM (1.6)	ENSG00000228044 (1.6)
MP:0005079	defective cytotoxic T cell cytolysis	0.76	> 0.20	GMIP (2.2)	SLC44A2 (2.1)	PBX4 (1.9)	ABCG8 (1.4)	CEACAM19 (1.3)	PARP10 (1.2)	ENSG00000238078 (1.2)	ENSG00000235545 (1.2)	ABCG5 (1.2)	ENSG00000228044 (1.0)
KEGG_COLORECTAL_CANCER	KEGG_COLORECTAL_CANCER	0.76	> 0.20	GATAD2A (3.5)	PLCG1 (2.5)	CLPTM1 (2.3)	TMEM57 (1.9)	MARK4 (1.9)	DNM2 (1.9)	SLC44A2 (1.9)	SH2B3 (1.9)	ZNF180 (1.8)	MYLIP (1.7)
ENSG00000100614	PPM1A PPI subnetwork	0.76	> 0.20	DNM2 (2.5)	HLX (2.4)	TMEM57 (1.5)	CYP7A1 (1.4)	MARK4 (1.4)	AMIGO1 (1.3)	GATAD2A (1.3)	LPA (1.3)	NYNRIN (1.3)	NCAN (1.3)
GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	0.76	> 0.20	ENSG00000226645 (2.3)	PVRL2 (2.2)	NYNRIN (2.0)	CEACAM19 (1.8)	MARK4 (1.6)	ABO (1.5)	CARM1 (1.3)	ENSG00000254235 (1.3)	KANK2 (1.3)	BCAM (1.2)
GO:0045652	regulation of megakaryocyte differentiation	0.76	> 0.20	ZNF180 (2.6)	ENSG00000226648 (2.4)	TMEM57 (2.1)	TSSK6 (2.0)	GMPR (1.9)	ITGB3 (1.9)	BUD13 (1.8)	RHCE (1.5)	POLK (1.4)	BRAP (1.4)
ENSG00000008735	MAPK8IP2 PPI subnetwork	0.76	> 0.20	PVR (3.1)	PPP1R37 (2.5)	SLC44A2 (2.3)	SORT1 (2.2)	MARK4 (2.1)	LPAR2 (2.0)	KIAA1324 (1.9)	POLK (1.8)	GATAD2A (1.7)	DNM2 (1.7)
ENSG00000165637	VDAC2 PPI subnetwork	0.76	> 0.20	ACAD10 (3.4)	OGDH (3.2)	NT5DC1 (2.3)	ERP29 (2.0)	KIAA1324 (1.8)	TMEM50A (1.6)	AP1M2 (1.6)	NYNRIN (1.3)	TMED4 (1.3)	HNF1A (1.3)
ENSG00000136146	MED4 PPI subnetwork	0.76	> 0.20	POC5 (2.9)	MAPKAPK5 (2.7)	BRAP (2.5)	BUD13 (2.5)	TXNL4B (2.4)	BLOC1S3 (2.1)	GEMIN7 (2.0)	ATXN7L2 (2.0)	ZNF180 (1.7)	TRAFD1 (1.6)
ENSG00000166451	CENPN PPI subnetwork	0.76	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.6)	ENSG00000228044 (1.1)	ENSG00000226648 (1.0)	ZNF180 (0.9)	ZHX3 (0.9)	USP24 (0.6)	LPIN3 (0.6)
MP:0004856	decreased ovary weight	0.76	> 0.20	LPIN3 (2.2)	LDLR (2.1)	FRK (1.8)	DNAH11 (1.8)	ATXN7L2 (1.5)	HAVCR1 (1.5)	LPAR2 (1.4)	GOT2P1 (1.4)	ENSG00000226645 (1.3)	COL4A3BP (1.2)
ENSG00000165588	OTX2 PPI subnetwork	0.76	> 0.20	COL4A3BP (2.5)	SUGP1 (2.2)	BUD13 (2.1)	DNAH11 (2.1)	SORT1 (1.9)	PSMA5 (1.6)	SARS (1.3)	HAPLN4 (1.3)	TXNL4B (1.3)	TRIB1 (1.3)
ENSG00000185633	NDUFA4L2 PPI subnetwork	0.76	> 0.20	NKPD1 (4.4)	AP1M2 (3.0)	HMGCR (2.4)	CYB561D1 (2.0)	C1orf63 (2.0)	UBXN2B (1.9)	YIPF2 (1.8)	FADS1 (1.8)	HNF1A (1.8)	ATXN7L2 (1.7)
ENSG00000170248	PDCD6IP PPI subnetwork	0.76	> 0.20	PPP1R37 (2.9)	PLEC (2.2)	GMIP (1.9)	CYB561D1 (1.8)	PSRC1 (1.8)	TRAFD1 (1.8)	TRAPPC6A (1.8)	NCAN (1.7)	GRINA (1.7)	MAU2 (1.7)
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1:AMPK	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1:AMPK	0.76	> 0.20	BRAP (5.0)	PTPN11 (3.2)	GMPR (2.9)	C12orf51 (2.9)	C12orf43 (2.8)	AMIGO1 (2.1)	USP24 (2.0)	SYPL2 (2.0)	C19orf52 (1.8)	CYP7A1 (1.7)
ENSG00000102901	CENPT PPI subnetwork	0.76	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	POC5 (3.7)	USP1 (3.5)	ENSG00000226648 (1.1)	ZNF180 (1.0)	ZHX3 (1.0)	ENSG00000228044 (0.8)	USP24 (0.7)	ILF3 (0.7)
GO:0048873	homeostasis of number of cells within a tissue	0.76	> 0.20	DNAH11 (2.7)	C17orf57 (1.8)	ZNF180 (1.6)	ITGB3 (1.3)	POLK (1.2)	ENSG00000228044 (1.1)	GCNT4 (1.1)	QTRT1 (1.0)	C19orf52 (1.0)	FRK (0.9)
GO:0009126	purine nucleoside monophosphate metabolic process	0.76	> 0.20	NT5DC1 (3.1)	ANKRD31 (3.1)	DHODH (2.4)	ENSG00000226648 (2.2)	ENSG00000228044 (2.1)	SYPL2 (1.9)	QTRT1 (1.8)	ZNF259 (1.7)	PMFBP1 (1.6)	NAA25 (1.2)
GO:0009167	purine ribonucleoside monophosphate metabolic process	0.76	> 0.20	NT5DC1 (3.1)	ANKRD31 (3.1)	DHODH (2.4)	ENSG00000226648 (2.2)	ENSG00000228044 (2.1)	SYPL2 (1.9)	QTRT1 (1.8)	ZNF259 (1.7)	PMFBP1 (1.6)	NAA25 (1.2)
ENSG00000145191	EIF2B5 PPI subnetwork	0.76	> 0.20	TXNL4B (4.1)	DDX56 (3.5)	SARS (3.3)	ZNF259 (2.9)	BRAP (2.6)	QTRT1 (2.4)	DHODH (2.2)	GOT2P1 (1.9)	TOMM40 (1.9)	ATXN2 (1.8)
ENSG00000171549	ENSG00000171549 PPI subnetwork	0.76	> 0.20	ALDH2 (3.2)	HAPLN4 (3.1)	C11orf9 (2.5)	MOSC1 (2.4)	RPH3A (2.4)	NT5DC1 (2.2)	NCAN (2.0)	HP (1.8)	CYP7A1 (1.8)	ST3GAL4 (1.7)
ENSG00000182520	ENSG00000182520 PPI subnetwork	0.76	> 0.20	ALDH2 (3.2)	HAPLN4 (3.1)	C11orf9 (2.5)	MOSC1 (2.4)	RPH3A (2.4)	NT5DC1 (2.2)	NCAN (2.0)	HP (1.8)	CYP7A1 (1.8)	ST3GAL4 (1.7)
ENSG00000152253	SPC25 PPI subnetwork	0.76	> 0.20	PSRC1 (5.7)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.5)	ENSG00000226648 (1.2)	ENSG00000228044 (1.0)	ZNF180 (1.0)	ZHX3 (0.8)	LPIN3 (0.7)	PBX4 (0.6)
GO:0035924	cellular response to vascular endothelial growth factor stimulus	0.76	> 0.20	HLX (3.0)	C17orf57 (3.0)	PVR (2.8)	TSSK6 (2.5)	SH2B3 (2.4)	KANK2 (2.0)	PVRL2 (1.9)	ENSG00000226645 (1.7)	POLK (1.5)	TMEM116 (1.4)
MP:0003858	enhanced coordination	0.76	> 0.20	C12orf47 (4.7)	CELSR2 (3.3)	NCAN (3.0)	TSSK6 (2.9)	PVR (2.2)	ENSG00000226645 (2.2)	HAVCR1 (2.0)	ST3GAL4 (1.9)	C11orf9 (1.8)	CEACAM19 (1.6)
GO:0033688	regulation of osteoblast proliferation	0.76	> 0.20	SLC44A2 (4.2)	PLEKHH2 (2.6)	OASL (2.0)	ENSG00000238078 (1.6)	C17orf57 (1.6)	GMPR (1.5)	TRAPPC6A (1.4)	CETP (1.3)	HAVCR1 (1.3)	YIPF2 (1.3)
GO:0030278	regulation of ossification	0.76	> 0.20	CILP2 (2.7)	MYLIP (2.5)	MAFB (2.4)	ENSG00000226648 (1.8)	ABO (1.5)	CEACAM19 (1.5)	PLEKHH2 (1.4)	NYNRIN (1.4)	TMEM57 (1.4)	RHCE (1.4)
ENSG00000170142	UBE2E1 PPI subnetwork	0.76	> 0.20	PSRC1 (4.9)	POC5 (2.7)	FEN1 (2.6)	ATXN2 (2.4)	LPIN3 (2.0)	C12orf51 (1.7)	BRAP (1.4)	USP1 (1.4)	ENSG00000228044 (1.4)	USP24 (1.3)
MP:0001917	intraventricular hemorrhage	0.76	> 0.20	NYNRIN (2.7)	GATAD2A (2.4)	GOT2P1 (2.3)	GMIP (1.9)	UBXN2B (1.8)	ACAD10 (1.7)	TMEM50A (1.7)	C1orf63 (1.6)	PTPN11 (1.6)	GCNT4 (1.6)
GO:0042516	regulation of tyrosine phosphorylation of Stat3 protein	0.76	> 0.20	PVR (2.8)	ENSG00000238078 (2.5)	PBX4 (2.4)	CYB561D1 (2.1)	ENSG00000254235 (1.9)	ZNF101 (1.8)	DYNC2LI1 (1.5)	TIMD4 (1.3)	NKPD1 (1.3)	ENSG00000228044 (1.3)
GO:0017085	response to insecticide	0.76	> 0.20	DNAH11 (3.0)	RHCE (2.6)	RHD (2.2)	FRK (2.0)	PMFBP1 (1.9)	CYP7A1 (1.8)	COL4A3BP (1.8)	ADAM1 (1.5)	POLK (1.4)	GOT2P1 (1.4)
REACTOME_MITOTIC_G2:G2M_PHASES	REACTOME_MITOTIC_G2:G2M_PHASES	0.76	> 0.20	PSRC1 (4.0)	POC5 (3.4)	FEN1 (3.0)	PBX4 (2.5)	SMARCA4 (2.2)	DYNC2LI1 (2.0)	USP1 (1.9)	POLK (1.8)	BUD13 (1.6)	C12orf51 (1.6)
GO:0021513	spinal cord dorsal/ventral patterning	0.76	> 0.20	ENSG00000254235 (2.6)	DNAH11 (2.2)	LPIN3 (2.1)	GOT2P1 (1.7)	ATXN7L2 (1.6)	HNF1A (1.6)	TMEM116 (1.6)	DYNC2LI1 (1.5)	NCAN (1.4)	ENSG00000226648 (1.4)
GO:0033558	protein deacetylase activity	0.76	> 0.20	ATXN7L2 (4.1)	PLCG1 (2.4)	HNF1A (2.4)	PSRC1 (1.5)	DHX38 (1.2)	BUD13 (1.1)	SUGP1 (1.1)	PPP1R37 (1.1)	RELB (1.1)	NT5DC1 (1.1)
GO:0004407	histone deacetylase activity	0.76	> 0.20	ATXN7L2 (4.1)	PLCG1 (2.4)	HNF1A (2.4)	PSRC1 (1.5)	DHX38 (1.2)	BUD13 (1.1)	SUGP1 (1.1)	PPP1R37 (1.1)	RELB (1.1)	NT5DC1 (1.1)
ENSG00000145423	SFRP2 PPI subnetwork	0.76	> 0.20	BCAM (3.2)	PVRL2 (2.1)	CELSR2 (1.8)	PLEKHH2 (1.6)	CBLC (1.6)	LPAR2 (1.5)	TSSK6 (1.5)	ABO (1.3)	NYNRIN (1.2)	AMIGO1 (1.1)
ENSG00000186141	POLR3C PPI subnetwork	0.76	> 0.20	GMPR (2.6)	DDX56 (2.6)	QTRT1 (2.3)	C19orf52 (2.0)	ZNF259 (1.7)	GEMIN7 (1.6)	NAA25 (1.4)	ATP13A1 (1.4)	ZHX3 (1.2)	C12orf47 (1.2)
ENSG00000049541	RFC2 PPI subnetwork	0.76	> 0.20	FEN1 (5.1)	USP1 (4.4)	ATP13A1 (2.7)	ILF3 (2.2)	SMARCA4 (2.0)	NT5DC1 (1.6)	PSRC1 (1.6)	AMIGO1 (1.4)	QTRT1 (1.4)	DDX56 (1.3)
GO:0000930	gamma-tubulin complex	0.76	> 0.20	TRAPPC6A (2.5)	C12orf51 (2.3)	BLOC1S3 (2.0)	PMFBP1 (1.9)	ENSG00000228044 (1.7)	ZNF180 (1.6)	POLK (1.6)	POC5 (1.5)	GEMIN7 (1.5)	DHODH (1.5)
GO:0015074	DNA integration	0.76	> 0.20	POC5 (2.7)	ZNF101 (2.6)	POLK (2.4)	TMEM116 (2.2)	ZNF180 (2.0)	FRK (1.9)	NT5DC1 (1.8)	UBXN2B (1.8)	LPAR2 (1.6)	C17orf57 (1.4)
ENSG00000180581	ENSG00000180581 PPI subnetwork	0.76	> 0.20	KANK2 (2.5)	TOP1 (2.2)	GMPR (2.1)	ZHX3 (1.9)	PLCG1 (1.9)	SMARCA4 (1.7)	ADAM1 (1.7)	TMEM116 (1.7)	DNAH11 (1.4)	SH2B3 (1.3)
ENSG00000143742	SRP9 PPI subnetwork	0.76	> 0.20	KANK2 (2.5)	TOP1 (2.2)	GMPR (2.1)	ZHX3 (1.9)	PLCG1 (1.9)	SMARCA4 (1.7)	ADAM1 (1.7)	TMEM116 (1.7)	DNAH11 (1.4)	SH2B3 (1.3)
GO:0004532	exoribonuclease activity	0.76	> 0.20	DHODH (3.2)	OASL (3.1)	PARP10 (3.0)	MAPKAPK5 (2.9)	POC5 (2.7)	DDX56 (2.1)	SUGP1 (2.1)	QTRT1 (2.0)	ZNF259 (2.0)	NT5DC1 (1.9)
ENSG00000042088	TDP1 PPI subnetwork	0.76	> 0.20	ENSG00000226648 (2.4)	DYNC2LI1 (2.0)	POLK (2.0)	ZNF259 (1.8)	TSSK6 (1.7)	CEACAM19 (1.7)	SUGP1 (1.6)	QTRT1 (1.5)	GCNT4 (1.5)	ILF3 (1.4)
ENSG00000123080	CDKN2C PPI subnetwork	0.76	> 0.20	ATXN7L2 (2.4)	SLC44A2 (2.3)	ENSG00000235545 (2.2)	SARS (2.1)	MARK4 (2.1)	TMED4 (1.8)	TRAPPC6A (1.8)	FADS2 (1.7)	BCAM (1.3)	POC5 (1.3)
GO:0007006	mitochondrial membrane organization	0.76	> 0.20	GEMIN7 (4.0)	ZNF259 (3.0)	TOMM40 (2.7)	BRAP (1.9)	TRAPPC6A (1.8)	C12orf43 (1.5)	C12orf47 (1.4)	PPP1R37 (1.4)	BLOC1S3 (1.4)	HAVCR1 (1.3)
GO:0030295	protein kinase activator activity	0.76	> 0.20	CETP (2.4)	C17orf57 (2.3)	TSSK6 (2.1)	ITGB3 (1.9)	GMIP (1.9)	GMPR (1.8)	PTPN11 (1.7)	SLC22A1 (1.5)	C12orf51 (1.5)	AMIGO1 (1.3)
ENSG00000167900	TK1 PPI subnetwork	0.76	> 0.20	FADS2 (2.7)	PSRC1 (2.3)	FADS1 (1.9)	CEACAM19 (1.8)	SARS (1.7)	POLK (1.6)	TRAPPC6A (1.5)	ATXN7L2 (1.5)	GMIP (1.5)	TMEM116 (1.5)
KEGG_NOTCH_SIGNALING_PATHWAY	KEGG_NOTCH_SIGNALING_PATHWAY	0.76	> 0.20	CELSR2 (3.3)	NCAN (2.7)	PLCG1 (2.3)	USP24 (2.2)	ABO (2.2)	PLEC (2.2)	PPP1R37 (1.9)	SLC44A2 (1.9)	MARK4 (1.8)	BCAM (1.8)
ENSG00000118007	STAG1 PPI subnetwork	0.76	> 0.20	USP1 (4.1)	TOP1 (2.3)	DOCK7 (2.1)	COL4A3BP (1.8)	UBXN2B (1.7)	PARP10 (1.7)	NYNRIN (1.6)	ATXN7L2 (1.4)	POLK (1.2)	DNM2 (1.2)
GO:0043542	endothelial cell migration	0.76	> 0.20	PVR (2.7)	ENSG00000226645 (2.5)	PVRL2 (2.0)	HLX (2.0)	SLC44A2 (1.9)	PLCG1 (1.5)	POLK (1.4)	CETP (1.4)	SH2B3 (1.3)	HNF1A (1.3)
GO:0003230	cardiac atrium development	0.76	> 0.20	ENSG00000238078 (2.3)	C11orf9 (2.3)	HNF1A (1.8)	ATXN7L2 (1.8)	GCNT4 (1.7)	ENSG00000226648 (1.7)	DHODH (1.6)	ACAD10 (1.5)	ENSG00000254235 (1.4)	C19orf52 (1.3)
ENSG00000114480	GBE1 PPI subnetwork	0.76	> 0.20	OASL (3.4)	PSMA5 (3.2)	PARP10 (2.5)	ENSG00000226648 (2.1)	FADS2 (1.9)	SARS (1.8)	DOCK7 (1.8)	MOSC1 (1.8)	FADS1 (1.7)	ATXN2 (1.7)
GO:0032494	response to peptidoglycan	0.76	> 0.20	ENSG00000235545 (2.7)	BCL3 (2.0)	RELB (2.0)	GOT2P1 (1.6)	ENSG00000228044 (1.6)	PVR (1.5)	ENSG00000254235 (1.5)	PARP10 (1.5)	TRIB1 (1.3)	GRINA (1.3)
MP:0000249	abnormal blood vessel physiology	0.76	> 0.20	SYPL2 (3.4)	C12orf47 (2.8)	TMEM50A (2.1)	HLX (2.1)	APOC1 (1.7)	GMPR (1.7)	BCAM (1.6)	ENSG00000235545 (1.4)	SLC44A2 (1.3)	ANGPTL3 (1.2)
ENSG00000010671	BTK PPI subnetwork	0.76	> 0.20	GMIP (4.0)	SH2B3 (2.9)	SMARCA4 (2.5)	MAFB (2.1)	DNM2 (1.9)	PTPN11 (1.9)	USP24 (1.8)	ZNF101 (1.8)	PMFBP1 (1.7)	ADAM1 (1.7)
ENSG00000164080	RAD54L2 PPI subnetwork	0.76	> 0.20	MYLIP (2.0)	ILF3 (1.9)	CARM1 (1.9)	C12orf47 (1.8)	GMPR (1.5)	ABO (1.4)	YIPF2 (1.4)	MOSC1 (1.2)	NYNRIN (1.2)	ENSG00000235545 (1.2)
GO:0060053	neurofilament cytoskeleton	0.76	> 0.20	HAPLN4 (3.8)	COL4A3BP (2.5)	AMIGO1 (2.1)	ZNF180 (1.8)	RHCE (1.8)	CELSR2 (1.7)	OGDH (1.6)	NT5DC1 (1.5)	RPH3A (1.4)	TMEM116 (1.4)
ENSG00000127920	GNG11 PPI subnetwork	0.76	> 0.20	TM6SF2 (1.9)	PVRL2 (1.9)	ENSG00000254235 (1.8)	GMIP (1.6)	PTPN11 (1.5)	ATXN2 (1.4)	TMEM57 (1.4)	ABO (1.4)	SLC44A2 (1.4)	ENSG00000235545 (1.2)
MP:0005617	increased susceptibility to type IV hypersensitivity reaction	0.76	> 0.20	OASL (3.5)	MAFB (2.8)	TRAFD1 (2.2)	APOE (1.7)	TIMD4 (1.6)	PMFBP1 (1.4)	PARP10 (1.4)	ZNF101 (1.3)	CILP2 (1.2)	LPAR2 (1.2)
ENSG00000143499	SMYD2 PPI subnetwork	0.76	> 0.20	DNM2 (2.1)	SMARCA4 (1.9)	ILF3 (1.9)	DOCK7 (1.9)	CARM1 (1.7)	TIMD4 (1.4)	C19orf52 (1.2)	ST3GAL4 (1.1)	POC5 (1.1)	HNF1A (1.1)
MP:0010029	abnormal basicranium morphology	0.76	> 0.20	CILP2 (6.5)	NYNRIN (2.4)	MAFB (2.3)	CEACAM19 (2.0)	PLEKHH2 (1.6)	DYNC2LI1 (1.5)	ALDH2 (1.4)	TRAPPC6A (1.3)	TRAFD1 (1.3)	NCAN (1.3)
GO:0005031	tumor necrosis factor-activated receptor activity	0.76	> 0.20	TRAFD1 (2.5)	PBX4 (2.2)	CYB561D1 (2.2)	RELB (2.1)	LPAR2 (2.0)	POLK (1.8)	PLEKHH2 (1.8)	NYNRIN (1.7)	CETP (1.6)	PARP10 (1.5)
ENSG00000060237	WNK1 PPI subnetwork	0.76	> 0.20	COL4A3BP (2.8)	PTPN11 (2.7)	MARK4 (2.6)	KANK2 (2.1)	ST3GAL4 (1.9)	HAPLN4 (1.8)	ATXN7L2 (1.7)	BLOC1S3 (1.7)	ZNF180 (1.7)	ATXN2 (1.7)
ENSG00000204642	HLA-F PPI subnetwork	0.76	> 0.20	PLCG1 (3.0)	PARP10 (2.0)	ENSG00000228044 (2.0)	ZNF101 (1.5)	HAVCR1 (1.4)	DHODH (1.3)	MARK4 (1.3)	TMEM50A (1.2)	YIPF2 (1.2)	TMED4 (1.1)
MP:0008294	abnormal zona fasciculata morphology	0.76	> 0.20	PPP1R37 (2.5)	GPAM (1.9)	ST3GAL4 (1.9)	FADS2 (1.8)	DNAH11 (1.7)	LDLR (1.6)	FADS1 (1.6)	TSSK6 (1.6)	PLEC (1.5)	CYB561D1 (1.3)
ENSG00000069974	RAB27A PPI subnetwork	0.76	> 0.20	KIAA1324 (2.3)	PBX4 (1.8)	LDLR (1.6)	ST3GAL4 (1.6)	LPA (1.3)	CELSR2 (1.3)	ADAM1 (1.3)	CYP7A1 (1.2)	CYB561D1 (1.2)	POLK (1.2)
ENSG00000160551	TAOK1 PPI subnetwork	0.76	> 0.20	PSRC1 (6.1)	FEN1 (4.1)	USP1 (3.4)	POC5 (3.4)	C12orf51 (1.7)	ZNF180 (1.4)	USP24 (1.3)	ENSG00000226648 (1.2)	BUD13 (1.1)	ILF3 (1.1)
ENSG00000141030	COPS3 PPI subnetwork	0.76	> 0.20	ENSG00000226648 (2.6)	SUGP1 (1.9)	SLC44A2 (1.8)	DYNC2LI1 (1.7)	SYPL2 (1.6)	USP24 (1.6)	DDX56 (1.4)	BUD13 (1.4)	SARS (1.3)	ST3GAL4 (1.3)
ENSG00000162961	DPY30 PPI subnetwork	0.76	> 0.20	ANKRD31 (2.4)	PSRC1 (2.3)	HAVCR1 (2.3)	C12orf51 (1.7)	C19orf52 (1.7)	DNAH11 (1.6)	MAU2 (1.6)	DDX56 (1.2)	ENSG00000228044 (1.2)	APOC1 (1.1)
GO:0007265	Ras protein signal transduction	0.76	> 0.20	GATAD2A (3.0)	SLC44A2 (2.9)	MARK4 (2.6)	GMIP (2.5)	DNM2 (2.4)	LPAR2 (2.3)	CBLC (2.3)	LPIN3 (2.1)	SH2B3 (2.0)	PLEC (2.0)
GO:0018210	peptidyl-threonine modification	0.76	> 0.20	C1orf63 (2.7)	GCNT4 (2.1)	PTPN11 (2.0)	CYB561D1 (1.9)	ZHX3 (1.8)	C12orf51 (1.5)	FRK (1.4)	SORT1 (1.3)	ZNF180 (1.3)	SLC44A2 (1.3)
GO:0060443	mammary gland morphogenesis	0.76	> 0.20	PPP1R37 (2.9)	PLEKHH2 (2.6)	KIAA1324 (2.3)	BCAM (2.0)	CBLC (1.9)	AP1M2 (1.7)	CELSR2 (1.6)	C17orf57 (1.6)	PVRL2 (1.4)	MYLIP (1.3)
GO:0022604	regulation of cell morphogenesis	0.76	> 0.20	C11orf9 (2.6)	SLC44A2 (2.3)	ABO (2.1)	PVRL2 (2.0)	PPP1R37 (2.0)	PLEC (1.9)	PLEKHH2 (1.8)	CELSR2 (1.7)	SH2B3 (1.6)	NCAN (1.5)
GO:0031032	actomyosin structure organization	0.76	> 0.20	SYPL2 (3.2)	HNF1A (2.5)	CEACAM19 (2.3)	KANK2 (2.0)	ENSG00000226648 (2.0)	ANKRD31 (1.8)	GMPR (1.8)	ENSG00000254235 (1.8)	C17orf57 (1.5)	SORT1 (1.3)
MP:0000938	motor neuron degeneration	0.76	> 0.20	DOCK7 (2.5)	ALDH2 (2.4)	USP24 (2.3)	GOT2P1 (2.2)	FADS2 (2.1)	C12orf51 (1.8)	KIAA1324 (1.7)	ATXN2 (1.7)	DHX38 (1.6)	NCAN (1.4)
GO:0032580	Golgi cisterna membrane	0.76	> 0.20	YIPF2 (4.4)	ST3GAL4 (4.0)	TMED4 (3.4)	LPIN3 (2.4)	CYB561D1 (2.2)	ERP29 (1.8)	SLC44A2 (1.6)	TMEM57 (1.6)	PPP1R37 (1.6)	CILP2 (1.5)
GO:0001763	morphogenesis of a branching structure	0.76	> 0.20	PLEKHH2 (3.0)	PVRL2 (2.6)	BCAM (2.1)	MYLIP (2.0)	ENSG00000254235 (2.0)	NYNRIN (1.9)	KANK2 (1.5)	KIAA1324 (1.5)	HLX (1.5)	AP1M2 (1.4)
ENSG00000151065	DCP1B PPI subnetwork	0.76	> 0.20	TXNL4B (3.4)	SARS (2.4)	POLK (2.3)	POC5 (2.1)	CEACAM19 (1.9)	OASL (1.9)	BRAP (1.7)	SUGP1 (1.6)	BUD13 (1.3)	USP24 (1.2)
GO:0002720	positive regulation of cytokine production involved in immune response	0.76	> 0.20	GCNT4 (3.2)	SH2B3 (1.8)	HLX (1.6)	ZNF101 (1.6)	BUD13 (1.5)	HAVCR1 (1.2)	BRAP (1.2)	ZNF180 (1.1)	PBX4 (1.1)	POC5 (1.1)
ENSG00000115207	GTF3C2 PPI subnetwork	0.76	> 0.20	ATP13A1 (3.1)	TOMM40 (2.0)	C19orf52 (2.0)	DDX56 (1.7)	DOCK7 (1.7)	QTRT1 (1.7)	ATXN2 (1.7)	ILF3 (1.6)	GPAM (1.5)	DNM2 (1.5)
GO:0031329	regulation of cellular catabolic process	0.76	> 0.20	ZHX3 (2.7)	C12orf51 (2.1)	DNM2 (1.9)	HLX (1.5)	SH2B3 (1.5)	CETP (1.4)	USP24 (1.4)	CBLC (1.3)	GMIP (1.3)	ENSG00000228044 (1.3)
ENSG00000138778	CENPE PPI subnetwork	0.76	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	USP1 (3.5)	POC5 (3.4)	ENSG00000226648 (1.0)	ZNF180 (1.0)	ZHX3 (0.9)	ENSG00000228044 (0.9)	PBX4 (0.8)	LPIN3 (0.6)
ENSG00000128487	SPECC1 PPI subnetwork	0.76	> 0.20	PLEC (3.7)	FRK (2.7)	GATAD2A (2.3)	SARS (2.1)	PLCG1 (2.0)	ABCG8 (1.9)	AP1M2 (1.8)	ITGB3 (1.7)	PVR (1.7)	DOCK7 (1.6)
GO:0061383	trabecula morphogenesis	0.76	> 0.20	CEACAM19 (3.0)	ATXN7L2 (3.0)	CARM1 (2.6)	ENSG00000254235 (2.4)	C19orf52 (2.0)	GOT2P1 (1.9)	ENSG00000238078 (1.7)	UBXN2B (1.7)	KIAA1324 (1.7)	KANK2 (1.5)
ENSG00000139722	VPS37B PPI subnetwork	0.76	> 0.20	TMEM50A (3.2)	GRINA (3.1)	UBXN2B (1.6)	MAU2 (1.5)	ACAD10 (1.5)	MAFB (1.5)	GMPR (1.4)	C1orf63 (1.3)	ENSG00000226645 (1.3)	TRAPPC6A (1.2)
GO:0034762	regulation of transmembrane transport	0.76	> 0.20	AMIGO1 (2.3)	PLEKHH2 (1.8)	MYLIP (1.7)	PVR (1.7)	SYPL2 (1.6)	SH2B3 (1.5)	GRINA (1.5)	OASL (1.3)	PPP1R37 (1.2)	CLPTM1 (1.1)
GO:0001945	lymph vessel development	0.76	> 0.20	CEACAM19 (2.7)	PVRL2 (2.5)	ZNF180 (2.3)	BLOC1S3 (2.3)	TSSK6 (2.1)	CETP (2.1)	SLC44A2 (2.1)	C19orf52 (1.6)	BCAM (1.6)	PLCG1 (1.4)
ENSG00000183691	NOG PPI subnetwork	0.76	> 0.20	CILP2 (2.3)	ABO (2.2)	PVR (1.9)	MAFB (1.7)	SLC22A1 (1.4)	MOSC1 (1.3)	GMPR (1.2)	HLX (1.2)	PLEKHH2 (1.2)	NPC1L1 (1.2)
ENSG00000142541	RPL13A PPI subnetwork	0.76	> 0.20	NKPD1 (2.8)	ZNF259 (2.5)	QTRT1 (2.3)	NAA25 (2.3)	DDX56 (2.3)	ILF3 (2.3)	ANKRD31 (2.0)	DHX38 (1.9)	ATP13A1 (1.8)	ADAM1 (1.8)
ENSG00000034053	APBA2 PPI subnetwork	0.76	> 0.20	NCAN (3.4)	CELSR2 (2.6)	PLEC (2.2)	RPH3A (2.2)	HAVCR1 (2.1)	GRINA (2.0)	PLCG1 (1.9)	TMEM116 (1.8)	PVR (1.8)	CLPTM1 (1.8)
MP:0001777	abnormal body temperature homeostasis	0.76	> 0.20	SYPL2 (3.5)	TM6SF2 (3.3)	ABCG5 (2.8)	ABCG8 (2.3)	PMFBP1 (2.0)	AMIGO1 (1.9)	NPC1L1 (1.8)	NCAN (1.8)	ABO (1.6)	RPH3A (1.6)
GO:0034622	cellular macromolecular complex assembly	0.76	> 0.20	C12orf47 (1.9)	POC5 (1.8)	ENSG00000226648 (1.8)	USP1 (1.7)	PSRC1 (1.6)	C19orf52 (1.5)	ZNF180 (1.4)	GMPR (1.4)	BUD13 (1.4)	TXNL4B (1.2)
ENSG00000197756	RPL37A PPI subnetwork	0.76	> 0.20	NKPD1 (2.9)	MOSC1 (1.9)	ZNF180 (1.8)	GATAD2A (1.6)	ANKRD31 (1.5)	ENSG00000226645 (1.4)	CEACAM19 (1.4)	NAA25 (1.3)	DNAH11 (1.3)	CBLC (1.3)
GO:0045862	positive regulation of proteolysis	0.76	> 0.20	ENSG00000235545 (2.4)	BLOC1S3 (2.3)	GEMIN7 (2.2)	CLPTM1 (2.1)	ZNF180 (2.1)	ENSG00000254235 (2.0)	DYNC2LI1 (1.9)	GRINA (1.9)	ENSG00000228044 (1.5)	TRAFD1 (1.4)
GO:0035591	signaling adaptor activity	0.76	> 0.20	GMIP (2.5)	ITGB3 (2.5)	C17orf57 (2.4)	FRK (2.1)	ZNF101 (1.9)	MAU2 (1.5)	TRIB1 (1.5)	PLCG1 (1.5)	PLEKHH2 (1.5)	LPAR2 (1.3)
GO:0051146	striated muscle cell differentiation	0.76	> 0.20	SYPL2 (4.0)	ANKRD31 (2.6)	HNF1A (2.2)	ENSG00000226648 (2.0)	GMPR (1.9)	OGDH (1.8)	BCAM (1.8)	KANK2 (1.6)	CEACAM19 (1.3)	ATXN7L2 (1.3)
GO:0050679	positive regulation of epithelial cell proliferation	0.76	> 0.20	HLX (1.8)	ENSG00000226645 (1.8)	KANK2 (1.5)	CBLC (1.5)	TRAPPC6A (1.5)	ENSG00000254235 (1.5)	NCAN (1.3)	SLC44A2 (1.2)	ST3GAL4 (1.2)	PVR (1.1)
GO:0051297	centrosome organization	0.76	> 0.20	POC5 (3.6)	UBXN2B (2.6)	POLK (2.5)	DYNC2LI1 (2.4)	BUD13 (2.1)	PSRC1 (2.0)	PLEKHH2 (1.9)	PBX4 (1.8)	TXNL4B (1.6)	ENSG00000226648 (1.6)
ENSG00000131100	ATP6V1E1 PPI subnetwork	0.76	> 0.20	GRINA (4.3)	SARS (3.7)	COL4A3BP (3.6)	SORT1 (2.4)	GMPR (2.0)	BRAP (2.0)	ZNF101 (1.6)	ENSG00000238078 (1.4)	C1orf63 (1.4)	UBXN2B (1.4)
MP:0008511	thin retinal inner nuclear layer	0.76	> 0.20	APOC1 (2.5)	PBX4 (1.8)	QTRT1 (1.7)	SYPL2 (1.4)	MAFB (1.4)	TMEM116 (1.3)	PMFBP1 (1.3)	KANK2 (1.2)	NYNRIN (1.1)	MAPKAPK5 (1.1)
KEGG_SELENOAMINO_ACID_METABOLISM	KEGG_SELENOAMINO_ACID_METABOLISM	0.76	> 0.20	SARS (5.6)	ALDH2 (2.8)	ZHX3 (2.6)	PSMA5 (2.1)	NT5DC1 (2.0)	YIPF2 (2.0)	KIAA1324 (1.9)	TM6SF2 (1.8)	SORT1 (1.8)	DDX56 (1.7)
ENSG00000180198	RCC1 PPI subnetwork	0.76	> 0.20	C19orf52 (2.3)	USP1 (2.2)	GMPR (2.1)	FEN1 (1.8)	PSRC1 (1.7)	DNAH11 (1.7)	BUD13 (1.6)	FADS1 (1.6)	GATAD2A (1.5)	SMARCA4 (1.4)
GO:0010721	negative regulation of cell development	0.76	> 0.20	NCAN (2.8)	ABO (2.8)	GCNT4 (2.6)	NYNRIN (2.6)	LPAR2 (2.6)	PPP1R37 (2.3)	CELSR2 (2.2)	DNAH11 (1.8)	PBX4 (1.8)	C11orf9 (1.6)
GO:0010632	regulation of epithelial cell migration	0.76	> 0.20	ENSG00000226648 (4.1)	HNF1A (2.7)	PLEKHH2 (2.5)	ENSG00000228044 (2.3)	C17orf57 (1.6)	ENSG00000254235 (1.5)	ABO (1.4)	DOCK7 (1.4)	PVR (1.2)	PMFBP1 (1.2)
ENSG00000066117	SMARCD1 PPI subnetwork	0.76	> 0.20	KIAA1324 (3.0)	CARM1 (2.9)	C12orf51 (2.7)	TOP1 (2.4)	SMARCA4 (2.3)	MAPKAPK5 (2.3)	BUD13 (1.9)	BRAP (1.8)	TRIB1 (1.8)	ILF3 (1.7)
ENSG00000077549	CAPZB PPI subnetwork	0.76	> 0.20	TMEM50A (2.8)	TOP1 (2.7)	PSMA5 (2.4)	C1orf63 (2.0)	DNM2 (1.9)	QTRT1 (1.9)	GMPR (1.8)	SMARCA4 (1.7)	TOMM40 (1.6)	ADAM1 (1.6)
MP:0008439	abnormal cortical plate morphology	0.76	> 0.20	MOSC1 (3.8)	GPAM (3.5)	NCAN (2.3)	ENSG00000226645 (1.9)	PLCG1 (1.8)	KANK2 (1.7)	SORT1 (1.7)	SLC22A1 (1.6)	ENSG00000235545 (1.5)	ENSG00000238078 (1.4)
MP:0005150	cachexia	0.76	> 0.20	APOE (2.2)	BCAM (2.1)	BCL3 (2.0)	CLPTM1 (2.0)	PBX4 (1.7)	TIMD4 (1.6)	ENSG00000226645 (1.6)	CBLC (1.6)	FRK (1.5)	APOC1 (1.4)
ENSG00000132604	TERF2 PPI subnetwork	0.76	> 0.20	TXNL4B (3.3)	POLK (3.0)	DHODH (2.9)	FEN1 (2.2)	USP1 (2.2)	BUD13 (2.0)	UBXN2B (2.0)	TMEM57 (1.9)	TMEM116 (1.9)	POC5 (1.7)
ENSG00000181690	PLAG1 PPI subnetwork	0.76	> 0.20	BCL3 (2.0)	PPP1R37 (1.9)	TIMD4 (1.7)	CBLC (1.7)	RELB (1.7)	ZNF180 (1.6)	TRIB1 (1.5)	ALDH2 (1.3)	ITGB3 (1.2)	RPH3A (1.2)
GO:0003309	type B pancreatic cell differentiation	0.77	> 0.20	ANKRD31 (3.5)	GCNT4 (3.2)	C11orf9 (2.5)	DNAH11 (2.0)	HAPLN4 (1.9)	CEACAM19 (1.8)	UBXN2B (1.7)	C17orf57 (1.6)	HNF1A (1.6)	ENSG00000226645 (1.4)
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	0.77	> 0.20	NKPD1 (2.6)	GATAD2A (1.6)	ILF3 (1.6)	UBXN2B (1.6)	GEMIN7 (1.3)	ANKRD31 (1.3)	CEACAM19 (1.2)	MOSC1 (1.2)	MAU2 (1.2)	GPAM (1.1)
GO:0071577	zinc ion transmembrane transport	0.77	> 0.20	NPC1L1 (2.0)	AP1M2 (1.8)	YIPF2 (1.7)	NKPD1 (1.5)	ATP13A1 (1.5)	TMED4 (1.4)	ERP29 (1.4)	CYB561D1 (1.2)	ENSG00000235545 (1.1)	POC5 (1.1)
ENSG00000163520	FBLN2 PPI subnetwork	0.77	> 0.20	BCAM (4.1)	PLEC (2.6)	C17orf57 (2.3)	APOE (2.2)	PLEKHH2 (2.0)	OGDH (2.0)	CILP2 (1.9)	USP24 (1.8)	CELSR2 (1.8)	MOSC1 (1.6)
REACTOME_VIRAL_MRNA_TRANSLATION	REACTOME_VIRAL_MRNA_TRANSLATION	0.77	> 0.20	NKPD1 (3.0)	MOSC1 (1.8)	UBXN2B (1.7)	ANKRD31 (1.5)	GATAD2A (1.4)	CEACAM19 (1.3)	TSSK6 (1.3)	SYPL2 (1.2)	TMEM57 (1.2)	C1orf63 (1.2)
GO:0002448	mast cell mediated immunity	0.77	> 0.20	GEMIN7 (2.6)	CYB561D1 (2.4)	BLOC1S3 (2.1)	NKPD1 (1.9)	ALDH2 (1.6)	DNAH11 (1.5)	GMIP (1.5)	ST3GAL4 (1.5)	C12orf47 (1.4)	GMPR (1.4)
GO:0048469	cell maturation	0.77	> 0.20	RHCE (2.6)	TMEM116 (2.2)	CETP (2.1)	MYLIP (1.8)	CILP2 (1.7)	ENSG00000226648 (1.4)	RHD (1.4)	CELSR2 (1.3)	ANKRD31 (1.2)	PBX4 (1.2)
GO:0043372	positive regulation of CD4-positive, alpha-beta T cell differentiation	0.77	> 0.20	ZNF101 (2.3)	NT5DC1 (1.8)	TMEM57 (1.7)	ENSG00000226645 (1.5)	MYLIP (1.5)	ENSG00000235545 (1.3)	CETP (1.3)	HLX (1.2)	TSSK6 (1.1)	PBX4 (1.1)
GO:2000516	positive regulation of CD4-positive, alpha-beta T cell activation	0.77	> 0.20	ZNF101 (2.3)	NT5DC1 (1.8)	TMEM57 (1.7)	ENSG00000226645 (1.5)	MYLIP (1.5)	ENSG00000235545 (1.3)	CETP (1.3)	HLX (1.2)	TSSK6 (1.1)	PBX4 (1.1)
GO:0007210	serotonin receptor signaling pathway	0.77	> 0.20	GOT2P1 (4.7)	ANKRD31 (2.7)	GCNT4 (2.6)	ENSG00000226648 (2.6)	ABO (2.5)	DNAH11 (1.9)	ENSG00000226645 (1.8)	RPH3A (1.8)	BRAP (1.2)	AMIGO1 (1.1)
ENSG00000198618	ENSG00000198618 PPI subnetwork	0.77	> 0.20	ADAM1 (3.4)	PLEC (3.1)	C1orf63 (2.9)	OGDH (2.4)	NPC1L1 (2.4)	PVR (2.0)	ERP29 (1.9)	SARS (1.9)	ALDH2 (1.8)	FRK (1.8)
ENSG00000196262	PPIA PPI subnetwork	0.77	> 0.20	ADAM1 (3.4)	PLEC (3.1)	C1orf63 (2.9)	OGDH (2.4)	NPC1L1 (2.4)	PVR (2.0)	ERP29 (1.9)	SARS (1.9)	ALDH2 (1.8)	FRK (1.8)
ENSG00000169271	HSPB3 PPI subnetwork	0.77	> 0.20	ZNF180 (2.3)	ENSG00000226648 (2.1)	PLCG1 (2.0)	GEMIN7 (2.0)	POC5 (1.9)	PPP1R37 (1.7)	ENSG00000235545 (1.6)	GMIP (1.4)	CLPTM1 (1.3)	ERP29 (1.3)
ENSG00000137944	CCBL2 PPI subnetwork	0.77	> 0.20	ATXN7L2 (2.7)	SLC44A2 (2.3)	COL4A3BP (2.3)	CYB561D1 (2.3)	ST3GAL4 (2.2)	SARS (1.9)	PSRC1 (1.8)	OGDH (1.8)	NYNRIN (1.7)	TSSK6 (1.6)
ENSG00000119318	RAD23B PPI subnetwork	0.77	> 0.20	PSMA5 (5.3)	TRAFD1 (2.4)	NT5DC1 (2.4)	SUGP1 (2.1)	BRAP (2.1)	NAA25 (2.0)	TOMM40 (1.8)	SARS (1.6)	DDX56 (1.5)	SMARCA4 (1.4)
MP:0002100	abnormal tooth morphology	0.77	> 0.20	ABO (2.6)	BCAM (2.2)	MYLIP (2.1)	PMFBP1 (2.1)	CELSR2 (1.9)	MAFB (1.8)	LPA (1.6)	HNF1A (1.3)	BLOC1S3 (1.3)	ENSG00000254235 (1.2)
GO:0051298	centrosome duplication	0.77	> 0.20	POLK (3.5)	POC5 (2.9)	UBXN2B (2.8)	PLEKHH2 (2.5)	ENSG00000226648 (2.4)	ZNF180 (2.3)	DNAH11 (2.1)	BUD13 (2.0)	DYNC2LI1 (2.0)	PSRC1 (1.9)
ENSG00000151617	EDNRA PPI subnetwork	0.77	> 0.20	KIAA1324 (1.6)	TMEM50A (1.6)	ST3GAL4 (1.6)	FADS2 (1.6)	DNM2 (1.6)	YIPF2 (1.5)	LDLR (1.4)	QTRT1 (1.3)	PVR (1.3)	TRIB1 (1.3)
ENSG00000213463	SYNJ2BP PPI subnetwork	0.77	> 0.20	SORT1 (2.4)	UBXN2B (2.3)	DNAH11 (2.0)	AMIGO1 (2.0)	USP24 (1.9)	TSSK6 (1.9)	PBX4 (1.8)	MOSC1 (1.6)	LDLR (1.5)	PVRL2 (1.5)
ENSG00000124507	PACSIN1 PPI subnetwork	0.77	> 0.20	RPH3A (2.8)	PPP1R37 (2.6)	ATXN2 (2.5)	HAVCR1 (2.3)	PLEKHH2 (2.0)	ST3GAL4 (1.9)	TMEM116 (1.9)	HAPLN4 (1.8)	LPIN3 (1.7)	C12orf51 (1.6)
GO:0071285	cellular response to lithium ion	0.77	> 0.20	UBXN2B (2.2)	CYB561D1 (2.0)	ZNF101 (1.8)	ENSG00000254235 (1.8)	PBX4 (1.6)	DYNC2LI1 (1.5)	BLOC1S3 (1.4)	YIPF2 (1.3)	MOSC1 (1.3)	C19orf52 (1.3)
GO:0006940	regulation of smooth muscle contraction	0.77	> 0.20	ABO (3.9)	C17orf57 (2.6)	ENSG00000226648 (2.5)	ITGB3 (2.2)	BLOC1S3 (2.2)	NKPD1 (2.2)	ENSG00000228044 (1.8)	KIAA1324 (1.8)	TXNL4B (1.3)	KANK2 (1.2)
ENSG00000140374	ETFA PPI subnetwork	0.77	> 0.20	TRAPPC6A (2.7)	QTRT1 (1.9)	RHD (1.8)	ACAD10 (1.7)	C19orf52 (1.6)	TMEM116 (1.5)	RHCE (1.5)	PVRL2 (1.5)	TRIB1 (1.4)	FRK (1.3)
GO:0030073	insulin secretion	0.77	> 0.20	KIAA1324 (4.9)	ANKRD31 (2.3)	COL4A3BP (2.2)	HNF1A (2.2)	ABO (1.8)	HAPLN4 (1.7)	ENSG00000228044 (1.6)	ENSG00000238078 (1.5)	PLEKHH2 (1.5)	MOSC1 (1.5)
MP:0004132	absent embryonic cilia	0.77	> 0.20	DYNC2LI1 (8.5)	UBXN2B (2.1)	POC5 (1.9)	POLK (1.9)	C17orf57 (1.8)	DOCK7 (1.8)	PBX4 (1.8)	ATXN7L2 (1.7)	ACAD10 (1.3)	TXNL4B (1.3)
GO:0048525	negative regulation of viral reproduction	0.77	> 0.20	OASL (7.2)	PARP10 (2.4)	ENSG00000235545 (2.4)	MAU2 (1.8)	ENSG00000228044 (1.8)	TRAFD1 (1.7)	TSSK6 (1.6)	TXNL4B (1.6)	GCNT4 (1.5)	GMPR (1.4)
GO:0045071	negative regulation of viral genome replication	0.77	> 0.20	OASL (7.2)	PARP10 (2.4)	ENSG00000235545 (2.4)	MAU2 (1.8)	ENSG00000228044 (1.8)	TRAFD1 (1.7)	TSSK6 (1.6)	TXNL4B (1.6)	GCNT4 (1.5)	GMPR (1.4)
GO:0031124	mRNA 3'-end processing	0.77	> 0.20	C1orf63 (4.2)	ADAM1 (2.8)	BUD13 (2.7)	TOP1 (2.7)	ENSG00000226645 (2.3)	ILF3 (2.2)	MAPKAPK5 (2.2)	ENSG00000226648 (1.9)	ATXN7L2 (1.9)	NT5DC1 (1.7)
ENSG00000141503	MINK1 PPI subnetwork	0.77	> 0.20	UBXN2B (3.1)	C1orf63 (2.7)	FRK (2.3)	TMEM50A (2.0)	NKPD1 (2.0)	CEACAM19 (1.9)	CETP (1.8)	LPIN3 (1.5)	RPH3A (1.4)	ABO (1.4)
ENSG00000127588	GNG13 PPI subnetwork	0.77	> 0.20	ITGB3 (3.8)	TMEM50A (1.9)	GCNT4 (1.7)	TM6SF2 (1.5)	CYP7A1 (1.5)	CETP (1.4)	KIAA1324 (1.3)	C12orf47 (1.3)	ENSG00000254235 (1.2)	RPH3A (1.1)
GO:0030217	T cell differentiation	0.77	> 0.20	ZNF101 (6.0)	PLCG1 (3.7)	PBX4 (3.4)	DNAH11 (2.1)	GMIP (1.3)	ENSG00000254235 (1.2)	SLC44A2 (1.2)	PARP10 (1.2)	ANKRD31 (1.1)	TMEM57 (1.0)
GO:0006939	smooth muscle contraction	0.77	> 0.20	ENSG00000226648 (3.8)	ABO (3.6)	KANK2 (2.6)	C17orf57 (2.3)	ITGB3 (2.1)	NKPD1 (1.9)	HLX (1.7)	KIAA1324 (1.7)	CBLC (1.2)	TMED4 (1.2)
ENSG00000105357	MYH14 PPI subnetwork	0.77	> 0.20	SYPL2 (2.4)	PLEC (2.0)	ITGB3 (2.0)	GATAD2A (1.7)	LPIN3 (1.7)	TRAFD1 (1.6)	PVR (1.5)	ALDH2 (1.5)	SARS (1.4)	PLCG1 (1.4)
ENSG00000031691	CENPQ PPI subnetwork	0.77	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.5)	POC5 (3.5)	ENSG00000228044 (1.1)	ENSG00000226648 (1.1)	ZHX3 (0.9)	ZNF180 (0.8)	PBX4 (0.7)	USP24 (0.6)
GO:0043303	mast cell degranulation	0.77	> 0.20	CYB561D1 (2.6)	GEMIN7 (2.2)	DNAH11 (1.9)	NKPD1 (1.9)	BLOC1S3 (1.9)	GMIP (1.5)	GMPR (1.3)	ST3GAL4 (1.3)	C12orf47 (1.3)	ALDH2 (1.2)
MP:0001392	abnormal locomotor behavior	0.77	> 0.20	RPH3A (2.7)	HAPLN4 (2.4)	GOT2P1 (1.7)	PPP1R37 (1.7)	APOC1 (1.6)	PLEKHH2 (1.6)	NYNRIN (1.6)	ERP29 (1.5)	ENSG00000235545 (1.5)	AMIGO1 (1.4)
MP:0005241	abnormal retinal ganglion layer morphology	0.77	> 0.20	CELSR2 (2.5)	NCAN (2.0)	SORT1 (1.8)	DYNC2LI1 (1.7)	DNAH11 (1.6)	PVRL2 (1.6)	PPP1R37 (1.5)	QTRT1 (1.4)	C11orf9 (1.4)	PSRC1 (1.4)
GO:0006497	protein lipidation	0.77	> 0.20	CYB561D1 (3.5)	TRAPPC6A (2.6)	TMEM116 (2.5)	ATP13A1 (2.4)	TMED4 (2.1)	ERP29 (2.0)	CEACAM19 (2.0)	NT5DC1 (1.9)	ANKRD31 (1.8)	TSSK6 (1.7)
GO:0048599	oocyte development	0.77	> 0.20	CEACAM19 (3.7)	NKPD1 (2.7)	ABO (2.5)	LPIN3 (2.0)	FRK (1.7)	NYNRIN (1.6)	RHCE (1.4)	PMFBP1 (1.4)	AP1M2 (1.4)	YIPF2 (1.2)
ENSG00000125968	ID1 PPI subnetwork	0.77	> 0.20	SYPL2 (2.7)	MYLIP (2.0)	TOP1 (1.6)	RPH3A (1.4)	APOC1 (1.4)	ENSG00000226645 (1.4)	PPP1R37 (1.4)	ENSG00000238078 (1.3)	NCAN (1.3)	ADAM1 (1.2)
GO:0015171	amino acid transmembrane transporter activity	0.77	> 0.20	ABCG8 (3.1)	SARS (3.1)	HAPLN4 (2.7)	NPC1L1 (2.5)	TM6SF2 (2.5)	NCAN (2.5)	ABCG5 (2.2)	ATP13A1 (2.1)	GRINA (1.9)	CELSR2 (1.8)
ENSG00000110318	KIAA1377 PPI subnetwork	0.77	> 0.20	ZNF180 (2.5)	SARS (2.3)	FEN1 (2.3)	PSRC1 (2.0)	USP1 (1.8)	HAPLN4 (1.8)	TXNL4B (1.5)	C12orf47 (1.4)	GEMIN7 (1.4)	APOE (1.3)
GO:0007435	salivary gland morphogenesis	0.77	> 0.20	PLEKHH2 (3.0)	GCNT4 (2.2)	TSSK6 (2.0)	BCAM (1.9)	PBX4 (1.7)	DOCK7 (1.7)	PVR (1.7)	AP1M2 (1.6)	PVRL2 (1.5)	AMIGO1 (1.4)
GO:0071887	leukocyte apoptotic process	0.77	> 0.20	CETP (2.7)	PBX4 (2.4)	ZNF101 (2.4)	TIMD4 (2.0)	GMIP (1.9)	HLX (1.9)	TRAFD1 (1.9)	ENSG00000235545 (1.7)	ST3GAL4 (1.3)	PARP10 (1.3)
GO:0046885	regulation of hormone biosynthetic process	0.77	> 0.20	ATXN7L2 (2.6)	BLOC1S3 (2.3)	ZNF180 (1.7)	TMEM57 (1.6)	TMEM50A (1.6)	ST3GAL4 (1.6)	CYB561D1 (1.5)	COL4A3BP (1.3)	SLC44A2 (1.2)	BCAM (1.2)
ENSG00000085999	RAD54L PPI subnetwork	0.77	> 0.20	YIPF2 (3.0)	FEN1 (3.0)	DHODH (2.3)	SUGP1 (2.2)	DHX38 (2.1)	C19orf52 (1.9)	TOP1 (1.9)	ATP13A1 (1.9)	ERP29 (1.8)	USP1 (1.8)
GO:0032886	regulation of microtubule-based process	0.77	> 0.20	POC5 (4.2)	DNAH11 (3.5)	POLK (2.8)	UBXN2B (2.8)	PSRC1 (2.6)	PBX4 (2.3)	LPAR2 (1.9)	C12orf51 (1.7)	C12orf47 (1.6)	COL4A3BP (1.3)
MP:0002693	abnormal pancreas physiology	0.77	> 0.20	KIAA1324 (3.0)	HAPLN4 (2.4)	DYNC2LI1 (2.0)	CYB561D1 (2.0)	SORT1 (1.6)	ATXN7L2 (1.6)	CELSR2 (1.6)	FRK (1.4)	DNAH11 (1.3)	PVR (1.3)
GO:0030042	actin filament depolymerization	0.77	> 0.20	RHCE (3.0)	RHD (3.0)	ENSG00000238078 (2.4)	ADAM1 (2.0)	PMFBP1 (2.0)	TSSK6 (1.7)	TMEM50A (1.6)	C1orf63 (1.6)	GMPR (1.6)	PLEC (1.4)
GO:0000186	activation of MAPKK activity	0.77	> 0.20	POLK (2.6)	TMEM116 (2.1)	AMIGO1 (1.9)	PTPN11 (1.9)	MARK4 (1.5)	ENSG00000228044 (1.5)	HLX (1.5)	CYB561D1 (1.4)	SORT1 (1.4)	CARM1 (1.4)
ENSG00000130707	ASS1 PPI subnetwork	0.77	> 0.20	YIPF2 (2.5)	CARM1 (2.2)	PSMA5 (2.2)	AMIGO1 (2.2)	SARS (1.9)	ATXN2 (1.9)	TMEM116 (1.7)	ATXN7L2 (1.6)	ATP13A1 (1.6)	SORT1 (1.6)
ENSG00000166579	NDEL1 PPI subnetwork	0.77	> 0.20	PSRC1 (5.8)	FEN1 (4.0)	POC5 (3.4)	USP1 (3.2)	ZNF180 (1.8)	ENSG00000228044 (1.3)	TMEM116 (1.0)	TXNL4B (0.9)	ENSG00000226648 (0.9)	LPIN3 (0.8)
ENSG00000089220	PEBP1 PPI subnetwork	0.77	> 0.20	MAU2 (2.5)	SH2B3 (2.2)	DNM2 (2.1)	MAPKAPK5 (2.1)	PTPN11 (2.1)	GCNT4 (1.9)	UBXN2B (1.7)	CYB561D1 (1.4)	LPA (1.2)	ZHX3 (1.1)
GO:0071418	cellular response to amine stimulus	0.77	> 0.20	ATXN7L2 (2.7)	ANKRD31 (2.3)	C17orf57 (2.0)	C19orf52 (1.8)	MYLIP (1.8)	C11orf9 (1.6)	DNAH11 (1.5)	AP1M2 (1.4)	APOE (1.3)	C12orf51 (1.2)
MP:0001258	decreased body length	0.77	> 0.20	GPAM (2.7)	PLEKHH2 (2.7)	CILP2 (2.5)	MOSC1 (2.2)	ENSG00000238078 (1.9)	TMEM116 (1.9)	C12orf47 (1.5)	ZHX3 (1.4)	MYLIP (1.3)	MAFB (1.2)
MP:0004527	abnormal outer hair cell stereociliary bundle morphology	0.77	> 0.20	HAVCR1 (2.8)	PBX4 (2.2)	HNF1A (2.2)	PMFBP1 (1.8)	AMIGO1 (1.8)	CELSR2 (1.7)	C11orf9 (1.7)	ENSG00000226645 (1.6)	ZNF101 (1.5)	ENSG00000226648 (1.4)
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	0.77	> 0.20	ITGB3 (4.3)	TMEM50A (2.3)	ENSG00000235545 (2.1)	CETP (1.8)	HLX (1.6)	TMEM57 (1.5)	COL4A3BP (1.4)	DNM2 (1.2)	SH2B3 (1.2)	RPH3A (1.1)
GO:0071391	cellular response to estrogen stimulus	0.77	> 0.20	HNF1A (2.6)	TMEM57 (2.5)	PBX4 (1.7)	C12orf47 (1.4)	ABO (1.4)	NKPD1 (1.4)	LPAR2 (1.3)	TRAPPC6A (1.3)	KIAA1324 (1.3)	PVRL2 (1.2)
MP:0004678	split xiphoid process	0.77	> 0.20	BCAM (3.2)	C11orf9 (2.8)	APOB (2.5)	HNF1A (2.2)	ABO (2.2)	NYNRIN (2.2)	PLEKHH2 (1.9)	CBLC (1.9)	PVRL2 (1.7)	APOC1 (1.6)
GO:0001012	RNA polymerase II regulatory region DNA binding	0.77	> 0.20	RHD (2.3)	ENSG00000226648 (2.1)	CELSR2 (2.1)	PARP10 (1.9)	RHCE (1.8)	MYLIP (1.8)	PBX4 (1.7)	HAVCR1 (1.6)	PMFBP1 (1.6)	ITGB3 (1.5)
ENSG00000180902	D2HGDH PPI subnetwork	0.77	> 0.20	AP1M2 (3.3)	HAPLN4 (3.1)	CBLC (3.1)	SLC44A2 (2.0)	CARM1 (1.8)	FRK (1.8)	TOP1 (1.5)	GCNT4 (1.4)	C1orf63 (1.4)	HNF1A (1.3)
ENSG00000215692	ENSG00000215692 PPI subnetwork	0.77	> 0.20	AP1M2 (3.3)	HAPLN4 (3.1)	CBLC (3.1)	SLC44A2 (2.0)	CARM1 (1.8)	FRK (1.8)	TOP1 (1.5)	GCNT4 (1.4)	C1orf63 (1.4)	HNF1A (1.3)
GO:0009994	oocyte differentiation	0.77	> 0.20	CEACAM19 (4.0)	NKPD1 (2.8)	ABO (2.4)	LPIN3 (1.9)	FRK (1.7)	NYNRIN (1.6)	AP1M2 (1.5)	RHCE (1.4)	PMFBP1 (1.4)	YIPF2 (1.2)
GO:0043092	L-amino acid import	0.77	> 0.20	NCAN (3.4)	UBXN2B (2.5)	CYP7A1 (2.3)	ENSG00000228044 (2.0)	ZHX3 (1.9)	PBX4 (1.8)	LPIN3 (1.8)	ABCG8 (1.8)	ENSG00000235545 (1.8)	RPH3A (1.7)
ENSG00000136158	SPRY2 PPI subnetwork	0.77	> 0.20	MAU2 (2.5)	DOCK7 (2.5)	DNM2 (2.3)	ST3GAL4 (2.3)	COL4A3BP (2.2)	ATXN2 (2.1)	CEACAM19 (2.0)	C12orf51 (2.0)	ATP13A1 (2.0)	PPP1R37 (2.0)
GO:0035113	embryonic appendage morphogenesis	0.77	> 0.20	DNAH11 (2.5)	NYNRIN (2.4)	MYLIP (2.2)	ENSG00000238078 (1.9)	DYNC2LI1 (1.9)	CILP2 (1.8)	NKPD1 (1.6)	ATXN7L2 (1.4)	ZHX3 (1.3)	CARM1 (1.3)
GO:0030326	embryonic limb morphogenesis	0.77	> 0.20	DNAH11 (2.5)	NYNRIN (2.4)	MYLIP (2.2)	ENSG00000238078 (1.9)	DYNC2LI1 (1.9)	CILP2 (1.8)	NKPD1 (1.6)	ATXN7L2 (1.4)	ZHX3 (1.3)	CARM1 (1.3)
ENSG00000197321	SVIL PPI subnetwork	0.77	> 0.20	PLEC (2.5)	ENSG00000238078 (2.5)	TRAFD1 (2.0)	ITGB3 (1.8)	MOSC1 (1.6)	ANKRD31 (1.6)	ABCG8 (1.6)	FRK (1.5)	HAPLN4 (1.5)	NPC1L1 (1.5)
GO:0001542	ovulation from ovarian follicle	0.77	> 0.20	GPAM (1.8)	GCNT4 (1.7)	ANKRD31 (1.6)	TSSK6 (1.6)	MOSC1 (1.5)	HAVCR1 (1.4)	UBXN2B (1.4)	FRK (1.4)	APOB (1.3)	CELSR2 (1.3)
ENSG00000012211	PRICKLE3 PPI subnetwork	0.77	> 0.20	LPAR2 (2.9)	NYNRIN (2.8)	OGDH (2.0)	MARK4 (1.9)	GATAD2A (1.8)	PBX4 (1.7)	CARM1 (1.7)	PPP1R37 (1.7)	FADS2 (1.7)	CELSR2 (1.6)
GO:0003777	microtubule motor activity	0.77	> 0.20	DNAH11 (5.1)	PSRC1 (3.8)	POC5 (2.1)	DYNC2LI1 (2.1)	COL4A3BP (1.8)	POLK (1.6)	FEN1 (1.3)	C12orf51 (1.2)	HAPLN4 (1.2)	C11orf9 (1.1)
GO:0030032	lamellipodium assembly	0.77	> 0.20	PBX4 (3.4)	DOCK7 (3.2)	ANKRD31 (2.7)	PMFBP1 (2.4)	LPIN3 (2.0)	POLK (2.0)	TMEM50A (1.9)	ZHX3 (1.8)	CYB561D1 (1.7)	ADAM1 (1.6)
ENSG00000138092	CENPO PPI subnetwork	0.77	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.5)	POC5 (3.5)	ENSG00000228044 (1.0)	ENSG00000226648 (1.0)	ZNF180 (1.0)	ZHX3 (0.8)	PBX4 (0.6)	LPIN3 (0.6)
MP:0002114	abnormal axial skeleton morphology	0.77	> 0.20	CILP2 (3.4)	NYNRIN (2.3)	MAFB (2.1)	TMEM57 (1.4)	CBLC (1.4)	PLCG1 (1.3)	PLEC (1.2)	GOT2P1 (1.2)	MAPKAPK5 (1.1)	BCAM (1.1)
MP:0000761	thin diaphragm muscle	0.77	> 0.20	PVR (3.2)	YIPF2 (2.3)	GATAD2A (2.1)	SYPL2 (1.8)	LPIN3 (1.7)	KIAA1324 (1.7)	CARM1 (1.7)	ERP29 (1.5)	C19orf52 (1.4)	NPC1L1 (1.3)
MP:0009754	enhanced behavioral response to cocaine	0.77	> 0.20	ITGB3 (2.9)	RPH3A (2.3)	C12orf47 (2.3)	CELSR2 (2.2)	CBLC (1.7)	ABCG5 (1.6)	KIAA1324 (1.6)	MARK4 (1.5)	CILP2 (1.5)	CARM1 (1.5)
MP:0002865	increased growth rate	0.77	> 0.20	MOSC1 (3.9)	NCAN (2.7)	GCNT4 (2.2)	C17orf57 (1.8)	GPAM (1.5)	PTPN11 (1.3)	ANKRD31 (1.2)	NT5DC1 (1.2)	RPH3A (1.2)	DHODH (1.1)
GO:0046326	positive regulation of glucose import	0.77	> 0.20	GPAM (3.4)	NPC1L1 (2.6)	MOSC1 (2.1)	SORT1 (1.8)	COL4A3BP (1.6)	ST3GAL4 (1.6)	PTPN11 (1.3)	DNAH11 (1.2)	UBXN2B (1.2)	ABCG8 (1.2)
ENSG00000214517	PPME1 PPI subnetwork	0.77	> 0.20	TOMM40 (2.5)	CLPTM1 (2.4)	OGDH (2.4)	CELSR2 (2.2)	QTRT1 (2.1)	RPH3A (1.8)	ENSG00000226645 (1.8)	CEACAM19 (1.5)	PPP1R37 (1.5)	NAA25 (1.5)
ENSG00000171786	NHLH1 PPI subnetwork	0.77	> 0.20	DYNC2LI1 (2.3)	C12orf43 (2.0)	GEMIN7 (1.9)	CYB561D1 (1.7)	DNAH11 (1.4)	C19orf52 (1.3)	PBX4 (1.2)	DHODH (1.1)	DOCK7 (1.1)	PSMA5 (1.1)
ENSG00000117650	NEK2 PPI subnetwork	0.77	> 0.20	POC5 (3.5)	PSRC1 (3.3)	FEN1 (2.8)	ADAM1 (2.7)	SUGP1 (2.5)	C1orf63 (1.8)	LPIN3 (1.8)	USP1 (1.7)	ATP13A1 (1.5)	DDX56 (1.5)
ENSG00000136160	EDNRB PPI subnetwork	0.77	> 0.20	KIAA1324 (2.1)	C17orf57 (1.5)	PVR (1.5)	LPIN3 (1.4)	TM6SF2 (1.3)	CETP (1.3)	SH2B3 (1.3)	TMEM50A (1.3)	TRIB1 (1.3)	ITGB3 (1.2)
ENSG00000182473	EXOC7 PPI subnetwork	0.77	> 0.20	SUGP1 (2.8)	CARM1 (2.7)	POLK (2.5)	PTPN11 (2.3)	DNM2 (2.2)	ENSG00000238078 (2.0)	COL4A3BP (1.8)	NPC1L1 (1.8)	MAU2 (1.6)	OGDH (1.6)
ENSG00000137055	PLAA PPI subnetwork	0.77	> 0.20	TMEM57 (3.6)	GMPR (2.9)	C19orf52 (2.1)	BRAP (2.0)	SUGP1 (1.7)	ENSG00000226645 (1.5)	ATXN2 (1.4)	DNAH11 (1.4)	GRINA (1.1)	ENSG00000235545 (1.1)
ENSG00000114346	ECT2 PPI subnetwork	0.77	> 0.20	POC5 (3.3)	COL4A3BP (2.7)	PSRC1 (2.6)	ENSG00000254235 (2.5)	MYLIP (2.0)	ITGB3 (1.8)	FEN1 (1.7)	USP1 (1.6)	ENSG00000226645 (1.5)	TSSK6 (1.5)
ENSG00000010810	FYN PPI subnetwork	0.77	> 0.20	GMIP (3.8)	ITGB3 (2.6)	RPH3A (2.5)	SLC44A2 (2.4)	DNM2 (2.1)	PLEC (1.9)	CETP (1.8)	PLCG1 (1.8)	C17orf57 (1.7)	LPAR2 (1.7)
MP:0002639	micrognathia	0.77	> 0.20	GPAM (2.4)	CILP2 (2.1)	TMED4 (1.9)	MAFB (1.9)	HMGCR (1.8)	CBLC (1.8)	PCSK9 (1.7)	TMEM116 (1.7)	PMFBP1 (1.6)	ST3GAL4 (1.6)
GO:0048305	immunoglobulin secretion	0.77	> 0.20	PBX4 (3.3)	GCNT4 (2.3)	DNAH11 (2.0)	NT5DC1 (1.8)	TXNL4B (1.5)	ENSG00000226645 (1.4)	MOSC1 (1.4)	C11orf9 (1.3)	TRAPPC6A (1.1)	PTPN11 (1.1)
MP:0006086	decreased body mass index	0.77	> 0.20	TIMD4 (2.7)	NT5DC1 (2.3)	SORT1 (2.2)	ENSG00000254235 (2.0)	PMFBP1 (2.0)	MOSC1 (1.9)	ST3GAL4 (1.7)	BLOC1S3 (1.7)	ALDH2 (1.6)	PLEKHH2 (1.6)
GO:0001774	microglial cell activation	0.77	> 0.20	DOCK7 (1.9)	ZNF101 (1.8)	AMIGO1 (1.7)	DNAH11 (1.5)	TMED4 (1.5)	RHCE (1.5)	PPP1R37 (1.4)	GMPR (1.4)	ZNF180 (1.4)	ADAM1 (1.3)
GO:0046632	alpha-beta T cell differentiation	0.77	> 0.20	ZNF101 (3.7)	PBX4 (2.7)	ENSG00000235545 (2.5)	BLOC1S3 (2.0)	NKPD1 (1.9)	ENSG00000254235 (1.7)	NT5DC1 (1.6)	PLCG1 (1.6)	GMIP (1.5)	DNAH11 (1.5)
ENSG00000206308	HLA-DRA PPI subnetwork	0.77	> 0.20	PLCG1 (3.7)	ZNF101 (2.4)	ALDH2 (1.8)	MAFB (1.6)	YIPF2 (1.6)	TIMD4 (1.6)	APOE (1.4)	ERP29 (1.4)	CETP (1.4)	APOC1 (1.3)
ENSG00000152495	CAMK4 PPI subnetwork	0.77	> 0.20	COL4A3BP (2.7)	LPIN3 (2.0)	ZHX3 (2.0)	BCL3 (1.7)	C12orf51 (1.7)	GMIP (1.7)	RELB (1.6)	UBXN2B (1.4)	C12orf43 (1.4)	PLEC (1.4)
GO:0042503	tyrosine phosphorylation of Stat3 protein	0.77	> 0.20	PVR (2.8)	PBX4 (2.3)	ENSG00000238078 (2.1)	ZNF101 (2.0)	CYB561D1 (1.8)	ENSG00000254235 (1.8)	DYNC2LI1 (1.4)	NKPD1 (1.4)	TIMD4 (1.2)	COL4A3BP (1.1)
GO:0010259	multicellular organismal aging	0.77	> 0.20	ZNF180 (2.4)	BLOC1S3 (2.4)	GCNT4 (2.2)	TRAPPC6A (2.1)	ENSG00000254235 (2.1)	PBX4 (1.8)	DNAH11 (1.6)	RHCE (1.5)	ERP29 (1.3)	GEMIN7 (1.3)
MP:0004184	abnormal baroreceptor physiology	0.77	> 0.20	PVR (2.0)	TMED4 (1.6)	HNF1A (1.6)	ENSG00000238078 (1.5)	PCSK9 (1.4)	SLC22A1 (1.4)	LPA (1.4)	DHODH (1.4)	PLG (1.3)	LDLR (1.3)
GO:0048596	embryonic camera-type eye morphogenesis	0.77	> 0.20	ZHX3 (2.5)	TMED4 (2.4)	MAU2 (2.3)	ADAM1 (2.0)	C17orf57 (2.0)	FRK (1.9)	ENSG00000226645 (1.8)	C19orf52 (1.4)	ATXN2 (1.4)	PPP1R37 (1.4)
MP:0000091	short premaxilla	0.77	> 0.20	KANK2 (2.4)	CARM1 (2.3)	SMARCA4 (2.1)	UBXN2B (1.9)	ZHX3 (1.8)	TMEM116 (1.8)	MAFB (1.7)	ANKRD31 (1.4)	GCNT4 (1.3)	C12orf51 (1.3)
REACTOME_G1S:SPECIFIC_TRANSCRIPTION	REACTOME_G1S:SPECIFIC_TRANSCRIPTION	0.77	> 0.20	FEN1 (6.3)	USP1 (4.4)	RHD (2.1)	HAPLN4 (1.4)	PSRC1 (1.4)	CILP2 (1.3)	ERP29 (1.3)	TXNL4B (1.2)	MAFB (1.1)	RHCE (1.1)
ENSG00000115310	RTN4 PPI subnetwork	0.77	> 0.20	HAPLN4 (3.0)	CELSR2 (2.8)	RPH3A (2.8)	GRINA (2.8)	C12orf43 (2.2)	C11orf9 (1.8)	SARS (1.7)	C12orf47 (1.7)	C12orf51 (1.6)	NCAN (1.5)
GO:0050321	tau-protein kinase activity	0.77	> 0.20	CELSR2 (2.6)	PPP1R37 (2.1)	LPAR2 (2.0)	RPH3A (1.9)	GEMIN7 (1.8)	BLOC1S3 (1.7)	NCAN (1.6)	BRAP (1.6)	PVRL2 (1.5)	TSSK6 (1.5)
GO:0033276	transcription factor TFTC complex	0.78	> 0.20	ATXN7L2 (3.2)	MAPKAPK5 (2.7)	ZHX3 (2.0)	UBXN2B (1.9)	TOP1 (1.9)	ATXN2 (1.7)	POC5 (1.6)	CARM1 (1.4)	QTRT1 (1.3)	C17orf57 (1.2)
ENSG00000174233	ADCY6 PPI subnetwork	0.78	> 0.20	LPAR2 (2.5)	C12orf43 (1.9)	BLOC1S3 (1.8)	MAU2 (1.8)	GMPR (1.7)	GATAD2A (1.6)	MAPKAPK5 (1.6)	NCAN (1.6)	ADAM1 (1.6)	PMFBP1 (1.5)
GO:0015695	organic cation transport	0.78	> 0.20	TMEM116 (3.1)	RHD (2.2)	ACAD10 (1.9)	RHCE (1.8)	TM6SF2 (1.7)	SYPL2 (1.5)	NT5DC1 (1.5)	CILP2 (1.5)	C19orf52 (1.5)	ABO (1.4)
MP:0003360	abnormal depression-related behavior	0.78	> 0.20	HAPLN4 (3.8)	RPH3A (2.8)	ZHX3 (1.7)	UBXN2B (1.6)	C11orf9 (1.6)	AMIGO1 (1.4)	MAFB (1.3)	PBX4 (1.2)	SORT1 (1.2)	FRK (1.2)
GO:0060541	respiratory system development	0.78	> 0.20	C11orf9 (4.5)	PLEKHH2 (4.3)	DYNC2LI1 (2.3)	HLX (2.2)	CYP7A1 (2.1)	BCAM (2.1)	ALDH2 (2.0)	NYNRIN (2.0)	KANK2 (1.8)	DOCK7 (1.6)
ENSG00000101331	C20orf160 PPI subnetwork	0.78	> 0.20	PLEC (3.8)	FRK (3.0)	GATAD2A (2.2)	SARS (2.1)	PLCG1 (2.0)	AP1M2 (1.9)	ABCG8 (1.8)	ITGB3 (1.8)	DOCK7 (1.8)	PVR (1.7)
ENSG00000163083	INHBB PPI subnetwork	0.78	> 0.20	PVR (2.0)	MARK4 (1.9)	PVRL2 (1.9)	SLC22A1 (1.7)	BCAM (1.7)	CLPTM1 (1.7)	MOSC1 (1.5)	BLOC1S3 (1.3)	GPAM (1.3)	TMEM57 (1.3)
ENSG00000183283	DAZAP2 PPI subnetwork	0.78	> 0.20	BRAP (3.4)	RHCE (2.2)	RHD (2.2)	DYNC2LI1 (2.1)	CEACAM19 (2.0)	TRAFD1 (2.0)	PTPN11 (1.9)	GRINA (1.9)	CARM1 (1.8)	LPIN3 (1.7)
MP:0005405	axon degeneration	0.78	> 0.20	HAPLN4 (4.3)	C11orf9 (2.2)	SORT1 (2.1)	RPH3A (2.1)	PMFBP1 (2.0)	APOE (1.8)	GOT2P1 (1.4)	ST3GAL4 (1.4)	SARS (1.4)	HMGCR (1.4)
MP:0000231	hypertension	0.78	> 0.20	BCAM (3.3)	ZHX3 (2.4)	ABO (2.2)	TMEM116 (2.2)	KIAA1324 (1.8)	C12orf47 (1.8)	CILP2 (1.6)	ANKRD31 (1.6)	GCNT4 (1.6)	GMPR (1.4)
ENSG00000132470	ITGB4 PPI subnetwork	0.78	> 0.20	PLEC (4.8)	ITGB3 (2.5)	KANK2 (2.4)	SH2B3 (2.2)	BCAM (2.2)	CELSR2 (1.5)	PLCG1 (1.4)	ADAM1 (1.4)	ENSG00000238078 (1.3)	MARK4 (1.2)
ENSG00000070831	CDC42 PPI subnetwork	0.78	> 0.20	DNM2 (3.1)	PLEC (2.4)	MARK4 (2.4)	UBXN2B (2.4)	PVRL2 (2.2)	GMIP (1.8)	POLK (1.6)	POC5 (1.6)	KANK2 (1.5)	C11orf9 (1.5)
GO:0010001	glial cell differentiation	0.78	> 0.20	NCAN (4.2)	ENSG00000254235 (2.4)	ENSG00000226648 (2.2)	C11orf9 (2.0)	CELSR2 (1.9)	ABO (1.6)	C19orf52 (1.6)	ANKRD31 (1.6)	ST3GAL4 (1.4)	PBX4 (1.3)
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.78	> 0.20	KANK2 (3.1)	PLEC (2.6)	SYPL2 (2.2)	BCAM (2.1)	PTPN11 (2.1)	CLPTM1 (1.9)	GMPR (1.7)	OGDH (1.7)	CEACAM19 (1.7)	PVRL2 (1.7)
GO:0034593	phosphatidylinositol bisphosphate phosphatase activity	0.78	> 0.20	POC5 (3.2)	ATXN2 (3.2)	SH2B3 (2.3)	HAPLN4 (1.9)	CEACAM19 (1.6)	TMED4 (1.6)	C12orf51 (1.5)	CBLC (1.4)	CYP7A1 (1.4)	AP1M2 (1.3)
ENSG00000072682	P4HA2 PPI subnetwork	0.78	> 0.20	ERP29 (4.9)	CLPTM1 (2.5)	ATP13A1 (2.3)	DNM2 (2.0)	TSSK6 (1.8)	DOCK7 (1.8)	PPP1R37 (1.6)	PLEC (1.6)	SARS (1.5)	PSMA5 (1.5)
ENSG00000131503	ANKHD1 PPI subnetwork	0.78	> 0.20	RELB (3.3)	CETP (2.3)	ENSG00000235545 (2.3)	GMPR (2.2)	ENSG00000238078 (2.2)	PLEKHH2 (2.1)	PTPN11 (1.7)	C19orf52 (1.7)	TIMD4 (1.6)	CYP7A1 (1.5)
GO:0042044	fluid transport	0.78	> 0.20	ENSG00000228044 (3.0)	ENSG00000235545 (2.4)	ADAM1 (2.1)	GOT2P1 (2.1)	ITGB3 (2.0)	LPIN3 (2.0)	ST3GAL4 (1.9)	GMPR (1.9)	AMIGO1 (1.6)	ZHX3 (1.6)
GO:0002902	regulation of B cell apoptotic process	0.78	> 0.20	BLOC1S3 (2.4)	PPP1R37 (2.3)	GEMIN7 (2.0)	C17orf57 (1.6)	SH2B3 (1.2)	DNAH11 (1.2)	DYNC2LI1 (1.1)	HAVCR1 (1.1)	TIMD4 (1.1)	ENSG00000226648 (1.0)
GO:0043543	protein acylation	0.78	> 0.20	ATXN7L2 (3.0)	BRAP (2.7)	BUD13 (2.4)	ILF3 (2.4)	ZNF180 (2.3)	MAPKAPK5 (1.9)	C17orf57 (1.8)	UBXN2B (1.6)	MAU2 (1.5)	ZNF101 (1.5)
ENSG00000151725	MLF1IP PPI subnetwork	0.78	> 0.20	PSRC1 (6.0)	FEN1 (4.4)	POC5 (3.6)	USP1 (3.4)	ENSG00000228044 (1.1)	ENSG00000226648 (1.1)	ZHX3 (1.0)	ZNF180 (0.9)	LPIN3 (0.7)	USP24 (0.6)
ENSG00000155657	TTN PPI subnetwork	0.78	> 0.20	SYPL2 (6.1)	UBXN2B (1.6)	TMEM50A (1.5)	ENSG00000226648 (1.4)	PLEC (1.4)	ENSG00000238078 (1.3)	ITGB3 (1.3)	GMPR (1.2)	HMGCR (1.2)	PTPN11 (1.1)
ENSG00000101751	POLI PPI subnetwork	0.78	> 0.20	ADAM1 (2.3)	FEN1 (2.2)	USP1 (2.1)	PTPN11 (2.1)	KANK2 (2.0)	PBX4 (1.6)	PLCG1 (1.5)	PSRC1 (1.4)	DYNC2LI1 (1.4)	TMEM116 (1.1)
ENSG00000174827	PDZK1 PPI subnetwork	0.78	> 0.20	HAVCR1 (3.9)	ABO (2.1)	PPP1R37 (1.9)	NCAN (1.8)	C11orf9 (1.8)	FADS2 (1.8)	ATXN7L2 (1.7)	DYNC2LI1 (1.6)	MAU2 (1.5)	KIAA1324 (1.4)
ENSG00000184845	DRD1 PPI subnetwork	0.78	> 0.20	BLOC1S3 (3.2)	CELSR2 (2.8)	RPH3A (2.7)	HAPLN4 (2.4)	ANKRD31 (1.9)	FRK (1.8)	NPC1L1 (1.7)	CETP (1.7)	HAVCR1 (1.6)	PPP1R37 (1.6)
MP:0002799	abnormal passive avoidance behavior	0.78	> 0.20	GCNT4 (2.5)	LPAR2 (2.2)	DNAH11 (2.0)	C11orf9 (2.0)	TRAPPC6A (1.8)	TMEM50A (1.6)	TSSK6 (1.5)	OASL (1.4)	C12orf43 (1.4)	CYP7A1 (1.3)
MP:0004905	decreased uterus weight	0.78	> 0.20	KIAA1324 (3.6)	TXNL4B (2.0)	GOT2P1 (1.9)	LPIN3 (1.8)	TRIB1 (1.7)	LPA (1.6)	TIMD4 (1.4)	SLC22A1 (1.3)	PMFBP1 (1.2)	OASL (1.0)
ENSG00000183474	GTF2H2C PPI subnetwork	0.78	> 0.20	POC5 (3.6)	POLK (3.0)	MAPKAPK5 (2.7)	TXNL4B (2.6)	C17orf57 (2.4)	BRAP (2.3)	C12orf43 (2.1)	SUGP1 (2.1)	TOP1 (1.8)	GOT2P1 (1.8)
GO:0002407	dendritic cell chemotaxis	0.78	> 0.20	NKPD1 (4.5)	ZNF101 (3.3)	CETP (2.4)	ENSG00000235545 (1.9)	ZNF180 (1.8)	ST3GAL4 (1.6)	TMEM116 (1.6)	CEACAM19 (1.6)	BRAP (1.5)	BLOC1S3 (1.5)
GO:0034312	diol biosynthetic process	0.78	> 0.20	DNAH11 (3.2)	BLOC1S3 (2.2)	ADAM1 (2.1)	CILP2 (1.9)	PMFBP1 (1.9)	GMPR (1.8)	HNF1A (1.8)	ANKRD31 (1.6)	TSSK6 (1.6)	NKPD1 (1.6)
GO:0042423	catecholamine biosynthetic process	0.78	> 0.20	DNAH11 (3.2)	BLOC1S3 (2.2)	ADAM1 (2.1)	CILP2 (1.9)	PMFBP1 (1.9)	GMPR (1.8)	HNF1A (1.8)	ANKRD31 (1.6)	TSSK6 (1.6)	NKPD1 (1.6)
GO:0009713	catechol-containing compound biosynthetic process	0.78	> 0.20	DNAH11 (3.2)	BLOC1S3 (2.2)	ADAM1 (2.1)	CILP2 (1.9)	PMFBP1 (1.9)	GMPR (1.8)	HNF1A (1.8)	ANKRD31 (1.6)	TSSK6 (1.6)	NKPD1 (1.6)
ENSG00000065717	TLE2 PPI subnetwork	0.78	> 0.20	PPP1R37 (2.9)	HLX (2.7)	BLOC1S3 (2.1)	C12orf47 (2.0)	ENSG00000238078 (1.7)	TOP1 (1.7)	NKPD1 (1.6)	HAVCR1 (1.6)	PLCG1 (1.6)	MYLIP (1.5)
MP:0006060	increased cerebral infarction size	0.78	> 0.20	TRIB1 (2.8)	ENSG00000238078 (2.4)	PMFBP1 (2.1)	HLX (2.0)	BCAM (1.6)	ADAM1 (1.6)	ENSG00000226648 (1.6)	CELSR2 (1.5)	TXNL4B (1.5)	MYLIP (1.4)
GO:2000045	regulation of G1/S transition of mitotic cell cycle	0.78	> 0.20	PSMA5 (3.3)	NT5DC1 (2.5)	TRAFD1 (2.3)	NAA25 (2.1)	BRAP (1.9)	POLK (1.8)	SUGP1 (1.7)	TXNL4B (1.5)	ZNF180 (1.4)	TOMM40 (1.3)
GO:0050873	brown fat cell differentiation	0.78	> 0.20	ST3GAL4 (3.2)	MOSC1 (2.6)	GPAM (2.6)	HAPLN4 (2.0)	AMIGO1 (1.8)	GOT2P1 (1.6)	SYPL2 (1.6)	HP (1.6)	ENSG00000238078 (1.5)	SORT1 (1.5)
REACTOME_PLC_BETA_MEDIATED_EVENTS	REACTOME_PLC_BETA_MEDIATED_EVENTS	0.78	> 0.20	ITGB3 (3.1)	SORT1 (3.0)	SH2B3 (2.8)	POLK (1.8)	ST3GAL4 (1.6)	OGDH (1.6)	GMPR (1.5)	HLX (1.5)	GOT2P1 (1.4)	AMIGO1 (1.3)
GO:0000718	nucleotide-excision repair, DNA damage removal	0.78	> 0.20	NT5DC1 (3.1)	TRAPPC6A (2.7)	SUGP1 (2.4)	ENSG00000235545 (2.2)	ENSG00000226648 (2.2)	BLOC1S3 (2.2)	ZNF180 (2.1)	TXNL4B (1.9)	C17orf57 (1.8)	GOT2P1 (1.7)
GO:0044349	DNA excision	0.78	> 0.20	NT5DC1 (3.1)	TRAPPC6A (2.7)	SUGP1 (2.4)	ENSG00000235545 (2.2)	ENSG00000226648 (2.2)	BLOC1S3 (2.2)	ZNF180 (2.1)	TXNL4B (1.9)	C17orf57 (1.8)	GOT2P1 (1.7)
ENSG00000128641	MYO1B PPI subnetwork	0.78	> 0.20	ITGB3 (2.7)	ADAM1 (2.5)	ZHX3 (2.5)	GMPR (2.2)	PLEC (2.2)	TXNL4B (2.2)	ANKRD31 (2.1)	C12orf43 (1.9)	BRAP (1.7)	C19orf52 (1.7)
ENSG00000175213	ZNF408 PPI subnetwork	0.78	> 0.20	TXNL4B (2.2)	ANKRD31 (2.1)	SUGP1 (2.1)	KANK2 (2.0)	PPP1R37 (1.8)	BUD13 (1.8)	SARS (1.4)	YIPF2 (1.3)	HNF1A (1.3)	QTRT1 (1.3)
ENSG00000058866	DGKG PPI subnetwork	0.78	> 0.20	LPAR2 (3.1)	TMEM57 (2.8)	GMPR (2.5)	TMEM50A (2.3)	SYPL2 (2.3)	RHD (2.0)	RHCE (2.0)	LPIN3 (1.9)	PLCG1 (1.8)	HAVCR1 (1.6)
MP:0000936	small telencephalic vesicles	0.78	> 0.20	TMEM116 (2.7)	POLK (2.2)	PSRC1 (2.1)	SORT1 (1.8)	SLC44A2 (1.7)	OASL (1.7)	TRAPPC6A (1.6)	UBXN2B (1.6)	NYNRIN (1.5)	ZNF101 (1.5)
ENSG00000198900	TOP1 PPI subnetwork	0.78	> 0.20	USP1 (4.0)	ILF3 (3.2)	SMARCA4 (3.2)	FEN1 (3.1)	DHX38 (2.1)	PLCG1 (2.0)	ADAM1 (2.0)	TOMM40 (1.9)	NT5DC1 (1.8)	MAPKAPK5 (1.8)
GO:0009164	nucleoside catabolic process	0.78	> 0.20	TXNL4B (2.1)	TSSK6 (2.1)	C17orf57 (2.0)	TRAPPC6A (2.0)	SYPL2 (1.9)	DNAH11 (1.9)	TM6SF2 (1.7)	GEMIN7 (1.6)	CILP2 (1.5)	ABCG8 (1.5)
MP:0001353	increased aggression towards mice	0.78	> 0.20	KIAA1324 (4.1)	CETP (2.5)	FRK (2.5)	GPAM (2.4)	HNF1A (2.3)	CELSR2 (2.2)	MOSC1 (2.2)	SORT1 (1.7)	TSSK6 (1.7)	SYPL2 (1.5)
GO:0033177	proton-transporting two-sector ATPase complex, proton-transporting domain	0.78	> 0.20	TMEM116 (3.2)	SORT1 (3.0)	ERP29 (2.7)	OGDH (2.6)	PSMA5 (2.5)	ACAD10 (2.3)	ENSG00000238078 (2.1)	CLPTM1 (2.0)	ADAM1 (1.8)	C12orf47 (1.7)
ENSG00000148835	TAF5 PPI subnetwork	0.78	> 0.20	SUGP1 (3.6)	SMARCA4 (2.6)	MAPKAPK5 (2.1)	C19orf52 (2.0)	ATXN2 (1.9)	DHX38 (1.9)	BUD13 (1.9)	QTRT1 (1.7)	PSMA5 (1.7)	ILF3 (1.7)
MP:0001924	infertility	0.78	> 0.20	RHD (3.3)	PLEKHH2 (2.5)	TSSK6 (2.3)	RHCE (2.1)	KANK2 (1.8)	C12orf51 (1.7)	HAVCR1 (1.7)	TIMD4 (1.6)	PMFBP1 (1.4)	RPH3A (1.4)
GO:0043367	CD4-positive, alpha-beta T cell differentiation	0.78	> 0.20	ENSG00000235545 (2.6)	ENSG00000254235 (2.1)	GMIP (1.6)	ZNF101 (1.6)	CETP (1.5)	PBX4 (1.5)	BCL3 (1.4)	BLOC1S3 (1.4)	HLX (1.4)	TMEM57 (1.3)
ENSG00000102391	ENSG00000102391 PPI subnetwork	0.78	> 0.20	NKPD1 (3.1)	MOSC1 (2.0)	DNAH11 (1.7)	CEACAM19 (1.4)	ANKRD31 (1.3)	ERP29 (1.3)	GATAD2A (1.2)	ZNF101 (1.2)	PLEKHH2 (1.1)	UBXN2B (1.1)
ENSG00000102010	BMX PPI subnetwork	0.78	> 0.20	TIMD4 (1.9)	POLK (1.9)	HLX (1.9)	GRINA (1.9)	PARP10 (1.8)	ENSG00000228044 (1.8)	CETP (1.7)	NCAN (1.4)	TRAFD1 (1.4)	BCL3 (1.4)
ENSG00000088305	DNMT3B PPI subnetwork	0.78	> 0.20	USP1 (4.4)	FEN1 (3.2)	PSRC1 (2.6)	FRK (2.1)	ILF3 (1.9)	ZNF180 (1.6)	SMARCA4 (1.6)	CYP7A1 (1.6)	TSSK6 (1.5)	C19orf52 (1.4)
ENSG00000113356	POLR3G PPI subnetwork	0.78	> 0.20	ZNF259 (3.8)	DDX56 (3.2)	QTRT1 (2.7)	C12orf43 (2.7)	ADAM1 (2.5)	GEMIN7 (2.3)	MAPKAPK5 (2.3)	BUD13 (2.2)	C12orf47 (2.0)	SUGP1 (1.6)
GO:0006505	GPI anchor metabolic process	0.78	> 0.20	CYB561D1 (2.8)	CEACAM19 (2.7)	ATP13A1 (2.7)	TRAPPC6A (2.5)	ANKRD31 (2.4)	ERP29 (2.0)	TMED4 (1.9)	TMEM116 (1.8)	YIPF2 (1.8)	TSSK6 (1.7)
ENSG00000121068	TBX2 PPI subnetwork	0.78	> 0.20	HLX (2.3)	PBX4 (2.0)	TRAFD1 (1.8)	LPIN3 (1.7)	PLCG1 (1.6)	NCAN (1.5)	ABO (1.5)	ITGB3 (1.5)	ST3GAL4 (1.4)	MOSC1 (1.3)
REACTOME_DOUBLE:STRAND_BREAK_REPAIR	REACTOME_DOUBLE:STRAND_BREAK_REPAIR	0.78	> 0.20	FEN1 (4.3)	USP1 (2.9)	POLK (2.0)	UBXN2B (2.0)	SMARCA4 (1.9)	PSRC1 (1.8)	ENSG00000228044 (1.7)	AMIGO1 (1.5)	NT5DC1 (1.5)	POC5 (1.3)
ENSG00000043462	LCP2 PPI subnetwork	0.78	> 0.20	ZNF101 (3.7)	GMIP (3.5)	MAFB (3.0)	PLCG1 (2.6)	PBX4 (1.8)	ITGB3 (1.7)	APOE (1.7)	LPAR2 (1.7)	CETP (1.6)	TIMD4 (1.4)
GO:0043084	penile erection	0.78	> 0.20	NKPD1 (3.5)	LPIN3 (3.4)	ANKRD31 (2.3)	ZHX3 (2.1)	CEACAM19 (1.9)	CBLC (1.8)	C12orf47 (1.8)	HNF1A (1.7)	GOT2P1 (1.6)	LPAR2 (1.5)
GO:0050771	negative regulation of axonogenesis	0.78	> 0.20	GCNT4 (4.2)	TSSK6 (2.2)	CELSR2 (2.2)	C12orf47 (2.0)	ANKRD31 (1.9)	TMEM50A (1.9)	NYNRIN (1.8)	PPP1R37 (1.8)	SLC44A2 (1.6)	ABO (1.4)
REACTOME_PROLACTIN_RECEPTOR_SIGNALING	REACTOME_PROLACTIN_RECEPTOR_SIGNALING	0.78	> 0.20	AMIGO1 (2.5)	GPAM (2.4)	MYLIP (2.4)	USP24 (2.1)	ALDH2 (2.1)	ZHX3 (2.0)	TRAFD1 (1.8)	BLOC1S3 (1.5)	DNAH11 (1.3)	PTPN11 (1.2)
MP:0001953	respiratory failure	0.78	> 0.20	LDLR (2.9)	HMGCR (2.0)	HLX (1.9)	SYPL2 (1.8)	PLEC (1.7)	COL4A3BP (1.6)	PCSK9 (1.6)	KIAA1324 (1.4)	ATXN2 (1.4)	CELSR2 (1.3)
ENSG00000068796	KIF2A PPI subnetwork	0.78	> 0.20	PSRC1 (5.9)	FEN1 (4.4)	POC5 (3.6)	USP1 (3.5)	ENSG00000228044 (1.4)	ZNF180 (1.2)	ENSG00000226648 (0.9)	ZHX3 (0.8)	ABCG8 (0.5)	CEACAM19 (0.5)
ENSG00000066136	NFYC PPI subnetwork	0.78	> 0.20	AMIGO1 (1.9)	SLC44A2 (1.8)	MAU2 (1.7)	LDLR (1.6)	PTPN11 (1.6)	GATAD2A (1.5)	ENSG00000228044 (1.5)	MAPKAPK5 (1.5)	SARS (1.4)	ATXN7L2 (1.3)
ENSG00000157927	RADIL PPI subnetwork	0.78	> 0.20	NCAN (2.6)	MYLIP (1.9)	C11orf9 (1.8)	HAPLN4 (1.8)	PVR (1.7)	GATAD2A (1.6)	DYNC2LI1 (1.5)	PLCG1 (1.5)	POLK (1.5)	CARM1 (1.5)
GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	0.78	> 0.20	PPP1R37 (3.3)	CLPTM1 (3.1)	MAU2 (2.1)	DNM2 (2.0)	ABO (1.9)	DOCK7 (1.9)	GEMIN7 (1.7)	PVRL2 (1.7)	ENSG00000226645 (1.7)	AP1M2 (1.6)
ENSG00000101442	ACTR5 PPI subnetwork	0.78	> 0.20	ATXN7L2 (3.3)	C12orf43 (3.3)	SUGP1 (3.1)	MAPKAPK5 (2.8)	ZNF180 (2.4)	BRAP (2.3)	POC5 (2.0)	ZNF259 (1.8)	DYNC2LI1 (1.7)	GEMIN7 (1.6)
GO:0000165	MAPK cascade	0.78	> 0.20	HLX (2.3)	PVR (2.2)	PTPN11 (2.1)	PLEKHH2 (2.0)	LPAR2 (2.0)	TRIB1 (1.9)	ENSG00000228044 (1.6)	ABO (1.5)	SH2B3 (1.5)	C11orf9 (1.5)
GO:0015893	drug transport	0.78	> 0.20	HAVCR1 (2.2)	LPAR2 (1.9)	TRAPPC6A (1.9)	TMED4 (1.8)	ANGPTL3 (1.8)	DYNC2LI1 (1.7)	ATP13A1 (1.7)	TMEM116 (1.5)	SYPL2 (1.4)	DNAH11 (1.3)
GO:0006839	mitochondrial transport	0.78	> 0.20	GOT2P1 (3.4)	OGDH (3.1)	GEMIN7 (2.9)	ACAD10 (2.5)	TOMM40 (2.2)	TRAPPC6A (1.9)	ZNF259 (1.9)	BRAP (1.8)	BLOC1S3 (1.7)	C19orf52 (1.6)
GO:0051606	detection of stimulus	0.78	> 0.20	ENSG00000228044 (3.2)	GOT2P1 (2.8)	ENSG00000235545 (2.0)	PMFBP1 (2.0)	OASL (1.5)	ANKRD31 (1.2)	TRAFD1 (1.1)	TMEM116 (1.1)	ZNF180 (1.0)	GCNT4 (1.0)
ENSG00000133107	TRPC4 PPI subnetwork	0.78	> 0.20	OASL (4.2)	PARP10 (3.4)	HAPLN4 (2.4)	ENSG00000226645 (1.9)	C11orf9 (1.8)	PLEKHH2 (1.8)	DNAH11 (1.7)	C12orf51 (1.7)	KANK2 (1.6)	ATP13A1 (1.5)
MP:0002391	abnormal Peyer's patch germinal center morphology	0.78	> 0.20	RELB (8.1)	GMIP (4.1)	BCL3 (2.5)	BCAM (2.0)	PBX4 (1.9)	CLPTM1 (1.6)	ALDH2 (1.5)	SH2B3 (1.5)	LPIN3 (1.5)	AMIGO1 (1.4)
ENSG00000108433	GOSR2 PPI subnetwork	0.78	> 0.20	TMEM57 (2.1)	RHCE (2.1)	YIPF2 (2.1)	RHD (2.1)	CLPTM1 (1.6)	BLOC1S3 (1.5)	OGDH (1.4)	CYP7A1 (1.4)	C12orf51 (1.3)	CEACAM19 (1.3)
ENSG00000198641	ENSG00000198641 PPI subnetwork	0.78	> 0.20	YIPF2 (3.3)	CLPTM1 (3.0)	ERP29 (2.7)	ABCG8 (2.6)	CYB561D1 (2.1)	TMED4 (2.1)	AMIGO1 (2.0)	TMEM50A (2.0)	CBLC (1.6)	GOT2P1 (1.6)
MP:0008044	increased NK cell number	0.78	> 0.20	UBXN2B (2.7)	ENSG00000226648 (2.1)	GMIP (2.1)	TIMD4 (2.0)	PBX4 (1.9)	DNAH11 (1.8)	MAFB (1.5)	APOC1 (1.4)	BRAP (1.2)	C12orf43 (1.2)
GO:0006506	GPI anchor biosynthetic process	0.78	> 0.20	CYB561D1 (3.2)	TRAPPC6A (2.6)	ATP13A1 (2.6)	CEACAM19 (2.5)	ANKRD31 (2.3)	YIPF2 (1.9)	TMEM116 (1.9)	ERP29 (1.9)	TMED4 (1.8)	TMEM50A (1.8)
MP:0002622	abnormal cochlear hair cell morphology	0.78	> 0.20	APOE (2.8)	ANKRD31 (2.3)	BCAM (2.1)	NPC1L1 (2.0)	HAVCR1 (1.8)	PMFBP1 (1.7)	TRIB1 (1.7)	C11orf9 (1.6)	AP1M2 (1.6)	HAPLN4 (1.5)
ENSG00000116016	EPAS1 PPI subnetwork	0.78	> 0.20	GOT2P1 (2.5)	DYNC2LI1 (1.8)	UBXN2B (1.8)	TMEM116 (1.7)	FRK (1.6)	PLEC (1.5)	TMEM50A (1.4)	QTRT1 (1.4)	MAU2 (1.4)	GCNT4 (1.4)
ENSG00000150687	PRSS23 PPI subnetwork	0.78	> 0.20	ATXN2 (2.6)	POC5 (2.3)	USP1 (1.9)	BLOC1S3 (1.9)	COL4A3BP (1.8)	ACAD10 (1.8)	PSRC1 (1.6)	ST3GAL4 (1.4)	BUD13 (1.4)	GRINA (1.3)
MP:0000519	hydronephrosis	0.78	> 0.20	HNF1A (2.4)	ERP29 (1.9)	HLX (1.8)	BCAM (1.7)	ST3GAL4 (1.7)	NYNRIN (1.5)	MYLIP (1.4)	TMED4 (1.3)	PLG (1.3)	ENSG00000228044 (1.3)
MP:0005650	abnormal limb bud morphology	0.78	> 0.20	NYNRIN (3.7)	KANK2 (2.0)	LPAR2 (1.7)	BCAM (1.6)	DYNC2LI1 (1.5)	PSRC1 (1.5)	ALDH2 (1.4)	CBLC (1.4)	PVRL2 (1.3)	MYLIP (1.1)
ENSG00000125378	BMP4 PPI subnetwork	0.78	> 0.20	AMIGO1 (2.5)	ENSG00000254235 (2.4)	ANKRD31 (1.9)	ST3GAL4 (1.7)	TMEM116 (1.7)	CARM1 (1.6)	PLEKHH2 (1.5)	LPA (1.4)	CEACAM19 (1.4)	PVRL2 (1.4)
MP:0004392	abnormal CD8-positive T cell physiology	0.78	> 0.20	RELB (3.2)	TRAFD1 (3.1)	PARP10 (3.1)	PVRL2 (2.5)	PVR (2.0)	PBX4 (1.9)	TRAPPC6A (1.8)	DHODH (1.6)	TMEM50A (1.4)	ENSG00000235545 (1.3)
GO:0043112	receptor metabolic process	0.78	> 0.20	LPIN3 (3.0)	ADAM1 (2.2)	TMEM50A (2.1)	COL4A3BP (1.8)	TMEM57 (1.7)	C12orf51 (1.6)	PTPN11 (1.6)	TOP1 (1.6)	ABO (1.6)	ATXN7L2 (1.5)
ENSG00000132305	IMMT PPI subnetwork	0.78	> 0.20	ATXN7L2 (2.6)	YIPF2 (2.6)	TOMM40 (2.2)	HAVCR1 (1.9)	C19orf52 (1.9)	TXNL4B (1.8)	GMPR (1.8)	SARS (1.8)	ILF3 (1.7)	SUGP1 (1.6)
GO:0006302	double-strand break repair	0.78	> 0.20	UBXN2B (2.5)	BUD13 (2.4)	ENSG00000228044 (2.3)	POC5 (1.9)	USP1 (1.7)	FEN1 (1.5)	NT5DC1 (1.5)	AMIGO1 (1.3)	ATXN7L2 (1.3)	ANKRD31 (1.2)
GO:0090342	regulation of cell aging	0.78	> 0.20	HAPLN4 (2.2)	PSRC1 (1.7)	AMIGO1 (1.6)	ANKRD31 (1.6)	LPAR2 (1.3)	GMIP (1.2)	PARP10 (1.2)	CARM1 (1.2)	MAU2 (1.2)	ATXN7L2 (1.2)
GO:0072012	glomerulus vasculature development	0.78	> 0.20	NYNRIN (3.8)	PLEKHH2 (2.9)	C11orf9 (1.6)	BCAM (1.4)	NKPD1 (1.4)	MYLIP (1.3)	ENSG00000238078 (1.3)	LPIN3 (1.3)	ATXN7L2 (1.3)	HLX (1.2)
GO:0006405	RNA export from nucleus	0.78	> 0.20	C1orf63 (5.1)	ADAM1 (3.8)	TOP1 (2.9)	ILF3 (2.6)	MAPKAPK5 (2.5)	BRAP (2.5)	BUD13 (2.1)	ATXN7L2 (2.0)	TXNL4B (2.0)	USP24 (1.7)
ENSG00000004700	RECQL PPI subnetwork	0.78	> 0.20	FEN1 (4.1)	USP1 (2.9)	POC5 (2.5)	POLK (2.0)	PSRC1 (1.8)	PLCG1 (1.6)	ENSG00000235545 (1.6)	SMARCA4 (1.6)	FADS1 (1.5)	ANKRD31 (1.3)
ENSG00000178982	EIF3K PPI subnetwork	0.78	> 0.20	C12orf43 (2.4)	NKPD1 (2.2)	SARS (2.2)	UBXN2B (2.2)	C19orf52 (2.0)	ADAM1 (2.0)	ILF3 (1.9)	DDX56 (1.8)	POLK (1.8)	TMEM57 (1.8)
GO:0050714	positive regulation of protein secretion	0.78	> 0.20	ENSG00000228044 (2.3)	ENSG00000226648 (1.8)	GEMIN7 (1.8)	KIAA1324 (1.6)	ST3GAL4 (1.3)	CYP7A1 (1.2)	NYNRIN (1.1)	MAFB (1.1)	HLX (1.0)	C11orf9 (1.0)
GO:0007029	endoplasmic reticulum organization	0.78	> 0.20	ATXN7L2 (2.7)	TMEM57 (2.4)	YIPF2 (2.4)	SYPL2 (2.3)	MAU2 (2.1)	NKPD1 (2.0)	PPP1R37 (1.6)	ENSG00000228044 (1.3)	C17orf57 (1.2)	TSSK6 (1.2)
ENSG00000101189	C20orf20 PPI subnetwork	0.78	> 0.20	SMARCA4 (2.4)	PCSK9 (2.0)	SUGP1 (1.8)	ZNF180 (1.6)	ATXN7L2 (1.6)	USP1 (1.6)	TMEM57 (1.4)	DYNC2LI1 (1.4)	ADAM1 (1.3)	BCAM (1.3)
REACTOME_THE_ROLE_OF_NEF_IN_HIV:1_REPLICATION_AND_DISEASE_PATHOGENESIS	REACTOME_THE_ROLE_OF_NEF_IN_HIV:1_REPLICATION_AND_DISEASE_PATHOGENESIS	0.78	> 0.20	CLPTM1 (3.3)	GRINA (2.6)	OGDH (2.6)	PLCG1 (2.4)	CETP (2.0)	MARK4 (2.0)	DNM2 (1.9)	ZNF101 (1.7)	GMIP (1.7)	GATAD2A (1.7)
ENSG00000189367	KIAA0408 PPI subnetwork	0.78	> 0.20	CELSR2 (2.3)	PLEC (2.2)	AP1M2 (2.1)	PPP1R37 (2.1)	UBXN2B (2.1)	YIPF2 (1.7)	PARP10 (1.7)	NCAN (1.7)	MYLIP (1.5)	CBLC (1.4)
ENSG00000174021	GNG5 PPI subnetwork	0.78	> 0.20	ITGB3 (3.4)	TMEM50A (1.9)	TM6SF2 (1.6)	CETP (1.5)	ENSG00000254235 (1.3)	CYP7A1 (1.2)	C1orf63 (1.0)	TXNL4B (1.0)	SLC22A1 (0.9)	PMFBP1 (0.9)
GO:0055010	ventricular cardiac muscle tissue morphogenesis	0.78	> 0.20	ENSG00000254235 (2.6)	ENSG00000238078 (2.6)	TSSK6 (2.1)	CEACAM19 (2.0)	GMPR (1.9)	CILP2 (1.8)	ACAD10 (1.4)	NKPD1 (1.4)	TRAPPC6A (1.3)	SYPL2 (1.3)
ENSG00000186871	ERCC6L PPI subnetwork	0.78	> 0.20	PSRC1 (5.8)	FEN1 (4.4)	USP1 (3.7)	POC5 (3.6)	ENSG00000228044 (1.1)	ZNF180 (0.9)	ENSG00000226648 (0.9)	LPIN3 (0.9)	ZHX3 (0.7)	C17orf57 (0.6)
GO:0032098	regulation of appetite	0.78	> 0.20	KIAA1324 (2.4)	ENSG00000226645 (2.3)	TSSK6 (2.2)	ENSG00000235545 (1.6)	ENSG00000228044 (1.5)	ABCG8 (1.5)	HAPLN4 (1.5)	TMED4 (1.4)	FRK (1.4)	ERP29 (1.1)
GO:0042102	positive regulation of T cell proliferation	0.78	> 0.20	PBX4 (2.7)	TIMD4 (2.4)	CETP (2.1)	ENSG00000226645 (1.9)	ZNF101 (1.9)	ENSG00000235545 (1.5)	ENSG00000254235 (1.3)	SLC22A1 (1.2)	POC5 (1.2)	TRAFD1 (1.2)
ENSG00000119772	DNMT3A PPI subnetwork	0.78	> 0.20	USP1 (3.0)	HAVCR1 (2.2)	PSRC1 (2.1)	FEN1 (2.0)	TSSK6 (2.0)	ZNF180 (1.8)	ATP13A1 (1.6)	SLC44A2 (1.5)	BUD13 (1.5)	MAFB (1.5)
ENSG00000108001	EBF3 PPI subnetwork	0.78	> 0.20	PLCG1 (3.3)	TMEM57 (2.6)	C12orf51 (2.4)	PBX4 (2.1)	HAVCR1 (2.0)	QTRT1 (2.0)	GATAD2A (1.8)	ALDH2 (1.8)	PPP1R37 (1.7)	FADS2 (1.6)
ENSG00000124641	MED20 PPI subnetwork	0.78	> 0.20	GEMIN7 (3.3)	BRAP (2.8)	BUD13 (2.4)	BLOC1S3 (2.4)	POC5 (2.3)	TXNL4B (2.2)	MAPKAPK5 (2.0)	C17orf57 (1.5)	C12orf47 (1.5)	ZNF180 (1.5)
ENSG00000077943	ITGA8 PPI subnetwork	0.78	> 0.20	APOE (4.7)	ENSG00000226648 (2.7)	APOC1 (2.5)	TSSK6 (2.0)	PLEKHH2 (2.0)	NCAN (1.8)	PMFBP1 (1.7)	TMEM116 (1.7)	PVRL2 (1.6)	PLEC (1.4)
GO:0005097	Rab GTPase activator activity	0.78	> 0.20	CYB561D1 (2.4)	POLK (2.2)	ENSG00000226645 (1.9)	DYNC2LI1 (1.8)	CARM1 (1.8)	BLOC1S3 (1.7)	ABO (1.7)	LPIN3 (1.7)	SORT1 (1.6)	C12orf51 (1.6)
MP:0003985	renal fibrosis	0.78	> 0.20	ZHX3 (3.1)	ERP29 (2.7)	DOCK7 (2.2)	USP24 (2.0)	PMFBP1 (1.9)	PLG (1.8)	BCAM (1.8)	TMEM50A (1.7)	ANGPTL3 (1.6)	NT5DC1 (1.6)
ENSG00000111229	ARPC3 PPI subnetwork	0.78	> 0.20	OGDH (3.8)	TMEM50A (2.4)	ITGB3 (2.3)	PLEC (1.8)	ENSG00000238078 (1.6)	DNM2 (1.5)	C11orf9 (1.5)	SLC44A2 (1.5)	SH2B3 (1.5)	ACAD10 (1.4)
ENSG00000131981	LGALS3 PPI subnetwork	0.78	> 0.20	GOT2P1 (2.1)	POC5 (1.8)	GRINA (1.7)	PARP10 (1.5)	BLOC1S3 (1.5)	PLEC (1.5)	CILP2 (1.5)	NYNRIN (1.5)	CARM1 (1.4)	DNM2 (1.2)
GO:0006338	chromatin remodeling	0.78	> 0.20	ATXN2 (2.3)	TMEM57 (1.8)	ADAM1 (1.6)	SMARCA4 (1.5)	ENSG00000226648 (1.5)	RHCE (1.4)	CARM1 (1.4)	USP24 (1.4)	PSRC1 (1.4)	USP1 (1.4)
GO:0045063	T-helper 1 cell differentiation	0.78	> 0.20	ZNF101 (3.3)	ST3GAL4 (2.1)	NT5DC1 (2.0)	BLOC1S3 (2.0)	CEACAM19 (1.8)	BCL3 (1.8)	CETP (1.8)	PBX4 (1.5)	TMEM57 (1.5)	GRINA (1.3)
GO:0007032	endosome organization	0.78	> 0.20	BLOC1S3 (3.1)	PPP1R37 (2.4)	HAPLN4 (2.3)	LPAR2 (2.2)	COL4A3BP (2.0)	YIPF2 (2.0)	PTPN11 (1.9)	FRK (1.8)	HAVCR1 (1.7)	AP1M2 (1.6)
ENSG00000170776	AKAP13 PPI subnetwork	0.78	> 0.20	ZHX3 (2.0)	GPAM (1.9)	OGDH (1.8)	SH2B3 (1.8)	GOT2P1 (1.5)	PTPN11 (1.5)	GRINA (1.5)	MARK4 (1.3)	GCNT4 (1.3)	PVRL2 (1.2)
ENSG00000109475	RPL34 PPI subnetwork	0.78	> 0.20	NKPD1 (2.6)	DNAH11 (1.8)	MOSC1 (1.6)	ANKRD31 (1.5)	CEACAM19 (1.5)	CBLC (1.3)	ZNF101 (1.2)	GATAD2A (1.2)	ERP29 (1.0)	DYNC2LI1 (1.0)
KEGG_ENDOCYTOSIS	KEGG_ENDOCYTOSIS	0.78	> 0.20	MARK4 (2.9)	PPP1R37 (2.5)	DNM2 (2.3)	CLPTM1 (2.2)	GRINA (2.1)	C17orf57 (1.9)	C11orf9 (1.9)	PTPN11 (1.9)	POLK (1.9)	PLEC (1.8)
ENSG00000179841	AKAP5 PPI subnetwork	0.78	> 0.20	POLK (2.8)	MYLIP (2.5)	GPAM (2.2)	KIAA1324 (2.1)	GCNT4 (1.8)	AP1M2 (1.7)	KANK2 (1.5)	COL4A3BP (1.4)	ZNF180 (1.4)	SH2B3 (1.3)
ENSG00000118579	MED28 PPI subnetwork	0.78	> 0.20	TXNL4B (3.1)	GEMIN7 (3.0)	C12orf47 (2.3)	BRAP (2.2)	POC5 (2.2)	MAPKAPK5 (2.2)	BUD13 (2.1)	BLOC1S3 (2.1)	DHX38 (1.9)	C19orf52 (1.7)
ENSG00000109103	UNC119 PPI subnetwork	0.79	> 0.20	ALDH2 (2.9)	TMEM50A (2.8)	DYNC2LI1 (2.3)	TIMD4 (2.2)	MAFB (1.6)	ILF3 (1.5)	AP1M2 (1.5)	BUD13 (1.5)	GEMIN7 (1.3)	TRAFD1 (1.3)
GO:0048477	oogenesis	0.79	> 0.20	CEACAM19 (4.5)	NKPD1 (3.0)	CBLC (2.2)	LPIN3 (1.7)	YIPF2 (1.7)	AP1M2 (1.6)	LPAR2 (1.6)	NYNRIN (1.5)	TSSK6 (1.5)	HNF1A (1.4)
MP:0000286	abnormal mitral valve morphology	0.79	> 0.20	TRIB1 (3.1)	RPH3A (2.1)	PVR (2.0)	PLEC (1.8)	SH2B3 (1.6)	ERP29 (1.6)	NCAN (1.4)	GMIP (1.4)	ENSG00000254235 (1.4)	ENSG00000226645 (1.4)
GO:0006029	proteoglycan metabolic process	0.79	> 0.20	CILP2 (6.6)	ANKRD31 (2.9)	ST3GAL4 (2.3)	GCNT4 (2.2)	ENSG00000226645 (1.7)	TMEM50A (1.7)	SLC44A2 (1.4)	TMED4 (1.2)	PLEKHH2 (1.2)	YIPF2 (1.1)
MP:0008681	increased interleukin-17 secretion	0.79	> 0.20	CETP (3.0)	MAFB (2.0)	PPP1R37 (1.5)	ENSG00000226648 (1.5)	HAVCR1 (1.4)	POLK (1.4)	DNM2 (1.3)	APOA5 (1.3)	TRAFD1 (1.1)	CILP2 (1.0)
MP:0002998	abnormal bone remodeling	0.79	> 0.20	APOE (2.9)	ITGB3 (2.9)	ADAM1 (2.1)	FRK (2.0)	MAFB (1.9)	SLC44A2 (1.7)	APOC1 (1.7)	TMEM57 (1.7)	PCSK9 (1.5)	ANGPTL3 (1.5)
GO:0030983	mismatched DNA binding	0.79	> 0.20	USP1 (2.7)	FEN1 (2.5)	POC5 (2.2)	ANKRD31 (2.2)	TMEM116 (2.0)	DYNC2LI1 (1.7)	ENSG00000235545 (1.5)	ADAM1 (1.5)	MAPKAPK5 (1.4)	TSSK6 (1.4)
GO:0002764	immune response-regulating signaling pathway	0.79	> 0.20	ZNF101 (3.6)	GMIP (3.4)	SH2B3 (2.5)	MAFB (2.5)	PBX4 (2.2)	CYB561D1 (2.0)	TIMD4 (1.9)	LPAR2 (1.9)	RELB (1.6)	PARP10 (1.5)
ENSG00000205659	LIN52 PPI subnetwork	0.79	> 0.20	RHD (3.0)	RHCE (2.4)	USP1 (2.3)	PLCG1 (2.0)	FEN1 (1.9)	GRINA (1.9)	ADAM1 (1.8)	PSRC1 (1.6)	UBXN2B (1.6)	MAPKAPK5 (1.5)
GO:0050704	regulation of interleukin-1 secretion	0.79	> 0.20	NPC1L1 (2.2)	BLOC1S3 (2.2)	CEACAM19 (2.1)	CYB561D1 (2.0)	ZNF101 (1.7)	NKPD1 (1.7)	ABCG5 (1.6)	TM6SF2 (1.5)	ST3GAL4 (1.4)	ABCG8 (1.4)
GO:0050706	regulation of interleukin-1 beta secretion	0.79	> 0.20	NPC1L1 (2.2)	BLOC1S3 (2.2)	CEACAM19 (2.1)	CYB561D1 (2.0)	ZNF101 (1.7)	NKPD1 (1.7)	ABCG5 (1.6)	TM6SF2 (1.5)	ST3GAL4 (1.4)	ABCG8 (1.4)
ENSG00000169592	INO80E PPI subnetwork	0.79	> 0.20	C12orf43 (3.5)	SUGP1 (3.2)	ATXN7L2 (3.0)	MAPKAPK5 (2.6)	ZNF180 (2.4)	POC5 (2.4)	BUD13 (2.3)	BRAP (2.2)	ZNF259 (2.1)	PCSK9 (1.9)
GO:0031123	RNA 3'-end processing	0.79	> 0.20	C1orf63 (3.5)	TOP1 (3.0)	ADAM1 (3.0)	BUD13 (2.8)	MAPKAPK5 (2.0)	ILF3 (1.8)	UBXN2B (1.8)	NT5DC1 (1.8)	ENSG00000226648 (1.7)	ENSG00000226645 (1.6)
GO:0047485	protein N-terminus binding	0.79	> 0.20	C12orf43 (2.4)	TMEM57 (2.3)	SUGP1 (2.2)	MARK4 (2.1)	TRAFD1 (2.1)	PTPN11 (2.0)	PBX4 (2.0)	NYNRIN (1.9)	BUD13 (1.9)	UBXN2B (1.8)
REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION	REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION	0.79	> 0.20	NKPD1 (2.7)	C11orf9 (2.5)	CBLC (2.2)	CETP (2.0)	APOC1 (1.9)	PLEKHH2 (1.7)	CLPTM1 (1.6)	ENSG00000228044 (1.6)	C17orf57 (1.6)	HAVCR1 (1.5)
ENSG00000177889	UBE2N PPI subnetwork	0.79	> 0.20	GMPR (2.8)	MYLIP (2.3)	RHD (2.1)	C19orf52 (2.1)	TMEM116 (1.9)	ENSG00000226645 (1.8)	ENSG00000235545 (1.8)	TMEM57 (1.8)	RHCE (1.7)	ZNF180 (1.3)
MP:0005091	increased double-positive T cell number	0.79	> 0.20	RELB (4.4)	PLCG1 (3.5)	ZNF101 (3.4)	GMIP (3.0)	PARP10 (2.6)	BCL3 (2.4)	PBX4 (2.3)	CYP7A1 (1.4)	PLEC (1.4)	RHD (1.4)
MP:0002187	abnormal fibula morphology	0.79	> 0.20	CILP2 (3.4)	NYNRIN (2.4)	PLEKHH2 (2.4)	MAFB (2.4)	ALDH2 (2.3)	TXNL4B (1.6)	NKPD1 (1.4)	PMFBP1 (1.3)	ZNF180 (1.1)	HLX (1.1)
ENSG00000185359	HGS PPI subnetwork	0.79	> 0.20	DOCK7 (2.6)	DNM2 (2.3)	MAU2 (2.3)	SARS (2.0)	C12orf51 (2.0)	SUGP1 (2.0)	USP24 (1.9)	GRINA (1.8)	DHX38 (1.8)	FRK (1.7)
GO:0018205	peptidyl-lysine modification	0.79	> 0.20	ATXN7L2 (3.6)	ILF3 (2.6)	BUD13 (2.6)	MAU2 (1.9)	DHX38 (1.8)	PLCG1 (1.6)	C12orf51 (1.6)	ATXN2 (1.6)	SMARCA4 (1.4)	ZNF180 (1.4)
GO:0008287	protein serine/threonine phosphatase complex	0.79	> 0.20	PTPN11 (2.1)	MARK4 (2.1)	OGDH (2.0)	TOP1 (2.0)	ZNF180 (1.7)	COL4A3BP (1.7)	ANKRD31 (1.6)	TOMM40 (1.4)	PVRL2 (1.3)	PLEKHH2 (1.3)
REACTOME_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE	REACTOME_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE	0.79	> 0.20	GEMIN7 (3.6)	C12orf43 (3.1)	SUGP1 (2.8)	TRAPPC6A (2.8)	TXNL4B (2.4)	MARK4 (2.2)	ZNF259 (2.0)	MAPKAPK5 (1.9)	CLPTM1 (1.9)	PSMA5 (1.8)
GO:0010458	exit from mitosis	0.79	> 0.20	BLOC1S3 (3.7)	C17orf57 (2.2)	C1orf63 (2.1)	POC5 (2.1)	CEACAM19 (2.1)	PSRC1 (2.0)	DNM2 (2.0)	ENSG00000226645 (2.0)	C19orf52 (1.9)	BUD13 (1.6)
ENSG00000203283	ENSG00000203283 PPI subnetwork	0.79	> 0.20	MAFB (3.2)	ITGB3 (3.0)	KIAA1324 (2.8)	C17orf57 (2.2)	HAVCR1 (2.2)	ZNF101 (1.8)	NPC1L1 (1.5)	BCL3 (1.3)	PLCG1 (1.3)	RELB (1.2)
ENSG00000161570	CCL5 PPI subnetwork	0.79	> 0.20	MAFB (3.2)	ITGB3 (3.0)	KIAA1324 (2.8)	C17orf57 (2.2)	HAVCR1 (2.2)	ZNF101 (1.8)	NPC1L1 (1.5)	BCL3 (1.3)	PLCG1 (1.3)	RELB (1.2)
ENSG00000107262	BAG1 PPI subnetwork	0.79	> 0.20	GRINA (3.0)	TRIB1 (2.8)	CELSR2 (2.3)	CARM1 (2.2)	PLCG1 (2.2)	BCAM (2.0)	TSSK6 (1.9)	GMPR (1.9)	PLEC (1.8)	DHX38 (1.7)
ENSG00000204308	RNF5 PPI subnetwork	0.79	> 0.20	C12orf47 (3.4)	LPAR2 (2.5)	BRAP (2.4)	ADAM1 (2.1)	GRINA (2.0)	SH2B3 (1.8)	DHX38 (1.8)	SORT1 (1.8)	SLC44A2 (1.8)	HNF1A (1.7)
ENSG00000183574	RNF5 PPI subnetwork	0.79	> 0.20	C12orf47 (3.4)	LPAR2 (2.5)	BRAP (2.4)	ADAM1 (2.1)	GRINA (2.0)	SH2B3 (1.8)	DHX38 (1.8)	SORT1 (1.8)	SLC44A2 (1.8)	HNF1A (1.7)
ENSG00000206254	ENSG00000206254 PPI subnetwork	0.79	> 0.20	C12orf47 (3.4)	LPAR2 (2.5)	BRAP (2.4)	ADAM1 (2.1)	GRINA (2.0)	SH2B3 (1.8)	DHX38 (1.8)	SORT1 (1.8)	SLC44A2 (1.8)	HNF1A (1.7)
REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING	REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING	0.79	> 0.20	AP1M2 (2.8)	TM6SF2 (2.7)	TXNL4B (2.4)	RHCE (2.2)	ACAD10 (2.2)	HAVCR1 (2.0)	AMIGO1 (2.0)	BCAM (2.0)	NT5DC1 (2.0)	KIAA1324 (1.9)
ENSG00000154839	SKA1 PPI subnetwork	0.79	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	USP1 (3.6)	POC5 (3.4)	ENSG00000228044 (1.3)	ENSG00000226648 (1.0)	ZNF180 (1.0)	ZHX3 (0.7)	LPIN3 (0.7)	C17orf57 (0.6)
GO:0005819	spindle	0.79	> 0.20	PSRC1 (6.4)	POC5 (4.4)	FEN1 (3.4)	USP1 (3.2)	POLK (1.9)	BUD13 (1.6)	PBX4 (1.2)	ILF3 (1.2)	ZNF180 (1.1)	DYNC2LI1 (1.1)
ENSG00000111245	MYL2 PPI subnetwork	0.79	> 0.20	SYPL2 (2.3)	BLOC1S3 (1.8)	OGDH (1.7)	PVR (1.6)	SORT1 (1.5)	PLCG1 (1.5)	TIMD4 (1.4)	DNM2 (1.3)	CARM1 (1.2)	ENSG00000228044 (1.2)
GO:0007093	mitotic cell cycle checkpoint	0.79	> 0.20	PSMA5 (3.1)	POC5 (2.4)	PSRC1 (2.4)	TRAFD1 (2.1)	SUGP1 (2.0)	BRAP (2.0)	POLK (2.0)	NAA25 (1.8)	GEMIN7 (1.7)	ZNF180 (1.4)
GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	0.79	> 0.20	PPP1R37 (2.5)	BLOC1S3 (2.3)	HLX (2.3)	GMIP (2.0)	KANK2 (1.8)	DOCK7 (1.8)	SORT1 (1.7)	POLK (1.6)	APOE (1.5)	DNM2 (1.4)
MP:0000284	double outlet heart right ventricle	0.79	> 0.20	C11orf9 (3.3)	NYNRIN (2.6)	PLCG1 (2.0)	BCAM (2.0)	PVRL2 (1.9)	SORT1 (1.9)	APOB (1.9)	TMEM57 (1.8)	PCSK9 (1.8)	HNF1A (1.7)
GO:0040018	positive regulation of multicellular organism growth	0.79	> 0.20	KIAA1324 (2.6)	C12orf47 (2.4)	ANKRD31 (2.1)	HNF1A (1.9)	GEMIN7 (1.7)	USP24 (1.7)	MOSC1 (1.3)	PPP1R37 (1.3)	AMIGO1 (1.3)	C19orf52 (1.2)
ENSG00000177565	TBL1XR1 PPI subnetwork	0.79	> 0.20	TMEM57 (2.2)	BUD13 (2.0)	SMARCA4 (2.0)	CARM1 (2.0)	ILF3 (1.9)	ATXN2 (1.8)	DHX38 (1.5)	MAPKAPK5 (1.4)	C19orf52 (1.4)	PLCG1 (1.4)
GO:0008343	adult feeding behavior	0.79	> 0.20	ENSG00000228044 (3.4)	ENSG00000235545 (2.4)	TSSK6 (1.7)	PMFBP1 (1.7)	GOT2P1 (1.3)	ANKRD31 (1.3)	DNAH11 (1.3)	C12orf47 (1.3)	KIAA1324 (1.2)	TMED4 (1.2)
ENSG00000085365	ENSG00000085365 PPI subnetwork	0.79	> 0.20	ENSG00000226648 (2.6)	COL4A3BP (2.4)	PTPN11 (2.3)	ENSG00000235545 (2.3)	MAU2 (2.0)	CLPTM1 (1.9)	USP24 (1.9)	GOT2P1 (1.8)	POLK (1.8)	MARK4 (1.8)
ENSG00000119929	CUTC PPI subnetwork	0.79	> 0.20	BLOC1S3 (2.9)	LPIN3 (2.4)	LPAR2 (2.4)	GCNT4 (2.2)	CARM1 (2.0)	GMPR (1.9)	MAPKAPK5 (1.6)	BUD13 (1.6)	DHODH (1.5)	ABCG8 (1.4)
MP:0001407	short stride length	0.79	> 0.20	GRINA (3.4)	SORT1 (2.8)	COL4A3BP (2.3)	TIMD4 (2.1)	APOE (2.1)	MAFB (2.0)	AMIGO1 (1.9)	PPP1R37 (1.8)	TMEM50A (1.7)	ACAD10 (1.7)
GO:0033198	response to ATP	0.79	> 0.20	ADAM1 (2.7)	PMFBP1 (2.3)	CYP7A1 (2.3)	ERP29 (2.1)	C12orf43 (2.1)	ENSG00000238078 (1.8)	C12orf47 (1.7)	SH2B3 (1.6)	C12orf51 (1.6)	NKPD1 (1.5)
MP:0000111	cleft palate	0.79	> 0.20	MYLIP (2.5)	CILP2 (2.3)	MAFB (2.1)	NYNRIN (2.0)	ABO (1.6)	PVRL2 (1.5)	PLEKHH2 (1.5)	MARK4 (1.5)	LDLR (1.4)	CARM1 (1.4)
ENSG00000182568	SATB1 PPI subnetwork	0.79	> 0.20	TOP1 (4.4)	NT5DC1 (2.6)	SMARCA4 (2.4)	USP24 (2.3)	PLCG1 (2.3)	TMED4 (2.1)	FRK (1.8)	C12orf51 (1.8)	ATXN2 (1.7)	MARK4 (1.5)
GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	0.79	> 0.20	KIAA1324 (3.5)	CILP2 (2.5)	PPP1R37 (2.5)	ANKRD31 (2.2)	GOT2P1 (2.0)	ENSG00000238078 (1.8)	C12orf47 (1.6)	TMEM116 (1.4)	PBX4 (1.3)	ATXN2 (1.3)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
REACTOME_HIV:1_TRANSCRIPTION_INITIATION	REACTOME_HIV:1_TRANSCRIPTION_INITIATION	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
REACTOME_RNA_POLYMERASE_II_HIV:1_PROMOTER_ESCAPE	REACTOME_RNA_POLYMERASE_II_HIV:1_PROMOTER_ESCAPE	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION_AND_PROMOTER_CLEARANCE	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION_AND_PROMOTER_CLEARANCE	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_PRE:INITIATION_AND_PROMOTER_OPENING	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_PRE:INITIATION_AND_PROMOTER_OPENING	0.79	> 0.20	PSMA5 (3.4)	MAPKAPK5 (3.1)	TXNL4B (2.5)	GEMIN7 (2.4)	POC5 (2.1)	C12orf43 (2.0)	SUGP1 (1.8)	ATXN2 (1.7)	TMED4 (1.6)	TOP1 (1.6)
MP:0003446	renal hypoplasia	0.79	> 0.20	PVRL2 (3.8)	NYNRIN (3.8)	BCAM (2.0)	KANK2 (1.9)	MYLIP (1.8)	AMIGO1 (1.8)	TSSK6 (1.7)	ATXN7L2 (1.5)	HLX (1.5)	PLCG1 (1.3)
GO:0042166	acetylcholine binding	0.79	> 0.20	ATXN7L2 (3.4)	SYPL2 (3.0)	ANKRD31 (2.2)	RPH3A (2.2)	SORT1 (2.1)	GEMIN7 (2.0)	ABO (2.0)	CYB561D1 (1.8)	PMFBP1 (1.8)	GOT2P1 (1.5)
MP:0004322	abnormal sternebra morphology	0.79	> 0.20	NYNRIN (2.4)	ATXN7L2 (2.1)	PLCG1 (1.7)	CEACAM19 (1.4)	MAFB (1.3)	ALDH2 (1.3)	NCAN (1.2)	ATXN2 (1.2)	TMEM57 (1.2)	ANKRD31 (1.2)
GO:0070507	regulation of microtubule cytoskeleton organization	0.79	> 0.20	POC5 (4.2)	DNAH11 (3.4)	POLK (2.9)	UBXN2B (2.5)	PSRC1 (2.5)	PBX4 (2.4)	LPAR2 (1.9)	C12orf47 (1.4)	CEACAM19 (1.4)	C12orf51 (1.3)
GO:0070851	growth factor receptor binding	0.79	> 0.20	PLEKHH2 (2.7)	BCL3 (2.3)	PVR (2.2)	SH2B3 (2.1)	C17orf57 (1.7)	TIMD4 (1.6)	OASL (1.3)	RELB (1.3)	C11orf9 (1.2)	ENSG00000226645 (1.1)
GO:0048017	inositol lipid-mediated signaling	0.79	> 0.20	DNAH11 (2.9)	NKPD1 (2.1)	MYLIP (2.1)	LPIN3 (1.8)	MAU2 (1.7)	HAPLN4 (1.6)	PSRC1 (1.6)	HAVCR1 (1.4)	TMEM57 (1.3)	TSSK6 (1.3)
GO:0048015	phosphatidylinositol-mediated signaling	0.79	> 0.20	DNAH11 (2.9)	NKPD1 (2.1)	MYLIP (2.1)	LPIN3 (1.8)	MAU2 (1.7)	HAPLN4 (1.6)	PSRC1 (1.6)	HAVCR1 (1.4)	TMEM57 (1.3)	TSSK6 (1.3)
ENSG00000123411	IKZF4 PPI subnetwork	0.79	> 0.20	RELB (3.2)	ATXN7L2 (3.0)	SMARCA4 (2.8)	CARM1 (2.4)	MAU2 (1.9)	ACAD10 (1.8)	PMFBP1 (1.8)	YIPF2 (1.7)	ENSG00000226648 (1.7)	ENSG00000226645 (1.7)
MP:0003789	osteosarcoma	0.79	> 0.20	SLC44A2 (3.1)	DYNC2LI1 (2.8)	TMEM50A (1.9)	TRAPPC6A (1.6)	PLEKHH2 (1.6)	PBX4 (1.6)	MARK4 (1.6)	OGDH (1.5)	KIAA1324 (1.5)	USP1 (1.4)
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	0.79	> 0.20	CLPTM1 (3.7)	COL4A3BP (3.0)	CYB561D1 (2.8)	YIPF2 (2.6)	DNM2 (2.4)	BLOC1S3 (2.3)	C17orf57 (2.3)	AP1M2 (2.2)	GRINA (2.1)	PPP1R37 (2.1)
GO:0035710	CD4-positive, alpha-beta T cell activation	0.79	> 0.20	ENSG00000235545 (2.7)	ENSG00000254235 (2.2)	PBX4 (1.6)	GMIP (1.6)	CETP (1.5)	BCL3 (1.5)	HLX (1.3)	TMEM57 (1.3)	NT5DC1 (1.2)	BLOC1S3 (1.2)
GO:0033180	proton-transporting V-type ATPase, V1 domain	0.79	> 0.20	GRINA (3.0)	SARS (2.9)	UBXN2B (2.6)	KIAA1324 (2.5)	TMEM50A (2.1)	SORT1 (2.0)	ENSG00000238078 (1.9)	CELSR2 (1.9)	AP1M2 (1.9)	COL4A3BP (1.8)
MP:0001505	hunched posture	0.79	> 0.20	KANK2 (2.4)	GRINA (2.3)	CLPTM1 (2.2)	C12orf51 (2.0)	RELB (2.0)	ABCG8 (1.9)	PARP10 (1.8)	PBX4 (1.8)	ATP13A1 (1.8)	NPC1L1 (1.6)
ENSG00000140694	PARN PPI subnetwork	0.79	> 0.20	DHODH (3.2)	CARM1 (3.1)	UBXN2B (3.0)	ILF3 (2.9)	SUGP1 (2.7)	GATAD2A (2.6)	PLEKHH2 (2.2)	SMARCA4 (2.2)	TXNL4B (2.2)	TOP1 (1.8)
KEGG_DILATED_CARDIOMYOPATHY	KEGG_DILATED_CARDIOMYOPATHY	0.79	> 0.20	KANK2 (3.0)	SYPL2 (3.0)	GMPR (2.2)	PTPN11 (1.9)	PLEC (1.9)	SLC44A2 (1.8)	SORT1 (1.7)	ST3GAL4 (1.6)	PVR (1.6)	BCAM (1.5)
ENSG00000139180	NDUFA9 PPI subnetwork	0.79	> 0.20	ACAD10 (3.7)	OGDH (3.3)	TRAPPC6A (3.1)	TMED4 (2.3)	C12orf47 (2.1)	MAU2 (1.8)	HNF1A (1.7)	GMPR (1.5)	PTPN11 (1.4)	FRK (1.4)
GO:0030057	desmosome	0.79	> 0.20	CELSR2 (3.5)	CBLC (3.0)	AP1M2 (2.6)	BCAM (2.3)	PVRL2 (1.6)	CEACAM19 (1.6)	C11orf9 (1.6)	LPIN3 (1.3)	NKPD1 (1.3)	PCSK9 (1.2)
GO:0043388	positive regulation of DNA binding	0.79	> 0.20	ENSG00000238078 (4.2)	ZNF180 (2.0)	ATXN7L2 (2.0)	ZNF101 (1.9)	C1orf63 (1.8)	MARK4 (1.7)	BLOC1S3 (1.5)	FRK (1.4)	BUD13 (1.3)	DNAH11 (1.2)
MP:0002675	asthenozoospermia	0.79	> 0.20	TSSK6 (4.9)	PMFBP1 (3.8)	GPAM (1.1)	PBX4 (1.1)	NT5DC1 (1.1)	ZNF180 (1.1)	TMED4 (1.1)	DYNC2LI1 (1.1)	GOT2P1 (0.9)	USP1 (0.8)
MP:0006344	small second branchial arch	0.79	> 0.20	PLCG1 (4.1)	MAFB (3.5)	SLC44A2 (3.2)	CETP (2.0)	PVRL2 (1.8)	ANKRD31 (1.7)	BCAM (1.7)	TSSK6 (1.6)	ZNF101 (1.5)	BLOC1S3 (1.5)
MP:0004686	decreased length of long bones	0.79	> 0.20	CILP2 (5.4)	PLEKHH2 (2.7)	MAFB (2.0)	HAVCR1 (1.8)	PLCG1 (1.8)	DYNC2LI1 (1.4)	PLEC (1.1)	HAPLN4 (1.1)	ERP29 (1.0)	PPP1R37 (1.0)
ENSG00000140382	HMG20A PPI subnetwork	0.79	> 0.20	BUD13 (2.4)	GRINA (2.3)	SH2B3 (2.3)	ZNF259 (2.2)	POLK (2.0)	RELB (1.9)	ENSG00000226645 (1.8)	DYNC2LI1 (1.6)	PLEC (1.6)	TMEM116 (1.5)
MP:0001208	blistering	0.79	> 0.20	BCAM (3.7)	CBLC (3.6)	CELSR2 (2.9)	PLEC (2.4)	AP1M2 (2.3)	C17orf57 (2.1)	MAFB (1.6)	RELB (1.6)	GRINA (1.5)	CYP7A1 (1.2)
GO:0031435	mitogen-activated protein kinase kinase kinase binding	0.79	> 0.20	PPP1R37 (3.3)	C11orf9 (3.0)	DNM2 (2.5)	CYB561D1 (2.2)	ATXN7L2 (2.0)	PBX4 (1.9)	RELB (1.6)	SMARCA4 (1.5)	C1orf63 (1.4)	PTPN11 (1.4)
GO:0030662	coated vesicle membrane	0.79	> 0.20	YIPF2 (3.3)	HAPLN4 (3.0)	RPH3A (3.0)	KIAA1324 (2.3)	CLPTM1 (2.2)	HMGCR (2.2)	GRINA (2.1)	C12orf51 (2.0)	FADS2 (1.8)	PPP1R37 (1.8)
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	0.79	> 0.20	HAPLN4 (3.3)	RPH3A (3.0)	NCAN (2.6)	C12orf51 (2.3)	SORT1 (2.0)	SLC22A1 (1.9)	CYP7A1 (1.8)	ABCG8 (1.7)	ZHX3 (1.6)	APOC4 (1.6)
GO:0030496	midbody	0.79	> 0.20	PSRC1 (4.1)	POC5 (3.1)	PBX4 (2.0)	MARK4 (2.0)	FEN1 (1.9)	C11orf9 (1.7)	TXNL4B (1.7)	USP1 (1.7)	DYNC2LI1 (1.5)	CARM1 (1.4)
MP:0000164	abnormal cartilage development	0.79	> 0.20	CILP2 (6.8)	PLEKHH2 (2.4)	KIAA1324 (1.7)	CEACAM19 (1.6)	MAFB (1.4)	TMEM57 (1.2)	BCAM (1.2)	CYP7A1 (1.2)	GOT2P1 (1.2)	NT5DC1 (1.2)
REACTOME_P2Y_RECEPTORS	REACTOME_P2Y_RECEPTORS	0.79	> 0.20	MAFB (2.9)	CETP (2.1)	HLX (2.0)	NKPD1 (1.8)	POLK (1.8)	ST3GAL4 (1.7)	TRAFD1 (1.6)	TRIB1 (1.5)	CBLC (1.5)	TIMD4 (1.3)
MP:0000964	small dorsal root ganglion	0.79	> 0.20	TSSK6 (3.1)	GMPR (2.2)	C17orf57 (2.1)	BCAM (2.1)	CEACAM19 (2.0)	KANK2 (1.8)	ABO (1.6)	TRAPPC6A (1.6)	TRIB1 (1.5)	KIAA1324 (1.5)
GO:0003209	cardiac atrium morphogenesis	0.79	> 0.20	C11orf9 (2.4)	ENSG00000238078 (2.3)	HNF1A (2.2)	ATXN7L2 (1.9)	ENSG00000226648 (1.6)	ENSG00000254235 (1.6)	DHODH (1.5)	C19orf52 (1.4)	ACAD10 (1.4)	NPC1L1 (1.3)
GO:0050650	chondroitin sulfate proteoglycan biosynthetic process	0.79	> 0.20	CILP2 (4.3)	C19orf52 (2.2)	PMFBP1 (1.8)	ST3GAL4 (1.7)	ADAM1 (1.5)	UBXN2B (1.5)	LPA (1.2)	HLX (1.1)	TMED4 (1.1)	ENSG00000226645 (1.1)
ENSG00000136270	TBRG4 PPI subnetwork	0.79	> 0.20	PLEC (2.1)	ENSG00000238078 (2.0)	ENSG00000254235 (1.7)	DOCK7 (1.7)	AP1M2 (1.6)	CELSR2 (1.5)	CBLC (1.5)	SARS (1.5)	ALDH2 (1.2)	PVRL2 (1.2)
MP:0005192	increased motor neuron number	0.79	> 0.20	NCAN (3.4)	C12orf47 (2.0)	GATAD2A (2.0)	PPP1R37 (1.9)	TRAPPC6A (1.8)	DYNC2LI1 (1.8)	PMFBP1 (1.7)	POLK (1.6)	QTRT1 (1.5)	ATXN7L2 (1.4)
GO:0016896	exoribonuclease activity, producing 5'-phosphomonoesters	0.79	> 0.20	DHODH (3.6)	OASL (3.2)	PARP10 (3.0)	POC5 (2.3)	MAPKAPK5 (2.3)	GRINA (2.2)	ZNF259 (2.1)	QTRT1 (2.0)	TRAPPC6A (2.0)	NT5DC1 (1.8)
MP:0003352	increased circulating renin level	0.79	> 0.20	BCAM (3.4)	ZHX3 (3.1)	ANKRD31 (3.1)	ENSG00000228044 (2.1)	KIAA1324 (1.9)	ERP29 (1.6)	PLG (1.5)	TM6SF2 (1.4)	AP1M2 (1.4)	PARP10 (1.4)
GO:0097031	mitochondrial respiratory chain complex I biogenesis	0.79	> 0.20	GOT2P1 (3.0)	C12orf47 (2.2)	DYNC2LI1 (2.0)	DHODH (1.8)	ACAD10 (1.4)	GCNT4 (1.2)	QTRT1 (1.2)	POC5 (1.2)	DNAH11 (1.1)	ENSG00000235545 (1.1)
GO:0032981	mitochondrial respiratory chain complex I assembly	0.79	> 0.20	GOT2P1 (3.0)	C12orf47 (2.2)	DYNC2LI1 (2.0)	DHODH (1.8)	ACAD10 (1.4)	GCNT4 (1.2)	QTRT1 (1.2)	POC5 (1.2)	DNAH11 (1.1)	ENSG00000235545 (1.1)
GO:0010257	NADH dehydrogenase complex assembly	0.79	> 0.20	GOT2P1 (3.0)	C12orf47 (2.2)	DYNC2LI1 (2.0)	DHODH (1.8)	ACAD10 (1.4)	GCNT4 (1.2)	QTRT1 (1.2)	POC5 (1.2)	DNAH11 (1.1)	ENSG00000235545 (1.1)
ENSG00000187079	TEAD1 PPI subnetwork	0.79	> 0.20	SYPL2 (2.8)	FRK (2.6)	ATXN2 (2.4)	SLC44A2 (2.3)	ST3GAL4 (2.2)	BLOC1S3 (1.9)	TMEM116 (1.5)	DYNC2LI1 (1.5)	GMPR (1.5)	PTPN11 (1.4)
MP:0002801	abnormal long term object recognition memory	0.79	> 0.20	CELSR2 (2.6)	TRIB1 (2.5)	RPH3A (2.4)	MARK4 (2.2)	NCAN (2.1)	ATXN7L2 (1.6)	PVR (1.6)	CETP (1.6)	NKPD1 (1.5)	SH2B3 (1.5)
REACTOME_GPCR_LIGAND_BINDING	REACTOME_GPCR_LIGAND_BINDING	0.79	> 0.20	KIAA1324 (2.6)	MAFB (2.0)	ABO (1.9)	C12orf47 (1.9)	CETP (1.8)	HLX (1.8)	ENSG00000235545 (1.6)	NPC1L1 (1.3)	OASL (1.2)	RPH3A (1.2)
MP:0002759	abnormal caudal vertebrae morphology	0.79	> 0.20	CILP2 (2.7)	PCSK9 (2.5)	USP24 (1.8)	LPAR2 (1.7)	PLEKHH2 (1.6)	MYLIP (1.6)	KANK2 (1.5)	C19orf52 (1.5)	TRAPPC6A (1.4)	MOSC1 (1.3)
GO:0045086	positive regulation of interleukin-2 biosynthetic process	0.79	> 0.20	CYB561D1 (2.7)	POLK (2.3)	ENSG00000235545 (1.9)	PBX4 (1.8)	ANKRD31 (1.7)	DYNC2LI1 (1.6)	PLCG1 (1.2)	GCNT4 (1.2)	TMEM57 (1.1)	TIMD4 (1.0)
ENSG00000129351	ILF3 PPI subnetwork	0.79	> 0.20	ILF3 (3.8)	QTRT1 (3.2)	SMARCA4 (2.8)	TOP1 (2.6)	C1orf63 (2.5)	SARS (2.3)	TOMM40 (2.2)	GATAD2A (2.1)	PTPN11 (2.1)	PLCG1 (2.1)
GO:0071636	positive regulation of transforming growth factor beta production	0.79	> 0.20	PLEKHH2 (3.2)	GCNT4 (3.0)	POLK (2.2)	HNF1A (2.0)	COL4A3BP (2.0)	TMED4 (1.8)	PMFBP1 (1.6)	CYB561D1 (1.6)	ABO (1.6)	PVR (1.4)
GO:0042100	B cell proliferation	0.79	> 0.20	GCNT4 (2.7)	C17orf57 (2.4)	PBX4 (2.3)	POLK (1.7)	ZNF101 (1.7)	DNAH11 (1.5)	TOP1 (1.4)	ENSG00000226645 (1.4)	GMIP (1.4)	TIMD4 (1.4)
ENSG00000166407	LMO1 PPI subnetwork	0.79	> 0.20	MARK4 (3.1)	RHD (3.0)	CELSR2 (2.6)	GMPR (2.3)	RHCE (2.3)	TMEM57 (2.3)	MAFB (2.2)	GRINA (1.8)	HLX (1.7)	LPAR2 (1.7)
MP:0000222	decreased neutrophil cell number	0.79	> 0.20	GMIP (2.9)	HLX (2.6)	ZNF101 (2.4)	HP (2.1)	MAFB (1.7)	TRIB1 (1.7)	GRINA (1.4)	C12orf47 (1.3)	CILP2 (1.2)	TSSK6 (1.2)
GO:0008211	glucocorticoid metabolic process	0.79	> 0.20	ST3GAL4 (2.5)	AMIGO1 (2.3)	ZNF180 (2.0)	TMEM50A (1.8)	PMFBP1 (1.8)	CYB561D1 (1.7)	APOC1 (1.7)	LPIN3 (1.7)	FADS1 (1.5)	YIPF2 (1.4)
REACTOME_RNA_POLYMERASE_II_PRE:TRANSCRIPTION_EVENTS	REACTOME_RNA_POLYMERASE_II_PRE:TRANSCRIPTION_EVENTS	0.79	> 0.20	MAPKAPK5 (3.1)	PSMA5 (2.9)	TXNL4B (2.4)	BUD13 (2.4)	SUGP1 (2.4)	ZNF259 (2.2)	TOP1 (1.9)	C19orf52 (1.6)	DNM2 (1.5)	GEMIN7 (1.5)
ENSG00000141367	CLTC PPI subnetwork	0.79	> 0.20	CLPTM1 (3.4)	RELB (2.7)	DNM2 (2.6)	PLEC (2.5)	SMARCA4 (2.4)	MARK4 (2.0)	GMIP (2.0)	COL4A3BP (1.9)	SH2B3 (1.9)	PPP1R37 (1.9)
MP:0008568	abnormal interleukin secretion	0.79	> 0.20	PLCG1 (1.9)	POLK (1.8)	ABO (1.6)	PBX4 (1.6)	SH2B3 (1.5)	ANGPTL3 (1.5)	SLC44A2 (1.3)	C12orf43 (1.3)	ENSG00000228044 (1.3)	TMEM116 (1.1)
MP:0005298	abnormal clavicle morphology	0.79	> 0.20	ABO (2.7)	CARM1 (2.1)	MAU2 (2.0)	CEACAM19 (1.6)	NYNRIN (1.4)	PLEKHH2 (1.4)	CILP2 (1.3)	LPAR2 (1.3)	MAFB (1.3)	CBLC (1.2)
ENSG00000115325	DOK1 PPI subnetwork	0.79	> 0.20	GMIP (3.3)	MAFB (3.1)	GATAD2A (3.0)	SH2B3 (3.0)	USP24 (1.8)	LPAR2 (1.6)	MARK4 (1.5)	DNM2 (1.5)	TSSK6 (1.4)	TMEM57 (1.4)
ENSG00000102580	DNAJC3 PPI subnetwork	0.79	> 0.20	TRIB1 (3.1)	BLOC1S3 (2.9)	TXNL4B (2.6)	CELSR2 (2.0)	C1orf63 (1.9)	AP1M2 (1.9)	MYLIP (1.7)	PSRC1 (1.6)	COL4A3BP (1.5)	OASL (1.5)
ENSG00000140105	WARS PPI subnetwork	0.79	> 0.20	GRINA (3.8)	SARS (3.1)	COL4A3BP (2.6)	CLPTM1 (2.5)	TM6SF2 (2.3)	TMED4 (2.3)	TOMM40 (2.2)	UBXN2B (2.1)	PSMA5 (1.9)	NKPD1 (1.8)
GO:0016755	transferase activity, transferring amino-acyl groups	0.79	> 0.20	RHCE (3.9)	NKPD1 (3.3)	CEACAM19 (3.2)	GMPR (2.6)	ITGB3 (2.6)	RHD (2.2)	BCAM (1.9)	BLOC1S3 (1.7)	PVR (1.6)	ENSG00000226648 (1.5)
GO:0071560	cellular response to transforming growth factor beta stimulus	0.79	> 0.20	GCNT4 (2.4)	NCAN (2.1)	ANKRD31 (1.8)	ENSG00000254235 (1.6)	SLC44A2 (1.6)	CYP7A1 (1.5)	POLK (1.4)	CBLC (1.2)	CEACAM19 (1.2)	DYNC2LI1 (1.2)
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON:LIKE_PEPTIDE:1_GLP:1	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON:LIKE_PEPTIDE:1_GLP:1	0.79	> 0.20	KIAA1324 (4.4)	MOSC1 (2.9)	ERP29 (2.3)	TMEM50A (2.2)	ST3GAL4 (1.8)	TRIB1 (1.6)	TMED4 (1.6)	C12orf47 (1.5)	C12orf43 (1.4)	SORT1 (1.4)
GO:0072075	metanephric mesenchyme development	0.79	> 0.20	BLOC1S3 (2.4)	BCAM (2.1)	TMED4 (1.7)	NKPD1 (1.6)	ENSG00000238078 (1.6)	PLEKHH2 (1.6)	NYNRIN (1.5)	PMFBP1 (1.5)	HAPLN4 (1.5)	PPP1R37 (1.4)
ENSG00000145414	NAF1 PPI subnetwork	0.79	> 0.20	GATAD2A (3.2)	QTRT1 (2.6)	NAA25 (2.6)	TOMM40 (2.5)	USP24 (2.5)	ATP13A1 (2.4)	ZNF259 (2.4)	DDX56 (2.1)	ILF3 (2.1)	CARM1 (2.0)
ENSG00000131143	COX4I1 PPI subnetwork	0.79	> 0.20	TRAPPC6A (3.5)	GOT2P1 (2.2)	C12orf47 (2.1)	OGDH (2.0)	ACAD10 (1.7)	TMEM116 (1.6)	BLOC1S3 (1.6)	MAU2 (1.6)	HAVCR1 (1.3)	TRAFD1 (1.3)
GO:0033875	ribonucleoside bisphosphate metabolic process	0.79	> 0.20	TM6SF2 (3.3)	ABCG5 (2.9)	ABCG8 (2.7)	HAPLN4 (2.6)	NKPD1 (2.5)	CYP7A1 (2.2)	FRK (2.1)	ENSG00000228044 (1.8)	PBX4 (1.8)	NPC1L1 (1.3)
GO:0034035	purine ribonucleoside bisphosphate metabolic process	0.79	> 0.20	TM6SF2 (3.3)	ABCG5 (2.9)	ABCG8 (2.7)	HAPLN4 (2.6)	NKPD1 (2.5)	CYP7A1 (2.2)	FRK (2.1)	ENSG00000228044 (1.8)	PBX4 (1.8)	NPC1L1 (1.3)
GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process	0.79	> 0.20	TM6SF2 (3.3)	ABCG5 (2.9)	ABCG8 (2.7)	HAPLN4 (2.6)	NKPD1 (2.5)	CYP7A1 (2.2)	FRK (2.1)	ENSG00000228044 (1.8)	PBX4 (1.8)	NPC1L1 (1.3)
GO:0034032	purine nucleoside bisphosphate metabolic process	0.79	> 0.20	TM6SF2 (3.3)	ABCG5 (2.9)	ABCG8 (2.7)	HAPLN4 (2.6)	NKPD1 (2.5)	CYP7A1 (2.2)	FRK (2.1)	ENSG00000228044 (1.8)	PBX4 (1.8)	NPC1L1 (1.3)
MP:0003139	patent ductus arteriosus	0.79	> 0.20	CYB561D1 (2.2)	PLEKHH2 (2.1)	TRIB1 (1.8)	AP1M2 (1.7)	MAFB (1.6)	HAVCR1 (1.6)	CARM1 (1.6)	ENSG00000238078 (1.5)	DNM2 (1.5)	MAU2 (1.5)
MP:0003058	increased insulin secretion	0.79	> 0.20	KIAA1324 (4.2)	NPC1L1 (3.8)	MOSC1 (3.7)	GPAM (2.8)	TMED4 (2.4)	CBLC (2.2)	TM6SF2 (2.2)	HNF1A (2.2)	HAPLN4 (1.9)	ENSG00000226645 (1.9)
GO:0022627	cytosolic small ribosomal subunit	0.79	> 0.20	NKPD1 (3.1)	GEMIN7 (2.5)	CLPTM1 (1.7)	MOSC1 (1.7)	CEACAM19 (1.5)	GATAD2A (1.5)	CBLC (1.3)	TSSK6 (1.2)	ERP29 (1.2)	ZNF101 (1.2)
GO:0006884	cell volume homeostasis	0.79	> 0.20	PLEC (2.0)	C12orf51 (1.8)	FADS1 (1.6)	FADS2 (1.6)	RHD (1.5)	ENSG00000226645 (1.5)	CILP2 (1.4)	ST3GAL4 (1.3)	CYP7A1 (1.3)	DYNC2LI1 (1.2)
GO:0035107	appendage morphogenesis	0.79	> 0.20	NYNRIN (2.4)	DNAH11 (2.4)	CILP2 (2.2)	ENSG00000238078 (1.7)	MYLIP (1.7)	DYNC2LI1 (1.7)	PLCG1 (1.6)	CARM1 (1.4)	DOCK7 (1.3)	ANKRD31 (1.2)
GO:0035108	limb morphogenesis	0.79	> 0.20	NYNRIN (2.4)	DNAH11 (2.4)	CILP2 (2.2)	ENSG00000238078 (1.7)	MYLIP (1.7)	DYNC2LI1 (1.7)	PLCG1 (1.6)	CARM1 (1.4)	DOCK7 (1.3)	ANKRD31 (1.2)
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.79	> 0.20	PPP1R37 (2.6)	GMIP (2.3)	MARK4 (2.2)	ZHX3 (2.2)	C12orf51 (2.1)	CYB561D1 (2.0)	PLCG1 (1.9)	PLEKHH2 (1.9)	POC5 (1.8)	HAPLN4 (1.8)
GO:0060117	auditory receptor cell development	0.79	> 0.20	ENSG00000226645 (2.9)	CEACAM19 (2.2)	ENSG00000226648 (2.0)	GOT2P1 (1.9)	DNAH11 (1.6)	TMED4 (1.5)	TIMD4 (1.4)	HAPLN4 (1.3)	AMIGO1 (1.3)	HNF1A (1.2)
GO:0042053	regulation of dopamine metabolic process	0.79	> 0.20	C12orf47 (2.6)	GCNT4 (2.5)	ENSG00000235545 (2.2)	TSSK6 (2.1)	NKPD1 (1.9)	DNAH11 (1.9)	HNF1A (1.7)	PMFBP1 (1.5)	AMIGO1 (1.2)	UBXN2B (1.1)
GO:0005669	transcription factor TFIID complex	0.79	> 0.20	MAPKAPK5 (2.3)	POC5 (2.2)	UBXN2B (1.9)	SUGP1 (1.8)	C1orf63 (1.8)	LPIN3 (1.7)	TOP1 (1.5)	ATXN7L2 (1.4)	C12orf47 (1.3)	PBX4 (1.3)
GO:0003081	regulation of systemic arterial blood pressure by renin-angiotensin	0.79	> 0.20	TMED4 (2.8)	PMFBP1 (2.7)	C12orf47 (2.2)	ADAM1 (2.0)	C17orf57 (1.9)	ZHX3 (1.9)	COL4A3BP (1.9)	HNF1A (1.8)	AMIGO1 (1.8)	DNAH11 (1.8)
ENSG00000120053	GOT1 PPI subnetwork	0.79	> 0.20	TMED4 (2.6)	GMPR (2.3)	ENSG00000235545 (1.9)	DOCK7 (1.9)	C19orf52 (1.9)	QTRT1 (1.8)	TMEM116 (1.7)	YIPF2 (1.7)	HAVCR1 (1.7)	ILF3 (1.6)
GO:0032613	interleukin-10 production	0.79	> 0.20	GCNT4 (2.2)	PBX4 (1.7)	ST3GAL4 (1.4)	TRAFD1 (1.4)	ZNF180 (1.3)	COL4A3BP (1.1)	SH2B3 (1.1)	GMIP (1.0)	ENSG00000235545 (1.0)	TXNL4B (1.0)
ENSG00000059769	DNAJC25 PPI subnetwork	0.80	> 0.20	ITGB3 (2.8)	TM6SF2 (2.0)	DNM2 (1.9)	ENSG00000254235 (1.6)	TOMM40 (1.5)	TXNL4B (1.5)	COL4A3BP (1.2)	PMFBP1 (1.2)	HLX (1.1)	SLC44A2 (1.0)
ENSG00000151150	ANK3 PPI subnetwork	0.80	> 0.20	HAVCR1 (3.5)	FRK (2.3)	ZHX3 (2.0)	TRIB1 (1.6)	FADS2 (1.5)	TMEM57 (1.3)	HAPLN4 (1.3)	KIAA1324 (1.3)	C19orf52 (1.2)	RPH3A (1.2)
GO:0070664	negative regulation of leukocyte proliferation	0.80	> 0.20	ENSG00000254235 (1.8)	HNF1A (1.8)	GCNT4 (1.6)	TRAFD1 (1.6)	ADAM1 (1.5)	ENSG00000228044 (1.3)	DNAH11 (1.3)	PBX4 (1.3)	PMFBP1 (1.3)	ENSG00000235545 (1.2)
GO:0051693	actin filament capping	0.80	> 0.20	RHCE (3.1)	RHD (3.1)	ENSG00000238078 (2.7)	PMFBP1 (2.4)	ENSG00000235545 (2.3)	C17orf57 (2.2)	ADAM1 (1.9)	TMEM50A (1.8)	TSSK6 (1.7)	CYB561D1 (1.7)
ENSG00000035862	TIMP2 PPI subnetwork	0.80	> 0.20	CLPTM1 (3.1)	HP (3.0)	C12orf47 (2.7)	GRINA (2.7)	MOSC1 (2.3)	ALDH2 (2.3)	ITGB3 (2.2)	BCAM (2.2)	FADS1 (2.1)	SARS (1.9)
GO:0031674	I band	0.80	> 0.20	SYPL2 (7.4)	GMPR (2.4)	TMEM50A (1.5)	PLEC (1.4)	NPC1L1 (1.2)	RPH3A (1.0)	ENSG00000226648 (1.0)	HNF1A (0.8)	PVR (0.8)	ZNF101 (0.8)
GO:0055008	cardiac muscle tissue morphogenesis	0.80	> 0.20	ENSG00000238078 (3.5)	CEACAM19 (2.5)	ENSG00000254235 (2.4)	SYPL2 (2.1)	C19orf52 (1.7)	GMPR (1.7)	CILP2 (1.5)	C11orf9 (1.3)	TRAPPC6A (1.2)	TSSK6 (1.2)
GO:0072164	mesonephric tubule development	0.80	> 0.20	BCAM (3.4)	HAVCR1 (2.8)	C11orf9 (2.7)	TSSK6 (2.6)	HNF1A (2.2)	DYNC2LI1 (2.0)	AP1M2 (2.0)	PMFBP1 (1.9)	TXNL4B (1.7)	NKPD1 (1.6)
GO:0072163	mesonephric epithelium development	0.80	> 0.20	BCAM (3.4)	HAVCR1 (2.8)	C11orf9 (2.7)	TSSK6 (2.6)	HNF1A (2.2)	DYNC2LI1 (2.0)	AP1M2 (2.0)	PMFBP1 (1.9)	TXNL4B (1.7)	NKPD1 (1.6)
MP:0005445	abnormal neurotransmitter secretion	0.80	> 0.20	CYP7A1 (3.2)	AMIGO1 (2.5)	C12orf51 (2.4)	HAPLN4 (2.3)	ENSG00000254235 (2.1)	MARK4 (1.9)	PMFBP1 (1.7)	TMEM57 (1.7)	OGDH (1.7)	HNF1A (1.5)
ENSG00000152268	ENSG00000152268 PPI subnetwork	0.80	> 0.20	ERP29 (4.3)	YIPF2 (3.0)	TMED4 (3.0)	BCAM (2.8)	CLPTM1 (2.6)	RPH3A (2.5)	GRINA (2.2)	CELSR2 (2.1)	NCAN (1.9)	DHODH (1.5)
GO:0060173	limb development	0.80	> 0.20	CILP2 (3.2)	NYNRIN (2.2)	DNAH11 (2.1)	DYNC2LI1 (2.0)	MYLIP (1.7)	PLCG1 (1.7)	ENSG00000238078 (1.6)	CARM1 (1.4)	PLEKHH2 (1.2)	CEACAM19 (1.1)
GO:0048736	appendage development	0.80	> 0.20	CILP2 (3.2)	NYNRIN (2.2)	DNAH11 (2.1)	DYNC2LI1 (2.0)	MYLIP (1.7)	PLCG1 (1.7)	ENSG00000238078 (1.6)	CARM1 (1.4)	PLEKHH2 (1.2)	CEACAM19 (1.1)
ENSG00000175279	APITD1 PPI subnetwork	0.80	> 0.20	PSRC1 (5.9)	FEN1 (4.5)	POC5 (3.5)	USP1 (3.4)	ENSG00000226648 (1.5)	ENSG00000228044 (1.2)	ZHX3 (1.1)	ZNF180 (1.0)	PBX4 (0.8)	C17orf57 (0.8)
ENSG00000133511	ENSG00000133511 PPI subnetwork	0.80	> 0.20	LPIN3 (2.1)	MARK4 (2.0)	GRINA (2.0)	C12orf51 (1.9)	HAVCR1 (1.9)	BRAP (1.8)	PPP1R37 (1.7)	FRK (1.6)	TRAPPC6A (1.6)	ERP29 (1.5)
MP:0000890	thin cerebellar molecular layer	0.80	> 0.20	ZHX3 (2.5)	RPH3A (2.0)	TMEM57 (1.7)	NCAN (1.6)	C12orf51 (1.5)	C12orf47 (1.4)	HAPLN4 (1.4)	YIPF2 (1.4)	PLEKHH2 (1.3)	AMIGO1 (1.3)
ENSG00000164754	RAD21 PPI subnetwork	0.80	> 0.20	USP1 (4.4)	DHX38 (2.6)	ILF3 (2.3)	FEN1 (2.1)	DNM2 (2.0)	TOP1 (2.0)	COL4A3BP (2.0)	SMARCA4 (1.8)	BRAP (1.8)	USP24 (1.7)
GO:0043624	cellular protein complex disassembly	0.80	> 0.20	UBXN2B (2.3)	TSSK6 (2.3)	ADAM1 (1.8)	HAVCR1 (1.7)	NKPD1 (1.6)	PMFBP1 (1.6)	ABO (1.6)	SLC44A2 (1.6)	LPAR2 (1.4)	CEACAM19 (1.4)
GO:0001614	purinergic nucleotide receptor activity	0.80	> 0.20	NKPD1 (2.3)	MAFB (2.1)	PMFBP1 (2.1)	POLK (1.9)	TIMD4 (1.7)	HLX (1.6)	CETP (1.5)	LDLR (1.4)	ABO (1.3)	CBLC (1.3)
GO:0016502	nucleotide receptor activity	0.80	> 0.20	NKPD1 (2.3)	MAFB (2.1)	PMFBP1 (2.1)	POLK (1.9)	TIMD4 (1.7)	HLX (1.6)	CETP (1.5)	LDLR (1.4)	ABO (1.3)	CBLC (1.3)
ENSG00000135018	UBQLN1 PPI subnetwork	0.80	> 0.20	TRAFD1 (3.1)	PSMA5 (2.6)	DDX56 (2.4)	NAA25 (2.4)	SUGP1 (2.1)	NT5DC1 (2.1)	SARS (1.9)	CELSR2 (1.6)	SMARCA4 (1.5)	YIPF2 (1.5)
GO:2000117	negative regulation of cysteine-type endopeptidase activity	0.80	> 0.20	ENSG00000238078 (2.9)	TMED4 (2.5)	ADAM1 (1.7)	TRAPPC6A (1.7)	CEACAM19 (1.5)	HNF1A (1.5)	ALDH2 (1.4)	TMEM116 (1.4)	LDLR (1.3)	ITGB3 (1.3)
GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	0.80	> 0.20	PSMA5 (4.0)	TRAFD1 (2.5)	SUGP1 (2.3)	NAA25 (2.2)	POC5 (1.9)	C12orf47 (1.8)	LPIN3 (1.7)	DDX56 (1.7)	NT5DC1 (1.7)	C12orf43 (1.4)
ENSG00000215719	ENSG00000215719 PPI subnetwork	0.80	> 0.20	TXNL4B (3.0)	ATXN2 (2.7)	MAPKAPK5 (2.6)	COL4A3BP (2.6)	SUGP1 (2.3)	GATAD2A (2.2)	POC5 (2.1)	MAU2 (2.0)	UBXN2B (1.8)	C19orf52 (1.7)
GO:0061036	positive regulation of cartilage development	0.80	> 0.20	LPIN3 (2.9)	ZHX3 (2.2)	ENSG00000238078 (2.0)	ENSG00000226645 (1.7)	PVRL2 (1.5)	CEACAM19 (1.5)	C17orf57 (1.5)	CILP2 (1.4)	POC5 (1.3)	YIPF2 (1.3)
ENSG00000198719	DLL1 PPI subnetwork	0.80	> 0.20	BCAM (3.0)	ABO (2.8)	USP24 (2.7)	ATXN7L2 (2.3)	CELSR2 (2.1)	SLC44A2 (1.8)	ENSG00000254235 (1.8)	PLEC (1.7)	C19orf52 (1.7)	ATXN2 (1.6)
ENSG00000162736	NCSTN PPI subnetwork	0.80	> 0.20	TMED4 (3.9)	CLPTM1 (3.6)	PTPN11 (2.8)	ERP29 (2.7)	YIPF2 (2.6)	TMEM50A (2.5)	ENSG00000226645 (2.3)	TRAPPC6A (2.1)	TMEM57 (1.8)	CYB561D1 (1.8)
ENSG00000132485	ZRANB2 PPI subnetwork	0.80	> 0.20	C1orf63 (3.4)	TOP1 (2.8)	ENSG00000254235 (2.3)	AMIGO1 (1.6)	BUD13 (1.6)	OGDH (1.6)	C12orf47 (1.5)	TOMM40 (1.3)	DNM2 (1.3)	LPA (1.2)
GO:0035773	insulin secretion involved in cellular response to glucose stimulus	0.80	> 0.20	DNAH11 (2.8)	ENSG00000226648 (2.1)	ST3GAL4 (1.9)	KIAA1324 (1.8)	AP1M2 (1.7)	YIPF2 (1.5)	GEMIN7 (1.3)	PLEKHH2 (1.1)	NYNRIN (1.0)	CEACAM19 (1.0)
GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	0.80	> 0.20	DNAH11 (2.8)	ENSG00000226648 (2.1)	ST3GAL4 (1.9)	KIAA1324 (1.8)	AP1M2 (1.7)	YIPF2 (1.5)	GEMIN7 (1.3)	PLEKHH2 (1.1)	NYNRIN (1.0)	CEACAM19 (1.0)
GO:0051224	negative regulation of protein transport	0.80	> 0.20	ZNF101 (2.5)	LPAR2 (1.7)	PBX4 (1.4)	ENSG00000235545 (1.3)	MOSC1 (1.3)	CETP (1.2)	PLCG1 (1.1)	COL4A3BP (1.1)	RELB (1.1)	PPP1R37 (1.0)
ENSG00000114850	SSR3 PPI subnetwork	0.80	> 0.20	PPP1R37 (2.9)	GRINA (2.5)	C12orf47 (2.5)	YIPF2 (2.3)	C19orf52 (2.3)	BCAM (2.2)	HNF1A (2.2)	ERP29 (2.0)	QTRT1 (1.8)	ATP13A1 (1.8)
ENSG00000198728	LDB1 PPI subnetwork	0.80	> 0.20	GMPR (3.7)	RHD (3.4)	NCAN (2.6)	RHCE (2.2)	CARM1 (2.0)	ABO (1.8)	ENSG00000235545 (1.7)	COL4A3BP (1.6)	MAU2 (1.6)	YIPF2 (1.6)
ENSG00000071054	MAP4K4 PPI subnetwork	0.80	> 0.20	POLK (4.0)	COL4A3BP (3.4)	FRK (2.2)	LPAR2 (2.2)	C1orf63 (1.9)	C11orf9 (1.8)	GATAD2A (1.7)	TMEM50A (1.6)	SH2B3 (1.5)	CYB561D1 (1.4)
ENSG00000163466	ARPC2 PPI subnetwork	0.80	> 0.20	OGDH (3.4)	SH2B3 (2.7)	GATAD2A (2.4)	TMEM50A (1.9)	SLC44A2 (1.9)	FRK (1.9)	PLEC (1.8)	DNM2 (1.7)	CARM1 (1.7)	ITGB3 (1.6)
GO:0032944	regulation of mononuclear cell proliferation	0.80	> 0.20	TIMD4 (2.7)	PBX4 (2.5)	ENSG00000226645 (1.9)	ZNF101 (1.8)	HLX (1.7)	TRAFD1 (1.7)	CETP (1.7)	POLK (1.2)	GMIP (1.2)	GCNT4 (1.2)
GO:0043484	regulation of RNA splicing	0.80	> 0.20	C1orf63 (6.9)	ADAM1 (2.9)	MAU2 (2.5)	C17orf57 (2.4)	PPP1R37 (2.0)	LPIN3 (1.9)	TOP1 (1.8)	ILF3 (1.6)	QTRT1 (1.5)	BUD13 (1.3)
GO:0006221	pyrimidine nucleotide biosynthetic process	0.80	> 0.20	DYNC2LI1 (4.0)	AMIGO1 (2.9)	PMFBP1 (2.1)	TSSK6 (1.9)	DNAH11 (1.9)	QTRT1 (1.6)	C12orf43 (1.6)	GEMIN7 (1.6)	NAA25 (1.4)	ENSG00000226648 (1.4)
ENSG00000203814	HIST2H2BF PPI subnetwork	0.80	> 0.20	SMARCA4 (2.5)	BUD13 (2.3)	TMEM57 (2.1)	USP1 (2.0)	ILF3 (1.8)	DDX56 (1.6)	DOCK7 (1.5)	GMPR (1.5)	DNAH11 (1.3)	ATXN2 (1.2)
MP:0003911	increased drinking behavior	0.80	> 0.20	APOC1 (2.7)	HNF1A (2.3)	GPAM (2.2)	ST3GAL4 (2.1)	MOSC1 (1.9)	ERP29 (1.7)	SORT1 (1.5)	PLG (1.4)	GMPR (1.3)	SYPL2 (1.3)
GO:0045577	regulation of B cell differentiation	0.80	> 0.20	CYB561D1 (2.7)	DNAH11 (2.3)	CEACAM19 (2.2)	GMIP (1.9)	ST3GAL4 (1.8)	SLC44A2 (1.5)	ERP29 (1.5)	BLOC1S3 (1.5)	ENSG00000254235 (1.5)	DYNC2LI1 (1.4)
GO:0044450	microtubule organizing center part	0.80	> 0.20	DYNC2LI1 (3.8)	POC5 (3.3)	POLK (3.2)	PSRC1 (2.8)	C12orf51 (2.0)	UBXN2B (1.8)	TMED4 (1.6)	USP1 (1.6)	TSSK6 (1.4)	PMFBP1 (1.3)
GO:0007009	plasma membrane organization	0.80	> 0.20	BCAM (2.9)	C12orf47 (2.7)	AP1M2 (2.7)	HAVCR1 (2.2)	C11orf9 (2.0)	CBLC (1.7)	PTPN11 (1.7)	C19orf52 (1.5)	ZHX3 (1.5)	ANKRD31 (1.5)
ENSG00000115266	APC2 PPI subnetwork	0.80	> 0.20	LPAR2 (2.2)	MARK4 (2.0)	NAA25 (1.9)	PLCG1 (1.9)	GCNT4 (1.8)	ADAM1 (1.8)	C11orf9 (1.7)	C12orf43 (1.7)	MAPKAPK5 (1.6)	NKPD1 (1.5)
ENSG00000204632	HLA-G PPI subnetwork	0.80	> 0.20	PLCG1 (2.8)	PARP10 (2.5)	ENSG00000228044 (2.0)	YIPF2 (1.5)	HAVCR1 (1.5)	TMED4 (1.4)	POLK (1.3)	TMEM50A (1.2)	ZNF101 (1.1)	CEACAM19 (1.1)
ENSG00000206506	HLA-G PPI subnetwork	0.80	> 0.20	PLCG1 (2.8)	PARP10 (2.5)	ENSG00000228044 (2.0)	YIPF2 (1.5)	HAVCR1 (1.5)	TMED4 (1.4)	POLK (1.3)	TMEM50A (1.2)	ZNF101 (1.1)	CEACAM19 (1.1)
ENSG00000206443	ENSG00000206443 PPI subnetwork	0.80	> 0.20	PLCG1 (2.8)	PARP10 (2.5)	ENSG00000228044 (2.0)	YIPF2 (1.5)	HAVCR1 (1.5)	TMED4 (1.4)	POLK (1.3)	TMEM50A (1.2)	ZNF101 (1.1)	CEACAM19 (1.1)
ENSG00000172638	EFEMP2 PPI subnetwork	0.80	> 0.20	ZNF101 (2.9)	POLK (2.4)	SH2B3 (1.7)	RHD (1.7)	GMIP (1.6)	PPP1R37 (1.5)	RHCE (1.4)	NYNRIN (1.4)	ENSG00000226648 (1.4)	CILP2 (1.4)
ENSG00000117385	LEPRE1 PPI subnetwork	0.80	> 0.20	BRAP (4.0)	C19orf52 (2.4)	TXNL4B (2.3)	MAPKAPK5 (2.3)	MAU2 (2.1)	GEMIN7 (1.9)	BUD13 (1.8)	PLEKHH2 (1.8)	TRAPPC6A (1.8)	BLOC1S3 (1.8)
MP:0008828	abnormal lymph node cell ratio	0.80	> 0.20	RHD (4.0)	CETP (3.7)	RHCE (3.5)	TIMD4 (3.4)	PLCG1 (2.6)	MAFB (2.1)	ZNF101 (2.0)	SLC44A2 (1.7)	TRAFD1 (1.6)	APOC1 (1.4)
GO:0043022	ribosome binding	0.80	> 0.20	ATP13A1 (2.7)	ZNF259 (2.4)	TOMM40 (2.4)	SARS (2.1)	PSMA5 (2.0)	NAA25 (2.0)	BRAP (1.8)	AMIGO1 (1.8)	USP24 (1.8)	TOP1 (1.8)
GO:0007096	regulation of exit from mitosis	0.80	> 0.20	C12orf47 (2.6)	PSRC1 (2.5)	BLOC1S3 (2.4)	ZNF180 (2.3)	BUD13 (2.3)	POC5 (2.2)	C1orf63 (1.9)	TMED4 (1.7)	NKPD1 (1.6)	TXNL4B (1.3)
ENSG00000077080	ACTL6B PPI subnetwork	0.80	> 0.20	SUGP1 (2.7)	TMEM57 (2.3)	SMARCA4 (2.1)	PCSK9 (1.9)	GMPR (1.8)	BUD13 (1.7)	C19orf52 (1.6)	PMFBP1 (1.5)	CARM1 (1.4)	TMEM50A (1.3)
ENSG00000159479	MED8 PPI subnetwork	0.80	> 0.20	GEMIN7 (3.2)	TXNL4B (3.1)	BRAP (2.6)	BUD13 (2.4)	POC5 (2.2)	BLOC1S3 (2.1)	ATXN7L2 (1.8)	MAPKAPK5 (1.7)	CARM1 (1.7)	DHX38 (1.5)
MP:0003890	abnormal embryonic-extraembryonic boundary morphology	0.80	> 0.20	TRIB1 (2.1)	TMEM57 (2.0)	ATXN7L2 (1.9)	DOCK7 (1.8)	CELSR2 (1.7)	APOE (1.5)	PLCG1 (1.4)	PSRC1 (1.4)	ENSG00000228044 (1.3)	MAPKAPK5 (1.3)
ENSG00000116824	CD2 PPI subnetwork	0.80	> 0.20	PLCG1 (2.4)	ST3GAL4 (2.3)	UBXN2B (2.3)	PBX4 (2.3)	GMIP (2.0)	SLC44A2 (1.9)	C19orf52 (1.8)	CYB561D1 (1.3)	POLK (1.2)	OGDH (1.1)
ENSG00000052723	SIKE1 PPI subnetwork	0.80	> 0.20	MARK4 (3.1)	C11orf9 (3.0)	ZNF180 (2.8)	PVRL2 (2.2)	PVR (2.0)	CLPTM1 (1.7)	DNM2 (1.7)	ENSG00000235545 (1.5)	CARM1 (1.5)	CBLC (1.5)
GO:0043967	histone H4 acetylation	0.80	> 0.20	ZNF180 (2.7)	BUD13 (2.2)	UBXN2B (2.1)	C17orf57 (2.0)	BRAP (1.9)	ZNF101 (1.9)	ATXN2 (1.8)	C12orf51 (1.7)	ATXN7L2 (1.7)	USP24 (1.6)
MP:0002144	abnormal B cell differentiation	0.80	> 0.20	GMIP (3.9)	ZNF101 (2.8)	RELB (2.8)	SMARCA4 (2.2)	TIMD4 (2.1)	MYLIP (1.6)	PBX4 (1.3)	ENSG00000254235 (1.2)	HAVCR1 (1.2)	GRINA (1.1)
ENSG00000007168	PAFAH1B1 PPI subnetwork	0.80	> 0.20	PSRC1 (5.6)	FEN1 (4.0)	POC5 (3.1)	USP1 (3.1)	ILF3 (1.0)	ZNF180 (0.9)	USP24 (0.9)	TXNL4B (0.9)	ZHX3 (0.8)	AP1M2 (0.8)
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	0.80	> 0.20	POC5 (3.2)	PSRC1 (3.0)	SMARCA4 (2.7)	PBX4 (2.5)	C12orf51 (2.3)	DYNC2LI1 (2.1)	FEN1 (1.8)	POLK (1.7)	BUD13 (1.7)	TMEM57 (1.5)
REACTOME_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATIONFROM_THE_CENTROSOME	REACTOME_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATIONFROM_THE_CENTROSOME	0.80	> 0.20	POC5 (3.2)	PSRC1 (3.0)	SMARCA4 (2.7)	PBX4 (2.5)	C12orf51 (2.3)	DYNC2LI1 (2.1)	FEN1 (1.8)	POLK (1.7)	BUD13 (1.7)	TMEM57 (1.5)
GO:0015294	solute:cation symporter activity	0.80	> 0.20	TM6SF2 (4.5)	ABCG5 (3.1)	TMEM116 (3.1)	ABCG8 (2.5)	HAPLN4 (2.5)	NCAN (2.3)	PLG (2.1)	NPC1L1 (1.7)	BLOC1S3 (1.7)	PMFBP1 (1.6)
MP:0000061	fragile skeleton	0.80	> 0.20	CILP2 (2.1)	SYPL2 (2.1)	SLC44A2 (2.0)	PVRL2 (2.0)	TMEM116 (1.9)	APOE (1.7)	RHCE (1.7)	CETP (1.6)	RHD (1.4)	ZNF259 (1.4)
ENSG00000197448	GSTK1 PPI subnetwork	0.80	> 0.20	SARS (3.5)	ATP13A1 (3.2)	CLPTM1 (2.6)	ILF3 (2.3)	FEN1 (2.3)	DDX56 (2.3)	DHX38 (2.2)	NAA25 (2.0)	SMARCA4 (1.8)	TOMM40 (1.7)
GO:0006376	mRNA splice site selection	0.80	> 0.20	BRAP (4.0)	C12orf43 (2.6)	C17orf57 (2.5)	ATXN2 (2.4)	ANKRD31 (2.2)	CEACAM19 (2.0)	ADAM1 (2.0)	PBX4 (1.7)	ERP29 (1.7)	C1orf63 (1.6)
GO:0005680	anaphase-promoting complex	0.80	> 0.20	POC5 (3.6)	PSRC1 (3.3)	LPIN3 (3.0)	SUGP1 (2.4)	RHCE (2.1)	ATP13A1 (2.0)	MAU2 (2.0)	DOCK7 (2.0)	USP1 (1.5)	TMEM116 (1.4)
ENSG00000143079	CTTNBP2NL PPI subnetwork	0.80	> 0.20	MARK4 (3.9)	C11orf9 (3.2)	PVRL2 (2.9)	ZNF180 (2.8)	PVR (2.5)	CLPTM1 (2.1)	CBLC (1.9)	UBXN2B (1.7)	ENSG00000235545 (1.7)	TMEM50A (1.7)
GO:0030835	negative regulation of actin filament depolymerization	0.80	> 0.20	RHCE (3.1)	RHD (3.1)	ENSG00000238078 (2.5)	ADAM1 (2.4)	PMFBP1 (2.2)	TSSK6 (2.2)	C17orf57 (1.6)	GMPR (1.6)	C1orf63 (1.6)	C12orf51 (1.5)
ENSG00000005513	SOX8 PPI subnetwork	0.80	> 0.20	NCAN (3.4)	TRIB1 (2.4)	CILP2 (2.2)	NPC1L1 (1.8)	POLK (1.8)	ADAM1 (1.7)	MAPKAPK5 (1.5)	ZHX3 (1.3)	HNF1A (1.2)	MAU2 (1.2)
GO:0014812	muscle cell migration	0.80	> 0.20	LPIN3 (2.8)	CILP2 (2.3)	C17orf57 (2.0)	ANKRD31 (1.6)	PMFBP1 (1.6)	PVRL2 (1.5)	C12orf47 (1.5)	KIAA1324 (1.4)	PVR (1.3)	NKPD1 (1.3)
GO:0006493	protein O-linked glycosylation	0.80	> 0.20	TMED4 (3.0)	C1orf63 (2.7)	GCNT4 (2.5)	KIAA1324 (2.1)	TMEM57 (1.9)	USP24 (1.9)	ENSG00000254235 (1.7)	ADAM1 (1.6)	PMFBP1 (1.5)	YIPF2 (1.5)
GO:0004954	prostanoid receptor activity	0.80	> 0.20	ABO (2.9)	NKPD1 (2.0)	ST3GAL4 (1.9)	MOSC1 (1.9)	CYB561D1 (1.7)	HAVCR1 (1.5)	ENSG00000238078 (1.5)	HLX (1.5)	PLEKHH2 (1.5)	C12orf47 (1.4)
GO:0004953	icosanoid receptor activity	0.80	> 0.20	ABO (2.9)	NKPD1 (2.0)	ST3GAL4 (1.9)	MOSC1 (1.9)	CYB561D1 (1.7)	HAVCR1 (1.5)	ENSG00000238078 (1.5)	HLX (1.5)	PLEKHH2 (1.5)	C12orf47 (1.4)
GO:0006413	translational initiation	0.80	> 0.20	C12orf43 (3.1)	ZNF259 (2.7)	SARS (2.6)	TMEM57 (2.4)	QTRT1 (2.4)	DDX56 (2.3)	NKPD1 (2.2)	BRAP (2.2)	SUGP1 (2.1)	ADAM1 (2.1)
MP:0008545	absent sperm flagellum	0.80	> 0.20	DYNC2LI1 (3.6)	TSSK6 (3.5)	HAVCR1 (2.2)	TXNL4B (2.0)	GOT2P1 (1.6)	TMEM116 (1.6)	C1orf63 (1.5)	C12orf47 (1.4)	FADS1 (1.3)	ABO (1.3)
GO:0010737	protein kinase A signaling cascade	0.80	> 0.20	ENSG00000235545 (2.9)	KIAA1324 (1.8)	C19orf52 (1.7)	GCNT4 (1.7)	COL4A3BP (1.7)	HAVCR1 (1.6)	ST3GAL4 (1.5)	YIPF2 (1.3)	CYB561D1 (1.2)	SUGP1 (1.2)
GO:0000018	regulation of DNA recombination	0.80	> 0.20	ENSG00000226645 (3.1)	POC5 (2.9)	ENSG00000235545 (2.3)	HAVCR1 (1.6)	GCNT4 (1.3)	ZNF101 (1.2)	POLK (1.2)	RHCE (1.2)	C17orf57 (1.1)	TMEM50A (1.1)
ENSG00000139239	ENSG00000139239 PPI subnetwork	0.80	> 0.20	ILF3 (2.3)	TOP1 (2.3)	SUGP1 (2.2)	NAA25 (2.2)	GATAD2A (2.1)	DDX56 (2.0)	SMARCA4 (1.8)	ATP13A1 (1.6)	ENSG00000226645 (1.5)	ADAM1 (1.5)
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.80	> 0.20	SYPL2 (3.7)	PTPN11 (2.4)	KANK2 (2.4)	GMPR (2.3)	PLEC (2.2)	PVR (1.9)	BCAM (1.7)	SLC44A2 (1.7)	ADAM1 (1.3)	KIAA1324 (1.3)
GO:0005313	L-glutamate transmembrane transporter activity	0.80	> 0.20	NCAN (4.0)	ABCG8 (3.6)	HAPLN4 (3.4)	GCNT4 (2.5)	ABCG5 (2.4)	TM6SF2 (2.3)	CYP7A1 (2.1)	RPH3A (1.7)	AMIGO1 (1.5)	TSSK6 (1.5)
ENSG00000071564	TCF3 PPI subnetwork	0.80	> 0.20	HLX (3.5)	RHD (3.0)	RHCE (2.6)	GMPR (2.3)	ATXN7L2 (2.2)	PLCG1 (2.1)	NCAN (2.0)	DHX38 (1.6)	ENSG00000226648 (1.6)	TMEM57 (1.4)
ENSG00000181817	LSM10 PPI subnetwork	0.80	> 0.20	GEMIN7 (2.7)	ENSG00000226645 (2.7)	ZNF259 (2.7)	CYB561D1 (2.3)	PVR (2.2)	C12orf47 (2.2)	TXNL4B (2.0)	ZNF180 (1.9)	ADAM1 (1.9)	DYNC2LI1 (1.5)
ENSG00000069956	MAPK6 PPI subnetwork	0.80	> 0.20	MARK4 (3.1)	LPAR2 (2.8)	GATAD2A (2.7)	GMIP (2.7)	C12orf51 (2.3)	SLC44A2 (2.1)	ATXN2 (1.9)	SORT1 (1.8)	ENSG00000226648 (1.8)	DNM2 (1.6)
REACTOME_INTERLEUKIN:2_SIGNALING	REACTOME_INTERLEUKIN:2_SIGNALING	0.80	> 0.20	GMIP (3.9)	DNM2 (3.1)	SH2B3 (2.1)	HLX (2.0)	COL4A3BP (2.0)	PARP10 (1.8)	GRINA (1.8)	PBX4 (1.7)	SMARCA4 (1.7)	RELB (1.4)
GO:0007051	spindle organization	0.80	> 0.20	PSRC1 (4.9)	POC5 (4.7)	ENSG00000228044 (2.0)	USP1 (1.9)	ZNF180 (1.8)	PBX4 (1.7)	BUD13 (1.4)	DNAH11 (1.4)	FEN1 (1.4)	ILF3 (1.3)
GO:0042472	inner ear morphogenesis	0.80	> 0.20	C17orf57 (2.6)	CILP2 (2.5)	ENSG00000238078 (2.0)	DYNC2LI1 (2.0)	TMED4 (1.9)	GOT2P1 (1.8)	PLEKHH2 (1.6)	ABO (1.5)	TSSK6 (1.5)	HAPLN4 (1.5)
ENSG00000174292	TNK1 PPI subnetwork	0.80	> 0.20	CBLC (3.1)	AP1M2 (2.6)	TMEM57 (2.5)	NCAN (2.2)	FRK (2.1)	DOCK7 (2.0)	CELSR2 (2.0)	DNAH11 (1.7)	BUD13 (1.5)	TSSK6 (1.3)
MP:0003045	fibrosis	0.80	> 0.20	SYPL2 (2.3)	HNF1A (2.2)	POLK (2.0)	KIAA1324 (1.7)	TRIB1 (1.5)	C17orf57 (1.5)	ENSG00000226645 (1.5)	ITGB3 (1.4)	COL4A3BP (1.4)	PLEKHH2 (1.4)
ENSG00000112237	CCNC PPI subnetwork	0.80	> 0.20	GEMIN7 (2.9)	C12orf51 (2.9)	ATXN2 (2.8)	MAPKAPK5 (2.3)	POC5 (2.2)	SMARCA4 (2.1)	BUD13 (2.1)	DHX38 (2.0)	C12orf43 (2.0)	NYNRIN (2.0)
ENSG00000140988	RPS2 PPI subnetwork	0.80	> 0.20	NAA25 (2.6)	ZNF259 (2.5)	DDX56 (2.4)	SARS (2.4)	ILF3 (2.2)	NKPD1 (2.2)	QTRT1 (2.0)	TOP1 (2.0)	GATAD2A (1.9)	C12orf43 (1.7)
GO:0006486	protein glycosylation	0.80	> 0.20	YIPF2 (4.1)	TMED4 (3.4)	ERP29 (3.4)	TMEM57 (2.8)	ATP13A1 (2.2)	TMEM50A (2.1)	CYB561D1 (2.0)	CLPTM1 (1.9)	ABO (1.7)	ST3GAL4 (1.7)
GO:0043413	macromolecule glycosylation	0.80	> 0.20	YIPF2 (4.1)	TMED4 (3.4)	ERP29 (3.4)	TMEM57 (2.8)	ATP13A1 (2.2)	TMEM50A (2.1)	CYB561D1 (2.0)	CLPTM1 (1.9)	ABO (1.7)	ST3GAL4 (1.7)
MP:0005582	increased renin activity	0.80	> 0.20	ANKRD31 (2.8)	ZHX3 (2.7)	KIAA1324 (2.3)	BCAM (2.2)	PLG (2.1)	SLC22A1 (1.9)	TMEM116 (1.8)	AP1M2 (1.7)	C12orf47 (1.4)	TM6SF2 (1.4)
ENSG00000009830	POMT2 PPI subnetwork	0.80	> 0.20	ATP13A1 (3.2)	ERP29 (2.9)	TMED4 (2.7)	CLPTM1 (2.3)	SLC44A2 (2.3)	CEACAM19 (2.3)	TMEM57 (2.2)	ACAD10 (2.2)	TMEM50A (2.0)	YIPF2 (2.0)
GO:0060415	muscle tissue morphogenesis	0.80	> 0.20	ENSG00000238078 (3.2)	SYPL2 (3.0)	CEACAM19 (2.3)	ENSG00000254235 (1.9)	GMPR (1.7)	BLOC1S3 (1.5)	CILP2 (1.4)	TRAPPC6A (1.4)	C19orf52 (1.4)	TSSK6 (1.2)
ENSG00000067191	CACNB1 PPI subnetwork	0.80	> 0.20	HAVCR1 (3.6)	C12orf51 (3.3)	SMARCA4 (3.2)	NCAN (2.1)	ATP13A1 (1.8)	NYNRIN (1.8)	ZHX3 (1.7)	ILF3 (1.7)	USP24 (1.7)	PLEC (1.7)
GO:0060612	adipose tissue development	0.80	> 0.20	ENSG00000235545 (2.0)	NKPD1 (1.7)	C12orf51 (1.5)	ACAD10 (1.4)	NYNRIN (1.4)	MAPKAPK5 (1.4)	TMEM116 (1.3)	MOSC1 (1.3)	HNF1A (1.3)	GPAM (1.2)
MP:0002190	disorganized myocardium	0.80	> 0.20	PLCG1 (1.8)	KANK2 (1.7)	APOE (1.5)	HNF1A (1.5)	BCL3 (1.4)	UBXN2B (1.4)	ENSG00000226648 (1.4)	ENSG00000228044 (1.2)	PTPN11 (1.2)	PMFBP1 (1.2)
KEGG_PROTEIN_EXPORT	KEGG_PROTEIN_EXPORT	0.80	> 0.20	ERP29 (4.7)	YIPF2 (3.6)	TMED4 (3.5)	C12orf47 (1.9)	ATP13A1 (1.8)	C19orf52 (1.5)	TMEM57 (1.4)	FEN1 (1.4)	ENSG00000254235 (1.3)	PSMA5 (1.3)
ENSG00000169744	LDB2 PPI subnetwork	0.80	> 0.20	ABO (3.1)	NCAN (2.6)	CARM1 (1.6)	ALDH2 (1.6)	C11orf9 (1.5)	NYNRIN (1.5)	HLX (1.4)	GRINA (1.4)	MOSC1 (1.4)	UBXN2B (1.4)
GO:0051898	negative regulation of protein kinase B signaling cascade	0.80	> 0.20	BLOC1S3 (2.0)	C11orf9 (1.9)	PPP1R37 (1.7)	TMED4 (1.7)	CELSR2 (1.7)	PLEC (1.5)	SORT1 (1.4)	ST3GAL4 (1.3)	TM6SF2 (1.2)	CILP2 (1.2)
ENSG00000181788	SIAH2 PPI subnetwork	0.80	> 0.20	FRK (3.4)	PARP10 (2.2)	GCNT4 (1.5)	NYNRIN (1.5)	LPAR2 (1.4)	CELSR2 (1.2)	OASL (1.1)	TRIB1 (1.0)	TRAFD1 (1.0)	RELB (1.0)
GO:0031432	titin binding	0.80	> 0.20	SYPL2 (5.9)	TMEM50A (2.1)	GMPR (1.9)	PVR (1.6)	RPH3A (1.2)	ENSG00000238078 (1.1)	HNF1A (1.0)	CILP2 (1.0)	ENSG00000226648 (1.0)	ZNF180 (1.0)
REACTOME_IRS:MEDIATED_SIGNALLING	REACTOME_IRS:MEDIATED_SIGNALLING	0.80	> 0.20	PTPN11 (3.7)	ZHX3 (2.7)	COL4A3BP (2.2)	GPAM (2.1)	CARM1 (2.0)	HAPLN4 (2.0)	C11orf9 (1.9)	SARS (1.9)	PLEKHH2 (1.9)	MAPKAPK5 (1.8)
REACTOME_IRS:RELATED_EVENTS	REACTOME_IRS:RELATED_EVENTS	0.80	> 0.20	PTPN11 (3.7)	ZHX3 (2.7)	COL4A3BP (2.2)	GPAM (2.1)	CARM1 (2.0)	HAPLN4 (2.0)	C11orf9 (1.9)	SARS (1.9)	PLEKHH2 (1.9)	MAPKAPK5 (1.8)
GO:0019080	viral genome expression	0.80	> 0.20	NKPD1 (2.7)	MAPKAPK5 (2.0)	ANKRD31 (2.0)	SUGP1 (1.9)	GEMIN7 (1.8)	MAU2 (1.8)	GATAD2A (1.7)	ENSG00000226645 (1.7)	ATXN7L2 (1.7)	UBXN2B (1.6)
GO:0019083	viral transcription	0.80	> 0.20	NKPD1 (2.7)	MAPKAPK5 (2.0)	ANKRD31 (2.0)	SUGP1 (1.9)	GEMIN7 (1.8)	MAU2 (1.8)	GATAD2A (1.7)	ENSG00000226645 (1.7)	ATXN7L2 (1.7)	UBXN2B (1.6)
MP:0002133	abnormal respiratory system physiology	0.80	> 0.20	SLC44A2 (2.4)	RHCE (2.0)	PLEKHH2 (1.8)	MAFB (1.8)	LPAR2 (1.7)	UBXN2B (1.7)	HLX (1.7)	NKPD1 (1.5)	ENSG00000235545 (1.5)	SH2B3 (1.4)
GO:0001755	neural crest cell migration	0.80	> 0.20	ENSG00000254235 (2.6)	C17orf57 (2.3)	TSSK6 (2.2)	ZNF101 (2.1)	ST3GAL4 (1.8)	CBLC (1.8)	NKPD1 (1.7)	C12orf47 (1.5)	AMIGO1 (1.5)	COL4A3BP (1.4)
MP:0005633	increased circulating sodium level	0.80	> 0.20	TMEM116 (4.0)	SLC22A1 (3.5)	PLG (2.9)	ANGPTL3 (2.7)	C12orf47 (2.5)	FRK (2.4)	HNF1A (1.4)	TXNL4B (1.3)	AP1M2 (1.3)	DYNC2LI1 (1.3)
GO:0032291	axon ensheathment in central nervous system	0.80	> 0.20	C11orf9 (2.9)	PMFBP1 (2.3)	HAPLN4 (2.3)	CEACAM19 (2.3)	NCAN (2.1)	HNF1A (2.0)	ZNF180 (1.6)	SORT1 (1.5)	CELSR2 (1.4)	PBX4 (1.4)
GO:0022010	central nervous system myelination	0.80	> 0.20	C11orf9 (2.9)	PMFBP1 (2.3)	HAPLN4 (2.3)	CEACAM19 (2.3)	NCAN (2.1)	HNF1A (2.0)	ZNF180 (1.6)	SORT1 (1.5)	CELSR2 (1.4)	PBX4 (1.4)
MP:0008026	abnormal brain white matter morphology	0.80	> 0.20	GRINA (2.8)	APOE (2.3)	NCAN (2.3)	ATXN2 (2.1)	ENSG00000254235 (2.1)	APOC1 (1.9)	HAPLN4 (1.9)	ACAD10 (1.8)	LPA (1.7)	MAPKAPK5 (1.7)
ENSG00000157349	DDX19B PPI subnetwork	0.80	> 0.20	ATXN7L2 (2.2)	DHODH (2.1)	BLOC1S3 (1.8)	TMEM50A (1.7)	TSSK6 (1.6)	ZNF180 (1.5)	USP1 (1.5)	TXNL4B (1.5)	CELSR2 (1.5)	MARK4 (1.5)
MP:0005620	abnormal muscle contractility	0.80	> 0.20	SYPL2 (5.6)	GMPR (2.8)	HAPLN4 (2.6)	ITGB3 (2.4)	ENSG00000226648 (2.2)	KANK2 (2.0)	GPAM (1.9)	ENSG00000226645 (1.9)	NPC1L1 (1.7)	ZHX3 (1.5)
ENSG00000167549	CORO6 PPI subnetwork	0.80	> 0.20	CARM1 (2.7)	UBXN2B (2.6)	DNM2 (2.1)	TOP1 (1.8)	ALDH2 (1.7)	TOMM40 (1.6)	GATAD2A (1.3)	ABO (1.2)	TMEM50A (1.1)	CLPTM1 (1.1)
GO:0010639	negative regulation of organelle organization	0.80	> 0.20	RHCE (2.7)	RHD (2.4)	POC5 (2.2)	PSRC1 (2.2)	CBLC (1.7)	C12orf51 (1.6)	LPAR2 (1.5)	TMEM57 (1.4)	SLC44A2 (1.4)	GMPR (1.4)
MP:0000623	decreased salivation	0.80	> 0.20	KIAA1324 (3.6)	TMEM116 (2.8)	GOT2P1 (2.8)	NT5DC1 (2.7)	DYNC2LI1 (2.1)	SLC44A2 (1.8)	C12orf43 (1.7)	PLEKHH2 (1.6)	KANK2 (1.3)	CYB561D1 (1.3)
MP:0010418	perimembraneous ventricular septal defect	0.80	> 0.20	PLCG1 (2.5)	HLX (2.3)	MYLIP (1.7)	KANK2 (1.6)	MAFB (1.5)	NYNRIN (1.5)	CEACAM19 (1.4)	TOP1 (1.4)	APOE (1.3)	C11orf9 (1.3)
GO:0055080	cation homeostasis	0.80	> 0.20	RHCE (2.0)	RHD (2.0)	ERP29 (2.0)	TMEM116 (1.9)	ABO (1.8)	PBX4 (1.7)	COL4A3BP (1.6)	SYPL2 (1.6)	AMIGO1 (1.6)	GRINA (1.5)
MP:0001385	pup cannibalization	0.80	> 0.20	HAPLN4 (3.2)	KIAA1324 (3.0)	CELSR2 (2.5)	PCSK9 (2.4)	FRK (2.2)	AP1M2 (1.8)	MYLIP (1.6)	ENSG00000226645 (1.6)	APOE (1.4)	NPC1L1 (1.4)
ENSG00000176444	CLK2 PPI subnetwork	0.80	> 0.20	C1orf63 (4.1)	TMEM57 (3.1)	GRINA (2.8)	TOP1 (2.8)	FADS2 (2.0)	DOCK7 (2.0)	DNM2 (1.8)	DNAH11 (1.6)	SLC44A2 (1.6)	APOE (1.5)
GO:0007566	embryo implantation	0.80	> 0.20	CEACAM19 (2.9)	PLEKHH2 (2.3)	TMED4 (1.9)	TMEM116 (1.8)	DNAH11 (1.7)	ENSG00000238078 (1.5)	GOT2P1 (1.4)	ERP29 (1.4)	BCAM (1.3)	ENSG00000228044 (1.3)
GO:0006368	transcription elongation from RNA polymerase II promoter	0.80	> 0.20	TXNL4B (2.9)	MAPKAPK5 (2.7)	SUGP1 (2.3)	GEMIN7 (2.2)	ZNF259 (2.0)	C19orf52 (1.9)	BLOC1S3 (1.9)	BUD13 (1.9)	PSMA5 (1.9)	ATXN7L2 (1.7)
ENSG00000187446	ENSG00000187446 PPI subnetwork	0.80	> 0.20	ABO (2.9)	BRAP (2.3)	SLC44A2 (2.2)	ATXN7L2 (2.0)	SORT1 (2.0)	POLK (1.9)	SUGP1 (1.8)	CYB561D1 (1.8)	KIAA1324 (1.7)	GCNT4 (1.5)
GO:0045682	regulation of epidermis development	0.80	> 0.20	LPIN3 (2.1)	PMFBP1 (1.9)	CBLC (1.8)	CELSR2 (1.7)	ENSG00000238078 (1.7)	GOT2P1 (1.7)	GCNT4 (1.7)	AP1M2 (1.6)	ENSG00000235545 (1.5)	PBX4 (1.4)
MP:0008533	abnormal anterior visceral endoderm morphology	0.80	> 0.20	APOE (2.9)	USP24 (2.7)	COL4A3BP (2.1)	MAU2 (1.8)	ATXN7L2 (1.6)	PMFBP1 (1.6)	PCSK9 (1.5)	APOB (1.5)	PVR (1.4)	ST3GAL4 (1.4)
ENSG00000097007	ABL1 PPI subnetwork	0.80	> 0.20	GMIP (4.1)	USP24 (2.4)	PTPN11 (2.0)	DNM2 (2.0)	PLEC (1.9)	CELSR2 (1.9)	GRINA (1.8)	PSRC1 (1.7)	SH2B3 (1.6)	KANK2 (1.6)
GO:0045648	positive regulation of erythrocyte differentiation	0.80	> 0.20	ENSG00000226645 (2.8)	RHCE (2.3)	PBX4 (2.1)	TMEM57 (2.1)	ENSG00000226648 (1.9)	PLCG1 (1.8)	MYLIP (1.8)	C12orf51 (1.6)	C1orf63 (1.6)	CILP2 (1.5)
GO:2000108	positive regulation of leukocyte apoptotic process	0.80	> 0.20	ENSG00000235545 (2.0)	GMIP (1.8)	HLX (1.6)	PBX4 (1.6)	C17orf57 (1.5)	TRAPPC6A (1.4)	ENSG00000254235 (1.3)	QTRT1 (1.2)	PPP1R37 (1.2)	DYNC2LI1 (1.2)
ENSG00000173540	GMPPB PPI subnetwork	0.80	> 0.20	TMEM57 (2.9)	C19orf52 (2.5)	DDX56 (2.5)	OGDH (2.5)	TRAFD1 (2.0)	PPP1R37 (2.0)	PSMA5 (1.8)	LPA (1.8)	CYP7A1 (1.6)	ALDH2 (1.5)
ENSG00000174405	LIG4 PPI subnetwork	0.80	> 0.20	ACAD10 (2.5)	ANKRD31 (2.5)	NT5DC1 (2.4)	SMARCA4 (2.0)	GCNT4 (1.8)	HAPLN4 (1.8)	ZNF101 (1.8)	PTPN11 (1.7)	UBXN2B (1.6)	FEN1 (1.6)
ENSG00000136950	ARPC5L PPI subnetwork	0.80	> 0.20	TMEM50A (2.5)	CYB561D1 (2.1)	NCAN (2.0)	FRK (2.0)	PLEC (1.9)	HAVCR1 (1.9)	POLK (1.7)	OGDH (1.7)	C12orf47 (1.6)	C1orf63 (1.5)
ENSG00000165606	DRGX PPI subnetwork	0.80	> 0.20	CARM1 (2.9)	MARK4 (2.5)	GATAD2A (2.3)	ABO (2.2)	PPP1R37 (2.1)	ATXN7L2 (1.8)	BCAM (1.6)	ZHX3 (1.6)	CELSR2 (1.5)	SMARCA4 (1.4)
MP:0000759	abnormal skeletal muscle morphology	0.80	> 0.20	SYPL2 (7.1)	KIAA1324 (1.9)	GMPR (1.8)	SLC44A2 (1.6)	ZHX3 (1.6)	KANK2 (1.5)	PVR (1.2)	LPIN3 (1.1)	PLEC (1.0)	HLX (1.0)
GO:0043014	alpha-tubulin binding	0.80	> 0.20	DYNC2LI1 (2.7)	RHD (1.8)	BRAP (1.6)	GMPR (1.5)	RHCE (1.5)	TSSK6 (1.4)	ZNF259 (1.4)	LDLR (1.4)	MAU2 (1.4)	TXNL4B (1.3)
ENSG00000169252	ADRB2 PPI subnetwork	0.80	> 0.20	AMIGO1 (3.0)	ZNF101 (2.2)	CETP (2.1)	KIAA1324 (2.0)	SH2B3 (1.9)	TRIB1 (1.8)	ZHX3 (1.4)	PLEC (1.4)	ENSG00000235545 (1.4)	GATAD2A (1.3)
ENSG00000165059	PRKACG PPI subnetwork	0.80	> 0.20	PLEKHH2 (2.2)	PLEC (2.1)	ST3GAL4 (1.9)	C12orf47 (1.8)	KANK2 (1.8)	AMIGO1 (1.8)	GMPR (1.7)	RPH3A (1.6)	OGDH (1.5)	ALDH2 (1.5)
MP:0000149	abnormal scapula morphology	0.80	> 0.20	NYNRIN (2.2)	PLEKHH2 (2.0)	CARM1 (1.7)	FRK (1.7)	KIAA1324 (1.6)	ENSG00000254235 (1.6)	KANK2 (1.5)	ENSG00000228044 (1.4)	CEACAM19 (1.3)	LPAR2 (1.3)
GO:0045445	myoblast differentiation	0.80	> 0.20	LPIN3 (2.5)	NKPD1 (2.0)	TMEM116 (1.9)	GEMIN7 (1.8)	ABO (1.6)	SYPL2 (1.4)	KANK2 (1.3)	ALDH2 (1.1)	TXNL4B (1.1)	ST3GAL4 (1.0)
ENSG00000176601	YSK4 PPI subnetwork	0.80	> 0.20	ZHX3 (3.5)	MAU2 (2.2)	DNAH11 (1.8)	C19orf52 (1.7)	PTPN11 (1.7)	SORT1 (1.7)	SARS (1.5)	PSMA5 (1.4)	ATXN7L2 (1.2)	HP (1.2)
ENSG00000212664	ENSG00000212664 PPI subnetwork	0.80	> 0.20	ZNF259 (3.2)	DDX56 (2.7)	NAA25 (2.5)	SUGP1 (2.4)	DHODH (2.3)	QTRT1 (2.1)	TOMM40 (1.8)	GATAD2A (1.8)	NKPD1 (1.7)	ILF3 (1.6)
ENSG00000115317	HTRA2 PPI subnetwork	0.80	> 0.20	PARP10 (3.5)	TRAFD1 (3.1)	RELB (2.6)	OASL (2.2)	PTPN11 (1.7)	C12orf51 (1.7)	C12orf43 (1.5)	USP24 (1.4)	BCL3 (1.4)	CEACAM19 (1.2)
GO:2000142	regulation of transcription initiation, DNA-dependent	0.81	> 0.20	ENSG00000254235 (3.3)	FRK (3.2)	HNF1A (3.0)	CEACAM19 (2.7)	CYB561D1 (1.8)	HAVCR1 (1.4)	ZHX3 (1.4)	LPIN3 (1.2)	BUD13 (1.1)	ABCG8 (1.1)
GO:0060260	regulation of transcription initiation from RNA polymerase II promoter	0.81	> 0.20	ENSG00000254235 (3.3)	FRK (3.2)	HNF1A (3.0)	CEACAM19 (2.7)	CYB561D1 (1.8)	HAVCR1 (1.4)	ZHX3 (1.4)	LPIN3 (1.2)	BUD13 (1.1)	ABCG8 (1.1)
ENSG00000100083	GGA1 PPI subnetwork	0.81	> 0.20	CYB561D1 (2.4)	C12orf51 (2.3)	YIPF2 (2.2)	COL4A3BP (2.2)	ENSG00000226645 (2.2)	PTPN11 (2.1)	PLEKHH2 (2.0)	ADAM1 (1.8)	GRINA (1.8)	PPP1R37 (1.7)
GO:0002532	production of molecular mediator involved in inflammatory response	0.81	> 0.20	LPIN3 (2.9)	CYB561D1 (2.4)	ST3GAL4 (1.9)	GMPR (1.9)	UBXN2B (1.8)	ADAM1 (1.5)	PMFBP1 (1.4)	ALDH2 (1.2)	FRK (1.2)	HP (1.2)
ENSG00000149554	CHEK1 PPI subnetwork	0.81	> 0.20	FEN1 (3.0)	PTPN11 (2.4)	USP1 (2.3)	RELB (1.9)	GMPR (1.8)	PSRC1 (1.7)	ZNF101 (1.5)	POLK (1.4)	LPAR2 (1.4)	DOCK7 (1.3)
GO:0060537	muscle tissue development	0.81	> 0.20	SYPL2 (4.2)	ATXN7L2 (2.3)	KANK2 (1.8)	GMPR (1.7)	BCAM (1.7)	CEACAM19 (1.6)	PLEKHH2 (1.5)	ANKRD31 (1.4)	ENSG00000238078 (1.4)	OGDH (1.3)
MP:0009940	abnormal hippocampus pyramidal cell morphology	0.81	> 0.20	NCAN (3.0)	CELSR2 (2.8)	C12orf51 (2.4)	RPH3A (2.2)	APOE (2.2)	CETP (2.2)	MARK4 (2.1)	FADS2 (2.0)	GOT2P1 (1.9)	TIMD4 (1.7)
MP:0000334	decreased granulocyte number	0.81	> 0.20	GMIP (3.6)	DNM2 (3.2)	LPAR2 (3.1)	MAU2 (2.2)	CEACAM19 (2.0)	HLX (1.7)	MAFB (1.5)	PBX4 (1.4)	ATP13A1 (1.4)	ALDH2 (1.3)
ENSG00000196374	HIST1H2BM PPI subnetwork	0.81	> 0.20	SMARCA4 (3.0)	ILF3 (2.7)	USP1 (2.3)	DDX56 (2.3)	BUD13 (2.2)	SUGP1 (1.7)	TMEM57 (1.6)	ZNF259 (1.6)	GMPR (1.6)	MAPKAPK5 (1.5)
ENSG00000099882	ENSG00000099882 PPI subnetwork	0.81	> 0.20	NCAN (2.8)	RPH3A (2.6)	CELSR2 (2.5)	ZHX3 (2.3)	PLCG1 (2.3)	PPP1R37 (2.3)	ITGB3 (2.1)	MARK4 (2.0)	GATAD2A (2.0)	C17orf57 (1.7)
GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	0.81	> 0.20	C17orf57 (3.2)	TMEM116 (2.8)	ENSG00000226648 (2.1)	PVR (2.0)	ENSG00000254235 (1.9)	PMFBP1 (1.5)	KANK2 (1.3)	PLEKHH2 (1.3)	ENSG00000228044 (1.3)	ENSG00000226645 (1.3)
MP:0004433	abnormal cochlear inner hair cell physiology	0.81	> 0.20	ZHX3 (3.0)	HAVCR1 (2.7)	BCAM (2.6)	KIAA1324 (2.3)	TM6SF2 (2.1)	HNF1A (2.0)	CBLC (1.8)	ABCG5 (1.8)	HAPLN4 (1.8)	SLC22A1 (1.6)
ENSG00000071655	MBD3 PPI subnetwork	0.81	> 0.20	SMARCA4 (4.6)	CARM1 (2.6)	USP1 (2.5)	PLCG1 (2.4)	ILF3 (2.4)	BUD13 (2.4)	DNM2 (2.3)	KANK2 (2.2)	TOP1 (2.2)	USP24 (2.1)
GO:0034105	positive regulation of tissue remodeling	0.81	> 0.20	ENSG00000235545 (3.4)	DNAH11 (2.6)	SLC22A1 (2.0)	FRK (1.9)	ADAM1 (1.7)	RHCE (1.7)	C17orf57 (1.6)	TMED4 (1.5)	ENSG00000226645 (1.3)	YIPF2 (1.2)
GO:0006471	protein ADP-ribosylation	0.81	> 0.20	C12orf47 (2.6)	ENSG00000235545 (2.5)	ZNF180 (2.2)	POC5 (1.8)	RHCE (1.5)	POLK (1.4)	ATXN7L2 (1.2)	GEMIN7 (1.2)	YIPF2 (1.2)	BLOC1S3 (1.2)
GO:2000021	regulation of ion homeostasis	0.81	> 0.20	HAVCR1 (2.4)	ABO (2.3)	NKPD1 (2.1)	RPH3A (1.9)	BLOC1S3 (1.7)	ENSG00000226648 (1.7)	PLCG1 (1.7)	ITGB3 (1.6)	C12orf47 (1.4)	MARK4 (1.2)
MP:0008023	abnormal styloid process morphology	0.81	> 0.20	CEACAM19 (2.5)	CILP2 (2.3)	KIAA1324 (2.1)	DYNC2LI1 (2.1)	PLCG1 (1.9)	PVRL2 (1.8)	ENSG00000228044 (1.6)	AMIGO1 (1.5)	SLC44A2 (1.5)	TMEM57 (1.4)
GO:0006414	translational elongation	0.81	> 0.20	NKPD1 (3.1)	ANKRD31 (2.1)	AMIGO1 (1.8)	ADAM1 (1.8)	DNAH11 (1.7)	UBXN2B (1.5)	C12orf43 (1.3)	ERP29 (1.3)	DHODH (1.2)	CEACAM19 (1.2)
ENSG00000151491	EPS8 PPI subnetwork	0.81	> 0.20	AP1M2 (4.0)	CBLC (2.9)	KIAA1324 (2.5)	ABCG5 (2.1)	YIPF2 (1.8)	GATAD2A (1.6)	DYNC2LI1 (1.6)	ST3GAL4 (1.5)	ABCG8 (1.5)	NPC1L1 (1.5)
GO:0032465	regulation of cytokinesis	0.81	> 0.20	DYNC2LI1 (3.8)	PSRC1 (2.2)	TMEM50A (2.2)	UBXN2B (2.1)	BLOC1S3 (1.8)	PBX4 (1.6)	TXNL4B (1.4)	TMEM116 (1.3)	GCNT4 (1.3)	ZNF180 (1.2)
GO:0015697	quaternary ammonium group transport	0.81	> 0.20	C19orf52 (2.2)	MOSC1 (2.1)	TMEM116 (1.9)	ACAD10 (1.7)	BRAP (1.7)	TM6SF2 (1.6)	CILP2 (1.6)	AMIGO1 (1.5)	PBX4 (1.4)	GMPR (1.3)
ENSG00000136982	DSCC1 PPI subnetwork	0.81	> 0.20	FEN1 (4.9)	USP1 (3.1)	PSRC1 (2.4)	MAPKAPK5 (2.1)	ZNF180 (1.5)	ERP29 (1.4)	ILF3 (1.4)	POC5 (1.3)	GEMIN7 (1.3)	DNAH11 (1.3)
MP:0003953	abnormal hormone level	0.81	> 0.20	GPAM (3.4)	MOSC1 (3.2)	NPC1L1 (2.6)	C12orf47 (2.5)	KIAA1324 (2.2)	ZHX3 (2.0)	SORT1 (1.9)	ST3GAL4 (1.6)	PPP1R37 (1.6)	ENSG00000226645 (1.6)
ENSG00000111057	KRT18 PPI subnetwork	0.81	> 0.20	PLEC (2.7)	FRK (2.4)	CELSR2 (2.0)	AP1M2 (1.9)	PLCG1 (1.9)	ENSG00000238078 (1.8)	GOT2P1 (1.5)	HP (1.4)	C1orf63 (1.4)	ANGPTL3 (1.4)
ENSG00000075651	PLD1 PPI subnetwork	0.81	> 0.20	GATAD2A (3.2)	TMEM50A (2.4)	PVR (2.2)	PVRL2 (2.1)	MARK4 (2.1)	TXNL4B (1.9)	CARM1 (1.9)	OGDH (1.7)	GOT2P1 (1.5)	ENSG00000254235 (1.5)
MP:0003354	astrocytosis	0.81	> 0.20	ATP13A1 (3.7)	CLPTM1 (3.3)	ERP29 (3.3)	GRINA (2.5)	APOE (2.5)	CELSR2 (2.4)	SORT1 (2.3)	COL4A3BP (2.2)	CETP (2.0)	ACAD10 (2.0)
ENSG00000131069	ACSS2 PPI subnetwork	0.81	> 0.20	SARS (4.8)	NAA25 (2.4)	MAU2 (2.2)	ILF3 (2.0)	ATP13A1 (2.0)	SMARCA4 (1.7)	NT5DC1 (1.5)	ADAM1 (1.5)	PMFBP1 (1.5)	CARM1 (1.5)
GO:0042698	ovulation cycle	0.81	> 0.20	ABO (2.3)	ST3GAL4 (2.1)	CEACAM19 (1.9)	YIPF2 (1.7)	KIAA1324 (1.6)	GPAM (1.6)	PLEKHH2 (1.6)	AMIGO1 (1.5)	FRK (1.3)	NT5DC1 (1.2)
ENSG00000170734	POLH PPI subnetwork	0.81	> 0.20	GMPR (3.2)	NT5DC1 (2.3)	ENSG00000226645 (1.9)	MYLIP (1.8)	PARP10 (1.7)	POLK (1.5)	ENSG00000235545 (1.5)	MOSC1 (1.3)	CETP (1.3)	TMEM57 (1.2)
ENSG00000152684	PELO PPI subnetwork	0.81	> 0.20	QTRT1 (2.4)	TOMM40 (2.3)	ENSG00000235545 (2.2)	ATP13A1 (2.1)	TRAPPC6A (2.1)	OGDH (1.7)	GOT2P1 (1.5)	DHODH (1.4)	ACAD10 (1.3)	SARS (1.3)
GO:0000086	G2/M transition of mitotic cell cycle	0.81	> 0.20	POC5 (3.5)	PSRC1 (3.1)	PBX4 (2.6)	POLK (2.5)	SMARCA4 (1.8)	DYNC2LI1 (1.7)	BUD13 (1.7)	ATXN7L2 (1.6)	USP1 (1.6)	TSSK6 (1.5)
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	0.81	> 0.20	POLK (3.6)	KIAA1324 (3.5)	NPC1L1 (2.0)	SUGP1 (1.9)	POC5 (1.9)	COL4A3BP (1.4)	MYLIP (1.2)	MAFB (1.2)	NAA25 (1.1)	DYNC2LI1 (1.0)
GO:0007219	Notch signaling pathway	0.81	> 0.20	ABO (3.2)	ENSG00000254235 (3.1)	CELSR2 (2.1)	CEACAM19 (2.0)	TRAPPC6A (1.9)	TSSK6 (1.9)	LPIN3 (1.8)	C19orf52 (1.8)	C12orf47 (1.7)	CBLC (1.5)
ENSG00000091651	ORC6 PPI subnetwork	0.81	> 0.20	FEN1 (6.5)	USP1 (4.7)	PSRC1 (1.8)	NT5DC1 (1.6)	ENSG00000235545 (1.6)	ENSG00000228044 (1.5)	POC5 (1.3)	DHODH (1.2)	TMEM116 (1.2)	PSMA5 (1.0)
ENSG00000167863	ATP5H PPI subnetwork	0.81	> 0.20	OGDH (3.3)	ACAD10 (3.2)	PSMA5 (2.9)	TOMM40 (2.1)	GOT2P1 (2.1)	NT5DC1 (1.7)	C12orf47 (1.7)	ENSG00000238078 (1.6)	TOP1 (1.6)	C1orf63 (1.6)
GO:0046782	regulation of viral transcription	0.81	> 0.20	MAPKAPK5 (3.1)	BUD13 (2.9)	SUGP1 (2.4)	TXNL4B (2.3)	GEMIN7 (2.0)	GATAD2A (1.7)	C12orf43 (1.7)	ZNF259 (1.7)	BRAP (1.7)	ENSG00000226645 (1.5)
GO:0030125	clathrin vesicle coat	0.81	> 0.20	GRINA (3.1)	TMEM50A (2.6)	CLPTM1 (2.4)	ZHX3 (2.4)	ERP29 (2.2)	C1orf63 (2.2)	POLK (2.0)	PPP1R37 (1.9)	C12orf51 (1.9)	SARS (1.8)
ENSG00000013503	POLR3B PPI subnetwork	0.81	> 0.20	C19orf52 (2.9)	DDX56 (2.6)	BUD13 (2.5)	ZNF259 (2.4)	GMPR (2.3)	SUGP1 (2.0)	ATP13A1 (1.7)	GEMIN7 (1.7)	QTRT1 (1.6)	TOMM40 (1.5)
GO:0010948	negative regulation of cell cycle process	0.81	> 0.20	ENSG00000228044 (3.1)	POLK (2.4)	POC5 (2.4)	PSRC1 (2.0)	USP1 (1.8)	MAU2 (1.7)	SUGP1 (1.7)	DNAH11 (1.7)	FEN1 (1.6)	ZNF180 (1.5)
MP:0002280	abnormal intercostal muscle morphology	0.81	> 0.20	SYPL2 (3.0)	GMPR (2.3)	KIAA1324 (2.3)	NPC1L1 (2.3)	QTRT1 (2.1)	ALDH2 (2.0)	PVR (2.0)	RPH3A (2.0)	ENSG00000228044 (1.6)	CARM1 (1.5)
ENSG00000117091	CD48 PPI subnetwork	0.81	> 0.20	SLC44A2 (2.7)	PBX4 (2.2)	UBXN2B (2.2)	CYB561D1 (2.2)	ENSG00000238078 (2.2)	ST3GAL4 (2.1)	ATXN7L2 (2.0)	SARS (1.3)	PSMA5 (1.1)	LPA (1.0)
GO:0007431	salivary gland development	0.81	> 0.20	PLEKHH2 (2.8)	TSSK6 (2.0)	DOCK7 (2.0)	BCAM (1.8)	PVR (1.8)	ENSG00000226648 (1.8)	GCNT4 (1.6)	PBX4 (1.6)	AP1M2 (1.5)	PVRL2 (1.5)
GO:0007052	mitotic spindle organization	0.81	> 0.20	PSRC1 (4.4)	POC5 (4.2)	DNAH11 (2.3)	POLK (1.6)	USP1 (1.6)	ACAD10 (1.3)	ERP29 (1.3)	ENSG00000228044 (1.3)	TXNL4B (1.3)	ILF3 (1.1)
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N:GLYCAN_BIOSYTHESIS	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N:GLYCAN_BIOSYTHESIS	0.81	> 0.20	YIPF2 (4.5)	KIAA1324 (2.3)	BLOC1S3 (2.2)	C12orf43 (2.0)	TMEM57 (1.6)	QTRT1 (1.6)	ZNF259 (1.5)	C19orf52 (1.4)	TIMD4 (1.3)	TMEM116 (1.3)
MP:0006395	abnormal epiphyseal plate morphology	0.81	> 0.20	CILP2 (5.0)	PLEKHH2 (4.2)	APOE (2.5)	MYLIP (2.2)	APOC1 (1.9)	SORT1 (1.8)	GMPR (1.6)	ITGB3 (1.5)	TMEM116 (1.5)	PLCG1 (1.4)
REACTOME_RNA_POLYMERASE_I_PROMOTER_CLEARANCE	REACTOME_RNA_POLYMERASE_I_PROMOTER_CLEARANCE	0.81	> 0.20	BUD13 (2.0)	DYNC2LI1 (1.9)	TXNL4B (1.9)	ZNF259 (1.9)	ZNF180 (1.9)	GMPR (1.7)	ENSG00000226645 (1.5)	DHX38 (1.5)	ENSG00000235545 (1.4)	ATXN7L2 (1.2)
GO:0005795	Golgi stack	0.81	> 0.20	YIPF2 (4.5)	LPIN3 (2.6)	TMED4 (2.6)	ST3GAL4 (2.5)	SLC44A2 (2.3)	CYB561D1 (2.2)	TMEM57 (2.1)	BLOC1S3 (1.9)	PVRL2 (1.8)	CILP2 (1.5)
ENSG00000079841	RIMS1 PPI subnetwork	0.81	> 0.20	C12orf51 (2.8)	LPA (2.4)	KIAA1324 (2.4)	FRK (2.2)	HNF1A (2.1)	CEACAM19 (1.7)	RPH3A (1.7)	HAPLN4 (1.6)	C12orf47 (1.6)	TMEM57 (1.6)
MP:0000539	distended urinary bladder	0.81	> 0.20	LDLR (3.5)	FADS2 (3.2)	HMGCR (2.5)	FADS1 (2.4)	ERP29 (2.2)	CYB561D1 (2.0)	NT5DC1 (2.0)	PCSK9 (1.8)	SORT1 (1.8)	HLX (1.7)
ENSG00000120549	KIAA1217 PPI subnetwork	0.81	> 0.20	BCAM (3.4)	MARK4 (3.2)	TRAPPC6A (2.7)	TOMM40 (2.6)	TSSK6 (2.4)	CYB561D1 (2.1)	PPP1R37 (1.8)	C11orf9 (1.8)	PLEKHH2 (1.6)	ENSG00000226645 (1.6)
ENSG00000095564	BTAF1 PPI subnetwork	0.81	> 0.20	BUD13 (2.4)	C12orf47 (1.8)	SUGP1 (1.8)	GMPR (1.6)	SMARCA4 (1.6)	PCSK9 (1.5)	HMGCR (1.5)	ATXN2 (1.4)	TMEM57 (1.4)	FADS1 (1.4)
ENSG00000196981	WDR5B PPI subnetwork	0.81	> 0.20	KIAA1324 (2.5)	FEN1 (2.3)	BUD13 (2.3)	GOT2P1 (2.3)	C19orf52 (2.2)	ANKRD31 (2.0)	KANK2 (1.9)	MAU2 (1.7)	ZNF259 (1.6)	ILF3 (1.6)
ENSG00000039068	CDH1 PPI subnetwork	0.81	> 0.20	PLCG1 (2.8)	PLEC (2.6)	DOCK7 (2.5)	TIMD4 (2.3)	USP24 (1.9)	AP1M2 (1.8)	PTPN11 (1.7)	ENSG00000226648 (1.6)	LPIN3 (1.6)	BCAM (1.5)
GO:0070371	ERK1 and ERK2 cascade	0.81	> 0.20	GEMIN7 (2.3)	PVR (2.2)	KIAA1324 (2.0)	CETP (1.8)	ENSG00000228044 (1.8)	ENSG00000254235 (1.7)	PLEKHH2 (1.7)	TSSK6 (1.5)	C11orf9 (1.5)	AP1M2 (1.3)
GO:0022406	membrane docking	0.81	> 0.20	DYNC2LI1 (2.4)	TMEM50A (2.3)	CYB561D1 (2.3)	C19orf52 (1.8)	NT5DC1 (1.5)	YIPF2 (1.5)	TIMD4 (1.4)	DNAH11 (1.4)	ATXN7L2 (1.3)	ENSG00000226645 (1.2)
ENSG00000105856	HBP1 PPI subnetwork	0.81	> 0.20	KANK2 (2.5)	PLCG1 (2.4)	POC5 (2.3)	PSRC1 (2.2)	CELSR2 (1.9)	ATXN2 (1.8)	C1orf63 (1.8)	TOP1 (1.8)	SUGP1 (1.8)	DOCK7 (1.7)
REACTOME_TRANSLATION	REACTOME_TRANSLATION	0.81	> 0.20	ERP29 (3.7)	SARS (2.8)	ATP13A1 (2.8)	NKPD1 (2.7)	TMEM57 (2.4)	ANKRD31 (2.0)	C19orf52 (1.9)	DDX56 (1.8)	YIPF2 (1.8)	TMED4 (1.7)
REACTOME_HIV:1_TRANSCRIPTION_ELONGATION	REACTOME_HIV:1_TRANSCRIPTION_ELONGATION	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	ZNF259 (2.5)	TXNL4B (2.4)	BUD13 (2.1)	DHX38 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	PTPN11 (1.8)	DDX56 (1.7)
REACTOME_FORMATION_OF_HIV:1_ELONGATION_COMPLEX_CONTAINING_HIV:1_TAT	REACTOME_FORMATION_OF_HIV:1_ELONGATION_COMPLEX_CONTAINING_HIV:1_TAT	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	ZNF259 (2.5)	TXNL4B (2.4)	BUD13 (2.1)	DHX38 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	PTPN11 (1.8)	DDX56 (1.7)
REACTOME_TAT:MEDIATED_ELONGATION_OF_THE_HIV:1_TRANSCRIPT	REACTOME_TAT:MEDIATED_ELONGATION_OF_THE_HIV:1_TRANSCRIPT	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	ZNF259 (2.5)	TXNL4B (2.4)	BUD13 (2.1)	DHX38 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	PTPN11 (1.8)	DDX56 (1.7)
MP:0000875	abnormal cerebellar Purkinje cell layer	0.81	> 0.20	APOE (3.4)	NYNRIN (3.0)	ATP13A1 (2.2)	ZHX3 (2.1)	C12orf51 (2.1)	HLX (2.0)	CLPTM1 (1.9)	MAFB (1.9)	GRINA (1.9)	TMED4 (1.8)
GO:0048365	Rac GTPase binding	0.81	> 0.20	ENSG00000235545 (3.0)	HLX (2.4)	DNM2 (2.1)	PPP1R37 (1.8)	ATP13A1 (1.8)	DOCK7 (1.8)	ADAM1 (1.7)	GRINA (1.7)	KANK2 (1.7)	PLEC (1.7)
MP:0000278	abnormal myocardial fiber morphology	0.81	> 0.20	SYPL2 (2.7)	ACAD10 (2.2)	BCAM (1.7)	HAVCR1 (1.6)	HP (1.5)	GMPR (1.5)	SORT1 (1.5)	GRINA (1.3)	DHX38 (1.2)	PLEC (1.2)
GO:0000217	DNA secondary structure binding	0.81	> 0.20	POC5 (2.9)	DYNC2LI1 (2.6)	FEN1 (2.5)	ZNF180 (2.5)	USP1 (2.1)	FADS1 (2.1)	UBXN2B (1.9)	USP24 (1.8)	MAPKAPK5 (1.6)	TMEM57 (1.6)
GO:0031575	mitotic cell cycle G1/S transition checkpoint	0.81	> 0.20	PSMA5 (3.4)	NT5DC1 (2.5)	TRAFD1 (2.4)	NAA25 (2.1)	POLK (2.0)	BRAP (1.9)	SUGP1 (1.7)	TXNL4B (1.4)	TOMM40 (1.2)	ZNF180 (1.2)
GO:0030888	regulation of B cell proliferation	0.81	> 0.20	GCNT4 (2.6)	C17orf57 (2.2)	PBX4 (2.2)	ENSG00000226645 (2.1)	DNAH11 (1.7)	TIMD4 (1.4)	C12orf47 (1.4)	DYNC2LI1 (1.2)	GMIP (1.2)	TRIB1 (1.2)
GO:0031122	cytoplasmic microtubule organization	0.81	> 0.20	C17orf57 (2.4)	ENSG00000235545 (2.2)	TMEM57 (1.9)	MAPKAPK5 (1.9)	ZHX3 (1.8)	DOCK7 (1.8)	POC5 (1.7)	ZNF259 (1.7)	ZNF180 (1.6)	AMIGO1 (1.5)
MP:0003560	osteoarthritis	0.81	> 0.20	CILP2 (10.9)	PLEKHH2 (3.5)	SLC44A2 (2.1)	ENSG00000254235 (1.8)	MAFB (1.6)	FRK (1.6)	BCAM (1.4)	YIPF2 (1.4)	ALDH2 (1.3)	TOP1 (1.1)
GO:0043547	positive regulation of GTPase activity	0.81	> 0.20	ENSG00000226645 (2.7)	CBLC (1.8)	HAVCR1 (1.7)	DNM2 (1.6)	SH2B3 (1.6)	ZHX3 (1.6)	LPIN3 (1.6)	ENSG00000254235 (1.5)	HLX (1.5)	C12orf51 (1.5)
ENSG00000095139	ARCN1 PPI subnetwork	0.81	> 0.20	YIPF2 (6.1)	SARS (2.3)	TMEM57 (1.7)	KIAA1324 (1.6)	PSMA5 (1.6)	ST3GAL4 (1.6)	ZNF259 (1.5)	QTRT1 (1.5)	C12orf47 (1.4)	BLOC1S3 (1.4)
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON:LIKE_PEPTIDE:1	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON:LIKE_PEPTIDE:1	0.81	> 0.20	ITGB3 (4.4)	KIAA1324 (2.8)	ST3GAL4 (2.3)	ABO (2.2)	SH2B3 (2.0)	TMEM50A (1.6)	YIPF2 (1.6)	COL4A3BP (1.5)	C1orf63 (1.3)	SORT1 (1.3)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_ELONGATION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_ELONGATION	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	TXNL4B (2.4)	ZNF259 (2.4)	DHX38 (2.1)	BUD13 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	QTRT1 (1.8)	PTPN11 (1.7)
REACTOME_FORMATION_OF_HIV:1_ELONGATION_COMPLEX_IN_THE_ABSENCE_OF_HIV:1_TAT	REACTOME_FORMATION_OF_HIV:1_ELONGATION_COMPLEX_IN_THE_ABSENCE_OF_HIV:1_TAT	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	TXNL4B (2.4)	ZNF259 (2.4)	DHX38 (2.1)	BUD13 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	QTRT1 (1.8)	PTPN11 (1.7)
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	0.81	> 0.20	SUGP1 (3.0)	MAPKAPK5 (2.7)	TXNL4B (2.4)	ZNF259 (2.4)	DHX38 (2.1)	BUD13 (2.1)	DNM2 (1.9)	PSMA5 (1.8)	QTRT1 (1.8)	PTPN11 (1.7)
REACTOME_CTLA4_INHIBITORY_SIGNALING	REACTOME_CTLA4_INHIBITORY_SIGNALING	0.81	> 0.20	MARK4 (3.3)	MOSC1 (2.1)	PLCG1 (2.0)	DHX38 (1.9)	OGDH (1.7)	CLPTM1 (1.7)	DOCK7 (1.7)	TIMD4 (1.6)	NCAN (1.4)	SLC44A2 (1.3)
GO:0001619	lysosphingolipid and lysophosphatidic acid receptor activity	0.81	> 0.20	SLC44A2 (3.7)	PBX4 (3.4)	TMEM116 (2.7)	CYB561D1 (2.6)	C19orf52 (2.3)	AP1M2 (1.7)	ZNF101 (1.7)	KIAA1324 (1.7)	GMIP (1.7)	LDLR (1.5)
ENSG00000115977	AAK1 PPI subnetwork	0.81	> 0.20	C12orf51 (3.4)	USP24 (2.4)	MARK4 (2.2)	PTPN11 (2.0)	GMIP (1.9)	POLK (1.8)	SORT1 (1.6)	GMPR (1.6)	PSRC1 (1.6)	ATXN2 (1.5)
ENSG00000184117	NIPSNAP1 PPI subnetwork	0.81	> 0.20	NCAN (2.6)	GOT2P1 (2.3)	MARK4 (2.0)	DNAH11 (1.9)	C12orf43 (1.8)	RPH3A (1.8)	TMEM50A (1.7)	ZNF180 (1.5)	NYNRIN (1.5)	HAPLN4 (1.4)
ENSG00000067829	IDH3G PPI subnetwork	0.81	> 0.20	PSMA5 (3.8)	ATP13A1 (2.6)	NAA25 (2.4)	DDX56 (2.4)	ENSG00000226648 (1.9)	TOMM40 (1.8)	SARS (1.8)	QTRT1 (1.7)	OGDH (1.6)	BRAP (1.5)
ENSG00000143537	ADAM15 PPI subnetwork	0.81	> 0.20	ENSG00000238078 (2.7)	ENSG00000254235 (2.4)	SH2B3 (2.3)	ST3GAL4 (2.2)	LPIN3 (2.1)	SLC44A2 (2.1)	PBX4 (1.7)	GPAM (1.7)	CBLC (1.6)	CETP (1.6)
GO:0043241	protein complex disassembly	0.81	> 0.20	TSSK6 (2.4)	UBXN2B (2.3)	HAVCR1 (1.9)	ADAM1 (1.8)	SLC44A2 (1.7)	ABO (1.6)	LPAR2 (1.6)	PMFBP1 (1.4)	CEACAM19 (1.4)	ATXN7L2 (1.3)
ENSG00000159210	SNF8 PPI subnetwork	0.81	> 0.20	CYB561D1 (3.0)	POLK (2.8)	DYNC2LI1 (2.5)	TRIB1 (2.5)	TMEM50A (2.4)	POC5 (2.4)	PSMA5 (2.2)	BLOC1S3 (1.9)	TMED4 (1.7)	HNF1A (1.7)
GO:0001706	endoderm formation	0.81	> 0.20	ENSG00000226648 (3.1)	TRIB1 (2.9)	LPAR2 (2.6)	TSSK6 (2.1)	DNAH11 (1.7)	C17orf57 (1.6)	GCNT4 (1.4)	C19orf52 (1.4)	ENSG00000254235 (1.0)	ANKRD31 (1.0)
GO:0006415	translational termination	0.81	> 0.20	NKPD1 (3.4)	UBXN2B (2.5)	ANKRD31 (2.1)	AMIGO1 (1.5)	CEACAM19 (1.5)	ENSG00000226645 (1.4)	DNAH11 (1.4)	ADAM1 (1.3)	ZNF101 (1.3)	ENSG00000226648 (1.3)
ENSG00000108264	TADA2A PPI subnetwork	0.81	> 0.20	C19orf52 (3.0)	BUD13 (2.8)	C12orf51 (2.3)	ATXN2 (2.0)	ATXN7L2 (2.0)	ILF3 (2.0)	CARM1 (2.0)	ZNF180 (1.8)	DHX38 (1.7)	GATAD2A (1.6)
GO:0016567	protein ubiquitination	0.81	> 0.20	BRAP (4.0)	TRAFD1 (3.4)	ENSG00000226645 (2.5)	C19orf52 (2.3)	ZNF180 (2.0)	TMEM57 (2.0)	MAU2 (1.9)	POC5 (1.9)	BUD13 (1.7)	SUGP1 (1.7)
MP:0001984	abnormal olfaction	0.81	> 0.20	MYLIP (2.2)	TMEM116 (2.0)	TMEM50A (2.0)	MAPKAPK5 (2.0)	C12orf43 (1.9)	TSSK6 (1.8)	APOE (1.7)	GCNT4 (1.5)	C12orf51 (1.4)	DYNC2LI1 (1.4)
GO:0006040	amino sugar metabolic process	0.81	> 0.20	BLOC1S3 (2.9)	YIPF2 (2.3)	C12orf47 (1.9)	ENSG00000228044 (1.7)	DYNC2LI1 (1.6)	ZNF259 (1.5)	CYB561D1 (1.4)	COL4A3BP (1.3)	ST3GAL4 (1.3)	ERP29 (1.2)
GO:0043410	positive regulation of MAPK cascade	0.81	> 0.20	ST3GAL4 (2.1)	HLX (2.0)	C11orf9 (2.0)	ENSG00000226645 (1.8)	PPP1R37 (1.8)	CETP (1.6)	PLEKHH2 (1.6)	PVR (1.4)	ENSG00000235545 (1.4)	POLK (1.3)
KEGG_TIGHT_JUNCTION	KEGG_TIGHT_JUNCTION	0.81	> 0.20	AP1M2 (4.9)	PVRL2 (4.0)	CBLC (3.9)	BCAM (3.2)	SYPL2 (2.7)	DNM2 (2.1)	SLC44A2 (2.0)	C11orf9 (1.9)	PVR (1.7)	SORT1 (1.7)
ENSG00000124092	CTCFL PPI subnetwork	0.81	> 0.20	ABO (2.5)	MAU2 (2.3)	DHODH (2.1)	SUGP1 (1.9)	TRAPPC6A (1.9)	TMEM116 (1.8)	BRAP (1.8)	PARP10 (1.7)	C17orf57 (1.6)	LPAR2 (1.4)
GO:2000696	regulation of epithelial cell differentiation involved in kidney development	0.81	> 0.20	HAVCR1 (3.9)	DNAH11 (2.8)	BCAM (2.0)	C17orf57 (1.8)	DYNC2LI1 (1.7)	TMEM116 (1.6)	ENSG00000238078 (1.6)	LPAR2 (1.6)	PMFBP1 (1.4)	CILP2 (1.4)
ENSG00000198018	ENTPD7 PPI subnetwork	0.81	> 0.20	CLPTM1 (3.9)	YIPF2 (2.7)	MAU2 (2.6)	PBX4 (2.4)	TMEM50A (2.3)	MARK4 (2.1)	ZNF101 (1.9)	GRINA (1.9)	DNM2 (1.8)	TRAPPC6A (1.8)
ENSG00000143093	FAM40A PPI subnetwork	0.81	> 0.20	MARK4 (3.8)	PVRL2 (3.1)	C11orf9 (3.1)	ZNF180 (2.5)	PVR (2.4)	ENSG00000235545 (1.7)	UBXN2B (1.7)	PPP1R37 (1.7)	DNM2 (1.6)	CARM1 (1.4)
REACTOME_G2M_TRANSITION	REACTOME_G2M_TRANSITION	0.81	> 0.20	PSRC1 (4.0)	POC5 (3.7)	FEN1 (2.6)	PBX4 (2.4)	SMARCA4 (2.3)	DYNC2LI1 (2.0)	POLK (1.8)	C12orf51 (1.8)	USP1 (1.7)	BUD13 (1.6)
ENSG00000197459	HIST1H2BH PPI subnetwork	0.81	> 0.20	DDX56 (2.1)	SMARCA4 (2.1)	TMEM57 (1.8)	DOCK7 (1.7)	ILF3 (1.7)	BUD13 (1.6)	GATAD2A (1.5)	USP1 (1.4)	SUGP1 (1.2)	TOP1 (1.1)
GO:0030547	receptor inhibitor activity	0.81	> 0.20	NKPD1 (2.7)	OASL (2.6)	ENSG00000235545 (2.0)	CEACAM19 (2.0)	CYB561D1 (1.8)	DOCK7 (1.7)	MYLIP (1.5)	TMEM116 (1.5)	PVRL2 (1.3)	TMED4 (1.2)
GO:0048019	receptor antagonist activity	0.81	> 0.20	NKPD1 (2.7)	OASL (2.6)	ENSG00000235545 (2.0)	CEACAM19 (2.0)	CYB561D1 (1.8)	DOCK7 (1.7)	MYLIP (1.5)	TMEM116 (1.5)	PVRL2 (1.3)	TMED4 (1.2)
GO:0061061	muscle structure development	0.81	> 0.20	SYPL2 (5.5)	KANK2 (2.6)	GMPR (2.4)	ATXN7L2 (2.4)	BCAM (1.6)	PLEC (1.4)	CEACAM19 (1.3)	ANKRD31 (1.2)	CARM1 (1.2)	TMED4 (1.1)
REACTOME_AQUAPORIN:MEDIATED_TRANSPORT	REACTOME_AQUAPORIN:MEDIATED_TRANSPORT	0.81	> 0.20	ITGB3 (4.1)	ST3GAL4 (2.8)	ENSG00000235545 (1.9)	ENSG00000228044 (1.5)	PMFBP1 (1.4)	NYNRIN (1.3)	TM6SF2 (1.2)	SH2B3 (1.1)	GOT2P1 (1.0)	ADAM1 (1.0)
GO:0050670	regulation of lymphocyte proliferation	0.81	> 0.20	TIMD4 (2.6)	PBX4 (2.5)	ENSG00000226645 (2.1)	ZNF101 (1.8)	HLX (1.8)	TRAFD1 (1.7)	CETP (1.7)	GCNT4 (1.3)	ENSG00000254235 (1.2)	GMIP (1.2)
GO:0006044	N-acetylglucosamine metabolic process	0.81	> 0.20	BLOC1S3 (2.9)	YIPF2 (2.4)	ENSG00000228044 (2.2)	DYNC2LI1 (2.1)	CYB561D1 (1.7)	TMEM116 (1.5)	COL4A3BP (1.5)	ZNF259 (1.4)	ERP29 (1.4)	ST3GAL4 (1.2)
GO:0006041	glucosamine metabolic process	0.81	> 0.20	BLOC1S3 (2.9)	YIPF2 (2.4)	ENSG00000228044 (2.2)	DYNC2LI1 (2.1)	CYB561D1 (1.7)	TMEM116 (1.5)	COL4A3BP (1.5)	ZNF259 (1.4)	ERP29 (1.4)	ST3GAL4 (1.2)
GO:0046330	positive regulation of JNK cascade	0.81	> 0.20	ST3GAL4 (3.5)	ENSG00000235545 (3.4)	UBXN2B (2.2)	BLOC1S3 (2.0)	CYB561D1 (1.7)	LPAR2 (1.6)	DYNC2LI1 (1.5)	CETP (1.5)	FRK (1.4)	C11orf9 (1.4)
MP:0005112	abnormal spinal cord ventral horn morphology	0.81	> 0.20	NCAN (3.3)	CYP7A1 (2.9)	ENSG00000228044 (2.5)	RPH3A (2.2)	C1orf63 (2.1)	HAPLN4 (2.1)	CELSR2 (2.0)	NKPD1 (1.8)	APOC4 (1.8)	SYPL2 (1.6)
ENSG00000160307	S100B PPI subnetwork	0.81	> 0.20	PLEC (3.8)	BCL3 (2.1)	GMIP (1.9)	BCAM (1.8)	OGDH (1.8)	ENSG00000235545 (1.7)	ATXN7L2 (1.6)	CYB561D1 (1.6)	NT5DC1 (1.6)	RPH3A (1.5)
ENSG00000112214	FHL5 PPI subnetwork	0.81	> 0.20	TSSK6 (3.1)	BCL3 (2.2)	TRIB1 (2.0)	GCNT4 (1.8)	CEACAM19 (1.7)	PBX4 (1.6)	LPIN3 (1.6)	ENSG00000226648 (1.4)	C12orf47 (1.3)	CETP (1.3)
GO:0031012	extracellular matrix	0.81	> 0.20	CILP2 (5.9)	BCAM (2.9)	PLEKHH2 (2.6)	APOE (2.1)	KANK2 (1.7)	AP1M2 (1.7)	HP (1.4)	MOSC1 (1.3)	MAFB (1.2)	ENSG00000238078 (1.1)
ENSG00000020922	MRE11A PPI subnetwork	0.81	> 0.20	FEN1 (3.5)	USP1 (3.3)	TOP1 (2.5)	SMARCA4 (2.4)	ZNF180 (2.1)	C1orf63 (2.0)	BUD13 (1.8)	RHCE (1.6)	PSRC1 (1.6)	ENSG00000226645 (1.6)
ENSG00000105894	PTN PPI subnetwork	0.81	> 0.20	UBXN2B (2.4)	NCAN (2.4)	ERP29 (2.1)	ENSG00000226645 (2.0)	C19orf52 (1.7)	DYNC2LI1 (1.7)	ALDH2 (1.7)	C12orf43 (1.6)	ENSG00000254235 (1.6)	SMARCA4 (1.4)
GO:0030659	cytoplasmic vesicle membrane	0.81	> 0.20	YIPF2 (2.7)	SORT1 (2.7)	KIAA1324 (2.5)	RPH3A (2.4)	CLPTM1 (2.3)	HAPLN4 (2.2)	C12orf51 (2.0)	PPP1R37 (1.8)	SH2B3 (1.6)	GRINA (1.6)
GO:0021533	cell differentiation in hindbrain	0.81	> 0.20	ADAM1 (3.1)	BRAP (2.9)	DNAH11 (2.5)	HAPLN4 (2.3)	TMEM116 (2.1)	ENSG00000226648 (2.1)	ERP29 (1.9)	C12orf51 (1.8)	TMEM57 (1.8)	CILP2 (1.7)
GO:0070663	regulation of leukocyte proliferation	0.81	> 0.20	TIMD4 (2.7)	PBX4 (2.4)	ENSG00000226645 (1.9)	TRAFD1 (1.7)	CETP (1.7)	HLX (1.6)	ZNF101 (1.5)	ENSG00000254235 (1.3)	POLK (1.2)	ENSG00000235545 (1.1)
ENSG00000058668	ATP2B4 PPI subnetwork	0.81	> 0.20	PPP1R37 (2.9)	C11orf9 (2.4)	RPH3A (2.2)	ADAM1 (2.0)	KIAA1324 (1.9)	CYB561D1 (1.8)	GATAD2A (1.7)	SORT1 (1.6)	ST3GAL4 (1.6)	MARK4 (1.5)
GO:0001655	urogenital system development	0.81	> 0.20	PLEKHH2 (2.4)	NYNRIN (2.3)	BCAM (2.0)	DYNC2LI1 (2.0)	AP1M2 (1.9)	ENSG00000228044 (1.6)	TMED4 (1.6)	MYLIP (1.5)	ATXN7L2 (1.4)	CELSR2 (1.4)
MP:0004965	inner cell mass degeneration	0.81	> 0.20	DHX38 (2.8)	USP1 (2.6)	UBXN2B (2.5)	ILF3 (2.4)	FEN1 (2.1)	DHODH (2.1)	TOP1 (2.1)	ENSG00000226648 (2.0)	TMEM50A (1.8)	SUGP1 (1.7)
GO:0043299	leukocyte degranulation	0.81	> 0.20	CYB561D1 (3.0)	C17orf57 (2.3)	UBXN2B (2.1)	ALDH2 (2.0)	GMIP (2.0)	BLOC1S3 (2.0)	ST3GAL4 (1.4)	GEMIN7 (1.3)	GMPR (1.2)	C19orf52 (1.1)
ENSG00000118762	PKD2 PPI subnetwork	0.81	> 0.20	C11orf9 (1.9)	PPP1R37 (1.9)	SYPL2 (1.8)	ITGB3 (1.6)	UBXN2B (1.6)	CILP2 (1.6)	ANKRD31 (1.4)	CARM1 (1.4)	TSSK6 (1.3)	TMEM116 (1.3)
GO:0090079	translation regulator activity, nucleic acid binding	0.81	> 0.20	BRAP (2.6)	ILF3 (1.9)	NAA25 (1.7)	COL4A3BP (1.6)	SMARCA4 (1.6)	PVR (1.4)	QTRT1 (1.3)	NT5DC1 (1.2)	C19orf52 (1.1)	SLC22A1 (1.1)
ENSG00000152382	TADA1 PPI subnetwork	0.81	> 0.20	ATXN7L2 (3.5)	PLCG1 (2.3)	GEMIN7 (2.2)	ACAD10 (2.2)	C17orf57 (2.1)	ILF3 (2.1)	ENSG00000226648 (2.0)	ATXN2 (1.9)	QTRT1 (1.9)	DYNC2LI1 (1.6)
ENSG00000146047	HIST1H2BA PPI subnetwork	0.81	> 0.20	BUD13 (2.1)	POLK (2.0)	USP1 (1.9)	PSMA5 (1.7)	PPP1R37 (1.7)	AMIGO1 (1.6)	HLX (1.6)	TSSK6 (1.5)	PSRC1 (1.4)	PBX4 (1.4)
GO:0007263	nitric oxide mediated signal transduction	0.81	> 0.20	ANKRD31 (2.2)	HAVCR1 (2.2)	ADAM1 (2.2)	SORT1 (1.5)	CETP (1.5)	ENSG00000254235 (1.5)	APOC1 (1.4)	ATXN7L2 (1.4)	AMIGO1 (1.2)	HP (1.0)
ENSG00000118515	SGK1 PPI subnetwork	0.81	> 0.20	TMEM57 (3.3)	CARM1 (3.0)	C12orf43 (2.7)	NAA25 (2.4)	TOMM40 (2.0)	KIAA1324 (2.0)	OGDH (1.9)	SMARCA4 (1.8)	ADAM1 (1.5)	DNM2 (1.5)
ENSG00000057608	GDI2 PPI subnetwork	0.81	> 0.20	GATAD2A (2.9)	COL4A3BP (2.3)	TMEM50A (2.2)	GEMIN7 (1.9)	DNM2 (1.8)	MARK4 (1.6)	C12orf47 (1.3)	POLK (1.2)	MYLIP (1.2)	ENSG00000238078 (1.2)
ENSG00000167414	GNG8 PPI subnetwork	0.81	> 0.20	ITGB3 (2.6)	TM6SF2 (1.7)	TMEM50A (1.6)	KIAA1324 (1.4)	CYP7A1 (1.2)	SLC22A1 (1.2)	ATXN7L2 (1.2)	MYLIP (1.1)	ENSG00000235545 (1.1)	CETP (1.1)
ENSG00000065000	AP3D1 PPI subnetwork	0.81	> 0.20	PVRL2 (2.2)	GOT2P1 (2.2)	DHX38 (2.1)	CLPTM1 (1.9)	DNM2 (1.8)	GRINA (1.8)	TXNL4B (1.6)	DOCK7 (1.5)	MAU2 (1.4)	TRAPPC6A (1.4)
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	0.81	> 0.20	POC5 (3.4)	PSRC1 (3.1)	SMARCA4 (2.6)	PBX4 (2.3)	C12orf51 (2.1)	FEN1 (2.0)	BUD13 (1.9)	DYNC2LI1 (1.8)	POLK (1.8)	DOCK7 (1.4)
REACTOME_CENTROSOME_MATURATION	REACTOME_CENTROSOME_MATURATION	0.81	> 0.20	POC5 (3.4)	PSRC1 (3.1)	SMARCA4 (2.6)	PBX4 (2.3)	C12orf51 (2.1)	FEN1 (2.0)	BUD13 (1.9)	DYNC2LI1 (1.8)	POLK (1.8)	DOCK7 (1.4)
ENSG00000111880	RNGTT PPI subnetwork	0.81	> 0.20	TXNL4B (3.2)	DHX38 (3.1)	PSMA5 (3.0)	TOMM40 (2.3)	ILF3 (2.3)	C19orf52 (2.2)	GEMIN7 (1.9)	TRAPPC6A (1.9)	SMARCA4 (1.9)	SUGP1 (1.8)
ENSG00000179051	RCC2 PPI subnetwork	0.81	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (3.6)	POC5 (2.9)	ENSG00000228044 (1.7)	ZHX3 (1.5)	CBLC (1.0)	ZNF180 (0.9)	ENSG00000226648 (0.9)	ZNF101 (0.8)
GO:0030003	cellular cation homeostasis	0.81	> 0.20	ERP29 (2.3)	SYPL2 (1.7)	RHD (1.7)	AMIGO1 (1.6)	ABO (1.6)	GRINA (1.5)	RHCE (1.5)	RPH3A (1.5)	COL4A3BP (1.5)	C12orf47 (1.5)
MP:0001898	abnormal long term depression	0.81	> 0.20	NCAN (3.1)	RPH3A (3.0)	ENSG00000254235 (2.4)	HAPLN4 (2.2)	ZNF101 (2.0)	C11orf9 (1.9)	ENSG00000226645 (1.8)	AMIGO1 (1.4)	PTPN11 (1.4)	ITGB3 (1.3)
MP:0001636	irregular heartbeat	0.81	> 0.20	BCAM (2.9)	C11orf9 (2.2)	HAVCR1 (1.5)	PMFBP1 (1.4)	ANKRD31 (1.3)	APOB (1.3)	TMEM116 (1.3)	ENSG00000238078 (1.3)	DHODH (1.2)	GOT2P1 (1.2)
ENSG00000198899	MT-ATP6 PPI subnetwork	0.81	> 0.20	OGDH (4.4)	ACAD10 (3.5)	C12orf47 (2.8)	PSMA5 (2.7)	TOMM40 (2.2)	GOT2P1 (1.9)	HNF1A (1.7)	ERP29 (1.7)	CLPTM1 (1.6)	TMEM116 (1.5)
GO:0045444	fat cell differentiation	0.81	> 0.20	ENSG00000238078 (2.6)	ST3GAL4 (1.9)	GPAM (1.6)	MAFB (1.4)	UBXN2B (1.4)	DYNC2LI1 (1.3)	FADS1 (1.3)	MOSC1 (1.1)	ATXN2 (1.1)	BLOC1S3 (1.0)
ENSG00000160293	VAV2 PPI subnetwork	0.81	> 0.20	GMIP (2.1)	SH2B3 (2.0)	DNM2 (1.9)	SLC44A2 (1.8)	ERP29 (1.7)	PLEC (1.7)	ZHX3 (1.5)	PVRL2 (1.5)	GATAD2A (1.5)	TRAFD1 (1.4)
ENSG00000168556	ING2 PPI subnetwork	0.81	> 0.20	UBXN2B (2.4)	C1orf63 (2.2)	POC5 (2.1)	TOP1 (2.0)	MAPKAPK5 (1.8)	TMED4 (1.8)	ZNF259 (1.5)	ATXN7L2 (1.4)	BLOC1S3 (1.3)	PSMA5 (1.3)
GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	0.81	> 0.20	PSMA5 (4.0)	TRAFD1 (2.4)	SUGP1 (2.2)	POC5 (2.1)	NAA25 (2.1)	LPIN3 (1.8)	DDX56 (1.6)	BRAP (1.4)	NT5DC1 (1.4)	C12orf47 (1.2)
GO:0055024	regulation of cardiac muscle tissue development	0.81	> 0.20	C11orf9 (2.8)	CEACAM19 (2.2)	ALDH2 (1.7)	C19orf52 (1.6)	PLEKHH2 (1.6)	C17orf57 (1.4)	LPAR2 (1.2)	GEMIN7 (1.1)	PBX4 (1.1)	TRAPPC6A (1.1)
ENSG00000096401	CDC5L PPI subnetwork	0.81	> 0.20	USP1 (3.4)	FEN1 (3.4)	TMEM57 (2.6)	TMEM50A (2.5)	AMIGO1 (2.3)	PSRC1 (2.0)	ILF3 (1.5)	TOP1 (1.4)	C19orf52 (1.4)	DOCK7 (1.4)
MP:0002608	increased hematocrit	0.81	> 0.20	AP1M2 (3.1)	RHCE (3.0)	PLG (2.1)	RHD (1.9)	FRK (1.8)	SLC44A2 (1.7)	ANGPTL3 (1.5)	ERP29 (1.5)	ENSG00000226648 (1.4)	TMEM116 (1.4)
ENSG00000103043	VAC14 PPI subnetwork	0.81	> 0.20	DHX38 (3.2)	ZNF180 (2.5)	SARS (2.4)	DDX56 (2.1)	C12orf47 (1.9)	TOMM40 (1.8)	HAVCR1 (1.7)	FEN1 (1.6)	SMARCA4 (1.5)	CARM1 (1.5)
ENSG00000196226	HIST1H2BB PPI subnetwork	0.81	> 0.20	SMARCA4 (2.8)	BUD13 (2.3)	USP1 (2.2)	ILF3 (1.9)	DDX56 (1.5)	TMEM57 (1.5)	GMPR (1.5)	SUGP1 (1.5)	DOCK7 (1.4)	ATXN2 (1.3)
ENSG00000197822	OCLN PPI subnetwork	0.81	> 0.20	CBLC (2.8)	PTPN11 (2.3)	BRAP (2.0)	SORT1 (1.9)	NPC1L1 (1.9)	TMEM57 (1.8)	SH2B3 (1.8)	PVR (1.7)	PLCG1 (1.7)	NCAN (1.6)
MP:0001404	no spontaneous movement	0.81	> 0.20	NCAN (3.4)	FADS1 (3.2)	HMGCR (3.0)	SYPL2 (2.8)	FADS2 (2.5)	LDLR (2.1)	RPH3A (2.0)	C12orf47 (1.9)	LPIN3 (1.7)	CELSR2 (1.7)
ENSG00000130066	SAT1 PPI subnetwork	0.81	> 0.20	SLC44A2 (2.6)	ATXN7L2 (2.5)	SARS (1.7)	FADS2 (1.6)	MYLIP (1.3)	FRK (1.3)	TMEM116 (1.3)	DYNC2LI1 (1.2)	TIMD4 (1.1)	NT5DC1 (1.1)
ENSG00000164611	PTTG1 PPI subnetwork	0.81	> 0.20	PSRC1 (3.1)	POC5 (2.4)	FEN1 (2.2)	LPIN3 (2.1)	ADAM1 (2.0)	DOCK7 (1.9)	BRAP (1.9)	ATP13A1 (1.7)	RHCE (1.6)	SUGP1 (1.5)
ENSG00000085978	ATG16L1 PPI subnetwork	0.81	> 0.20	C1orf63 (2.9)	KIAA1324 (2.5)	TSSK6 (2.0)	ZNF180 (1.9)	DNM2 (1.9)	POC5 (1.8)	TXNL4B (1.6)	C19orf52 (1.6)	TMED4 (1.5)	CEACAM19 (1.5)
GO:0060193	positive regulation of lipase activity	0.81	> 0.20	AMIGO1 (2.6)	PMFBP1 (2.1)	PLEKHH2 (2.1)	ZHX3 (2.0)	ST3GAL4 (1.9)	ITGB3 (1.6)	GOT2P1 (1.4)	C12orf47 (1.2)	RPH3A (1.2)	SLC44A2 (1.2)
GO:0070570	regulation of neuron projection regeneration	0.81	> 0.20	GCNT4 (3.5)	ABO (3.3)	NKPD1 (3.1)	CEACAM19 (2.7)	ENSG00000228044 (2.2)	HAPLN4 (2.1)	ANKRD31 (2.0)	TMEM50A (1.6)	NYNRIN (1.5)	RPH3A (1.2)
GO:0048679	regulation of axon regeneration	0.81	> 0.20	GCNT4 (3.5)	ABO (3.3)	NKPD1 (3.1)	CEACAM19 (2.7)	ENSG00000228044 (2.2)	HAPLN4 (2.1)	ANKRD31 (2.0)	TMEM50A (1.6)	NYNRIN (1.5)	RPH3A (1.2)
GO:0000578	embryonic axis specification	0.81	> 0.20	PVRL2 (1.9)	ABO (1.8)	DNAH11 (1.6)	C11orf9 (1.5)	ADAM1 (1.4)	DYNC2LI1 (1.4)	DOCK7 (1.2)	LPAR2 (1.2)	KANK2 (1.1)	MOSC1 (1.0)
MP:0004988	increased osteoblast cell number	0.81	> 0.20	ENSG00000226648 (2.4)	ALDH2 (2.4)	LPIN3 (2.0)	GRINA (2.0)	CBLC (2.0)	ZHX3 (1.8)	KANK2 (1.7)	LPAR2 (1.6)	TRIB1 (1.5)	PLEKHH2 (1.5)
ENSG00000173366	ENSG00000173366 PPI subnetwork	0.81	> 0.20	DNM2 (2.0)	POC5 (1.9)	ZNF101 (1.8)	POLK (1.7)	CYB561D1 (1.7)	C1orf63 (1.7)	ERP29 (1.6)	OGDH (1.6)	TMEM50A (1.5)	LPIN3 (1.4)
ENSG00000134640	MTNR1B PPI subnetwork	0.81	> 0.20	ERP29 (4.8)	SARS (2.0)	TSSK6 (1.7)	TMEM50A (1.7)	DOCK7 (1.6)	TMED4 (1.5)	PSMA5 (1.4)	ENSG00000235545 (1.4)	BLOC1S3 (1.3)	ATP13A1 (1.2)
ENSG00000064393	HIPK2 PPI subnetwork	0.81	> 0.20	PLCG1 (2.5)	TRAFD1 (2.4)	MYLIP (2.4)	BCAM (1.9)	PBX4 (1.9)	DOCK7 (1.7)	ENSG00000228044 (1.6)	TRIB1 (1.6)	LPIN3 (1.5)	TMEM50A (1.4)
MP:0002856	abnormal vestibular ganglion morphology	0.81	> 0.20	TRAPPC6A (2.4)	GMIP (2.2)	C17orf57 (2.2)	PMFBP1 (2.2)	NT5DC1 (2.0)	LPAR2 (1.9)	TMEM50A (1.8)	ATP13A1 (1.8)	SORT1 (1.7)	CELSR2 (1.6)
GO:0042481	regulation of odontogenesis	0.81	> 0.20	ABO (2.2)	CYB561D1 (1.9)	TRAPPC6A (1.5)	MYLIP (1.4)	SLC44A2 (1.4)	TMEM57 (1.4)	POLK (1.2)	PBX4 (1.1)	ENSG00000226648 (1.1)	BUD13 (1.1)
GO:0006098	pentose-phosphate shunt	0.81	> 0.20	BLOC1S3 (3.6)	TRAPPC6A (3.6)	FRK (2.7)	NT5DC1 (2.3)	ACAD10 (2.1)	C1orf63 (1.9)	CEACAM19 (1.7)	ERP29 (1.7)	ALDH2 (1.6)	QTRT1 (1.5)
GO:0034695	response to prostaglandin E stimulus	0.81	> 0.20	CETP (2.7)	ZNF101 (2.6)	NT5DC1 (1.8)	GOT2P1 (1.8)	ZNF180 (1.8)	BLOC1S3 (1.7)	AMIGO1 (1.6)	TIMD4 (1.5)	CEACAM19 (1.1)	LPA (1.0)
MP:0009743	preaxial polydactyly	0.81	> 0.20	DYNC2LI1 (7.2)	ACAD10 (3.0)	PBX4 (2.3)	KIAA1324 (2.1)	DOCK7 (1.6)	ATXN7L2 (1.5)	QTRT1 (1.5)	PLCG1 (1.3)	LPIN3 (1.2)	NYNRIN (1.2)
GO:0019201	nucleotide kinase activity	0.81	> 0.20	C11orf9 (2.8)	OASL (2.6)	GCNT4 (2.6)	ZNF101 (1.5)	DNAH11 (1.5)	NT5DC1 (1.3)	PARP10 (1.2)	RPH3A (1.2)	ENSG00000235545 (1.1)	FRK (1.1)
REACTOME_RHO_GTPASE_CYCLE	REACTOME_RHO_GTPASE_CYCLE	0.81	> 0.20	GMIP (4.0)	DNM2 (3.3)	HLX (3.2)	PLEKHH2 (2.7)	SH2B3 (2.6)	GATAD2A (2.1)	LPAR2 (2.0)	OGDH (1.8)	DNAH11 (1.8)	AP1M2 (1.7)
REACTOME_SIGNALING_BY_RHO_GTPASES	REACTOME_SIGNALING_BY_RHO_GTPASES	0.81	> 0.20	GMIP (4.0)	DNM2 (3.3)	HLX (3.2)	PLEKHH2 (2.7)	SH2B3 (2.6)	GATAD2A (2.1)	LPAR2 (2.0)	OGDH (1.8)	DNAH11 (1.8)	AP1M2 (1.7)
ENSG00000168398	BDKRB2 PPI subnetwork	0.81	> 0.20	ZHX3 (3.8)	SH2B3 (3.0)	PLG (2.2)	ENSG00000235545 (1.9)	ITGB3 (1.6)	CETP (1.5)	PLEC (1.5)	TMEM57 (1.5)	USP24 (1.4)	AMIGO1 (1.3)
GO:0043174	nucleoside salvage	0.81	> 0.20	ENSG00000228044 (3.1)	TXNL4B (3.1)	ANKRD31 (2.5)	DHODH (2.1)	C17orf57 (2.0)	CEACAM19 (1.5)	TMEM116 (1.5)	NKPD1 (1.5)	TRAPPC6A (1.4)	PBX4 (1.4)
ENSG00000161835	GRASP PPI subnetwork	0.81	> 0.20	NCAN (4.6)	MARK4 (2.9)	RPH3A (2.7)	ZHX3 (2.6)	BLOC1S3 (2.0)	FRK (1.9)	ENSG00000226648 (1.8)	SMARCA4 (1.6)	ENSG00000226645 (1.5)	ST3GAL4 (1.5)
ENSG00000100412	ACO2 PPI subnetwork	0.82	> 0.20	NAA25 (4.9)	ZNF259 (4.2)	DDX56 (3.8)	TOMM40 (3.5)	DHODH (3.2)	C12orf43 (2.7)	QTRT1 (1.4)	ENSG00000226645 (1.4)	DNAH11 (1.3)	USP24 (1.3)
GO:0032313	regulation of Rab GTPase activity	0.82	> 0.20	CYB561D1 (3.1)	ENSG00000226645 (2.8)	BLOC1S3 (2.4)	ENSG00000254235 (2.0)	LPIN3 (1.9)	TMEM116 (1.8)	POLK (1.7)	ABO (1.7)	DYNC2LI1 (1.5)	PPP1R37 (1.5)
GO:0032483	regulation of Rab protein signal transduction	0.82	> 0.20	CYB561D1 (3.1)	ENSG00000226645 (2.8)	BLOC1S3 (2.4)	ENSG00000254235 (2.0)	LPIN3 (1.9)	TMEM116 (1.8)	POLK (1.7)	ABO (1.7)	DYNC2LI1 (1.5)	PPP1R37 (1.5)
GO:0018195	peptidyl-arginine modification	0.82	> 0.20	QTRT1 (3.2)	CYB561D1 (2.5)	ATXN7L2 (2.4)	LPAR2 (2.0)	DHODH (2.0)	ZNF180 (1.9)	LPIN3 (1.7)	PMFBP1 (1.6)	TOMM40 (1.5)	AMIGO1 (1.4)
MP:0002563	shortened circadian period	0.82	> 0.20	ABCG8 (2.2)	SH2B3 (2.2)	TMEM57 (1.9)	ENSG00000228044 (1.7)	TRIB1 (1.7)	KANK2 (1.5)	HMGCR (1.3)	PBX4 (1.2)	ATXN2 (1.2)	ENSG00000238078 (1.2)
MP:0003675	kidney cysts	0.82	> 0.20	NYNRIN (4.0)	BCAM (3.2)	DYNC2LI1 (3.1)	PLEKHH2 (3.0)	KANK2 (3.0)	MYLIP (2.6)	PLCG1 (2.5)	ZHX3 (2.2)	TMEM116 (1.6)	FRK (1.6)
GO:0015837	amine transport	0.82	> 0.20	HAPLN4 (2.6)	ABCG8 (2.3)	PMFBP1 (2.2)	TM6SF2 (2.0)	GMPR (2.0)	GCNT4 (1.9)	LPAR2 (1.7)	ATP13A1 (1.7)	ERP29 (1.6)	NPC1L1 (1.5)
MP:0003043	hypoalgesia	0.82	> 0.20	AMIGO1 (2.9)	PMFBP1 (2.5)	HLX (2.0)	ITGB3 (1.8)	ENSG00000226648 (1.5)	ENSG00000254235 (1.5)	BCAM (1.5)	CEACAM19 (1.4)	ENSG00000235545 (1.3)	NCAN (1.3)
GO:0001658	branching involved in ureteric bud morphogenesis	0.82	> 0.20	ENSG00000228044 (3.0)	HNF1A (2.9)	TSSK6 (2.6)	BCAM (2.2)	PVRL2 (1.9)	PLEKHH2 (1.9)	TMED4 (1.7)	NYNRIN (1.7)	HAVCR1 (1.6)	ENSG00000238078 (1.6)
GO:0034605	cellular response to heat	0.82	> 0.20	ENSG00000228044 (1.9)	HAVCR1 (1.8)	ANKRD31 (1.5)	ABO (1.4)	ENSG00000235545 (1.4)	YIPF2 (1.3)	PMFBP1 (1.3)	ZNF180 (1.2)	UBXN2B (1.2)	HNF1A (1.1)
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	0.82	> 0.20	HAPLN4 (3.0)	RPH3A (2.8)	C12orf51 (2.2)	AMIGO1 (1.8)	FRK (1.7)	SLC22A1 (1.4)	BCAM (1.4)	SARS (1.3)	HAVCR1 (1.2)	MARK4 (1.2)
ENSG00000182511	FES PPI subnetwork	0.82	> 0.20	USP24 (2.3)	FADS2 (2.3)	DNAH11 (2.1)	PARP10 (2.1)	DOCK7 (2.0)	DNM2 (1.9)	GMIP (1.8)	NCAN (1.8)	CETP (1.6)	PTPN11 (1.6)
GO:0009968	negative regulation of signal transduction	0.82	> 0.20	CILP2 (3.0)	MYLIP (2.9)	TRIB1 (2.4)	ATXN2 (2.0)	MARK4 (1.9)	PPP1R37 (1.9)	MAU2 (1.7)	SH2B3 (1.6)	PLCG1 (1.5)	PVR (1.5)
ENSG00000171314	PGAM1 PPI subnetwork	0.82	> 0.20	C1orf63 (2.4)	C17orf57 (2.3)	OGDH (1.9)	CELSR2 (1.9)	C11orf9 (1.7)	RPH3A (1.6)	TMEM50A (1.4)	HAPLN4 (1.4)	SARS (1.4)	ZNF101 (1.3)
ENSG00000168214	RBPJ PPI subnetwork	0.82	> 0.20	SMARCA4 (2.4)	SLC44A2 (2.4)	PLCG1 (2.3)	USP24 (2.1)	NCAN (2.1)	C12orf51 (2.1)	MAU2 (1.7)	ENSG00000226648 (1.7)	CELSR2 (1.6)	DHX38 (1.5)
ENSG00000198681	MAGEA1 PPI subnetwork	0.82	> 0.20	TRAPPC6A (2.6)	FRK (2.1)	OASL (2.0)	BRAP (1.9)	TMEM57 (1.7)	TRAFD1 (1.5)	TMEM116 (1.4)	POLK (1.4)	ENSG00000228044 (1.3)	PBX4 (1.3)
GO:0008603	cAMP-dependent protein kinase regulator activity	0.82	> 0.20	TRAFD1 (3.1)	KIAA1324 (2.7)	DYNC2LI1 (2.1)	GMPR (1.9)	PARP10 (1.8)	OASL (1.7)	SH2B3 (1.7)	NCAN (1.6)	SORT1 (1.5)	AMIGO1 (1.5)
REACTOME_TELOMERE_MAINTENANCE	REACTOME_TELOMERE_MAINTENANCE	0.82	> 0.20	FEN1 (5.1)	USP1 (4.9)	ZNF180 (1.9)	DHODH (1.9)	ENSG00000235545 (1.9)	PSRC1 (1.7)	TXNL4B (1.5)	AMIGO1 (1.4)	FADS1 (1.3)	BUD13 (1.2)
GO:0006379	mRNA cleavage	0.82	> 0.20	TSSK6 (2.2)	UBXN2B (2.0)	DYNC2LI1 (2.0)	TXNL4B (1.6)	ENSG00000226648 (1.6)	ENSG00000235545 (1.5)	ENSG00000226645 (1.4)	MAU2 (1.4)	ZNF180 (1.3)	LPIN3 (1.3)
GO:0001516	prostaglandin biosynthetic process	0.82	> 0.20	NKPD1 (2.8)	GMPR (2.0)	ALDH2 (1.9)	HNF1A (1.9)	TMEM57 (1.9)	C11orf9 (1.6)	TMEM50A (1.4)	CBLC (1.1)	AP1M2 (1.0)	DHODH (1.0)
GO:0046457	prostanoid biosynthetic process	0.82	> 0.20	NKPD1 (2.8)	GMPR (2.0)	ALDH2 (1.9)	HNF1A (1.9)	TMEM57 (1.9)	C11orf9 (1.6)	TMEM50A (1.4)	CBLC (1.1)	AP1M2 (1.0)	DHODH (1.0)
MP:0008827	abnormal thymus cell ratio	0.82	> 0.20	RELB (3.7)	PARP10 (3.0)	BCL3 (2.6)	TRAFD1 (2.3)	ENSG00000238078 (1.9)	ZNF101 (1.8)	C12orf43 (1.6)	ATXN7L2 (1.5)	TIMD4 (1.4)	DHX38 (1.4)
GO:0032735	positive regulation of interleukin-12 production	0.82	> 0.20	DNAH11 (3.3)	TRAFD1 (2.7)	ST3GAL4 (1.6)	TXNL4B (1.6)	ZNF101 (1.6)	PBX4 (1.4)	HLX (1.4)	MYLIP (1.3)	NAA25 (1.3)	ALDH2 (1.3)
ENSG00000178999	AURKB PPI subnetwork	0.82	> 0.20	PSRC1 (5.2)	FEN1 (4.2)	POC5 (4.2)	USP1 (3.3)	ENSG00000226648 (1.2)	LPIN3 (1.2)	ILF3 (1.1)	ZNF180 (0.8)	ENSG00000238078 (0.7)	ENSG00000228044 (0.7)
ENSG00000186831	ENSG00000186831 PPI subnetwork	0.82	> 0.20	CBLC (2.6)	BCAM (2.5)	ERP29 (2.4)	ENSG00000226645 (2.1)	PLEC (1.9)	AP1M2 (1.8)	FRK (1.8)	C12orf43 (1.7)	TOP1 (1.5)	SH2B3 (1.4)
GO:0006475	internal protein amino acid acetylation	0.82	> 0.20	ATXN7L2 (3.4)	BUD13 (2.8)	ILF3 (2.4)	ZNF180 (1.9)	BRAP (1.8)	ATXN2 (1.6)	PLCG1 (1.6)	MAPKAPK5 (1.6)	ZNF101 (1.5)	C12orf51 (1.4)
ENSG00000160957	RECQL4 PPI subnetwork	0.82	> 0.20	MAFB (2.0)	TM6SF2 (2.0)	LPAR2 (2.0)	SLC44A2 (1.8)	C19orf52 (1.7)	FRK (1.7)	CETP (1.6)	SUGP1 (1.6)	BLOC1S3 (1.4)	TRAFD1 (1.3)
ENSG00000130741	EIF2S3 PPI subnetwork	0.82	> 0.20	C19orf52 (3.4)	DDX56 (2.8)	C12orf43 (2.7)	ZNF259 (2.6)	ILF3 (2.6)	SARS (2.5)	TMEM57 (2.4)	QTRT1 (2.3)	NKPD1 (2.2)	MYLIP (2.2)
MP:0005171	absent coat pigmentation	0.82	> 0.20	APOE (2.1)	GMPR (2.0)	MYLIP (1.9)	ST3GAL4 (1.7)	ENSG00000254235 (1.7)	TRIB1 (1.7)	HAVCR1 (1.7)	NKPD1 (1.5)	TMEM116 (1.4)	CELSR2 (1.4)
ENSG00000143466	IKBKE PPI subnetwork	0.82	> 0.20	SARS (3.5)	TOMM40 (3.4)	PSMA5 (3.3)	ERP29 (1.9)	TMEM50A (1.9)	ZNF259 (1.9)	CLPTM1 (1.8)	PTPN11 (1.8)	NAA25 (1.7)	ILF3 (1.7)
ENSG00000168961	LGALS9 PPI subnetwork	0.82	> 0.20	BCAM (3.0)	CLPTM1 (2.3)	GEMIN7 (2.2)	SARS (2.1)	TRAPPC6A (1.9)	NYNRIN (1.8)	ACAD10 (1.8)	GRINA (1.8)	C12orf51 (1.8)	C12orf47 (1.8)
ENSG00000122545	SEPT7 PPI subnetwork	0.82	> 0.20	POLK (2.7)	PSRC1 (2.6)	TRAPPC6A (2.1)	FADS2 (1.8)	GATAD2A (1.6)	RPH3A (1.6)	DNM2 (1.5)	MYLIP (1.4)	NYNRIN (1.3)	SLC44A2 (1.2)
MP:0003400	kinked neural tube	0.82	> 0.20	GATAD2A (2.3)	PLCG1 (1.9)	USP24 (1.8)	APOE (1.8)	ALDH2 (1.8)	NYNRIN (1.7)	TOP1 (1.5)	DOCK7 (1.5)	CLPTM1 (1.5)	FADS2 (1.3)
GO:0035412	regulation of catenin import into nucleus	0.82	> 0.20	TMEM116 (2.4)	DOCK7 (2.4)	CILP2 (2.3)	SLC44A2 (1.8)	PPP1R37 (1.6)	NKPD1 (1.6)	ITGB3 (1.5)	ABO (1.5)	ST3GAL4 (1.5)	BLOC1S3 (1.4)
MP:0002007	increased cellular sensitivity to gamma-irradiation	0.82	> 0.20	POLK (3.5)	FEN1 (2.6)	ZHX3 (2.0)	ZNF180 (2.0)	USP1 (1.9)	POC5 (1.8)	PSRC1 (1.7)	FADS1 (1.5)	TMEM57 (1.4)	BUD13 (1.4)
MP:0003861	abnormal nervous system development	0.82	> 0.20	DYNC2LI1 (4.6)	NYNRIN (2.4)	FADS2 (2.1)	PSRC1 (2.1)	PLCG1 (2.1)	PCSK9 (2.0)	HLX (1.9)	DNAH11 (1.8)	ABO (1.7)	CARM1 (1.6)
MP:0002938	white spotting	0.82	> 0.20	GMPR (2.9)	MYLIP (2.5)	APOE (2.4)	DOCK7 (2.3)	TMEM116 (1.9)	ENSG00000226648 (1.9)	ST3GAL4 (1.5)	ZNF180 (1.4)	GATAD2A (1.4)	APOB (1.2)
GO:0071600	otic vesicle morphogenesis	0.82	> 0.20	ANKRD31 (2.3)	TSSK6 (2.1)	ZNF101 (1.9)	DYNC2LI1 (1.8)	CEACAM19 (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.5)	ENSG00000238078 (1.5)	PMFBP1 (1.5)	BLOC1S3 (1.4)
REACTOME_DOWNSTREAM_TCR_SIGNALING	REACTOME_DOWNSTREAM_TCR_SIGNALING	0.82	> 0.20	RELB (3.2)	ZNF101 (2.5)	PLCG1 (2.0)	ALDH2 (2.0)	SH2B3 (1.9)	PBX4 (1.8)	HAVCR1 (1.8)	BCL3 (1.6)	APOC1 (1.6)	APOE (1.6)
ENSG00000157601	MX1 PPI subnetwork	0.82	> 0.20	OASL (5.6)	TRAFD1 (3.2)	PARP10 (3.1)	BUD13 (3.0)	PLEKHH2 (2.8)	ATP13A1 (1.7)	FEN1 (1.7)	PSRC1 (1.6)	DHODH (1.6)	GATAD2A (1.5)
MP:0001844	autoimmune response	0.82	> 0.20	RELB (4.3)	GMIP (2.2)	TRAFD1 (2.0)	PARP10 (1.9)	SH2B3 (1.8)	TIMD4 (1.4)	GCNT4 (1.4)	C17orf57 (1.4)	BCL3 (1.4)	C12orf43 (1.2)
ENSG00000116459	ATP5F1 PPI subnetwork	0.82	> 0.20	OGDH (2.6)	ACAD10 (2.6)	ENSG00000238078 (2.6)	C19orf52 (2.3)	GOT2P1 (2.3)	C12orf47 (2.2)	PSMA5 (2.1)	HNF1A (2.0)	TOMM40 (1.4)	ANGPTL3 (1.3)
ENSG00000054611	TBC1D22A PPI subnetwork	0.82	> 0.20	YIPF2 (3.5)	TMED4 (2.5)	HMGCR (2.4)	CYB561D1 (2.2)	CLPTM1 (2.0)	ATXN7L2 (1.9)	ENSG00000238078 (1.8)	LDLR (1.5)	TMEM50A (1.5)	ENSG00000235545 (1.5)
GO:0008017	microtubule binding	0.82	> 0.20	LPAR2 (3.6)	PSRC1 (3.1)	PBX4 (2.6)	CELSR2 (2.3)	MAU2 (2.2)	C12orf51 (2.2)	POC5 (2.1)	SARS (1.9)	PLEC (1.8)	CEACAM19 (1.8)
GO:0005875	microtubule associated complex	0.82	> 0.20	DNAH11 (4.1)	DYNC2LI1 (2.5)	MARK4 (2.2)	POC5 (2.1)	PSRC1 (2.1)	PBX4 (1.9)	COL4A3BP (1.7)	TMEM50A (1.3)	POLK (1.2)	CEACAM19 (1.1)
ENSG00000123106	CCDC91 PPI subnetwork	0.82	> 0.20	ERP29 (2.9)	TRAPPC6A (2.6)	PLCG1 (2.4)	UBXN2B (2.3)	C17orf57 (2.2)	TOP1 (2.2)	TMEM57 (2.1)	NT5DC1 (2.1)	USP24 (1.9)	ILF3 (1.7)
ENSG00000100931	ENSG00000100931 PPI subnetwork	0.82	> 0.20	MAPKAPK5 (2.9)	TRAPPC6A (2.7)	FRK (2.7)	SUGP1 (2.6)	C17orf57 (2.3)	TRAFD1 (2.2)	BRAP (2.0)	LPIN3 (1.9)	TMEM50A (1.8)	C12orf43 (1.8)
ENSG00000197780	TAF13 PPI subnetwork	0.82	> 0.20	TXNL4B (3.6)	MAPKAPK5 (3.1)	SUGP1 (3.1)	ATXN2 (2.8)	POC5 (2.3)	PSMA5 (2.3)	COL4A3BP (2.1)	TOP1 (1.9)	MAU2 (1.9)	GATAD2A (1.8)
ENSG00000065989	PDE4A PPI subnetwork	0.82	> 0.20	C12orf51 (3.3)	USP24 (3.2)	GMIP (2.7)	SORT1 (2.4)	PTPN11 (2.3)	MARK4 (1.9)	BUD13 (1.8)	PLCG1 (1.8)	ATXN2 (1.8)	SH2B3 (1.5)
ENSG00000151332	MBIP PPI subnetwork	0.82	> 0.20	ENSG00000226648 (2.4)	MARK4 (1.8)	CYB561D1 (1.7)	BRAP (1.6)	UBXN2B (1.6)	POC5 (1.6)	TSSK6 (1.6)	ATXN7L2 (1.5)	DHX38 (1.5)	C19orf52 (1.4)
GO:0048712	negative regulation of astrocyte differentiation	0.82	> 0.20	NCAN (4.0)	ENSG00000235545 (2.6)	NYNRIN (2.2)	C17orf57 (1.6)	NPC1L1 (1.4)	CELSR2 (1.3)	PBX4 (1.3)	ZNF180 (1.3)	C19orf52 (1.2)	ENSG00000254235 (1.2)
MP:0002584	small ectoplacental cone	0.82	> 0.20	MAU2 (2.2)	CARM1 (2.2)	COL4A3BP (2.2)	C12orf51 (2.0)	USP24 (1.9)	ATXN7L2 (1.9)	SLC44A2 (1.4)	C17orf57 (1.4)	KANK2 (1.4)	TSSK6 (1.4)
GO:0043030	regulation of macrophage activation	0.82	> 0.20	C17orf57 (3.6)	PMFBP1 (2.1)	DHODH (2.0)	HP (1.4)	CETP (1.3)	PCSK9 (1.3)	DNAH11 (1.2)	ENSG00000226645 (1.2)	TSSK6 (1.1)	PBX4 (1.1)
MP:0000130	abnormal trabecular bone morphology	0.82	> 0.20	CILP2 (6.5)	MAFB (3.2)	CETP (1.9)	TRIB1 (1.9)	ITGB3 (1.4)	APOE (1.2)	FRK (1.2)	TMEM116 (1.1)	TMEM57 (1.0)	TIMD4 (1.0)
REACTOME_ORGANIC_CATIONANIONZWITTERION_TRANSPORT	REACTOME_ORGANIC_CATIONANIONZWITTERION_TRANSPORT	0.82	> 0.20	PLG (5.6)	ANGPTL3 (4.2)	MOSC1 (2.8)	SLC22A1 (2.5)	ALDH2 (1.9)	PARP10 (1.6)	SYPL2 (1.6)	RHCE (1.5)	POLK (1.3)	UBXN2B (1.3)
GO:0035094	response to nicotine	0.82	> 0.20	C12orf47 (3.3)	ADAM1 (2.4)	ABO (2.3)	ATXN7L2 (2.1)	C17orf57 (2.1)	GEMIN7 (1.3)	GOT2P1 (1.3)	C12orf43 (1.3)	ERP29 (1.3)	CETP (1.2)
GO:0015669	gas transport	0.82	> 0.20	RHCE (6.3)	RHD (5.1)	HAVCR1 (2.2)	GMPR (2.2)	DNAH11 (1.8)	ENSG00000235545 (1.5)	RPH3A (1.2)	GEMIN7 (1.0)	ZNF101 (1.0)	MYLIP (0.9)
MP:0003232	abnormal forebrain development	0.82	> 0.20	DOCK7 (2.9)	TMEM57 (2.1)	ZNF180 (1.9)	CILP2 (1.7)	MARK4 (1.6)	GPAM (1.5)	PVRL2 (1.5)	APOE (1.5)	DYNC2LI1 (1.4)	SLC44A2 (1.4)
ENSG00000161021	MAML1 PPI subnetwork	0.82	> 0.20	TOP1 (2.4)	PLCG1 (2.2)	SH2B3 (2.1)	NCAN (2.1)	USP24 (2.1)	ATXN2 (2.0)	C12orf51 (2.0)	ENSG00000226645 (1.9)	BCAM (1.9)	GATAD2A (1.7)
MP:0004936	impaired branching involved in ureteric bud morphogenesis	0.82	> 0.20	NYNRIN (3.8)	PLEKHH2 (3.4)	KANK2 (3.3)	PLCG1 (2.4)	AP1M2 (2.3)	PVRL2 (2.2)	SORT1 (1.9)	AMIGO1 (1.7)	ENSG00000238078 (1.6)	FADS1 (1.6)
ENSG00000133030	MPRIP PPI subnetwork	0.82	> 0.20	CBLC (3.8)	AP1M2 (3.6)	PLEC (3.6)	DNM2 (2.6)	TMEM50A (2.2)	ENSG00000238078 (2.1)	ADAM1 (2.1)	FRK (1.8)	C17orf57 (1.8)	HNF1A (1.7)
GO:0045768	positive regulation of anti-apoptosis	0.82	> 0.20	ENSG00000238078 (2.8)	TRIB1 (2.4)	MAFB (2.1)	HAVCR1 (1.9)	CETP (1.7)	LPIN3 (1.6)	BCL3 (1.2)	TOP1 (1.2)	NT5DC1 (1.1)	GRINA (1.0)
ENSG00000121022	COPS5 PPI subnetwork	0.82	> 0.20	TXNL4B (2.0)	C19orf52 (2.0)	ATXN7L2 (1.9)	MAU2 (1.8)	BUD13 (1.7)	QTRT1 (1.4)	CARM1 (1.3)	UBXN2B (1.3)	ENSG00000226645 (1.3)	RHD (1.3)
GO:0045080	positive regulation of chemokine biosynthetic process	0.82	> 0.20	ENSG00000228044 (2.2)	ATXN7L2 (1.8)	MAFB (1.6)	OASL (1.5)	ENSG00000226645 (1.4)	TRAFD1 (1.4)	ENSG00000235545 (1.2)	PLEKHH2 (1.2)	TXNL4B (1.1)	DYNC2LI1 (1.0)
GO:0016409	palmitoyltransferase activity	0.82	> 0.20	NKPD1 (3.7)	BRAP (2.8)	CYB561D1 (2.8)	UBXN2B (2.5)	TMEM50A (2.1)	ABO (2.0)	MAPKAPK5 (2.0)	OGDH (1.8)	LPIN3 (1.7)	C12orf43 (1.6)
MP:0005578	teratozoospermia	0.82	> 0.20	TSSK6 (5.3)	PMFBP1 (3.7)	MARK4 (1.7)	TMEM57 (1.5)	GCNT4 (1.3)	ZNF180 (1.3)	TXNL4B (1.1)	BRAP (1.1)	ATXN7L2 (1.1)	PBX4 (1.0)
MP:0004737	absent distortion product otoacoustic emissions	0.82	> 0.20	KIAA1324 (1.7)	ENSG00000226645 (1.7)	FRK (1.7)	AMIGO1 (1.5)	HAVCR1 (1.4)	MYLIP (1.4)	AP1M2 (1.4)	TMEM57 (1.4)	ABO (1.4)	APOB (1.4)
GO:0060536	cartilage morphogenesis	0.82	> 0.20	HLX (3.1)	MYLIP (2.6)	ANKRD31 (1.7)	ENSG00000238078 (1.6)	ATXN2 (1.5)	ENSG00000226648 (1.5)	DYNC2LI1 (1.3)	ENSG00000235545 (1.2)	PMFBP1 (1.1)	KANK2 (1.1)
ENSG00000164919	COX6C PPI subnetwork	0.82	> 0.20	TRAPPC6A (3.3)	GOT2P1 (2.8)	POLK (1.7)	ACAD10 (1.4)	PVRL2 (1.4)	C12orf47 (1.3)	MOSC1 (1.2)	ADAM1 (1.2)	GMPR (1.2)	ZNF180 (1.2)
MP:0009538	abnormal synapse morphology	0.82	> 0.20	PCSK9 (4.0)	HMGCR (3.8)	FADS1 (3.5)	APOC1 (2.6)	FADS2 (2.5)	RPH3A (2.5)	NPC1L1 (1.5)	HLX (1.5)	TMEM57 (1.4)	GPAM (1.4)
ENSG00000099399	MAGEB2 PPI subnetwork	0.82	> 0.20	DOCK7 (3.3)	PMFBP1 (2.7)	TRAPPC6A (2.1)	KIAA1324 (2.0)	SUGP1 (1.9)	ATP13A1 (1.7)	TMEM57 (1.6)	C1orf63 (1.5)	DHX38 (1.4)	TMEM50A (1.3)
GO:0032570	response to progesterone stimulus	0.82	> 0.20	AMIGO1 (2.6)	TRIB1 (2.5)	MYLIP (1.9)	BCL3 (1.8)	YIPF2 (1.7)	COL4A3BP (1.6)	PVR (1.6)	LPAR2 (1.5)	GRINA (1.5)	TSSK6 (1.5)
ENSG00000158864	NDUFS2 PPI subnetwork	0.82	> 0.20	OGDH (3.9)	ACAD10 (3.0)	TRAPPC6A (2.6)	MAU2 (1.9)	GOT2P1 (1.9)	C12orf47 (1.8)	PSMA5 (1.8)	ATP13A1 (1.7)	TOMM40 (1.6)	FRK (1.4)
MP:0000749	muscle degeneration	0.82	> 0.20	SYPL2 (7.5)	KANK2 (2.6)	GMPR (2.6)	CYB561D1 (2.0)	SORT1 (1.6)	PLEC (1.5)	RPH3A (1.5)	OGDH (1.2)	C12orf47 (1.1)	HAPLN4 (1.1)
REACTOME_CLASS_B2_SECRETIN_FAMILY_RECEPTORS	REACTOME_CLASS_B2_SECRETIN_FAMILY_RECEPTORS	0.82	> 0.20	NPC1L1 (2.8)	BCAM (2.4)	ABO (2.2)	SLC44A2 (1.9)	AMIGO1 (1.9)	HAPLN4 (1.9)	KIAA1324 (1.8)	RPH3A (1.7)	AP1M2 (1.7)	HLX (1.6)
GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	0.82	> 0.20	YIPF2 (4.6)	ERP29 (3.2)	TMED4 (2.8)	TMEM50A (2.7)	ATP13A1 (2.2)	SLC44A2 (2.0)	MOSC1 (1.7)	CLPTM1 (1.7)	ADAM1 (1.6)	C17orf57 (1.5)
GO:0035137	hindlimb morphogenesis	0.82	> 0.20	MYLIP (2.8)	ABO (2.4)	NKPD1 (1.8)	NYNRIN (1.8)	DNAH11 (1.7)	ANKRD31 (1.4)	PMFBP1 (1.3)	AP1M2 (1.2)	ENSG00000235545 (1.2)	LPAR2 (1.2)
GO:0007224	smoothened signaling pathway	0.82	> 0.20	DYNC2LI1 (3.5)	NYNRIN (2.5)	PLCG1 (2.4)	PBX4 (2.1)	ANKRD31 (2.0)	AMIGO1 (1.8)	CYB561D1 (1.5)	DNAH11 (1.4)	PLEKHH2 (1.4)	PPP1R37 (1.3)
MP:0001093	small trigeminal ganglion	0.82	> 0.20	ZNF180 (1.8)	ZHX3 (1.5)	GMPR (1.4)	TSSK6 (1.3)	CILP2 (1.3)	SLC44A2 (1.2)	CBLC (1.2)	NKPD1 (1.1)	PMFBP1 (1.1)	GOT2P1 (1.0)
GO:0001669	acrosomal vesicle	0.82	> 0.20	TSSK6 (4.9)	PMFBP1 (4.0)	PBX4 (1.7)	ADAM1 (1.6)	OGDH (1.5)	ERP29 (1.5)	ENSG00000228044 (1.3)	TRAFD1 (1.3)	PCSK9 (1.2)	LPAR2 (1.2)
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	0.82	> 0.20	OGDH (5.3)	ACAD10 (4.5)	GMPR (2.9)	CLPTM1 (1.8)	C1orf63 (1.7)	TMED4 (1.6)	TMEM116 (1.3)	ALDH2 (1.2)	NT5DC1 (1.2)	HAPLN4 (1.1)
ENSG00000162236	STX5 PPI subnetwork	0.82	> 0.20	YIPF2 (4.6)	TMEM50A (3.2)	CLPTM1 (3.0)	TMED4 (2.8)	CYB561D1 (2.0)	TMEM57 (1.8)	SARS (1.6)	MAU2 (1.5)	DNM2 (1.5)	PSMA5 (1.4)
ENSG00000103051	COG4 PPI subnetwork	0.82	> 0.20	YIPF2 (3.8)	SUGP1 (2.8)	C1orf63 (2.0)	ENSG00000228044 (1.9)	TMEM57 (1.8)	DNM2 (1.6)	DHX38 (1.6)	KIAA1324 (1.6)	LPIN3 (1.4)	ATP13A1 (1.3)
ENSG00000186469	GNG2 PPI subnetwork	0.82	> 0.20	ITGB3 (2.6)	HAPLN4 (1.9)	MAPKAPK5 (1.7)	TMEM50A (1.5)	ENSG00000226648 (1.4)	TXNL4B (1.3)	PTPN11 (1.2)	MYLIP (1.1)	DHX38 (1.1)	C12orf47 (1.0)
GO:0034329	cell junction assembly	0.82	> 0.20	BCAM (3.5)	ITGB3 (2.8)	PVRL2 (2.8)	PLEC (2.5)	AP1M2 (2.4)	C17orf57 (2.3)	CBLC (2.1)	GEMIN7 (2.0)	GCNT4 (1.8)	KANK2 (1.6)
ENSG00000142186	SCYL1 PPI subnetwork	0.82	> 0.20	NAA25 (3.3)	ENSG00000238078 (2.5)	SARS (2.4)	ZNF180 (2.0)	ATXN7L2 (2.0)	DDX56 (1.9)	MAPKAPK5 (1.9)	C12orf47 (1.8)	ADAM1 (1.8)	CARM1 (1.7)
GO:0008094	DNA-dependent ATPase activity	0.82	> 0.20	FEN1 (4.3)	USP1 (3.2)	ILF3 (2.1)	POC5 (2.0)	ZNF180 (1.7)	SUGP1 (1.7)	POLK (1.6)	SMARCA4 (1.5)	DYNC2LI1 (1.4)	DHX38 (1.3)
MP:0004740	sensorineural hearing loss	0.82	> 0.20	GPAM (2.9)	GCNT4 (2.6)	SORT1 (2.3)	NKPD1 (2.1)	TMEM116 (2.1)	BCAM (1.9)	LPA (1.4)	NCAN (1.3)	SLC44A2 (1.3)	ZHX3 (1.3)
GO:0043149	stress fiber assembly	0.82	> 0.20	C17orf57 (2.6)	USP24 (2.3)	PBX4 (1.7)	CEACAM19 (1.7)	NYNRIN (1.6)	CARM1 (1.5)	ABO (1.4)	ENSG00000226645 (1.3)	ITGB3 (1.2)	PTPN11 (1.2)
GO:0043623	cellular protein complex assembly	0.82	> 0.20	HAVCR1 (2.1)	C17orf57 (1.9)	ITGB3 (1.7)	GMPR (1.6)	C12orf47 (1.5)	USP24 (1.5)	POC5 (1.5)	PSRC1 (1.1)	ANGPTL3 (1.1)	OGDH (1.0)
GO:0071356	cellular response to tumor necrosis factor	0.82	> 0.20	CYB561D1 (3.2)	PARP10 (1.9)	TRAFD1 (1.8)	ZNF180 (1.8)	RELB (1.7)	HAVCR1 (1.6)	FRK (1.6)	TRAPPC6A (1.4)	BCL3 (1.4)	LPIN3 (1.3)
GO:0070566	adenylyltransferase activity	0.82	> 0.20	OASL (6.4)	PARP10 (3.2)	C19orf52 (2.8)	C12orf47 (2.3)	ACAD10 (2.0)	BRAP (1.8)	C1orf63 (1.6)	GPAM (1.5)	LPIN3 (1.5)	TSSK6 (1.3)
ENSG00000101152	DNAJC5 PPI subnetwork	0.82	> 0.20	PMFBP1 (2.9)	YIPF2 (2.7)	FRK (2.2)	SLC22A1 (2.1)	SORT1 (2.1)	MOSC1 (1.9)	LPA (1.6)	C12orf47 (1.5)	DHODH (1.4)	GRINA (1.3)
GO:0006997	nucleus organization	0.82	> 0.20	TSSK6 (4.7)	PMFBP1 (3.6)	GATAD2A (1.6)	ENSG00000228044 (1.5)	GEMIN7 (1.4)	ZNF259 (1.4)	ABCG8 (1.3)	USP24 (1.3)	FRK (1.2)	DNAH11 (1.2)
MP:0000024	lowered ear position	0.82	> 0.20	ZHX3 (2.5)	CARM1 (2.4)	PLCG1 (2.2)	C19orf52 (1.9)	CILP2 (1.6)	PPP1R37 (1.6)	ENSG00000226648 (1.5)	TSSK6 (1.5)	MYLIP (1.3)	ILF3 (1.3)
GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	0.82	> 0.20	C17orf57 (2.8)	HNF1A (2.8)	ENSG00000238078 (2.7)	PLEKHH2 (2.2)	TSSK6 (1.9)	ABO (1.8)	HAVCR1 (1.7)	ENSG00000235545 (1.6)	CYP7A1 (1.4)	ENSG00000228044 (1.4)
GO:0017002	activin-activated receptor activity	0.82	> 0.20	MAFB (2.0)	TMEM57 (1.8)	TMED4 (1.7)	ABO (1.7)	AMIGO1 (1.7)	PVRL2 (1.6)	ZNF101 (1.5)	NYNRIN (1.5)	FRK (1.5)	CYB561D1 (1.4)
REACTOME_PYRUVATE_METABOLISM	REACTOME_PYRUVATE_METABOLISM	0.82	> 0.20	OGDH (3.9)	GPAM (3.4)	ACAD10 (2.2)	CLPTM1 (2.2)	GMPR (2.1)	DHODH (1.9)	TOMM40 (1.6)	TXNL4B (1.5)	MOSC1 (1.4)	TRAPPC6A (1.3)
GO:0007080	mitotic metaphase plate congression	0.82	> 0.20	POC5 (4.8)	PSRC1 (3.5)	POLK (3.2)	BUD13 (3.0)	SORT1 (1.7)	TXNL4B (1.6)	HAVCR1 (1.5)	GEMIN7 (1.5)	CEACAM19 (1.5)	ZNF259 (1.5)
GO:0052472	modulation by host of symbiont transcription	0.82	> 0.20	BUD13 (2.6)	ENSG00000226645 (2.6)	ENSG00000235545 (2.2)	C1orf63 (2.0)	GATAD2A (1.9)	MAPKAPK5 (1.9)	ZNF101 (1.7)	CARM1 (1.5)	ADAM1 (1.5)	PLCG1 (1.4)
GO:0043921	modulation by host of viral transcription	0.82	> 0.20	BUD13 (2.6)	ENSG00000226645 (2.6)	ENSG00000235545 (2.2)	C1orf63 (2.0)	GATAD2A (1.9)	MAPKAPK5 (1.9)	ZNF101 (1.7)	CARM1 (1.5)	ADAM1 (1.5)	PLCG1 (1.4)
GO:0000090	mitotic anaphase	0.82	> 0.20	TMEM116 (3.0)	POC5 (2.8)	LPIN3 (2.2)	ZNF101 (1.9)	PSRC1 (1.9)	C12orf43 (1.8)	TMEM57 (1.8)	BRAP (1.7)	MAU2 (1.6)	ENSG00000254235 (1.6)
GO:0009913	epidermal cell differentiation	0.82	> 0.20	NKPD1 (4.4)	ENSG00000226648 (3.4)	CEACAM19 (3.3)	C17orf57 (2.3)	CBLC (2.3)	LPIN3 (1.9)	AP1M2 (1.6)	PMFBP1 (1.6)	CELSR2 (1.5)	FRK (1.0)
ENSG00000106546	AHR PPI subnetwork	0.82	> 0.20	TOP1 (2.9)	C12orf51 (2.6)	MAU2 (2.5)	OASL (2.5)	ZHX3 (2.3)	ATXN2 (2.2)	PARP10 (2.0)	GRINA (1.8)	CYP7A1 (1.6)	CARM1 (1.5)
GO:0015872	dopamine transport	0.82	> 0.20	CETP (2.1)	AMIGO1 (2.1)	RPH3A (1.9)	LPA (1.9)	PMFBP1 (1.5)	RHCE (1.4)	GOT2P1 (1.2)	NKPD1 (1.2)	BLOC1S3 (1.2)	LPAR2 (1.2)
GO:0045667	regulation of osteoblast differentiation	0.82	> 0.20	CILP2 (2.5)	ENSG00000226648 (2.0)	PLEKHH2 (2.0)	PLCG1 (1.9)	MAFB (1.8)	NYNRIN (1.8)	CARM1 (1.6)	ATXN2 (1.5)	AMIGO1 (1.5)	KANK2 (1.5)
ENSG00000163519	TRAT1 PPI subnetwork	0.82	> 0.20	ZNF101 (4.7)	PLCG1 (4.0)	PBX4 (2.2)	COL4A3BP (2.0)	ZHX3 (2.0)	PPP1R37 (1.9)	LPAR2 (1.9)	DNM2 (1.8)	HAVCR1 (1.7)	TMEM57 (1.7)
ENSG00000126777	KTN1 PPI subnetwork	0.82	> 0.20	CETP (2.5)	PTPN11 (2.3)	TMEM50A (1.9)	RELB (1.8)	HAVCR1 (1.8)	PSRC1 (1.7)	PLEC (1.6)	CILP2 (1.4)	AMIGO1 (1.3)	SMARCA4 (1.2)
GO:0042069	regulation of catecholamine metabolic process	0.82	> 0.20	GCNT4 (2.4)	C12orf47 (2.3)	TSSK6 (2.0)	HNF1A (2.0)	NKPD1 (1.9)	ENSG00000235545 (1.8)	PMFBP1 (1.5)	ENSG00000238078 (1.5)	ENSG00000226648 (1.4)	DNAH11 (1.4)
ENSG00000185658	BRWD1 PPI subnetwork	0.82	> 0.20	USP24 (4.8)	COL4A3BP (2.7)	CARM1 (2.6)	C12orf51 (2.3)	GRINA (2.2)	DOCK7 (2.1)	DHX38 (2.0)	MAU2 (2.0)	SUGP1 (1.5)	ATXN2 (1.5)
MP:0008277	abnormal sternum ossification	0.82	> 0.20	NYNRIN (2.9)	NCAN (2.7)	ALDH2 (2.5)	PLCG1 (1.8)	ENSG00000226645 (1.8)	MARK4 (1.6)	CILP2 (1.6)	GOT2P1 (1.5)	SYPL2 (1.4)	KIAA1324 (1.4)
MP:0000550	abnormal forelimb morphology	0.82	> 0.20	CILP2 (3.4)	ENSG00000226648 (1.9)	CBLC (1.9)	MAFB (1.5)	HNF1A (1.5)	MYLIP (1.5)	PLEKHH2 (1.5)	PLEC (1.3)	PLCG1 (1.3)	ATXN2 (1.2)
GO:0072341	modified amino acid binding	0.82	> 0.20	ALDH2 (5.2)	PCSK9 (3.1)	GPAM (2.9)	C11orf9 (2.6)	FADS1 (2.0)	TRAPPC6A (1.8)	SORT1 (1.7)	APOE (1.7)	ST3GAL4 (1.6)	MOSC1 (1.5)
ENSG00000152583	SPARCL1 PPI subnetwork	0.82	> 0.20	ERP29 (4.2)	NCAN (2.9)	RPH3A (2.8)	TMED4 (2.5)	CLPTM1 (2.4)	GRINA (2.1)	BCAM (2.1)	CELSR2 (2.1)	ATP13A1 (1.8)	PCSK9 (1.8)
GO:0060251	regulation of glial cell proliferation	0.82	> 0.20	NCAN (2.6)	NYNRIN (2.2)	ENSG00000226648 (2.1)	ZNF180 (2.0)	UBXN2B (1.8)	USP24 (1.6)	BLOC1S3 (1.6)	GMPR (1.5)	BRAP (1.4)	TMEM57 (1.4)
GO:0061005	cell differentiation involved in kidney development	0.82	> 0.20	BCAM (3.2)	NYNRIN (2.4)	PLEKHH2 (2.2)	NKPD1 (1.9)	BLOC1S3 (1.8)	C11orf9 (1.6)	AP1M2 (1.6)	DYNC2LI1 (1.3)	CELSR2 (1.2)	TSSK6 (1.2)
MP:0001488	increased startle reflex	0.82	> 0.20	RPH3A (3.2)	SORT1 (3.1)	NCAN (2.9)	HAPLN4 (2.5)	CELSR2 (2.4)	APOC1 (2.2)	TSSK6 (2.0)	PPP1R37 (1.8)	C11orf9 (1.7)	CLPTM1 (1.4)
MP:0010872	increased trabecular bone mass	0.82	> 0.20	APOC1 (3.5)	ITGB3 (2.9)	MAPKAPK5 (2.2)	APOE (2.1)	MAU2 (2.1)	SORT1 (2.0)	C12orf47 (1.9)	MAFB (1.6)	CILP2 (1.6)	ALDH2 (1.5)
MP:0002065	abnormal fear/anxiety-related behavior	0.82	> 0.20	ZHX3 (3.3)	ADAM1 (2.7)	PLCG1 (2.5)	ZNF180 (2.5)	GCNT4 (2.5)	ABCG5 (2.0)	TM6SF2 (1.8)	PPP1R37 (1.7)	MAPKAPK5 (1.7)	RPH3A (1.6)
MP:0002014	increased papilloma incidence	0.82	> 0.20	TMEM57 (3.7)	TRAPPC6A (3.1)	PBX4 (2.8)	C12orf47 (2.3)	TSSK6 (2.2)	HP (2.1)	LPAR2 (1.9)	MYLIP (1.8)	ZNF101 (1.8)	SLC44A2 (1.7)
GO:0042752	regulation of circadian rhythm	0.82	> 0.20	C12orf47 (2.1)	ENSG00000254235 (2.0)	LPIN3 (2.0)	ENSG00000226648 (1.8)	HNF1A (1.8)	HAVCR1 (1.6)	HAPLN4 (1.4)	TSSK6 (1.4)	ENSG00000235545 (1.4)	PBX4 (1.3)
GO:0000314	organellar small ribosomal subunit	0.82	> 0.20	C12orf43 (2.8)	PSMA5 (2.7)	GEMIN7 (2.5)	TRAPPC6A (1.5)	TOMM40 (1.4)	ERP29 (1.4)	C12orf47 (1.1)	MAPKAPK5 (1.1)	SARS (1.1)	ATXN7L2 (1.0)
GO:0005763	mitochondrial small ribosomal subunit	0.82	> 0.20	C12orf43 (2.8)	PSMA5 (2.7)	GEMIN7 (2.5)	TRAPPC6A (1.5)	TOMM40 (1.4)	ERP29 (1.4)	C12orf47 (1.1)	MAPKAPK5 (1.1)	SARS (1.1)	ATXN7L2 (1.0)
ENSG00000129083	COPB1 PPI subnetwork	0.82	> 0.20	YIPF2 (5.4)	MAU2 (2.3)	C19orf52 (2.2)	OGDH (2.2)	HLX (2.1)	CARM1 (2.1)	BLOC1S3 (2.0)	SARS (1.9)	QTRT1 (1.8)	DNM2 (1.8)
MP:0000192	abnormal mineral level	0.82	> 0.20	DYNC2LI1 (2.8)	UBXN2B (2.7)	SLC22A1 (2.3)	KIAA1324 (2.3)	RHD (2.3)	NYNRIN (2.1)	DNM2 (1.9)	ANKRD31 (1.8)	C11orf9 (1.8)	ATP13A1 (1.8)
MP:0004098	abnormal cerebellar granule cell morphology	0.82	> 0.20	NCAN (4.7)	APOE (2.5)	ENSG00000226648 (2.0)	GMPR (1.8)	FRK (1.7)	DOCK7 (1.6)	APOC1 (1.5)	ATP13A1 (1.4)	AMIGO1 (1.4)	NYNRIN (1.4)
GO:0061025	membrane fusion	0.82	> 0.20	BLOC1S3 (4.5)	POLK (2.4)	CYB561D1 (2.3)	ANKRD31 (2.1)	BRAP (2.1)	TSSK6 (1.7)	TRAPPC6A (1.5)	PMFBP1 (1.5)	CEACAM19 (1.4)	GEMIN7 (1.3)
GO:0048066	developmental pigmentation	0.83	> 0.20	NKPD1 (2.6)	ST3GAL4 (2.6)	MYLIP (2.3)	C12orf43 (1.8)	MAU2 (1.7)	DOCK7 (1.7)	GMPR (1.6)	PPP1R37 (1.5)	ZNF101 (1.4)	ENSG00000228044 (1.4)
REACTOME_G:PROTEIN_MEDIATED_EVENTS	REACTOME_G:PROTEIN_MEDIATED_EVENTS	0.83	> 0.20	ITGB3 (2.9)	SORT1 (2.7)	SH2B3 (2.6)	POLK (1.7)	ST3GAL4 (1.5)	GOT2P1 (1.5)	AMIGO1 (1.5)	GMPR (1.4)	OGDH (1.4)	HLX (1.4)
ENSG00000114857	NKTR PPI subnetwork	0.83	> 0.20	GOT2P1 (2.1)	AMIGO1 (2.0)	SH2B3 (1.9)	NKPD1 (1.9)	DYNC2LI1 (1.7)	RHCE (1.6)	TIMD4 (1.5)	NAA25 (1.5)	C11orf9 (1.5)	DNAH11 (1.5)
GO:0000407	pre-autophagosomal structure	0.83	> 0.20	BRAP (5.4)	TMEM57 (3.6)	MAPKAPK5 (3.5)	C1orf63 (2.8)	C12orf47 (2.3)	TXNL4B (2.2)	C12orf51 (2.1)	TMEM116 (1.7)	ENSG00000226645 (1.6)	YIPF2 (1.6)
ENSG00000120087	HOXB7 PPI subnetwork	0.83	> 0.20	SMARCA4 (2.7)	UBXN2B (2.6)	TOP1 (2.3)	ANKRD31 (2.3)	GATAD2A (2.1)	ILF3 (2.0)	C1orf63 (1.9)	CARM1 (1.7)	ABO (1.7)	ATXN7L2 (1.6)
GO:0001077	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	0.83	> 0.20	TRIB1 (4.6)	NYNRIN (2.4)	PVRL2 (1.7)	SH2B3 (1.7)	CELSR2 (1.6)	PSRC1 (1.6)	BCL3 (1.5)	GMPR (1.5)	RHD (1.4)	C11orf9 (1.3)
ENSG00000115350	POLE4 PPI subnetwork	0.83	> 0.20	FEN1 (3.1)	DHODH (2.8)	ADAM1 (2.4)	SLC44A2 (2.4)	USP1 (2.4)	C12orf47 (2.2)	MAPKAPK5 (2.1)	PSRC1 (2.0)	PTPN11 (1.9)	TMEM116 (1.6)
GO:0005758	mitochondrial intermembrane space	0.83	> 0.20	RHD (3.2)	ACAD10 (2.6)	RHCE (2.1)	GEMIN7 (2.1)	TRAPPC6A (2.0)	TOMM40 (1.8)	DHODH (1.6)	USP24 (1.6)	GMPR (1.5)	FADS1 (1.5)
ENSG00000051180	RAD51 PPI subnetwork	0.83	> 0.20	FEN1 (4.2)	USP1 (3.1)	ZNF180 (2.1)	ENSG00000235545 (2.0)	MAU2 (2.0)	POC5 (1.6)	TRAPPC6A (1.4)	PSRC1 (1.3)	BLOC1S3 (1.3)	HAVCR1 (1.1)
ENSG00000071243	ING3 PPI subnetwork	0.83	> 0.20	C12orf43 (2.9)	ADAM1 (2.9)	SUGP1 (2.4)	ILF3 (2.4)	SMARCA4 (2.3)	ATXN7L2 (2.3)	MAPKAPK5 (2.3)	ZNF259 (2.2)	BUD13 (2.2)	PCSK9 (2.0)
ENSG00000113812	ACTR8 PPI subnetwork	0.83	> 0.20	BUD13 (2.2)	GMPR (1.8)	TOP1 (1.6)	SMARCA4 (1.4)	ATXN7L2 (1.3)	TMEM50A (1.3)	SUGP1 (1.3)	ZNF180 (1.2)	C19orf52 (1.1)	DDX56 (0.9)
GO:0031902	late endosome membrane	0.83	> 0.20	TMEM50A (3.4)	TRAFD1 (2.3)	GRINA (2.0)	COL4A3BP (1.8)	C12orf43 (1.7)	ITGB3 (1.7)	MAFB (1.6)	BRAP (1.5)	C11orf9 (1.5)	ERP29 (1.5)
ENSG00000154556	SORBS2 PPI subnetwork	0.83	> 0.20	SMARCA4 (3.1)	GMIP (2.8)	ATXN2 (2.7)	LPIN3 (2.6)	OGDH (2.5)	CARM1 (2.4)	HAVCR1 (2.4)	C17orf57 (2.4)	PLEC (2.1)	USP24 (2.0)
MP:0003204	decreased neuron apoptosis	0.83	> 0.20	BCAM (2.9)	TRIB1 (2.8)	TRAFD1 (2.8)	MAFB (2.4)	POLK (2.4)	ATXN7L2 (2.2)	FRK (2.2)	GRINA (1.9)	PSRC1 (1.8)	CELSR2 (1.8)
ENSG00000168118	RAB4A PPI subnetwork	0.83	> 0.20	COL4A3BP (2.4)	SLC44A2 (1.9)	PMFBP1 (1.9)	PVRL2 (1.8)	MARK4 (1.8)	PVR (1.8)	TRAPPC6A (1.8)	BLOC1S3 (1.7)	GEMIN7 (1.7)	UBXN2B (1.7)
ENSG00000156976	EIF4A2 PPI subnetwork	0.83	> 0.20	NKPD1 (2.4)	ANKRD31 (2.4)	DHX38 (2.2)	GATAD2A (2.1)	DDX56 (1.8)	ILF3 (1.8)	SARS (1.7)	ATP13A1 (1.7)	SUGP1 (1.6)	TMEM57 (1.6)
GO:0007276	gamete generation	0.83	> 0.20	TSSK6 (5.6)	PMFBP1 (3.4)	ENSG00000228044 (1.9)	PLEKHH2 (1.2)	MARK4 (1.0)	CEACAM19 (0.9)	DYNC2LI1 (0.8)	FRK (0.8)	CILP2 (0.6)	UBXN2B (0.6)
MP:0006316	increased urine sodium level	0.83	> 0.20	AP1M2 (4.3)	CBLC (3.0)	PLG (2.8)	ZHX3 (2.8)	TMEM116 (2.1)	ANGPTL3 (2.0)	TRIB1 (1.8)	FRK (1.5)	HNF1A (1.3)	SLC22A1 (1.2)
MP:0001951	abnormal breathing pattern	0.83	> 0.20	NCAN (3.5)	FADS1 (3.0)	CELSR2 (2.4)	NKPD1 (2.4)	HMGCR (2.3)	FADS2 (2.3)	LDLR (2.3)	HAPLN4 (2.2)	PLCG1 (2.2)	ENSG00000228044 (1.6)
ENSG00000130811	EIF3G PPI subnetwork	0.83	> 0.20	ILF3 (2.6)	DHX38 (2.5)	GATAD2A (2.5)	DDX56 (2.4)	ATP13A1 (2.3)	ANKRD31 (2.3)	TOP1 (2.3)	SARS (2.2)	QTRT1 (2.0)	SUGP1 (2.0)
GO:0008278	cohesin complex	0.83	> 0.20	USP1 (3.3)	TOP1 (1.8)	OASL (1.8)	ANKRD31 (1.7)	ZHX3 (1.6)	PLEKHH2 (1.6)	ATXN7L2 (1.4)	FEN1 (1.3)	PBX4 (1.2)	BCAM (1.1)
GO:0010390	histone monoubiquitination	0.83	> 0.20	GCNT4 (3.1)	CYB561D1 (1.9)	ZNF259 (1.9)	TOP1 (1.8)	DYNC2LI1 (1.6)	C19orf52 (1.5)	DNAH11 (1.5)	SUGP1 (1.4)	PARP10 (1.3)	TMEM57 (1.3)
KEGG_GAP_JUNCTION	KEGG_GAP_JUNCTION	0.83	> 0.20	ITGB3 (3.6)	C12orf51 (1.8)	C11orf9 (1.6)	KANK2 (1.6)	HLX (1.5)	FADS2 (1.5)	C1orf63 (1.4)	SH2B3 (1.4)	APOE (1.4)	GCNT4 (1.4)
GO:0007507	heart development	0.83	> 0.20	CEACAM19 (2.2)	C17orf57 (2.1)	KANK2 (1.9)	ATXN2 (1.9)	NYNRIN (1.8)	PVRL2 (1.8)	ENSG00000238078 (1.6)	ATXN7L2 (1.5)	ACAD10 (1.5)	C11orf9 (1.4)
ENSG00000157404	KIT PPI subnetwork	0.83	> 0.20	SH2B3 (3.0)	GMIP (2.8)	USP24 (2.3)	PTPN11 (2.2)	DNM2 (2.0)	PLEKHH2 (2.0)	CYB561D1 (1.6)	MYLIP (1.5)	POLK (1.5)	GATAD2A (1.4)
ENSG00000138031	ADCY3 PPI subnetwork	0.83	> 0.20	C12orf43 (2.6)	GATAD2A (2.0)	POLK (1.8)	LPAR2 (1.8)	MAU2 (1.7)	ENSG00000238078 (1.6)	DNM2 (1.6)	CARM1 (1.5)	SLC44A2 (1.5)	MARK4 (1.4)
GO:0032543	mitochondrial translation	0.83	> 0.20	C12orf43 (4.2)	ACAD10 (3.1)	GOT2P1 (2.3)	ANKRD31 (2.3)	TMEM116 (2.2)	DHODH (2.2)	NT5DC1 (2.0)	UBXN2B (2.0)	MAPKAPK5 (2.0)	C19orf52 (1.8)
GO:0007254	JNK cascade	0.83	> 0.20	ST3GAL4 (3.0)	LPAR2 (2.5)	UBXN2B (2.4)	FRK (2.2)	PTPN11 (1.6)	POLK (1.6)	CYB561D1 (1.4)	C11orf9 (1.4)	CBLC (1.4)	YIPF2 (1.4)
GO:0003205	cardiac chamber development	0.83	> 0.20	ENSG00000238078 (3.0)	ATXN7L2 (2.6)	C11orf9 (2.4)	NYNRIN (1.8)	C19orf52 (1.7)	CEACAM19 (1.4)	ALDH2 (1.4)	PVRL2 (1.3)	LPAR2 (1.3)	GMPR (1.2)
GO:0015299	solute:hydrogen antiporter activity	0.83	> 0.20	ENSG00000226645 (2.6)	COL4A3BP (2.1)	LPAR2 (2.1)	ABO (1.6)	SLC44A2 (1.5)	CYB561D1 (1.4)	ENSG00000235545 (1.4)	DNAH11 (1.4)	PPP1R37 (1.4)	SYPL2 (1.3)
GO:0031985	Golgi cisterna	0.83	> 0.20	YIPF2 (5.0)	ST3GAL4 (3.4)	TMED4 (3.2)	LPIN3 (2.3)	CYB561D1 (2.1)	TMEM57 (1.9)	ERP29 (1.8)	SLC44A2 (1.8)	ENSG00000235545 (1.7)	FRK (1.4)
GO:0005671	Ada2/Gcn5/Ada3 transcription activator complex	0.83	> 0.20	ATXN7L2 (4.0)	MAPKAPK5 (3.1)	USP24 (2.5)	CYB561D1 (1.8)	ATP13A1 (1.6)	SH2B3 (1.6)	DHX38 (1.5)	USP1 (1.5)	ILF3 (1.4)	PARP10 (1.4)
ENSG00000101132	PFDN4 PPI subnetwork	0.83	> 0.20	GATAD2A (2.5)	C12orf47 (2.2)	TXNL4B (2.2)	SMARCA4 (2.1)	FEN1 (2.1)	ADAM1 (2.0)	PSRC1 (1.9)	USP1 (1.7)	ENSG00000226645 (1.7)	ILF3 (1.7)
MP:0005323	dystonia	0.83	> 0.20	APOC4 (3.2)	DOCK7 (2.2)	RPH3A (1.9)	ZNF180 (1.9)	MARK4 (1.8)	GEMIN7 (1.8)	HAPLN4 (1.7)	CYP7A1 (1.6)	TOMM40 (1.6)	DNAH11 (1.6)
MP:0006030	abnormal otic vesicle development	0.83	> 0.20	MYLIP (2.6)	LPA (1.9)	LPIN3 (1.4)	APOE (1.3)	PLCG1 (1.3)	TOP1 (1.3)	CARM1 (1.2)	GMIP (1.2)	HLX (1.2)	BLOC1S3 (1.2)
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	0.83	> 0.20	PTPN11 (3.8)	ZHX3 (2.6)	C11orf9 (2.3)	GPAM (2.2)	HAPLN4 (2.2)	PLEKHH2 (2.2)	CARM1 (2.1)	SARS (2.0)	USP24 (2.0)	COL4A3BP (1.9)
ENSG00000123136	DDX39A PPI subnetwork	0.83	> 0.20	TOP1 (3.1)	ILF3 (2.5)	DDX56 (2.1)	TMEM116 (2.0)	NAA25 (1.8)	TRAFD1 (1.8)	ERP29 (1.8)	BUD13 (1.8)	PMFBP1 (1.7)	C19orf52 (1.7)
ENSG00000002016	RAD52 PPI subnetwork	0.83	> 0.20	FEN1 (4.0)	USP1 (2.8)	ZNF180 (2.6)	ENSG00000235545 (1.9)	TMEM57 (1.6)	FADS1 (1.6)	POLK (1.4)	POC5 (1.3)	SMARCA4 (1.2)	LPIN3 (1.1)
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH:CONE_COLLAPSE	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH:CONE_COLLAPSE	0.83	> 0.20	SLC44A2 (3.0)	PVRL2 (2.9)	BCAM (2.9)	AP1M2 (2.5)	TMEM50A (2.2)	ADAM1 (2.0)	PLEC (1.9)	C11orf9 (1.8)	PPP1R37 (1.8)	ITGB3 (1.8)
ENSG00000113240	CLK4 PPI subnetwork	0.83	> 0.20	TMEM57 (2.8)	CETP (2.2)	C1orf63 (2.0)	DNAH11 (1.8)	KIAA1324 (1.7)	APOE (1.6)	AP1M2 (1.5)	USP24 (1.5)	TOP1 (1.4)	TMEM116 (1.3)
MP:0005120	decreased circulating growth hormone level	0.83	> 0.20	KIAA1324 (4.7)	TSSK6 (2.3)	HNF1A (2.2)	YIPF2 (2.2)	AP1M2 (2.0)	C19orf52 (1.6)	C12orf47 (1.5)	PPP1R37 (1.5)	NKPD1 (1.3)	PARP10 (1.3)
GO:0006516	glycoprotein catabolic process	0.83	> 0.20	C1orf63 (2.4)	CLPTM1 (2.2)	YIPF2 (2.1)	DNAH11 (1.9)	ERP29 (1.8)	TMEM50A (1.8)	TRAPPC6A (1.7)	ENSG00000228044 (1.7)	GRINA (1.5)	TMEM57 (1.5)
GO:0007015	actin filament organization	0.83	> 0.20	C11orf9 (2.8)	HAVCR1 (2.2)	ITGB3 (2.1)	ABO (2.0)	PLEC (1.9)	ADAM1 (1.9)	ST3GAL4 (1.9)	PVRL2 (1.7)	C17orf57 (1.3)	CBLC (1.3)
GO:0031461	cullin-RING ubiquitin ligase complex	0.83	> 0.20	SUGP1 (2.8)	TRAFD1 (2.8)	LPIN3 (2.6)	CARM1 (2.5)	POC5 (2.3)	MAU2 (2.3)	TMEM116 (2.2)	BUD13 (1.9)	DYNC2LI1 (1.7)	BRAP (1.7)
GO:0007033	vacuole organization	0.83	> 0.20	ERP29 (3.5)	BRAP (3.2)	TMEM50A (2.6)	TXNL4B (2.6)	TRAPPC6A (2.5)	C1orf63 (2.3)	YIPF2 (2.3)	BLOC1S3 (2.1)	ENSG00000228044 (2.0)	ACAD10 (2.0)
ENSG00000132963	POMP PPI subnetwork	0.83	> 0.20	PSMA5 (6.8)	TRAFD1 (3.2)	TMEM50A (3.0)	NAA25 (1.8)	C12orf47 (1.7)	NT5DC1 (1.6)	ENSG00000254235 (1.5)	CYB561D1 (1.5)	LPA (1.5)	C19orf52 (1.3)
MP:0006117	aortic valve stenosis	0.83	> 0.20	PLEKHH2 (2.5)	PVR (2.4)	TRIB1 (2.0)	CEACAM19 (1.9)	ENSG00000226645 (1.6)	CILP2 (1.4)	ACAD10 (1.4)	PVRL2 (1.4)	UBXN2B (1.4)	TSSK6 (1.4)
ENSG00000137818	RPLP1 PPI subnetwork	0.83	> 0.20	GATAD2A (2.5)	C1orf63 (2.3)	NKPD1 (2.0)	NAA25 (1.7)	ZNF101 (1.5)	ILF3 (1.5)	ANKRD31 (1.3)	SMARCA4 (1.3)	HAVCR1 (1.3)	HMGCR (1.2)
GO:0009880	embryonic pattern specification	0.83	> 0.20	ABO (2.4)	DYNC2LI1 (1.8)	KANK2 (1.5)	DNAH11 (1.4)	NKPD1 (1.3)	CBLC (1.3)	ENSG00000226648 (1.3)	ENSG00000235545 (1.3)	LPAR2 (1.2)	NYNRIN (1.2)
GO:0033599	regulation of mammary gland epithelial cell proliferation	0.83	> 0.20	DNAH11 (2.9)	C17orf57 (2.0)	BLOC1S3 (1.8)	TRAPPC6A (1.8)	HLX (1.7)	PPP1R37 (1.7)	NKPD1 (1.3)	TMEM57 (1.3)	ENSG00000226648 (1.2)	ATXN7L2 (1.2)
ENSG00000112769	LAMA4 PPI subnetwork	0.83	> 0.20	SLC44A2 (2.7)	TMEM116 (1.9)	ZNF180 (1.8)	MARK4 (1.8)	FADS2 (1.5)	GEMIN7 (1.4)	PSRC1 (1.4)	NT5DC1 (1.4)	SARS (1.2)	ADAM1 (1.1)
ENSG00000198637	ENSG00000198637 PPI subnetwork	0.83	> 0.20	NKPD1 (3.2)	MOSC1 (1.6)	CEACAM19 (1.5)	ANKRD31 (1.4)	GATAD2A (1.4)	DNAH11 (1.3)	ENSG00000226645 (1.2)	CBLC (1.2)	DOCK7 (1.2)	ZNF101 (1.1)
ENSG00000176534	ENSG00000176534 PPI subnetwork	0.83	> 0.20	NKPD1 (3.2)	MOSC1 (1.6)	CEACAM19 (1.5)	ANKRD31 (1.4)	GATAD2A (1.4)	DNAH11 (1.3)	ENSG00000226645 (1.2)	CBLC (1.2)	DOCK7 (1.2)	ZNF101 (1.1)
ENSG00000196681	ENSG00000196681 PPI subnetwork	0.83	> 0.20	NKPD1 (3.2)	MOSC1 (1.6)	CEACAM19 (1.5)	ANKRD31 (1.4)	GATAD2A (1.4)	DNAH11 (1.3)	ENSG00000226645 (1.2)	CBLC (1.2)	DOCK7 (1.2)	ZNF101 (1.1)
MP:0002730	head shaking	0.83	> 0.20	NCAN (2.6)	ALDH2 (2.6)	CYP7A1 (2.0)	CELSR2 (2.0)	FRK (2.0)	APOE (1.9)	ANGPTL3 (1.8)	APOC1 (1.6)	CETP (1.6)	TMED4 (1.5)
ENSG00000196792	STRN3 PPI subnetwork	0.83	> 0.20	PSMA5 (3.1)	ZNF180 (3.0)	GOT2P1 (2.4)	COL4A3BP (2.1)	DYNC2LI1 (2.0)	TMEM50A (2.0)	MARK4 (1.9)	SARS (1.9)	UBXN2B (1.8)	DNAH11 (1.5)
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	0.83	> 0.20	ITGB3 (4.8)	SH2B3 (2.4)	TMEM50A (2.0)	ST3GAL4 (1.9)	HLX (1.8)	PVRL2 (1.8)	C12orf47 (1.3)	FADS2 (1.3)	ENSG00000235545 (1.2)	PTPN11 (1.2)
GO:0031984	organelle subcompartment	0.83	> 0.20	YIPF2 (4.9)	TMED4 (3.2)	ST3GAL4 (3.1)	LPIN3 (2.3)	SLC44A2 (2.1)	CYB561D1 (2.0)	ENSG00000235545 (1.9)	TMEM57 (1.7)	ERP29 (1.7)	CILP2 (1.3)
GO:0030947	regulation of vascular endothelial growth factor receptor signaling pathway	0.83	> 0.20	KANK2 (2.4)	TMEM116 (2.2)	PVR (2.1)	C17orf57 (2.1)	DNAH11 (1.7)	ENSG00000226648 (1.5)	SH2B3 (1.4)	CYP7A1 (1.4)	HLX (1.4)	TSSK6 (1.4)
GO:0008016	regulation of heart contraction	0.83	> 0.20	PPP1R37 (2.6)	ENSG00000226648 (2.4)	TMEM116 (1.9)	ABO (1.6)	NKPD1 (1.6)	C12orf47 (1.6)	KANK2 (1.5)	KIAA1324 (1.5)	ACAD10 (1.3)	C17orf57 (1.3)
ENSG00000102781	KATNAL1 PPI subnetwork	0.83	> 0.20	SARS (4.2)	TMEM50A (3.2)	TMEM57 (3.0)	POC5 (2.8)	C12orf51 (2.5)	PSMA5 (2.3)	BLOC1S3 (2.1)	TMED4 (2.1)	PBX4 (2.1)	TXNL4B (1.9)
ENSG00000071909	MYO3B PPI subnetwork	0.83	> 0.20	PLEC (2.3)	DOCK7 (2.0)	LPIN3 (2.0)	PLCG1 (2.0)	BRAP (1.8)	GATAD2A (1.6)	TRAFD1 (1.5)	SARS (1.5)	ABCG8 (1.5)	PVR (1.5)
GO:0006833	water transport	0.83	> 0.20	ENSG00000235545 (2.6)	ST3GAL4 (2.5)	ADAM1 (2.3)	ENSG00000228044 (2.3)	ITGB3 (1.9)	GMPR (1.8)	ZHX3 (1.7)	AMIGO1 (1.6)	GOT2P1 (1.6)	PMFBP1 (1.5)
GO:0031648	protein destabilization	0.83	> 0.20	YIPF2 (2.3)	GOT2P1 (2.0)	POLK (2.0)	SLC44A2 (1.8)	GATAD2A (1.7)	TRAPPC6A (1.6)	GEMIN7 (1.6)	ATXN2 (1.5)	CEACAM19 (1.4)	TSSK6 (1.3)
ENSG00000145391	SETD7 PPI subnetwork	0.83	> 0.20	PSRC1 (2.1)	PBX4 (1.6)	HAPLN4 (1.5)	MYLIP (1.5)	MARK4 (1.4)	PARP10 (1.4)	GATAD2A (1.4)	AMIGO1 (1.4)	GEMIN7 (1.3)	C12orf47 (1.3)
MP:0000036	absent semicircular canals	0.83	> 0.20	CILP2 (2.0)	MYLIP (1.8)	KIAA1324 (1.6)	NKPD1 (1.6)	TSSK6 (1.5)	AP1M2 (1.5)	BLOC1S3 (1.4)	PPP1R37 (1.3)	NCAN (1.3)	GMIP (1.2)
ENSG00000053900	ANAPC4 PPI subnetwork	0.83	> 0.20	PSRC1 (6.2)	FEN1 (3.6)	POC5 (2.9)	USP1 (1.7)	LPIN3 (1.7)	GEMIN7 (1.3)	RHCE (1.3)	CBLC (1.3)	CETP (1.2)	SUGP1 (1.1)
MP:0003123	paternal imprinting	0.83	> 0.20	ATXN7L2 (2.2)	MOSC1 (2.2)	AP1M2 (2.1)	GMPR (1.9)	DNAH11 (1.7)	OGDH (1.7)	PCSK9 (1.5)	PMFBP1 (1.5)	HAPLN4 (1.4)	C11orf9 (1.4)
ENSG00000126214	KLC1 PPI subnetwork	0.83	> 0.20	DNM2 (2.9)	LPAR2 (2.7)	ATXN2 (2.6)	AP1M2 (2.6)	CBLC (2.4)	MAU2 (2.3)	SMARCA4 (2.2)	GRINA (2.1)	UBXN2B (2.1)	PLEC (2.1)
ENSG00000133392	MYH11 PPI subnetwork	0.83	> 0.20	ALDH2 (2.5)	CELSR2 (2.5)	SH2B3 (2.0)	DNM2 (1.9)	C11orf9 (1.9)	ENSG00000226648 (1.9)	MARK4 (1.8)	PTPN11 (1.6)	NCAN (1.6)	NT5DC1 (1.5)
MP:0004851	increased testis weight	0.83	> 0.20	ENSG00000228044 (2.6)	ST3GAL4 (2.4)	GMPR (2.0)	CYB561D1 (1.9)	BCL3 (1.8)	TSSK6 (1.7)	DOCK7 (1.7)	PLEC (1.4)	PLEKHH2 (1.3)	FRK (1.3)
GO:0021854	hypothalamus development	0.83	> 0.20	GOT2P1 (3.3)	POLK (2.2)	GEMIN7 (2.0)	NKPD1 (1.9)	PPP1R37 (1.9)	ANKRD31 (1.7)	ATXN7L2 (1.7)	ZNF101 (1.5)	ST3GAL4 (1.5)	ABO (1.4)
GO:0042517	positive regulation of tyrosine phosphorylation of Stat3 protein	0.83	> 0.20	ENSG00000254235 (2.6)	PVR (2.3)	CYB561D1 (2.1)	PBX4 (2.1)	ENSG00000238078 (1.8)	ALDH2 (1.2)	DYNC2LI1 (1.2)	NKPD1 (1.2)	MOSC1 (1.1)	KIAA1324 (1.0)
ENSG00000114698	PLSCR4 PPI subnetwork	0.83	> 0.20	SUGP1 (2.7)	C12orf43 (2.1)	USP1 (1.9)	MAPKAPK5 (1.9)	ADAM1 (1.8)	PCSK9 (1.7)	SMARCA4 (1.7)	PPP1R37 (1.7)	POC5 (1.7)	GEMIN7 (1.6)
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE	0.83	> 0.20	HLX (2.7)	SH2B3 (2.3)	FADS2 (1.9)	SORT1 (1.9)	LDLR (1.5)	FADS1 (1.4)	PPP1R37 (1.4)	CBLC (1.4)	PMFBP1 (1.4)	PCSK9 (1.3)
ENSG00000127946	HIP1 PPI subnetwork	0.83	> 0.20	POLK (4.2)	C17orf57 (2.6)	C12orf51 (2.4)	SORT1 (2.3)	C1orf63 (2.2)	COL4A3BP (2.2)	SYPL2 (2.2)	PPP1R37 (2.0)	CEACAM19 (2.0)	C12orf43 (1.9)
GO:0042994	cytoplasmic sequestering of transcription factor	0.83	> 0.20	ENSG00000238078 (2.2)	ATXN7L2 (2.1)	PBX4 (2.0)	LPAR2 (2.0)	ZNF101 (1.8)	PMFBP1 (1.7)	ABO (1.6)	RELB (1.5)	ENSG00000235545 (1.4)	AMIGO1 (1.2)
GO:0042522	regulation of tyrosine phosphorylation of Stat5 protein	0.83	> 0.20	PBX4 (3.3)	ANKRD31 (2.4)	GCNT4 (1.8)	DNAH11 (1.3)	SH2B3 (1.2)	ENSG00000254235 (1.2)	KIAA1324 (1.2)	SLC22A1 (1.2)	GEMIN7 (1.0)	TIMD4 (0.9)
ENSG00000158402	CDC25C PPI subnetwork	0.83	> 0.20	PSRC1 (5.1)	FEN1 (3.0)	LPIN3 (2.8)	PLCG1 (2.5)	GRINA (2.4)	ENSG00000226648 (2.2)	CARM1 (2.1)	ENSG00000226645 (2.0)	ZNF101 (1.9)	HAPLN4 (1.8)
GO:0008285	negative regulation of cell proliferation	0.83	> 0.20	TRIB1 (2.4)	MYLIP (2.0)	MAFB (1.7)	ENSG00000226648 (1.6)	ENSG00000226645 (1.3)	ST3GAL4 (1.2)	ATXN2 (1.1)	CILP2 (1.1)	HLX (1.1)	ENSG00000228044 (1.0)
ENSG00000102977	ACD PPI subnetwork	0.83	> 0.20	TXNL4B (2.4)	SUGP1 (2.2)	NKPD1 (2.0)	POLK (1.8)	RHCE (1.7)	TMEM57 (1.7)	DHODH (1.6)	C19orf52 (1.6)	ZNF101 (1.6)	TMEM116 (1.4)
ENSG00000162244	RPL29 PPI subnetwork	0.83	> 0.20	NKPD1 (3.8)	ERP29 (1.9)	MOSC1 (1.6)	GATAD2A (1.4)	LPAR2 (1.4)	CEACAM19 (1.4)	CBLC (1.4)	PLEKHH2 (1.3)	ZNF101 (1.2)	ADAM1 (1.2)
ENSG00000075624	ACTB PPI subnetwork	0.83	> 0.20	SMARCA4 (3.0)	ITGB3 (2.9)	PLEC (2.7)	DOCK7 (2.6)	ADAM1 (2.2)	ILF3 (2.0)	SARS (1.9)	ATXN2 (1.9)	OGDH (1.7)	TMEM50A (1.5)
GO:0010002	cardioblast differentiation	0.83	> 0.20	C11orf9 (3.1)	NYNRIN (2.7)	ENSG00000226648 (2.1)	LPIN3 (1.9)	NPC1L1 (1.4)	LPAR2 (1.4)	NKPD1 (1.4)	KANK2 (1.4)	ACAD10 (1.2)	AP1M2 (1.2)
GO:0007498	mesoderm development	0.83	> 0.20	ENSG00000238078 (2.6)	ENSG00000226648 (2.5)	NYNRIN (2.2)	ATXN7L2 (1.9)	ADAM1 (1.7)	ENSG00000254235 (1.6)	CARM1 (1.5)	AMIGO1 (1.4)	PVRL2 (1.4)	NKPD1 (1.3)
ENSG00000128245	YWHAH PPI subnetwork	0.83	> 0.20	AP1M2 (2.4)	CBLC (2.1)	SLC44A2 (2.1)	ATXN2 (2.1)	HAPLN4 (2.0)	COL4A3BP (1.9)	MARK4 (1.8)	KANK2 (1.8)	BCAM (1.8)	SMARCA4 (1.7)
MP:0001429	dehydration	0.83	> 0.20	AP1M2 (2.8)	CEACAM19 (2.5)	NKPD1 (2.3)	CELSR2 (2.1)	RHCE (1.9)	ENSG00000235545 (1.6)	YIPF2 (1.6)	GRINA (1.5)	GPAM (1.5)	CBLC (1.4)
GO:0050686	negative regulation of mRNA processing	0.83	> 0.20	ADAM1 (3.6)	ATXN2 (2.9)	C12orf43 (2.8)	C1orf63 (2.7)	BRAP (2.6)	BUD13 (2.4)	MAPKAPK5 (2.3)	C17orf57 (2.1)	ERP29 (2.0)	TOP1 (1.9)
MP:0005353	abnormal patella morphology	0.83	> 0.20	CILP2 (4.8)	PLEKHH2 (2.7)	CEACAM19 (2.4)	ENSG00000226645 (2.1)	KANK2 (1.9)	UBXN2B (1.6)	PMFBP1 (1.6)	NT5DC1 (1.5)	HAVCR1 (1.3)	MAFB (1.2)
GO:0009303	rRNA transcription	0.83	> 0.20	DDX56 (3.0)	ENSG00000226645 (2.2)	C12orf43 (2.1)	NAA25 (2.0)	TXNL4B (1.9)	QTRT1 (1.8)	C19orf52 (1.7)	TOMM40 (1.7)	ZNF259 (1.6)	ATP13A1 (1.5)
ENSG00000166313	APBB1 PPI subnetwork	0.83	> 0.20	MAU2 (2.8)	CLPTM1 (2.5)	TMEM50A (2.3)	CELSR2 (2.3)	SUGP1 (2.2)	HAVCR1 (2.0)	RPH3A (2.0)	ATXN2 (1.9)	PLEKHH2 (1.6)	C11orf9 (1.6)
MP:0008028	pregnancy-related premature death	0.83	> 0.20	KANK2 (2.5)	POLK (2.2)	ENSG00000226645 (2.1)	ST3GAL4 (1.8)	ZHX3 (1.8)	KIAA1324 (1.6)	ERP29 (1.6)	DOCK7 (1.5)	CBLC (1.5)	PVR (1.4)
ENSG00000159023	EPB41 PPI subnetwork	0.83	> 0.20	TMEM50A (3.2)	PSMA5 (1.9)	TOMM40 (1.8)	RHD (1.7)	TMED4 (1.7)	ADAM1 (1.7)	SMARCA4 (1.7)	OGDH (1.6)	GATAD2A (1.5)	PTPN11 (1.5)
ENSG00000125484	GTF3C4 PPI subnetwork	0.83	> 0.20	DDX56 (3.6)	ATP13A1 (2.5)	C12orf43 (2.4)	ZNF259 (2.3)	QTRT1 (2.2)	ENSG00000226645 (2.1)	TOMM40 (2.0)	ATXN7L2 (1.7)	ILF3 (1.7)	SUGP1 (1.6)
ENSG00000138107	ACTR1A PPI subnetwork	0.83	> 0.20	CYB561D1 (2.3)	C12orf51 (2.3)	TXNL4B (2.3)	AMIGO1 (2.1)	SMARCA4 (2.1)	SARS (1.9)	BRAP (1.9)	TMEM50A (1.8)	MAU2 (1.7)	TMEM57 (1.7)
ENSG00000108848	LUC7L3 PPI subnetwork	0.83	> 0.20	C1orf63 (3.9)	TXNL4B (3.1)	TOP1 (2.9)	GEMIN7 (2.2)	BUD13 (2.0)	ZNF180 (1.9)	BLOC1S3 (1.8)	C19orf52 (1.8)	TRAPPC6A (1.7)	BRAP (1.6)
MP:0004970	kidney atrophy	0.83	> 0.20	HNF1A (2.9)	TMED4 (2.7)	BCAM (2.5)	NT5DC1 (2.4)	TMEM116 (2.3)	C11orf9 (2.1)	ERP29 (1.6)	C17orf57 (1.6)	PVRL2 (1.4)	PLEKHH2 (1.4)
GO:0010810	regulation of cell-substrate adhesion	0.83	> 0.20	SLC44A2 (4.0)	PBX4 (2.9)	PLEKHH2 (2.6)	ITGB3 (2.3)	ANKRD31 (2.1)	CILP2 (2.0)	GCNT4 (2.0)	SORT1 (1.5)	ZHX3 (1.5)	C17orf57 (1.5)
ENSG00000112282	MED23 PPI subnetwork	0.83	> 0.20	BUD13 (3.2)	GEMIN7 (3.1)	C12orf51 (2.2)	USP24 (2.1)	BRAP (2.1)	MAPKAPK5 (2.1)	C17orf57 (2.0)	MAU2 (1.8)	DHX38 (1.8)	TXNL4B (1.7)
GO:0010922	positive regulation of phosphatase activity	0.83	> 0.20	TRAFD1 (2.3)	ENSG00000226645 (1.7)	PMFBP1 (1.7)	GCNT4 (1.7)	ENSG00000235545 (1.6)	ENSG00000238078 (1.6)	POLK (1.6)	POC5 (1.3)	YIPF2 (1.3)	HAVCR1 (1.3)
ENSG00000121957	GPSM2 PPI subnetwork	0.83	> 0.20	HAVCR1 (2.8)	PSRC1 (2.2)	BUD13 (2.1)	PLEC (2.0)	ZNF180 (1.8)	PSMA5 (1.7)	SARS (1.7)	USP1 (1.6)	SYPL2 (1.6)	C11orf9 (1.5)
GO:0048863	stem cell differentiation	0.83	> 0.20	NYNRIN (2.3)	CELSR2 (2.1)	BCAM (1.9)	ENSG00000254235 (1.5)	NCAN (1.5)	ENSG00000226648 (1.5)	TSSK6 (1.3)	DYNC2LI1 (1.3)	ENSG00000235545 (1.3)	DOCK7 (1.2)
GO:0045639	positive regulation of myeloid cell differentiation	0.83	> 0.20	RHCE (2.9)	ITGB3 (2.9)	ENSG00000238078 (2.7)	PBX4 (2.2)	ENSG00000235545 (2.2)	MYLIP (2.2)	RHD (2.1)	C1orf63 (1.9)	ENSG00000226645 (1.9)	C12orf51 (1.5)
REACTOME_PLATELET_HOMEOSTASIS	REACTOME_PLATELET_HOMEOSTASIS	0.83	> 0.20	ITGB3 (4.1)	SORT1 (2.4)	HLX (2.4)	MOSC1 (2.2)	CETP (2.2)	C12orf51 (1.7)	KANK2 (1.3)	TMEM50A (1.3)	GOT2P1 (1.1)	PLEKHH2 (1.0)
GO:0006406	mRNA export from nucleus	0.83	> 0.20	C1orf63 (5.2)	TOP1 (3.3)	ILF3 (2.5)	TXNL4B (2.4)	ADAM1 (2.4)	DHODH (2.0)	BUD13 (2.0)	SUGP1 (2.0)	ATXN7L2 (2.0)	MAPKAPK5 (1.9)
ENSG00000099624	ATP5D PPI subnetwork	0.83	> 0.20	PSMA5 (3.6)	C12orf47 (3.0)	GOT2P1 (2.4)	OGDH (2.4)	ZNF180 (1.7)	ACAD10 (1.5)	CLPTM1 (1.4)	C19orf52 (1.4)	ENSG00000238078 (1.3)	DYNC2LI1 (1.3)
GO:0032069	regulation of nuclease activity	0.83	> 0.20	OASL (4.1)	PARP10 (2.6)	NKPD1 (2.3)	C1orf63 (2.0)	PMFBP1 (1.9)	LPIN3 (1.8)	TXNL4B (1.8)	HAVCR1 (1.7)	HNF1A (1.7)	ENSG00000254235 (1.6)
MP:0006386	absent somites	0.83	> 0.20	NAA25 (2.8)	SH2B3 (2.2)	ATP13A1 (2.1)	CEACAM19 (2.1)	APOE (2.1)	PLCG1 (1.8)	DOCK7 (1.7)	HNF1A (1.7)	MAU2 (1.6)	ZNF101 (1.5)
REACTOME_PI3K_CASCADE	REACTOME_PI3K_CASCADE	0.83	> 0.20	PTPN11 (3.5)	HAPLN4 (2.7)	ZHX3 (2.7)	GPAM (2.5)	BRAP (2.5)	TMEM57 (2.2)	USP24 (2.2)	C11orf9 (2.0)	COL4A3BP (2.0)	PLEKHH2 (1.8)
ENSG00000072864	NDE1 PPI subnetwork	0.83	> 0.20	PSRC1 (5.8)	FEN1 (4.7)	USP1 (3.5)	POC5 (3.4)	ENSG00000226648 (1.1)	ENSG00000228044 (1.0)	ZNF180 (1.0)	ZHX3 (0.7)	C17orf57 (0.7)	ILF3 (0.6)
GO:0006446	regulation of translational initiation	0.83	> 0.20	BRAP (2.7)	ZNF259 (2.7)	TXNL4B (2.3)	DDX56 (2.3)	MAPKAPK5 (2.1)	C12orf43 (2.0)	SARS (2.0)	TMEM57 (1.9)	MYLIP (1.7)	ILF3 (1.7)
MP:0008050	decreased memory T cell number	0.83	> 0.20	RELB (3.2)	ZNF101 (2.3)	GEMIN7 (2.2)	TRAFD1 (1.8)	ENSG00000235545 (1.4)	PBX4 (1.4)	C12orf43 (1.4)	TRAPPC6A (1.3)	CYB561D1 (1.3)	PARP10 (1.3)
GO:0090278	negative regulation of peptide hormone secretion	0.83	> 0.20	KIAA1324 (4.7)	MOSC1 (2.2)	GPAM (2.1)	AMIGO1 (2.1)	ANKRD31 (1.9)	AP1M2 (1.6)	ENSG00000228044 (1.4)	TMED4 (1.4)	LPIN3 (1.2)	ENSG00000238078 (1.2)
GO:0050699	WW domain binding	0.83	> 0.20	AP1M2 (2.7)	SLC44A2 (2.5)	NKPD1 (2.2)	ST3GAL4 (2.1)	CBLC (2.0)	BCL3 (1.7)	GRINA (1.7)	NYNRIN (1.7)	ENSG00000226648 (1.6)	PSRC1 (1.4)
MP:0010867	abnormal bone trabecula morphology	0.83	> 0.20	TRIB1 (2.7)	PLEKHH2 (2.3)	ADAM1 (2.1)	MAFB (2.0)	ALDH2 (1.8)	MAPKAPK5 (1.8)	KANK2 (1.5)	ENSG00000238078 (1.4)	POLK (1.3)	CYP7A1 (1.2)
ENSG00000198929	NOS1AP PPI subnetwork	0.83	> 0.20	GOT2P1 (3.2)	SORT1 (2.5)	KIAA1324 (2.5)	HAVCR1 (2.0)	HAPLN4 (1.9)	MARK4 (1.9)	USP24 (1.6)	C12orf47 (1.6)	GCNT4 (1.5)	FADS1 (1.5)
ENSG00000161011	SQSTM1 PPI subnetwork	0.83	> 0.20	TXNL4B (2.5)	SLC44A2 (2.3)	ENSG00000226645 (2.0)	TMEM50A (1.7)	PMFBP1 (1.6)	COL4A3BP (1.6)	ZNF101 (1.6)	ACAD10 (1.5)	ILF3 (1.5)	TMEM116 (1.4)
MP:0009862	abnormal aorta elastic tissue morphology	0.83	> 0.20	PLEKHH2 (2.1)	KANK2 (2.0)	APOC1 (1.4)	SLC44A2 (1.4)	CILP2 (1.3)	ATXN7L2 (1.3)	ENSG00000226648 (1.2)	DYNC2LI1 (1.2)	HLX (1.1)	NYNRIN (1.0)
MP:0004384	small interparietal bone	0.83	> 0.20	PVR (2.2)	TMEM57 (1.8)	YIPF2 (1.6)	CARM1 (1.4)	MAU2 (1.3)	NYNRIN (1.2)	ABO (1.2)	PLEC (1.1)	PLCG1 (1.1)	ENSG00000254235 (1.0)
MP:0000522	kidney cortex cysts	0.83	> 0.20	HAVCR1 (3.4)	PLEKHH2 (3.3)	KANK2 (2.5)	C11orf9 (2.3)	BCAM (2.3)	HNF1A (2.2)	FRK (2.0)	DYNC2LI1 (2.0)	PMFBP1 (1.8)	HLX (1.5)
ENSG00000213611	ENSG00000213611 PPI subnetwork	0.83	> 0.20	ITGB3 (3.4)	TM6SF2 (1.9)	ENSG00000254235 (1.4)	HAPLN4 (1.3)	ST3GAL4 (1.1)	TMEM50A (1.1)	CETP (1.1)	PMFBP1 (1.1)	ABCG8 (1.1)	MOSC1 (1.0)
GO:0008430	selenium binding	0.83	> 0.20	APOE (3.3)	TMEM50A (2.5)	ENSG00000228044 (2.1)	TRAPPC6A (2.1)	RHD (2.1)	PSMA5 (1.9)	CETP (1.4)	NCAN (1.4)	ANGPTL3 (1.3)	RHCE (1.3)
GO:0045022	early endosome to late endosome transport	0.83	> 0.20	AP1M2 (3.0)	YIPF2 (2.9)	CYB561D1 (2.9)	AMIGO1 (2.1)	HAVCR1 (2.1)	FRK (2.0)	ZNF180 (2.0)	UBXN2B (1.9)	COL4A3BP (1.8)	CBLC (1.7)
MP:0003672	abnormal ureter development	0.83	> 0.20	PLEKHH2 (2.7)	MYLIP (2.5)	KANK2 (2.2)	TMED4 (2.1)	NYNRIN (2.0)	TRIB1 (1.9)	HLX (1.8)	PVRL2 (1.3)	C19orf52 (1.3)	TMEM116 (1.2)
MP:0008585	absent photoreceptor outer segment	0.84	> 0.20	DYNC2LI1 (2.7)	RHCE (2.1)	TMEM116 (2.0)	PMFBP1 (1.8)	KIAA1324 (1.7)	ABO (1.5)	MYLIP (1.5)	ATXN7L2 (1.5)	GOT2P1 (1.1)	UBXN2B (1.0)
GO:0060795	cell fate commitment involved in formation of primary germ layer	0.84	> 0.20	C19orf52 (2.1)	DYNC2LI1 (1.9)	TSSK6 (1.8)	NYNRIN (1.7)	DNAH11 (1.4)	LPIN3 (1.4)	ENSG00000254235 (1.4)	ANKRD31 (1.2)	ALDH2 (1.2)	ZNF101 (1.2)
ENSG00000168421	RHOH PPI subnetwork	0.84	> 0.20	SLC44A2 (2.3)	TMEM57 (2.1)	NYNRIN (2.0)	RHCE (1.9)	AP1M2 (1.7)	GMIP (1.6)	RHD (1.5)	BCAM (1.4)	NPC1L1 (1.3)	ZNF180 (1.2)
ENSG00000114353	GNAI2 PPI subnetwork	0.84	> 0.20	KIAA1324 (2.3)	AMIGO1 (2.0)	ITGB3 (1.9)	HLX (1.8)	MYLIP (1.4)	SORT1 (1.4)	GCNT4 (1.3)	DNAH11 (1.2)	KANK2 (1.2)	PSRC1 (1.1)
ENSG00000134242	PTPN22 PPI subnetwork	0.84	> 0.20	GMIP (3.2)	ZNF101 (3.0)	PLCG1 (2.6)	C19orf52 (2.0)	COL4A3BP (1.7)	ALDH2 (1.5)	DNM2 (1.4)	MAFB (1.4)	DNAH11 (1.2)	OGDH (1.2)
GO:0032288	myelin assembly	0.84	> 0.20	ENSG00000228044 (2.8)	C11orf9 (2.5)	GCNT4 (2.2)	HAPLN4 (2.2)	GEMIN7 (2.1)	PMFBP1 (1.7)	SORT1 (1.7)	ENSG00000235545 (1.6)	KIAA1324 (1.4)	CYB561D1 (1.4)
GO:0007090	regulation of S phase of mitotic cell cycle	0.84	> 0.20	MAU2 (3.9)	ENSG00000226648 (2.4)	C19orf52 (2.0)	GATAD2A (2.0)	TXNL4B (2.0)	PLCG1 (1.6)	SUGP1 (1.5)	PPP1R37 (1.5)	UBXN2B (1.5)	DHX38 (1.4)
REACTOME_MEIOSIS	REACTOME_MEIOSIS	0.84	> 0.20	USP1 (3.7)	FEN1 (2.9)	TMEM116 (1.6)	ANKRD31 (1.4)	ENSG00000235545 (1.3)	TXNL4B (1.3)	PSRC1 (1.1)	KANK2 (1.0)	POC5 (0.9)	PLEKHH2 (0.9)
ENSG00000147854	UHRF2 PPI subnetwork	0.84	> 0.20	MAPKAPK5 (2.6)	POC5 (2.3)	COL4A3BP (2.2)	C1orf63 (2.2)	C19orf52 (2.1)	USP1 (2.1)	DYNC2LI1 (1.8)	TXNL4B (1.7)	TOP1 (1.6)	C17orf57 (1.5)
ENSG00000108039	XPNPEP1 PPI subnetwork	0.84	> 0.20	MAPKAPK5 (2.0)	ABO (1.9)	DNAH11 (1.9)	UBXN2B (1.8)	TMED4 (1.8)	NT5DC1 (1.7)	AMIGO1 (1.6)	ABCG8 (1.6)	GOT2P1 (1.5)	TOMM40 (1.4)
MP:0003105	abnormal heart atrium morphology	0.84	> 0.20	BCAM (2.5)	ATXN2 (2.4)	NYNRIN (2.4)	PVRL2 (1.8)	C11orf9 (1.7)	SLC44A2 (1.6)	BLOC1S3 (1.6)	MARK4 (1.6)	ENSG00000238078 (1.5)	CETP (1.5)
GO:0005089	Rho guanyl-nucleotide exchange factor activity	0.84	> 0.20	PLCG1 (3.1)	PLEC (2.1)	AP1M2 (2.1)	CBLC (2.1)	LPAR2 (2.1)	PBX4 (2.0)	FRK (2.0)	DNM2 (1.9)	GATAD2A (1.9)	SH2B3 (1.9)
ENSG00000182899	RPL35A PPI subnetwork	0.84	> 0.20	NKPD1 (2.6)	NAA25 (2.0)	ZNF259 (1.9)	C12orf43 (1.7)	SARS (1.7)	ADAM1 (1.7)	PTPN11 (1.5)	ILF3 (1.5)	ANKRD31 (1.5)	TRAFD1 (1.5)
GO:0048010	vascular endothelial growth factor receptor signaling pathway	0.84	> 0.20	HLX (2.7)	C17orf57 (2.6)	PVR (2.5)	TSSK6 (2.1)	SH2B3 (2.0)	KANK2 (1.8)	PVRL2 (1.8)	TMEM116 (1.4)	DNAH11 (1.2)	GEMIN7 (1.1)
GO:0043304	regulation of mast cell degranulation	0.84	> 0.20	BLOC1S3 (2.4)	ENSG00000235545 (1.9)	ALDH2 (1.8)	NKPD1 (1.8)	GEMIN7 (1.7)	GMIP (1.6)	ERP29 (1.5)	GMPR (1.5)	ST3GAL4 (1.5)	C12orf47 (1.4)
ENSG00000139921	TMX1 PPI subnetwork	0.84	> 0.20	C12orf51 (3.2)	MARK4 (3.1)	LPAR2 (2.6)	GMIP (2.3)	ATXN2 (2.2)	USP24 (2.2)	SORT1 (2.1)	POLK (1.9)	SLC44A2 (1.8)	BUD13 (1.7)
GO:0035064	methylated histone residue binding	0.84	> 0.20	USP1 (3.1)	COL4A3BP (2.6)	C19orf52 (2.5)	CYB561D1 (2.4)	ENSG00000235545 (2.0)	C1orf63 (2.0)	FEN1 (1.9)	ENSG00000226645 (1.8)	BUD13 (1.7)	PPP1R37 (1.7)
MP:0010736	abnormal extraembryonic ectoderm morphology	0.84	> 0.20	DOCK7 (2.4)	TRIB1 (2.2)	ENSG00000226648 (2.0)	GCNT4 (1.8)	CELSR2 (1.8)	MYLIP (1.7)	NCAN (1.7)	KIAA1324 (1.5)	CILP2 (1.4)	TRAFD1 (1.3)
GO:0034694	response to prostaglandin stimulus	0.84	> 0.20	BLOC1S3 (2.6)	CETP (2.2)	ZNF101 (1.8)	NKPD1 (1.7)	NT5DC1 (1.7)	AMIGO1 (1.7)	HAVCR1 (1.6)	ZNF180 (1.6)	GOT2P1 (1.6)	TIMD4 (1.5)
GO:0002579	positive regulation of antigen processing and presentation	0.84	> 0.20	CEACAM19 (2.5)	BLOC1S3 (2.5)	ENSG00000235545 (2.4)	ZNF101 (2.2)	NKPD1 (2.2)	CETP (2.0)	ALDH2 (2.0)	PARP10 (1.7)	TIMD4 (1.7)	CYB561D1 (1.6)
ENSG00000185920	PTCH1 PPI subnetwork	0.84	> 0.20	PLEKHH2 (1.8)	TM6SF2 (1.7)	ZHX3 (1.7)	C12orf51 (1.6)	KIAA1324 (1.5)	FEN1 (1.4)	TMED4 (1.4)	NKPD1 (1.3)	DNAH11 (1.3)	ENSG00000235545 (1.3)
GO:0032095	regulation of response to food	0.84	> 0.20	KIAA1324 (2.3)	GCNT4 (1.9)	MAPKAPK5 (1.8)	TSSK6 (1.6)	C1orf63 (1.5)	LPIN3 (1.5)	ADAM1 (1.5)	ABCG8 (1.4)	ENSG00000235545 (1.3)	ENSG00000228044 (1.2)
MP:0004800	decreased susceptibility to experimental autoimmune encephalomyelitis	0.84	> 0.20	MAFB (2.9)	SH2B3 (2.6)	RELB (2.2)	MYLIP (2.0)	BCL3 (2.0)	PARP10 (1.8)	HLX (1.7)	GMIP (1.7)	TRAFD1 (1.2)	TRIB1 (1.2)
ENSG00000185024	BRF1 PPI subnetwork	0.84	> 0.20	GEMIN7 (4.0)	C12orf43 (2.7)	POC5 (2.4)	PTPN11 (2.3)	MAPKAPK5 (2.2)	TOMM40 (2.1)	DDX56 (1.8)	ADAM1 (1.7)	ZNF259 (1.6)	GOT2P1 (1.6)
MP:0008329	decreased somatotroph cell number	0.84	> 0.20	NKPD1 (4.2)	KIAA1324 (3.2)	HNF1A (2.8)	CELSR2 (2.7)	BCAM (2.4)	PMFBP1 (2.2)	TSSK6 (2.0)	C11orf9 (1.9)	TXNL4B (1.4)	PPP1R37 (1.4)
ENSG00000065135	GNAI3 PPI subnetwork	0.84	> 0.20	TMEM50A (2.5)	ZHX3 (2.4)	SH2B3 (2.4)	MYLIP (2.3)	ZNF180 (2.1)	AMIGO1 (1.8)	HLX (1.7)	ERP29 (1.5)	SORT1 (1.4)	DNAH11 (1.4)
ENSG00000139719	VPS33A PPI subnetwork	0.84	> 0.20	ACAD10 (3.6)	BRAP (3.3)	ZNF259 (3.0)	C12orf43 (2.9)	PTPN11 (2.1)	DDX56 (2.1)	ZNF101 (2.0)	SUGP1 (1.9)	C12orf47 (1.8)	SARS (1.7)
GO:0042572	retinol metabolic process	0.84	> 0.20	NKPD1 (3.2)	ALDH2 (1.9)	ENSG00000235545 (1.8)	LPAR2 (1.7)	PBX4 (1.6)	PCSK9 (1.5)	PMFBP1 (1.4)	MOSC1 (1.3)	DYNC2LI1 (1.3)	ABCG8 (1.3)
ENSG00000169021	UQCRFS1 PPI subnetwork	0.84	> 0.20	C19orf52 (3.6)	UBXN2B (2.8)	ACAD10 (2.3)	TRAPPC6A (2.2)	HP (2.0)	OGDH (1.8)	AMIGO1 (1.8)	MAU2 (1.8)	C12orf47 (1.6)	GRINA (1.5)
GO:0032653	regulation of interleukin-10 production	0.84	> 0.20	GCNT4 (2.0)	PBX4 (1.7)	TRAFD1 (1.4)	ZNF180 (1.3)	ENSG00000235545 (1.3)	TXNL4B (1.1)	ST3GAL4 (1.1)	MYLIP (1.0)	ANKRD31 (0.9)	POC5 (0.9)
GO:0048634	regulation of muscle organ development	0.84	> 0.20	ATXN7L2 (2.2)	C17orf57 (1.9)	GEMIN7 (1.6)	GMPR (1.6)	ENSG00000226648 (1.4)	SYPL2 (1.4)	PPP1R37 (1.3)	TXNL4B (1.2)	OGDH (1.0)	SLC44A2 (1.0)
ENSG00000114019	AMOTL2 PPI subnetwork	0.84	> 0.20	ITGB3 (2.0)	ZNF101 (1.9)	GMPR (1.9)	PPP1R37 (1.6)	ABCG8 (1.5)	LPIN3 (1.5)	TM6SF2 (1.4)	ACAD10 (1.4)	ADAM1 (1.3)	CYP7A1 (1.3)
GO:0071599	otic vesicle development	0.84	> 0.20	TSSK6 (2.9)	ANKRD31 (2.5)	C17orf57 (2.0)	PMFBP1 (1.9)	CILP2 (1.9)	ENSG00000238078 (1.7)	TMEM116 (1.6)	DYNC2LI1 (1.5)	ZNF101 (1.5)	PLEKHH2 (1.4)
GO:0005083	small GTPase regulator activity	0.84	> 0.20	GMIP (3.2)	C12orf51 (3.1)	DNM2 (3.1)	PLCG1 (2.6)	PPP1R37 (2.6)	SH2B3 (2.5)	PLEC (2.3)	HLX (2.1)	ZHX3 (2.1)	USP24 (1.9)
ENSG00000164951	PDP1 PPI subnetwork	0.84	> 0.20	TXNL4B (4.1)	DHODH (3.2)	UBXN2B (2.5)	DHX38 (2.5)	SUGP1 (2.0)	C19orf52 (1.7)	GRINA (1.7)	POLK (1.6)	PMFBP1 (1.5)	USP24 (1.5)
MP:0008753	abnormal osteocyte morphology	0.84	> 0.20	MAFB (3.2)	TMEM116 (3.2)	FRK (2.3)	ENSG00000226648 (1.8)	BCAM (1.8)	ADAM1 (1.5)	TRIB1 (1.5)	CILP2 (1.4)	MYLIP (1.3)	ENSG00000228044 (1.2)
ENSG00000196284	SUPT3H PPI subnetwork	0.84	> 0.20	MAPKAPK5 (2.2)	ATXN2 (2.2)	TOP1 (2.0)	C19orf52 (2.0)	SMARCA4 (2.0)	SUGP1 (2.0)	USP1 (1.9)	ZNF180 (1.8)	C12orf51 (1.8)	BUD13 (1.8)
ENSG00000113048	MRPS27 PPI subnetwork	0.84	> 0.20	GOT2P1 (2.2)	PLEKHH2 (1.7)	GMPR (1.6)	ZNF259 (1.6)	NAA25 (1.5)	DNAH11 (1.4)	DHODH (1.4)	DDX56 (1.3)	TOMM40 (1.3)	LPAR2 (1.3)
GO:0060765	regulation of androgen receptor signaling pathway	0.84	> 0.20	C1orf63 (2.9)	C19orf52 (2.1)	AMIGO1 (2.0)	NT5DC1 (1.9)	SUGP1 (1.5)	PMFBP1 (1.4)	KANK2 (1.3)	ENSG00000226648 (1.3)	ILF3 (1.2)	TMEM50A (1.2)
ENSG00000151164	RAD9B PPI subnetwork	0.84	> 0.20	FEN1 (4.8)	USP1 (4.3)	POC5 (3.1)	TXNL4B (1.9)	TMEM116 (1.7)	ZNF180 (1.7)	TMED4 (1.5)	MAPKAPK5 (1.5)	NT5DC1 (1.5)	ENSG00000228044 (1.3)
GO:0010631	epithelial cell migration	0.84	> 0.20	ENSG00000226648 (2.8)	PLEKHH2 (2.4)	ENSG00000228044 (2.2)	ABO (2.2)	C17orf57 (2.1)	HNF1A (2.0)	PMFBP1 (1.8)	TRAPPC6A (1.8)	NYNRIN (1.3)	KANK2 (1.2)
GO:0090132	epithelium migration	0.84	> 0.20	ENSG00000226648 (2.8)	PLEKHH2 (2.4)	ENSG00000228044 (2.2)	ABO (2.2)	C17orf57 (2.1)	HNF1A (2.0)	PMFBP1 (1.8)	TRAPPC6A (1.8)	NYNRIN (1.3)	KANK2 (1.2)
ENSG00000085274	MYNN PPI subnetwork	0.84	> 0.20	C12orf51 (2.8)	ATXN2 (2.7)	PLEC (2.3)	CELSR2 (2.1)	NYNRIN (1.9)	COL4A3BP (1.8)	TOP1 (1.8)	AP1M2 (1.6)	SLC44A2 (1.6)	NKPD1 (1.6)
ENSG00000198924	DCLRE1A PPI subnetwork	0.84	> 0.20	ENSG00000226645 (3.0)	ENSG00000235545 (2.6)	USP1 (2.4)	FEN1 (2.2)	DYNC2LI1 (1.9)	ATXN2 (1.8)	C1orf63 (1.6)	COL4A3BP (1.6)	FRK (1.5)	ZNF180 (1.4)
MP:0002885	abnormal AMPA-mediated synaptic currents	0.84	> 0.20	NCAN (3.3)	RPH3A (3.1)	ENSG00000228044 (2.1)	TSSK6 (2.1)	TRIB1 (1.9)	ZNF180 (1.8)	PPP1R37 (1.7)	C11orf9 (1.6)	ZHX3 (1.5)	HAPLN4 (1.5)
ENSG00000134909	ARHGAP32 PPI subnetwork	0.84	> 0.20	LPIN3 (3.2)	CBLC (3.0)	NCAN (3.0)	PTPN11 (2.7)	PLCG1 (2.2)	RPH3A (2.1)	MARK4 (2.0)	DOCK7 (1.8)	HNF1A (1.8)	GATAD2A (1.8)
MP:0003194	abnormal frequency of paradoxical sleep	0.84	> 0.20	TRIB1 (4.9)	MOSC1 (3.3)	ENSG00000238078 (2.6)	NCAN (2.3)	AMIGO1 (1.9)	RPH3A (1.8)	GPAM (1.5)	SORT1 (1.4)	HNF1A (1.4)	ENSG00000254235 (1.4)
GO:0046034	ATP metabolic process	0.84	> 0.20	NKPD1 (3.7)	OGDH (2.8)	HAPLN4 (2.2)	CLPTM1 (1.8)	C1orf63 (1.8)	USP24 (1.7)	TMEM116 (1.7)	ACAD10 (1.6)	SORT1 (1.6)	SYPL2 (1.5)
ENSG00000118705	RPN2 PPI subnetwork	0.84	> 0.20	TOMM40 (2.6)	SMARCA4 (2.3)	GATAD2A (2.1)	ILF3 (2.0)	PSMA5 (1.9)	SARS (1.9)	PLCG1 (1.8)	HAVCR1 (1.7)	USP1 (1.5)	NAA25 (1.5)
ENSG00000185787	MORF4L1 PPI subnetwork	0.84	> 0.20	SMARCA4 (2.3)	BUD13 (2.2)	ATXN2 (2.2)	SUGP1 (1.9)	ADAM1 (1.8)	C12orf43 (1.8)	ZNF259 (1.8)	TMEM50A (1.7)	USP1 (1.7)	BRAP (1.6)
ENSG00000100796	SMEK1 PPI subnetwork	0.84	> 0.20	GMPR (2.1)	C19orf52 (1.9)	PSRC1 (1.5)	ENSG00000226645 (1.4)	BUD13 (1.3)	TMEM50A (1.2)	TSSK6 (1.2)	MYLIP (1.2)	TRAPPC6A (1.1)	ANGPTL3 (1.0)
GO:0043043	peptide biosynthetic process	0.84	> 0.20	AMIGO1 (2.6)	KIAA1324 (2.4)	ENSG00000226648 (2.4)	TXNL4B (2.3)	ENSG00000235545 (2.0)	HAVCR1 (2.0)	AP1M2 (2.0)	GOT2P1 (1.8)	NPC1L1 (1.8)	RHCE (1.7)
GO:0007216	G-protein coupled glutamate receptor signaling pathway	0.84	> 0.20	C12orf47 (2.7)	PMFBP1 (2.3)	RPH3A (2.1)	CYB561D1 (1.9)	LPAR2 (1.8)	ANKRD31 (1.6)	C19orf52 (1.6)	ENSG00000228044 (1.5)	TSSK6 (1.5)	GEMIN7 (1.4)
ENSG00000168242	HIST1H2BI PPI subnetwork	0.84	> 0.20	TMEM57 (2.4)	SMARCA4 (2.1)	DDX56 (2.1)	USP1 (2.0)	DOCK7 (1.7)	BUD13 (1.7)	C19orf52 (1.7)	TOP1 (1.7)	ILF3 (1.5)	ZNF259 (1.5)
ENSG00000197846	HIST1H2BF PPI subnetwork	0.84	> 0.20	TMEM57 (2.4)	SMARCA4 (2.1)	DDX56 (2.1)	USP1 (2.0)	DOCK7 (1.7)	BUD13 (1.7)	C19orf52 (1.7)	TOP1 (1.7)	ILF3 (1.5)	ZNF259 (1.5)
ENSG00000187990	HIST1H2BG PPI subnetwork	0.84	> 0.20	TMEM57 (2.4)	SMARCA4 (2.1)	DDX56 (2.1)	USP1 (2.0)	DOCK7 (1.7)	BUD13 (1.7)	C19orf52 (1.7)	TOP1 (1.7)	ILF3 (1.5)	ZNF259 (1.5)
ENSG00000180596	HIST1H2BC PPI subnetwork	0.84	> 0.20	TMEM57 (2.4)	SMARCA4 (2.1)	DDX56 (2.1)	USP1 (2.0)	DOCK7 (1.7)	BUD13 (1.7)	C19orf52 (1.7)	TOP1 (1.7)	ILF3 (1.5)	ZNF259 (1.5)
ENSG00000180900	SCRIB PPI subnetwork	0.84	> 0.20	CARM1 (2.6)	ENSG00000226648 (2.6)	LPIN3 (2.2)	NCAN (2.1)	TRAFD1 (1.6)	RPH3A (1.6)	BUD13 (1.6)	POLK (1.6)	MAPKAPK5 (1.5)	ATXN7L2 (1.4)
MP:0000484	abnormal pulmonary artery morphology	0.84	> 0.20	BCAM (2.4)	NPC1L1 (1.8)	SORT1 (1.7)	TMEM116 (1.6)	PSRC1 (1.5)	SH2B3 (1.5)	ATXN7L2 (1.4)	ABCG5 (1.4)	GCNT4 (1.4)	PVR (1.3)
ENSG00000197903	HIST1H2BK PPI subnetwork	0.84	> 0.20	SMARCA4 (2.5)	USP1 (2.3)	DDX56 (2.1)	TMEM57 (2.1)	BUD13 (1.8)	DOCK7 (1.8)	ZNF259 (1.6)	GATAD2A (1.4)	ILF3 (1.4)	TOP1 (1.3)
MP:0008788	abnormal fetal cardiomyocyte morphology	0.84	> 0.20	C12orf51 (2.8)	ATXN2 (2.4)	SORT1 (2.1)	MARK4 (2.0)	C1orf63 (2.0)	KANK2 (1.9)	NKPD1 (1.7)	ENSG00000226648 (1.6)	PLEKHH2 (1.6)	PTPN11 (1.6)
GO:0010389	regulation of G2/M transition of mitotic cell cycle	0.84	> 0.20	DNAH11 (2.6)	ZNF180 (2.4)	USP1 (2.1)	PSRC1 (2.0)	LPIN3 (2.0)	FEN1 (1.7)	TMEM116 (1.7)	ANKRD31 (1.6)	SYPL2 (1.6)	LPAR2 (1.5)
ENSG00000169155	ZBTB43 PPI subnetwork	0.84	> 0.20	KIAA1324 (2.7)	MYLIP (2.4)	NPC1L1 (2.4)	AMIGO1 (2.3)	ALDH2 (1.7)	ENSG00000226648 (1.6)	NCAN (1.6)	RELB (1.4)	TMEM57 (1.4)	ABCG8 (1.3)
GO:0005921	gap junction	0.84	> 0.20	NKPD1 (3.6)	CBLC (2.6)	CEACAM19 (2.3)	ENSG00000228044 (2.2)	C11orf9 (1.9)	ST3GAL4 (1.8)	DNAH11 (1.5)	PVRL2 (1.1)	TOMM40 (1.1)	PMFBP1 (1.0)
REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME	REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME	0.84	> 0.20	MAPKAPK5 (3.0)	PSMA5 (2.7)	TXNL4B (2.4)	BUD13 (2.3)	ZNF259 (2.3)	SUGP1 (2.3)	TOP1 (1.9)	C19orf52 (1.7)	DNM2 (1.6)	PTPN11 (1.5)
ENSG00000165917	RAPSN PPI subnetwork	0.84	> 0.20	TMED4 (2.5)	C19orf52 (2.3)	TRAFD1 (2.3)	ATXN2 (2.2)	SYPL2 (2.2)	SORT1 (2.0)	ERP29 (1.9)	PVRL2 (1.8)	USP1 (1.6)	BRAP (1.6)
ENSG00000205531	NAP1L4 PPI subnetwork	0.84	> 0.20	BUD13 (2.7)	RPH3A (2.5)	NCAN (2.0)	MYLIP (1.8)	BRAP (1.8)	TMEM57 (1.8)	APOC1 (1.7)	NKPD1 (1.5)	ENSG00000226645 (1.5)	TRAPPC6A (1.4)
ENSG00000057468	MSH4 PPI subnetwork	0.84	> 0.20	USP1 (2.7)	FEN1 (2.3)	ITGB3 (1.8)	PPP1R37 (1.7)	SMARCA4 (1.6)	PCSK9 (1.5)	ILF3 (1.5)	TOMM40 (1.4)	TOP1 (1.4)	PSRC1 (1.4)
ENSG00000124155	PIGT PPI subnetwork	0.84	> 0.20	CYB561D1 (2.9)	ATP13A1 (2.6)	ERP29 (2.6)	TMED4 (2.3)	TMEM50A (1.9)	GRINA (1.8)	AMIGO1 (1.8)	HAVCR1 (1.6)	SORT1 (1.5)	NT5DC1 (1.5)
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	0.84	> 0.20	SYPL2 (3.8)	RPH3A (3.7)	AMIGO1 (2.8)	NCAN (2.6)	HAPLN4 (2.4)	CELSR2 (2.1)	C12orf43 (2.1)	TSSK6 (2.0)	HNF1A (1.7)	HAVCR1 (1.7)
GO:0004697	protein kinase C activity	0.84	> 0.20	MARK4 (2.6)	DNM2 (2.4)	PLCG1 (1.8)	SORT1 (1.7)	PLEKHH2 (1.6)	NYNRIN (1.6)	GMIP (1.5)	SLC44A2 (1.5)	ZNF101 (1.4)	USP24 (1.4)
MP:0004842	abnormal large intestine crypts of Lieberkuhn morphology	0.84	> 0.20	CBLC (3.6)	KIAA1324 (3.1)	UBXN2B (2.3)	PLEC (2.2)	AP1M2 (2.2)	NYNRIN (2.1)	TM6SF2 (1.9)	CARM1 (1.8)	C17orf57 (1.5)	ZNF101 (1.4)
ENSG00000115677	HDLBP PPI subnetwork	0.84	> 0.20	SARS (3.6)	DHX38 (3.4)	ATP13A1 (2.4)	SMARCA4 (2.2)	ILF3 (2.1)	NAA25 (2.1)	PTPN11 (2.0)	MAPKAPK5 (1.8)	TXNL4B (1.8)	OASL (1.7)
MP:0008272	abnormal endochondral bone ossification	0.84	> 0.20	NYNRIN (5.4)	PLEKHH2 (4.5)	PLCG1 (2.9)	CILP2 (2.3)	MAFB (1.7)	KIAA1324 (1.7)	CEACAM19 (1.5)	NCAN (1.4)	HLX (1.2)	APOE (1.2)
MP:0005140	decreased cardiac muscle contractility	0.84	> 0.20	BCAM (3.4)	SYPL2 (2.0)	SORT1 (1.6)	NPC1L1 (1.3)	TM6SF2 (1.3)	HP (1.3)	TSSK6 (1.2)	PVR (1.2)	MAPKAPK5 (1.1)	TMEM50A (1.1)
GO:0045604	regulation of epidermal cell differentiation	0.84	> 0.20	LPIN3 (3.7)	ENSG00000226648 (2.7)	AP1M2 (2.5)	CBLC (2.3)	GOT2P1 (1.7)	ENSG00000238078 (1.6)	CILP2 (1.6)	PMFBP1 (1.5)	TRAPPC6A (1.3)	PBX4 (1.2)
KEGG_RIBOSOME	KEGG_RIBOSOME	0.84	> 0.20	NKPD1 (2.8)	CEACAM19 (1.6)	UBXN2B (1.5)	MOSC1 (1.4)	GATAD2A (1.3)	ERP29 (1.1)	APOC1 (1.1)	ADAM1 (1.0)	NYNRIN (1.0)	ENSG00000226645 (1.0)
ENSG00000085733	CTTN PPI subnetwork	0.84	> 0.20	TRAFD1 (2.6)	NCAN (2.6)	ITGB3 (2.4)	SMARCA4 (2.2)	ADAM1 (2.1)	DNM2 (2.0)	C1orf63 (1.9)	PLEC (1.8)	TOP1 (1.8)	SORT1 (1.5)
ENSG00000078674	PCM1 PPI subnetwork	0.84	> 0.20	DYNC2LI1 (4.8)	UBXN2B (2.7)	NT5DC1 (2.4)	KIAA1324 (2.3)	DOCK7 (2.2)	ENSG00000228044 (2.1)	POC5 (2.1)	TMEM116 (1.9)	FRK (1.8)	C17orf57 (1.7)
GO:0030513	positive regulation of BMP signaling pathway	0.84	> 0.20	ENSG00000226648 (2.6)	ABO (2.5)	NYNRIN (2.3)	ALDH2 (1.9)	PVRL2 (1.3)	ENSG00000254235 (1.2)	PBX4 (1.1)	ATXN7L2 (1.1)	TSSK6 (1.1)	PPP1R37 (1.1)
ENSG00000163032	VSNL1 PPI subnetwork	0.84	> 0.20	RHD (3.2)	ITGB3 (2.7)	RPH3A (2.5)	ABO (2.5)	RHCE (2.1)	PMFBP1 (1.9)	PBX4 (1.4)	ATXN7L2 (1.4)	DYNC2LI1 (1.3)	TMEM116 (1.3)
GO:0021510	spinal cord development	0.84	> 0.20	ANKRD31 (3.4)	DNAH11 (2.6)	ATXN7L2 (2.6)	C12orf47 (2.5)	NCAN (2.3)	ZHX3 (1.8)	TSSK6 (1.4)	C19orf52 (1.4)	CILP2 (1.4)	ENSG00000226648 (1.3)
GO:0006501	C-terminal protein lipidation	0.84	> 0.20	CYB561D1 (3.3)	ATP13A1 (3.2)	YIPF2 (2.3)	ERP29 (2.1)	TMEM116 (2.1)	UBXN2B (2.1)	TRAPPC6A (2.1)	TSSK6 (1.9)	TMED4 (1.7)	ZNF180 (1.7)
ENSG00000108854	SMURF2 PPI subnetwork	0.84	> 0.20	SYPL2 (3.2)	HAVCR1 (2.7)	AP1M2 (2.0)	MAPKAPK5 (2.0)	PVRL2 (1.9)	CBLC (1.8)	ATXN2 (1.7)	SH2B3 (1.7)	FRK (1.5)	ALDH2 (1.4)
GO:0051322	anaphase	0.84	> 0.20	TMEM116 (3.2)	LPIN3 (2.4)	ENSG00000228044 (2.3)	ENSG00000226645 (2.2)	POC5 (2.1)	TMEM57 (2.0)	MAU2 (1.7)	ADAM1 (1.7)	ACAD10 (1.6)	BRAP (1.6)
ENSG00000119048	UBE2B PPI subnetwork	0.84	> 0.20	TMEM57 (1.9)	ENSG00000226645 (1.8)	ENSG00000235545 (1.7)	PSMA5 (1.6)	SUGP1 (1.5)	TMEM50A (1.4)	ZNF180 (1.3)	TRAFD1 (1.3)	DOCK7 (1.2)	ATXN2 (1.2)
ENSG00000173674	EIF1AX PPI subnetwork	0.84	> 0.20	ADAM1 (2.4)	C12orf43 (2.3)	NKPD1 (2.3)	ILF3 (2.1)	C19orf52 (2.0)	GATAD2A (2.0)	ANKRD31 (1.8)	NAA25 (1.8)	ZNF180 (1.7)	QTRT1 (1.7)
MP:0003731	abnormal retinal outer nuclear layer morphology	0.84	> 0.20	ATXN7L2 (2.6)	ENSG00000226648 (2.2)	DYNC2LI1 (2.2)	NCAN (1.8)	HNF1A (1.7)	SORT1 (1.6)	MAPKAPK5 (1.6)	ST3GAL4 (1.4)	GPAM (1.2)	ATP13A1 (1.1)
GO:0051954	positive regulation of amine transport	0.84	> 0.20	ABO (3.7)	BLOC1S3 (1.9)	ERP29 (1.8)	CETP (1.8)	KIAA1324 (1.8)	NKPD1 (1.7)	COL4A3BP (1.5)	CEACAM19 (1.4)	TMEM57 (1.4)	C17orf57 (1.3)
GO:0051205	protein insertion into membrane	0.84	> 0.20	C12orf47 (1.9)	GATAD2A (1.8)	AMIGO1 (1.6)	PPP1R37 (1.6)	SARS (1.6)	GEMIN7 (1.5)	ENSG00000226648 (1.5)	HAVCR1 (1.4)	PBX4 (1.3)	ERP29 (1.1)
GO:0006661	phosphatidylinositol biosynthetic process	0.84	> 0.20	CYB561D1 (2.9)	TRAPPC6A (2.7)	ATP13A1 (2.5)	TMED4 (2.2)	YIPF2 (1.9)	TSSK6 (1.9)	CEACAM19 (1.9)	TMEM50A (1.8)	DYNC2LI1 (1.6)	NT5DC1 (1.5)
GO:0016574	histone ubiquitination	0.84	> 0.20	DNAH11 (2.7)	TMEM57 (2.5)	C19orf52 (2.0)	BRAP (1.9)	GCNT4 (1.8)	ZNF259 (1.8)	HNF1A (1.8)	TOP1 (1.7)	HAVCR1 (1.5)	ATXN2 (1.5)
MP:0001650	abnormal seizure response to electrical stimulation	0.84	> 0.20	TRIB1 (2.7)	RPH3A (2.2)	TSSK6 (2.0)	POC5 (1.8)	ENSG00000238078 (1.7)	ZNF180 (1.4)	MYLIP (1.3)	C12orf51 (1.3)	GOT2P1 (1.2)	LPA (1.2)
ENSG00000167110	GOLGA2 PPI subnetwork	0.84	> 0.20	SYPL2 (2.1)	MAFB (1.9)	C12orf47 (1.8)	YIPF2 (1.7)	TMED4 (1.6)	UBXN2B (1.5)	TIMD4 (1.5)	TSSK6 (1.5)	ENSG00000228044 (1.5)	AP1M2 (1.4)
GO:0048535	lymph node development	0.84	> 0.20	ZNF101 (2.7)	TIMD4 (2.6)	ENSG00000238078 (2.0)	ENSG00000226645 (1.9)	GEMIN7 (1.8)	CYB561D1 (1.8)	NKPD1 (1.8)	SH2B3 (1.7)	HAVCR1 (1.6)	GMIP (1.5)
GO:0008080	N-acetyltransferase activity	0.84	> 0.20	C19orf52 (2.4)	MAU2 (1.9)	UBXN2B (1.8)	PLCG1 (1.7)	COL4A3BP (1.7)	TMEM57 (1.6)	ZHX3 (1.6)	DHODH (1.5)	BLOC1S3 (1.5)	BUD13 (1.5)
GO:0071456	cellular response to hypoxia	0.84	> 0.20	DNAH11 (3.2)	POLK (2.9)	C17orf57 (2.3)	ADAM1 (1.9)	SARS (1.5)	CEACAM19 (1.2)	CILP2 (1.2)	TOP1 (1.1)	ZNF180 (1.0)	ATXN2 (1.0)
GO:0006941	striated muscle contraction	0.84	> 0.20	SYPL2 (5.6)	ENSG00000226648 (2.1)	GMPR (2.1)	CYB561D1 (1.6)	ENSG00000238078 (1.3)	C1orf63 (1.3)	TXNL4B (1.2)	RPH3A (1.2)	C17orf57 (1.1)	ERP29 (1.1)
MP:0001745	increased circulating corticosterone level	0.84	> 0.20	KIAA1324 (2.8)	SH2B3 (2.1)	NPC1L1 (2.1)	CELSR2 (2.0)	FADS1 (1.8)	FADS2 (1.6)	APOC1 (1.6)	TSSK6 (1.6)	ENSG00000226645 (1.5)	C12orf47 (1.5)
GO:0046415	urate metabolic process	0.84	> 0.20	HAVCR1 (2.1)	GCNT4 (2.0)	PMFBP1 (1.9)	CEACAM19 (1.7)	HNF1A (1.6)	ENSG00000226648 (1.5)	C12orf47 (1.4)	PLG (1.4)	ANGPTL3 (1.3)	ZHX3 (1.3)
MP:0004100	abnormal spinal cord interneuron morphology	0.84	> 0.20	DYNC2LI1 (3.1)	NCAN (2.4)	C12orf47 (2.3)	ACAD10 (2.1)	ANKRD31 (2.1)	TSSK6 (2.0)	ENSG00000254235 (1.8)	ABO (1.8)	UBXN2B (1.7)	TMEM116 (1.6)
ENSG00000133710	SPINK5 PPI subnetwork	0.84	> 0.20	HAPLN4 (3.6)	RPH3A (3.1)	NCAN (2.0)	ALDH2 (1.9)	C11orf9 (1.9)	CELSR2 (1.4)	ENSG00000254235 (1.4)	FADS2 (1.4)	ST3GAL4 (1.3)	FRK (1.3)
ENSG00000215782	ENSG00000215782 PPI subnetwork	0.84	> 0.20	OASL (2.8)	PMFBP1 (2.4)	MAFB (2.2)	RELB (2.1)	BCL3 (2.0)	TRAFD1 (1.8)	DOCK7 (1.6)	HLX (1.5)	USP24 (1.5)	ENSG00000235545 (1.4)
ENSG00000121807	CCR2 PPI subnetwork	0.84	> 0.20	OASL (2.8)	PMFBP1 (2.4)	MAFB (2.2)	RELB (2.1)	BCL3 (2.0)	TRAFD1 (1.8)	DOCK7 (1.6)	HLX (1.5)	USP24 (1.5)	ENSG00000235545 (1.4)
MP:0004957	abnormal blastocyst morphology	0.84	> 0.20	GMIP (2.0)	HAVCR1 (1.9)	HNF1A (1.7)	DHX38 (1.6)	ERP29 (1.3)	APOE (1.3)	BRAP (1.3)	APOC1 (1.3)	ABO (1.3)	COL4A3BP (1.3)
ENSG00000148606	POLR3A PPI subnetwork	0.84	> 0.20	DDX56 (3.0)	ZNF259 (2.4)	SUGP1 (2.3)	BUD13 (2.1)	QTRT1 (2.1)	GEMIN7 (2.0)	TOMM40 (1.7)	GMPR (1.6)	C19orf52 (1.5)	ENSG00000226645 (1.5)
MP:0000269	abnormal heart looping	0.84	> 0.20	NYNRIN (2.6)	HLX (2.0)	KANK2 (2.0)	DOCK7 (1.6)	BCAM (1.6)	CYP7A1 (1.5)	ALDH2 (1.5)	PVRL2 (1.3)	ACAD10 (1.1)	HMGCR (1.1)
GO:0010464	regulation of mesenchymal cell proliferation	0.84	> 0.20	ENSG00000238078 (2.3)	NYNRIN (1.7)	PLEKHH2 (1.7)	DYNC2LI1 (1.6)	NKPD1 (1.5)	C11orf9 (1.4)	PPP1R37 (1.4)	CBLC (1.3)	TMEM116 (1.1)	CEACAM19 (1.1)
GO:0007130	synaptonemal complex assembly	0.84	> 0.20	LPIN3 (1.9)	ENSG00000238078 (1.9)	ANKRD31 (1.6)	PBX4 (1.5)	MAPKAPK5 (1.2)	ADAM1 (1.2)	ATXN7L2 (1.1)	DNAH11 (1.1)	DYNC2LI1 (1.0)	ITGB3 (1.0)
GO:0045005	maintenance of fidelity involved in DNA-dependent DNA replication	0.84	> 0.20	TRAPPC6A (2.6)	NKPD1 (1.9)	DHODH (1.9)	BLOC1S3 (1.7)	BUD13 (1.5)	ANKRD31 (1.3)	PMFBP1 (1.3)	FEN1 (1.2)	C12orf47 (1.1)	USP1 (1.1)
ENSG00000025796	SEC63 PPI subnetwork	0.84	> 0.20	YIPF2 (3.0)	TMEM50A (2.9)	TMED4 (2.8)	ATP13A1 (2.7)	ERP29 (2.6)	CYB561D1 (1.9)	PMFBP1 (1.9)	TM6SF2 (1.7)	PPP1R37 (1.7)	NT5DC1 (1.6)
GO:0035966	response to topologically incorrect protein	0.84	> 0.20	BLOC1S3 (2.5)	TXNL4B (2.3)	TMED4 (2.2)	TMEM57 (2.1)	YIPF2 (2.0)	ERP29 (1.9)	SARS (1.8)	TSSK6 (1.7)	TOP1 (1.3)	C1orf63 (1.2)
ENSG00000141655	TNFRSF11A PPI subnetwork	0.84	> 0.20	RELB (3.2)	GMIP (2.6)	SLC22A1 (2.1)	CETP (2.0)	LPAR2 (1.8)	CARM1 (1.7)	PTPN11 (1.6)	PVRL2 (1.6)	FRK (1.5)	ATXN2 (1.3)
ENSG00000108798	ABI3 PPI subnetwork	0.85	> 0.20	MARK4 (2.7)	MYLIP (2.4)	PTPN11 (2.0)	TRAPPC6A (1.9)	PLEKHH2 (1.8)	GEMIN7 (1.7)	C17orf57 (1.6)	DYNC2LI1 (1.6)	GMIP (1.5)	ZNF101 (1.4)
MP:0003109	short femur	0.85	> 0.20	CILP2 (6.2)	PLEKHH2 (2.8)	MAFB (2.5)	KIAA1324 (2.0)	FRK (1.4)	TMEM116 (1.4)	SLC22A1 (1.4)	MYLIP (1.3)	ENSG00000226645 (1.3)	ENSG00000254235 (1.1)
GO:0032740	positive regulation of interleukin-17 production	0.85	> 0.20	GCNT4 (2.1)	SH2B3 (1.7)	FRK (1.6)	SLC22A1 (1.5)	ENSG00000235545 (1.5)	ENSG00000226645 (1.4)	TRAFD1 (1.4)	ALDH2 (1.2)	TIMD4 (1.1)	LPIN3 (1.1)
GO:0043588	skin development	0.85	> 0.20	AP1M2 (3.4)	GCNT4 (2.9)	CBLC (2.7)	CELSR2 (2.4)	BCAM (2.0)	SLC44A2 (1.8)	CYB561D1 (1.7)	TSSK6 (1.6)	C17orf57 (1.5)	ENSG00000254235 (1.4)
GO:0051494	negative regulation of cytoskeleton organization	0.85	> 0.20	C17orf57 (3.4)	ENSG00000238078 (2.9)	RHD (2.3)	RHCE (2.0)	TSSK6 (2.0)	C12orf51 (1.8)	PMFBP1 (1.8)	GMPR (1.6)	SLC44A2 (1.6)	CYB561D1 (1.5)
ENSG00000163634	THOC7 PPI subnetwork	0.85	> 0.20	TMEM57 (2.5)	BLOC1S3 (2.2)	TXNL4B (2.0)	SUGP1 (1.8)	ENSG00000226648 (1.7)	DDX56 (1.7)	SARS (1.6)	ZNF101 (1.6)	CYB561D1 (1.6)	PSMA5 (1.5)
GO:0016879	ligase activity, forming carbon-nitrogen bonds	0.85	> 0.20	BRAP (3.7)	ATXN2 (3.0)	TRAFD1 (2.7)	C12orf51 (2.5)	USP24 (2.4)	C19orf52 (2.0)	TMEM57 (1.9)	MAU2 (1.6)	PARP10 (1.6)	CARM1 (1.6)
GO:0048644	muscle organ morphogenesis	0.85	> 0.20	SYPL2 (3.5)	ENSG00000238078 (2.9)	CEACAM19 (2.4)	ENSG00000254235 (1.7)	CILP2 (1.6)	GMPR (1.6)	TRAPPC6A (1.5)	TSSK6 (1.5)	NKPD1 (1.4)	C17orf57 (1.3)
GO:0034979	NAD-dependent protein deacetylase activity	0.85	> 0.20	ATXN7L2 (3.0)	HNF1A (2.0)	PLCG1 (1.6)	C1orf63 (1.4)	SUGP1 (1.4)	RELB (1.2)	TXNL4B (1.2)	DHX38 (1.1)	C17orf57 (1.0)	ST3GAL4 (1.0)
GO:0017136	NAD-dependent histone deacetylase activity	0.85	> 0.20	ATXN7L2 (3.0)	HNF1A (2.0)	PLCG1 (1.6)	C1orf63 (1.4)	SUGP1 (1.4)	RELB (1.2)	TXNL4B (1.2)	DHX38 (1.1)	C17orf57 (1.0)	ST3GAL4 (1.0)
MP:0004363	stria vascularis degeneration	0.85	> 0.20	ZHX3 (2.7)	ST3GAL4 (2.2)	GPAM (1.8)	HNF1A (1.8)	SLC44A2 (1.5)	PMFBP1 (1.4)	C12orf47 (1.4)	ENSG00000226648 (1.4)	PTPN11 (1.3)	APOE (1.2)
GO:0030916	otic vesicle formation	0.85	> 0.20	ANKRD31 (2.3)	ENSG00000228044 (2.3)	DYNC2LI1 (1.7)	PMFBP1 (1.6)	ZNF101 (1.6)	TMEM116 (1.5)	PLEKHH2 (1.4)	ENSG00000238078 (1.4)	CEACAM19 (1.3)	ZNF180 (1.3)
GO:0031519	PcG protein complex	0.85	> 0.20	MARK4 (2.0)	USP1 (1.9)	CARM1 (1.8)	ENSG00000254235 (1.6)	HLX (1.6)	MYLIP (1.5)	ILF3 (1.5)	ENSG00000235545 (1.2)	TOP1 (1.2)	ATXN7L2 (1.2)
REACTOME_INTERLEUKIN:3_5_AND_GM:CSF_SIGNALING	REACTOME_INTERLEUKIN:3_5_AND_GM:CSF_SIGNALING	0.85	> 0.20	GMIP (3.4)	SH2B3 (3.3)	DNM2 (2.2)	USP24 (2.1)	HLX (2.1)	GPAM (1.6)	COL4A3BP (1.4)	TIMD4 (1.4)	RELB (1.4)	SLC44A2 (1.3)
MP:0003850	abnormal thymocyte activation	0.85	> 0.20	SLC44A2 (3.6)	PBX4 (3.1)	PLCG1 (2.8)	GMIP (2.2)	RELB (2.0)	CETP (1.6)	ZNF101 (1.6)	SH2B3 (1.4)	LPAR2 (1.4)	PTPN11 (1.2)
ENSG00000176386	CDC26 PPI subnetwork	0.85	> 0.20	PSRC1 (6.1)	FEN1 (3.6)	POC5 (3.0)	LPIN3 (1.9)	USP1 (1.7)	LPAR2 (1.3)	SUGP1 (1.3)	RHCE (1.3)	CBLC (1.2)	CETP (1.2)
MP:0005105	abnormal middle ear ossicle morphology	0.85	> 0.20	MYLIP (3.0)	MAFB (2.8)	CILP2 (2.2)	NYNRIN (1.7)	TMEM57 (1.5)	CEACAM19 (1.4)	DYNC2LI1 (1.3)	PLCG1 (1.3)	ENSG00000238078 (1.2)	ANKRD31 (1.1)
ENSG00000114209	PDCD10 PPI subnetwork	0.85	> 0.20	TMEM50A (2.8)	PVRL2 (2.7)	MARK4 (2.5)	ZNF180 (2.1)	TMED4 (1.9)	LPIN3 (1.9)	NYNRIN (1.7)	PLEKHH2 (1.5)	UBXN2B (1.5)	DNM2 (1.3)
MP:0003786	premature aging	0.85	> 0.20	BLOC1S3 (2.9)	ATP13A1 (2.5)	CLPTM1 (2.3)	CBLC (2.1)	SUGP1 (2.0)	MARK4 (1.9)	GEMIN7 (1.9)	CARM1 (1.6)	TOMM40 (1.6)	PVR (1.5)
ENSG00000069966	GNB5 PPI subnetwork	0.85	> 0.20	HMGCR (3.8)	LDLR (2.7)	FADS2 (2.5)	FADS1 (2.4)	PCSK9 (2.4)	ST3GAL4 (2.0)	RPH3A (1.6)	PPP1R37 (1.5)	SLC44A2 (1.4)	MOSC1 (1.3)
ENSG00000179603	GRM8 PPI subnetwork	0.85	> 0.20	KANK2 (3.1)	TMEM57 (2.8)	ENSG00000235545 (2.0)	COL4A3BP (2.0)	PLEC (1.6)	SORT1 (1.5)	CLPTM1 (1.5)	C17orf57 (1.4)	ITGB3 (1.4)	SH2B3 (1.3)
ENSG00000148773	MKI67 PPI subnetwork	0.85	> 0.20	USP1 (3.1)	FEN1 (3.1)	PSRC1 (2.8)	ILF3 (2.4)	SMARCA4 (2.2)	TOP1 (2.0)	DDX56 (2.0)	NAA25 (1.7)	ATP13A1 (1.6)	NCAN (1.5)
MP:0008825	abnormal cardiac epithelial to mesenchymal transition	0.85	> 0.20	C11orf9 (2.8)	ENSG00000254235 (2.8)	SH2B3 (2.1)	SLC22A1 (1.8)	TMEM57 (1.7)	APOB (1.6)	ABO (1.6)	FADS1 (1.3)	PCSK9 (1.2)	MAPKAPK5 (1.1)
GO:0034330	cell junction organization	0.85	> 0.20	BCAM (3.5)	PVRL2 (3.0)	ITGB3 (2.6)	AP1M2 (2.5)	PLEC (2.3)	CBLC (2.3)	C17orf57 (2.0)	C11orf9 (2.0)	PVR (1.9)	GEMIN7 (1.7)
ENSG00000107779	BMPR1A PPI subnetwork	0.85	> 0.20	ABO (3.0)	MARK4 (2.4)	ALDH2 (2.1)	NYNRIN (2.1)	DOCK7 (2.0)	PTPN11 (1.8)	LPIN3 (1.4)	ZNF180 (1.3)	PVRL2 (1.3)	ILF3 (1.3)
GO:0010226	response to lithium ion	0.85	> 0.20	UBXN2B (3.6)	CYB561D1 (2.4)	HAPLN4 (2.2)	CEACAM19 (1.8)	PBX4 (1.6)	GOT2P1 (1.5)	SYPL2 (1.5)	ENSG00000254235 (1.5)	ADAM1 (1.4)	CYP7A1 (1.4)
ENSG00000114573	ATP6V1A PPI subnetwork	0.85	> 0.20	OGDH (3.2)	SARS (3.1)	TOMM40 (2.4)	HMGCR (2.1)	PSMA5 (1.9)	FEN1 (1.8)	DDX56 (1.7)	CLPTM1 (1.7)	GRINA (1.7)	ENSG00000238078 (1.6)
GO:0035253	ciliary rootlet	0.85	> 0.20	PTPN11 (2.5)	ABO (2.3)	LPAR2 (2.1)	YIPF2 (2.0)	CYB561D1 (2.0)	TMEM50A (1.8)	RPH3A (1.7)	AMIGO1 (1.6)	HAPLN4 (1.5)	TMED4 (1.2)
MP:0008083	decreased single-positive T cell number	0.85	> 0.20	RELB (3.2)	PARP10 (2.5)	ZNF101 (2.0)	SH2B3 (1.7)	PLCG1 (1.7)	ZHX3 (1.6)	SMARCA4 (1.6)	USP24 (1.5)	GMIP (1.5)	LPIN3 (1.5)
ENSG00000134318	ROCK2 PPI subnetwork	0.85	> 0.20	GATAD2A (2.3)	RPH3A (2.2)	TMEM50A (2.1)	BRAP (2.1)	PTPN11 (2.0)	C12orf51 (2.0)	TIMD4 (2.0)	OGDH (1.9)	ALDH2 (1.9)	ATXN2 (1.7)
ENSG00000180228	PRKRA PPI subnetwork	0.85	> 0.20	OASL (2.8)	DOCK7 (2.2)	TMED4 (2.0)	MAU2 (1.5)	PARP10 (1.5)	DNAH11 (1.4)	PSRC1 (1.4)	ENSG00000235545 (1.3)	CARM1 (1.3)	GEMIN7 (1.3)
MP:0000379	decreased hair follicle number	0.85	> 0.20	CBLC (4.4)	AP1M2 (4.4)	CELSR2 (2.3)	DYNC2LI1 (1.9)	LPAR2 (1.8)	TMEM116 (1.8)	LPIN3 (1.7)	LDLR (1.7)	DOCK7 (1.6)	ANKRD31 (1.5)
GO:0030518	intracellular steroid hormone receptor signaling pathway	0.85	> 0.20	ATXN2 (3.3)	C12orf51 (2.2)	GOT2P1 (2.2)	ENSG00000226648 (2.0)	BUD13 (2.0)	COL4A3BP (1.9)	TOP1 (1.7)	KANK2 (1.6)	KIAA1324 (1.5)	MAPKAPK5 (1.4)
ENSG00000008988	RPS20 PPI subnetwork	0.85	> 0.20	NKPD1 (2.4)	TOP1 (2.2)	SARS (2.1)	DDX56 (2.0)	ANKRD31 (2.0)	DNAH11 (1.9)	PLEC (1.7)	CEACAM19 (1.7)	PTPN11 (1.7)	NAA25 (1.7)
GO:0002286	T cell activation involved in immune response	0.85	> 0.20	BCL3 (1.7)	BLOC1S3 (1.6)	PVR (1.6)	NT5DC1 (1.6)	ENSG00000235545 (1.6)	ANKRD31 (1.5)	GMIP (1.4)	RELB (1.4)	ST3GAL4 (1.3)	TRAFD1 (1.1)
GO:0060840	artery development	0.85	> 0.20	CEACAM19 (2.4)	FRK (2.0)	BLOC1S3 (1.9)	MYLIP (1.8)	C19orf52 (1.6)	ATXN7L2 (1.5)	KANK2 (1.5)	TSSK6 (1.5)	TMEM57 (1.4)	NYNRIN (1.3)
ENSG00000120837	NFYB PPI subnetwork	0.85	> 0.20	TOP1 (2.5)	CARM1 (2.4)	ATXN7L2 (1.9)	MAPKAPK5 (1.8)	BUD13 (1.6)	C1orf63 (1.6)	C17orf57 (1.6)	ENSG00000226645 (1.5)	TOMM40 (1.4)	USP1 (1.3)
ENSG00000180098	TRNAU1AP PPI subnetwork	0.85	> 0.20	ANKRD31 (4.0)	CEACAM19 (2.9)	C12orf47 (2.8)	PPP1R37 (2.2)	NYNRIN (2.0)	CELSR2 (1.9)	TMED4 (1.9)	DYNC2LI1 (1.6)	PBX4 (1.6)	CARM1 (1.3)
ENSG00000135441	BLOC1S1 PPI subnetwork	0.85	> 0.20	BLOC1S3 (3.2)	PPP1R37 (3.1)	ZNF101 (2.7)	TXNL4B (2.7)	NKPD1 (2.3)	CYB561D1 (2.1)	ATXN7L2 (2.0)	GATAD2A (1.9)	C12orf47 (1.9)	CARM1 (1.9)
GO:0043966	histone H3 acetylation	0.85	> 0.20	ATXN7L2 (4.0)	C17orf57 (3.4)	C19orf52 (2.5)	ILF3 (2.3)	BUD13 (2.0)	MAPKAPK5 (1.9)	UBXN2B (1.8)	CYB561D1 (1.6)	ENSG00000226648 (1.5)	MAU2 (1.5)
ENSG00000161647	MPP3 PPI subnetwork	0.85	> 0.20	ALDH2 (2.3)	CELSR2 (2.1)	ZNF101 (2.1)	CYP7A1 (2.0)	ENSG00000238078 (1.9)	C11orf9 (1.8)	TRAFD1 (1.7)	NCAN (1.7)	PSRC1 (1.7)	TMED4 (1.6)
GO:0042573	retinoic acid metabolic process	0.85	> 0.20	LPA (2.2)	LPAR2 (2.1)	CYP7A1 (2.1)	ENSG00000254235 (2.0)	PMFBP1 (2.0)	FRK (2.0)	CYB561D1 (1.8)	CILP2 (1.7)	NYNRIN (1.6)	NKPD1 (1.5)
MP:0003076	increased susceptibility to ischemic brain injury	0.85	> 0.20	SORT1 (3.6)	ZNF180 (2.6)	ERP29 (2.5)	ADAM1 (2.5)	LPAR2 (2.4)	BRAP (2.3)	MOSC1 (2.1)	C12orf47 (2.0)	SLC44A2 (2.0)	NCAN (1.6)
MP:0000078	abnormal supraoccipital bone morphology	0.85	> 0.20	ENSG00000254235 (2.7)	NYNRIN (2.4)	MYLIP (2.2)	TMEM116 (1.8)	ALDH2 (1.6)	CEACAM19 (1.5)	MAFB (1.3)	BLOC1S3 (1.2)	GMPR (1.2)	CILP2 (1.2)
GO:0060048	cardiac muscle contraction	0.85	> 0.20	ENSG00000238078 (3.3)	ENSG00000226648 (2.3)	SYPL2 (2.0)	ACAD10 (1.9)	CEACAM19 (1.8)	ENSG00000254235 (1.6)	ANKRD31 (1.5)	C1orf63 (1.4)	ERP29 (1.4)	SLC44A2 (1.3)
ENSG00000115561	CHMP3 PPI subnetwork	0.85	> 0.20	CBLC (3.0)	DYNC2LI1 (2.1)	UBXN2B (1.8)	PPP1R37 (1.7)	KIAA1324 (1.7)	TRAPPC6A (1.6)	DOCK7 (1.6)	LPIN3 (1.5)	TMEM50A (1.4)	ANKRD31 (1.3)
ENSG00000116251	RPL22 PPI subnetwork	0.85	> 0.20	C1orf63 (2.6)	PTPN11 (1.7)	ILF3 (1.6)	TMEM50A (1.6)	ADAM1 (1.6)	NKPD1 (1.6)	MYLIP (1.5)	DOCK7 (1.4)	ENSG00000226648 (1.3)	TRAFD1 (1.1)
GO:0008408	3'-5' exonuclease activity	0.85	> 0.20	DHODH (3.1)	QTRT1 (2.6)	ZNF259 (2.6)	PARP10 (2.5)	NKPD1 (2.4)	DDX56 (2.3)	LPIN3 (2.3)	POC5 (2.3)	TRAPPC6A (2.2)	ENSG00000226645 (2.1)
MP:0005627	increased circulating potassium level	0.85	> 0.20	AP1M2 (2.8)	TMEM116 (2.5)	SYPL2 (2.3)	GMPR (2.0)	ZHX3 (2.0)	LPIN3 (1.8)	FRK (1.6)	BCAM (1.5)	TRAPPC6A (1.4)	CELSR2 (1.3)
GO:0051930	regulation of sensory perception of pain	0.85	> 0.20	HAPLN4 (2.8)	C17orf57 (2.7)	C12orf43 (2.1)	BLOC1S3 (1.9)	ANKRD31 (1.6)	TIMD4 (1.6)	CETP (1.4)	C12orf47 (1.3)	RPH3A (1.3)	NKPD1 (1.2)
GO:0051931	regulation of sensory perception	0.85	> 0.20	HAPLN4 (2.8)	C17orf57 (2.7)	C12orf43 (2.1)	BLOC1S3 (1.9)	ANKRD31 (1.6)	TIMD4 (1.6)	CETP (1.4)	C12orf47 (1.3)	RPH3A (1.3)	NKPD1 (1.2)
GO:0046639	negative regulation of alpha-beta T cell differentiation	0.85	> 0.20	GOT2P1 (1.9)	ENSG00000254235 (1.7)	HNF1A (1.6)	NKPD1 (1.5)	ANKRD31 (1.5)	AMIGO1 (1.5)	C12orf47 (1.2)	ENSG00000235545 (1.1)	LPAR2 (1.0)	TXNL4B (0.9)
GO:0008361	regulation of cell size	0.85	> 0.20	AMIGO1 (2.4)	TMEM50A (2.1)	C1orf63 (2.1)	TSSK6 (2.1)	TMEM57 (2.0)	ATXN7L2 (2.0)	PLEC (1.7)	ENSG00000226645 (1.6)	ABO (1.5)	C12orf47 (1.4)
ENSG00000111669	TPI1 PPI subnetwork	0.85	> 0.20	GRINA (2.5)	NT5DC1 (2.5)	CYP7A1 (2.1)	C11orf9 (2.0)	HAPLN4 (1.9)	SARS (1.8)	OGDH (1.7)	TSSK6 (1.5)	COL4A3BP (1.5)	SYPL2 (1.4)
ENSG00000168646	AXIN2 PPI subnetwork	0.85	> 0.20	MARK4 (2.7)	ABO (2.5)	ATXN7L2 (2.2)	ATXN2 (2.0)	ENSG00000226645 (2.0)	PTPN11 (1.9)	PLEC (1.5)	CELSR2 (1.3)	C19orf52 (1.3)	DOCK7 (1.1)
MP:0002216	abnormal seminiferous tubule morphology	0.85	> 0.20	NYNRIN (2.3)	ST3GAL4 (2.2)	LPAR2 (1.7)	TSSK6 (1.7)	GATAD2A (1.7)	TMED4 (1.6)	MARK4 (1.5)	CYP7A1 (1.5)	ATXN7L2 (1.5)	FEN1 (1.4)
MP:0000961	abnormal dorsal root ganglion morphology	0.85	> 0.20	TRIB1 (2.4)	KANK2 (2.1)	ATXN7L2 (1.9)	CELSR2 (1.6)	LDLR (1.6)	GRINA (1.5)	TSSK6 (1.5)	NCAN (1.5)	PPP1R37 (1.4)	COL4A3BP (1.4)
GO:0001503	ossification	0.85	> 0.20	CILP2 (4.6)	PLEKHH2 (2.6)	ENSG00000226645 (2.4)	MAFB (2.1)	ENSG00000226648 (1.6)	MYLIP (1.6)	RHCE (1.5)	ST3GAL4 (1.5)	CEACAM19 (1.4)	ABO (1.4)
GO:0042506	tyrosine phosphorylation of Stat5 protein	0.85	> 0.20	PBX4 (3.2)	ANKRD31 (2.0)	GCNT4 (1.6)	ENSG00000254235 (1.2)	ENSG00000226645 (1.2)	SH2B3 (1.1)	SLC22A1 (1.0)	LPAR2 (1.0)	KIAA1324 (0.9)	DNAH11 (0.9)
GO:0031023	microtubule organizing center organization	0.85	> 0.20	POC5 (3.4)	POLK (2.8)	DYNC2LI1 (2.6)	UBXN2B (2.3)	BUD13 (2.0)	PBX4 (1.9)	PSRC1 (1.8)	PLEKHH2 (1.6)	ENSG00000226648 (1.5)	DNAH11 (1.3)
MP:0009747	impaired behavioral response to xenobiotic	0.85	> 0.20	TM6SF2 (3.1)	ABO (2.3)	RPH3A (2.1)	ABCG8 (1.9)	NPC1L1 (1.9)	ABCG5 (1.7)	TMEM116 (1.7)	MYLIP (1.4)	GCNT4 (1.4)	GOT2P1 (1.3)
MP:0004703	abnormal vertebral column morphology	0.85	> 0.20	CILP2 (3.3)	LDLR (2.9)	CLPTM1 (2.5)	PCSK9 (2.3)	HMGCR (2.2)	PVR (2.0)	PLCG1 (1.9)	FADS2 (1.7)	PVRL2 (1.4)	GEMIN7 (1.4)
ENSG00000110042	DTX4 PPI subnetwork	0.85	> 0.20	GATAD2A (3.4)	NKPD1 (3.1)	SORT1 (2.4)	MAU2 (1.9)	ENSG00000254235 (1.7)	BUD13 (1.5)	PLCG1 (1.4)	C12orf43 (1.3)	NCAN (1.2)	C17orf57 (1.1)
GO:0043536	positive regulation of blood vessel endothelial cell migration	0.85	> 0.20	ENSG00000228044 (3.1)	ENSG00000226645 (2.0)	TMED4 (2.0)	PVR (1.9)	ZHX3 (1.8)	ABO (1.6)	PLEKHH2 (1.6)	DNAH11 (1.5)	BLOC1S3 (1.3)	DOCK7 (1.3)
MP:0004939	abnormal B cell morphology	0.85	> 0.20	ZNF101 (2.9)	RELB (2.8)	MAFB (2.1)	POLK (2.0)	GMIP (1.7)	PBX4 (1.7)	TRAFD1 (1.7)	BCL3 (1.6)	RHCE (1.5)	GRINA (1.4)
GO:0060627	regulation of vesicle-mediated transport	0.85	> 0.20	CILP2 (1.9)	YIPF2 (1.8)	ALDH2 (1.7)	GMPR (1.6)	BLOC1S3 (1.5)	CETP (1.4)	PLEKHH2 (1.4)	RPH3A (1.3)	ERP29 (1.3)	ANKRD31 (1.2)
GO:0071417	cellular response to organic nitrogen	0.85	> 0.20	ATXN7L2 (2.2)	ANKRD31 (2.2)	C17orf57 (1.9)	DNAH11 (1.8)	C19orf52 (1.7)	MYLIP (1.6)	AP1M2 (1.6)	ENSG00000238078 (1.3)	C12orf51 (1.3)	C11orf9 (1.3)
GO:0016202	regulation of striated muscle tissue development	0.85	> 0.20	ENSG00000226648 (2.2)	ATXN7L2 (2.2)	C17orf57 (1.8)	GEMIN7 (1.7)	GMPR (1.7)	CEACAM19 (1.6)	SYPL2 (1.5)	PPP1R37 (1.3)	PLEKHH2 (1.2)	TXNL4B (1.1)
GO:0005814	centriole	0.85	> 0.20	DYNC2LI1 (3.9)	POC5 (3.3)	PSRC1 (3.3)	POLK (2.3)	BUD13 (2.2)	USP1 (1.9)	UBXN2B (1.8)	PMFBP1 (1.7)	FEN1 (1.5)	DNAH11 (1.4)
ENSG00000141556	TBCD PPI subnetwork	0.85	> 0.20	PLCG1 (2.7)	ENSG00000226645 (2.1)	NT5DC1 (1.5)	PMFBP1 (1.3)	ZNF101 (1.3)	POLK (1.2)	GEMIN7 (1.2)	C19orf52 (1.2)	CELSR2 (1.2)	TRAFD1 (1.1)
GO:0042755	eating behavior	0.85	> 0.20	C17orf57 (2.9)	ENSG00000235545 (2.5)	ABO (2.4)	LPIN3 (2.3)	KIAA1324 (2.2)	ERP29 (2.1)	TSSK6 (1.9)	GCNT4 (1.9)	ADAM1 (1.8)	C12orf51 (1.6)
ENSG00000154764	WNT7A PPI subnetwork	0.85	> 0.20	CILP2 (5.0)	CELSR2 (2.5)	BCAM (2.3)	ZNF180 (2.2)	KIAA1324 (2.1)	PVRL2 (1.9)	TRAPPC6A (1.9)	TXNL4B (1.9)	DYNC2LI1 (1.8)	AMIGO1 (1.7)
ENSG00000151577	DRD3 PPI subnetwork	0.85	> 0.20	DNM2 (2.8)	COL4A3BP (2.8)	ZNF101 (2.0)	TRAFD1 (1.9)	PBX4 (1.9)	GEMIN7 (1.8)	TOMM40 (1.8)	KANK2 (1.7)	PLEKHH2 (1.7)	GMIP (1.5)
ENSG00000175220	ARHGAP1 PPI subnetwork	0.85	> 0.20	COL4A3BP (3.4)	NYNRIN (2.3)	GEMIN7 (2.2)	NCAN (2.0)	GRINA (1.8)	RPH3A (1.7)	LPIN3 (1.7)	FADS2 (1.7)	ITGB3 (1.6)	LDLR (1.6)
MP:0005226	abnormal vertebral arch development	0.85	> 0.20	CILP2 (2.3)	ENSG00000254235 (2.0)	CEACAM19 (1.9)	DYNC2LI1 (1.6)	FADS2 (1.4)	KANK2 (1.3)	NYNRIN (1.2)	ENSG00000238078 (1.1)	MARK4 (1.1)	C11orf9 (1.0)
ENSG00000172116	CD8B PPI subnetwork	0.85	> 0.20	PLCG1 (3.6)	PPP1R37 (2.6)	MARK4 (2.4)	ZNF101 (2.3)	GRINA (2.1)	CLPTM1 (2.1)	ENSG00000228044 (1.8)	APOE (1.8)	SARS (1.6)	C1orf63 (1.2)
GO:0000783	nuclear telomere cap complex	0.85	> 0.20	TXNL4B (3.3)	DHODH (3.2)	POLK (2.6)	SARS (2.3)	DHX38 (2.2)	ZNF101 (2.0)	NYNRIN (1.9)	SUGP1 (1.9)	UBXN2B (1.8)	TMEM116 (1.7)
GO:0000782	telomere cap complex	0.85	> 0.20	TXNL4B (3.3)	DHODH (3.2)	POLK (2.6)	SARS (2.3)	DHX38 (2.2)	ZNF101 (2.0)	NYNRIN (1.9)	SUGP1 (1.9)	UBXN2B (1.8)	TMEM116 (1.7)
ENSG00000182872	RBM10 PPI subnetwork	0.85	> 0.20	CARM1 (4.0)	ILF3 (3.1)	SMARCA4 (2.1)	SUGP1 (2.0)	TOMM40 (2.0)	QTRT1 (1.9)	C12orf43 (1.8)	DHX38 (1.7)	NAA25 (1.6)	DDX56 (1.5)
MP:0008995	early reproductive senescence	0.85	> 0.20	TMEM116 (2.6)	PMFBP1 (2.5)	PCSK9 (2.3)	TRIB1 (2.1)	C12orf47 (2.1)	APOC1 (1.9)	ATXN7L2 (1.6)	ZHX3 (1.6)	LPAR2 (1.5)	DHX38 (1.5)
GO:0000188	inactivation of MAPK activity	0.85	> 0.20	TRIB1 (3.6)	DNAH11 (2.4)	PVR (2.0)	POC5 (1.9)	ENSG00000226645 (1.8)	ENSG00000238078 (1.6)	ENSG00000235545 (1.3)	SYPL2 (1.3)	SH2B3 (1.1)	GCNT4 (1.1)
GO:0043252	sodium-independent organic anion transport	0.85	> 0.20	CYP7A1 (2.6)	SLC22A1 (2.3)	TMEM116 (2.2)	ANGPTL3 (2.1)	NT5DC1 (1.8)	PLG (1.8)	CYB561D1 (1.8)	C19orf52 (1.8)	HAVCR1 (1.8)	HNF1A (1.7)
GO:0002016	regulation of blood volume by renin-angiotensin	0.85	> 0.20	PMFBP1 (2.4)	TMED4 (2.4)	C12orf47 (2.1)	C17orf57 (1.9)	DNAH11 (1.8)	HNF1A (1.7)	ENSG00000235545 (1.7)	COL4A3BP (1.7)	NPC1L1 (1.5)	ZHX3 (1.4)
GO:0007617	mating behavior	0.85	> 0.20	ZHX3 (2.9)	GOT2P1 (2.2)	NKPD1 (2.2)	ERP29 (2.1)	DNAH11 (2.0)	AMIGO1 (1.8)	CEACAM19 (1.7)	GCNT4 (1.7)	TSSK6 (1.7)	TMED4 (1.6)
ENSG00000165410	CFL2 PPI subnetwork	0.85	> 0.20	BRAP (2.8)	LPIN3 (2.5)	KANK2 (2.5)	ADAM1 (2.4)	TRAFD1 (2.2)	GATAD2A (2.2)	PLCG1 (2.1)	PTPN11 (1.8)	PVR (1.8)	BCAM (1.8)
GO:0001702	gastrulation with mouth forming second	0.85	> 0.20	ABO (2.7)	LPAR2 (2.1)	HNF1A (1.8)	NYNRIN (1.6)	ATXN7L2 (1.5)	TMED4 (1.4)	PVRL2 (1.4)	TMEM57 (1.1)	PCSK9 (1.1)	C19orf52 (1.0)
GO:0005815	microtubule organizing center	0.85	> 0.20	DYNC2LI1 (4.8)	POC5 (4.4)	PSRC1 (3.8)	USP1 (2.5)	PBX4 (2.3)	FEN1 (2.0)	POLK (1.9)	BUD13 (1.9)	UBXN2B (1.8)	PLCG1 (1.4)
GO:0030971	receptor tyrosine kinase binding	0.85	> 0.20	MAFB (3.1)	HLX (2.4)	PLCG1 (1.6)	HAVCR1 (1.6)	TMEM57 (1.6)	NPC1L1 (1.3)	PARP10 (1.3)	TRIB1 (1.2)	BCAM (1.2)	PSRC1 (1.2)
GO:0001190	RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription	0.85	> 0.20	NYNRIN (3.0)	TMEM57 (2.9)	TRIB1 (2.5)	GCNT4 (1.8)	C19orf52 (1.5)	SLC22A1 (1.5)	ENSG00000226648 (1.5)	NCAN (1.5)	CELSR2 (1.3)	LPAR2 (1.3)
GO:0001105	RNA polymerase II transcription coactivator activity	0.85	> 0.20	NYNRIN (3.0)	TMEM57 (2.9)	TRIB1 (2.5)	GCNT4 (1.8)	C19orf52 (1.5)	SLC22A1 (1.5)	ENSG00000226648 (1.5)	NCAN (1.5)	CELSR2 (1.3)	LPAR2 (1.3)
ENSG00000182541	LIMK2 PPI subnetwork	0.85	> 0.20	C12orf51 (3.9)	USP24 (3.2)	GMIP (2.9)	MARK4 (2.9)	ATXN2 (2.7)	SORT1 (2.5)	PTPN11 (2.2)	BUD13 (1.8)	GATAD2A (1.8)	PSRC1 (1.6)
ENSG00000164162	ANAPC10 PPI subnetwork	0.85	> 0.20	PSRC1 (4.6)	FEN1 (3.3)	USP1 (2.4)	POC5 (1.9)	SLC44A2 (1.8)	LPAR2 (1.7)	LPIN3 (1.7)	RHCE (1.3)	GEMIN7 (1.2)	LDLR (1.2)
ENSG00000139182	CLSTN3 PPI subnetwork	0.85	> 0.20	ERP29 (3.9)	TMED4 (3.2)	NCAN (2.6)	BCAM (2.6)	CELSR2 (2.5)	CLPTM1 (2.5)	YIPF2 (2.4)	RPH3A (2.2)	GRINA (1.7)	PCSK9 (1.5)
GO:0051310	metaphase plate congression	0.85	> 0.20	POC5 (5.3)	PSRC1 (3.2)	POLK (3.1)	BUD13 (3.1)	UBXN2B (1.6)	ZNF259 (1.4)	HAVCR1 (1.4)	NKPD1 (1.4)	ENSG00000226648 (1.2)	TXNL4B (1.1)
ENSG00000145242	EPHA5 PPI subnetwork	0.85	> 0.20	PLEKHH2 (2.6)	BCL3 (2.6)	LPIN3 (2.6)	LPAR2 (2.3)	HP (2.3)	LPA (2.2)	GMIP (2.2)	GEMIN7 (1.8)	ALDH2 (1.5)	PPP1R37 (1.4)
MP:0008673	decreased interleukin-13 secretion	0.85	> 0.20	OASL (4.2)	PARP10 (2.1)	NKPD1 (2.0)	POC5 (1.7)	MAFB (1.6)	CILP2 (1.5)	TRIB1 (1.5)	ENSG00000228044 (1.4)	RHCE (1.4)	C11orf9 (1.4)
ENSG00000138709	LARP1B PPI subnetwork	0.85	> 0.20	TOP1 (3.9)	DDX56 (3.6)	NAA25 (3.5)	ZNF259 (3.0)	SUGP1 (2.0)	TMEM57 (1.9)	C12orf43 (1.9)	SMARCA4 (1.8)	SARS (1.8)	QTRT1 (1.8)
GO:0008194	UDP-glycosyltransferase activity	0.85	> 0.20	TMED4 (2.5)	ST3GAL4 (2.5)	ERP29 (2.1)	SLC44A2 (1.7)	PVR (1.7)	ENSG00000235545 (1.6)	TMEM50A (1.6)	PVRL2 (1.6)	HAVCR1 (1.6)	GCNT4 (1.5)
ENSG00000162105	SHANK2 PPI subnetwork	0.85	> 0.20	PPP1R37 (3.7)	CELSR2 (3.2)	ZHX3 (2.2)	ITGB3 (2.1)	GATAD2A (1.9)	LPAR2 (1.8)	NCAN (1.8)	RPH3A (1.7)	PBX4 (1.7)	FRK (1.6)
GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	0.85	> 0.20	PSMA5 (3.8)	TRAFD1 (2.4)	POC5 (2.3)	SUGP1 (2.2)	NAA25 (1.8)	LPIN3 (1.8)	DDX56 (1.6)	PSRC1 (1.6)	C12orf47 (1.3)	BRAP (1.3)
GO:0042327	positive regulation of phosphorylation	0.85	> 0.20	ENSG00000226645 (3.2)	SH2B3 (2.1)	GCNT4 (2.0)	PVR (1.9)	PLEKHH2 (1.6)	COL4A3BP (1.5)	HLX (1.4)	PTPN11 (1.3)	ENSG00000228044 (1.2)	POC5 (1.1)
ENSG00000076356	PLXNA2 PPI subnetwork	0.85	> 0.20	ADAM1 (3.0)	ATXN2 (2.8)	ATXN7L2 (2.1)	C12orf51 (1.8)	HLX (1.7)	SH2B3 (1.7)	PLEKHH2 (1.7)	ACAD10 (1.7)	FRK (1.6)	DOCK7 (1.6)
GO:0000118	histone deacetylase complex	0.85	> 0.20	SMARCA4 (2.9)	PLCG1 (2.9)	PPP1R37 (2.4)	CARM1 (2.3)	ATXN7L2 (2.1)	MYLIP (2.0)	CELSR2 (1.9)	ADAM1 (1.9)	ATXN2 (1.7)	KANK2 (1.7)
GO:0042287	MHC protein binding	0.85	> 0.20	PARP10 (2.7)	ALDH2 (2.4)	TRAFD1 (2.2)	GRINA (2.1)	OASL (2.1)	APOE (1.4)	ATP13A1 (1.4)	NKPD1 (1.4)	C19orf52 (1.2)	HAVCR1 (1.2)
ENSG00000078328	RBFOX1 PPI subnetwork	0.85	> 0.20	PPP1R37 (3.7)	MARK4 (2.3)	NYNRIN (2.2)	ATXN7L2 (2.0)	CARM1 (1.9)	DOCK7 (1.9)	HAVCR1 (1.9)	GRINA (1.6)	TOMM40 (1.5)	KANK2 (1.4)
ENSG00000171621	SPSB1 PPI subnetwork	0.85	> 0.20	PVRL2 (2.1)	TRAPPC6A (1.8)	ATXN2 (1.8)	ENSG00000226648 (1.8)	YIPF2 (1.7)	MYLIP (1.7)	HAVCR1 (1.5)	SLC44A2 (1.5)	BLOC1S3 (1.4)	APOE (1.4)
GO:0010720	positive regulation of cell development	0.85	> 0.20	ENSG00000254235 (2.3)	NCAN (2.3)	CELSR2 (1.7)	ANKRD31 (1.7)	GEMIN7 (1.6)	PLEC (1.6)	PPP1R37 (1.6)	DYNC2LI1 (1.5)	ATXN7L2 (1.3)	GCNT4 (1.2)
ENSG00000185825	BCAP31 PPI subnetwork	0.85	> 0.20	TMEM50A (3.3)	TMED4 (2.6)	GRINA (2.6)	NT5DC1 (2.6)	BCAM (2.1)	TRAPPC6A (2.0)	SYPL2 (1.7)	ITGB3 (1.7)	C17orf57 (1.6)	ENSG00000238078 (1.5)
GO:0012506	vesicle membrane	0.85	> 0.20	YIPF2 (2.7)	SORT1 (2.7)	RPH3A (2.4)	CLPTM1 (2.4)	HAPLN4 (2.3)	KIAA1324 (2.2)	C12orf51 (2.0)	PPP1R37 (1.9)	SH2B3 (1.6)	GRINA (1.6)
GO:0032446	protein modification by small protein conjugation	0.85	> 0.20	BRAP (3.9)	TRAFD1 (3.3)	C19orf52 (2.4)	ENSG00000226645 (2.2)	MAU2 (2.1)	TMEM57 (2.1)	ZNF180 (2.0)	POC5 (1.9)	SUGP1 (1.8)	BUD13 (1.7)
ENSG00000154723	ATP5J PPI subnetwork	0.85	> 0.20	OGDH (4.5)	PSMA5 (3.5)	ACAD10 (3.5)	C12orf47 (2.9)	BUD13 (2.3)	TOMM40 (1.7)	GOT2P1 (1.7)	CLPTM1 (1.6)	C19orf52 (1.6)	ENSG00000226648 (1.5)
ENSG00000091106	NLRC4 PPI subnetwork	0.85	> 0.20	C1orf63 (2.4)	TMEM50A (2.0)	BLOC1S3 (2.0)	CEACAM19 (1.8)	LPAR2 (1.8)	NT5DC1 (1.7)	PARP10 (1.7)	ALDH2 (1.7)	LPIN3 (1.5)	TOP1 (1.3)
GO:0045780	positive regulation of bone resorption	0.85	> 0.20	ENSG00000235545 (3.0)	DNAH11 (2.9)	ENSG00000226648 (2.6)	RHCE (2.4)	FRK (2.0)	PMFBP1 (2.0)	TSSK6 (1.8)	RHD (1.8)	CILP2 (1.7)	ENSG00000226645 (1.6)
GO:0046852	positive regulation of bone remodeling	0.85	> 0.20	ENSG00000235545 (3.0)	DNAH11 (2.9)	ENSG00000226648 (2.6)	RHCE (2.4)	FRK (2.0)	PMFBP1 (2.0)	TSSK6 (1.8)	RHD (1.8)	CILP2 (1.7)	ENSG00000226645 (1.6)
GO:0001649	osteoblast differentiation	0.85	> 0.20	PLEKHH2 (3.0)	CILP2 (2.7)	ENSG00000226648 (2.5)	KANK2 (1.7)	MAFB (1.7)	NYNRIN (1.5)	CEACAM19 (1.3)	CARM1 (1.2)	MYLIP (1.2)	AMIGO1 (1.1)
GO:0050678	regulation of epithelial cell proliferation	0.85	> 0.20	HLX (2.0)	KANK2 (1.6)	CBLC (1.6)	ENSG00000226645 (1.6)	C19orf52 (1.5)	ANKRD31 (1.4)	CILP2 (1.4)	MAFB (1.3)	SLC44A2 (1.3)	ENSG00000254235 (1.3)
ENSG00000186716	BCR PPI subnetwork	0.85	> 0.20	GMIP (3.3)	DNM2 (3.2)	C17orf57 (2.3)	LPAR2 (2.2)	COL4A3BP (1.9)	OGDH (1.8)	TOP1 (1.7)	SMARCA4 (1.6)	SLC44A2 (1.6)	SH2B3 (1.6)
ENSG00000204523	ENSG00000204523 PPI subnetwork	0.85	> 0.20	TOMM40 (3.2)	PSMA5 (3.2)	SARS (2.6)	NAA25 (1.9)	TMEM50A (1.9)	ERP29 (1.9)	SMARCA4 (1.7)	ZNF259 (1.7)	NT5DC1 (1.6)	CLPTM1 (1.5)
ENSG00000117399	CDC20 PPI subnetwork	0.85	> 0.20	PSRC1 (5.8)	FEN1 (4.2)	POC5 (3.6)	USP1 (3.3)	ENSG00000228044 (1.1)	LPIN3 (0.8)	GEMIN7 (0.8)	TMEM116 (0.7)	RHD (0.7)	C12orf47 (0.7)
ENSG00000140986	RPL3L PPI subnetwork	0.85	> 0.20	NKPD1 (2.9)	MOSC1 (1.7)	DNAH11 (1.6)	CEACAM19 (1.4)	ANKRD31 (1.4)	GATAD2A (1.3)	ENSG00000226645 (1.3)	UBXN2B (1.2)	ZNF101 (1.1)	CBLC (1.1)
GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	0.85	> 0.20	PSMA5 (3.9)	TRAFD1 (2.4)	SUGP1 (2.2)	POC5 (2.2)	NAA25 (2.1)	LPIN3 (1.8)	DDX56 (1.7)	NT5DC1 (1.4)	C12orf47 (1.4)	BRAP (1.3)
ENSG00000145494	NDUFS6 PPI subnetwork	0.85	> 0.20	OGDH (3.7)	ACAD10 (2.9)	TRAPPC6A (2.9)	C12orf47 (2.4)	MAU2 (1.6)	GOT2P1 (1.5)	GMPR (1.4)	FRK (1.3)	ADAM1 (1.3)	HAVCR1 (1.2)
ENSG00000125954	CHURC1-FNTB PPI subnetwork	0.85	> 0.20	TM6SF2 (3.3)	SYPL2 (2.5)	TMEM116 (2.3)	DNAH11 (2.0)	MYLIP (2.0)	ENSG00000226645 (2.0)	ABCG8 (2.0)	NPC1L1 (1.9)	ADAM1 (1.5)	TSSK6 (1.5)
KEGG_MELANOGENESIS	KEGG_MELANOGENESIS	0.85	> 0.20	PLEKHH2 (2.6)	CELSR2 (2.1)	SORT1 (2.0)	AMIGO1 (2.0)	MARK4 (1.8)	ZHX3 (1.8)	PLEC (1.7)	ABO (1.7)	BCAM (1.6)	CARM1 (1.5)
GO:0048333	mesodermal cell differentiation	0.85	> 0.20	NYNRIN (2.0)	ENSG00000238078 (1.7)	CILP2 (1.6)	DYNC2LI1 (1.5)	KANK2 (1.5)	AP1M2 (1.5)	C19orf52 (1.4)	YIPF2 (1.3)	LPIN3 (1.2)	BLOC1S3 (1.2)
ENSG00000028277	POU2F2 PPI subnetwork	0.85	> 0.20	KIAA1324 (3.6)	FRK (3.0)	ALDH2 (2.2)	PLEC (1.9)	ANKRD31 (1.8)	MOSC1 (1.7)	HAPLN4 (1.5)	BRAP (1.5)	ABCG5 (1.5)	SLC22A1 (1.3)
GO:0015851	nucleobase transport	0.85	> 0.20	CEACAM19 (2.5)	PMFBP1 (2.2)	TMEM116 (2.1)	GOT2P1 (2.0)	NKPD1 (1.8)	UBXN2B (1.8)	TM6SF2 (1.6)	HAVCR1 (1.5)	ABCG8 (1.5)	SLC44A2 (1.5)
GO:0042523	positive regulation of tyrosine phosphorylation of Stat5 protein	0.85	> 0.20	PBX4 (3.5)	ANKRD31 (2.3)	KIAA1324 (1.5)	GCNT4 (1.4)	DNAH11 (1.4)	ENSG00000254235 (1.3)	SH2B3 (1.2)	SLC22A1 (1.2)	GEMIN7 (1.0)	PLEKHH2 (0.9)
MP:0005404	abnormal axon morphology	0.85	> 0.20	HAPLN4 (3.9)	CELSR2 (3.1)	RPH3A (2.6)	GRINA (2.0)	SORT1 (2.0)	SARS (1.9)	C11orf9 (1.7)	C12orf51 (1.7)	MAFB (1.5)	HMGCR (1.4)
GO:0055002	striated muscle cell development	0.85	> 0.20	SYPL2 (4.7)	ENSG00000226648 (2.8)	OGDH (1.9)	ANKRD31 (1.9)	GMPR (1.9)	SLC44A2 (1.8)	KANK2 (1.7)	AMIGO1 (1.6)	HNF1A (1.5)	CEACAM19 (1.3)
MP:0004310	small otic vesicle	0.85	> 0.20	KIAA1324 (1.9)	MYLIP (1.8)	CILP2 (1.8)	UBXN2B (1.7)	CEACAM19 (1.6)	PLCG1 (1.6)	DYNC2LI1 (1.5)	DNAH11 (1.5)	CBLC (1.4)	BLOC1S3 (1.3)
MP:0005598	decreased ventricle muscle contractility	0.85	> 0.20	ACAD10 (1.9)	SYPL2 (1.8)	SORT1 (1.7)	BCAM (1.7)	GMPR (1.5)	OGDH (1.5)	TRAFD1 (1.4)	HP (1.3)	ST3GAL4 (1.2)	SH2B3 (1.2)
GO:0045671	negative regulation of osteoclast differentiation	0.85	> 0.20	DYNC2LI1 (3.1)	GCNT4 (2.9)	DNAH11 (2.2)	LPIN3 (2.1)	TMEM116 (1.8)	ERP29 (1.5)	UBXN2B (1.4)	PPP1R37 (1.0)	ENSG00000226645 (0.9)	C19orf52 (0.9)
GO:0072498	embryonic skeletal joint development	0.85	> 0.20	CILP2 (3.1)	PLEKHH2 (2.1)	LPAR2 (2.0)	CEACAM19 (2.0)	HNF1A (1.8)	NPC1L1 (1.8)	MYLIP (1.7)	NYNRIN (1.7)	PMFBP1 (1.7)	TMEM116 (1.6)
ENSG00000177106	EPS8L2 PPI subnetwork	0.85	> 0.20	TXNL4B (2.3)	HNF1A (2.1)	UBXN2B (2.0)	SUGP1 (1.9)	FRK (1.9)	TMEM50A (1.9)	MAPKAPK5 (1.6)	MARK4 (1.5)	NPC1L1 (1.5)	DHX38 (1.4)
GO:0045822	negative regulation of heart contraction	0.85	> 0.20	HAVCR1 (3.2)	ENSG00000226648 (3.0)	PTPN11 (3.0)	ENSG00000226645 (2.7)	TMEM116 (2.5)	RPH3A (2.1)	ZHX3 (1.9)	OGDH (1.9)	ENSG00000254235 (1.9)	ENSG00000238078 (1.8)
ENSG00000106400	ZNHIT1 PPI subnetwork	0.85	> 0.20	C12orf43 (3.0)	SUGP1 (2.6)	MAPKAPK5 (2.1)	USP1 (2.1)	ILF3 (1.9)	PPP1R37 (1.9)	ADAM1 (1.8)	PCSK9 (1.7)	SMARCA4 (1.7)	POC5 (1.6)
ENSG00000117676	RPS6KA1 PPI subnetwork	0.85	> 0.20	TRIB1 (4.6)	UBXN2B (3.0)	SH2B3 (2.7)	C1orf63 (2.3)	PTPN11 (2.1)	AMIGO1 (2.0)	ZHX3 (1.8)	TSSK6 (1.8)	COL4A3BP (1.7)	CELSR2 (1.5)
GO:0010769	regulation of cell morphogenesis involved in differentiation	0.85	> 0.20	ABO (3.1)	CELSR2 (2.7)	PPP1R37 (2.1)	ATXN7L2 (2.0)	GCNT4 (1.9)	C11orf9 (1.9)	PBX4 (1.8)	RPH3A (1.7)	PLEKHH2 (1.7)	SLC44A2 (1.5)
GO:0035088	establishment or maintenance of apical/basal cell polarity	0.85	> 0.20	LPAR2 (2.2)	AP1M2 (1.6)	GMPR (1.5)	KANK2 (1.4)	BCAM (1.3)	PLEKHH2 (1.3)	LPIN3 (1.1)	NYNRIN (1.1)	DYNC2LI1 (1.1)	PVRL2 (1.0)
GO:0061245	establishment or maintenance of bipolar cell polarity	0.85	> 0.20	LPAR2 (2.2)	AP1M2 (1.6)	GMPR (1.5)	KANK2 (1.4)	BCAM (1.3)	PLEKHH2 (1.3)	LPIN3 (1.1)	NYNRIN (1.1)	DYNC2LI1 (1.1)	PVRL2 (1.0)
ENSG00000158373	HIST1H2BD PPI subnetwork	0.85	> 0.20	SMARCA4 (2.9)	USP1 (2.3)	BUD13 (2.3)	ILF3 (2.1)	DDX56 (1.7)	SUGP1 (1.7)	ATXN2 (1.6)	TMEM57 (1.6)	GMPR (1.6)	GATAD2A (1.3)
ENSG00000078140	UBE2K PPI subnetwork	0.85	> 0.20	RELB (2.3)	C12orf47 (2.1)	PSMA5 (2.0)	HNF1A (1.9)	ENSG00000235545 (1.7)	SARS (1.7)	BCL3 (1.6)	C12orf43 (1.4)	DYNC2LI1 (1.4)	HAVCR1 (1.4)
GO:0045176	apical protein localization	0.85	> 0.20	HAPLN4 (2.7)	ENSG00000226648 (2.3)	COL4A3BP (2.0)	ZNF180 (1.7)	CELSR2 (1.7)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	SORT1 (1.6)	SLC44A2 (1.6)	PVRL2 (1.6)
ENSG00000173171	MTX1 PPI subnetwork	0.85	> 0.20	SYPL2 (3.0)	GMPR (2.9)	TOMM40 (2.9)	ATXN2 (2.6)	DHODH (2.1)	BRAP (2.1)	OGDH (2.0)	PBX4 (2.0)	C17orf57 (1.9)	PMFBP1 (1.4)
GO:0060487	lung epithelial cell differentiation	0.85	> 0.20	KIAA1324 (4.3)	PLEKHH2 (3.0)	DYNC2LI1 (2.1)	AP1M2 (2.1)	BLOC1S3 (1.7)	ALDH2 (1.6)	C11orf9 (1.5)	COL4A3BP (1.5)	C19orf52 (1.4)	ATXN2 (1.4)
GO:0031228	intrinsic to Golgi membrane	0.85	> 0.20	SLC44A2 (1.9)	TMEM57 (1.8)	TMED4 (1.7)	CYB561D1 (1.6)	AMIGO1 (1.6)	C12orf47 (1.6)	ENSG00000254235 (1.5)	RHCE (1.5)	HLX (1.5)	ITGB3 (1.4)
ENSG00000187953	ENSG00000187953 PPI subnetwork	0.85	> 0.20	FEN1 (3.8)	ENSG00000226648 (3.2)	USP1 (2.9)	POLK (2.9)	ZNF180 (2.7)	LPAR2 (1.6)	TMEM57 (1.4)	ANKRD31 (1.4)	ENSG00000235545 (1.3)	ITGB3 (1.2)
ENSG00000122512	PMS2 PPI subnetwork	0.85	> 0.20	FEN1 (3.8)	ENSG00000226648 (3.2)	USP1 (2.9)	POLK (2.9)	ZNF180 (2.7)	LPAR2 (1.6)	TMEM57 (1.4)	ANKRD31 (1.4)	ENSG00000235545 (1.3)	ITGB3 (1.2)
GO:0048286	lung alveolus development	0.85	> 0.20	PLEKHH2 (4.1)	C11orf9 (3.4)	DYNC2LI1 (2.7)	ENSG00000228044 (2.5)	NKPD1 (2.3)	ALDH2 (1.9)	KANK2 (1.8)	BCAM (1.7)	PVRL2 (1.6)	TOP1 (1.5)
GO:0043523	regulation of neuron apoptotic process	0.85	> 0.20	GOT2P1 (2.7)	TSSK6 (2.7)	LPIN3 (2.1)	PPP1R37 (1.9)	FRK (1.3)	GRINA (1.3)	TRAPPC6A (1.3)	CELSR2 (1.2)	ENSG00000228044 (1.1)	DNAH11 (1.1)
GO:0030551	cyclic nucleotide binding	0.85	> 0.20	MOSC1 (2.9)	ITGB3 (2.5)	GOT2P1 (2.1)	ENSG00000254235 (2.0)	CETP (1.6)	SORT1 (1.6)	CYP7A1 (1.5)	AMIGO1 (1.2)	ALDH2 (1.0)	SH2B3 (1.0)
GO:0007220	Notch receptor processing	0.86	> 0.20	ENSG00000226648 (2.6)	CYB561D1 (2.1)	DNAH11 (2.0)	TMEM50A (1.9)	LPIN3 (1.9)	ENSG00000254235 (1.9)	TRAPPC6A (1.6)	CLPTM1 (1.5)	CELSR2 (1.5)	ABO (1.4)
GO:0070665	positive regulation of leukocyte proliferation	0.86	> 0.20	TIMD4 (2.6)	PBX4 (2.6)	ENSG00000226645 (2.3)	CETP (1.9)	ZNF101 (1.6)	TRAFD1 (1.4)	HLX (1.1)	RELB (1.0)	GMIP (1.0)	POLK (1.0)
GO:0001914	regulation of T cell mediated cytotoxicity	0.86	> 0.20	ZNF180 (2.5)	PARP10 (2.3)	ADAM1 (2.0)	NKPD1 (1.8)	CEACAM19 (1.7)	LPIN3 (1.6)	TMED4 (1.4)	DNAH11 (1.4)	NAA25 (1.3)	PBX4 (1.3)
REACTOME_G1_PHASE	REACTOME_G1_PHASE	0.86	> 0.20	SLC44A2 (2.4)	ATXN7L2 (2.1)	DNM2 (1.9)	SORT1 (1.8)	TOP1 (1.7)	SMARCA4 (1.4)	DYNC2LI1 (1.4)	GCNT4 (1.4)	PSRC1 (1.3)	ENSG00000235545 (1.3)
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	0.86	> 0.20	SLC44A2 (2.4)	ATXN7L2 (2.1)	DNM2 (1.9)	SORT1 (1.8)	TOP1 (1.7)	SMARCA4 (1.4)	DYNC2LI1 (1.4)	GCNT4 (1.4)	PSRC1 (1.3)	ENSG00000235545 (1.3)
MP:0002861	abnormal tail bud morphology	0.86	> 0.20	LPAR2 (1.9)	GOT2P1 (1.9)	ANKRD31 (1.9)	APOE (1.7)	KANK2 (1.6)	UBXN2B (1.6)	ILF3 (1.5)	LPA (1.5)	BRAP (1.3)	CILP2 (1.3)
GO:0006944	cellular membrane fusion	0.86	> 0.20	BLOC1S3 (4.4)	CYB561D1 (2.7)	POLK (2.6)	ANKRD31 (2.2)	BRAP (2.0)	TSSK6 (1.9)	PMFBP1 (1.5)	C19orf52 (1.4)	TRAPPC6A (1.3)	C12orf43 (1.3)
GO:0010977	negative regulation of neuron projection development	0.86	> 0.20	ABO (3.2)	ANKRD31 (2.7)	C17orf57 (2.0)	NKPD1 (2.0)	GCNT4 (1.7)	NYNRIN (1.7)	HAPLN4 (1.5)	UBXN2B (1.5)	NCAN (1.2)	PBX4 (1.2)
GO:2000677	regulation of transcription regulatory region DNA binding	0.86	> 0.20	ENSG00000226648 (4.1)	MYLIP (2.5)	C19orf52 (2.3)	ENSG00000238078 (2.1)	DNAH11 (1.9)	ENSG00000226645 (1.8)	UBXN2B (1.6)	LPAR2 (1.6)	RHCE (1.4)	ENSG00000254235 (1.4)
ENSG00000152601	MBNL1 PPI subnetwork	0.86	> 0.20	HNF1A (3.2)	SARS (2.2)	C19orf52 (2.1)	TM6SF2 (1.7)	TOP1 (1.6)	ILF3 (1.5)	GCNT4 (1.5)	HAPLN4 (1.4)	GOT2P1 (1.4)	QTRT1 (1.4)
ENSG00000154928	EPHB1 PPI subnetwork	0.86	> 0.20	ST3GAL4 (2.0)	NYNRIN (2.0)	SH2B3 (1.6)	MAFB (1.5)	DNM2 (1.5)	PVRL2 (1.5)	SLC44A2 (1.4)	LPAR2 (1.3)	C11orf9 (1.3)	PBX4 (1.3)
GO:0006740	NADPH regeneration	0.86	> 0.20	BLOC1S3 (4.0)	TRAPPC6A (3.6)	FRK (2.6)	NT5DC1 (1.9)	ACAD10 (1.9)	C1orf63 (1.8)	ERP29 (1.7)	MOSC1 (1.7)	FADS1 (1.7)	FADS2 (1.7)
GO:0005813	centrosome	0.86	> 0.20	POC5 (4.4)	DYNC2LI1 (4.2)	PSRC1 (3.7)	USP1 (2.7)	FEN1 (2.2)	PBX4 (2.1)	BUD13 (2.0)	POLK (1.9)	PLCG1 (1.7)	PTPN11 (1.6)
GO:0071634	regulation of transforming growth factor beta production	0.86	> 0.20	GCNT4 (2.9)	HNF1A (2.4)	ABO (2.4)	PLEKHH2 (2.4)	POLK (2.2)	C17orf57 (1.9)	ENSG00000254235 (1.6)	COL4A3BP (1.6)	TSSK6 (1.6)	PVR (1.5)
GO:0071604	transforming growth factor beta production	0.86	> 0.20	GCNT4 (2.9)	HNF1A (2.4)	ABO (2.4)	PLEKHH2 (2.4)	POLK (2.2)	C17orf57 (1.9)	ENSG00000254235 (1.6)	COL4A3BP (1.6)	TSSK6 (1.6)	PVR (1.5)
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	0.86	> 0.20	PLCG1 (3.5)	RELB (2.9)	PBX4 (2.4)	GMIP (2.2)	SLC44A2 (2.1)	COL4A3BP (2.0)	MARK4 (1.6)	ZNF101 (1.4)	ZHX3 (1.3)	BCL3 (1.3)
ENSG00000212875	ENSG00000212875 PPI subnetwork	0.86	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.7)	ACAD10 (2.4)	C12orf47 (2.2)	TMEM116 (2.0)	OGDH (1.6)	HAVCR1 (1.5)	ALDH2 (1.5)	ERP29 (1.4)	C19orf52 (1.3)
ENSG00000198804	MT-CO1 PPI subnetwork	0.86	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.7)	ACAD10 (2.4)	C12orf47 (2.2)	TMEM116 (2.0)	OGDH (1.6)	HAVCR1 (1.5)	ALDH2 (1.5)	ERP29 (1.4)	C19orf52 (1.3)
ENSG00000100075	SLC25A1 PPI subnetwork	0.86	> 0.20	OGDH (2.5)	YIPF2 (2.1)	QTRT1 (2.0)	ATP13A1 (1.7)	ACAD10 (1.6)	DHODH (1.6)	SLC44A2 (1.4)	ERP29 (1.3)	DNM2 (1.3)	FRK (1.3)
ENSG00000165416	SUGT1 PPI subnetwork	0.86	> 0.20	TXNL4B (3.1)	DYNC2LI1 (2.5)	ZNF180 (2.4)	BRAP (2.2)	ENSG00000228044 (2.2)	ATXN2 (1.7)	COL4A3BP (1.7)	MAPKAPK5 (1.6)	USP24 (1.3)	CILP2 (1.3)
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	0.86	> 0.20	CELSR2 (3.8)	CLPTM1 (2.9)	ANKRD31 (2.5)	TIMD4 (2.0)	KIAA1324 (2.0)	TRAPPC6A (1.9)	ABO (1.9)	PVRL2 (1.8)	ENSG00000226645 (1.8)	TMED4 (1.7)
ENSG00000197697	HIST1H2BE PPI subnetwork	0.86	> 0.20	TMEM57 (2.3)	SMARCA4 (2.1)	DDX56 (2.1)	USP1 (1.9)	C19orf52 (1.7)	TOP1 (1.7)	DOCK7 (1.7)	BUD13 (1.7)	ILF3 (1.5)	ZNF259 (1.5)
GO:0090130	tissue migration	0.86	> 0.20	ENSG00000226648 (2.8)	HNF1A (2.6)	ABO (2.5)	PLEKHH2 (2.1)	ENSG00000228044 (1.9)	PMFBP1 (1.7)	C17orf57 (1.6)	TRAPPC6A (1.6)	KANK2 (1.4)	NYNRIN (1.3)
MP:0001158	abnormal prostate gland morphology	0.86	> 0.20	ALDH2 (2.9)	MAFB (2.4)	NYNRIN (2.2)	ERP29 (2.2)	LPAR2 (1.6)	ATXN2 (1.5)	ZNF180 (1.5)	ATXN7L2 (1.5)	ADAM1 (1.3)	ABO (1.3)
GO:0060479	lung cell differentiation	0.86	> 0.20	KIAA1324 (4.2)	PLEKHH2 (2.7)	DYNC2LI1 (2.2)	AP1M2 (2.0)	BLOC1S3 (1.7)	ALDH2 (1.7)	HLX (1.4)	C19orf52 (1.4)	C11orf9 (1.4)	COL4A3BP (1.4)
ENSG00000106976	DNM1 PPI subnetwork	0.86	> 0.20	SARS (2.1)	ITGB3 (2.1)	PLCG1 (2.0)	RPH3A (2.0)	PBX4 (2.0)	PLEC (1.9)	C17orf57 (1.9)	KANK2 (1.8)	ZHX3 (1.8)	DNM2 (1.6)
ENSG00000116903	EXOC8 PPI subnetwork	0.86	> 0.20	POLK (2.9)	SUGP1 (2.6)	COL4A3BP (2.1)	DNAH11 (2.0)	DYNC2LI1 (2.0)	C17orf57 (1.9)	ACAD10 (1.5)	SARS (1.4)	BLOC1S3 (1.2)	TRAFD1 (1.2)
MP:0010053	decreased grip strength	0.86	> 0.20	USP24 (3.2)	SYPL2 (2.7)	DOCK7 (2.4)	CELSR2 (2.2)	RPH3A (1.8)	BCAM (1.7)	PLEC (1.7)	AMIGO1 (1.4)	TMED4 (1.4)	TMEM116 (1.3)
ENSG00000105880	DLX5 PPI subnetwork	0.86	> 0.20	NCAN (2.0)	KIAA1324 (1.9)	UBXN2B (1.8)	C12orf51 (1.7)	MARK4 (1.6)	C19orf52 (1.5)	MYLIP (1.4)	MAFB (1.3)	GCNT4 (1.3)	DNAH11 (1.2)
GO:0045920	negative regulation of exocytosis	0.86	> 0.20	BLOC1S3 (3.8)	DNAH11 (2.3)	ALDH2 (1.9)	CETP (1.7)	ABO (1.3)	TIMD4 (1.3)	NYNRIN (1.2)	CILP2 (1.2)	CYB561D1 (1.2)	TSSK6 (1.1)
ENSG00000015285	WAS PPI subnetwork	0.86	> 0.20	GATAD2A (4.0)	SH2B3 (3.0)	GMIP (3.0)	COL4A3BP (2.9)	DNM2 (2.8)	CARM1 (1.9)	TMEM50A (1.8)	ITGB3 (1.8)	MARK4 (1.6)	ATXN2 (1.5)
ENSG00000128050	PAICS PPI subnetwork	0.86	> 0.20	NCAN (2.4)	GOT2P1 (2.1)	MARK4 (2.0)	C12orf43 (2.0)	HAPLN4 (2.0)	ZNF180 (1.9)	DNAH11 (1.8)	SORT1 (1.8)	UBXN2B (1.8)	C11orf9 (1.6)
ENSG00000169750	RAC3 PPI subnetwork	0.86	> 0.20	GMIP (3.2)	DNM2 (2.6)	DOCK7 (1.9)	LPAR2 (1.8)	SMARCA4 (1.8)	DNAH11 (1.8)	TMEM57 (1.8)	UBXN2B (1.7)	POC5 (1.7)	ANKRD31 (1.7)
ENSG00000138041	SMEK2 PPI subnetwork	0.86	> 0.20	GMPR (2.2)	C19orf52 (2.1)	PSRC1 (1.6)	ENSG00000226645 (1.4)	BUD13 (1.3)	TRAPPC6A (1.1)	MYLIP (1.1)	TMEM50A (1.1)	TSSK6 (1.1)	ANGPTL3 (1.0)
MP:0000688	lymphoid hyperplasia	0.86	> 0.20	RELB (1.7)	PLEKHH2 (1.7)	KANK2 (1.6)	PARP10 (1.6)	POC5 (1.5)	MOSC1 (1.4)	COL4A3BP (1.3)	POLK (1.3)	C19orf52 (1.3)	C12orf43 (1.2)
ENSG00000141052	MYOCD PPI subnetwork	0.86	> 0.20	ENSG00000238078 (2.2)	CARM1 (2.0)	LDLR (1.9)	GMIP (1.7)	NT5DC1 (1.5)	C12orf51 (1.4)	CEACAM19 (1.4)	ATXN7L2 (1.0)	CELSR2 (1.0)	PVR (1.0)
ENSG00000101350	KIF3B PPI subnetwork	0.86	> 0.20	GEMIN7 (2.7)	DOCK7 (2.3)	CYB561D1 (1.8)	C1orf63 (1.8)	ENSG00000235545 (1.7)	UBXN2B (1.6)	SORT1 (1.5)	SARS (1.4)	BCAM (1.4)	COL4A3BP (1.4)
GO:0004691	cAMP-dependent protein kinase activity	0.86	> 0.20	SYPL2 (2.8)	BRAP (2.7)	GMPR (2.3)	PTPN11 (2.3)	OGDH (2.0)	POLK (1.9)	ZHX3 (1.9)	SORT1 (1.9)	ADAM1 (1.7)	SLC44A2 (1.6)
GO:0030018	Z disc	0.86	> 0.20	SYPL2 (6.1)	GMPR (2.3)	TMEM50A (1.7)	PLEC (1.4)	SORT1 (1.3)	NPC1L1 (1.1)	TSSK6 (1.1)	KANK2 (0.9)	RPH3A (0.9)	NCAN (0.9)
ENSG00000165288	BRWD3 PPI subnetwork	0.86	> 0.20	USP24 (4.2)	COL4A3BP (3.4)	MAU2 (1.8)	CARM1 (1.7)	GMPR (1.5)	C12orf51 (1.5)	PTPN11 (1.5)	PBX4 (1.4)	BUD13 (1.4)	DOCK7 (1.4)
ENSG00000172943	PHF8 PPI subnetwork	0.86	> 0.20	MAPKAPK5 (3.2)	ADAM1 (2.7)	UBXN2B (2.2)	COL4A3BP (2.1)	POC5 (1.9)	TXNL4B (1.8)	SMARCA4 (1.7)	DHX38 (1.6)	DYNC2LI1 (1.5)	TOP1 (1.5)
ENSG00000134333	LDHA PPI subnetwork	0.86	> 0.20	FADS2 (2.5)	NCAN (2.3)	ENSG00000226648 (2.1)	PTPN11 (1.9)	POC5 (1.9)	FADS1 (1.8)	DOCK7 (1.7)	C11orf9 (1.6)	ST3GAL4 (1.5)	ITGB3 (1.5)
ENSG00000111481	COPZ1 PPI subnetwork	0.86	> 0.20	YIPF2 (5.3)	KIAA1324 (1.9)	ABCG8 (1.8)	C19orf52 (1.7)	SARS (1.6)	BLOC1S3 (1.6)	RHCE (1.6)	RHD (1.5)	CYP7A1 (1.4)	BUD13 (1.4)
ENSG00000157625	TAB3 PPI subnetwork	0.86	> 0.20	LPAR2 (2.7)	ZNF101 (2.5)	FRK (2.3)	ITGB3 (2.3)	GEMIN7 (2.2)	MAU2 (2.2)	ZNF259 (1.9)	ZHX3 (1.9)	MAPKAPK5 (1.8)	BUD13 (1.8)
MP:0004423	abnormal squamosal bone morphology	0.86	> 0.20	HAPLN4 (2.8)	CEACAM19 (2.2)	TMEM57 (2.1)	KANK2 (1.7)	ST3GAL4 (1.6)	CILP2 (1.5)	DYNC2LI1 (1.4)	PLCG1 (1.3)	KIAA1324 (1.1)	LPIN3 (1.1)
ENSG00000065613	SLK PPI subnetwork	0.86	> 0.20	ST3GAL4 (3.3)	ABO (1.9)	NT5DC1 (1.6)	ZNF180 (1.6)	OASL (1.6)	ILF3 (1.5)	FRK (1.5)	GMIP (1.3)	SYPL2 (1.3)	C1orf63 (1.3)
GO:0008589	regulation of smoothened signaling pathway	0.86	> 0.20	ENSG00000235545 (2.7)	NYNRIN (2.7)	DYNC2LI1 (2.4)	ENSG00000228044 (2.3)	PLEKHH2 (2.0)	PLCG1 (2.0)	PBX4 (1.6)	AMIGO1 (1.4)	HAPLN4 (1.3)	ZHX3 (1.3)
ENSG00000118094	TREH PPI subnetwork	0.86	> 0.20	ENSG00000226645 (2.2)	C12orf47 (2.0)	NKPD1 (1.8)	PBX4 (1.8)	DNAH11 (1.7)	TM6SF2 (1.6)	HAPLN4 (1.6)	LDLR (1.5)	HMGCR (1.5)	ST3GAL4 (1.4)
ENSG00000172613	RAD9A PPI subnetwork	0.86	> 0.20	FEN1 (5.7)	USP1 (4.7)	ERP29 (2.3)	POC5 (2.2)	ZNF180 (2.0)	PPP1R37 (1.8)	LPIN3 (1.8)	POLK (1.8)	PSRC1 (1.5)	TMEM116 (1.4)
GO:0001963	synaptic transmission, dopaminergic	0.86	> 0.20	DNAH11 (3.2)	BLOC1S3 (3.0)	TSSK6 (1.8)	ADAM1 (1.7)	PMFBP1 (1.6)	ABO (1.5)	COL4A3BP (1.4)	GCNT4 (1.4)	ST3GAL4 (1.3)	AMIGO1 (1.2)
GO:0072210	metanephric nephron development	0.86	> 0.20	HNF1A (2.8)	PLEKHH2 (2.7)	TSSK6 (1.9)	AP1M2 (1.7)	BCAM (1.6)	DYNC2LI1 (1.6)	NYNRIN (1.6)	PMFBP1 (1.6)	TMEM116 (1.5)	AMIGO1 (1.5)
REACTOME_P38MAPK_EVENTS	REACTOME_P38MAPK_EVENTS	0.86	> 0.20	MAPKAPK5 (2.7)	LPAR2 (2.4)	PVRL2 (2.3)	MARK4 (2.2)	PLEC (2.2)	GATAD2A (2.2)	AP1M2 (2.1)	LPIN3 (2.0)	BCL3 (1.8)	GEMIN7 (1.7)
ENSG00000151914	DST PPI subnetwork	0.86	> 0.20	BCAM (2.4)	PLCG1 (2.4)	CBLC (2.3)	PLEC (1.9)	TMEM116 (1.8)	CELSR2 (1.8)	BRAP (1.8)	TM6SF2 (1.6)	KANK2 (1.6)	DOCK7 (1.5)
GO:0016651	oxidoreductase activity, acting on NADH or NADPH	0.86	> 0.20	ACAD10 (3.8)	OGDH (3.6)	ALDH2 (3.1)	TRAPPC6A (2.6)	GOT2P1 (2.0)	PSMA5 (1.9)	C12orf47 (1.9)	FRK (1.6)	GMPR (1.5)	PTPN11 (1.1)
ENSG00000154978	VOPP1 PPI subnetwork	0.86	> 0.20	PSMA5 (3.6)	CYB561D1 (3.4)	C12orf47 (2.6)	GRINA (2.5)	NKPD1 (2.5)	C11orf9 (2.2)	SLC44A2 (2.1)	PPP1R37 (2.0)	GEMIN7 (2.0)	PSRC1 (2.0)
GO:0001829	trophectodermal cell differentiation	0.86	> 0.20	ATXN7L2 (2.0)	CEACAM19 (1.9)	NKPD1 (1.9)	DNAH11 (1.6)	TRIB1 (1.6)	TSSK6 (1.6)	ADAM1 (1.6)	LPIN3 (1.5)	TMEM116 (1.5)	CBLC (1.4)
MP:0004007	abnormal lung vasculature morphology	0.86	> 0.20	PLEKHH2 (3.7)	LDLR (2.5)	BCAM (2.4)	FADS2 (2.0)	KANK2 (1.8)	FADS1 (1.8)	HLX (1.8)	C11orf9 (1.6)	GCNT4 (1.5)	LPIN3 (1.4)
GO:0050802	circadian sleep/wake cycle, sleep	0.86	> 0.20	ENSG00000226648 (4.4)	RPH3A (2.1)	HNF1A (1.9)	LPIN3 (1.5)	C12orf47 (1.3)	CEACAM19 (1.3)	TSSK6 (1.3)	PPP1R37 (1.3)	ENSG00000228044 (1.2)	CILP2 (1.2)
GO:0022410	circadian sleep/wake cycle process	0.86	> 0.20	ENSG00000226648 (4.4)	RPH3A (2.1)	HNF1A (1.9)	LPIN3 (1.5)	C12orf47 (1.3)	CEACAM19 (1.3)	TSSK6 (1.3)	PPP1R37 (1.3)	ENSG00000228044 (1.2)	CILP2 (1.2)
ENSG00000183337	BCOR PPI subnetwork	0.86	> 0.20	MARK4 (2.3)	CARM1 (2.3)	ILF3 (1.9)	ATXN7L2 (1.9)	TRAFD1 (1.7)	USP24 (1.6)	ATXN2 (1.6)	PLCG1 (1.5)	ENSG00000235545 (1.5)	AMIGO1 (1.5)
GO:0048146	positive regulation of fibroblast proliferation	0.86	> 0.20	DYNC2LI1 (2.3)	POLK (2.3)	HAVCR1 (2.1)	HNF1A (1.6)	GCNT4 (1.6)	PBX4 (1.6)	ENSG00000228044 (1.4)	ATXN7L2 (1.3)	KANK2 (1.2)	TMED4 (1.1)
ENSG00000197969	VPS13A PPI subnetwork	0.86	> 0.20	USP1 (4.4)	FEN1 (4.0)	POC5 (2.7)	ERP29 (1.7)	ZHX3 (1.6)	ZNF180 (1.6)	PTPN11 (1.4)	CYP7A1 (1.2)	ENSG00000238078 (1.1)	NAA25 (1.1)
GO:0030539	male genitalia development	0.86	> 0.20	PMFBP1 (2.9)	DNAH11 (2.6)	ENSG00000238078 (2.3)	PLEKHH2 (2.2)	TSSK6 (2.0)	NYNRIN (1.8)	NKPD1 (1.4)	ST3GAL4 (1.4)	ALDH2 (1.4)	ABO (1.3)
GO:0046426	negative regulation of JAK-STAT cascade	0.86	> 0.20	TRAFD1 (2.0)	ENSG00000238078 (1.8)	PARP10 (1.7)	GCNT4 (1.4)	HAPLN4 (1.2)	CYB561D1 (1.1)	NPC1L1 (1.1)	UBXN2B (1.0)	ENSG00000226645 (1.0)	DNM2 (1.0)
GO:0045295	gamma-catenin binding	0.86	> 0.20	DOCK7 (3.4)	TIMD4 (3.0)	AP1M2 (2.1)	CELSR2 (1.8)	SORT1 (1.7)	CLPTM1 (1.6)	ALDH2 (1.5)	SMARCA4 (1.5)	PLCG1 (1.4)	HMGCR (1.4)
ENSG00000130307	USHBP1 PPI subnetwork	0.86	> 0.20	DNAH11 (3.6)	BLOC1S3 (2.7)	NYNRIN (2.5)	RHD (2.5)	ENSG00000226648 (2.1)	RHCE (1.8)	MAU2 (1.7)	PSRC1 (1.5)	TSSK6 (1.5)	PPP1R37 (1.4)
MP:0000350	abnormal cell proliferation	0.86	> 0.20	C1orf63 (3.5)	MAU2 (3.4)	POLK (2.7)	UBXN2B (1.8)	ENSG00000235545 (1.8)	DOCK7 (1.6)	ZNF101 (1.5)	HNF1A (1.5)	TMED4 (1.3)	MYLIP (1.3)
ENSG00000067208	EVI5 PPI subnetwork	0.86	> 0.20	GEMIN7 (3.0)	C12orf51 (2.9)	POC5 (2.8)	ENSG00000254235 (2.6)	TSSK6 (1.9)	SH2B3 (1.6)	COL4A3BP (1.5)	PSRC1 (1.5)	RHD (1.2)	DYNC2LI1 (1.1)
ENSG00000112640	PPP2R5D PPI subnetwork	0.86	> 0.20	TSSK6 (2.7)	MOSC1 (2.5)	C11orf9 (2.1)	PSRC1 (2.1)	HLX (2.0)	TOP1 (1.7)	DHODH (1.5)	ATXN7L2 (1.5)	TOMM40 (1.4)	LDLR (1.4)
ENSG00000129559	NEDD8 PPI subnetwork	0.86	> 0.20	ENSG00000226645 (2.2)	ZNF259 (2.1)	SUGP1 (2.0)	GATAD2A (1.9)	CARM1 (1.9)	MARK4 (1.9)	TMEM57 (1.7)	HAPLN4 (1.7)	ZNF180 (1.7)	NKPD1 (1.5)
GO:0030126	COPI vesicle coat	0.86	> 0.20	YIPF2 (4.5)	PSMA5 (2.4)	KIAA1324 (2.3)	DNM2 (2.1)	SARS (2.1)	MAU2 (2.0)	ATP13A1 (2.0)	POC5 (1.9)	BLOC1S3 (1.9)	ABCG8 (1.7)
ENSG00000108528	SLC25A11 PPI subnetwork	0.86	> 0.20	OGDH (3.0)	ACAD10 (2.7)	POLK (2.4)	TMEM116 (1.8)	ATP13A1 (1.8)	QTRT1 (1.7)	PSRC1 (1.6)	ABCG5 (1.5)	SORT1 (1.3)	PARP10 (1.3)
GO:0005200	structural constituent of cytoskeleton	0.86	> 0.20	RHD (4.0)	RHCE (3.9)	PMFBP1 (2.6)	GMPR (2.6)	CELSR2 (2.2)	TSSK6 (1.7)	BCAM (1.5)	PLEC (1.5)	C12orf51 (1.4)	ITGB3 (1.4)
MP:0009006	prolonged estrous cycle	0.86	> 0.20	GPAM (3.7)	KIAA1324 (1.8)	C12orf47 (1.5)	HP (1.4)	LPA (1.3)	NCAN (1.3)	ZHX3 (1.3)	MOSC1 (1.2)	PLCG1 (1.2)	TIMD4 (1.2)
GO:0043449	cellular alkene metabolic process	0.86	> 0.20	CYB561D1 (4.1)	NKPD1 (3.8)	CEACAM19 (3.2)	ALDH2 (2.1)	LPIN3 (2.0)	TMEM116 (1.8)	BLOC1S3 (1.8)	SORT1 (1.7)	ENSG00000235545 (1.6)	PMFBP1 (1.6)
GO:0006691	leukotriene metabolic process	0.86	> 0.20	CYB561D1 (4.1)	NKPD1 (3.8)	CEACAM19 (3.2)	ALDH2 (2.1)	LPIN3 (2.0)	TMEM116 (1.8)	BLOC1S3 (1.8)	SORT1 (1.7)	ENSG00000235545 (1.6)	PMFBP1 (1.6)
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	0.86	> 0.20	ITGB3 (2.7)	KIAA1324 (2.5)	ABO (2.5)	HLX (2.3)	C12orf47 (1.7)	GMIP (1.6)	CETP (1.6)	DNAH11 (1.6)	NPC1L1 (1.4)	ENSG00000235545 (1.4)
GO:0032663	regulation of interleukin-2 production	0.86	> 0.20	PBX4 (3.6)	POLK (2.1)	PMFBP1 (1.8)	ENSG00000235545 (1.7)	TIMD4 (1.6)	ENSG00000254235 (1.4)	SLC44A2 (1.3)	RELB (1.3)	CYB561D1 (1.3)	ANKRD31 (1.2)
GO:0035116	embryonic hindlimb morphogenesis	0.86	> 0.20	ABO (2.8)	MYLIP (2.4)	AP1M2 (1.7)	CILP2 (1.7)	ENSG00000238078 (1.5)	DNAH11 (1.5)	NYNRIN (1.4)	ATXN2 (1.3)	NKPD1 (1.2)	UBXN2B (1.2)
GO:0018394	peptidyl-lysine acetylation	0.86	> 0.20	ATXN7L2 (3.5)	ILF3 (2.5)	BUD13 (2.5)	ZNF180 (2.0)	BRAP (1.6)	PLCG1 (1.6)	MAU2 (1.5)	MAPKAPK5 (1.5)	ATXN2 (1.4)	DHX38 (1.4)
GO:0017119	Golgi transport complex	0.86	> 0.20	SUGP1 (4.2)	YIPF2 (3.7)	DHX38 (3.1)	MAPKAPK5 (2.0)	C12orf43 (1.9)	ENSG00000228044 (1.9)	MAU2 (1.9)	ACAD10 (1.8)	KIAA1324 (1.6)	TRAFD1 (1.6)
GO:0090179	planar cell polarity pathway involved in neural tube closure	0.86	> 0.20	ATXN7L2 (3.9)	ENSG00000235545 (2.7)	NYNRIN (2.5)	TMEM116 (2.3)	SLC44A2 (2.0)	ABO (1.9)	AMIGO1 (1.8)	CILP2 (1.5)	DYNC2LI1 (1.5)	C19orf52 (1.5)
GO:0090178	regulation of establishment of planar polarity involved in neural tube closure	0.86	> 0.20	ATXN7L2 (3.9)	ENSG00000235545 (2.7)	NYNRIN (2.5)	TMEM116 (2.3)	SLC44A2 (2.0)	ABO (1.9)	AMIGO1 (1.8)	CILP2 (1.5)	DYNC2LI1 (1.5)	C19orf52 (1.5)
ENSG00000106278	PTPRZ1 PPI subnetwork	0.86	> 0.20	RHCE (3.1)	NCAN (3.1)	RHD (2.5)	ABO (2.3)	APOE (1.9)	HNF1A (1.7)	C12orf51 (1.6)	RPH3A (1.5)	ZHX3 (1.5)	CLPTM1 (1.3)
ENSG00000122966	CIT PPI subnetwork	0.86	> 0.20	NCAN (3.0)	ATXN2 (2.4)	TRIB1 (2.1)	ENSG00000238078 (1.9)	DYNC2LI1 (1.7)	POLK (1.6)	DOCK7 (1.5)	KANK2 (1.3)	ADAM1 (1.3)	ALDH2 (1.3)
MP:0008703	decreased interleukin-5 secretion	0.86	> 0.20	OASL (4.6)	PARP10 (2.1)	HNF1A (2.1)	GMIP (1.6)	PLCG1 (1.3)	RHCE (1.2)	POLK (1.2)	C11orf9 (1.1)	CETP (1.0)	HAVCR1 (1.0)
ENSG00000136999	NOV PPI subnetwork	0.86	> 0.20	APOE (2.8)	PLEC (2.1)	KANK2 (2.1)	CILP2 (2.0)	APOC1 (1.7)	BCAM (1.6)	TIMD4 (1.6)	MAFB (1.5)	LPA (1.4)	APOB (1.2)
ENSG00000189308	LIN54 PPI subnetwork	0.86	> 0.20	RHD (3.0)	RHCE (2.4)	PLCG1 (2.1)	USP1 (2.1)	GRINA (1.9)	FEN1 (1.8)	MAPKAPK5 (1.8)	GOT2P1 (1.8)	PSRC1 (1.7)	UBXN2B (1.6)
MP:0005274	abnormal viscerocranium morphology	0.86	> 0.20	CILP2 (3.7)	TMEM116 (2.0)	ACAD10 (2.0)	HAVCR1 (1.9)	POLK (1.6)	GOT2P1 (1.5)	NPC1L1 (1.5)	GATAD2A (1.5)	ATXN2 (1.3)	MARK4 (1.3)
GO:0050865	regulation of cell activation	0.86	> 0.20	ZNF101 (3.7)	TIMD4 (2.6)	PBX4 (2.6)	PLCG1 (2.5)	CETP (2.1)	GMIP (1.7)	ITGB3 (1.4)	RELB (1.3)	POLK (1.2)	APOE (1.2)
GO:0010594	regulation of endothelial cell migration	0.86	> 0.20	PVR (3.0)	ENSG00000226645 (2.7)	HLX (2.0)	SLC44A2 (1.7)	DNAH11 (1.6)	HNF1A (1.6)	PVRL2 (1.5)	ITGB3 (1.5)	CETP (1.4)	CEACAM19 (1.2)
ENSG00000171346	KRT15 PPI subnetwork	0.86	> 0.20	TRIB1 (2.7)	UBXN2B (2.4)	MAFB (2.1)	ATXN2 (1.8)	POLK (1.8)	NKPD1 (1.8)	ENSG00000235545 (1.7)	SUGP1 (1.6)	C12orf43 (1.5)	DNAH11 (1.5)
GO:0001510	RNA methylation	0.86	> 0.20	ZNF259 (2.6)	QTRT1 (2.4)	TXNL4B (2.3)	SUGP1 (2.3)	C19orf52 (2.2)	DDX56 (2.0)	MAPKAPK5 (1.9)	BUD13 (1.8)	DHODH (1.7)	ZNF180 (1.6)
GO:0050688	regulation of defense response to virus	0.86	> 0.20	OASL (2.7)	ENSG00000235545 (2.6)	ATP13A1 (2.5)	PBX4 (2.4)	PARP10 (2.1)	CLPTM1 (2.0)	MAU2 (2.0)	TXNL4B (1.9)	GEMIN7 (1.9)	OGDH (1.9)
ENSG00000105486	LIG1 PPI subnetwork	0.86	> 0.20	FEN1 (5.0)	USP1 (3.7)	OASL (3.4)	ZNF180 (2.0)	PARP10 (1.9)	ILF3 (1.9)	BUD13 (1.7)	C12orf43 (1.7)	FADS1 (1.6)	C11orf9 (1.3)
GO:0032946	positive regulation of mononuclear cell proliferation	0.86	> 0.20	PBX4 (2.7)	TIMD4 (2.6)	ENSG00000226645 (2.2)	CETP (1.9)	ZNF101 (1.7)	TRAFD1 (1.3)	HLX (1.1)	RELB (1.0)	POLK (1.0)	GMIP (1.0)
GO:0008272	sulfate transport	0.86	> 0.20	TMEM116 (4.0)	PBX4 (2.5)	FRK (2.4)	CYB561D1 (2.2)	ENSG00000228044 (2.1)	NT5DC1 (2.0)	PMFBP1 (1.7)	BLOC1S3 (1.5)	MOSC1 (1.4)	ANKRD31 (1.4)
ENSG00000099800	TIMM13 PPI subnetwork	0.86	> 0.20	TOMM40 (3.1)	GEMIN7 (2.8)	TRAPPC6A (2.1)	PSMA5 (2.0)	ZNF259 (1.9)	ZNF180 (1.4)	DNAH11 (1.4)	BUD13 (1.3)	DDX56 (1.2)	LPA (1.2)
ENSG00000174227	PIGG PPI subnetwork	0.86	> 0.20	CYB561D1 (2.8)	ATP13A1 (2.8)	CLPTM1 (2.6)	TMEM50A (2.3)	ERP29 (2.1)	TMED4 (2.1)	NT5DC1 (1.5)	CYP7A1 (1.4)	DNAH11 (1.4)	ENSG00000235545 (1.3)
GO:0002021	response to dietary excess	0.86	> 0.20	PMFBP1 (2.0)	C12orf47 (2.0)	C17orf57 (1.9)	RPH3A (1.9)	MOSC1 (1.6)	C12orf51 (1.4)	POC5 (1.3)	AMIGO1 (1.3)	ERP29 (1.2)	NKPD1 (1.2)
ENSG00000171530	TBCA PPI subnetwork	0.86	> 0.20	C12orf47 (3.0)	GMPR (2.5)	ATXN7L2 (1.8)	ENSG00000226645 (1.7)	GATAD2A (1.6)	C11orf9 (1.6)	SYPL2 (1.5)	NCAN (1.4)	HAVCR1 (1.3)	ZNF259 (1.3)
GO:0001910	regulation of leukocyte mediated cytotoxicity	0.86	> 0.20	PBX4 (1.9)	PARP10 (1.8)	GEMIN7 (1.4)	ZNF180 (1.3)	TRAFD1 (1.3)	POLK (1.3)	ENSG00000235545 (1.3)	CEACAM19 (1.2)	AMIGO1 (1.2)	ENSG00000228044 (1.1)
ENSG00000168399	ENSG00000168399 PPI subnetwork	0.86	> 0.20	PLCG1 (4.9)	ZNF101 (2.7)	SLC44A2 (2.4)	TIMD4 (1.9)	HAVCR1 (1.5)	CETP (1.4)	GMIP (1.3)	MAFB (1.3)	ABO (1.2)	ALDH2 (1.2)
ENSG00000204273	ENSG00000204273 PPI subnetwork	0.86	> 0.20	PLCG1 (4.9)	ZNF101 (2.7)	SLC44A2 (2.4)	TIMD4 (1.9)	HAVCR1 (1.5)	CETP (1.4)	GMIP (1.3)	MAFB (1.3)	ABO (1.2)	ALDH2 (1.2)
MP:0004738	abnormal brainstem auditory evoked potential	0.86	> 0.20	RPH3A (3.0)	ENSG00000226648 (2.1)	HNF1A (1.9)	SORT1 (1.9)	MOSC1 (1.8)	HAPLN4 (1.7)	NPC1L1 (1.6)	FRK (1.6)	AP1M2 (1.6)	TMEM116 (1.6)
ENSG00000137203	TFAP2A PPI subnetwork	0.86	> 0.20	UBXN2B (3.3)	MAFB (2.7)	C1orf63 (2.4)	LPIN3 (2.2)	C12orf51 (2.2)	TMEM50A (2.0)	NYNRIN (1.8)	TOP1 (1.6)	BCAM (1.6)	MYLIP (1.5)
MP:0001081	abnormal cranial ganglia morphology	0.86	> 0.20	TSSK6 (2.3)	HAVCR1 (2.0)	BCAM (1.5)	PLEC (1.4)	HNF1A (1.4)	ATXN2 (1.4)	TRIB1 (1.3)	LPAR2 (1.3)	ANKRD31 (1.3)	ATXN7L2 (1.3)
GO:0042454	ribonucleoside catabolic process	0.86	> 0.20	TSSK6 (2.5)	TXNL4B (2.3)	C19orf52 (2.0)	C12orf47 (1.9)	SYPL2 (1.8)	FRK (1.8)	TMEM116 (1.8)	TM6SF2 (1.8)	NPC1L1 (1.7)	ABCG5 (1.6)
GO:0008484	sulfuric ester hydrolase activity	0.86	> 0.20	COL4A3BP (2.4)	ERP29 (2.1)	ACAD10 (1.7)	PARP10 (1.7)	NKPD1 (1.7)	ATP13A1 (1.6)	TMEM50A (1.6)	NT5DC1 (1.6)	POLK (1.5)	UBXN2B (1.4)
GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	0.86	> 0.20	BLOC1S3 (3.4)	DHX38 (2.0)	ZNF180 (2.0)	GEMIN7 (1.8)	UBXN2B (1.8)	MAU2 (1.7)	TOMM40 (1.7)	CARM1 (1.6)	ATXN7L2 (1.4)	C19orf52 (1.4)
GO:0050884	neuromuscular process controlling posture	0.86	> 0.20	HAPLN4 (3.9)	TRAPPC6A (3.4)	ENSG00000235545 (2.5)	ENSG00000254235 (2.1)	PMFBP1 (1.9)	HAVCR1 (1.6)	CILP2 (1.5)	NKPD1 (1.5)	ERP29 (1.5)	CYB561D1 (1.3)
ENSG00000148943	LIN7C PPI subnetwork	0.86	> 0.20	NCAN (2.6)	AP1M2 (2.2)	CELSR2 (2.1)	C12orf43 (1.9)	RPH3A (1.8)	PPP1R37 (1.8)	FRK (1.7)	ZNF180 (1.6)	DNAH11 (1.4)	TSSK6 (1.4)
GO:0005769	early endosome	0.86	> 0.20	COL4A3BP (3.5)	BLOC1S3 (2.3)	PTPN11 (2.2)	SH2B3 (1.9)	DNM2 (1.6)	GMIP (1.6)	TMEM50A (1.5)	CLPTM1 (1.5)	POLK (1.5)	DOCK7 (1.5)
MP:0004805	absent oocytes	0.86	> 0.20	C12orf47 (2.4)	PBX4 (2.1)	PLEKHH2 (1.5)	GATAD2A (1.5)	NT5DC1 (1.5)	TSSK6 (1.4)	MYLIP (1.4)	ILF3 (1.3)	OASL (1.1)	NYNRIN (1.1)
GO:0032148	activation of protein kinase B activity	0.86	> 0.20	ABO (3.1)	TSSK6 (1.6)	ENSG00000226645 (1.4)	HNF1A (1.3)	DOCK7 (1.1)	CEACAM19 (1.1)	AMIGO1 (1.1)	CYB561D1 (1.1)	GCNT4 (1.1)	UBXN2B (1.1)
GO:0016667	oxidoreductase activity, acting on a sulfur group of donors	0.86	> 0.20	ERP29 (4.0)	ACAD10 (2.7)	KIAA1324 (2.4)	MOSC1 (1.9)	DHODH (1.8)	NT5DC1 (1.7)	TXNL4B (1.4)	TIMD4 (1.3)	TMED4 (1.3)	TRAPPC6A (1.3)
GO:0043161	proteasomal ubiquitin-dependent protein catabolic process	0.86	> 0.20	TRAFD1 (2.7)	PSMA5 (2.6)	SUGP1 (1.9)	BRAP (1.9)	LPIN3 (1.9)	DHX38 (1.8)	CLPTM1 (1.6)	TMEM57 (1.5)	GRINA (1.5)	POC5 (1.4)
ENSG00000154229	PRKCA PPI subnetwork	0.86	> 0.20	PLEC (2.9)	PVR (2.4)	SLC44A2 (2.0)	NCAN (2.0)	SORT1 (1.9)	RPH3A (1.9)	ITGB3 (1.8)	KANK2 (1.8)	RELB (1.6)	AP1M2 (1.6)
GO:0014706	striated muscle tissue development	0.86	> 0.20	SYPL2 (4.3)	ATXN7L2 (2.3)	GMPR (1.8)	KANK2 (1.7)	BCAM (1.6)	CEACAM19 (1.5)	PLEKHH2 (1.5)	ANKRD31 (1.5)	ENSG00000238078 (1.4)	OGDH (1.3)
MP:0001148	enlarged testis	0.86	> 0.20	GPAM (2.4)	KANK2 (2.0)	FADS2 (2.0)	ZNF101 (2.0)	FADS1 (1.9)	PCSK9 (1.8)	ENSG00000226648 (1.5)	HP (1.4)	TSSK6 (1.3)	USP1 (1.3)
KEGG_BASAL_CELL_CARCINOMA	KEGG_BASAL_CELL_CARCINOMA	0.86	> 0.20	PLEKHH2 (2.7)	BCAM (2.6)	PBX4 (1.9)	NYNRIN (1.9)	PLCG1 (1.8)	AMIGO1 (1.7)	PVRL2 (1.6)	ALDH2 (1.6)	CARM1 (1.5)	LPAR2 (1.5)
ENSG00000164707	SLC13A4 PPI subnetwork	0.86	> 0.20	TM6SF2 (3.4)	NPC1L1 (3.2)	ABCG8 (2.3)	SYPL2 (2.2)	ABCG5 (1.7)	HAPLN4 (1.7)	MYLIP (1.7)	ZNF101 (1.4)	NKPD1 (1.4)	TMEM116 (1.4)
ENSG00000081800	SLC13A1 PPI subnetwork	0.86	> 0.20	TM6SF2 (3.4)	NPC1L1 (3.2)	ABCG8 (2.3)	SYPL2 (2.2)	ABCG5 (1.7)	HAPLN4 (1.7)	MYLIP (1.7)	ZNF101 (1.4)	NKPD1 (1.4)	TMEM116 (1.4)
GO:0032011	ARF protein signal transduction	0.86	> 0.20	MAPKAPK5 (2.6)	PPP1R37 (2.6)	ENSG00000226648 (2.3)	MAU2 (2.3)	BLOC1S3 (2.3)	HAPLN4 (1.9)	DNM2 (1.8)	CYB561D1 (1.7)	POC5 (1.6)	HAVCR1 (1.6)
GO:0005247	voltage-gated chloride channel activity	0.86	> 0.20	TMEM57 (2.9)	FADS2 (2.6)	USP24 (2.4)	FADS1 (2.4)	ALDH2 (2.1)	SYPL2 (2.1)	LDLR (2.0)	AP1M2 (1.8)	RPH3A (1.7)	RHD (1.7)
GO:0060429	epithelium development	0.86	> 0.20	AP1M2 (2.8)	PVRL2 (2.1)	BCAM (2.1)	ENSG00000226648 (2.1)	PLEKHH2 (1.9)	CBLC (1.9)	KANK2 (1.8)	NYNRIN (1.5)	ENSG00000254235 (1.5)	DYNC2LI1 (1.5)
MP:0001932	abnormal spermiogenesis	0.86	> 0.20	TSSK6 (4.8)	ABO (2.5)	PMFBP1 (2.4)	C11orf9 (1.8)	LPIN3 (1.8)	BCAM (1.5)	C12orf47 (1.3)	PPP1R37 (1.3)	SORT1 (1.2)	CLPTM1 (1.2)
GO:0050681	androgen receptor binding	0.86	> 0.20	BUD13 (2.5)	DNM2 (2.4)	TOP1 (2.3)	PLCG1 (2.1)	GOT2P1 (2.0)	RHCE (2.0)	CETP (2.0)	C1orf63 (2.0)	POC5 (2.0)	KANK2 (1.8)
ENSG00000185722	ANKFY1 PPI subnetwork	0.86	> 0.20	PLCG1 (2.8)	TXNL4B (2.5)	ZNF101 (2.3)	C1orf63 (2.1)	LPAR2 (2.1)	C11orf9 (2.0)	NKPD1 (2.0)	BRAP (2.0)	MAU2 (1.9)	ALDH2 (1.7)
GO:0001938	positive regulation of endothelial cell proliferation	0.86	> 0.20	ENSG00000226645 (2.9)	HLX (2.4)	C17orf57 (1.8)	TRIB1 (1.7)	ENSG00000226648 (1.7)	PMFBP1 (1.5)	PVR (1.5)	ZNF101 (1.5)	CYP7A1 (1.3)	PPP1R37 (1.2)
GO:0004842	ubiquitin-protein ligase activity	0.86	> 0.20	BRAP (3.8)	TRAFD1 (3.7)	ATXN2 (2.6)	OASL (2.2)	C12orf51 (2.2)	USP24 (2.2)	PARP10 (2.1)	MAU2 (2.1)	C19orf52 (2.0)	MAPKAPK5 (1.7)
ENSG00000180209	MYLPF PPI subnetwork	0.86	> 0.20	USP1 (2.3)	RHCE (2.0)	POLK (2.0)	SUGP1 (1.8)	GATAD2A (1.6)	BUD13 (1.6)	ENSG00000226648 (1.6)	RHD (1.5)	ZNF101 (1.5)	KANK2 (1.2)
ENSG00000134684	YARS PPI subnetwork	0.86	> 0.20	GEMIN7 (4.3)	C12orf47 (3.2)	ENSG00000226645 (2.4)	TRAPPC6A (2.2)	SARS (2.0)	RELB (1.9)	RHD (1.8)	YIPF2 (1.7)	ZNF101 (1.6)	MAPKAPK5 (1.5)
ENSG00000089289	IGBP1 PPI subnetwork	0.86	> 0.20	ZNF259 (2.7)	NAA25 (2.1)	TOMM40 (2.0)	SARS (2.0)	NT5DC1 (1.8)	PSMA5 (1.7)	DDX56 (1.6)	CEACAM19 (1.4)	COL4A3BP (1.4)	GRINA (1.4)
GO:0009268	response to pH	0.86	> 0.20	HAVCR1 (2.3)	COL4A3BP (2.1)	UBXN2B (2.0)	CILP2 (2.0)	DNAH11 (1.9)	PMFBP1 (1.6)	C17orf57 (1.6)	AMIGO1 (1.4)	GOT2P1 (1.3)	ATXN7L2 (1.3)
ENSG00000188846	RPL14 PPI subnetwork	0.86	> 0.20	NAA25 (2.6)	TOP1 (2.4)	NKPD1 (2.3)	SUGP1 (2.2)	ILF3 (1.8)	ANKRD31 (1.8)	DDX56 (1.7)	ADAM1 (1.7)	ENSG00000226645 (1.7)	ATP13A1 (1.6)
ENSG00000171848	RRM2 PPI subnetwork	0.86	> 0.20	MAU2 (3.1)	FEN1 (2.2)	SUGP1 (2.2)	KIAA1324 (2.1)	PSRC1 (2.0)	TOMM40 (1.6)	PVRL2 (1.6)	BRAP (1.3)	DNM2 (1.2)	CBLC (1.2)
GO:0015036	disulfide oxidoreductase activity	0.87	> 0.20	ERP29 (3.6)	KIAA1324 (2.8)	ACAD10 (2.1)	TIMD4 (2.0)	DHODH (1.9)	PMFBP1 (1.7)	YIPF2 (1.5)	NT5DC1 (1.5)	HNF1A (1.4)	CETP (1.4)
MP:0008587	short photoreceptor outer segment	0.87	> 0.20	DYNC2LI1 (2.2)	ENSG00000235545 (1.8)	C12orf47 (1.7)	RHCE (1.5)	ST3GAL4 (1.3)	PSRC1 (1.3)	ZHX3 (1.2)	ENSG00000226648 (1.2)	MAPKAPK5 (1.1)	GPAM (1.1)
MP:0008332	decreased lactotroph cell number	0.87	> 0.20	PMFBP1 (2.7)	YIPF2 (2.6)	HAVCR1 (2.5)	KIAA1324 (2.5)	FADS1 (2.4)	TSSK6 (2.1)	MOSC1 (2.1)	MYLIP (1.8)	AMIGO1 (1.6)	BCAM (1.5)
GO:0009416	response to light stimulus	0.87	> 0.20	GEMIN7 (1.8)	BLOC1S3 (1.8)	C12orf47 (1.7)	ZNF180 (1.7)	ENSG00000235545 (1.3)	ENSG00000226648 (1.2)	TRAPPC6A (1.2)	ATXN7L2 (1.2)	DNAH11 (1.1)	TRIB1 (1.0)
MP:0010403	atrial septal defect	0.87	> 0.20	ATXN2 (2.5)	NPC1L1 (2.1)	NYNRIN (1.6)	DOCK7 (1.4)	ANKRD31 (1.4)	HAVCR1 (1.3)	C12orf51 (1.3)	USP24 (1.2)	TM6SF2 (1.2)	ALDH2 (1.1)
REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX	REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX	0.87	> 0.20	SUGP1 (3.4)	C12orf43 (3.0)	MAPKAPK5 (2.7)	GEMIN7 (2.5)	ZNF259 (2.4)	TXNL4B (2.2)	QTRT1 (2.1)	DNM2 (2.0)	PSMA5 (2.0)	SMARCA4 (1.9)
REACTOME_FORMATION_OF_THE_HIV:1_EARLY_ELONGATION_COMPLEX	REACTOME_FORMATION_OF_THE_HIV:1_EARLY_ELONGATION_COMPLEX	0.87	> 0.20	SUGP1 (3.4)	C12orf43 (3.0)	MAPKAPK5 (2.7)	GEMIN7 (2.5)	ZNF259 (2.4)	TXNL4B (2.2)	QTRT1 (2.1)	DNM2 (2.0)	PSMA5 (2.0)	SMARCA4 (1.9)
GO:0006488	dolichol-linked oligosaccharide biosynthetic process	0.87	> 0.20	YIPF2 (3.9)	BLOC1S3 (3.1)	ATP13A1 (2.3)	TMEM116 (2.3)	QTRT1 (1.9)	ZNF259 (1.9)	C12orf43 (1.9)	C19orf52 (1.7)	CLPTM1 (1.7)	TMED4 (1.6)
ENSG00000114841	DNAH1 PPI subnetwork	0.87	> 0.20	HAVCR1 (2.1)	HAPLN4 (1.9)	RPH3A (1.8)	C11orf9 (1.8)	PLEC (1.8)	C17orf57 (1.8)	ZNF101 (1.7)	CELSR2 (1.6)	C12orf51 (1.6)	OGDH (1.6)
MP:0000154	rib fusion	0.87	> 0.20	NYNRIN (3.7)	PLCG1 (2.6)	ATXN7L2 (2.5)	USP24 (1.7)	CILP2 (1.5)	PVRL2 (1.2)	PPP1R37 (1.2)	MYLIP (1.1)	HLX (1.1)	BCAM (1.0)
GO:0050664	oxidoreductase activity, acting on NADH or NADPH, oxygen as acceptor	0.87	> 0.20	ALDH2 (2.4)	PLG (2.1)	NYNRIN (1.8)	LPIN3 (1.8)	SLC22A1 (1.8)	ENSG00000235545 (1.7)	C17orf57 (1.5)	PMFBP1 (1.4)	HNF1A (1.4)	SLC44A2 (1.4)
ENSG00000082805	ERC1 PPI subnetwork	0.87	> 0.20	ENSG00000235545 (2.4)	ENSG00000226648 (2.4)	ENSG00000226645 (2.1)	ENSG00000254235 (1.8)	PTPN11 (1.7)	ENSG00000238078 (1.7)	ZHX3 (1.7)	RELB (1.6)	ITGB3 (1.6)	HAPLN4 (1.4)
GO:0010669	epithelial structure maintenance	0.87	> 0.20	KIAA1324 (3.0)	ATXN7L2 (2.2)	CEACAM19 (1.4)	GCNT4 (1.3)	QTRT1 (1.3)	CELSR2 (1.3)	HAVCR1 (1.1)	TSSK6 (1.1)	UBXN2B (1.1)	PMFBP1 (1.1)
MP:0003425	abnormal optic vesicle formation	0.87	> 0.20	LPAR2 (2.5)	NYNRIN (1.6)	HLX (1.5)	PLEKHH2 (1.5)	APOB (1.4)	DOCK7 (1.3)	ENSG00000254235 (1.3)	TM6SF2 (1.2)	ENSG00000226648 (1.2)	TMED4 (1.1)
GO:2000756	regulation of peptidyl-lysine acetylation	0.87	> 0.20	GOT2P1 (2.4)	ST3GAL4 (2.3)	FRK (2.0)	ABO (1.9)	MYLIP (1.4)	SH2B3 (1.4)	PPP1R37 (1.3)	TMEM57 (1.2)	CARM1 (1.0)	POC5 (0.9)
GO:0002076	osteoblast development	0.87	> 0.20	ENSG00000226648 (2.3)	CARM1 (1.6)	YIPF2 (1.5)	ENSG00000254235 (1.4)	PLEKHH2 (1.3)	GOT2P1 (1.3)	KIAA1324 (1.2)	MYLIP (1.2)	AMIGO1 (1.2)	CEACAM19 (1.1)
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	0.87	> 0.20	SYPL2 (2.9)	CYB561D1 (2.6)	NCAN (2.5)	AMIGO1 (2.3)	CELSR2 (2.1)	MAPKAPK5 (2.0)	C12orf43 (1.9)	TSSK6 (1.8)	SORT1 (1.7)	HAPLN4 (1.7)
ENSG00000198933	TBKBP1 PPI subnetwork	0.87	> 0.20	C12orf51 (3.7)	GMIP (3.0)	MARK4 (2.8)	BUD13 (2.2)	PTPN11 (2.1)	USP24 (2.1)	SORT1 (2.0)	PVRL2 (1.9)	LPAR2 (1.8)	ATXN2 (1.8)
ENSG00000115085	ZAP70 PPI subnetwork	0.87	> 0.20	GMIP (2.7)	PLCG1 (2.7)	HAVCR1 (2.3)	APOE (2.0)	SLC44A2 (1.7)	ZNF101 (1.7)	MAFB (1.6)	CYB561D1 (1.5)	OGDH (1.5)	PBX4 (1.4)
ENSG00000102683	SGCG PPI subnetwork	0.87	> 0.20	SYPL2 (3.4)	KANK2 (3.4)	NPC1L1 (2.1)	HNF1A (1.7)	ST3GAL4 (1.6)	GMPR (1.6)	ZHX3 (1.5)	DOCK7 (1.4)	TMED4 (1.2)	LPIN3 (1.2)
ENSG00000111348	ARHGDIB PPI subnetwork	0.87	> 0.20	C11orf9 (2.1)	DNM2 (1.8)	ALDH2 (1.6)	LPIN3 (1.6)	OGDH (1.5)	MARK4 (1.3)	CILP2 (1.3)	CETP (1.2)	GEMIN7 (1.2)	ERP29 (1.1)
GO:0010463	mesenchymal cell proliferation	0.87	> 0.20	ENSG00000238078 (2.6)	NYNRIN (1.8)	MYLIP (1.6)	NKPD1 (1.4)	DYNC2LI1 (1.3)	C11orf9 (1.3)	KANK2 (1.2)	PPP1R37 (1.2)	PLEKHH2 (1.1)	CARM1 (1.1)
ENSG00000102804	TSC22D1 PPI subnetwork	0.87	> 0.20	SARS (3.7)	ATP13A1 (3.2)	PSMA5 (2.9)	DHX38 (2.7)	ZNF259 (2.7)	TOMM40 (2.5)	DDX56 (2.4)	ILF3 (2.1)	CLPTM1 (2.0)	FEN1 (2.0)
GO:0021772	olfactory bulb development	0.87	> 0.20	ATXN7L2 (3.8)	ENSG00000235545 (3.3)	PBX4 (3.0)	TMEM116 (2.5)	NCAN (2.3)	ANKRD31 (2.1)	CEACAM19 (2.0)	DNAH11 (1.9)	DYNC2LI1 (1.9)	DOCK7 (1.8)
GO:0021988	olfactory lobe development	0.87	> 0.20	ATXN7L2 (3.8)	ENSG00000235545 (3.3)	PBX4 (3.0)	TMEM116 (2.5)	NCAN (2.3)	ANKRD31 (2.1)	CEACAM19 (2.0)	DNAH11 (1.9)	DYNC2LI1 (1.9)	DOCK7 (1.8)
MP:0003056	abnormal hyoid bone morphology	0.87	> 0.20	CILP2 (3.3)	CEACAM19 (2.0)	MYLIP (2.0)	PLCG1 (1.8)	MARK4 (1.8)	DNAH11 (1.8)	PSRC1 (1.2)	HLX (1.1)	SORT1 (1.1)	OASL (1.1)
MP:0001629	abnormal heart rate	0.87	> 0.20	AMIGO1 (2.8)	GOT2P1 (2.3)	BCAM (2.0)	ANKRD31 (1.7)	DHODH (1.5)	ALDH2 (1.5)	POLK (1.5)	ENSG00000228044 (1.4)	MYLIP (1.3)	ENSG00000235545 (1.2)
GO:0055074	calcium ion homeostasis	0.87	> 0.20	C12orf47 (2.8)	SYPL2 (2.0)	ABO (1.6)	RPH3A (1.6)	ERP29 (1.5)	AMIGO1 (1.3)	SLC44A2 (1.3)	PBX4 (1.2)	KIAA1324 (1.2)	CETP (1.2)
GO:0060389	pathway-restricted SMAD protein phosphorylation	0.87	> 0.20	C19orf52 (2.3)	ENSG00000226645 (2.3)	KANK2 (1.9)	C11orf9 (1.9)	DNM2 (1.8)	SLC44A2 (1.5)	CARM1 (1.5)	ZNF180 (1.4)	TMEM50A (1.3)	PVR (1.2)
GO:0002009	morphogenesis of an epithelium	0.87	> 0.20	PLEKHH2 (3.4)	PVRL2 (2.7)	BCAM (2.6)	NYNRIN (2.3)	AP1M2 (2.1)	KANK2 (2.1)	ENSG00000254235 (2.0)	CBLC (1.6)	DYNC2LI1 (1.4)	MYLIP (1.4)
MP:0000562	polydactyly	0.87	> 0.20	DYNC2LI1 (6.1)	NYNRIN (4.0)	DOCK7 (2.2)	PLEKHH2 (2.0)	BCAM (1.8)	ATXN7L2 (1.7)	MYLIP (1.7)	ZHX3 (1.7)	PLCG1 (1.6)	PSRC1 (1.5)
GO:0045911	positive regulation of DNA recombination	0.87	> 0.20	HAVCR1 (2.0)	LPIN3 (1.9)	ADAM1 (1.8)	C12orf43 (1.4)	TRAFD1 (1.2)	COL4A3BP (1.2)	ENSG00000254235 (1.2)	SLC44A2 (1.2)	SH2B3 (1.0)	DNAH11 (1.0)
ENSG00000099250	NRP1 PPI subnetwork	0.87	> 0.20	BCAM (2.2)	PVRL2 (2.1)	SLC44A2 (2.0)	ENSG00000226645 (1.8)	PPP1R37 (1.8)	GRINA (1.6)	CETP (1.5)	CILP2 (1.2)	HLX (1.2)	ENSG00000226648 (1.2)
ENSG00000160075	SSU72 PPI subnetwork	0.87	> 0.20	C12orf51 (2.6)	NYNRIN (2.0)	USP24 (2.0)	PSMA5 (1.8)	TXNL4B (1.7)	POC5 (1.6)	CYB561D1 (1.6)	MAU2 (1.4)	ZNF180 (1.3)	PTPN11 (1.2)
ENSG00000138674	SEC31A PPI subnetwork	0.87	> 0.20	BRAP (2.5)	YIPF2 (2.4)	MAPKAPK5 (2.4)	BUD13 (2.4)	ADAM1 (2.2)	C1orf63 (1.9)	NPC1L1 (1.8)	PTPN11 (1.7)	ATXN2 (1.7)	TMED4 (1.4)
GO:0006487	protein N-linked glycosylation	0.87	> 0.20	YIPF2 (4.8)	ERP29 (3.6)	TMED4 (3.5)	ATP13A1 (2.9)	CLPTM1 (2.4)	TMEM57 (2.2)	TMEM50A (1.6)	C19orf52 (1.5)	CYB561D1 (1.3)	ADAM1 (1.2)
ENSG00000136888	ATP6V1G1 PPI subnetwork	0.87	> 0.20	GRINA (3.4)	SARS (2.8)	COL4A3BP (2.6)	TXNL4B (2.3)	SORT1 (2.2)	ENSG00000228044 (2.1)	CLPTM1 (2.0)	UBXN2B (2.0)	APOE (1.7)	ENSG00000238078 (1.6)
ENSG00000181085	MAPK15 PPI subnetwork	0.87	> 0.20	GMIP (3.3)	LPA (1.8)	LPAR2 (1.7)	GATAD2A (1.5)	CBLC (1.5)	PPP1R37 (1.4)	HAVCR1 (1.4)	BLOC1S3 (1.4)	GEMIN7 (1.4)	TSSK6 (1.3)
ENSG00000173210	ABLIM3 PPI subnetwork	0.87	> 0.20	PLEC (3.7)	FRK (2.8)	GATAD2A (2.3)	SARS (2.1)	PLCG1 (2.0)	AP1M2 (2.0)	ABCG8 (1.9)	DOCK7 (1.5)	PVRL2 (1.4)	TRAFD1 (1.4)
GO:0048710	regulation of astrocyte differentiation	0.87	> 0.20	NCAN (3.9)	ENSG00000254235 (2.4)	HAVCR1 (2.3)	CEACAM19 (2.2)	C17orf57 (1.9)	CYB561D1 (1.6)	PPP1R37 (1.6)	PBX4 (1.6)	CELSR2 (1.5)	NYNRIN (1.5)
GO:0045947	negative regulation of translational initiation	0.87	> 0.20	TMEM57 (2.6)	DDX56 (2.4)	UBXN2B (2.4)	ZNF259 (2.2)	HNF1A (2.1)	BRAP (2.1)	MAPKAPK5 (1.9)	RHCE (1.7)	NAA25 (1.7)	SARS (1.6)
ENSG00000197959	DNM3 PPI subnetwork	0.87	> 0.20	C12orf51 (3.7)	SMARCA4 (3.5)	NCAN (2.6)	HAVCR1 (2.2)	ACAD10 (2.0)	SYPL2 (1.9)	DOCK7 (1.7)	SARS (1.7)	USP24 (1.6)	POC5 (1.6)
ENSG00000206294	ENSG00000206294 PPI subnetwork	0.87	> 0.20	PLCG1 (4.3)	ZNF101 (2.6)	SLC44A2 (2.0)	APOE (1.9)	PBX4 (1.7)	ALDH2 (1.6)	YIPF2 (1.5)	HAVCR1 (1.5)	APOC1 (1.4)	MAFB (1.4)
ENSG00000122692	SMU1 PPI subnetwork	0.87	> 0.20	PPP1R37 (2.4)	PLCG1 (2.4)	KANK2 (2.3)	GATAD2A (2.3)	LPIN3 (2.1)	PVRL2 (2.0)	HLX (1.9)	BRAP (1.8)	PVR (1.8)	FRK (1.7)
ENSG00000136717	BIN1 PPI subnetwork	0.87	> 0.20	MARK4 (2.9)	C12orf51 (2.5)	SH2B3 (2.3)	DNM2 (1.9)	DOCK7 (1.9)	USP24 (1.8)	C11orf9 (1.8)	PLEC (1.8)	MAFB (1.7)	LPIN3 (1.7)
ENSG00000049449	RCN1 PPI subnetwork	0.87	> 0.20	LPAR2 (2.1)	FRK (1.8)	COL4A3BP (1.7)	ENSG00000235545 (1.6)	MAFB (1.5)	BCAM (1.5)	POLK (1.5)	PLCG1 (1.5)	YIPF2 (1.4)	TMED4 (1.3)
GO:0045028	G-protein coupled purinergic nucleotide receptor activity	0.87	> 0.20	POLK (2.2)	MAFB (2.0)	ST3GAL4 (2.0)	TIMD4 (1.9)	PMFBP1 (1.9)	HLX (1.7)	CBLC (1.5)	CETP (1.5)	NKPD1 (1.5)	TXNL4B (1.3)
GO:0001608	G-protein coupled nucleotide receptor activity	0.87	> 0.20	POLK (2.2)	MAFB (2.0)	ST3GAL4 (2.0)	TIMD4 (1.9)	PMFBP1 (1.9)	HLX (1.7)	CBLC (1.5)	CETP (1.5)	NKPD1 (1.5)	TXNL4B (1.3)
ENSG00000122026	RPL21 PPI subnetwork	0.87	> 0.20	ILF3 (2.6)	NKPD1 (2.0)	ADAM1 (2.0)	SUGP1 (2.0)	C1orf63 (1.9)	TOP1 (1.9)	GATAD2A (1.8)	ANKRD31 (1.7)	PTPN11 (1.6)	C12orf43 (1.5)
GO:0006749	glutathione metabolic process	0.87	> 0.20	ALDH2 (2.6)	AMIGO1 (2.3)	TXNL4B (2.2)	BLOC1S3 (1.9)	TM6SF2 (1.8)	SORT1 (1.7)	NT5DC1 (1.7)	TRAPPC6A (1.7)	KIAA1324 (1.5)	LPIN3 (1.5)
GO:0001947	heart looping	0.87	> 0.20	LPIN3 (2.4)	NYNRIN (2.0)	ENSG00000226648 (2.0)	C17orf57 (1.7)	DYNC2LI1 (1.5)	PVRL2 (1.4)	ADAM1 (1.4)	ATXN7L2 (1.2)	C1orf63 (1.2)	COL4A3BP (1.1)
GO:0061371	determination of heart left/right asymmetry	0.87	> 0.20	LPIN3 (2.4)	NYNRIN (2.0)	ENSG00000226648 (2.0)	C17orf57 (1.7)	DYNC2LI1 (1.5)	PVRL2 (1.4)	ADAM1 (1.4)	ATXN7L2 (1.2)	C1orf63 (1.2)	COL4A3BP (1.1)
GO:0009218	pyrimidine ribonucleotide metabolic process	0.87	> 0.20	DYNC2LI1 (3.8)	AMIGO1 (2.8)	C12orf43 (2.7)	PMFBP1 (2.4)	PBX4 (2.3)	ANKRD31 (1.8)	ENSG00000226648 (1.5)	GEMIN7 (1.5)	TSSK6 (1.4)	GCNT4 (1.4)
MP:0006089	abnormal vestibular saccule morphology	0.87	> 0.20	MYLIP (2.9)	KIAA1324 (2.6)	TMEM116 (2.3)	DYNC2LI1 (1.5)	ABO (1.5)	NCAN (1.4)	ST3GAL4 (1.4)	GMPR (1.3)	CYB561D1 (1.2)	ANKRD31 (1.2)
GO:0006266	DNA ligation	0.87	> 0.20	ZNF101 (2.7)	ANKRD31 (2.6)	ACAD10 (2.1)	ENSG00000228044 (2.0)	NT5DC1 (2.0)	PSRC1 (2.0)	CBLC (1.7)	C17orf57 (1.7)	TRAPPC6A (1.6)	NKPD1 (1.4)
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	0.87	> 0.20	OGDH (5.0)	ACAD10 (4.2)	TRAPPC6A (2.6)	GOT2P1 (2.3)	C12orf47 (2.0)	GMPR (1.9)	TOMM40 (1.6)	CLPTM1 (1.6)	PSMA5 (1.6)	ALDH2 (1.4)
GO:0060438	trachea development	0.87	> 0.20	PLEKHH2 (3.3)	GCNT4 (2.9)	HLX (2.2)	BLOC1S3 (2.1)	NKPD1 (2.0)	MYLIP (1.6)	UBXN2B (1.5)	BCAM (1.4)	ZNF101 (1.3)	SLC44A2 (1.3)
GO:0018130	heterocycle biosynthetic process	0.87	> 0.20	C12orf47 (3.0)	GOT2P1 (2.8)	RHD (2.7)	RHCE (2.3)	HNF1A (2.1)	ACAD10 (2.0)	LPIN3 (1.9)	SYPL2 (1.6)	AMIGO1 (1.6)	PMFBP1 (1.6)
REACTOME_PURINE_SALVAGE	REACTOME_PURINE_SALVAGE	0.87	> 0.20	SYPL2 (3.1)	TRAPPC6A (2.8)	LPIN3 (2.6)	PSMA5 (2.1)	CILP2 (2.1)	NKPD1 (1.9)	RHCE (1.9)	ZHX3 (1.9)	RHD (1.8)	DHODH (1.8)
MP:0001293	anophthalmia	0.87	> 0.20	PLEKHH2 (2.2)	TMEM116 (2.1)	OASL (2.0)	DYNC2LI1 (1.8)	DOCK7 (1.6)	PPP1R37 (1.5)	AP1M2 (1.5)	GRINA (1.5)	TMED4 (1.5)	PBX4 (1.4)
ENSG00000168522	FNTA PPI subnetwork	0.87	> 0.20	TMEM50A (3.7)	COL4A3BP (2.4)	C1orf63 (1.9)	TMEM57 (1.9)	SLC44A2 (1.9)	UBXN2B (1.8)	PLEC (1.8)	TXNL4B (1.7)	BCAM (1.7)	POLK (1.6)
GO:0004527	exonuclease activity	0.87	> 0.20	POC5 (2.7)	ZNF259 (2.2)	FEN1 (2.2)	NKPD1 (2.1)	DDX56 (2.1)	LPIN3 (1.9)	USP1 (1.9)	OASL (1.8)	PARP10 (1.8)	ANKRD31 (1.7)
GO:0035850	epithelial cell differentiation involved in kidney development	0.87	> 0.20	BCAM (2.5)	HAVCR1 (2.2)	PMFBP1 (2.0)	NYNRIN (1.6)	C11orf9 (1.6)	TMEM116 (1.6)	DNAH11 (1.5)	ENSG00000238078 (1.4)	BLOC1S3 (1.4)	DYNC2LI1 (1.3)
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RBE2F1	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RBE2F1	0.87	> 0.20	FEN1 (4.1)	USP1 (2.9)	ATXN7L2 (2.1)	ENSG00000235545 (2.1)	TOMM40 (1.8)	ZNF180 (1.6)	NKPD1 (1.6)	AMIGO1 (1.5)	SORT1 (1.4)	TSSK6 (1.3)
ENSG00000163682	RPL9 PPI subnetwork	0.87	> 0.20	NKPD1 (2.9)	NAA25 (1.8)	ADAM1 (1.8)	GATAD2A (1.6)	ILF3 (1.6)	ATP13A1 (1.5)	ATXN7L2 (1.5)	ERP29 (1.4)	DNAH11 (1.4)	SUGP1 (1.4)
ENSG00000182754	ENSG00000182754 PPI subnetwork	0.87	> 0.20	NKPD1 (2.9)	NAA25 (1.8)	ADAM1 (1.8)	GATAD2A (1.6)	ILF3 (1.6)	ATP13A1 (1.5)	ATXN7L2 (1.5)	ERP29 (1.4)	DNAH11 (1.4)	SUGP1 (1.4)
ENSG00000198846	TOX PPI subnetwork	0.87	> 0.20	FADS1 (2.1)	BUD13 (2.1)	GMPR (2.0)	SUGP1 (1.9)	TMEM57 (1.7)	TOP1 (1.4)	C19orf52 (1.4)	PCSK9 (1.4)	FEN1 (1.3)	DDX56 (1.3)
ENSG00000124097	ENSG00000124097 PPI subnetwork	0.87	> 0.20	FADS1 (2.1)	BUD13 (2.1)	GMPR (2.0)	SUGP1 (1.9)	TMEM57 (1.7)	TOP1 (1.4)	C19orf52 (1.4)	PCSK9 (1.4)	FEN1 (1.3)	DDX56 (1.3)
ENSG00000103460	TOX3 PPI subnetwork	0.87	> 0.20	FADS1 (2.1)	BUD13 (2.1)	GMPR (2.0)	SUGP1 (1.9)	TMEM57 (1.7)	TOP1 (1.4)	C19orf52 (1.4)	PCSK9 (1.4)	FEN1 (1.3)	DDX56 (1.3)
GO:0070169	positive regulation of biomineral tissue development	0.87	> 0.20	MYLIP (2.7)	POLK (2.7)	TMEM116 (2.0)	PLEKHH2 (2.0)	GMPR (1.8)	AMIGO1 (1.7)	MAFB (1.6)	BCAM (1.6)	POC5 (1.6)	NYNRIN (1.5)
MP:0000131	abnormal long bone epiphysis morphology	0.87	> 0.20	CILP2 (4.2)	MYLIP (2.5)	PLEC (1.9)	YIPF2 (1.8)	POLK (1.8)	ENSG00000226645 (1.6)	SLC44A2 (1.4)	MAFB (1.4)	HAVCR1 (1.4)	AMIGO1 (1.3)
ENSG00000172680	MOS PPI subnetwork	0.87	> 0.20	PLEC (2.2)	PVR (2.0)	LPIN3 (1.9)	SLC44A2 (1.9)	PBX4 (1.8)	PVRL2 (1.8)	GEMIN7 (1.6)	CARM1 (1.5)	MAFB (1.3)	ENSG00000254235 (1.2)
GO:0006986	response to unfolded protein	0.87	> 0.20	BLOC1S3 (2.6)	TXNL4B (2.4)	TMEM57 (2.3)	TMED4 (2.2)	YIPF2 (2.0)	SARS (1.8)	ERP29 (1.8)	TSSK6 (1.5)	TOP1 (1.4)	GCNT4 (1.4)
GO:0030279	negative regulation of ossification	0.87	> 0.20	TMEM57 (2.7)	TMEM116 (2.4)	ST3GAL4 (2.4)	CILP2 (2.2)	SH2B3 (2.1)	RHCE (2.0)	SLC44A2 (1.6)	ITGB3 (1.5)	C17orf57 (1.4)	ZNF180 (1.4)
ENSG00000104131	EIF3J PPI subnetwork	0.87	> 0.20	ILF3 (2.7)	ZNF180 (2.3)	NKPD1 (2.1)	SARS (1.6)	PTPN11 (1.6)	TOP1 (1.5)	UBXN2B (1.4)	POLK (1.4)	ATP13A1 (1.4)	GATAD2A (1.4)
GO:0010453	regulation of cell fate commitment	0.87	> 0.20	KIAA1324 (3.5)	LPAR2 (2.2)	ENSG00000254235 (2.1)	ANKRD31 (1.9)	PLCG1 (1.5)	ENSG00000238078 (1.4)	MYLIP (1.4)	ENSG00000226645 (1.4)	PBX4 (1.3)	AP1M2 (1.3)
GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	0.87	> 0.20	UBXN2B (2.9)	ENSG00000226645 (1.8)	TMEM116 (1.4)	ENSG00000228044 (1.4)	C11orf9 (1.4)	CILP2 (1.4)	TOP1 (1.3)	DNAH11 (1.3)	CBLC (1.2)	ZNF180 (1.2)
GO:0010498	proteasomal protein catabolic process	0.87	> 0.20	TRAFD1 (2.7)	PSMA5 (2.6)	SUGP1 (1.9)	BRAP (1.9)	LPIN3 (1.8)	TMEM57 (1.7)	DHX38 (1.7)	CLPTM1 (1.6)	POC5 (1.4)	GRINA (1.3)
GO:0034612	response to tumor necrosis factor	0.87	> 0.20	TRAFD1 (2.3)	FRK (2.1)	TRAPPC6A (1.9)	CYB561D1 (1.8)	PARP10 (1.8)	RELB (1.7)	BCL3 (1.5)	ZNF180 (1.4)	CILP2 (1.4)	AP1M2 (1.4)
ENSG00000108861	DUSP3 PPI subnetwork	0.87	> 0.20	ITGB3 (3.2)	PARP10 (2.8)	CBLC (2.4)	AMIGO1 (2.0)	PLCG1 (1.8)	AP1M2 (1.7)	GCNT4 (1.4)	OASL (1.3)	ENSG00000228044 (1.2)	PTPN11 (1.2)
ENSG00000071082	RPL31 PPI subnetwork	0.87	> 0.20	ILF3 (2.1)	NAA25 (1.8)	TOP1 (1.6)	GATAD2A (1.6)	DDX56 (1.6)	C12orf43 (1.5)	SARS (1.5)	ZNF259 (1.4)	NKPD1 (1.4)	ERP29 (1.4)
ENSG00000107949	BCCIP PPI subnetwork	0.87	> 0.20	POLK (2.7)	TRAFD1 (2.4)	MYLIP (2.4)	ATXN2 (2.1)	HLX (2.1)	ENSG00000226645 (2.0)	PTPN11 (1.9)	DHODH (1.7)	C12orf43 (1.7)	PVR (1.6)
ENSG00000147246	HTR2C PPI subnetwork	0.87	> 0.20	FADS2 (2.2)	CYP7A1 (1.9)	COL4A3BP (1.6)	ITGB3 (1.6)	ZNF180 (1.5)	RPH3A (1.5)	PLEKHH2 (1.4)	ZHX3 (1.3)	HLX (1.3)	ENSG00000254235 (1.3)
MP:0006317	decreased urine sodium level	0.87	> 0.20	HAVCR1 (2.9)	TMEM116 (2.5)	PLG (2.1)	TMED4 (2.0)	ZHX3 (2.0)	AP1M2 (1.9)	TM6SF2 (1.5)	DNM2 (1.4)	BCAM (1.3)	USP24 (1.2)
GO:0032924	activin receptor signaling pathway	0.87	> 0.20	BLOC1S3 (2.1)	ENSG00000226645 (1.6)	ANKRD31 (1.5)	TMEM50A (1.5)	C12orf47 (1.4)	HAVCR1 (1.4)	ZNF101 (1.4)	C17orf57 (1.3)	ZNF180 (1.3)	HNF1A (1.2)
ENSG00000130382	MLLT1 PPI subnetwork	0.87	> 0.20	CARM1 (3.3)	ATXN2 (3.0)	MARK4 (2.6)	MAPKAPK5 (2.5)	PTPN11 (2.3)	GATAD2A (2.2)	TMEM57 (2.1)	BRAP (2.1)	ILF3 (2.0)	BUD13 (1.8)
MP:0002023	B cell derived lymphoma	0.87	> 0.20	SLC44A2 (2.4)	ZNF101 (2.4)	C1orf63 (2.3)	TRAPPC6A (2.1)	C19orf52 (2.0)	NYNRIN (1.9)	FEN1 (1.9)	ATXN7L2 (1.9)	ADAM1 (1.8)	C12orf47 (1.8)
GO:0031954	positive regulation of protein autophosphorylation	0.87	> 0.20	ENSG00000226645 (2.9)	POLK (2.8)	ZNF259 (2.0)	ATXN7L2 (1.9)	GEMIN7 (1.6)	DYNC2LI1 (1.4)	COL4A3BP (1.4)	BUD13 (1.4)	ENSG00000228044 (1.1)	CYB561D1 (1.1)
REACTOME_RNA_POLYMERASE_I_CHAIN_ELONGATION	REACTOME_RNA_POLYMERASE_I_CHAIN_ELONGATION	0.87	> 0.20	DYNC2LI1 (2.1)	GMPR (2.1)	BUD13 (2.0)	ZNF259 (1.8)	ENSG00000226645 (1.7)	TXNL4B (1.7)	ATXN7L2 (1.7)	DDX56 (1.6)	ENSG00000235545 (1.4)	GEMIN7 (1.3)
ENSG00000131381	ZFYVE20 PPI subnetwork	0.87	> 0.20	C12orf43 (3.4)	BRAP (3.1)	SARS (3.0)	MAPKAPK5 (2.9)	ACAD10 (2.8)	TMEM57 (2.5)	PTPN11 (2.3)	TRAFD1 (2.3)	TMEM50A (2.1)	SUGP1 (2.1)
GO:0046676	negative regulation of insulin secretion	0.87	> 0.20	KIAA1324 (4.5)	AMIGO1 (2.0)	ENSG00000226648 (2.0)	GPAM (1.6)	MOSC1 (1.6)	TMED4 (1.5)	ENSG00000238078 (1.4)	ANKRD31 (1.4)	C12orf47 (1.3)	AP1M2 (1.3)
GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	0.87	> 0.20	MAPKAPK5 (2.9)	ADAM1 (2.6)	BUD13 (2.1)	NT5DC1 (1.6)	TRIB1 (1.6)	BRAP (1.4)	ENSG00000254235 (1.4)	MAU2 (1.3)	ILF3 (1.3)	ENSG00000226645 (1.3)
GO:0009264	deoxyribonucleotide catabolic process	0.87	> 0.20	TRAPPC6A (3.4)	ENSG00000226648 (3.1)	NKPD1 (2.0)	DYNC2LI1 (2.0)	CEACAM19 (1.8)	NT5DC1 (1.8)	ZHX3 (1.8)	LPIN3 (1.7)	FRK (1.6)	ANKRD31 (1.6)
ENSG00000183092	BEGAIN PPI subnetwork	0.87	> 0.20	UBXN2B (2.7)	ENSG00000235545 (1.9)	ENSG00000226648 (1.9)	ZHX3 (1.8)	TMEM57 (1.7)	TSSK6 (1.6)	LPAR2 (1.4)	NCAN (1.4)	ENSG00000228044 (1.3)	RPH3A (1.3)
ENSG00000173349	SFT2D3 PPI subnetwork	0.87	> 0.20	YIPF2 (3.9)	MAU2 (3.6)	TMED4 (2.2)	ERP29 (2.2)	C12orf51 (2.1)	CLPTM1 (2.1)	TXNL4B (2.0)	TSSK6 (1.9)	BRAP (1.9)	COL4A3BP (1.7)
KEGG_O_GLYCAN_BIOSYNTHESIS	KEGG_O_GLYCAN_BIOSYNTHESIS	0.87	> 0.20	KIAA1324 (3.0)	TMED4 (2.5)	TMEM57 (2.1)	TSSK6 (1.8)	TMEM50A (1.8)	SLC44A2 (1.6)	C17orf57 (1.6)	DNAH11 (1.5)	CILP2 (1.5)	HAPLN4 (1.4)
GO:0008227	G-protein coupled amine receptor activity	0.87	> 0.20	GOT2P1 (3.1)	RPH3A (2.4)	ABO (2.1)	PPP1R37 (2.0)	AMIGO1 (1.8)	GCNT4 (1.5)	BCAM (1.4)	ENSG00000235545 (1.3)	C12orf47 (1.2)	ENSG00000226645 (1.2)
GO:0045622	regulation of T-helper cell differentiation	0.87	> 0.20	ENSG00000254235 (1.9)	ENSG00000235545 (1.7)	ANKRD31 (1.6)	PBX4 (1.5)	TMEM57 (1.4)	ST3GAL4 (1.3)	BLOC1S3 (1.2)	NAA25 (1.1)	CETP (1.1)	DNAH11 (1.1)
ENSG00000176248	ANAPC2 PPI subnetwork	0.87	> 0.20	PSRC1 (5.5)	FEN1 (4.1)	POC5 (3.4)	USP1 (2.5)	LPIN3 (1.9)	ILF3 (1.7)	TOP1 (1.5)	RHD (1.2)	BRAP (1.1)	C1orf63 (0.9)
MP:0001380	reduced male mating frequency	0.87	> 0.20	KIAA1324 (3.3)	SORT1 (2.8)	NT5DC1 (2.5)	AMIGO1 (2.2)	PMFBP1 (2.2)	TOP1 (2.0)	ANKRD31 (1.9)	CELSR2 (1.8)	COL4A3BP (1.6)	SLC22A1 (1.5)
GO:0000460	maturation of 5.8S rRNA	0.87	> 0.20	DDX56 (2.4)	ZNF259 (2.3)	QTRT1 (2.2)	NAA25 (2.2)	MAPKAPK5 (2.2)	DHX38 (2.1)	DHODH (1.9)	C12orf47 (1.9)	POC5 (1.8)	SUGP1 (1.8)
ENSG00000153487	ING1 PPI subnetwork	0.87	> 0.20	SMARCA4 (2.8)	BUD13 (2.7)	UBXN2B (2.5)	ILF3 (2.0)	USP1 (2.0)	SUGP1 (1.9)	ADAM1 (1.9)	TMEM50A (1.8)	TOP1 (1.6)	CARM1 (1.6)
GO:0006626	protein targeting to mitochondrion	0.87	> 0.20	ZNF259 (3.0)	ENSG00000226645 (2.5)	GEMIN7 (2.4)	TOMM40 (2.4)	TXNL4B (2.2)	BRAP (2.1)	DHODH (2.0)	GOT2P1 (1.9)	DNAH11 (1.8)	TRAPPC6A (1.8)
GO:0031110	regulation of microtubule polymerization or depolymerization	0.87	> 0.20	POC5 (3.4)	DNAH11 (2.9)	CEACAM19 (2.2)	C17orf57 (2.1)	LPAR2 (2.1)	PBX4 (1.8)	POLK (1.7)	C12orf47 (1.4)	UBXN2B (1.4)	ENSG00000238078 (1.2)
GO:0050768	negative regulation of neurogenesis	0.87	> 0.20	NCAN (3.5)	GCNT4 (2.4)	LPAR2 (2.3)	NYNRIN (2.2)	PBX4 (2.0)	ABO (2.0)	CELSR2 (2.0)	CYB561D1 (2.0)	PPP1R37 (1.8)	ADAM1 (1.5)
GO:0031958	corticosteroid receptor signaling pathway	0.87	> 0.20	HNF1A (2.8)	ATXN2 (2.3)	DHODH (2.2)	GOT2P1 (2.1)	C12orf47 (2.1)	USP24 (2.0)	C12orf43 (2.0)	OGDH (1.9)	C1orf63 (1.9)	FRK (1.8)
GO:0018393	internal peptidyl-lysine acetylation	0.87	> 0.20	ATXN7L2 (3.3)	BUD13 (2.6)	ILF3 (2.5)	ZNF180 (1.9)	BRAP (1.6)	PLCG1 (1.6)	ZNF101 (1.6)	MAU2 (1.5)	ATXN2 (1.5)	MAPKAPK5 (1.5)
MP:0005296	abnormal humerus morphology	0.87	> 0.20	CILP2 (2.1)	C19orf52 (1.8)	HAPLN4 (1.8)	KIAA1324 (1.7)	NYNRIN (1.7)	MAFB (1.6)	TRAPPC6A (1.5)	ABO (1.5)	CEACAM19 (1.3)	PVR (1.1)
ENSG00000173805	HAP1 PPI subnetwork	0.87	> 0.20	UBXN2B (4.1)	BUD13 (2.5)	TMEM116 (2.4)	YIPF2 (2.1)	NT5DC1 (1.7)	SARS (1.7)	C12orf43 (1.6)	ZNF101 (1.5)	C19orf52 (1.5)	ZNF259 (1.5)
GO:0043254	regulation of protein complex assembly	0.87	> 0.20	TMEM50A (2.7)	C17orf57 (2.6)	ENSG00000238078 (2.4)	BRAP (1.8)	ITGB3 (1.7)	TSSK6 (1.7)	ADAM1 (1.6)	C1orf63 (1.5)	PLEC (1.3)	C12orf51 (1.2)
REACTOME_CLASS_C3_METABOTROPIC_GLUTAMATEPHEROMONE_RECEPTORS	REACTOME_CLASS_C3_METABOTROPIC_GLUTAMATEPHEROMONE_RECEPTORS	0.87	> 0.20	RPH3A (5.0)	NCAN (3.0)	ENSG00000228044 (2.4)	DNAH11 (2.1)	ANKRD31 (2.0)	GOT2P1 (2.0)	TSSK6 (1.7)	CYB561D1 (1.4)	C12orf47 (1.2)	ZHX3 (1.2)
ENSG00000125977	EIF2S2 PPI subnetwork	0.87	> 0.20	QTRT1 (3.5)	DDX56 (3.3)	ZNF259 (2.6)	ILF3 (2.5)	ATP13A1 (2.5)	SARS (2.4)	GATAD2A (2.1)	NKPD1 (2.1)	DHX38 (2.1)	TOMM40 (1.9)
GO:0030029	actin filament-based process	0.87	> 0.20	SYPL2 (4.1)	PLEC (2.3)	C17orf57 (2.1)	C11orf9 (1.7)	PVRL2 (1.6)	ITGB3 (1.5)	GMPR (1.5)	SLC44A2 (1.5)	GMIP (1.4)	KANK2 (1.4)
GO:0051056	regulation of small GTPase mediated signal transduction	0.87	> 0.20	DNM2 (2.6)	ENSG00000226645 (2.4)	GMIP (2.4)	C12orf51 (2.4)	PPP1R37 (2.4)	PLEKHH2 (1.9)	ZHX3 (1.9)	PLEC (1.8)	PBX4 (1.8)	USP24 (1.8)
MP:0001739	abnormal adrenal gland secretion	0.87	> 0.20	KIAA1324 (3.5)	DNAH11 (3.3)	HAPLN4 (2.4)	TSSK6 (1.8)	CYB561D1 (1.7)	TMEM57 (1.6)	NKPD1 (1.4)	NCAN (1.4)	ZHX3 (1.4)	GCNT4 (1.4)
GO:0045597	positive regulation of cell differentiation	0.87	> 0.20	HLX (2.3)	PLCG1 (2.0)	ZNF101 (1.9)	PBX4 (1.4)	ITGB3 (1.3)	ENSG00000238078 (1.3)	SH2B3 (1.2)	ENSG00000226648 (1.2)	KIAA1324 (1.2)	NCAN (1.2)
ENSG00000084733	RAB10 PPI subnetwork	0.87	> 0.20	NCAN (2.7)	TMEM50A (2.3)	ERP29 (2.0)	DNAH11 (1.9)	C12orf43 (1.9)	RPH3A (1.9)	NYNRIN (1.9)	ZNF180 (1.8)	FRK (1.5)	AMIGO1 (1.3)
ENSG00000139220	PPFIA2 PPI subnetwork	0.87	> 0.20	C11orf9 (3.2)	NCAN (2.6)	LPIN3 (2.1)	HAPLN4 (2.0)	TSSK6 (2.0)	TMEM57 (1.9)	ENSG00000235545 (1.6)	PTPN11 (1.5)	CBLC (1.4)	PPP1R37 (1.3)
GO:0042476	odontogenesis	0.87	> 0.20	MYLIP (2.6)	BCAM (2.4)	ENSG00000235545 (1.7)	NYNRIN (1.7)	AP1M2 (1.5)	PBX4 (1.4)	ENSG00000238078 (1.4)	C19orf52 (1.4)	CYB561D1 (1.4)	ZNF101 (1.3)
GO:0031055	chromatin remodeling at centromere	0.87	> 0.20	PSRC1 (2.8)	POC5 (2.5)	NKPD1 (2.2)	TXNL4B (2.1)	USP1 (1.9)	DYNC2LI1 (1.9)	ZNF180 (1.7)	TRAPPC6A (1.7)	TMEM116 (1.6)	ENSG00000226648 (1.5)
ENSG00000144596	ENSG00000144596 PPI subnetwork	0.87	> 0.20	ABO (2.9)	SH2B3 (2.9)	RHD (2.5)	NCAN (2.4)	PTPN11 (1.9)	ITGB3 (1.7)	ENSG00000226645 (1.6)	MARK4 (1.5)	HNF1A (1.5)	RHCE (1.4)
ENSG00000164331	ANKRA2 PPI subnetwork	0.87	> 0.20	ENSG00000238078 (2.8)	MAFB (2.4)	HNF1A (2.1)	ENSG00000235545 (1.7)	DOCK7 (1.5)	ST3GAL4 (1.5)	UBXN2B (1.4)	AMIGO1 (1.4)	MYLIP (1.3)	CELSR2 (1.2)
GO:0070670	response to interleukin-4	0.87	> 0.20	ENSG00000254235 (3.0)	ENSG00000235545 (2.6)	PMFBP1 (2.4)	PLCG1 (1.7)	ENSG00000226645 (1.6)	HNF1A (1.5)	C12orf43 (1.5)	CYB561D1 (1.4)	PBX4 (1.4)	TSSK6 (1.2)
ENSG00000116544	DLGAP3 PPI subnetwork	0.87	> 0.20	FRK (3.0)	ZHX3 (2.9)	RPH3A (2.2)	PLCG1 (1.9)	SH2B3 (1.6)	ITGB3 (1.6)	ENSG00000235545 (1.5)	ENSG00000226645 (1.5)	GPAM (1.5)	PPP1R37 (1.5)
GO:0050908	detection of light stimulus involved in visual perception	0.87	> 0.20	GOT2P1 (2.3)	C12orf47 (2.2)	NKPD1 (2.1)	TSSK6 (1.9)	ATXN7L2 (1.7)	LPIN3 (1.4)	ST3GAL4 (1.4)	DYNC2LI1 (1.2)	PMFBP1 (1.2)	FRK (1.2)
GO:0050962	detection of light stimulus involved in sensory perception	0.87	> 0.20	GOT2P1 (2.3)	C12orf47 (2.2)	NKPD1 (2.1)	TSSK6 (1.9)	ATXN7L2 (1.7)	LPIN3 (1.4)	ST3GAL4 (1.4)	DYNC2LI1 (1.2)	PMFBP1 (1.2)	FRK (1.2)
MP:0011290	decreased nephron number	0.87	> 0.20	NYNRIN (2.9)	PLEKHH2 (2.8)	ENSG00000228044 (2.8)	KANK2 (2.4)	ITGB3 (1.5)	TSSK6 (1.3)	CELSR2 (1.3)	CETP (1.2)	CARM1 (1.2)	DYNC2LI1 (1.1)
ENSG00000167461	RAB8A PPI subnetwork	0.87	> 0.20	GMPR (1.9)	DNM2 (1.8)	C12orf51 (1.8)	SLC44A2 (1.6)	AP1M2 (1.6)	ZNF101 (1.6)	GEMIN7 (1.6)	KANK2 (1.5)	OGDH (1.5)	FRK (1.4)
GO:0043073	germ cell nucleus	0.87	> 0.20	TSSK6 (4.1)	FEN1 (2.6)	USP1 (2.3)	PSRC1 (1.7)	PCSK9 (1.5)	PBX4 (1.5)	ENSG00000235545 (1.5)	C12orf47 (1.4)	PLEKHH2 (1.3)	ADAM1 (1.1)
GO:0045624	positive regulation of T-helper cell differentiation	0.87	> 0.20	TMEM57 (2.5)	ST3GAL4 (1.9)	HLX (1.7)	NT5DC1 (1.7)	BLOC1S3 (1.6)	ZNF101 (1.5)	DNAH11 (1.2)	ENSG00000226645 (1.2)	NAA25 (1.2)	CETP (1.1)
ENSG00000177283	FZD8 PPI subnetwork	0.87	> 0.20	BCAM (3.0)	CBLC (2.6)	C11orf9 (2.1)	NYNRIN (1.6)	NPC1L1 (1.6)	CILP2 (1.6)	TSSK6 (1.6)	AMIGO1 (1.5)	PBX4 (1.3)	ABO (1.2)
GO:0071229	cellular response to acid	0.87	> 0.20	C17orf57 (3.5)	ANKRD31 (3.3)	MYLIP (2.0)	ATXN7L2 (2.0)	AP1M2 (1.6)	KANK2 (1.4)	COL4A3BP (1.3)	C19orf52 (1.3)	NYNRIN (1.3)	ENSG00000238078 (1.3)
ENSG00000124406	ATP8A1 PPI subnetwork	0.87	> 0.20	SLC22A1 (2.0)	CLPTM1 (2.0)	DHX38 (2.0)	ERP29 (2.0)	TXNL4B (2.0)	ATP13A1 (1.9)	CEACAM19 (1.8)	CBLC (1.6)	SORT1 (1.6)	HMGCR (1.5)
GO:0005801	cis-Golgi network	0.87	> 0.20	YIPF2 (4.7)	TMEM50A (3.0)	CYB561D1 (2.9)	TMED4 (2.8)	POC5 (2.1)	PSMA5 (1.8)	LPIN3 (1.6)	TMEM57 (1.6)	KIAA1324 (1.5)	MAU2 (1.5)
MP:0001402	hypoactivity	0.87	> 0.20	CELSR2 (2.0)	ALDH2 (1.8)	C11orf9 (1.7)	C12orf47 (1.7)	ENSG00000254235 (1.6)	RPH3A (1.6)	APOC4 (1.5)	MARK4 (1.3)	ZHX3 (1.3)	TSSK6 (1.3)
ENSG00000136238	RAC1 PPI subnetwork	0.87	> 0.20	SORT1 (2.4)	GMIP (2.2)	DNM2 (2.2)	MARK4 (2.2)	NCAN (1.9)	RPH3A (1.8)	CELSR2 (1.8)	HAPLN4 (1.8)	C11orf9 (1.8)	PLEC (1.6)
ENSG00000124333	VAMP7 PPI subnetwork	0.87	> 0.20	COL4A3BP (3.1)	UBXN2B (2.6)	POLK (2.5)	HAVCR1 (2.1)	USP24 (2.1)	DOCK7 (2.0)	DNM2 (1.9)	FADS1 (1.8)	FADS2 (1.5)	MYLIP (1.5)
GO:0050671	positive regulation of lymphocyte proliferation	0.87	> 0.20	PBX4 (2.8)	TIMD4 (2.5)	ENSG00000226645 (2.4)	CETP (1.9)	ZNF101 (1.7)	TRAFD1 (1.4)	HLX (1.1)	GCNT4 (1.1)	GMIP (1.0)	RELB (1.0)
MP:0008892	abnormal sperm flagellum morphology	0.87	> 0.20	TSSK6 (4.1)	PMFBP1 (2.7)	ADAM1 (2.3)	MAPKAPK5 (2.2)	ATXN7L2 (1.8)	BRAP (1.8)	NT5DC1 (1.8)	PCSK9 (1.5)	LDLR (1.5)	TMED4 (1.3)
GO:0030574	collagen catabolic process	0.87	> 0.20	CEACAM19 (3.1)	FRK (2.7)	ENSG00000238078 (2.1)	DNAH11 (1.8)	ENSG00000228044 (1.8)	CILP2 (1.6)	PLEKHH2 (1.6)	HP (1.2)	ITGB3 (1.1)	TSSK6 (1.0)
ENSG00000198010	DLGAP2 PPI subnetwork	0.87	> 0.20	PPP1R37 (2.1)	GCNT4 (2.1)	RPH3A (2.1)	ENSG00000235545 (1.9)	PLCG1 (1.8)	MAFB (1.5)	NCAN (1.5)	FRK (1.5)	OGDH (1.4)	ITGB3 (1.4)
GO:0008509	anion transmembrane transporter activity	0.87	> 0.20	PLG (3.0)	ANGPTL3 (2.9)	CLPTM1 (2.7)	TMEM116 (2.3)	SLC22A1 (2.0)	SYPL2 (2.0)	TM6SF2 (1.8)	ATP13A1 (1.7)	BCAM (1.7)	GRINA (1.4)
MP:0011186	abnormal visceral endoderm morphology	0.87	> 0.20	ADAM1 (2.6)	FRK (2.2)	PTPN11 (2.0)	HAVCR1 (1.8)	POC5 (1.6)	ATXN7L2 (1.6)	DOCK7 (1.5)	TRIB1 (1.4)	PVR (1.4)	TMEM50A (1.4)
ENSG00000174996	KLC2 PPI subnetwork	0.87	> 0.20	CBLC (3.7)	AP1M2 (3.4)	LPAR2 (2.9)	CELSR2 (2.7)	PLEC (2.5)	MARK4 (2.2)	PPP1R37 (2.1)	C12orf51 (2.1)	HAPLN4 (2.0)	DNM2 (1.9)
GO:0055003	cardiac myofibril assembly	0.88	> 0.20	ENSG00000226648 (2.8)	SYPL2 (1.9)	ENSG00000254235 (1.6)	HNF1A (1.6)	ANKRD31 (1.6)	ERP29 (1.5)	ST3GAL4 (1.4)	ENSG00000238078 (1.4)	TMEM116 (1.3)	CEACAM19 (1.2)
GO:0044057	regulation of system process	0.88	> 0.20	RPH3A (2.6)	HAPLN4 (2.3)	SYPL2 (1.9)	NPC1L1 (1.9)	NCAN (1.8)	ABO (1.8)	C17orf57 (1.6)	CELSR2 (1.5)	PPP1R37 (1.5)	BCAM (1.4)
MP:0001218	thin epidermis	0.88	> 0.20	CBLC (4.2)	AP1M2 (2.3)	BLOC1S3 (2.3)	DYNC2LI1 (2.1)	TMEM116 (1.9)	ABCG8 (1.6)	PTPN11 (1.6)	PLEKHH2 (1.6)	LPAR2 (1.4)	CELSR2 (1.4)
GO:0002792	negative regulation of peptide secretion	0.88	> 0.20	KIAA1324 (4.7)	GPAM (2.1)	MOSC1 (2.0)	AMIGO1 (1.9)	ANKRD31 (1.8)	AP1M2 (1.7)	TMED4 (1.4)	ENSG00000228044 (1.3)	CELSR2 (1.1)	DOCK7 (1.1)
ENSG00000075539	FRYL PPI subnetwork	0.88	> 0.20	MARK4 (3.2)	GMIP (2.8)	BUD13 (2.6)	C12orf51 (2.6)	LPAR2 (2.3)	PSRC1 (2.1)	USP24 (2.0)	SORT1 (1.9)	ATXN2 (1.9)	ILF3 (1.6)
ENSG00000122786	CALD1 PPI subnetwork	0.88	> 0.20	PSRC1 (2.5)	C19orf52 (1.9)	PTPN11 (1.8)	NYNRIN (1.6)	DNAH11 (1.6)	GATAD2A (1.6)	ZNF180 (1.5)	CETP (1.5)	PBX4 (1.4)	ENSG00000228044 (1.3)
GO:0048638	regulation of developmental growth	0.88	> 0.20	GCNT4 (2.1)	ENSG00000226645 (1.8)	PPP1R37 (1.7)	PLEKHH2 (1.5)	CILP2 (1.4)	PVRL2 (1.4)	C11orf9 (1.3)	C1orf63 (1.3)	ATXN2 (1.2)	ATXN7L2 (1.2)
ENSG00000163069	SGCB PPI subnetwork	0.88	> 0.20	SYPL2 (2.9)	KANK2 (2.8)	ST3GAL4 (2.2)	NPC1L1 (2.1)	FRK (1.5)	HNF1A (1.3)	GPAM (1.2)	LPIN3 (1.1)	GMPR (1.1)	ZHX3 (1.1)
GO:0014704	intercalated disc	0.88	> 0.20	PLEC (3.0)	SYPL2 (2.2)	BCAM (2.2)	ALDH2 (1.5)	PTPN11 (1.5)	RPH3A (1.5)	GMPR (1.5)	PVR (1.5)	KANK2 (1.4)	PCSK9 (1.3)
GO:0032689	negative regulation of interferon-gamma production	0.88	> 0.20	PBX4 (1.9)	ZNF101 (1.6)	ENSG00000238078 (1.5)	DNAH11 (1.5)	TIMD4 (1.4)	GRINA (1.2)	ZNF180 (1.2)	NYNRIN (1.0)	NKPD1 (0.9)	KIAA1324 (0.8)
MP:0008869	anovulation	0.88	> 0.20	APOB (2.4)	NT5DC1 (2.1)	TMEM50A (1.9)	KIAA1324 (1.8)	PMFBP1 (1.8)	APOE (1.6)	ZNF101 (1.5)	AMIGO1 (1.5)	GPAM (1.5)	UBXN2B (1.5)
GO:0021532	neural tube patterning	0.88	> 0.20	DYNC2LI1 (2.5)	AMIGO1 (2.3)	PBX4 (2.3)	ENSG00000226648 (2.0)	DNAH11 (2.0)	TMEM116 (2.0)	CARM1 (1.9)	LPAR2 (1.7)	ANKRD31 (1.4)	C12orf43 (1.4)
ENSG00000171703	TCEA2 PPI subnetwork	0.88	> 0.20	AMIGO1 (2.6)	TSSK6 (2.3)	ATXN7L2 (2.2)	TRAFD1 (2.0)	MYLIP (1.9)	SUGP1 (1.9)	PSMA5 (1.9)	NCAN (1.8)	ATXN2 (1.7)	LPIN3 (1.6)
MP:0006032	abnormal ureteric bud morphology	0.88	> 0.20	PLEKHH2 (2.8)	AP1M2 (2.6)	SORT1 (2.2)	HLX (2.0)	PVRL2 (1.9)	DOCK7 (1.8)	ENSG00000238078 (1.8)	NYNRIN (1.7)	CETP (1.5)	PLCG1 (1.4)
GO:0080008	CUL4 RING ubiquitin ligase complex	0.88	> 0.20	MAU2 (2.6)	PMFBP1 (2.1)	TRAPPC6A (1.7)	SUGP1 (1.6)	TMEM116 (1.6)	TRAFD1 (1.6)	RHCE (1.5)	C12orf51 (1.5)	PARP10 (1.4)	CARM1 (1.4)
GO:0007613	memory	0.88	> 0.20	AMIGO1 (2.1)	C12orf47 (1.8)	GCNT4 (1.5)	RPH3A (1.5)	ABO (1.5)	ADAM1 (1.5)	DNAH11 (1.4)	GEMIN7 (1.3)	TSSK6 (1.3)	SORT1 (1.3)
ENSG00000105372	RPS19 PPI subnetwork	0.88	> 0.20	SARS (2.3)	ADAM1 (2.2)	ILF3 (2.0)	NKPD1 (2.0)	DDX56 (1.9)	PTPN11 (1.7)	C12orf43 (1.4)	GATAD2A (1.4)	QTRT1 (1.4)	ERP29 (1.4)
GO:0030135	coated vesicle	0.88	> 0.20	YIPF2 (3.2)	HAPLN4 (2.8)	CLPTM1 (2.5)	RPH3A (2.2)	KIAA1324 (2.1)	GRINA (2.0)	C12orf51 (1.9)	FADS2 (1.7)	SORT1 (1.7)	HMGCR (1.6)
GO:0001913	T cell mediated cytotoxicity	0.88	> 0.20	ZNF180 (2.6)	PARP10 (2.2)	ADAM1 (2.1)	CEACAM19 (2.0)	TMED4 (1.4)	LPIN3 (1.4)	PVR (1.2)	PBX4 (1.2)	NAA25 (1.2)	DHODH (1.1)
GO:0006303	double-strand break repair via nonhomologous end joining	0.88	> 0.20	ANKRD31 (4.0)	ZNF101 (2.7)	GCNT4 (2.7)	UBXN2B (2.1)	TMEM116 (1.9)	DOCK7 (1.8)	NT5DC1 (1.7)	POC5 (1.6)	ADAM1 (1.5)	ENSG00000235545 (1.4)
GO:0032319	regulation of Rho GTPase activity	0.88	> 0.20	PPP1R37 (3.0)	ENSG00000226645 (2.4)	ST3GAL4 (2.0)	LPAR2 (1.9)	CBLC (1.7)	PBX4 (1.7)	PLEKHH2 (1.7)	UBXN2B (1.6)	AP1M2 (1.6)	ZHX3 (1.5)
GO:0014046	dopamine secretion	0.88	> 0.20	ABO (2.1)	RPH3A (1.9)	PPP1R37 (1.9)	CEACAM19 (1.8)	C19orf52 (1.7)	CETP (1.7)	RHCE (1.6)	PMFBP1 (1.6)	BLOC1S3 (1.4)	C17orf57 (1.4)
GO:0014059	regulation of dopamine secretion	0.88	> 0.20	ABO (2.1)	RPH3A (1.9)	PPP1R37 (1.9)	CEACAM19 (1.8)	C19orf52 (1.7)	CETP (1.7)	RHCE (1.6)	PMFBP1 (1.6)	BLOC1S3 (1.4)	C17orf57 (1.4)
ENSG00000149480	MTA2 PPI subnetwork	0.88	> 0.20	SMARCA4 (3.1)	CARM1 (2.6)	MARK4 (2.5)	ATXN2 (2.5)	NT5DC1 (2.1)	DHX38 (2.0)	USP24 (2.0)	ATXN7L2 (2.0)	PLCG1 (1.8)	DNM2 (1.7)
GO:0016796	exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	0.88	> 0.20	NKPD1 (3.5)	OASL (2.9)	DHODH (2.7)	FEN1 (2.5)	LPIN3 (2.3)	PARP10 (2.3)	MAPKAPK5 (2.2)	POC5 (2.1)	QTRT1 (1.8)	DDX56 (1.7)
MP:0003787	abnormal imprinting	0.88	> 0.20	YIPF2 (3.5)	HAPLN4 (2.8)	ATP13A1 (2.3)	CILP2 (2.2)	SLC44A2 (1.9)	SMARCA4 (1.9)	DNM2 (1.9)	GCNT4 (1.8)	ERP29 (1.7)	CARM1 (1.6)
ENSG00000171362	ENSG00000171362 PPI subnetwork	0.88	> 0.20	NYNRIN (2.3)	ENSG00000235545 (2.0)	RHD (2.0)	GEMIN7 (2.0)	FADS2 (1.7)	ATXN2 (1.5)	RPH3A (1.5)	ABO (1.4)	COL4A3BP (1.4)	DNAH11 (1.4)
ENSG00000214717	ZBED1 PPI subnetwork	0.88	> 0.20	BLOC1S3 (3.0)	APOE (2.6)	GRINA (2.1)	NKPD1 (2.0)	TRAPPC6A (2.0)	HAVCR1 (1.6)	GEMIN7 (1.5)	C19orf52 (1.5)	APOC1 (1.4)	ANKRD31 (1.4)
ENSG00000160447	PKN3 PPI subnetwork	0.88	> 0.20	C12orf51 (3.7)	ATXN2 (2.7)	GMIP (2.6)	MARK4 (2.6)	USP24 (2.4)	SORT1 (2.4)	BUD13 (2.3)	PTPN11 (1.9)	LPAR2 (1.9)	ST3GAL4 (1.7)
ENSG00000037280	FLT4 PPI subnetwork	0.88	> 0.20	SH2B3 (3.3)	KANK2 (2.4)	PVRL2 (2.3)	ADAM1 (2.2)	GPAM (2.1)	HLX (2.1)	MAPKAPK5 (1.9)	CETP (1.7)	C12orf43 (1.6)	GEMIN7 (1.6)
GO:0006829	zinc ion transport	0.88	> 0.20	YIPF2 (3.3)	ENSG00000226648 (2.6)	ENSG00000235545 (2.2)	TMED4 (1.8)	PMFBP1 (1.8)	ATP13A1 (1.6)	CYB561D1 (1.4)	ERP29 (1.4)	BLOC1S3 (1.4)	TMEM57 (1.3)
REACTOME_G_ALPHA_1213_SIGNALLING_EVENTS	REACTOME_G_ALPHA_1213_SIGNALLING_EVENTS	0.88	> 0.20	DNM2 (2.8)	GMIP (2.6)	GATAD2A (2.3)	NCAN (2.1)	SLC44A2 (2.1)	SH2B3 (2.1)	PLEC (1.9)	HLX (1.6)	MARK4 (1.5)	PLCG1 (1.5)
GO:0010517	regulation of phospholipase activity	0.88	> 0.20	AMIGO1 (2.9)	ST3GAL4 (2.1)	PLEKHH2 (2.1)	PMFBP1 (2.1)	ZHX3 (2.0)	ITGB3 (1.7)	C12orf47 (1.3)	ABO (1.3)	ENSG00000235545 (1.3)	KIAA1324 (1.3)
MP:0009937	abnormal neuron differentiation	0.88	> 0.20	CELSR2 (3.7)	PSRC1 (3.3)	NCAN (2.6)	FADS2 (1.8)	AMIGO1 (1.8)	LPIN3 (1.7)	ATXN7L2 (1.6)	PMFBP1 (1.5)	PLCG1 (1.5)	TRIB1 (1.3)
ENSG00000108100	CCNY PPI subnetwork	0.88	> 0.20	C1orf63 (2.4)	ILF3 (2.2)	TOP1 (2.1)	CLPTM1 (2.0)	ANKRD31 (1.9)	DOCK7 (1.9)	GATAD2A (1.8)	ENSG00000226645 (1.7)	SMARCA4 (1.5)	CELSR2 (1.5)
ENSG00000100034	PPM1F PPI subnetwork	0.88	> 0.20	POLK (2.7)	TMEM57 (2.3)	HNF1A (2.2)	TXNL4B (2.2)	SARS (2.1)	SH2B3 (2.1)	CEACAM19 (1.9)	HAPLN4 (1.6)	UBXN2B (1.6)	ANKRD31 (1.5)
ENSG00000131899	LLGL1 PPI subnetwork	0.88	> 0.20	NYNRIN (2.3)	UBXN2B (1.9)	TMED4 (1.9)	PVRL2 (1.8)	AP1M2 (1.6)	C1orf63 (1.4)	NT5DC1 (1.4)	TMEM50A (1.3)	ATXN2 (1.2)	SLC22A1 (1.2)
MP:0000534	abnormal ureter morphology	0.88	> 0.20	KANK2 (3.5)	NYNRIN (3.1)	PVRL2 (2.3)	TRIB1 (2.1)	PLEKHH2 (1.9)	HLX (1.9)	TMED4 (1.8)	DOCK7 (1.5)	AP1M2 (1.5)	PLCG1 (1.4)
GO:0048846	axon extension involved in axon guidance	0.88	> 0.20	NYNRIN (2.4)	PLEKHH2 (2.2)	TSSK6 (1.7)	ENSG00000238078 (1.7)	ATXN7L2 (1.6)	TMEM57 (1.6)	TMED4 (1.6)	ENSG00000254235 (1.6)	NKPD1 (1.5)	PVRL2 (1.4)
GO:0006367	transcription initiation from RNA polymerase II promoter	0.88	> 0.20	MAPKAPK5 (2.8)	GEMIN7 (2.6)	BUD13 (2.3)	TOP1 (2.1)	ATXN7L2 (2.0)	ATXN2 (2.0)	POC5 (1.9)	SUGP1 (1.6)	DHX38 (1.5)	ENSG00000254235 (1.5)
MP:0008762	embryonic lethality	0.88	> 0.20	DOCK7 (1.9)	TMEM50A (1.9)	PARP10 (1.9)	ACAD10 (1.7)	LPAR2 (1.6)	USP24 (1.6)	C12orf51 (1.6)	RHCE (1.5)	RHD (1.4)	TOP1 (1.3)
GO:0030890	positive regulation of B cell proliferation	0.88	> 0.20	DNAH11 (2.5)	GCNT4 (2.0)	PBX4 (1.9)	ENSG00000226645 (1.8)	C17orf57 (1.7)	HAVCR1 (1.5)	SH2B3 (1.5)	DYNC2LI1 (1.4)	QTRT1 (1.2)	GMIP (1.1)
GO:0055015	ventricular cardiac muscle cell development	0.88	> 0.20	ENSG00000254235 (2.7)	CEACAM19 (1.8)	GCNT4 (1.7)	ENSG00000226648 (1.5)	TXNL4B (1.5)	PSRC1 (1.4)	PBX4 (1.4)	ENSG00000238078 (1.4)	HNF1A (1.3)	RHCE (1.3)
GO:0035065	regulation of histone acetylation	0.88	> 0.20	GOT2P1 (2.5)	ST3GAL4 (2.5)	ABO (1.8)	SH2B3 (1.7)	FRK (1.5)	PPP1R37 (1.1)	MYLIP (1.1)	ZNF101 (1.0)	CARM1 (1.0)	PMFBP1 (0.9)
ENSG00000139835	GRTP1 PPI subnetwork	0.88	> 0.20	TM6SF2 (2.6)	NPC1L1 (2.4)	ABCG8 (2.3)	LDLR (2.2)	NKPD1 (1.9)	PBX4 (1.9)	TMEM116 (1.6)	GATAD2A (1.4)	ABCG5 (1.3)	COL4A3BP (1.3)
GO:0030500	regulation of bone mineralization	0.88	> 0.20	MYLIP (2.3)	TMEM116 (2.1)	POLK (2.0)	MAFB (2.0)	TMEM57 (2.0)	RHCE (1.7)	GMPR (1.5)	PLEKHH2 (1.4)	ITGB3 (1.3)	CILP2 (1.2)
GO:0032838	cell projection cytoplasm	0.88	> 0.20	DNAH11 (4.0)	TSSK6 (3.1)	TRAPPC6A (2.0)	NKPD1 (1.9)	TM6SF2 (1.7)	ABO (1.6)	PBX4 (1.5)	C19orf52 (1.5)	RPH3A (1.3)	DYNC2LI1 (1.1)
GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity	0.88	> 0.20	LPAR2 (2.2)	PLEKHH2 (2.2)	NYNRIN (2.0)	GCNT4 (1.8)	PVRL2 (1.8)	AP1M2 (1.6)	POC5 (1.6)	GMPR (1.6)	LPIN3 (1.5)	NKPD1 (1.3)
GO:0005048	signal sequence binding	0.88	> 0.20	YIPF2 (4.3)	ERP29 (2.7)	KIAA1324 (2.6)	C19orf52 (2.5)	PTPN11 (2.2)	CARM1 (2.0)	ATP13A1 (1.8)	TMEM50A (1.7)	PVR (1.7)	ZHX3 (1.6)
MP:0001973	increased thermal nociceptive threshold	0.88	> 0.20	BCAM (3.7)	RPH3A (2.5)	AMIGO1 (2.4)	GMPR (1.7)	TRIB1 (1.6)	ITGB3 (1.3)	APOE (1.3)	PVR (1.3)	MOSC1 (1.2)	ATXN2 (1.1)
ENSG00000075891	PAX2 PPI subnetwork	0.88	> 0.20	DYNC2LI1 (4.0)	C11orf9 (3.5)	CILP2 (2.8)	CELSR2 (2.4)	MAPKAPK5 (1.8)	BCAM (1.7)	C12orf43 (1.7)	GMPR (1.5)	POC5 (1.5)	TMED4 (1.3)
ENSG00000115507	OTX1 PPI subnetwork	0.88	> 0.20	PVRL2 (2.5)	NYNRIN (2.0)	ANKRD31 (1.9)	MARK4 (1.8)	LPAR2 (1.8)	MAPKAPK5 (1.7)	CEACAM19 (1.6)	C19orf52 (1.3)	BCAM (1.3)	TRIB1 (1.2)
MP:0000572	abnormal autopod morphology	0.88	> 0.20	PCSK9 (4.2)	HMGCR (3.2)	LDLR (2.9)	FADS1 (2.7)	FADS2 (2.5)	MAFB (2.3)	CILP2 (2.0)	PLEKHH2 (1.6)	CELSR2 (1.3)	YIPF2 (1.3)
GO:0003002	regionalization	0.88	> 0.20	ATXN7L2 (2.3)	DYNC2LI1 (2.1)	ENSG00000254235 (2.0)	CEACAM19 (2.0)	ABO (1.7)	NYNRIN (1.6)	PLEKHH2 (1.2)	BCAM (1.2)	PLCG1 (1.2)	ANKRD31 (1.1)
GO:0050930	induction of positive chemotaxis	0.88	> 0.20	PLEKHH2 (2.4)	TMEM116 (2.0)	AP1M2 (1.8)	PMFBP1 (1.7)	TIMD4 (1.7)	HNF1A (1.5)	KIAA1324 (1.4)	LPAR2 (1.4)	GOT2P1 (1.3)	KANK2 (1.3)
GO:0043090	amino acid import	0.88	> 0.20	NCAN (3.4)	UBXN2B (2.6)	ABCG8 (2.1)	ENSG00000235545 (2.0)	ENSG00000228044 (1.9)	CYP7A1 (1.8)	LPIN3 (1.7)	RPH3A (1.6)	PBX4 (1.5)	SARS (1.5)
ENSG00000164252	AGGF1 PPI subnetwork	0.88	> 0.20	ENSG00000226645 (3.2)	HLX (2.7)	SUGP1 (2.5)	ATXN7L2 (2.4)	BUD13 (2.1)	MAPKAPK5 (1.4)	PSRC1 (1.3)	POLK (1.3)	CEACAM19 (1.2)	USP1 (1.1)
GO:0070085	glycosylation	0.88	> 0.20	YIPF2 (4.2)	TMED4 (3.4)	ERP29 (3.3)	TMEM57 (2.6)	CYB561D1 (2.2)	ATP13A1 (2.2)	TMEM50A (1.9)	CLPTM1 (1.8)	ST3GAL4 (1.7)	C19orf52 (1.6)
GO:0032400	melanosome localization	0.88	> 0.20	C12orf43 (2.8)	ENSG00000228044 (2.7)	DYNC2LI1 (2.1)	TMEM116 (1.5)	ENSG00000254235 (1.5)	TXNL4B (1.4)	PMFBP1 (1.4)	PPP1R37 (1.3)	GOT2P1 (1.3)	BLOC1S3 (1.3)
ENSG00000120910	PPP3CC PPI subnetwork	0.88	> 0.20	COL4A3BP (2.5)	KIAA1324 (2.3)	ZHX3 (2.0)	PLEC (2.0)	C12orf47 (1.7)	GMIP (1.7)	SH2B3 (1.5)	AMIGO1 (1.3)	BCAM (1.3)	C1orf63 (1.2)
ENSG00000116288	PARK7 PPI subnetwork	0.88	> 0.20	COL4A3BP (2.9)	GATAD2A (2.9)	MAPKAPK5 (2.4)	MARK4 (2.3)	POLK (2.1)	ATXN2 (1.9)	GOT2P1 (1.7)	ZNF101 (1.6)	USP1 (1.3)	ADAM1 (1.3)
GO:0072529	pyrimidine-containing compound catabolic process	0.88	> 0.20	TSSK6 (2.3)	ANKRD31 (2.3)	UBXN2B (2.2)	LPA (2.0)	TMEM116 (2.0)	ACAD10 (1.9)	ANGPTL3 (1.7)	APOC4 (1.6)	CILP2 (1.6)	BRAP (1.6)
GO:0002577	regulation of antigen processing and presentation	0.88	> 0.20	ZNF101 (2.6)	ENSG00000235545 (2.3)	BLOC1S3 (2.2)	CEACAM19 (2.2)	CETP (2.1)	ALDH2 (2.0)	NKPD1 (1.8)	PARP10 (1.6)	CYB561D1 (1.5)	TIMD4 (1.5)
GO:0030521	androgen receptor signaling pathway	0.88	> 0.20	ENSG00000226648 (2.1)	ATXN2 (2.1)	GOT2P1 (2.0)	C1orf63 (1.9)	BUD13 (1.8)	UBXN2B (1.8)	C12orf51 (1.7)	ZNF180 (1.6)	TMEM57 (1.5)	TOP1 (1.4)
GO:0015813	L-glutamate transport	0.88	> 0.20	HAPLN4 (3.3)	GCNT4 (3.0)	ABCG8 (2.3)	NCAN (2.2)	TMED4 (1.7)	C12orf43 (1.7)	TM6SF2 (1.7)	ENSG00000228044 (1.6)	RPH3A (1.6)	TMEM116 (1.3)
GO:0007585	respiratory gaseous exchange	0.88	> 0.20	DNAH11 (2.2)	C12orf47 (1.7)	TMEM116 (1.5)	TSSK6 (1.5)	C17orf57 (1.5)	HAPLN4 (1.4)	RPH3A (1.4)	ENSG00000228044 (1.4)	NKPD1 (1.4)	ANKRD31 (1.3)
MP:0000031	abnormal cochlea morphology	0.88	> 0.20	CILP2 (2.2)	NCAN (1.8)	PPP1R37 (1.6)	ZHX3 (1.6)	TIMD4 (1.5)	APOE (1.4)	MAFB (1.4)	ANKRD31 (1.2)	APOC1 (1.2)	KIAA1324 (1.2)
GO:0051145	smooth muscle cell differentiation	0.88	> 0.20	ANKRD31 (2.8)	HLX (2.4)	NYNRIN (2.3)	PLEKHH2 (2.2)	HNF1A (2.1)	ALDH2 (1.9)	KANK2 (1.8)	CEACAM19 (1.8)	GMPR (1.5)	ENSG00000254235 (1.2)
GO:0044243	multicellular organismal catabolic process	0.88	> 0.20	FRK (2.7)	CEACAM19 (2.6)	NPC1L1 (2.1)	ENSG00000238078 (1.9)	ENSG00000228044 (1.8)	PLEKHH2 (1.6)	TM6SF2 (1.5)	ADAM1 (1.3)	CILP2 (1.3)	C11orf9 (1.3)
ENSG00000185130	HIST1H2BL PPI subnetwork	0.88	> 0.20	SMARCA4 (2.9)	USP1 (2.4)	ILF3 (2.0)	DOCK7 (1.9)	BUD13 (1.8)	TMEM57 (1.8)	SUGP1 (1.8)	GMPR (1.6)	FEN1 (1.5)	ZNF180 (1.4)
MP:0000913	abnormal brain development	0.88	> 0.20	NYNRIN (2.3)	PLCG1 (2.2)	DOCK7 (2.1)	PLEKHH2 (2.0)	ATXN2 (2.0)	NCAN (1.9)	CELSR2 (1.7)	HAVCR1 (1.6)	TRIB1 (1.5)	ENSG00000235545 (1.5)
GO:0070167	regulation of biomineral tissue development	0.88	> 0.20	MYLIP (2.7)	MAFB (2.0)	TMEM57 (1.9)	POLK (1.8)	TMEM116 (1.7)	RHCE (1.6)	TRAPPC6A (1.5)	ENSG00000235545 (1.5)	ENSG00000226648 (1.4)	CILP2 (1.4)
GO:0032728	positive regulation of interferon-beta production	0.88	> 0.20	OASL (3.3)	PARP10 (2.9)	ADAM1 (2.8)	DNAH11 (2.2)	BRAP (2.0)	TSSK6 (2.0)	FRK (2.0)	CYB561D1 (2.0)	POC5 (2.0)	C19orf52 (1.9)
ENSG00000088930	XRN2 PPI subnetwork	0.88	> 0.20	C1orf63 (2.8)	TXNL4B (1.9)	SUGP1 (1.9)	DHODH (1.9)	TOP1 (1.8)	YIPF2 (1.7)	POC5 (1.4)	USP1 (1.3)	DDX56 (1.2)	PVR (1.2)
ENSG00000169032	MAP2K1 PPI subnetwork	0.88	> 0.20	RPH3A (2.5)	PLEC (2.4)	PVR (2.4)	SORT1 (2.1)	BCL3 (1.6)	NCAN (1.6)	UBXN2B (1.5)	C11orf9 (1.5)	MARK4 (1.5)	TRIB1 (1.4)
MP:0003641	small lung	0.88	> 0.20	NYNRIN (4.9)	PLEKHH2 (4.2)	BCAM (2.8)	LDLR (2.4)	CELSR2 (2.0)	CBLC (1.7)	PVRL2 (1.6)	FADS2 (1.6)	PLCG1 (1.5)	KANK2 (1.5)
KEGG_VIBRIO_CHOLERAE_INFECTION	KEGG_VIBRIO_CHOLERAE_INFECTION	0.88	> 0.20	SORT1 (3.5)	KIAA1324 (2.8)	ENSG00000238078 (2.7)	SARS (2.3)	ERP29 (2.2)	GRINA (2.1)	TMED4 (2.0)	ATP13A1 (2.0)	ADAM1 (1.9)	AP1M2 (1.8)
GO:0035235	ionotropic glutamate receptor signaling pathway	0.88	> 0.20	ENSG00000226648 (3.1)	RPH3A (2.7)	GOT2P1 (2.1)	GCNT4 (2.1)	PBX4 (1.9)	QTRT1 (1.7)	ENSG00000254235 (1.7)	NKPD1 (1.6)	ZNF180 (1.6)	BLOC1S3 (1.5)
ENSG00000123562	MORF4L2 PPI subnetwork	0.88	> 0.20	USP1 (2.8)	ADAM1 (2.3)	PCSK9 (2.3)	TMED4 (2.1)	BRAP (2.0)	MAPKAPK5 (2.0)	C12orf43 (1.9)	POC5 (1.8)	BUD13 (1.8)	GEMIN7 (1.8)
GO:0044060	regulation of endocrine process	0.88	> 0.20	ENSG00000226645 (2.7)	GCNT4 (2.6)	LPIN3 (2.0)	BLOC1S3 (1.8)	C12orf43 (1.6)	ENSG00000254235 (1.5)	ENSG00000228044 (1.5)	GPAM (1.4)	CILP2 (1.4)	ST3GAL4 (1.3)
GO:0070168	negative regulation of biomineral tissue development	0.88	> 0.20	CILP2 (3.1)	RHCE (2.9)	GOT2P1 (2.3)	RHD (1.9)	TRAPPC6A (1.7)	TMEM116 (1.5)	ENSG00000226648 (1.3)	ZNF259 (1.1)	ANKRD31 (1.0)	TMEM57 (1.0)
GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	0.88	> 0.20	POLK (2.9)	ALDH2 (2.5)	PCSK9 (2.2)	ITGB3 (1.9)	CEACAM19 (1.9)	ST3GAL4 (1.8)	HNF1A (1.7)	C17orf57 (1.4)	TRAPPC6A (1.2)	SH2B3 (1.2)
GO:0008601	protein phosphatase type 2A regulator activity	0.88	> 0.20	CARM1 (3.2)	CEACAM19 (3.1)	MARK4 (2.4)	OASL (2.1)	CELSR2 (1.8)	TOMM40 (1.8)	ATXN7L2 (1.6)	CLPTM1 (1.4)	ENSG00000226645 (1.3)	GOT2P1 (1.3)
ENSG00000100852	ARHGAP5 PPI subnetwork	0.88	> 0.20	PVR (3.6)	PLEC (2.8)	ITGB3 (2.7)	TRIB1 (2.6)	PVRL2 (2.4)	GMIP (2.4)	C17orf57 (1.6)	APOC1 (1.6)	GEMIN7 (1.6)	MARK4 (1.6)
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE	0.88	> 0.20	ZNF101 (4.2)	SMARCA4 (2.2)	FEN1 (2.1)	ERP29 (2.0)	TMED4 (1.8)	GCNT4 (1.6)	PSMA5 (1.4)	ENSG00000254235 (1.4)	LPA (1.4)	BLOC1S3 (1.3)
REACTOME_BASIGIN_INTERACTIONS	REACTOME_BASIGIN_INTERACTIONS	0.88	> 0.20	CLPTM1 (2.6)	SARS (2.6)	PBX4 (2.2)	CELSR2 (2.1)	ATP13A1 (2.0)	C11orf9 (2.0)	NCAN (2.0)	PLEC (1.9)	GPAM (1.8)	SYPL2 (1.6)
ENSG00000168959	GRM5 PPI subnetwork	0.88	> 0.20	SH2B3 (3.0)	NCAN (2.2)	PLCG1 (2.2)	PSRC1 (2.0)	ZNF180 (1.8)	PBX4 (1.7)	PLEKHH2 (1.7)	CYB561D1 (1.6)	ZHX3 (1.5)	MARK4 (1.5)
ENSG00000132109	TRIM21 PPI subnetwork	0.88	> 0.20	UBXN2B (4.3)	PARP10 (2.6)	TRAFD1 (2.3)	BLOC1S3 (2.2)	PLEC (1.7)	TOP1 (1.7)	MAU2 (1.6)	PTPN11 (1.5)	COL4A3BP (1.3)	OASL (1.3)
ENSG00000206156	ENSG00000206156 PPI subnetwork	0.88	> 0.20	ALDH2 (1.9)	C11orf9 (1.8)	MYLIP (1.8)	LPIN3 (1.8)	GEMIN7 (1.8)	MARK4 (1.8)	ERP29 (1.4)	OGDH (1.4)	ITGB3 (1.3)	TRAFD1 (1.3)
ENSG00000149970	CNKSR2 PPI subnetwork	0.88	> 0.20	FRK (3.0)	LPIN3 (2.1)	MAPKAPK5 (2.1)	PPP1R37 (2.0)	SORT1 (1.8)	GCNT4 (1.6)	TMEM116 (1.6)	RPH3A (1.5)	CBLC (1.4)	ANKRD31 (1.3)
ENSG00000101199	ARFGAP1 PPI subnetwork	0.88	> 0.20	YIPF2 (3.9)	CLPTM1 (2.3)	SUGP1 (2.3)	TMEM50A (2.2)	MAU2 (2.2)	ATP13A1 (2.2)	DNM2 (2.1)	SARS (2.1)	GRINA (1.9)	KIAA1324 (1.8)
ENSG00000136436	CALCOCO2 PPI subnetwork	0.88	> 0.20	GRINA (2.3)	PBX4 (2.0)	DHX38 (1.9)	AP1M2 (1.7)	TSSK6 (1.7)	TXNL4B (1.7)	HAVCR1 (1.5)	DNM2 (1.2)	HNF1A (1.2)	C19orf52 (1.2)
MP:0001394	circling	0.88	> 0.20	NPC1L1 (2.8)	KIAA1324 (2.0)	HNF1A (1.9)	PMFBP1 (1.8)	OASL (1.8)	HAPLN4 (1.5)	NT5DC1 (1.4)	POLK (1.4)	PPP1R37 (1.3)	MYLIP (1.2)
ENSG00000198954	KIAA1279 PPI subnetwork	0.88	> 0.20	MYLIP (2.3)	ACAD10 (2.2)	POLK (2.0)	TRAPPC6A (1.9)	CEACAM19 (1.9)	MAPKAPK5 (1.9)	ALDH2 (1.8)	TMEM116 (1.7)	POC5 (1.6)	C1orf63 (1.6)
ENSG00000197597	ENSG00000197597 PPI subnetwork	0.88	> 0.20	SMARCA4 (2.9)	BUD13 (2.3)	USP1 (2.3)	ILF3 (2.1)	DDX56 (1.7)	SUGP1 (1.7)	GMPR (1.7)	ATXN2 (1.6)	TMEM57 (1.6)	DOCK7 (1.3)
GO:0070972	protein localization in endoplasmic reticulum	0.88	> 0.20	YIPF2 (4.4)	TMED4 (3.1)	TMEM57 (2.8)	CYB561D1 (2.6)	ERP29 (2.6)	ADAM1 (2.2)	ATP13A1 (2.0)	CLPTM1 (2.0)	GOT2P1 (1.8)	KIAA1324 (1.5)
ENSG00000107581	EIF3A PPI subnetwork	0.88	> 0.20	ZNF259 (3.2)	TOP1 (3.1)	NAA25 (3.1)	ILF3 (2.6)	PTPN11 (2.6)	DHX38 (2.5)	DDX56 (2.4)	SARS (2.4)	QTRT1 (2.4)	GATAD2A (2.4)
ENSG00000111540	RAB5B PPI subnetwork	0.88	> 0.20	HLX (2.7)	ENSG00000254235 (2.4)	DNAH11 (2.4)	ANKRD31 (2.2)	SH2B3 (2.0)	HAVCR1 (2.0)	ENSG00000226645 (1.9)	PMFBP1 (1.8)	COL4A3BP (1.8)	RHCE (1.5)
GO:0046933	hydrogen ion transporting ATP synthase activity, rotational mechanism	0.88	> 0.20	OGDH (3.1)	C19orf52 (2.7)	ENSG00000238078 (2.6)	GRINA (2.6)	SARS (2.4)	AP1M2 (2.3)	CLPTM1 (2.1)	PSMA5 (2.1)	C1orf63 (2.1)	ERP29 (2.1)
MP:0009758	impaired behavioral response to cocaine	0.88	> 0.20	KIAA1324 (2.5)	NCAN (2.2)	TRAPPC6A (2.0)	APOC1 (2.0)	GMPR (2.0)	APOE (1.9)	PLG (1.6)	SLC22A1 (1.5)	CELSR2 (1.5)	CBLC (1.5)
KEGG_VIRAL_MYOCARDITIS	KEGG_VIRAL_MYOCARDITIS	0.88	> 0.20	SYPL2 (3.5)	SH2B3 (1.8)	PBX4 (1.5)	OGDH (1.5)	RELB (1.2)	ADAM1 (1.2)	KANK2 (1.0)	USP24 (1.0)	BCL3 (0.9)	ERP29 (0.9)
GO:0001710	mesodermal cell fate commitment	0.88	> 0.20	NYNRIN (1.8)	DYNC2LI1 (1.8)	TSSK6 (1.7)	LPIN3 (1.7)	CEACAM19 (1.6)	MYLIP (1.6)	CILP2 (1.5)	YIPF2 (1.4)	C19orf52 (1.4)	AP1M2 (1.3)
GO:0014048	regulation of glutamate secretion	0.88	> 0.20	C17orf57 (2.6)	GOT2P1 (2.5)	ENSG00000228044 (2.3)	HNF1A (2.3)	NCAN (1.9)	RHCE (1.5)	LPAR2 (1.5)	C11orf9 (1.3)	ENSG00000235545 (1.3)	FRK (1.3)
GO:0008064	regulation of actin polymerization or depolymerization	0.88	> 0.20	ADAM1 (2.6)	ENSG00000238078 (2.5)	ABO (2.1)	ST3GAL4 (1.9)	C17orf57 (1.9)	TMEM50A (1.8)	CBLC (1.8)	CYB561D1 (1.7)	C11orf9 (1.7)	CETP (1.6)
ENSG00000196890	HIST3H2BB PPI subnetwork	0.88	> 0.20	SMARCA4 (2.8)	USP1 (2.5)	BUD13 (2.3)	ILF3 (2.0)	ATXN2 (1.8)	GMPR (1.7)	SUGP1 (1.5)	DDX56 (1.5)	TMEM57 (1.5)	FEN1 (1.3)
KEGG_HOMOLOGOUS_RECOMBINATION	KEGG_HOMOLOGOUS_RECOMBINATION	0.88	> 0.20	FEN1 (4.2)	USP1 (3.6)	POLK (2.3)	POC5 (2.2)	BUD13 (2.1)	DHODH (2.1)	ZNF180 (2.0)	PSRC1 (1.8)	TMEM116 (1.6)	BLOC1S3 (1.5)
ENSG00000163960	UBXN7 PPI subnetwork	0.88	> 0.20	USP24 (2.6)	TMEM57 (2.6)	COL4A3BP (2.3)	SUGP1 (2.2)	GRINA (2.2)	NT5DC1 (2.1)	DHX38 (1.8)	BRAP (1.7)	DOCK7 (1.7)	POC5 (1.6)
ENSG00000150753	CCT5 PPI subnetwork	0.88	> 0.20	NAA25 (2.6)	NT5DC1 (2.4)	TMEM50A (2.3)	SARS (2.1)	TOMM40 (1.9)	DDX56 (1.9)	PSMA5 (1.7)	ENSG00000235545 (1.6)	TRAFD1 (1.6)	ZNF259 (1.5)
ENSG00000205726	ITSN1 PPI subnetwork	0.88	> 0.20	C1orf63 (2.7)	ATXN2 (2.0)	GMIP (2.0)	DOCK7 (2.0)	TMEM50A (1.9)	MARK4 (1.9)	TOP1 (1.9)	USP24 (1.9)	GATAD2A (1.8)	NCAN (1.8)
GO:0072079	nephron tubule formation	0.88	> 0.20	HAVCR1 (3.8)	DYNC2LI1 (1.8)	BCAM (1.8)	ABO (1.7)	AP1M2 (1.6)	TSSK6 (1.4)	NKPD1 (1.4)	KIAA1324 (1.3)	PPP1R37 (1.3)	TMEM116 (1.3)
GO:0000082	G1/S transition of mitotic cell cycle	0.88	> 0.20	PSMA5 (2.5)	FEN1 (2.0)	USP1 (2.0)	ZNF180 (1.7)	TXNL4B (1.5)	NAA25 (1.5)	TOMM40 (1.5)	ENSG00000226648 (1.4)	LPIN3 (1.4)	NT5DC1 (1.3)
GO:0060675	ureteric bud morphogenesis	0.88	> 0.20	ENSG00000228044 (2.8)	HNF1A (2.8)	TSSK6 (2.6)	PVRL2 (2.2)	BCAM (2.1)	ENSG00000238078 (1.8)	HAVCR1 (1.7)	NYNRIN (1.7)	PLEKHH2 (1.6)	TMED4 (1.4)
GO:0051983	regulation of chromosome segregation	0.88	> 0.20	PSRC1 (3.8)	POC5 (2.8)	TSSK6 (1.6)	USP1 (1.5)	PBX4 (1.4)	GEMIN7 (1.4)	BLOC1S3 (1.4)	FEN1 (1.2)	GCNT4 (1.2)	C1orf63 (1.1)
ENSG00000157766	ACAN PPI subnetwork	0.88	> 0.20	MAFB (3.0)	RHCE (1.7)	HP (1.6)	ENSG00000228044 (1.6)	ENSG00000238078 (1.5)	MYLIP (1.5)	ABCG5 (1.4)	GRINA (1.4)	HAVCR1 (1.2)	AP1M2 (1.2)
MP:0000133	abnormal long bone metaphysis morphology	0.88	> 0.20	CILP2 (6.1)	APOE (3.1)	MAFB (2.1)	APOC1 (1.7)	TMEM116 (1.7)	PLEKHH2 (1.5)	PLEC (1.4)	BCAM (1.3)	RHCE (1.3)	GMIP (1.3)
ENSG00000132692	BCAN PPI subnetwork	0.88	> 0.20	FRK (2.6)	HP (2.3)	DNAH11 (2.1)	ITGB3 (2.0)	ENSG00000228044 (1.5)	SLC22A1 (1.4)	NPC1L1 (1.3)	ENSG00000238078 (1.2)	CILP2 (1.2)	PVR (1.1)
ENSG00000188486	H2AFX PPI subnetwork	0.88	> 0.20	BUD13 (3.4)	SMARCA4 (2.7)	USP1 (2.5)	ILF3 (2.5)	FEN1 (2.1)	DDX56 (2.0)	SUGP1 (2.0)	CARM1 (1.9)	ZNF259 (1.8)	ENSG00000226645 (1.7)
ENSG00000136631	VPS45 PPI subnetwork	0.88	> 0.20	BLOC1S3 (3.1)	ZNF101 (2.7)	SARS (2.6)	BRAP (2.5)	MAPKAPK5 (2.4)	ZNF259 (2.3)	ACAD10 (2.3)	SUGP1 (2.1)	C12orf43 (1.9)	LPIN3 (1.9)
GO:0033176	proton-transporting V-type ATPase complex	0.88	> 0.20	GRINA (3.5)	SARS (2.7)	TMEM116 (2.5)	TMEM50A (2.4)	ERP29 (2.1)	SORT1 (2.0)	CLPTM1 (1.9)	KIAA1324 (1.9)	ENSG00000238078 (1.8)	COL4A3BP (1.8)
MP:0008702	increased interleukin-5 secretion	0.88	> 0.20	TRIB1 (2.3)	SH2B3 (2.0)	APOE (2.0)	MAFB (1.7)	TIMD4 (1.6)	TRAFD1 (1.6)	NKPD1 (1.5)	CETP (1.2)	PMFBP1 (1.2)	RHD (1.2)
ENSG00000070950	RAD18 PPI subnetwork	0.88	> 0.20	ZNF180 (3.1)	DYNC2LI1 (2.1)	POLK (1.9)	ENSG00000226645 (1.6)	GEMIN7 (1.6)	FEN1 (1.5)	TMEM116 (1.4)	USP1 (1.4)	UBXN2B (1.4)	SUGP1 (1.4)
ENSG00000183814	LIN9 PPI subnetwork	0.88	> 0.20	RHD (3.2)	RHCE (2.6)	USP1 (2.3)	PLCG1 (2.3)	MAPKAPK5 (1.9)	FEN1 (1.8)	GRINA (1.8)	PSRC1 (1.6)	ZNF101 (1.6)	GOT2P1 (1.5)
GO:0035303	regulation of dephosphorylation	0.88	> 0.20	ENSG00000238078 (2.8)	BRAP (2.7)	PPP1R37 (2.4)	ADAM1 (2.2)	HNF1A (2.1)	PMFBP1 (2.1)	HAVCR1 (2.0)	TXNL4B (1.9)	PTPN11 (1.7)	POLK (1.6)
KEGG_GRAFT_VERSUS_HOST_DISEASE	KEGG_GRAFT_VERSUS_HOST_DISEASE	0.88	> 0.20	RELB (1.8)	BCL3 (1.4)	TRAFD1 (1.3)	COL4A3BP (1.2)	MAFB (1.2)	SH2B3 (1.0)	APOE (1.0)	PBX4 (1.0)	ADAM1 (0.9)	POLK (0.9)
MP:0000137	abnormal vertebrae morphology	0.88	> 0.20	CILP2 (4.1)	PLEKHH2 (2.3)	PLCG1 (2.3)	NYNRIN (2.3)	KANK2 (2.2)	MAFB (2.0)	ENSG00000254235 (1.7)	DOCK7 (1.7)	MYLIP (1.5)	TMEM57 (1.4)
ENSG00000179958	DCTPP1 PPI subnetwork	0.88	> 0.20	C12orf51 (4.2)	MARK4 (2.6)	SORT1 (2.4)	BUD13 (2.3)	GMIP (2.1)	USP24 (2.1)	ATXN2 (2.0)	PSRC1 (1.7)	PTPN11 (1.7)	ILF3 (1.5)
GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	0.88	> 0.20	C19orf52 (2.3)	TMEM116 (1.7)	ANKRD31 (1.7)	C12orf43 (1.6)	ST3GAL4 (1.4)	BLOC1S3 (1.4)	TRAFD1 (1.4)	ITGB3 (1.3)	POLK (1.2)	UBXN2B (1.2)
ENSG00000137878	GCOM1 PPI subnetwork	0.88	> 0.20	RHCE (2.8)	USP1 (2.3)	ZNF180 (2.1)	C12orf47 (2.0)	POC5 (1.9)	BUD13 (1.7)	TSSK6 (1.7)	USP24 (1.6)	PLEKHH2 (1.6)	SARS (1.2)
GO:0008081	phosphoric diester hydrolase activity	0.88	> 0.20	SORT1 (2.4)	LPIN3 (2.1)	MAFB (2.0)	NKPD1 (1.9)	NCAN (1.9)	MOSC1 (1.8)	CETP (1.7)	AMIGO1 (1.6)	HLX (1.3)	GCNT4 (1.3)
GO:0007184	SMAD protein import into nucleus	0.89	> 0.20	PPP1R37 (2.8)	POLK (2.7)	PLCG1 (2.7)	C11orf9 (2.7)	KANK2 (2.6)	GATAD2A (1.9)	GCNT4 (1.8)	PVR (1.7)	BLOC1S3 (1.3)	HNF1A (1.3)
MP:0000886	abnormal cerebellar granule layer	0.89	> 0.20	PCSK9 (2.6)	APOE (2.1)	TMED4 (2.0)	HP (2.0)	GRINA (1.9)	ALDH2 (1.7)	NYNRIN (1.6)	DOCK7 (1.4)	C11orf9 (1.4)	YIPF2 (1.3)
ENSG00000027075	PRKCH PPI subnetwork	0.89	> 0.20	GATAD2A (2.3)	PVR (2.3)	SORT1 (2.1)	ADAM1 (2.0)	LPA (1.8)	C12orf51 (1.8)	ATXN2 (1.7)	MOSC1 (1.6)	PVRL2 (1.5)	ZHX3 (1.4)
ENSG00000106100	NOD1 PPI subnetwork	0.89	> 0.20	C1orf63 (3.5)	ST3GAL4 (2.4)	BLOC1S3 (2.0)	TXNL4B (1.6)	FRK (1.6)	TRAFD1 (1.5)	DNAH11 (1.4)	PARP10 (1.3)	LPAR2 (1.3)	MAU2 (1.2)
GO:0042625	ATPase activity, coupled to transmembrane movement of ions	0.89	> 0.20	COL4A3BP (2.9)	SORT1 (2.7)	CLPTM1 (2.6)	ATP13A1 (2.5)	GRINA (2.4)	AP1M2 (2.3)	TMEM116 (2.3)	SLC44A2 (2.2)	GMPR (2.2)	NKPD1 (2.0)
ENSG00000179071	CCDC89 PPI subnetwork	0.89	> 0.20	LPIN3 (3.1)	NKPD1 (2.7)	ATXN7L2 (2.6)	NT5DC1 (1.9)	ACAD10 (1.6)	NCAN (1.4)	DYNC2LI1 (1.3)	BCL3 (1.3)	ENSG00000254235 (1.3)	ABCG8 (1.2)
ENSG00000110148	CCKBR PPI subnetwork	0.89	> 0.20	ABO (3.1)	SH2B3 (3.0)	C17orf57 (2.7)	RPH3A (2.5)	COL4A3BP (1.9)	NPC1L1 (1.9)	C12orf47 (1.7)	ENSG00000235545 (1.7)	C12orf43 (1.5)	ZHX3 (1.5)
ENSG00000007047	MARK4 PPI subnetwork	0.89	> 0.20	PTPN11 (3.1)	SYPL2 (2.2)	C12orf51 (2.2)	ENSG00000235545 (2.1)	C12orf47 (1.8)	MARK4 (1.8)	ZNF101 (1.7)	HMGCR (1.7)	NYNRIN (1.7)	C17orf57 (1.6)
GO:0048663	neuron fate commitment	0.89	> 0.20	ABO (3.0)	DNAH11 (2.6)	NKPD1 (2.5)	TSSK6 (2.0)	PMFBP1 (1.8)	NCAN (1.7)	C12orf47 (1.6)	ANKRD31 (1.6)	HAPLN4 (1.6)	C19orf52 (1.6)
GO:0006582	melanin metabolic process	0.89	> 0.20	PMFBP1 (2.0)	NKPD1 (1.6)	GMPR (1.6)	ST3GAL4 (1.5)	CELSR2 (1.4)	C12orf47 (1.3)	MYLIP (1.2)	ERP29 (1.2)	C12orf43 (1.1)	ENSG00000235545 (1.1)
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	0.89	> 0.20	ITGB3 (3.5)	TMEM50A (1.9)	CETP (1.7)	ENSG00000254235 (1.4)	HLX (1.3)	TM6SF2 (1.3)	PMFBP1 (1.1)	ZNF180 (1.0)	RPH3A (0.9)	ACAD10 (0.8)
REACTOME_SRP:DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	REACTOME_SRP:DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	0.89	> 0.20	ERP29 (4.2)	TMED4 (2.8)	ATP13A1 (2.5)	TMEM50A (2.5)	YIPF2 (2.4)	NKPD1 (1.9)	KIAA1324 (1.7)	TMEM57 (1.7)	CLPTM1 (1.4)	ANKRD31 (1.4)
MP:0004173	abnormal intervertebral disk morphology	0.89	> 0.20	CILP2 (5.7)	HAPLN4 (2.7)	FRK (2.5)	MAFB (2.2)	TMEM57 (1.8)	ENSG00000254235 (1.7)	LDLR (1.7)	ENSG00000238078 (1.6)	ERP29 (1.6)	LPAR2 (1.6)
GO:0007501	mesodermal cell fate specification	0.89	> 0.20	ENSG00000226648 (2.0)	DYNC2LI1 (2.0)	DNAH11 (1.9)	PMFBP1 (1.8)	ENSG00000238078 (1.8)	CILP2 (1.7)	KIAA1324 (1.6)	ENSG00000254235 (1.6)	NYNRIN (1.6)	PLCG1 (1.6)
GO:0018196	peptidyl-asparagine modification	0.89	> 0.20	YIPF2 (4.8)	ERP29 (3.7)	TMED4 (3.4)	ATP13A1 (2.6)	TMEM57 (2.2)	CLPTM1 (2.1)	C19orf52 (1.6)	TMEM50A (1.4)	CYB561D1 (1.2)	ENSG00000235545 (1.2)
GO:0018279	protein N-linked glycosylation via asparagine	0.89	> 0.20	YIPF2 (4.8)	ERP29 (3.7)	TMED4 (3.4)	ATP13A1 (2.6)	TMEM57 (2.2)	CLPTM1 (2.1)	C19orf52 (1.6)	TMEM50A (1.4)	CYB561D1 (1.2)	ENSG00000235545 (1.2)
GO:0055081	anion homeostasis	0.89	> 0.20	TM6SF2 (3.4)	AP1M2 (2.7)	HAVCR1 (2.7)	NPC1L1 (2.6)	TMEM116 (2.5)	CILP2 (2.3)	ABCG8 (2.0)	ABCG5 (1.8)	FRK (1.7)	SYPL2 (1.5)
ENSG00000172432	GTPBP2 PPI subnetwork	0.89	> 0.20	PLEKHH2 (2.4)	TMED4 (2.3)	TRAPPC6A (2.0)	GCNT4 (1.9)	ERP29 (1.9)	ALDH2 (1.6)	POC5 (1.6)	AP1M2 (1.6)	POLK (1.5)	YIPF2 (1.3)
GO:0030901	midbrain development	0.89	> 0.20	C12orf47 (2.1)	DYNC2LI1 (1.8)	AMIGO1 (1.8)	ATXN2 (1.7)	ADAM1 (1.6)	ENSG00000238078 (1.6)	ENSG00000254235 (1.6)	ZHX3 (1.4)	ABO (1.4)	ZNF101 (1.3)
GO:0051225	spindle assembly	0.89	> 0.20	POC5 (3.1)	ZNF180 (2.9)	PSRC1 (2.8)	NKPD1 (1.9)	TXNL4B (1.7)	UBXN2B (1.5)	USP1 (1.2)	MAPKAPK5 (1.1)	DYNC2LI1 (1.1)	C1orf63 (1.1)
GO:0001558	regulation of cell growth	0.89	> 0.20	CILP2 (3.2)	POLK (1.8)	PVR (1.7)	C12orf43 (1.7)	TMEM50A (1.5)	TXNL4B (1.5)	TMED4 (1.5)	ST3GAL4 (1.4)	ENSG00000238078 (1.4)	ENSG00000226645 (1.4)
GO:0035112	genitalia morphogenesis	0.89	> 0.20	TSSK6 (2.6)	ALDH2 (2.6)	PLEKHH2 (2.4)	PBX4 (1.8)	C19orf52 (1.7)	LPAR2 (1.7)	ANKRD31 (1.5)	PLCG1 (1.5)	KIAA1324 (1.5)	ENSG00000238078 (1.5)
ENSG00000104637	ENSG00000104637 PPI subnetwork	0.89	> 0.20	TMEM50A (2.7)	PTPN11 (2.6)	ERP29 (2.1)	TRAPPC6A (1.8)	DOCK7 (1.8)	TOP1 (1.8)	TOMM40 (1.7)	NAA25 (1.7)	ADAM1 (1.6)	ENSG00000238078 (1.6)
MP:0000745	tremors	0.89	> 0.20	RPH3A (4.6)	HAPLN4 (4.4)	CELSR2 (2.5)	APOE (2.4)	GRINA (2.3)	COL4A3BP (1.8)	ATP13A1 (1.7)	C11orf9 (1.7)	C12orf51 (1.5)	CYP7A1 (1.5)
GO:0019829	cation-transporting ATPase activity	0.89	> 0.20	GRINA (3.5)	COL4A3BP (3.2)	ATP13A1 (2.8)	AP1M2 (2.8)	CLPTM1 (2.7)	GMPR (2.2)	OGDH (2.1)	HAPLN4 (2.0)	ENSG00000238078 (1.9)	SARS (1.9)
GO:0006206	pyrimidine base metabolic process	0.89	> 0.20	ANKRD31 (2.6)	LPA (2.6)	TXNL4B (2.5)	DHODH (2.2)	ANGPTL3 (2.0)	SLC22A1 (1.8)	UBXN2B (1.7)	LPIN3 (1.6)	PLG (1.6)	ACAD10 (1.6)
GO:0043114	regulation of vascular permeability	0.89	> 0.20	FRK (2.5)	ENSG00000238078 (2.3)	PVRL2 (1.9)	ABO (1.9)	PLEKHH2 (1.3)	NKPD1 (1.2)	DNAH11 (1.1)	YIPF2 (1.1)	C11orf9 (1.0)	CELSR2 (1.0)
GO:0048284	organelle fusion	0.89	> 0.20	BLOC1S3 (3.2)	HAVCR1 (2.6)	CYB561D1 (2.4)	YIPF2 (2.1)	POLK (2.1)	TRAPPC6A (1.8)	POC5 (1.7)	BRAP (1.5)	ANKRD31 (1.5)	C19orf52 (1.5)
ENSG00000169509	CRCT1 PPI subnetwork	0.89	> 0.20	KIAA1324 (2.4)	ZNF180 (1.9)	NT5DC1 (1.7)	FRK (1.7)	APOE (1.6)	UBXN2B (1.6)	ATXN7L2 (1.6)	PLEC (1.4)	HAVCR1 (1.4)	FADS2 (1.4)
ENSG00000133818	RRAS2 PPI subnetwork	0.89	> 0.20	SH2B3 (2.6)	USP24 (2.4)	GMIP (2.3)	COL4A3BP (2.2)	MAU2 (2.2)	NCAN (2.1)	RELB (2.0)	C11orf9 (2.0)	DNM2 (1.8)	SLC44A2 (1.8)
GO:0042659	regulation of cell fate specification	0.89	> 0.20	LPAR2 (2.8)	ENSG00000226648 (2.0)	TMEM116 (1.8)	BCAM (1.8)	KIAA1324 (1.7)	CILP2 (1.7)	PPP1R37 (1.7)	TSSK6 (1.5)	FRK (1.5)	ENSG00000254235 (1.5)
GO:0003151	outflow tract morphogenesis	0.89	> 0.20	ENSG00000238078 (3.1)	NYNRIN (2.1)	ABO (1.8)	LPAR2 (1.7)	ATXN7L2 (1.4)	C11orf9 (1.4)	BCAM (1.4)	CILP2 (1.3)	TSSK6 (1.3)	PVRL2 (1.3)
ENSG00000177951	BET1L PPI subnetwork	0.89	> 0.20	YIPF2 (5.5)	BLOC1S3 (2.7)	TMEM57 (2.1)	DNM2 (2.0)	TMED4 (1.8)	SARS (1.8)	MAU2 (1.7)	KIAA1324 (1.7)	ZNF259 (1.7)	OGDH (1.6)
ENSG00000119487	MAPKAP1 PPI subnetwork	0.89	> 0.20	AP1M2 (2.7)	TOMM40 (2.4)	DHODH (2.1)	PVRL2 (2.0)	QTRT1 (1.9)	NYNRIN (1.7)	ATP13A1 (1.6)	CARM1 (1.6)	SORT1 (1.6)	C1orf63 (1.5)
ENSG00000182400	TRAPPC6B PPI subnetwork	0.89	> 0.20	YIPF2 (2.9)	BLOC1S3 (2.5)	GEMIN7 (2.5)	TMEM50A (2.4)	PSMA5 (2.4)	TMED4 (1.9)	ZNF259 (1.9)	SUGP1 (1.6)	QTRT1 (1.5)	TMEM57 (1.4)
ENSG00000106299	WASL PPI subnetwork	0.89	> 0.20	SH2B3 (3.6)	GATAD2A (2.3)	COL4A3BP (2.2)	TMEM50A (2.0)	DNM2 (1.9)	C1orf63 (1.9)	ITGB3 (1.8)	FRK (1.5)	AP1M2 (1.4)	KANK2 (1.4)
ENSG00000109814	UGDH PPI subnetwork	0.89	> 0.20	BRAP (2.8)	PVRL2 (2.3)	PLCG1 (2.1)	PVR (2.1)	KANK2 (1.9)	PLEC (1.9)	GATAD2A (1.7)	SYPL2 (1.7)	TM6SF2 (1.6)	TMEM116 (1.6)
ENSG00000211456	SACM1L PPI subnetwork	0.89	> 0.20	YIPF2 (4.3)	KIAA1324 (3.3)	SORT1 (2.4)	TMEM57 (2.3)	PSMA5 (2.2)	CLPTM1 (2.1)	ERP29 (2.1)	BLOC1S3 (2.1)	SARS (2.1)	DOCK7 (1.8)
GO:0001833	inner cell mass cell proliferation	0.89	> 0.20	PPP1R37 (3.0)	MAU2 (2.3)	ATP13A1 (1.9)	YIPF2 (1.7)	QTRT1 (1.7)	AMIGO1 (1.7)	GOT2P1 (1.6)	SUGP1 (1.6)	DHX38 (1.6)	NKPD1 (1.6)
GO:0005217	intracellular ligand-gated ion channel activity	0.89	> 0.20	ENSG00000235545 (2.9)	ABO (1.7)	ADAM1 (1.7)	GMPR (1.5)	LPIN3 (1.5)	MAU2 (1.5)	C17orf57 (1.4)	OGDH (1.4)	SLC44A2 (1.3)	CYB561D1 (1.3)
GO:0018410	C-terminal protein amino acid modification	0.89	> 0.20	ATP13A1 (2.8)	CYB561D1 (2.7)	UBXN2B (2.6)	ERP29 (2.5)	YIPF2 (2.4)	TMEM116 (2.3)	TMED4 (2.2)	TMEM50A (2.1)	TSSK6 (2.0)	ZNF180 (1.9)
REACTOME_INSULIN_RECEPTOR_RECYCLING	REACTOME_INSULIN_RECEPTOR_RECYCLING	0.89	> 0.20	GRINA (3.0)	TMEM116 (2.8)	SORT1 (2.6)	SARS (2.4)	APOE (2.1)	ENSG00000238078 (2.0)	TMEM50A (2.0)	ERP29 (2.0)	COL4A3BP (1.8)	GMPR (1.7)
GO:0050906	detection of stimulus involved in sensory perception	0.89	> 0.20	ENSG00000235545 (3.2)	ENSG00000228044 (3.0)	GOT2P1 (2.6)	PMFBP1 (1.4)	DNAH11 (1.2)	FRK (1.1)	MOSC1 (1.1)	ADAM1 (1.1)	ANKRD31 (1.0)	DYNC2LI1 (1.0)
GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	0.89	> 0.20	ENSG00000235545 (2.3)	PBX4 (2.0)	ENSG00000254235 (1.6)	MYLIP (1.6)	ANKRD31 (1.2)	GMIP (1.2)	BCL3 (1.2)	CETP (1.1)	SLC22A1 (1.1)	TMEM57 (1.0)
GO:0045123	cellular extravasation	0.89	> 0.20	MOSC1 (2.0)	RELB (2.0)	ENSG00000238078 (1.9)	TIMD4 (1.8)	TXNL4B (1.8)	CILP2 (1.7)	CEACAM19 (1.4)	BCL3 (1.4)	FRK (1.3)	MAFB (1.3)
ENSG00000108691	CCL2 PPI subnetwork	0.89	> 0.20	HP (3.4)	MAFB (2.8)	RHCE (2.3)	ZNF101 (2.1)	TRIB1 (1.6)	ZNF180 (1.5)	GRINA (1.4)	BCL3 (1.3)	PVR (1.2)	ITGB3 (1.1)
ENSG00000080603	SRCAP PPI subnetwork	0.89	> 0.20	SMARCA4 (2.5)	BUD13 (2.3)	TXNL4B (2.2)	USP1 (1.7)	SUGP1 (1.5)	C19orf52 (1.5)	TOP1 (1.5)	ZNF180 (1.4)	GMPR (1.3)	DHX38 (1.2)
ENSG00000115275	MOGS PPI subnetwork	0.89	> 0.20	ATP13A1 (2.9)	QTRT1 (2.8)	YIPF2 (2.7)	ILF3 (2.3)	ACAD10 (2.3)	ERP29 (2.2)	TMEM116 (2.1)	TOMM40 (1.9)	ATXN7L2 (1.8)	ST3GAL4 (1.7)
REACTOME_GLUCAGON:TYPE_LIGAND_RECEPTORS	REACTOME_GLUCAGON:TYPE_LIGAND_RECEPTORS	0.89	> 0.20	NPC1L1 (4.0)	TM6SF2 (3.3)	KIAA1324 (2.6)	ITGB3 (2.0)	ABCG8 (1.9)	AP1M2 (1.7)	ABCG5 (1.7)	HLX (1.7)	ST3GAL4 (1.4)	ENSG00000235545 (1.1)
ENSG00000106483	SFRP4 PPI subnetwork	0.89	> 0.20	BCAM (3.1)	CELSR2 (2.1)	CBLC (1.9)	PVRL2 (1.8)	LPAR2 (1.5)	TSSK6 (1.5)	AMIGO1 (1.5)	PLEKHH2 (1.5)	AP1M2 (1.2)	PBX4 (1.1)
ENSG00000120057	SFRP5 PPI subnetwork	0.89	> 0.20	BCAM (3.1)	CELSR2 (2.1)	CBLC (1.9)	PVRL2 (1.8)	LPAR2 (1.5)	TSSK6 (1.5)	AMIGO1 (1.5)	PLEKHH2 (1.5)	AP1M2 (1.2)	PBX4 (1.1)
ENSG00000104332	SFRP1 PPI subnetwork	0.89	> 0.20	BCAM (3.1)	CELSR2 (2.1)	CBLC (1.9)	PVRL2 (1.8)	LPAR2 (1.5)	TSSK6 (1.5)	AMIGO1 (1.5)	PLEKHH2 (1.5)	AP1M2 (1.2)	PBX4 (1.1)
KEGG_MELANOMA	KEGG_MELANOMA	0.89	> 0.20	KANK2 (2.3)	AP1M2 (2.2)	PTPN11 (2.0)	TSSK6 (1.8)	PPP1R37 (1.4)	PLEKHH2 (1.3)	CARM1 (1.3)	BLOC1S3 (1.2)	GRINA (1.2)	ITGB3 (1.2)
ENSG00000153774	CFDP1 PPI subnetwork	0.89	> 0.20	ATXN2 (2.7)	ILF3 (2.5)	MAPKAPK5 (2.4)	SMARCA4 (2.2)	ZNF180 (2.1)	TXNL4B (1.9)	USP1 (1.9)	DHX38 (1.6)	BUD13 (1.4)	SUGP1 (1.4)
REACTOME_MITOTIC_SPINDLE_CHECKPOINT	REACTOME_MITOTIC_SPINDLE_CHECKPOINT	0.89	> 0.20	PSRC1 (3.4)	POC5 (3.1)	FEN1 (2.8)	LPIN3 (2.7)	SUGP1 (2.5)	ADAM1 (2.4)	GEMIN7 (1.6)	ATP13A1 (1.6)	CETP (1.5)	SLC44A2 (1.5)
GO:0009220	pyrimidine ribonucleotide biosynthetic process	0.89	> 0.20	DYNC2LI1 (4.2)	C12orf43 (2.7)	AMIGO1 (2.6)	PMFBP1 (2.5)	PBX4 (1.9)	ENSG00000226648 (1.7)	NAA25 (1.4)	GCNT4 (1.3)	LPA (1.3)	ACAD10 (1.2)
GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	0.89	> 0.20	C19orf52 (3.0)	ENSG00000254235 (2.6)	KANK2 (2.1)	TMEM116 (1.9)	ENSG00000235545 (1.7)	ENSG00000226645 (1.6)	TMED4 (1.5)	ZNF180 (1.5)	CILP2 (1.4)	ENSG00000226648 (1.2)
MP:0004324	vestibular hair cell degeneration	0.89	> 0.20	HNF1A (3.6)	AP1M2 (2.5)	TMEM116 (2.2)	CBLC (2.0)	NPC1L1 (1.9)	LPIN3 (1.6)	FRK (1.5)	PBX4 (1.3)	NT5DC1 (1.3)	CETP (1.2)
GO:0000226	microtubule cytoskeleton organization	0.89	> 0.20	POC5 (4.1)	PSRC1 (4.1)	PBX4 (2.6)	DNAH11 (2.1)	POLK (2.0)	USP1 (1.7)	C12orf51 (1.5)	UBXN2B (1.4)	ENSG00000228044 (1.2)	FEN1 (1.2)
GO:0072273	metanephric nephron morphogenesis	0.89	> 0.20	HNF1A (3.3)	ENSG00000238078 (2.1)	C11orf9 (2.0)	TSSK6 (1.9)	PMFBP1 (1.7)	C17orf57 (1.5)	BCAM (1.4)	ABO (1.4)	ENSG00000235545 (1.4)	DYNC2LI1 (1.3)
ENSG00000184304	PRKD1 PPI subnetwork	0.89	> 0.20	SLC44A2 (2.8)	GATAD2A (2.4)	ADAM1 (2.1)	TRIB1 (2.1)	ENSG00000238078 (2.1)	DOCK7 (1.8)	CEACAM19 (1.8)	TMEM50A (1.8)	ZHX3 (1.7)	ENSG00000226648 (1.6)
GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	0.89	> 0.20	ENSG00000254235 (2.5)	KANK2 (2.4)	ENSG00000226645 (2.1)	NYNRIN (2.0)	C19orf52 (1.9)	CARM1 (1.7)	PVRL2 (1.7)	TMED4 (1.5)	SLC44A2 (1.4)	MARK4 (1.4)
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	0.89	> 0.20	CETP (2.9)	TIMD4 (2.3)	MAFB (1.9)	GMIP (1.8)	OASL (1.5)	ITGB3 (1.4)	KIAA1324 (1.3)	APOE (1.3)	ZNF101 (1.3)	HLX (1.3)
ENSG00000134245	WNT2B PPI subnetwork	0.89	> 0.20	CILP2 (5.0)	CELSR2 (2.4)	KIAA1324 (2.3)	LPAR2 (1.9)	DYNC2LI1 (1.8)	TXNL4B (1.8)	ZNF180 (1.8)	AMIGO1 (1.7)	BCAM (1.7)	TRAPPC6A (1.6)
MP:0005114	premature hair loss	0.89	> 0.20	UBXN2B (2.7)	GRINA (2.2)	POLK (1.9)	POC5 (1.8)	PARP10 (1.6)	CBLC (1.6)	DOCK7 (1.6)	USP24 (1.5)	CYB561D1 (1.5)	CEACAM19 (1.3)
ENSG00000154277	UCHL1 PPI subnetwork	0.89	> 0.20	HAPLN4 (2.4)	TRIB1 (2.2)	ENSG00000254235 (2.1)	ZNF101 (1.6)	NCAN (1.5)	PCSK9 (1.4)	PLEKHH2 (1.4)	GRINA (1.3)	CYB561D1 (1.3)	MAU2 (1.2)
GO:0005930	axoneme	0.89	> 0.20	DYNC2LI1 (5.8)	DNAH11 (4.4)	TSSK6 (1.3)	POLK (1.0)	DOCK7 (1.0)	TRAPPC6A (0.9)	PMFBP1 (0.8)	NT5DC1 (0.8)	PLEKHH2 (0.7)	NKPD1 (0.7)
ENSG00000145703	IQGAP2 PPI subnetwork	0.89	> 0.20	TMEM116 (2.3)	SLC44A2 (2.1)	RHCE (1.9)	TMEM50A (1.9)	DNM2 (1.9)	HLX (1.8)	ATP13A1 (1.7)	QTRT1 (1.7)	RHD (1.6)	CILP2 (1.5)
MP:0004029	spontaneous chromosome breakage	0.89	> 0.20	UBXN2B (4.0)	ZNF101 (2.6)	DOCK7 (1.6)	NT5DC1 (1.6)	DHODH (1.5)	SMARCA4 (1.5)	POC5 (1.4)	ACAD10 (1.3)	ENSG00000235545 (1.2)	C12orf51 (1.2)
GO:0001843	neural tube closure	0.89	> 0.20	DYNC2LI1 (3.0)	ATXN7L2 (2.9)	ADAM1 (2.0)	TMEM116 (2.0)	PVRL2 (2.0)	PPP1R37 (1.9)	NYNRIN (1.7)	MARK4 (1.6)	DOCK7 (1.6)	ABO (1.4)
ENSG00000206456	ENSG00000206456 PPI subnetwork	0.89	> 0.20	RPH3A (3.2)	HAPLN4 (3.1)	ALDH2 (2.0)	NCAN (1.8)	CELSR2 (1.6)	FADS2 (1.4)	PTPN11 (1.4)	MOSC1 (1.4)	ENSG00000235545 (1.3)	ENSG00000254235 (1.3)
ENSG00000204655	MOG PPI subnetwork	0.89	> 0.20	RPH3A (3.2)	HAPLN4 (3.1)	ALDH2 (2.0)	NCAN (1.8)	CELSR2 (1.6)	FADS2 (1.4)	PTPN11 (1.4)	MOSC1 (1.4)	ENSG00000235545 (1.3)	ENSG00000254235 (1.3)
ENSG00000137345	MOG PPI subnetwork	0.89	> 0.20	RPH3A (3.2)	HAPLN4 (3.1)	ALDH2 (2.0)	NCAN (1.8)	CELSR2 (1.6)	FADS2 (1.4)	PTPN11 (1.4)	MOSC1 (1.4)	ENSG00000235545 (1.3)	ENSG00000254235 (1.3)
ENSG00000129562	DAD1 PPI subnetwork	0.89	> 0.20	TMED4 (3.1)	ATP13A1 (2.8)	PCSK9 (2.6)	ERP29 (2.0)	AMIGO1 (1.9)	OGDH (1.6)	ENSG00000254235 (1.5)	RHCE (1.5)	TMEM57 (1.3)	NKPD1 (1.3)
MP:0008260	abnormal autophagy	0.89	> 0.20	TRAFD1 (2.9)	ATP13A1 (2.8)	BLOC1S3 (2.5)	ALDH2 (2.3)	MAU2 (2.2)	DNM2 (2.1)	ATXN7L2 (2.1)	C1orf63 (2.0)	BRAP (1.9)	C12orf51 (1.9)
GO:0030501	positive regulation of bone mineralization	0.89	> 0.20	POLK (2.9)	MYLIP (2.6)	TMEM116 (2.4)	PLEKHH2 (2.3)	POC5 (1.7)	AMIGO1 (1.7)	GMPR (1.6)	MAFB (1.6)	BLOC1S3 (1.6)	TMED4 (1.3)
ENSG00000137124	ALDH1B1 PPI subnetwork	0.89	> 0.20	ATP13A1 (2.7)	DHODH (1.8)	OGDH (1.8)	ACAD10 (1.8)	YIPF2 (1.6)	C19orf52 (1.6)	PVRL2 (1.5)	QTRT1 (1.4)	DNM2 (1.4)	ILF3 (1.3)
ENSG00000139546	TARBP2 PPI subnetwork	0.89	> 0.20	USP24 (2.8)	OASL (2.5)	C12orf51 (2.1)	ATXN2 (2.1)	C12orf47 (2.0)	ABO (1.9)	COL4A3BP (1.7)	PTPN11 (1.6)	KANK2 (1.5)	DOCK7 (1.5)
GO:0051972	regulation of telomerase activity	0.89	> 0.20	UBXN2B (3.0)	POLK (2.3)	ATP13A1 (2.1)	GOT2P1 (2.0)	POC5 (1.8)	TXNL4B (1.6)	GEMIN7 (1.5)	C12orf43 (1.5)	C19orf52 (1.4)	BUD13 (1.4)
MP:0005039	hypoxia	0.89	> 0.20	HMGCR (3.9)	LDLR (3.7)	FADS1 (3.0)	SYPL2 (2.9)	FADS2 (2.9)	RHD (2.2)	PVR (2.0)	GMPR (1.8)	CEACAM19 (1.8)	DHODH (1.8)
GO:0051187	cofactor catabolic process	0.89	> 0.20	ACAD10 (4.3)	OGDH (3.7)	ENSG00000226648 (2.6)	GMPR (2.4)	TMEM116 (2.3)	PMFBP1 (1.9)	HAPLN4 (1.5)	ENSG00000238078 (1.4)	ENSG00000235545 (1.4)	C1orf63 (1.4)
GO:0006911	phagocytosis, engulfment	0.89	> 0.20	HAVCR1 (3.2)	MAFB (2.5)	ZNF101 (2.1)	C17orf57 (2.0)	TMEM116 (1.9)	CILP2 (1.6)	ANKRD31 (1.4)	MYLIP (1.4)	APOE (1.3)	ENSG00000254235 (1.2)
GO:0002694	regulation of leukocyte activation	0.89	> 0.20	ZNF101 (3.9)	PLCG1 (2.7)	PBX4 (2.6)	TIMD4 (2.4)	CETP (1.8)	GMIP (1.8)	DNAH11 (1.4)	POLK (1.3)	RELB (1.2)	SH2B3 (1.2)
MP:0004448	abnormal presphenoid bone morphology	0.89	> 0.20	KANK2 (2.0)	ZHX3 (1.8)	TMEM50A (1.7)	TRIB1 (1.6)	ENSG00000235545 (1.6)	NYNRIN (1.5)	CEACAM19 (1.3)	PVR (1.2)	NKPD1 (1.2)	MAFB (1.1)
ENSG00000196501	ENSG00000196501 PPI subnetwork	0.89	> 0.20	SMARCA4 (2.8)	BUD13 (2.5)	ILF3 (2.3)	USP1 (2.3)	SUGP1 (1.6)	GMPR (1.6)	ATXN2 (1.6)	DDX56 (1.5)	TMEM57 (1.4)	FEN1 (1.3)
GO:0032970	regulation of actin filament-based process	0.89	> 0.20	C17orf57 (2.4)	ABO (2.3)	PLEC (2.1)	C11orf9 (2.0)	NYNRIN (1.7)	PBX4 (1.6)	ADAM1 (1.5)	CBLC (1.5)	DOCK7 (1.3)	ZNF101 (1.3)
ENSG00000166266	CUL5 PPI subnetwork	0.89	> 0.20	ATXN7L2 (2.7)	ENSG00000226648 (2.6)	ENSG00000226645 (2.5)	GRINA (2.1)	TXNL4B (2.0)	ST3GAL4 (1.6)	BUD13 (1.6)	NKPD1 (1.5)	MARK4 (1.5)	C19orf52 (1.5)
MP:0002199	abnormal brain commissure morphology	0.89	> 0.20	NCAN (3.6)	PSRC1 (2.0)	PLCG1 (2.0)	PPP1R37 (1.9)	CELSR2 (1.8)	ZHX3 (1.7)	CLPTM1 (1.5)	DYNC2LI1 (1.3)	FADS2 (1.2)	NKPD1 (1.2)
GO:0030118	clathrin coat	0.89	> 0.20	CLPTM1 (3.1)	PPP1R37 (2.5)	GRINA (2.5)	C1orf63 (2.4)	DNM2 (2.4)	YIPF2 (2.3)	ZNF101 (1.9)	SARS (1.9)	OGDH (1.8)	C12orf51 (1.8)
GO:0021885	forebrain cell migration	0.89	> 0.20	ATXN7L2 (2.4)	ENSG00000254235 (2.2)	TSSK6 (2.1)	ENSG00000235545 (1.9)	TMEM116 (1.9)	PBX4 (1.8)	TMED4 (1.8)	C19orf52 (1.6)	NCAN (1.6)	CELSR2 (1.5)
GO:0035239	tube morphogenesis	0.89	> 0.20	PVRL2 (3.1)	BCAM (2.4)	PLEKHH2 (2.2)	MYLIP (2.1)	NYNRIN (2.1)	AP1M2 (2.0)	KANK2 (1.9)	PPP1R37 (1.8)	DYNC2LI1 (1.8)	ENSG00000254235 (1.6)
ENSG00000101158	TH1L PPI subnetwork	0.89	> 0.20	TRAPPC6A (3.5)	PSMA5 (3.1)	DHX38 (3.0)	SUGP1 (2.7)	TOMM40 (2.3)	CLPTM1 (2.3)	TXNL4B (2.1)	DNM2 (1.9)	MARK4 (1.9)	ZNF259 (1.8)
ENSG00000161542	PRPSAP1 PPI subnetwork	0.89	> 0.20	ENSG00000228044 (2.8)	POC5 (2.3)	TRAPPC6A (2.3)	NT5DC1 (2.0)	SYPL2 (1.8)	UBXN2B (1.8)	SARS (1.7)	TMEM50A (1.6)	C19orf52 (1.5)	LPAR2 (1.4)
REACTOME_REGULATION_OF_INSULIN_SECRETION	REACTOME_REGULATION_OF_INSULIN_SECRETION	0.89	> 0.20	KIAA1324 (4.4)	TMEM50A (2.3)	HAPLN4 (2.1)	ITGB3 (1.8)	HLX (1.7)	NPC1L1 (1.7)	MARK4 (1.7)	COL4A3BP (1.6)	ST3GAL4 (1.6)	ENSG00000238078 (1.6)
ENSG00000198918	RPL39 PPI subnetwork	0.89	> 0.20	NKPD1 (3.2)	UBXN2B (1.7)	ANKRD31 (1.6)	DNAH11 (1.6)	MOSC1 (1.5)	ZNF101 (1.4)	CEACAM19 (1.4)	ATXN7L2 (1.3)	LPAR2 (1.2)	PLEKHH2 (1.1)
MP:0008271	abnormal bone ossification	0.89	> 0.20	CILP2 (3.6)	MAFB (3.5)	MYLIP (2.6)	ALDH2 (2.5)	OASL (1.6)	PLEC (1.5)	KIAA1324 (1.3)	ENSG00000226648 (1.3)	LDLR (1.2)	C12orf47 (1.1)
ENSG00000140416	TPM1 PPI subnetwork	0.89	> 0.20	SYPL2 (2.7)	KANK2 (2.5)	ADAM1 (2.2)	TMEM50A (1.9)	GMPR (1.8)	UBXN2B (1.7)	CEACAM19 (1.5)	NPC1L1 (1.4)	PVRL2 (1.3)	ITGB3 (1.3)
MP:0008214	increased immature B cell number	0.89	> 0.20	RELB (2.4)	ZNF101 (2.3)	PBX4 (2.0)	GMIP (1.9)	MYLIP (1.8)	POLK (1.8)	CETP (1.5)	ERP29 (1.4)	TMEM116 (1.4)	COL4A3BP (1.3)
GO:0014014	negative regulation of gliogenesis	0.89	> 0.20	NCAN (3.7)	NYNRIN (2.3)	BLOC1S3 (2.2)	PBX4 (1.9)	PPP1R37 (1.7)	LPAR2 (1.7)	ENSG00000254235 (1.6)	MAPKAPK5 (1.4)	ENSG00000235545 (1.3)	ANKRD31 (1.2)
GO:0055117	regulation of cardiac muscle contraction	0.89	> 0.20	ENSG00000238078 (1.8)	KANK2 (1.7)	ANKRD31 (1.5)	GCNT4 (1.4)	PLEKHH2 (1.4)	ENSG00000254235 (1.4)	C12orf51 (1.4)	HAVCR1 (1.4)	ALDH2 (1.3)	HAPLN4 (1.3)
ENSG00000140262	TCF12 PPI subnetwork	0.89	> 0.20	HLX (3.3)	ATXN2 (2.0)	KANK2 (1.8)	MYLIP (1.7)	ENSG00000238078 (1.6)	NCAN (1.6)	C12orf51 (1.5)	RHCE (1.4)	RHD (1.2)	USP24 (1.2)
MP:0004768	abnormal axonal transport	0.89	> 0.20	DOCK7 (3.1)	USP24 (3.0)	C12orf51 (2.9)	PTPN11 (2.7)	OGDH (2.5)	PLEC (1.9)	DHX38 (1.9)	TXNL4B (1.7)	ZNF180 (1.7)	SUGP1 (1.6)
ENSG00000140553	UNC45A PPI subnetwork	0.89	> 0.20	POLK (3.3)	GRINA (2.4)	HLX (1.8)	GMPR (1.8)	GEMIN7 (1.5)	QTRT1 (1.4)	BCAM (1.4)	HNF1A (1.3)	PPP1R37 (1.3)	PSRC1 (1.1)
GO:0007517	muscle organ development	0.89	> 0.20	SYPL2 (5.6)	ATXN7L2 (2.4)	GMPR (2.3)	KANK2 (2.1)	SLC44A2 (1.5)	ENSG00000238078 (1.5)	PLEC (1.5)	PLEKHH2 (1.3)	BCAM (1.3)	ENSG00000226648 (1.1)
ENSG00000117153	KLHL12 PPI subnetwork	0.89	> 0.20	USP24 (2.8)	BUD13 (2.1)	TMEM57 (2.1)	C1orf63 (2.1)	COL4A3BP (2.0)	GRINA (2.0)	DHX38 (1.9)	CARM1 (1.8)	MAU2 (1.5)	ZHX3 (1.4)
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	0.89	> 0.20	FEN1 (6.0)	USP1 (4.0)	RHD (1.8)	PSRC1 (1.6)	NT5DC1 (1.5)	AMIGO1 (1.3)	CILP2 (1.3)	MAU2 (1.2)	POC5 (1.1)	GOT2P1 (1.1)
MP:0003830	abnormal testis development	0.89	> 0.20	RHCE (2.0)	ENSG00000226648 (2.0)	RHD (2.0)	ST3GAL4 (1.8)	GPAM (1.8)	AMIGO1 (1.8)	LPIN3 (1.7)	LPAR2 (1.6)	ABO (1.5)	TMEM116 (1.5)
ENSG00000050405	LIMA1 PPI subnetwork	0.89	> 0.20	KANK2 (2.8)	PLEC (2.5)	AP1M2 (2.3)	TMEM50A (2.2)	SLC44A2 (1.9)	LPAR2 (1.8)	ITGB3 (1.6)	PLCG1 (1.6)	FRK (1.6)	PVR (1.6)
GO:0016881	acid-amino acid ligase activity	0.89	> 0.20	BRAP (3.7)	TRAFD1 (3.2)	ATXN2 (2.9)	C12orf51 (2.6)	C19orf52 (2.4)	USP24 (2.3)	MAU2 (1.9)	COL4A3BP (1.8)	TMEM57 (1.7)	PARP10 (1.6)
GO:0004835	tubulin-tyrosine ligase activity	0.89	> 0.20	DNAH11 (3.8)	CYB561D1 (2.0)	PMFBP1 (1.7)	ENSG00000228044 (1.6)	ADAM1 (1.6)	ENSG00000235545 (1.5)	ATXN7L2 (1.5)	POLK (1.5)	C11orf9 (1.4)	ST3GAL4 (1.3)
ENSG00000213782	DDX47 PPI subnetwork	0.89	> 0.20	MAU2 (2.6)	TMEM57 (2.5)	ATP13A1 (2.2)	TOP1 (2.1)	ABCG8 (2.0)	TMEM116 (2.0)	YIPF2 (1.9)	DDX56 (1.8)	SUGP1 (1.8)	MARK4 (1.7)
MP:0006254	thin cerebral cortex	0.89	> 0.20	TMED4 (3.2)	DOCK7 (2.8)	UBXN2B (2.3)	DYNC2LI1 (2.3)	NCAN (1.7)	ENSG00000228044 (1.7)	CEACAM19 (1.7)	TXNL4B (1.6)	CELSR2 (1.6)	ENSG00000226648 (1.3)
ENSG00000124172	ATP5E PPI subnetwork	0.89	> 0.20	OGDH (4.7)	PSMA5 (3.5)	C12orf47 (3.2)	ACAD10 (3.0)	TOMM40 (2.2)	GOT2P1 (2.0)	CLPTM1 (1.9)	ERP29 (1.6)	TMEM116 (1.6)	ZNF180 (1.5)
ENSG00000087274	ADD1 PPI subnetwork	0.89	> 0.20	C12orf51 (2.7)	UBXN2B (2.6)	RPH3A (2.5)	NCAN (2.4)	TMEM50A (2.2)	ZNF180 (2.1)	GOT2P1 (2.0)	CELSR2 (1.8)	C12orf43 (1.6)	SLC44A2 (1.5)
GO:0010765	positive regulation of sodium ion transport	0.89	> 0.20	AP1M2 (2.6)	ZNF180 (2.3)	CYB561D1 (2.1)	TMEM116 (1.8)	SLC44A2 (1.6)	NT5DC1 (1.5)	AMIGO1 (1.4)	CBLC (1.4)	SORT1 (1.3)	BLOC1S3 (1.3)
GO:0034067	protein localization in Golgi apparatus	0.89	> 0.20	FRK (2.5)	ZNF180 (2.0)	BRAP (1.7)	USP24 (1.6)	MAU2 (1.5)	YIPF2 (1.5)	TMEM116 (1.5)	ANKRD31 (1.5)	CYB561D1 (1.4)	BLOC1S3 (1.4)
GO:0016655	oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor	0.89	> 0.20	OGDH (3.5)	ACAD10 (3.2)	TRAPPC6A (2.7)	C12orf47 (2.6)	PSMA5 (1.8)	GOT2P1 (1.7)	FRK (1.7)	MAU2 (1.6)	GMPR (1.3)	ALDH2 (1.3)
GO:0021879	forebrain neuron differentiation	0.89	> 0.20	C17orf57 (2.9)	DNAH11 (2.7)	C12orf47 (2.3)	PBX4 (2.0)	C19orf52 (1.9)	ANKRD31 (1.9)	KIAA1324 (1.6)	TMEM116 (1.3)	POLK (1.3)	ENSG00000238078 (1.2)
ENSG00000183856	IQGAP3 PPI subnetwork	0.89	> 0.20	TMEM50A (2.7)	DHODH (1.9)	SLC44A2 (1.9)	PPP1R37 (1.7)	ILF3 (1.7)	TRAFD1 (1.6)	TXNL4B (1.6)	DOCK7 (1.5)	TOMM40 (1.5)	CLPTM1 (1.4)
GO:0072074	kidney mesenchyme development	0.89	> 0.20	C11orf9 (2.4)	BLOC1S3 (2.4)	BCAM (2.2)	NYNRIN (1.9)	PLEKHH2 (1.9)	TMED4 (1.7)	NKPD1 (1.7)	GMPR (1.5)	AP1M2 (1.5)	PPP1R37 (1.4)
GO:0031594	neuromuscular junction	0.89	> 0.20	SYPL2 (3.7)	PLCG1 (2.7)	ANKRD31 (2.0)	RPH3A (1.9)	AMIGO1 (1.9)	PBX4 (1.7)	PLEKHH2 (1.7)	GMPR (1.6)	KANK2 (1.5)	LPIN3 (1.4)
GO:0005840	ribosome	0.89	> 0.20	GEMIN7 (4.1)	TOMM40 (2.3)	C12orf43 (2.1)	DHODH (1.8)	PSMA5 (1.5)	DDX56 (1.5)	ZNF259 (1.5)	C19orf52 (1.4)	QTRT1 (1.4)	TRAPPC6A (1.3)
GO:0033209	tumor necrosis factor-mediated signaling pathway	0.89	> 0.20	CYB561D1 (3.2)	ZNF180 (1.9)	TRAFD1 (1.6)	LPIN3 (1.5)	TRAPPC6A (1.4)	SH2B3 (1.4)	PARP10 (1.3)	GEMIN7 (1.3)	GMIP (1.3)	RELB (1.3)
MP:0003827	abnormal Wolffian duct morphology	0.89	> 0.20	PVRL2 (2.2)	AP1M2 (2.2)	NYNRIN (1.9)	CYP7A1 (1.8)	PLCG1 (1.6)	POLK (1.4)	PLEKHH2 (1.3)	KANK2 (1.3)	SLC22A1 (1.3)	C11orf9 (1.2)
ENSG00000181610	MRPS23 PPI subnetwork	0.89	> 0.20	C12orf43 (2.6)	ILF3 (2.5)	ERP29 (2.3)	MAPKAPK5 (2.3)	C12orf47 (2.3)	NAA25 (2.2)	ACAD10 (2.1)	NT5DC1 (2.0)	NKPD1 (1.6)	C19orf52 (1.6)
GO:0043555	regulation of translation in response to stress	0.89	> 0.20	RHCE (3.0)	DDX56 (2.9)	BRAP (2.7)	C12orf43 (2.6)	MAPKAPK5 (2.3)	TMEM57 (2.3)	NAA25 (2.2)	C12orf51 (2.1)	ZNF259 (2.0)	QTRT1 (1.7)
GO:0015807	L-amino acid transport	0.89	> 0.20	ABCG8 (2.7)	NPC1L1 (2.5)	HAPLN4 (2.2)	TM6SF2 (1.9)	PMFBP1 (1.9)	NCAN (1.9)	SARS (1.9)	DNAH11 (1.8)	ERP29 (1.7)	ABCG5 (1.7)
GO:0031233	intrinsic to external side of plasma membrane	0.89	> 0.20	ST3GAL4 (2.4)	TMED4 (1.9)	PVRL2 (1.9)	CEACAM19 (1.8)	NYNRIN (1.8)	AP1M2 (1.8)	FRK (1.8)	ZHX3 (1.6)	RPH3A (1.6)	BCAM (1.6)
MP:0001823	thymus hypoplasia	0.89	> 0.20	PLCG1 (4.6)	ZNF101 (4.0)	GMIP (2.4)	SMARCA4 (2.1)	TOP1 (2.0)	HAVCR1 (1.8)	UBXN2B (1.4)	MAFB (1.3)	SLC44A2 (1.2)	DNM2 (1.2)
ENSG00000161405	IKZF3 PPI subnetwork	0.89	> 0.20	CARM1 (2.8)	PPP1R37 (2.4)	PVRL2 (2.3)	GATAD2A (2.1)	MARK4 (2.1)	ADAM1 (1.9)	ZNF180 (1.8)	CELSR2 (1.7)	MAU2 (1.7)	PLCG1 (1.6)
ENSG00000106144	CASP2 PPI subnetwork	0.89	> 0.20	TRAFD1 (3.1)	ST3GAL4 (2.4)	C12orf51 (2.3)	HLX (1.9)	PTPN11 (1.8)	BLOC1S3 (1.7)	POLK (1.6)	FRK (1.6)	MARK4 (1.5)	BRAP (1.4)
GO:0050684	regulation of mRNA processing	0.89	> 0.20	C1orf63 (3.3)	TOP1 (2.7)	C17orf57 (2.2)	MAU2 (2.1)	POLK (2.0)	BUD13 (2.0)	ATXN2 (1.9)	TRIB1 (1.9)	ADAM1 (1.8)	ENSG00000226645 (1.6)
GO:0019717	synaptosome	0.89	> 0.20	RPH3A (4.2)	NCAN (2.7)	CELSR2 (2.5)	HAPLN4 (2.5)	ABCG8 (2.1)	AMIGO1 (2.0)	APOE (1.8)	ABCG5 (1.8)	C12orf43 (1.7)	C12orf51 (1.6)
ENSG00000168036	CTNNB1 PPI subnetwork	0.89	> 0.20	GATAD2A (2.8)	PLCG1 (2.8)	PLEC (2.6)	MARK4 (2.6)	CARM1 (2.4)	SMARCA4 (2.3)	CELSR2 (2.2)	C11orf9 (2.1)	PVRL2 (2.0)	DOCK7 (1.8)
MP:0005352	small cranium	0.89	> 0.20	CILP2 (2.4)	KANK2 (2.3)	MYLIP (2.0)	HAPLN4 (1.8)	FRK (1.7)	FADS2 (1.7)	FADS1 (1.5)	TMEM116 (1.3)	PPP1R37 (1.3)	APOE (1.3)
GO:2000027	regulation of organ morphogenesis	0.89	> 0.20	ENSG00000238078 (2.7)	BCAM (2.4)	PLEKHH2 (2.2)	MYLIP (2.0)	TSSK6 (1.8)	NYNRIN (1.7)	PLCG1 (1.7)	AP1M2 (1.7)	DYNC2LI1 (1.6)	ATXN7L2 (1.6)
GO:0071453	cellular response to oxygen levels	0.89	> 0.20	DNAH11 (3.0)	POLK (2.3)	C17orf57 (2.3)	ADAM1 (1.9)	SARS (1.4)	CEACAM19 (1.3)	PVR (1.3)	LPIN3 (1.3)	CILP2 (1.2)	TOP1 (1.2)
GO:0035050	embryonic heart tube development	0.89	> 0.20	LPIN3 (3.4)	DYNC2LI1 (2.3)	PVRL2 (2.1)	C17orf57 (1.8)	NYNRIN (1.6)	TSSK6 (1.5)	ENSG00000226648 (1.5)	CEACAM19 (1.4)	BCAM (1.4)	CYB561D1 (1.3)
ENSG00000163939	PBRM1 PPI subnetwork	0.89	> 0.20	BUD13 (2.4)	SMARCA4 (2.2)	GMPR (2.0)	ZNF180 (1.8)	DOCK7 (1.6)	TMEM57 (1.5)	TOP1 (1.5)	ILF3 (1.3)	KIAA1324 (1.2)	ZNF259 (1.0)
ENSG00000132773	TOE1 PPI subnetwork	0.89	> 0.20	C11orf9 (2.7)	PPP1R37 (2.7)	C1orf63 (2.1)	ADAM1 (2.0)	SUGP1 (2.0)	CEACAM19 (1.9)	C12orf43 (1.8)	DNM2 (1.8)	MARK4 (1.7)	LPAR2 (1.6)
GO:0070997	neuron death	0.89	> 0.20	GOT2P1 (3.0)	TSSK6 (2.9)	PPP1R37 (2.0)	FRK (1.7)	LPIN3 (1.5)	GRINA (1.5)	CELSR2 (1.3)	BLOC1S3 (1.3)	MYLIP (1.3)	DNAH11 (1.3)
GO:0051220	cytoplasmic sequestering of protein	0.89	> 0.20	ZNF101 (2.2)	ENSG00000238078 (2.0)	PBX4 (1.9)	ABO (1.7)	FRK (1.7)	ADAM1 (1.5)	LPAR2 (1.5)	ATXN7L2 (1.5)	RELB (1.3)	NT5DC1 (1.3)
GO:0031253	cell projection membrane	0.89	> 0.20	AP1M2 (3.7)	SLC44A2 (3.0)	TMEM116 (2.9)	NCAN (2.7)	PVR (2.5)	CELSR2 (2.3)	DOCK7 (2.3)	SORT1 (2.0)	DYNC2LI1 (1.7)	PLEKHH2 (1.7)
REACTOME_TCR_SIGNALING	REACTOME_TCR_SIGNALING	0.89	> 0.20	ZNF101 (3.0)	PLCG1 (3.0)	GMIP (2.8)	RELB (2.6)	HAVCR1 (1.9)	PBX4 (1.9)	APOC1 (1.7)	APOE (1.7)	SH2B3 (1.5)	MAFB (1.5)
GO:0010595	positive regulation of endothelial cell migration	0.89	> 0.20	PVR (3.1)	ENSG00000226645 (3.0)	ITGB3 (2.1)	TMED4 (2.0)	SLC44A2 (1.6)	GMPR (1.5)	PLCG1 (1.5)	ENSG00000228044 (1.5)	HLX (1.4)	LPIN3 (1.3)
GO:0051250	negative regulation of lymphocyte activation	0.89	> 0.20	PBX4 (2.2)	ZNF101 (2.1)	GCNT4 (1.5)	DNAH11 (1.4)	TRAFD1 (1.3)	ENSG00000235545 (1.3)	ANKRD31 (1.3)	TIMD4 (1.1)	CEACAM19 (1.1)	PLCG1 (1.1)
ENSG00000104738	MCM4 PPI subnetwork	0.89	> 0.20	FEN1 (6.2)	USP1 (5.0)	ENSG00000235545 (2.4)	NT5DC1 (1.4)	PSRC1 (1.4)	TXNL4B (1.3)	HAPLN4 (1.3)	ENSG00000228044 (1.2)	NCAN (1.2)	TMEM116 (1.2)
GO:0032956	regulation of actin cytoskeleton organization	0.89	> 0.20	C17orf57 (2.5)	ABO (2.1)	C11orf9 (2.0)	PLEC (1.9)	NYNRIN (1.8)	ADAM1 (1.7)	CBLC (1.6)	DOCK7 (1.5)	PBX4 (1.5)	ITGB3 (1.4)
MP:0000433	microcephaly	0.89	> 0.20	C17orf57 (2.3)	PSRC1 (2.0)	HAVCR1 (1.7)	USP24 (1.7)	TRIB1 (1.5)	OASL (1.4)	PMFBP1 (1.3)	ATXN2 (1.3)	USP1 (1.3)	GEMIN7 (1.3)
REACTOME_RAP1_SIGNALLING	REACTOME_RAP1_SIGNALLING	0.89	> 0.20	SLC44A2 (3.2)	SH2B3 (3.0)	CYB561D1 (2.0)	GMIP (1.7)	DNM2 (1.7)	AP1M2 (1.7)	GATAD2A (1.5)	ST3GAL4 (1.4)	TOP1 (1.4)	OGDH (1.4)
GO:0042753	positive regulation of circadian rhythm	0.89	> 0.20	HNF1A (2.5)	PPP1R37 (2.1)	ENSG00000228044 (1.9)	ENSG00000226648 (1.7)	CILP2 (1.5)	LPIN3 (1.4)	C12orf47 (1.4)	TMEM116 (1.3)	CLPTM1 (1.3)	KIAA1324 (1.3)
ENSG00000156052	GNAQ PPI subnetwork	0.89	> 0.20	HLX (3.2)	ABO (2.3)	RPH3A (2.1)	KANK2 (2.0)	MYLIP (1.9)	C12orf47 (1.9)	DNAH11 (1.8)	ITGB3 (1.7)	AMIGO1 (1.7)	PLEKHH2 (1.6)
GO:0006336	DNA replication-independent nucleosome assembly	0.89	> 0.20	PSRC1 (2.9)	POC5 (2.8)	TXNL4B (2.6)	NKPD1 (2.0)	DYNC2LI1 (1.9)	USP1 (1.8)	ZNF180 (1.6)	ENSG00000226648 (1.5)	TRAPPC6A (1.5)	TMEM116 (1.4)
GO:0034080	CenH3-containing nucleosome assembly at centromere	0.89	> 0.20	PSRC1 (2.9)	POC5 (2.8)	TXNL4B (2.6)	NKPD1 (2.0)	DYNC2LI1 (1.9)	USP1 (1.8)	ZNF180 (1.6)	ENSG00000226648 (1.5)	TRAPPC6A (1.5)	TMEM116 (1.4)
GO:0034724	DNA replication-independent nucleosome organization	0.89	> 0.20	PSRC1 (2.9)	POC5 (2.8)	TXNL4B (2.6)	NKPD1 (2.0)	DYNC2LI1 (1.9)	USP1 (1.8)	ZNF180 (1.6)	ENSG00000226648 (1.5)	TRAPPC6A (1.5)	TMEM116 (1.4)
MP:0004144	hypotonia	0.89	> 0.20	NCAN (4.2)	ALDH2 (2.0)	GMPR (1.8)	ENSG00000228044 (1.7)	TSSK6 (1.6)	ERP29 (1.5)	ABCG8 (1.4)	APOE (1.3)	FADS2 (1.3)	C11orf9 (1.3)
ENSG00000104290	FZD3 PPI subnetwork	0.89	> 0.20	CBLC (3.4)	BCAM (3.3)	C11orf9 (2.3)	TSSK6 (2.1)	NYNRIN (2.0)	AMIGO1 (1.7)	ABO (1.7)	CILP2 (1.5)	YIPF2 (1.5)	PVRL2 (1.5)
GO:0035240	dopamine binding	0.89	> 0.20	ST3GAL4 (3.2)	BLOC1S3 (2.7)	C12orf47 (2.5)	GMPR (2.2)	DNAH11 (2.1)	AMIGO1 (1.8)	NKPD1 (1.8)	ALDH2 (1.5)	ENSG00000235545 (1.4)	COL4A3BP (1.4)
ENSG00000136531	SCN2A PPI subnetwork	0.89	> 0.20	ALDH2 (2.4)	HNF1A (2.3)	USP24 (2.1)	RPH3A (1.9)	AMIGO1 (1.9)	SYPL2 (1.9)	AP1M2 (1.8)	SORT1 (1.8)	CEACAM19 (1.7)	NKPD1 (1.5)
ENSG00000137713	PPP2R1B PPI subnetwork	0.89	> 0.20	COL4A3BP (3.4)	MARK4 (1.9)	GOT2P1 (1.8)	DNM2 (1.7)	NT5DC1 (1.7)	OGDH (1.7)	TMEM50A (1.6)	SARS (1.5)	CLPTM1 (1.4)	ALDH2 (1.4)
MP:0009435	abnormal miniature inhibitory postsynaptic currents	0.89	> 0.20	RPH3A (3.0)	ABO (3.0)	PPP1R37 (2.6)	GCNT4 (2.4)	KIAA1324 (2.1)	CLPTM1 (1.8)	CARM1 (1.7)	ENSG00000228044 (1.6)	ALDH2 (1.5)	GRINA (1.4)
ENSG00000091436	ENSG00000091436 PPI subnetwork	0.89	> 0.20	USP24 (2.7)	SORT1 (2.6)	C12orf51 (2.4)	ZNF180 (2.1)	UBXN2B (2.0)	MAU2 (2.0)	PTPN11 (1.9)	BUD13 (1.7)	LPAR2 (1.7)	MARK4 (1.6)
GO:0001556	oocyte maturation	0.89	> 0.20	PLEKHH2 (2.3)	PSRC1 (2.0)	ENSG00000228044 (1.6)	HNF1A (1.6)	ABO (1.6)	NKPD1 (1.5)	TMEM116 (1.4)	RHCE (1.4)	PBX4 (1.3)	GOT2P1 (1.3)
MP:0003964	abnormal noradrenaline level	0.89	> 0.20	DNAH11 (2.2)	KIAA1324 (2.1)	AMIGO1 (1.9)	COL4A3BP (1.7)	POLK (1.7)	ADAM1 (1.7)	GPAM (1.3)	HAPLN4 (1.3)	HNF1A (1.1)	ZHX3 (1.1)
REACTOME_KINESINS	REACTOME_KINESINS	0.90	> 0.20	PSRC1 (6.2)	POC5 (3.0)	FEN1 (2.4)	USP1 (1.9)	ENSG00000226645 (1.5)	PBX4 (1.5)	DYNC2LI1 (1.3)	HAPLN4 (1.3)	COL4A3BP (1.2)	AP1M2 (1.2)
ENSG00000067704	IARS2 PPI subnetwork	0.90	> 0.20	SARS (5.1)	DHX38 (2.7)	SUGP1 (2.6)	HAPLN4 (2.2)	C12orf47 (2.2)	ERP29 (2.1)	ATXN2 (1.8)	PLEC (1.5)	SMARCA4 (1.3)	ENSG00000235545 (1.3)
MP:0010404	ostium primum atrial septal defect	0.90	> 0.20	PVR (2.7)	NYNRIN (2.6)	CILP2 (2.4)	PLEKHH2 (1.8)	KANK2 (1.6)	SYPL2 (1.6)	PBX4 (1.5)	C11orf9 (1.4)	RPH3A (1.4)	TRIB1 (1.4)
ENSG00000089818	NECAP1 PPI subnetwork	0.90	> 0.20	USP24 (3.5)	HNF1A (3.3)	MAFB (2.6)	GRINA (2.5)	DHX38 (1.7)	TOP1 (1.6)	HAVCR1 (1.5)	MARK4 (1.3)	TIMD4 (1.3)	PLEKHH2 (1.2)
GO:0051261	protein depolymerization	0.90	> 0.20	TSSK6 (2.4)	RHD (2.3)	RHCE (2.2)	SLC44A2 (2.1)	PMFBP1 (2.1)	ENSG00000238078 (1.9)	C17orf57 (1.8)	ADAM1 (1.6)	C12orf51 (1.6)	TMEM57 (1.6)
ENSG00000120008	WDR11 PPI subnetwork	0.90	> 0.20	USP24 (4.5)	COL4A3BP (2.8)	GRINA (2.2)	CARM1 (1.9)	C12orf51 (1.9)	DOCK7 (1.7)	DHX38 (1.5)	MAU2 (1.4)	ZHX3 (1.4)	ATXN2 (1.4)
MP:0005092	decreased double-positive T cell number	0.90	> 0.20	RELB (3.7)	PLCG1 (3.6)	PBX4 (3.2)	ZNF101 (3.1)	GMIP (3.0)	SMARCA4 (1.6)	MAFB (1.4)	TIMD4 (1.4)	TOP1 (1.3)	GRINA (1.2)
ENSG00000184672	RALYL PPI subnetwork	0.90	> 0.20	ATXN7L2 (3.0)	TOMM40 (2.5)	BRAP (2.5)	BLOC1S3 (1.9)	TRAFD1 (1.9)	BUD13 (1.7)	GRINA (1.7)	DNAH11 (1.6)	C19orf52 (1.5)	ERP29 (1.5)
ENSG00000137825	ITPKA PPI subnetwork	0.90	> 0.20	NCAN (2.5)	SORT1 (2.3)	RPH3A (2.1)	MARK4 (1.9)	ITGB3 (1.8)	GOT2P1 (1.7)	CELSR2 (1.7)	SYPL2 (1.6)	TRAFD1 (1.3)	CLPTM1 (1.3)
GO:0048232	male gamete generation	0.90	> 0.20	TSSK6 (5.4)	PMFBP1 (3.6)	ENSG00000228044 (1.5)	PBX4 (1.5)	DYNC2LI1 (1.2)	MARK4 (1.1)	PLEKHH2 (0.9)	CILP2 (0.9)	TMEM116 (0.9)	BRAP (0.8)
GO:0007283	spermatogenesis	0.90	> 0.20	TSSK6 (5.4)	PMFBP1 (3.6)	ENSG00000228044 (1.5)	PBX4 (1.5)	DYNC2LI1 (1.2)	MARK4 (1.1)	PLEKHH2 (0.9)	CILP2 (0.9)	TMEM116 (0.9)	BRAP (0.8)
MP:0003119	abnormal digestive system development	0.90	> 0.20	NYNRIN (2.1)	C11orf9 (2.0)	MARK4 (2.0)	HAPLN4 (1.8)	LPA (1.8)	CILP2 (1.3)	DOCK7 (1.3)	MYLIP (1.2)	CETP (1.2)	ALDH2 (1.2)
MP:0005193	abnormal anterior eye segment morphology	0.90	> 0.20	CILP2 (2.4)	ABO (1.9)	NYNRIN (1.8)	C11orf9 (1.6)	TMEM116 (1.3)	PVRL2 (1.3)	HAVCR1 (1.1)	SYPL2 (1.1)	LPAR2 (1.1)	ST3GAL4 (1.1)
ENSG00000087263	OGFOD1 PPI subnetwork	0.90	> 0.20	TOP1 (3.3)	DHODH (2.4)	POC5 (2.4)	CARM1 (2.2)	TXNL4B (2.1)	TMEM57 (2.0)	DDX56 (1.8)	BRAP (1.8)	ANKRD31 (1.8)	DHX38 (1.6)
GO:0010591	regulation of lamellipodium assembly	0.90	> 0.20	ENSG00000238078 (3.6)	ANKRD31 (3.0)	PBX4 (2.3)	LPIN3 (2.0)	TMEM50A (2.0)	DOCK7 (1.9)	ST3GAL4 (1.8)	ACAD10 (1.8)	PMFBP1 (1.3)	USP24 (1.3)
GO:0051647	nucleus localization	0.90	> 0.20	C17orf57 (3.0)	DNAH11 (2.4)	USP24 (2.1)	PBX4 (1.6)	DOCK7 (1.6)	ANKRD31 (1.5)	TSSK6 (1.4)	KANK2 (1.4)	ZHX3 (1.3)	C12orf51 (1.3)
GO:0072207	metanephric epithelium development	0.90	> 0.20	HAVCR1 (3.1)	DYNC2LI1 (2.2)	CELSR2 (1.8)	NCAN (1.7)	BCAM (1.7)	CILP2 (1.5)	ENSG00000254235 (1.2)	PMFBP1 (1.2)	TMEM116 (1.2)	CYB561D1 (1.1)
MP:0008071	absent B cells	0.90	> 0.20	GMIP (3.4)	SMARCA4 (2.7)	ZNF101 (2.3)	DOCK7 (2.1)	UBXN2B (1.7)	BCL3 (1.5)	CARM1 (1.5)	SLC44A2 (1.4)	ENSG00000235545 (1.4)	RELB (1.4)
GO:0045214	sarcomere organization	0.90	> 0.20	HNF1A (3.1)	CEACAM19 (2.1)	TSSK6 (1.9)	ENSG00000226648 (1.8)	SYPL2 (1.8)	ENSG00000254235 (1.7)	TMEM50A (1.6)	BLOC1S3 (1.4)	ANKRD31 (1.1)	GMPR (1.1)
MP:0003209	abnormal pulmonary elastic fiber morphology	0.90	> 0.20	KANK2 (3.3)	PLEKHH2 (3.2)	BCAM (2.2)	CLPTM1 (1.8)	KIAA1324 (1.7)	ITGB3 (1.7)	ENSG00000238078 (1.6)	SORT1 (1.6)	BLOC1S3 (1.5)	PVRL2 (1.5)
GO:0034502	protein localization to chromosome	0.90	> 0.20	PSRC1 (2.7)	DHX38 (2.2)	POC5 (2.1)	TXNL4B (2.1)	ANKRD31 (2.1)	BUD13 (2.1)	NKPD1 (1.9)	PBX4 (1.9)	ENSG00000228044 (1.9)	MAU2 (1.7)
ENSG00000164930	FZD6 PPI subnetwork	0.90	> 0.20	BCAM (3.2)	CBLC (2.8)	C11orf9 (2.5)	CILP2 (1.8)	TSSK6 (1.7)	NYNRIN (1.7)	AMIGO1 (1.6)	ABO (1.5)	YIPF2 (1.3)	ATXN7L2 (1.2)
ENSG00000111432	FZD10 PPI subnetwork	0.90	> 0.20	BCAM (3.2)	CBLC (2.8)	C11orf9 (2.5)	CILP2 (1.8)	TSSK6 (1.7)	NYNRIN (1.7)	AMIGO1 (1.6)	ABO (1.5)	YIPF2 (1.3)	ATXN7L2 (1.2)
KEGG_PRIMARY_IMMUNODEFICIENCY	KEGG_PRIMARY_IMMUNODEFICIENCY	0.90	> 0.20	PLCG1 (4.1)	ZNF101 (3.6)	PBX4 (2.4)	PARP10 (2.3)	GMIP (2.2)	TIMD4 (1.6)	SLC44A2 (1.4)	RELB (1.3)	GCNT4 (1.2)	MAFB (1.1)
GO:0014015	positive regulation of gliogenesis	0.90	> 0.20	ENSG00000254235 (3.3)	NCAN (3.2)	HAPLN4 (2.9)	ABO (1.9)	CEACAM19 (1.7)	C11orf9 (1.4)	UBXN2B (1.1)	CYB561D1 (1.1)	SH2B3 (1.1)	GATAD2A (1.0)
MP:0002777	absent ovarian follicles	0.90	> 0.20	C12orf47 (2.3)	USP1 (1.8)	NYNRIN (1.7)	FEN1 (1.7)	LPAR2 (1.4)	OASL (1.3)	ST3GAL4 (1.3)	PLEKHH2 (1.2)	ILF3 (1.1)	GATAD2A (1.1)
ENSG00000135903	PAX3 PPI subnetwork	0.90	> 0.20	SH2B3 (2.1)	NCAN (2.0)	GATAD2A (2.0)	OGDH (1.9)	DNM2 (1.8)	PLCG1 (1.7)	ENSG00000226645 (1.4)	ENSG00000238078 (1.3)	PMFBP1 (1.2)	MYLIP (1.2)
GO:0072528	pyrimidine-containing compound biosynthetic process	0.90	> 0.20	DYNC2LI1 (2.6)	AMIGO1 (2.1)	TXNL4B (1.8)	ANKRD31 (1.8)	ENSG00000228044 (1.6)	QTRT1 (1.5)	PMFBP1 (1.5)	ADAM1 (1.4)	OASL (1.3)	MOSC1 (1.1)
ENSG00000198791	CNOT7 PPI subnetwork	0.90	> 0.20	TMED4 (3.1)	TRIB1 (2.3)	POLK (2.1)	C1orf63 (1.8)	PSRC1 (1.7)	USP1 (1.6)	MOSC1 (1.4)	FEN1 (1.3)	ENSG00000226648 (1.3)	HLX (1.2)
ENSG00000111731	KIAA0528 PPI subnetwork	0.90	> 0.20	MARK4 (2.9)	C12orf51 (2.7)	GMIP (2.6)	LPAR2 (2.5)	SORT1 (2.2)	ATXN2 (2.2)	SLC44A2 (2.0)	POLK (2.0)	USP24 (2.0)	GATAD2A (1.5)
ENSG00000198625	MDM4 PPI subnetwork	0.90	> 0.20	POLK (2.5)	FEN1 (2.0)	PSRC1 (1.8)	TOP1 (1.6)	PTPN11 (1.5)	ENSG00000226645 (1.5)	BCL3 (1.4)	UBXN2B (1.4)	TMEM50A (1.3)	CARM1 (1.2)
ENSG00000178951	ZBTB7A PPI subnetwork	0.90	> 0.20	KIAA1324 (2.4)	BCL3 (2.0)	AMIGO1 (1.9)	CARM1 (1.9)	PCSK9 (1.4)	ZNF180 (1.4)	USP1 (1.3)	ENSG00000226648 (1.3)	MAU2 (1.2)	USP24 (1.2)
MP:0006345	absent second branchial arch	0.90	> 0.20	MAFB (3.2)	TOP1 (2.5)	HLX (2.2)	CYB561D1 (2.0)	PLCG1 (1.9)	PLEKHH2 (1.8)	BCAM (1.8)	GPAM (1.7)	ATXN2 (1.4)	MARK4 (1.3)
ENSG00000155980	KIF5A PPI subnetwork	0.90	> 0.20	SARS (3.2)	C12orf51 (2.8)	HAPLN4 (2.3)	PBX4 (2.1)	ABO (2.0)	PTPN11 (2.0)	UBXN2B (1.9)	LPAR2 (1.8)	ENSG00000228044 (1.8)	DOCK7 (1.6)
GO:0045333	cellular respiration	0.90	> 0.20	OGDH (4.5)	ACAD10 (3.8)	GOT2P1 (3.2)	C12orf47 (2.8)	TRAPPC6A (2.2)	TMEM116 (2.1)	C19orf52 (1.7)	GMPR (1.7)	FRK (1.5)	TMED4 (1.5)
GO:0014009	glial cell proliferation	0.90	> 0.20	NCAN (2.7)	LPIN3 (2.0)	UBXN2B (2.0)	NYNRIN (1.9)	CYB561D1 (1.8)	TMEM57 (1.8)	ENSG00000226648 (1.6)	GMPR (1.6)	BLOC1S3 (1.5)	ZNF180 (1.4)
ENSG00000113312	TTC1 PPI subnetwork	0.90	> 0.20	CELSR2 (3.7)	POLK (2.6)	AP1M2 (2.1)	GRINA (1.7)	BCAM (1.6)	SLC44A2 (1.6)	SORT1 (1.6)	DNM2 (1.5)	CLPTM1 (1.4)	PSRC1 (1.4)
ENSG00000137474	MYO7A PPI subnetwork	0.90	> 0.20	AP1M2 (4.2)	HNF1A (2.1)	C19orf52 (1.8)	C1orf63 (1.7)	PBX4 (1.6)	DNM2 (1.6)	ILF3 (1.6)	ALDH2 (1.5)	SMARCA4 (1.4)	CARM1 (1.4)
MP:0003050	abnormal sacral vertebrae morphology	0.90	> 0.20	NYNRIN (2.3)	MYLIP (2.0)	PLEKHH2 (2.0)	AMIGO1 (1.7)	KANK2 (1.6)	PLCG1 (1.6)	ABO (1.6)	PCSK9 (1.6)	LPAR2 (1.4)	ENSG00000238078 (1.1)
ENSG00000183918	SH2D1A PPI subnetwork	0.90	> 0.20	SLC44A2 (3.5)	PBX4 (2.4)	TMEM50A (2.3)	CETP (2.0)	ENSG00000235545 (1.7)	ENSG00000238078 (1.7)	CYB561D1 (1.7)	RPH3A (1.6)	MOSC1 (1.6)	TSSK6 (1.5)
GO:0014002	astrocyte development	0.90	> 0.20	ENSG00000226648 (3.1)	ENSG00000235545 (2.9)	NCAN (2.3)	ENSG00000254235 (2.1)	ST3GAL4 (2.1)	C19orf52 (1.6)	PMFBP1 (1.3)	MAPKAPK5 (1.3)	C11orf9 (1.2)	PBX4 (1.0)
ENSG00000178568	ERBB4 PPI subnetwork	0.90	> 0.20	TRIB1 (2.4)	COL4A3BP (2.4)	ATXN2 (2.3)	PVR (2.2)	ALDH2 (1.9)	ZHX3 (1.8)	CBLC (1.8)	POLK (1.7)	MARK4 (1.5)	TMED4 (1.5)
GO:0030837	negative regulation of actin filament polymerization	0.90	> 0.20	C17orf57 (3.3)	ENSG00000238078 (2.8)	RHD (2.8)	RHCE (2.6)	PMFBP1 (2.3)	TSSK6 (2.2)	ENSG00000235545 (2.1)	TMEM50A (2.0)	ATXN7L2 (1.9)	GMPR (1.7)
GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	0.90	> 0.20	C17orf57 (2.4)	AMIGO1 (2.2)	PVRL2 (2.0)	ANKRD31 (2.0)	MAFB (1.8)	SLC44A2 (1.7)	BCAM (1.6)	NKPD1 (1.4)	TMED4 (1.4)	LPA (1.0)
ENSG00000166501	PRKCB PPI subnetwork	0.90	> 0.20	PVR (2.5)	PLEC (1.9)	HAVCR1 (1.7)	C12orf47 (1.7)	RPH3A (1.6)	ITGB3 (1.6)	PTPN11 (1.6)	TRIB1 (1.5)	C12orf51 (1.4)	NCAN (1.4)
GO:0072507	divalent inorganic cation homeostasis	0.90	> 0.20	C12orf47 (2.5)	SYPL2 (2.1)	RPH3A (1.7)	ABO (1.6)	ERP29 (1.5)	YIPF2 (1.5)	AMIGO1 (1.4)	PBX4 (1.4)	SLC44A2 (1.3)	KIAA1324 (1.3)
GO:0090102	cochlea development	0.90	> 0.20	ENSG00000254235 (2.5)	GCNT4 (2.4)	ABO (2.2)	C19orf52 (1.6)	NKPD1 (1.5)	NCAN (1.5)	DYNC2LI1 (1.4)	FADS2 (1.3)	CELSR2 (1.3)	NYNRIN (1.2)
GO:0016049	cell growth	0.90	> 0.20	CILP2 (3.0)	PVR (2.3)	TMEM50A (2.2)	POLK (1.9)	ENSG00000238078 (1.9)	ST3GAL4 (1.5)	PPP1R37 (1.5)	PVRL2 (1.3)	KANK2 (1.2)	TMED4 (1.2)
ENSG00000058335	RASGRF1 PPI subnetwork	0.90	> 0.20	SLC44A2 (3.1)	GATAD2A (2.7)	MARK4 (2.5)	CARM1 (2.3)	PVRL2 (2.0)	BCAM (1.9)	C11orf9 (1.8)	PTPN11 (1.8)	GRINA (1.8)	GOT2P1 (1.8)
GO:0060395	SMAD protein signal transduction	0.90	> 0.20	HNF1A (3.9)	C11orf9 (2.8)	ENSG00000226645 (2.1)	ADAM1 (1.8)	PMFBP1 (1.8)	TRIB1 (1.6)	BUD13 (1.6)	APOB (1.4)	TM6SF2 (1.3)	NPC1L1 (1.3)
ENSG00000161270	NPHS1 PPI subnetwork	0.90	> 0.20	TMEM50A (2.6)	PVRL2 (2.1)	ITGB3 (2.1)	CEACAM19 (2.1)	MARK4 (1.9)	BCAM (1.7)	LPAR2 (1.6)	PBX4 (1.5)	SLC44A2 (1.5)	TOP1 (1.4)
GO:0061136	regulation of proteasomal protein catabolic process	0.90	> 0.20	BLOC1S3 (2.9)	CARM1 (1.9)	GEMIN7 (1.9)	ENSG00000254235 (1.8)	ZNF180 (1.7)	TOMM40 (1.7)	C19orf52 (1.7)	CLPTM1 (1.7)	DHX38 (1.5)	POLK (1.5)
MP:0005106	abnormal incus morphology	0.90	> 0.20	MYLIP (2.8)	PLEC (2.3)	NCAN (1.8)	C19orf52 (1.5)	DYNC2LI1 (1.4)	AMIGO1 (1.4)	CEACAM19 (1.3)	ABO (1.3)	PPP1R37 (1.2)	CILP2 (1.2)
ENSG00000139637	C12orf10 PPI subnetwork	0.90	> 0.20	SARS (4.2)	DHX38 (2.3)	ALDH2 (2.1)	ATXN2 (2.0)	DHODH (1.8)	CARM1 (1.8)	SMARCA4 (1.7)	SUGP1 (1.7)	COL4A3BP (1.5)	ENSG00000235545 (1.5)
GO:0071230	cellular response to amino acid stimulus	0.90	> 0.20	C17orf57 (2.8)	MYLIP (2.1)	ATXN7L2 (2.1)	ANKRD31 (1.9)	AP1M2 (1.8)	GOT2P1 (1.4)	KANK2 (1.4)	NYNRIN (1.4)	APOE (1.2)	ENSG00000238078 (1.2)
GO:0051402	neuron apoptotic process	0.90	> 0.20	TSSK6 (3.0)	GOT2P1 (2.8)	PPP1R37 (2.0)	LPIN3 (1.8)	GRINA (1.6)	FRK (1.6)	CELSR2 (1.3)	MYLIP (1.2)	ZNF101 (1.2)	TMED4 (1.2)
GO:0033028	myeloid cell apoptotic process	0.90	> 0.20	DNAH11 (2.3)	C12orf47 (1.9)	GEMIN7 (1.5)	ANKRD31 (1.5)	GPAM (1.5)	MOSC1 (1.4)	TIMD4 (1.3)	TXNL4B (1.1)	ST3GAL4 (1.0)	HP (1.0)
GO:0032467	positive regulation of cytokinesis	0.90	> 0.20	PSRC1 (2.4)	CEACAM19 (1.8)	BLOC1S3 (1.7)	DYNC2LI1 (1.6)	TMEM50A (1.6)	TMEM116 (1.5)	ENSG00000238078 (1.4)	POC5 (1.0)	ENSG00000254235 (1.0)	USP1 (1.0)
GO:0006458	'de novo' protein folding	0.90	> 0.20	C12orf47 (2.4)	ZNF259 (2.0)	ENSG00000238078 (1.7)	TXNL4B (1.7)	ERP29 (1.6)	HAVCR1 (1.6)	NAA25 (1.4)	PVR (1.3)	ZNF101 (1.2)	DNAH11 (1.2)
GO:0001158	enhancer sequence-specific DNA binding	0.90	> 0.20	RHD (3.1)	MARK4 (2.7)	GMPR (2.6)	RHCE (2.4)	CELSR2 (2.2)	ITGB3 (1.9)	TRAPPC6A (1.8)	SLC44A2 (1.7)	C19orf52 (1.5)	TRIB1 (1.4)
GO:0001673	male germ cell nucleus	0.90	> 0.20	TSSK6 (4.5)	FEN1 (2.6)	USP1 (2.2)	PSRC1 (1.6)	PCSK9 (1.6)	PBX4 (1.6)	ENSG00000235545 (1.5)	PLEKHH2 (1.5)	POC5 (1.3)	ADAM1 (1.2)
GO:0031670	cellular response to nutrient	0.90	> 0.20	BLOC1S3 (2.6)	AP1M2 (2.0)	CYB561D1 (1.8)	C17orf57 (1.8)	ZNF180 (1.8)	ZNF101 (1.7)	LPAR2 (1.7)	TXNL4B (1.6)	ENSG00000235545 (1.5)	ENSG00000238078 (1.4)
ENSG00000153162	BMP6 PPI subnetwork	0.90	> 0.20	AMIGO1 (2.6)	LPAR2 (2.3)	DOCK7 (2.2)	NYNRIN (2.2)	ENSG00000228044 (2.0)	ZNF101 (1.8)	ENSG00000254235 (1.7)	PLEKHH2 (1.5)	ATXN2 (1.4)	PLCG1 (1.4)
GO:0001917	photoreceptor inner segment	0.90	> 0.20	ABO (2.2)	ST3GAL4 (2.0)	ATXN7L2 (1.4)	DYNC2LI1 (1.4)	GOT2P1 (1.1)	TMEM116 (1.1)	C11orf9 (1.0)	ADAM1 (1.0)	HNF1A (1.0)	NYNRIN (0.9)
ENSG00000163512	AZI2 PPI subnetwork	0.90	> 0.20	C12orf51 (3.6)	MARK4 (3.0)	GMIP (2.9)	PTPN11 (2.0)	USP24 (1.9)	SORT1 (1.9)	BUD13 (1.9)	PVRL2 (1.8)	MAU2 (1.8)	ATXN2 (1.8)
GO:0043244	regulation of protein complex disassembly	0.90	> 0.20	SLC44A2 (2.4)	RHD (2.3)	ENSG00000235545 (2.2)	RHCE (2.1)	DNM2 (2.0)	PMFBP1 (2.0)	C12orf51 (1.8)	TSSK6 (1.8)	PLEC (1.6)	CYB561D1 (1.5)
ENSG00000067369	TP53BP1 PPI subnetwork	0.90	> 0.20	FEN1 (3.3)	USP1 (3.0)	CELSR2 (2.0)	POLK (1.9)	BUD13 (1.9)	RPH3A (1.9)	PSRC1 (1.7)	HAPLN4 (1.7)	C12orf51 (1.3)	FADS1 (1.3)
GO:0045580	regulation of T cell differentiation	0.90	> 0.20	ZNF101 (4.1)	PBX4 (3.7)	PLCG1 (2.2)	DNAH11 (1.7)	GMIP (1.5)	NKPD1 (1.5)	COL4A3BP (1.4)	MAU2 (1.3)	ENSG00000254235 (1.2)	ENSG00000235545 (1.2)
GO:0017145	stem cell division	0.90	> 0.20	ENSG00000226648 (3.0)	DNAH11 (2.6)	ZHX3 (2.4)	CILP2 (2.3)	PLCG1 (2.3)	ANKRD31 (2.1)	PLEKHH2 (2.1)	PMFBP1 (1.9)	LPAR2 (1.8)	PPP1R37 (1.8)
GO:0001936	regulation of endothelial cell proliferation	0.90	> 0.20	ENSG00000226645 (3.3)	HLX (2.2)	CILP2 (2.2)	PVR (1.9)	C17orf57 (1.7)	PMFBP1 (1.7)	ENSG00000226648 (1.6)	ADAM1 (1.5)	TRIB1 (1.4)	CETP (1.3)
GO:0044291	cell-cell contact zone	0.90	> 0.20	PLEC (2.8)	SYPL2 (2.0)	BCAM (1.9)	GMPR (1.5)	PTPN11 (1.5)	RPH3A (1.5)	HAPLN4 (1.5)	PVR (1.4)	ALDH2 (1.3)	PVRL2 (1.1)
GO:0006700	C21-steroid hormone biosynthetic process	0.90	> 0.20	LPIN3 (3.2)	ST3GAL4 (2.5)	CYB561D1 (2.0)	GCNT4 (1.8)	PMFBP1 (1.7)	ZHX3 (1.7)	FADS1 (1.6)	NKPD1 (1.6)	AMIGO1 (1.5)	ATXN7L2 (1.4)
MP:0008438	abnormal cutaneous collagen fibril morphology	0.90	> 0.20	CILP2 (2.3)	KANK2 (2.1)	ATP13A1 (1.7)	MYLIP (1.6)	ERP29 (1.5)	AP1M2 (1.3)	TMEM57 (1.3)	LPA (1.2)	PLEKHH2 (1.1)	APOE (1.1)
GO:0050871	positive regulation of B cell activation	0.90	> 0.20	DNAH11 (2.6)	PBX4 (1.8)	GCNT4 (1.6)	C17orf57 (1.5)	GMIP (1.1)	ENSG00000226645 (1.1)	POLK (1.1)	TRAFD1 (1.0)	ITGB3 (1.0)	SH2B3 (1.0)
GO:0005882	intermediate filament	0.90	> 0.20	CELSR2 (1.4)	PMFBP1 (1.4)	ENSG00000228044 (0.8)	FADS1 (0.7)	PLEC (0.6)	TRAPPC6A (0.5)	SYPL2 (0.5)	RPH3A (0.5)	GMPR (0.4)	FADS2 (0.4)
MP:0008101	lymph node hypoplasia	0.90	> 0.20	ZNF101 (4.7)	GMIP (2.6)	PLCG1 (2.3)	RELB (1.7)	PBX4 (1.5)	HAVCR1 (1.4)	SLC44A2 (1.3)	TIMD4 (1.2)	CEACAM19 (1.1)	PVR (1.1)
GO:0070848	response to growth factor stimulus	0.90	> 0.20	SLC44A2 (2.3)	HLX (2.1)	KANK2 (1.9)	ENSG00000226645 (1.8)	PVRL2 (1.6)	PVR (1.5)	GPAM (1.3)	TMEM57 (1.3)	SH2B3 (1.3)	MAFB (1.3)
ENSG00000108819	ENSG00000108819 PPI subnetwork	0.90	> 0.20	SORT1 (2.7)	KANK2 (2.5)	OGDH (2.3)	ZHX3 (2.0)	NPC1L1 (1.9)	BRAP (1.9)	C19orf52 (1.9)	SLC44A2 (1.7)	TSSK6 (1.6)	FRK (1.6)
GO:0000242	pericentriolar material	0.90	> 0.20	POLK (4.0)	C12orf51 (3.2)	POC5 (2.5)	UBXN2B (2.1)	ENSG00000228044 (1.8)	C17orf57 (1.8)	C12orf43 (1.7)	DYNC2LI1 (1.7)	COL4A3BP (1.4)	FRK (1.4)
MP:0004981	decreased neuronal precursor cell number	0.90	> 0.20	CELSR2 (3.3)	BCAM (2.8)	PSRC1 (2.8)	C12orf47 (2.4)	SLC44A2 (1.9)	PLEC (1.9)	ABO (1.8)	ATXN7L2 (1.7)	NCAN (1.6)	TMEM116 (1.6)
MP:0005431	decreased oocyte number	0.90	> 0.20	ANKRD31 (2.6)	GOT2P1 (1.8)	CEACAM19 (1.7)	PLEKHH2 (1.7)	ENSG00000226645 (1.4)	NT5DC1 (1.3)	FRK (1.3)	LPA (1.3)	TXNL4B (1.3)	NYNRIN (1.1)
ENSG00000010803	SCMH1 PPI subnetwork	0.90	> 0.20	ATXN7L2 (2.2)	TRAFD1 (2.2)	MARK4 (2.2)	PSRC1 (1.9)	HLX (1.9)	CYB561D1 (1.7)	C19orf52 (1.7)	ILF3 (1.6)	ATXN2 (1.6)	TMEM57 (1.6)
REACTOME_TRANSPORT_OF_INORGANIC_CATIONSANIONS_AND_AMINO_ACIDSOLIGOPEPTIDES	REACTOME_TRANSPORT_OF_INORGANIC_CATIONSANIONS_AND_AMINO_ACIDSOLIGOPEPTIDES	0.90	> 0.20	TMEM116 (3.7)	TM6SF2 (3.1)	ATP13A1 (2.2)	NCAN (2.1)	NPC1L1 (1.9)	HAPLN4 (1.9)	SARS (1.9)	CLPTM1 (1.9)	SORT1 (1.8)	ERP29 (1.6)
MP:0003073	abnormal metacarpal bone morphology	0.90	> 0.20	NYNRIN (2.9)	MAFB (2.6)	PLEKHH2 (2.5)	GOT2P1 (1.3)	AMIGO1 (1.2)	C19orf52 (1.1)	ABO (1.0)	ENSG00000238078 (0.9)	KANK2 (0.9)	CARM1 (0.9)
ENSG00000133773	CCDC59 PPI subnetwork	0.90	> 0.20	C19orf52 (2.6)	ABO (2.4)	TXNL4B (2.1)	CYB561D1 (1.9)	RHCE (1.9)	ITGB3 (1.7)	BUD13 (1.7)	RHD (1.6)	PVRL2 (1.6)	YIPF2 (1.4)
ENSG00000119969	HELLS PPI subnetwork	0.90	> 0.20	ATP13A1 (2.4)	OGDH (2.0)	ACAD10 (1.9)	MAU2 (1.8)	DHODH (1.8)	ATXN2 (1.7)	FRK (1.6)	QTRT1 (1.5)	ILF3 (1.5)	ENSG00000235545 (1.4)
GO:0007588	excretion	0.90	> 0.20	FRK (3.2)	CEACAM19 (3.0)	TMEM116 (2.5)	BCAM (1.8)	ENSG00000228044 (1.8)	ENSG00000226648 (1.7)	PMFBP1 (1.6)	ZHX3 (1.5)	AP1M2 (1.5)	TM6SF2 (1.5)
ENSG00000179091	CYC1 PPI subnetwork	0.90	> 0.20	OGDH (2.1)	C19orf52 (1.9)	TRAPPC6A (1.7)	TMEM116 (1.7)	ACAD10 (1.6)	UBXN2B (1.4)	ABO (1.3)	C12orf47 (1.3)	PARP10 (1.2)	TMED4 (1.1)
ENSG00000103326	SOLH PPI subnetwork	0.90	> 0.20	BLOC1S3 (3.8)	C12orf43 (2.4)	AMIGO1 (2.3)	C19orf52 (2.0)	NCAN (1.7)	HAPLN4 (1.4)	TMEM57 (1.4)	PPP1R37 (1.3)	DHX38 (1.3)	COL4A3BP (1.3)
MP:0003137	abnormal impulse conducting system conduction	0.90	> 0.20	BCAM (2.9)	TMEM116 (2.4)	HAPLN4 (2.1)	SORT1 (1.8)	ALDH2 (1.7)	GRINA (1.7)	CILP2 (1.6)	GOT2P1 (1.4)	ENSG00000226648 (1.3)	ACAD10 (1.3)
ENSG00000125166	GOT2 PPI subnetwork	0.90	> 0.20	ALDH2 (3.6)	HAPLN4 (3.2)	MOSC1 (2.8)	RPH3A (2.5)	NCAN (2.3)	ZNF101 (1.9)	GPAM (1.8)	C11orf9 (1.8)	NT5DC1 (1.7)	CELSR2 (1.4)
ENSG00000100242	SUN2 PPI subnetwork	0.90	> 0.20	TXNL4B (3.7)	BLOC1S3 (2.4)	C17orf57 (2.3)	CYB561D1 (2.1)	C1orf63 (2.0)	PSRC1 (1.7)	POLK (1.7)	TMED4 (1.7)	MAU2 (1.6)	TMEM50A (1.2)
GO:0007620	copulation	0.90	> 0.20	PMFBP1 (2.6)	LPIN3 (2.4)	NKPD1 (2.4)	CEACAM19 (2.1)	C17orf57 (1.9)	HNF1A (1.9)	ABO (1.6)	CBLC (1.6)	ZHX3 (1.6)	NPC1L1 (1.5)
MP:0000043	organ of Corti degeneration	0.90	> 0.20	HNF1A (2.5)	TMEM116 (2.1)	APOC1 (1.9)	ZNF101 (1.8)	PBX4 (1.6)	GPAM (1.6)	TRAPPC6A (1.6)	AP1M2 (1.5)	FRK (1.4)	ANKRD31 (1.4)
GO:0030324	lung development	0.90	> 0.20	C11orf9 (4.4)	PLEKHH2 (4.0)	CYP7A1 (2.1)	BCAM (2.0)	NYNRIN (2.0)	ALDH2 (2.0)	DYNC2LI1 (1.8)	HLX (1.7)	KANK2 (1.6)	PVRL2 (1.5)
ENSG00000172354	GNB2 PPI subnetwork	0.90	> 0.20	TMEM50A (2.1)	ENSG00000254235 (1.8)	PMFBP1 (1.7)	MOSC1 (1.5)	HLX (1.5)	TOMM40 (1.5)	BLOC1S3 (1.5)	RPH3A (1.4)	HAPLN4 (1.4)	GEMIN7 (1.4)
REACTOME_CONVERSION_FROM_APCCCDC20_TO_APCCCDH1_IN_LATE_ANAPHASE	REACTOME_CONVERSION_FROM_APCCCDC20_TO_APCCCDH1_IN_LATE_ANAPHASE	0.90	> 0.20	POC5 (3.0)	LPIN3 (2.9)	PSRC1 (2.8)	SUGP1 (2.1)	ADAM1 (1.9)	DOCK7 (1.9)	C12orf43 (1.8)	LPAR2 (1.8)	C12orf51 (1.4)	FEN1 (1.4)
ENSG00000018699	TTC27 PPI subnetwork	0.90	> 0.20	QTRT1 (2.8)	ACAD10 (2.5)	BRAP (2.2)	ATP13A1 (2.0)	YIPF2 (2.0)	ZNF101 (2.0)	ALDH2 (1.9)	DHODH (1.8)	C19orf52 (1.8)	GPAM (1.6)
ENSG00000126432	PRDX5 PPI subnetwork	0.90	> 0.20	SMARCA4 (2.3)	TMEM116 (2.1)	PSRC1 (1.8)	ZNF101 (1.7)	ENSG00000226648 (1.5)	CYB561D1 (1.4)	TOMM40 (1.4)	HAPLN4 (1.3)	C19orf52 (1.2)	RHCE (1.1)
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	0.90	> 0.20	ITGB3 (3.6)	ST3GAL4 (2.5)	PMFBP1 (1.4)	SH2B3 (1.4)	ENSG00000235545 (1.3)	ZHX3 (1.3)	GOT2P1 (1.2)	SORT1 (1.1)	ENSG00000228044 (1.1)	MYLIP (1.0)
GO:0045686	negative regulation of glial cell differentiation	0.90	> 0.20	NCAN (3.5)	BLOC1S3 (1.8)	NYNRIN (1.8)	ENSG00000254235 (1.7)	PBX4 (1.6)	C17orf57 (1.4)	PPP1R37 (1.4)	C19orf52 (1.3)	ENSG00000235545 (1.2)	NPC1L1 (1.1)
KEGG_CELL_ADHESION_MOLECULES_CAMS	KEGG_CELL_ADHESION_MOLECULES_CAMS	0.90	> 0.20	APOE (2.9)	TIMD4 (2.6)	BCAM (2.6)	AP1M2 (2.4)	APOC1 (1.9)	SLC44A2 (1.8)	CEACAM19 (1.8)	RELB (1.7)	PVRL2 (1.7)	CYP7A1 (1.7)
ENSG00000062822	POLD1 PPI subnetwork	0.90	> 0.20	USP1 (5.0)	FEN1 (4.8)	POC5 (2.0)	ENSG00000235545 (1.9)	NKPD1 (1.8)	DHODH (1.6)	ILF3 (1.5)	TMEM116 (1.4)	SORT1 (1.4)	FADS1 (1.2)
ENSG00000169189	NSMCE1 PPI subnetwork	0.90	> 0.20	USP1 (3.4)	ZNF180 (2.7)	BLOC1S3 (2.1)	NT5DC1 (2.0)	ENSG00000235545 (2.0)	FEN1 (1.8)	AMIGO1 (1.5)	GEMIN7 (1.4)	BRAP (1.4)	POC5 (1.3)
GO:0007281	germ cell development	0.90	> 0.20	TSSK6 (5.3)	PMFBP1 (3.6)	CEACAM19 (1.8)	PLEKHH2 (1.6)	ABO (1.5)	DYNC2LI1 (1.4)	LPIN3 (1.0)	GMPR (1.0)	YIPF2 (1.0)	MARK4 (0.9)
GO:0006942	regulation of striated muscle contraction	0.90	> 0.20	SYPL2 (4.5)	ENSG00000226648 (1.7)	CYB561D1 (1.4)	TXNL4B (1.4)	ANKRD31 (1.4)	ENSG00000238078 (1.4)	RPH3A (1.4)	SORT1 (1.3)	CEACAM19 (1.3)	ERP29 (1.3)
MP:0000527	abnormal kidney development	0.90	> 0.20	PLEKHH2 (4.9)	NYNRIN (3.8)	BCAM (3.6)	KANK2 (2.7)	PVRL2 (2.5)	AMIGO1 (1.9)	MYLIP (1.9)	DYNC2LI1 (1.9)	PLCG1 (1.8)	TMED4 (1.8)
GO:0042074	cell migration involved in gastrulation	0.90	> 0.20	ABO (3.4)	LPAR2 (2.1)	CEACAM19 (2.1)	HNF1A (1.8)	AP1M2 (1.7)	ENSG00000238078 (1.5)	DNAH11 (1.5)	ADAM1 (1.5)	YIPF2 (1.3)	C12orf47 (1.3)
ENSG00000127603	MACF1 PPI subnetwork	0.90	> 0.20	MYLIP (2.0)	NCAN (2.0)	ATXN2 (1.8)	TMEM57 (1.5)	LPIN3 (1.2)	ATP13A1 (1.2)	PTPN11 (1.2)	CLPTM1 (1.2)	GMIP (1.1)	LPAR2 (1.1)
GO:0051905	establishment of pigment granule localization	0.90	> 0.20	ENSG00000228044 (2.6)	DYNC2LI1 (2.0)	PMFBP1 (1.8)	ANKRD31 (1.6)	C1orf63 (1.4)	UBXN2B (1.4)	CEACAM19 (1.4)	ENSG00000254235 (1.4)	C12orf43 (1.4)	HAVCR1 (1.2)
ENSG00000127314	RAP1B PPI subnetwork	0.90	> 0.20	KIAA1324 (2.1)	TMEM57 (2.0)	GATAD2A (1.8)	RELB (1.7)	POLK (1.6)	ENSG00000238078 (1.4)	GCNT4 (1.4)	BRAP (1.3)	SLC44A2 (1.2)	PMFBP1 (1.1)
ENSG00000148660	CAMK2G PPI subnetwork	0.90	> 0.20	HAVCR1 (2.0)	KIAA1324 (2.0)	CYB561D1 (2.0)	ENSG00000226648 (1.7)	PVR (1.7)	ZNF180 (1.7)	C12orf47 (1.7)	AMIGO1 (1.6)	ATXN7L2 (1.5)	SORT1 (1.5)
GO:0006874	cellular calcium ion homeostasis	0.90	> 0.20	C12orf47 (3.0)	SYPL2 (2.0)	ERP29 (1.6)	RPH3A (1.5)	ABO (1.5)	AMIGO1 (1.5)	CETP (1.1)	NKPD1 (1.1)	PBX4 (1.1)	SLC44A2 (1.0)
MP:0004613	fusion of vertebral arches	0.90	> 0.20	NYNRIN (3.3)	ABO (3.1)	ACAD10 (2.2)	MARK4 (1.9)	ATXN7L2 (1.9)	BCAM (1.8)	PVRL2 (1.3)	TRAPPC6A (1.3)	DYNC2LI1 (1.3)	TMEM116 (1.2)
GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	0.90	> 0.20	ENSG00000235545 (2.4)	PBX4 (2.1)	ENSG00000254235 (1.8)	MYLIP (1.5)	BCL3 (1.2)	CETP (1.2)	GMIP (1.2)	ANKRD31 (1.2)	TRAFD1 (1.1)	SLC22A1 (0.9)
GO:0048745	smooth muscle tissue development	0.90	> 0.20	MYLIP (2.0)	PPP1R37 (1.9)	FRK (1.8)	HNF1A (1.6)	ENSG00000254235 (1.5)	HLX (1.4)	PMFBP1 (1.3)	PLEKHH2 (1.2)	NYNRIN (1.2)	MAU2 (1.1)
ENSG00000172757	CFL1 PPI subnetwork	0.90	> 0.20	ADAM1 (2.4)	GATAD2A (2.2)	PSMA5 (1.9)	ZNF259 (1.9)	BRAP (1.7)	KANK2 (1.7)	QTRT1 (1.6)	ACAD10 (1.6)	NPC1L1 (1.5)	TOMM40 (1.3)
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT:GROWTH	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT:GROWTH	0.90	> 0.20	PLEKHH2 (3.1)	CELSR2 (2.1)	MARK4 (2.1)	CILP2 (2.0)	PLEC (1.7)	MAU2 (1.6)	C17orf57 (1.6)	C12orf51 (1.5)	SLC44A2 (1.4)	FADS2 (1.4)
MP:0006027	impaired lung alveolus development	0.90	> 0.20	PLEKHH2 (3.6)	BCAM (2.6)	LDLR (2.1)	HLX (2.1)	HMGCR (2.1)	NCAN (2.0)	DYNC2LI1 (1.8)	NYNRIN (1.8)	KANK2 (1.7)	CBLC (1.6)
ENSG00000172725	CORO1B PPI subnetwork	0.90	> 0.20	DOCK7 (2.1)	PLEC (2.1)	BRAP (2.0)	SH2B3 (1.9)	PLCG1 (1.9)	PVR (1.9)	KANK2 (1.8)	LPIN3 (1.7)	GATAD2A (1.3)	ZHX3 (1.2)
ENSG00000012983	MAP4K5 PPI subnetwork	0.90	> 0.20	C12orf51 (3.3)	MARK4 (3.1)	ATXN2 (2.9)	GMIP (2.3)	USP24 (2.3)	LPAR2 (2.2)	BUD13 (1.9)	PTPN11 (1.8)	PBX4 (1.6)	PVRL2 (1.6)
ENSG00000206306	HLA-DRB1 PPI subnetwork	0.90	> 0.20	PLCG1 (4.2)	ZNF101 (2.8)	HAVCR1 (2.0)	ALDH2 (1.9)	MAFB (1.7)	APOE (1.5)	YIPF2 (1.4)	COL4A3BP (1.4)	TIMD4 (1.4)	APOC1 (1.2)
ENSG00000206240	HLA-DRB1 PPI subnetwork	0.90	> 0.20	PLCG1 (4.2)	ZNF101 (2.8)	HAVCR1 (2.0)	ALDH2 (1.9)	MAFB (1.7)	APOE (1.5)	YIPF2 (1.4)	COL4A3BP (1.4)	TIMD4 (1.4)	APOC1 (1.2)
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	0.90	> 0.20	KIAA1324 (3.1)	HLX (2.4)	ABO (2.2)	MOSC1 (1.7)	CETP (1.5)	ST3GAL4 (1.4)	PMFBP1 (1.4)	LPIN3 (1.4)	C12orf47 (1.3)	NPC1L1 (1.2)
GO:0031225	anchored to membrane	0.90	> 0.20	HP (2.2)	CELSR2 (2.2)	NCAN (1.9)	BCAM (1.9)	AP1M2 (1.7)	TMED4 (1.6)	TMEM50A (1.6)	CILP2 (1.6)	PVRL2 (1.6)	ABO (1.5)
REACTOME_RECYCLING_PATHWAY_OF_L1	REACTOME_RECYCLING_PATHWAY_OF_L1	0.90	> 0.20	CLPTM1 (2.8)	DNM2 (2.7)	OGDH (2.6)	PLEC (2.5)	C1orf63 (2.2)	HAVCR1 (1.9)	PPP1R37 (1.8)	SARS (1.8)	GEMIN7 (1.6)	AP1M2 (1.6)
ENSG00000135363	LMO2 PPI subnetwork	0.90	> 0.20	GMPR (3.8)	RHD (3.3)	RHCE (2.9)	PARP10 (2.3)	SH2B3 (2.0)	TRAFD1 (1.7)	MAU2 (1.7)	ATXN7L2 (1.7)	DNM2 (1.5)	TMEM57 (1.4)
MP:0004609	vertebral fusion	0.90	> 0.20	ABO (2.4)	NYNRIN (2.3)	ATXN7L2 (2.1)	PVRL2 (2.1)	NCAN (2.0)	CLPTM1 (1.7)	KIAA1324 (1.4)	FADS2 (1.4)	GPAM (1.3)	TMEM50A (1.2)
MP:0005089	decreased double-negative T cell number	0.90	> 0.20	UBXN2B (2.6)	PBX4 (2.4)	GMIP (2.2)	NCAN (1.8)	LPAR2 (1.8)	MAFB (1.7)	ZNF101 (1.6)	RELB (1.6)	PLCG1 (1.5)	SMARCA4 (1.4)
GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	0.90	> 0.20	KANK2 (3.0)	ENSG00000226645 (2.2)	CEACAM19 (2.2)	ENSG00000254235 (2.1)	NYNRIN (1.8)	CARM1 (1.7)	TMED4 (1.5)	ENSG00000238078 (1.3)	PVR (1.3)	PVRL2 (1.1)
ENSG00000187323	DCC PPI subnetwork	0.90	> 0.20	ANKRD31 (1.8)	ALDH2 (1.7)	BLOC1S3 (1.6)	GMPR (1.6)	PBX4 (1.6)	CEACAM19 (1.5)	GRINA (1.5)	LPIN3 (1.4)	C1orf63 (1.3)	TRAFD1 (1.3)
GO:0045216	cell-cell junction organization	0.90	> 0.20	C11orf9 (3.0)	BCAM (2.8)	PVRL2 (2.8)	AP1M2 (2.3)	GCNT4 (2.2)	LPAR2 (2.0)	ABO (2.0)	CEACAM19 (1.6)	LPIN3 (1.6)	SORT1 (1.6)
ENSG00000071242	RPS6KA2 PPI subnetwork	0.90	> 0.20	C12orf51 (3.2)	UBXN2B (1.9)	PTPN11 (1.5)	ZNF180 (1.5)	ENSG00000238078 (1.4)	ST3GAL4 (1.4)	MAFB (1.4)	NCAN (1.3)	ALDH2 (1.2)	GOT2P1 (1.2)
GO:0019884	antigen processing and presentation of exogenous antigen	0.90	> 0.20	PARP10 (3.1)	MAU2 (1.9)	NKPD1 (1.8)	MYLIP (1.5)	TRAFD1 (1.3)	ZNF180 (1.3)	TMED4 (1.2)	ERP29 (1.2)	RHCE (1.2)	DOCK7 (1.1)
GO:0051493	regulation of cytoskeleton organization	0.90	> 0.20	PLEC (2.2)	POLK (2.1)	POC5 (2.0)	PBX4 (1.9)	C17orf57 (1.7)	DOCK7 (1.7)	SLC44A2 (1.6)	NYNRIN (1.5)	PSRC1 (1.5)	CBLC (1.5)
MP:0005421	loose skin	0.90	> 0.20	APOE (2.1)	CLPTM1 (2.1)	CILP2 (1.7)	TM6SF2 (1.6)	LPAR2 (1.6)	PLEKHH2 (1.6)	C11orf9 (1.5)	CYB561D1 (1.4)	TIMD4 (1.3)	PBX4 (1.3)
ENSG00000101997	CCDC22 PPI subnetwork	0.90	> 0.20	ZNF101 (3.0)	CYB561D1 (2.3)	DOCK7 (2.1)	BLOC1S3 (2.0)	AMIGO1 (2.0)	POC5 (1.8)	PTPN11 (1.6)	MAPKAPK5 (1.5)	NT5DC1 (1.5)	PLCG1 (1.4)
ENSG00000140350	ANP32A PPI subnetwork	0.90	> 0.20	ILF3 (2.4)	MYLIP (1.8)	CARM1 (1.6)	PBX4 (1.6)	BUD13 (1.5)	TMEM57 (1.4)	HNF1A (1.3)	NT5DC1 (1.2)	TRIB1 (1.1)	TSSK6 (1.1)
MP:0001053	abnormal neuromuscular synapse morphology	0.90	> 0.20	SYPL2 (4.0)	AMIGO1 (2.7)	RPH3A (2.2)	GMPR (1.9)	BCAM (1.9)	PLEC (1.8)	PMFBP1 (1.7)	CELSR2 (1.7)	ANKRD31 (1.7)	PBX4 (1.6)
GO:0030553	cGMP binding	0.90	> 0.20	MOSC1 (2.7)	CETP (2.6)	GOT2P1 (2.2)	ENSG00000235545 (1.9)	ITGB3 (1.6)	CYP7A1 (1.5)	HLX (1.5)	ENSG00000238078 (1.4)	ENSG00000254235 (1.3)	LPIN3 (1.3)
ENSG00000183049	CAMK1D PPI subnetwork	0.90	> 0.20	UBXN2B (2.5)	C12orf43 (2.5)	NCAN (2.3)	ZNF180 (2.0)	C12orf47 (2.0)	GOT2P1 (1.9)	HAVCR1 (1.9)	CELSR2 (1.8)	TMEM50A (1.7)	AMIGO1 (1.7)
MP:0011386	increased metanephric mesenchyme apoptosis	0.90	> 0.20	PVRL2 (3.2)	C11orf9 (2.8)	HLX (2.5)	NYNRIN (2.5)	PLEKHH2 (2.2)	FADS2 (2.0)	AP1M2 (2.0)	ENSG00000238078 (1.5)	MYLIP (1.4)	AMIGO1 (1.3)
GO:0048814	regulation of dendrite morphogenesis	0.90	> 0.20	ABO (3.6)	RPH3A (2.5)	ATXN7L2 (1.9)	GEMIN7 (1.8)	DNAH11 (1.7)	PBX4 (1.5)	LPIN3 (1.5)	ENSG00000235545 (1.4)	TSSK6 (1.3)	DOCK7 (1.2)
GO:0000002	mitochondrial genome maintenance	0.90	> 0.20	ACAD10 (2.9)	DHODH (2.6)	C12orf43 (2.5)	TXNL4B (2.1)	BLOC1S3 (2.0)	DNAH11 (1.8)	UBXN2B (1.7)	C17orf57 (1.6)	C19orf52 (1.5)	DYNC2LI1 (1.5)
GO:0030173	integral to Golgi membrane	0.90	> 0.20	SLC44A2 (2.3)	TMEM57 (2.1)	TMED4 (2.0)	ENSG00000254235 (2.0)	AMIGO1 (1.7)	ITGB3 (1.6)	ST3GAL4 (1.4)	CYB561D1 (1.3)	TMEM50A (1.3)	PLEKHH2 (1.2)
ENSG00000130779	CLIP1 PPI subnetwork	0.90	> 0.20	TMEM50A (2.5)	USP24 (2.5)	C12orf51 (2.1)	COL4A3BP (2.0)	SMARCA4 (2.0)	TRIB1 (1.9)	PLEC (1.9)	DOCK7 (1.6)	GOT2P1 (1.6)	HMGCR (1.6)
GO:0021761	limbic system development	0.90	> 0.20	GOT2P1 (3.4)	UBXN2B (2.1)	ATXN7L2 (2.1)	TSSK6 (2.1)	DNAH11 (1.9)	ST3GAL4 (1.7)	NCAN (1.6)	ABO (1.5)	PBX4 (1.5)	GCNT4 (1.5)
GO:0035121	tail morphogenesis	0.90	> 0.20	ABO (3.1)	ATXN7L2 (2.8)	CILP2 (2.7)	ADAM1 (2.4)	PMFBP1 (2.0)	CEACAM19 (2.0)	C12orf47 (1.8)	ENSG00000238078 (1.8)	ANKRD31 (1.6)	TSSK6 (1.5)
GO:0045930	negative regulation of mitotic cell cycle	0.90	> 0.20	MAU2 (2.8)	ENSG00000226648 (2.4)	PPP1R37 (2.0)	CYB561D1 (1.9)	FRK (1.8)	TMEM116 (1.8)	CILP2 (1.8)	C19orf52 (1.7)	DHX38 (1.7)	ZNF180 (1.6)
GO:0006301	postreplication repair	0.90	> 0.20	DNAH11 (2.6)	C1orf63 (2.3)	POLK (2.3)	ZNF180 (2.1)	TMEM57 (2.0)	ENSG00000235545 (2.0)	C12orf51 (1.9)	TMEM116 (1.6)	ERP29 (1.6)	DYNC2LI1 (1.5)
MP:0000250	abnormal vasoconstriction	0.90	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	GOT2P1 (2.0)	HNF1A (2.0)	POLK (1.7)	SORT1 (1.7)	PARP10 (1.3)	SLC22A1 (1.2)	TMEM50A (1.0)	DHODH (1.0)
ENSG00000104725	ENSG00000104725 PPI subnetwork	0.90	> 0.20	C11orf9 (3.5)	HAPLN4 (3.0)	RPH3A (2.8)	ATXN2 (2.0)	C12orf43 (1.8)	ST3GAL4 (1.6)	BRAP (1.5)	OGDH (1.4)	MARK4 (1.4)	CELSR2 (1.4)
ENSG00000153707	PTPRD PPI subnetwork	0.90	> 0.20	PTPN11 (2.4)	PLCG1 (2.1)	TSSK6 (1.9)	MAFB (1.9)	C11orf9 (1.8)	BCAM (1.7)	HAVCR1 (1.7)	ITGB3 (1.6)	ZHX3 (1.6)	NCAN (1.5)
GO:0000726	non-recombinational repair	0.90	> 0.20	ANKRD31 (4.4)	ZNF101 (2.6)	ENSG00000235545 (2.5)	GCNT4 (2.5)	DOCK7 (2.2)	UBXN2B (2.0)	TMEM116 (1.8)	ZNF259 (1.5)	ADAM1 (1.4)	NT5DC1 (1.4)
ENSG00000061938	TNK2 PPI subnetwork	0.91	> 0.20	SH2B3 (2.7)	USP24 (2.6)	FADS2 (2.4)	APOE (2.4)	ERP29 (2.2)	MAFB (2.0)	CETP (1.9)	DNAH11 (1.8)	TMEM57 (1.6)	TIMD4 (1.6)
GO:0007163	establishment or maintenance of cell polarity	0.91	> 0.20	DOCK7 (3.3)	HAVCR1 (2.9)	ENSG00000235545 (2.5)	PLEC (2.2)	USP24 (2.1)	ENSG00000238078 (2.0)	LPIN3 (1.8)	PSRC1 (1.7)	C12orf51 (1.7)	POC5 (1.7)
MP:0005094	abnormal T cell proliferation	0.91	> 0.20	PLCG1 (2.6)	PBX4 (2.6)	ZNF101 (2.3)	RELB (2.1)	TRAFD1 (2.1)	HAVCR1 (2.1)	GMIP (1.9)	ENSG00000238078 (1.4)	PARP10 (1.2)	ALDH2 (1.2)
MP:0006054	spinal hemorrhage	0.91	> 0.20	NYNRIN (2.6)	TMED4 (2.0)	PVRL2 (1.8)	TOP1 (1.4)	C17orf57 (1.3)	GMIP (1.2)	ANKRD31 (1.2)	ABCG5 (1.0)	TMEM50A (1.0)	PTPN11 (1.0)
ENSG00000047936	ROS1 PPI subnetwork	0.91	> 0.20	ZHX3 (3.7)	SLC44A2 (3.0)	CARM1 (2.0)	HAVCR1 (1.8)	GATAD2A (1.7)	ANKRD31 (1.7)	MAU2 (1.7)	NCAN (1.6)	C17orf57 (1.6)	DNM2 (1.6)
MP:0002204	abnormal neurotransmitter level	0.91	> 0.20	HNF1A (2.5)	GMPR (2.2)	C12orf47 (1.7)	PTPN11 (1.6)	HAPLN4 (1.6)	DNAH11 (1.6)	ZHX3 (1.6)	AMIGO1 (1.5)	GEMIN7 (1.4)	C12orf51 (1.3)
MP:0000163	abnormal cartilage morphology	0.91	> 0.20	CILP2 (6.9)	PLEKHH2 (1.9)	GOT2P1 (1.8)	MAFB (1.7)	PVR (1.6)	RHCE (1.5)	RHD (1.4)	TMEM57 (1.2)	ENSG00000254235 (1.2)	YIPF2 (1.0)
GO:0045879	negative regulation of smoothened signaling pathway	0.91	> 0.20	ENSG00000235545 (3.0)	PLCG1 (2.5)	HAVCR1 (2.3)	ENSG00000228044 (2.1)	NYNRIN (1.9)	ZHX3 (1.5)	ANKRD31 (1.5)	PMFBP1 (1.4)	CEACAM19 (1.4)	NCAN (1.4)
GO:0021696	cerebellar cortex morphogenesis	0.91	> 0.20	ENSG00000226648 (3.4)	TMEM116 (2.9)	HAPLN4 (2.7)	TMEM57 (2.1)	ENSG00000235545 (2.1)	DNAH11 (2.0)	ADAM1 (1.9)	BRAP (1.8)	ZHX3 (1.7)	C17orf57 (1.7)
ENSG00000164258	NDUFS4 PPI subnetwork	0.91	> 0.20	OGDH (3.5)	TRAPPC6A (2.9)	C12orf47 (2.7)	ACAD10 (2.6)	MAU2 (1.9)	FRK (1.7)	PSMA5 (1.6)	GOT2P1 (1.5)	PTPN11 (1.3)	GMPR (1.3)
ENSG00000056661	PCGF2 PPI subnetwork	0.91	> 0.20	USP1 (2.1)	TRAFD1 (2.0)	CARM1 (2.0)	ILF3 (1.9)	TMEM57 (1.8)	ATXN2 (1.8)	SMARCA4 (1.7)	GATAD2A (1.7)	C19orf52 (1.6)	ATXN7L2 (1.6)
ENSG00000074181	NOTCH3 PPI subnetwork	0.91	> 0.20	NCAN (3.1)	PLEC (2.6)	CELSR2 (2.3)	PARP10 (1.9)	LPAR2 (1.7)	PLCG1 (1.6)	ABO (1.6)	SH2B3 (1.5)	GMIP (1.5)	HLX (1.5)
ENSG00000178562	CD28 PPI subnetwork	0.91	> 0.20	ZNF101 (3.2)	PLCG1 (2.9)	TMED4 (2.0)	MAFB (1.9)	TMEM57 (1.8)	DYNC2LI1 (1.7)	SUGP1 (1.7)	DNAH11 (1.7)	C12orf51 (1.6)	HAVCR1 (1.5)
GO:0051131	chaperone-mediated protein complex assembly	0.91	> 0.20	PPP1R37 (2.9)	TSSK6 (2.2)	YIPF2 (1.9)	PMFBP1 (1.8)	ZNF259 (1.6)	ANGPTL3 (1.4)	ATP13A1 (1.4)	TRAPPC6A (1.2)	SARS (1.2)	QTRT1 (1.1)
GO:0044455	mitochondrial membrane part	0.91	> 0.20	OGDH (4.2)	ACAD10 (3.3)	TRAPPC6A (2.4)	C12orf47 (2.4)	GOT2P1 (2.0)	TOMM40 (2.0)	PSMA5 (1.8)	TMEM116 (1.6)	GMPR (1.4)	ALDH2 (1.3)
GO:0048291	isotype switching to IgG isotypes	0.91	> 0.20	PBX4 (1.9)	C17orf57 (1.9)	DNAH11 (1.8)	GCNT4 (1.8)	NT5DC1 (1.5)	SLC44A2 (1.5)	COL4A3BP (1.4)	C12orf43 (1.3)	PMFBP1 (1.3)	HAVCR1 (1.2)
MP:0001700	abnormal embryo turning	0.91	> 0.20	ADAM1 (2.3)	C12orf43 (1.7)	CLPTM1 (1.7)	MARK4 (1.7)	POC5 (1.5)	SMARCA4 (1.5)	ENSG00000235545 (1.5)	C17orf57 (1.4)	PVRL2 (1.4)	NAA25 (1.4)
GO:0019787	small conjugating protein ligase activity	0.91	> 0.20	BRAP (3.9)	TRAFD1 (3.5)	ATXN2 (2.4)	C19orf52 (2.3)	MAU2 (2.1)	USP24 (2.0)	COL4A3BP (2.0)	TMEM57 (2.0)	C12orf51 (1.9)	OASL (1.9)
ENSG00000111664	GNB3 PPI subnetwork	0.91	> 0.20	ITGB3 (2.9)	TMEM50A (1.9)	TM6SF2 (1.9)	SLC44A2 (1.5)	CYP7A1 (1.4)	HAPLN4 (1.4)	ENSG00000254235 (1.4)	HLX (1.4)	CETP (1.3)	COL4A3BP (1.3)
MP:0004393	abnormal cochlear inner hair cell morphology	0.91	> 0.20	CILP2 (4.0)	PLEKHH2 (3.0)	CELSR2 (2.7)	BCAM (2.5)	RELB (2.3)	ATXN7L2 (2.0)	DHX38 (1.8)	CEACAM19 (1.6)	ATP13A1 (1.4)	ATXN2 (1.4)
GO:0030832	regulation of actin filament length	0.91	> 0.20	ADAM1 (2.8)	ENSG00000238078 (2.4)	ABO (2.0)	C17orf57 (1.9)	ST3GAL4 (1.9)	CYB561D1 (1.8)	TMEM50A (1.7)	CBLC (1.7)	C1orf63 (1.6)	C11orf9 (1.6)
GO:0023019	signal transduction involved in regulation of gene expression	0.91	> 0.20	ABO (3.2)	LPAR2 (2.8)	AP1M2 (2.2)	C11orf9 (1.6)	DNAH11 (1.4)	HNF1A (1.2)	ENSG00000238078 (1.2)	NPC1L1 (1.1)	KIAA1324 (1.0)	PMFBP1 (1.0)
ENSG00000198744	ENSG00000198744 PPI subnetwork	0.91	> 0.20	OGDH (4.4)	ACAD10 (3.4)	PSMA5 (3.1)	C12orf47 (2.6)	TOMM40 (1.9)	GOT2P1 (1.8)	CLPTM1 (1.7)	ERP29 (1.7)	C19orf52 (1.5)	FRK (1.5)
ENSG00000168393	DTYMK PPI subnetwork	0.91	> 0.20	USP1 (2.6)	C1orf63 (2.1)	TMEM50A (1.9)	BRAP (1.8)	FEN1 (1.8)	ACAD10 (1.7)	MYLIP (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.5)	DHODH (1.5)
ENSG00000215694	ENSG00000215694 PPI subnetwork	0.91	> 0.20	USP1 (2.6)	C1orf63 (2.1)	TMEM50A (1.9)	BRAP (1.8)	FEN1 (1.8)	ACAD10 (1.7)	MYLIP (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.5)	DHODH (1.5)
ENSG00000089009	RPL6 PPI subnetwork	0.91	> 0.20	ILF3 (2.5)	NAA25 (2.1)	DDX56 (2.0)	TOP1 (1.9)	NKPD1 (1.7)	ADAM1 (1.7)	GATAD2A (1.7)	DHX38 (1.7)	ZNF259 (1.5)	C12orf43 (1.5)
GO:0048070	regulation of developmental pigmentation	0.91	> 0.20	C12orf43 (2.6)	MYLIP (2.4)	HNF1A (2.0)	DNAH11 (1.9)	BRAP (1.9)	GATAD2A (1.8)	POLK (1.7)	C17orf57 (1.7)	TRAPPC6A (1.4)	ERP29 (1.3)
GO:0055069	zinc ion homeostasis	0.91	> 0.20	YIPF2 (2.3)	NPC1L1 (2.0)	PBX4 (1.7)	ENSG00000226648 (1.6)	HNF1A (1.4)	RHCE (1.4)	ATP13A1 (1.4)	CILP2 (1.3)	TOP1 (1.3)	ZHX3 (1.2)
GO:0006882	cellular zinc ion homeostasis	0.91	> 0.20	YIPF2 (2.3)	NPC1L1 (2.0)	PBX4 (1.7)	ENSG00000226648 (1.6)	HNF1A (1.4)	RHCE (1.4)	ATP13A1 (1.4)	CILP2 (1.3)	TOP1 (1.3)	ZHX3 (1.2)
REACTOME_NUCLEOSOME_ASSEMBLY	REACTOME_NUCLEOSOME_ASSEMBLY	0.91	> 0.20	PSRC1 (4.2)	FEN1 (3.4)	USP1 (3.1)	POC5 (1.6)	DYNC2LI1 (1.6)	GMPR (1.5)	TXNL4B (1.2)	ZNF180 (1.1)	MYLIP (0.9)	RHCE (0.9)
REACTOME_DEPOSITION_OF_NEW_CENPA:CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	REACTOME_DEPOSITION_OF_NEW_CENPA:CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	0.91	> 0.20	PSRC1 (4.2)	FEN1 (3.4)	USP1 (3.1)	POC5 (1.6)	DYNC2LI1 (1.6)	GMPR (1.5)	TXNL4B (1.2)	ZNF180 (1.1)	MYLIP (0.9)	RHCE (0.9)
GO:0043486	histone exchange	0.91	> 0.20	PSRC1 (2.8)	POC5 (2.8)	TSSK6 (2.6)	TXNL4B (2.5)	ENSG00000226648 (2.3)	NKPD1 (2.1)	PMFBP1 (1.9)	USP1 (1.9)	DYNC2LI1 (1.5)	TRAPPC6A (1.4)
MP:0005503	abnormal tendon morphology	0.91	> 0.20	CILP2 (8.0)	MYLIP (2.2)	FRK (2.2)	BLOC1S3 (1.6)	MAFB (1.2)	CYB561D1 (1.2)	KANK2 (1.2)	ENSG00000254235 (1.1)	PCSK9 (1.1)	KIAA1324 (0.9)
GO:0000313	organellar ribosome	0.91	> 0.20	GEMIN7 (4.1)	TOMM40 (2.5)	PSMA5 (2.4)	C12orf43 (2.1)	TRAPPC6A (1.8)	C19orf52 (1.5)	DHODH (1.5)	C12orf47 (1.1)	TMEM116 (1.0)	ERP29 (1.0)
GO:0005761	mitochondrial ribosome	0.91	> 0.20	GEMIN7 (4.1)	TOMM40 (2.5)	PSMA5 (2.4)	C12orf43 (2.1)	TRAPPC6A (1.8)	C19orf52 (1.5)	DHODH (1.5)	C12orf47 (1.1)	TMEM116 (1.0)	ERP29 (1.0)
REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS	0.91	> 0.20	PLG (3.6)	ANGPTL3 (3.1)	SYPL2 (2.1)	TMEM116 (1.9)	TM6SF2 (1.7)	DHODH (1.6)	CILP2 (1.6)	ABO (1.4)	C11orf9 (1.4)	PMFBP1 (1.3)
ENSG00000104142	VPS18 PPI subnetwork	0.91	> 0.20	C12orf43 (3.8)	BRAP (3.4)	TRAFD1 (2.4)	SARS (2.3)	ACAD10 (2.3)	ZNF259 (2.1)	TXNL4B (1.9)	MAPKAPK5 (1.9)	ZNF101 (1.8)	SORT1 (1.8)
ENSG00000062725	APPBP2 PPI subnetwork	0.91	> 0.20	C19orf52 (3.6)	YIPF2 (2.7)	ABO (2.5)	UBXN2B (2.1)	PARP10 (2.0)	SUGP1 (1.9)	TRAFD1 (1.7)	SYPL2 (1.6)	GOT2P1 (1.6)	DHX38 (1.4)
MP:0008528	polycystic kidney	0.91	> 0.20	DYNC2LI1 (5.2)	HAVCR1 (3.1)	PLEKHH2 (2.4)	AMIGO1 (2.4)	C17orf57 (2.0)	HNF1A (1.9)	C11orf9 (1.9)	KANK2 (1.7)	DOCK7 (1.6)	BCAM (1.6)
GO:0031109	microtubule polymerization or depolymerization	0.91	> 0.20	POC5 (3.6)	C17orf57 (2.1)	CEACAM19 (1.9)	PSRC1 (1.9)	DNAH11 (1.8)	LPAR2 (1.7)	PBX4 (1.5)	UBXN2B (1.5)	POLK (1.4)	TSSK6 (1.3)
MP:0008263	abnormal hippocampus CA1 region morphology	0.91	> 0.20	NCAN (2.7)	CELSR2 (2.3)	TMED4 (2.3)	PARP10 (2.1)	GCNT4 (2.0)	C19orf52 (1.8)	MYLIP (1.7)	APOE (1.7)	HLX (1.6)	TMEM50A (1.3)
MP:0000820	abnormal choroid plexus morphology	0.91	> 0.20	ERP29 (1.9)	HAVCR1 (1.9)	DYNC2LI1 (1.7)	CELSR2 (1.7)	BCAM (1.7)	SLC44A2 (1.5)	APOE (1.4)	GCNT4 (1.4)	PVRL2 (1.3)	ATP13A1 (1.3)
GO:0002042	cell migration involved in sprouting angiogenesis	0.91	> 0.20	CEACAM19 (2.5)	TRIB1 (2.4)	ATXN7L2 (2.2)	PVR (1.6)	ENSG00000228044 (1.5)	TSSK6 (1.5)	TMEM116 (1.5)	ENSG00000226648 (1.3)	SH2B3 (1.3)	FRK (1.3)
ENSG00000188763	FZD9 PPI subnetwork	0.91	> 0.20	CBLC (3.2)	BCAM (3.2)	C11orf9 (2.5)	NYNRIN (2.1)	CILP2 (1.9)	TSSK6 (1.5)	AMIGO1 (1.5)	YIPF2 (1.4)	ABO (1.4)	LPAR2 (1.3)
GO:0019098	reproductive behavior	0.91	> 0.20	ZHX3 (2.9)	GOT2P1 (2.4)	ERP29 (2.1)	NKPD1 (2.0)	CEACAM19 (1.9)	C17orf57 (1.9)	GCNT4 (1.9)	DNAH11 (1.6)	COL4A3BP (1.5)	TSSK6 (1.5)
GO:0070585	protein localization in mitochondrion	0.91	> 0.20	GEMIN7 (3.3)	ZNF259 (3.0)	TOMM40 (2.7)	BRAP (2.1)	ENSG00000226645 (2.1)	TRAPPC6A (2.0)	TXNL4B (2.0)	DHODH (1.8)	C12orf47 (1.6)	ACAD10 (1.6)
ENSG00000144713	RPL32 PPI subnetwork	0.91	> 0.20	NKPD1 (3.1)	NAA25 (1.8)	MAPKAPK5 (1.8)	MOSC1 (1.6)	PTPN11 (1.5)	ADAM1 (1.4)	ERP29 (1.4)	ATP13A1 (1.3)	GATAD2A (1.3)	CEACAM19 (1.2)
GO:0010623	developmental programmed cell death	0.91	> 0.20	LPIN3 (2.0)	ANKRD31 (2.0)	TSSK6 (1.9)	AP1M2 (1.7)	NKPD1 (1.6)	CEACAM19 (1.6)	UBXN2B (1.5)	GATAD2A (1.5)	PVR (1.4)	QTRT1 (1.3)
ENSG00000101213	PTK6 PPI subnetwork	0.91	> 0.20	FADS2 (2.5)	DOCK7 (2.5)	AP1M2 (2.3)	DNAH11 (2.3)	TMEM57 (2.2)	MYLIP (1.5)	CELSR2 (1.5)	CETP (1.4)	POLK (1.4)	FRK (1.4)
MP:0000826	abnormal third ventricle morphology	0.91	> 0.20	MARK4 (2.7)	CLPTM1 (2.1)	CELSR2 (2.1)	C12orf51 (2.0)	GRINA (1.9)	POLK (1.9)	PPP1R37 (1.6)	ATXN2 (1.6)	GEMIN7 (1.6)	ATP13A1 (1.4)
MP:0010263	total cataracts	0.91	> 0.20	ADAM1 (2.2)	C12orf47 (2.1)	GOT2P1 (1.9)	NPC1L1 (1.8)	PMFBP1 (0.9)	ABCG8 (0.8)	QTRT1 (0.8)	GCNT4 (0.7)	HNF1A (0.7)	UBXN2B (0.7)
GO:0015935	small ribosomal subunit	0.91	> 0.20	GEMIN7 (4.2)	C12orf43 (1.8)	TRAPPC6A (1.7)	TOMM40 (1.6)	NKPD1 (1.4)	ERP29 (1.3)	DDX56 (1.2)	GMPR (1.1)	CBLC (1.1)	QTRT1 (1.0)
GO:0051057	positive regulation of small GTPase mediated signal transduction	0.91	> 0.20	ANKRD31 (3.4)	PBX4 (3.3)	GEMIN7 (2.3)	PLEKHH2 (1.9)	C17orf57 (1.9)	TIMD4 (1.7)	LPA (1.7)	PTPN11 (1.6)	ENSG00000228044 (1.4)	TMEM50A (1.4)
GO:0030323	respiratory tube development	0.91	> 0.20	C11orf9 (4.4)	PLEKHH2 (4.1)	CYP7A1 (2.0)	BCAM (2.0)	ALDH2 (1.9)	NYNRIN (1.9)	DYNC2LI1 (1.7)	HLX (1.7)	ENSG00000226648 (1.6)	KANK2 (1.6)
GO:0008105	asymmetric protein localization	0.91	> 0.20	ENSG00000226648 (2.7)	COL4A3BP (2.7)	HAPLN4 (2.2)	SLC44A2 (2.2)	DYNC2LI1 (1.8)	CELSR2 (1.8)	ENSG00000235545 (1.6)	TRAPPC6A (1.5)	SORT1 (1.5)	BLOC1S3 (1.4)
ENSG00000127564	PKMYT1 PPI subnetwork	0.91	> 0.20	PSRC1 (4.2)	ILF3 (2.1)	NCAN (1.8)	POC5 (1.8)	ZNF101 (1.7)	ENSG00000226648 (1.7)	BUD13 (1.7)	MARK4 (1.6)	OASL (1.6)	UBXN2B (1.5)
GO:0072527	pyrimidine-containing compound metabolic process	0.91	> 0.20	TSSK6 (2.6)	DYNC2LI1 (2.6)	ANKRD31 (2.5)	TXNL4B (2.1)	LPA (2.0)	ADAM1 (1.8)	TMEM116 (1.6)	ACAD10 (1.5)	ANGPTL3 (1.4)	AMIGO1 (1.4)
ENSG00000124635	HIST1H2BJ PPI subnetwork	0.91	> 0.20	SMARCA4 (2.9)	USP1 (2.3)	BUD13 (2.3)	ILF3 (2.1)	SUGP1 (1.7)	DDX56 (1.7)	GMPR (1.7)	ATXN2 (1.6)	TMEM57 (1.6)	DNAH11 (1.3)
GO:0035023	regulation of Rho protein signal transduction	0.91	> 0.20	LPAR2 (3.1)	PBX4 (2.8)	ENSG00000226645 (2.2)	PLEKHH2 (2.0)	CBLC (1.9)	AP1M2 (1.9)	GMIP (1.8)	LPIN3 (1.8)	PPP1R37 (1.8)	ST3GAL4 (1.7)
GO:0015175	neutral amino acid transmembrane transporter activity	0.91	> 0.20	SARS (5.0)	NPC1L1 (2.2)	RHD (2.1)	ERP29 (2.0)	RHCE (2.0)	PCSK9 (1.8)	GPAM (1.7)	BLOC1S3 (1.6)	TM6SF2 (1.6)	ATP13A1 (1.6)
GO:0001727	lipid kinase activity	0.91	> 0.20	PPP1R37 (3.3)	GATAD2A (3.0)	BLOC1S3 (2.9)	HAPLN4 (2.7)	GMIP (2.3)	DNM2 (2.2)	CYB561D1 (2.0)	TMEM57 (1.7)	MARK4 (1.6)	NT5DC1 (1.5)
MP:0001292	abnormal lens vesicle development	0.91	> 0.20	TRAPPC6A (2.0)	MAFB (1.7)	MYLIP (1.7)	TMED4 (1.5)	ENSG00000226648 (1.4)	CELSR2 (1.4)	PBX4 (1.3)	MOSC1 (1.2)	LPAR2 (1.1)	DOCK7 (1.1)
ENSG00000127586	CHTF18 PPI subnetwork	0.91	> 0.20	FEN1 (5.2)	USP1 (5.2)	PSRC1 (2.4)	ILF3 (2.2)	AMIGO1 (1.6)	SORT1 (1.5)	ATP13A1 (1.3)	ENSG00000228044 (1.2)	SMARCA4 (1.2)	ERP29 (1.1)
GO:0033057	multicellular organismal reproductive behavior	0.91	> 0.20	GOT2P1 (3.6)	NKPD1 (2.9)	ZHX3 (2.8)	C17orf57 (2.5)	HNF1A (2.2)	CEACAM19 (1.9)	COL4A3BP (1.8)	ERP29 (1.8)	KIAA1324 (1.3)	C12orf47 (1.3)
GO:0021695	cerebellar cortex development	0.91	> 0.20	TMEM116 (2.7)	HAPLN4 (2.5)	ENSG00000238078 (2.3)	C12orf51 (2.1)	ERP29 (2.0)	ENSG00000226648 (2.0)	ENSG00000235545 (1.9)	ZHX3 (1.8)	ANKRD31 (1.6)	DNAH11 (1.5)
GO:0009952	anterior/posterior pattern specification	0.91	> 0.20	ATXN7L2 (2.4)	ABO (2.1)	ANKRD31 (1.9)	NYNRIN (1.9)	CEACAM19 (1.7)	ENSG00000254235 (1.4)	TSSK6 (1.4)	BCAM (1.3)	UBXN2B (1.3)	PVRL2 (1.2)
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.91	> 0.20	PSRC1 (2.7)	SORT1 (2.4)	GATAD2A (2.0)	FEN1 (1.9)	PVRL2 (1.8)	MYLIP (1.7)	USP1 (1.7)	DNM2 (1.4)	ENSG00000238078 (1.3)	CELSR2 (1.3)
GO:0046939	nucleotide phosphorylation	0.91	> 0.20	DYNC2LI1 (3.8)	ENSG00000226648 (2.8)	PMFBP1 (2.0)	DNAH11 (2.0)	PBX4 (1.8)	ZNF180 (1.7)	C12orf43 (1.6)	NT5DC1 (1.6)	GEMIN7 (1.4)	MOSC1 (1.3)
GO:0019002	GMP binding	0.91	> 0.20	MOSC1 (2.5)	CETP (2.4)	GOT2P1 (2.3)	ENSG00000235545 (2.1)	LPIN3 (1.6)	ITGB3 (1.5)	CYP7A1 (1.5)	LPA (1.2)	ENSG00000238078 (1.2)	ENSG00000254235 (1.2)
ENSG00000113368	LMNB1 PPI subnetwork	0.91	> 0.20	PSRC1 (2.7)	C11orf9 (2.3)	ABCG8 (2.2)	SH2B3 (2.1)	USP1 (1.8)	POC5 (1.7)	FEN1 (1.6)	CYP7A1 (1.5)	ENSG00000228044 (1.5)	ENSG00000238078 (1.5)
ENSG00000170145	SIK2 PPI subnetwork	0.91	> 0.20	MARK4 (3.1)	C12orf51 (2.8)	PSRC1 (2.2)	BUD13 (2.1)	GMIP (2.0)	LPAR2 (1.9)	SORT1 (1.6)	ATXN2 (1.6)	USP24 (1.6)	PTPN11 (1.5)
GO:0050863	regulation of T cell activation	0.91	> 0.20	ZNF101 (4.3)	PLCG1 (3.2)	PBX4 (2.7)	TIMD4 (2.3)	CETP (2.0)	POLK (1.4)	OGDH (1.4)	GMIP (1.3)	RELB (1.1)	TRAFD1 (1.1)
GO:0009950	dorsal/ventral axis specification	0.91	> 0.20	CEACAM19 (2.3)	ENSG00000226648 (2.1)	LPAR2 (2.1)	C11orf9 (2.0)	TMEM116 (1.8)	NYNRIN (1.6)	C19orf52 (1.6)	MARK4 (1.5)	PVRL2 (1.5)	AMIGO1 (1.2)
MP:0008027	abnormal spinal cord white matter morphology	0.91	> 0.20	AMIGO1 (2.3)	USP24 (2.2)	NCAN (2.1)	HAPLN4 (2.0)	ENSG00000254235 (1.9)	APOE (1.6)	CYP7A1 (1.5)	GMPR (1.5)	FADS2 (1.4)	LPA (1.4)
ENSG00000163251	FZD5 PPI subnetwork	0.91	> 0.20	BCAM (2.8)	CBLC (2.6)	CILP2 (2.1)	C11orf9 (2.0)	NYNRIN (1.6)	TSSK6 (1.5)	YIPF2 (1.4)	PBX4 (1.3)	ABO (1.2)	AMIGO1 (1.2)
MP:0002016	ovary cysts	0.91	> 0.20	MYLIP (2.3)	KANK2 (2.2)	ABO (2.1)	NKPD1 (1.8)	DYNC2LI1 (1.5)	TIMD4 (1.4)	APOC1 (1.4)	TRAFD1 (1.3)	GOT2P1 (1.3)	TXNL4B (1.2)
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX	0.91	> 0.20	OGDH (4.0)	GPAM (3.5)	ACAD10 (2.1)	TXNL4B (2.0)	UBXN2B (1.8)	C19orf52 (1.8)	SYPL2 (1.5)	NT5DC1 (1.4)	DHODH (1.3)	TSSK6 (1.2)
ENSG00000198087	CD2AP PPI subnetwork	0.91	> 0.20	GMIP (3.1)	MAFB (2.8)	ATXN2 (2.7)	MAPKAPK5 (2.6)	C12orf47 (2.5)	DNM2 (2.2)	TMEM50A (2.0)	AP1M2 (2.0)	TMEM57 (2.0)	PSMA5 (1.8)
ENSG00000115306	SPTBN1 PPI subnetwork	0.91	> 0.20	DNM2 (2.6)	ITGB3 (2.3)	SMARCA4 (2.3)	ENSG00000238078 (2.0)	TMEM50A (2.0)	SLC44A2 (1.8)	PLEC (1.8)	SORT1 (1.8)	MARK4 (1.8)	ABO (1.7)
GO:0003170	heart valve development	0.91	> 0.20	ENSG00000226648 (3.9)	MAFB (1.7)	C19orf52 (1.6)	GCNT4 (1.5)	MARK4 (1.5)	TMEM57 (1.4)	CILP2 (1.3)	TRAPPC6A (1.3)	TM6SF2 (1.3)	HLX (1.3)
GO:0090023	positive regulation of neutrophil chemotaxis	0.91	> 0.20	ENSG00000228044 (3.1)	CILP2 (2.0)	TIMD4 (1.6)	C12orf47 (1.6)	APOE (1.5)	CETP (1.4)	BLOC1S3 (1.3)	GMIP (1.0)	ZNF101 (0.9)	DHODH (0.9)
GO:0035690	cellular response to drug	0.91	> 0.20	DNAH11 (3.3)	PMFBP1 (2.1)	ENSG00000235545 (2.0)	HNF1A (1.9)	SH2B3 (1.5)	GEMIN7 (1.4)	ADAM1 (1.4)	ENSG00000226645 (1.1)	ENSG00000254235 (1.1)	ZNF101 (1.1)
KEGG_ERBB_SIGNALING_PATHWAY	KEGG_ERBB_SIGNALING_PATHWAY	0.91	> 0.20	MARK4 (3.1)	DNM2 (2.4)	PVR (2.2)	GATAD2A (2.2)	POLK (2.1)	NCAN (1.9)	ZHX3 (1.9)	TRIB1 (1.8)	CARM1 (1.8)	PTPN11 (1.7)
GO:0007018	microtubule-based movement	0.91	> 0.20	DNAH11 (5.2)	DYNC2LI1 (2.1)	PSRC1 (1.8)	POC5 (1.7)	C12orf51 (1.6)	POLK (1.2)	NKPD1 (1.2)	C12orf47 (1.2)	PBX4 (1.1)	ACAD10 (1.1)
GO:0046324	regulation of glucose import	0.91	> 0.20	GPAM (2.9)	NPC1L1 (2.7)	MOSC1 (2.0)	GCNT4 (1.9)	SORT1 (1.8)	AP1M2 (1.8)	PTPN11 (1.8)	TXNL4B (1.7)	TSSK6 (1.6)	ABCG8 (1.2)
ENSG00000175063	UBE2C PPI subnetwork	0.91	> 0.20	PSRC1 (4.9)	FEN1 (3.4)	POC5 (2.3)	ATXN2 (1.8)	SUGP1 (1.8)	USP1 (1.6)	RHCE (1.4)	DOCK7 (1.4)	LPAR2 (1.4)	MAU2 (1.3)
ENSG00000147677	EIF3H PPI subnetwork	0.91	> 0.20	SARS (2.6)	QTRT1 (2.5)	ILF3 (2.4)	C12orf43 (2.4)	PTPN11 (2.3)	NKPD1 (2.2)	DDX56 (2.1)	ZNF259 (2.0)	SUGP1 (2.0)	ATP13A1 (1.8)
GO:0007606	sensory perception of chemical stimulus	0.91	> 0.20	ENSG00000228044 (2.8)	GOT2P1 (2.8)	DNAH11 (2.7)	ABO (2.2)	PMFBP1 (2.0)	ENSG00000235545 (1.8)	CYB561D1 (1.7)	ZNF180 (1.2)	NKPD1 (0.9)	C17orf57 (0.7)
MP:0003203	increased neuron apoptosis	0.91	> 0.20	SORT1 (2.8)	TMEM57 (2.2)	TMED4 (2.2)	NT5DC1 (2.1)	TRIB1 (2.0)	PTPN11 (1.8)	HLX (1.7)	RHD (1.7)	RHCE (1.6)	PVR (1.6)
ENSG00000047056	WDR37 PPI subnetwork	0.91	> 0.20	NCAN (2.7)	AP1M2 (2.6)	PPP1R37 (2.1)	CELSR2 (2.1)	GOT2P1 (2.0)	C12orf43 (1.9)	ZNF180 (1.9)	UBXN2B (1.8)	LPIN3 (1.7)	RPH3A (1.7)
ENSG00000188386	PPP3R2 PPI subnetwork	0.91	> 0.20	COL4A3BP (2.5)	ZHX3 (1.9)	KIAA1324 (1.9)	SH2B3 (1.7)	C12orf47 (1.7)	GOT2P1 (1.7)	SLC44A2 (1.6)	GMIP (1.6)	HAVCR1 (1.5)	ATXN7L2 (1.4)
REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION	0.91	> 0.20	C11orf9 (2.7)	PVRL2 (2.5)	PVR (2.3)	TM6SF2 (2.3)	CEACAM19 (2.0)	PCSK9 (1.8)	BCAM (1.8)	TSSK6 (1.8)	TRAPPC6A (1.6)	NPC1L1 (1.5)
REACTOME_EGFR_DOWNREGULATION	REACTOME_EGFR_DOWNREGULATION	0.91	> 0.20	CLPTM1 (3.5)	DNM2 (3.4)	PPP1R37 (2.9)	MAU2 (2.4)	MARK4 (2.1)	SARS (2.0)	ENSG00000235545 (2.0)	CARM1 (2.0)	SMARCA4 (2.0)	DOCK7 (1.9)
GO:0060485	mesenchyme development	0.91	> 0.20	ENSG00000254235 (2.7)	MYLIP (2.3)	PLEKHH2 (2.3)	ABO (2.2)	NYNRIN (2.0)	KANK2 (1.9)	BCAM (1.6)	C11orf9 (1.6)	PVRL2 (1.6)	SLC44A2 (1.5)
ENSG00000183395	PMCH PPI subnetwork	0.91	> 0.20	KIAA1324 (2.6)	ENSG00000228044 (2.0)	NPC1L1 (1.9)	PMFBP1 (1.6)	ENSG00000235545 (1.6)	CELSR2 (1.4)	ADAM1 (1.4)	AMIGO1 (1.4)	C12orf47 (1.3)	MAU2 (1.2)
ENSG00000165672	PRDX3 PPI subnetwork	0.91	> 0.20	ACAD10 (3.0)	MOSC1 (2.1)	ENSG00000226645 (2.0)	ALDH2 (2.0)	TRAFD1 (1.7)	LPA (1.6)	USP24 (1.5)	MAPKAPK5 (1.4)	GPAM (1.3)	ENSG00000254235 (1.3)
GO:0050870	positive regulation of T cell activation	0.91	> 0.20	ZNF101 (3.3)	PLCG1 (2.6)	PBX4 (2.5)	TIMD4 (2.4)	CETP (2.4)	POLK (1.5)	GMIP (1.3)	OGDH (1.2)	RELB (1.2)	CYB561D1 (1.1)
ENSG00000149925	ALDOA PPI subnetwork	0.91	> 0.20	GRINA (2.9)	TRAFD1 (1.9)	CILP2 (1.8)	SYPL2 (1.8)	PARP10 (1.7)	POLK (1.7)	SARS (1.7)	POC5 (1.6)	ITGB3 (1.6)	SLC44A2 (1.5)
GO:0030665	clathrin coated vesicle membrane	0.91	> 0.20	RPH3A (4.0)	HAPLN4 (3.3)	GRINA (2.7)	PPP1R37 (2.4)	CELSR2 (2.2)	CLPTM1 (2.1)	AMIGO1 (1.9)	KIAA1324 (1.9)	C12orf51 (1.8)	SORT1 (1.7)
GO:0043525	positive regulation of neuron apoptotic process	0.91	> 0.20	PPP1R37 (2.5)	TRAPPC6A (2.1)	ADAM1 (2.0)	LPIN3 (1.8)	FRK (1.8)	LPAR2 (1.6)	TRAFD1 (1.6)	POLK (1.5)	GEMIN7 (1.5)	PBX4 (1.5)
GO:0030010	establishment of cell polarity	0.91	> 0.20	ENSG00000238078 (2.3)	PSRC1 (2.0)	PPP1R37 (1.7)	DYNC2LI1 (1.7)	HAVCR1 (1.6)	POC5 (1.6)	CETP (1.6)	ENSG00000226645 (1.4)	PTPN11 (1.3)	PLEC (1.3)
ENSG00000107130	NCS1 PPI subnetwork	0.91	> 0.20	ALDH2 (2.5)	NPC1L1 (2.3)	ABO (2.0)	TMEM57 (1.9)	CEACAM19 (1.8)	TM6SF2 (1.8)	GRINA (1.7)	ABCG8 (1.6)	NKPD1 (1.5)	GCNT4 (1.5)
GO:0002478	antigen processing and presentation of exogenous peptide antigen	0.91	> 0.20	PARP10 (2.7)	TMED4 (1.8)	NKPD1 (1.7)	C19orf52 (1.6)	ENSG00000235545 (1.5)	MYLIP (1.5)	APOE (1.5)	ALDH2 (1.5)	ABO (1.4)	MAU2 (1.3)
GO:0000209	protein polyubiquitination	0.91	> 0.20	BRAP (2.9)	TRAFD1 (2.8)	PSMA5 (2.6)	MAU2 (2.0)	NAA25 (1.8)	C19orf52 (1.7)	C12orf43 (1.6)	SUGP1 (1.6)	ENSG00000226645 (1.4)	ATXN2 (1.3)
GO:0045669	positive regulation of osteoblast differentiation	0.91	> 0.20	MAFB (2.0)	CARM1 (2.0)	ENSG00000226648 (1.8)	LPIN3 (1.6)	CILP2 (1.6)	POC5 (1.5)	ALDH2 (1.5)	ABO (1.4)	PLEKHH2 (1.3)	ZNF101 (1.3)
GO:0008308	voltage-gated anion channel activity	0.91	> 0.20	SYPL2 (2.7)	TMEM57 (2.6)	FADS2 (2.5)	FADS1 (2.4)	USP24 (2.3)	CLPTM1 (1.9)	AMIGO1 (1.7)	HMGCR (1.6)	LDLR (1.5)	RPH3A (1.5)
MP:0004215	abnormal myocardial fiber physiology	0.91	> 0.20	RHD (2.4)	BCAM (1.9)	SORT1 (1.6)	MOSC1 (1.6)	KANK2 (1.6)	SYPL2 (1.5)	GPAM (1.5)	HLX (1.4)	OGDH (1.3)	HP (1.3)
ENSG00000124588	NQO2 PPI subnetwork	0.91	> 0.20	MARK4 (3.8)	C12orf51 (3.5)	USP24 (2.6)	SORT1 (2.4)	LPAR2 (2.4)	GMIP (2.3)	BUD13 (2.0)	ATXN2 (1.9)	SLC44A2 (1.8)	PBX4 (1.7)
GO:0032616	interleukin-13 production	0.91	> 0.20	GCNT4 (2.1)	NT5DC1 (1.7)	NKPD1 (1.4)	ANKRD31 (1.2)	CETP (1.2)	TIMD4 (1.2)	DYNC2LI1 (1.1)	DNAH11 (1.1)	C17orf57 (1.1)	C12orf47 (1.0)
ENSG00000090520	DNAJB11 PPI subnetwork	0.91	> 0.20	GMPR (2.7)	PSRC1 (2.6)	DNM2 (2.2)	ATXN7L2 (2.1)	POLK (1.9)	CELSR2 (1.8)	PSMA5 (1.7)	NT5DC1 (1.6)	HLX (1.6)	BLOC1S3 (1.5)
ENSG00000213281	NRAS PPI subnetwork	0.91	> 0.20	DNM2 (2.5)	SH2B3 (2.0)	MAPKAPK5 (1.9)	ZNF101 (1.5)	ENSG00000228044 (1.5)	PLEC (1.5)	CARM1 (1.4)	TMEM50A (1.4)	GMIP (1.3)	TMEM57 (1.3)
MP:0006035	abnormal mitochondrial morphology	0.91	> 0.20	OGDH (3.1)	POC5 (2.7)	ENSG00000238078 (2.7)	ACAD10 (2.6)	DHODH (2.3)	MAPKAPK5 (2.2)	COL4A3BP (1.9)	BRAP (1.7)	GPAM (1.6)	NT5DC1 (1.6)
ENSG00000157168	NRG1 PPI subnetwork	0.91	> 0.20	GATAD2A (3.2)	PPP1R37 (2.0)	RPH3A (1.9)	C17orf57 (1.7)	ENSG00000226645 (1.5)	ANKRD31 (1.4)	OGDH (1.4)	BUD13 (1.3)	GOT2P1 (1.3)	NKPD1 (1.2)
GO:0015035	protein disulfide oxidoreductase activity	0.91	> 0.20	ERP29 (3.4)	KIAA1324 (2.5)	ACAD10 (2.4)	TIMD4 (2.1)	HNF1A (1.8)	DHODH (1.8)	YIPF2 (1.8)	PMFBP1 (1.7)	PSMA5 (1.5)	MOSC1 (1.4)
GO:0006888	ER to Golgi vesicle-mediated transport	0.91	> 0.20	YIPF2 (4.9)	C19orf52 (2.8)	CYB561D1 (2.7)	TMED4 (2.4)	TMEM57 (2.2)	SUGP1 (1.8)	OGDH (1.4)	BLOC1S3 (1.4)	TXNL4B (1.2)	LPIN3 (1.2)
MP:0004994	abnormal brain wave pattern	0.91	> 0.20	HAPLN4 (5.7)	RPH3A (4.9)	AMIGO1 (2.2)	ZHX3 (1.6)	FRK (1.5)	MAU2 (1.3)	ENSG00000226645 (1.3)	NCAN (1.2)	SORT1 (1.2)	ENSG00000226648 (1.1)
MP:0008079	decreased CD8-positive T cell number	0.91	> 0.20	ZNF101 (3.5)	PLCG1 (2.7)	GMIP (2.4)	RELB (2.4)	PARP10 (2.4)	PBX4 (1.6)	MAFB (1.4)	CETP (1.2)	TRAFD1 (1.2)	TIMD4 (1.0)
ENSG00000119139	TJP2 PPI subnetwork	0.91	> 0.20	AP1M2 (2.7)	PVRL2 (2.5)	PLEC (2.4)	SMARCA4 (1.9)	UBXN2B (1.8)	CELSR2 (1.7)	ATXN2 (1.6)	ADAM1 (1.6)	FRK (1.6)	HAVCR1 (1.6)
MP:0000755	hindlimb paralysis	0.91	> 0.20	TMED4 (3.1)	HAPLN4 (2.5)	APOE (2.5)	CLPTM1 (2.4)	GRINA (2.2)	TRAPPC6A (2.1)	DNM2 (2.1)	ERP29 (2.1)	C11orf9 (1.9)	SORT1 (1.8)
ENSG00000152700	SAR1B PPI subnetwork	0.91	> 0.20	YIPF2 (5.0)	TMED4 (2.5)	ABCG8 (2.3)	ADAM1 (1.6)	DHX38 (1.6)	PSMA5 (1.6)	C12orf51 (1.5)	DOCK7 (1.5)	ATXN2 (1.4)	OGDH (1.3)
MP:0000005	increased brown adipose tissue amount	0.91	> 0.20	SYPL2 (3.6)	GPAM (2.3)	MOSC1 (2.2)	HAPLN4 (2.0)	GMPR (1.5)	ENSG00000226645 (1.5)	POLK (1.3)	PMFBP1 (1.3)	CELSR2 (1.3)	HP (1.2)
GO:0031235	intrinsic to internal side of plasma membrane	0.91	> 0.20	RHD (6.1)	RHCE (5.7)	SLC44A2 (2.8)	PLEC (2.0)	RPH3A (1.9)	ABO (1.9)	ZNF101 (1.8)	USP24 (1.7)	KANK2 (1.6)	ENSG00000226648 (1.5)
ENSG00000139970	RTN1 PPI subnetwork	0.91	> 0.20	RPH3A (2.8)	C11orf9 (2.5)	HAPLN4 (2.2)	TMEM50A (2.2)	TRAFD1 (2.0)	GRINA (1.8)	ALDH2 (1.8)	PVRL2 (1.8)	ABCG8 (1.7)	ENSG00000226645 (1.7)
GO:0097061	dendritic spine organization	0.91	> 0.20	HNF1A (3.6)	NCAN (2.4)	ANKRD31 (2.1)	PLEKHH2 (2.0)	LPAR2 (1.9)	LPIN3 (1.8)	GOT2P1 (1.8)	TMEM116 (1.5)	RPH3A (1.5)	ACAD10 (1.3)
GO:0060997	dendritic spine morphogenesis	0.91	> 0.20	HNF1A (3.6)	NCAN (2.4)	ANKRD31 (2.1)	PLEKHH2 (2.0)	LPAR2 (1.9)	LPIN3 (1.8)	GOT2P1 (1.8)	TMEM116 (1.5)	RPH3A (1.5)	ACAD10 (1.3)
ENSG00000038382	TRIO PPI subnetwork	0.91	> 0.20	PLEC (2.8)	ALDH2 (2.4)	DNM2 (2.2)	PBX4 (1.9)	BLOC1S3 (1.9)	LPIN3 (1.9)	SH2B3 (1.7)	POLK (1.6)	GOT2P1 (1.4)	ENSG00000254235 (1.4)
ENSG00000112739	PRPF4B PPI subnetwork	0.91	> 0.20	FEN1 (2.3)	TOMM40 (2.3)	USP1 (2.3)	C1orf63 (2.2)	ILF3 (1.9)	ERP29 (1.6)	SYPL2 (1.5)	NAA25 (1.4)	C12orf43 (1.4)	DDX56 (1.4)
MP:0003393	decreased cardiac output	0.91	> 0.20	SORT1 (3.1)	KIAA1324 (2.6)	GMPR (2.3)	ENSG00000228044 (1.7)	AMIGO1 (1.6)	HAVCR1 (1.6)	ACAD10 (1.5)	SYPL2 (1.4)	GCNT4 (1.3)	PMFBP1 (1.3)
GO:0051784	negative regulation of nuclear division	0.91	> 0.20	POC5 (3.1)	PSRC1 (2.3)	GEMIN7 (2.2)	TMEM116 (1.8)	C11orf9 (1.5)	C1orf63 (1.4)	ENSG00000228044 (1.4)	SUGP1 (1.3)	UBXN2B (1.3)	CBLC (1.3)
GO:0045839	negative regulation of mitosis	0.91	> 0.20	POC5 (3.1)	PSRC1 (2.3)	GEMIN7 (2.2)	TMEM116 (1.8)	C11orf9 (1.5)	C1orf63 (1.4)	ENSG00000228044 (1.4)	SUGP1 (1.3)	UBXN2B (1.3)	CBLC (1.3)
MP:0000830	abnormal diencephalon morphology	0.91	> 0.20	NYNRIN (2.3)	SMARCA4 (2.0)	HAPLN4 (1.6)	ABO (1.3)	NT5DC1 (1.2)	NCAN (1.2)	FADS1 (1.2)	ZNF101 (1.2)	C17orf57 (1.1)	ALDH2 (1.1)
GO:0046134	pyrimidine nucleoside biosynthetic process	0.91	> 0.20	TXNL4B (2.6)	GOT2P1 (2.5)	ANKRD31 (2.0)	LPIN3 (1.8)	DHX38 (1.7)	DHODH (1.5)	CEACAM19 (1.5)	ACAD10 (1.5)	ADAM1 (1.3)	QTRT1 (1.2)
ENSG00000121067	SPOP PPI subnetwork	0.91	> 0.20	MAU2 (2.7)	GMIP (2.7)	LPAR2 (2.5)	BLOC1S3 (2.5)	GRINA (2.2)	ENSG00000238078 (1.9)	ATP13A1 (1.9)	UBXN2B (1.7)	DNM2 (1.7)	PARP10 (1.5)
GO:0052312	modulation of transcription in other organism involved in symbiotic interaction	0.91	> 0.20	ENSG00000226645 (2.7)	BUD13 (2.7)	ZNF101 (2.0)	ENSG00000235545 (1.9)	C1orf63 (1.8)	ADAM1 (1.8)	CARM1 (1.7)	GATAD2A (1.6)	ENSG00000238078 (1.6)	MAPKAPK5 (1.6)
ENSG00000176894	PXMP2 PPI subnetwork	0.91	> 0.20	ZHX3 (2.1)	TRAPPC6A (1.6)	MAFB (1.6)	UBXN2B (1.5)	MAPKAPK5 (1.4)	C19orf52 (1.4)	TXNL4B (1.4)	MOSC1 (1.4)	ACAD10 (1.3)	SLC44A2 (1.3)
ENSG00000173786	CNP PPI subnetwork	0.91	> 0.20	NCAN (2.3)	RPH3A (2.3)	C12orf43 (2.1)	DNAH11 (2.0)	ERP29 (1.9)	TMEM50A (1.9)	AMIGO1 (1.9)	GOT2P1 (1.7)	FADS1 (1.7)	CELSR2 (1.5)
GO:0015172	acidic amino acid transmembrane transporter activity	0.91	> 0.20	NCAN (3.7)	ABCG8 (3.4)	HAPLN4 (3.2)	GCNT4 (2.5)	ABCG5 (2.2)	CYP7A1 (2.2)	TM6SF2 (2.1)	RPH3A (1.8)	AMIGO1 (1.7)	ALDH2 (1.4)
MP:0006000	abnormal corneal epithelium morphology	0.91	> 0.20	LPA (2.7)	CILP2 (2.4)	MAFB (2.0)	BCAM (2.0)	ENSG00000254235 (1.7)	CELSR2 (1.7)	HAVCR1 (1.5)	SLC22A1 (1.4)	APOC1 (1.3)	FRK (1.3)
MP:0008974	proportional dwarf	0.91	> 0.20	KIAA1324 (2.9)	ANKRD31 (1.8)	GCNT4 (1.7)	GPAM (1.7)	APOA5 (1.7)	TMED4 (1.5)	C17orf57 (1.4)	CETP (1.4)	C12orf47 (1.2)	MOSC1 (1.1)
GO:0046323	glucose import	0.91	> 0.20	GPAM (3.0)	NPC1L1 (2.5)	PTPN11 (2.2)	MOSC1 (2.1)	GCNT4 (2.0)	TSSK6 (1.8)	SORT1 (1.8)	AP1M2 (1.8)	TXNL4B (1.4)	KIAA1324 (1.3)
ENSG00000174903	RAB1B PPI subnetwork	0.91	> 0.20	CYB561D1 (2.7)	TMED4 (2.4)	PMFBP1 (2.0)	POLK (1.9)	ENSG00000238078 (1.9)	HAPLN4 (1.8)	COL4A3BP (1.8)	HLX (1.7)	SARS (1.7)	GMIP (1.7)
ENSG00000161326	DUSP14 PPI subnetwork	0.91	> 0.20	TM6SF2 (3.1)	ABCG8 (2.4)	LPIN3 (2.4)	NPC1L1 (2.1)	HAPLN4 (2.0)	MYLIP (1.9)	PBX4 (1.6)	LDLR (1.6)	DNAH11 (1.6)	ENSG00000226645 (1.5)
REACTOME_BRANCHED:CHAIN_AMINO_ACID_CATABOLISM	REACTOME_BRANCHED:CHAIN_AMINO_ACID_CATABOLISM	0.91	> 0.20	ACAD10 (3.6)	DYNC2LI1 (2.8)	ALDH2 (2.7)	TRAPPC6A (2.5)	NT5DC1 (2.3)	QTRT1 (2.3)	DHODH (2.2)	GPAM (2.1)	OGDH (2.1)	UBXN2B (1.6)
GO:0002088	lens development in camera-type eye	0.91	> 0.20	C17orf57 (1.6)	C11orf9 (1.6)	ANKRD31 (1.4)	C19orf52 (1.3)	TMEM57 (1.0)	ZHX3 (1.0)	PLEC (0.9)	PBX4 (0.9)	TMED4 (0.9)	CILP2 (0.8)
ENSG00000130288	ENSG00000130288 PPI subnetwork	0.91	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.7)	C12orf47 (2.6)	GOT2P1 (1.8)	MAU2 (1.7)	PSMA5 (1.6)	FRK (1.6)	GMPR (1.4)	TMED4 (1.3)
ENSG00000182149	IST1 PPI subnetwork	0.91	> 0.20	TXNL4B (3.3)	DDX56 (2.7)	DHODH (2.6)	TOMM40 (2.5)	SARS (2.4)	SUGP1 (2.3)	ZNF259 (1.8)	GOT2P1 (1.7)	TRAPPC6A (1.7)	PSMA5 (1.6)
GO:0006892	post-Golgi vesicle-mediated transport	0.91	> 0.20	C17orf57 (3.5)	GEMIN7 (3.2)	YIPF2 (2.5)	C1orf63 (2.5)	FRK (2.3)	COL4A3BP (2.1)	BLOC1S3 (2.1)	USP24 (2.0)	MAU2 (1.9)	AP1M2 (1.8)
MP:0005643	decreased dopamine level	0.91	> 0.20	GMPR (2.5)	AMIGO1 (2.2)	BLOC1S3 (2.0)	PMFBP1 (1.6)	ENSG00000254235 (1.6)	PVR (1.5)	RHCE (1.5)	C12orf51 (1.5)	ST3GAL4 (1.4)	ZHX3 (1.3)
ENSG00000185345	PARK2 PPI subnetwork	0.91	> 0.20	DNAH11 (2.4)	ENSG00000254235 (2.1)	PSMA5 (2.0)	ENSG00000226648 (1.9)	SORT1 (1.9)	RPH3A (1.7)	NCAN (1.7)	C1orf63 (1.7)	CELSR2 (1.6)	GMPR (1.6)
REACTOME_RNA_POLYMERASE_I_PROMOTER_OPENING	REACTOME_RNA_POLYMERASE_I_PROMOTER_OPENING	0.91	> 0.20	ENSG00000226645 (1.6)	GMPR (1.4)	PSRC1 (1.3)	MYLIP (1.3)	BUD13 (1.2)	TMEM57 (1.1)	C19orf52 (1.1)	ZNF180 (1.0)	ENSG00000235545 (1.0)	USP1 (1.0)
ENSG00000133318	RTN3 PPI subnetwork	0.91	> 0.20	C12orf43 (2.5)	NCAN (2.3)	SORT1 (2.1)	ALDH2 (1.9)	CELSR2 (1.9)	TMEM50A (1.9)	RPH3A (1.8)	AMIGO1 (1.8)	FADS1 (1.6)	ZNF180 (1.5)
GO:0001934	positive regulation of protein phosphorylation	0.91	> 0.20	ENSG00000226645 (2.6)	SH2B3 (2.0)	COL4A3BP (1.8)	PVR (1.8)	PLEKHH2 (1.5)	PTPN11 (1.4)	MYLIP (1.4)	GCNT4 (1.2)	HLX (1.2)	POC5 (1.2)
ENSG00000184313	HEATR8 PPI subnetwork	0.91	> 0.20	DHX38 (2.4)	TXNL4B (1.9)	FEN1 (1.7)	PMFBP1 (1.6)	COL4A3BP (1.5)	DHODH (1.5)	DNAH11 (1.4)	CETP (1.3)	ILF3 (1.3)	SORT1 (1.2)
ENSG00000097033	SH3GLB1 PPI subnetwork	0.91	> 0.20	PPP1R37 (2.2)	GMIP (1.9)	PLEC (1.9)	ATP13A1 (1.9)	NKPD1 (1.7)	CLPTM1 (1.6)	QTRT1 (1.6)	USP24 (1.5)	DNM2 (1.5)	PLEKHH2 (1.3)
ENSG00000153147	SMARCA5 PPI subnetwork	0.91	> 0.20	TOP1 (2.4)	SMARCA4 (2.2)	GMPR (2.2)	USP1 (2.0)	ATXN2 (1.9)	DOCK7 (1.7)	C12orf47 (1.6)	ILF3 (1.4)	TMEM57 (1.4)	MARK4 (1.4)
KEGG_ALLOGRAFT_REJECTION	KEGG_ALLOGRAFT_REJECTION	0.91	> 0.20	TRAFD1 (2.0)	PBX4 (1.8)	APOE (1.7)	MYLIP (1.3)	RELB (1.3)	ADAM1 (1.1)	SH2B3 (1.0)	TMED4 (1.0)	PARP10 (1.0)	BCL3 (0.9)
ENSG00000088832	FKBP1A PPI subnetwork	0.91	> 0.20	TOP1 (2.2)	PSMA5 (2.0)	SMARCA4 (1.9)	DHODH (1.9)	ANKRD31 (1.8)	BRAP (1.7)	C12orf43 (1.7)	GPAM (1.6)	NCAN (1.6)	COL4A3BP (1.5)
MP:0009379	abnormal foot pigmentation	0.91	> 0.20	DOCK7 (2.6)	COL4A3BP (2.4)	APOE (2.4)	CYB561D1 (2.0)	TIMD4 (1.7)	POLK (1.5)	ZHX3 (1.5)	TRIB1 (1.4)	C17orf57 (1.4)	PLEKHH2 (1.4)
GO:0003179	heart valve morphogenesis	0.92	> 0.20	ENSG00000226648 (3.7)	C19orf52 (1.8)	TMEM57 (1.6)	MAFB (1.6)	TRAPPC6A (1.5)	GCNT4 (1.5)	MARK4 (1.4)	HLX (1.4)	TM6SF2 (1.4)	LPIN3 (1.3)
GO:0030545	receptor regulator activity	0.92	> 0.20	TMEM116 (2.6)	BCAM (2.5)	NKPD1 (2.3)	OASL (2.1)	PVRL2 (1.7)	CILP2 (1.3)	TRAFD1 (1.2)	GOT2P1 (1.2)	CEACAM19 (1.2)	GCNT4 (1.2)
ENSG00000145817	YIPF5 PPI subnetwork	0.92	> 0.20	TMEM50A (3.3)	CLPTM1 (3.0)	YIPF2 (2.9)	CEACAM19 (2.3)	AP1M2 (2.1)	GEMIN7 (2.0)	COL4A3BP (1.7)	ENSG00000228044 (1.7)	HAVCR1 (1.6)	GATAD2A (1.6)
ENSG00000141570	CBX8 PPI subnetwork	0.92	> 0.20	ILF3 (2.2)	TRAFD1 (2.0)	TMEM57 (1.8)	C19orf52 (1.8)	PPP1R37 (1.7)	MARK4 (1.6)	ATXN7L2 (1.5)	USP1 (1.5)	AMIGO1 (1.5)	NAA25 (1.4)
MP:0001693	failure of primitive streak formation	0.92	> 0.20	ADAM1 (2.8)	ATXN2 (2.4)	PVR (2.2)	TMED4 (1.9)	ATXN7L2 (1.9)	TMEM50A (1.8)	MAPKAPK5 (1.7)	PSMA5 (1.6)	ENSG00000254235 (1.5)	ITGB3 (1.5)
ENSG00000185214	ENSG00000185214 PPI subnetwork	0.92	> 0.20	USP24 (5.1)	COL4A3BP (2.7)	CARM1 (2.0)	DOCK7 (2.0)	GRINA (2.0)	DHX38 (1.9)	TMEM57 (1.8)	C12orf51 (1.8)	ZHX3 (1.7)	ATXN2 (1.7)
GO:0051150	regulation of smooth muscle cell differentiation	0.92	> 0.20	ANKRD31 (2.2)	PLEKHH2 (2.1)	NKPD1 (2.0)	C11orf9 (1.9)	KANK2 (1.9)	HLX (1.8)	ENSG00000228044 (1.8)	PVR (1.4)	CARM1 (1.3)	HNF1A (1.2)
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS	0.92	> 0.20	OGDH (4.1)	ACAD10 (3.7)	TRAPPC6A (2.8)	C12orf47 (2.5)	GOT2P1 (2.2)	PSMA5 (1.9)	GMPR (1.5)	TOMM40 (1.4)	MAU2 (1.4)	TMED4 (1.2)
ENSG00000189043	NDUFA4 PPI subnetwork	0.92	> 0.20	OGDH (3.6)	ACAD10 (3.1)	TRAPPC6A (2.5)	C12orf47 (2.5)	GMPR (2.1)	PSMA5 (1.7)	SYPL2 (1.6)	C1orf63 (1.3)	FRK (1.3)	HAVCR1 (1.2)
MP:0005424	jerky movement	0.92	> 0.20	TIMD4 (2.9)	NPC1L1 (2.7)	HAPLN4 (2.6)	CETP (2.6)	DOCK7 (2.3)	HNF1A (2.2)	APOE (1.7)	RPH3A (1.7)	C12orf51 (1.5)	ENSG00000235545 (1.5)
MP:0009886	failure of palatal shelf elevation	0.92	> 0.20	HLX (2.2)	AP1M2 (2.1)	KANK2 (1.9)	C11orf9 (1.6)	ANKRD31 (1.5)	TMEM57 (1.5)	C17orf57 (1.4)	TM6SF2 (1.3)	MARK4 (1.3)	CARM1 (1.3)
ENSG00000142230	SAE1 PPI subnetwork	0.92	> 0.20	ZNF180 (3.9)	MARK4 (2.7)	GMIP (2.6)	HAPLN4 (2.1)	PVRL2 (2.0)	GEMIN7 (1.9)	PSRC1 (1.8)	MAU2 (1.7)	MAFB (1.6)	POLK (1.6)
MP:0008148	abnormal rib-sternum attachment	0.92	> 0.20	NYNRIN (2.6)	ATXN7L2 (2.6)	USP24 (2.1)	BCAM (2.1)	ALDH2 (1.9)	PPP1R37 (1.9)	MAPKAPK5 (1.9)	TMEM57 (1.6)	DOCK7 (1.4)	MARK4 (1.4)
ENSG00000177485	ZBTB33 PPI subnetwork	0.92	> 0.20	USP24 (2.2)	CARM1 (2.2)	TRAFD1 (2.2)	ATXN2 (1.9)	ILF3 (1.8)	MARK4 (1.8)	ATXN7L2 (1.7)	TMEM57 (1.7)	GATAD2A (1.7)	SMARCA4 (1.4)
MP:0001328	disorganized retinal layers	0.92	> 0.20	NCAN (2.6)	ANKRD31 (2.1)	PSRC1 (2.0)	APOC4 (1.7)	TRIB1 (1.7)	FADS2 (1.5)	ENSG00000235545 (1.5)	PVRL2 (1.5)	DHODH (1.5)	KIAA1324 (1.4)
ENSG00000100285	NEFH PPI subnetwork	0.92	> 0.20	TMEM50A (3.0)	CLPTM1 (2.9)	ZNF101 (2.1)	DNM2 (1.9)	CARM1 (1.8)	GOT2P1 (1.8)	AMIGO1 (1.8)	CELSR2 (1.8)	SLC44A2 (1.6)	GRINA (1.5)
ENSG00000159131	GART PPI subnetwork	0.92	> 0.20	GATAD2A (2.4)	FEN1 (2.2)	USP1 (2.2)	GEMIN7 (2.2)	SARS (2.1)	SMARCA4 (2.0)	BUD13 (1.8)	NAA25 (1.7)	POC5 (1.5)	ILF3 (1.4)
GO:0090287	regulation of cellular response to growth factor stimulus	0.92	> 0.20	TMEM116 (2.6)	KANK2 (2.4)	DNAH11 (2.1)	PVR (1.9)	C17orf57 (1.8)	PLEKHH2 (1.5)	TSSK6 (1.4)	ENSG00000226648 (1.4)	HLX (1.3)	SH2B3 (1.3)
GO:0072655	establishment of protein localization in mitochondrion	0.92	> 0.20	GEMIN7 (3.0)	ZNF259 (3.0)	TOMM40 (2.7)	TRAPPC6A (2.2)	ENSG00000226645 (2.2)	TXNL4B (2.0)	BRAP (1.9)	DHODH (1.9)	C12orf47 (1.8)	ACAD10 (1.6)
ENSG00000011600	TYROBP PPI subnetwork	0.92	> 0.20	GCNT4 (2.6)	ENSG00000235545 (2.4)	APOE (2.3)	MAFB (2.1)	MYLIP (2.0)	APOC1 (1.9)	TMEM50A (1.5)	MARK4 (1.3)	NCAN (1.3)	SORT1 (1.3)
ENSG00000120533	ENY2 PPI subnetwork	0.92	> 0.20	C12orf51 (3.3)	CARM1 (2.7)	C17orf57 (2.5)	ATXN2 (2.2)	MAPKAPK5 (2.2)	ZNF101 (2.1)	PARP10 (1.9)	ILF3 (1.9)	UBXN2B (1.8)	ATXN7L2 (1.5)
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	0.92	> 0.20	UBXN2B (2.7)	FRK (2.4)	SUGP1 (2.2)	BRAP (2.2)	LPIN3 (1.9)	TRAPPC6A (1.9)	ENSG00000226645 (1.9)	DYNC2LI1 (1.8)	CYB561D1 (1.8)	POLK (1.8)
GO:0014888	striated muscle adaptation	0.92	> 0.20	SYPL2 (3.6)	LPIN3 (2.9)	CYB561D1 (2.5)	CEACAM19 (2.5)	ATXN7L2 (1.9)	ENSG00000254235 (1.9)	C17orf57 (1.5)	ENSG00000226645 (1.5)	HNF1A (1.4)	FRK (1.4)
ENSG00000180914	OXTR PPI subnetwork	0.92	> 0.20	C17orf57 (2.8)	ZHX3 (2.6)	KIAA1324 (2.2)	TMEM57 (1.7)	COL4A3BP (1.5)	AMIGO1 (1.5)	FADS2 (1.4)	GPAM (1.3)	SH2B3 (1.2)	CBLC (1.1)
ENSG00000108094	CUL2 PPI subnetwork	0.92	> 0.20	ZHX3 (2.7)	DOCK7 (2.6)	USP24 (2.5)	BRAP (2.2)	TMEM57 (1.9)	TRAFD1 (1.7)	DHX38 (1.7)	COL4A3BP (1.7)	GRINA (1.5)	PLCG1 (1.3)
GO:0000083	regulation of transcription involved in G1/S phase of mitotic cell cycle	0.92	> 0.20	BUD13 (2.5)	USP1 (2.3)	FEN1 (2.3)	ZNF180 (1.8)	NKPD1 (1.4)	C1orf63 (1.3)	AMIGO1 (1.2)	ERP29 (1.2)	TSSK6 (1.2)	RHCE (1.1)
GO:0030036	actin cytoskeleton organization	0.92	> 0.20	PLEC (2.4)	KANK2 (1.9)	C11orf9 (1.9)	C17orf57 (1.9)	PVRL2 (1.7)	ITGB3 (1.7)	SLC44A2 (1.7)	GMIP (1.6)	ABO (1.6)	SYPL2 (1.4)
GO:0007389	pattern specification process	0.92	> 0.20	ATXN7L2 (2.4)	ENSG00000254235 (2.1)	DYNC2LI1 (1.9)	CEACAM19 (1.8)	HLX (1.7)	NYNRIN (1.7)	ABO (1.6)	ANKRD31 (1.6)	PLCG1 (1.4)	ENSG00000226648 (1.3)
ENSG00000170445	HARS PPI subnetwork	0.92	> 0.20	SARS (2.5)	PSMA5 (2.4)	HAPLN4 (2.2)	PLEKHH2 (1.9)	ATXN7L2 (1.8)	ENSG00000235545 (1.8)	ZNF180 (1.7)	DHX38 (1.7)	TXNL4B (1.5)	GCNT4 (1.5)
MP:0008582	short photoreceptor inner segment	0.92	> 0.20	RHCE (2.6)	RHD (1.8)	ZHX3 (1.8)	C12orf47 (1.7)	NCAN (1.5)	ENSG00000254235 (1.4)	DYNC2LI1 (1.2)	ENSG00000235545 (1.1)	SORT1 (1.1)	APOE (1.0)
GO:0060606	tube closure	0.92	> 0.20	DYNC2LI1 (3.1)	ATXN7L2 (2.6)	ADAM1 (2.0)	PPP1R37 (1.9)	PVRL2 (1.9)	NYNRIN (1.9)	PLEKHH2 (1.8)	TMEM116 (1.8)	MARK4 (1.5)	DOCK7 (1.5)
GO:0019905	syntaxin binding	0.92	> 0.20	RPH3A (3.1)	HAPLN4 (2.7)	KIAA1324 (2.2)	CYB561D1 (2.1)	CELSR2 (2.1)	GRINA (2.0)	AMIGO1 (2.0)	MARK4 (1.6)	TMEM50A (1.6)	AP1M2 (1.6)
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	0.92	> 0.20	BCAM (5.2)	PVRL2 (4.3)	CBLC (2.5)	NYNRIN (2.1)	ENSG00000226645 (2.1)	LPIN3 (2.0)	CELSR2 (1.9)	LPAR2 (1.6)	APOE (1.6)	CEACAM19 (1.5)
MP:0005656	decreased aggression	0.92	> 0.20	TRIB1 (3.7)	DYNC2LI1 (2.3)	KIAA1324 (2.2)	C12orf47 (1.9)	TMED4 (1.9)	GOT2P1 (1.9)	POLK (1.8)	POC5 (1.8)	ENSG00000226648 (1.7)	TXNL4B (1.6)
ENSG00000166887	VPS39 PPI subnetwork	0.92	> 0.20	COL4A3BP (2.7)	ENSG00000226645 (2.6)	TRAFD1 (2.0)	GCNT4 (1.7)	MYLIP (1.7)	ERP29 (1.5)	TMEM50A (1.4)	SYPL2 (1.4)	C1orf63 (1.4)	SLC44A2 (1.3)
GO:0071299	cellular response to vitamin A	0.92	> 0.20	MYLIP (2.0)	PMFBP1 (1.9)	ENSG00000235545 (1.7)	POLK (1.7)	ENSG00000238078 (1.6)	LPAR2 (1.3)	HAPLN4 (1.2)	ABO (1.1)	AP1M2 (1.1)	TSSK6 (1.1)
GO:0071300	cellular response to retinoic acid	0.92	> 0.20	MYLIP (2.0)	PMFBP1 (1.9)	ENSG00000235545 (1.7)	POLK (1.7)	ENSG00000238078 (1.6)	LPAR2 (1.3)	HAPLN4 (1.2)	ABO (1.1)	AP1M2 (1.1)	TSSK6 (1.1)
ENSG00000068781	STON1-GTF2A1L PPI subnetwork	0.92	> 0.20	CYB561D1 (3.1)	GOT2P1 (2.7)	PTPN11 (2.6)	TXNL4B (2.5)	C1orf63 (1.6)	MYLIP (1.5)	CARM1 (1.4)	ADAM1 (1.3)	ZNF180 (1.2)	CYP7A1 (1.2)
ENSG00000099725	ENSG00000099725 PPI subnetwork	0.92	> 0.20	PLEKHH2 (2.2)	PLEC (2.0)	NYNRIN (1.9)	C12orf47 (1.7)	RPH3A (1.5)	OGDH (1.5)	C1orf63 (1.4)	AMIGO1 (1.4)	ST3GAL4 (1.4)	KANK2 (1.3)
GO:0072283	metanephric renal vesicle morphogenesis	0.92	> 0.20	ENSG00000238078 (2.9)	HNF1A (2.7)	C17orf57 (2.6)	HAVCR1 (2.0)	TSSK6 (1.9)	PMFBP1 (1.6)	TMEM116 (1.6)	ENSG00000235545 (1.5)	ENSG00000228044 (1.5)	ZHX3 (1.3)
GO:0032733	positive regulation of interleukin-10 production	0.92	> 0.20	PBX4 (2.5)	ENSG00000235545 (1.8)	GCNT4 (1.7)	TXNL4B (1.5)	MYLIP (1.5)	GOT2P1 (1.5)	DNAH11 (1.3)	ADAM1 (1.2)	MOSC1 (1.2)	COL4A3BP (1.1)
MP:0000034	abnormal vestibule morphology	0.92	> 0.20	ZHX3 (2.2)	KIAA1324 (2.0)	ABO (2.0)	PBX4 (1.6)	MYLIP (1.5)	DYNC2LI1 (1.5)	TM6SF2 (1.4)	NKPD1 (1.3)	C17orf57 (1.3)	SLC22A1 (1.1)
ENSG00000148158	SNX30 PPI subnetwork	0.92	> 0.20	ZNF259 (3.0)	YIPF2 (2.4)	ENSG00000226645 (2.3)	ATXN7L2 (2.1)	SUGP1 (1.8)	FEN1 (1.7)	HNF1A (1.7)	BUD13 (1.7)	NYNRIN (1.3)	ENSG00000235545 (1.1)
GO:0002063	chondrocyte development	0.92	> 0.20	CILP2 (7.7)	UBXN2B (3.1)	YIPF2 (2.0)	ENSG00000254235 (1.8)	ENSG00000228044 (1.7)	LPAR2 (1.7)	PBX4 (1.5)	NKPD1 (1.3)	PLEKHH2 (1.2)	BLOC1S3 (1.2)
MP:0004252	abnormal direction of heart looping	0.92	> 0.20	DYNC2LI1 (6.4)	ACAD10 (2.6)	UBXN2B (2.5)	POC5 (1.7)	DNAH11 (1.6)	PVRL2 (1.6)	PLEKHH2 (1.6)	DOCK7 (1.4)	BUD13 (1.4)	TMEM116 (1.3)
GO:0042634	regulation of hair cycle	0.92	> 0.20	POLK (2.9)	PBX4 (2.4)	TXNL4B (2.1)	TRAFD1 (1.8)	ANKRD31 (1.5)	GCNT4 (1.4)	NKPD1 (1.3)	PMFBP1 (1.2)	SLC44A2 (1.2)	MAU2 (1.1)
GO:0050730	regulation of peptidyl-tyrosine phosphorylation	0.92	> 0.20	TIMD4 (2.2)	SH2B3 (1.9)	ENSG00000226645 (1.8)	GEMIN7 (1.8)	ADAM1 (1.6)	PVR (1.6)	MYLIP (1.4)	GPAM (1.3)	PLEKHH2 (1.2)	MOSC1 (1.2)
GO:0001919	regulation of receptor recycling	0.92	> 0.20	LPIN3 (2.9)	ABO (2.8)	ZNF101 (2.6)	TMEM50A (2.4)	TMED4 (2.4)	HNF1A (2.3)	ADAM1 (2.0)	TMEM57 (1.7)	AMIGO1 (1.5)	TSSK6 (1.4)
ENSG00000169992	NLGN2 PPI subnetwork	0.92	> 0.20	RPH3A (4.2)	FRK (3.3)	PPP1R37 (2.8)	CELSR2 (2.4)	AMIGO1 (2.3)	GCNT4 (2.0)	CBLC (1.7)	NCAN (1.6)	PLCG1 (1.5)	LPIN3 (1.5)
GO:0007618	mating	0.92	> 0.20	ZHX3 (2.7)	NKPD1 (2.3)	PMFBP1 (2.1)	C17orf57 (1.8)	CBLC (1.7)	CEACAM19 (1.7)	GOT2P1 (1.4)	AMIGO1 (1.3)	LPIN3 (1.3)	GCNT4 (1.2)
GO:0060122	inner ear receptor stereocilium organization	0.92	> 0.20	ENSG00000226648 (4.5)	GOT2P1 (2.1)	AMIGO1 (1.9)	DNAH11 (1.6)	TMEM57 (1.5)	FRK (1.3)	CEACAM19 (1.1)	PLEKHH2 (1.0)	APOE (1.0)	HAVCR1 (1.0)
ENSG00000122034	GTF3A PPI subnetwork	0.92	> 0.20	C12orf43 (2.7)	MAPKAPK5 (2.6)	PTPN11 (2.6)	POC5 (2.4)	C12orf47 (2.3)	DDX56 (2.0)	ADAM1 (2.0)	TMED4 (1.9)	ATXN2 (1.8)	MAU2 (1.6)
GO:0007017	microtubule-based process	0.92	> 0.20	DNAH11 (4.2)	PSRC1 (3.7)	POC5 (3.5)	PBX4 (2.5)	POLK (1.9)	C12orf51 (1.7)	DYNC2LI1 (1.3)	USP1 (1.2)	ATXN2 (1.2)	DOCK7 (1.1)
ENSG00000162735	PEX19 PPI subnetwork	0.92	> 0.20	NT5DC1 (2.6)	GPAM (2.5)	AMIGO1 (2.5)	GOT2P1 (2.1)	C19orf52 (1.8)	ALDH2 (1.7)	MOSC1 (1.7)	BLOC1S3 (1.7)	ENSG00000226648 (1.7)	SORT1 (1.7)
ENSG00000184886	PIGW PPI subnetwork	0.92	> 0.20	ERP29 (3.4)	NT5DC1 (3.2)	FRK (3.0)	TMED4 (2.9)	ATP13A1 (2.9)	YIPF2 (2.2)	TMEM50A (2.1)	CLPTM1 (1.8)	TMEM116 (1.7)	NKPD1 (1.7)
GO:0015711	organic anion transport	0.92	> 0.20	TMEM116 (3.6)	PLG (1.9)	ANGPTL3 (1.9)	TM6SF2 (1.9)	C11orf9 (1.8)	SLC22A1 (1.7)	ENSG00000228044 (1.7)	NT5DC1 (1.6)	HNF1A (1.6)	PBX4 (1.5)
MP:0002163	abnormal gland morphology	0.92	> 0.20	MOSC1 (3.0)	GOT2P1 (2.1)	KIAA1324 (2.1)	PBX4 (2.0)	ZNF101 (2.0)	C11orf9 (1.9)	FRK (1.8)	LPAR2 (1.6)	PMFBP1 (1.4)	ATXN7L2 (1.2)
GO:0016998	cell wall macromolecule catabolic process	0.92	> 0.20	GCNT4 (3.9)	TSSK6 (3.3)	PMFBP1 (2.8)	PBX4 (1.6)	TMED4 (1.4)	DYNC2LI1 (1.3)	HNF1A (1.1)	HAVCR1 (1.0)	C1orf63 (1.0)	POC5 (0.9)
GO:0048485	sympathetic nervous system development	0.92	> 0.20	ENSG00000226648 (3.1)	TMED4 (2.3)	TSSK6 (2.0)	ANKRD31 (1.8)	ADAM1 (1.6)	C12orf47 (1.6)	TMEM57 (1.5)	BLOC1S3 (1.4)	C19orf52 (1.4)	NYNRIN (1.4)
GO:0006878	cellular copper ion homeostasis	0.92	> 0.20	BLOC1S3 (2.6)	NKPD1 (2.3)	C17orf57 (1.8)	TMEM50A (1.6)	ENSG00000254235 (1.5)	TMED4 (1.5)	C19orf52 (1.4)	GEMIN7 (1.4)	DOCK7 (1.3)	GOT2P1 (1.3)
ENSG00000107341	UBE2R2 PPI subnetwork	0.92	> 0.20	OASL (3.8)	TMEM57 (3.0)	ATXN2 (2.2)	CARM1 (2.1)	GRINA (2.1)	BRAP (2.1)	MAPKAPK5 (1.8)	GMPR (1.7)	ENSG00000235545 (1.6)	C12orf51 (1.5)
ENSG00000076864	RAP1GAP PPI subnetwork	0.92	> 0.20	NCAN (2.7)	C11orf9 (2.0)	MARK4 (1.7)	TMEM50A (1.7)	RPH3A (1.7)	CELSR2 (1.6)	C12orf43 (1.6)	HAVCR1 (1.5)	DNAH11 (1.5)	AMIGO1 (1.4)
MP:0001322	abnormal iris morphology	0.92	> 0.20	MYLIP (2.2)	TMEM116 (2.2)	APOE (2.1)	OASL (1.8)	HAVCR1 (1.7)	DOCK7 (1.5)	ATXN2 (1.5)	ST3GAL4 (1.4)	FRK (1.3)	PVRL2 (1.1)
ENSG00000104435	STMN2 PPI subnetwork	0.92	> 0.20	NCAN (2.4)	PSRC1 (2.1)	NKPD1 (1.9)	ZNF101 (1.8)	AMIGO1 (1.8)	RPH3A (1.5)	C17orf57 (1.5)	BLOC1S3 (1.4)	CYB561D1 (1.4)	GCNT4 (1.3)
ENSG00000156973	PDE6D PPI subnetwork	0.92	> 0.20	TMEM50A (2.6)	ATXN2 (2.0)	CARM1 (1.9)	GATAD2A (1.8)	PPP1R37 (1.6)	DYNC2LI1 (1.5)	CLPTM1 (1.5)	QTRT1 (1.4)	BLOC1S3 (1.3)	TRIB1 (1.2)
MP:0008075	decreased CD4-positive T cell number	0.92	> 0.20	GMIP (3.5)	PLCG1 (3.2)	ZNF101 (2.9)	MAFB (2.7)	PBX4 (2.0)	RELB (2.0)	TIMD4 (1.9)	CETP (1.5)	GRINA (1.1)	HAVCR1 (1.0)
GO:0045778	positive regulation of ossification	0.92	> 0.20	MYLIP (2.6)	TMEM116 (2.5)	MAFB (1.9)	POLK (1.9)	BLOC1S3 (1.7)	NYNRIN (1.7)	CEACAM19 (1.7)	TMED4 (1.7)	ABO (1.7)	PLEKHH2 (1.6)
GO:0001937	negative regulation of endothelial cell proliferation	0.92	> 0.20	CILP2 (3.0)	C12orf47 (1.8)	CEACAM19 (1.8)	CETP (1.5)	ADAM1 (1.4)	ZNF180 (1.3)	ENSG00000228044 (1.2)	APOC1 (1.2)	HNF1A (1.2)	AP1M2 (1.2)
GO:0033630	positive regulation of cell adhesion mediated by integrin	0.92	> 0.20	ENSG00000238078 (2.4)	CETP (2.1)	NKPD1 (2.0)	KIAA1324 (1.7)	ENSG00000226645 (1.6)	PLEKHH2 (1.5)	TMEM116 (1.4)	ZNF101 (1.4)	QTRT1 (1.4)	PVRL2 (1.3)
ENSG00000085832	EPS15 PPI subnetwork	0.92	> 0.20	SH2B3 (2.9)	USP24 (2.9)	COL4A3BP (2.5)	C17orf57 (2.5)	PPP1R37 (2.3)	MARK4 (2.1)	DNM2 (2.0)	C12orf51 (1.9)	CLPTM1 (1.8)	C1orf63 (1.6)
ENSG00000105298	C19orf29 PPI subnetwork	0.92	> 0.20	MAFB (2.7)	ZNF259 (2.4)	RELB (2.2)	BUD13 (2.2)	MAPKAPK5 (2.1)	C12orf43 (1.8)	PSMA5 (1.5)	TRAPPC6A (1.4)	NKPD1 (1.3)	APOE (1.1)
GO:0031112	positive regulation of microtubule polymerization or depolymerization	0.92	> 0.20	POC5 (3.1)	DNAH11 (2.2)	PBX4 (2.0)	UBXN2B (1.9)	POLK (1.7)	ANKRD31 (1.7)	CELSR2 (1.6)	C12orf47 (1.5)	PTPN11 (1.3)	BLOC1S3 (1.2)
GO:0072078	nephron tubule morphogenesis	0.92	> 0.20	HAVCR1 (3.7)	BCAM (2.1)	DYNC2LI1 (2.0)	AP1M2 (1.8)	TSSK6 (1.6)	ENSG00000238078 (1.6)	HNF1A (1.3)	MYLIP (1.3)	KIAA1324 (1.2)	TMEM116 (1.2)
GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	0.92	> 0.20	HNF1A (2.3)	PPP1R37 (2.2)	HAVCR1 (2.1)	COL4A3BP (1.9)	POLK (1.8)	ENSG00000226648 (1.6)	FRK (1.5)	PMFBP1 (1.5)	MAPKAPK5 (1.5)	UBXN2B (1.5)
GO:0004402	histone acetyltransferase activity	0.92	> 0.20	COL4A3BP (3.0)	C19orf52 (2.2)	ATXN2 (2.1)	MAU2 (2.1)	C12orf51 (2.0)	UBXN2B (2.0)	ATXN7L2 (1.9)	DHODH (1.7)	C17orf57 (1.5)	PLCG1 (1.5)
GO:0042354	L-fucose metabolic process	0.92	> 0.20	FRK (3.0)	CBLC (2.7)	KIAA1324 (2.3)	CYB561D1 (2.3)	YIPF2 (2.0)	LPIN3 (1.8)	ERP29 (1.7)	NKPD1 (1.5)	TRAPPC6A (1.4)	ZNF101 (1.3)
MP:0002465	abnormal eosinophil physiology	0.92	> 0.20	SH2B3 (3.2)	MAFB (2.8)	GMIP (1.7)	ATXN7L2 (1.5)	SLC44A2 (1.4)	NYNRIN (1.3)	OGDH (1.2)	TIMD4 (1.2)	NCAN (1.1)	GCNT4 (1.1)
GO:0031369	translation initiation factor binding	0.92	> 0.20	MAPKAPK5 (2.6)	DDX56 (2.3)	APOB (2.2)	NAA25 (1.9)	SARS (1.8)	GEMIN7 (1.7)	DHODH (1.6)	CARM1 (1.5)	ZNF259 (1.5)	APOE (1.4)
GO:0035813	regulation of renal sodium excretion	0.92	> 0.20	HNF1A (2.6)	C12orf47 (2.5)	CEACAM19 (2.3)	HAVCR1 (2.0)	PMFBP1 (1.8)	C17orf57 (1.7)	NKPD1 (1.5)	ZHX3 (1.5)	ANGPTL3 (1.4)	ENSG00000228044 (1.3)
GO:0035812	renal sodium excretion	0.92	> 0.20	HNF1A (2.6)	C12orf47 (2.5)	CEACAM19 (2.3)	HAVCR1 (2.0)	PMFBP1 (1.8)	C17orf57 (1.7)	NKPD1 (1.5)	ZHX3 (1.5)	ANGPTL3 (1.4)	ENSG00000228044 (1.3)
ENSG00000137693	YAP1 PPI subnetwork	0.92	> 0.20	GRINA (3.4)	BCAM (3.0)	MARK4 (2.4)	PVRL2 (1.9)	TMEM57 (1.7)	PLEC (1.6)	CELSR2 (1.5)	ENSG00000238078 (1.5)	C11orf9 (1.4)	DNM2 (1.4)
GO:0008154	actin polymerization or depolymerization	0.92	> 0.20	ST3GAL4 (2.2)	ADAM1 (2.1)	ABO (2.0)	TMEM50A (1.9)	ITGB3 (1.9)	TSSK6 (1.7)	CETP (1.7)	C11orf9 (1.7)	ENSG00000238078 (1.7)	C1orf63 (1.6)
MP:0001970	abnormal pain threshold	0.92	> 0.20	RPH3A (2.4)	AMIGO1 (2.1)	C12orf47 (1.9)	NKPD1 (1.8)	COL4A3BP (1.7)	DYNC2LI1 (1.5)	PMFBP1 (1.5)	MOSC1 (1.4)	C11orf9 (1.3)	BCAM (1.2)
ENSG00000177479	ARIH2 PPI subnetwork	0.92	> 0.20	CYB561D1 (3.4)	TXNL4B (2.2)	GMIP (2.0)	DHX38 (1.9)	ERP29 (1.8)	COL4A3BP (1.7)	CLPTM1 (1.7)	TRAPPC6A (1.5)	QTRT1 (1.5)	DNAH11 (1.4)
GO:0045830	positive regulation of isotype switching	0.92	> 0.20	HAVCR1 (1.8)	LPIN3 (1.7)	ADAM1 (1.5)	C12orf43 (1.5)	ENSG00000254235 (1.4)	TRAFD1 (1.4)	NT5DC1 (1.2)	SLC44A2 (1.1)	SH2B3 (1.1)	C17orf57 (1.0)
REACTOME_OPIOID_SIGNALLING	REACTOME_OPIOID_SIGNALLING	0.92	> 0.20	ITGB3 (3.2)	TMEM50A (2.0)	SH2B3 (1.9)	OGDH (1.5)	GOT2P1 (1.4)	MOSC1 (1.4)	ST3GAL4 (1.4)	ENSG00000238078 (1.3)	MARK4 (1.3)	POLK (1.3)
ENSG00000213619	NDUFS3 PPI subnetwork	0.92	> 0.20	OGDH (3.7)	ACAD10 (3.4)	TRAPPC6A (2.5)	C12orf47 (2.1)	MAU2 (1.9)	PSMA5 (1.8)	GOT2P1 (1.6)	ATP13A1 (1.3)	FRK (1.3)	TOMM40 (1.2)
REACTOME_CRMPS_IN_SEMA3A_SIGNALING	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	0.92	> 0.20	NCAN (3.8)	HLX (2.3)	NYNRIN (2.1)	ENSG00000254235 (1.8)	ADAM1 (1.6)	MAFB (1.6)	C12orf47 (1.6)	SMARCA4 (1.6)	GMIP (1.5)	PBX4 (1.5)
GO:0043094	cellular metabolic compound salvage	0.92	> 0.20	LPIN3 (2.2)	DHODH (2.2)	SYPL2 (2.1)	TRAPPC6A (2.0)	TXNL4B (2.0)	QTRT1 (1.7)	CEACAM19 (1.7)	ENSG00000228044 (1.6)	DOCK7 (1.5)	NT5DC1 (1.3)
MP:0008080	abnormal CD8-positive T cell differentiation	0.92	> 0.20	PLCG1 (4.6)	ZNF101 (4.6)	PBX4 (1.7)	ENSG00000238078 (1.5)	GEMIN7 (1.4)	ABO (1.3)	SLC44A2 (1.2)	NKPD1 (1.1)	TMEM50A (1.1)	C19orf52 (1.1)
ENSG00000169131	ZNF354A PPI subnetwork	0.92	> 0.20	C12orf51 (4.1)	SMARCA4 (3.8)	HAVCR1 (3.2)	ATP13A1 (2.3)	NCAN (2.2)	ACAD10 (1.9)	SYPL2 (1.8)	PLEC (1.8)	USP24 (1.7)	FADS2 (1.7)
ENSG00000085276	MECOM PPI subnetwork	0.92	> 0.20	PPP1R37 (2.4)	PLCG1 (2.2)	GATAD2A (1.7)	ZHX3 (1.6)	USP24 (1.6)	NT5DC1 (1.5)	C12orf51 (1.5)	AMIGO1 (1.4)	PARP10 (1.4)	KANK2 (1.3)
ENSG00000147601	TERF1 PPI subnetwork	0.92	> 0.20	ZHX3 (3.4)	USP1 (3.2)	UBXN2B (2.3)	NYNRIN (2.3)	KANK2 (2.2)	MARK4 (1.9)	ENSG00000226648 (1.7)	PSRC1 (1.6)	POLK (1.5)	TXNL4B (1.5)
MP:0005441	increased urine calcium level	0.92	> 0.20	AP1M2 (3.6)	TMEM116 (3.5)	SLC22A1 (2.8)	HAVCR1 (2.8)	PLG (2.6)	ANGPTL3 (2.3)	SYPL2 (1.9)	TM6SF2 (1.8)	C12orf47 (1.7)	BLOC1S3 (1.7)
ENSG00000164091	WDR82 PPI subnetwork	0.92	> 0.20	BUD13 (2.2)	ILF3 (2.0)	GATAD2A (1.9)	FEN1 (1.9)	ADAM1 (1.8)	KIAA1324 (1.8)	TRAPPC6A (1.7)	SUGP1 (1.7)	NKPD1 (1.7)	QTRT1 (1.7)
ENSG00000197915	HRNR PPI subnetwork	0.92	> 0.20	ST3GAL4 (2.7)	GOT2P1 (2.3)	TMEM116 (2.1)	AMIGO1 (1.9)	SYPL2 (1.8)	BCAM (1.6)	C17orf57 (1.6)	C11orf9 (1.6)	SORT1 (1.4)	DNM2 (1.4)
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	0.92	> 0.20	ITGB3 (4.1)	TMEM50A (2.4)	CETP (1.9)	SH2B3 (1.6)	ENSG00000254235 (1.5)	PMFBP1 (1.4)	TM6SF2 (1.3)	ENSG00000235545 (1.3)	ST3GAL4 (1.1)	HLX (1.0)
ENSG00000204227	RING1 PPI subnetwork	0.92	> 0.20	TRAFD1 (2.4)	TMEM57 (2.3)	USP1 (2.0)	CELSR2 (1.8)	TOP1 (1.8)	ATXN2 (1.7)	HLX (1.6)	ILF3 (1.5)	BLOC1S3 (1.5)	GATAD2A (1.5)
ENSG00000206215	ENSG00000206215 PPI subnetwork	0.92	> 0.20	TRAFD1 (2.4)	TMEM57 (2.3)	USP1 (2.0)	CELSR2 (1.8)	TOP1 (1.8)	ATXN2 (1.7)	HLX (1.6)	ILF3 (1.5)	BLOC1S3 (1.5)	GATAD2A (1.5)
ENSG00000206287	RING1 PPI subnetwork	0.92	> 0.20	TRAFD1 (2.4)	TMEM57 (2.3)	USP1 (2.0)	CELSR2 (1.8)	TOP1 (1.8)	ATXN2 (1.7)	HLX (1.6)	ILF3 (1.5)	BLOC1S3 (1.5)	GATAD2A (1.5)
GO:0021766	hippocampus development	0.92	> 0.20	ENSG00000235545 (2.9)	GOT2P1 (2.7)	ATXN7L2 (2.4)	DNAH11 (2.1)	UBXN2B (2.1)	GCNT4 (2.0)	TSSK6 (2.0)	NCAN (1.9)	TMED4 (1.7)	ST3GAL4 (1.5)
ENSG00000012061	ERCC1 PPI subnetwork	0.92	> 0.20	SUGP1 (2.9)	FEN1 (2.8)	NT5DC1 (2.6)	USP1 (2.1)	POC5 (1.9)	PSMA5 (1.8)	TOMM40 (1.6)	SARS (1.4)	TRAPPC6A (1.4)	QTRT1 (1.4)
GO:0035295	tube development	0.92	> 0.20	PVRL2 (2.8)	BCAM (2.7)	PLEKHH2 (2.7)	DYNC2LI1 (2.2)	KANK2 (2.2)	AP1M2 (2.1)	NYNRIN (1.8)	PLCG1 (1.7)	PPP1R37 (1.6)	ENSG00000226648 (1.4)
GO:0022029	telencephalon cell migration	0.92	> 0.20	ATXN7L2 (2.6)	ENSG00000254235 (2.5)	TSSK6 (2.2)	TMEM116 (2.1)	ENSG00000235545 (2.0)	PBX4 (1.8)	C19orf52 (1.7)	TMED4 (1.7)	NCAN (1.6)	CELSR2 (1.5)
ENSG00000113721	PDGFRB PPI subnetwork	0.92	> 0.20	USP24 (2.5)	PARP10 (2.2)	CETP (1.8)	AP1M2 (1.7)	C11orf9 (1.7)	PLEKHH2 (1.7)	SH2B3 (1.7)	SLC44A2 (1.7)	APOE (1.4)	DOCK7 (1.3)
KEGG_AXON_GUIDANCE	KEGG_AXON_GUIDANCE	0.92	> 0.20	NYNRIN (3.4)	LPAR2 (3.3)	MARK4 (2.9)	CELSR2 (2.8)	PVRL2 (2.5)	PBX4 (2.3)	MAFB (2.2)	PLEC (2.2)	SLC44A2 (1.8)	LPIN3 (1.8)
GO:0030165	PDZ domain binding	0.92	> 0.20	CELSR2 (3.5)	BCAM (3.2)	TMEM116 (2.7)	DNAH11 (2.6)	SORT1 (2.3)	AMIGO1 (2.3)	ENSG00000235545 (2.1)	MOSC1 (2.0)	C19orf52 (1.4)	PPP1R37 (1.4)
REACTOME_NACL:_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	REACTOME_NACL:_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	0.92	> 0.20	HNF1A (2.1)	ZHX3 (2.0)	TM6SF2 (1.9)	ST3GAL4 (1.8)	ENSG00000235545 (1.6)	ABO (1.6)	BLOC1S3 (1.6)	RPH3A (1.5)	HAPLN4 (1.4)	CILP2 (1.4)
GO:0005112	Notch binding	0.92	> 0.20	NCAN (3.2)	CELSR2 (2.4)	BCAM (2.2)	LPIN3 (1.9)	PLEC (1.8)	CETP (1.7)	APOE (1.5)	GRINA (1.5)	USP24 (1.5)	FADS2 (1.4)
GO:0014031	mesenchymal cell development	0.92	> 0.20	ENSG00000254235 (3.2)	MYLIP (2.6)	ABO (2.4)	KANK2 (1.9)	NYNRIN (1.3)	MAFB (1.3)	NKPD1 (1.2)	KIAA1324 (1.2)	ENSG00000226645 (1.2)	SLC44A2 (1.2)
ENSG00000145649	GZMA PPI subnetwork	0.92	> 0.20	ITGB3 (2.3)	AP1M2 (2.1)	ENSG00000235545 (2.0)	TRIB1 (1.8)	LPAR2 (1.8)	LPIN3 (1.7)	FRK (1.7)	ILF3 (1.7)	TOP1 (1.6)	HMGCR (1.6)
GO:0001076	RNA polymerase II transcription factor binding transcription factor activity	0.92	> 0.20	ATXN7L2 (2.3)	ATXN2 (2.2)	BUD13 (2.1)	TMEM57 (1.9)	C19orf52 (1.8)	TRIB1 (1.6)	BLOC1S3 (1.5)	CARM1 (1.4)	TOP1 (1.4)	BRAP (1.4)
ENSG00000127914	AKAP9 PPI subnetwork	0.92	> 0.20	SORT1 (2.7)	RPH3A (1.9)	NCAN (1.6)	ITGB3 (1.6)	DNM2 (1.6)	SMARCA4 (1.5)	C1orf63 (1.4)	TMEM50A (1.4)	PVR (1.3)	CELSR2 (1.2)
ENSG00000148400	NOTCH1 PPI subnetwork	0.92	> 0.20	USP24 (2.7)	TOP1 (2.1)	ATXN2 (2.1)	TMEM57 (1.8)	RELB (1.7)	C12orf47 (1.7)	NCAN (1.7)	PLCG1 (1.7)	C12orf51 (1.7)	BCAM (1.6)
ENSG00000122126	OCRL PPI subnetwork	0.92	> 0.20	COL4A3BP (3.1)	TMEM50A (3.0)	GATAD2A (2.2)	C19orf52 (1.9)	MAU2 (1.7)	C1orf63 (1.7)	ANKRD31 (1.5)	CYB561D1 (1.5)	DNM2 (1.5)	YIPF2 (1.4)
GO:0051249	regulation of lymphocyte activation	0.92	> 0.20	ZNF101 (3.8)	PBX4 (2.8)	PLCG1 (2.6)	TIMD4 (2.2)	POLK (1.6)	GMIP (1.5)	CETP (1.5)	TRAFD1 (1.3)	RELB (1.3)	CYB561D1 (1.2)
ENSG00000111816	FRK PPI subnetwork	0.92	> 0.20	FADS2 (2.5)	TMEM57 (2.5)	GCNT4 (1.9)	CETP (1.9)	FRK (1.7)	POLK (1.7)	MYLIP (1.7)	MAPKAPK5 (1.5)	KANK2 (1.5)	COL4A3BP (1.4)
GO:0030431	sleep	0.92	> 0.20	ENSG00000226648 (5.3)	RPH3A (2.1)	HNF1A (1.7)	CEACAM19 (1.4)	KIAA1324 (1.3)	C12orf47 (1.2)	DNAH11 (1.2)	PPP1R37 (1.2)	HAPLN4 (1.2)	CETP (1.1)
ENSG00000135090	TAOK3 PPI subnetwork	0.92	> 0.20	C12orf51 (3.1)	MARK4 (2.7)	GMIP (2.4)	SORT1 (2.1)	BUD13 (2.1)	ATXN2 (2.0)	ST3GAL4 (1.9)	LPAR2 (1.9)	PTPN11 (1.8)	PSRC1 (1.7)
MP:0004401	increased cochlear outer hair cell number	0.92	> 0.20	BCAM (3.5)	NCAN (3.3)	NYNRIN (2.7)	CELSR2 (2.5)	CBLC (1.6)	POLK (1.6)	DYNC2LI1 (1.5)	GPAM (1.5)	PVRL2 (1.2)	ANKRD31 (1.2)
ENSG00000117592	PRDX6 PPI subnetwork	0.92	> 0.20	ALDH2 (3.3)	C11orf9 (3.1)	HAPLN4 (2.6)	RPH3A (2.5)	MOSC1 (2.2)	NT5DC1 (1.8)	NCAN (1.7)	CYP7A1 (1.6)	ST3GAL4 (1.5)	HP (1.4)
GO:0051881	regulation of mitochondrial membrane potential	0.92	> 0.20	ITGB3 (2.3)	ENSG00000226645 (2.3)	TRAPPC6A (2.2)	TMEM116 (2.1)	BLOC1S3 (2.0)	POLK (2.0)	GMPR (1.9)	HAPLN4 (1.6)	ENSG00000226648 (1.6)	C19orf52 (1.6)
ENSG00000092203	TOX4 PPI subnetwork	0.92	> 0.20	USP24 (2.6)	CARM1 (2.4)	ATXN7L2 (2.1)	DOCK7 (1.9)	TMEM57 (1.8)	ATXN2 (1.8)	ILF3 (1.7)	SMARCA4 (1.7)	TRAFD1 (1.5)	USP1 (1.4)
ENSG00000134250	NOTCH2 PPI subnetwork	0.92	> 0.20	NCAN (2.2)	PLEC (1.8)	USP24 (1.7)	PLCG1 (1.7)	PARP10 (1.7)	FADS2 (1.5)	CELSR2 (1.3)	GMIP (1.3)	ABO (1.2)	BCAM (1.2)
ENSG00000169020	ATP5I PPI subnetwork	0.92	> 0.20	OGDH (4.2)	ACAD10 (3.6)	PSMA5 (3.2)	C12orf47 (2.5)	C19orf52 (2.0)	ERP29 (1.9)	BUD13 (1.8)	FRK (1.7)	TMEM116 (1.7)	TOMM40 (1.7)
GO:0030833	regulation of actin filament polymerization	0.92	> 0.20	C17orf57 (2.3)	TMEM50A (2.2)	ABO (2.2)	ENSG00000238078 (2.1)	ADAM1 (2.1)	CYB561D1 (2.0)	ATXN7L2 (1.8)	TSSK6 (1.8)	ZNF101 (1.8)	C1orf63 (1.6)
GO:0051294	establishment of spindle orientation	0.92	> 0.20	PSRC1 (3.2)	ENSG00000226645 (2.9)	BUD13 (2.5)	PPP1R37 (2.3)	POC5 (2.3)	CYB561D1 (1.8)	PMFBP1 (1.6)	DYNC2LI1 (1.5)	ENSG00000238078 (1.4)	ENSG00000235545 (1.4)
GO:0000132	establishment of mitotic spindle orientation	0.92	> 0.20	PSRC1 (3.2)	ENSG00000226645 (2.9)	BUD13 (2.5)	PPP1R37 (2.3)	POC5 (2.3)	CYB561D1 (1.8)	PMFBP1 (1.6)	DYNC2LI1 (1.5)	ENSG00000238078 (1.4)	ENSG00000235545 (1.4)
GO:0071559	response to transforming growth factor beta stimulus	0.92	> 0.20	GCNT4 (1.9)	NCAN (1.7)	POLK (1.6)	CYP7A1 (1.5)	DYNC2LI1 (1.4)	SLC44A2 (1.1)	TMED4 (1.1)	PMFBP1 (1.0)	ENSG00000254235 (1.0)	GATAD2A (0.9)
GO:0051301	cell division	0.92	> 0.20	POC5 (4.6)	PSRC1 (4.5)	USP1 (2.5)	DNAH11 (2.3)	FEN1 (1.9)	ENSG00000226648 (1.9)	BUD13 (1.7)	DYNC2LI1 (1.7)	PBX4 (1.4)	ENSG00000228044 (1.3)
MP:0003451	absent olfactory bulb	0.92	> 0.20	ENSG00000226648 (2.0)	ZHX3 (1.9)	CARM1 (1.8)	CELSR2 (1.7)	DYNC2LI1 (1.7)	ATXN2 (1.7)	MARK4 (1.6)	PSRC1 (1.5)	TRIB1 (1.5)	PLCG1 (1.4)
GO:0032874	positive regulation of stress-activated MAPK cascade	0.92	> 0.20	ENSG00000235545 (3.2)	HLX (1.8)	UBXN2B (1.6)	ST3GAL4 (1.6)	MAU2 (1.6)	ZNF180 (1.5)	BLOC1S3 (1.4)	QTRT1 (1.1)	ENSG00000226648 (1.1)	DYNC2LI1 (1.1)
GO:0014047	glutamate secretion	0.92	> 0.20	HAPLN4 (3.0)	FRK (2.8)	RPH3A (2.8)	ENSG00000238078 (2.6)	ENSG00000254235 (2.1)	ENSG00000228044 (1.9)	HNF1A (1.7)	C12orf51 (1.6)	C12orf43 (1.4)	CELSR2 (1.3)
ENSG00000145216	FIP1L1 PPI subnetwork	0.92	> 0.20	GATAD2A (3.3)	ZNF259 (2.9)	TXNL4B (2.7)	BUD13 (2.6)	ENSG00000226645 (2.5)	CARM1 (2.4)	NKPD1 (2.0)	TOP1 (1.9)	TSSK6 (1.6)	SMARCA4 (1.5)
ENSG00000147443	DOK2 PPI subnetwork	0.92	> 0.20	GMIP (2.9)	POLK (2.5)	ZNF180 (2.2)	SH2B3 (1.7)	ABO (1.6)	MARK4 (1.6)	ATXN2 (1.6)	CILP2 (1.5)	ENSG00000238078 (1.1)	NCAN (1.0)
MP:0000852	small cerebellum	0.92	> 0.20	RPH3A (2.8)	ZHX3 (2.7)	PLCG1 (2.5)	OGDH (2.3)	DOCK7 (2.3)	USP24 (2.2)	HAVCR1 (1.8)	PCSK9 (1.8)	TMED4 (1.8)	APOE (1.7)
ENSG00000105509	HAS1 PPI subnetwork	0.92	> 0.20	TMEM50A (3.7)	ZNF259 (1.9)	TMEM57 (1.9)	USP24 (1.9)	GPAM (1.8)	C12orf43 (1.7)	CYB561D1 (1.6)	ENSG00000226645 (1.6)	ST3GAL4 (1.5)	TXNL4B (1.5)
ENSG00000154608	ENSG00000154608 PPI subnetwork	0.92	> 0.20	CYB561D1 (2.9)	GEMIN7 (2.8)	DDX56 (2.6)	MAU2 (2.5)	LPAR2 (2.3)	AP1M2 (2.3)	YIPF2 (2.1)	NKPD1 (2.0)	KANK2 (1.8)	LPIN3 (1.7)
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	0.92	> 0.20	C11orf9 (2.9)	PVR (2.3)	PLEKHH2 (2.1)	PVRL2 (2.1)	CEACAM19 (2.0)	ENSG00000226645 (1.8)	ANKRD31 (1.7)	BCAM (1.7)	ABO (1.7)	TSSK6 (1.6)
ENSG00000117152	RGS4 PPI subnetwork	0.92	> 0.20	DOCK7 (3.2)	PSMA5 (2.2)	KIAA1324 (1.9)	DNM2 (1.8)	LPIN3 (1.8)	YIPF2 (1.8)	SORT1 (1.7)	C11orf9 (1.6)	ZHX3 (1.5)	CYP7A1 (1.4)
GO:0051293	establishment of spindle localization	0.92	> 0.20	PSRC1 (3.9)	ENSG00000238078 (2.4)	POC5 (2.4)	BUD13 (2.0)	ENSG00000226645 (1.9)	PPP1R37 (1.6)	CYB561D1 (1.5)	ENSG00000228044 (1.5)	ENSG00000235545 (1.3)	ITGB3 (1.3)
GO:0051653	spindle localization	0.92	> 0.20	PSRC1 (3.9)	ENSG00000238078 (2.4)	POC5 (2.4)	BUD13 (2.0)	ENSG00000226645 (1.9)	PPP1R37 (1.6)	CYB561D1 (1.5)	ENSG00000228044 (1.5)	ENSG00000235545 (1.3)	ITGB3 (1.3)
MP:0008660	increased interleukin-10 secretion	0.92	> 0.20	RELB (2.7)	APOE (1.8)	ZNF101 (1.7)	BCL3 (1.7)	POLK (1.3)	TIMD4 (1.3)	YIPF2 (1.3)	NKPD1 (1.2)	KIAA1324 (1.2)	LPAR2 (1.2)
MP:0005253	abnormal eye physiology	0.92	> 0.20	ENSG00000235545 (2.2)	C11orf9 (2.1)	SORT1 (1.8)	CELSR2 (1.4)	ST3GAL4 (1.3)	PMFBP1 (1.3)	FADS1 (1.3)	PSRC1 (1.2)	APOE (1.2)	GOT2P1 (0.9)
MP:0005537	abnormal cerebral aqueduct morphology	0.92	> 0.20	CELSR2 (2.5)	C12orf51 (2.2)	ATP13A1 (2.2)	TSSK6 (1.9)	ABCG8 (1.7)	LPIN3 (1.7)	AP1M2 (1.7)	BLOC1S3 (1.6)	PLEC (1.6)	ATXN2 (1.5)
ENSG00000069424	KCNAB2 PPI subnetwork	0.92	> 0.20	RPH3A (4.2)	SLC22A1 (2.5)	ALDH2 (2.1)	C1orf63 (2.0)	GRINA (1.8)	UBXN2B (1.8)	KIAA1324 (1.8)	APOC1 (1.6)	ENSG00000228044 (1.5)	C12orf43 (1.4)
GO:0048641	regulation of skeletal muscle tissue development	0.92	> 0.20	ENSG00000226648 (2.5)	ATXN7L2 (2.4)	COL4A3BP (2.1)	GMPR (2.1)	SYPL2 (2.0)	POLK (1.7)	CEACAM19 (1.6)	SLC44A2 (1.6)	GEMIN7 (1.4)	OGDH (1.2)
MP:0004770	abnormal synaptic vesicle recycling	0.92	> 0.20	RPH3A (4.1)	HAPLN4 (3.1)	ABO (2.4)	CELSR2 (2.1)	AP1M2 (1.9)	PPP1R37 (1.8)	TRAFD1 (1.6)	AMIGO1 (1.5)	KIAA1324 (1.4)	C12orf51 (1.4)
ENSG00000108107	RPL28 PPI subnetwork	0.92	> 0.20	NAA25 (2.3)	GATAD2A (2.2)	ILF3 (2.0)	NKPD1 (1.7)	ATP13A1 (1.6)	PTPN11 (1.6)	DNAH11 (1.6)	DHX38 (1.6)	ANKRD31 (1.5)	TOP1 (1.5)
GO:0016780	phosphotransferase activity, for other substituted phosphate groups	0.93	> 0.20	ZNF259 (2.4)	ATP13A1 (2.3)	ENSG00000226645 (2.1)	TMED4 (2.0)	UBXN2B (1.8)	YIPF2 (1.7)	HAVCR1 (1.7)	ABCG5 (1.6)	C17orf57 (1.6)	TSSK6 (1.6)
GO:0031214	biomineral tissue development	0.93	> 0.20	ABO (2.5)	CILP2 (2.3)	MYLIP (2.2)	TMEM57 (2.0)	MAFB (2.0)	ENSG00000226645 (2.0)	TMEM116 (1.8)	RHCE (1.7)	HNF1A (1.4)	CYB561D1 (1.3)
ENSG00000160973	FOXH1 PPI subnetwork	0.93	> 0.20	ATXN7L2 (2.0)	MYLIP (1.8)	PPP1R37 (1.8)	GEMIN7 (1.7)	HAVCR1 (1.7)	MAFB (1.6)	SH2B3 (1.4)	ENSG00000254235 (1.3)	COL4A3BP (1.2)	FADS2 (1.2)
GO:0010518	positive regulation of phospholipase activity	0.93	> 0.20	AMIGO1 (3.1)	ZHX3 (2.2)	PLEKHH2 (2.1)	PMFBP1 (2.0)	ITGB3 (1.8)	ST3GAL4 (1.8)	ENSG00000235545 (1.6)	ABO (1.3)	GOT2P1 (1.3)	C12orf47 (1.2)
REACTOME_POST:TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI:ANCHORED_PROTEINS	REACTOME_POST:TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI:ANCHORED_PROTEINS	0.93	> 0.20	ATP13A1 (3.8)	TRAPPC6A (2.7)	CYB561D1 (2.4)	ERP29 (2.4)	YIPF2 (2.4)	TMEM50A (2.3)	TMEM116 (1.9)	TMED4 (1.9)	CLPTM1 (1.9)	SLC44A2 (1.4)
MP:0000153	rib bifurcation	0.93	> 0.20	NYNRIN (2.9)	ATXN7L2 (2.6)	NCAN (1.9)	TMEM57 (1.8)	FADS2 (1.7)	PLCG1 (1.5)	PPP1R37 (1.5)	MYLIP (1.3)	GCNT4 (1.3)	BCAM (1.2)
GO:0050434	positive regulation of viral transcription	0.93	> 0.20	MAPKAPK5 (3.3)	BUD13 (2.9)	SUGP1 (2.5)	TXNL4B (2.4)	UBXN2B (2.0)	ZNF259 (1.8)	GEMIN7 (1.6)	C12orf43 (1.6)	QTRT1 (1.6)	BRAP (1.5)
GO:0035326	enhancer binding	0.93	> 0.20	RHD (3.0)	MARK4 (2.5)	GMPR (2.5)	CELSR2 (2.4)	RHCE (2.3)	ITGB3 (2.0)	SLC44A2 (2.0)	TRAPPC6A (1.6)	MYLIP (1.4)	KIAA1324 (1.3)
ENSG00000188459	ENSG00000188459 PPI subnetwork	0.93	> 0.20	TMEM50A (3.1)	LPIN3 (2.2)	GMIP (2.1)	ENSG00000238078 (2.1)	GATAD2A (2.0)	SLC44A2 (1.6)	C1orf63 (1.6)	ITGB3 (1.6)	ABO (1.5)	TSSK6 (1.3)
GO:0046631	alpha-beta T cell activation	0.93	> 0.20	PBX4 (3.0)	ZNF101 (2.8)	ENSG00000235545 (1.9)	NT5DC1 (1.5)	TIMD4 (1.5)	ENSG00000254235 (1.5)	GMIP (1.5)	ANKRD31 (1.5)	BLOC1S3 (1.5)	PLCG1 (1.4)
GO:0021915	neural tube development	0.93	> 0.20	DYNC2LI1 (3.1)	ATXN7L2 (2.9)	PLCG1 (2.5)	LPAR2 (2.1)	ENSG00000226648 (2.0)	PPP1R37 (1.9)	PVRL2 (1.8)	PBX4 (1.8)	NYNRIN (1.6)	AMIGO1 (1.5)
ENSG00000138175	ARL3 PPI subnetwork	0.93	> 0.20	POLK (2.5)	C12orf51 (2.4)	FADS2 (2.2)	SLC44A2 (1.9)	ADAM1 (1.8)	C12orf47 (1.8)	ZNF180 (1.7)	BLOC1S3 (1.7)	ENSG00000228044 (1.6)	BRAP (1.6)
GO:0021872	forebrain generation of neurons	0.93	> 0.20	DNAH11 (3.0)	C17orf57 (2.4)	C12orf47 (1.9)	ANKRD31 (1.9)	PBX4 (1.7)	C19orf52 (1.7)	ENSG00000226648 (1.7)	NCAN (1.5)	CELSR2 (1.3)	POLK (1.3)
GO:0003208	cardiac ventricle morphogenesis	0.93	> 0.20	ENSG00000254235 (2.6)	ENSG00000238078 (2.3)	CILP2 (1.8)	TSSK6 (1.5)	GMPR (1.4)	C11orf9 (1.3)	ATXN7L2 (1.2)	NYNRIN (1.2)	CEACAM19 (1.2)	ALDH2 (1.1)
GO:0001657	ureteric bud development	0.93	> 0.20	NYNRIN (2.3)	ENSG00000238078 (2.2)	PVRL2 (2.2)	BCAM (2.1)	MYLIP (1.9)	TMED4 (1.8)	HNF1A (1.8)	ENSG00000228044 (1.6)	AP1M2 (1.6)	PLEKHH2 (1.6)
ENSG00000030304	MUSK PPI subnetwork	0.93	> 0.20	CYB561D1 (1.9)	SYPL2 (1.8)	CILP2 (1.8)	ENSG00000226645 (1.6)	PVR (1.5)	GMPR (1.5)	ENSG00000226648 (1.5)	CEACAM19 (1.4)	AMIGO1 (1.4)	ATXN7L2 (1.3)
GO:0007264	small GTPase mediated signal transduction	0.93	> 0.20	GATAD2A (2.7)	PLEKHH2 (2.3)	DNM2 (2.2)	MARK4 (2.2)	AP1M2 (2.0)	COL4A3BP (2.0)	SH2B3 (1.9)	LPAR2 (1.9)	GMIP (1.9)	PPP1R37 (1.7)
ENSG00000151694	ADAM17 PPI subnetwork	0.93	> 0.20	CETP (2.6)	CELSR2 (2.3)	ST3GAL4 (2.2)	CBLC (2.2)	SLC44A2 (1.7)	GPAM (1.6)	KIAA1324 (1.5)	ENSG00000226648 (1.5)	ITGB3 (1.5)	PLEC (1.5)
MP:0001676	abnormal apical ectodermal ridge morphology	0.93	> 0.20	CBLC (3.4)	BCAM (2.9)	TRAPPC6A (2.5)	CELSR2 (2.0)	PCSK9 (1.6)	NYNRIN (1.4)	AP1M2 (1.3)	FADS1 (1.3)	C19orf52 (1.3)	NCAN (1.2)
GO:0043044	ATP-dependent chromatin remodeling	0.93	> 0.20	TXNL4B (2.9)	PSRC1 (2.8)	POC5 (2.6)	TSSK6 (2.4)	PMFBP1 (2.1)	ENSG00000226648 (2.1)	NKPD1 (1.9)	USP1 (1.8)	DYNC2LI1 (1.3)	TMEM116 (1.2)
ENSG00000198576	ARC PPI subnetwork	0.93	> 0.20	SORT1 (2.2)	ITGB3 (2.2)	RPH3A (2.1)	COL4A3BP (1.8)	CLPTM1 (1.8)	MARK4 (1.7)	PLEC (1.6)	OGDH (1.5)	C11orf9 (1.5)	NCAN (1.2)
GO:0000987	core promoter proximal region sequence-specific DNA binding	0.93	> 0.20	RHD (3.1)	ENSG00000226645 (2.1)	ENSG00000226648 (2.1)	MYLIP (1.6)	KIAA1324 (1.4)	POLK (1.4)	SYPL2 (1.4)	DNAH11 (1.4)	PLEC (1.3)	MAU2 (1.2)
GO:0021700	developmental maturation	0.93	> 0.20	PBX4 (1.7)	MYLIP (1.6)	ABO (1.6)	RHCE (1.6)	CELSR2 (1.5)	CILP2 (1.5)	ENSG00000226645 (1.4)	TMEM116 (1.4)	ENSG00000226648 (1.3)	MARK4 (1.3)
GO:0045727	positive regulation of translation	0.93	> 0.20	ENSG00000228044 (2.0)	TRAPPC6A (1.5)	ADAM1 (1.5)	SUGP1 (1.3)	C1orf63 (1.2)	TSSK6 (1.2)	C17orf57 (1.1)	ITGB3 (1.1)	TMEM57 (1.1)	CYB561D1 (1.0)
GO:0048806	genitalia development	0.93	> 0.20	PLEKHH2 (2.5)	ENSG00000238078 (2.4)	PMFBP1 (2.2)	ALDH2 (1.7)	ABO (1.6)	TSSK6 (1.6)	DNAH11 (1.5)	AP1M2 (1.5)	NKPD1 (1.4)	NYNRIN (1.3)
GO:0030742	GTP-dependent protein binding	0.93	> 0.20	COL4A3BP (2.7)	ALDH2 (2.1)	TXNL4B (2.1)	SORT1 (1.8)	ADAM1 (1.7)	POLK (1.5)	MAPKAPK5 (1.4)	DDX56 (1.4)	DOCK7 (1.3)	NYNRIN (1.3)
GO:0009142	nucleoside triphosphate biosynthetic process	0.93	> 0.20	TMEM116 (2.7)	ENSG00000226648 (2.6)	GOT2P1 (2.3)	OGDH (2.1)	SYPL2 (1.9)	HNF1A (1.9)	HAPLN4 (1.6)	DYNC2LI1 (1.6)	C1orf63 (1.6)	FRK (1.6)
ENSG00000150995	ITPR1 PPI subnetwork	0.93	> 0.20	HAPLN4 (2.4)	SORT1 (2.4)	NCAN (2.3)	CELSR2 (2.1)	RPH3A (2.0)	GCNT4 (1.9)	KIAA1324 (1.9)	AP1M2 (1.9)	ZNF180 (1.7)	TSSK6 (1.6)
ENSG00000117408	IPO13 PPI subnetwork	0.93	> 0.20	ATP13A1 (3.0)	ILF3 (2.2)	ERP29 (1.9)	SARS (1.6)	QTRT1 (1.5)	MAU2 (1.5)	C19orf52 (1.3)	ENSG00000226648 (1.3)	ENSG00000226645 (1.3)	ATXN7L2 (1.2)
ENSG00000126785	RHOJ PPI subnetwork	0.93	> 0.20	GMIP (2.5)	TMEM57 (2.3)	CLPTM1 (1.6)	SH2B3 (1.6)	TMEM50A (1.5)	NYNRIN (1.5)	ENSG00000254235 (1.5)	CYB561D1 (1.3)	POC5 (1.3)	MARK4 (1.2)
GO:0043266	regulation of potassium ion transport	0.93	> 0.20	KIAA1324 (3.4)	ENSG00000254235 (2.4)	ENSG00000226648 (2.3)	POLK (1.8)	RPH3A (1.5)	PPP1R37 (1.3)	BLOC1S3 (1.3)	GOT2P1 (1.3)	ENSG00000226645 (1.1)	DNAH11 (1.0)
ENSG00000151729	SLC25A4 PPI subnetwork	0.93	> 0.20	PLEC (2.5)	SH2B3 (2.1)	BCAM (2.1)	OGDH (2.0)	ENSG00000226648 (2.0)	ACAD10 (2.0)	PLCG1 (1.9)	TMEM50A (1.6)	MYLIP (1.4)	POLK (1.4)
MP:0009967	abnormal neuron proliferation	0.93	> 0.20	AMIGO1 (2.2)	PMFBP1 (2.0)	CYB561D1 (2.0)	C12orf47 (1.7)	TSSK6 (1.5)	MAFB (1.5)	SMARCA4 (1.5)	TMEM116 (1.1)	HLX (1.0)	PSMA5 (1.0)
GO:0005583	fibrillar collagen	0.93	> 0.20	CILP2 (6.3)	APOE (2.1)	ATXN7L2 (1.7)	PLEKHH2 (1.7)	NPC1L1 (1.5)	FADS2 (1.4)	FRK (1.4)	MYLIP (1.2)	MAFB (1.2)	HLX (1.0)
ENSG00000168005	C11orf84 PPI subnetwork	0.93	> 0.20	TIMD4 (2.5)	PTPN11 (2.2)	NKPD1 (2.1)	ENSG00000238078 (1.9)	AMIGO1 (1.9)	SMARCA4 (1.8)	GRINA (1.5)	DOCK7 (1.5)	GATAD2A (1.4)	DNM2 (1.3)
MP:0005630	increased lung weight	0.93	> 0.20	TMEM116 (2.6)	OGDH (2.3)	FRK (2.1)	NPC1L1 (2.1)	MYLIP (2.0)	APOB (1.9)	ABCG5 (1.7)	CYP7A1 (1.5)	HLX (1.5)	C17orf57 (1.2)
MP:0005545	abnormal lens development	0.93	> 0.20	TMED4 (2.4)	MAFB (2.1)	TRAPPC6A (1.7)	PBX4 (1.5)	CILP2 (1.4)	APOB (1.4)	PMFBP1 (1.4)	CETP (1.3)	MYLIP (1.3)	TRAFD1 (1.2)
ENSG00000130561	SAG PPI subnetwork	0.93	> 0.20	PTPN11 (3.1)	C19orf52 (2.4)	ENSG00000228044 (2.3)	ENSG00000235545 (1.6)	PVR (1.6)	PLEKHH2 (1.3)	C12orf47 (1.3)	ENSG00000254235 (1.3)	KANK2 (1.2)	GATAD2A (1.2)
MP:0000445	short snout	0.93	> 0.20	CILP2 (3.6)	DOCK7 (2.2)	PLEKHH2 (2.1)	MYLIP (2.0)	NYNRIN (1.9)	MAFB (1.8)	KANK2 (1.7)	ATXN2 (1.7)	CBLC (1.5)	ENSG00000238078 (1.3)
GO:0005802	trans-Golgi network	0.93	> 0.20	SORT1 (3.0)	YIPF2 (2.9)	KIAA1324 (2.4)	AP1M2 (2.3)	C12orf51 (2.3)	USP24 (2.2)	C17orf57 (1.9)	ZHX3 (1.9)	DOCK7 (1.8)	PTPN11 (1.8)
ENSG00000142949	PTPRF PPI subnetwork	0.93	> 0.20	PVRL2 (3.5)	MARK4 (2.7)	AP1M2 (2.3)	LPIN3 (2.2)	PLCG1 (1.9)	NCAN (1.7)	KANK2 (1.7)	CELSR2 (1.7)	GPAM (1.6)	PTPN11 (1.6)
GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	0.93	> 0.20	ATXN2 (3.4)	MAPKAPK5 (2.3)	ENSG00000235545 (2.2)	COL4A3BP (2.0)	ACAD10 (2.0)	DDX56 (1.8)	TRAPPC6A (1.8)	C17orf57 (1.8)	DYNC2LI1 (1.7)	SUGP1 (1.6)
ENSG00000059573	ALDH18A1 PPI subnetwork	0.93	> 0.20	ATXN2 (1.9)	ILF3 (1.9)	QTRT1 (1.8)	ACAD10 (1.7)	ERP29 (1.5)	PCSK9 (1.5)	TMEM116 (1.5)	ZNF101 (1.5)	POC5 (1.4)	TRIB1 (1.4)
GO:0010660	regulation of muscle cell apoptotic process	0.93	> 0.20	CILP2 (2.1)	SLC22A1 (2.1)	ADAM1 (1.6)	ENSG00000235545 (1.3)	ENSG00000238078 (1.2)	ENSG00000226645 (1.0)	BCAM (1.0)	DNAH11 (1.0)	ENSG00000226648 (0.9)	HLX (0.9)
GO:0045111	intermediate filament cytoskeleton	0.93	> 0.20	CELSR2 (1.4)	PMFBP1 (1.2)	ENSG00000228044 (0.7)	SYPL2 (0.6)	RPH3A (0.6)	GMPR (0.5)	PLEC (0.5)	TRAPPC6A (0.5)	FADS1 (0.5)	OGDH (0.5)
GO:0043395	heparan sulfate proteoglycan binding	0.93	> 0.20	CILP2 (4.5)	PLG (3.5)	ANGPTL3 (3.1)	HP (2.9)	APOC4 (2.7)	BCAM (2.5)	MOSC1 (2.3)	CYP7A1 (2.2)	APOC1 (2.0)	APOB (1.8)
ENSG00000089250	NOS1 PPI subnetwork	0.93	> 0.20	NCAN (2.7)	SORT1 (2.2)	RPH3A (2.2)	AMIGO1 (1.9)	CELSR2 (1.8)	C12orf51 (1.7)	ITGB3 (1.6)	MARK4 (1.6)	SYPL2 (1.5)	PPP1R37 (1.4)
ENSG00000106682	EIF4H PPI subnetwork	0.93	> 0.20	SARS (2.3)	GATAD2A (2.3)	CLPTM1 (1.9)	UBXN2B (1.9)	ILF3 (1.8)	NKPD1 (1.6)	GEMIN7 (1.6)	CBLC (1.5)	SUGP1 (1.5)	GRINA (1.4)
GO:0043243	positive regulation of protein complex disassembly	0.93	> 0.20	AMIGO1 (2.7)	TMEM57 (2.3)	ENSG00000235545 (2.2)	DYNC2LI1 (1.9)	DNAH11 (1.7)	ST3GAL4 (1.6)	POC5 (1.6)	TXNL4B (1.1)	TSSK6 (1.1)	TMEM116 (1.1)
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	0.93	> 0.20	GMIP (2.6)	PLEC (2.6)	PBX4 (2.6)	LPAR2 (2.4)	CELSR2 (2.4)	GATAD2A (2.3)	HAPLN4 (1.7)	DNM2 (1.7)	DOCK7 (1.7)	C12orf51 (1.5)
MP:0003120	abnormal tracheal cartilage morphology	0.93	> 0.20	CILP2 (4.4)	PLEKHH2 (4.3)	DYNC2LI1 (2.3)	KIAA1324 (2.0)	HAPLN4 (1.9)	HLX (1.7)	C11orf9 (1.7)	SORT1 (1.6)	SLC44A2 (1.5)	KANK2 (1.3)
ENSG00000078295	ADCY2 PPI subnetwork	0.93	> 0.20	C12orf43 (2.0)	MARK4 (1.7)	DNM2 (1.6)	LPAR2 (1.5)	ZNF180 (1.5)	HAVCR1 (1.4)	OASL (1.4)	NYNRIN (1.4)	GMIP (1.3)	CARM1 (1.3)
MP:0001145	abnormal male reproductive system morphology	0.93	> 0.20	ANKRD31 (2.3)	KIAA1324 (2.2)	C12orf47 (1.8)	PBX4 (1.8)	DOCK7 (1.7)	ADAM1 (1.6)	ALDH2 (1.6)	LPAR2 (1.5)	GCNT4 (1.4)	PLEKHH2 (1.4)
REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	0.93	> 0.20	PSRC1 (3.2)	POC5 (2.8)	LPIN3 (2.8)	LPAR2 (2.7)	FEN1 (2.6)	ADAM1 (2.5)	SUGP1 (2.1)	DOCK7 (2.1)	ATP13A1 (1.9)	MAU2 (1.8)
GO:0021795	cerebral cortex cell migration	0.93	> 0.20	ENSG00000235545 (3.1)	NCAN (2.5)	PBX4 (2.5)	DNAH11 (1.8)	TMEM116 (1.7)	TSSK6 (1.7)	DOCK7 (1.6)	C19orf52 (1.6)	ENSG00000226648 (1.5)	CELSR2 (1.5)
GO:0021987	cerebral cortex development	0.93	> 0.20	DNAH11 (3.3)	TSSK6 (2.8)	PBX4 (2.2)	CELSR2 (2.1)	NCAN (1.8)	C12orf47 (1.8)	ZHX3 (1.5)	AMIGO1 (1.5)	UBXN2B (1.4)	C17orf57 (1.2)
ENSG00000122877	EGR2 PPI subnetwork	0.93	> 0.20	CELSR2 (3.3)	PLEKHH2 (2.1)	APOE (1.8)	NCAN (1.8)	APOC1 (1.5)	MARK4 (1.4)	SH2B3 (1.3)	DOCK7 (1.3)	MAPKAPK5 (1.3)	RPH3A (1.2)
GO:0032409	regulation of transporter activity	0.93	> 0.20	SYPL2 (3.0)	RPH3A (2.1)	AMIGO1 (2.0)	PLEKHH2 (1.8)	CYB561D1 (1.7)	C12orf47 (1.3)	CARM1 (1.3)	KIAA1324 (1.1)	PVR (1.1)	ATXN7L2 (1.1)
GO:0072503	cellular divalent inorganic cation homeostasis	0.93	> 0.20	C12orf47 (2.7)	SYPL2 (2.1)	RPH3A (1.6)	ERP29 (1.6)	ABO (1.5)	AMIGO1 (1.5)	YIPF2 (1.3)	PBX4 (1.2)	KIAA1324 (1.2)	SLC44A2 (1.1)
ENSG00000072401	UBE2D1 PPI subnetwork	0.93	> 0.20	PSRC1 (5.2)	FEN1 (2.9)	USP1 (2.4)	LPIN3 (1.9)	C12orf51 (1.9)	USP24 (1.8)	POC5 (1.8)	ATXN2 (1.7)	GEMIN7 (1.5)	TMEM57 (1.4)
ENSG00000154342	WNT3A PPI subnetwork	0.93	> 0.20	CILP2 (4.1)	KIAA1324 (2.3)	MOSC1 (1.6)	TXNL4B (1.6)	AMIGO1 (1.5)	LPAR2 (1.5)	CELSR2 (1.5)	TRAPPC6A (1.4)	PPP1R37 (1.4)	ZNF180 (1.4)
ENSG00000106244	PDAP1 PPI subnetwork	0.93	> 0.20	RHD (2.4)	GRINA (2.0)	PLCG1 (1.9)	RHCE (1.8)	PSRC1 (1.4)	GOT2P1 (1.4)	CBLC (1.3)	APOE (1.2)	KANK2 (1.2)	MAPKAPK5 (1.2)
MP:0001364	decreased anxiety-related response	0.93	> 0.20	RPH3A (3.2)	CELSR2 (2.7)	GCNT4 (2.5)	NCAN (2.5)	C12orf47 (1.9)	ENSG00000226645 (1.9)	AMIGO1 (1.5)	ABO (1.5)	FRK (1.4)	KIAA1324 (1.2)
MP:0008547	abnormal neocortex morphology	0.93	> 0.20	NCAN (2.8)	CELSR2 (2.4)	ABCG8 (2.1)	SORT1 (2.0)	PSRC1 (2.0)	ENSG00000254235 (1.8)	BLOC1S3 (1.7)	ABCG5 (1.6)	PPP1R37 (1.6)	FADS1 (1.5)
GO:0051781	positive regulation of cell division	0.93	> 0.20	ENSG00000228044 (2.3)	TMED4 (1.9)	TMEM116 (1.5)	C11orf9 (1.5)	AP1M2 (1.4)	ENSG00000235545 (1.4)	KANK2 (1.3)	TMEM50A (1.3)	PSRC1 (1.2)	PVR (1.2)
GO:0046961	proton-transporting ATPase activity, rotational mechanism	0.93	> 0.20	GRINA (3.8)	ENSG00000238078 (3.3)	SARS (2.9)	GMPR (2.1)	SORT1 (1.8)	AP1M2 (1.8)	C19orf52 (1.7)	CLPTM1 (1.7)	COL4A3BP (1.7)	ERP29 (1.7)
GO:0042147	retrograde transport, endosome to Golgi	0.93	> 0.20	BLOC1S3 (2.3)	COL4A3BP (2.1)	LPAR2 (2.0)	TXNL4B (1.9)	C19orf52 (1.9)	ENSG00000254235 (1.8)	BRAP (1.6)	CYB561D1 (1.5)	DNAH11 (1.3)	ENSG00000226648 (1.3)
GO:0046635	positive regulation of alpha-beta T cell activation	0.93	> 0.20	ENSG00000235545 (3.0)	ZNF101 (2.4)	PBX4 (2.3)	ENSG00000226645 (1.6)	ANKRD31 (1.5)	ENSG00000254235 (1.5)	NT5DC1 (1.3)	TIMD4 (1.2)	BLOC1S3 (1.2)	NKPD1 (1.2)
ENSG00000105568	PPP2R1A PPI subnetwork	0.93	> 0.20	MARK4 (3.6)	GOT2P1 (2.1)	SORT1 (2.0)	GATAD2A (1.9)	PTPN11 (1.9)	PPP1R37 (1.7)	RPH3A (1.4)	ZNF180 (1.4)	PVRL2 (1.3)	DNM2 (1.3)
GO:0030317	sperm motility	0.93	> 0.20	TSSK6 (6.4)	PMFBP1 (4.1)	ABCG8 (2.0)	ADAM1 (1.8)	HAVCR1 (1.1)	ABCG5 (1.1)	ENSG00000228044 (1.1)	HNF1A (1.1)	ATXN7L2 (1.1)	CILP2 (1.1)
ENSG00000127184	COX7C PPI subnetwork	0.93	> 0.20	TRAPPC6A (3.7)	GOT2P1 (2.4)	ZNF180 (2.3)	ACAD10 (2.1)	POC5 (1.8)	TMEM116 (1.7)	C12orf47 (1.7)	TRAFD1 (1.5)	BRAP (1.5)	ADAM1 (1.4)
MP:0002269	muscular atrophy	0.93	> 0.20	GMPR (2.3)	PLEC (2.2)	SARS (2.1)	SYPL2 (2.0)	MAPKAPK5 (1.8)	MAU2 (1.6)	COL4A3BP (1.5)	SUGP1 (1.5)	KIAA1324 (1.4)	ATP13A1 (1.4)
ENSG00000115145	STAM2 PPI subnetwork	0.93	> 0.20	MAU2 (3.1)	DNM2 (3.1)	DOCK7 (2.8)	SMARCA4 (2.4)	SUGP1 (2.3)	ENSG00000235545 (2.1)	SH2B3 (2.0)	PSMA5 (1.9)	USP24 (1.8)	GMIP (1.7)
ENSG00000167977	KCTD5 PPI subnetwork	0.93	> 0.20	ABO (2.0)	ATP13A1 (1.6)	PVRL2 (1.5)	CARM1 (1.5)	PSMA5 (1.5)	SARS (1.5)	TSSK6 (1.2)	DNM2 (1.2)	GRINA (1.2)	GATAD2A (1.1)
GO:0060561	apoptotic process involved in morphogenesis	0.93	> 0.20	ZNF101 (2.6)	AP1M2 (2.1)	ANKRD31 (2.1)	NKPD1 (1.9)	PPP1R37 (1.8)	ST3GAL4 (1.6)	UBXN2B (1.5)	CEACAM19 (1.4)	YIPF2 (1.3)	PARP10 (1.2)
MP:0004359	short ulna	0.93	> 0.20	PLEKHH2 (3.5)	NYNRIN (2.6)	CILP2 (2.2)	GOT2P1 (1.5)	PLCG1 (1.5)	FRK (1.4)	MAFB (1.4)	MYLIP (1.4)	KANK2 (1.2)	KIAA1324 (1.1)
GO:0044441	cilium part	0.93	> 0.20	DYNC2LI1 (5.5)	DNAH11 (4.1)	HAVCR1 (1.1)	DOCK7 (1.1)	YIPF2 (0.9)	POC5 (0.9)	NKPD1 (0.8)	PLEKHH2 (0.8)	TMED4 (0.8)	POLK (0.7)
ENSG00000163082	SGPP2 PPI subnetwork	0.93	> 0.20	NKPD1 (2.5)	TMEM50A (2.5)	C11orf9 (2.4)	ATP13A1 (1.8)	CYB561D1 (1.7)	CLPTM1 (1.6)	NT5DC1 (1.6)	HMGCR (1.6)	SORT1 (1.4)	COL4A3BP (1.3)
ENSG00000197579	TOPORS PPI subnetwork	0.93	> 0.20	USP24 (2.3)	PVRL2 (2.2)	COL4A3BP (1.8)	TMEM57 (1.7)	PMFBP1 (1.6)	BRAP (1.5)	NKPD1 (1.4)	OASL (1.4)	PLEKHH2 (1.3)	TRAFD1 (1.3)
GO:0051904	pigment granule transport	0.93	> 0.20	ENSG00000228044 (2.1)	DYNC2LI1 (2.1)	PMFBP1 (1.8)	CEACAM19 (1.7)	ENSG00000254235 (1.4)	UBXN2B (1.4)	C1orf63 (1.3)	C12orf43 (1.2)	HAVCR1 (1.2)	ZNF180 (1.1)
GO:0048762	mesenchymal cell differentiation	0.93	> 0.20	ENSG00000254235 (2.9)	MYLIP (2.5)	ABO (2.3)	PLEKHH2 (2.1)	KANK2 (2.0)	NYNRIN (1.8)	MAFB (1.3)	SLC44A2 (1.2)	BCAM (1.1)	CBLC (1.1)
GO:0051890	regulation of cardioblast differentiation	0.93	> 0.20	ENSG00000226648 (2.6)	NYNRIN (2.5)	C11orf9 (2.4)	LPAR2 (2.1)	LPIN3 (1.8)	C17orf57 (1.6)	NPC1L1 (1.5)	C19orf52 (1.4)	GCNT4 (1.3)	GEMIN7 (1.3)
ENSG00000170743	SYT9 PPI subnetwork	0.93	> 0.20	RPH3A (3.0)	AMIGO1 (2.8)	C12orf51 (2.5)	ENSG00000226645 (2.5)	HAPLN4 (2.4)	CEACAM19 (2.1)	ENSG00000254235 (2.0)	BCAM (1.7)	TOP1 (1.7)	ABO (1.5)
ENSG00000124214	STAU1 PPI subnetwork	0.93	> 0.20	C1orf63 (3.5)	COL4A3BP (2.5)	ILF3 (2.4)	TMEM50A (2.2)	CYB561D1 (2.0)	PTPN11 (1.8)	GCNT4 (1.7)	TOP1 (1.6)	USP1 (1.6)	ENSG00000226648 (1.6)
GO:0045182	translation regulator activity	0.93	> 0.20	BRAP (2.4)	PVR (2.4)	PTPN11 (2.0)	COL4A3BP (1.8)	ILF3 (1.7)	PMFBP1 (1.7)	CEACAM19 (1.6)	ITGB3 (1.6)	TRAPPC6A (1.3)	SMARCA4 (1.3)
GO:0002438	acute inflammatory response to antigenic stimulus	0.93	> 0.20	C19orf52 (2.6)	DNAH11 (2.2)	ENSG00000235545 (2.2)	ZNF180 (2.0)	ZNF101 (1.9)	ENSG00000226648 (1.8)	PBX4 (1.8)	UBXN2B (1.7)	AMIGO1 (1.4)	YIPF2 (1.3)
ENSG00000023228	NDUFS1 PPI subnetwork	0.93	> 0.20	OGDH (3.3)	ACAD10 (2.9)	PSMA5 (2.6)	TRAPPC6A (2.5)	C12orf47 (2.4)	GOT2P1 (1.8)	FRK (1.8)	C1orf63 (1.8)	ADAM1 (1.6)	MAU2 (1.5)
GO:0042745	circadian sleep/wake cycle	0.93	> 0.20	ENSG00000226648 (4.3)	RPH3A (1.9)	HNF1A (1.7)	LPIN3 (1.6)	C12orf47 (1.5)	DNAH11 (1.5)	TSSK6 (1.5)	CETP (1.4)	CILP2 (1.3)	PPP1R37 (1.3)
ENSG00000078018	MAP2 PPI subnetwork	0.93	> 0.20	NCAN (3.0)	RPH3A (2.6)	SORT1 (1.9)	MARK4 (1.7)	C11orf9 (1.7)	CELSR2 (1.6)	C12orf51 (1.5)	TMEM50A (1.5)	COL4A3BP (1.5)	CYB561D1 (1.4)
GO:0015081	sodium ion transmembrane transporter activity	0.93	> 0.20	TM6SF2 (3.9)	TMEM116 (3.0)	ABCG8 (2.9)	NCAN (2.8)	ABCG5 (2.8)	HAPLN4 (2.5)	SYPL2 (2.3)	GCNT4 (2.1)	PLG (2.0)	RPH3A (1.8)
ENSG00000153107	ANAPC1 PPI subnetwork	0.93	> 0.20	PSRC1 (5.6)	FEN1 (3.8)	POC5 (2.8)	USP1 (2.1)	GEMIN7 (1.7)	LPIN3 (1.5)	ILF3 (1.3)	LPAR2 (1.1)	RHCE (1.1)	SUGP1 (1.1)
REACTOME_PHOSPHORYLATION_OF_THE_APCC	REACTOME_PHOSPHORYLATION_OF_THE_APCC	0.93	> 0.20	PSRC1 (3.5)	POC5 (3.2)	LPIN3 (2.5)	FEN1 (2.4)	ADAM1 (2.1)	SUGP1 (1.8)	LPAR2 (1.8)	DOCK7 (1.6)	GEMIN7 (1.6)	SLC44A2 (1.5)
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	0.93	> 0.20	SARS (3.1)	PTPN11 (3.0)	COL4A3BP (2.6)	SORT1 (2.2)	BRAP (2.2)	HAPLN4 (2.1)	ZHX3 (1.9)	USP24 (1.9)	APOE (1.8)	TMEM57 (1.7)
ENSG00000183779	ZNF703 PPI subnetwork	0.93	> 0.20	PPP1R37 (2.9)	GATAD2A (2.4)	MARK4 (2.2)	ABO (1.9)	BCAM (1.9)	NAA25 (1.6)	CARM1 (1.5)	CLPTM1 (1.5)	SMARCA4 (1.5)	PTPN11 (1.3)
GO:0035250	UDP-galactosyltransferase activity	0.93	> 0.20	ST3GAL4 (3.9)	YIPF2 (2.3)	AMIGO1 (2.2)	ENSG00000254235 (2.0)	ERP29 (1.9)	SLC44A2 (1.8)	CBLC (1.6)	LPIN3 (1.6)	TMED4 (1.6)	CYB561D1 (1.6)
ENSG00000111262	KCNA1 PPI subnetwork	0.93	> 0.20	GCNT4 (3.7)	RPH3A (3.5)	HAPLN4 (1.6)	FRK (1.6)	POLK (1.6)	PLCG1 (1.4)	CELSR2 (1.4)	AMIGO1 (1.3)	LPAR2 (1.3)	C12orf43 (1.2)
GO:0046636	negative regulation of alpha-beta T cell activation	0.93	> 0.20	ENSG00000254235 (2.3)	PBX4 (2.1)	HNF1A (2.1)	ANKRD31 (1.8)	C17orf57 (1.5)	AMIGO1 (1.4)	COL4A3BP (1.1)	TMEM57 (1.1)	PMFBP1 (1.1)	LPIN3 (1.0)
GO:0009953	dorsal/ventral pattern formation	0.93	> 0.20	DYNC2LI1 (3.0)	DNAH11 (2.5)	LPAR2 (2.0)	ENSG00000226648 (1.8)	TMEM116 (1.6)	PLEKHH2 (1.6)	HAPLN4 (1.6)	C11orf9 (1.5)	ENSG00000254235 (1.5)	CEACAM19 (1.3)
GO:0003143	embryonic heart tube morphogenesis	0.93	> 0.20	ENSG00000226648 (2.4)	LPIN3 (2.3)	NYNRIN (2.0)	C17orf57 (1.7)	PVRL2 (1.7)	DYNC2LI1 (1.5)	ADAM1 (1.0)	ATXN7L2 (1.0)	COL4A3BP (1.0)	BCAM (0.9)
GO:0009201	ribonucleoside triphosphate biosynthetic process	0.93	> 0.20	ENSG00000226648 (2.6)	TMEM116 (2.5)	GOT2P1 (2.4)	OGDH (2.2)	SYPL2 (2.0)	HNF1A (1.9)	DYNC2LI1 (1.7)	GCNT4 (1.6)	HAPLN4 (1.6)	PMFBP1 (1.6)
GO:0009948	anterior/posterior axis specification	0.93	> 0.20	PVRL2 (2.0)	ABO (2.0)	C11orf9 (1.9)	ENSG00000238078 (1.7)	ADAM1 (1.6)	PCSK9 (1.4)	HNF1A (1.3)	CEACAM19 (1.2)	TMED4 (1.2)	TSSK6 (1.1)
GO:0032105	negative regulation of response to extracellular stimulus	0.93	> 0.20	GCNT4 (2.2)	KIAA1324 (1.8)	MAPKAPK5 (1.6)	GPAM (1.6)	ABCG8 (1.5)	LPIN3 (1.5)	ADAM1 (1.4)	C1orf63 (1.4)	ST3GAL4 (1.3)	AP1M2 (1.3)
GO:0032108	negative regulation of response to nutrient levels	0.93	> 0.20	GCNT4 (2.2)	KIAA1324 (1.8)	MAPKAPK5 (1.6)	GPAM (1.6)	ABCG8 (1.5)	LPIN3 (1.5)	ADAM1 (1.4)	C1orf63 (1.4)	ST3GAL4 (1.3)	AP1M2 (1.3)
ENSG00000185313	SCN10A PPI subnetwork	0.93	> 0.20	HLX (2.7)	OGDH (2.2)	SLC44A2 (1.7)	ATXN7L2 (1.6)	C12orf47 (1.6)	LDLR (1.6)	RPH3A (1.6)	DDX56 (1.5)	NCAN (1.4)	PBX4 (1.4)
ENSG00000198873	GRK5 PPI subnetwork	0.93	> 0.20	AMIGO1 (2.3)	PPP1R37 (2.1)	BCAM (2.0)	RPH3A (1.9)	POLK (1.6)	PSRC1 (1.5)	C17orf57 (1.5)	GOT2P1 (1.4)	GCNT4 (1.4)	RHCE (1.3)
GO:0050911	detection of chemical stimulus involved in sensory perception of smell	0.93	> 0.20	ENSG00000235545 (4.0)	ENSG00000228044 (3.0)	DNAH11 (2.5)	GOT2P1 (2.0)	PMFBP1 (1.3)	HNF1A (0.8)	NT5DC1 (0.7)	HAPLN4 (0.6)	C12orf51 (0.6)	POLK (0.5)
MP:0000430	absent maxillary shelf	0.93	> 0.20	MYLIP (1.3)	DNAH11 (1.2)	KANK2 (1.2)	ENSG00000235545 (1.2)	TRAFD1 (1.2)	MAFB (1.0)	YIPF2 (0.9)	C11orf9 (0.9)	TMEM57 (0.8)	LDLR (0.8)
ENSG00000213496	ENSG00000213496 PPI subnetwork	0.93	> 0.20	OGDH (3.6)	ACAD10 (3.1)	TRAPPC6A (2.8)	C12orf47 (2.6)	GOT2P1 (1.6)	FRK (1.6)	MAU2 (1.6)	PSMA5 (1.4)	GMPR (1.4)	TMED4 (1.2)
ENSG00000127481	UBR4 PPI subnetwork	0.93	> 0.20	USP24 (3.5)	COL4A3BP (3.5)	TMEM57 (2.4)	DHX38 (2.0)	OASL (1.7)	GRINA (1.6)	CARM1 (1.6)	PVRL2 (1.4)	BUD13 (1.4)	GMPR (1.3)
MP:0010392	prolonged QRS complex duration	0.93	> 0.20	BCAM (2.6)	SORT1 (2.0)	TMEM116 (2.0)	ALDH2 (1.7)	KANK2 (1.5)	ENSG00000226648 (1.3)	CYB561D1 (1.2)	GCNT4 (1.1)	PLEC (1.1)	DOCK7 (1.1)
GO:0055070	copper ion homeostasis	0.93	> 0.20	BLOC1S3 (2.1)	ENSG00000254235 (1.9)	NKPD1 (1.9)	GEMIN7 (1.7)	DYNC2LI1 (1.7)	C17orf57 (1.4)	TMEM50A (1.4)	ZNF259 (1.3)	ABO (1.2)	DOCK7 (1.2)
GO:0021591	ventricular system development	0.93	> 0.20	ANKRD31 (4.9)	DYNC2LI1 (2.8)	ENSG00000226648 (2.2)	ADAM1 (2.0)	PBX4 (2.0)	ZNF180 (1.6)	BRAP (1.5)	ACAD10 (1.3)	TSSK6 (1.2)	MAPKAPK5 (1.2)
GO:0034704	calcium channel complex	0.93	> 0.20	SYPL2 (2.9)	PLEKHH2 (2.5)	RPH3A (2.4)	KIAA1324 (2.3)	HAPLN4 (2.1)	C12orf47 (1.9)	ENSG00000226645 (1.9)	GCNT4 (1.8)	CARM1 (1.7)	AMIGO1 (1.5)
GO:0030546	receptor activator activity	0.93	> 0.20	BCAM (2.5)	CILP2 (2.4)	TMEM116 (2.1)	CARM1 (1.8)	AP1M2 (1.6)	GMPR (1.3)	ERP29 (1.2)	QTRT1 (1.1)	MAFB (1.1)	PLEC (1.1)
GO:0023021	termination of signal transduction	0.93	> 0.20	ENSG00000226648 (3.0)	DNAH11 (1.8)	ZNF180 (1.8)	NKPD1 (1.8)	SH2B3 (1.5)	PMFBP1 (1.5)	CYB561D1 (1.4)	POLK (1.1)	GMPR (1.1)	NT5DC1 (0.9)
ENSG00000013455	ENSG00000013455 PPI subnetwork	0.93	> 0.20	TMEM50A (3.1)	GATAD2A (2.5)	CARM1 (2.5)	PPP1R37 (2.1)	ITGB3 (2.0)	ZNF101 (1.9)	QTRT1 (1.8)	DOCK7 (1.7)	ENSG00000235545 (1.5)	GMIP (1.5)
ENSG00000185619	PCGF3 PPI subnetwork	0.93	> 0.20	ATXN2 (2.7)	CARM1 (2.6)	ILF3 (2.3)	GATAD2A (2.1)	MARK4 (2.0)	SMARCA4 (1.9)	USP1 (1.6)	TOP1 (1.5)	TMEM57 (1.4)	PTPN11 (1.4)
MP:0004860	dilated kidney collecting duct	0.93	> 0.20	PLG (2.4)	NYNRIN (2.2)	ENSG00000235545 (1.9)	ANGPTL3 (1.5)	MAU2 (1.5)	ZHX3 (1.4)	CLPTM1 (1.4)	APOA5 (1.4)	GRINA (1.3)	TRAPPC6A (1.2)
ENSG00000185518	SV2B PPI subnetwork	0.93	> 0.20	ZNF259 (3.2)	ATP13A1 (3.0)	TOMM40 (2.7)	DDX56 (2.7)	NAA25 (2.2)	QTRT1 (2.2)	GATAD2A (2.1)	C19orf52 (2.1)	MAPKAPK5 (2.1)	NKPD1 (1.9)
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG:NER	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG:NER	0.93	> 0.20	NT5DC1 (2.7)	SUGP1 (2.5)	TRAPPC6A (2.5)	FEN1 (2.2)	TXNL4B (1.9)	POC5 (1.8)	ENSG00000235545 (1.7)	PSMA5 (1.5)	POLK (1.4)	ENSG00000226648 (1.4)
REACTOME_DUAL_INCISION_REACTION_IN_GG:NER	REACTOME_DUAL_INCISION_REACTION_IN_GG:NER	0.93	> 0.20	NT5DC1 (2.7)	SUGP1 (2.5)	TRAPPC6A (2.5)	FEN1 (2.2)	TXNL4B (1.9)	POC5 (1.8)	ENSG00000235545 (1.7)	PSMA5 (1.5)	POLK (1.4)	ENSG00000226648 (1.4)
MP:0002826	tonic seizures	0.93	> 0.20	HAPLN4 (2.8)	RPH3A (2.7)	ENSG00000254235 (1.9)	GMPR (1.8)	APOE (1.8)	GCNT4 (1.8)	ENSG00000226648 (1.6)	APOC1 (1.5)	SORT1 (1.5)	C11orf9 (1.4)
GO:0043101	purine-containing compound salvage	0.93	> 0.20	LPIN3 (2.8)	TRAPPC6A (2.8)	NKPD1 (2.8)	CILP2 (2.1)	SYPL2 (2.1)	ENSG00000226648 (1.8)	TXNL4B (1.6)	ENSG00000228044 (1.5)	ZHX3 (1.5)	CEACAM19 (1.5)
GO:0000152	nuclear ubiquitin ligase complex	0.93	> 0.20	PSRC1 (2.9)	POC5 (2.7)	LPIN3 (2.6)	SUGP1 (2.3)	FEN1 (2.2)	USP1 (1.9)	ACAD10 (1.8)	MAU2 (1.7)	TMEM116 (1.7)	LPAR2 (1.6)
ENSG00000105989	WNT2 PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000143816	WNT9A PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000158955	WNT9B PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000135925	WNT10A PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000085741	WNT11 PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000075290	WNT8B PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000169884	WNT10B PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000061492	WNT8A PPI subnetwork	0.93	> 0.20	CILP2 (5.1)	CELSR2 (2.6)	KIAA1324 (2.4)	BCAM (1.9)	TXNL4B (1.8)	DYNC2LI1 (1.8)	AMIGO1 (1.7)	LPAR2 (1.7)	PVRL2 (1.5)	ZNF180 (1.5)
ENSG00000176749	CDK5R1 PPI subnetwork	0.93	> 0.20	CELSR2 (3.3)	SORT1 (3.1)	RPH3A (2.6)	HAPLN4 (2.5)	NCAN (2.4)	ENSG00000226648 (2.3)	PPP1R37 (2.1)	FRK (1.8)	PLCG1 (1.7)	PLEC (1.6)
GO:0030514	negative regulation of BMP signaling pathway	0.93	> 0.20	ENSG00000254235 (2.7)	C19orf52 (2.5)	ENSG00000238078 (2.0)	LPAR2 (1.8)	TMEM116 (1.8)	KANK2 (1.7)	C17orf57 (1.6)	ZNF180 (1.6)	ENSG00000226645 (1.6)	SLC44A2 (1.4)
GO:0042136	neurotransmitter biosynthetic process	0.93	> 0.20	DNAH11 (2.7)	HNF1A (2.0)	C12orf51 (1.8)	COL4A3BP (1.7)	NKPD1 (1.6)	AMIGO1 (1.5)	ADAM1 (1.5)	GEMIN7 (1.5)	PMFBP1 (1.3)	BLOC1S3 (1.3)
ENSG00000141985	SH3GL1 PPI subnetwork	0.93	> 0.20	NCAN (2.6)	C12orf51 (2.1)	RPH3A (1.9)	NYNRIN (1.7)	C12orf47 (1.7)	C12orf43 (1.7)	AP1M2 (1.5)	ERP29 (1.4)	MARK4 (1.2)	C11orf9 (1.2)
GO:0043450	alkene biosynthetic process	0.93	> 0.20	NKPD1 (4.2)	CYB561D1 (3.8)	CEACAM19 (2.7)	ALDH2 (2.2)	ENSG00000235545 (2.0)	SORT1 (1.9)	GMPR (1.6)	BLOC1S3 (1.6)	LPIN3 (1.6)	PMFBP1 (1.5)
GO:0019370	leukotriene biosynthetic process	0.93	> 0.20	NKPD1 (4.2)	CYB561D1 (3.8)	CEACAM19 (2.7)	ALDH2 (2.2)	ENSG00000235545 (2.0)	SORT1 (1.9)	GMPR (1.6)	BLOC1S3 (1.6)	LPIN3 (1.6)	PMFBP1 (1.5)
ENSG00000176884	GRIN1 PPI subnetwork	0.93	> 0.20	RPH3A (3.7)	CELSR2 (3.1)	MARK4 (2.4)	PPP1R37 (2.4)	SORT1 (2.3)	CLPTM1 (2.2)	NCAN (1.8)	C11orf9 (1.5)	ENSG00000226648 (1.4)	HMGCR (1.4)
GO:0042417	dopamine metabolic process	0.93	> 0.20	ABO (2.5)	GCNT4 (2.4)	TSSK6 (2.1)	DNAH11 (2.0)	NKPD1 (2.0)	PMFBP1 (1.7)	CILP2 (1.5)	C12orf47 (1.1)	HNF1A (1.1)	RPH3A (1.1)
GO:0043524	negative regulation of neuron apoptotic process	0.93	> 0.20	ENSG00000228044 (2.4)	TSSK6 (1.8)	DNAH11 (1.6)	GOT2P1 (1.3)	ERP29 (1.3)	AMIGO1 (1.3)	LPIN3 (1.3)	RHCE (1.2)	MARK4 (1.2)	GRINA (1.0)
ENSG00000105245	NUMBL PPI subnetwork	0.93	> 0.20	NCAN (2.5)	NYNRIN (2.4)	BCAM (2.3)	RPH3A (2.1)	NKPD1 (2.1)	GATAD2A (1.9)	USP24 (1.8)	DHODH (1.7)	CELSR2 (1.7)	DOCK7 (1.7)
ENSG00000151746	BICD1 PPI subnetwork	0.93	> 0.20	SMARCA4 (2.4)	BRAP (2.4)	CYB561D1 (2.3)	TXNL4B (2.1)	ATXN2 (2.1)	C12orf47 (2.0)	C12orf51 (1.8)	ENSG00000235545 (1.8)	DNAH11 (1.6)	GOT2P1 (1.5)
GO:0004385	guanylate kinase activity	0.93	> 0.20	FRK (2.9)	RPH3A (2.6)	C11orf9 (2.5)	ALDH2 (2.0)	DOCK7 (1.5)	AP1M2 (1.3)	MAPKAPK5 (1.3)	GMPR (1.3)	GCNT4 (1.3)	SORT1 (1.2)
ENSG00000066027	PPP2R5A PPI subnetwork	0.93	> 0.20	TOP1 (2.8)	GCNT4 (2.6)	GOT2P1 (2.2)	OASL (2.1)	TRAFD1 (2.1)	MARK4 (2.0)	COL4A3BP (1.7)	GRINA (1.7)	NAA25 (1.7)	CBLC (1.7)
GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	0.93	> 0.20	BLOC1S3 (4.6)	ZNF180 (3.4)	C19orf52 (2.2)	UBXN2B (2.1)	HAVCR1 (1.7)	DHX38 (1.6)	CLPTM1 (1.3)	TOMM40 (1.3)	TRAFD1 (1.2)	POLK (1.2)
MP:0000778	abnormal nervous system tract morphology	0.93	> 0.20	CELSR2 (2.7)	COL4A3BP (2.3)	SYPL2 (1.9)	NCAN (1.9)	ATXN7L2 (1.7)	LPIN3 (1.7)	ENSG00000235545 (1.6)	C19orf52 (1.5)	CARM1 (1.4)	ACAD10 (1.4)
GO:0001539	ciliary or flagellar motility	0.93	> 0.20	DNAH11 (4.1)	DYNC2LI1 (2.8)	ENSG00000228044 (1.3)	TSSK6 (1.2)	C12orf47 (1.1)	ACAD10 (1.1)	PBX4 (1.0)	TXNL4B (1.0)	NT5DC1 (0.9)	TMEM116 (0.8)
ENSG00000110876	SELPLG PPI subnetwork	0.93	> 0.20	ITGB3 (2.9)	PVR (2.6)	ALDH2 (2.1)	TIMD4 (1.9)	MOSC1 (1.7)	ERP29 (1.6)	ZNF101 (1.4)	ZNF180 (1.3)	POLK (1.3)	TXNL4B (1.3)
MP:0001306	small lens	0.93	> 0.20	ATXN2 (2.5)	HLX (1.4)	CELSR2 (1.4)	MAFB (1.3)	FRK (1.3)	ST3GAL4 (1.2)	TRIB1 (1.2)	NPC1L1 (1.2)	PVRL2 (1.0)	UBXN2B (1.0)
MP:0001004	abnormal retinal photoreceptor morphology	0.93	> 0.20	SORT1 (1.9)	MYLIP (1.8)	ATXN7L2 (1.6)	C19orf52 (1.5)	PMFBP1 (1.4)	KANK2 (1.3)	ST3GAL4 (1.2)	DYNC2LI1 (1.2)	C11orf9 (1.1)	ATXN2 (1.0)
REACTOME_MRNA_CAPPING	REACTOME_MRNA_CAPPING	0.93	> 0.20	GEMIN7 (3.0)	C12orf43 (3.0)	TXNL4B (2.7)	SUGP1 (2.6)	ZNF259 (2.4)	TRAPPC6A (2.3)	MAPKAPK5 (2.0)	ILF3 (1.8)	MARK4 (1.7)	TOMM40 (1.6)
GO:0015800	acidic amino acid transport	0.93	> 0.20	HAPLN4 (3.3)	GCNT4 (2.6)	NCAN (2.4)	ABCG8 (2.4)	CYP7A1 (1.8)	RPH3A (1.8)	TM6SF2 (1.5)	TMED4 (1.4)	GEMIN7 (1.4)	ENSG00000228044 (1.3)
MP:0003087	absent allantois	0.93	> 0.20	ATXN7L2 (2.4)	APOE (1.6)	ABO (1.5)	PLG (1.5)	PARP10 (1.4)	TM6SF2 (1.2)	LPAR2 (1.2)	ANGPTL3 (1.2)	COL4A3BP (1.2)	HNF1A (1.1)
GO:0048512	circadian behavior	0.93	> 0.20	ENSG00000226648 (4.6)	PPP1R37 (1.9)	RPH3A (1.6)	HNF1A (1.6)	CILP2 (1.5)	CETP (1.5)	TSSK6 (1.5)	DNAH11 (1.4)	LPIN3 (1.2)	ACAD10 (1.2)
MP:0002574	increased vertical activity	0.93	> 0.20	CELSR2 (2.3)	RPH3A (2.2)	C11orf9 (2.0)	ZHX3 (1.8)	C12orf51 (1.8)	ABO (1.7)	ATXN2 (1.6)	TSSK6 (1.6)	UBXN2B (1.4)	ABCG8 (1.4)
ENSG00000082397	EPB41L3 PPI subnetwork	0.93	> 0.20	RHD (3.7)	ENSG00000238078 (2.9)	RHCE (2.2)	RPH3A (2.1)	ENSG00000228044 (1.7)	FADS1 (1.6)	DOCK7 (1.5)	PVR (1.4)	C12orf51 (1.4)	PTPN11 (1.4)
GO:0031343	positive regulation of cell killing	0.93	> 0.20	PBX4 (1.9)	POLK (1.9)	TRAFD1 (1.8)	GEMIN7 (1.8)	PARP10 (1.7)	ITGB3 (1.3)	ENSG00000235545 (1.3)	BLOC1S3 (1.2)	MAU2 (1.2)	ZNF101 (1.1)
ENSG00000134508	CABLES1 PPI subnetwork	0.93	> 0.20	OASL (1.9)	PBX4 (1.8)	TRAFD1 (1.8)	RHD (1.7)	GMPR (1.6)	LPIN3 (1.5)	TOP1 (1.5)	C1orf63 (1.5)	CELSR2 (1.4)	PVRL2 (1.4)
GO:0071174	mitotic cell cycle spindle checkpoint	0.93	> 0.20	POC5 (4.0)	PSRC1 (3.0)	GEMIN7 (2.6)	SUGP1 (1.7)	TMEM116 (1.6)	UBXN2B (1.6)	LPIN3 (1.5)	DOCK7 (1.5)	C1orf63 (1.4)	USP1 (1.1)
MP:0004599	abnormal vertebral arch morphology	0.93	> 0.20	CILP2 (2.3)	NYNRIN (2.2)	C19orf52 (1.9)	ATXN7L2 (1.8)	TSSK6 (1.7)	PLEKHH2 (1.4)	TMEM50A (1.3)	LPAR2 (1.2)	PVRL2 (1.1)	DOCK7 (1.1)
ENSG00000182606	TRAK1 PPI subnetwork	0.93	> 0.20	C1orf63 (3.7)	ABO (2.3)	OGDH (1.9)	ATXN2 (1.9)	ATXN7L2 (1.7)	C11orf9 (1.5)	CBLC (1.5)	MAPKAPK5 (1.4)	MARK4 (1.4)	ALDH2 (1.4)
REACTOME_FRS2:MEDIATED_CASCADE	REACTOME_FRS2:MEDIATED_CASCADE	0.93	> 0.20	C11orf9 (3.0)	PLEKHH2 (3.0)	PTPN11 (1.9)	CARM1 (1.8)	ENSG00000226645 (1.7)	HAPLN4 (1.7)	ABO (1.6)	PVR (1.6)	ZHX3 (1.6)	MAPKAPK5 (1.5)
ENSG00000101246	ARFRP1 PPI subnetwork	0.93	> 0.20	ERP29 (3.3)	CYB561D1 (3.3)	SORT1 (2.6)	TMED4 (2.6)	LDLR (2.2)	YIPF2 (2.2)	HMGCR (1.9)	TMEM50A (1.9)	PSMA5 (1.6)	ST3GAL4 (1.5)
ENSG00000140612	SEC11A PPI subnetwork	0.93	> 0.20	NKPD1 (3.1)	FADS1 (2.5)	C19orf52 (2.4)	LDLR (2.2)	ST3GAL4 (2.1)	FADS2 (2.0)	HMGCR (1.9)	BLOC1S3 (1.9)	ERP29 (1.8)	TMEM50A (1.7)
GO:0042475	odontogenesis of dentin-containing tooth	0.93	> 0.20	BCAM (2.3)	PBX4 (2.1)	C19orf52 (1.8)	ABO (1.8)	BLOC1S3 (1.6)	MYLIP (1.5)	NYNRIN (1.5)	CYB561D1 (1.4)	ZNF101 (1.4)	ENSG00000235545 (1.3)
GO:0030663	COPI coated vesicle membrane	0.93	> 0.20	YIPF2 (4.9)	KIAA1324 (2.3)	PSMA5 (2.1)	POC5 (2.0)	SARS (1.9)	DNM2 (1.8)	MAU2 (1.8)	SUGP1 (1.8)	ATP13A1 (1.7)	ABCG8 (1.7)
GO:0061333	renal tubule morphogenesis	0.93	> 0.20	HAVCR1 (4.5)	BCAM (2.1)	DYNC2LI1 (2.0)	AP1M2 (1.9)	HNF1A (1.6)	ANKRD31 (1.5)	PMFBP1 (1.4)	TMEM116 (1.4)	TSSK6 (1.3)	ABO (1.2)
GO:0005871	kinesin complex	0.93	> 0.20	PSRC1 (2.8)	DYNC2LI1 (2.2)	HAPLN4 (1.7)	MARK4 (1.7)	COL4A3BP (1.7)	PBX4 (1.4)	CETP (1.4)	TMEM57 (1.3)	NKPD1 (1.3)	TMEM116 (1.2)
GO:0060428	lung epithelium development	0.93	> 0.20	PLEKHH2 (4.5)	KIAA1324 (3.3)	C11orf9 (3.0)	ALDH2 (2.4)	DYNC2LI1 (2.0)	PPP1R37 (2.0)	HNF1A (1.9)	AP1M2 (1.8)	HAPLN4 (1.7)	CBLC (1.7)
ENSG00000162923	WDR26 PPI subnetwork	0.93	> 0.20	BUD13 (3.2)	DOCK7 (2.7)	KIAA1324 (2.0)	ANKRD31 (1.9)	C12orf51 (1.8)	KANK2 (1.7)	NYNRIN (1.6)	C19orf52 (1.5)	PLCG1 (1.5)	ILF3 (1.3)
ENSG00000160801	PTH1R PPI subnetwork	0.93	> 0.20	BCAM (3.0)	TMEM50A (2.3)	KIAA1324 (2.2)	COL4A3BP (2.1)	PPP1R37 (1.7)	AMIGO1 (1.6)	SLC44A2 (1.6)	FRK (1.6)	NPC1L1 (1.6)	HNF1A (1.5)
ENSG00000188529	SRSF10 PPI subnetwork	0.93	> 0.20	C1orf63 (4.5)	TOP1 (2.7)	QTRT1 (2.7)	ILF3 (2.7)	ERP29 (1.9)	CBLC (1.9)	ENSG00000226648 (1.9)	NKPD1 (1.9)	PPP1R37 (1.8)	ENSG00000226645 (1.8)
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	REACTOME_LYSOSOME_VESICLE_BIOGENESIS	0.93	> 0.20	YIPF2 (3.7)	ERP29 (3.3)	LPAR2 (2.6)	CLPTM1 (2.4)	ATP13A1 (2.4)	AP1M2 (2.3)	GATAD2A (2.3)	GMIP (2.2)	GRINA (2.0)	C19orf52 (1.8)
GO:0016254	preassembly of GPI anchor in ER membrane	0.94	> 0.20	CYB561D1 (2.9)	TMEM116 (2.5)	UBXN2B (2.2)	YIPF2 (2.1)	ATP13A1 (2.1)	CEACAM19 (1.9)	ANKRD31 (1.8)	POLK (1.6)	TMEM50A (1.6)	TXNL4B (1.5)
ENSG00000198888	MT-ND1 PPI subnetwork	0.94	> 0.20	OGDH (3.8)	ACAD10 (3.1)	C12orf47 (2.7)	TRAPPC6A (2.7)	MAU2 (1.7)	PSMA5 (1.6)	GOT2P1 (1.6)	FRK (1.3)	GPAM (1.3)	GMPR (1.2)
ENSG00000069869	NEDD4 PPI subnetwork	0.94	> 0.20	OASL (3.0)	GRINA (2.1)	TRAFD1 (1.9)	AP1M2 (1.8)	UBXN2B (1.7)	PARP10 (1.6)	TMEM50A (1.5)	CBLC (1.5)	HAVCR1 (1.5)	TRIB1 (1.4)
GO:0060736	prostate gland growth	0.94	> 0.20	KIAA1324 (2.0)	UBXN2B (1.8)	GOT2P1 (1.7)	HAPLN4 (1.7)	COL4A3BP (1.6)	CYP7A1 (1.5)	YIPF2 (1.2)	ST3GAL4 (1.1)	TRAPPC6A (1.1)	GEMIN7 (1.1)
ENSG00000078369	GNB1 PPI subnetwork	0.94	> 0.20	HAPLN4 (2.6)	ENSG00000226648 (2.2)	PPP1R37 (2.0)	ST3GAL4 (1.9)	BLOC1S3 (1.5)	ITGB3 (1.4)	ENSG00000254235 (1.3)	GMPR (1.2)	ATP13A1 (1.2)	MARK4 (1.0)
ENSG00000176170	SPHK1 PPI subnetwork	0.94	> 0.20	RHD (2.7)	CYB561D1 (2.2)	PMFBP1 (1.7)	APOE (1.7)	TRAFD1 (1.6)	ENSG00000238078 (1.6)	CLPTM1 (1.5)	ST3GAL4 (1.5)	ZNF101 (1.5)	HLX (1.3)
MP:0001447	abnormal nest building behavior	0.94	> 0.20	KIAA1324 (2.6)	NPC1L1 (2.6)	RPH3A (2.2)	C11orf9 (2.1)	GCNT4 (2.0)	AMIGO1 (1.9)	ABCG5 (1.8)	PCSK9 (1.7)	TMED4 (1.5)	LPIN3 (1.4)
GO:0043576	regulation of respiratory gaseous exchange	0.94	> 0.20	ANKRD31 (3.4)	DNAH11 (2.7)	ENSG00000226648 (2.5)	NCAN (2.4)	TSSK6 (2.0)	HAVCR1 (1.9)	HAPLN4 (1.8)	PBX4 (1.7)	RPH3A (1.6)	NKPD1 (1.6)
ENSG00000111186	WNT5B PPI subnetwork	0.94	> 0.20	CILP2 (4.5)	KIAA1324 (2.6)	CELSR2 (2.5)	LPAR2 (2.0)	PVRL2 (1.8)	DYNC2LI1 (1.7)	BCAM (1.6)	TXNL4B (1.6)	AMIGO1 (1.6)	TRAPPC6A (1.6)
ENSG00000130758	MAP3K10 PPI subnetwork	0.94	> 0.20	DYNC2LI1 (2.8)	CETP (2.3)	CARM1 (1.7)	RHCE (1.7)	COL4A3BP (1.6)	TMEM57 (1.6)	MARK4 (1.5)	PBX4 (1.4)	C11orf9 (1.3)	HAVCR1 (1.3)
ENSG00000065675	PRKCQ PPI subnetwork	0.94	> 0.20	ST3GAL4 (2.6)	ZNF180 (2.2)	MARK4 (2.2)	SH2B3 (2.2)	NCAN (1.6)	C12orf51 (1.5)	USP24 (1.4)	PLCG1 (1.4)	PTPN11 (1.4)	PBX4 (1.3)
MP:0001496	audiogenic seizures	0.94	> 0.20	ANGPTL3 (4.1)	PLG (3.8)	CYP7A1 (2.5)	MOSC1 (2.3)	USP24 (2.2)	APOE (1.8)	APOA5 (1.6)	APOC4 (1.4)	CELSR2 (1.4)	ENSG00000254235 (1.4)
GO:0006688	glycosphingolipid biosynthetic process	0.94	> 0.20	HAVCR1 (3.2)	AMIGO1 (2.3)	ENSG00000254235 (2.0)	SLC44A2 (1.8)	CYB561D1 (1.8)	DNAH11 (1.5)	TMEM50A (1.4)	ZNF180 (1.4)	ZHX3 (1.4)	ABO (1.4)
GO:0042162	telomeric DNA binding	0.94	> 0.20	SUGP1 (2.2)	POLK (2.2)	DHODH (2.1)	UBXN2B (2.1)	C1orf63 (2.1)	ENSG00000235545 (1.9)	DOCK7 (1.9)	SMARCA4 (1.9)	NKPD1 (1.8)	AMIGO1 (1.8)
MP:0008227	absent anterior commissure	0.94	> 0.20	CELSR2 (3.9)	NCAN (3.4)	NYNRIN (2.5)	OASL (2.0)	DNAH11 (1.9)	GEMIN7 (1.8)	PCSK9 (1.8)	MARK4 (1.6)	C12orf51 (1.5)	PLCG1 (1.4)
GO:0035173	histone kinase activity	0.94	> 0.20	PSRC1 (2.8)	USP1 (2.3)	FEN1 (2.0)	PLEKHH2 (2.0)	USP24 (1.9)	BUD13 (1.6)	POLK (1.5)	POC5 (1.4)	GMIP (1.4)	C19orf52 (1.4)
MP:0008723	impaired eosinophil recruitment	0.94	> 0.20	BCL3 (3.2)	GMIP (2.7)	ITGB3 (2.5)	LPAR2 (2.2)	HP (1.5)	KIAA1324 (1.5)	NKPD1 (1.5)	C17orf57 (1.4)	CETP (1.3)	RELB (1.2)
MP:0001982	decreased chemically-elicited antinociception	0.94	> 0.20	ITGB3 (3.4)	RPH3A (2.7)	CETP (2.3)	TSSK6 (1.7)	NCAN (1.6)	C11orf9 (1.6)	AMIGO1 (1.6)	PMFBP1 (1.4)	PBX4 (1.4)	C12orf47 (1.3)
REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING	REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING	0.94	> 0.20	GMIP (3.0)	HLX (2.1)	DNM2 (2.0)	SH2B3 (2.0)	COL4A3BP (1.6)	GRINA (1.4)	RELB (1.4)	TRAFD1 (1.4)	USP24 (1.3)	ENSG00000226645 (1.2)
MP:0006358	absent pinna reflex	0.94	> 0.20	HAPLN4 (2.3)	AP1M2 (2.2)	ST3GAL4 (2.1)	HNF1A (1.7)	ZNF180 (1.7)	PMFBP1 (1.6)	RPH3A (1.4)	PTPN11 (1.4)	APOE (1.4)	MYLIP (1.4)
GO:0051084	'de novo' posttranslational protein folding	0.94	> 0.20	C12orf47 (2.5)	ZNF259 (2.0)	ENSG00000238078 (1.9)	ERP29 (1.8)	TXNL4B (1.4)	ZNF101 (1.4)	HAVCR1 (1.3)	PVR (1.3)	NAA25 (1.2)	DNAH11 (1.1)
GO:0030041	actin filament polymerization	0.94	> 0.20	TMEM50A (2.4)	TSSK6 (2.2)	ST3GAL4 (1.9)	ITGB3 (1.9)	ADAM1 (1.9)	ABO (1.8)	C1orf63 (1.7)	ENSG00000238078 (1.7)	PMFBP1 (1.6)	C17orf57 (1.5)
ENSG00000170298	LGALS9B PPI subnetwork	0.94	> 0.20	ACAD10 (2.4)	CLPTM1 (2.3)	GEMIN7 (2.1)	C12orf47 (1.8)	ERP29 (1.8)	OASL (1.7)	CEACAM19 (1.6)	LPAR2 (1.5)	BCAM (1.5)	AP1M2 (1.4)
ENSG00000171916	LGALS9C PPI subnetwork	0.94	> 0.20	ACAD10 (2.4)	CLPTM1 (2.3)	GEMIN7 (2.1)	C12orf47 (1.8)	ERP29 (1.8)	OASL (1.7)	CEACAM19 (1.6)	LPAR2 (1.5)	BCAM (1.5)	AP1M2 (1.4)
GO:0061001	regulation of dendritic spine morphogenesis	0.94	> 0.20	HNF1A (4.1)	PLEKHH2 (2.3)	RPH3A (2.2)	TMEM116 (2.1)	C1orf63 (2.1)	C17orf57 (2.1)	ADAM1 (2.0)	UBXN2B (1.8)	LPAR2 (1.6)	LPIN3 (1.4)
ENSG00000141564	RPTOR PPI subnetwork	0.94	> 0.20	CARM1 (2.5)	GEMIN7 (2.1)	TRAPPC6A (2.1)	COL4A3BP (2.1)	BRAP (1.7)	MAPKAPK5 (1.7)	TOMM40 (1.7)	TSSK6 (1.6)	SARS (1.3)	DHODH (1.3)
GO:0048708	astrocyte differentiation	0.94	> 0.20	NCAN (5.1)	ENSG00000254235 (2.6)	ENSG00000226648 (2.4)	ENSG00000235545 (2.0)	CYB561D1 (1.9)	HAVCR1 (1.8)	CEACAM19 (1.7)	HAPLN4 (1.6)	PPP1R37 (1.4)	GEMIN7 (1.3)
GO:0001159	core promoter proximal region DNA binding	0.94	> 0.20	RHD (2.8)	NCAN (2.1)	DNAH11 (2.1)	KIAA1324 (1.9)	ENSG00000226645 (1.8)	ENSG00000226648 (1.7)	SH2B3 (1.4)	MYLIP (1.4)	CELSR2 (1.4)	POLK (1.3)
GO:0006692	prostanoid metabolic process	0.94	> 0.20	NKPD1 (2.5)	ALDH2 (2.2)	GMPR (1.8)	HNF1A (1.8)	C11orf9 (1.6)	GOT2P1 (1.5)	TMEM57 (1.4)	ADAM1 (1.3)	UBXN2B (1.2)	PMFBP1 (1.1)
ENSG00000197265	GTF2E2 PPI subnetwork	0.94	> 0.20	MAPKAPK5 (2.6)	PSMA5 (2.5)	ATXN2 (2.4)	TXNL4B (1.8)	GEMIN7 (1.8)	BUD13 (1.7)	TMED4 (1.6)	MARK4 (1.6)	SUGP1 (1.6)	POC5 (1.4)
GO:0040001	establishment of mitotic spindle localization	0.94	> 0.20	PSRC1 (3.9)	POC5 (2.5)	BUD13 (2.2)	ENSG00000226645 (2.1)	PPP1R37 (1.8)	PMFBP1 (1.4)	C12orf51 (1.3)	PBX4 (1.3)	RHCE (1.3)	GOT2P1 (1.3)
GO:0030509	BMP signaling pathway	0.94	> 0.20	ENSG00000254235 (2.1)	CARM1 (1.9)	KANK2 (1.8)	C19orf52 (1.8)	ENSG00000238078 (1.8)	ENSG00000228044 (1.7)	ZNF101 (1.6)	ENSG00000226645 (1.6)	NYNRIN (1.4)	LPAR2 (1.3)
REACTOME_MTORC1:MEDIATED_SIGNALLING	REACTOME_MTORC1:MEDIATED_SIGNALLING	0.94	> 0.20	SARS (3.0)	TMEM57 (2.7)	C12orf43 (2.5)	GPAM (2.4)	USP24 (2.4)	DHX38 (2.3)	DHODH (2.2)	COL4A3BP (2.2)	SMARCA4 (2.1)	ILF3 (2.0)
GO:0009225	nucleotide-sugar metabolic process	0.94	> 0.20	YIPF2 (2.8)	ZNF259 (2.1)	KIAA1324 (1.8)	ZNF180 (1.8)	CYB561D1 (1.5)	ST3GAL4 (1.5)	C19orf52 (1.5)	NT5DC1 (1.4)	C12orf43 (1.4)	SLC22A1 (1.4)
MP:0000953	abnormal oligodendrocyte morphology	0.94	> 0.20	NCAN (5.3)	C11orf9 (4.8)	APOE (3.6)	HAPLN4 (2.2)	MAFB (1.8)	APOC1 (1.7)	RPH3A (1.5)	CELSR2 (1.3)	PTPN11 (1.2)	ENSG00000254235 (1.1)
GO:0048588	developmental cell growth	0.94	> 0.20	ABO (2.2)	C12orf47 (2.0)	CELSR2 (1.9)	PMFBP1 (1.7)	NCAN (1.7)	PPP1R37 (1.6)	GCNT4 (1.5)	LPAR2 (1.5)	ACAD10 (1.4)	C1orf63 (1.3)
MP:0005461	abnormal dendritic cell morphology	0.94	> 0.20	GMIP (3.2)	RELB (2.3)	MYLIP (1.8)	ZNF101 (1.8)	PLCG1 (1.4)	USP24 (1.4)	BCL3 (1.3)	LPAR2 (1.1)	ENSG00000235545 (1.0)	TMEM57 (0.9)
ENSG00000088367	EPB41L1 PPI subnetwork	0.94	> 0.20	LDLR (3.3)	FADS1 (3.0)	PCSK9 (2.5)	FADS2 (2.3)	GRINA (1.8)	C11orf9 (1.7)	DOCK7 (1.6)	APOE (1.6)	C17orf57 (1.5)	RPH3A (1.4)
GO:0032855	positive regulation of Rac GTPase activity	0.94	> 0.20	HNF1A (2.7)	ST3GAL4 (2.5)	UBXN2B (2.4)	ABO (1.8)	GMIP (1.7)	PMFBP1 (1.7)	ANKRD31 (1.6)	C11orf9 (1.6)	CBLC (1.5)	HAVCR1 (1.4)
MP:0009888	palatal shelves fail to meet at midline	0.94	> 0.20	KANK2 (2.3)	LDLR (2.2)	MYLIP (2.1)	MAFB (1.9)	HMGCR (1.8)	PCSK9 (1.8)	FADS1 (1.7)	ANKRD31 (1.6)	FRK (1.5)	C19orf52 (1.5)
REACTOME_HORMONE_LIGAND:BINDING_RECEPTORS	REACTOME_HORMONE_LIGAND:BINDING_RECEPTORS	0.94	> 0.20	KIAA1324 (4.0)	ST3GAL4 (2.2)	TMED4 (2.2)	PMFBP1 (1.8)	YIPF2 (1.5)	MOSC1 (1.5)	HAVCR1 (1.4)	TXNL4B (1.3)	ENSG00000226648 (1.2)	CEACAM19 (1.1)
MP:0008518	retinal outer nuclear layer degeneration	0.94	> 0.20	C11orf9 (1.9)	DYNC2LI1 (1.9)	PVR (1.8)	C12orf47 (1.8)	ATXN7L2 (1.6)	PMFBP1 (1.5)	TRIB1 (1.5)	ENSG00000235545 (1.5)	OASL (1.3)	GPAM (1.2)
ENSG00000164032	H2AFZ PPI subnetwork	0.94	> 0.20	C19orf52 (2.7)	TXNL4B (2.1)	BUD13 (2.0)	USP1 (1.9)	SMARCA4 (1.9)	TOP1 (1.7)	TMEM57 (1.5)	PSRC1 (1.4)	ZNF180 (1.4)	ILF3 (1.4)
GO:0042491	auditory receptor cell differentiation	0.94	> 0.20	ENSG00000226645 (2.9)	DNAH11 (2.5)	ENSG00000226648 (2.4)	CEACAM19 (2.1)	ATXN7L2 (1.6)	BCAM (1.6)	HNF1A (1.2)	ANKRD31 (1.1)	PMFBP1 (1.1)	ADAM1 (1.0)
GO:0051258	protein polymerization	0.94	> 0.20	C17orf57 (1.9)	ITGB3 (1.9)	C11orf9 (1.7)	TMEM50A (1.7)	GMPR (1.5)	ADAM1 (1.5)	RHD (1.4)	ATXN7L2 (1.4)	HAVCR1 (1.4)	ENSG00000238078 (1.4)
ENSG00000124217	MOCS3 PPI subnetwork	0.94	> 0.20	TMEM116 (1.9)	ATXN7L2 (1.7)	POC5 (1.7)	OGDH (1.7)	DOCK7 (1.6)	ENSG00000235545 (1.5)	POLK (1.5)	MAPKAPK5 (1.4)	C12orf47 (1.3)	LPA (1.3)
ENSG00000135823	STX6 PPI subnetwork	0.94	> 0.20	COL4A3BP (2.9)	TMEM50A (2.6)	C1orf63 (2.4)	ZNF259 (2.3)	BRAP (2.1)	SH2B3 (2.0)	ENSG00000226645 (2.0)	BLOC1S3 (1.9)	SLC44A2 (1.5)	POLK (1.4)
MP:0008540	abnormal cerebrum morphology	0.94	> 0.20	NCAN (4.0)	DYNC2LI1 (2.4)	NYNRIN (2.0)	RPH3A (1.8)	C11orf9 (1.4)	PMFBP1 (1.4)	APOE (1.4)	ENSG00000235545 (1.4)	CELSR2 (1.3)	ABCG5 (1.3)
GO:0034332	adherens junction organization	0.94	> 0.20	BCAM (2.7)	PVRL2 (2.5)	ENSG00000226645 (2.2)	ABO (2.1)	CEACAM19 (1.9)	LPIN3 (1.9)	BLOC1S3 (1.8)	NYNRIN (1.6)	LPAR2 (1.5)	CBLC (1.4)
ENSG00000183943	PRKX PPI subnetwork	0.94	> 0.20	PLEKHH2 (2.2)	PLEC (2.0)	NYNRIN (1.6)	SYPL2 (1.6)	AMIGO1 (1.6)	C12orf47 (1.5)	ST3GAL4 (1.5)	OGDH (1.4)	GPAM (1.4)	C1orf63 (1.4)
ENSG00000173175	ADCY5 PPI subnetwork	0.94	> 0.20	PMFBP1 (2.2)	ENSG00000238078 (2.1)	PLEKHH2 (2.0)	CARM1 (1.9)	C12orf43 (1.8)	MARK4 (1.8)	HAVCR1 (1.6)	ZHX3 (1.5)	ENSG00000226645 (1.3)	NYNRIN (1.2)
ENSG00000022355	GABRA1 PPI subnetwork	0.94	> 0.20	NCAN (2.3)	MYLIP (2.2)	COL4A3BP (1.8)	ANKRD31 (1.6)	RPH3A (1.5)	UBXN2B (1.3)	ATP13A1 (1.2)	C11orf9 (1.1)	HAVCR1 (1.1)	LPIN3 (1.1)
MP:0003817	abnormal pituitary diverticulum morphology	0.94	> 0.20	HLX (2.8)	NYNRIN (2.1)	CARM1 (1.7)	TMED4 (1.6)	ANKRD31 (1.4)	MARK4 (1.3)	ABO (1.3)	ZNF101 (1.2)	C11orf9 (1.2)	CILP2 (1.2)
ENSG00000148798	INA PPI subnetwork	0.94	> 0.20	RPH3A (2.9)	LPIN3 (2.0)	CELSR2 (2.0)	C12orf51 (2.0)	PLCG1 (1.7)	SMARCA4 (1.6)	CLPTM1 (1.5)	HAPLN4 (1.5)	GOT2P1 (1.5)	CETP (1.4)
MP:0001943	abnormal respiration	0.94	> 0.20	NPC1L1 (2.0)	OGDH (1.6)	TIMD4 (1.6)	TMED4 (1.4)	CETP (1.4)	CILP2 (1.3)	NYNRIN (1.2)	RPH3A (1.2)	TMEM57 (1.2)	C11orf9 (1.1)
GO:0051668	localization within membrane	0.94	> 0.20	PBX4 (3.0)	HAVCR1 (2.0)	ZNF101 (1.8)	DNAH11 (1.7)	SARS (1.5)	GATAD2A (1.5)	C19orf52 (1.3)	DDX56 (1.2)	GOT2P1 (1.1)	ENSG00000226648 (1.1)
REACTOME_MEMBRANE_TRAFFICKING	REACTOME_MEMBRANE_TRAFFICKING	0.94	> 0.20	YIPF2 (4.4)	DNM2 (2.6)	CLPTM1 (2.6)	AP1M2 (2.4)	SUGP1 (1.9)	COL4A3BP (1.7)	DHX38 (1.6)	FRK (1.6)	GRINA (1.6)	CBLC (1.6)
GO:0090183	regulation of kidney development	0.94	> 0.20	BCAM (2.7)	HNF1A (2.3)	HAVCR1 (2.3)	TSSK6 (2.2)	PLEKHH2 (1.9)	AMIGO1 (1.8)	ENSG00000228044 (1.7)	PMFBP1 (1.7)	ZNF101 (1.6)	PVRL2 (1.5)
GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	0.94	> 0.20	ENSG00000226648 (3.1)	C12orf47 (2.5)	ENSG00000228044 (2.2)	AMIGO1 (2.1)	FRK (2.1)	TMED4 (2.0)	HAVCR1 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.6)	ZNF101 (1.6)
ENSG00000128731	HERC2 PPI subnetwork	0.94	> 0.20	CETP (2.4)	HAVCR1 (2.0)	DOCK7 (1.9)	SLC44A2 (1.5)	AMIGO1 (1.5)	COL4A3BP (1.5)	ADAM1 (1.5)	SORT1 (1.5)	CYB561D1 (1.3)	ENSG00000238078 (1.3)
GO:0022904	respiratory electron transport chain	0.94	> 0.20	OGDH (3.9)	ACAD10 (3.8)	GOT2P1 (3.4)	C12orf47 (3.0)	TRAPPC6A (2.6)	TMEM116 (1.6)	C19orf52 (1.6)	MAU2 (1.5)	FRK (1.5)	GMPR (1.5)
GO:0060603	mammary gland duct morphogenesis	0.94	> 0.20	KIAA1324 (3.0)	PLEKHH2 (2.8)	CELSR2 (1.7)	AP1M2 (1.6)	PPP1R37 (1.6)	PLEC (1.5)	CBLC (1.5)	PVRL2 (1.5)	BCAM (1.3)	MYLIP (1.2)
GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	0.94	> 0.20	RHD (3.6)	KIAA1324 (2.3)	ABO (2.0)	RHCE (1.9)	TOP1 (1.8)	CELSR2 (1.8)	ZNF101 (1.7)	NCAN (1.6)	ENSG00000226645 (1.5)	LPAR2 (1.4)
MP:0000528	delayed kidney development	0.94	> 0.20	PLEKHH2 (4.4)	NYNRIN (2.5)	C11orf9 (2.5)	PVRL2 (2.5)	LPAR2 (2.1)	HAPLN4 (2.1)	AP1M2 (2.0)	BCAM (2.0)	DYNC2LI1 (1.7)	FADS2 (1.7)
GO:0051303	establishment of chromosome localization	0.94	> 0.20	POC5 (5.4)	PSRC1 (4.2)	BUD13 (3.0)	POLK (2.5)	ENSG00000226648 (1.9)	NKPD1 (1.6)	AMIGO1 (1.4)	GEMIN7 (1.1)	FEN1 (1.1)	UBXN2B (1.1)
GO:0050000	chromosome localization	0.94	> 0.20	POC5 (5.4)	PSRC1 (4.2)	BUD13 (3.0)	POLK (2.5)	ENSG00000226648 (1.9)	NKPD1 (1.6)	AMIGO1 (1.4)	GEMIN7 (1.1)	FEN1 (1.1)	UBXN2B (1.1)
ENSG00000158301	GPRASP2 PPI subnetwork	0.94	> 0.20	ENSG00000226645 (2.8)	KIAA1324 (2.3)	NCAN (2.1)	GCNT4 (2.0)	ABO (1.8)	CELSR2 (1.5)	TRIB1 (1.4)	CYB561D1 (1.4)	ATP13A1 (1.3)	PPP1R37 (1.3)
GO:0003197	endocardial cushion development	0.94	> 0.20	ABO (1.9)	LPIN3 (1.7)	KANK2 (1.5)	C11orf9 (1.4)	PVRL2 (1.4)	PPP1R37 (1.4)	TMED4 (1.3)	ALDH2 (1.3)	ENSG00000254235 (1.3)	ATXN2 (1.2)
GO:0021889	olfactory bulb interneuron differentiation	0.94	> 0.20	DNAH11 (3.1)	ENSG00000235545 (2.9)	ATXN7L2 (2.7)	CEACAM19 (2.5)	ANKRD31 (2.4)	PBX4 (2.2)	ENSG00000228044 (2.0)	ENSG00000226645 (1.5)	DOCK7 (1.5)	C17orf57 (1.5)
MP:0000740	impaired smooth muscle contractility	0.94	> 0.20	SORT1 (3.6)	KANK2 (3.2)	PTPN11 (2.1)	C17orf57 (2.0)	AMIGO1 (1.9)	TRAPPC6A (1.8)	CYB561D1 (1.6)	OGDH (1.5)	CBLC (1.5)	ENSG00000226645 (1.4)
GO:0021527	spinal cord association neuron differentiation	0.94	> 0.20	C12orf47 (3.8)	GMPR (2.4)	ENSG00000226648 (2.0)	PBX4 (1.8)	ATXN7L2 (1.7)	TMEM116 (1.5)	TSSK6 (1.5)	ZHX3 (1.4)	RHCE (1.2)	DNAH11 (1.2)
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN:1_SIGNALING	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN:1_SIGNALING	0.94	> 0.20	PLEKHH2 (2.8)	ENSG00000226645 (2.1)	ZHX3 (1.9)	KANK2 (1.8)	NKPD1 (1.7)	ENSG00000226648 (1.6)	C12orf51 (1.5)	ENSG00000235545 (1.5)	ITGB3 (1.5)	GOT2P1 (1.4)
ENSG00000121440	PDZRN3 PPI subnetwork	0.94	> 0.20	LPIN3 (2.5)	NKPD1 (2.0)	NT5DC1 (1.7)	ATXN7L2 (1.7)	C1orf63 (1.7)	ACAD10 (1.5)	ZNF259 (1.4)	FRK (1.4)	LPA (1.4)	ABCG8 (1.2)
ENSG00000180340	FZD2 PPI subnetwork	0.94	> 0.20	BCAM (2.7)	C11orf9 (2.6)	CBLC (2.6)	CILP2 (2.0)	NYNRIN (1.9)	TSSK6 (1.8)	AMIGO1 (1.4)	YIPF2 (1.4)	FADS2 (1.3)	PCSK9 (1.2)
REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS	REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS	0.94	> 0.20	ITGB3 (2.6)	TMEM50A (2.1)	C1orf63 (1.8)	TM6SF2 (1.8)	ABO (1.6)	CETP (1.5)	ENSG00000254235 (1.4)	HLX (1.3)	C12orf47 (1.1)	KIAA1324 (0.9)
ENSG00000013441	CLK1 PPI subnetwork	0.94	> 0.20	TOP1 (3.7)	C1orf63 (3.5)	BUD13 (2.7)	ILF3 (2.4)	USP24 (2.1)	TMEM57 (2.0)	FADS2 (1.7)	DNM2 (1.6)	GATAD2A (1.5)	USP1 (1.4)
ENSG00000144891	AGTR1 PPI subnetwork	0.94	> 0.20	ZHX3 (3.3)	SH2B3 (2.4)	AMIGO1 (2.1)	PTPN11 (2.0)	C17orf57 (1.8)	APOE (1.7)	GRINA (1.7)	SORT1 (1.4)	DNM2 (1.4)	APOA5 (1.2)
MP:0000846	abnormal medulla oblongata morphology	0.94	> 0.20	ATXN7L2 (1.9)	PMFBP1 (1.7)	COL4A3BP (1.6)	TMEM57 (1.5)	MAPKAPK5 (1.5)	USP24 (1.5)	GPAM (1.5)	ACAD10 (1.5)	PBX4 (1.4)	ATXN2 (1.4)
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	0.94	> 0.20	OGDH (3.6)	ACAD10 (3.4)	TRAPPC6A (3.1)	C12orf47 (2.4)	GOT2P1 (1.9)	PSMA5 (1.5)	MAU2 (1.5)	GMPR (1.4)	TOMM40 (1.3)	TMED4 (1.2)
KEGG_REGULATION_OF_AUTOPHAGY	KEGG_REGULATION_OF_AUTOPHAGY	0.94	> 0.20	TXNL4B (2.6)	COL4A3BP (2.3)	GOT2P1 (2.2)	BRAP (2.2)	TMEM50A (2.1)	CYP7A1 (2.1)	MAU2 (2.1)	TRAFD1 (2.0)	C1orf63 (1.8)	BLOC1S3 (1.6)
ENSG00000211810	ENSG00000211810 PPI subnetwork	0.94	> 0.20	PLCG1 (3.1)	ZNF101 (2.7)	APOE (2.3)	CEACAM19 (1.8)	ALDH2 (1.5)	C19orf52 (1.4)	PBX4 (1.4)	ADAM1 (1.2)	APOC1 (1.2)	HAVCR1 (1.1)
ENSG00000211739	ENSG00000211739 PPI subnetwork	0.94	> 0.20	PLCG1 (3.1)	ZNF101 (2.7)	APOE (2.3)	CEACAM19 (1.8)	ALDH2 (1.5)	C19orf52 (1.4)	PBX4 (1.4)	ADAM1 (1.2)	APOC1 (1.2)	HAVCR1 (1.1)
ENSG00000211735	ENSG00000211735 PPI subnetwork	0.94	> 0.20	PLCG1 (3.1)	ZNF101 (2.7)	APOE (2.3)	CEACAM19 (1.8)	ALDH2 (1.5)	C19orf52 (1.4)	PBX4 (1.4)	ADAM1 (1.2)	APOC1 (1.2)	HAVCR1 (1.1)
ENSG00000211799	ENSG00000211799 PPI subnetwork	0.94	> 0.20	PLCG1 (3.1)	ZNF101 (2.7)	APOE (2.3)	CEACAM19 (1.8)	ALDH2 (1.5)	C19orf52 (1.4)	PBX4 (1.4)	ADAM1 (1.2)	APOC1 (1.2)	HAVCR1 (1.1)
GO:0048302	regulation of isotype switching to IgG isotypes	0.94	> 0.20	C17orf57 (2.1)	PBX4 (2.1)	GCNT4 (1.8)	SLC44A2 (1.7)	DNAH11 (1.5)	PMFBP1 (1.3)	COL4A3BP (1.3)	NT5DC1 (1.3)	TRAFD1 (1.3)	C12orf43 (1.2)
GO:0051797	regulation of hair follicle development	0.94	> 0.20	POLK (2.6)	PBX4 (2.3)	TXNL4B (2.3)	GCNT4 (1.6)	TRAFD1 (1.6)	ENSG00000235545 (1.5)	SLC44A2 (1.3)	GOT2P1 (1.2)	ANKRD31 (1.2)	PMFBP1 (1.2)
ENSG00000153767	GTF2E1 PPI subnetwork	0.94	> 0.20	MAPKAPK5 (3.2)	C12orf43 (2.3)	PSMA5 (2.3)	ATXN2 (2.2)	SUGP1 (2.0)	ZNF259 (1.7)	TOP1 (1.7)	USP1 (1.6)	BUD13 (1.6)	MARK4 (1.6)
GO:0060538	skeletal muscle organ development	0.94	> 0.20	SYPL2 (4.9)	ATXN7L2 (2.5)	ANKRD31 (1.9)	SLC44A2 (1.7)	PLEKHH2 (1.6)	GMPR (1.5)	ZHX3 (1.5)	AMIGO1 (1.4)	ENSG00000226648 (1.3)	KANK2 (1.3)
MP:0004434	abnormal cochlear outer hair cell physiology	0.94	> 0.20	HNF1A (3.1)	AMIGO1 (2.7)	PLEKHH2 (2.2)	ADAM1 (2.1)	MOSC1 (2.0)	NCAN (2.0)	KIAA1324 (1.9)	BLOC1S3 (1.5)	HAVCR1 (1.5)	AP1M2 (1.4)
GO:0046579	positive regulation of Ras protein signal transduction	0.94	> 0.20	PBX4 (3.6)	ANKRD31 (2.6)	GEMIN7 (2.0)	C17orf57 (1.7)	PLEKHH2 (1.6)	TIMD4 (1.6)	PTPN11 (1.6)	ENSG00000228044 (1.5)	CYB561D1 (1.5)	LPA (1.3)
ENSG00000153933	DGKE PPI subnetwork	0.94	> 0.20	C19orf52 (2.4)	USP1 (1.9)	ENSG00000228044 (1.8)	KANK2 (1.8)	MOSC1 (1.7)	ENSG00000254235 (1.7)	C12orf47 (1.6)	AMIGO1 (1.6)	ENSG00000226648 (1.5)	PSRC1 (1.3)
GO:0043242	negative regulation of protein complex disassembly	0.94	> 0.20	ENSG00000238078 (2.5)	RHD (2.4)	C17orf57 (2.2)	TSSK6 (2.1)	PMFBP1 (2.0)	RHCE (2.0)	C12orf51 (1.9)	DNM2 (1.7)	SLC44A2 (1.7)	ADAM1 (1.6)
ENSG00000189369	GSPT2 PPI subnetwork	0.94	> 0.20	NKPD1 (2.7)	MOSC1 (1.9)	UBXN2B (1.8)	ANKRD31 (1.4)	CEACAM19 (1.3)	ENSG00000226645 (1.2)	DNAH11 (1.2)	GPAM (1.2)	SYPL2 (1.1)	GATAD2A (1.1)
MP:0000864	abnormal cerebellum vermis morphology	0.94	> 0.20	DYNC2LI1 (1.8)	ANKRD31 (1.8)	NCAN (1.6)	PCSK9 (1.5)	OGDH (1.5)	CARM1 (1.3)	PLCG1 (1.3)	HAPLN4 (1.3)	ZHX3 (1.3)	ATXN7L2 (1.3)
GO:0045060	negative thymic T cell selection	0.94	> 0.20	GOT2P1 (2.0)	HAVCR1 (1.9)	C17orf57 (1.7)	ZNF101 (1.7)	PLCG1 (1.6)	PBX4 (1.4)	TMEM116 (1.3)	ANKRD31 (1.2)	ENSG00000228044 (1.2)	CARM1 (1.1)
ENSG00000155463	OXA1L PPI subnetwork	0.94	> 0.20	PSMA5 (4.1)	C12orf47 (1.9)	OGDH (1.7)	DYNC2LI1 (1.6)	AMIGO1 (1.4)	CYB561D1 (1.4)	FRK (1.4)	TMEM116 (1.3)	TOMM40 (1.3)	GOT2P1 (1.2)
ENSG00000154016	GRAP PPI subnetwork	0.94	> 0.20	ATXN2 (3.3)	DNM2 (3.3)	TMEM57 (2.6)	ADAM1 (2.3)	USP24 (2.2)	PTPN11 (2.1)	SH2B3 (1.9)	PBX4 (1.9)	C12orf51 (1.8)	CARM1 (1.6)
ENSG00000156049	GNA14 PPI subnetwork	0.94	> 0.20	ABO (2.4)	RPH3A (2.2)	ITGB3 (1.9)	ST3GAL4 (1.8)	HLX (1.6)	AMIGO1 (1.6)	GCNT4 (1.6)	C12orf47 (1.3)	PMFBP1 (1.3)	GPAM (1.2)
ENSG00000175595	ERCC4 PPI subnetwork	0.94	> 0.20	FEN1 (3.3)	SUGP1 (2.7)	ENSG00000235545 (2.7)	USP1 (2.2)	ZNF180 (1.8)	NT5DC1 (1.7)	POC5 (1.7)	FADS1 (1.6)	RHD (1.5)	TMEM116 (1.4)
GO:0016573	histone acetylation	0.94	> 0.20	ATXN7L2 (3.2)	BUD13 (2.5)	ILF3 (2.4)	ZNF180 (2.0)	MAPKAPK5 (1.6)	MAU2 (1.6)	PLCG1 (1.6)	BRAP (1.5)	ZNF101 (1.5)	ATXN2 (1.5)
GO:0006972	hyperosmotic response	0.94	> 0.20	ABO (2.4)	C12orf47 (2.0)	GOT2P1 (2.0)	LPIN3 (1.3)	TMEM116 (1.2)	BRAP (1.1)	C19orf52 (1.1)	CILP2 (1.1)	ZHX3 (1.1)	BCAM (1.0)
GO:0044062	regulation of excretion	0.94	> 0.20	HNF1A (3.2)	C11orf9 (2.2)	CEACAM19 (2.0)	C12orf47 (1.8)	HAVCR1 (1.8)	FRK (1.8)	BCAM (1.7)	NKPD1 (1.5)	PMFBP1 (1.4)	ANGPTL3 (1.4)
ENSG00000015153	YAF2 PPI subnetwork	0.94	> 0.20	ILF3 (2.0)	TRAFD1 (1.8)	MARK4 (1.8)	CARM1 (1.7)	USP24 (1.6)	C19orf52 (1.5)	ATXN7L2 (1.5)	USP1 (1.5)	GATAD2A (1.4)	SMARCA4 (1.4)
GO:0050852	T cell receptor signaling pathway	0.94	> 0.20	ZNF101 (4.3)	PLCG1 (3.5)	PBX4 (2.9)	CYB561D1 (2.5)	GMIP (2.2)	HAVCR1 (2.1)	LPAR2 (1.9)	ADAM1 (1.7)	TRAPPC6A (1.7)	POLK (1.6)
ENSG00000158022	TRIM63 PPI subnetwork	0.94	> 0.20	SYPL2 (6.0)	GMPR (2.8)	TMEM50A (1.5)	ACAD10 (1.1)	HNF1A (1.1)	HP (0.9)	AP1M2 (0.9)	TRAPPC6A (0.8)	PVRL2 (0.7)	CILP2 (0.7)
GO:0005096	GTPase activator activity	0.94	> 0.20	SH2B3 (3.2)	HLX (3.1)	GMIP (3.0)	DNM2 (2.7)	C12orf51 (2.6)	ZHX3 (2.4)	PLCG1 (2.0)	LPIN3 (1.8)	CBLC (1.7)	PLEKHH2 (1.6)
ENSG00000111790	FGFR1OP2 PPI subnetwork	0.94	> 0.20	GCNT4 (2.5)	UBXN2B (1.8)	ENSG00000226645 (1.7)	PVRL2 (1.7)	C17orf57 (1.6)	C11orf9 (1.6)	C19orf52 (1.5)	PSMA5 (1.3)	SLC44A2 (1.3)	C1orf63 (1.3)
GO:0009185	ribonucleoside diphosphate metabolic process	0.94	> 0.20	C12orf47 (2.7)	ERP29 (2.5)	ACAD10 (2.1)	C19orf52 (1.9)	TMEM116 (1.9)	OGDH (1.9)	HAVCR1 (1.8)	TMED4 (1.8)	HNF1A (1.7)	NKPD1 (1.7)
ENSG00000157483	MYO1E PPI subnetwork	0.94	> 0.20	DYNC2LI1 (2.1)	GMIP (2.0)	PPP1R37 (2.0)	TMEM50A (1.9)	OGDH (1.9)	CARM1 (1.8)	GATAD2A (1.7)	DHX38 (1.6)	HAVCR1 (1.5)	TOMM40 (1.5)
ENSG00000136824	SMC2 PPI subnetwork	0.94	> 0.20	USP1 (2.7)	YIPF2 (2.1)	ACAD10 (2.0)	PSRC1 (1.9)	FEN1 (1.7)	POC5 (1.6)	AMIGO1 (1.6)	ENSG00000228044 (1.4)	ILF3 (1.4)	TMEM50A (1.1)
GO:0050769	positive regulation of neurogenesis	0.94	> 0.20	NCAN (3.0)	ENSG00000254235 (2.4)	CELSR2 (2.3)	PBX4 (1.9)	PPP1R37 (1.6)	TMED4 (1.5)	GEMIN7 (1.4)	ANKRD31 (1.3)	PLEC (1.3)	C11orf9 (1.2)
ENSG00000154917	RAB6B PPI subnetwork	0.94	> 0.20	ADAM1 (2.7)	ERP29 (2.5)	ATXN2 (2.4)	C12orf43 (1.9)	HAVCR1 (1.8)	NYNRIN (1.7)	C12orf47 (1.7)	C12orf51 (1.6)	TMEM50A (1.5)	COL4A3BP (1.4)
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	0.94	> 0.20	PLEKHH2 (3.6)	C11orf9 (3.1)	ENSG00000226645 (2.3)	PVR (1.9)	ALDH2 (1.8)	PVRL2 (1.8)	ABO (1.7)	HAPLN4 (1.6)	PCSK9 (1.6)	PTPN11 (1.5)
ENSG00000104915	STX10 PPI subnetwork	0.94	> 0.20	C19orf52 (3.3)	TMEM50A (2.9)	YIPF2 (2.8)	TMEM57 (2.7)	SUGP1 (2.4)	ZNF101 (2.0)	SARS (1.9)	SLC44A2 (1.9)	BLOC1S3 (1.9)	TRAPPC6A (1.8)
ENSG00000128578	FAM40B PPI subnetwork	0.94	> 0.20	PVRL2 (2.2)	DNM2 (2.1)	MARK4 (2.0)	NYNRIN (1.9)	GEMIN7 (1.9)	UBXN2B (1.8)	PSMA5 (1.8)	ENSG00000226648 (1.6)	GCNT4 (1.5)	ENSG00000226645 (1.4)
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	0.94	> 0.20	MAFB (3.4)	APOE (2.9)	HLX (2.6)	SH2B3 (2.3)	APOC1 (2.3)	ADAM1 (2.1)	PVR (1.5)	NCAN (1.4)	MAU2 (1.4)	C12orf47 (1.3)
ENSG00000167774	NDUFA7 PPI subnetwork	0.94	> 0.20	OGDH (3.7)	ACAD10 (3.3)	C12orf47 (2.9)	TRAPPC6A (2.6)	GOT2P1 (1.8)	FRK (1.6)	ADAM1 (1.5)	MAU2 (1.4)	PTPN11 (1.4)	GMPR (1.3)
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	0.94	> 0.20	SYPL2 (3.4)	PLG (3.1)	ENSG00000226648 (2.6)	RPH3A (2.4)	AMIGO1 (2.1)	SORT1 (2.1)	RHD (2.1)	HAVCR1 (2.1)	ANGPTL3 (1.9)	ENSG00000235545 (1.8)
GO:0010657	muscle cell apoptotic process	0.94	> 0.20	CILP2 (2.2)	ADAM1 (2.2)	SLC22A1 (1.9)	ENSG00000226648 (1.7)	ENSG00000226645 (1.2)	ENSG00000228044 (1.2)	ENSG00000235545 (1.1)	HLX (1.1)	BCAM (1.0)	TMED4 (1.0)
ENSG00000125084	WNT1 PPI subnetwork	0.94	> 0.20	CILP2 (3.3)	BCAM (2.8)	LPAR2 (1.8)	PVRL2 (1.7)	CELSR2 (1.6)	PLEKHH2 (1.4)	PLCG1 (1.4)	AMIGO1 (1.4)	MAFB (1.4)	TMEM116 (1.3)
GO:0030312	external encapsulating structure	0.94	> 0.20	NCAN (4.1)	RPH3A (1.8)	PPP1R37 (1.6)	PCSK9 (1.6)	C11orf9 (1.2)	ABO (1.2)	USP24 (1.2)	ENSG00000238078 (1.1)	GCNT4 (1.1)	GOT2P1 (1.1)
ENSG00000037042	TUBG2 PPI subnetwork	0.94	> 0.20	POC5 (2.3)	SUGP1 (2.1)	AMIGO1 (1.7)	BRAP (1.7)	PPP1R37 (1.6)	TMEM50A (1.4)	ATXN7L2 (1.4)	C12orf43 (1.4)	DYNC2LI1 (1.3)	DDX56 (1.3)
GO:0008608	attachment of spindle microtubules to kinetochore	0.94	> 0.20	PSRC1 (4.2)	POC5 (3.6)	UBXN2B (2.6)	ENSG00000228044 (1.8)	TXNL4B (1.6)	DNAH11 (1.6)	ENSG00000226648 (1.6)	AP1M2 (1.3)	PBX4 (1.3)	GCNT4 (1.2)
ENSG00000163050	ADCK3 PPI subnetwork	0.94	> 0.20	MARK4 (3.6)	C12orf51 (3.5)	PVRL2 (2.3)	GMIP (2.2)	SORT1 (2.1)	ATXN2 (2.1)	PSRC1 (1.8)	LPAR2 (1.8)	BUD13 (1.6)	ZNF180 (1.6)
ENSG00000143119	CD53 PPI subnetwork	0.94	> 0.20	SLC44A2 (3.2)	PTPN11 (2.3)	APOE (2.2)	TIMD4 (2.1)	BCAM (1.9)	CETP (1.8)	APOC1 (1.8)	TMEM116 (1.6)	POLK (1.6)	ITGB3 (1.4)
ENSG00000070808	CAMK2A PPI subnetwork	0.94	> 0.20	RPH3A (3.6)	SORT1 (2.3)	ENSG00000226648 (2.0)	COL4A3BP (2.0)	C12orf51 (1.9)	AMIGO1 (1.8)	CELSR2 (1.7)	PVR (1.7)	HAPLN4 (1.7)	UBXN2B (1.6)
ENSG00000164093	PITX2 PPI subnetwork	0.94	> 0.20	CYB561D1 (2.1)	SORT1 (1.8)	PSMA5 (1.6)	ATXN7L2 (1.6)	TMEM50A (1.6)	HNF1A (1.6)	C12orf51 (1.5)	TMED4 (1.4)	BUD13 (1.3)	ZNF259 (1.3)
ENSG00000165775	FUNDC2 PPI subnetwork	0.94	> 0.20	GMPR (2.7)	SLC44A2 (1.9)	PLEKHH2 (1.7)	MAPKAPK5 (1.6)	DYNC2LI1 (1.4)	ZHX3 (1.4)	TRIB1 (1.3)	TMED4 (1.2)	LPAR2 (1.1)	FRK (1.1)
ENSG00000135624	CCT7 PPI subnetwork	0.94	> 0.20	PSMA5 (2.7)	TMEM50A (2.5)	NAA25 (2.0)	NT5DC1 (1.7)	ZNF259 (1.7)	SARS (1.5)	DDX56 (1.5)	COL4A3BP (1.5)	PARP10 (1.3)	OGDH (1.2)
ENSG00000155111	CDK19 PPI subnetwork	0.94	> 0.20	BLOC1S3 (3.6)	TXNL4B (3.1)	BRAP (3.0)	GEMIN7 (2.9)	C19orf52 (2.8)	C1orf63 (2.6)	TMEM57 (1.9)	TOP1 (1.9)	MAU2 (1.7)	BUD13 (1.6)
GO:0048747	muscle fiber development	0.94	> 0.20	SYPL2 (3.9)	ENSG00000226648 (2.5)	OGDH (2.1)	AMIGO1 (2.1)	ATXN7L2 (1.8)	PLEKHH2 (1.8)	SLC44A2 (1.8)	GMPR (1.7)	PMFBP1 (1.6)	LPIN3 (1.5)
ENSG00000111716	LDHB PPI subnetwork	0.94	> 0.20	C11orf9 (2.3)	NT5DC1 (2.1)	PTPN11 (1.9)	ZNF180 (1.8)	TOMM40 (1.8)	ST3GAL4 (1.7)	C17orf57 (1.6)	ADAM1 (1.6)	CELSR2 (1.6)	SORT1 (1.5)
ENSG00000135723	FHOD1 PPI subnetwork	0.94	> 0.20	DYNC2LI1 (3.7)	GOT2P1 (2.4)	SYPL2 (1.9)	C12orf43 (1.8)	POLK (1.8)	PSMA5 (1.8)	DHX38 (1.6)	CETP (1.5)	MAPKAPK5 (1.5)	C17orf57 (1.5)
ENSG00000084092	NOA1 PPI subnetwork	0.94	> 0.20	TOMM40 (2.6)	CILP2 (2.5)	QTRT1 (2.3)	ENSG00000235545 (2.3)	LPAR2 (2.0)	SUGP1 (1.6)	GMPR (1.6)	HLX (1.6)	ILF3 (1.4)	DHODH (1.4)
ENSG00000160654	CD3G PPI subnetwork	0.94	> 0.20	PLCG1 (2.9)	APOE (2.4)	ZNF101 (2.3)	CEACAM19 (1.8)	ALDH2 (1.6)	C19orf52 (1.4)	PBX4 (1.3)	ADAM1 (1.2)	APOC1 (1.2)	PARP10 (1.2)
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	0.94	> 0.20	CBLC (3.8)	ST3GAL4 (2.7)	PLEKHH2 (2.1)	FRK (2.0)	PVRL2 (1.9)	ERP29 (1.9)	ENSG00000235545 (1.8)	SORT1 (1.8)	YIPF2 (1.7)	LDLR (1.5)
GO:0007622	rhythmic behavior	0.94	> 0.20	ENSG00000226648 (4.6)	HNF1A (1.7)	DNAH11 (1.6)	PPP1R37 (1.5)	CETP (1.5)	TSSK6 (1.5)	CILP2 (1.4)	RPH3A (1.4)	C12orf47 (1.4)	GEMIN7 (1.2)
GO:0030695	GTPase regulator activity	0.94	> 0.20	SH2B3 (3.4)	C12orf51 (3.2)	DNM2 (3.2)	GMIP (3.1)	PLCG1 (2.5)	ZHX3 (2.4)	USP24 (2.3)	HLX (2.3)	PLEC (2.1)	PLEKHH2 (1.8)
MP:0005195	abnormal posterior eye segment morphology	0.94	> 0.20	CILP2 (3.3)	PLEKHH2 (2.7)	ATXN2 (2.1)	PVRL2 (1.8)	MYLIP (1.8)	BCAM (1.7)	C11orf9 (1.6)	SLC44A2 (1.4)	GOT2P1 (1.4)	DYNC2LI1 (1.3)
GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	0.94	> 0.20	POLK (3.4)	NT5DC1 (2.1)	CEACAM19 (2.0)	ST3GAL4 (1.9)	PSRC1 (1.6)	HLX (1.5)	C17orf57 (1.5)	ALDH2 (1.4)	C12orf43 (1.2)	DNAH11 (1.2)
GO:0071363	cellular response to growth factor stimulus	0.94	> 0.20	SLC44A2 (2.4)	HLX (2.2)	ENSG00000226645 (1.9)	SH2B3 (1.6)	KANK2 (1.5)	PVRL2 (1.5)	PVR (1.4)	TMEM57 (1.3)	ADAM1 (1.3)	MAFB (1.3)
GO:0030282	bone mineralization	0.94	> 0.20	PLEKHH2 (2.5)	CILP2 (2.3)	MAFB (2.3)	MYLIP (2.3)	RHCE (2.0)	TMEM116 (2.0)	TMEM57 (1.4)	POLK (1.2)	HNF1A (1.2)	MOSC1 (1.2)
GO:0072384	organelle transport along microtubule	0.94	> 0.20	GOT2P1 (2.5)	COL4A3BP (2.4)	C17orf57 (2.2)	PBX4 (2.1)	CYB561D1 (2.0)	C19orf52 (1.8)	C12orf51 (1.5)	UBXN2B (1.2)	LPIN3 (1.1)	BLOC1S3 (1.0)
GO:0032107	regulation of response to nutrient levels	0.94	> 0.20	MAPKAPK5 (2.3)	KIAA1324 (2.2)	AP1M2 (2.0)	LPIN3 (1.9)	C1orf63 (1.6)	ENSG00000235545 (1.6)	TMEM50A (1.5)	ATXN7L2 (1.5)	BLOC1S3 (1.4)	C17orf57 (1.3)
GO:0032104	regulation of response to extracellular stimulus	0.94	> 0.20	MAPKAPK5 (2.3)	KIAA1324 (2.2)	AP1M2 (2.0)	LPIN3 (1.9)	C1orf63 (1.6)	ENSG00000235545 (1.6)	TMEM50A (1.5)	ATXN7L2 (1.5)	BLOC1S3 (1.4)	C17orf57 (1.3)
GO:0032715	negative regulation of interleukin-6 production	0.94	> 0.20	C12orf47 (2.1)	GMIP (1.7)	PMFBP1 (1.4)	MYLIP (1.4)	ADAM1 (1.4)	TRIB1 (1.4)	PBX4 (1.3)	TSSK6 (1.2)	POC5 (1.2)	ZNF101 (1.1)
GO:0021680	cerebellar Purkinje cell layer development	0.94	> 0.20	C12orf47 (2.9)	TMEM116 (2.5)	SARS (2.4)	ERP29 (2.2)	ANKRD31 (2.0)	C12orf51 (1.8)	ADAM1 (1.6)	DOCK7 (1.5)	DHX38 (1.5)	HAPLN4 (1.4)
GO:0016050	vesicle organization	0.94	> 0.20	YIPF2 (4.8)	POLK (1.9)	BLOC1S3 (1.8)	HAPLN4 (1.7)	DNM2 (1.5)	DOCK7 (1.5)	GEMIN7 (1.5)	PPP1R37 (1.2)	PMFBP1 (1.1)	SORT1 (1.1)
MP:0002102	abnormal ear morphology	0.94	> 0.20	ABO (2.9)	CEACAM19 (2.0)	PLEKHH2 (2.0)	ENSG00000228044 (1.9)	TM6SF2 (1.5)	HAPLN4 (1.5)	TRAPPC6A (1.4)	PBX4 (1.4)	C12orf47 (1.3)	HNF1A (1.3)
GO:0007143	female meiosis	0.94	> 0.20	ENSG00000226648 (3.2)	AMIGO1 (3.1)	POC5 (2.3)	PSRC1 (2.1)	ZNF180 (2.0)	DYNC2LI1 (1.8)	ITGB3 (1.7)	BLOC1S3 (1.5)	TSSK6 (1.4)	NKPD1 (1.4)
ENSG00000161800	RACGAP1 PPI subnetwork	0.94	> 0.20	PSRC1 (3.5)	CBLC (3.5)	AP1M2 (2.3)	FRK (2.1)	FEN1 (2.1)	PLEC (1.9)	ENSG00000226645 (1.7)	CELSR2 (1.6)	ENSG00000238078 (1.6)	HNF1A (1.6)
GO:0003924	GTPase activity	0.94	> 0.20	ITGB3 (2.4)	C12orf43 (2.2)	MYLIP (2.1)	GATAD2A (2.0)	PTPN11 (1.9)	DYNC2LI1 (1.7)	OASL (1.7)	TRAFD1 (1.6)	TXNL4B (1.4)	TMEM50A (1.2)
GO:0009060	aerobic respiration	0.94	> 0.20	OGDH (4.1)	ACAD10 (3.8)	TMEM116 (2.4)	GMPR (2.1)	ENSG00000226648 (1.8)	C1orf63 (1.8)	TMED4 (1.8)	NT5DC1 (1.7)	C19orf52 (1.7)	PMFBP1 (1.3)
ENSG00000082074	FYB PPI subnetwork	0.94	> 0.20	GMIP (4.7)	ITGB3 (2.7)	ZNF101 (2.5)	PLCG1 (2.5)	POLK (2.2)	CETP (2.0)	TIMD4 (1.9)	OGDH (1.9)	C17orf57 (1.7)	COL4A3BP (1.6)
MP:0011228	abnormal vitamin D level	0.94	> 0.20	ANGPTL3 (4.1)	PLG (3.4)	TMEM116 (3.4)	AP1M2 (2.9)	SLC22A1 (2.4)	C12orf47 (2.4)	HAVCR1 (2.2)	TM6SF2 (1.6)	HP (1.6)	FRK (1.5)
MP:0008714	lung carcinoma	0.94	> 0.20	ENSG00000226648 (3.1)	C17orf57 (2.6)	PSRC1 (2.4)	FEN1 (2.1)	USP1 (1.9)	TMEM116 (1.5)	PMFBP1 (1.5)	POLK (1.4)	ZHX3 (1.3)	NYNRIN (1.3)
ENSG00000111361	EIF2B1 PPI subnetwork	0.94	> 0.20	ZNF259 (3.7)	QTRT1 (2.7)	DDX56 (2.7)	TXNL4B (2.6)	SARS (2.6)	DHODH (2.5)	GEMIN7 (1.8)	PSMA5 (1.6)	ATP13A1 (1.5)	TOMM40 (1.4)
GO:0014821	phasic smooth muscle contraction	0.94	> 0.20	ENSG00000226648 (3.2)	LPIN3 (2.0)	NKPD1 (1.7)	KIAA1324 (1.6)	TMED4 (1.5)	AMIGO1 (1.4)	HAVCR1 (1.2)	PVR (1.2)	ABO (1.1)	ST3GAL4 (1.0)
ENSG00000080839	RBL1 PPI subnetwork	0.94	> 0.20	GATAD2A (2.9)	USP1 (2.7)	FEN1 (2.2)	PLCG1 (2.0)	KANK2 (1.7)	PSRC1 (1.5)	MARK4 (1.4)	SMARCA4 (1.3)	TMED4 (1.2)	C11orf9 (1.2)
ENSG00000143771	CNIH4 PPI subnetwork	0.94	> 0.20	YIPF2 (3.3)	TMEM50A (2.5)	TXNL4B (2.4)	CLPTM1 (2.4)	SUGP1 (2.2)	TRAFD1 (2.0)	C19orf52 (1.9)	ATXN7L2 (1.7)	SARS (1.6)	MAU2 (1.6)
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	0.94	> 0.20	ITGB3 (3.1)	TMEM50A (2.5)	CETP (1.9)	DNM2 (1.5)	C1orf63 (1.1)	HLX (1.1)	ENSG00000254235 (1.0)	ZNF180 (1.0)	OASL (1.0)	TXNL4B (1.0)
GO:0090177	establishment of planar polarity involved in neural tube closure	0.94	> 0.20	ATXN7L2 (3.6)	ENSG00000235545 (2.2)	NYNRIN (2.1)	TMEM116 (2.0)	LPAR2 (1.6)	ABO (1.5)	DYNC2LI1 (1.5)	AMIGO1 (1.5)	SLC44A2 (1.4)	CELSR2 (1.4)
ENSG00000162302	RPS6KA4 PPI subnetwork	0.94	> 0.20	CBLC (2.5)	MAPKAPK5 (1.8)	CYB561D1 (1.8)	CARM1 (1.7)	ENSG00000238078 (1.7)	UBXN2B (1.4)	TOMM40 (1.4)	TSSK6 (1.4)	LPIN3 (1.3)	AP1M2 (1.3)
MP:0000458	abnormal mandible morphology	0.94	> 0.20	MYLIP (1.9)	MAFB (1.7)	TRIB1 (1.6)	ENSG00000226648 (1.6)	CILP2 (1.4)	LDLR (1.4)	ANKRD31 (1.3)	KANK2 (1.2)	ENSG00000254235 (1.1)	TMED4 (1.1)
ENSG00000163132	MSX1 PPI subnetwork	0.94	> 0.20	MYLIP (2.3)	ATXN2 (2.0)	BUD13 (1.7)	KANK2 (1.4)	NKPD1 (1.3)	CARM1 (1.2)	MAU2 (1.1)	FRK (1.1)	TRAFD1 (1.1)	NCAN (1.0)
MP:0002687	oligozoospermia	0.94	> 0.20	KIAA1324 (2.0)	TSSK6 (1.9)	FEN1 (1.6)	MAPKAPK5 (1.6)	PMFBP1 (1.4)	PBX4 (1.4)	TRIB1 (1.3)	ZNF180 (1.2)	TXNL4B (1.2)	PSRC1 (1.1)
ENSG00000069329	VPS35 PPI subnetwork	0.94	> 0.20	SARS (2.7)	C12orf51 (2.6)	ERP29 (2.5)	COL4A3BP (2.5)	PTPN11 (2.1)	ENSG00000254235 (1.8)	NKPD1 (1.6)	C12orf43 (1.5)	ADAM1 (1.4)	RHD (1.4)
ENSG00000156374	PCGF6 PPI subnetwork	0.94	> 0.20	ATXN2 (2.5)	ILF3 (2.3)	CARM1 (2.2)	GATAD2A (2.1)	TMEM57 (2.0)	MARK4 (1.9)	SMARCA4 (1.8)	PTPN11 (1.7)	TRAFD1 (1.4)	USP1 (1.3)
ENSG00000128340	RAC2 PPI subnetwork	0.94	> 0.20	GMIP (2.7)	POC5 (2.1)	DNM2 (1.9)	DNAH11 (1.8)	DOCK7 (1.7)	NCAN (1.6)	POLK (1.6)	CELSR2 (1.5)	TMEM57 (1.4)	GATAD2A (1.2)
MP:0001694	failure to form egg cylinders	0.94	> 0.20	CELSR2 (2.3)	KIAA1324 (2.1)	GATAD2A (1.9)	ACAD10 (1.8)	USP1 (1.8)	ILF3 (1.6)	BUD13 (1.6)	BRAP (1.4)	ZNF180 (1.3)	FEN1 (1.3)
GO:0002028	regulation of sodium ion transport	0.94	> 0.20	PPP1R37 (2.8)	ZNF180 (2.5)	BLOC1S3 (2.4)	CLPTM1 (2.3)	TMEM116 (2.2)	OGDH (2.2)	AP1M2 (1.8)	KIAA1324 (1.8)	CYB561D1 (1.8)	BCAM (1.7)
GO:0060079	regulation of excitatory postsynaptic membrane potential	0.94	> 0.20	RPH3A (2.5)	GOT2P1 (2.3)	PPP1R37 (1.9)	NCAN (1.9)	C12orf43 (1.7)	ENSG00000226648 (1.5)	ATXN7L2 (1.4)	HAPLN4 (1.3)	CYB561D1 (1.2)	ENSG00000235545 (1.2)
GO:0006865	amino acid transport	0.94	> 0.20	HAPLN4 (3.3)	TM6SF2 (2.2)	ABCG8 (2.1)	ATP13A1 (2.0)	LPAR2 (2.0)	GCNT4 (1.9)	NPC1L1 (1.7)	NCAN (1.6)	PMFBP1 (1.6)	TMEM116 (1.5)
ENSG00000130294	KIF1A PPI subnetwork	0.94	> 0.20	HAVCR1 (2.3)	ACAD10 (2.0)	C11orf9 (1.7)	CYB561D1 (1.7)	CELSR2 (1.6)	PMFBP1 (1.5)	GOT2P1 (1.3)	ENSG00000235545 (1.3)	HMGCR (1.3)	SH2B3 (1.2)
ENSG00000100351	GRAP2 PPI subnetwork	0.94	> 0.20	DOCK7 (2.3)	C1orf63 (2.1)	LPAR2 (1.9)	HAVCR1 (1.6)	CEACAM19 (1.6)	TOP1 (1.5)	LPIN3 (1.5)	TMEM57 (1.5)	ZHX3 (1.4)	DNM2 (1.3)
GO:0032410	negative regulation of transporter activity	0.94	> 0.20	TSSK6 (2.4)	CYB561D1 (2.1)	DNAH11 (2.0)	CILP2 (1.5)	POLK (1.4)	SLC44A2 (1.2)	TMEM50A (1.1)	APOB (1.0)	RPH3A (1.0)	ZNF101 (1.0)
MP:0009750	impaired behavioral response to addictive substance	0.94	> 0.20	C12orf47 (2.9)	CELSR2 (2.5)	ITGB3 (2.1)	ZHX3 (2.1)	C11orf9 (2.0)	SORT1 (1.9)	LPA (1.8)	ALDH2 (1.6)	TSSK6 (1.5)	PPP1R37 (1.1)
GO:0052742	phosphatidylinositol kinase activity	0.94	> 0.20	DNM2 (3.0)	TMEM57 (2.3)	MAU2 (2.2)	BLOC1S3 (1.9)	DOCK7 (1.7)	YIPF2 (1.6)	GMIP (1.6)	HAVCR1 (1.6)	CELSR2 (1.5)	PARP10 (1.5)
GO:0005154	epidermal growth factor receptor binding	0.94	> 0.20	PLEKHH2 (3.4)	TRIB1 (2.9)	NKPD1 (2.4)	PVR (2.2)	TIMD4 (2.1)	PVRL2 (2.0)	YIPF2 (1.9)	MARK4 (1.7)	FRK (1.6)	POLK (1.6)
GO:0032350	regulation of hormone metabolic process	0.94	> 0.20	BLOC1S3 (2.0)	ZNF180 (1.7)	ATXN7L2 (1.7)	ADAM1 (1.6)	PMFBP1 (1.6)	TMEM50A (1.5)	BCAM (1.5)	TMEM57 (1.4)	AMIGO1 (1.1)	HAVCR1 (1.0)
GO:0030104	water homeostasis	0.94	> 0.20	TSSK6 (3.1)	AP1M2 (2.6)	GOT2P1 (2.2)	PBX4 (2.0)	ENSG00000235545 (1.5)	C12orf47 (1.5)	ZHX3 (1.5)	AMIGO1 (1.4)	PLEC (1.3)	ENSG00000228044 (1.3)
GO:0019233	sensory perception of pain	0.94	> 0.20	AMIGO1 (2.9)	RPH3A (2.2)	PMFBP1 (1.8)	NKPD1 (1.7)	KIAA1324 (1.6)	LPIN3 (1.6)	HAPLN4 (1.3)	C12orf43 (1.3)	C17orf57 (1.3)	MAFB (1.2)
GO:0007019	microtubule depolymerization	0.94	> 0.20	POC5 (3.3)	TSSK6 (2.5)	LPAR2 (2.4)	TMEM57 (1.9)	CEACAM19 (1.7)	PSRC1 (1.6)	C17orf57 (1.5)	SLC44A2 (1.5)	NCAN (1.4)	C12orf47 (1.4)
ENSG00000107758	PPP3CB PPI subnetwork	0.94	> 0.20	C12orf47 (2.5)	ZHX3 (2.3)	TSSK6 (1.8)	BCL3 (1.6)	GMIP (1.5)	ABO (1.5)	HAVCR1 (1.5)	PLEC (1.4)	KIAA1324 (1.4)	GOT2P1 (1.3)
ENSG00000164889	SLC4A2 PPI subnetwork	0.94	> 0.20	RHCE (5.6)	RHD (5.5)	UBXN2B (2.6)	USP24 (2.0)	PLCG1 (1.8)	PSRC1 (1.7)	TOP1 (1.3)	TMED4 (1.3)	GOT2P1 (1.3)	LPA (1.2)
GO:0070925	organelle assembly	0.94	> 0.20	TXNL4B (3.6)	BRAP (2.9)	C1orf63 (2.5)	PSRC1 (2.3)	POC5 (2.1)	ZNF180 (1.8)	NKPD1 (1.4)	ADAM1 (1.3)	C12orf43 (1.3)	DHX38 (1.2)
GO:0045746	negative regulation of Notch signaling pathway	0.94	> 0.20	ADAM1 (3.2)	C12orf47 (2.0)	ENSG00000254235 (2.0)	MYLIP (1.8)	MAPKAPK5 (1.6)	CBLC (1.5)	NCAN (1.5)	PMFBP1 (1.5)	ENSG00000238078 (1.4)	C12orf43 (1.4)
ENSG00000139668	WDFY2 PPI subnetwork	0.94	> 0.20	GRINA (2.7)	KIAA1324 (2.4)	PPP1R37 (2.3)	CLPTM1 (2.2)	COL4A3BP (2.1)	TMEM50A (2.0)	BLOC1S3 (1.8)	POC5 (1.7)	NT5DC1 (1.6)	ZHX3 (1.6)
ENSG00000198399	ITSN2 PPI subnetwork	0.94	> 0.20	ATXN7L2 (3.3)	C12orf43 (2.9)	QTRT1 (2.8)	CARM1 (2.6)	NT5DC1 (2.3)	MYLIP (2.1)	DNM2 (2.1)	NCAN (2.0)	HAVCR1 (1.9)	ANKRD31 (1.9)
MP:0002626	increased heart rate	0.94	> 0.20	BCAM (2.4)	C12orf47 (2.4)	KIAA1324 (1.7)	TMEM50A (1.5)	FRK (1.5)	PPP1R37 (1.5)	PARP10 (1.3)	SH2B3 (1.3)	TMED4 (1.3)	HLX (1.2)
ENSG00000114554	PLXNA1 PPI subnetwork	0.94	> 0.20	NCAN (3.0)	HLX (2.2)	SORT1 (2.2)	C11orf9 (1.9)	C12orf51 (1.9)	CELSR2 (1.8)	FADS2 (1.7)	TMEM50A (1.7)	RPH3A (1.6)	MARK4 (1.6)
GO:0044070	regulation of anion transport	0.94	> 0.20	GOT2P1 (3.4)	AMIGO1 (3.0)	LPIN3 (2.9)	TMED4 (1.9)	ENSG00000228044 (1.9)	DYNC2LI1 (1.4)	CILP2 (1.2)	ENSG00000226648 (1.1)	SYPL2 (1.0)	GEMIN7 (1.0)
MP:0004986	abnormal osteoblast morphology	0.94	> 0.20	TMEM116 (3.2)	KIAA1324 (2.9)	TMEM57 (2.2)	CILP2 (2.2)	ITGB3 (2.0)	APOE (1.8)	MYLIP (1.8)	CETP (1.6)	AP1M2 (1.6)	YIPF2 (1.6)
ENSG00000198822	GRM3 PPI subnetwork	0.94	> 0.20	SH2B3 (2.8)	PBX4 (2.6)	TMEM57 (2.1)	CYP7A1 (1.7)	PLEKHH2 (1.5)	COL4A3BP (1.3)	MYLIP (1.3)	HAPLN4 (1.3)	CETP (1.3)	UBXN2B (1.2)
MP:0002237	abnormal nasal cavity morphology	0.94	> 0.20	CILP2 (4.2)	FADS2 (3.0)	FADS1 (2.6)	CARM1 (2.2)	HMGCR (2.2)	LDLR (2.1)	TRAFD1 (1.9)	OASL (1.8)	GOT2P1 (1.5)	NPC1L1 (1.4)
ENSG00000128524	ATP6V1F PPI subnetwork	0.94	> 0.20	GRINA (3.7)	SARS (2.9)	UBXN2B (2.5)	SORT1 (2.3)	APOE (2.2)	ERP29 (2.0)	COL4A3BP (2.0)	TXNL4B (1.6)	DYNC2LI1 (1.6)	GMPR (1.5)
GO:0044087	regulation of cellular component biogenesis	0.94	> 0.20	PLEC (2.1)	C11orf9 (2.0)	TMEM50A (1.8)	PVRL2 (1.8)	ENSG00000238078 (1.7)	ABO (1.7)	BRAP (1.6)	ITGB3 (1.6)	CETP (1.6)	PBX4 (1.5)
ENSG00000130640	TUBGCP2 PPI subnetwork	0.94	> 0.20	ATP13A1 (2.6)	ENSG00000235545 (2.3)	OGDH (2.2)	QTRT1 (1.8)	DHODH (1.7)	POC5 (1.6)	ATXN7L2 (1.5)	SARS (1.5)	ENSG00000226648 (1.5)	DNM2 (1.5)
ENSG00000196510	ANAPC7 PPI subnetwork	0.94	> 0.20	PSRC1 (5.4)	POC5 (3.6)	FEN1 (3.0)	USP1 (2.2)	C12orf51 (1.6)	ILF3 (1.6)	LPIN3 (1.5)	LPAR2 (1.5)	CILP2 (1.4)	CBLC (1.2)
ENSG00000143437	ARNT PPI subnetwork	0.94	> 0.20	TRIB1 (3.2)	MAFB (2.5)	FRK (2.3)	TMEM116 (2.3)	HLX (1.7)	CELSR2 (1.7)	PLEC (1.6)	TOP1 (1.6)	TSSK6 (1.6)	ATXN2 (1.5)
GO:0072676	lymphocyte migration	0.94	> 0.20	NKPD1 (2.2)	HAVCR1 (1.9)	ZNF101 (1.7)	ENSG00000238078 (1.4)	GMIP (1.3)	DYNC2LI1 (1.3)	MAFB (1.3)	SH2B3 (1.1)	RELB (1.1)	PBX4 (1.1)
GO:0032272	negative regulation of protein polymerization	0.94	> 0.20	C17orf57 (4.0)	ENSG00000238078 (3.8)	RHD (2.9)	RHCE (2.8)	PMFBP1 (2.4)	TMEM50A (2.2)	TSSK6 (1.9)	C12orf51 (1.8)	ABO (1.8)	GMPR (1.6)
GO:0042063	gliogenesis	0.94	> 0.20	NCAN (4.2)	ENSG00000226648 (2.5)	C11orf9 (2.1)	ENSG00000254235 (1.9)	CELSR2 (1.6)	C19orf52 (1.5)	YIPF2 (1.4)	ALDH2 (1.3)	PBX4 (1.2)	ST3GAL4 (1.1)
ENSG00000159788	RGS12 PPI subnetwork	0.94	> 0.20	MARK4 (2.8)	CARM1 (2.8)	ATXN7L2 (2.8)	CELSR2 (2.7)	SLC44A2 (2.1)	CYB561D1 (2.0)	DNM2 (2.0)	LPIN3 (1.9)	PLEC (1.5)	C19orf52 (1.5)
ENSG00000160803	UBQLN4 PPI subnetwork	0.94	> 0.20	KIAA1324 (4.1)	HAPLN4 (2.1)	DNM2 (1.9)	RPH3A (1.8)	KANK2 (1.8)	ATP13A1 (1.7)	TMEM50A (1.6)	GCNT4 (1.5)	MARK4 (1.4)	YIPF2 (1.4)
ENSG00000128626	MRPS12 PPI subnetwork	0.95	> 0.20	FADS2 (2.6)	DHODH (2.3)	HMGCR (2.3)	TRAPPC6A (2.2)	FADS1 (2.0)	NT5DC1 (1.9)	GOT2P1 (1.7)	GEMIN7 (1.7)	PSMA5 (1.5)	HAPLN4 (1.2)
GO:0010092	specification of organ identity	0.95	> 0.20	PLEKHH2 (2.6)	ZHX3 (2.2)	C17orf57 (2.2)	ENSG00000238078 (2.2)	ENSG00000228044 (1.8)	HAVCR1 (1.6)	MYLIP (1.4)	ATXN7L2 (1.4)	LPIN3 (1.3)	DYNC2LI1 (1.3)
MP:0001793	altered susceptibility to infection	0.95	> 0.20	TRAFD1 (2.2)	PARP10 (2.1)	C17orf57 (2.0)	OASL (1.6)	POC5 (1.6)	RPH3A (1.4)	PLEKHH2 (1.3)	COL4A3BP (1.3)	POLK (1.2)	ACAD10 (1.2)
ENSG00000182185	RAD51B PPI subnetwork	0.95	> 0.20	POLK (2.6)	C19orf52 (1.9)	FEN1 (1.7)	ZNF180 (1.5)	PSRC1 (1.5)	TMEM57 (1.5)	TXNL4B (1.4)	GMPR (1.4)	KANK2 (1.3)	TMEM116 (1.2)
GO:0004984	olfactory receptor activity	0.95	> 0.20	ENSG00000235545 (3.7)	ENSG00000228044 (2.8)	HNF1A (2.7)	DNAH11 (1.7)	GOT2P1 (1.5)	ABO (1.4)	NT5DC1 (1.2)	HAVCR1 (1.0)	RHCE (1.0)	QTRT1 (0.8)
MP:0004485	increased response of heart to induced stress	0.95	> 0.20	SYPL2 (3.9)	ST3GAL4 (1.7)	GCNT4 (1.6)	UBXN2B (1.5)	ENSG00000226648 (1.5)	POC5 (1.4)	ENSG00000238078 (1.4)	MAPKAPK5 (1.3)	SH2B3 (1.2)	CEACAM19 (1.2)
ENSG00000108688	CCL7 PPI subnetwork	0.95	> 0.20	MAFB (2.5)	CILP2 (1.9)	FRK (1.6)	ENSG00000254235 (1.4)	OASL (1.3)	BUD13 (1.0)	CARM1 (1.0)	ZNF101 (1.0)	BCL3 (0.9)	ENSG00000226645 (0.9)
ENSG00000005249	PRKAR2B PPI subnetwork	0.95	> 0.20	NCAN (3.2)	SORT1 (2.6)	RPH3A (2.3)	TSSK6 (2.0)	GOT2P1 (1.9)	CLPTM1 (1.6)	MARK4 (1.5)	CELSR2 (1.3)	UBXN2B (1.2)	C11orf9 (1.2)
ENSG00000152556	PFKM PPI subnetwork	0.95	> 0.20	HAVCR1 (2.7)	SYPL2 (2.6)	SMARCA4 (2.4)	C12orf51 (2.3)	GMPR (2.0)	SARS (1.8)	TMEM116 (1.6)	ITGB3 (1.6)	ATXN2 (1.4)	ACAD10 (1.4)
GO:0016776	phosphotransferase activity, phosphate group as acceptor	0.95	> 0.20	DYNC2LI1 (2.5)	C11orf9 (2.2)	OASL (1.9)	GCNT4 (1.5)	PMFBP1 (1.5)	SYPL2 (1.4)	ENSG00000226648 (1.4)	TMEM116 (1.4)	FADS2 (1.4)	TMED4 (1.2)
GO:0005253	anion channel activity	0.95	> 0.20	CLPTM1 (2.2)	SORT1 (2.0)	RPH3A (2.0)	LPIN3 (1.9)	FRK (1.6)	ALDH2 (1.6)	FADS2 (1.5)	SYPL2 (1.5)	KIAA1324 (1.5)	ST3GAL4 (1.4)
GO:2000826	regulation of heart morphogenesis	0.95	> 0.20	LPIN3 (2.4)	ENSG00000238078 (2.1)	HNF1A (2.0)	NYNRIN (1.9)	C19orf52 (1.8)	TSSK6 (1.6)	ENSG00000254235 (1.5)	ALDH2 (1.5)	PPP1R37 (1.5)	HLX (1.3)
GO:0017153	sodium:dicarboxylate symporter activity	0.95	> 0.20	NCAN (3.0)	GCNT4 (2.3)	PMFBP1 (2.0)	MAPKAPK5 (1.7)	TM6SF2 (1.6)	LPAR2 (1.5)	PLG (1.5)	ABCG8 (1.4)	SARS (1.3)	SLC44A2 (1.3)
GO:0015085	calcium ion transmembrane transporter activity	0.95	> 0.20	NCAN (2.6)	KIAA1324 (2.4)	PTPN11 (2.1)	HMGCR (2.0)	GPAM (1.9)	SYPL2 (1.9)	ITGB3 (1.9)	C12orf51 (1.8)	RPH3A (1.8)	GMPR (1.7)
GO:0048551	metalloenzyme inhibitor activity	0.95	> 0.20	GPAM (2.5)	DYNC2LI1 (2.4)	C11orf9 (2.3)	ST3GAL4 (2.0)	MOSC1 (1.9)	TMEM116 (1.4)	ENSG00000238078 (1.3)	ANKRD31 (1.2)	ZNF180 (1.2)	PVR (1.2)
GO:0008191	metalloendopeptidase inhibitor activity	0.95	> 0.20	GPAM (2.5)	DYNC2LI1 (2.4)	C11orf9 (2.3)	ST3GAL4 (2.0)	MOSC1 (1.9)	TMEM116 (1.4)	ENSG00000238078 (1.3)	ANKRD31 (1.2)	ZNF180 (1.2)	PVR (1.2)
ENSG00000130396	MLLT4 PPI subnetwork	0.95	> 0.20	PVRL2 (2.6)	MARK4 (2.5)	DNM2 (2.4)	LPAR2 (2.3)	CELSR2 (2.2)	SLC44A2 (2.2)	NCAN (2.0)	PLEC (1.9)	GATAD2A (1.8)	AP1M2 (1.6)
GO:0006085	acetyl-CoA biosynthetic process	0.95	> 0.20	OGDH (3.4)	TXNL4B (2.7)	C19orf52 (2.7)	ACAD10 (2.6)	GPAM (1.9)	UBXN2B (1.8)	GOT2P1 (1.8)	PMFBP1 (1.8)	TMEM116 (1.8)	NT5DC1 (1.7)
ENSG00000206229	ENSG00000206229 PPI subnetwork	0.95	> 0.20	PLCG1 (4.7)	ZNF101 (2.7)	SLC44A2 (2.0)	ALDH2 (1.7)	HAVCR1 (1.6)	GMIP (1.4)	MAFB (1.4)	TIMD4 (1.4)	KIAA1324 (1.3)	APOE (1.3)
ENSG00000206293	ENSG00000206293 PPI subnetwork	0.95	> 0.20	PLCG1 (4.7)	ZNF101 (2.7)	SLC44A2 (2.0)	ALDH2 (1.7)	HAVCR1 (1.6)	GMIP (1.4)	MAFB (1.4)	TIMD4 (1.4)	KIAA1324 (1.3)	APOE (1.3)
ENSG00000204257	HLA-DMA PPI subnetwork	0.95	> 0.20	PLCG1 (4.7)	ZNF101 (2.7)	SLC44A2 (2.0)	ALDH2 (1.7)	HAVCR1 (1.6)	GMIP (1.4)	MAFB (1.4)	TIMD4 (1.4)	KIAA1324 (1.3)	APOE (1.3)
GO:0031345	negative regulation of cell projection organization	0.95	> 0.20	GCNT4 (2.7)	ANKRD31 (2.3)	ABO (2.2)	TMEM50A (2.1)	TSSK6 (2.1)	C12orf47 (2.1)	NYNRIN (2.0)	RPH3A (1.8)	PBX4 (1.7)	CELSR2 (1.6)
GO:0048489	synaptic vesicle transport	0.95	> 0.20	DNAH11 (3.1)	RPH3A (2.4)	C12orf51 (2.4)	HAPLN4 (2.1)	HNF1A (2.1)	BLOC1S3 (1.6)	C12orf43 (1.3)	HAVCR1 (1.3)	PPP1R37 (1.1)	AMIGO1 (1.1)
MP:0004263	abnormal limb posture	0.95	> 0.20	MAU2 (2.1)	SARS (1.9)	NCAN (1.8)	SYPL2 (1.8)	CELSR2 (1.7)	ENSG00000235545 (1.5)	TSSK6 (1.4)	ATXN7L2 (1.3)	TMEM116 (1.3)	CETP (1.3)
GO:0015662	ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism	0.95	> 0.20	COL4A3BP (2.8)	SYPL2 (2.6)	SORT1 (2.4)	TMEM116 (2.3)	SLC44A2 (2.2)	HAPLN4 (2.2)	NKPD1 (2.1)	ATP13A1 (2.1)	AMIGO1 (1.8)	RPH3A (1.6)
ENSG00000114784	EIF1B PPI subnetwork	0.95	> 0.20	PSMA5 (3.7)	TMEM50A (2.8)	SARS (2.7)	TOMM40 (2.6)	QTRT1 (1.8)	NAA25 (1.6)	SMARCA4 (1.6)	DDX56 (1.5)	ZNF259 (1.5)	ILF3 (1.4)
ENSG00000163932	PRKCD PPI subnetwork	0.95	> 0.20	PLEC (2.7)	NCAN (2.3)	SH2B3 (2.3)	CBLC (2.1)	TMEM50A (1.9)	USP24 (1.8)	GMIP (1.8)	PARP10 (1.7)	DNM2 (1.5)	CELSR2 (1.5)
MP:0005270	abnormal zygomatic bone morphology	0.95	> 0.20	MAU2 (1.7)	DNAH11 (1.6)	KANK2 (1.6)	DYNC2LI1 (1.4)	ALDH2 (1.3)	TMEM57 (1.3)	RHCE (1.3)	NCAN (1.1)	PARP10 (1.1)	GPAM (1.1)
GO:0043383	negative T cell selection	0.95	> 0.20	ZNF101 (2.4)	PLCG1 (2.2)	GOT2P1 (2.1)	C17orf57 (1.9)	HAVCR1 (1.9)	TMEM116 (1.6)	ENSG00000228044 (1.4)	ANKRD31 (1.3)	POLK (1.2)	PBX4 (1.1)
GO:0007034	vacuolar transport	0.95	> 0.20	BLOC1S3 (3.9)	COL4A3BP (3.0)	POLK (3.0)	UBXN2B (2.6)	TMEM50A (2.3)	TMED4 (2.0)	FRK (1.6)	YIPF2 (1.6)	MAU2 (1.4)	LPIN3 (1.3)
GO:0043113	receptor clustering	0.95	> 0.20	HAVCR1 (2.8)	LPIN3 (2.2)	CELSR2 (2.1)	PBX4 (2.0)	CYB561D1 (1.9)	ENSG00000238078 (1.8)	PPP1R37 (1.8)	ATP13A1 (1.6)	NCAN (1.6)	TSSK6 (1.4)
GO:0072028	nephron morphogenesis	0.95	> 0.20	HNF1A (2.9)	BCAM (2.4)	ENSG00000238078 (2.3)	HAVCR1 (2.1)	TSSK6 (2.0)	PMFBP1 (1.8)	AP1M2 (1.7)	NYNRIN (1.5)	PLEKHH2 (1.5)	DYNC2LI1 (1.4)
GO:0009125	nucleoside monophosphate catabolic process	0.95	> 0.20	PMFBP1 (2.0)	PBX4 (1.7)	PCSK9 (1.6)	TXNL4B (1.4)	GCNT4 (1.4)	TRAPPC6A (1.4)	OGDH (1.3)	C17orf57 (1.3)	TMED4 (1.1)	CEACAM19 (1.1)
ENSG00000120149	MSX2 PPI subnetwork	0.95	> 0.20	C19orf52 (1.7)	SMARCA4 (1.6)	MYLIP (1.5)	KIAA1324 (1.4)	GOT2P1 (1.4)	NYNRIN (1.4)	DOCK7 (1.3)	ATXN2 (1.3)	MAFB (1.2)	MARK4 (1.2)
MP:0008877	abnormal DNA methylation	0.95	> 0.20	AP1M2 (2.2)	HAPLN4 (2.0)	SH2B3 (1.9)	TMEM116 (1.8)	USP1 (1.7)	FEN1 (1.6)	DNM2 (1.5)	YIPF2 (1.5)	C19orf52 (1.4)	ZNF180 (1.4)
MP:0001257	increased body length	0.95	> 0.20	PLEKHH2 (2.1)	KIAA1324 (2.1)	TSSK6 (1.8)	ABCG8 (1.8)	GPAM (1.7)	MOSC1 (1.7)	LPA (1.5)	C12orf47 (1.5)	BCL3 (1.4)	HLX (1.2)
MP:0009890	cleft secondary palate	0.95	> 0.20	KANK2 (2.4)	MYLIP (1.9)	HLX (1.8)	LDLR (1.8)	PLEKHH2 (1.6)	CILP2 (1.4)	HMGCR (1.4)	PLEC (1.2)	CBLC (1.1)	DYNC2LI1 (1.1)
GO:0050868	negative regulation of T cell activation	0.95	> 0.20	ZNF101 (2.1)	PBX4 (1.9)	COL4A3BP (1.7)	PLCG1 (1.5)	GCNT4 (1.4)	TRAFD1 (1.4)	C17orf57 (1.3)	ENSG00000254235 (1.3)	ANKRD31 (1.3)	DNAH11 (0.9)
ENSG00000184983	NDUFA6 PPI subnetwork	0.95	> 0.20	OGDH (3.3)	ACAD10 (2.8)	TRAPPC6A (2.6)	C12orf47 (2.6)	PSMA5 (1.7)	GOT2P1 (1.7)	MAU2 (1.6)	GMPR (1.5)	FRK (1.5)	PTPN11 (1.1)
ENSG00000115953	ENSG00000115953 PPI subnetwork	0.95	> 0.20	ZHX3 (3.0)	ZNF180 (2.7)	MARK4 (2.1)	COL4A3BP (1.9)	TSSK6 (1.8)	C12orf47 (1.6)	PVR (1.5)	RPH3A (1.5)	C17orf57 (1.4)	ENSG00000228044 (1.4)
ENSG00000113068	PFDN1 PPI subnetwork	0.95	> 0.20	BUD13 (1.8)	ZNF101 (1.6)	TRAFD1 (1.5)	ENSG00000238078 (1.4)	POC5 (1.4)	BLOC1S3 (1.3)	FRK (1.3)	SH2B3 (1.2)	MAPKAPK5 (1.2)	C12orf47 (1.2)
ENSG00000167881	SRP68 PPI subnetwork	0.95	> 0.20	SARS (2.0)	USP24 (1.9)	POC5 (1.7)	DDX56 (1.7)	PMFBP1 (1.7)	ADAM1 (1.7)	ENSG00000254235 (1.7)	C12orf43 (1.6)	DOCK7 (1.6)	CYB561D1 (1.5)
MP:0001408	stereotypic behavior	0.95	> 0.20	ZHX3 (2.6)	RPH3A (2.2)	TMEM116 (1.9)	SLC22A1 (1.8)	HAPLN4 (1.8)	GMPR (1.6)	ADAM1 (1.6)	LPA (1.6)	NPC1L1 (1.4)	AP1M2 (1.4)
ENSG00000122218	COPA PPI subnetwork	0.95	> 0.20	YIPF2 (3.9)	BLOC1S3 (2.5)	SARS (2.3)	ATP13A1 (2.0)	BRAP (1.8)	SUGP1 (1.8)	DHX38 (1.7)	PSMA5 (1.6)	DNM2 (1.5)	TMED4 (1.5)
REACTOME_INFLAMMASOMES	REACTOME_INFLAMMASOMES	0.95	> 0.20	DNAH11 (2.3)	ZNF101 (2.3)	CYB561D1 (2.1)	C12orf43 (1.7)	HLX (1.6)	OGDH (1.5)	TSSK6 (1.4)	ENSG00000238078 (1.4)	ZNF180 (1.3)	POLK (1.2)
ENSG00000011485	PPP5C PPI subnetwork	0.95	> 0.20	SORT1 (2.3)	HLX (1.9)	NCAN (1.9)	CELSR2 (1.7)	CLPTM1 (1.6)	GOT2P1 (1.6)	TOP1 (1.5)	OGDH (1.4)	MARK4 (1.4)	TSSK6 (1.4)
ENSG00000196584	XRCC2 PPI subnetwork	0.95	> 0.20	POC5 (2.7)	TMEM116 (2.5)	POLK (2.3)	UBXN2B (2.2)	ZNF180 (2.1)	FEN1 (2.0)	BLOC1S3 (1.7)	BUD13 (1.4)	PSRC1 (1.4)	MARK4 (1.4)
ENSG00000063978	RNF4 PPI subnetwork	0.95	> 0.20	KIAA1324 (3.2)	CELSR2 (1.9)	NT5DC1 (1.7)	HAPLN4 (1.7)	ATXN2 (1.5)	BCL3 (1.5)	ANKRD31 (1.5)	ALDH2 (1.4)	CYP7A1 (1.4)	LPIN3 (1.4)
ENSG00000049283	EPN3 PPI subnetwork	0.95	> 0.20	ENSG00000235545 (2.2)	BRAP (2.0)	NKPD1 (2.0)	USP24 (1.9)	COL4A3BP (1.8)	TMEM50A (1.8)	SH2B3 (1.7)	SARS (1.6)	TMEM57 (1.6)	GMIP (1.5)
GO:0014032	neural crest cell development	0.95	> 0.20	ENSG00000254235 (3.0)	DOCK7 (1.8)	ZNF101 (1.5)	PLEKHH2 (1.5)	PLCG1 (1.4)	TSSK6 (1.3)	NKPD1 (1.2)	FRK (1.2)	DYNC2LI1 (1.1)	CBLC (1.1)
ENSG00000136521	NDUFB5 PPI subnetwork	0.95	> 0.20	OGDH (3.3)	ACAD10 (3.2)	TRAPPC6A (2.9)	C12orf47 (2.9)	MAU2 (1.7)	GOT2P1 (1.4)	TMED4 (1.4)	FRK (1.4)	PSMA5 (1.3)	ADAM1 (1.3)
MP:0002689	abnormal molar morphology	0.95	> 0.20	MYLIP (2.9)	DYNC2LI1 (2.3)	CELSR2 (2.3)	PBX4 (2.2)	GCNT4 (1.9)	MAFB (1.6)	ENSG00000238078 (1.5)	SORT1 (1.5)	CILP2 (1.5)	TMEM116 (1.4)
ENSG00000119013	NDUFB3 PPI subnetwork	0.95	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	PSMA5 (1.7)	MAU2 (1.7)	GOT2P1 (1.6)	FRK (1.5)	GMPR (1.4)	TMED4 (1.3)
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	0.95	> 0.20	YIPF2 (4.9)	KIAA1324 (2.4)	DNM2 (2.2)	MAU2 (2.0)	PSMA5 (1.7)	ABCG8 (1.7)	ATP13A1 (1.6)	AP1M2 (1.6)	BLOC1S3 (1.6)	SUGP1 (1.6)
REACTOME_COPI_MEDIATED_TRANSPORT	REACTOME_COPI_MEDIATED_TRANSPORT	0.95	> 0.20	YIPF2 (4.9)	KIAA1324 (2.4)	DNM2 (2.2)	MAU2 (2.0)	PSMA5 (1.7)	ABCG8 (1.7)	ATP13A1 (1.6)	AP1M2 (1.6)	BLOC1S3 (1.6)	SUGP1 (1.6)
MP:0008544	impaired olfaction	0.95	> 0.20	APOC1 (4.3)	ANKRD31 (2.7)	NCAN (1.6)	CETP (1.5)	ENSG00000235545 (1.4)	PLCG1 (1.3)	TRAPPC6A (1.3)	TIMD4 (1.2)	ALDH2 (1.1)	GMPR (1.1)
GO:0003338	metanephros morphogenesis	0.95	> 0.20	HNF1A (3.3)	ENSG00000238078 (2.3)	TSSK6 (2.0)	HAVCR1 (1.8)	ABO (1.7)	PMFBP1 (1.6)	ENSG00000228044 (1.6)	DYNC2LI1 (1.5)	TMED4 (1.5)	AP1M2 (1.4)
REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	0.95	> 0.20	OGDH (4.2)	ACAD10 (3.6)	PSMA5 (3.0)	C12orf47 (2.8)	TOMM40 (1.8)	ENSG00000238078 (1.6)	C1orf63 (1.4)	CLPTM1 (1.4)	TMEM116 (1.4)	FRK (1.4)
ENSG00000204580	DDR1 PPI subnetwork	0.95	> 0.20	CILP2 (2.7)	SORT1 (2.4)	PSRC1 (2.1)	ENSG00000226648 (2.0)	MARK4 (1.8)	C12orf51 (1.8)	DOCK7 (1.7)	ABO (1.5)	USP1 (1.5)	SLC44A2 (1.2)
ENSG00000215522	DDR1 PPI subnetwork	0.95	> 0.20	CILP2 (2.7)	SORT1 (2.4)	PSRC1 (2.1)	ENSG00000226648 (2.0)	MARK4 (1.8)	C12orf51 (1.8)	DOCK7 (1.7)	ABO (1.5)	USP1 (1.5)	SLC44A2 (1.2)
ENSG00000137332	DDR1 PPI subnetwork	0.95	> 0.20	CILP2 (2.7)	SORT1 (2.4)	PSRC1 (2.1)	ENSG00000226648 (2.0)	MARK4 (1.8)	C12orf51 (1.8)	DOCK7 (1.7)	ABO (1.5)	USP1 (1.5)	SLC44A2 (1.2)
ENSG00000101412	E2F1 PPI subnetwork	0.95	> 0.20	ATXN2 (3.0)	USP1 (2.9)	FEN1 (2.9)	NYNRIN (2.3)	C12orf51 (2.3)	TOP1 (2.0)	MAU2 (1.9)	PSRC1 (1.5)	GMIP (1.5)	BUD13 (1.4)
ENSG00000215699	ENSG00000215699 PPI subnetwork	0.95	> 0.20	PPP1R37 (2.7)	PLCG1 (2.7)	AP1M2 (2.1)	KANK2 (2.0)	FRK (1.9)	LPIN3 (1.9)	PVR (1.7)	ERP29 (1.6)	TRAFD1 (1.6)	C17orf57 (1.6)
MP:0004249	abnormal crista ampullaris morphology	0.95	> 0.20	TMEM116 (1.7)	ZHX3 (1.6)	NPC1L1 (1.5)	KIAA1324 (1.5)	DYNC2LI1 (1.5)	AP1M2 (1.4)	C17orf57 (1.4)	ST3GAL4 (1.3)	NT5DC1 (1.2)	ENSG00000228044 (1.2)
ENSG00000147509	RGS20 PPI subnetwork	0.95	> 0.20	POLK (2.6)	HMGCR (2.5)	CLPTM1 (2.3)	ERP29 (2.0)	QTRT1 (1.7)	TSSK6 (1.7)	TOMM40 (1.5)	BLOC1S3 (1.5)	TMED4 (1.5)	ITGB3 (1.4)
ENSG00000120860	CCDC53 PPI subnetwork	0.95	> 0.20	SUGP1 (3.6)	C12orf43 (2.5)	NPC1L1 (1.7)	PSRC1 (1.7)	SARS (1.6)	GCNT4 (1.5)	PMFBP1 (1.5)	MAPKAPK5 (1.5)	TRAFD1 (1.4)	ERP29 (1.3)
REACTOME_G_BETAGAMMA_SIGNALLING_THROUGH_PI3KGAMMA	REACTOME_G_BETAGAMMA_SIGNALLING_THROUGH_PI3KGAMMA	0.95	> 0.20	ITGB3 (2.7)	TMEM50A (1.9)	ZNF180 (1.9)	ENSG00000254235 (1.5)	PMFBP1 (1.4)	C1orf63 (1.3)	CETP (1.3)	SLC44A2 (1.2)	SH2B3 (1.1)	DNM2 (1.1)
ENSG00000198055	GRK6 PPI subnetwork	0.95	> 0.20	ABO (2.6)	HLX (2.2)	SLC44A2 (1.9)	KANK2 (1.7)	ITGB3 (1.6)	BLOC1S3 (1.6)	PSRC1 (1.4)	RHCE (1.3)	ST3GAL4 (1.2)	CELSR2 (1.2)
GO:0030136	clathrin-coated vesicle	0.95	> 0.20	HAPLN4 (2.9)	RPH3A (2.7)	GRINA (2.3)	CLPTM1 (2.3)	SORT1 (2.1)	COL4A3BP (1.9)	CELSR2 (1.8)	C12orf51 (1.7)	AMIGO1 (1.7)	PPP1R37 (1.5)
MP:0011448	decreased dopaminergic neuron number	0.95	> 0.20	GMPR (2.6)	PMFBP1 (2.4)	DNAH11 (2.0)	PTPN11 (1.7)	C19orf52 (1.6)	ABO (1.6)	RHCE (1.4)	CILP2 (1.4)	CELSR2 (1.4)	ENSG00000254235 (1.3)
GO:0030675	Rac GTPase activator activity	0.95	> 0.20	GMIP (3.2)	UBXN2B (2.2)	ST3GAL4 (2.2)	NYNRIN (1.9)	C12orf51 (1.7)	DNM2 (1.6)	SH2B3 (1.5)	GOT2P1 (1.5)	ZHX3 (1.5)	OGDH (1.4)
MP:0000787	abnormal telencephalon morphology	0.95	> 0.20	NCAN (4.1)	DYNC2LI1 (3.1)	CELSR2 (2.4)	DOCK7 (2.4)	ENSG00000235545 (1.9)	ATXN2 (1.7)	YIPF2 (1.7)	ACAD10 (1.7)	PBX4 (1.6)	PPP1R37 (1.6)
MP:0010900	abnormal pulmonary interalveolar septum morphology	0.95	> 0.20	PLEKHH2 (3.0)	DYNC2LI1 (2.1)	BLOC1S3 (1.8)	ENSG00000228044 (1.7)	ENSG00000235545 (1.6)	ITGB3 (1.5)	APOC1 (1.5)	NKPD1 (1.5)	C11orf9 (1.4)	AP1M2 (1.4)
ENSG00000060558	GNA15 PPI subnetwork	0.95	> 0.20	RPH3A (2.2)	HLX (2.2)	ITGB3 (2.1)	ABO (1.8)	AMIGO1 (1.8)	PLEKHH2 (1.7)	ST3GAL4 (1.4)	GPAM (1.4)	C12orf47 (1.3)	PMFBP1 (1.2)
GO:0071897	DNA biosynthetic process	0.95	> 0.20	POLK (2.8)	ZNF180 (1.8)	BLOC1S3 (1.5)	GEMIN7 (1.4)	C12orf51 (1.4)	CILP2 (1.4)	BUD13 (1.3)	DNAH11 (1.3)	HAVCR1 (1.3)	HNF1A (1.3)
MP:0010948	abnormal double-strand DNA break repair	0.95	> 0.20	ANKRD31 (2.7)	TMEM116 (2.0)	MAPKAPK5 (1.6)	AP1M2 (1.6)	DNAH11 (1.5)	ENSG00000228044 (1.4)	PSRC1 (1.3)	MAU2 (1.3)	FEN1 (1.3)	TMED4 (1.2)
GO:0051926	negative regulation of calcium ion transport	0.95	> 0.20	TSSK6 (3.3)	C17orf57 (2.7)	AMIGO1 (2.4)	DNAH11 (2.2)	SH2B3 (2.0)	PVR (2.0)	C12orf47 (1.8)	ENSG00000228044 (1.6)	ZNF180 (1.5)	POLK (1.5)
ENSG00000114670	NEK11 PPI subnetwork	0.95	> 0.20	C12orf51 (3.3)	MARK4 (2.3)	ATXN2 (2.0)	PSRC1 (1.9)	ST3GAL4 (1.9)	USP24 (1.8)	PTPN11 (1.8)	BUD13 (1.7)	ABO (1.6)	GMIP (1.6)
GO:0007094	mitotic cell cycle spindle assembly checkpoint	0.95	> 0.20	POC5 (3.8)	PSRC1 (2.7)	GEMIN7 (2.6)	SUGP1 (1.8)	UBXN2B (1.7)	TMEM116 (1.6)	DOCK7 (1.6)	LPIN3 (1.5)	C1orf63 (1.4)	USP1 (1.1)
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	0.95	> 0.20	PLCG1 (2.7)	ALDH2 (1.7)	COL4A3BP (1.7)	TIMD4 (1.7)	OGDH (1.6)	ZNF101 (1.6)	APOC1 (1.4)	DOCK7 (1.3)	RELB (1.3)	APOE (1.2)
ENSG00000155974	GRIP1 PPI subnetwork	0.95	> 0.20	BCAM (2.5)	NCAN (2.5)	TSSK6 (2.0)	PPP1R37 (1.9)	CYP7A1 (1.8)	MARK4 (1.8)	CELSR2 (1.7)	YIPF2 (1.5)	OASL (1.3)	LPIN3 (1.3)
ENSG00000101421	CHMP4B PPI subnetwork	0.95	> 0.20	TXNL4B (2.4)	MAPKAPK5 (2.2)	PPP1R37 (2.2)	DYNC2LI1 (1.9)	TRAFD1 (1.9)	BLOC1S3 (1.8)	MARK4 (1.7)	FRK (1.7)	SUGP1 (1.7)	ENSG00000238078 (1.5)
ENSG00000101558	VAPA PPI subnetwork	0.95	> 0.20	ZNF259 (4.7)	NAA25 (3.7)	DDX56 (3.2)	TOMM40 (3.1)	DHODH (2.8)	SARS (2.5)	TOP1 (2.4)	ADAM1 (2.0)	TRAPPC6A (1.8)	PSMA5 (1.8)
ENSG00000137672	TRPC6 PPI subnetwork	0.95	> 0.20	OASL (4.1)	PARP10 (2.6)	ITGB3 (2.1)	PLEKHH2 (1.9)	SH2B3 (1.8)	C12orf51 (1.7)	GMIP (1.6)	ATP13A1 (1.3)	ENSG00000226645 (1.3)	HAPLN4 (1.2)
MP:0011049	impaired adaptive thermogenesis	0.95	> 0.20	GPAM (3.7)	MOSC1 (3.5)	SORT1 (3.5)	TIMD4 (2.3)	ACAD10 (2.3)	OGDH (2.2)	GMPR (2.1)	ALDH2 (1.7)	GOT2P1 (1.6)	SYPL2 (1.6)
GO:0022900	electron transport chain	0.95	> 0.20	OGDH (3.5)	ACAD10 (3.3)	GOT2P1 (3.2)	TRAPPC6A (3.0)	C12orf47 (2.9)	TMEM116 (1.7)	FRK (1.7)	ENSG00000238078 (1.6)	C19orf52 (1.4)	TOMM40 (1.3)
GO:0005578	proteinaceous extracellular matrix	0.95	> 0.20	CILP2 (5.8)	PLEKHH2 (2.8)	BCAM (2.6)	APOE (1.9)	AP1M2 (1.7)	MAFB (1.3)	NPC1L1 (1.3)	KANK2 (1.2)	MOSC1 (1.1)	ABCG5 (1.0)
GO:0048247	lymphocyte chemotaxis	0.95	> 0.20	NKPD1 (2.1)	DYNC2LI1 (1.8)	ANKRD31 (1.7)	HAVCR1 (1.6)	ENSG00000254235 (1.3)	MAFB (1.3)	ENSG00000238078 (1.1)	RELB (1.1)	TMED4 (1.1)	CEACAM19 (1.0)
GO:0004690	cyclic nucleotide-dependent protein kinase activity	0.95	> 0.20	SYPL2 (2.8)	BRAP (2.7)	PTPN11 (2.5)	GMPR (2.3)	OGDH (2.3)	ENSG00000238078 (2.0)	ADAM1 (1.8)	ZHX3 (1.6)	SLC44A2 (1.4)	C12orf43 (1.4)
GO:0022401	negative adaptation of signaling pathway	0.95	> 0.20	BLOC1S3 (2.7)	ENSG00000226648 (2.6)	AMIGO1 (2.1)	C12orf47 (1.5)	ST3GAL4 (1.4)	POC5 (1.4)	NKPD1 (1.4)	CILP2 (1.3)	TSSK6 (1.2)	C17orf57 (1.1)
GO:0002029	desensitization of G-protein coupled receptor protein signaling pathway	0.95	> 0.20	BLOC1S3 (2.7)	ENSG00000226648 (2.6)	AMIGO1 (2.1)	C12orf47 (1.5)	ST3GAL4 (1.4)	POC5 (1.4)	NKPD1 (1.4)	CILP2 (1.3)	TSSK6 (1.2)	C17orf57 (1.1)
GO:0023058	adaptation of signaling pathway	0.95	> 0.20	BLOC1S3 (2.7)	ENSG00000226648 (2.6)	AMIGO1 (2.1)	C12orf47 (1.5)	ST3GAL4 (1.4)	POC5 (1.4)	NKPD1 (1.4)	CILP2 (1.3)	TSSK6 (1.2)	C17orf57 (1.1)
MP:0005191	head tilt	0.95	> 0.20	ITGB3 (2.2)	PMFBP1 (2.1)	TRIB1 (2.0)	HNF1A (2.0)	BCL3 (1.7)	TRAPPC6A (1.6)	ENSG00000228044 (1.5)	KIAA1324 (1.4)	RELB (1.4)	NT5DC1 (1.3)
GO:0032925	regulation of activin receptor signaling pathway	0.95	> 0.20	BLOC1S3 (2.3)	ZNF101 (2.0)	TMEM57 (1.5)	TMEM116 (1.5)	ENSG00000226645 (1.5)	TMEM50A (1.4)	PCSK9 (1.4)	ZNF180 (1.3)	ANKRD31 (1.3)	TMED4 (1.3)
GO:0042640	anagen	0.95	> 0.20	DNAH11 (2.0)	BLOC1S3 (1.9)	ANKRD31 (1.6)	CYB561D1 (1.6)	ENSG00000254235 (1.4)	ENSG00000226645 (1.3)	DOCK7 (1.1)	RPH3A (1.0)	NT5DC1 (1.0)	GMPR (0.8)
GO:0010927	cellular component assembly involved in morphogenesis	0.95	> 0.20	DYNC2LI1 (4.5)	SYPL2 (1.9)	TXNL4B (1.8)	CEACAM19 (1.5)	DNAH11 (1.4)	ENSG00000254235 (1.3)	UBXN2B (1.3)	ENSG00000226648 (1.1)	TMED4 (1.0)	PMFBP1 (0.8)
GO:0006914	autophagy	0.95	> 0.20	BRAP (3.5)	TMEM50A (2.8)	ACAD10 (2.4)	MAU2 (2.3)	YIPF2 (2.0)	C12orf51 (2.0)	C1orf63 (1.9)	TXNL4B (1.8)	TMEM57 (1.8)	TMEM116 (1.7)
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING	0.95	> 0.20	PBX4 (3.2)	ITGB3 (2.6)	USP24 (2.4)	PLCG1 (2.1)	GATAD2A (2.0)	SH2B3 (2.0)	ZNF101 (1.8)	TMEM50A (1.8)	NCAN (1.6)	SLC44A2 (1.5)
ENSG00000179344	HLA-DQB1 PPI subnetwork	0.95	> 0.20	PLCG1 (4.3)	ZNF101 (3.7)	ALDH2 (2.6)	KIAA1324 (1.8)	TIMD4 (1.8)	HAVCR1 (1.7)	CEACAM19 (1.5)	RHCE (1.4)	PBX4 (1.4)	MAFB (1.4)
GO:0045621	positive regulation of lymphocyte differentiation	0.95	> 0.20	PBX4 (3.6)	ZNF101 (3.0)	NKPD1 (1.7)	HLX (1.5)	MYLIP (1.4)	GMIP (1.4)	DNAH11 (1.3)	POLK (1.2)	ENSG00000226645 (1.2)	NT5DC1 (1.1)
ENSG00000164164	OTUD4 PPI subnetwork	0.95	> 0.20	C1orf63 (2.9)	BRAP (2.5)	POC5 (2.4)	COL4A3BP (2.4)	TMEM50A (2.1)	DHX38 (2.1)	DHODH (2.0)	SUGP1 (2.0)	ACAD10 (2.0)	GMPR (1.9)
ENSG00000164885	CDK5 PPI subnetwork	0.95	> 0.20	HAPLN4 (3.1)	RPH3A (3.0)	CELSR2 (2.0)	AMIGO1 (1.9)	NCAN (1.9)	PTPN11 (1.7)	DNM2 (1.6)	PLEC (1.5)	MARK4 (1.5)	ILF3 (1.3)
GO:0051640	organelle localization	0.95	> 0.20	POC5 (2.9)	PSRC1 (2.5)	YIPF2 (2.5)	DNM2 (1.9)	OGDH (1.6)	BUD13 (1.5)	DOCK7 (1.5)	POLK (1.4)	SORT1 (1.4)	GOT2P1 (1.4)
GO:0061082	myeloid leukocyte cytokine production	0.95	> 0.20	MAFB (3.4)	GCNT4 (2.1)	C12orf47 (1.6)	ENSG00000235545 (1.5)	QTRT1 (1.4)	ATXN7L2 (1.4)	APOE (1.2)	C19orf52 (1.0)	CETP (0.9)	SH2B3 (0.9)
ENSG00000134809	TIMM10 PPI subnetwork	0.95	> 0.20	DHODH (2.4)	GEMIN7 (2.1)	TOMM40 (2.0)	C12orf43 (1.8)	POC5 (1.8)	DDX56 (1.6)	C19orf52 (1.5)	TRAFD1 (1.5)	NAA25 (1.4)	AMIGO1 (1.4)
GO:0021515	cell differentiation in spinal cord	0.95	> 0.20	C12orf47 (3.6)	DNAH11 (2.8)	ATXN7L2 (2.7)	ANKRD31 (2.4)	NCAN (2.0)	NKPD1 (1.8)	DYNC2LI1 (1.4)	RPH3A (1.4)	GMPR (1.3)	PMFBP1 (1.3)
GO:0045841	negative regulation of mitotic metaphase/anaphase transition	0.95	> 0.20	POC5 (3.5)	PSRC1 (2.6)	GEMIN7 (2.5)	TMEM116 (1.9)	SUGP1 (1.8)	DOCK7 (1.7)	LPIN3 (1.6)	UBXN2B (1.5)	C1orf63 (1.3)	TMED4 (1.1)
MP:0000150	abnormal rib morphology	0.95	> 0.20	CILP2 (4.1)	NYNRIN (2.0)	PPP1R37 (1.6)	PLEKHH2 (1.5)	HLX (1.4)	PLEC (1.2)	PLCG1 (1.2)	ATXN7L2 (1.1)	GOT2P1 (1.0)	MAFB (1.0)
MP:0004835	abnormal miniature endplate potential	0.95	> 0.20	BCAM (2.6)	RPH3A (2.5)	SYPL2 (2.2)	AMIGO1 (2.1)	HAVCR1 (2.0)	PVR (2.0)	CILP2 (1.9)	C12orf47 (1.8)	LPIN3 (1.7)	HAPLN4 (1.6)
GO:0031114	regulation of microtubule depolymerization	0.95	> 0.20	POC5 (3.0)	DNAH11 (2.5)	LPAR2 (2.4)	CEACAM19 (2.3)	SLC44A2 (1.8)	C12orf47 (1.7)	NCAN (1.7)	MAPKAPK5 (1.5)	C19orf52 (1.2)	TMEM57 (1.2)
GO:0018345	protein palmitoylation	0.95	> 0.20	TMEM116 (2.5)	BRAP (2.5)	ADAM1 (2.1)	TXNL4B (2.0)	SYPL2 (1.8)	C17orf57 (1.8)	HAPLN4 (1.6)	MAPKAPK5 (1.6)	ENSG00000226645 (1.5)	TMED4 (1.5)
ENSG00000139132	FGD4 PPI subnetwork	0.95	> 0.20	ST3GAL4 (2.5)	RPH3A (2.3)	MARK4 (2.1)	PBX4 (1.9)	CLPTM1 (1.7)	COL4A3BP (1.7)	ADAM1 (1.6)	PLEC (1.6)	HLX (1.3)	SYPL2 (1.3)
ENSG00000173218	VANGL1 PPI subnetwork	0.95	> 0.20	AP1M2 (2.0)	PPP1R37 (2.0)	NYNRIN (1.9)	ABO (1.9)	MARK4 (1.9)	CBLC (1.7)	PLEC (1.7)	YIPF2 (1.6)	CARM1 (1.6)	LPAR2 (1.5)
GO:0047555	3',5'-cyclic-GMP phosphodiesterase activity	0.95	> 0.20	MOSC1 (1.8)	SORT1 (1.6)	DYNC2LI1 (1.5)	HAVCR1 (1.3)	AMIGO1 (1.3)	RHCE (1.2)	ENSG00000226648 (1.2)	TXNL4B (1.1)	ENSG00000238078 (1.0)	PVR (1.0)
GO:0015631	tubulin binding	0.95	> 0.20	C12orf51 (2.9)	LPAR2 (2.6)	PSRC1 (2.5)	PBX4 (2.4)	CELSR2 (2.1)	UBXN2B (1.9)	MAU2 (1.9)	POC5 (1.7)	SMARCA4 (1.6)	GRINA (1.6)
MP:0002747	abnormal aortic valve morphology	0.95	> 0.20	CEACAM19 (2.7)	TRIB1 (2.1)	PVR (2.0)	CILP2 (1.9)	PVRL2 (1.9)	NYNRIN (1.6)	TMED4 (1.6)	RPH3A (1.6)	BCAM (1.5)	TIMD4 (1.4)
ENSG00000090615	GOLGA3 PPI subnetwork	0.95	> 0.20	ST3GAL4 (2.5)	FRK (2.0)	TRAFD1 (1.8)	NT5DC1 (1.7)	MAU2 (1.7)	BLOC1S3 (1.4)	TRAPPC6A (1.4)	C12orf51 (1.3)	POC5 (1.3)	MAPKAPK5 (1.2)
GO:0045685	regulation of glial cell differentiation	0.95	> 0.20	NCAN (3.8)	ENSG00000254235 (2.6)	PBX4 (1.9)	ABO (1.8)	C11orf9 (1.7)	LPAR2 (1.6)	HAPLN4 (1.5)	PPP1R37 (1.3)	NYNRIN (1.2)	DNAH11 (1.1)
ENSG00000136044	APPL2 PPI subnetwork	0.95	> 0.20	TRAFD1 (2.2)	BLOC1S3 (1.8)	TOP1 (1.8)	PARP10 (1.6)	OASL (1.5)	MARK4 (1.4)	SARS (1.3)	COL4A3BP (1.3)	C19orf52 (1.2)	PTPN11 (1.2)
GO:0005184	neuropeptide hormone activity	0.95	> 0.20	ERP29 (2.6)	C12orf47 (2.5)	KIAA1324 (2.5)	ADAM1 (2.3)	PMFBP1 (1.7)	RHCE (1.4)	HAPLN4 (1.4)	NPC1L1 (1.4)	ATXN7L2 (1.3)	CILP2 (1.2)
MP:0000102	abnormal nasal bone morphology	0.95	> 0.20	CILP2 (3.3)	MYLIP (2.3)	KANK2 (1.6)	PSRC1 (1.5)	ST3GAL4 (1.4)	NYNRIN (1.4)	MOSC1 (1.2)	NCAN (1.2)	HAPLN4 (1.2)	ENSG00000238078 (1.1)
GO:0004065	arylsulfatase activity	0.95	> 0.20	HNF1A (2.3)	PARP10 (2.1)	PMFBP1 (1.7)	NKPD1 (1.6)	COL4A3BP (1.6)	CELSR2 (1.6)	ANKRD31 (1.5)	TMEM50A (1.3)	CILP2 (1.3)	RPH3A (1.3)
MP:0002766	situs inversus	0.95	> 0.20	DYNC2LI1 (4.4)	HAVCR1 (3.6)	HNF1A (2.2)	PBX4 (1.9)	UBXN2B (1.7)	LPIN3 (1.5)	ENSG00000238078 (1.5)	POLK (1.4)	MYLIP (1.4)	DNAH11 (1.3)
ENSG00000198851	CD3E PPI subnetwork	0.95	> 0.20	PLCG1 (3.6)	ZNF101 (3.2)	APOE (1.8)	C19orf52 (1.5)	PBX4 (1.5)	TIMD4 (1.5)	ALDH2 (1.5)	MARK4 (1.2)	HAVCR1 (1.2)	GMIP (1.1)
GO:0031111	negative regulation of microtubule polymerization or depolymerization	0.95	> 0.20	POC5 (2.4)	ENSG00000238078 (2.3)	CEACAM19 (2.0)	C17orf57 (2.0)	LPAR2 (2.0)	DNAH11 (2.0)	C12orf51 (1.7)	PBX4 (1.7)	C12orf47 (1.6)	NCAN (1.6)
MP:0005480	increased circulating triiodothyronine level	0.95	> 0.20	GOT2P1 (2.4)	ZHX3 (2.2)	AMIGO1 (2.0)	FRK (1.8)	TXNL4B (1.7)	CILP2 (1.7)	KIAA1324 (1.7)	NYNRIN (1.5)	TSSK6 (1.4)	SLC44A2 (1.4)
MP:0001706	abnormal left-right axis patterning	0.95	> 0.20	DYNC2LI1 (5.1)	DOCK7 (1.8)	UBXN2B (1.6)	PLEKHH2 (1.6)	COL4A3BP (1.2)	DNAH11 (1.1)	POC5 (1.1)	TMED4 (1.1)	ATXN2 (1.0)	C12orf43 (1.0)
KEGG_CALCIUM_SIGNALING_PATHWAY	KEGG_CALCIUM_SIGNALING_PATHWAY	0.95	> 0.20	RPH3A (2.5)	SYPL2 (2.5)	NCAN (2.3)	ABO (2.3)	AMIGO1 (2.1)	PLEKHH2 (2.0)	C12orf47 (1.9)	ZHX3 (1.8)	ST3GAL4 (1.5)	ITGB3 (1.4)
GO:0006754	ATP biosynthetic process	0.95	> 0.20	OGDH (2.5)	TMEM116 (2.3)	GOT2P1 (2.3)	HNF1A (2.1)	ENSG00000226648 (1.9)	SYPL2 (1.9)	HAPLN4 (1.8)	C1orf63 (1.6)	ACAD10 (1.6)	NKPD1 (1.5)
ENSG00000101901	ALG13 PPI subnetwork	0.95	> 0.20	MARK4 (2.8)	PPP1R37 (2.8)	ABO (2.2)	BCAM (2.1)	CARM1 (2.0)	SMARCA4 (1.5)	UBXN2B (1.5)	GATAD2A (1.5)	TOP1 (1.5)	ATXN2 (1.5)
MP:0003072	abnormal metatarsal bone morphology	0.95	> 0.20	CILP2 (2.8)	GOT2P1 (2.6)	MAFB (2.5)	NYNRIN (1.3)	LPIN3 (1.2)	NT5DC1 (1.0)	GMIP (1.0)	CEACAM19 (1.0)	GMPR (1.0)	DYNC2LI1 (0.9)
GO:0071295	cellular response to vitamin	0.95	> 0.20	C17orf57 (1.9)	LPAR2 (1.7)	MYLIP (1.7)	ENSG00000235545 (1.6)	AP1M2 (1.6)	PBX4 (1.5)	ZNF101 (1.5)	ZNF180 (1.4)	POLK (1.4)	CYB561D1 (1.2)
MP:0001147	small testis	0.95	> 0.20	PBX4 (2.2)	FEN1 (1.9)	TSSK6 (1.7)	ATXN7L2 (1.6)	USP1 (1.4)	ANKRD31 (1.4)	PLEKHH2 (1.2)	CEACAM19 (1.0)	KIAA1324 (1.0)	NT5DC1 (1.0)
ENSG00000068400	GRIPAP1 PPI subnetwork	0.95	> 0.20	HMGCR (2.3)	TMEM57 (2.3)	ENSG00000228044 (2.0)	ABO (1.5)	ENSG00000226645 (1.5)	BRAP (1.4)	RELB (1.4)	PVR (1.3)	MAPKAPK5 (1.3)	NCAN (1.2)
GO:0048853	forebrain morphogenesis	0.95	> 0.20	C17orf57 (4.2)	DYNC2LI1 (3.4)	ENSG00000235545 (2.7)	C12orf47 (1.6)	PLEKHH2 (1.5)	PBX4 (1.5)	ST3GAL4 (1.4)	DHODH (1.3)	C1orf63 (1.1)	NKPD1 (1.1)
GO:0001841	neural tube formation	0.95	> 0.20	DYNC2LI1 (3.3)	ATXN7L2 (2.6)	ADAM1 (2.3)	DOCK7 (2.2)	TMEM116 (1.8)	PLCG1 (1.8)	PVRL2 (1.7)	PPP1R37 (1.7)	MARK4 (1.6)	KANK2 (1.5)
GO:0060600	dichotomous subdivision of an epithelial terminal unit	0.95	> 0.20	ADAM1 (2.5)	ABO (2.2)	TSSK6 (2.1)	SLC44A2 (2.0)	PMFBP1 (2.0)	ENSG00000226648 (1.9)	NT5DC1 (1.7)	FRK (1.7)	CELSR2 (1.5)	LPAR2 (1.5)
REACTOME_G:PROTEIN_ACTIVATION	REACTOME_G:PROTEIN_ACTIVATION	0.95	> 0.20	ITGB3 (3.4)	TMEM50A (2.2)	CETP (1.7)	TXNL4B (1.5)	ENSG00000254235 (1.2)	TSSK6 (1.2)	NYNRIN (1.2)	KIAA1324 (1.0)	CYP7A1 (0.9)	ATXN7L2 (0.9)
GO:0043621	protein self-association	0.95	> 0.20	ATXN7L2 (3.3)	NT5DC1 (3.0)	RELB (2.7)	PLCG1 (2.6)	HAPLN4 (2.3)	MARK4 (2.1)	AMIGO1 (2.0)	TMED4 (1.7)	C19orf52 (1.7)	SYPL2 (1.5)
GO:0032026	response to magnesium ion	0.95	> 0.20	ENSG00000228044 (2.9)	PMFBP1 (2.5)	DNAH11 (2.0)	HNF1A (2.0)	ENSG00000226648 (2.0)	GOT2P1 (2.0)	ENSG00000254235 (1.2)	ANGPTL3 (1.2)	RHD (1.0)	ABO (1.0)
ENSG00000204842	ATXN2 PPI subnetwork	0.95	> 0.20	BRAP (2.8)	C12orf43 (2.7)	GMPR (2.1)	MAPKAPK5 (2.1)	NCAN (1.9)	NAA25 (1.8)	C12orf51 (1.8)	SMARCA4 (1.6)	DNM2 (1.6)	RHD (1.5)
GO:0033628	regulation of cell adhesion mediated by integrin	0.95	> 0.20	C11orf9 (2.0)	NKPD1 (1.7)	PVRL2 (1.7)	CETP (1.7)	PVR (1.7)	PLEKHH2 (1.6)	ENSG00000226645 (1.6)	HAPLN4 (1.4)	HNF1A (1.2)	ENSG00000226648 (1.1)
REACTOME_NETRIN:1_SIGNALING	REACTOME_NETRIN:1_SIGNALING	0.95	> 0.20	TMEM50A (2.4)	NCAN (2.3)	C11orf9 (2.2)	ABO (2.2)	GATAD2A (2.2)	USP24 (1.9)	PLCG1 (1.7)	ZHX3 (1.6)	PBX4 (1.6)	ITGB3 (1.5)
MP:0002423	abnormal mast cell physiology	0.95	> 0.20	PMFBP1 (1.7)	TIMD4 (1.5)	GMIP (1.4)	TRAPPC6A (1.3)	ST3GAL4 (1.3)	NYNRIN (1.2)	ENSG00000235545 (1.1)	GMPR (1.1)	PBX4 (1.1)	TMEM57 (1.1)
ENSG00000138814	PPP3CA PPI subnetwork	0.95	> 0.20	RPH3A (2.4)	CLPTM1 (2.2)	COL4A3BP (2.1)	PLEC (2.1)	SORT1 (1.6)	C1orf63 (1.5)	C12orf51 (1.4)	MARK4 (1.2)	OGDH (1.1)	UBXN2B (1.1)
GO:0006099	tricarboxylic acid cycle	0.95	> 0.20	OGDH (4.1)	ACAD10 (3.9)	GMPR (2.2)	ENSG00000226648 (2.0)	TMEM116 (1.8)	TMED4 (1.7)	C1orf63 (1.6)	PMFBP1 (1.5)	C19orf52 (1.4)	ENSG00000238078 (1.3)
GO:0009260	ribonucleotide biosynthetic process	0.95	> 0.20	SYPL2 (2.6)	ENSG00000226648 (2.5)	GOT2P1 (2.3)	OGDH (2.1)	TMEM116 (1.9)	ACAD10 (1.9)	PMFBP1 (1.7)	HAPLN4 (1.7)	AMIGO1 (1.6)	GCNT4 (1.6)
ENSG00000147869	CER1 PPI subnetwork	0.95	> 0.20	CBLC (2.6)	BCAM (2.1)	TSSK6 (2.1)	C11orf9 (1.9)	AP1M2 (1.6)	ABO (1.6)	HAPLN4 (1.4)	PLEKHH2 (1.1)	PBX4 (1.1)	PVRL2 (1.1)
MP:0003235	abnormal alisphenoid bone morphology	0.95	> 0.20	MYLIP (2.1)	MAFB (1.6)	LPIN3 (1.5)	TMEM57 (1.4)	PLCG1 (1.3)	BLOC1S3 (1.2)	MARK4 (1.1)	ZHX3 (1.1)	ST3GAL4 (1.1)	DNAH11 (1.0)
ENSG00000111237	VPS29 PPI subnetwork	0.95	> 0.20	ENSG00000226645 (2.7)	NPC1L1 (2.3)	DHODH (2.0)	ATXN2 (1.9)	C12orf51 (1.9)	UBXN2B (1.5)	NT5DC1 (1.5)	PMFBP1 (1.4)	COL4A3BP (1.3)	ZNF259 (1.3)
MP:0000531	right pulmonary isomerism	0.95	> 0.20	HAVCR1 (2.3)	PVRL2 (1.7)	ATXN2 (1.6)	TRAPPC6A (1.5)	GCNT4 (1.4)	MARK4 (1.4)	YIPF2 (1.3)	BCAM (1.3)	NYNRIN (1.2)	PCSK9 (1.2)
GO:0048934	peripheral nervous system neuron differentiation	0.95	> 0.20	TSSK6 (3.1)	PMFBP1 (2.6)	ENSG00000238078 (2.4)	DNAH11 (1.8)	ZNF180 (1.7)	COL4A3BP (1.4)	MAPKAPK5 (1.4)	ANKRD31 (1.3)	C12orf47 (1.3)	HAPLN4 (1.1)
GO:0048935	peripheral nervous system neuron development	0.95	> 0.20	TSSK6 (3.1)	PMFBP1 (2.6)	ENSG00000238078 (2.4)	DNAH11 (1.8)	ZNF180 (1.7)	COL4A3BP (1.4)	MAPKAPK5 (1.4)	ANKRD31 (1.3)	C12orf47 (1.3)	HAPLN4 (1.1)
GO:0001837	epithelial to mesenchymal transition	0.95	> 0.20	ABO (3.0)	MYLIP (2.5)	ENSG00000254235 (2.5)	ENSG00000226645 (2.2)	KANK2 (1.6)	GATAD2A (1.5)	MAFB (1.3)	TMEM57 (1.2)	CARM1 (1.2)	CYB561D1 (1.2)
MP:0003993	abnormal ventral spinal root morphology	0.95	> 0.20	HAPLN4 (5.1)	RPH3A (3.9)	AMIGO1 (2.7)	ALDH2 (2.0)	COL4A3BP (1.7)	SLC22A1 (1.5)	MAFB (1.4)	CYP7A1 (1.4)	ERP29 (1.3)	C12orf51 (1.2)
MP:0000966	decreased sensory neuron number	0.95	> 0.20	AMIGO1 (3.1)	PMFBP1 (3.0)	TSSK6 (2.9)	ABO (2.3)	CELSR2 (2.3)	KIAA1324 (2.2)	ENSG00000226648 (2.2)	MOSC1 (1.7)	LPIN3 (1.5)	OASL (1.4)
ENSG00000105402	NAPA PPI subnetwork	0.95	> 0.20	YIPF2 (2.9)	C1orf63 (2.9)	TMEM50A (2.8)	C19orf52 (2.0)	TM6SF2 (2.0)	NPC1L1 (1.8)	C12orf43 (1.8)	TMED4 (1.8)	CYB561D1 (1.7)	ZNF259 (1.6)
GO:0010165	response to X-ray	0.95	> 0.20	ZNF180 (3.1)	POLK (2.5)	UBXN2B (2.5)	TMEM116 (2.4)	POC5 (1.7)	C17orf57 (1.7)	ANKRD31 (1.6)	NT5DC1 (1.6)	CELSR2 (1.5)	ZNF101 (1.5)
ENSG00000006451	RALA PPI subnetwork	0.95	> 0.20	TMEM50A (2.3)	SLC44A2 (2.0)	DYNC2LI1 (2.0)	POLK (2.0)	MYLIP (2.0)	NT5DC1 (1.8)	UBXN2B (1.7)	DOCK7 (1.6)	SORT1 (1.5)	MAFB (1.5)
ENSG00000133103	COG6 PPI subnetwork	0.95	> 0.20	MAU2 (3.7)	SUGP1 (3.4)	YIPF2 (2.8)	TXNL4B (2.7)	CLPTM1 (2.6)	ATP13A1 (2.3)	MOSC1 (2.1)	C19orf52 (2.1)	POC5 (2.0)	ATXN7L2 (2.0)
ENSG00000065057	NTHL1 PPI subnetwork	0.95	> 0.20	DHODH (2.8)	DDX56 (1.7)	QTRT1 (1.6)	TRAPPC6A (1.4)	SYPL2 (1.3)	NT5DC1 (1.3)	TSSK6 (1.3)	BRAP (1.3)	ZHX3 (1.2)	NAA25 (1.2)
GO:0045055	regulated secretory pathway	0.95	> 0.20	CYB561D1 (2.7)	UBXN2B (2.1)	ALDH2 (1.9)	BLOC1S3 (1.8)	GMIP (1.7)	C17orf57 (1.3)	LPIN3 (1.3)	GEMIN7 (1.3)	LPAR2 (1.2)	DNAH11 (1.2)
ENSG00000074966	TXK PPI subnetwork	0.95	> 0.20	FADS2 (2.2)	SLC44A2 (2.0)	AP1M2 (1.9)	DNAH11 (1.8)	USP24 (1.7)	ZNF101 (1.6)	DOCK7 (1.4)	PBX4 (1.3)	TIMD4 (1.3)	BUD13 (1.3)
GO:0006704	glucocorticoid biosynthetic process	0.95	> 0.20	CYB561D1 (2.2)	TMEM116 (2.2)	ZNF180 (2.1)	NKPD1 (1.9)	PMFBP1 (1.9)	ST3GAL4 (1.9)	AMIGO1 (1.8)	ZHX3 (1.6)	ATXN7L2 (1.4)	FADS1 (1.4)
MP:0000857	abnormal cerebellar foliation	0.95	> 0.20	NCAN (2.5)	TMED4 (2.1)	DOCK7 (1.9)	PCSK9 (1.8)	FADS2 (1.6)	NYNRIN (1.4)	ZHX3 (1.4)	TMEM116 (1.3)	ALDH2 (1.2)	USP24 (1.1)
MP:0006069	abnormal retinal neuronal layer morphology	0.95	> 0.20	NCAN (2.4)	SORT1 (1.9)	PSRC1 (1.7)	GEMIN7 (1.5)	ATXN2 (1.4)	MYLIP (1.4)	ST3GAL4 (1.4)	CELSR2 (1.3)	GCNT4 (1.3)	PVR (1.1)
GO:0060078	regulation of postsynaptic membrane potential	0.95	> 0.20	RPH3A (2.9)	NCAN (2.6)	C12orf47 (2.6)	HAPLN4 (2.0)	PPP1R37 (2.0)	ENSG00000235545 (2.0)	DNAH11 (1.7)	C12orf43 (1.5)	ANKRD31 (1.5)	TMEM116 (1.4)
GO:0007492	endoderm development	0.95	> 0.20	ABO (3.1)	ENSG00000226648 (2.4)	TRIB1 (2.4)	LPAR2 (2.4)	TSSK6 (1.9)	COL4A3BP (1.6)	POLK (1.6)	C17orf57 (1.5)	C11orf9 (1.3)	ENSG00000254235 (1.2)
GO:0006949	syncytium formation	0.95	> 0.20	ZNF180 (2.8)	ENSG00000228044 (2.7)	GEMIN7 (2.4)	ATXN7L2 (2.0)	CYB561D1 (2.0)	MARK4 (1.5)	C11orf9 (1.4)	ZHX3 (1.3)	POLK (1.3)	NT5DC1 (1.2)
GO:0010576	metalloenzyme regulator activity	0.95	> 0.20	GPAM (2.5)	CILP2 (2.3)	C11orf9 (2.3)	DYNC2LI1 (2.2)	MOSC1 (2.1)	ST3GAL4 (1.9)	ENSG00000238078 (1.8)	TMEM116 (1.7)	NT5DC1 (1.5)	ANKRD31 (1.3)
GO:0014020	primary neural tube formation	0.95	> 0.20	ATXN7L2 (2.8)	DYNC2LI1 (2.8)	ADAM1 (2.3)	PVRL2 (2.1)	TMEM116 (2.1)	PPP1R37 (1.7)	DOCK7 (1.6)	MARK4 (1.5)	NYNRIN (1.4)	PLEKHH2 (1.4)
ENSG00000162946	DISC1 PPI subnetwork	0.95	> 0.20	C12orf51 (3.4)	SMARCA4 (3.3)	DOCK7 (3.1)	SARS (2.8)	ATXN2 (2.1)	RPH3A (2.1)	SUGP1 (1.8)	NCAN (1.8)	PLCG1 (1.7)	TMEM57 (1.7)
MP:0008037	abnormal T cell morphology	0.95	> 0.20	PLCG1 (4.8)	ZNF101 (3.3)	PBX4 (2.9)	PARP10 (2.2)	TIMD4 (1.5)	SMARCA4 (1.3)	GMIP (1.3)	PSMA5 (1.0)	RELB (1.0)	BCL3 (0.9)
MP:0001526	abnormal placing response	0.95	> 0.20	DYNC2LI1 (3.4)	FRK (2.6)	UBXN2B (2.1)	CELSR2 (2.1)	MYLIP (1.7)	AP1M2 (1.6)	TRAPPC6A (1.5)	APOE (1.5)	TMEM116 (1.4)	TXNL4B (1.4)
GO:0038032	termination of G-protein coupled receptor signaling pathway	0.95	> 0.20	ENSG00000226648 (3.2)	DNAH11 (2.0)	ZNF180 (1.9)	PMFBP1 (1.4)	SH2B3 (1.3)	NKPD1 (1.0)	CYB561D1 (1.0)	ENSG00000228044 (1.0)	GMPR (0.9)	NT5DC1 (0.9)
GO:0030804	positive regulation of cyclic nucleotide biosynthetic process	0.95	> 0.20	PMFBP1 (2.6)	AMIGO1 (2.3)	ABO (2.1)	ST3GAL4 (2.0)	GOT2P1 (1.8)	COL4A3BP (1.7)	PLEKHH2 (1.7)	LPIN3 (1.6)	C12orf47 (1.6)	ENSG00000228044 (1.5)
GO:0030810	positive regulation of nucleotide biosynthetic process	0.95	> 0.20	PMFBP1 (2.6)	AMIGO1 (2.3)	ABO (2.1)	ST3GAL4 (2.0)	GOT2P1 (1.8)	COL4A3BP (1.7)	PLEKHH2 (1.7)	LPIN3 (1.6)	C12orf47 (1.6)	ENSG00000228044 (1.5)
GO:0030331	estrogen receptor binding	0.95	> 0.20	PLCG1 (2.4)	ZHX3 (2.2)	COL4A3BP (2.2)	C12orf51 (1.6)	DYNC2LI1 (1.5)	ENSG00000226648 (1.4)	PTPN11 (1.4)	ENSG00000238078 (1.2)	TMEM57 (1.1)	MAFB (1.1)
ENSG00000169139	UBE2V2 PPI subnetwork	0.95	> 0.20	NCAN (3.0)	ZNF180 (2.8)	UBXN2B (2.1)	DNAH11 (2.1)	RPH3A (1.5)	C12orf43 (1.5)	C12orf47 (1.5)	HAVCR1 (1.5)	HAPLN4 (1.4)	SORT1 (1.3)
REACTOME_PACKAGING_OF_TELOMERE_ENDS	REACTOME_PACKAGING_OF_TELOMERE_ENDS	0.95	> 0.20	C19orf52 (2.2)	TXNL4B (2.2)	ENSG00000235545 (1.9)	GMPR (1.8)	BUD13 (1.5)	PSRC1 (1.5)	MYLIP (1.3)	SUGP1 (1.3)	TMEM57 (1.3)	ENSG00000226645 (1.3)
ENSG00000102081	FMR1 PPI subnetwork	0.95	> 0.20	TOP1 (4.2)	ILF3 (3.0)	ENSG00000226645 (2.8)	MARK4 (2.0)	C19orf52 (2.0)	CARM1 (1.9)	MAFB (1.8)	SMARCA4 (1.7)	NT5DC1 (1.6)	TMEM57 (1.5)
MP:0001849	ear inflammation	0.95	> 0.20	CBLC (2.6)	HAPLN4 (1.8)	TSSK6 (1.7)	CYP7A1 (1.5)	DNAH11 (1.5)	AP1M2 (1.4)	PLEKHH2 (1.4)	GEMIN7 (1.4)	CILP2 (1.3)	GOT2P1 (1.3)
ENSG00000169282	KCNAB1 PPI subnetwork	0.95	> 0.20	RPH3A (3.1)	HAPLN4 (3.1)	GOT2P1 (2.1)	C11orf9 (2.0)	GRINA (1.9)	C12orf43 (1.7)	BRAP (1.7)	SARS (1.6)	ALDH2 (1.5)	C1orf63 (1.5)
ENSG00000147123	NDUFB11 PPI subnetwork	0.95	> 0.20	OGDH (3.8)	ACAD10 (3.1)	C12orf47 (2.8)	TRAPPC6A (2.7)	MAU2 (1.6)	FRK (1.6)	GOT2P1 (1.5)	PSMA5 (1.5)	GMPR (1.4)	TMED4 (1.3)
GO:0005891	voltage-gated calcium channel complex	0.95	> 0.20	SYPL2 (2.6)	RPH3A (2.6)	KIAA1324 (2.5)	C12orf47 (2.4)	PLEKHH2 (2.4)	HAPLN4 (1.9)	ATXN7L2 (1.8)	AMIGO1 (1.6)	CARM1 (1.4)	PVR (1.4)
ENSG00000008300	CELSR3 PPI subnetwork	0.95	> 0.20	USP24 (2.8)	C12orf51 (2.4)	PLEC (2.1)	ALDH2 (1.8)	SH2B3 (1.8)	ABO (1.6)	GMIP (1.6)	MARK4 (1.5)	SORT1 (1.5)	ENSG00000235545 (1.5)
ENSG00000173327	MAP3K11 PPI subnetwork	0.95	> 0.20	MARK4 (3.0)	C11orf9 (2.5)	ILF3 (2.4)	SH2B3 (2.2)	DYNC2LI1 (2.2)	ATXN7L2 (2.2)	DNM2 (1.9)	PTPN11 (1.8)	CARM1 (1.6)	PLCG1 (1.6)
MP:0005018	decreased T cell number	0.95	> 0.20	ZNF101 (3.9)	PLCG1 (3.3)	GMIP (2.8)	PBX4 (2.5)	SLC44A2 (2.4)	TIMD4 (2.2)	GCNT4 (1.3)	TOP1 (1.1)	GRINA (1.1)	CETP (1.0)
MP:0009780	abnormal chondrocyte physiology	0.95	> 0.20	CILP2 (3.6)	KIAA1324 (2.2)	PLEC (1.9)	RHCE (1.8)	GPAM (1.8)	YIPF2 (1.7)	BCAM (1.7)	POLK (1.7)	TMEM50A (1.6)	TRAFD1 (1.6)
GO:0008366	axon ensheathment	0.95	> 0.20	C11orf9 (3.2)	HAPLN4 (2.6)	RPH3A (2.3)	NCAN (1.9)	SORT1 (1.9)	CELSR2 (1.6)	ANKRD31 (1.5)	NKPD1 (1.4)	PBX4 (1.3)	BCAM (1.3)
GO:0007272	ensheathment of neurons	0.95	> 0.20	C11orf9 (3.2)	HAPLN4 (2.6)	RPH3A (2.3)	NCAN (1.9)	SORT1 (1.9)	CELSR2 (1.6)	ANKRD31 (1.5)	NKPD1 (1.4)	PBX4 (1.3)	BCAM (1.3)
ENSG00000104517	UBR5 PPI subnetwork	0.95	> 0.20	ILF3 (2.8)	SMARCA4 (2.4)	KIAA1324 (1.7)	CARM1 (1.5)	TRAPPC6A (1.4)	C1orf63 (1.3)	HAVCR1 (1.3)	TOP1 (1.3)	DOCK7 (1.3)	ANKRD31 (1.2)
MP:0001906	increased dopamine level	0.95	> 0.20	CETP (2.7)	NCAN (2.5)	C12orf47 (2.1)	SLC44A2 (1.8)	ALDH2 (1.7)	LPA (1.7)	CELSR2 (1.6)	ZHX3 (1.6)	TMEM50A (1.5)	FADS2 (1.4)
ENSG00000180817	PPA1 PPI subnetwork	0.95	> 0.20	MARK4 (1.8)	NKPD1 (1.8)	GRINA (1.7)	C12orf47 (1.7)	PBX4 (1.7)	ZNF101 (1.6)	ILF3 (1.4)	OGDH (1.2)	BCAM (1.2)	TRIB1 (1.1)
GO:0030801	positive regulation of cyclic nucleotide metabolic process	0.95	> 0.20	PMFBP1 (2.5)	AMIGO1 (2.5)	ST3GAL4 (2.1)	ABO (2.1)	PLEKHH2 (1.8)	C12orf47 (1.7)	GOT2P1 (1.6)	COL4A3BP (1.5)	LPIN3 (1.5)	ENSG00000228044 (1.4)
ENSG00000115254	ENSG00000115254 PPI subnetwork	0.95	> 0.20	C19orf52 (2.6)	PSMA5 (2.6)	TMEM57 (2.2)	C12orf43 (2.1)	CARM1 (1.8)	ENSG00000235545 (1.7)	NT5DC1 (1.7)	C1orf63 (1.7)	AMIGO1 (1.6)	HMGCR (1.6)
GO:0008277	regulation of G-protein coupled receptor protein signaling pathway	0.95	> 0.20	NKPD1 (2.4)	ENSG00000226648 (2.2)	ZNF180 (1.8)	AMIGO1 (1.8)	BLOC1S3 (1.7)	CEACAM19 (1.6)	SH2B3 (1.6)	CETP (1.3)	POC5 (1.2)	RPH3A (1.2)
GO:0009206	purine ribonucleoside triphosphate biosynthetic process	0.95	> 0.20	ENSG00000226648 (2.5)	TMEM116 (2.4)	GOT2P1 (2.4)	OGDH (2.3)	SYPL2 (2.0)	HNF1A (1.9)	HAPLN4 (1.6)	DYNC2LI1 (1.6)	C1orf63 (1.6)	PMFBP1 (1.6)
GO:0003954	NADH dehydrogenase activity	0.95	> 0.20	OGDH (3.7)	ACAD10 (3.0)	C12orf47 (2.8)	TRAPPC6A (2.7)	FRK (1.6)	MAU2 (1.6)	GOT2P1 (1.5)	PSMA5 (1.5)	GMPR (1.4)	TMED4 (1.2)
GO:0008137	NADH dehydrogenase (ubiquinone) activity	0.95	> 0.20	OGDH (3.7)	ACAD10 (3.0)	C12orf47 (2.8)	TRAPPC6A (2.7)	FRK (1.6)	MAU2 (1.6)	GOT2P1 (1.5)	PSMA5 (1.5)	GMPR (1.4)	TMED4 (1.2)
GO:0050136	NADH dehydrogenase (quinone) activity	0.95	> 0.20	OGDH (3.7)	ACAD10 (3.0)	C12orf47 (2.8)	TRAPPC6A (2.7)	FRK (1.6)	MAU2 (1.6)	GOT2P1 (1.5)	PSMA5 (1.5)	GMPR (1.4)	TMED4 (1.2)
GO:0019205	nucleobase-containing compound kinase activity	0.95	> 0.20	DYNC2LI1 (3.1)	DNAH11 (2.2)	GCNT4 (2.0)	NT5DC1 (1.6)	C11orf9 (1.4)	TRAPPC6A (1.3)	OASL (1.3)	MAPKAPK5 (1.3)	PSRC1 (1.2)	POLK (1.2)
GO:0070227	lymphocyte apoptotic process	0.95	> 0.20	PBX4 (2.1)	ZNF101 (1.9)	TRAFD1 (1.8)	PARP10 (1.6)	GMIP (1.5)	ENSG00000226648 (1.4)	QTRT1 (1.4)	DNAH11 (1.4)	C17orf57 (1.3)	CYB561D1 (1.3)
ENSG00000163159	VPS72 PPI subnetwork	0.95	> 0.20	SMARCA4 (2.2)	BUD13 (2.0)	SUGP1 (1.9)	USP1 (1.8)	TXNL4B (1.7)	ZNF180 (1.5)	ILF3 (1.5)	GMPR (1.5)	PSRC1 (1.5)	MAPKAPK5 (1.4)
ENSG00000160695	ENSG00000160695 PPI subnetwork	0.95	> 0.20	ZNF259 (3.7)	BRAP (2.8)	MAPKAPK5 (2.7)	C12orf43 (2.6)	ACAD10 (2.3)	TRAFD1 (2.2)	SARS (2.1)	MARK4 (1.8)	SUGP1 (1.8)	DDX56 (1.7)
ENSG00000166862	CACNG2 PPI subnetwork	0.95	> 0.20	RPH3A (3.6)	PLEKHH2 (2.1)	KIAA1324 (1.9)	C11orf9 (1.9)	ADAM1 (1.8)	YIPF2 (1.7)	PPP1R37 (1.7)	ABO (1.5)	SORT1 (1.5)	CYB561D1 (1.3)
ENSG00000184640	SEPT9 PPI subnetwork	0.95	> 0.20	GATAD2A (2.6)	TMEM50A (2.3)	FRK (1.9)	ZNF101 (1.7)	NT5DC1 (1.7)	PLCG1 (1.6)	NCAN (1.5)	PTPN11 (1.5)	ADAM1 (1.5)	CILP2 (1.4)
GO:0072203	cell proliferation involved in metanephros development	0.95	> 0.20	GEMIN7 (2.4)	BCAM (2.3)	CYB561D1 (2.0)	PMFBP1 (2.0)	C11orf9 (1.9)	NYNRIN (1.8)	AMIGO1 (1.7)	TRIB1 (1.6)	ZNF101 (1.5)	TSSK6 (1.5)
MP:0000077	abnormal interparietal bone morphology	0.95	> 0.20	CILP2 (2.3)	MAFB (1.6)	GOT2P1 (1.4)	DYNC2LI1 (1.2)	ST3GAL4 (1.2)	MAU2 (1.2)	GCNT4 (1.1)	CEACAM19 (1.1)	TXNL4B (1.1)	PVRL2 (1.0)
GO:0006370	mRNA capping	0.95	> 0.20	GEMIN7 (3.4)	TXNL4B (3.1)	C12orf43 (3.0)	SUGP1 (2.5)	ZNF259 (2.1)	MAPKAPK5 (2.0)	TRAPPC6A (1.9)	QTRT1 (1.6)	BLOC1S3 (1.5)	MAU2 (1.3)
MP:0001096	abnormal glossopharyngeal ganglion morphology	0.95	> 0.20	C11orf9 (2.0)	TSSK6 (1.9)	BCAM (1.6)	POC5 (1.5)	PCSK9 (1.4)	FADS2 (1.4)	C19orf52 (1.4)	PVRL2 (1.3)	NYNRIN (1.3)	CBLC (1.2)
GO:0051592	response to calcium ion	0.95	> 0.20	TRIB1 (2.2)	DYNC2LI1 (1.6)	AMIGO1 (1.5)	TMEM50A (1.4)	AP1M2 (1.3)	ENSG00000226648 (1.3)	DNAH11 (1.2)	ADAM1 (1.2)	APOB (1.1)	ANKRD31 (1.1)
GO:0060271	cilium morphogenesis	0.95	> 0.20	DYNC2LI1 (6.9)	DOCK7 (2.3)	DNAH11 (2.1)	UBXN2B (1.3)	POLK (1.2)	TXNL4B (1.1)	PBX4 (1.0)	QTRT1 (0.9)	PLEKHH2 (0.9)	C12orf43 (0.9)
GO:0001968	fibronectin binding	0.95	> 0.20	CILP2 (4.8)	BCAM (2.4)	MAFB (2.2)	APOE (1.9)	TMEM116 (1.7)	PVRL2 (1.5)	FADS2 (1.4)	ENSG00000238078 (1.3)	MOSC1 (1.2)	FRK (1.1)
ENSG00000120658	ENOX1 PPI subnetwork	0.95	> 0.20	MAFB (2.6)	CYB561D1 (2.3)	LPIN3 (2.1)	ABCG8 (1.9)	ENSG00000226645 (1.8)	ABCG5 (1.8)	FRK (1.8)	LPAR2 (1.8)	HAPLN4 (1.8)	TM6SF2 (1.7)
ENSG00000213920	MDP1 PPI subnetwork	0.95	> 0.20	FRK (2.9)	TRAPPC6A (2.9)	MAPKAPK5 (2.1)	UBXN2B (2.0)	TMEM50A (2.0)	TRAFD1 (1.8)	LPIN3 (1.8)	BRAP (1.8)	DYNC2LI1 (1.7)	C12orf43 (1.6)
MP:0004399	abnormal cochlear outer hair cell morphology	0.95	> 0.20	NYNRIN (3.0)	MARK4 (2.4)	C11orf9 (1.9)	HAVCR1 (1.9)	LPAR2 (1.8)	HAPLN4 (1.6)	NKPD1 (1.5)	ANKRD31 (1.5)	TIMD4 (1.4)	CELSR2 (1.4)
ENSG00000131242	RAB11FIP4 PPI subnetwork	0.96	> 0.20	ITGB3 (2.2)	TSSK6 (2.2)	RHD (2.1)	DNAH11 (1.8)	DYNC2LI1 (1.7)	HAVCR1 (1.6)	POC5 (1.6)	RHCE (1.6)	POLK (1.6)	ENSG00000228044 (1.6)
GO:0005095	GTPase inhibitor activity	0.96	> 0.20	PLEC (2.4)	TMEM116 (2.4)	ZNF259 (2.0)	SLC44A2 (1.8)	PBX4 (1.8)	DNAH11 (1.7)	NT5DC1 (1.7)	MYLIP (1.6)	TRAPPC6A (1.4)	ILF3 (1.3)
ENSG00000162512	SDC3 PPI subnetwork	0.96	> 0.20	CILP2 (2.7)	NCAN (2.5)	APOE (1.8)	TIMD4 (1.8)	C17orf57 (1.7)	KANK2 (1.7)	FADS2 (1.4)	MAFB (1.3)	PLCG1 (1.3)	ZNF101 (1.3)
GO:0010634	positive regulation of epithelial cell migration	0.96	> 0.20	ENSG00000226648 (3.8)	HNF1A (3.6)	ADAM1 (2.2)	PVR (1.7)	ZHX3 (1.6)	TRAPPC6A (1.4)	PMFBP1 (1.4)	ENSG00000235545 (1.2)	TOP1 (1.2)	TMEM116 (1.2)
MP:0008535	enlarged lateral ventricles	0.96	> 0.20	NCAN (3.5)	NYNRIN (3.4)	DHODH (2.7)	OASL (2.6)	CELSR2 (2.4)	DOCK7 (2.1)	PSRC1 (1.8)	ENSG00000235545 (1.7)	MAPKAPK5 (1.7)	HMGCR (1.4)
ENSG00000135390	ATP5G2 PPI subnetwork	0.96	> 0.20	C12orf47 (3.7)	ACAD10 (3.0)	ERP29 (2.9)	PSMA5 (2.3)	OGDH (2.2)	SARS (2.2)	ALDH2 (1.9)	GMPR (1.7)	C12orf51 (1.7)	LPIN3 (1.7)
KEGG_PURINE_METABOLISM	KEGG_PURINE_METABOLISM	0.96	> 0.20	DHODH (2.3)	QTRT1 (1.9)	TXNL4B (1.8)	FEN1 (1.8)	POLK (1.5)	PSMA5 (1.5)	ZHX3 (1.4)	DDX56 (1.4)	DYNC2LI1 (1.2)	GOT2P1 (1.1)
GO:0008556	potassium-transporting ATPase activity	0.96	> 0.20	SYPL2 (4.3)	RPH3A (2.1)	AMIGO1 (1.8)	RHD (1.7)	NCAN (1.7)	HAPLN4 (1.7)	OASL (1.6)	OGDH (1.6)	C11orf9 (1.5)	TSSK6 (1.5)
ENSG00000148053	NTRK2 PPI subnetwork	0.96	> 0.20	PBX4 (4.1)	ZHX3 (2.8)	ZNF101 (2.6)	MARK4 (2.5)	RPH3A (2.1)	HAPLN4 (1.8)	SLC44A2 (1.7)	ADAM1 (1.7)	GATAD2A (1.5)	CETP (1.5)
ENSG00000103194	USP10 PPI subnetwork	0.96	> 0.20	NKPD1 (2.6)	CARM1 (2.5)	DHX38 (2.2)	GRINA (2.0)	C17orf57 (1.9)	SARS (1.8)	MARK4 (1.6)	MAU2 (1.5)	SMARCA4 (1.4)	CEACAM19 (1.3)
ENSG00000197312	DDI2 PPI subnetwork	0.96	> 0.20	QTRT1 (2.3)	C19orf52 (2.2)	SARS (2.0)	POLK (2.0)	ADAM1 (1.6)	HAPLN4 (1.6)	HAVCR1 (1.5)	PSMA5 (1.5)	C1orf63 (1.4)	C12orf47 (1.4)
MP:0002458	abnormal B cell number	0.96	> 0.20	GMIP (3.6)	TIMD4 (2.5)	RELB (1.7)	SLC44A2 (1.4)	SH2B3 (1.4)	OGDH (1.4)	C17orf57 (1.3)	ZNF101 (1.3)	PARP10 (1.3)	DNM2 (1.2)
GO:0030276	clathrin binding	0.96	> 0.20	AMIGO1 (2.7)	POLK (2.6)	KIAA1324 (2.2)	C1orf63 (2.0)	MYLIP (2.0)	TMEM57 (1.7)	GRINA (1.6)	YIPF2 (1.6)	CLPTM1 (1.4)	USP24 (1.4)
GO:0016504	peptidase activator activity	0.96	> 0.20	NT5DC1 (2.9)	ST3GAL4 (2.2)	PARP10 (2.0)	PCSK9 (2.0)	FRK (1.9)	MAPKAPK5 (1.8)	POLK (1.7)	ALDH2 (1.5)	CILP2 (1.3)	ENSG00000254235 (1.2)
ENSG00000167792	NDUFV1 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	C12orf47 (2.9)	TRAPPC6A (2.8)	ACAD10 (2.8)	MAU2 (1.8)	PSMA5 (1.6)	FRK (1.6)	TMED4 (1.5)	GOT2P1 (1.4)	GMPR (1.3)
MP:0008056	abnormal retinal ganglion cell morphology	0.96	> 0.20	CELSR2 (4.0)	PBX4 (2.9)	BCAM (2.0)	GCNT4 (2.0)	HAVCR1 (1.7)	LPAR2 (1.7)	PSRC1 (1.6)	MOSC1 (1.5)	ANKRD31 (1.5)	SLC44A2 (1.5)
MP:0008948	decreased neuron number	0.96	> 0.20	CELSR2 (2.9)	ZHX3 (2.6)	ABO (1.9)	MAPKAPK5 (1.7)	AMIGO1 (1.7)	ATXN2 (1.6)	HNF1A (1.5)	TMED4 (1.5)	NCAN (1.4)	SORT1 (1.4)
GO:0006298	mismatch repair	0.96	> 0.20	POC5 (2.9)	ANKRD31 (2.4)	TMEM116 (2.1)	ENSG00000226648 (1.9)	POLK (1.7)	C12orf47 (1.7)	C17orf57 (1.7)	ENSG00000235545 (1.6)	USP1 (1.5)	ZNF180 (1.5)
GO:0005242	inward rectifier potassium channel activity	0.96	> 0.20	HAPLN4 (3.1)	CYB561D1 (2.9)	CELSR2 (2.8)	RPH3A (2.7)	TMEM116 (2.4)	SORT1 (2.2)	PPP1R37 (1.8)	KIAA1324 (1.7)	GMPR (1.6)	ENSG00000228044 (1.6)
ENSG00000090266	NDUFB2 PPI subnetwork	0.96	> 0.20	OGDH (3.6)	ACAD10 (3.0)	C12orf47 (2.7)	TRAPPC6A (2.6)	MAU2 (1.7)	GOT2P1 (1.6)	PSMA5 (1.5)	FRK (1.5)	TMED4 (1.4)	GMPR (1.3)
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	0.96	> 0.20	CLPTM1 (2.8)	PPP1R37 (2.6)	YIPF2 (2.5)	MARK4 (2.4)	BLOC1S3 (2.1)	SARS (2.0)	C12orf43 (1.9)	ZHX3 (1.9)	AP1M2 (1.8)	COL4A3BP (1.8)
GO:0016505	apoptotic protease activator activity	0.96	> 0.20	POLK (3.1)	NT5DC1 (3.0)	ST3GAL4 (2.2)	C17orf57 (1.7)	PSRC1 (1.6)	UBXN2B (1.5)	C12orf43 (1.4)	FRK (1.4)	ZNF101 (1.3)	CEACAM19 (1.3)
GO:0035148	tube formation	0.96	> 0.20	DYNC2LI1 (3.1)	TMEM116 (2.1)	PPP1R37 (1.9)	PLEKHH2 (1.9)	LPAR2 (1.9)	DOCK7 (1.9)	PVRL2 (1.9)	AP1M2 (1.8)	ATXN7L2 (1.7)	CELSR2 (1.7)
ENSG00000165219	GAPVD1 PPI subnetwork	0.96	> 0.20	C12orf51 (3.4)	MARK4 (3.2)	GMIP (2.6)	SORT1 (2.4)	ATXN2 (2.4)	USP24 (2.1)	DNM2 (1.9)	PTPN11 (1.8)	BUD13 (1.8)	MAU2 (1.5)
GO:0022037	metencephalon development	0.96	> 0.20	CILP2 (2.2)	ANKRD31 (2.2)	DNAH11 (2.2)	ZHX3 (2.1)	DYNC2LI1 (2.1)	NCAN (1.9)	TMEM116 (1.8)	HAPLN4 (1.7)	CELSR2 (1.5)	C12orf51 (1.5)
ENSG00000078053	AMPH PPI subnetwork	0.96	> 0.20	NCAN (2.5)	RPH3A (2.4)	C12orf51 (2.0)	GRINA (1.9)	C12orf47 (1.8)	C1orf63 (1.6)	SARS (1.6)	NYNRIN (1.6)	CELSR2 (1.5)	ERP29 (1.5)
ENSG00000144285	SCN1A PPI subnetwork	0.96	> 0.20	DHX38 (3.3)	SUGP1 (3.3)	BUD13 (2.9)	NKPD1 (2.6)	SARS (2.3)	USP1 (2.0)	FEN1 (2.0)	ZNF180 (1.9)	NAA25 (1.7)	ILF3 (1.6)
ENSG00000143207	RFWD2 PPI subnetwork	0.96	> 0.20	BUD13 (2.3)	FEN1 (2.3)	NYNRIN (1.9)	GATAD2A (1.5)	TRIB1 (1.5)	ADAM1 (1.4)	TRAPPC6A (1.4)	KANK2 (1.4)	BLOC1S3 (1.3)	POLK (1.2)
ENSG00000075711	DLG1 PPI subnetwork	0.96	> 0.20	RPH3A (4.0)	CELSR2 (3.6)	C11orf9 (2.6)	SORT1 (2.3)	PPP1R37 (2.1)	NCAN (1.9)	CYB561D1 (1.4)	AMIGO1 (1.4)	GOT2P1 (1.3)	UBXN2B (1.3)
ENSG00000115286	NDUFS7 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	ACAD10 (3.0)	C12orf47 (2.8)	TRAPPC6A (2.6)	GOT2P1 (1.6)	MAU2 (1.5)	ADAM1 (1.5)	PSMA5 (1.5)	TMED4 (1.4)	FRK (1.3)
GO:0048704	embryonic skeletal system morphogenesis	0.96	> 0.20	NYNRIN (1.8)	CILP2 (1.7)	C19orf52 (1.6)	ATXN7L2 (1.6)	MYLIP (1.5)	PMFBP1 (1.5)	PLEKHH2 (1.5)	CEACAM19 (1.4)	ENSG00000238078 (1.3)	HLX (1.1)
MP:0008212	absent mature B cells	0.96	> 0.20	SMARCA4 (2.4)	GPAM (2.1)	ZNF101 (1.9)	GMIP (1.8)	DOCK7 (1.6)	ACAD10 (1.6)	ERP29 (1.5)	UBXN2B (1.5)	HLX (1.3)	FADS1 (1.3)
ENSG00000136861	CDK5RAP2 PPI subnetwork	0.96	> 0.20	ENSG00000226645 (2.7)	BUD13 (2.1)	PLCG1 (2.1)	LPAR2 (2.1)	TMEM116 (2.0)	HMGCR (1.9)	FADS1 (1.8)	CYB561D1 (1.8)	HAPLN4 (1.6)	UBXN2B (1.4)
GO:0009145	purine nucleoside triphosphate biosynthetic process	0.96	> 0.20	ENSG00000226648 (2.5)	TMEM116 (2.5)	GOT2P1 (2.3)	OGDH (2.3)	SYPL2 (2.0)	HNF1A (1.9)	DYNC2LI1 (1.6)	PBX4 (1.6)	PMFBP1 (1.6)	ACAD10 (1.6)
GO:0008060	ARF GTPase activator activity	0.96	> 0.20	PLCG1 (3.4)	SH2B3 (2.9)	ZHX3 (2.8)	C11orf9 (2.5)	HLX (2.4)	DNM2 (2.4)	PPP1R37 (2.1)	TRAFD1 (1.9)	GMIP (1.9)	PLEC (1.7)
GO:0000149	SNARE binding	0.96	> 0.20	RPH3A (2.4)	TMEM50A (2.4)	HNF1A (2.0)	HAPLN4 (1.9)	C12orf51 (1.7)	CYB561D1 (1.6)	AP1M2 (1.6)	AMIGO1 (1.6)	C1orf63 (1.6)	MARK4 (1.5)
MP:0003212	increased susceptibility to age related obesity	0.96	> 0.20	PMFBP1 (2.6)	C12orf47 (2.4)	C11orf9 (2.0)	ST3GAL4 (1.9)	ABO (1.6)	C1orf63 (1.6)	RHCE (1.4)	RHD (1.3)	PVR (1.3)	DYNC2LI1 (1.2)
GO:0042101	T cell receptor complex	0.96	> 0.20	PLCG1 (4.7)	ZNF101 (4.3)	GMIP (2.1)	SLC44A2 (1.7)	HAVCR1 (1.6)	MAFB (1.5)	TIMD4 (1.4)	ENSG00000228044 (1.1)	ALDH2 (1.0)	MARK4 (0.9)
ENSG00000127527	EPS15L1 PPI subnetwork	0.96	> 0.20	C12orf51 (2.6)	ENSG00000235545 (2.5)	DNM2 (2.3)	USP24 (1.9)	DOCK7 (1.7)	ENSG00000226645 (1.6)	GMPR (1.6)	TRIB1 (1.6)	PPP1R37 (1.6)	CETP (1.6)
ENSG00000130299	GTPBP3 PPI subnetwork	0.96	> 0.20	ATP13A1 (2.0)	KANK2 (1.6)	C12orf51 (1.5)	DYNC2LI1 (1.4)	POLK (1.3)	SUGP1 (1.2)	PBX4 (1.2)	DHODH (1.2)	GPAM (1.1)	TOMM40 (1.1)
ENSG00000167286	CD3D PPI subnetwork	0.96	> 0.20	PLCG1 (2.4)	APOE (2.2)	ZNF101 (2.1)	CEACAM19 (1.7)	C19orf52 (1.4)	ADAM1 (1.2)	HAVCR1 (1.2)	ABCG8 (1.1)	APOC1 (1.1)	PARP10 (0.9)
GO:0015879	carnitine transport	0.96	> 0.20	C19orf52 (2.6)	PBX4 (2.0)	DOCK7 (1.8)	MOSC1 (1.8)	ACAD10 (1.7)	OGDH (1.6)	AMIGO1 (1.4)	BRAP (1.4)	TSSK6 (1.4)	LPAR2 (1.4)
GO:0015838	betaine transport	0.96	> 0.20	C19orf52 (2.6)	PBX4 (2.0)	DOCK7 (1.8)	MOSC1 (1.8)	ACAD10 (1.7)	OGDH (1.6)	AMIGO1 (1.4)	BRAP (1.4)	TSSK6 (1.4)	LPAR2 (1.4)
ENSG00000072315	TRPC5 PPI subnetwork	0.96	> 0.20	OASL (4.1)	PARP10 (2.9)	TMEM50A (1.9)	C12orf51 (1.8)	KANK2 (1.7)	C11orf9 (1.7)	PSRC1 (1.6)	GCNT4 (1.5)	GATAD2A (1.5)	PLCG1 (1.4)
GO:0004707	MAP kinase activity	0.96	> 0.20	PLCG1 (2.7)	MARK4 (2.2)	ENSG00000226648 (2.2)	TMEM57 (1.9)	MAPKAPK5 (1.7)	ITGB3 (1.7)	RPH3A (1.6)	GATAD2A (1.5)	ZHX3 (1.5)	ST3GAL4 (1.4)
MP:0010107	abnormal renal reabsorbtion	0.96	> 0.20	HAVCR1 (4.4)	ABO (3.9)	PLG (2.9)	TMEM116 (2.8)	ANGPTL3 (2.4)	SYPL2 (2.2)	AP1M2 (1.8)	TM6SF2 (1.8)	TMED4 (1.3)	SLC22A1 (1.2)
GO:0045271	respiratory chain complex I	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.1)	C12orf47 (2.7)	TRAPPC6A (2.7)	MAU2 (1.7)	PSMA5 (1.7)	GOT2P1 (1.5)	FRK (1.5)	TMED4 (1.4)	GMPR (1.3)
GO:0030964	NADH dehydrogenase complex	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.1)	C12orf47 (2.7)	TRAPPC6A (2.7)	MAU2 (1.7)	PSMA5 (1.7)	GOT2P1 (1.5)	FRK (1.5)	TMED4 (1.4)	GMPR (1.3)
GO:0005747	mitochondrial respiratory chain complex I	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.1)	C12orf47 (2.7)	TRAPPC6A (2.7)	MAU2 (1.7)	PSMA5 (1.7)	GOT2P1 (1.5)	FRK (1.5)	TMED4 (1.4)	GMPR (1.3)
GO:0032839	dendrite cytoplasm	0.96	> 0.20	ABO (2.3)	TM6SF2 (2.2)	C19orf52 (1.9)	TIMD4 (1.7)	TRAPPC6A (1.7)	DOCK7 (1.7)	NKPD1 (1.7)	PSMA5 (1.5)	CYB561D1 (1.5)	ENSG00000235545 (1.5)
GO:0048339	paraxial mesoderm development	0.96	> 0.20	CEACAM19 (2.7)	FRK (2.3)	TMEM116 (2.2)	CYB561D1 (2.2)	PLCG1 (2.0)	LPIN3 (2.0)	ENSG00000254235 (1.7)	HAVCR1 (1.7)	DYNC2LI1 (1.6)	DOCK7 (1.6)
MP:0003990	decreased neurotransmitter release	0.96	> 0.20	RPH3A (3.2)	AMIGO1 (2.9)	HAPLN4 (2.7)	BCAM (2.0)	BLOC1S3 (1.9)	GRINA (1.7)	MARK4 (1.6)	C12orf47 (1.5)	ANKRD31 (1.5)	C12orf43 (1.4)
ENSG00000198648	STK39 PPI subnetwork	0.96	> 0.20	C11orf9 (3.5)	HAPLN4 (2.8)	PTPN11 (2.0)	RPH3A (2.0)	NT5DC1 (1.9)	ALDH2 (1.9)	ST3GAL4 (1.9)	SORT1 (1.8)	ENSG00000226648 (1.8)	MOSC1 (1.7)
MP:0004610	small vertebrae	0.96	> 0.20	FRK (2.2)	NPC1L1 (1.8)	ENSG00000235545 (1.8)	APOB (1.5)	HNF1A (1.4)	GEMIN7 (1.4)	PLEKHH2 (1.3)	C17orf57 (1.2)	TMEM57 (1.2)	HAVCR1 (1.2)
GO:0009954	proximal/distal pattern formation	0.96	> 0.20	DNAH11 (2.5)	PLEKHH2 (2.3)	ANKRD31 (2.3)	BLOC1S3 (2.1)	TSSK6 (1.9)	ENSG00000228044 (1.8)	C19orf52 (1.7)	NYNRIN (1.6)	ATXN7L2 (1.5)	PCSK9 (1.4)
GO:0000139	Golgi membrane	0.96	> 0.20	YIPF2 (4.9)	TMEM50A (3.4)	TMED4 (3.1)	CLPTM1 (2.5)	TMEM57 (2.4)	ERP29 (2.3)	KIAA1324 (2.2)	ST3GAL4 (2.2)	CYB561D1 (2.2)	SLC44A2 (2.0)
MP:0002920	decreased paired-pulse facilitation	0.96	> 0.20	RPH3A (3.5)	ABO (2.5)	HAVCR1 (2.4)	C12orf47 (2.3)	AMIGO1 (2.3)	HAPLN4 (1.4)	DNAH11 (1.3)	KIAA1324 (1.1)	TMEM50A (0.9)	UBXN2B (0.9)
GO:0030031	cell projection assembly	0.96	> 0.20	DYNC2LI1 (4.3)	DOCK7 (2.9)	PBX4 (2.4)	PLEC (2.3)	POLK (2.0)	C11orf9 (1.4)	COL4A3BP (1.4)	C12orf47 (1.2)	ST3GAL4 (1.1)	ENSG00000238078 (1.1)
GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	0.96	> 0.20	ENSG00000226645 (2.6)	C19orf52 (2.6)	C11orf9 (1.9)	CEACAM19 (1.7)	KANK2 (1.4)	ALDH2 (1.4)	BLOC1S3 (1.4)	CARM1 (1.2)	TMED4 (1.2)	YIPF2 (1.2)
GO:0051153	regulation of striated muscle cell differentiation	0.96	> 0.20	CEACAM19 (2.7)	ANKRD31 (2.0)	LPIN3 (2.0)	HNF1A (1.8)	GEMIN7 (1.8)	SYPL2 (1.7)	PMFBP1 (1.6)	ENSG00000226648 (1.5)	TXNL4B (1.5)	AP1M2 (1.4)
REACTOME_G_BETAGAMMA_SIGNALLING_THROUGH_PLC_BETA	REACTOME_G_BETAGAMMA_SIGNALLING_THROUGH_PLC_BETA	0.96	> 0.20	ITGB3 (2.6)	TMEM50A (1.7)	C1orf63 (1.6)	TM6SF2 (1.5)	ENSG00000254235 (1.4)	ABO (1.4)	HLX (1.2)	CETP (1.1)	COL4A3BP (1.1)	ACAD10 (1.0)
GO:0005201	extracellular matrix structural constituent	0.96	> 0.20	CILP2 (6.3)	BCAM (2.8)	PLEKHH2 (2.1)	AP1M2 (1.9)	SLC44A2 (1.8)	MOSC1 (1.4)	APOE (1.3)	ABO (1.2)	MYLIP (1.1)	CELSR2 (1.1)
MP:0004924	abnormal behavior	0.96	> 0.20	C12orf51 (2.5)	RPH3A (2.2)	CELSR2 (2.2)	ABCG8 (2.0)	PLCG1 (1.9)	PBX4 (1.9)	ZHX3 (1.5)	TM6SF2 (1.4)	LPA (1.2)	GPAM (1.2)
ENSG00000174307	PHLDA3 PPI subnetwork	0.96	> 0.20	SARS (3.7)	ZNF259 (3.5)	DDX56 (2.7)	NAA25 (2.6)	ATP13A1 (2.6)	PSMA5 (2.5)	QTRT1 (2.1)	ERP29 (2.0)	DHX38 (1.9)	FEN1 (1.6)
ENSG00000131626	PPFIA1 PPI subnetwork	0.96	> 0.20	C11orf9 (2.1)	MARK4 (2.1)	PTPN11 (1.9)	TMEM116 (1.8)	CBLC (1.8)	GOT2P1 (1.8)	NCAN (1.7)	PBX4 (1.7)	CILP2 (1.6)	LPA (1.5)
GO:0006613	cotranslational protein targeting to membrane	0.96	> 0.20	YIPF2 (3.8)	ERP29 (3.4)	TMEM50A (2.8)	ENSG00000226645 (2.6)	TMEM57 (2.4)	FRK (2.0)	TMED4 (2.0)	NKPD1 (1.8)	ZNF101 (1.8)	C19orf52 (1.6)
GO:0032732	positive regulation of interleukin-1 production	0.96	> 0.20	CYB561D1 (2.1)	TMEM116 (1.6)	TRAFD1 (1.6)	C12orf43 (1.5)	ENSG00000238078 (1.4)	NKPD1 (1.3)	ST3GAL4 (1.3)	CEACAM19 (1.3)	ALDH2 (1.3)	MAFB (1.2)
ENSG00000134086	VHL PPI subnetwork	0.96	> 0.20	TMEM50A (2.9)	TOMM40 (2.5)	PSMA5 (2.4)	CLPTM1 (2.1)	ERP29 (1.8)	GATAD2A (1.8)	SARS (1.8)	NT5DC1 (1.6)	USP1 (1.5)	ADAM1 (1.5)
GO:0014033	neural crest cell differentiation	0.96	> 0.20	ENSG00000254235 (3.0)	TSSK6 (2.0)	PLEKHH2 (1.6)	CBLC (1.5)	DOCK7 (1.5)	DYNC2LI1 (1.3)	ZNF101 (1.2)	BCAM (1.1)	LPIN3 (1.1)	SLC44A2 (1.1)
MP:0001501	abnormal sleep pattern	0.96	> 0.20	ZHX3 (2.5)	ABCG5 (2.4)	PMFBP1 (2.3)	TRIB1 (2.2)	ENSG00000226645 (2.1)	HAPLN4 (2.0)	GPAM (1.7)	MOSC1 (1.5)	TM6SF2 (1.5)	PBX4 (1.5)
GO:0015078	hydrogen ion transmembrane transporter activity	0.96	> 0.20	TMEM116 (3.0)	OGDH (3.0)	ACAD10 (2.4)	SORT1 (2.2)	COL4A3BP (1.9)	ENSG00000238078 (1.8)	GMPR (1.7)	ERP29 (1.6)	TMED4 (1.5)	CLPTM1 (1.5)
GO:0071173	spindle assembly checkpoint	0.96	> 0.20	POC5 (3.8)	PSRC1 (2.9)	GEMIN7 (2.4)	UBXN2B (1.7)	SUGP1 (1.7)	TMEM116 (1.6)	DOCK7 (1.6)	LPIN3 (1.4)	C1orf63 (1.3)	USP1 (1.1)
GO:0030510	regulation of BMP signaling pathway	0.96	> 0.20	ENSG00000254235 (2.1)	ENSG00000226645 (1.9)	C19orf52 (1.9)	PVRL2 (1.6)	LPAR2 (1.6)	ABO (1.6)	KANK2 (1.5)	NYNRIN (1.4)	ENSG00000238078 (1.3)	CARM1 (1.2)
GO:0042613	MHC class II protein complex	0.96	> 0.20	ALDH2 (3.0)	APOC1 (2.2)	APOE (2.1)	PARP10 (2.0)	YIPF2 (1.7)	SH2B3 (1.5)	MYLIP (1.3)	DOCK7 (1.2)	MAU2 (1.1)	DHODH (1.1)
GO:0003007	heart morphogenesis	0.96	> 0.20	ENSG00000238078 (2.3)	CILP2 (1.8)	C11orf9 (1.7)	PVRL2 (1.7)	NYNRIN (1.6)	C19orf52 (1.4)	ALDH2 (1.3)	CARM1 (1.2)	BCAM (1.2)	LPAR2 (1.2)
ENSG00000033627	ATP6V0A1 PPI subnetwork	0.96	> 0.20	GRINA (3.7)	SARS (2.6)	COL4A3BP (2.3)	SORT1 (2.1)	ENSG00000238078 (1.9)	APOE (1.9)	UBXN2B (1.7)	HAPLN4 (1.5)	BLOC1S3 (1.4)	TXNL4B (1.4)
GO:0031577	spindle checkpoint	0.96	> 0.20	POC5 (3.6)	PSRC1 (2.9)	TMEM116 (2.3)	GEMIN7 (1.9)	UBXN2B (1.8)	SUGP1 (1.8)	DOCK7 (1.5)	LPIN3 (1.3)	C1orf63 (1.3)	USP1 (1.2)
REACTOME_FGFR3C_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR3C_LIGAND_BINDING_AND_ACTIVATION	0.96	> 0.20	C11orf9 (3.2)	PVR (2.4)	BCAM (2.0)	PLEKHH2 (1.8)	PVRL2 (1.8)	ENSG00000226645 (1.8)	TSSK6 (1.7)	ALDH2 (1.6)	ANKRD31 (1.5)	CEACAM19 (1.4)
REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION	0.96	> 0.20	C11orf9 (3.2)	PVR (2.4)	BCAM (2.0)	PLEKHH2 (1.8)	PVRL2 (1.8)	ENSG00000226645 (1.8)	TSSK6 (1.7)	ALDH2 (1.6)	ANKRD31 (1.5)	CEACAM19 (1.4)
GO:0031116	positive regulation of microtubule polymerization	0.96	> 0.20	ANKRD31 (2.4)	POC5 (2.1)	UBXN2B (2.1)	POLK (2.1)	CELSR2 (1.9)	BLOC1S3 (1.8)	PBX4 (1.7)	GEMIN7 (1.5)	SORT1 (1.5)	CYB561D1 (1.3)
ENSG00000110841	PPFIBP1 PPI subnetwork	0.96	> 0.20	MYLIP (2.6)	PLEC (2.6)	PTPN11 (2.5)	AP1M2 (2.0)	TMEM116 (1.9)	TMEM50A (1.8)	TSSK6 (1.6)	ENSG00000238078 (1.6)	ENSG00000226648 (1.6)	PLCG1 (1.4)
ENSG00000077782	FGFR1 PPI subnetwork	0.96	> 0.20	ENSG00000226645 (3.4)	LPAR2 (2.9)	PLEKHH2 (2.3)	UBXN2B (2.2)	ABO (1.9)	HNF1A (1.5)	ZNF101 (1.4)	PTPN11 (1.4)	PCSK9 (1.3)	GPAM (1.3)
ENSG00000111752	PHC1 PPI subnetwork	0.96	> 0.20	USP1 (2.7)	TRAFD1 (2.6)	CELSR2 (2.2)	MARK4 (2.0)	PSRC1 (2.0)	AMIGO1 (1.8)	ILF3 (1.6)	CYB561D1 (1.6)	PPP1R37 (1.5)	GATAD2A (1.5)
ENSG00000130592	LSP1 PPI subnetwork	0.96	> 0.20	LPIN3 (2.5)	NKPD1 (2.2)	BCL3 (2.0)	NT5DC1 (1.9)	DYNC2LI1 (1.7)	ACAD10 (1.6)	ATP13A1 (1.4)	ZNF259 (1.3)	PVR (1.2)	ATXN7L2 (1.1)
ENSG00000183648	NDUFB1 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	ACAD10 (3.1)	TRAPPC6A (2.9)	C12orf47 (2.8)	MAU2 (1.9)	FRK (1.7)	PSMA5 (1.6)	GOT2P1 (1.5)	GMPR (1.4)	TMED4 (1.3)
GO:0009452	RNA capping	0.96	> 0.20	GEMIN7 (3.8)	TXNL4B (3.1)	C12orf43 (2.9)	SUGP1 (2.5)	ZNF259 (2.1)	MAPKAPK5 (2.1)	TRAPPC6A (2.0)	QTRT1 (1.5)	ENSG00000226645 (1.5)	BLOC1S3 (1.3)
ENSG00000128654	MTX2 PPI subnetwork	0.96	> 0.20	GOT2P1 (2.5)	ATXN2 (2.4)	OGDH (2.4)	DHODH (2.1)	C19orf52 (2.0)	TMEM57 (1.8)	C17orf57 (1.6)	PSMA5 (1.5)	MAPKAPK5 (1.4)	TOMM40 (1.4)
GO:0046356	acetyl-CoA catabolic process	0.96	> 0.20	OGDH (4.1)	ACAD10 (3.9)	ENSG00000226648 (2.2)	TMEM116 (2.1)	GMPR (2.1)	ENSG00000238078 (1.7)	PMFBP1 (1.7)	C1orf63 (1.6)	NT5DC1 (1.5)	C19orf52 (1.5)
GO:0021514	ventral spinal cord interneuron differentiation	0.96	> 0.20	DNAH11 (2.1)	CYB561D1 (1.7)	ATXN7L2 (1.7)	HAPLN4 (1.6)	TSSK6 (1.5)	PPP1R37 (1.5)	C12orf47 (1.4)	TMEM116 (1.4)	NCAN (1.4)	GOT2P1 (1.3)
GO:0009219	pyrimidine deoxyribonucleotide metabolic process	0.96	> 0.20	ANKRD31 (2.8)	TXNL4B (1.8)	TMEM116 (1.7)	DYNC2LI1 (1.7)	TSSK6 (1.7)	ADAM1 (1.5)	BRAP (1.4)	OASL (1.4)	AMIGO1 (1.4)	C1orf63 (1.4)
GO:0005942	phosphatidylinositol 3-kinase complex	0.96	> 0.20	GMIP (2.8)	DNM2 (2.6)	COL4A3BP (2.4)	TMEM57 (2.3)	POC5 (2.1)	SMARCA4 (1.9)	CELSR2 (1.9)	USP24 (1.8)	LPAR2 (1.7)	ZHX3 (1.7)
ENSG00000133703	KRAS PPI subnetwork	0.96	> 0.20	GMIP (2.7)	COL4A3BP (2.3)	MAU2 (1.7)	MYLIP (1.6)	TOP1 (1.5)	TSSK6 (1.5)	USP24 (1.4)	UBXN2B (1.4)	GOT2P1 (1.4)	SH2B3 (1.4)
GO:0030296	protein tyrosine kinase activator activity	0.96	> 0.20	AP1M2 (3.2)	ITGB3 (2.7)	OASL (2.6)	SLC22A1 (2.3)	LPIN3 (2.2)	C12orf43 (1.7)	ABCG8 (1.6)	KIAA1324 (1.6)	CEACAM19 (1.5)	C17orf57 (1.5)
MP:0004672	short ribs	0.96	> 0.20	SYPL2 (4.1)	CILP2 (3.0)	HNF1A (2.1)	GOT2P1 (1.6)	UBXN2B (1.5)	PCSK9 (1.5)	PLEKHH2 (1.5)	HLX (1.2)	ALDH2 (1.2)	CARM1 (1.0)
MP:0001825	arrested T cell differentiation	0.96	> 0.20	PLCG1 (5.4)	ZNF101 (4.8)	SMARCA4 (2.3)	GMIP (2.1)	PBX4 (1.7)	TIMD4 (1.7)	GCNT4 (1.4)	CETP (1.4)	ADAM1 (1.1)	SLC44A2 (1.1)
GO:0060914	heart formation	0.96	> 0.20	ENSG00000238078 (2.3)	LPIN3 (2.1)	COL4A3BP (2.0)	DNAH11 (1.9)	ANKRD31 (1.8)	NYNRIN (1.8)	DYNC2LI1 (1.8)	ALDH2 (1.7)	BLOC1S3 (1.7)	GMPR (1.3)
GO:0003401	axis elongation	0.96	> 0.20	PLEKHH2 (3.1)	C19orf52 (2.2)	ENSG00000254235 (2.0)	KIAA1324 (1.7)	DYNC2LI1 (1.7)	PPP1R37 (1.4)	LPAR2 (1.4)	ABO (1.3)	NYNRIN (1.3)	MYLIP (1.2)
MP:0000066	osteoporosis	0.96	> 0.20	FRK (2.3)	ATP13A1 (2.1)	KIAA1324 (1.9)	CILP2 (1.8)	SLC44A2 (1.7)	CLPTM1 (1.7)	PVR (1.7)	CYB561D1 (1.7)	YIPF2 (1.5)	ZHX3 (1.4)
ENSG00000105963	ADAP1 PPI subnetwork	0.96	> 0.20	GCNT4 (2.7)	C1orf63 (2.3)	PTPN11 (1.7)	QTRT1 (1.6)	TOP1 (1.6)	ENSG00000235545 (1.5)	KIAA1324 (1.5)	CELSR2 (1.5)	DHODH (1.5)	NKPD1 (1.4)
GO:0002087	regulation of respiratory gaseous exchange by neurological system process	0.96	> 0.20	ANKRD31 (4.3)	NCAN (2.9)	TSSK6 (2.7)	UBXN2B (2.6)	ENSG00000226648 (2.5)	HAVCR1 (2.4)	C17orf57 (2.3)	HAPLN4 (2.1)	AMIGO1 (2.1)	RPH3A (1.9)
GO:0044065	regulation of respiratory system process	0.96	> 0.20	ANKRD31 (4.3)	NCAN (2.9)	TSSK6 (2.7)	UBXN2B (2.6)	ENSG00000226648 (2.5)	HAVCR1 (2.4)	C17orf57 (2.3)	HAPLN4 (2.1)	AMIGO1 (2.1)	RPH3A (1.9)
GO:0003211	cardiac ventricle formation	0.96	> 0.20	NYNRIN (3.3)	HLX (2.1)	NCAN (1.9)	BLOC1S3 (1.9)	LPIN3 (1.9)	C17orf57 (1.7)	DNAH11 (1.7)	MARK4 (1.5)	ATXN7L2 (1.5)	ENSG00000238078 (1.4)
MP:0002276	abnormal lung interstitium morphology	0.96	> 0.20	LPIN3 (2.6)	CBLC (2.3)	ZHX3 (2.0)	GRINA (1.7)	TMEM116 (1.6)	PARP10 (1.6)	AMIGO1 (1.6)	HP (1.6)	TOP1 (1.5)	CYP7A1 (1.4)
MP:0002637	small uterus	0.96	> 0.20	KIAA1324 (2.6)	PMFBP1 (2.3)	GCNT4 (2.0)	TRIB1 (1.6)	YIPF2 (1.5)	ENSG00000226645 (1.5)	OASL (1.4)	ENSG00000226648 (1.4)	TMED4 (1.2)	NT5DC1 (1.1)
GO:0043010	camera-type eye development	0.96	> 0.20	NYNRIN (2.1)	LPIN3 (1.5)	GOT2P1 (1.5)	HAVCR1 (1.4)	DYNC2LI1 (1.3)	ATXN2 (1.3)	ABO (1.3)	FRK (1.2)	TMED4 (1.1)	MYLIP (1.1)
GO:0007320	insemination	0.96	> 0.20	C17orf57 (2.7)	PMFBP1 (2.6)	HNF1A (2.5)	ABO (1.8)	NPC1L1 (1.5)	ITGB3 (1.4)	GOT2P1 (1.3)	YIPF2 (1.2)	KIAA1324 (1.1)	TMEM116 (1.1)
GO:0045921	positive regulation of exocytosis	0.96	> 0.20	ENSG00000235545 (2.7)	GMPR (1.8)	PMFBP1 (1.8)	AMIGO1 (1.8)	C12orf47 (1.6)	ZHX3 (1.6)	YIPF2 (1.5)	CYB561D1 (1.5)	CILP2 (1.3)	ST3GAL4 (1.2)
ENSG00000155760	FZD7 PPI subnetwork	0.96	> 0.20	C11orf9 (2.7)	CBLC (2.6)	BCAM (2.6)	TSSK6 (1.8)	CILP2 (1.7)	AMIGO1 (1.5)	NYNRIN (1.5)	ILF3 (1.2)	YIPF2 (1.2)	FADS2 (1.2)
ENSG00000060140	STYK1 PPI subnetwork	0.96	> 0.20	FADS2 (2.7)	DNAH11 (2.2)	TMEM57 (2.1)	CETP (2.0)	GRINA (1.8)	USP24 (1.8)	NCAN (1.6)	DOCK7 (1.6)	APOE (1.5)	TMEM116 (1.3)
ENSG00000125508	SRMS PPI subnetwork	0.96	> 0.20	FADS2 (2.7)	DNAH11 (2.2)	TMEM57 (2.1)	CETP (2.0)	GRINA (1.8)	USP24 (1.8)	NCAN (1.6)	DOCK7 (1.6)	APOE (1.5)	TMEM116 (1.3)
GO:0016303	1-phosphatidylinositol-3-kinase activity	0.96	> 0.20	DNM2 (2.6)	GMIP (2.3)	TMEM57 (2.0)	YIPF2 (1.8)	CELSR2 (1.7)	POLK (1.7)	LPAR2 (1.6)	ZNF180 (1.6)	ENSG00000226645 (1.6)	ERP29 (1.5)
GO:0035004	phosphatidylinositol 3-kinase activity	0.96	> 0.20	DNM2 (2.6)	GMIP (2.3)	TMEM57 (2.0)	YIPF2 (1.8)	CELSR2 (1.7)	POLK (1.7)	LPAR2 (1.6)	ZNF180 (1.6)	ENSG00000226645 (1.6)	ERP29 (1.5)
GO:0045981	positive regulation of nucleotide metabolic process	0.96	> 0.20	AMIGO1 (2.6)	PMFBP1 (2.4)	ST3GAL4 (2.3)	ABO (2.0)	PLEKHH2 (1.9)	C12orf47 (1.7)	ENSG00000226648 (1.6)	LPIN3 (1.6)	COL4A3BP (1.5)	GOT2P1 (1.4)
GO:0044447	axoneme part	0.96	> 0.20	DYNC2LI1 (5.4)	DNAH11 (3.5)	TSSK6 (1.6)	DOCK7 (1.3)	PBX4 (1.2)	CEACAM19 (1.0)	YIPF2 (1.0)	PMFBP1 (0.8)	TRAPPC6A (0.7)	POC5 (0.6)
GO:0001104	RNA polymerase II transcription cofactor activity	0.96	> 0.20	TMEM57 (2.3)	ATXN2 (2.3)	BUD13 (2.2)	BRAP (2.1)	C12orf47 (1.8)	C19orf52 (1.6)	TOP1 (1.5)	POC5 (1.5)	FRK (1.3)	TRIB1 (1.3)
ENSG00000109107	ALDOC PPI subnetwork	0.96	> 0.20	C11orf9 (3.1)	RPH3A (2.8)	NCAN (2.1)	TRAFD1 (2.0)	HAPLN4 (2.0)	ENSG00000235545 (1.8)	POC5 (1.7)	C12orf43 (1.5)	ST3GAL4 (1.5)	CELSR2 (1.4)
GO:0046634	regulation of alpha-beta T cell activation	0.96	> 0.20	PBX4 (2.8)	ENSG00000235545 (2.2)	ENSG00000254235 (1.9)	ANKRD31 (1.7)	ZNF101 (1.6)	GMIP (1.5)	TIMD4 (1.2)	NKPD1 (1.2)	CETP (1.2)	BLOC1S3 (1.1)
GO:0051148	negative regulation of muscle cell differentiation	0.96	> 0.20	PMFBP1 (2.3)	LPIN3 (2.2)	TXNL4B (1.5)	HNF1A (1.5)	CARM1 (1.5)	OGDH (1.4)	CEACAM19 (1.3)	YIPF2 (1.3)	DHX38 (1.2)	HLX (1.1)
MP:0000934	abnormal telencephalon development	0.96	> 0.20	NCAN (2.6)	TMEM57 (2.2)	PTPN11 (1.8)	PPP1R37 (1.7)	NYNRIN (1.6)	MAU2 (1.5)	ENSG00000254235 (1.3)	MAPKAPK5 (1.2)	PLCG1 (1.2)	GATAD2A (1.1)
ENSG00000168593	ENSG00000168593 PPI subnetwork	0.96	> 0.20	C19orf52 (3.1)	DDX56 (2.3)	GEMIN7 (2.0)	C1orf63 (1.9)	ZNF259 (1.8)	SUGP1 (1.7)	C12orf43 (1.6)	TOMM40 (1.6)	TMED4 (1.5)	TMEM116 (1.3)
ENSG00000206440	NFKBIL1 PPI subnetwork	0.96	> 0.20	C19orf52 (3.1)	DDX56 (2.3)	GEMIN7 (2.0)	C1orf63 (1.9)	ZNF259 (1.8)	SUGP1 (1.7)	C12orf43 (1.6)	TOMM40 (1.6)	TMED4 (1.5)	TMEM116 (1.3)
ENSG00000157388	CACNA1D PPI subnetwork	0.96	> 0.20	HAPLN4 (2.1)	C12orf43 (1.7)	NCAN (1.7)	PLEKHH2 (1.6)	GPAM (1.6)	MARK4 (1.6)	ENSG00000238078 (1.4)	SLC44A2 (1.3)	ADAM1 (1.3)	CARM1 (1.3)
ENSG00000212869	ENSG00000212869 PPI subnetwork	0.96	> 0.20	OGDH (3.6)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	GOT2P1 (1.6)	FRK (1.6)	PSMA5 (1.5)	GMPR (1.3)	TMED4 (1.3)
ENSG00000198695	MT-ND6 PPI subnetwork	0.96	> 0.20	OGDH (3.6)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	GOT2P1 (1.6)	FRK (1.6)	PSMA5 (1.5)	GMPR (1.3)	TMED4 (1.3)
MP:0003031	acidosis	0.96	> 0.20	TMEM116 (2.6)	ZHX3 (2.3)	PLG (2.2)	RHCE (2.0)	SYPL2 (2.0)	ANGPTL3 (1.8)	ENSG00000235545 (1.5)	ENSG00000228044 (1.4)	SLC22A1 (1.4)	SORT1 (1.4)
ENSG00000159199	ATP5G1 PPI subnetwork	0.96	> 0.20	ACAD10 (3.9)	OGDH (3.7)	C12orf47 (2.7)	PSMA5 (2.6)	GOT2P1 (2.2)	TOMM40 (2.1)	ENSG00000238078 (1.6)	C19orf52 (1.5)	TMEM116 (1.5)	ERP29 (1.5)
GO:0060562	epithelial tube morphogenesis	0.96	> 0.20	PVRL2 (3.1)	PLEKHH2 (2.6)	BCAM (2.2)	DYNC2LI1 (2.2)	KANK2 (2.1)	NYNRIN (2.0)	AP1M2 (2.0)	PPP1R37 (1.9)	MYLIP (1.5)	KIAA1324 (1.5)
ENSG00000152413	HOMER1 PPI subnetwork	0.96	> 0.20	ENSG00000226648 (2.4)	GCNT4 (2.4)	C1orf63 (1.9)	NCAN (1.7)	OASL (1.7)	C17orf57 (1.6)	MARK4 (1.5)	CBLC (1.5)	CILP2 (1.4)	RPH3A (1.2)
GO:0007605	sensory perception of sound	0.96	> 0.20	ANKRD31 (3.3)	HNF1A (2.1)	CILP2 (2.1)	NKPD1 (2.0)	GCNT4 (2.0)	FRK (1.8)	PMFBP1 (1.7)	ZHX3 (1.6)	AP1M2 (1.6)	TRAPPC6A (1.5)
ENSG00000007312	CD79B PPI subnetwork	0.96	> 0.20	GMIP (3.3)	SLC44A2 (3.2)	PLCG1 (3.2)	ZNF101 (3.1)	TIMD4 (2.6)	PBX4 (2.4)	LPAR2 (2.0)	MAFB (1.4)	MOSC1 (1.3)	DOCK7 (1.3)
MP:0002904	increased circulating parathyroid hormone level	0.96	> 0.20	AP1M2 (2.3)	TMEM116 (1.8)	KIAA1324 (1.8)	TRIB1 (1.8)	LPAR2 (1.7)	SLC22A1 (1.7)	CYB561D1 (1.6)	SYPL2 (1.6)	ENSG00000226648 (1.4)	C17orf57 (1.4)
GO:0030120	vesicle coat	0.96	> 0.20	YIPF2 (4.1)	DNM2 (2.2)	SARS (2.1)	DOCK7 (1.8)	C12orf51 (1.8)	ZHX3 (1.6)	KIAA1324 (1.6)	OGDH (1.6)	PSMA5 (1.6)	TMEM57 (1.4)
GO:0042992	negative regulation of transcription factor import into nucleus	0.96	> 0.20	ZNF101 (2.2)	PBX4 (2.0)	ENSG00000235545 (1.8)	LPAR2 (1.8)	TMEM57 (1.6)	PMFBP1 (1.5)	PPP1R37 (1.2)	RELB (1.2)	MAPKAPK5 (1.1)	MAFB (1.1)
ENSG00000159593	NAE1 PPI subnetwork	0.96	> 0.20	ENSG00000235545 (2.8)	HAPLN4 (2.5)	SUGP1 (2.5)	CELSR2 (2.0)	SLC44A2 (2.0)	RHCE (1.7)	MARK4 (1.7)	NKPD1 (1.7)	ZNF180 (1.6)	RHD (1.5)
ENSG00000090273	NUDC PPI subnetwork	0.96	> 0.20	PSRC1 (5.0)	FEN1 (4.1)	POC5 (2.7)	USP1 (2.5)	C12orf43 (1.3)	ZNF180 (1.3)	RPH3A (1.2)	NCAN (1.1)	ZHX3 (1.1)	HAPLN4 (1.0)
ENSG00000183570	PCBP3 PPI subnetwork	0.96	> 0.20	ABO (3.5)	GEMIN7 (2.3)	ATXN7L2 (1.6)	TRAPPC6A (1.4)	UBXN2B (1.4)	PTPN11 (1.4)	TOP1 (1.2)	PVR (1.2)	GATAD2A (1.1)	MAPKAPK5 (1.1)
ENSG00000145362	ANK2 PPI subnetwork	0.96	> 0.20	RHD (3.1)	AMIGO1 (2.8)	RHCE (2.6)	ATXN2 (2.1)	CELSR2 (2.1)	LPAR2 (1.9)	BRAP (1.9)	SYPL2 (1.7)	CYB561D1 (1.6)	SORT1 (1.6)
GO:0007274	neuromuscular synaptic transmission	0.96	> 0.20	ABO (3.4)	CYB561D1 (2.9)	SYPL2 (2.4)	ATXN7L2 (1.9)	ZHX3 (1.7)	ANKRD31 (1.6)	PMFBP1 (1.5)	RPH3A (1.5)	DYNC2LI1 (1.4)	C12orf43 (1.1)
ENSG00000211790	ENSG00000211790 PPI subnetwork	0.96	> 0.20	PLCG1 (3.0)	ZNF101 (2.5)	APOE (2.2)	ALDH2 (1.6)	CEACAM19 (1.6)	C19orf52 (1.6)	PBX4 (1.4)	APOC1 (1.2)	ADAM1 (1.2)	PARP10 (1.1)
GO:0050690	regulation of defense response to virus by virus	0.96	> 0.20	CLPTM1 (2.5)	TXNL4B (2.2)	OGDH (2.2)	ZNF101 (2.1)	GOT2P1 (2.0)	PLCG1 (2.0)	PBX4 (1.7)	PPP1R37 (1.7)	MARK4 (1.6)	GRINA (1.5)
GO:0046578	regulation of Ras protein signal transduction	0.96	> 0.20	PPP1R37 (2.7)	C12orf51 (2.5)	ENSG00000226645 (2.5)	DNM2 (2.3)	PBX4 (2.2)	CYB561D1 (2.1)	LPAR2 (2.0)	PLEKHH2 (2.0)	ZHX3 (1.9)	GMIP (1.9)
GO:0033627	cell adhesion mediated by integrin	0.96	> 0.20	PVR (2.6)	PVRL2 (2.0)	TMEM116 (1.9)	PLEKHH2 (1.5)	ZNF101 (1.1)	C11orf9 (1.1)	USP24 (1.1)	ENSG00000254235 (1.1)	ENSG00000226648 (1.1)	MAPKAPK5 (1.1)
ENSG00000131652	THOC6 PPI subnetwork	0.96	> 0.20	CARM1 (2.6)	ATXN2 (2.4)	MARK4 (2.3)	ILF3 (2.2)	GATAD2A (2.2)	SMARCA4 (1.9)	TMEM57 (1.7)	TOP1 (1.5)	USP1 (1.5)	BLOC1S3 (1.4)
MP:0006301	abnormal mesenchyme morphology	0.96	> 0.20	DOCK7 (3.3)	MYLIP (2.2)	PLEKHH2 (1.8)	KIAA1324 (1.6)	ATXN7L2 (1.4)	ATXN2 (1.4)	KANK2 (1.2)	NT5DC1 (1.2)	NKPD1 (1.1)	NYNRIN (1.1)
ENSG00000115596	WNT6 PPI subnetwork	0.96	> 0.20	CILP2 (5.0)	CELSR2 (2.5)	KIAA1324 (2.2)	TXNL4B (1.9)	DYNC2LI1 (1.9)	BCAM (1.8)	AMIGO1 (1.8)	LPAR2 (1.7)	TRAPPC6A (1.6)	PVRL2 (1.4)
KEGG_ASTHMA	KEGG_ASTHMA	0.96	> 0.20	SH2B3 (1.8)	TMED4 (1.3)	HLX (1.3)	BCL3 (1.2)	GEMIN7 (1.2)	APOE (1.2)	RHCE (1.1)	DHODH (1.1)	RELB (1.1)	TM6SF2 (1.0)
ENSG00000143870	PDIA6 PPI subnetwork	0.96	> 0.20	ERP29 (4.3)	TMEM50A (3.2)	TMED4 (2.4)	CLPTM1 (2.3)	NCAN (1.9)	PCSK9 (1.9)	RPH3A (1.9)	CELSR2 (1.8)	YIPF2 (1.8)	GRINA (1.8)
GO:0009081	branched chain family amino acid metabolic process	0.96	> 0.20	ACAD10 (3.3)	TRAPPC6A (2.6)	DYNC2LI1 (2.4)	NT5DC1 (2.3)	DHODH (2.0)	UBXN2B (1.9)	QTRT1 (1.7)	ALDH2 (1.7)	C19orf52 (1.5)	OGDH (1.4)
GO:0045995	regulation of embryonic development	0.96	> 0.20	NYNRIN (2.9)	LPAR2 (2.7)	DYNC2LI1 (2.5)	PLEKHH2 (2.1)	MYLIP (2.0)	AP1M2 (1.9)	ATXN7L2 (1.6)	PPP1R37 (1.4)	BCAM (1.3)	PLCG1 (1.3)
GO:0051428	peptide hormone receptor binding	0.96	> 0.20	MOSC1 (2.4)	GPAM (1.9)	COL4A3BP (1.8)	BRAP (1.8)	ENSG00000228044 (1.7)	GOT2P1 (1.6)	ANKRD31 (1.6)	NKPD1 (1.3)	TSSK6 (1.2)	MAPKAPK5 (1.2)
MP:0004398	cochlear inner hair cell degeneration	0.96	> 0.20	APOC1 (2.3)	HNF1A (2.2)	AP1M2 (2.2)	SORT1 (2.1)	NCAN (2.1)	FRK (2.0)	SLC44A2 (1.8)	CBLC (1.6)	GPAM (1.6)	PTPN11 (1.5)
MP:0000088	short mandible	0.96	> 0.20	CILP2 (4.3)	CARM1 (2.4)	MAFB (2.3)	PLCG1 (1.6)	ANKRD31 (1.6)	DOCK7 (1.5)	MYLIP (1.3)	ATXN2 (1.2)	HLX (1.2)	DYNC2LI1 (1.1)
MP:0000536	hydroureter	0.96	> 0.20	PVRL2 (2.3)	CARM1 (2.0)	MYLIP (1.8)	KANK2 (1.7)	ABO (1.5)	PLCG1 (1.5)	NYNRIN (1.4)	PLEKHH2 (1.4)	AP1M2 (1.3)	NT5DC1 (1.3)
REACTOME_MEIOTIC_RECOMBINATION	REACTOME_MEIOTIC_RECOMBINATION	0.96	> 0.20	FEN1 (3.6)	USP1 (3.4)	PSRC1 (1.9)	TMEM116 (1.8)	ENSG00000235545 (1.4)	POLK (1.3)	GMPR (1.3)	ENSG00000226645 (1.2)	AMIGO1 (1.2)	TXNL4B (1.1)
GO:0072088	nephron epithelium morphogenesis	0.96	> 0.20	HNF1A (3.2)	HAVCR1 (2.6)	TSSK6 (2.1)	ENSG00000238078 (1.9)	BCAM (1.9)	AP1M2 (1.6)	TMEM116 (1.5)	PMFBP1 (1.4)	DYNC2LI1 (1.4)	C17orf57 (1.3)
GO:0034311	diol metabolic process	0.96	> 0.20	DNAH11 (2.5)	POLK (1.9)	ABO (1.6)	CILP2 (1.5)	GCNT4 (1.4)	TRAPPC6A (1.2)	ENSG00000235545 (1.1)	ENSG00000254235 (1.1)	TSSK6 (1.1)	PMFBP1 (1.1)
GO:0009712	catechol-containing compound metabolic process	0.96	> 0.20	DNAH11 (2.5)	POLK (1.9)	ABO (1.6)	CILP2 (1.5)	GCNT4 (1.4)	TRAPPC6A (1.2)	ENSG00000235545 (1.1)	ENSG00000254235 (1.1)	TSSK6 (1.1)	PMFBP1 (1.1)
GO:0006584	catecholamine metabolic process	0.96	> 0.20	DNAH11 (2.5)	POLK (1.9)	ABO (1.6)	CILP2 (1.5)	GCNT4 (1.4)	TRAPPC6A (1.2)	ENSG00000235545 (1.1)	ENSG00000254235 (1.1)	TSSK6 (1.1)	PMFBP1 (1.1)
ENSG00000107295	SH3GL2 PPI subnetwork	0.96	> 0.20	C12orf51 (2.6)	MARK4 (2.6)	CARM1 (2.5)	PPP1R37 (2.2)	GRINA (1.8)	CLPTM1 (1.8)	NCAN (1.6)	DNM2 (1.6)	YIPF2 (1.6)	RPH3A (1.5)
GO:0050954	sensory perception of mechanical stimulus	0.96	> 0.20	ANKRD31 (3.3)	GCNT4 (2.2)	NKPD1 (2.1)	FRK (1.8)	CILP2 (1.7)	HNF1A (1.6)	AMIGO1 (1.5)	AP1M2 (1.5)	PMFBP1 (1.4)	ZHX3 (1.4)
GO:0016592	mediator complex	0.96	> 0.20	GEMIN7 (3.6)	BRAP (2.4)	BUD13 (2.4)	BLOC1S3 (2.0)	TXNL4B (1.8)	C19orf52 (1.8)	MAPKAPK5 (1.7)	C12orf43 (1.6)	C17orf57 (1.5)	ATXN7L2 (1.2)
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	0.96	> 0.20	ITGB3 (2.8)	C12orf51 (2.0)	SH2B3 (2.0)	PLCG1 (2.0)	DNAH11 (1.8)	CYB561D1 (1.7)	GMIP (1.7)	KIAA1324 (1.7)	PMFBP1 (1.6)	USP24 (1.4)
ENSG00000173156	RHOD PPI subnetwork	0.96	> 0.20	SLC44A2 (2.3)	AP1M2 (2.0)	TMEM57 (1.9)	CARM1 (1.9)	MARK4 (1.9)	PLEC (1.8)	ENSG00000254235 (1.6)	POLK (1.4)	DOCK7 (1.4)	TMEM50A (1.4)
GO:0060198	clathrin sculpted vesicle	0.96	> 0.20	GRINA (2.3)	RPH3A (2.1)	GCNT4 (1.9)	C12orf51 (1.8)	SARS (1.7)	FRK (1.6)	GOT2P1 (1.6)	BLOC1S3 (1.6)	MARK4 (1.6)	CYB561D1 (1.5)
ENSG00000106723	SPIN1 PPI subnetwork	0.96	> 0.20	NYNRIN (2.3)	ENSG00000254235 (2.2)	C19orf52 (2.2)	ATXN7L2 (1.8)	PVRL2 (1.8)	PSRC1 (1.8)	PTPN11 (1.6)	LPA (1.5)	AMIGO1 (1.4)	DNM2 (1.3)
ENSG00000198807	PAX9 PPI subnetwork	0.96	> 0.20	FRK (2.5)	NT5DC1 (2.2)	TRAPPC6A (1.9)	POLK (1.8)	C12orf43 (1.8)	NPC1L1 (1.7)	ENSG00000226645 (1.6)	ZNF101 (1.5)	NCAN (1.5)	GEMIN7 (1.4)
GO:0032535	regulation of cellular component size	0.96	> 0.20	TMEM50A (2.5)	ADAM1 (2.4)	ABO (2.4)	C1orf63 (2.3)	PLEC (2.2)	ATXN7L2 (2.1)	TSSK6 (2.0)	ENSG00000238078 (1.5)	CYB561D1 (1.4)	C17orf57 (1.3)
GO:0043587	tongue morphogenesis	0.96	> 0.20	NKPD1 (3.9)	PMFBP1 (2.0)	PLCG1 (1.6)	TMEM116 (1.5)	PBX4 (1.3)	C19orf52 (1.3)	FRK (1.3)	CILP2 (1.2)	SLC44A2 (1.2)	TRAPPC6A (1.1)
GO:0034453	microtubule anchoring	0.96	> 0.20	PSRC1 (3.3)	POC5 (3.1)	UBXN2B (2.2)	POLK (2.0)	DNAH11 (1.7)	CBLC (1.7)	TXNL4B (1.5)	COL4A3BP (1.4)	USP24 (1.4)	DYNC2LI1 (1.4)
ENSG00000109390	NDUFC1 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.7)	GOT2P1 (1.7)	FRK (1.6)	PSMA5 (1.5)	GMPR (1.3)	TMED4 (1.3)
GO:0006386	termination of RNA polymerase III transcription	0.96	> 0.20	GEMIN7 (3.9)	ADAM1 (3.7)	C12orf43 (2.8)	ZNF259 (2.1)	C12orf47 (1.9)	TOMM40 (1.7)	TSSK6 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	TMEM116 (1.5)
GO:0006385	transcription elongation from RNA polymerase III promoter	0.96	> 0.20	GEMIN7 (3.9)	ADAM1 (3.7)	C12orf43 (2.8)	ZNF259 (2.1)	C12orf47 (1.9)	TOMM40 (1.7)	TSSK6 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	TMEM116 (1.5)
ENSG00000186908	ZDHHC17 PPI subnetwork	0.96	> 0.20	HAVCR1 (3.4)	TSSK6 (2.6)	YIPF2 (2.5)	CYB561D1 (2.2)	ENSG00000238078 (1.9)	ATP13A1 (1.6)	DNAH11 (1.6)	PPP1R37 (1.5)	LPIN3 (1.5)	ENSG00000235545 (1.5)
GO:0031076	embryonic camera-type eye development	0.96	> 0.20	TMED4 (2.0)	ZHX3 (1.9)	MAU2 (1.8)	ENSG00000235545 (1.8)	NYNRIN (1.8)	ADAM1 (1.7)	HNF1A (1.5)	LPIN3 (1.4)	C19orf52 (1.4)	ATXN2 (1.4)
GO:0030216	keratinocyte differentiation	0.96	> 0.20	NKPD1 (4.3)	CEACAM19 (3.3)	ENSG00000226648 (3.1)	C17orf57 (2.4)	CBLC (2.4)	LPIN3 (1.7)	AP1M2 (1.6)	PMFBP1 (1.6)	CELSR2 (1.4)	DYNC2LI1 (0.8)
GO:0035587	purinergic receptor signaling pathway	0.96	> 0.20	RPH3A (2.0)	C12orf47 (1.7)	NKPD1 (1.6)	GMPR (1.5)	ITGB3 (1.5)	POLK (1.4)	ACAD10 (1.3)	YIPF2 (1.3)	ERP29 (1.3)	SLC44A2 (1.3)
REACTOME_G:PROTEIN_BETAGAMMA_SIGNALLING	REACTOME_G:PROTEIN_BETAGAMMA_SIGNALLING	0.96	> 0.20	ITGB3 (2.3)	TMEM50A (2.0)	ZNF180 (1.8)	C1orf63 (1.8)	HLX (1.5)	ENSG00000254235 (1.4)	MARK4 (1.2)	GMIP (1.2)	SH2B3 (1.2)	SLC44A2 (1.2)
MP:0011095	complete embryonic lethality between implantation and placentation	0.96	> 0.20	COL4A3BP (2.1)	ALDH2 (2.0)	DHX38 (1.9)	CBLC (1.9)	ENSG00000226645 (1.8)	ACAD10 (1.7)	ATXN2 (1.7)	ATP13A1 (1.7)	ATXN7L2 (1.4)	CYP7A1 (1.4)
MP:0003743	abnormal facial morphology	0.96	> 0.20	BCAM (2.1)	CELSR2 (2.0)	GEMIN7 (1.8)	AP1M2 (1.8)	ATXN2 (1.7)	PLEC (1.6)	NCAN (1.6)	PVRL2 (1.5)	ENSG00000228044 (1.3)	ATP13A1 (1.3)
ENSG00000134490	TMEM241 PPI subnetwork	0.96	> 0.20	MAU2 (3.6)	YIPF2 (3.2)	CLPTM1 (3.1)	C11orf9 (2.4)	DNM2 (2.0)	ATXN7L2 (2.0)	ENSG00000226645 (1.7)	ZNF259 (1.6)	ST3GAL4 (1.6)	LPAR2 (1.5)
GO:0001502	cartilage condensation	0.96	> 0.20	CILP2 (7.4)	ANKRD31 (2.6)	GOT2P1 (2.0)	CEACAM19 (1.9)	FRK (1.2)	TRAPPC6A (1.1)	YIPF2 (1.0)	PLEKHH2 (0.8)	C19orf52 (0.8)	GEMIN7 (0.8)
MP:0002175	decreased brain weight	0.96	> 0.20	RPH3A (2.5)	PBX4 (2.1)	PSRC1 (1.9)	AMIGO1 (1.9)	USP24 (1.9)	COL4A3BP (1.8)	RHCE (1.6)	CELSR2 (1.6)	GPAM (1.5)	HMGCR (1.5)
GO:0021953	central nervous system neuron differentiation	0.96	> 0.20	DNAH11 (3.3)	NCAN (2.7)	ANKRD31 (2.7)	C12orf47 (2.1)	CILP2 (1.8)	CELSR2 (1.6)	C19orf52 (1.4)	ATXN7L2 (1.3)	PBX4 (1.3)	NKPD1 (1.3)
ENSG00000171195	MUC7 PPI subnetwork	0.96	> 0.20	KIAA1324 (2.4)	ENSG00000235545 (2.1)	DNAH11 (1.8)	HP (1.6)	UBXN2B (1.6)	ACAD10 (1.3)	ERP29 (1.2)	AMIGO1 (1.2)	C12orf51 (1.1)	TMEM50A (1.1)
GO:0009247	glycolipid biosynthetic process	0.96	> 0.20	HAVCR1 (3.2)	AMIGO1 (2.1)	ABO (2.1)	SLC44A2 (1.9)	ENSG00000254235 (1.7)	CYB561D1 (1.6)	TMEM116 (1.3)	TMEM50A (1.3)	ZNF180 (1.3)	PVRL2 (1.3)
ENSG00000198821	CD247 PPI subnetwork	0.96	> 0.20	GMIP (2.3)	PLCG1 (2.3)	ZNF101 (1.8)	APOE (1.8)	SLC44A2 (1.5)	APOC1 (1.2)	C19orf52 (1.2)	USP24 (1.1)	PARP10 (1.1)	ADAM1 (1.1)
ENSG00000184752	NDUFA12 PPI subnetwork	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.2)	TRAPPC6A (2.7)	C12orf47 (2.6)	GOT2P1 (1.9)	MAU2 (1.9)	TMED4 (1.3)	GMPR (1.3)	FRK (1.3)	PSMA5 (1.2)
GO:0097094	craniofacial suture morphogenesis	0.96	> 0.20	LDLR (2.1)	NKPD1 (1.8)	HMGCR (1.7)	TRAPPC6A (1.6)	TMEM57 (1.5)	MYLIP (1.4)	FADS1 (1.4)	C11orf9 (1.4)	BLOC1S3 (1.4)	GEMIN7 (1.3)
GO:0060363	cranial suture morphogenesis	0.96	> 0.20	LDLR (2.1)	NKPD1 (1.8)	HMGCR (1.7)	TRAPPC6A (1.6)	TMEM57 (1.5)	MYLIP (1.4)	FADS1 (1.4)	C11orf9 (1.4)	BLOC1S3 (1.4)	GEMIN7 (1.3)
MP:0000851	cerebellum hypoplasia	0.96	> 0.20	ZHX3 (2.8)	RPH3A (1.9)	ADAM1 (1.9)	YIPF2 (1.9)	CYP7A1 (1.5)	DYNC2LI1 (1.5)	POLK (1.4)	ATXN2 (1.4)	PPP1R37 (1.4)	NPC1L1 (1.4)
MP:0000454	abnormal jaw morphology	0.96	> 0.20	CILP2 (2.5)	TMEM57 (2.1)	KANK2 (1.7)	C17orf57 (1.7)	ZHX3 (1.6)	MAFB (1.5)	CBLC (1.5)	DNAH11 (1.1)	FADS1 (1.1)	MAU2 (1.1)
ENSG00000159840	ZYX PPI subnetwork	0.96	> 0.20	KIAA1324 (2.7)	FRK (2.3)	HAVCR1 (1.8)	AP1M2 (1.7)	PTPN11 (1.6)	SORT1 (1.6)	HNF1A (1.6)	PMFBP1 (1.5)	CETP (1.5)	POLK (1.4)
MP:0002764	short tibia	0.96	> 0.20	CILP2 (3.7)	PLEKHH2 (2.8)	MAFB (1.9)	ZHX3 (1.9)	KANK2 (1.8)	KIAA1324 (1.7)	CARM1 (1.4)	NPC1L1 (1.3)	PLCG1 (1.2)	FRK (1.1)
GO:0045187	regulation of circadian sleep/wake cycle, sleep	0.96	> 0.20	ENSG00000226648 (3.7)	C12orf47 (1.8)	PPP1R37 (1.7)	HNF1A (1.7)	RPH3A (1.7)	LPIN3 (1.3)	TMED4 (1.3)	NPC1L1 (1.2)	TSSK6 (1.1)	KIAA1324 (1.0)
GO:0042749	regulation of circadian sleep/wake cycle	0.96	> 0.20	ENSG00000226648 (3.7)	C12orf47 (1.8)	PPP1R37 (1.7)	HNF1A (1.7)	RPH3A (1.7)	LPIN3 (1.3)	TMED4 (1.3)	NPC1L1 (1.2)	TSSK6 (1.1)	KIAA1324 (1.0)
GO:0060602	branch elongation of an epithelium	0.96	> 0.20	PLEKHH2 (2.7)	ENSG00000254235 (2.0)	C19orf52 (1.9)	DYNC2LI1 (1.9)	PPP1R37 (1.5)	MYLIP (1.5)	KIAA1324 (1.4)	LPIN3 (1.4)	C17orf57 (1.3)	ABO (1.2)
GO:0021846	cell proliferation in forebrain	0.96	> 0.20	ENSG00000235545 (3.0)	NCAN (2.7)	C17orf57 (2.6)	TSSK6 (2.5)	ENSG00000226648 (2.4)	HAPLN4 (2.2)	PBX4 (2.0)	DNAH11 (1.9)	CELSR2 (1.8)	POLK (1.6)
GO:0007269	neurotransmitter secretion	0.96	> 0.20	RPH3A (3.8)	HAPLN4 (3.6)	AMIGO1 (2.7)	ABO (2.5)	DNAH11 (2.4)	C12orf51 (1.9)	PMFBP1 (1.5)	C12orf47 (1.5)	TSSK6 (1.5)	BLOC1S3 (1.5)
GO:0051251	positive regulation of lymphocyte activation	0.96	> 0.20	ZNF101 (3.0)	PBX4 (2.5)	TIMD4 (2.2)	PLCG1 (2.2)	CETP (1.9)	GMIP (1.6)	CYB561D1 (1.5)	POLK (1.4)	RELB (1.4)	SH2B3 (1.2)
GO:0045661	regulation of myoblast differentiation	0.96	> 0.20	COL4A3BP (2.0)	ABO (2.0)	PMFBP1 (1.9)	SYPL2 (1.8)	ENSG00000226645 (1.8)	AP1M2 (1.8)	HLX (1.6)	OGDH (1.4)	ENSG00000226648 (1.3)	KANK2 (1.0)
ENSG00000139112	GABARAPL1 PPI subnetwork	0.96	> 0.20	TRAPPC6A (2.5)	TXNL4B (2.4)	SARS (2.3)	BLOC1S3 (2.1)	GRINA (2.1)	SUGP1 (2.0)	TRAFD1 (1.6)	ZNF180 (1.5)	PSMA5 (1.5)	ADAM1 (1.5)
ENSG00000150086	GRIN2B PPI subnetwork	0.96	> 0.20	RPH3A (3.1)	SORT1 (2.9)	CELSR2 (2.6)	NCAN (2.3)	PPP1R37 (2.1)	MARK4 (1.9)	CYB561D1 (1.9)	ENSG00000226648 (1.7)	CLPTM1 (1.7)	COL4A3BP (1.4)
ENSG00000168653	NDUFS5 PPI subnetwork	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.2)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.7)	PSMA5 (1.6)	GOT2P1 (1.5)	FRK (1.4)	TMED4 (1.4)	GMPR (1.4)
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	0.96	> 0.20	PLEKHH2 (3.3)	C11orf9 (2.9)	ALDH2 (2.0)	HAPLN4 (1.9)	PVR (1.8)	ABO (1.7)	PCSK9 (1.7)	ANGPTL3 (1.5)	TM6SF2 (1.4)	HNF1A (1.4)
GO:0031346	positive regulation of cell projection organization	0.96	> 0.20	PBX4 (2.8)	ATXN7L2 (2.1)	LPIN3 (2.0)	DOCK7 (2.0)	PLEC (1.5)	CELSR2 (1.4)	CETP (1.3)	ENSG00000235545 (1.3)	PVRL2 (1.2)	CARM1 (1.1)
MP:0000743	muscle spasm	0.96	> 0.20	RPH3A (3.3)	TSSK6 (2.6)	HAVCR1 (2.5)	ZHX3 (2.2)	CELSR2 (2.1)	C12orf51 (2.0)	CETP (1.5)	ERP29 (1.3)	C12orf47 (1.2)	ENSG00000235545 (1.2)
GO:0045619	regulation of lymphocyte differentiation	0.96	> 0.20	ZNF101 (4.1)	PBX4 (3.7)	DNAH11 (1.8)	PLCG1 (1.7)	GMIP (1.7)	ENSG00000235545 (1.6)	MAU2 (1.4)	HLX (1.4)	NKPD1 (1.3)	C19orf52 (1.0)
ENSG00000115252	PDE1A PPI subnetwork	0.96	> 0.20	RPH3A (2.8)	NCAN (2.5)	UBXN2B (2.0)	C12orf51 (1.9)	SORT1 (1.9)	FADS1 (1.9)	CELSR2 (1.8)	TMEM50A (1.8)	HLX (1.5)	MARK4 (1.5)
GO:0032318	regulation of Ras GTPase activity	0.96	> 0.20	ENSG00000226645 (3.3)	PPP1R37 (3.0)	ZHX3 (2.7)	C12orf51 (2.5)	DNM2 (1.9)	CYB561D1 (1.9)	CBLC (1.8)	ST3GAL4 (1.8)	PBX4 (1.6)	LPIN3 (1.4)
ENSG00000155959	VBP1 PPI subnetwork	0.96	> 0.20	TXNL4B (1.9)	C12orf43 (1.9)	GATAD2A (1.7)	MAU2 (1.6)	USP1 (1.5)	ADAM1 (1.4)	SUGP1 (1.4)	FEN1 (1.4)	TMEM50A (1.3)	ZNF101 (1.3)
ENSG00000212876	ENSG00000212876 PPI subnetwork	0.96	> 0.20	OGDH (3.6)	C12orf47 (2.9)	ACAD10 (2.9)	TRAPPC6A (2.8)	MAU2 (1.7)	GOT2P1 (1.7)	FRK (1.7)	PSMA5 (1.4)	GMPR (1.2)	TMED4 (1.2)
ENSG00000198763	MT-ND2 PPI subnetwork	0.96	> 0.20	OGDH (3.6)	C12orf47 (2.9)	ACAD10 (2.9)	TRAPPC6A (2.8)	MAU2 (1.7)	GOT2P1 (1.7)	FRK (1.7)	PSMA5 (1.4)	GMPR (1.2)	TMED4 (1.2)
ENSG00000054796	SPO11 PPI subnetwork	0.96	> 0.20	DYNC2LI1 (3.1)	ANKRD31 (2.0)	CEACAM19 (1.9)	C1orf63 (1.8)	ACAD10 (1.4)	TSSK6 (1.3)	USP1 (1.3)	USP24 (1.2)	TMEM116 (1.2)	YIPF2 (1.1)
GO:0007405	neuroblast proliferation	0.96	> 0.20	DOCK7 (2.6)	CELSR2 (2.2)	NCAN (2.2)	PSRC1 (2.1)	PBX4 (1.8)	ZNF101 (1.7)	ENSG00000254235 (1.7)	CEACAM19 (1.7)	TSSK6 (1.7)	DNAH11 (1.6)
GO:0060589	nucleoside-triphosphatase regulator activity	0.96	> 0.20	SH2B3 (3.4)	C12orf51 (3.3)	DNM2 (3.1)	GMIP (3.1)	PLCG1 (2.5)	ZHX3 (2.5)	USP24 (2.4)	HLX (2.3)	PLEC (2.1)	PLEKHH2 (1.8)
ENSG00000198216	CACNA1E PPI subnetwork	0.96	> 0.20	NCAN (3.3)	CELSR2 (3.1)	SLC44A2 (2.1)	ZHX3 (1.9)	ADAM1 (1.7)	ENSG00000238078 (1.6)	CYB561D1 (1.5)	GMPR (1.5)	PSRC1 (1.4)	SYPL2 (1.4)
MP:0003384	abnormal ventral body wall morphology	0.96	> 0.20	NYNRIN (3.9)	C11orf9 (2.6)	APOB (2.1)	BCAM (1.9)	MYLIP (1.8)	PVRL2 (1.5)	HLX (1.4)	NPC1L1 (1.3)	HAVCR1 (1.2)	PLEKHH2 (1.1)
GO:0007157	heterophilic cell-cell adhesion	0.96	> 0.20	ITGB3 (2.3)	TIMD4 (2.1)	ENSG00000254235 (2.0)	ENSG00000228044 (1.4)	PVRL2 (1.3)	HNF1A (1.2)	ST3GAL4 (1.2)	TXNL4B (1.1)	GOT2P1 (1.1)	BCL3 (1.1)
ENSG00000086065	CHMP5 PPI subnetwork	0.96	> 0.20	BRAP (3.1)	CARM1 (3.0)	MAU2 (2.9)	MAPKAPK5 (2.6)	ZNF101 (2.4)	GATAD2A (2.3)	OASL (1.8)	PLCG1 (1.8)	SUGP1 (1.7)	ATXN2 (1.7)
ENSG00000087074	PPP1R15A PPI subnetwork	0.96	> 0.20	DYNC2LI1 (2.1)	PTPN11 (1.9)	ZHX3 (1.9)	NCAN (1.7)	BRAP (1.6)	BUD13 (1.5)	TOP1 (1.5)	TMEM116 (1.4)	PBX4 (1.4)	ADAM1 (1.3)
MP:0002217	small lymph nodes	0.96	> 0.20	ZNF101 (4.5)	GMIP (2.2)	PBX4 (2.1)	SLC44A2 (2.0)	PLCG1 (2.0)	C1orf63 (1.3)	HLX (1.3)	CETP (1.2)	ANKRD31 (1.2)	PSMA5 (1.2)
MP:0003078	aphakia	0.96	> 0.20	TXNL4B (1.9)	ZNF180 (1.9)	TMED4 (1.7)	HLX (1.5)	CILP2 (1.4)	LPAR2 (1.4)	TRAFD1 (1.3)	TMEM116 (1.1)	BUD13 (1.0)	LPA (0.9)
ENSG00000089053	ANAPC5 PPI subnetwork	0.96	> 0.20	PSRC1 (5.9)	FEN1 (3.3)	POC5 (2.9)	LPIN3 (1.8)	USP1 (1.7)	LPAR2 (1.3)	ILF3 (1.3)	UBXN2B (1.3)	SUGP1 (1.1)	SORT1 (1.0)
ENSG00000148408	CACNA1B PPI subnetwork	0.96	> 0.20	RPH3A (3.2)	HAPLN4 (2.1)	ENSG00000226645 (2.1)	FRK (2.0)	ENSG00000238078 (1.8)	KIAA1324 (1.7)	CELSR2 (1.6)	AMIGO1 (1.6)	PPP1R37 (1.6)	NCAN (1.5)
MP:0001525	impaired balance	0.96	> 0.20	RPH3A (4.4)	C12orf51 (3.1)	HAPLN4 (2.8)	ZHX3 (2.8)	GRINA (2.5)	TRAPPC6A (2.0)	NCAN (1.9)	CELSR2 (1.9)	ENSG00000238078 (1.7)	USP24 (1.7)
ENSG00000125356	NDUFA1 PPI subnetwork	0.96	> 0.20	OGDH (3.4)	ACAD10 (3.3)	TRAPPC6A (2.9)	C12orf47 (2.6)	FRK (1.7)	MAU2 (1.6)	GOT2P1 (1.6)	PSMA5 (1.6)	GMPR (1.5)	TMED4 (1.4)
MP:0005423	abnormal somatic nervous system physiology	0.96	> 0.20	CELSR2 (3.5)	RPH3A (3.1)	NCAN (2.6)	HAPLN4 (2.3)	ENSG00000228044 (2.0)	TSSK6 (1.9)	ANKRD31 (1.6)	ZHX3 (1.5)	UBXN2B (1.4)	HLX (1.4)
GO:0032814	regulation of natural killer cell activation	0.96	> 0.20	CYB561D1 (2.6)	GEMIN7 (2.4)	PBX4 (1.8)	TRAFD1 (1.7)	ZNF180 (1.6)	ENSG00000235545 (1.6)	ENSG00000228044 (1.5)	BLOC1S3 (1.5)	AMIGO1 (1.4)	ZNF101 (1.3)
MP:0000556	abnormal hindlimb morphology	0.96	> 0.20	CILP2 (5.3)	HAPLN4 (1.7)	TRAPPC6A (1.5)	CBLC (1.3)	HNF1A (1.1)	HAVCR1 (1.0)	AP1M2 (1.0)	KANK2 (0.9)	MAFB (0.9)	PCSK9 (0.9)
GO:0048538	thymus development	0.96	> 0.20	C19orf52 (2.8)	DNAH11 (2.6)	BLOC1S3 (2.5)	MYLIP (2.5)	LPAR2 (2.3)	ENSG00000238078 (2.1)	MAU2 (1.8)	C1orf63 (1.8)	LPIN3 (1.8)	CYB561D1 (1.8)
GO:0046928	regulation of neurotransmitter secretion	0.96	> 0.20	ABO (3.9)	AMIGO1 (2.4)	RPH3A (2.2)	DNAH11 (2.0)	HAPLN4 (1.7)	ENSG00000235545 (1.6)	GOT2P1 (1.6)	RHCE (1.5)	PMFBP1 (1.4)	DYNC2LI1 (1.3)
ENSG00000070759	TESK2 PPI subnetwork	0.96	> 0.20	C12orf51 (3.2)	USP24 (3.2)	MARK4 (2.3)	BUD13 (2.3)	NCAN (2.1)	GMIP (1.8)	POLK (1.7)	PTPN11 (1.7)	SORT1 (1.6)	DNAH11 (1.6)
ENSG00000166963	MAP1A PPI subnetwork	0.96	> 0.20	TXNL4B (3.5)	C1orf63 (3.0)	RPH3A (2.6)	HAPLN4 (2.0)	DHX38 (1.8)	C12orf51 (1.7)	NKPD1 (1.7)	COL4A3BP (1.6)	KANK2 (1.3)	GMPR (1.2)
GO:0007512	adult heart development	0.96	> 0.20	C17orf57 (2.1)	ACAD10 (1.9)	TSSK6 (1.6)	DHODH (1.4)	TMEM116 (1.4)	SYPL2 (1.4)	CILP2 (1.1)	DYNC2LI1 (1.1)	ERP29 (1.0)	HAVCR1 (0.9)
MP:0004811	abnormal neuron physiology	0.96	> 0.20	MARK4 (2.5)	HAVCR1 (2.2)	RPH3A (2.0)	C12orf51 (1.9)	C11orf9 (1.6)	FRK (1.6)	ST3GAL4 (1.6)	LPAR2 (1.6)	CELSR2 (1.5)	AMIGO1 (1.4)
GO:0072234	metanephric nephron tubule development	0.96	> 0.20	HAVCR1 (3.6)	NCAN (2.1)	DYNC2LI1 (1.9)	CYB561D1 (1.6)	CELSR2 (1.6)	TMEM116 (1.3)	ZHX3 (1.3)	HNF1A (1.2)	BCAM (1.0)	ENSG00000254235 (1.0)
GO:0072243	metanephric nephron epithelium development	0.96	> 0.20	HAVCR1 (3.6)	NCAN (2.1)	DYNC2LI1 (1.9)	CYB561D1 (1.6)	CELSR2 (1.6)	TMEM116 (1.3)	ZHX3 (1.3)	HNF1A (1.2)	BCAM (1.0)	ENSG00000254235 (1.0)
REACTOME_APC:CDC20_MEDIATED_DEGRADATION_OF_NEK2A	REACTOME_APC:CDC20_MEDIATED_DEGRADATION_OF_NEK2A	0.96	> 0.20	PSRC1 (3.7)	POC5 (2.9)	FEN1 (2.8)	LPIN3 (2.5)	LPAR2 (2.3)	SUGP1 (2.3)	ADAM1 (2.3)	DOCK7 (1.8)	ATP13A1 (1.7)	GEMIN7 (1.4)
ENSG00000104388	RAB2A PPI subnetwork	0.96	> 0.20	C11orf9 (2.9)	ALDH2 (2.7)	MOSC1 (2.4)	HAPLN4 (2.3)	RPH3A (2.2)	NCAN (2.0)	ZNF101 (1.9)	ST3GAL4 (1.7)	NT5DC1 (1.7)	ENSG00000226648 (1.6)
GO:0045616	regulation of keratinocyte differentiation	0.96	> 0.20	ENSG00000226648 (2.3)	LPIN3 (2.3)	AP1M2 (2.1)	CBLC (2.1)	PBX4 (1.9)	UBXN2B (1.8)	GOT2P1 (1.8)	LPAR2 (1.5)	ENSG00000238078 (1.3)	ZNF101 (1.3)
ENSG00000166136	NDUFB8 PPI subnetwork	0.96	> 0.20	OGDH (3.4)	ACAD10 (3.0)	C12orf47 (3.0)	TRAPPC6A (2.7)	MAU2 (1.7)	PSMA5 (1.7)	FRK (1.6)	TMED4 (1.5)	GOT2P1 (1.3)	ADAM1 (1.2)
GO:0030155	regulation of cell adhesion	0.96	> 0.20	SLC44A2 (4.0)	PVR (2.3)	ITGB3 (2.3)	AP1M2 (1.9)	ANKRD31 (1.8)	PVRL2 (1.7)	BCAM (1.7)	HLX (1.7)	PLEKHH2 (1.6)	USP24 (1.4)
ENSG00000198886	MT-ND4 PPI subnetwork	0.96	> 0.20	OGDH (3.5)	ACAD10 (3.1)	C12orf47 (2.9)	TRAPPC6A (2.7)	MAU2 (1.9)	GOT2P1 (1.6)	FRK (1.5)	PSMA5 (1.5)	TMED4 (1.3)	GMPR (1.2)
GO:0001975	response to amphetamine	0.96	> 0.20	TSSK6 (2.3)	C17orf57 (1.9)	GOT2P1 (1.8)	C12orf47 (1.5)	TXNL4B (1.3)	PMFBP1 (1.3)	BLOC1S3 (1.3)	ENSG00000226645 (1.1)	NT5DC1 (1.1)	C12orf51 (1.0)
ENSG00000177302	TOP3A PPI subnetwork	0.96	> 0.20	USP1 (3.7)	FEN1 (3.5)	POC5 (2.7)	DHODH (2.6)	ENSG00000235545 (1.9)	C17orf57 (1.8)	ERP29 (1.7)	ZNF180 (1.4)	BRAP (1.3)	C12orf43 (1.3)
GO:0035335	peptidyl-tyrosine dephosphorylation	0.96	> 0.20	ENSG00000226648 (2.7)	ZHX3 (2.1)	CYB561D1 (1.9)	GCNT4 (1.7)	TRIB1 (1.5)	PVR (1.5)	MAPKAPK5 (1.4)	C17orf57 (1.4)	DNAH11 (1.3)	MYLIP (1.3)
ENSG00000211889	ENSG00000211889 PPI subnetwork	0.96	> 0.20	PLCG1 (2.9)	ZNF101 (2.5)	APOE (2.2)	CEACAM19 (1.7)	ALDH2 (1.6)	C19orf52 (1.5)	ADAM1 (1.3)	APOC1 (1.2)	PBX4 (1.1)	DHODH (1.1)
REACTOME_THE_NLRP3_INFLAMMASOME	REACTOME_THE_NLRP3_INFLAMMASOME	0.96	> 0.20	HLX (2.8)	CYB561D1 (2.3)	MAFB (1.9)	TMEM50A (1.7)	ABCG8 (1.5)	ZNF101 (1.4)	DNAH11 (1.3)	PARP10 (1.3)	OGDH (1.3)	CYP7A1 (1.2)
MP:0001264	increased body size	0.96	> 0.20	SORT1 (2.3)	GPAM (1.8)	TSSK6 (1.6)	PLEKHH2 (1.5)	MYLIP (1.5)	KIAA1324 (1.4)	CYB561D1 (1.3)	PBX4 (1.3)	C17orf57 (1.3)	MOSC1 (1.3)
ENSG00000152822	GRM1 PPI subnetwork	0.96	> 0.20	RPH3A (2.6)	SORT1 (2.4)	NCAN (1.9)	MARK4 (1.9)	ITGB3 (1.7)	SH2B3 (1.5)	CELSR2 (1.4)	SMARCA4 (1.3)	PVR (1.3)	CLPTM1 (1.3)
ENSG00000198898	CAPZA2 PPI subnetwork	0.96	> 0.20	C1orf63 (3.3)	SYPL2 (2.2)	SARS (2.0)	TMEM50A (1.9)	ERP29 (1.7)	GATAD2A (1.7)	PVRL2 (1.6)	PLCG1 (1.4)	CEACAM19 (1.3)	PLEC (1.3)
ENSG00000021574	SPAST PPI subnetwork	0.96	> 0.20	LPAR2 (2.4)	RHD (2.4)	PBX4 (2.1)	LPIN3 (1.9)	TMEM50A (1.8)	TRAFD1 (1.8)	FRK (1.7)	TSSK6 (1.7)	POC5 (1.6)	NPC1L1 (1.6)
MP:0002945	abnormal inhibitory postsynaptic currents	0.96	> 0.20	RPH3A (6.0)	NCAN (4.7)	HAPLN4 (2.9)	PPP1R37 (2.0)	CELSR2 (1.8)	C11orf9 (1.7)	APOE (1.5)	TIMD4 (1.3)	LPA (1.3)	C12orf47 (1.3)
ENSG00000188878	FBF1 PPI subnetwork	0.96	> 0.20	TRAFD1 (2.7)	PMFBP1 (1.9)	RELB (1.6)	CYP7A1 (1.5)	YIPF2 (1.4)	C1orf63 (1.4)	ABCG8 (1.2)	C17orf57 (1.2)	HNF1A (1.2)	HAVCR1 (1.1)
ENSG00000111276	CDKN1B PPI subnetwork	0.96	> 0.20	GATAD2A (2.5)	USP1 (2.2)	FEN1 (2.1)	ENSG00000226645 (2.0)	PSRC1 (1.6)	CARM1 (1.6)	ENSG00000238078 (1.6)	ADAM1 (1.3)	TOMM40 (1.2)	SMARCA4 (1.1)
ENSG00000109061	MYH1 PPI subnetwork	0.96	> 0.20	GATAD2A (2.6)	ILF3 (2.4)	TOP1 (2.3)	MAFB (2.1)	CARM1 (1.9)	PLCG1 (1.7)	TMEM50A (1.6)	RHD (1.6)	ENSG00000235545 (1.4)	C12orf51 (1.4)
GO:0031333	negative regulation of protein complex assembly	0.96	> 0.20	ENSG00000238078 (3.7)	C17orf57 (3.6)	TMEM50A (2.6)	RHCE (2.0)	RHD (2.0)	TMEM57 (1.8)	PMFBP1 (1.8)	TSSK6 (1.7)	GMPR (1.7)	CYB561D1 (1.6)
ENSG00000130725	UBE2M PPI subnetwork	0.96	> 0.20	ENSG00000235545 (2.4)	PSMA5 (2.4)	TOMM40 (2.3)	ZNF180 (2.2)	CELSR2 (2.1)	CLPTM1 (1.9)	HAPLN4 (1.9)	PTPN11 (1.7)	DDX56 (1.5)	SUGP1 (1.5)
GO:0016079	synaptic vesicle exocytosis	0.96	> 0.20	RPH3A (2.7)	HAPLN4 (2.3)	DNAH11 (2.3)	AMIGO1 (2.1)	C12orf43 (2.0)	HAVCR1 (1.6)	HNF1A (1.4)	TMEM57 (1.4)	C12orf51 (1.2)	GRINA (1.1)
ENSG00000198786	MT-ND5 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.9)	GOT2P1 (1.6)	FRK (1.5)	PSMA5 (1.5)	GMPR (1.2)	TMED4 (1.1)
ENSG00000212870	ENSG00000212870 PPI subnetwork	0.96	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.9)	GOT2P1 (1.6)	FRK (1.5)	PSMA5 (1.5)	GMPR (1.2)	TMED4 (1.1)
GO:0090184	positive regulation of kidney development	0.96	> 0.20	HNF1A (2.9)	ENSG00000228044 (2.5)	PMFBP1 (1.9)	AMIGO1 (1.8)	ZNF101 (1.7)	TMED4 (1.6)	TSSK6 (1.5)	SLC44A2 (1.5)	CILP2 (1.4)	ABO (1.3)
ENSG00000198785	GRIN3A PPI subnetwork	0.96	> 0.20	C12orf51 (2.9)	SMARCA4 (2.5)	HAVCR1 (2.2)	NCAN (2.2)	SYPL2 (2.0)	CELSR2 (1.8)	ADAM1 (1.8)	ATXN2 (1.7)	ITGB3 (1.7)	SARS (1.5)
ENSG00000134853	PDGFRA PPI subnetwork	0.96	> 0.20	APOE (3.0)	USP24 (2.3)	PLEKHH2 (1.9)	PARP10 (1.9)	KANK2 (1.8)	C11orf9 (1.7)	PTPN11 (1.6)	CETP (1.4)	GPAM (1.4)	TMEM50A (1.4)
ENSG00000138032	PPM1B PPI subnetwork	0.96	> 0.20	OASL (4.4)	PARP10 (2.2)	AMIGO1 (1.8)	C11orf9 (1.7)	PCSK9 (1.7)	PVR (1.7)	SORT1 (1.3)	SUGP1 (1.3)	PBX4 (1.3)	C19orf52 (1.3)
GO:0060037	pharyngeal system development	0.96	> 0.20	CYB561D1 (2.5)	KIAA1324 (2.4)	BLOC1S3 (2.1)	ENSG00000238078 (1.9)	AMIGO1 (1.8)	TMEM116 (1.5)	PLCG1 (1.4)	ENSG00000226648 (1.4)	TMED4 (1.3)	SLC44A2 (1.2)
GO:0005003	ephrin receptor activity	0.96	> 0.20	LPAR2 (3.7)	NYNRIN (2.8)	CELSR2 (2.2)	PVRL2 (2.0)	CBLC (2.0)	MARK4 (1.7)	PLEKHH2 (1.7)	NKPD1 (1.4)	PSRC1 (1.3)	LPIN3 (1.3)
GO:0005246	calcium channel regulator activity	0.96	> 0.20	RPH3A (2.9)	NCAN (2.5)	TMEM50A (2.1)	FRK (1.9)	C12orf47 (1.8)	ENSG00000226645 (1.8)	APOB (1.6)	PLG (1.5)	CILP2 (1.4)	RHCE (1.3)
MP:0003025	increased vasoconstriction	0.96	> 0.20	HLX (1.7)	DHODH (1.7)	ATXN7L2 (1.3)	GCNT4 (1.3)	KANK2 (1.2)	ERP29 (1.1)	ABO (1.1)	ITGB3 (1.1)	ILF3 (1.1)	ENSG00000238078 (1.1)
ENSG00000185737	NRG3 PPI subnetwork	0.96	> 0.20	ENSG00000226645 (3.0)	UBXN2B (2.5)	RELB (2.4)	NCAN (2.2)	BCL3 (2.0)	CBLC (1.9)	HAPLN4 (1.7)	MAPKAPK5 (1.6)	ABCG8 (1.5)	ZHX3 (1.4)
ENSG00000108306	FBXL20 PPI subnetwork	0.96	> 0.20	OASL (3.8)	GRINA (2.3)	CARM1 (2.2)	TMEM57 (2.0)	LPIN3 (1.8)	ENSG00000238078 (1.6)	ATXN2 (1.6)	OGDH (1.5)	PARP10 (1.5)	RPH3A (1.4)
ENSG00000131495	NDUFA2 PPI subnetwork	0.97	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.6)	C12orf47 (2.5)	MAU2 (1.7)	FRK (1.6)	GOT2P1 (1.6)	PSMA5 (1.5)	GMPR (1.3)	TMED4 (1.3)
ENSG00000153563	CD8A PPI subnetwork	0.97	> 0.20	PLCG1 (3.5)	ZNF101 (2.0)	C1orf63 (1.5)	C19orf52 (1.3)	HAVCR1 (1.2)	APOE (1.2)	TOMM40 (1.1)	ENSG00000228044 (1.0)	USP24 (1.0)	PARP10 (0.8)
GO:0060322	head development	0.97	> 0.20	MYLIP (2.2)	ENSG00000235545 (2.2)	GCNT4 (2.0)	ENSG00000238078 (1.8)	TSSK6 (1.5)	DNAH11 (1.4)	DYNC2LI1 (1.4)	ANKRD31 (1.3)	TMEM57 (1.3)	DOCK7 (1.3)
ENSG00000105649	RAB3A PPI subnetwork	0.97	> 0.20	NCAN (2.9)	RPH3A (2.7)	C12orf43 (2.2)	FRK (2.2)	CELSR2 (2.2)	AMIGO1 (2.1)	ZNF180 (2.1)	SORT1 (2.1)	GOT2P1 (1.8)	AP1M2 (1.8)
MP:0004409	abnormal crista ampullaris neuroepithelium morphology	0.97	> 0.20	ENSG00000235545 (2.4)	ABO (2.4)	NPC1L1 (1.8)	ZHX3 (1.7)	NCAN (1.7)	CILP2 (1.6)	DNAH11 (1.6)	TM6SF2 (1.5)	ST3GAL4 (1.3)	KIAA1324 (1.3)
REACTOME_ION_TRANSPORT_BY_P:TYPE_ATPASES	REACTOME_ION_TRANSPORT_BY_P:TYPE_ATPASES	0.97	> 0.20	COL4A3BP (2.8)	HAPLN4 (2.5)	HNF1A (2.3)	SLC44A2 (2.2)	AMIGO1 (1.9)	SORT1 (1.8)	ATP13A1 (1.7)	HMGCR (1.7)	TMEM116 (1.6)	RPH3A (1.6)
GO:0032816	positive regulation of natural killer cell activation	0.97	> 0.20	CYB561D1 (2.5)	GEMIN7 (2.4)	PBX4 (1.9)	ZNF180 (1.7)	ZNF101 (1.6)	TRAFD1 (1.5)	ENSG00000235545 (1.5)	BLOC1S3 (1.4)	NKPD1 (1.4)	AMIGO1 (1.2)
ENSG00000124357	NAGK PPI subnetwork	0.97	> 0.20	DNAH11 (2.2)	MYLIP (2.2)	ERP29 (2.1)	PLCG1 (2.1)	BRAP (2.0)	PPP1R37 (1.8)	ENSG00000228044 (1.8)	MAPKAPK5 (1.6)	NKPD1 (1.5)	MOSC1 (1.5)
ENSG00000064300	NGFR PPI subnetwork	0.97	> 0.20	RELB (4.9)	PBX4 (2.6)	BCL3 (2.2)	SH2B3 (2.2)	ATXN2 (2.1)	MARK4 (1.9)	C11orf9 (1.7)	CLPTM1 (1.6)	ADAM1 (1.5)	PSMA5 (1.4)
ENSG00000212871	ENSG00000212871 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	FRK (1.5)	GOT2P1 (1.5)	PSMA5 (1.4)	TMED4 (1.4)	GMPR (1.3)
ENSG00000198868	ENSG00000198868 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	FRK (1.5)	GOT2P1 (1.5)	PSMA5 (1.4)	TMED4 (1.4)	GMPR (1.3)
ENSG00000212872	ENSG00000212872 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	FRK (1.5)	GOT2P1 (1.5)	PSMA5 (1.4)	TMED4 (1.4)	GMPR (1.3)
ENSG00000198840	MT-ND3 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.8)	C12orf47 (2.7)	MAU2 (1.6)	FRK (1.5)	GOT2P1 (1.5)	PSMA5 (1.4)	TMED4 (1.4)	GMPR (1.3)
GO:0005254	chloride channel activity	0.97	> 0.20	SORT1 (2.4)	RPH3A (2.0)	ATP13A1 (1.8)	KIAA1324 (1.8)	FRK (1.7)	CLPTM1 (1.7)	ALDH2 (1.6)	LPIN3 (1.6)	FADS2 (1.5)	C11orf9 (1.4)
MP:0010386	abnormal urinary bladder physiology	0.97	> 0.20	GOT2P1 (2.1)	CBLC (2.1)	HAVCR1 (1.8)	YIPF2 (1.7)	CILP2 (1.6)	ABO (1.4)	CYB561D1 (1.4)	ATXN7L2 (1.3)	MYLIP (1.2)	RPH3A (1.1)
GO:0003333	amino acid transmembrane transport	0.97	> 0.20	NPC1L1 (2.7)	SARS (2.3)	LPAR2 (2.0)	TM6SF2 (2.0)	TMEM116 (1.9)	ERP29 (1.8)	PMFBP1 (1.7)	HNF1A (1.6)	HAPLN4 (1.5)	ATP13A1 (1.4)
ENSG00000160194	NDUFV3 PPI subnetwork	0.97	> 0.20	OGDH (3.7)	ACAD10 (3.0)	TRAPPC6A (2.6)	C12orf47 (2.6)	GOT2P1 (1.9)	FRK (1.6)	MAU2 (1.5)	PSMA5 (1.5)	TMED4 (1.3)	GMPR (1.1)
GO:0030117	membrane coat	0.97	> 0.20	YIPF2 (4.2)	DNM2 (3.0)	OGDH (2.5)	DOCK7 (2.3)	C12orf51 (2.1)	SARS (1.9)	CLPTM1 (1.9)	SMARCA4 (1.8)	SUGP1 (1.7)	ATP13A1 (1.6)
GO:0048475	coated membrane	0.97	> 0.20	YIPF2 (4.2)	DNM2 (3.0)	OGDH (2.5)	DOCK7 (2.3)	C12orf51 (2.1)	SARS (1.9)	CLPTM1 (1.9)	SMARCA4 (1.8)	SUGP1 (1.7)	ATP13A1 (1.6)
ENSG00000165264	NDUFB6 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.9)	C12orf47 (2.8)	MAU2 (1.7)	PSMA5 (1.5)	FRK (1.5)	TMED4 (1.4)	GOT2P1 (1.4)	GMPR (1.3)
ENSG00000112049	ENSG00000112049 PPI subnetwork	0.97	> 0.20	PLEC (2.2)	NCAN (1.9)	CELSR2 (1.8)	PARP10 (1.8)	SLC44A2 (1.7)	ABO (1.7)	ATXN7L2 (1.6)	SH2B3 (1.5)	MARK4 (1.5)	PLCG1 (1.5)
GO:0005798	Golgi-associated vesicle	0.97	> 0.20	YIPF2 (4.0)	BLOC1S3 (2.4)	KIAA1324 (2.1)	CELSR2 (1.9)	ERP29 (1.7)	CLPTM1 (1.6)	C11orf9 (1.5)	FRK (1.5)	DYNC2LI1 (1.5)	MAU2 (1.5)
GO:0014072	response to isoquinoline alkaloid	0.97	> 0.20	ENSG00000235545 (3.6)	ST3GAL4 (2.2)	KIAA1324 (2.0)	ADAM1 (1.7)	NKPD1 (1.7)	ANKRD31 (1.6)	ZHX3 (1.3)	OASL (1.3)	NPC1L1 (1.3)	LPIN3 (1.1)
GO:0043278	response to morphine	0.97	> 0.20	ENSG00000235545 (3.6)	ST3GAL4 (2.2)	KIAA1324 (2.0)	ADAM1 (1.7)	NKPD1 (1.7)	ANKRD31 (1.6)	ZHX3 (1.3)	OASL (1.3)	NPC1L1 (1.3)	LPIN3 (1.1)
ENSG00000144674	GOLGA4 PPI subnetwork	0.97	> 0.20	GRINA (2.4)	SUGP1 (1.7)	GOT2P1 (1.7)	PTPN11 (1.6)	KANK2 (1.6)	CYB561D1 (1.5)	USP1 (1.4)	SMARCA4 (1.4)	RHD (1.4)	POC5 (1.3)
GO:0016272	prefoldin complex	0.97	> 0.20	CYB561D1 (2.6)	C12orf47 (2.4)	AMIGO1 (2.4)	TXNL4B (2.0)	BRAP (2.0)	MAPKAPK5 (1.7)	QTRT1 (1.6)	ZHX3 (1.6)	RPH3A (1.6)	PSMA5 (1.5)
GO:0060065	uterus development	0.97	> 0.20	LPAR2 (2.1)	FRK (2.0)	ST3GAL4 (1.4)	NKPD1 (1.4)	AP1M2 (1.4)	NT5DC1 (1.3)	TMED4 (1.2)	PMFBP1 (1.2)	C17orf57 (1.2)	CBLC (1.1)
MP:0002790	decreased circulating follicle stimulating hormone level	0.97	> 0.20	KIAA1324 (3.3)	ATXN7L2 (2.0)	PMFBP1 (1.7)	ENSG00000226645 (1.5)	GCNT4 (1.3)	TMED4 (1.2)	MOSC1 (1.1)	ENSG00000235545 (1.1)	LDLR (1.1)	AMIGO1 (1.1)
GO:0042552	myelination	0.97	> 0.20	C11orf9 (3.0)	HAPLN4 (2.8)	RPH3A (2.1)	NCAN (2.1)	SORT1 (1.9)	CELSR2 (1.5)	BCAM (1.4)	ANKRD31 (1.4)	NKPD1 (1.3)	PBX4 (1.1)
ENSG00000034677	RNF19A PPI subnetwork	0.97	> 0.20	OASL (2.5)	PSMA5 (2.2)	RHCE (2.1)	RHD (2.1)	TRAFD1 (2.0)	C12orf43 (2.0)	C19orf52 (1.8)	PLEKHH2 (1.7)	PARP10 (1.7)	ATXN2 (1.5)
ENSG00000214021	TTLL3 PPI subnetwork	0.97	> 0.20	TMEM50A (2.7)	ITGB3 (2.3)	OGDH (2.1)	ENSG00000238078 (1.9)	C1orf63 (1.9)	SH2B3 (1.7)	GATAD2A (1.5)	C11orf9 (1.4)	PPP1R37 (1.4)	PLEC (1.2)
ENSG00000166147	FBN1 PPI subnetwork	0.97	> 0.20	CILP2 (3.5)	CEACAM19 (2.1)	MOSC1 (2.0)	TMED4 (1.7)	GRINA (1.3)	PBX4 (1.2)	CARM1 (1.2)	BCAM (1.2)	TRAPPC6A (1.1)	OGDH (1.1)
ENSG00000120251	GRIA2 PPI subnetwork	0.97	> 0.20	NCAN (2.7)	UBXN2B (1.8)	BCAM (1.8)	ZHX3 (1.8)	PPP1R37 (1.7)	PLCG1 (1.6)	USP24 (1.5)	C11orf9 (1.5)	CYP7A1 (1.4)	APOE (1.4)
MP:0006378	abnormal spermatogonia morphology	0.97	> 0.20	ZHX3 (2.5)	MOSC1 (2.5)	TMED4 (2.5)	SH2B3 (1.9)	PBX4 (1.9)	KANK2 (1.7)	ENSG00000226645 (1.7)	KIAA1324 (1.6)	BRAP (1.5)	GATAD2A (1.4)
GO:0009109	coenzyme catabolic process	0.97	> 0.20	ACAD10 (4.1)	OGDH (3.6)	ENSG00000226648 (2.9)	TMEM116 (2.3)	GMPR (2.1)	PMFBP1 (1.8)	HAPLN4 (1.7)	ENSG00000238078 (1.6)	C1orf63 (1.5)	C19orf52 (1.4)
MP:0001513	limb grasping	0.97	> 0.20	RPH3A (3.7)	HAPLN4 (2.2)	TMED4 (2.1)	DOCK7 (1.8)	GCNT4 (1.8)	SORT1 (1.7)	USP24 (1.7)	MAFB (1.5)	TIMD4 (1.4)	COL4A3BP (1.4)
MP:0005221	abnormal rostral-caudal axis patterning	0.97	> 0.20	NYNRIN (2.0)	ABO (2.0)	ADAM1 (1.9)	MARK4 (1.8)	APOB (1.7)	PTPN11 (1.7)	LPAR2 (1.7)	ENSG00000226648 (1.6)	COL4A3BP (1.6)	PLCG1 (1.5)
ENSG00000120798	NR2C1 PPI subnetwork	0.97	> 0.20	COL4A3BP (2.6)	TXNL4B (2.4)	TRAFD1 (2.3)	BRAP (2.2)	TOP1 (1.9)	TMEM57 (1.8)	ATXN2 (1.7)	LPIN3 (1.7)	NKPD1 (1.6)	MAU2 (1.5)
ENSG00000121892	PDS5A PPI subnetwork	0.97	> 0.20	USP1 (3.7)	AMIGO1 (1.9)	DHX38 (1.8)	UBXN2B (1.8)	USP24 (1.5)	BCAM (1.3)	HLX (1.3)	TOP1 (1.2)	POLK (1.2)	TXNL4B (1.2)
GO:0010506	regulation of autophagy	0.97	> 0.20	C12orf51 (2.8)	TMEM116 (2.5)	BRAP (2.5)	C17orf57 (2.4)	AMIGO1 (2.3)	TMEM57 (2.2)	BLOC1S3 (2.1)	ZNF180 (1.8)	FRK (1.7)	USP24 (1.5)
GO:0046633	alpha-beta T cell proliferation	0.97	> 0.20	PBX4 (3.0)	ADAM1 (2.5)	TIMD4 (2.0)	ANKRD31 (1.7)	GCNT4 (1.5)	ALDH2 (1.5)	BLOC1S3 (1.4)	CETP (1.3)	TMEM57 (1.2)	POLK (1.1)
ENSG00000102312	PORCN PPI subnetwork	0.97	> 0.20	BCAM (2.4)	TSSK6 (2.3)	CBLC (2.3)	C11orf9 (1.9)	AP1M2 (1.7)	HAPLN4 (1.6)	PLEKHH2 (1.4)	POLK (1.4)	HMGCR (1.1)	PBX4 (1.1)
ENSG00000180628	PCGF5 PPI subnetwork	0.97	> 0.20	ATXN2 (2.5)	ILF3 (2.4)	CARM1 (2.3)	MARK4 (2.3)	GATAD2A (2.1)	SMARCA4 (2.0)	TOP1 (1.7)	TMEM57 (1.6)	ATXN7L2 (1.5)	NKPD1 (1.4)
GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	0.97	> 0.20	ENSG00000226648 (3.9)	BLOC1S3 (1.9)	ZNF180 (1.5)	CILP2 (1.4)	MYLIP (1.4)	SH2B3 (1.4)	DNAH11 (1.3)	LPIN3 (1.3)	GMPR (1.2)	POC5 (1.1)
ENSG00000120889	TNFRSF10B PPI subnetwork	0.97	> 0.20	PVR (2.2)	OGDH (2.0)	C12orf43 (1.8)	ZNF180 (1.7)	C11orf9 (1.7)	TRAFD1 (1.6)	HAVCR1 (1.5)	APOE (1.5)	FRK (1.4)	SH2B3 (1.3)
MP:0000165	abnormal long bone hypertrophic chondrocyte zone	0.97	> 0.20	CILP2 (4.9)	MAFB (2.5)	PLEKHH2 (2.5)	TRIB1 (2.0)	KIAA1324 (1.9)	FRK (1.3)	YIPF2 (1.3)	MYLIP (1.2)	NPC1L1 (1.2)	RHCE (1.1)
ENSG00000142731	PLK4 PPI subnetwork	0.97	> 0.20	ZNF180 (2.1)	PTPN11 (1.6)	PMFBP1 (1.6)	MYLIP (1.5)	C19orf52 (1.4)	ILF3 (1.4)	AP1M2 (1.4)	CELSR2 (1.3)	RHD (1.3)	TMEM116 (1.3)
ENSG00000156076	WIF1 PPI subnetwork	0.97	> 0.20	CBLC (2.6)	BCAM (2.5)	TSSK6 (2.5)	AP1M2 (1.5)	C11orf9 (1.4)	PBX4 (1.3)	HAPLN4 (1.2)	PLEKHH2 (1.2)	NYNRIN (1.2)	SLC44A2 (1.2)
GO:0045851	pH reduction	0.97	> 0.20	UBXN2B (2.7)	CEACAM19 (2.6)	AMIGO1 (2.4)	PPP1R37 (2.0)	TMEM116 (2.0)	ENSG00000238078 (1.9)	HNF1A (1.9)	TMED4 (1.8)	ERP29 (1.8)	COL4A3BP (1.7)
GO:0030137	COPI-coated vesicle	0.97	> 0.20	YIPF2 (4.6)	KIAA1324 (2.7)	SARS (1.9)	PSMA5 (1.9)	POC5 (1.7)	SUGP1 (1.7)	ATP13A1 (1.6)	MAU2 (1.5)	ABCG8 (1.3)	DNM2 (1.3)
ENSG00000063176	SPHK2 PPI subnetwork	0.97	> 0.20	RHD (3.1)	DNM2 (2.4)	ZNF101 (2.1)	CLPTM1 (2.0)	CYB561D1 (1.9)	ENSG00000235545 (1.7)	ENSG00000238078 (1.7)	MARK4 (1.7)	MOSC1 (1.5)	GPAM (1.4)
GO:0008593	regulation of Notch signaling pathway	0.97	> 0.20	C12orf47 (2.9)	NCAN (2.3)	KIAA1324 (2.1)	CBLC (1.8)	CELSR2 (1.7)	GOT2P1 (1.7)	ENSG00000254235 (1.5)	MYLIP (1.4)	C12orf43 (1.4)	GEMIN7 (1.3)
ENSG00000186051	TAL2 PPI subnetwork	0.97	> 0.20	MYLIP (2.9)	NCAN (2.0)	UBXN2B (1.8)	NYNRIN (1.6)	ENSG00000226648 (1.5)	HLX (1.5)	C12orf47 (1.4)	TMEM57 (1.2)	SMARCA4 (1.2)	MAFB (1.1)
GO:0010656	negative regulation of muscle cell apoptotic process	0.97	> 0.20	CEACAM19 (2.2)	SLC22A1 (2.1)	ENSG00000226648 (1.8)	HNF1A (1.7)	C12orf47 (1.6)	TMEM116 (1.4)	ENSG00000228044 (1.4)	ENSG00000238078 (1.3)	CILP2 (1.3)	TSSK6 (1.3)
GO:0016486	peptide hormone processing	0.97	> 0.20	KIAA1324 (4.2)	ST3GAL4 (1.9)	TMED4 (1.8)	YIPF2 (1.8)	AMIGO1 (1.7)	ZNF101 (1.4)	C12orf47 (1.3)	ENSG00000235545 (1.3)	ENSG00000238078 (1.2)	HNF1A (1.2)
ENSG00000176697	BDNF PPI subnetwork	0.97	> 0.20	KIAA1324 (3.3)	CELSR2 (2.3)	DHX38 (2.0)	C11orf9 (2.0)	GMPR (1.9)	BCAM (1.7)	GOT2P1 (1.6)	PMFBP1 (1.6)	AMIGO1 (1.6)	SLC44A2 (1.5)
ENSG00000157240	FZD1 PPI subnetwork	0.97	> 0.20	BCAM (3.0)	CBLC (2.8)	C11orf9 (2.4)	NYNRIN (1.9)	TSSK6 (1.4)	CILP2 (1.4)	ENSG00000235545 (1.4)	ILF3 (1.4)	LPA (1.3)	CELSR2 (1.3)
ENSG00000136573	BLK PPI subnetwork	0.97	> 0.20	DNAH11 (2.9)	FADS2 (2.6)	CETP (2.0)	DOCK7 (1.7)	TIMD4 (1.7)	AP1M2 (1.6)	GRINA (1.6)	POLK (1.6)	ITGB3 (1.5)	GMIP (1.5)
GO:0009881	photoreceptor activity	0.97	> 0.20	CEACAM19 (1.6)	MAPKAPK5 (1.4)	ENSG00000235545 (1.2)	NKPD1 (1.1)	BLOC1S3 (1.1)	GOT2P1 (1.1)	TRIB1 (1.0)	C12orf47 (1.0)	C19orf52 (1.0)	ATXN7L2 (1.0)
GO:0090022	regulation of neutrophil chemotaxis	0.97	> 0.20	ENSG00000228044 (2.8)	CILP2 (2.1)	TIMD4 (1.8)	APOE (1.4)	BLOC1S3 (1.2)	TXNL4B (1.1)	DNAH11 (1.1)	SLC22A1 (1.0)	TRAPPC6A (0.9)	DHODH (0.9)
GO:0005876	spindle microtubule	0.97	> 0.20	PSRC1 (6.0)	POC5 (2.9)	FEN1 (2.8)	USP1 (2.3)	DYNC2LI1 (1.8)	ENSG00000228044 (1.2)	TMEM57 (1.1)	POLK (1.0)	BUD13 (1.0)	SORT1 (1.0)
MP:0004395	increased cochlear inner hair cell number	0.97	> 0.20	BCAM (3.9)	MYLIP (2.4)	NYNRIN (2.1)	CELSR2 (1.6)	NCAN (1.4)	PVRL2 (1.3)	ENSG00000238078 (1.1)	USP24 (1.0)	DYNC2LI1 (1.0)	TRIB1 (1.0)
GO:0060993	kidney morphogenesis	0.97	> 0.20	HNF1A (3.1)	HAVCR1 (3.0)	FRK (2.4)	PLEKHH2 (2.4)	ENSG00000238078 (2.3)	AP1M2 (2.1)	TSSK6 (2.1)	BCAM (2.0)	ABO (1.8)	NYNRIN (1.6)
GO:0048741	skeletal muscle fiber development	0.97	> 0.20	SYPL2 (3.7)	ENSG00000226648 (2.9)	AMIGO1 (2.1)	ZHX3 (2.0)	ATXN7L2 (1.9)	OGDH (1.9)	LPIN3 (1.8)	ANKRD31 (1.8)	SLC44A2 (1.8)	PLEKHH2 (1.5)
GO:0007519	skeletal muscle tissue development	0.97	> 0.20	SYPL2 (4.8)	ATXN7L2 (2.3)	ANKRD31 (1.8)	SLC44A2 (1.8)	ZHX3 (1.7)	AMIGO1 (1.7)	ENSG00000226648 (1.5)	PLEKHH2 (1.4)	OGDH (1.4)	KANK2 (1.4)
KEGG_HUNTINGTONS_DISEASE	KEGG_HUNTINGTONS_DISEASE	0.97	> 0.20	OGDH (3.9)	C12orf47 (2.8)	ACAD10 (2.7)	TRAPPC6A (2.4)	PSMA5 (2.2)	GOT2P1 (1.9)	TOMM40 (1.6)	C1orf63 (1.5)	CLPTM1 (1.4)	MAU2 (1.3)
GO:0048706	embryonic skeletal system development	0.97	> 0.20	ATXN7L2 (1.9)	CILP2 (1.8)	ENSG00000238078 (1.6)	CEACAM19 (1.5)	NYNRIN (1.4)	PMFBP1 (1.4)	HLX (1.3)	MYLIP (1.3)	ENSG00000235545 (1.3)	PLEKHH2 (1.3)
ENSG00000013583	HEBP1 PPI subnetwork	0.97	> 0.20	RHD (2.6)	ALDH2 (2.5)	DOCK7 (2.3)	HAVCR1 (2.1)	TMEM116 (2.1)	RHCE (2.0)	GMPR (1.9)	PBX4 (1.8)	ERP29 (1.8)	TMED4 (1.8)
GO:0019722	calcium-mediated signaling	0.97	> 0.20	C12orf47 (3.3)	DNAH11 (2.5)	ADAM1 (2.1)	ITGB3 (2.0)	RPH3A (1.8)	ZNF101 (1.7)	ABO (1.5)	NKPD1 (1.3)	HAVCR1 (1.2)	PLCG1 (1.1)
ENSG00000163104	SMARCAD1 PPI subnetwork	0.97	> 0.20	ADAM1 (2.9)	C12orf47 (2.2)	ATXN2 (2.1)	POC5 (1.9)	GEMIN7 (1.9)	MAU2 (1.7)	C12orf51 (1.6)	ZNF101 (1.6)	TMED4 (1.3)	HAPLN4 (1.2)
GO:0004721	phosphoprotein phosphatase activity	0.97	> 0.20	TRIB1 (3.2)	PVR (2.4)	SH2B3 (2.2)	SYPL2 (1.7)	SORT1 (1.7)	AMIGO1 (1.6)	PTPN11 (1.6)	MAPKAPK5 (1.5)	HLX (1.5)	USP1 (1.4)
ENSG00000189060	H1F0 PPI subnetwork	0.97	> 0.20	QTRT1 (2.8)	PLCG1 (1.8)	FADS1 (1.7)	KIAA1324 (1.5)	C17orf57 (1.5)	ZNF259 (1.5)	CARM1 (1.3)	C19orf52 (1.3)	GATAD2A (1.3)	ILF3 (1.2)
MP:0000162	lordosis	0.97	> 0.20	CILP2 (5.8)	PBX4 (2.7)	MAFB (2.5)	NCAN (2.2)	PSRC1 (1.8)	CARM1 (1.6)	YIPF2 (1.5)	ENSG00000228044 (1.5)	GATAD2A (1.3)	MAU2 (1.2)
ENSG00000130787	HIP1R PPI subnetwork	0.97	> 0.20	C12orf51 (3.6)	SMARCA4 (3.6)	USP24 (3.2)	ACAD10 (2.6)	ATXN2 (2.5)	DNM2 (2.4)	ZNF259 (1.9)	SARS (1.9)	PTPN11 (1.8)	SUGP1 (1.8)
GO:0004576	oligosaccharyl transferase activity	0.97	> 0.20	ERP29 (4.7)	ATP13A1 (3.3)	TMED4 (3.2)	TMEM50A (2.8)	CLPTM1 (2.3)	YIPF2 (2.2)	PSMA5 (1.9)	SORT1 (1.9)	TMEM57 (1.6)	SLC44A2 (1.3)
GO:0000045	autophagic vacuole assembly	0.97	> 0.20	BRAP (4.6)	TXNL4B (4.1)	C1orf63 (2.9)	BLOC1S3 (2.9)	TMEM50A (2.3)	ENSG00000226645 (2.3)	MAU2 (2.0)	ACAD10 (2.0)	C12orf51 (1.7)	C19orf52 (1.7)
KEGG_LONG_TERM_POTENTIATION	KEGG_LONG_TERM_POTENTIATION	0.97	> 0.20	CYB561D1 (2.4)	NCAN (2.2)	ZHX3 (2.0)	TSSK6 (1.8)	SH2B3 (1.8)	C12orf51 (1.7)	PLEKHH2 (1.6)	ATXN7L2 (1.5)	MARK4 (1.4)	TMEM50A (1.4)
GO:0004115	3',5'-cyclic-AMP phosphodiesterase activity	0.97	> 0.20	SORT1 (2.1)	MAU2 (1.7)	NCAN (1.7)	TMEM116 (1.6)	PCSK9 (1.5)	TMED4 (1.4)	POLK (1.4)	TRIB1 (1.4)	GOT2P1 (1.3)	OGDH (1.2)
ENSG00000172939	OXSR1 PPI subnetwork	0.97	> 0.20	TMEM57 (2.8)	USP24 (2.3)	HNF1A (2.3)	KIAA1324 (1.8)	ABO (1.8)	SORT1 (1.7)	PTPN11 (1.6)	ANGPTL3 (1.6)	CEACAM19 (1.5)	PLG (1.4)
GO:0060076	excitatory synapse	0.97	> 0.20	NCAN (5.9)	CELSR2 (3.4)	RPH3A (3.0)	C11orf9 (2.2)	HAPLN4 (1.9)	ABCG8 (1.8)	GCNT4 (1.6)	GPAM (1.6)	CYP7A1 (1.5)	CBLC (1.5)
GO:0070228	regulation of lymphocyte apoptotic process	0.97	> 0.20	GMIP (1.9)	PARP10 (1.7)	PBX4 (1.5)	C12orf47 (1.3)	ZNF101 (1.3)	HLX (1.2)	C17orf57 (1.1)	CYB561D1 (1.1)	QTRT1 (1.0)	SH2B3 (1.0)
GO:0048813	dendrite morphogenesis	0.97	> 0.20	NCAN (2.7)	GOT2P1 (2.0)	RPH3A (2.0)	ABO (1.7)	C12orf51 (1.7)	CELSR2 (1.6)	C12orf43 (1.5)	PBX4 (1.4)	DOCK7 (1.3)	ATXN7L2 (1.3)
GO:0071103	DNA conformation change	0.97	> 0.20	ENSG00000226648 (2.5)	PSRC1 (2.4)	PMFBP1 (2.3)	TSSK6 (2.3)	USP1 (2.1)	C19orf52 (2.0)	FEN1 (1.6)	POC5 (1.3)	ZNF180 (1.3)	TMEM57 (1.2)
GO:0070229	negative regulation of lymphocyte apoptotic process	0.97	> 0.20	C12orf47 (2.1)	PBX4 (2.0)	HNF1A (1.6)	ENSG00000226648 (1.4)	TXNL4B (1.4)	CYB561D1 (1.3)	BLOC1S3 (1.3)	ZNF101 (1.2)	PARP10 (1.2)	TRAFD1 (1.1)
GO:0043462	regulation of ATPase activity	0.97	> 0.20	ENSG00000235545 (1.8)	GMPR (1.8)	TMEM50A (1.8)	NKPD1 (1.7)	SYPL2 (1.5)	CEACAM19 (1.4)	LPAR2 (1.4)	C12orf47 (1.3)	KANK2 (1.2)	DHODH (1.2)
GO:0004890	GABA-A receptor activity	0.97	> 0.20	LPIN3 (2.0)	MYLIP (1.9)	HAPLN4 (1.6)	RPH3A (1.6)	C11orf9 (1.3)	ANKRD31 (1.3)	FRK (1.3)	NCAN (1.2)	C12orf43 (1.2)	KIAA1324 (1.1)
MP:0002239	abnormal nasal septum morphology	0.97	> 0.20	NYNRIN (2.7)	CILP2 (1.7)	TMED4 (1.5)	TRAFD1 (1.5)	POLK (1.5)	C12orf47 (1.4)	ITGB3 (1.3)	HLX (1.3)	MARK4 (1.1)	CLPTM1 (1.1)
ENSG00000196735	HLA-DQA1 PPI subnetwork	0.97	> 0.20	PLCG1 (4.2)	ZNF101 (3.1)	ALDH2 (2.9)	KIAA1324 (1.9)	APOE (1.6)	MAFB (1.5)	HAVCR1 (1.4)	TIMD4 (1.4)	RHCE (1.3)	APOC1 (1.2)
ENSG00000132698	RAB25 PPI subnetwork	0.97	> 0.20	AP1M2 (3.7)	DYNC2LI1 (2.2)	ZNF180 (2.0)	GCNT4 (1.8)	LPIN3 (1.8)	MARK4 (1.7)	ZHX3 (1.7)	PLCG1 (1.7)	GEMIN7 (1.6)	CLPTM1 (1.4)
KEGG_OOCYTE_MEIOSIS	KEGG_OOCYTE_MEIOSIS	0.97	> 0.20	PSRC1 (2.8)	FEN1 (2.4)	USP1 (2.0)	LPIN3 (1.8)	ENSG00000238078 (1.6)	CLPTM1 (1.4)	ENSG00000228044 (1.4)	COL4A3BP (1.3)	GATAD2A (1.2)	MARK4 (1.1)
ENSG00000214122	ENSG00000214122 PPI subnetwork	0.97	> 0.20	SARS (3.5)	COL4A3BP (3.0)	TRAFD1 (2.8)	TMEM50A (2.6)	PSMA5 (2.4)	ZNF259 (2.0)	C19orf52 (1.8)	SORT1 (1.6)	SUGP1 (1.6)	PVR (1.6)
GO:0005746	mitochondrial respiratory chain	0.97	> 0.20	OGDH (3.4)	ACAD10 (3.4)	C12orf47 (2.7)	TRAPPC6A (2.5)	GOT2P1 (1.5)	PSMA5 (1.5)	TMED4 (1.4)	MAU2 (1.3)	TMEM116 (1.2)	GMPR (1.2)
GO:0050853	B cell receptor signaling pathway	0.97	> 0.20	GMIP (2.1)	GCNT4 (1.9)	ZNF101 (1.8)	SH2B3 (1.6)	SLC44A2 (1.5)	TIMD4 (1.3)	C17orf57 (1.3)	ERP29 (1.3)	ENSG00000235545 (1.2)	TMEM116 (1.2)
ENSG00000188064	WNT7B PPI subnetwork	0.97	> 0.20	CILP2 (4.6)	BCAM (2.4)	CELSR2 (2.3)	KIAA1324 (2.3)	TXNL4B (1.9)	MOSC1 (1.8)	DYNC2LI1 (1.7)	LPAR2 (1.7)	TRAPPC6A (1.6)	AMIGO1 (1.6)
GO:0072077	renal vesicle morphogenesis	0.97	> 0.20	HNF1A (3.6)	ENSG00000228044 (1.8)	TSSK6 (1.7)	C17orf57 (1.6)	ENSG00000235545 (1.5)	PMFBP1 (1.5)	TMEM116 (1.4)	HAVCR1 (1.3)	ABO (1.3)	ENSG00000238078 (1.2)
MP:0005121	decreased circulating prolactin level	0.97	> 0.20	KIAA1324 (4.0)	GCNT4 (2.4)	LDLR (2.2)	C12orf51 (1.8)	MAU2 (1.6)	CELSR2 (1.6)	PVRL2 (1.5)	FRK (1.5)	C12orf47 (1.5)	BRAP (1.4)
GO:0042776	mitochondrial ATP synthesis coupled proton transport	0.97	> 0.20	OGDH (3.7)	C12orf47 (3.5)	ACAD10 (3.4)	ENSG00000238078 (2.2)	TMEM116 (2.0)	C19orf52 (1.9)	GOT2P1 (1.9)	PSMA5 (1.9)	ENSG00000226648 (1.8)	FRK (1.7)
ENSG00000127334	DYRK2 PPI subnetwork	0.97	> 0.20	FADS2 (2.8)	DOCK7 (1.8)	DNAH11 (1.8)	GRINA (1.8)	NCAN (1.8)	CETP (1.7)	POLK (1.7)	SH2B3 (1.7)	MYLIP (1.6)	TMEM57 (1.5)
ENSG00000154727	GABPA PPI subnetwork	0.97	> 0.20	CELSR2 (2.4)	ATXN2 (2.4)	USP1 (2.2)	C12orf51 (2.1)	BUD13 (1.8)	UBXN2B (1.7)	PLEC (1.6)	NCAN (1.4)	AMIGO1 (1.2)	TXNL4B (1.2)
MP:0004765	decreased brainstem auditory evoked potential	0.97	> 0.20	CILP2 (2.7)	PLEKHH2 (2.3)	BCAM (2.2)	NCAN (1.9)	PBX4 (1.8)	SORT1 (1.8)	HNF1A (1.5)	GPAM (1.5)	SLC44A2 (1.5)	ZHX3 (1.4)
GO:0032731	positive regulation of interleukin-1 beta production	0.97	> 0.20	ENSG00000238078 (2.0)	TRAFD1 (1.9)	CYB561D1 (1.8)	ST3GAL4 (1.5)	ALDH2 (1.5)	BLOC1S3 (1.5)	C12orf43 (1.4)	DOCK7 (1.4)	CEACAM19 (1.3)	NKPD1 (1.2)
ENSG00000172006	ZNF554 PPI subnetwork	0.97	> 0.20	PVR (2.4)	ERP29 (2.1)	ZNF180 (2.0)	PTPN11 (2.0)	APOE (1.8)	KANK2 (1.7)	TIMD4 (1.6)	ALDH2 (1.4)	POLK (1.2)	DYNC2LI1 (1.2)
GO:0002429	immune response-activating cell surface receptor signaling pathway	0.97	> 0.20	ZNF101 (4.6)	GMIP (2.8)	PLCG1 (2.5)	PBX4 (2.5)	CYB561D1 (2.1)	HAVCR1 (2.0)	TIMD4 (1.7)	MAFB (1.7)	TRAPPC6A (1.6)	ADAM1 (1.6)
ENSG00000105443	CYTH2 PPI subnetwork	0.97	> 0.20	SH2B3 (2.5)	TSSK6 (2.0)	NCAN (1.9)	GMIP (1.7)	TMED4 (1.7)	PTPN11 (1.7)	C19orf52 (1.5)	HAPLN4 (1.4)	CYP7A1 (1.3)	ZHX3 (1.3)
GO:0048024	regulation of nuclear mRNA splicing, via spliceosome	0.97	> 0.20	C1orf63 (4.2)	ADAM1 (2.9)	C17orf57 (2.4)	TOP1 (2.2)	BUD13 (1.9)	MAU2 (1.9)	ATXN2 (1.7)	BRAP (1.6)	C12orf43 (1.4)	ERP29 (1.4)
ENSG00000078269	SYNJ2 PPI subnetwork	0.97	> 0.20	LPIN3 (3.2)	CBLC (3.0)	AP1M2 (2.6)	COL4A3BP (2.5)	FRK (2.3)	ZHX3 (1.9)	PBX4 (1.9)	PSRC1 (1.8)	HAPLN4 (1.5)	C17orf57 (1.4)
ENSG00000089169	RPH3A PPI subnetwork	0.97	> 0.20	KIAA1324 (3.3)	C12orf51 (2.3)	NCAN (2.2)	C11orf9 (2.1)	RPH3A (2.0)	CELSR2 (1.8)	TMEM50A (1.8)	SORT1 (1.7)	UBXN2B (1.4)	FADS1 (1.4)
ENSG00000033050	ABCF2 PPI subnetwork	0.97	> 0.20	ENSG00000238078 (2.8)	DHX38 (2.4)	NAA25 (2.3)	TOP1 (2.3)	TOMM40 (2.2)	GMPR (2.2)	PLCG1 (2.2)	BRAP (2.1)	DDX56 (1.8)	ILF3 (1.7)
GO:0051313	attachment of spindle microtubules to chromosome	0.97	> 0.20	PSRC1 (4.3)	POC5 (3.9)	ENSG00000226648 (2.2)	UBXN2B (2.1)	DNAH11 (1.5)	TXNL4B (1.4)	ENSG00000228044 (1.4)	GCNT4 (1.1)	GEMIN7 (1.1)	AMIGO1 (1.1)
ENSG00000087008	ACOX3 PPI subnetwork	0.97	> 0.20	ABO (2.2)	C12orf51 (2.2)	USP24 (2.1)	UBXN2B (2.1)	ST3GAL4 (1.9)	MARK4 (1.8)	BUD13 (1.7)	PTPN11 (1.7)	SORT1 (1.6)	GMIP (1.5)
GO:0005525	GTP binding	0.97	> 0.20	C12orf43 (3.4)	DYNC2LI1 (3.1)	GATAD2A (1.7)	ITGB3 (1.7)	SARS (1.7)	ZNF259 (1.5)	TRAFD1 (1.5)	AP1M2 (1.5)	PTPN11 (1.4)	OASL (1.3)
GO:0032703	negative regulation of interleukin-2 production	0.97	> 0.20	PBX4 (2.6)	ADAM1 (2.2)	PMFBP1 (2.1)	TIMD4 (1.8)	LPAR2 (1.8)	MAU2 (1.3)	POC5 (1.2)	CYB561D1 (1.1)	UBXN2B (1.1)	GEMIN7 (1.0)
ENSG00000155130	MARCKS PPI subnetwork	0.97	> 0.20	NCAN (2.5)	RPH3A (2.4)	UBXN2B (2.1)	SORT1 (2.1)	TMEM50A (2.0)	C11orf9 (1.8)	C12orf51 (1.7)	CELSR2 (1.6)	GOT2P1 (1.5)	MARK4 (1.4)
ENSG00000168539	CHRM1 PPI subnetwork	0.97	> 0.20	SH2B3 (2.0)	RPH3A (1.9)	AMIGO1 (1.8)	CETP (1.8)	PVR (1.7)	C17orf57 (1.5)	NCAN (1.5)	TMEM50A (1.3)	ZNF180 (1.2)	COL4A3BP (1.0)
MP:0004131	abnormal embryonic cilium morphology	0.97	> 0.20	DYNC2LI1 (7.2)	DNAH11 (2.4)	PBX4 (2.2)	ACAD10 (2.1)	UBXN2B (1.9)	LPIN3 (1.6)	C17orf57 (1.4)	QTRT1 (1.4)	ATXN7L2 (1.3)	NKPD1 (1.2)
GO:0006873	cellular ion homeostasis	0.97	> 0.20	RPH3A (2.8)	SYPL2 (1.9)	HAPLN4 (1.8)	ABO (1.7)	C12orf47 (1.7)	ERP29 (1.7)	RHD (1.6)	AMIGO1 (1.5)	RHCE (1.5)	C11orf9 (1.4)
REACTOME_EICOSANOID_LIGAND:BINDING_RECEPTORS	REACTOME_EICOSANOID_LIGAND:BINDING_RECEPTORS	0.97	> 0.20	HLX (3.0)	C11orf9 (2.4)	ABO (2.3)	NKPD1 (1.5)	ITGB3 (1.5)	DNAH11 (1.4)	MAFB (1.2)	C12orf47 (1.1)	CILP2 (1.1)	POLK (1.1)
GO:0048703	embryonic viscerocranium morphogenesis	0.97	> 0.20	LPIN3 (3.3)	TMEM57 (2.5)	TSSK6 (2.1)	ENSG00000235545 (2.0)	CEACAM19 (1.9)	ZHX3 (1.8)	C19orf52 (1.5)	COL4A3BP (1.5)	POC5 (1.4)	ENSG00000228044 (1.3)
ENSG00000125266	EFNB2 PPI subnetwork	0.97	> 0.20	PLCG1 (3.3)	LPAR2 (3.1)	MARK4 (3.1)	PBX4 (2.4)	NYNRIN (2.4)	NCAN (2.2)	AMIGO1 (2.2)	CBLC (1.9)	SLC44A2 (1.8)	CELSR2 (1.7)
ENSG00000170906	NDUFA3 PPI subnetwork	0.97	> 0.20	OGDH (3.6)	ACAD10 (3.1)	C12orf47 (2.7)	TRAPPC6A (2.6)	MAU2 (1.7)	FRK (1.7)	GOT2P1 (1.6)	PSMA5 (1.5)	GMPR (1.4)	TMED4 (1.2)
MP:0009011	prolonged diestrus	0.97	> 0.20	GPAM (2.8)	MOSC1 (2.0)	SLC22A1 (1.6)	ST3GAL4 (1.6)	GEMIN7 (1.5)	C12orf47 (1.4)	TIMD4 (1.3)	NCAN (1.3)	ABO (1.2)	ZHX3 (1.1)
ENSG00000075292	ZNF638 PPI subnetwork	0.97	> 0.20	AP1M2 (3.0)	HAVCR1 (2.0)	KANK2 (1.6)	C17orf57 (1.6)	PBX4 (1.5)	ENSG00000226645 (1.5)	TRAPPC6A (1.3)	LPAR2 (1.3)	TMEM116 (1.2)	CELSR2 (1.2)
ENSG00000211762	ENSG00000211762 PPI subnetwork	0.97	> 0.20	PLCG1 (3.4)	APOE (2.3)	ZNF101 (2.2)	ALDH2 (1.8)	CEACAM19 (1.7)	C19orf52 (1.5)	APOC1 (1.3)	ADAM1 (1.2)	PBX4 (1.2)	HAVCR1 (1.2)
MP:0001905	abnormal dopamine level	0.97	> 0.20	ENSG00000228044 (2.6)	DNAH11 (2.5)	ENSG00000254235 (1.9)	TSSK6 (1.3)	CILP2 (1.3)	ACAD10 (1.3)	ENSG00000226645 (1.3)	ST3GAL4 (1.3)	TRIB1 (1.2)	AMIGO1 (1.2)
GO:0072175	epithelial tube formation	0.97	> 0.20	DYNC2LI1 (3.2)	PPP1R37 (2.1)	DOCK7 (2.0)	TMEM116 (2.0)	ATXN7L2 (2.0)	PVRL2 (1.9)	LPAR2 (1.7)	MYLIP (1.6)	CELSR2 (1.5)	AP1M2 (1.5)
GO:0033631	cell-cell adhesion mediated by integrin	0.97	> 0.20	NKPD1 (1.9)	CYB561D1 (1.5)	TSSK6 (1.5)	ADAM1 (1.5)	PVRL2 (1.5)	USP24 (1.4)	PBX4 (1.3)	TMEM50A (1.3)	MAPKAPK5 (1.3)	PTPN11 (1.1)
GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	0.97	> 0.20	ANKRD31 (2.8)	AMIGO1 (2.4)	MAFB (1.8)	TMED4 (1.7)	SLC44A2 (1.7)	PVRL2 (1.6)	C17orf57 (1.5)	BCAM (1.4)	CYB561D1 (1.4)	CBLC (1.2)
MP:0008347	decreased gamma-delta T cell number	0.97	> 0.20	BCAM (2.5)	PLCG1 (2.4)	PBX4 (2.3)	ZNF101 (2.2)	SMARCA4 (2.2)	PLEC (2.1)	RHD (2.0)	SLC44A2 (1.9)	MARK4 (1.4)	SH2B3 (1.3)
GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	0.97	> 0.20	KIAA1324 (3.4)	TMED4 (2.7)	CILP2 (2.1)	GCNT4 (2.1)	SLC44A2 (2.0)	TMEM50A (2.0)	ANKRD31 (1.9)	TMEM57 (1.6)	MYLIP (1.5)	ENSG00000235545 (1.5)
ENSG00000205155	PSENEN PPI subnetwork	0.97	> 0.20	CLPTM1 (4.0)	ADAM1 (3.0)	TMED4 (2.9)	ERP29 (2.6)	ENSG00000226645 (2.3)	TMEM50A (2.3)	PTPN11 (2.2)	YIPF2 (1.9)	SORT1 (1.6)	PVRL2 (1.5)
GO:0048709	oligodendrocyte differentiation	0.97	> 0.20	NCAN (3.6)	C11orf9 (2.2)	SORT1 (2.1)	C19orf52 (1.8)	DYNC2LI1 (1.8)	ALDH2 (1.8)	ABO (1.6)	CELSR2 (1.5)	ENSG00000254235 (1.4)	POLK (1.4)
REACTOME_OLFACTORY_SIGNALING_PATHWAY	REACTOME_OLFACTORY_SIGNALING_PATHWAY	0.97	> 0.20	ENSG00000228044 (2.8)	ENSG00000235545 (2.8)	HNF1A (2.3)	GOT2P1 (1.6)	DNAH11 (1.3)	ABO (1.2)	HAVCR1 (1.1)	RHCE (0.8)	NT5DC1 (0.7)	MOSC1 (0.6)
GO:0071837	HMG box domain binding	0.97	> 0.20	NCAN (3.1)	CILP2 (2.1)	HLX (1.9)	ENSG00000226648 (1.6)	MAFB (1.6)	NPC1L1 (1.3)	MYLIP (1.3)	SH2B3 (1.2)	PTPN11 (1.1)	ATXN7L2 (1.1)
GO:0070838	divalent metal ion transport	0.97	> 0.20	SYPL2 (2.2)	ABO (2.1)	RPH3A (2.0)	SLC44A2 (1.9)	KIAA1324 (1.9)	AMIGO1 (1.7)	CLPTM1 (1.7)	C12orf47 (1.6)	ENSG00000226645 (1.5)	C12orf43 (1.4)
ENSG00000175634	RPS6KB2 PPI subnetwork	0.97	> 0.20	ALDH2 (2.8)	ZNF101 (2.3)	ACAD10 (2.0)	C19orf52 (1.9)	COL4A3BP (1.8)	TOP1 (1.6)	TMEM57 (1.5)	TMEM50A (1.4)	PTPN11 (1.4)	GPAM (1.4)
ENSG00000092470	WDR76 PPI subnetwork	0.97	> 0.20	ZNF180 (3.2)	FEN1 (2.6)	USP1 (2.2)	POC5 (2.2)	BRAP (1.9)	NAA25 (1.6)	C19orf52 (1.4)	ZNF259 (1.3)	GEMIN7 (1.2)	NYNRIN (1.2)
ENSG00000156802	ATAD2 PPI subnetwork	0.97	> 0.20	TOP1 (3.4)	ILF3 (3.3)	C19orf52 (2.6)	FEN1 (2.6)	DHX38 (2.1)	DDX56 (2.0)	ZNF259 (1.9)	CELSR2 (1.9)	SMARCA4 (1.8)	GATAD2A (1.7)
GO:0007026	negative regulation of microtubule depolymerization	0.97	> 0.20	POC5 (3.0)	CEACAM19 (2.7)	LPAR2 (2.2)	DNAH11 (2.2)	NCAN (1.9)	SLC44A2 (1.3)	CYB561D1 (1.3)	MAPKAPK5 (1.3)	C19orf52 (1.1)	C12orf47 (1.1)
GO:0070888	E-box binding	0.97	> 0.20	HLX (2.6)	TMED4 (2.5)	CARM1 (2.0)	NPC1L1 (2.0)	RHD (1.9)	SYPL2 (1.8)	ATXN7L2 (1.6)	LPIN3 (1.5)	TMEM57 (1.5)	RHCE (1.5)
GO:0016236	macroautophagy	0.97	> 0.20	BRAP (4.4)	C1orf63 (3.2)	BLOC1S3 (3.1)	TXNL4B (2.9)	TMEM50A (2.6)	ACAD10 (2.4)	MAU2 (2.3)	TMEM57 (2.1)	C12orf51 (2.0)	DHX38 (1.6)
MP:0003233	prolonged QT interval	0.97	> 0.20	BCAM (2.6)	DNAH11 (2.5)	TMEM116 (2.4)	AMIGO1 (1.8)	ALDH2 (1.6)	PVR (1.6)	GCNT4 (1.3)	C12orf47 (1.3)	CYB561D1 (1.3)	RPH3A (1.2)
GO:0033178	proton-transporting two-sector ATPase complex, catalytic domain	0.97	> 0.20	SARS (3.2)	GRINA (3.0)	ENSG00000238078 (2.7)	AP1M2 (2.1)	C19orf52 (2.0)	SORT1 (1.9)	ACAD10 (1.8)	COL4A3BP (1.7)	BRAP (1.6)	CELSR2 (1.6)
ENSG00000108262	GIT1 PPI subnetwork	0.97	> 0.20	GMIP (2.7)	SH2B3 (2.7)	MARK4 (2.2)	LPIN3 (2.2)	UBXN2B (2.1)	PLEC (2.1)	SLC44A2 (2.0)	C12orf51 (1.9)	ATXN2 (1.8)	ENSG00000226645 (1.7)
MP:0002625	heart left ventricle hypertrophy	0.97	> 0.20	SYPL2 (2.3)	ERP29 (1.6)	ACAD10 (1.5)	BCAM (1.4)	CELSR2 (1.4)	GMPR (1.3)	C12orf47 (1.2)	TMEM116 (1.1)	SH2B3 (1.0)	USP24 (1.0)
GO:0072511	divalent inorganic cation transport	0.97	> 0.20	SYPL2 (2.3)	ABO (2.2)	SLC44A2 (2.1)	KIAA1324 (2.1)	RPH3A (1.9)	CLPTM1 (1.7)	ENSG00000226645 (1.7)	AMIGO1 (1.6)	C12orf47 (1.6)	C12orf43 (1.5)
REACTOME_INACTIVATION_OF_APCC_VIA_DIRECT_INHIBITION_OF_THE_APCC_COMPLEX	REACTOME_INACTIVATION_OF_APCC_VIA_DIRECT_INHIBITION_OF_THE_APCC_COMPLEX	0.97	> 0.20	PSRC1 (3.4)	POC5 (2.8)	FEN1 (2.8)	LPIN3 (2.7)	SUGP1 (2.4)	ADAM1 (2.1)	GEMIN7 (1.7)	LPAR2 (1.7)	DOCK7 (1.6)	ATP13A1 (1.6)
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APCC_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APCC_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	0.97	> 0.20	PSRC1 (3.4)	POC5 (2.8)	FEN1 (2.8)	LPIN3 (2.7)	SUGP1 (2.4)	ADAM1 (2.1)	GEMIN7 (1.7)	LPAR2 (1.7)	DOCK7 (1.6)	ATP13A1 (1.6)
GO:0030660	Golgi-associated vesicle membrane	0.97	> 0.20	YIPF2 (4.1)	KIAA1324 (2.6)	TMEM57 (2.3)	TRAFD1 (1.8)	ERP29 (1.8)	SUGP1 (1.8)	CLPTM1 (1.7)	TMEM50A (1.7)	SARS (1.7)	ATP13A1 (1.5)
GO:0048488	synaptic vesicle endocytosis	0.97	> 0.20	RPH3A (2.4)	C12orf51 (2.1)	GCNT4 (2.0)	DNAH11 (1.9)	C17orf57 (1.8)	PBX4 (1.5)	ENSG00000238078 (1.5)	HAPLN4 (1.5)	BLOC1S3 (1.5)	PPP1R37 (1.4)
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.97	> 0.20	AP1M2 (3.5)	ZHX3 (3.0)	SORT1 (3.0)	TMEM116 (2.9)	CELSR2 (2.4)	SYPL2 (2.3)	GCNT4 (1.4)	TRIB1 (1.3)	PLG (1.3)	MYLIP (1.3)
MP:0000438	abnormal cranium morphology	0.97	> 0.20	PLCG1 (2.3)	KANK2 (2.1)	NYNRIN (1.9)	NCAN (1.6)	ENSG00000226648 (1.4)	MYLIP (1.3)	KIAA1324 (1.3)	PLEC (1.2)	CILP2 (1.2)	ENSG00000238078 (1.2)
ENSG00000151532	VTI1A PPI subnetwork	0.97	> 0.20	SARS (3.1)	YIPF2 (2.4)	ZNF259 (2.3)	SUGP1 (2.3)	C12orf43 (2.1)	COL4A3BP (2.0)	CYB561D1 (2.0)	TRAFD1 (1.8)	C19orf52 (1.8)	SLC44A2 (1.8)
GO:0071774	response to fibroblast growth factor stimulus	0.97	> 0.20	ZHX3 (2.7)	ZNF101 (2.3)	ENSG00000226645 (2.1)	ZNF180 (1.8)	NKPD1 (1.6)	HAPLN4 (1.5)	PPP1R37 (1.5)	SLC44A2 (1.4)	MARK4 (1.3)	GPAM (1.3)
GO:0044344	cellular response to fibroblast growth factor stimulus	0.97	> 0.20	ZHX3 (2.7)	ZNF101 (2.3)	ENSG00000226645 (2.1)	ZNF180 (1.8)	NKPD1 (1.6)	HAPLN4 (1.5)	PPP1R37 (1.5)	SLC44A2 (1.4)	MARK4 (1.3)	GPAM (1.3)
MP:0008814	reduced nerve conduction velocity	0.97	> 0.20	GCNT4 (2.5)	SARS (2.4)	OGDH (2.3)	RPH3A (2.0)	TMEM116 (1.9)	ENSG00000226645 (1.6)	HAPLN4 (1.5)	POC5 (1.4)	NT5DC1 (1.4)	SORT1 (1.3)
ENSG00000147684	NDUFB9 PPI subnetwork	0.97	> 0.20	OGDH (3.4)	C12orf47 (2.8)	ACAD10 (2.7)	TRAPPC6A (2.3)	MAU2 (2.0)	PSMA5 (1.7)	GOT2P1 (1.3)	FRK (1.3)	PTPN11 (1.2)	GPAM (1.2)
GO:0005932	microtubule basal body	0.97	> 0.20	DYNC2LI1 (9.4)	PBX4 (2.3)	QTRT1 (1.9)	UBXN2B (1.7)	POLK (1.6)	POC5 (1.5)	PLEKHH2 (1.5)	DOCK7 (1.4)	DNAH11 (1.2)	BUD13 (1.2)
ENSG00000066468	FGFR2 PPI subnetwork	0.97	> 0.20	ENSG00000226645 (2.3)	AP1M2 (2.3)	HAPLN4 (2.3)	PLEKHH2 (2.1)	HNF1A (1.8)	LPAR2 (1.6)	PBX4 (1.6)	PVRL2 (1.5)	AMIGO1 (1.4)	GPAM (1.4)
GO:0048144	fibroblast proliferation	0.97	> 0.20	POLK (3.0)	DYNC2LI1 (2.2)	BLOC1S3 (2.1)	HAVCR1 (1.9)	PBX4 (1.5)	KANK2 (1.5)	CBLC (0.9)	AP1M2 (0.8)	TMED4 (0.8)	AMIGO1 (0.8)
ENSG00000043093	DCUN1D1 PPI subnetwork	0.97	> 0.20	BRAP (2.5)	ENSG00000254235 (2.5)	PTPN11 (2.4)	USP1 (1.8)	BUD13 (1.7)	MAPKAPK5 (1.7)	GMPR (1.5)	MYLIP (1.4)	ZNF180 (1.3)	TMEM116 (1.3)
GO:0051965	positive regulation of synapse assembly	0.97	> 0.20	NCAN (3.0)	ANKRD31 (2.5)	ZHX3 (2.4)	PLEKHH2 (2.1)	KIAA1324 (1.7)	CBLC (1.7)	PMFBP1 (1.4)	CELSR2 (1.4)	ABO (1.4)	RPH3A (1.4)
GO:0051962	positive regulation of nervous system development	0.97	> 0.20	NCAN (3.0)	ANKRD31 (2.5)	ZHX3 (2.4)	PLEKHH2 (2.1)	KIAA1324 (1.7)	CBLC (1.7)	PMFBP1 (1.4)	CELSR2 (1.4)	ABO (1.4)	RPH3A (1.4)
ENSG00000127955	GNAI1 PPI subnetwork	0.97	> 0.20	MYLIP (3.5)	TMEM50A (2.9)	AMIGO1 (2.1)	ERP29 (1.8)	KIAA1324 (1.7)	ZHX3 (1.7)	CELSR2 (1.7)	DNAH11 (1.7)	KANK2 (1.4)	CYB561D1 (1.4)
MP:0003463	abnormal single cell response	0.97	> 0.20	C12orf47 (4.1)	CEACAM19 (2.0)	RPH3A (1.5)	ENSG00000235545 (1.5)	NCAN (1.4)	CETP (1.4)	APOE (1.2)	LPA (1.2)	ENSG00000226645 (1.2)	ENSG00000254235 (1.2)
GO:0042375	quinone cofactor metabolic process	0.97	> 0.20	DHODH (2.9)	ACAD10 (2.9)	TMEM116 (2.6)	NT5DC1 (2.3)	C19orf52 (1.9)	OGDH (1.4)	GMPR (1.3)	ABCG8 (1.2)	TXNL4B (1.1)	C12orf43 (1.1)
ENSG00000159086	GCFC1 PPI subnetwork	0.97	> 0.20	CLPTM1 (3.2)	PPP1R37 (3.0)	HAPLN4 (2.1)	CETP (2.1)	ATP13A1 (1.8)	RPH3A (1.8)	AMIGO1 (1.6)	HAVCR1 (1.6)	BLOC1S3 (1.5)	SUGP1 (1.4)
GO:0004143	diacylglycerol kinase activity	0.97	> 0.20	CYB561D1 (2.2)	SH2B3 (2.2)	LPIN3 (2.1)	HAPLN4 (2.0)	PPP1R37 (1.7)	MARK4 (1.7)	GMIP (1.6)	MOSC1 (1.5)	PLCG1 (1.5)	TMEM116 (1.4)
GO:0021904	dorsal/ventral neural tube patterning	0.97	> 0.20	DYNC2LI1 (2.7)	PLEKHH2 (2.5)	AMIGO1 (2.5)	TMEM116 (2.2)	HNF1A (2.2)	C11orf9 (1.6)	NKPD1 (1.6)	TXNL4B (1.5)	PBX4 (1.5)	C12orf43 (1.4)
GO:0035809	regulation of urine volume	0.97	> 0.20	TMEM116 (2.6)	ENSG00000226648 (2.0)	ANGPTL3 (1.5)	ABO (1.5)	CEACAM19 (1.5)	AP1M2 (1.4)	FRK (1.2)	SLC44A2 (1.1)	BLOC1S3 (1.1)	BCAM (1.0)
GO:0010959	regulation of metal ion transport	0.97	> 0.20	SYPL2 (2.4)	KIAA1324 (2.3)	RPH3A (2.2)	AMIGO1 (2.1)	ABO (2.0)	MARK4 (1.6)	PPP1R37 (1.6)	CYB561D1 (1.5)	GMPR (1.5)	ENSG00000226645 (1.4)
ENSG00000151366	NDUFC2 PPI subnetwork	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.1)	TRAPPC6A (2.9)	C12orf47 (2.6)	MAU2 (1.7)	GOT2P1 (1.6)	FRK (1.6)	PSMA5 (1.4)	GMPR (1.2)	TMED4 (1.2)
GO:0014013	regulation of gliogenesis	0.97	> 0.20	NCAN (4.5)	ENSG00000254235 (2.4)	C11orf9 (2.2)	HAPLN4 (1.7)	NYNRIN (1.5)	LPAR2 (1.5)	PBX4 (1.4)	ABO (1.2)	BLOC1S3 (1.1)	CEACAM19 (1.1)
GO:0016469	proton-transporting two-sector ATPase complex	0.97	> 0.20	ENSG00000238078 (2.8)	TMEM116 (2.8)	SORT1 (2.6)	GRINA (2.5)	OGDH (2.4)	PSMA5 (2.3)	ERP29 (2.2)	SARS (2.2)	ACAD10 (2.0)	GMPR (1.8)
MP:0005297	spina bifida occulta	0.97	> 0.20	PVR (2.8)	POLK (2.4)	KANK2 (2.2)	GEMIN7 (2.0)	NCAN (1.8)	CEACAM19 (1.8)	FRK (1.7)	PPP1R37 (1.4)	ABO (1.3)	NYNRIN (1.2)
ENSG00000064490	RFXANK PPI subnetwork	0.97	> 0.20	TRAFD1 (2.7)	PARP10 (2.6)	C12orf51 (2.1)	ENSG00000238078 (1.9)	HLX (1.8)	DHX38 (1.7)	ACAD10 (1.5)	SMARCA4 (1.4)	SORT1 (1.4)	ENSG00000226648 (1.2)
MP:0000106	abnormal basisphenoid bone morphology	0.97	> 0.20	PLCG1 (1.8)	KANK2 (1.7)	DYNC2LI1 (1.6)	PLEKHH2 (1.3)	ST3GAL4 (1.3)	ENSG00000238078 (1.3)	ENSG00000235545 (1.2)	TMEM116 (1.2)	NYNRIN (1.0)	ABO (0.9)
GO:0004114	3',5'-cyclic-nucleotide phosphodiesterase activity	0.97	> 0.20	MOSC1 (2.5)	NCAN (1.9)	PBX4 (1.6)	POLK (1.6)	MYLIP (1.6)	PCSK9 (1.6)	SORT1 (1.5)	TMEM116 (1.4)	CETP (1.2)	HLX (1.1)
GO:0070469	respiratory chain	0.97	> 0.20	OGDH (3.5)	ACAD10 (3.4)	C12orf47 (2.6)	TRAPPC6A (2.5)	GOT2P1 (1.5)	PSMA5 (1.5)	TMED4 (1.5)	MAU2 (1.4)	GMPR (1.3)	TMEM116 (1.2)
MP:0003308	abnormal cochlear sensory epithelium morphology	0.97	> 0.20	CELSR2 (3.3)	BCAM (2.4)	PVRL2 (2.3)	HAPLN4 (2.3)	NCAN (1.9)	PLCG1 (1.7)	ZNF101 (1.5)	ENSG00000228044 (1.5)	SLC44A2 (1.4)	ZHX3 (1.4)
GO:0010863	positive regulation of phospholipase C activity	0.97	> 0.20	AMIGO1 (2.9)	PMFBP1 (2.1)	ZHX3 (2.1)	ITGB3 (1.8)	PLEKHH2 (1.8)	ST3GAL4 (1.6)	C12orf47 (1.5)	GOT2P1 (1.4)	ENSG00000235545 (1.3)	COL4A3BP (1.2)
GO:0001838	embryonic epithelial tube formation	0.97	> 0.20	DYNC2LI1 (3.2)	DOCK7 (2.2)	PPP1R37 (2.1)	ATXN7L2 (2.0)	TMEM116 (2.0)	PVRL2 (1.8)	LPAR2 (1.6)	MARK4 (1.6)	FRK (1.4)	MYLIP (1.4)
ENSG00000149968	MMP3 PPI subnetwork	0.97	> 0.20	MAFB (3.0)	CILP2 (1.9)	PVR (1.8)	APOE (1.7)	BCL3 (1.4)	NCAN (1.3)	LPA (1.1)	C11orf9 (1.1)	TMEM50A (1.1)	APOC1 (1.0)
ENSG00000121152	NCAPH PPI subnetwork	0.97	> 0.20	HAVCR1 (2.7)	PSRC1 (2.4)	RPH3A (2.1)	ENSG00000228044 (2.0)	HAPLN4 (1.9)	FEN1 (1.8)	NCAN (1.8)	USP1 (1.7)	CEACAM19 (1.6)	GCNT4 (1.5)
ENSG00000179899	ENSG00000179899 PPI subnetwork	0.97	> 0.20	USP1 (2.5)	TRAFD1 (2.3)	MARK4 (2.1)	TMEM57 (1.8)	ILF3 (1.8)	ATXN7L2 (1.7)	GATAD2A (1.5)	PSRC1 (1.5)	AMIGO1 (1.4)	DOCK7 (1.4)
GO:0007091	mitotic metaphase/anaphase transition	0.97	> 0.20	PSRC1 (3.6)	POC5 (3.4)	GEMIN7 (1.9)	USP1 (1.7)	UBXN2B (1.5)	LPIN3 (1.4)	SUGP1 (1.4)	C1orf63 (1.4)	DOCK7 (1.4)	ATP13A1 (1.2)
ENSG00000077522	ACTN2 PPI subnetwork	0.97	> 0.20	SYPL2 (3.2)	RPH3A (3.0)	SORT1 (2.7)	OGDH (2.2)	C12orf51 (1.9)	CLPTM1 (1.8)	GMPR (1.8)	MARK4 (1.8)	CELSR2 (1.6)	ITGB3 (1.6)
ENSG00000089094	KDM2B PPI subnetwork	0.97	> 0.20	CARM1 (2.3)	ATXN2 (2.3)	ILF3 (2.2)	GATAD2A (2.2)	MARK4 (2.1)	SMARCA4 (1.7)	TMEM57 (1.5)	TOP1 (1.5)	ATXN7L2 (1.5)	USP1 (1.4)
REACTOME_PHOSPHOLIPASE_C:MEDIATED_CASCADE	REACTOME_PHOSPHOLIPASE_C:MEDIATED_CASCADE	0.97	> 0.20	PLEKHH2 (2.8)	ZHX3 (2.3)	ALDH2 (2.0)	SH2B3 (1.9)	SORT1 (1.9)	PCSK9 (1.7)	PVR (1.6)	ABO (1.6)	PTPN11 (1.5)	KANK2 (1.5)
GO:0042026	protein refolding	0.97	> 0.20	TXNL4B (2.4)	PPP1R37 (1.9)	C12orf47 (1.9)	DYNC2LI1 (1.7)	POLK (1.6)	QTRT1 (1.6)	FRK (1.6)	BRAP (1.6)	GATAD2A (1.5)	C12orf43 (1.4)
ENSG00000072135	PTPN18 PPI subnetwork	0.97	> 0.20	C12orf51 (4.0)	ATXN2 (2.5)	GMIP (2.5)	MARK4 (2.4)	SORT1 (2.2)	USP24 (2.1)	BUD13 (1.9)	LPAR2 (1.9)	SLC44A2 (1.7)	PVRL2 (1.6)
GO:0045885	positive regulation of survival gene product expression	0.97	> 0.20	CYB561D1 (2.5)	SORT1 (2.0)	KIAA1324 (1.4)	GEMIN7 (1.4)	POLK (1.2)	ENSG00000254235 (1.2)	COL4A3BP (1.2)	DYNC2LI1 (1.0)	PMFBP1 (0.9)	PLEKHH2 (0.9)
GO:0031234	extrinsic to internal side of plasma membrane	0.97	> 0.20	ITGB3 (3.5)	CETP (2.9)	RPH3A (2.2)	SH2B3 (2.1)	TMEM50A (2.0)	LPIN3 (1.5)	GMIP (1.4)	HLX (1.4)	TIMD4 (0.9)	ST3GAL4 (0.9)
ENSG00000204301	NOTCH4 PPI subnetwork	0.97	> 0.20	SH2B3 (2.5)	PLEC (2.3)	TMEM57 (2.3)	ENSG00000226645 (1.9)	BCAM (1.8)	MAU2 (1.6)	PLCG1 (1.4)	TRIB1 (1.4)	USP24 (1.3)	POLK (1.3)
REACTOME_DSCAM_INTERACTIONS	REACTOME_DSCAM_INTERACTIONS	0.97	> 0.20	AP1M2 (2.5)	PBX4 (2.5)	GOT2P1 (2.3)	LPIN3 (2.1)	PMFBP1 (2.0)	GATAD2A (2.0)	ATXN7L2 (1.8)	TMEM57 (1.8)	FRK (1.4)	ENSG00000228044 (1.4)
ENSG00000126215	XRCC3 PPI subnetwork	0.97	> 0.20	FEN1 (2.2)	C1orf63 (1.8)	POC5 (1.8)	PSRC1 (1.8)	USP1 (1.7)	MAU2 (1.5)	SUGP1 (1.4)	PLEKHH2 (1.3)	TRAFD1 (1.2)	TXNL4B (1.1)
REACTOME_PD:1_SIGNALING	REACTOME_PD:1_SIGNALING	0.97	> 0.20	PLCG1 (2.6)	ALDH2 (2.6)	APOC1 (2.3)	APOE (2.2)	ZNF101 (1.7)	DOCK7 (1.4)	ZHX3 (1.2)	C19orf52 (1.1)	PARP10 (1.1)	YIPF2 (1.1)
ENSG00000147439	BIN3 PPI subnetwork	0.97	> 0.20	GATAD2A (3.8)	TOP1 (2.0)	SUGP1 (1.9)	HAVCR1 (1.5)	TIMD4 (1.5)	OGDH (1.5)	TMEM50A (1.4)	GMIP (1.3)	QTRT1 (1.3)	ITGB3 (1.3)
MP:0008221	abnormal hippocampal commissure morphology	0.97	> 0.20	NCAN (2.3)	OASL (2.3)	GPAM (2.0)	MOSC1 (1.9)	ZHX3 (1.8)	NKPD1 (1.5)	GRINA (1.5)	PLEKHH2 (1.5)	PSRC1 (1.3)	KANK2 (1.2)
MP:0003225	axonal dystrophy	0.97	> 0.20	TMEM57 (2.5)	ACAD10 (1.9)	C1orf63 (1.9)	DNAH11 (1.9)	USP24 (1.7)	ABO (1.7)	ATXN7L2 (1.5)	FADS2 (1.3)	TMED4 (1.2)	COL4A3BP (1.2)
GO:0042551	neuron maturation	0.97	> 0.20	ENSG00000254235 (3.3)	MYLIP (2.6)	AMIGO1 (2.0)	TMEM116 (1.8)	C19orf52 (1.7)	CELSR2 (1.6)	SORT1 (1.6)	PMFBP1 (1.5)	CILP2 (1.5)	C1orf63 (1.4)
ENSG00000111344	RASAL1 PPI subnetwork	0.97	> 0.20	TMED4 (2.6)	C11orf9 (2.3)	CILP2 (1.9)	SH2B3 (1.6)	RPH3A (1.5)	PVRL2 (1.5)	ATXN2 (1.5)	GOT2P1 (1.4)	DOCK7 (1.4)	PTPN11 (1.3)
ENSG00000160613	PCSK7 PPI subnetwork	0.97	> 0.20	YIPF2 (4.2)	TMEM57 (3.6)	ERP29 (2.8)	SARS (2.6)	USP24 (2.4)	TOP1 (2.2)	CYB561D1 (1.8)	ZNF259 (1.6)	BRAP (1.4)	DNAH11 (1.4)
ENSG00000188223	LIN37 PPI subnetwork	0.97	> 0.20	RHD (3.0)	RHCE (2.4)	USP1 (2.3)	FEN1 (1.9)	PLCG1 (1.9)	UBXN2B (1.8)	GRINA (1.8)	GOT2P1 (1.6)	PSRC1 (1.6)	MAPKAPK5 (1.6)
ENSG00000066735	KIF26A PPI subnetwork	0.97	> 0.20	NCAN (2.3)	GATAD2A (2.0)	PSRC1 (1.9)	HAPLN4 (1.7)	MAFB (1.7)	CELSR2 (1.4)	ZNF101 (1.2)	ENSG00000228044 (1.2)	PLCG1 (1.2)	MOSC1 (1.2)
MP:0000694	spleen hypoplasia	0.97	> 0.20	ZNF101 (3.8)	RELB (2.5)	HAVCR1 (2.2)	GMIP (2.1)	SMARCA4 (2.1)	PBX4 (2.0)	MAU2 (1.9)	UBXN2B (1.7)	TRAPPC6A (1.4)	BCL3 (1.3)
ENSG00000124688	MAD2L1BP PPI subnetwork	0.97	> 0.20	DNAH11 (3.8)	PSRC1 (2.5)	KIAA1324 (1.8)	GMIP (1.6)	FEN1 (1.5)	USP1 (1.5)	BLOC1S3 (1.4)	POC5 (1.4)	ERP29 (1.3)	HAPLN4 (1.2)
GO:0043062	extracellular structure organization	0.97	> 0.20	CILP2 (5.2)	CEACAM19 (2.3)	KANK2 (2.1)	FRK (1.8)	SLC44A2 (1.7)	PLEKHH2 (1.7)	AP1M2 (1.5)	ST3GAL4 (1.5)	BCAM (1.4)	CBLC (1.1)
GO:0030198	extracellular matrix organization	0.97	> 0.20	CILP2 (5.2)	CEACAM19 (2.3)	KANK2 (2.1)	FRK (1.8)	SLC44A2 (1.7)	PLEKHH2 (1.7)	AP1M2 (1.5)	ST3GAL4 (1.5)	BCAM (1.4)	CBLC (1.1)
GO:0001965	G-protein alpha-subunit binding	0.97	> 0.20	PVR (2.7)	TMEM116 (2.0)	ENSG00000226648 (1.8)	ENSG00000235545 (1.8)	FADS1 (1.7)	PLCG1 (1.6)	APOE (1.6)	SLC44A2 (1.5)	PTPN11 (1.4)	ANGPTL3 (1.4)
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	0.97	> 0.20	PVRL2 (2.5)	MARK4 (2.3)	PLEKHH2 (2.1)	PVR (1.9)	GEMIN7 (1.7)	PLEC (1.7)	CELSR2 (1.7)	SYPL2 (1.7)	CLPTM1 (1.7)	ENSG00000226645 (1.7)
GO:0007202	activation of phospholipase C activity	0.97	> 0.20	AMIGO1 (3.1)	PMFBP1 (2.2)	ZHX3 (2.0)	ITGB3 (1.8)	PLEKHH2 (1.8)	ST3GAL4 (1.7)	C12orf47 (1.5)	ENSG00000235545 (1.4)	COL4A3BP (1.4)	GOT2P1 (1.4)
MP:0002067	abnormal sensory capabilities/reflexes/nociception	0.97	> 0.20	ATXN7L2 (2.3)	CILP2 (2.3)	TMEM116 (1.8)	NCAN (1.7)	ANGPTL3 (1.7)	PLG (1.7)	PCSK9 (1.7)	ENSG00000238078 (1.6)	ENSG00000254235 (1.4)	C12orf47 (1.3)
MP:0002657	chondrodystrophy	0.97	> 0.20	CILP2 (3.6)	KIAA1324 (2.4)	HNF1A (2.2)	NYNRIN (2.1)	ENSG00000226645 (1.9)	PLEC (1.5)	TM6SF2 (1.5)	YIPF2 (1.5)	FRK (1.4)	PPP1R37 (1.4)
MP:0004221	abnormal iridocorneal angle	0.97	> 0.20	CILP2 (3.2)	MAFB (2.2)	PLCG1 (1.5)	C11orf9 (1.4)	TSSK6 (1.4)	SLC22A1 (1.3)	SYPL2 (1.2)	HAVCR1 (1.2)	PVR (1.1)	HNF1A (1.0)
GO:0090009	primitive streak formation	0.97	> 0.20	NKPD1 (1.8)	PCSK9 (1.8)	LPAR2 (1.7)	TSSK6 (1.6)	DNAH11 (1.5)	HNF1A (1.5)	CEACAM19 (1.4)	COL4A3BP (1.4)	ABO (1.2)	ATXN7L2 (1.1)
ENSG00000114742	WDR48 PPI subnetwork	0.97	> 0.20	PSMA5 (4.4)	USP24 (3.3)	TMEM57 (2.6)	DOCK7 (2.3)	SARS (2.2)	SUGP1 (2.2)	BRAP (1.7)	TMEM116 (1.5)	ATP13A1 (1.5)	PTPN11 (1.4)
GO:0032401	establishment of melanosome localization	0.97	> 0.20	ENSG00000228044 (2.8)	DYNC2LI1 (2.5)	C1orf63 (1.6)	ENSG00000254235 (1.4)	UBXN2B (1.3)	PMFBP1 (1.3)	C12orf43 (1.3)	COL4A3BP (1.3)	CEACAM19 (1.2)	ANKRD31 (1.2)
GO:0072087	renal vesicle development	0.97	> 0.20	HNF1A (3.7)	TSSK6 (1.9)	ENSG00000228044 (1.7)	TMEM116 (1.6)	PMFBP1 (1.5)	ENSG00000235545 (1.4)	HAVCR1 (1.4)	C17orf57 (1.3)	DYNC2LI1 (1.2)	ENSG00000238078 (1.2)
GO:0030315	T-tubule	0.97	> 0.20	SYPL2 (5.1)	SORT1 (2.3)	AMIGO1 (1.5)	NKPD1 (1.5)	AP1M2 (1.4)	BCAM (1.4)	KIAA1324 (1.4)	RPH3A (1.3)	GMPR (1.3)	HAPLN4 (1.3)
GO:0006198	cAMP catabolic process	0.97	> 0.20	PBX4 (2.3)	GOT2P1 (2.2)	NCAN (1.7)	SORT1 (1.6)	GCNT4 (1.5)	CEACAM19 (1.5)	ZNF101 (1.5)	MOSC1 (1.5)	OGDH (1.4)	TMEM116 (1.2)
GO:0003215	cardiac right ventricle morphogenesis	0.97	> 0.20	BLOC1S3 (2.3)	C11orf9 (2.3)	LPIN3 (1.9)	NYNRIN (1.8)	C17orf57 (1.5)	ATXN7L2 (1.4)	GCNT4 (1.2)	ENSG00000226648 (1.1)	GEMIN7 (1.1)	DNAH11 (1.0)
ENSG00000115756	HPCAL1 PPI subnetwork	0.97	> 0.20	ADAM1 (1.8)	SYPL2 (1.7)	PLG (1.7)	COL4A3BP (1.6)	PMFBP1 (1.6)	SLC22A1 (1.4)	C19orf52 (1.4)	DHODH (1.4)	ENSG00000238078 (1.4)	GEMIN7 (1.4)
ENSG00000206239	ENSG00000206239 PPI subnetwork	0.97	> 0.20	PLCG1 (3.9)	ZNF101 (2.7)	APOE (1.8)	SLC44A2 (1.8)	ALDH2 (1.7)	LPAR2 (1.6)	GMIP (1.5)	ADAM1 (1.3)	MAFB (1.2)	HAVCR1 (1.2)
ENSG00000206305	HLA-DQA1 PPI subnetwork	0.97	> 0.20	PLCG1 (3.9)	ZNF101 (2.7)	APOE (1.8)	SLC44A2 (1.8)	ALDH2 (1.7)	LPAR2 (1.6)	GMIP (1.5)	ADAM1 (1.3)	MAFB (1.2)	HAVCR1 (1.2)
GO:0060491	regulation of cell projection assembly	0.97	> 0.20	C11orf9 (3.2)	ZNF101 (2.5)	PVRL2 (2.4)	ENSG00000238078 (2.2)	PTPN11 (2.2)	COL4A3BP (2.0)	ENSG00000226648 (1.8)	CARM1 (1.4)	TMEM50A (1.3)	PVR (1.3)
KEGG_OXIDATIVE_PHOSPHORYLATION	KEGG_OXIDATIVE_PHOSPHORYLATION	0.97	> 0.20	OGDH (3.8)	ACAD10 (2.8)	TRAPPC6A (2.4)	C12orf47 (2.2)	TMEM116 (1.9)	PSMA5 (1.9)	ENSG00000238078 (1.6)	GOT2P1 (1.5)	GMPR (1.5)	MAU2 (1.4)
ENSG00000115289	PCGF1 PPI subnetwork	0.97	> 0.20	ATXN2 (2.5)	MARK4 (2.2)	GATAD2A (2.1)	CARM1 (2.1)	ILF3 (1.9)	TMEM57 (1.7)	SMARCA4 (1.7)	USP1 (1.4)	TRAFD1 (1.4)	TOP1 (1.4)
ENSG00000157152	ENSG00000157152 PPI subnetwork	0.97	> 0.20	NCAN (3.8)	RPH3A (2.7)	HAPLN4 (2.0)	CELSR2 (1.9)	GOT2P1 (1.9)	C12orf43 (1.7)	C12orf47 (1.6)	LPIN3 (1.5)	ALDH2 (1.4)	DNAH11 (1.4)
MP:0006092	abnormal olfactory neuron morphology	0.97	> 0.20	DYNC2LI1 (2.9)	C12orf47 (2.7)	CELSR2 (2.6)	GOT2P1 (2.0)	TMEM116 (1.8)	C12orf43 (1.8)	PSRC1 (1.3)	KIAA1324 (1.2)	GEMIN7 (1.2)	AMIGO1 (1.2)
ENSG00000126458	RRAS PPI subnetwork	0.97	> 0.20	GMIP (2.6)	NCAN (2.1)	COL4A3BP (2.0)	DNM2 (2.0)	SH2B3 (1.9)	LPAR2 (1.8)	SLC44A2 (1.5)	GATAD2A (1.4)	TMEM57 (1.4)	CELSR2 (1.4)
GO:0002825	regulation of T-helper 1 type immune response	0.97	> 0.20	PBX4 (3.0)	ENSG00000235545 (2.6)	ALDH2 (1.5)	NKPD1 (1.4)	ZNF101 (1.3)	ATXN7L2 (1.3)	DNAH11 (1.2)	ST3GAL4 (1.2)	BLOC1S3 (1.2)	ENSG00000238078 (1.1)
ENSG00000110717	NDUFS8 PPI subnetwork	0.97	> 0.20	OGDH (3.3)	TRAPPC6A (3.1)	C12orf47 (2.7)	ACAD10 (2.5)	GOT2P1 (1.9)	MAU2 (1.5)	PSMA5 (1.5)	TMED4 (1.5)	FRK (1.4)	ADAM1 (1.2)
MP:0000243	myoclonus	0.97	> 0.20	HAPLN4 (3.6)	RPH3A (3.2)	KIAA1324 (2.6)	SORT1 (2.4)	ADAM1 (2.0)	AMIGO1 (2.0)	COL4A3BP (1.7)	ENSG00000226648 (1.5)	ST3GAL4 (1.5)	CELSR2 (1.4)
ENSG00000008056	SYN1 PPI subnetwork	0.97	> 0.20	NCAN (3.0)	RPH3A (2.8)	C12orf43 (2.6)	CELSR2 (2.1)	GOT2P1 (1.9)	HAPLN4 (1.8)	PLEC (1.6)	COL4A3BP (1.3)	NYNRIN (1.3)	DNAH11 (1.2)
GO:0051480	cytosolic calcium ion homeostasis	0.97	> 0.20	SLC44A2 (2.0)	C12orf47 (1.9)	PBX4 (1.8)	LPIN3 (1.6)	SYPL2 (1.6)	KIAA1324 (1.4)	ABO (1.3)	HAVCR1 (1.3)	ERP29 (1.3)	CETP (1.3)
ENSG00000120256	LRP11 PPI subnetwork	0.97	> 0.20	DNAH11 (1.9)	TIMD4 (1.8)	USP24 (1.7)	TRAFD1 (1.6)	MAFB (1.5)	NKPD1 (1.4)	C12orf51 (1.4)	DOCK7 (1.3)	ENSG00000238078 (1.3)	ZNF101 (1.2)
ENSG00000145741	BTF3 PPI subnetwork	0.97	> 0.20	C19orf52 (2.6)	TRAPPC6A (2.1)	GMIP (1.7)	TSSK6 (1.6)	GATAD2A (1.6)	RELB (1.6)	ZNF101 (1.4)	PTPN11 (1.1)	ENSG00000228044 (1.1)	ENSG00000238078 (1.1)
ENSG00000085563	ABCB1 PPI subnetwork	0.97	> 0.20	OGDH (2.5)	HAVCR1 (2.0)	GOT2P1 (1.9)	DDX56 (1.9)	PSMA5 (1.8)	ADAM1 (1.8)	DHX38 (1.5)	ATP13A1 (1.5)	BUD13 (1.4)	QTRT1 (1.4)
GO:0002696	positive regulation of leukocyte activation	0.97	> 0.20	ZNF101 (3.0)	PBX4 (2.3)	PLCG1 (2.2)	TIMD4 (2.0)	CYB561D1 (1.7)	CETP (1.6)	GMIP (1.6)	POLK (1.5)	RELB (1.3)	SH2B3 (1.1)
GO:0006119	oxidative phosphorylation	0.97	> 0.20	OGDH (3.6)	C12orf47 (3.4)	ACAD10 (3.2)	TRAPPC6A (2.7)	GOT2P1 (2.1)	GMPR (1.6)	TMEM116 (1.6)	FRK (1.5)	ENSG00000235545 (1.4)	TMED4 (1.3)
GO:0021543	pallium development	0.97	> 0.20	DNAH11 (3.2)	TSSK6 (2.9)	NCAN (2.3)	TMED4 (1.9)	C12orf47 (1.9)	CELSR2 (1.8)	UBXN2B (1.7)	PBX4 (1.7)	ATXN7L2 (1.6)	GOT2P1 (1.3)
ENSG00000204220	PFDN6 PPI subnetwork	0.97	> 0.20	SMARCA4 (2.5)	SUGP1 (2.1)	HAVCR1 (2.0)	PSRC1 (1.9)	ATXN2 (1.8)	POC5 (1.7)	DHX38 (1.5)	TXNL4B (1.5)	SARS (1.2)	ADAM1 (1.2)
ENSG00000206283	PFDN6 PPI subnetwork	0.97	> 0.20	SMARCA4 (2.5)	SUGP1 (2.1)	HAVCR1 (2.0)	PSRC1 (1.9)	ATXN2 (1.8)	POC5 (1.7)	DHX38 (1.5)	TXNL4B (1.5)	SARS (1.2)	ADAM1 (1.2)
ENSG00000206211	ENSG00000206211 PPI subnetwork	0.97	> 0.20	SMARCA4 (2.5)	SUGP1 (2.1)	HAVCR1 (2.0)	PSRC1 (1.9)	ATXN2 (1.8)	POC5 (1.7)	DHX38 (1.5)	TXNL4B (1.5)	SARS (1.2)	ADAM1 (1.2)
MP:0003997	tonic-clonic seizures	0.97	> 0.20	HAPLN4 (4.5)	RPH3A (3.2)	NCAN (2.6)	C12orf51 (2.4)	COL4A3BP (2.4)	YIPF2 (1.8)	TSSK6 (1.7)	TRIB1 (1.7)	CELSR2 (1.5)	SORT1 (1.5)
ENSG00000131711	MAP1B PPI subnetwork	0.97	> 0.20	C1orf63 (2.1)	SARS (2.1)	C12orf51 (1.9)	GRINA (1.8)	ANGPTL3 (1.7)	FADS2 (1.7)	ADAM1 (1.5)	GATAD2A (1.4)	RHCE (1.4)	NYNRIN (1.4)
ENSG00000084234	APLP2 PPI subnetwork	0.97	> 0.20	ERP29 (3.8)	TMED4 (2.8)	CELSR2 (2.7)	NCAN (2.7)	BCAM (2.4)	CLPTM1 (2.3)	RPH3A (2.3)	YIPF2 (2.1)	ZHX3 (1.9)	TMEM50A (1.7)
MP:0000564	syndactyly	0.97	> 0.20	HMGCR (3.3)	FADS2 (3.0)	FADS1 (2.7)	LDLR (2.7)	PCSK9 (2.4)	BCAM (1.8)	CELSR2 (1.8)	AP1M2 (1.7)	CBLC (1.6)	TMED4 (1.4)
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	0.97	> 0.20	PVRL2 (2.7)	MARK4 (2.4)	PLEKHH2 (2.3)	CELSR2 (2.0)	PLEC (2.0)	ATXN2 (1.7)	PVR (1.7)	PSRC1 (1.7)	SYPL2 (1.6)	ENSG00000226645 (1.6)
ENSG00000116641	DOCK7 PPI subnetwork	0.97	> 0.20	ATXN2 (3.8)	C12orf51 (2.6)	TMEM50A (2.0)	SARS (1.9)	UBXN2B (1.8)	ILF3 (1.7)	CEACAM19 (1.6)	DOCK7 (1.6)	PTPN11 (1.5)	PVRL2 (1.5)
GO:0006333	chromatin assembly or disassembly	0.97	> 0.20	C19orf52 (2.2)	TMEM57 (1.7)	PMFBP1 (1.6)	TSSK6 (1.5)	USP1 (1.4)	PSRC1 (1.4)	ENSG00000226648 (1.3)	ZNF180 (1.3)	BUD13 (1.1)	GCNT4 (1.1)
ENSG00000206466	GABBR1 PPI subnetwork	0.97	> 0.20	RPH3A (4.1)	ERP29 (3.7)	HAPLN4 (2.4)	TMED4 (2.0)	NCAN (2.0)	SARS (1.7)	BCAM (1.6)	YIPF2 (1.6)	CLPTM1 (1.5)	ENSG00000254235 (1.5)
ENSG00000204681	GABBR1 PPI subnetwork	0.97	> 0.20	RPH3A (4.1)	ERP29 (3.7)	HAPLN4 (2.4)	TMED4 (2.0)	NCAN (2.0)	SARS (1.7)	BCAM (1.6)	YIPF2 (1.6)	CLPTM1 (1.5)	ENSG00000254235 (1.5)
ENSG00000206511	GABBR1 PPI subnetwork	0.97	> 0.20	RPH3A (4.1)	ERP29 (3.7)	HAPLN4 (2.4)	TMED4 (2.0)	NCAN (2.0)	SARS (1.7)	BCAM (1.6)	YIPF2 (1.6)	CLPTM1 (1.5)	ENSG00000254235 (1.5)
GO:0017022	myosin binding	0.97	> 0.20	SYPL2 (2.9)	KIAA1324 (2.5)	SORT1 (2.0)	TMEM116 (1.9)	ENSG00000226648 (1.8)	GMPR (1.5)	NPC1L1 (1.4)	CILP2 (1.4)	TM6SF2 (1.3)	KANK2 (1.3)
GO:0006323	DNA packaging	0.97	> 0.20	PMFBP1 (2.6)	PSRC1 (2.5)	TSSK6 (2.5)	C19orf52 (2.5)	ENSG00000226648 (2.3)	USP1 (1.9)	FEN1 (1.4)	POC5 (1.3)	ZNF180 (1.2)	TMED4 (1.2)
ENSG00000125798	FOXA2 PPI subnetwork	0.97	> 0.20	ZHX3 (2.6)	UBXN2B (2.0)	DOCK7 (1.8)	MYLIP (1.5)	ATXN2 (1.5)	CEACAM19 (1.5)	ENSG00000238078 (1.3)	SARS (1.2)	APOA5 (1.2)	LPIN3 (1.1)
ENSG00000111711	GOLT1B PPI subnetwork	0.97	> 0.20	YIPF2 (3.7)	CYB561D1 (3.2)	ATP13A1 (2.3)	CLPTM1 (2.1)	MAU2 (1.8)	TMED4 (1.7)	AP1M2 (1.6)	TSSK6 (1.5)	ERP29 (1.5)	TMEM50A (1.4)
ENSG00000048540	LMO3 PPI subnetwork	0.98	> 0.20	QTRT1 (2.4)	SARS (2.3)	TOMM40 (1.9)	TMEM116 (1.8)	GEMIN7 (1.8)	MARK4 (1.8)	MAFB (1.7)	CARM1 (1.7)	BCAM (1.5)	MAU2 (1.4)
ENSG00000145335	SNCA PPI subnetwork	0.98	> 0.20	GRINA (2.4)	CLPTM1 (2.4)	PTPN11 (2.4)	SLC44A2 (2.3)	GATAD2A (1.9)	RPH3A (1.9)	SARS (1.8)	NKPD1 (1.8)	MARK4 (1.7)	PPP1R37 (1.7)
ENSG00000198692	EIF1AY PPI subnetwork	0.98	> 0.20	MAPKAPK5 (2.6)	SYPL2 (2.5)	TOP1 (2.4)	C12orf47 (2.3)	ADAM1 (2.3)	QTRT1 (2.2)	NCAN (2.2)	PTPN11 (1.9)	NAA25 (1.7)	RHCE (1.6)
MP:0001178	pulmonary hypoplasia	0.98	> 0.20	PLEKHH2 (3.8)	FADS2 (3.3)	CILP2 (2.8)	NYNRIN (2.7)	LDLR (2.3)	FADS1 (2.3)	C11orf9 (2.0)	PVRL2 (1.8)	DYNC2LI1 (1.8)	BCAM (1.7)
GO:0018202	peptidyl-histidine modification	0.98	> 0.20	ADAM1 (2.7)	ATXN7L2 (2.5)	CYB561D1 (2.0)	DHODH (2.0)	ACAD10 (1.8)	TXNL4B (1.7)	DYNC2LI1 (1.7)	QTRT1 (1.6)	TRAPPC6A (1.6)	HNF1A (1.6)
GO:0050848	regulation of calcium-mediated signaling	0.98	> 0.20	C12orf47 (3.5)	NKPD1 (2.3)	ZNF101 (2.2)	PLCG1 (1.9)	ST3GAL4 (1.5)	GCNT4 (1.4)	TRAPPC6A (1.3)	ANKRD31 (1.2)	LPAR2 (1.1)	RPH3A (1.1)
ENSG00000100146	SOX10 PPI subnetwork	0.98	> 0.20	NCAN (3.2)	ATXN7L2 (2.0)	CILP2 (1.9)	NKPD1 (1.6)	USP24 (1.5)	CEACAM19 (1.4)	TRAFD1 (1.3)	MAPKAPK5 (1.2)	NPC1L1 (1.2)	CELSR2 (1.1)
ENSG00000150938	CRIM1 PPI subnetwork	0.98	> 0.20	KIAA1324 (2.4)	ENSG00000238078 (2.1)	AP1M2 (2.1)	LPA (2.0)	APOA5 (2.0)	FRK (1.8)	SLC22A1 (1.8)	CILP2 (1.7)	NT5DC1 (1.6)	APOC4 (1.4)
ENSG00000106829	TLE4 PPI subnetwork	0.98	> 0.20	DNAH11 (2.4)	PPP1R37 (2.1)	ATXN2 (1.8)	NCAN (1.8)	ALDH2 (1.7)	TSSK6 (1.6)	TRIB1 (1.6)	DYNC2LI1 (1.5)	KIAA1324 (1.5)	NKPD1 (1.2)
MP:0001399	hyperactivity	0.98	> 0.20	NCAN (3.0)	RPH3A (2.8)	SORT1 (2.5)	CELSR2 (2.0)	NPC1L1 (1.9)	HAPLN4 (1.9)	ABCG5 (1.6)	PMFBP1 (1.6)	APOC1 (1.4)	APOE (1.4)
GO:0016572	histone phosphorylation	0.98	> 0.20	PLEKHH2 (2.1)	ENSG00000226645 (1.7)	POLK (1.5)	GRINA (1.3)	DNAH11 (1.2)	PSRC1 (1.2)	SH2B3 (1.1)	POC5 (1.0)	OASL (0.9)	GMIP (0.8)
GO:0005109	frizzled binding	0.98	> 0.20	C11orf9 (2.6)	CBLC (2.0)	PCSK9 (1.5)	PLEKHH2 (1.4)	ZHX3 (1.4)	LPAR2 (1.3)	MARK4 (1.3)	AP1M2 (1.3)	CYP7A1 (1.2)	PPP1R37 (1.1)
GO:0048639	positive regulation of developmental growth	0.98	> 0.20	GEMIN7 (2.2)	ABO (1.8)	PMFBP1 (1.5)	ENSG00000226645 (1.4)	COL4A3BP (1.3)	CEACAM19 (1.3)	GOT2P1 (1.2)	DHODH (1.2)	ENSG00000235545 (1.0)	TSSK6 (1.0)
ENSG00000111266	DUSP16 PPI subnetwork	0.98	> 0.20	KIAA1324 (2.5)	AMIGO1 (2.4)	PLCG1 (1.8)	CBLC (1.8)	GATAD2A (1.7)	TMEM57 (1.6)	ENSG00000228044 (1.5)	PMFBP1 (1.4)	PBX4 (1.2)	LPIN3 (1.2)
MP:0005136	decreased growth hormone level	0.98	> 0.20	KIAA1324 (4.1)	TRIB1 (2.8)	C12orf47 (2.3)	CELSR2 (2.0)	BCL3 (1.5)	LDLR (1.4)	YIPF2 (1.3)	MAU2 (1.2)	ABCG5 (1.2)	ATXN7L2 (1.2)
ENSG00000088320	REM1 PPI subnetwork	0.98	> 0.20	TSSK6 (2.6)	ABO (2.4)	UBXN2B (2.3)	PLEKHH2 (1.9)	ZNF101 (1.9)	DYNC2LI1 (1.8)	TMEM50A (1.4)	HLX (1.2)	CEACAM19 (1.2)	C1orf63 (1.2)
ENSG00000100395	L3MBTL2 PPI subnetwork	0.98	> 0.20	TMEM57 (2.3)	CARM1 (2.1)	ILF3 (2.0)	USP24 (1.7)	GATAD2A (1.6)	MARK4 (1.6)	ATXN2 (1.5)	USP1 (1.4)	DOCK7 (1.4)	TRAFD1 (1.3)
ENSG00000105968	H2AFV PPI subnetwork	0.98	> 0.20	C19orf52 (2.4)	TXNL4B (2.1)	BUD13 (2.1)	TOP1 (1.9)	SMARCA4 (1.6)	GMPR (1.6)	ZNF180 (1.5)	TMEM57 (1.5)	USP1 (1.5)	ATXN2 (1.4)
GO:0001656	metanephros development	0.98	> 0.20	PLEKHH2 (2.9)	AP1M2 (2.2)	MYLIP (2.1)	DYNC2LI1 (2.0)	TMEM116 (1.8)	NYNRIN (1.8)	ENSG00000228044 (1.7)	TMED4 (1.5)	BCAM (1.5)	PMFBP1 (1.4)
MP:0003562	abnormal pancreatic beta cell physiology	0.98	> 0.20	KIAA1324 (4.4)	HAPLN4 (2.4)	HNF1A (2.0)	FRK (2.0)	PARP10 (2.0)	DNAH11 (1.9)	GCNT4 (1.6)	COL4A3BP (1.6)	DYNC2LI1 (1.5)	PLEKHH2 (1.5)
GO:0034707	chloride channel complex	0.98	> 0.20	KIAA1324 (2.3)	LPIN3 (1.9)	RPH3A (1.8)	C11orf9 (1.8)	SORT1 (1.7)	AP1M2 (1.7)	ALDH2 (1.6)	CBLC (1.5)	PMFBP1 (1.5)	ADAM1 (1.4)
ENSG00000160752	FDPS PPI subnetwork	0.98	> 0.20	NT5DC1 (3.7)	DHODH (2.5)	TXNL4B (2.4)	HMGCR (1.9)	ANKRD31 (1.8)	PSMA5 (1.7)	LDLR (1.6)	MAPKAPK5 (1.5)	TRAPPC6A (1.4)	NCAN (1.4)
GO:0043204	perikaryon	0.98	> 0.20	AMIGO1 (2.2)	ABO (2.2)	PCSK9 (2.0)	TSSK6 (1.9)	RPH3A (1.9)	FADS1 (1.7)	PVRL2 (1.6)	C1orf63 (1.5)	TMEM50A (1.5)	FADS2 (1.3)
MP:0006074	abnormal retinal rod bipolar cell morphology	0.98	> 0.20	C12orf47 (2.5)	TSSK6 (2.3)	HAVCR1 (2.1)	PVR (1.8)	ABCG5 (1.7)	NPC1L1 (1.6)	CELSR2 (1.6)	ST3GAL4 (1.5)	TM6SF2 (1.3)	DNAH11 (1.3)
MP:0001516	abnormal motor coordination/ balance	0.98	> 0.20	GRINA (2.5)	CELSR2 (2.4)	RPH3A (2.2)	CLPTM1 (1.9)	ZHX3 (1.8)	FADS2 (1.8)	HAPLN4 (1.7)	APOE (1.7)	OGDH (1.6)	ATP13A1 (1.6)
ENSG00000182621	PLCB1 PPI subnetwork	0.98	> 0.20	RPH3A (2.9)	ITGB3 (2.2)	SORT1 (2.1)	SMARCA4 (1.8)	PLEC (1.7)	COL4A3BP (1.6)	C12orf51 (1.4)	PVR (1.3)	NCAN (1.3)	CYB561D1 (1.3)
GO:0051147	regulation of muscle cell differentiation	0.98	> 0.20	LPIN3 (2.5)	SYPL2 (2.5)	ANKRD31 (2.4)	HLX (2.2)	HNF1A (2.2)	CARM1 (2.1)	CEACAM19 (1.6)	AMIGO1 (1.6)	KANK2 (1.4)	TMED4 (1.2)
ENSG00000169018	FEM1B PPI subnetwork	0.98	> 0.20	SARS (3.3)	ENSG00000226645 (1.8)	LPAR2 (1.7)	RPH3A (1.6)	TMEM57 (1.5)	YIPF2 (1.5)	ENSG00000226648 (1.4)	TMEM116 (1.4)	PLEKHH2 (1.2)	NT5DC1 (1.2)
GO:0019827	stem cell maintenance	0.98	> 0.20	NYNRIN (2.7)	CELSR2 (2.5)	ENSG00000226648 (1.8)	NCAN (1.8)	TSSK6 (1.4)	ENSG00000235545 (1.3)	DYNC2LI1 (1.3)	TRIB1 (1.3)	BCAM (1.2)	ANKRD31 (1.2)
GO:0030238	male sex determination	0.98	> 0.20	DNAH11 (2.4)	ST3GAL4 (1.9)	POC5 (1.4)	ADAM1 (1.3)	GEMIN7 (1.1)	ZNF259 (1.1)	ENSG00000235545 (1.0)	TMEM116 (1.0)	ATXN2 (1.0)	TXNL4B (1.0)
GO:0006906	vesicle fusion	0.98	> 0.20	YIPF2 (2.1)	TMEM50A (2.1)	CYB561D1 (2.0)	HAVCR1 (1.8)	POLK (1.7)	FRK (1.5)	ANKRD31 (1.5)	DOCK7 (1.4)	BLOC1S3 (1.4)	ATXN7L2 (1.3)
MP:0000746	weakness	0.98	> 0.20	HAPLN4 (2.9)	GRINA (2.6)	RPH3A (2.6)	FADS1 (2.4)	OGDH (2.3)	CLPTM1 (2.3)	BLOC1S3 (2.3)	ATP13A1 (2.1)	BCAM (2.0)	ST3GAL4 (1.7)
GO:0042220	response to cocaine	0.98	> 0.20	ENSG00000235545 (3.3)	HNF1A (2.4)	C12orf47 (2.1)	ZHX3 (2.0)	PMFBP1 (1.5)	ANKRD31 (1.5)	BLOC1S3 (1.4)	SORT1 (1.2)	FRK (1.2)	TSSK6 (1.2)
GO:0014073	response to tropane	0.98	> 0.20	ENSG00000235545 (3.3)	HNF1A (2.4)	C12orf47 (2.1)	ZHX3 (2.0)	PMFBP1 (1.5)	ANKRD31 (1.5)	BLOC1S3 (1.4)	SORT1 (1.2)	FRK (1.2)	TSSK6 (1.2)
GO:0043087	regulation of GTPase activity	0.98	> 0.20	ENSG00000226645 (2.9)	ZHX3 (2.8)	C12orf51 (2.3)	PPP1R37 (1.8)	DNM2 (1.7)	SH2B3 (1.7)	HLX (1.6)	USP24 (1.5)	CYB561D1 (1.5)	PLCG1 (1.4)
GO:0044442	microtubule-based flagellum part	0.98	> 0.20	TSSK6 (3.1)	DNAH11 (2.9)	PMFBP1 (2.7)	TMEM116 (1.1)	DYNC2LI1 (1.0)	NT5DC1 (0.9)	ENSG00000228044 (0.9)	ABCG8 (0.8)	YIPF2 (0.7)	CILP2 (0.7)
GO:0044460	flagellum part	0.98	> 0.20	TSSK6 (3.1)	DNAH11 (2.9)	PMFBP1 (2.7)	TMEM116 (1.1)	DYNC2LI1 (1.0)	NT5DC1 (0.9)	ENSG00000228044 (0.9)	ABCG8 (0.8)	YIPF2 (0.7)	CILP2 (0.7)
GO:0060323	head morphogenesis	0.98	> 0.20	ENSG00000235545 (2.3)	GCNT4 (2.1)	MYLIP (2.0)	TMEM57 (1.8)	ENSG00000238078 (1.4)	FRK (1.4)	MAU2 (1.1)	ANKRD31 (1.1)	DOCK7 (1.1)	C17orf57 (1.1)
ENSG00000137575	SDCBP PPI subnetwork	0.98	> 0.20	HAVCR1 (2.1)	YIPF2 (1.8)	TOP1 (1.6)	PLCG1 (1.6)	APOC1 (1.5)	APOE (1.5)	CETP (1.4)	AP1M2 (1.4)	C11orf9 (1.4)	CELSR2 (1.4)
GO:0009898	internal side of plasma membrane	0.98	> 0.20	ITGB3 (2.6)	CETP (2.6)	SH2B3 (2.1)	RHCE (2.0)	LPIN3 (1.9)	RPH3A (1.7)	RHD (1.6)	ST3GAL4 (1.5)	RELB (1.5)	PARP10 (1.1)
MP:0005543	corneal thinning	0.98	> 0.20	CILP2 (6.2)	C11orf9 (2.3)	YIPF2 (1.7)	AP1M2 (1.4)	OASL (1.4)	ENSG00000226648 (1.3)	APOE (1.3)	C12orf47 (1.2)	PLEKHH2 (1.1)	MAFB (1.1)
ENSG00000140990	NDUFB10 PPI subnetwork	0.98	> 0.20	OGDH (3.5)	C12orf47 (2.9)	ACAD10 (2.9)	TRAPPC6A (2.5)	FRK (2.3)	MAU2 (2.3)	GMPR (1.7)	PSMA5 (1.4)	TMED4 (1.3)	GOT2P1 (1.1)
GO:0030071	regulation of mitotic metaphase/anaphase transition	0.98	> 0.20	POC5 (3.6)	PSRC1 (3.2)	GEMIN7 (2.7)	SUGP1 (1.8)	LPIN3 (1.5)	MAU2 (1.4)	C1orf63 (1.4)	DOCK7 (1.3)	UBXN2B (1.2)	TMEM116 (1.2)
MP:0002557	abnormal social/conspecific interaction	0.98	> 0.20	LPIN3 (2.3)	ABO (2.0)	HAPLN4 (2.0)	KANK2 (1.8)	MOSC1 (1.6)	ATXN7L2 (1.5)	TMEM57 (1.4)	ABCG5 (1.3)	PBX4 (1.2)	RPH3A (1.2)
GO:0050851	antigen receptor-mediated signaling pathway	0.98	> 0.20	ZNF101 (4.4)	PBX4 (2.8)	GMIP (2.8)	PLCG1 (2.7)	CYB561D1 (2.3)	HAVCR1 (2.0)	TRAPPC6A (1.7)	LPAR2 (1.6)	ADAM1 (1.4)	TIMD4 (1.4)
GO:0050772	positive regulation of axonogenesis	0.98	> 0.20	PBX4 (3.4)	PPP1R37 (2.9)	GEMIN7 (1.9)	CELSR2 (1.8)	ATXN7L2 (1.8)	ENSG00000235545 (1.7)	PMFBP1 (1.6)	PLEC (1.4)	DNAH11 (1.4)	OGDH (1.3)
GO:0009152	purine ribonucleotide biosynthetic process	0.98	> 0.20	SYPL2 (2.7)	ENSG00000226648 (2.6)	GOT2P1 (2.3)	OGDH (2.2)	TMEM116 (2.1)	HAPLN4 (2.0)	ACAD10 (1.8)	PMFBP1 (1.6)	GCNT4 (1.5)	DYNC2LI1 (1.4)
MP:0003459	increased fear-related response	0.98	> 0.20	TRAFD1 (2.5)	OASL (2.2)	NCAN (1.9)	CYP7A1 (1.6)	POC5 (1.6)	CELSR2 (1.6)	ENSG00000254235 (1.6)	C11orf9 (1.5)	HP (1.4)	GPAM (1.3)
GO:0030313	cell envelope	0.98	> 0.20	NCAN (4.6)	RPH3A (2.1)	ABO (1.6)	USP24 (1.3)	PCSK9 (1.3)	C11orf9 (1.3)	PPP1R37 (1.2)	GCNT4 (1.1)	APOE (1.1)	ADAM1 (1.1)
GO:0044462	external encapsulating structure part	0.98	> 0.20	NCAN (4.6)	RPH3A (2.1)	ABO (1.6)	USP24 (1.3)	PCSK9 (1.3)	C11orf9 (1.3)	PPP1R37 (1.2)	GCNT4 (1.1)	APOE (1.1)	ADAM1 (1.1)
MP:0010099	abnormal thoracic cage shape	0.98	> 0.20	DYNC2LI1 (3.7)	CELSR2 (2.8)	SYPL2 (2.5)	CILP2 (2.5)	PLEKHH2 (1.9)	C11orf9 (1.6)	YIPF2 (1.5)	ALDH2 (1.5)	APOE (1.3)	PLEC (1.3)
GO:0072001	renal system development	0.98	> 0.20	PLEKHH2 (2.9)	DYNC2LI1 (2.2)	BCAM (2.1)	HAVCR1 (2.1)	FRK (1.9)	AP1M2 (1.8)	TMED4 (1.8)	NYNRIN (1.6)	ENSG00000235545 (1.6)	TSSK6 (1.5)
ENSG00000082014	SMARCD3 PPI subnetwork	0.98	> 0.20	TOP1 (2.9)	CARM1 (2.5)	LDLR (2.2)	TOMM40 (1.9)	C12orf51 (1.7)	SMARCA4 (1.7)	ILF3 (1.7)	BUD13 (1.7)	COL4A3BP (1.6)	FADS1 (1.6)
ENSG00000104863	LIN7B PPI subnetwork	0.98	> 0.20	RPH3A (2.9)	NCAN (2.6)	CELSR2 (2.2)	C11orf9 (2.1)	AMIGO1 (2.0)	C12orf51 (1.9)	PPP1R37 (1.8)	SORT1 (1.6)	GOT2P1 (1.6)	MARK4 (1.4)
GO:0048854	brain morphogenesis	0.98	> 0.20	C17orf57 (3.7)	DYNC2LI1 (3.7)	ENSG00000226648 (2.2)	ENSG00000235545 (1.9)	C1orf63 (1.8)	TXNL4B (1.7)	C19orf52 (1.6)	TMEM116 (1.5)	ABO (1.5)	ANKRD31 (1.3)
MP:0000428	abnormal craniofacial morphology	0.98	> 0.20	NYNRIN (3.2)	DOCK7 (2.1)	TMED4 (1.7)	ATXN2 (1.5)	PLCG1 (1.5)	PTPN11 (1.4)	AMIGO1 (1.4)	ATXN7L2 (1.3)	GATAD2A (1.3)	CLPTM1 (1.2)
ENSG00000168283	BMI1 PPI subnetwork	0.98	> 0.20	USP1 (2.2)	PSRC1 (2.2)	TRAFD1 (2.0)	TMEM57 (1.8)	ATXN2 (1.8)	BUD13 (1.7)	ATXN7L2 (1.6)	SARS (1.6)	ILF3 (1.4)	CELSR2 (1.4)
ENSG00000185046	ANKS1B PPI subnetwork	0.98	> 0.20	NCAN (3.5)	GMIP (2.8)	SLC44A2 (2.2)	APOE (2.0)	MAFB (1.9)	PLEC (1.8)	CELSR2 (1.4)	BCAM (1.4)	ZHX3 (1.4)	LPAR2 (1.3)
ENSG00000102218	RP2 PPI subnetwork	0.98	> 0.20	DYNC2LI1 (2.3)	MARK4 (2.1)	CILP2 (1.8)	PBX4 (1.8)	CELSR2 (1.7)	SLC44A2 (1.7)	ATXN2 (1.7)	GOT2P1 (1.5)	PMFBP1 (1.5)	HAVCR1 (1.4)
GO:0035282	segmentation	0.98	> 0.20	ABO (2.8)	BLOC1S3 (1.8)	ENSG00000254235 (1.6)	PLCG1 (1.4)	CILP2 (1.4)	DYNC2LI1 (1.3)	CEACAM19 (1.3)	ATXN7L2 (1.2)	UBXN2B (1.1)	ATXN2 (1.0)
MP:0002685	abnormal spermatogonia proliferation	0.98	> 0.20	ZHX3 (2.8)	HAPLN4 (2.5)	TMEM57 (2.5)	PBX4 (2.2)	TRAPPC6A (2.0)	DNM2 (1.6)	RPH3A (1.6)	MAPKAPK5 (1.6)	LPIN3 (1.5)	ILF3 (1.4)
GO:0005753	mitochondrial proton-transporting ATP synthase complex	0.98	> 0.20	OGDH (3.8)	ACAD10 (3.3)	C12orf47 (3.2)	PSMA5 (2.9)	C1orf63 (2.0)	TMEM116 (2.0)	ENSG00000238078 (1.7)	C19orf52 (1.7)	ERP29 (1.6)	TOMM40 (1.6)
ENSG00000137218	FRS3 PPI subnetwork	0.98	> 0.20	C11orf9 (3.8)	PLEKHH2 (3.2)	HAPLN4 (2.2)	PTPN11 (2.0)	TMEM50A (1.8)	ABO (1.8)	PVR (1.7)	ANGPTL3 (1.6)	ENSG00000226645 (1.5)	NKPD1 (1.4)
ENSG00000134216	CHIA PPI subnetwork	0.98	> 0.20	FEN1 (2.6)	ATXN2 (2.1)	ZHX3 (1.6)	TXNL4B (1.6)	YIPF2 (1.5)	RHCE (1.5)	TMEM57 (1.5)	TMED4 (1.5)	USP1 (1.5)	ERP29 (1.4)
GO:0030934	anchoring collagen	0.98	> 0.20	CILP2 (5.7)	PLEKHH2 (3.1)	C17orf57 (1.4)	ATXN7L2 (1.3)	MYLIP (1.2)	RELB (1.2)	AP1M2 (1.2)	ENSG00000228044 (1.1)	APOE (1.0)	C19orf52 (1.0)
ENSG00000000419	DPM1 PPI subnetwork	0.98	> 0.20	YIPF2 (2.3)	ATP13A1 (2.2)	PSMA5 (2.0)	TRAPPC6A (1.6)	SARS (1.6)	TOMM40 (1.6)	DDX56 (1.5)	POLK (1.5)	TXNL4B (1.4)	BCAM (1.4)
GO:0021799	cerebral cortex radially oriented cell migration	0.98	> 0.20	PBX4 (2.8)	ENSG00000235545 (2.2)	NCAN (2.1)	ENSG00000226645 (2.0)	ATXN7L2 (1.6)	CELSR2 (1.5)	ZHX3 (1.4)	TM6SF2 (1.3)	DYNC2LI1 (1.3)	TSSK6 (1.2)
ENSG00000213672	NCKIPSD PPI subnetwork	0.98	> 0.20	GATAD2A (2.3)	PPP1R37 (2.0)	TRAPPC6A (2.0)	RPH3A (1.9)	MARK4 (1.8)	ENSG00000238078 (1.7)	CYP7A1 (1.6)	TMEM57 (1.5)	C17orf57 (1.5)	GMIP (1.4)
ENSG00000154518	ATP5G3 PPI subnetwork	0.98	> 0.20	ACAD10 (3.9)	C12orf47 (3.1)	PSMA5 (2.9)	ERP29 (2.7)	C19orf52 (2.6)	OGDH (2.5)	SARS (2.4)	TMEM116 (2.0)	TOMM40 (1.9)	ALDH2 (1.6)
MP:0004405	absent cochlear hair cells	0.98	> 0.20	KIAA1324 (4.1)	TMEM116 (2.5)	ST3GAL4 (2.4)	AP1M2 (2.1)	HAPLN4 (2.0)	PBX4 (1.9)	NT5DC1 (1.8)	LPA (1.8)	C12orf47 (1.6)	ABO (1.4)
ENSG00000126821	SGPP1 PPI subnetwork	0.98	> 0.20	C11orf9 (3.5)	TMEM50A (2.5)	CYB561D1 (2.0)	SLC44A2 (1.7)	HMGCR (1.6)	SORT1 (1.6)	CLPTM1 (1.6)	ATP13A1 (1.5)	NKPD1 (1.5)	DNM2 (1.4)
GO:0007020	microtubule nucleation	0.98	> 0.20	DNAH11 (1.9)	ATXN7L2 (1.8)	GOT2P1 (1.7)	ST3GAL4 (1.6)	POC5 (1.5)	UBXN2B (1.5)	PMFBP1 (1.5)	MAU2 (1.4)	USP24 (1.4)	POLK (1.3)
ENSG00000077420	APBB1IP PPI subnetwork	0.98	> 0.20	GMIP (3.5)	SLC44A2 (2.2)	GATAD2A (2.1)	RELB (1.9)	TMEM50A (1.5)	MAPKAPK5 (1.5)	OGDH (1.4)	SH2B3 (1.3)	TOMM40 (1.2)	CYB561D1 (1.2)
ENSG00000043591	ADRB1 PPI subnetwork	0.98	> 0.20	RPH3A (2.7)	DNM2 (2.0)	CETP (1.8)	YIPF2 (1.8)	NCAN (1.7)	SORT1 (1.6)	HAPLN4 (1.5)	PVRL2 (1.4)	NYNRIN (1.4)	AMIGO1 (1.3)
GO:0061311	cell surface receptor signaling pathway involved in heart development	0.98	> 0.20	ENSG00000226645 (2.6)	LPIN3 (2.4)	LPAR2 (2.1)	MYLIP (1.7)	ABO (1.5)	ENSG00000238078 (1.4)	ENSG00000226648 (1.4)	C1orf63 (1.3)	YIPF2 (1.3)	ENSG00000254235 (1.1)
GO:0061077	chaperone-mediated protein folding	0.98	> 0.20	TXNL4B (2.4)	ERP29 (2.3)	TMED4 (2.3)	C12orf47 (2.2)	C12orf43 (2.1)	ENSG00000226648 (1.8)	BRAP (1.8)	UBXN2B (1.6)	AMIGO1 (1.5)	POLK (1.3)
GO:0045785	positive regulation of cell adhesion	0.98	> 0.20	SLC44A2 (3.0)	ITGB3 (2.8)	CILP2 (2.8)	ENSG00000228044 (2.2)	TMEM116 (1.9)	PLEKHH2 (1.9)	ZNF101 (1.7)	PVR (1.7)	ENSG00000226645 (1.5)	AP1M2 (1.4)
MP:0001330	abnormal optic nerve morphology	0.98	> 0.20	PBX4 (2.9)	NCAN (2.1)	GRINA (1.9)	ST3GAL4 (1.7)	QTRT1 (1.7)	PMFBP1 (1.6)	C11orf9 (1.5)	FADS1 (1.3)	RPH3A (1.3)	CLPTM1 (1.3)
ENSG00000164742	ADCY1 PPI subnetwork	0.98	> 0.20	C12orf43 (2.2)	MARK4 (1.9)	SYPL2 (1.7)	ZNF180 (1.6)	PMFBP1 (1.5)	GATAD2A (1.5)	CARM1 (1.3)	POLK (1.3)	GMIP (1.3)	ANKRD31 (1.3)
MP:0003604	single kidney	0.98	> 0.20	NYNRIN (2.6)	PLEKHH2 (2.5)	HLX (2.5)	KANK2 (2.3)	PVRL2 (2.3)	PLCG1 (2.2)	MYLIP (1.8)	ENSG00000228044 (1.8)	BCAM (1.6)	SORT1 (1.5)
GO:0042554	superoxide anion generation	0.98	> 0.20	ALDH2 (2.8)	TRAPPC6A (2.4)	HAVCR1 (2.1)	ITGB3 (1.9)	ENSG00000235545 (1.9)	C19orf52 (1.9)	LPIN3 (1.6)	HNF1A (1.5)	ERP29 (1.4)	APOE (1.3)
ENSG00000182957	SPATA13 PPI subnetwork	0.98	> 0.20	ZNF101 (3.3)	COL4A3BP (2.5)	POLK (2.1)	TXNL4B (2.1)	UBXN2B (1.9)	C1orf63 (1.8)	DOCK7 (1.8)	ENSG00000254235 (1.5)	TMEM50A (1.5)	ENSG00000238078 (1.4)
ENSG00000167674	ENSG00000167674 PPI subnetwork	0.98	> 0.20	PTPN11 (3.0)	C12orf47 (2.1)	BUD13 (2.0)	ATXN7L2 (2.0)	ENSG00000254235 (1.8)	AMIGO1 (1.7)	NKPD1 (1.7)	SARS (1.6)	C1orf63 (1.5)	C11orf9 (1.5)
GO:0007420	brain development	0.98	> 0.20	NCAN (3.0)	PLCG1 (2.5)	PBX4 (2.2)	DNAH11 (2.2)	CELSR2 (2.2)	TSSK6 (1.9)	ATXN2 (1.8)	ANKRD31 (1.7)	ENSG00000226648 (1.5)	PPP1R37 (1.5)
MP:0002988	decreased urine osmolality	0.98	> 0.20	PLG (2.5)	AP1M2 (2.3)	BCAM (1.8)	TMEM116 (1.6)	SYPL2 (1.3)	HNF1A (1.3)	ANGPTL3 (1.2)	SLC22A1 (1.2)	SORT1 (1.1)	ERP29 (1.1)
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	0.98	> 0.20	MARK4 (2.9)	PVRL2 (2.5)	PLEKHH2 (2.2)	ENSG00000226645 (2.1)	GEMIN7 (1.9)	PLEC (1.7)	CELSR2 (1.7)	PVR (1.6)	PSRC1 (1.4)	ATXN2 (1.3)
GO:0007610	behavior	0.98	> 0.20	ABO (2.2)	NCAN (2.1)	RPH3A (2.1)	PMFBP1 (2.1)	C12orf47 (1.9)	DNAH11 (1.9)	AMIGO1 (1.8)	CELSR2 (1.7)	SORT1 (1.3)	PLEKHH2 (1.2)
MP:0009885	abnormal palatal shelf elevation	0.98	> 0.20	NYNRIN (2.1)	KANK2 (1.9)	HLX (1.8)	PLEKHH2 (1.7)	C11orf9 (1.4)	ATXN7L2 (1.3)	ENSG00000226648 (1.3)	SORT1 (1.3)	PSRC1 (1.2)	LDLR (1.1)
GO:0009312	oligosaccharide biosynthetic process	0.98	> 0.20	YIPF2 (3.7)	BLOC1S3 (2.9)	C12orf43 (2.1)	QTRT1 (1.9)	ATP13A1 (1.9)	GEMIN7 (1.8)	TMEM116 (1.8)	C19orf52 (1.7)	TMEM57 (1.7)	CLPTM1 (1.6)
ENSG00000155511	GRIA1 PPI subnetwork	0.98	> 0.20	ZHX3 (1.9)	TMED4 (1.8)	PCSK9 (1.6)	POLK (1.6)	GOT2P1 (1.5)	PLEKHH2 (1.5)	SORT1 (1.5)	ENSG00000238078 (1.4)	HAVCR1 (1.4)	AP1M2 (1.3)
GO:0033124	regulation of GTP catabolic process	0.98	> 0.20	ZHX3 (2.9)	ENSG00000226645 (2.8)	C12orf51 (2.4)	DNM2 (1.8)	SH2B3 (1.7)	PPP1R37 (1.7)	CYB561D1 (1.6)	HLX (1.6)	PLCG1 (1.5)	USP24 (1.4)
GO:0000307	cyclin-dependent protein kinase holoenzyme complex	0.98	> 0.20	GATAD2A (2.9)	AMIGO1 (1.8)	TMED4 (1.7)	TOP1 (1.7)	FEN1 (1.5)	PTPN11 (1.4)	USP1 (1.4)	TOMM40 (1.4)	CYP7A1 (1.3)	POLK (1.2)
GO:0048864	stem cell development	0.98	> 0.20	NYNRIN (2.4)	CELSR2 (2.3)	NCAN (1.9)	ENSG00000226648 (1.5)	KANK2 (1.4)	BCAM (1.3)	DYNC2LI1 (1.3)	DOCK7 (1.2)	ANKRD31 (1.2)	TRIB1 (1.2)
GO:0007413	axonal fasciculation	0.98	> 0.20	CYB561D1 (2.9)	PBX4 (2.7)	LPAR2 (2.3)	TSSK6 (2.3)	ANKRD31 (1.9)	NCAN (1.9)	CELSR2 (1.8)	ABO (1.8)	ATXN7L2 (1.8)	AMIGO1 (1.8)
GO:0021895	cerebral cortex neuron differentiation	0.98	> 0.20	ENSG00000235545 (2.9)	C19orf52 (2.4)	ABO (2.1)	PBX4 (1.8)	ENSG00000226648 (1.7)	NCAN (1.6)	BLOC1S3 (1.5)	PTPN11 (1.3)	ACAD10 (1.2)	KIAA1324 (1.2)
ENSG00000160271	RALGDS PPI subnetwork	0.98	> 0.20	PVRL2 (2.4)	CYB561D1 (2.3)	SLC44A2 (2.3)	TMEM116 (2.3)	PLEKHH2 (2.1)	TOP1 (1.7)	TMEM50A (1.7)	MAPKAPK5 (1.6)	NCAN (1.6)	BCAM (1.6)
GO:0032314	regulation of Rac GTPase activity	0.98	> 0.20	PBX4 (2.3)	TSSK6 (2.0)	ACAD10 (2.0)	LPAR2 (1.8)	ZHX3 (1.7)	TMEM116 (1.6)	PPP1R37 (1.6)	C1orf63 (1.4)	ZNF101 (1.4)	POC5 (1.4)
MP:0002115	abnormal limb bone morphology	0.98	> 0.20	CILP2 (4.3)	MAFB (3.2)	PLEKHH2 (1.9)	FRK (1.9)	NYNRIN (1.7)	MYLIP (1.7)	CARM1 (1.2)	RHCE (1.1)	KANK2 (1.1)	TMEM57 (1.0)
ENSG00000174775	HRAS PPI subnetwork	0.98	> 0.20	GMIP (3.4)	DNM2 (3.2)	MARK4 (2.3)	SH2B3 (1.9)	GATAD2A (1.6)	SLC44A2 (1.6)	UBXN2B (1.5)	PLEC (1.5)	COL4A3BP (1.5)	NCAN (1.4)
ENSG00000108587	GOSR1 PPI subnetwork	0.98	> 0.20	YIPF2 (4.2)	CYB561D1 (3.8)	TMEM50A (3.3)	TMED4 (2.8)	MAU2 (2.3)	TXNL4B (2.3)	TMEM57 (1.7)	C19orf52 (1.6)	ST3GAL4 (1.5)	DNAH11 (1.5)
ENSG00000177189	RPS6KA3 PPI subnetwork	0.98	> 0.20	NCAN (3.2)	RPH3A (2.7)	SORT1 (2.3)	C11orf9 (1.9)	CELSR2 (1.7)	C12orf51 (1.5)	MARK4 (1.4)	TSSK6 (1.4)	HLX (1.3)	KIAA1324 (1.2)
GO:0072111	cell proliferation involved in kidney development	0.98	> 0.20	BCAM (2.3)	NYNRIN (2.2)	C11orf9 (2.1)	GEMIN7 (1.9)	PMFBP1 (1.8)	ZNF101 (1.8)	AMIGO1 (1.5)	AP1M2 (1.5)	CYB561D1 (1.5)	PLEKHH2 (1.4)
ENSG00000010017	RANBP9 PPI subnetwork	0.98	> 0.20	ATXN2 (2.7)	ATXN7L2 (2.7)	ENSG00000238078 (1.8)	BCAM (1.6)	ADAM1 (1.6)	SLC44A2 (1.5)	NCAN (1.5)	MYLIP (1.4)	CYP7A1 (1.4)	LDLR (1.3)
MP:0002576	abnormal enamel morphology	0.98	> 0.20	MYLIP (2.3)	GCNT4 (2.0)	MAFB (1.7)	ST3GAL4 (1.5)	ZHX3 (1.5)	NPC1L1 (1.4)	PLCG1 (1.4)	FRK (1.4)	TMEM116 (1.3)	CELSR2 (1.3)
ENSG00000100554	ATP6V1D PPI subnetwork	0.98	> 0.20	BLOC1S3 (2.7)	GRINA (2.7)	SORT1 (2.5)	SARS (2.3)	TXNL4B (2.1)	ENSG00000238078 (2.0)	HAPLN4 (1.9)	C19orf52 (1.8)	UBXN2B (1.8)	AP1M2 (1.7)
ENSG00000106665	CLIP2 PPI subnetwork	0.98	> 0.20	C12orf51 (3.8)	SMARCA4 (3.5)	HAVCR1 (3.1)	NCAN (2.2)	USP24 (2.1)	SYPL2 (2.0)	SARS (2.0)	ATP13A1 (1.9)	ACAD10 (1.8)	ATXN2 (1.5)
GO:0070588	calcium ion transmembrane transport	0.98	> 0.20	GCNT4 (2.4)	ENSG00000226645 (2.3)	C12orf47 (2.2)	C1orf63 (2.1)	C12orf51 (2.0)	GMPR (2.0)	HAPLN4 (1.9)	ENSG00000226648 (1.9)	ADAM1 (1.6)	PLEKHH2 (1.6)
ENSG00000047579	DTNBP1 PPI subnetwork	0.98	> 0.20	C19orf52 (2.8)	C17orf57 (2.4)	CYB561D1 (2.2)	ENSG00000228044 (2.1)	ZNF101 (1.9)	TMEM57 (1.7)	ZHX3 (1.6)	SARS (1.5)	HAVCR1 (1.5)	NCAN (1.5)
ENSG00000169118	CSNK1G1 PPI subnetwork	0.98	> 0.20	GMIP (2.0)	CEACAM19 (2.0)	C17orf57 (1.9)	HP (1.8)	LPA (1.7)	PLEKHH2 (1.6)	LPIN3 (1.6)	MAPKAPK5 (1.4)	ERP29 (1.2)	GEMIN7 (1.2)
MP:0008143	abnormal dendrite morphology	0.98	> 0.20	C12orf51 (2.7)	CELSR2 (2.5)	ZHX3 (2.1)	PVR (2.0)	TMEM57 (1.8)	APOC1 (1.8)	C12orf47 (1.7)	PLCG1 (1.7)	C12orf43 (1.6)	RPH3A (1.5)
GO:0010579	positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	0.98	> 0.20	ABO (2.4)	GOT2P1 (2.3)	AMIGO1 (2.2)	ENSG00000226648 (2.1)	ENSG00000226645 (2.0)	KIAA1324 (1.6)	BLOC1S3 (1.6)	TMEM116 (1.6)	HAPLN4 (1.6)	PMFBP1 (1.4)
GO:0010578	regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	0.98	> 0.20	ABO (2.4)	GOT2P1 (2.3)	AMIGO1 (2.2)	ENSG00000226648 (2.1)	ENSG00000226645 (2.0)	KIAA1324 (1.6)	BLOC1S3 (1.6)	TMEM116 (1.6)	HAPLN4 (1.6)	PMFBP1 (1.4)
GO:0007189	adenylate cyclase-activating G-protein coupled receptor signaling pathway	0.98	> 0.20	ABO (2.4)	GOT2P1 (2.3)	AMIGO1 (2.2)	ENSG00000226648 (2.1)	ENSG00000226645 (2.0)	KIAA1324 (1.6)	BLOC1S3 (1.6)	TMEM116 (1.6)	HAPLN4 (1.6)	PMFBP1 (1.4)
GO:0002768	immune response-regulating cell surface receptor signaling pathway	0.98	> 0.20	ZNF101 (4.7)	GMIP (2.8)	PBX4 (2.6)	PLCG1 (2.5)	CYB561D1 (2.0)	HAVCR1 (2.0)	TIMD4 (1.7)	MAFB (1.6)	ADAM1 (1.5)	TRAPPC6A (1.5)
GO:0006929	substrate-dependent cell migration	0.98	> 0.20	ENSG00000226648 (3.2)	UBXN2B (3.0)	TMEM116 (2.3)	ADAM1 (1.7)	GOT2P1 (1.4)	DYNC2LI1 (1.3)	CILP2 (1.2)	GCNT4 (1.2)	FRK (1.2)	PLCG1 (1.1)
ENSG00000144283	PKP4 PPI subnetwork	0.98	> 0.20	YIPF2 (2.4)	CELSR2 (2.3)	BCAM (2.0)	TMEM116 (1.7)	C11orf9 (1.3)	MAU2 (1.3)	LPAR2 (1.2)	RPH3A (1.2)	CLPTM1 (1.2)	PTPN11 (1.1)
ENSG00000187239	FNBP1 PPI subnetwork	0.98	> 0.20	RPH3A (2.3)	C12orf43 (2.3)	C12orf51 (2.2)	NCAN (2.0)	CELSR2 (1.8)	C11orf9 (1.6)	UBXN2B (1.6)	SORT1 (1.6)	NYNRIN (1.5)	AMIGO1 (1.5)
GO:0015296	anion:cation symporter activity	0.98	> 0.20	PLG (3.5)	TMEM116 (3.4)	ANGPTL3 (2.8)	NCAN (2.4)	SLC22A1 (1.9)	TM6SF2 (1.8)	PLEKHH2 (1.6)	RPH3A (1.6)	BCAM (1.6)	SYPL2 (1.5)
GO:0060081	membrane hyperpolarization	0.98	> 0.20	C12orf47 (4.4)	RPH3A (3.0)	ANKRD31 (2.4)	NCAN (2.4)	TMEM116 (2.1)	ENSG00000226648 (2.1)	HAPLN4 (1.8)	ENSG00000226645 (1.8)	ST3GAL4 (1.6)	NKPD1 (1.4)
ENSG00000151834	GABRA2 PPI subnetwork	0.98	> 0.20	LPIN3 (2.2)	HAPLN4 (1.7)	ANKRD31 (1.6)	C11orf9 (1.4)	RPH3A (1.4)	PCSK9 (1.1)	UBXN2B (1.1)	MYLIP (1.1)	LPA (1.1)	C12orf43 (1.0)
GO:0051648	vesicle localization	0.98	> 0.20	YIPF2 (3.9)	BLOC1S3 (1.8)	C19orf52 (1.5)	DNM2 (1.5)	OGDH (1.4)	PMFBP1 (1.4)	LPIN3 (1.3)	PPP1R37 (1.3)	DYNC2LI1 (1.3)	DHX38 (1.2)
GO:0019001	guanyl nucleotide binding	0.98	> 0.20	C12orf43 (3.4)	DYNC2LI1 (2.9)	ITGB3 (1.9)	GATAD2A (1.7)	SARS (1.5)	TRAFD1 (1.5)	AP1M2 (1.5)	PTPN11 (1.5)	ZNF259 (1.4)	POLK (1.4)
GO:0032561	guanyl ribonucleotide binding	0.98	> 0.20	C12orf43 (3.4)	DYNC2LI1 (2.9)	ITGB3 (1.9)	GATAD2A (1.7)	SARS (1.5)	TRAFD1 (1.5)	AP1M2 (1.5)	PTPN11 (1.5)	ZNF259 (1.4)	POLK (1.4)
ENSG00000175115	PACS1 PPI subnetwork	0.98	> 0.20	C12orf51 (2.8)	GRINA (2.0)	SORT1 (2.0)	ERP29 (1.7)	UBXN2B (1.7)	C12orf43 (1.6)	NCAN (1.6)	MARK4 (1.6)	PPP1R37 (1.5)	RPH3A (1.5)
GO:0017137	Rab GTPase binding	0.98	> 0.20	COL4A3BP (2.0)	ST3GAL4 (1.6)	YIPF2 (1.5)	KIAA1324 (1.5)	ABO (1.5)	POLK (1.5)	C12orf51 (1.4)	GCNT4 (1.4)	AP1M2 (1.3)	ZHX3 (1.3)
GO:0007340	acrosome reaction	0.98	> 0.20	TSSK6 (6.2)	PMFBP1 (5.1)	PBX4 (3.3)	HNF1A (2.0)	C12orf47 (1.9)	ENSG00000228044 (1.8)	ENSG00000235545 (1.5)	BRAP (1.4)	TRAPPC6A (1.3)	HAVCR1 (1.1)
GO:0003735	structural constituent of ribosome	0.98	> 0.20	GEMIN7 (4.4)	C12orf43 (1.8)	TOMM40 (1.7)	TRAPPC6A (1.4)	ERP29 (1.2)	DHODH (1.2)	PSMA5 (1.1)	ATXN7L2 (1.1)	DDX56 (1.0)	CEACAM19 (0.9)
GO:0021549	cerebellum development	0.98	> 0.20	TMEM116 (2.2)	CILP2 (2.2)	ZHX3 (2.0)	NCAN (1.9)	ANKRD31 (1.9)	HAPLN4 (1.8)	DYNC2LI1 (1.7)	C12orf51 (1.6)	DNAH11 (1.5)	ERP29 (1.4)
MP:0005132	decreased luteinizing hormone level	0.98	> 0.20	KIAA1324 (3.2)	TRIB1 (2.4)	YIPF2 (2.1)	ATXN7L2 (1.6)	PVR (1.5)	GEMIN7 (1.4)	HAVCR1 (1.2)	DNAH11 (1.1)	APOE (1.1)	ENSG00000226645 (1.1)
GO:0032391	photoreceptor connecting cilium	0.98	> 0.20	DYNC2LI1 (9.1)	DOCK7 (2.3)	PBX4 (1.9)	HMGCR (1.4)	DHODH (1.2)	TMEM116 (1.2)	ZHX3 (1.1)	QTRT1 (1.0)	PMFBP1 (0.9)	PLEKHH2 (0.9)
ENSG00000100503	NIN PPI subnetwork	0.98	> 0.20	NCAN (2.4)	RPH3A (2.3)	CELSR2 (1.9)	AP1M2 (1.8)	MARK4 (1.7)	C12orf51 (1.7)	SORT1 (1.7)	GOT2P1 (1.7)	GRINA (1.7)	UBXN2B (1.6)
GO:0001822	kidney development	0.98	> 0.20	PLEKHH2 (2.7)	HAVCR1 (2.3)	DYNC2LI1 (2.1)	FRK (2.1)	BCAM (2.0)	ENSG00000235545 (1.8)	TMED4 (1.8)	TSSK6 (1.8)	NYNRIN (1.7)	AP1M2 (1.6)
ENSG00000112079	STK38 PPI subnetwork	0.98	> 0.20	PTPN11 (4.1)	C19orf52 (2.2)	AMIGO1 (2.0)	TOP1 (1.9)	ENSG00000254235 (1.8)	GATAD2A (1.7)	SH2B3 (1.5)	C12orf47 (1.5)	ENSG00000228044 (1.5)	GMIP (1.4)
GO:0060425	lung morphogenesis	0.98	> 0.20	PLEKHH2 (4.7)	LPAR2 (3.0)	C11orf9 (2.8)	HAPLN4 (1.9)	ENSG00000254235 (1.8)	NYNRIN (1.8)	HLX (1.7)	ENSG00000228044 (1.5)	AP1M2 (1.3)	ENSG00000235545 (1.2)
MP:0000849	abnormal cerebellum morphology	0.98	> 0.20	HAPLN4 (2.4)	ZHX3 (2.1)	ATP13A1 (2.0)	APOE (1.9)	ATXN2 (1.9)	ERP29 (1.9)	RPH3A (1.7)	TMED4 (1.7)	GRINA (1.6)	COL4A3BP (1.6)
MP:0002428	abnormal semicircular canal morphology	0.98	> 0.20	MYLIP (2.3)	HLX (1.8)	PLCG1 (1.8)	LPA (1.7)	TMEM116 (1.7)	DYNC2LI1 (1.4)	CILP2 (1.2)	TRIB1 (1.1)	KIAA1324 (1.1)	CEACAM19 (1.1)
ENSG00000149782	PLCB3 PPI subnetwork	0.98	> 0.20	COL4A3BP (2.3)	PLEC (1.7)	HAPLN4 (1.7)	BCAM (1.6)	KANK2 (1.5)	ABCG8 (1.5)	RPH3A (1.5)	ZHX3 (1.2)	C11orf9 (1.2)	GOT2P1 (1.1)
MP:0004452	abnormal pterygoid process morphology	0.98	> 0.20	MYLIP (2.0)	DYNC2LI1 (1.8)	CILP2 (1.7)	HLX (1.6)	TMEM57 (1.4)	NYNRIN (1.4)	NKPD1 (1.3)	CEACAM19 (1.3)	KANK2 (1.3)	FRK (1.2)
MP:0001354	increased aggression towards males	0.98	> 0.20	PVR (2.8)	ZHX3 (2.8)	ALDH2 (2.4)	ERP29 (1.8)	ENSG00000226645 (1.7)	GRINA (1.7)	TMED4 (1.5)	NCAN (1.2)	PLEKHH2 (1.1)	GOT2P1 (1.1)
MP:0003169	abnormal scala media morphology	0.98	> 0.20	TMEM116 (3.0)	ZHX3 (2.3)	ABO (1.8)	DYNC2LI1 (1.7)	ENSG00000238078 (1.6)	ST3GAL4 (1.5)	ENSG00000228044 (1.5)	PTPN11 (1.3)	GMPR (1.1)	PBX4 (1.0)
GO:0060284	regulation of cell development	0.98	> 0.20	NCAN (2.7)	CELSR2 (2.5)	PPP1R37 (2.0)	ABO (1.8)	MARK4 (1.6)	ATXN7L2 (1.5)	C11orf9 (1.5)	NYNRIN (1.4)	PLCG1 (1.3)	PBX4 (1.3)
GO:0051453	regulation of intracellular pH	0.98	> 0.20	AMIGO1 (3.7)	UBXN2B (3.2)	ERP29 (2.6)	ENSG00000235545 (2.3)	COL4A3BP (2.2)	PBX4 (1.9)	NKPD1 (1.8)	PPP1R37 (1.6)	LPAR2 (1.6)	TMEM116 (1.6)
ENSG00000096433	ITPR3 PPI subnetwork	0.98	> 0.20	HAPLN4 (3.5)	PLEKHH2 (2.4)	PMFBP1 (2.3)	RPH3A (1.9)	ZHX3 (1.7)	ENSG00000238078 (1.7)	SORT1 (1.6)	SH2B3 (1.6)	ADAM1 (1.4)	KANK2 (1.4)
MP:0001900	impaired synaptic plasticity	0.98	> 0.20	NCAN (3.3)	CELSR2 (3.1)	ITGB3 (3.1)	RHCE (2.4)	C11orf9 (1.8)	MARK4 (1.6)	FADS2 (1.6)	PLEKHH2 (1.6)	C12orf43 (1.5)	RHD (1.5)
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	0.98	> 0.20	TMEM116 (2.6)	ATP13A1 (2.5)	TMEM50A (2.3)	YIPF2 (2.1)	CYB561D1 (1.9)	DHODH (1.5)	TRAPPC6A (1.4)	CEACAM19 (1.4)	C1orf63 (1.4)	SLC44A2 (1.3)
GO:0045095	keratin filament	0.98	> 0.20	CELSR2 (1.5)	PMFBP1 (1.2)	TRAPPC6A (0.8)	ENSG00000228044 (0.7)	DYNC2LI1 (0.6)	HAVCR1 (0.6)	BCAM (0.6)	FADS1 (0.6)	PLEKHH2 (0.5)	AP1M2 (0.5)
MP:0000880	decreased Purkinje cell number	0.98	> 0.20	DOCK7 (2.8)	APOE (2.4)	ERP29 (2.4)	ZHX3 (2.2)	SORT1 (1.8)	PLCG1 (1.8)	TMED4 (1.7)	RPH3A (1.6)	AMIGO1 (1.5)	YIPF2 (1.4)
GO:0048145	regulation of fibroblast proliferation	0.98	> 0.20	POLK (3.3)	DYNC2LI1 (2.1)	BLOC1S3 (1.9)	HAVCR1 (1.7)	PBX4 (1.5)	KANK2 (1.1)	TMED4 (0.7)	CILP2 (0.7)	AMIGO1 (0.7)	CBLC (0.6)
GO:0010171	body morphogenesis	0.98	> 0.20	MAU2 (1.9)	NYNRIN (1.8)	MYLIP (1.8)	LPAR2 (1.6)	PMFBP1 (1.6)	CILP2 (1.4)	C17orf57 (1.3)	GCNT4 (1.3)	ENSG00000235545 (1.3)	ENSG00000238078 (1.3)
MP:0005130	decreased follicle stimulating hormone level	0.98	> 0.20	KIAA1324 (2.6)	ATXN7L2 (2.6)	LPA (2.0)	HAVCR1 (1.9)	ENSG00000238078 (1.7)	YIPF2 (1.5)	APOB (1.3)	LPIN3 (1.3)	ABCG8 (1.2)	C12orf47 (1.2)
GO:0015988	energy coupled proton transport, against electrochemical gradient	0.98	> 0.20	TMEM116 (3.4)	ENSG00000238078 (3.0)	ERP29 (2.4)	GRINA (2.3)	NKPD1 (2.1)	SORT1 (2.0)	COL4A3BP (2.0)	SARS (1.7)	TSSK6 (1.7)	ACAD10 (1.6)
GO:0015991	ATP hydrolysis coupled proton transport	0.98	> 0.20	TMEM116 (3.4)	ENSG00000238078 (3.0)	ERP29 (2.4)	GRINA (2.3)	NKPD1 (2.1)	SORT1 (2.0)	COL4A3BP (2.0)	SARS (1.7)	TSSK6 (1.7)	ACAD10 (1.6)
ENSG00000118680	MYL12B PPI subnetwork	0.98	> 0.20	OGDH (2.4)	DOCK7 (2.2)	SH2B3 (2.1)	FRK (2.0)	TMEM50A (1.9)	ATXN2 (1.9)	KANK2 (1.8)	PLEC (1.8)	ENSG00000238078 (1.6)	ALDH2 (1.5)
GO:0051302	regulation of cell division	0.98	> 0.20	DYNC2LI1 (2.2)	PSRC1 (1.8)	TMEM50A (1.7)	ENSG00000228044 (1.7)	AP1M2 (1.6)	TMEM116 (1.5)	KANK2 (1.3)	RHD (1.2)	UBXN2B (1.2)	POC5 (1.1)
GO:0021756	striatum development	0.98	> 0.20	UBXN2B (2.5)	DYNC2LI1 (2.3)	TMEM116 (1.9)	POLK (1.7)	TXNL4B (1.6)	ENSG00000254235 (1.5)	C12orf43 (1.3)	TMEM50A (1.2)	ZNF180 (1.2)	FRK (1.1)
GO:0015812	gamma-aminobutyric acid transport	0.98	> 0.20	ENSG00000226648 (3.1)	HAPLN4 (3.0)	RPH3A (2.8)	ABO (2.6)	NCAN (2.5)	CYP7A1 (1.5)	C17orf57 (1.3)	ENSG00000226645 (1.3)	COL4A3BP (1.2)	ZHX3 (1.1)
GO:0010830	regulation of myotube differentiation	0.98	> 0.20	CEACAM19 (3.4)	ENSG00000226648 (2.5)	ATXN7L2 (2.4)	GMPR (2.3)	LPIN3 (1.8)	PMFBP1 (1.7)	BLOC1S3 (1.7)	NKPD1 (1.5)	SYPL2 (1.5)	ZNF180 (1.2)
ENSG00000135333	EPHA7 PPI subnetwork	0.98	> 0.20	UBXN2B (2.7)	GRINA (2.2)	DOCK7 (2.0)	MARK4 (1.8)	LPIN3 (1.6)	PPP1R37 (1.4)	SMARCA4 (1.4)	C12orf51 (1.3)	TOMM40 (1.3)	AMIGO1 (1.3)
ENSG00000157500	APPL1 PPI subnetwork	0.98	> 0.20	PTPN11 (2.9)	CLPTM1 (2.9)	PPP1R37 (2.9)	NCAN (1.9)	MARK4 (1.7)	ZNF180 (1.6)	TMEM50A (1.5)	ATXN2 (1.5)	RPH3A (1.3)	SORT1 (1.3)
GO:0050919	negative chemotaxis	0.98	> 0.20	TMED4 (2.7)	PLEKHH2 (2.5)	ANKRD31 (2.3)	PBX4 (2.0)	TMEM57 (1.9)	LPAR2 (1.8)	NYNRIN (1.7)	NKPD1 (1.6)	ENSG00000228044 (1.5)	GCNT4 (1.5)
ENSG00000103769	RAB11A PPI subnetwork	0.98	> 0.20	TMEM50A (2.5)	COL4A3BP (2.4)	POLK (2.1)	C11orf9 (1.9)	PVR (1.4)	MYLIP (1.3)	CYB561D1 (1.3)	ZNF259 (1.3)	PSMA5 (1.2)	ENSG00000228044 (1.2)
ENSG00000152578	GRIA4 PPI subnetwork	0.98	> 0.20	NCAN (3.0)	HAPLN4 (2.9)	ZHX3 (2.8)	GOT2P1 (2.5)	SORT1 (2.4)	AP1M2 (2.0)	CBLC (2.0)	RPH3A (1.9)	KIAA1324 (1.8)	TIMD4 (1.7)
MP:0008070	absent T cells	0.98	> 0.20	PLCG1 (5.4)	ZNF101 (4.5)	SLC44A2 (2.0)	GMIP (2.0)	UBXN2B (1.9)	PBX4 (1.7)	HAVCR1 (1.4)	DOCK7 (1.3)	SMARCA4 (1.2)	OGDH (1.2)
MP:0009347	increased trabecular bone thickness	0.98	> 0.20	FRK (2.8)	CEACAM19 (2.7)	PARP10 (2.2)	CELSR2 (2.1)	HLX (1.8)	KIAA1324 (1.8)	DNAH11 (1.8)	MYLIP (1.6)	PCSK9 (1.4)	POLK (1.3)
GO:0021516	dorsal spinal cord development	0.98	> 0.20	ENSG00000226648 (2.6)	C12orf47 (2.5)	GMPR (2.3)	ZHX3 (2.1)	TMEM116 (1.9)	TSSK6 (1.8)	PBX4 (1.6)	PMFBP1 (1.5)	NKPD1 (1.4)	ANKRD31 (1.3)
ENSG00000117410	ATP6V0B PPI subnetwork	0.98	> 0.20	SARS (3.0)	TMEM50A (3.0)	ERP29 (2.9)	CLPTM1 (2.6)	SORT1 (2.6)	TMEM57 (2.1)	ATP13A1 (2.1)	TMED4 (1.7)	GRINA (1.6)	GEMIN7 (1.6)
ENSG00000107862	GBF1 PPI subnetwork	0.98	> 0.20	PTPN11 (2.6)	NT5DC1 (2.5)	GRINA (2.5)	FRK (1.9)	MAPKAPK5 (1.8)	TOP1 (1.6)	RPH3A (1.5)	CARM1 (1.3)	YIPF2 (1.3)	OGDH (1.3)
GO:0005892	acetylcholine-gated channel complex	0.98	> 0.20	SYPL2 (2.8)	ATXN7L2 (2.7)	PMFBP1 (2.2)	CILP2 (1.9)	SORT1 (1.8)	CYB561D1 (1.8)	ABO (1.7)	AMIGO1 (1.6)	ANKRD31 (1.4)	MOSC1 (1.3)
GO:0007204	elevation of cytosolic calcium ion concentration	0.98	> 0.20	PBX4 (2.2)	C12orf47 (2.1)	SLC44A2 (1.9)	SYPL2 (1.8)	LPIN3 (1.7)	ABO (1.7)	ERP29 (1.5)	KIAA1324 (1.4)	GMIP (1.2)	ZNF101 (1.1)
MP:0001409	increased stereotypic behavior	0.98	> 0.20	AMIGO1 (2.4)	RHCE (2.3)	BLOC1S3 (1.9)	C17orf57 (1.6)	C12orf51 (1.6)	PLCG1 (1.6)	ZNF259 (1.4)	HNF1A (1.4)	CETP (1.4)	ZHX3 (1.3)
ENSG00000170820	FSHR PPI subnetwork	0.98	> 0.20	PTPN11 (2.3)	ZHX3 (1.7)	PVR (1.5)	HAVCR1 (1.4)	OGDH (1.3)	TSSK6 (1.2)	TMEM116 (1.1)	CILP2 (1.1)	TXNL4B (1.1)	ST3GAL4 (1.0)
MP:0000807	abnormal hippocampus morphology	0.98	> 0.20	NCAN (4.5)	CELSR2 (4.4)	FADS1 (2.4)	UBXN2B (2.0)	APOE (1.9)	PBX4 (1.8)	APOC1 (1.7)	C12orf51 (1.7)	GRINA (1.6)	FADS2 (1.6)
ENSG00000116957	TBCE PPI subnetwork	0.98	> 0.20	PSRC1 (2.4)	FEN1 (2.3)	SUGP1 (1.9)	GATAD2A (1.4)	ENSG00000238078 (1.3)	ENSG00000226645 (1.3)	SMARCA4 (1.2)	HMGCR (1.1)	RPH3A (1.1)	PSMA5 (1.1)
ENSG00000159720	ATP6V0D1 PPI subnetwork	0.98	> 0.20	GRINA (2.3)	SARS (1.9)	RPH3A (1.8)	HAPLN4 (1.8)	BRAP (1.7)	PSMA5 (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	TRAPPC6A (1.4)	ENSG00000226648 (1.4)
ENSG00000136810	TXN PPI subnetwork	0.98	> 0.20	GRINA (3.0)	HAPLN4 (2.3)	CYB561D1 (1.9)	TXNL4B (1.9)	ENSG00000238078 (1.8)	RELB (1.7)	TMEM116 (1.7)	PARP10 (1.6)	MAU2 (1.6)	PCSK9 (1.5)
ENSG00000174804	FZD4 PPI subnetwork	0.98	> 0.20	C11orf9 (2.6)	BCAM (2.5)	CBLC (2.5)	CILP2 (1.9)	TSSK6 (1.8)	AMIGO1 (1.5)	NYNRIN (1.4)	FADS2 (1.3)	PPP1R37 (1.1)	TMED4 (1.1)
MP:0000832	abnormal thalamus morphology	0.98	> 0.20	NCAN (2.8)	DNM2 (1.9)	ZHX3 (1.8)	CELSR2 (1.8)	MAU2 (1.7)	C12orf51 (1.7)	USP24 (1.6)	SLC22A1 (1.6)	GRINA (1.5)	APOB (1.5)
ENSG00000132535	DLG4 PPI subnetwork	0.98	> 0.20	RPH3A (4.5)	NCAN (3.5)	CELSR2 (3.4)	SORT1 (2.5)	AMIGO1 (2.3)	PPP1R37 (2.2)	MARK4 (2.0)	C11orf9 (2.0)	CLPTM1 (1.2)	C12orf51 (1.0)
GO:0055078	sodium ion homeostasis	0.98	> 0.20	HNF1A (2.7)	ENSG00000226648 (1.8)	FRK (1.8)	C12orf47 (1.7)	AP1M2 (1.6)	BCAM (1.6)	AMIGO1 (1.5)	HAVCR1 (1.4)	KIAA1324 (1.4)	C17orf57 (1.4)
GO:0050931	pigment cell differentiation	0.98	> 0.20	ST3GAL4 (2.5)	MYLIP (2.4)	ENSG00000235545 (2.1)	DOCK7 (2.0)	KIAA1324 (1.7)	MAU2 (1.5)	CELSR2 (1.4)	ENSG00000228044 (1.4)	NKPD1 (1.1)	ITGB3 (1.1)
GO:0008250	oligosaccharyltransferase complex	0.98	> 0.20	ERP29 (4.8)	TMED4 (3.5)	ATP13A1 (3.0)	YIPF2 (2.7)	TMEM50A (2.7)	CLPTM1 (2.0)	SORT1 (2.0)	PSMA5 (1.7)	TMEM57 (1.5)	SLC44A2 (1.3)
GO:0090307	spindle assembly involved in mitosis	0.98	> 0.20	PSRC1 (2.8)	POC5 (2.5)	DYNC2LI1 (2.1)	BLOC1S3 (1.8)	ACAD10 (1.5)	TMEM116 (1.4)	PMFBP1 (1.4)	UBXN2B (1.3)	LPIN3 (1.1)	CETP (1.1)
GO:0019003	GDP binding	0.98	> 0.20	COL4A3BP (2.7)	MAPKAPK5 (2.2)	BRAP (2.1)	ANKRD31 (2.0)	PLEKHH2 (2.0)	GRINA (1.4)	C12orf43 (1.4)	TMEM50A (1.4)	TRAFD1 (1.3)	ALDH2 (1.2)
GO:0046785	microtubule polymerization	0.98	> 0.20	PBX4 (2.1)	UBXN2B (1.9)	POC5 (1.8)	C12orf51 (1.7)	LPIN3 (1.5)	CELSR2 (1.3)	C12orf47 (1.3)	C17orf57 (1.3)	BLOC1S3 (1.3)	SORT1 (1.2)
ENSG00000124702	KLHDC3 PPI subnetwork	0.98	> 0.20	BRAP (2.3)	PLCG1 (1.9)	LPIN3 (1.8)	FRK (1.5)	ZHX3 (1.5)	NT5DC1 (1.5)	ATXN2 (1.4)	GMPR (1.4)	ADAM1 (1.4)	BUD13 (1.4)
MP:0001529	abnormal vocalization	0.98	> 0.20	LDLR (3.3)	FADS2 (3.1)	HMGCR (2.9)	FADS1 (2.5)	PCSK9 (2.5)	AMIGO1 (1.8)	C12orf47 (1.3)	POC5 (1.2)	CELSR2 (1.2)	ERP29 (1.0)
GO:0046658	anchored to plasma membrane	0.98	> 0.20	BCAM (3.2)	AP1M2 (2.6)	CELSR2 (2.5)	NYNRIN (2.4)	TMEM116 (2.3)	AMIGO1 (1.8)	CYB561D1 (1.6)	ENSG00000228044 (1.6)	PVRL2 (1.3)	ENSG00000226645 (1.3)
MP:0006397	disorganized long bone epiphyseal plate	0.98	> 0.20	CILP2 (4.0)	UBXN2B (2.4)	PLEKHH2 (1.9)	ANKRD31 (1.8)	ERP29 (1.7)	TMEM116 (1.5)	HAVCR1 (1.4)	TRIB1 (1.4)	YIPF2 (1.4)	C17orf57 (1.3)
GO:0042249	establishment of planar polarity of embryonic epithelium	0.98	> 0.20	ATXN7L2 (3.5)	ENSG00000235545 (2.5)	TMEM116 (1.9)	NYNRIN (1.8)	ABO (1.7)	PLEKHH2 (1.4)	DYNC2LI1 (1.4)	CELSR2 (1.3)	C19orf52 (1.2)	AMIGO1 (1.2)
ENSG00000081248	CACNA1S PPI subnetwork	0.98	> 0.20	SYPL2 (3.5)	NCAN (1.8)	PLEKHH2 (1.6)	HAPLN4 (1.6)	GPAM (1.5)	HAVCR1 (1.5)	ADAM1 (1.4)	GMPR (1.4)	CARM1 (1.3)	SLC44A2 (1.2)
MP:0004620	cervical vertebral fusion	0.98	> 0.20	CILP2 (2.0)	ATXN2 (1.8)	ABO (1.7)	NYNRIN (1.6)	ALDH2 (1.6)	USP24 (1.6)	TMED4 (1.3)	TMEM50A (1.3)	PPP1R37 (1.3)	BCAM (1.3)
MP:0002314	abnormal respiratory mechanics	0.98	> 0.20	C17orf57 (2.3)	ENSG00000228044 (2.1)	KANK2 (1.9)	C11orf9 (1.9)	RPH3A (1.9)	POLK (1.9)	DYNC2LI1 (1.7)	TMEM116 (1.7)	BCAM (1.5)	SORT1 (1.5)
ENSG00000151067	CACNA1C PPI subnetwork	0.98	> 0.20	HAPLN4 (2.3)	RPH3A (1.9)	TSSK6 (1.7)	PLEKHH2 (1.6)	CYB561D1 (1.5)	ENSG00000238078 (1.5)	FRK (1.4)	HAVCR1 (1.3)	CARM1 (1.3)	AMIGO1 (1.3)
ENSG00000105737	GRIK5 PPI subnetwork	0.98	> 0.20	NCAN (2.1)	PVRL2 (2.0)	CBLC (1.8)	DOCK7 (1.8)	PLEC (1.7)	GRINA (1.5)	KIAA1324 (1.4)	ABO (1.3)	ACAD10 (1.3)	ERP29 (1.3)
MP:0009749	enhanced behavioral response to addictive substance	0.98	> 0.20	RPH3A (2.7)	SH2B3 (2.6)	ITGB3 (2.2)	ENSG00000226645 (1.7)	GMPR (1.5)	BLOC1S3 (1.5)	OGDH (1.5)	PMFBP1 (1.5)	ST3GAL4 (1.5)	ALDH2 (1.4)
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINENORADRENALINE	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINENORADRENALINE	0.98	> 0.20	TMEM50A (1.9)	CETP (1.8)	KIAA1324 (1.7)	ITGB3 (1.7)	KANK2 (1.6)	MARK4 (1.4)	ENSG00000254235 (1.4)	OASL (1.2)	NYNRIN (1.2)	PVRL2 (1.1)
ENSG00000119383	PPP2R4 PPI subnetwork	0.98	> 0.20	POLK (2.0)	TOP1 (1.6)	MYLIP (1.5)	ENSG00000226645 (1.4)	ZNF180 (1.4)	TMEM57 (1.3)	GOT2P1 (1.3)	C19orf52 (1.2)	PTPN11 (1.2)	CARM1 (1.1)
MP:0000467	abnormal esophagus morphology	0.98	> 0.20	KIAA1324 (2.2)	CELSR2 (2.1)	PMFBP1 (1.9)	TMEM116 (1.8)	ENSG00000235545 (1.7)	DOCK7 (1.5)	PLEC (1.5)	POLK (1.3)	AP1M2 (1.1)	LPAR2 (1.1)
GO:0051656	establishment of organelle localization	0.98	> 0.20	YIPF2 (3.2)	POC5 (2.7)	PSRC1 (2.6)	DNM2 (2.1)	OGDH (1.6)	DOCK7 (1.5)	ENSG00000228044 (1.4)	BUD13 (1.4)	SORT1 (1.3)	SUGP1 (1.3)
MP:0009434	paraparesis	0.98	> 0.20	USP24 (3.5)	HAVCR1 (3.4)	C11orf9 (2.5)	CELSR2 (2.4)	RPH3A (2.4)	HAPLN4 (2.3)	COL4A3BP (2.2)	NCAN (2.1)	BCAM (1.9)	SYPL2 (1.4)
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	0.98	> 0.20	NCAN (4.4)	RPH3A (3.5)	SYPL2 (3.0)	HAPLN4 (2.8)	CELSR2 (1.8)	LPIN3 (1.7)	AMIGO1 (1.6)	CEACAM19 (1.5)	C12orf43 (1.5)	CYB561D1 (1.4)
MP:0001413	abnormal response to new environment	0.98	> 0.20	APOC1 (2.3)	GMPR (2.1)	C12orf43 (1.9)	ZHX3 (1.8)	RPH3A (1.8)	PTPN11 (1.7)	TMEM116 (1.7)	ITGB3 (1.6)	GEMIN7 (1.6)	ABO (1.4)
MP:0004901	decreased male germ cell number	0.98	> 0.20	KIAA1324 (3.0)	NT5DC1 (1.8)	PBX4 (1.6)	ST3GAL4 (1.5)	FEN1 (1.5)	MAPKAPK5 (1.4)	POC5 (1.3)	TSSK6 (1.2)	FRK (1.1)	PLEKHH2 (1.1)
MP:0004182	abnormal spermiation	0.98	> 0.20	DYNC2LI1 (2.4)	CILP2 (2.1)	ENSG00000226645 (1.8)	PLG (1.7)	TIMD4 (1.7)	PLEKHH2 (1.6)	ANKRD31 (1.6)	TMEM116 (1.6)	C11orf9 (1.5)	APOB (1.4)
ENSG00000154174	TOMM70A PPI subnetwork	0.98	> 0.20	ENSG00000226648 (2.2)	AP1M2 (2.1)	GMPR (2.1)	PSMA5 (1.8)	CLPTM1 (1.7)	GOT2P1 (1.5)	CELSR2 (1.5)	TOMM40 (1.3)	MOSC1 (1.2)	ALDH2 (1.1)
GO:0043015	gamma-tubulin binding	0.98	> 0.20	ST3GAL4 (2.3)	BLOC1S3 (1.9)	CBLC (1.9)	ZNF259 (1.8)	NYNRIN (1.7)	TSSK6 (1.7)	TIMD4 (1.6)	ENSG00000226648 (1.6)	GEMIN7 (1.3)	BUD13 (1.3)
ENSG00000110448	CD5 PPI subnetwork	0.98	> 0.20	PLCG1 (4.1)	TIMD4 (2.9)	SLC44A2 (2.9)	GMIP (2.7)	CETP (2.6)	ZNF101 (2.1)	MAFB (1.7)	POC5 (1.5)	PTPN11 (1.4)	COL4A3BP (1.3)
ENSG00000103415	HMOX2 PPI subnetwork	0.98	> 0.20	ZNF180 (2.7)	PVR (2.1)	APOE (1.9)	ERP29 (1.7)	C17orf57 (1.7)	ALDH2 (1.6)	TIMD4 (1.5)	KANK2 (1.3)	HNF1A (1.1)	TRAFD1 (1.1)
ENSG00000099864	PALM PPI subnetwork	0.98	> 0.20	PVR (2.0)	ERP29 (1.9)	HNF1A (1.7)	APOE (1.6)	TIMD4 (1.5)	PTPN11 (1.4)	AMIGO1 (1.4)	ZNF180 (1.4)	POLK (1.3)	ALDH2 (1.3)
GO:0031201	SNARE complex	0.98	> 0.20	AP1M2 (3.1)	YIPF2 (2.4)	TRAPPC6A (2.3)	C1orf63 (2.1)	GRINA (2.0)	OGDH (2.0)	HAPLN4 (2.0)	BRAP (2.0)	TXNL4B (1.8)	CYB561D1 (1.8)
MP:0003313	abnormal locomotor activation	0.98	> 0.20	RPH3A (2.4)	CELSR2 (2.4)	NKPD1 (2.2)	ERP29 (2.1)	HNF1A (2.1)	AMIGO1 (2.0)	ABO (1.9)	ADAM1 (1.8)	ATP13A1 (1.7)	ZHX3 (1.7)
ENSG00000164061	BSN PPI subnetwork	0.98	> 0.20	RPH3A (3.0)	HAPLN4 (2.7)	PPP1R37 (2.0)	C12orf51 (1.9)	AP1M2 (1.8)	CELSR2 (1.8)	LPIN3 (1.7)	CLPTM1 (1.6)	CYB561D1 (1.3)	SORT1 (1.3)
GO:0044089	positive regulation of cellular component biogenesis	0.98	> 0.20	NCAN (3.0)	ANKRD31 (2.4)	ZHX3 (2.4)	KIAA1324 (1.8)	RPH3A (1.6)	PLEKHH2 (1.6)	CBLC (1.6)	CELSR2 (1.5)	PMFBP1 (1.4)	TMEM57 (1.3)
GO:0050885	neuromuscular process controlling balance	0.98	> 0.20	ENSG00000238078 (2.6)	ENSG00000226645 (2.4)	RPH3A (2.4)	HAVCR1 (2.1)	ERP29 (2.1)	AMIGO1 (1.9)	PPP1R37 (1.9)	ZHX3 (1.7)	GCNT4 (1.7)	ANKRD31 (1.6)
MP:0002798	abnormal active avoidance behavior	0.98	> 0.20	GCNT4 (1.8)	CLPTM1 (1.8)	C12orf43 (1.7)	ZNF101 (1.6)	ABCG5 (1.3)	KANK2 (1.3)	ITGB3 (1.3)	PMFBP1 (1.2)	GATAD2A (1.2)	TRAPPC6A (1.1)
GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	0.98	> 0.20	LPIN3 (2.3)	HAPLN4 (1.8)	ZHX3 (1.8)	ST3GAL4 (1.7)	MAPKAPK5 (1.7)	AMIGO1 (1.6)	DNAH11 (1.6)	COL4A3BP (1.6)	BLOC1S3 (1.3)	TSSK6 (1.3)
GO:0050867	positive regulation of cell activation	0.98	> 0.20	ZNF101 (3.1)	PBX4 (2.4)	TIMD4 (2.1)	PLCG1 (2.0)	CETP (1.7)	GMIP (1.7)	POLK (1.4)	CYB561D1 (1.4)	RELB (1.3)	BCL3 (1.1)
MP:0004084	abnormal cardiac muscle relaxation	0.98	> 0.20	BCAM (2.0)	ENSG00000228044 (1.6)	PTPN11 (1.3)	MAU2 (1.3)	NAA25 (1.2)	SORT1 (1.2)	ACAD10 (1.1)	KANK2 (1.1)	ATXN7L2 (1.1)	ERP29 (0.9)
ENSG00000169242	EFNA1 PPI subnetwork	0.98	> 0.20	CBLC (1.7)	LPIN3 (1.7)	LPAR2 (1.6)	CELSR2 (1.6)	NYNRIN (1.3)	PCSK9 (1.2)	PLEKHH2 (1.2)	PBX4 (1.1)	AMIGO1 (1.0)	PMFBP1 (1.0)
ENSG00000136026	CKAP4 PPI subnetwork	0.98	> 0.20	SARS (2.7)	DDX56 (2.1)	GATAD2A (2.1)	ADAM1 (1.8)	PVR (1.7)	ITGB3 (1.7)	OGDH (1.5)	PPP1R37 (1.5)	BRAP (1.4)	FRK (1.4)
GO:0032489	regulation of Cdc42 protein signal transduction	0.98	> 0.20	PPP1R37 (2.3)	LPAR2 (2.3)	AP1M2 (2.1)	CBLC (1.7)	HAVCR1 (1.7)	C12orf47 (1.6)	TMEM116 (1.6)	GMIP (1.5)	PBX4 (1.2)	NKPD1 (1.2)
GO:0043088	regulation of Cdc42 GTPase activity	0.98	> 0.20	PPP1R37 (2.3)	LPAR2 (2.3)	AP1M2 (2.1)	CBLC (1.7)	HAVCR1 (1.7)	C12orf47 (1.6)	TMEM116 (1.6)	GMIP (1.5)	PBX4 (1.2)	NKPD1 (1.2)
MP:0005551	abnormal eye electrophysiology	0.98	> 0.20	APOC1 (2.5)	ENSG00000235545 (2.3)	GPAM (1.9)	PMFBP1 (1.9)	APOE (1.9)	NCAN (1.8)	SORT1 (1.4)	C11orf9 (1.4)	PSRC1 (1.3)	ST3GAL4 (1.3)
MP:0004355	short radius	0.98	> 0.20	PLEKHH2 (3.6)	CILP2 (2.3)	NYNRIN (2.1)	DYNC2LI1 (2.0)	MAFB (1.8)	GOT2P1 (1.4)	CARM1 (1.3)	MYLIP (1.1)	C17orf57 (1.0)	PVR (0.9)
MP:0000087	absent mandible	0.98	> 0.20	CILP2 (2.2)	ZHX3 (1.5)	TXNL4B (1.4)	HMGCR (1.4)	C17orf57 (1.3)	PLCG1 (1.2)	AP1M2 (1.2)	PSRC1 (1.1)	LPAR2 (1.0)	APOB (1.0)
GO:0001505	regulation of neurotransmitter levels	0.98	> 0.20	RPH3A (4.0)	HAPLN4 (3.2)	ABO (2.5)	AMIGO1 (2.3)	C12orf51 (2.2)	PMFBP1 (1.5)	DNAH11 (1.5)	HNF1A (1.4)	TSSK6 (1.4)	NCAN (1.3)
GO:0050856	regulation of T cell receptor signaling pathway	0.98	> 0.20	PBX4 (3.4)	CYB561D1 (3.1)	ZNF101 (3.1)	TRAPPC6A (2.6)	PLCG1 (2.2)	NT5DC1 (1.5)	GCNT4 (1.4)	TXNL4B (1.3)	ENSG00000228044 (1.3)	POLK (1.2)
ENSG00000172020	GAP43 PPI subnetwork	0.98	> 0.20	C11orf9 (3.5)	NCAN (2.7)	RPH3A (2.2)	CELSR2 (2.1)	SLC44A2 (1.9)	PTPN11 (1.6)	ALDH2 (1.5)	PBX4 (1.5)	GCNT4 (1.4)	ENSG00000235545 (1.4)
ENSG00000099795	NDUFB7 PPI subnetwork	0.98	> 0.20	OGDH (3.4)	ACAD10 (3.0)	TRAPPC6A (2.9)	C12orf47 (2.7)	GOT2P1 (1.6)	MAU2 (1.5)	PSMA5 (1.4)	FRK (1.4)	GMPR (1.3)	ADAM1 (1.2)
ENSG00000141522	ARHGDIA PPI subnetwork	0.98	> 0.20	C11orf9 (3.7)	SH2B3 (1.8)	DNM2 (1.7)	PBX4 (1.6)	PPP1R37 (1.6)	ENSG00000235545 (1.5)	ST3GAL4 (1.5)	PTPN11 (1.5)	OGDH (1.1)	TRAFD1 (1.1)
GO:0015985	energy coupled proton transport, down electrochemical gradient	0.98	> 0.20	OGDH (3.5)	C12orf47 (3.4)	ACAD10 (3.3)	ENSG00000238078 (2.8)	TMEM116 (2.6)	ENSG00000226648 (2.1)	GOT2P1 (2.1)	HNF1A (2.0)	ERP29 (1.8)	FRK (1.8)
GO:0015986	ATP synthesis coupled proton transport	0.98	> 0.20	OGDH (3.5)	C12orf47 (3.4)	ACAD10 (3.3)	ENSG00000238078 (2.8)	TMEM116 (2.6)	ENSG00000226648 (2.1)	GOT2P1 (2.1)	HNF1A (2.0)	ERP29 (1.8)	FRK (1.8)
GO:0048016	inositol phosphate-mediated signaling	0.98	> 0.20	C12orf47 (2.0)	PMFBP1 (1.8)	LPIN3 (1.8)	ST3GAL4 (1.7)	NKPD1 (1.6)	AMIGO1 (1.6)	PLEKHH2 (1.5)	ENSG00000235545 (1.4)	ITGB3 (1.3)	ABO (1.2)
ENSG00000131747	TOP2A PPI subnetwork	0.98	> 0.20	USP1 (3.9)	FEN1 (3.4)	ILF3 (2.9)	SMARCA4 (2.8)	PTPN11 (2.2)	PLCG1 (2.2)	PSRC1 (2.1)	POLK (1.7)	NKPD1 (1.6)	GATAD2A (1.4)
GO:0042308	negative regulation of protein import into nucleus	0.98	> 0.20	ENSG00000235545 (2.2)	ZNF101 (2.1)	PPP1R37 (2.1)	ABO (1.9)	PBX4 (1.8)	GATAD2A (1.4)	PMFBP1 (1.3)	MAFB (1.2)	PLCG1 (1.2)	LPAR2 (1.1)
ENSG00000164104	HMGB2 PPI subnetwork	0.98	> 0.20	CELSR2 (2.2)	PBX4 (2.1)	KIAA1324 (1.7)	GOT2P1 (1.6)	C19orf52 (1.6)	UBXN2B (1.6)	HAPLN4 (1.5)	C1orf63 (1.5)	ADAM1 (1.4)	PCSK9 (1.3)
GO:0006750	glutathione biosynthetic process	0.98	> 0.20	RHCE (2.1)	AP1M2 (2.0)	TM6SF2 (2.0)	AMIGO1 (2.0)	TXNL4B (1.9)	PMFBP1 (1.9)	NPC1L1 (1.6)	CYB561D1 (1.6)	RHD (1.6)	ENSG00000235545 (1.5)
MP:0001938	delayed sexual maturation	0.98	> 0.20	KIAA1324 (3.5)	NKPD1 (2.6)	C11orf9 (2.5)	TXNL4B (2.2)	C12orf47 (2.0)	SLC44A2 (2.0)	PMFBP1 (1.8)	AP1M2 (1.7)	ATXN7L2 (1.6)	CILP2 (1.6)
MP:0002919	enhanced paired-pulse facilitation	0.98	> 0.20	RPH3A (4.7)	NCAN (4.5)	HAPLN4 (3.4)	PLEKHH2 (2.1)	HAVCR1 (2.0)	PPP1R37 (2.0)	ZHX3 (1.8)	RHCE (1.8)	ENSG00000238078 (1.7)	ENSG00000254235 (1.6)
GO:0004089	carbonate dehydratase activity	0.98	> 0.20	RHD (4.4)	RHCE (4.1)	DNAH11 (3.5)	ENSG00000235545 (2.6)	UBXN2B (1.9)	MOSC1 (1.8)	SORT1 (1.7)	C11orf9 (1.5)	AP1M2 (1.5)	KIAA1324 (1.4)
ENSG00000206286	VPS52 PPI subnetwork	0.98	> 0.20	CLPTM1 (2.7)	ATP13A1 (2.4)	SARS (2.0)	GRINA (1.9)	DDX56 (1.9)	NKPD1 (1.8)	ENSG00000228044 (1.6)	ATXN7L2 (1.6)	CELSR2 (1.5)	TXNL4B (1.5)
ENSG00000112478	ENSG00000112478 PPI subnetwork	0.98	> 0.20	CLPTM1 (2.7)	ATP13A1 (2.4)	SARS (2.0)	GRINA (1.9)	DDX56 (1.9)	NKPD1 (1.8)	ENSG00000228044 (1.6)	ATXN7L2 (1.6)	CELSR2 (1.5)	TXNL4B (1.5)
ENSG00000206214	ENSG00000206214 PPI subnetwork	0.98	> 0.20	CLPTM1 (2.7)	ATP13A1 (2.4)	SARS (2.0)	GRINA (1.9)	DDX56 (1.9)	NKPD1 (1.8)	ENSG00000228044 (1.6)	ATXN7L2 (1.6)	CELSR2 (1.5)	TXNL4B (1.5)
ENSG00000185973	TMLHE PPI subnetwork	0.98	> 0.20	GEMIN7 (3.7)	C12orf47 (2.6)	TXNL4B (2.5)	PSMA5 (2.3)	NT5DC1 (2.1)	CLPTM1 (1.9)	PTPN11 (1.9)	C12orf43 (1.8)	MAPKAPK5 (1.8)	TOMM40 (1.7)
ENSG00000169067	ACTBL2 PPI subnetwork	0.98	> 0.20	C12orf47 (3.2)	PTPN11 (2.9)	FADS2 (2.3)	AMIGO1 (1.9)	GRINA (1.9)	ATXN7L2 (1.7)	ENSG00000254235 (1.6)	C11orf9 (1.4)	ADAM1 (1.4)	NKPD1 (1.3)
ENSG00000075089	ACTR6 PPI subnetwork	0.98	> 0.20	BUD13 (2.7)	SUGP1 (2.6)	POC5 (2.3)	ZNF259 (2.2)	C1orf63 (2.1)	TOP1 (2.0)	ILF3 (1.9)	SMARCA4 (1.7)	GATAD2A (1.6)	TXNL4B (1.6)
ENSG00000036672	USP2 PPI subnetwork	0.98	> 0.20	RELB (4.5)	LPAR2 (2.1)	CBLC (1.7)	YIPF2 (1.7)	AP1M2 (1.6)	PBX4 (1.5)	PPP1R37 (1.5)	POLK (1.5)	BCL3 (1.5)	QTRT1 (1.4)
MP:0000808	abnormal hippocampus development	0.98	> 0.20	NCAN (2.9)	CELSR2 (2.6)	TMEM57 (2.3)	PARP10 (2.1)	DYNC2LI1 (1.8)	DNAH11 (1.6)	TMED4 (1.6)	CYB561D1 (1.5)	GCNT4 (1.4)	NYNRIN (1.2)
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	0.98	> 0.20	ITGB3 (3.0)	MOSC1 (2.8)	CETP (2.2)	HLX (2.1)	SORT1 (2.0)	PLEKHH2 (1.8)	KANK2 (1.4)	GOT2P1 (1.4)	ENSG00000238078 (1.4)	TXNL4B (1.2)
ENSG00000172057	ORMDL3 PPI subnetwork	0.98	> 0.20	TXNL4B (3.4)	TRAPPC6A (2.6)	C12orf43 (2.4)	HAPLN4 (2.3)	TOMM40 (2.1)	OGDH (1.9)	BLOC1S3 (1.9)	ACAD10 (1.7)	GEMIN7 (1.6)	DDX56 (1.6)
MP:0000588	thick tail	0.98	> 0.20	CILP2 (1.8)	PLCG1 (1.7)	TRAPPC6A (1.5)	COL4A3BP (1.5)	MAFB (1.4)	NKPD1 (1.4)	ALDH2 (1.3)	ADAM1 (1.3)	KIAA1324 (1.3)	ENSG00000254235 (1.2)
ENSG00000166225	FRS2 PPI subnetwork	0.98	> 0.20	C11orf9 (3.6)	PLEKHH2 (2.4)	PVRL2 (2.1)	ABO (2.0)	BCAM (1.7)	TMEM50A (1.7)	HAPLN4 (1.7)	PVR (1.6)	ALDH2 (1.5)	NCAN (1.5)
GO:0030332	cyclin binding	0.98	> 0.20	CYP7A1 (1.8)	DDX56 (1.6)	USP1 (1.6)	GMPR (1.6)	AMIGO1 (1.5)	OGDH (1.5)	HLX (1.4)	LPIN3 (1.4)	PSRC1 (1.3)	ATXN2 (1.3)
MP:0008284	abnormal hippocampus pyramidal cell layer	0.98	> 0.20	NCAN (2.1)	CELSR2 (1.9)	ENSG00000254235 (1.7)	ABCG5 (1.5)	PBX4 (1.5)	ABCG8 (1.3)	GOT2P1 (1.3)	CEACAM19 (1.2)	MARK4 (1.2)	FADS1 (1.2)
ENSG00000169016	E2F6 PPI subnetwork	0.98	> 0.20	TMEM57 (2.4)	TRAFD1 (2.0)	ATXN2 (1.9)	CARM1 (1.9)	GATAD2A (1.8)	USP24 (1.8)	MARK4 (1.7)	ILF3 (1.6)	ATXN7L2 (1.3)	USP1 (1.3)
GO:0031341	regulation of cell killing	0.98	> 0.20	PBX4 (1.9)	PARP10 (1.7)	POLK (1.6)	TRAFD1 (1.6)	ITGB3 (1.6)	GEMIN7 (1.4)	ZNF101 (1.2)	CEACAM19 (1.1)	ENSG00000235545 (1.0)	ZNF180 (1.0)
ENSG00000155097	ATP6V1C1 PPI subnetwork	0.98	> 0.20	ENSG00000238078 (2.6)	SORT1 (2.4)	TXNL4B (2.4)	SARS (2.2)	HMGCR (1.9)	COL4A3BP (1.6)	BLOC1S3 (1.5)	MAU2 (1.4)	GRINA (1.4)	APOE (1.3)
ENSG00000162511	LAPTM5 PPI subnetwork	0.98	> 0.20	NCAN (2.7)	RPH3A (2.6)	GOT2P1 (2.2)	C12orf51 (2.1)	C12orf43 (2.0)	AMIGO1 (1.8)	MARK4 (1.6)	UBXN2B (1.6)	GRINA (1.5)	CELSR2 (1.5)
GO:0004112	cyclic-nucleotide phosphodiesterase activity	0.98	> 0.20	MOSC1 (2.4)	NCAN (2.0)	PCSK9 (1.8)	MYLIP (1.5)	POLK (1.5)	SORT1 (1.5)	TMEM116 (1.4)	PBX4 (1.3)	CETP (1.1)	TXNL4B (1.1)
GO:0000380	alternative nuclear mRNA splicing, via spliceosome	0.98	> 0.20	C1orf63 (4.0)	C17orf57 (2.5)	TOP1 (2.1)	FRK (2.0)	ADAM1 (1.9)	MAU2 (1.7)	TMEM57 (1.7)	ANKRD31 (1.4)	ILF3 (1.4)	QTRT1 (1.4)
GO:0048515	spermatid differentiation	0.98	> 0.20	TSSK6 (6.3)	PMFBP1 (3.5)	DYNC2LI1 (1.6)	C12orf47 (1.2)	ABO (1.1)	TMEM116 (1.1)	PBX4 (1.1)	CEACAM19 (1.0)	BRAP (1.0)	FRK (1.0)
MP:0005333	decreased heart rate	0.98	> 0.20	BCAM (2.3)	SORT1 (1.7)	AMIGO1 (1.7)	SLC22A1 (1.6)	TMEM116 (1.4)	NPC1L1 (1.3)	KIAA1324 (1.3)	CETP (1.3)	GOT2P1 (1.3)	RPH3A (1.1)
ENSG00000139842	CUL4A PPI subnetwork	0.98	> 0.20	TXNL4B (2.8)	BUD13 (2.6)	ZNF180 (1.9)	FEN1 (1.3)	CYP7A1 (1.2)	USP1 (1.1)	NYNRIN (1.0)	BRAP (1.0)	PSRC1 (1.0)	DOCK7 (0.9)
GO:0021536	diencephalon development	0.98	> 0.20	TSSK6 (2.5)	NKPD1 (2.1)	GOT2P1 (2.1)	ABO (2.0)	ENSG00000238078 (1.9)	ANKRD31 (1.8)	KIAA1324 (1.8)	PBX4 (1.6)	C19orf52 (1.5)	YIPF2 (1.4)
ENSG00000175189	INHBC PPI subnetwork	0.98	> 0.20	BCAM (1.9)	PVRL2 (1.8)	C12orf47 (1.7)	TMEM57 (1.7)	MARK4 (1.6)	PVR (1.6)	BLOC1S3 (1.4)	APOC4 (1.4)	CILP2 (1.4)	HLX (1.4)
MP:0000837	abnormal hypothalamus morphology	0.98	> 0.20	PBX4 (3.1)	C12orf47 (2.4)	TMED4 (2.4)	CELSR2 (2.0)	SYPL2 (1.9)	NKPD1 (1.8)	C17orf57 (1.7)	GMIP (1.6)	TSSK6 (1.6)	AMIGO1 (1.5)
KEGG_PARKINSONS_DISEASE	KEGG_PARKINSONS_DISEASE	0.98	> 0.20	OGDH (3.9)	ACAD10 (3.0)	C12orf47 (2.9)	TRAPPC6A (2.0)	PSMA5 (2.0)	GMPR (1.9)	C1orf63 (1.7)	GOT2P1 (1.7)	FRK (1.4)	TMEM116 (1.3)
ENSG00000004779	NDUFAB1 PPI subnetwork	0.98	> 0.20	OGDH (3.1)	C12orf47 (2.6)	TRAPPC6A (2.6)	ACAD10 (2.4)	FRK (1.9)	GOT2P1 (1.6)	MAU2 (1.5)	GMPR (1.4)	PSMA5 (1.4)	TMED4 (1.3)
GO:0048193	Golgi vesicle transport	0.98	> 0.20	YIPF2 (5.4)	C19orf52 (2.5)	TMED4 (2.3)	CYB561D1 (2.3)	MAU2 (2.3)	SUGP1 (2.0)	TMEM57 (1.9)	BLOC1S3 (1.7)	DNM2 (1.7)	LPIN3 (1.6)
GO:0032012	regulation of ARF protein signal transduction	0.98	> 0.20	PPP1R37 (3.0)	MAPKAPK5 (2.6)	ZHX3 (2.5)	MAU2 (2.5)	DNM2 (2.3)	BLOC1S3 (2.3)	C12orf51 (1.9)	CYB561D1 (1.8)	TSSK6 (1.8)	PLCG1 (1.6)
GO:0061387	regulation of extent of cell growth	0.98	> 0.20	C12orf47 (2.1)	ENSG00000226645 (1.7)	PMFBP1 (1.6)	GCNT4 (1.6)	TMEM50A (1.5)	CELSR2 (1.5)	TSSK6 (1.5)	ACAD10 (1.4)	ATXN7L2 (1.4)	C1orf63 (1.4)
REACTOME_CDO_IN_MYOGENESIS	REACTOME_CDO_IN_MYOGENESIS	0.98	> 0.20	SYPL2 (3.0)	HLX (2.4)	TMED4 (1.7)	CARM1 (1.5)	LPIN3 (1.5)	HNF1A (1.4)	PLCG1 (1.4)	ZHX3 (1.3)	AMIGO1 (1.3)	TMEM57 (1.3)
REACTOME_MYOGENESIS	REACTOME_MYOGENESIS	0.98	> 0.20	SYPL2 (3.0)	HLX (2.4)	TMED4 (1.7)	CARM1 (1.5)	LPIN3 (1.5)	HNF1A (1.4)	PLCG1 (1.4)	ZHX3 (1.3)	AMIGO1 (1.3)	TMEM57 (1.3)
GO:0030259	lipid glycosylation	0.98	> 0.20	FRK (2.2)	ENSG00000228044 (2.2)	ADAM1 (1.9)	ABCG5 (1.9)	ENSG00000235545 (1.8)	ABCG8 (1.5)	C19orf52 (1.4)	SLC22A1 (1.3)	HAPLN4 (1.2)	CYP7A1 (1.2)
GO:0001578	microtubule bundle formation	0.98	> 0.20	LPAR2 (2.7)	DYNC2LI1 (2.5)	TMEM116 (2.0)	MAU2 (1.7)	POLK (1.7)	FRK (1.6)	SUGP1 (1.6)	ZNF180 (1.3)	ATXN2 (1.3)	CYB561D1 (1.3)
GO:0009132	nucleoside diphosphate metabolic process	0.98	> 0.20	DYNC2LI1 (3.4)	AMIGO1 (2.4)	TMEM116 (2.2)	ERP29 (1.9)	ENSG00000226648 (1.9)	PBX4 (1.8)	ACAD10 (1.7)	C12orf43 (1.7)	ENSG00000228044 (1.7)	PMFBP1 (1.6)
MP:0006142	abnormal sinoatrial node conduction	0.98	> 0.20	RPH3A (2.6)	PLEKHH2 (2.4)	GOT2P1 (1.7)	SORT1 (1.7)	PPP1R37 (1.6)	TMEM116 (1.5)	HAPLN4 (1.4)	GCNT4 (1.4)	CLPTM1 (1.4)	HAVCR1 (1.4)
GO:0007215	glutamate receptor signaling pathway	0.98	> 0.20	RPH3A (2.4)	ENSG00000226648 (1.9)	C12orf47 (1.9)	NCAN (1.8)	BLOC1S3 (1.7)	GCNT4 (1.6)	ZNF180 (1.5)	PPP1R37 (1.5)	HAVCR1 (1.4)	ZHX3 (1.4)
ENSG00000176177	ENTHD1 PPI subnetwork	0.98	> 0.20	BRAP (2.1)	NKPD1 (2.0)	ENSG00000235545 (2.0)	COL4A3BP (1.9)	USP24 (1.7)	SARS (1.7)	LPIN3 (1.6)	TMEM50A (1.5)	PSMA5 (1.4)	TMEM57 (1.4)
GO:0045620	negative regulation of lymphocyte differentiation	0.98	> 0.20	CEACAM19 (2.2)	AMIGO1 (1.9)	DNAH11 (1.8)	ZNF101 (1.5)	NKPD1 (1.3)	BLOC1S3 (1.2)	ENSG00000254235 (1.1)	MAU2 (1.1)	LPAR2 (1.1)	C11orf9 (1.0)
ENSG00000033122	LRRC7 PPI subnetwork	0.98	> 0.20	NCAN (2.4)	ENSG00000228044 (2.1)	ATXN2 (2.1)	RPH3A (2.0)	HNF1A (2.0)	TSSK6 (2.0)	DHODH (1.5)	SYPL2 (1.5)	CELSR2 (1.4)	CLPTM1 (1.3)
MP:0002825	abnormal notochord morphology	0.98	> 0.20	AMIGO1 (2.2)	GATAD2A (2.2)	ADAM1 (1.8)	PLCG1 (1.7)	C12orf43 (1.6)	ABO (1.6)	NYNRIN (1.6)	PLEKHH2 (1.6)	APOE (1.5)	PVRL2 (1.5)
ENSG00000159082	SYNJ1 PPI subnetwork	0.98	> 0.20	C1orf63 (2.3)	HAPLN4 (2.0)	USP24 (2.0)	DNM2 (1.9)	TMEM50A (1.8)	SH2B3 (1.8)	SARS (1.8)	RPH3A (1.8)	TRAFD1 (1.6)	PPP1R37 (1.5)
GO:0070979	protein K11-linked ubiquitination	0.98	> 0.20	POC5 (2.7)	LPIN3 (2.4)	UBXN2B (1.9)	MAPKAPK5 (1.8)	DOCK7 (1.7)	MAU2 (1.6)	BRAP (1.6)	ATXN2 (1.5)	C12orf43 (1.5)	ADAM1 (1.4)
GO:0051193	regulation of cofactor metabolic process	0.98	> 0.20	OGDH (2.9)	TXNL4B (2.3)	C19orf52 (2.2)	UBXN2B (2.0)	PMFBP1 (2.0)	TSSK6 (1.9)	GMPR (1.8)	ACAD10 (1.6)	GPAM (1.6)	ENSG00000226648 (1.5)
GO:0051196	regulation of coenzyme metabolic process	0.98	> 0.20	OGDH (2.9)	TXNL4B (2.3)	C19orf52 (2.2)	UBXN2B (2.0)	PMFBP1 (2.0)	TSSK6 (1.9)	GMPR (1.8)	ACAD10 (1.6)	GPAM (1.6)	ENSG00000226648 (1.5)
GO:0050654	chondroitin sulfate proteoglycan metabolic process	0.98	> 0.20	CILP2 (4.1)	C19orf52 (1.9)	UBXN2B (1.8)	ST3GAL4 (1.7)	KANK2 (1.4)	ANKRD31 (1.4)	LPA (1.3)	TMEM57 (1.3)	TMED4 (1.3)	NT5DC1 (1.3)
GO:0006820	anion transport	0.98	> 0.20	TMEM116 (3.3)	TM6SF2 (1.8)	CLPTM1 (1.7)	ST3GAL4 (1.7)	HAPLN4 (1.7)	ANGPTL3 (1.5)	FRK (1.5)	PMFBP1 (1.3)	PLG (1.3)	SYPL2 (1.3)
MP:0002546	mydriasis	0.99	> 0.20	HLX (2.0)	HAVCR1 (1.8)	TRIB1 (1.5)	FRK (1.4)	CYB561D1 (1.2)	SORT1 (1.2)	RPH3A (1.1)	TMEM116 (1.1)	PMFBP1 (1.0)	ALDH2 (1.0)
ENSG00000183020	AP2A2 PPI subnetwork	0.99	> 0.20	C12orf51 (2.9)	CLPTM1 (2.6)	PPP1R37 (2.3)	AP1M2 (2.2)	GATAD2A (2.2)	CETP (2.0)	DNM2 (1.9)	ATXN2 (1.8)	TOP1 (1.8)	USP24 (1.7)
MP:0005407	hyperalgesia	0.99	> 0.20	MOSC1 (3.4)	GPAM (3.0)	NCAN (2.6)	RPH3A (2.2)	ZHX3 (1.6)	FRK (1.6)	CELSR2 (1.5)	KIAA1324 (1.4)	ENSG00000228044 (1.3)	ENSG00000226645 (1.2)
MP:0008235	increased susceptibility to neuronal excitotoxicity	0.99	> 0.20	KIAA1324 (2.8)	RHCE (2.0)	SH2B3 (1.9)	HLX (1.6)	RHD (1.6)	FADS1 (1.3)	ENSG00000228044 (1.3)	YIPF2 (1.2)	NCAN (1.1)	MOSC1 (1.1)
ENSG00000196470	SIAH1 PPI subnetwork	0.99	> 0.20	NT5DC1 (1.9)	TMED4 (1.9)	NYNRIN (1.7)	ABO (1.5)	CARM1 (1.4)	HMGCR (1.3)	NPC1L1 (1.1)	TOP1 (1.1)	HNF1A (1.1)	SMARCA4 (1.1)
ENSG00000087258	GNAO1 PPI subnetwork	0.99	> 0.20	MYLIP (2.5)	HLX (2.2)	TMEM50A (2.2)	DNM2 (2.0)	KIAA1324 (2.0)	SORT1 (2.0)	TMEM57 (1.9)	C17orf57 (1.8)	PSRC1 (1.6)	MARK4 (1.5)
GO:0001958	endochondral ossification	0.99	> 0.20	CILP2 (4.2)	MAPKAPK5 (2.0)	PLEKHH2 (1.9)	ALDH2 (1.9)	ENSG00000226648 (1.8)	NYNRIN (1.6)	HNF1A (1.4)	YIPF2 (1.4)	MARK4 (1.4)	GOT2P1 (1.4)
GO:0030705	cytoskeleton-dependent intracellular transport	0.99	> 0.20	C12orf51 (2.2)	DOCK7 (1.7)	C17orf57 (1.6)	RPH3A (1.5)	CYB561D1 (1.5)	PBX4 (1.3)	GOT2P1 (1.2)	DYNC2LI1 (1.1)	OGDH (1.0)	POC5 (1.0)
ENSG00000156467	UQCRB PPI subnetwork	0.99	> 0.20	OGDH (2.6)	UBXN2B (2.4)	ACAD10 (1.5)	SYPL2 (1.4)	TRAPPC6A (1.2)	C12orf47 (1.2)	PMFBP1 (1.0)	ABO (1.0)	RELB (1.0)	C19orf52 (0.9)
ENSG00000106571	GLI3 PPI subnetwork	0.99	> 0.20	PTPN11 (2.6)	GATAD2A (2.4)	MARK4 (2.4)	MAU2 (2.1)	SUGP1 (2.0)	CARM1 (1.9)	COL4A3BP (1.7)	ATXN2 (1.5)	ILF3 (1.5)	NKPD1 (1.4)
MP:0000812	abnormal dentate gyrus morphology	0.99	> 0.20	NCAN (3.5)	CELSR2 (2.8)	MAU2 (2.5)	C12orf43 (1.9)	TMED4 (1.8)	PSRC1 (1.8)	TMEM50A (1.7)	USP24 (1.6)	C12orf51 (1.6)	ATXN7L2 (1.4)
ENSG00000183741	CBX6 PPI subnetwork	0.99	> 0.20	TMEM57 (2.2)	C19orf52 (2.1)	ATXN2 (2.0)	ILF3 (2.0)	GATAD2A (1.8)	TRAFD1 (1.7)	CARM1 (1.7)	MARK4 (1.7)	USP24 (1.5)	DOCK7 (1.5)
ENSG00000111450	STX2 PPI subnetwork	0.99	> 0.20	KIAA1324 (3.2)	CYB561D1 (2.9)	TMEM50A (2.6)	C1orf63 (2.5)	AP1M2 (2.3)	CELSR2 (2.2)	SORT1 (1.9)	SARS (1.8)	AMIGO1 (1.7)	HAPLN4 (1.6)
GO:0021537	telencephalon development	0.99	> 0.20	NCAN (2.9)	PBX4 (2.6)	TSSK6 (2.5)	ATXN7L2 (2.3)	CELSR2 (2.2)	ENSG00000235545 (2.2)	ABO (2.2)	ZHX3 (1.7)	DNAH11 (1.6)	AMIGO1 (1.5)
GO:0030426	growth cone	0.99	> 0.20	C12orf51 (2.5)	RPH3A (2.4)	NCAN (2.3)	CELSR2 (2.3)	ADAM1 (1.9)	LPIN3 (1.8)	C12orf47 (1.7)	CLPTM1 (1.4)	FADS2 (1.3)	ATXN2 (1.3)
MP:0009719	reduced cerebellar foliation	0.99	> 0.20	DYNC2LI1 (3.2)	POLK (2.3)	NYNRIN (2.1)	GEMIN7 (2.0)	C17orf57 (1.7)	ZHX3 (1.7)	GPAM (1.7)	DOCK7 (1.6)	PLCG1 (1.6)	PBX4 (1.6)
GO:0006900	membrane budding	0.99	> 0.20	YIPF2 (5.2)	ABCG8 (1.6)	OGDH (1.5)	DNM2 (1.4)	GEMIN7 (1.3)	PPP1R37 (1.3)	MAU2 (1.2)	CLPTM1 (1.1)	SARS (1.1)	SUGP1 (1.1)
GO:0051924	regulation of calcium ion transport	0.99	> 0.20	SYPL2 (2.8)	ABO (2.4)	C12orf47 (1.9)	TSSK6 (1.9)	AMIGO1 (1.8)	RPH3A (1.7)	GEMIN7 (1.5)	GMPR (1.5)	MARK4 (1.4)	CYB561D1 (1.4)
GO:0030816	positive regulation of cAMP metabolic process	0.99	> 0.20	PMFBP1 (2.7)	AMIGO1 (2.6)	ABO (2.1)	ST3GAL4 (2.0)	GOT2P1 (1.9)	LPIN3 (1.8)	COL4A3BP (1.7)	ENSG00000226645 (1.7)	KIAA1324 (1.6)	C12orf47 (1.5)
GO:0030819	positive regulation of cAMP biosynthetic process	0.99	> 0.20	PMFBP1 (2.7)	AMIGO1 (2.6)	ABO (2.1)	ST3GAL4 (2.0)	GOT2P1 (1.9)	LPIN3 (1.8)	COL4A3BP (1.7)	ENSG00000226645 (1.7)	KIAA1324 (1.6)	C12orf47 (1.5)
ENSG00000092054	MYH7 PPI subnetwork	0.99	> 0.20	SYPL2 (3.8)	RPH3A (2.4)	C11orf9 (2.3)	GMPR (2.1)	TMEM50A (2.0)	OGDH (1.8)	ENSG00000238078 (1.6)	NT5DC1 (1.6)	TRAPPC6A (1.5)	NCAN (1.4)
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	0.99	> 0.20	RPH3A (2.9)	SLC44A2 (2.0)	HAPLN4 (1.7)	ATXN7L2 (1.5)	HAVCR1 (1.5)	PPP1R37 (1.4)	TMEM50A (1.4)	NCAN (1.3)	CYB561D1 (1.3)	MYLIP (1.3)
MP:0008546	abnormal vesicle-mediated transport	0.99	> 0.20	ENSG00000226645 (2.4)	YIPF2 (2.3)	KIAA1324 (2.2)	PBX4 (2.0)	BLOC1S3 (1.9)	ZNF259 (1.9)	HAPLN4 (1.8)	KANK2 (1.6)	RHD (1.5)	ENSG00000228044 (1.5)
MP:0001130	abnormal ovarian folliculogenesis	0.99	> 0.20	NCAN (1.8)	POLK (1.8)	ENSG00000226648 (1.6)	GPAM (1.6)	LPAR2 (1.5)	ENSG00000235545 (1.5)	NKPD1 (1.4)	YIPF2 (1.4)	TRIB1 (1.3)	GEMIN7 (1.3)
GO:0051963	regulation of synapse assembly	0.99	> 0.20	ZHX3 (2.7)	NCAN (2.7)	ABO (2.7)	ANKRD31 (2.5)	PLEKHH2 (2.3)	ENSG00000226645 (2.1)	RPH3A (2.1)	HAVCR1 (1.9)	CBLC (1.8)	KIAA1324 (1.7)
GO:0046640	regulation of alpha-beta T cell proliferation	0.99	> 0.20	PBX4 (3.6)	GCNT4 (2.2)	ADAM1 (2.0)	ZNF101 (1.9)	TMEM57 (1.8)	TIMD4 (1.6)	ALDH2 (1.4)	BLOC1S3 (1.3)	CETP (1.1)	TRAPPC6A (1.1)
GO:0042775	mitochondrial ATP synthesis coupled electron transport	0.99	> 0.20	C12orf47 (3.6)	OGDH (3.5)	ACAD10 (3.5)	TRAPPC6A (2.7)	GOT2P1 (2.2)	FRK (1.7)	TMED4 (1.7)	GMPR (1.5)	MAU2 (1.5)	TMEM116 (1.5)
GO:0042773	ATP synthesis coupled electron transport	0.99	> 0.20	C12orf47 (3.6)	OGDH (3.5)	ACAD10 (3.5)	TRAPPC6A (2.7)	GOT2P1 (2.2)	FRK (1.7)	TMED4 (1.7)	GMPR (1.5)	MAU2 (1.5)	TMEM116 (1.5)
GO:0002040	sprouting angiogenesis	0.99	> 0.20	CEACAM19 (2.1)	SLC44A2 (1.8)	ATXN7L2 (1.8)	HLX (1.7)	NYNRIN (1.7)	PVR (1.7)	POLK (1.4)	TRIB1 (1.4)	SH2B3 (1.3)	TMEM116 (1.2)
MP:0002407	abnormal double-negative T cell morphology	0.99	> 0.20	PLCG1 (3.6)	GMIP (3.3)	ZNF101 (2.7)	PBX4 (2.2)	HAVCR1 (1.8)	RELB (1.7)	LPAR2 (1.6)	CYB561D1 (1.3)	PARP10 (1.3)	GRINA (0.9)
ENSG00000215639	ENSG00000215639 PPI subnetwork	0.99	> 0.20	DOCK7 (2.6)	POC5 (1.9)	KIAA1324 (1.6)	UBXN2B (1.6)	NKPD1 (1.5)	SUGP1 (1.4)	HAVCR1 (1.3)	GCNT4 (1.3)	LPAR2 (1.3)	ST3GAL4 (1.3)
GO:0007030	Golgi organization	0.99	> 0.20	YIPF2 (4.5)	ENSG00000226648 (2.0)	TXNL4B (1.9)	C19orf52 (1.7)	BLOC1S3 (1.7)	SUGP1 (1.6)	ATP13A1 (1.6)	ACAD10 (1.6)	ATXN2 (1.6)	DNAH11 (1.3)
ENSG00000165629	ATP5C1 PPI subnetwork	0.99	> 0.20	OGDH (3.7)	PSMA5 (2.9)	SARS (2.5)	TOMM40 (2.4)	DYNC2LI1 (2.2)	ENSG00000238078 (1.7)	QTRT1 (1.6)	ATP13A1 (1.6)	ACAD10 (1.5)	C1orf63 (1.5)
ENSG00000158290	CUL4B PPI subnetwork	0.99	> 0.20	BUD13 (3.5)	DOCK7 (2.2)	COL4A3BP (2.0)	USP24 (1.9)	DHX38 (1.8)	TXNL4B (1.8)	ANKRD31 (1.7)	BRAP (1.6)	ZHX3 (1.4)	ZNF180 (1.3)
ENSG00000204434	ENSG00000204434 PPI subnetwork	0.99	> 0.20	C12orf47 (3.3)	PTPN11 (2.8)	PLEKHH2 (1.9)	ENSG00000254235 (1.9)	ADAM1 (1.7)	NAA25 (1.7)	HAVCR1 (1.5)	AMIGO1 (1.5)	PVR (1.5)	CYB561D1 (1.3)
MP:0000233	abnormal blood flow velocity	0.99	> 0.20	APOC1 (3.9)	C17orf57 (2.7)	ITGB3 (2.5)	BCAM (2.4)	ATXN7L2 (2.0)	PVRL2 (1.9)	CBLC (1.4)	HLX (1.3)	SH2B3 (1.2)	C1orf63 (1.1)
GO:0030111	regulation of Wnt receptor signaling pathway	0.99	> 0.20	PLEKHH2 (2.6)	NYNRIN (1.8)	PPP1R37 (1.6)	ATXN2 (1.6)	GATAD2A (1.6)	DYNC2LI1 (1.6)	CILP2 (1.5)	MARK4 (1.4)	PLCG1 (1.4)	CBLC (1.3)
ENSG00000173230	GOLGB1 PPI subnetwork	0.99	> 0.20	PTPN11 (2.4)	ENSG00000226645 (2.0)	DYNC2LI1 (1.8)	CYB561D1 (1.7)	HAVCR1 (1.7)	ATXN7L2 (1.6)	AP1M2 (1.5)	ERP29 (1.4)	SH2B3 (1.1)	MOSC1 (1.1)
GO:0031497	chromatin assembly	0.99	> 0.20	C19orf52 (2.5)	PSRC1 (1.7)	ENSG00000226648 (1.6)	ZNF180 (1.4)	TMED4 (1.4)	USP1 (1.4)	PMFBP1 (1.3)	TMEM116 (1.1)	TMEM57 (1.1)	POC5 (1.1)
GO:0006817	phosphate ion transport	0.99	> 0.20	TMEM116 (3.6)	ENSG00000226648 (2.4)	CILP2 (2.1)	HAVCR1 (1.8)	FRK (1.8)	TMEM57 (1.8)	PMFBP1 (1.7)	TM6SF2 (1.7)	GOT2P1 (1.5)	ANGPTL3 (1.5)
ENSG00000172500	FIBP PPI subnetwork	0.99	> 0.20	C1orf63 (2.4)	ENSG00000238078 (2.2)	PCSK9 (2.0)	ZHX3 (1.9)	TOP1 (1.8)	ZNF180 (1.7)	PLCG1 (1.4)	PSRC1 (1.2)	YIPF2 (1.2)	ENSG00000226648 (1.2)
GO:0046488	phosphatidylinositol metabolic process	0.99	> 0.20	BLOC1S3 (3.1)	CYB561D1 (2.5)	TRAPPC6A (2.1)	UBXN2B (2.0)	LPAR2 (2.0)	C12orf51 (1.9)	ATP13A1 (1.8)	NT5DC1 (1.8)	TMED4 (1.7)	TSSK6 (1.7)
REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	0.99	> 0.20	SYPL2 (2.6)	ATXN7L2 (2.1)	PMFBP1 (2.0)	ABO (1.8)	NKPD1 (1.5)	CILP2 (1.5)	AMIGO1 (1.5)	SORT1 (1.4)	GEMIN7 (1.4)	ENSG00000235545 (1.4)
GO:0048199	vesicle targeting, to, from or within Golgi	0.99	> 0.20	YIPF2 (5.4)	TMED4 (1.9)	OGDH (1.6)	C19orf52 (1.5)	SUGP1 (1.4)	LPIN3 (1.3)	ABCG8 (1.3)	ZHX3 (1.0)	PMFBP1 (1.0)	DNM2 (1.0)
ENSG00000132142	ACACA PPI subnetwork	0.99	> 0.20	PTPN11 (3.3)	BRAP (2.9)	TXNL4B (2.5)	ENSG00000228044 (2.4)	GMPR (2.0)	C1orf63 (1.9)	SYPL2 (1.7)	CYB561D1 (1.7)	CETP (1.6)	PSMA5 (1.5)
ENSG00000215305	VPS16 PPI subnetwork	0.99	> 0.20	ZNF259 (3.2)	C12orf43 (2.9)	BRAP (2.5)	ACAD10 (2.3)	SARS (2.0)	ZNF101 (2.0)	TRAFD1 (1.8)	DDX56 (1.7)	MAPKAPK5 (1.6)	NKPD1 (1.5)
GO:0045132	meiotic chromosome segregation	0.99	> 0.20	C17orf57 (2.9)	PSRC1 (2.5)	ANKRD31 (2.5)	POC5 (2.2)	TMEM116 (1.8)	PMFBP1 (1.7)	AP1M2 (1.5)	NKPD1 (1.5)	ADAM1 (1.3)	USP1 (1.2)
ENSG00000147883	CDKN2B PPI subnetwork	0.99	> 0.20	TSSK6 (2.4)	ZNF259 (2.3)	CARM1 (2.2)	DYNC2LI1 (1.9)	ATXN7L2 (1.8)	CYB561D1 (1.7)	HAVCR1 (1.6)	NYNRIN (1.6)	TOMM40 (1.4)	PMFBP1 (1.4)
GO:0007041	lysosomal transport	0.99	> 0.20	BLOC1S3 (3.4)	POLK (3.1)	COL4A3BP (2.7)	UBXN2B (2.5)	TMED4 (2.3)	TMEM50A (2.2)	FRK (1.9)	MAU2 (1.7)	YIPF2 (1.5)	DOCK7 (1.3)
ENSG00000170558	CDH2 PPI subnetwork	0.99	> 0.20	NCAN (3.0)	SORT1 (2.5)	CELSR2 (2.1)	MARK4 (2.0)	RPH3A (1.7)	COL4A3BP (1.6)	TOP1 (1.5)	TMEM50A (1.5)	PVRL2 (1.4)	TRAFD1 (1.4)
ENSG00000164111	ANXA5 PPI subnetwork	0.99	> 0.20	CILP2 (4.2)	HMGCR (2.2)	C12orf43 (1.6)	TMEM50A (1.6)	HNF1A (1.6)	LDLR (1.5)	ZNF101 (1.5)	POLK (1.5)	FEN1 (1.3)	ERP29 (1.3)
MP:0001890	anencephaly	0.99	> 0.20	DNAH11 (1.8)	GEMIN7 (1.5)	HAPLN4 (1.3)	MARK4 (1.3)	MYLIP (1.2)	KANK2 (1.1)	ATXN2 (1.1)	CBLC (1.1)	ENSG00000226648 (1.0)	CARM1 (1.0)
GO:0060119	inner ear receptor cell development	0.99	> 0.20	ENSG00000226648 (2.5)	CEACAM19 (1.9)	GOT2P1 (1.6)	AMIGO1 (1.5)	DNAH11 (1.5)	HAVCR1 (1.4)	TMEM57 (1.2)	SORT1 (1.1)	HAPLN4 (1.0)	CARM1 (1.0)
ENSG00000151239	TWF1 PPI subnetwork	0.99	> 0.20	LPIN3 (2.4)	ABCG8 (2.2)	GMIP (1.7)	ENSG00000254235 (1.6)	PVR (1.4)	NKPD1 (1.4)	ATXN7L2 (1.4)	CARM1 (1.4)	BCL3 (1.3)	LPA (1.3)
MP:0004876	decreased mean systemic arterial blood pressure	0.99	> 0.20	HLX (2.1)	ZHX3 (2.0)	POLK (1.8)	KANK2 (1.7)	PLEKHH2 (1.3)	C17orf57 (1.2)	PLG (1.2)	SH2B3 (1.2)	SLC22A1 (1.1)	MAU2 (1.1)
MP:0000520	absent kidney	0.99	> 0.20	BCAM (2.8)	PVRL2 (2.6)	PLCG1 (2.5)	PLEKHH2 (2.5)	ZHX3 (2.3)	SORT1 (2.2)	KANK2 (2.0)	ENSG00000238078 (1.7)	NYNRIN (1.7)	CELSR2 (1.6)
GO:2001014	regulation of skeletal muscle cell differentiation	0.99	> 0.20	CEACAM19 (2.8)	ENSG00000226648 (2.8)	GMPR (2.4)	ATXN7L2 (2.1)	LPIN3 (2.0)	PMFBP1 (1.7)	BLOC1S3 (1.7)	SYPL2 (1.5)	NKPD1 (1.1)	HLX (1.1)
ENSG00000171132	PRKCE PPI subnetwork	0.99	> 0.20	TMEM50A (2.4)	NCAN (2.4)	SORT1 (2.2)	SYPL2 (2.0)	RPH3A (2.0)	MARK4 (1.5)	SH2B3 (1.5)	PVR (1.2)	RHD (1.1)	ENSG00000238078 (1.1)
ENSG00000175137	SH3BP5L PPI subnetwork	0.99	> 0.20	TOP1 (3.6)	ZNF101 (2.4)	ATXN7L2 (1.9)	GMIP (1.5)	UBXN2B (1.5)	BUD13 (1.4)	DDX56 (1.3)	PLCG1 (1.3)	MAU2 (1.2)	ADAM1 (1.2)
GO:0003207	cardiac chamber formation	0.99	> 0.20	NYNRIN (3.1)	HLX (2.0)	NCAN (1.9)	LPIN3 (1.8)	BLOC1S3 (1.8)	ENSG00000226648 (1.6)	DNAH11 (1.4)	MARK4 (1.3)	ALDH2 (1.2)	ATXN7L2 (1.2)
ENSG00000116329	OPRD1 PPI subnetwork	0.99	> 0.20	ERP29 (2.6)	SH2B3 (2.5)	GMIP (2.1)	TMEM50A (2.1)	DNM2 (2.0)	NCAN (2.0)	HLX (1.7)	ITGB3 (1.4)	COL4A3BP (1.4)	TXNL4B (1.3)
GO:0001764	neuron migration	0.99	> 0.20	CELSR2 (2.7)	TSSK6 (2.5)	ABO (2.1)	NCAN (2.0)	HAVCR1 (1.8)	TMEM116 (1.8)	ATXN7L2 (1.7)	DNAH11 (1.6)	PBX4 (1.4)	KIAA1324 (1.4)
GO:0071305	cellular response to vitamin D	0.99	> 0.20	C17orf57 (2.6)	TRAFD1 (2.0)	PBX4 (2.0)	ZNF180 (2.0)	TMEM116 (1.9)	BLOC1S3 (1.8)	CEACAM19 (1.4)	TXNL4B (1.4)	C12orf47 (1.3)	LPAR2 (1.2)
GO:0033151	V(D)J recombination	0.99	> 0.20	ZNF101 (6.3)	UBXN2B (3.0)	PLCG1 (2.9)	ANKRD31 (2.8)	SMARCA4 (2.6)	NT5DC1 (2.0)	GCNT4 (1.7)	ENSG00000228044 (1.6)	C17orf57 (1.5)	PBX4 (1.4)
GO:0006086	acetyl-CoA biosynthetic process from pyruvate	0.99	> 0.20	OGDH (3.4)	TXNL4B (2.4)	C19orf52 (2.4)	UBXN2B (2.2)	ACAD10 (2.0)	GPAM (1.8)	PMFBP1 (1.8)	TSSK6 (1.7)	TMEM116 (1.6)	NT5DC1 (1.4)
GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate	0.99	> 0.20	OGDH (3.4)	TXNL4B (2.4)	C19orf52 (2.4)	UBXN2B (2.2)	ACAD10 (2.0)	GPAM (1.8)	PMFBP1 (1.8)	TSSK6 (1.7)	TMEM116 (1.6)	NT5DC1 (1.4)
MP:0008976	delayed female fertility	0.99	> 0.20	TMEM57 (2.6)	FADS2 (2.2)	PCSK9 (2.0)	LDLR (1.6)	FADS1 (1.5)	GMPR (1.4)	ITGB3 (1.3)	HMGCR (1.3)	C12orf47 (1.2)	GATAD2A (1.2)
ENSG00000167641	PPP1R14A PPI subnetwork	0.99	> 0.20	UBXN2B (1.6)	TMEM57 (1.5)	DNM2 (1.5)	MARK4 (1.4)	NPC1L1 (1.4)	SH2B3 (1.3)	ENSG00000226645 (1.3)	CARM1 (1.3)	C11orf9 (1.2)	PPP1R37 (1.2)
ENSG00000175224	ATG13 PPI subnetwork	0.99	> 0.20	ERP29 (2.2)	APOE (1.9)	PVR (1.8)	TIMD4 (1.7)	ZNF180 (1.7)	PTPN11 (1.5)	C17orf57 (1.3)	ALDH2 (1.3)	CETP (1.2)	POLK (1.2)
ENSG00000162613	FUBP1 PPI subnetwork	0.99	> 0.20	RPH3A (2.6)	NCAN (2.2)	GOT2P1 (2.1)	C12orf43 (2.0)	UBXN2B (2.0)	NYNRIN (1.8)	CILP2 (1.6)	AMIGO1 (1.6)	ATXN2 (1.5)	SORT1 (1.5)
ENSG00000092850	TEKT2 PPI subnetwork	0.99	> 0.20	ENSG00000254235 (1.7)	ABO (1.7)	COL4A3BP (1.5)	TSSK6 (1.4)	GPAM (1.4)	C17orf57 (1.4)	TMEM57 (1.4)	ANKRD31 (1.4)	ACAD10 (1.3)	PLCG1 (1.2)
MP:0000872	abnormal cerebellum external granule cell layer morphology	0.99	> 0.20	NCAN (2.8)	ZHX3 (2.1)	RPH3A (1.6)	GRINA (1.6)	NYNRIN (1.5)	TMED4 (1.5)	APOE (1.4)	PCSK9 (1.3)	HAPLN4 (1.3)	YIPF2 (1.3)
MP:0009456	impaired cued conditioning behavior	0.99	> 0.20	NCAN (3.3)	GCNT4 (2.9)	TMED4 (2.1)	AMIGO1 (2.1)	RPH3A (1.7)	PLCG1 (1.7)	PPP1R37 (1.6)	LPAR2 (1.6)	CARM1 (1.3)	ACAD10 (1.2)
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY	REACTOME_CD28_DEPENDENT_VAV1_PATHWAY	0.99	> 0.20	MAFB (2.7)	PBX4 (2.3)	TMEM50A (2.1)	TIMD4 (1.8)	POLK (1.7)	GMIP (1.7)	PLCG1 (1.4)	NYNRIN (1.4)	C19orf52 (1.3)	OGDH (1.2)
GO:0006612	protein targeting to membrane	0.99	> 0.20	YIPF2 (2.5)	C19orf52 (2.5)	FRK (2.1)	ENSG00000226645 (2.0)	ERP29 (2.0)	C12orf47 (1.8)	ENSG00000226648 (1.6)	HAVCR1 (1.6)	TMED4 (1.5)	ZNF259 (1.4)
GO:2000177	regulation of neural precursor cell proliferation	0.99	> 0.20	ENSG00000235545 (2.9)	NCAN (2.6)	TMEM116 (2.1)	CYB561D1 (1.9)	DOCK7 (1.8)	CELSR2 (1.7)	PBX4 (1.6)	ENSG00000226648 (1.6)	PSRC1 (1.3)	C17orf57 (1.3)
MP:0009907	decreased tongue size	0.99	> 0.20	MYLIP (2.1)	KANK2 (1.9)	DYNC2LI1 (1.7)	HAVCR1 (1.4)	SYPL2 (1.2)	PLEKHH2 (1.2)	PTPN11 (1.2)	PVR (1.1)	TMEM57 (1.1)	ABCG8 (1.0)
GO:0004725	protein tyrosine phosphatase activity	0.99	> 0.20	TRIB1 (3.7)	PVR (2.5)	SH2B3 (2.2)	GMIP (1.8)	SORT1 (1.6)	SYPL2 (1.4)	MAPKAPK5 (1.3)	DNAH11 (1.2)	ZHX3 (1.1)	HLX (1.1)
MP:0000285	abnormal heart valve morphology	0.99	> 0.20	PLEKHH2 (3.7)	PVR (2.6)	ALDH2 (2.1)	ENSG00000226645 (1.8)	ITGB3 (1.6)	CILP2 (1.5)	OGDH (1.3)	OASL (1.2)	MOSC1 (1.2)	SYPL2 (1.2)
GO:0030427	site of polarized growth	0.99	> 0.20	C12orf51 (2.5)	RPH3A (2.4)	CELSR2 (2.4)	NCAN (2.3)	ADAM1 (1.9)	LPIN3 (1.7)	C12orf47 (1.7)	CLPTM1 (1.3)	ATXN2 (1.3)	PPP1R37 (1.2)
MP:0001566	hyperphosphatemia	0.99	> 0.20	TMEM116 (2.3)	ANKRD31 (1.8)	CARM1 (1.7)	PLEKHH2 (1.7)	AP1M2 (1.6)	KIAA1324 (1.6)	POLK (1.4)	ENSG00000226648 (1.4)	SLC44A2 (1.3)	ABO (1.2)
REACTOME_SHC:MEDIATED_CASCADE	REACTOME_SHC:MEDIATED_CASCADE	0.99	> 0.20	PLEKHH2 (3.4)	C11orf9 (2.7)	ENSG00000226645 (1.8)	HAPLN4 (1.8)	ABO (1.7)	PVR (1.5)	TM6SF2 (1.4)	PTPN11 (1.3)	ANGPTL3 (1.3)	GPAM (1.2)
GO:0008088	axon cargo transport	0.99	> 0.20	ENSG00000228044 (2.6)	RPH3A (2.4)	ZNF180 (2.0)	PPP1R37 (1.9)	C12orf51 (1.9)	OGDH (1.9)	ENSG00000235545 (1.7)	HAPLN4 (1.6)	ACAD10 (1.6)	TMEM116 (1.5)
GO:0050854	regulation of antigen receptor-mediated signaling pathway	0.99	> 0.20	CYB561D1 (3.4)	PBX4 (3.4)	ZNF101 (2.9)	TRAPPC6A (2.5)	PLCG1 (1.9)	NT5DC1 (1.6)	POLK (1.4)	HAVCR1 (1.3)	C19orf52 (1.2)	ENSG00000228044 (1.2)
ENSG00000108797	CNTNAP1 PPI subnetwork	0.99	> 0.20	C11orf9 (3.2)	HAPLN4 (2.6)	RPH3A (2.4)	ZHX3 (2.1)	ABO (1.7)	C17orf57 (1.6)	C12orf43 (1.6)	PMFBP1 (1.5)	APOC1 (1.4)	C12orf47 (1.3)
GO:0009584	detection of visible light	0.99	> 0.20	C12orf47 (2.3)	PMFBP1 (1.7)	NKPD1 (1.7)	ATXN7L2 (1.5)	GOT2P1 (1.4)	ENSG00000228044 (1.4)	C17orf57 (1.4)	TSSK6 (1.3)	GEMIN7 (1.2)	ST3GAL4 (1.1)
ENSG00000135250	SRPK2 PPI subnetwork	0.99	> 0.20	TOMM40 (3.6)	GATAD2A (2.7)	NAA25 (2.2)	DDX56 (2.2)	TOP1 (2.0)	PVR (2.0)	ATXN2 (1.9)	C1orf63 (1.8)	RHCE (1.8)	CEACAM19 (1.6)
GO:0003254	regulation of membrane depolarization	0.99	> 0.20	BLOC1S3 (2.9)	ENSG00000226645 (2.4)	ITGB3 (2.3)	HAPLN4 (2.0)	TMEM116 (1.9)	RHCE (1.7)	ALDH2 (1.6)	RHD (1.6)	RPH3A (1.5)	C1orf63 (1.2)
GO:0051588	regulation of neurotransmitter transport	0.99	> 0.20	ABO (4.0)	ENSG00000235545 (3.1)	RPH3A (2.0)	AMIGO1 (2.0)	ST3GAL4 (1.5)	TSSK6 (1.3)	GOT2P1 (1.2)	HNF1A (1.1)	MARK4 (1.1)	ADAM1 (1.1)
GO:0030177	positive regulation of Wnt receptor signaling pathway	0.99	> 0.20	PLEKHH2 (3.7)	C11orf9 (2.7)	DYNC2LI1 (2.1)	ENSG00000228044 (2.1)	C1orf63 (2.0)	CBLC (1.7)	LPAR2 (1.6)	PPP1R37 (1.6)	CILP2 (1.5)	MYLIP (1.5)
GO:0046641	positive regulation of alpha-beta T cell proliferation	0.99	> 0.20	PBX4 (2.8)	ADAM1 (2.1)	ENSG00000235545 (2.0)	ALDH2 (1.8)	ZNF101 (1.7)	BLOC1S3 (1.6)	GCNT4 (1.6)	TIMD4 (1.5)	TRAPPC6A (1.5)	POLK (1.2)
ENSG00000100151	PICK1 PPI subnetwork	0.99	> 0.20	ABO (2.7)	NCAN (2.2)	BCAM (2.2)	PVRL2 (1.9)	CBLC (1.8)	PLEKHH2 (1.6)	C11orf9 (1.6)	PVR (1.6)	MARK4 (1.6)	SH2B3 (1.5)
GO:0016775	phosphotransferase activity, nitrogenous group as acceptor	0.99	> 0.20	GMPR (2.7)	NKPD1 (2.1)	SYPL2 (2.0)	GPAM (1.9)	TRAPPC6A (1.8)	PLEKHH2 (1.7)	ACAD10 (1.7)	RPH3A (1.6)	HAPLN4 (1.3)	TXNL4B (1.3)
GO:0007271	synaptic transmission, cholinergic	0.99	> 0.20	ENSG00000226648 (3.8)	ATXN7L2 (3.0)	PMFBP1 (2.8)	SYPL2 (2.3)	GEMIN7 (1.6)	PBX4 (1.2)	POC5 (1.1)	RPH3A (1.1)	ENSG00000226645 (1.1)	MYLIP (1.0)
MP:0002064	seizures	0.99	> 0.20	HAPLN4 (4.7)	APOE (3.4)	RPH3A (2.3)	COL4A3BP (2.3)	CETP (2.2)	NCAN (2.2)	ST3GAL4 (1.8)	MAFB (1.6)	GRINA (1.5)	C12orf51 (1.5)
GO:0045581	negative regulation of T cell differentiation	0.99	> 0.20	ZNF101 (2.0)	HNF1A (1.7)	COL4A3BP (1.6)	PLCG1 (1.6)	AMIGO1 (1.4)	LPAR2 (1.4)	TXNL4B (1.2)	QTRT1 (1.2)	NKPD1 (1.2)	CEACAM19 (1.1)
GO:0030318	melanocyte differentiation	0.99	> 0.20	ST3GAL4 (2.4)	MYLIP (2.3)	DOCK7 (1.9)	KIAA1324 (1.7)	ENSG00000235545 (1.6)	CELSR2 (1.5)	NKPD1 (1.4)	MAU2 (1.3)	C12orf43 (1.1)	ITGB3 (1.1)
GO:0032781	positive regulation of ATPase activity	0.99	> 0.20	TXNL4B (1.9)	TMEM50A (1.9)	ENSG00000235545 (1.5)	CEACAM19 (1.4)	GMPR (1.3)	ERP29 (1.3)	ANGPTL3 (1.2)	YIPF2 (1.2)	PLG (1.2)	DHODH (1.2)
GO:0051452	intracellular pH reduction	0.99	> 0.20	UBXN2B (3.1)	AMIGO1 (3.0)	COL4A3BP (2.3)	ERP29 (2.2)	ENSG00000235545 (2.0)	CEACAM19 (1.9)	LPAR2 (1.9)	PBX4 (1.7)	NKPD1 (1.6)	RHCE (1.6)
GO:0030516	regulation of axon extension	0.99	> 0.20	ENSG00000226645 (2.1)	C12orf47 (1.7)	PMFBP1 (1.6)	TSSK6 (1.5)	ATXN7L2 (1.5)	CETP (1.3)	CELSR2 (1.3)	C1orf63 (1.3)	OGDH (1.2)	TMEM50A (1.2)
ENSG00000100883	SRP54 PPI subnetwork	0.99	> 0.20	DYNC2LI1 (2.9)	ADAM1 (2.9)	C12orf43 (2.8)	LPIN3 (2.6)	DDX56 (2.2)	NAA25 (2.2)	BRAP (2.1)	DHX38 (2.1)	ERP29 (2.0)	MAPKAPK5 (2.0)
GO:0001654	eye development	0.99	> 0.20	NYNRIN (1.8)	LPIN3 (1.7)	DYNC2LI1 (1.5)	GOT2P1 (1.5)	C19orf52 (1.1)	MYLIP (1.1)	ATXN2 (1.1)	ABO (1.0)	PVRL2 (0.9)	ZHX3 (0.9)
MP:0009142	decreased prepulse inhibition	0.99	> 0.20	NCAN (3.0)	PBX4 (2.3)	LPAR2 (2.2)	ABO (2.2)	AMIGO1 (2.1)	FADS2 (2.1)	SORT1 (1.8)	USP24 (1.8)	HNF1A (1.8)	ENSG00000238078 (1.7)
ENSG00000087470	DNM1L PPI subnetwork	0.99	> 0.20	ERP29 (2.3)	OGDH (1.8)	ACAD10 (1.7)	PVR (1.6)	SH2B3 (1.4)	HAPLN4 (1.4)	SARS (1.4)	MAPKAPK5 (1.3)	OASL (1.3)	C12orf47 (1.2)
MP:0006007	abnormal basal ganglion morphology	0.99	> 0.20	DYNC2LI1 (3.5)	NCAN (3.4)	C17orf57 (2.3)	TMEM116 (2.2)	QTRT1 (2.0)	ENSG00000226648 (1.9)	CELSR2 (1.6)	APOE (1.6)	LPAR2 (1.5)	DOCK7 (1.4)
MP:0006090	abnormal utricle morphology	0.99	> 0.20	ABO (2.0)	ZHX3 (1.5)	PBX4 (1.5)	DYNC2LI1 (1.4)	ENSG00000228044 (1.4)	NYNRIN (1.4)	TXNL4B (1.3)	TMEM116 (1.2)	NCAN (1.2)	KIAA1324 (1.2)
REACTOME_NCAM1_INTERACTIONS	REACTOME_NCAM1_INTERACTIONS	0.99	> 0.20	PLEKHH2 (3.3)	CILP2 (2.1)	CELSR2 (1.7)	FADS2 (1.6)	MAU2 (1.5)	BCAM (1.2)	ATXN7L2 (1.2)	MYLIP (1.1)	C17orf57 (1.1)	AP1M2 (1.0)
GO:0048593	camera-type eye morphogenesis	0.99	> 0.20	CILP2 (1.8)	TMED4 (1.6)	DYNC2LI1 (1.5)	ZHX3 (1.5)	PMFBP1 (1.4)	NYNRIN (1.3)	C11orf9 (1.3)	PPP1R37 (1.3)	ENSG00000254235 (1.2)	GOT2P1 (1.1)
ENSG00000100968	NFATC4 PPI subnetwork	0.99	> 0.20	PVR (2.4)	C12orf51 (1.8)	SARS (1.7)	TM6SF2 (1.4)	TMEM57 (1.4)	UBXN2B (1.3)	TSSK6 (1.3)	GCNT4 (1.2)	GATAD2A (1.2)	MARK4 (1.2)
ENSG00000175582	RAB6A PPI subnetwork	0.99	> 0.20	ATXN2 (3.1)	SARS (2.9)	C12orf51 (2.5)	COL4A3BP (2.2)	POC5 (2.1)	PSRC1 (1.9)	ERP29 (1.7)	DOCK7 (1.6)	NYNRIN (1.3)	ENSG00000235545 (1.3)
ENSG00000171533	MAP6 PPI subnetwork	0.99	> 0.20	NCAN (3.4)	RPH3A (2.0)	C12orf43 (2.0)	GOT2P1 (1.6)	C12orf47 (1.5)	C11orf9 (1.5)	UBXN2B (1.4)	LPIN3 (1.4)	NYNRIN (1.3)	SORT1 (1.3)
ENSG00000141552	ANAPC11 PPI subnetwork	0.99	> 0.20	PSRC1 (5.3)	FEN1 (3.3)	POC5 (2.5)	USP1 (1.7)	LPAR2 (1.5)	C1orf63 (1.2)	ILF3 (1.2)	SUGP1 (1.2)	ATP13A1 (1.1)	RHCE (1.0)
GO:0016311	dephosphorylation	0.99	> 0.20	PTPN11 (2.1)	AMIGO1 (1.8)	SH2B3 (1.8)	ZHX3 (1.7)	MAPKAPK5 (1.6)	PVR (1.6)	OGDH (1.4)	DNAH11 (1.4)	BRAP (1.3)	TRIB1 (1.3)
REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION	0.99	> 0.20	PLEKHH2 (2.7)	ABO (2.0)	C11orf9 (1.9)	HAPLN4 (1.8)	ALDH2 (1.7)	PVR (1.7)	TSSK6 (1.6)	CEACAM19 (1.5)	ENSG00000226645 (1.3)	PTPN11 (1.2)
GO:0030002	cellular anion homeostasis	0.99	> 0.20	HAVCR1 (2.8)	AP1M2 (2.5)	TMEM116 (2.2)	FRK (1.7)	TM6SF2 (1.7)	CILP2 (1.5)	NPC1L1 (1.3)	C1orf63 (1.1)	ADAM1 (1.0)	TMEM57 (0.9)
GO:0032271	regulation of protein polymerization	0.99	> 0.20	C17orf57 (2.7)	ENSG00000238078 (2.4)	TMEM50A (2.0)	CYB561D1 (1.9)	ZNF101 (1.7)	ADAM1 (1.6)	ATXN7L2 (1.3)	TSSK6 (1.3)	PBX4 (1.3)	BRAP (1.3)
GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	0.99	> 0.20	CEACAM19 (2.4)	ENSG00000226645 (2.3)	HNF1A (1.3)	ENSG00000226648 (1.3)	ITGB3 (1.2)	TMED4 (1.2)	C19orf52 (1.2)	C11orf9 (1.2)	BLOC1S3 (1.1)	ALDH2 (1.1)
ENSG00000181072	CHRM2 PPI subnetwork	0.99	> 0.20	DYNC2LI1 (2.2)	SH2B3 (2.1)	AMIGO1 (2.1)	CETP (2.0)	ENSG00000235545 (1.8)	TMEM57 (1.7)	TMEM50A (1.7)	ITGB3 (1.6)	PVR (1.6)	COL4A3BP (1.4)
MP:0000298	absent atrioventricular cushions	0.99	> 0.20	SORT1 (2.9)	CYB561D1 (2.2)	ITGB3 (1.7)	C17orf57 (1.5)	ENSG00000254235 (1.4)	HAVCR1 (1.3)	SH2B3 (1.2)	GOT2P1 (1.2)	DHODH (1.2)	C11orf9 (1.1)
MP:0006065	abnormal heart position or orientation	0.99	> 0.20	PVRL2 (2.1)	LPAR2 (2.0)	ATXN2 (2.0)	MARK4 (2.0)	CARM1 (2.0)	TRIB1 (1.7)	NYNRIN (1.6)	HLX (1.6)	MAU2 (1.4)	COL4A3BP (1.2)
GO:0050718	positive regulation of interleukin-1 beta secretion	0.99	> 0.20	CEACAM19 (2.5)	BLOC1S3 (2.2)	NKPD1 (1.5)	CYB561D1 (1.5)	ENSG00000238078 (1.4)	TRAFD1 (1.3)	RPH3A (1.3)	NT5DC1 (1.2)	C12orf43 (1.1)	LPAR2 (1.1)
GO:0050716	positive regulation of interleukin-1 secretion	0.99	> 0.20	CEACAM19 (2.5)	BLOC1S3 (2.2)	NKPD1 (1.5)	CYB561D1 (1.5)	ENSG00000238078 (1.4)	TRAFD1 (1.3)	RPH3A (1.3)	NT5DC1 (1.2)	C12orf43 (1.1)	LPAR2 (1.1)
GO:0008340	determination of adult lifespan	0.99	> 0.20	ZNF180 (2.7)	TMEM116 (2.1)	KIAA1324 (2.1)	PBX4 (2.1)	DYNC2LI1 (1.9)	ENSG00000226648 (1.8)	CYB561D1 (1.7)	ERP29 (1.7)	ENSG00000254235 (1.4)	FRK (1.4)
ENSG00000039560	RAI14 PPI subnetwork	0.99	> 0.20	PLCG1 (2.3)	PLEC (2.0)	PVR (1.8)	KANK2 (1.8)	LPIN3 (1.5)	BRAP (1.5)	GATAD2A (1.3)	FRK (1.2)	ZHX3 (1.2)	C17orf57 (1.2)
GO:0035914	skeletal muscle cell differentiation	0.99	> 0.20	HNF1A (2.5)	CYB561D1 (2.2)	ATXN7L2 (2.2)	SYPL2 (2.2)	AMIGO1 (1.7)	CEACAM19 (1.6)	GMPR (1.4)	ZHX3 (1.4)	C11orf9 (1.2)	CARM1 (1.2)
GO:0034394	protein localization at cell surface	0.99	> 0.20	GCNT4 (2.0)	ABO (1.8)	TMEM116 (1.7)	PTPN11 (1.7)	AP1M2 (1.6)	FRK (1.6)	KANK2 (1.5)	LDLR (1.5)	CBLC (1.3)	ENSG00000228044 (1.3)
GO:0048701	embryonic cranial skeleton morphogenesis	0.99	> 0.20	MYLIP (2.6)	C19orf52 (2.1)	TMEM57 (1.6)	USP24 (1.2)	ZHX3 (1.2)	AMIGO1 (1.2)	CARM1 (1.0)	CEACAM19 (1.0)	PPP1R37 (0.9)	SYPL2 (0.9)
REACTOME_GLUTAMATE_BINDING_ACTIVATION_OF_AMPA_RECEPTORS_AND_SYNAPTIC_PLASTICITY	REACTOME_GLUTAMATE_BINDING_ACTIVATION_OF_AMPA_RECEPTORS_AND_SYNAPTIC_PLASTICITY	0.99	> 0.20	NCAN (4.0)	ZHX3 (3.2)	RPH3A (2.9)	CLPTM1 (2.7)	LPIN3 (2.2)	POLK (1.8)	PPP1R37 (1.8)	ABO (1.6)	KIAA1324 (1.5)	HAPLN4 (1.4)
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	0.99	> 0.20	NCAN (4.0)	ZHX3 (3.2)	RPH3A (2.9)	CLPTM1 (2.7)	LPIN3 (2.2)	POLK (1.8)	PPP1R37 (1.8)	ABO (1.6)	KIAA1324 (1.5)	HAPLN4 (1.4)
GO:0030902	hindbrain development	0.99	> 0.20	ANKRD31 (2.4)	ADAM1 (2.3)	CILP2 (2.3)	PLCG1 (2.3)	NCAN (2.1)	TMEM116 (2.1)	HAPLN4 (2.1)	ZHX3 (2.0)	ATXN2 (1.9)	DYNC2LI1 (1.9)
GO:0044319	wound healing, spreading of cells	0.99	> 0.20	DNAH11 (2.5)	ENSG00000226648 (2.4)	PVR (2.3)	AP1M2 (2.2)	ENSG00000226645 (1.8)	ERP29 (1.7)	NYNRIN (1.4)	TMEM116 (1.3)	NKPD1 (1.3)	GEMIN7 (1.2)
GO:0043666	regulation of phosphoprotein phosphatase activity	0.99	> 0.20	HNF1A (2.4)	ACAD10 (2.2)	BRAP (2.2)	ERP29 (2.0)	TXNL4B (1.9)	PMFBP1 (1.9)	HAVCR1 (1.6)	PTPN11 (1.5)	DHX38 (1.4)	C12orf47 (1.4)
ENSG00000125249	RAP2A PPI subnetwork	0.99	> 0.20	SORT1 (2.4)	RPH3A (2.0)	NCAN (1.9)	MARK4 (1.9)	C11orf9 (1.8)	COL4A3BP (1.7)	ITGB3 (1.7)	TMEM50A (1.4)	CELSR2 (1.3)	OGDH (1.3)
GO:0007631	feeding behavior	0.99	> 0.20	ABO (3.5)	C12orf47 (3.0)	PMFBP1 (2.6)	DNAH11 (2.2)	KIAA1324 (2.2)	ENSG00000235545 (1.9)	TSSK6 (1.7)	ERP29 (1.7)	ADAM1 (1.7)	NPC1L1 (1.5)
GO:0050773	regulation of dendrite development	0.99	> 0.20	ABO (3.3)	RPH3A (2.7)	ENSG00000235545 (2.4)	NCAN (2.1)	LPIN3 (2.0)	HAVCR1 (1.7)	DOCK7 (1.6)	PBX4 (1.5)	DNAH11 (1.4)	TSSK6 (1.3)
ENSG00000102024	PLS3 PPI subnetwork	0.99	> 0.20	ADAM1 (2.6)	PVR (2.5)	GATAD2A (2.2)	PLCG1 (2.2)	ENSG00000226648 (2.0)	C12orf43 (1.9)	ITGB3 (1.6)	TXNL4B (1.6)	C12orf51 (1.6)	MARK4 (1.4)
ENSG00000148468	FAM171A1 PPI subnetwork	0.99	> 0.20	HAPLN4 (2.9)	RPH3A (2.6)	PPP1R37 (2.4)	COL4A3BP (2.2)	SORT1 (1.9)	C12orf51 (1.8)	AP1M2 (1.6)	CYB561D1 (1.6)	CLPTM1 (1.5)	C1orf63 (1.5)
MP:0006113	abnormal heart septum morphology	0.99	> 0.20	C17orf57 (2.3)	RPH3A (2.3)	C11orf9 (2.1)	SLC22A1 (1.6)	TRAFD1 (1.5)	NYNRIN (1.4)	USP24 (1.3)	TSSK6 (1.1)	NCAN (1.1)	CEACAM19 (1.0)
ENSG00000139318	DUSP6 PPI subnetwork	0.99	> 0.20	PLCG1 (2.9)	AMIGO1 (2.7)	CBLC (2.4)	MARK4 (2.1)	TMEM57 (2.0)	CYB561D1 (1.8)	TOMM40 (1.6)	SORT1 (1.6)	ENSG00000238078 (1.5)	ZNF180 (1.5)
ENSG00000100949	RABGGTA PPI subnetwork	0.99	> 0.20	NKPD1 (2.9)	ATXN7L2 (2.2)	DYNC2LI1 (1.9)	LPIN3 (1.6)	POC5 (1.5)	DNAH11 (1.4)	NT5DC1 (1.4)	ADAM1 (1.3)	GPAM (1.1)	HNF1A (1.0)
ENSG00000174469	CNTNAP2 PPI subnetwork	0.99	> 0.20	HAPLN4 (3.5)	RPH3A (2.7)	CELSR2 (2.7)	ATXN2 (2.4)	C12orf51 (1.7)	ANKRD31 (1.4)	FRK (1.4)	DOCK7 (1.3)	ZHX3 (1.3)	TIMD4 (1.2)
GO:0051650	establishment of vesicle localization	0.99	> 0.20	YIPF2 (4.5)	OGDH (1.7)	DNM2 (1.6)	C19orf52 (1.6)	LPIN3 (1.5)	ANKRD31 (1.5)	PMFBP1 (1.3)	SUGP1 (1.3)	BLOC1S3 (1.2)	PPP1R37 (1.2)
GO:0060041	retina development in camera-type eye	0.99	> 0.20	DYNC2LI1 (2.1)	GEMIN7 (2.0)	PMFBP1 (1.7)	HNF1A (1.5)	LPIN3 (1.4)	GOT2P1 (1.4)	MAPKAPK5 (1.3)	HAVCR1 (1.3)	TMEM116 (1.1)	ATXN2 (1.0)
ENSG00000125675	GRIA3 PPI subnetwork	0.99	> 0.20	NCAN (2.6)	ERP29 (2.5)	ZHX3 (2.4)	TSSK6 (2.2)	AP1M2 (1.8)	USP24 (1.8)	CBLC (1.7)	YIPF2 (1.6)	SARS (1.5)	PBX4 (1.5)
ENSG00000204271	SPIN3 PPI subnetwork	0.99	> 0.20	PTPN11 (3.5)	DOCK7 (2.4)	ENSG00000235545 (2.0)	USP1 (1.7)	SUGP1 (1.6)	AMIGO1 (1.5)	C19orf52 (1.5)	TOP1 (1.5)	DNM2 (1.4)	BUD13 (1.3)
ENSG00000186787	SPIN2B PPI subnetwork	0.99	> 0.20	PTPN11 (3.5)	DOCK7 (2.4)	ENSG00000235545 (2.0)	USP1 (1.7)	SUGP1 (1.6)	AMIGO1 (1.5)	C19orf52 (1.5)	TOP1 (1.5)	DNM2 (1.4)	BUD13 (1.3)
REACTOME_ACTIVATION_OF_RAC	REACTOME_ACTIVATION_OF_RAC	0.99	> 0.20	MARK4 (2.7)	ABO (1.8)	LPAR2 (1.8)	TMEM50A (1.7)	ENSG00000238078 (1.6)	DNAH11 (1.6)	USP24 (1.4)	PBX4 (1.3)	OGDH (1.3)	ATXN2 (1.3)
GO:0016331	morphogenesis of embryonic epithelium	0.99	> 0.20	DYNC2LI1 (2.8)	BCAM (2.1)	LPAR2 (2.1)	PVRL2 (2.0)	CELSR2 (1.9)	NYNRIN (1.8)	TMEM116 (1.8)	PLEKHH2 (1.7)	AP1M2 (1.7)	MARK4 (1.6)
ENSG00000136152	COG3 PPI subnetwork	0.99	> 0.20	YIPF2 (3.6)	SUGP1 (3.1)	TMEM57 (2.9)	CYB561D1 (2.0)	NKPD1 (2.0)	DHX38 (2.0)	LPIN3 (1.9)	C12orf43 (1.7)	DYNC2LI1 (1.6)	BRAP (1.6)
MP:0000159	abnormal xiphoid process morphology	0.99	> 0.20	PLCG1 (3.0)	NYNRIN (2.7)	CILP2 (1.7)	C11orf9 (1.6)	ZHX3 (1.2)	CARM1 (1.2)	NCAN (1.1)	C19orf52 (1.1)	ENSG00000226648 (1.1)	SORT1 (1.1)
GO:0006120	mitochondrial electron transport, NADH to ubiquinone	0.99	> 0.20	C12orf47 (3.5)	OGDH (3.4)	ACAD10 (3.1)	TRAPPC6A (2.6)	GOT2P1 (2.0)	FRK (2.0)	MAU2 (1.7)	TMED4 (1.5)	ENSG00000235545 (1.3)	TMEM116 (1.3)
GO:0048278	vesicle docking	0.99	> 0.20	CYB561D1 (3.3)	TMEM50A (2.3)	DYNC2LI1 (1.9)	C19orf52 (1.7)	YIPF2 (1.7)	ATXN7L2 (1.6)	ENSG00000226645 (1.6)	SORT1 (1.3)	POLK (1.3)	BRAP (1.2)
ENSG00000161040	FBXL13 PPI subnetwork	0.99	> 0.20	TOMM40 (3.1)	C12orf43 (2.8)	NAA25 (2.6)	DHODH (2.4)	ZNF259 (2.2)	ACAD10 (2.1)	MAPKAPK5 (2.0)	DDX56 (2.0)	NKPD1 (1.8)	OGDH (1.8)
ENSG00000136002	ARHGEF4 PPI subnetwork	0.99	> 0.20	SUGP1 (2.5)	DHX38 (2.2)	ZNF180 (2.1)	ENSG00000235545 (1.8)	FEN1 (1.7)	BUD13 (1.5)	GATAD2A (1.5)	NKPD1 (1.5)	USP1 (1.4)	MARK4 (1.3)
GO:0051955	regulation of amino acid transport	0.99	> 0.20	NCAN (2.3)	MOSC1 (1.9)	ABCG8 (1.7)	C12orf51 (1.6)	ERP29 (1.6)	CYP7A1 (1.6)	COL4A3BP (1.5)	TXNL4B (1.4)	PMFBP1 (1.3)	ENSG00000226648 (1.2)
GO:0033121	regulation of purine nucleotide catabolic process	0.99	> 0.20	ZHX3 (2.9)	C12orf51 (2.3)	ENSG00000226645 (2.2)	SH2B3 (1.8)	DNM2 (1.6)	USP24 (1.5)	ENSG00000228044 (1.4)	HLX (1.4)	PPP1R37 (1.4)	PLCG1 (1.3)
GO:0030811	regulation of nucleotide catabolic process	0.99	> 0.20	ZHX3 (2.9)	C12orf51 (2.3)	ENSG00000226645 (2.2)	SH2B3 (1.8)	DNM2 (1.6)	USP24 (1.5)	ENSG00000228044 (1.4)	HLX (1.4)	PPP1R37 (1.4)	PLCG1 (1.3)
ENSG00000145348	TBCK PPI subnetwork	0.99	> 0.20	NPC1L1 (2.4)	AMIGO1 (2.2)	ABCG8 (2.1)	C12orf47 (1.7)	PSRC1 (1.7)	TMED4 (1.7)	TOP1 (1.6)	DOCK7 (1.6)	HAPLN4 (1.5)	ZHX3 (1.5)
GO:0034728	nucleosome organization	0.99	> 0.20	C19orf52 (2.0)	PMFBP1 (1.8)	ENSG00000226648 (1.7)	PSRC1 (1.6)	TMEM57 (1.5)	TSSK6 (1.5)	USP1 (1.4)	C12orf47 (1.3)	TXNL4B (1.2)	ZNF180 (1.1)
MP:0010856	dilated respiratory conducting tubes	0.99	> 0.20	PLEKHH2 (3.0)	SORT1 (2.3)	NYNRIN (1.9)	SLC44A2 (1.8)	PVR (1.7)	YIPF2 (1.7)	C11orf9 (1.7)	GCNT4 (1.6)	ENSG00000226648 (1.6)	CILP2 (1.6)
MP:0004163	abnormal adenohypophysis morphology	0.99	> 0.20	NKPD1 (3.0)	HNF1A (2.3)	C11orf9 (1.8)	PMFBP1 (1.7)	OASL (1.7)	TMEM50A (1.6)	TXNL4B (1.6)	C12orf47 (1.5)	CELSR2 (1.4)	TMEM57 (1.3)
GO:0090317	negative regulation of intracellular protein transport	0.99	> 0.20	ZNF101 (2.6)	ABO (2.1)	PBX4 (1.8)	ENSG00000235545 (1.8)	PLCG1 (1.8)	PPP1R37 (1.6)	LPAR2 (1.3)	BLOC1S3 (1.3)	GATAD2A (1.0)	MAFB (1.0)
ENSG00000166863	TAC3 PPI subnetwork	0.99	> 0.20	AMIGO1 (1.8)	CYB561D1 (1.7)	TMED4 (1.7)	NCAN (1.6)	ZNF259 (1.5)	ENSG00000235545 (1.5)	C12orf51 (1.4)	PSRC1 (1.1)	GCNT4 (1.0)	APOE (1.0)
ENSG00000126583	PRKCG PPI subnetwork	0.99	> 0.20	RPH3A (2.1)	PVR (2.1)	SORT1 (1.8)	TSSK6 (1.6)	PLEC (1.6)	ITGB3 (1.6)	C12orf47 (1.6)	MARK4 (1.5)	PLEKHH2 (1.4)	NCAN (1.4)
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	0.99	> 0.20	ALDH2 (2.8)	APOC1 (2.4)	APOE (2.4)	ZNF101 (2.3)	PLCG1 (2.3)	C19orf52 (1.3)	HAVCR1 (1.3)	DOCK7 (1.3)	PBX4 (1.2)	MAFB (1.2)
ENSG00000133816	MICAL2 PPI subnetwork	0.99	> 0.20	GPAM (3.0)	ENSG00000235545 (2.5)	NKPD1 (2.2)	ZHX3 (2.2)	AMIGO1 (2.0)	CYB561D1 (1.8)	ENSG00000254235 (1.5)	ENSG00000228044 (1.5)	MAU2 (1.4)	HLX (1.4)
ENSG00000139549	DHH PPI subnetwork	0.99	> 0.20	PLEKHH2 (2.8)	HLX (1.9)	GPAM (1.7)	ZNF180 (1.4)	HAVCR1 (1.4)	ST3GAL4 (1.4)	DYNC2LI1 (1.4)	MAFB (1.2)	SLC44A2 (1.1)	BCAM (1.1)
ENSG00000080802	CNOT4 PPI subnetwork	0.99	> 0.20	BRAP (4.2)	TMEM57 (3.7)	TXNL4B (2.9)	SUGP1 (2.4)	ATXN2 (2.2)	SARS (2.0)	ZNF259 (1.9)	DDX56 (1.8)	MAPKAPK5 (1.8)	ADAM1 (1.7)
ENSG00000133019	CHRM3 PPI subnetwork	0.99	> 0.20	ST3GAL4 (1.9)	GEMIN7 (1.8)	PVR (1.8)	RPH3A (1.8)	PTPN11 (1.7)	C17orf57 (1.5)	AMIGO1 (1.5)	LDLR (1.4)	BLOC1S3 (1.4)	TIMD4 (1.3)
GO:0007625	grooming behavior	0.99	> 0.20	HNF1A (3.1)	NKPD1 (2.6)	C17orf57 (1.8)	TRAPPC6A (1.7)	TSSK6 (1.4)	ERP29 (1.3)	PBX4 (1.2)	TMED4 (1.2)	TXNL4B (1.2)	C12orf47 (1.1)
GO:0015992	proton transport	0.99	> 0.20	TMEM116 (2.9)	ENSG00000238078 (2.8)	COL4A3BP (2.5)	ACAD10 (2.4)	OGDH (2.3)	ADAM1 (2.2)	SORT1 (2.0)	GOT2P1 (1.8)	ERP29 (1.8)	GMPR (1.6)
MP:0000160	kyphosis	0.99	> 0.20	SYPL2 (3.2)	CILP2 (3.2)	PLEC (2.8)	SLC44A2 (2.3)	CLPTM1 (2.0)	PVR (1.7)	CBLC (1.6)	CELSR2 (1.6)	TMED4 (1.5)	HAVCR1 (1.5)
GO:0048715	negative regulation of oligodendrocyte differentiation	0.99	> 0.20	NCAN (2.3)	PBX4 (2.3)	BLOC1S3 (2.3)	DNAH11 (1.6)	ABO (1.6)	C19orf52 (1.5)	NKPD1 (1.4)	UBXN2B (1.3)	DYNC2LI1 (1.2)	MYLIP (1.0)
GO:0001738	morphogenesis of a polarized epithelium	0.99	> 0.20	ATXN7L2 (2.5)	NYNRIN (2.5)	BCAM (2.3)	CELSR2 (2.2)	AP1M2 (2.1)	LPAR2 (2.0)	PLEKHH2 (1.8)	CBLC (1.7)	DYNC2LI1 (1.7)	ABO (1.5)
ENSG00000204531	POU5F1 PPI subnetwork	0.99	> 0.20	HAPLN4 (2.9)	C12orf47 (2.1)	CELSR2 (1.8)	KIAA1324 (1.7)	DHX38 (1.7)	MYLIP (1.6)	DHODH (1.5)	GRINA (1.5)	ALDH2 (1.4)	COL4A3BP (1.4)
ENSG00000206454	POU5F1 PPI subnetwork	0.99	> 0.20	HAPLN4 (2.9)	C12orf47 (2.1)	CELSR2 (1.8)	KIAA1324 (1.7)	DHX38 (1.7)	MYLIP (1.6)	DHODH (1.5)	GRINA (1.5)	ALDH2 (1.4)	COL4A3BP (1.4)
ENSG00000206349	ENSG00000206349 PPI subnetwork	0.99	> 0.20	HAPLN4 (2.9)	C12orf47 (2.1)	CELSR2 (1.8)	KIAA1324 (1.7)	DHX38 (1.7)	MYLIP (1.6)	DHODH (1.5)	GRINA (1.5)	ALDH2 (1.4)	COL4A3BP (1.4)
GO:0009434	microtubule-based flagellum	0.99	> 0.20	TSSK6 (4.1)	DYNC2LI1 (4.1)	PMFBP1 (3.0)	DNAH11 (2.7)	YIPF2 (1.3)	TRAPPC6A (1.3)	TMEM116 (1.2)	NKPD1 (1.2)	PBX4 (1.1)	CILP2 (0.8)
ENSG00000105409	ATP1A3 PPI subnetwork	0.99	> 0.20	C11orf9 (2.2)	RPH3A (2.2)	FRK (2.0)	ENSG00000235545 (1.9)	NT5DC1 (1.9)	HAPLN4 (1.5)	HNF1A (1.5)	BUD13 (1.4)	C1orf63 (1.4)	TRAPPC6A (1.3)
ENSG00000127337	YEATS4 PPI subnetwork	0.99	> 0.20	BUD13 (2.7)	SMARCA4 (2.4)	USP1 (1.8)	TXNL4B (1.7)	C19orf52 (1.6)	PSRC1 (1.4)	ILF3 (1.4)	ZNF180 (1.2)	PCSK9 (1.2)	ITGB3 (1.1)
ENSG00000120875	DUSP4 PPI subnetwork	0.99	> 0.20	SORT1 (2.7)	NCAN (2.0)	C1orf63 (1.9)	TSSK6 (1.9)	RPH3A (1.9)	ITGB3 (1.5)	MARK4 (1.5)	CYB561D1 (1.4)	CLPTM1 (1.3)	GOT2P1 (1.3)
GO:0047496	vesicle transport along microtubule	0.99	> 0.20	C17orf57 (2.6)	PBX4 (2.6)	DYNC2LI1 (1.9)	BLOC1S3 (1.9)	GOT2P1 (1.8)	COL4A3BP (1.5)	ATXN2 (1.4)	UBXN2B (1.3)	PMFBP1 (1.3)	CYB561D1 (1.1)
GO:0043586	tongue development	0.99	> 0.20	NKPD1 (3.1)	PMFBP1 (2.6)	ANKRD31 (2.3)	AMIGO1 (1.9)	BCAM (1.6)	SLC44A2 (1.5)	TSSK6 (1.3)	CELSR2 (1.3)	CYB561D1 (1.2)	ATXN7L2 (1.2)
ENSG00000204197	KIFC1 PPI subnetwork	0.99	> 0.20	PSRC1 (2.6)	SMARCA4 (2.1)	FEN1 (1.9)	C12orf47 (1.6)	HAPLN4 (1.5)	C12orf51 (1.5)	SARS (1.4)	POC5 (1.3)	C11orf9 (1.3)	AMIGO1 (1.1)
ENSG00000056678	ENSG00000056678 PPI subnetwork	0.99	> 0.20	PSRC1 (2.6)	SMARCA4 (2.1)	FEN1 (1.9)	C12orf47 (1.6)	HAPLN4 (1.5)	C12orf51 (1.5)	SARS (1.4)	POC5 (1.3)	C11orf9 (1.3)	AMIGO1 (1.1)
MP:0005205	abnormal eye anterior chamber morphology	0.99	> 0.20	CILP2 (2.9)	SORT1 (2.3)	ST3GAL4 (1.6)	ZHX3 (1.6)	YIPF2 (1.5)	MOSC1 (1.3)	DOCK7 (1.2)	C19orf52 (1.0)	ABCG8 (1.0)	TMED4 (1.0)
GO:0006904	vesicle docking involved in exocytosis	0.99	> 0.20	CYB561D1 (3.5)	ENSG00000226645 (2.2)	TMEM50A (2.1)	DYNC2LI1 (2.0)	YIPF2 (1.8)	ATXN7L2 (1.8)	C19orf52 (1.7)	BLOC1S3 (1.4)	BRAP (1.3)	SORT1 (1.3)
ENSG00000108852	MPP2 PPI subnetwork	0.99	> 0.20	HAPLN4 (3.2)	RPH3A (2.7)	NCAN (2.3)	ADAM1 (1.8)	ENSG00000235545 (1.7)	PTPN11 (1.5)	CELSR2 (1.5)	ALDH2 (1.3)	SORT1 (1.2)	TMEM50A (1.2)
GO:0030858	positive regulation of epithelial cell differentiation	0.99	> 0.20	ANKRD31 (3.1)	ITGB3 (2.7)	LPIN3 (1.7)	C19orf52 (1.5)	C12orf47 (1.4)	PLCG1 (1.4)	BLOC1S3 (1.3)	C1orf63 (1.3)	ZHX3 (1.2)	SLC44A2 (1.2)
ENSG00000178127	NDUFV2 PPI subnetwork	0.99	> 0.20	OGDH (3.6)	C12orf47 (2.2)	TRAPPC6A (2.1)	GOT2P1 (1.9)	ACAD10 (1.8)	TMED4 (1.7)	ALDH2 (1.7)	FRK (1.5)	HAPLN4 (1.5)	PTPN11 (1.5)
MP:0001491	unresponsive to tactile stimuli	0.99	> 0.20	RPH3A (3.5)	LPIN3 (2.3)	SYPL2 (2.3)	C12orf51 (2.0)	AMIGO1 (1.9)	HAVCR1 (1.6)	COL4A3BP (1.6)	FADS1 (1.6)	ANKRD31 (1.4)	TSSK6 (1.3)
MP:0009838	abnormal sperm axoneme morphology	0.99	> 0.20	TSSK6 (4.4)	PMFBP1 (3.3)	DYNC2LI1 (2.1)	CEACAM19 (1.8)	NKPD1 (1.6)	GOT2P1 (1.6)	PLEKHH2 (1.3)	KIAA1324 (1.2)	TMED4 (1.2)	YIPF2 (1.1)
GO:0050680	negative regulation of epithelial cell proliferation	0.99	> 0.20	C19orf52 (2.6)	CILP2 (1.8)	PLEKHH2 (1.5)	NYNRIN (1.2)	TMED4 (1.1)	SLC44A2 (1.1)	DYNC2LI1 (1.0)	PMFBP1 (0.9)	MAFB (0.9)	HLX (0.9)
REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION	0.99	> 0.20	ANKRD31 (2.3)	PVR (1.6)	ABO (1.6)	HAPLN4 (1.6)	PVRL2 (1.5)	C11orf9 (1.5)	TM6SF2 (1.3)	GOT2P1 (1.3)	ENSG00000226645 (1.3)	CEACAM19 (1.2)
GO:0070232	regulation of T cell apoptotic process	0.99	> 0.20	PBX4 (2.5)	HNF1A (2.0)	GMIP (1.8)	C12orf47 (1.8)	CYB561D1 (1.7)	ATXN7L2 (1.7)	TSSK6 (1.5)	PARP10 (1.5)	LPIN3 (1.3)	TXNL4B (1.2)
GO:0032413	negative regulation of ion transmembrane transporter activity	0.99	> 0.20	TSSK6 (3.8)	DNAH11 (2.6)	CYB561D1 (2.1)	AMIGO1 (2.0)	ZNF180 (1.8)	BLOC1S3 (1.6)	SLC44A2 (1.3)	PPP1R37 (1.2)	RPH3A (1.1)	CILP2 (1.1)
GO:0032266	phosphatidylinositol-3-phosphate binding	0.99	> 0.20	FRK (2.6)	GEMIN7 (2.1)	DOCK7 (1.9)	DYNC2LI1 (1.8)	TMEM57 (1.8)	COL4A3BP (1.7)	CARM1 (1.6)	PPP1R37 (1.5)	LPIN3 (1.5)	ZHX3 (1.5)
GO:0004930	G-protein coupled receptor activity	0.99	> 0.20	CELSR2 (1.9)	ENSG00000235545 (1.7)	ENSG00000228044 (1.6)	NCAN (1.5)	DNAH11 (1.4)	ABO (1.4)	RPH3A (1.4)	HLX (1.3)	TRIB1 (1.2)	BCAM (1.2)
ENSG00000120896	SORBS3 PPI subnetwork	0.99	> 0.20	C1orf63 (2.1)	PTPN11 (2.0)	LPAR2 (1.9)	ITGB3 (1.9)	UBXN2B (1.6)	PBX4 (1.5)	GPAM (1.5)	GCNT4 (1.3)	KANK2 (1.3)	TRAFD1 (1.2)
GO:0060026	convergent extension	0.99	> 0.20	C19orf52 (2.1)	TMEM116 (2.0)	AMIGO1 (2.0)	ENSG00000238078 (1.7)	ATXN7L2 (1.7)	DYNC2LI1 (1.7)	ABO (1.5)	CILP2 (1.5)	PPP1R37 (1.3)	ZHX3 (1.2)
MP:0002980	abnormal postural reflex	0.99	> 0.20	HAPLN4 (4.4)	RPH3A (3.1)	TMEM116 (2.1)	PMFBP1 (2.0)	POLK (2.0)	GEMIN7 (1.7)	USP24 (1.7)	PLEKHH2 (1.5)	C12orf47 (1.5)	ZNF101 (1.5)
MP:0002196	absent corpus callosum	0.99	> 0.20	CELSR2 (2.8)	NCAN (2.7)	NYNRIN (2.5)	TMEM116 (1.4)	DOCK7 (1.4)	DYNC2LI1 (1.4)	PSRC1 (1.2)	OASL (1.2)	PBX4 (1.2)	TSSK6 (1.1)
GO:0072506	trivalent inorganic anion homeostasis	0.99	> 0.20	TMEM116 (3.1)	AP1M2 (3.0)	FRK (2.6)	CILP2 (2.3)	HAVCR1 (2.3)	HNF1A (2.2)	TM6SF2 (2.1)	SYPL2 (1.8)	TSSK6 (1.5)	PMFBP1 (1.3)
GO:0055062	phosphate ion homeostasis	0.99	> 0.20	TMEM116 (3.1)	AP1M2 (3.0)	FRK (2.6)	CILP2 (2.3)	HAVCR1 (2.3)	HNF1A (2.2)	TM6SF2 (2.1)	SYPL2 (1.8)	TSSK6 (1.5)	PMFBP1 (1.3)
GO:0006334	nucleosome assembly	0.99	> 0.20	C19orf52 (2.3)	PSRC1 (1.8)	ENSG00000226648 (1.7)	ZNF180 (1.5)	USP1 (1.3)	PMFBP1 (1.3)	TXNL4B (1.3)	TMED4 (1.3)	POC5 (1.2)	DNAH11 (1.1)
GO:0048742	regulation of skeletal muscle fiber development	0.99	> 0.20	SYPL2 (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	PMFBP1 (1.6)	LPIN3 (1.5)	OGDH (1.4)	HLX (1.4)	SLC44A2 (1.4)	CEACAM19 (1.3)	GMPR (1.3)
GO:0010970	microtubule-based transport	0.99	> 0.20	C12orf51 (2.1)	RPH3A (1.8)	PBX4 (1.6)	DOCK7 (1.6)	CYB561D1 (1.3)	C17orf57 (1.3)	OGDH (1.2)	PTPN11 (1.2)	GOT2P1 (1.1)	PPP1R37 (1.0)
GO:0046875	ephrin receptor binding	0.99	> 0.20	LPAR2 (3.9)	PBX4 (3.4)	TOP1 (2.7)	MARK4 (2.6)	PLEKHH2 (2.5)	UBXN2B (2.3)	PSRC1 (2.1)	NYNRIN (2.0)	HAPLN4 (1.9)	CELSR2 (1.8)
ENSG00000116191	RALGPS2 PPI subnetwork	0.99	> 0.20	BRAP (3.2)	AP1M2 (2.4)	C19orf52 (1.9)	GATAD2A (1.9)	ATXN2 (1.8)	LDLR (1.8)	ZNF101 (1.6)	COL4A3BP (1.6)	UBXN2B (1.5)	ENSG00000226645 (1.4)
GO:0034508	centromere complex assembly	0.99	> 0.20	PSRC1 (2.8)	ZNF180 (2.4)	C19orf52 (2.3)	NKPD1 (1.8)	ENSG00000226648 (1.7)	PBX4 (1.5)	C1orf63 (1.4)	ENSG00000254235 (1.3)	BUD13 (1.3)	DNAH11 (1.2)
MP:0004351	short humerus	0.99	> 0.20	PLEKHH2 (4.2)	CILP2 (3.7)	NYNRIN (2.1)	FRK (1.9)	MAFB (1.7)	PLCG1 (1.5)	MYLIP (1.3)	HAPLN4 (1.2)	CARM1 (1.1)	GOT2P1 (1.0)
ENSG00000184702	SEPT5 PPI subnetwork	0.99	> 0.20	NCAN (2.4)	RPH3A (2.2)	C11orf9 (1.8)	C12orf51 (1.7)	GOT2P1 (1.7)	MARK4 (1.7)	SORT1 (1.6)	C12orf43 (1.6)	TMEM50A (1.6)	NYNRIN (1.5)
GO:0006891	intra-Golgi vesicle-mediated transport	0.99	> 0.20	MAU2 (3.0)	YIPF2 (2.7)	C12orf51 (2.4)	ENSG00000226648 (2.2)	CYB561D1 (2.2)	BRAP (2.1)	TMED4 (2.0)	TRAPPC6A (2.0)	SUGP1 (1.8)	POC5 (1.7)
ENSG00000212868	ENSG00000212868 PPI subnetwork	0.99	> 0.20	OGDH (2.8)	ACAD10 (2.6)	TOMM40 (2.4)	UBXN2B (2.0)	C12orf47 (1.9)	C19orf52 (1.6)	GEMIN7 (1.5)	SARS (1.4)	PMFBP1 (1.3)	TRAPPC6A (1.3)
ENSG00000198727	MT-CYB PPI subnetwork	0.99	> 0.20	OGDH (2.8)	ACAD10 (2.6)	TOMM40 (2.4)	UBXN2B (2.0)	C12orf47 (1.9)	C19orf52 (1.6)	GEMIN7 (1.5)	SARS (1.4)	PMFBP1 (1.3)	TRAPPC6A (1.3)
GO:0045259	proton-transporting ATP synthase complex	0.99	> 0.20	OGDH (3.8)	ACAD10 (3.4)	C12orf47 (3.0)	PSMA5 (2.4)	C1orf63 (2.2)	ENSG00000238078 (1.8)	TMEM116 (1.8)	TOMM40 (1.5)	C19orf52 (1.5)	HNF1A (1.5)
REACTOME_GABA_B_RECEPTOR_ACTIVATION	REACTOME_GABA_B_RECEPTOR_ACTIVATION	0.99	> 0.20	RPH3A (2.1)	NYNRIN (1.9)	TMEM50A (1.8)	NCAN (1.6)	MYLIP (1.5)	USP24 (1.4)	HAVCR1 (1.4)	SLC44A2 (1.3)	CETP (1.3)	ENSG00000228044 (1.2)
REACTOME_ACTIVATION_OF_GABAB_RECEPTORS	REACTOME_ACTIVATION_OF_GABAB_RECEPTORS	0.99	> 0.20	RPH3A (2.1)	NYNRIN (1.9)	TMEM50A (1.8)	NCAN (1.6)	MYLIP (1.5)	USP24 (1.4)	HAVCR1 (1.4)	SLC44A2 (1.3)	CETP (1.3)	ENSG00000228044 (1.2)
GO:0060841	venous blood vessel development	0.99	> 0.20	ENSG00000254235 (2.4)	HNF1A (2.4)	C11orf9 (1.9)	ENSG00000235545 (1.4)	UBXN2B (1.4)	MAU2 (1.3)	ZHX3 (1.3)	LPIN3 (1.2)	ENSG00000226648 (1.1)	ENSG00000226645 (1.1)
MP:0000029	abnormal malleus morphology	0.99	> 0.20	MYLIP (2.7)	CILP2 (2.4)	NYNRIN (1.8)	TMEM57 (1.7)	CEACAM19 (1.7)	MAFB (1.6)	PLEC (1.5)	CARM1 (1.4)	AMIGO1 (1.4)	NKPD1 (1.3)
ENSG00000120696	KBTBD7 PPI subnetwork	0.99	> 0.20	USP24 (4.1)	COL4A3BP (2.6)	DHX38 (2.2)	TMEM57 (2.2)	BUD13 (2.2)	CARM1 (1.8)	GRINA (1.4)	ZHX3 (1.4)	BRAP (1.4)	GMPR (1.3)
MP:0000885	ectopic Purkinje cell	0.99	> 0.20	MAFB (3.4)	DOCK7 (2.6)	NYNRIN (2.2)	POLK (2.1)	NCAN (2.0)	TMED4 (2.0)	PLCG1 (2.0)	PBX4 (1.9)	ENSG00000226645 (1.9)	SORT1 (1.8)
GO:0014902	myotube differentiation	0.99	> 0.20	HNF1A (2.4)	CYB561D1 (2.2)	ATXN7L2 (1.8)	SYPL2 (1.8)	AMIGO1 (1.6)	GMPR (1.4)	ZHX3 (1.4)	C11orf9 (1.2)	CEACAM19 (1.1)	CARM1 (1.1)
GO:0006901	vesicle coating	0.99	> 0.20	YIPF2 (5.2)	GEMIN7 (1.6)	OGDH (1.6)	DNM2 (1.5)	PPP1R37 (1.4)	ABCG8 (1.3)	CLPTM1 (1.3)	SUGP1 (1.2)	AP1M2 (1.1)	PSMA5 (1.1)
ENSG00000137955	RABGGTB PPI subnetwork	0.99	> 0.20	C12orf43 (1.4)	PVR (1.4)	HAPLN4 (1.4)	C19orf52 (1.4)	TMED4 (1.4)	OGDH (1.4)	ZNF180 (1.2)	GEMIN7 (1.2)	KIAA1324 (1.1)	GMPR (1.1)
MP:0002894	abnormal otolith morphology	0.99	> 0.20	ANKRD31 (2.6)	ENSG00000228044 (2.5)	HNF1A (2.3)	TMEM116 (1.9)	HLX (1.8)	PBX4 (1.6)	ZHX3 (1.2)	C17orf57 (1.1)	ILF3 (1.0)	NT5DC1 (1.0)
GO:0050770	regulation of axonogenesis	0.99	> 0.20	CELSR2 (3.1)	PBX4 (2.7)	PPP1R37 (2.7)	RPH3A (1.9)	NCAN (1.7)	PLEC (1.7)	ATXN7L2 (1.6)	C12orf47 (1.6)	HAPLN4 (1.5)	CLPTM1 (1.5)
ENSG00000166900	STX3 PPI subnetwork	0.99	> 0.20	AP1M2 (3.3)	PTPN11 (2.4)	CYB561D1 (2.3)	KIAA1324 (2.0)	BRAP (1.9)	C1orf63 (1.9)	ITGB3 (1.9)	SORT1 (1.7)	TMEM50A (1.5)	PMFBP1 (1.5)
MP:0001327	decreased retinal photoreceptor cell number	0.99	> 0.20	NCAN (2.7)	ENSG00000235545 (2.6)	ZNF180 (1.6)	ST3GAL4 (1.4)	SORT1 (1.3)	RHCE (1.2)	NAA25 (1.2)	TMEM116 (1.2)	PSRC1 (1.0)	PMFBP1 (1.0)
GO:0006816	calcium ion transport	0.99	> 0.20	C12orf47 (2.3)	SYPL2 (2.3)	KIAA1324 (2.1)	RPH3A (2.0)	ABO (2.0)	AMIGO1 (1.6)	ENSG00000226645 (1.4)	NCAN (1.3)	GMPR (1.3)	SLC44A2 (1.2)
MP:0005307	head tossing	0.99	> 0.20	HAPLN4 (2.7)	APOE (2.3)	NPC1L1 (1.9)	POLK (1.8)	HNF1A (1.8)	C11orf9 (1.8)	DNAH11 (1.7)	RPH3A (1.5)	SORT1 (1.3)	AP1M2 (1.3)
GO:0021871	forebrain regionalization	0.99	> 0.20	ABO (2.3)	PBX4 (1.9)	TMEM116 (1.7)	TSSK6 (1.6)	TMED4 (1.6)	C11orf9 (1.6)	LPAR2 (1.3)	PPP1R37 (1.3)	C12orf47 (1.2)	AMIGO1 (1.1)
MP:0004022	abnormal cone electrophysiology	0.99	> 0.20	ENSG00000235545 (2.4)	DYNC2LI1 (1.7)	C12orf47 (1.7)	MAPKAPK5 (1.2)	ENSG00000226648 (1.2)	TSSK6 (1.2)	HAVCR1 (1.1)	PSRC1 (1.0)	ST3GAL4 (1.0)	GOT2P1 (0.9)
GO:0031952	regulation of protein autophosphorylation	0.99	> 0.20	ENSG00000226645 (3.0)	POLK (2.7)	ZNF259 (2.0)	COL4A3BP (1.8)	BUD13 (1.8)	PVR (1.7)	ATXN7L2 (1.6)	DYNC2LI1 (1.6)	GEMIN7 (1.1)	TMEM50A (1.0)
ENSG00000168872	DDX19A PPI subnetwork	0.99	> 0.20	BLOC1S3 (2.4)	POLK (2.2)	CYB561D1 (1.8)	ATXN7L2 (1.8)	CELSR2 (1.7)	LPAR2 (1.6)	ENSG00000226645 (1.6)	ENSG00000226648 (1.6)	C1orf63 (1.5)	MARK4 (1.5)
MP:0009358	environmentally induced seizures	0.99	> 0.20	HAPLN4 (3.6)	PLG (3.1)	COL4A3BP (2.5)	PCSK9 (2.4)	ANGPTL3 (2.3)	HNF1A (2.0)	CYP7A1 (2.0)	ENSG00000226645 (1.7)	GCNT4 (1.4)	APOC4 (1.4)
ENSG00000105700	KXD1 PPI subnetwork	0.99	> 0.20	SUGP1 (4.0)	CYB561D1 (2.5)	C12orf43 (2.4)	TRAFD1 (2.3)	BRAP (2.3)	TXNL4B (2.2)	DHX38 (2.2)	POC5 (1.5)	GCNT4 (1.5)	DNM2 (1.4)
GO:0048147	negative regulation of fibroblast proliferation	0.99	> 0.20	TRAPPC6A (2.1)	BLOC1S3 (2.0)	NT5DC1 (1.9)	POLK (1.8)	DNAH11 (1.6)	YIPF2 (1.6)	QTRT1 (1.4)	ENSG00000254235 (1.2)	CILP2 (1.2)	GATAD2A (1.1)
GO:0007286	spermatid development	0.99	> 0.20	TSSK6 (6.4)	PMFBP1 (3.6)	DYNC2LI1 (1.5)	BRAP (1.2)	C12orf47 (1.2)	TMEM116 (1.1)	ABO (1.1)	CEACAM19 (0.9)	TMED4 (0.8)	ABCG8 (0.8)
ENSG00000121542	SEC22A PPI subnetwork	0.99	> 0.20	YIPF2 (4.2)	SARS (2.1)	CLPTM1 (1.8)	SUGP1 (1.7)	TMEM57 (1.7)	ZNF259 (1.4)	DNM2 (1.4)	CYB561D1 (1.2)	C19orf52 (1.2)	KIAA1324 (1.1)
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	0.99	> 0.20	C12orf51 (2.2)	RPH3A (2.1)	MOSC1 (1.7)	MARK4 (1.7)	HAPLN4 (1.6)	AMIGO1 (1.4)	GRINA (1.4)	HNF1A (1.2)	C12orf43 (1.2)	PMFBP1 (1.2)
GO:0043271	negative regulation of ion transport	0.99	> 0.20	TSSK6 (3.2)	ENSG00000235545 (2.7)	AMIGO1 (2.6)	POLK (2.1)	C12orf47 (1.7)	DNAH11 (1.7)	ENSG00000228044 (1.5)	COL4A3BP (1.5)	GEMIN7 (1.4)	ITGB3 (1.4)
ENSG00000125354	SEPT6 PPI subnetwork	0.99	> 0.20	NCAN (2.5)	SORT1 (2.1)	C11orf9 (2.0)	C12orf51 (1.9)	RPH3A (1.9)	TMEM50A (1.8)	SLC44A2 (1.8)	NYNRIN (1.5)	C12orf43 (1.5)	GOT2P1 (1.5)
ENSG00000139116	KIF21A PPI subnetwork	0.99	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.1)	FADS1 (2.1)	SORT1 (2.0)	UBXN2B (1.9)	TMEM50A (1.6)	COL4A3BP (1.6)	HLX (1.6)	CELSR2 (1.6)
MP:0001391	abnormal tail movements	0.99	> 0.20	CELSR2 (2.0)	RPH3A (2.0)	MAPKAPK5 (1.9)	NPC1L1 (1.9)	GOT2P1 (1.8)	ENSG00000235545 (1.6)	CILP2 (1.4)	ZHX3 (1.4)	ATXN7L2 (1.3)	SUGP1 (1.3)
GO:0045749	negative regulation of S phase of mitotic cell cycle	0.99	> 0.20	MAU2 (3.8)	ENSG00000226648 (2.9)	C19orf52 (2.5)	UBXN2B (2.1)	CYB561D1 (1.8)	DNAH11 (1.8)	CILP2 (1.8)	SUGP1 (1.7)	NCAN (1.7)	C12orf51 (1.6)
GO:0001967	suckling behavior	0.99	> 0.20	PMFBP1 (2.9)	NKPD1 (2.2)	C17orf57 (2.1)	CEACAM19 (1.7)	PBX4 (1.5)	HAPLN4 (1.4)	LPAR2 (1.3)	AMIGO1 (1.3)	DYNC2LI1 (1.3)	ZHX3 (1.2)
GO:0045773	positive regulation of axon extension	0.99	> 0.20	GEMIN7 (2.0)	GOT2P1 (1.9)	TSSK6 (1.7)	ABO (1.6)	OGDH (1.5)	ENSG00000226645 (1.4)	CETP (1.2)	ACAD10 (1.2)	PBX4 (1.2)	C12orf47 (1.2)
ENSG00000167083	GNGT2 PPI subnetwork	0.99	> 0.20	ITGB3 (2.1)	HAPLN4 (1.9)	TMEM50A (1.7)	ENSG00000235545 (1.5)	KIAA1324 (1.4)	ENSG00000254235 (1.3)	PPP1R37 (1.3)	TM6SF2 (1.2)	RPH3A (1.0)	ABCG8 (1.0)
GO:0002827	positive regulation of T-helper 1 type immune response	0.99	> 0.20	PBX4 (3.3)	ENSG00000235545 (2.8)	C19orf52 (2.5)	NKPD1 (2.2)	TRAPPC6A (1.9)	ALDH2 (1.9)	ATXN7L2 (1.8)	DNAH11 (1.5)	BLOC1S3 (1.3)	TSSK6 (0.8)
ENSG00000149295	DRD2 PPI subnetwork	0.99	> 0.20	NYNRIN (2.7)	CYB561D1 (2.4)	ITGB3 (2.0)	CELSR2 (1.9)	HAPLN4 (1.8)	TSSK6 (1.8)	DNM2 (1.6)	AP1M2 (1.6)	GMIP (1.4)	SARS (1.4)
ENSG00000104921	FCER2 PPI subnetwork	0.99	> 0.20	APOE (2.8)	TIMD4 (2.0)	CETP (1.8)	MAFB (1.6)	PTPN11 (1.5)	PVR (1.5)	ERP29 (1.5)	ENSG00000235545 (1.4)	ZNF180 (1.4)	ENSG00000238078 (1.2)
ENSG00000101224	CDC25B PPI subnetwork	0.99	> 0.20	PSRC1 (2.8)	FEN1 (2.7)	GATAD2A (2.2)	LPIN3 (1.8)	CELSR2 (1.7)	USP1 (1.7)	CBLC (1.6)	ENSG00000226648 (1.6)	PLCG1 (1.5)	ENSG00000226645 (1.4)
ENSG00000140395	WDR61 PPI subnetwork	0.99	> 0.20	C19orf52 (2.0)	GATAD2A (2.0)	BRAP (2.0)	BLOC1S3 (1.8)	NYNRIN (1.7)	KANK2 (1.7)	FEN1 (1.5)	PVR (1.4)	ITGB3 (1.2)	ZNF101 (1.1)
GO:0031623	receptor internalization	0.99	> 0.20	C12orf51 (2.2)	ATXN7L2 (2.1)	ENSG00000254235 (1.6)	CILP2 (1.6)	ADAM1 (1.6)	TMEM57 (1.5)	TOP1 (1.4)	COL4A3BP (1.4)	TXNL4B (1.1)	PTPN11 (1.1)
ENSG00000168397	ATG4B PPI subnetwork	0.99	> 0.20	GRINA (3.1)	SARS (2.3)	C11orf9 (2.0)	RHCE (1.7)	C12orf51 (1.6)	HAVCR1 (1.6)	TXNL4B (1.5)	ALDH2 (1.2)	NCAN (1.2)	GOT2P1 (1.2)
ENSG00000215697	ENSG00000215697 PPI subnetwork	0.99	> 0.20	GRINA (3.1)	SARS (2.3)	C11orf9 (2.0)	RHCE (1.7)	C12orf51 (1.6)	HAVCR1 (1.6)	TXNL4B (1.5)	ALDH2 (1.2)	NCAN (1.2)	GOT2P1 (1.2)
GO:0004629	phospholipase C activity	0.99	> 0.20	ITGB3 (2.0)	HLX (1.8)	ABO (1.8)	SORT1 (1.7)	PMFBP1 (1.7)	C12orf47 (1.6)	RPH3A (1.6)	LPIN3 (1.5)	AMIGO1 (1.3)	SH2B3 (1.2)
ENSG00000183495	EP400 PPI subnetwork	0.99	> 0.20	QTRT1 (2.4)	ILF3 (1.9)	YIPF2 (1.8)	BUD13 (1.7)	PLCG1 (1.5)	DHODH (1.3)	ENSG00000235545 (1.3)	TMEM50A (1.3)	ATXN7L2 (1.3)	TOMM40 (1.3)
GO:0032006	regulation of TOR signaling cascade	0.99	> 0.20	BLOC1S3 (4.0)	COL4A3BP (2.6)	PPP1R37 (2.1)	SARS (2.0)	MAU2 (1.9)	GEMIN7 (1.8)	USP24 (1.8)	ZNF180 (1.5)	TMEM57 (1.3)	BRAP (1.1)
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI:_AND_TRIPHOSPHATES	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI:_AND_TRIPHOSPHATES	0.99	> 0.20	TMEM57 (2.1)	DYNC2LI1 (2.1)	PSMA5 (1.9)	LPIN3 (1.8)	KIAA1324 (1.5)	TMEM50A (1.5)	TRAFD1 (1.5)	ADAM1 (1.4)	USP1 (1.4)	AMIGO1 (1.3)
MP:0000565	oligodactyly	0.99	> 0.20	ZHX3 (3.5)	MAFB (2.3)	NKPD1 (2.0)	TMEM116 (1.6)	CILP2 (1.5)	C12orf51 (1.5)	ENSG00000226648 (1.5)	HLX (1.4)	NCAN (1.4)	MYLIP (1.3)
ENSG00000138443	ABI2 PPI subnetwork	0.99	> 0.20	ZHX3 (2.3)	ITGB3 (1.8)	CYB561D1 (1.8)	DNAH11 (1.7)	C12orf51 (1.6)	ABO (1.6)	PLCG1 (1.4)	CARM1 (1.4)	KIAA1324 (1.4)	PVR (1.4)
MP:0002862	altered righting response	0.99	> 0.20	FRK (2.6)	CELSR2 (2.3)	PMFBP1 (2.0)	NCAN (2.0)	RPH3A (1.9)	GEMIN7 (1.7)	LPIN3 (1.6)	FADS2 (1.6)	SLC22A1 (1.6)	ENSG00000254235 (1.5)
ENSG00000133083	DCLK1 PPI subnetwork	0.99	> 0.20	NCAN (2.6)	TMEM50A (2.1)	ERP29 (2.0)	RPH3A (1.9)	C12orf43 (1.9)	GOT2P1 (1.8)	DNAH11 (1.7)	C11orf9 (1.5)	ZNF180 (1.5)	SORT1 (1.4)
GO:0071824	protein-DNA complex subunit organization	0.99	> 0.20	C19orf52 (2.0)	TMEM57 (1.9)	PSRC1 (1.7)	USP1 (1.6)	ENSG00000226648 (1.6)	TSSK6 (1.5)	C12orf47 (1.4)	ZNF180 (1.4)	BUD13 (1.3)	PMFBP1 (1.2)
GO:0005227	calcium activated cation channel activity	0.99	> 0.20	PMFBP1 (2.8)	KIAA1324 (2.6)	ZNF180 (2.1)	AMIGO1 (2.1)	CYP7A1 (2.0)	GOT2P1 (1.6)	KANK2 (1.6)	CEACAM19 (1.5)	PLEC (1.4)	POLK (1.3)
MP:0008098	decreased plasma cell number	0.99	> 0.20	HLX (2.2)	ZNF101 (2.2)	ATXN7L2 (1.9)	TIMD4 (1.7)	DHODH (1.3)	ENSG00000235545 (1.3)	OGDH (1.3)	KIAA1324 (1.1)	PPP1R37 (1.1)	NPC1L1 (1.0)
MP:0009454	impaired contextual conditioning behavior	0.99	> 0.20	AMIGO1 (3.0)	PPP1R37 (2.7)	CELSR2 (2.6)	NCAN (2.5)	RPH3A (2.5)	GOT2P1 (2.2)	HAPLN4 (2.1)	COL4A3BP (1.9)	DNAH11 (1.9)	GCNT4 (1.7)
GO:0000301	retrograde transport, vesicle recycling within Golgi	0.99	> 0.20	FRK (2.0)	CYB561D1 (2.0)	TMEM116 (1.8)	ENSG00000226648 (1.7)	BRAP (1.6)	ZNF180 (1.5)	MAU2 (1.5)	TMED4 (1.3)	HAVCR1 (1.2)	YIPF2 (1.2)
MP:0002066	abnormal motor capabilities/coordination/movement	0.99	> 0.20	HAPLN4 (4.5)	RPH3A (2.9)	CELSR2 (1.8)	C12orf51 (1.7)	ATP13A1 (1.7)	PTPN11 (1.5)	ZHX3 (1.4)	GRINA (1.4)	GMPR (1.3)	APOE (1.3)
ENSG00000004939	SLC4A1 PPI subnetwork	0.99	> 0.20	RHD (9.4)	RHCE (7.6)	SLC44A2 (2.8)	GMPR (2.0)	ZNF101 (1.8)	HLX (1.7)	SORT1 (1.6)	C12orf51 (1.6)	ENSG00000226648 (1.4)	PCSK9 (1.4)
GO:0051491	positive regulation of filopodium assembly	0.99	> 0.20	BLOC1S3 (2.7)	ZNF101 (2.5)	ZNF180 (2.1)	CETP (1.6)	PBX4 (1.5)	ENSG00000226648 (1.5)	C11orf9 (1.4)	TMEM116 (1.4)	CARM1 (1.3)	ZNF259 (1.3)
MP:0008456	abnormal retinal rod cell outer segment morphology	0.99	> 0.20	ENSG00000235545 (2.7)	C17orf57 (1.8)	LPIN3 (1.5)	ST3GAL4 (1.4)	CEACAM19 (1.4)	SORT1 (1.4)	PMFBP1 (1.3)	PSRC1 (1.3)	DYNC2LI1 (1.1)	TSSK6 (0.7)
GO:0004889	acetylcholine-activated cation-selective channel activity	0.99	> 0.20	SYPL2 (3.0)	ATXN7L2 (2.4)	PMFBP1 (2.1)	CILP2 (1.9)	SORT1 (1.5)	AMIGO1 (1.5)	PLEKHH2 (1.4)	CYB561D1 (1.4)	MOSC1 (1.3)	GEMIN7 (1.3)
GO:0044297	cell body	0.99	> 0.20	RPH3A (3.7)	CELSR2 (2.6)	NCAN (2.3)	AMIGO1 (1.9)	C11orf9 (1.9)	APOE (1.6)	PLCG1 (1.5)	C12orf51 (1.5)	ABO (1.4)	ENSG00000226648 (1.4)
MP:0001092	abnormal trigeminal ganglion morphology	0.99	> 0.20	HAVCR1 (2.8)	CELSR2 (2.7)	BCAM (2.6)	LPA (1.7)	ENSG00000254235 (1.6)	ACAD10 (1.4)	ANKRD31 (1.4)	ATXN7L2 (1.3)	CILP2 (1.2)	PCSK9 (1.2)
REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	0.99	> 0.20	RPH3A (3.5)	HAPLN4 (2.5)	C12orf51 (2.4)	MARK4 (1.7)	ENSG00000238078 (1.6)	CYP7A1 (1.5)	GRINA (1.3)	C12orf47 (1.2)	AMIGO1 (1.1)	PMFBP1 (1.1)
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	0.99	> 0.20	RPH3A (3.5)	HAPLN4 (2.5)	C12orf51 (2.4)	MARK4 (1.7)	ENSG00000238078 (1.6)	CYP7A1 (1.5)	GRINA (1.3)	C12orf47 (1.2)	AMIGO1 (1.1)	PMFBP1 (1.1)
GO:0003014	renal system process	0.99	> 0.20	C12orf47 (2.0)	AMIGO1 (1.9)	ENSG00000228044 (1.4)	PMFBP1 (1.4)	GPAM (1.4)	BCAM (1.4)	ENSG00000235545 (1.4)	HNF1A (1.4)	TMEM116 (1.3)	CEACAM19 (1.3)
GO:0006814	sodium ion transport	0.99	> 0.20	TMEM116 (3.5)	GCNT4 (3.0)	ENSG00000235545 (2.5)	AMIGO1 (2.1)	HAPLN4 (2.0)	RPH3A (2.0)	GOT2P1 (1.8)	SYPL2 (1.8)	TM6SF2 (1.7)	HAVCR1 (1.5)
GO:0007608	sensory perception of smell	0.99	> 0.20	DNAH11 (3.0)	ENSG00000228044 (2.3)	ZNF180 (2.0)	ENSG00000235545 (1.8)	GEMIN7 (1.6)	C12orf47 (1.5)	CYB561D1 (1.5)	ABO (1.4)	PMFBP1 (1.4)	GOT2P1 (1.3)
GO:0006818	hydrogen transport	0.99	> 0.20	TMEM116 (2.9)	COL4A3BP (2.5)	ENSG00000238078 (2.4)	ACAD10 (2.4)	OGDH (2.3)	ADAM1 (2.1)	SORT1 (2.1)	GOT2P1 (1.8)	ERP29 (1.7)	TMED4 (1.6)
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	0.99	> 0.20	TMEM50A (2.2)	C1orf63 (2.1)	C12orf43 (1.9)	MYLIP (1.8)	HAPLN4 (1.8)	RPH3A (1.8)	SARS (1.6)	TMED4 (1.5)	COL4A3BP (1.3)	SUGP1 (1.2)
GO:0035019	somatic stem cell maintenance	0.99	> 0.20	NYNRIN (2.5)	CELSR2 (2.3)	DYNC2LI1 (2.1)	NCAN (1.9)	ENSG00000235545 (1.8)	AMIGO1 (1.6)	ADAM1 (1.6)	CBLC (1.6)	LPAR2 (1.5)	ENSG00000226648 (1.4)
KEGG_HEDGEHOG_SIGNALING_PATHWAY	KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.99	> 0.20	PLEKHH2 (2.4)	BCAM (2.1)	ENSG00000226645 (1.7)	C11orf9 (1.7)	NYNRIN (1.6)	PBX4 (1.6)	TSSK6 (1.5)	PVRL2 (1.4)	POLK (1.4)	SLC44A2 (1.3)
GO:0043025	neuronal cell body	0.99	> 0.20	RPH3A (3.7)	CELSR2 (2.4)	NCAN (2.2)	AMIGO1 (2.0)	C11orf9 (1.7)	C12orf51 (1.4)	APOE (1.4)	PLCG1 (1.4)	HAPLN4 (1.4)	ENSG00000226648 (1.4)
REACTOME_TRANSLOCATION_OF_ZAP:70_TO_IMMUNOLOGICAL_SYNAPSE	REACTOME_TRANSLOCATION_OF_ZAP:70_TO_IMMUNOLOGICAL_SYNAPSE	0.99	> 0.20	PLCG1 (2.9)	ALDH2 (2.9)	ZNF101 (2.4)	APOC1 (2.2)	APOE (2.0)	DOCK7 (1.6)	C19orf52 (1.5)	PBX4 (1.3)	HAVCR1 (1.3)	MAFB (1.1)
ENSG00000107282	APBA1 PPI subnetwork	0.99	> 0.20	RPH3A (3.2)	PLCG1 (2.0)	NCAN (1.9)	CELSR2 (1.8)	NKPD1 (1.7)	C12orf47 (1.7)	TSSK6 (1.5)	HLX (1.4)	AMIGO1 (1.3)	ALDH2 (1.3)
GO:0010976	positive regulation of neuron projection development	0.99	> 0.20	LPIN3 (3.1)	PMFBP1 (1.8)	AMIGO1 (1.6)	CYP7A1 (1.6)	RPH3A (1.5)	NKPD1 (1.4)	ATXN7L2 (1.3)	CEACAM19 (1.2)	TMEM57 (1.2)	UBXN2B (1.0)
ENSG00000132334	PTPRE PPI subnetwork	0.99	> 0.20	NCAN (2.6)	SORT1 (2.1)	C12orf51 (2.1)	TMEM50A (1.9)	RPH3A (1.8)	C11orf9 (1.8)	MARK4 (1.8)	CELSR2 (1.6)	NYNRIN (1.6)	GRINA (1.5)
GO:0043195	terminal button	0.99	> 0.20	C12orf47 (2.6)	ABO (2.6)	HAPLN4 (2.3)	KIAA1324 (2.2)	RPH3A (1.8)	NCAN (1.4)	ERP29 (1.3)	C12orf51 (1.3)	SH2B3 (1.2)	ADAM1 (1.2)
GO:0016917	GABA receptor activity	0.99	> 0.20	RPH3A (2.5)	MYLIP (1.9)	HAPLN4 (1.8)	LPIN3 (1.7)	NCAN (1.7)	C12orf43 (1.2)	C11orf9 (1.1)	GCNT4 (1.0)	FRK (1.0)	ANKRD31 (1.0)
MP:0003161	absent lateral semicircular canal	0.99	> 0.20	HLX (2.0)	PPP1R37 (1.8)	PLCG1 (1.3)	BLOC1S3 (1.2)	NKPD1 (1.2)	TMEM116 (1.2)	ALDH2 (1.2)	TMED4 (1.2)	ZNF101 (1.2)	NCAN (1.0)
GO:0019208	phosphatase regulator activity	0.99	> 0.20	DNM2 (2.6)	CARM1 (2.0)	OASL (2.0)	PTPN11 (2.0)	TMEM50A (1.7)	TOMM40 (1.7)	TOP1 (1.6)	ENSG00000226645 (1.5)	BUD13 (1.5)	MYLIP (1.5)
GO:0001750	photoreceptor outer segment	0.99	> 0.20	GOT2P1 (1.5)	MAPKAPK5 (1.2)	TMEM57 (1.1)	FRK (1.1)	ADAM1 (1.1)	HAVCR1 (1.1)	CYB561D1 (0.9)	PMFBP1 (0.9)	HNF1A (0.9)	CEACAM19 (0.8)
GO:0042384	cilium assembly	0.99	> 0.20	DYNC2LI1 (6.2)	DOCK7 (1.7)	POLK (1.2)	UBXN2B (1.2)	TXNL4B (1.2)	TMED4 (1.1)	PBX4 (1.1)	ENSG00000238078 (1.0)	DNAH11 (1.0)	PLEKHH2 (1.0)
ENSG00000169862	CTNND2 PPI subnetwork	0.99	> 0.20	LPIN3 (3.3)	ABO (2.4)	PTPN11 (2.0)	TMEM116 (1.9)	ENSG00000238078 (1.8)	NCAN (1.7)	ZHX3 (1.7)	SLC44A2 (1.7)	DDX56 (1.5)	MAFB (1.3)
GO:0051349	positive regulation of lyase activity	0.99	> 0.20	AMIGO1 (2.5)	ABO (2.4)	PMFBP1 (2.3)	BLOC1S3 (1.9)	GOT2P1 (1.9)	ENSG00000226648 (1.6)	KIAA1324 (1.5)	ENSG00000228044 (1.4)	ENSG00000226645 (1.2)	LPIN3 (1.2)
GO:0008328	ionotropic glutamate receptor complex	0.99	> 0.20	NCAN (5.4)	RPH3A (2.7)	CELSR2 (1.8)	PPP1R37 (1.6)	HNF1A (1.6)	ZHX3 (1.5)	ABO (1.5)	USP24 (1.5)	ENSG00000226645 (1.4)	C11orf9 (1.3)
GO:0016337	cell-cell adhesion	0.99	> 0.20	AP1M2 (2.9)	FRK (2.7)	CBLC (2.2)	SLC44A2 (1.9)	CELSR2 (1.7)	BCAM (1.7)	ANKRD31 (1.7)	ENSG00000254235 (1.6)	CILP2 (1.6)	PVRL2 (1.5)
GO:0051882	mitochondrial depolarization	0.99	> 0.20	ITGB3 (2.6)	HAPLN4 (2.6)	ENSG00000226648 (2.4)	ENSG00000226645 (2.2)	RHCE (1.9)	TMEM116 (1.7)	POLK (1.6)	RPH3A (1.5)	GMPR (1.4)	C12orf47 (1.4)
MP:0001958	emphysema	0.99	> 0.20	PLEKHH2 (2.9)	C11orf9 (2.2)	TMEM116 (2.2)	DYNC2LI1 (1.9)	KIAA1324 (1.9)	BCAM (1.8)	SLC44A2 (1.7)	HAVCR1 (1.6)	ITGB3 (1.5)	AP1M2 (1.3)
MP:0008151	increased diameter of long bones	0.99	> 0.20	CILP2 (5.3)	ERP29 (2.1)	PLEKHH2 (1.8)	TMEM57 (1.8)	KIAA1324 (1.7)	ABO (1.6)	FRK (1.4)	HAVCR1 (1.4)	ENSG00000226645 (1.3)	PPP1R37 (1.3)
MP:0008450	retinal photoreceptor degeneration	0.99	> 0.20	PMFBP1 (1.8)	GPAM (1.6)	DYNC2LI1 (1.5)	MAPKAPK5 (1.5)	GOT2P1 (1.4)	SORT1 (1.4)	ENSG00000235545 (1.3)	C12orf47 (1.2)	NAA25 (1.1)	GEMIN7 (1.1)
GO:0060560	developmental growth involved in morphogenesis	0.99	> 0.20	CILP2 (2.9)	ABO (2.0)	C12orf47 (2.0)	LPAR2 (1.9)	CELSR2 (1.8)	PPP1R37 (1.8)	PMFBP1 (1.5)	ENSG00000254235 (1.5)	TSSK6 (1.5)	DYNC2LI1 (1.5)
ENSG00000141582	CBX4 PPI subnetwork	0.99	> 0.20	TRAFD1 (2.5)	TMEM57 (2.3)	ATXN7L2 (2.3)	ATXN2 (2.2)	CELSR2 (2.2)	USP24 (1.9)	C19orf52 (1.6)	TOP1 (1.5)	BUD13 (1.5)	CYB561D1 (1.3)
GO:0010921	regulation of phosphatase activity	0.99	> 0.20	TRAFD1 (2.3)	BRAP (2.2)	ENSG00000235545 (2.1)	PMFBP1 (2.1)	PTPN11 (2.1)	YIPF2 (1.9)	HAVCR1 (1.9)	ACAD10 (1.8)	POLK (1.7)	HNF1A (1.6)
MP:0004769	abnormal synaptic vesicle morphology	0.99	> 0.20	HAPLN4 (4.5)	RPH3A (3.9)	APOC1 (2.9)	C12orf47 (2.4)	PBX4 (2.3)	ENSG00000226645 (1.8)	ENSG00000254235 (1.7)	PPP1R37 (1.5)	AMIGO1 (1.5)	CETP (1.4)
GO:0007603	phototransduction, visible light	0.99	> 0.20	LPIN3 (1.9)	C12orf47 (1.7)	TSSK6 (1.7)	PMFBP1 (1.7)	TMEM116 (1.5)	C17orf57 (1.5)	ENSG00000228044 (1.4)	ATXN7L2 (1.3)	ABCG8 (1.1)	ENSG00000235545 (0.9)
MP:0010103	small thoracic cage	0.99	> 0.20	CILP2 (3.8)	PLEKHH2 (2.1)	NCAN (1.8)	NYNRIN (1.8)	SLC44A2 (1.5)	MAPKAPK5 (1.4)	CELSR2 (1.3)	DOCK7 (1.3)	GPAM (1.3)	ENSG00000235545 (1.2)
ENSG00000121083	DYNLL2 PPI subnetwork	0.99	> 0.20	FADS2 (3.5)	FADS1 (2.7)	C1orf63 (1.7)	TRAPPC6A (1.6)	PBX4 (1.6)	COL4A3BP (1.6)	NKPD1 (1.5)	ILF3 (1.4)	PPP1R37 (1.4)	GPAM (1.3)
ENSG00000163527	STT3B PPI subnetwork	0.99	> 0.20	ERP29 (3.1)	YIPF2 (2.7)	ATP13A1 (2.7)	TMEM50A (2.4)	PSMA5 (2.3)	TMED4 (2.1)	TMEM57 (2.0)	QTRT1 (1.8)	DHODH (1.6)	C11orf9 (1.4)
ENSG00000000938	FGR PPI subnetwork	0.99	> 0.20	GMIP (3.1)	FADS2 (2.6)	HLX (1.8)	ITGB3 (1.7)	CETP (1.7)	TIMD4 (1.6)	DNM2 (1.6)	DNAH11 (1.6)	SH2B3 (1.4)	DOCK7 (1.3)
ENSG00000163681	SLMAP PPI subnetwork	0.99	> 0.20	C11orf9 (2.9)	C1orf63 (2.1)	TMEM50A (1.8)	CARM1 (1.6)	PSMA5 (1.5)	GEMIN7 (1.5)	MARK4 (1.5)	LDLR (1.4)	FRK (1.4)	LPIN3 (1.4)
GO:0004222	metalloendopeptidase activity	0.99	> 0.20	ACAD10 (2.3)	FRK (2.0)	OGDH (2.0)	TM6SF2 (1.9)	PVRL2 (1.6)	PLEKHH2 (1.5)	DOCK7 (1.5)	CARM1 (1.5)	NPC1L1 (1.5)	LPIN3 (1.5)
REACTOME_TRAFFICKING_OF_GLUR2:CONTAINING_AMPA_RECEPTORS	REACTOME_TRAFFICKING_OF_GLUR2:CONTAINING_AMPA_RECEPTORS	0.99	> 0.20	CLPTM1 (3.9)	ZHX3 (2.8)	NCAN (2.6)	PPP1R37 (2.4)	HAPLN4 (1.9)	SARS (1.7)	PVRL2 (1.7)	CBLC (1.6)	GRINA (1.6)	MARK4 (1.5)
ENSG00000111269	CREBL2 PPI subnetwork	0.99	> 0.20	TRAFD1 (2.1)	QTRT1 (1.9)	PBX4 (1.8)	DYNC2LI1 (1.8)	BRAP (1.6)	TMEM57 (1.3)	CYB561D1 (1.2)	GMPR (1.2)	TRAPPC6A (1.1)	DNAH11 (1.0)
GO:0007190	activation of adenylate cyclase activity	0.99	> 0.20	AMIGO1 (2.5)	PMFBP1 (2.4)	ABO (2.2)	BLOC1S3 (2.1)	GOT2P1 (1.9)	ENSG00000228044 (1.6)	KIAA1324 (1.5)	LPIN3 (1.5)	ENSG00000226645 (1.5)	ENSG00000226648 (1.5)
GO:0030641	regulation of cellular pH	0.99	> 0.20	AMIGO1 (3.4)	UBXN2B (2.9)	ERP29 (2.8)	ENSG00000235545 (2.3)	COL4A3BP (2.3)	LPIN3 (1.7)	TMEM116 (1.6)	PBX4 (1.5)	NKPD1 (1.5)	LPAR2 (1.5)
MP:0002961	abnormal axon guidance	0.99	> 0.20	CELSR2 (3.9)	NCAN (3.4)	PBX4 (2.6)	GCNT4 (2.0)	C12orf47 (1.9)	ATXN7L2 (1.7)	TSSK6 (1.6)	PLEC (1.4)	ABO (1.3)	LPAR2 (1.2)
GO:0021544	subpallium development	0.99	> 0.20	UBXN2B (2.4)	DYNC2LI1 (2.2)	ENSG00000226648 (2.1)	TMEM116 (1.8)	C12orf43 (1.7)	TMED4 (1.7)	TXNL4B (1.4)	ABO (1.3)	C17orf57 (1.2)	AP1M2 (1.2)
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	0.99	> 0.20	NCAN (3.7)	SYPL2 (2.6)	CYB561D1 (2.4)	HAPLN4 (2.0)	CELSR2 (1.9)	C12orf43 (1.9)	AMIGO1 (1.8)	MAPKAPK5 (1.7)	SORT1 (1.7)	TSSK6 (1.7)
MP:0002578	impaired ability to fire action potentials	0.99	> 0.20	HAPLN4 (5.1)	RPH3A (3.8)	PMFBP1 (2.5)	PLEKHH2 (1.6)	ADAM1 (1.6)	AMIGO1 (1.4)	BLOC1S3 (1.3)	DNAH11 (1.2)	PCSK9 (1.2)	C12orf51 (1.1)
GO:0008376	acetylgalactosaminyltransferase activity	0.99	> 0.20	CILP2 (2.8)	TMED4 (2.6)	KIAA1324 (2.2)	GCNT4 (2.1)	SLC44A2 (2.1)	ENSG00000235545 (2.0)	ST3GAL4 (1.8)	YIPF2 (1.7)	TMEM57 (1.6)	FRK (1.5)
ENSG00000099991	CABIN1 PPI subnetwork	0.99	> 0.20	FRK (2.4)	NT5DC1 (2.0)	MYLIP (1.8)	CARM1 (1.6)	C12orf51 (1.6)	HNF1A (1.6)	MARK4 (1.5)	TSSK6 (1.5)	SMARCA4 (1.5)	RPH3A (1.4)
GO:0032008	positive regulation of TOR signaling cascade	0.99	> 0.20	COL4A3BP (2.8)	ANKRD31 (2.4)	BLOC1S3 (2.2)	GEMIN7 (2.2)	PPP1R37 (1.6)	C19orf52 (1.3)	ZNF180 (1.2)	LPIN3 (1.2)	C12orf47 (1.1)	MAPKAPK5 (1.1)
GO:0006693	prostaglandin metabolic process	0.99	> 0.20	NKPD1 (3.0)	HNF1A (2.0)	C11orf9 (1.9)	TMEM57 (1.8)	ALDH2 (1.7)	GMPR (1.6)	UBXN2B (1.4)	TMED4 (1.1)	CBLC (1.0)	TMEM50A (1.0)
ENSG00000108387	SEPT4 PPI subnetwork	0.99	> 0.20	RPH3A (2.6)	NCAN (2.6)	C12orf51 (2.5)	SORT1 (2.1)	GOT2P1 (2.0)	C12orf43 (1.7)	C11orf9 (1.5)	AMIGO1 (1.4)	CELSR2 (1.4)	UBXN2B (1.4)
ENSG00000131504	DIAPH1 PPI subnetwork	0.99	> 0.20	GATAD2A (2.8)	TMEM50A (2.7)	PLEC (2.6)	DYNC2LI1 (2.2)	SMARCA4 (1.8)	DOCK7 (1.8)	C1orf63 (1.8)	NCAN (1.7)	PSMA5 (1.7)	GMIP (1.6)
GO:0009083	branched chain family amino acid catabolic process	0.99	> 0.20	ACAD10 (3.8)	DYNC2LI1 (2.9)	TRAPPC6A (2.5)	UBXN2B (2.4)	DHODH (2.1)	NT5DC1 (2.1)	QTRT1 (2.1)	ALDH2 (1.8)	OGDH (1.7)	ENSG00000226645 (1.6)
MP:0005322	abnormal serotonin level	0.99	> 0.20	ZHX3 (1.8)	PLEKHH2 (1.8)	ADAM1 (1.6)	ABCG5 (1.6)	PTPN11 (1.6)	CELSR2 (1.4)	HAPLN4 (1.2)	PMFBP1 (1.2)	ABO (1.2)	SH2B3 (1.1)
GO:0090263	positive regulation of canonical Wnt receptor signaling pathway	0.99	> 0.20	PLEKHH2 (3.5)	DYNC2LI1 (2.6)	C11orf9 (2.5)	CBLC (2.4)	CILP2 (2.1)	ENSG00000228044 (2.1)	C1orf63 (1.4)	KANK2 (1.4)	PPP1R37 (1.4)	NYNRIN (1.3)
GO:0061351	neural precursor cell proliferation	0.99	> 0.20	NCAN (4.1)	CELSR2 (2.6)	ENSG00000235545 (2.5)	PBX4 (2.4)	PSRC1 (2.3)	TSSK6 (1.9)	ENSG00000226648 (1.8)	POLK (1.8)	DOCK7 (1.5)	HAPLN4 (1.4)
GO:0004950	chemokine receptor activity	0.99	> 0.20	ZNF101 (2.8)	TIMD4 (2.3)	PLCG1 (1.9)	MAFB (1.6)	LPAR2 (1.6)	GMIP (1.6)	TRIB1 (1.4)	NCAN (1.3)	TMEM116 (1.3)	PBX4 (1.2)
GO:0001637	G-protein coupled chemoattractant receptor activity	0.99	> 0.20	ZNF101 (2.8)	TIMD4 (2.3)	PLCG1 (1.9)	MAFB (1.6)	LPAR2 (1.6)	GMIP (1.6)	TRIB1 (1.4)	NCAN (1.3)	TMEM116 (1.3)	PBX4 (1.2)
GO:0006903	vesicle targeting	0.99	> 0.20	YIPF2 (5.2)	TMED4 (2.0)	C19orf52 (1.9)	DNM2 (1.9)	OGDH (1.8)	SUGP1 (1.6)	LPIN3 (1.5)	BLOC1S3 (1.3)	ENSG00000235545 (1.2)	TMEM57 (1.1)
MP:0001523	impaired righting response	0.99	> 0.20	HAPLN4 (5.1)	RPH3A (4.0)	APOE (2.3)	AMIGO1 (2.0)	ZHX3 (1.4)	OGDH (1.4)	PVR (1.1)	CEACAM19 (1.1)	NCAN (1.1)	MYLIP (1.1)
MP:0002286	cryptorchism	0.99	> 0.20	LPAR2 (3.2)	KIAA1324 (2.4)	PLEKHH2 (2.3)	PBX4 (2.0)	NYNRIN (1.7)	CYP7A1 (1.4)	PSRC1 (1.4)	PVRL2 (1.3)	GCNT4 (1.2)	MOSC1 (1.2)
ENSG00000100365	NCF4 PPI subnetwork	0.99	> 0.20	ALDH2 (2.7)	TRIB1 (2.1)	SH2B3 (2.0)	HLX (2.0)	DOCK7 (1.9)	GMIP (1.8)	SMARCA4 (1.6)	PSMA5 (1.5)	PLEC (1.4)	TMEM50A (1.2)
GO:0051482	elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway	0.99	> 0.20	SLC44A2 (1.8)	ENSG00000228044 (1.7)	C12orf47 (1.6)	ENSG00000235545 (1.5)	BCAM (1.5)	ANKRD31 (1.3)	KIAA1324 (1.3)	POLK (1.2)	BRAP (1.1)	C19orf52 (1.1)
GO:0002090	regulation of receptor internalization	0.99	> 0.20	ENSG00000254235 (3.3)	ENSG00000238078 (2.3)	TXNL4B (1.9)	ATXN7L2 (1.9)	HNF1A (1.9)	ANKRD31 (1.7)	C12orf47 (1.7)	CILP2 (1.5)	LPIN3 (1.4)	YIPF2 (1.2)
ENSG00000003096	KLHL13 PPI subnetwork	0.99	> 0.20	USP24 (3.5)	COL4A3BP (2.3)	ZHX3 (2.2)	DOCK7 (2.2)	ATXN2 (2.0)	GRINA (2.0)	C12orf51 (1.7)	PMFBP1 (1.5)	CARM1 (1.2)	DHX38 (1.2)
GO:0065004	protein-DNA complex assembly	0.99	> 0.20	C19orf52 (2.2)	PSRC1 (1.8)	ENSG00000226648 (1.8)	ZNF180 (1.7)	USP1 (1.6)	TMEM57 (1.5)	TMED4 (1.2)	POC5 (1.2)	TXNL4B (1.1)	C12orf47 (1.1)
GO:0003203	endocardial cushion morphogenesis	0.99	> 0.20	ENSG00000226645 (2.6)	CYB561D1 (2.2)	ABO (1.8)	LPIN3 (1.7)	MYLIP (1.3)	C19orf52 (1.2)	ENSG00000238078 (1.1)	ENSG00000254235 (1.1)	DOCK7 (1.1)	ENSG00000226648 (0.9)
GO:0060113	inner ear receptor cell differentiation	0.99	> 0.20	DNAH11 (2.2)	ENSG00000226648 (1.5)	CEACAM19 (1.5)	BCAM (1.4)	HNF1A (1.3)	ALDH2 (1.2)	PMFBP1 (1.2)	APOE (1.1)	NCAN (1.1)	BLOC1S3 (1.0)
MP:0002686	globozoospermia	0.99	> 0.20	NT5DC1 (2.7)	NKPD1 (2.5)	ZNF180 (2.4)	MAPKAPK5 (2.3)	ADAM1 (1.9)	CEACAM19 (1.9)	COL4A3BP (1.6)	BRAP (1.5)	ATXN2 (1.4)	C19orf52 (1.4)
GO:0043394	proteoglycan binding	0.99	> 0.20	CILP2 (4.8)	PLG (3.0)	ANGPTL3 (2.8)	HP (2.4)	MOSC1 (2.2)	BCAM (2.0)	APOE (1.9)	APOC4 (1.9)	APOC1 (1.9)	TMED4 (1.7)
GO:0000155	two-component sensor activity	0.99	> 0.20	TRAPPC6A (2.6)	PLEKHH2 (2.3)	GPAM (2.1)	GMPR (1.7)	NKPD1 (1.6)	SORT1 (1.6)	RPH3A (1.6)	TXNL4B (1.5)	ACAD10 (1.5)	DHODH (1.3)
GO:0004673	protein histidine kinase activity	0.99	> 0.20	TRAPPC6A (2.6)	PLEKHH2 (2.3)	GPAM (2.1)	GMPR (1.7)	NKPD1 (1.6)	SORT1 (1.6)	RPH3A (1.6)	TXNL4B (1.5)	ACAD10 (1.5)	DHODH (1.3)
MP:0003089	decreased skin tensile strength	0.99	> 0.20	AP1M2 (2.6)	CILP2 (1.7)	GEMIN7 (1.5)	C17orf57 (1.4)	CELSR2 (1.3)	TMEM57 (1.2)	CBLC (1.2)	BCAM (1.2)	APOE (1.2)	MYLIP (1.1)
ENSG00000132872	SYT4 PPI subnetwork	0.99	> 0.20	PMFBP1 (2.3)	C12orf43 (1.7)	GEMIN7 (1.7)	TSSK6 (1.7)	MAPKAPK5 (1.7)	ENSG00000226645 (1.5)	RPH3A (1.3)	TOMM40 (1.3)	SLC22A1 (1.3)	ENSG00000226648 (1.2)
GO:0050858	negative regulation of antigen receptor-mediated signaling pathway	0.99	> 0.20	CYB561D1 (2.5)	ENSG00000238078 (2.2)	ENSG00000228044 (2.0)	AP1M2 (1.5)	PBX4 (1.5)	POC5 (1.4)	POLK (1.4)	PTPN11 (1.4)	PMFBP1 (1.2)	ITGB3 (1.2)
GO:0050860	negative regulation of T cell receptor signaling pathway	0.99	> 0.20	CYB561D1 (2.5)	ENSG00000238078 (2.2)	ENSG00000228044 (2.0)	AP1M2 (1.5)	PBX4 (1.5)	POC5 (1.4)	POLK (1.4)	PTPN11 (1.4)	PMFBP1 (1.2)	ITGB3 (1.2)
MP:0001765	abnormal ion homeostasis	0.99	> 0.20	RHCE (4.3)	RHD (3.1)	FRK (2.4)	CBLC (1.8)	PLEC (1.7)	GMPR (1.7)	AP1M2 (1.5)	SLC22A1 (1.4)	CYB561D1 (1.4)	AMIGO1 (1.4)
GO:0043583	ear development	0.99	> 0.20	NKPD1 (1.8)	CILP2 (1.7)	DYNC2LI1 (1.7)	C17orf57 (1.7)	NYNRIN (1.6)	PLCG1 (1.4)	AMIGO1 (1.4)	PLEKHH2 (1.3)	MYLIP (1.2)	DNAH11 (1.1)
GO:0080025	phosphatidylinositol-3,5-bisphosphate binding	0.99	> 0.20	GEMIN7 (2.7)	GCNT4 (2.2)	DYNC2LI1 (2.1)	ENSG00000228044 (1.6)	TMEM57 (1.4)	SARS (1.3)	SORT1 (1.3)	BRAP (1.2)	DOCK7 (1.2)	SUGP1 (1.1)
ENSG00000114251	WNT5A PPI subnetwork	0.99	> 0.20	CILP2 (4.4)	DYNC2LI1 (2.3)	TMEM116 (2.1)	PLEKHH2 (1.9)	CELSR2 (1.8)	KIAA1324 (1.8)	LPAR2 (1.7)	BCAM (1.5)	AMIGO1 (1.5)	ATP13A1 (1.4)
ENSG00000102468	HTR2A PPI subnetwork	0.99	> 0.20	GEMIN7 (2.2)	PPP1R37 (2.1)	ALDH2 (1.9)	DYNC2LI1 (1.7)	USP24 (1.7)	RPH3A (1.6)	TOMM40 (1.6)	TMEM57 (1.5)	APOE (1.5)	ZHX3 (1.4)
ENSG00000091704	CPA1 PPI subnetwork	0.99	> 0.20	NCAN (2.5)	MOSC1 (1.9)	NYNRIN (1.6)	PLCG1 (1.6)	MAFB (1.5)	ILF3 (1.5)	USP1 (1.5)	C19orf52 (1.3)	ADAM1 (1.3)	PPP1R37 (1.2)
GO:0015804	neutral amino acid transport	0.99	> 0.20	SARS (2.6)	NPC1L1 (2.5)	PMFBP1 (2.3)	HNF1A (2.1)	HAPLN4 (1.8)	RHCE (1.7)	TM6SF2 (1.7)	BLOC1S3 (1.6)	ATP13A1 (1.6)	ERP29 (1.5)
GO:0061053	somite development	0.99	> 0.20	ABO (2.6)	LPAR2 (1.9)	ATXN7L2 (1.6)	AMIGO1 (1.6)	CILP2 (1.5)	ENSG00000254235 (1.5)	PLCG1 (1.5)	HNF1A (1.5)	ADAM1 (1.2)	ENSG00000228044 (1.1)
ENSG00000108379	WNT3 PPI subnetwork	0.99	> 0.20	CILP2 (4.7)	CELSR2 (2.6)	DYNC2LI1 (2.2)	KIAA1324 (2.1)	TMEM116 (2.1)	AMIGO1 (1.9)	BCAM (1.7)	TRAPPC6A (1.7)	TXNL4B (1.6)	LPAR2 (1.5)
MP:0002145	abnormal T cell differentiation	0.99	> 0.20	PLCG1 (5.1)	ZNF101 (4.7)	GMIP (3.7)	RELB (2.1)	PBX4 (2.0)	DNM2 (1.6)	MAFB (1.5)	SLC44A2 (1.5)	HAVCR1 (1.4)	PARP10 (1.3)
GO:0060325	face morphogenesis	0.99	> 0.20	MYLIP (2.5)	ENSG00000235545 (2.3)	GCNT4 (1.8)	TMEM57 (1.7)	ENSG00000238078 (1.5)	FRK (1.3)	NKPD1 (1.3)	C17orf57 (1.2)	MAU2 (1.2)	CILP2 (1.1)
GO:0030252	growth hormone secretion	0.99	> 0.20	ENSG00000226648 (3.8)	TMED4 (2.8)	KIAA1324 (2.7)	C11orf9 (1.8)	HNF1A (1.8)	C12orf47 (1.8)	BLOC1S3 (1.5)	ABO (1.4)	C12orf51 (1.4)	YIPF2 (1.3)
ENSG00000136854	STXBP1 PPI subnetwork	0.99	> 0.20	RPH3A (3.2)	NCAN (3.2)	HAPLN4 (3.0)	C11orf9 (2.8)	CELSR2 (2.1)	C12orf43 (1.8)	C12orf51 (1.8)	SARS (1.4)	APOE (1.3)	GCNT4 (1.3)
GO:0006470	protein dephosphorylation	0.99	> 0.20	AMIGO1 (1.7)	TRIB1 (1.5)	MAPKAPK5 (1.4)	SYPL2 (1.4)	SH2B3 (1.4)	ENSG00000226645 (1.3)	SORT1 (1.2)	ZHX3 (1.2)	C17orf57 (1.1)	MARK4 (1.0)
MP:0000940	abnormal motor neuron innervation	0.99	> 0.20	FRK (2.7)	CELSR2 (2.0)	ABCG5 (1.8)	PVR (1.8)	SORT1 (1.8)	GEMIN7 (1.7)	PLEKHH2 (1.7)	ENSG00000228044 (1.6)	KIAA1324 (1.6)	ANKRD31 (1.4)
GO:0008543	fibroblast growth factor receptor signaling pathway	0.99	> 0.20	ZHX3 (2.6)	ENSG00000226645 (2.1)	ZNF101 (1.8)	HAPLN4 (1.7)	COL4A3BP (1.7)	ZNF180 (1.7)	PPP1R37 (1.5)	MARK4 (1.4)	AMIGO1 (1.2)	NKPD1 (1.2)
GO:0031105	septin complex	0.99	> 0.20	PLCG1 (2.0)	CETP (2.0)	NCAN (1.8)	GATAD2A (1.6)	ABO (1.5)	TMED4 (1.4)	ZNF101 (1.3)	PBX4 (1.3)	CARM1 (1.3)	TRAPPC6A (1.3)
GO:0032156	septin cytoskeleton	0.99	> 0.20	PLCG1 (2.0)	CETP (2.0)	NCAN (1.8)	GATAD2A (1.6)	ABO (1.5)	TMED4 (1.4)	ZNF101 (1.3)	PBX4 (1.3)	CARM1 (1.3)	TRAPPC6A (1.3)
GO:0031344	regulation of cell projection organization	0.99	> 0.20	PBX4 (2.6)	RPH3A (2.3)	C11orf9 (2.2)	CELSR2 (2.1)	NCAN (2.0)	PLEC (1.7)	LPIN3 (1.6)	DOCK7 (1.5)	ABO (1.3)	ATXN7L2 (1.2)
MP:0001441	increased grooming behavior	0.99	> 0.20	RPH3A (1.9)	NT5DC1 (1.8)	C12orf51 (1.8)	UBXN2B (1.6)	CELSR2 (1.6)	ST3GAL4 (1.5)	HAVCR1 (1.4)	COL4A3BP (1.4)	ANKRD31 (1.3)	APOC1 (1.3)
GO:0045058	T cell selection	0.99	> 0.20	ZNF101 (3.8)	PLCG1 (3.4)	TMEM116 (2.5)	PBX4 (1.8)	C19orf52 (1.8)	CYB561D1 (1.4)	POLK (1.4)	NKPD1 (1.1)	ALDH2 (1.1)	CARM1 (0.9)
GO:0006895	Golgi to endosome transport	0.99	> 0.20	GEMIN7 (2.4)	TMEM116 (2.2)	ZHX3 (1.9)	PMFBP1 (1.9)	TMEM57 (1.8)	ENSG00000254235 (1.7)	CYB561D1 (1.6)	NT5DC1 (1.6)	CEACAM19 (1.5)	YIPF2 (1.5)
ENSG00000176788	BASP1 PPI subnetwork	0.99	> 0.20	RPH3A (2.7)	NCAN (2.4)	SORT1 (2.2)	C12orf51 (2.1)	FADS1 (2.0)	UBXN2B (1.8)	TMEM50A (1.7)	CELSR2 (1.6)	ALDH2 (1.6)	MARK4 (1.5)
GO:0006885	regulation of pH	0.99	> 0.20	TMEM116 (3.9)	AMIGO1 (2.7)	CEACAM19 (2.6)	SLC44A2 (2.2)	ERP29 (2.1)	COL4A3BP (2.1)	PBX4 (2.1)	LPIN3 (2.0)	ENSG00000235545 (1.9)	NKPD1 (1.9)
GO:0072170	metanephric tubule development	0.99	> 0.20	HAVCR1 (3.4)	NCAN (2.0)	DYNC2LI1 (1.8)	CELSR2 (1.6)	CYB561D1 (1.6)	HNF1A (1.5)	ZHX3 (1.2)	TMEM116 (1.2)	BCAM (1.1)	PBX4 (1.0)
ENSG00000171867	PRNP PPI subnetwork	0.99	> 0.20	ERP29 (3.6)	RPH3A (3.3)	NCAN (3.2)	CELSR2 (2.9)	C11orf9 (2.3)	HAPLN4 (2.1)	CLPTM1 (2.0)	GRINA (1.9)	TMED4 (1.8)	BCAM (1.7)
MP:0001475	reduced long term depression	0.99	> 0.20	NCAN (4.5)	RPH3A (4.0)	CELSR2 (2.5)	AMIGO1 (2.2)	ABO (2.0)	ZHX3 (1.9)	PPP1R37 (1.9)	TSSK6 (1.9)	ADAM1 (1.8)	PLCG1 (1.7)
GO:0007600	sensory perception	0.99	> 0.20	GOT2P1 (2.7)	PMFBP1 (2.3)	ENSG00000235545 (1.5)	ST3GAL4 (1.3)	DYNC2LI1 (1.2)	ABO (1.1)	ENSG00000228044 (1.1)	ANKRD31 (1.1)	NKPD1 (1.1)	TMEM116 (1.0)
MP:0003637	cochlear ganglion hypoplasia	0.99	> 0.20	ABO (3.3)	CEACAM19 (2.4)	CILP2 (2.0)	HAVCR1 (1.9)	TRAPPC6A (1.9)	GMPR (1.7)	YIPF2 (1.4)	TSSK6 (1.4)	NKPD1 (1.4)	BLOC1S3 (1.4)
ENSG00000164056	SPRY1 PPI subnetwork	0.99	> 0.20	MAU2 (3.1)	ENSG00000235545 (3.0)	DNM2 (2.4)	ENSG00000226645 (2.3)	MARK4 (2.2)	ATP13A1 (2.1)	PBX4 (1.9)	FRK (1.9)	LPAR2 (1.8)	PPP1R37 (1.8)
MP:0000854	abnormal cerebellum development	0.99	> 0.20	APOE (1.8)	NCAN (1.6)	C19orf52 (1.6)	ZHX3 (1.5)	MAFB (1.4)	ENSG00000254235 (1.4)	HAVCR1 (1.1)	PMFBP1 (1.1)	ATP13A1 (1.1)	DHX38 (1.1)
GO:0043269	regulation of ion transport	0.99	> 0.20	SYPL2 (2.5)	RPH3A (2.4)	AMIGO1 (2.3)	KIAA1324 (2.2)	PPP1R37 (2.0)	ABO (1.5)	SLC44A2 (1.4)	MARK4 (1.4)	ENSG00000226645 (1.4)	GMPR (1.3)
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	0.99	> 0.20	PLCG1 (3.8)	ZNF101 (2.7)	APOC1 (2.4)	GMIP (2.0)	ALDH2 (1.9)	APOE (1.9)	DOCK7 (1.8)	HAVCR1 (1.6)	MAFB (1.5)	PBX4 (1.4)
GO:0016197	endosomal transport	0.99	> 0.20	COL4A3BP (3.2)	BLOC1S3 (3.0)	POLK (2.2)	CYB561D1 (2.0)	BRAP (2.0)	MAU2 (1.9)	DYNC2LI1 (1.8)	UBXN2B (1.8)	FRK (1.7)	AP1M2 (1.6)
GO:0060219	camera-type eye photoreceptor cell differentiation	0.99	> 0.20	ENSG00000235545 (3.2)	LPIN3 (1.7)	HNF1A (1.7)	DNAH11 (1.6)	AP1M2 (1.3)	CBLC (1.2)	NCAN (1.2)	ZNF180 (1.2)	GOT2P1 (1.1)	ENSG00000254235 (1.1)
GO:0045762	positive regulation of adenylate cyclase activity	0.99	> 0.20	AMIGO1 (2.4)	PMFBP1 (2.4)	ABO (2.2)	BLOC1S3 (2.0)	GOT2P1 (1.8)	ENSG00000228044 (1.6)	ENSG00000226648 (1.6)	KIAA1324 (1.5)	LPIN3 (1.4)	ENSG00000226645 (1.4)
GO:0031281	positive regulation of cyclase activity	0.99	> 0.20	AMIGO1 (2.4)	PMFBP1 (2.4)	ABO (2.2)	BLOC1S3 (2.0)	GOT2P1 (1.8)	ENSG00000228044 (1.6)	ENSG00000226648 (1.6)	KIAA1324 (1.5)	LPIN3 (1.4)	ENSG00000226645 (1.4)
MP:0000774	decreased brain size	0.99	> 0.20	NCAN (4.1)	PTPN11 (3.9)	DOCK7 (2.7)	ATXN2 (2.4)	FADS1 (2.0)	C12orf51 (2.0)	KANK2 (1.9)	LDLR (1.8)	SORT1 (1.7)	RPH3A (1.6)
ENSG00000102001	CACNA1F PPI subnetwork	0.99	> 0.20	ENSG00000238078 (2.1)	NCAN (1.7)	HAPLN4 (1.7)	MARK4 (1.6)	SYPL2 (1.5)	MOSC1 (1.4)	GOT2P1 (1.3)	GPAM (1.3)	ADAM1 (1.2)	OGDH (1.2)
GO:0005251	delayed rectifier potassium channel activity	0.99	> 0.20	RPH3A (3.0)	HAPLN4 (2.9)	ABO (2.9)	SORT1 (2.2)	CELSR2 (2.1)	RHCE (1.7)	TMEM116 (1.2)	AMIGO1 (1.1)	DHODH (1.0)	ZHX3 (1.0)
ENSG00000135338	LCA5 PPI subnetwork	0.99	> 0.20	HAPLN4 (3.3)	RPH3A (2.9)	NCAN (2.5)	ADAM1 (1.9)	CELSR2 (1.8)	ENSG00000235545 (1.6)	C11orf9 (1.4)	PTPN11 (1.3)	ALDH2 (1.3)	SORT1 (1.3)
ENSG00000168702	LRP1B PPI subnetwork	0.99	> 0.20	PVR (2.6)	PVRL2 (2.1)	NCAN (2.0)	GATAD2A (1.9)	TMED4 (1.7)	SH2B3 (1.6)	ERP29 (1.3)	ENSG00000228044 (1.2)	PTPN11 (1.2)	ITGB3 (1.1)
MP:0000455	abnormal maxilla morphology	0.99	> 0.20	CILP2 (2.3)	MYLIP (2.2)	DYNC2LI1 (2.1)	MAFB (1.7)	HLX (1.5)	PLEKHH2 (1.4)	PSRC1 (1.3)	TRAFD1 (1.0)	ABO (1.0)	CARM1 (0.9)
ENSG00000008277	ADAM22 PPI subnetwork	0.99	> 0.20	RPH3A (2.7)	ALDH2 (2.2)	HAPLN4 (2.2)	NCAN (2.1)	GRINA (2.0)	MOSC1 (1.8)	ATXN2 (1.6)	C11orf9 (1.4)	ST3GAL4 (1.4)	CELSR2 (1.3)
GO:0046823	negative regulation of nucleocytoplasmic transport	0.99	> 0.20	ZNF101 (2.6)	ENSG00000235545 (2.2)	PBX4 (2.1)	PPP1R37 (2.0)	ABO (1.8)	PLCG1 (1.6)	ATXN7L2 (1.5)	LPAR2 (1.4)	GATAD2A (1.3)	MAFB (1.1)
ENSG00000068793	CYFIP1 PPI subnetwork	0.99	> 0.20	RPH3A (2.0)	MARK4 (1.9)	UBXN2B (1.9)	CELSR2 (1.8)	C12orf43 (1.7)	GOT2P1 (1.4)	NCAN (1.4)	HAPLN4 (1.4)	AMIGO1 (1.4)	ATXN2 (1.3)
ENSG00000141622	RNF165 PPI subnetwork	0.99	> 0.20	POC5 (1.7)	MAU2 (1.7)	ZNF180 (1.4)	DYNC2LI1 (1.4)	NKPD1 (1.4)	MARK4 (1.4)	CYB561D1 (1.3)	PARP10 (1.3)	ATXN7L2 (1.2)	LPIN3 (1.2)
GO:0030433	ER-associated protein catabolic process	0.99	> 0.20	TMED4 (3.7)	YIPF2 (3.2)	ERP29 (2.8)	GRINA (2.0)	ATP13A1 (1.6)	TSSK6 (1.5)	AMIGO1 (1.3)	TMEM57 (1.2)	C1orf63 (1.1)	C12orf47 (1.0)
GO:0031362	anchored to external side of plasma membrane	0.99	> 0.20	AP1M2 (2.7)	BCAM (2.3)	NYNRIN (1.9)	CETP (1.9)	CELSR2 (1.8)	YIPF2 (1.8)	ENSG00000226645 (1.7)	ZHX3 (1.7)	CEACAM19 (1.6)	HLX (1.5)
MP:0000877	abnormal Purkinje cell morphology	0.99	> 0.20	HAPLN4 (2.8)	SORT1 (2.6)	APOE (2.5)	ZHX3 (2.5)	NCAN (2.0)	C12orf51 (1.9)	RPH3A (1.8)	PLCG1 (1.6)	ERP29 (1.6)	AMIGO1 (1.5)
GO:0007423	sensory organ development	0.99	> 0.20	NYNRIN (1.8)	DYNC2LI1 (1.7)	GOT2P1 (1.6)	CILP2 (1.5)	LPIN3 (1.3)	MYLIP (1.2)	TMED4 (1.0)	PMFBP1 (1.0)	PVRL2 (1.0)	ZHX3 (1.0)
GO:0071554	cell wall organization or biogenesis	0.99	> 0.20	GCNT4 (2.7)	TSSK6 (2.5)	PMFBP1 (2.5)	NKPD1 (1.8)	HNF1A (1.7)	CYB561D1 (1.7)	TMED4 (1.6)	PBX4 (1.4)	HAVCR1 (1.4)	UBXN2B (1.0)
GO:0044036	cell wall macromolecule metabolic process	0.99	> 0.20	GCNT4 (2.7)	TSSK6 (2.5)	PMFBP1 (2.5)	NKPD1 (1.8)	HNF1A (1.7)	CYB561D1 (1.7)	TMED4 (1.6)	PBX4 (1.4)	HAVCR1 (1.4)	UBXN2B (1.0)
MP:0003461	abnormal response to novel object	0.99	> 0.20	NCAN (3.3)	CELSR2 (1.9)	PARP10 (1.8)	TMEM116 (1.7)	USP24 (1.6)	UBXN2B (1.4)	ABCG5 (1.3)	FADS1 (1.3)	TMEM57 (1.1)	DNAH11 (1.1)
GO:0032279	asymmetric synapse	0.99	> 0.20	NCAN (3.9)	KIAA1324 (2.6)	SORT1 (2.5)	ENSG00000235545 (2.4)	RPH3A (2.3)	GCNT4 (1.9)	HAVCR1 (1.9)	PSRC1 (1.9)	CELSR2 (1.7)	ENSG00000228044 (1.6)
GO:0042597	periplasmic space	0.99	> 0.20	NCAN (4.5)	RPH3A (2.1)	ABO (1.7)	C11orf9 (1.6)	USP24 (1.6)	PPP1R37 (1.4)	ENSG00000226648 (1.2)	APOE (1.2)	HAVCR1 (1.1)	DNAH11 (1.0)
GO:0030288	outer membrane-bounded periplasmic space	0.99	> 0.20	NCAN (4.5)	RPH3A (2.1)	ABO (1.7)	C11orf9 (1.6)	USP24 (1.6)	PPP1R37 (1.4)	ENSG00000226648 (1.2)	APOE (1.2)	HAVCR1 (1.1)	DNAH11 (1.0)
MP:0001005	abnormal retinal rod cell morphology	0.99	> 0.20	HAVCR1 (2.7)	PMFBP1 (1.9)	C12orf47 (1.9)	SORT1 (1.8)	DYNC2LI1 (1.6)	PLEKHH2 (1.5)	LPIN3 (1.5)	AMIGO1 (1.4)	ZNF101 (1.3)	TXNL4B (1.3)
ENSG00000145864	GABRB2 PPI subnetwork	0.99	> 0.20	ANKRD31 (1.8)	RPH3A (1.7)	HAPLN4 (1.7)	NCAN (1.7)	MYLIP (1.5)	C12orf51 (1.4)	PCSK9 (1.2)	ADAM1 (1.1)	LPIN3 (1.1)	C11orf9 (1.0)
GO:0009214	cyclic nucleotide catabolic process	0.99	> 0.20	SORT1 (2.0)	CEACAM19 (1.8)	PBX4 (1.7)	NCAN (1.6)	PCSK9 (1.6)	ZNF101 (1.5)	GOT2P1 (1.4)	MOSC1 (1.2)	GCNT4 (1.1)	TXNL4B (1.0)
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	0.99	> 0.20	ITGB3 (3.7)	SH2B3 (2.6)	TMEM50A (2.0)	CETP (1.9)	ABO (1.3)	CYP7A1 (1.2)	MYLIP (1.1)	GMIP (1.1)	MARK4 (0.9)	HLX (0.9)
GO:0045103	intermediate filament-based process	0.99	> 0.20	C17orf57 (2.5)	NKPD1 (1.9)	ENSG00000226648 (1.5)	BRAP (1.3)	GOT2P1 (1.2)	COL4A3BP (1.2)	HAPLN4 (1.1)	RHCE (1.0)	RPH3A (1.0)	TMED4 (1.0)
ENSG00000170275	CRTAP PPI subnetwork	0.99	> 0.20	ERP29 (2.3)	PVR (2.2)	APOE (1.9)	HNF1A (1.8)	TIMD4 (1.6)	ZNF180 (1.3)	SARS (1.2)	HAPLN4 (1.1)	PLCG1 (1.1)	GEMIN7 (1.1)
GO:0072006	nephron development	0.99	> 0.20	BCAM (2.4)	HAVCR1 (2.1)	AP1M2 (2.0)	TMEM116 (2.0)	PLEKHH2 (2.0)	HNF1A (1.6)	DYNC2LI1 (1.6)	FRK (1.5)	NYNRIN (1.5)	MYLIP (1.4)
GO:0002495	antigen processing and presentation of peptide antigen via MHC class II	0.99	> 0.20	DOCK7 (1.9)	NKPD1 (1.8)	ALDH2 (1.8)	C19orf52 (1.8)	AP1M2 (1.4)	RHCE (1.4)	UBXN2B (1.3)	TMED4 (1.3)	ERP29 (1.2)	ENSG00000235545 (1.2)
MP:0000644	dextrocardia	0.99	> 0.20	HAVCR1 (3.5)	DYNC2LI1 (2.6)	ATXN2 (1.7)	PVRL2 (1.7)	YIPF2 (1.5)	ANKRD31 (1.4)	TRAPPC6A (1.3)	CEACAM19 (1.3)	DNAH11 (1.3)	ZHX3 (1.2)
GO:0001508	regulation of action potential	0.99	> 0.20	C11orf9 (2.7)	RPH3A (2.3)	SORT1 (2.3)	ANKRD31 (2.1)	NCAN (2.0)	NKPD1 (2.0)	HAPLN4 (1.8)	BCAM (1.1)	COL4A3BP (1.1)	C12orf43 (1.0)
ENSG00000198947	DMD PPI subnetwork	0.99	> 0.20	SYPL2 (3.5)	LPIN3 (2.4)	TRAFD1 (2.1)	KANK2 (2.0)	CEACAM19 (1.8)	SUGP1 (1.8)	PCSK9 (1.8)	ZHX3 (1.7)	PLCG1 (1.4)	ENSG00000226645 (1.2)
ENSG00000198604	BAZ1A PPI subnetwork	0.99	> 0.20	USP1 (1.7)	ABO (1.5)	TXNL4B (1.4)	CYP7A1 (1.4)	PLEKHH2 (1.2)	TMED4 (1.2)	DHX38 (1.1)	DOCK7 (1.1)	SLC44A2 (1.1)	TOP1 (1.0)
MP:0002243	abnormal vomeronasal organ morphology	0.99	> 0.20	TMED4 (2.1)	CILP2 (2.0)	HLX (2.0)	MYLIP (1.7)	TMEM57 (1.6)	DYNC2LI1 (1.5)	PSRC1 (1.5)	OASL (1.5)	TMEM116 (1.4)	GMPR (1.1)
MP:0002823	abnormal rib development	0.99	> 0.20	SYPL2 (2.9)	SLC44A2 (1.9)	CILP2 (1.8)	TRAPPC6A (1.5)	TMED4 (1.5)	PCSK9 (1.5)	NYNRIN (1.5)	BCAM (1.2)	GMPR (1.2)	OASL (1.2)
ENSG00000168259	DNAJC7 PPI subnetwork	0.99	> 0.20	BLOC1S3 (2.4)	QTRT1 (2.2)	MAPKAPK5 (2.0)	SH2B3 (1.8)	POLK (1.8)	GATAD2A (1.7)	ENSG00000228044 (1.7)	PPP1R37 (1.6)	TXNL4B (1.5)	AMIGO1 (1.5)
GO:0042805	actinin binding	0.99	> 0.20	SYPL2 (4.0)	KIAA1324 (2.1)	BCAM (1.9)	AP1M2 (1.9)	HNF1A (1.8)	PLEC (1.6)	SORT1 (1.6)	PTPN11 (1.5)	NCAN (1.5)	PVRL2 (1.2)
MP:0004101	abnormal brain interneuron morphology	0.99	> 0.20	NCAN (3.2)	PVR (2.3)	C12orf51 (2.2)	TMEM57 (2.1)	PBX4 (1.8)	ZNF180 (1.7)	CEACAM19 (1.6)	GCNT4 (1.3)	ERP29 (1.3)	ENSG00000228044 (1.1)
ENSG00000105669	COPE PPI subnetwork	0.99	> 0.20	YIPF2 (4.8)	BLOC1S3 (4.1)	KIAA1324 (2.2)	PPP1R37 (2.1)	ABCG8 (2.0)	PSMA5 (1.9)	TMED4 (1.7)	SARS (1.6)	TMEM57 (1.5)	TRAFD1 (1.5)
ENSG00000204104	TRAF3IP1 PPI subnetwork	0.99	> 0.20	C1orf63 (2.4)	CYB561D1 (2.3)	ZNF180 (2.2)	AMIGO1 (2.1)	PMFBP1 (2.0)	TXNL4B (1.8)	MAU2 (1.6)	C19orf52 (1.6)	PBX4 (1.4)	ENSG00000254235 (1.3)
MP:0001417	decreased exploration in new environment	0.99	> 0.20	ENSG00000226645 (2.1)	CELSR2 (1.6)	ATXN7L2 (1.6)	TMEM50A (1.4)	RPH3A (1.3)	TMEM116 (1.3)	NCAN (1.2)	LPA (1.2)	HNF1A (1.1)	ENSG00000235545 (1.1)
MP:0000441	increased cranium width	0.99	> 0.20	PLEKHH2 (2.2)	C11orf9 (2.2)	MAU2 (1.9)	HNF1A (1.8)	GPAM (1.8)	ZHX3 (1.8)	DHX38 (1.7)	KIAA1324 (1.5)	POC5 (1.4)	TXNL4B (1.4)
GO:0051865	protein autoubiquitination	0.99	> 0.20	TSSK6 (2.6)	C19orf52 (2.5)	BRAP (2.4)	PMFBP1 (2.2)	ZNF180 (2.1)	MAU2 (1.9)	POC5 (1.5)	C1orf63 (1.4)	POLK (1.4)	BLOC1S3 (1.4)
GO:0003156	regulation of organ formation	0.99	> 0.20	ENSG00000238078 (3.3)	LPIN3 (2.5)	PPP1R37 (2.2)	PLEKHH2 (2.0)	BLOC1S3 (1.7)	ATXN7L2 (1.7)	ZHX3 (1.5)	NYNRIN (1.5)	PVRL2 (1.3)	C19orf52 (1.3)
GO:0009394	2'-deoxyribonucleotide metabolic process	0.99	> 0.20	ANKRD31 (2.5)	TRAPPC6A (2.3)	TXNL4B (2.0)	DYNC2LI1 (2.0)	NKPD1 (1.9)	TMEM116 (1.8)	ENSG00000226648 (1.8)	NT5DC1 (1.7)	MAPKAPK5 (1.7)	ACAD10 (1.5)
GO:0032154	cleavage furrow	0.99	> 0.20	PSRC1 (3.1)	PBX4 (2.3)	ADAM1 (2.3)	HAVCR1 (1.9)	PTPN11 (1.9)	SH2B3 (1.9)	FEN1 (1.5)	C12orf43 (1.5)	POC5 (1.4)	OGDH (1.4)
MP:0003148	decreased cochlear coiling	0.99	> 0.20	TMEM116 (2.2)	NCAN (1.8)	CILP2 (1.8)	NKPD1 (1.4)	DYNC2LI1 (1.4)	ZHX3 (1.4)	MYLIP (1.3)	LPA (1.2)	PPP1R37 (1.2)	ENSG00000238078 (1.2)
GO:0031514	motile cilium	0.99	> 0.20	DYNC2LI1 (7.0)	TMEM116 (1.7)	POLK (1.5)	ENSG00000226648 (1.3)	ACAD10 (1.1)	C12orf47 (1.1)	PSRC1 (1.0)	ENSG00000228044 (1.0)	TSSK6 (0.9)	TMED4 (0.9)
GO:0016493	C-C chemokine receptor activity	0.99	> 0.20	ZNF101 (2.0)	GCNT4 (2.0)	PBX4 (1.9)	PLCG1 (1.9)	TIMD4 (1.8)	HNF1A (1.8)	KIAA1324 (1.5)	TRIB1 (1.4)	ERP29 (1.4)	GMIP (1.2)
ENSG00000070182	SPTB PPI subnetwork	0.99	> 0.20	RHD (5.6)	C12orf51 (4.4)	RHCE (4.2)	GMPR (3.0)	SYPL2 (2.2)	HAVCR1 (2.1)	SORT1 (1.6)	ENSG00000238078 (1.5)	PTPN11 (1.4)	CELSR2 (1.3)
GO:0070231	T cell apoptotic process	0.99	> 0.20	PBX4 (3.0)	TRAFD1 (1.6)	ZNF101 (1.6)	ENSG00000226648 (1.3)	HLX (1.3)	TSSK6 (1.2)	GMIP (1.2)	PARP10 (1.2)	NKPD1 (1.2)	ATXN7L2 (1.2)
ENSG00000143476	DTL PPI subnetwork	0.99	> 0.20	BUD13 (2.4)	C19orf52 (2.2)	KIAA1324 (1.9)	QTRT1 (1.8)	TXNL4B (1.7)	C1orf63 (1.4)	PPP1R37 (1.4)	ILF3 (1.3)	GATAD2A (1.2)	ANKRD31 (1.2)
REACTOME_L1CAM_INTERACTIONS	REACTOME_L1CAM_INTERACTIONS	0.99	> 0.20	RPH3A (3.0)	PLEC (2.3)	CELSR2 (2.2)	ITGB3 (2.0)	PTPN11 (1.9)	DNM2 (1.9)	SARS (1.8)	GOT2P1 (1.7)	OGDH (1.7)	NCAN (1.6)
ENSG00000182255	KCNA4 PPI subnetwork	0.99	> 0.20	FRK (3.6)	RPH3A (2.3)	C11orf9 (1.8)	CELSR2 (1.6)	ZNF101 (1.6)	SYPL2 (1.5)	UBXN2B (1.4)	PLCG1 (1.4)	ALDH2 (1.3)	HNF1A (1.3)
ENSG00000124164	VAPB PPI subnetwork	0.99	> 0.20	TMEM50A (3.5)	C1orf63 (2.5)	DNM2 (2.1)	ERP29 (1.8)	SARS (1.7)	CYB561D1 (1.6)	PSMA5 (1.4)	TOP1 (1.4)	BLOC1S3 (1.3)	HAPLN4 (1.3)
MP:0002666	increased circulating aldosterone level	0.99	> 0.20	AP1M2 (3.6)	TMEM116 (2.8)	FRK (2.6)	CBLC (1.9)	ZHX3 (1.8)	ZNF180 (1.7)	MAFB (1.5)	KIAA1324 (1.5)	HNF1A (1.4)	ZNF101 (1.3)
MP:0002910	abnormal excitatory postsynaptic currents	0.99	> 0.20	RPH3A (4.3)	NCAN (3.7)	HAPLN4 (3.1)	APOE (2.3)	ABO (2.0)	C12orf51 (1.6)	PPP1R37 (1.6)	USP24 (1.4)	APOC4 (1.2)	CELSR2 (1.2)
ENSG00000168447	SCNN1B PPI subnetwork	0.99	> 0.20	AP1M2 (2.4)	LPIN3 (2.3)	KIAA1324 (2.2)	NCAN (1.8)	CEACAM19 (1.8)	DOCK7 (1.6)	ZHX3 (1.6)	PLEC (1.5)	NKPD1 (1.4)	TMEM50A (1.4)
GO:0030534	adult behavior	0.99	> 0.20	PMFBP1 (2.8)	ENSG00000235545 (2.5)	ANKRD31 (2.3)	TSSK6 (2.2)	RPH3A (2.1)	C12orf47 (2.0)	ABO (1.6)	CILP2 (1.6)	COL4A3BP (1.5)	ERP29 (1.4)
GO:0045109	intermediate filament organization	1.00	> 0.20	HAPLN4 (1.7)	PMFBP1 (1.5)	BLOC1S3 (1.4)	ENSG00000226648 (1.2)	ADAM1 (1.2)	ENSG00000254235 (1.1)	NCAN (1.0)	NKPD1 (1.0)	ENSG00000235545 (1.0)	GMPR (1.0)
GO:0051900	regulation of mitochondrial depolarization	1.00	> 0.20	ITGB3 (2.7)	TMEM116 (1.9)	ENSG00000226645 (1.8)	RHCE (1.8)	POLK (1.8)	ENSG00000226648 (1.7)	BLOC1S3 (1.7)	HAPLN4 (1.6)	RHD (1.5)	GMPR (1.3)
GO:0048194	Golgi vesicle budding	1.00	> 0.20	YIPF2 (5.7)	BLOC1S3 (2.4)	TMED4 (1.8)	KIAA1324 (1.7)	MAU2 (1.7)	C19orf52 (1.5)	LPIN3 (1.5)	SUGP1 (1.3)	DNM2 (1.3)	ERP29 (1.2)
MP:0002572	abnormal emotion/affect behavior	1.00	> 0.20	CELSR2 (3.1)	GOT2P1 (2.2)	ST3GAL4 (2.1)	RPH3A (2.0)	OASL (1.7)	PARP10 (1.7)	DYNC2LI1 (1.6)	NCAN (1.5)	PVR (1.3)	TSSK6 (1.2)
ENSG00000013561	RNF14 PPI subnetwork	1.00	> 0.20	KIAA1324 (2.3)	SH2B3 (1.9)	TMEM57 (1.6)	DOCK7 (1.5)	POLK (1.5)	GATAD2A (1.4)	RHCE (1.3)	GCNT4 (1.3)	CYP7A1 (1.3)	PTPN11 (1.3)
GO:0004435	phosphatidylinositol phospholipase C activity	1.00	> 0.20	ABO (2.5)	PMFBP1 (2.2)	SORT1 (2.2)	ATXN7L2 (2.0)	HLX (2.0)	AMIGO1 (1.9)	C12orf47 (1.7)	ITGB3 (1.7)	GCNT4 (1.5)	NCAN (1.4)
GO:0019932	second-messenger-mediated signaling	1.00	> 0.20	C12orf47 (2.9)	AMIGO1 (2.1)	RPH3A (2.0)	LPIN3 (1.8)	PMFBP1 (1.7)	DNAH11 (1.5)	ENSG00000235545 (1.1)	ITGB3 (1.1)	ZNF101 (0.9)	CETP (0.9)
GO:0009124	nucleoside monophosphate biosynthetic process	1.00	> 0.20	C12orf47 (3.6)	ENSG00000228044 (2.2)	PMFBP1 (2.2)	AMIGO1 (1.8)	ABO (1.6)	RPH3A (1.6)	TSSK6 (1.5)	LPIN3 (1.4)	CETP (1.3)	ENSG00000235545 (1.0)
GO:0007289	spermatid nucleus differentiation	1.00	> 0.20	TSSK6 (5.3)	PMFBP1 (3.6)	NKPD1 (1.8)	NT5DC1 (1.7)	ENSG00000226648 (1.2)	GEMIN7 (1.2)	FRK (1.2)	SLC44A2 (1.1)	MARK4 (1.1)	BCAM (1.0)
GO:0035313	wound healing, spreading of epidermal cells	1.00	> 0.20	ENSG00000226648 (2.4)	DNAH11 (2.3)	AP1M2 (2.1)	PVR (1.9)	NYNRIN (1.8)	ENSG00000226645 (1.8)	ERP29 (1.6)	TMEM116 (1.3)	CYB561D1 (1.3)	NKPD1 (1.3)
GO:0007520	myoblast fusion	1.00	> 0.20	CYB561D1 (2.3)	C12orf47 (2.1)	ATXN7L2 (2.0)	ZNF180 (1.9)	HNF1A (1.8)	ENSG00000228044 (1.4)	ANKRD31 (1.4)	MAPKAPK5 (1.3)	ZHX3 (1.3)	GEMIN7 (1.2)
REACTOME_LIGAND:GATED_ION_CHANNEL_TRANSPORT	REACTOME_LIGAND:GATED_ION_CHANNEL_TRANSPORT	1.00	> 0.20	RPH3A (1.8)	MYLIP (1.4)	ANKRD31 (1.4)	TM6SF2 (1.3)	FRK (1.3)	ATP13A1 (1.0)	BCAM (1.0)	APOE (1.0)	NCAN (1.0)	APOA5 (1.0)
ENSG00000188428	MUTED PPI subnetwork	1.00	> 0.20	GEMIN7 (2.6)	PVR (2.0)	HNF1A (1.8)	APOE (1.6)	ZNF180 (1.5)	TIMD4 (1.4)	C12orf43 (1.4)	ALDH2 (1.3)	SARS (1.3)	TRAFD1 (1.3)
GO:0004970	ionotropic glutamate receptor activity	1.00	> 0.20	NCAN (4.4)	RPH3A (2.2)	ABO (1.9)	C11orf9 (1.5)	USP24 (1.5)	PPP1R37 (1.5)	ENSG00000226648 (1.1)	APOE (1.1)	PCSK9 (1.1)	CELSR2 (1.0)
ENSG00000145041	VPRBP PPI subnetwork	1.00	> 0.20	USP24 (3.2)	ZHX3 (2.2)	DOCK7 (2.1)	COL4A3BP (2.1)	GRINA (2.0)	ATXN2 (1.9)	C12orf51 (1.6)	CARM1 (1.5)	PMFBP1 (1.4)	APOE (1.1)
GO:0008528	G-protein coupled peptide receptor activity	1.00	> 0.20	TRIB1 (1.7)	APOE (1.6)	HNF1A (1.6)	TIMD4 (1.6)	C12orf47 (1.6)	PMFBP1 (1.4)	LPAR2 (1.4)	CELSR2 (1.2)	APOC1 (1.2)	MAFB (1.2)
ENSG00000115935	WIPF1 PPI subnetwork	1.00	> 0.20	TOP1 (2.3)	GATAD2A (2.1)	ITGB3 (2.1)	OGDH (1.7)	TMEM50A (1.6)	ENSG00000238078 (1.4)	ATXN2 (1.3)	PLG (1.3)	HAPLN4 (1.2)	TIMD4 (1.1)
GO:0031683	G-protein beta/gamma-subunit complex binding	1.00	> 0.20	SH2B3 (1.9)	NCAN (1.9)	FADS2 (1.8)	ZHX3 (1.6)	HLX (1.4)	TMEM50A (1.4)	ABCG8 (1.3)	MARK4 (1.3)	DYNC2LI1 (1.3)	HMGCR (1.2)
GO:0030900	forebrain development	1.00	> 0.20	PBX4 (2.8)	NCAN (2.8)	TSSK6 (2.2)	CELSR2 (2.0)	DNAH11 (1.9)	ABO (1.8)	ANKRD31 (1.6)	ATXN2 (1.5)	GOT2P1 (1.5)	ZHX3 (1.4)
GO:0000910	cytokinesis	1.00	> 0.20	PSRC1 (3.0)	DYNC2LI1 (2.8)	POC5 (2.4)	COL4A3BP (1.9)	TXNL4B (1.8)	TMEM50A (1.7)	PBX4 (1.7)	UBXN2B (1.5)	BLOC1S3 (1.3)	SLC44A2 (1.3)
GO:0001653	peptide receptor activity	1.00	> 0.20	C12orf47 (1.8)	APOE (1.7)	HNF1A (1.7)	TRIB1 (1.6)	TIMD4 (1.5)	MAFB (1.3)	GPAM (1.3)	PMFBP1 (1.2)	CETP (1.2)	LPAR2 (1.2)
ENSG00000108231	LGI1 PPI subnetwork	1.00	> 0.20	HAPLN4 (3.1)	RPH3A (2.8)	NCAN (2.4)	CELSR2 (1.9)	ADAM1 (1.8)	ENSG00000235545 (1.5)	C11orf9 (1.5)	PTPN11 (1.5)	SORT1 (1.4)	FRK (1.4)
GO:0016247	channel regulator activity	1.00	> 0.20	RPH3A (3.5)	KIAA1324 (2.1)	FRK (1.9)	GCNT4 (1.9)	ENSG00000226645 (1.7)	BCAM (1.6)	AMIGO1 (1.5)	TMEM116 (1.5)	SORT1 (1.3)	ALDH2 (1.2)
GO:0070098	chemokine-mediated signaling pathway	1.00	> 0.20	CEACAM19 (2.1)	CETP (1.8)	MAFB (1.6)	TRAPPC6A (1.5)	LPAR2 (1.4)	TMEM50A (1.4)	TMED4 (1.4)	TIMD4 (1.4)	C17orf57 (1.3)	ZNF101 (1.3)
ENSG00000147416	ATP6V1B2 PPI subnetwork	1.00	> 0.20	TXNL4B (2.8)	TMEM50A (2.5)	PSMA5 (2.1)	DYNC2LI1 (2.0)	TRAFD1 (1.8)	SARS (1.8)	GRINA (1.8)	C19orf52 (1.7)	ENSG00000238078 (1.5)	ENSG00000235545 (1.5)
ENSG00000144191	CNGA3 PPI subnetwork	1.00	> 0.20	MOSC1 (2.1)	ABO (2.0)	MAFB (1.5)	ZNF101 (1.3)	C19orf52 (1.2)	PLCG1 (1.2)	ILF3 (1.2)	C12orf51 (1.2)	NCAN (1.1)	USP1 (1.0)
MP:0003633	abnormal nervous system physiology	1.00	> 0.20	RPH3A (3.6)	HAPLN4 (3.1)	CELSR2 (2.5)	APOE (2.2)	SORT1 (1.9)	ALDH2 (1.8)	TSSK6 (1.7)	COL4A3BP (1.7)	NCAN (1.6)	CYP7A1 (1.4)
ENSG00000105829	BET1 PPI subnetwork	1.00	> 0.20	YIPF2 (4.5)	OGDH (1.9)	ABCG8 (1.7)	SARS (1.6)	PSMA5 (1.6)	TMED4 (1.5)	BLOC1S3 (1.4)	AP1M2 (1.3)	TMEM57 (1.3)	RHCE (1.2)
MP:0000937	abnormal motor neuron morphology	1.00	> 0.20	HAPLN4 (3.3)	C11orf9 (2.5)	RPH3A (2.0)	PMFBP1 (1.8)	ALDH2 (1.8)	NKPD1 (1.6)	AMIGO1 (1.6)	TRIB1 (1.6)	ENSG00000254235 (1.4)	COL4A3BP (1.4)
ENSG00000165688	PMPCA PPI subnetwork	1.00	> 0.20	ATXN7L2 (2.2)	NKPD1 (2.1)	LPIN3 (1.9)	C1orf63 (1.9)	FEN1 (1.5)	USP1 (1.4)	POC5 (1.3)	ZNF259 (1.3)	NT5DC1 (1.2)	C12orf43 (1.1)
MP:0003732	abnormal retinal outer plexiform layer morphology	1.00	> 0.20	DYNC2LI1 (1.9)	NCAN (1.6)	PSRC1 (1.5)	MAPKAPK5 (1.3)	C12orf47 (1.3)	GEMIN7 (1.2)	ENSG00000226648 (1.1)	TXNL4B (1.0)	MYLIP (0.9)	FADS2 (0.9)
MP:0010760	abnormal macrophage chemotaxis	1.00	> 0.20	TIMD4 (2.4)	MAFB (2.4)	TOP1 (1.3)	GMIP (1.2)	TMED4 (1.2)	RHCE (1.2)	ACAD10 (1.2)	ZNF101 (1.2)	TMEM116 (1.1)	YIPF2 (1.1)
MP:0003996	clonic seizures	1.00	> 0.20	RPH3A (6.0)	HAPLN4 (5.8)	NKPD1 (2.0)	NCAN (2.0)	CELSR2 (1.4)	DNAH11 (1.4)	ABO (1.3)	APOE (1.3)	ANGPTL3 (1.2)	PLG (1.2)
GO:0048205	COPI coating of Golgi vesicle	1.00	> 0.20	YIPF2 (5.7)	BLOC1S3 (2.6)	MAU2 (1.8)	KIAA1324 (1.7)	TMED4 (1.6)	LPIN3 (1.6)	ATP13A1 (1.4)	OGDH (1.4)	CLPTM1 (1.4)	DNM2 (1.3)
GO:0048200	Golgi transport vesicle coating	1.00	> 0.20	YIPF2 (5.7)	BLOC1S3 (2.6)	MAU2 (1.8)	KIAA1324 (1.7)	TMED4 (1.6)	LPIN3 (1.6)	ATP13A1 (1.4)	OGDH (1.4)	CLPTM1 (1.4)	DNM2 (1.3)
GO:0035964	COPI-coated vesicle budding	1.00	> 0.20	YIPF2 (5.7)	BLOC1S3 (2.6)	MAU2 (1.8)	KIAA1324 (1.7)	TMED4 (1.6)	LPIN3 (1.6)	ATP13A1 (1.4)	OGDH (1.4)	CLPTM1 (1.4)	DNM2 (1.3)
GO:0031901	early endosome membrane	1.00	> 0.20	COL4A3BP (2.8)	BLOC1S3 (2.1)	PTPN11 (2.1)	SH2B3 (1.9)	TMEM57 (1.7)	PPP1R37 (1.5)	C17orf57 (1.3)	SARS (1.2)	ACAD10 (1.2)	MAU2 (1.1)
GO:0045454	cell redox homeostasis	1.00	> 0.20	ERP29 (4.0)	TSSK6 (3.3)	PMFBP1 (1.9)	TMED4 (1.8)	KIAA1324 (1.7)	BLOC1S3 (1.6)	C12orf47 (1.6)	CYB561D1 (1.6)	ACAD10 (1.4)	DHODH (1.3)
ENSG00000113327	GABRG2 PPI subnetwork	1.00	> 0.20	NCAN (2.4)	RPH3A (1.7)	MYLIP (1.6)	ERP29 (1.6)	COL4A3BP (1.3)	BCL3 (1.2)	GRINA (1.2)	HNF1A (1.2)	C12orf43 (1.1)	HAPLN4 (1.0)
ENSG00000198400	NTRK1 PPI subnetwork	1.00	> 0.20	COL4A3BP (2.3)	MARK4 (2.1)	DNM2 (2.1)	GMIP (2.1)	C12orf51 (1.6)	ZHX3 (1.6)	PTPN11 (1.6)	PPP1R37 (1.6)	CELSR2 (1.5)	AMIGO1 (1.4)
ENSG00000130733	YIPF2 PPI subnetwork	1.00	> 0.20	ANKRD31 (2.5)	TMEM57 (2.2)	YIPF2 (2.1)	GRINA (2.1)	FRK (2.1)	TMEM50A (1.7)	COL4A3BP (1.7)	TMED4 (1.5)	PBX4 (1.5)	C12orf43 (1.4)
GO:0022898	regulation of transmembrane transporter activity	1.00	> 0.20	SYPL2 (3.0)	AMIGO1 (2.2)	RPH3A (2.1)	CYB561D1 (1.8)	PLEKHH2 (1.7)	KIAA1324 (1.6)	C12orf47 (1.5)	PPP1R37 (1.4)	ATXN7L2 (1.3)	TSSK6 (1.3)
ENSG00000101977	MCF2 PPI subnetwork	1.00	> 0.20	DNM2 (2.2)	CETP (2.0)	APOE (1.9)	BUD13 (1.8)	GATAD2A (1.8)	SH2B3 (1.8)	SLC44A2 (1.7)	GMIP (1.5)	C1orf63 (1.3)	USP1 (1.3)
ENSG00000130429	ARPC1B PPI subnetwork	1.00	> 0.20	TMEM50A (3.7)	FRK (3.4)	GMIP (3.4)	C1orf63 (2.2)	HNF1A (2.1)	LPIN3 (1.8)	CARM1 (1.7)	DYNC2LI1 (1.6)	CYB561D1 (1.5)	HAVCR1 (1.5)
MP:0002805	abnormal conditioned taste aversion behavior	1.00	> 0.20	HAPLN4 (2.6)	TRIB1 (2.6)	PMFBP1 (2.1)	LPA (2.1)	RPH3A (1.7)	APOC4 (1.7)	SH2B3 (1.7)	CELSR2 (1.4)	PVR (1.3)	RELB (1.3)
MP:0003492	abnormal involuntary movement	1.00	> 0.20	HAPLN4 (4.2)	C11orf9 (2.5)	RPH3A (2.1)	C12orf51 (1.9)	APOE (1.9)	HNF1A (1.7)	PPP1R37 (1.4)	USP24 (1.4)	MAFB (1.1)	MARK4 (1.1)
ENSG00000135655	USP15 PPI subnetwork	1.00	> 0.20	TXNL4B (3.0)	PSMA5 (2.2)	TSSK6 (2.2)	MARK4 (2.1)	CARM1 (1.9)	NKPD1 (1.8)	ATXN7L2 (1.7)	CYB561D1 (1.7)	BUD13 (1.7)	HAVCR1 (1.6)
MP:0005547	abnormal Muller cell morphology	1.00	> 0.20	NCAN (2.6)	ATXN7L2 (2.2)	CELSR2 (2.2)	PMFBP1 (2.2)	CYB561D1 (2.1)	LPIN3 (1.7)	LPAR2 (1.4)	PSRC1 (1.4)	APOE (1.3)	PBX4 (1.3)
GO:0030204	chondroitin sulfate metabolic process	1.00	> 0.20	C19orf52 (2.2)	TMEM57 (2.0)	UBXN2B (1.9)	ST3GAL4 (1.8)	CILP2 (1.6)	ANKRD31 (1.5)	HAVCR1 (1.3)	C12orf47 (1.2)	TSSK6 (1.2)	TMEM116 (1.2)
GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	1.00	> 0.20	LPIN3 (2.4)	ENSG00000226648 (2.3)	C12orf51 (2.0)	HAPLN4 (1.9)	PPP1R37 (1.8)	PLCG1 (1.7)	ADAM1 (1.5)	C12orf43 (1.4)	ENSG00000226645 (1.3)	ABO (1.1)
REACTOME_AXON_GUIDANCE	REACTOME_AXON_GUIDANCE	1.00	> 0.20	NCAN (2.5)	CELSR2 (2.4)	PLEC (2.3)	PLEKHH2 (2.3)	MARK4 (2.0)	OGDH (1.9)	PVRL2 (1.8)	PVR (1.7)	ITGB3 (1.5)	SLC44A2 (1.5)
GO:0044327	dendritic spine head	1.00	> 0.20	NCAN (3.3)	RPH3A (3.0)	MARK4 (2.5)	CELSR2 (2.4)	C11orf9 (2.0)	PPP1R37 (1.9)	ZNF180 (1.6)	SORT1 (1.3)	HAVCR1 (1.3)	FRK (1.3)
GO:0014069	postsynaptic density	1.00	> 0.20	NCAN (3.3)	RPH3A (3.0)	MARK4 (2.5)	CELSR2 (2.4)	C11orf9 (2.0)	PPP1R37 (1.9)	ZNF180 (1.6)	SORT1 (1.3)	HAVCR1 (1.3)	FRK (1.3)
GO:0030903	notochord development	1.00	> 0.20	CILP2 (3.0)	LPAR2 (2.3)	PVRL2 (1.9)	AP1M2 (1.6)	ZNF180 (1.6)	PLEKHH2 (1.5)	PSRC1 (1.3)	C17orf57 (1.3)	TMEM116 (1.3)	HAPLN4 (1.1)
ENSG00000049245	VAMP3 PPI subnetwork	1.00	> 0.20	TRAPPC6A (3.2)	C12orf51 (2.9)	TMEM50A (2.4)	GEMIN7 (2.0)	SARS (2.0)	BRAP (1.8)	HAVCR1 (1.8)	MAPKAPK5 (1.7)	MYLIP (1.6)	HAPLN4 (1.5)
MP:0004624	abnormal thoracic cage morphology	1.00	> 0.20	LPIN3 (2.5)	KIAA1324 (2.4)	MYLIP (2.1)	TMEM57 (2.1)	TRAPPC6A (1.9)	SLC44A2 (1.9)	CYB561D1 (1.7)	SORT1 (1.6)	TMEM50A (1.6)	GCNT4 (1.2)
GO:0051085	chaperone mediated protein folding requiring cofactor	1.00	> 0.20	TMED4 (2.0)	ERP29 (1.9)	ATP13A1 (1.8)	ENSG00000226648 (1.6)	C19orf52 (1.5)	C12orf47 (1.4)	TXNL4B (1.4)	UBXN2B (1.2)	CYP7A1 (1.1)	BRAP (1.0)
ENSG00000100167	SEPT3 PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	SORT1 (2.3)	NCAN (2.1)	C12orf51 (2.0)	MARK4 (1.7)	TMEM50A (1.7)	UBXN2B (1.7)	FADS1 (1.7)	GRINA (1.6)	CELSR2 (1.6)
GO:0007368	determination of left/right symmetry	1.00	> 0.20	DYNC2LI1 (3.4)	ENSG00000226648 (1.9)	ATXN7L2 (1.6)	LPIN3 (1.6)	UBXN2B (1.3)	NYNRIN (1.3)	DNAH11 (1.2)	DOCK7 (1.2)	HLX (0.9)	MAPKAPK5 (0.9)
GO:0006836	neurotransmitter transport	1.00	> 0.20	HAPLN4 (3.9)	RPH3A (3.8)	AMIGO1 (2.6)	ABO (2.5)	PMFBP1 (1.8)	C12orf51 (1.7)	NCAN (1.2)	SORT1 (1.2)	ZHX3 (1.2)	HAVCR1 (1.1)
GO:0031929	TOR signaling cascade	1.00	> 0.20	BLOC1S3 (3.8)	COL4A3BP (3.1)	SARS (2.6)	USP24 (2.0)	MAU2 (1.8)	TMEM57 (1.8)	PPP1R37 (1.8)	GEMIN7 (1.7)	LPIN3 (1.5)	UBXN2B (1.3)
GO:0035567	non-canonical Wnt receptor signaling pathway	1.00	> 0.20	LPAR2 (2.3)	TMEM116 (2.1)	NYNRIN (1.9)	BCAM (1.8)	C11orf9 (1.7)	PVRL2 (1.7)	CILP2 (1.6)	AP1M2 (1.5)	PLEKHH2 (1.5)	CBLC (1.3)
GO:0050905	neuromuscular process	1.00	> 0.20	RPH3A (3.0)	AMIGO1 (2.7)	ANKRD31 (2.1)	HAVCR1 (1.9)	PPP1R37 (1.8)	ATXN7L2 (1.6)	ERP29 (1.4)	NKPD1 (1.4)	ENSG00000238078 (1.4)	PMFBP1 (1.3)
MP:0006398	increased long bone epiphyseal plate size	1.00	> 0.20	CILP2 (5.2)	APOE (2.0)	ITGB3 (2.0)	TRAFD1 (1.9)	PPP1R37 (1.6)	C11orf9 (1.3)	BCAM (1.3)	GMIP (1.2)	CLPTM1 (1.2)	NPC1L1 (1.1)
GO:0017157	regulation of exocytosis	1.00	> 0.20	BLOC1S3 (2.5)	CYB561D1 (2.3)	KIAA1324 (2.1)	AMIGO1 (1.9)	CILP2 (1.7)	RPH3A (1.5)	YIPF2 (1.3)	C12orf47 (1.2)	ALDH2 (1.2)	GMPR (1.2)
ENSG00000196557	CACNA1H PPI subnetwork	1.00	> 0.20	PLEKHH2 (1.7)	ENSG00000226645 (1.6)	PMFBP1 (1.5)	GATAD2A (1.5)	ADAM1 (1.4)	ZHX3 (1.4)	PPP1R37 (1.3)	NCAN (1.3)	SH2B3 (1.3)	YIPF2 (1.2)
ENSG00000198932	GPRASP1 PPI subnetwork	1.00	> 0.20	HAVCR1 (3.1)	GEMIN7 (3.0)	AMIGO1 (2.5)	PSMA5 (2.2)	C12orf43 (2.1)	KIAA1324 (1.9)	RPH3A (1.8)	CYB561D1 (1.6)	ENSG00000235545 (1.6)	PSRC1 (1.6)
GO:0008021	synaptic vesicle	1.00	> 0.20	RPH3A (3.9)	HAPLN4 (3.5)	AMIGO1 (2.3)	CELSR2 (2.0)	SORT1 (1.7)	KIAA1324 (1.6)	CLPTM1 (1.5)	GRINA (1.3)	GEMIN7 (1.2)	PMFBP1 (1.1)
ENSG00000174851	YIF1A PPI subnetwork	1.00	> 0.20	TMEM50A (2.7)	COL4A3BP (2.4)	CLPTM1 (2.3)	GRINA (2.3)	YIPF2 (2.2)	ENSG00000228044 (1.8)	CEACAM19 (1.8)	PMFBP1 (1.5)	AP1M2 (1.4)	MAU2 (1.4)
ENSG00000168172	HOOK3 PPI subnetwork	1.00	> 0.20	NCAN (2.7)	CELSR2 (2.2)	RPH3A (2.1)	C12orf51 (2.0)	SORT1 (1.8)	MARK4 (1.5)	UBXN2B (1.5)	C12orf43 (1.4)	TMEM50A (1.4)	SARS (1.3)
ENSG00000140941	MAP1LC3B PPI subnetwork	1.00	> 0.20	TXNL4B (3.8)	MAU2 (3.2)	C1orf63 (2.9)	BLOC1S3 (2.1)	COL4A3BP (2.0)	SARS (2.0)	SUGP1 (1.9)	PMFBP1 (1.9)	ATXN2 (1.8)	UBXN2B (1.7)
GO:0009581	detection of external stimulus	1.00	> 0.20	PMFBP1 (1.9)	GOT2P1 (1.7)	GEMIN7 (1.7)	OASL (1.3)	NKPD1 (1.2)	TMEM116 (1.2)	BLOC1S3 (1.1)	AMIGO1 (1.1)	TSSK6 (1.1)	TRAFD1 (1.1)
GO:0031294	lymphocyte costimulation	1.00	> 0.20	PLCG1 (3.4)	ZNF101 (2.3)	CETP (2.2)	TIMD4 (2.0)	CYB561D1 (1.7)	HAVCR1 (1.7)	OGDH (1.4)	POLK (1.4)	TMEM50A (1.3)	TMEM57 (1.2)
GO:0031295	T cell costimulation	1.00	> 0.20	PLCG1 (3.4)	ZNF101 (2.3)	CETP (2.2)	TIMD4 (2.0)	CYB561D1 (1.7)	HAVCR1 (1.7)	OGDH (1.4)	POLK (1.4)	TMEM50A (1.3)	TMEM57 (1.2)
ENSG00000163531	NFASC PPI subnetwork	1.00	> 0.20	NCAN (3.8)	ERP29 (3.4)	RPH3A (3.0)	CELSR2 (2.9)	BCAM (2.1)	TMED4 (1.9)	CLPTM1 (1.8)	ENSG00000254235 (1.6)	APOE (1.6)	YIPF2 (1.5)
MP:0001438	aphagia	1.00	> 0.20	USP24 (2.3)	NCAN (2.2)	C12orf47 (1.8)	CELSR2 (1.7)	DOCK7 (1.7)	CEACAM19 (1.6)	CYB561D1 (1.6)	CILP2 (1.5)	ATXN7L2 (1.5)	CBLC (1.4)
GO:0045342	MHC class II biosynthetic process	1.00	> 0.20	UBXN2B (1.7)	TIMD4 (1.5)	MAFB (1.4)	ITGB3 (1.2)	ERP29 (1.2)	RHD (1.2)	TRAFD1 (1.1)	PMFBP1 (1.0)	RHCE (1.0)	ADAM1 (1.0)
ENSG00000101150	TPD52L2 PPI subnetwork	1.00	> 0.20	NCAN (2.5)	C12orf51 (2.2)	C11orf9 (2.2)	CELSR2 (2.1)	SORT1 (2.1)	UBXN2B (1.8)	TMEM50A (1.7)	RPH3A (1.6)	C12orf43 (1.5)	GRINA (1.4)
GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	1.00	> 0.20	ADAM1 (2.8)	TRAPPC6A (2.0)	UBXN2B (1.9)	PMFBP1 (1.6)	ATXN7L2 (1.5)	ENSG00000238078 (1.4)	MAU2 (1.4)	YIPF2 (1.3)	BCAM (1.2)	ZNF180 (1.2)
ENSG00000079819	EPB41L2 PPI subnetwork	1.00	> 0.20	C12orf51 (2.5)	RPH3A (2.3)	NCAN (2.2)	TMEM50A (1.7)	GOT2P1 (1.6)	C11orf9 (1.5)	SORT1 (1.5)	UBXN2B (1.5)	CELSR2 (1.4)	FADS1 (1.3)
ENSG00000054356	PTPRN PPI subnetwork	1.00	> 0.20	HAPLN4 (3.3)	RPH3A (3.1)	KIAA1324 (2.5)	TMED4 (2.0)	ATXN7L2 (1.6)	PLEC (1.6)	AMIGO1 (1.6)	C12orf51 (1.5)	CELSR2 (1.4)	SMARCA4 (1.4)
ENSG00000105426	PTPRS PPI subnetwork	1.00	> 0.20	NCAN (2.3)	MYLIP (2.3)	ERP29 (2.0)	PLCG1 (2.0)	PPP1R37 (1.9)	HAVCR1 (1.6)	SLC44A2 (1.2)	PSRC1 (1.2)	C12orf51 (1.2)	ZNF180 (0.9)
GO:0002504	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	1.00	> 0.20	ALDH2 (1.8)	C19orf52 (1.7)	YIPF2 (1.6)	DOCK7 (1.6)	TMED4 (1.6)	NKPD1 (1.4)	GEMIN7 (1.4)	C17orf57 (1.3)	RHCE (1.2)	ADAM1 (1.2)
REACTOME_ACTIVATION_OF_NICOTINIC_ACETYLCHOLINE_RECEPTORS	REACTOME_ACTIVATION_OF_NICOTINIC_ACETYLCHOLINE_RECEPTORS	1.00	> 0.20	SYPL2 (2.3)	PMFBP1 (2.2)	ATXN7L2 (2.1)	CILP2 (1.5)	NKPD1 (1.5)	ABO (1.4)	PLEKHH2 (1.4)	MOSC1 (1.3)	AMIGO1 (1.3)	SORT1 (1.3)
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	1.00	> 0.20	SYPL2 (2.3)	PMFBP1 (2.2)	ATXN7L2 (2.1)	CILP2 (1.5)	NKPD1 (1.5)	ABO (1.4)	PLEKHH2 (1.4)	MOSC1 (1.3)	AMIGO1 (1.3)	SORT1 (1.3)
REACTOME_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	REACTOME_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	1.00	> 0.20	SYPL2 (2.3)	PMFBP1 (2.2)	ATXN7L2 (2.1)	CILP2 (1.5)	NKPD1 (1.5)	ABO (1.4)	PLEKHH2 (1.4)	MOSC1 (1.3)	AMIGO1 (1.3)	SORT1 (1.3)
ENSG00000047932	GOPC PPI subnetwork	1.00	> 0.20	APOE (2.4)	RPH3A (2.0)	NCAN (1.9)	ACAD10 (1.8)	C12orf51 (1.7)	C17orf57 (1.6)	TRAPPC6A (1.6)	FRK (1.4)	MAFB (1.4)	TMEM50A (1.4)
GO:0001840	neural plate development	1.00	> 0.20	TMEM116 (2.3)	LPAR2 (2.0)	AMIGO1 (1.8)	ATXN7L2 (1.8)	SLC44A2 (1.7)	C19orf52 (1.5)	NYNRIN (1.5)	ABO (1.5)	NKPD1 (1.4)	PLCG1 (1.4)
MP:0001384	abnormal pup retrieval	1.00	> 0.20	RPH3A (3.1)	KIAA1324 (2.4)	AMIGO1 (1.9)	MOSC1 (1.9)	CETP (1.8)	HAPLN4 (1.6)	C12orf51 (1.5)	PLEKHH2 (1.5)	TIMD4 (1.4)	MARK4 (1.4)
ENSG00000167645	YIF1B PPI subnetwork	1.00	> 0.20	COL4A3BP (2.7)	TMEM50A (2.7)	YIPF2 (2.3)	ENSG00000228044 (1.8)	CILP2 (1.8)	HAVCR1 (1.6)	CLPTM1 (1.5)	TMEM57 (1.5)	GRINA (1.5)	SARS (1.4)
GO:0009190	cyclic nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (4.0)	PMFBP1 (2.0)	ABO (2.0)	RPH3A (1.8)	AMIGO1 (1.7)	TSSK6 (1.5)	LPIN3 (1.4)	ENSG00000228044 (1.2)	CELSR2 (1.2)	CETP (1.1)
GO:0050803	regulation of synapse structure and activity	1.00	> 0.20	NCAN (3.0)	RPH3A (2.8)	LPIN3 (2.7)	ABO (2.5)	CELSR2 (2.3)	ZHX3 (2.1)	CEACAM19 (2.0)	CBLC (2.0)	HNF1A (1.8)	KIAA1324 (1.8)
GO:0048368	lateral mesoderm development	1.00	> 0.20	BLOC1S3 (2.0)	TMEM116 (1.7)	ENSG00000226648 (1.7)	LPIN3 (1.5)	KANK2 (1.5)	DOCK7 (1.5)	DYNC2LI1 (1.4)	ZNF101 (1.4)	AMIGO1 (1.4)	NKPD1 (1.3)
ENSG00000176903	PNMA1 PPI subnetwork	1.00	> 0.20	DYNC2LI1 (3.7)	POLK (2.5)	C11orf9 (2.2)	KANK2 (2.0)	PVR (1.9)	ZNF180 (1.8)	HAVCR1 (1.7)	CELSR2 (1.7)	C12orf51 (1.5)	ERP29 (1.4)
ENSG00000124194	GDAP1L1 PPI subnetwork	1.00	> 0.20	PVR (1.8)	APOE (1.8)	HNF1A (1.7)	ERP29 (1.7)	TIMD4 (1.6)	ZNF180 (1.5)	PTPN11 (1.5)	POLK (1.3)	ENSG00000235545 (1.3)	KANK2 (1.2)
GO:0032620	interleukin-17 production	1.00	> 0.20	TRAFD1 (1.5)	TIMD4 (1.5)	ENSG00000226645 (1.5)	HLX (1.2)	ENSG00000235545 (1.2)	TXNL4B (1.2)	GCNT4 (1.1)	SH2B3 (1.0)	SLC22A1 (1.0)	ADAM1 (1.0)
GO:0032660	regulation of interleukin-17 production	1.00	> 0.20	TRAFD1 (1.5)	TIMD4 (1.5)	ENSG00000226645 (1.5)	HLX (1.2)	ENSG00000235545 (1.2)	TXNL4B (1.2)	GCNT4 (1.1)	SH2B3 (1.0)	SLC22A1 (1.0)	ADAM1 (1.0)
GO:0048675	axon extension	1.00	> 0.20	C12orf47 (2.5)	ENSG00000238078 (2.3)	ATXN7L2 (2.0)	CELSR2 (1.9)	PMFBP1 (1.6)	TMEM50A (1.6)	ACAD10 (1.4)	LPAR2 (1.4)	PBX4 (1.2)	AMIGO1 (1.2)
GO:0031113	regulation of microtubule polymerization	1.00	> 0.20	PBX4 (3.1)	C17orf57 (1.8)	UBXN2B (1.7)	SORT1 (1.5)	CELSR2 (1.5)	C12orf51 (1.5)	BLOC1S3 (1.4)	POC5 (1.4)	C12orf47 (1.4)	POLK (1.3)
ENSG00000167460	TPM4 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	MOSC1 (2.0)	ILF3 (2.0)	PTPN11 (1.8)	NYNRIN (1.7)	PSRC1 (1.7)	C19orf52 (1.6)	GATAD2A (1.6)	ENSG00000235545 (1.4)	SYPL2 (1.4)
GO:0001964	startle response	1.00	> 0.20	DNAH11 (3.5)	AMIGO1 (2.2)	NKPD1 (2.1)	TSSK6 (1.8)	RPH3A (1.6)	NCAN (1.6)	ABO (1.6)	C12orf43 (1.6)	ANKRD31 (1.3)	PPP1R37 (1.1)
MP:0009038	decreased inferior colliculus size	1.00	> 0.20	ANKRD31 (2.2)	PCSK9 (1.6)	SLC44A2 (1.4)	HAVCR1 (1.4)	TRIB1 (1.3)	TMEM116 (1.2)	CARM1 (1.1)	NCAN (1.1)	C12orf47 (1.0)	TSSK6 (1.0)
GO:0032412	regulation of ion transmembrane transporter activity	1.00	> 0.20	SYPL2 (3.0)	AMIGO1 (2.4)	RPH3A (2.1)	PLEKHH2 (1.9)	CYB561D1 (1.9)	TSSK6 (1.6)	KIAA1324 (1.5)	PPP1R37 (1.5)	C12orf47 (1.4)	PVR (1.3)
ENSG00000063245	EPN1 PPI subnetwork	1.00	> 0.20	C12orf51 (3.1)	DNM2 (2.4)	COL4A3BP (2.3)	MAU2 (1.8)	MYLIP (1.6)	SH2B3 (1.6)	ENSG00000235545 (1.5)	USP24 (1.5)	C1orf63 (1.4)	GMPR (1.4)
GO:0045104	intermediate filament cytoskeleton organization	1.00	> 0.20	C17orf57 (2.5)	NKPD1 (1.7)	ENSG00000226648 (1.5)	GOT2P1 (1.5)	BRAP (1.3)	HAPLN4 (1.2)	RPH3A (1.0)	TM6SF2 (1.0)	RHCE (0.9)	COL4A3BP (0.9)
ENSG00000111087	GLI1 PPI subnetwork	1.00	> 0.20	GATAD2A (3.1)	PTPN11 (2.4)	MAU2 (2.3)	SUGP1 (2.2)	PMFBP1 (2.1)	DNM2 (2.1)	MARK4 (2.0)	POLK (1.7)	ENSG00000226645 (1.6)	ZHX3 (1.6)
ENSG00000070961	ATP2B1 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	SORT1 (2.2)	RPH3A (2.1)	CELSR2 (2.0)	FADS1 (2.0)	MARK4 (1.9)	C12orf51 (1.8)	AMIGO1 (1.6)	HLX (1.5)	FADS2 (1.4)
ENSG00000166086	JAM3 PPI subnetwork	1.00	> 0.20	UBXN2B (2.3)	PVRL2 (2.2)	APOC1 (2.1)	SORT1 (1.9)	ENSG00000226648 (1.7)	AP1M2 (1.5)	ENSG00000235545 (1.4)	POLK (1.4)	C11orf9 (1.4)	DHODH (1.3)
GO:0030178	negative regulation of Wnt receptor signaling pathway	1.00	> 0.20	CILP2 (2.1)	ENSG00000254235 (1.5)	DOCK7 (1.4)	ATXN2 (1.4)	NYNRIN (1.4)	TSSK6 (1.4)	PLCG1 (1.3)	MARK4 (1.3)	ATXN7L2 (1.0)	PPP1R37 (1.0)
MP:0002741	small olfactory bulb	1.00	> 0.20	NCAN (4.1)	DYNC2LI1 (2.8)	GPAM (2.3)	DNAH11 (1.9)	ENSG00000235545 (1.7)	TMED4 (1.5)	ATXN2 (1.4)	CILP2 (1.3)	NYNRIN (1.3)	C17orf57 (1.2)
GO:0032312	regulation of ARF GTPase activity	1.00	> 0.20	ZHX3 (2.5)	PLCG1 (2.5)	PPP1R37 (2.0)	LPIN3 (1.7)	SH2B3 (1.7)	DNM2 (1.7)	C11orf9 (1.7)	MAU2 (1.6)	MAPKAPK5 (1.6)	PMFBP1 (1.6)
GO:0060601	lateral sprouting from an epithelium	1.00	> 0.20	NYNRIN (2.9)	PLEKHH2 (2.4)	LPAR2 (2.2)	ENSG00000228044 (2.0)	AMIGO1 (1.7)	BLOC1S3 (1.5)	ENSG00000235545 (1.5)	BCAM (1.4)	PVRL2 (1.3)	ATXN7L2 (1.2)
GO:0070243	regulation of thymocyte apoptotic process	1.00	> 0.20	HNF1A (2.5)	PBX4 (2.1)	GMIP (2.1)	CEACAM19 (1.7)	ATXN7L2 (1.4)	GCNT4 (1.4)	CYB561D1 (1.3)	C12orf47 (1.3)	ITGB3 (1.2)	TXNL4B (1.0)
GO:0005929	cilium	1.00	> 0.20	DYNC2LI1 (6.8)	DNAH11 (3.0)	POC5 (1.1)	DOCK7 (1.0)	POLK (1.0)	PBX4 (1.0)	PLEKHH2 (0.9)	PMFBP1 (0.7)	PSRC1 (0.7)	ZHX3 (0.7)
MP:0001415	increased exploration in new environment	1.00	> 0.20	CELSR2 (2.8)	ENSG00000235545 (2.2)	RPH3A (2.1)	NCAN (1.8)	ATXN2 (1.7)	ACAD10 (1.6)	C11orf9 (1.6)	GOT2P1 (1.6)	DOCK7 (1.5)	C12orf47 (1.5)
ENSG00000092531	SNAP23 PPI subnetwork	1.00	> 0.20	CYB561D1 (2.5)	COL4A3BP (2.1)	DNM2 (1.9)	TMEM50A (1.9)	C1orf63 (1.9)	AP1M2 (1.9)	SORT1 (1.8)	POLK (1.7)	KIAA1324 (1.6)	C12orf43 (1.5)
GO:0051899	membrane depolarization	1.00	> 0.20	RPH3A (3.7)	C12orf47 (2.7)	ADAM1 (2.3)	HAPLN4 (2.3)	ABO (1.6)	ATXN7L2 (1.5)	TMEM50A (1.4)	POLK (1.4)	PPP1R37 (1.3)	ENSG00000226645 (1.2)
MP:0002916	increased synaptic depression	1.00	> 0.20	RPH3A (3.1)	C12orf51 (2.4)	HAPLN4 (2.2)	AMIGO1 (2.0)	ENSG00000226645 (1.6)	PMFBP1 (1.5)	HAVCR1 (1.5)	ENSG00000238078 (1.4)	C12orf43 (1.2)	MARK4 (1.2)
GO:0042596	fear response	1.00	> 0.20	ENSG00000235545 (4.8)	DNAH11 (2.6)	C12orf47 (2.2)	GCNT4 (2.2)	TSSK6 (1.8)	NCAN (1.5)	RPH3A (1.3)	ZNF180 (1.1)	ENSG00000226648 (1.1)	TMEM50A (1.1)
GO:0007164	establishment of tissue polarity	1.00	> 0.20	ATXN7L2 (3.4)	CELSR2 (1.8)	NYNRIN (1.7)	ABO (1.6)	DYNC2LI1 (1.6)	TMEM116 (1.4)	TMED4 (1.3)	PLEKHH2 (1.3)	AP1M2 (1.3)	BCAM (1.2)
GO:0008045	motor axon guidance	1.00	> 0.20	LPAR2 (3.2)	ENSG00000238078 (2.3)	ENSG00000228044 (2.3)	PMFBP1 (2.2)	ANKRD31 (1.7)	CEACAM19 (1.6)	TMEM116 (1.5)	PBX4 (1.4)	GEMIN7 (1.3)	DNAH11 (1.3)
MP:0000955	abnormal spinal cord morphology	1.00	> 0.20	DYNC2LI1 (3.7)	NCAN (3.0)	DOCK7 (2.8)	CILP2 (2.2)	HAPLN4 (2.1)	ZHX3 (1.8)	ACAD10 (1.6)	CELSR2 (1.6)	UBXN2B (1.4)	CLPTM1 (1.2)
GO:0034654	nucleobase-containing compound biosynthetic process	1.00	> 0.20	C12orf47 (2.7)	AMIGO1 (1.9)	SYPL2 (1.9)	PMFBP1 (1.9)	LPIN3 (1.8)	RPH3A (1.8)	ENSG00000226648 (1.7)	GOT2P1 (1.6)	HNF1A (1.6)	TSSK6 (1.4)
GO:0046854	phosphatidylinositol phosphorylation	1.00	> 0.20	BLOC1S3 (2.7)	PPP1R37 (2.0)	MAU2 (1.8)	HAPLN4 (1.7)	BRAP (1.5)	C12orf51 (1.3)	CYB561D1 (1.2)	GATAD2A (1.2)	PMFBP1 (1.2)	C19orf52 (1.2)
ENSG00000184203	PPP1R2 PPI subnetwork	1.00	> 0.20	ERP29 (3.5)	CLPTM1 (2.7)	RPH3A (2.6)	BCAM (2.4)	CELSR2 (2.3)	GRINA (2.3)	TMED4 (2.3)	YIPF2 (2.0)	NCAN (1.7)	PTPN11 (1.6)
ENSG00000187558	ENSG00000187558 PPI subnetwork	1.00	> 0.20	ERP29 (3.5)	CLPTM1 (2.7)	RPH3A (2.6)	BCAM (2.4)	CELSR2 (2.3)	GRINA (2.3)	TMED4 (2.3)	YIPF2 (2.0)	NCAN (1.7)	PTPN11 (1.6)
GO:0019228	regulation of action potential in neuron	1.00	> 0.20	C11orf9 (3.0)	SORT1 (2.3)	HAPLN4 (2.2)	RPH3A (2.0)	NKPD1 (2.0)	NCAN (1.4)	ANKRD31 (1.3)	TXNL4B (1.3)	BCAM (1.3)	C12orf43 (1.1)
MP:0009712	impaired conditioned place preference behavior	1.00	> 0.20	TSSK6 (2.2)	C12orf47 (2.0)	KIAA1324 (1.9)	LPA (1.7)	CELSR2 (1.6)	C11orf9 (1.4)	RPH3A (1.4)	PMFBP1 (1.2)	PLCG1 (1.2)	NPC1L1 (1.2)
GO:0043198	dendritic shaft	1.00	> 0.20	NCAN (3.7)	GCNT4 (2.5)	CLPTM1 (2.4)	RPH3A (2.4)	SORT1 (2.0)	TMEM50A (1.8)	CELSR2 (1.8)	CYB561D1 (1.7)	HAPLN4 (1.6)	PTPN11 (1.5)
GO:0009798	axis specification	1.00	> 0.20	LPAR2 (2.0)	C11orf9 (1.9)	PVRL2 (1.7)	CEACAM19 (1.6)	DOCK7 (1.6)	BCAM (1.6)	NYNRIN (1.5)	ABO (1.5)	TSSK6 (1.4)	ENSG00000238078 (1.3)
GO:0060042	retina morphogenesis in camera-type eye	1.00	> 0.20	HNF1A (2.3)	YIPF2 (1.6)	HAVCR1 (1.5)	SORT1 (1.5)	TMED4 (1.5)	GEMIN7 (1.4)	PMFBP1 (1.4)	KIAA1324 (1.4)	C12orf47 (1.2)	ENSG00000235545 (1.2)
ENSG00000058799	YIPF1 PPI subnetwork	1.00	> 0.20	ANKRD31 (2.7)	FRK (2.1)	GRINA (2.1)	TMEM50A (2.0)	TMEM57 (1.9)	COL4A3BP (1.6)	YIPF2 (1.6)	C12orf43 (1.5)	C11orf9 (1.4)	NYNRIN (1.3)
GO:0072132	mesenchyme morphogenesis	1.00	> 0.20	LPIN3 (2.0)	ABO (1.8)	CYB561D1 (1.5)	ENSG00000226645 (1.5)	ZNF101 (1.3)	GEMIN7 (1.2)	BLOC1S3 (1.2)	TRAPPC6A (1.1)	GATAD2A (1.0)	MYLIP (1.0)
GO:0000381	regulation of alternative nuclear mRNA splicing, via spliceosome	1.00	> 0.20	C1orf63 (2.7)	C17orf57 (2.4)	FRK (1.5)	ADAM1 (1.4)	MAU2 (1.4)	ANKRD31 (1.3)	TOP1 (1.2)	QTRT1 (1.2)	LPIN3 (1.1)	BUD13 (1.1)
GO:0004012	phospholipid-translocating ATPase activity	1.00	> 0.20	SORT1 (2.1)	HNF1A (1.8)	AMIGO1 (1.7)	COL4A3BP (1.6)	POLK (1.5)	PMFBP1 (1.4)	TMEM116 (1.3)	LDLR (1.2)	TMED4 (1.1)	NT5DC1 (1.1)
GO:0060071	Wnt receptor signaling pathway, planar cell polarity pathway	1.00	> 0.20	NYNRIN (2.5)	ATXN7L2 (2.5)	TMEM116 (2.3)	AP1M2 (1.9)	CILP2 (1.8)	PLEKHH2 (1.7)	DYNC2LI1 (1.6)	TMED4 (1.6)	LPAR2 (1.5)	PLCG1 (1.4)
GO:0090175	regulation of establishment of planar polarity	1.00	> 0.20	NYNRIN (2.5)	ATXN7L2 (2.5)	TMEM116 (2.3)	AP1M2 (1.9)	CILP2 (1.8)	PLEKHH2 (1.7)	DYNC2LI1 (1.6)	TMED4 (1.6)	LPAR2 (1.5)	PLCG1 (1.4)
GO:0009262	deoxyribonucleotide metabolic process	1.00	> 0.20	TRAPPC6A (2.8)	NT5DC1 (2.5)	ENSG00000226648 (2.3)	ANKRD31 (2.2)	DYNC2LI1 (2.1)	TXNL4B (1.9)	TMEM116 (1.8)	ACAD10 (1.7)	LPIN3 (1.6)	CEACAM19 (1.5)
MP:0003755	abnormal palate morphology	1.00	> 0.20	DYNC2LI1 (1.7)	TRIB1 (1.6)	KANK2 (1.6)	MYLIP (1.4)	PMFBP1 (1.1)	KIAA1324 (1.1)	ENSG00000235545 (1.0)	MAFB (1.0)	ZHX3 (1.0)	DNAH11 (0.9)
ENSG00000092964	DPYSL2 PPI subnetwork	1.00	> 0.20	NCAN (2.7)	RPH3A (2.3)	C11orf9 (2.1)	CELSR2 (2.0)	C12orf47 (1.9)	C12orf43 (1.9)	GOT2P1 (1.7)	NYNRIN (1.7)	UBXN2B (1.4)	C12orf51 (1.4)
MP:0001440	abnormal grooming behavior	1.00	> 0.20	C11orf9 (2.6)	PMFBP1 (2.1)	NCAN (1.9)	ADAM1 (1.6)	HAPLN4 (1.5)	CELSR2 (1.2)	TRIB1 (1.1)	ATXN7L2 (1.1)	SORT1 (1.0)	PTPN11 (1.0)
ENSG00000171723	GPHN PPI subnetwork	1.00	> 0.20	SARS (4.3)	SMARCA4 (3.3)	HAVCR1 (2.7)	C12orf51 (2.7)	BRAP (2.3)	FADS2 (1.9)	SYPL2 (1.9)	ATXN2 (1.9)	SUGP1 (1.7)	ACAD10 (1.6)
GO:0005834	heterotrimeric G-protein complex	1.00	> 0.20	ITGB3 (3.3)	TMEM50A (2.6)	CETP (2.4)	RPH3A (2.2)	SH2B3 (1.7)	HLX (1.1)	ABCG8 (1.1)	TM6SF2 (1.0)	MARK4 (1.0)	KIAA1324 (1.0)
GO:0050807	regulation of synapse organization	1.00	> 0.20	NCAN (2.9)	ABO (2.7)	CEACAM19 (2.7)	ZHX3 (2.5)	RPH3A (2.5)	CELSR2 (2.1)	ENSG00000226645 (2.1)	CBLC (2.0)	LPIN3 (2.0)	HAPLN4 (1.9)
GO:0005234	extracellular-glutamate-gated ion channel activity	1.00	> 0.20	NCAN (4.5)	RPH3A (2.5)	ABO (1.9)	PPP1R37 (1.6)	C11orf9 (1.5)	USP24 (1.4)	APOE (1.1)	CELSR2 (1.1)	PCSK9 (1.0)	C12orf43 (0.9)
ENSG00000139323	POC1B PPI subnetwork	1.00	> 0.20	C19orf52 (2.2)	FEN1 (1.9)	ZNF180 (1.9)	BUD13 (1.9)	KANK2 (1.8)	BLOC1S3 (1.3)	ANKRD31 (1.2)	ILF3 (1.1)	YIPF2 (1.0)	C1orf63 (1.0)
GO:0006140	regulation of nucleotide metabolic process	1.00	> 0.20	ZHX3 (2.8)	ENSG00000226645 (2.6)	HLX (1.9)	C12orf51 (1.8)	ENSG00000228044 (1.8)	LPIN3 (1.7)	C12orf47 (1.5)	PLEKHH2 (1.4)	RPH3A (1.4)	ABO (1.4)
ENSG00000172794	RAB37 PPI subnetwork	1.00	> 0.20	C12orf47 (2.5)	NCAN (2.4)	CELSR2 (2.3)	C11orf9 (2.1)	UBXN2B (2.0)	RPH3A (1.8)	C12orf43 (1.7)	C12orf51 (1.7)	GOT2P1 (1.6)	SORT1 (1.6)
ENSG00000115760	BIRC6 PPI subnetwork	1.00	> 0.20	NCAN (2.2)	C12orf51 (2.2)	TMEM50A (1.9)	RPH3A (1.9)	C11orf9 (1.7)	SORT1 (1.7)	PSRC1 (1.6)	C1orf63 (1.5)	GOT2P1 (1.5)	C12orf43 (1.4)
MP:0001963	abnormal hearing physiology	1.00	> 0.20	ENSG00000226648 (2.2)	GMPR (1.8)	HAPLN4 (1.8)	PLEKHH2 (1.8)	HNF1A (1.7)	RPH3A (1.6)	APOE (1.5)	PTPN11 (1.3)	MYLIP (1.2)	ATXN2 (1.2)
ENSG00000171700	RGS19 PPI subnetwork	1.00	> 0.20	SORT1 (2.6)	TXNL4B (2.6)	CYB561D1 (2.4)	ITGB3 (2.4)	CARM1 (2.3)	MARK4 (2.3)	DNM2 (2.1)	TMEM50A (1.9)	BLOC1S3 (1.9)	NCAN (1.8)
GO:0045263	proton-transporting ATP synthase complex, coupling factor F(o)	1.00	> 0.20	C12orf47 (3.6)	ACAD10 (3.0)	OGDH (2.7)	PSMA5 (2.1)	TRAPPC6A (1.8)	TMEM116 (1.7)	GOT2P1 (1.7)	ENSG00000238078 (1.5)	SORT1 (1.4)	HNF1A (1.3)
ENSG00000018236	CNTN1 PPI subnetwork	1.00	> 0.20	CELSR2 (4.2)	NCAN (3.4)	ERP29 (3.3)	RPH3A (3.0)	GRINA (2.5)	TMED4 (2.3)	BCAM (2.2)	ENSG00000254235 (2.2)	CLPTM1 (2.0)	HAPLN4 (1.8)
ENSG00000163430	FSTL1 PPI subnetwork	1.00	> 0.20	HNF1A (1.9)	PVR (1.9)	MAFB (1.7)	APOE (1.6)	ZNF180 (1.6)	TIMD4 (1.6)	POLK (1.6)	PTPN11 (1.5)	ERP29 (1.5)	ALDH2 (1.4)
REACTOME_DEPOLARIZATION_OF_THE_PRESYNAPTIC_TERMINAL_TRIGGERS_THE_OPENING_OF_CALCIUM_CHANNELS	REACTOME_DEPOLARIZATION_OF_THE_PRESYNAPTIC_TERMINAL_TRIGGERS_THE_OPENING_OF_CALCIUM_CHANNELS	1.00	> 0.20	RPH3A (3.4)	ABO (2.1)	PLEKHH2 (1.8)	AMIGO1 (1.7)	ADAM1 (1.7)	KIAA1324 (1.6)	PVR (1.5)	TMEM57 (1.3)	C12orf51 (1.3)	GMPR (1.3)
ENSG00000076554	TPD52 PPI subnetwork	1.00	> 0.20	NCAN (2.3)	C12orf51 (2.1)	C12orf43 (2.0)	CELSR2 (1.9)	RPH3A (1.8)	SORT1 (1.8)	UBXN2B (1.7)	GOT2P1 (1.6)	C11orf9 (1.5)	TMEM50A (1.4)
GO:0048839	inner ear development	1.00	> 0.20	C17orf57 (1.9)	DYNC2LI1 (1.8)	CILP2 (1.7)	PLEKHH2 (1.6)	NKPD1 (1.6)	ENSG00000238078 (1.3)	TMED4 (1.3)	TSSK6 (1.2)	GOT2P1 (1.2)	BLOC1S3 (1.1)
GO:0030672	synaptic vesicle membrane	1.00	> 0.20	RPH3A (5.1)	HAPLN4 (4.3)	AMIGO1 (2.2)	KIAA1324 (2.0)	CELSR2 (2.0)	PPP1R37 (1.5)	SORT1 (1.3)	PMFBP1 (1.2)	GCNT4 (1.1)	GRINA (1.1)
ENSG00000146463	ZMYM4 PPI subnetwork	1.00	> 0.20	ZHX3 (3.0)	DYNC2LI1 (2.0)	TMEM50A (2.0)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	CYB561D1 (1.6)	NYNRIN (1.2)	GEMIN7 (1.1)	ITGB3 (1.1)	ENSG00000254235 (1.1)
GO:0043679	axon terminus	1.00	> 0.20	KIAA1324 (3.3)	RPH3A (2.5)	HAPLN4 (2.4)	ABO (2.3)	C12orf47 (2.1)	ERP29 (1.6)	C12orf43 (1.5)	TSSK6 (1.5)	SH2B3 (1.4)	CELSR2 (1.3)
ENSG00000138758	SEPT11 PPI subnetwork	1.00	> 0.20	NCAN (2.8)	RPH3A (2.4)	C12orf51 (2.0)	C11orf9 (1.9)	SORT1 (1.9)	UBXN2B (1.9)	TMEM50A (1.7)	MARK4 (1.6)	HAPLN4 (1.5)	FADS1 (1.5)
MP:0004021	abnormal rod electrophysiology	1.00	> 0.20	ENSG00000235545 (2.1)	TSSK6 (1.4)	ENSG00000226648 (1.3)	DYNC2LI1 (1.3)	C12orf47 (1.2)	ST3GAL4 (1.2)	GPAM (1.2)	MAPKAPK5 (1.1)	PSRC1 (1.0)	LPIN3 (0.9)
ENSG00000125814	NAPB PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	NCAN (2.6)	C12orf51 (2.1)	TMEM50A (2.0)	SORT1 (1.9)	C11orf9 (1.5)	MARK4 (1.5)	FADS1 (1.5)	CELSR2 (1.5)	C12orf43 (1.4)
ENSG00000175305	CCNE2 PPI subnetwork	1.00	> 0.20	MAPKAPK5 (2.5)	POLK (2.4)	MARK4 (2.1)	PSRC1 (2.0)	RHCE (1.8)	GRINA (1.7)	USP1 (1.5)	FEN1 (1.5)	CEACAM19 (1.4)	KANK2 (1.3)
ENSG00000006740	ARHGAP44 PPI subnetwork	1.00	> 0.20	RPH3A (2.6)	NCAN (2.3)	SORT1 (2.3)	C12orf51 (2.2)	TMEM50A (2.1)	UBXN2B (1.8)	MARK4 (1.8)	CELSR2 (1.7)	ALDH2 (1.5)	FADS1 (1.5)
MP:0005402	abnormal action potential	1.00	> 0.20	RPH3A (4.6)	HAPLN4 (4.0)	PMFBP1 (1.4)	PCSK9 (1.4)	AMIGO1 (1.3)	TSSK6 (1.2)	SORT1 (1.1)	BCAM (1.1)	COL4A3BP (1.1)	HLX (1.0)
ENSG00000100321	SYNGR1 PPI subnetwork	1.00	> 0.20	NCAN (3.0)	RPH3A (2.8)	SORT1 (2.5)	C11orf9 (2.3)	CELSR2 (2.2)	ENSG00000235545 (1.9)	HAPLN4 (1.8)	FRK (1.8)	C12orf43 (1.7)	ENSG00000226648 (1.6)
ENSG00000177301	KCNA2 PPI subnetwork	1.00	> 0.20	RPH3A (2.6)	HAPLN4 (2.6)	C11orf9 (2.2)	GCNT4 (1.9)	ERP29 (1.6)	HAVCR1 (1.6)	ILF3 (1.5)	HNF1A (1.4)	PLCG1 (1.3)	DYNC2LI1 (1.0)
ENSG00000105695	MAG PPI subnetwork	1.00	> 0.20	CILP2 (4.4)	APOE (2.2)	PBX4 (1.5)	SH2B3 (1.4)	PLEC (1.3)	PSRC1 (1.3)	MYLIP (1.1)	ATXN7L2 (1.1)	MOSC1 (1.1)	CELSR2 (1.1)
MP:0009936	abnormal dendritic spine morphology	1.00	> 0.20	HLX (3.3)	NYNRIN (2.3)	PPP1R37 (1.8)	GCNT4 (1.7)	MYLIP (1.6)	CEACAM19 (1.6)	GRINA (1.3)	ACAD10 (1.3)	PLCG1 (1.2)	KANK2 (1.1)
GO:0015464	acetylcholine receptor activity	1.00	> 0.20	SORT1 (2.8)	SYPL2 (2.4)	NKPD1 (2.2)	C12orf47 (2.2)	CILP2 (1.9)	CYB561D1 (1.6)	ATXN7L2 (1.5)	GEMIN7 (1.5)	ENSG00000235545 (1.4)	CELSR2 (1.4)
ENSG00000132639	SNAP25 PPI subnetwork	1.00	> 0.20	HAPLN4 (3.9)	RPH3A (3.4)	C11orf9 (2.1)	C12orf43 (2.0)	C12orf51 (2.0)	COL4A3BP (1.7)	DNM2 (1.5)	SORT1 (1.5)	GRINA (1.5)	PLEKHH2 (1.4)
GO:0015491	cation:cation antiporter activity	1.00	> 0.20	CYB561D1 (1.9)	TMEM116 (1.8)	SYPL2 (1.8)	ENSG00000226645 (1.6)	NCAN (1.6)	CLPTM1 (1.6)	TMEM57 (1.6)	SORT1 (1.6)	PPP1R37 (1.4)	RPH3A (1.3)
GO:0043584	nose development	1.00	> 0.20	ENSG00000235545 (2.7)	DYNC2LI1 (2.5)	DNAH11 (2.3)	UBXN2B (1.7)	MAU2 (1.7)	NCAN (1.5)	TXNL4B (1.3)	CILP2 (1.3)	C19orf52 (1.3)	TMED4 (1.3)
GO:0018149	peptide cross-linking	1.00	> 0.20	NKPD1 (4.0)	CEACAM19 (3.1)	ENSG00000226648 (3.0)	PMFBP1 (1.5)	RHCE (1.3)	C17orf57 (1.1)	KANK2 (1.1)	GMPR (1.0)	LPIN3 (0.9)	AP1M2 (0.9)
GO:0019888	protein phosphatase regulator activity	1.00	> 0.20	CARM1 (2.7)	TMEM50A (1.9)	DNM2 (1.9)	COL4A3BP (1.8)	OASL (1.7)	BUD13 (1.7)	TOMM40 (1.6)	OGDH (1.6)	SLC44A2 (1.5)	CEACAM19 (1.4)
GO:0030004	cellular monovalent inorganic cation homeostasis	1.00	> 0.20	AMIGO1 (3.8)	ENSG00000235545 (3.1)	UBXN2B (2.5)	ERP29 (2.5)	HNF1A (2.0)	COL4A3BP (2.0)	PBX4 (1.6)	PPP1R37 (1.6)	ADAM1 (1.4)	TMEM116 (1.3)
GO:0009123	nucleoside monophosphate metabolic process	1.00	> 0.20	C12orf47 (3.5)	PMFBP1 (2.1)	AMIGO1 (1.8)	RPH3A (1.7)	TSSK6 (1.4)	LPIN3 (1.4)	ENSG00000228044 (1.3)	ABO (1.3)	ENSG00000226648 (1.0)	NCAN (1.0)
MP:0001463	abnormal spatial learning	1.00	> 0.20	NCAN (4.3)	RPH3A (3.7)	CELSR2 (3.2)	AMIGO1 (1.8)	C12orf47 (1.7)	C11orf9 (1.4)	HAPLN4 (1.4)	SORT1 (1.4)	CYP7A1 (1.3)	MARK4 (1.2)
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	1.00	> 0.20	PMFBP1 (1.9)	ATXN7L2 (1.9)	ABO (1.6)	MOSC1 (1.6)	ADAM1 (1.5)	SYPL2 (1.4)	SORT1 (1.2)	ANKRD31 (1.2)	GEMIN7 (1.1)	CILP2 (1.0)
GO:0050891	multicellular organismal water homeostasis	1.00	> 0.20	TSSK6 (2.9)	ENSG00000226648 (2.4)	ZHX3 (2.3)	AP1M2 (2.2)	GOT2P1 (1.6)	PBX4 (1.3)	RHCE (1.2)	CEACAM19 (1.2)	PLEC (1.2)	SYPL2 (1.1)
MP:0001961	abnormal reflex	1.00	> 0.20	HAPLN4 (3.5)	RPH3A (1.9)	TM6SF2 (1.8)	UBXN2B (1.7)	NPC1L1 (1.6)	NCAN (1.6)	CETP (1.2)	CEACAM19 (1.1)	LPA (1.1)	SYPL2 (1.1)
GO:0048713	regulation of oligodendrocyte differentiation	1.00	> 0.20	NCAN (3.2)	DNAH11 (2.6)	PBX4 (1.8)	NKPD1 (1.7)	DYNC2LI1 (1.5)	BLOC1S3 (1.4)	UBXN2B (1.4)	C11orf9 (1.3)	ABO (1.2)	C19orf52 (1.2)
GO:0043368	positive T cell selection	1.00	> 0.20	ZNF101 (3.8)	TMEM116 (3.4)	PLCG1 (3.1)	PBX4 (2.4)	C19orf52 (2.3)	ZHX3 (1.6)	NKPD1 (1.4)	GOT2P1 (1.4)	LPAR2 (1.3)	DYNC2LI1 (1.2)
GO:0048592	eye morphogenesis	1.00	> 0.20	DYNC2LI1 (2.1)	ZHX3 (1.5)	CILP2 (1.5)	PMFBP1 (1.4)	C11orf9 (1.2)	C17orf57 (1.1)	C19orf52 (1.1)	NCAN (1.1)	ENSG00000228044 (1.0)	PPP1R37 (1.0)
ENSG00000104497	SNX16 PPI subnetwork	1.00	> 0.20	HNF1A (2.0)	APOE (1.8)	ERP29 (1.8)	PVR (1.6)	PTPN11 (1.6)	TIMD4 (1.5)	ALDH2 (1.4)	TXNL4B (1.2)	HAPLN4 (1.1)	C12orf43 (1.1)
GO:0035020	regulation of Rac protein signal transduction	1.00	> 0.20	GEMIN7 (2.4)	LPAR2 (2.3)	TSSK6 (2.0)	MAPKAPK5 (1.6)	C12orf43 (1.5)	CELSR2 (1.5)	PBX4 (1.5)	TMEM116 (1.4)	NYNRIN (1.3)	ZHX3 (1.3)
ENSG00000198689	SLC9A6 PPI subnetwork	1.00	> 0.20	ERP29 (3.8)	SORT1 (3.6)	HMGCR (2.7)	ENSG00000235545 (2.3)	FADS1 (2.0)	COL4A3BP (1.9)	GPAM (1.8)	TMEM50A (1.7)	LDLR (1.6)	C19orf52 (1.5)
GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	1.00	> 0.20	AMIGO1 (2.7)	C12orf47 (2.5)	PMFBP1 (1.6)	RPH3A (1.6)	DNAH11 (1.6)	CELSR2 (1.5)	GOT2P1 (1.5)	KIAA1324 (1.3)	ENSG00000226645 (1.2)	ENSG00000235545 (1.2)
ENSG00000112038	OPRM1 PPI subnetwork	1.00	> 0.20	PVR (2.1)	NCAN (1.9)	TSSK6 (1.9)	C17orf57 (1.7)	NKPD1 (1.5)	TMEM50A (1.5)	C12orf47 (1.4)	PLEC (1.4)	C1orf63 (1.4)	BCAM (1.2)
ENSG00000123349	PFDN5 PPI subnetwork	1.00	> 0.20	C12orf47 (2.1)	HAVCR1 (1.8)	FEN1 (1.7)	ENSG00000226645 (1.7)	C12orf51 (1.7)	ILF3 (1.6)	ADAM1 (1.6)	USP1 (1.6)	SMARCA4 (1.6)	PSRC1 (1.5)
GO:0005484	SNAP receptor activity	1.00	> 0.20	BRAP (2.2)	MAPKAPK5 (2.1)	TRAFD1 (2.1)	COL4A3BP (2.1)	C19orf52 (2.1)	TMEM50A (2.0)	YIPF2 (1.8)	SUGP1 (1.7)	C1orf63 (1.5)	TXNL4B (1.5)
ENSG00000101333	PLCB4 PPI subnetwork	1.00	> 0.20	HAPLN4 (2.5)	RPH3A (2.1)	C12orf51 (1.8)	C17orf57 (1.7)	SMARCA4 (1.3)	ZHX3 (1.2)	MARK4 (1.2)	SH2B3 (1.2)	NAA25 (1.1)	PLEC (1.0)
GO:0032155	cell division site part	1.00	> 0.20	PSRC1 (3.2)	PBX4 (2.2)	ADAM1 (2.1)	HAVCR1 (2.1)	SH2B3 (1.8)	FEN1 (1.7)	PTPN11 (1.7)	POC5 (1.5)	OGDH (1.5)	DNM2 (1.4)
GO:0032153	cell division site	1.00	> 0.20	PSRC1 (3.2)	PBX4 (2.2)	ADAM1 (2.1)	HAVCR1 (2.1)	SH2B3 (1.8)	FEN1 (1.7)	PTPN11 (1.7)	POC5 (1.5)	OGDH (1.5)	DNM2 (1.4)
GO:0021954	central nervous system neuron development	1.00	> 0.20	NCAN (2.7)	CILP2 (2.3)	ABO (2.2)	C12orf47 (1.9)	KIAA1324 (1.6)	CELSR2 (1.5)	PBX4 (1.5)	PMFBP1 (1.4)	NKPD1 (1.3)	GCNT4 (1.3)
GO:0015301	anion:anion antiporter activity	1.00	> 0.20	TMEM116 (3.2)	PLG (2.3)	AMIGO1 (2.2)	BCAM (1.9)	ANGPTL3 (1.8)	PBX4 (1.8)	ENSG00000235545 (1.7)	TMED4 (1.7)	GOT2P1 (1.5)	OGDH (1.5)
ENSG00000169213	RAB3B PPI subnetwork	1.00	> 0.20	RPH3A (2.7)	NCAN (2.6)	CELSR2 (1.7)	AP1M2 (1.7)	C12orf51 (1.7)	HAPLN4 (1.6)	TMEM50A (1.5)	C11orf9 (1.5)	SORT1 (1.5)	MARK4 (1.4)
GO:0019935	cyclic-nucleotide-mediated signaling	1.00	> 0.20	AMIGO1 (2.3)	C12orf47 (2.1)	RPH3A (1.7)	DNAH11 (1.7)	ENSG00000235545 (1.5)	PMFBP1 (1.4)	CELSR2 (1.3)	KIAA1324 (1.2)	CETP (1.2)	NCAN (1.1)
GO:0051705	behavioral interaction between organisms	1.00	> 0.20	ZHX3 (3.1)	GOT2P1 (2.1)	AMIGO1 (2.0)	TSSK6 (1.8)	NKPD1 (1.8)	ERP29 (1.7)	TMED4 (1.6)	CBLC (1.5)	NCAN (1.5)	DNAH11 (1.4)
GO:0005452	inorganic anion exchanger activity	1.00	> 0.20	PLG (3.3)	BCAM (3.2)	ANGPTL3 (2.8)	GOT2P1 (2.1)	AMIGO1 (1.9)	TMEM116 (1.8)	CLPTM1 (1.8)	ENSG00000235545 (1.5)	NCAN (1.3)	ABO (1.3)
ENSG00000133275	CSNK1G2 PPI subnetwork	1.00	> 0.20	POLK (3.3)	GMIP (2.6)	LPAR2 (2.2)	GEMIN7 (1.6)	DHODH (1.5)	PLEKHH2 (1.5)	LPA (1.4)	ADAM1 (1.4)	CEACAM19 (1.4)	HAVCR1 (1.4)
ENSG00000093100	ENSG00000093100 PPI subnetwork	1.00	> 0.20	GPAM (2.9)	NKPD1 (2.3)	ZHX3 (2.2)	AMIGO1 (2.1)	ENSG00000235545 (1.8)	MAU2 (1.5)	PLCG1 (1.5)	CYB561D1 (1.3)	HLX (1.2)	DYNC2LI1 (1.2)
ENSG00000173660	UQCRH PPI subnetwork	1.00	> 0.20	TRAPPC6A (2.2)	OGDH (2.1)	ACAD10 (2.1)	TMEM116 (2.0)	C19orf52 (1.8)	UBXN2B (1.7)	SARS (1.5)	TRIB1 (1.3)	PMFBP1 (1.1)	C12orf47 (1.0)
MP:0002914	abnormal endplate potential	1.00	> 0.20	RPH3A (2.9)	BCAM (2.3)	PVR (2.3)	CILP2 (2.3)	HAVCR1 (2.3)	SYPL2 (2.2)	CYB561D1 (1.6)	ANKRD31 (1.5)	C12orf47 (1.5)	GEMIN7 (1.3)
MP:0004919	abnormal positive T cell selection	1.00	> 0.20	PLCG1 (4.5)	ZNF101 (2.5)	ZHX3 (1.8)	USP24 (1.7)	HAVCR1 (1.6)	GMIP (1.5)	PBX4 (1.4)	APOE (1.4)	C19orf52 (1.2)	LPAR2 (1.2)
ENSG00000158186	MRAS PPI subnetwork	1.00	> 0.20	GMIP (2.7)	COL4A3BP (2.4)	C11orf9 (2.1)	DNM2 (2.0)	USP24 (1.8)	SH2B3 (1.7)	GATAD2A (1.5)	SLC44A2 (1.5)	NCAN (1.4)	LPAR2 (1.3)
MP:0000947	convulsive seizures	1.00	> 0.20	HAPLN4 (4.4)	OASL (3.8)	RPH3A (3.7)	CELSR2 (2.0)	SORT1 (1.8)	PARP10 (1.3)	C12orf51 (1.2)	AP1M2 (1.2)	TSSK6 (1.1)	TXNL4B (1.0)
GO:0010659	cardiac muscle cell apoptotic process	1.00	> 0.20	CILP2 (2.3)	C17orf57 (2.2)	ENSG00000226648 (2.1)	TMEM116 (1.7)	C12orf47 (1.6)	ENSG00000228044 (1.4)	PMFBP1 (1.4)	TXNL4B (1.2)	ADAM1 (1.1)	SLC22A1 (1.1)
GO:0005104	fibroblast growth factor receptor binding	1.00	> 0.20	HAPLN4 (2.0)	PLEKHH2 (2.0)	TM6SF2 (1.7)	C11orf9 (1.7)	PVR (1.7)	PTPN11 (1.5)	ABO (1.5)	CEACAM19 (1.4)	ALDH2 (1.4)	KANK2 (1.3)
GO:0045061	thymic T cell selection	1.00	> 0.20	PBX4 (2.8)	PLCG1 (2.6)	TMEM116 (2.5)	ZNF101 (2.1)	GOT2P1 (1.5)	NKPD1 (1.5)	HAVCR1 (1.4)	POLK (1.2)	COL4A3BP (1.1)	OGDH (1.0)
GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	1.00	> 0.20	C12orf47 (2.6)	ENSG00000226645 (2.0)	RPH3A (1.9)	CELSR2 (1.8)	CETP (1.8)	ABO (1.6)	TSSK6 (1.5)	DNAH11 (1.2)	C12orf51 (1.1)	TMEM50A (1.1)
GO:0060070	canonical Wnt receptor signaling pathway	1.00	> 0.20	NYNRIN (2.3)	CILP2 (2.1)	PLEKHH2 (1.8)	BCAM (1.7)	ENSG00000238078 (1.6)	LPAR2 (1.6)	MARK4 (1.4)	PPP1R37 (1.4)	CBLC (1.4)	PLCG1 (1.3)
ENSG00000159164	SV2A PPI subnetwork	1.00	> 0.20	NCAN (2.6)	C12orf51 (2.5)	RPH3A (2.4)	CELSR2 (2.3)	SORT1 (2.0)	FADS1 (1.9)	UBXN2B (1.8)	HLX (1.5)	TMEM50A (1.5)	C12orf43 (1.4)
GO:0008188	neuropeptide receptor activity	1.00	> 0.20	RPH3A (2.0)	CELSR2 (1.9)	DNAH11 (1.8)	AMIGO1 (1.6)	C11orf9 (1.6)	FRK (1.6)	C12orf47 (1.5)	SYPL2 (1.3)	PMFBP1 (1.3)	ABO (1.3)
GO:0030808	regulation of nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (4.1)	ABO (2.3)	PMFBP1 (2.0)	AMIGO1 (1.8)	RPH3A (1.6)	CELSR2 (1.3)	CETP (1.3)	TSSK6 (1.2)	ENSG00000228044 (1.1)	LPIN3 (1.1)
GO:0030802	regulation of cyclic nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (4.1)	ABO (2.3)	PMFBP1 (2.0)	AMIGO1 (1.8)	RPH3A (1.6)	CELSR2 (1.3)	CETP (1.3)	TSSK6 (1.2)	ENSG00000228044 (1.1)	LPIN3 (1.1)
MP:0002913	abnormal PNS synaptic transmission	1.00	> 0.20	RPH3A (3.2)	SARS (2.6)	HAPLN4 (2.5)	HAVCR1 (2.5)	C12orf47 (1.8)	TSSK6 (1.5)	NYNRIN (1.4)	YIPF2 (1.4)	BLOC1S3 (1.4)	ZNF259 (1.3)
ENSG00000136653	RASSF5 PPI subnetwork	1.00	> 0.20	SLC44A2 (2.9)	MAPKAPK5 (2.9)	COL4A3BP (2.6)	PVRL2 (1.7)	BLOC1S3 (1.6)	POLK (1.6)	GEMIN7 (1.5)	RELB (1.5)	DNM2 (1.4)	CYB561D1 (1.4)
ENSG00000111907	TPD52L1 PPI subnetwork	1.00	> 0.20	UBXN2B (2.5)	C1orf63 (1.8)	ADAM1 (1.8)	C17orf57 (1.7)	PMFBP1 (1.6)	KIAA1324 (1.6)	TOP1 (1.5)	BRAP (1.5)	BLOC1S3 (1.4)	PLCG1 (1.4)
ENSG00000120254	MTHFD1L PPI subnetwork	1.00	> 0.20	NCAN (3.1)	SORT1 (2.2)	RPH3A (2.0)	C12orf51 (2.0)	CELSR2 (1.9)	FADS1 (1.7)	GRINA (1.6)	AMIGO1 (1.5)	UBXN2B (1.4)	PPP1R37 (1.4)
ENSG00000156475	PPP2R2B PPI subnetwork	1.00	> 0.20	TRAPPC6A (2.4)	DHODH (1.9)	NCAN (1.9)	GOT2P1 (1.9)	ENSG00000228044 (1.5)	ZNF259 (1.5)	ILF3 (1.4)	AP1M2 (1.3)	CILP2 (1.3)	NKPD1 (1.3)
GO:0015459	potassium channel regulator activity	1.00	> 0.20	RPH3A (3.3)	GCNT4 (2.7)	SORT1 (2.3)	COL4A3BP (2.3)	POLK (1.9)	GEMIN7 (1.6)	HAPLN4 (1.6)	KIAA1324 (1.4)	HAVCR1 (1.3)	TMEM116 (1.3)
ENSG00000185008	ROBO2 PPI subnetwork	1.00	> 0.20	ENSG00000235545 (2.0)	KIAA1324 (1.8)	DNAH11 (1.7)	DOCK7 (1.6)	ENSG00000228044 (1.4)	CELSR2 (1.3)	ATXN7L2 (1.2)	PLEKHH2 (1.2)	MAFB (1.2)	ANKRD31 (1.1)
ENSG00000087302	C14orf166 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.4)	SORT1 (2.2)	C12orf51 (2.1)	UBXN2B (2.0)	FADS1 (1.9)	TMEM50A (1.8)	CELSR2 (1.6)	MARK4 (1.5)	FADS2 (1.4)
GO:0009263	deoxyribonucleotide biosynthetic process	1.00	> 0.20	ANKRD31 (3.0)	AMIGO1 (2.4)	OASL (2.1)	ENSG00000228044 (2.1)	TMEM57 (1.8)	TMEM116 (1.5)	ZNF101 (1.5)	C19orf52 (1.4)	USP1 (1.4)	C1orf63 (1.3)
ENSG00000099365	STX1B PPI subnetwork	1.00	> 0.20	TMEM50A (3.0)	C12orf51 (2.6)	C1orf63 (2.1)	RPH3A (2.0)	HNF1A (2.0)	PARP10 (1.9)	HAPLN4 (1.8)	HLX (1.7)	CYB561D1 (1.7)	KIAA1324 (1.5)
ENSG00000149182	ARFGAP2 PPI subnetwork	1.00	> 0.20	YIPF2 (4.0)	KIAA1324 (2.7)	TMED4 (1.6)	TMEM50A (1.6)	GRINA (1.5)	ENSG00000228044 (1.4)	CYB561D1 (1.4)	FEN1 (1.3)	C12orf43 (1.3)	ATXN7L2 (1.2)
GO:0060441	epithelial tube branching involved in lung morphogenesis	1.00	> 0.20	PLEKHH2 (4.2)	C11orf9 (2.3)	LPAR2 (2.0)	HAPLN4 (1.8)	DYNC2LI1 (1.7)	ENSG00000235545 (1.4)	HLX (1.4)	ALDH2 (1.4)	KIAA1324 (1.3)	CBLC (1.3)
GO:0010975	regulation of neuron projection development	1.00	> 0.20	RPH3A (2.7)	PBX4 (2.6)	CELSR2 (2.4)	NCAN (2.4)	LPIN3 (1.8)	ATXN7L2 (1.7)	PLEC (1.7)	DOCK7 (1.5)	PPP1R37 (1.5)	ABO (1.4)
ENSG00000037749	MFAP3 PPI subnetwork	1.00	> 0.20	APOE (2.0)	HNF1A (1.6)	PVR (1.6)	ERP29 (1.6)	TIMD4 (1.5)	ALDH2 (1.5)	ZNF180 (1.5)	POLK (1.4)	PTPN11 (1.3)	C12orf43 (1.2)
GO:0021983	pituitary gland development	1.00	> 0.20	NKPD1 (2.3)	PBX4 (2.2)	TSSK6 (2.1)	KIAA1324 (2.1)	ENSG00000226648 (2.1)	C19orf52 (1.8)	YIPF2 (1.2)	ABO (1.2)	GOT2P1 (1.2)	GEMIN7 (1.1)
MP:0001406	abnormal gait	1.00	> 0.20	HAPLN4 (4.8)	RPH3A (4.1)	COL4A3BP (2.3)	APOE (2.3)	ATP13A1 (1.8)	ERP29 (1.8)	SORT1 (1.5)	CLPTM1 (1.3)	C12orf51 (1.3)	TIMD4 (1.3)
MP:0001006	abnormal retinal cone cell morphology	1.00	> 0.20	ENSG00000235545 (2.4)	HAVCR1 (1.9)	LPIN3 (1.8)	PSRC1 (1.2)	RHCE (1.2)	HNF1A (1.2)	DYNC2LI1 (1.1)	KIAA1324 (1.1)	C12orf47 (1.1)	AP1M2 (0.9)
GO:0042490	mechanoreceptor differentiation	1.00	> 0.20	ENSG00000226648 (1.9)	DNAH11 (1.9)	CEACAM19 (1.7)	PMFBP1 (1.5)	HNF1A (1.4)	TSSK6 (1.3)	BCAM (1.3)	AMIGO1 (1.3)	GOT2P1 (1.1)	KIAA1324 (1.0)
ENSG00000134982	APC PPI subnetwork	1.00	> 0.20	CBLC (2.5)	PSRC1 (2.1)	DOCK7 (2.1)	MARK4 (1.9)	PLCG1 (1.7)	ATXN2 (1.6)	NKPD1 (1.6)	AP1M2 (1.4)	LDLR (1.3)	CARM1 (1.3)
ENSG00000213465	ARL2 PPI subnetwork	1.00	> 0.20	DHODH (1.8)	CEACAM19 (1.6)	NCAN (1.6)	ADAM1 (1.4)	MOSC1 (1.3)	C19orf52 (1.3)	OGDH (1.3)	TRAFD1 (1.3)	PTPN11 (1.0)	ACAD10 (1.0)
MP:0009247	meteorism	1.00	> 0.20	PLEKHH2 (2.2)	TRIB1 (1.6)	NCAN (1.5)	CILP2 (1.5)	HLX (1.4)	KIAA1324 (1.3)	KANK2 (1.3)	MAFB (1.2)	CEACAM19 (1.2)	ENSG00000235545 (1.1)
ENSG00000105514	RAB3D PPI subnetwork	1.00	> 0.20	RPH3A (2.5)	NCAN (2.3)	MARK4 (2.0)	C12orf51 (2.0)	SORT1 (1.6)	FADS1 (1.6)	AMIGO1 (1.6)	ZNF180 (1.5)	PPP1R37 (1.5)	UBXN2B (1.5)
ENSG00000103549	RNF40 PPI subnetwork	1.00	> 0.20	TOP1 (2.5)	CEACAM19 (2.1)	PTPN11 (2.0)	C11orf9 (1.7)	C1orf63 (1.7)	USP24 (1.5)	TMEM50A (1.4)	ZHX3 (1.3)	PLCG1 (1.3)	ITGB3 (1.3)
GO:0016055	Wnt receptor signaling pathway	1.00	> 0.20	MARK4 (2.6)	NYNRIN (2.3)	PLEKHH2 (2.1)	PLCG1 (1.8)	BLOC1S3 (1.8)	GATAD2A (1.7)	PPP1R37 (1.7)	LPAR2 (1.6)	CILP2 (1.5)	PVRL2 (1.4)
MP:0010412	atrioventricular septal defect	1.00	> 0.20	SORT1 (2.3)	NPC1L1 (2.2)	C11orf9 (1.5)	AP1M2 (1.4)	TM6SF2 (1.3)	ZHX3 (1.3)	DHODH (1.3)	LPA (1.0)	PVR (1.0)	DNAH11 (0.9)
ENSG00000082458	DLG3 PPI subnetwork	1.00	> 0.20	RPH3A (3.6)	CELSR2 (3.4)	NCAN (2.9)	MARK4 (2.3)	C11orf9 (2.0)	PPP1R37 (1.9)	SORT1 (1.8)	SYPL2 (1.6)	CLPTM1 (1.4)	AMIGO1 (1.3)
GO:0010662	regulation of striated muscle cell apoptotic process	1.00	> 0.20	C17orf57 (2.8)	CILP2 (2.0)	TMEM116 (2.0)	ENSG00000226648 (1.9)	SLC22A1 (1.6)	ITGB3 (1.5)	CEACAM19 (1.2)	TSSK6 (1.1)	PBX4 (1.1)	AP1M2 (1.1)
ENSG00000116584	ARHGEF2 PPI subnetwork	1.00	> 0.20	ATXN2 (2.4)	PVRL2 (2.3)	ZNF101 (1.8)	CARM1 (1.6)	ILF3 (1.5)	ENSG00000235545 (1.4)	TMEM50A (1.4)	SARS (1.3)	PCSK9 (1.3)	DOCK7 (1.2)
GO:0045346	regulation of MHC class II biosynthetic process	1.00	> 0.20	TIMD4 (1.4)	TRAFD1 (1.3)	ERP29 (1.3)	ITGB3 (1.2)	HLX (1.2)	GMPR (1.2)	RHD (1.1)	RHCE (1.1)	MAFB (1.0)	UBXN2B (1.0)
GO:0015949	nucleobase-containing small molecule interconversion	1.00	> 0.20	DYNC2LI1 (2.2)	TMEM57 (2.0)	AMIGO1 (1.8)	CEACAM19 (1.7)	LPIN3 (1.6)	TMEM50A (1.4)	ADAM1 (1.1)	DOCK7 (1.1)	CYB561D1 (1.0)	GCNT4 (1.0)
GO:0048168	regulation of neuronal synaptic plasticity	1.00	> 0.20	RPH3A (3.6)	ENSG00000226648 (2.7)	NCAN (2.4)	HAPLN4 (2.0)	ATXN7L2 (1.9)	CELSR2 (1.4)	PMFBP1 (1.4)	MARK4 (1.3)	HAVCR1 (1.3)	PPP1R37 (1.3)
ENSG00000036257	CUL3 PPI subnetwork	1.00	> 0.20	USP24 (3.3)	DHX38 (2.5)	DOCK7 (2.2)	COL4A3BP (2.1)	ZHX3 (2.0)	CARM1 (1.8)	NAA25 (1.8)	ZNF180 (1.6)	TRAFD1 (1.6)	BUD13 (1.6)
GO:0072073	kidney epithelium development	1.00	> 0.20	BCAM (2.5)	HAVCR1 (2.5)	TSSK6 (2.4)	HNF1A (2.1)	AP1M2 (2.1)	TMEM116 (1.9)	PMFBP1 (1.6)	ENSG00000226645 (1.5)	CELSR2 (1.4)	DYNC2LI1 (1.3)
MP:0002229	neurodegeneration	1.00	> 0.20	DOCK7 (2.7)	RPH3A (2.1)	ST3GAL4 (2.0)	NT5DC1 (1.9)	TMEM50A (1.9)	TMED4 (1.5)	GRINA (1.3)	ERP29 (1.3)	TRAPPC6A (1.2)	SORT1 (1.1)
MP:0008789	abnormal olfactory epithelium morphology	1.00	> 0.20	TRAFD1 (2.8)	DYNC2LI1 (2.6)	TMED4 (2.3)	C12orf47 (1.7)	CARM1 (1.4)	MAU2 (1.2)	CILP2 (1.2)	NYNRIN (1.1)	OASL (1.0)	C19orf52 (1.0)
ENSG00000144182	LIPT1 PPI subnetwork	1.00	> 0.20	CEACAM19 (2.4)	ATXN7L2 (2.3)	MAPKAPK5 (2.1)	NCAN (1.7)	NKPD1 (1.7)	C12orf43 (1.7)	USP24 (1.2)	BUD13 (1.2)	C19orf52 (1.2)	PMFBP1 (1.1)
MP:0002207	abnormal long term potentiation	1.00	> 0.20	NCAN (4.9)	RPH3A (2.3)	HAPLN4 (2.2)	ZHX3 (2.0)	MOSC1 (1.8)	C12orf43 (1.8)	C11orf9 (1.6)	PTPN11 (1.6)	CELSR2 (1.5)	ENSG00000238078 (1.5)
GO:0050780	dopamine receptor binding	1.00	> 0.20	ENSG00000226648 (2.5)	CELSR2 (2.2)	C11orf9 (2.2)	NCAN (2.1)	MARK4 (2.0)	C12orf51 (1.5)	APOE (1.3)	ENSG00000226645 (1.3)	LPAR2 (1.2)	NPC1L1 (1.2)
GO:0002052	positive regulation of neuroblast proliferation	1.00	> 0.20	ENSG00000254235 (2.2)	DOCK7 (2.1)	TMED4 (1.9)	CELSR2 (1.9)	ENSG00000235545 (1.5)	TSSK6 (1.5)	NCAN (1.5)	NKPD1 (1.3)	PBX4 (1.3)	ZNF101 (1.2)
GO:0015298	solute:cation antiporter activity	1.00	> 0.20	ENSG00000226645 (2.7)	PTPN11 (1.6)	ENSG00000235545 (1.5)	TMEM116 (1.5)	NCAN (1.4)	SYPL2 (1.4)	SORT1 (1.3)	PPP1R37 (1.3)	CYB561D1 (1.3)	HAPLN4 (1.3)
ENSG00000204218	ENSG00000204218 PPI subnetwork	1.00	> 0.20	COL4A3BP (2.5)	CYB561D1 (2.3)	LPAR2 (2.1)	ZNF259 (1.8)	RELB (1.6)	SARS (1.6)	OGDH (1.6)	GEMIN7 (1.4)	TMEM116 (1.4)	PSRC1 (1.3)
GO:0046834	lipid phosphorylation	1.00	> 0.20	PPP1R37 (2.8)	BLOC1S3 (2.6)	HAPLN4 (1.7)	MAU2 (1.7)	BRAP (1.6)	C12orf43 (1.4)	C12orf51 (1.3)	GATAD2A (1.3)	CYB561D1 (1.2)	PMFBP1 (1.2)
GO:0046847	filopodium assembly	1.00	> 0.20	PBX4 (3.1)	PLEC (2.2)	ATXN7L2 (1.3)	COL4A3BP (1.3)	ST3GAL4 (1.3)	DNM2 (1.3)	LPAR2 (1.2)	PPP1R37 (1.2)	TMEM57 (1.1)	ENSG00000254235 (1.1)
GO:0046839	phospholipid dephosphorylation	1.00	> 0.20	DNAH11 (2.8)	BLOC1S3 (2.8)	NKPD1 (2.2)	ZHX3 (1.8)	POC5 (1.7)	C12orf51 (1.6)	ENSG00000235545 (1.3)	UBXN2B (1.3)	DOCK7 (1.2)	YIPF2 (1.1)
ENSG00000144935	TRPC1 PPI subnetwork	1.00	> 0.20	OASL (3.4)	PARP10 (2.4)	NKPD1 (1.6)	PLEKHH2 (1.6)	DOCK7 (1.4)	KANK2 (1.3)	TSSK6 (1.1)	ZNF259 (1.0)	TMEM50A (1.0)	CYP7A1 (1.0)
ENSG00000171603	CLSTN1 PPI subnetwork	1.00	> 0.20	NCAN (3.3)	CELSR2 (2.8)	GRINA (2.6)	ERP29 (2.6)	RPH3A (2.5)	TMED4 (2.3)	BCAM (2.1)	YIPF2 (2.1)	CLPTM1 (2.0)	ATP13A1 (1.4)
REACTOME_BOTULINUM_NEUROTOXICITY	REACTOME_BOTULINUM_NEUROTOXICITY	1.00	> 0.20	HAPLN4 (2.9)	C12orf43 (2.1)	C1orf63 (2.1)	RPH3A (1.9)	TMEM50A (1.9)	SARS (1.7)	C12orf51 (1.6)	MYLIP (1.4)	COL4A3BP (1.3)	TMED4 (1.3)
MP:0008267	abnormal hippocampus CA3 region morphology	1.00	> 0.20	NCAN (2.9)	ABCG8 (1.9)	C11orf9 (1.8)	HAVCR1 (1.7)	PMFBP1 (1.7)	SORT1 (1.6)	PTPN11 (1.5)	APOE (1.4)	GMIP (1.4)	APOC1 (1.3)
ENSG00000023318	ERP44 PPI subnetwork	1.00	> 0.20	ERP29 (3.4)	RPH3A (2.7)	TMED4 (2.5)	NCAN (2.5)	HAPLN4 (2.0)	BCAM (2.0)	YIPF2 (1.8)	CLPTM1 (1.7)	GRINA (1.7)	ATP13A1 (1.4)
GO:0005245	voltage-gated calcium channel activity	1.00	> 0.20	SYPL2 (3.6)	NCAN (2.5)	RPH3A (2.5)	PLEKHH2 (2.2)	PVR (2.1)	KIAA1324 (2.0)	C12orf47 (1.5)	ADAM1 (1.4)	HAPLN4 (1.3)	ABO (1.2)
ENSG00000160867	FGFR4 PPI subnetwork	1.00	> 0.20	PVR (2.3)	PLEKHH2 (2.1)	CEACAM19 (2.1)	HAPLN4 (1.9)	ABO (1.9)	LPAR2 (1.4)	PARP10 (1.3)	C11orf9 (1.3)	TSSK6 (1.3)	TM6SF2 (1.2)
ENSG00000165868	HSPA12A PPI subnetwork	1.00	> 0.20	NCAN (2.8)	RPH3A (2.4)	SORT1 (2.2)	FADS1 (2.1)	C12orf51 (2.0)	CELSR2 (1.9)	UBXN2B (1.8)	TMEM50A (1.5)	AMIGO1 (1.4)	HLX (1.4)
GO:0045745	positive regulation of G-protein coupled receptor protein signaling pathway	1.00	> 0.20	CEACAM19 (3.8)	NKPD1 (3.4)	TSSK6 (2.1)	ZNF180 (1.4)	C11orf9 (1.2)	RPH3A (1.2)	SLC44A2 (1.2)	CELSR2 (1.1)	CYB561D1 (1.1)	BLOC1S3 (1.1)
ENSG00000100241	SBF1 PPI subnetwork	1.00	> 0.20	NCAN (2.5)	RPH3A (2.3)	FADS1 (2.1)	C12orf51 (2.0)	SORT1 (2.0)	CELSR2 (1.7)	UBXN2B (1.6)	ALDH2 (1.5)	TMEM50A (1.4)	FADS2 (1.4)
GO:0021781	glial cell fate commitment	1.00	> 0.20	NCAN (4.2)	ENSG00000226648 (1.9)	KIAA1324 (1.8)	DNAH11 (1.7)	CARM1 (1.4)	HAPLN4 (1.4)	DYNC2LI1 (1.2)	C19orf52 (1.2)	RHD (1.2)	CILP2 (1.2)
MP:0000828	abnormal fourth ventricle morphology	1.00	> 0.20	CELSR2 (2.9)	HP (1.7)	SORT1 (1.6)	C12orf51 (1.6)	ENSG00000226648 (1.5)	AMIGO1 (1.4)	ATXN2 (1.4)	CEACAM19 (1.2)	SYPL2 (1.1)	APOA5 (1.1)
MP:0008321	small adenohypophysis	1.00	> 0.20	C12orf47 (3.1)	TMED4 (2.3)	KIAA1324 (2.3)	YIPF2 (2.2)	ENSG00000238078 (2.1)	TSSK6 (1.9)	DNAH11 (1.9)	C19orf52 (1.5)	ERP29 (1.4)	AP1M2 (1.2)
GO:0030856	regulation of epithelial cell differentiation	1.00	> 0.20	ENSG00000238078 (2.7)	PMFBP1 (2.3)	LPIN3 (2.3)	AP1M2 (2.1)	PBX4 (1.6)	ITGB3 (1.5)	ZHX3 (1.4)	POLK (1.3)	DNAH11 (1.2)	COL4A3BP (1.2)
GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	1.00	> 0.20	YIPF2 (5.6)	SUGP1 (2.5)	DHX38 (2.0)	MAU2 (1.9)	ATP13A1 (1.8)	PBX4 (1.6)	DYNC2LI1 (1.5)	C19orf52 (1.5)	FRK (1.4)	DHODH (1.3)
MP:0003730	abnormal photoreceptor inner segment morphology	1.00	> 0.20	DYNC2LI1 (3.6)	UBXN2B (2.5)	ENSG00000226648 (1.6)	PMFBP1 (1.2)	COL4A3BP (1.0)	POC5 (0.9)	TMEM116 (0.9)	MYLIP (0.9)	POLK (0.8)	ATXN7L2 (0.7)
GO:0006821	chloride transport	1.00	> 0.20	PMFBP1 (2.0)	TMEM116 (1.8)	CEACAM19 (1.7)	HNF1A (1.6)	FRK (1.5)	ST3GAL4 (1.5)	SORT1 (1.3)	ATP13A1 (1.2)	AP1M2 (1.2)	TMEM57 (1.0)
GO:0055067	monovalent inorganic cation homeostasis	1.00	> 0.20	TMEM116 (3.1)	AMIGO1 (2.6)	CEACAM19 (2.1)	ENSG00000235545 (1.7)	ERP29 (1.7)	HNF1A (1.6)	AP1M2 (1.6)	LPIN3 (1.6)	PBX4 (1.5)	SLC44A2 (1.4)
ENSG00000100253	MIOX PPI subnetwork	1.00	> 0.20	APOE (1.7)	PVR (1.7)	ERP29 (1.6)	HNF1A (1.5)	ALDH2 (1.5)	ZNF180 (1.4)	TIMD4 (1.4)	KANK2 (1.3)	POLK (1.3)	ENSG00000235545 (1.1)
GO:0006184	GTP catabolic process	1.00	> 0.20	ENSG00000226645 (3.0)	CYB561D1 (1.8)	SH2B3 (1.6)	C12orf51 (1.6)	DNM2 (1.4)	COL4A3BP (1.3)	ZHX3 (1.3)	PPP1R37 (1.2)	ST3GAL4 (1.1)	HLX (1.1)
GO:0070242	thymocyte apoptotic process	1.00	> 0.20	PBX4 (2.1)	HNF1A (1.9)	GMIP (1.8)	GCNT4 (1.5)	CYB561D1 (1.5)	ITGB3 (1.4)	ENSG00000226648 (1.3)	ATXN7L2 (1.3)	TSSK6 (1.2)	CEACAM19 (1.1)
ENSG00000187672	ERC2 PPI subnetwork	1.00	> 0.20	RPH3A (3.7)	C12orf51 (2.1)	HAPLN4 (1.9)	PPP1R37 (1.6)	MARK4 (1.5)	TSSK6 (1.4)	AMIGO1 (1.4)	CEACAM19 (1.3)	NCAN (1.3)	UBXN2B (1.2)
GO:0045168	cell-cell signaling involved in cell fate commitment	1.00	> 0.20	PPP1R37 (2.7)	C17orf57 (1.9)	LPIN3 (1.8)	HAPLN4 (1.8)	HNF1A (1.8)	ALDH2 (1.6)	KIAA1324 (1.6)	COL4A3BP (1.2)	PLEKHH2 (1.2)	C11orf9 (1.1)
GO:0031513	nonmotile primary cilium	1.00	> 0.20	DYNC2LI1 (5.3)	PMFBP1 (1.2)	QTRT1 (1.1)	FRK (1.1)	HAVCR1 (1.1)	ADAM1 (0.9)	ZHX3 (0.9)	PLEKHH2 (0.9)	KIAA1324 (0.9)	ABO (0.8)
GO:0009187	cyclic nucleotide metabolic process	1.00	> 0.20	C12orf47 (3.8)	RPH3A (1.8)	PMFBP1 (1.8)	AMIGO1 (1.8)	ABO (1.6)	TSSK6 (1.5)	LPIN3 (1.5)	MYLIP (1.2)	NCAN (1.2)	PLEKHH2 (1.1)
GO:0050953	sensory perception of light stimulus	1.00	> 0.20	GOT2P1 (2.0)	PMFBP1 (1.6)	C12orf47 (1.6)	ENSG00000235545 (1.5)	DYNC2LI1 (1.5)	TMEM116 (1.4)	ST3GAL4 (1.2)	ENSG00000226648 (1.1)	HNF1A (1.1)	HAVCR1 (0.9)
REACTOME_SIGNALING_BY_ROBO_RECEPTOR	REACTOME_SIGNALING_BY_ROBO_RECEPTOR	1.00	> 0.20	PBX4 (2.5)	LPAR2 (2.3)	MARK4 (2.2)	DOCK7 (2.2)	GMIP (2.0)	PSRC1 (1.8)	POLK (1.6)	CARM1 (1.6)	USP24 (1.5)	NYNRIN (1.4)
GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	1.00	> 0.20	PMFBP1 (2.1)	C12orf47 (1.9)	AMIGO1 (1.9)	ENSG00000235545 (1.9)	ST3GAL4 (1.5)	NKPD1 (1.4)	CETP (1.4)	DNAH11 (1.2)	PLEKHH2 (1.2)	COL4A3BP (1.2)
KEGG_WNT_SIGNALING_PATHWAY	KEGG_WNT_SIGNALING_PATHWAY	1.00	> 0.20	MARK4 (2.8)	GATAD2A (2.4)	CILP2 (2.1)	SLC44A2 (1.9)	PLCG1 (1.8)	CARM1 (1.8)	ATXN2 (1.6)	CBLC (1.4)	AMIGO1 (1.4)	PTPN11 (1.4)
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	1.00	> 0.20	NKPD1 (1.9)	ABO (1.9)	PLEKHH2 (1.8)	HAPLN4 (1.7)	PVR (1.5)	ZHX3 (1.4)	TM6SF2 (1.3)	PTPN11 (1.3)	CEACAM19 (1.3)	TSSK6 (1.2)
GO:0010658	striated muscle cell apoptotic process	1.00	> 0.20	ENSG00000226648 (2.4)	C17orf57 (2.3)	CILP2 (2.2)	TMEM116 (1.5)	C12orf47 (1.4)	PBX4 (1.3)	PMFBP1 (1.3)	SLC22A1 (1.2)	ITGB3 (1.0)	ADAM1 (0.9)
GO:0008344	adult locomotory behavior	1.00	> 0.20	PMFBP1 (2.8)	HAPLN4 (2.4)	RPH3A (2.2)	C12orf47 (1.9)	TSSK6 (1.6)	LPAR2 (1.6)	TMEM50A (1.5)	COL4A3BP (1.4)	ENSG00000238078 (1.3)	ENSG00000228044 (1.3)
ENSG00000171345	KRT19 PPI subnetwork	1.00	> 0.20	ENSG00000235545 (2.4)	PLCG1 (1.8)	PVR (1.8)	KIAA1324 (1.7)	ERP29 (1.6)	C17orf57 (1.5)	APOE (1.4)	PTPN11 (1.3)	ZNF180 (1.3)	ZNF101 (1.2)
GO:0070936	protein K48-linked ubiquitination	1.00	> 0.20	C19orf52 (2.2)	MAPKAPK5 (1.9)	ATXN2 (1.6)	BRAP (1.6)	TMED4 (1.6)	COL4A3BP (1.4)	LPAR2 (1.4)	ENSG00000235545 (1.3)	GATAD2A (1.3)	TMEM57 (1.2)
MP:0002804	abnormal motor learning	1.00	> 0.20	C11orf9 (3.3)	RPH3A (2.1)	HAPLN4 (1.8)	PMFBP1 (1.6)	AMIGO1 (1.5)	ZNF180 (1.4)	COL4A3BP (1.4)	GEMIN7 (1.2)	TXNL4B (1.2)	POLK (1.2)
MP:0011143	thick lung-associated mesenchyme	1.00	> 0.20	BCAM (2.9)	PVRL2 (2.5)	NYNRIN (2.3)	CELSR2 (2.2)	C11orf9 (2.0)	CILP2 (1.9)	KIAA1324 (1.9)	AMIGO1 (1.7)	PLEKHH2 (1.7)	TMEM116 (1.5)
ENSG00000088986	DYNLL1 PPI subnetwork	1.00	> 0.20	DOCK7 (1.8)	C1orf63 (1.7)	C12orf51 (1.4)	RPH3A (1.4)	OGDH (1.4)	RHD (1.3)	FADS2 (1.2)	ITGB3 (1.1)	TMEM57 (1.1)	HAPLN4 (1.1)
GO:0000768	syncytium formation by plasma membrane fusion	1.00	> 0.20	C12orf47 (2.2)	CYB561D1 (2.1)	ATXN7L2 (1.7)	ENSG00000228044 (1.6)	MAPKAPK5 (1.5)	ZNF180 (1.4)	HNF1A (1.4)	GEMIN7 (1.2)	PLEC (1.1)	ZHX3 (1.1)
GO:0044306	neuron projection terminus	1.00	> 0.20	KIAA1324 (3.4)	RPH3A (3.0)	HAPLN4 (2.6)	ABO (1.8)	C12orf47 (1.7)	C12orf43 (1.5)	TSSK6 (1.4)	ERP29 (1.4)	HNF1A (1.3)	CELSR2 (1.2)
GO:0046039	GTP metabolic process	1.00	> 0.20	ENSG00000226645 (2.8)	CYB561D1 (1.7)	C12orf51 (1.6)	SH2B3 (1.6)	COL4A3BP (1.3)	C12orf43 (1.2)	DNM2 (1.2)	ST3GAL4 (1.2)	PPP1R37 (1.1)	ZHX3 (1.1)
GO:0030857	negative regulation of epithelial cell differentiation	1.00	> 0.20	ENSG00000238078 (2.5)	AP1M2 (1.7)	COL4A3BP (1.3)	TRAFD1 (1.1)	NYNRIN (1.0)	LPIN3 (0.9)	BCAM (0.9)	HLX (0.9)	ENSG00000235545 (0.8)	TMEM116 (0.8)
GO:0009583	detection of light stimulus	1.00	> 0.20	C12orf47 (1.9)	PMFBP1 (1.8)	TSSK6 (1.6)	NKPD1 (1.3)	ST3GAL4 (1.3)	GEMIN7 (1.3)	TMEM116 (1.1)	RHCE (1.1)	GOT2P1 (1.0)	ANKRD31 (0.8)
GO:0007616	long-term memory	1.00	> 0.20	AMIGO1 (2.7)	TSSK6 (2.5)	ATXN7L2 (1.8)	RPH3A (1.7)	HAVCR1 (1.6)	KIAA1324 (1.4)	C17orf57 (1.3)	PBX4 (1.1)	TMEM116 (1.1)	ADAM1 (1.1)
MP:0004491	abnormal orientation of outer hair cell stereociliary bundles	1.00	> 0.20	DYNC2LI1 (2.2)	HNF1A (2.2)	PVRL2 (2.1)	NYNRIN (2.1)	ANKRD31 (1.9)	HAVCR1 (1.8)	PLEKHH2 (1.2)	CBLC (1.1)	CLPTM1 (1.1)	AP1M2 (1.0)
REACTOME_CGMP_EFFECTS	REACTOME_CGMP_EFFECTS	1.00	> 0.20	MOSC1 (3.1)	SORT1 (2.4)	ITGB3 (2.0)	KANK2 (2.0)	HLX (1.4)	PBX4 (1.3)	ENSG00000238078 (1.1)	TXNL4B (1.1)	GPAM (1.0)	AMIGO1 (1.0)
REACTOME_INHIBITION__OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETAGAMMA_SUBUNITS	REACTOME_INHIBITION__OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETAGAMMA_SUBUNITS	1.00	> 0.20	RPH3A (2.9)	SLC44A2 (2.4)	NCAN (1.6)	HAVCR1 (1.5)	TMEM50A (1.5)	PBX4 (1.3)	PPP1R37 (1.1)	APOE (1.1)	ENSG00000254235 (1.1)	NYNRIN (1.0)
REACTOME_G_PROTEIN_GATED_POTASSIUM_CHANNELS	REACTOME_G_PROTEIN_GATED_POTASSIUM_CHANNELS	1.00	> 0.20	RPH3A (2.9)	SLC44A2 (2.4)	NCAN (1.6)	HAVCR1 (1.5)	TMEM50A (1.5)	PBX4 (1.3)	PPP1R37 (1.1)	APOE (1.1)	ENSG00000254235 (1.1)	NYNRIN (1.0)
REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS	REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS	1.00	> 0.20	RPH3A (2.9)	SLC44A2 (2.4)	NCAN (1.6)	HAVCR1 (1.5)	TMEM50A (1.5)	PBX4 (1.3)	PPP1R37 (1.1)	APOE (1.1)	ENSG00000254235 (1.1)	NYNRIN (1.0)
GO:0035249	synaptic transmission, glutamatergic	1.00	> 0.20	RPH3A (4.5)	HAPLN4 (2.4)	ABO (2.4)	NCAN (2.2)	C17orf57 (1.7)	C12orf43 (1.6)	DNAH11 (1.6)	KIAA1324 (1.2)	BLOC1S3 (1.2)	PPP1R37 (1.0)
GO:0008542	visual learning	1.00	> 0.20	RPH3A (2.6)	C12orf47 (2.3)	ENSG00000226648 (1.9)	TSSK6 (1.6)	ADAM1 (1.6)	GCNT4 (1.5)	NCAN (1.3)	GEMIN7 (1.2)	CYB561D1 (1.1)	C17orf57 (1.0)
ENSG00000163703	CRELD1 PPI subnetwork	1.00	> 0.20	ATXN7L2 (2.2)	ADAM1 (2.1)	PLEKHH2 (2.0)	SUGP1 (2.0)	TXNL4B (1.9)	USP1 (1.6)	NKPD1 (1.6)	TOP1 (1.5)	FEN1 (1.5)	PSRC1 (1.4)
MP:0006072	abnormal retinal apoptosis	1.00	> 0.20	TRIB1 (2.0)	PMFBP1 (1.8)	MAPKAPK5 (1.6)	ATXN7L2 (1.6)	LPIN3 (1.5)	DYNC2LI1 (1.5)	CELSR2 (1.4)	PBX4 (1.4)	PSRC1 (1.3)	POLK (1.3)
GO:0003407	neural retina development	1.00	> 0.20	CYB561D1 (2.7)	HAVCR1 (2.2)	C19orf52 (1.7)	AP1M2 (1.7)	LPIN3 (1.6)	YIPF2 (1.6)	ENSG00000254235 (1.5)	SORT1 (1.4)	FRK (1.3)	PMFBP1 (1.3)
GO:0007601	visual perception	1.00	> 0.20	GOT2P1 (2.0)	PMFBP1 (1.6)	C12orf47 (1.6)	ENSG00000235545 (1.5)	DYNC2LI1 (1.5)	TMEM116 (1.4)	ST3GAL4 (1.2)	HNF1A (1.0)	ENSG00000226648 (1.0)	HAVCR1 (0.9)
ENSG00000197548	ATG7 PPI subnetwork	1.00	> 0.20	TXNL4B (3.8)	COL4A3BP (3.0)	BRAP (2.3)	PMFBP1 (2.1)	SARS (1.9)	NT5DC1 (1.9)	TMEM50A (1.7)	C1orf63 (1.6)	ACAD10 (1.3)	UBXN2B (1.2)
GO:0046530	photoreceptor cell differentiation	1.00	> 0.20	ENSG00000235545 (2.7)	DYNC2LI1 (1.7)	NCAN (1.6)	ENSG00000226648 (1.4)	UBXN2B (1.1)	LPIN3 (1.1)	POLK (1.1)	DNAH11 (1.0)	GEMIN7 (0.9)	PMFBP1 (0.9)
GO:0042391	regulation of membrane potential	1.00	> 0.20	RPH3A (3.3)	HAPLN4 (2.5)	PPP1R37 (2.4)	NCAN (2.2)	SORT1 (2.0)	C12orf47 (1.8)	C11orf9 (1.6)	BCAM (1.3)	ANKRD31 (1.3)	CELSR2 (1.2)
GO:0001754	eye photoreceptor cell differentiation	1.00	> 0.20	ENSG00000235545 (2.0)	DYNC2LI1 (1.8)	ENSG00000226648 (1.7)	NCAN (1.3)	DNAH11 (1.1)	UBXN2B (1.1)	LPIN3 (1.1)	PMFBP1 (1.0)	ENSG00000228044 (1.0)	POLK (0.9)
GO:0030799	regulation of cyclic nucleotide metabolic process	1.00	> 0.20	C12orf47 (4.4)	ABO (2.0)	PMFBP1 (1.9)	AMIGO1 (1.8)	RPH3A (1.6)	CELSR2 (1.4)	TSSK6 (1.2)	NCAN (1.1)	HLX (1.1)	LPIN3 (1.1)
ENSG00000128595	CALU PPI subnetwork	1.00	> 0.20	ERP29 (4.1)	RPH3A (2.9)	TMED4 (2.1)	NCAN (1.8)	BCAM (1.8)	TIMD4 (1.8)	APOE (1.8)	AMIGO1 (1.6)	HAPLN4 (1.4)	CELSR2 (1.4)
KEGG_TYPE_I_DIABETES_MELLITUS	KEGG_TYPE_I_DIABETES_MELLITUS	1.00	> 0.20	APOE (1.6)	KIAA1324 (1.5)	RELB (1.5)	TRAFD1 (1.4)	MYLIP (1.2)	COL4A3BP (1.2)	HAPLN4 (1.1)	TMED4 (1.0)	SH2B3 (0.9)	ATXN7L2 (0.9)
MP:0004859	abnormal synaptic plasticity	1.00	> 0.20	ENSG00000226645 (2.2)	RPH3A (1.6)	HAVCR1 (1.6)	TMED4 (1.6)	ALDH2 (1.5)	AMIGO1 (1.4)	ENSG00000226648 (1.1)	KIAA1324 (1.1)	NCAN (0.9)	HLX (0.9)
MP:0004736	abnormal distortion product otoacoustic emission	1.00	> 0.20	MOSC1 (2.9)	SORT1 (2.0)	NCAN (1.9)	TMED4 (1.7)	GPAM (1.5)	ENSG00000226648 (1.5)	PVR (1.5)	FRK (1.3)	POLK (1.3)	PCSK9 (1.2)
MP:0001449	abnormal learning/ memory	1.00	> 0.20	PPP1R37 (2.6)	C12orf47 (2.3)	AMIGO1 (1.8)	ZHX3 (1.6)	USP24 (1.6)	ANGPTL3 (1.5)	DNAH11 (1.4)	NCAN (1.4)	MARK4 (1.3)	GPAM (1.3)
ENSG00000169347	GP2 PPI subnetwork	1.00	> 0.20	TIMD4 (1.8)	PVR (1.7)	HNF1A (1.6)	APOE (1.6)	ALDH2 (1.5)	KANK2 (1.4)	HAPLN4 (1.3)	ERP29 (1.3)	ZNF180 (1.2)	PTPN11 (1.1)
GO:0008066	glutamate receptor activity	1.00	> 0.20	NCAN (4.5)	RPH3A (4.2)	ABO (1.9)	PPP1R37 (1.3)	CELSR2 (1.1)	DNAH11 (1.1)	USP24 (1.1)	C12orf43 (1.1)	APOE (1.1)	HAVCR1 (1.1)
MP:0001504	abnormal posture	1.00	> 0.20	HAPLN4 (4.2)	RPH3A (4.1)	ZHX3 (1.8)	AMIGO1 (1.7)	TIMD4 (1.4)	COL4A3BP (1.3)	SYPL2 (1.2)	PLEC (1.2)	PVR (1.2)	CELSR2 (1.1)
GO:0045684	positive regulation of epidermis development	1.00	> 0.20	TXNL4B (2.6)	PBX4 (2.4)	LPAR2 (2.4)	LPIN3 (2.3)	PMFBP1 (2.2)	CILP2 (1.8)	C19orf52 (1.6)	BLOC1S3 (1.5)	ENSG00000226645 (1.5)	AP1M2 (1.5)
GO:0045666	positive regulation of neuron differentiation	1.00	> 0.20	ENSG00000254235 (2.2)	TMED4 (1.8)	PMFBP1 (1.8)	TMEM116 (1.7)	ENSG00000238078 (1.6)	NCAN (1.6)	HAPLN4 (1.5)	PSRC1 (1.5)	C11orf9 (1.2)	ABO (1.0)
GO:0072009	nephron epithelium development	1.00	> 0.20	HAVCR1 (2.7)	HNF1A (2.4)	BCAM (2.2)	TSSK6 (2.1)	AP1M2 (2.1)	TMEM116 (2.0)	PMFBP1 (1.6)	CELSR2 (1.4)	DYNC2LI1 (1.3)	FRK (1.3)
ENSG00000067836	ROGDI PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.3)	TMEM50A (1.9)	SORT1 (1.9)	C12orf51 (1.7)	UBXN2B (1.7)	CELSR2 (1.6)	DNAH11 (1.3)	AP1M2 (1.3)	FADS1 (1.3)
ENSG00000134072	CAMK1 PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	C12orf43 (2.6)	NCAN (2.5)	CELSR2 (1.8)	ERP29 (1.8)	SORT1 (1.7)	HAPLN4 (1.7)	C12orf51 (1.6)	AMIGO1 (1.5)	SARS (1.5)
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.00	> 0.20	C12orf47 (2.2)	RPH3A (2.0)	ABO (1.8)	KIAA1324 (1.8)	AMIGO1 (1.7)	PMFBP1 (1.6)	MYLIP (1.4)	MOSC1 (1.2)	HLX (1.2)	NCAN (1.0)
ENSG00000173020	ADRBK1 PPI subnetwork	1.00	> 0.20	C12orf47 (2.5)	TRIB1 (2.1)	POLK (1.9)	SH2B3 (1.8)	RPH3A (1.7)	HLX (1.7)	CETP (1.4)	TSSK6 (1.4)	COL4A3BP (1.4)	MARK4 (1.3)
GO:0016601	Rac protein signal transduction	1.00	> 0.20	CYB561D1 (2.2)	GATAD2A (1.9)	C11orf9 (1.8)	TMED4 (1.7)	TXNL4B (1.6)	HAPLN4 (1.5)	TSSK6 (1.4)	ENSG00000226645 (1.2)	PTPN11 (1.2)	GEMIN7 (1.0)
ENSG00000157087	ATP2B2 PPI subnetwork	1.00	> 0.20	BCAM (4.0)	CLPTM1 (3.2)	ERP29 (3.0)	CELSR2 (2.6)	TMED4 (2.6)	YIPF2 (2.5)	ZNF101 (2.0)	RPH3A (1.9)	GRINA (1.8)	OGDH (1.7)
GO:0042772	DNA damage response, signal transduction resulting in transcription	1.00	> 0.20	ADAM1 (2.3)	TRAPPC6A (2.1)	UBXN2B (1.9)	ATXN7L2 (1.9)	PMFBP1 (1.6)	GEMIN7 (1.4)	ENSG00000238078 (1.2)	MAU2 (1.2)	ZNF180 (1.1)	YIPF2 (1.0)
GO:0060998	regulation of dendritic spine development	1.00	> 0.20	HNF1A (3.8)	PLEKHH2 (2.7)	LPAR2 (2.2)	TMEM116 (2.2)	ABO (2.0)	ADAM1 (1.9)	RPH3A (1.8)	NCAN (1.6)	LPIN3 (1.6)	PBX4 (1.4)
GO:0009165	nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (2.8)	AMIGO1 (2.2)	PMFBP1 (2.1)	TSSK6 (1.8)	SYPL2 (1.8)	RPH3A (1.7)	ENSG00000226648 (1.7)	HNF1A (1.5)	LPIN3 (1.4)	TMEM116 (1.3)
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	1.00	> 0.20	ITGB3 (2.6)	C1orf63 (1.7)	KIAA1324 (1.7)	TMEM50A (1.6)	RPH3A (1.5)	TM6SF2 (1.3)	ENSG00000226648 (1.3)	COL4A3BP (1.2)	CETP (1.0)	ABO (1.0)
GO:0015269	calcium-activated potassium channel activity	1.00	> 0.20	AMIGO1 (2.2)	CYP7A1 (2.2)	ZNF180 (2.1)	PBX4 (1.7)	KIAA1324 (1.6)	APOC4 (1.5)	NCAN (1.4)	PMFBP1 (1.4)	CEACAM19 (1.3)	SORT1 (1.3)
GO:0060291	long-term synaptic potentiation	1.00	> 0.20	ENSG00000235545 (3.9)	NCAN (2.2)	ANKRD31 (2.0)	ABCG5 (2.0)	NPC1L1 (1.7)	ABCG8 (1.7)	ENSG00000254235 (1.6)	TM6SF2 (1.4)	C11orf9 (1.4)	GMPR (1.4)
GO:0005262	calcium channel activity	1.00	> 0.20	PLEKHH2 (2.5)	SYPL2 (2.3)	C12orf51 (2.2)	RPH3A (2.0)	PVR (1.9)	C12orf47 (1.6)	C1orf63 (1.5)	NCAN (1.4)	GMPR (1.4)	PMFBP1 (1.3)
GO:0015297	antiporter activity	1.00	> 0.20	TMEM116 (2.9)	SORT1 (2.1)	CLPTM1 (2.0)	ATP13A1 (1.9)	ENSG00000235545 (1.9)	SYPL2 (1.8)	ALDH2 (1.8)	AMIGO1 (1.6)	CYB561D1 (1.6)	NCAN (1.6)
GO:0051149	positive regulation of muscle cell differentiation	1.00	> 0.20	SYPL2 (2.8)	COL4A3BP (2.3)	LPIN3 (2.3)	AMIGO1 (2.2)	HLX (2.0)	KANK2 (1.6)	CARM1 (1.5)	HNF1A (1.5)	NYNRIN (1.4)	PMFBP1 (1.3)
MP:0001393	ataxia	1.00	> 0.20	HAPLN4 (5.1)	RPH3A (4.7)	APOE (2.5)	ZHX3 (2.1)	GRINA (2.0)	SORT1 (1.9)	ERP29 (1.7)	CELSR2 (1.6)	COL4A3BP (1.5)	C11orf9 (1.4)
MP:0001539	decreased caudal vertebrae number	1.00	> 0.20	NCAN (2.2)	ENSG00000226648 (2.1)	ZHX3 (2.0)	CILP2 (1.8)	UBXN2B (1.8)	KANK2 (1.7)	ERP29 (1.4)	PLCG1 (1.4)	FADS2 (1.3)	LPAR2 (1.3)
GO:0007626	locomotory behavior	1.00	> 0.20	PMFBP1 (2.8)	RPH3A (2.3)	COL4A3BP (2.2)	ABO (2.1)	CELSR2 (1.9)	TSSK6 (1.6)	ANKRD31 (1.6)	ERP29 (1.5)	RHCE (1.3)	CILP2 (1.3)
GO:0010811	positive regulation of cell-substrate adhesion	1.00	> 0.20	CILP2 (3.9)	PLEKHH2 (3.3)	SLC44A2 (3.1)	PBX4 (2.7)	TMEM116 (1.8)	AP1M2 (1.7)	HNF1A (1.6)	ITGB3 (1.6)	GEMIN7 (1.4)	SORT1 (1.2)
ENSG00000061676	NCKAP1 PPI subnetwork	1.00	> 0.20	NCAN (2.3)	TMEM50A (2.1)	ALDH2 (2.1)	RPH3A (1.9)	GOT2P1 (1.8)	C12orf43 (1.7)	CELSR2 (1.5)	UBXN2B (1.4)	SORT1 (1.4)	C11orf9 (1.3)
ENSG00000074047	GLI2 PPI subnetwork	1.00	> 0.20	GATAD2A (2.6)	PLCG1 (2.4)	ZHX3 (2.2)	NYNRIN (1.7)	POLK (1.5)	HLX (1.4)	ENSG00000254235 (1.4)	AMIGO1 (1.4)	MARK4 (1.4)	DNM2 (1.3)
ENSG00000184408	KCND2 PPI subnetwork	1.00	> 0.20	HAPLN4 (3.2)	RPH3A (2.9)	AMIGO1 (2.3)	NCAN (2.2)	PBX4 (2.2)	CETP (2.2)	CYB561D1 (2.1)	PPP1R37 (1.9)	DNAH11 (1.6)	ENSG00000226645 (1.6)
ENSG00000085224	ATRX PPI subnetwork	1.00	> 0.20	USP1 (2.8)	PSRC1 (2.3)	ENSG00000226648 (2.1)	TMEM116 (1.9)	TRAFD1 (1.8)	ATXN2 (1.7)	OASL (1.5)	BUD13 (1.5)	PLCG1 (1.5)	ZHX3 (1.4)
ENSG00000165996	PTPLA PPI subnetwork	1.00	> 0.20	TRAPPC6A (3.5)	FADS2 (2.9)	FADS1 (2.9)	NKPD1 (2.5)	BLOC1S3 (2.2)	ALDH2 (2.0)	MAU2 (2.0)	HMGCR (1.7)	YIPF2 (1.4)	ENSG00000226645 (1.3)
GO:0007416	synapse assembly	1.00	> 0.20	ZHX3 (2.3)	ENSG00000226648 (2.1)	RPH3A (2.1)	NCAN (2.0)	HNF1A (1.8)	CELSR2 (1.7)	ANKRD31 (1.5)	FRK (1.4)	ABO (1.3)	AP1M2 (1.3)
GO:0048013	ephrin receptor signaling pathway	1.00	> 0.20	LPAR2 (3.4)	PLEKHH2 (1.9)	PBX4 (1.8)	ACAD10 (1.5)	LPIN3 (1.4)	CETP (1.3)	NCAN (1.2)	AMIGO1 (1.1)	UBXN2B (1.0)	NKPD1 (1.0)
GO:0006171	cAMP biosynthetic process	1.00	> 0.20	C12orf47 (3.7)	PMFBP1 (2.0)	ABO (2.0)	RPH3A (1.9)	AMIGO1 (1.8)	DNAH11 (1.5)	CELSR2 (1.4)	NCAN (1.3)	CETP (1.3)	LPIN3 (1.2)
ENSG00000181790	BAI1 PPI subnetwork	1.00	> 0.20	RPH3A (2.9)	NCAN (2.8)	C12orf51 (2.1)	CELSR2 (2.0)	SORT1 (2.0)	C11orf9 (1.9)	UBXN2B (1.7)	C12orf43 (1.5)	FADS1 (1.5)	AMIGO1 (1.4)
GO:0005001	transmembrane receptor protein tyrosine phosphatase activity	1.00	> 0.20	C11orf9 (1.8)	TMED4 (1.7)	CBLC (1.7)	CELSR2 (1.6)	BCAM (1.4)	TMEM57 (1.3)	PVRL2 (1.3)	ABCG8 (1.1)	ST3GAL4 (1.1)	ABCG5 (1.0)
GO:0019198	transmembrane receptor protein phosphatase activity	1.00	> 0.20	C11orf9 (1.8)	TMED4 (1.7)	CBLC (1.7)	CELSR2 (1.6)	BCAM (1.4)	TMEM57 (1.3)	PVRL2 (1.3)	ABCG8 (1.1)	ST3GAL4 (1.1)	ABCG5 (1.0)
ENSG00000108578	BLMH PPI subnetwork	1.00	> 0.20	NKPD1 (3.9)	CYB561D1 (2.2)	TXNL4B (2.1)	DYNC2LI1 (2.1)	PCSK9 (1.9)	DHX38 (1.8)	QTRT1 (1.7)	ZHX3 (1.3)	ENSG00000254235 (1.3)	DOCK7 (1.3)
MP:0004077	abnormal striatum morphology	1.00	> 0.20	NCAN (2.7)	CELSR2 (2.4)	UBXN2B (2.4)	ERP29 (2.0)	AMIGO1 (1.6)	CLPTM1 (1.5)	TMED4 (1.5)	FADS1 (1.3)	ACAD10 (1.3)	ATP13A1 (1.3)
ENSG00000117533	VAMP4 PPI subnetwork	1.00	> 0.20	YIPF2 (2.7)	SARS (2.2)	CYB561D1 (1.9)	DNM2 (1.9)	SUGP1 (1.7)	KIAA1324 (1.6)	TMEM50A (1.3)	PSMA5 (1.3)	AP1M2 (1.3)	SLC44A2 (1.2)
GO:0071436	sodium ion export	1.00	> 0.20	ENSG00000238078 (2.1)	PMFBP1 (2.0)	ZHX3 (1.9)	NCAN (1.8)	GCNT4 (1.7)	SORT1 (1.7)	ENSG00000235545 (1.4)	CYB561D1 (1.3)	C12orf51 (1.3)	CEACAM19 (1.3)
ENSG00000139998	RAB15 PPI subnetwork	1.00	> 0.20	RPH3A (2.6)	C12orf51 (2.5)	NCAN (2.5)	SORT1 (2.1)	FADS1 (2.1)	CELSR2 (1.8)	UBXN2B (1.7)	TMEM50A (1.7)	HLX (1.7)	C12orf43 (1.6)
ENSG00000129990	SYT5 PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	NCAN (2.5)	C12orf51 (2.1)	CELSR2 (1.9)	SORT1 (1.8)	TMEM50A (1.7)	MARK4 (1.6)	C11orf9 (1.6)	FADS1 (1.5)	AMIGO1 (1.5)
ENSG00000158623	COPG2 PPI subnetwork	1.00	> 0.20	YIPF2 (3.7)	ATP13A1 (2.2)	SARS (1.8)	PSMA5 (1.8)	ACAD10 (1.7)	DOCK7 (1.6)	BRAP (1.6)	OGDH (1.5)	DNM2 (1.5)	MAU2 (1.5)
ENSG00000214133	ENSG00000214133 PPI subnetwork	1.00	> 0.20	YIPF2 (3.7)	ATP13A1 (2.2)	SARS (1.8)	PSMA5 (1.8)	ACAD10 (1.7)	DOCK7 (1.6)	BRAP (1.6)	OGDH (1.5)	DNM2 (1.5)	MAU2 (1.5)
GO:0019861	flagellum	1.00	> 0.20	DYNC2LI1 (5.0)	TSSK6 (4.4)	PMFBP1 (2.5)	DNAH11 (1.8)	TMEM116 (1.4)	YIPF2 (1.4)	TRAPPC6A (1.2)	PBX4 (1.0)	CILP2 (0.7)	NKPD1 (0.6)
KEGG_OLFACTORY_TRANSDUCTION	KEGG_OLFACTORY_TRANSDUCTION	1.00	> 0.20	ENSG00000235545 (3.6)	ENSG00000228044 (2.0)	GOT2P1 (1.8)	ZNF180 (1.7)	CYB561D1 (1.3)	TMED4 (1.0)	GMPR (0.9)	HNF1A (0.9)	COL4A3BP (0.8)	DNAH11 (0.7)
GO:0007214	gamma-aminobutyric acid signaling pathway	1.00	> 0.20	RPH3A (2.5)	LPIN3 (1.8)	ADAM1 (1.7)	HAPLN4 (1.7)	GCNT4 (1.5)	MYLIP (1.4)	PMFBP1 (1.1)	C12orf43 (1.1)	ERP29 (1.0)	BLOC1S3 (1.0)
GO:0050808	synapse organization	1.00	> 0.20	ZHX3 (2.9)	ENSG00000226648 (2.8)	CELSR2 (2.5)	NCAN (2.4)	RPH3A (2.2)	ABO (1.8)	PLEKHH2 (1.7)	ANKRD31 (1.7)	PMFBP1 (1.5)	HAPLN4 (1.5)
GO:0060324	face development	1.00	> 0.20	MYLIP (2.4)	ENSG00000235545 (1.9)	ENSG00000238078 (1.7)	C1orf63 (1.6)	NKPD1 (1.5)	C17orf57 (1.5)	CYB561D1 (1.4)	TMEM57 (1.3)	GCNT4 (1.1)	TSSK6 (1.1)
GO:0048169	regulation of long-term neuronal synaptic plasticity	1.00	> 0.20	ENSG00000226648 (2.9)	RPH3A (2.3)	HAVCR1 (1.7)	NCAN (1.6)	CELSR2 (1.4)	PPP1R37 (1.4)	AMIGO1 (1.2)	GEMIN7 (1.2)	PMFBP1 (1.2)	ENSG00000226645 (1.1)
GO:0060828	regulation of canonical Wnt receptor signaling pathway	1.00	> 0.20	PLEKHH2 (2.8)	DYNC2LI1 (2.3)	CILP2 (2.0)	NYNRIN (1.6)	PLCG1 (1.5)	PPP1R37 (1.5)	CBLC (1.4)	ENSG00000228044 (1.2)	MARK4 (1.2)	GATAD2A (1.2)
GO:0050872	white fat cell differentiation	1.00	> 0.20	UBXN2B (2.2)	TIMD4 (1.7)	PPP1R37 (1.7)	BLOC1S3 (1.6)	C12orf43 (1.4)	ATXN2 (1.3)	MAPKAPK5 (1.3)	ENSG00000228044 (1.2)	C19orf52 (1.1)	GPAM (1.1)
GO:0001736	establishment of planar polarity	1.00	> 0.20	ATXN7L2 (3.4)	CELSR2 (1.9)	NYNRIN (1.7)	DYNC2LI1 (1.6)	TMEM116 (1.5)	TMED4 (1.4)	PLEKHH2 (1.4)	AP1M2 (1.4)	ABO (1.3)	CILP2 (1.3)
MP:0002887	decreased susceptibility to pharmacologically induced seizures	1.00	> 0.20	NCAN (3.5)	ENSG00000235545 (3.1)	RPH3A (2.4)	KIAA1324 (2.2)	ENSG00000226645 (2.1)	TMEM50A (2.0)	ATXN7L2 (1.8)	ABO (1.6)	CELSR2 (1.6)	TRIB1 (1.5)
MP:0001524	impaired limb coordination	1.00	> 0.20	HAPLN4 (3.8)	RPH3A (3.7)	USP24 (2.1)	SARS (1.8)	TSSK6 (1.8)	NCAN (1.6)	C12orf47 (1.6)	ERP29 (1.4)	C12orf51 (1.4)	CELSR2 (1.4)
MP:0003862	decreased aggression towards males	1.00	> 0.20	NCAN (2.1)	GOT2P1 (2.0)	ABO (2.0)	OASL (1.5)	PARP10 (1.4)	CELSR2 (1.4)	APOC1 (1.4)	GRINA (1.2)	C19orf52 (1.2)	GCNT4 (1.1)
GO:0060174	limb bud formation	1.00	> 0.20	LPAR2 (2.3)	CILP2 (2.0)	HAPLN4 (1.6)	ENSG00000226648 (1.6)	PLEKHH2 (1.5)	DOCK7 (1.5)	ENSG00000235545 (1.5)	NYNRIN (1.4)	TRAPPC6A (1.4)	ENSG00000228044 (1.4)
MP:0001363	increased anxiety-related response	1.00	> 0.20	NCAN (3.3)	RPH3A (3.3)	GOT2P1 (2.2)	PMFBP1 (2.1)	ENSG00000226645 (1.9)	C12orf51 (1.7)	HAPLN4 (1.6)	TMEM50A (1.4)	APOC1 (1.3)	AMIGO1 (1.2)
GO:0005231	excitatory extracellular ligand-gated ion channel activity	1.00	> 0.20	ABO (2.4)	NCAN (2.1)	C12orf47 (1.9)	SYPL2 (1.9)	RPH3A (1.8)	ATXN7L2 (1.8)	NKPD1 (1.5)	CILP2 (1.4)	CYB561D1 (1.3)	ADAM1 (1.2)
MP:0002736	abnormal nociception after inflammation	1.00	> 0.20	RPH3A (2.6)	BCAM (2.3)	YIPF2 (2.1)	ITGB3 (2.1)	AMIGO1 (2.0)	PMFBP1 (1.8)	C12orf47 (1.7)	CELSR2 (1.3)	ENSG00000235545 (1.2)	AP1M2 (1.2)
GO:0031128	developmental induction	1.00	> 0.20	PPP1R37 (2.6)	C17orf57 (1.8)	HNF1A (1.7)	HAPLN4 (1.7)	LPIN3 (1.7)	ALDH2 (1.6)	KIAA1324 (1.6)	C11orf9 (1.3)	C19orf52 (1.3)	COL4A3BP (1.3)
MP:0004321	short sternum	1.00	> 0.20	UBXN2B (2.1)	NYNRIN (1.8)	TMED4 (1.6)	SYPL2 (1.5)	PLEC (1.5)	CARM1 (1.3)	SLC44A2 (1.2)	PLCG1 (1.2)	DOCK7 (1.0)	POC5 (1.0)
ENSG00000183023	SLC8A1 PPI subnetwork	1.00	> 0.20	SYPL2 (3.1)	TSSK6 (2.1)	GOT2P1 (1.7)	NCAN (1.6)	ZNF259 (1.5)	RPH3A (1.3)	MARK4 (1.3)	ADAM1 (1.3)	TIMD4 (1.2)	RHD (1.2)
GO:0007379	segment specification	1.00	> 0.20	DYNC2LI1 (2.5)	PLCG1 (2.3)	BLOC1S3 (2.1)	PBX4 (1.7)	KIAA1324 (1.6)	PLEKHH2 (1.6)	GCNT4 (1.5)	NKPD1 (1.4)	CILP2 (1.3)	TMEM116 (1.2)
ENSG00000149294	NCAM1 PPI subnetwork	1.00	> 0.20	ZHX3 (2.3)	CYP7A1 (1.8)	CELSR2 (1.7)	MARK4 (1.7)	RHD (1.6)	ITGB3 (1.5)	TMED4 (1.5)	GRINA (1.5)	ADAM1 (1.5)	ENSG00000238078 (1.4)
ENSG00000136527	TRA2B PPI subnetwork	1.00	> 0.20	C1orf63 (2.7)	BRAP (2.6)	TOP1 (2.4)	ADAM1 (2.1)	NAA25 (2.0)	ERP29 (2.0)	GATAD2A (2.0)	COL4A3BP (1.6)	BCAM (1.5)	ACAD10 (1.5)
MP:0004726	abnormal nasal capsule morphology	1.00	> 0.20	CILP2 (1.8)	MAFB (1.7)	DYNC2LI1 (1.5)	CARM1 (1.5)	PLCG1 (1.4)	PSRC1 (1.3)	HAPLN4 (1.2)	MYLIP (1.2)	ZHX3 (0.9)	ATP13A1 (0.8)
GO:0017158	regulation of calcium ion-dependent exocytosis	1.00	> 0.20	C12orf47 (2.3)	AMIGO1 (2.2)	ENSG00000238078 (2.1)	YIPF2 (1.5)	HAVCR1 (1.5)	TSSK6 (1.4)	RPH3A (1.4)	CILP2 (1.4)	KIAA1324 (1.4)	NYNRIN (1.3)
GO:0042461	photoreceptor cell development	1.00	> 0.20	ENSG00000235545 (2.2)	ENSG00000226648 (2.0)	DYNC2LI1 (1.9)	PMFBP1 (1.3)	DNAH11 (1.1)	GOT2P1 (1.0)	C12orf47 (1.0)	ENSG00000228044 (1.0)	UBXN2B (0.9)	CYB561D1 (0.9)
GO:0001756	somitogenesis	1.00	> 0.20	ABO (3.1)	ATXN7L2 (1.9)	CILP2 (1.5)	SYPL2 (1.2)	USP24 (1.1)	TMEM50A (1.1)	ATXN2 (1.1)	AMIGO1 (1.0)	PLCG1 (1.0)	LPAR2 (1.0)
GO:0009855	determination of bilateral symmetry	1.00	> 0.20	DYNC2LI1 (3.5)	LPIN3 (1.7)	ATXN7L2 (1.7)	ENSG00000226648 (1.6)	UBXN2B (1.4)	NYNRIN (1.2)	TSSK6 (1.2)	MAPKAPK5 (1.2)	DOCK7 (1.2)	HLX (1.1)
MP:0000968	abnormal sensory neuron innervation pattern	1.00	> 0.20	CILP2 (1.8)	GEMIN7 (1.7)	GCNT4 (1.4)	TMED4 (1.3)	APOA5 (1.2)	CETP (1.1)	HLX (1.0)	TSSK6 (1.0)	DNAH11 (0.9)	ABO (0.9)
ENSG00000143858	SYT2 PPI subnetwork	1.00	> 0.20	RPH3A (2.5)	NCAN (2.5)	C12orf51 (2.5)	CELSR2 (1.9)	C11orf9 (1.8)	MARK4 (1.6)	FADS1 (1.6)	TMEM50A (1.5)	SORT1 (1.5)	C12orf43 (1.5)
GO:0042693	muscle cell fate commitment	1.00	> 0.20	SYPL2 (3.9)	TSSK6 (2.2)	LPIN3 (1.9)	ENSG00000226648 (1.8)	ENSG00000235545 (1.4)	TMED4 (1.3)	COL4A3BP (1.2)	PLEKHH2 (1.2)	BLOC1S3 (1.1)	HLX (0.9)
GO:0008306	associative learning	1.00	> 0.20	C12orf47 (2.7)	TSSK6 (2.3)	RPH3A (2.2)	GCNT4 (2.1)	ENSG00000226648 (1.9)	UBXN2B (1.8)	NCAN (1.6)	ADAM1 (1.5)	AMIGO1 (1.2)	ENSG00000226645 (1.2)
ENSG00000102109	PCSK1N PPI subnetwork	1.00	> 0.20	C12orf51 (2.4)	RPH3A (2.4)	NCAN (2.1)	SORT1 (2.1)	FADS1 (2.1)	CELSR2 (1.8)	HLX (1.8)	UBXN2B (1.7)	AMIGO1 (1.6)	TMEM50A (1.5)
GO:0030817	regulation of cAMP biosynthetic process	1.00	> 0.20	C12orf47 (3.7)	ABO (2.1)	AMIGO1 (2.0)	RPH3A (1.8)	PMFBP1 (1.7)	DNAH11 (1.5)	CELSR2 (1.5)	NCAN (1.3)	KIAA1324 (1.2)	CETP (1.2)
ENSG00000206210	ENSG00000206210 PPI subnetwork	1.00	> 0.20	CYB561D1 (2.3)	LPAR2 (2.1)	COL4A3BP (2.0)	ZNF259 (1.9)	TMEM116 (1.8)	RELB (1.8)	SARS (1.7)	MAPKAPK5 (1.6)	OGDH (1.4)	PSRC1 (1.4)
ENSG00000206282	RGL2 PPI subnetwork	1.00	> 0.20	CYB561D1 (2.3)	LPAR2 (2.1)	COL4A3BP (2.0)	ZNF259 (1.9)	TMEM116 (1.8)	RELB (1.8)	SARS (1.7)	MAPKAPK5 (1.6)	OGDH (1.4)	PSRC1 (1.4)
GO:0072522	purine-containing compound biosynthetic process	1.00	> 0.20	C12orf47 (3.5)	ENSG00000226648 (2.3)	PMFBP1 (2.1)	AMIGO1 (1.9)	RPH3A (1.7)	SYPL2 (1.6)	GOT2P1 (1.4)	HNF1A (1.1)	TMEM116 (1.1)	LPIN3 (1.1)
ENSG00000165023	DIRAS2 PPI subnetwork	1.00	> 0.20	RPH3A (2.6)	C12orf51 (2.5)	NCAN (2.3)	SORT1 (2.1)	FADS1 (2.0)	UBXN2B (1.9)	CELSR2 (1.8)	C12orf43 (1.6)	TMEM50A (1.6)	HLX (1.4)
GO:0045601	regulation of endothelial cell differentiation	1.00	> 0.20	ITGB3 (3.3)	PLCG1 (1.7)	C12orf47 (1.5)	HLX (1.5)	LPIN3 (1.4)	GMPR (1.4)	CETP (1.3)	BLOC1S3 (1.1)	BUD13 (1.0)	SH2B3 (0.9)
REACTOME_GABA_RECEPTOR_ACTIVATION	REACTOME_GABA_RECEPTOR_ACTIVATION	1.00	> 0.20	RPH3A (2.3)	MYLIP (1.9)	NCAN (1.7)	HAVCR1 (1.4)	TMEM50A (1.3)	CLPTM1 (1.2)	NYNRIN (1.2)	ENSG00000228044 (1.0)	C12orf43 (1.0)	ENSG00000254235 (0.8)
ENSG00000025772	TOMM34 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.2)	SORT1 (1.9)	CELSR2 (1.8)	UBXN2B (1.8)	C12orf43 (1.7)	TMEM50A (1.7)	FADS1 (1.5)	C11orf9 (1.4)
MP:0003729	abnormal photoreceptor outer segment morphology	1.00	> 0.20	DYNC2LI1 (2.6)	ATXN7L2 (1.8)	GPAM (1.7)	PMFBP1 (1.7)	ENSG00000235545 (1.2)	C11orf9 (1.2)	MAPKAPK5 (1.2)	UBXN2B (1.1)	PSRC1 (1.0)	C12orf47 (0.9)
MP:0003345	decreased rib number	1.00	> 0.20	PLCG1 (2.3)	NYNRIN (2.1)	ATXN7L2 (1.7)	SLC44A2 (1.6)	AMIGO1 (1.5)	ALDH2 (1.5)	PCSK9 (1.4)	CARM1 (1.4)	C19orf52 (1.2)	OASL (1.1)
ENSG00000066248	NGEF PPI subnetwork	1.00	> 0.20	NCAN (2.4)	RPH3A (2.3)	C12orf51 (2.2)	SORT1 (2.2)	TMEM50A (2.1)	MARK4 (1.8)	CELSR2 (1.8)	C11orf9 (1.7)	UBXN2B (1.7)	C12orf43 (1.5)
MP:0001410	head bobbing	1.00	> 0.20	HAPLN4 (3.6)	HNF1A (2.2)	NT5DC1 (1.9)	FRK (1.7)	CILP2 (1.6)	MOSC1 (1.5)	TMEM116 (1.3)	C17orf57 (1.2)	KIAA1324 (1.1)	C11orf9 (1.0)
GO:0004428	inositol or phosphatidylinositol kinase activity	1.00	> 0.20	ZNF180 (1.9)	GMIP (1.7)	ACAD10 (1.7)	C11orf9 (1.5)	DNM2 (1.5)	SLC44A2 (1.4)	LPAR2 (1.4)	MOSC1 (1.3)	TMED4 (1.3)	DOCK7 (1.3)
GO:0001504	neurotransmitter uptake	1.00	> 0.20	RPH3A (2.1)	GOT2P1 (1.7)	GMPR (1.6)	BRAP (1.4)	ENSG00000226648 (1.4)	HAPLN4 (1.4)	SORT1 (1.3)	PTPN11 (1.2)	PMFBP1 (1.1)	NCAN (1.0)
ENSG00000183454	GRIN2A PPI subnetwork	1.00	> 0.20	RPH3A (3.5)	SORT1 (2.4)	NCAN (2.2)	CELSR2 (2.2)	C11orf9 (2.2)	PPP1R37 (1.9)	ENSG00000226648 (1.9)	CLPTM1 (1.7)	MARK4 (1.5)	GOT2P1 (1.1)
GO:0001759	organ induction	1.00	> 0.20	ENSG00000238078 (2.2)	PLEKHH2 (2.2)	PPP1R37 (2.1)	LPIN3 (2.0)	KIAA1324 (1.3)	BLOC1S3 (1.2)	C19orf52 (1.2)	ZHX3 (1.1)	SYPL2 (1.1)	PTPN11 (1.1)
GO:0009799	specification of symmetry	1.00	> 0.20	DYNC2LI1 (3.4)	ATXN7L2 (1.7)	LPIN3 (1.5)	ENSG00000226648 (1.4)	UBXN2B (1.4)	NYNRIN (1.3)	HLX (1.3)	MAPKAPK5 (1.3)	TSSK6 (1.2)	PLEKHH2 (1.1)
GO:0045980	negative regulation of nucleotide metabolic process	1.00	> 0.20	C12orf47 (3.4)	RPH3A (2.4)	CETP (1.9)	CELSR2 (1.7)	ABO (1.5)	NCAN (1.5)	DNAH11 (1.4)	LPAR2 (1.2)	SLC44A2 (1.2)	C12orf51 (1.1)
ENSG00000068078	FGFR3 PPI subnetwork	1.00	> 0.20	HAPLN4 (2.5)	ABO (2.3)	RPH3A (2.0)	TSSK6 (2.0)	CARM1 (1.9)	PARP10 (1.8)	PLEKHH2 (1.8)	PVRL2 (1.6)	POC5 (1.2)	AP1M2 (1.2)
GO:0033205	cell cycle cytokinesis	1.00	> 0.20	PSRC1 (3.2)	POC5 (2.3)	DYNC2LI1 (1.6)	C12orf43 (1.2)	TMEM116 (1.2)	GEMIN7 (1.2)	LPIN3 (1.2)	ZHX3 (1.1)	ATXN2 (1.1)	BUD13 (1.1)
GO:0060996	dendritic spine development	1.00	> 0.20	HNF1A (3.0)	PLEKHH2 (2.7)	LPAR2 (2.5)	NCAN (2.2)	LPIN3 (1.8)	TMEM116 (1.8)	FADS2 (1.3)	RPH3A (1.3)	CELSR2 (1.2)	ANKRD31 (1.1)
GO:0008212	mineralocorticoid metabolic process	1.00	> 0.20	NKPD1 (2.0)	PMFBP1 (1.9)	AMIGO1 (1.6)	ZNF180 (1.5)	TSSK6 (1.5)	TRAPPC6A (1.3)	CILP2 (1.3)	TMEM50A (1.1)	LPIN3 (1.1)	ST3GAL4 (1.1)
ENSG00000102189	EEA1 PPI subnetwork	1.00	> 0.20	PTPN11 (3.3)	BLOC1S3 (3.1)	COL4A3BP (2.4)	MAPKAPK5 (1.8)	HAPLN4 (1.6)	BRAP (1.6)	SH2B3 (1.4)	DYNC2LI1 (1.4)	NKPD1 (1.3)	ATXN2 (1.3)
GO:0007632	visual behavior	1.00	> 0.20	RPH3A (2.3)	ENSG00000226648 (2.1)	C12orf47 (2.0)	NCAN (1.8)	TSSK6 (1.6)	ADAM1 (1.5)	GEMIN7 (1.4)	C17orf57 (1.4)	ATXN7L2 (1.3)	GCNT4 (1.1)
GO:0008038	neuron recognition	1.00	> 0.20	PBX4 (3.4)	LPAR2 (2.7)	NCAN (2.6)	CYB561D1 (2.1)	PMFBP1 (1.7)	CELSR2 (1.7)	C12orf43 (1.5)	TXNL4B (1.4)	C12orf47 (1.3)	GCNT4 (1.2)
GO:0042347	negative regulation of NF-kappaB import into nucleus	1.00	> 0.20	ENSG00000235545 (2.2)	ZNF101 (2.1)	PTPN11 (1.7)	ENSG00000238078 (1.5)	PBX4 (1.5)	PMFBP1 (1.5)	RELB (1.2)	AMIGO1 (1.1)	SUGP1 (1.1)	MYLIP (1.0)
MP:0001968	abnormal touch/ nociception	1.00	> 0.20	RPH3A (4.9)	PMFBP1 (1.6)	KIAA1324 (1.5)	C17orf57 (1.4)	SH2B3 (1.4)	DHODH (1.2)	APOC1 (1.2)	SARS (1.1)	HLX (1.1)	AMIGO1 (1.0)
GO:0060123	regulation of growth hormone secretion	1.00	> 0.20	ENSG00000226648 (3.5)	HNF1A (1.9)	KIAA1324 (1.9)	TMED4 (1.9)	C12orf47 (1.6)	TMEM116 (1.5)	C12orf51 (1.5)	LPIN3 (1.3)	BRAP (1.2)	ANKRD31 (1.1)
GO:0048266	behavioral response to pain	1.00	> 0.20	C12orf47 (3.6)	ENSG00000226648 (3.0)	NKPD1 (2.4)	ENSG00000226645 (2.4)	ABO (2.1)	PMFBP1 (2.0)	RPH3A (1.8)	BRAP (1.6)	ADAM1 (1.2)	ERP29 (1.1)
MP:0005225	abnormal vertebrae development	1.00	> 0.20	NYNRIN (3.2)	CILP2 (2.4)	MAFB (2.2)	PLCG1 (1.5)	ENSG00000238078 (1.2)	TMEM50A (1.2)	PLEKHH2 (1.2)	TMEM116 (1.1)	NCAN (1.0)	C19orf52 (0.9)
GO:0030814	regulation of cAMP metabolic process	1.00	> 0.20	C12orf47 (3.8)	AMIGO1 (2.1)	ABO (2.0)	RPH3A (1.8)	PMFBP1 (1.7)	DNAH11 (1.5)	CELSR2 (1.5)	NCAN (1.3)	KIAA1324 (1.1)	ENSG00000226645 (1.1)
ENSG00000067715	SYT1 PPI subnetwork	1.00	> 0.20	RPH3A (4.5)	HAPLN4 (3.1)	NCAN (2.1)	C11orf9 (1.7)	AMIGO1 (1.6)	FRK (1.6)	KIAA1324 (1.6)	TMEM50A (1.5)	C12orf43 (1.4)	CELSR2 (1.4)
GO:0022839	ion gated channel activity	1.00	> 0.20	AMIGO1 (2.8)	KIAA1324 (2.4)	CYP7A1 (2.1)	APOC4 (1.9)	PBX4 (1.7)	ZNF180 (1.5)	ZNF101 (1.4)	TRAPPC6A (1.3)	ALDH2 (1.3)	TXNL4B (1.2)
KEGG_CARDIAC_MUSCLE_CONTRACTION	KEGG_CARDIAC_MUSCLE_CONTRACTION	1.00	> 0.20	SYPL2 (4.6)	C12orf47 (2.6)	OGDH (1.9)	GOT2P1 (1.6)	RPH3A (1.5)	GMPR (1.2)	PTPN11 (1.1)	TMEM50A (1.1)	HAPLN4 (1.0)	TMEM116 (1.0)
GO:0007156	homophilic cell adhesion	1.00	> 0.20	FRK (2.5)	CBLC (1.9)	HNF1A (1.8)	CELSR2 (1.7)	ENSG00000226648 (1.6)	AP1M2 (1.3)	TMED4 (1.1)	NCAN (1.1)	NKPD1 (1.1)	BCAM (1.1)
GO:0045927	positive regulation of growth	1.00	> 0.20	GEMIN7 (2.0)	C12orf47 (2.0)	ENSG00000238078 (1.7)	KIAA1324 (1.7)	AMIGO1 (1.5)	C17orf57 (1.5)	USP24 (1.3)	COL4A3BP (1.1)	AP1M2 (1.0)	PTPN11 (1.0)
GO:0051155	positive regulation of striated muscle cell differentiation	1.00	> 0.20	NKPD1 (2.8)	LPIN3 (2.5)	CEACAM19 (2.4)	SYPL2 (2.2)	AMIGO1 (2.0)	HNF1A (2.0)	PMFBP1 (1.8)	BLOC1S3 (1.7)	TMEM116 (1.5)	ABO (1.5)
ENSG00000156113	KCNMA1 PPI subnetwork	1.00	> 0.20	C12orf43 (2.2)	PTPN11 (2.1)	NCAN (2.1)	HNF1A (1.9)	RPH3A (1.8)	C11orf9 (1.7)	ERP29 (1.6)	POLK (1.3)	ENSG00000235545 (1.3)	KANK2 (1.3)
GO:0050767	regulation of neurogenesis	1.00	> 0.20	NCAN (3.5)	CELSR2 (2.7)	PBX4 (2.0)	C11orf9 (1.9)	MARK4 (1.6)	PPP1R37 (1.6)	PLCG1 (1.3)	LPAR2 (1.2)	RPH3A (1.2)	ENSG00000254235 (1.1)
ENSG00000103496	STX4 PPI subnetwork	1.00	> 0.20	C1orf63 (3.2)	TMEM50A (2.8)	CYB561D1 (2.6)	SORT1 (1.9)	HNF1A (1.7)	PTPN11 (1.7)	TRAPPC6A (1.6)	SARS (1.5)	AP1M2 (1.5)	GEMIN7 (1.4)
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	1.00	> 0.20	RPH3A (4.3)	RHD (3.0)	C12orf51 (2.7)	RHCE (2.5)	AMIGO1 (2.5)	SORT1 (2.4)	CELSR2 (2.1)	BCAM (2.0)	CYB561D1 (1.7)	SYPL2 (1.5)
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	1.00	> 0.20	YIPF2 (2.7)	BRAP (1.9)	C1orf63 (1.9)	BLOC1S3 (1.9)	TMEM50A (1.9)	SUGP1 (1.7)	TRAPPC6A (1.6)	C19orf52 (1.6)	GEMIN7 (1.6)	HAPLN4 (1.5)
GO:0045843	negative regulation of striated muscle tissue development	1.00	> 0.20	ATXN7L2 (2.7)	CEACAM19 (2.3)	C1orf63 (1.9)	SYPL2 (1.8)	C17orf57 (1.7)	PLCG1 (1.6)	PBX4 (1.5)	GMPR (1.3)	ENSG00000238078 (1.3)	ZHX3 (1.3)
GO:0015300	solute:solute antiporter activity	1.00	> 0.20	TMEM116 (2.9)	ENSG00000235545 (1.9)	AMIGO1 (1.9)	CLPTM1 (1.8)	SYPL2 (1.8)	ALDH2 (1.7)	NCAN (1.7)	GMPR (1.6)	CYB561D1 (1.6)	TMED4 (1.4)
GO:0048265	response to pain	1.00	> 0.20	RPH3A (2.6)	C12orf47 (2.5)	BRAP (2.0)	ADAM1 (1.9)	ENSG00000226648 (1.9)	ABO (1.5)	PMFBP1 (1.4)	TMEM50A (1.3)	DNAH11 (1.3)	TMEM116 (1.2)
GO:0030800	negative regulation of cyclic nucleotide metabolic process	1.00	> 0.20	C12orf47 (3.2)	RPH3A (2.3)	CETP (2.0)	CELSR2 (1.7)	ABO (1.7)	NCAN (1.6)	DNAH11 (1.4)	LPAR2 (1.3)	SLC44A2 (1.0)	C12orf51 (0.9)
GO:0030809	negative regulation of nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (3.2)	RPH3A (2.3)	CETP (2.0)	CELSR2 (1.7)	ABO (1.7)	NCAN (1.6)	DNAH11 (1.4)	LPAR2 (1.3)	SLC44A2 (1.0)	C12orf51 (0.9)
GO:0030803	negative regulation of cyclic nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (3.2)	RPH3A (2.3)	CETP (2.0)	CELSR2 (1.7)	ABO (1.7)	NCAN (1.6)	DNAH11 (1.4)	LPAR2 (1.3)	SLC44A2 (1.0)	C12orf51 (0.9)
GO:0033267	axon part	1.00	> 0.20	HAPLN4 (4.7)	RPH3A (4.6)	CELSR2 (2.1)	C11orf9 (2.1)	KIAA1324 (1.9)	TSSK6 (1.8)	ABO (1.6)	SORT1 (1.6)	C12orf47 (1.5)	AMIGO1 (1.4)
REACTOME_ION_CHANNEL_TRANSPORT	REACTOME_ION_CHANNEL_TRANSPORT	1.00	> 0.20	RPH3A (2.1)	ATP13A1 (2.0)	HAPLN4 (1.8)	HNF1A (1.7)	COL4A3BP (1.7)	HAVCR1 (1.3)	SORT1 (1.3)	TMEM116 (1.2)	GCNT4 (1.2)	NCAN (1.1)
MP:0005170	cleft lip	1.00	> 0.20	HLX (2.4)	DYNC2LI1 (1.9)	ADAM1 (1.6)	QTRT1 (1.6)	ABO (1.5)	PPP1R37 (1.5)	NKPD1 (1.5)	NCAN (1.5)	GATAD2A (1.4)	ZHX3 (1.3)
MP:0004008	abnormal GABA-mediated receptor currents	1.00	> 0.20	HAPLN4 (3.1)	RPH3A (2.3)	LPIN3 (1.6)	NCAN (1.4)	C11orf9 (1.3)	UBXN2B (1.3)	MYLIP (1.2)	ATP13A1 (1.2)	NKPD1 (1.1)	CEACAM19 (1.0)
ENSG00000164402	SEPT8 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.6)	C12orf51 (2.0)	C11orf9 (1.9)	SORT1 (1.8)	HAPLN4 (1.7)	UBXN2B (1.6)	FADS1 (1.5)	C12orf43 (1.5)	TMEM50A (1.4)
GO:0031644	regulation of neurological system process	1.00	> 0.20	RPH3A (3.7)	NCAN (3.2)	HAPLN4 (3.1)	CELSR2 (2.1)	C12orf43 (1.8)	MARK4 (1.6)	AMIGO1 (1.6)	ABO (1.2)	GEMIN7 (1.1)	ZHX3 (1.1)
GO:0006164	purine nucleotide biosynthetic process	1.00	> 0.20	C12orf47 (3.2)	PMFBP1 (2.2)	AMIGO1 (2.1)	ENSG00000226648 (2.1)	RPH3A (1.8)	SYPL2 (1.5)	GOT2P1 (1.4)	TSSK6 (1.2)	TMEM116 (1.2)	ABO (1.0)
MP:0002797	increased thigmotaxis	1.00	> 0.20	CELSR2 (2.7)	ENSG00000226648 (2.2)	C12orf43 (1.7)	RPH3A (1.7)	MYLIP (1.6)	C12orf47 (1.5)	CETP (1.4)	BCAM (1.2)	TMEM116 (1.1)	SORT1 (1.1)
GO:0072080	nephron tubule development	1.00	> 0.20	HAVCR1 (3.6)	BCAM (2.7)	AP1M2 (2.1)	TMEM116 (1.8)	CELSR2 (1.7)	DYNC2LI1 (1.6)	PMFBP1 (1.5)	TSSK6 (1.4)	DNAH11 (1.2)	ZHX3 (1.0)
MP:0001522	impaired swimming	1.00	> 0.20	HAPLN4 (3.0)	HNF1A (2.7)	RPH3A (2.2)	AP1M2 (1.8)	AMIGO1 (1.8)	ZHX3 (1.7)	ANKRD31 (1.7)	CELSR2 (1.6)	TMEM116 (1.5)	NPC1L1 (1.4)
GO:0060317	cardiac epithelial to mesenchymal transition	1.00	> 0.20	MYLIP (1.9)	C19orf52 (1.8)	ENSG00000226645 (1.7)	TRAPPC6A (1.4)	ENSG00000254235 (1.4)	ABO (1.3)	YIPF2 (1.2)	ENSG00000238078 (1.2)	C1orf63 (1.1)	CYB561D1 (1.0)
ENSG00000164076	CAMKV PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	C12orf51 (2.5)	NCAN (2.3)	FADS1 (2.2)	SORT1 (2.0)	CELSR2 (1.8)	UBXN2B (1.7)	HLX (1.7)	AMIGO1 (1.6)	C12orf43 (1.5)
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	1.00	> 0.20	RPH3A (4.8)	HAPLN4 (3.5)	ABO (2.3)	SORT1 (1.6)	CELSR2 (1.6)	C11orf9 (1.3)	NCAN (1.3)	CYB561D1 (1.3)	ENSG00000228044 (1.3)	AMIGO1 (1.2)
MP:0008572	abnormal Purkinje cell dendrite morphology	1.00	> 0.20	RPH3A (3.0)	HAPLN4 (2.8)	NCAN (2.4)	NYNRIN (2.4)	YIPF2 (2.1)	APOE (1.7)	PLCG1 (1.2)	MAFB (1.0)	C19orf52 (1.0)	ALDH2 (1.0)
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	1.00	> 0.20	RPH3A (3.5)	NCAN (2.8)	HAPLN4 (1.9)	SORT1 (1.8)	ABO (1.5)	C12orf51 (1.4)	CELSR2 (1.4)	ZHX3 (1.3)	C12orf43 (1.3)	AMIGO1 (1.3)
GO:0007602	phototransduction	1.00	> 0.20	C12orf47 (1.9)	PMFBP1 (1.8)	TMEM116 (1.7)	TSSK6 (1.5)	GEMIN7 (1.2)	ANKRD31 (1.1)	ST3GAL4 (0.9)	ENSG00000235545 (0.9)	TRAPPC6A (0.8)	BLOC1S3 (0.8)
MP:0002761	abnormal hippocampal mossy fiber morphology	1.00	> 0.20	NCAN (5.4)	CELSR2 (2.6)	ENSG00000235545 (2.1)	C12orf47 (1.5)	ADAM1 (1.5)	CILP2 (1.4)	CYB561D1 (1.4)	C12orf51 (1.3)	PSRC1 (1.3)	GMIP (1.3)
MP:0000951	sporadic seizures	1.00	> 0.20	RPH3A (3.2)	SORT1 (3.2)	CELSR2 (2.7)	HAPLN4 (2.3)	MARK4 (1.8)	NT5DC1 (1.7)	C12orf51 (1.7)	PMFBP1 (1.4)	PPP1R37 (1.3)	ATXN7L2 (1.2)
MP:0001489	decreased startle reflex	1.00	> 0.20	RPH3A (2.8)	ZHX3 (1.9)	APOC1 (1.6)	MAFB (1.6)	NKPD1 (1.5)	APOE (1.4)	PVR (1.4)	TRAPPC6A (1.4)	C12orf47 (1.4)	TSSK6 (1.1)
REACTOME_GABA_A_RECEPTOR_ACTIVATION	REACTOME_GABA_A_RECEPTOR_ACTIVATION	1.00	> 0.20	RPH3A (1.8)	LPIN3 (1.8)	HAPLN4 (1.7)	UBXN2B (1.3)	NCAN (1.3)	C11orf9 (1.1)	MYLIP (1.1)	ATP13A1 (1.0)	C12orf43 (1.0)	ANKRD31 (1.0)
MP:0002063	abnormal learning/memory/conditioning	1.00	> 0.20	NCAN (2.4)	RPH3A (1.7)	CETP (1.7)	C11orf9 (1.5)	SORT1 (1.3)	COL4A3BP (1.3)	C12orf47 (1.3)	PLCG1 (1.2)	HAPLN4 (1.2)	C17orf57 (1.1)
GO:0060590	ATPase regulator activity	1.00	> 0.20	ERP29 (1.8)	TMEM50A (1.8)	C12orf47 (1.7)	BRAP (1.5)	ENSG00000235545 (1.5)	KIAA1324 (1.5)	ALDH2 (1.4)	C1orf63 (1.3)	AMIGO1 (1.3)	TMEM57 (1.1)
MP:0002062	abnormal associative learning	1.00	> 0.20	PTPN11 (2.2)	ZHX3 (2.0)	KIAA1324 (1.7)	ENSG00000235545 (1.6)	PLCG1 (1.5)	PPP1R37 (1.4)	CYP7A1 (1.4)	CETP (1.3)	APOA5 (1.3)	CELSR2 (1.3)
GO:0009582	detection of abiotic stimulus	1.00	> 0.20	PMFBP1 (1.7)	C12orf47 (1.6)	GOT2P1 (1.5)	GEMIN7 (1.3)	ENSG00000235545 (1.3)	ST3GAL4 (1.3)	TMEM116 (1.3)	NKPD1 (1.2)	ANKRD31 (1.1)	TSSK6 (1.1)
ENSG00000003393	ALS2 PPI subnetwork	1.00	> 0.20	APOE (1.9)	PVR (1.7)	POLK (1.6)	TIMD4 (1.5)	ALDH2 (1.4)	ZNF180 (1.3)	ERP29 (1.3)	PTPN11 (1.2)	C17orf57 (1.2)	AMIGO1 (1.2)
MP:0000967	abnormal sensory neuron projections	1.00	> 0.20	NYNRIN (3.1)	TSSK6 (1.6)	UBXN2B (1.3)	CELSR2 (1.1)	HAVCR1 (1.1)	ALDH2 (1.0)	CEACAM19 (1.0)	CYP7A1 (1.0)	AMIGO1 (1.0)	CILP2 (0.9)
GO:0048167	regulation of synaptic plasticity	1.00	> 0.20	RPH3A (3.6)	NCAN (3.5)	HAPLN4 (2.8)	CELSR2 (2.0)	ENSG00000226648 (1.9)	C11orf9 (1.6)	HAVCR1 (1.3)	ENSG00000254235 (1.2)	SORT1 (1.1)	ATXN7L2 (1.1)
MP:0009757	impaired behavioral response to morphine	1.00	> 0.20	KIAA1324 (2.1)	RPH3A (1.7)	CELSR2 (1.4)	NPC1L1 (1.4)	MYLIP (1.3)	SORT1 (1.2)	LPAR2 (1.2)	ENSG00000235545 (1.2)	ENSG00000226648 (1.2)	MOSC1 (1.1)
ENSG00000214826	ENSG00000214826 PPI subnetwork	1.00	> 0.20	PSRC1 (3.1)	USP1 (2.3)	FEN1 (2.0)	GATAD2A (1.7)	PLCG1 (1.5)	ZHX3 (1.5)	ILF3 (1.3)	DHX38 (1.1)	ERP29 (1.1)	RPH3A (1.1)
ENSG00000111788	ENSG00000111788 PPI subnetwork	1.00	> 0.20	PSRC1 (3.1)	USP1 (2.3)	FEN1 (2.0)	GATAD2A (1.7)	PLCG1 (1.5)	ZHX3 (1.5)	ILF3 (1.3)	DHX38 (1.1)	ERP29 (1.1)	RPH3A (1.1)
MP:0001473	reduced long term potentiation	1.00	> 0.20	NCAN (3.0)	RPH3A (2.9)	CELSR2 (2.8)	AMIGO1 (1.8)	C12orf43 (1.7)	MARK4 (1.5)	KIAA1324 (1.4)	PLEKHH2 (1.4)	ABO (1.2)	SH2B3 (1.0)
ENSG00000008869	HEATR5B PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.6)	C12orf51 (2.6)	SORT1 (2.2)	FADS1 (2.0)	CELSR2 (1.8)	C12orf43 (1.7)	AMIGO1 (1.5)	HLX (1.4)	TMEM50A (1.4)
MP:0001486	abnormal startle reflex	1.00	> 0.20	TOP1 (2.3)	UBXN2B (2.1)	ST3GAL4 (1.9)	PBX4 (1.6)	HAPLN4 (1.5)	TRIB1 (1.3)	ZNF101 (1.3)	RPH3A (1.2)	TRAPPC6A (1.1)	ENSG00000226648 (1.1)
ENSG00000038274	MAT2B PPI subnetwork	1.00	> 0.20	C12orf51 (2.6)	NCAN (2.6)	RPH3A (2.6)	SORT1 (2.1)	FADS1 (2.1)	CELSR2 (1.7)	HLX (1.5)	AMIGO1 (1.5)	MARK4 (1.5)	UBXN2B (1.5)
GO:0060571	morphogenesis of an epithelial fold	1.00	> 0.20	PLEKHH2 (2.4)	LPAR2 (2.4)	AMIGO1 (1.9)	CBLC (1.7)	PBX4 (1.3)	ALDH2 (1.2)	DYNC2LI1 (1.2)	NYNRIN (1.1)	C19orf52 (1.1)	BLOC1S3 (1.1)
GO:0005230	extracellular ligand-gated ion channel activity	1.00	> 0.20	RPH3A (2.3)	NCAN (2.1)	ABO (2.0)	ANKRD31 (1.5)	ADAM1 (1.5)	NKPD1 (1.4)	C12orf43 (1.3)	C12orf47 (1.0)	APOE (1.0)	HAPLN4 (1.0)
MP:0003728	abnormal retinal photoreceptor layer morphology	1.00	> 0.20	NCAN (2.4)	ENSG00000226648 (2.2)	MAPKAPK5 (2.0)	MAFB (1.6)	ST3GAL4 (1.6)	ENSG00000235545 (1.3)	UBXN2B (1.1)	C12orf47 (1.1)	DYNC2LI1 (1.0)	SORT1 (0.9)
GO:0017156	calcium ion-dependent exocytosis	1.00	> 0.20	TSSK6 (3.7)	PMFBP1 (2.9)	HNF1A (2.3)	HAVCR1 (2.0)	AMIGO1 (1.9)	PBX4 (1.8)	RPH3A (1.8)	C12orf47 (1.7)	BRAP (1.5)	BLOC1S3 (1.5)
GO:0051966	regulation of synaptic transmission, glutamatergic	1.00	> 0.20	RPH3A (2.8)	ENSG00000226648 (2.2)	C17orf57 (2.2)	NCAN (1.8)	C12orf43 (1.5)	TSSK6 (1.3)	KIAA1324 (1.3)	ABO (1.1)	GEMIN7 (1.0)	YIPF2 (0.8)
MP:0003312	abnormal locomotor coordination	1.00	> 0.20	RPH3A (3.0)	PPP1R37 (2.4)	C17orf57 (2.0)	HAPLN4 (1.7)	OGDH (1.6)	APOE (1.4)	ATXN7L2 (1.3)	BCAM (1.2)	ADAM1 (1.2)	C12orf51 (1.2)
GO:0022890	inorganic cation transmembrane transporter activity	1.00	> 0.20	TMEM116 (3.3)	HAPLN4 (3.2)	SORT1 (3.1)	RPH3A (2.9)	NCAN (2.1)	CYB561D1 (2.0)	OGDH (2.0)	SYPL2 (1.8)	CELSR2 (1.6)	GOT2P1 (1.6)
MP:0001395	bidirectional circling	1.00	> 0.20	TM6SF2 (2.3)	TMED4 (1.6)	DNAH11 (1.4)	TMEM116 (1.3)	NCAN (1.1)	ALDH2 (1.0)	ZNF101 (0.9)	HAPLN4 (0.9)	LPIN3 (0.9)	BCL3 (0.9)
ENSG00000108828	VAT1 PPI subnetwork	1.00	> 0.20	RPH3A (2.8)	C12orf51 (2.7)	NCAN (2.4)	SORT1 (2.1)	FADS1 (2.0)	CELSR2 (1.7)	AMIGO1 (1.7)	UBXN2B (1.6)	HLX (1.6)	GRINA (1.5)
GO:0044309	neuron spine	1.00	> 0.20	NCAN (3.6)	RPH3A (3.1)	CELSR2 (2.5)	MARK4 (2.4)	C11orf9 (1.7)	ZNF180 (1.6)	PTPN11 (1.5)	HAVCR1 (1.4)	SORT1 (1.2)	PPP1R37 (1.1)
GO:0043197	dendritic spine	1.00	> 0.20	NCAN (3.6)	RPH3A (3.1)	CELSR2 (2.5)	MARK4 (2.4)	C11orf9 (1.7)	ZNF180 (1.6)	PTPN11 (1.5)	HAVCR1 (1.4)	SORT1 (1.2)	PPP1R37 (1.1)
MP:0003008	enhanced long term potentiation	1.00	> 0.20	NCAN (4.0)	RPH3A (2.5)	C11orf9 (2.4)	CELSR2 (2.3)	PLCG1 (1.8)	PBX4 (1.7)	ZNF101 (1.6)	ADAM1 (1.5)	PSRC1 (1.5)	SH2B3 (1.2)
ENSG00000013573	DDX11 PPI subnetwork	1.00	> 0.20	PSRC1 (3.5)	USP1 (2.3)	FEN1 (1.9)	PLCG1 (1.6)	GATAD2A (1.5)	RPH3A (1.4)	ZHX3 (1.2)	AMIGO1 (1.2)	ILF3 (1.1)	SUGP1 (1.0)
MP:0005157	holoprosencephaly	1.00	> 0.20	DYNC2LI1 (3.5)	HAVCR1 (2.3)	CILP2 (2.3)	AP1M2 (2.1)	PLEKHH2 (1.7)	LPAR2 (1.6)	GEMIN7 (1.5)	TMEM116 (1.4)	PSRC1 (1.4)	DOCK7 (1.3)
GO:0050850	positive regulation of calcium-mediated signaling	1.00	> 0.20	C12orf47 (2.4)	ZNF101 (2.2)	NKPD1 (2.2)	PLCG1 (2.0)	TRAPPC6A (1.7)	CYB561D1 (1.6)	PMFBP1 (1.4)	RPH3A (1.2)	CILP2 (1.2)	LPAR2 (1.2)
GO:0030818	negative regulation of cAMP biosynthetic process	1.00	> 0.20	C12orf47 (3.1)	RPH3A (2.3)	CETP (2.0)	CELSR2 (1.8)	NCAN (1.6)	ABO (1.4)	DNAH11 (1.4)	LPAR2 (1.3)	SLC44A2 (1.1)	C12orf51 (0.9)
GO:0030815	negative regulation of cAMP metabolic process	1.00	> 0.20	C12orf47 (3.1)	RPH3A (2.3)	CETP (2.0)	CELSR2 (1.8)	NCAN (1.6)	ABO (1.4)	DNAH11 (1.4)	LPAR2 (1.3)	SLC44A2 (1.1)	C12orf51 (0.9)
GO:0007411	axon guidance	1.00	> 0.20	NCAN (2.2)	CELSR2 (2.1)	C17orf57 (1.9)	PBX4 (1.8)	ENSG00000254235 (1.7)	MARK4 (1.6)	PLEKHH2 (1.5)	LPAR2 (1.4)	DOCK7 (1.3)	PVRL2 (1.3)
MP:0008283	small hippocampus	1.00	> 0.20	DYNC2LI1 (3.0)	TMEM116 (2.6)	POLK (1.8)	C12orf51 (1.7)	CELSR2 (1.7)	C12orf43 (1.6)	GOT2P1 (1.5)	BRAP (1.4)	UBXN2B (1.3)	NCAN (1.3)
ENSG00000164418	GRIK2 PPI subnetwork	1.00	> 0.20	NCAN (2.5)	RPH3A (2.4)	SORT1 (2.3)	CELSR2 (2.2)	MARK4 (1.6)	TSSK6 (1.6)	CLPTM1 (1.4)	PLEC (1.3)	UBXN2B (1.3)	C11orf9 (1.3)
MP:0009453	enhanced contextual conditioning behavior	1.00	> 0.20	NCAN (3.4)	ENSG00000226645 (1.7)	FRK (1.6)	PVRL2 (1.6)	HAVCR1 (1.6)	NKPD1 (1.5)	ABO (1.5)	HNF1A (1.4)	RPH3A (1.4)	KIAA1324 (1.3)
MP:0009745	abnormal behavioral response to xenobiotic	1.00	> 0.20	RPH3A (2.8)	KIAA1324 (2.4)	SORT1 (1.9)	LPA (1.6)	CELSR2 (1.5)	TMEM50A (1.5)	ATP13A1 (1.5)	RHD (1.5)	C1orf63 (1.5)	NCAN (1.3)
GO:0051969	regulation of transmission of nerve impulse	1.00	> 0.20	RPH3A (3.7)	NCAN (3.3)	HAPLN4 (2.8)	CELSR2 (2.1)	C12orf43 (1.7)	MARK4 (1.5)	AMIGO1 (1.4)	ABO (1.3)	ZHX3 (1.1)	SORT1 (1.1)
GO:0042462	eye photoreceptor cell development	1.00	> 0.20	ENSG00000226648 (2.2)	DYNC2LI1 (2.0)	PMFBP1 (1.4)	DNAH11 (1.1)	LPIN3 (1.1)	UBXN2B (1.1)	QTRT1 (1.0)	DHODH (1.0)	ZHX3 (1.0)	ENSG00000235545 (1.0)
MP:0005236	abnormal olfactory nerve morphology	1.00	> 0.20	HLX (2.4)	C17orf57 (2.3)	ENSG00000226648 (1.6)	POLK (1.4)	NYNRIN (1.3)	TMED4 (1.2)	NCAN (1.1)	PLEC (1.1)	PLCG1 (1.0)	MAFB (0.9)
GO:0008333	endosome to lysosome transport	1.00	> 0.20	POLK (2.6)	UBXN2B (2.5)	AP1M2 (2.4)	BLOC1S3 (2.1)	COL4A3BP (1.9)	TMED4 (1.9)	YIPF2 (1.4)	DYNC2LI1 (1.4)	TRAFD1 (1.3)	DOCK7 (1.2)
GO:0061326	renal tubule development	1.00	> 0.20	HAVCR1 (4.1)	BCAM (2.6)	AP1M2 (2.3)	TMEM116 (2.0)	DYNC2LI1 (1.9)	CELSR2 (1.6)	PMFBP1 (1.4)	TSSK6 (1.4)	ZHX3 (1.2)	DNAH11 (1.0)
ENSG00000146677	ENSG00000146677 PPI subnetwork	1.00	> 0.20	NKPD1 (4.2)	ADAM1 (2.1)	PMFBP1 (1.4)	KIAA1324 (1.3)	C19orf52 (1.1)	NAA25 (1.0)	ATP13A1 (1.0)	GATAD2A (1.0)	DYNC2LI1 (0.9)	BRAP (0.9)
GO:0021984	adenohypophysis development	1.00	> 0.20	C12orf47 (3.0)	HNF1A (2.3)	NKPD1 (2.2)	ENSG00000254235 (1.7)	ENSG00000238078 (1.6)	TSSK6 (1.5)	YIPF2 (1.4)	PPP1R37 (1.3)	KIAA1324 (1.2)	C19orf52 (1.1)
GO:0043616	keratinocyte proliferation	1.00	> 0.20	CBLC (4.7)	AP1M2 (2.9)	ENSG00000228044 (1.9)	PMFBP1 (1.6)	LPAR2 (1.4)	PLEKHH2 (1.3)	BLOC1S3 (1.3)	C19orf52 (1.3)	FRK (1.3)	ALDH2 (1.1)
GO:0002244	hemopoietic progenitor cell differentiation	1.00	> 0.20	BLOC1S3 (2.2)	PBX4 (1.7)	C19orf52 (1.6)	TMEM116 (1.5)	TMEM57 (1.4)	CYB561D1 (1.4)	DNAH11 (1.4)	C12orf47 (1.4)	UBXN2B (1.3)	NKPD1 (1.3)
ENSG00000176732	PFN4 PPI subnetwork	1.00	> 0.20	USP24 (2.1)	SYPL2 (2.0)	C1orf63 (1.5)	PBX4 (1.4)	PVR (1.4)	C12orf51 (1.4)	CARM1 (1.3)	TMEM50A (1.3)	GMIP (1.2)	COL4A3BP (1.1)
GO:0046058	cAMP metabolic process	1.00	> 0.20	C12orf47 (3.5)	RPH3A (1.9)	PMFBP1 (1.9)	AMIGO1 (1.8)	ABO (1.7)	NCAN (1.4)	LPIN3 (1.3)	ENSG00000226645 (1.3)	CELSR2 (1.2)	CETP (1.1)
ENSG00000134444	KIAA1468 PPI subnetwork	1.00	> 0.20	NCAN (2.7)	RPH3A (2.5)	C12orf51 (2.2)	SORT1 (2.1)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.7)	HAPLN4 (1.6)	C12orf43 (1.6)	HLX (1.4)
ENSG00000163462	TRIM46 PPI subnetwork	1.00	> 0.20	RPH3A (2.6)	C12orf51 (2.5)	NCAN (2.4)	SORT1 (2.0)	FADS1 (2.0)	CELSR2 (1.8)	HLX (1.7)	TMEM50A (1.6)	AMIGO1 (1.6)	UBXN2B (1.4)
MP:0002206	abnormal CNS synaptic transmission	1.00	> 0.20	RPH3A (5.1)	NCAN (3.5)	HAPLN4 (2.4)	AMIGO1 (1.9)	CELSR2 (1.4)	PPP1R37 (1.2)	C12orf51 (1.2)	C12orf43 (1.1)	C11orf9 (1.1)	APOE (1.1)
ENSG00000090372	STRN4 PPI subnetwork	1.00	> 0.20	SARS (3.2)	C11orf9 (2.1)	NCAN (1.9)	QTRT1 (1.8)	ITGB3 (1.6)	C19orf52 (1.5)	DDX56 (1.5)	TMED4 (1.5)	DYNC2LI1 (1.4)	SUGP1 (1.2)
GO:0051960	regulation of nervous system development	1.00	> 0.20	NCAN (3.5)	CELSR2 (3.0)	C11orf9 (2.0)	PBX4 (1.8)	PPP1R37 (1.6)	MARK4 (1.6)	ATXN7L2 (1.4)	ABO (1.3)	HAPLN4 (1.3)	NYNRIN (1.3)
GO:0007611	learning or memory	1.00	> 0.20	RPH3A (2.7)	NCAN (2.5)	SORT1 (2.0)	ADAM1 (1.8)	AMIGO1 (1.6)	C12orf47 (1.4)	CELSR2 (1.3)	TRIB1 (1.3)	GOT2P1 (1.1)	TSSK6 (1.1)
ENSG00000114450	GNB4 PPI subnetwork	1.00	> 0.20	ENSG00000235545 (2.0)	TOMM40 (1.7)	TMEM50A (1.6)	ERP29 (1.6)	NT5DC1 (1.4)	ITGB3 (1.3)	PSMA5 (1.2)	ADAM1 (1.1)	PTPN11 (1.1)	ZHX3 (1.0)
ENSG00000133812	SBF2 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.6)	C12orf51 (2.3)	SORT1 (2.1)	FADS1 (1.9)	CELSR2 (1.9)	AMIGO1 (1.7)	HAPLN4 (1.6)	C12orf43 (1.5)	TMEM50A (1.5)
MP:0009450	abnormal axon fasiculation	1.00	> 0.20	NCAN (3.7)	CELSR2 (2.6)	PLEKHH2 (2.0)	BCAM (1.6)	ENSG00000235545 (1.6)	HNF1A (1.5)	TIMD4 (1.5)	TMED4 (1.3)	C12orf47 (1.1)	LPIN3 (1.1)
ENSG00000171724	VAT1L PPI subnetwork	1.00	> 0.20	NCAN (2.7)	RPH3A (2.5)	C12orf51 (2.2)	SORT1 (2.2)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.6)	C12orf43 (1.5)	HAPLN4 (1.5)	MARK4 (1.4)
GO:0051602	response to electrical stimulus	1.00	> 0.20	ENSG00000235545 (2.4)	TSSK6 (2.0)	C12orf43 (1.6)	NCAN (1.5)	ENSG00000226645 (1.5)	C19orf52 (1.4)	TRAPPC6A (1.2)	SORT1 (1.2)	ZNF101 (1.2)	ZHX3 (1.2)
MP:0002690	akinesia	1.00	> 0.20	HAPLN4 (4.2)	RPH3A (3.3)	AMIGO1 (2.1)	PLEKHH2 (1.8)	HNF1A (1.7)	ENSG00000226645 (1.7)	HLX (1.6)	SH2B3 (1.4)	DOCK7 (1.4)	C12orf51 (1.3)
ENSG00000180190	C8orf42 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.3)	SORT1 (2.1)	CELSR2 (1.9)	FADS1 (1.8)	AMIGO1 (1.7)	HLX (1.5)	C12orf43 (1.5)	TMEM50A (1.5)
GO:0015698	inorganic anion transport	1.00	> 0.20	TMEM116 (3.7)	FRK (2.2)	ST3GAL4 (1.9)	PMFBP1 (1.8)	ATP13A1 (1.5)	AP1M2 (1.5)	TM6SF2 (1.2)	TMEM57 (1.1)	UBXN2B (1.1)	HAPLN4 (1.0)
ENSG00000112379	KIAA1244 PPI subnetwork	1.00	> 0.20	NCAN (2.7)	RPH3A (2.6)	C12orf51 (2.3)	SORT1 (2.0)	FADS1 (1.9)	CELSR2 (1.8)	HAPLN4 (1.5)	C12orf43 (1.5)	AMIGO1 (1.5)	HLX (1.4)
ENSG00000063601	MTMR1 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.3)	SORT1 (2.0)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.6)	C12orf43 (1.5)	TMEM50A (1.4)	HAPLN4 (1.4)
MP:0000819	abnormal olfactory bulb morphology	1.00	> 0.20	NCAN (3.5)	ZHX3 (2.3)	PBX4 (1.7)	GPAM (1.7)	PTPN11 (1.5)	ATXN2 (1.4)	TMEM57 (1.3)	RPH3A (1.1)	ENSG00000235545 (1.0)	C12orf51 (1.0)
ENSG00000139433	GLTP PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.2)	SORT1 (2.0)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.6)	HAPLN4 (1.5)	HLX (1.5)	MARK4 (1.3)
GO:0045664	regulation of neuron differentiation	1.00	> 0.20	NCAN (3.5)	CELSR2 (2.8)	PPP1R37 (1.9)	PBX4 (1.7)	RPH3A (1.7)	HAPLN4 (1.5)	C11orf9 (1.5)	PLCG1 (1.5)	ABO (1.5)	ATXN7L2 (1.4)
ENSG00000123360	PDE1B PPI subnetwork	1.00	> 0.20	NCAN (2.5)	RPH3A (2.4)	C12orf51 (2.3)	SORT1 (2.0)	FADS1 (1.9)	CELSR2 (1.7)	AMIGO1 (1.7)	HAPLN4 (1.6)	C12orf43 (1.5)	HLX (1.4)
MP:0008536	enlarged third ventricle	1.00	> 0.20	NCAN (4.0)	OASL (3.9)	CELSR2 (2.6)	DYNC2LI1 (2.5)	DOCK7 (2.2)	AMIGO1 (2.0)	DHODH (1.9)	DHX38 (1.9)	ENSG00000235545 (1.7)	FADS2 (1.7)
MP:0008415	abnormal neurite morphology	1.00	> 0.20	ENSG00000235545 (3.0)	PBX4 (2.8)	NCAN (2.7)	LPAR2 (1.8)	BLOC1S3 (1.8)	CELSR2 (1.7)	C12orf47 (1.6)	MOSC1 (1.6)	MAU2 (1.5)	HLX (1.4)
GO:2000179	positive regulation of neural precursor cell proliferation	1.00	> 0.20	NCAN (2.5)	ENSG00000235545 (2.4)	PBX4 (1.9)	CELSR2 (1.8)	DOCK7 (1.7)	TMEM116 (1.5)	TMED4 (1.5)	ENSG00000254235 (1.4)	CYB561D1 (1.4)	TSSK6 (1.2)
GO:0045665	negative regulation of neuron differentiation	1.00	> 0.20	NCAN (3.7)	DNAH11 (2.4)	CELSR2 (2.1)	ENSG00000226648 (2.1)	TSSK6 (1.3)	PLCG1 (1.3)	DYNC2LI1 (1.3)	HAPLN4 (1.3)	PMFBP1 (1.2)	GATAD2A (1.2)
MP:0001899	absent long term depression	1.00	> 0.20	NCAN (2.7)	ABO (2.3)	TSSK6 (2.1)	KIAA1324 (2.0)	USP24 (1.9)	APOC4 (1.6)	ENSG00000228044 (1.5)	CELSR2 (1.5)	ENSG00000226648 (1.5)	AMIGO1 (1.4)
GO:0032331	negative regulation of chondrocyte differentiation	1.00	> 0.20	TMEM116 (1.8)	CILP2 (1.7)	DYNC2LI1 (1.7)	ABO (1.4)	TSSK6 (1.4)	AP1M2 (1.3)	ALDH2 (1.2)	PLEKHH2 (1.2)	TRAPPC6A (1.1)	PLEC (1.1)
ENSG00000196872	C2orf55 PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.5)	C12orf51 (2.3)	SORT1 (2.0)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.6)	HAPLN4 (1.5)	C12orf43 (1.4)	HLX (1.4)
MP:0004066	abnormal primitive node morphology	1.00	> 0.20	DYNC2LI1 (2.2)	DNAH11 (2.1)	COL4A3BP (1.8)	C11orf9 (1.7)	HNF1A (1.5)	ZHX3 (1.5)	TSSK6 (1.4)	HAVCR1 (1.2)	POLK (1.2)	AMIGO1 (1.0)
GO:0016358	dendrite development	1.00	> 0.20	NCAN (2.8)	CELSR2 (1.7)	RPH3A (1.6)	GOT2P1 (1.6)	ABO (1.5)	MARK4 (1.4)	DOCK7 (1.3)	C12orf51 (1.2)	ZHX3 (1.2)	TMEM50A (1.1)
ENSG00000103740	ACSBG1 PPI subnetwork	1.00	> 0.20	NCAN (2.4)	RPH3A (2.4)	C12orf51 (2.3)	SORT1 (2.3)	CELSR2 (1.8)	FADS1 (1.6)	AMIGO1 (1.6)	HLX (1.5)	C12orf43 (1.5)	HAPLN4 (1.4)
ENSG00000091428	RAPGEF4 PPI subnetwork	1.00	> 0.20	PLEKHH2 (2.2)	LDLR (1.9)	TMEM116 (1.9)	GEMIN7 (1.9)	SLC44A2 (1.8)	ENSG00000226645 (1.8)	PVRL2 (1.7)	PTPN11 (1.7)	PMFBP1 (1.6)	NCAN (1.5)
GO:0032281	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex	1.00	> 0.20	NCAN (6.4)	RPH3A (2.5)	ZHX3 (2.1)	CELSR2 (1.9)	HAPLN4 (1.9)	KIAA1324 (1.6)	FADS2 (1.5)	PTPN11 (1.4)	ENSG00000226645 (1.4)	GCNT4 (1.4)
ENSG00000116852	KIF21B PPI subnetwork	1.00	> 0.20	RPH3A (2.5)	NCAN (2.5)	C12orf51 (2.2)	SORT1 (2.2)	FADS1 (1.9)	CELSR2 (1.8)	AMIGO1 (1.6)	HAPLN4 (1.6)	C12orf43 (1.5)	HLX (1.4)
GO:0007213	G-protein coupled acetylcholine receptor signaling pathway	1.00	> 0.20	C1orf63 (2.0)	PPP1R37 (1.7)	AMIGO1 (1.7)	CELSR2 (1.6)	RPH3A (1.5)	TXNL4B (1.4)	CYB561D1 (1.4)	SORT1 (1.4)	C12orf47 (1.4)	UBXN2B (1.3)
GO:0019206	nucleoside kinase activity	1.00	> 0.20	MAPKAPK5 (2.8)	KIAA1324 (2.1)	HNF1A (2.0)	TXNL4B (1.9)	FEN1 (1.6)	AMIGO1 (1.5)	DHODH (1.4)	ADAM1 (1.4)	NKPD1 (1.4)	ENSG00000228044 (1.3)
MP:0003635	abnormal synaptic transmission	1.00	> 0.20	RPH3A (3.9)	C12orf43 (2.5)	HAPLN4 (2.1)	RHD (2.0)	NCAN (1.7)	AMIGO1 (1.7)	C12orf51 (1.6)	SORT1 (1.4)	CARM1 (1.3)	RHCE (1.3)
GO:0032387	negative regulation of intracellular transport	1.00	> 0.20	ZNF101 (2.6)	PBX4 (1.5)	ENSG00000235545 (1.5)	ABO (1.4)	PPP1R37 (1.4)	PLCG1 (1.1)	GATAD2A (1.0)	LPAR2 (1.0)	MAFB (0.9)	BLOC1S3 (0.9)
ENSG00000100568	VTI1B PPI subnetwork	1.00	> 0.20	YIPF2 (2.3)	TMEM50A (2.2)	AP1M2 (1.8)	TRAPPC6A (1.8)	SARS (1.6)	C1orf63 (1.5)	DNM2 (1.5)	BLOC1S3 (1.4)	HNF1A (1.4)	ZNF259 (1.2)
GO:0045761	regulation of adenylate cyclase activity	1.00	> 0.20	C12orf47 (3.2)	ABO (2.2)	RPH3A (1.9)	AMIGO1 (1.7)	PMFBP1 (1.7)	CELSR2 (1.6)	BLOC1S3 (1.5)	NCAN (1.4)	DNAH11 (1.3)	ENSG00000226645 (1.2)
ENSG00000144848	ATG3 PPI subnetwork	1.00	> 0.20	TXNL4B (3.5)	GRINA (2.3)	COL4A3BP (2.2)	BRAP (2.1)	SARS (2.1)	ALDH2 (1.8)	TMEM50A (1.6)	DHX38 (1.4)	C12orf51 (1.3)	GOT2P1 (1.3)
GO:0007218	neuropeptide signaling pathway	1.00	> 0.20	DNAH11 (2.6)	TSSK6 (2.1)	CELSR2 (2.1)	PMFBP1 (2.1)	FRK (1.9)	AMIGO1 (1.7)	ATXN7L2 (1.5)	CILP2 (1.4)	KIAA1324 (1.4)	ENSG00000226648 (1.3)
GO:0045494	photoreceptor cell maintenance	1.00	> 0.20	HAVCR1 (2.8)	DYNC2LI1 (2.7)	TMEM116 (2.4)	C12orf47 (1.6)	ADAM1 (1.4)	HNF1A (1.4)	ZNF180 (1.2)	LPIN3 (1.2)	POLK (1.2)	TRAPPC6A (1.1)
GO:0002320	lymphoid progenitor cell differentiation	1.00	> 0.20	NKPD1 (2.4)	ZNF101 (2.3)	PBX4 (2.2)	CYB561D1 (2.2)	BLOC1S3 (2.1)	UBXN2B (1.6)	TMEM57 (1.5)	DNAH11 (1.4)	ATXN7L2 (1.2)	C12orf47 (1.1)
MP:0001360	abnormal social investigation	1.00	> 0.20	NCAN (3.1)	CEACAM19 (2.5)	CELSR2 (2.5)	GOT2P1 (1.7)	AMIGO1 (1.6)	ENSG00000226645 (1.5)	USP24 (1.3)	ENSG00000238078 (1.2)	HAPLN4 (1.2)	ZHX3 (1.1)
GO:0072372	primary cilium	1.00	> 0.20	DYNC2LI1 (6.1)	PLEKHH2 (1.5)	ZHX3 (1.3)	QTRT1 (1.1)	TMEM116 (0.9)	KIAA1324 (0.8)	PMFBP1 (0.8)	PSRC1 (0.8)	FRK (0.7)	ATXN7L2 (0.7)
GO:0015701	bicarbonate transport	1.00	> 0.20	TMEM116 (4.2)	ENSG00000235545 (3.0)	PBX4 (2.0)	FRK (2.0)	CYB561D1 (1.9)	LPAR2 (1.8)	AMIGO1 (1.6)	ZHX3 (1.3)	GEMIN7 (1.3)	C11orf9 (1.1)
MP:0002912	abnormal excitatory postsynaptic potential	1.00	> 0.20	NCAN (4.0)	RPH3A (3.9)	CELSR2 (3.0)	MARK4 (1.8)	HAPLN4 (1.7)	KIAA1324 (1.5)	CETP (1.1)	ENSG00000235545 (1.1)	SH2B3 (1.1)	C11orf9 (1.0)
GO:0007188	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	1.00	> 0.20	C12orf47 (2.9)	AMIGO1 (1.8)	ENSG00000226645 (1.8)	CETP (1.4)	KIAA1324 (1.4)	PMFBP1 (1.3)	RPH3A (1.3)	CELSR2 (1.2)	CYB561D1 (1.1)	SLC44A2 (1.1)
MP:0003484	abnormal channel response	1.00	> 0.20	RPH3A (3.1)	C12orf47 (2.9)	NCAN (2.8)	C11orf9 (1.9)	ZHX3 (1.2)	APOC1 (1.2)	C12orf43 (1.2)	ATXN7L2 (1.1)	C12orf51 (1.1)	HLX (1.0)
MP:0002878	abnormal corticospinal tract morphology	1.00	> 0.20	PBX4 (2.8)	CELSR2 (2.6)	NCAN (2.3)	UBXN2B (1.9)	SORT1 (1.8)	NYNRIN (1.4)	TSSK6 (1.4)	TMEM116 (1.3)	RPH3A (1.3)	PLG (1.3)
MP:0001405	impaired coordination	1.00	> 0.20	RPH3A (4.0)	CELSR2 (2.9)	SORT1 (2.8)	NCAN (2.7)	C12orf51 (2.5)	AMIGO1 (2.2)	HAPLN4 (2.0)	COL4A3BP (1.6)	GCNT4 (1.5)	OGDH (1.4)
ENSG00000058091	CDK14 PPI subnetwork	1.00	> 0.20	PVR (1.8)	CARM1 (1.6)	ZHX3 (1.6)	TMEM50A (1.6)	DYNC2LI1 (1.6)	GATAD2A (1.5)	ZNF101 (1.5)	MARK4 (1.3)	POLK (1.3)	PTPN11 (1.3)
GO:0051489	regulation of filopodium assembly	1.00	> 0.20	ZNF101 (2.7)	BLOC1S3 (2.2)	ENSG00000226648 (1.9)	ZNF180 (1.8)	COL4A3BP (1.4)	PBX4 (1.3)	PTPN11 (1.3)	C11orf9 (1.2)	CETP (1.1)	NKPD1 (1.1)
ENSG00000075239	ACAT1 PPI subnetwork	1.00	> 0.20	C19orf52 (1.7)	ALDH2 (1.6)	FADS2 (1.5)	ACAD10 (1.5)	GMPR (1.4)	TRAPPC6A (1.2)	PSMA5 (1.1)	TMEM116 (1.1)	ABCG8 (1.1)	TMEM50A (0.9)
ENSG00000138308	PLA2G12B PPI subnetwork	1.00	> 0.20	NCAN (2.6)	RPH3A (2.4)	C12orf51 (2.2)	SORT1 (2.2)	CELSR2 (1.9)	AMIGO1 (1.7)	FADS1 (1.7)	TMEM50A (1.5)	MARK4 (1.5)	C12orf43 (1.5)
ENSG00000073969	NSF PPI subnetwork	1.00	> 0.20	CLPTM1 (2.2)	TMEM50A (2.0)	NCAN (2.0)	PSMA5 (2.0)	RPH3A (1.7)	CYB561D1 (1.5)	TRAFD1 (1.5)	SORT1 (1.4)	COL4A3BP (1.4)	C1orf63 (1.4)
ENSG00000138698	RAP1GDS1 PPI subnetwork	1.00	> 0.20	PSMA5 (2.6)	ATXN7L2 (2.2)	GEMIN7 (1.9)	POLK (1.8)	SLC44A2 (1.8)	MAPKAPK5 (1.7)	TMEM50A (1.7)	SH2B3 (1.6)	DYNC2LI1 (1.6)	SARS (1.5)
ENSG00000160972	PPP1R16A PPI subnetwork	1.00	> 0.20	NCAN (2.7)	TRAFD1 (2.5)	TOP1 (2.5)	DYNC2LI1 (2.2)	ENSG00000228044 (2.1)	CYB561D1 (2.1)	KIAA1324 (1.7)	ATXN7L2 (1.7)	ABO (1.7)	PLCG1 (1.7)
GO:0034765	regulation of ion transmembrane transport	1.00	> 0.20	AMIGO1 (2.8)	SYPL2 (2.7)	RPH3A (2.1)	KIAA1324 (1.9)	ADAM1 (1.9)	CYB561D1 (1.6)	TSSK6 (1.5)	C1orf63 (1.5)	PLEKHH2 (1.3)	PPP1R37 (1.3)
MP:0008840	abnormal spike wave discharge	1.00	> 0.20	HAPLN4 (5.4)	RPH3A (4.8)	NCAN (2.1)	C12orf51 (1.8)	PBX4 (1.7)	PPP1R37 (1.5)	MAU2 (1.4)	C11orf9 (1.3)	CARM1 (1.0)	NKPD1 (0.9)
GO:0035725	sodium ion transmembrane transport	1.00	> 0.20	AP1M2 (2.8)	ZHX3 (2.1)	TMEM116 (1.8)	CYB561D1 (1.7)	SORT1 (1.7)	SLC44A2 (1.5)	ENSG00000235545 (1.5)	PMFBP1 (1.4)	ENSG00000226648 (1.3)	CEACAM19 (1.1)
GO:0060572	morphogenesis of an epithelial bud	1.00	> 0.20	PLEKHH2 (2.2)	LPAR2 (2.1)	AMIGO1 (2.0)	PBX4 (1.6)	BLOC1S3 (1.5)	DYNC2LI1 (1.4)	TMEM116 (1.4)	C11orf9 (1.4)	NYNRIN (1.4)	ALDH2 (1.3)
GO:0043954	cellular component maintenance	1.00	> 0.20	DYNC2LI1 (2.8)	HAVCR1 (2.5)	TMEM116 (2.2)	TXNL4B (1.6)	ENSG00000228044 (1.5)	GOT2P1 (1.5)	MAPKAPK5 (1.4)	PMFBP1 (1.2)	LPIN3 (1.2)	C12orf47 (1.2)
GO:0001518	voltage-gated sodium channel complex	1.00	> 0.20	RPH3A (4.6)	BCAM (2.6)	AMIGO1 (2.1)	SORT1 (2.0)	HLX (1.9)	ALDH2 (1.9)	ENSG00000226645 (1.8)	GCNT4 (1.7)	GOT2P1 (1.5)	ANKRD31 (1.4)
ENSG00000179915	NRXN1 PPI subnetwork	1.00	> 0.20	NCAN (5.1)	RPH3A (4.0)	PBX4 (2.1)	ABO (1.6)	C12orf51 (1.6)	HAPLN4 (1.6)	KIAA1324 (1.5)	NKPD1 (1.4)	HAVCR1 (1.3)	PLEKHH2 (1.3)
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS	REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS	1.00	> 0.20	ENSG00000226648 (3.0)	RPH3A (2.7)	NCAN (2.1)	PPP1R37 (1.8)	KIAA1324 (1.6)	C11orf9 (1.5)	C12orf43 (1.3)	DOCK7 (1.1)	TSSK6 (1.0)	LPA (1.0)
REACTOME_ACTIVATION_OF_CA:PERMEABLE_KAINATE_RECEPTOR	REACTOME_ACTIVATION_OF_CA:PERMEABLE_KAINATE_RECEPTOR	1.00	> 0.20	ENSG00000226648 (3.0)	RPH3A (2.7)	NCAN (2.1)	PPP1R37 (1.8)	KIAA1324 (1.6)	C11orf9 (1.5)	C12orf43 (1.3)	DOCK7 (1.1)	TSSK6 (1.0)	LPA (1.0)
GO:0045211	postsynaptic membrane	1.00	> 0.20	RPH3A (3.9)	NCAN (2.7)	CELSR2 (2.4)	PPP1R37 (1.9)	AMIGO1 (1.8)	ANKRD31 (1.5)	MYLIP (1.2)	SORT1 (1.2)	MARK4 (1.0)	C11orf9 (1.0)
GO:0030307	positive regulation of cell growth	1.00	> 0.20	C17orf57 (2.3)	ENSG00000238078 (1.7)	GEMIN7 (1.7)	TMEM116 (1.6)	C12orf47 (1.4)	TMEM50A (1.3)	C12orf43 (1.2)	PMFBP1 (1.1)	POLK (1.1)	RPH3A (1.0)
GO:0050890	cognition	1.00	> 0.20	NCAN (2.7)	RPH3A (2.7)	SORT1 (2.2)	ADAM1 (1.7)	AMIGO1 (1.6)	CELSR2 (1.6)	C12orf47 (1.6)	TRIB1 (1.2)	C12orf43 (1.1)	TSSK6 (1.0)
GO:0051339	regulation of lyase activity	1.00	> 0.20	C12orf47 (3.5)	ABO (2.2)	PMFBP1 (1.8)	RPH3A (1.7)	AMIGO1 (1.6)	CELSR2 (1.6)	BLOC1S3 (1.4)	ENSG00000226645 (1.4)	TSSK6 (1.4)	NCAN (1.3)
MP:0008128	abnormal brain internal capsule morphology	1.00	> 0.20	ENSG00000235545 (1.8)	NCAN (1.7)	ERP29 (1.5)	CBLC (1.5)	AMIGO1 (1.3)	C12orf51 (1.2)	PSRC1 (1.1)	ATXN7L2 (1.0)	CEACAM19 (1.0)	PARP10 (1.0)
ENSG00000152208	GRID2 PPI subnetwork	1.00	> 0.20	TSSK6 (3.5)	PPP1R37 (2.8)	CYB561D1 (2.1)	CELSR2 (2.0)	BLOC1S3 (1.9)	CBLC (1.5)	TRAPPC6A (1.4)	QTRT1 (1.3)	NYNRIN (1.3)	PTPN11 (1.3)
MP:0000811	hippocampal neuron degeneration	1.00	> 0.20	SORT1 (2.5)	GPAM (1.7)	UBXN2B (1.7)	PMFBP1 (1.6)	USP24 (1.5)	ZHX3 (1.5)	PTPN11 (1.4)	RPH3A (1.3)	DYNC2LI1 (1.3)	COL4A3BP (1.2)
GO:0048635	negative regulation of muscle organ development	1.00	> 0.20	ATXN7L2 (2.5)	PBX4 (2.3)	C17orf57 (2.1)	ENSG00000238078 (1.6)	SYPL2 (1.4)	PLCG1 (1.3)	C1orf63 (1.3)	TSSK6 (1.1)	GMPR (1.1)	CEACAM19 (1.0)
GO:0031279	regulation of cyclase activity	1.00	> 0.20	C12orf47 (3.5)	ABO (2.0)	PMFBP1 (1.9)	RPH3A (1.7)	AMIGO1 (1.6)	CELSR2 (1.5)	BLOC1S3 (1.4)	NCAN (1.4)	TSSK6 (1.3)	ENSG00000226645 (1.3)
GO:0004864	protein phosphatase inhibitor activity	1.00	> 0.20	TMEM50A (1.9)	SORT1 (1.6)	COL4A3BP (1.5)	NYNRIN (1.4)	BUD13 (1.3)	TMEM116 (1.1)	OGDH (1.1)	TM6SF2 (1.0)	ERP29 (1.0)	DNM2 (1.0)
GO:0042734	presynaptic membrane	1.00	> 0.20	NCAN (4.0)	RPH3A (3.5)	C12orf51 (1.8)	HAPLN4 (1.7)	CELSR2 (1.3)	APOE (1.3)	ZNF180 (1.2)	ENSG00000226645 (1.0)	TSSK6 (1.0)	ATP13A1 (1.0)
MP:0000194	hypercalcemia	1.00	> 0.20	PLG (3.8)	TMEM116 (3.5)	ANGPTL3 (2.8)	AP1M2 (1.8)	C12orf47 (1.8)	SYPL2 (1.7)	SLC22A1 (1.7)	CILP2 (1.3)	USP24 (1.2)	ENSG00000226645 (1.1)
GO:0060134	prepulse inhibition	1.00	> 0.20	DNAH11 (1.9)	AMIGO1 (1.8)	NKPD1 (1.6)	C19orf52 (1.6)	NCAN (1.6)	RPH3A (1.5)	TSSK6 (1.2)	C12orf43 (1.1)	ABO (1.1)	ZNF259 (1.0)
GO:0007158	neuron cell-cell adhesion	1.00	> 0.20	NCAN (4.0)	UBXN2B (1.8)	ANKRD31 (1.8)	RPH3A (1.7)	ENSG00000254235 (1.6)	ZHX3 (1.5)	AMIGO1 (1.4)	PMFBP1 (1.2)	HAVCR1 (1.2)	C12orf47 (1.1)
GO:0007612	learning	1.00	> 0.20	RPH3A (2.7)	NCAN (2.5)	ADAM1 (2.3)	C12orf47 (2.2)	AMIGO1 (1.6)	UBXN2B (1.6)	GOT2P1 (1.5)	TSSK6 (1.5)	CELSR2 (1.3)	ATXN7L2 (1.2)
GO:0007409	axonogenesis	1.00	> 0.20	CELSR2 (3.2)	NCAN (3.0)	RPH3A (2.0)	DOCK7 (1.9)	ABO (1.9)	MARK4 (1.8)	PBX4 (1.8)	C12orf51 (1.7)	PLEC (1.7)	PPP1R37 (1.5)
GO:0050982	detection of mechanical stimulus	1.00	> 0.20	AMIGO1 (2.3)	NKPD1 (1.7)	PLEKHH2 (1.6)	CILP2 (1.6)	ANKRD31 (1.5)	PPP1R37 (1.2)	NCAN (1.2)	TMEM57 (1.2)	GEMIN7 (1.1)	ENSG00000226648 (1.1)
GO:0022834	ligand-gated channel activity	1.00	> 0.20	RPH3A (3.0)	HAPLN4 (2.3)	SORT1 (1.7)	NCAN (1.6)	ANKRD31 (1.6)	ABO (1.5)	BCAM (1.5)	KIAA1324 (1.4)	C11orf9 (1.2)	MYLIP (1.2)
GO:0015276	ligand-gated ion channel activity	1.00	> 0.20	RPH3A (3.0)	HAPLN4 (2.3)	SORT1 (1.7)	NCAN (1.6)	ANKRD31 (1.6)	ABO (1.5)	BCAM (1.5)	KIAA1324 (1.4)	C11orf9 (1.2)	MYLIP (1.2)
MP:0004792	abnormal synaptic vesicle number	1.00	> 0.20	RPH3A (5.1)	HAPLN4 (3.1)	C12orf51 (2.8)	AMIGO1 (2.8)	PBX4 (1.7)	CYB561D1 (1.5)	NCAN (1.4)	CELSR2 (1.4)	PLEKHH2 (1.1)	ATXN7L2 (1.0)
MP:0004833	ovary atrophy	1.00	> 0.20	BRAP (2.8)	NCAN (1.9)	GMIP (1.5)	MOSC1 (1.5)	PARP10 (1.2)	DHX38 (1.2)	TMEM57 (1.2)	BUD13 (1.1)	ILF3 (1.1)	TMEM116 (1.1)
GO:0090090	negative regulation of canonical Wnt receptor signaling pathway	1.00	> 0.20	CILP2 (2.3)	ENSG00000254235 (1.7)	DYNC2LI1 (1.5)	PLCG1 (1.3)	DOCK7 (1.2)	UBXN2B (1.0)	PPP1R37 (0.9)	FRK (0.9)	C19orf52 (0.8)	LPAR2 (0.8)
GO:0007628	adult walking behavior	1.00	> 0.20	HAPLN4 (3.4)	GEMIN7 (1.9)	LPAR2 (1.7)	TRAPPC6A (1.7)	ERP29 (1.7)	RPH3A (1.4)	C12orf43 (1.4)	ANKRD31 (1.3)	HAVCR1 (1.2)	UBXN2B (1.1)
ENSG00000168280	KIF5C PPI subnetwork	1.00	> 0.20	C12orf51 (2.4)	PTPN11 (1.8)	KANK2 (1.5)	DOCK7 (1.5)	C11orf9 (1.3)	UBXN2B (1.3)	TMEM57 (1.2)	CYB561D1 (1.1)	DNAH11 (1.0)	HAPLN4 (0.9)
GO:0019933	cAMP-mediated signaling	1.00	> 0.20	C12orf47 (2.1)	AMIGO1 (1.6)	CETP (1.5)	RPH3A (1.5)	LPIN3 (1.4)	KIAA1324 (1.4)	NCAN (1.1)	CYB561D1 (1.1)	DNAH11 (1.1)	PMFBP1 (1.1)
ENSG00000091129	NRCAM PPI subnetwork	1.00	> 0.20	CELSR2 (3.6)	SORT1 (3.1)	NCAN (2.7)	USP24 (2.2)	C12orf51 (2.0)	RPH3A (1.7)	ATXN2 (1.6)	CEACAM19 (1.6)	PTPN11 (1.5)	C11orf9 (1.5)
GO:0001662	behavioral fear response	1.00	> 0.20	ENSG00000235545 (4.7)	C12orf47 (3.0)	NCAN (1.7)	DNAH11 (1.7)	GCNT4 (1.6)	ENSG00000226648 (1.2)	TMEM50A (1.1)	C19orf52 (1.0)	RPH3A (1.0)	SYPL2 (0.9)
GO:0005248	voltage-gated sodium channel activity	1.00	> 0.20	RPH3A (4.4)	BCAM (2.5)	HLX (2.3)	AMIGO1 (2.2)	SORT1 (2.1)	ENSG00000226645 (2.0)	ALDH2 (1.9)	GCNT4 (1.7)	ANKRD31 (1.5)	SYPL2 (1.3)
GO:0033555	multicellular organismal response to stress	1.00	> 0.20	RPH3A (2.8)	ENSG00000235545 (2.7)	C12orf47 (2.3)	ENSG00000226648 (2.0)	DNAH11 (1.9)	AMIGO1 (1.7)	ALDH2 (1.5)	C12orf51 (1.5)	KIAA1324 (1.4)	TMEM50A (1.3)
MP:0008911	induced hyperactivity	1.00	> 0.20	NCAN (3.7)	ENSG00000226645 (2.0)	HAPLN4 (1.6)	UBXN2B (1.6)	PARP10 (1.6)	KIAA1324 (1.4)	APOA5 (1.4)	APOE (1.3)	PSRC1 (1.3)	TMEM116 (1.2)
GO:0019212	phosphatase inhibitor activity	1.00	> 0.20	TMEM50A (1.9)	SORT1 (1.6)	ERP29 (1.4)	NYNRIN (1.2)	BUD13 (1.1)	USP1 (1.1)	TM6SF2 (1.1)	NAA25 (1.1)	TMEM116 (1.0)	PSRC1 (1.0)
GO:0007194	negative regulation of adenylate cyclase activity	1.00	> 0.20	C12orf47 (3.0)	RPH3A (2.3)	CELSR2 (1.9)	CETP (1.6)	NCAN (1.5)	ENSG00000226645 (1.5)	LPAR2 (1.4)	ABO (1.3)	TSSK6 (1.0)	DNAH11 (1.0)
GO:0031280	negative regulation of cyclase activity	1.00	> 0.20	C12orf47 (3.0)	RPH3A (2.3)	CELSR2 (1.9)	CETP (1.6)	NCAN (1.5)	ENSG00000226645 (1.5)	LPAR2 (1.4)	ABO (1.3)	TSSK6 (1.0)	DNAH11 (1.0)
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS	1.00	> 0.20	KIAA1324 (2.3)	NKPD1 (2.0)	HLX (2.0)	LPIN3 (1.9)	CYB561D1 (1.8)	ACAD10 (1.8)	ABO (1.7)	AP1M2 (1.7)	YIPF2 (1.7)	PLEKHH2 (1.6)
GO:0046873	metal ion transmembrane transporter activity	1.00	> 0.20	HAPLN4 (3.8)	RPH3A (3.6)	NCAN (2.8)	SORT1 (2.7)	CYB561D1 (2.2)	TMEM116 (2.1)	CELSR2 (2.0)	AMIGO1 (2.0)	TM6SF2 (1.6)	ZHX3 (1.5)
GO:0030424	axon	1.00	> 0.20	RPH3A (4.8)	HAPLN4 (3.3)	CELSR2 (2.4)	C11orf9 (1.8)	NCAN (1.8)	AMIGO1 (1.6)	C12orf51 (1.6)	APOE (1.4)	ABO (1.3)	SORT1 (1.3)
MP:0000781	decreased corpus callosum size	1.00	> 0.20	NCAN (5.3)	CELSR2 (2.7)	PTPN11 (1.8)	ATXN2 (1.8)	DYNC2LI1 (1.7)	FADS1 (1.7)	C12orf51 (1.6)	RPH3A (1.5)	CETP (1.3)	C12orf47 (1.3)
MP:0002757	decreased vertical activity	1.00	> 0.20	CELSR2 (2.5)	C12orf47 (2.5)	C12orf51 (2.2)	RPH3A (1.9)	GRINA (1.5)	COL4A3BP (1.3)	APOC1 (1.3)	BCAM (1.2)	ERP29 (1.2)	CLPTM1 (1.1)
MP:0002561	abnormal circadian phase	1.00	> 0.20	RPH3A (2.0)	PMFBP1 (1.8)	BUD13 (1.5)	HLX (1.5)	ZHX3 (1.5)	UBXN2B (1.2)	ATXN2 (1.2)	ENSG00000235545 (1.2)	C12orf47 (1.1)	HNF1A (1.1)
GO:0031290	retinal ganglion cell axon guidance	1.00	> 0.20	LPAR2 (2.6)	PBX4 (2.2)	NKPD1 (2.0)	C12orf47 (1.9)	ACAD10 (1.7)	TMEM116 (1.7)	AMIGO1 (1.7)	ANKRD31 (1.6)	YIPF2 (1.4)	C19orf52 (1.3)
ENSG00000115514	TXNDC9 PPI subnetwork	1.00	> 0.20	NCAN (1.9)	ACAD10 (1.6)	DYNC2LI1 (1.2)	PSRC1 (1.2)	SMARCA4 (1.2)	ENSG00000254235 (1.2)	C12orf51 (1.1)	SH2B3 (1.0)	APOE (1.0)	TMEM57 (1.0)
ENSG00000106089	STX1A PPI subnetwork	1.00	> 0.20	RPH3A (4.1)	HAPLN4 (3.9)	KIAA1324 (2.9)	SARS (2.3)	SORT1 (2.2)	C12orf51 (2.1)	BLOC1S3 (1.8)	PTPN11 (1.8)	AMIGO1 (1.7)	CELSR2 (1.7)
GO:0030594	neurotransmitter receptor activity	1.00	> 0.20	C12orf47 (2.3)	RPH3A (2.2)	ABO (1.9)	SYPL2 (1.7)	AMIGO1 (1.4)	PMFBP1 (1.4)	NKPD1 (1.3)	ENSG00000226645 (1.3)	CELSR2 (1.3)	CILP2 (1.3)
GO:0051350	negative regulation of lyase activity	1.00	> 0.20	C12orf47 (3.0)	RPH3A (2.3)	CELSR2 (2.0)	ENSG00000226645 (1.7)	CETP (1.6)	NCAN (1.5)	LPAR2 (1.4)	ABO (1.3)	TSSK6 (1.1)	C12orf51 (0.9)
GO:0007270	neuron-neuron synaptic transmission	1.00	> 0.20	RPH3A (3.8)	DNAH11 (2.4)	HAPLN4 (2.3)	ABO (2.0)	CELSR2 (1.4)	TSSK6 (1.4)	C12orf43 (1.3)	NCAN (1.3)	C12orf47 (1.1)	SORT1 (1.1)
GO:0043508	negative regulation of JUN kinase activity	1.00	> 0.20	YIPF2 (2.1)	MAU2 (1.8)	POLK (1.5)	CILP2 (1.4)	TRAPPC6A (1.3)	FRK (1.3)	ADAM1 (1.3)	UBXN2B (1.3)	TXNL4B (1.3)	NT5DC1 (1.2)
ENSG00000139190	VAMP1 PPI subnetwork	1.00	> 0.20	TMEM50A (3.8)	PLCG1 (1.9)	C1orf63 (1.7)	NPC1L1 (1.4)	SORT1 (1.3)	PVR (1.3)	ENSG00000226648 (1.3)	RPH3A (1.2)	BRAP (1.2)	C12orf47 (1.2)
MP:0005587	abnormal Meckel's cartilage morphology	1.00	> 0.20	CILP2 (3.2)	MAFB (1.5)	CEACAM19 (1.4)	CARM1 (1.3)	PPP1R37 (1.1)	HAPLN4 (1.1)	LPIN3 (1.1)	NYNRIN (1.0)	MYLIP (0.9)	ALDH2 (0.8)
GO:0051925	regulation of calcium ion transport via voltage-gated calcium channel activity	1.00	> 0.20	SYPL2 (2.6)	C12orf47 (2.4)	TSSK6 (1.9)	RPH3A (1.9)	PLEKHH2 (1.9)	AMIGO1 (1.6)	KIAA1324 (1.5)	NCAN (1.3)	CILP2 (1.3)	PVR (1.2)
GO:0060004	reflex	1.00	> 0.20	HAVCR1 (2.5)	HAPLN4 (2.4)	TRAPPC6A (1.5)	DNAH11 (1.4)	TSSK6 (1.3)	CILP2 (1.0)	ZNF259 (1.0)	PLEKHH2 (0.9)	C12orf47 (0.9)	UBXN2B (0.9)
GO:0050804	regulation of synaptic transmission	1.00	> 0.20	RPH3A (4.2)	NCAN (3.4)	HAPLN4 (3.0)	CELSR2 (2.0)	AMIGO1 (1.5)	MARK4 (1.5)	ENSG00000226648 (1.5)	C12orf43 (1.4)	GRINA (1.3)	ABO (1.2)
ENSG00000158445	KCNB1 PPI subnetwork	1.00	> 0.20	RPH3A (2.1)	PLEKHH2 (1.9)	C12orf47 (1.7)	HAVCR1 (1.6)	KIAA1324 (1.5)	FRK (1.3)	CELSR2 (1.2)	LPAR2 (1.1)	C12orf51 (1.1)	ITGB3 (1.0)
GO:0005272	sodium channel activity	1.00	> 0.20	RPH3A (4.4)	BCAM (2.5)	ENSG00000226645 (2.1)	AMIGO1 (2.1)	GCNT4 (1.9)	PMFBP1 (1.9)	AP1M2 (1.8)	ANKRD31 (1.7)	HAPLN4 (1.7)	SORT1 (1.5)
GO:0002209	behavioral defense response	1.00	> 0.20	ENSG00000235545 (4.5)	C12orf47 (2.6)	DNAH11 (1.8)	NCAN (1.5)	RPH3A (1.5)	GCNT4 (1.5)	ENSG00000226648 (1.1)	C19orf52 (1.0)	C1orf63 (1.0)	TMEM50A (0.9)
GO:0034220	ion transmembrane transport	1.00	> 0.20	TMEM116 (2.7)	CYB561D1 (2.0)	AMIGO1 (2.0)	AP1M2 (1.8)	SORT1 (1.7)	ENSG00000226648 (1.6)	KIAA1324 (1.6)	C12orf51 (1.5)	CLPTM1 (1.5)	SYPL2 (1.4)
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE__POSTSYNAPTIC_CELL	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE__POSTSYNAPTIC_CELL	1.00	> 0.20	RPH3A (2.8)	NCAN (2.5)	SORT1 (1.6)	HAVCR1 (1.4)	C12orf43 (1.3)	CLPTM1 (1.2)	ABO (1.2)	CELSR2 (1.2)	ZHX3 (0.9)	CYB561D1 (0.9)
GO:0015077	monovalent inorganic cation transmembrane transporter activity	1.00	> 0.20	HAPLN4 (3.4)	SORT1 (3.3)	TMEM116 (3.0)	RPH3A (2.9)	OGDH (2.0)	CYB561D1 (2.0)	NCAN (2.0)	CELSR2 (1.9)	SYPL2 (1.7)	AMIGO1 (1.7)
GO:0050974	detection of mechanical stimulus involved in sensory perception	1.00	> 0.20	AMIGO1 (2.4)	PLEKHH2 (2.0)	NCAN (1.6)	ANKRD31 (1.4)	POLK (1.3)	CILP2 (1.2)	CEACAM19 (1.1)	APOE (1.0)	ATXN7L2 (1.0)	ST3GAL4 (0.9)
GO:0007212	dopamine receptor signaling pathway	1.00	> 0.20	ENSG00000226648 (1.7)	ENSG00000226645 (1.4)	C12orf47 (1.3)	ZNF180 (1.2)	KIAA1324 (1.0)	MARK4 (1.0)	RPH3A (0.9)	C11orf9 (0.9)	TSSK6 (0.8)	CELSR2 (0.8)
GO:0097060	synaptic membrane	1.00	> 0.20	RPH3A (4.2)	NCAN (3.2)	CELSR2 (2.5)	PPP1R37 (1.8)	AMIGO1 (1.8)	ANKRD31 (1.3)	HAPLN4 (1.1)	MARK4 (1.1)	MYLIP (1.0)	SORT1 (0.9)
GO:0030199	collagen fibril organization	1.00	> 0.20	CILP2 (6.7)	CEACAM19 (1.5)	PLEKHH2 (1.4)	ATXN7L2 (1.4)	ENSG00000238078 (1.2)	FRK (1.1)	C19orf52 (1.1)	YIPF2 (0.9)	AP1M2 (0.9)	CYB561D1 (0.8)
GO:0035176	social behavior	1.00	> 0.20	ZHX3 (2.4)	TSSK6 (1.9)	C12orf47 (1.8)	GEMIN7 (1.7)	GOT2P1 (1.7)	AMIGO1 (1.7)	NKPD1 (1.5)	NCAN (1.4)	RPH3A (1.4)	ERP29 (1.2)
MP:0001469	abnormal contextual conditioning behavior	1.00	> 0.20	NCAN (5.2)	RPH3A (1.8)	CELSR2 (1.5)	ZHX3 (1.5)	PBX4 (1.5)	ENSG00000254235 (1.3)	PTPN11 (1.2)	MARK4 (1.2)	CYP7A1 (1.1)	UBXN2B (1.1)
GO:0044456	synapse part	1.00	> 0.20	RPH3A (4.6)	NCAN (2.6)	CELSR2 (2.6)	HAPLN4 (2.5)	AMIGO1 (2.0)	SORT1 (1.7)	PPP1R37 (1.3)	KIAA1324 (1.3)	C12orf51 (1.3)	ANKRD31 (1.1)
MP:0005403	abnormal nerve conduction	1.00	> 0.20	RPH3A (4.2)	DOCK7 (2.8)	ENSG00000226645 (2.3)	SARS (2.2)	HAPLN4 (2.0)	SORT1 (1.9)	TSSK6 (1.8)	TMEM116 (1.6)	SH2B3 (1.1)	ST3GAL4 (1.1)
GO:0051932	synaptic transmission, GABAergic	1.00	> 0.20	ENSG00000226648 (3.4)	RPH3A (2.3)	C17orf57 (1.9)	CELSR2 (1.5)	MARK4 (1.5)	NCAN (1.4)	UBXN2B (1.4)	ERP29 (1.3)	TXNL4B (1.3)	ADAM1 (1.0)
MP:0003063	increased coping response	1.00	> 0.20	APOE (2.7)	NCAN (1.9)	RPH3A (1.8)	GRINA (1.6)	ZNF101 (1.6)	SYPL2 (1.5)	FADS1 (1.3)	CILP2 (1.3)	C1orf63 (1.2)	PLEKHH2 (1.2)
GO:0034706	sodium channel complex	1.00	> 0.20	RPH3A (3.4)	SORT1 (2.7)	BCAM (2.4)	AP1M2 (2.2)	KIAA1324 (1.9)	ENSG00000226645 (1.6)	GOT2P1 (1.5)	NKPD1 (1.4)	AMIGO1 (1.3)	GCNT4 (1.3)
GO:0021952	central nervous system projection neuron axonogenesis	1.00	> 0.20	PBX4 (2.5)	NCAN (2.4)	CILP2 (1.9)	CELSR2 (1.9)	TMEM116 (1.8)	NKPD1 (1.7)	NYNRIN (1.6)	LPAR2 (1.4)	PMFBP1 (1.2)	AMIGO1 (1.0)
MP:0002272	abnormal nervous system electrophysiology	1.00	> 0.20	RPH3A (5.9)	HAPLN4 (4.9)	SORT1 (2.5)	NCAN (2.0)	HLX (1.7)	AMIGO1 (1.6)	CELSR2 (1.5)	C12orf47 (1.3)	PMFBP1 (1.3)	APOE (1.2)
GO:0015672	monovalent inorganic cation transport	1.00	> 0.20	HAPLN4 (3.3)	TMEM116 (3.1)	RPH3A (2.9)	AMIGO1 (2.6)	SORT1 (2.5)	CYB561D1 (2.2)	GOT2P1 (1.8)	HAVCR1 (1.5)	PPP1R37 (1.5)	KIAA1324 (1.4)
GO:0030425	dendrite	1.00	> 0.20	RPH3A (3.6)	NCAN (3.4)	CELSR2 (2.7)	MARK4 (1.9)	AMIGO1 (1.6)	PPP1R37 (1.4)	PLCG1 (1.4)	SORT1 (1.3)	C12orf51 (1.3)	GRINA (1.1)
ENSG00000179036	ENSG00000179036 PPI subnetwork	1.00	> 0.20	TMEM50A (3.2)	HAPLN4 (2.9)	SARS (2.4)	SORT1 (2.0)	C1orf63 (1.8)	CYB561D1 (1.7)	YIPF2 (1.7)	AP1M2 (1.5)	RPH3A (1.5)	PSMA5 (1.4)
REACTOME_NEURONAL_SYSTEM	REACTOME_NEURONAL_SYSTEM	1.00	> 0.20	RPH3A (4.1)	HAPLN4 (3.3)	NCAN (2.7)	SORT1 (2.0)	AMIGO1 (1.6)	CELSR2 (1.5)	ABO (1.4)	HAVCR1 (1.3)	ZHX3 (1.2)	C12orf43 (1.0)
REACTOME_POTASSIUM_CHANNELS	REACTOME_POTASSIUM_CHANNELS	1.00	> 0.20	RPH3A (4.2)	HAPLN4 (3.2)	NCAN (1.9)	AMIGO1 (1.8)	CELSR2 (1.6)	CYB561D1 (1.6)	SORT1 (1.4)	KIAA1324 (1.4)	PPP1R37 (1.3)	ABO (1.2)
GO:0021955	central nervous system neuron axonogenesis	1.00	> 0.20	NCAN (2.0)	PBX4 (2.0)	TMEM116 (1.9)	CILP2 (1.9)	PMFBP1 (1.7)	CELSR2 (1.5)	NKPD1 (1.4)	ATXN2 (1.3)	TXNL4B (1.2)	ACAD10 (1.2)
GO:0032228	regulation of synaptic transmission, GABAergic	1.00	> 0.20	ENSG00000226648 (3.7)	C17orf57 (2.2)	RPH3A (2.1)	CELSR2 (1.8)	NCAN (1.8)	MARK4 (1.7)	TXNL4B (1.4)	ERP29 (1.3)	KIAA1324 (1.3)	UBXN2B (1.3)
MP:0009748	abnormal behavioral response to addictive substance	1.00	> 0.20	C12orf47 (2.9)	PLEKHH2 (2.0)	COL4A3BP (1.7)	PCSK9 (1.7)	C19orf52 (1.7)	C17orf57 (1.3)	TSSK6 (1.1)	ATXN7L2 (1.1)	ENSG00000235545 (1.0)	DHODH (1.0)
GO:0071805	potassium ion transmembrane transport	1.00	> 0.20	AMIGO1 (2.6)	CYB561D1 (2.1)	HAPLN4 (2.1)	HAVCR1 (1.9)	NCAN (1.8)	ZHX3 (1.6)	UBXN2B (1.6)	ABO (1.4)	SORT1 (1.4)	GOT2P1 (1.3)
GO:0071804	cellular potassium ion transport	1.00	> 0.20	AMIGO1 (2.6)	CYB561D1 (2.1)	HAPLN4 (2.1)	HAVCR1 (1.9)	NCAN (1.8)	ZHX3 (1.6)	UBXN2B (1.6)	ABO (1.4)	SORT1 (1.4)	GOT2P1 (1.3)
GO:0031646	positive regulation of neurological system process	1.00	> 0.20	ENSG00000226648 (3.3)	ENSG00000235545 (2.5)	NCAN (1.8)	C17orf57 (1.8)	RPH3A (1.7)	PMFBP1 (1.6)	KIAA1324 (1.6)	GEMIN7 (1.5)	C12orf43 (1.4)	ENSG00000254235 (1.2)
GO:0045202	synapse	1.00	> 0.20	RPH3A (4.6)	NCAN (2.8)	CELSR2 (2.5)	AMIGO1 (2.3)	HAPLN4 (2.2)	SORT1 (1.6)	PPP1R37 (1.5)	C12orf51 (1.3)	ABO (1.3)	MARK4 (1.0)
GO:0005249	voltage-gated potassium channel activity	1.00	> 0.20	RPH3A (4.4)	HAPLN4 (3.5)	CYB561D1 (2.8)	CELSR2 (2.5)	KIAA1324 (2.1)	SORT1 (2.1)	PPP1R37 (1.4)	HAVCR1 (1.3)	NCAN (1.3)	ZHX3 (1.2)
MP:0002906	increased susceptibility to pharmacologically induced seizures	1.00	> 0.20	RPH3A (3.9)	NCAN (3.7)	HAPLN4 (2.4)	CELSR2 (2.3)	C12orf47 (1.6)	AMIGO1 (1.6)	KIAA1324 (1.5)	SORT1 (1.4)	PMFBP1 (1.2)	ATXN7L2 (1.1)
GO:0006813	potassium ion transport	1.00	> 0.20	HAPLN4 (3.5)	RPH3A (3.4)	CYB561D1 (2.8)	AMIGO1 (2.3)	SORT1 (1.8)	HAVCR1 (1.8)	ZHX3 (1.5)	PPP1R37 (1.5)	ENSG00000226648 (1.4)	KIAA1324 (1.4)
GO:0051971	positive regulation of transmission of nerve impulse	1.00	> 0.20	ENSG00000226648 (3.6)	ENSG00000235545 (2.4)	C17orf57 (1.9)	RPH3A (1.9)	NCAN (1.9)	PMFBP1 (1.7)	KIAA1324 (1.6)	ENSG00000254235 (1.3)	GEMIN7 (1.3)	HAPLN4 (1.2)
GO:0034702	ion channel complex	1.00	> 0.20	RPH3A (3.4)	SORT1 (2.6)	KIAA1324 (2.5)	HAPLN4 (2.4)	CYB561D1 (1.8)	SYPL2 (1.6)	AMIGO1 (1.6)	GOT2P1 (1.3)	BCAM (1.3)	CELSR2 (1.2)
GO:0015267	channel activity	1.00	> 0.20	RPH3A (4.4)	NCAN (2.3)	SORT1 (2.2)	HAPLN4 (2.1)	AMIGO1 (1.8)	C11orf9 (1.4)	KIAA1324 (1.4)	SYPL2 (1.3)	PPP1R37 (1.2)	CYB561D1 (1.2)
GO:0022803	passive transmembrane transporter activity	1.00	> 0.20	RPH3A (4.4)	NCAN (2.3)	SORT1 (2.2)	HAPLN4 (2.1)	AMIGO1 (1.8)	C11orf9 (1.4)	KIAA1324 (1.4)	SYPL2 (1.3)	PPP1R37 (1.2)	CYB561D1 (1.2)
GO:0005267	potassium channel activity	1.00	> 0.20	RPH3A (3.9)	HAPLN4 (3.4)	CYB561D1 (2.9)	SORT1 (2.4)	CELSR2 (2.3)	AMIGO1 (1.9)	KIAA1324 (1.7)	NCAN (1.6)	HAVCR1 (1.4)	ZHX3 (1.4)
GO:0008076	voltage-gated potassium channel complex	1.00	> 0.20	HAPLN4 (3.0)	RPH3A (2.9)	CYB561D1 (2.9)	CELSR2 (2.5)	SORT1 (2.3)	KIAA1324 (2.1)	HAVCR1 (1.6)	NCAN (1.2)	AMIGO1 (1.1)	PPP1R37 (1.0)
GO:0034705	potassium channel complex	1.00	> 0.20	HAPLN4 (3.0)	RPH3A (2.9)	CYB561D1 (2.9)	CELSR2 (2.5)	SORT1 (2.3)	KIAA1324 (2.1)	HAVCR1 (1.6)	NCAN (1.2)	AMIGO1 (1.1)	PPP1R37 (1.0)
GO:0022838	substrate-specific channel activity	1.00	> 0.20	RPH3A (4.4)	NCAN (2.4)	SORT1 (2.3)	HAPLN4 (2.2)	AMIGO1 (1.8)	KIAA1324 (1.4)	SYPL2 (1.3)	C11orf9 (1.2)	CYB561D1 (1.2)	PPP1R37 (1.2)
GO:0005216	ion channel activity	1.00	> 0.20	RPH3A (4.5)	HAPLN4 (2.3)	NCAN (2.3)	SORT1 (2.2)	AMIGO1 (1.8)	KIAA1324 (1.5)	SYPL2 (1.3)	PPP1R37 (1.3)	C11orf9 (1.3)	CYB561D1 (1.2)
GO:0005261	cation channel activity	1.00	> 0.20	RPH3A (4.2)	HAPLN4 (2.4)	AMIGO1 (2.2)	SORT1 (2.1)	CYB561D1 (2.0)	KIAA1324 (1.7)	NCAN (1.5)	PPP1R37 (1.3)	SYPL2 (1.3)	ABO (1.1)
GO:0034703	cation channel complex	1.00	> 0.20	RPH3A (3.6)	HAPLN4 (2.9)	KIAA1324 (2.7)	CYB561D1 (2.3)	SORT1 (2.1)	AMIGO1 (1.5)	CELSR2 (1.5)	GCNT4 (1.3)	ENSG00000226645 (1.3)	AP1M2 (1.1)
GO:0050806	positive regulation of synaptic transmission	1.00	> 0.20	ENSG00000226648 (4.7)	RPH3A (2.2)	NCAN (2.2)	ENSG00000235545 (1.8)	C17orf57 (1.7)	PMFBP1 (1.7)	KIAA1324 (1.5)	GEMIN7 (1.3)	HAPLN4 (1.1)	C12orf43 (1.0)
GO:0015079	potassium ion transmembrane transporter activity	1.00	> 0.20	RPH3A (4.1)	HAPLN4 (3.7)	CYB561D1 (2.7)	SORT1 (2.4)	CELSR2 (2.2)	AMIGO1 (2.1)	NCAN (2.1)	ZHX3 (1.8)	HAVCR1 (1.5)	KIAA1324 (1.4)
GO:0022843	voltage-gated cation channel activity	1.00	> 0.20	RPH3A (5.0)	HAPLN4 (3.2)	KIAA1324 (2.3)	CYB561D1 (2.2)	NCAN (1.8)	SORT1 (1.8)	AMIGO1 (1.7)	CELSR2 (1.7)	PPP1R37 (1.4)	SYPL2 (1.3)
MP:0001454	abnormal cued conditioning behavior	1.00	> 0.20	NCAN (3.0)	PBX4 (2.3)	CELSR2 (2.1)	ADAM1 (1.8)	ZHX3 (1.7)	CILP2 (1.4)	PLCG1 (1.3)	MARK4 (1.2)	SH2B3 (1.2)	PLEKHH2 (1.1)
GO:0005244	voltage-gated ion channel activity	1.00	> 0.20	RPH3A (5.2)	HAPLN4 (3.2)	AMIGO1 (2.0)	CYB561D1 (1.9)	NCAN (1.9)	SORT1 (1.7)	KIAA1324 (1.6)	PPP1R37 (1.4)	CELSR2 (1.4)	SYPL2 (1.4)
GO:0022832	voltage-gated channel activity	1.00	> 0.20	RPH3A (5.2)	HAPLN4 (3.2)	AMIGO1 (2.0)	CYB561D1 (1.9)	NCAN (1.9)	SORT1 (1.7)	KIAA1324 (1.6)	PPP1R37 (1.4)	CELSR2 (1.4)	SYPL2 (1.4)
GO:0022836	gated channel activity	1.00	> 0.20	RPH3A (4.1)	HAPLN4 (2.7)	NCAN (2.0)	SORT1 (1.9)	KIAA1324 (1.8)	AMIGO1 (1.7)	SYPL2 (1.3)	CYB561D1 (1.3)	C11orf9 (1.2)	ZHX3 (1.1)
